PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bocedi, A; Fabrini, R; Lo Bello, M; Caccuri, AM; Federici, G; Mannervik, B; Cornish-Bowden, A; Ricci, G				Bocedi, Alessio; Fabrini, Raffaele; Lo Bello, Mario; Caccuri, Anna Maria; Federici, Giorgio; Mannervik, Bengt; Cornish-Bowden, Athel; Ricci, Giorgio			Evolution of Negative Cooperativity in Glutathione Transferase Enabled Preservation of Enzyme Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; DIGLUTATHIONYL-IRON COMPLEX; OF-THE-SITES; S-TRANSFERASE; ESCHERICHIA-COLI; NITRIC-OXIDE; DIMER INTERFACE; PHYSIOLOGICAL SIGNIFICANCE; POSITIVE COOPERATIVITY; PLASMODIUM-FALCIPARUM	Negative cooperativity in enzyme reactions, in which the first event makes subsequent events less favorable, is sometimes well understood at the molecular level, but its physiological role has often been obscure. Negative cooperativity occurs in human glutathione transferase (GST) GSTP1-1 when it binds and neutralizes a toxic nitric oxide adduct, the dinitrosyl-diglutathionyl iron complex (DNDGIC). However, the generality of this behavior across the divergent GST family and its evolutionary significance were unclear. To investigate, we studied 16 different GSTs, revealing that negative cooperativity is present only in more recently evolved GSTs, indicating evolutionary drift in this direction. In some variants, Hill coefficients were close to 0.5, the highest degree of negative cooperativity commonly observed (although smaller values of n(H) are theoretically possible). As DNDGIC is also a strong inhibitor of GSTs, we suggest negative cooperativity might have evolved to maintain a residual conjugating activity of GST against toxins even in the presence of high DNDGIC concentrations. Interestingly, two human isoenzymes that play a special protective role, safeguarding DNA from DNDGIC, display a classical half-of-the-sites interaction. Analysis of GST structures identified elements that could play a role in negative cooperativity in GSTs. Beside the well known lock-and-key and clasp motifs, other alternative structural interactions between subunits may be proposed for a few GSTs. Taken together, our findings suggest the evolution of self-preservation of enzyme function as a novel facility emerging from negative cooperativity.	[Bocedi, Alessio; Fabrini, Raffaele; Federici, Giorgio; Ricci, Giorgio] Univ Roma Tor Vergata, Dept Chem Sci & Technol, Via Ric Sci 1, I-00133 Rome, Italy; [Lo Bello, Mario] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Caccuri, Anna Maria] Univ Roma Tor Vergata, Dept Expt Med & Surg, I-00133 Rome, Italy; [Mannervik, Bengt] Stockholm Univ, Dept Neurochem, SE-10691 Stockholm, Sweden; [Cornish-Bowden, Athel] Aix Marseille Univ, CNRS, Bioenerget & Ingn Prot, Inst Microbiol Mediterranee, F-13009 Marseille, France	University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; Stockholm University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Ricci, G (corresponding author), Univ Roma Tor Vergata, Dept Chem Sci & Technol, Via Ric Sci 1, I-00133 Rome, Italy.	riccig@uniroma2.it	Cornish-Bowden, Athel/G-7362-2019; CACCURI, ANNA MARIA/AFU-2643-2022	Cornish-Bowden, Athel/0000-0001-6670-3006; 	grant "Consolidate the Foundations," University of Rome "Tor Vergata" [E82F16000810005]; Swedish Research Council	grant "Consolidate the Foundations," University of Rome "Tor Vergata"; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported in part by the grant "Consolidate the Foundations," University of Rome "Tor Vergata" (E82F16000810005) and by a grant from the Swedish Research Council. The authors declare that they have no conflicts of interest with the contents of this article.	Abeliovich H, 2005, BIOPHYS J, V89, P76, DOI 10.1529/biophysj.105.060194; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Bocedi A, 2013, J BIOL CHEM, V288, P24936, DOI 10.1074/jbc.M113.476135; Boese M, 1997, J BIOL CHEM, V272, P21767, DOI 10.1074/jbc.272.35.21767; Caccuri AM, 1999, J BIOL CHEM, V274, P19276, DOI 10.1074/jbc.274.27.19276; Cesareo E, 2005, J BIOL CHEM, V280, P42172, DOI 10.1074/jbc.M507916200; CONWAY A, 1968, BIOCHEMISTRY-US, V7, P4011, DOI 10.1021/bi00851a031; Cornish-Bowden A, 2014, FEBS J, V281, P621, DOI 10.1111/febs.12469; Cornish-Bowden A, 2013, J THEOR BIOL, V319, P144, DOI 10.1016/j.jtbi.2012.12.010; CORNISHBOWDEN A, 1975, J THEOR BIOL, V51, P233, DOI 10.1016/0022-5193(75)90149-6; DANIELSON UH, 1985, BIOCHEM J, V231, P263, DOI 10.1042/bj2310263; De Maria F, 2003, J BIOL CHEM, V278, P42283, DOI 10.1074/jbc.M305568200; Eaton DL, 1999, TOXICOL SCI, V49, P156, DOI 10.1093/toxsci/49.2.156; EVANS CT, 1980, BIOCHEMISTRY-US, V19, P5809, DOI 10.1021/bi00566a023; Fabrini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014125; Gite SU, 1996, BIOCHEMISTRY-US, V35, P2658, DOI 10.1021/bi952640y; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hayeshi R, 2007, FOOD CHEM TOXICOL, V45, P286, DOI 10.1016/j.fct.2006.07.027; Hegazy UM, 2004, J BIOL CHEM, V279, P9586, DOI 10.1074/jbc.M312320200; Hegazy UM, 2013, J MOL BIOL, V425, P1509, DOI 10.1016/j.jmb.2013.01.038; HERZFELD J, 1981, BIOCHEMISTRY-US, V20, P4936, DOI 10.1021/bi00520a020; Hornby JAT, 2002, BIOCHEMISTRY-US, V41, P14238, DOI 10.1021/bi020548d; JAKOBSON I, 1979, J BIOL CHEM, V254, P7085; Koshland DE, 1996, CURR OPIN STRUC BIOL, V6, P757, DOI 10.1016/S0959-440X(96)80004-2; Labrou NE, 2000, EUR J BIOCHEM, V267, P6657, DOI 10.1046/j.1432-1327.2000.01761.x; Labrou NE, 2001, EUR J BIOCHEM, V268, P3950, DOI 10.1046/j.1432-1327.2001.02307.x; Laidler K. J., 1999, PHYS CHEM, P169; Larsson E, 2011, ANAL BIOCHEM, V412, P96, DOI 10.1016/j.ab.2011.01.024; Lee P, 1999, BIOCHEMISTRY-US, V38, P5754, DOI 10.1021/bi982779j; Liebau E, 2005, J BIOL CHEM, V280, P26121, DOI 10.1074/jbc.M503889200; Liebau E, 2009, J BIOL CHEM, V284, P22133, DOI 10.1074/jbc.M109.015198; Lien S, 2001, J BIOL CHEM, V276, P35599, DOI 10.1074/jbc.M103789200; Lo Bello M, 1998, J MOL BIOL, V284, P1717; Lo Bello M, 2001, J BIOL CHEM, V276, P42138; LOBELLO M, 1995, J BIOL CHEM, V270, P1249; Lobysheva II, 1999, FEBS LETT, V454, P177, DOI 10.1016/S0014-5793(99)00777-2; Magnet S, 2001, BIOCHEMISTRY-US, V40, P3700, DOI 10.1021/bi002736e; MANNERVIK B, 1982, J BIOL CHEM, V257, P9909; MOCK WL, 1995, BIOORG MED CHEM LETT, V5, P627, DOI 10.1016/0960-894X(95)00085-8; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Paumi CM, 2004, BIOCHEMISTRY-US, V43, P2345, DOI 10.1021/bi035936+; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Protasevich II, 2004, BIOCHEMISTRY-US, V43, P13380, DOI 10.1021/bi0492509; REILLY RT, 1995, MOL PHARMACOL, V48, P72; REINEMER P, 1992, J MOL BIOL, V227, P214, DOI 10.1016/0022-2836(92)90692-D; RICCI G, 1995, J BIOL CHEM, V270, P1243, DOI 10.1074/jbc.270.3.1243; Ricci G, 2003, BIOCHEM J, V376, P71, DOI 10.1042/BJ20030860; RICCI G, 1989, J BIOL CHEM, V264, P5462; Rinaldi R, 2002, DRUG METAB DISPOS, V30, P1053, DOI 10.1124/dmd.30.10.1053; Rowe JD, 1997, BIOCHEM J, V325, P481, DOI 10.1042/bj3250481; Sayed Y, 2000, FEBS LETT, V465, P169, DOI 10.1016/S0014-5793(99)01747-0; Stella L, 2007, J BIOL CHEM, V282, P6372, DOI 10.1074/jbc.M609906200; Stenberg G, 2000, BIOCHEM BIOPH RES CO, V271, P59, DOI 10.1006/bbrc.2000.2579; TAHIR MK, 1986, J BIOL CHEM, V261, P1048; Taylor J.R., 1997, INTRO ERROR ANAL THE, V2nd ed., P45; TOMICH JM, 1981, BIOCHEMISTRY-US, V20, P6711, DOI 10.1021/bi00526a029; Vararattanavech A, 2003, PROTEIN PEPTIDE LETT, V10, P441, DOI 10.2174/0929866033478654; Vasilieva SV, 2004, BIOCHEMISTRY-MOSCOW+, V69, P883, DOI 10.1023/B:BIRY.0000040220.13586.45; Wongsantichon J, 2006, BIOCHEM J, V394, P135, DOI 10.1042/BJ20050915; Xiao B, 1999, BIOCHEMISTRY-US, V38, P11887, DOI 10.1021/bi990468i	60	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26739	26749		10.1074/jbc.M116.749507	http://dx.doi.org/10.1074/jbc.M116.749507			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27815499	hybrid, Green Published			2022-12-26	WOS:000391571400013
J	Men, XC; Shibata, Y; Takeshita, T; Yamashita, Y				Men, Xiaochen; Shibata, Yukie; Takeshita, Toru; Yamashita, Yoshihisa			Identification of Anion Channels Responsible for Fluoride Resistance in Oral Streptococci	PLOS ONE			English	Article							MUTANS; TRANSFORMATION	Recently, it has been reported that eriC and crcB are involved in bacterial fluoride resistance. However, the fluoride-resistance mechanism in oral streptococci remains unclear. BLAST studies showed that two types of eriCs (eriC1 and eriC2) and two types of crcBs (crcB1 and crcB2) are present across 18 oral streptococci, which were identified in >= 10% of 166 orally healthy subjects with >= 0.01% of the mean relative abundance. They were divided into three groups based on the distribution of these four genes: group I, only eriC1; group II, eriC1 and eriC2; and group III, eriC2, crcB1, and crcB2. Group I consisted of Streptococcus mutans, in which one of the two eriC1s predominantly affected fluoride resistance. Group II consisted of eight species, and eriC1 was responsible for fluoride resistance, but eriC2 was not, in Streptococcus anginosus as a representative species. Group III consisted of nine species, and both crcB1 and crcB2 were crucial for fluoride resistance, but eriC2 was not, in Streptococcus sanguinis as a representative species. Based on these results, either EriC1 or CrcBs play a role in fluoride resistance in oral streptococci. Complementation between S. mutans EriC1 and S. sanguinis CrcB1/CrcB2 was confirmed in both S. mutans and S. sanguinis. However, neither transfer of S. sanguinis CrcB1/CrcB2 into wild-type S. mutans nor S. mutans EriC1 into wild-type S. sanguinis increased the fluoride resistance of the wild-type strain. Co-existence of different F-channels (EriC and CrcB) did not cause the additive effect on fluoride resistance in oral Streptococcus species.	[Men, Xiaochen; Shibata, Yukie; Takeshita, Toru; Yamashita, Yoshihisa] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Sect Prevent & Publ Hlth Dent, Fukuoka, Japan	Kyushu University	Yamashita, Y (corresponding author), Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Sect Prevent & Publ Hlth Dent, Fukuoka, Japan.	yoshi@dent.kyushu-u.ac.jp	Takeshita, Toru/AAT-2321-2021		Ministry of Education, Culture, Sports, Science and Technology of Japan [25463251, 25293428]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Grants-in Aid for Scientific Research 25463251 (YS) and 25293428 (YY) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; S. sanguinis SK36 was kindly provided by M. Kilian, Department of Biomedicine, Aarhus University, Aarhus, Denmark and S. Kawabata, Department of Oral and Molecular Microbiology, Osaka University Graduate School of Dentistry, Osaka, Japan. S. anginosus NCTC 10707 was kindly provided by A. Yoshida, Department of Oral Microbiology, Matsumoto Dental University, Shiojiri, Japan. This study was supported in part by Grants-in Aid for Scientific Research 25463251 (YS) and 25293428 (YY) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Baker JL, 2012, SCIENCE, V335, P233, DOI 10.1126/science.1215063; BROWN LR, 1983, J DENT RES, V62, P746, DOI 10.1177/00220345830620061201; BUNICK FJ, 1981, INFECT IMMUN, V34, P856, DOI 10.1128/IAI.34.3.856-863.1981; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hoelscher GL, 1996, CURR MICROBIOL, V32, P156, DOI 10.1007/s002849900028; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Kawada-Matsuo M, 2009, ORAL MICROBIOL IMMUN, V24, P173, DOI 10.1111/j.1399-302X.2008.00485.x; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; Li D, 2012, APPL ENVIRON MICROB, V80, P97, DOI [10.1073/pnas.1210896109, DOI 10.1073/PNAS.1210896109]; Li SS, 2013, P NATL ACAD SCI USA, V110, P19018, DOI 10.1073/pnas.1310439110; Liao Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122630; Maduke M, 1999, J GEN PHYSIOL, V114, P713, DOI 10.1085/jgp.114.5.713; MALTZ M, 1982, J DENT RES, V61, P786, DOI 10.1177/00220345820610062701; Marquis RE, 2003, FEMS MICROBIOL REV, V26, P493, DOI 10.1111/j.1574-6976.2003.tb00627.x; MAYHEW RR, 1981, J DENT RES, V60, P1809, DOI 10.1177/00220345810600101301; Moritani K, 2015, ORAL DIS, V21, P748, DOI 10.1111/odi.12341; Murata T, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw101; PERRY D, 1983, INFECT IMMUN, V41, P722, DOI 10.1128/IAI.41.2.722-727.1983; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; Sambrook J, 2001, MOL LAB MANUAL; Silver S, 1996, GENE, V179, P9, DOI 10.1016/S0378-1119(96)00323-X; Stockbridge RB, 2012, P NATL ACAD SCI USA, V109, P15289, DOI 10.1073/pnas.1210896109; STRECKFUSS JL, 1980, J DENT RES, V59, P151, DOI 10.1177/00220345800590021501; Takeshita T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08136; VANLOVEREN C, 1991, J DENT RES, V70, P1491, DOI 10.1177/00220345910700120401; VANLOVEREN C, 1991, ORAL MICROBIOL IMMUN, V6, P288	27	17	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165900	10.1371/journal.pone.0165900	http://dx.doi.org/10.1371/journal.pone.0165900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824896	gold, Green Published, Green Submitted			2022-12-26	WOS:000387615200042
J	Keesman, M; Aarts, H; Vermeent, S; Hafner, M; Papies, EK				Keesman, Mike; Aarts, Henk; Vermeent, Stefan; Haefner, Michael; Papies, Esther K.			Consumption Simulations Induce Salivation to Food Cues	PLOS ONE			English	Article							APPETITE; GHRELIN; HUNGER; EXPOSURE; BEHAVIOR; HUMANS; DEPRIVATION; PERCEPTION; REACTIVITY; RESPONSES	Salivation to food cues is typically explained in terms of mere stimulus-response links. However, food cues seem to especially increase salivation when food is attractive, suggesting a more complex psychological process. Adopting a grounded cognition perspective, we suggest that perceiving a food triggers simulations of consuming it, especially when attractive. These simulations then induce salivation, which effectively prepares the body for eating the food. In two experiments, we systematically examined the role of simulations on salivation to food cues. As stimuli, both experiments used an attractive, a neutral, and a sour food, as well as a non-food control object. In Experiment 1, participants were instructed to simulate eating every object they would be exposed to. We then exposed them to each object separately. Salivation was assessed by having participants spit their saliva into a cup after one minute of exposure. In Experiment 2, we instructed half of participants to simulate eating each object, and half to merely look at them, while measuring salivation as in Experiment 1. Afterwards, participants rated their simulations and desire to eat for each object separately. As predicted, foods increased salivation compared to the non-food control object, especially when they were attractive or sour (Exp. 1 and 2). Importantly, attractive and sour foods especially increased salivation when instructed to simulate (Exp. 2). These findings suggest that consumption simulations play an important role in inducing salivary responses to food cues. We discuss directions for future research as well as the role of simulations for other appetitive processes.	[Keesman, Mike; Aarts, Henk; Vermeent, Stefan] Univ Utrecht, Dept Psychol, Utrecht, Netherlands; [Haefner, Michael] Berlin Univ Arts, Commun Psychol, Berlin, Germany; [Papies, Esther K.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	Utrecht University; University of Glasgow	Keesman, M (corresponding author), Univ Utrecht, Dept Psychol, Utrecht, Netherlands.	m.keesman@uu.nl	Vermeent, Stefan/GRS-4234-2022	Vermeent, Stefan/0000-0002-9595-5373; Papies, Esther K./0000-0002-8460-675X				Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 2009, PHILOS T R SOC B, V364, P1281, DOI 10.1098/rstb.2008.0319; BARSALOU LW, 2002, REPRESENTATION MEMOR, P1; BERRIDGE KC, 1991, APPETITE, V16, P103, DOI 10.1016/0195-6663(91)90036-R; Chen J, CORE EATING IN PRESS; CHRISTENSEN CM, 1984, APPETITE, V5, P307, DOI 10.1016/S0195-6663(84)80003-3; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Crum AJ, 2011, HEALTH PSYCHOL, V30, P424, DOI 10.1037/a0023467; de Almeida Patricia Del Vigna, 2008, J Contemp Dent Pract, V9, P72; Finch G, 1938, AM J PHYSIOL, V123, P379, DOI 10.1152/ajplegacy.1938.123.2.379; Frank S, 2010, BRAIN RES, V1350, P159, DOI 10.1016/j.brainres.2010.04.030; Hardman CA, 2014, APPETITE, V76, P153, DOI [10.1016/j.appet2014.02.005, 10.1016/j.appet.2014.02.005]; Herman C. P., 1980, OBESITY; Hesslow G, 2002, TRENDS COGN SCI, V6, P242, DOI 10.1016/S1364-6613(02)01913-7; Hofmann W, 2012, J PERS SOC PSYCHOL, V102, P1318, DOI 10.1037/a0026545; Holland RW, 2005, PSYCHOL SCI, V16, P689, DOI 10.1111/j.1467-9280.2005.01597.x; Holyoak K.J., 1994, ADV CON NEUR COMP TH, P113; Inui A, 2004, FASEB J, V18, P439, DOI 10.1096/fj.03-0641rev; Jansen A, 1998, BEHAV RES THER, V36, P257, DOI 10.1016/S0005-7967(98)00055-2; Jansen A, 2010, PSYCHOTHER PSYCHOSOM, V79, P257, DOI 10.1159/000315131; Kaplan Mitchell, 1993, Dysphagia, V8, P225, DOI 10.1007/BF01354542; KLAJNER F, 1981, PHYSIOL BEHAV, V27, P195, DOI 10.1016/0031-9384(81)90256-0; LEGOFF DB, 1988, APPETITE, V11, P15, DOI 10.1016/S0195-6663(88)80018-7; Lindquist KA, 2012, TRENDS COGN SCI, V16, P533, DOI 10.1016/j.tics.2012.09.005; Marteau TM, 2012, SCIENCE, V337, P1492, DOI 10.1126/science.1226918; Myrick H, 2004, NEUROPSYCHOPHARMACOL, V29, P393, DOI 10.1038/sj.npp.1300295; Naumann E, 2013, APPETITE, V65, P103, DOI 10.1016/j.appet.2013.01.021; Nederkoorn C, 2000, APPETITE, V35, P45, DOI 10.1006/appe.2000.0328; Nederkoorn C, 1999, APPETITE, V33, P361, DOI 10.1006/appe.1999.0268; Nederkoorn Chantal, 2002, Eat Behav, V3, P61, DOI 10.1016/S1471-0153(01)00045-9; Neyraud E, 2012, ARCH ORAL BIOL, V57, P556, DOI 10.1016/j.archoralbio.2011.09.016; Papies EK, 2014, INT J OBESITY, V38, P597, DOI 10.1038/ijo.2013.136; Papies E.K., 2015, PSYCHOL DESIRE; Papies EK, 2016, HLTH PSYCHOL REV, P1; Papies EK, 2015, J PERS SOC PSYCHOL, V108, P148, DOI 10.1037/a0038032; Papies EK, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00838; Buzalaf MAR, 2012, J APPL ORAL SCI, V20, P493, DOI 10.1590/S1678-77572012000500001; Rad Maryam, 2010, J Dent Res Dent Clin Dent Prospects, V4, P110, DOI 10.5681/joddd.2010.028; ROGERS PJ, 1989, ADDICT BEHAV, V14, P387, DOI 10.1016/0306-4603(89)90026-9; Sanchez-Perez L, 2015, INT J PAEDIAT DENT; Schmid DA, 2005, NEUROPSYCHOPHARMACOL, V30, P1187, DOI 10.1038/sj.npp.1300670; Seibt B, 2007, EUR J SOC PSYCHOL, V37, P359, DOI 10.1002/ejsp.365; Smith E.R., 1998, HDB SOCIAL PSYCHOL, P391; Spence C, 2011, J TEXTURE STUD, V42, P157, DOI 10.1111/j.1745-4603.2011.00299.x; Tang DW, 2012, PHYSIOL BEHAV, V106, P317, DOI 10.1016/j.physbeh.2012.03.009; Tiggemann M, 2005, APPETITE, V45, P305, DOI 10.1016/j.appet.2005.06.004; Tolkien JRR, 2001, NY TIMES; Trudgill NJ, 1998, SCAND J GASTROENTERO, V33, P568; Van Gucht D, 2008, APPETITE, V50, P19, DOI 10.1016/j.appet.2007.05.003; WATANABE S, 1988, ARCH ORAL BIOL, V33, P1, DOI 10.1016/0003-9969(88)90089-1; WHITE KD, 1978, PSYCHOPHYSIOLOGY, V15, P196, DOI 10.1111/j.1469-8986.1978.tb01363.x; WOOLEY OW, 1981, APPETITE, V2, P331, DOI 10.1016/S0195-6663(81)80019-0; WOOLEY OW, 1975, J COMP PHYSIOL PSYCH, V89, P619, DOI 10.1037/h0077455; WOOLEY SC, 1973, PSYCHOSOM MED, V35, P136, DOI 10.1097/00006842-197303000-00006; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992	55	38	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165449	10.1371/journal.pone.0165449	http://dx.doi.org/10.1371/journal.pone.0165449			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB8BB	27820842	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000387614800009
J	Bai, GN; Korfage, IJ; Hafkamp-de Groen, E; Jaddoe, VWV; Mautner, E; Raat, H				Bai, Guannan; Korfage, Ida J.; Hafkamp-de Groen, Esther; Jaddoe, Vincent W. V.; Mautner, Eva; Raat, Hein			Associations between Nausea, Vomiting, Fatigue and Health-Related Quality of Life of Women in Early Pregnancy: The Generation R Study	PLOS ONE			English	Article							PERCEIVED STRESS; SOCIAL SUPPORT; VALIDATION; QUESTIONNAIRE; ADAPTATION; BURDEN	The objective of this study was to evaluate the independent associations between nausea, vomiting, fatigue and health-related quality of life of women in early pregnancy in the Generation R study, which is a prospective mother and child cohort. Analyses were based on 5079 women in early pregnancy in the Rotterdam area, the Netherlands. The information on nausea, vomiting and fatigue in the previous three months was measured in the questionnaire at enrollment, as well as potential confounders (i.e., maternal/gestational age, ethnic background, educational level, parity, marital status, body mass index, tobacco and alcohol use, chronic/infectious conditions, uro-genital conditions/symptoms, sleep quality, headache, anxiety, and depression). Health-related quality of life was assessed by the 12-item Short Form Health Survey and physical and mental component summary scores were calculated. Multivariate regression models were performed to evaluate the independent associations of the presence of nausea, vomiting and fatigue with health-related quality of life, adjusting for potential confounders. 33.6% of women experienced daily presence of nausea, 9.6% for vomiting and 44.4% for fatigue. Comparing with women who never reported nausea, vomiting and fatigue, women with daily presence of at least one of these symptoms had significantly lower scores of physical component summary and mental component summary, after adjusting for potential confounders. Our study shows how common nausea, vomiting and fatigue are among women in early pregnancy and how much each of these symptoms negatively impact on health-related quality of life. We call for awareness of this issue from health care professionals, pregnant women and their families.	[Bai, Guannan; Korfage, Ida J.; Hafkamp-de Groen, Esther; Raat, Hein] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Bai, Guannan; Jaddoe, Vincent W. V.] Univ Med Ctr Rotterdam, Generat R Grp, Erasmus MC, Rotterdam, Netherlands; [Jaddoe, Vincent W. V.] Univ Med Ctr Rotterdam, Dept Epidemiol, Erasmus MC, Rotterdam, Netherlands; [Mautner, Eva] Med Univ Graz, Dept Obstet & Gynaecol, Graz, Austria	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Medical University of Graz	Raat, H (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	h.raat@erasmusmc.nl			China Scholarship Council(CSC) in Erasmus MC, Rotterdam, the Netherlands; CSC [201406010271]	China Scholarship Council(CSC) in Erasmus MC, Rotterdam, the Netherlands; CSC	GB is supported by China Scholarship Council(CSC) PhD Fellowship for her PhD study in Erasmus MC, Rotterdam, the Netherlands. The scholarship file number is 201406010271, CSC URL: [http://www.csc.edu.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFONSO DD, 1990, BIRTH-ISS PERINAT C, V17, P121, DOI 10.1111/j.1523-536X.1990.tb00716.x; [Anonymous], 2015, OBSTET GYNECOL, V126, pe12, DOI [10.1097/AOG.0000000000001048, DOI 10.1097/AOG.0000000000001048]; Attard CL, 2002, AM J OBSTET GYNECOL, V186, pS220, DOI 10.1067/mob.2002.122605; Canavarro MC, 2009, INT J BEHAV MED, V16, P116, DOI 10.1007/s12529-008-9024-2; Chou FH, 2008, INT J NURS STUD, V45, P1185, DOI 10.1016/j.ijnurstu.2007.08.004; Chou FH, 2006, J MIDWIFERY WOM HEAL, V51, P370, DOI 10.1016/j.jmwh.2006.04.009; Chou FH, 2008, KAOHSIUNG J MED SCI, V24, P306, DOI 10.1016/S1607-551X(08)70157-8; Chou FH, 2003, J NURS SCHOLARSHIP, V35, P119, DOI 10.1111/j.1547-5069.2003.00119.x; Davis M, 2004, J PERINAT NEONAT NUR, V18, P312, DOI 10.1097/00005237-200410000-00002; Fairbrother N, 2008, PSYCHOL ASSESSMENT, V20, P150, DOI 10.1037/1040-3590.20.2.150; GADSBY R, 1993, BRIT J GEN PRACT, V43, P245; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Heitmann K, 2016, SCAND J PRIM HEALTH, V34, P13, DOI 10.3109/02813432.2015.1132894; Hofman A, 2004, PAEDIATR PERINAT EP, V18, P61, DOI 10.1111/j.1365-3016.2003.00521.x; Houben-van Herten M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125083; Hueston WJ, 1998, J FAM PRACTICE, V47, P209; Isbir GG, 2013, ASIAN NURS RES, V7, P175, DOI 10.1016/j.anr.2013.09.006; Jaddoe VWV, 2006, EUR J EPIDEMIOL, V21, P475, DOI 10.1007/s10654-006-9022-0; Jaddoe VWV, 2012, EUR J EPIDEMIOL, V27, P739, DOI 10.1007/s10654-012-9735-1; Jaddoe VWV, 2008, EUR J EPIDEMIOL, V23, P801, DOI 10.1007/s10654-008-9309-4; Koren G, 2002, AM J OBSTET GYNECOL, V186, pS228, DOI 10.1067/mob.2002.123054; Kosinski M, 1995, SF 12 SCORE SF 12 PH; Kugahara Tomoko, 2006, Nurs Health Sci, V8, P179, DOI 10.1111/j.1442-2018.2006.00279.x; Lacasse A, 2008, BJOG-INT J OBSTET GY, V115, P1484, DOI 10.1111/j.1471-0528.2008.01891.x; Lacasse A, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-32; Lee NM, 2011, GASTROENTEROL CLIN N, V40, P309, DOI 10.1016/j.gtc.2011.03.009; Liu MC, 2014, BIOL RES NURS, V16, P378, DOI 10.1177/1099800413506036; Matthews A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007575.pub4; Miller F, 2002, AM J OBSTET GYNECOL, V186, pS182, DOI 10.1067/mob.2002.122594; Mols F, 2009, QUAL LIFE RES, V18, P403, DOI 10.1007/s11136-009-9455-5; Munch S, 2011, J PERINATOL, V31, P10, DOI 10.1038/jp.2010.54; Nazik E, 2014, J CLIN NURS, V23, P1736, DOI 10.1111/jocn.12323; NERI A, 1995, BRIT J OBSTET GYNAEC, V102, P671, DOI 10.1111/j.1471-0528.1995.tb11412.x; OBRIEN B, 1992, BIRTH-ISS PERINAT C, V19, P138, DOI 10.1111/j.1523-536X.1992.tb00671.x; Otchet F, 1999, OBSTET GYNECOL, V94, P935, DOI 10.1016/S0029-7844(99)00439-1; PUGH LC, 1995, APPL NURS RES, V8, P140, DOI 10.1016/S0897-1897(95)80593-1; Smith C, 2000, AUST NZ J OBSTET GYN, V40, P397, DOI 10.1111/j.1479-828X.2000.tb01167.x; Statistics Netherlands, 2004, MIGR NETH 2004; Statistics Netherlands, 2008, 2006 SOI STAT NETH; Swallow B L, 2005, J Obstet Gynaecol, V25, P544, DOI 10.1080/01443610500230783; VANLIER D, 1993, BIRTH-ISS PERINAT C, V20, P193; VELLACOTT ID, 1988, INT J GYNECOL OBSTET, V27, P57, DOI 10.1016/0020-7292(88)90088-4; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Westert GP, 2005, EUR J PUBLIC HEALTH, V15, P59, DOI 10.1093/eurpub/cki116; World Medical Association, 2009, J INDIAN MED ASSOC, V107, P403	47	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166133	10.1371/journal.pone.0166133	http://dx.doi.org/10.1371/journal.pone.0166133			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8TH	27814390	Green Published, Green Submitted, gold			2022-12-26	WOS:000386911100034
J	Rojas-Hernandez, N; Veliz, D; Riveros, MP; Fuentes, JP; Pardo, LM				Rojas-Hernandez, Noemi; Veliz, David; Riveros, Marcela P.; Fuentes, Juan P.; Pardo, Luis M.			Highly Connected Populations and Temporal Stability in Allelic Frequencies of a Harvested Crab from the Southern Pacific Coast	PLOS ONE			English	Article							CHAOTIC GENETIC PATCHINESS; REPRODUCTIVE OUTPUT; LARVAL DISPERSAL; KIN AGGREGATION; EFFECTIVE SIZE; LIFE-HISTORY; N-E; RECRUITMENT; DIVERSITY; MIGRATION	For marine invertebrates with a benthic adult form and a planktonic larva phase, the connectivity among populations is mainly based on larval dispersal. While an extended larval phase will promote gene flow, other factors such as an intensive fishery and geographical barriers could lead to changes in genetic variability. In this study, the population genetic structure of the commercial crab Metacarcinus edwardsii was analyzed along 700 km of the Chilean coast. The analysis, based on eight microsatellite loci genotyped from megalopae and adult crabs, considered temporal and spatial patterns of genetic variation. The results showed no evidence of spatial patterns in genetic structure, suggesting high connectivity among the sampling sites. The temporal analysis showed no evidence of changes in allele frequencies and no evidence of a recent bottleneck. The lack of spatial structure and allele variation over time could be explained by the interaction of factors such as i) low reproductive variance due to the capability of females to store sperm in the seminal receptacle, which can be used for successive broods, ii) high larval dispersal and iii) high individual reproductive output. Using our data as priors, a genetic modelling approach coincided, predicting this temporal and spatial stability. The same analysis showed that a reduction in population size leads to the loss of genetic variability in populations, as well as of the genetic cohesiveness between populations, pointing out the importance management for species under exploitation, such as M. edwardsii.	[Rojas-Hernandez, Noemi; Veliz, David] Univ Chile, Dept Ciencias Ecol, IEB,Fac Ciencias, Nucleo Milenio Ecol & Manejo Sustentable ESMOI, Santiago, Chile; [Riveros, Marcela P.; Fuentes, Juan P.; Pardo, Luis M.] Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile; [Pardo, Luis M.] Ctr Invest Dinam Ecosistemas Marinos Altas Latitu, Valdivia, Chile	Universidad de Chile; Universidad Austral de Chile	Veliz, D (corresponding author), Univ Chile, Dept Ciencias Ecol, IEB,Fac Ciencias, Nucleo Milenio Ecol & Manejo Sustentable ESMOI, Santiago, Chile.	dveliz@uchile.cl	Pardo, L M/A-3178-2008; Véliz, David/J-4205-2013	Pardo, L M/0000-0003-2005-4922; Véliz, David/0000-0002-5768-9887; Pardo, Luis Miguel/0000-0002-8179-5057	Milenio grant [P05-002, NC120030]; Conicyt Basal grant [PFB 023]; Fondecyt [1110445, 1150388]; FONDAP-IDEAL [15150003]; IEB	Milenio grant; Conicyt Basal grant; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDAP-IDEAL; IEB	This work was supported by: Milenio grant P05-002, NC120030, Conicyt Basal grant PFB 023 (DV). Fondecyt grant 1110445, 1150388, FONDAP-IDEAL 15150003 (LMP). IEB Master Thesis (NRH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Balloux F, 2001, J HERED, V92, P301, DOI 10.1093/jhered/92.3.301; Barcia AR, 2005, MOL ECOL, V14, P2933, DOI 10.1111/j.1365-294X.2005.02613.x; Barshis DJ, 2011, MAR ECOL PROG SER, V439, P139, DOI 10.3354/meps09339; Bartilotti C, 2014, MAR ECOL PROG SER, V507, P233, DOI 10.3354/meps10817; Beebee TJC, 2009, MOL ECOL, V18, P4790, DOI 10.1111/j.1365-294X.2009.04398.x; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Belkhir K, 2002, MOL ECOL NOTES, V2, P611, DOI 10.1046/j.1471-8286.2002.00273.x; Belkhir K., 2004, GENETIX 4 05 LOGICIE; Broquet T, 2013, EVOLUTION, V67, P1660, DOI 10.1111/j.1558-5646.2012.01826.x; Camus PA, 2001, REV CHIL HIST NAT, V74, P587, DOI 10.4067/S0716-078X2001000300008; Cardenas L, 2009, J BIOGEOGR, V36, P969, DOI 10.1111/j.1365-2699.2008.02056.x; Colson I, 2004, MOL ECOL, V13, P2223, DOI 10.1111/j.1365-294X.2004.02245.x; Cornuet JM, 1996, GENETICS, V144, P2001; Cowen RK, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.26; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Domingues CP, 2011, HEREDITY, V106, P832, DOI 10.1038/hdy.2010.126; Duchesne P, 2012, J HERED, V103, P734, DOI 10.1093/jhered/ess038; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Farias M, 2010, SCIENCE, V329, P916, DOI 10.1126/science.1192094; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hauser L, 2002, P NATL ACAD SCI USA, V99, P11742, DOI 10.1073/pnas.172242899; Haye PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088613; HINES AH, 1991, CAN J FISH AQUAT SCI, V48, P267, DOI 10.1139/f91-037; Iacchei M, 2013, MOL ECOL, V22, P3476, DOI 10.1111/mec.12341; JARA F, 1994, B MAR SCI, V55, P295; JOHNSON MS, 1984, EVOLUTION, V38, P1371, DOI 10.1111/j.1558-5646.1984.tb05658.x; JOHNSON MS, 1982, MAR BIOL, V70, P157, DOI 10.1007/BF00397680; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; KORDOS LM, 1993, MAR BIOL, V117, P227, DOI 10.1007/BF00345667; Kyle CJ, 2000, MAR BIOL, V137, P835, DOI 10.1007/s002270000412; Laughlin KM, 2012, ECOL EVOL, V2, P1584, DOI 10.1002/ece3.283; Lee HJE, 2009, MOL ECOL, V18, P2165, DOI 10.1111/j.1365-294X.2009.04169.x; LEFEVRE J, 1992, TRENDS ECOL EVOL, V7, P288, DOI 10.1016/0169-5347(92)90223-X; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Pardo LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115525; Pardo LM, 2012, HELGOLAND MAR RES, V66, P253, DOI 10.1007/s10152-011-0267-y; Pardo LM, 2012, LAT AM J AQUAT RES, V40, P142, DOI 10.3856/vol40-issue1-fulltext-14; Pardo LM, 2009, J MAR BIOL ASSOC UK, V89, P1627, DOI 10.1017/S0025315409000010; Pardo LM, 2009, J MAR BIOL ASSOC UK, V89, P481, DOI 10.1017/S0025315409003233; Morgan Steven G., 1995, P279; Morgan SG, 2010, MAR ECOL PROG SER, V404, P109, DOI 10.3354/meps08476; Natunewicz CC, 2001, MAR ECOL PROG SER, V212, P217, DOI 10.3354/meps212217; Nunney L, 2002, AM NAT, V160, P195, DOI 10.1086/341017; Nunziata SO, 2015, CONSERV GENET, V16, P1335, DOI 10.1007/s10592-015-0743-z; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Pardo LM, 2016, BEHAV ECOL SOCIOBIOL, V70, P73, DOI 10.1007/s00265-015-2026-6; Pardo LM, 2010, J EXP MAR BIOL ECOL, V393, P100, DOI 10.1016/j.jembe.2010.07.008; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pineda J, 2009, POPUL ECOL, V51, P17, DOI 10.1007/s10144-008-0118-0; Poulsen NA, 2006, MOL ECOL, V15, P321, DOI 10.1111/j.1365-294X.2005.02777.x; Pritchard JK, 2000, GENETICS, V155, P945; Puebla O, 2008, CAN J FISH AQUAT SCI, V65, P425, DOI 10.1139/F07-163; Queiroga H, 2007, PROG OCEANOGR, V74, P174, DOI 10.1016/j.pocean.2007.04.007; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Quintana R., 1983, REP USA MAR BIOL I K, V5, P1; Rojas-Hernandez N, 2014, MAR BIOL RES, V10, P839, DOI 10.1080/17451000.2013.863350; ROUGHGARDEN J, 1988, SCIENCE, V241, P1460, DOI 10.1126/science.11538249; Selkoe KA, 2006, ECOLOGY, V87, P3082, DOI 10.1890/0012-9658(2006)87[3082:CSAKAE]2.0.CO;2; SERNAPESCA, 2011, SERNAPESCA SER 2001; Shanks AL, 2003, ECOL APPL, V13, pS159; Shanks AL, 2009, MAR ECOL PROG SER, V385, P189, DOI 10.3354/meps08043; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; SMITH PJ, 1991, FISH RES, V10, P309, DOI 10.1016/0165-7836(91)90082-Q; St-Onge P, 2015, OECOLOGIA, V178, P733, DOI 10.1007/s00442-015-3245-2; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Teske PR, 2007, MAR BIOL, V152, P697, DOI 10.1007/s00227-007-0724-y; Therkildsen NO, 2010, CAN J FISH AQUAT SCI, V67, P1585, DOI 10.1139/F10-084; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Duong TY, 2013, MOL ECOL, V22, P1282, DOI 10.1111/mec.12167; Treml EA, 2012, INTEGR COMP BIOL, V52, P525, DOI 10.1093/icb/ics101; Ungfors A, 2009, ICES J MAR SCI, V66, P462, DOI 10.1093/icesjms/fsn223; Vadopalas B, 2012, J SHELLFISH RES, V31, P697, DOI 10.2983/035.031.0314; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Veliz D, 2006, MOL ECOL, V15, P4193, DOI 10.1111/j.1365-294X.2006.03078.x; Vinuesa JH, 1999, SCI MAR, V63, P321, DOI 10.3989/scimar.1999.63s1321; Waples RS, 2014, GENETICS, V197, P769, DOI 10.1534/genetics.114.164822; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; WAPLES RS, 1990, CONSERV BIOL, V4, P144, DOI 10.1111/j.1523-1739.1990.tb00103.x; Waters JM, 2004, MOL ECOL, V13, P2797, DOI 10.1111/j.1365-294X.2004.02282.x; Yannicelli B, 2012, PROG OCEANOGR, V92-95, P206, DOI 10.1016/j.pocean.2011.07.005	86	6	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166029	10.1371/journal.pone.0166029	http://dx.doi.org/10.1371/journal.pone.0166029			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814382	Green Published, Green Submitted, gold			2022-12-26	WOS:000386911100026
J	Rosychuk, RJ; Graham, MM; Holroyd, BR; Rowe, BH				Rosychuk, Rhonda J.; Graham, Michelle M.; Holroyd, Brian R.; Rowe, Brian H.			Volume Matters: Improved Outcomes for Patients Presenting to High-Volume Emergency Departments with Atrial Flutter and Fibrillation	PLOS ONE			English	Article							HEART-FAILURE; GUIDELINES; MORTALITY; ICD-9-CM	Objectives Clinical familiarity plays a role in health outcomes; the relationship between emergency department (ED) volume and outcomes for atrial fibrillation and flutter (AFF) are not clear. We compared ED presentation outcomes for AFF between high (HV) and low volume (LV) EDs in Alberta, Canada. Methods 45,372 AFF presentations for patients aged >= 35 years from all 104 EDs in Alberta during 1999 to 2011 using administrative health databases formed a retrospective cohort. EDs were grouped by annual AFF volume: 11 high (>100 presentations) or 93 low (<= 100 presentations). Outcomes included hospital admission rate, return to ED for AFF within 30 and 90 days, and death within 30 and 90 days. Analyses included statistical tests and mixed effects modeling. Results Mean age at ED presentation was 69.8 years (52% male). HV ED presentations were associated with lower admissions (adjusted odds ratio [aOR] = 0.68, 95% confidence interval [CI] 0.64, 0.72; p-value [p]<0.001), ED returns at 90 (aOR = 0.81, 95% CI 0.73, 0.90; p<0.001) days, and a higher likelihood of specialist visits at 30 (aOR = 1.81, 95% CI 1.68, 1.94; p<0.001) and 90 (aOR = 1.82, 95% CI 1.76, 2.03; p<0.001) days. For admitted patients, there were fewer returns to HV EDs at 30 (aOR = 0.37, 95% CI 0.15, 0.87; p = 4 0.02) and 90 (aOR = 0.48, 95% CI 0.26, 0.89; p = 0.02) days after hospital discharge. There was no difference in death between the two groups. Conclusions AFF patients presenting to HV EDs experienced fewer admissions and AFF ED revisit and higher specialist referrals compared to LV EDs.	[Rosychuk, Rhonda J.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Rosychuk, Rhonda J.] Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Graham, Michelle M.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Holroyd, Brian R.; Rowe, Brian H.] Univ Alberta, Dept Emergency Med, Edmonton, AB, Canada; [Holroyd, Brian R.; Rowe, Brian H.] Alberta Hlth Serv, Edmonton, AB, Canada; [Rowe, Brian H.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; Alberta Health Services (AHS); University of Alberta	Rosychuk, RJ (corresponding author), Univ Alberta, Dept Pediat, Edmonton, AB, Canada.; Rosychuk, RJ (corresponding author), Women & Childrens Hlth Res Inst, Edmonton, AB, Canada.	rhonda.rosychuk@ualberta.ca	Rosychuk, Rhonda J./AAG-8299-2019	Holroyd, Brian/0000-0001-8221-1327; Rosychuk, Rhonda J./0000-0001-8019-5466	Women & Children's Health Research Institute (Edmonton, Canada); Alberta Health (Edmonton, Canada); Alberta Innovates-Health Solutions (AI-HS, Edmonton, Canada); Canada Research Chair in Evidence-based Emergency Medicine from the Canadian Institutes of Health Research (CIHR, Ottawa, Canada)	Women & Children's Health Research Institute (Edmonton, Canada); Alberta Health (Edmonton, Canada); Alberta Innovates-Health Solutions (AI-HS, Edmonton, Canada); Canada Research Chair in Evidence-based Emergency Medicine from the Canadian Institutes of Health Research (CIHR, Ottawa, Canada)	This study was funded by an Innovation Grant from the Women & Children's Health Research Institute (www.wchri.org; Edmonton, Canada) and Alberta Health (www.health.alberta.ca; Edmonton, Canada). RJR was salary supported by Alberta Innovates-Health Solutions (AI-HS, http://www.aihealthsolutions.ca/; Edmonton, Canada) as a Health Scholar. BHR is supported by a Tier 1 Canada Research Chair in Evidence-based Emergency Medicine from the Canadian Institutes of Health Research (CIHR, www.cihr.ca; Ottawa, Canada). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberta Health and Wellness, 2004, AMB CAR ALB US AMB C; Brar S, 2013, CIRC-HEART FAIL, V6, P1147, DOI 10.1161/CIRCHEARTFAILURE.113.000415; Bullard MJ, 2008, CAN J EMERG MED, V10, P136; Canadian Institute for Health Information, 2015, NAT AMB CAR REP SYST; Canadian Institute for Health Information, 2001, CAN ENH ICD 10; Canadian Institute for Health Information, 2012, CAN CLASS HLTH INT C; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fuster V, 2011, CIRCULATION, V123, pE269, DOI 10.1161/CIR.0b013e318214876d; Gamble JM, 2011, CIRC-HEART FAIL, V4, P317, DOI 10.1161/CIRCHEARTFAILURE.110.959262; Heart and Stroke Foundation, 2016, HEART DIS ATR FIBR; Kocher KE, 2014, ANN EMERG MED, V64, P446, DOI 10.1016/j.annemergmed.2014.06.008; *PRACT MAN INF COR, 1989, INT CLASS DIS; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Ro YS, 2012, RESUSCITATION, V83, P855, DOI 10.1016/j.resuscitation.2012.02.002; Rogenstein C, 2012, ACAD EMERG MED, V19, P1255, DOI 10.1111/acem.12016; Ross JS, 2010, NEW ENGL J MED, V362, P1110, DOI 10.1056/NEJMsa0907130; Skanes AC, 2012, CAN J CARDIOL, V28, P125, DOI 10.1016/j.cjca.2012.01.021; Stiell IG, 2011, ANN EMERG MED, V57, P13, DOI 10.1016/j.annemergmed.2010.07.005; Tsai AC, 2006, HEALTH SERV RES, V41, P252, DOI 10.1111/j.1475-6773.2005.00461.x; van Diepen S, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001708; Wong MKY, 2015, CAN MED ASSOC J, V187, pE160, DOI 10.1503/cmaj.141294	21	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165894	10.1371/journal.pone.0165894	http://dx.doi.org/10.1371/journal.pone.0165894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814387	gold, Green Submitted, Green Published			2022-12-26	WOS:000386911100021
J	Vuillier, L; Bryce, D; Szucs, D; Whitebread, D				Vuillier, Laura; Bryce, Donna; Szucs, Denes; Whitebread, David			The Maturation of Interference Suppression and Response Inhibition: ERP Analysis of a Cued Go/Nogo Task	PLOS ONE			English	Article							LATENT-VARIABLE ANALYSIS; EVENT-RELATED POTENTIALS; COGNITIVE CONTROL; EXECUTIVE FUNCTION; STROOP TASK; PSYCHOPHYSIOLOGICAL ANALYSIS; NOGO TASK; CONFLICT; ACTIVATION; ATTENTION	Inhibitory control is a core function that allows us to resist interference from our surroundings and to stop an ongoing action. To date, it is not clear whether inhibitory control is a single process or whether it is composed of different processes. Further, whether these processes are separate or clustered in childhood is under debate. In this study, we investigated the existence and development of two hypothesized component processes of inhibitory control-interference suppression and response inhibition-using a single task and event related potential components. Twenty 8-year-old children and seventeen adults performed a spatially cued Go/Nogo task while their brain activity was recorded using electroencephalography. Mean N2 amplitudes confirmed the expected pattern for response inhibition with both the children and the adults showing more negative N2 for Nogo vs. Go trials. The interference suppression N2 effect was only present in adults and appeared as a more negative N2 in response to Go trials with a congruent cue than Go trials with an incongruent cue. Contrary to previous findings, there was no evidence that the interference suppression N2 effect was later occurring than the response inhibition N2 effect. Overall, response inhibition was present in both the children and the adults whereas interference suppression was only present in the adults. These results provide evidence of distinct maturational processes for both component processes of inhibitory control, with interference suppression probably continuing to develop into late childhood.	[Vuillier, Laura] Bournemouth Univ, Dept Psychol, Bournemouth, Dorset, England; [Bryce, Donna] Univ Tubingen, Dept Psychol, Tubingen, Germany; [Szucs, Denes] Univ Cambridge, Dept Psychol, Cambridge, England; [Whitebread, David] Univ Cambridge, Fac Educ, Cambridge, England	Bournemouth University; Eberhard Karls University of Tubingen; University of Cambridge; University of Cambridge	Vuillier, L (corresponding author), Bournemouth Univ, Dept Psychol, Bournemouth, Dorset, England.	lrenshawvuillier@bournemouth.ac.uk	Bryce, Donna/H-2031-2013	Bryce, Donna/0000-0001-8311-4457; Vuillier, Laura/0000-0002-1596-9303; Szucs, Denes/0000-0002-9477-0801	PhD scholarship from Faculty of Education at the University of Cambridge, UK	PhD scholarship from Faculty of Education at the University of Cambridge, UK	This study was supported by a PhD scholarship received by LV from the Faculty of Education at the University of Cambridge, UK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Band GPH, 2003, PSYCHOL RES-PSYCH FO, V67, P266, DOI 10.1007/s00426-002-0127-0; Bartholow BD, 2005, PSYCHOPHYSIOLOGY, V42, P33, DOI 10.1111/j.1469-8986.2005.00258.x; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Bryce D, 2011, NEUROIMAGE, V57, P671, DOI 10.1016/j.neuroimage.2010.12.006; Brydges CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069826; Brydges CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034482; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Bunge SA, 2007, CURR OPIN NEUROBIOL, V17, P243, DOI 10.1016/j.conb.2007.02.005; COLES MGH, 1989, PSYCHOPHYSIOLOGY, V26, P251, DOI 10.1111/j.1469-8986.1989.tb01916.x; CRAFT JL, 1970, J EXP PSYCHOL, V83, P415, DOI 10.1037/h0028843; DEJONG R, 1990, J EXP PSYCHOL HUMAN, V16, P164, DOI 10.1037/0096-1523.16.1.164; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; GRATTON G, 1988, J EXP PSYCHOL HUMAN, V14, P331, DOI 10.1037/0096-1523.14.3.331; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; JODO E, 1992, ELECTROEN CLIN NEURO, V82, P477, DOI 10.1016/0013-4694(92)90054-L; Johnstone SJ, 2005, J PSYCHOPHYSIOL, V19, P11, DOI 10.1027/0269-8803.19.1.11; Jongen EMM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-82; Kao CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013036; Karayanidis F, 1997, ELECTROEN CLIN NEURO, V103, P282, DOI 10.1016/S0013-4694(97)96077-6; Kobor A, DEV NEUROPSYCHOL; Kopp B, 1996, ELECTROEN CLIN NEURO, V99, P19, DOI 10.1016/0921-884X(96)95617-9; Kramer UM, 2011, J COGNITIVE NEUROSCI, V23, P2481, DOI 10.1162/jocn.2010.21573; Lamm C, 2006, NEUROPSYCHOLOGIA, V44, P2139, DOI 10.1016/j.neuropsychologia.2005.10.013; Logan Gordon D., 1994, P189; Martens U, 2010, J EXP PSYCHOL HUMAN, V36, P103, DOI 10.1037/a0017167; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; PFEFFERBAUM A, 1985, ELECTROEN CLIN NEURO, V60, P423, DOI 10.1016/0013-4694(85)91017-X; Randall WM, 2011, CLIN NEUROPHYSIOL, V122, P2400, DOI 10.1016/j.clinph.2011.05.012; SCHROGER E, 1993, BIOL PSYCHOL, V36, P183, DOI 10.1016/0301-0511(93)90017-3; Smith JL, 2007, CLIN NEUROPHYSIOL, V118, P343, DOI 10.1016/j.clinph.2006.09.027; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Szucs D, 2012, FUNCTIONAL DEFINITIO, DOI [10.1186/1471-2202-13-35, DOI 10.1186/1471-2202-13-35]; Szucs D, 2008, BRAIN RES, V1190, P143, DOI 10.1016/j.brainres.2007.11.010; Szucs D, 2007, NEUROPSYCHOLOGIA, V45, P3190, DOI 10.1016/j.neuropsychologia.2007.06.013; Szucs D, 2009, J COGNITIVE NEUROSCI, V21, P2195, DOI 10.1162/jocn.2009.21220; Szucs D, 2009, NEUROIMAGE, V47, P1960, DOI 10.1016/j.neuroimage.2009.05.048; Tillman CM, 2011, PSYCHOPHYSIOLOGY, V48, P1405, DOI 10.1111/j.1469-8986.2011.01203.x; Valle-Inclan F, 1998, PSYCHOPHYSIOLOGY, V35, P366, DOI 10.1017/S0048577298960917; van Boxtel GJM, 2001, BIOL PSYCHOL, V58, P229, DOI 10.1016/S0301-0511(01)00117-X; van Mourik R, 2005, J CHILD PSYCHOL PSYC, V46, P150, DOI 10.1111/j.1469-7610.2004.00345.x; Verbruggen F, 2004, ACTA PSYCHOL, V116, P21, DOI 10.1016/j.actpsy.2003.12.011; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006	50	27	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165697	10.1371/journal.pone.0165697	http://dx.doi.org/10.1371/journal.pone.0165697			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8TH	27814356	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000386911100016
J	Vogel, JP; Moore, JE; Timmings, C; Khan, S; Khan, DN; Defar, A; Hadush, A; Terefe, MM; Teshome, L; Ba-Thike, K; Than, KK; Makuwani, A; Mbaruku, G; Mrisho, M; Mugerwa, KY; Ritchie, LMP; Rashid, S; Straus, SE; Gulmezoglu, AM				Vogel, Joshua P.; Moore, Julia E.; Timmings, Caitlyn; Khan, Sobia; Khan, Dina N.; Defar, Atkure; Hadush, Azmach; Terefe, Marta Minwyelet; Teshome, Luwam; Ba-Thike, Katherine; Than, Kyu Kyu; Makuwani, Ahmad; Mbaruku, Godfrey; Mrisho, Mwifadhi; Mugerwa, Kidza Yvonne; Ritchie, Lisa M. Puchalski; Rashid, Shusmita; Straus, Sharon E.; Gulmezoglu, A. Metin			Barriers, Facilitators and Priorities for Implementation of WHO Maternal and Perinatal Health Guidelines in Four Lower-Income Countries: A GREAT Network Research Activity	PLOS ONE			English	Article								Background Health systems often fail to use evidence in clinical practice. In maternal and perinatal health, the majority of maternal, fetal and newborn mortality is preventable through implementing effective interventions. To meet this challenge, WHO's Department of Reproductive Health and Research partnered with the Knowledge Translation Program at St. Michael's Hospital (SMH), University of Toronto, Canada to establish a collaboration on knowledge translation (KT) in maternal and perinatal health, called the GREAT Network (Guideline-driven, Research priorities, Evidence synthesis, Application of evidence, and Transfer of knowledge). We applied a systematic approach incorporating evidence and theory to identifying barriers and facilitators to implementation of WHO maternal heath recommendations in four lower-income countries and to identifying implementation strategies to address these. Methods We conducted a mixed-methods study in Myanmar, Uganda, Tanzania and Ethiopia. In each country, stakeholder surveys, focus group discussions and prioritization exercises were used, involving multiple groups of health system stakeholders (including administrators, policymakers, NGOs, professional associations, frontline healthcare providers and researchers). Results Despite differences in guideline priorities and contexts, barriers identified across countries were often similar. Health system level factors, including health workforce shortages, and need for strengthened drug and equipment procurement, distribution and management systems, were consistently highlighted as limiting the capacity of providers to deliver high-quality care. Evidence-based health policies to support implementation, and improve the knowledge and skills of healthcare providers were also identified. Stakeholders identified a range of tailored strategies to address local barriers and leverage facilitators. Conclusion This approach to identifying barriers, facilitators and potential strategies for improving implementation proved feasible in these four lower-income country settings. Further evaluation of the impact of implementing these strategies is needed.	[Vogel, Joshua P.; Khan, Dina N.; Gulmezoglu, A. Metin] WHO, Dept Reprod Hlth & Res, UNDP UNFPA UNICEF WHO World Bank Special Programm, Geneva, Switzerland; [Moore, Julia E.; Timmings, Caitlyn; Khan, Sobia; Ritchie, Lisa M. Puchalski; Rashid, Shusmita; Straus, Sharon E.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Knowledge Translat Program, Toronto, ON, Canada; [Defar, Atkure] Ethiopian Publ Hlth Inst, Hlth Syst & Reprod Hlth Res Directorate, Addis Ababa, Ethiopia; [Hadush, Azmach; Teshome, Luwam] WHO Country Off, Addis Ababa, Ethiopia; [Terefe, Marta Minwyelet] Minist Hlth, Maternal & Child Hlth Directorate, Addis Ababa, Ethiopia; [Than, Kyu Kyu] Burnet Inst, Melbourne, Vic, Australia; [Than, Kyu Kyu] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Makuwani, Ahmad] Minist Hlth Community Dev Gender Elderly & Childr, Dar Es Salaam, Tanzania; [Mbaruku, Godfrey; Mrisho, Mwifadhi] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Mugerwa, Kidza Yvonne] Makerere Univ, Kampala, Uganda; [Ritchie, Lisa M. Puchalski] Univ Hlth Network, Dept Emergency Med, Toronto, ON, Canada	The World Bank; United Nations Population Fund; World Health Organization; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Burnet Institute; University of Melbourne; Ifakara Health Institute; Makerere University; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Vogel, JP (corresponding author), WHO, Dept Reprod Hlth & Res, UNDP UNFPA UNICEF WHO World Bank Special Programm, Geneva, Switzerland.	vogeljo@who.int	Vogel, Joshua/K-7649-2019; Ritchie, Lisa Puchalski/AAI-3717-2021	Vogel, Joshua/0000-0002-3214-7096; Ritchie, Lisa Puchalski/0000-0002-1791-5368	UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, WHO; St Michael's Hospital, Toronto, Canada; Canadian Institutes of Health Research [NC1-122929]; UN Commission on Life Saving Commodities for Women and Children (Uganda, Tanzania, Ethiopia); Alliance for Health Policy and Systems Research, World Health Organization (Myanmar); KT Canada Strategic Training Initiative in Health Research Fellowship	UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, WHO; St Michael's Hospital, Toronto, Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); UN Commission on Life Saving Commodities for Women and Children (Uganda, Tanzania, Ethiopia); Alliance for Health Policy and Systems Research, World Health Organization (Myanmar); KT Canada Strategic Training Initiative in Health Research Fellowship	Financial support for these activities was provided by UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, WHO (www.who.int/reproductivehealth); St Michael's Hospital, Toronto, Canada (www.stmichaelshospital.com/); Canadian Institutes of Health Research (grant number NC1-122929) (http://www.cihr-irsc.gc.ca/); the UN Commission on Life Saving Commodities for Women and Children (for activities in Uganda, Tanzania, Ethiopia) (http//www.lifesavingcommodities.org/); and the Alliance for Health Policy and Systems Research, World Health Organization (for activities in Myanmar) (http://www.who.int/alliance-hpsr/en/). LMPR was funded by a KT Canada Strategic Training Initiative in Health Research Fellowship Award in 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker R, 2014, COCHRANE DB SYST REV, V4; Bohren MA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-71; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; DAD, 2011, MAIL INTERNET SURVEY; Fervers B, 2006, INT J QUAL HEALTH C, V18, P167, DOI 10.1093/intqhc/mzi108; Fitch K., 2001, RAND UCLA APPROPRIAT; Graham ID, 2007, ACAD EMERG MED, V14, P936, DOI 10.1197/j.aem.2007.07.004; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Jagosh J, 2012, MILBANK Q, V90, P311, DOI 10.1111/j.1468-0009.2012.00665.x; Kennedy J, 2004, CAN MED ASSOC J, V171, P455, DOI 10.1503/cmaj.1040170; Kiesler DJ, 2006, PATIENT EDUC COUNS, V61, P319, DOI 10.1016/j.pec.2005.08.002; Lassi ZS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007754.pub3; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; O'Connor AM, 2007, MED DECIS MAKING, V27, P554, DOI 10.1177/0272989x07307319; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; Pimlott NJG, 2003, CAN MED ASSOC J, V168, P835; Saldana J, 2021, CODING MANUAL QUALIT; Shah BR, 2003, J POPUL THER CLIN PH, V11, pe239; Straus SE, 2013, BMJ BOOKS; Straus SE, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-108; Straus SE, 2009, CAN MED ASSOC J, V181, P165, DOI 10.1503/cmaj.081229; Tricco AC, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0370-1; Tuncalp O, 2015, BJOG; UNICEF World Health Organization, 2014, COUNTD 2015 FULF HLT; United Nations, 2014, MILL DEV GOALS REP 2; United Nations Population Division, 2018, WORLD POP PROSP; Wang ZC, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0440-4; WHO, 2014, WHO REC AUGM LAB; WHO, 2011, WHO REC IND LAB; WHO UNICEF, 2013, TRENDS MAT MORT 1990; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; Wooding S, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-47; World Health Organization, 2014, WHO HDB GUID DEV, V2nd; World Health Organization, 2012, OPTIMIZEMNH WHO REC; World Health Organization, 2011, WHO REC PREV TREATM; World Health Organization WHO, 2012, RECOMMENDATIONS PREV	39	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0160020	10.1371/journal.pone.0160020	http://dx.doi.org/10.1371/journal.pone.0160020			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6DJ	27806041	Green Published, gold, Green Submitted			2022-12-26	WOS:000386715500004
J	Calinescu, O; Linder, M; Wohlert, D; Yildiz, O; Kuhlbrandt, W; Fendler, K				Calinescu, Octavian; Linder, Mark; Woehlert, David; Yildiz, Oezkan; Kuehlbrandt, Werner; Fendler, Klaus			Electrogenic Cation Binding in the Electroneutral Na+/H+ Antiporter of Pyrococcus abyssi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROLES	Na+/H+ antiporters in the CPA1 branch of the cation proton antiporter family drive the electroneutral exchange of H+ against Na+ ions and ensure pH homeostasis in eukaryotic and prokaryotic organisms. Although their transport cycle is overall electroneutral, specific partial reactions are electrogenic. Here, we present an electrophysiological study of the PaNhaP Na+/H+ antiporter from Pyrococcus abyssi reconstituted into liposomes. Positive transient currents were recorded upon addition of Na+ to PaNhaP proteoliposomes, indicating a reaction where positive charge is rapidly displaced into the proteoliposomes with a rate constant of k > 200 s(-1). We attribute the recorded currents to an electrogenic reaction that includes Na+ binding and possibly occlusion. Subsequently, positive charge is transported out of the cell associated with H+ binding, so that the overall reaction is electroneutral. We show that the differences in pH profile and Na+ affinity of PaNhaP and the related MjNhaP1 from Methanocaldococcus jannaschii can be attributed to an additional negatively charged glutamate residue in PaNhaP. The results are discussed in the context of the physiological function of PaNhaP and other microbial Na+/H+ exchangers. We propose that both, electroneutral and electrogenic Na+/H+ antiporters, represent a carefully tuned self-regulatory system, which drives the cytoplasmic pH back to neutral after any deviation.	[Calinescu, Octavian; Linder, Mark; Fendler, Klaus] Max Planck Inst Biophys, Dept Biol Chem, D-60438 Frankfurt, Germany; [Linder, Mark; Woehlert, David; Yildiz, Oezkan; Kuehlbrandt, Werner] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany; [Calinescu, Octavian] Carol Davila Univ Med & Pharm, Dept Biophys, Bucharest 050474, Romania	Max Planck Society; Max Planck Society; Carol Davila University of Medicine & Pharmacy	Fendler, K (corresponding author), Max Planck Inst Biophys, Max von Laue Str 3, D-60438 Frankfurt, Germany.	fendler@biophys.mpg.de	Calinescu, Octavian/P-4278-2014; Yildiz, Ozkan/P-9207-2016	Calinescu, Octavian/0000-0001-8003-0442; Kuhlbrandt, Werner/0000-0002-2013-4810; Yildiz, Ozkan/0000-0003-3659-2805; Wohlert, David/0000-0002-2030-3952; Fendler, Klaus/0000-0002-5699-7060	Israel Science Foundation [284/12]; Deutsche Forschungsgemeinschaft [SFB 807]; Romanian National Authority for Scientific Research and Innovation program CNCS-UEFISCDI project [PN-II-RU-TE-2014-4-0604]	Israel Science Foundation(Israel Science Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Romanian National Authority for Scientific Research and Innovation program CNCS-UEFISCDI project	This work was supported in part by Israel Science Foundation Grant 284/12 (to K. F. and O. C.), Deutsche Forschungsgemeinschaft Grant SFB 807 (to K. F., W. K., and D. W.), and Romanian National Authority for Scientific Research and Innovation program CNCS-UEFISCDI project PN-II-RU-TE-2014-4-0604 (to O. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Bazzone A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156392; Bazzone A, 2013, JOVE-J VIS EXP, DOI 10.3791/50230; Braman J, 1996, Methods Mol Biol, V57, P31; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Calinescu O, 2015, BIOL CHEM, V396, P1091, DOI 10.1515/hsz-2014-0278; Calinescu O, 2014, FEBS LETT, V588, P3111, DOI 10.1016/j.febslet.2014.05.066; Calinescu O, 2014, J BIOL CHEM, V289, P13168, DOI 10.1074/jbc.M113.542993; Cohen GN, 2003, MOL MICROBIOL, V47, P1495, DOI 10.1046/j.1365-2958.2003.03381.x; Donowitz M, 2013, MOL ASPECTS MED, V34, P236, DOI 10.1016/j.mam.2012.05.001; ERAUSO G, 1993, ARCH MICROBIOL, V160, P338; Fuster DG, 2014, PFLUG ARCH EUR J PHY, V466, P61, DOI 10.1007/s00424-013-1408-8; Garcia-Celma JJ, 2010, BIOCHEMISTRY-US, V49, P6115, DOI 10.1021/bi100492p; Garcia-Celma JJ, 2009, P NATL ACAD SCI USA, V106, P7373, DOI 10.1073/pnas.0902471106; JONES WJ, 1983, ARCH MICROBIOL, V136, P254, DOI 10.1007/BF00425213; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Mager T, 2011, J BIOL CHEM, V286, P23570, DOI 10.1074/jbc.M111.230235; Padan E, 2016, METAL IONS LIFE SCI, V16, P391, DOI 10.1007/978-3-319-21756-7_12; Paulino C, 2014, ELIFE, V3, DOI 10.7554/eLife.03583; Prokofeva MI, 2005, EXTREMOPHILES, V9, P437, DOI 10.1007/s00792-005-0461-4; Schulz P, 2008, METHODS, V46, P97, DOI 10.1016/j.ymeth.2008.07.002; Teske A, 2009, EXTREMOPHILES, V13, P905, DOI 10.1007/s00792-009-0278-7; Wohlert D, 2014, ELIFE, V3, DOI 10.7554/eLife.03579	22	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26786	26793		10.1074/jbc.M116.761080	http://dx.doi.org/10.1074/jbc.M116.761080			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27821589	hybrid, Green Published			2022-12-26	WOS:000391571400017
J	Sato, S; Tomomori-Sato, C; Tsai, KL; Yu, XD; Sardiu, M; Saraf, A; Washburn, MP; Florens, L; Asturias, FJ; Conaway, RC; Conaway, JW				Sato, Shigeo; Tomomori-Sato, Chieri; Tsai, Kuang-Lei; Yu, Xiaodi; Sardiu, Mihaela; Saraf, Anita; Washburn, Michael P.; Florens, Laurence; Asturias, Francisco J.; Conaway, Ronald C.; Conaway, Joan W.			Role for the MED21-MED7 Hinge in Assembly of the Mediator-RNA Polymerase II Holoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IDENTIFICATION TECHNOLOGY; CARBOXY-TERMINAL DOMAIN; HEAD MODULE; TRANSCRIPTIONAL REGULATION; INITIATION COMPLEX; YEAST; ORGANIZATION; ARCHITECTURE; SUBUNIT; CONFORMATION	Mediator plays an integral role in activation of RNA polymerase II (Pol II) transcription. A key step in activation is binding of Mediator to Pol II to form the Mediator-Pol II holoenzyme. Here, we exploit a combination of biochemistry and macromolecular EM to investigate holoenzyme assembly. We identify a subset of human Mediator head module subunits that bind Pol II independent of other subunits and thus probably contribute to a major Pol II binding site. In addition, we show that binding of human Mediator to Pol II depends on the integrity of a conserved "hinge" in the middle module MED21-MED7 heterodimer. Point mutations in the hinge region leave core Mediator intact but lead to increased disorder of the middle module and markedly reduced affinity for Pol II. These findings highlight the importance of Mediator conformation for holoenzyme assembly.	[Sato, Shigeo; Tomomori-Sato, Chieri; Sardiu, Mihaela; Saraf, Anita; Washburn, Michael P.; Florens, Laurence; Conaway, Ronald C.; Conaway, Joan W.] Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA; [Tsai, Kuang-Lei; Asturias, Francisco J.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Conaway, Ronald C.; Conaway, Joan W.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; Scripps Research Institute; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Conaway, JW (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	jlc@stowers.org		Florens, Laurence/0000-0002-9310-6650; Tomomori-Sato, Chieri/0000-0002-2543-293X	Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; NIGMS, National Institutes of Health [GM41628, GM067167]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041628, R01GM041628, R01GM067167] Funding Source: NIH RePORTER	Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a grant to the Stowers Institute from the Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation and by NIGMS, National Institutes of Health, Grants GM41628 (to R. C. C. and J. W. C.) and GM067167 (to F. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Baumli S, 2005, J BIOL CHEM, V280, P18171, DOI 10.1074/jbc.M413466200; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Cai G, 2012, STRUCTURE, V20, P899, DOI 10.1016/j.str.2012.02.023; Cevher MA, 2014, NAT STRUCT MOL BIOL, V21, P1028, DOI 10.1038/nsmb.2914; Chao DM, 1996, NATURE, V380, P82, DOI 10.1038/380082a0; Conaway RC, 2013, BBA-GENE REGUL MECH, V1829, P69, DOI 10.1016/j.bbagrm.2012.08.017; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens Laurence, 2006, V328, P159; Gromoller A, 2000, FEBS LETT, V484, P48, DOI 10.1016/S0014-5793(00)02123-2; Gromoller A, 2000, EMBO J, V19, P6845, DOI 10.1093/emboj/19.24.6845; HENGARTNER CJ, 1995, GENE DEV, V9, P897, DOI 10.1101/gad.9.8.897; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; Kang JS, 2001, J BIOL CHEM, V276, P42003, DOI 10.1074/jbc.M105961200; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kwon JY, 2001, FEBS LETT, V508, P305, DOI 10.1016/S0014-5793(01)03072-1; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lariviere L, 2013, NUCLEIC ACIDS RES, V41, P9266, DOI 10.1093/nar/gkt704; Lariviere L, 2012, NATURE, V492, P448, DOI 10.1038/nature11670; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Mittler G, 2001, EMBO REP, V2, P808, DOI 10.1093/embo-reports/kve186; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Naar AM, 2002, GENE DEV, V16, P1339, DOI 10.1101/gad.987602; Plaschka C, 2015, NATURE, V518, P376, DOI 10.1038/nature14229; Robinson PJ, 2016, CELL, V166, P1411, DOI 10.1016/j.cell.2016.08.050; Robinson PJ, 2015, ELIFE, V4, DOI 10.7554/eLife.08719; Robinson PJJ, 2012, P NATL ACAD SCI USA, V109, P17931, DOI 10.1073/pnas.1215241109; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Sato S, 2003, J BIOL CHEM, V278, P15123, DOI 10.1074/jbc.C300054200; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Soutourina J, 2011, SCIENCE, V331, P1451, DOI 10.1126/science.1200188; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Takagi Y, 2006, MOL CELL, V23, P355, DOI 10.1016/j.molcel.2006.06.007; Tomomori-Sato Chieri, 2013, Methods Mol Biol, V977, P273, DOI 10.1007/978-1-62703-284-1_22; Tsai KL, 2014, CELL, V157, P1430, DOI 10.1016/j.cell.2014.05.015; Tsai KL, 2013, NAT STRUCT MOL BIOL, V20, P611, DOI 10.1038/nsmb.2549; Tudor M, 1999, GENE DEV, V13, P2365, DOI 10.1101/gad.13.18.2365; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wang XJ, 2014, CELL RES, V24, P796, DOI 10.1038/cr.2014.64; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999	50	13	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26886	26898		10.1074/jbc.M116.756098	http://dx.doi.org/10.1074/jbc.M116.756098			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27821593	Green Published, hybrid			2022-12-26	WOS:000391571400025
J	Sullivan, CS; Kumper, M; Temple, BS; Maness, PF				Sullivan, Chelsea S.; Kumper, Maike; Temple, Brenda S.; Maness, Patricia F.			The Neural Cell Adhesion Molecule (NCAM) Promotes Clustering and Activation of EphA3 Receptors in GABAergic Interneurons to Induce Ras Homolog Gene Family, Member A (RhoA)/Rho-associated protein kinase (ROCK)-mediated Growth Cone Collapse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN-BINDING DOMAIN; BIPOLAR DISORDER; PSA-NCAM; N-CAM; SYNAPTIC DEVELOPMENT; INHIBITORY SYNAPSES; POLYSIALIC ACID; CANDIDATE GENES; SCHIZOPHRENIA; ECTODOMAIN	Establishment of a proper balance of excitatory and inhibitory connectivity is achieved during development of cortical networks and adjusted through synaptic plasticity. The neural cell adhesion molecule (NCAM) and the receptor tyrosine kinase EphA3 regulate the perisomatic synapse density of inhibitory GABAergic interneurons in the mouse frontal cortex through ephrin-A5-induced growth cone collapse. In this study, it was demonstrated that binding of NCAM and EphA3 occurred between the NCAM Ig2 domain and EphA3 cysteine-rich domain (CRD). The binding interface was further refined through molecular modeling and mutagenesis and shown to be comprised of complementary charged residues in the NCAM Ig2 domain (Arg-156 and Lys-162) and the EphA3 CRD (Glu-248 and Glu-264). Ephrin-A5 induced co-clustering of surface-bound NCAM and EphA3 in GABAergic cortical interneurons in culture. Receptor clustering was impaired by a charge reversal mutation that disrupted NCAM/EphA3 association, emphasizing the importance of the NCAM/EphA3 binding interface for cluster formation. NCAM enhanced ephrin-A5-induced EphA3 autophosphorylation and activation of RhoA GTPase, indicating a role for NCAM in activating EphA3 signaling through clustering. NCAM-mediated clustering of EphA3 was essential for ephrin-A5-induced growth cone collapse in cortical GABAergic interneurons, and RhoA and a principal effector, Rho-associated protein kinase, mediated the collapse response. This study delineates a mechanism in which NCAM promotes ephrin-A5-dependent clustering of EphA3 through interaction of the NCAM Ig2 domain and the EphA3 CRD, stimulating EphA3 autophosphorylation and RhoA signaling necessary for growth cone repulsion in GABAergic interneurons in vitro, which may extend to remodeling of axonal terminals of interneurons in vivo.	[Sullivan, Chelsea S.; Kumper, Maike; Temple, Brenda S.; Maness, Patricia F.] Univ N Carolina, Sch Med, RL Juliano Struct Bioinformat Core, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Maness, PF (corresponding author), Univ North Carolina Chapel Hill, Sch Med, Dept Biochem & Biophys, 3020 Genet Med Res Bldg,Campus Box 7260, Chapel Hill, NC 27599 USA.	srclab@med.unc.edu	Ariel, Pablo/AGJ-4118-2022		National Institute of Health [R01 MH101605, F32 MH111189, P30 CA016086]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101605, R01MH113280, F32MH111189] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institute of Health Grants R01 MH101605, F32 MH111189, and P30 CA016086. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albrecht A, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00043; Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Gomez-Climent MA, 2011, CEREB CORTEX, V21, P1028, DOI 10.1093/cercor/bhq177; Arai M, 2004, BIOL PSYCHIAT, V55, P804, DOI 10.1016/j.biopsych.2004.01.009; Atz ME, 2007, PSYCHIAT GENET, V17, P55, DOI 10.1097/YPG.0b013e328012d850; BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Brennaman LH, 2014, J NEUROCHEM, V128, P267, DOI 10.1111/jnc.12468; Brennaman LH, 2013, CEREB CORTEX, V23, P162, DOI 10.1093/cercor/bhr392; Brennaman LH, 2008, MOL CELL NEUROSCI, V37, P781, DOI 10.1016/j.mcn.2008.01.006; Casey JP, 2012, HUM GENET, V131, P565, DOI 10.1007/s00439-011-1094-6; Chen JL, 2012, NEURON, V74, P361, DOI 10.1016/j.neuron.2012.02.030; COLE GJ, 1989, NEURON, V2, P1157, DOI 10.1016/0896-6273(89)90182-7; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Davis TL, 2008, STRUCTURE, V16, P873, DOI 10.1016/j.str.2008.03.008; Demyanenko GP, 2011, CEREB CORTEX, V21, P401, DOI 10.1093/cercor/bhq115; Dudanova I, 2010, CURR BIOL, V20, P2150, DOI 10.1016/j.cub.2010.11.021; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Gray LJ, 2010, PSYCHIAT RES, V178, P374, DOI 10.1016/j.psychres.2008.07.012; Hata K, 2007, J NEUROSCI, V27, P14481, DOI 10.1523/JNEUROSCI.3847-07.2007; Himanen JP, 2012, SEMIN CELL DEV BIOL, V23, P35, DOI 10.1016/j.semcdb.2011.10.025; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Hinkle CL, 2006, J NEUROBIOL, V66, P1378, DOI 10.1002/neu.20257; Ikeda M, 2010, BIOL PSYCHIAT, V67, P263, DOI 10.1016/j.biopsych.2009.08.030; Inan M, 2013, NEUROBIOL DIS, V53, P36, DOI 10.1016/j.nbd.2012.11.013; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Janes PW, 2011, J CELL BIOL, V195, P1033, DOI 10.1083/jcb.201104037; Janes PW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000215; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; KALLAPUR SG, 1992, J NEUROSCI RES, V33, P538, DOI 10.1002/jnr.490330406; Kania A, 2016, NAT REV MOL CELL BIO, V17, P240, DOI 10.1038/nrm.2015.16; Keck T, 2011, NEURON, V71, P869, DOI 10.1016/j.neuron.2011.06.034; Klein R, 2014, CURR OPIN NEUROBIOL, V27, P16, DOI 10.1016/j.conb.2014.02.006; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lewis DA, 2008, NEUROPSYCHOPHARMACOL, V33, P141, DOI 10.1038/sj.npp.1301563; Lisabeth EM, 2013, COLD SPRING HARB PER, V5, P1; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Mann EO, 2009, J NEUROSCI, V29, P7513, DOI 10.1523/JNEUROSCI.6162-08.2009; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; Meiri KF, 1998, J NEUROSCI, V18, P10429; Noren NK, 2009, BIOCHEM J, V422, P433, DOI 10.1042/BJ20090014; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; PERSOHN E, 1989, J COMP NEUROL, V288, P92, DOI 10.1002/cne.902880108; Puchkov D, 2011, CEREB CORTEX, V21, P2217, DOI 10.1093/cercor/bhq283; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rossignol E, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/649325; Rubenstein JLR, 2010, CURR OPIN NEUROL, V23, P118, DOI 10.1097/WCO.0b013e328336eb13; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Seiradake E., 2010, NAT STRUCT MOL BIOL; Seiradake E, 2013, NAT STRUCT MOL BIOL, V20, P958, DOI 10.1038/nsmb.2617; Seshadri S, 2013, NEUROBIOL DIS, V53, P26, DOI 10.1016/j.nbd.2013.01.009; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shi GF, 2010, CELL RES, V20, P1263, DOI 10.1038/cr.2010.115; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; Soroka V, 2002, J BIOL CHEM, V277, P24676, DOI 10.1074/jbc.M109694200; Soroka V, 2010, ADV EXP MED BIOL, V663, P3, DOI 10.1007/978-1-4419-1170-4_1; Sullivan PF, 2007, BIOL PSYCHIAT, V61, P902, DOI 10.1016/j.biopsych.2006.07.036; Tremblay R, 2016, NEURON, V91, P260, DOI 10.1016/j.neuron.2016.06.033; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015; Varea E, 2012, J PSYCHIATR RES, V46, P189, DOI 10.1016/j.jpsychires.2011.10.011; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Weledji EP, 2014, ANN MED SURG, V3, P77, DOI 10.1016/j.amsu.2014.06.014; Wilson GM, 2006, HUM MOL GENET, V15, P743, DOI 10.1093/hmg/ddi489; Wu H, 2010, MOL CELL BIOL, V30, P5207, DOI 10.1128/MCB.00366-10; Xu K, 2013, P NATL ACAD SCI USA, V110, P14634, DOI 10.1073/pnas.1311000110; Yue Xin, 2013, Methods Mol Biol, V1018, P221, DOI 10.1007/978-1-62703-444-9_21	77	14	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26262	26272		10.1074/jbc.M116.760017	http://dx.doi.org/10.1074/jbc.M116.760017			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27803162	Green Published, hybrid			2022-12-26	WOS:000391568200003
J	Imberdis, T; Heeres, JT; Yueh, H; Fang, C; Zhen, J; Rich, CB; Glicksman, M; Beeler, AB; Harris, DA				Imberdis, Thibaut; Heeres, James T.; Yueh, Han; Fang, Cheng; Zhen, Jessie; Rich, Celeste B.; Glicksman, Marcie; Beeler, Aaron B.; Harris, David A.			Identification of Anti-prion Compounds using a Novel Cellular Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CULTURED-CELLS; TRANSGENIC MICE; CONGO RED; PROTEIN; DISEASE; PRP; SCRAPIE; INHIBITION; RESISTANT	Prion diseases are devastating neurodegenerative disorders with no known cure. One strategy for developing therapies for these diseases is to identify compounds that block conversion of the cellular form of the prion protein (PrPC) into the infectious isoform (PrPSc). Most previous efforts to discover such molecules by high-throughput screening methods have utilized, as a read-out, a single kind of cellular assay system: neuroblastoma cells that are persistently infected with scrapie prions. Here, we describe the use of an alternative cellular assay based on suppressing the spontaneous cytotoxicity of a mutant form of PrP (Delta 105-125). Using this assay, we screened 75,000 compounds, and identified a group of phenethyl piperidines (exemplified by LD7), which reduces the accumulation of PrPSc in infected neuroblastoma cells by >90% at low micromolar doses, and inhibits PrPSc-induced synaptotoxicity in hippocampal neurons. By analyzing the structure-activity relationships of 35 chemical derivatives, we defined the pharmacophore of LD7, and identified a more potent derivative. Active compounds do not alter total or cell-surface levels of PrPC, and do not bind to recombinant PrP in surface plasmon resonance experiments, although at high concentrations they inhibit PrPSc-seeded conversion of recombinant PrP to a misfolded state in an in vitro reaction (RT-QuIC). This class of small molecules may provide valuable therapeutic leads, as well as chemical biological tools to identify cellular pathways underlying PrPSc metabolism and PrPC function.	[Imberdis, Thibaut; Heeres, James T.; Fang, Cheng; Rich, Celeste B.; Harris, David A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Yueh, Han; Zhen, Jessie; Beeler, Aaron B.] Boston Univ, Dept Chem, Boston, MA 02115 USA; [Glicksman, Marcie] Harvard Med Sch, Brigham & Womens Hosp, Lab Drug Discovery Neurodegenerat, Cambridge, MA 02139 USA; [Glicksman, Marcie] ORIG3N Inc, 27 Drydock Ave,6th Floor, Boston, MA 02210 USA	Boston University; Boston University; Harvard University; Brigham & Women's Hospital	Harris, DA (corresponding author), Boston Univ, Sch Med, 72 East Concord St, Boston, MA 02118 USA.	daharris@bu.edu		Harris, David/0000-0002-6985-5790; Imberdis, thibaut/0000-0002-0818-2617	National Institutes of Health [R01 NS065244, U24 NS049339]; Harvard NeuroDiscovery Center	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard NeuroDiscovery Center	This work was supported by National Institutes of Health Grants R01 NS065244 (to D. A. H.) and U24 NS049339 (to M. G.) and by the Harvard NeuroDiscovery Center (to M. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Science Foundation.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Belay ED, 2005, ANNU REV PUBL HEALTH, V26, P191, DOI 10.1146/annurev.publhealth.26.021304.144536; Biasini E, 2013, J NEUROSCI, V33, P2408, DOI 10.1523/JNEUROSCI.3406-12.2013; Biasini E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033472; Biasini E, 2012, TRENDS NEUROSCI, V35, P92, DOI 10.1016/j.tins.2011.10.002; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Carr RAE, 2005, DRUG DISCOV TODAY, V10, P987, DOI 10.1016/S1359-6446(05)03511-7; CAUGHEY B, 1994, J VIROL, V68, P2135, DOI 10.1128/JVI.68.4.2135-2141.1994; CAUGHEY B, 1993, J VIROL, V67, P6270, DOI 10.1128/JVI.67.10.6270-6272.1993; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Caughey WS, 1998, P NATL ACAD SCI USA, V95, P12117, DOI 10.1073/pnas.95.21.12117; Collinge J, 2009, LANCET NEUROL, V8, P334, DOI 10.1016/S1474-4422(09)70049-3; Fang C, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005623; Fluharty BR, 2013, J BIOL CHEM, V288, P7857, DOI 10.1074/jbc.M112.423954; Haik S, 2014, LANCET NEUROL, V13, P150, DOI 10.1016/S1474-4422(13)70307-7; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2009, PRION, V3, P195, DOI 10.4161/pri.3.4.9981; Massignan T, 2016, SCI REP-UK, V6, DOI 10.1038/srep23180; Massignan T, 2011, METHODS, V53, P214, DOI 10.1016/j.ymeth.2010.11.005; Massignan T, 2010, J BIOL CHEM, V285, P7752, DOI 10.1074/jbc.M109.064949; Miller MB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002128; Nicoll AJ, 2010, P NATL ACAD SCI USA, V107, P17610, DOI 10.1073/pnas.1009062107; Pan T, 2002, BIOCHEM J, V368, P81, DOI 10.1042/BJ20020773; Poncet-Montange G, 2011, J BIOL CHEM, V286, P27718, DOI 10.1074/jbc.M111.234393; Priola SA, 2000, SCIENCE, V287, P1503, DOI 10.1126/science.287.5457.1503; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RACE RE, 1988, J VIROL, V62, P2845, DOI 10.1128/JVI.62.8.2845-2849.1988; Safar JG, 2002, NAT BIOTECHNOL, V20, P1147, DOI 10.1038/nbt748; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; Silber BM, 2014, BIOORGAN MED CHEM, V22, P1960, DOI 10.1016/j.bmc.2014.01.001; Sim Valerie L., 2012, Infectious Disorders - Drug Targets, V12, P144; Solomon IH, 2011, J BIOL CHEM, V286, P14724, DOI 10.1074/jbc.M110.214973; Solomon IH, 2010, J BIOL CHEM, V285, P26719, DOI 10.1074/jbc.M110.134619; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; Turnbaugh JA, 2012, J NEUROSCI, V32, P8817, DOI 10.1523/JNEUROSCI.1103-12.2012; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200; WELLS GAH, 1995, BRAIN PATHOL, V5, P91, DOI 10.1111/j.1750-3639.1995.tb00580.x; Westergard L, 2011, J NEUROSCI, V31, P14005, DOI 10.1523/JNEUROSCI.1243-11.2011; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217	46	20	20	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26164	26176		10.1074/jbc.M116.745612	http://dx.doi.org/10.1074/jbc.M116.745612			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27803163	Green Published, hybrid			2022-12-26	WOS:000390345200033
J	Gouwy, M; Ruytinx, P; Radice, E; Claudi, F; Van Raemdonck, K; Bonecchi, R; Locati, M; Struyf, S				Gouwy, Mieke; Ruytinx, Pieter; Radice, Egle; Claudi, Federico; Van Raemdonck, Katrien; Bonecchi, Raffaella; Locati, Massimo; Struyf, Sofie			CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; CHEMOKINE PLATELET-FACTOR-4; RECEPTOR; EXPRESSION; VARIANT; POLARIZATION; LYMPHOCYTES; ACTIVATION; INHIBITOR; MOLECULES	Upon inflammation, circulating monocytes leave the bloodstream and migrate into the tissues, where they differentiate after exposure to various growth factors, cytokines or infectious agents. The best defined macrophage polarization types are M1 and M2. However, the platelet-derived CXC chemokine CXCL4 induces the polarization of macrophages into a unique phenotype. In this study, we compared the effect of CXCL4 and its variant CXCL4L1 on the differentiation of monocytes into macrophages and into immature monocyte-derived dendritic cells (iMDDC). Differently to M-CSF and CXCL4, CXCL4L1 is not a survival factor for monocytes. Moreover, the expression of the chemokine receptors CCR2, CCR5 and CXCR3 was significantly higher on CXCL4L1-treated monocytes compared to M-CSF- and CXCL4-stimulated monocytes. IL-1 receptor antagonist (IL-1RN) expression was upregulated by CXCL4 and downregulated by CXCL4L1, respectively, whereas both chemokines reduced the expression of the mannose receptor (MRC). Furthermore, through activation of CXCR3, CXCL4L1-stimulated monocytes released significantly higher amounts of CCL2 and CXCL8 compared to CXCL4-treated monocytes, indicating more pronounced inflammatory traits for CXCL4L1. In contrast, in CXCL4L1-treated monocytes, the production of CCL22 was lower. Compared to iMDDC generated in the presence of CXCL4L1, CXCL4treated iMDDC showed an enhanced phagocytic capacity and downregulation of expression of certain surface markers (e.g. CD1a) and specific enzymes (e.g. MMP-9 and MMP-12). CXCL4 and CXCL4L1 did not affect the chemokine receptor expression on iMDDC and cytokine production (CCL2, CCL18, CCL22, CXCL8, IL-10) by CXCL4- or CXCL4L1-differentiated iMDDC was similar. We can conclude that both CXCL4 and CXCL4L1 exert a direct effect on monocytes and iMDDC. However, the resulting phenotypes are different, which suggests a unique role for the two CXCL4 variants in physiology and/or pathology.	[Gouwy, Mieke; Ruytinx, Pieter; Radice, Egle; Claudi, Federico; Van Raemdonck, Katrien; Struyf, Sofie] Univ Leuven, KU Leuven, Dept Microbiol & Immunol, Rega Inst Med Res,Lab Mol Immunol, Leuven, Belgium; [Bonecchi, Raffaella; Locati, Massimo] Humanitas Clin & Res Ctr, Rozzano, Italy	KU Leuven; IRCCS Humanitas Research Hospital	Struyf, S (corresponding author), Univ Leuven, KU Leuven, Dept Microbiol & Immunol, Rega Inst Med Res,Lab Mol Immunol, Leuven, Belgium.	sofie.struf@kuleuven.be	Bonecchi, Raffaella/ABI-2390-2020; Locati, Massimo/ABF-6807-2021; Van Raemdonck, Katrien/AAG-4286-2020; Gouwy, Mieke/I-4642-2018; Struyf, Sofie/U-2455-2017	Gouwy, Mieke/0000-0002-4035-4810; Struyf, Sofie/0000-0003-4558-0769; Bonecchi, Raffaella/0000-0003-3346-5333	Concerted Research Actions (G.O.A.) of the Regional Government of Flanders; Fund for Scientific Research of Flanders (F.W.O - Vlaanderen); Interuniversity Attraction Poles Program-Belgian Science Policy [P7/40]	Concerted Research Actions (G.O.A.) of the Regional Government of Flanders; Fund for Scientific Research of Flanders (F.W.O - Vlaanderen)(FWO); Interuniversity Attraction Poles Program-Belgian Science Policy(Belgian Federal Science Policy Office)	This work was supported by the Concerted Research Actions (G.O.A.) of the Regional Government of Flanders (SS), the Fund for Scientific Research of Flanders (F.W.O. - Vlaanderen) (SS) and the Interuniversity Attraction Poles Program (P7/40)-Belgian Science Policy (SS).	Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bellora F, 2012, EUR J IMMUNOL, V42, P1618, DOI 10.1002/eji.201142173; Biswas SK, 2008, J IMMUNOL, V180, P2011, DOI 10.4049/jimmunol.180.4.2011; Colin S, 2014, IMMUNOL REV, V262, P153, DOI 10.1111/imr.12218; Erbel C, 2015, INNATE IMMUN-LONDON, V21, P255, DOI 10.1177/1753425914526461; Fricke I, 2004, FASEB J, V18, P1588, DOI 10.1096/fj.03-1435fje; Furuya M, 2012, CANCER BIOL THER, V13, P671, DOI 10.4161/cbt.20084; Gleissner CA, 2008, ARTERIOSCL THROM VAS, V28, P1920, DOI 10.1161/ATVBAHA.108.169417; Gleissner CA, 2012, CURR VASC PHARMACOL, V10, P563; Gleissner CA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00001; Gleissner CA, 2010, J IMMUNOL, V184, P4810, DOI 10.4049/jimmunol.0901368; Gleissner CA, 2010, CIRC RES, V106, P203, DOI 10.1161/CIRCRESAHA.109.199505; Goetzl EJ, 1996, J IMMUNOL, V156, P1; Gordon S, 2012, CIRC RES, V110, P1546, DOI 10.1161/RES.0b013e31825ec26d; Gouwy M, 2014, IMMUNOBIOLOGY, V219, P218, DOI 10.1016/j.imbio.2013.10.004; Jian J, 2016, ONCOTARGET IN PRESS; KAMEYOSHI Y, 1992, J EXP MED, V176, P587, DOI 10.1084/jem.176.2.587; Kasper B, 2011, EUR J CELL BIOL, V90, P521, DOI 10.1016/j.ejcb.2010.12.002; Lasagni L, 2003, J EXP MED, V197, P1537, DOI 10.1084/jem.20021897; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUSTER AD, 1995, J EXP MED, V182, P219, DOI 10.1084/jem.182.1.219; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mortier A, 2008, PHARMACOL THERAPEUT, V120, P197, DOI 10.1016/j.pharmthera.2008.08.006; Mueller A, 2008, J LEUKOCYTE BIOL, V83, P875, DOI 10.1189/jlb.1006645; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nesmelova IV, 2008, J BIOL CHEM, V283, P24155, DOI 10.1074/jbc.M803308200; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Parihar A, 2010, J INNATE IMMUN, V2, P204, DOI 10.1159/000296507; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Schaer CA, 2006, CIRC RES, V99, P943, DOI 10.1161/01.RES.0000247067.34173.1b; Scheuerer B, 2000, BLOOD, V95, P1158, DOI 10.1182/blood.V95.4.1158.004k31_1158_1166; Schutyser E, 2002, J BIOL CHEM, V277, P24584, DOI 10.1074/jbc.M112275200; Schwartzkopff F, 2012, INNATE IMMUN-LONDON, V18, P124, DOI 10.1177/1753425910388833; Sozzani S, 1998, J IMMUNOL, V161, P1083; Strieter RM, 2006, EUR J CANCER, V42, P768, DOI 10.1016/j.ejca.2006.01.006; Struyf S, 2004, CIRC RES, V95, P855, DOI 10.1161/01.RES.0000146674.38319.07; Struyf S, 2007, CANCER RES, V67, P5940, DOI 10.1158/0008-5472.CAN-06-4682; Tanaka T, 1997, NAT MED, V3, P437, DOI 10.1038/nm0497-437; Van Raemdonck K, 2014, ANGIOGENESIS, V17, P631, DOI 10.1007/s10456-014-9417-6; Vandercappellen J, 2011, CYTOKINE GROWTH F R, V22, P1, DOI 10.1016/j.cytogfr.2010.10.011; Vandooren J, 2015, BIOCHEM J, V465, P259, DOI 10.1042/BJ20140418; Varin A, 2009, IMMUNOBIOLOGY, V214, P630, DOI 10.1016/j.imbio.2008.11.009; Verbeke H, 2010, HUM PATHOL, V41, P990, DOI 10.1016/j.humpath.2009.09.021; Xia CQ, 2003, INT IMMUNOL, V15, P1007, DOI 10.1093/intimm/dxg100	46	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166006	10.1371/journal.pone.0166006	http://dx.doi.org/10.1371/journal.pone.0166006			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828999	Green Submitted, Green Published, gold			2022-12-26	WOS:000387724300073
J	Kieffer, A; Cardoso, GP; Thill, C; Verspyck, E; Marret, S				Kieffer, Amelie; Cardoso, Gaelle Pinto; Thill, Caroline; Verspyck, Eric; Marret, Stephane		Perinatal Network Haute-Normandie	Outcome at Two Years of Very Preterm Infants Born after Rupture of Membranes before Viability	PLOS ONE			English	Article							MIDTRIMESTER PREMATURE RUPTURE; EXPECTANT MANAGEMENT; PULMONARY HYPOPLASIA; 2ND-TRIMESTER RUPTURE; CEREBRAL-PALSY; SURVIVAL; CHORIOAMNIONITIS; MORTALITY; DELIVERY	Purpose To compare the respiratory and neurological outcomes at two years of age of preterm children born before 33 weeks of gestation (WG) after early preterm premature rupture of membranes (EPPROM) between 14 and 24 WG with preterm children without EPPROM. Design and Patients This single-center case-control retrospective study was conducted at Rouen University Hospital between 1 st January 2000 and 31 st December 2010. All the cases with EPPROM born from 26WG to 32WG were included. Each newborn was matched by sex, gestational age (GA) and year of birth to two very preterm children, born without EPPROM. At two years of corrected age, motor and cognitive abilities were assessed by routine score based on the Amiel-Tison and Denver developmental scales. Results Ninety-four cases with EPPROM before 24WG have been included. The 31 children born from 26WG to 32WG were matched with 62 controls. The EPPROM group had poorer clinical evaluation at one year for motor (p = 0.003) and cognitive developmental scores (p = 0.016). Neuromotor rehabilitation was performed more often (p = 0.013). However, there was no difference at 2 years of age. Children born after EPPROM were hospitalized more often for bronchiolitis (p<0.001) during their first 2 years, which correlates with increased incidence of pneumothorax (p = 0.017), pulmonary hypoplasia (p = 0.004) and bronchopulmonary dysplasia (p = 0.005) during neonatal period. Conclusion At two years, despite an increase in severe bronchiolitis and the need for more neuromotor rehabilitation during the first month of the life after discharge, there was no difference in neurological outcomes in the very preterm children of the EPPROM group compared to those born at a similar GA without EPPROM.	[Kieffer, Amelie; Cardoso, Gaelle Pinto; Marret, Stephane] Rouen Univ Hosp, Dept Neonatal Med, Funct Educ Ctr, Child & Reference Ctr Learning Disabil, Rouen, France; [Kieffer, Amelie; Cardoso, Gaelle Pinto; Verspyck, Eric; Marret, Stephane] Univ Rouen, Inst Biomed Res & Innovat, Sch Med, Reg Inserm Team ERI Neovasc Microvasc Endothelium, Rouen, France; [Thill, Caroline] Rouen Univ Hosp, Dept Biostat, Rouen, France; [Verspyck, Eric] Rouen Univ Hosp, Dept Obstet, Rouen, France	CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; Universite de Rouen Normandie; CHU de Rouen; CHU de Rouen	Kieffer, A (corresponding author), Rouen Univ Hosp, Dept Neonatal Med, Funct Educ Ctr, Child & Reference Ctr Learning Disabil, Rouen, France.; Kieffer, A (corresponding author), Univ Rouen, Inst Biomed Res & Innovat, Sch Med, Reg Inserm Team ERI Neovasc Microvasc Endothelium, Rouen, France.	a.kieffer@ch-calais.fr		Marret, Stephane/0000-0002-2858-148X	FEDER (the European Regional Development Fund of Haute-Normandie)	FEDER (the European Regional Development Fund of Haute-Normandie)	This study was supported by the FEDER (the European Regional Development Fund of Haute-Normandie). The funder had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.; We are grateful to Nikki-Sabourin-Gibbs, Rouen University Hospital, for reviewing the manuscript in English, and Nathalie Mestre, for providing assistance. This study was supported by the FEDER (the European Regional Development Fund of Haute-Normandie). We are indebted to the women and children who participated in the study. The composition of the Perinatal network of Haute-Normandie was as follows: Belvedere Hospital (Mont St-Aignan): Dr. S. Pauthier, Dr C. Levavasseur; Bernay Hospital: Dr. F. Faggianelli, Dr. F. Mokdad; Dieppe Hospital: Dr. M. Cingotti, Dr. E. Jeannot; ElbeufHospital: Dr. M. Paquet, Dr. N. Demarque; Evreux Hospital: Dr. E. Machevin, Dr. M. Levy; Fecamp Hospital: Dr. J-Y. Baril, Dr H. Lahrach; Gisors Hospital: Dr. B. Louis-Juste; Le Havre Hospital: Dr. A. Talbot, Dr. H. Bruel; Clinic Aubepines (Dieppe): Dr. J. Le Long, Dr. C. Lambert; Lillebonne Hospital: Dr. S. Ba; Clinic Mathilde (Rouen): Dr. M. Durand-Reville, Dr. F. Levavasseur; L'Estuaire private Hospital (Le Havre): Dr J-F Le Digabel, Dr J. Stoller; Vernon Hospital: Dr F. Truong-Canh, Dr. M. Rouha; Rouen University Hospital: Prof. L. Marpeau, Prof. S. Marret, and Mrs C. Leveque.	Amiel-Tison C, 2011, NEUROLOGICAL DEV BIR; Arnaud C, 2007, ARCH PEDIAT ADOL MED, V161, P1053, DOI 10.1001/archpedi.161.11.1053; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Dinsmoor MJ, 2004, AM J OBSTET GYNECOL, V190, P183, DOI 10.1016/S0002-9378(03)00926-8; Farooqi A, 1998, OBSTET GYNECOL, V92, P895, DOI 10.1016/S0029-7844(98)00287-7; Foix-L'Helias L, 2008, BJOG-INT J OBSTET GY, V115, P275, DOI 10.1111/j.1471-0528.2007.01566.x; FRANKENBURG WK, 1992, PEDIATRICS, V89, P91; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Henderson-Smart DJ, 2006, ARCH DIS CHILD-FETAL, V91, pF40, DOI 10.1136/adc.2005.072264; Johanzon M, 2008, OBSTET GYNECOL, V111, P42, DOI 10.1097/01.AOG.0000295866.97499.35; Kilbride HW, 1996, AM J OBSTET GYNECOL, V175, P675; Laudy JAM, 2002, PEDIATRICS, V109, P250, DOI 10.1542/peds.109.2.250; Lee T, 2001, CLIN PERINATOL, V28, P721, DOI 10.1016/S0095-5108(03)00073-3; Lindner W, 2002, J PEDIATR-US, V140, P177, DOI 10.1067/mpd.2002.121697; Manuck TA, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.045; Manuck TA, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.030; Medina TM, 2006, AM FAM PHYSICIAN, V73, P659; Melamed N, 2011, AM J OBSTET GYNECOL, V204, DOI [10.1016/j.ajog.2010.08.02, DOI 10.1016/J.AJOG.2010.08.02]; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Pasquier JC, 2009, EUR J OBSTET GYN R B, V143, P18, DOI 10.1016/j.ejogrb.2008.10.017; Pristauz G, 2008, INT J GYNECOL OBSTET, V101, P264, DOI 10.1016/j.ijgo.2007.12.007; RIB DM, 1993, AM J PERINAT, V10, P369, DOI 10.1055/s-2007-994764; Schucker JL, 1996, SEMIN PERINATOL, V20, P389, DOI 10.1016/S0146-0005(96)80006-1; Storme L, 2007, ARCH PEDIATRIE, V14, pS42, DOI 10.1016/S0929-693X(07)80010-8; Svigos JM, 2001, AUST NZ J OBSTET GYN, V41, P170, DOI 10.1111/j.1479-828X.2001.tb01203.x; Tanir HM, 2003, INT J GYNECOL OBSTET, V82, P167, DOI 10.1016/S0020-7292(03)00125-5; Verspyck E, 2014, ACTA PAEDIATR, V103, P256, DOI 10.1111/apa.12489; Watterberg KL, 1996, PEDIATRICS, V97, P210; Winn HN, 2000, AM J OBSTET GYNECOL, V182, P1638, DOI 10.1067/mob.2000.107435; Wu YW, 2000, JAMA-J AM MED ASSOC, V284, P1417, DOI 10.1001/jama.284.11.1417; Xiao ZH, 2000, EUR J OBSTET GYN R B, V90, P67, DOI 10.1016/S0301-2115(99)00232-8	31	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166130	10.1371/journal.pone.0166130	http://dx.doi.org/10.1371/journal.pone.0166130			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829004	gold, Green Published, Green Submitted			2022-12-26	WOS:000387724300087
J	Pansini, R; Shi, L; Wang, RW				Pansini, Riccardo; Shi, Lei; Wang, Rui-Wu			Women Tend to Defect in a Social Dilemma Game in Southwest China	PLOS ONE			English	Article							GENDER-DIFFERENCES; MATRILINEAL MOSUO; COOPERATION; PUNISHMENT; EVOLUTION; SEX; PROMOTES; GREED; FEAR	Cooperation theories assume that interacting individuals can change their strategies under different expected payoffs, depending on their social status or social situations. When looking at sex differences in cooperation, the existing studies have found that the genders cooperate at similar frequencies. However, the majority of the data originate within Western human societies. In this paper, we explore whether there are gender differences in cooperation in China. An Iterated Prisoner's Dilemma game with a punishment option was used to gather data about Southwest Chinese subjects in a culture in which men have a hierarchical advantage over women. Results indicate that men invested into partners significantly more than women did (34% male vs. 24% female) while women, in turn, were more likely to defect (65% female vs. 50% male). In this region, women have customarily held less economic power and they are used to obtain a payoff typically lower than men. We suggest that the women's willingness to invest in cooperation has decreased throughout evolutionary time, providing us with an illustration of a culturally-driven shift towards a disparity in gender cooperation interests.	[Pansini, Riccardo] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China; [Pansini, Riccardo; Shi, Lei] Yunnan Univ Finance & Econ, Stat & Math Coll, Kunming 650221, Peoples R China; [Wang, Rui-Wu] Northwestern Polytech Univ, Ctr Ecol & Environm Sci, Xian 710072, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University of Finance & Economics; Northwestern Polytechnical University	Pansini, R (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China.; Pansini, R (corresponding author), Yunnan Univ Finance & Econ, Stat & Math Coll, Kunming 650221, Peoples R China.; Wang, RW (corresponding author), Northwestern Polytech Univ, Ctr Ecol & Environm Sci, Xian 710072, Peoples R China.	r.pansini@gmail.com; ruiwukiz@hotmail.com	Pansini, Riccardo/AAP-2686-2020	Pansini, Riccardo/0000-0001-5046-0601	National Science Fund for Distinguished Young Scholars [31325005]; National Natural Science Foundation of China-Yunnan United fund [U1302267]; Chinese Academy of Science (CAS) Special Fund for the Excellent Youth [KSCX2-EW-Q-9]; CAS [2015PB058]; NSFC [31300318, 31170408, 31270433, 31450110421, 11671348]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China-Yunnan United fund(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science (CAS) Special Fund for the Excellent Youth; CAS(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC))	Funding was obtained from the National Science Fund for Distinguished Young Scholars (31325005), and National Natural Science Foundation of China-Yunnan United fund (U1302267), the Chinese Academy of Science (CAS) Special Fund for the Excellent Youth (KSCX2-EW-Q-9), the CAS President's International Fellowship Initiative (2015PB058), and other NSFC grants (31300318, 31170408, 31270433, 31450110421, 11671348). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank our experimental subjects, who managed to entertain themselves for little money in exchange. Thanks to Haiqiang Lan, Master's student of the Behavioral and Experimental Economics Research Center, who contributed to data collection. Derek Dunn, Marko Jusup, Zhen Wang, Michele Mignini, Rebekka Kesberg, Anna Dreber kindly commented on earlier versions of the manuscript. Funding was obtained from the National Science Fund for Distinguished Young Scholars (31325005), and National Natural Science Foundation of China-Yunnan United fund (U1302267), the Chinese Academy of Science (CAS) Special Fund for the Excellent Youth (KSCX2-EW-Q-9), the CAS President's International Fellowship Initiative (2015PB058), and other NSFC grants (31300318, 31170408, 31270433, 31450110421, 11671348).	Molina JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083700; Attane I, 2012, CHINA PERSPECT, V4, P5; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Balafoutas L, 2014, P NATL ACAD SCI USA, V111, P15924, DOI 10.1073/pnas.1413170111; Balliet D, 2011, PSYCHOL BULL, V137, P881, DOI 10.1037/a0025354; Balliet D, 2011, PSYCHOL BULL, V137, P594, DOI 10.1037/a0023489; Barker JL, 2016, J EVOLUTION BIOL, V29, P560, DOI 10.1111/jeb.12805; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Birnbaum GE, 2014, PERSONALITY SOCIAL P; Boehm C., 1999, HIERARCHY FOREST EVO; Charness G, 2009, ECONOMETRICA, V77, P909, DOI 10.3982/ECTA7416; Cox JC, 2013, SOUTH ECON J, V79, P496, DOI 10.4284/0038-4038-2012.186; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; Dal Bo P, 2005, AM ECON REV, V95, P1591; David-Barrett T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118329; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Dyble M, 2015, SCIENCE, V348, P796, DOI 10.1126/science.aaa5139; Eagle N, 2010, SCIENCE, V328, P1029, DOI 10.1126/science.1186605; Falk A, 2015, CESIFO AR C BEH EC M; Fehl K, 2011, ECOL LETT, V14, P546, DOI 10.1111/j.1461-0248.2011.01615.x; Fehr E, 2007, ANNU REV SOCIOL, V33, P43, DOI 10.1146/annurev.soc.33.040406.131812; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Friebel G, 2013, WORKING PAPER; FUDENBERG D, 1994, ECONOMETRICA, V62, P997, DOI 10.2307/2951505; Gachter S, 2010, PHILOS T R SOC B, V365, P2651, DOI 10.1098/rstb.2010.0135; Gintis H, 2009, GAME THEORY EVOLVING: A PROBLEM-CENTERED INTRODUCTION TO MODELING STRATEGIC INTERACTION, SECOND EDITION, P1; Gong BL, 2015, EXP ECON, V18, P302, DOI 10.1007/s10683-014-9403-2; Gong BL, 2012, J ECON BEHAV ORGAN, V83, P59, DOI 10.1016/j.jebo.2011.06.010; Kuwabara K, 2005, SOC FORCES, V84, P1257, DOI 10.1353/sof.2006.0020; Ma ZQ, 2011, INT J MOD PHYS C, V22, P1257, DOI 10.1142/S0129183111016877; Mattison SM, 2014, AM ANTHROPOL, V116, P591, DOI 10.1111/aman.12125; Nee V, 1996, AM J SOCIOL, V101, P908, DOI 10.1086/230784; Niederle M, 2015, HDB EXPT EC, V2; Page SE, 2007, DIFFERENCE: HOW THE POWER OF DIVERSITY CREATES BETTER GROUPS, FIRMS, SCHOOLS, AND SOCIETIES, P1; R Core Team, 2021, R LANGUAGE ENV STAT; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Reuters, 2015, REUTERS; Seabright P, 2012, WAR OF THE SEXES: HOW CONFLICT AND COOPERATION HAVE SHAPED MEN AND WOMEN FROM PREHISTORY TO THE PRESENT, P1; Sigmund K., 2010, CALCULUS SELFISHNESS; Simpson B, 2003, SOC FORCES, V82, P35, DOI 10.1353/sof.2003.0081; SIMPSON JA, 1992, J PERS, V60, P31, DOI 10.1111/j.1467-6494.1992.tb00264.x; Stewart AJ, 2014, P NATL ACAD SCI USA, V111, P17558, DOI 10.1073/pnas.1408618111; Szathmary E, 1995, MAJOR TRANSITIONS EV; Talhelm T, 2014, SCIENCE, V344, P603, DOI 10.1126/science.1246850; Tomasello M, 2012, CURR ANTHROPOL, V53, P673, DOI 10.1086/668207; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Wang J, 2012, CHINESE SCI BULL, V57, P724, DOI 10.1007/s11434-011-4890-4; Wang RW, 2010, SCI CHINA LIFE SCI, V53, P1041, DOI 10.1007/s11427-010-4016-2; Wang Z, 2015, PHYS LIFE REV, V14, P1, DOI 10.1016/j.plrev.2015.04.033; Wang Z, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60270-7; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Wu JJ, 2009, P NATL ACAD SCI USA, V106, P17448, DOI 10.1073/pnas.0905918106; Xia CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129542; Xia CY, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/58002; Xiu L, 2013, CONTEMP ECON POLICY, V31, P235, DOI 10.1111/j.1465-7287.2011.00307.x	55	3	5	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166101	10.1371/journal.pone.0166101	http://dx.doi.org/10.1371/journal.pone.0166101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9OG	27829046	Green Submitted, Green Published, gold			2022-12-26	WOS:000387724300080
J	Villanueva, R; Vidal, EAG; Fernandez-Alvarez, FA; Nabhitabhata, J				Villanueva, Roger; Vidal, Erica A. G.; Fernandez-Alvarez, Fernando A.; Nabhitabhata, Jaruwat			Early Mode of Life and Hatchling Size in Cephalopod Molluscs: Influence on the Species Distributional Ranges	PLOS ONE			English	Article							SQUID DOSIDICUS-GIGAS; OCTOPUS ENTEROCTOPUS-MEGALOCYATHUS; CALAMARY SEPIOTEUTHIS-AUSTRALIS; PELAGIC LARVAL DURATION; GULF-OF-CALIFORNIA; EMBRYONIC-DEVELOPMENT; DEEP-SEA; 1ST DESCRIPTION; LABORATORY CULTURE; LOLIGINID SQUIDS	Cephalopods (nautiluses, cuttlefishes, squids and octopuses) exhibit direct development and display two major developmental modes: planktonic and benthic. Planktonic hatchlings are small and go through some degree of morphological changes during the planktonic phase, which can last from days to months, with ocean currents enhancing their dispersal capacity. Benthic hatchlings are usually large, miniature-like adults and have comparatively reduced dispersal potential. We examined the relationship between early developmental mode, hatchling size and species latitudinal distribution range of 110 species hatched in the laboratory, which represent 13% of the total number of live cephalopod species described to date. Results showed that species with planktonic hatchlings reach broader distributional ranges in comparison with species with benthic hatchlings. In addition, squids and octopods follow an inverse relationship between hatchling size and species latitudinal distribution. In both groups, species with smaller hatchlings have broader latitudinal distribution ranges. Thus, squid and octopod species with larger hatchlings have latitudinal distributions of comparatively minor extension. This pattern also emerges when all species are grouped by genus (n = 41), but was not detected for cuttlefishes, a group composed mainly of species with large and benthic hatchlings. However, when hatchling size was compared to adult size, it was observed that the smaller the hatchlings, the broader the latitudinal distributional range of the species for cuttlefishes, squids and octopuses. This was also valid for all cephalopod species with benthic hatchlings pooled together. Hatchling size and associated developmental mode and dispersal potential seem to be main influential factors in determining the distributional range of cephalopods.	[Villanueva, Roger; Vidal, Erica A. G.; Fernandez-Alvarez, Fernando A.] Passeig Maritim Barceloneta, CSIC, Inst Ciencies Mar, Barcelona, Spain; [Vidal, Erica A. G.] Univ Fed Parana UFPR, Ctr Estudos Mar, Pontal Do Parana, Brazil; [Nabhitabhata, Jaruwat] Prince Songkla Univ, Fac Sci, Excellence Ctr Biodivers Peninsular Thailand CBIP, Hat Yai, Songkhla, Thailand	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Universidade Federal do Parana; Prince of Songkla University	Villanueva, R (corresponding author), Passeig Maritim Barceloneta, CSIC, Inst Ciencies Mar, Barcelona, Spain.	roger@icm.csic.es	Vidal, Erica A G/C-9032-2013; Fernández-Álvarez, Fernando Ángel/B-6196-2014; Nabhitabhata, Jaruwat/AAF-2144-2019; Villanueva, Roger/D-6911-2011	Vidal, Erica A G/0000-0003-4781-8670; Fernández-Álvarez, Fernando Ángel/0000-0002-8679-7377; Villanueva, Roger/0000-0001-8122-3449	Spanish Ministry of Economy and Competiveness [BES-2013-063551]; Brazilian National Research Council Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [250017/2013-0, 207680/2014-0]; Spanish Ministry of Education and Culture [PRX15/00100, AGL2012-39077, CALOCEAN-2]	Spanish Ministry of Economy and Competiveness(Spanish Government); Brazilian National Research Council Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Spanish Ministry of Education and Culture(Spanish Government)	FAFA was supported by a predoctoral fellowship (BES-2013-063551) of the Spanish Ministry of Economy and Competiveness; URL: http://www.mineco.gob.es/portal/siteimineco?lang_choosenzen. EAGV was funded by the Brazilian National Research Council Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Grants no. 250017/2013-0; 207680/2014-0); URL: http://www.ctmq.br/. RV was funded by the Spanish Ministry of Education and Culture (Grant no. PRX15/00100); URL: http://mm.mecd.gob.es/portada-mecdi and by the Spanish Ministry of Economy and Competiveness (Grant no. AGL2012-39077, CALOCEAN-2); URL: http://www.mineco.gob.es/portal/siteimireco?chnosen=en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam W., 1962, CEPHALOPODES ARCHIPE, P7; Allcock AL, 1997, MAR BIOL, V129, P97, DOI 10.1007/s002270050150; AMBROSE RF, 1981, VELIGER, V24, P139; Anderson FE, 2011, J MOLLUS STUD, V77, P65, DOI 10.1093/mollus/eyq034; Arkhipkin AI, 2000, J MOLLUS STUD, V66, P551, DOI 10.1093/mollus/66.4.551; Arkhipkin AI, 1999, J PLANKTON RES, V21, P401, DOI 10.1093/plankt/21.2.401; Arnold John M., 1990, Journal of Cephalopod Biology, V1, P117; Aungtonya Charatsee, 2011, Phuket Marine Biological Center Research Bulletin, V70, P15; BAEG GH, 1992, VELIGER, V35, P234; Barratt IM, 2007, MAR BIOL, V150, P387, DOI 10.1007/s00227-006-0365-6; Bartol IK, 2009, J EXP BIOL, V212, P1506, DOI 10.1242/jeb.026948; Bartol IK, 2008, INTEGR COMP BIOL, V48, P720, DOI 10.1093/icb/icn043; BATHAM E. J., 1957, TRANS ROY SOC NEW ZEALAND, V84, P629; Bergstrom B., 1983, P75; Blackburn S, 1998, VELIGER, V41, P249; BOERO F, 1993, BIOL J LINN SOC, V48, P239, DOI 10.1111/j.1095-8312.1993.tb00890.x; Boletzky S.v., 1983, P53; Boletzky S. v., 1983, P31; Boletzky S.v., 1987, P5; BOLETZKY S V, 1983, Memoirs of the National Museum of Victoria, V44, P147; BOLETZKY SV, 1975, B SOC ZOOL FR, V100, P361; BOLETZKY SV, 1971, MAR BIOL, V8, P82, DOI 10.1007/BF00349349; Boletzky SV, 1988, RAPPORT COMMISSION I, V31, P256; BOUCHAUD O, 1991, B MAR SCI, V49, P333; Bower JR, 2012, BIOL BULL-US, V223, P259, DOI 10.1086/BBLv223n3p259; Bower JR, 1999, MAR ECOL PROG SER, V185, P203, DOI 10.3354/meps185203; Boyle P.R., 1983, P365; Boyle P. R., 2005, CEPHALOPODS ECOLOGY; Bozzano A, 2009, MAR BIOL, V156, P1359, DOI 10.1007/s00227-009-1177-2; BRIDGES TS, 1993, BIOL BULL, V184, P144, DOI 10.2307/1542224; BROUGH EJ, 1965, T ROY SOC NZ ZOOL, V6, P7; Byern J V, 2012, AQUAT BIOL, V17, P19, DOI DOI 10.3354/AB00445; Caamal-Monsreal C, 2015, AQUACULTURE, V441, P84, DOI 10.1016/j.aquaculture.2015.01.020; Caldwell RL, COMMUNICATION; Cardoso Franz, 2013, Rev. peru biol., V20, P129; Carrasco JF, 2006, AQUAC RES, V37, P1601, DOI 10.1111/j.1365-2109.2006.01594.x; Carrasco SA, 2014, NEW ZEAL J ZOOL, V41, P32, DOI 10.1080/03014223.2013.827126; Ceriola L, 2010, J MAR BIOL ASSOC UK, V90, P755, DOI 10.1017/S0025315409991445; Chen DS, 1996, BIOL BULL, V190, P69, DOI 10.2307/1542676; Cheng RB, 2012, MOL BIOL REP, V39, P3461, DOI 10.1007/s11033-011-1118-2; Cheng SH, 2014, HYDROBIOLOGIA, V725, P165, DOI 10.1007/s10750-013-1778-0; CHOE S, 1966, B MAR SCI, V16, P330; Collins MA, 2001, J MAR BIOL ASSOC UK, V81, P105, DOI 10.1017/S0025315401003459; Collins MA, 2006, OCEANOGR MAR BIOL, V44, P277; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Cronin ER, 2000, MAR BIOL, V136, P863, DOI 10.1007/s002270000274; Dan S, 2012, AQUAT BIOL, V17, P181, DOI 10.3354/ab00474; Alejo-Plata MD, 2014, AM MALACOL BULL, V32, P132, DOI 10.4003/006.032.0101; DERUSHA R H, 1987, Pacific Science, V41, P104; Dominguez-Contreras JF, 2013, AM MALACOL BULL, V31, P95, DOI 10.4003/006.031.0122; Doubleday ZA, 2016, CURR BIOL, V26, pR406, DOI 10.1016/j.cub.2016.04.002; Downey-Breedt NJ, 2016, FISH OCEANOGR, V25, P28, DOI 10.1111/fog.12132; Durward R.D., 1980, ICNAF SEL PAPERS, V6, P7; Farias A, 2011, CIENC MAR, V37, P11, DOI 10.7773/cm.v37i1.1736; Fernandez-Alvarez FA, 2016, ZOOLOGICAL IN PRESS, DOI [10.1371/journal.pone.0165334, DOI 10.1371/JOURNAL.PONE.0165334]; Finn J., 2013, CEPHALOPODS WORLD AN, V3, P228; FORSYTHE J W, 1985, Vie et Milieu, V35, P273; FORSYTHE JW, 1991, B MAR SCI, V49, P88; FORSYTHE JW, 1994, J ZOOL, V233, P175, DOI 10.1111/j.1469-7998.1994.tb08582.x; Gleadall Ian G., 2016, Species Diversity, V21, P31, DOI 10.12782/sd.21.1.031; Gowland FC, 2002, J ZOOL, V258, P505, DOI 10.1017/S0952836902001668; Grasse B, 2014, DRUM CROAKER, V45, P58; Guerra A, 2001, VELIGER, V44, P109; Guzik MT, 2004, THESIS; HAIMOVICI M, 1991, B MAR SCI, V49, P221; Hanlon R.T., 1983, P293; Hanlon R.T., 1983, P251; HANLON R T, 1989, Aquaculture and Fisheries Management, V20, P15, DOI 10.1111/j.1365-2109.1989.tb00438.x; HANLON RT, 1985, LAB ANIM SCI, V35, P33; HANLON RT, 1987, FISH B-NOAA, V85, P163; Hanlon RT, 1997, BIOL BULL-US, V192, P364, DOI 10.2307/1542746; Hanlon RT, 1845, SMITHSONIAN CONTRIBU, V513, P37; Hanlon RT, 1980, B AM MALACOLOGICAL U, V1979, P53; HARTWICK B, 1983, CEPHALOPOD LIFE CYCL, V1, P277; Hayashi S., 1995, B TOYAMA PREFECTURAL, V7, P1; Higgins FA, 2012, J THERM BIOL, V37, P83, DOI 10.1016/j.jtherbio.2011.11.004; Higgins KL, 2013, MAR ECOL PROG SER, V486, P203, DOI 10.3354/meps10330; Hochberg FG, 2006, MOLLUSCAN RES, V26, P128; Hochberg FG., 1992, SMITHSON CONTRIB ZOO, P213; Hoving HJT, 2014, ADV MAR BIOL, V67, P235, DOI 10.1016/B978-0-12-800287-2.00003-2; Ibanez CM, 2014, HYDROBIOLOGIA, V725, P205, DOI 10.1007/s10750-013-1518-5; Iglesias J, 2004, AQUACULT INT, V12, P481, DOI 10.1023/B:AQUI.0000042142.88449.bc; Iglesias J, 2014, CEPHALOPOD CULTURE; Ignatius B, 2006, CURR SCI INDIA, V91, P1089; Ikeda Y, 2005, AQUAC RES, V36, P409, DOI 10.1111/j.1365-2109.2005.01217.x; Ikeda Y, 1999, J MAR BIOL ASSOC UK, V79, P757, DOI 10.1017/S0025315498000939; IRIBARNE OO, 1991, J ZOOL, V223, P549, DOI 10.1111/j.1469-7998.1991.tb04387.x; Itami K., 1963, Bulletin of the Japanese Society of Scientific Fisheries, V29, P514; ITO H, 1985, Bulletin of the Hokkaido National Fisheries Research Institute, P99; Ivarez F, 2015, GENUS OMMASTREPHES O; Jereb P, 2013, CEPHALOPODS WORLD AN, V3; Jereb P., 2010, MYOPSID OEGOPSID SQU, V2, P605; Jivaluk Jutamas, 2005, Phuket Marine Biological Center Research Bulletin, V66, P117; Johnsen S, 1999, BIOL BULL, V197, P26, DOI 10.2307/1542994; JOLL LM, 1976, MAR BIOL, V36, P327, DOI 10.1007/BF00389194; Jones NJE, 2010, J SHELLFISH RES, V29, P241, DOI 10.2983/035.029.0121; Kaneko N, 2006, MOLLUSCAN RES, V26, P113; Kaneko N, 2011, MALACOLOGIA, V54, P97, DOI 10.4002/040.054.0102; Kim Byung Gyun, 2001, Korean Journal of Malacology, V17, P85; KUBODERA T, 1991, B MAR SCI, V49, P235; Lang MA, 1997, P WORKSH FISH MARK P; Laptikhovsky V, 2013, AQUAT BIOL, V18, P21, DOI 10.3354/ab00486; LAROE ET, 1971, MAR BIOL, V9, P9, DOI 10.1007/BF00348813; Leite TS, COMMUNICATION; Lenz TM, 2015, AM MALACOL BULL, V33, P101, DOI 10.4003/006.033.0115; Lester SE, 2005, P ROY SOC B-BIOL SCI, V272, P585, DOI 10.1098/rspb.2004.2985; Levin Lisa A., 1995, P1; Gonzalez ML, 2008, AQUAC RES, V39, P1569, DOI 10.1111/j.1365-2109.2008.02019.x; Macpherson E, 2006, MAR ECOL PROG SER, V327, P257, DOI 10.3354/meps327257; Mangold K., 1983, P387; MANGOLD K, 1971, MAR BIOL, V8, P109, DOI 10.1007/BF00350926; Mangold Katharina, 1998, Smithsonian Contributions to Zoology, V586, P521; Mangold-Wirz K, 1976, RAPPORT COMMISSION I, V23, P83; Markaida U, 2005, FISH B-NOAA, V103, P219; Marquez L, 2013, HELGOLAND MAR RES, V67, P461, DOI 10.1007/s10152-012-0335-y; Marshall DJ, 2008, ADV MAR BIOL, V53, P1, DOI 10.1016/S0065-2881(07)53001-4; Martins RS, 2014, FISH OCEANOGR, V23, P116, DOI 10.1111/fog.12046; Martins RS, 2010, J EXP MAR BIOL ECOL, V386, P19, DOI 10.1016/j.jembe.2010.02.014; MAURIS E, 1989, MAR BEHAV PHYSIOL, V14, P189, DOI 10.1080/10236248909378705; MCCONATHY DA, 1980, MALACOLOGIA, V19, P279; Miske V, 2006, MOLLUSCAN RES, V26, P169; Miyahara K, 2006, J MOLLUS STUD, V72, P199, DOI 10.1093/mollus/eyi068; Mladineo Ivona, 2003, Acta Adriatica, V44, P77; Moreira AA, 2011, J EXP MAR BIOL ECOL, V407, P34, DOI 10.1016/j.jembe.2011.06.029; Muus B, 2002, MALACOLOGIA, V44, P175; Nabhitabhata J., 1998, SPECIAL PUBLICATION, V18, P25; Nabhitabhata J., 2005, PHUKET MAR BIOL CTR, V66, P337; Nabhitabhata J., COMMUNICATION; Nabhitabhata J, 2003, DEP FISHERIES CONTRI, P17; Nabhitabhata J, 2004, RAYONG COASTAL FISHE; Nabhitabhata J, 2015, ALLOPATRIC VARIATION, P97; Nabhitabhata Jaruwat, 1996, Phuket Marine Biological Center Special Publication, V16, P83; Nabhitabhata Jaruwat, 2005, Phuket Marine Biological Center Research Bulletin, V66, P351; Nabhitabhata Jaruwat, 1997, Phuket Marine Biological Center Special Publication, V17, P289; Nathan Ran, 2001, Trends in Ecology and Evolution, V16, P481, DOI 10.1016/S0169-5347(01)02272-8; NATSUKARI Y, 1991, MAR BEHAV PHYSIOL, V18, P149, DOI 10.1080/10236249109378785; Natsukari Y, 1970, B FACULTY FISHERIES, V30, P15; Nesis K. N., 1987, CEPHALOPODS WORLD; Norman M. D., 2013, CEPHALOPODS WORLD AN, V3, P36; Norman Mark, 2000, P1; NORMAN MD, 1993, P BIOL SOC WASH, V106, P645; Norman MD, 2000, CEPHALOPODS WORLD GU; ODOR RK, 1986, AM MALACOL BULL, V4, P55; OKUBO S, 1995, VELIGER, V38, P192; Okubo S., 1979, ANIMALS NATURE, V9, P2; Okubo S, 1980, SHIMA MARINELAND Q, V25, P4; Okutani T., 1987, P1; OKUTANI T, 1978, Venus the Japanese Journal of Malacology, V37, P245; Okutani T, 1988, B OCEAN RES I U TOKY, V26; Okutani T, 2007, J MOLLUS STUD, V73, P287, DOI 10.1093/mollus/eym026; Ortiz N, 2006, J PLANKTON RES, V28, P881, DOI 10.1093/plankt/fbl023; Ortiz N, 2011, FISH RES, V110, P217, DOI 10.1016/j.fishres.2011.03.016; Ortiz N, 2011, J MAR BIOL ASSOC UK, V91, P705, DOI 10.1017/S0025315410001232; OShea S., 1999, NIWA BIODIVERSITY ME, V112, P1; Otero J, 2009, MAR ECOL PROG SER, V386, P123, DOI 10.3354/meps08041; OVERATH H, 1974, MAR BIOL, V27, P333, DOI 10.1007/BF00394369; da Silva VCP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103480, 10.1371/journal.pone.0093049, 10.1371/journal.pone.0105072, 10.1371/journal.pone.0087588, 10.1371/journal.pone.0103267, 10.1371/journal.pone.0091910, 10.1371/journal.pone.0107196, 10.1371/journal.pone.0110033, 10.1371/journal.pone.0096514, 10.1371/journal.pone.0087348, 10.1371/journal.pone.0103535, 10.1371/journal.pone.0095536, 10.1371/journal.pone.0099366, 10.1371/journal.pone.0113637, 10.1371/journal.pone.0095422]; PACKARD A, 1969, NATURE, V221, P875, DOI 10.1038/221875a0; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; Palumbi Stephen R., 1995, P369; Pecl GT, 2004, MAR FRESHWATER RES, V55, P387, DOI 10.1071/MF03153; Perez-Losada M, 2002, HEREDITY, V89, P417, DOI 10.1038/sj.hdy.6800160; Promboon P, 2011, SCI MAR, V75, P811, DOI 10.3989/scimar.2011.75n4811; Puneeta P, 2015, J EXP BIOL, V218, P3825, DOI 10.1242/jeb.127670; Quintana D, 2015, AQUACULTURE, V446, P206, DOI 10.1016/j.aquaculture.2015.04.023; Reid A., 2005, CHAMBERED NAUTILUSES, V1, P57; Reid A., 2005, FAO SPECIES CATALOGU, V1, P153; Reid A, 2005, CEPHALOPODS WORLD AN, V1, P204; Roberts MJ, 2005, AFR J MAR SCI, V27, P375, DOI 10.2989/18142320509504096; Robison B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103437; RODANICHE AF, 1984, B MAR SCI, V35, P99; Rodrigues M, 2011, HELGOLAND MAR RES, V65, P43, DOI 10.1007/s10152-010-0199-y; Roper, 2010, CEPHALOPODS WORLD AN, P384; Roper C.F., 2006, CHAMBERED NAUTILUSES, V1; Roper C. F. E., 2010, FAO SPECIES CATALOGU, V2, P269; Roper CFE, 2010, CEPHALOPODS WORLD AN, V2, P200; Roper CFE, 2010, CEPHALOPODS WORLD AN, P183; Rosa R, 2012, MAR ECOL PROG SER, V464, P153, DOI 10.3354/meps09822; Rowell T.W., 1985, Northwest Atlantic Fisheries Organization Scientific Council Studies, P77; Saito Hiroaki, 1993, P457; Sakaguchi Hideo, 2002, Bulletin of the Japanese Society of Fisheries Oceanography, V66, P11; Sakai M, 1998, S AFR J MARINE SCI, V20, P255; SAKURAI Y, 1995, VELIGER, V38, P185; Sales Joao Braullio L, 2014, PLoS One, V9, pe88693, DOI 10.1371/journal.pone.0088693; SANCHEZ P, 1988, S AFR J MARINE SCI, V7, P69, DOI 10.2989/025776188784379107; Sato N, 2009, ICES J MAR SCI, V66, P811, DOI 10.1093/icesjms/fsp145; SCHELTEMA RS, 1989, OLSEN INT S, P183; SEGAWA S, 1988, VELIGER, V30, P230; Segawa S, 2002, B MAR SCI, V71, P801; Singley C.T., 1983, P69; Snyder S., 1986, AM MALACOL B, V4, P241; Snyder S, 1986, AM ASS ZOOL PARKS AQ, P781; Sreeja V, 2012, MOLLUSCAN RES, V32, P43; Staaf D, 2010, MARINE ECOLOGY PROGR, V418, P168; Staaf DJ, 2008, J MAR BIOL ASSOC UK, V88, P759, DOI 10.1017/S0025315408001422; Steer MA, 2003, MAR ECOL PROG SER, V261, P175, DOI 10.3354/meps261175; Steer MA, 2003, MAR FRESHWATER RES, V54, P217, DOI 10.1071/MF02107; Stranks TN, 1996, AM MALACOL BULL, V12, P145; STRATHMANN RR, 1982, AM NAT, V119, P91, DOI 10.1086/283892; Strugnell JM, 2011, DEEP-SEA RES PT II, V58, P196, DOI 10.1016/j.dsr2.2010.05.015; Sugimoto C, 2012, FISHERIES SCI, V78, P287, DOI 10.1007/s12562-011-0464-2; Sukhsangchan Charuay, 2007, Kasetsart Journal Natural Sciences, V41, P531; Summers William C., 1989, Journal of Cephalopod Biology, V1, P21; Teixeira PB., 2011, BIOL REPROD POLVO OC; THOMAS RF, 1977, B MAR SCI, V27, P353; Thore S., 1949, Dana Reports, VNo. 33, P1; TRANTER DJ, 1973, MAR BIOL, V18, P115, DOI 10.1007/BF00348686; Triantafillos L, 2005, ICES J MAR SCI, V62, P1665, DOI 10.1016/j.icesjms.2005.06.004; TURK P E, 1986, Vie et Milieu, V36, P9; Umezu Y, 2012, GROWTH MATURATION ME, P28; Uriarte I., 2014, CEPHALOPOD CULTURE, P365, DOI DOI 10.1007/978-94-017-8648-5; Uriarte I, 2010, BIOL BULL-US, V218, P200, DOI 10.1086/BBLv218n2p200; van der Vyver JSF, 2016, J MAR BIOL ASSOC UK, V96, P1507, DOI 10.1017/S0025315415001794; van Heukelem W.F., 1983, P267; VECCHIONE M, 1995, S AFR J MARINE SCI, V15, P1; Vecchione M, 1997, VIE MILIEU, V47; Veness C., MOVABLE TYPE SCRIPTS; Vidal E. A. G., 2014, CEPHALOPOD CULTURE, P271, DOI [10.1007/978-94-017-8648-5_16, DOI 10.1007/978-94-017-8648-5_16]; Vidal EAG, 2005, AQUAT LIVING RESOUR, V18, P385, DOI 10.1051/alr:2005040; Vidal EAG, 2002, MAR BIOL, V140, P117, DOI 10.1007/s002270100683; Vidal EAG, 2002, B MAR SCI, V71, P915; Vidal EAG, COMMUNICATION; Vidal EAG, 2010, FISH RES, V106, P199, DOI 10.1016/j.fishres.2010.08.009; VILLANUEVA R, 1993, J NAT HIST, V27, P15, DOI 10.1080/00222939300770021; Villanueva R, 2000, MAR BIOL, V136, P449, DOI 10.1007/s002270050704; Villanueva R, 1995, CAN J FISH AQUAT SCI, V52, P2639, DOI 10.1139/f95-853; Villanueva R, 1997, MAR BIOL, V129, P113, DOI 10.1007/s002270050152; Villanueva R, 1997, J EXP MAR BIOL ECOL, V208, P169, DOI 10.1016/S0022-0981(96)02670-6; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Villanueva R, 2012, AQUACULTURE, V342, P125, DOI 10.1016/j.aquaculture.2012.02.025; Villanueva R, 2011, J EXP MAR BIOL ECOL, V407, P54, DOI 10.1016/j.jembe.2011.07.012; Voight JR, 2004, J MOLLUS STUD, V70, P400, DOI 10.1093/mollus/70.4.400; von Boletsky S., 1973, Helgolander Wissenschaftliche Meeresuntersuchungen, V25, P135; von Boletzky S., 1984, Vie et Milieu, V34, P87; von Boletzky S, 2001, J MAR BIOL ASSOC UK, V81, P703, DOI 10.1017/S002531540100443X; VONBOLETZKY S, 1982, MALACOLOGIA, V22, P197; VOSS G L, 1990, Proceedings of the California Academy of Sciences, V47, P47; Voss G.L., 1988, P253; VOSS GIBERT L., 1963, U S NATL MUS BULL, V234, P1; Voss Gilbert L., 1998, Smithsonian Contributions to Zoology, V586, P457; Warnke K, 1999, VELIGER, V42, P211; Warnke KM, 2012, NEUES JAHRB GEOL P-A, V266, P51, DOI 10.1127/0077-7749/2012/0259; Watanabe K, 1996, AM MALACOL BULL, V13, P73; Wood JB, 2000, MAR BIOL, V136, P91, DOI 10.1007/s002270050012; Wood JB, 1998, MALACOLOGIA, V39, P11; Yamazaki A, 2002, ZOOL SCI, V19, P763, DOI 10.2108/zsj.19.763; YANG WT, 1986, FISH B-NOAA, V84, P771; Yatsu A, 1999, FISHERIES SCI, V65, P904, DOI 10.2331/fishsci.65.904; Ylitalo HA, 2014, MOLLUSCAN RES, V34, P79, DOI 10.1080/13235818.2013.860871; Yoo HK, 2014, FISHERIES SCI, V80, P925, DOI 10.1007/s12562-014-0767-1; YOUNG RE, 1988, MALACOLOGIA, V29, P201; YOUNG RE, 1972, PAC SCI, V26, P400; YOUNG RE, 1989, VELIGER, V32, P152; Zheng XD., 2014, CEPHALOPOD CULTURE C, P415, DOI [10.1007/978-94-017-8648-5_22, DOI 10.1007/978-94-017-8648-5, DOI 10.1007/978-94-017-8648-5_22]; Zheng Xiaodong, 2010, Transactions of Oceanology and Limnology, V3, P24	255	50	52	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165334	10.1371/journal.pone.0165334	http://dx.doi.org/10.1371/journal.pone.0165334			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829039	gold, Green Published, Green Submitted			2022-12-26	WOS:000387724300039
J	Strate, LL; Singh, P; Boylan, MR; Piawah, S; Cao, Y; Chan, AT				Strate, Lisa L.; Singh, Prashant; Boylan, Matthew R.; Piawah, Sorbarikor; Cao, Yin; Chan, Andrew T.			A Prospective Study of Alcohol Consumption and Smoking and the Risk of Major Gastrointestinal Bleeding in Men	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; COLONIC DIVERTICULAR HEMORRHAGE; HELICOBACTER-PYLORI INFECTION; MALE HEALTH-PROFESSIONALS; ACUTE CORONARY SYNDROMES; HUMAN GASTRIC-MUCOSA; LONG-TERM USE; UNITED-STATES; ASPIRIN; ULCER	Background and Aims Data regarding smoking and alcohol consumption and risk of gastrointestinal bleeding (GIB) are sparse and conflicting. We assessed the risk of major GIB associated with smoking and alcohol consumption in a large, prospective cohort. Methods We prospectively studied 48,000 men in the Health Professional follow-up Study (HPFS) who were aged 40-75 years at baseline in 1986. We identified men with major GIB requiring hospitalization and/or blood transfusion via biennial questionnaires and chart review. Results We documented 305 episodes of major GIB during 26 years of follow-up. Men who consumed >30 g/day of alcohol had a multivariable relative risk (RR) of 1.43 (95% confidence interval (CI), 0.88-2.35; P for trend 0.006) for major GIB when compared with nondrinkers. Alcohol consumption appeared to be primarily related to upper GIB (multivariable RR for >30 g/day vs. nondrinkers was 1.35; 95% CI, 0.66-2.77; P for trend 0.02). Men who consumed >= 5 drinks/week vs. < 1 drink/month of liquor had a multivariable RR of 1.72 (95% CI, 1.26-2.35, P for trend <0.001). Wine and beer were not significantly associated with major GIB. The risk of GIB associated with NSAIDs/aspirin use increased with greater alcohol consumption (multivariable RR 1.37; 95% CI, 0.85-2.19 for 1-14g/day of alcohol, RR 1.75; 95% CI, 1.07-2.88 for-15g/ day compared to nondrinkers). Smoking was not significantly associated with GIB. Conclusions Alcohol consumption, but not smoking, was associated with an increased risk of major GIB. Associations were most notable for upper GIB associated with liquor intake. Alcohol appeared to potentiate the risk of NSAID-associated GIB.	[Strate, Lisa L.] Univ Washington, Sch Med, Dept Med, Div Gastroenterol, Seattle, WA 98195 USA; [Singh, Prashant] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA USA; [Boylan, Matthew R.; Cao, Yin; Chan, Andrew T.] Harvard Med Sch, Massachusetts Gen Hosp, Div Gastroenterol, Dept Med, Boston, MA 02115 USA; [Boylan, Matthew R.; Cao, Yin; Chan, Andrew T.] Harvard Med Sch, Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA 02115 USA; [Piawah, Sorbarikor] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA USA; [Cao, Yin] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Chan, Andrew T.] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Dept Med, Boston, MA 02115 USA	University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Chan, AT (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Div Gastroenterol, Dept Med, Boston, MA 02115 USA.; Chan, AT (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA 02115 USA.; Chan, AT (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Dept Med, Boston, MA 02115 USA.	achan@partners.org	Cao, Yin/ABE-2332-2021; singh, prashant/AAQ-4412-2020	Cao, Yin/0000-0001-9835-7662; 	National Institutes of Health, National Cancer Institute [UM1 CM 67552]; National Institutes of Health, National Institute for Diabetes and Digestive and Kidney Diseases [R01 DK095964, K24 DK098311]	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, National Institute for Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by the following: National Institutes of Health, National Cancer Institute UM1 CM 67552; National Institutes of Health, National Institute for Diabetes and Digestive and Kidney Diseases R01 DK095964 ATC; and National Institutes of Health, National Institute for Diabetes and Digestive and Kidney Diseases K24 DK098311 ATC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Al-Mallah M, 2007, J THROMB THROMBOLYS, V23, P51, DOI 10.1007/s11239-006-9005-8; Andersen IB, 2000, EPIDEMIOLOGY, V11, P434; Ballard HS, 1997, ALCOHOL HEALTH RES W, V21, P42; BARTLE WR, 1986, ARCH INTERN MED, V146, P2365, DOI 10.1001/archinte.146.12.2365; BATTAGLIA G, 1993, ITAL J GASTROENTEROL, V25, P419; Bode C, 1996, GUT, V39, P348, DOI 10.1136/gut.39.3.348; Chan AT, 2004, ANN INTERN MED, V140, P157, DOI 10.7326/0003-4819-140-3-200402030-00006; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Chen SH, 2005, WORLD J GASTROENTERO, V11, P3746, DOI 10.3748/wjg.v11.i24.3746; Chen WY, 2011, JAMA-J AM MED ASSOC, V306, P1884, DOI 10.1001/jama.2011.1590; Cho E, 2012, AM J CLIN NUTR, V95, P413, DOI 10.3945/ajcn.111.022145; COGGON D, 1982, GUT, V23, P340, DOI 10.1136/gut.23.4.340; DAVENPOR.HW, 1969, GASTROENTEROLOGY, V56, P439; Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; Fisher L, 2007, ALIMENT PHARM THER, V25, P297, DOI 10.1111/j.1365-2006.03187.x; Gallerani M, 2004, J CLIN EPIDEMIOL, V57, P103, DOI 10.1016/S0895-4356(03)00255-5; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; GOULSTON K, 1968, BRIT MED J, V4, P664, DOI 10.1136/bmj.4.5632.664; HENRY D, 1993, GASTROENTEROLOGY, V105, P1078, DOI 10.1016/0016-5085(93)90952-9; Hiraishi H, 1999, J PHARMACOL EXP THER, V289, P103; HOLVOET J, 1991, GUT, V32, P730, DOI 10.1136/gut.32.7.730; Huang ES, 2011, AM J MED, V124, P426, DOI 10.1016/j.amjmed.2010.12.022; Huang ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015721; Jansen A, 2009, WORLD J GASTROENTERO, V15, P457, DOI 10.3748/wjg.15.457; Kang JM, 2011, SCAND J GASTROENTERO, V46, P1295, DOI 10.3109/00365521.2011.605468; Kaplan RC, 2002, AGE AGEING, V31, P217, DOI 10.1093/ageing/31.3.217; Kaplan RC, 2002, PREV MED, V34, P455, DOI 10.1006/pmed.2002.1008; Kaplan RC, 2001, J AM GERIATR SOC, V49, P126, DOI 10.1046/j.1532-5415.2001.49032.x; Karkkainen JM, 2015, DIGEST DIS SCI, V60, P3707, DOI 10.1007/s10620-015-3806-6; Kaufman DW, 1999, AM J GASTROENTEROL, V94, P3189, DOI 10.1111/j.1572-0241.1999.01517.x; KELLY JP, 1995, AM J GASTROENTEROL, V90, P1058; Kudoh K, 2003, J NUTR SCI VITAMINOL, V49, P451, DOI 10.3177/jnsv.49.451; Laine L, 2012, AM J GASTROENTEROL, V107, P1190, DOI 10.1038/ajg.2012.168; Matsuhashi T, 2007, DIGEST DIS SCI, V52, P434, DOI 10.1007/s10620-006-9571-9; Nagata N, 2014, J GASTROEN HEPATOL, V29, P1786, DOI 10.1111/jgh.12595; Nikolsky E, 2009, J AM COLL CARDIOL, V54, P1293, DOI 10.1016/j.jacc.2009.07.019; OATES PJ, 1988, GASTROENTEROLOGY, V94, P10, DOI 10.1016/0016-5085(88)90604-X; Pai JK, 2012, EUR HEART J, V33, P1598, DOI 10.1093/eurheartj/ehs047; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; PESKAR BM, 1988, BRIT J PHARMACOL, V93, P937, DOI 10.1111/j.1476-5381.1988.tb11483.x; Prakash UNS, 2010, APPL PHYSIOL NUTR ME, V35, P134, DOI 10.1139/H09-133; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Roberts SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049507; SCHUBERT TT, 1993, AM J MED, V94, P413, DOI 10.1016/0002-9343(93)90153-G; SEDMAN AJ, 1976, J STUD ALCOHOL, V37, P1197, DOI 10.15288/jsa.1976.37.1197; Stack WA, 2002, ALIMENT PHARM THER, V16, P497, DOI 10.1046/j.1365-2036.2002.01197.x; TARNAWSKI A, 1987, CLIN INVEST MED, V10, P259; TARNAWSKI A, 1985, GASTROENTEROLOGY, V88, P334, DOI 10.1016/S0016-5085(85)80188-8; Tsuruoka N, 2011, J GASTROEN HEPATOL, V26, P1047, DOI 10.1111/j.1440-1746.2010.06610.x; Udd M, 2007, SCAND J GASTROENTERO, V42, P1395, DOI 10.1080/00365520701478758; Weil J, 2000, GUT, V46, P27, DOI 10.1136/gut.46.1.27; Yamada A, 2008, DIS COLON RECTUM, V51, P116, DOI 10.1007/s10350-007-9137-8; ZOUCAS E, 1982, EUR SURG RES, V14, P33, DOI 10.1159/000128220	54	17	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165278	10.1371/journal.pone.0165278	http://dx.doi.org/10.1371/journal.pone.0165278			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824864	gold, Green Submitted, Green Published			2022-12-26	WOS:000387615200015
J	Suh, KJ; Cheong, JW; Kim, I; Kim, HJ; Shin, DY; Koh, Y; Yoon, SS; Min, YH; Ahn, JS; Kim, YK; Lee, YG; Lee, JO; Bang, SM; Mun, YC; Seong, CM; Park, Y; Kim, BS; Hong, J; Park, J; Lee, JH; Kim, SY; Lee, HG				Suh, Koung Jin; Cheong, June-Won; Kim, Inho; Kim, Hyeoung-Joon; Shin, Dong-Yeop; Koh, Youngil; Yoon, Sung -Soo; Min, Yoo Hong; Ahn, Jae-Sook; Kim, Yeo-Kyeoung; Lee, Yun-Gyoo; Lee, Jeong-Ok; Bang, Soo-Mee; Mun, Yeung-Chul; Seong, Chu-Myoung; Park, Yong; Kim, Byung-Soo; Hong, Junshik; Park, Jinny; Lee, Jae Hoon; Kim, Sung -Yong; Lee, Hong Ghi			Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome	PLOS ONE			English	Article							MONOSOMAL KARYOTYPE; SCORING SYSTEM; PHASE-III; SURVIVAL; MDS; AZACITIDINE; MUTATIONS; STRATIFICATION; OUTCOMES	Chromosomal translocations are rare in myelodysplastic syndrome (MDS) and their impact on overall survival (OS) and response to hypomethylating agents (HMA) is unknown. The prognostic impact of the revised International Prognostic Scoring System (IPSS-R) and for chromosomal translocations was assessed in 751 patients from the Korea MDS Registry. IPSS-R effectively discriminated patients according to leukaemia evolution risk and OS. We identified 40 patients (5.3%) carrying translocations, 30 (75%) of whom also fulfilled complex karyotype criteria. Translocation presence was associated with a shorter OS (median, 12.0 versus 79.7 months, P < 0.01). Multivariate analysis demonstrated that translocations (hazard ratio [HR] 1.64 [1.06-2.63]; P = 0.03) as well as age, sex, IPSS-R, and CK were independent predictors of OS. In the IPSS-R high and very high risk subgroup (n=260), translocations remained independently associated with OS (HR 1.68 [1.06-2.69], P = 0.03) whereas HMA treatment was not associated with improved survival (median OS, 20.9 versus 21.2 months, P = 0.43). However, translocation carriers exhibited enhanced survival following HMA treatment (median 2.1 versus 12.4 months, P = 0.03). Our data suggest that chromosomal translocation is an independent predictor of adverse outcome and has an additional prognostic value in discriminating patients with MDS having higher risk IPSS-R who could benefit from HMA treatment.	[Suh, Koung Jin; Kim, Inho; Shin, Dong-Yeop; Koh, Youngil; Yoon, Sung -Soo] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul Natl Univ Hosp,Dept Internal Med, Seoul, South Korea; [Cheong, June-Won; Min, Yoo Hong] Yonsei Univ, Dept Internal Med, Severance Hosp, Seoul, South Korea; [Kim, Hyeoung-Joon; Ahn, Jae-Sook; Kim, Yeo-Kyeoung] Chonnam Natl Univ, Dept Internal Med, Hwasun Hosp, Hwasun, Chonnam, South Korea; [Lee, Yun-Gyoo] Kangbuk Samsung Hosp, Dept Internal Med, Seoul, South Korea; [Lee, Jeong-Ok; Bang, Soo-Mee] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Songnam, Gyeonggi, South Korea; [Mun, Yeung-Chul; Seong, Chu-Myoung] Ewha Womans Univ, Dept Internal Med, Mokdong Hosp, Seoul, South Korea; [Park, Yong; Kim, Byung-Soo] Korea Univ, Anam Hosp, Dept Internal Med, Seoul, South Korea; [Hong, Junshik; Park, Jinny; Lee, Jae Hoon] Gachon Univ, Dept Internal Med, Gil Med Ctr, Inchon, South Korea; [Kim, Sung -Yong; Lee, Hong Ghi] Konkuk Univ, Dept Internal Med, Sch Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Yonsei University; Yonsei University Health System; Chonnam National University; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Ewha Womans University; Korea University; Korea University Medicine (KU Medicine); Gachon University; Konkuk University; Konkuk University Medical Center	Kim, I (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul Natl Univ Hosp,Dept Internal Med, Seoul, South Korea.; Kim, HJ (corresponding author), Chonnam Natl Univ, Dept Internal Med, Hwasun Hosp, Hwasun, Chonnam, South Korea.	ihkimmd@snu.ac.kr; hjoonk@chonnam.ac.kr	Yoon, Sung-Soo/J-2773-2012	Suh, Koung Jin/0000-0002-1881-8738; CHEONG, JUNE-WON/0000-0002-1744-0921; Mun, Yeung-Chul/0000-0002-1882-3983; min, yoo hong/0000-0001-8542-9583				Ai J, 2015, CL LYMPH MYELOM LEUK, V15, P489, DOI 10.1016/j.clml.2015.03.017; Bejar R, 2014, BLOOD, V124, P2793, DOI 10.1182/blood-2014-04-522136; Bejar R, 2014, BLOOD, V124, P2705, DOI 10.1182/blood-2014-06-582809; BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x; Bernal T, 2015, LEUKEMIA, V29, P1875, DOI 10.1038/leu.2015.115; Chun K, 2010, LEUKEMIA RES, V34, P160, DOI 10.1016/j.leukres.2009.07.006; Cluzeau T, 2013, AM J HEMATOL, V88, P780, DOI 10.1002/ajh.23509; Costa D, 2013, GENE CHROMOSOME CANC, V52, P753, DOI 10.1002/gcc.22071; Dvorak P, 2014, HEMATOL ONCOL, V32, P82, DOI 10.1002/hon.2089; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Gangat N, 2013, AM J HEMATOL, V88, P690, DOI 10.1002/ajh.23477; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Gurion R, 2010, HAEMATOL-HEMATOL J, V95, P303, DOI 10.3324/haematol.2009.010611; Haase D, 2007, BLOOD, V110, P4385, DOI 10.1182/blood-2007-03-082404; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Lubbert M, 2011, J CLIN ONCOL, V30, P9245; Lubbert M, 2016, ANN HEMATOL, V95, P191, DOI 10.1007/s00277-015-2547-0; Malcovati L, 2013, BLOOD, V122, P2943, DOI 10.1182/blood-2013-03-492884; McQuilten ZK, 2015, CANCER-AM CANCER SOC, V121, P2892, DOI 10.1002/cncr.29396; Nomdedeu M, 2016, GENE CHROMOSOME CANC, V55, P322, DOI 10.1002/gcc.22333; Nomenclature ISC on HC, 2013, ISCN 2013 INT SYSTEM; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Traina F, 2014, LEUKEMIA, V28, P78, DOI 10.1038/leu.2013.269; Valcarcel D, 2013, J CLIN ONCOL, V31, P916, DOI 10.1200/JCO.2012.41.6073; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Walker A, 2013, GENE CHROMOSOME CANC, V52, P385, DOI 10.1002/gcc.22036; Walter MJ, 2013, LEUKEMIA, V27, P1275, DOI 10.1038/leu.2013.58; Xing RX, 2014, AM J HEMATOL, V89, pE163, DOI 10.1002/ajh.23801; Yang YT, 2014, AM J HEMATOL, V89, pE142, DOI 10.1002/ajh.23765; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496	31	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166245	10.1371/journal.pone.0166245	http://dx.doi.org/10.1371/journal.pone.0166245			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824923	gold, Green Submitted, Green Published			2022-12-26	WOS:000387615200076
J	Kim, SH; Vlijm, R; van der Torre, J; Dalal, Y; Dekker, C				Kim, Sung Hyun; Vlijm, Rifka; van der Torre, Jaco; Dalal, Yamini; Dekker, Cees			CENP-A and H3 Nucleosomes Display a Similar Stability to Force-Mediated Disassembly	PLOS ONE			English	Article							HISTONE CHAPERONE NAP1; CENTROMERIC NUCLEOSOME; SINGLE-MOLECULE; MAGNETIC TWEEZERS; CRYSTAL-STRUCTURE; CHROMATIN FIBERS; KINETOCHORE; DNA; DYNAMICS; CORE	Centromere-specific nucleosomes are a central feature of the kinetochore complex during mitosis, in which microtubules exert pulling and pushing forces upon the centromere. CENP-A nucleosomes have been assumed to be structurally unique, thereby providing resilience under tension relative to their H3 canonical counterparts. Here, we directly test this hypothesis by subjecting CENP-A and H3 octameric nucleosomes, assembled on random or on centromeric DNA sequences, to varying amounts of applied force by using single-molecule magnetic tweezers. We monitor individual disassembly events of CENP-A and H3 nucleosomes. Regardless of the DNA sequence, the force-mediated disassembly experiments for CENP-A and H3 nucleosomes demonstrate similar rupture forces, life time residency and disassembly steps. From these experiments, we conclude that CENP-A does not, by itself, contribute unique structural features to the nucleosome that lead to a significant resistance against force-mediated disruption. The data present insights into the mechanistic basis for how CENP-A nucleosomes might contribute to the structural foundation of the centromere in vivo.	[Kim, Sung Hyun; Vlijm, Rifka; van der Torre, Jaco; Dekker, Cees] Delft Univ Technol, Kavli Inst Nanosci Delft, Dept Bionanosci, Delft, Netherlands; [Dalal, Yamini] NCI, Chromatin Struct & Epigenet Mech Unit, Lab Receptor Biol & Gene Express, Ctr Canc Res,NHI, Bethesda, MD 20892 USA; [Vlijm, Rifka] German Canc Res Ctr, Div Opt Nanoscopy, Heidelberg, Germany	Delft University of Technology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Helmholtz Association; German Cancer Research Center (DKFZ)	Dekker, C (corresponding author), Delft Univ Technol, Kavli Inst Nanosci Delft, Dept Bionanosci, Delft, Netherlands.; Dalal, Y (corresponding author), NCI, Chromatin Struct & Epigenet Mech Unit, Lab Receptor Biol & Gene Express, Ctr Canc Res,NHI, Bethesda, MD 20892 USA.	dalaly@mail.nih.gov; C.Dekker@tudelft.nl	Vlijm, Rifka/ABB-9663-2020	Vlijm, Rifka/0000-0001-8909-9518; van der Torre, Jaco/0000-0002-5405-3824; Kim, Sung Hyun/0000-0001-9272-7036	ERC Advanced Grant SynDiv [669598]; Netherlands Organization for Scientific Research (NWO/OCW) [as part of the Frontiers of Nanoscience program]; intramural research program of the Center for Cancer Research under the auspices of the National Cancer Institute at the NIH; NATIONAL CANCER INSTITUTE [ZIABC011207] Funding Source: NIH RePORTER	ERC Advanced Grant SynDiv; Netherlands Organization for Scientific Research (NWO/OCW) [as part of the Frontiers of Nanoscience program]; intramural research program of the Center for Cancer Research under the auspices of the National Cancer Institute at the NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the ERC Advanced Grant SynDiv [grant number 669598 to C.D.]; the Netherlands Organization for Scientific Research (NWO/OCW) [as part of the Frontiers of Nanoscience program]. YD is funded by the intramural research program of the Center for Cancer Research under the auspices of the National Cancer Institute at the NIH.	Andrews AJ, 2010, MOL CELL, V37, P834, DOI 10.1016/j.molcel.2010.01.037; Bancaud A, 2007, MOL CELL, V27, P135, DOI 10.1016/j.molcel.2007.05.037; Bergmann JH, 2011, EMBO J, V30, P328, DOI 10.1038/emboj.2010.329; Bintu L, 2012, CELL, V151, P738, DOI 10.1016/j.cell.2012.10.009; Black BE, 2008, CURR OPIN CELL BIOL, V20, P91, DOI 10.1016/j.ceb.2007.11.007; Black B, 2011, CELL, V144, P471, DOI 10.1016/j.cell.2011.02.002; Bloom KS, 2014, ANNU REV GENET, V48, P457, DOI 10.1146/annurev-genet-120213-092033; Brower-Toland BD, 2002, P NATL ACAD SCI USA, V99, P1960, DOI 10.1073/pnas.022638399; Chien FT, 2009, CURR PHARM BIOTECHNO, V10, P474, DOI 10.2174/138920109788922128; Dalai Y, 2007, P NATL ACAD SCI USA, V104, P15974, DOI 10.1073/pnas.0707648104; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; De Vlaminck I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041432; Dechassa ML, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1320; EARNSHAW WC, 1980, CELL, V21, P373, DOI 10.1016/0092-8674(80)90474-2; Eeftens JM, 2015, BMC BIOPHYS, V8, DOI 10.1186/s13628-015-0023-9; Falk SJ, 2016, NAT STRUCT MOL BIOL, V23, P204, DOI 10.1038/nsmb.3175; Falk SJ, 2015, SCIENCE, V348, P699, DOI 10.1126/science.1259308; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; FUJIINAKATA T, 1992, J BIOL CHEM, V267, P20980; Fukagawa T, 2014, DEV CELL, V30, P497, DOI 10.1016/j.devcel.2014.08.016; Gascoigne KE, 2011, CELL, V145, P410, DOI 10.1016/j.cell.2011.03.031; Greaves IK, 2007, P NATL ACAD SCI USA, V104, P525, DOI 10.1073/pnas.0607870104; Hayden KE, 2013, MOL CELL BIOL, V33, P763, DOI 10.1128/MCB.01198-12; Hu H, 2011, GENE DEV, V25, P901, DOI 10.1101/gad.2045111; Jannink G, 1996, BIOPHYS J, V71, P451, DOI 10.1016/S0006-3495(96)79247-0; Katan AJ, 2015, SMALL, V11, P976, DOI 10.1002/smll.201401318; Kato H, 2013, SCIENCE, V340, P1110, DOI 10.1126/science.1235532; Killian JL, 2012, CURR OPIN STRUC BIOL, V22, P80, DOI 10.1016/j.sbi.2011.11.003; KLEIMAN L, 1972, J MOL BIOL, V64, P1, DOI 10.1016/0022-2836(72)90317-8; Kruithof M, 2009, BIOPHYS J, V96, P3708, DOI [10.1016/j.bpj.2009.01.048, 10.1016/j.bpj.2009.01.04X]; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Lyubchenko YL, 2014, NAT STRUCT MOL BIOL, V21, P8, DOI 10.1038/nsmb.2745; Mazurkiewicz J, 2006, J BIOL CHEM, V281, P16462, DOI 10.1074/jbc.M511619200; McEwen BF, 1997, J CELL BIOL, V137, P1567, DOI 10.1083/jcb.137.7.1567; Melters DP, 2015, GENES-BASEL, V6, P751, DOI 10.3390/genes6030751; Meng H, 2015, NUCLEIC ACIDS RES, V43, P3578, DOI 10.1093/nar/gkv215; Miell MDD, 2013, NAT STRUCT MOL BIOL, V20, P763, DOI 10.1038/nsmb.2574; Miga KH, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv671; Mihardja S, 2006, P NATL ACAD SCI USA, V103, P15871, DOI 10.1073/pnas.0607526103; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Moyle-Heyrman G, 2011, J MOL BIOL, V412, P634, DOI 10.1016/j.jmb.2011.07.032; Nag R, 2009, MUTAT RES-REV MUTAT, V682, P13, DOI 10.1016/j.mrrev.2009.01.002; Nakagawa T, 2001, J BIOL CHEM, V276, P27384, DOI 10.1074/jbc.M101331200; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; NICKLAS RB, 1983, J CELL BIOL, V97, P542, DOI 10.1083/jcb.97.2.542; Okamoto Y, 2007, EMBO J, V26, P1279, DOI 10.1038/sj.emboj.7601584; Petrovic A, 2014, MOL CELL, V53, P591, DOI 10.1016/j.molcel.2014.01.019; Przewloka MR, 2009, ANNU REV GENET, V43, P439, DOI 10.1146/annurev-genet-102108-134310; Ribeiro SA, 2010, P NATL ACAD SCI USA, V107, P10484, DOI 10.1073/pnas.1002325107; Screpanti E, 2011, CURR BIOL, V21, P391, DOI 10.1016/j.cub.2010.12.039; Sheinin MY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3579; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; Silva NCE, 2007, J MOL BIOL, V370, P555, DOI 10.1016/j.jmb.2007.04.064; Stellfox ME, 2013, CELL MOL LIFE SCI, V70, P387, DOI 10.1007/s00018-012-1048-8; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Teves SS, 2014, NUCLEUS-AUSTIN, V5, P211, DOI 10.4161/nucl.29086; Teves SS, 2014, NAT STRUCT MOL BIOL, V21, P88, DOI 10.1038/nsmb.2723; van Loenhout MTJ, 2012, BIOPHYS J, V102, P2362, DOI 10.1016/j.bpj.2012.03.073; Verdaasdonk JS, 2011, NAT REV MOL CELL BIO, V12, P320, DOI 10.1038/nrm3107; Vlijm R, 2015, CELL REP, V10, P216, DOI 10.1016/j.celrep.2014.12.022; Vlijm R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046306; Walkiewicz MP, 2014, METHODS MOL BIOL, V1170, P589, DOI 10.1007/978-1-4939-0888-2_34; Walkiewicz MP, 2014, NAT STRUCT MOL BIOL, V21, P2, DOI 10.1038/nsmb.2742; WAYE JS, 1987, NUCLEIC ACIDS RES, V15, P7549, DOI 10.1093/nar/15.18.7549; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100; Winogradoff D, 2015, SCI REP-UK, V5, DOI 10.1038/srep17038; Yang C., 2020, ELIFE, DOI [10.7554/eLife.51339, DOI 10.7554/ELIFE.02482, 10.7554/eLife.02482, DOI 10.7554/ELIFE.03254]; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697	71	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165078	10.1371/journal.pone.0165078	http://dx.doi.org/10.1371/journal.pone.0165078			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820823	Green Published, Green Submitted, gold			2022-12-26	WOS:000387614800006
J	Kim, B; Hyun, CK				Kim, Bobae; Hyun, Chang-Kee			Gender-Specific Mechanisms Underlying the Amelioration of High-Fat Diet-Induced Glucose Intolerance in B-Cell-Activating Factor Deficient Mice	PLOS ONE			English	Article							ADIPOSE-TISSUE; AUTOIMMUNE-DISEASES; INSULIN-RESISTANCE; BROWN-FAT; OBESITY; WHITE; IRISIN; BAFF; AMPK; PGC-1-ALPHA	It has recently been found that B cell activating factor (BAFF) plays an important role in the regulation of energy homeostasis. We also have previously reported that BAFF deficiency reverses high-fat (HF) diet-induced glucose intolerance by potentiating adipose tissue function. In the present study, we found that BAFF deficient (BAFF(-/-)) mice exhibit gender-specific differences in protection against diet-induced glucose intolerance, and aimed to characterize the gender-dependent molecular alterations in energy metabolism. Under HF feeding conditions, serum BAFF level of female wild-type (WT) mice was considerably higher than that of male mice. Despite increased body weight gain, both male and female BAFF(-/-) mice showed significantly improved glucose tolerance compared to their WT counterparts. Expressions of genes involved in glucose transport, thermogenesis and lipid oxidation were up-regulated in brown adipose tissues of both male and female BAFF(-/-) mice. Interestingly, the expression of thermogenic genes in subcutaneous adipose tissue was significantly enhanced in female BAFF(-/-) compared to WT mice, but the difference was not observed between male BAFF(-/-) and WT mice. The enhanced thermogenic program was confirmed by higher protein levels of UCP1 and irisin in female BAFF(-/-) than in WT mice. Additionally, adiponectin production in white adipose tissues and AMPK phosphorylation in subcutaneous adipose tissue were also significantly elevated in female BAFF(-/-) compared to WT mice, but not in male BAFF(-/-) mice. Our findings define a comprehensive scenario for the enhancing effect of BAFF depletion on glucose tolerance wherein the underlying mechanism is, at least in part, gender-specific, and suggest that gender difference should be considered as an important factor in the use of BAFF blockade as a therapeutic approach for the prevention and treatment of type 2 diabetes.	[Kim, Bobae; Hyun, Chang-Kee] Handong Global Univ, Sch Life Sci, Pohang, Gyungbuk, South Korea	Handong Global University	Hyun, CK (corresponding author), Handong Global Univ, Sch Life Sci, Pohang, Gyungbuk, South Korea.	ckhyun@handong.edu			Basic Science Research Program through National Research Foundation of Korea - Ministry of Education [NRF-2015R1D1A1A01058699]	Basic Science Research Program through National Research Foundation of Korea - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (NRF-2015R1D1A1A01058699). The URL of funder's website is http:/www.nrf.re.kr/nrf_eng_cms/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amur S, 2012, J AUTOIMMUN, V38, pJ254, DOI 10.1016/j.jaut.2011.12.001; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bienertova-Vasku J, 2012, CENT EUR J MED, V7, P275, DOI 10.2478/s11536-011-0153-7; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Castillo-Quan JI, 2012, DIS MODEL MECH, V5, P293, DOI 10.1242/dmm.009894; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Hamada M, 2011, OBESITY, V19, P1915, DOI 10.1038/oby.2011.165; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Her M, 2016, J ALLERGY CLIN IMMUN, V137, P19, DOI 10.1016/j.jaci.2015.10.023; Hughes GC, 2014, NAT REV RHEUMATOL, V10, P740, DOI 10.1038/nrrheum.2014.144; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Hui XY, 2015, CELL METAB, V22, P279, DOI 10.1016/j.cmet.2015.06.004; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kim B, 2015, BIOCHEM BIOPH RES CO, V464, P1171, DOI 10.1016/j.bbrc.2015.07.099; Kim E, 2011, EUR J PHARMACOL, V672, P38, DOI 10.1016/j.ejphar.2011.09.172; Kovats S, 2015, CELL IMMUNOL, V294, P63, DOI 10.1016/j.cellimm.2015.01.018; Litwak SA, 2014, ENDOCRINOLOGY, V155, P4447, DOI 10.1210/en.2014-1342; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Miyake T, 2013, HEPATOL INT, V7, P539, DOI 10.1007/s12072-012-9345-8; Ng LG, 2005, MOL IMMUNOL, V42, P763, DOI 10.1016/j.molimm.2004.06.041; Palmer BF, 2015, MOL CELL ENDOCRINOL, V402, P113, DOI 10.1016/j.mce.2014.11.029; Panchanathan R, 2013, MOL IMMUNOL, V53, P15, DOI 10.1016/j.molimm.2012.06.013; Pennell LM, 2012, J AUTOIMMUN, V38, pJ282, DOI 10.1016/j.jaut.2011.11.013; Pers JO, 2005, ANN NY ACAD SCI, V1050, P34, DOI 10.1196/annals.1313.004; Rasouli N, 2008, J CLIN ENDOCR METAB, V93, pS64, DOI 10.1210/jc.2008-1613; Rickert RC, 2011, IMMUNOL REV, V244, P115, DOI 10.1111/j.1600-065X.2011.01067.x; Tiniakou E, 2013, CLIN IMMUNOL, V149, P182, DOI 10.1016/j.clim.2013.02.011; Tuomilehto J, 2003, DIABETES CARE, V26, P61; Varlamov O, 2015, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00241; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wan ZX, 2014, OBESITY, V22, P730, DOI 10.1002/oby.20605; White UA, 2014, BBA-MOL BASIS DIS, V1842, P377, DOI 10.1016/j.bbadis.2013.05.006; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106; Zonca M, 2012, TISSUE ENG PT A, V18, P853, DOI [10.1089/ten.tea.2011.0316, 10.1089/ten.TEA.2011.0316]	39	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166225	10.1371/journal.pone.0166225	http://dx.doi.org/10.1371/journal.pone.0166225			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814392	gold, Green Submitted, Green Published			2022-12-26	WOS:000386911100037
J	Roche, SL; Wyse-Jackson, AC; Gomez-Vicente, V; Lax, P; Ruiz-Lopez, AM; Byrne, AM; Cuenca, N; Cotter, TG				Roche, Sarah L.; Wyse-Jackson, Alice C.; Gomez-Vicente, Violeta; Lax, Pedro; Ruiz-Lopez, Ana M.; Byrne, Ashleigh M.; Cuenca, Nicolas; Cotter, Thomas G.			Progesterone Attenuates Microglial-Driven Retinal Degeneration and Stimulates Protective Fractalkine-CX3CR1 Signaling	PLOS ONE			English	Article							PHOTORECEPTOR CELL-DEATH; RD10 MOUSE MODEL; 18 KDA TSPO; INFLAMMATORY RESPONSE; IN-VIVO; ACTIVATION; IDENTIFICATION; NEUROTOXICITY; MIGRATION; CLEAVAGE	Retinitis pigmentosa (RP) is a degenerative disease leading to photoreceptor cell loss. Mouse models of RP, such as the rd10 mouse (B6.CXBl-Pde6brd10/J), have enhanced our understanding of the disease, allowing for development of potential therapeutics. In 2011, our group first demonstrated that the synthetic progesterone analogue 'Norgestrel' is neuroprotective in two mouse models of retinal degeneration, including the rd10 mouse. We have since elucidated several mechanisms by which Norgestrel protects stressed photoreceptors, such as upregulating growth factors. This study consequently aimed to further characterize Norgestrel's neuroprotective effects. Specifically, we sought to investigate the role that microglia might play; for microglial-derived inflammation has been shown to potentiate neurodegeneration. Dams of post-natal day (P) 10 rd10 pups were given a Norgestrel-supplemented diet (80mg/kg). Upon weaning, pups remained on Norgestrel. Tissue was harvested from P15-P50 rd10 mice on control or Norgestrel-supplemented diet. Norgestrel-diet administration provided significant retinal protection out to P40 in rd10 mice. Alterations in microglial activity coincided with significant protection, implicating microglial changes in Norgestrel-induced neuroprotection. Utilizing primary cultures of retinal microglia and 661W photoreceptor-like cells, we show that rd10 microglia drive neuronal cell death. We reveal a novel role of Norgestrel, acting directly on microglia to reduce pro-inflammatory activation and prevent neuronal cell death. Norgestrel effectively suppresses cytokine, chemokine and danger-associated molecular pattern molecule (DAMP) expression in the rd10 retina. Remarkably, Norgestrel upregulates fractalkine-CX3CR1 signaling 1 000-fold at the RNA level, in the rd10 mouse. Fractalkine-CX3CR1 signaling has been shown to protect neurons by regulating retinal microglial activation and migration. Ultimately, these results present Norgestrel as a promising treatment for RP, with dual actions as a neuroprotective and anti-inflammatory agent in the retina.	[Roche, Sarah L.; Wyse-Jackson, Alice C.; Ruiz-Lopez, Ana M.; Byrne, Ashleigh M.; Cotter, Thomas G.] Univ Coll Cork, Cell Dev & Dis Lab, Dept Biochem, Biosci Inst, Cork, Ireland; [Gomez-Vicente, Violeta] Univ Alicante, Dept Opt Farmacol & Anat, Alicante, Spain; [Lax, Pedro; Cuenca, Nicolas] Univ Alicante, Dept Fisiol Genet & Microbiol, Alicante, Spain	University College Cork; Universitat d'Alacant; Universitat d'Alacant	Cotter, TG (corresponding author), Univ Coll Cork, Cell Dev & Dis Lab, Dept Biochem, Biosci Inst, Cork, Ireland.	t.cotter@ucc.ie	Cuenca, Nicolas/I-2007-2015; Lax, Pedro/M-9074-2014; Gómez-Vicente, Violeta/A-6089-2013	Cuenca, Nicolas/0000-0002-6767-5710; Lax, Pedro/0000-0001-6931-1008; Gómez-Vicente, Violeta/0000-0002-5696-8673; Cotter, Thomas/0000-0003-4626-5613	Science Foundation Ireland [SFI 13/IA/1783]; Fighting Blindness Ireland [FB13COT]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Fighting Blindness Ireland	This work was supported by grants from Science Foundation Ireland (SFI 13/IA/1783) and Fighting Blindness Ireland (FB13COT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Arroba AI, 2011, INVEST OPHTH VIS SCI, V52, P9124, DOI 10.1167/iovs.11-7736; Barhoum R, 2008, NEUROSCIENCE, V155, P698, DOI 10.1016/j.neuroscience.2008.06.042; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Byrne AM, 2016, MOL VIS, V22, P264; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Cardona SM, 2015, ASN NEURO, V7, DOI 10.1177/1759091415608204; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Cross AK, 1999, J NEUROSCI RES, V55, P17, DOI 10.1002/(SICI)1097-4547(19990101)55:1<17::AID-JNR3>3.0.CO;2-J; Doonan F, 2011, J NEUROCHEM, V118, P915, DOI 10.1111/j.1471-4159.2011.07354.x; DUVALL E, 1985, IMMUNOLOGY, V56, P351; Dworzak J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127730; Eaton SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072457; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Garton KJ, 2001, J BIOL CHEM, V276, P37993; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Guo CR, 2012, EXP EYE RES, V104, P39, DOI 10.1016/j.exer.2012.08.013; Han JJ, 2013, MOL VIS, V19, P2579; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Huang YW, 2009, J BIOL CHEM, V284, P29644, DOI 10.1074/jbc.M109.045682; Hundhausen Christian, 2003, Blood, V102, P1186; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Jackson ACW, 2016, EUR J NEUROSCI, V43, P899, DOI 10.1111/ejn.13166; Jackson ACW, 2016, J NEUROCHEM, V136, P63, DOI 10.1111/jnc.13388; Karlstetter M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-3; Karlstetter M, 2010, IMMUNOBIOLOGY, V215, P685, DOI 10.1016/j.imbio.2010.05.010; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Liu GY, 2005, J BIOL CHEM, V280, P19858, DOI 10.1074/jbc.M413073200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucas M, 2006, J IMMUNOL, V177, P4047, DOI 10.4049/jimmunol.177.6.4047; Lugrin J, 2015, J IMMUNOL, V194, P499, DOI 10.4049/jimmunol.1401948; Lyons A, 2009, J NEUROCHEM, V110, P1547, DOI 10.1111/j.1471-4159.2009.06253.x; Madeira MH, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/673090; de la Camara CMF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11764; Mattison HA, 2013, J NEUROIMMUNOL, V257, P110, DOI 10.1016/j.jneuroim.2013.02.008; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Peng B, 2014, J NEUROSCI, V34, P8139, DOI 10.1523/JNEUROSCI.5200-13.2014; Pennesi ME, 2012, INVEST OPHTH VIS SCI, V53, P4644, DOI 10.1167/iovs.12-9611; Roche SL, 2016, INT J DEV BIOL, V60, P127, DOI 10.1387/ijdb.150400tc; Rutar M, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0224-1; Saijo K, 2011, CELL, V145, P584, DOI 10.1016/j.cell.2011.03.050; Samardzija M, 2012, EXP EYE RES, V99, P17, DOI 10.1016/j.exer.2012.04.004; Santos NC, 2003, BIOCHEM PHARMACOL, V65, P1035, DOI 10.1016/S0006-2952(03)00002-9; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scholz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0431-4; Scholz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0422-5; Thacker MA, 2009, EUR J PAIN, V13, P263, DOI 10.1016/j.ejpain.2008.04.017; Wang AL, 2005, NEUROCHEM INT, V47, P152, DOI 10.1016/j.neuint.2005.04.018; Wang K, 2014, GLIA, V62, P1943, DOI 10.1002/glia.22715; Wang MH, 2014, J NEUROSCI, V34, P3793, DOI 10.1523/JNEUROSCI.3153-13.2014; Weigelt K, 2007, J LEUKOCYTE BIOL, V82, P1564, DOI 10.1189/jlb.0707447; Yang LP, 2007, MOL VIS, V13, P2048; Yang LP, 2007, MOL VIS, V13, P1073; Yoshida N, 2013, OPHTHALMOLOGY, V120, pE5, DOI 10.1016/j.ophtha.2012.07.008; Zabel MK, 2016, GLIA, V64, P1479, DOI 10.1002/glia.23016; Zeng H, 2014, NEUROSCIENCE, V275, P54, DOI 10.1016/j.neuroscience.2014.05.065; Zeng HY, 2005, INVEST OPHTH VIS SCI, V46, P2992, DOI 10.1167/iovs.05-0118; Zhang C, 2005, MOL VIS, V11, P887; Zhang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035446; Zhao L, 2015, EMBO MOL MED, V7, P1179, DOI 10.15252/emmm.201505298; Zieger M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106562; Zujovic V, 2000, GLIA, V29, P305, DOI 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V	71	38	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165197	10.1371/journal.pone.0165197	http://dx.doi.org/10.1371/journal.pone.0165197			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814376	Green Published, gold, Green Submitted			2022-12-26	WOS:000386911100008
J	Shi, HR; Wang, B; Yang, PJ; Li, YB; Miao, F				Shi, Huarong; Wang, Bin; Yang, Piaojuan; Li, Yibo; Miao, Fang			Differences in Sugar Accumulation and Mobilization between Sequential and Non-Sequential Senescence Wheat Cultivars under Natural and Drought Conditions	PLOS ONE			English	Article							MONOCARPIC SENESCENCE; STARCH ACCUMULATION; SUCROSE SYNTHASE; TOMATO FRUIT; WATER-STRESS; METABOLISM; PHOTOSYNTHESIS; EXPRESSION; ENZYMES; GROWTH	Wheat leaf non-sequential senescence at the late grain-filling stage involves the early senescence of younger flag leaves compared to that observed in older second leaves. On the other hand, sequential senescence involves leaf senescence that follows an age-related pattern, in which flag leaves are the latest to undergo senescence. The characteristics of sugar metabolism in two sequential senescence cultivars and two non-sequential senescence cultivars under both natural and drought conditions were studied to elucidate the underlying mechanism of drought tolerance in two different senescence modes. The results showed that compared to sequential senescence wheat cultivars, under natural and drought conditions, non-sequential senescence wheat cultivars showed a higher leaf net photosynthetic rate, higher soluble sugar levels in leaves, leaf sheaths, and internodes, higher leaf sucrose synthase (SS) and sucrose phosphate synthase (SPS) activity, and higher grain SS activity, thereby suggesting that non-sequential senescence wheat cultivars had stronger source activity. Spike weight, grain weight per spike, and 100-grain weight of non-sequential senescence cultivars at maturity were significantly higher than those of sequential senescence cultivars under both natural and drought conditions. These findings indicate that the higher rate of accumulation and the higher mobilization of soluble sugar in the leaves, leaf sheaths and internodes of non-sequential senescence cultivars improve grain weight and drought tolerance. At the late grain-filling stage, drought conditions adversely affected leaf chlorophyll content, net photosynthetic rate, soluble sugar and sucrose content, SS and SPS activity, gain SS activity, and weight. This study showed that higher rates of soluble sugar accumulation in the source was one of the reasons of triggering leaf non-sequential senescence, and higher rates of soluble sugar mobilization during leaf non-sequential senescence promoted high and stable wheat yield and drought tolerance.	[Shi, Huarong; Wang, Bin; Yang, Piaojuan; Li, Yibo; Miao, Fang] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Miao, F (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China.	miaofangmf@nwsuaf.edu.cn			National Natural Science Foundation of China [31170366]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (31170366), http://www.nsfc.gov.cn/, Miao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Akbar Moayedi, 2009, Australian Journal of Basic and Applied Sciences, V3, P4408; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BISWAS AK, 1980, PLANT PHYSIOL, V65, P340, DOI 10.1104/pp.65.2.340; Calvino M, 2008, RICE, V1, P166, DOI 10.1007/s12284-008-9012-9; Champigny ML, 1995, PHOTOSYNTH RES, V46, P117, DOI 10.1007/BF00020422; Chen DQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137026; CRAFTSBRANDNER SJ, 1984, PLANT PHYSIOL, V75, P318, DOI 10.1104/pp.75.2.318; CRAFTSBRANDNER SJ, 1987, J EXP BOT, V38, P2043, DOI 10.1093/jxb/38.12.2043; Dai N, 1999, PLANT CELL, V11, P1253, DOI 10.1105/tpc.11.7.1253; Douglas CD, 1988, PLANT PHYSIOL, V86, P1013; Ehdaie B, 2006, CROP SCI, V46, P2093, DOI 10.2135/cropsci2006.01.0013; Fujiki Y, 2000, PLANT PHYSIOL, V124, P1139, DOI 10.1104/pp.124.3.1139; Gan SS, 1997, PLANT PHYSIOL, V113, P313, DOI 10.1104/pp.113.2.313; GRBIC V, 1995, PLANT J, V8, P595, DOI 10.1046/j.1365-313X.1995.8040595.x; HENSEL LL, 1993, PLANT CELL, V5, P553, DOI 10.1105/tpc.5.5.553; HoffmannThoma G, 1996, PHYSIOL PLANTARUM, V97, P277, DOI 10.1034/j.1399-3054.1996.970210.x; Ishimaru K, 2007, PLANT PHYSIOL BIOCH, V45, P799, DOI 10.1016/j.plaphy.2007.07.004; Jang JC, 1997, PLANT CELL, V9, P5, DOI 10.1105/tpc.9.1.5; Jiang Dong, 2003, Acta Agronomica Sinica, V29, P31; Joudi M, 2012, PHYSIOL PLANTARUM, V144, P1, DOI 10.1111/j.1399-3054.2011.01517.x; Kaur K, 2012, AGROCHIMICA, V56, P42; LEOPOLD AC, 1959, PLANT PHYSIOL, V34, P570, DOI 10.1104/pp.34.5.570; LI Y G, 2001, ACTA AGR SIN, V27, P658; Masclaux C, 2000, PLANTA, V211, P510, DOI 10.1007/s004250000310; MCKERSIE BD, 1992, CAN J BOT, V70, P2245, DOI 10.1139/b92-278; Molisch H, 1938, LONGEVITY PLANTS, P123; MONDAL WA, 1985, PHYSIOL PLANTARUM, V65, P221, DOI 10.1111/j.1399-3054.1985.tb02386.x; MONDAL WA, 1984, PHYSIOL PLANTARUM, V61, P287, DOI 10.1111/j.1399-3054.1984.tb05910.x; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Noh YS, 1999, PLANT MOL BIOL, V41, P181, DOI 10.1023/A:1006342412688; Nooden LD, 1997, PHYSIOL PLANTARUM, V101, P746, DOI 10.1111/j.1399-3054.1997.tb01059.x; OULEE TM, 1985, PLANT PHYSIOL, V79, P852, DOI 10.1104/pp.79.3.852; Quirino BF, 2000, TRENDS PLANT SCI, V5, P278, DOI 10.1016/S1360-1385(00)01655-1; Quirino BF, 2001, PLANT MOL BIOL, V46, P447, DOI 10.1023/A:1010639015959; Samarah NH, 2009, J AGRON CROP SCI, V195, P427, DOI 10.1111/j.1439-037X.2009.00387.x; Schaffer AA, 1997, PLANT PHYSIOL, V113, P739, DOI 10.1104/pp.113.3.739; Stessman D, 2002, PHOTOSYNTH RES, V72, P27, DOI 10.1023/A:1016043003839; THIMANN KV, 1977, PLANT PHYSIOL, V59, P448, DOI 10.1104/pp.59.3.448; THOMAS H, 1992, J PLANT PHYSIOL, V139, P403, DOI 10.1016/S0176-1617(11)80486-4; van Doorn WG, 2008, J EXP BOT, V59, P1963, DOI 10.1093/jxb/ern076; VONSCHAEWEN A, 1990, EMBO J, V9, P3033, DOI 10.1002/j.1460-2075.1990.tb07499.x; Wang BS, 2015, PHOTOSYNTH RES, V126, P363, DOI 10.1007/s11120-015-0126-9; WANG F, 1993, PLANT PHYSIOL, V101, P321, DOI 10.1104/pp.101.1.321; WARDLAW IF, 1994, AUST J PLANT PHYSIOL, V21, P255, DOI 10.1071/PP9940255; Wardlaw IF, 2000, NEW PHYTOL, V148, P413, DOI 10.1046/j.1469-8137.2000.00777.x; Wiedemuth K, 2005, J PLANT PHYSIOL, V162, P1226, DOI 10.1016/j.jplph.2005.01.010; Wingler A, 2006, J EXP BOT, V57, P391, DOI 10.1093/jxb/eri279; Yang JC, 2006, NEW PHYTOL, V169, P223, DOI 10.1111/j.1469-8137.2005.01597.x; Yang JC, 2004, PLANTA, V220, P331, DOI 10.1007/s00425-004-1338-y; Yang JC, 2002, AGRON J, V94, P102, DOI 10.2134/agronj2002.0102; Yang JianChang, 2004, Acta Agronomica Sinica, V30, P108; YEMM EW, 1954, BIOCHEM J, V57, P508, DOI 10.1042/bj0570508; Yoshida S, 2003, CURR OPIN PLANT BIOL, V6, P79, DOI 10.1016/S1369526602000092; Zhang SongWu, 2012, Acta Agronomica Sinica, V38, P2258, DOI 10.3724/SP.J.1006.2012.02258; Zhang SongWu, 2010, Scientia Agricultura Sinica, V43, P2229; ZRENNER R, 1995, PLANT J, V7, P97, DOI 10.1046/j.1365-313X.1995.07010097.x	56	40	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166155	10.1371/journal.pone.0166155	http://dx.doi.org/10.1371/journal.pone.0166155			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814393	Green Published, gold, Green Submitted			2022-12-26	WOS:000386911100035
J	Ferrao, M; Colatreli, O; de Fraga, R; Kaefer, IL; Moravec, J; Lima, AP				Ferrao, Miqueias; Colatreli, Olavo; de Fraga, Rafael; Kaefer, Igor L.; Moravec, Jiri; Lima, Albertina P.			High Species Richness of Scinax Treefrogs (Hylidae) in a Threatened Amazonian Landscape Revealed by an Integrative Approach	PLOS ONE			English	Article							ALLOBATES ANURA AROMOBATIDAE; MOLECULAR PHYLOGENY; AMPHIBIA ANURA; RIVER-BASIN; PARA STATE; DIVERSITY; CONSERVATION; FROGS; BIODIVERSITY; TAXONOMY	Rising habitat loss is one of the main drivers of the global amphibian decline. Nevertheless, knowledge of amphibian diversity needed for effective habitat protection is still highly inadequate in remote tropical regions, the greater part of the Amazonia. In this study we integrated molecular, morphological and bioacoustic evidence to evaluate the species richness of the treefrogs genus Scinax over a 1000 km transect across rainforest of the Purus-Madeira interfluve, and along the east bank of the upper Madeira river, Brazilian Amazonia. Analysis revealed that 82% of the regional species richness of Scinax is still undescribed; two nominal species, seven confirmed candidate species, two unconfirmed candidate species, and one deep conspecific lineage were detected in the study area. DNA barcoding based analysis of the 16s rRNA gene indicates possible existence of three discrete species groups within the genus Scinax, in addition to the already-known S. rostratus species Group. Quantifying and characterizing the number of undescribed Scinax taxa on a regional scale, we provide a framework for future taxonomic study in Amazonia. These findings indicate that the level to which Amazonian anura species richness has been underestimated is far greater than expected. Consequently, special attention should be paid both to taxonomic studies and protection of the still-neglected Amazonian Scinax treefrogs.	[Ferrao, Miqueias; de Fraga, Rafael] Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Ecol, Manaus, Amazonas, Brazil; [Colatreli, Olavo; Lima, Albertina P.] Inst Nacl de Pesquisas da Amazonia, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil; [Kaefer, Igor L.] Univ Fed Amazonas, Inst Ciencias Biol, Manaus, Amazonas, Brazil; [Moravec, Jiri] Natl Museum, Dept Zool, Prague, Czech Republic	Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia; Universidade Federal de Amazonas; National Museum	Ferrao, M (corresponding author), Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Ecol, Manaus, Amazonas, Brazil.	uranoscodon@gmail.com	Ferrão, Miquéias/L-1234-2019; Kaefer, Igor L/A-3413-2009; Kaefer, Igor/AAP-2418-2021	Ferrão, Miquéias/0000-0001-7035-8276; Kaefer, Igor L/0000-0001-6515-0278; Kaefer, Igor/0000-0001-6515-0278; Lima, Albertina Pimentel/0000-0003-4586-5633; Colatreli, Olavo/0000-0003-1935-8080	PRONEX - FAPEAM/CNPq [003/2009, 653/2009]; Ministry of Culture of the Czech Republic [00023272]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), via Centro de Estudos Integrados da Biodiversidade Amazonica (CENBAM) [573721/2008-4]; Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	PRONEX - FAPEAM/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Culture of the Czech Republic; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), via Centro de Estudos Integrados da Biodiversidade Amazonica (CENBAM)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)(Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by PRONEX - FAPEAM/CNPq (proj. 003/2009, proc. 653/2009) and its publication was funded by Ministry of Culture of the Czech Republic (DKRVO 2016/15, National Museum, 00023272). Miqueias Ferrao had a fellowship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq proc. 573721/2008-4), via Centro de Estudos Integrados da Biodiversidade Amazonica (CENBAM). Currently, Miqueias Ferrao receives a PhD scholarship from the Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM). Rafael de Fraga had a PhD scholarship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank William Etges, Edgar Lehr and an anonymous reviewer for their suggestions on this manuscript; Santo Antonio Energia S.A. for support with the fieldwork on the upper Madeira river; Centro de Estudos Integrados da Biodiversidade Amazonica (CENBAM) for assistance with fieldwork at the northern interfluve between the Purus and Madeira rivers; Fernanda Werneck and Ariane Silva for access to the INPA-H zoological collection; Alexandre Pinheiro de Almeida for the advertisement call of Scinax sp. 3. Adrian Barnett helped with the English. While conducting this study Miqueias Ferrao had a fellowship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) under grant CNPq-proc. 573721/2008-4, via Centro de Estudos Integrados da Biodiversidade Amazonica (CENBAM), while conducting this study. Currently, Miqueias Ferrao receives a PhD scholarship from the Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM). Rafael de Fraga had a PhD scholarship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). Work of Jiri Moravec was financially supported by Ministry of Culture of the Czech Republic (DKRVO 2016/15, National Museum, 00023272).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2014, TRACER V1 6; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bioacoustics Research Program, 2015, RAV PRO INT SOUND AN; Brusquetti F, 2014, ZOOL J LINN SOC-LOND, V171, P783, DOI 10.1111/zoj.12148; Caminer MA, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.370.6291; Campbell H.W., 1982, U S FISH AND WILDLIFE SERVICE WILDLIFE RESEARCH REPORT, V13, P193; Cintra BBL, 2013, BIOGEOSCIENCES, V10, P7759, DOI 10.5194/bg-10-7759-2013; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Carvalho TR, 2015, PHYLLOMEDUSA, V14, P139, DOI 10.11606/issn.2316-9079.v14i2p139-146; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Duellman W., 1993, OCCASIONAL PAPER MUS, V153, P1; Duellman W.E., 1970, Monograph Mus nat Hist Univ Kans, V1, P1; DUELLMAN WE, 1972, COPEIA, P265; Duellman WE, 2016, ZOOTAXA, V4104, P1, DOI 10.11646/zootaxa.4104.1.1; Elmer KR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-247; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; Faivovich J, 2002, CLADISTICS, V18, P367, DOI 10.1111/j.1096-0031.2002.tb00157.x; Fearnside PM, 2006, ENVIRON MANAGE, V38, P705, DOI 10.1007/s00267-005-0295-y; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Fouquet A, 2007, MOL PHYLOGENET EVOL, V43, P567, DOI 10.1016/j.ympev.2006.12.006; Fouquet A, 2014, J BIOGEOGR, V41, P855, DOI 10.1111/jbi.12250; Fouquet A, 2012, MOL PHYLOGENET EVOL, V65, P547, DOI 10.1016/j.ympev.2012.07.012; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; Gehara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103958; Giam XL, 2012, P ROY SOC B-BIOL SCI, V279, P67, DOI 10.1098/rspb.2011.0433; Guarnizo CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127312; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HEYER W R, 1990, Arquivos de Zoologia (Sao Paulo), V31, P231; IBGE Instituto Brasileiro de Geografia e Estatistica, 1997, REC NAT MEIO AMB BRA; Jansen M, 2011, ZOOL SCR, V40, P567, DOI 10.1111/j.1463-6409.2011.00498.x; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Junca FA, 2015, HERPETOLOGICA, V71, P299, DOI 10.1655/HERPETOLOGICA-D-14-00032; Jungfer KH, 2013, ZOOL SCR, V42, P351, DOI 10.1111/zsc.12015; Kaefer IL, 2013, EVOL BIOL, V40, P228, DOI 10.1007/s11692-012-9205-4; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Kohler J, 2005, BIOSCIENCE, V55, P693, DOI 10.1641/0006-3568(2005)055[0693:NAAGCA]2.0.CO;2; Lescure J, 2000, PATRIMOINES NATURELS, V45, P1; Lima AP, 2015, ZOOTAXA, V3980, P501, DOI 10.11646/zootaxa.3980.4.3; Lima AP, 2014, ZOOTAXA, V3889, P355, DOI 10.11646/zootaxa.3889.3.2; Magnusson W.E., 2013, BIODIVERSIDADE MONIT; Maldonado FD, 2012, RIO PURUS AGUA TERRI, P183; Ortega-Andrade HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143392; Menezes L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154626; MYERS C W, 1982, American Museum Novitates, P1; Napoli MF, 2005, HERPETOLOGICA, V61, P63, DOI 10.1655/03-41; Nogueira L, 2016, GENET MOL BIOL, V39, P49, DOI 10.1590/1678-4685-GMB-2015-0037; Nunes I, 2010, ZOOTAXA, P24; Nunes I, 2012, COPEIA, P554, DOI 10.1643/CH-11-088; Nunes I, 2011, HERPETOLOGICA, V67, P80, DOI 10.1655/HERPETOLOGICA-D-10-00026.1; Padial JM, 2009, ZOOL J LINN SOC-LOND, V155, P97, DOI 10.1111/j.1096-3642.2008.00424.x; Palumbi SR, 1991, SAMPLE TOOLS GUIDE P; Pombal-Junior Jose Perez, 1995, Naturalia (Rio Claro), V20, P213; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ron SR, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.229.3580; Rosetti DF, 2015, QUATERNARY RES, V63, P78, DOI [10.1016/j.ygres.2004.10.001, DOI 10.1016/J.YGRES.2004.10.001]; Salducci MD, 2005, CR BIOL, V328, P1009, DOI 10.1016/j.crvi.2005.07.005; Salducci MD, 2002, CR BIOL, V325, P141, DOI 10.1016/S1631-0691(02)01423-3; Savage J. M., 1967, BEITR NEOTROP FAUNA, V5, P111, DOI DOI 10.1080/01650526709360400; Simoes PI, 2010, ZOOTAXA, P1; Simoes PI, 2013, ZOOTAXA, V3746, P401, DOI 10.11646/zootaxa.3746.3.1; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Sombroek Wim, 2000, Acta Amazonica, V30, P81; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Sturaro Marcelo José, 2014, Pap. Avulsos Zool. (São Paulo), V54, P9, DOI 10.1590/0031-1049.2014.54.02; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toledo LF, 2012, BIOTROPICA, V44, P785, DOI 10.1111/j.1744-7429.2012.00866.x; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Peloso PLV, 2010, ZOOLOGIA-CURITIBA, V27, P667, DOI 10.1590/S1984-46702010000500001; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Wiens JJ, 2010, MOL PHYLOGENET EVOL, V55, P871, DOI 10.1016/j.ympev.2010.03.013; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	83	34	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165679	10.1371/journal.pone.0165679	http://dx.doi.org/10.1371/journal.pone.0165679			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806089	Green Published, gold, Green Submitted			2022-12-26	WOS:000386715500048
J	Gulcu, A; Akman, A; Demirkan, AF; Yorukoglu, AC; Kaleli, I; Bir, F				Gulcu, Anil; Akman, Alp; Demirkan, Ahmet Fahir; Yorukoglu, Ali Cagdas; Kaleli, Ilknur; Bir, Ferda			Fosfomycin Addition to Poly((D,L)-Lactide) Coating Does Not Affect Prophylaxis Efficacy in Rat Implant-Related Infection Model, But That of Gentamicin Does	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PSEUDOMONAS-AERUGINOSA BIOFILMS; FOREIGN-BODY INFECTION; IN-VITRO; ANTIBIOTIC-RESISTANCE; TITANIUM IMPLANTS; GROWTH-FACTORS; IGF-I; OSTEOMYELITIS; RELEASE	Gentamicin is the preferred antimicrobial agent used in implant coating for the prevention of implant-related infections (IRI). However, the present heavy local and systemic administration of gentamicin can lead to increased resistance, which has made its future use uncertain, together with related preventive technologies. Fosfomycin is an alternative antimicrobial agent that lacks the cross-resistance presented by other classes of antibiotics. We evaluated the efficacy of prophylaxis of 10% fosfomycin-containing poly((D,L)-lactide) (PDL) coated K-wires in a rat IRI model and compared it with uncoated (Control 1), PDL-coated (Control 2), and 10% gentamicin-containing PDL-coated groups with a single layer of coating. Stainless steel K-wires were implanted and methicillin-resistant Staphylococcus aureus (ATCC 43300) suspensions (10(3) CFU/10 mu l) were injected into a cavity in the left tibiae. Thereafter, K-wires were removed and cultured in tryptic soy broth and then 5% sheep blood agar mediums. Sliced sections were removed from the tibiae, stained with hematoxylin-eosin, and semi-quantitatively evaluated with X-rays. The addition of fosfomycin into PDL did not affect the X-ray and histopathological evaluation scores; however, the addition of gentamicin lowered them. The addition of gentamicin showed a protective effect after the 28(th) day of X-ray evaluations. PDL-only coating provided no protection, while adding fosfomycin to PDL offered a 20% level protection and adding gentamicin offered 80%. Furthermore, there were 10(3) CFU level growths in the gentamicin-added group, while the other groups had 10(5). Thus, the addition of fosfomycin to PDL does not affect the efficacy of prophylaxis, but the addition of gentamicin does. We therefore do not advise the use of fosfomycin as a single antimicrobial agent in coating for IRI prophylaxis.	[Gulcu, Anil; Akman, Alp; Demirkan, Ahmet Fahir; Yorukoglu, Ali Cagdas] Pamukkale Univ, Orthoped & Traumatol Dept, Fac Med, Denizli, Turkey; [Kaleli, Ilknur] Pamukkale Univ, Dept Microbiol, Fac Med, Denizli, Turkey; [Bir, Ferda] Pamukkale Univ, Dept Pathol, Fac Med, Denizli, Turkey	Pamukkale University; Pamukkale University; Akdeniz University; Pamukkale University	Akman, A (corresponding author), Pamukkale Univ, Orthoped & Traumatol Dept, Fac Med, Denizli, Turkey.	alpakman@gmail.com	Bir, Ferda/HGE-9200-2022; GULCU, Anil/AAB-2932-2021; AKMAN, Alp/AAV-6767-2021	AKMAN, Alp/0000-0001-7830-1979; Gulcu, Anil/0000-0002-9012-8053; Demirkan, Ahmet Fahir/0000-0002-1393-7068				Ahire JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123648; Allerberger F, 1999, J ANTIMICROB CHEMOTH, V43, P211, DOI 10.1093/jac/43.2.211; Alt V, 2014, ACTA BIOMATER, V10, P4518, DOI 10.1016/j.actbio.2014.06.013; Amsden GW, 1999, J ANTIMICROB CHEMOTH, V34, P853; An YH, 1997, J MICROBIOL METH, V30, P141, DOI 10.1016/S0167-7012(97)00058-4; An YHH, 1998, J INVEST SURG, V11, P139, DOI 10.3109/08941939809032193; Annunziata M, 2015, J CRANIOFAC SURG, V26, P1691, DOI 10.1097/SCS.0000000000001786; Arens S, 1996, J BONE JOINT SURG BR, V78B, P647, DOI 10.1302/0301-620X.78B4.0780647; BARRY AL, 1993, EUR J CLIN MICROBIOL, V12, P352, DOI 10.1007/BF01964433; Cai Y, 2009, J ANTIMICROB CHEMOTH, V64, P563, DOI 10.1093/jac/dkp224; Chao YK, 2015, INT J PHARMACEUT, V484, P38, DOI 10.1016/j.ijpharm.2015.02.048; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Diefenbeck M, 2006, INJURY, V37, P95, DOI 10.1016/j.injury.2006.04.015; Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226; Fuchs T, 2011, ARCH ORTHOP TRAUM SU, V131, P1419, DOI 10.1007/s00402-011-1321-6; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Garrigos C, 2013, ANTIMICROB AGENTS CH, V57, P606, DOI 10.1128/AAC.01570-12; GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258; Hoyle B D, 1991, Prog Drug Res, V37, P91; Jennings JA, 2015, CLIN ORTHOP RELAT R, V473, P2270, DOI 10.1007/s11999-014-4130-8; Jiang J, 2015, PHARM RES-DORDR, V32, P2851, DOI 10.1007/s11095-015-1667-5; Kandziora F, 2002, SPINE, V27, P1710, DOI 10.1097/00007632-200208150-00006; Kusachi S, 2011, J INFECT CHEMOTHER, V17, P91, DOI 10.1007/s10156-010-0167-0; Lucke M, 2003, BONE, V32, P521, DOI 10.1016/S8756-3282(03)00050-4; Lucke M, 2005, BONE, V36, P770, DOI 10.1016/j.bone.2005.01.008; Malhas AM, 2015, SURG-J R COLL SURG E, V13, P250, DOI 10.1016/j.surge.2014.04.002; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; Mastouri M, 2006, PATHOL BIOL, V54, P33, DOI 10.1016/j.patbio.2004.10.009; MEISSNER A, 1989, INFECTION, V17, P146, DOI 10.1007/BF01644014; Mihailescu R, 2014, ANTIMICROB AGENTS CH, V58, P2547, DOI 10.1128/AAC.02420-12; Mikuniya Takeshi, 2007, Journal of Infection and Chemotherapy, V13, P285, DOI 10.1007/s10156-007-0534-7; Monden Koichi, 2002, Journal of Infection and Chemotherapy, V8, P218, DOI 10.1007/s10156-002-0186-6; Montanaro L, 2011, INT J ARTIF ORGANS, V34, P781, DOI 10.5301/ijao.5000052; PETTY W, 1985, J BONE JOINT SURG AM, V67A, P1236, DOI 10.2106/00004623-198567080-00015; Poeppl W, 2014, ANTIMICROB AGENTS CH, V58, P5111, DOI 10.1128/AAC.02720-13; Rodriguez-Martinez JM, 2007, INT J ANTIMICROB AG, V30, P366, DOI 10.1016/j.ijantimicag.2007.05.005; Schmidmaier G, 2001, J BIOMED MATER RES, V58, P449; Sheehan E, 2004, J ORTHOP RES, V22, P39, DOI 10.1016/S0736-0266(03)00152-9; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Strobel C, 2011, INT J ARTIF ORGANS, V34, P304, DOI 10.5301/IJAO.2011.6470; Teller M, 2007, J BIOMED MATER RES B, V81B, P23, DOI 10.1002/jbm.b.30631; Vester H, 2010, INJURY, V41, P1053, DOI 10.1016/j.injury.2010.05.010; Wildemann B, 2004, J CONTROL RELEASE, V95, P249, DOI 10.1016/j.jconrel.2003.11.014; WITTMANN DH, 1980, INFECTION, V8, P330, DOI 10.1007/BF01640931; Zhang L, 2014, INT J NANOMED, V9, P3027, DOI 10.2147/IJN.S63991; ZHANG XC, 1994, J PHARM PHARMACOL, V46, P718, DOI 10.1111/j.2042-7158.1994.tb03890.x	46	5	7	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165544	10.1371/journal.pone.0165544	http://dx.doi.org/10.1371/journal.pone.0165544			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806071	gold, Green Submitted, Green Published			2022-12-26	WOS:000386715500036
J	Urbinati, C; Grillo, E; Chiodelli, P; Tobia, C; Caccuri, F; Fiorentini, S; David, G; Rusnati, M				Urbinati, C.; Grillo, E.; Chiodelli, P.; Tobia, C.; Caccuri, F.; Fiorentini, S.; David, G.; Rusnati, M.			Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via alpha(v)beta(3)/pp60src/pp125FAK pathway	ONCOGENE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HEPARAN-SULFATE PROTEOGLYCANS; INTEGRIN-MEDIATED ADHESION; ENDOTHELIAL-CELLS; IN-VIVO; SIGNALING PATHWAY; VASCULAR-PERMEABILITY; CYTOPLASMIC DOMAINS; INDUCED CHEMOTAXIS; MULTIPLE-MYELOMA	Syndecan-1 is a heparan sulfate proteoglycan (HSPG) commonly upregulated in AIDS-related B lymphoid malignancies. Tat is the main HIV-1 transactivating factor that has a major role in the pathogenesis of AIDS-related lymphomas (ARL) by engaging heparan sulfate proteoglycans (HSPGs), chemokine receptors and integrins at the lymphoid cell (LC) surface. Here B-lymphoid Namalwa cell clones that do not express or overexpress syndecan-1 (EV-Ncs and SYN-Ncs, respectively) were compared for their responsiveness with Tat: in the absence of syndecan-1, Tat induces a limited EV-Nc migration via C-X-C motif chemokine receptor 4 (CXCR4), G-proteins and Rac. Syndecan-1 overexpression increases SYN-Nc responsiveness to Tat and makes this response independent from CXCR4 and G-protein and dependent instead on pp60src phosphorylation. Tat-induced SYN-Nc migration and pp60src phosphorylation require the engagement of alpha(v)beta(3) integrin and consequent pp125FAK phosphorylation. This complex set of Tat-driven activations is orchestrated by the direct interaction of syndecan-1 with pp60src and its simultaneous coupling with alpha(v)beta(3). The Tat/syndecan-1/alpha(v)beta(3) interplay is retained in vivo and is shared also by other syndecan-1(+) B-LCs, including BJAB cells, whose responsiveness to Tat is inhibited by syndecan-1 knockdown. In conclusion, overexpression of syndecan-1 confers to B-LCs an increased capacity to migrate in response to Tat, owing to a switch from a CXCR4/G-protein/Rac to a syndecan-1/alpha(v)beta(3)/pp60src/pp125FAK signal transduction pathway that depends on the formation of a complex in which syndecan-1 interacts with Tat via its HS-chains, with alpha(v)beta(3) via its core protein ectodomain and with pp60src via its intracellular tail. These findings have implications in ARL progression and may help in identifying new therapeutical targets for the treatment of AIDS-associated neoplasia.	[Urbinati, C.; Grillo, E.; Chiodelli, P.; Tobia, C.; Rusnati, M.] Univ Brescia, Dept Mol & Translat Med, Sect Expt Oncol & Immunol, Viale Europa 11, I-25123 Brescia, Italy; [Caccuri, F.; Fiorentini, S.] Univ Brescia, Dept Mol & Translat Med, Sect Microbiol, Brescia, Italy; [David, G.] Univ Leuven, Dept Human Genet, Leuven, Belgium; [David, G.] Flanders Inst Biotechnol, Leuven, Belgium	University of Brescia; University of Brescia; KU Leuven; Flanders Institute for Biotechnology (VIB)	Rusnati, M (corresponding author), Univ Brescia, Dept Mol & Translat Med, Sect Expt Oncol & Immunol, Viale Europa 11, I-25123 Brescia, Italy.	marco.rusnati@unibs.it	Tobia, Chiara/ABA-5682-2021; Rusnati, Marco/F-1168-2010; Grillo, Elisabetta/AAS-3884-2021; Caccuri, Francesca/AAC-1281-2022	Rusnati, Marco/0000-0001-9968-5908; Caccuri, Francesca/0000-0002-1923-9033; FIORENTINI, SIMONA/0000-0002-1866-314X; Grillo, Elisabetta/0000-0002-8403-0607; Urbinati, Chiara Eva/0000-0002-0138-7871; Tobia, Chiara/0000-0002-0985-7356	MIUR; Fondazione Italiana per la Ricerca sul Cancro Fellowship	MIUR(Ministry of Education, Universities and Research (MIUR)); Fondazione Italiana per la Ricerca sul Cancro Fellowship(Fondazione AIRC per la ricerca sul cancro)	We thank Professor Marco Presta (University of Brescia) for helpful discussion. This work was supported by grants from MIUR to MR. PC was supported by Fondazione Italiana per la Ricerca sul Cancro Fellowship.	Akula SM, 2001, VIROLOGY, V282, P245, DOI 10.1006/viro.2000.0851; Arai A, 2005, CELL SIGNAL, V17, P497, DOI 10.1016/j.cellsig.2004.09.007; Arai A, 2006, CELL SIGNAL, V18, P2162, DOI 10.1016/j.cellsig.2006.05.001; Arese M, 2001, J IMMUNOL, V166, P1380, DOI 10.4049/jimmunol.166.2.1380; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Bonnet F, 2008, CURR OPIN ONCOL, V20, P534, DOI 10.1097/CCO.0b013e32830a5080; Brule S, 2009, BBA-GEN SUBJECTS, V1790, P1643, DOI 10.1016/j.bbagen.2009.08.001; Calpe E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081221; Carbone A, 1999, INT J BIOL MARKER, V14, P144, DOI 10.1177/172460089901400304; Chirivi RGS, 1999, BLOOD, V94, P1747, DOI 10.1182/blood.V94.5.1747.417a02_1747_1754; Choi Y, 2010, BIOCHEM BIOPH RES CO, V391, P921, DOI 10.1016/j.bbrc.2009.11.165; Colombrino E, 2004, EXP CELL RES, V295, P539, DOI 10.1016/j.yexcr.2004.01.018; Cross LM, 2003, ARTERIOSCL THROM VAS, V23, P911, DOI 10.1161/01.ATV.0000068685.72914.7E; Dhawan S, 1997, BLOOD, V90, P1535; Dhodapkar MV, 1999, LEUKEMIA LYMPHOMA, V34, P35, DOI 10.3109/10428199909083378; Fadnes B, 2012, GLYCOCONJUGATE J, V29, P513, DOI 10.1007/s10719-012-9427-9; Feistritzer C, 2005, EXP CELL RES, V305, P214, DOI 10.1016/j.yexcr.2005.01.001; Gatignol A, 2000, Adv Pharmacol, V48, P209; Ghezzi S, 2000, BIOCHEM BIOPH RES CO, V270, P992, DOI 10.1006/bbrc.2000.2523; Hamon M, 2004, GLYCOBIOLOGY, V14, P311, DOI 10.1093/glycob/cwh038; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Hoffmann C, 2005, BLOOD, V106, P1762, DOI 10.1182/blood-2004-12-4631; Huang LL, 1997, BIOCHEM BIOPH RES CO, V237, P461, DOI 10.1006/bbrc.1997.7162; Ingold K, 2005, J EXP MED, V201, P1375, DOI 10.1084/jem.20042309; Jarousse N, 2011, J IMMUNOL, V187, P5540, DOI 10.4049/jimmunol.1003495; Jarousse N, 2008, J VIROL, V82, P12591, DOI 10.1128/JVI.01167-08; Kaneider NC, 2002, J CELL SCI, V115, P227; Kinnunen T, 1998, J BIOL CHEM, V273, P10702, DOI 10.1074/jbc.273.17.10702; Kundu RK, 1999, BLOOD, V94, P275, DOI 10.1182/blood.V94.1.275.413a30_275_282; Lafrenie RM, 1996, J IMMUNOL, V156, P1638; Lamorte S, 2012, LEUKEMIA, V26, P1081, DOI 10.1038/leu.2011.290; Lebakken CS, 2000, EXP CELL RES, V259, P315, DOI 10.1006/excr.2000.4981; Lebakken CS, 1996, J CELL BIOL, V132, P1209, DOI 10.1083/jcb.132.6.1209; LEVINE AM, 1992, BLOOD, V80, P8; LINDAHL U, 1994, THROMB RES, V75, P1, DOI 10.1016/0049-3848(94)90136-8; Liu WS, 1998, CELL SIGNAL, V10, P529, DOI 10.1016/S0898-6568(98)00012-6; Martis N, 2012, CURR HEMATOL MALIG R, V7, P228, DOI 10.1007/s11899-012-0125-2; Mennerich D, 2004, EUR J CANCER, V40, P1373, DOI 10.1016/j.ejca.2004.01.038; Mitola S, 1997, BLOOD, V90, P1365, DOI 10.1182/blood.V90.4.1365.1365_1365_1372; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Montecucco F, 2006, ANN NY ACAD SCI, V1069, P463, DOI 10.1196/annals.1351.045; Mosheimer BA, 2005, J CLIN ENDOCR METAB, V90, P2964, DOI 10.1210/jc.2004-1895; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Noonan D, 2000, Adv Pharmacol, V48, P229; Okabe S, 2002, J HEMATOTH STEM CELL, V11, P923, DOI 10.1089/152581602321080583; Ott VL, 1998, J BIOL CHEM, V273, P35291, DOI 10.1074/jbc.273.52.35291; Pals ST, 2007, BLOOD, V110, P3102, DOI 10.1182/blood-2007-05-075176; Rabkin CS, 2001, EUR J CANCER, V37, P1316, DOI 10.1016/S0959-8049(01)00104-6; Rapraeger AC, 2013, FEBS J, V280, P2207, DOI 10.1111/febs.12160; Reijmers RM, 2013, FEBS J, V280, P2180, DOI 10.1111/febs.12180; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Rusnati M, 1999, J BIOL CHEM, V274, P28198, DOI 10.1074/jbc.274.40.28198; Safaiyan F, 1999, J BIOL CHEM, V274, P36267, DOI 10.1074/jbc.274.51.36267; SALCEDO R, 1995, CELL IMMUNOL, V160, P165, DOI 10.1016/0008-8749(95)80023-C; Sanderson RD, 2002, ANN HEMATOL, V81, P125, DOI 10.1007/s00277-002-0437-8; Saphire ACS, 2001, J VIROL, V75, P9187, DOI 10.1128/JVI.75.19.9187-9200.2001; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Shah BK, 2010, J CLIN ONCOL, V28, pE459, DOI 10.1200/JCO.2010.28.3077; Toborek M, 2003, J NEUROCHEM, V84, P169, DOI 10.1046/j.1471-4159.2003.01543.x; Toschi E, 2001, MOL BIOL CELL, V12, P2934, DOI 10.1091/mbc.12.10.2934; Urbinati C, 2005, ARTERIOSCL THROM VAS, V25, P2315, DOI 10.1161/01.ATV.0000186182.14908.7b; Urbinati C, 2005, J CELL SCI, V118, P3949, DOI 10.1242/jcs.02518; Urbinati C, 2009, BLOOD, V114, P3335, DOI 10.1182/blood-2009-01-198945; Vacca A, 2001, EXP HEMATOL, V29, P993, DOI 10.1016/S0301-472X(01)00674-9; van der Voort R, 2000, J EXP MED, V192, P1115, DOI 10.1084/jem.192.8.1115; Volinsky N, 2006, BIOCHEM J, V397, P213, DOI 10.1042/BJ20051655; Wang HY, 2010, J BIOL CHEM, V285, P13569, DOI 10.1074/jbc.M110.102137; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Whiteford JR, 2007, EXP CELL RES, V313, P3902, DOI 10.1016/j.yexcr.2007.08.002; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Yarchoan R, 2005, NAT CLIN PRACT ONCOL, V2, P406, DOI 10.1038/ncponc0253; Zhang Z, 2001, J BIOL CHEM, V276, P41921, DOI 10.1074/jbc.M106608200	72	4	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 4	2017	36	18					2609	2618		10.1038/onc.2016.420	http://dx.doi.org/10.1038/onc.2016.420			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET9AN	27819680				2022-12-26	WOS:000400597300011
J	Kayode, O; Wang, RY; Pendlebury, DF; Cohen, I; Henin, RD; Hockla, A; Soares, AS; Papo, N; Caulfield, TR; Radisky, ES				Kayode, Olumide; Wang, Ruiying; Pendlebury, Devon F.; Cohen, Itay; Henin, Rachel D.; Hockla, Alexandra; Soares, Alexei S.; Papo, Niv; Caulfield, Thomas R.; Radisky, Evette S.			An Acrobatic Substrate Metamorphosis Reveals a Requirement for Substrate Conformational Dynamics in Trypsin Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETED MOLECULAR-DYNAMICS; SERINE-PROTEASE MECHANISM; ENERGY LANDSCAPE; CATIONIC TRYPSIN; PEPTIDE-BOND; INHIBITOR; MESOTRYPSIN; SIMULATIONS; KUNITZ; DETERMINANTS	The molecular basis of enzyme catalytic power and specificity derives from dynamic interactions between enzyme and substrate during catalysis. Although considerable effort has been devoted to understanding how conformational dynamics within enzymes affect catalysis, the role of conformational dynamics within protein substrates has not been addressed. Here, we examine the importance of substrate dynamics in the cleavage of Kunitz-bovine pancreatic trypsin inhibitor protease inhibitors by mesotrypsin, finding that the varied conformational dynamics of structurally similar substrates can profoundly impact the rate of catalysis. A 1.4-angstrom crystal structure of a mesotrypsin-product complex formed with a rapidly cleaved substrate reveals a dramatic conformational change in the substrate upon proteolysis. By using long all-atom molecular dynamics simulations of acyl-enzyme intermediates with proteolysis rates spanning 3 orders of magnitude, we identify global and local dynamic features of substrates on the nanosecond-microsecond time scale that correlate with enzymatic rates and explain differential susceptibility to proteolysis. By integrating multiple enhanced sampling methods for molecular dynamics, we model a viable conformational pathway between substrate-like and product-like states, linking substrate dynamics on the nanosecond-microsecond time scale with large collective substrate motions on the much slower time scale of catalysis. Our findings implicate substrate flexibility as a critical determinant of catalysis.	[Kayode, Olumide; Wang, Ruiying; Pendlebury, Devon F.; Henin, Rachel D.; Hockla, Alexandra; Radisky, Evette S.] Mayo Clin, Coll Med, Dept Canc Biol, Jacksonville, FL 32224 USA; [Caulfield, Thomas R.] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; [Cohen, Itay; Papo, Niv] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel; [Cohen, Itay; Papo, Niv] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Soares, Alexei S.] Brookhaven Natl Lab, Photon Sci Directorate, Upton, NY 11973 USA; [Pendlebury, Devon F.] Univ Michigan, Program Chem Biol, Ann Arbor, MI 48109 USA	Mayo Clinic; Mayo Clinic; Ben Gurion University; Ben Gurion University; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Michigan System; University of Michigan	Caulfield, TR (corresponding author), Mayo Clin, Dept Neurosci, 310 Birdsall Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA.; Radisky, ES (corresponding author), Mayo Clin, Dept Canc Biol, 310 Griffin Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	caulfield.thomas@mayo.edu; radisky.evette@mayo.edu	Papo, Niv/R-3946-2017; Radisky, Evette S/C-8526-2012	Radisky, Evette S/0000-0003-3121-109X; Caulfield, Thomas/0000-0002-1055-3069	National Institutes of Health [R01CA154387]; European Research Council [33604]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA154387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01CA154387 (to E. S. R.), European Research Council "Ideas Program" ERC-2013-StG Grant 33604 (to N. P.), and a Prostate Cancer Foundation grant (to N. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alloy AP, 2015, J BIOL CHEM, V290, P21523, DOI 10.1074/jbc.M115.662429; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Arolas JL, 2011, ANGEW CHEM INT EDIT, V50, P10357, DOI 10.1002/anie.201103262; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Buch I, 2011, P NATL ACAD SCI USA, V108, P10184, DOI 10.1073/pnas.1103547108; Caulfield T, 2012, PROTEINS, V80, P2489, DOI 10.1002/prot.24131; Caulfield T, 2011, J STRUCT BIOL, V176, P185, DOI 10.1016/j.jsb.2011.07.015; Caulfield Thomas R, 2011, J Biophys, V2011, P219515, DOI 10.1155/2011/219515; Caulfield TR, 2011, J MOL GRAPH MODEL, V29, P1006, DOI 10.1016/j.jmgm.2011.04.005; Cecchini M, 2004, J CHEM PHYS, V121, P10748, DOI 10.1063/1.1809588; Cheatham TE, 2001, BIOPOLYMERS, V56, P232; Cohen I, 2016, BIOCHEM J, V473, P1329, DOI 10.1042/BJ20151410; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGELS M, 1992, PROTEIN ENG, V5, P669, DOI 10.1093/protein/5.7.669; ESTELL DA, 1980, BIOCHEMISTRY-US, V19, P131, DOI 10.1021/bi00542a020; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hubbard SJ, 1998, PROTEIN ENG, V11, P349, DOI 10.1093/protein/11.5.349; HUBBARD SJ, 1994, PROTEIN SCI, V3, P757; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9; Joosten RP, 2009, J APPL CRYSTALLOGR, V42, P376, DOI 10.1107/S0021889809008784; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kazanov MD, 2011, J PROTEOME RES, V10, P3642, DOI 10.1021/pr200271w; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger Elmar, 2003, Methods Biochem Anal, V44, P509; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; Kubitzki MB, 2007, BIOPHYS J, V92, P4262, DOI 10.1529/biophysj.106.103101; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LEESON DT, 1995, NAT STRUCT BIOL, V2, P848, DOI 10.1038/nsb1095-848; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; Maximova T, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004619; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaneetham D, 2010, J BIOCHEM, V148, P467, DOI 10.1093/jb/mvq080; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ovchinnikov V, 2012, J PHYS CHEM B, V116, P8584, DOI 10.1021/jp212634z; Pendlebury D, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.609560; Perakyla M, 2000, J AM CHEM SOC, V122, P3436, DOI 10.1021/ja991602p; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plattner N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8653; Radisky ES, 2006, P NATL ACAD SCI USA, V103, P6835, DOI 10.1073/pnas.0601910103; Radisky ES, 2004, BIOCHEMISTRY-US, V43, P13648, DOI 10.1021/bi048797k; Radisky ES, 2003, BIOCHEMISTRY-US, V42, P6484, DOI 10.1021/bi034275d; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006; Reblova K, 2007, BIOPHYS J, V93, P3932, DOI 10.1529/biophysj.107.110056; Reblova K, 2006, BIOPOLYMERS, V82, P504, DOI 10.1002/bip.20503; ROSENFIELD RE, 1978, ACTA CRYSTALLOGR A, V34, P828, DOI 10.1107/S0567739478001692; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; Salameh MA, 2012, PROTEIN SCI, V21, P1103, DOI 10.1002/pro.2097; Salameh MA, 2011, BIOCHEM J, V440, P95, DOI 10.1042/BJ20110788; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; Salameh MA, 2010, J BIOL CHEM, V285, P1939, DOI 10.1074/jbc.M109.057216; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHLITTER J, 1994, J MOL GRAPHICS, V12, P84, DOI 10.1016/0263-7855(94)80072-3; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Szabo A, 2014, J BIOL CHEM, V289, P4753, DOI 10.1074/jbc.M113.538884; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Torbeev VY, 2011, P NATL ACAD SCI USA, V108, P20982, DOI 10.1073/pnas.1111202108; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Watt ED, 2007, P NATL ACAD SCI USA, V104, P11981, DOI 10.1073/pnas.0702551104; Whittier SK, 2013, SCIENCE, V341, P899, DOI 10.1126/science.1241735; Winn M., 2001, CCP4 NEWSLETTER, V39; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Wriggers W, 1999, PROTEINS, V35, P262, DOI 10.1002/(SICI)1097-0134(19990501)35:2<262::AID-PROT11>3.0.CO;2-N; Ye SJ, 2015, CHEM SCI, V6, P5246, DOI 10.1039/c4sc03227f; Zakharova E, 2009, P NATL ACAD SCI USA, V106, P11034, DOI 10.1073/pnas.0902463106; Zhou YZ, 2016, J PHYS CHEM LETT, V7, P1138, DOI 10.1021/acs.jpclett.6b00373	79	17	18	1	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26304	26319		10.1074/jbc.M116.758417	http://dx.doi.org/10.1074/jbc.M116.758417			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27810896	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000391568200006
J	Xia, L; Wang, XR; Wang, XL; Liu, SH; Ding, XW; Chen, GQ; Lu, Y				Xia, Li; Wang, Xin-Ran; Wang, Xiao-Ling; Liu, Su-Hui; Ding, Xiao-Wei; Chen, Guo-Qiang; Lu, Ying			A Novel Role for Pyruvate Kinase M2 as a Corepressor for P53 during the DNA Damage Response in Human Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; GENE-TRANSCRIPTION; PKM2; CANCER; EXPRESSION; MDM2; TUMORIGENESIS; ACTIVATION; APOPTOSIS; PROMOTES	The pyruvate kinase (PK) is a rate-limiting glycolytic enzyme catalyzing the dephosphorylation of phosphoenolpyruvate to pyruvate, yielding one molecule of ATP. The M2 isoform of PK (PKM2) is predominantly expressed in normal proliferating cells and tumors, and both metabolic and non-metabolic activities for the enzyme in promoting tumor cell proliferation have been identified. However, the exact roles of PKM2 in tumor initiation, growth and maintenance are not yet fully understood. Using immunoprecipitation-coupled LC-MS/MS in MCF7 cells exposed to DNA-damaging agent, we report that the nuclear PKM2 interacts directly with P53 protein, a critical safeguard for genome stability. Specifically, PKM2 inhibits P53-dependent transactivation of the P21 gene by preventing P53 binding to the P21 promoter, leading to a nonstop G(1) phase. As a result, PKM2 expression provides a growth advantage for tumor cells in the presence of a DNA damage stimulus. In addition, PKM2 interferes with phosphorylation of P53 at serine 15, known to stimulate P53 activity by the ATM serine/threonine kinase. These findings reveal a new role for PKM2 in modulating the DNA damage response and illustrate a novel mechanism of PKM2 participating in tumorigenesis.	[Xia, Li; Wang, Xin-Ran; Wang, Xiao-Ling; Liu, Su-Hui; Ding, Xiao-Wei; Chen, Guo-Qiang; Lu, Ying] SJTU SM, Minist Educ, Key Lab Cell Differentiat & Apoptosis, Dept Pathophysiol, Shanghai 200025, Peoples R China; [Chen, Guo-Qiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200025, Peoples R China; [Chen, Guo-Qiang] SJTU SM, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Chen, GQ; Lu, Y (corresponding author), 280 Chong Qing South Rd, Shanghai 200025, Peoples R China.	chengq@shsmu.edu.cn; stove@shsmu.edu.cn		chen, guo qiang/0000-0003-4936-2363; Wang, Xinran/0000-0001-9505-9221	National Key Research Program of China [2015CB910403]; National Natural Science Foundation [81370652, 81230048, 81430061, 31570824]; Foundation for the author of National Excellent Doctoral Dissertation of China [201074]; Science and Technology Committee of Shanghai [13431900501]; Shanghai Human Resource and Social Security Bureau	National Key Research Program of China; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Foundation for the author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Science and Technology Committee of Shanghai(Shanghai Science & Technology Committee); Shanghai Human Resource and Social Security Bureau	This work was supported by National Key Research Program of China (NO2015CB910403), National Natural Science Foundation (81370652, 81230048, 81430061, 31570824), Foundation for the author of National Excellent Doctoral Dissertation of China (201074), Grants from Science and Technology Committee of Shanghai (13431900501) and Talent Development Project of Shanghai Human Resource and Social Security Bureau. The authors declare that they have no conflicts of interest with the contents of this article.	Akahira J, 2004, CLIN CANCER RES, V10, P2687, DOI 10.1158/1078-0432.CCR-03-0510; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; ASHIZAWA K, 1991, J BIOL CHEM, V266, P16842; Bluemlein K, 2011, ONCOTARGET, V2, P393; Bouvard V, 2000, ONCOGENE, V19, P649, DOI 10.1038/sj.onc.1203366; Cao LL, 2016, SCI CHINA LIFE SCI, V59, P257, DOI 10.1007/s11427-016-5011-z; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Cortes-Cros M, 2013, P NATL ACAD SCI USA, V110, P489, DOI 10.1073/pnas.1212780110; Cui D, 2014, ONCOGENE, V33, P2225, DOI 10.1038/onc.2013.170; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Gao XL, 2013, J BIOL CHEM, V288, P15971, DOI 10.1074/jbc.M112.448753; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Goldberg MS, 2012, J EXP MED, V209, P217, DOI 10.1084/jem.20111487; Hathurusinghe HR, 2007, ANN SURG ONCOL, V14, P2714, DOI 10.1245/s10434-007-9481-x; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052576; Ikeda Y, 1997, J BIOL CHEM, V272, P20495, DOI 10.1074/jbc.272.33.20495; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Jenkins LMM, 2012, CARCINOGENESIS, V33, P1441, DOI 10.1093/carcin/bgs145; Jiang YH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6566; Jiang YH, 2014, MOL CELL, V53, P75, DOI 10.1016/j.molcel.2013.11.001; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Keller KE, 2014, MOL CELL, V53, P700, DOI 10.1016/j.molcel.2014.02.015; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lu Y, 2006, LEUKEMIA, V20, P987, DOI 10.1038/sj.leu.2404218; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; NAGASAWA H, 1995, CANCER RES, V55, P1842; Pabla N, 2008, J BIOL CHEM, V283, P6572, DOI 10.1074/jbc.M707568200; Papadaki C, 2014, BRIT J CANCER, V111, P1757, DOI 10.1038/bjc.2014.492; Shandilya J, 2012, P NATL ACAD SCI USA, V109, P18797, DOI 10.1073/pnas.1207483109; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wang YH, 2014, CELL, V158, P1309, DOI 10.1016/j.cell.2014.07.048; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932	44	22	23	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26138	26150		10.1074/jbc.M116.737056	http://dx.doi.org/10.1074/jbc.M116.737056			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27810895	Green Published, hybrid			2022-12-26	WOS:000390345200031
J	Cheng, BB; Bandi, V; Wei, MY; Pei, YB; D'Souza, F; Nguyen, KT; Hong, Y; Yuan, BH				Cheng, Bingbing; Bandi, Venugopal; Wei, Ming-Yuan; Pei, Yanbo; D'Souza, Francis; Nguyen, Kytai T.; Hong, Yi; Yuan, Baohong			High-Resolution Ultrasound-Switchable Fluorescence Imaging in Centimeter-Deep Tissue Phantoms with High Signal-To-Noise Ratio and High Sensitivity via Novel Contrast Agents	PLOS ONE			English	Article							ENCODED LIGHT; MICROSCOPY; TOMOGRAPHY; REGIME	For many years, investigators have sought after high-resolution fluorescence imaging in centimeter-deep tissue because many interesting in vivo phenomena-such as the presence of immune system cells, tumor angiogenesis, and metastasis-may be located deep in tissue. Previously, we developed a new imaging technique to achieve high spatial resolution in sub-centimeter deep tissue phantoms named continuous-wave ultrasound-switchable fluorescence (CW-USF). The principle is to use a focused ultrasound wave to externally and locally switch on and off the fluorophore emission from a small volume (close to ultrasound focal volume). By making improvements in three aspects of this technique: excellent near-infrared USF contrast agents, a sensitive frequency-domain USF imaging system, and an effective signal processing algorithm, for the first time this study has achieved high spatial resolution (similar to 900 mu m) in 3-centimeter-deep tissue phantoms with high signal-to-noise ratio (SNR) and high sensitivity (3.4 picomoles of fluorophore in a volume of 68 nanoliters can be detected). We have achieved these results in both tissue-mimic phantoms and porcine muscle tissues. We have also demonstrated multi-color USF to image and distinguish two fluorophores with different wavelengths, which might be very useful for simultaneously imaging of multiple targets and observing their interactions in the future. This work has opened the door for future studies of high-resolution centimeter-deep tissue fluorescence imaging.	[Cheng, Bingbing; Wei, Ming-Yuan; Pei, Yanbo; Yuan, Baohong] Univ Texas Arlington, Dept Bioengn, Ultrasound & Opt Imaging Lab, Arlington, TX 76010 USA; [Cheng, Bingbing; Wei, Ming-Yuan; Pei, Yanbo; Nguyen, Kytai T.; Hong, Yi; Yuan, Baohong] Univ Texas Arlington, Joint Biomed Engn Program, Dallas, TX 75235 USA; [Cheng, Bingbing; Wei, Ming-Yuan; Pei, Yanbo; Nguyen, Kytai T.; Hong, Yi; Yuan, Baohong] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75235 USA; [Bandi, Venugopal; D'Souza, Francis] Univ North Texas, Dept Chem, 1155 Union Circle,305070, Denton, TX 76203 USA; [Nguyen, Kytai T.; Hong, Yi] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76010 USA	University of Texas System; University of Texas Arlington; University of Texas System; University of Texas Arlington; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of North Texas System; University of North Texas Denton; University of Texas System; University of Texas Arlington	Yuan, BH (corresponding author), Univ Texas Arlington, Dept Bioengn, Ultrasound & Opt Imaging Lab, Arlington, TX 76010 USA.; Yuan, BH (corresponding author), Univ Texas Arlington, Joint Biomed Engn Program, Dallas, TX 75235 USA.; Yuan, BH (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75235 USA.	baohong@uta.edu	Hong, Yi/AAA-8971-2022; Wei, Michael Ming-Yuan/B-1529-2014; Bandi, Venu/I-8391-2018	Wei, Michael Ming-Yuan/0000-0002-4626-0014; Bandi, Venu/0000-0003-3602-9641; Hong, Yi/0000-0002-5846-2596; Cheng, Bingbing/0000-0002-1336-4781	NSF [CBET-1253199, 1401188]; NHARP [13310]; NIH/NIBIB [7R15EB012312-02]; CPRIT [RP120052]; NIH/NHLBI [R01HL118498]	NSF(National Science Foundation (NSF)); NHARP; NIH/NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); CPRIT; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by funding from the NSF CBET-1253199 (BY), the NHARP 13310 (BY), the NIH/NIBIB 7R15EB012312-02 (BY), the CPRIT RP120052 (BY), the NIH/NHLBI R01HL118498 (KN), and the NSF 1401188 (FD).	Andresen V, 2009, CURR OPIN BIOTECH, V20, P54, DOI 10.1016/j.copbio.2009.02.008; AYERS F, 2008, P SOC PHOTO-OPT INS, V6870; Cai WB, 2008, J NUCL MED, V49, p113S, DOI 10.2967/jnumed.107.045922; Cheng BB, 2014, IEEE J SEL TOP QUANT, V20, DOI 10.1109/JSTQE.2013.2280997; Corlu A, 2007, OPT EXPRESS, V15, P6696, DOI 10.1364/OE.15.006696; Grabtchak S, 2014, PHYS MED BIOL, V59, P2431, DOI 10.1088/0031-9155/59/10/2431; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hong GS, 2014, NAT PHOTONICS, V8, P723, DOI [10.1038/NPHOTON.2014.166, 10.1038/nphoton.2014.166]; Horstmeyer R, 2015, NAT PHOTONICS, V9, P563, DOI [10.1038/nphoton.2015.140, 10.1038/NPHOTON.2015.140]; Huynh NT, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.020505; Judkewitz B, 2013, NAT PHOTONICS, V7, P300, DOI [10.1038/nphoton.2013.31, 10.1038/NPHOTON.2013.31]; Lai PX, 2013, LASER PHYS LETT, V10, DOI 10.1088/1612-2011/10/7/075604; Lin YT, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.056007; Lin YT, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3681378; Marriott G, 2008, P NATL ACAD SCI USA, V105, P17789, DOI 10.1073/pnas.0808882105; McDonald DM, 2003, NAT MED, V9, P713, DOI 10.1038/nm0603-713; Pei YB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04690; REICHARDT C, 1994, CHEM REV, V94, P2319, DOI 10.1021/cr00032a005; Si K, 2012, NAT PHOTONICS, V6, P657, DOI [10.1038/nphoton.2012.205, 10.1038/NPHOTON.2012.205]; Si K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00748; Wang LV, 2009, NAT PHOTONICS, V3, P503, DOI 10.1038/NPHOTON.2009.157; Wang YM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1925; Xu H, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3258838; Xu XA, 2011, NAT PHOTONICS, V5, P154, DOI 10.1038/NPHOTON.2010.306; Yuan BH, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4737211	25	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165963	10.1371/journal.pone.0165963	http://dx.doi.org/10.1371/journal.pone.0165963			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829050	Green Published, Green Submitted, gold			2022-12-26	WOS:000387724300070
J	Syberg-Olsen, MJ; Irwin, NAT; Vannini, C; Erra, F; Di Giuseppe, G; Boscaro, V; Keeling, PJ				Syberg-Olsen, Mitchell J.; Irwin, Nicholas A. T.; Vannini, Claudia; Erra, Fabrizio; Di Giuseppe, Graziano; Boscaro, Vittorio; Keeling, Patrick J.			Biogeography and Character Evolution of the Ciliate Genus Euplotes (Spirotrichea, Euplotia), with Description of Euplotes curdsi sp nov.	PLOS ONE			English	Article							N. SP; SPECIES IDENTIFICATION; PROTOZOAN CILIATE; MARINE CILIATE; CILIOPHORA; RNA; PHYLOGENY; SEQUENCE; HYPOTRICHIDA; WOODRUFFI	Ciliates comprise a diverse and ecologically important phylum of unicellular protists. One of the most specious and best-defined genera is Euplotes, which constitutes more than 70 morphospecies, many of which have never been molecularly tested. The increasing number of described Euplotes taxa emphasizes the importance for detailed characterizations of new ones, requiring standardized morphological observations, sequencing of molecular markers and careful comparison with previous literature. Here we describe Euplotes curdsi sp. nov., distinguishable by the combination of the following features: 45-65 mu m length, oval or elongated shape with both ends rounded, narrow peristome with 25-34 adoral membranelles, conspicuous paroral membrane, double-eurystomus dorsal argyrome type, 6-7 dorsolateral kineties and 10 frontoventral cirri. Three populations of the novel species have been found in brackish and marine samples in the Mediterranean and the White Sea. We provide the SSU rRNA gene sequences of these populations, and an updated phylogeny of the genus Euplotes. Using the molecular phylogenetic tree, we inferred aspects of the biogeographical history of the genus and the evolution of its most important taxonomic characters in order to provide a frame for future descriptions. Ultimately, these data reveal recurrent trends of freshwater invasion and highlight the dynamic, yet convergent, morphological evolution of Euplotes.	[Syberg-Olsen, Mitchell J.; Irwin, Nicholas A. T.; Boscaro, Vittorio; Keeling, Patrick J.] Univ British Columbia, Canadian Inst Adv Res, Dept Bot, Vancouver, BC, Canada; [Vannini, Claudia; Erra, Fabrizio; Di Giuseppe, Graziano] Univ Pisa, Dipartimento Biol, Pisa, Italy	Canadian Institute for Advanced Research (CIFAR); University of British Columbia; University of Pisa	Boscaro, V (corresponding author), Univ British Columbia, Canadian Inst Adv Res, Dept Bot, Vancouver, BC, Canada.	vittorio.boscaro@botany.ubc.ca	Boscaro, Vittorio/J-5857-2012	Boscaro, Vittorio/0000-0003-4374-1231; Keeling, Patrick/0000-0002-7644-0745; Syberg-Olsen, Mitchell/0000-0003-1627-8472; Di Giuseppe, Graziano/0000-0002-9999-7650	Natural Sciences and Engineering Research Council [227301]; Tula Foundation to the Centre for Microbial Diversity and Evolution	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Tula Foundation to the Centre for Microbial Diversity and Evolution	This work was supported by a grant from the Natural Sciences and Engineering Research Council (227301). VB was supported by a fellowship from the Tula Foundation to the Centre for Microbial Diversity and Evolution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGAMALIEV F. G., 1966, ACTA PROTOZOOL, V4, P169; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; BEALE G, 1990, TRENDS GENET, V6, P137, DOI 10.1016/0168-9525(90)90132-P; BEAVER JR, 1989, MICROBIAL ECOL, V17, P111, DOI 10.1007/BF02011847; BORROR AC, 1995, J EUKARYOT MICROBIOL, V42, P457, DOI 10.1111/j.1550-7408.1995.tb05891.x; BORROR AC, 1968, J PROTOZOOL, V15, P802, DOI 10.1111/j.1550-7408.1968.tb02218.x; Boscaro V, 2014, PROTIST, V165, P527, DOI 10.1016/j.protis.2014.05.004; Boscaro V, 2013, P NATL ACAD SCI USA, V110, P18590, DOI 10.1073/pnas.1316687110; CARTER HP, 1972, T AM MICROSC SOC, V91, P466, DOI 10.2307/3225477; Chen XR, 2014, CHIN J OCEANOL LIMN, V32, P426, DOI 10.1007/s00343-014-3147-x; Chen XR, 2013, ACTA PROTOZOOL, V52, P73, DOI 10.4467/16890027AP.13.008.1087; CURDS C R, 1975, Bulletin of the British Museum (Natural History) Zoology, V28, P3; Dai RH, 2013, J EUKARYOT MICROBIOL, V60, P70, DOI 10.1111/jeu.12007; Di Giuseppe G, 2014, EUR J PROTISTOL, V50, P402, DOI 10.1016/j.ejop.2014.05.001; Di Giuseppe G, 2011, P NATL ACAD SCI USA, V108, P3181, DOI 10.1073/pnas.1019432108; DILLER WF, 1966, BIOL BULL, V131, P437, DOI 10.2307/1539983; Dolan JR, 2012, J EUKARYOT MICROBIOL, V59, P511, DOI 10.1111/j.1550-7408.2012.00646.x; Dragesco J., 1966, Archiv fuer Protistenkunde, V109, P155; FENCHEL T, 1972, Archiv fuer Protistenkunde, V114, P231; Foissner Wilhelm, 2002, Denisia, V5, P1; Fokin SI, 2008, J EUKARYOT MICROBIOL, V55, P214, DOI 10.1111/j.1550-7408.2008.00322.x; Fokin SI, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-203; Fotedar R, 2016, J EUKARYOT MICROBIOL, V63, P578, DOI 10.1111/jeu.12305; Gallagher AE, 1971, ESSENTIALS PRACTICAL; Gates M.A., 1979, Bulletin of the British Museum (Natural History) Zoology, V35, P127; Gentekaki E, 2010, J EUKARYOT MICROBIOL, V57, P508, DOI 10.1111/j.1550-7408.2010.00505.x; Gortz H-D, PROKARYOTES; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; HECKMANN K, 1983, J PROTOZOOL, V30, P284, DOI 10.1111/j.1550-7408.1983.tb02917.x; Jiang JM, 2010, EUR J PROTISTOL, V46, P121, DOI 10.1016/j.ejop.2009.11.003; Jiang JM, 2010, INT J SYST EVOL MICR, V60, P1241, DOI 10.1099/ijs.0.012120-0; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; La Terza A, 2001, MOL ECOL, V10, P1061, DOI 10.1046/j.1365-294X.2001.01242.x; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lessard EJ, 1996, J EXP MAR BIOL ECOL, V204, P43, DOI 10.1016/0022-0981(96)02580-4; Liu MJ, 2015, ACTA PROTOZOOL, V54, P171, DOI 10.4467/16890027AP.15.014.3211; Lobban CS, 2005, MAR BIOL, V147, P1055, DOI 10.1007/s00227-005-0024-3; Lynn D.H, 2008, CIL PROT CHAR CLASS, V3rd ed.; Marziale F, 2008, FEBS J, V275, P5367, DOI 10.1111/j.1742-4658.2008.06666.x; Petroni G, 2002, MOL PHYLOGENET EVOL, V22, P118, DOI 10.1006/mpev.2001.1030; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosati G, 2004, J EUKARYOT MICROBIOL, V51, P49, DOI 10.1111/j.1550-7408.2004.tb00160.x; Rossi A, 2016, EUR J PROTISTOL, V53, P11, DOI 10.1016/j.ejop.2015.12.005; Schmidt SL, 2007, J EUKARYOT MICROBIOL, V54, P201, DOI 10.1111/j.1550-7408.2007.00250.x; Schwarz MVJ, 2007, J EUKARYOT MICROBIOL, V54, P125, DOI 10.1111/j.1550-7408.2007.00243x; Senra MVX, 2016, MICROB ECOL, V71, P505, DOI 10.1007/s00248-015-0668-6; Shao C, 2010, CHIN J OCEANOL LIMN, V28, P593, DOI 10.1007/s00343-010-9128-9; SONNEBORN TM, 1975, T AM MICROSC SOC, V94, P155, DOI 10.2307/3224977; Stoeck T, 2014, MOL ECOL RESOUR, V14, P458, DOI 10.1111/1755-0998.12195; Tuffrau M, 2000, EUR J PROTISTOL, V36, P355, DOI 10.1016/S0932-4739(00)80041-3; TUFFRAU MICHEL, 1960, HYDROBIOLOGIA, V15, P1, DOI 10.1007/BF00048080; VALBONESI A, 1990, POLAR BIOL, V11, P47; VALBONESI A, 1995, EUR J PROTISTOL, V31, P32, DOI 10.1016/S0932-4739(11)80353-6; VALLESI A, 1995, NATURE, V376, P522, DOI 10.1038/376522a0; Vallesi A, 2008, MOL PHYLOGENET EVOL, V47, P439, DOI 10.1016/j.ympev.2007.11.025; Vallesi A, 2014, J EUKARYOT MICROBIOL, V61, P620, DOI 10.1111/jeu.12140; Vannini C, 2005, J EUKARYOT MICROBIOL, V52, P116, DOI 10.1111/j.1550-7408.2005.04-3319.x; Vannini C, 2004, INT J SYST EVOL MICR, V54, P1151, DOI 10.1099/ijs.0.02759-0; Vannini C, 2007, ENVIRON MICROBIOL, V9, P347, DOI 10.1111/j.1462-2920.2006.01144.x; Vannini C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087718; Vannini C, 2012, ENVIRON MICROBIOL, V14, P2553, DOI 10.1111/j.1462-2920.2012.02760.x; Vogt A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004032; Wallengren H, 1900, BIH K SVENSK VET, V26, P1; WASHBURN ES, 1972, J PROTOZOOL, V19, P604, DOI 10.1111/j.1550-7408.1972.tb03541.x; Wichterman E., 1964, T AM MICROSC SOC, V83, P362; Wichterman R., 1986, BIOL PARAMECIUM, V2nd ed., DOI DOI 10.1007/978-1-4757-0372-6; Wilbert N, 2008, J NAT HIST, V42, P979, DOI 10.1080/00222930701877540; Zhao Y, 2016, MOL PHYLOGENET EVOL, V94, P718, DOI 10.1016/j.ympev.2015.10.017	70	28	29	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165442	10.1371/journal.pone.0165442	http://dx.doi.org/10.1371/journal.pone.0165442			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828996	Green Submitted, Green Published, gold			2022-12-26	WOS:000387724300046
J	Wang, YH; Xiao, L; Guo, SM; An, FY; Du, DZ				Wang, Yanhua; Xiao, Lu; Guo, Shaomin; An, Fengyun; Du, Dezhi			Fine Mapping and Whole-Genome Resequencing Identify the Seed Coat Color Gene in Brassica rapa	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; DISEASE-RESISTANCE; MOLECULAR MARKERS; CAMPESTRIS L; NAPUS L; YELLOW; QTL; IDENTIFICATION; POPULATIONS; BLACK	A yellow seed coat is a desirable agronomic trait in the seeds of oilseed-type Brassica crops. In this study, we identified a candidate gene for seed coat color in Dahuang, a land race of Brassica rapa. A previous study of Dahuang mapped the seed coat color gene Brsc1 to a 2.8-Mb interval on chromosome A9 of B. rapa. In the present study, the density of the linkage map for Brsc1 was increased by adding simple sequence repeat (SSR) markers, and the candidate region for Brsc1 was narrowed to 1.04 Mb. In addition, whole-genome resequencing with bulked segregant analysis (BSA) was conducted to identify candidate intervals for Brsc1. A genome-wide comparison of SNP profiles was performed between yellow-seeded and brown-seeded bulk samples. SNP index analyses identified a major candidate interval on chromosome A9 (A09:18,255,838-18,934,000, 678 kb) containing a long overlap with the target region recovered from the fine mapping results. According to gene annotation, Bra028067(BrTT1) is an important candidate gene for Brsc1 in the overlapping region. Quantitative reverse transcription (qRT)-PCR revealed that BrTT1 mainly functions in the seed. Point mutations and small deletions in BrTT1 were found between yellow- and brown-seeded Dahuang plants. Collectively, the expression and sequence analysis results provide preliminary evidence that BrTT1 is a candidate gene for the seed coat color trait in Dahuang.	[Wang, Yanhua; Xiao, Lu; Guo, Shaomin; An, Fengyun; Du, Dezhi] Qinghai Univ, Acad Agr & Forestry Sci, Qinghai Res Branch, Natl Rapeseed Genet Improvement Ctr,Key Lab Sprin, Xining, Qinghai, Peoples R China	Qinghai University	Du, DZ (corresponding author), Qinghai Univ, Acad Agr & Forestry Sci, Qinghai Res Branch, Natl Rapeseed Genet Improvement Ctr,Key Lab Sprin, Xining, Qinghai, Peoples R China.	qhurape@126.com	wang, yanhua/GPT-1596-2022		National Key Research and Development Plan of China [2016YFD0101300]; Industry Technology System of Rapeseed in China [CARS-13]; National Natural Science Foundation of China [31560398]; National High-level personnel of special support program	National Key Research and Development Plan of China; Industry Technology System of Rapeseed in China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-level personnel of special support program	The work was funded by National Key Research and Development Plan of China (2016YFD0101300), Industry Technology System of Rapeseed in China (CARS-13), National Natural Science Foundation of China (31560398) and National High-level personnel of special support program.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; AHMED SU, 1971, CROP SCI, V11, P309, DOI 10.2135/cropsci1971.0011183X001100020047x; Appelhagen I, 2014, PLANTA, V240, P955, DOI 10.1007/s00425-014-2088-0; Appelhagen I, 2011, PLANT J, V67, P406, DOI 10.1111/j.1365-313X.2011.04603.x; Appleby Nikki, 2009, V513, P19, DOI 10.1007/978-1-59745-427-8_2; Bagheri H, 2013, SPAN J AGRIC RES, V11, P1085, DOI 10.5424/sjar/2013114-4160; CHEN BY, 1992, EUPHYTICA, V59, P157, DOI 10.1007/BF00041268; Debeaujon I, 2003, PLANT CELL, V15, P2514, DOI 10.1105/tpc.014043; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Grover A, 2016, CRIT REV BIOTECHNOL, V36, P290, DOI 10.3109/07388551.2014.959891; Guo N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-426; He JF, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00484; Jiang JJ, 2013, J INTEGR PLANT BIOL, V55, P537, DOI 10.1111/jipb.12039; Kebede B, 2012, GENOME, V55, P813, DOI 10.1139/g2012-066; Kosambi DD, 1944, AM MATH MON, P382, DOI [10.1080/00029890.1944.11999118, DOI 10.1007/978-81-322-3676-4_17, 10.1007/978-81-322-3676-4_17]; Lee J, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0424-6; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044145; Li X, 2015, SHOCK VIB, V2015, DOI 10.1155/2015/431476; Liu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071110; Lou P, 2007, J EXP BOT, V58, P4005, DOI 10.1093/jxb/erm255; Lu HF, 2014, THEOR APPL GENET, V127, P1491, DOI 10.1007/s00122-014-2313-z; Marles MAS, 2004, J SCI FOOD AGR, V84, P251, DOI 10.1002/jsfa.1621; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miah G, 2013, INT J MOL SCI, V14, P22499, DOI 10.3390/ijms141122499; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Padmaja LK, 2014, THEOR APPL GENET, V127, P339, DOI 10.1007/s00122-013-2222-6; Qu CM, 2013, J EXP BOT, V64, P2885, DOI 10.1093/jxb/ert148; Rahman MH, 2001, PLANT BREEDING, V120, P463, DOI 10.1046/j.1439-0523.2001.00640.x; Rahman M, 2007, THEOR APPL GENET, V115, P1101, DOI 10.1007/s00122-007-0636-8; Rahman M, 2014, PLANT BREEDING, V133, P381, DOI 10.1111/pbr.12165; Sagasser M, 2002, GENE DEV, V16, P138, DOI 10.1101/gad.212702; SHIRZADEGAN M, 1985, FETT WISS TECHNOL, V87, P235, DOI 10.1002/lipi.19850870605; Stein A, 2013, PLANT BREEDING, V132, P382, DOI 10.1111/pbr.12073; Stringam G, 1974, P 4 INT RAP C GERM G; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Xiao L, 2012, THEOR APPL GENET, V124, P903, DOI 10.1007/s00122-011-1754-x; Yang HA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-318; Yu CY, 2013, J APPL GENET, V54, P135, DOI 10.1007/s13353-012-0132-y; Zaman M. W., 1989, Sveriges Utsadesforenings Tidskrift, V99, P205; Zhang JF, 2009, PLANT MOL BIOL, V69, P553, DOI 10.1007/s11103-008-9437-y; Zhao HuiYan, 2014, Acta Agronomica Sinica, V40, P965; Zhao JJ, 2005, THEOR APPL GENET, V110, P1301, DOI 10.1007/s00122-005-1967-y	44	24	28	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166464	10.1371/journal.pone.0166464	http://dx.doi.org/10.1371/journal.pone.0166464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829069	Green Published, gold, Green Submitted			2022-12-26	WOS:000387724300108
J	Boehm-Cagen, A; Bar, R; Harats, D; Shaish, A; Levkovitz, H; Bielicki, JK; Johansson, JO; Michaelson, DM				Boehm-Cagen, Anat; Bar, Roni; Harats, Dror; Shaish, Aviv; Levkovitz, Hana; Bielicki, John K.; Johansson, Jan O.; Michaelson, Daniel M.			Differential Effects of apoE4 and Activation of ABCA1 on Brain and Plasma Lipoproteins	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEINS; CENTRAL-NERVOUS-SYSTEM; SPORADIC ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; TRANSGENIC MICE; CARDIOVASCULAR-DISEASE; CHOLESTEROL TRANSPORT; TARGETED REPLACEMENT; MOUSE MODEL; WILD-TYPE	Apolipoprotein E4 (apoE4), the leading genetic risk factor for Alzheimer's disease (AD), is less lipidated compared to the most common and AD-benign allele, apoE3. We have recently shown that i.p. injections of the ATP-binding cassette A1 (ABCA1) agonist peptide CS-6253 to apoE mice reverse the hypolipidation of apoE4 and the associated brain pathology and behavioral deficits. While in the brain apoE is the main cholesterol transporter, in the periphery apoE and apoA-I both serve as the major cholesterol transporters. We presently investigated the extent to which apoE genotype and CS-6253 treatment to apoE3 and apoE4-targeted replacement mice affects the plasma levels and lipid particle distribution of apoE, and those of plasma and brain apoA-I and apoJ. This revealed that plasma levels of apoE4 were lower and eluted faster following FPLC than plasma apoE3. Treatment with CS-6253 increased the levels of plasma apoE4 and rendered the elution profile of apoE4 similar to that of apoE3. Similarly, the levels of plasma apoA-I were lower in the apoE4 mice compared to apoE3 mice, and this effect was partially reversed by CS-6253. Conversely, the levels of apoA-I in the brain which were higher in the apoE4 mice, were unaffected by CS-6253. The plasma levels of apoJ were higher in apoE4 mice than apoE3 mice and this effect was abolished by CS-6253. Similar but less pronounced effects were obtained in the brain. In conclusion, these results suggest that apoE4 affects the levels of apoA-I and apoJ and that the anti-apoE4 beneficial effects of CS-6253 may be related to both central and peripheral mechanisms.	[Boehm-Cagen, Anat; Bar, Roni; Michaelson, Daniel M.] Tel Aviv Univ, Sagol Sch Neurosci, George S Wise Fac Life Sci, Dept Neurobiol, IL-6997801 Tel Aviv, Israel; [Harats, Dror] Tel Aviv Univ, Sackler Fac Med, IL-6997801 Tel Aviv, Israel; [Harats, Dror; Shaish, Aviv; Levkovitz, Hana] Bert W Strassburger Lipid Ctr, Sheba Med Ctr, IL-5265601 Tel Hashomer, Israel; [Bielicki, John K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Johansson, Jan O.] Artery Therapeut Inc, San Ramon, CA USA	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Michaelson, DM (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, George S Wise Fac Life Sci, Dept Neurobiol, IL-6997801 Tel Aviv, Israel.	dmichael@post.tau.ac.il		Johansson, Jan/0000-0002-3576-2748	Legacy Heritage Bio-Medical Program of the Israel Science Foundation [1575/14]; Joseph K. and Inez Eichenbaum Foundation; Harold and Eleanore Foonberg Foundation; Teva Pharmaceutical Industries Ltd., Israeli National Network of Excellence in Neuroscience (NNE); Artery Therapeutics, Inc.	Legacy Heritage Bio-Medical Program of the Israel Science Foundation; Joseph K. and Inez Eichenbaum Foundation; Harold and Eleanore Foonberg Foundation; Teva Pharmaceutical Industries Ltd., Israeli National Network of Excellence in Neuroscience (NNE); Artery Therapeutics, Inc.	This research was supported in part by grants from the Legacy Heritage Bio-Medical Program of the Israel Science Foundation (grant No. 1575/14), from the Joseph K. and Inez Eichenbaum Foundation, from the Harold and Eleanore Foonberg Foundation, and from Teva Pharmaceutical Industries Ltd., as part of the Israeli National Network of Excellence in Neuroscience (NNE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Artery Therapeutics, Inc. provided support in the form of salaries for author JOJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this authors is articulated in the 'author contributions' section.; We thank Alex Smolar for his technical assistance. This research was supported in part by grants from the Legacy Heritage Bio-Medical Program of the Israel Science Foundation (grant No. 1575/14), from the Joseph K. and Inez Eichenbaum Foundation, from the Harold and Eleanore Foonberg Foundation, and from Teva Pharmaceutical Industries Ltd., as part of the Israeli National Network of Excellence in Neuroscience (NNE). DMM is the incumbent of the Myriam Lebach Chair in Molecular Neurodegeneration.	Belinson H, 2008, J NEUROSCI, V28, P4690, DOI 10.1523/JNEUROSCI.5633-07.2008; Belinson H, 2009, J NEURAL TRANSM, V116, P1427, DOI 10.1007/s00702-009-0218-9; Bielicki JK, 2010, J LIPID RES, V51, P1496, DOI 10.1194/jlr.M003665; Boehm-Cagan A, 2016, J ALZHEIMERS DIS, V54, P1219, DOI 10.3233/JAD-160467; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DeMattos RB, 2001, NEUROCHEM INT, V39, P415, DOI 10.1016/S0197-0186(01)00049-3; DESILVA HV, 1990, BIOCHEMISTRY-US, V29, P5380, DOI 10.1021/bi00474a025; Elliott DA, 2010, CLIN LIPIDOL, V5, P555, DOI 10.2217/CLP.10.37; Fagan AM, 1999, J BIOL CHEM, V274, P30001, DOI 10.1074/jbc.274.42.30001; Gelissen IC, 1998, BIOCHEM J, V331, P231, DOI 10.1042/bj3310231; GREGG RE, 1986, J CLIN INVEST, V78, P815, DOI 10.1172/JCI112645; Grosskopf I, 2012, ATHEROSCLEROSIS, V224, P75, DOI 10.1016/j.atherosclerosis.2012.04.011; Haas A, 2012, NEURODEGENER DIS, V10, P41, DOI 10.1159/000334902; Hafiane A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131997; Hanson AJ, 2013, JAMA NEUROL, V70, P972, DOI 10.1001/jamaneurol.2013.396; HEDRICK CC, 1993, J BIOL CHEM, V268, P20676; Heeren J, 2006, ARTERIOSCL THROM VAS, V26, P442, DOI 10.1161/01.ATV.0000201282.64751.47; Hirsch-Reinshagen V, 2004, J BIOL CHEM, V279, P41197, DOI 10.1074/jbc.M407962200; Hopkins PCR, 2002, J LIPID RES, V43, P1881, DOI 10.1194/jlr.M200172-JLR200; Hu J, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0001-3; Huang YD, 1995, J CLIN INVEST, V96, P2693, DOI 10.1172/JCI118336; Jansen PJ, 2009, J ALZHEIMERS DIS, V18, P319, DOI 10.3233/JAD-2009-1150; JONAS A, 1990, J BIOL CHEM, V265, P22123; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Kockx M, 2004, J BIOL CHEM, V279, P25966, DOI 10.1074/jbc.M401177200; Koldamova R, 2014, NEUROBIOL DIS, V72, P13, DOI 10.1016/j.nbd.2014.05.007; LaDu MJ, 2000, ANN NY ACAD SCI, V903, P167, DOI 10.1111/j.1749-6632.2000.tb06365.x; Levi O, 2003, NEUROBIOL DIS, V13, P273, DOI 10.1016/S0969-9961(03)00045-7; Li H, 2013, ARTERIOSCL THROM VAS, V33, P687, DOI 10.1161/ATVBAHA.112.301193; LINTON MF, 1991, J CLIN INVEST, V88, P270, DOI 10.1172/JCI115288; Liraz O, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-16; Mahley RW, 2016, ARTERIOSCL THROM VAS, V36, P1305, DOI 10.1161/ATVBAHA.116.307023; Mahley RW, 2006, J CLIN INVEST, V116, P1226, DOI 10.1172/JCI28632; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAHLEY RW, 1984, J LIPID RES, V25, P1277; Michel D, 1997, BIOCHEM J, V328, P45, DOI 10.1042/bj3280045; Michikawa M, 2000, J NEUROCHEM, V74, P1008, DOI 10.1046/j.1471-4159.2000.0741008.x; Minagawa Hirohisa, 2009, J Neurosci Res, V87, P2498, DOI 10.1002/jnr.22073; Mulder M, 1998, HAEMOSTASIS, V28, P174; Okoro EU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044430; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Phillips MC, 2013, J LIPID RES, V54, P2034, DOI 10.1194/jlr.R034025; PITAS RE, 1987, BIOCHIM BIOPHYS ACTA, V917, P148, DOI 10.1016/0005-2760(87)90295-5; PITAS RE, 1987, J BIOL CHEM, V262, P14352; Poirier J, 2005, NEUROBIOL AGING, V26, P355, DOI 10.1016/j.neurobiolaging.2004.09.003; POIRIER J, 1993, NEUROSCIENCE, V55, P81, DOI 10.1016/0306-4522(93)90456-P; Poirier J, 2014, NEUROBIOL AGING, V35, pS3, DOI 10.1016/j.neurobiolaging.2014.03.037; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; Robciuc MR, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-59; Robert J, 2016, BBA-MOL BASIS DIS, V1862, P1027, DOI 10.1016/j.bbadis.2015.10.005; Rohn TT, 2014, INT J CLIN EXP PATHO, V7, P3504; Roses AD, 1996, ANNU REV MED, V47, P387, DOI 10.1146/annurev.med.47.1.387; Rye KA, 1996, J BIOL CHEM, V271, P4243; Rye K, 2006, J LIPID RES, V47, P1025, DOI 10.1194/jlr.M500525-JLR200; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Stukas S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001156; Stukas S, 2014, CELL METAB, V19, P574, DOI 10.1016/j.cmet.2014.01.003; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Tai LM, 2014, J BIOL CHEM, V289, P30538, DOI 10.1074/jbc.M114.600833; Tai LM, 2013, J BIOL CHEM, V288, P5914, DOI 10.1074/jbc.M112.442103; Tang CR, 2009, BBA-MOL CELL BIOL L, V1791, P563, DOI 10.1016/j.bbalip.2009.03.011; Ulrich JD, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-13; Vance JE, 2010, BBA-MOL CELL BIOL L, V1801, P806, DOI 10.1016/j.bbalip.2010.02.007; Vitali C, 2014, CARDIOVASC RES, V103, P405, DOI 10.1093/cvr/cvu148; Wahrle SE, 2004, J BIOL CHEM, V279, P40987, DOI 10.1074/jbc.M407963200; Wellington CL, 2016, CURR OPIN LIPIDOL, V27, P225, DOI 10.1097/MOL.0000000000000291; Wyatt AR, 2009, J BIOL CHEM, V284, P21920, DOI 10.1074/jbc.M109.033688; Yassine HN, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002886; Yu JT, 2012, MOL NEUROBIOL, V45, P314, DOI 10.1007/s12035-012-8237-1; Zlokovic BV, 2013, JAMA NEUROL, V70, P440, DOI 10.1001/jamaneurol.2013.2152	70	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166195	10.1371/journal.pone.0166195	http://dx.doi.org/10.1371/journal.pone.0166195			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824936	Green Published, gold, Green Submitted			2022-12-26	WOS:000387615200070
J	Fujima, N; Sakashita, T; Homma, A; Hirata, K; Shiga, T; Kudo, K; Shirato, H				Fujima, Noriyuki; Sakashita, Tomohiro; Homma, Akihiro; Hirata, Kenji; Shiga, Tohru; Kudo, Kohsuke; Shirato, Hiroki			Glucose Metabolism and Its Complicated Relationship with Tumor Growth and Perfusion in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							BLOOD-FLOW; CANCER; PET; TOMOGRAPHY; HYPOXIA; CT	Objective To determine the relationship between tumor glucose metabolism and tumor blood flow (TBF) in head and neck squamous cell carcinoma (HNSCC). Methods We retrospectively analyzed 57 HNSCC patients. Tumor glucose metabolism was assessed by maximum and mean standardized uptake values (SUVmax and SUVmean) obtained by 18 F-fluorodeoxyglucose positron-emission tomography. TBF values were obtained by arterial spin labeling with 3-tesla MRI. The correlations between both SUVs and TBF were assessed in the total series and among patients divided by T-stage (T1-T3 and T4 groups) and tumor location (pharynx/oral cavity and sinonasal cavity groups). Pearson's correlation coefficients were calculated for significant correlations. Results Significant correlations were detected: a negative correlation in the advanced T-stage group (TBF and SUV max: r, -0.61, SUVmean: r, -0.62), a positive correlation in the non-advanced T-stage pharynx/oral cavity group (TBF and SUVmax: r, 0.70, SUVmean: r, 0.73), a negative correlation in the advanced T-stage pharynx/oral cavity group (TBF and SUVmax: r, -0.62, SUVmean: r, -0.65), and a negative correlation in the advanced Tstage sinonasal cavity group (TBF and SUVmax: r, -0.61, SUVmean: r, -0.65). Conclusion Significant correlations between glucose uptake and TBF in HNSCC were revealed by the division of T-stage and tumor location.	[Fujima, Noriyuki; Kudo, Kohsuke] Hokkaido Univ Hosp, Dept Diagnost & Intervent Radiol, Sapporo, Hokkaido, Japan; [Sakashita, Tomohiro; Homma, Akihiro] Hokkaido Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Sapporo, Hokkaido, Japan; [Hirata, Kenji; Shiga, Tohru] Hokkaido Univ, Dept Nucl Med, Grad Sch Med, Sapporo, Hokkaido, Japan; [Shirato, Hiroki] Hokkaido Univ, Dept Radiat Med, Grad Sch Med, Sapporo, Hokkaido, Japan; [Shirato, Hiroki] Global Inst Collaborat Res & Educ, Global Stn Quantum Med Sci & Engn, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Fujima, N (corresponding author), Hokkaido Univ Hosp, Dept Diagnost & Intervent Radiol, Sapporo, Hokkaido, Japan.	Noyuki.Fujima@mb9.seikyou.ne.jp	Kudo, Kohsuke/AAK-9938-2021; Fujima, Noriyuki/AAF-7270-2020	Kudo, Kohsuke/0000-0001-5351-9242; Fujima, Noriyuki/0000-0001-9021-347X	Ministry of Education, Culture, Sports, Science and Technology - Japan [25861047]	Ministry of Education, Culture, Sports, Science and Technology - Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology - Japan (ID; 25861047)(https://kaken.nii.ac.jp/d/p/25861047.ja.html), received by NF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisdas S, 2008, AM J NEURORADIOL, V29, P1376, DOI 10.3174/ajnr.A1111; Fruehwald-Pallamar J, 2011, EUR J NUCL MED MOL I, V38, P1009, DOI 10.1007/s00259-010-1718-4; Fujima N, 2016, AM J NEURORADIOL, V37, P342, DOI 10.3174/ajnr.A4513; Fujima N, 2015, DENTOMAXILLOFAC RAD, V44, DOI 10.1259/dmfr.20150074; Fujima N, 2015, EUR J RADIOL, V84, P2187, DOI 10.1016/j.ejrad.2015.07.026; Fujima N, 2015, J MAGN RESON IMAGING, V41, P983, DOI [10.1002/jmri.24637, 10.1002/jmri.24885]; Goh V, 2012, J NUCL MED, V53, P687, DOI 10.2967/jnumed.111.098525; Hirasawa S, 2007, ACAD RADIOL, V14, P312, DOI 10.1016/j.acra.2006.12.017; Kato H, 2015, EUR RADIOL, V25, P3247, DOI 10.1007/s00330-015-3755-7; Komar G, 2014, EUR J NUCL MED MOL I, V41, P2042, DOI 10.1007/s00259-014-2818-3; Komar G, 2008, J NUCL MED, V49, P1944, DOI 10.2967/jnumed.108.053785; Lin YT, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-194; Newbold K, 2009, INT J RADIAT ONCOL, V74, P29, DOI 10.1016/j.ijrobp.2008.07.039; Panin VY, 2006, IEEE T MED IMAGING, V25, P907, DOI 10.1109/TMI.2006.876171; Rischin D, 2007, INT J RADIAT ONCOL, V69, pS61, DOI 10.1016/j.ijrobp.2007.05.043; Sato J, 2014, EUR J NUCL MED MOL I, V41, P2031, DOI 10.1007/s00259-014-2810-y; Sheikhbahaei S, 2015, PET CLIN, V10, P125, DOI 10.1016/j.cpet.2014.12.001; Srinivasan A, 2012, AM J NEURORADIOL, V33, P586, DOI 10.3174/ajnr.A2535; Taghipour M, 2016, JAMA OTOLARYNGOL, V142, P79, DOI 10.1001/jamaoto.2015.2607; Veit-Haibach P, 2013, EUR RADIOL, V23, P163, DOI 10.1007/s00330-012-2564-5	20	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166236	10.1371/journal.pone.0166236	http://dx.doi.org/10.1371/journal.pone.0166236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824931	Green Published, Green Submitted, gold			2022-12-26	WOS:000387615200075
J	Shao, FJ; Zhang, Q; Liu, HW; Lu, SF; Qiu, DY				Shao, Fenjuan; Zhang, Qian; Liu, Hongwei; Lu, Shanfa; Qiu, Deyou			Genome-Wide Identification and Analysis of MicroRNAs Involved in Witches'-Broom Phytoplasma Response in Ziziphus jujuba	PLOS ONE			English	Article							CHINESE JUJUBE; PLANT; EXPRESSION; GENE; AURANTIFOLIA; GENERATION; PATHWAYS; DATABASE; DISEASE; MIR172	MicroRNAs (miRNAs) play an important role in responding to biotic and abiotic stresses in plants. Jujube witches'-broom a phytoplasma disease of Ziziphus jujuba is prevalent in China and is a serious problem to the industry. However, the molecular mechanism of the disease is poorly understood. In this study, genome-wide identification and analysis of microRNAs in response to witches'-broom was performed. A total of 85 conserved miRNA unique sequences belonging to 32 miRNA families and 24 novel miRNA unique sequences, including their complementary miRNA* strands were identified from small RNA libraries derived from a uninfected and witches'-broom infected Z. jujuba plant. Differentially expressed miRNAs associated with Jujube witches'-broom disease were investigated between the two libraries, and 12 up-regulated miRNAs and 10 down-regulated miRNAs identified with more than 2 fold changes. Additionally, 40 target genes of 85 conserved miRNAs and 49 target genes of 24 novel miRNAs were predicted and their putative functions assigned. Using the modified 5'-RACE method, we confirmed that SPL and MYB were cleaved by miR156 and miR159, respectively. Our results provide insight into the molecular mechanisms of witches'-broom disease in Z. jujuba.	[Shao, Fenjuan; Zhang, Qian; Liu, Hongwei; Qiu, Deyou] Chinese Acad Forestry, Res Inst Forestry, Key Lab Tree Breeding & Cultivat State Forestry A, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Lu, Shanfa] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China; [Lu, Shanfa] Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Qiu, DY (corresponding author), Chinese Acad Forestry, Res Inst Forestry, Key Lab Tree Breeding & Cultivat State Forestry A, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.; Lu, SF (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China.; Lu, SF (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	sflu@implad.ac.cn; peterqdy@aliyun.com	Lu, Shanfa/AAF-7424-2020	Lu, Shanfa/0000-0001-6284-4389	National Key Research and Development Program of China [2016YFD0600104]; Basic Research Fund of RIF [RIF2014-01]	National Key Research and Development Program of China; Basic Research Fund of RIF	The work was supported by the National Key Research and Development Program of China (grant number 2016YFD0600104) and the Basic Research Fund of RIF (grant number RIF2014-01).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Blumwald E, 1998, TRENDS PLANT SCI, V3, P342, DOI 10.1016/S1360-1385(98)01289-8; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Chen L, 2012, PLANTA, V235, P873, DOI 10.1007/s00425-011-1548-z; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Christensen NM, 2005, TRENDS PLANT SCI, V10, P526, DOI 10.1016/j.tplants.2005.09.008; Dai XB, 2011, BRIEF BIOINFORM, V12, P115, DOI 10.1093/bib/bbq065; DOI Y., 1967, Annals of the Phytopathological Society of Japan, V33, P259; Ehya F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066372; Fang SZ, 2009, INT J FOOD SCI TECH, V44, P1818, DOI 10.1111/j.1365-2621.2009.02005.x; Gai YP, 2014, SCI REP-UK, V4, DOI 10.1038/srep05378; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Huijser P, 2011, DEVELOPMENT, V138, P4117, DOI 10.1242/dev.063511; Inal B, 2014, PLANTA, V240, P1287, DOI 10.1007/s00425-014-2153-8; Jung HY, 2003, INT J SYST EVOL MICR, V53, P1037, DOI 10.1099/ijs.0.02393-0; Lee J. T., 1988, RES REPORTS RURAL DE, V31, P155; Levy A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-524; Li JW, 2007, FOOD CHEM, V103, P454, DOI 10.1016/j.foodchem.2006.08.016; Liu MJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6315; Liu XG, 2012, PLANT CELL TISS ORG, V108, P339, DOI 10.1007/s11240-011-0031-7; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Monavarfeshani A, 2013, J PROTEOME RES, V12, P785, DOI 10.1021/pr300865t; Namba S., 2002, Journal of General Plant Pathology, V68, P257, DOI 10.1007/PL00013086; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Rubio-Somoza I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003374; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shao FJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-512; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Strauss E, 2009, SCIENCE, V325, P388, DOI 10.1126/science.325_388; Streten C, 2006, AUSTRALAS PLANT PATH, V35, P129, DOI 10.1071/AP06004; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Wei S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-169; Wei S, 2010, J AGR FOOD CHEM, V58, P9572, DOI 10.1021/jf102635f; Wilke A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-141; Wu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044385; Zamharir MG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-1; Zhang H, 2010, FOOD CHEM TOXICOL, V48, P1461, DOI 10.1016/j.fct.2010.03.011; Zhang LS, 2014, J INTEGR PLANT BIOL, V56, P38, DOI 10.1111/jipb.12111; Zhang WX, 2011, PLANT MOL BIOL, V75, P93, DOI 10.1007/s11103-010-9710-8; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	43	13	18	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166099	10.1371/journal.pone.0166099	http://dx.doi.org/10.1371/journal.pone.0166099			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824938	Green Submitted, gold, Green Published			2022-12-26	WOS:000387615200062
J	Hering, T; Braubach, P; Landwehrmeyer, GB; Lindenberg, KS; Melzer, W				Hering, Tanja; Braubach, Peter; Landwehrmeyer, G. Bernhard; Lindenberg, Katrin S.; Melzer, Werner			Fast-to-Slow Transition of Skeletal Muscle Contractile Function and Corresponding Changes in Myosin Heavy and Light Chain Formation in the R6/2 Mouse Model of Huntington's Disease	PLOS ONE			English	Article							MUTANT HUNTINGTIN; TRANSGENIC MICE; FIBER TYPES; MITOCHONDRIAL DYSFUNCTION; MOLECULAR PATHOGENESIS; WIDESPREAD EXPRESSION; GENE-EXPRESSION; ISOFORMS; RAT; MOTOR	Huntington's disease (HD) is a hereditary neurodegenerative disease resulting from an expanded polyglutamine sequence (poly-Q) in the protein huntingtin (HTT). Various studies report atrophy and metabolic pathology of skeletal muscle in HD and suggest as part of the process a fast-to-slow fiber type transition that may be caused by the pathological changes in central motor control or/and by mutant HTT in the muscle tissue itself. To investigate muscle pathology in HD, we used R6/2 mice, a common animal model for a rapidly progressing variant of the disease expressing exon 1 of the mutant human gene. We investigated alterations in the extensor digitorum longus (EDL), a typical fast-twitch muscle, and the soleus (SOL), a slow-twitch muscle. We focussed on mechanographic measurements of excised muscles using single and repetitive electrical stimulation and on the expression of the various myosin isoforms (heavy and light chains) using dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) of whole muscle and single fiber preparations. In EDL of R6/2, the functional tests showed a left shift of the force-frequency relation and decrease in specific force. Moreover, the estimated relative contribution of the fastest myosin isoform MyHC IIb decreased, whereas the contribution of the slower MyHC IIx isoform increased. An additional change occurred in the alkali MyLC forms showing a decrease in 3f and an increase in 1f level. In SOL, a shift from fast MyHC IIa to the slow isoform I was detectable in male R6/2 mice only, and there was no evidence of isoform interconversion in the MyLC pattern. These alterations point to a partial remodeling of the contractile apparatus of R6/2 mice towards a slower contractile phenotype, predominantly in fast glycolytic fibers.	[Hering, Tanja; Braubach, Peter; Melzer, Werner] Univ Ulm, Inst Appl Physiol, Ulm, Germany; [Hering, Tanja; Landwehrmeyer, G. Bernhard; Lindenberg, Katrin S.] Univ Ulm, Dept Neurol, Ulm, Germany; [Braubach, Peter] Hannover Med Sch, Inst Pathol, Hannover, Germany	Ulm University; Ulm University; Hannover Medical School	Melzer, W (corresponding author), Univ Ulm, Inst Appl Physiol, Ulm, Germany.	werner.melzer@uni-ulm.de	Landwehrmeyer, Georg Bernhard/AHB-4443-2022	Landwehrmeyer, Georg Bernhard/0000-0003-3375-790X				Agbulut O, 2003, BIOL CELL, V95, P399, DOI 10.1016/S0248-4900(03)00087-X; Andruchov O, 2006, J PHYSIOL-LONDON, V571, P231, DOI 10.1113/jphysiol.2005.099770; Andruchov O, 2004, AM J PHYSIOL-CELL PH, V287, pC1725, DOI 10.1152/ajpcell.00255.2004; [Anonymous], 2014, R LANG ENV STAT; Asmussen G, 2003, EXP NEUROL, V184, P758, DOI 10.1016/S0014-4886(03)00294-2; Baldo B, 2012, CHEM BIOL, V19, P264, DOI 10.1016/j.chembiol.2011.12.020; BAR A, 1989, EUR J BIOCHEM, V178, P591, DOI 10.1111/j.1432-1033.1989.tb14486.x; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Bossy-Wetzel E, 2008, TRENDS NEUROSCI, V31, P609, DOI 10.1016/j.tins.2008.09.004; BOTTINELLI R, 1994, J PHYSIOL-LONDON, V478, P341, DOI 10.1113/jphysiol.1994.sp020254; Bottinelli R, 2001, PFLUG ARCH EUR J PHY, V443, P6, DOI 10.1007/s004240100700; Braubach P, 2014, J GEN PHYSIOL, V144, P393, DOI 10.1085/jgp.201411255; Browne SE, 2008, ANN NY ACAD SCI, V1147, P358, DOI 10.1196/annals.1427.018; Busse ME, 2008, J NEUROL, V255, P1534, DOI 10.1007/s00415-008-0964-x; Cepeda C, 2007, PROG NEUROBIOL, V81, P253, DOI 10.1016/j.pneurobio.2006.11.001; Chaturvedi RK, 2009, HUM MOL GENET, V18, P3048, DOI 10.1093/hmg/ddp243; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Djousse L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF; Friedrich O, 2008, BIOPHYS J, V94, P4751, DOI 10.1529/biophysj.107.126557; Gizatullina ZZ, 2006, ANN NEUROL, V59, P407, DOI 10.1002/ana.20754; Hamilton JM, 2004, J NEUROL NEUROSUR PS, V75, P209, DOI 10.1136/jnnp.2003.017822; Hering T, 2015, EXP NEUROL, V266, P22, DOI 10.1016/j.expneurol.2015.02.004; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Jacobs RA, 2013, J GERONTOL A-BIOL, V68, P1010, DOI 10.1093/gerona/gls335; Jordan T, 2004, J CELL SCI, V117, P6175, DOI 10.1242/jcs.01543; Kosinski CM, 2007, MOVEMENT DISORD, V22, P1637, DOI 10.1002/mds.21550; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Lodi R, 2000, ANN NEUROL, V48, P72; LOWEY S, 1995, BIOPHYS J, V68, pS120; Lowey S, 2010, J BIOL CHEM, V285, P16403, DOI 10.1074/jbc.R109.025551; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1911, DOI 10.1093/hmg/11.17.1911; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mielcarek M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005021; Miller BR, 2010, FUTUR NEUROL, V5, P735, DOI 10.2217/FNL.10.41; Moffitt H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008025; Orth M, 2003, J NEUROCHEM, V87, P1, DOI 10.1046/j.1471-4159.2003.02009.x; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Ribchester RR, 2004, EUR J NEUROSCI, V20, P3092, DOI 10.1111/j.1460-9568.2004.03783.x; ROBERT B, 1984, CELL, V39, P129, DOI 10.1016/0092-8674(84)90198-3; Ross CA, 2001, CLIN NEUROSCI RES, V1, P142, DOI 10.1016/S1566-2772(00)00014-1; Ross CA, 2014, MOVEMENT DISORD, V29, P1351, DOI 10.1002/mds.26012; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Ryder JW, 2007, J BIOL CHEM, V282, P20447, DOI 10.1074/jbc.M702927200; Sassone J, 2009, EXP NEUROL, V219, P385, DOI 10.1016/j.expneurol.2009.05.012; Sathasivam K, 1999, HUM MOL GENET, V8, P803; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Singh R, 2009, J NEUROL SCI, V285, P159, DOI 10.1016/j.jns.2009.06.030; STEPKOWSKI D, 1995, FEBS LETT, V374, P6, DOI 10.1016/0014-5793(95)01049-K; Strand AD, 2005, HUM MOL GENET, V14, P1863, DOI 10.1093/hmg/ddi192; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; Svensson C, 1997, J CELL BIOCHEM, V67, P241, DOI 10.1002/(SICI)1097-4644(19971101)67:2<241::AID-JCB9>3.0.CO;2-X; Thu DCV, 2010, BRAIN, V133, P1094, DOI 10.1093/brain/awq047; Tikunov BA, 2001, J APPL PHYSIOL, V90, P1927, DOI 10.1152/jappl.2001.90.5.1927; Timson DJ, 2003, BIOCHIMIE, V85, P639, DOI 10.1016/S0300-9084(03)00131-7; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; Turner C, 2010, J BIOENERG BIOMEMBR, V42, P193, DOI 10.1007/s10863-010-9290-y; Turner C, 2007, MOVEMENT DISORD, V22, P1715, DOI 10.1002/mds.21540; Ursu D, 2001, J PHYSIOL-LONDON, V533, P367, DOI 10.1111/j.1469-7793.2001.0367a.x; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Waters CW, 2013, P NATL ACAD SCI USA, V110, P9160, DOI 10.1073/pnas.1220068110; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Zielonka D, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00380	66	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166106	10.1371/journal.pone.0166106	http://dx.doi.org/10.1371/journal.pone.0166106			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820862	Green Published, gold, Green Submitted			2022-12-26	WOS:000387614800034
J	Huang, AB; Sang, YY; Sun, W; Fu, Y; Yang, ZB				Huang, Aobo; Sang, Yuying; Sun, Wenfeng; Fu, Ying; Yang, Zhenbiao			Transcriptomic Analysis of Responses to Imbalanced Carbon: Nitrogen Availabilities in Rice Seedlings	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; ALTERNATIVE OXIDASE; GENE-EXPRESSION; JASMONIC ACID; METHYL JASMONATE; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; CHALCONE SYNTHASE; PLANT-GROWTH; PHYTOPHTHORA-INFESTANS	The internal C:N balance must be tightly controlled for the normal growth and development of plants. However, the underlying mechanisms, by which plants sense and balance the intracellular C:N status correspondingly to exogenous C:N availabilities remain elusive. In this study, we use comparative gene expression analysis to identify genes that are responsive to imbalanced C:N treatments in the aerial parts of rice seedlings. Transcripts of rice seedlings treated with four C:N availabilities (1:1, 1:60, 60:1 and 60:60) were compared and two groups of genes were classified:high C:low N responsive genes and low C:high N responsive genes. Our analysis identified several functional correlated genes including chalcone synthase (CHS), chlorophyll a-b binding protein (CAB) and other genes that are implicated in C:N balancing mechanism, such as alternative oxidase 1B (OsAOX1B), malate dehydrogenase (OsMDH) and lysine and histidine specific transporter 1 (OsLHT1). Additionally, six jasmonate synthetic genes and key regulatory genes involved in abiotic and biotic stresses, such as OsMYB4, autoinhibited calcium ATPase 3 (OsACA3) and pleiotropic drug resistance 9 (OsPDR9), were differentially expressed under high C:low N treatment. Gene ontology analysis showed that high C:low N up-regulated genes were primarily enriched in fatty acid biosynthesis and defense responses. Coexpression network analysis of these genes identified eight jasmonate ZIM domain protein (OsJAZ) genes and several defense response related regulators, suggesting that high C:low N status may act as a stress condition, which induces defense responses mediated by jasmonate signaling pathway. Our transcriptome analysis shed new light on the C:N balancing mechanisms and revealed several important regulators of C:N status in rice seedlings.	[Huang, Aobo; Fu, Ying] China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing, Peoples R China; [Huang, Aobo; Sun, Wenfeng; Yang, Zhenbiao] Fujian Agr & Forestry Univ, Hort Plant Biol & Metab Ctr, Haixia Inst Sci & Technol, Fuzhou, Peoples R China; [Sang, Yuying] Chinese Acad Sci, Natl Key Lab Plant Mol Genet, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Yang, Zhenbiao] Univ Calif Riverside, Ctr Plant Cell Biol, Inst Integrated Genome Biol, Riverside, CA 92521 USA; [Yang, Zhenbiao] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA	China Agricultural University; Fujian Agriculture & Forestry University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of California System; University of California Riverside; University of California System; University of California Riverside	Yang, ZB (corresponding author), Fujian Agr & Forestry Univ, Hort Plant Biol & Metab Ctr, Haixia Inst Sci & Technol, Fuzhou, Peoples R China.; Yang, ZB (corresponding author), Univ Calif Riverside, Ctr Plant Cell Biol, Inst Integrated Genome Biol, Riverside, CA 92521 USA.; Yang, ZB (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	yang@ucr.edu		Huang, Aobo/0000-0002-0774-1501	California's Agricultural Experimental Station at University of California-Riverside; Horticultural Plant Biology and Metabolomics Center, Haixia Institute of Science Technology, Fujian Agriculture and Forestry University, Fuzhou, Fujian, China; Joint NSFC-ISF Research Program; National Natural Science Foundation of China; Israel Science Foundation [31361140354]	California's Agricultural Experimental Station at University of California-Riverside; Horticultural Plant Biology and Metabolomics Center, Haixia Institute of Science Technology, Fujian Agriculture and Forestry University, Fuzhou, Fujian, China; Joint NSFC-ISF Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Israel Science Foundation(Israel Science Foundation)	This work is partly supported by funds from California's Agricultural Experimental Station at University of California-Riverside, and Horticultural Plant Biology and Metabolomics Center, Haixia Institute of Science Technology, Fujian Agriculture and Forestry University, Fuzhou, Fujian, China to ZBY, and by the Joint NSFC-ISF Research Program (jointly funded by the National Natural Science Foundation of China and the Israel Science Foundation) (31361140354) to YF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalou A, 2008, PLANT MOL BIOL, V66, P87, DOI 10.1007/s11103-007-9255-7; Agrawal GK, 2004, BIOCHEM BIOPH RES CO, V317, P1, DOI 10.1016/j.bbrc.2004.03.020; Agrawal GK, 2003, BIOCHEM BIOPH RES CO, V310, P1073, DOI 10.1016/j.bbrc.2003.09.123; Agrawal GK, 2002, PLANT PHYSIOL BIOCH, V40, P771, DOI 10.1016/S0981-9428(02)01429-8; Aoyama S, 2014, PLANT CELL PHYSIOL, V55, P293, DOI 10.1093/pcp/pcu002; Appel HM, 2012, NEW PHYTOL, V195, P419, DOI 10.1111/j.1469-8137.2012.04171.x; Arnold TM, 2012, PLANT SIGNAL BEHAV, V7, P1498, DOI 10.4161/psb.21900; Bouguyon E, 2012, SEMIN CELL DEV BIOL, V23, P648, DOI 10.1016/j.semcdb.2012.01.004; Carretero-Paulet L, 2010, PLANT PHYSIOL, V153, P1398, DOI 10.1104/pp.110.153593; Champigny ML, 1995, PHOTOSYNTH RES, V46, P117, DOI 10.1007/BF00020422; Chen DQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137026; Chen LS, 1997, PLANT PHYSIOL, V115, P1127, DOI 10.1104/pp.115.3.1127; Chen XB, 2016, CURR BIOL, V26, P640, DOI 10.1016/j.cub.2015.12.066; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Ciftci-Yilmaz S, 2008, CELL MOL LIFE SCI, V65, P1150, DOI 10.1007/s00018-007-7473-4; COLLINGE DB, 1993, PLANT J, V3, P31, DOI 10.1046/j.1365-313X.1993.t01-1-00999.x; CORONADO C, 1995, PLANT PHYSIOL, V108, P533, DOI 10.1104/pp.108.2.533; Coruzzi GM, 2001, CURR OPIN PLANT BIOL, V4, P247, DOI 10.1016/S1369-5266(00)00168-0; Dobrenel T, 2016, ANNU REV PLANT BIOL, V67, P261, DOI 10.1146/annurev-arplant-043014-114648; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Englbrecht CC, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-39; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Feng HQ, 2013, ACTA BIOCH BIOPH SIN, V45, P985, DOI 10.1093/abbs/gmt094; Ferrieri AP, 2013, PLANT PHYSIOL, V161, P692, DOI 10.1104/pp.112.208868; Feyissa DN, 2009, PLANTA, V230, P747, DOI 10.1007/s00425-009-0978-3; Fine PVA, 2006, ECOLOGY, V87, pS150, DOI 10.1890/0012-9658(2006)87[150:TGTAHS]2.0.CO;2; Forchhammer K, 2004, FEMS MICROBIOL REV, V28, P319, DOI 10.1016/j.femsre.2003.11.001; Foyer CH, 2006, ANNU PLANT REV, V22, P325; Gaffney BJ, 1996, ANNU REV BIOPH BIOM, V25, P431, DOI 10.1146/annurev.bb.25.060196.002243; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Gandin A, 2014, J EXP BOT, V65, P3133, DOI 10.1093/jxb/eru158; Gao P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001387; Gfeller A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3109cm3; Gomez S, 2010, NEW PHYTOL, V188, P835, DOI 10.1111/j.1469-8137.2010.03414.x; GOWARD CR, 1994, PROTEIN SCI, V3, P1883, DOI 10.1002/pro.5560031027; Grechkin A, 1998, PROG LIPID RES, V37, P317, DOI 10.1016/S0163-7827(98)00014-9; Gutierrez RA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r7; Haga K, 2004, PLANT CELL PHYSIOL, V45, P119, DOI 10.1093/pcp/pch025; Hashimoto M, 2004, PLANT CELL PHYSIOL, V45, P550, DOI 10.1093/pcp/pch063; Heckmann AB, 2006, PLANT PHYSIOL, V142, P1739, DOI 10.1104/pp.106.089508; Herbers K, 2000, MOL PLANT PATHOL, V1, P51, DOI 10.1046/j.1364-3703.2000.00007.x; Hirner A, 2006, PLANT CELL, V18, P1931, DOI 10.1105/tpc.106.041012; Hristova VA, 2002, PHOTOSYNTHETICA, V40, P567, DOI 10.1023/A:1024356120016; Huda KMK, 2013, PLANT PHYSIOL BIOCH, V65, P32, DOI 10.1016/j.plaphy.2013.01.002; Itoh H, 2005, PLANT J, V44, P669, DOI 10.1111/j.1365-313X.2005.02562.x; Jasinski M, 2003, PLANT PHYSIOL, V131, P1169, DOI 10.1104/pp.102.014720; Jiang JF, 2006, TOXICON, V47, P133, DOI 10.1016/j.toxicon.2005.10.010; Jiang P, 2007, BIOCHEMISTRY-US, V46, P12979, DOI 10.1021/bi701062t; Juszczuk IM, 2003, ACTA BIOCHIM POL, V50, P1257; Kang JM, 2003, P NATL ACAD SCI USA, V100, P6872, DOI 10.1073/pnas.1030961100; Katiyar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-544; Klein D, 2000, PLANT CELL ENVIRON, V23, P863, DOI 10.1046/j.1365-3040.2000.00593.x; Krouk G, 2011, TRENDS PLANT SCI, V16, P178, DOI 10.1016/j.tplants.2011.02.004; Laura M, 2010, PLANT PHYSIOL BIOCH, V48, P764, DOI 10.1016/j.plaphy.2010.06.003; Lee YH, 2004, PLANT J, V40, P60, DOI 10.1111/j.1365-313X.2004.02186.x; Lemmermeyer S, 2015, AM NAT, V186, P264, DOI 10.1086/682005; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; Lionetti V, 2012, J PLANT PHYSIOL, V169, P1623, DOI 10.1016/j.jplph.2012.05.006; Maekawa S, 2012, PLANT MOL BIOL, V79, P217, DOI 10.1007/s11103-012-9907-0; MAKINO A, 1991, PLANT PHYSIOL, V96, P355, DOI 10.1104/pp.96.2.355; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.010475; Matyssek R, 2005, PLANT BIOLOGY, V7, P557, DOI 10.1055/s-2005-873000; Meuriot F, 2004, PHYSIOL PLANTARUM, V120, P113, DOI 10.1111/j.0031-9317.2004.0210.x; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; Mittelstrass K, 2006, PLANT BIOLOGY, V8, P653, DOI 10.1055/s-2006-924085; Miyashima S, 2009, PLANT CELL PHYSIOL, V50, P626, DOI 10.1093/pcp/pcp020; Molitor A, 2011, MOL PLANT MICROBE IN, V24, P1427, DOI 10.1094/MPMI-06-11-0177; Moons A, 2003, FEBS LETT, V553, P370, DOI 10.1016/S0014-5793(03)01060-3; Nabity PD, 2013, J EXP BOT, V64, P685, DOI 10.1093/jxb/ers364; Ninfa AJ, 2000, TRENDS MICROBIOL, V8, P172, DOI 10.1016/S0966-842X(00)01709-1; Nishii A, 2000, BIOSCI BIOTECH BIOCH, V64, P1402, DOI 10.1271/bbb.64.1402; Noguchi K, 2006, PLANT CELL ENVIRON, V29, P710, DOI 10.1111/j.1365-3040.2005.01457.x; Nunes-Nesi A, 2005, PLANT PHYSIOL, V137, P611, DOI 10.1104/pp.104.055566; Nunes-Nesi A, 2010, MOL PLANT, V3, P973, DOI 10.1093/mp/ssq049; Nuruzzaman M, 2014, J INTEGR PLANT BIOL, V56, P729, DOI 10.1111/jipb.12196; Ono K, 1997, PLANT CELL PHYSIOL, V38, P1032, DOI 10.1093/oxfordjournals.pcp.a029268; Palenchar PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r91; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Pasquali G, 2008, PLANT CELL REP, V27, P1677, DOI 10.1007/s00299-008-0587-9; PAZARES J, 1987, EMBO J, V6, P3553, DOI 10.1002/j.1460-2075.1987.tb02684.x; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Porta H, 2002, PLANT PHYSIOL, V130, P15, DOI 10.1104/pp.010787; RADIN JW, 1986, PLANT PHYSIOL, V82, P869, DOI 10.1104/pp.82.3.869; REIMOLD U, 1983, EMBO J, V2, P1801, DOI 10.1002/j.1460-2075.1983.tb01661.x; Reyes TH, 2016, PLANT PHYSIOL BIOCH, V105, P195, DOI 10.1016/j.plaphy.2016.04.030; Rohde J, 2001, J BIOL CHEM, V276, P9583, DOI 10.1074/jbc.R000034200; Ros B, 2008, PHYSIOL PLANTARUM, V133, P386, DOI 10.1111/j.1399-3054.2008.01048.x; Ross CA, 2007, J INTEGR PLANT BIOL, V49, P827, DOI 10.1111/j.1744-7909.2007.00504.x; Rossato L, 2002, J EXP BOT, V53, P1131, DOI 10.1093/jexbot/53.371.1131; Saika H, 2002, GENES GENET SYST, V77, P31, DOI 10.1266/ggs.77.31; Sato T, 2009, PLANT J, V60, P852, DOI 10.1111/j.1365-313X.2009.04006.x; Sato Y, 2013, NUCLEIC ACIDS RES, V41, pD1214, DOI 10.1093/nar/gks1122; Sharoni AM, 2011, PLANT CELL PHYSIOL, V52, P344, DOI 10.1093/pcp/pcq196; SHEEN J, 1990, PLANT CELL, V2, P1027, DOI 10.1105/tpc.2.10.1027; Sieger SM, 2005, J EXP BOT, V56, P1499, DOI 10.1093/jxb/eri146; Singh A, 2014, FEBS J, V281, P894, DOI 10.1111/febs.12656; Soltesz A, 2012, J APPL GENET, V53, P133, DOI 10.1007/s13353-011-0081-x; Stitt M, 1999, PLANT CELL ENVIRON, V22, P583, DOI 10.1046/j.1365-3040.1999.00386.x; Sun WF, 2013, J PLANT GROWTH REGUL, V32, P575, DOI 10.1007/s00344-013-9324-x; Svennerstam H, 2007, PLANT PHYSIOL, V143, P1853, DOI 10.1104/pp.106.092205; Tani T, 2008, PLANTA, V227, P517, DOI 10.1007/s00425-007-0635-7; Tegeder M, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00021; Thibaud MC, 2004, PLANT PHYSIOL BIOCH, V42, P81, DOI 10.1016/j.plaphy.2003.10.012; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Tian CG, 2004, PLANT MOL BIOL, V54, P519, DOI 10.1023/B:PLAN.0000038256.89809.57; Tian GW, 2006, DEV BIOL, V294, P83, DOI 10.1016/j.ydbio.2006.02.026; TSUKAYA H, 1991, PLANT PHYSIOL, V97, P1414, DOI 10.1104/pp.97.4.1414; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Umate P, 2011, PLANT SIGNAL BEHAV, V6, P335, DOI 10.4161/psb.6.3.13546; Umate P, 2010, PLANT SIGNAL BEHAV, V5, P1537, DOI 10.4161/psb.5.12.13410; Van Aken O, 2009, PHYSIOL PLANTARUM, V137, P354, DOI 10.1111/j.1399-3054.2009.01240.x; Vanholme B, 2007, TRENDS PLANT SCI, V12, P239, DOI 10.1016/j.tplants.2007.04.004; Vanlerberghe GC, 1997, ANNU REV PLANT PHYS, V48, P703, DOI 10.1146/annurev.arplant.48.1.703; Vannini C, 2004, PLANT J, V37, P115, DOI 10.1046/j.1365-313X.2003.01938.x; Vannini C, 2007, PLANT SCI, V173, P231, DOI 10.1016/j.plantsci.2007.05.007; VICK BA, 1986, PLANT PHYSIOL, V80, P202, DOI 10.1104/pp.80.1.202; VINCENTZ M, 1993, PLANT J, V3, P315, DOI 10.1046/j.1365-313X.1993.t01-16-00999.x; Wang H, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1933-5; Wu H, 2015, PLANT SCI, V232, P1, DOI 10.1016/j.plantsci.2014.12.010; Xiong Y, 2013, NATURE, V496, P181, DOI 10.1038/nature12030; Yamada S, 2012, PLANT CELL PHYSIOL, V53, P2060, DOI 10.1093/pcp/pcs145; Yamanouchi U, 2002, P NATL ACAD SCI USA, V99, P7530, DOI 10.1073/pnas.112209199; Yanagisawa S, 2004, P NATL ACAD SCI USA, V101, P7833, DOI 10.1073/pnas.0402267101; Yang DH, 2000, FEBS LETT, V466, P385, DOI 10.1016/S0014-5793(00)01107-8; Yang WZ, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0425-5; YATES RC, 1949, AM J BOT, V36, P390, DOI 10.2307/2437736; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; Yoeun S, 2015, J PLANT RES, V128, P201, DOI 10.1007/s10265-014-0670-y; Yokotani N, 2014, MOL PLANT MICROBE IN, V27, P1027, DOI 10.1094/MPMI-03-14-0065-R; Zhang HM, 1999, P NATL ACAD SCI USA, V96, P6529, DOI 10.1073/pnas.96.11.6529; Zhang SX, 2012, PLANT MOL BIOL, V80, P571, DOI 10.1007/s11103-012-9967-1; Zhao HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049210; Zheng ZL, 2009, PLANT SIGNAL BEHAV, V4, P584, DOI 10.4161/psb.4.7.8540; Zhou B, 2013, AM J BOT, V100, P2458, DOI 10.3732/ajb.1300305	135	12	13	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165732	10.1371/journal.pone.0165732	http://dx.doi.org/10.1371/journal.pone.0165732			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820840	Green Published, Green Submitted, gold			2022-12-26	WOS:000387614800016
J	Iwai, S; Weinmaier, T; Schmidt, BL; Albertson, DG; Poloso, NJ; Dabbagh, K; DeSantis, TZ				Iwai, Shoko; Weinmaier, Thomas; Schmidt, Brian L.; Albertson, Donna G.; Poloso, Neil J.; Dabbagh, Karim; DeSantis, Todd Z.			Piphillin: Improved Prediction of Metagenomic Content by Direct Inference from Human Microbiomes	PLOS ONE			English	Article							SIMILARITY SEARCH TOOL; ALIGNMENT; RECONSTRUCTION	Functional analysis of a clinical microbiome facilitates the elucidation of mechanisms by which microbiome perturbation can cause a phenotypic change in the patient. The direct approach for the analysis of the functional capacity of the microbiome is via shotgun metagenomics. An inexpensive method to estimate the functional capacity of a microbial community is through collecting 16S rRNA gene profiles then indirectly inferring the abundance of functional genes. This inference approach has been implemented in the PICRUSt and Tax4Fun software tools. However, those tools have important limitations since they rely on outdated functional databases and uncertain phylogenetic trees and require very specific data pre-processing protocols. Here we introduce Piphillin, a straightforward algorithm independent of any proposed phylogenetic tree, leveraging contemporary functional databases and not obliged to any singular data pre-processing protocol. When all three inference tools were evaluated against actual shotgun metagenomics, Piphillin was superior in predicting gene composition in human clinical samples compared to both PICRUSt and Tax4Fun (p<0.01 and p<0.001, respectively) and Piphillin's ability to predict disease associations with specific gene orthologs exhibited a 15% increase in balanced accuracy compared to PICRUSt. From laboratory animal samples, no performance advantage was observed for any one of the tools over the others and for environmental samples all produced unsatisfactory predictions. Our results demonstrate that functional inference using the direct method implemented in Piphillin is preferable for clinical biospecimens.	[Iwai, Shoko; Weinmaier, Thomas; Dabbagh, Karim; DeSantis, Todd Z.] Second Genome Inc, Dept Informat, San Francisco, CA USA; [Schmidt, Brian L.; Albertson, Donna G.] NYU, Coll Dent, Bluestone Ctr Clin Res, New York, NY USA; [Schmidt, Brian L.; Albertson, Donna G.] NYU, Coll Dent, Dept Oral & Maxillofacial Surg, New York, NY USA; [Albertson, Donna G.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Poloso, Neil J.] Allergen PLC, Res & External Sci Innovat Dept, Irvine, CA USA	New York University; New York University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	DeSantis, TZ (corresponding author), Second Genome Inc, Dept Informat, San Francisco, CA USA.	todd@secondgenome.com	Weinmaier, Thomas/K-5780-2013	Weinmaier, Thomas/0000-0002-9552-3220	National Center for Research Resources; National Center for Advancing Translational Sciences; Office of the Director, National Institutes of Health, through University of San Francisco CTSI [UL1 RR024129]; National Cancer Institute [R01 CM 31286, R21 CA163019]; National Institute of Dental and Craniofacial Research [R01 DE019796]; US government; Second Genome Inc; Allergan PLC; Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [R21CA163019, R01CA131286] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019796] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Office of the Director, National Institutes of Health, through University of San Francisco CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); US government; Second Genome Inc; Allergan PLC(AbbVieAllergan); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by the National Center for Research Resources, the National Center for Advancing Translational Sciences, and the Office of the Director, National Institutes of Health, through University of San Francisco CTSI grant number UL1 RR024129, and individual investigator awards from the National Cancer Institute grant (R01 CM 31286, R21 CA163019) and the National Institute of Dental and Craniofacial Research (R01 DE019796). These US government funders provided support in the form of salaries for authors DA & BS. This work was also supported in part by Second Genome Inc and Allergan PLC. These commercial funders provided support in the form of salaries for authors NP, SI, TD, KD, & TW. All funders, including government program mangers and corporate investors had no role in study design, data collection and analysis, decision to publish, nor preparation of the manuscript. The specific funded roles of each of the seven authors are articulated in the 'author contributions' section.; This work was supported in part by the National Center for Research Resources, the National Center for Advancing Translational Sciences, and the Office of the Director, National Institutes of Health, through University of San Francisco CTSI grant number UL1 RR024129, and individual investigator awards from the National Cancer Institute grant (R01 CA131286, R21 CA163019) and the National Institute of Dental and Craniofacial Research (R01 DE019796). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. We thank Tanya Yatsunenko and Morgan Langille for helpful discussions and input on the Piphillin algorithm. We also want to thank Ali Faruqi for his help with the implementation of the Piphillin website.	Asshauer KP, 2015, TAX4FUN PREDICTING F, P2; Avdeyev P, 2016, J COMPUT BIOL, V23, P150, DOI 10.1089/cmb.2015.0160; Aviles-Jimenez F, 2015, CLIN MICROBIOL INFEC, V22, DOI [10.1016/j.cmi.2015.10, DOI 10.1016/J.CMI.2015.10]; Barton NH, 2007, EVOLUTION, P1; Brown CT, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-30; Callahan BJ, 2015, BIORXIV, P0, DOI [10.1101/024034, DOI 10.1101/024034]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Cunningham CW, 1999, SYST BIOL, V48, P665, DOI 10.1080/106351599260238; Curtis MM, 2014, CELL HOST MICROBE, V16, P759, DOI 10.1016/j.chom.2014.11.005; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Glaeser SP, 2015, SYST APPL MICROBIOL, V38, P237, DOI 10.1016/j.syapm.2015.03.007; Harris JK, 2013, ISME J, V7, P50, DOI 10.1038/ismej.2012.79; Iantorno S, 2014, METHODS MOL BIOL, V1079, P59, DOI 10.1007/978-1-62703-646-7_4; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kemena C, 2009, BIOINFORMATICS, V25, P2455, DOI 10.1093/bioinformatics/btp452; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Krzywinski M, 2014, NAT METHODS, V11, P467, DOI 10.1038/nmeth.2937; Kunin Victor, 2008, Mol Syst Biol, V4, P198, DOI 10.1038/msb.2008.35; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Litsios G, 2012, SYST BIOL, V61, P533, DOI 10.1093/sysbio/syr124; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Scheinin I, 2014, GENOME RES, P1; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098741; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Tan G, 2015, SYST BIOL, V64, P778, DOI 10.1093/sysbio/syv033; Wortman J, 2010, DATA ANAL COORDINATI, V11, P2010, DOI [10.1186/gb-2010-11-S1-O13, DOI 10.1186/GB-2010-11-S1-O13]; Ye YZ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-159; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595	37	207	207	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166104	10.1371/journal.pone.0166104	http://dx.doi.org/10.1371/journal.pone.0166104			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820856	gold, Green Published, Green Submitted			2022-12-26	WOS:000387614800033
J	Komnig, D; Imgrund, S; Reich, A; Grunder, S; Falkenburger, BH				Komnig, Daniel; Imgrund, Silke; Reich, Arno; Gruender, Stefan; Falkenburger, Bjoern H.			ASIC1a Deficient Mice Show Unaltered Neurodegeneration in the Subacute MPTP Model of Parkinson Disease	PLOS ONE			English	Article							SENSING ION CHANNELS; TUMOR-NECROSIS-FACTOR; ACTIVATED CURRENTS; SUBSTANTIA-NIGRA; MOUSE MODEL; CALCIUM; NEUROPROTECTION; NEUROTOXICITY; INFLAMMATION; CONTRIBUTES	Inflammation contributes to the death of dopaminergic neurons in Parkinson disease and can be accompanied by acidification of extracellular pH, which may activate acid-sensing ion channels (ASIC). Accordingly, amiloride, a non-selective inhibitor of ASIC, was protective in an acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson disease. To complement these findings we determined MPTP toxicity in mice deficient for ASIC1a, the most common ASIC isoform in neurons. MPTP was applied i.p. in doses of 30 mg per kg on five consecutive days. We determined the number of dopaminergic neurons in the substantia nigra, assayed by stereological counting 14 days after the last MPTP injection, the number of Nissl positive neurons in the substantia nigra, and the concentration of catecholamines in the striatum. There was no difference between ASIC1a-deficient mice and wildtype controls. We are therefore not able to confirm that ASIC1a are involved in MPTP toxicity. The difference might relate to the subacute MPTP model we used, which more closely resembles the pathogenesis of Parkinson disease, or to further targets of amiloride.	[Komnig, Daniel; Reich, Arno; Falkenburger, Bjoern H.] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany; [Imgrund, Silke; Gruender, Stefan] Rhein Westfal TH Aachen, Inst Physiol, Aachen, Germany; [Falkenburger, Bjoern H.] JARA BRAIN Inst II, Julich, Germany; [Falkenburger, Bjoern H.] JARA BRAIN Inst II, Aachen, Germany	RWTH Aachen University; RWTH Aachen University	Falkenburger, BH (corresponding author), Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany.; Falkenburger, BH (corresponding author), JARA BRAIN Inst II, Julich, Germany.; Falkenburger, BH (corresponding author), JARA BRAIN Inst II, Aachen, Germany.	bfalkenburger@ukaachen.de	Gründer, Stefan/I-2495-2019	Gründer, Stefan/0000-0002-7635-9883; Falkenburger, Bjoern/0000-0002-2387-526X	Interdisciplinary Center for Clinical Research (IZKF) Aachen [N7-1]	Interdisciplinary Center for Clinical Research (IZKF) Aachen	This work was supported by the Interdisciplinary Center for Clinical Research (IZKF) Aachen [N7-1].	Ago Y, 2011, NEUROPHARMACOLOGY, V61, P1441, DOI 10.1016/j.neuropharm.2011.08.041; Arias RL, 2008, NEUROBIOL DIS, V31, P334, DOI 10.1016/j.nbd.2008.05.008; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Bartoi T, 2014, P NATL ACAD SCI USA, V111, P8281, DOI 10.1073/pnas.1324060111; BOKA G, 1994, NEUROSCI LETT, V172, P151, DOI 10.1016/0304-3940(94)90684-X; BOWEN BC, 1995, AM J NEURORADIOL, V16, P61; Chen HL, 2003, ARCH NEUROL-CHICAGO, V60, P1059, DOI 10.1001/archneur.60.8.1059; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Frank T, 2012, BRAIN, V135, P1914, DOI 10.1093/brain/aws054; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Grunder S, 2015, NEUROPHARMACOLOGY, V94, P9, DOI 10.1016/j.neuropharm.2014.12.016; Gu XS, 2016, NEUROCHEM RES, V41, P2923, DOI 10.1007/s11064-016-2011-0; JACKSONLEWIS V, 1995, NEURODEGENERATION, V4, P257, DOI 10.1016/1055-8330(95)90015-2; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Khananshvili D, 2014, PFLUG ARCH EUR J PHY, V466, P43, DOI 10.1007/s00424-013-1405-y; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; Koga K, 2006, EUR J NEUROSCI, V23, P1077, DOI 10.1111/j.1460-9568.2006.04610.x; Komnig D, 2016, J NEUROCHEM, V139, P848, DOI 10.1111/jnc.13847; Kowsky S, 2007, P NATL ACAD SCI USA, V104, P20049, DOI 10.1073/pnas.0706177104; KUPSCH A, 1995, NEUROREPORT, V6, P621, DOI 10.1097/00001756-199503000-00009; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Meredith GE, 2011, J PARKINSON DIS, V1, P19, DOI 10.3233/JPD-2011-11023; MOGI M, 1994, NEUROSCI LETT, V165, P208, DOI 10.1016/0304-3940(94)90746-3; Okajima F, 2013, CELL SIGNAL, V25, P2263, DOI 10.1016/j.cellsig.2013.07.022; Pignataro G, 2007, BRAIN, V130, P151, DOI 10.1093/brain/awl325; Przedborski S, 2001, J NEUROCHEM, V76, P1265, DOI 10.1046/j.1471-4159.2001.00183.x; Przedborski S, 2003, ANN NY ACAD SCI, V991, P189; Rocha NP, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/628192; Sheehan JP, 1997, J NEUROCHEM, V68, P1221; Sherwood TW, 2011, J NEUROSCI, V31, P9723, DOI 10.1523/JNEUROSCI.1665-11.2011; Tatton NA, 1997, NEUROSCIENCE, V77, P1037, DOI 10.1016/S0306-4522(96)00545-3; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; Toulorge D, 2016, J NEUROCHEM, V139, P27, DOI 10.1111/jnc.13696; Viswanath V, 2001, J NEUROSCI, V21, P9519, DOI 10.1523/JNEUROSCI.21-24-09519.2001; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Zundorf G, 2011, ANTIOXID REDOX SIGN, V14, P1275, DOI 10.1089/ars.2010.3359	39	14	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165235	10.1371/journal.pone.0165235	http://dx.doi.org/10.1371/journal.pone.0165235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820820	Green Published, Green Submitted, gold			2022-12-26	WOS:000387614800008
J	Olesen, LO; Bouzinova, EV; Severino, M; Sivasaravanaparan, M; Hasselstrom, JB; Finsen, B; Wiborg, O				Olesen, Louise Orum; Bouzinova, Elena V.; Severino, Maurizio; Sivasaravanaparan, Mithula; Hasselstrom, Jorgen Bo; Finsen, Bente; Wiborg, Ove			Behavioural Phenotyping of APP(swe)/PS1(delta E9) Mice: Age-Rrelated Changes and Effect of Long-Term Paroxetine Treatment	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MOUSE MODEL; TRANSGENIC MICE; COGNITIVE IMPAIRMENT; EXPLORATORY ACTIVITY; SOCIAL-INTERACTION; AMYLOID-BETA; ANXIETY; SYMPTOMS; DEMENTIA	Alzheimer's disease (AD) is a devastating illness characterized by a progressive loss of cognitive, social, and emotional functions, including memory impairments and more global cognitive deficits. Clinical-epidemiological evidence suggests that neuropsychiatric symptoms precede the onset of cognitive symptoms both in humans with early and late onset AD. The behavioural profile promoted by the AD pathology is believed to associate with degeneration of the serotonergic system. Using the APP(swe)/PS1(delta E9) model of AD-like pathology starting with 9 months old mice, we characterised long term non-cognitive behavioural changes measured at 9, 12, 15, and 18 months of age and applied principal component analysis on data obtained from open field, elevated plus maze, and social interaction tests. Long-term treatment with the selective serotonin reuptake inhibitor (SSRI) paroxetine was applied to assess the role of 5-HT on the behavioural profile; duration of treatment was 9 months, initiated when mice were 9 months of age. Treatment with paroxetine delays the decline in locomotion, in exploration and risk assessment behaviour, found in the APP/PS1 mice. APP/PS1 mice also exhibit low social activity and less aggressiveness, both of which are not affected by treatment with paroxetine. The APP/PS1 behavioural phenotype, demonstrated in this study, only begins to manifest itself from 12 months of age. Our results indicate that treatment with SSRI might ameliorate some of the behavioural deficits found in aged APP/PS1 mice.	[Olesen, Louise Orum; Bouzinova, Elena V.; Wiborg, Ove] Aarhus Univ, Dept Clin Med, Hlth, Risskov, Denmark; [Severino, Maurizio; Sivasaravanaparan, Mithula; Finsen, Bente] Univ Southern Denmark, Inst Mol Med, Dept Neurobiol Res, Odense C, Denmark; [Hasselstrom, Jorgen Bo] Aarhus Univ, Dept Forens Med, Hlth, Aarhus N, Denmark	Aarhus University; University of Southern Denmark; Aarhus University	Wiborg, O (corresponding author), Aarhus Univ, Dept Clin Med, Hlth, Risskov, Denmark.	ove.wiborg@clin.au.dk		Finsen, Bente/0000-0002-8323-9329	Danish Medical Research Foundation; Lundbeck Foundation	Danish Medical Research Foundation; Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Danish Medical Research Foundation (BF OW) and the Lundbeck Foundation (BF OW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Alexander G, 2011, BEHAV BRAIN RES, V216, P77, DOI 10.1016/j.bbr.2010.07.016; ARAI H, 1992, PROG NEURO-PSYCHOPH, V16, P883; Babcock AA, 2015, BRAIN BEHAV IMMUN, V48, P86, DOI 10.1016/j.bbi.2015.03.006; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Chung JA, 2000, NEUROL CLIN, V18, P829, DOI 10.1016/S0733-8619(05)70228-0; Cirrito JR, 2011, P NATL ACAD SCI USA, V108, P14968, DOI 10.1073/pnas.1107411108; CROSS AJ, 1984, J NEUROCHEM, V43, P1574, DOI 10.1111/j.1471-4159.1984.tb06081.x; Egashira N, 2007, BEHAV BRAIN RES, V178, P123, DOI 10.1016/j.bbr.2006.12.009; El Mansari M, 2007, INT J NEUROPSYCHOPH, V10, P31, DOI 10.1017/S1461145705006462; Emilsson JF, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010053; Ferguson SA, 2013, BEHAV BRAIN RES, V242, P125, DOI 10.1016/j.bbr.2012.12.055; Filali M, 2015, J NEUROSCI RES, V93, P948, DOI 10.1002/jnr.23552; Filali M, 2011, PHYSIOL BEHAV, V104, P880, DOI 10.1016/j.physbeh.2011.05.023; Filali M, 2009, BRAIN RES, V1292, P93, DOI 10.1016/j.brainres.2009.07.066; FILE SE, 1978, BRIT J PHARMACOL, V62, P19, DOI 10.1111/j.1476-5381.1978.tb07001.x; Garcia MF, 2004, NEUROREPORT, V15, P73, DOI 10.1097/00001756-200401190-00015; Garcia-Alloza M, 2005, NEUROPSYCHOLOGIA, V43, P442, DOI 10.1016/j.neuropsychologia.2004.06.007; Geda YE, 2013, ALZHEIMERS DEMENT, V9, P602, DOI 10.1016/j.jalz.2012.12.001; Hasselbalch SG, 2008, NEUROBIOL AGING, V29, P1830, DOI 10.1016/j.neurobiolaging.2007.04.011; Hasselstrom J, 2011, J CHROMATOGR B, V879, P123, DOI 10.1016/j.jchromb.2010.11.024; Hendricksen M, 2004, AM J PSYCHIAT, V161, P1096, DOI 10.1176/appi.ajp.161.6.1096; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Huang H, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu116; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jimenez AJ, 1996, CELL TISSUE RES, V284, P193, DOI 10.1007/s004410050579; Rodriguez JJ, 2012, PROG NEUROBIOL, V99, P15, DOI 10.1016/j.pneurobio.2012.06.010; Kalueff AV, 2005, EUR J PHARMACOL, V508, P147, DOI 10.1016/j.ejphar.2004.11.054; KRSIAK M, 1990, PSYCHOPHARMACOLOGY, V101, P396, DOI 10.1007/BF02244060; Lalonde R, 2005, NEUROSCI LETT, V390, P87, DOI 10.1016/j.neulet.2005.08.028; Lalonde R, 2004, NEUROSCI LETT, V369, P156, DOI 10.1016/j.neulet.2004.07.069; Lanctot KL, 2007, AM J GERIAT PSYCHIAT, V15, P888, DOI 10.1097/JGP.0b013e3180488325; Liu Y, 2008, J NEUROSCI, V28, P13805, DOI 10.1523/JNEUROSCI.4218-08.2008; Lok K, 2013, J NEUROL SCI, V335, P145, DOI 10.1016/j.jns.2013.09.018; Lyness SA, 2003, NEUROBIOL AGING, V24, P1, DOI 10.1016/S0197-4580(02)00057-X; Madsen K, 2011, J ALZHEIMERS DIS, V26, P457, DOI 10.3233/JAD-2011-110056; Masters MC, 2015, NEUROLOGY, V84, P617, DOI 10.1212/WNL.0000000000001238; Nelson RL, 2007, EXP NEUROL, V205, P166, DOI 10.1016/j.expneurol.2007.01.037; Pietropaolo S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.012; Pugh PL, 2007, BEHAV BRAIN RES, V178, P18, DOI 10.1016/j.bbr.2006.11.044; Reiserer RS, 2007, GENES BRAIN BEHAV, V6, P54, DOI 10.1111/j.1601-183X.2006.00221.x; Ringman JM, 2015, BRAIN, V138, P1036, DOI 10.1093/brain/awv004; Romano A, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu020; Sheline YI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008169; Sood A, 2007, NEUROPHARMACOLOGY, V53, P588, DOI 10.1016/j.neuropharm.2007.06.028; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Trillo L, 2013, NEUROSCI BIOBEHAV R, V37, P1363, DOI 10.1016/j.neubiorev.2013.05.008; Vermeiren Y, 2014, NEUROBIOL AGING, V35, P2691, DOI 10.1016/j.neurobiolaging.2014.05.031; Webster SJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00088; Webster SJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt182	51	25	25	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165144	10.1371/journal.pone.0165144	http://dx.doi.org/10.1371/journal.pone.0165144			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814403	Green Published, gold, Green Submitted			2022-12-26	WOS:000386911100007
J	Kindinger, LM; Kyrgiou, M; MacIntyre, DA; Cacciatore, S; Yulia, A; Cook, J; Terzidou, V; Teoh, TG; Bennett, PR				Kindinger, Lindsay M.; Kyrgiou, Maria; MacIntyre, David A.; Cacciatore, Stefano; Yulia, Angela; Cook, Joanna; Terzidou, Vasso; Teoh, T. G.; Bennett, Phillip R.			Preterm Birth Prevention Post-Conization: A Model of Cervical Length Screening with Targeted Cerclage	PLOS ONE			English	Article							PREGNANCY OUTCOMES; INTRAEPITHELIAL NEOPLASIA; PROPHYLACTIC CERCLAGE; TRANSFORMATION ZONE; OBSTETRIC OUTCOMES; LOOP EXCISION; DELIVERY; METAANALYSIS; PREDICTION; WOMEN	Women with a history of excisional treatment (conization) for cervical intra-epithelial neoplasia (CIN) are at increased risk of preterm birth, perinatal morbidity and mortality in subsequent pregnancy. We aimed to develop a screening model to effectively differentiate pregnancies post-conization into low-and high-risk for preterm birth, and to evaluate the impact of suture material on the efficacy of ultrasound indicated cervical cerclage. We analysed longitudinal cervical length (CL) data from 725 pregnant women post-conization attending preterm surveillance clinics at three London university Hospitals over a ten year period (2004-2014). Rates of preterm birth <37 weeks after targeted cerclage for CL<25mm were compared with local and national background rates and expected rates for this cohort. Rates for cerclage using monofilament or braided suture material were also compared. Of 725 women post-conization 13.5% (98/725) received an ultrasound indicated cerclage and 9.7% (70/725) delivered prematurely, <37weeks; 24.5% (24/98) of these despite insertion of cerclage. The preterm birth rate was lower for those that had monofilament (9/60, 15%) versus braided (15/38, 40%) cerclage (RR 0.7, 95% CI 0.54 to 0.94, P = 0.008). Accuracy parameters of interval reduction in CL between longitudinal second trimester screenings were calculated to identify women at low risk of preterm birth, who could safely discontinue surveillance. A reduction of CL <10% between screening timepoints predicts term birth, >37weeks. Our triage model enables timely discharge of low risk women, eliminating 36% of unnecessary follow-up CL scans. We demonstrate that preterm birth in women post-conization may be reduced by targeted cervical cerclage. Cerclage efficacy is however suture material-dependant: monofilament is preferable to braided suture. The introduction of triage prediction models has the potential to reduce the number of unnecessary CL scan for women at low risk of preterm birth.	[Kindinger, Lindsay M.; Kyrgiou, Maria; MacIntyre, David A.; Cacciatore, Stefano; Yulia, Angela; Cook, Joanna; Terzidou, Vasso; Teoh, T. G.; Bennett, Phillip R.] Imperial Coll, Inst Reprod & Dev Biol, Dept Surg & Canc, London, England; [Kindinger, Lindsay M.; Teoh, T. G.] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept Obstet & Gynaecol, London, England; [Kyrgiou, Maria; Bennett, Phillip R.] Imperial Coll Healthcare NHS Trust, Queen Charlottes & Chelsea Hammersmith Hosp, Dept Obstet & Gynaecol, London, England; [Yulia, Angela; Terzidou, Vasso] Chelsea & Westminster Hosp NHS Trust, Dept Obstet & Gynaecol, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London	Kyrgiou, M (corresponding author), Imperial Coll, Inst Reprod & Dev Biol, Dept Surg & Canc, London, England.; Kyrgiou, M (corresponding author), Imperial Coll Healthcare NHS Trust, Queen Charlottes & Chelsea Hammersmith Hosp, Dept Obstet & Gynaecol, London, England.	m.kyrgiou@imperial.ac.uk	MacIntyre, David A/D-9267-2012	MacIntyre, David/0000-0002-4186-5567; Bennett, Phillip/0000-0002-6253-4919; Cacciatore, Stefano/0000-0001-7052-7156	Genesis Research Trust [P51389]; British Society of Colposcopy Cervical Pathology Jordan/Singer Award [P47773]; Imperial Healthcare NHS Trust Biomedical Research Centre [P45272]; British Society of Colposcopy and Cervical Pathology; Imperial College Healthcare Charity	Genesis Research Trust; British Society of Colposcopy Cervical Pathology Jordan/Singer Award; Imperial Healthcare NHS Trust Biomedical Research Centre; British Society of Colposcopy and Cervical Pathology; Imperial College Healthcare Charity	This study was supported in part by the Genesis Research Trust (P51389), the British Society of Colposcopy Cervical Pathology Jordan/Singer Award (P47773), and by the Imperial Healthcare NHS Trust Biomedical Research Centre (Grant Ref P45272). MK received support and a research award from the British Society of Colposcopy and Cervical Pathology and the Imperial College Healthcare Charity.	Albrechtsen S, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1343; Alfirevic Z, 2013, ULTRASOUND OBST GYN, V41, P146, DOI 10.1002/uog.12300; Arabin B, 2013, ULTRASOUND OBST GYN, V42, P390, DOI 10.1002/uog.12540; Arbyn M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1284; Behrendt N, 2013, OBSTET GYNECOL, V121, P260, DOI 10.1097/AOG.0b013e31827d8e1b; Berghella V, 2004, AM J OBSTET GYNECOL, V191, P1393, DOI 10.1016/j.ajog.2004.06.087; Berghella V, 2007, OBSTET GYNECOL, V110, P311, DOI 10.1097/01.AOG.0000270112.05025.1d; Berghella V, 2012, J MATERN-FETAL NEO M, V25, P2287, DOI 10.3109/14767058.2012.688081; Breiman L., 1984, CLASSIFICATION REGRE; Bruinsma FJ, 2011, BJOG-INT J OBSTET GY, V118, P1031, DOI 10.1111/j.1471-0528.2011.02944.x; Chandiramani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052412; Dilek TUK, 2007, GYNECOL OBSTET INVES, V64, P175, DOI 10.1159/000106486; Fowler JR, 2013, CLIN ORTHOP RELAT R, V471, P665, DOI 10.1007/s11999-012-2593-z; Fox NS, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.004; Grimes-Dennis J, 2007, CURR OPIN OBSTET GYN, V19, P191, DOI 10.1097/GCO.0b013e3280895dd3; Henry-Stanley MJ, 2010, SURG INFECT, V11, P433, DOI 10.1089/sur.2010.006; Israfil-Bayli F, 2014, J MATERN-FETAL NEO M, V27, P1584, DOI 10.3109/14767058.2013.870551; Kindinger L, 2013, BJOG-INT J OBSTET GY, V120, P50; Kindinger LM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1026; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Kyrgiou M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5847; Kyrgiou M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3633; Kyrgiou M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6192; Mehta P, 2004, BRIT J OPHTHALMOL, V88, P361, DOI 10.1136/bjo.2002.009951; Moroz LA, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.11.017; Naim A, CHANGES CERVICAL LEN, P0002; Nam KH, 2010, J GYNECOL ONCOL, V21, P225, DOI 10.3802/jgo.2010.21.4.225; Noehr B, 2009, OBSTET GYNECOL, V114, P1232, DOI 10.1097/AOG.0b013e3181bf1ef2; Noehr B, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.02.004; Odibo AO, 2007, AM J PERINAT, V24, P55, DOI 10.1055/s-2006-958165; Odibo Anthony O, 2003, J Perinatol, V23, P664, DOI 10.1038/sj.jp.7211004; Oh H Y, 2015, Clin Microbiol Infect, V21, DOI 10.1016/j.cmi.2015.02.026; ONS, 2008, GEST SPEC INF MORT E; Owen J, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.08.015; Pils S, 2014, BJOG-INT J OBSTET GY, V121, P457, DOI 10.1111/1471-0528.12390; Poon LCY, 2012, BJOG-INT J OBSTET GY, V119, P692, DOI 10.1111/j.1471-0528.2011.03203.x; QUINN M, 1993, BRIT J OBSTET GYNAEC, V100, P1154, DOI 10.1111/j.1471-0528.1993.tb15198.x; Rafaeli-Yehudai T, 2014, J MATERN-FETAL NEO M, V27, P1594, DOI 10.3109/14767058.2013.871254; Romero R, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.003; Sharp AN, 2014, BJOG-INT J OBSTET GY, V121, P417, DOI 10.1111/1471-0528.12512; Shin MY, 2010, J GYNECOL ONCOL, V21, P230, DOI 10.3802/jgo.2010.21.4.230; Slack M, 2006, INT UROGYNECOL J, V17, P106, DOI 10.1007/s00192-005-1320-7; Souka AP, 2011, J ULTRAS MED, V30, P997, DOI 10.7863/jum.2011.30.7.997; VANWINKLE W, 1975, SURG GYNECOL OBSTET, V140, P7	44	26	32	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0163793	10.1371/journal.pone.0163793	http://dx.doi.org/10.1371/journal.pone.0163793			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812088	Green Submitted, gold, Green Published			2022-12-26	WOS:000386910000004
J	Rivera, AL; Estanol, B; Fossion, R; Toledo-Roy, JC; Callejas-Rojas, JA; Gien-Lopez, JA; Delgado-Garcia, GR; Frank, A				Leonor Rivera, Ana; Estanol, Bruno; Fossion, Ruben; Toledo-Roy, Juan C.; Callejas-Rojas, Jose A.; Gien-Lopez, Jose A.; Delgado-Garcia, Guillermo R.; Frank, Alejandro			Loss of Breathing Modulation of Heart Rate Variability in Patients with Recent and Long Standing Diabetes Mellitus Type II	PLOS ONE			English	Article							POWER SPECTRAL-ANALYSIS; RESPIRATORY SINUS ARRHYTHMIA; AUTONOMIC NEUROPATHY; CARDIAC CONTROL; AGE; TESTS; BEAT	Healthy subjects under rhythmic breathing have heart interbeat intervals with a respiratory band in the frequency domain that can be an index of vagal activity. Diabetes Mellitus Type II (DM) affects the autonomic nervous system of patients, thus it can be expected changes on the vagal activity. Here, the influence of DM on the breathing modulation of the heart rate is evaluated by analyzing in the frequency domain heart interbeat interval (IBI) records obtained from 30 recently diagnosed, 15 long standing DM patients, and 30 control subjects during standardized clinical tests of controlled breathing at 0.1 Hz, supine rest and standing upright. Fourier spectral analysis of IBI records quantifies heart rate variability in different regions: low-frequencies (LF, 0.04-0.15 Hz), high-frequencies (HF, 0.15-0.4 Hz), and a controlled breathing peak (RP, centered around 0.1 Hz). Two new parameters are introduced: the frequency radius r(f) (square root of the sum of LF and HF squared) and beta (power of RP divided by the sum of LF and HF). As diabetes evolves, the controlled breathing peak loses power and shifts to smaller frequencies, indicating that heart rate modulation is slower in diabetic patients than in controls. In contrast to the traditional parameters LF, HF and LF/HF, which do not show significant differences between the three populations in neither of the clinical tests, the new parameters r(f) and beta, distinguish between control and diabetic subjects in the case of controlled breathing. Sympathetic activity that is driven by the baroreceptor reflex associated with the 0.1 Hz breathing modulations is affected in DM patients. Diabetes produces not only a rigid heartbeat with less autonomic induced variability (r(f) diminishes), but also alters the coupling between breathing and heart rate (reduced beta), due to a progressive decline of vagal and sympathetic activity.	[Leonor Rivera, Ana; Fossion, Ruben; Frank, Alejandro] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City, DF, Mexico; [Leonor Rivera, Ana; Estanol, Bruno; Fossion, Ruben; Toledo-Roy, Juan C.; Frank, Alejandro] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City, DF, Mexico; [Estanol, Bruno; Callejas-Rojas, Jose A.; Gien-Lopez, Jose A.; Delgado-Garcia, Guillermo R.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Neurol & Psiquiatria, Lab Neurofisiol, Mexico City, DF, Mexico; [Delgado-Garcia, Guillermo R.] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Dept Med Interna, Monterrey, Nuevo Leon, Mexico; [Frank, Alejandro] Colegio Nacl, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon	Rivera, AL (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City, DF, Mexico.; Rivera, AL (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City, DF, Mexico.	anarivera2000@gmail.com	Rivera, Ana Leonor/L-4433-2019; Fossion, Ruben/X-1682-2019; Rivera, Ana Leonor/B-5062-2010; Delgado-García, Guillermo/R-3050-2018; Toledo-Roy, Juan Claudio/N-6666-2019; Toledo-Roy, Juan/G-6071-2019; Nucleares, Instituto/AAK-6270-2020	Rivera, Ana Leonor/0000-0002-0296-7966; Fossion, Ruben/0000-0001-8456-2075; Rivera, Ana Leonor/0000-0002-0296-7966; Delgado-García, Guillermo/0000-0002-3123-5879; Toledo-Roy, Juan Claudio/0000-0002-0267-3378; Toledo-Roy, Juan/0000-0002-0267-3378; 	Consejo Nacional de Ciencia y Tecnologia; Universidad Nacional Autonoma de Mexico [UNAM/DGAPA/PAPIIT IN106215, UNAM/DGAPA/PAPIIT IV100116, CONACYT CB-2011-01-167441]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	We thank Consejo Nacional de Ciencia y Tecnologia and Universidad Nacional Autonoma de Mexico for financial support through grants: UNAM/DGAPA/PAPIIT IN106215; UNAM/DGAPA/PAPIIT IV100116 and CONACYT CB-2011-01-167441. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 1995, DIABETES CARE S1, V18, P59, DOI [10.2337/diacare.18.1.S59, DOI 10.2337/DIACARE.18.1.S59]; APPEL ML, 1989, J AM COLL CARDIOL, V14, P1139, DOI 10.1016/0735-1097(89)90408-7; BELLAVERE F, 1992, DIABETES, V41, P633, DOI 10.2337/diabetes.41.5.633; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; BIANCHI A, 1990, MED BIOL ENG COMPUT, V28, P205, DOI 10.1007/BF02442668; BIGGER jr JT, 1995, CARDIAC ELECTROPHYSI, P1151; Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00222, 10.3389/fphys.2013.00026]; BROWN TE, 1993, J APPL PHYSIOL, V75, P2310, DOI 10.1152/jappl.1993.75.5.2310; Camm AJ, 1996, CIRCULATION, V93, P1043; Camm AJ, 1996, EUR HEART J, V17, P354; Chen J, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0070-z; ECKBERG DL, 1980, CIRC RES, V47, P208, DOI 10.1161/01.RES.47.2.208; Eckert S, 2002, BLOOD PRESS MONIT, V7, P179, DOI 10.1097/00126097-200206000-00006; EWING DJ, 1985, DIABETES CARE, V8, P491, DOI 10.2337/diacare.8.5.491; FREEMAN R, 1991, ARCH NEUROL-CHICAGO, V48, P185, DOI 10.1001/archneur.1991.00530140079020; GROSSMAN P, 1991, PSYCHOPHYSIOLOGY, V28, P201, DOI 10.1111/j.1469-8986.1991.tb00412.x; Houle MS, 1999, AM J PHYSIOL-HEART C, V276, pH215, DOI 10.1152/ajpheart.1999.276.1.H215; KAMATH MV, 1993, CRIT REV BIOMED ENG, V21, P245; KITNEY R I, 1982, Automedica (London), V4, P155; Koenig J, 2016, NEUROSCI BIOBEHAV R, V64, P288, DOI 10.1016/j.neubiorev.2016.03.007; Rivera AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148378; LEVY MN, 1971, CIRC RES, V29, P437, DOI 10.1161/01.RES.29.5.437; MACKAY JD, 1983, DIABETOLOGIA, V24, P253; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; MALPAS SC, 1990, DIABETES, V39, P1177, DOI 10.2337/diabetes.39.10.1177; Michel-Chavez A, 2015, ARQ BRAS CARDIOL, V105, P276, DOI 10.5935/abc.20150073; Moak JP, 2007, HEART RHYTHM, V4, P1523, DOI 10.1016/j.hrthm.2007.07.019; Notarius CF, 2001, EUROPACE, V3, P29, DOI 10.1053/eupc.2000.0136; OBRIEN IAD, 1986, BRIT HEART J, V55, P348; PAGANI M, 1988, J AUTONOM NERV SYST, V23, P143, DOI 10.1016/0165-1838(88)90078-1; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Parati G, 2000, J HYPERTENS, V18, P7, DOI 10.1097/00004872-200018010-00003; Schmitt DT, 2007, AM J PHYSIOL-REG I, V293, pR1923, DOI 10.1152/ajpregu.00372.2007; SMITH SA, 1982, BRIT MED J, V285, P1599, DOI 10.1136/bmj.285.6355.1599; Sucharita S, 2011, Indian J Endocrinol Metab, V15, P198, DOI 10.4103/2230-8210.83406; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Van Den Akker T. J., 1983, Automedica, V4, P201; Vaschillo EG, 2006, APPL PSYCHOPHYS BIOF, V31, P129, DOI 10.1007/s10484-006-9009-3; Voss A, 2012, PHYSIOL MEAS, V33, P1289, DOI 10.1088/0967-3334/33/8/1289	42	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165904	10.1371/journal.pone.0165904	http://dx.doi.org/10.1371/journal.pone.0165904			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802329	Green Published, gold, Green Submitted			2022-12-26	WOS:000386714200066
J	Brocks, T; Fedorchenko, O; Schliermann, N; Stein, A; Moll, UM; Seegobin, S; Dewor, M; Hallek, M; Marquardt, Y; Fietkau, K; Heise, R; Huth, S; Pfister, H; Bernhagen, J; Bucala, R; Baron, JM; Fingerle-Rowson, G				Brocks, Tania; Fedorchenko, Oleg; Schliermann, Nicola; Stein, Astrid; Moll, Ute M.; Seegobin, Seth; Dewor, Manfred; Hallek, Michael; Marquardt, Yvonne; Fietkau, Katharina; Heise, Ruth; Huth, Sebastian; Pfister, Herbert; Bernhagen, Juergen; Bucala, Richard; Baron, Jens M.; Fingerle-Rowson, Guenter			Macrophage migration inhibitory factor protects from nonmelanoma epidermal tumors by regulating the number of antigen-presenting cells in skin	FASEB JOURNAL			English	Article						skin carcinogenesis; chemokine; CD74; CD44; DMBA/TPA	ULTRAVIOLET-B RADIATION; FACTOR MIF; DENDRITIC CELLS; LANGERHANS CELLS; RECEPTOR COMPLEX; DNA-DAMAGE; T-CELLS; CANCER; EXPRESSION; INFLAMMATION	The response of the skin to harmful environmental agents is shaped decisively by the status of the immune system. Keratinocytes constitutively express and secrete the chemokine-like mediator, macrophage migration inhibitory factor (MIF), more strongly than dermal fibroblasts, thereby creating a MIF gradient in skin. By using global and epidermis-restricted Mif-knockout (Mif(-1-) and K14-Cre(+ltg) ;Mif(fllft)) mice, we found that MIF both recruits and maintains antigen-presenting cells in the dermis/epidermis. The reduced presence of antigen-presenting cells in the absence of MIF was associated with accelerated and increased formation of nonmelanoma skin tumors during chemical carcinogenesis. Our results demonstrate that MIF is essential for maintaining innate immunity in skin. Loss of keratinocyte-derived MIF leads to a loss of control of epithelial skin tumor formation in chemical skin carcinogenesis, which highlights an unexpected tumor-suppressive activity of MIF in murine skin.- Brocks, T., Fedorchenko, O., Schliermann, N., Stein, A., Moll, U. M., Seegobin, S., Dewor, M., Hallek, M., Marquardt, Y., Fietkau, K., Heise, R., Huth, S., Pfister, H., Bernhagen, J., Bucala, R., Baron, J. M., Fingerle-Rowson, G. Macrophage migration inhibitory factor protects from nonmelanoma epidermal tumors by regulating the number of antigen-presenting cells in skin.	[Brocks, Tania; Fedorchenko, Oleg; Schliermann, Nicola; Hallek, Michael; Fingerle-Rowson, Guenter] Univ Hosp, Dept Internal Med 1, Kerpener Str 62, D-50937 Cologne, Germany; [Stein, Astrid] Univ Hosp, Inst Pathol & Cytol, Cologne, Germany; [Pfister, Herbert] Univ Hosp, Inst Virol, Cologne, Germany; [Brocks, Tania; Fedorchenko, Oleg; Schliermann, Nicola; Hallek, Michael; Fingerle-Rowson, Guenter] Ctr Integrated Oncol Koln Bonn, Cologne, Germany; [Moll, Ute M.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Moll, Ute M.] Georg August Univ, Gottingen Ctr Mol Biosci, Dept Mol Oncol, Ernst Caspari Haus, Gottingen, Germany; [Seegobin, Seth] Guys Hosp, Kings Coll London, Sch Med, Dept Med & Mol Genet, London, England; [Dewor, Manfred; Bernhagen, Juergen] Rhein Westfal TH Aachen, Inst Biochem & Mol Cell Biol, Aachen, Germany; [Marquardt, Yvonne; Fietkau, Katharina; Heise, Ruth; Huth, Sebastian; Baron, Jens M.] Rhein Westfal TH Aachen, Dept Dermatol, Aachen, Germany; [Bernhagen, Juergen] Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Inst Stroke & Dementia Res, Dept Vasc Biol, Munich, Germany; [Bernhagen, Juergen] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Bucala, Richard] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	University of Cologne; University of Cologne; University of Cologne; University of Cologne; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Gottingen; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; RWTH Aachen University; RWTH Aachen University; University of Munich; University of Munich; Yale University	Fingerle-Rowson, G (corresponding author), Univ Hosp, Dept Internal Med 1, Kerpener Str 62, D-50937 Cologne, Germany.	g.fingerle-rowson@gmx.de	Baron, Jens M/N-2934-2016; Hallek, Michael/Y-3191-2019; Fedorchenko, Oleg/AAA-6533-2021	Baron, Jens M/0000-0002-1174-6946; Hallek, Michael/0000-0002-7425-4455; 	Deutsche Forschungsgemeinschaft (German Research Council) [Fi 712/2, BA1803/7-1, BE1977/4-2, SFB1123-A03, SFB 832]; German Jose Carreras Leukemia Foundation [R06/20, AI042310]; START programs of the Medical Faculty of the Rheinisch-Westfalische Technische Hochschule Aachen; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042310, R56AI042310] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (German Research Council)(German Research Foundation (DFG)); German Jose Carreras Leukemia Foundation; START programs of the Medical Faculty of the Rheinisch-Westfalische Technische Hochschule Aachen; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Prof. A. Sharpe (Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA) for helping with BALB/c blastocyst injections and the generation of chimaeric conditional MIF mice. The K14-Cre transgenic mice were obtained from Drs. C. Niessen and A. Roers (University Hospital Cologne), and from Prof. Dr. I. Forster (University of Dusseldorf, Dusseldorf, Germany). This work was supported by the Deutsche Forschungsgemeinschaft (German Research Council) Grant Fi 712/2 (to G.F.-R.), Grant BA1803/7-1 (to J.M.B.), Grant BE1977/4-2 and SFB1123-A03 (to J.B.), Grant A16 of SFB 832 (to M.H.), Grant R06/20 of the German Jose Carreras Leukemia Foundation (to G.F.-R.), Grant AI042310 (to R.B.), and by the START programs of the Medical Faculty of the Rheinisch-Westfalische Technische Hochschule Aachen (to J.M.B., R.H., and J.B.). The authors declare no conflicts of interest.	Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Bernhagen J, 1996, J EXP MED, V183, P277, DOI 10.1084/jem.183.1.277; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bifulco C, 2008, CURR PHARM DESIGN, V14, P3790, DOI 10.2174/138161208786898608; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; Conroy H, 2010, QJM-INT J MED, V103, P831, DOI 10.1093/qjmed/hcq148; Cornelissen C, 2011, BRIT J DERMATOL, V165, P966, DOI 10.1111/j.1365-2133.2011.10487.x; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Feijoo E, 2005, INT J CANCER, V116, P275, DOI 10.1002/ijc.21046; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Fingerle-Rowson G, 2003, AM J PATHOL, V162, P47, DOI 10.1016/S0002-9440(10)63797-2; Gilliver SC, 2011, EXP DERMATOL, V20, P1, DOI 10.1111/j.1600-0625.2010.01194.x; Girardi M, 2003, J EXP MED, V198, P747, DOI 10.1084/jem.20021282; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; Greven D, 2010, EXPERT OPIN THER TAR, V14, P253, DOI 10.1517/14728220903551304; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Heise R, 2012, PHOTOCHEM PHOTOBIOL, V88, P1157, DOI 10.1111/j.1751-1097.2012.01108.x; Honda A, 2009, CARCINOGENESIS, V30, P1597, DOI 10.1093/carcin/bgp160; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Kabashima K, 2007, AM J PATHOL, V171, P1249, DOI 10.2353/ajpath.2007.070225; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Koch S, 2006, J ALLERGY CLIN IMMUN, V117, P163, DOI 10.1016/j.jaci.2005.10.003; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lewis J, 2010, TRENDS IMMUNOL, V31, P460, DOI 10.1016/j.it.2010.10.001; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Lue HQ, 2006, CELL SIGNAL, V18, P688, DOI 10.1016/j.cellsig.2005.06.013; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martin J, 2009, FASEB J, V23, P720, DOI 10.1096/fj.08-119628; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Modi BG, 2012, SCIENCE, V335, P104, DOI 10.1126/science.1211600; MOON D C, 1992, Journal of Dermatology (Tokyo), V19, P146; Mueller MM, 2006, EUR J CANCER, V42, P735, DOI 10.1016/j.ejca.2006.01.014; Muller WA, 2001, J EXP MED, V194, pF47, DOI 10.1084/jem.194.9.f47; Neis MM, 2010, SKIN PHARMACOL PHYS, V23, P29, DOI 10.1159/000257261; Petrenko O, 2005, MOL CELL, V17, P225, DOI 10.1016/j.molcel.2004.11.052; Petrenko O, 2003, J BIOL CHEM, V278, P11078, DOI 10.1074/jbc.M211985200; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Reinart N, 2013, BLOOD, V121, P812, DOI 10.1182/blood-2012-05-431452; Roberts SJ, 2007, P NATL ACAD SCI USA, V104, P6770, DOI 10.1073/pnas.0604982104; RUGGERI B, 1993, P NATL ACAD SCI USA, V90, P1013, DOI 10.1073/pnas.90.3.1013; Santos LL, 2011, ARTHRITIS RHEUM-US, V63, P960, DOI 10.1002/art.30203; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Schaper ID, 2005, CANCER RES, V65, P1394, DOI 10.1158/0008-5472.CAN-04-3263; Schulz R, 2012, J EXP MED, V209, P275, DOI 10.1084/jem.20111117; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Shimizu T, 1999, J INVEST DERMATOL, V112, P210, DOI 10.1046/j.1523-1747.1999.00486.x; Shimizu T, 2005, J DERMATOL SCI, V37, P65, DOI 10.1016/j.jdermsci.2004.08.007; Shimizu T, 2003, EUR J IMMUNOL, V33, P1478, DOI 10.1002/eji.200323751; Shimizu T, 1996, FEBS LETT, V381, P199, DOI 10.1016/0014-5793(96)00120-2; Sperling T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002833; Talos F, 2005, CELL DEATH DIFFER, V12, P1319, DOI 10.1038/sj.cdd.4401653; Taylor JA, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-135; Timares L, 2008, PHOTOCHEM PHOTOBIOL, V84, P422, DOI 10.1111/j.1751-1097.2007.00284.x; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wang LC, 2008, J IMMUNOL, V180, P4722, DOI 10.4049/jimmunol.180.7.4722; Weber C, 2008, P NATL ACAD SCI USA, V105, P16278, DOI 10.1073/pnas.0804017105; Wilson JM, 2005, GASTROENTEROLOGY, V129, P1485, DOI 10.1053/j.gastro.2005.07.061; Yoshihisa Y, 2011, J INVEST DERMATOL, V131, P925, DOI 10.1038/jid.2010.418; Zhang SL, 1998, P NATL ACAD SCI USA, V95, P2429, DOI 10.1073/pnas.95.5.2429	60	14	14	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					526	543		10.1096/fj.201600860R	http://dx.doi.org/10.1096/fj.201600860R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27825106	Green Published			2022-12-26	WOS:000394235400009
J	Kong, QR; Xie, BT; Zhang, H; Li, JY; Huang, TQ; Wei, RY; Liu, ZH				Kong, Qing-Ran; Xie, Bing-Teng; Zhang, Heng; Li, Jing-Yu; Huang, Tian-Qing; Wei, Ren-Yue; Liu, Zhong-Hua			RE1-silencing Transcription Factor (REST) Is Required for Nuclear Reprogramming by Inhibiting Transforming Growth Factor beta Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOMATIC-CELLS; TARGET; IDENTIFICATION; PLURIPOTENCY; HISTONE; DISEASE; MEMORY; NANOG	Differentiated cells can be reprogrammed by transcription factors, and these factors that are responsible for successful reprogramming need to be further identified. Here, we show that the neuronal repressor RE1-silencing transcription factor (REST) is rich in porcine oocytes and requires for nuclear transfer (NT)-mediated reprogramming through inhibiting TGF beta signaling pathway. REST was dramatically degraded after oocyte activation, but the residual REST was incorporated into the transferred donor nuclei during reprogramming in NT embryos. Inhibition of REST function in oocytes compromised the development of NT embryos but not that of IVF and PA embryos. Bioinformation analysis of putative targets of REST indicated that REST might function on reprogramming in NT embryos by inhibiting TGF beta pathway. Further results showed that the developmental failure of REST-inhibited NT embryos could be rescued by treatment of SB431542, an inhibitor of TGF beta pathway. Thus, REST is a newly discovered transcription factor that is required for NT-mediated nuclear reprogramming.	[Kong, Qing-Ran; Xie, Bing-Teng; Zhang, Heng; Li, Jing-Yu; Huang, Tian-Qing; Wei, Ren-Yue; Liu, Zhong-Hua] Northeast Agr Univ, Coll Life Sci, Key Lab Anim Cell & Genet Engn Heilongjiang Prov, Harbin 150030, Peoples R China	Northeast Agricultural University - China	Liu, ZH (corresponding author), Northeast Agr Univ, Coll Life Sci, Key Lab Anim Cell & Genet Engn Heilongjiang Prov, Harbin 150030, Peoples R China.	liu086@126.com	Li, Jingyu/GSD-1924-2022		National Natural Science Foundation of China [31470079]; National Basic Research Program of China [2011CBA01006]; Fund for Fostering Talents in Basic Science of the National Natural Science Foundation of China [J1210069]; "Academic Backbone" Project of Northeast Agricultural University [15XG19]; Doctoral Research Foundation of Northeast Agricultural University [2009RC56, 2012RCB06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Fund for Fostering Talents in Basic Science of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Academic Backbone" Project of Northeast Agricultural University; Doctoral Research Foundation of Northeast Agricultural University	This work was support by National Natural Science Foundation of China Grant 31470079, National Basic Research Program of China Grant 2011CBA01006, the Fund for Fostering Talents in Basic Science of the National Natural Science Foundation of China Grant J1210069, "Academic Backbone" Project of Northeast Agricultural University Grant 15XG19, and Doctoral Research Foundation of Northeast Agricultural University Grants 2009RC56 and 2012RCB06. The authors declare that they have no conflicts of interest with the contents of this article.	Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Cao SY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-4; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; Gonda K, 2003, NAT CELL BIOL, V5, P205, DOI 10.1038/ncb939; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Hansis C, 2004, CURR BIOL, V14, P1475, DOI 10.1016/j.cub.2004.08.031; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Jullien J, 2010, P NATL ACAD SCI USA, V107, P5483, DOI 10.1073/pnas.1000599107; Kagalwala MN, 2008, COLD SH Q B, V73, P227, DOI 10.1101/sqb.2008.73.042; Kikyo N, 2000, SCIENCE, V289, P2360, DOI 10.1126/science.289.5488.2360; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kong QR, 2014, J BIOL CHEM, V289, P6960, DOI 10.1074/jbc.M113.543793; Miyamoto K, 2011, P NATL ACAD SCI USA, V108, P7040, DOI 10.1073/pnas.1013634108; Negrini S, 2013, TRENDS CELL BIOL, V23, P289, DOI 10.1016/j.tcb.2013.01.006; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Papanayotou C, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0539; Park Kyung-Soon, 2011, Int J Stem Cells, V4, P18; Perera A, 2015, CELL REP, V11, P283, DOI 10.1016/j.celrep.2015.03.020; Qureshi IA, 2010, CELL CYCLE, V9, P4477, DOI 10.4161/cc.9.22.13973; Qureshi IA, 2010, ANN NY ACAD SCI, V1204, pE20, DOI 10.1111/j.1749-6632.2010.05718.x; Robertson EJ, 2014, SEMIN CELL DEV BIOL, V32, P73, DOI 10.1016/j.semcdb.2014.03.028; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Tada M, 2003, DEV DYNAM, V227, P504, DOI 10.1002/dvdy.10337; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takaoka K, 2011, NAT CELL BIOL, V13, P743, DOI 10.1038/ncb2251; Tamada H, 2006, MOL CELL BIOL, V26, P1259, DOI 10.1128/MCB.26.4.1259-1271.2006; Tokoyoda K, 2012, CELL MOL LIFE SCI, V69, P1609, DOI 10.1007/s00018-012-0969-6; Wen DC, 2014, P NATL ACAD SCI USA, V111, P7325, DOI 10.1073/pnas.1406389111; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	36	5	5	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27334	27342		10.1074/jbc.M116.743849	http://dx.doi.org/10.1074/jbc.M116.743849			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27821591	Green Published, hybrid			2022-12-26	WOS:000391576300030
J	Venugopal, S; Martinez-Arguelles, DB; Chebbi, S; Hullin-Matsuda, F; Kobayashi, T; Papadopoulos, V				Venugopal, Sathvika; Martinez-Arguelles, Daniel Benjamin; Chebbi, Seimia; Hullin-Matsuda, Francoise; Kobayashi, Toshihide; Papadopoulos, Vassilios			Plasma Membrane Origin of the Steroidogenic Pool of Cholesterol Used in Hormone-induced Acute Steroid Formation in Leydig Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFRINGOLYSIN-O; TUMOR-CELLS; ENDOSOMAL CHOLESTEROL; ENDOPLASMIC-RETICULUM; LIPID ORGANIZATION; ADRENAL-CORTEX; LIVING CELLS; TRANSPORT; TRAFFICKING; MITOCHONDRIA	Hormone-sensitive acute steroid biosynthesis requires trafficking of cholesterol from intracellular sources to the inner mitochondrial membrane. The precise location of the intracellular cholesterol and its transport mechanism are uncertain. Perfringolysin O, produced by Clostridium perfringens, binds cholesterol. Its fourth domain D4) retains cholesterol-binding properties but not cytotoxicity. We transfected steroidogenic MA-10 cells of mouse Leydig cell tumors with the mCherry-D4 plasmid. Tagged D4 with fluorescent proteins enabled us to track cholesterol. The staining was primarily localized to the inner leaflet of the plasma membrane and was partially released upon treatment with dibutyryl-cAMP Bt(2)cAMP), a cAMP analog. Inhibitors of cholesterol import into mitochondria blocked steroidogenesis and prevented release of D4 and presumably cholesterol) from the plasma membrane. We conclude that the bulk of the steroidogenic pool of cholesterol, mobilized by Bt(2)cAMP for acute steroidogenesis, originates from the plasma membrane. Treatment of the cells with steroid metabolites, 22R)-hydroxycholesterol and pregnenolone, also reduced D4 release from the plasma membrane, perhaps evidence for a feedback effect of elevated steroid formation on cholesterol release. Interestingly, D4 staining was localized to endosomes during Bt(2)cAMP stimulation suggesting that these organelles are on the route of cholesterol trafficking from the plasma membrane to mitochondria. Finally, D4 was expressed in primary rat Leydig cells with a lentivirus and was released from the plasma membrane following Bt(2)cAMP treatment. Weconclude that the plasma membrane is the source of cholesterol for steroidogenesis in these cells as well as in MA-10 cells.	[Venugopal, Sathvika; Martinez-Arguelles, Daniel Benjamin; Chebbi, Seimia; Papadopoulos, Vassilios] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H4A 3J1, Canada; [Venugopal, Sathvika; Martinez-Arguelles, Daniel Benjamin; Chebbi, Seimia; Papadopoulos, Vassilios] McGill Univ, Dept Med, Montreal, PQ H4A 3J1, Canada; [Hullin-Matsuda, Francoise; Kobayashi, Toshihide] RIKEN, Adv Sci Inst, Lipid Biol Lab, Wako, Saitama 3510198, Japan; [Hullin-Matsuda, Francoise; Kobayashi, Toshihide] Univ Lyon 1, INSA Lyon, INSERM, U1060, F-69621 Villeurbanne, France; [Kobayashi, Toshihide] Univ Strasbourg, CNRS, UMR 7213, F-67401 Illkirch Graffenstaden, France; [Papadopoulos, Vassilios] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Papadopoulos, Vassilios] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; RIKEN; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; McGill University; McGill University	Papadopoulos, V (corresponding author), Univ Southern Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, 1985 Zonal Ave, Los Angeles, CA 90089 USA.	vpapadop@usc.edu	Papadopoulos, Vassilios/AAI-2613-2019; Hullin-Matsuda, Françoise/N-3880-2017; KOBAYASHI, TOSHIHIDE/S-8313-2019; Carmen, Team1/Y-7382-2019	Papadopoulos, Vassilios/0000-0002-1183-8568; Hullin-Matsuda, Françoise/0000-0002-6042-2841; KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Carmen, Team1/0000-0003-4234-1746; Lab, Carmen/0000-0002-5935-3236	Le Fonds de la Recherche du Quebec-Sante	Le Fonds de la Recherche du Quebec-Sante	We thank Dr. Mario Ascoli (University of Iowa, Iowa City) for supplying the MA-10 cell line; Edward Daly and Pushwinder Kaur for their assistance with the mass spectrometry studies; and Rachel Chan and Esha Sanyal for their assistance in subcellular organelle isolations procedure. The Research Institute of McGill University Health Centre was supported by a Center Grant from Le Fonds de la Recherche du Quebec-Sante.	Abe M, 2012, MOL CELL BIOL, V32, P1396, DOI 10.1128/MCB.06113-11; Achleitner G, 1999, EUR J BIOCHEM, V264, P545, DOI 10.1046/j.1432-1327.1999.00658.x; Akula N, 2012, BIOORG MED CHEM LETT, V22, P4139, DOI 10.1016/j.bmcl.2012.04.058; AOKI A, 1975, CELL TISSUE RES, V165, P49; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; BOYD GS, 1983, J STEROID BIOCHEM, V19, P1017, DOI 10.1016/0022-4731(83)90048-1; BRETSCHER MS, 1972, NATURE-NEW BIOL, V236, P11, DOI 10.1038/newbio236011a0; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Christian AE, 1997, J LIPID RES, V38, P2264; Cox BE, 2007, J LIPID RES, V48, P1012, DOI 10.1194/jlr.M600390-JLR200; Crompton M, 2002, BIOCHIMIE, V84, P143, DOI 10.1016/S0300-9084(02)01368-8; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; de Araujo Mariana Eca Guimaraes, 2008, V424, P317, DOI 10.1007/978-1-60327-064-9_25; FREEMAN DA, 1987, J BIOL CHEM, V262, P13061; FREEMAN DA, 1989, ENDOCRINOLOGY, V124, P2527, DOI 10.1210/endo-124-5-2527; GOCZE PM, 1993, EXP CELL RES, V209, P21, DOI 10.1006/excr.1993.1279; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; HARMALA AS, 1994, BBA-LIPID LIPID MET, V1211, P317, DOI 10.1016/0005-2760(94)90156-2; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Holtta-Vuori M, 2000, CURR BIOL, V10, P95, DOI 10.1016/S0960-9822(99)99991-8; Hughson FM, 2010, CURR OPIN CELL BIOL, V22, P454, DOI 10.1016/j.ceb.2010.03.011; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Ingolfsson HI, 2014, J AM CHEM SOC, V136, P14554, DOI 10.1021/ja507832e; Ishitsuka R, 2011, J LIPID RES, V52, P2084, DOI 10.1194/jlr.D018184; Issop L, 2015, ENDOCRINOLOGY, V156, P334, DOI 10.1210/en.2014-1503; Issop L, 2013, MOL CELL ENDOCRINOL, V371, P34, DOI 10.1016/j.mce.2012.12.003; Jefcoate C, 2002, J CLIN INVEST, V110, P881, DOI 10.1172/JCI200216771; Johnson BB, 2012, BIOCHEMISTRY-US, V51, P3373, DOI 10.1021/bi3003132; Kase ET, 2006, BBA-MOL CELL BIOL L, V1761, P1515, DOI 10.1016/j.bbalip.2006.09.010; Kennedy BE, 2012, J LIPID RES, V53, P2632, DOI 10.1194/jlr.M029942; KLINEFELTER GR, 1987, BIOL REPROD, V36, P769, DOI 10.1095/biolreprod36.3.769; Koziel K, 2009, INT J BIOCHEM CELL B, V41, P2440, DOI 10.1016/j.biocel.2009.07.003; Lebiedzinska M, 2009, ARCH BIOCHEM BIOPHYS, V486, P73, DOI 10.1016/j.abb.2009.03.007; Maekawa M, 2016, TOXINS, V8, DOI 10.3390/toxins8030067; Maekawa M, 2015, J CELL SCI, V128, P1422, DOI 10.1242/jcs.164715; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; Midzak AS, 2015, PHARMACOL RES, V99, P393, DOI 10.1016/j.phrs.2015.03.023; Miller WL, 2011, J LIPID RES, V52, P2111, DOI 10.1194/jlr.R016675; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Nan XL, 2006, BIOPHYS J, V91, P728, DOI 10.1529/biophysj.105.074534; Ohno-Iwashita Y, 2004, ANAEROBE, V10, P125, DOI 10.1016/j.anaerobe.2003.09.003; Papadopoulos V, 2007, MOL CELL ENDOCRINOL, V265, P59, DOI 10.1016/j.mce.2006.12.004; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Pichler H, 2001, EUR J BIOCHEM, V268, P2351, DOI 10.1046/j.1432-1327.2001.02116.x; Porpaczy Z, 1997, EXP CELL RES, V234, P217, DOI 10.1006/excr.1997.3612; Prinz WA, 2007, PROG LIPID RES, V46, P297, DOI 10.1016/j.plipres.2007.06.002; Prinz WA, 2014, J CELL BIOL, V205, P759, DOI 10.1083/jcb.201401126; Prinz WA, 2010, CELL, V143, P870, DOI 10.1016/j.cell.2010.11.031; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rao RM, 2003, BIOL REPROD, V68, P114, DOI 10.1095/biolreprod.102.007518; Rone MB, 2012, MOL ENDOCRINOL, V26, P1868, DOI 10.1210/me.2012-1159; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; Shen WJ, 2012, ENDOCRINOLOGY, V153, P3249, DOI 10.1210/en.2012-1048; Shimada Y, 2002, EUR J BIOCHEM, V269, P6195, DOI 10.1046/j.1432-1033.2002.03338.x; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; STEVENS VL, 1992, ENDOCRINOLOGY, V130, P1557, DOI 10.1210/en.130.3.1557; Suski JM, 2014, NAT PROTOC, V9, P312, DOI 10.1038/nprot.2014.016; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; Wustner D, 2005, TRAFFIC, V6, P396, DOI 10.1111/j.1600-0854.2005.00285.x; Yan DG, 2008, INT REV CYTOL, V265, P253, DOI 10.1016/S0074-7696(07)65007-4; ZOLLER LC, 1975, ANAT REC, V182, P473, DOI 10.1002/ar.1091820406	66	34	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26109	26125		10.1074/jbc.M116.740928	http://dx.doi.org/10.1074/jbc.M116.740928			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27815506	Green Published, hybrid			2022-12-26	WOS:000390345200029
J	de Thoisy, B; Fayad, I; Clement, L; Barrioz, S; Poirier, E; Gond, V				de Thoisy, Benoit; Fayad, Ibrahim; Clement, Luc; Barrioz, Sebastien; Poirier, Eddy; Gond, Valery			Predators, Prey and Habitat Structure: Can Key Conservation Areas and Early Signs of Population Collapse Be Detected in Neotropical Forests?	PLOS ONE			English	Article							FRENCH-GUIANA; HEIGHT ESTIMATION; CITIZEN-SCIENCE; PROTECTED AREAS; CAMERA TRAPS; LANDSCAPE; ABUNDANCE; JAGUARS; CANOPY; MAMMALS	Tropical forests with a low human population and absence of large-scale deforestation provide unique opportunities to study successful conservation strategies, which should be based on adequate monitoring tools. This study explored the conservation status of a large predator, the jaguar, considered an indicator of the maintenance of how well ecological processes are maintained. We implemented an original integrative approach, exploring successive ecosystem status proxies, from habitats and responses to threats of predators and their prey, to canopy structure and forest biomass. Niche modeling allowed identification of more suitable habitats, significantly related to canopy height and forest biomass. Capture/recapture methods showed that jaguar density was higher in habitats identified as more suitable by the niche model. Surveys of ungulates, large rodents and birds also showed higher density where jaguars were more abundant. Although jaguar density does not allow early detection of overall vertebrate community collapse, a decrease in the abundance of large terrestrial birds was noted as good first evidence of disturbance. The most promising tool comes from easily acquired LiDAR data and radar images: a decrease in canopy roughness was closely associated with the disturbance of forests and associated decreasing vertebrate biomass. This mixed approach, focusing on an apex predator, ecological modeling and remote-sensing information, not only helps detect early population declines in large mammals, but is also useful to discuss the relevance of large predators as indicators and the efficiency of conservation measures. It can also be easily extrapolated and adapted in a timely manner, since important open-source data are increasingly available and relevant for large-scale and real-time monitoring of biodiversity.	[de Thoisy, Benoit; Clement, Luc; Barrioz, Sebastien; Poirier, Eddy] Kwata NGO, BP 972, Cayenne, French Guiana; [Fayad, Ibrahim] IRSTEA, UMR TETIS, Montpellier, France; [Gond, Valery] CIRAD, Forests & Soc unit, Montpellier, France	AgroParisTech; INRAE; CIRAD	de Thoisy, B (corresponding author), Kwata NGO, BP 972, Cayenne, French Guiana.	benoit@kwata.net		Gond, Valery/0000-0002-0080-3140; de thoisy, benoit/0000-0002-8420-5112	Wildlife Conservation Society; SPECIES project; WWF Network; European Funds (FEDER); FFEM; DGIS; French Ministry of Higher Education and Research; Diren Guyane; DEAL Guyane; ONF Guyane; Reserve Naturelle Nationale de la Trinite	Wildlife Conservation Society; SPECIES project; WWF Network; European Funds (FEDER)(European Commission); FFEM; DGIS; French Ministry of Higher Education and Research; Diren Guyane; DEAL Guyane; ONF Guyane; Reserve Naturelle Nationale de la Trinite	The camera-trapping surveys were funded by the Wildlife Conservation Society and the SPECIES project, the WWF Network, European Funds (FEDER), FFEM, the DGIS and the French Ministry of Higher Education and Research. Field surveys for prey were funded by Diren Guyane, DEAL Guyane, ONF Guyane, and the Reserve Naturelle Nationale de la Trinite.; The camera-trapping surveys were funded by the Wildlife Conservation Society and the SPECIES project, the WWF Network, European Funds (FEDER), FFEM, the DGIS and the French Ministry of Higher Education and Research. Field surveys for prey were funded by Diren Guyane, DEAL Guyane, ONF Guyane, and the Reserve Naturelle Nationale de la Trinite. We are grateful to Leo Maffei (WCS) for his advice and assistance in the field for the first camera trapping session in French Guiana. We acknowledge the Nouragues Nature Reserve, the CNRS Guyane, and the DEAL Guyane, for field support during the Nouragues trap session.	Alvarez-Berrios Nora L., 2015, Environmental Research Letters, V10, DOI 10.1088/1748-9326/10/1/014006; Barbier N, 2010, GLOBAL ECOL BIOGEOGR, V19, P72, DOI 10.1111/j.1466-8238.2009.00493.x; Beck H, 2013, BIOL CONSERV, V163, P115, DOI 10.1016/j.biocon.2013.03.012; Boron V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153973; Bourbier L, 2013, BOIS FOR TROP, V315, P3; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Briant G, 2010, BIOL CONSERV, V143, P2763, DOI 10.1016/j.biocon.2010.07.024; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Caro T, 2004, ANIM CONSERV, V7, P63, DOI 10.1017/S136794300300115X; de Azevedo FCC, 2007, BIOL CONSERV, V137, P391, DOI 10.1016/j.biocon.2007.02.022; Caso A., 2008, PANTHERA ONCA IUCN R; Chen Q, 2010, REMOTE SENS ENVIRON, V114, P1610, DOI 10.1016/j.rse.2010.02.016; Clement L, 2014, TROPICAL CONSERVATIO, V7, P193; Conde DA, 2010, BIOL CONSERV, V143, P1980, DOI 10.1016/j.biocon.2010.04.049; Couvet D, 2015, ENVIRON DEV, V13, P39, DOI 10.1016/j.envdev.2014.11.003; De Barros AE, 2014, CONSERV BIOL, V28, P580, DOI 10.1111/cobi.12202; De Sy V, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/124004; de Thoisy B, 2005, ORYX, V39, P149, DOI 10.1017/S0030605305000384; de Thoisy B, 2008, BIODIVERS CONSERV, V17, P2627, DOI 10.1007/s10531-008-9337-0; de Thoisy B, 2010, BIODIVERS CONSERV, V19, P1567, DOI 10.1007/s10531-010-9787-z; de Thoisy Benoit, 2009, P389, DOI 10.1007/978-0-387-78705-3_15; DEGRANVILLE JJ, 1988, TAXON, V37, P578, DOI 10.2307/1221101; Dudik M., 2005, NIPS 05 P 18 INT C N, V18, P323; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Eva HD, 2012, REMOTE SENS-BASEL, V4, P1369, DOI 10.3390/rs4051369; Farhadinia MS, 2015, BIOL CONSERV, V191, P770, DOI 10.1016/j.biocon.2015.08.027; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Fayad I, 2014, REMOTE SENS-BASEL, V6, P11883, DOI 10.3390/rs61211883; Foster RJ, 2010, J ZOOL, V280, P309, DOI 10.1111/j.1469-7998.2009.00663.x; Garmendia A, 2013, J TROP ECOL, V29, P331, DOI 10.1017/S0266467413000370; Gilpin ME., 1989, ENDANGERED SPECIES U, V6-10, P15; Gond V., 2005, BOIS FOR TS TROP, V286, P5; Gond V, 2011, INT J APPL EARTH OBS, V13, P357, DOI 10.1016/j.jag.2011.01.004; Gonzalez CAL, 2002, WEST N AM NATURALIST, V62, P218; Goodwin A., 1996, PRINCIPLES PRECAMBRI; Groenendijk J, 1998, REV DISTRIBUTION CON; Guitet S, 2016, J TROP ECOL, V32, P22, DOI 10.1017/S0266467415000620; Guitet S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138456; Guitet S, 2015, BIODIVERS CONSERV, V24, P1215, DOI 10.1007/s10531-014-0854-8; Guitet S, 2013, J MAPS, V9, P325, DOI 10.1080/17445647.2013.785371; Guitet S, 2012, FOREST ECOL MANAG, V277, P124, DOI 10.1016/j.foreco.2012.04.011; Hammond DS, 2015, ENVIRON CONSERV, V42, P256, DOI 10.1017/S0376892914000411; Hammond DS, 2007, AMBIO, V36, P661, DOI 10.1579/0044-7447(2007)36[661:CACOAT]2.0.CO;2; Hammond DS, 2005, TROPICAL FORESTS OF THE GUIANA SHIELD: ANCIENT FORESTS IN A MODERN WORLD, P1, DOI 10.1079/9780851995366.0001; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Haugaasen T, 2005, J TROP ECOL, V21, P133, DOI 10.1017/s026646740400207X; Haugaasen T, 2008, BIRD CONSERV INT, V18, P87, DOI 10.1017/S0959270908000130; Hayward Matt W., 2016, Frontiers in Ecology and Evolution, V3, P148; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hilbert C, 2012, REMOTE SENS-BASEL, V4, P2210, DOI 10.3390/rs4082210; Hudson LN, 2014, ECOL EVOL, V4, P4701, DOI 10.1002/ece3.1303; Jorge MLSP, 2013, BIOL CONSERV, V163, P49, DOI 10.1016/j.biocon.2013.04.018; Kehl TN, 2012, SUSTAINABILITY-BASEL, V4, P2566, DOI 10.3390/su4102566; Kelly MJ, 2014, ANAL 5 YEARS DATA RI; Lefsky MA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023971; Leisher C., 2013, Diversity, V5, P779; Levi T, 2013, BIOL CONSERV, V163, P99, DOI 10.1016/j.biocon.2013.03.016; Lewis SL, 2015, SCIENCE, V349, P827, DOI 10.1126/science.aaa9932; Lindeman JC, 1989, FLORISTIC INVENTORY, P375; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Loos J, 2015, J NAT CONSERV, V26, P45, DOI 10.1016/j.jnc.2015.05.001; Lopes MA, 2000, CONSERV BIOL, V14, P1658, DOI 10.1111/j.1523-1739.2000.98402.x; Montoya D, 2009, GLOBAL ECOL BIOGEOGR, V18, P662, DOI 10.1111/j.1466-8238.2009.00478.x; Moreira-Arce D, 2016, FOREST ECOL MANAG, V369, P135, DOI 10.1016/j.foreco.2016.03.024; Nagendra H, 2013, ECOL INDIC, V33, P45, DOI 10.1016/j.ecolind.2012.09.014; Noss AJ, 2006, PUMAS JAGUARES SIMPA, P229; Nunez-Iturri G, 2008, BIOL CONSERV, V141, P1536, DOI 10.1016/j.biocon.2008.03.020; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Peres CA, 2000, OECOLOGIA, V122, P175, DOI 10.1007/PL00008845; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Picard N, 2012, CAN J FOREST RES, V42, P605, DOI [10.1139/X2012-018, 10.1139/x2012-018]; Pithon S, 2013, INT J REMOTE SENS, V34, P700, DOI 10.1080/01431161.2012.706719; Pitman RT, 2015, BIODIVERS CONSERV, V24, P1975, DOI 10.1007/s10531-015-0921-9; Rabinowitz A, 2010, BIOL CONSERV, V143, P939, DOI 10.1016/j.biocon.2010.01.002; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Rheingantz ML, 2014, TROP CONSERV SCI, V7, P224; Richard-Hansen C, 1999, J ZOOL, V247, P419, DOI 10.1017/S095283699900401X; Richard-Hansen C, 2015, J TROP ECOL, V31, P423, DOI 10.1017/S0266467415000255; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Rose RA, 2015, CONSERV BIOL, V29, P350, DOI 10.1111/cobi.12397; Schipper J, 2007, RMRSP49 USDA FOR SER; Sexton JO, 2016, NAT CLIM CHANGE, V6, P192, DOI [10.1038/NCLIMATE2816, 10.1038/nclimate2816]; Silver SC, 2004, ORYX, V38, P148, DOI 10.1017/S0030605304000286; Taber A, 2008, DESTINO ARQUITECTOS; Thornton D, 2016, ECOL APPL, V26, P1112, DOI 10.1890/15-0602; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484; Tobler MW, 2014, ORYX, V48, P410, DOI 10.1017/S0030605312001652; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; Toogood M, 2013, GEOGR COMPASS, V7, P611, DOI 10.1111/gec3.12067; Torres NM, 2012, DIVERS DISTRIB, V18, P615, DOI 10.1111/j.1472-4642.2012.00892.x; Turner W, 2015, BIOL CONSERV, V182, P173, DOI 10.1016/j.biocon.2014.11.048; Valiente-Banuet A, 2015, FUNCT ECOL, V29, P299, DOI 10.1111/1365-2435.12356; Vierling KT, 2008, FRONT ECOL ENVIRON, V6, P90, DOI 10.1890/070001; White GC, 1982, LA8787NERP; Wilkie DS, 2011, ANN NY ACAD SCI, V1223, P120, DOI 10.1111/j.1749-6632.2010.05908.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wright SJ, 2000, CONSERV BIOL, V14, P227, DOI 10.1046/j.1523-1739.2000.98333.x; ZELLER K., 2007, JAGUARS NEW MILLENNI; Zimmermann NE, 2010, ECOGRAPHY, V33, P985, DOI 10.1111/j.1600-0587.2010.06953.x	100	11	11	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165362	10.1371/journal.pone.0165362	http://dx.doi.org/10.1371/journal.pone.0165362			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828993	Green Published, gold, Green Submitted			2022-12-26	WOS:000387724300040
J	Leroy, EC; Samaran, F; Bonnel, J; Royer, JY				Leroy, Emmanuelle C.; Samaran, Flore; Bonnel, Julien; Royer, Jean-Yves			Seasonal and Diel Vocalization Patterns of Antarctic Blue Whale (Balaenoptera musculus intermedia) in the Southern Indian Ocean: A Multi-Year and Multi-Site Study	PLOS ONE			English	Article							VERTICAL MIGRATION; ACOUSTIC PRESENCE; CALLS; SOUND; SITE; HEMISPHERE; INCREASES; FREQUENCY; ISLAND	Passive acoustic monitoring is an efficient way to provide insights on the ecology of large whales. This approach allows for long-term and species-specific monitoring over large areas. In this study, we examined six years (2010 to 2015) of continuous acoustic recordings at up to seven different locations in the Central and Southern Indian Basin to assess the peak periods of presence, seasonality and migration movements of Antarctic blue whales (Balaenoptera musculus intermedia). An automated method is used to detect the Antarctic blue whale stereotyped call, known as Z-call. Detection results are analyzed in terms of distribution, seasonal presence and diel pattern of emission at each site. Z-calls are detected year-round at each site, except for one located in the equatorial Indian Ocean, and display highly seasonal distribution. This seasonality is stable across years for every site, but varies between sites. Z-calls are mainly detected during autumn and spring at the subantarctic locations, suggesting that these sites are on the Antarctic blue whale migration routes, and mostly during winter at the subtropical sites. In addition to these seasonal trends, there is a significant diel pattern in Z-call emission, with more Z-calls in daytime than in nighttime. This diel pattern may be related to the blue whale feeding ecology.	[Leroy, Emmanuelle C.; Royer, Jean-Yves] Univ Brest, F-29280 Plouzane, France; [Leroy, Emmanuelle C.; Royer, Jean-Yves] IUEM, CNRS, Lab Geosci Brest, F-29280 Plouzane, France; [Leroy, Emmanuelle C.; Samaran, Flore; Bonnel, Julien] ENSTA Bretagne, UMR CNRS Lab STICC 6285, F-29806 Brest, France	Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); ENSTA Bretagne	Royer, JY (corresponding author), Univ Brest, F-29280 Plouzane, France.; Royer, JY (corresponding author), IUEM, CNRS, Lab Geosci Brest, F-29280 Plouzane, France.	jean-yves.royer@univ-brest.fr	Leroy, Emmanuelle/Q-9995-2019; Royer, Jean-Yves/B-4312-2010	Leroy, Emmanuelle/0000-0002-6469-1758; Royer, Jean-Yves/0000-0002-7653-7715	French Polar Institute (IPEV) [MD174/175, MD185, MD189, MD193, MD197, MD200, MD201 cruises, VT109/112-MD174/175, VT115-MD185, VT119-MD189, VT128-MD193, VT135-MD197, VT141-MD200, VT146-MD201]; NOAA/PMEL; INCOIS [SK 307]; Institut National des Sciences de l'Univers of CNRS; University of Brest; Regional Council of Brittany (Conseil Regional de Bretagne); Regional Council of Brittany (CPER); INSU-CNRS	French Polar Institute (IPEV); NOAA/PMEL(National Oceanic Atmospheric Admin (NOAA) - USA); INCOIS; Institut National des Sciences de l'Univers of CNRS; University of Brest; Regional Council of Brittany (Conseil Regional de Bretagne)(Region Bretagne); Regional Council of Brittany (CPER)(Region Bretagne); INSU-CNRS(Centre National de la Recherche Scientifique (CNRS))	Deployment and recovery cruises were funded by the French Polar Institute (IPEV; MD174/175, MD185, MD189, MD193, MD197, MD200, MD201 cruises) and by NOAA/PMEL and INCOIS (SK 307). Additional support for the acoustic experiments was provided by the Institut National des Sciences de l'Univers of CNRS. E.C.L. was supported by a Ph.D. fellowship from the University of Brest and from the Regional Council of Brittany (Conseil Regional de Bretagne). Moorings and hydrophones were funded by the Regional Council of Brittany (CPER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the Captains and crews of RV Marion Dufresne for the successful deployments and recoveries of the hydrophones of the OHASISBIO experiment and of ORV Sagar Kanya for the recovery of the RAMA hydrophone. French cruises were funded by the French Polar Institute (IPEV; cruises VT109/112-MD174/175, VT115-MD185, VT119-MD189, VT128-MD193, VT135-MD197, VT141-MD200 and VT146-MD201), with additional support from INSU-CNRS. We thank NOAA/PMEL and INCOIS for the opportunity to recover the RAMA hydrophone. E.C.L. was supported by a Ph.D. fellowship from the University of Brest and from the Regional Council of Brittany (Conseil Regional de Bretagne). The contribution of Mickael Beauverger at LGO in the preparation and realization of the cruises is greatly appreciated. Comments from three anonymous reviewers greatly helped improving this manuscript.	Aroyan JL, 2000, SPR HDB AUD, V12, P409; ATKINSON A, 1992, MAR BIOL, V113, P583, DOI 10.1007/BF00349702; Attard CRM, 2016, SCI REP-UK, V6, DOI 10.1038/srep22291; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Branch T.A., 2007, Journal of Cetacean Research and Management, V9, P253; Branch TA, 2007, MAMMAL REV, V37, P116, DOI 10.1111/j.1365-2907.2007.00106.x; Branch TA, 2004, MAR MAMMAL SCI, V20, P726, DOI 10.1111/j.1748-7692.2004.tb01190.x; Brown SG, 1954, DISPERSAL BLUE FIN W; Croll DA, 2002, NATURE, V417, P809, DOI 10.1038/417809a; Duhamel G, 2000, POLAR BIOL, V23, P106, DOI 10.1007/s003000050015; Gaten E, 2008, J GENET, V87, P473, DOI 10.1007/s12041-008-0070-y; Gavrilov AN, 2012, J ACOUST SOC AM, V131, P4476, DOI 10.1121/1.4707425; Gavrilov AN, 2011, J ACOUST SOC AM, V130, P3651, DOI 10.1121/1.3651817; Gedamke J, 2007, SCI COMM INT WHAL CO; Gill PC, 2011, MAR ECOL PROG SER, V421, P243, DOI 10.3354/meps08914; Hamame M, 2010, DEEP-SEA RES PT II, V57, P642, DOI 10.1016/j.dsr2.2009.10.013; Helble TA, 2013, J ACOUST SOC AM, V134, pEL400, DOI 10.1121/1.4822319; Helble TA, 2013, J ACOUST SOC AM, V134, P2556, DOI 10.1121/1.4816581; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Ljungblad Donald K., 1998, Report of the International Whaling Commission, V48, P439; Mackintosh NA., 1966, WHALES DOLPHINS PORP, P125; Mackintosh NA, 1929, SO BLUE FIN WHALES; McDonald MA, 2006, NEW ZEAL J MAR FRESH, V40, P519, DOI 10.1080/00288330.2006.9517442; McDonald MA, 2006, J ACOUST SOC AM, V120, P711, DOI 10.1121/1.2216565; McDonald Mark A., 2009, Endangered Species Research, V9, P13, DOI 10.3354/esr00217; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Miksis-Olds JL, 2016, J ACOUST SOC AM, V139, P501, DOI 10.1121/1.4938237; Miksis-Olds JL, 2015, AQUAT MAMM, V41, P444, DOI 10.1578/AM.41.4.2015.444; Miksis-Olds JL, 2013, J ACOUST SOC AM, V134, P3464, DOI 10.1121/1.4821537; Miller BS, 2015, ENDANGER SPECIES RES, V26, P257, DOI 10.3354/esr00642; Miller BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107740; Nemoto T., 1970, P241; Oleson EM, 2007, MAR ECOL PROG SER, V330, P269, DOI 10.3354/meps330269; R Core Team, 2021, R LANGUAGE ENV STAT; Rankin Shannon, 2005, Journal of Cetacean Research and Management, V7, P13; Reilly SB, 2008, IUCN RED LIST THREAT; Royer JY, 2015, GEOPHYS J INT, V202, P748, DOI 10.1093/gji/ggv178; Samaran F., 2008, CAN ACOUST, V36, P93; Samaran F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071561; Samaran F, 2010, APPL ACOUST, V71, P1099, DOI 10.1016/j.apacoust.2010.05.014; Samaran Flore, 2010, Endangered Species Research, V12, P157, DOI 10.3354/esr00302; Samaran F, 2010, J ACOUST SOC AM, V127, P3800, DOI 10.1121/1.3409479; Sirovic A, 2004, DEEP-SEA RES PT II, V51, P2327, DOI 10.1016/j.dsr2.2004.08.005; Sirovic A, 2007, J ACOUST SOC AM, V122, P1208, DOI 10.1121/1.2749452; Sirovic A, 2015, ENDANGER SPECIES RES, V28, P61, DOI 10.3354/esr00676; Sirovic A, 2009, MAR MAMMAL SCI, V25, P125, DOI 10.1111/j.1748-7692.2008.00239.x; Socheleau FX, 2015, J ACOUST SOC AM, V138, P3105, DOI 10.1121/1.4934271; Stafford KM, 2005, ANIM BEHAV, V69, P951, DOI 10.1016/j.anbehav.2004.06.025; Stafford KM, 2004, DEEP-SEA RES PT I, V51, P1337, DOI 10.1016/j.dsr.2004.05.007; Stan Development Team, 2016, RSTANARM BAYES APPL; Thode AM, 2000, J ACOUST SOC AM, V107, P1286, DOI 10.1121/1.428417; Thomisch K, 2016, ENDANGER SPECIES RES, V30, P239, DOI 10.3354/esr00739; Tripovich JS, 2015, J MAMMAL, V96, P603, DOI 10.1093/jmammal/gyv065; Tsang-Hin-Sun E, 2016, GEOPHYS J INT, V206, P1232, DOI 10.1093/gji/ggw201; Tsang-Hin-Sun E, 2015, J ACOUST SOC AM, V138, P3439, DOI 10.1121/1.4936855; Wiggins Sean M., 2005, Aquatic Mammals, V31, P161, DOI 10.1578/AM.31.2.2005.161; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269	58	33	35	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0163587	10.1371/journal.pone.0163587	http://dx.doi.org/10.1371/journal.pone.0163587			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828976	Green Published, gold			2022-12-26	WOS:000387724300008
J	Pendleton, L; Comte, A; Langdon, C; Ekstrom, JA; Cooley, SR; Suatoni, L; Beck, MW; Brander, LM; Burke, L; Cinner, JE; Doherty, C; Edwards, PET; Gledhill, D; Jiang, LQ; van Hooidonk, RJ; Teh, L; Waldbusser, GG; Ritter, J				Pendleton, Linwood; Comte, Adrien; Langdon, Chris; Ekstrom, Julia A.; Cooley, Sarah R.; Suatoni, Lisa; Beck, Michael W.; Brander, Luke M.; Burke, Lauretta; Cinner, Josh E.; Doherty, Carolyn; Edwards, Peter E. T.; Gledhill, Dwight; Jiang, Li-Qing; van Hooidonk, Ruben J.; Teh, Louise; Waldbusser, George G.; Ritter, Jessica			Coral Reefs and People in a High-CO2 World: Where Can Science Make a Difference to People?	PLOS ONE			English	Article							GREAT-BARRIER-REEF; OCEAN ACIDIFICATION; CLIMATE-CHANGE; VULNERABILITY; CALCIFICATION; ADAPTATION; SUSTAINABILITY; DISTURBANCES; TEMPERATURE; RESILIENCE	Reefs and People at Risk Increasing levels of carbon dioxide in the atmosphere put shallow, warm-water coral reef ecosystems, and the people who depend upon them at risk from two key global environmental stresses: 1) elevated sea surface temperature (that can cause coral bleaching and related mortality), and 2) ocean acidification. These global stressors: cannot be avoided by local management, compound local stressors, and hasten the loss of ecosystem services. Impacts to people will be most grave where a) human dependence on coral reef ecosystems is high, b) sea surface temperature reaches critical levels soonest, and c) ocean acidification levels are most severe. Where these elements align, swift action will be needed to protect people's lives and livelihoods, but such action must be informed by data and science. An Indicator Approach Designing policies to offset potential harm to coral reef ecosystems and people requires a better understanding of where CO2-related global environmental stresses could cause the most severe impacts. Mapping indicators has been proposed as a way of combining natural and social science data to identify policy actions even when the needed science is relatively nascent. To identify where people are at risk and where more science is needed, we map indicators of biological, physical and social science factors to understand how human dependence on coral reef ecosystems will be affected by globally-driven threats to corals expected in a high-CO2 world. Western Mexico, Micronesia, Indonesia and parts of Australia have high human dependence and will likely face severe combined threats. As a region, Southeast Asia is particularly at risk. Many of the countries most dependent upon coral reef ecosystems are places for which we have the least robust data on ocean acidification. These areas require new data and interdisciplinary scientific research to help coral reef-dependent human communities better prepare for a high CO2 world.	[Pendleton, Linwood; Comte, Adrien] Univ Bretagne Occidentale, AMURE UMR6308, IUEM, Plouzane, France; [Doherty, Carolyn] Duke Univ, Durham, NC USA; [Langdon, Chris] Univ Miami, RSMAS MBE, Miami, FL USA; [Ekstrom, Julia A.] Univ Calif Davis, Policy Inst Energy Environm & Econ, Davis, CA 95616 USA; [Cooley, Sarah R.] Ocean Conservancy, Washington, DC USA; [Suatoni, Lisa] Nat Resources Def Council, New York, NY USA; [Beck, Michael W.] Nature Conservancy, Santa Cruz, CA USA; [Beck, Michael W.] Univ Calif Santa Cruz, Ocean Sci, Santa Cruz, CA 95064 USA; [Brander, Luke M.] Vrije Univ Amsterdam, Inst Environm Studies, Amsterdam, Netherlands; [Burke, Lauretta] World Resources Inst, Washington, DC 20006 USA; [Cinner, Josh E.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Edwards, Peter E. T.] NOAA, Coral Reef Conservat Program, Silver Spring, MD USA; [Gledhill, Dwight] NOAA, Ocean Acidificat Program, Silver Spring, MD USA; [Jiang, Li-Qing] Univ Maryland, Cooperat Inst Climate & Satellites, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; [van Hooidonk, Ruben J.] NOAA, Atlantic Oceanog & Meteorol Lab, Ocean Chem & Ecosyst Div, Miami, FL 33149 USA; [van Hooidonk, Ruben J.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Cooperat Inst Marine & Atmospher Studies, 4600 Rickenbacker Causeway, Miami, FL 33149 USA; [Teh, Louise] Univ British Columbia, Inst Oceans & Fisheries, Vancouver, BC, Canada; [Waldbusser, George G.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Ritter, Jessica] Natl Wildlife Fdn, Washington, DC USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Duke University; University of Miami; University of California System; University of California Davis; Nature Conservancy; University of California System; University of California Santa Cruz; Vrije Universiteit Amsterdam; James Cook University; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; University System of Maryland; University of Maryland College Park; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); University of Miami; University of British Columbia; Oregon State University	Pendleton, L (corresponding author), Univ Bretagne Occidentale, AMURE UMR6308, IUEM, Plouzane, France.	linwood.pendleton@duke.edu	Cooley, Sarah R/K-7373-2012; Cinner, Joshua e/E-8966-2011; Jiang, Li-Qing/G-5228-2014; Cinner, Joshua/AAA-6823-2021; Langdon, Chris/A-1543-2016; Beck, Michael W./AAB-2844-2019; BITOUN, RACHEL Elisabeth/AAC-9538-2021; van Hooidonk, Ruben J/F-7395-2010	Cooley, Sarah R/0000-0002-1034-0653; Cinner, Joshua e/0000-0003-2675-9317; Jiang, Li-Qing/0000-0003-3311-1658; Langdon, Chris/0000-0002-3043-3806; Beck, Michael W./0000-0002-5107-9973; BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; van Hooidonk, Ruben J/0000-0002-3804-1233; Brander, Luke/0000-0002-5862-4030; Ekstrom, Julia/0000-0003-1060-5276; Edwards, Peter E T/0000-0002-8628-4694; Waldbusser, George/0000-0002-8334-580X; Comte, Adrien/0000-0001-9895-0669	National Socio-Environmental Synthesis Center (SESYNC) - National Science Foundation [DBI-1052875]; Prince Albert II Foundation; "Laboratoire d'Excellence" LabexMER - French government under the program "Investissements 'Avenir" [ANR-10-LABX-19]; Region of Brittany; Direct For Biological Sciences [1639145] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1052875] Funding Source: National Science Foundation	National Socio-Environmental Synthesis Center (SESYNC) - National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Prince Albert II Foundation; "Laboratoire d'Excellence" LabexMER - French government under the program "Investissements 'Avenir"; Region of Brittany(Region Bretagne); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Socio-Environmental Synthesis Center (SESYNC) under funding received from the National Science Foundation DBI-1052875, a grant from the Prince Albert II Foundation, and research effort for LP and AC was supported by the "Laboratoire d'Excellence" LabexMER (ANR-10-LABX-19), co-funded by a grant from the French government under the program "Investissements 'Avenir" and the Region of Brittany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2016, SCIENCE, V352, P338, DOI 10.1126/science.aac7125; Albright R, 2016, NATURE, V531, P362, DOI 10.1038/nature17155; Albright R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056468; Albright R, 2010, P NATL ACAD SCI USA, V107, P20400, DOI 10.1073/pnas.1007273107; Allemand D, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P119, DOI 10.1007/978-94-007-0114-4_9; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Anthony KRN, 2015, GLOBAL CHANGE BIOL, V21, P48, DOI 10.1111/gcb.12700; Barnett J, 2010, GLOBAL ENVIRON CHANG, V20, P211, DOI 10.1016/j.gloenvcha.2009.11.004; Beck MW, 2014, COASTS RISK ASSESSME, V85; Brander LM, 2012, CLIM CHANG ECON, V3, DOI 10.1142/S2010007812500029; Breshears DD, 2011, AMBIO, V40, P256, DOI 10.1007/s13280-010-0106-4; Bryant D, 1998, NATL GEOGRAPHIC; Burke L., 2011, REEFS RISK REVISITED; Center for International Earth Science Information Network (CIESIN)/ Columbia University, 2013, LOW EL COAST ZON URB, P1; Chan NCS, 2013, GLOBAL CHANGE BIOL, V19, P282, DOI 10.1111/gcb.12011; Cinner JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074321; Cinner JE, 2016, REG ENVIRON CHANGE, V16, P1133, DOI 10.1007/s10113-015-0832-z; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Ekstrom JA, 2015, NAT CLIM CHANGE, V5, P207, DOI 10.1038/NCLIMATE2508; Evans L, 2011, LIMITS CLIMATE CHANG, P1, DOI [10.1371/journal.pone.0150575, DOI 10.1371/JOURNAL.PONE.0150575]; Fabricius KE, 2008, LIMNOL OCEANOGR, V53, P690, DOI 10.4319/lo.2008.53.2.0690; Fernando H., 2005, EOS T AM GEOPHYS UN, V86, P301, DOI [10.1029/2005EO330002, DOI 10.1029/2005EO330002]; Ferrario F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4794; Gattuso JP, 2015, SCIENCE, V349, DOI 10.1126/science.aac4722; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Hinkel J, 2011, GLOBAL ENVIRON CHANG, V21, P198, DOI 10.1016/j.gloenvcha.2010.08.002; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 2014, OCEAN 5 ASSESSMENT R; Howes EL, 2015, STUDIES, V2, P52, DOI [10.3389/fmars.2015.00036, DOI 10.3389/FMARS.2015.00036]; Hughes S, 2012, ENVIRON SCI POLICY, V23, P95, DOI 10.1016/j.envsci.2012.07.012; IPCC, 2013, CLIM CHANG 2013 PHYS, V33; Jiang LQ, 2015, GLOBAL BIOGEOCHEM CY, V29, P1656, DOI 10.1002/2015GB005198; Juwana I, 2012, SCI TOTAL ENVIRON, V438, P357, DOI 10.1016/j.scitotenv.2012.08.093; Kwiatkowski L, 2015, NAT CLIM CHANGE, V5, P777, DOI [10.1038/NCLIMATE2655, 10.1038/nclimate2655]; Lurig M, 2015, J SEA RES, V99, P26, DOI 10.1016/j.seares.2015.01.005; Maina J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023064; Manzello DP, 2014, GEOPHYS RES LETT, V41, P9001, DOI 10.1002/2014GL062501; Maynard J, 2015, NAT CLIM CHANGE, V5, P688, DOI 10.1038/nclimate2625; McClanahan TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042884; McClanahan TR, 2015, CLIMATIC CHANGE, V131, P607, DOI 10.1007/s10584-015-1399-x; McLeod E, 2012, COAST MANAGE, V40, P651, DOI 10.1080/08920753.2012.728123; Mongin M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10732; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Muehllehner N, 2016, GLOB BIOCH CYCLES; Newton J.A., 2015, GLOBAL OCEAN ACIDIFI; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Obura D, 2009, CORAL REEFS; Pendleton LH, 2016, MULTIPLE STRESSORS E, V3, P1, DOI [10.3389/fmars.2016.00036, DOI 10.3389/FMARS.2016.00036]; Pramova E, 2011, CLIM POLICY, P37; Rau GH, 2012, NAT CLIM CHANGE, V2, P720, DOI 10.1038/NCLIMATE1555; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; Sheppard C, 2005, ESTUAR COAST SHELF S, V64, P223, DOI 10.1016/j.ecss.2005.02.016; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Teh LSL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065397; Unsworth RKF, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024026; van Hooidonk R, 2014, GLOBAL CHANGE BIOL, V20, P103, DOI 10.1111/gcb.12394; Venn AA, 2013, P NATL ACAD SCI USA, V110, P1634, DOI 10.1073/pnas.1216153110; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wolff NH, 2015, GLOBAL CHANGE BIOL, V21, P3982, DOI 10.1111/gcb.13015; Yang Y., 2015, EARTH SYST SCI DATA, V8, P889, DOI [10.5194/essdd-8-889-2015, DOI 10.5194/ESSDD-8-889-2015]; Yeakel KL, 2015, P NATL ACAD SCI USA, V112, P14512, DOI 10.1073/pnas.1507021112	63	45	45	5	169	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0164699	10.1371/journal.pone.0164699	http://dx.doi.org/10.1371/journal.pone.0164699			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828972	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000387724300020
J	Germeraad, EA; Hogerwerf, L; Faye-Joof, T; Goossens, B; van der Hoek, W; Jeng, M; Lamin, M; Manneh, IL; Nwakanma, D; Roest, HIJ; Secka, A; Stegeman, A; Wegmuller, R; van der Sande, MAB; Secka, O				Germeraad, Eveline A.; Hogerwerf, Lenny; Faye-Joof, Tisbeh; Goossens, Bart; van der Hoek, Wim; Jeng, Momodou; Lamin, Modou; Manneh, Ismaila L.; Nwakanma, Davis; Roest, Hendrik I. J.; Secka, Arss; Stegeman, Arjan; Wegmuller, Rita; van der Sande, Marianne A. B.; Secka, Ousman			Low Seroprevalence of Brucellosis in Humans and Small Ruminants in the Gambia	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; FEBRILE ILLNESS; EPIDEMIOLOGY; DIAGNOSIS	Background Brucellosis is a worldwide zoonosis with significant impact on rural livelihoods and a potentially underestimated contributor to febrile illnesses. The aim of this study was to estimate the seroprevalence of brucellosis in humans and small ruminants in The Gambia. Methods The study was carried out in rural and urban areas. In 12 rural villages in Kiang West district, sera were collected from humans (n = 599) and small ruminants (n = 623) from the same compounds. From lactating small ruminants, milk samples and vaginal swabs were obtained. At the urban study sites, sera were collected from small ruminants (n = 500) from slaughterhouses and livestock markets. Information on possible risk factors for seropositivity was collected through questionnaires. Sera were screened for antibodies against Brucella spp. with the Rose Bengal Test, ELISA and Micro Agglutination Test (human sera only). PCR was performed on 10 percent of the milk samples and vaginal swabs from small ruminants. Results One human and 14 sheep sera were positive by the Rose Bengal Test. The rest were negative in all serological tests used. The PCR results were all negative. Conclusions The results suggest that brucellosis is currently not a generalized problem in humans or small ruminants in The Gambia.	[Germeraad, Eveline A.; Hogerwerf, Lenny; van der Hoek, Wim; van der Sande, Marianne A. B.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [Faye-Joof, Tisbeh; Manneh, Ismaila L.] Med Res Council Unit Gambia, Dept Vaccinol, Banjul, Fajara, Gambia; [Goossens, Bart] Kombo Vet Serv, Bakau, Gambia; [Jeng, Momodou; Secka, Arss] Int Trypanotolerance Ctr, Banjul, Gambia; [Lamin, Modou; Nwakanma, Davis; Secka, Ousman] MRC Unit, Dept Dis Control & Eliminat, Banjul, Fajara, Gambia; [Roest, Hendrik I. J.] Cent Vet Inst, Dept Bacteriol & Epidemiol, Lelystad, Netherlands; [Stegeman, Arjan] Univ Utrecht, Dept Farm Anim Hlth, Utrecht, Netherlands; [Wegmuller, Rita] MRC, Int Nutr Grp, MRC Unit Gambia, Keneba, Gambia; [van der Sande, Marianne A. B.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Wageningen University & Research; Utrecht University; University of London; London School of Hygiene & Tropical Medicine; Utrecht University; Utrecht University Medical Center	Hogerwerf, L (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands.	lenny.hogerwerf@rivm.nl		Jeng, Momodou/0000-0001-7869-6229; Hogerwerf, Lenny/0000-0001-6329-7831; Nwakanma, Davis/0000-0002-6706-6069; van der Sande, Marianne AB/0000-0002-4778-6739; Germeraad, Evelien/0000-0001-9146-5580	Ministry of Health, Welfare and Sports, the Netherlands; Ministry of Economic Affairs, the Netherlands [W0T-01-002-006.01]	Ministry of Health, Welfare and Sports, the Netherlands; Ministry of Economic Affairs, the Netherlands(Ministry of Economic Affairs, Netherlands)	This work was supported by Ministry of Health, Welfare and Sports, the Netherlands and by the Ministry of Economic Affairs, the Netherlands (www.government.nl/ministries) via the project 'Brucellosis', grant number W0T-01-002-006.01. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan KJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003899; [Anonymous], 2014, R LANG ENV STAT COMP; Banfi G., 2002, USE ANTICOAGULANTS D; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; Crump JA, 2012, CLIN INFECT DIS, V54, P1107, DOI 10.1093/cid/cis024; De Blas I, 2006, WORKING EPIDEMIOLOGY; Dean AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071501; Ducrotoy MJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003008; Fosgate GT, 2002, EMERG INFECT DIS, V8, P672, DOI 10.3201/eid0807.010351; Gething PW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000301; Godfroid J, 2010, CROAT MED J, V51, P296, DOI 10.3325/cmj.2010.51.296; Goossens B, 1998, VET REC, V142, P277, DOI 10.1136/vr.142.11.277; Klaasen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085424; Maio E, 2014, VET MICROBIOL, V173, P118, DOI 10.1016/j.vetmic.2014.07.010; McDermott JJ, 2002, VET MICROBIOL, V90, P111, DOI 10.1016/S0378-1135(02)00249-3; Medical Research Council D International Nutrition Group, KIANG W DEM SURV SYS; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; Regional Project on Sustainable Management of Endemic Ruminant Livestock in West Africa (PROGEBE), 2013, ANN REPORT; Sanogo M, 2013, VET J, V195, P114, DOI 10.1016/j.tvjl.2012.06.007; Seleem MN, 2010, VET MICROBIOL, V140, P392, DOI 10.1016/j.vetmic.2009.06.021; Unger F., 2003, RISK ASS BOVINE BRUC; Vanderburg S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002787; Vialle-Valentin Catherine E, 2015, J Pharm Policy Pract, V8, P1, DOI 10.1186/s40545-014-0024-0; World Health Organization, 2007, ASS TB PREV POP BAS; World Organisation for Animal Health (OIE), 2012, MANUAL DIAGNOSTIC TE, P616	28	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166035	10.1371/journal.pone.0166035	http://dx.doi.org/10.1371/journal.pone.0166035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824952	Green Published, Green Submitted, gold			2022-12-26	WOS:000387615200055
J	Manousek, J; Stejskal, V; Kubena, P; Jarkovsky, J; Nemec, P; Lokaj, P; Dostalova, L; Zadakova, A; Pavlusova, M; Benesova, K; Kala, P; Miklik, R; Spinar, J; Parenica, J				Manousek, Jan; Stejskal, Vera; Kubena, Petr; Jarkovsky, Jiri; Nemec, Petr; Lokaj, Petr; Dostalova, Ludmila; Zadakova, Andrea; Pavlusova, Marie; Benesova, Klara; Kala, Petr; Miklik, Roman; Spinar, Jindrich; Parenica, Jiri			Delayed-Type Hypersensitivity to Metals of Environmental Burden in Patients with Takotsubo Syndrome - Is There a Clinical Relevance?	PLOS ONE			English	Article							CARDIOMYOPATHY; ALLERGY; PROGESTERONE; ASSOCIATION; SENSITIVITY; PREGNANCY; MERCURY; STRESS	Objective Takotsubo syndrome (TS) is a heart condition characterised by a sudden transient left ventricular dysfunction; its pathophysiology is probably associated with elevated levels of catecholamines but the exact mechanism is not known as yet. Literature and clinical experience suggest that TS affects persons with various comorbidities. This pilot work aims to evaluate the frequency of comorbidities with potential pathological immune reactivity, and to evaluate the potential association between TS and hypersensitivity to metals assessed by LTT-MELISA (R). Methodology, Results A total of 24 patients (23 women, 1 man) with a history of TS attack and 27 healthy controls were evaluated. Hypersensitivity was evaluated by a lymphocyte transformation test (LTT-MELISA (R)); a questionnaire of environmental burden was used to select evaluated metals. A total of 19 patients (79%) had at least one condition that might potentially be associated with pathological immune reactivity (autoimmune thyroid disease, drug allergy, bronchial asthma, cancer, contact dermatitis, rheumatoid arthritis). Hypersensitivity to metals was identified significantly more frequently in TS patients than in healthy controls (positive reaction to at least one metal was identified in 95.8% of TS patients and in 59.3% of controls; p = 0.003); the difference was statistically significant for mercury (45.8% and 14.8%, respectively; p = 0.029). Conclusion Our work shows that conditions with pathological immune reactivity occur frequently in TS patients, and our data suggest a possible association between TS and hypersensitivity tometals (mercury in particular) evaluated by LTT-MELISA (R). We also suggest that apart from the triggering stress factor, potential existence of other serious conditions should be considered when taking medical history of TS patients.	[Manousek, Jan; Kubena, Petr; Lokaj, Petr; Dostalova, Ludmila; Zadakova, Andrea; Pavlusova, Marie; Kala, Petr; Miklik, Roman; Spinar, Jindrich; Parenica, Jiri] Univ Hosp Brno, Dept Internal Med & Cardiol, Brno, Czech Republic; [Stejskal, Vera] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden; [Stejskal, Vera] Masaryk Univ, Fac Sci, Res Ctr Tox Cpds Environm RECETOX, Brno, Czech Republic; [Jarkovsky, Jiri; Benesova, Klara] Masaryk Univ, Fac Med, Inst Biostat & Anal, Brno, Czech Republic; [Nemec, Petr] Ctr Cardiovasc Surg & Transplantat, Brno, Czech Republic; [Nemec, Petr; Lokaj, Petr; Pavlusova, Marie; Kala, Petr; Spinar, Jindrich; Parenica, Jiri] Masaryk Univ, Fac Med, Brno, Czech Republic	University Hospital Brno; Stockholm University; Masaryk University Brno; Institute of Biostatistics & Analyses; Masaryk University Brno; Masaryk University Brno	Parenica, J (corresponding author), Univ Hosp Brno, Dept Internal Med & Cardiol, Brno, Czech Republic.; Parenica, J (corresponding author), Masaryk Univ, Fac Med, Brno, Czech Republic.	jiri.parenica@atlas.cz	Lokaj, Petr/AAG-4405-2020; Jarkovsky, Jiri/G-5494-2017		Ministry of Health of the Czech Republic-conceptual development of research organisation (FNBr) [65269705]; Masaryk University (Brno, CzechRepublic) [MUNI/A/1362/2015]; Czech Society of Cardiology	Ministry of Health of the Czech Republic-conceptual development of research organisation (FNBr); Masaryk University (Brno, CzechRepublic)(Czech Republic Government); Czech Society of Cardiology	This work was supported by Ministry of Health of the Czech Republic-conceptual development of research organisation (FNBr, 65269705), project MUNI/A/1362/2015 of the Masaryk University (Brno, Czech Republic) and by a grant of the Czech Society of Cardiology.	Akashi YJ, 2015, NAT REV CARDIOL, V12, P387, DOI 10.1038/nrcardio.2015.39; Akashi YJ, 2008, CIRCULATION, V118, P2754, DOI 10.1161/CIRCULATIONAHA.108.767012; Amariles P, 2011, CURR CLIN PHARMACOL, V6, P1, DOI 10.2174/157488411794941340; Ando Giuseppe, 2010, Acute Card Care, V12, P70, DOI 10.3109/17482941003732758; Basselin C, 2011, PHARMACOTHERAPY, V31, P226, DOI 10.1592/phco.31.2.226; Bernards J, 2014, INT J CARDIOL, V177, pE53, DOI 10.1016/j.ijcard.2014.09.130; Bernhard D, 2005, IUBMB LIFE, V57, P805, DOI 10.1080/15216540500459667; Bybee KA, 2004, ANN INTERN MED, V141, P858, DOI 10.7326/0003-4819-141-11-200412070-00010; Caforio ALP, 2009, EUR J HEART FAIL, V11, P428, DOI 10.1093/eurjhf/hfp008; Coli S, 2015, J CARDIOVASC MED, V16, P646, DOI 10.2459/JCM.0000000000000204; Eitel I, 2010, EUR RADIOL, V20, P422, DOI 10.1007/s00330-009-1549-5; Han LJ, 2014, INT J CARDIOL, V177, pE145, DOI 10.1016/j.ijcard.2014.09.049; Hwang S. A, 2001, HYPERSENSITIVITY T L; Hybenova M, 2010, NEUROENDOCRINOL LETT, V31, P283; James SJ, 2004, AM J CLIN NUTR, V80, P1611, DOI 10.1093/ajcn/80.6.1611; Kamada T, 2015, INTERNAL MED, V54, P31, DOI 10.2169/internalmedicine.54.3239; Kneale BJ, 2000, J AM COLL CARDIOL, V36, P1233, DOI 10.1016/S0735-1097(00)00849-4; Knott K, 2014, INT J CARDIOL, V177, pE65, DOI 10.1016/j.ijcard.2014.09.154; Koci F, 2014, TEX HEART I J, V41, P638, DOI 10.14503/THIJ-13-3500; Krejci J, 2016, HEART VESSELS, V31, P416, DOI 10.1007/s00380-014-0618-0; Lushchak Volodymyr I, 2012, J Amino Acids, V2012, P736837, DOI 10.1155/2012/736837; Lyon AR, 2016, EUR J HEART FAIL, V18, P8, DOI 10.1002/ejhf.424; Mutter J, 2011, J OCCUP MED TOXICOL, V6, DOI 10.1186/1745-6673-6-2; Pelliccia F, 2015, AM J MED, V128, DOI 10.1016/j.amjmed.2015.01.016; Postema PG, 2014, NETH HEART J, V22, P456, DOI 10.1007/s12471-012-0320-8; Prochazkova J, 2004, NEUROENDOCRINOL LETT, V25, P211; Prochazkova J, 2000, DIS MARKERS, V16, P135, DOI 10.1155/2000/205757; Saint-Mezard P, 2004, EUR J DERMATOL, V14, P131; Sato H, CLIN ASPECT MYOCARDI, P56; SIITERI PK, 1977, ANN NY ACAD SCI, V286, P384, DOI 10.1111/j.1749-6632.1977.tb29431.x; Smith-Sivertsen T, 1999, J AM ACAD DERMATOL, V40, P726, DOI 10.1016/S0190-9622(99)70154-4; Stejskal Jenny, 1999, Neuro Endocrinol Lett, V20, P351; STEJSKAL VDM, 1994, TOXICOL IN VITRO, V8, P991, DOI 10.1016/0887-2333(94)90233-X; Stejskal VDM, 1996, J CLIN IMMUNOL, V16, P31, DOI 10.1007/BF01540970; Stejskal V, 2015, J TRACE ELEM MED BIO, V31, P230, DOI 10.1016/j.jtemb.2015.01.001; SZEKERESBARTHO J, 1985, J REPROD IMMUNOL, V7, P121, DOI 10.1016/0165-0378(85)90066-X; Templin C, 2015, NEW ENGL J MED, V373, P929, DOI 10.1056/NEJMoa1406761; Thyssen JP, 2010, CHEM RES TOXICOL, V23, P309, DOI 10.1021/tx9002726; Trio O, 2015, VNITRNI LEKARSTVI, V61, P619; Trio Olimpia, 2010, Ther Adv Cardiovasc Dis, V4, P105, DOI 10.1177/1753944709356013; Yaqob A, 2006, NEUROENDOCRINOL LETT, V27, P189	41	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0164786	10.1371/journal.pone.0164786	http://dx.doi.org/10.1371/journal.pone.0164786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824862	gold, Green Published, Green Submitted			2022-12-26	WOS:000387615200008
J	Huang, YH; Wu, Y				Huang, Yunhui; Wu, Yin			Ownership Effect Can Be a Result of Other-Derogation: Evidence from Behavioral and Electrophysiological Studies	PLOS ONE			English	Article							IMPLICIT ASSOCIATION TEST; PANCULTURAL SELF-ENHANCEMENT; MERE OWNERSHIP; SOCIAL COGNITION; ENDOWMENT; OBJECTS; PERCEPTION; ATTITUDES; RESPONSES; IMAGERY	Growing evidence suggests that people overvalue their own objects compared to those owned by others, even when the two objects are virtually identical (i.e., ownership effect). Most researchers seem to consider self-enhancement as the underlying mechanism while neglecting the possible process of other-derogation. Here, we attempted to compare these two perspectives, adopting both implicit and neurocognitive methodologies to overcome social desirability confounds. In Study 1, we found that the ownership effect (measured by Implicit Association Test), was correlated with other-derogation but not with self-enhancement (both measured by the Go/No-Go Association Task). In Study 2, by using the eventrelated potentials (ERPs) technique, we showed that positive-framed other-owned objects elicited significant evaluative incongruity (i.e. indexed by late positive potentials) compared to negative-framed other-owned objects. In contrast, negative-framed self-owned objects did not evoke significant evaluative incongruity relative to positive-framed self-owned objects. Our research suggests that, in addition to the self-enhancement that has been widely demonstrated, it is also important to keep other-derogation in mind when examining the ownership effect.	[Huang, Yunhui] Nanjing Univ, Dept Mkt & Elect Business, Nanjing, Jiangsu, Peoples R China; [Wu, Yin] Shenzhen Univ, Res Ctr Brain Funct & Psychol Sci, Shenzhen 518060, Peoples R China; [Wu, Yin] Peking Univ, Ctr Brain & Cognit Sci, Beijing 100871, Peoples R China; [Wu, Yin] Peking Univ, Sch Psychol & Cognit Sci, Beijing 100871, Peoples R China	Nanjing University; Shenzhen University; Peking University; Peking University	Wu, Y (corresponding author), Shenzhen Univ, Res Ctr Brain Funct & Psychol Sci, Shenzhen 518060, Peoples R China.; Wu, Y (corresponding author), Peking Univ, Ctr Brain & Cognit Sci, Beijing 100871, Peoples R China.; Wu, Y (corresponding author), Peking Univ, Sch Psychol & Cognit Sci, Beijing 100871, Peoples R China.	yinwu0407@gmail.com		Wu, Yin/0000-0002-6364-4597	National Natural Science Foundation of China [71102037, 71472084, 31600923]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from National Natural Science Foundation of China (71102037 and 71472084 to YH and 31600923 to YW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartholow BD, 2003, J PERS SOC PSYCHOL, V85, P627, DOI 10.1037/0022-3514.85.4.627; Bartholow BD, 2001, PSYCHOL SCI, V12, P197, DOI 10.1111/1467-9280.00336; Baumeister R. F., 1998, THE SELF; BEGGAN JK, 1992, J PERS SOC PSYCHOL, V62, P229, DOI 10.1037/0022-3514.62.2.229; BELK RW, 1988, J CONSUM RES, V15, P139, DOI 10.1086/209154; Brunel FF, 2004, J CONSUM PSYCHOL, V14, P385, DOI 10.1207/s15327663jcp1404_8; CACIOPPO JT, 1994, J PERS SOC PSYCHOL, V67, P115, DOI 10.1037/0022-3514.67.1.115; Dai XC, 2013, J MARKETING RES, V50, P207, DOI 10.1509/jmr.11.0189; De Dreu CKW, 2005, J PERS SOC PSYCHOL, V89, P345, DOI 10.1037/0022-3514.89.3.345; De Houwer J, 2007, J EXP SOC PSYCHOL, V43, P972, DOI 10.1016/j.jesp.2006.10.007; Dieguez S, 2009, CURR BIOL, V19, pR1108, DOI 10.1016/j.cub.2009.10.055; Dommer SL, 2013, J CONSUM RES, V39, P1034, DOI 10.1086/666737; Evans N, 2013, NEUROIMAGE, V64, P216, DOI 10.1016/j.neuroimage.2012.09.027; Fazio RH, 1986, J PERS SOC PSYCHOL, V50, P1062; Fein S, 1997, J PERS SOC PSYCHOL, V73, P31, DOI 10.1037/0022-3514.73.1.31; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Gregg AP, 2006, J PERS SOC PSYCHOL, V90, P1, DOI 10.1037/0022-3514.90.1.1; Herring DR, 2011, EMOTION, V11, P794, DOI 10.1037/a0022804; Hoorens V, 1999, J ECON PSYCHOL, V20, P383, DOI 10.1016/S0167-4870(99)00014-8; Huang YH, 2009, PERS SOC PSYCHOL B, V35, P713, DOI 10.1177/0146167209333046; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Kitayama S, 1997, J PERS SOC PSYCHOL, V72, P1245, DOI 10.1037/0022-3514.72.6.1245; Morewedge CK, 2015, TRENDS COGN SCI, V19, P339, DOI 10.1016/j.tics.2015.04.004; Morewedge CK, 2009, J EXP SOC PSYCHOL, V45, P947, DOI 10.1016/j.jesp.2009.05.014; Nesselroade KP, 1999, PSYCHOL MARKET, V16, P21; Nosek B.A., 2007, AUTOMATIC PROCESSES, P265, DOI DOI 10.1037/0022-3514.89.3.277; Nosek BA, 2001, SOC COGNITION, V19, P625, DOI 10.1521/soco.19.6.625.20886; Peck J, 2013, J CONSUM PSYCHOL, V23, P189, DOI 10.1016/j.jcps.2012.09.001; Press C, 2008, J COGNITIVE NEUROSCI, V20, P312, DOI 10.1162/jocn.2008.20022; Rothermund K, 2004, J EXP PSYCHOL GEN, V133, P139, DOI 10.1037/0096-3445.133.2.139; Sedikides C, 2005, J PERS SOC PSYCHOL, V89, P539, DOI 10.1037/0022-3514.89.4.539; Sedikides C, 2003, J PERS SOC PSYCHOL, V84, P60, DOI 10.1037/0022-3514.84.1.60; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Van Duynslaeger M, 2007, SOC COGN AFFECT NEUR, V2, P174, DOI 10.1093/scan/nsm016; Vignemont FD, 2011, CONSCIOUS COGN, V20, P82; WILLS TA, 1981, PSYCHOL BULL, V90, P245, DOI 10.1037/0033-2909.90.2.245; Wu Y, 2013, BIOL PSYCHOL, V92, P179, DOI 10.1016/j.biopsycho.2012.11.011; Wyer RS, 2010, CHINESE CONSUMER BEH	42	0	1	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166054	10.1371/journal.pone.0166054	http://dx.doi.org/10.1371/journal.pone.0166054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8TH	27814395	Green Submitted, gold, Green Published			2022-12-26	WOS:000386911100027
J	Kremer, IEH; Evers, SMAA; Jongen, PJ; van der Weijden, T; van de Kolk, I; Hiligsmann, M				Kremer, Ingrid E. H.; Evers, Silvia M. A. A.; Jongen, Peter J.; van der Weijden, Trudy; van de Kolk, Ilona; Hiligsmann, Mickael			Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling	PLOS ONE			English	Article							CHOICE EXPERIMENTS; CONJOINT-ANALYSIS; PREGNANCY; PREFERENCES; MANAGEMENT; THERAPIES; CHECKLIST; ADHERENCE; WOMEN; MODEL	Objectives Understanding the preferences of patients with multiple sclerosis (MS) for disease-modifying drugs and involving these patients in clinical decision making can improve the concordance between medical decisions and patient values and may, subsequently, improve adherence to disease-modifying drugs. This study aims first to identify which characteristics-or attributes-of disease-modifying drugs influence patients A decisions about these treatments and second to quantify the attributes' relative importance among patients. Methods First, three focus groups of relapsing-remitting MS patients were formed to compile a preliminary list of attributes using a nominal group technique. Based on this qualitative research, a survey with several choice tasks (best-worst scaling) was developed to prioritize attributes, asking a larger patient group to choose the most and least important attributes. The attributes' mean relative importance scores (RIS) were calculated. Results Nineteen patients reported 34 attributes during the focus groups and 185 patients evaluated the importance of the attributes in the survey. The effect on disease progression received the highest RIS (RIS = 9.64, 95% confidence interval: [9.48-9.81]), followed by quality of life (RIS = 9.21 [9.00-9.42]), relapse rate (RIS = 7.76 [7.39-8.13]), severity of side effects (RIS = 7.63 [7.33-7.94]) and relapse severity (RIS = 7.39 [7.06-7.73]). Subgroup analyses showed heterogeneity in preference of patients. For example, side effectrelated attributes were statistically more important for patients who had no experience in using disease-modifying drugs compared to experienced patients (p<.001). Conclusions This study shows that, on average, patients valued effectiveness and unwanted effects as most important. Clinicians should be aware of the average preferences but also that attributes of disease-modifying drugs are valued differently by different patients. Person-centred clinical decision making would be needed and requires eliciting individual preferences.	[Kremer, Ingrid E. H.; Evers, Silvia M. A. A.; Hiligsmann, Mickael] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Hlth Serv Res, Maastricht, Netherlands; [Evers, Silvia M. A. A.] Netherlands Inst Mental Hlth & Addict, Trimbos Inst, Publ Mental Hlth, Utrecht, Netherlands; [Jongen, Peter J.] MS4 Res Inst, Nijmegen, Netherlands; [Jongen, Peter J.] Univ Groningen, Univ Med Ctr Groningen, Dept Community & Occupat Med, Groningen, Netherlands; [van der Weijden, Trudy] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Family Med, Maastricht, Netherlands; [van de Kolk, Ilona] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Dept Hlth Promot, Maastricht, Netherlands	Maastricht University; Trimbos Institute; University of Groningen; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Kremer, IEH (corresponding author), Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Hlth Serv Res, Maastricht, Netherlands.	i.kremer@maastrichtuniversity.nl	Evers, Silvia MAA/K-9720-2015; Evers, Silvia/ABG-2128-2020; van de Kolk, Ilona/L-7707-2019	Evers, Silvia MAA/0000-0003-1026-570X; Evers, Silvia/0000-0003-1026-570X; van de Kolk, Ilona/0000-0003-1565-5707; van der weijden, trudy/0000-0002-7469-3781	Maastricht University in the Netherlands	Maastricht University in the Netherlands	We thank the neurologists and nurses for providing their opinions during the exploratory phase of the study. We thank the patients with MS for participating in our study and the National MS Foundation The Netherlands, MS Vereniging Nederland and MS-Anders for their cooperation in informing patients about the study. The Master's thesis based on this study has been awarded the Catharina Pijls Encouragement Award 2015 for an excellent Master's thesis in the health sciences, an initiative of Maastricht University in the Netherlands.	[Anonymous], 2000, SAWTOOTH SOFTWARE RE; Bove R, 2014, OBSTET GYNECOL, V124, P1157, DOI 10.1097/AOG.0000000000000541; Bridges JFP, 2011, VALUE HEALTH, V14, P403, DOI 10.1016/j.jval.2010.11.013; Centraal Bureau voor de Statistiek, 2013, BER BEH OND NAAR PER; Clark JP, 2003, PEER REV HLTH SCI, P219; Coyle PK, 2016, THER ADV NEUROL DISO, V9, P198, DOI 10.1177/1756285616631897; DELBECQ AL, 1971, J APPL BEHAV SCI, V7, P466, DOI 10.1177/002188637100700404; Delbecq AL, 1975, J HUMAN SCI; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Elwyn G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5146; English C, 2015, CLIN THER, V37, P691, DOI 10.1016/j.clinthera.2015.03.001; European Medicines Agency, EUR PUBL ASS REP NAT; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Flynn TN, 2007, J HEALTH ECON, V26, P171, DOI 10.1016/j.jhealeco.2006.04.002; Gommer AM, 2010, ACHTERGRONDCIJFERS B; Hanson KA, 2013, PATIENT PREFER ADHER, V7, DOI 10.2147/PPA.S41992; Heesen C, 2004, MULT SCLER J, V10, P643, DOI 10.1191/1352458504ms1112oa; Herbstritt S, 2016, MULT SCLER J, V22, P810, DOI 10.1177/1352458515623366; Hiligsmann M, 2013, PATIENT PREFER ADHER, V7, P133, DOI 10.2147/PPA.S38408; Johnson FR, 2009, J NEUROL, V256, P554, DOI 10.1007/s00415-009-0084-2; Joosten EAG, 2008, PSYCHOTHER PSYCHOSOM, V77, P219, DOI 10.1159/000126073; Lu E, 2013, EXPERT REV NEUROTHER, V13, P251, DOI [10.1586/ERN.13.12, 10.1586/ern.13.12]; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Menzin J, 2013, J MANAGE CARE PHARM, V19, pS24, DOI 10.18553/jmcp.2013.19.s1.S24; Michel Laure, 2015, Presse Med, V44, pe137, DOI 10.1016/j.lpm.2015.02.008; O'Connor Annette M, 2004, Health Aff (Millwood), VSuppl Variation, pVAR63; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Poulos C, 2016, THER ADV NEUROL DISO, V9, P95, DOI 10.1177/1756285615622736; Poulos C, 2016, PATIENT, V9, P171, DOI 10.1007/s40271-015-0136-x; Sawtooth Software Inc, 2014, SSI WEB V8 3 SOFTW W; Tan H, 2011, ADV THER, V28, P51, DOI 10.1007/s12325-010-0093-7; Thiel S, 2016, MULT SCLER J, V22, P801, DOI 10.1177/1352458516634872; Utz KS, 2014, THER ADV NEUROL DISO, V7, P263, DOI 10.1177/1756285614555335; Visser LH, 2011, EUR J NEUROL, V18, P1343, DOI 10.1111/j.1468-1331.2011.03411.x; Wicks P, 2015, INTERACT J MED RES, V4, P3, DOI 10.2196/ijmr.3776; Wilson L, 2014, J NEUROL SCI, V344, P80, DOI 10.1016/j.jns.2014.06.030; Wilson Leslie S, 2015, Int J MS Care, V17, P74, DOI 10.7224/1537-2073.2013-053	37	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164862	10.1371/journal.pone.0164862	http://dx.doi.org/10.1371/journal.pone.0164862			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812117	Green Published, gold, Green Submitted			2022-12-26	WOS:000386910000014
J	Panwar, B; Judd, SE; Howard, VJ; Jenny, NS; Wadley, VG; Gutierrez, OM				Panwar, Bhupesh; Judd, Suzanne E.; Howard, Virginia J.; Jenny, Nancy S.; Wadley, Virginia G.; Gutierrez, Orlando M.			Vitamin D, Fibroblast Growth Factor 23 and Incident Cognitive Impairment: Findings from the REGARDS Study	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; SERUM 25-HYDROXYVITAMIN D; RACIAL-DIFFERENCES; PARATHYROID-HORMONE; D SUPPLEMENTATION; NATIONAL-HEALTH; DECLINE; RISK; WOMEN; RATS	Vitamin D protects against cognitive decline in animals but evidence in humans has been inconsistent. Fibroblast growth factor 23 (FGF23) is a hormone that inhibits vitamin D activation yet few studies examined whether FGF23 is associated with cognitive impairment. The objective of this study was to examine associations of 25(OH) D and FGF23 with incident cognitive impairment in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, a cohort of black and white adults >= 45 years old. FGF23 and 25(OH) D were measured in 474 incident impairment cases and 561 controls. In multivariable-adjusted models, there were no significant associations of FGF23 with incident cognitive impairment. In analyses using clinically-relevant categories of 25(OH) D (<20 ng/ml, 20-29.9 ng/ml, >= 30 ng/ml), there was no statistically significant association of lower 25(OH) D concentrations with odds of incident cognitive impairment in models adjusted for demographic, clinical, and laboratory variables and season of blood draw (tertile 1 [>= 30 ng/ml] reference; tertile 2 [20-29.9 ng/ml], odds ratio [OR] 0.96, 95% CI 0.67, 1.38; tertile 3 [<20 ng/ml] OR 1.26, 95% CI 0.83, 1.91). When 25(OH) D was modeled as race-specific tertiles, there were no significant associations of 25(OH) D with incident cognitive impairment in whites, whereas lower 25(OH) D was associated with higher odds in blacks (tertile 1 [>23 ng/ml] reference; tertile 2 [15-23 ng/ml], OR 2.96, 95% CI 1.48,5.94; tertile 3 [<15 ng/ml] OR 2.40, 95% CI 1.07,5.40) in the fully adjusted model. In this cohort of older adults, lower race-specific tertiles of 25(OH) D were associated with higher incidence of cognitive impairment in black individuals but not white individuals. These data suggest that treating low 25(OH) D may be a novel strategy for addressing racial disparities in neurocognitive outcomes.	[Panwar, Bhupesh; Wadley, Virginia G.; Gutierrez, Orlando M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Judd, Suzanne E.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Howard, Virginia J.; Gutierrez, Orlando M.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35233 USA; [Jenny, Nancy S.] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Vermont	Gutierrez, OM (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.; Gutierrez, OM (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35233 USA.	ogutierrez@uabmc.edu		Gutierrez, Orlando/0000-0001-6593-3571	National Institute of Neurological Disorders and Stroke, National Institutes of Health, USA [R01NS080850];  [U01 NS041588]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by a cooperative agreement U01 NS041588 and by R01NS080850 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, USA. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health or the American Heart Association. Representatives of the funding agency have been involved in the review of the manuscript but not directly involved in the collection, management, analysis or interpretation of the data.	Alrefaie Z, 2015, BEHAV BRAIN RES, V287, P156, DOI 10.1016/j.bbr.2015.03.050; Annweiler C, 2012, J AM GERIATR SOC, V60, P793, DOI 10.1111/j.1532-5415.2011.03877.x; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Brewer LD, 2006, CELL CALCIUM, V40, P277, DOI 10.1016/j.ceca.2006.04.001; Callahan CM, 2002, MED CARE, V40, P771, DOI 10.1097/00005650-200209000-00007; Cluse ZN, 2012, ANN CLIN BIOCHEM, V49, P159, DOI 10.1258/acb.2011.011018; Cushman M, 2014, STROKE, V45, P1646, DOI 10.1161/STROKEAHA.114.004712; Dubal DB, 2014, CELL REP, V7, P1065, DOI 10.1016/j.celrep.2014.03.076; Erbas O, 2014, LIFE SCI, V103, P68, DOI 10.1016/j.lfs.2014.03.035; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Gezen-Ak D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017553; Gillett SR, 2015, CLIN NEUROPSYCHOL, V29, P466, DOI 10.1080/13854046.2015.1042524; Granic A, 2015, EUR J NEUROL, V22, P106, DOI 10.1111/ene.12539; Gutierrez OM, 2011, OSTEOPOROSIS INT, V22, P1745, DOI 10.1007/s00198-010-1383-2; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Jovanovich AJ, 2014, CLIN NEPHROL, V82, pS1, DOI 10.5414/CN108365; Kim Joong-Seok, 2006, J Clin Neurol, V2, P252, DOI 10.3988/jcn.2006.2.4.252; Landfield PW, 1998, NEUROBIOL AGING, V19, P469, DOI 10.1016/S0197-4580(98)00079-7; Langub MC, 2001, NEUROSCIENCE, V104, P49, DOI 10.1016/S0306-4522(01)00049-5; Latimer CS, 2014, P NATL ACAD SCI USA, V111, pE4359, DOI 10.1073/pnas.1404477111; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Littlejohns TJ, 2014, NEUROLOGY, V83, P920, DOI 10.1212/WNL.0000000000000755; Llewellyn DJ, 2010, ARCH INTERN MED, V170, P1135, DOI 10.1001/archinternmed.2010.173; McCann JC, 2008, FASEB J, V22, P982, DOI 10.1096/fj.07-9326rev; MELCHIOR LA, 1993, EDUC PSYCHOL MEAS, V53, P1117, DOI 10.1177/0013164493053004024; Miller JW, 2015, JAMA NEUROL, V72, P1295, DOI 10.1001/jamaneurol.2015.2115; Moon JH, 2015, CLIN ENDOCRINOL, V83, P36, DOI 10.1111/cen.12733; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Nesby-O'Dell S, 2002, AM J CLIN NUTR, V76, P187, DOI 10.1093/ajcn/76.1.187; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Rossom RC, 2012, J AM GERIATR SOC, V60, P2197, DOI 10.1111/jgs.12032; Slinin Y, 2010, NEUROLOGY, V74, P33, DOI 10.1212/WNL.0b013e3181c7197b; Slinin Y, 2012, J GERONTOL A-BIOL, V67, P1092, DOI 10.1093/gerona/gls075; Smith MP, 2006, NEUROCHEM RES, V31, P533, DOI 10.1007/s11064-006-9048-4; Strauss E, 2006, COMPENDIUM NEUROPSYC; Wilson VK, 2014, J AM GERIATR SOC, V62, P636, DOI 10.1111/jgs.12765; Zadshir Ashraf, 2005, Ethn Dis, V15, pS5; Zhu CW, 2013, J AM GERIATR SOC, V61, P396, DOI 10.1111/jgs.12132	38	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165671	10.1371/journal.pone.0165671	http://dx.doi.org/10.1371/journal.pone.0165671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812184	Green Published, Green Submitted, gold			2022-12-26	WOS:000386910000045
J	Yu, XQ; Wang, YH; Lin, J; Hu, Y; Kawai, T; Taubman, MA; Han, XZ				Yu, Xiaoqian; Wang, Yuhua; Lin, Jiang; Hu, Yang; Kawai, Toshihisa; Taubman, Martin A.; Han, Xiaozhe			Lipopolysaccharides-Induced Suppression of Innate-Like B Cell Apoptosis Is Enhanced by CpG Oligodeoxynucleotide and Requires Toll-Like Receptors 2 and 4	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS LIPOPOLYSACCHARIDE; NF-KAPPA-B; PERIODONTAL-DISEASE; IMMUNE-RESPONSES; ACTIVATION; MICE; LPS; DYSBIOSIS; SUBSETS; CYCLE	Innate-like B lymphocytes play an important role in innate immunity in periodontal disease through Toll-like receptor (TLR) signaling. However, it is unknown how innate-like B cell apoptosis is affected by the periodontal infection-associated innate signals. This study is to determine the effects of two major TLR ligands, lipopolysaccharide (LPS) and CpG-oligodeoxynucleotides (CpG-ODN), on innate-like B cell apoptosis. Spleen B cells were isolated from wild type (WT), TLR2 knockout (KO) and TLR4 KO mice and cultured with E. coli LPS alone, P. gingivalis LPS alone, or combined with CpG-ODN for 2 days. B cell apoptosis and expressions of specific apoptosis-related genes were analyzed by flow cytometry and real-time PCR respectively. P. gingivalis LPS, but not E. coli LPS, reduced the percentage of AnnexinV(+)/7-AAD(-) cells within IgM(high)CD23(low)CD43(-)CD93(-) marginal zone (MZ) B cell sub-population and IgM(high)CD23(low)CD43(+)CD93(+) innate response activator (IRA) B cell subpopulation in WT but not TLR2KO or TLR4KO mice. CpG-ODN combined with P. gingivalis LPS further reduced the percentage of AnnexinV(+)/7-AAD(-) cells within MZ B cells and IRA B cells in WT but not TLR2 KO or TLR4 KO mice. Pro-apoptotic CASP4, CASP9 and Dapk1 were significantly down-regulated in P. gingivalis LPS- and CpG-ODN-treated B cells from WT but not TLR2 KO or TLR4 KO mice. Anti-apoptotic IL-10 was significantly up-regulated in P. gingivalis LPS-and CpG-ODN-treated B cells from WT and TLR2 KO but not TLR4 KO mice. These results suggested that both TLR2 and TLR4 signaling are required for P. gingivalis LPS-induced, CpG-ODN-enhanced suppression of innate-like B cell apoptosis.	[Yu, Xiaoqian; Wang, Yuhua; Lin, Jiang; Hu, Yang; Kawai, Toshihisa; Taubman, Martin A.; Han, Xiaozhe] Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA USA; [Yu, Xiaoqian] Peking Univ, Sch & Hosp Stomatol, Dept Periodontol, Beijing, Peoples R China; [Wang, Yuhua] Shanghai Jiao Tong Univ, Sch Med, Dept Prosthodont, Peoples Hosp 9,Coll Stomatol,Shanghai Key Lab, Shanghai, Peoples R China; [Lin, Jiang] Harbin Med Univ, Dept Stomatol, Hosp 4, Harbin, Peoples R China	Harvard University; Forsyth Institute; Peking University; Shanghai Jiao Tong University; Harbin Medical University	Han, XZ (corresponding author), Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA USA.	Xhan@forsyth.org	Han, Xiaozhe/I-7532-2019; lin, jiang/AAC-4001-2020	Han, Xiaozhe/0000-0001-8357-1471; 	National Natural Science Foundation of China [81470740]; National Institute of Dental and Craniofacial Research [R21DE021837, R56DE023807]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE021837, R56DE023807, R01DE025255] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	National Natural Science Foundation of China 81470740 to X Yu; National Institute of Dental and Craniofacial Research R21DE021837 and R56DE023807 to X Han.	Alenzi FQB, 2004, BRIT J BIOMED SCI, V61, P99, DOI 10.1080/09674845.2004.11732652; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Andrukhov O, 2014, ACTA ODONTOL SCAND, V72, P337, DOI 10.3109/00016357.2013.834535; Bainbridge BW, 2001, ACTA ODONTOL SCAND, V59, P131, DOI 10.1080/000163501750266710; Baker PJ, 2000, MICROBES INFECT, V2, P1181, DOI 10.1016/S1286-4579(00)01272-7; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bi W, 2014, MOL MED REP, V10, P1793, DOI 10.3892/mmr.2014.2480; Boffey J, 2004, J NEUROIMMUNOL, V152, P98, DOI 10.1016/j.jneuroim.2004.04.002; Bohnhorst J, 2006, LEUKEMIA, V20, P1138, DOI 10.1038/sj.leu.2404225; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Cognasse F, 2008, IMMUNOLOGY, V125, P430, DOI 10.1111/j.1365-2567.2008.02844.x; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; de Andres B, 2012, J IMMUNOL, V189, P2300, DOI 10.4049/jimmunol.1200224; Fanzo JC, 2003, J EXP MED, V197, P303, DOI 10.1084/jem.20020717; Fujita Y, 2011, HUM REPROD, V26, P2799, DOI 10.1093/humrep/der234; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Herath TDK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058496; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kearney JF, 2005, SPRINGER SEMIN IMMUN, V26, P377, DOI 10.1007/s00281-004-0184-0; Kinch LN, 2011, PROTEINS, V79, P21, DOI 10.1002/prot.23190; KOURY MJ, 1992, EXP HEMATOL, V20, P391; Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926; Lopez-Hoyos M, 1998, INT J MOL MED, V1, P475; Lorencini M, 2009, TISSUE CELL, V41, P43, DOI 10.1016/j.tice.2008.07.001; Maddi A, 2013, AM J DENT, V26, P249; Maekawa T, 2014, CELL HOST MICROBE, V15, P768, DOI 10.1016/j.chom.2014.05.012; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; Moore-Connors JM, 2015, MUCOSAL IMMUNOL, V8, P94, DOI 10.1038/mi.2014.45; Nebel D, 2013, ACTA ODONTOL SCAND, V71, P892, DOI 10.3109/00016357.2012.734415; O'Flaherty E, 2000, IMMUNOLOGY, V100, P289, DOI 10.1046/j.1365-2567.2000.00048.x; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Ouyang L, 2012, CELL PROLIFERAT, V45, P487, DOI 10.1111/j.1365-2184.2012.00845.x; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Reid S, 1999, BLOOD, V93, P1524, DOI 10.1182/blood.V93.5.1524.405k07_1524_1533; Rosado MM, 2014, METHODS MOL BIOL, V1190, P3, DOI 10.1007/978-1-4939-1161-5_1; Rubtsov AV, 2008, J IMMUNOL, V180, P3882, DOI 10.4049/jimmunol.180.6.3882; Schmid-Burgk JL, 2015, EUR J IMMUNOL, V45, P2911, DOI 10.1002/eji.201545523; Tedder TF, 2015, J IMMUNOL, V194, P1395, DOI 10.4049/jimmunol.1401329; Traver D, 1998, IMMUNITY, V9, P47, DOI 10.1016/S1074-7613(00)80587-7; Vermeulen K, 2003, CELL PROLIFERAT, V36, P165, DOI 10.1046/j.1365-2184.2003.00267.x; Wang ZH, 1997, CELL IMMUNOL, V180, P162, DOI 10.1006/cimm.1997.1156; Xie H, 2012, J PERIODONTAL RES, V47, P578, DOI 10.1111/j.1600-0765.2012.01469.x; Yi AK, 1999, INT IMMUNOL, V11, P2015, DOI 10.1093/intimm/11.12.2015; Yi AK, 1998, J IMMUNOL, V160, P5898; Yoo HJ, 2012, CELL SIGNAL, V24, P1471, DOI 10.1016/j.cellsig.2012.03.010; Zenobia C, 2015, VIRULENCE, V6, P236, DOI 10.1080/21505594.2014.999567; Zhang D, 2008, INNATE IMMUN-LONDON, V14, P99, DOI 10.1177/1753425907088244; Zhang Y, 2013, CANCER IMMUNOL IMMUN, V62, P87, DOI 10.1007/s00262-012-1313-6; Zouali M, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00063	52	9	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165862	10.1371/journal.pone.0165862	http://dx.doi.org/10.1371/journal.pone.0165862			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812176	Green Submitted, Green Published, gold			2022-12-26	WOS:000386910000073
J	Zheng, HJ; Liang, H; Wang, YZ; Miao, MH; Shi, T; Yang, F; Liu, EN; Yuan, W; Ji, ZS; Li, DK				Zheng, Huajun; Liang, Hong; Wang, Yuezhu; Miao, Maohua; Shi, Tao; Yang, Fen; Liu, Enuo; Yuan, Wei; Ji, Zai-Si; Li, De-Kun			Altered Gut Microbiota Composition Associated with Eczema in Infants	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; FECAL MICROBIOTA; IMMUNE-SYSTEM; ATOPIC-DERMATITIS; AT-RISK; DISEASE; CHILDHOOD; CHILDREN; ASTHMA; COHORT	Eczema is frequently the first manifestation of an atopic diathesis and alteration in the diversity of gut microbiota has been reported in infants with eczema. To identify specific bacterial communities associated with eczema, we conducted a case-control study of 50 infants with eczema (cases) and 51 healthy infants (controls). We performed high-throughput sequencing for V3-V4 hypervariable regions of the 16S rRNA genes from the gut fecal material. A total of 12,386 OTUs (operational taxonomic units) at a 97% similarity level were obtained from the two groups, and we observed a difference in taxa abundance, but not the taxonomic composition, of gut microbiota between the two groups. We identified four genera enriched in healthy infants: Bifidobacterium, Megasphaera, Haemophilus and Streptococcus; and five genera enriched in infants with eczema: Escherichia/Shigella, Veillonella, Faecalibacterium, Lachnospiraceae incertae sedis and Clostridium XlVa. Several species, such as Faecalibacterium prausnitzii and Ruminococcus gnavus, that are known to be associated with atopy or inflammation, were found to be significantly enriched in infants with eczema. Higher abundance of Akkermansia muciniphila in eczematous infants might reduce the integrity of intestinal barrier function and therefore increase the risk of developing eczema. On the other hand, Bacteroides fragilis and Streptococcus salivarius, which are known for their anti-inflammatory properties, were less abundant in infants with eczema. The observed differences in genera and species between cases and controls in this study may provide insight into the link between the microbiome and eczema risk.	[Zheng, Huajun; Liang, Hong; Miao, Maohua; Shi, Tao; Yang, Fen; Liu, Enuo; Yuan, Wei; Ji, Zai-Si] Fudan Univ, Key Lab Reprod Regulat NPFPC, SIPPR, IRD, Shanghai 200032, Peoples R China; [Wang, Yuezhu] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai 201203, Peoples R China; [Li, De-Kun] Kaiser Fdn, Res Inst, Div Res, 2000 Broadway, Oakland, CA 94612 USA	Fudan University	Yuan, W; Ji, ZS (corresponding author), Fudan Univ, Key Lab Reprod Regulat NPFPC, SIPPR, IRD, Shanghai 200032, Peoples R China.	yuanwei11@yahoo.com; zai-si_ji@kta.biglobe.ne.jp	Zheng, Huajun/AAN-4973-2020		Foundation of Shanghai Health and Family Planning Commission [20154Y0031]; Shanghai Natural Science Foundation [15ZR1435100]	Foundation of Shanghai Health and Family Planning Commission; Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai)	This work was supported by the Foundation of Shanghai Health and Family Planning Commission [20154Y0031] and Shanghai Natural Science Foundation [15ZR1435100]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillon S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111519; Beaud D, 2005, MICROBIOL-SGM, V151, P2323, DOI 10.1099/mic.0.27712-0; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Candela M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-95; Chiu CM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/906168; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Eichenfield LF, 2003, PEDIATRICS, V111, P608, DOI 10.1542/peds.111.3.608; Fiocchi A, 2012, WORLD ALLERGY ORGAN, V5, P148, DOI 10.1097/WOX.0b013e3182784ee0; Forno Erick, 2008, Clin Mol Allergy, V6, P11, DOI 10.1186/1476-7961-6-11; Gronlund MM, 2000, ARCH DIS CHILD-FETAL, V83, pF186, DOI 10.1136/fn.83.3.F186; Hong PY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009964; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kim JY, 2010, PEDIAT ALLERG IMM-UK, V21, pE386, DOI 10.1111/j.1399-3038.2009.00958.x; LILLY DM, 1965, SCIENCE, V147, P747, DOI 10.1126/science.147.3659.747; Ling ZX, 2014, APPL ENVIRON MICROB, V80, P2546, DOI 10.1128/AEM.00003-14; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Myers JMB, 2010, J PEDIATR-US, V157, P704, DOI 10.1016/j.jpeds.2010.07.009; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Nylund L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-12; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rautava S, 2012, J ALLERGY CLIN IMMUN, V130, P1355, DOI 10.1016/j.jaci.2012.09.003; Rousseau C, 2011, J CLIN MICROBIOL, V49, P858, DOI 10.1128/JCM.01507-10; Saunes M, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-168; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P518, DOI 10.1111/j.1365-2222.2008.03156.x; Sonoyama K, 2010, BRIT J NUTR, V103, P218, DOI 10.1017/S0007114509991589; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Toh ZQ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00171; Troy EB, 2010, FRONT BIOSCI-LANDMRK, V15, P25, DOI 10.2741/3603; Turroni F, 2009, APPL ENVIRON MICROB, V75, P1534, DOI 10.1128/AEM.02216-08; Vael C, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-8; von Kobyletzki LB, 2012, BMC DERMATOL, V12, DOI 10.1186/1471-5945-12-11; Wang M, 2008, J ALLERGY CLIN IMMUN, V121, P129, DOI 10.1016/j.jaci.2007.09.011; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yap Gaik Chin, 2014, BMC Res Notes, V7, P166, DOI 10.1186/1756-0500-7-166	43	89	90	6	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166026	10.1371/journal.pone.0166026	http://dx.doi.org/10.1371/journal.pone.0166026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812181	Green Published, gold, Green Submitted			2022-12-26	WOS:000386910000096
J	Gilchrist, S; Gomes, AL; Kinchesh, P; Kersemans, V; Allen, PD; Smart, SC				Gilchrist, Stuart; Gomes, Ana L.; Kinchesh, Paul; Kersemans, Veerle; Allen, Philip D.; Smart, Sean C.			An MRI-Compatible High Frequency AC Resistive Heating System for Homeothermic Maintenance in Small Animals	PLOS ONE			English	Article							BODY-TEMPERATURE; ANESTHESIA; RATS; HYPOTHERMIA; MICE	Purpose To develop an MRI-compatible resistive heater, using high frequency alternating current (AC), for temperature maintenance of anaesthetised animals. Materials and Methods An MRI-compatible resistive electrical heater was formed from narrow gauge wire connected to a high frequency (10-100 kHz) AC power source. Multiple gradient echo images covering a range of echo times, and pulse-acquire spectra were acquired with the wire heater powered using high frequency AC or DC power sources and without any current flowing in order to assess the sensitivity of the MRI acquisitions to the presence of current flow through the heater wire. The efficacy of temperature maintenance using the AC heater was assessed by measuring rectal temperature immediately following induction of general anaesthesia for a period of 30 minutes in three different mice. Results Images and spectra acquired in the presence and absence of 50-100 kHz AC through the wire heater were indistinguishable, whereas DC power created field shifts and lineshape distortions. Temperature lost during induction of anaesthesia was recovered within approximately 20 minutes and a stable temperature was reached as the mouse's temperature approached the set target. Conclusion The AC-powered wire heater maintains adequate heat input to the animal to maintain body temperature, and does not compromise image quality.	[Gilchrist, Stuart] Canc Res UK, Oxford, England; Univ Oxford, MRC, Oxford Inst Radiat Oncol, Dept Oncol, Oxford, England	Cancer Research UK; University of Oxford	Gilchrist, S (corresponding author), Canc Res UK, Oxford, England.	Stuart.Gilchrist@oncology.ox.ac.uk	Kersemans, Veerle/AAG-3005-2020	Kersemans, Veerle/0000-0002-4669-236X; Allen, Danny/0000-0002-6200-0925	Cancer Research UK (CRUK grant) [C5255/A12678, C2522/A10339]; Engineering and Physical Sciences Research Council (EPSRC) [C2522/A10339]; Medical Research Council Unit Grant for the Oxford Institute for Radiation Oncology; Cancer Research UK [16466] Funding Source: researchfish	Cancer Research UK (CRUK grant); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council Unit Grant for the Oxford Institute for Radiation Oncology; Cancer Research UK(Cancer Research UK)	The work presented was supported financially by Cancer Research UK (CRUK grants C5255/A12678, C2522/A10339), http://www.cancerresearchuk.org/home-page, the Engineering and Physical Sciences Research Council (EPSRC grant C2522/A10339), https://www.epsrc.ac.uk/, and the Medical Research Council Unit Grant for the Oxford Institute for Radiation Oncology, http://www.mrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caro AC, 2013, J AM ASSOC LAB ANIM, V52, P577; Grahn DA, 1996, J APPL PHYSIOL, V81, P2547, DOI 10.1152/jappl.1996.81.6.2547; Kersemans V, 2015, MAGN RESON IMAGING, V33, P847, DOI 10.1016/j.mri.2015.03.011; McConville P, 2011, METHODS MOL BIOL, V771, P89, DOI 10.1007/978-1-61779-219-9_5; Murase K, 2013, MAGN RESON IMAGING, V31, P1744, DOI 10.1016/j.mri.2013.08.005; Rembert MS, 2004, LAB ANIM-UK, V38, P55, DOI 10.1258/00236770460734407; Reynolds RP, 2010, J AM ASSOC LAB ANIM, V49, P592; Sessler DI, 2001, ANESTHESIOLOGY, V95, P531, DOI 10.1097/00000542-200108000-00040; Taylor DK, 2007, J AM ASSOC LAB ANIM, V46, P37; Torossian A, 2004, CRIT CARE MED, V32, P1899, DOI 10.1097/01.CCM.0000139608.34486.FD; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642	11	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0164920	10.1371/journal.pone.0164920	http://dx.doi.org/10.1371/journal.pone.0164920			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806062	gold, Green Published, Green Submitted			2022-12-26	WOS:000386715500017
J	O'Dwyer, L; Tanner, C; van Dongen, EV; Greven, CU; Bralten, J; Zwiers, MP; Franke, B; Heslenfeld, D; Oosterlaan, J; Hoekstra, PJ; Hartman, CA; Groen, W; Rommelse, N; Buitelaar, JK				O'Dwyer, Laurence; Tanner, Colby; van Dongen, Eelco V.; Greven, Corina U.; Bralten, Janita; Zwiers, Marcel P.; Franke, Barbara; Heslenfeld, Dirk; Oosterlaan, Jaap; Hoekstra, Pieter J.; Hartman, Catharina A.; Groen, Wouter; Rommelse, Nanda; Buitelaar, Jan K.			Decreased Left Caudate Volume Is Associated with Increased Severity of Autistic-Like Symptoms in a Cohort of ADHD Patients and Their Unaffected Siblings	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; PERVASIVE DEVELOPMENTAL DISORDERS; OBSESSIVE-COMPULSIVE DISORDER; BEHAVIOR QUESTIONNAIRE CSBQ; VOXEL-BASED MORPHOMETRY; LARGE MULTICENTER ADHD; WHOLE-BRAIN ANALYSIS; SPECTRUM DISORDER; BASAL GANGLIA; NEUROPSYCHIATRIC DISORDERS	Autism spectrum disorder (ASD) symptoms frequently occur in individuals with attention-deficit/ hyperactivity disorder (ADHD). While there is evidence that both ADHD and ASD have differential structural brain correlates, knowledge of the structural brain profile of individuals with ADHD with raised ASD symptoms is limited. The presence of ASD-like symptoms was measured by the Children's Social Behavior Questionnaire (CSBQ) in a sample of typically developing controls (n = 154), participants with ADHD (n = 239), and their unaffected siblings (n = 144) between the ages of 8 and 29. Structural magnetic resonance imaging (MRI) correlates of ASD ratings were analysed by studying the relationship between ASD ratings and grey matter volumes using mixed effects models which controlled for ADHD symptom count and total brain volume. ASD ratings were significantly elevated in participants with ADHD relative to controls and unaffected siblings. For the entire group (participants with ADHD, unaffected siblings and TD controls), mixed effect models revealed that the left caudate nucleus volume was negatively correlated with ASD ratings (t = 2.83; P = 0.005). The current findings are consistent with the role of the caudate nucleus in executive function, including the selection of goals based on the evaluation of action outcomes and the use of social reward to update reward representations. There is a specific volumetric profile associated with subclinical ASD-like symptoms in participants with ADHD, unaffected siblings and controls with the caudate nucleus and globus pallidus being of critical importance in predicting the level of ASD-like symptoms in all three groups.	[O'Dwyer, Laurence; van Dongen, Eelco V.; Greven, Corina U.; Bralten, Janita; Zwiers, Marcel P.; Buitelaar, Jan K.] Radboud UMC, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, Nijmegen, Netherlands; [Tanner, Colby] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Greven, Corina U.] Kings Coll London, MRC Social Genet & Dev Psychiat Ctr, Inst Psychiat, London, England; [Bralten, Janita; Franke, Barbara] Radboud UMC, Dept Human Genet, Nijmegen, Netherlands; [Franke, Barbara; Groen, Wouter; Rommelse, Nanda] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Psychiat, Nijmegen, Netherlands; [Heslenfeld, Dirk; Oosterlaan, Jaap] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Amsterdam, Netherlands; [Heslenfeld, Dirk] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands; [Hoekstra, Pieter J.; Hartman, Catharina A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Greven, Corina U.; Groen, Wouter; Rommelse, Nanda; Buitelaar, Jan K.] Karakter Child & Adolescent Psychiat Univ Ctr Nij, Nijmegen, Netherlands	Radboud University Nijmegen; University of Lausanne; University of London; King's College London; Radboud University Nijmegen; Radboud University Nijmegen; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Groningen; Radboud University Nijmegen	O'Dwyer, L (corresponding author), Radboud UMC, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, Nijmegen, Netherlands.	larodwyer@gmail.com	Rommelse, Nanda NJ/D-4872-2009; Greven, Corina/GRS-7921-2022; Greven, Corina U/F-9729-2010; Franke, Barbara/D-4836-2009; Buitelaar, J.K./AAY-7522-2020; Bralten, Janita/AAB-9566-2019; Zwiers, Marcel P/D-2968-2009	Rommelse, Nanda NJ/0000-0002-1711-0359; Greven, Corina U/0000-0002-5433-7878; Franke, Barbara/0000-0003-4375-6572; Bralten, Janita/0000-0003-1440-8675; Zwiers, Marcel P/0000-0001-5483-2935; Greven, Corina U./0000-0003-2402-3074	NIH [R01MH62873]; NWO [1750102007010]; Radboud University Nijmegen Medical Center; University Medical Center Groningen and Accare; Vrije Universiteit Amsterdam; Brain & Cognition Excellence Program of the Netherlands Organization for Scientific Research (NWO) [433-09-242, 056-13-015]; European Community [278948, 602450]; Innovative Medicines Initiative Joint Undertaking under European Union [115300]; Marie Curie Fellowship under FP7; Vici grant from the Netherlands Organization for Scientific Research (NWO) [016-130-669]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NWO(Netherlands Organization for Scientific Research (NWO)); Radboud University Nijmegen Medical Center; University Medical Center Groningen and Accare; Vrije Universiteit Amsterdam; Brain & Cognition Excellence Program of the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission); Innovative Medicines Initiative Joint Undertaking under European Union; Marie Curie Fellowship under FP7; Vici grant from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The NeuroIMAGE study was supported by NIH grant R01MH62873 (to Stephen V. Faraone), NWO Large Investment Grant 1750102007010 (to Jan Buitelaar) and matching grants from Radboud University Nijmegen Medical Center, University Medical Center Groningen and Accare, and Vrije Universiteit Amsterdam. This study was supported by a grant from the Brain & Cognition Excellence Program of the Netherlands Organization for Scientific Research (NWO grant 433-09-242 and 056-13-015). The research leading to these results also received support from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 278948 (TACTICS) and 602450 (IMAGEMEND), and the Innovative Medicines Initiative Joint Undertaking under grant agreement number 115300 (EU-AIMS), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007 - 2013) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) companies' in kind contribution. CT was supported by a Marie Curie Fellowship under FP7, and BF received funding from a Vici grant from the Netherlands Organization for Scientific Research (NWO; grant number 016-130-669). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell F, 1999, NEUROREPORT, V10, P1647, DOI 10.1097/00001756-199906030-00005; Abrams DA, 2013, P NATL ACAD SCI USA, V110, P12060, DOI 10.1073/pnas.1302982110; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Amer Psychiatric Pub Incorporated, 2013, DIAGN STAT MAN MENT; Ames CS, 2011, J AUTISM DEV DISORD, V41, P357, DOI 10.1007/s10803-010-1049-0; Asato MR, 2010, CEREB CORTEX, V20, P2122, DOI 10.1093/cercor/bhp282; Aylward EH, 2002, NEUROLOGY, V59, P175, DOI 10.1212/WNL.59.2.175; Barnea-Goraly N, 2014, PROG NEURO-PSYCHOPH, V48, P124, DOI 10.1016/j.pnpbp.2013.09.010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boddaert N, 2004, NEUROIMAGE, V23, P364, DOI 10.1016/j.neuroimage.2004.06.016; Bolton PF, 1997, LANCET, V349, P392, DOI 10.1016/S0140-6736(97)80012-8; Booth R, 2010, J EXP CHILD PSYCHOL, V107, P377, DOI 10.1016/j.jecp.2010.06.003; Brambilla P, 2003, BRAIN RES BULL, V61, P557, DOI 10.1016/j.brainresbull.2003.06.001; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; Conners CK, 1997, J ABNORM CHILD PSYCH, V25, P487, DOI 10.1023/A:1022637815797; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P257, DOI 10.1023/A:1022602400621; Conners CK., 1999, CONNERS ADULT ADHD R, DOI DOI 10.1038/s41588-018-0269-7; Constantino JN, 2005, BIOL PSYCHIAT, V57, P655, DOI 10.1016/j.biopsych.2004.12.014; Corbett BA, 2009, PSYCHIAT RES, V166, P210, DOI 10.1016/j.psychres.2008.02.005; COURCHESNE E, 1988, NEW ENGL J MED, V318, P1349, DOI 10.1056/NEJM198805263182102; Crawley M.J., 2007, R BOOK; Cule E., 2012, RIDGE RIDGE REGRESSI; Cule E., 2012, SEMIAUTOMATIC METHOD; DAWSON G, 1983, J AUTISM DEV DISORD, V13, P269, DOI 10.1007/BF01531566; de Bildt A, 2009, J AUTISM DEV DISORD, V39, P1350, DOI 10.1007/s10803-009-0749-9; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Ecker C, 2010, J NEUROSCI, V30, P10612, DOI 10.1523/JNEUROSCI.5413-09.2010; Estes A, 2011, AUTISM RES, V4, P212, DOI 10.1002/aur.193; FEIN D, 1984, PSYCHOL BULL, V95, P258, DOI 10.1037/0033-2909.95.2.258; Fine JG, 2008, J AUTISM DEV DISORD, V38, P1797, DOI 10.1007/s10803-008-0570-x; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Frodl T, 2012, ACTA PSYCHIAT SCAND, V125, P114, DOI 10.1111/j.1600-0447.2011.01786.x; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Grahn JA, 2009, BEHAV BRAIN RES, V199, P53, DOI 10.1016/j.bbr.2008.11.020; Greene W. H., 1997, ECONOMETRIC ANAL; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Happe F, 1999, TRENDS COGN SCI, V3, P216, DOI 10.1016/S1364-6613(99)01318-2; Happe F, 2006, BRAIN COGNITION, V61, P25, DOI 10.1016/j.bandc.2006.03.004; Hardan AY, 2006, PSYCHIAT RES-NEUROIM, V147, P145, DOI 10.1016/j.pscychresns.2005.12.009; Hartman CA, 2006, J AUTISM DEV DISORD, V36, P325, DOI 10.1007/s10803-005-0072-z; Heimer L, 2003, AM J PSYCHIAT, V160, P1726, DOI 10.1176/appi.ajp.160.10.1726; Herbert MR, 2005, BRAIN, V128, P213, DOI 10.1093/brain/awh330; Herbert MR, 2003, BRAIN, V126, P1182, DOI 10.1093/brain/awg110; Hollander E, 2005, BIOL PSYCHIAT, V58, P226, DOI 10.1016/j.biopsych.2005.03.040; Howlin P, 2000, J CHILD PSYCHOL PSYC, V41, P561, DOI 10.1017/S0021963099005806; Jang SH, 2014, NEUROSCI LETT, V579, P140, DOI 10.1016/j.neulet.2014.07.024; Jaspers M, 2013, J ABNORM CHILD PSYCH, V41, P71, DOI 10.1007/s10802-012-9653-4; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jou RJ, 2013, BEHAV BRAIN RES, V251, P163, DOI 10.1016/j.bbr.2013.04.021; Kanner L, 1943, NERV CHILD, V2, P217; Kleinhans NM, 2008, BRAIN RES, V1221, P115, DOI 10.1016/j.brainres.2008.04.080; Kohls G, 2013, SOC COGN AFFECT NEUR, V8, P565, DOI 10.1093/scan/nss033; KRUG DA, 1980, J CHILD PSYCHOL PSYC, V21, P221, DOI 10.1111/j.1469-7610.1980.tb01797.x; Lange N, 2015, AUTISM RES, V8, P82, DOI 10.1002/aur.1427; Langen M, 2007, BIOL PSYCHIAT, V62, P262, DOI 10.1016/j.biopsych.2006.09.040; Langen M, 2014, BIOL PSYCHIAT, V76, P405, DOI 10.1016/j.biopsych.2013.08.013; Langen M, 2009, BIOL PSYCHIAT, V66, P327, DOI 10.1016/j.biopsych.2009.03.017; Leyfer OT, 2006, J AUTISM DEV DISORD, V36, P849, DOI 10.1007/s10803-006-0123-0; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Lim L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063660, 10.1371/journal.pone.0084487]; Luteijn EF, 2000, EUR CHILD ADOLES PSY, V9, P168, DOI 10.1007/s007870070040; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; McAlonan GM, 2005, BRAIN, V128, P268, DOI 10.1093/brain/awh332; Milardi D, 2015, CEREB CORTEX, V25, P406, DOI 10.1093/cercor/bht231; Muller UC, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-55; Muller UC, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-54; Mulligan A, 2009, J AUTISM DEV DISORD, V39, P197, DOI 10.1007/s10803-008-0621-3; Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281; Nickl-Jockschat T, 2012, HUM BRAIN MAPP, V33, P1470, DOI 10.1002/hbm.21299; Nijmeijer JS, 2009, J ABNORM CHILD PSYCH, V37, P443, DOI 10.1007/s10802-008-9282-0; O'Dwyer L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101130; Ozonoff S, 1996, BRAIN LANG, V52, P411, DOI 10.1006/brln.1996.0022; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pellicano E, 2012, TRENDS COGN SCI, V16, P504, DOI 10.1016/j.tics.2012.08.009; Peterson BS, 2003, ARCH GEN PSYCHIAT, V60, P415, DOI 10.1001/archpsyc.60.4.415; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Plichta MM, 2014, NEUROSCI BIOBEHAV R, V38, P125, DOI 10.1016/j.neubiorev.2013.07.012; Redcay E, 2008, NEUROSCI BIOBEHAV R, V32, P123, DOI 10.1016/j.neubiorev.2007.06.004; Reiersen AM, 2007, J CHILD PSYCHOL PSYC, V48, P464, DOI 10.1111/j.1469-7610.2006.01720.x; Riva D, 2011, AM J NEURORADIOL, V32, P1430, DOI 10.3174/ajnr.A2527; Robert R., 2013, BIOMETRY PRINCIPLES; Rojas DC, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-56; Rommelse NNJ, 2008, ARCH CLIN NEUROPSYCH, V23, P579, DOI 10.1016/j.acn.2008.06.002; Rommelse NNJ, 2011, NEUROSCI BIOBEHAV R, V35, P1363, DOI 10.1016/j.neubiorev.2011.02.015; Rommelse NNJ, 2010, EUR CHILD ADOLES PSY, V19, P281, DOI 10.1007/s00787-010-0092-x; Ronald A, 2008, J CHILD PSYCHOL PSYC, V49, P535, DOI 10.1111/j.1469-7610.2007.01857.x; Rosenberg DR, 1997, ARCH GEN PSYCHIAT, V54, P824; Rutter M, 2003, J CHILD PSYCHOL PSYC, V44, P1092, DOI 10.1111/1469-7610.00194; Saitoh O, 2001, BRAIN, V124, P1317, DOI 10.1093/brain/124.7.1317; SCARONE S, 1992, PSYCHIAT RES-NEUROIM, V45, P115, DOI 10.1016/0925-4927(92)90005-O; Sears LL, 1999, PROG NEURO-PSYCHOPH, V23, P613, DOI 10.1016/S0278-5846(99)00020-2; Seltzer MM, 2004, MENT RETARD DEV D R, V10, P234, DOI 10.1002/mrdd.20038; Silk TJ, 2006, AM J PSYCHIAT, V163, P1440, DOI 10.1176/appi.ajp.163.8.1440; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Sucksmith E, 2011, NEUROPSYCHOL REV, V21, P360, DOI 10.1007/s11065-011-9183-9; 't Hart-Kerkhoffs LA, 2009, J CLIN PSYCHIAT, V70, P266, DOI 10.4088/JCP.08m04635; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; THOMPSON RL, 1959, J COMP PHYSIOL PSYCH, V52, P650, DOI 10.1037/h0038893; Turner Katherine C, 2006, Behav Brain Funct, V2, P34, DOI 10.1186/1744-9081-2-34; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; van der Meer JMJ, 2012, J AM ACAD CHILD PSY, V51, P1160, DOI 10.1016/j.jaac.2012.08.024; van Steijn DJ, 2012, J CHILD PSYCHOL PSYC, V53, P954, DOI 10.1111/j.1469-7610.2012.02556.x; von Rhein D, 2015, EUR CHILD ADOLES PSY, V24, P265, DOI 10.1007/s00787-014-0573-4; Zeileis, DIAGNOSTIC CHECKING	107	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165620	10.1371/journal.pone.0165620	http://dx.doi.org/10.1371/journal.pone.0165620			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6DJ	27806078	gold, Green Published, Green Submitted			2022-12-26	WOS:000386715500044
J	Stohr, S; Martynov, A				Stohr, Sabine; Martynov, Alexander			Paedomorphosis as an Evolutionary Driving Force: Insights from Deep-Sea Brittle Stars	PLOS ONE			English	Article							POSTLARVAL DEVELOPMENT; DEVELOPMENTAL BIOLOGY; AMPHIURA-FILIFORMIS; LARVAL DEVELOPMENT; EVO-DEVO; ECHINODERMATA; HETEROCHRONY; ONTOGENY; OPHIUROIDEA; PHYLOGENY	Heterochronic development has been proposed to have played an important role in the evolution of echinoderms. In the class Ophiuroidea, paedomorphosis (retention of juvenile characters into adulthood) has been documented in the families Ophiuridae and Ophiolepididae but not been investigated on a broader taxonomic scale. Historical errors, confusing juvenile stages with paedomorphic species, show the difficulties in correctly identifying the effects of heterochrony on development and evolution. This study presents a detailed analysis of 40 species with morphologies showing various degrees of juvenile appearance in late ontogeny. They are compared to a range of early ontogenetic stages from paedomorphic and non-paedomorphic species. Both quantitative and qualitative measurements are taken and analysed. The results suggest that strongly paedomorphic species are usually larger than other species at comparable developmental stage. The findings support recent notions of polyphyletic origin of the families Ophiuridae and Ophiolepididae. The importance of paedomorphosis and its correct recognition for the practice of taxonomy and phylogeny are emphasized.	[Stohr, Sabine] Swedish Museum Nat Hist, Dept Zool, Stockholm, Sweden; [Martynov, Alexander] Moscow MV Lomonosov State Univ, Zool Museum, Moscow, Russia	Swedish Museum of Natural History; Lomonosov Moscow State University	Stohr, S (corresponding author), Swedish Museum Nat Hist, Dept Zool, Stockholm, Sweden.; Martynov, A (corresponding author), Moscow MV Lomonosov State Univ, Zool Museum, Moscow, Russia.	sabine.stohr@nrm.se; martynov@zmmu.msu.ru	Martynov, Alexander/AAE-3682-2021; Stöhr, Sabine/B-8629-2011	Stöhr, Sabine/0000-0002-2586-7239	Riksmusei vanner (Swedish Museum of Natural History); MSU Zoological Museum [A16-116021660077-3]; Russian Science Foundation [14-50-00029]	Riksmusei vanner (Swedish Museum of Natural History); MSU Zoological Museum; Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Riksmusei vanner (supporters of the Swedish Museum of Natural History; travel grant and extensive SEM), Research project of MSU Zoological Museum (AAAA-A16-116021660077-3) and by the Russian Science Foundation (grant 14-50-00029, morphological and SEM study, specimens deposition).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; Bizzorini F, 2001, BOLL MUS CIV STORIA, V51, P187; Bonett RM, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-27; Breton G, 1997, LETHAIA, V30, P135; BROADHEAD TW, 1987, PALEOBIOLOGY, V13, P177; Clark HL, 1914, PAP DEP MAR BIOL CAR, V5, P91; De Beer G. R., 1930, EMBRYOLOGY AND EVOLU; Dylus DV, 2016, EVODEVO, V7, DOI 10.1186/s13227-015-0039-x; Garstang W., 1922, Journal of the Linnean Society Zoology, V35, P81; Gilbert SF, 1996, DEV BIOL, V173, P357, DOI 10.1006/dbio.1996.0032; Gould SJ, 1977, ONTOGENY AND PHYLOGE; Haeckel E., 1866, ALLGEMEINE GRUNDZUGE; Hall BK, 1999, EVOLUTIONARY DEVELOP; HENDLER G, 1979, Proceedings of the Biological Society of Washington, V92, P783; HENDLER G, 1988, BIOL BULL, V174, P20, DOI 10.2307/1541755; HESS HANS, 1960, ECLOGAE GEOL HELVETIAE, V53, P335; HOTCHKISS FHC, 1980, J NAT HIST, V14, P91, DOI 10.1080/00222938000770101; Hotchkiss FHC, 2012, ZOOSYMPOSIA, V7, P121, DOI 10.11646/zoosymposia.7.1.12; Jeffery JE, 2002, SYST BIOL, V51, P478, DOI 10.1080/10635150290069904; Kjaer CR, 1999, PALEOBIOLOGY, V25, P29; Klingenberg CP, 1998, BIOL REV, V73, P79, DOI 10.1017/S000632319800512X; Koehler R., 1897, Annales des Sciences Naturelles, V(8), P277; Litvinova Nina M., 1998, Zoosystema, V20, P439; Love AC, 2003, EVOL DEV, V5, P327, DOI 10.1046/j.1525-142X.2003.03040.x; Ludwig H., 1899, SB Ak Berlin, P210; Ludwig H, 1881, ZUR ENTWICKLUNGSGESC, P91; Mabee PM, 2007, TRENDS ECOL EVOL, V22, P345, DOI 10.1016/j.tree.2007.03.013; Marshall N.B., 1984, P91; Martynov AV, 2012, PALEONTOL J+, V46, P833, DOI 10.1134/S0031030112080072; Martynov A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139463; Martynov A, 2010, ZOOTAXA, P1; Martynov A, 2011, J MOLLUS STUD, V77, P129, DOI 10.1093/mollus/eyq047; Martynov AV, 2008, MAR BIOL RES, V4, P76, DOI 10.1080/17451000701840066; Matsumoto, 1917, J COLL SCI IMP U TOK, V38, P1; MCKINNEY ML, 1986, PALEOBIOLOGY, V12, P282, DOI 10.1017/S0094837300013786; MCNAMARA KJ, 1986, J PALEONTOL, V60, P4, DOI 10.1017/S0022336000021454; Mehnert E., 1897, MORPHOL ARBEIT, V7, P1, DOI [10.1159/000393310, DOI 10.1159/000393310]; MESSING CG, 1984, MAR BIOL, V80, P83, DOI 10.1007/BF00393131; Minelli A, 2015, EVOLUTIONARY DEV BIO, V1, P1, DOI DOI 10.1007/978-3-7091-1862-7_1; MOOI R, 1990, PALEOBIOLOGY, V16, P25, DOI 10.1017/S0094837300009714; O'Hara TD, 2014, CURR BIOL, V24, P1874, DOI 10.1016/j.cub.2014.06.060; Olsson L, 2010, NATURWISSENSCHAFTEN, V97, P951, DOI 10.1007/s00114-010-0720-9; Parsley R, 2009, PALEONTOL J+, V43, P1406, DOI 10.1134/S0031030109110057; Raff RA, 2000, NAT REV GENET, V1, P74, DOI 10.1038/35049594; Rozhnov SV, 2007, PALAEOGEOGR PALAEOCL, V245, P306, DOI 10.1016/j.palaeo.2006.02.026; SCHOENER A, 1967, DEEP-SEA RES, V14, P645, DOI 10.1016/S0011-7471(67)80003-2; SCHOENER A, 1969, DEEP-SEA RES, V16, P127, DOI 10.1016/0011-7471(69)90069-2; Sedgwick A., 1909, THE INFLUENCE OF DAR; Severtsov A.N, 1912, ESSAYS THEORY EVOLUT; Simms MJ, 1988, SIXTH INTERNATIONAL, P97; SMITH AB, 1995, ZOOL J LINN SOC-LOND, V114, P213, DOI 10.1006/zjls.1995.0024; Spencer W.K., 1966, TREATISE INVERTEBRAT, V3, pU4; Spencer WK., 1922, PALAEONTOGRAPHICAL S, V76, P237; Stohr S, 2005, ZOOL J LINN SOC-LOND, V143, P543, DOI 10.1111/j.1096-3642.2005.00155.x; Stohr S., 2015, WORLD OPHIUROIDEA DA; Stohr S, 2013, EUR J TAXON, V68, P1, DOI 10.5852/ejt.2013.68; Stohr S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031940; Sumida PYG, 1998, ZOOL J LINN SOC-LOND, V124, P267, DOI 10.1111/j.1096-3642.1998.tb00577.x; Thuy B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156140; Turner R. L., 1988, ECHINODERM BIOL, P493; VADON C, 1990, J NAT HIST, V24, P165, DOI 10.1080/00222939000770111; VADON C, 1991, Memoires du Museum National d'Histoire Naturelle Serie A Zoologie, V151, P335; Vadon C., 1988, ECHINODERM BIOL, P323; WEBB CM, 1985, MAR BIOL, V89, P281, DOI 10.1007/BF00393662; Webster M, 2005, PALEOBIOLOGY, V31, P354, DOI 10.1666/0094-8373(2005)031[0354:EMOOHA]2.0.CO;2; Wiens JJ, 2005, SYST BIOL, V54, P91, DOI 10.1080/10635150590906037; Wolfe JM, 2014, CLADISTICS, V30, P366, DOI 10.1111/cla.12051	68	26	27	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0164562	10.1371/journal.pone.0164562	http://dx.doi.org/10.1371/journal.pone.0164562			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806039	gold, Green Published, Green Submitted			2022-12-26	WOS:000386715500011
J	Su, X; He, CY; Ma, JJ; Tang, T; Zhang, X; Ye, ZL; Long, YK; Shao, Q; Shao, JY; Yang, AK				Su, Xuan; He, Caiyun; Ma, Jiangjun; Tang, Tao; Zhang, Xiao; Ye, Zulu; Long, Yakang; Shao, Qiong; Shao, Jianyong; Yang, Ankui			RET/PTC Rearrangements Are Associated with Elevated Postoperative TSH Levels and Multifocal Lesions in Papillary Thyroid Cancer without Concomitant Thyroid Benign Disease	PLOS ONE			English	Article							CARCINOMA; NODULES	RET/PTC rearrangements, resulting in aberrant activity of the RET protein tyrosine kinase receptor, occur exclusively in papillary thyroid cancer (PTC). In this study, we examined the association between RET/PTC rearrangements and thyroid hormone homeostasis, and explored whether concomitant diseases such as nodular goiter and Hashimoto's thyroiditis influenced this association. A total of 114 patients diagnosed with PTC were enrolled in this study. Thyroid hormone levels, clinicopathological parameters and lifestyle were obtained through medical records and surgical pathology reports. RET/PTC rearrangements were detected using TaqMan RT-PCR and validated by direct sequencing. No RET/PTC rearrangements were detected in benign thyroid tissues. RET/PTC rearrangements were detected in 23.68% (27/114) of PTC tissues. No association between thyroid function, clinicopathological parameters and lifestyle was observed either in total thyroid cancer patients or the subgroup of patients with concomitant disease. In the subgroup of PTC patients without concomitant disease, RET/PTC rearrangement was associated with multifocal cancer (P = 0.018). RET/PTC rearrangement was also correlated with higher TSH levels at one month post-surgery (P = 0.037). Based on likelihood-ratio regression analysis, the RET/PTC-positive PTC cases showed an increased risk of multifocal cancers in the thyroid gland (OR = 5.57, 95% CI, 1.39-22.33). Our findings suggest that concomitant diseases such as nodular goiter and Hashimoto's thyroiditis in PTC may be a confounding factor when examining the effects of RET/PTC rearrangements. Excluding the potential effect of this confounding factor showed that RET/PTC may confer an increased risk for the development of multifocal cancers in the thyroid gland. Aberrantly increased post-operative levels of TSH were also associated with RET/PTC rearrangement. Together, our data provides useful information for the treatment of papillary thyroid cancer.	[Su, Xuan; Yang, Ankui] Sun Yat Sen Univ, Canc Ctr, Dept Head & Neck, Guangzhou, Guangdong, Peoples R China; [Su, Xuan; Yang, Ankui] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Su, Xuan; He, Caiyun; Ma, Jiangjun; Tang, Tao; Zhang, Xiao; Ye, Zulu; Long, Yakang; Shao, Qiong; Shao, Jianyong; Yang, Ankui] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [He, Caiyun; Ma, Jiangjun; Tang, Tao; Zhang, Xiao; Ye, Zulu; Long, Yakang; Shao, Qiong; Shao, Jianyong] Sun Yat Sen Univ, Ctr Canc, Dept Mol Diagnost, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; State Key Lab Oncology South China; Sun Yat Sen University	Yang, AK (corresponding author), Sun Yat Sen Univ, Canc Ctr, Dept Head & Neck, Guangzhou, Guangdong, Peoples R China.; Yang, AK (corresponding author), State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.; Shao, JY; Yang, AK (corresponding author), Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.; Shao, JY (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Mol Diagnost, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	shaojy@sysucc.org.cn; yangak@sysucc.org.cn			National Natural Science Foundation of China [81272955, 81602426]; Medical Science and Technology Research Fund Project of Guangdong Province [A2015003]; Natural Science Foundation of Guangdong Province [2016A030310198]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Science and Technology Research Fund Project of Guangdong Province; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work is supported by grants from the National Natural Science Foundation of China [grant numbers 81272955 and 81602426]; the Medical Science and Technology Research Fund Project of Guangdong Province [grant number A2015003]; and Natural Science Foundation of Guangdong Province [grant number 2016A030310198]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal M, 2013, AM J SURG PATHOL, V37, P1586, DOI 10.1097/PAS.0b013e318292b780; Boelaert K, 2006, J CLIN ENDOCR METAB, V91, P4295, DOI 10.1210/jc.2006-0527; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Lu ZM, 2016, J PATHOL, V239, P72, DOI 10.1002/path.4696; Machens A, 2007, WORLD J SURG, V31, P1960, DOI 10.1007/s00268-007-9185-1; Mazzaferri EL, 2001, J CLIN ENDOCR METAB, V86, P1447, DOI 10.1210/jc.86.4.1447; Rhoden KJ, 2006, J CLIN ENDOCR METAB, V91, P2414, DOI 10.1210/jc.2006-0240; Shattuck TM, 2005, NEW ENGL J MED, V352, P2406, DOI 10.1056/NEJMoa044190; Sugg SL, 1998, J CLIN ENDOCR METAB, V83, P4116, DOI 10.1210/jc.83.11.4116	9	10	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165596	10.1371/journal.pone.0165596	http://dx.doi.org/10.1371/journal.pone.0165596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802347	Green Published, gold, Green Submitted			2022-12-26	WOS:000386714200031
J	Schiemer, J; Bohm, A; Lin, L; Merrill-Skoloff, G; Flaumenhaft, R; Huang, JS; Le Breton, GC; Chishti, AH				Schiemer, James; Bohm, Andrew; Lin, Li; Merrill-Skoloff, Glenn; Flaumenhaft, Robert; Huang, Jin-Sheng; Le Breton, Guy C.; Chishti, Athar H.			G alpha(13) Switch Region 2 Relieves Talin Autoinhibition to Activate alpha IIb beta 3 Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED CELL-ADHESION; G-PROTEIN; INSIDE-OUT; CONFORMATIONAL ACTIVATION; THROMBUS FORMATION; STRUCTURAL BASIS; HEAD DOMAIN; OUTSIDE-IN; PLATELETS; RETRACTION	Integrins function as bi-directional signaling transducers that regulate cell-cell and cell-matrix signals across the membrane. A key modulator of integrin activation is talin, a large cytoskeletal protein that exists in an autoinhibited state in quiescent cells. Talin is a large 235-kDa protein composed of an N-terminal 45-kDa FERM (4.1, ezrin-, radixin-, and moesin-related protein) domain, also known as the talin head domain, and a series of helical bundles known as the rod domain. The talin head domain consists of four distinct lobes designated as F0-F3. Integrin binding and activation are mediated through the F3 region, a critically regulated domain in talin. Regulation of the F3 lobe is accomplished through autoinhibition via anti-parallel dimerization. In the anti-parallel dimerization model, the rod domain region of one talin molecule binds to the F3 lobe on an adjacent talin molecule, thus achieving the state of autoinhibition. Platelet functionality requires integrin activation for adherence and thrombus formation, and thus regulation of talin presents a critical node where pharmacological intervention is possible. A major mechanism of integrin activation in platelets is through heterotrimeric G protein signaling regulating hemostasis and thrombosis. Here, we provide evidence that switch region 2 (SR2) of the ubiquitously expressed G protein (G alpha 13) directly interacts with talin, relieves its state of autoinhibition, and triggers integrin activation. Biochemical analysis of G alpha 13 shows SR2 binds directly to the F3 lobe of talin's head domain and competes with the rod domain for binding. Intramolecular FRET analysis shows G alpha 13 can relieve autoinhibition in a cellular milieu. Finally, a myristoylated SR2 peptide shows demonstrable decrease in thrombosis in vivo. Altogether, we present a mechanistic basis for the regulation of talin through G alpha 13.	[Schiemer, James; Bohm, Andrew; Lin, Li; Chishti, Athar H.] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Schiemer, James; Chishti, Athar H.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Program Cellular & Mol Physiol, Boston, MA 02111 USA; [Lin, Li; Chishti, Athar H.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Program Pharmacol & Expt Therapeut & Mol Microbio, Boston, MA 02111 USA; [Merrill-Skoloff, Glenn; Flaumenhaft, Robert] Harvard Med Sch, Div Hemostasis & Thrombosis, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Huang, Jin-Sheng] Univ Illinois, Prot Res Lab, Res Resources Ctr, Chicago, IL 60612 USA; [Le Breton, Guy C.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA	Tufts University; Tufts University; Tufts University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Chishti, AH (corresponding author), Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA.	athar.chishti@tufts.edu		Merrill-Skoloff, Glenn/0000-0003-2337-5107	National Institutes of Health [HL089517, HL060961, HL24530-29]; American Society of Hematology Bridge Grant Award; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112809, R01HL089517, R01HL024530, R01HL060961, R01HL125275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology Bridge Grant Award; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants HL089517 (to A. H. C.), HL060961 (to A. H. C.), and HL24530-29 (to G. C. L.), American Society of Hematology Bridge Grant Award (to A. S. H.), and a grant-in-aid from the American Heart Association. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anthis NJ, 2010, STRUCTURE, V18, P1654, DOI 10.1016/j.str.2010.09.018; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Cabrita LD, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-12; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; CHEN YP, 1994, J BIOL CHEM, V269, P18307; COLLIER NC, 1982, J BIOL CHEM, V257, P6937; Falati S, 2002, NAT MED, V8, P1175, DOI 10.1038/nm782; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Furie B, 2005, J CLIN INVEST, V115, P3355, DOI 10.1172/JCI26987; Gautam N, 2003, STRUCTURE, V11, P359, DOI 10.1016/S0969-2126(03)00054-6; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; GOLDMANN WH, 1994, J STRUCT BIOL, V112, P3, DOI 10.1006/jsbi.1994.1002; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Goult BT, 2013, J STRUCT BIOL, V184, P21, DOI 10.1016/j.jsb.2013.05.014; Goult BT, 2009, J BIOL CHEM, V284, P15097, DOI 10.1074/jbc.M900078200; Gros E., 1967, METHOD ENZYMOL, V11, P238; Haling JR, 2011, BLOOD, V117, P1719, DOI 10.1182/blood-2010-09-305433; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; He LS, 2003, CYTOM PART A, V55A, P71, DOI 10.1002/cyto.a.10073; Huang JS, 2007, J BIOL CHEM, V282, P10210, DOI 10.1074/jbc.M605678200; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Kreutz B, 2006, BIOCHEMISTRY-US, V45, P167, DOI 10.1021/bi051729t; Lagarrigue F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9492; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Legate KR, 2011, EMBO J, V30, P4539, DOI 10.1038/emboj.2011.332; Leisner TM, 2011, BLOOD, V117, P1442, DOI 10.1182/blood-2010-11-317230; Liu Yang, 2012, World J Exp Med, V2, P30, DOI 10.5493/wjem.v2.i2.30; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Manganello JM, 2003, J BIOL CHEM, V278, P124, DOI 10.1074/jbc.M209219200; Moore DT, 2012, P NATL ACAD SCI USA, V109, P793, DOI 10.1073/pnas.1117220108; Nagy P., 2001, CURR PROTOC CYTOM; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Plow EF, 2015, BLOOD, V125, P207, DOI 10.1182/blood-2014-11-608992; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shen B, 2013, NATURE, V503, P131, DOI 10.1038/nature12613; Shen B, 2012, CURR OPIN CELL BIOL, V24, P600, DOI 10.1016/j.ceb.2012.08.011; Song XQ, 2012, CELL RES, V22, P1533, DOI 10.1038/cr.2012.97; Spagnuolo CC, 2006, J AM CHEM SOC, V128, P12040, DOI 10.1021/ja063212q; Springer TA, 2004, ADV PROTEIN CHEM, V68, P29; Srinivasan S, 2015, J BIOL CHEM, V290, P25129, DOI 10.1074/jbc.M115.650978; Stefanini L, 2014, BLOOD, V123, P2722, DOI 10.1182/blood-2013-12-543363; Stritt S, 2015, BLOOD, V125, P219, DOI 10.1182/blood-2014-08-597542; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Vaiskunaite R, 2000, J BIOL CHEM, V275, P26206, DOI 10.1074/jbc.M001863200; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wang JH, 2012, CELL RES, V22, P1512, DOI 10.1038/cr.2012.103; Worzfeld T, 2008, TRENDS PHARMACOL SCI, V29, P582, DOI 10.1016/j.tips.2008.08.002; Yang J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6880; Ye X, 2016, BBA-BIOMEMBRANES, V1858, P1833, DOI 10.1016/j.bbamem.2016.05.005; Zg H., 2016, STRUCTURE, V24, P721	53	9	10	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26598	26612		10.1074/jbc.M116.747279	http://dx.doi.org/10.1074/jbc.M116.747279			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27803165	Green Published, hybrid			2022-12-26	WOS:000391571400002
J	Hein, L; Bagstad, K; Edens, B; Obst, C; de Jong, R; Lesschen, JP				Hein, Lars; Bagstad, Ken; Edens, Bram; Obst, Carl; de Jong, Rixt; Lesschen, Jan Peter			Defining Ecosystem Assets for Natural Capital Accounting	PLOS ONE			English	Article							CONCEPTUAL-FRAMEWORK; SERVICE FLOWS; LAND-USE; CAPACITY; SCIENCE	In natural capital accounting, ecosystems are assets that provide ecosystem services to people. Assets can be measured using both physical and monetary units. In the international System of Environmental-Economic Accounting, ecosystem assets are generally valued on the basis of the net present value of the expected flow of ecosystem services. In this paper we argue that several additional conceptualisations of ecosystem assets are needed to understand ecosystems as assets, in support of ecosystem assessments, ecosystem accounting and ecosystem management. In particular, we define ecosystems' capacity and capability to supply ecosystem services, as well as the potential supply of ecosystem services. Capacity relates to sustainable use levels of multiple ecosystem services, capability involves prioritising the use of one ecosystem service over a basket of services, and potential supply considers the ability of ecosystems to generate services regardless of demand for these services. We ground our definitions in the ecosystem services and accounting literature, and illustrate and compare the concepts of flow, capacity, capability, and potential supply with a range of conceptual and real-world examples drawn from case studies in Europe and North America. Our paper contributes to the development of measurement frameworks for natural capital to support environmental accounting and other assessment frameworks.	[Hein, Lars] Wageningen Univ, Wageningen, Netherlands; [Bagstad, Ken] World Bank, Wealth Accounting & Valuat Ecosyst Serv WAVES Pro, 1818 H St NW, Washington, DC 20433 USA; [Bagstad, Ken] US Geol Survey, Geosci & Environm Change Sci Ctr, Box 25046, Denver, CO 80225 USA; [Edens, Bram; de Jong, Rixt] Stat Netherlands, The Hague, Netherlands; [Obst, Carl] Univ Melbourne, Melbourne Sustainable Soc Inst, Parkville, Vic, Australia; [Lesschen, Jan Peter] Wageningen UR, Alterra, Wageningen, Netherlands	Wageningen University & Research; The World Bank; United States Department of the Interior; United States Geological Survey; University of Melbourne; Wageningen University & Research	Hein, L (corresponding author), Wageningen Univ, Wageningen, Netherlands.	lars.hein@wur.nl		Bagstad, Kenneth/0000-0001-8857-5615; Lesschen, Jan Peter/0000-0003-1535-8294				[Anonymous], 2010, EC ECOSYSTEMS EFFICI; Bagstad KJ, 2014, ECOL SOC, V19, DOI 10.5751/ES-06523-190264; Bagstad KJ, 2013, ECOSYST SERV, V4, P117, DOI 10.1016/j.ecoser.2012.07.012; Bastian O, 2012, ECOL INDIC, V21, P7, DOI 10.1016/j.ecolind.2011.03.014; Bourassa SC, 2004, ENVIRON PLANN A, V36, P1427, DOI 10.1068/a36103; Boyd J, 2007, ECOL ECON, V63, P616, DOI 10.1016/j.ecolecon.2007.01.002; Brookhuis BJ, 2016, FOREST POLICY ECON, V62, P118, DOI 10.1016/j.forpol.2015.10.002; Burkhard B, 2014, LANDSCAPE ONLINE, V34, P1, DOI [DOI 10.3097/LO.201434, 10.3097/lo.201434, 10.3097/LO.201434]; Carpenter S, 2001, ECOSYSTEMS, V4, P765, DOI 10.1007/s10021-001-0045-9; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Coleman K, 1999, ROTHC 26 3 MODEL TUR, V11; Convertino M, 2014, ENVIRON MODELL SOFTW, V51, P296, DOI 10.1016/j.envsoft.2013.10.001; Convertino M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065056; Costanza R, 2002, ECOL MONOGR, V72, P203, DOI 10.1890/0012-9615(2002)072[0203:IEEMOT]2.0.CO;2; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; Daly E, 2010, ECOLOGICAL EC PRINCI; de Groot R. S., 1992, FUNCTIONS NATURE EVA; Diaz S, 2015, CURR OPIN ENV SUST, V14, P1, DOI 10.1016/j.cosust.2014.11.002; Edens B, 2010, IARIW 2010 C; Edens B, 2013, ECOL ECON, V90, P41, DOI 10.1016/j.ecolecon.2013.03.003; Edens B, 2013, ENVIRON RESOUR ECON, V54, P419, DOI 10.1007/s10640-012-9601-3; Eggleston HS, 2006, IPCC 2006 GUIDELINES; European Commission, 2011, OUR LIF INS OUR NAT; Finke PA, 2001, 389 ALT; Granhus A, 2012, STAT SKOGTORHOLDOG S; Guerry AD, 2015, P NATL ACAD SCI USA, V112, P7348, DOI 10.1073/pnas.1503751112; Haines-Young R., 2010, ECOSYSTEM ECOLOGY NE, DOI DOI 10.1017/CBO9780511750458.007; Harrison Ann., 1993, IMPROVED ACCOUNTING; Hein L, 2015, CURR OPIN ENV SUST, V14, P86, DOI 10.1016/j.cosust.2015.04.002; Holling CS, 2002, PANARCHY UNDERSTANDI, P63; Jackson RB, 2005, SCIENCE, V310, P1944, DOI 10.1126/science.1119282; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Lesschen JP, 2012, 2396 ALT; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lilly GR, 2008, LOW WAKE FI, V24, P67, DOI 10.4027/rgsfcc.2008.04; Maes J, TRENDS ECOSYSTEMS EC; Manning R. E., 2010, STUDIES OUTDOOR RECR; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Obst C, 2016, ENVIRON RESOUR ECON, V64, P1, DOI 10.1007/s10640-015-9921-1; Obst C, 2014, OXFORD REV ECON POL, V30, P126, DOI 10.1093/oxrep/gru003; [OMB] Office of Management and Budget, 2015, M1601 OMB EX OFF PRE; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; Remme RP, 2014, ECOSYST SERV, V10, P6, DOI 10.1016/j.ecoser.2014.07.006; Remme RP, 2015, ECOL ECON, V112, P116, DOI 10.1016/j.ecolecon.2015.02.015; Remme RP, 2015, ECOSYSTEM ACCOUNTI 2; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Schroter M, 2015, ECOSYST SERV, V13, P64, DOI 10.1016/j.ecoser.2014.07.003; Schroter M, 2014, ECOL INDIC, V36, P539, DOI 10.1016/j.ecolind.2013.09.018; SSB, 2012, STAT YB 2012; Statistics Netherlands and Wageningen University, 2015, EC ACC LIMB PROV N 1; Sumarga E, 2014, ENVIRON MANAGE, V54, P84, DOI 10.1007/s00267-014-0282-2; TEEB, 2010, EC EC BIOD MAINSTR E; Turner RK, 2000, ECOL ECON, V35, P7, DOI 10.1016/S0921-8009(00)00164-6; UN, 2014, SYST ENV EC ACC EXP; United Nations, 2016, SEEA EXP EC ACC TECH; United Nations, 2009, SYST NAT ACC; VANOLI A, 1995, REV INCOME WEALTH, P113; Villa F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091001; Villamagna AM, 2013, ECOL COMPLEX, V15, P114, DOI 10.1016/j.ecocom.2013.07.004; Walker B., 2002, PANARCHY UNDERSTANDI, P293; Weber J.-L., 2014, TECHNICAL SERIES, V77, P248; Weber JL, 2007, ECOL ECON, V61, P695, DOI 10.1016/j.ecolecon.2006.05.023; Zank B, 2016, LANDSCAPE URBAN PLAN, V149, P31, DOI 10.1016/j.landurbplan.2016.01.004	63	55	58	14	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e164460	10.1371/journal.pone.0164460	http://dx.doi.org/10.1371/journal.pone.0164460			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9OG	27828969	Green Published, gold, Green Submitted			2022-12-26	WOS:000387724300017
J	Lamp, B; Url, A; Seitz, K; Eichhorn, J; Riedel, C; Sinn, LJ; Indik, S; Koglberger, H; Rumenapf, T				Lamp, Benjamin; Url, Angelika; Seitz, Kerstin; Eichhorn, Juergen; Riedel, Christiane; Sinn, Leonie Janina; Indik, Stanislav; Koeglberger, Hemma; Ruemenapf, Till			Construction and Rescue of a Molecular Clone of Deformed Wing Virus (DWV)	PLOS ONE			English	Article							PICORNA-LIKE VIRUS; DESTRUCTOR ACARI VARROIDAE; HONEY-BEE COLONIES; APIS-MELLIFERA; INFECTIOUS TRANSCRIPTS; PHYLOGENETIC ANALYSIS; TRANSMISSION; VARROA-DESTRUCTOR-VIRUS-1; IDENTIFICATION; REPLICATION	European honey bees are highly important in crop pollination, increasing the value of global agricultural production by billions of dollars. Current knowledge about virulence and pathogenicity of Deformed wing virus (DWV), a major factor in honey bee colony mortality, is limited. With this study, we close the gap between field research and laboratory investigations by establishing a complete in vitro model for DWV pathogenesis. Infectious DWV was rescued from a molecular clone of a DWV-A genome that induces DWV symptoms such as crippled wings and discoloration. The expression of DWV proteins, production of infectious virus progeny, and DWV host cell tropism could be confirmed using newly generated anti-DWV monoclonal antibodies. The recombinant RNA fulfills Koch's postulates circumventing the need of virus isolation and propagation of pure virus cultures. In conclusion, we describe the development and application of a reverse genetics system for the study of DWV pathogenesis.	[Lamp, Benjamin; Seitz, Kerstin; Eichhorn, Juergen; Riedel, Christiane; Sinn, Leonie Janina; Indik, Stanislav; Ruemenapf, Till] Univ Vet Med, Inst Virol, Dept Pathobiol, Vienna, Austria; [Url, Angelika] Univ Vet Med, Inst Pathol & Forens Vet Med, Dept Pathobiol, Vienna, Austria; [Koeglberger, Hemma] Austrian Agcy Hlth & Food Safety, Agr Inspect Serv, Inst Apiculture, Vienna, Austria; [Koeglberger, Hemma] Austrian Agcy Hlth & Food Safety, Res Ctr Vienna, Vienna, Austria; [Koeglberger, Hemma] Fed Off Food Safety, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Lamp, B (corresponding author), Univ Vet Med, Inst Virol, Dept Pathobiol, Vienna, Austria.	Benjamin.Lamp@vetmeduni.ac.at	Ruemenapf, Till/D-4143-2017; Lamp, Benjamin/A-8053-2015; Riedel, Christiane/W-6679-2019	Ruemenapf, Till/0000-0002-2951-7471; Lamp, Benjamin/0000-0002-9668-1896; Seitz, Kerstin/0000-0003-2852-5047; Riedel, Christiane/0000-0002-4349-996X; Indik, Stanislav/0000-0001-8255-6544	BIOS Science Austria [2012_vetmediuni_2]; University of veterinary medicine [PP23014275]	BIOS Science Austria; University of veterinary medicine	This study was funded by "BIOS Science Austria" (http://bios-science.at/index.php/en/; grant: 2012_vetmediuni_2) and the "University of veterinary medicine" (http://www.vetmeduni.ac.at/en/; grant: PP23014275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; Bakonyi T, 2002, APPL ENVIRON MICROB, V68, P6446, DOI 10.1128/AEM.68.12.6446-6450.2002; Benjeddou M, 2002, J GEN VIROL, V83, P3139, DOI 10.1099/0022-1317-83-12-3139; Berenyi O, 2006, APPL ENVIRON MICROB, V72, P2414, DOI 10.1128/AEM.72.4.2414-2420.2006; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; BOYER JC, 1994, VIROLOGY, V198, P415, DOI 10.1006/viro.1994.1053; CIB, 2009, CTR PROM IMP DEV COU; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dainat B, 2013, J INVERTEBR PATHOL, V112, P278, DOI 10.1016/j.jip.2012.12.009; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; Devillers J, 2014, IN SILICO BEES, P179; EVANS AS, 1976, YALE J BIOL MED, V49, P175; FALKOW S, 1988, REV INFECT DIS, V10, pS274; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Fujiyuki T, 2004, J VIROL, V78, P1093, DOI 10.1128/JVI.78.3.1093-1100.2004; Fujiyuki T, 2009, J VIROL, V83, P11560, DOI 10.1128/JVI.00519-09; Fyg W., 1956, J SWISS ENTOMOLOGICA, V29, P404; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Grabensteiner E, 2001, CLIN DIAGN LAB IMMUN, V8, P93, DOI 10.1128/CDLI.8.1.93-104.2001; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Iwasaki JM, 2015, AMBIO, V44, P694, DOI 10.1007/s13280-015-0679-z; Kanbar G, 2005, GENET MOL RES, V4, P465; Kielmanowicz MG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004816; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Lamp B, 2011, J VIROL, V85, P3607, DOI 10.1128/JVI.02206-10; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Locke B, 2012, APPL ENVIRON MICROB, V78, P227, DOI 10.1128/AEM.06094-11; Loeffler F., 1884, MITTHEILUNGEN KAISER, V2, P421; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Mockel N, 2011, J GEN VIROL, V92, P370, DOI 10.1099/vir.0.025940-0; Moore J, 2011, J GEN VIROL, V92, P156, DOI 10.1099/vir.0.025965-0; Mordecai GJ, 2016, ISME J, V10, P1182, DOI 10.1038/ismej.2015.186; Mordecai GJ, 2016, ISME J, V10, P1264, DOI 10.1038/ismej.2015.178; Murakami R, 2014, ARCH VIROL, V159, P585, DOI 10.1007/s00705-013-1850-0; Ongus JR, 2004, J GEN VIROL, V85, P3747, DOI 10.1099/vir.0.80470-0; Ongus JR, 2006, J GEN VIROL, V87, P3397, DOI 10.1099/vir.0.82122-0; Pekosz A, 1999, P NATL ACAD SCI USA, V96, P8804, DOI 10.1073/pnas.96.16.8804; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Ryabov EV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004230; Steinhauer NA, 2014, J APICULT RES, V53, P1, DOI 10.3896/IBRA.1.53.1.01; Stokstad E, 2007, SCIENCE, V316, P970, DOI 10.1126/science.316.5827.970; Thompson CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105164; Vandervalk LP, 2014, J ECON ENTOMOL, V107, P2030, DOI 10.1603/EC14048; Wantuch HA, 2009, J ECON ENTOMOL, V102, P2033, DOI 10.1603/029.102.0603; Wilfert L, 2016, SCIENCE, V351, P594, DOI 10.1126/science.aac9976; Winfree R, 2011, ECOL ECON, V71, P80, DOI 10.1016/j.ecolecon.2011.08.001; Yue C, 2007, J GEN VIROL, V88, P2329, DOI 10.1099/vir.0.83101-0; Zhang QS, 2007, J INVERTEBR PATHOL, V96, P97, DOI 10.1016/j.jip.2007.03.019; Zioni N, 2011, VIROLOGY, V417, P106, DOI 10.1016/j.virol.2011.05.009	52	39	43	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0164639	10.1371/journal.pone.0164639	http://dx.doi.org/10.1371/journal.pone.0164639			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828961	Green Published, Green Submitted, gold			2022-12-26	WOS:000387724300019
J	Skrunes, R; Svarstad, E; Reisaeter, AV; Marti, HP; Vikse, BE				Skrunes, Rannveig; Svarstad, Einar; Reisaeter, Anna Varberg; Marti, Hans-Peter; Vikse, Bjorn Egil			End Stage Renal Disease Predicts Increased Risk of Death in First Degree Relatives in the Norwegian Population	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR-DISEASE; NEPHROTIC SYNDROME; ASSOCIATION; MORTALITY; MELLITUS; EUROPE; FSGS; MEN; ERA	Background Increased risk of end stage renal disease (ESRD) and death in Norwegian living kidney donors has been reported, most of the donors were related to the recipient. The present study investigates risk of death in first degree relatives of ESRD patients. Methods The Norwegian Population Registry, The Norwegian Cause of Death Registry and the Norwegian Renal Registry were linked. All citizens born in Norway, alive in 1960 and with at least one registered first degree relative were included; individuals who died during the first year of life were excluded. A cohort-design was used, ESRD in a first degree relative was the main exposure variable and death and causes of death were the main outcome variables. Cox regression statistics were used to investigate mortality risks. Results 5 130 600 individuals were included, 27 508 had at least one first degree relative with ESRD. 828 022 died during follow-up, of whom 4105 had a first degree relative with ESRD. Adjusted hazard ratio (aHR) for death was 1.13 (1.09-1.16) in individuals with a relative with ESRD compared to those without a relative with ESRD. Excluding known hereditary renal disease, aHR decreased to 1.12 (1.09-1.15). Cardiovascular death aHR was 1.15 (1.10-1.21), of which cerebrovascular death 1.34 (1.22-1.50). aHR for death due to non-hereditary renal/ureteric disease was 2.29 (1.81-2.91) with renal failure 1.80 (1.26-2.56) and glomerular disease 5.69 (3.88-8.34) as main contributors. Diabetes mellitus death aHR was 1.68 (1.35-2.10). Absolute mortality risks increased most for the oldest cohorts with excess mortality of 148 per 100.000 person years for the cohort born 1920-39 and 218 for the cohort born 1900-1919. Conclusions ESRD in first degree relatives was associated with increased hazard ratio for death. Death due to cardiovascular disease, renal disease and diabetes mellitus increased the most.	[Skrunes, Rannveig; Svarstad, Einar; Marti, Hans-Peter] Haukeland Hosp, Dept Med, Bergen, Norway; [Skrunes, Rannveig; Svarstad, Einar; Marti, Hans-Peter; Vikse, Bjorn Egil] Univ Bergen, Dept Clin Med, Bergen, Norway; [Reisaeter, Anna Varberg] Oslo Univ Hosp, Dept Transplantat Med, Rikshosp, Oslo, Norway; [Vikse, Bjorn Egil] Haugesund Hosp, Dept Med, Haugesund, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Oslo; National Hospital Norway	Skrunes, R (corresponding author), Haukeland Hosp, Dept Med, Bergen, Norway.; Skrunes, R (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.	rannvsk@online.no			Helse-Vest	Helse-Vest	Funded by PhD grant from Helse-Vest http://www.helse-vest.no/en/Sider/default.aspx awarded to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Brancati FL, 1997, JAMA-J AM MED ASSOC, V278, P2069, DOI 10.1001/jama.278.23.2069; Brown EJ, 2014, KIDNEY INT, V85, P1030, DOI 10.1038/ki.2014.48; Finne P, 2005, JAMA-J AM MED ASSOC, V294, P1782, DOI 10.1001/jama.294.14.1782; Florez JC, 2003, ANNU REV GENOM HUM G, V4, P257, DOI 10.1146/annurev.genom.4.070802.110436; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goldfarb-Rumyantzev AS, 2006, AM J NEPHROL, V26, P142, DOI 10.1159/000092280; Koene RJ, 2016, CIRCULATION, V133, P1104, DOI 10.1161/CIRCULATIONAHA.115.020406; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Mjoen G, 2014, KIDNEY INT, V86, P162, DOI 10.1038/ki.2013.460; Naiman N, 2009, AM J NEPHROL, V29, P237, DOI 10.1159/000156721; Pollak MR, 2002, J AM SOC NEPHROL, V13, P3016, DOI 10.1097/01.ASN.0000039569.34360.5E; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Sesso HD, 2001, CIRCULATION, V104, P393, DOI 10.1161/hc2901.093115; Skrunes R, 2014, CLIN J AM SOC NEPHRO, V9, P1692, DOI 10.2215/CJN.01680214; Stewart JH, 2003, J AM SOC NEPHROL, V14, P197, DOI 10.1097/01.ASN.0000039608.81046.81; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; van Dijk PCW, 2001, NEPHROL DIAL TRANSPL, V16, P1120, DOI 10.1093/ndt/16.6.1120; Wong G, 2009, J AM SOC NEPHROL, V20, P1341, DOI 10.1681/ASN.2008090998	20	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165026	10.1371/journal.pone.0165026	http://dx.doi.org/10.1371/journal.pone.0165026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828975	Green Published, gold, Green Submitted			2022-12-26	WOS:000387724300025
J	Notohamiprodjo, M; Kalnins, A; Andrassy, M; Kolb, M; Ehle, B; Mueller, S; Thomas, MN; Werner, J; Guba, M; Nikolaou, K; Andrassy, J				Notohamiprodjo, Mike; Kalnins, Aivars; Andrassy, Martin; Kolb, Manuel; Ehle, Benjamin; Mueller, Susanna; Thomas, Michael N.; Werner, Jens; Guba, Markus; Nikolaou, Konstantin; Andrassy, Joachim			Multiparametric Functional MRI: A Tool to Uncover Subtle Changes following Allogeneic Renal Transplantation	PLOS ONE			English	Article							SPIN-LABELING MRI; LONG-TERM; ALLOGRAFT SURVIVAL; UNITED-STATES; IN-VIVO; DIFFUSION; PERFUSION; KIDNEY; MICE; PARAMETERS	Purpose To investigate multiparametric functional MRI to characterize acute rejection in a murine allogeneic renal transplant model and evaluate the effect of novel therapeutics. Material and Methods We performed allogeneic and syngeneic orthotopic transplantations (Balb/c to C57Bl/6 and C57Bl/6 to C57Bl/6). Allogeneic Groups (n = 5) were either treated with the anti-CCL2-Spiegelmer (mNOX-E36) in monotherapy or in combination with low doses of Ciclosporin-A (10mg/kgBW/d) for 10 days. Controls received equivalent doses of a non-functional spiegelmer (revmNOX-E36) or low dose Ciclosporin-A. Diffusion-weighted (DWI) and Dynamic-contrast-enhanced (DCE-) MRI-scans were performed using a clinical 3T-scanner. DWI analysis (b-values from 0-800 s/mm(2)) was performed mono-and biexponentially, while DCE-MRI was assessed with deconvolution analysis. Therapy effects were assessed ex vivo with histopathology, immunohistochemistry and RT-PCR. Statistical analysis was performed with unpaired t-tests and Spearman As correlation coefficient. Results DWI showed a significant diffusion restriction in allogeneic compared to syngeneic transplants (ADC: 0.63 +/- 0.08 vs. 1.29 +/- 0.12 mm(2)/s*10(3)) with decreasing diffusion restriction under therapy. DCE-MRI showed restored organ perfusion under Ciclosporin A alone and combination therapy (Plasma Flow: 43.43 +/- 12.49; 38.75 +/- 7.53ml/100ml/min) compared to syngeneic controls (51.03 +/- 12.49ml/100ml/min). Ex vivo analysis showed reduced monocytic infiltrates, attenuated levels of inflammatory cytokines under mNOX-E36 monotherapy with an additive effect of low dose Ciclosporin A. There was a significant (p<0.05) negative correlation between ADC and interstitial inflammation (r = -0.73) or macrophage infiltration (r = -0.81) and between organ perfusion and intimal arteritis (r = -0.63). Conclusion Multiparametric functional MRI is suited to detect renal allograft rejection in an experimental murine model and allows to characterize effects of immunosuppressive therapy alleviating acute rejection processes in allogeneic transplantation.	[Notohamiprodjo, Mike; Kolb, Manuel; Nikolaou, Konstantin] Univ Hosp Tuebingen, Dept Radiol, Tubingen, Germany; [Notohamiprodjo, Mike; Kolb, Manuel] Univ Hosp Munich, Dept Clin Radiol, Munich, Germany; [Kalnins, Aivars; Ehle, Benjamin; Thomas, Michael N.; Werner, Jens; Guba, Markus; Andrassy, Joachim] Univ Hosp Munich, Dept Surg, Munich, Germany; [Andrassy, Martin] Rupprecht Karls Univ, Dept Med, Heidelberg, Germany; [Mueller, Susanna] Ludwig Maximilians Univ Munchen, Dept Pathol, Munich, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; University of Munich; Ruprecht Karls University Heidelberg; University of Munich	Notohamiprodjo, M (corresponding author), Univ Hosp Tuebingen, Dept Radiol, Tubingen, Germany.; Notohamiprodjo, M (corresponding author), Univ Hosp Munich, Dept Clin Radiol, Munich, Germany.	Mike.Notohamiprodjo@med.uni-tuebingen.de	Guba, Markus/M-4309-2019		Else-Kroner-Fresenius Stiftung [A 80/09]; Fbrderprogramm fur Forschung und Lehre of the Ludwig-Maximilians-University Munich [762]	Else-Kroner-Fresenius Stiftung; Fbrderprogramm fur Forschung und Lehre of the Ludwig-Maximilians-University Munich	This work was supported by the Else-Kroner-Fresenius Stiftung (J.A. A 80/09) and by the Fbrderprogramm fur Forschung and Lehre (Antr. 762) of the Ludwig-Maximilians-University Munich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi R, 2004, J IMMUNOL, V172, P767, DOI 10.4049/jimmunol.172.2.767; Belperio JA, 2001, J CLIN INVEST, V108, P547, DOI 10.1172/JCI200112214; Braunagel M, 2016, INVEST RADIOL, V51, P316, DOI 10.1097/RLI.0000000000000245; Broecker V, 2015, TRANSPL INT, V28, P136, DOI 10.1111/tri.12446; Callot V, 2003, MAGN RESON MED, V50, P531, DOI 10.1002/mrm.10568; Chandarana H, 2011, INVEST RADIOL, V46, P285, DOI 10.1097/RLI.0b013e3181ffc485; Darisipudi MN, 2011, AM J PATHOL, V179, P116, DOI 10.1016/j.ajpath.2011.03.004; Eisenberger U, 2010, EUR RADIOL, V20, P1374, DOI 10.1007/s00330-009-1679-9; Franke M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114737; Furness PN, 2003, AM J SURG PATHOL, V27, P805, DOI 10.1097/00000478-200306000-00012; Gondos A, 2012, KIDNEY GRAFT SURVIVA; Hancock WW, 2003, IMMUNOL REV, V196, P37, DOI 10.1046/j.1600-065X.2003.00084.x; Heusch P, 2014, J MAGN RESON IMAGING, V40, P84, DOI 10.1002/jmri.24336; Heusch P, 2013, ACTA RADIOL, V54, P1210, DOI 10.1177/0284185113491090; Heusch P, 2013, INVEST RADIOL, V48, P140, DOI 10.1097/RLI.0b013e318277bfe3; Hoffmann S., 2011, CURR PROTOC NUCL ACI, V4, P41; Hueper K, 2016, INVEST RADIOL, V51, P58, DOI 10.1097/RLI.0000000000000205; Hueper K, 2014, RADIOLOGY, V270, P117, DOI 10.1148/radiol.13130367; Hueper K, 2012, INVEST RADIOL, V47, P430, DOI 10.1097/RLI.0b013e31824f272d; Hueper K, 2011, EUR RADIOL, V21, P2427, DOI 10.1007/s00330-011-2189-0; Johnston DR, 2002, FRONT BIOSCI-LANDMRK, V7, pE116, DOI 10.2741/johnston; Kalnins A, 2015, SCAND J IMMUNOL; Klussmann S, 1996, NAT BIOTECHNOL, V14, P1112, DOI 10.1038/nbt0996-1112; Kulkarni O, 2009, J PHARMACOL EXP THER, V328, P371, DOI 10.1124/jpet.108.142711; Lamb KE, 2011, AM J TRANSPLANT, V11, P450, DOI 10.1111/j.1600-6143.2010.03283.x; Lanzman RS, 2013, RADIOLOGY, V266, P218, DOI 10.1148/radiol.12112522; Lanzman RS, 2010, EUR RADIOL, V20, P1485, DOI 10.1007/s00330-009-1675-0; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Lee YR, 2005, BLOOD, V105, P3951, DOI 10.1182/blood-2004-10-3927; Lodhi SA, 2011, AM J TRANSPLANT, V11, P1226, DOI 10.1111/j.1600-6143.2011.03539.x; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; Ninichuk V, 2008, AM J PATHOL, V172, P628, DOI 10.2353/ajpath.2008.070601; Notohamiprodjo M, 2014, MAGNETIC RESONANCE M; Notohamiprodjo M, 2008, INVEST RADIOL, V43, P677, DOI 10.1097/RLI.0b013e31817d14e6; Notohamiprodjo M, 2010, EUR J RADIOL, V76, P337, DOI 10.1016/j.ejrad.2010.05.033; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; RUSSELL PS, 1978, J EXP MED, V147, P1449, DOI 10.1084/jem.147.5.1449; Wirestam R, 2001, ACTA RADIOL, V42, P123, DOI 10.1080/028418501127346459; Yang DW, 2004, RADIOLOGY, V231, P702, DOI 10.1148/radiol.2313021587	39	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165532	10.1371/journal.pone.0165532	http://dx.doi.org/10.1371/journal.pone.0165532			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820833	Green Submitted, Green Published, gold			2022-12-26	WOS:000387614800012
J	Huang, P; Huang, HH; Luo, QL; Mo, L				Huang, Ping; Huang, Hanhua; Luo, Qiuling; Mo, Lei			The Difference between Aesthetic Appreciation of Artistic and Popular Music: Evidence from an fMRI Study	PLOS ONE			English	Article							BRAIN; EMOTION; SYSTEMS; ATTENTION; REWARDS; EMPATHY	To test the hypothesis that pleasure from artistic music is intellectual while that from popular music is physiological, this study investigated the different functional mechanisms between aesthetic appreciation of artistic and popular music using fMRI. 18 male non-musicians were scanned while they performed an aesthetic rating task for excerpts of artistic music, popular music and musical notes playing and singing (control). The rating scores of artistic and popular music excerpts were both significantly higher than that of control materials while the scores of them were not different. The fMRI results showed both artistic and popular conditions activated the VS and vmPFC, compared with control condition. When contrasted popular and artistic condition directly, we found popular music activated right putamen, while artistic music activated right mPFC. By parametric analysis, we found the activation of right putamen tracked the aesthetic ratings of popular music, whereas the BOLD signal in right mPFC tracked the aesthetic ratings of artistic music. These results indicate the reward induced by popular music is closer to a primary reward while that induced by artistic music is closer to a secondary reward. We also found artistic music activated ToM areas, including PCC/PC, arMFC and TPJ, when compared with popular music. And these areas also tracked aesthetic ratings of artistic music but not those of popular music. These results imply that the pleasure from former comes from cognitive empathy. In conclusion, this study gives clear neuronal evidences supporting the view that artistic music is of intelligence and social cognition involved while the popular music is of physiology.	[Huang, Ping; Luo, Qiuling; Mo, Lei] South China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Huang, Hanhua] South China Normal Univ, Sch Mus, Guangzhou, Guangdong, Peoples R China	South China Normal University; South China Normal University	Mo, L (corresponding author), South China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China.	molei@scnu.edu.cn			National Natural Science Foundation of China (NSFC) [31170997]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	The work is supported by National Natural Science Foundation of China (NSFC, No. 31170997). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorno Theodor, 2002, ESSAYS MUSIC; Berenson Bernard, 1964, SELECTED LETT B BERE; Berlyne D. E., 1971, AESTHETICS PSYCHOBIO; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Bray S, 2007, J NEUROPHYSIOL, V97, P3036, DOI 10.1152/jn.01211.2006; Brown S, 2004, NEUROREPORT, V15, P2033, DOI 10.1097/00001756-200409150-00008; Brown S, 2011, NEUROIMAGE, V58, P250, DOI 10.1016/j.neuroimage.2011.06.012; Cabeza R., 2010, SOCIAL COGNITIVE AFF, V6, P138; Cinzia D, 2009, CURR OPIN NEUROBIOL, V19, P682, DOI 10.1016/j.conb.2009.09.001; Cupchik GC, 2002, CULT PSYCHOL, V8, P155, DOI 10.1177/1354067X02008002437; Di Dio C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001201; Engelmann JB, 2009, BRAIN RES, V1290, P28, DOI 10.1016/j.brainres.2009.06.078; Freedberg D, 2007, TRENDS COGN SCI, V11, P197, DOI 10.1016/j.tics.2007.02.003; Geday J, 2009, BRAIN COGNITION, V69, P344, DOI 10.1016/j.bandc.2008.08.009; Gracyk T., 2007, LISTENING POPULAR MU; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Ishizu T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021852; Jacobsen T, 2006, NEUROIMAGE, V29, P276, DOI 10.1016/j.neuroimage.2005.07.010; Kawabata H, 2004, J NEUROPHYSIOL, V91, P1699, DOI 10.1152/jn.00696.2003; Kirk U, 2009, BRAIN COGNITION, V69, P306, DOI 10.1016/j.bandc.2008.08.004; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Kranz F, 2006, CURR BIOL, V16, P63, DOI 10.1016/j.cub.2005.10.070; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Mende-Siedlecki P, 2012, SOCIAL COGNITIVE AFF; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; Mohanty A, 2007, PSYCHOPHYSIOLOGY, V44, P343, DOI 10.1111/j.1469-8986.2007.00515.x; Nummenmaa L, 2008, NEUROIMAGE, V43, P571, DOI 10.1016/j.neuroimage.2008.08.014; O'Doherty J, 2003, J NEUROSCI, V23, P7931; Sescousse G, 2013, NEUROSCI BIOBEHAV R, V37, P681, DOI 10.1016/j.neubiorev.2013.02.002; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Trost W, 2012, CEREB CORTEX, V22, P2769, DOI 10.1093/cercor/bhr353; Vartanian O, 2004, NEUROREPORT, V15, P893, DOI 10.1097/00001756-200404090-00032; Vessel EA, 2012, FRONT HUM NEUROSCI, V6; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wang T, 2014, SOCIAL COGNITIVE AFF; Warburg Aby, 1999, RENEWAL PAGAN ANTIQU; Winston JS, 2007, NEUROPSYCHOLOGIA, V45, P195, DOI 10.1016/j.neuropsychologia.2006.05.009; Yu HC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0066447, 10.1371/journal.pone.0055705, 10.1371/journal.pone.0057111]	38	6	6	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165377	10.1371/journal.pone.0165377	http://dx.doi.org/10.1371/journal.pone.0165377			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814379	Green Published, gold, Green Submitted			2022-12-26	WOS:000386911100009
J	Wagland, R; Brindle, L; Ewings, S; James, E; Moore, M; Rivas, C; Esqueda, AI; Corner, J				Wagland, Richard; Brindle, Lucy; Ewings, Sean; James, Elizabeth; Moore, Mike; Rivas, Carol; Esqueda, Ana Ibanez; Corner, Jessica			Promoting Help-Seeking in Response to Symptoms amongst Primary Care Patients at High Risk of Lung Cancer: A Mixed Method Study	PLOS ONE			English	Article							DIAGNOSIS; DELAY; GP; EXPERIENCES; AWARENESS; SURVIVAL; IMPACT; UK	Background Lung cancer symptoms are vague and difficult to detect. Interventions are needed to promote early diagnosis, however health services are already pressurised. This study explored symptomology and help-seeking behaviours of primary care patients at 'high-risk' of lung cancer (>= 50 years old, recent smoking history), to inform targeted interventions. Methods Mixed method study with patients at eight general practitioner (GP) practices across south England. Study incorporated: postal symptom questionnaire; clinical records review of participant consultation behaviour 12 months pre-and post-questionnaire; qualitative participant interviews (n = 38) with a purposive sample. Results A small, clinically relevant group (n = 61/908, 6.7%) of primary care patients was identified who, despite reporting potential symptoms of lung cancer in questionnaires, had not consulted a GP >= 12 months. Of nine symptoms associated with lung cancer, 53.4% (629/1172) of total respondents reported >= 1, and 35% (411/1172) reported >= 2. Most participants (77.3%, n = 686/908) had comorbid conditions; 47.8%, (n = 414/908) associated with chest and respiratory symptoms. Participant consulting behaviour significantly increased in the 3-month period following questionnaire completion compared with the previous 3month period (p = .002), indicating questionnaires impacted upon consulting behaviour. Symptomatic non-consulters were predominantly younger, employed, with higher multiple deprivation scores than their GP practice mean. Of symptomatic non-consulters, 30% (18/61) consulted <= 1 month post-questionnaire, with comorbidities subsequently diagnosed for five participants. Interviews ( n = 39) indicated three overarching differences between the views of consulting and non-consulting participants: concern over wasting their own as well as GP time; high tolerance threshold for symptoms; a greater tendency to self-manage symptoms. Conclusions This first study to examine symptoms and consulting behaviour amongst a primary care population at 'high-risk' of lung cancer, found symptomatic patients who rarely consult GPs, might respond to a targeted symptom elicitation intervention. Such GP-based interventions may promote early diagnosis of lung cancer or other comorbidities, without burdening already pressurised services.	[Wagland, Richard; Brindle, Lucy; James, Elizabeth; Rivas, Carol; Esqueda, Ana Ibanez] Univ Southampton, Fac Hlth Sci, Southampton SO17 1BJ, Hants, England; [Ewings, Sean] Univ Southampton, Southampton Stat Sci Res Inst, Fac Social Human & Math Sci, Southampton, Hants, England; [Moore, Mike] Univ Southampton, Fac Med, Southampton SO17 1BJ, Hants, England; [Corner, Jessica] Univ Nottingham, Execut Off, Univ Pk, Nottingham NG7 2RD, England	University of Southampton; University of Southampton; University of Southampton; University of Nottingham	Wagland, R (corresponding author), Univ Southampton, Fac Hlth Sci, Southampton SO17 1BJ, Hants, England.	R.Wagland@soton.ac.uk	rivas, carol/Q-1196-2015; Moore, Michael/C-3447-2011	rivas, carol/0000-0002-0316-8090; Moore, Michael/0000-0002-5127-4509; Wagland, Richard/0000-0003-1825-7587; Corner, Jessica/0000-0002-2240-8133; Ewings, Sean/0000-0001-7214-4917	National Awareness and Early Diagnosis Initiative (NAEDI) [C3801/A14137]; National Institute for Health Research [14/156/15] Funding Source: researchfish	National Awareness and Early Diagnosis Initiative (NAEDI); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the National Awareness and Early Diagnosis Initiative (NAEDI), grant number C3801/A14137.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athey VL, 2012, THORAX, V67, P412, DOI 10.1136/thoraxjnl-2011-200714; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Birt L, 2013, BMJ OPEN RESPIR RES, V1, DOI 10.1136/bmjresp-2014-000067; Biswas M, 2015, BRIT J CANCER, V112, P271, DOI 10.1038/bjc.2014.597; Bowen EF, 2002, LUNG CANCER-J IASLC, V37, P227, DOI 10.1016/S0169-5002(02)00143-5; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brindle LA, 2014, EUR J CANCER CARE, V23, P3; Brindle LA, 2015, BEHALF IPCARD FEASIB; Brindle L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001977; Cancer Research UK, 2014, BE CLEAR CANC EV SUM; Chambers SK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-184; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Corner J, 2005, THORAX, V60, P314, DOI 10.1136/thx.2004.029264; Corner J, 2006, THORAX, V60, P1382; Corner J, 2011, J EPIDEMIOL COMMUN H, V65, P477, DOI 10.1136/jech.2008.084285; Cromme SK, 2016, BRIT J GEN PRACT, V66, pE474, DOI 10.3399/bjgp16X685621; Department of Health, 2014, IMPR OUTC STRAT CANC; Hamilton W, 2005, THORAX, V60, P1059, DOI 10.1136/thx.2005.045880; Hamilton W, 2004, FAM PRACT, V21, P605, DOI 10.1093/fampra/cmh605; Hamilton W, 2009, BRIT J CANCER, V101, pS80, DOI 10.1038/sj.bjc.6605396; Hippisley-Cox J, 2013, BR J GEN PRACT; Hippisley-Cox J, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X606627; Ironmonger L, 2015, BRIT J CANCER, V112, P207, DOI 10.1038/bjc.2014.596; Lyratzopoulos G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7400; Moffat J, 2015, BRIT J CANCER, V112, pS14, DOI 10.1038/bjc.2015.31; Molassiotis A, 2010, EUR J CANCER CARE, V19, P98, DOI 10.1111/j.1365-2354.2008.01020.x; Murray SR, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008046; Newcombe RG, 1998, STAT MED, V17, P2635, DOI 10.1002/(SICI)1097-0258(19981130)17:22<2635::AID-SIM954>3.0.CO;2-C; O'Dowd EL, 2015, THORAX, V70, P161, DOI 10.1136/thoraxjnl-2014-205692; PULSE, 2014, 3 WEEK COUGH LUNG CA; Richards MA, 2009, BRIT J CANCER, V101, pS125, DOI 10.1038/sj.bjc.6605402; Rose PW, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007212; Rubin G, 2006, BRIT J GEN PRACT, V56, P743; Scott SE, 2013, BRIT J HEALTH PSYCH, V18, P45, DOI 10.1111/j.2044-8287.2012.02077.x; Simon AE, 2010, CANCER EPIDEM BIOMAR, V19, P2272, DOI 10.1158/1055-9965.EPI-10-0219; Smith LK, 2005, LANCET, V366, P825, DOI 10.1016/S0140-6736(05)67030-4; Smith SM, 2009, THORAX, V64, P523, DOI 10.1136/thx.2008.096560; Smith S, 2013, BRIT J GEN PRACT, V63, DOI 10.3399/bjgp13X660779; Walter FM, 2015, BRIT J CANCER, V112, pS6, DOI 10.1038/bjc.2015.30; Walton L, 2013, FAM PRACT; Weller D, 2012, BRIT J CANCER, V106, P1262, DOI 10.1038/bjc.2012.68; Young RP, 2009, EUR RESPIR J, V34, P380, DOI 10.1183/09031936.00144208	42	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165677	10.1371/journal.pone.0165677	http://dx.doi.org/10.1371/journal.pone.0165677			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814375	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000386911100013
J	Wang, T; Meng, J; Li, L; Zhang, GF				Wang, Ting; Meng, Jie; Li, Li; Zhang, Guofan			Characterization of CgHIF alpha-Like, a Novel bHLH-PAS Transcription Factor Family Member, and Its Role under Hypoxia Stress in the Pacific Oyster Crassostrea gigas	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; PROLYL HYDROXYLASES PHD1; GENE-EXPRESSION; LITTORINA-LITTOREA; ENERGY-METABOLISM; PROLONGED ANOXIA; SEASONAL-CHANGE; MESSENGER-RNA; T-LYMPHOCYTES; FACTOR-LOT	Hypoxia-inducible factor (HIF), a critical member of the basic-helix-loop-helix (bHLH)-containing Per-Arnt-Sim (PAS) protein family, is a master transcription factor involved in maintaining oxygen homeostasis. In the present study, we isolated and characterized a novel bHLH-PAS family member, CgHIF alpha-like gene, from the Pacific oyster Crassostrea gigas, and determined its importance during hypoxia stress. The 3020-bp CgHIF alpha-like cDNA encoded a protein of 888 amino acids. The predicted CgHIF alpha-like amino acid sequence was conserved in the N-terminal bHLH, PAS, and PAC domains (but not in the C-terminal domain) and was most closely related to the HIF family in the bHLH-PAS protein phylogenic tree. Similar to the mammalian HIF-1a, CgHIF alpha-like could be expressed as four mRNA iso-forms containing alternative 50-untranslated regions and different translation initiation codons. At the mRNA level, these isoforms were expressed in a tissue-specific manner and showed increased transcription to varying degrees under hypoxic conditions. Additionally, the western blot analysis demonstrated that CgHIF alpha-like was induced by hypoxia. Electrophoretic mobility shift assay indicated that CgHIF alpha-like could bind to the hypoxia responsive element (HRE), whereas dual-luciferase reporter analysis demonstrated that CgHIF alpha-like could transactivate the reporter gene containing the HREs. In addition to CgHIF alpha-like, we identified CgARNT from the C. gigas, analyzed its expression pattern, and confirmed its interaction with CgHIF alpha-like using a yeast two-hybrid assay. In conclusion, this is the first report on the cloning and characterization of a novel hypoxia transcription factor in mollusks, which could accumulate under hypoxia and regulate hypoxia related gene expression by binding to HRE and dimerizing with CgARNT. As only one member of HIF has been identified in invertebrates to date, our results provide new insights into the unique mechanisms of hypoxia tolerance in mollusks.	[Wang, Ting; Meng, Jie; Li, Li; Zhang, Guofan] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Wang, Ting] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Ting; Zhang, Guofan] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Meng, Jie; Li, Li] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries & Aquaculture, Qingdao, Shandong, Peoples R China; [Wang, Ting; Meng, Jie; Li, Li; Zhang, Guofan] Chinese Acad Sci, Natl & Local Joint Engn Lab Ecol Mariculture, Inst Oceanol, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Qingdao National Laboratory for Marine Science & Technology; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; Institute of Oceanology, CAS	Li, L; Zhang, GF (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.; Zhang, GF (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.; Li, L (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries & Aquaculture, Qingdao, Shandong, Peoples R China.; Li, L; Zhang, GF (corresponding author), Chinese Acad Sci, Natl & Local Joint Engn Lab Ecol Mariculture, Inst Oceanol, Qingdao, Peoples R China.	lili@qdio.ac.cn; gfzhang@qdio.ac.cn	li, li/GPX-3938-2022; LI, LI/GVS-5344-2022; li, li/HII-4157-2022; Li, Li/AEM-3636-2022		National Basic Research Program of China (973 Program) [2010CB126401]; National Natural Science Foundation of China [31530079]; Earmarked Fund for Modern Agro-industry Technology Research System [CARS-48]; Taishan Scholars Climbing Program of Shandong	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for Modern Agro-industry Technology Research System; Taishan Scholars Climbing Program of Shandong	The authors would like to thank Prof. Cunming Duan (University of Michigan) for providing the p2.1 reporter gene. This research was supported by National Basic Research Program of China (973 Program, No.2010CB126401), the National Natural Science Foundation of China (31530079), the Earmarked Fund for Modern Agro-industry Technology Research System (CARS-48), and Taishan Scholars Climbing Program of Shandong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Azevedo SV, 2011, J INSECT PHYSIOL, V57, P38, DOI 10.1016/j.jinsphys.2010.09.004; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Boutilier RG, 2001, J EXP BIOL, V204, P3171; Bracken CP, 2003, CELL MOL LIFE SCI, V60, P1376, DOI 10.1007/s00018-003-2370-y; Brahimi-Horn MC, 2007, FEBS LETT, V581, P3582, DOI 10.1016/j.febslet.2007.06.018; Cai XH, 2014, GENE, V534, P256, DOI 10.1016/j.gene.2013.10.048; Choi SH, 2013, FISH SHELLFISH IMMUN, V35, P476, DOI 10.1016/j.fsi.2013.05.001; Depping R, 2004, BIOL REPROD, V71, P331, DOI 10.1095/biolreprod.104.027797; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Du YS, 2013, FISH SHELLFISH IMMUN, V34, P939, DOI 10.1016/j.fsi.2012.12.007; EBERLEE JC, 1983, CAN J ZOOL, V61, P2682, DOI 10.1139/z83-353; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Feala JD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100139; Gao S, 2014, FASEB J, V28, P1880, DOI 10.1096/fj.12-220152; Giannetto A, 2015, MAR BIOTECHNOL, V17, P768, DOI 10.1007/s10126-015-9655-7; Gorr TA, 2006, J INSECT PHYSIOL, V52, P349, DOI 10.1016/j.jinsphys.2006.01.002; Gray JS, 2002, MAR ECOL PROG SER, V238, P249, DOI 10.3354/meps238249; Greenway SC, 2001, CAN J ZOOL, V79, P907, DOI 10.1139/cjz-79-5-907; Greenway SC, 2000, J COMP PHYSIOL B, V170, P285, DOI 10.1007/s003600000098; Hampton-Smith RJ, 2009, ANN NY ACAD SCI, V1177, P19, DOI 10.1111/j.1749-6632.2009.05035.x; Hardy KM, 2012, COMP BIOCHEM PHYS A, V163, P137, DOI 10.1016/j.cbpa.2012.05.195; Hoback WW, 2001, J INSECT PHYSIOL, V47, P533, DOI 10.1016/S0022-1910(00)00153-0; Hochachka PW, 2001, COMP BIOCHEM PHYS B, V130, P435, DOI 10.1016/S1096-4959(01)00408-0; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kawabe S, 2012, MAR BIOTECHNOL, V14, P106, DOI 10.1007/s10126-011-9394-3; Kawabe S, 2010, FISHERIES SCI, V76, P841, DOI 10.1007/s12562-010-0263-1; Kietzmann T, 2001, BIOCHEM J, V354, P531, DOI 10.1042/0264-6021:3540531; Larade K, 2002, MOL CELL BIOCHEM, V232, P121, DOI 10.1023/A:1014811017753; Larade K., 2002, CELL MOL RESPONSES S, P27, DOI DOI 10.1016/S1568-1254(02)80005-5; Le Moullac G, 2007, MAR BIOL RES, V3, P357, DOI 10.1080/17451000701635128; Li TD, 2007, COMP BIOCHEM PHYS B, V147, P11, DOI 10.1016/j.cbpb.2006.12.018; LINDEBRO MC, 1995, EMBO J, V14, P3528, DOI 10.1002/j.1460-2075.1995.tb07359.x; Liu CC, 2014, MAR ENVIRON RES, V99, P44, DOI 10.1016/j.marenvres.2014.05.012; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; Lukashev D, 2001, J BIOL CHEM, V276, P48754, DOI 10.1074/jbc.M104782200; Lukashev D, 2008, HUM IMMUNOL, V69, P421, DOI 10.1016/j.humimm.2008.05.004; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Nambu JR, 1996, GENE, V172, P249, DOI 10.1016/0378-1119(96)00060-1; Piontkivska H, 2011, COMP BIOCHEM PHYS D, V6, P103, DOI 10.1016/j.cbd.2010.10.003; Portner HO, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002561; Powell-Coffman JA, 1998, P NATL ACAD SCI USA, V95, P2844, DOI 10.1073/pnas.95.6.2844; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Rytkonen KT, 2014, GENE, V541, P60, DOI 10.1016/j.gene.2014.03.007; Rytkonen KT, 2011, MOL BIOL EVOL, V28, P1913, DOI 10.1093/molbev/msr012; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Simionato E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-33; Sonanez-Organis JG, 2009, COMP BIOCHEM PHYS C, V150, P395, DOI 10.1016/j.cbpc.2009.06.005; STICKLE WB, 1989, BIOL BULL, V177, P303, DOI 10.2307/1541945; Storey KB, 2004, INT CONGR SER, V1275, P47, DOI 10.1016/j.ics.2004.08.072; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Sussarellu R, 2012, J EXP MAR BIOL ECOL, V412, P87, DOI 10.1016/j.jembe.2011.11.007; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tokishita SI, 2006, GENE, V376, P231, DOI 10.1016/j.gene.2006.03.022; WANG GC, 2014, PLOS ONE, V9; WANG GL, 1993, J BIOL CHEM, V268, P21513; WIDDOWS J, 1989, BIOL BULL, V177, P154, DOI 10.2307/1541843; Wiener CM, 1996, BIOCHEM BIOPH RES CO, V225, P485, DOI 10.1006/bbrc.1996.1199; Woods SL, 2002, J BIOL CHEM, V277, P10236, DOI 10.1074/jbc.M110752200; Wu R, 2002, MAR POLLUT BULL, V45, P1, DOI 10.1016/S0025-326X(02)00182-0; Yu AY, 1998, AM J PHYSIOL-LUNG C, V275, pL818, DOI 10.1152/ajplung.1998.275.4.L818; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zhang P, 2012, AM J PHYSIOL-REG I, V303, pR1165, DOI 10.1152/ajpregu.00340.2012; Zhou D, 2013, ANNU REV GENOM HUM G, V14, P25, DOI 10.1146/annurev-genom-091212-153439	68	9	9	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166057	10.1371/journal.pone.0166057	http://dx.doi.org/10.1371/journal.pone.0166057			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814402	gold, Green Submitted, Green Published			2022-12-26	WOS:000386911100028
J	Aguirre, GK; Datta, R; Benson, NC; Prasad, S; Jacobson, SG; Cideciyan, AV; Bridge, H; Watkins, KE; Butt, OH; Dain, AS; Brandes, L; Gennatas, ED				Aguirre, Geoffrey K.; Datta, Ritobrato; Benson, Noah C.; Prasad, Sashank; Jacobson, Samuel G.; Cideciyan, Artur V.; Bridge, Holly; Watkins, Kate E.; Butt, Omar H.; Dain, Aleksandra S.; Brandes, Lauren; Gennatas, Efstathios D.			Patterns of Individual Variation in Visual Pathway Structure and Function in the Sighted and Blind	PLOS ONE			English	Article							CROSS-MODAL PLASTICITY; SURFACE-BASED ANALYSIS; CORTICAL THICKNESS; GEOMETRICALLY ACCURATE; STRIATE CORTEX; FIBER TRACTS; HUMAN BRAIN; DEPRIVATION; VOLUME; AREAS	Many structural and functional brain alterations accompany blindness, with substantial individual variation in these effects. In normally sighted people, there is correlated individual variation in some visual pathway structures. Here we examined if the changes in brain anatomy produced by blindness alter the patterns of anatomical variation found in the sighted. We derived eight measures of central visual pathway anatomy from a structural image of the brain from 59 sighted and 53 blind people. These measures showed highly significant differences in mean size between the sighted and blind cohorts. When we examined the measurements across individuals within each group we found three clusters of correlated variation, with V1 surface area and pericalcarine volume linked, and independent of the thickness of V1 cortex. These two clusters were in turn relatively independent of the volumes of the optic chiasm and lateral geniculate nucleus. This same pattern of variation in visual pathway anatomy was found in the sighted and the blind. Anatomical changes within these clusters were graded by the timing of onset of blindness, with those subjects with a post-natal onset of blindness having alterations in brain anatomy that were intermediate to those seen in the sighted and congenitally blind. Many of the blind and sighted subjects also contributed functional MRI measures of cross-modal responses within visual cortex, and a diffusion tensor imaging measure of fractional anisotropy within the optic radiations and the splenium of the corpus callosum. We again found group differences between the blind and sighted in these measures. The previously identified clusters of anatomical variation were also found to be differentially related to these additional measures: across subjects, V1 cortical thickness was related to cross-modal activation, and the volume of the optic chiasm and lateral geniculate was related to fractional anisotropy in the visual pathway. Our findings show that several of the structural and functional effects of blindness may be reduced to a smaller set of dimensions. It also seems that the changes in the brain that accompany blindness are on a continuum with normal variation found in the sighted.	[Aguirre, Geoffrey K.; Datta, Ritobrato; Benson, Noah C.; Prasad, Sashank; Butt, Omar H.; Dain, Aleksandra S.; Brandes, Lauren; Gennatas, Efstathios D.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Jacobson, Samuel G.; Cideciyan, Artur V.] Univ Penn, Perelman Sch Med, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Bridge, Holly] Univ Oxford, FMRIB Ctr, Clin Neurosci, Oxford OX3 9DU, England; [Watkins, Kate E.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Oxford; University of Oxford	Aguirre, GK (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA.	aguirreg@mail.med.upenn.edu	Cideciyan, Artur V/A-1075-2007; Watkins, Kate E/A-6559-2012	Cideciyan, Artur V/0000-0002-2018-0905; Watkins, Kate E/0000-0002-2621-482X; Jacobson, Samuel/0000-0003-2122-169X; Benson, Noah/0000-0002-2365-8265; Gennatas, Efstathios/0000-0001-9280-3609	National Institutes of Health [R01 EY020516, P30 EY001583, P30 NS045839]; NATIONAL EYE INSTITUTE [P30EY001583, R01EY020516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants R01 EY020516 (GKA), P30 EY001583 (Core Grant for Vision Research), and P30 NS045839 (Neuroscience Neuroimaging Center Core Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 2007, PLOS MED, V4, P1117, DOI 10.1371/journal.pmed.0040230; Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Aleman TS, 2011, INVEST OPHTH VIS SCI, V52, P6898, DOI 10.1167/iovs.11-7701; Andrews TJ, 1997, J NEUROSCI, V17, P2859; Anurova I, 2015, CEREB CORTEX, V25, P2035, DOI 10.1093/cercor/bhu009; Avants B, 2004, NEUROIMAGE, V23, pS139, DOI 10.1016/j.neuroimage.2004.07.010; Bakken TE, 2012, P NATL ACAD SCI USA, V109, P3985, DOI 10.1073/pnas.1105829109; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bedny M, 2011, P NATL ACAD SCI USA, V108, P4429, DOI 10.1073/pnas.1014818108; Benson NC, 2012, CURR BIOL, V22, P2081, DOI 10.1016/j.cub.2012.09.014; Bock AS, 2013, NEUROIMAGE, V81, P325, DOI 10.1016/j.neuroimage.2013.05.038; Bogorodzki P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093682; BOURGEOIS JP, 1989, P NATL ACAD SCI USA, V86, P4297, DOI 10.1073/pnas.86.11.4297; Bridge H, 2009, BRAIN, V132, P3467, DOI 10.1093/brain/awp279; Burge WK, 2016, SCI REP-UK, V6, DOI 10.1038/srep23268; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Burgel U, 1999, NEUROIMAGE, V10, P489, DOI 10.1006/nimg.1999.0497; Butt OH, 2013, J NEUROSCI, V33, P16209, DOI 10.1523/JNEUROSCI.0363-13.2013; Cecchetti L, 2016, BRAIN STRUCT FUNCT, V221, P1465, DOI 10.1007/s00429-014-0984-5; Cideciyan AV, 2007, HUM MUTAT, V28, P1074, DOI 10.1002/humu.20565; Cohen LG, 1999, ANN NEUROL, V45, P451, DOI 10.1002/1531-8249(199904)45:4<451::AID-ANA6>3.0.CO;2-B; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; Coullon GSL, 2015, J NEUROPHYSIOL, V113, P2889, DOI 10.1152/jn.01031.2014; Cunningham SI, 2015, VISION RES, V111, P197, DOI 10.1016/j.visres.2014.10.015; d'Almeida OC, 2013, NEUROIMAGE, V81, P222, DOI 10.1016/j.neuroimage.2013.05.032; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Deen B, 2015, J COGNITIVE NEUROSCI, V27, P1633, DOI 10.1162/jocn_a_00807; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; DeVolder AG, 1997, BRAIN RES, V750, P235, DOI 10.1016/S0006-8993(96)01352-2; Duncan RO, 2003, NEURON, V38, P659, DOI 10.1016/S0896-6273(03)00265-4; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Frank SM, 2016, CEREB CORTEX, V26, P1211, DOI 10.1093/cercor/bhu309; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Hernowo AT, 2014, CORTEX, V56, P99, DOI 10.1016/j.cortex.2013.01.003; Hinds OP, 2008, NEUROIMAGE, V39, P1585, DOI 10.1016/j.neuroimage.2007.10.033; Hogstrom LJ, 2013, CEREB CORTEX, V23, P2521, DOI 10.1093/cercor/bhs231; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; INNOCENTI GM, 1984, DEV BRAIN RES, V14, P143, DOI 10.1016/0165-3806(84)90019-1; Jiang JF, 2009, J NEUROSCI, V29, P2205, DOI 10.1523/JNEUROSCI.5451-08.2009; Kucera H., 1967, COMPUTATIONAL ANAL P; Lepore N, 2010, NEUROIMAGE, V49, P134, DOI 10.1016/j.neuroimage.2009.07.048; Levin N, 2010, NEURON, V65, P21, DOI 10.1016/j.neuron.2009.12.006; Li QJ, 2017, BRAIN IMAGING BEHAV, V11, P1029, DOI 10.1007/s11682-016-9576-8; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; Noppeney U, 2005, CURR BIOL, V15, pR488, DOI 10.1016/j.cub.2005.06.053; Pan WJ, 2007, NEUROIMAGE, V37, P212, DOI 10.1016/j.neuroimage.2007.05.014; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Park HJ, 2009, NEUROIMAGE, V47, P98, DOI 10.1016/j.neuroimage.2009.03.076; Pearce E, 2013, ANN HUM BIOL, V40, P531, DOI 10.3109/03014460.2013.815272; Plank T, 2011, NEUROIMAGE, V56, P1556, DOI 10.1016/j.neuroimage.2011.02.055; Prins D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146684; Ptito M, 2008, EXP BRAIN RES, V187, P41, DOI 10.1007/s00221-008-1273-4; Reislev NL, 2016, BRAIN STRUCT FUNCT, V221, P2891, DOI 10.1007/s00429-015-1078-8; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Shimony JS, 2006, CEREB CORTEX, V16, P1653, DOI 10.1093/cercor/bhj102; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Song C, 2015, NEURON, V85, P641, DOI 10.1016/j.neuron.2014.12.041; STRYKER MP, 1986, J NEUROSCI, V6, P2117; Taki Y, 2013, HUM BRAIN MAPP, V34, P1842, DOI 10.1002/hbm.22027; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Tomaiuolo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107871; VERAART C, 1990, BRAIN RES, V510, P115, DOI 10.1016/0006-8993(90)90735-T; Voss P, 2015, NEUROIMAGE, V108, P194, DOI 10.1016/j.neuroimage.2014.12.063; Voss P, 2014, BRAIN, V137, P1224, DOI 10.1093/brain/awu030; Voss P, 2012, CEREB CORTEX, V22, P2455, DOI 10.1093/cercor/bhr311; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang JJ, 2002, MAGN RESON MED, V48, P242, DOI 10.1002/mrm.10211; Wang Z, 2008, MAGN RESON IMAGING, V26, P261, DOI 10.1016/j.mri.2007.07.003; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Yu LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073208; Zhang Y, 2012, BRAIN RES, V1458, P34, DOI 10.1016/j.brainres.2012.04.012	81	29	29	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164677	10.1371/journal.pone.0164677	http://dx.doi.org/10.1371/journal.pone.0164677			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812129	Green Submitted, Green Published, gold			2022-12-26	WOS:000386910000011
J	Gonzalez, CC; Mon-Williams, M; Burke, S; Burke, MR				Gonzalez, Claudia C.; Mon-Williams, Mark; Burke, Siobhan; Burke, Melanie R.			Cognitive Control of Saccadic Eye Movements in Children with Developmental Coordination Disorder	PLOS ONE			English	Article							SUPERIOR COLLICULUS; VOLUNTARY CONTROL; INTERNAL-MODEL; ATTENTION; INITIATION; FIXATION; BEHAVIOR; ABILITY; DEFICIT; FIELD	The ability to use advance information to prepare and execute a movement requires cognitive control of behaviour (e.g., anticipation and inhibition). Our aim was to explore the integrity of saccadic eye movement control in developmental coordination disorder (DCD) and typically developing (TD) children (8-12 years) and assess how these children plan and inhibit saccadic responses, the principal mechanisms within visual attention control. Eye movements and touch responses were measured (separately and concurrently) in Cued and Non-Cued conditions. We found that children with DCD had similar saccade kinematics to the TD group during saccade initiation. Advance information decreased hand movement duration in both groups during Cued trials, but decrements in accuracy were significantly worse in the DCD group. In addition, children with DCD exhibited greater inhibitory errors and inaccurate fixation during the Cued trials. Thus, children with DCD were reasonably proficient in executing saccades during reflexive (Non-Cued) conditions, but showed deficits in more complex control processes involving prediction and inhibition. These findings have implications for our understanding of motor control in children with DCD.	[Gonzalez, Claudia C.] Brunel Univ London, Coll Hlth & Life Sci, Sports Hlth & Exercise Sci, Uxbridge, Middx, England; [Mon-Williams, Mark; Burke, Melanie R.] Univ Leeds, Sch Psychol, Fac Med & Hlth, Leeds, W Yorkshire, England; [Burke, Siobhan] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England	Brunel University; University of Leeds; University of East Anglia	Gonzalez, CC (corresponding author), Brunel Univ London, Coll Hlth & Life Sci, Sports Hlth & Exercise Sci, Uxbridge, Middx, England.	Claudia.Gonzalez@brunel.ac.uk		Mon-Williams, Mark/0000-0001-7595-8545; Burke, Melanie/0000-0002-2561-053X				Adams ILJ, 2014, NEUROSCI BIOBEHAV R, V47, P225, DOI 10.1016/j.neubiorev.2014.08.011; Alahyane N, 2014, NEUROIMAGE, V98, P103, DOI 10.1016/j.neuroimage.2014.03.008; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; BAHILL AT, 1975, INVEST OPHTH VISUAL, V14, P317; Black D.W., 2014, DSM 5 GUIDEBOOK ESSE; BRONSTEIN AM, 1987, VISION RES, V27, P517, DOI 10.1016/0042-6989(87)90037-X; Burke MR, 2008, CEREB CORTEX, V18, P126, DOI 10.1093/cercor/bhm038; Chen-Harris H, 2008, J NEUROSCI, V28, P2804, DOI 10.1523/JNEUROSCI.5300-07.2008; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Gonzalez CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117783; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Izawa Y, 2009, J NEUROPHYSIOL, V102, P2410, DOI 10.1152/jn.00234.2009; Katschmarsky S, 2001, EXP BRAIN RES, V136, P73, DOI 10.1007/s002210000535; Kirby A, 2014, ARCH DIS CHILD, V99, P292, DOI 10.1136/archdischild-2012-303569; LOSSE A, 1991, DEV MED CHILD NEUROL, V33, P55, DOI 10.1111/j.1469-8749.1991.tb14785.x; Majerus S, 2016, CEREB CORTEX, V26, P166, DOI 10.1093/cercor/bhu189; Mandich A, 2002, BRAIN COGNITION, V50, P150, DOI 10.1016/S0278-2626(02)00020-9; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Munoz DP, 2003, J NEUROPHYSIOL, V90, P503, DOI 10.1152/jn.00192.2003; Quaia C, 1999, J NEUROPHYSIOL, V82, P999, DOI 10.1152/jn.1999.82.2.999; ROBINSON DA, 1973, KYBERNETIK, V14, P71, DOI 10.1007/BF00288906; Sparks D, 2000, VISION RES, V40, P2763, DOI 10.1016/S0042-6989(00)00133-4; Tsai CL, 2010, RES DEV DISABIL, V31, P642, DOI 10.1016/j.ridd.2010.01.003; Wilmut K, 2006, CHILD CARE HLTH DEV, V32, P665, DOI 10.1111/j.1365-2214.2006.00678.x; Wilmut K, 2008, EXP BRAIN RES, V191, P403, DOI 10.1007/s00221-008-1532-4; Wilmut K, 2007, DISABIL REHABIL, V29, P47, DOI 10.1080/09638280600947765; Wilson PH, 1998, J CHILD PSYCHOL PSYC, V39, P829, DOI 10.1111/1469-7610.00384; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Zwicker JG, 2012, EUR J PAEDIATR NEURO, V16, P573, DOI 10.1016/j.ejpn.2012.05.005; Zwicker JG, 2011, INT J DEV NEUROSCI, V29, P145, DOI 10.1016/j.ijdevneu.2010.12.002; Zwicker JG, 2009, J CHILD NEUROL, V24, P1273, DOI 10.1177/0883073809333537	32	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165380	10.1371/journal.pone.0165380	http://dx.doi.org/10.1371/journal.pone.0165380			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812128	Green Accepted, Green Published, gold			2022-12-26	WOS:000386910000028
J	Martel, C; Cairampoma, L; Stauffer, FW; Ayasse, M				Martel, Carlos; Cairampoma, Lianka; Stauffer, Fred W.; Ayasse, Manfred			Telipogon peruvianus (Orchidaceae) Flowers Elicit Pre-Mating Behaviour in Eudejeania (Tachinidae) Males for Pollination	PLOS ONE			English	Article							SEXUALLY DECEPTIVE ORCHID; GEOBLASTA-PENNICILLATA; CHEMICAL COMMUNICATION; OPHRYS ORCHIDACEAE; DRIVEN SPECIATION; MASS-SPECTROMETRY; FUNGUS GNATS; TRAP-FLOWERS; ODOR SIGNALS; HOUSE-FLY	Several neotropical orchid genera have been proposed as being sexually deceptive; however, this has been carefully tested in only a few cases. The genus Telipogon has long been assumed to be pollinated by male tachinid flies during pseudocopulatory events but no detailed confirmatory reports are available. Here, we have used an array of methods to elucidate the pollination mechanism in Telipogon peruvianus. The species presents flowers that have a mean floral longevity of 33 days and that are self-compatible, although spontaneous self-pollination does not occur. The flowers attract males of four tachinid species but only the males of an undescribed Eudejeania (Eudejeania aff. browni; Tachinidae) species are specific pollinators. Males visit the flowers during the first few hours of the day and the pollination success is very high (42% in one patch) compared with other sexually deceptive species. Female-seeking males are attracted to the flowers but do not attempt copulation with the flowers, as is usually described in sexually deceptive species. Nevertheless, morphological analysis and behavioural tests have shown an imperfect mimicry between flowers and females suggesting that the attractant stimulus is not based only on visual cues, as long thought. Challenging previous conclusions, our chemical analysis has confirmed that flowers of Telipogon release volatile compounds; however, the role of these volatiles in pollinator behaviour remains to be established. Pollinator behaviour and histological analyses indicate that Telipogon flowers possess scent-producing structures throughout the corolla. Our study provides the first confirmed case of (i) a sexually deceptive species in the Onciidinae, (ii) pollination by pre-copulatory behaviour and (iii) pollination by sexual deception involving tachinid flies.	[Martel, Carlos; Ayasse, Manfred] Univ Ulm, Inst Evolutionary Ecol & Conservat Genom, Helmholtzstr 10-1, D-89081 Ulm, Germany; [Cairampoma, Lianka] Johannes Gutenberg Univ Mainz, Inst Spezielle Bot & Bot Garten, D-55099 Mainz, Germany; [Stauffer, Fred W.] Univ Geneva, Conservatoire & Jardin Bot Ville Geneve, CP 60, CH-1292 Geneva, Switzerland	Ulm University; Johannes Gutenberg University of Mainz; University of Geneva	Martel, C (corresponding author), Univ Ulm, Inst Evolutionary Ecol & Conservat Genom, Helmholtzstr 10-1, D-89081 Ulm, Germany.	carlos.martel-gora@uni-ulm.de	Martel, Carlos/N-8162-2019	Martel, Carlos/0000-0001-9892-1999	Institute of Evolutionary Ecology and Conservation Genomics, University of Ulm; German Academic Exchange Service; New Hampshire Orchid Society; South Florida Orchid Society; San Diego County Orchid Society; National Geographic Society; German Academic Exchange Service (DAAD); New Hampshire Orchid Society (NHOS); South Florida Orchid Society (SFOS); San Diego County Orchid Society (SDCOS); National Geographic Society from Global Exploration Fund (Northern Europe)	Institute of Evolutionary Ecology and Conservation Genomics, University of Ulm; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); New Hampshire Orchid Society; South Florida Orchid Society; San Diego County Orchid Society; National Geographic Society(National Geographic Society); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); New Hampshire Orchid Society (NHOS); South Florida Orchid Society (SFOS); San Diego County Orchid Society (SDCOS); National Geographic Society from Global Exploration Fund (Northern Europe)	This work was funded by the Institute of Evolutionary Ecology and Conservation Genomics, University of Ulm; the German Academic Exchange Service; the New Hampshire Orchid Society; the South Florida Orchid Society; the San Diego County Orchid Society; and the National Geographic Society.; We are deeply grateful to Hermenegildo Martel for field assistance and William Nauray for providing information on Telipogon species from Southern Peru. Gunter Gerlach (M) and Martin Timana (PUCP) gave helpful comments on an earlier version of the manuscript. Two anonymous reviewers provided helpful comments and suggestions. The Central Facility for Electron Microscopy (Ulm University) allowed CM the use of its SEM. Monty Wood (CANA-COL) kindly helped with tachinid identification. Heiko Bellmann (dagger 2014) took the photos shown in Fig 2. CM acknowledges the German Academic Exchange Service (DAAD) for supporting his PhD studies at Ulm University and the New Hampshire Orchid Society (NHOS), the South Florida Orchid Society (SFOS) and the San Diego County Orchid Society (SDCOS) for financial support. CM and MA acknowledge the National Geographic Society for an award from its Global Exploration Fund (Northern Europe).	Agren L., 1984, Nova Acta Regiae Societatis Scientiarum Upsaliensis, V:C, V3, P15; ALCOCK J, 1995, J KANSAS ENTOMOL SOC, V68, P85; Ascensao L, 2005, AM J BOT, V92, P1059, DOI 10.3732/ajb.92.7.1059; Ayasse M, 2003, P ROY SOC B-BIOL SCI, V270, P517, DOI 10.1098/rspb.2002.2271; Ayasse M, 2000, EVOLUTION, V54, P1995, DOI 10.1111/j.0014-3820.2000.tb01243.x; Ayasse M, 2001, ANNU REV ENTOMOL, V46, P31, DOI 10.1146/annurev.ento.46.1.31; Ayasse M, 2006, BIOLOGY OF FLORAL SCENT, P219; Ayasse M, 2011, PHYTOCHEMISTRY, V72, P1667, DOI 10.1016/j.phytochem.2011.03.023; Benitez-Vieyra S, 2009, J EVOLUTION BIOL, V22, P2354, DOI 10.1111/j.1420-9101.2009.01840.x; BINO RJ, 1982, NEW PHYTOL, V90, P315, DOI 10.1111/j.1469-8137.1982.tb03263.x; Blanco MA, 2005, ANN BOT-LONDON, V95, P763, DOI 10.1093/aob/mci090; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Bohman B, 2016, CURR OPIN PLANT BIOL, V32, P37, DOI 10.1016/j.pbi.2016.06.004; Bohman B, 2014, NEW PHYTOL, V203, P939, DOI 10.1111/nph.12800; Bontonou Gwenaelle, 2014, Insects, V5, P439, DOI 10.3390/insects5020439; BORGKARLSON AK, 1990, PHYTOCHEMISTRY, V29, P1359, DOI 10.1016/0031-9422(90)80086-V; Brodmann J, 2008, CURR BIOL, V18, P740, DOI 10.1016/j.cub.2008.04.040; BUSER HR, 1983, ANAL CHEM, V55, P818, DOI 10.1021/ac00257a003; CARLSON DA, 1971, SCIENCE, V174, P76, DOI 10.1126/science.174.4004.76; Christensen DE, 1994, ORCHID BIOL REV PERS, VVI, P415; Ciotek L, 2006, FLORA, V201, P365, DOI 10.1016/j.flora.2005.07.012; Cozzolino S, 2005, TRENDS ECOL EVOL, V20, P487, DOI 10.1016/j.tree.2005.06.004; DAFNI A, 1984, ANNU REV ECOL SYST, V15, P259, DOI 10.1146/annurev.es.15.110184.001355; DAFNI A, 1990, EVOL BIOL, V24, P193; de Jager ML, 2016, FUNCT ECOL, V30, P537, DOI 10.1111/1365-2435.12517; Dobson HEM, 2005, PRACTICAL POLLINATIO, P197; Dodson CH, 2003, SELBYANA, V24, P217; Dodson CH, 1987, ORQUIDEOLOGIA, V17, P3; Dodson CH, 1962, AM ORCHID SOC B, V31, P525; Dodson CH, 2003, LANKESTERIANA, V7, P99, DOI [10.15517/lank.v3i2.23028, DOI 10.15517/LANK.V3I2.23028]; Dressler R.L., 1981, ORCHIDS NATURAL HIST; DUNKELBLUM E, 1985, J CHEM ECOL, V11, P265, DOI 10.1007/BF01411414; Effmert U, 2006, BIOLOGY OF FLORAL SCENT, P105; Ellis AG, 2010, AM NAT, V176, pE143, DOI 10.1086/656487; Faegri K., 1979, PRINCIPLES POLLINATI; Gaskett AC, 2008, AM NAT, V171, pE206, DOI 10.1086/587532; Gaskett AC, 2011, BIOL REV, V86, P33, DOI 10.1111/j.1469-185X.2010.00134.x; Gaskett AC, 2010, NATURWISSENSCHAFTEN, V97, P97, DOI 10.1007/s00114-009-0611-0; GRANT V, 1994, P NATL ACAD SCI USA, V91, P3, DOI 10.1073/pnas.91.1.3; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; Jersakova J, 2006, BIOL REV, V81, P219, DOI 10.1017/S1464793105006986; Jetter R, 2006, BIOLOGY OF FLORAL SCENT, P125; Kullenberg B., 1961, Zoologiska Bidrag fran Uppsala, V34, P1; Larson BMH, 2001, CAN ENTOMOL, V133, P439, DOI 10.4039/Ent133439-4; Mant J, 2005, J CHEM ECOL, V31, P1765, DOI 10.1007/s10886-005-5926-5; Martel C., 2015, Harvard Papers in Botany, V20, P93; Martel C, 2013, CANDOLLEA, V68, P245, DOI 10.15553/c2012v682a8; NILSSON LA, 1992, TRENDS ECOL EVOL, V7, P255, DOI 10.1016/0169-5347(92)90170-G; Oguma Y., 1992, Chemoecology, V3, P60, DOI 10.1007/BF01261458; PAULUS HF, 1990, ISRAEL J BOT, V39, P43; PEAKALL R, 1990, FUNCT ECOL, V4, P159, DOI 10.2307/2389335; PEAKALL R, 1989, PLANT SYST EVOL, V167, P137, DOI 10.1007/BF00936402; PEAKALL R, 1987, OECOLOGIA, V73, P522, DOI 10.1007/BF00379410; Peakall R, 2010, NEW PHYTOL, V188, P437, DOI 10.1111/j.1469-8137.2010.03308.x; Phillips RD, 2014, ANN BOT-LONDON, V113, P629, DOI 10.1093/aob/mct295; Phillips RD, 2013, J ECOL, V101, P826, DOI 10.1111/1365-2745.12068; Pridgeon AM, 2009, GENERA ORCHIDACEARUM, V5; REITZ SR, 1991, ANN ENTOMOL SOC AM, V84, P111, DOI 10.1093/aesa/84.1.111; Robertson C, 1928, ECOLOGY, V9, P505, DOI 10.2307/1929418; Schiestl FP, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-27; Schiestl FP, 2003, SCIENCE, V302, P437, DOI 10.1126/science.1087835; Schiestl FP, 2005, NATURWISSENSCHAFTEN, V92, P255, DOI 10.1007/s00114-005-0636-y; Schiestl FP, 1999, NATURE, V399, P421, DOI 10.1038/20829; Schiestl FP, 2004, BOT J LINN SOC, V144, P199, DOI 10.1111/j.1095-8339.2003.00249.x; Schiestl FP, 2002, PLANT SYST EVOL, V234, P111, DOI 10.1007/s00606-002-0187-z; Scopece G, 2010, AM NAT, V175, P98, DOI 10.1086/648555; Singer RB, 2004, ANN BOT-LONDON, V93, P755, DOI 10.1093/aob/mch091; Singer RB, 2002, ANN BOT-LONDON, V89, P157, DOI 10.1093/aob/mcf021; Spaethe J, 2007, PLANT SYST EVOL, V264, P31, DOI 10.1007/s00606-006-0503-0; STEINER KE, 1994, AM J BOT, V81, P185, DOI 10.2307/2445632; Stireman JO, 2006, ANNU REV ENTOMOL, V51, P525, DOI 10.1146/annurev.ento.51.110104.151133; Stireman JO, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.3901; Stokl J, 2005, PLANT SYST EVOL, V254, P105, DOI 10.1007/s00606-005-0330-8; UEBEL EC, 1977, J CHEM ECOL, V3, P269, DOI 10.1007/BF00988443; van der Cingel N. A., 2001, ATLAS ORCHID POLLINA; Van der Pijl L., 1966, ORCHID FLOWERS THEIR; Vereecken NJ, 2012, P ROY SOC B-BIOL SCI, V279, P4786, DOI 10.1098/rspb.2012.1804; Vereecken NJ, 2009, SIGNAL COMMUN PLANTS, P203, DOI 10.1007/978-3-540-89230-4_11; Vogel S, 1990, ROLE SCENT GLANDS PO; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Wicker-Thomas C, 2007, J INSECT PHYSIOL, V53, P1089, DOI 10.1016/j.jinsphys.2007.07.003; Wood DM, 1987, AGR CANADA MONOGRAPH, V2	82	18	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165896	10.1371/journal.pone.0165896	http://dx.doi.org/10.1371/journal.pone.0165896			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812201	gold, Green Published, Green Submitted			2022-12-26	WOS:000386910000075
J	Sima, M; Novotny, M; Pravda, L; Sumova, P; Rohousova, I; Volf, P				Sima, Michal; Novotny, Marian; Pravda, Lukas; Sumova, Petra; Rohousova, Iva; Volf, Petr			The Diversity of Yellow-Related Proteins in Sand Flies (Diptera: Psychodidae)	PLOS ONE			English	Article							SALIVARY-GLAND TRANSCRIPTOMES; FLY LUTZOMYIA-LONGIPALPIS; ANTIBODY-RESPONSE; VISCERAL LEISHMANIASIS; PHLEBOTOMINE SANDFLIES; IDENTIFICATION; VECTOR; EXPOSURE; PAPATASI; IMMUNITY	Yellow-related proteins (YRPs) present in sand fly saliva act as affinity binders of bioamines, and help the fly to complete a bloodmeal by scavenging the physiological signals of damaged cells. They are also the main antigens in sand fly saliva and their recombinant form is used as a marker of host exposure to sand flies. Moreover, several salivary proteins and plasmids coding these proteins induce strong immune response in hosts bitten by sand flies and are being used to design protecting vaccines against Leishmania parasites. In this study, thirty two 3D models of different yellow-related proteins from thirteen sand fly species of two genera were constructed based on the known protein structure from Lutzomyia longipalpis. We also studied evolutionary relationships among species based on protein sequences as well as sequence and structural variability of their ligand-binding site. All of these 33 sand fly YRPs shared a similar structure, including a unique tunnel that connects the ligand-binding site with the solvent by two independent paths. However, intraspecific modifications found among these proteins affects the charges of the entrances to the tunnel, the length of the tunnel and its hydrophobicity. We suggest that these structural and sequential differences influence the ligand-binding abilities of these proteins and provide sand flies with a greater number of YRP paralogs with more nuanced answers to bioamines. All these characteristics allow us to better evaluate these proteins with respect to their potential use as part of anti-Leishmania vaccines or as an antigen to measure host exposure to sand flies.	[Sima, Michal; Sumova, Petra; Rohousova, Iva; Volf, Petr] Charles Univ Prague, Fac Sci, Dept Parasitol, Prague, Czech Republic; [Novotny, Marian] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic; [Pravda, Lukas] Masaryk Univ, CEITEC Cent European Inst Technol, Brno, Czech Republic; [Pravda, Lukas] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Brno, Czech Republic	Charles University Prague; Charles University Prague; Masaryk University Brno; Masaryk University Brno	Sima, M (corresponding author), Charles Univ Prague, Fac Sci, Dept Parasitol, Prague, Czech Republic.	michal-sima@seznam.cz	Pravda, Lukáš/I-7241-2013; Sima, Michal/F-2961-2016; Rohousova, Iva/B-4852-2011; Novotny, Marian/B-7036-2008; Volf, Petr/C-4300-2012; Sumova, Petra/C-2097-2017	Pravda, Lukáš/0000-0002-6435-4719; Sima, Michal/0000-0001-6927-8615; Rohousova, Iva/0000-0003-1830-0813; Novotny, Marian/0000-0001-8788-3202; Volf, Petr/0000-0003-1790-1123; Sumova, Petra/0000-0002-3480-7254	Charles University (GAUK) [120516/B-BIO]; UNCE [204013]; Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC [LQ1601]; Czech Science Foundation [P506 13-05292S]	Charles University (GAUK); UNCE; Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC; Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by Charles University (GAUK project no. 120516/B-BIO, http://www.cuni.cz/UKEN-1.html, PS; UNCE 204013, http://www.cuni.cz/UKEN-1.html, MS). LP was supported by Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC 2020 (LQ1601) (http://www.msmt.cz/?lang=2, LP) Czech Science Foundation (Project Number: P506 13-05292S, https://gacr.cz/en/, to MS, PS, IK, PV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abdeladhim M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004771; Abdeladhim M, 2014, INFECT GENET EVOL, V28, P691, DOI 10.1016/j.meegid.2014.07.028; Abdeladhim M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047347; Abrudan J, 2013, INSECT MOL BIOL, V22, P211, DOI 10.1111/imb.12015; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alves-Silva J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-213; Anderson JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-52; Aransay AM, 2000, INSECT MOL BIOL, V9, P157, DOI 10.1046/j.1365-2583.2000.00168.x; Atta AM, 2004, MEM I OSWALDO CRUZ, V99, P525, DOI 10.1590/S0074-02762004000500012; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Charlab R, 1999, P NATL ACAD SCI USA, V96, P15155, DOI 10.1073/pnas.96.26.15155; CID H, 1992, PROTEIN ENG, V5, P373, DOI 10.1093/protein/5.5.373; Collin N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000441; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Moura TR, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000084; de Moura TR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002242; Fiuza JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004322; Gidwani K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001296; Goldman N, 2000, MOL BIOL EVOL, V17, P975, DOI 10.1093/oxfordjournals.molbev.a026378; Gomes R, 2012, J INVEST DERMATOL, V132, P2735, DOI 10.1038/jid.2012.205; HANES J, 1992, J APICULT RES, V31, P22, DOI 10.1080/00218839.1992.11101256; Hofinger ESA, 2007, GLYCOBIOLOGY, V17, P444, DOI 10.1093/glycob/cwm003; Hostomska J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-282; Johnson JK, 2001, INSECT BIOCHEM MOLEC, V31, P1125, DOI 10.1016/S0965-1748(01)00072-8; Julenius K, 2007, GLYCOBIOLOGY, V17, P868, DOI 10.1093/glycob/cwm050; Kato H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-226; Kato H, 2013, INFECT GENET EVOL, V13, P56, DOI 10.1016/j.meegid.2012.08.024; Kostalova T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003855; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Martin-Martin I, 2014, VET PARASITOL, V202, P207, DOI 10.1016/j.vetpar.2014.02.045; Marzouki S, 2011, AM J TROP MED HYG, V84, P653, DOI 10.4269/ajtmh.2011.10-0598; NASH WG, 1983, BIOCHEM GENET, V21, P1135, DOI 10.1007/BF00488465; Oliveira F, 2006, VACCINE, V24, P374, DOI 10.1016/j.vaccine.2005.07.085; Oliveira MCG, 2007, NEUROSCIENCE, V145, P708, DOI 10.1016/j.neuroscience.2006.12.021; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Reddy VB, 2000, J BIOL CHEM, V275, P15861, DOI 10.1074/jbc.275.21.15861; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; Rohousova I, 2005, PARASITOLOGY, V130, P493, DOI 10.1017/S003118200400681X; Rohousova I, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001660; Rohousova I, 2012, ACTA TROP, V122, P80, DOI 10.1016/j.actatropica.2011.12.004; SALI A, 1994, PROTEIN SCI, V3, P1582, DOI 10.1002/pro.5560030923; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sehnal D, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-39; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sima M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004553; Souza AP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000649; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teixeira C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000638; Valenzuela JG, 2004, J EXP BIOL, V207, P3717, DOI 10.1242/jeb.01185; Valenzuela JG, 2001, J EXP MED, V194, P331, DOI 10.1084/jem.194.3.331; Vlkova M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002709; Vlkova M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001344; Volf P, 2002, EUR J BIOCHEM, V269, P6294, DOI 10.1046/j.1432-1033.2002.03349.x; Volf P, 2000, MED VET ENTOMOL, V14, P251, DOI 10.1046/j.1365-2915.2000.00240.x; Xanthos DN, 2008, PAIN, V137, P640, DOI 10.1016/j.pain.2007.10.031; Xu XQ, 2011, J BIOL CHEM, V286, P32383, DOI 10.1074/jbc.M111.268904	59	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166191	10.1371/journal.pone.0166191	http://dx.doi.org/10.1371/journal.pone.0166191			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812196	Green Submitted, Green Published, gold			2022-12-26	WOS:000386910000106
J	Yadav, A; Radhakrishnan, A; Panda, A; Singh, A; Sinha, H; Bhanot, G				Yadav, Anupama; Radhakrishnan, Aparna; Panda, Anshuman; Singh, Amartya; Sinha, Himanshu; Bhanot, Gyan			The Modular Adaptive Ribosome	PLOS ONE			English	Article							SPECIALIZED RIBOSOMES; PROTEIN GENES; YEAST; GENOME; TRANSLATION; INTRONS; SPECIFICITY; DEPLETION; SELECTION; SUBUNITS	The ribosome is an ancient machine, performing the same function across organisms. Although functionally unitary, recent experiments suggest specialized roles for some ribosomal proteins. Our central thesis is that ribosomal proteins function in a modular fashion to decode genetic information in a context dependent manner. We show through large data analyses that although many ribosomal proteins are essential with consistent effect on growth in different conditions in yeast and similar expression across cell and tissue types in mice and humans, some ribosomal proteins are used in an environment specific manner. The latter set of variable ribosomal proteins further function in a coordinated manner forming modules, which are adapted to different environmental cues in different organisms. We show that these environment specific modules of ribosomal proteins in yeast have differential genetic interactions with other pathways and their 5'UTRs show differential signatures of selection in yeast strains, presumably to facilitate adaptation. Similarly, we show that in higher metazoans such as mice and humans, different modules of ribosomal proteins are expressed in different cell types and tissues. A clear example is nervous tissue that uses a ribosomal protein module distinct from the rest of the tissues in both mice and humans. Our results suggest a novel stratification of ribosomal proteins that could have played a role in adaptation, presumably to optimize translation for adaptation to diverse ecological niches and tissue microenvironments.	[Yadav, Anupama; Radhakrishnan, Aparna; Sinha, Himanshu] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India; [Panda, Anshuman; Singh, Amartya; Bhanot, Gyan] Rutgers State Univ, Dept Phys, Piscataway, NJ 08854 USA; [Sinha, Himanshu] Indian Inst Technol Madras, Dept Biotechnol, Madras 600036, Tamil Nadu, India; [Sinha, Himanshu] Indian Inst Technol Madras, Initiat Biol Syst Engn, Madras 600036, Tamil Nadu, India; [Bhanot, Gyan] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Bhanot, Gyan] Canc Inst New Jersey, New Brunswick, NJ 08903 USA	Tata Institute of Fundamental Research (TIFR); Rutgers State University New Brunswick; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Sinha, H (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India.; Bhanot, G (corresponding author), Rutgers State Univ, Dept Phys, Piscataway, NJ 08854 USA.; Sinha, H (corresponding author), Indian Inst Technol Madras, Dept Biotechnol, Madras 600036, Tamil Nadu, India.; Sinha, H (corresponding author), Indian Inst Technol Madras, Initiat Biol Syst Engn, Madras 600036, Tamil Nadu, India.; Bhanot, G (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.; Bhanot, G (corresponding author), Canc Inst New Jersey, New Brunswick, NJ 08903 USA.	sinha@iitm.ac.in; gbhanot@rutgers.edu	Panda, Anshuman/T-5101-2018; Sinha, Himanshu/AAT-7853-2021	Panda, Anshuman/0000-0001-7917-0317; Sinha, Himanshu/0000-0001-7031-0491; Radhakrishnan, Aparna/0000-0002-8153-9037; Yadav, Anupama/0000-0001-5338-0455	National Science Foundation [PHY-1066293]; NCI/NIH [R01CA169182-01]; Rutgers Cancer Institute of New Jersey; Tata Institute of Fundamental Research [12P-0120]	National Science Foundation(National Science Foundation (NSF)); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Rutgers Cancer Institute of New Jersey; Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR))	GB thanks the Aspen Center for Physics (ACP), which was supported by the National Science Foundation grant PHY-1066293, for their hospitality while this work was initiated. GB was supported in part by an R01 Grant (NCI/NIH)-R01CA169182-01. AP was supported by the Rutgers Cancer Institute of New Jersey. HS was supported by an intra-mural grant (12P-0120) from Tata Institute of Fundamental Research. The funders had no role in study design, data collection	Araujo PR, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/475731; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Ares M, 1999, RNA, V5, P1138, DOI 10.1017/S1355838299991379; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; de las Heras-Rubio A, 2014, CANCER METAST REV, V33, P115, DOI 10.1007/s10555-013-9460-6; Diesch J, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-43; Dinman JD, 2016, J MOL BIOL, V428, P2186, DOI 10.1016/j.jmb.2015.12.021; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Enyenihi AH, 2003, GENETICS, V163, P47; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Goldstein AL, 1999, YEAST, V15, P507, DOI 10.1002/(SICI)1097-0061(199904)15:6<507::AID-YEA369>3.0.CO;2-P; Haarer B, 2007, GENE DEV, V21, P148, DOI 10.1101/gad.1477507; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Jenner L, 2012, CURR OPIN STRUC BIOL, V22, P759, DOI 10.1016/j.sbi.2012.07.013; Kachroo AH, 2015, SCIENCE, V348, P921, DOI 10.1126/science.aaa0769; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Lee ASY, 2013, P NATL ACAD SCI USA, V110, P324, DOI 10.1073/pnas.1216454109; Lee CR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004727; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; McCann KL, 2013, SCIENCE, V341, P849, DOI 10.1126/science.1244156; McCormick MA, 2015, CELL METAB, V22, P895, DOI 10.1016/j.cmet.2015.09.008; Ni L, 2001, MOL BIOL CELL, V12, P2147, DOI 10.1091/mbc.12.7.2147; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P443, DOI 10.1074/mcp.M800258-MCP200; Parenteau J, 2011, CELL, V147, P320, DOI 10.1016/j.cell.2011.08.044; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; Ramakrishnan V, 2014, CELL, V159, P979, DOI 10.1016/j.cell.2014.10.052; ROTENBERG MO, 1988, GENE DEV, V2, P160, DOI 10.1101/gad.2.2.160; Sauert M, 2015, BIOCHIMIE, V114, P39, DOI 10.1016/j.biochi.2014.12.011; Shi Z, 2015, ANNU REV CELL DEV BI, V31, P31, DOI 10.1146/annurev-cellbio-100814-125346; Slavov N, 2015, CELL REP, V13, P865, DOI 10.1016/j.celrep.2015.09.056; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037; Steffen KK, 2012, GENETICS, V191, P107, DOI 10.1534/genetics.111.136549; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teixeira MC, 2011, CURR OPIN BIOTECH, V22, P150, DOI 10.1016/j.copbio.2010.10.011; Teng T, 2013, CURR OPIN GENET DEV, V23, P63, DOI 10.1016/j.gde.2013.02.001; Vinckenbosch N, 2006, P NATL ACAD SCI USA, V103, P3220, DOI 10.1073/pnas.0511307103; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wilkening S, 2014, GENETICS, V196, P853, DOI 10.1534/genetics.113.160291; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wong QWL, 2014, RNA BIOL, V11, P33, DOI 10.4161/rna.27427; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; Yoshihama M, 2002, GENOME RES, V12, P379, DOI 10.1101/gr.214202	58	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166021	10.1371/journal.pone.0166021	http://dx.doi.org/10.1371/journal.pone.0166021			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812193	Green Published, Green Submitted, gold			2022-12-26	WOS:000386910000094
J	Lang, JK; Young, RF; Ashraf, H; Canty, JM				Lang, Jennifer K.; Young, Rebeccah F.; Ashraf, Hashmat; Canty, John M., Jr.			Inhibiting Extracellular Vesicle Release from Human Cardiosphere Derived Cells with Lentiviral Knockdown of nSMase2 Differentially Effects Proliferation and Apoptosis in Cardiomyocytes, Fibroblasts and Endothelial Cells In Vitro	PLOS ONE			English	Article							CARDIAC-FUNCTION; HEART-DISEASE; EXOSOMES; STEM; THERAPY; REGENERATION; MECHANISMS; EFFICACY; REPAIR; AGENTS	Numerous studies have shown a beneficial effect of cardiosphere-derived cell (CDC) therapy on regeneration of injured myocardium. Paracrine signaling by CDC secreted exo-somes may contribute to improved cardiac function. However, it has not yet been demonstrated by a genetic approach that exosome release contributes to the therapeutic effect of transplanted CDCs. By employing a lentiviral knockdown (KD) strategy against neutral spingomyelinase 2 (nSMase2), a crucial gene in exosome secretion, we have defined the role of physiologically secreted human CDC-derived exosomes on cardiac fibroblast, endothelial cell and primary cardiomyocyte proliferation, cell death, migration and angiogenesis using a series of in vitro coculture assays. We found that secretion of hCDC-derived exosomes was effectively inhibited by nSMase2 lentiviral KD and shRNAi expression was stable and constitutive. hCDC exosome release contributed to the angiogenic and pro-migratory effects of hCDCs on HUVECs, decreased proliferation of fibroblasts, and decreased apoptosis of cardiomyocytes. These in vitro reactions support a role for exosome secretion as a paracrine mechanism of stem cell-mediated cardiac repair in vivo. Importantly, we have established a novel tool to test constitutive inhibition of exosome secretion in stem cell populations in animal models of cardiac disease.	[Lang, Jennifer K.; Young, Rebeccah F.; Canty, John M., Jr.] Jacobs Sch Med & Biomed Sci, Dept Med, Div Cardiol, Buffalo, NY 14203 USA; [Ashraf, Hashmat] Kaleida Hlth, Dept Cardiothorac Surg, Buffalo, NY 14203 USA; [Canty, John M., Jr.] VA WNY Healthcare Syst, Buffalo, NY 14215 USA	Kaleida Health	Lang, JK (corresponding author), Jacobs Sch Med & Biomed Sci, Dept Med, Div Cardiol, Buffalo, NY 14203 USA.	jklang@buffalo.edu	Canty, John M/C-5349-2009		John C. Sable Memorial Heart Fund; National Heart Lung and Blood Institute [HL-55324, HL-61610]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001412] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061610, R01HL055324] Funding Source: NIH RePORTER	John C. Sable Memorial Heart Fund; National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the John C. Sable Memorial Heart Fund (JKL) and the National Heart Lung and Blood Institute (HL-55324 and HL-61610) (JMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Zhenghong Yuan for supplying the lentiviral vectors for scrambled and nSMase2 shRNA. We would like to thank Dr. Jessica Reynolds for assistance with Nano particle Tracking Analysis. This work was supported by the John C. Sable Memorial Heart Fund and the National Heart Lung and Blood Institute (HL-55324 and HL-61610).	Arslan F, 2013, STEM CELL RES, V10, P301, DOI 10.1016/j.scr.2013.01.002; Barile L, 2014, CARDIOVASC RES, V103, P530, DOI 10.1093/cvr/cvu167; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Gallet R, 2017, EUR HEART J, V38, P201, DOI 10.1093/eurheartj/ehw240; Ghosh AK, 2014, MANUAL RES TECHNIQUE; Goldsmith EC, 2004, DEV DYNAM, V230, P787, DOI 10.1002/dvdy.20095; Gray WD, 2015, CIRC RES, V116, P255, DOI 10.1161/CIRCRESAHA.116.304360; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Ibrahim AGE, 2014, STEM CELL REP, V2, P606, DOI 10.1016/j.stemcr.2014.04.006; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; Juric V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031303; Kanazawa H, 2015, CIRC-HEART FAIL, V8, P322, DOI 10.1161/CIRCHEARTFAILURE.114.001484; Khan M, 2015, CIRC RES, V117, P52, DOI 10.1161/CIRCRESAHA.117.305990; Kreke M, 2012, EXPERT REV CARDIOVAS, V10, P1185, DOI [10.1586/ERC.12.102, 10.1586/erc.12.102]; Li JH, 2013, NAT IMMUNOL, V14, P793, DOI 10.1038/ni.2647; Lim HJ, 1999, CIRCULATION, V100, P2380, DOI 10.1161/01.CIR.100.23.2380; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Malliaras K, 2014, J AM COLL CARDIOL, V63, P110, DOI 10.1016/j.jacc.2013.08.724; Malliaras K, 2012, CIRCULATION, V125, P100, DOI 10.1161/CIRCULATIONAHA.111.042598; Ratajczak MZ, 2012, LEUKEMIA, V26, P1166, DOI 10.1038/leu.2011.389; Sahoo S, 2014, CIRC RES, V114, P333, DOI 10.1161/CIRCRESAHA.114.300639; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Supinski GS, 2015, AM J PHYSIOL-LUNG C, V309, pL614, DOI 10.1152/ajplung.00141.2015; Suzuki G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113009; Taylor DD, 2011, METHODS MOL BIOL, V728, P235, DOI 10.1007/978-1-61779-068-3_15; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tongers J, 2011, EUR HEART J, V32, P1197, DOI 10.1093/eurheartj/ehr018; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Weil BR, 2015, CIRC RES, V117, P634, DOI 10.1161/CIRCRESAHA.115.306850; Wollert KC, 2010, NAT REV CARDIOL, V7, P204, DOI 10.1038/nrcardio.2010.1; Yee K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113805	33	43	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165926	10.1371/journal.pone.0165926	http://dx.doi.org/10.1371/journal.pone.0165926			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806113	gold, Green Published, Green Submitted			2022-12-26	WOS:000386715500071
J	Li, WJ; Sui, XL; Kuss, P; Liu, YY; Li, AR; Guan, KY				Li, Wen-Jun; Sui, Xiao-Lin; Kuss, Patrick; Liu, Yan-Yan; Li, Ai-Rong; Guan, Kai-Yun			Long-Distance Dispersal after the Last Glacial Maximum (LGM) Led to the Disjunctive Distribution of Pedicularis kansuensis (Orobanchaceae) between the Qinghai-Tibetan Plateau and Tianshan Region	PLOS ONE			English	Article							MOLECULAR PHYLOGEOGRAPHY; CLIMATIC OSCILLATIONS; QUATERNARY CLIMATE; SEQUENCE VARIATION; NONCODING REGIONS; GENETIC DIVERSITY; ALPINE PLANTS; DNA; CHINA; EVOLUTION	Quaternary climate fluctuations have profoundly affected the current distribution patterns and genetic structures of many plant and animal species in the Qinghai-Tibetan Plateau (QTP) and adjacent mountain ranges, e.g. Tianshan (TSR), Altay, etc. In this greater area disjunct distributions are prominent but have nevertheless received little attention with respect to the historical processes involved. Here, we focus on Pedicularis kansuensis to test whether the current QTP and TSR disjunction is the result of a recent Holocene range expansion involving dispersal across arid land bridge(s) or a Pleistocene range fragmentation involving persistence in refugia. Two chloroplast DNA spacers were sequenced for 319 individuals from 34 populations covering the entire distribution range of this species in China. We found a total of 17 haplotypes of which all occurred in the QTP, and only five in the TSR. Overall genetic diversity was high (H-T = 0.882, H-S = 0.559) and higher in the QTP than in the TSR. Genetic differentiation among regions and populations was relatively low (G(ST) = 0.366) and little evidence for a phylogeographic pattern emerged. The divergence times for the four main lineages could be dated to the early Pleistocene. Surprisingly, the two ubiquitous haplotypes diverged just before or around the Last Glacial Maximum (LGM) and were found in different phylogenetic lineages. The Species Distribution Model suggested a disappearance of P. kansuensis from the TSR during the LGM in contrast to a relatively constant potential distribution in the QTP. We conclude that P. kansuensis colonized the TSR after the LGM. The improbable long-distance dispersal by wind or water across arid land seed flow may well have had birds or men as vector.	[Li, Wen-Jun; Liu, Yan-Yan; Guan, Kai-Yun] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi 830011, Peoples R China; [Li, Wen-Jun] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Sui, Xiao-Lin; Li, Ai-Rong; Guan, Kai-Yun] Chinese Acad Sci, Kunming Inst Bot, Yunnan Key Lab Res & Dev Wild Plant Resources, Kunming 650201, Peoples R China; [Kuss, Patrick] Univ Zurich, Inst Systemat & Evolutionary Bot, CH-8008 Zurich, Switzerland	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; University of Zurich	Guan, KY (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi 830011, Peoples R China.; Li, AR; Guan, KY (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Yunnan Key Lab Res & Dev Wild Plant Resources, Kunming 650201, Peoples R China.	airongli@mail.kib.ac.cn; guanky@mail.kib.ac.cn	Li, Ai-Rong/M-1858-2013	Li, Ai-Rong/0000-0002-6134-9471; Kuss, Patrick/0000-0002-0302-6658	Natural Science Foundation of China [U1303201, 31600447, 31370512, 31400440]; Youth Innovation Promotion Association of CAS; Stiftung zur Forderung der Pflanzenkenntnis (Basel/CH); US National Science Foundation [DEB-1119098]; Direct For Biological Sciences [1119098] Funding Source: National Science Foundation	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association of CAS; Stiftung zur Forderung der Pflanzenkenntnis (Basel/CH); US National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Natural Science Foundation of China (U1303201, 31600447, 31370512, 31400440), a grant from The Youth Innovation Promotion Association of CAS (to ARL), the Stiftung zur Forderung der Pflanzenkenntnis (Basel/CH), and the US National Science Foundation (No. DEB-1119098) (to PK).	Abbott RJ, 2000, SCIENCE, V289, P1343, DOI 10.1126/science.289.5483.1343; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bendiksby M, 2014, J BIOGEOGR, V41, P2020, DOI 10.1111/jbi.12347; Cancio I, 2016, BIODIVERS CONSERV, V25, P693, DOI 10.1007/s10531-016-1085-y; Chen JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060948; Chen SY, 2008, BOT J LINN SOC, V157, P125, DOI 10.1111/j.1095-8339.2008.00785.x; Clark MK, 2005, GEOLOGY, V33, P525, DOI 10.1130/G21265.1; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; de Groot GA, 2016, CONSERV GENET, V17, P111, DOI 10.1007/s10592-015-0765-6; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Friar EA, 2000, MOL ECOL, V9, P2027, DOI 10.1046/j.1365-294X.2000.01111.x; FU YX, 1993, GENETICS, V133, P693; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; Gao QB, 2012, BOT J LINN SOC, V168, P204, DOI 10.1111/j.1095-8339.2011.01193.x; Gao XY, 2014, BIOCHEM SYST ECOL, V55, P93, DOI 10.1016/j.bse.2014.03.002; Gussarova G, 2015, AM J BOT, V102, P1703, DOI 10.3732/ajb.1500072; Guu YP, 2010, J SYST EVOL, V48, P153, DOI 10.1111/j.1759-6831.2010.00073.x; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hu R., 2004, PHYS GEOGRAPHY TIANS; Jiang XL, 2014, PLANT SYST EVOL, V300, P51, DOI 10.1007/s00606-013-0859-x; Kropf M, 2006, NEW PHYTOL, V172, P169, DOI 10.1111/j.1469-8137.2006.01795.x; Kuss P, 2015, NEPAL INTRO NATURAL; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Li GJ, 2011, GEOLOGY, V39, P199, DOI 10.1130/G31734.1; Li Kai-Hui, 2006, Acta Botanica Yunnanica, V28, P421; Li N, 2016, SCI REP-UK, V6, DOI 10.1038/srep17489; Li Y, 2010, MOL BIOL EVOL, V27, P1001, DOI 10.1093/molbev/msp301; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu JQ, 2012, J SYST EVOL, V50, P267, DOI 10.1111/j.1759-6831.2012.00214.x; Liu ML, 2013, PLANT SYST EVOL, V299, P1645, DOI 10.1007/s00606-013-0821-y; [柳妍妍 LIU Yanyan], 2011, [水土保持通报, Bulletin of Soil and Water Conservation], V31, P52; [柳妍妍 Liu Yanyan], 2011, [自然资源学报, Journal of Natural Resources], V26, P48; Liu YY, 2011, B SOIL WATER CONSERV, V31, P65; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Meng HH, 2013, MOL PHYLOGENET EVOL, V68, P398, DOI 10.1016/j.ympev.2013.04.012; Meng LH, 2007, MOL ECOL, V16, P4128, DOI 10.1111/j.1365-294X.2007.03459.x; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; MONMONIER MS, 1973, GEOGR ANAL, V5, P245; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Nybom Hilde, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P93, DOI 10.1078/1433-8319-00006; Pellerin M, 2016, BASIC APPL ECOL, V17, P321, DOI 10.1016/j.baae.2016.01.005; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pons O, 1996, GENETICS, V144, P1237; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prain D., 1890, ANN ROYAL BOT GARDEN, V3, P1; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; R Core Team, 2016, R LANG ENV STAT; Ram MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142597; Rambaut A., 2007, TRACER V1 4; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; REBOUD X, 1994, HEREDITY, V72, P132, DOI 10.1038/hdy.1994.19; Ree RH, 2005, INT J PLANT SCI, V166, P595, DOI 10.1086/430191; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; RUDDIMAN WF, 1991, SCI AM, V264, P66, DOI 10.1038/scientificamerican0391-66; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shi XJ, 2015, J PLANT RES, V128, P269, DOI 10.1007/s10265-014-0699-y; Shi YF, 1998, UPLIFT ENV CHANGES Q; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Sui XL, 2015, J PLANT RES, V128, P563, DOI 10.1007/s10265-015-0727-6; Sui XL, 2016, J ARID LAND, V8, P453, DOI 10.1007/s40333-016-0004-0; [隋晓琳 Sui Xiaolin], 2013, [生态环境学报, Ecology and Environmental Sciences], V22, P1099; Sun JM, 1998, EPISODES, V21, P28; Sun JM, 2004, EARTH PLANET SC LETT, V219, P239, DOI 10.1016/S0012-821X(04)00008-1; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang LY, 1996, ACTA MICROPALAEONTOL, V13, P321; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tkach N, 2014, MOL PHYLOGENET EVOL, V76, P75, DOI 10.1016/j.ympev.2014.03.004; Villaverde T, 2015, J BIOGEOGR, V42, P1820, DOI 10.1111/jbi.12559; Wang JF, 2013, J BIOGEOGR, V40, P1741, DOI 10.1111/jbi.12114; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025896; Wang LY, 2009, MOL ECOL, V18, P709, DOI 10.1111/j.1365-294X.2008.04055.x; Wang WanLin, 2010, Xinjiang Agricultural Sciences, V47, P1242; Wang ZJ, 2011, J SYST EVOL, V49, P72, DOI 10.1111/j.1759-6831.2010.00108.x; Wen J, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00004; Williams MA, 1993, QUATERNARY ENV; Wright S, 1943, GENETICS, V28, P114; Xu TT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-194; Xu ZQ, 2013, PRECAMBRIAN RES, V235, P150, DOI 10.1016/j.precamres.2013.06.001; Yang FMY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040196; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Yang H-B, 1998, FLORA CHINA, V16, P97; Zhang HX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061954, 10.1371/journal.pone.0069046]; Zhang HX, 2012, PALAEOGEOGR PALAEOCL, V353, P93, DOI 10.1016/j.palaeo.2012.07.013; Zhang HX, 2012, J SYST EVOL, V50, P295, DOI 10.1111/j.1759-6831.2012.00198.x; Zhang JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112923; Zhang XM, 2013, J SYST EVOL, V51, P564, DOI 10.1111/jse.12026; Zheng BX, 2002, QUATERN INT, V97-8, P93, DOI 10.1016/S1040-6182(02)00054-X; Zhou SZ, 2006, QUATERN INT, V154, P44, DOI 10.1016/j.quaint.2006.02.002; Zou JB, 2012, J SYST EVOL, V50, P341, DOI 10.1111/j.1759-6831.2012.00207.x	101	10	10	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165700	10.1371/journal.pone.0165700	http://dx.doi.org/10.1371/journal.pone.0165700			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806090	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000386715500050
J	Li, YC; Sun, R; Wang, YC; Li, HY; Zheng, XF				Li, Yongcheng; Sun, Rong; Wang, Yuechao; Li, Hongyi; Zheng, Xiongfei			A Novel Robot System Integrating Biological and Mechanical Intelligence Based on Dissociated Neural Network-Controlled Closed-Loop Environment	PLOS ONE			English	Article							LONG-TERM POTENTIATION; STIMULATION; FABRICATION; PLASTICITY; ACTUATORS; PATTERNS; DENSITY; NEURONS; DEVICES; MOTORS	We propose the architecture of a novel robot system merging biological and artificial intelligence based on a neural controller connected to an external agent. We initially built a framework that connected the dissociated neural network to a mobile robot system to implement a realistic vehicle. The mobile robot system characterized by a camera and two-wheeled robot was designed to execute the target-searching task. We modified a software architecture and developed a home-made stimulation generator to build a bi-directional connection between the biological and the artificial components via simple binomial coding/decoding schemes. In this paper, we utilized a specific hierarchical dissociated neural network for the first time as the neural controller. Based on our work, neural cultures were successfully employed to control an artificial agent resulting in high performance. Surprisingly, under the tetanus stimulus training, the robot performed better and better with the increasement of training cycle because of the short-term plasticity of neural network (a kind of reinforced learning). Comparing to the work previously reported, we adopted an effective experimental proposal (i.e. increasing the training cycle) to make sure of the occurrence of the short-term plasticity, and preliminarily demonstrated that the improvement of the robot's performance could be caused independently by the plasticity development of dissociated neural network. This new framework may provide some possible solutions for the learning abilities of intelligent robots by the engineering application of the plasticity processing of neural networks, also for the development of theoretical inspiration for the next generation neuro-prostheses on the basis of the bi-directional exchange of information within the hierarchical neural networks.	[Li, Yongcheng; Wang, Yuechao; Li, Hongyi; Zheng, Xiongfei] Chinese Acad Sci, State Key Lab Robot, Shenyang Inst Automat, Shenyang, Liaoning, Peoples R China; [Li, Yongcheng] Univ Chinese Acad Sci, Beijing, Peoples R China; [Sun, Rong] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Automation, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zheng, XF (corresponding author), Chinese Acad Sci, State Key Lab Robot, Shenyang Inst Automat, Shenyang, Liaoning, Peoples R China.	zhengxiongfei@sia.cn		Sun, Rong/0000-0002-0950-1480	Research Equipment Development Program of the Chinese Academy of Sciences [YZ201545]; National Natural Science Foundation of China [51305438]; National High Technology Research and Development Program of China (863 Program) [2015AA020312]; General Reserve Department of PLA [9140A26060214ZK63424]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R00AA020312, K99AA020312] Funding Source: NIH RePORTER	Research Equipment Development Program of the Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); General Reserve Department of PLA; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The work has been supported by the Research Equipment Development Program of the Chinese Academy of Sciences (YZ201545, http://www.kjtj.cas.cn), National Natural Science Foundation of China (51305438, https://isisn.nsfc.gov.cn/egrartweb), National High Technology Research and Development Program of China (863 Program 2015AA020312, http://program.most.gov.cn/), and General Reserve Department of PLA (9140A26060214ZK63424, http://www.mod.gov.cn/topnews/node_47615.htm). The funders had a key role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors want to thank the Prof. Guoqiang Bi and Prof. Pakming Lau in University of Science and Technology of China. We appreciate their useful instruction and support of the setup for our experiments. The work has been supported by the Research Equipment Development Program of the Chinese Academy of Sciences (YZ201545), National Natural Science Foundation of China (51305438), National High Technology Research and Development Program of China (863 Program 2015AA020312), and General Reserve Department of PLA (9140A26060214ZK63424).	Al-Fandi M, 2010, IET NANOBIOTECHNOL, V4, P61, DOI 10.1049/iet-nbt.2010.0003; Bakkum DJ, 2008, J NEURAL ENG, V5, P310, DOI 10.1088/1741-2560/5/3/004; Bi GQ, 2005, TRENDS NEUROSCI, V28, P222, DOI 10.1016/j.tins.2005.02.002; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Chan V, 2012, LAB CHIP, V12, P88, DOI 10.1039/c1lc20688e; Chen CP, 2006, BIOSYSTEMS, V85, P137, DOI 10.1016/j.biosystems.2005.12.006; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; Cvetkovic C, 2014, P NATL ACAD SCI USA, V111, P10125, DOI 10.1073/pnas.1401577111; Erickson J, 2008, J NEUROSCI METH, V175, P1, DOI 10.1016/j.jneumeth.2008.07.023; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; Feinerman O, 2008, NAT PHYS, V4, P967, DOI 10.1038/nphys1099; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; FRANCIS NR, 1994, J MOL BIOL, V235, P1261, DOI 10.1006/jmbi.1994.1079; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hyman JM, 2003, J NEUROSCI, V23, P11725; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Jarosiewicz B, 2008, P NATL ACAD SCI USA, V105, P19486, DOI 10.1073/pnas.0808113105; Jun SB, 2007, J NEUROSCI METH, V160, P317, DOI 10.1016/j.jneumeth.2006.09.009; Kim J, 2007, LAB CHIP, V7, P1504, DOI 10.1039/b705367c; Kim MJ, 2008, SMALL, V4, P111, DOI 10.1002/smll.200700641; Lamsa K, 2005, NAT NEUROSCI, V8, P916, DOI 10.1038/nn1486; Lau PM, 2005, P NATL ACAD SCI USA, V102, P10333, DOI 10.1073/pnas.0500717102; le Feber J, 2007, J NEURAL ENG, V4, P54, DOI 10.1088/1741-2560/4/2/006; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Li Y, 2015, PLOS ONE, V10, DOI [10. 10338, 10.1073/pnas.0500717102, DOI 10.1073/PNAS.0500717102]; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; MAEDA E, 1995, J NEUROSCI, V15, P6834; Martel S, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P426, DOI 10.1109/IROS.2009.5353964; Martinoia S, 2004, NEUROCOMPUTING, V58, P1065, DOI 10.1016/j.neucom.2004.01.167; Nawroth JC, 2012, NAT BIOTECHNOL, V30, P792, DOI 10.1038/nbt.2269; Neal D, 2013, IEEE ENG MED BIO, P326, DOI 10.1109/EMBC.2013.6609503; Novellino A, 2007, Comput Intell Neurosci, P12725, DOI 10.1155/2007/12725; O'Doherty JE, 2011, NATURE, V479, P228, DOI 10.1038/nature10489; Pizzi RMR, 2009, BIOSYSTEMS, V95, P137, DOI 10.1016/j.biosystems.2008.09.006; Potter A, 2004, P BRAIN INSP COGN SY; Raichman N, 2006, NEUROCOMPUTING, V69, P1150, DOI 10.1016/j.neucom.2005.12.064; Rubinsky L, 2008, NEURAL NETWORKS, V21, P1232, DOI 10.1016/j.neunet.2008.06.008; Sakamoto K, 2015, NEURAL NETWORKS, V62, P67, DOI 10.1016/j.neunet.2014.06.009; Sakar MS, 2012, LAB CHIP, V12, P4976, DOI 10.1039/c2lc40338b; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Schwartz AB, 2006, NEURON, V52, P205, DOI 10.1016/j.neuron.2006.09.019; Shahaf G, 2001, J NEUROSCI, V21, P8782, DOI 10.1523/JNEUROSCI.21-22-08782.2001; Steager EB, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/3/035001; Tessadori J, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00099; van Pelt J, 2004, IEEE T BIO-MED ENG, V51, P2051, DOI 10.1109/TBME.2004.827936; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wagenaar DA, 2002, J NEUROSCI METH, V120, P113, DOI 10.1016/S0165-0270(02)00149-8; Warwick K, 2008, NEUROCOMPUTING, V71, P2619, DOI 10.1016/j.neucom.2007.06.017; Warwick K, 2010, DEFENCE SCI J, V60, P5, DOI 10.14429/dsj.60.11; Xi JZ, 2005, NAT MATER, V4, P180, DOI 10.1038/nmat1308; Xu SJ, 2012, NAT NEUROSCI, V15, P449, DOI 10.1038/nn.3036; Yanagisawa T, 2012, ANN NEUROL, V71, P353, DOI 10.1002/ana.22613	53	1	1	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165600	10.1371/journal.pone.0165600	http://dx.doi.org/10.1371/journal.pone.0165600			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806074	gold, Green Published, Green Submitted			2022-12-26	WOS:000386715500041
J	Wu, P; Jiang, XX; Guo, XJ; Li, L; Chen, T				Wu, Ping; Jiang, Xiaoxu; Guo, Xijie; Li, Long; Chen, Tao			Genome-Wide Analysis of Differentially Expressed microRNA in Bombyx mori Infected with Nucleopolyhedrosis Virus	PLOS ONE			English	Article							RNA METHYLTRANSFERASE DNMT2; BACULOVIRUS INFECTION; DROSOPHILA; HOST; REPLICATION; IMMUNITY; TRANSCRIPTS; CELLS; DNA	Bombyx mori nucleopolyhedrosis virus (BmNPV) is a major pathogen that threatens the growth and sustainability of the sericulture industry. Since microRNAs (miRNAs) have been shown to play important roles in host-pathogen interactions, in this study we investigated the effects of BmNPV infection on silkworm microRNAs expression profile. To achieve this, we constructed and deep-sequenced two small RNA libraries generated from BmNPV infected and un-infected larvae. The results revealed that 38 silkworm miRNAs were differentially expressed after BmNPV infection. Based on the GO analysis, their predicted target genes were found to be involved in diverse functions such as binding, catalytic, virion and immune response to stimulus suggesting their potential roles in host-virus interactions. Using the dual-luciferase reporter assay, we confirmed that Bmo-miR-277-5p, up-regulated in BmNPV-infected larvae, targeted the B. mori DNA cytosine-5 methyltransferase (Dnmt2) gene which may play potential role in silkworm-BmNPV interaction. These results provide new insights into exploring the interaction mechanism between silkworm and BmNPV.	[Wu, Ping; Guo, Xijie; Li, Long; Chen, Tao] Jiangsu Univ Sci & Technol, Sericultural Res Inst, Zhenjiang, Jiangsu, Peoples R China; [Wu, Ping; Li, Long; Chen, Tao] Minist Agr, Qual Inspect Ctr Sericulture Prod, Zhenjiang, Jiangsu, Peoples R China; [Jiang, Xiaoxu] Jiangsu Univ Sci & Technol, Sch Biol, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University of Science & Technology; Ministry of Agriculture & Rural Affairs; Jiangsu University of Science & Technology	Wu, P; Chen, T (corresponding author), Jiangsu Univ Sci & Technol, Sericultural Res Inst, Zhenjiang, Jiangsu, Peoples R China.; Wu, P; Chen, T (corresponding author), Minist Agr, Qual Inspect Ctr Sericulture Prod, Zhenjiang, Jiangsu, Peoples R China.	wp4114@163.com; zjchentao@sina.com	Guo, Xijie/GPX-9247-2022		National Nature Science Foundation of China [31502016]; Natural Science Foundation of Jiangsu, China [BK20141286]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu, China(Natural Science Foundation of Jiangsu Province)	This research was financially supported by the National Nature Science Foundation of China (Grant No. 31502016) and the Natural Science Foundation of Jiangsu, China (No. BK20141286) to PW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was financially supported by the National Nature Science Foundation of China (Grant No. 31502016) and the Natural Science Foundation of Jiangsu, China (No. BK20141286). PW was the receiver.	Bao YY, 2009, GENOMICS, V94, P138, DOI 10.1016/j.ygeno.2009.04.003; Blanco S, 2014, CURR OPIN CELL BIOL, V31, P1, DOI 10.1016/j.ceb.2014.06.006; Campbell CL, 2014, INSECT MOL BIOL, V23, P132, DOI 10.1111/imb.12070; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Courteau LA, 2012, CRYOBIOLOGY, V65, P210, DOI 10.1016/j.cryobiol.2012.06.005; Durdevic Z, 2013, CELL REP, V4, P931, DOI 10.1016/j.celrep.2013.07.046; Durdevic Z, 2013, EMBO REP, V14, P269, DOI 10.1038/embor.2013.3; Esslinger SM, 2013, RNA BIOL, V10, P1042, DOI 10.4161/rna.24810; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gu C, 2015, INT J CLIN EXP PATHO, V8, P10050; Gundersen-Rindal DE, 2010, ARCH VIROL, V155, P783, DOI 10.1007/s00705-010-0616-1; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hussain M, 2010, J VIROL, V84, P612, DOI 10.1128/JVI.01794-09; Ingle H, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3183; Jayachandran B, 2013, J INVERTEBR PATHOL, V114, P151, DOI 10.1016/j.jip.2013.07.004; Jiang L, 2014, INSECT BIOCHEM MOLEC, V48, P1, DOI 10.1016/j.ibmb.2014.02.003; Jiang L, 2013, ANTIVIR RES, V98, P171, DOI 10.1016/j.antiviral.2013.02.015; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lekha G, 2015, GENOMICS, V106, P393, DOI 10.1016/j.ygeno.2015.09.002; Li L, 2012, J INSECT PHYSIOL, V58, P1438, DOI 10.1016/j.jinsphys.2012.08.008; Lin MJ, 2005, J BIOL CHEM, V280, P861, DOI 10.1074/jbc.C400477200; Mead EA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-244; Mehrabadi M, 2013, J GEN VIROL, V94, P1385, DOI 10.1099/vir.0.051060-0; NAM S, 2005, GENOMICS INFORM, V3, P53; Padmanabhan C, 2009, CURR OPIN PLANT BIOL, V12, P465, DOI 10.1016/j.pbi.2009.06.005; Rahman MM, 2004, VIRUS RES, V101, P109, DOI 10.1016/j.virusres.2003.12.027; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rohrmann GF, 2013, BACULOVIRUS MOL BIOL, V3rd; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Schaefer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001414; Simon-Mateo C, 2006, J VIROL, V80, P2429, DOI 10.1128/JVI.80.5.2429-2436.2006; Singh CP, 2014, INSECT BIOCHEM MOLEC, V49, P59, DOI 10.1016/j.ibmb.2014.03.008; Singh CP, 2012, J VIROL, V86, P7867, DOI 10.1128/JVI.00064-12; Singh J, 2010, VIROLOGY, V407, P120, DOI 10.1016/j.virol.2010.07.033; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tan HP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002681; Vilmos P, 2013, GENETICS, V195, P469, DOI 10.1534/genetics.113.153585; Wang L, 2015, REV MED VIROL, V25, P320, DOI 10.1002/rmv.1850; Wu P, 2016, GENE, V575, P264, DOI 10.1016/j.gene.2015.09.009; Wu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068209; Ye YXH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066482; Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110; Zhang YL, 2015, GENE, V557, P215, DOI 10.1016/j.gene.2014.12.038; Zhong L, 2015, 4TH INTERNATIONAL CONFERENCE ON MATERIALS ENGINEERING FOR ADVANCED TECHNOLOGIES (ICMEAT 2015), P5	47	18	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165865	10.1371/journal.pone.0165865	http://dx.doi.org/10.1371/journal.pone.0165865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806111	Green Published, Green Submitted, gold			2022-12-26	WOS:000386715500064
J	Zhang, LY; Niu, K; Zhu, K; Xia, C; Yan, J; Zhao, W; Wei, JR; Duan, ML; Zheng, GX				Zhang, Luyao; Niu, Kai; Zhu, Kang; Xia, Cui; Yan, Jing; Zhao, Wei; Wei, Junrong; Duan, Maoli; Zheng, Guoxi			Long-Term Prognostic Analysis after Endoscopic Endonasal Surgery for Olfactory Neuroblastoma: A Retrospective Study of 13 Cases	PLOS ONE			English	Article							ESTHESIONEUROBLASTOMA; EXPERIENCE; MANAGEMENT; RESECTION; CHEMOTHERAPY; METAANALYSIS; OUTCOMES; THERAPY; TUMORS	Objectives To summarize the characteristics and long-term outcomes of olfactory neuroblastoma through the analysis of 13 cases in single institution, with the assessment of treatment modality, prognostic factors. Method A retrospective study of thirteen cases diagnosed as olfactory neuroblastoma and underwent combined treatments during the period 2000-2010. Statistical analysis was performed to search for prognostic factors and compared different treatment modalities. Results 13 patients were enrolled in this study, including 8 male and 5 female, ranging from 15 to 69 (median 43) years old. One patient at stage A was only treated with endoscopic endonasal surgery (EES). Seven patients were treated with preoperative radiotherapy and EES, two with EES and postoperative radiotherapy, and the other three with combined radiotherapy and chemotherapy. The range of follow-up time varied from 23 to 116 months (median 65 months). The 5-year overall survival rate was 46.2% (6/13). To date, these thirteen patients have not suffered local recurrences while two patients had lymph node recurrences and one had distant metastasis in the bone marrow. In 13 patients, 61.5% were diagnosed as late T stage (T3/4), 69.2% late Kadish stage (C/D) and 53.8% were high Hyams grade (I/II), which indicated poor prognosis. Related prognostic factors were the TNM stage (T stage P = 0.028, N stage P = 0.000, M stage P = 0.007), Kadish stage (P = 0.025) and treatment modality (P = 0.015). Conclusion Late stage of TNM and Kadish staging system indicated a poor prognosis. Combined treatment modality, including endoscopic endonasal surgery, achieved a better outcome than non-surgical approach.	[Zhang, Luyao; Zhu, Kang; Xia, Cui; Yan, Jing; Wei, Junrong; Zheng, Guoxi] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Otorhinolaryngol Head & Neck Surg, Xian, Shaanxi, Peoples R China; [Niu, Kai; Duan, Maoli] Karolinska Inst, Karolinska Hosp, Dept Clin Sci Technol & Intervent, Stockholm, Sweden; [Niu, Kai] Jilin Univ, Affiliated Hosp 1, Dept Otorhinolaryngol Head & Neck Surg, Changchun, Jilin, Peoples R China; [Zhao, Wei] Shangluo Cent Hosp, Dept Otorhinolaryngol, Shangluo, Shaanxi, Peoples R China	Xi'an Jiaotong University; Karolinska Institutet; Karolinska University Hospital; Jilin University	Zheng, GX (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Otorhinolaryngol Head & Neck Surg, Xian, Shaanxi, Peoples R China.; Duan, ML (corresponding author), Karolinska Inst, Karolinska Hosp, Dept Clin Sci Technol & Intervent, Stockholm, Sweden.	Maoli.Duan@ki.se; zhengguoxi@21cn.com			National Natural Science Foundation of China [81271057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the National Natural Science Foundation of China (No. 81271057,) (http://www.nsfc.gov.cn/publish/portall/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bachar G, 2008, HEAD NECK-J SCI SPEC, V30, P1607, DOI 10.1002/hed.20920; Bell D, 2015, HEAD NECK PATHOL, V9, P51, DOI 10.1007/s12105-014-0547-3; Bossi P, 2015, CANCER TREAT REV, V41, P836, DOI 10.1016/j.ctrv.2015.07.004; Bradley Patrick J, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P112, DOI 10.1097/00020840-200304000-00009; Castelnuovo P, 2007, HEAD NECK-J SCI SPEC, V29, P845, DOI 10.1002/hed.20610; Devaiah AK, 2009, LARYNGOSCOPE, V119, P1412, DOI 10.1002/lary.20280; Devaney K, 1996, MODERN PATHOL, V9, P658; Devi Parvathi, 2014, J Oral Maxillofac Pathol, V18, pS135, DOI 10.4103/0973-029X.141367; DULGUEROV P, 1992, LARYNGOSCOPE, V102, P843, DOI 10.1288/00005537-199208000-00001; Dulguerov P, 2001, LANCET ONCOL, V2, P683, DOI 10.1016/S1470-2045(01)00558-7; Ferlito A, 2003, LARYNGOSCOPE, V113, P1935, DOI 10.1097/00005537-200311000-00015; FOOTE RL, 1993, INT J RADIAT ONCOL, V27, P835, DOI 10.1016/0360-3016(93)90457-7; Fu TS, 2016, HEAD NECK-J SCI SPEC, V38, pE2306, DOI 10.1002/hed.24233; Guled M, 2008, MODERN PATHOL, V21, P770, DOI 10.1038/modpathol.2008.57; HIROSE T, 1995, CANCER, V76, P4, DOI 10.1002/1097-0142(19950701)76:1<4::AID-CNCR2820760103>3.0.CO;2-E; Jethanamest D, 2007, ARCH OTOLARYNGOL, V133, P276, DOI 10.1001/archotol.133.3.276; KADISH S, 1976, CANCER, V37, P1571, DOI 10.1002/1097-0142(197603)37:3<1571::AID-CNCR2820370347>3.0.CO;2-L; Kane AJ, 2010, J NEUROSURG, V113, P340, DOI 10.3171/2010.2.JNS091897; Komotar RJ, 2013, WORLD NEUROSURG, V80, P148, DOI 10.1016/j.wneu.2012.12.003; Lund VJ, 2015, RHINOLOGY, V53, P204, DOI 10.4193/Rhino14.318; Lund VJ, 1998, HEAD NECK-J SCI SPEC, V20, P97, DOI 10.1002/(SICI)1097-0347(199803)20:2<97::AID-HED1>3.0.CO;2-Y; Malouf GG, 2013, EUR J CANCER, V49, P1324, DOI 10.1016/j.ejca.2012.12.008; McElroy EA, 1998, NEUROSURGERY, V42, P1023, DOI 10.1097/00006123-199805000-00040; MORITA A, 1993, NEUROSURGERY, V32, P706, DOI 10.1227/00006123-199305000-00002; Ow TJ, 2014, HEAD NECK-J SCI SPEC, V36, P524, DOI 10.1002/hed.23327; Porter AB, 2008, J NEURO-ONCOL, V90, P201, DOI 10.1007/s11060-008-9645-y; Saade RE, 2015, CURR ONCOL REP, V17, DOI 10.1007/s11912-014-0423-z; Song CM, 2012, LARYNGOSCOPE, V122, P2389, DOI 10.1002/lary.23641; Tajudeen BA, 2015, J NEUROL SURG PART B, V76, P43, DOI 10.1055/s-0034-1390011; Thompson LDR, 2009, HEAD NECK PATHOL, V3, P252, DOI 10.1007/s12105-009-0125-2; TROJANOWSKI JQ, 1982, NEW ENGL J MED, V307, P159, DOI 10.1056/NEJM198207153070305; Unger F, 2001, MINIM INVAS NEUROSUR, V44, P79, DOI 10.1055/s-2001-16000; Vucinic N, 2015, ACTA NEUROL BELG, V115, P195, DOI 10.1007/s13760-014-0319-6; Zafereo ME, 2008, OTOLARYNG HEAD NECK, V138, P452, DOI 10.1016/j.otohns.2007.12.038	34	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0166046	10.1371/journal.pone.0166046	http://dx.doi.org/10.1371/journal.pone.0166046			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806104	Green Published, Green Submitted, gold			2022-12-26	WOS:000386715500079
J	Amatngalim, GD; Broekman, W; Daniel, NM; van der Vlugt, LEPM; van Schadewijk, A; Taube, C; Hiemstra, PS				Amatngalim, Gimano D.; Broekman, Winifred; Daniel, Nadia M.; van der Vlugt, Lucien E. P. M.; van Schadewijk, Annemarie; Taube, Christian; Hiemstra, Pieter S.			Cigarette Smoke Modulates Repair and Innate Immunity following Injury to Airway Epithelial Cells	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; BASAL-CELLS; DIFFERENTIATION; PROLIFERATION; ROLES	Cigarette smoking is the main risk factor associated with chronic obstructive pulmonary disease (COPD), and contributes to COPD development and progression by causing epithelial injury and inflammation. Whereas it is known that cigarette smoke (CS) may affect the innate immune function of airway epithelial cells and epithelial repair, this has so far not been explored in an integrated design using mucociliary differentiated airway epithelial cells. In this study, we examined the effect of whole CS exposure on wound repair and the innate immune activity of mucociliary differentiated primary bronchial epithelial cells, upon injury induced by disruption of epithelial barrier integrity or by mechanical wounding. Upon mechanical injury CS caused a delayed recovery in the epithelial barrier integrity and wound closure. Furthermore CS enhanced innate immune responses, as demonstrated by increased expression of the antimicrobial protein RNase 7. These differential effects on epithelial repair and innate immunity were both mediated by CS-induced oxidative stress. Overall, our findings demonstrate modulation of wound repair and innate immune responses of injured airway epithelial cells that may contribute to COPD development and progression.	[Amatngalim, Gimano D.; Broekman, Winifred; Daniel, Nadia M.; van der Vlugt, Lucien E. P. M.; van Schadewijk, Annemarie; Taube, Christian; Hiemstra, Pieter S.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Amatngalim, GD (corresponding author), Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands.	G.D.Amatngalim@lumc.nl	Amatngalim, Gimano/AGQ-6886-2022; M.Daniel, Nadia/AAF-5778-2019	Amatngalim, Gimano/0000-0003-3442-1754; M.Daniel, Nadia/0000-0001-7907-4675	Galapagos N.V., the Netherlands	Galapagos N.V., the Netherlands(Netherlands Government)	This work was supported by an unrestricted research grant from Galapagos N.V., the Netherlands. The funder had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander LEC, 2015, CHEST, V148, P1307, DOI 10.1378/chest.15-0409; Allen-Gipson DS, 2013, AM J RESP CELL MOL, V48, P665, DOI 10.1165/rcmb.2011-0273OC; Amatngalim GD, 2015, J IMMUNOL, V194, P3340, DOI 10.4049/jimmunol.1402169; Beisswenger C, 2004, RESPIRATION, V71, P402, DOI 10.1159/000079647; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Burgel PR, 2008, EUR RESPIR J, V32, P1068, DOI 10.1183/09031936.00172007; Burgel PR, 2004, THORAX, V59, P992, DOI 10.1136/thx.2003.018879; Erjefalt JS, 1997, THORAX, V52, P213, DOI 10.1136/thx.52.3.213; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Heijink IH, 2012, EUR RESPIR J, V39, P419, DOI 10.1183/09031936.00193810; Heijink IH, 2014, AM J RESP CRIT CARE, V189, P1439, DOI 10.1164/rccm.201311-1982LE; Hiemstra PS, 2015, EUR RESPIR J, V45, P1150, DOI 10.1183/09031936.00141514; Jakiela B, 2008, AM J RESP CELL MOL, V38, P517, DOI 10.1165/rcmb.2007-0050OC; Luppi F, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-140; Malhotra D, 2008, AM J RESP CRIT CARE, V178, P592, DOI 10.1164/rccm.200803-380OC; Malhotra D, 2009, AM J RESP CRIT CARE, V180, P1196, DOI 10.1164/rccm.200903-0324OC; Perotin JM, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0151-9; Pezzulo AA, 2011, AM J PHYSIOL-LUNG C, V300, pL25, DOI 10.1152/ajplung.00256.2010; Puchelle Edith, 2006, Proc Am Thorac Soc, V3, P726, DOI 10.1513/pats.200605-126SF; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Shaykhiev R, 2005, AM J PHYSIOL-LUNG C, V289, pL842, DOI 10.1152/ajplung.00286.2004; Shaykhiev R, 2015, EUR RESPIR J, V46, P894, DOI 10.1183/13993003.00521-2015; Shaykhiev Renat, 2014, Ann Am Thorac Soc, V11 Suppl 5, pS252, DOI 10.1513/AnnalsATS.201402-049AW; Teixeira VH, 2013, ELIFE, P2; Thai P, 2013, AM J RESP CELL MOL, V49, P204, DOI 10.1165/rcmb.2013-0159RC; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; van Wetering S, 2007, MOL IMMUNOL, V44, P803, DOI 10.1016/j.molimm.2006.04.008; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wang HJ, 2001, AM J RESP CELL MOL, V25, P772, DOI 10.1165/ajrcmb.25.6.4458; White SR, 2008, AM J PHYSIOL-LUNG C, V295, pL1018, DOI 10.1152/ajplung.00065.2008	33	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166255	10.1371/journal.pone.0166255	http://dx.doi.org/10.1371/journal.pone.0166255			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829065	Green Published, gold, Green Submitted			2022-12-26	WOS:000387724300101
J	Cheng, YC; Hannaoui, S; John, TR; Dudas, S; Czub, S; Gilch, S				Cheng, Yo Ching; Hannaoui, Samia; John, Theodore R.; Dudas, Sandor; Czub, Stefanie; Gilch, Sabine			Early and Non-Invasive Detection of Chronic Wasting Disease Prions in Elk Feces by Real Time Quaking Induced Conversion	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CERVUS-ELAPHUS-NELSONI; TRANSGENIC MICE; ORAL-TRANSMISSION; INFECTIOUS PRIONS; SPECIES BARRIERS; DEER; PROTEIN; SCRAPIE; ANIMALS	Chronic wasting disease (CWD) is a fatal prion disease of wild and captive cervids in North America. Prions are infectious agents composed of a misfolded version of a host-encoded protein, termed PrPsc. Infected cervids excrete and secrete prions, contributing to lateral transmission. Geographical distribution is expanding and case numbers in wild cervids are increasing. Recently, the first European cases of CWD have been reported in a wild reindeer and two moose from Norway. Therefore, methods to detect the infection early in the incubation time using easily available samples are desirable to facilitate effective disease management. We have adapted the real-time quaking induced conversion (RT-QuIC) assay, a sensitive in vitro prion amplification method, for pre-clinical detection of prion seeding activity in elk feces. Testing fecal samples from orally inoculated elk taken at various time points post infection revealed early shedding and detectable prion seeding activity throughout the disease course. Early shedding was also found in two elk encoding a PrP genotype associated with reduced susceptibility for CWD. In summary, we suggest that detection of CWD prions in feces by RT-QuIC may become a useful tool to support CWD surveillance in wild and captive cervids. The finding of early shedding independent of the elk's prion protein genotype raises the question whether prolonged survival is beneficial, considering accumulation of environmental prions and its contribution to CWD transmission upon extended duration of shedding.	[Cheng, Yo Ching; Hannaoui, Samia; Gilch, Sabine] Univ Calgary, Dept Ecosyst & Publ Hlth, Fac Vet Med, Calgary, AB, Canada; [John, Theodore R.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; [Dudas, Sandor; Czub, Stefanie] Lethbridge Labs, Canadian Food Inspect Agcy, Lethbridge, AB, Canada	University of Calgary; University of Wyoming; Canadian Food Inspection Agency	Gilch, S (corresponding author), Univ Calgary, Dept Ecosyst & Publ Hlth, Fac Vet Med, Calgary, AB, Canada.	sgilch@ucalgary.ca			Canada Research Chair program; Alberta Prion Research Institute [201300027]; Margaret Gunn Endowment for Animal Research	Canada Research Chair program(Canada Research Chairs); Alberta Prion Research Institute; Margaret Gunn Endowment for Animal Research	SG is supported by the Canada Research Chair program (http://www.chairs-chaires.gc.ca/home-accuell-eng.aspx). This work was supported by grant 201300027 from the Alberta Prion Research Institute (http://www.prioninstitute.ca/) and a grant from the Margaret Gunn Endowment for Animal Research to SG.	Angers RC, 2009, EMERG INFECT DIS, V15, P696, DOI 10.3201/eid1505.081458; Angers RC, 2006, SCIENCE, V311, P1117, DOI 10.1126/science.1122864; Asano Sanae, 2005, Animal Science Journal, V76, P447, DOI 10.1111/j.1740-0929.2005.00289.x; Balachandran A, 2010, CAN VET J, V51, P169; Barria MA, 2011, J BIOL CHEM, V286, P7490, DOI 10.1074/jbc.M110.198465; Basu U, 2012, PRION, V6, P282, DOI 10.4161/pri.19915; Benestad SL, 2016, VET RES, V47, DOI 10.1186/s13567-016-0375-4; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Cortez L, 2014, PRION, V8; Davenport KA, 2015, J VIROL, V89, P9524, DOI 10.1128/JVI.01439-15; Denkers ND, 2016, J GEN VIROL; Elder AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080203; Gavier-Widen D, 2005, J VET DIAGN INVEST, V17, P509, DOI 10.1177/104063870501700601; Gilch S, 2011, TOP CURR CHEM, V305, P51, DOI 10.1007/128_2011_159; Gordon PMK, 2009, NUCLEIC ACIDS RES, V37, P550, DOI 10.1093/nar/gkn963; Green KM, 2008, J GEN VIROL, V89, P598, DOI 10.1099/vir.0.83168-0; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Hamir AN, 2006, J VET DIAGN INVEST, V18, P110, DOI 10.1177/104063870601800118; Henderson D.M., 2014, J GEN VIROL; Henderson DM, 2015, J VIROL, V89, P9338, DOI 10.1128/JVI.01118-15; Henderson DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074377; Horiuchi M, 2000, P NATL ACAD SCI USA, V97, P5836, DOI 10.1073/pnas.110523897; Hughson AG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005914; John TR, 2013, PRION, V7, P253, DOI 10.4161/pri.24430; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Kruger D, 2009, VET RES, V40, DOI 10.1051/vetres:2008042; Kujala P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002449; Kyle LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066715; LANSBURY PT, 1994, SCIENCE, V265, P1510, DOI 10.1126/science.8079159; Lasmezas CI, 1996, NATURE, V381, P743, DOI 10.1038/381743a0; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Orru CD, 2015, PLOS PATHOG, V11, DOI [10.1371/journal.ppat.1004983, 10.1371/journal.ppat.1005117]; Orru CD, 2015, J CLIN MICROBIOL, V53, P1115, DOI 10.1128/JCM.02906-14; Orru CD, 2011, MBIO, V2, DOI 10.1128/mBio.00078-11; Pritzkow S, 2015, CELL REP, V11, P1168, DOI 10.1016/j.celrep.2015.04.036; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Pulford B, 2012, J WILDLIFE DIS, V48, P425, DOI 10.7589/0090-3558-48.2.425; Robinson SJ, 2012, PRION, V6, P153, DOI 10.4161/pri.19640; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar JG, 2008, J INFECT DIS, V198, P81, DOI 10.1086/588193; Sandberg MK, 2010, J GEN VIROL, V91, P2651, DOI 10.1099/vir.0.024380-0; Saunders SE, 2012, EMERG INFECT DIS, V18, P369, DOI 10.3201/eid1803.110685; Schatzl HM, 1997, LANCET, V349, P1603, DOI 10.1016/S0140-6736(05)61632-7; Scott MR, 2005, J VIROL, V79, P5259, DOI 10.1128/JVI.79.9.5259-5271.2005; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Sigurdson CJ, 2011, J NEUROSCI, V31, P13840, DOI 10.1523/JNEUROSCI.3504-11.2011; Sigurdson CJ, 2010, J CLIN INVEST, V120, P2590, DOI 10.1172/JCI42051; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; Tamguney G, 2009, NATURE, V461, P529, DOI 10.1038/nature08289; Terry LA, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-65; Vascellari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048969; Watts JC, 2006, PLOS PATHOG, V2, P152, DOI 10.1371/journal.ppat.0020026; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Williams ES, 2002, REV SCI TECH OIE, V21, P305, DOI 10.20506/rst.21.2.1340	55	44	44	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166187	10.1371/journal.pone.0166187	http://dx.doi.org/10.1371/journal.pone.0166187			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829062	gold, Green Published, Green Submitted			2022-12-26	WOS:000387724300094
J	De Angelis, R; Melino, S; Prosposito, P; Casalboni, M; Lamastra, FR; Nanni, F; Bruno, L; Congestri, R				De Angelis, Roberta; Melino, Sonia; Prosposito, Paolo; Casalboni, Mauro; Lamastra, Francesca Romana; Nanni, Francesca; Bruno, Laura; Congestri, Roberta			The Diatom Staurosirella pinnata for Photoactive Material Production	PLOS ONE			English	Article							ACCUMULATION; INTEGRATION; GROWTH	A native isolate of the colonial benthic diatom Staurosirella pinnata was cultivated for biosilica production. The silicified cell walls (frustules) were used as a source of homogeneous and structurally predictable porous biosilica for dye trapping and random laser applications. This was coupled with the extraction of lipids from biomass showing potential to fabricate photoactive composite materials sustainably. The strain was selected for its ease of growth in culture and harvesting. Biosilica and lipids were obtained at the end of growth in indoor photobioreactors. Frustules were structurally characterized microscopically and their chemistry analyzed with Fourier Transform Infrared Spectroscopy. Frustule capacity of binding laser dyes was evaluated on a set of frustules/Rhodamine B (Rho B) solutions and with respect to silicon dioxide and diatomite by Fluorescence Spectroscopy demonstrating a high affinity for the organic dye. The effect of dye trapping property in conveying Rho B emission to frustules, with enhancement of scattering events, was analyzed on Rho B doped polyacrylamide gels filled or not with frustules. Amplified spontaneous emission was recorded at increasing pump power indicating the onset of a random laser effect in frustule filled gels at lower power threshold compared to unfilled matrices.	[De Angelis, Roberta; Prosposito, Paolo; Casalboni, Mauro] Univ Roma Tor Vergata, Dept Ind Engn, Rome, Italy; [De Angelis, Roberta; Prosposito, Paolo; Casalboni, Mauro; Lamastra, Francesca Romana; Nanni, Francesca] NSTM Consortium, Res Unit Roma Tor Vergata, Rome, Italy; [Melino, Sonia] Univ Roma Tor Vergata, Dept Chem Sci & Technol, Rome, Italy; [Nanni, Francesca] Univ Roma Tor Vergata, Dept Enterprise Engn, Rome, Italy; [Bruno, Laura; Congestri, Roberta] Univ Roma Tor Vergata, Dept Biol, Lab Biol Algae, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata	Bruno, L (corresponding author), Univ Roma Tor Vergata, Dept Biol, Lab Biol Algae, Rome, Italy.	laura.bruno@uniroma2.it	nanni, francesca/AAS-2924-2020	nanni, francesca/0000-0002-0484-8637; MELINO, SONIA/0000-0001-7694-5279; BRUNO, LAURA/0000-0003-4703-2088				Bailleul B, 2015, NATURE, V524, P366, DOI 10.1038/nature14599; Bao ZH, 2007, NATURE, V446, P172, DOI 10.1038/nature05570; Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3; Bozarth A, 2009, APPL MICROBIOL BIOT, V82, P195, DOI 10.1007/s00253-008-1804-8; Brunner E, 2009, APPL MICROBIOL BIOT, V84, P607, DOI 10.1007/s00253-009-2140-3; Cao H, 2013, NATURE, V503, P200, DOI 10.1038/503200a; Cullis AG, 1997, J APPL PHYS, V82, P909, DOI 10.1063/1.366536; d'Ippolito G, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0212-4; De Bhowmick G, 2015, RENEW SUST ENERG REV, V50, P1239, DOI 10.1016/j.rser.2015.04.131; De Stefano M, 2009, SUPERLATTICE MICROST, V46, P64, DOI 10.1016/j.spmi.2008.12.007; Di Caprio G, 2014, J BIOPHOTONICS, V7, P341, DOI 10.1002/jbio.201200198; Di Pippo F, 2013, J APPL PHYCOL, V25, P1697, DOI 10.1007/s10811-013-0028-1; Ferrara MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103750; Fresewinkel M, 2014, ENG LIFE SCI, V14, P560, DOI 10.1002/elsc.201300153; Gheorghiu S, 2004, AICHE J, V50, P812, DOI 10.1002/aic.10076; Gismondi A, 2016, INT J PHYTOREMEDIAT, V18, P869, DOI 10.1080/15226514.2016.1156640; Griffiths MJ, 2009, J APPL PHYCOL, V21, P493, DOI 10.1007/s10811-008-9392-7; Guillard R.R.L., 1973, HDB PHYCOLOGICAL MET, P289; Gulturk E., 2011, J ACHIEV MAT MANUF E, V46, P196; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Hildebrand M, 2012, BIOFUELS-UK, V3, P221, DOI 10.4155/bfs.11.157; Kieu K, 2014, OPT EXPRESS, V22, P15992, DOI 10.1364/OE.22.015992; Kroger N, 2008, ANNU REV GENET, V42, P83, DOI 10.1146/annurev.genet.41.110306.130109; Lamastra FR, 2014, RSC ADV, V4, P61809, DOI 10.1039/c4ra12519c; Lang Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03205; Lettieri S, 2008, ADV FUNCT MATER, V18, P1257, DOI 10.1002/adfm.200701124; Levitan O, 2014, TRENDS BIOTECHNOL, V32, P117, DOI 10.1016/j.tibtech.2014.01.004; Liang HK, 2013, ADV MATER, V25, P6859, DOI 10.1002/adma.201303122; Losic D, 2009, ADV MATER, V21, P2947, DOI 10.1002/adma.200803778; Lynch F, 2015, ALGAL RES, V11, P411, DOI 10.1016/j.algal.2015.05.015; Magni P, 2005, HYDROBIOLOGIA, V550, P105, DOI 10.1007/s10750-005-4367-z; Masojidek J, 2010, DEVEL APPL PHYCOL, V4, P277, DOI 10.1007/978-90-481-9268-7_13; Mohan N., 2012, J ALGAL BIOMASS UTLN, V3, P52; Olof SN, 2012, NANO LETT, V12, P6018, DOI 10.1021/nl303585w; Qin T, 2008, ACS NANO, V2, P1296, DOI 10.1021/nn800114q; Qin T, 2008, J NANOSCI NANOTECHNO, V8, P2392, DOI 10.1166/jnn.2008.241; Renaud SM, 1999, AQUACULTURE, V170, P147, DOI 10.1016/S0044-8486(98)00399-8; Singh P, 2016, RENEW SUST ENERG REV, V55, P1, DOI 10.1016/j.rser.2015.11.001; Singho ND, 2012, INT J ELECTROCHEM SC, V7, P5604; Su Y, 2015, NANO RES, V8, P2363, DOI 10.1007/s12274-015-0746-6; Tesson B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014300; Toster J, 2013, NANOSCALE, V5, P873, DOI 10.1039/c2nr32716c; Van Eynde E, 2013, PHOTOCH PHOTOBIO SCI, V12, P690, DOI 10.1039/c2pp25229e; Wang Y, 2013, APPL MICROBIOL BIOT, V97, P453, DOI 10.1007/s00253-012-4568-0; Wu MC, 2012, PROCESS BIOCHEM, V47, P2204, DOI 10.1016/j.procbio.2012.08.015; Yang ZK, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-67	46	14	14	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165571	10.1371/journal.pone.0165571	http://dx.doi.org/10.1371/journal.pone.0165571			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828985	Green Submitted, gold, Green Published			2022-12-26	WOS:000387724300051
J	Negin, J; Gregson, S; Eaton, JW; Schur, N; Takaruza, A; Mason, P; Nyamukapa, C				Negin, Joel; Gregson, Simon; Eaton, Jeffrey W.; Schur, Nadine; Takaruza, Albert; Mason, Peter; Nyamukapa, Constance			Rising Levels of HIV Infection in Older Adults in Eastern Zimbabwe	PLOS ONE			English	Article							RURAL SOUTH-AFRICA; SEXUAL-BEHAVIOR; WEST UGANDA; PREVALENCE; COHORT; POPULATION; DECLINE; COMMUNITY; EPIDEMIC; TRENDS	Background With the scale-up of antiretroviral treatment across Africa, many people are living longer with HIV. Understanding the ageing of the HIV cohort and sexual behaviour among older adults are important for appropriately responding to the changing demographics of people living with HIV. Methods We used data from a large population-based open cohort in eastern Zimbabwe to examine HIV prevalence trends and incidence among those aged 45 years and older. Five survey rounds have been completed between 1998 and 2011. Incidence was analysed using midpoint between last negative and first positive HIV test. Results Across the survey rounds, 13,071 individuals were followed for 57,676 person years. While HIV prevalence among people aged 15-44 has fallen across the five rounds, HIV prevalence among those aged 45-54 has increased since the 2006-08 survey round. In the 2009-11 round, HIV prevalence among men aged 45-54 was 23.4% compared to 11.0% among those aged 15-44. HIV positive people aged 45-54 now represent more than 20% of all those living with HIV in Manicaland. Among those aged 45 years and older, there were 85 seroconversions in 11,999 person years for an HIV incidence of 0.708 per 100 person years. Analysis of cohort data and assessment of behavioural risk factors for HIV infection among older people shows significantly lower levels of condom use among older adults and a number of seroconversions past the age of 50. Conclusions The cohort of people living with HIV is ageing in Zimbabwe and the behaviour of older adults puts them at risk of HIV infection. Older adults must be included in both HIV prevention and treatment programs.	[Negin, Joel] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Gregson, Simon; Takaruza, Albert; Mason, Peter; Nyamukapa, Constance] Biomed Res & Training Inst, Harare, Zimbabwe; [Gregson, Simon; Eaton, Jeffrey W.; Schur, Nadine; Nyamukapa, Constance] Imperial Coll, Dept Infect Dis Epidemiol, Sch Publ Hlth, London, England; [Mason, Peter] Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe	University of Sydney; Biomedical Research Training Institute; Imperial College London; University of Zimbabwe	Negin, J (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia.	joel.negin@sydney.edu.au		Gregson, Simon/0000-0003-2707-0714; Eaton, Jeffrey/0000-0001-7728-728X; Nyamukapa, Constance/0000-0001-6779-4069	Wellcome Trust; Medical Research Council [MR/K010174/1B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Wellcome Trust funded the Manicaland HIV/STD Prevention project from which data was used for this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors are grateful to all participants in the Manicaland HIV/STD Prevention Project.; The Wellcome Trust funded the Manicaland HIV/STD Prevention project from which data was used for this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We are grateful to all participants in the Manicaland HIV/STD Prevention Project.	Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; Barnighausen T, 2009, AIDS RES HUM RETROV, V25, P405, DOI 10.1089/aid.2008.0211; Biraro S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055060; Campbell C, 2013, AIDS CARE, V25, pS114, DOI 10.1080/09540121.2012.748170; Drew Olivia, 2008, Menopause Int, V14, P134, DOI 10.1258/mi.2008.008020; Eaton JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070447; Gomez-Olive FX, 2013, AIDS CARE, V25, P1122, DOI 10.1080/09540121.2012.750710; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gregson S, 2013, AIDS CARE, V25, pS88, DOI 10.1080/09540121.2012.748171; Halperin DT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000414; Hargreaves JR, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000300534.97601.d6; Hontelez Jan A C, 2012, AIDS, V26 Suppl 1, pS19; Karim QA, 2011, INT J EPIDEMIOL, V40, P922, DOI 10.1093/ije/dyq176; Kuteesa MO, 2012, AJAR-AFR J AIDS RES, V11, P295, DOI 10.2989/16085906.2012.754829; Lekalakala-Mokgele E, 2014, SAHARA J-J SOC ASP H, V11, P67, DOI 10.1080/17290376.2014.931816; Mahy M, 2014, AIDS, V28, pS453, DOI 10.1097/QAD.0000000000000479; Mbulaiteye SM, 2002, LANCET, V360, P41, DOI 10.1016/S0140-6736(02)09331-5; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; National AIDS Control Council National AIDS and STI Control Programme, 2012, KEN AIDS EP UPD 2011; Negin J, 2016, ARCH SEX BEHAV, V45, P441, DOI 10.1007/s10508-015-0582-5; Negin Joel, 2012, AIDS, V26 Suppl 1, pS55; Negin J, 2012, AIDS BEHAV, V16, P63, DOI 10.1007/s10461-011-9994-y; Negin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026546; Negin J, 2010, B WORLD HEALTH ORGAN, V88, P847, DOI 10.2471/BLT.10.076349; Nyirenda M, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.19201; Okiria AG, 2013, AIDS BEHAV; Rehle T, 2007, SAMJ S AFR MED J, V97, P194; Shafer LA, 2008, AIDS, V22, P1641, DOI 10.1097/QAD.0b013e32830a7502; UNAIDS, 2013, HIV AG SPEC SUPPL UN; UNAIDS, 2011, GET ZER FAST SMART B; UNAIDS, 2014, THE GAP REP; Wallrauch C, 2010, SAMJ S AFR MED J, V100, P812, DOI 10.7196/SAMJ.4181; Whitworth JAG, 2002, TROP MED INT HEALTH, V7, P1047, DOI 10.1046/j.1365-3156.2002.00973.x; Zaidi J, 2013, AIDS, V27, P2301, DOI 10.1097/QAD.0b013e328362e832	34	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0162967	10.1371/journal.pone.0162967	http://dx.doi.org/10.1371/journal.pone.0162967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9OG	27828979	Green Submitted, gold, Green Published			2022-12-26	WOS:000387724300005
J	Praputra, AV; Bong, IW; Ekowati, D; Hofstee, C; Maryudi, A				Praputra, Andhika Vega; Bong, Indah Waty; Ekowati, Dian; Hofstee, Carole; Maryudi, Ahmad			Getting the Data Flowing: Lessons Learned from Existing Reporting Systems in the Forestry Sector in Indonesia for REDD plus MRV	PLOS ONE			English	Article							COMMUNITY; DEFORESTATION; EMISSIONS	In the context of REDD+, Measurement, Reporting and Verification (MRV) is one way to manage forest change information. A national carbon and non-carbon database will be used in REDD+ to negotiate compensation schemes with the international community. Much of this data will be collected at the local level, thus a reporting system that can integrate these locally collected data into the national database is crucial. In this paper we compare and draw lessons from three existing local to national reporting systems that include the participation of local communities: 1) the government extension services, 2) the government owned forestry company, and 3) a private logging company in Indonesia, and provide recommendations for REDD+ reporting systems. The results suggest that the main desired conditions for effective data flow are: benefits to motivate local participation, based on contributions to reporting activities; simple data format and reporting procedures to allow local participation in the reporting process, and to support data aggregation at the national level; a facilitator to mediate data aggregation at the village level to ensure data consistency, completeness and accuracy; and a transparent and clear data flow. Under these conditions, continuous, accountable and consistent data flow from the local level will reach the national level where it can be fully utilized.	[Praputra, Andhika Vega; Bong, Indah Waty; Ekowati, Dian; Hofstee, Carole] Ctr Int Forestry Res, Bogor, Indonesia; [Maryudi, Ahmad] Gadjah Mada Univ, Fac Forestry, Bulaksumur, Yogyakarta, Indonesia	CGIAR; Center for International Forestry Research (CIFOR); Gadjah Mada University	Praputra, AV (corresponding author), Ctr Int Forestry Res, Bogor, Indonesia.	andhika.vega@gmail.com	Maryudi, Ahmad/T-8029-2019	Maryudi, Ahmad/0000-0001-5051-7217; Praputra, Andhika Vega/0000-0002-7976-9204	U.S. Agency for International Development (USAID) [MT0069018]; Norwegian Agency for Development Cooperation (NORAD) [GLO-3945, QZA 12/0882]; Republic of Germany [KI II 7-42206-6/75]; Consultative Group for International Agricultural Research (CGIAR), under Forests, Tree and Agroforestry: Livelihoods, Landscapes and Governance (FTA) [TF 069018]; USAID; Norwegian Agency for Development Cooperation (Norad); International Climate Initiative (IKI) of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB); CGIAR	U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); Norwegian Agency for Development Cooperation (NORAD); Republic of Germany; Consultative Group for International Agricultural Research (CGIAR), under Forests, Tree and Agroforestry: Livelihoods, Landscapes and Governance (FTA); USAID(United States Agency for International Development (USAID)); Norwegian Agency for Development Cooperation (Norad); International Climate Initiative (IKI) of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB); CGIAR(CGIAR)	Funded by: 1. The U.S. Agency for International Development (USAID), grant number MT0069018, http//www.usaid.gov/. 2. The Norwegian Agency for Development Cooperation (NORAD), grant number GLO-3945, QZA 12/0882, http://www.norad.no/. 3. The Republic of Germany, represented by the Federal Minister for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB), grant number KI II 7-42206-6/75, http://www.bmub.bund.de/en/. 4. The Consultative Group for International Agricultural Research (CGIAR), under Forests, Tree and Agroforestry: Livelihoods, Landscapes and Governance (FTA), grant number TF 069018, http://www.cgiar.org/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the local communities and forestry stakeholders in Wonosobo, Mamberamo Raya and Kapuas Hulu Districts for their participation in this study. We specially thank Manuel Boissiere, the PMRV project leader, for his continuous support in the research and writing process. We thank Douglas Sheil for his reviews and inputs during the writing process. We also thank the PMRV team members Mary Elizabeth Felker, Guillaume Beaudoin, Sandra Dharmadi Hawthorne, Arief Wijaya, Wahid Ullah, Serge Rafanoharana, and Gilang Aria Seta, for their continued support, inputs and numerous reviews during the long development process of this paper. They would also like to acknowledge other members of the team, Anggoro Santoso Edy Widayat, Haris Iskandar, Ermayanti, Lina Farida, Yuli Nugroho, Alice Bortzmeyer, Walker H. Depuy, Isack Yable, and Bagus Sartono for their contribution to the research. They also thank Glen Mulcahy, the anonymous reviewers, and the PLoS ONE editors for their valuable comments and editing. This research was carried out by the Center for International Forestry Research (CIFOR) and the Centre de cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD), and in collaboration with the University of Gadjah Mada (UGM). This research forms part of the CGIAR Research Program on Forests, Trees and Agroforestry and the Global Comparative Study on REDD+, with funding support from the USAID, the Norwegian Agency for Development Cooperation (Norad), the International Climate Initiative (IKI) of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB), and the CGIAR.	Agrawal A, 2011, ANNU REV ENV RESOUR, V36, P373, DOI 10.1146/annurev-environ-042009-094508; [Anonymous], CAPACITY DEV NATL FO; [Anonymous], J MANAG SUSTAIN; Awang SA, 2006, YEAR 3 REPORT JAVA C; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Boissiere M, 2014, FORESTS, V5, P1855, DOI 10.3390/f5081855; Danielsen F, 2013, COMMUNITY MONITORING, P18; Danielsen F, 2011, CONSERV LETT, V4, P158, DOI 10.1111/j.1755-263X.2010.00159.x; Djamhuri TL, 2012, FOREST POLICY ECON, V25, P10, DOI 10.1016/j.forpol.2012.02.004; Fry B, 2011, ENVIRON SCI POLICY, V14, P181, DOI 10.1016/j.envsci.2010.12.004; GOFC-GOLD, 2012, GOGC GODL REP VERS; IIED, 2014, BRIEF WHAT PEOPL WAN; Indonesian REDD+Task Force, 2013, REDD NAT STRAT; Murdiyarso D, 2008, ECOHYDROLOGY INITIAL; Pemerintah Indonesia, 2006, UND UND REP IND 16 T; Pemerintah Republik Indonesia, 2015, PER PRES REP IND 16; Pratihast AK, 2011, COMMUNITY BASED MONI; Pratihast AK, 2013, CARBON MANAG, V4, P91, DOI [10.4155/cmt.12.75, 10.4155/CMT.12.75]; Romijn E, 2012, ENVIRON SCI POLICY, V19-20, P33, DOI 10.1016/j.envsci.2012.01.005; Skutsch M, 2014, FORESTS, V5, P1596, DOI 10.3390/f5071596; Tim Kerja MRV Satgas REDD+, 2013, STRAT DAN RENC IMPL, P1; UNFCCC, 2009, COST IMPLEMENTING ME; UNFCCC. Report of the conference of the parties on its fifteenth session, 2010, C PART ITS 16 SESS H, P1; United Nations Framework Convention on Climate Change (UNFCCC), 2010, C PART ITS 15 SESS H; Yokota Y, 2014, JARQ-JPN AGR RES Q, V48, P363, DOI 10.6090/jarq.48.363	25	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0156743	10.1371/journal.pone.0156743	http://dx.doi.org/10.1371/journal.pone.0156743			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828959	Green Published, gold, Green Submitted			2022-12-26	WOS:000387724300001
J	von Beeren, C; Maruyama, M; Kronauer, DJC				von Beeren, Christoph; Maruyama, Munetoshi; Kronauer, Daniel J. C.			Community Sampling and Integrative Taxonomy Reveal New Species and Host Specificity in the Army Ant-Associated Beetle Genus Tetradonia (Coleoptera, Staphylinidae, Aleocharinae)	PLOS ONE			English	Article							EXPERIMENTAL EVOLUTION; MOLECULAR PHYLOGENY; FLIES DIPTERA; SPECIALIZATION; ECITOCHARINI; HYMENOPTERA; DIVERSITY	Army ant colonies host a diverse community of arthropod symbionts. Among the best-studied symbiont communities are those of Neotropical army ants of the genus Eciton. It is clear, however, that even in these comparatively well studied systems, a large proportion of symbiont biodiversity remains unknown. Even more striking is our lack of knowledge regarding the nature and specificity of these host-symbiont interactions. Here we surveyed the diversity and host specificity of rove beetles of the genus Tetradonia Wasmann, 1894 (Staphylinidae: Aleocharinae). Systematic community sampling of 58 colonies of the six local Eciton species at La Selva Biological Station, Costa Rica, combined with an integrative taxonomic approach, allowed us to uncover species diversity, host specificity, and co-occurrence patterns of symbionts in unprecedented detail. We used an integrative taxonomic approach combining morphological and genetic analyses, to delineate species boundaries. Mitochondrial DNA barcodes were analyzed for 362 Tetradonia specimens, and additional nuclear markers for a subset of 88 specimens. All analyses supported the presence of five Tetradonia species, including two species new to science. Host specificity is highly variable across species, ranging from generalists such as T. laticeps, which parasitizes all six local Eciton species, to specialists such as T. lizonae, which primarily parasitizes a single species, E. hamatum. Here we provide a dichotomous key along with diagnostic molecular characters for identification of Tetradonia species at La Selva Biological Station. By reliably assessing biodiversity and providing tools for species identification, we hope to set the baseline for future studies of the ecological and evolutionary dynamics in these species-rich host-symbiont networks.	[von Beeren, Christoph; Kronauer, Daniel J. C.] Rockefeller Univ, Lab Social Evolut & Behav, New York, NY 10065 USA; [von Beeren, Christoph] Tech Univ Darmstadt, Dept Biol, Ecol Networks, D-64287 Darmstadt, Germany; [Maruyama, Munetoshi] Kyushu Univ Museum, Hakozaki 6-10-1, Fukuoka 8128581, Japan	Rockefeller University; Technical University of Darmstadt	von Beeren, C (corresponding author), Rockefeller Univ, Lab Social Evolut & Behav, New York, NY 10065 USA.; von Beeren, C (corresponding author), Tech Univ Darmstadt, Dept Biol, Ecol Networks, D-64287 Darmstadt, Germany.	cvonbeeren@gmail.com			German Science Foundation [BE 5177/1-1, BE 5177/3-1]; National Geographic Society's Committee for Research and Exploration [9393-13]; Bristol-Myers Squibb Postdoctoral Fellowship from The Rockefeller University	German Science Foundation(German Research Foundation (DFG)); National Geographic Society's Committee for Research and Exploration(National Geographic Society); Bristol-Myers Squibb Postdoctoral Fellowship from The Rockefeller University	CvB was supported by the German Science Foundation (BE 5177/1-1 and BE 5177/3-1), the National Geographic Society's Committee for Research and Exploration (9393-13) and a Bristol-Myers Squibb Postdoctoral Fellowship from The Rockefeller University.	AKRE ROGER D., 1966, J KANS ENTOMOL SOC, V39, P745; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bili M, 2016, OECOLOGIA, P1; Borgmeier T., 1955, Studia Entomologica Rio de Janeiro, Vno. 3, P1; Borgmeier T., 1953, VORARBEITEN REVISION; Combes Claude, 2005, ART BEING PARASITE; Disney RHL, 2007, SOCIOBIOLOGY, V49, P1; Donisthorpe H. St. G. K., 1927; Ellwood MDF, 2009, ECOL LETT, V12, P277, DOI 10.1111/j.1461-0248.2009.01284.x; Ellwood MD, 2016, ACTA OECOLOGICA; Elven H, 2012, ZOOL SCR, V41, P617, DOI 10.1111/j.1463-6409.2012.00553.x; Fabricius JC, 1781, HAMBURGI CAROL ERNES, DOI DOI 10.5962/BHL.TITLE.36509; Funk WC, 2011, P ROYAL SOC B, P1; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Gotwald WH, 1995, ARMY ANTS BIOL SOCIA; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hlavac P, 2011, ZOOTAXA, P1; HOLLDOBL.B, 1969, SCIENCE, V166, P757, DOI 10.1126/science.166.3906.757; Holldobler B., 1990, pi; Hughes DP, 2008, TRENDS ECOL EVOL, V23, P672, DOI 10.1016/j.tree.2008.07.011; Ivens ABF, 2016, ANNU REV ENTOMOL, V61, P353, DOI 10.1146/annurev-ento-010715-023719; Jacobson HR, 1998, SOCIOBIOLOGY, V31, P151; JOSHI A, 1995, EVOL ECOL, V9, P82, DOI 10.1007/BF01237699; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; KATAKURA H, 1989, EVOLUTION, V43, P1045, DOI 10.1111/j.1558-5646.1989.tb02549.x; Kistner D. H., 1982, Social insects. Vol. III, P1; KISTNER DH, 1990, SOCIOBIOLOGY, V17, P333; Kraft NJB, 2015, FUNCT ECOL, V29, P592, DOI 10.1111/1365-2435.12345; Legros M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-159; Longino J, 2007, ANTS COSTA RICA; Malenke JR, 2009, EVOLUTION, V63, P1427, DOI 10.1111/j.1558-5646.2009.00642.x; Maruyama Munetoshi, 2004, Elytra, V32, P276; Maruyama Munetoshi, 2006, National Science Museum Monographs, P1; Mayr E., 1942, P1; Mayr G., 1886, WIENER ENTOMOLOGISCH, V5, P115; Mittelbach GG, 2012, COMMUNITY ECOLOGY, P1; Morand S, 2015, PARASITE DIVERSITY AND DIVERSIFICATION: EVOLUTIONARY ECOLOGY MEETS PHYLOGENETICS, P1, DOI 10.1017/CBO9781139794749; Osswald J, 2013, SYST ENTOMOL, V38, P507, DOI 10.1111/syen.12011; Pace R., 2008, BIODIVERSITY S AM, V1, P225; Pace Roberto, 2015, Beitraege zur Entomologie, V65, P85; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Parker J, 2014, CURR BIOL, V24, P2428, DOI 10.1016/j.cub.2014.08.068; Parker Meaghan, 2012, Methods Mol Biol, V858, P269, DOI 10.1007/978-1-61779-591-6_13; Parmentier T, 2016, INSECTES SOCIAUX; Poulin R, 2003, PARASITOLOGY, V126, P473, DOI 10.1017/S0031182003002993; REICHENSPERGER AUGUST, 1935, ARB MORPHOL U TAX ENT BERLIN DAHLEM, V2, P188; Rettenmeyer CW, 2011, INSECT SOC, V58, P281, DOI 10.1007/s00040-010-0128-8; RETTENMEYER CARL W., 1963, ANN ENTOMOL SOC AMER, V56, P170; Rettenmeyer CW., 1961, ARTHROPODS ASS NEOTR; Rettenmeyer CW., 1962, P N CENTRAL BRANCH E, V17, P14; Roger J, 1863, BERLINER ENTOMOLOGIS, V7, P131, DOI DOI 10.1002/MMND.18630070116; Sawada K, 1972, CONTRIBUTIONS BIOL L, V24, P31; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; SEEVERS CHARLES H., 1965, FIELDI ANA ZOOL, V47, P139; Smith F., 1859, CATALOGUE HYMENOPTER; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas JA, 2005, SPECIALIZATIONS HOST; von Beeren C, 2016, MOL ECOL, V25, P990, DOI 10.1111/mec.13500; von Beeren C, 2015, SCI REP-UK, V5, DOI 10.1038/srep08297; Wasmann E, 1894, ANGABE LEBENSWEISE B; WATKINS JF, 1982, J KANSAS ENTOMOL SOC, V55, P197; Watkins JF., 1976, IDENTIFICATION DISTR; WEBER NEAL A., 1949, AMER MUS NOVITATES, V1441, P1; Weitschek E, 2013, MOL ECOL RESOUR, V13, P1043, DOI 10.1111/1755-0998.12073	66	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165056	10.1371/journal.pone.0165056	http://dx.doi.org/10.1371/journal.pone.0165056			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829037	Green Published, gold, Green Submitted			2022-12-26	WOS:000387724300028
J	Walsh, DM; Merson, TD; Landman, KA; Hughes, BD				Walsh, Darragh M.; Merson, Tobias D.; Landman, Kerry A.; Hughes, Barry D.			Evidence for Cooperative Selection of Axons for Myelination by Adjacent Oligodendrocytes in the Optic Nerve	PLOS ONE			English	Article							IN-VIVO; INDIVIDUAL OLIGODENDROCYTES; MICE; SYSTEM; NUMBER	The cellular mechanisms that regulate the topographic arrangement of myelin internodes along axons remain largely uncharacterized. Recent clonal analysis of oligodendrocyte morphologies in the mouse optic nerve revealed that adjacent oligodendrocytes frequently formed adjacent internodes on one or more axons in common, whereas oligodendrocytes in the optic nerve were never observed to myelinate the same axon more than once. By modelling the process of axonal selection at the single cell level, we demonstrate that internode length and primary process length constrain the capacity of oligodendrocytes to myelinate the same axon more than once. On the other hand, probabilistic analysis reveals that the observed juxtaposition of myelin internodes among common sets of axons by adjacent oligodendrocytes is highly unlikely to occur by chance. Our analysis may reveal a hitherto unknown level of communication between adjacent oligodendrocytes in the selection of axons for myelination. Together, our analyses provide novel insights into the mechanisms that define the spatial organization of myelin internodes within white matter at the single cell level.	[Walsh, Darragh M.; Landman, Kerry A.; Hughes, Barry D.] Univ Melbourne, Sch Math & Stat, Melbourne, Vic 3010, Australia; [Merson, Tobias D.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health	Walsh, DM (corresponding author), Univ Melbourne, Sch Math & Stat, Melbourne, Vic 3010, Australia.	darragh.walsh@unimelb.edu.au	Merson, Tobias D/D-5375-2015; Hughes, Barry Douglas/AAB-9382-2020; Walsh, Darragh/C-8084-2019	Merson, Tobias D/0000-0002-7246-3608; Hughes, Barry Douglas/0000-0003-3594-4303; Walsh, Darragh/0000-0003-4903-1046	Australian Research Council Discovery Project [DP140100339]; Melbourne Neuroscience Institute Interdisciplinary Seed Funding Scheme; Australian Research Council [FT150100207]	Australian Research Council Discovery Project(Australian Research Council); Melbourne Neuroscience Institute Interdisciplinary Seed Funding Scheme; Australian Research Council(Australian Research Council)	This research was supported by an Australian Research Council Discovery Project (DP140100339) and the Melbourne Neuroscience Institute Interdisciplinary Seed Funding Scheme. Dr. Tobias Merson was supported by an Australian Research Council Future Fellowship (FT150100207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by an Australian Research Council Discovery Project (DP140100339) and the Melbourne Neuroscience Institute Interdisciplinary Seed Funding Scheme. Dr. Tobias Merson was supported by an Australian Research Council Future Fellowship (FT150100207). We thank Dr. Laura Dumas for helpful discussions on her data, Dr. William R. Holmes for valuable discussions and Dr. James McCaw and Dr. James Osborne for useful comments on the manuscript.	Bartsch S, 1997, BRAIN RES, V762, P231, DOI 10.1016/S0006-8993(97)00484-8; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Czopka T, 2013, DEV CELL, V25, P599, DOI 10.1016/j.devcel.2013.05.013; Dangata YY, 1996, J ANAT, V189, P117; Dangata YY, 1997, EUR J MORPHOL, V35, P3, DOI 10.1076/ejom.35.1.3.13057; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Dumas L, 2015, GLIA, V63, P699, DOI 10.1002/glia.22779; Edgar JM, 2004, J CELL BIOL, V166, P121, DOI 10.1083/jcb.200312012; Feller W., 1971, INTRO PROBABILITY TH, VI; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; GYLLENSTEN L, 1963, J EMBRYOL EXP MORPH, V11, P255; Hines JH, 2015, NAT NEUROSCI, V18, P683, DOI 10.1038/nn.3992; HONJIN R, 1977, ARCH HISTOL JAPON, V40, P321, DOI 10.1679/aohc1950.40.321; Mensch S, 2015, NAT NEUROSCI, V18, P628, DOI 10.1038/nn.3991; Simons M, 2013, CURR OPIN CELL BIOL, V25, P512, DOI 10.1016/j.ceb.2013.04.007; Tijms H., 2007, UNDERSTANDING PROBAB, V2nd, P17; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998	17	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165673	10.1371/journal.pone.0165673	http://dx.doi.org/10.1371/journal.pone.0165673			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829049	Green Published, Green Submitted, gold			2022-12-26	WOS:000387724300054
J	McIntyre, MK; Peacock, TJ; Akers, KS; Burmeister, DM				McIntyre, Matthew K.; Peacock, Trent J.; Akers, Kevin S.; Burmeister, David M.			Initial Characterization of the Pig Skin Bacteriome and Its Effect on In Vitro Models of Wound Healing	PLOS ONE			English	Article								Elucidating the roles and composition of the human skin microbiome has revealed a delicate interplay between resident microbes and wound healing. Evolutionarily speaking, normal cutaneous flora likely has been selected for because it potentiates or, at minimum, does not impede wound healing. While pigs are the gold standard model for wound healing studies, the porcine skin microbiome has not been studied in detail. Herein, we performed 16S rDNA sequencing to characterize the pig skin bacteriome at several anatomical locations. Additionally, we used bacterial conditioned-media with in vitro techniques to examine the paracrine effects of bacterial-derived proteins on human keratinocytes (NHEK) and fibroblasts (NHDF). We found that at the phyla level, the pig skin bacteriome is similar to that of humans and largely consists of Firmicutes (55.6%), Bacteroidetes (20.8%), Actinobacteria (13.3%), and Proteobacteria (5.1%) however species-level differences between anatomical locations exist. Studies of bacterial supernatant revealed location-dependent effects on NHDF migration and NHEK apoptosis and growth factor release. These results expand the limited knowledge of the cutaneous bacteriome of healthy swine, and suggest that naturally occurring bacterial flora affects wound healing differentially depending on anatomical location. Ultimately, the pig might be considered the best surrogate for not only wound healing studies but also the cutaneous microbiome. This would not only facilitate investigations into the microbiome's role in recovery from injury, but also provide microbial targets for enhancing or accelerating wound healing.	[McIntyre, Matthew K.; Burmeister, David M.] US Army, Damage Control Resuscitat, Inst Surg Res, Ft Sam Houston, TX 78234 USA; [Peacock, Trent J.] US Army, Dent Trauma Res Detachment, Inst Surg Res, Ft Sam Houston, TX USA; [Akers, Kevin S.] US Army, Extrem Trauma & Regenerat Med, Inst Surg Res, Ft Sam Houston, TX USA		Burmeister, DM (corresponding author), US Army, Damage Control Resuscitat, Inst Surg Res, Ft Sam Houston, TX 78234 USA.	David.m.Burmeister3.civ@mail.mil		Burmeister, David/0000-0002-1256-0158	Oak Ridge Institute for Science and Education; US Army Medical Research and Materiel Command	Oak Ridge Institute for Science and Education(General Electric); US Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This study was supported by the Oak Ridge Institute for Science and Education and the US Army Medical Research and Materiel Command. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi A, 2014, CELL MOL LIFE SCI, V71, P3241, DOI 10.1007/s00018-014-1612-5; Bradley CW, 2016, J INVEST DERMATOL; Canesso MCC, 2014, J IMMUNOLOGY, V193; Capone KA, 2011, J INVEST DERMATOL, V131, P2026, DOI 10.1038/jid.2011.168; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; de Hemptinne I, 2008, WOUND REPAIR REGEN, V16, P132, DOI 10.1111/j.1524-475X.2007.00340.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gallant CL, 2004, WOUND REPAIR REGEN, V12, P305, DOI 10.1111/j.1067-1927.2004.012311.x; Gallant-Behm CL, 2007, J INVEST DERMATOL, V127, P233, DOI 10.1038/sj.jid.5700482; Gallo RL, 2011, J INVESTIGATIVE DERM, V131; Grice EA, 2010, PNAS, V107; Grice EA, 2011, NAT REV MICROBIOL, V9, DOI 10.1038/nrmicro2619; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hybbinette S, 1999, EXP DERMATOL, V8, P30, DOI 10.1111/j.1600-0625.1999.tb00345.x; Jones SG, 2004, INT J LOW EXTREM WOU, V3; Kolmeder CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153294; Kong HH, 2012, GENOME RES; Laborel-Preneron E., 2015, PLOS ONE, V10; Lai Y, 2010, J INVESTIGATIVE DERM, V130; Lai Y, 2009, NATURE MED, V15; Lozupone C., 2005, APPL ENVIRON MICROB, V71, P12, DOI DOI 10.1128/AEM.71.12.82288235.2005; Magistrelli D, 2016, J AGR FOOD CHEM, V64, P2046, DOI 10.1021/acs.jafc.5b05732; Marano RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13296; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Misic AM, 2014, ADV WOUND CARE NEW R, V3; Moissenet D, 2012, J CLIN MICROBIOL, V50, P1495, DOI 10.1128/JCM.06038-11; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nakatsuji T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2441; Normand J, 1995, IN VITRO CELL DEV BI, V31; Oh J, 2012, GENOME MED, V4, DOI 10.1186/gm378; Poutahidis T, 2013, PLOS ONE, V8; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ramos M, 2008, J BURN CARE RES, V29; SanMiguel A, 2015, CELL MOL LIFE SCI, V72, P1499, DOI 10.1007/s00018-014-1812-z; Seaton M, 2015, ILAR J, V56, P127, DOI 10.1093/ilar/ilv016; Shrivastava HY, 2005, FREE RADIC BIOL MED, V38; Singer A, 2003, METHODS MOL MED, V78; Singer AJ, 2016, BURNS, V42, P184, DOI 10.1016/j.burns.2015.09.016; Singer AJ, 2008, N ENGL J MED, V359; Song H, 2016, J ALLERGY CLIN IMMUN, V137, P852, DOI 10.1016/j.jaci.2015.08.021; Stephens P, 2003, BR J DERMATOL, V148; Sullivan T, 2001, WOUND REPAIR REGENER, V9; Swe PM, 2014, PLOS NEGLECTED TROPI, V8; Takao K, 2015, P NATL ACAD SCI US, V112; Wang J, 2008, LAB INVEST, V88; Wang X-Q, 2009, BURNS, V35; Ward CL, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0412-x; Yao F, 2001, WOUND REPAIR REGEN, V9, P371, DOI 10.1046/j.1524-475x.2001.00371.x; Zeeuwen PLJM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r101; Zhang M, 2015, MICROBIAL ECOLOGY, V69	50	24	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166176	10.1371/journal.pone.0166176	http://dx.doi.org/10.1371/journal.pone.0166176			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824921	gold, Green Published			2022-12-26	WOS:000387615200066
J	Ding, YM; Cao, YK; Wang, B; Wang, L; Zhang, YM; Zhang, DL; Chen, XY; Li, MX; Wang, CH				Ding, Youming; Cao, Yingkang; Wang, Bin; Wang, Lei; Zhang, Yemin; Zhang, Deling; Chen, Xiaoyan; Li, Mingxin; Wang, Changhua			APPL1-Mediating Leptin Signaling Contributes to Proliferation and Migration of Cancer Cells	PLOS ONE			English	Article							BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; INSULIN-RESISTANCE; INDUCED APOPTOSIS; PROSTATE-CANCER; GROWTH-FACTOR; PPAR-ALPHA; OBESITY; APPL; EXPRESSION	Leptin has been implicated in tumorigenesis and tumor progression, particularly in obese patients. As a multifunctional adaptor protein, APPL1 (containing pleckstrin homology domain, phosphotyrosine binding domain, and a leucine zipper motif 1) plays a critical role in regulating adiponectin and insulin signaling pathways. Currently, high APPL1 level has been suggested to be related to metastases and progression of some types of cancer. However, the intercourse between leptin signaling pathway and APPL1 remains poorly understood. Here, we show that the protein levels and phosphorylation statues of APPL1-were highly expressed in tissues from human hepatocellular carcinoma and triple-positive breast cancer. Leptin stimulated APPL1 phosphorylation in a time-dependent manner in both human hepatocellular carcinoma HepG2 cell and breast cancer MCF-7 cell. Overexpression or suppression of APPL1 promoted or attenuated, respectively, leptin-induced phosphorylation of STAT3, ERK1/2, and Akt in the cancer cells, accompanied with enhanced or mitigated cell proliferation and migration. In addition, we identified that APPL1 directly bound to both leptin receptor and STAT3. This interaction was significantly enhanced by leptin stimulation. Our results suggested that APPL1 positively mediated leptin signaling and promoted leptin-induced proliferation and migration of cancer cells. This finding reveals a novel mechanism by which leptin promotes the motility and growth of cancer cells.	[Ding, Youming; Wang, Bin; Wang, Lei; Chen, Xiaoyan] Wuhan Univ, Dept Hepatobiliary & Laparascop Surg, Renmin Hosp, Wuhan 430060, Peoples R China; [Cao, Yingkang; Zhang, Yemin; Zhang, Deling; Li, Mingxin; Wang, Changhua] Wuhan Univ, Dept Pathol & Pathophysiol, Sch Basic Med Sci, Wuhan 430071, Peoples R China	Wuhan University; Wuhan University	Wang, CH (corresponding author), Wuhan Univ, Dept Pathol & Pathophysiol, Sch Basic Med Sci, Wuhan 430071, Peoples R China.	chwang0525@whu.edu.cn	chen, xia/GXM-5435-2022; chen, xia/GYR-3948-2022; chen, xi/GXH-3653-2022		National Natural Science Foundation of China [81170790]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (No. 81170790) to Dr. Changhua Wang.; We thank Drs. Feng Liu and Lily Q. Dong (University of Texas Health Sciences Center at San Antonio, USA) for the kind gifts of plasmids of adenovirus carrying APPL1, APPL1/shRNA, and scrambled shRNA, respectively. This work was supported by a grant from the National Natural Science Foundation of China (No. 81170790) to Dr. Changhua Wang.	Agrawal Ganesh K., 2009, V527, P3, DOI 10.1007/978-1-60327-834-8_1; Ando S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00340; Arnold M, 2016, CANCER EPIDEMIOL, V41, P8, DOI 10.1016/j.canep.2016.01.003; Bai JX, 2006, J PHARMACOL EXP THER, V319, P1435, DOI 10.1124/jpet.106.110007; Belouzard S, 2004, J BIOL CHEM, V279, P28499, DOI 10.1074/jbc.M400508200; De Luis DA, 2009, MINERVA MED, V100, P229; Diradourian C, 2008, BBA-MOL CELL BIOL L, V1781, P239, DOI 10.1016/j.bbalip.2008.02.002; Duan XF, 2013, INT J CANCER, V133, P1776, DOI 10.1002/ijc.28105; Font-Burgada J, 2016, CELL METAB, V23, P48, DOI 10.1016/j.cmet.2015.12.015; Garcia-Robles MJ, 2013, J INTERF CYTOK RES, V33, P717, DOI 10.1089/jir.2012.0168; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; Ghose A, 2015, NUTR CANCER, V67, P197, DOI 10.1080/01635581.2015.990569; Guan F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146553; Hennig J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.167; Iyengar NM, 2015, ANNU REV MED, V66, P297, DOI 10.1146/annurev-med-050913-022228; Jiang N, 2014, DRUG DES DEV THER, V8, P2295, DOI 10.2147/DDDT.S69004; Johnson IRD, 2015, ONCOTARGET, V6, P37919, DOI 10.18632/oncotarget.6114; Johnson IRD, 2014, MOL CANCER RES, V12, P1851, DOI 10.1158/1541-7786.MCR-14-0074; Kew MC, 2015, ANN HEPATOL, V14, P299, DOI 10.1016/S1665-2681(19)31267-0; Liu ML, 2012, J BIOL CHEM, V287, P26087, DOI 10.1074/jbc.M112.372292; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Newman G, 2014, MOL CELL ENDOCRINOL, V382, P570, DOI 10.1016/j.mce.2013.03.025; Russo VC, 2004, ENDOCRINOLOGY, V145, P4103, DOI 10.1210/en.2003-1767; Ryu JY, 2014, CELL REP, V7, P1227, DOI 10.1016/j.celrep.2014.04.006; Saito T, 2007, J BIOL CHEM, V282, P32280, DOI 10.1074/jbc.M704150200; Saxena NK, 2007, CANCER RES, V67, P2497, DOI 10.1158/0008-5472.CAN-06-3075; Schmidt S, 2015, OBES REV, V16, P473, DOI 10.1111/obr.12281; Schulenberg B, 2004, ELECTROPHORESIS, V25, P2526, DOI 10.1002/elps.200406007; Sepulveda VAT, 2002, ENDOCRINOLOGY, V143, P596, DOI 10.1210/en.143.2.596; Sinha A, 2013, CELL REP, V4, P649, DOI 10.1016/j.celrep.2013.07.029; Somasundar P, 2004, J SURG RES, V116, P337, DOI 10.1016/j.jss.2003.09.004; Song J, 2016, ONCOTARGET, V7, P279, DOI 10.18632/oncotarget.6346; VanSaun MN, 2013, CLIN CANCER RES, V19, P1926, DOI 10.1158/1078-0432.CCR-12-0930; Wang CH, 2009, J BIOL CHEM, V284, P31608, DOI 10.1074/jbc.M109.010355; Xu Miao, 2013, Zhonghua Yi Xue Za Zhi, V93, P1432; Zhang YM, 2015, ACTA PHARMACOL SIN, V36, P987, DOI 10.1038/aps.2015.37; Zhao Z, 2010, CANCER SCI, V101, P1454, DOI 10.1111/j.1349-7006.2010.01558.x; Zhu S, 2013, ASIAN PAC J CANCER P, V14, P5687, DOI 10.7314/APJCP.2013.14.10.5687; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	41	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166172	10.1371/journal.pone.0166172	http://dx.doi.org/10.1371/journal.pone.0166172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820851	Green Published, gold, Green Submitted			2022-12-26	WOS:000387614800039
J	Debus, F; Lefering, R; Lechler, P; Schwarting, T; Bockmann, B; Strasser, E; Mand, C; Ruchholtz, S; Frink, M				Debus, Florian; Lefering, Rolf; Lechler, Philipp; Schwarting, Tim; Bockmann, Benjamin; Strasser, Erwin; Mand, Carsten; Ruchholtz, Steffen; Frink, Michael		TraumaRegister DGU	Association of an In-House Blood Bank with Therapy and Outcome in Severely Injured Patients: An Analysis of 18,573 Patients from the TraumaRegister DGU (R)	PLOS ONE			English	Article							PROTHROMBIN COMPLEX CONCENTRATE; BLEEDING TRAUMA PATIENTS; MASSIVE TRANSFUSION; POLYTRAUMA PATIENTS; COAGULOPATHY; FIBRINOGEN; MANAGEMENT; MORTALITY; GUIDELINE; ROTEM(R)	Introduction Hemorrhagic shock remains one of the most common causes of death in severely injured patients. It is unknown to what extent the presence of a blood bank in a trauma center influences therapy and outcome in such patients. Material and Methods We retrospectively analyzed prospectively recorded data from the TraumaRegister DGU (R) and the TraumaNetzwerk DGU (R). Inclusion criteria were Injury Severity Score (ISS) >= 16, primarily treated patients, and hospital admission 2 years before or after the audit process. Results Complete data sets of 18,573 patients were analyzed. Of 457 hospitals included, 33.3% had an in-house blood bank. In trauma centers with a blood bank (HospBB), packed red blood cells (PRBCs) (21.0% vs. 17.4%, p < 0.001) and fresh frozen plasma (FFP) (13.9% vs. 10.2%, p < 0.001) were transfused significantly more often than in hospitals without a blood bank (Hosp0). However, no significant difference was found for in-hospital mortality (standard mortality ratio [ SMR, 0.907 vs. 0.945; p = 0.25). In patients with clinically apparent shock on admission, no difference of performed transfusions were present between HospBB and Hosp0 (PRBCs, 51.4% vs. 50.4%, p = 0.67; FFP, 32.7% vs. 32.7%, p = 0.99), and no difference in in-hospital mortality was observed (SMR, 0.907 vs. 1.004; p = 0.21). Discussion In HospBB transfusions were performed more frequently in severely injured patients without positively affecting the 24h mortality or in- house mortality. Easy access may explain a more liberal transfusion concept.	[Debus, Florian; Lechler, Philipp; Schwarting, Tim; Bockmann, Benjamin; Mand, Carsten; Ruchholtz, Steffen; Frink, Michael] Univ Hosp Giessen & Marburg, Dept Trauma Hand & Reconstruct Surg, Marburg, Germany; [Lefering, Rolf] Univ Witten Herdecke, Inst Res Operat Med IFOM, Cologne, Germany; [Lefering, Rolf; Ruchholtz, Steffen; Frink, Michael] German Trauma Soc, Sekt NIS, Comm Emergency Med Intens Care & Trauma Managemen, Berlin, Germany; [Strasser, Erwin] Univ Hosp Erlangen, Dept Transfus Med & Hemostaseol, Erlangen, Germany	University Hospital of Giessen & Marburg; Witten Herdecke University; University of Erlangen Nuremberg	Frink, M (corresponding author), Univ Hosp Giessen & Marburg, Dept Trauma Hand & Reconstruct Surg, Marburg, Germany.; Frink, M (corresponding author), German Trauma Soc, Sekt NIS, Comm Emergency Med Intens Care & Trauma Managemen, Berlin, Germany.	frink@med.uni-marburg.de						Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; ACS, SHOCK ADV TRAUM LIF; Bawazeer M, 2015, INJURY, V46, P21, DOI 10.1016/j.injury.2014.09.020; Bhananker Sanjay M, 2011, Int J Crit Illn Inj Sci, V1, P51, DOI 10.4103/2229-5151.79282; Cantor SB, 1998, J CLIN ONCOL, V16, P2364, DOI 10.1200/JCO.1998.16.7.2364; Davenport R, 2013, TRANSFUSION, V53, p23S, DOI 10.1111/trf.12032; Deras P, 2014, J TRAUMA ACUTE CARE, V77, P433, DOI 10.1097/TA.0000000000000314; Deutsche Gesellschaft fur Unfallchirurgie e. V. (DGU), 2012, WEISSB SCHWERV; DGU, 2013, TRAUMAREGISTER DGU J; Dunne JR, 2002, J SURG RES, V102, P237, DOI 10.1006/jsre.2001.6330; Fantus B., 1937, JAMA-J AM MED ASSOC, V251, P647; Fries D, 2013, TRANSFUSION, V53, p91S, DOI 10.1111/trf.12041; Goodwin ML, 2014, J TRAUMA ACUTE CARE, V77, P182, DOI 10.1097/TA.0000000000000162; Hess JR, 2014, VOX SANG, DOI [10.1111/vox.12130, DOI 10.1111/V0X.12130]; Huber-Wagner S, 2007, VOX SANG, V92, P69, DOI 10.1111/j.1423-0410.2006.00858.x; Judd W J, 1999, Immunohematology, V15, P41; Kahl JE, 2013, J TRAUMA ACUTE CARE, V75, P195, DOI 10.1097/TA.0b013e3182997865; Kaur Paramjit, 2011, J Emerg Trauma Shock, V4, P103, DOI 10.4103/0974-2700.76844; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Klein HG, 2010, BIOLOGICALS, V38, P100, DOI 10.1016/j.biologicals.2009.10.008; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Maegele M, 2009, VOX SANG, V97, P39, DOI 10.1111/j.1423-0410.2009.01179.x; Meyer MAS, 2011, VOX SANG, V101, P185, DOI 10.1111/j.1423-0410.2011.01478.x; Mitra B, 2013, ANZ J SURG, V83, P918, DOI 10.1111/ans.12417; Munoz M, 2007, VOX SANG, V92, P381, DOI 10.1111/j.1423-0410.2007.00894.x; Napolitano LM, 2009, CRIT CARE MED, V37, P3124, DOI 10.1097/CCM.0b013e3181b39f1b; Ogura T, 2014, J TRAUMA ACUTE CARE, V76, P1243, DOI 10.1097/TA.0000000000000200; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Rossaint R, 2010, CRIT CARE, V14, DOI 10.1186/cc8943; SAWYER PR, 1990, VOX SANG, V58, P199, DOI 10.1111/j.1423-0410.1990.tb02090.x; Schochl H, 2010, ANAESTHESIA, V65, P199, DOI 10.1111/j.1365-2044.2009.06188.x; Tauber H, 2011, BRIT J ANAESTH, V107, P378, DOI 10.1093/bja/aer158; Teixeira PGR, 2008, AM SURGEON, V74, P953; Valeri CR, 2009, VOX SANG, V96, P180, DOI 10.1111/j.1423-0410.2008.01126.x; Valle EJ, 2014, J TRAUMA ACUTE CARE, V76, P1373, DOI 10.1097/TA.0000000000000242; van de Watering L, 2011, VOX SANG, V100, P36, DOI 10.1111/j.1423-0410.2010.01441.x; Wafaisade A, 2012, J TRAUMA ACUTE CARE, V72, P936, DOI 10.1097/TA.0b013e31823dca70; Zimmermann R, 1999, TRANSFUSION, V39, P351, DOI 10.1046/j.1537-2995.1999.39499235665.x	38	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0148736	10.1371/journal.pone.0148736	http://dx.doi.org/10.1371/journal.pone.0148736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812103	Green Published, gold, Green Submitted			2022-12-26	WOS:000386910000001
J	Fujita, H; Suzuki, K; Numao, A; Watanabe, Y; Uchiyama, T; Miyamoto, T; Miyamoto, M; Hirata, K				Fujita, Hiroaki; Suzuki, Keisuke; Numao, Ayaka; Watanabe, Yuji; Uchiyama, Tomoyuki; Miyamoto, Tomoyuki; Miyamoto, Masayuki; Hirata, Koichi			Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes	PLOS ONE			English	Article							I-123-MIBG MYOCARDIAL SCINTIGRAPHY; PROGRESSIVE SUPRANUCLEAR PALSY; ODOR IDENTIFICATION TEST; MULTIPLE SYSTEM ATROPHY; TRANSCRANIAL SONOGRAPHY; CLINICAL-DIAGNOSIS; JAPANESE PATIENTS; RESEARCH CRITERIA; ACCURACY; DYSFUNCTION	Background We aimed to evaluate the utility of the combined use of cardiac I-123-metaiodobenzylguanidine (MIBG) scintigraphy, olfactory testing, and substantia nigra (SN) hyperechogenicity on transcranial sonography (TCS) in differentiating Parkinson's disease (PD) from atypical parkinsonian syndromes (APSs), such as multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). Methods Cardiac MIBG scintigraphy, card-type odor identification testing (Open Essence (OE), Wako, Japan), and TCS were performed with 101 patients with PD and 38 patients with APSs (MSA and PSP). Receiver operating characteristic (ROC) curve analysis was used to assess the sensitivity and specificity of these batteries for diagnosing PD from APSs. The diagnostic accuracy of the three tests was also assessed among patients at the early disease stage (drug-naive patients with a disease duration of 3 years or less). Results In differentiating PD from APSs, the area under the ROC curve was 0.74 (95% CI, 0.65-0.83), 0.8 (95% CI, 0.73-0.87), and 0.75 (95% CI, 0.67-0.82) for TCS, cardiac MIBG scintigraphy, and olfactory testing, respectively. The diagnostic sensitivity and specificity were 53.1% and 91.7%, respectively, for TCS, 70.3% and 86.8%, respectively, for cardiac MIBG scintigraphy, 58.4% and 76.3%, respectively, for OE. Among early-stage patients, sensitivity and specificity were 50.0% and 93.8%, respectively, for TCS, 57.1% and 87.5%, respectively, for cardiac MIBG scintigraphy, and 54.8% and 79.2%, respectively, for OE. At least one positive result from 3 tests improved sensitivity (86.1%) but decreased specificity (63.2%). In contrast, at least 2 positive results from 3 tests had good discrimination for both early-stage patients (50.0% sensitivity and 93.8% specificity) and patients overall (57.8% sensitivity and 95.8% specificity). Positive results for all 3 tests yielded 100% specificity but low sensitivity (25%). Conclusions At least 2 positive results from among TCS, cardiac MIBG scintigraphy, and olfactory testing can support clinical diagnosis in distinguishing PD from APSs.	[Fujita, Hiroaki; Suzuki, Keisuke; Numao, Ayaka; Watanabe, Yuji; Uchiyama, Tomoyuki; Hirata, Koichi] Dokkyo Med Univ, Dept Neurol, Mibu, Tochigi, Japan; [Uchiyama, Tomoyuki] Dokkyo Med Univ, Continence Ctr, Mibu, Tochigi, Japan; [Miyamoto, Tomoyuki] Dokkyo Med Univ, Koshigaya Hosp, Dept Neurol, Saitama, Japan; [Miyamoto, Masayuki] Dokkyo Med Univ, Sch Nursing, Dept Clin Med Nursing, Mibu, Tochigi, Japan	Dokkyo Medical University; Dokkyo Medical University; Dokkyo Medical University; Dokkyo Medical University	Suzuki, K (corresponding author), Dokkyo Med Univ, Dept Neurol, Mibu, Tochigi, Japan.	keisuke@dokkyomed.ac.jp	Suzuki, Keisuke/I-5464-2014	Suzuki, Keisuke/0000-0003-0320-8993	Dokkyo Medical University [2015-14]	Dokkyo Medical University	This study was partly supported by a Dokkyo Medical University young investigator award (No. 2015-14 to Dr. Hiroaki Fujita). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CH, 2014, NEUROLOGY, V83, P406, DOI 10.1212/WNL.0000000000000641; Baba T, 2012, BRAIN, V135, P161, DOI 10.1093/brain/awr321; Behnke S, 2013, MOVEMENT DISORD, V28, P455, DOI 10.1002/mds.25193; Berg D, 1999, NEUROLOGY, V53, P1026, DOI 10.1212/WNL.53.5.1026; Berg D, 2008, LANCET NEUROL, V7, P1044, DOI 10.1016/S1474-4422(08)70239-4; Berg D, 2015, MOVEMENT DISORD, V30, P1600, DOI 10.1002/mds.26431; Berg D, 2013, MOVEMENT DISORD, V28, P216, DOI 10.1002/mds.25192; Berg D, 2011, MOVEMENT DISORD, V26, P979, DOI 10.1002/mds.23766; Berg D, 2011, J NEURAL TRANSM, V118, P453, DOI 10.1007/s00702-010-0469-5; Busse K, 2012, J NEUROL NEUROSUR PS, V83, P441, DOI 10.1136/jnnp-2011-301719; Doty RL, 2012, NAT REV NEUROL, V8, P329, DOI 10.1038/nrneurol.2012.80; DOTY RL, 1993, NEUROLOGY, V43, P962, DOI 10.1212/WNL.43.5.962; Driver-Dunckley E, 2014, PARKINSONISM RELAT D, V20, P1260, DOI 10.1016/j.parkreldis.2014.08.006; Fujio H, 2012, ANN OTO RHINOL LARYN, V121, P413, DOI 10.1177/000348941212100609; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Iijima M, 2010, MOVEMENT DISORD, V25, P1143, DOI 10.1002/mds.23001; Izawa MO, 2012, EUR J NEUROL, V19, P411, DOI 10.1111/j.1468-1331.2011.03533.x; Kagi G, 2010, J NEUROL NEUROSUR PS, V81, P5, DOI 10.1136/jnnp.2008.157370; Kajimoto Y, 2009, PARKINSONISM RELAT D, V15, P270, DOI 10.1016/j.parkreldis.2008.06.004; Kikuchi A, 2011, PARKINSONISM RELAT D, V17, P698, DOI 10.1016/j.parkreldis.2011.07.011; Lauckaite K, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-12; Lee PH, 2006, MOVEMENT DISORD, V21, P1975, DOI 10.1002/mds.21083; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Marek K, 2009, NEUROLOGY, V72, pS21, DOI 10.1212/WNL.0b013e318198df97; Miyamoto T, 2006, NEUROLOGY, V67, P2236, DOI 10.1212/01.wnl.0000249313.25627.2e; Miyamoto T, 2008, SLEEP, V31, P717, DOI 10.1093/sleep/31.5.717; Miyamoto T, 2009, MOVEMENT DISORD, V24, P268, DOI 10.1002/mds.22361; Mizutani Y, 2014, PARKINSONISM RELAT D, V20, P520, DOI 10.1016/j.parkreldis.2014.02.010; Navarro-Otano J, 2014, PARKINSONISM RELAT D, V20, P192, DOI 10.1016/j.parkreldis.2013.10.025; Oka H, 2010, J NEUROL, V257, P969, DOI 10.1007/s00415-009-5447-1; Okawa M, 2007, INTERNAL MED, V46, P1527, DOI 10.2169/internalmedicine.46.0271; Orimo S, 2016, AGEING RES REV, V30, P122, DOI 10.1016/j.arr.2016.01.001; Orimo S, 2012, PARKINSONISM RELAT D, V18, P494, DOI 10.1016/j.parkreldis.2012.01.009; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; Postuma RB, 2012, MOVEMENT DISORD, V27, P617, DOI 10.1002/mds.24996; Rizzo G, 2016, NEUROLOGY, V86, P566, DOI 10.1212/WNL.0000000000002350; Saito S, 2003, J JPN ASS ODOR ENV, V34, P1; Suzuki M, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-157; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Tsujikawa K, 2015, J NEUROL NEUROSUR PS, V86, P945, DOI 10.1136/jnnp-2015-310327; Umemura A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061066; Vlaar AMM, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-27; Walter U, 2003, NEUROLOGY, V60, P74, DOI 10.1212/WNL.60.1.74	45	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165869	10.1371/journal.pone.0165869	http://dx.doi.org/10.1371/journal.pone.0165869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812167	Green Published, Green Submitted, gold			2022-12-26	WOS:000386910000074
J	Resnick, A				Resnick, Andrew			HIF Stabilization Weakens Primary Cilia	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; TUMOR-SUPPRESSOR PROTEIN; MECHANICAL-PROPERTIES; FLEXURAL RIGIDITY; MICROTUBULES; CALCIUM; MECHANOSENSATION; CILIOGENESIS; COMPARTMENT; PATHWAYS	Although solitary or sensory cilia are present in most cells of the body and their existence has been known since the sixties, very little is known about their functions. One suspected function is fluid flow sensing-physical bending of cilia produces an influx of Ca++, which can then result in a variety of activated signaling pathways. Defective cilia and ciliary-associated proteins have been shown to result in cystic diseases. Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a progressive disease, typically appearing in the 5th decade of life and is one of the most common monogenetic inherited human diseases, affecting approximately 600,000 people in the United States. Because the mechanical properties of cilia impact their response to applied flow, we asked how the stiffness of cilia can be controlled pharmacologically. We performed an experiment subjecting cilia to Taxol (a microtubule stabilizer) and CoCl2 (a HIF stabilizer to model hypoxia). Madin-Darby Canine Kidney (MDCK) cells were selected as our model system. After incubation with a selected pharmacological agent, cilia were optically trapped and the bending modulus measured. We found that HIF stabilization significantly weakens cilia. These results illustrate a method to alter the mechanical properties of primary cilia and potentially alter the flow sensing properties of cilia.	[Resnick, Andrew] Cleveland State Univ, Dept Phys, Cleveland, OH 44115 USA; [Resnick, Andrew] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA	University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University	Resnick, A (corresponding author), Cleveland State Univ, Dept Phys, Cleveland, OH 44115 USA.; Resnick, A (corresponding author), Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA.	a.resnick@csuohio.edu	Resnick, Andrew H/A-6841-2018	Resnick, Andrew H/0000-0002-7526-6394				Abdul-Majeed S, 2012, CELL MOL LIFE SCI, V69, P165, DOI 10.1007/s00018-011-0744-0; Bernhardt WM, 2007, AM J PATHOL, V170, P830, DOI 10.2353/ajpath.2007.060455; Besschetnova TY, 2010, CURR BIOL, V20, P182, DOI 10.1016/j.cub.2009.11.072; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Broekhuis JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108470; Brown JM, 2003, MOL BIOL CELL, V14, P3192, DOI 10.1091/mbc.e03-03-0166; Delling M, 2013, NATURE, V504, P311, DOI 10.1038/nature12833; Esteban MA, 2006, J AM SOC NEPHROL, V17, P1801, DOI 10.1681/ASN.2006020181; Felgner H, 1996, J CELL SCI, V109, P509; Garcia Galo 3rd, 2016, Cilia, V5, P17, DOI 10.1186/s13630-016-0038-0; GARDNER KD, 1991, KIDNEY INT, V39, P718, DOI 10.1038/ki.1991.87; Gill J, 2014, TRANSPLANTATION, V97, P668, DOI 10.1097/01.TP.0000438637.29214.10; Glaser J, 2014, OPT ENG, V53, DOI 10.1117/1.OE.53.7.074110; Han SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22281; Hawkins TL, 2013, BIOPHYS J, V104, P1517, DOI 10.1016/j.bpj.2013.02.026; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Hu QC, 2011, CYTOSKELETON, V68, P313, DOI 10.1002/cm.20514; Huang TC, 1964, REPORT; Jin XJ, 2014, CELL MOL LIFE SCI, V71, P2165, DOI 10.1007/s00018-013-1483-1; Kikumoto M, 2006, BIOPHYS J, V90, P1687, DOI 10.1529/biophysj.104.055483; Landau L.D., 2012, THEORY ELASTICITY, V7; Lehmann H, 2015, J AM SOC NEPHROL, V26, P2778, DOI 10.1681/ASN.2014090875; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Lin YC, 2013, NAT CHEM BIOL, V9, P437, DOI [10.1038/NCHEMBIO.1252, 10.1038/nchembio.1252]; Ma M, 2013, NAT GENET, V45, P1004, DOI 10.1038/ng.2715; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MICKEY B, 1995, J CELL BIOL, V130, P909, DOI 10.1083/jcb.130.4.909; Mofrad MRK, 2010, CELLULAR MECHANOTRAN, V465, pxii; Mohieldin AM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15982; Naranjo-Suarez S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030470; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Pei Y, 2001, TRENDS MOL MED, V7, P151, DOI 10.1016/S1471-4914(01)01953-0; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Qutub AA, 2008, MOL CELL BIOL, V28, P5106, DOI 10.1128/MCB.00060-08; Rankin HV, 2007, ULTRASTRUCT PATHOL, V31, P339, DOI 10.1080/01913120701643686; Resnick A, 2007, BIOPHYS J, V93, P1380, DOI 10.1529/biophysj.107.105007; Resnick A, 2015, BIOPHYS J, V109, P18, DOI 10.1016/j.bpj.2015.05.031; Resnick A, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3316378; ROTH KE, 1988, J CELL SCI, V89, P457; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; Saigusa T, 2015, PHYSIOLOGY, V30, P195, DOI 10.1152/physiol.00032.2014; Schwartz EA, 1997, AM J PHYSIOL-RENAL, V272, pF132, DOI 10.1152/ajprenal.1997.272.1.F132; Thoma CR, 2007, NAT CELL BIOL, V9, P588, DOI 10.1038/ncb1579; Troilo A, 2014, EMBO REP, V15, P77, DOI 10.1002/embr.201337688; Verghese E, 2008, NEPHROL DIAL TRANSPL, V23, P834, DOI 10.1093/ndt/gfm743; Verghese E, 2011, CELL BIOL INT, V35, P909, DOI 10.1042/CBI20090154; WANG GL, 1993, BLOOD, V82, P3610; Wann Angus Kt, 2013, Cilia, V2, P17, DOI 10.1186/2046-2530-2-17; Weimbs T, 2007, AM J PHYSIOL-RENAL, V293, pF1423, DOI 10.1152/ajprenal.00275.2007; Young YN, 2012, BIOPHYS J, V103, P629, DOI 10.1016/j.bpj.2012.07.009; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200	51	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165907	10.1371/journal.pone.0165907	http://dx.doi.org/10.1371/journal.pone.0165907			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812213	Green Published, Green Submitted, gold			2022-12-26	WOS:000386910000077
J	Ryden, A; Sorstadius, E; Bergenheim, K; Romanovschi, A; Thoren, F; Witt, EA; Sternhufvud, C				Ryden, Anna; Sorstadius, Elisabeth; Bergenheim, Klas; Romanovschi, Alexandru; Thoren, Fredrik; Witt, Edward A.; Sternhufvud, Catarina			The Humanistic Burden of Type 1 Diabetes Mellitus in Europe: Examining Health Outcomes and the Role of Complications	PLOS ONE			English	Article							SCORE DIFFERENCES; CHILDREN; TRENDS; RISK	Aims Diagnoses of Type 1 Diabetes Mellitus (T1DM) in Europe appear to be on the rise. Therefore it is imperative that researchers understand the potential impact that increases in prevalence could have on the affected individuals as well as on society as a whole. Accordingly this study examined the humanistic and economic burden of T1DM in patients relative to those without the condition across a number of health outcomes including health status, work productivity loss, activity impairment, and healthcare resource use. Methods Survey data from a large, representative sample of EU adults (The EU National Health and Wellness Survey) were examined. Results Results suggest that overall burden is higher for those diagnosed with T1DM than respondents without diabetes and that burden increases as complications associated with T1DM increase. Conclusions Taken together, these results suggest that treatment strategies for T1DM should balance clinical, humanistic, and economic burden and patients should be educated on the role of complications in disease outcomes.	[Ryden, Anna; Sorstadius, Elisabeth; Bergenheim, Klas; Thoren, Fredrik; Sternhufvud, Catarina] AstraZeneca, Molndal, Sweden; [Romanovschi, Alexandru] AstraZeneca, Mississauga, ON, Canada; [Witt, Edward A.] Kantar Hlth, Princeton, NJ USA	AstraZeneca; AstraZeneca	Ryden, A (corresponding author), AstraZeneca, Molndal, Sweden.	anna.ryden@astrazeneca.com			AstraZeneca	AstraZeneca(AstraZeneca)	This work was funded by AstraZeneca, a commercial company. AstraZeneca provided additional support in the form of salaries for authors AR, ES, KB, AR, FT, and CS. Kantar Health, a commercial company, provided support in the form of salary for author EW. These funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alleman CJM, 2015, DIABETES RES CLIN PR, V109, P215, DOI 10.1016/j.diabres.2015.04.031; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Bjorner JB, 2007, CURR MED RES OPIN, V23, P731, DOI 10.1185/030079907X178757; Bjorner JB, 2013, VALUE HEALTH, V16, P993, DOI 10.1016/j.jval.2013.06.022; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Conway B, 2010, DIABETIC MED, V27, P398, DOI 10.1111/j.1464-5491.2010.02956.x; Eckel RH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004219; Ehehalt S, 2012, PEDIATR DIABETES, V13, P15, DOI 10.1111/j.1399-5448.2011.00799.x; Germano G, 2012, EUR HEART J, V33, P137; Harjutsalo V, 2008, LANCET, V371, P1777, DOI 10.1016/S0140-6736(08)60765-5; Huxley RR, 2015, LANCET DIABETES ENDO, V3, P198, DOI 10.1016/S2213-8587(14)70248-7; Leidig-Bruckner G, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-33; Livingstone SJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001321; MASER RE, 1991, ARTERIOSCLER THROMB, V11, P958, DOI 10.1161/01.ATV.11.4.958; Melendez-Ramirez LY, 2010, ENDOCRIN METAB CLIN, V39, P625, DOI 10.1016/j.ecl.2010.05.009; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nuhoho S, 2014, VALUE HEALTH, V17, pA356, DOI 10.1016/j.jval.2014.08.761; Orchard TJ, 2006, DIABETES CARE, V29, P2528, DOI 10.2337/dc06-1161; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; Sinclair A, 2012, J AM MED DIR ASSOC, V13, P497, DOI 10.1016/j.jamda.2012.04.012; Thunander M, 2008, DIABETES RES CLIN PR, V82, P247, DOI 10.1016/j.diabres.2008.07.022; Tuominen JT, 1999, DIABETES CARE, V22, P1196, DOI 10.2337/diacare.22.7.1196; van Acker K, 2014, DIABETES-METAB RES, V30, P635, DOI 10.1002/dmrr.2523; Ware JE, 2007, USERS MANUAL SF 36V2	26	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164977	10.1371/journal.pone.0164977	http://dx.doi.org/10.1371/journal.pone.0164977			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812145	Green Published, Green Submitted, gold			2022-12-26	WOS:000386910000020
J	Song, M; Lee, H; Nam, MH; Jeong, E; Kim, S; Hong, Y; Kim, N; Yim, HY; Yoo, YJ; Kim, JS; Kim, JS; Cho, YY; Mills, GB; Kim, WY; Yoon, S				Song, Mee; Lee, Hani; Nam, Myung-Hee; Jeong, Euna; Kim, Somin; Hong, Yourae; Kim, Nayoung; Yim, Hwa Young; Yoo, Young-Ji; Kim, Jung Seok; Kim, Jin-Seok; Cho, Yong-Yeon; Mills, Gordon B.; Kim, Woo-Young; Yoon, Sukjoon			Loss-of-function screens of druggable targetome against cancer stem-like cells	FASEB JOURNAL			English	Article						CSLC sphere culture; lipid profile; network analysis; siRNA screening	METABOLISM	Cancer stem-like cells (CSLCs) contribute to the initiation and recurrence of tumors and to their resistance to conventional therapies. In this study, small interfering RNA (siRNA)-based screening of approximate to 4800 druggable genes in 3-dimensional CSLC cultures in comparison to 2-dimensional bulk cultures of U87 glioma cells revealed 3 groups of genes essential for the following: survival of the CSLC population only, bulk-cultured population only, or both populations. While diverse biologic processes were associated with siRNAs reducing the bulk-cultured population, CSLC-eliminating siRNAs were enriched in a few functional categories, such as lipid metabolism, protein metabolism, and gene expression. Interestingly, siRNAs that selectively reduced CSLC only were found to target genes for cholesterol and unsaturated fatty acid synthesis. The lipidomic profile of CSLCs revealed increased levels of monounsaturated lipids. Pharmacologic blockage of these target pathways reduced CSLCs, and this effect was eliminated by addition of downstream metabolite products. The present CSLC-sensitive target categories provide a useful resource that can be exploited for the selective elimination of CSLCs.	[Song, Mee; Jeong, Euna; Kim, Somin; Kim, Nayoung; Yim, Hwa Young; Yoon, Sukjoon] Sookmyung Womens Univ, Ctr Adv Bioinformat & Syst Med, Cheongpa Ro 47 Gil, Seoul 04310, South Korea; [Lee, Hani; Yoo, Young-Ji; Kim, Jung Seok; Kim, Jin-Seok; Kim, Woo-Young] Sookmyung Womens Univ, Coll Pharm, Res Ctr Cell Fate Control, Cheongpa Ro 47 Gil, Seoul 04310, South Korea; [Hong, Yourae; Kim, Nayoung; Yoon, Sukjoon] Sookmyung Womens Univ, Dept Biol Sci, Seoul, South Korea; [Nam, Myung-Hee] Korea Basic Sci Inst, Environm Risk & Welf Res Team, Seoul, South Korea; [Cho, Yong-Yeon] Catholic Univ Korea, Coll Pharm, Gyeonggi Do, South Korea; [Mills, Gordon B.] Univ Texas Houston, MD Anderson Canc Ctr, Syst Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA	Sookmyung Women's University; Sookmyung Women's University; Sookmyung Women's University; Korea Basic Science Institute (KBSI); Catholic University of Korea; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Yoon, S (corresponding author), Sookmyung Womens Univ, Ctr Adv Bioinformat & Syst Med, Cheongpa Ro 47 Gil, Seoul 04310, South Korea.; Kim, WY (corresponding author), Sookmyung Womens Univ, Coll Pharm, Res Ctr Cell Fate Control, Cheongpa Ro 47 Gil, Seoul 04310, South Korea.	wykim@sookmyung.ac.kr; yoonsj@sookmyung.ac.kr	Cho, Yong-Yeon/AAD-4263-2020	Cho, Yong-Yeon/0000-0003-1107-2651; Hong, Yourae/0000-0001-6683-433X; Mills, Gordon/0000-0002-0144-9614	National Research Foundation (NRF) of Korea - Korean government (MEST) [NRF-2012M3A9B6055398, NRF-2012M3A9B6055466, NRF-2016R1A5A1011974, NRF-2013R1A1A2059115, NRF-2015R1D1A1A01056594]	National Research Foundation (NRF) of Korea - Korean government (MEST)	This work was supported by grants from the National Research Foundation (NRF) of Korea, including the Bio and Medical Technology Development Program (NRF-2012M3A9B6055398 and NRF-2012M3A9B6055466), the Science Research Center Program (NRF-2016R1A5A1011974), and Basic Science Research Program (NRF-2013R1A1A2059115 and NRF-2015R1D1A1A01056594), funded by the Korean government (MEST).	Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Beloribi-Djefaflia S, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.49; Ben-David U, 2013, CELL STEM CELL, V12, P167, DOI 10.1016/j.stem.2012.11.015; Das UN, 2011, CANCER METAST REV, V30, P311, DOI 10.1007/s10555-011-9316-x; Gilbert CA, 2009, J CELL BIOCHEM, V108, P1031, DOI 10.1002/jcb.22350; Ginestier C, 2012, STEM CELLS, V30, P1327, DOI 10.1002/stem.1122; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Ivanova PT, 2009, CURR OPIN CHEM BIOL, V13, P526, DOI 10.1016/j.cbpa.2009.08.011; Jung Y, 2015, ARCH PHARM RES, V38, P414, DOI 10.1007/s12272-015-0570-2; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Matchett KB, 2014, STEM CELLS, V32, P2563, DOI 10.1002/stem.1798; Mazur S, 2012, RNA BIOL, V9, P624, DOI 10.4161/rna.19759; Mollinedo Faustino, 2015, Adv Biol Regul, V57, P130, DOI 10.1016/j.jbior.2014.10.003; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Song M, 2015, COMPUT BIOL CHEM, V58, P192, DOI 10.1016/j.compbiolchem.2015.07.005; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Tirinato L, 2015, STEM CELLS, V33, P35, DOI 10.1002/stem.1837; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; Vidal SJ, 2014, ONCOGENE, V33, P4451, DOI 10.1038/onc.2013.411; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065	23	23	23	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					625	635		10.1096/fj.201600953	http://dx.doi.org/10.1096/fj.201600953			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27811063	Green Published, hybrid			2022-12-26	WOS:000394235400016
J	Imasawa, T; Obre, E; Bellance, N; Lavie, J; Imasawa, T; Rigothier, C; Delmas, Y; Combe, C; Lacombe, D; Benard, G; Claverol, S; Bonneu, M; Rossignol, R				Imasawa, Toshiyuki; Obre, Emilie; Bellance, Nadege; Lavie, Julie; Imasawa, Tomoko; Rigothier, Claire; Delmas, Yahsou; Combe, Christian; Lacombe, Didier; Benard, Giovanni; Claverol, Stephane; Bonneu, Marc; Rossignol, Rodrigue			High glucose repatterns human podocyte energy metabolism during differentiation and diabetic nephropathy	FASEB JOURNAL			English	Article						mitochondria; MEF2C; human kidney	FOCAL SEGMENTAL GLOMERULOSCLEROSIS; FREE FATTY-ACIDS; MITOCHONDRIAL DYSFUNCTION; MOLECULAR-MECHANISMS; SKELETAL-MUSCLE; KIDNEY-DISEASE; MESSENGER-RNA; ATP SYNTHASE; ACTIVATION; EXPRESSION	Podocytes play a key role in diabetic nephropathy pathogenesis, but alteration of their metabolism remains unknown in human kidney. By using a conditionally differentiating human podocyte cell line, we addressed the functional and molecular changes in podocyte energetics during in vitro development or under high glucose conditions. In 5 mM glucose medium, we observed a stepwise activation of oxidative metabolism during cell differentiation that was characterized by peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha)-dependent stimulation of mitochondrial biogenesis and function, with concomitant reduction of the glycolytic enzyme content. Conversely, when podocytes were cultured in high glucose (20 mM), stepwise oxidative phosphorylation biogenesis was aborted, and a glycolytic switch occurred, with consecutive lactic acidosis. Expression of the master regulators of oxidative metabolism transcription factor A mitochondrial, PGC-1 alpha, AMPK, and serine-threonine liver kinase B1 was altered by high glucose, as well as their downstream signaling networks. Focused transcriptomics revealed that myocyte-specific enhancer factor 2C (MEF2C) and myogenic factor 5(MYF5) expression was inhibited by high glucose levels, and endoribo nuclease-prepared small interfering RNA-mediated combined inhibition of those transcription factors phenocopied the glycolytic shift that was observed in high glucose conditions. Accordingly, a reduced expression of MEF2C, MYF5, and PGC-1 alpha was found in kidney tissue sections that were obtained from patients with diabetic nephropathy. These findings obtained in human samples demonstrate that MEF2C-MYF5-dependent bioenergetic dedifferentiation occurs in podocytes that are confronted with a high-glucose milieu.-Imasawa, T., Obre, E., Bellance, N., Lavie, J., Imasawa, T., Rigothier, C., Delmas, Y., Combe, C., Lacombe, D., Benard, G., Claverol, S., Bonneu, M., Rossignol, R. High glucose repatterns human podocyte energy metabolism during differentiation and diabetic nephropathy.	[Imasawa, Toshiyuki] Chiba East Hosp, Kidney Ctr, Natl Hosp Org, Chiba, Japan; [Obre, Emilie; Bellance, Nadege; Lavie, Julie; Imasawa, Tomoko; Lacombe, Didier; Benard, Giovanni; Rossignol, Rodrigue] INSERM, U1211, Lab Rare Dis Metab & Genet, Bordeaux, France; [Claverol, Stephane; Bonneu, Marc] Bordeaux Univ, Ctr Funct Genom, Bordeaux, France; [Obre, Emilie; Rossignol, Rodrigue] Ctr Hosp Univ Pellegrin, Cellomet, Bordeaux, France; [Rigothier, Claire; Delmas, Yahsou; Combe, Christian] Bordeaux Univ Hosp Ctr, Dept Nephrol Transplantat & Dialysis, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux; CHU Bordeaux	Imasawa, T (corresponding author), Univ Bordeaux, Ctr Hosp Univ Pellegrin, INSERM, Ecole Sages Femmes,U1211, Pl Amelie Raba Leon, F-33000 Bordeaux, France.	imasawa@cehpnet.com; rodrigue.rossignol@u-bordeaux.fr	Bénard, Giovanni/M-3485-2014; Combe, Christian/N-3726-2015	Bénard, Giovanni/0000-0003-0036-9425; Lacombe, Didier/0000-0002-8956-2207; Lavie, Julie/0000-0002-7208-3154; bellance, nadege/0000-0002-8868-8596; Combe, Christian/0000-0002-0360-573X	Japan Society for the Promotion of Science (KAKENHI) [80348276]; National Hospital Organization of Japan; French Association Against Myopathies; Grants-in-Aid for Scientific Research [16K09638] Funding Source: KAKEN	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Hospital Organization of Japan; French Association Against Myopathies; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Welsh GI, Academic and Children's Renal Unit (Bristol University, Southmead Hospital, Bristol, United Kingdom) for providing the human podocytes, and Dr. Akira Hiwatashi (Tsukuba University, Tsukuba, Japan) and Mori Tachibana (National Hospital Organization Chiba-East Hospital) for valuable technical advice and assistance. This work was supported by the Japan Society for the Promotion of Science (KAKENHI) Grant 80348276 (to T.I), a grant from the National Hospital Organization of Japan (to T.I.), and the French Association Against Myopathies. The authors declare no conflicts of interest.	Abe Y, 2010, AM J PHYSIOL-CELL PH, V299, pC464, DOI 10.1152/ajpcell.00563.2009; Ahmed M, 2010, ISLETS, V2, P283, DOI 10.4161/isl.2.5.12639; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Carraro M, 2014, J BIOL CHEM, V289, P15980, DOI 10.1074/jbc.C114.559633; Cheval L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046876; Coimbra TM, 2000, KIDNEY INT, V57, P167, DOI 10.1046/j.1523-1755.2000.00836.x; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; Emma F, 2016, NAT REV NEPHROL, V12, P267, DOI 10.1038/nrneph.2015.214; Fessart D, 2014, J MOL CELL CARDIOL, V66, P41, DOI 10.1016/j.yjmcc.2013.10.015; Gao CL, 2010, MOL CELL ENDOCRINOL, V320, P25, DOI 10.1016/j.mce.2010.01.039; Gassler N, 2001, KIDNEY INT, V60, P106, DOI 10.1046/j.1523-1755.2001.00777.x; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Gucer S, 2005, PEDIATR DEVEL PATHOL, V8, P710, DOI 10.1007/s10024-005-0058-z; Hara M, 2012, DIABETOLOGIA, V55, P2913, DOI 10.1007/s00125-012-2661-7; Heerspink HJL, 2013, BRIT J CLIN PHARMACO, V76, P536, DOI 10.1111/bcp.12195; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Ihalmo P, 2008, DIABETOLOGIA, V51, P86, DOI 10.1007/s00125-007-0854-2; Imasawa T, 2013, INT J BIOCHEM CELL B, V45, P2109, DOI 10.1016/j.biocel.2013.06.013; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; Johanson M, 1999, BIOCHEM BIOPH RES CO, V265, P222, DOI 10.1006/bbrc.1999.1390; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Lee MJ, 2010, CELL SIGNAL, V22, P65, DOI 10.1016/j.cellsig.2009.09.011; Leinninger GM, 2006, NAT CLIN PRACT NEURO, V2, P620, DOI 10.1038/ncpneuro0320; Li JJ, 2007, KIDNEY INT, V72, pS36, DOI 10.1038/sj.ki.5002384; Li SY, 2014, KIDNEY INT, V86, P358, DOI 10.1038/ki.2014.67; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Marfella R, 2001, J CLIN INVEST, V108, P635, DOI 10.1172/JCI13727; May CJ, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00148; McGee SL, 2006, CLIN EXP PHARMACOL P, V33, P395, DOI 10.1111/j.1440-1681.2006.04362.x; Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001; Melser S, 2013, CELL METAB, V17, P719, DOI 10.1016/j.cmet.2013.03.014; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nishikawa T, 2007, ANTIOXID REDOX SIGN, V9, P343, DOI 10.1089/ars.2006.1458; O'Brien LL, 2016, DEVELOPMENT, V143, P595, DOI 10.1242/dev.127175; Ostojic J, 2013, CELL METAB, V18, P567, DOI 10.1016/j.cmet.2013.08.017; Panda AC, 2016, NUCLEIC ACIDS RES, V44, P2393, DOI 10.1093/nar/gkw023; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Reidy K, 2014, J CLIN INVEST, V124, P2333, DOI 10.1172/JCI72271; Rigothier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037695; Russell NDF, 2015, DIABETOLOGIA, V58, P1708, DOI 10.1007/s00125-015-3600-1; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sharma K, 2013, J AM SOC NEPHROL, V24, P1901, DOI 10.1681/ASN.2013020126; Sieber J, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00186; Stieger N, 2012, METABOLISM, V61, P1073, DOI 10.1016/j.metabol.2011.12.003; Velpula KK, 2013, CANCER RES, V73, P7277, DOI 10.1158/0008-5472.CAN-13-1868; Walkin L, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-18; Wang WJ, 2012, CELL METAB, V15, P186, DOI 10.1016/j.cmet.2012.01.009; Xu JX, 2006, BIOCHEM BIOPH RES CO, V344, P827, DOI 10.1016/j.bbrc.2006.03.211; Yan K, 2012, CELL CYCLE, V11, P1504, DOI 10.4161/cc.19825; Yang LC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5436; Yuan YG, 2012, KIDNEY INT, V82, P771, DOI 10.1038/ki.2012.188; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	55	51	60	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					294	307		10.1096/fj.201600293R	http://dx.doi.org/10.1096/fj.201600293R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27825100	hybrid, Green Published			2022-12-26	WOS:000392177600028
J	Nouri, K; Fansa, EK; Amin, E; Dvorsky, R; Gremer, L; Willbold, D; Schmitt, L; Timson, DJ; Ahmadian, MR				Nouri, Kazem; Fansa, Eyad K.; Amin, Ehsan; Dvorsky, Radovan; Gremer, Lothar; Willbold, Dieter; Schmitt, Lutz; Timson, David J.; Ahmadian, Mohammad R.			IQGAP1 Interaction with RHO Family Proteins Revisited KINETIC AND EQUILIBRIUM EVIDENCE FOR MULTIPLE DISTINCT BINDING SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; CELL-CELL ADHESION; CRYSTAL-STRUCTURE; ACTIN-FILAMENTS; SECONDARY STRUCTURE; SYSTEMATIC-APPROACH; NEURITE OUTGROWTH; FUNCTIONAL BASIS; STRUCTURAL BASIS; CDC42	IQ motif-containing GTPase activating protein 1 (IQGAP1) plays a central role in the physical assembly of relevant signaling networks that are responsible for various cellular processes, including cell adhesion, polarity, and transmigration. The RHO family proteins CDC42 and RAC1 have been shown to mainly interact with the GAP-related domain (GRD) of IQGAP1. However, the role of its RASGAPC-terminal (RGCT) and C-terminal domains in the interactions with RHO proteins has remained obscure. Here, we demonstrate that IQGAP1 interactions with RHO proteins underlie a multiple-step binding mechanism: (i) a high affinity, GTP-dependent binding of RGCT to the switch regions of CDC42 or RAC1 and (ii) a very low affinity binding of GRD and a C terminus adjacent to the switch regions. These data were confirmed by phosphomimetic mutation of serine 1443 to glutamate within RGCT, which led to a significant reduction of IQGAP1 affinity for CDC42 and RAC1, clearly disclosing the critical role of RGCT for these interactions. Unlike CDC42, an extremely low affinity was determined for the RAC1-GRD interaction, suggesting that the molecular nature of IQGAP1 interaction with CDC42 partially differs from that of RAC1. Our study provides new insights into the interaction characteristics of IQGAP1 with RHO family proteins and highlights the complementary importance of kinetic and equilibrium analyses. We propose that the ability of IQGAP1 to interact with RHO proteins is based on a multiple-step binding process, which is a prerequisite for the dynamic functions of IQGAP1 as a scaffolding protein and a critical mechanism in temporal regulation and integration of IQGAP1-mediated cellular responses.	[Nouri, Kazem; Fansa, Eyad K.; Amin, Ehsan; Dvorsky, Radovan; Ahmadian, Mohammad R.] Heinrich Heine Univ, Fac Med, Inst Biochem & Mol Biol 2, Univ Str 1,Gebaude 22-03, D-40225 Dusseldorf, Germany; [Gremer, Lothar; Willbold, Dieter] Heinrich Heine Univ, Inst Phys Biol, D-40225 Dusseldorf, Germany; [Gremer, Lothar; Willbold, Dieter] Forschungszentrum Julich, ICS 6, D-52428 Julich, Germany; [Schmitt, Lutz] Heinrich Heine Univ, Inst Biochem, D-40225 Dusseldorf, Germany; [Timson, David J.] Univ Brighton, Sch Pharm & Biomol Sci, Huxley Bldg,Lewes Rd, Brighton BN2 4GJ, E Sussex, England; [Fansa, Eyad K.] Max Planck Inst Mol Physiol, Struct Biol Grp, D-44227 Dortmund, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; University of Brighton; Max Planck Society	Ahmadian, MR (corresponding author), Heinrich Heine Univ, Fac Med, Inst Biochem & Mol Biol 2, Univ Str 1,Gebaude 22-03, D-40225 Dusseldorf, Germany.	reza.ahmadian@uni-duesseldorf.de	Amin, Ehsan/GPC-5382-2022; Dvorsky, Radovan/ABE-3042-2020; Willbold, Dieter/A-6280-2013; Gremer, Lothar/H-9128-2013	Willbold, Dieter/0000-0002-0065-7366; Gremer, Lothar/0000-0001-7065-5027; Nouri, Kazem/0000-0001-7787-1304; Timson, David/0000-0002-0985-8818; Amin, Ehsan/0000-0003-2995-8864	German Research Foundation (Deutsche Forschungsgemeinschaft) [SFB 974, IRTG 1902]; International Graduate School of Protein Science and Technology (iGRASP); Research Committee of the Medical Faculty of the Heinrich-Heine University Dusseldorf [9772617]; Biotechnology and Biological Sciences Research Council (BBSRC, UK) "Biochemical analysis of human IQGAP proteins" [BB/D000394/1]; Action Cancer Grant [PG2 2005]; BBSRC [BB/D000394/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D000394/1] Funding Source: researchfish	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); International Graduate School of Protein Science and Technology (iGRASP); Research Committee of the Medical Faculty of the Heinrich-Heine University Dusseldorf; Biotechnology and Biological Sciences Research Council (BBSRC, UK) "Biochemical analysis of human IQGAP proteins"(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Action Cancer Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the German Research Foundation (Deutsche Forschungsgemeinschaft) through both the Collaborative Research Center 974 (SFB 974) "Communication and Systems Relevance during Liver Injury and Regeneration" and the International Research Training Group 1902 (IRTG 1902) "Intra- and interorgan communication of the cardiovascular system," and by the International Graduate School of Protein Science and Technology (iGRASP), the Research Committee of the Medical Faculty of the Heinrich-Heine University Dusseldorf (Grant 9772617), Biotechnology and Biological Sciences Research Council (BBSRC, UK) "Biochemical analysis of human IQGAP proteins" Grant BB/D000394/1, and Action Cancer Grant PG2 2005. The authors declare that they have no conflicts of interest with the contents of this article.	Abel AM, 2015, MOL IMMUNOL, V65, P336, DOI 10.1016/j.molimm.2015.02.012; Amin E, 2016, J BIOL CHEM, V291, P20353, DOI 10.1074/jbc.M116.736967; Amin E, 2013, BIOL CHEM, V394, P1399, DOI 10.1515/hsz-2013-0181; Bhattacharya M, 2014, J CLIN INVEST, V124, P4895, DOI 10.1172/JCI76658; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Brill S, 1996, MOL CELL BIOL, V16, P4869; Brown MD, 2007, J BIOL CHEM, V282, P30265, DOI 10.1074/jbc.M702537200; Carlier MF, 2015, CELL MOL LIFE SCI, V72, P3051, DOI 10.1007/s00018-015-1914-2; Casteel DE, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.377499; Choi Suyong, 2015, Advances in Biological Regulation, V60, P29, DOI 10.1016/j.jbior.2015.10.004; Dolnik O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004463; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Elliott Sarah F, 2012, World J Biol Chem, V3, P53, DOI 10.4331/wjbc.v3.i3.53; Fansa EK, 2013, BIOCHEM BIOPH RES CO, V434, P785, DOI 10.1016/j.bbrc.2013.04.012; Fiegen D, 2002, FEBS LETT, V525, P100, DOI 10.1016/S0014-5793(02)03094-6; Fukata M, 1999, J BIOL CHEM, V274, P26044, DOI 10.1074/jbc.274.37.26044; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Gotthardt K, 2007, BIOL CHEM, V388, P67, DOI 10.1515/BC.2007.008; Grohmanova K, 2004, J BIOL CHEM, V279, P48495, DOI 10.1074/jbc.M408113200; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Hemsath L, 2005, METHODS, V37, P173, DOI 10.1016/j.ymeth.2005.05.014; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Hota PK, 2012, CELL MOL LIFE SCI, V69, P3765, DOI 10.1007/s00018-012-1019-0; Izumi G, 2004, J CELL BIOL, V166, P237, DOI 10.1083/jcb.200401078; Jaiswal M, 2013, J BIOL CHEM, V288, P4486, DOI 10.1074/jbc.M112.429746; Jaiswal M, 2013, BIOL CHEM, V394, P89, DOI 10.1515/hsz-2012-0207; Jaiswal M, 2012, METHODS MOL BIOL, V827, P37, DOI 10.1007/978-1-61779-442-1_3; Jausoro I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056574; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Kimura T, 2013, MOL CELL BIOL, V33, P4834, DOI 10.1128/MCB.00895-13; Kurella VB, 2009, J BIOL CHEM, V284, P14857, DOI 10.1074/jbc.M808974200; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V262, P1, DOI 10.1006/bbrc.1999.1122; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Lam B Daniel, 2013, Small GTPases, V4, P78, DOI 10.4161/sgtp.23310; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Le Clainche C, 2007, J BIOL CHEM, V282, P426, DOI 10.1074/jbc.M607711200; LeCour L, 2016, STRUCTURE, V24, P1499, DOI 10.1016/j.str.2016.06.016; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li R, 1999, J BIOL CHEM, V274, P29648, DOI 10.1074/jbc.274.42.29648; Li ZG, 2005, J BIOL CHEM, V280, P13871, DOI 10.1074/jbc.M413482200; Liu J, 2014, J PROTEOME RES, V13, P1156, DOI 10.1021/pr400787p; Malarkannan S, 2012, J IMMUNOL, V188, P2057, DOI 10.4049/jimmunol.1102439; Mataraza JM, 2003, BIOCHEM BIOPH RES CO, V305, P315, DOI 10.1016/S0006-291X(03)00759-9; McCallum SJ, 1996, J BIOL CHEM, V271, P21732, DOI 10.1074/jbc.271.36.21732; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; Nomanbhoy T, 1999, BIOCHEMISTRY-US, V38, P15878, DOI 10.1021/bi9916832; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Nouri K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143634; Owen D, 2008, J BIOL CHEM, V283, P1692, DOI 10.1074/jbc.M707257200; Pathmanathan S, 2011, BIOCHEM SOC T, V39, P694, DOI 10.1042/BST0390694; Raines RT, 2015, METHODS MOL BIOL, V1278, P323, DOI 10.1007/978-1-4939-2425-7_19; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Ruiz-Velasco R, 2002, J BIOL CHEM, V277, P33081, DOI 10.1074/jbc.M202664200; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Suyama M, 1999, NUCLEIC ACIDS RES, V27, P338, DOI 10.1093/nar/27.1.338; Takeda S, 2011, BIOCHEM BIOPH RES CO, V410, P29, DOI 10.1016/j.bbrc.2011.05.099; Usatyuk PV, 2009, J BIOL CHEM, V284, P15339, DOI 10.1074/jbc.M109.005439; Vidal-Quadras M, 2011, TRAFFIC, V12, P1879, DOI 10.1111/j.1600-0854.2011.01274.x; Wang SJ, 2007, J CELL SCI, V120, P567, DOI 10.1242/jcs.03356; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Watanabe T, 2015, CELL STRUCT FUNCT, V40, DOI 10.1247/csf.15003; Watanabe T, 2009, J CELL SCI, V122, P2969, DOI 10.1242/jcs.046649; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Xu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042975; Zhang BL, 1997, J BIOL CHEM, V272, P21999, DOI 10.1074/jbc.272.35.21999; Zhang BL, 1998, J BIOL CHEM, V273, P8776, DOI 10.1074/jbc.273.15.8776; Zhang S, 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1155/2014/302702	76	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26364	26376		10.1074/jbc.M116.752121	http://dx.doi.org/10.1074/jbc.M116.752121			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27815503	Green Published, hybrid			2022-12-26	WOS:000391568200011
J	Liu, S; Li, SJ; Wang, BJ; Lin, X; Wu, Y; Liu, H; Qu, XM; Dai, JH; Zhou, XT; Zhou, H				Liu, Shuai; Li, Shengjie; Wang, Bingjie; Lin, Xiao; Wu, Yi; Liu, Hong; Qu, Xiaomei; Dai, Jinhui; Zhou, Xingtao; Zhou, Hao			Scleral Cross-Linking Using Riboflavin UVA Irradiation for the Prevention of Myopia Progression in a Guinea Pig Model: Blocked Axial Extension and Altered Scleral Microstructure	PLOS ONE			English	Article							COLLAGEN; REINFORCEMENT; ULTRAVIOLET; ELONGATION; MONKEYS	Purpose To develop methods of collagen cross-linking (CXL) in the sclera for the treatment of progressive myopia and to investigate the biomechanical and histological changes that occur in as a result. Methods Twenty 14-day-old guinea pigs were divided into 3 groups: the cross-linking group (CL, n = 8), non cross-linking group (NCL, n = 8), and control group (n = 4). The scleras of the right eyes of the guinea pigs in the CL group were surgically exposed and riboflavin was dropped onto the irradiation zone for 20 seconds prior to ultraviolet-A (UVA) irradiation. The same procedure was conducted on the NCL group but without UVA irradiation. No procedure was conducted on the control group. The right eyes of the guinea pigs in the CL and NCL groups were then fitted with -10.00DS optics for six weeks. Retinoscopy and the axial lengths (AXL) were measured at baseline, and at the second, fourth and sixth weeks post-treatment in all three groups. All animal subjects were euthanized after the sixth week and then biomechanical and histopathological examinations of the scleras were conducted. Results The mean AXL of the NCL group was longer than both the control and CL groups at six weeks (P = 0.001). The mean refractive error in the NCL group was statistically significantly more negative than both the control and the CL groups at six weeks (P = 0.001). The scleral collagen fiber arrangements of the CL and control groups were denser and more regularly distributed than the NCL group. Ultimate stress of the sclera was lowest in the NCL group, followed by the CL then the control group (P<0.05). Ultimate strain (%) of the sclera was lowest in the CL group followed by the NCL and then the control group (P<0.05). Conclusion Our study demonstrates that scleral CXL using riboflavin UVA irradiation effectively prevents the progression of myopia by increasing scleral biomechanical strength in a guinea pig model.	[Liu, Shuai; Li, Shengjie; Wang, Bingjie; Lin, Xiao; Liu, Hong; Qu, Xiaomei; Dai, Jinhui; Zhou, Xingtao; Zhou, Hao] Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Ophthalmol & Visual Sci, Shanghai, Peoples R China; [Liu, Shuai] First Peoples Hosp Hefei, Dept Prehosp Emergency, Hefei, Anhui, Peoples R China; [Wang, Bingjie; Lin, Xiao; Liu, Hong; Qu, Xiaomei; Dai, Jinhui; Zhou, Xingtao; Zhou, Hao] Fudan Univ, Minist Hlth, Key Lab Myopia, Shanghai, Peoples R China; [Wang, Bingjie; Lin, Xiao; Liu, Hong; Qu, Xiaomei; Dai, Jinhui; Zhou, Xingtao; Zhou, Hao] Fudan Univ, Shanghai Key Lab Visual Impairment & Restorat, Shanghai, Peoples R China; [Li, Shengjie] Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Clin Lab, Shanghai, Peoples R China; [Wu, Yi] Anhui Med Univ, Peoples Hosp Fuyang, Infect Dept, Hefei, Anhui, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Anhui Medical University	Zhou, H (corresponding author), Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Ophthalmol & Visual Sci, Shanghai, Peoples R China.; Zhou, H (corresponding author), Fudan Univ, Minist Hlth, Key Lab Myopia, Shanghai, Peoples R China.; Zhou, H (corresponding author), Fudan Univ, Shanghai Key Lab Visual Impairment & Restorat, Shanghai, Peoples R China.	zheent@163.com	zhou, xt/GWZ-9212-2022; Li, Shengjie/AAU-7902-2021	Wang, Bingjie/0000-0002-1199-6240; Lin, Xiao/0000-0002-5867-6455	Shanghai Science and Technology Committee [134119a5100]	Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This research project was supported by Shanghai Science and Technology Committee (134119a5100).; This research project was supported by the Shanghai Science and Technology Committee (134119a5100). The authors would like to acknowledge Dr Rajeev Naidu, BOptom (Hons), B. Sc. (UNSW), Sydney, Australia, for his help in editing and proofreading the final paper.	Avetisov ES, 1997, ACTA OPHTHALMOL SCAN, V75, P618; BALDWIN WR, 1981, AM J OPTOM PHYS OPT, V58, P516; Choi S, 2013, LASER MED SCI, V28, P1289, DOI 10.1007/s10103-012-1237-6; CURTIN BJ, 1979, ARCH OPHTHALMOL-CHIC, V97, P912, DOI 10.1001/archopht.1979.01020010470017; Dotan A, 2014, EXP EYE RES, V127, P190, DOI 10.1016/j.exer.2014.07.019; FUNATA M, 1990, GRAEF ARCH CLIN EXP, V228, P174, DOI 10.1007/BF02764314; Gilmartin B, 2004, CLIN EXP OPHTHALMOL, V32, P305, DOI 10.1111/j.1442-9071.2004.00831.x; Hovakimyan M, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/406850; Hung LF, 2000, INVEST OPHTH VIS SCI, V41, P1259; IUVONE PM, 1991, INVEST OPHTH VIS SCI, V32, P1674; Jacob JT, 1997, J BIOMED MATER RES, V37, P525, DOI 10.1002/(SICI)1097-4636(19971215)37:4<525::AID-JBM11>3.0.CO;2-7; LIU K-R, 1986, Taiwan yixuehui zazhi, V85, P1032; Lu F, 2009, EXP EYE RES, V89, P101, DOI 10.1016/j.exer.2009.02.019; MCBRIEN NA, 1994, EXP EYE RES, V59, P475, DOI 10.1006/exer.1994.1133; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; McFadden SA, 2004, VISION RES, V44, P643, DOI 10.1016/j.visres.2003.11.002; NORTON TT, 1995, INVEST OPHTH VIS SCI, V36, pS760; Pitts JD, 2002, PHOTOCHEM PHOTOBIOL, V76, P135, DOI 10.1562/0031-8655(2002)076<0135:NPFMET>2.0.CO;2; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Saw SM, 2002, BRIT J OPHTHALMOL, V86, P1306, DOI 10.1136/bjo.86.11.1306; SMITH EL, 1980, INVEST OPHTH VIS SCI, V19, P1250; Spoerl E, 2004, CURR EYE RES, V29, P35, DOI 10.1080/02713680490513182; Weiss AH, 2003, BRIT J OPHTHALMOL, V87, P1025, DOI 10.1136/bjo.87.8.1025; Wollensak G, 2005, ACTA OPHTHALMOL SCAN, V83, P477, DOI 10.1111/j.1600-0420.2005.00447.x; Wollensak G, 2004, J CATARACT REFR SURG, V30, P689, DOI 10.1016/j.jcrs.2003.11.032; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1	26	17	21	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165792	10.1371/journal.pone.0165792	http://dx.doi.org/10.1371/journal.pone.0165792			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829051	Green Published, gold, Green Submitted			2022-12-26	WOS:000387724300061
J	Lutz, AF; Immerzeel, WW; Kraaijenbrink, PDA; Shrestha, AB; Bierkens, MFP				Lutz, A. F.; Immerzeel, W. W.; Kraaijenbrink, P. D. A.; Shrestha, A. B.; Bierkens, M. F. P.			Climate Change Impacts on the Upper Indus Hydrology: Sources, Shifts and Extremes	PLOS ONE			English	Article							GLACIER MASS BALANCES; RISING RIVER FLOWS; BIAS CORRECTION; SNOW COVER; KARAKORAM-HIMALAYA; STATISTICAL CORRECTION; WATER-RESOURCES; PRECIPITATION; BASIN; MODEL	The Indus basin heavily depends on its upstream mountainous part for the downstream supply of water while downstream demands are high. Since downstream demands will likely continue to increase, accurate hydrological projections for the future supply are important. We use an ensemble of statistically downscaled CMIP5 General Circulation Model outputs for RCP4.5 and RCP8.5 to force a cryospheric-hydrological model and generate transient hydrological projections for the entire 21 st century for the upper Indus basin. Three methodological advances are introduced: (i) A new precipitation dataset that corrects for the underestimation of high-altitude precipitation is used. (ii) The model is calibrated using data on river runoff, snow cover and geodetic glacier mass balance. (iii) An advanced statistical downscaling technique is used that accounts for changes in precipitation extremes. The analysis of the results focuses on changes in sources of runoff, seasonality and hydrological extremes. We conclude that the future of the upper Indus basin's water availability is highly uncertain in the long run, mainly due to the large spread in the future precipitation projections. Despite large uncertainties in the future climate and long-term water availability, basin-wide patterns and trends of seasonal shifts in water availability are consistent across climate change scenarios. Most prominent is the attenuation of the annual hydrograph and shift from summer peak flow towards the other seasons for most ensemble members. In addition there are distinct spatial patterns in the response that relate to monsoon influence and the importance of meltwater. Analysis of future hydrological extremes reveals that increases in intensity and frequency of extreme discharges are very likely for most of the upper Indus basin and most ensemble members.	[Lutz, A. F.; Immerzeel, W. W.] FutureWater, Costerweg 1V, NL-6702 AA Wageningen, Netherlands; [Lutz, A. F.; Immerzeel, W. W.; Kraaijenbrink, P. D. A.; Bierkens, M. F. P.] Univ Utrecht, Dept Phys Geog, POB 80115, NL-3508 TC Utrecht, Netherlands; [Shrestha, A. B.] Int Ctr Integrated Mt Dev, GPO Box 3226, Khumaltar, Kathmandu, Nepal	Utrecht University	Lutz, AF (corresponding author), FutureWater, Costerweg 1V, NL-6702 AA Wageningen, Netherlands.; Lutz, AF (corresponding author), Univ Utrecht, Dept Phys Geog, POB 80115, NL-3508 TC Utrecht, Netherlands.	a.lutz@futurewater.nl	Bierkens, Marc F.P./AAE-8176-2019	Lutz, Arthur/0000-0002-6327-1487; Immerzeel, Walter/0000-0002-2010-9543; Kraaijenbrink, Philip/0000-0002-0126-8602; Bierkens, Marc F.P./0000-0002-7411-6562	United Kingdom's Department for International Development (DFID); e International Development Research Centre (IDRC), Ottawa, Canada; European Research Council (ERC) [676819]; ICIMOD; AFL; WWI; ABS; WWI [676819]	United Kingdom's Department for International Development (DFID); e International Development Research Centre (IDRC), Ottawa, Canada; European Research Council (ERC)(European Research Council (ERC)); ICIMOD; AFL; WWI; ABS; WWI	This study was undertaken under the Indus Basin Programme of ICI MOD, funded in part by the United Kingdom's Department for International Development (DFID), through their financial support of core research at ICIMOD. This work is partly carried out by the Himalayan Adaptation, Water and Resilience (HI-AWARE) consortium under the Collaborative Adaptation Research Initiative in Africa and Asia (CARIAA) with financial support from the United Kingdom's Department for International Development (DFID) and the International Development Research Centre (IDRC), Ottawa, Canada. This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement 676819). In addition, this work was partially supported by core funds of ICIMOD contributed by the governments of Afghanistan, Australia, Austria, Bangladesh, Bhutan, China, India, Myanmar, Nepal, Norway, Pakistan, Switzerland, and the United Kingdom. DFID partly funds ICIMOD's Indus Basin Programme, under which this study was undertaken. These funds partly supported the contributions of AFL, WWI and ABS. DFID and IDRC funds the HI-AWARE consortium, of which ICIMOD and FutureWater are consortium members. These funds partly supported the contributions of AFL, WWI and ABS. ERC partly funded the contribution of WWI through grant agreement 676819. ICIMOD core funds partly funded the contribution of ABS. AFL and WWI are employed by FutureWater. Future Water provided support in the form of salaries for authors AFL and WWI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ali S, 2015, ENVIRON RES LETT, P10, DOI [10.1086/1748-9326/10/014007, DOI 10.1086/1748-9326/10/014007]; Archer DR, 2004, HYDROL EARTH SYST SC, V8, P47, DOI 10.5194/hess-8-47-2004; Arnell NW, 1999, GLOBAL ENVIRON CHANG, V9, pS31, DOI 10.1016/S0959-3780(99)00017-5; Arora VK, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046270; Bahr DB, 1997, J GEOPHYS RES-SOL EA, V102, P20355, DOI 10.1029/97JB01696; Bajracharya S.R., 2011, STATUS GLACIERS HIND; Barros AP, 2004, NAT HAZARD EARTH SYS, V4, P29, DOI 10.5194/nhess-4-29-2004; Barros V, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, pIX; Bernhardt M, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043086; Berthier E, 2007, REMOTE SENS ENVIRON, V108, P327, DOI 10.1016/j.rse.2006.11.017; Beven K, 2006, J HYDROL, V320, P18, DOI 10.1016/j.jhydrol.2005.07.007; Biemans H, 2013, SCI TOTAL ENVIRON, V468, pS117, DOI 10.1016/j.scitotenv.2013.05.092; Biemans H, 2009, J HYDROMETEOROL, V10, P1011, DOI 10.1175/2008JHM1067.1; Bliss A, 2014, J GEOPHYS RES-EARTH, V119, P717, DOI 10.1002/2013JF002931; Bocchiola D, 2011, HYDROL EARTH SYST SC, V15, P2059, DOI 10.5194/hess-15-2059-2011; Bocchiola D, 2013, THEOR APPL CLIMATOL, V113, P611, DOI 10.1007/s00704-012-0803-y; Bookhagen B, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001426; Bordoy R, 2013, J APPL METEOROL CLIM, V52, P82, DOI 10.1175/JAMC-D-11-0149.1; Cannon AJ, 2015, J CLIMATE, V28, P1260, DOI 10.1175/JCLI-D-14-00636.1; Cannon F, 2016, THEOR APPL CLIMATOL, V125, P27, DOI 10.1007/s00704-015-1489-8; Cannon F, 2015, CLIM DYNAM, V44, P441, DOI 10.1007/s00382-014-2248-8; Cheema MJM, 2014, GROUNDWATER, V52, P25, DOI 10.1111/gwat.12027; Cheema MJM, 2012, INT J REMOTE SENS, V33, P2603, DOI 10.1080/01431161.2011.617397; Dahri ZH, 2016, SCI TOTAL ENVIRON, V548, P289, DOI 10.1016/j.scitotenv.2016.01.001; De Souza K, 2015, REG ENVIRON CHANGE, V15, P747, DOI 10.1007/s10113-015-0755-8; Defourny P., 2007, P ISPRS COMM 7 MIDT, P8; Deque M, 2007, GLOBAL PLANET CHANGE, V57, P16, DOI 10.1016/j.gloplacha.2006.11.030; Doherty J., 2005, PEST MODEL INDEPENDE, V5th; Ehret U, 2012, HYDROL EARTH SYST SC, V16, P3391, DOI 10.5194/hess-16-3391-2012; FAO/IIASA/ISRIC/ISS-CAS/JRC, 2012, HARM WORLD SOIL DAT; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Forsythe N, 2014, J HYDROL, V517, P1019, DOI 10.1016/j.jhydrol.2014.06.031; Fowler HJ, 2006, J CLIMATE, V19, P4276, DOI 10.1175/JCLI3860.1; Frey H, 2014, CRYOSPHERE, V8, P2313, DOI 10.5194/tc-8-2313-2014; Gardelle J, 2013, CRYOSPHERE, V7, P1263, DOI 10.5194/tc-7-1263-2013; Gardner AS, 2013, SCIENCE, V340, P852, DOI 10.1126/science.1234532; Gleeson T, 2012, NATURE, V488, P197, DOI 10.1038/nature11295; Gobiet A, 2015, HYDROL EARTH SYST SC, V19, P4055, DOI 10.5194/hess-19-4055-2015; Gumbel EJ, 1941, ANN MATH STAT, V12, P163, DOI 10.1214/aoms/1177731747; Hall DK, 2002, REMOTE SENS ENVIRON, V83, P181, DOI 10.1016/S0034-4257(02)00095-0; Hasson S, 2014, HYDROL EARTH SYST SC, V18, P4077, DOI 10.5194/hess-18-4077-2014; Hempel S, 2013, EARTH SYST DYNAM, V4, P219, DOI 10.5194/esd-4-219-2013; Hewitt K, 2007, J GLACIOL, V53, P181, DOI 10.3189/172756507782202829; Hewitt K, 2011, MT RES DEV, V31, P188, DOI 10.1659/MRD-JOURNAL-D-11-00020.1; Hock R, 2003, J HYDROL, V282, P104, DOI 10.1016/S0022-1694(03)00257-9; Houze RA, 2011, B AM METEOROL SOC, V92, P291, DOI 10.1175/2010BAMS3173.1; Huss M, 2013, CRYOSPHERE, V7, P877, DOI 10.5194/tc-7-877-2013; Immerzeel WW, 2015, HYDROL EARTH SYST SC, V19, P4673, DOI 10.5194/hess-19-4673-2015; Immerzeel WW, 2013, NAT GEOSCI, V6, P742, DOI [10.1038/NGEO1896, 10.1038/ngeo1896]; Immerzeel WW, 2012, NAT GEOSCI, V5, P841, DOI 10.1038/ngeo1643; Immerzeel WW, 2009, REMOTE SENS ENVIRON, V113, P40, DOI 10.1016/j.rse.2008.08.010; Immerzeel WW, 2012, MT RES DEV, V32, P30, DOI 10.1659/MRD-JOURNAL-D-11-00097.1; Jain SK, 2007, INDUS BASIN HYDROLOG; Joseph, 2016, CRYOSPH DISCUSS, P1, DOI [10.5194/tc-2016-197, DOI 10.5194/TC-2016-197]; Kaab A, 2015, CRYOSPHERE, V9, P557, DOI 10.5194/tc-9-557-2015; Kaab A, 2012, NATURE, V488, P495, DOI 10.1038/nature11324; Kapnick SB, 2014, NAT GEOSCI, V7, P834, DOI 10.1038/NGEO2269; Kay AL, 2009, CLIMATIC CHANGE, V92, P41, DOI 10.1007/s10584-008-9471-4; Keshavarzi A., 2010, ProEnvironment / ProMediu, V3, P322; Khan F, 2015, INT J GLOBAL WARM, V8, P46, DOI 10.1504/IJGW.2015.071583; Knutti R, 2013, NAT CLIM CHANGE, V3, P369, DOI [10.1038/nclimate1716, 10.1038/NCLIMATE1716]; Koppes M, 2015, FRONT EARTH SC-SWITZ, V3, DOI 10.3389/feart.2015.00059; Kraaijenbrink P., 2013, ADV DELTA CHANGE MET; Leander R, 2007, J HYDROL, V332, P487, DOI 10.1016/j.jhydrol.2006.08.006; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; Lenaerts JTM, 2010, CRYOSPHERE, V4, P179, DOI 10.5194/tc-4-179-2010; Lutz AF, 2014, NAT CLIM CHANGE, V4, P587, DOI [10.1038/NCLIMATE2237, 10.1038/nclimate2237]; Lutz AF, 2013, HYDROL EARTH SYST SC, V17, P3661, DOI 10.5194/hess-17-3661-2013; Lutz AF, 2016, INT J CLIMA IN PRESS; MacDonald MK, 2010, HYDROL EARTH SYST SC, V14, P1401, DOI 10.5194/hess-14-1401-2010; Mathison C, 2015, HYDROL EARTH SYST SC, V19, P4783, DOI 10.5194/hess-19-4783-2015; Maurer EP, 2014, HYDROL EARTH SYST SC, V18, P915, DOI 10.5194/hess-18-915-2014; Maussion F, 2014, J CLIMATE, V27, P1910, DOI 10.1175/JCLI-D-13-00282.1; Mir RA, 2015, INT J REMOTE SENS, V36, P3837, DOI 10.1080/01431161.2015.1070320; Mirza UK, 2008, RENEW SUST ENERG REV, V12, P1641, DOI 10.1016/j.rser.2007.01.028; Mishra V, 2015, J GEOPHYS RES-ATMOS, V120, P2689, DOI 10.1002/2014JD022650; Molg T, 2014, NAT CLIM CHANGE, V4, P68, DOI [10.1038/nclimate2055, 10.1038/NCLIMATE2055]; Mukhopadhyay B, 2015, INT J RIVER BASIN MA, V13, P87, DOI 10.1080/15715124.2014.965718; Mukhopadhyay B, 2015, J HYDROL, V527, P119, DOI 10.1016/j.jhydrol.2015.04.045; Mukhopadhyay B, 2014, J HYDROL, V513, P192, DOI 10.1016/j.jhydrol.2014.03.042; Mukhopadhyay B, 2014, J HYDROL, V509, P549, DOI 10.1016/j.jhydrol.2013.11.059; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Nepal S, 2015, INT J WATER RESOUR D, V31, P201, DOI 10.1080/07900627.2015.1030494; Nuimura T, 2015, CRYOSPHERE, V9, P849, DOI 10.5194/tc-9-849-2015; Palazzi E, 2013, J GEOPHYS RES-ATMOS, V118, P85, DOI 10.1029/2012JD018697; Palazzi E, 2015, CLIM DYNAM, V45, P21, DOI 10.1007/s00382-014-2341-z; Parajka J, 2013, HYDROL EARTH SYST SC, V17, P1783, DOI 10.5194/hess-17-1783-2013; Paul F, 2004, REMOTE SENS ENVIRON, V89, P510, DOI 10.1016/j.rse.2003.11.007; Pellicciotti F, 2012, MT RES DEV, V32, P39, DOI 10.1659/MRD-JOURNAL-D-11-00092.1; Pepin N, 2015, NAT CLIM CHANGE, V5, P424, DOI [10.1038/nclimate2563, 10.1038/NCLIMATE2563]; Pfeffer WT, 2014, J GLACIOL, V60, P537, DOI 10.3189/2014JoG13J176; Quincey DJ, 2009, J GLACIOL, V55, P1061, DOI 10.3189/002214309790794913; Quincey DJ, 2015, J GEOPHYS RES-EARTH, V120, P1288, DOI 10.1002/2015JF003515; Qureshi AS, 2011, MT RES DEV, V31, P252, DOI 10.1659/MRD-JOURNAL-D-11-00019.1; Radic V, 2014, CLIM DYNAM, V42, P37, DOI 10.1007/s00382-013-1719-7; Ragettli S, 2013, WATER RESOUR RES, V49, P6048, DOI 10.1002/wrcr.20450; Rajbhandari R, 2015, CLIM DYNAM, V44, P339, DOI 10.1007/s00382-014-2183-8; Ramesh KV, 2014, SCI REP-UK, V4, DOI 10.1038/srep04071; Rangwala I, 2012, CLIMATIC CHANGE, V114, P527, DOI 10.1007/s10584-012-0419-3; Reggiani P, 2015, HYDROL RES, V46, P446, DOI 10.2166/nh.2014.060; Richey AS, 2015, WATER RESOUR RES, V51, P5217, DOI 10.1002/2015WR017349; Rozenberg J, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/9/095006; Scherler D, 2011, NAT GEOSCI, V4, P156, DOI [10.1038/ngeo1068, 10.1038/NGEO1068]; Sharif M, 2013, HYDROL EARTH SYST SC, V17, P1503, DOI 10.5194/hess-17-1503-2013; Siddiqi A, 2012, ENERG POLICY, V50, P228, DOI 10.1016/j.enpol.2012.06.063; Soncini A, 2015, J HYDROMETEOROL, V16, P306, DOI 10.1175/JHM-D-14-0043.1; Sorg A, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/104018; Sperber K, 2013, CLIM DYNAM, V41, P2711, DOI 10.1007/s00382-012-1607-6; Sperber KR, 2014, CLIM DYNAM, V43, P3219, DOI 10.1007/s00382-014-2099-3; Strasser U, 2008, CRYOSPHERE, V2, P53, DOI 10.5194/tc-2-53-2008; Tachikawa T, 2011, INT GEOSCI REMOTE SE, P3657, DOI 10.1109/IGARSS.2011.6050017; Tahir AA, 2011, HYDROL EARTH SYST SC, V15, P2275, DOI 10.5194/hess-15-2275-2011; Tahir AA, 2015, SCI TOTAL ENVIRON, V505, P748, DOI 10.1016/j.scitotenv.2014.10.065; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Terink W, 2015, GEOSCI MODEL DEV, V8, P2009, DOI 10.5194/gmd-8-2009-2015; Themessl MJ, 2011, INT J CLIMATOL, V31, P1530, DOI 10.1002/joc.2168; Turner AG, 2012, NAT CLIM CHANGE, V2, P587, DOI 10.1038/NCLIMATE1495; United Nations, 2015, ESAPWP241 UN; van Pelt SC, 2012, HYDROL EARTH SYST SC, V16, P4517, DOI 10.5194/hess-16-4517-2012; Viste E, 2015, CRYOSPHERE, V9, P1147, DOI 10.5194/tc-9-1147-2015; Wagnon P, 2013, CRYOSPHERE, V7, P1769, DOI 10.5194/tc-7-1769-2013; Wanders N, 2015, J HYDROL, V526, P208, DOI 10.1016/j.jhydrol.2014.10.047; Wilcke RAI, 2016, ENVIRON MODELL SOFTW, V78, P191, DOI 10.1016/j.envsoft.2016.01.002; Yatagai A, 2012, B AM METEOROL SOC, V93, P1401, DOI 10.1175/BAMS-D-11-00122.1; Zhang Y, 2006, ANN GLACIOL-SER, V43, P301, DOI 10.3189/172756406781811952; Zhao LY, 2014, GLOBAL PLANET CHANGE, V122, P197, DOI 10.1016/j.gloplacha.2014.08.006	126	170	172	11	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165630	10.1371/journal.pone.0165630	http://dx.doi.org/10.1371/journal.pone.0165630			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828994	Green Published, gold			2022-12-26	WOS:000387724300052
J	Mansfeldt, CB; Heavner, GW; Rowe, AR; Hayete, B; Church, BW; Richardson, RE				Mansfeldt, Cresten B.; Heavner, Gretchen W.; Rowe, Annette R.; Hayete, Boris; Church, Bruce W.; Richardson, Ruth E.			Inferring Gene Networks for Strains of Dehalococcoides Highlights Conserved Relationships between Genes Encoding Core Catabolic and Cell-Wall Structural Proteins	PLOS ONE			English	Article							TRANSCRIPTOMIC MICROARRAY ANALYSIS; ORGANOHALIDE-RESPIRING BACTERIA; REDUCTIVE-DEHALOGENASE; VINYL-CHLORIDE; ENRICHMENT CULTURES; FIELD DEMONSTRATION; RESPIRATION RATES; MCCARTYI STRAIN; MESSENGER-RNA; ETHENOGENES	The interpretation of high-throughput gene expression data for non-model microorganisms remains obscured because of the high fraction of hypothetical genes and the limited number of methods for the robust inference of gene networks. Therefore, to elucidate gene gene and gene-condition linkages in the bioremediation-important genus Dehalococcoides, we applied a Bayesian inference strategy called Reverse Engineering/Forward Simulation (REFS (TM)) on transcriptomic data collected from two organohalide-respiring communities containing different Dehalococcoides mccartyi strains: the Cornell University mixed community D2 and the commercially available KB-1 (R) bioaugmentation culture. In total, 49 and 24 microarray datasets were included in the REFS (TM) analysis to generate an ensemble of 1,000 networks for the Dehalococcoides population in the Cornell D2 and KB-1 (R) culture, respectively. Considering only linkages that appeared in the consensus network for each culture (exceeding the determined frequency cutoff of >= 60%), the resulting Cornell D2 and KB-1 (R) consensus networks maintained 1,105 nodes (genes or conditions) with 974 edges and 1,714 nodes with 1,455 edges, respectively. These consensus networks captured multiple strong and biologically informative relationships. One of the main highlighted relationships shared between these two cultures was a direct edge between the transcript encoding for the major reductive dehalogenase (tceA (D2) or vcrA (KB-1 (R))) and the transcript for the putative S-layer cell wall protein (DET1407 (D2) or KB1_1396 (KB-1 (R))). Additionally, transcripts for two key oxidoreductases (a [Ni Fe] hydrogenase, Hup, and a protein with similarity to a formate dehydrogenase, "Fdh") were strongly linked, generalizing a strong relationship noted previously for Dehalococcoides mccartyi strain 195 to multiple strains of Dehalococcoides. Notably, the pangenome array utilized when monitoring the KB-1 (R) culture was capable of resolving signals from multiple strains, and the network inference engine was able to reconstruct gene networks in the distinct strain populations.	[Mansfeldt, Cresten B.; Heavner, Gretchen W.; Richardson, Ruth E.] Cornell Univ, Dept Civil & Environm Engn, Ithaca, NY 14853 USA; [Rowe, Annette R.] Cornell Univ, Field Microbiol, Ithaca, NY USA; [Hayete, Boris; Church, Bruce W.] GNS Healthcare, Cambridge, MA USA	Cornell University; Cornell University	Mansfeldt, CB (corresponding author), Cornell Univ, Dept Civil & Environm Engn, Ithaca, NY 14853 USA.	cbm59@cornell.edu	Richardson, Ruth E/B-8265-2017; Hayete, Boris/ABD-4515-2020	Hayete, Boris/0000-0002-2521-1889; Mansfeldt, Cresten/0000-0002-5656-6463; Rowe, Annette/0000-0002-8761-6857	Department of Defense Army Research Office [W911NF-07-1-0249]; National Science Foundation Chemical, Bioengineering, Environmental, and Transport Systems (CBET) Program [CBET-0731169]; GNS Healthcare	Department of Defense Army Research Office(United States Department of Defense); National Science Foundation Chemical, Bioengineering, Environmental, and Transport Systems (CBET) Program; GNS Healthcare	Funding was provided to RER for this study by the Department of Defense Army Research Office (http://www.aro.army.mil/; W911NF-07-1-0249) and the National Science Foundation Chemical, Bioengineering, Environmental, and Transport Systems (CBET) Program (http://www.nsf.gov/div/index.jsp?div=CBET; CBET-0731169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GNS Healthcare provided support in the form of salaries for authors [BH, BWC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	DISTEFANO TD, 1991, APPL ENVIRON MICROB, V57, P2287, DOI 10.1128/AEM.57.8.2287-2292.1991; Duhamel M, 2002, WATER RES, V36, P4193, DOI 10.1016/S0043-1354(02)00151-3; Duhamel M, 2004, APPL ENVIRON MICROB, V70, P5538, DOI 10.1128/AEM.70.9.5538-5545.2004; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Heavner G., 2013, BIOKINETIC MODELING; Heavner GLW, 2013, ENVIRON SCI TECHNOL, V47, P3724, DOI 10.1021/es303517s; Hug LA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-327; Hug LA, 2011, APPL ENVIRON MICROB, V77, P5361, DOI 10.1128/AEM.00063-11; Islam MA, 2016, MICROB BIOTECHNOL, V9, P47, DOI 10.1111/1751-7915.12315; Islam MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083783; Johnson DR, 2008, APPL ENVIRON MICROB, V74, P2864, DOI 10.1128/AEM.02208-07; Johnson DR, 2009, FEMS MICROBIOL LETT, V294, P198, DOI 10.1111/j.1574-6968.2009.01569.x; Kublik A, 2016, ENVIRON MICROBIOL, V18, P3044, DOI 10.1111/1462-2920.13200; Lee PKH, 2012, APPL ENVIRON MICROB, V78, P1424, DOI 10.1128/AEM.06792-11; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Loffler FE, 2013, INT J SYST EVOL MICR, V63, P625, DOI 10.1099/ijs.0.034926-0; Magnuson JK, 2000, APPL ENVIRON MICROB, V66, P5141, DOI 10.1128/AEM.66.12.5141-5147.2000; Major DW, 2002, ENVIRON SCI TECHNOL, V36, P5106, DOI 10.1021/es0255711; Mansfeldt CB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118404; Mansfeldt CB, 2014, APPL ENVIRON MICROB, V80, P6062, DOI 10.1128/AEM.02130-14; Maphosa F, 2010, TRENDS BIOTECHNOL, V28, P308, DOI 10.1016/j.tibtech.2010.03.005; Marco-Urrea E, 2011, J BACTERIOL, V193, P5171, DOI 10.1128/JB.05120-11; Marshall IPG, 2014, FEMS MICROBIOL ECOL, V87, P428, DOI 10.1111/1574-6941.12235; McMurdie PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000714; Morris RM, 2007, APPL ENVIRON MICROB, V73, P320, DOI 10.1128/AEM.02129-06; Neumann A, 1998, J BACTERIOL, V180, P4140, DOI 10.1128/JB.180.16.4140-4145.1998; Parthasarathy A, 2015, J AM CHEM SOC, V137, P3525, DOI 10.1021/ja511653d; Rahm BG, 2008, ENVIRON SCI TECHNOL, V42, P5099, DOI 10.1021/es702912t; Rahm BG, 2008, ENVIRON SCI TECHNOL, V42, P416, DOI 10.1021/es071455s; Rahm BG, 2006, APPL ENVIRON MICROB, V72, P5486, DOI 10.1128/AEM.00855-06; Rowe AR, 2015, APPL MICROBIOL BIOT, V99, P2313, DOI 10.1007/s00253-014-6220-7; Rowe AR, 2012, ENVIRON SCI TECHNOL, V46, P9388, DOI 10.1021/es300996c; Scheutz C, 2008, ENVIRON SCI TECHNOL, V42, P9302, DOI 10.1021/es800764t; Seshadri R, 2005, SCIENCE, V307, P105, DOI 10.1126/science.1102226; Tang SQ, 2013, APPL ENVIRON MICROB, V79, P974, DOI 10.1128/AEM.01873-12; Tang YJJ, 2009, J BACTERIOL, V191, P5224, DOI 10.1128/JB.00085-09; Wagner A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0317; Waller AS, 2012, APPL ENVIRON MICROB, V78, P1178, DOI 10.1128/AEM.06416-11; Waller AS, 2005, APPL ENVIRON MICROB, V71, P8257, DOI 10.1128/AEM.71.12.8257-8264.2005; Werner JJ, 2009, ENVIRON MICROBIOL, V11, P2687, DOI 10.1111/j.1462-2920.2009.01996.x; Xiang Y, 2014, GENE REGUL SYST BIO, V8, P45, DOI 10.4137/GRSB.S13140; Xing H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001105	42	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166234	10.1371/journal.pone.0166234	http://dx.doi.org/10.1371/journal.pone.0166234			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829029	gold, Green Published, Green Submitted			2022-12-26	WOS:000387724300098
J	Stevenson, NJ; Boylan, GB; Hellstrom-Westas, L; Vanhatalo, S				Stevenson, Nathan J.; Boylan, Geraldine B.; Hellstrom-Westas, Lena; Vanhatalo, Sampsa			Treatment Trials for Neonatal Seizures: The Effect of Design on Sample Size	PLOS ONE			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; ELECTROGRAPHIC SEIZURES; HYPOTHERMIA; BURDEN; EEG; PHENOBARBITONE; LIDOCAINE; EFFICACY	Neonatal seizures are common in the neonatal intensive care unit. Clinicians treat these seizures with several anti-epileptic drugs (AEDs) to reduce seizures in a neonate. Current AEDs exhibit sub-optimal efficacy and several randomized control trials (RCT) of novel AEDs are planned. The aim of this study was to measure the influence of trial design on the required sample size of a RCT. We used seizure time courses from 41 term neonates with hypoxic ischaemic encephalopathy to build seizure treatment trial simulations. We used five outcome measures, three AED protocols, eight treatment delays from seizure onset (T-d) and four levels of trial AED efficacy to simulate different RCTs. We performed power calculations for each RCT design and analysed the resultant sample size. We also assessed the rate of false positives, or placebo effect, in typical uncontrolled studies. We found that the false positive rate ranged from 5 to 85% of patients depending on RCT design. For controlled trials, the choice of outcome measure had the largest effect on sample size with median differences of 30.7 fold (IQR: 13.7-40.0) across a range of AED protocols, Td and trial AED efficacy (p<0.001). RCTs that compared the trial AED with positive controls required sample sizes with a median fold increase of 3.2 ( IQR: 1.9-11.9; p<0.001). Delays in AED administration from seizure onset also increased the required sample size 2.1 fold (IQR: 1.7-2.9; p<0.001). Subgroup analysis showed that RCTs in neonates treated with hypothermia required a median fold increase in sample size of 2.6 (IQR: 2.4-3.0) compared to trials in normothermic neonates (p<0.001). These results show that RCT design has a profound influence on the required sample size. Trials that use a control group, appropriate outcome measure, and control for differences in Td between groups in analysis will be valid and minimise sample size.	[Stevenson, Nathan J.; Boylan, Geraldine B.] Univ Coll Cork, Irish Ctr Fetal & Neonatal Translat Res, Cork, Ireland; [Stevenson, Nathan J.; Boylan, Geraldine B.] Univ Coll Cork, Dept Paediat & Child Hlth, Cork, Ireland; [Hellstrom-Westas, Lena] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Vanhatalo, Sampsa] Univ Helsinki, Cent Hosp, Dept Clin Neurophysiol, HUS Med Imaging Ctr, Helsinki, Finland; [Stevenson, Nathan J.; Vanhatalo, Sampsa] Univ Helsinki, Dept Neurol Sci, Clinicum, Helsinki, Finland	University College Cork; University College Cork; Uppsala University; Hyvinkaan Sairaala; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Stevenson, NJ (corresponding author), Univ Coll Cork, Irish Ctr Fetal & Neonatal Translat Res, Cork, Ireland.; Stevenson, NJ (corresponding author), Univ Coll Cork, Dept Paediat & Child Hlth, Cork, Ireland.; Stevenson, NJ (corresponding author), Univ Helsinki, Dept Neurol Sci, Clinicum, Helsinki, Finland.	nathan.stevenson@helsinki.fi		Boylan, Geraldine/0000-0003-0920-5291; Hellstrom-Westas, Lena/0000-0003-3498-6069	EU Marie Sktodowska Curie Individual Fellowship [H2020-MCSA-IF-656131]; Science Foundation Ireland [12/RC/2272]; Academy of Finland [276523, 288220]; Sigrid Juselius Foundation; European Union [FP7-HEALTH-2009-4.2-1, 241479]; Health Research Board [RP/2008/238]; Wellcome Trust [085249]	EU Marie Sktodowska Curie Individual Fellowship; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); European Union(European Commission); Health Research Board; Wellcome Trust(Wellcome TrustEuropean Commission)	NJS was supported by an EU Marie Sktodowska Curie Individual Fellowship (H2020-MCSA-IF-656131), GBB was supported by Science Foundation Ireland (12/RC/2272). SV was supported by Academy of Finland (#276523 and #288220), Sigrid Juselius Foundation, and the European Union (FP7-HEALTH-2009-4.2-1, grant agreement 241479). The data used in this study was supported by Principal Investigator Awards to GBB from the Health Research Board (RP/2008/238) and the Wellcome Trust (085249). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; NJS was supported by an EU Marie Sklodowska Curie Individual Fellowship (H2020-MCSA-IF-656131), GBB was supported by Science Foundation Ireland (12/RC/2272). SV was supported by Academy of Finland (#276523 and #288220), Sigrid Juselius Foundation, and the European Union (FP7-HEALTH-2009-4.2-1, grant agreement 241479). The data used in this study was supported by Principal Investigator Awards to GBB from the Health Research Board (RP/2008/238) and the Wellcome Trust (085249). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abend NS, 2011, J CHILD NEUROL, V26, P465, DOI 10.1177/0883073810384263; Bjorkman ST, 2010, NEUROSCIENCE, V166, P157, DOI 10.1016/j.neuroscience.2009.11.067; Boylan GB, 2002, ARCH DIS CHILD-FETAL, V86, P165; Boylan GB, 2013, SEMIN FETAL NEONAT M, V18, P202, DOI 10.1016/j.siny.2013.04.004; Clancy RR, 2006, PEDIATRICS, V117, pS23, DOI 10.1542/peds.2005-0620D; Cock HR, 2011, EPILEPSIA, V52, P50, DOI 10.1111/j.1528-1167.2011.03237.x; Desu MM, 1990, SAMPLE SIZE METHODOL, P30; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Glass HC, 2014, CLIN PERINATOL, V41, P177, DOI 10.1016/j.clp.2013.10.004; Goldenholz DM, 2015, ANN NEUROL, V78, P329, DOI 10.1002/ana.24470; HELLSTROMWESTAS L, 1988, ACTA PAEDIATR SCAND, V77, P79, DOI 10.1111/j.1651-2227.1988.tb10602.x; Low E, 2016, NEONATOLOGY, V110, P40, DOI 10.1159/000443782; Low E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100973; Low E, 2012, ARCH DIS CHILD-FETAL, V97, pF267, DOI 10.1136/archdischild-2011-300716; Lynch NE, 2015, SEIZURE-EUR J EPILEP, V33, P60, DOI 10.1016/j.seizure.2015.10.007; Lynch NE, 2012, EPILEPSIA, V53, P549, DOI 10.1111/j.1528-1167.2011.03401.x; Murray DM, 2008, ARCH DIS CHILD-FETAL, V93, pF187, DOI 10.1136/adc.2005.086314; Painter MJ, 1999, NEW ENGL J MED, V341, P485, DOI 10.1056/NEJM199908123410704; Pressler RM, 2015, LANCET NEUROL, V14, P469, DOI 10.1016/S1474-4422(14)70303-5; Sanchez SM, 2013, EPILEPSIA, V54, P1419, DOI 10.1111/epi.12261; Srinivasakumar P, 2015, PEDIATRICS, V136, pE1302, DOI 10.1542/peds.2014-3777; Stevenson NJ, 2015, ANN CLIN TRANSL NEUR, V2, P1002, DOI 10.1002/acn3.249; van den Broek MPH, 2013, ARCH DIS CHILD-FETAL, V98, pF341, DOI 10.1136/archdischild-2012-302678; van Rooij LGM, 2010, PEDIATRICS, V125, pE358, DOI 10.1542/peds.2009-0136; VanDevanter DR, 2011, J CYST FIBROS, V10, P453, DOI 10.1016/j.jcf.2011.07.003; Vasudevan C, 2013, SEMIN FETAL NEONAT M, V18, P185, DOI 10.1016/j.siny.2013.05.008; Wusthoff CJ, 2011, J CHILD NEUROL, V26, P724, DOI 10.1177/0883073810390036	27	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165693	10.1371/journal.pone.0165693	http://dx.doi.org/10.1371/journal.pone.0165693			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824913	Green Submitted, Green Published, gold			2022-12-26	WOS:000387615200028
J	Gomes, E; Capinha, C; Rocha, J; Sousa, C				Gomes, Eduardo; Capinha, Cesar; Rocha, Jorge; Sousa, Carla			Mapping Risk of Malaria Transmission in Mainland Portugal Using a Mathematical Modelling Approach	PLOS ONE			English	Article							PRESENCE-ONLY DATA; ENVIRONMENTAL SUITABILITY; HABITAT SUITABILITY; ANOPHELES-GAMBIAE; AREAS	Malaria is currently one of the world's major health problems. About a half-million deaths are recorded every year. In Portugal, malaria cases were significantly high until the end of the 1950s but the disease was considered eliminated in 1973. In the past few years, endemic malaria cases have been recorded in some European countries. With the increasing human mobility from countries with endemic malaria to Portugal, there is concern about the resurgence of this disease in the country. Here, we model and map the risk of malaria transmission for mainland Portugal, considering 3 different scenarios of existing imported infections. This risk assessment resulted from entomological studies on An. atroparvus, the only known mosquito capable of transmitting malaria in the study area. We used the malariogenic potential (determined by receptivity, infectivity and vulnerability) applied over geospatial data sets to estimate spatial variation in malaria risk. The results suggest that the risk exists, and the hotspots are concentrated in the northeast region of the country and in the upper and lower Alentejo regions.	[Gomes, Eduardo; Rocha, Jorge] Univ Lisbon, Inst Geog & Ordenamento Terr, Ctr Estudos Geog, Lisbon, Portugal; [Capinha, Cesar] Univ Porto, CIBIO InBIO, Ctr Invest Biodiversidade & Recursos Genet, Catedra Infraestruturas Portugal Biodiversidade, Oporto, Portugal; [Capinha, Cesar] Zool Forsch Museum Alexander Koenig, Bonn, Germany; [Sousa, Carla] Univ Nova Lisboa, Global Hlth & Trop Med, GHTM, Inst Higiene & Med Trop, Lisbon, Portugal	Universidade de Lisboa; Universidade do Porto; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	Gomes, E (corresponding author), Univ Lisbon, Inst Geog & Ordenamento Terr, Ctr Estudos Geog, Lisbon, Portugal.	eduardojonas@campus.ul.pt	Capinha, César D/K-6439-2017; Gomes, Eduardo/V-6159-2017; Sousa, Carla/G-6531-2012; Rocha, Jorge/F-3185-2017	Capinha, César D/0000-0002-0666-9755; Gomes, Eduardo/0000-0001-8703-1763; Sousa, Carla/0000-0002-2386-7577; Rocha, Jorge/0000-0002-7228-6330	EU grant [GOCE-2003-010284 EDEN]; Arbovirus dos mosquitos de Portugal [POCTI/35775/ESP/2000, GHTM UID/Multi/04413/2013]; Fundação para a Ciência e a Tecnologia [UID/Multi/04413/2013] Funding Source: FCT	EU grant(European Commission); Arbovirus dos mosquitos de Portugal; Fundação para a Ciência e a Tecnologia	This publication was partially funded by: (i) EU grant GOCE-2003-010284 EDEN (www.edenfp6project.net), (ii) Arbovirus dos mosquitos de Portugal (POCTI/35775/ESP/2000) and GHTM UID/Multi/04413/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrane YA, 2006, AM J TROP MED HYG, V74, P772, DOI 10.4269/ajtmh.2006.74.772; Alten B, 2007, ECOL CONT VECTOR-BOR, V1, P35; [Anonymous], 2003, MOSQUITOES THEIR CON; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Benali A, 2014, REMOTE SENS ENVIRON, V145, P116, DOI 10.1016/j.rse.2014.01.014; Bueno-Mari, 2012, TROP BIOMED, V29, P39; Buttner PG, 2012, IMPLEMENTATION ACHIE; Cambournac F, 1938, T 3 INT C TROP MED M, V2, P1938; Cambournac F., 1942, EPIDEMIOLOGIA SEZONI; Cano Jorge, 2006, Malaria Journal, V5, P1; Capinha C, 2009, GEOSPATIAL HEALTH, V3, P177, DOI 10.4081/gh.2009.219; Coetzee BWT, 2009, GLOBAL ECOL BIOGEOGR, V18, P701, DOI 10.1111/j.1466-8238.2009.00485.x; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; da Saude D-G, 2015, DOENC DECL OBR 2010; de Saude E, 2011, DOENC DECL OBR 2004; Detinova T, 1963, METHODES APPL CLASSE; Elith J, 2006, NOVEL METHODS IMPROV, V2; Elyazar IRF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037325; Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7; Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241; Gomes ED, 2016, CORDIS, P1; Grillet ME, 2010, SPAT SPATIO-TEMPORAL, V1, P251, DOI 10.1016/j.sste.2010.09.007; Hanafi-Bojd AA, 2012, ACTA TROP, V122, P132, DOI 10.1016/j.actatropica.2012.01.003; Hastie T, 2013, ECOGRAPHY, V36, P864, DOI 10.1111/j.1600-0587.2013.00321.x; Hijmans R. J., 2016, SPECIES DISTRIBUTION; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2006, ECOL MODEL, V199, P142, DOI 10.1016/j.ecolmodel.2006.05.017; INE, 2011, 15 REC GER POP HAB; Knell AJ, 1991, MALARIA; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lawler JJ, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P271, DOI 10.1007/978-1-4419-7390-0_14; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Miranda P.M.A., 2006, ALTERA ES CLIM TICAS, P47; Molineaux L, 1988, EPIDEMIOLOGY MALARIA; Muller S, 2015, MOLECULES, V20, P10511, DOI 10.3390/molecules200610511; O'Hanley JR, 2009, ECOGRAPHY, V32, P89, DOI 10.1111/j.1600-0587.2008.05601.x; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; Park YS, 2003, ECOL MODEL, V160, P265, DOI 10.1016/S0304-3800(02)00258-2; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pires C, 1982, DO I HIG MED TROP, V8, P79; Poncon N, 2008, QUANTITATIVE RISK AS, V7, P1; Ramos H, 1978, I HIG MED TROP LISB, V1, P79; Reisen W. K., 1989, Bulletin of the Society for Vector Ecology, V14, P39; Ribeiro H, 1992, GARCIA HORTA Z, V16, P137; Ribeiro H, 2002, GARCIA HORTA Z, V24, P2002; Ribeiro H, 1999, GARCIA HORTA Z, V23, P1999; Roura-Pascual N, 2009, BIOL INVASIONS, V11, P1017, DOI 10.1007/s10530-008-9313-3; Salvi C, 2016, HIST MALARIA ELIMINA; Santos LC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-96; Sousa C.A., 2008, MALARIA VECTORIAL CA; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Walther H, 1988, MALARIA PRINCIPLES P; WHO, 2015, WORLD MAL REP 2015; Zaniewski AE, 2002, ECOL MODEL, V157, P261, DOI 10.1016/S0304-3800(02)00199-0	56	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0164788	10.1371/journal.pone.0164788	http://dx.doi.org/10.1371/journal.pone.0164788			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814371	Green Published, Green Submitted, gold			2022-12-26	WOS:000386911100004
J	Zhao, MX; Brofeldt, S; Li, QH; Xu, JC; Danielsen, F; Laessoe, SBL; Poulsen, MK; Gottlieb, A; Maxwell, JF; Theilade, I				Zhao, Mingxu; Brofeldt, Soren; Li, Qiaohong; Xu, Jianchu; Danielsen, Finn; Laessoe, Simon Bjarke Laegaard; Poulsen, Michael Koie; Gottlieb, Anna; Maxwell, James Franklin; Theilade, Ida			Can Community Members Identify Tropical Tree Species for REDD plus Carbon and Biodiversity Measurements?	PLOS ONE			English	Review							TRADITIONAL ECOLOGICAL KNOWLEDGE; INDIGENOUS KNOWLEDGE; LOCAL KNOWLEDGE; GENERAL-PRINCIPLES; CONSERVATION; CLASSIFICATION; INVENTORY; MANAGEMENT; PEOPLE; FOLK	Biodiversity conservation is a required co-benefit of REDD+. Biodiversity monitoring is therefore needed, yet in most areas it will be constrained by limitations in the available human professional and financial resources. REDD+ programs that use forest plots for biomass monitoring may be able to take advantage of the same data for detecting changes in the tree diversity, using the richness and abundance of canopy trees as a proxy for biodiversity. If local community members are already assessing the above-ground biomass in a representative network of forest vegetation plots, it may require minimal further effort to collect data on the diversity of trees. We compare community members and trained scientists' data on tree diversity in permanent vegetation plots in montane forest in Yunnan, China. We show that local community members here can collect tree diversity data of comparable quality to trained botanists, at one third the cost. Without access to herbaria, identification guides or the Internet, community members could provide the ethno-taxonomical names for 95% of 1071 trees in 60 vegetation plots. Moreover, we show that the community-led survey spent 89% of the expenses at village level as opposed to 23% of funds in the monitoring by botanists. In participatory REDD+ programs in areas where community members demonstrate great knowledge of forest trees, community-based collection of tree diversity data can be a cost-effective approach for obtaining tree diversity information.	[Zhao, Mingxu; Li, Qiaohong; Xu, Jianchu] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Zhao, Mingxu] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhao, Mingxu; Li, Qiaohong; Xu, Jianchu] World Agroforestry Ctr, East & Cent Asia, Kunming, Yunnan, Peoples R China; [Brofeldt, Soren; Laessoe, Simon Bjarke Laegaard; Theilade, Ida] Univ Copenhagen, Dept Food & Resource Econ, Fac Sci, Copenhagen, Denmark; [Brofeldt, Soren; Danielsen, Finn; Poulsen, Michael Koie; Gottlieb, Anna] Nord Fdn Dev & Ecol NORDECO, Copenhagen, Denmark; [Maxwell, James Franklin] Chiang Mai Univ, Dept Biol, Fac Sci, Chiang Mai, Thailand	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Copenhagen; Chiang Mai University	Theilade, I (corresponding author), Univ Copenhagen, Dept Food & Resource Econ, Fac Sci, Copenhagen, Denmark.	idat@ifro.ku.dk	Xu, Jianchu/Y-2890-2019; Theilade, Ida/A-6498-2010; Theilade, Ida/N-5882-2019	Theilade, Ida/0000-0003-3502-1277; Theilade, Ida/0000-0003-3502-1277; Danielsen, Finn/0000-0003-0229-2847; Poulsen, Michael Koie/0000-0002-3189-6423	European Community's Seventh Framework Research Programme; DANIDA research grant [13-08KU]	European Community's Seventh Framework Research Programme; DANIDA research grant	This study was part of the project Impacts of Reducing Emissions from Deforestation and Forest Degradation and Enhancing Carbon Stocks (I-REDD+) funded by the European Communitys Seventh Framework Research Programme (http://www.iredd.dk/) and DANIDA research grant 13-08KU (http://ifro.ku.dk/english/research/projects/projects_development/redd/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraao MB, 2008, J BIOGEOGR, V35, P2237, DOI 10.1111/j.1365-2699.2008.01975.x; [Anonymous], 1970, FLOR OF THAIL, V1-12; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Basset Y, 2000, BIOSCIENCE, V50, P899, DOI 10.1641/0006-3568(2000)050[0899:QBEWPA]2.0.CO;2; Basset Y, 2004, J APPL ECOL, V41, P163, DOI 10.1111/j.1365-2664.2004.00878.x; Beehler BM, 1994, TROPICAL BIODIVERSIT, V2, P333; BERLIN B, 1973, AM ANTHROPOL, V75, P214, DOI 10.1525/aa.1973.75.1.02a00140; BERLIN B, 1992, ETHNOBIOLOGICAL CLAS; de Lacerda AEB, 2010, FOREST ECOL MANAG, V259, P995, DOI 10.1016/j.foreco.2009.12.005; Boissiere M, 2014, FORESTS, V5, P1855, DOI 10.3390/f5081855; Brofeldt S, 2014, FORESTS, V5, P1834, DOI 10.3390/f5081834; Cardoso DBOS, 2010, J ETHNOBIOL, V30, P252, DOI 10.2993/0278-0771-30.2.252; CBD, 2011, CBD TECHN SER; Chalmers N, 2007, ECOL SOC, V12; CORLETT RT, 1994, J TROP ECOL, V10, P445, DOI 10.1017/S0266467400008129; Dalle SP, 2004, ECON BOT, V58, P38, DOI 10.1663/0013-0001(2004)058[0038:COUPAE]2.0.CO;2; Danielsen F, 2005, BIODIVERS CONSERV, V14, P2507, DOI 10.1007/s10531-005-8375-0; Danielsen F, 2005, BIODIVERS CONSERV, V9, P1671; Danielsen F, 2009, CONSERV BIOL, V23, P31, DOI 10.1111/j.1523-1739.2008.01063.x; Danielsen F, 2007, AMBIO, V36, P566, DOI 10.1579/0044-7447(2007)36[566:ICMABI]2.0.CO;2; Danielsen F, 2014, CONSERV LETT, V7, P380, DOI 10.1111/conl.12100; Danielsen F, 2014, BIOSCIENCE, V64, P236, DOI 10.1093/biosci/biu001; Danielsen F, 2013, ECOL SOC, V18, DOI 10.5751/ES-05464-180341; Danielsen F, 2011, CONSERV LETT, V4, P158, DOI 10.1111/j.1755-263X.2010.00159.x; Danielsen F, 2010, J APPL ECOL, V47, P1166, DOI 10.1111/j.1365-2664.2010.01874.x; Dickson B, 2012, CURR OPIN ENV SUST, V4, P717, DOI 10.1016/j.cosust.2012.09.017; Ellen R, 2008, ECON BOT, V62, P483, DOI 10.1007/s12231-008-9036-5; Epple C., 2011, MAKING BIODIVERSITY; Fleck David W., 2000, Journal of Ethnobiology, V20, P1; Fry B, 2011, ENVIRON SCI POLICY, V14, P181, DOI 10.1016/j.envsci.2010.12.004; Garcia NT, 2015, J ETHNOBIOL ETHNOMED, V11, P52, DOI [10.1186/s13002-015-0024-4, DOI 10.1186/S13002-015-0024-4]; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gardner TA, 2012, BIOL CONSERV, V154, P61, DOI 10.1016/j.biocon.2011.11.018; Gibson CC, 2005, WORLD DEV, V33, P273, DOI 10.1016/j.worlddev.2004.07.013; Gilmore MP, 2010, MAIJUNA PARTICIPATOR, P233; *GOFC GOLD, 2010, SOURC METH PROC MON; Gordon JE, 2006, FOREST ECOL MANAG, V237, P564, DOI 10.1016/j.foreco.2006.10.002; Halme KJ, 2007, BIODIVERS CONSERV, V16, P1785, DOI 10.1007/s10531-006-9071-4; Harrison ME, 2012, TROP CONSERV SCI, V5, P1; Hellier A, 1999, BIODIVERS CONSERV, V8, P869, DOI 10.1023/A:1008862005556; Hernandez-Stefanoni JL, 2006, ENVIRON MANAGE, V37, P686, DOI 10.1007/s00267-004-0371-8; Higgins MA, 2004, CONSERV BIOL, V18, P799, DOI 10.1111/j.1523-1739.2004.00235.x; Holman EW, 2002, J CLASSIF, V19, P131, DOI 10.1007/s00357-001-0036-8; Imai N, 2014, FOREST ECOL MANAG, V313, P169, DOI 10.1016/j.foreco.2013.10.041; Janzen DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018123; Janzen DH, 2004, J APPL ECOL, V41, P181, DOI 10.1111/j.1365-2664.2004.00879.x; Jinxiu W, 1992, CONSERV BIOL, V18, P1139; Kati V, 2004, CONSERV BIOL, V18, P667, DOI 10.1111/j.1523-1739.2004.00465.x; Larrazabal A, 2012, CURR OPIN ENV SUST, V4, P707, DOI 10.1016/j.cosust.2012.10.008; Martin G.J., 2004, ETHNOBOTANY METHODS; Martin GJ, 2002, PROJEK ETNOBOTANI KI; Miles L, 2008, SCIENCE, V320, P1454, DOI 10.1126/science.1155358; Mitchard ETA, 2014, GLOBAL ECOL BIOGEOGR, V23, P935, DOI 10.1111/geb.12168; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naidoo R, 2006, ENVIRON MANAGE, V38, P377, DOI 10.1007/s00267-004-0338-9; Oldekop JA, 2011, BIODIVERS CONSERV, V20, P2615, DOI 10.1007/s10531-011-0094-0; Padmanaba M, 2013, ENVIRON MANAGE, V52, P348, DOI 10.1007/s00267-013-0051-7; Paoli Gary D, 2010, Carbon Balance Manag, V5, P7, DOI 10.1186/1750-0680-5-7; Pfeiffer Jeanine, 2003, Telopea, V10, P61; Phillips OL, 2003, J TROP ECOL, V19, P629, DOI 10.1017/S0266467403006035; Pitman N., 2011, SOCIAL BIODIVERSITY; Pitman NCA, 2011, J ETHNOBIOL, V31, P233, DOI 10.2993/0278-0771-31.2.233; Prance GT, 2000, ANN MO BOT GARD, V87, P67, DOI 10.2307/2666209; Pratihast AK, 2014, FORESTS, V5, P2464, DOI 10.3390/f5102464; Sheil D, 2004, TRENDS ECOL EVOL, V19, P634, DOI 10.1016/j.tree.2004.09.019; Shepard G.J, 2004, ADV EC BOT, V15, P133; Shepard Junior Glenn H., 2001, Journal of Ethnobiology, V21, P1; Skutsch M, 2011, COMMUNITY FOREST MON, P73; Su JC, 2004, CONSERV BIOL, V18, P167, DOI 10.1111/j.1523-1739.2004.00337.x; Sutherland WJ, 2014, ORYX, V48, P1, DOI 10.1017/S0030605313001543; The Climate Community & Biodiversity Alliance (CBBA), 2008, CLIM COMM BIOD PROJ; Theilade Ida, 2015, Carbon Balance Manag, V10, P17; Thompson ORR, 2013, ECOL SOC, V18, DOI 10.5751/ES-05239-180117; TORRECUADROS MA, 2003, J ETHNOBIOL, V23, P287; [UNEP] United Nations Environment Programme, 2012, 2 SESS PLEN M DET MO; UNFCCC, 2011, UNFCCCSBSTA2011L25; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671; Vergara-Asenjo G, 2015, CONSERV LETT, V8, P432, DOI 10.1111/conl.12161; Webb CO, 2010, BIODIVERS CONSERV, V19, P955, DOI 10.1007/s10531-010-9817-x; Webb EL, 2016, BIOTROPICA, V48, P132, DOI 10.1111/btp.12299; Wilkie P, 1999, BIODIVERS CONSERV, V8, P1457, DOI 10.1023/A:1008930012467; Zy W, FLORA CHINA, V1-25; Zy W, 1977, FLORA YUNNANICA, V1-16	83	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0152061	10.1371/journal.pone.0152061	http://dx.doi.org/10.1371/journal.pone.0152061			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814370	Green Published, Green Submitted, gold			2022-12-26	WOS:000386911100001
J	Amato, DW; Bishop, JM; Glenn, CR; Dulai, H; Smith, CM				Amato, Daniel W.; Bishop, James M.; Glenn, Craig R.; Dulai, Henrietta; Smith, Celia M.			Impact of Submarine Groundwater Discharge on Marine Water Quality and Reef Biota of Maui	PLOS ONE			English	Article							CORAL-REEFS; MACROALGAL BLOOMS; SEWAGE POLLUTION; KANEOHE BAY; NUTRIENT ENRICHMENT; PHYSICAL HABITAT; WASTE-WATER; ULVA SPP.; NITROGEN; DELTA-N-15	Generally unseen and infrequently measured, submarine groundwater discharge (SGD) can transport potentially large loads of nutrients and other land-based contaminants to coastal ecosystems. To examine this linkage we employed algal bioassays, benthic community analysis, and geochemical methods to examine water quality and community parameters of nearshore reefs adjacent to a variety of potential, land-based nutrient sources on Maui. Three common reef algae, Acanthophora spicifera, Hypnea musciformis, and Ulva spp. were collected and/or deployed at six locations with SGD. Algal tissue nitrogen (N) parameters (delta N-15, N %, and C:N) were compared with nutrient and delta N-15-nitrate values of coastal groundwater and nearshore surface water at all locations. Benthic community composition was estimated for ten 10-m transects per location. Reefs adjacent to sugarcane farms had the greatest abundance of macroalgae, low species diversity, and the highest concentrations of N in algal tissues, coastal groundwater, and marine surface waters compared to locations with low anthropogenic impact. Based on delta N-15 values of algal tissues, we estimate ca. 0.31 km(2) of Kahului Bay is impacted by effluent injected underground at the Kahului Wastewater Reclamation Facility (WRF); this region is barren of corals and almost entirely dominated by colonial zoanthids. Significant correlations among parameters of algal tissue N with adjacent surface and coastal groundwater N indicate that these bioassays provided a useful measure of nutrient source and loading. A conceptual model that uses Ulva spp. tissue delta N-15 and N% to identify potential N source(s) and relative N loading is proposed for Hawai'i. These results indicate that SGD can be a significant transport pathway for land-based nutrients with important biogeochemical and ecological implications in tropical, oceanic islands.	[Amato, Daniel W.; Smith, Celia M.] Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA; [Bishop, James M.; Glenn, Craig R.; Dulai, Henrietta] Univ Hawaii Manoa, Dept Geol & Geophys, Honolulu, HI 96822 USA; [Bishop, James M.] US Geol Survey, 345 Middlefield Rd, Menlo Pk, CA 94025 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; United States Department of the Interior; United States Geological Survey	Amato, DW (corresponding author), Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA.	dwamato@hawaii.edu	Dulai, Henrietta/AAY-9632-2020	Dulai, Henrietta/0000-0001-5970-1483; Bishop, James/0000-0001-9394-4008; Amato, Daniel/0000-0003-0265-7711	National Oceanic and Atmospheric Administration [R/HE-17, R/SB-12, R/WR-2]; University of Hawaii Sea Grant College Program, SOEST from NOAA Office of Sea Grant, Department of Commerce [NA09OAR4170060, NA140AR4170071]; STAR Fellowship [FP-91727301-2]; U.S. Environmental Protection Agency; Office of Integrative Activities [1557349] Funding Source: National Science Foundation	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); University of Hawaii Sea Grant College Program, SOEST from NOAA Office of Sea Grant, Department of Commerce; STAR Fellowship; U.S. Environmental Protection Agency(United States Environmental Protection Agency); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This paper is funded in part by a grant/ cooperative agreement from the National Oceanic and Atmospheric Administration, Project R/HE-17, R/SB-12, R/WR-2, which is sponsored by the University of Hawaii Sea Grant College Program, SOEST, under Institutional Grant No. NA09OAR4170060, NA140AR4170071 from NOAA Office of Sea Grant, Department of Commerce. The views expressed herein are those of the author(s) and do not necessarily reflect the views of NOAA or any of its subagencies; UNIHI-SEAGRANT-JC-14-42; http://seagrant.soest.hawaii.edu/research-0. Daniel W. Amato was supported by a STAR Fellowship Assistance Agreement no. FP-91727301-2, awarded by the U.S. Environmental Protection Agency. The EPA has not formally reviewed the work and does not endorse any products or commercial services mentioned in this publication; https://cfpub.epa.gov/ncer_abstracts/index.cfm/fuseaction/display.abstractDetail/abstract/9899/report/0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1978, STABLE ISOT EARTH SC; ATKINSON MJ, 1983, LIMNOL OCEANOGR, V28, P568, DOI 10.4319/lo.1983.28.3.0568; Barr NG, 2013, MAR POLLUT BULL, V67, P203, DOI 10.1016/j.marpolbul.2012.11.033; Bird CE, 2001, PHOTOGRID BETA 1 0; Bishop JM, 2017, J HYDROL-REG STUD, V11, P194, DOI 10.1016/j.ejrh.2015.10.008; Brown Eric, 2004, Pacific Science, V58, P145, DOI 10.1353/psc.2004.0013; Burnett WC, 2003, BIOGEOCHEMISTRY, V66, P3, DOI 10.1023/B:BIOG.0000006066.21240.53; Burnham WL, 1977, 77469 US GEOL SURV; Casciotti KL, 2008, DEEP-SEA RES PT II, V55, P1661, DOI 10.1016/j.dsr2.2008.04.017; Cole ML, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003269; Conklin EJ, 2005, BIOL INVASIONS, V7, P1029, DOI 10.1007/s10530-004-3125-x; Costa OS, 2008, J S AM EARTH SCI, V25, P257, DOI 10.1016/j.jsames.2007.10.002; Costanzo SD, 2005, MAR POLLUT BULL, V51, P212, DOI 10.1016/j.marpolbul.2004.10.018; Costanzo SD, 2000, J PHYCOL, V36, P680, DOI 10.1046/j.1529-8817.2000.99180.x; Cox TE, 2013, MAR POLLUT BULL, V71, P92, DOI 10.1016/j.marpolbul.2013.03.030; Dailer M, 2013, PREVENTING INTRO SPR; Dailer ML, 2012, HARMFUL ALGAE, V17, P111, DOI 10.1016/j.hal.2012.03.008; Dailer ML, 2012, MAR POLLUT BULL, V64, P207, DOI 10.1016/j.marpolbul.2011.12.004; Dailer ML, 2010, MAR POLLUT BULL, V60, P655, DOI 10.1016/j.marpolbul.2009.12.021; Derse E, 2007, ENVIRON SCI TECHNOL, V41, P5217, DOI 10.1021/es0700449; DLNR-DAR UH-CRAMP, 2013, LONG TERM BENTH COV; Dollar S., 2011, EVALUATION CAUSAL FA; Dollar S, 1997, ALGAL BLOOMS W MAUI; Dulai H, 2016, J RADIOANAL NUCL CH, V307, P1865, DOI 10.1007/s10967-015-4580-9; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fertig B, 2009, ESTUAR COAST, V32, P773, DOI 10.1007/s12237-009-9148-x; Fong P, 2004, AQUAT BOT, V78, P83, DOI 10.1016/j.aquabot.2003.09.006; Friedlander Alan, 2008, NOAA Technical Memorandum NOS NCCOS, V73, P219; Friedlander AM, 2007, ECOL APPL, V17, P715, DOI 10.1890/06-0536; Garrison GH, 2003, LIMNOL OCEANOGR, V48, P920, DOI 10.4319/lo.2003.48.2.0920; Gaw S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0572; Glenn C.R., 2013, LAHAINA GROUNDWATER; Glenn C.R., 2012, LAHAINA GROUNDWATER; Gonzalez FUT, 2008, ESTUAR COAST SHELF S, V76, P418, DOI 10.1016/j.ecss.2007.07.025; Granger J, 2006, LIMNOL OCEANOGR-METH, V4, P205, DOI 10.4319/lom.2006.4.205; HEATON THE, 1986, CHEM GEOL, V59, P87, DOI [10.1016/0168-9622(86)90059-X, 10.1016/0009-2541(86)90046-X]; Hernandez-Delgado E, 2008, 11 INT COR REEF S FO; Hunt CD, 2009, 20095253 US GEOL SUR; HUNTER CL, 1995, B MAR SCI, V57, P501; Johnson AG, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034574; Jokiel PL, 2008, CORAL REEF ASSESSMEN; Kendall C, 2007, ECOL METHOD CONCEPT, P375, DOI 10.1002/9780470691854.ch12; Kim CJS, 2014, LINKING SEWAGE POLLU; LAPOINTE BE, 1992, ESTUARIES, V15, P465, DOI 10.2307/1352391; Lapointe BE, 1997, LIMNOL OCEANOGR, V42, P1119, DOI 10.4319/lo.1997.42.5_part_2.1119; Lapointe BE, 2010, MAR POLLUT BULL, V60, P334, DOI 10.1016/j.marpolbul.2009.10.020; Laroche J, 1997, GLOB CHANGE BIOL, V3, P397, DOI 10.1046/j.1365-2486.1997.00117.x; Laws EA, 2004, INT J ENVIRON POLLUT, V22, P531, DOI 10.1504/IJEP.2004.005908; Laws EA., 2000, AQUATIC POLLUTION IN, V3; Lecher AL, 2015, ENVIRON SCI TECHNOL, V49, P6665, DOI 10.1021/acs.est.5b00909; Lee YW, 2007, ESTUAR COAST SHELF S, V71, P309, DOI 10.1016/j.ecss.2006.08.004; Lirman D, 2001, CORAL REEFS, V19, P392, DOI 10.1007/s003380000125; Lyons DA, 2014, GLOBAL CHANGE BIOL, V20, P2712, DOI 10.1111/gcb.12644; Martinez JA, 2012, ESTUAR COAST SHELF S, V99, P42, DOI 10.1016/j.ecss.2011.12.022; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; Meador JP, 2016, ENVIRON POLLUT, V213, P254, DOI 10.1016/j.envpol.2016.01.088; Moynihan MA, 2012, MAR POLLUT BULL, V64, P1348, DOI 10.1016/j.marpolbul.2012.05.001; NAIM O, 1993, MAR ECOL PROG SER, V99, P137; Nishimura N., 2000, THESIS; O'Kelly CJ, 2010, J PHYCOL, V46, P728, DOI 10.1111/j.1529-8817.2010.00860.x; OWENS NJP, 1987, ADV MAR BIOL, V24, P389; Paerl HW, 2013, MICROB ECOL, V65, P995, DOI 10.1007/s00248-012-0159-y; Paytan A, 2006, LIMNOL OCEANOGR, V51, P343, DOI 10.4319/lo.2006.51.1.0343; Prichard E, 2016, ENVIRON SCI POLLUT R, V23, P22365, DOI 10.1007/s11356-016-7282-0; Riera P, 2000, ESTUAR COAST SHELF S, V51, P365, DOI 10.1006/ecss.2000.0684; Risk MJ, 2014, CURR OPIN ENV SUST, V7, P108, DOI 10.1016/j.cosust.2014.01.003; Risk MJ, 2009, MAR POLLUT BULL, V58, P793, DOI 10.1016/j.marpolbul.2009.02.008; Rodgers KS, 2015, PAC SCI, V69, P1, DOI 10.2984/69.1.1; Savage C, 2004, ECOL APPL, V14, P517, DOI 10.1890/02-5396; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sigman DM, 2001, ANAL CHEM, V73, P4145, DOI 10.1021/ac010088e; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Slomp CP, 2004, J HYDROL, V295, P64, DOI 10.1016/j.jhydrol.2004.02.018; Smith JE, 2005, MAR ECOL PROG SER, V302, P77, DOI 10.3354/meps302077; Smith JE, 2003, J PHYCOL, V39, P53, DOI [10.1111/j.0022-3646.2003.03906001_152.x, DOI 10.1111/J.0022-3646.2003.03906001_153.X]; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Smith Jennifer E., 2004, Pacific Science, V58, P325, DOI 10.1353/psc.2004.0023; Smith Jennifer E., 2002, Pacific Science, V56, P299, DOI 10.1353/psc.2002.0030; SMITH SV, 1981, PAC SCI, V35, P279; Soicher A. J., 1997, Pacific Science, V51, P221; State of Hawai`i Office of Planning, 2014, HAW STAT GIS PROGR; Teichberg M, 2010, GLOBAL CHANGE BIOL, V16, P2624, DOI 10.1111/j.1365-2486.2009.02108.x; Umezawa Y, 2002, LIMNOL OCEANOGR, V47, P1405, DOI 10.4319/lo.2002.47.5.1405; van Beukering Pieter J. H., 2004, Pacific Science, V58, P243, DOI 10.1353/psc.2004.0012; Van Houtan KS, 2014, PEERJ, V2, DOI 10.7717/peerj.602; WALSH GE, 1971, ZOOL J LINN SOC-LOND, V50, P161, DOI 10.1111/j.1096-3642.1971.tb00757.x; Walsh W, 2010, LONG TERM MONITORING; Wear SL, 2015, ANN NY ACAD SCI, V1355, P15, DOI 10.1111/nyas.12785; Welti N, 2015, ESTUAR COAST SHELF S, V163, P116, DOI 10.1016/j.ecss.2015.06.006; Whittier R.B., 2014, HUMAN HLTH ENV RISK; Yoshioka RM, 2016, MAR POLLUT BULL, V104, P313, DOI 10.1016/j.marpolbul.2016.01.002; Zhang J, 2012, CURR OPIN ENV SUST, V4, P219, DOI 10.1016/j.cosust.2012.03.006	93	67	69	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165825	10.1371/journal.pone.0165825	http://dx.doi.org/10.1371/journal.pone.0165825			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812171	gold, Green Published, Green Submitted			2022-12-26	WOS:000386910000067
J	Cho, KS; Park, MK; Mun, SJ; Park, HY; Yu, HS; Roh, HJ				Cho, Kyu-Sup; Park, Mi-Kyung; Mun, Sue-Jean; Park, Hee-Young; Yu, Hak-Sun; Roh, Hwan-Jung			Indoleamine 2,3-Dioxygenase Is Not a Pivotal Regulator Responsible for Suppressing Allergic Airway Inflammation through Adipose-Derived Stem Cells	PLOS ONE			English	Article							KIDNEY ALLOGRAFT TOLERANCE; T-CELLS; DENDRITIC CELLS; MOUSE MODEL; TRYPTOPHAN DEGRADATION; IDO; ASTHMA; EXPRESSION; INDUCTION; MICE	Background Although indoleamine 2,3-dioxygenase (IDO)-mediated immune suppression of mesenchymal stem cells (MSCs) has been revealed in septic and tumor microenvironments, the role of IDO in suppressing allergic airway inflammation by MSCs is not well documented. We evaluated the effects of adipose-derived stem cells (ASCs) on allergic inflammation in IDO-knockout (KO) asthmatic mice or asthmatic mice treated with ASCs derived from IDO-KO mice. Methods and Findings ASCs were injected intravenously in wild-type (WT) and IDO-KO asthmatic mice. Furthermore, asthmatic mice were injected with ASCs derived from IDO-KO mice. We investigated the immunomodulatory effects of ASCs between WT and IDO-KO mice or IDO-KO ASCs in asthmatic mice. In asthmatic mice, ASCs significantly reduced airway hyperresponsiveness, the number of total inflammatory cells and eosinophils in bronchoalveolar lavage fluid (BALF), eosinophilic inflammation, goblet hyperplasia, and serum concentrations of total and allergen-specific IgE and IgG1. ASCs significantly inhibited Th2 cytokines, such as interleukin (IL)-4, IL-5, and IL-13, and enhanced Th1 cytokine (interferon-gamma) and regulatory cytokines (IL-10, TGF-beta) in BALF and lung draining lymph nodes (LLNs). ASCs led to significant increases in regulatory T-cells (Tregs) and IL-10(+) T cell populations in LLNs. However, the immunosuppressive effects of ASCs did not significantly differ between WT and IDO-KO mice. Moreover, ASCs derived from IDO-KO mice showed immunosuppressive effects in allergic airway inflammation. Conclusions IDO did not play a pivotal role in the suppression of allergic airway inflammation through ASCs, suggesting that it is not the major regulator responsible for suppressing allergic airway inflammation.	[Cho, Kyu-Sup; Park, Hee-Young] Pusan Natl Univ Hosp, Dept Otorhinolaryngol, Busan, South Korea; [Cho, Kyu-Sup; Park, Hee-Young] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea; [Park, Mi-Kyung; Yu, Hak-Sun] Pusan Natl Univ, Dept Parasitol, Sch Med, Yangsan, South Korea; [Mun, Sue-Jean; Roh, Hwan-Jung] Pusan Natl Univ, Yangsan Hosp, Dept Otorhinolaryngol, Yangsan, South Korea; [Mun, Sue-Jean; Roh, Hwan-Jung] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Roh, HJ (corresponding author), Pusan Natl Univ, Yangsan Hosp, Dept Otorhinolaryngol, Yangsan, South Korea.; Roh, HJ (corresponding author), Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, South Korea.	rohhj@pusan.ac.kr			Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and future Planning [NRF-2014R1A2A1A11053502]	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and future Planning (NRF-2014R1A2A1A11053502. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Baban B, 2009, J IMMUNOL, V183, P2475, DOI 10.4049/jimmunol.0900986; Ball HJ, 2009, INT J BIOCHEM CELL B, V41, P467, DOI 10.1016/j.biocel.2008.01.005; Beutelspacher SC, 2006, AM J TRANSPLANT, V6, P1320, DOI 10.1111/j.1600-6143.2006.01324.x; Bonfield TL, 2010, AM J PHYSIOL-LUNG C, V299, pL760, DOI 10.1152/ajplung.00182.2009; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Castro-Manrreza ME, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/394917; Caterson E, 2002, MOL BIOTECHNOL, V20, P245, DOI 10.1385/MB:20:3:245; Chaves ACL, 2001, EUR J IMMUNOL, V31, P333, DOI 10.1002/1521-4141(200102)31:2&lt;333::AID-IMMU333&gt;3.0.CO;2-X; Cho KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131813; Cho KS, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/436476; Cho KS, 2010, CURR STEM CELL RES T, V5, P111, DOI 10.2174/157488810791268681; Cho KS, 2009, STEM CELLS, V27, P259, DOI 10.1634/stemcells.2008-0283; Ciccocioppo R, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0122-1; Croitoru-Lamoury J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014698; Cui L, 2007, TISSUE ENG, V13, P1185, DOI 10.1089/ten.2006.0315; Curti A, 2009, BLOOD, V113, P2394, DOI 10.1182/blood-2008-07-144485; Ebrahimi A, 2016, GENE, V576, P412, DOI 10.1016/j.gene.2015.10.054; English K, 2009, CLIN EXP IMMUNOL, V156, P149, DOI 10.1111/j.1365-2249.2009.03874.x; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fu JJ, 2014, INFLAMM RES, V63, P357, DOI 10.1007/s00011-014-0707-7; Fu QL, 2012, ALLERGY, V67, P1215, DOI [10.1111/j.1398-9995.2012.02875.x, 10.1111/j.1398-9995.2012.02875.x.]; Ge W, 2010, TRANSPLANTATION, V90, P1312, DOI 10.1097/TP.0b013e3181fed001; Ge XH, 2013, CELL BIOL INT, V37, P675, DOI 10.1002/cbin.10084; Goodwin M, 2011, STEM CELLS, V29, P1137, DOI 10.1002/stem.656; Hayashi T, 2004, J CLIN INVEST, V114, P270, DOI 10.1172/JCI200421275; He Y, 2015, TRANSPLANTATION, V99, P1829, DOI 10.1097/TP.0000000000000856; Jaffar Z, 2004, J IMMUNOL, V172, P3842, DOI 10.4049/jimmunol.172.6.3842; Kang JH, 2009, AM J RESP CRIT CARE, V179, P875, DOI 10.1164/rccm.200806-893OC; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Lee YE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144298; Ling WF, 2014, CANCER RES, V74, P1576, DOI 10.1158/0008-5472.CAN-13-1656; Luo CF, 2014, CURR STEM CELL RES T, V9, P36; Matysiak M, 2008, J NEUROIMMUNOL, V193, P12, DOI 10.1016/j.jneuroim.2007.07.025; Mbongue JC, 2015, VACCINES-BASEL, V3, P703, DOI 10.3390/vaccines3030703; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Moingeon P, 2006, ALLERGY, V61, P151, DOI 10.1111/j.1398-9995.2006.01002.x; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Nemeth K, 2010, P NATL ACAD SCI USA, V107, P5652, DOI 10.1073/pnas.0910720107; Odemuyiwa SO, 2004, J IMMUNOL, V173, P5909, DOI 10.4049/jimmunol.173.10.5909; Opitz CA, 2009, STEM CELLS, V27, P909, DOI 10.1002/stem.7; Park HK, 2010, STEM CELLS DEV, V19, P1811, DOI 10.1089/scd.2009.0513; Pellaton-Longaretti C, 2011, INT IMMUNOL, V23, P17, DOI 10.1093/intimm/dxq453; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Shi HZ, 2005, ALLERGY, V60, P986, DOI 10.1111/j.1398-9995.2005.00844.x; Spaggiari GM, 2013, IMMUNOL CELL BIOL, V91, P27, DOI 10.1038/icb.2012.62; Sucher R, 2010, INT J TRYPTOPHAN RES, V3, P113; Sun YQ, 2012, STEM CELLS, V30, P2692, DOI 10.1002/stem.1241; Taher YA, 2008, J ALLERGY CLIN IMMUN, V121, P983, DOI 10.1016/j.jaci.2007.11.021; Tournoy KG, 2000, CLIN EXP ALLERGY, V30, P79; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; von Bubnoff D, 2012, ALLERGY, V67, P718, DOI 10.1111/j.1398-9995.2012.02830.x; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572; Xu H, 2008, P NATL ACAD SCI USA, V105, P6690, DOI 10.1073/pnas.0708809105	56	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165661	10.1371/journal.pone.0165661	http://dx.doi.org/10.1371/journal.pone.0165661			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812173	Green Published, gold, Green Submitted			2022-12-26	WOS:000386910000044
J	Samarasinghe, SAPL; Shao, Y; Huang, PJ; Pishko, M; Chu, KH; Kameoka, J				Samarasinghe, S. A. P. L.; Shao, Yiru; Huang, Po-Jung; Pishko, Michael; Chu, Kung-Hui; Kameoka, Jun			Fabrication of Bacteria Environment Cubes with Dry Lift-Off Fabrication Process for Enhanced Nitrification	PLOS ONE			English	Article							SECRETING HEK293 CELLS; MICROFLUIDIC CHIP; CALCIUM ALGINATE; STEM-CELLS; I COLLAGEN; MONODISPERSE; GROWTH; SHAPE; MICROENVIRONMENT; DIFFERENTIATION	We have developed a 3D dry lift-off process to localize multiple types of nitrifying bacteria in polyethylene glycol diacrylate (PEGDA) cubes for enhanced nitrification, a two-step biological process that converts ammonium to nitrite and then to nitrate. Ammonia-oxidizing bacteria (AOB) is responsible for converting ammonia into nitrite, and nitrite-oxidizing bacteria (NOB) is responsible for converting nitrite to nitrate. Successful nitrification is often challenging to accomplish, in part because AOB and NOB are slow growers and highly susceptible to many organic and inorganic chemicals in wastewater. Most importantly, the transportation of chemicals among scattered bacteria is extremely inefficient and can be problematic. For example, nitrite, produced from ammonia oxidation, is toxic to AOB and can lead to the failure of nitrification. To address these challenges, we closely localize AOB and NOB in PEGDA cubes as microenvironment modules to promote synergetic interactions. The AOB is first localized in the vicinity of the surface of the PEGDA cubes that enable AOB to efficiently uptake ammonia from a liquid medium and convert it into nitrite. The produced nitrite is then efficiently transported to the NOB localized at the center of the PEGDA particle and converted into non-toxic nitrate. Additionally, the nanoscale PEGDA fibrous structures offer a protective environment for these strains, defending them from sudden toxic chemical shocks and immobilize in cubes. This engineered microenvironment cube significantly enhances nitrification and improves the overall ammonia removal rate per single AOB cell. This approach D encapsulation of multiple strains at close range in cube in order to control their interactions D not only offers a new strategy for enhancing nitrification, but also can be adapted to improve the production of fermentation products and biofuel, because microbial processes require synergetic reactions among multiple species.	[Samarasinghe, S. A. P. L.; Kameoka, Jun] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA; [Shao, Yiru; Chu, Kung-Hui] Texas A&M Univ, Zachry Dept Civil Engn, College Stn, TX USA; [Huang, Po-Jung; Kameoka, Jun] Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX 77843 USA; [Pishko, Michael] Texas A&M Univ, Dept Biomed Engn, College Stn, TX USA; [Samarasinghe, S. A. P. L.] Wisenbaker Engn Bldg,3128 TAMU,188 Bizzell St, College Stn, TX 77843 USA; [Shao, Yiru] CE Off Bldg,3136 TAMU,199 Spence St, College Stn, TX 77843 USA; [Huang, Po-Jung] Reed McDonald Bldg,575 Ross St, College Stn, TX 77840 USA; [Pishko, Michael] Emerging Technol Bldg,3120 TAMU,101 Bizzell St, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Kameoka, J (corresponding author), Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA.; Kameoka, J (corresponding author), Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX 77843 USA.	kameoka@ece.tamu.edu	Chu, Kung-Hui/C-4162-2016; Kameoka, Jun/AAW-7910-2021; Huang, Po-Jung/R-7595-2018	Chu, Kung-Hui/0000-0002-4212-1789; Huang, Po-Jung/0000-0003-1273-3060; Kameoka, Jun/0000-0003-3479-354X	NIH-NCRR [1S10RR22532-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022532] Funding Source: NIH RePORTER	NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The imaging work was partially supported by NIH-NCRR (1S10RR22532-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya G, 2010, J CONTROL RELEASE, V141, P314, DOI 10.1016/j.jconrel.2009.09.032; Bashan Y, 1998, BIOTECHNOL ADV, V16, P729, DOI 10.1016/S0734-9750(98)00003-2; Berman T, 1999, J PLANKTON RES, V21, P1423, DOI 10.1093/plankt/21.8.1423; Brown A. B. D., 2000, PHYS REV E, V62; Chan BP, 2007, BIOMATERIALS, V28, P4652, DOI 10.1016/j.biomaterials.2007.07.041; Chan-Park MB, 2003, LANGMUIR, V19, P4371, DOI 10.1021/la026967t; Chen CH, 2009, ADV MATER, V21, P3201, DOI 10.1002/adma.200900499; Cheng HW, 2011, BIOMATERIALS, V32, P1526, DOI 10.1016/j.biomaterials.2010.10.021; Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9; Dendukuri D, 2006, NAT MATER, V5, P365, DOI 10.1038/nmat1617; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3; Dong YW, 2014, ECOL ENG, V73, P809, DOI 10.1016/j.ecoleng.2014.09.020; Endres H.J., 2009, TECHNISCHE BIOPOLYME, P152; Garcia J, 2006, BIORESOURCE TECHNOL, V97, P1709, DOI 10.1016/j.biortech.2005.07.019; Gauvin R, 2012, WIRES NANOMED NANOBI, V4, P235, DOI 10.1002/wnan.171; Hatakeyama H, 2010, ADV POLYM SCI, V232, P1, DOI 10.1007/12_2009_12; Heo YJ, 2011, P NATL ACAD SCI USA, V108, P13399, DOI 10.1073/pnas.1104954108; Ho Choi Jin, 2014, [Journal of the Korean Society for Precision Engineering, 한국정밀공학회지], V31, P743, DOI 10.7736/KSPE.2014.31.8.743; Hong SM, 2012, LAB CHIP, V12, P3277, DOI 10.1039/c2lc40558j; Hunt NC, 2010, BIOTECHNOL LETT, V32, P733, DOI 10.1007/s10529-010-0221-0; Hwang DK, 2008, LAB CHIP, V8, P1640, DOI 10.1039/b805176c; Koh WG, 2002, LANGMUIR, V18, P2459, DOI 10.1021/la0115740; Lee M, 2009, BIOMATERIALS, V30, P1214, DOI 10.1016/j.biomaterials.2008.11.017; Lee NY, 2006, LANGMUIR, V22, P9018, DOI 10.1021/la060790b; Li YY, 2014, TISSUE ENG PT A, V20, P1379, DOI [10.1089/ten.tea.2013.0498, 10.1089/ten.TEA.2013.0498]; McGuigan AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002258; Mi L, 2011, ADV FUNCT MATER, V21, P4028, DOI 10.1002/adfm.201100871; Obst M, 2004, BIOMACROMOLECULES, V5, P1166, DOI 10.1021/bm049949u; Oh JK, 2008, PROG POLYM SCI, V33, P448, DOI 10.1016/j.progpolymsci.2008.01.002; Othmer K., 2000, ENCY CHEM TECHNOLOGY, P22950; Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863; Peteu SF, 2010, POLYMERS-BASEL, V2, P229, DOI 10.3390/polym2030229; Randall C.W., 1998, DESIGN RETROFIT WAST, V5, P434; Rolland JP, 2005, J AM CHEM SOC, V127, P10096, DOI 10.1021/ja051977c; Stachowiak AN, 2008, J BIOMED MATER RES A, V85A, P815, DOI 10.1002/jbm.a.31661; Sudarno U, 2011, BIORESOURCE TECHNOL, V102, P5665, DOI 10.1016/j.biortech.2011.02.078; Tan YC, 2006, SENSOR ACTUAT B-CHEM, V114, P350, DOI 10.1016/j.snb.2005.06.008; Tarre S, 2004, APPL ENVIRON MICROB, V70, P6481, DOI 10.1128/AEM.70.11.6481-6487.2004; Wandrey C, 2010, ENCAPSULATION TECHNOLOGIES FOR ACTIVE FOOD INGREDIENTS AND FOOD PROCESSING, P31, DOI 10.1007/978-1-4419-1008-0_3; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Wong HL, 2007, BIOMATERIALS, V28, P5369, DOI 10.1016/j.biomaterials.2007.08.016; Xu SQ, 2005, ANGEW CHEM INT EDIT, V44, P724, DOI 10.1002/anie.200462226; Yang L, 2008, BIOPHYS J, V94, P2204, DOI 10.1529/biophysj.107.111013; Yao L, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt320; Yeh CH, 2009, SENSOR ACTUAT A-PHYS, V151, P231, DOI 10.1016/j.sna.2009.02.036; Yeung CW, 2009, TISSUE ENG PT A, V15, P3071, DOI [10.1089/ten.tea.2008.0661, 10.1089/ten.TEA.2008.0661]; Yu B, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/9/095016	48	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165839	10.1371/journal.pone.0165839	http://dx.doi.org/10.1371/journal.pone.0165839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812154	Green Published, Green Submitted, gold			2022-12-26	WOS:000386910000068
J	van de Garde, MDB; Movita, D; van der Heide, M; Herschke, F; De Jonghe, S; Gama, L; Boonstra, A; Vanwolleghem, T				van de Garde, Martijn D. B.; Movita, Dowty; van der Heide, Marieke; Herschke, Florence; De Jonghe, Sandra; Gama, Lucio; Boonstra, Andre; Vanwolleghem, Thomas			Liver Monocytes and Kupffer Cells Remain Transcriptionally Distinct during Chronic Viral Infection	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; HEPATITIS-B; GENE-EXPRESSION; T-CELLS; IN-VIVO; INFLAMMATION; PERSISTENCE; INTERFERON; GLYCOPROTEIN; SUPPRESSION	Due to the scarcity of immunocompetent animal models for chronic viral hepatitis, little is known about the role of the innate intrahepatic immune system during viral replication in the liver. These insights are however fundamental for the understanding of the inappropriate adaptive immune responses during the chronic phase of the infection. We apply the Lymphocytic Choriomenigitis Virus (LCMV) clone 13 mouse model to examine chronic virus-host interactions of Kupffer cells (KC) and infiltrating monocytes (IM) in an infected liver. LCMV infection induced overt clinical hepatitis, with rise in ALT and serum cytokines, and increased intrahepatic F4/80 expression. Despite ongoing viral replication, whole liver transcriptome showed baseline expression levels of inflammatory cytokines, interferons, and interferon induced genes during the chronic infection phase. Transcriptome analyses of sorted KC and IMs using NanoString technology revealed two unique phenotypes with only minimal overlap. At the chronic viral infection phase, KC showed no increased transcription of activation markers Cd80 and Cd86, but an increased expression of genes related to antigen presentation, whereas monocytes were more activated and expressed higher levels of Tnf transcripts. Although both KCs and intrahepatic IM share the surface markers F4/80 and CD11b, their transcriptomes point towards distinctive roles during virus-induced chronic hepatitis.	[van de Garde, Martijn D. B.; Movita, Dowty; van der Heide, Marieke; Boonstra, Andre; Vanwolleghem, Thomas] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Herschke, Florence; De Jonghe, Sandra] Janssen Pharmaceut NV, Beerse, Belgium; [Gama, Lucio] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD USA	Erasmus University Rotterdam; Erasmus MC; Johnson & Johnson; Janssen Pharmaceuticals; Johns Hopkins University	Vanwolleghem, T (corresponding author), Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	t.vanwolleghem@erasmusmc.nl	Vanwolleghem, Thomas/AAD-4094-2022	Vanwolleghem, Thomas/0000-0002-0572-8741; van de Garde, Martijn/0000-0003-0509-7713; Boonstra, Andre/0000-0001-8607-1616	Virgo consortium; Dutch government [FES0908]; Janssen Infectious Diseases Diagnostics BVBA project ICD [551306]; Erasmus MC Fellowship; mandate of the Belgian Foundation Against Cancer [2014-087]	Virgo consortium; Dutch government; Janssen Infectious Diseases Diagnostics BVBA project ICD; Erasmus MC Fellowship; mandate of the Belgian Foundation Against Cancer	This study was supported by the Virgo consortium, funded by the Dutch government project number FES0908, and by the research collaboration with Janssen Infectious Diseases Diagnostics BVBA project number ICD#551306. TV is supported by an Erasmus MC Fellowship 2011 and a mandate of the Belgian Foundation Against Cancer (2014-087). FH and SdJ are employees of Janssen-Pharmaceutica NV. The funder provided support in the form of salaries for authors FH and SdJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bhattacharya A, 2015, IMMUNITY, V43, P974, DOI 10.1016/j.immuni.2015.10.013; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Boltjes A, 2015, J INFECT DIS, V211, P1268, DOI 10.1093/infdis/jiu599; Boltjes A, 2014, J HEPATOL, V61, P660, DOI 10.1016/j.jhep.2014.04.026; Boltjes A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097006; Chen LM, 2010, GASTROENTEROLOGY, V138, P1123, DOI 10.1053/j.gastro.2009.10.046; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Harvey CE, 2003, J LEUKOCYTE BIOL, V74, P360, DOI 10.1189/jlb.0303093; Heymann F, 2015, HEPATOLOGY, V62, P279, DOI 10.1002/hep.27793; Hosel M, 2009, HEPATOLOGY, V50, P1773, DOI 10.1002/hep.23226; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; LOHLER J, 1994, LAB INVEST, V70, P263; MATLOUBIAN M, 1993, J VIROL, V67, P7340, DOI 10.1128/JVI.67.12.7340-7349.1993; Movita D, 2015, J VIROL, V89, P4809, DOI 10.1128/JVI.03733-14; Noel N, 2014, AIDS, V28, P467, DOI 10.1097/QAD.0000000000000174; Norris BA, 2013, IMMUNITY, V38, P309, DOI 10.1016/j.immuni.2012.10.022; Peppa D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001227; Reis PP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-46; SALVATO M, 1991, J VIROL, V65, P1863, DOI 10.1128/JVI.65.4.1863-1869.1991; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wu JF, 2010, GASTROENTEROLOGY, V138, DOI DOI 10.1053/J.GASTRO.2009.09.018; Xia YC, 2016, GASTROENTEROLOGY, V150, P194, DOI 10.1053/j.gastro.2015.09.026; Zhou X, 2012, VIRUSES-BASEL, V4, P2650, DOI 10.3390/v4112650; ZINKERNAGEL RM, 1986, J EXP MED, V164, P1075, DOI 10.1084/jem.164.4.1075	33	8	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166094	10.1371/journal.pone.0166094	http://dx.doi.org/10.1371/journal.pone.0166094			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812182	Green Submitted, gold, Green Published			2022-12-26	WOS:000386910000101
J	Barai, P; Kumar, A; Mukherjee, PP				Barai, Pallab; Kumar, Aloke; Mukherjee, Partha P.			Modeling of Mesoscale Variability in Biofilm Shear Behavior	PLOS ONE			English	Article							MICROFLUIDIC DEVICE; FINITE-ELEMENT; FRACTURE; STREAMERS; TRANSPORT; MATRIX; ELASTICITY; MECHANICS; STRENGTH; SYSTEMS	Formation of bacterial colonies as biofilm on the surface/interface of various objects has the potential to impact not only human health and disease but also energy and environmental considerations. Biofilms can be regarded as soft materials, and comprehension of their shear response to external forces is a key element to the fundamental understanding. A mesoscale model has been presented in this article based on digitization of a biofilm microstructure. Its response under externally applied shear load is analyzed. Strain stiffening type behavior is readily observed under high strain loads due to the unfolding of chains within soft polymeric substrate. Sustained shear loading of the biofilm network results in strain localization along the diagonal direction. Rupture of the soft polymeric matrix can potentially reduce the intercellular interaction between the bacterial cells. Evolution of stiffness within the biofilm network under shear reveals two regimes: a) initial increase in stiffness due to strain stiffening of polymer matrix, and b) eventual reduction in stiffness because of tear in polymeric substrate.	[Barai, Pallab; Mukherjee, Partha P.] Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA; [Kumar, Aloke] Univ Alberta, Dept Mech Engn, Edmonton, AB, Canada; [Barai, Pallab] Lawrence Berkeley Natl Lab, Energy Storage & Distributed Resources Div, Berkeley, CA USA	Texas A&M University System; Texas A&M University College Station; University of Alberta; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Mukherjee, PP (corresponding author), Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA.; Kumar, A (corresponding author), Univ Alberta, Dept Mech Engn, Edmonton, AB, Canada.	aloke.kumar@ualberta.ca; pmukherjee@tamu.edu			Texas A&M University, Faculty Research Initiation Grant	Texas A&M University, Faculty Research Initiation Grant	This work was supported by Texas A&M University, Faculty Research Initiation Grant to PPM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support from Texas A&M University faculty research initiation grant is gratefully acknowledged.	Aggarwal S, 2012, LANGMUIR, V28, P2812, DOI 10.1021/la204342q; Aravas N, 2008, BIOTECHNOL BIOENG, V101, P196, DOI 10.1002/bit.21865; Arnoldi M, 2000, PHYS REV E, V62, P1034, DOI 10.1103/PhysRevE.62.1034; ARRUDA EM, 1993, J MECH PHYS SOLIDS, V41, P389, DOI 10.1016/0022-5096(93)90013-6; BISHOP PL, 1995, WATER SCI TECHNOL, V31, P143, DOI 10.1016/0273-1223(95)00162-G; Brown HR, 2007, MACROMOLECULES, V40, P3815, DOI 10.1021/ma062642y; Buehler MJ, 2007, J MECH MATER STRUCT, V2, P1019, DOI 10.2140/jomms.2007.2.1019; Buehler MJ, 2007, MATER TODAY, V10, P46, DOI 10.1016/S1369-7021(07)70208-0; Buxton GA, 2001, MODEL SIMUL MATER SC, V9, P485, DOI 10.1088/0965-0393/9/6/302; Cerf A, 2009, LANGMUIR, V25, P5731, DOI 10.1021/la9004642; COSTERTON JW, 1994, J BACTERIOL, V176, P2137, DOI 10.1128/JB.176.8.2137-2142.1994; Das S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07126; Drescher K, 2013, P NATL ACAD SCI USA, V110, P4345, DOI 10.1073/pnas.1300321110; Duddu R, 2008, INT J NUMER METH ENG, V74, P848, DOI 10.1002/nme.2200; Ehret AE, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0676; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Ghosh R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114613; HASHIN Z, 1963, J MECH PHYS SOLIDS, V11, P127, DOI 10.1016/0022-5096(63)90060-7; Hassanpourfard M, 2015, 2015150400098 ARXIV; Hohne DN, 2009, LANGMUIR, V25, P7743, DOI 10.1021/la803413x; Horn H, 2014, ADV BIOCHEM ENG BIOT, V146, P53, DOI 10.1007/10_2014_275; Houry A, 2012, P NATL ACAD SCI USA, V109, P13088, DOI 10.1073/pnas.1200791109; Karimi A, 2015, LAB CHIP, V15, P23, DOI 10.1039/c4lc01095g; Khoo X, 2011, MRS BULL, V36, P357, DOI 10.1557/mrs.2011.66; Kim JW, 2010, WATER RES, V44, P1193, DOI 10.1016/j.watres.2009.05.049; Klapper I, 2002, BIOTECHNOL BIOENG, V80, P289, DOI 10.1002/bit.10376; Korstgens V, 2001, J MICROBIOL METH, V46, P9, DOI 10.1016/S0167-7012(01)00248-2; Kumar A, 2013, MICROFLUID NANOFLUID, V14, P895, DOI 10.1007/s10404-012-1120-6; Kumar A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3600648; Laspidou CS, 2005, WATER SCI TECHNOL, V52, P161, DOI 10.2166/wst.2005.0196; Lembre P, 2012, COMPLEX WORLD OF POLYSACCHARIDES, P371, DOI 10.5772/51213; Li SF, 2000, INT J NUMER METH ENG, V48, P1285, DOI 10.1002/1097-0207(20000730)48:9<1285::AID-NME825>3.0.CO;2-H; Mohan SV, 2007, ENZYME MICROB TECH, V40, P1398, DOI 10.1016/j.enzmictec.2006.10.023; Nealson KH, 2011, MRS BULL, V36, P380, DOI 10.1557/mrs.2011.69; Nukala PKVV, 2005, BIOMATERIALS, V26, P6087, DOI 10.1016/j.biomaterials.2005.03.013; OHASHI A, 1994, WATER SCI TECHNOL, V29, P281, DOI 10.2166/wst.1994.0771; Picioreanu C, 2000, BIOTECHNOL BIOENG, V69, P504, DOI 10.1002/1097-0290(20000905)69:5<504::AID-BIT5>3.0.CO;2-S; Qi HJ, 2006, J ENG MATER-T ASME, V128, P509, DOI 10.1115/1.2345442; Renner LD, 2011, MRS BULL, V36, P347, DOI 10.1557/mrs.2011.65; Rudge TJ, 2012, ACS SYNTH BIOL, V1, P345, DOI 10.1021/sb300031n; Schaudinn C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100002; Shaw T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098102; Shrout JD, 2011, MRS BULL, V36, P367, DOI 10.1557/mrs.2011.67; Simoes M, 2010, LWT-FOOD SCI TECHNOL, V43, P573, DOI 10.1016/j.lwt.2009.12.008; Stoodley P, 2002, J IND MICROBIOL BIOT, V29, P361, DOI 10.1038/sj.jim.7000282; Storck T, 2014, BIOPHYS J, V106, P2037, DOI 10.1016/j.bpj.2014.03.015; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Tanaka Y, 2005, J PHYS CHEM B, V109, P11559, DOI 10.1021/jp0500790; Valiei A, 2012, LAB CHIP, V12, P5133, DOI 10.1039/c2lc40815e; van Loosdrecht MCM, 2002, ANTON LEEUW INT J G, V81, P245, DOI 10.1023/A:1020527020464; Wilking JN, 2013, P NATL ACAD SCI USA, V110, P848, DOI 10.1073/pnas.1216376110; Wilking JN, 2011, MRS BULL, V36, P385, DOI 10.1557/mrs.2011.71; Wingender J, 1999, MICROBIAL EXTRACELLU; Wong GCL, 2011, MRS BULL, V36, P339, DOI 10.1557/mrs.2011.64; ZHANG TC, 1994, WATER RES, V28, P2267, DOI 10.1016/0043-1354(94)90042-6; ZHANG TC, 1994, WATER SCI TECHNOL, V29, P263, DOI 10.2166/wst.1994.0769; Zhao GF, 2011, INT J NUMER ANAL MET, V35, P859, DOI 10.1002/nag.930	58	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165593	10.1371/journal.pone.0165593	http://dx.doi.org/10.1371/journal.pone.0165593			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806068	Green Published, Green Submitted, gold			2022-12-26	WOS:000386715500040
J	Huang, JH; Zhang, C; Zhang, DG; Li, L; Chen, X; Xu, DX				Huang, Jia-Hui; Zhang, Cheng; Zhang, Da-Gang; Li, Lu; Chen, Xi; Xu, De-Xiang			Rifampicin-Induced Hepatic Lipid Accumulation: Association with Up-Regulation of Peroxisome Proliferator-Activated Receptor gamma in Mouse Liver	PLOS ONE			English	Article							PREGNANE-X-RECEPTOR; PPAR-GAMMA; INDUCED HEPATOTOXICITY; LIPOGENIC PATHWAY; GENE-EXPRESSION; DISEASE; STEATOSIS; HEPATOCYTE; DRUG; MICE	Previous study found that rifampicin caused intrahepatic cholestasis. This study investigated the effects of rifampicin on hepatic lipid metabolism. Mice were orally administered with rifampicin (200 mg/kg) daily for different periods. Results showed that serum TG level was progressively reduced after a short elevation. By contrast, hepatic TG content was markedly increased in rifampicin-treated mice. An obvious hepatic lipid accumulation, as determined by Oil Red O staining, was observed in mice treated with rifampicin for more than one week. Moreover, mRNA levels of Fas, Acc and Scd-1, several key genes for fatty acid synthesis, were elevated in rifampicin-treated mice. In addition, the class B scavenger receptor CD36 was progressively up-regulated by rifampicin. Interestingly, hepatic SREBP-1c and LXR-a, two important transcription factors that regulate genes for hepatic fatty acid synthesis, were not activated by rifampicin. Instead, hepatic PXR was rapidly activated in rifampicin-treated mice. Hepatic PPAR., a downstream target of PXR, was transcriptionally up-regulated. Taken together, the increased hepatic lipid synthesis and uptake of fatty acids from circulation into liver jointly contribute to rifampicin-induced hepatic lipid accumulation. The increased uptake of fatty acids from circulation into liver might be partially attributed to rifampicin-induced up-regulation of PPAR. and its target genes.	[Huang, Jia-Hui; Zhang, Da-Gang; Li, Lu; Chen, Xi] Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China; [Zhang, Cheng; Xu, De-Xiang] Anhui Med Univ, Dept Toxicol, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University	Chen, X (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China.; Xu, DX (corresponding author), Anhui Med Univ, Dept Toxicol, Hefei, Peoples R China.	ayfychenxi@163.com; xudex@126.com			National Natural Science Foundation of China [81001480, 81373495]; Research Fund for the Doctoral Program of Higher Education of China [20133420110005]; Natural Science Foundation of Anhui Province [1308085MH120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province)	This project was supported by National Natural Science Foundation of China (81001480, 81373495), Research Fund for the Doctoral Program of Higher Education of China (20133420110005), Natural Science Foundation of Anhui Province (1308085MH120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amacher DE, 2014, SEMIN LIVER DIS, V34, P205, DOI 10.1055/s-0034-1375960; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Asrih M, 2014, CLIN NUTR, V33, P186, DOI 10.1016/j.clnu.2013.11.003; Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Chen X, 2011, EUR J PHARMACOL, V659, P53, DOI 10.1016/j.ejphar.2011.03.007; Chen X, 2009, TOXICOL APPL PHARM, V240, P26, DOI 10.1016/j.taap.2009.06.022; Chowdhury A, 2006, J HEPATOL, V45, P117, DOI 10.1016/j.jhep.2006.01.027; Enriquez-Cortina C, 2013, TOXICOL SCI, V135, P26, DOI 10.1093/toxsci/kft134; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Garcia-Monzon C, 2014, EUR J CLIN INVEST, V44, P65, DOI 10.1111/eci.12192; He JH, 2011, EXP BIOL MED, V236, P1116, DOI 10.1258/ebm.2011.011128; Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; Kazantzis M, 2012, BBA-MOL CELL BIOL L, V1821, P852, DOI 10.1016/j.bbalip.2011.09.010; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Meng Q, 2006, TOXICOL LETT, V166, P19, DOI 10.1016/j.toxlet.2006.05.008; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716; Moreau A, 2009, HEPATOLOGY, V49, P2068, DOI 10.1002/hep.22907; Nassir F, 2014, INT J MOL SCI, V15, P8713, DOI 10.3390/ijms15058713; Pieper-Furst U, 2013, BBA-MOL CELL BIOL L, V1831, P1191, DOI 10.1016/j.bbalip.2013.03.013; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schreurs M, 2010, OBES REV, V11, P380, DOI 10.1111/j.1467-789X.2009.00642.x; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Sheedfar F, 2014, AGING-US, V6, P281, DOI 10.18632/aging.100652; Shen C, 2009, CELL BIOL TOXICOL, V25, P265, DOI 10.1007/s10565-008-9076-8; Shih TY, 2013, CURR DRUG METAB, V14, P720, DOI 10.2174/1389200211314060008; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Staudinger JL, 2013, DRUG METAB REV, V45, P48, DOI 10.3109/03602532.2012.748793; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Xu X, 2013, SEMIN LIVER DIS, V33, P301, DOI 10.1055/s-0033-1358523; Yew WW, 2006, RESPIROLOGY, V11, P699, DOI 10.1111/j.1440-1843.2006.00941.x; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067959; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200; Zhu JZ, 2015, DIGEST DIS SCI, V60, P3194, DOI 10.1007/s10620-015-3728-3	43	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165787	10.1371/journal.pone.0165787	http://dx.doi.org/10.1371/journal.pone.0165787			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806127	Green Published, gold, Green Submitted			2022-12-26	WOS:000386715500055
J	MacIsaac, HJ; De Roy, EM; Leung, B; Grgicak-Mannion, A; Ruiz, GM				MacIsaac, Hugh J.; De Roy, Emma M.; Leung, Brian; Grgicak-Mannion, Alice; Ruiz, Gregory M.			Possible Ballast Water Transfer of Lionfish to the Eastern Pacific Ocean	PLOS ONE			English	Article							PTEROIS-VOLITANS LINNAEUS; GULF-OF-MEXICO; RECENT INVASION; ATLANTIC COAST; SCORPAENIDAE; TOLERANCE; SHIPS; NORTH	The Indo-Pacific Red Lionfish was first reported off the Florida coast in 1985, following which it has spread across much of the SE USA, Gulf of Mexico, and Caribbean Sea. Lion fish negatively impact fish and invertebrate assemblages and abundances, thus further spread is cause for concern. To date, the fish has not been reported on the Pacific coast of North or Central America. Here we examine the possibility of ballast water transfer of lion fish from colonized areas in the Atlantic Ocean to USA ports on the Pacific coast. Over an eight-year period, we documented 27 commercial vessel-trips in which ballast water was loaded in colonized sites and later discharged untreated into Pacific coast ports in the USA. California had the highest number of discharges including San Francisco Bay and Los Angeles-Long Beach. A species distribution model suggests that the probability of lionfish establishment is low for the western USA, Colombia and Panama, low to medium for Costa Rica, Nicaragua, El Salvador and Guatemala, medium to high for mainland Ecuador, and very high for western Mexico, Peru and the Galapagos Islands. Given the species' intolerance of freshwater conditions, we propose that ballast water exchange be conducted in Gatun Lake, Panama for western-bound vessels carrying 'risky' ballast water to prevent invasion of the eastern Pacific Ocean.	[MacIsaac, Hugh J.; De Roy, Emma M.; Grgicak-Mannion, Alice] Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON, Canada; [Leung, Brian] McGill Univ, Dept Biol, Montreal, PQ, Canada; [Ruiz, Gregory M.] Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA	University of Windsor; McGill University; Smithsonian Institution; Smithsonian Environmental Research Center	MacIsaac, HJ (corresponding author), Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON, Canada.	hughm@uwindsor.ca	macisaac, hugh/AAE-3742-2020	Ruiz, Gregory/0000-0003-2499-441X	Smithsonian Institution; NSERC Discovery grants; Canada Research Chair	Smithsonian Institution(Smithsonian Institution); NSERC Discovery grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	Financial support was provided by the Smithsonian Institution to GMR, NSERC Discovery grants to BL and HJM, and a Canada Research Chair to HJM.; We are grateful to two reviewers who helped improve the manuscript. Financial support was provided by the Smithsonian Institution to GMR, NSERC Discovery grants to BL and HJM, and a Canada Research Chair to HJM. We are grateful to the National Ballast Information Clearinghouse for database records, Dr. Pam Schofield of the United States Geological Survey for lionfish reports, Dr. Matthias Herb org for initial data compilation and GIS support and Dr. Nick Mandrak for information regarding lionfish biology.	Aguilar-Perera A, 2010, AQUAT INVASIONS, V5, pS9, DOI 10.3391/ai.2010.5.S1.003; Ahrenholz DW, 2010, ENVIRON BIOL FISH, V88, P305, DOI 10.1007/s10641-010-9647-4; Albins MA, 2013, ENVIRON BIOL FISH, V96, P1151, DOI 10.1007/s10641-011-9795-1; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Barker B., 2015, THESIS; Benkwitt CE, 2015, BIOL INVASIONS, V17, P1383, DOI 10.1007/s10530-014-0801-3; Betancur-R R, 2011, J BIOGEOGR, V38, P1281, DOI 10.1111/j.1365-2699.2011.02496.x; Cerino D, 2013, T AM FISH SOC, V142, P1522, DOI 10.1080/00028487.2013.811098; Coutts ADM, 2003, MAR POLLUT BULL, V46, P1510, DOI 10.1016/S0025-326X(03)00292-3; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Evangelista PH, 2016, AQUAT INVASIONS, V11, P313, DOI 10.3391/ai.2016.11.3.09; Ferreira CEL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123002; FIN (FishBase Information and Research Group), 2015, REV DISTR MAPS PTER; Fishelson L., 1975, Pubblicazioni Staz Zool Napoli, V39, P635; Gardner PG, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00007; Green SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032596; Hamner RM, 2007, J FISH BIOL, V71, P214, DOI 10.1111/j.1095-8649.2007.01575.x; Imamura Hisashi, 1996, Bulletin of the Faculty of Fisheries Hokkaido University, V47, P41; Johnston MW, 2014, BIOL INVASIONS, V16, P2681, DOI 10.1007/s10530-014-0696-z; Johnston MW, 2014, MAR POLLUT BULL, V88, P138, DOI 10.1016/j.marpolbul.2014.09.013; Johnston MA, 2016, BIOINVASIONS REC, V5, P115, DOI 10.3391/bir.2016.5.2.09; Jud ZR, 2015, ENVIRON BIOL FISH, V98, P135, DOI 10.1007/s10641-014-0242-y; Jud ZR, 2011, AQUAT BIOL, V13, P21, DOI 10.3354/ab00351; Kaschner K, 2013, AQUAMAPS ENV DATASET; Keith I., 2015, GALAPAGOS REPORT 201, P83; Kimball ME, 2004, MAR ECOL PROG SER, V283, P269, DOI 10.3354/meps283269; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; Layman CA, 2014, MAR BIOL, V161, P2179, DOI 10.1007/s00227-014-2491-x; Meister HS, 2005, SOUTHEAST NAT, V4, P193, DOI 10.1656/1528-7092(2005)004[0193:FEFTIA]2.0.CO;2; Mito S., 1958, SCI B FAC AGR KYUSHU, V16, P381; Morris JA, 2009, THESIS N CAROLINA ST; Poursanidis D., 2015, 11 PANH S OC FISH MY, P621; R Core Team, 2016, R FDN STAT COMP; Rahel FJ, 2007, FRESHWATER BIOL, V52, P696, DOI 10.1111/j.1365-2427.2006.01708.x; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Roche D, 2008, THESIS; Schloder C, 2013, AQUAT INVASIONS, V8, P443, DOI 10.3391/ai.2013.8.4.08; Schofield PJ, 2015, AQUAT INVASIONS, V10, P333, DOI 10.3391/ai.2015.10.3.08; Schofield Pamela J., 2009, Aquatic Invasions, V4, P473; Schofield PJ, 2015, PTEROIS VOLITANS MIL; Vasquez-Yeomans L, 2011, BIOL INVASIONS, V13, P2635, DOI 10.1007/s10530-011-9968-z; Watkins G., 2007, GALAPAGOS RISK SOCIO; Whitfield PE, 2002, MAR ECOL PROG SER, V235, P289, DOI 10.3354/meps235289; Williams SL, 2015, MANAG BIOL INVASION, V6, P13, DOI 10.3391/mbi.2015.6.1.02; Wonham MJ, 2000, MAR BIOL, V136, P1111, DOI 10.1007/s002270000303; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]	46	9	9	9	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165584	10.1371/journal.pone.0165584	http://dx.doi.org/10.1371/journal.pone.0165584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806076	gold, Green Published, Green Submitted			2022-12-26	WOS:000386715500038
J	Choi, SKY; Boyle, E; Cairney, J; Collins, EJ; Gardner, S; Bacon, J; Rourke, SB				Choi, Stephanie K. Y.; Boyle, Eleanor; Cairney, John; Collins, Evan J.; Gardner, Sandra; Bacon, Jean; Rourke, Sean B.			Prevalence, Recurrence, and Incidence of Current Depressive Symptoms among People Living with HIV in Ontario, Canada: Results from the Ontario HIV Treatment Network Cohort Study	PLOS ONE			English	Article							SUBSTANCE USE DISORDERS; MENTAL-HEALTH-SERVICES; QUALITY-OF-LIFE; INFECTED PATIENTS; RISK BEHAVIOR; ANTIRETROVIRAL THERAPY; PSYCHIATRIC-DISORDERS; POSITIVE INDIVIDUALS; ADULTS; CARE	Introduction Current studies of depression among people living with HIV focus on describing its point prevalence. Given the fluctuating nature of depression and its profound impacts on clinical and quality-of-life outcomes, this study aimed to examine the prevalence, recurrence and incidence of current depressive symptoms and its underlying catalysts longitudinally and systematically among these individuals. Methods We conducted a prospective cohort study between October 1, 2007 and December 31, 2012 using longitudinal linked data sources. Current depressive symptoms was identified using the Centre for Epidemiologic Studies Depression Scale or the Kessler Psychological Distress Scale, first at baseline and again during follow-up interviews. Multivariable regressions were used to characterize the three outcomes. Results Of the 3,816 HIV-positive participants, the point prevalence of depressive symptoms was estimated at 28%. Of the 957 participants who were identified with depressive symptoms at baseline and who had at least two years of follow-up, 43% had a recurrent episode. The cumulative incidence among 1,745 previously depressive symptoms free participants (at or prior to baseline) was 14%. During the five-year follow-up, our multivariable models showed that participants with greater risk of recurrent cases were more likely to feel worried about their housing situation. Participants at risk of developing incident cases were also likely to be younger, gay or bisexual, and unable to afford housing-related expenses. Conclusions Depressive symptoms are prevalent and likely to recur among people living with HIV. Our results support the direction of Ontario's HIV/AIDS Strategy to 2026, which addresses medical concerns associated with HIV (such as depression) and the social drivers of health in order to enhance the overall well-being of people living with or at risk of HIV. Our findings reinforce the importance of providing effective mental health care and demonstrate the need for long-term support and routine management of depression, particularly for individuals at high risk.	[Choi, Stephanie K. Y.] Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON, Canada; [Choi, Stephanie K. Y.; Bacon, Jean; Rourke, Sean B.] Ontario HIV Treatment Network, Toronto, ON, Canada; [Boyle, Eleanor; Cairney, John; Gardner, Sandra] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Boyle, Eleanor; Collins, Evan J.] Univ Southern Denmark, Inst Sports Sci & Clin Biomech, Odense, Denmark; [Cairney, John; Rourke, Sean B.] Univ Toronto, Dept Psychiat, Fac Med, Toronto, ON, Canada; [Cairney, John] McMaster Univ, Dept Family Med, Hamilton, ON, Canada; [Cairney, John] McMaster Univ, Infant & Child Hlth Lab, Hamilton, ON, Canada; [Cairney, John] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Cairney, John] McMaster Univ, CanChild Ctr Childhood Disabil Res, Hamilton, ON, Canada; [Cairney, John] McMaster Univ, Offord Ctr Child Studies, Hamilton, ON, Canada; [Cairney, John] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Cairney, John] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Cairney, John] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Cairney, John] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Collins, Evan J.] Univ Hlth Network, Toronto, ON, Canada; [Rourke, Sean B.] St Michaels Hosp, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Southern Denmark; University of Toronto; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Rourke, SB (corresponding author), Ontario HIV Treatment Network, Toronto, ON, Canada.; Rourke, SB (corresponding author), Univ Toronto, Dept Psychiat, Fac Med, Toronto, ON, Canada.; Rourke, SB (corresponding author), St Michaels Hosp, Toronto, ON, Canada.	sean.rourke@utoronto.ca	Boyle, Eleanor/G-4567-2016; Cairney, John/AAQ-9703-2020	Boyle, Eleanor/0000-0002-9012-9128; Cairney, John/0000-0003-2856-3967; Choi, Stephanie Ka Yee/0000-0003-3019-5729	Ontario HIV Treatment Network (OHTN) - Ontario Ministry of Health and Long-Term Care (MOHLTC); Institute for Clinical Evaluative Sciences - Ontario Ministry of Health and Long-Term Care (MOHLTC)	Ontario HIV Treatment Network (OHTN) - Ontario Ministry of Health and Long-Term Care (MOHLTC); Institute for Clinical Evaluative Sciences - Ontario Ministry of Health and Long-Term Care (MOHLTC)	This study was supported by the Ontario HIV Treatment Network (OHTN) and the Institute for Clinical Evaluative Sciences, which are funded by annual grants from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Ontario HIV Treatment Network (OHTN) and the Institute for Clinical Evaluative Sciences, which are funded by annual grants from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akena D, 2013, AIDS BEHAV, V17, P2802, DOI 10.1007/s10461-012-0383-y; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anagnostopoulos A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140943; Bess KD, 2013, AIDS PATIENT CARE ST, V27, P171, DOI 10.1089/apc.2012.0406; Bing EG, 2001, ARCH GEN PSYCHIAT, V58, P721, DOI 10.1001/archpsyc.58.8.721; Blashill AJ, 2012, AIDS BEHAV, V16, P2251, DOI 10.1007/s10461-011-0056-2; Bousman CA, 2009, J AFFECT DISORDERS, V119, P84, DOI 10.1016/j.jad.2009.04.006; Bradley MV, 2008, PSYCHOSOM MED, V70, P186, DOI 10.1097/PSY.0b013e3181642a1c; Burcusa SL, 2007, CLIN PSYCHOL REV, V27, P959, DOI 10.1016/j.cpr.2007.02.005; Burnam MA, 2001, ARCH GEN PSYCHIAT, V58, P729, DOI 10.1001/archpsyc.58.8.729; Cairney J, 2007, CAN J PSYCHIAT, V52, P111, DOI 10.1177/070674370705200209; Chibanda D, 2014, JAIDS S1, V67, P54; Choi SKY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156652; Choi SKY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142706; Choi SKY, 2015, AIDS CARE, V27, P1183, DOI 10.1080/09540121.2015.1036725; Cook JA, 2014, AIDS BEHAV, V18, P1094, DOI 10.1007/s10461-013-0679-6; Curran GM, 2011, AIDS CARE, V23, P1626, DOI 10.1080/09540121.2011.579943; Del Guerra FB, 2013, J NEUROVIROL, V19, P314, DOI 10.1007/s13365-013-0177-7; Do AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092842; Donker T, 2010, J AFFECT DISORDERS, V122, P253, DOI 10.1016/j.jad.2009.07.013; Elenga N, 2014, INT J STD AIDS, V25, P559, DOI 10.1177/0956462413514954; Eller LS, 2014, AIDS CARE, V26, P795, DOI 10.1080/09540121.2013.841842; Fiest KM, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0289-5; Hardeveld F, 2010, ACTA PSYCHIAT SCAND, V122, P184, DOI 10.1111/j.1600-0447.2009.01519.x; Harrell FE, 2001, REGRESSION MODELING; Himelhoch S, 2009, GEN HOSP PSYCHIAT, V31, P538, DOI 10.1016/j.genhosppsych.2009.05.009; Hirshfield S, 2004, AIDS CARE, V16, P1036, DOI 10.1080/09540120412331292525; Johnson JG, 1999, COMPR PSYCHIAT, V40, P31, DOI 10.1016/S0010-440X(99)90073-1; Katz MH, 1996, AIDS CARE, V8, P433, DOI 10.1080/09540129650125623; Kim S, 2014, AIDS CARE, V26, P1027, DOI 10.1080/09540121.2014.894613; King M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-70; Komiti A, 2002, DEPRESSION PEOPLE LI, V37, P70; KUPFER DJ, 1991, J CLIN PSYCHIAT, V52, P28; Lam RW, 2009, J AFFECT DISORDERS, V117, pS26, DOI 10.1016/j.jad.2009.06.041; Leaver CA, 2007, AIDS BEHAV, V11, pS85, DOI 10.1007/s10461-007-9246-3; Leserman J, 2008, PSYCHOSOM MED, V70, P539, DOI 10.1097/PSY.0b013e3181777a5f; Logie C, 2013, AIDS PATIENT CARE ST, V27, P114, DOI 10.1089/apc.2012.0296; Malee KM, 2014, JAIDS-J ACQ IMM DEF, V65, P526, DOI 10.1097/QAI.0000000000000070; Meade CS, 2008, DRUG ALCOHOL DEPEN, V92, P296, DOI 10.1016/j.drugalcdep.2007.07.013; Meade CS, 2005, CLIN PSYCHOL REV, V25, P433, DOI 10.1016/j.cpr.2005.02.001; Meader N, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X613151; Milloy MJ, 2012, CURR HIV-AIDS REP, V9, P364, DOI 10.1007/s11904-012-0137-5; Ministry of Health and Long-term Care, ONT PUBL DRUG PROGR; Mizuno Y, 2015, AIDS BEHAV, V19, P684, DOI 10.1007/s10461-014-0890-0; Nacher M, 2010, AIDS CARE, V22, P1086, DOI 10.1080/09540121003599232; Nanni MG, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-014-0530-4; Normen L, 2005, J NUTR, V135, P820, DOI 10.1093/jn/135.4.820; O'Leary A, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000167353.02289.b9; Owe-Larsson B, 2009, AFR J PSYCHIATRY, V12, P115; Parhami I, 2013, AIDS BEHAV, V17, P2792, DOI 10.1007/s10461-012-0386-8; Protopopescu C, 2012, ANTIVIR THER, V17, P1079, DOI 10.3851/IMP2102; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ramasubbu R, 2012, ANN CLIN PSYCHIATRY, V24, P82; Reif S, 2006, AIDS CARE, V18, pS10, DOI 10.1080/09540120600838738; Rourke SB, 2013, INT J EPIDEMIOL, V42, P402, DOI 10.1093/ije/dyr230; Rourke SB, 2012, AIDS BEHAV, V16, P2361, DOI 10.1007/s10461-012-0284-0; Schumacher JE, 2013, AIDS BEHAV, V17, P2781, DOI 10.1007/s10461-012-0342-7; Schuster R, 2012, BEHAV MODIF, V36, P123, DOI 10.1177/0145445511425231; Shacham E, 2009, AIDS PATIENT CARE ST, V23, P949, DOI 10.1089/apc.2009.0064; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; Sikkema KJ, 2010, AIDS BEHAV, V14, P252, DOI 10.1007/s10461-009-9650-y; Smit PJ, 2012, AIDS CARE, V24, P405, DOI 10.1080/09540121.2011.613910; Soller M, 2011, AIDS CARE, V23, P1351, DOI 10.1080/09540121.2011.565024; Springer SA, 2012, AIDS BEHAV, V16, P2119, DOI 10.1007/s10461-012-0212-3; StataCorp, 2013, STAT SOFTW; Taylor SL, 2004, J BEHAV HEALTH SER R, V31, P149; Tsai AC, 2014, JAIDS-J ACQ IMM DEF, V66, P503, DOI 10.1097/QAI.0000000000000210; Uthman OA, 2014, CURR HIV-AIDS REP, V11, P291, DOI 10.1007/s11904-014-0220-1; Vitiello B, 2003, AM J PSYCHIAT, V160, P547, DOI 10.1176/appi.ajp.160.3.547; Vittinghoff E, 2012, REGRESSION METHODS B; Weaver MR, 2008, JAIDS-J ACQ IMM DEF, V47, P449, DOI 10.1097/QAI.0b013e3181642244; Whetten K, 2008, PSYCHOSOM MED, V70, P531, DOI 10.1097/PSY.0b013e31817749dc; Williams P, 2005, AIDS EDUC PREV, V17, P119, DOI 10.1521/aeap.17.3.119.62903; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090; Zuniga JA, 2016, AIDS PATIENT CARE ST, V30, P34, DOI 10.1089/apc.2015.0214	75	15	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165816	10.1371/journal.pone.0165816	http://dx.doi.org/10.1371/journal.pone.0165816			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6CX	27802346	Green Published, Green Submitted, gold			2022-12-26	WOS:000386714200058
J	Huang, HC; Lee, CP; Liu, HK; Chang, MF; Lai, YH; Lee, YC; Huang, C				Huang, Hsiu-Chen; Lee, Chung-Pei; Liu, Hui-Kang; Chang, Ming-Fu; Lai, Yu-Heng; Lee, Yu-Ching; Huang, Cheng			Cellular Nuclear Export Factors TAP and Aly Are Required for HDAg-L-mediated Assembly of Hepatitis Delta Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPORT; FRAGMENT-LENGTH-POLYMORPHISM; SIGNAL-INTERACTING PROTEIN; B SURFACE-ANTIGEN; LARGE FORM; REPLICATION; DOMAIN; IDENTIFICATION; TRANSPORT; RECEPTOR	Hepatitis delta virus (HDV) is a satellite virus of hepatitis B virus (HBV). HDV genome encodes two forms of hepatitis delta antigen (HDAg), small HDAg (HDAg-S), which is required for viral replication, and large HDAg (HDAg-L), which is essential for viral assembly. HDAg-L is identical to HDAg-S except that it bears a 19-amino acid extension at the C terminus. Both HDAgs contain a nuclear localization signal (NLS), but only HDAg-L contains a CRM1-independent nuclear export signal at its C terminus. The nuclear export activity of HDAg-L is important for HDV particle formation. However, the mechanisms of HDAg-L-mediated nuclear export of HDV ribonucleoprotein are not clear. In this study, the host cellular RNA export complex TAP-Aly was found to form a complex with HDAg-L, but not with an export-defective HDAg-Lmutant, in which Pro(205) was replaced by Ala. HDAg-L was found to colocalize with TAP and Aly in the nucleus. The C-terminal domain of HDAg-L was shown to directly interact with the N terminus of TAP, whereas an HDAg-L mutant lacking the NLS failed to interact with full-length TAP. In addition, small hairpin RNA-mediated down-regulation of TAP or Aly reduced nuclear export of HDAg-L and assembly of HDV virions. Furthermore, a peptide, TAT-HDAg-L(198-210), containing the 10-amino acid TAT peptide and HDAg-L(198-210), inhibited the interaction between HDAg-L and TAP and blocked HDV virion assembly and secretion. These data demonstrate that formation and release of HDV particles are mediated by TAP and Aly.	[Huang, Hsiu-Chen] Natl Hsinchu Univ Educ, Dept Appl Sci, Hsinchu 30014, Taiwan; [Lee, Chung-Pei] Natl Taipei Univ Nursing & Hlth Sci, Sch Nursing, Taipei 11219, Taiwan; [Liu, Hui-Kang; Huang, Cheng] Minist Hlth & Welf, Natl Res Inst Chinese Med, Taipei 11221, Taiwan; [Liu, Hui-Kang] Taipei Med Univ, PhD Program Clin Drug Discovery Bot Herbs, Taipei 11031, Taiwan; [Chang, Ming-Fu] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 10051, Taiwan; [Lai, Yu-Heng] Chinese Culture Univ, Dept Chem, Taipei 11114, Taiwan; [Lee, Yu-Ching] Taipei Med Univ, Ctr Translat Med, Taipei 11031, Taiwan; [Lee, Yu-Ching] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Med Biotechnol, Taipei 11031, Taiwan; [Huang, Cheng] Univ Taipei, Dept Earth & Life Sci, Taipei 10048, Taiwan	National Tsing Hua University; National Taipei University of Nursing & Health Science (NTUNHS); National Research Institute of Chinese Medicine; Taipei Medical University; National Taiwan University; Chinese Culture University; Taipei Medical University; Taipei Medical University; University of Taipei	Huang, C (corresponding author), Natl Res Inst Chinese Med, 155-1,Sec 2,Linong St, Taipei 11221, Taiwan.	chengh@nricm.edu.tw		CHANG, MING-FU/0000-0001-7062-3578	Ministry of Science and Technology, Taiwan [MOST104-2320-B-077-003-MY3, MOST103-2313-B-134-001-MY3]; National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taiwan [MOHW105-NRICM-M-315-000106, MM10501-0274]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taiwan	This work was supported by Grants MOST104-2320-B-077-003-MY3 and MOST103-2313-B-134-001-MY3 from the Ministry of Science and Technology, Taiwan and Grants MOHW105-NRICM-M-315-000106 and MM10501-0274 from the National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taiwan. The authors declare that they have no conflicts of interest with the contents of this article.	Alves C, 2008, VIROLOGY, V370, P12, DOI 10.1016/j.virol.2007.07.034; Aly HH, 2007, J HEPATOL, V46, P26, DOI 10.1016/j.jhep.2006.08.018; Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; BONINO F, 1986, J VIROL, V58, P945, DOI 10.1128/JVI.58.3.945-950.1986; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; CHANG FL, 1991, P NATL ACAD SCI USA, V88, P8490, DOI 10.1073/pnas.88.19.8490; CHANG MF, 1988, J VIROL, V62, P2403, DOI 10.1128/JVI.62.7.2403-2410.1988; CHANG MF, 1994, J VIROL, V68, P646, DOI 10.1128/JVI.68.2.646-653.1994; CHANG MF, 1995, J VIROL, V69, P2508, DOI 10.1128/JVI.69.4.2508-2514.1995; CHANG MF, 1992, J VIROL, V66, P6019, DOI 10.1128/JVI.66.10.6019-6027.1992; Chou HC, 1998, J VIROL, V72, P3684, DOI 10.1128/JVI.72.5.3684-3690.1998; Chou YC, 2005, J VIROL, V79, P1813, DOI 10.1128/JVI.79.3.1813-1823.2005; Fattovich G, 2000, GUT, V46, P420, DOI 10.1136/gut.46.3.420; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; GLENN JS, 1992, SCIENCE, V256, P1331, DOI 10.1126/science.1598578; Hiriart E, 2003, J BIOL CHEM, V278, P335, DOI 10.1074/jbc.M208656200; Hsu SC, 2002, HEPATOLOGY, V35, P665, DOI 10.1053/jhep.2002.31777; Huang C, 2007, J VIROL, V81, P5985, DOI 10.1128/JVI.02809-06; Huang C, 2013, J VIROL, V87, P1596, DOI 10.1128/JVI.02357-12; Huang C, 2009, J VIROL, V83, P12314, DOI 10.1128/JVI.01044-09; Huang HC, 2012, J VIROL, V86, P9443, DOI 10.1128/JVI.00873-12; Huang YQ, 2004, P NATL ACAD SCI USA, V101, P9666, DOI 10.1073/pnas.0403533101; HWANG SB, 1993, J VIROL, V67, P7659, DOI 10.1128/JVI.67.12.7659-7662.1993; Johnson LA, 2009, J VIROL, V83, P6335, DOI 10.1128/JVI.00375-09; Johnson LA, 2009, J VIROL, V83, P1184, DOI 10.1128/JVI.02010-08; Juillard F, 2009, J VIROL, V83, P12759, DOI 10.1128/JVI.01276-09; Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593; Katahira J, 2009, EMBO J, V28, P556, DOI 10.1038/emboj.2009.5; Komla-Soukha I, 2006, J VIROL, V80, P4648, DOI 10.1128/JVI.80.10.4648-4655.2006; KUO MYP, 1989, J VIROL, V63, P1945, DOI 10.1128/JVI.63.5.1945-1950.1989; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; LAI MMC, 1995, ANNU REV BIOCHEM, V64, P259, DOI 10.1146/annurev.bi.64.070195.001355; Lee CH, 2001, J BIOL CHEM, V276, P8142, DOI 10.1074/jbc.M004477200; Liker E, 2000, EMBO J, V19, P5587, DOI 10.1093/emboj/19.21.5587; Lischka P, 2001, EMBO J, V20, P7271, DOI 10.1093/emboj/20.24.7271; LUO GX, 1990, J VIROL, V64, P1021, DOI 10.1128/JVI.64.3.1021-1027.1990; MACNAUGHTON TB, 1993, J VIROL, V67, P2228, DOI 10.1128/JVI.67.4.2228-2234.1993; Macnaughton TB, 2002, J VIROL, V76, P3928, DOI 10.1128/JVI.76.8.3928-3935.2002; O'Malley B, 2005, J VIROL, V79, P1142, DOI 10.1128/JVI.79.2.1142-1153.2005; Polson AG, 1998, MOL CELL BIOL, V18, P1919, DOI 10.1128/MCB.18.4.1919; Polson AG, 1996, NATURE, V380, P454; RIZZETTO M, 1983, HEPATOLOGY, V3, P729; RIZZETTO M, 1983, ANN INTERN MED, V98, P437, DOI 10.7326/0003-4819-98-4-437; Rizzuti M, 2015, DRUG DISCOV TODAY, V20, P76, DOI 10.1016/j.drudis.2014.09.017; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; SARACCO G, 1988, ANN INTERN MED, V108, P380, DOI 10.7326/0003-4819-108-3-380; SHARMEEN L, 1988, J VIROL, V62, P2674, DOI 10.1128/JVI.62.8.2674-2679.1988; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Thomas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022671; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wang D, 2001, J VIROL, V75, P3600, DOI 10.1128/JVI.75.8.3600-3604.2001; Wang YH, 2005, J VIROL, V79, P8113, DOI 10.1128/JVI.79.13.8113-8120.2005; WEINER AJ, 1988, J VIROL, V62, P594, DOI 10.1128/JVI.62.2.594-599.1988; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wente SR, 2000, SCIENCE, V288, P1374, DOI 10.1126/science.288.5470.1374; Wu JC, 1998, J GEN VIROL, V79, P1105, DOI 10.1099/0022-1317-79-5-1105; WU JC, 1995, LANCET, V346, P939, DOI 10.1016/S0140-6736(95)91558-3; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049	58	8	8	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26226	26238		10.1074/jbc.M116.754853	http://dx.doi.org/10.1074/jbc.M116.754853			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27807029	hybrid, Green Published			2022-12-26	WOS:000390345200038
J	Wheat, RE; Allen, JM; Miller, SDL; Wilmers, CC; Levi, T				Wheat, Rachel E.; Allen, Jennifer M.; Miller, Sophie D. L.; Wilmers, Christopher C.; Levi, Taal			Environmental DNA from Residual Saliva for Efficient Noninvasive Genetic Monitoring of Brown Bears (Ursus arctos)	PLOS ONE			English	Article							FECAL DNA; INDIVIDUAL IDENTIFICATION; PREDATOR IDENTIFICATION; MARK-RECAPTURE; BLACK BEARS; POPULATION; SALMON; SIZE; AMPLIFICATION; CONSERVATION	Noninvasive genetic sampling is an important tool in wildlife ecology and management, typically relying on hair snaring or scat sampling techniques, but hair snaring is labor and cost intensive, and scats yield relatively low quality DNA. New approaches utilizing environmental DNA (eDNA) may provide supplementary, cost-effective tools for noninvasive genetic sampling. We tested whether eDNA from residual saliva on partially-consumed Pacific salmon (Oncorhynchus spp.) carcasses might yield suitable DNA quality for noninvasive monitoring of brown bears (Ursus arctos). We compared the efficiency of monitoring brown bear populations using both fecal DNA and salivary eDNA collected from partially-consumed salmon carcasses in Southeast Alaska. We swabbed a range of tissue types from 156 partially-consumed salmon carcasses from a midseason run of lakeshore-spawning sockeye (O. nerka) and a late season run of stream-spawning chum (O. keta) salmon in 2014. We also swabbed a total of 272 scats from the same locations. Saliva swabs collected from the braincases of salmon had the best amplification rate, followed by swabs taken from individual bite holes. Saliva collected from salmon carcasses identified unique individuals more quickly and required much less labor to locate than scat samples. Salmon carcass swabbing is a promising method to aid in efficient and affordable monitoring of bear populations, and suggests that the swabbing of food remains or consumed baits from other animals may be an additional cost-effective and valuable tool in the study of the ecology and population biology of many elusive and/or wide-ranging species.	[Wheat, Rachel E.; Wilmers, Christopher C.] Univ Calif Santa Cruz, Dept Environm Studies, Ctr Integrated Spatial Res, Santa Cruz, CA 95064 USA; [Allen, Jennifer M.; Levi, Taal] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Miller, Sophie D. L.] Yunnan Univ, Lab Conservat & Utilizat Bioresource, Kunming, Peoples R China; [Miller, Sophie D. L.] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China	University of California System; University of California Santa Cruz; Oregon State University; Yunnan University; Chinese Academy of Sciences; Kunming Institute of Zoology	Wheat, RE (corresponding author), Univ Calif Santa Cruz, Dept Environm Studies, Ctr Integrated Spatial Res, Santa Cruz, CA 95064 USA.	rwheat@ucsc.edu		Levi, Taal/0000-0003-1853-8311	NSF GRF; International Bear Association; Alaska Chilkoot Bear Foundation; National Geographic Society [141544]; Thomas G. Scott Publication Fund	NSF GRF(National Science Foundation (NSF)); International Bear Association; Alaska Chilkoot Bear Foundation; National Geographic Society(National Geographic Society); Thomas G. Scott Publication Fund	This work was funded by an NSF GRF to REW, and grants from the International Bear Association, the Alaska Chilkoot Bear Foundation, and the National Geographic Society (grant #141544). Publication of this paper was supported, in part, by the Thomas G. Scott Publication Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADFG, 2014, SE MAN AR FISH REP S; Beier LR, 2005, WILDLIFE SOC B, V33, P766, DOI 10.2193/0091-7648(2005)33[766:FTFASS]2.0.CO;2; Bellemain E, 2005, CONSERV BIOL, V19, P150, DOI 10.1111/j.1523-1739.2005.00549.x; Bellemain E, 2004, MOL ECOL NOTES, V4, P519, DOI 10.1111/j.1471-8286.2004.00711.x; Blejwas KM, 2006, J WILDLIFE MANAGE, V70, P1087, DOI 10.2193/0022-541X(2006)70[1087:SDECBM]2.0.CO;2; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; De Barba M, 2010, J APPL ECOL, V47, P172, DOI 10.1111/j.1365-2664.2009.01752.x; Farley S, 2014, WILDLIFE SOC B, V38, P370, DOI 10.1002/wsb.391; Galpern P, 2012, MOL ECOL RESOUR, V12, P771, DOI 10.1111/j.1755-0998.2012.03137.x; Gende SM, 2001, OECOLOGIA, V127, P372, DOI 10.1007/s004420000590; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Harms V, 2015, J MAMMAL, V96, P138, DOI 10.1093/jmammal/gyu014; Hilderbrand GV, 1999, CAN J ZOOL, V77, P132, DOI 10.1139/cjz-77-1-132; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Karamanlidis AA, 2010, EUR J WILDLIFE RES, V56, P693, DOI 10.1007/s10344-010-0363-3; Kelly MJ, 2012, TECH ECOL CONSERVAT, P47; Kendall KC, 2008, J WILDLIFE MANAGE, V72, P1693, DOI 10.2193/2008-007; Kendall Katherine C., 2008, P141; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Levi T, 2015, PEERJ, V3, DOI 10.7717/peerj.1157; Lobo D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139765; Miller CR, 2005, MOL ECOL, V14, P1991, DOI 10.1111/j.1365-294X.2005.02577.x; Mumma MA, 2014, MOL ECOL RESOUR, V14, P100, DOI 10.1111/1755-0998.12153; Murphy MA, 2003, MOL ECOL, V12, P2261, DOI 10.1046/j.1365-294X.2003.01863.x; Murphy MA, 2007, CONSERV GENET, V8, P1219, DOI 10.1007/s10592-006-9264-0; Nichols RV, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1285-z; Nichols RV, 2015, OECOLOGIA, V178, P275, DOI 10.1007/s00442-014-3196-z; Nichols RV, 2012, MOL ECOL RESOUR, V12, P983, DOI 10.1111/j.1755-0998.2012.03172.x; Paetkau D, 2003, MOL ECOL, V12, P1375, DOI 10.1046/j.1365-294X.2003.01820.x; Paetkau D, 1998, CONSERV BIOL, V12, P418, DOI 10.1046/j.1523-1739.1998.96457.x; Pennell MW, 2013, MOL ECOL RESOUR, V13, P154, DOI 10.1111/1755-0998.12019; Piggott MP, 2004, WILDLIFE RES, V31, P485, DOI 10.1071/WR03096; Quinn TP, 2003, CAN J FISH AQUAT SCI, V60, P553, DOI 10.1139/F03-045; Quinn TP, 2001, CAN J ZOOL, V79, P1782, DOI 10.1139/cjz-79-10-1782; Roon DA, 2005, MOL ECOL, V14, P195, DOI 10.1111/j.1365-294X.2004.02385.x; Saito M, 2008, URSUS, V19, P162, DOI 10.2192/08GR006.1; Skrbinsek T, 2010, MOL ECOL RESOUR, V10, P495, DOI 10.1111/j.1755-0998.2009.02780.x; Sundqvist AK, 2008, CONSERV GENET, V9, P1275, DOI 10.1007/s10592-007-9454-4; Taberlet P, 1997, MOL ECOL, V6, P869, DOI 10.1111/j.1365-294X.1997.tb00141.x; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; van Bleijswijk JDL, 2014, MAR ECOL PROG SER, V513, P277, DOI 10.3354/meps11004; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2; Wasser SK, 2004, CAN J ZOOL, V82, P475, DOI 10.1139/Z04-020; Williams CL, 2003, WILDLIFE SOC B, V31, P926; Woods JG, 1999, WILDLIFE SOC B, V27, P616	47	27	27	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165259	10.1371/journal.pone.0165259	http://dx.doi.org/10.1371/journal.pone.0165259			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828988	Green Submitted, gold, Green Published			2022-12-26	WOS:000387724300035
J	Yang, Y; Shi, YZ; Zhang, N; Wang, S; Ungvari, GS; Ng, CH; Wang, YL; Zhao, XQ; Wang, YJ; Wang, CX; Xiang, YT				Yang, Yang; Shi, Yu-Zhi; Zhang, Ning; Wang, Shuo; Ungvari, Gabor S.; Ng, Chee H.; Wang, Yi-Long; Zhao, Xing-Quan; Wang, Yong-Jun; Wang, Chun-Xue; Xiang, Yu-Tao			The Disability Rate of 5-Year Post-Stroke and Its Correlation Factors: A National Survey in China	PLOS ONE			English	Article							AUCKLAND STROKE OUTCOMES; MODIFIED-RANKIN-SCALE; LONG-TERM DISABILITY; COGNITIVE IMPAIRMENT; 1ST-EVER STROKE; FUNCTIONAL RECOVERY; RECURRENT STROKE; PROGNOSTIC VALUE; NATURAL-HISTORY; ISCHEMIC-STROKE	Few studies on long-term functional outcome have been conducted in post-stroke patients in China. The objective of this study was to conduct a nationwide survey in China to investigate the 5-year prevalence of post-stroke disability and its correlation factors. A total of 893 patients with ischemic stroke were included. Demographic, clinical and neuro-imaging information were collected with standardized instruments that assessed stroke severity, depression, cognitive impairment, stroke recurrence and physical disability. Disability was assessed with the modified Ranking Score (mRS), of which a cutoff score >= 2 indicates disability. Statistical analysis included chi-square tests, two independent samples t-tests, Mann-Whitney U test and multiple logistic regression analysis. The frequency of disability in this study population was 45%. Multivariate analyses revealed that older age, lower education level, previous history of stroke, stroke severity at admission, depression, cognitive impairment at 3 months, and stroke recurrence within 5 years follow up were all significantly associated with post-stroke disability. The disability rate in 5-year post-stroke was high in Chinese patients. Treatment of depression, secondary prevention of stroke and rehabilitation may benefit disabled patients with stroke in China.	[Yang, Yang; Shi, Yu-Zhi; Zhang, Ning; Wang, Shuo; Wang, Yi-Long; Zhao, Xing-Quan; Wang, Yong-Jun; Wang, Chun-Xue] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurol, Beijing, Peoples R China; [Yang, Yang; Zhang, Ning; Wang, Chun-Xue] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neuropsychiat & Behav Neurol & Clin Psychol, Beijing, Peoples R China; [Yang, Yang; Shi, Yu-Zhi; Zhang, Ning; Wang, Shuo; Wang, Yi-Long; Zhao, Xing-Quan; Wang, Yong-Jun; Wang, Chun-Xue] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Yang, Yang; Shi, Yu-Zhi; Zhang, Ning; Wang, Shuo; Wang, Yi-Long; Zhao, Xing-Quan; Wang, Yong-Jun; Wang, Chun-Xue] Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China; [Yang, Yang; Shi, Yu-Zhi; Zhang, Ning; Wang, Shuo; Wang, Yi-Long; Zhao, Xing-Quan; Wang, Yong-Jun; Wang, Chun-Xue] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China; [Ungvari, Gabor S.] Univ Notre Dame Australia, Marian Ctr, Perth, WA, Australia; [Ungvari, Gabor S.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA, Australia; [Ng, Chee H.] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia; [Xiang, Yu-Tao] Univ Macau, Fac Hlth Sci, Unit Psychiat, Macau, Macao Sar, Peoples R China	Capital Medical University; Capital Medical University; University of Notre Dame Australia; University of Western Australia; University of Melbourne; University of Macau	Wang, CX (corresponding author), Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurol, Beijing, Peoples R China.; Wang, CX (corresponding author), Capital Med Univ, Beijing Tian Tan Hosp, Dept Neuropsychiat & Behav Neurol & Clin Psychol, Beijing, Peoples R China.; Wang, CX (corresponding author), China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.; Wang, CX (corresponding author), Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China.; Wang, CX (corresponding author), Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China.; Xiang, YT (corresponding author), Univ Macau, Fac Hlth Sci, Unit Psychiat, Macau, Macao Sar, Peoples R China.	snowsen@126.com; xyutly@gmail.com		Shi, YuZhi/0000-0002-4018-6984; Ng, Chee/0000-0002-3811-2732	Ministry of Science and Technology; Ministry of Health of the People's Republic of China; National 11th & 12th Five-year S & T Major Project [2006BAI01A11, 2011BAI08B01, 2011BAI08B02]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2013BAI09B03]; Ministry of Science and Technology of the People's Republic of China [2012ZX09303-005-001]; Beijing Institute for Brain Disorders [BIBD-PXM2013_014226_07_000084]; Beijing Biobank of Cerebral Vascular Disease [D131100005313003]; Beijing Brain Research [Z161100000216131]; Beijing Municipal Science & Technology Commission [Z151100004015127, Z151100003915117]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China; National 11th & 12th Five-year S & T Major Project; National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Beijing Institute for Brain Disorders; Beijing Biobank of Cerebral Vascular Disease; Beijing Brain Research; Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	This study was funded by the Ministry of Science and Technology and the Ministry of Health of the People's Republic of China. Individual grants include the National 11th & 12th Five-year S & T Major Project (2006BAI01A11, 2011BAI08B01, 2011BAI08B02), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2013BAI09B03), the Ministry of Science and Technology of the People's Republic of China (2012ZX09303-005-001), Beijing Institute for Brain Disorders (BIBD-PXM2013_014226_07_000084), Beijing Biobank of Cerebral Vascular Disease (D131100005313003), Beijing Brain Research (Z161100000216131) and Beijing Municipal Science & Technology Commission (Z151100004015127 and Z151100003915117).	Ayerbe L, 2014, J NEUROL NEUROSUR PS, V85, P514, DOI 10.1136/jnnp-2013-306448; Ayerbe L, 2013, STROKE, V44, P1105, DOI 10.1161/STROKEAHA.111.679340; Ayerbe L, 2013, BRIT J PSYCHIAT, V202, P14, DOI 10.1192/bjp.bp.111.107664; Barker-Collo S, 2010, NEUROLOGY, V75, P1608, DOI 10.1212/WNL.0b013e3181fb44c8; Dhamoon MS, 2015, NEUROLOGY, V84, P1002, DOI 10.1212/WNL.0000000000001331; Dhamoon MS, 2009, STROKE, V40, P2805, DOI 10.1161/STROKEAHA.109.549576; Dong YH, 2012, J NEUROL NEUROSUR PS, V83, P580, DOI 10.1136/jnnp-2011-302070; Donnellan C, 2010, INT J GERIATR PSYCH, V25, P1288, DOI 10.1002/gps.2482; Feigin VL, 2010, NEUROLOGY, V75, P1597, DOI 10.1212/WNL.0b013e3181fb44b3; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; First MB, 1994, DIAGNOSTIC STAT MANU, V1994; FOLSTEIN MF, 1977, J NEUROL NEUROSUR PS, V40, P1018, DOI 10.1136/jnnp.40.10.1018; Ghosal MK, 2014, J STROKE CEREBROVASC, V23, P2614, DOI 10.1016/j.jstrokecerebrovasdis.2014.06.001; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hankey GJ, 2002, STROKE, V33, P1034, DOI 10.1161/01.STR.0000012515.66889.24; Hardie K, 2004, STROKE, V35, P731, DOI 10.1161/01.STR.0000116183.50167.D9; Huybrechts KF, 2008, CEREBROVASC DIS, V26, P381, DOI 10.1159/000151678; Jia Q, 2011, STROKE, V42, P2758, DOI 10.1161/STROKEAHA.111.621649; Jokinen H, 2015, EUR J NEUROL, V22, P1288, DOI 10.1111/ene.12743; Jonsson AC, 2014, STROKE, V45, P1784, DOI 10.1161/STROKEAHA.114.005164; Kelly-Hayes Margaret, 2003, J Stroke Cerebrovasc Dis, V12, P119, DOI 10.1016/S1052-3057(03)00042-9; Knoflach M, 2012, NEUROLOGY, V78, P279, DOI 10.1212/WNL.0b013e31824367ab; KUNITZ SC, 1984, STROKE, V15, P740, DOI 10.1161/01.STR.15.4.740; Kutlubaev MA, 2014, INT J STROKE, V9, P1026, DOI 10.1111/ijs.12356; Liman TG, 2012, J NEUROL, V259, P1125, DOI 10.1007/s00415-011-6312-6; Liman TG, 2011, DEMENT GERIATR COGN, V31, P291, DOI 10.1159/000327358; LYDEN P, 1994, STROKE, V25, P2220, DOI 10.1161/01.STR.25.11.2220; Middleton LE, 2014, NEUROREHABILITATION, V34, P305, DOI 10.3233/NRE-131030; Moon HI, 2016, NEURORADIOLOGY, V58, P723, DOI 10.1007/s00234-016-1672-3; Narasimhalu K, 2011, STROKE, V42, P883, DOI 10.1161/STROKEAHA.110.594671; Nys GMS, 2005, NEUROLOGY, V64, P821, DOI 10.1212/01.WNL.0000152984.28420.5A; Park JH, 2016, EUR J NEUROL, V23, P361, DOI 10.1111/ene.12837; Quinn TJ, 2009, INT J STROKE, V4, P200, DOI 10.1111/j.1747-4949.2009.00271.x; Ullberg T, 2015, STROKE, V46, P389, DOI 10.1161/STROKEAHA.114.006538; Uyttenboogaart M, 2005, STROKE, V36, P1984, DOI 10.1161/01.STR.0000177872.87960.61; Wallace D, 2002, J CLIN EPIDEMIOL, V55, P922, DOI 10.1016/S0895-4356(02)00410-9; WOO J, 1992, NEUROEPIDEMIOLOGY, V11, P143, DOI 10.1159/000110924; Wu LY, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0505-z; Zhang N, 2012, CNS NEUROSCI THER, V18, P475, DOI 10.1111/j.1755-5949.2012.00312.x; ZHENG YP, 1988, BRIT J PSYCHIAT, V152, P660, DOI 10.1192/bjp.152.5.660	40	51	58	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165341	10.1371/journal.pone.0165341	http://dx.doi.org/10.1371/journal.pone.0165341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824877	gold, Green Published, Green Submitted			2022-12-26	WOS:000387615200017
J	Correa, A; Barba, A; Padilla, F				Correa, Angel; Barba, Antonio; Padilla, Francisca			Light Effects on Behavioural Performance Depend on the Individual State of Vigilance	PLOS ONE			English	Article							BRIGHT LIGHT; BLUE-LIGHT; SUSTAINED ATTENTION; TASK-PERFORMANCE; BRAIN RESPONSES; WORKING-MEMORY; HEART-RATE; ALERTNESS; SLEEP; SENSITIVITY	Research has shown that exposure to bright white light or blue-enriched light enhances alertness, but this effect is not consistently observed in tasks demanding high-level cognition (e.g., Sustained Attention to Response Task-SART, which measures inhibitory control). Individual differences in sensitivity to light effects might be mediated by variations in the basal level of arousal. We tested this hypothesis by measuring the participants' behavioural state of vigilance before light exposure, through the Psychomotor Vigilance Task. Then we compared the effects of a blue-enriched vs. dim light at nighttime on the performance of the auditory SART, by controlling for individual differences in basal arousal. The results replicated the alerting effects of blue-enriched light, as indexed by lower values of both proximal temperature and distal-proximal gradient. The main finding was that lighting effects on SART performance were highly variable across individuals and depended on their prior state of vigilance. Specifically, participants with higher levels of basal vigilance before light exposure benefited most from blue-enriched lighting, responding faster in the SART. These results highlight the importance of considering basal vigilance to define the boundary conditions of light effects on cognitive performance. Our study adds to current research delineating the complex and reciprocal interactions between lighting effects, arousal, cognitive task demands and behavioural performance.	[Correa, Angel; Barba, Antonio; Padilla, Francisca] Univ Granada, Ctr Invest Mente Cerebro & Comportamiento, Granada, Spain; [Correa, Angel; Padilla, Francisca] Univ Granada, Dept Psicol Expt, Granada, Spain	University of Granada; University of Granada	Correa, A (corresponding author), Univ Granada, Ctr Invest Mente Cerebro & Comportamiento, Granada, Spain.; Correa, A (corresponding author), Univ Granada, Dept Psicol Expt, Granada, Spain.	act@ugr.es		Correa, Angel/0000-0001-5256-4949	Spanish Ministerio de Economia y Competitividad (PLAN NACIONAL de I+D+i) [PSI2014-58041-P]; Junta de Andalucia [SEJ-3054]	Spanish Ministerio de Economia y Competitividad (PLAN NACIONAL de I+D+i); Junta de Andalucia(Junta de Andalucia)	This work was supported by the Spanish Ministerio de Economia y Competitividad (PLAN NACIONAL de I+D+i, grant number: PSI2014-58041-P. www.mineco.gob.es) to AC and by a pre-doctoral research contract to AB, and by the Junta de Andalucia (SEJ-3054, http://www.juntadeandalucia.es) to AC.	ADAN A, 1991, PERS INDIV DIFFER, V12, P241, DOI 10.1016/0191-8869(91)90110-W; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Beaven CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076707; Cajochen C, 2005, J CLIN ENDOCR METAB, V90, P1311, DOI 10.1210/jc.2004-0957; Cajochen C, 2000, BEHAV BRAIN RES, V115, P75, DOI 10.1016/S0166-4328(00)00236-9; Cajochen C, 2007, SLEEP MED REV, V11, P453, DOI 10.1016/j.smrv.2007.07.009; Chellappa SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016429; Colavito V, 2015, NEUROSCI BIOBEHAV R, V54, P3, DOI 10.1016/j.neubiorev.2014.11.021; Daneault V, 2014, SLEEP, V37, P85, DOI 10.5665/sleep.3314; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Edelstein K, 2003, NEUROSCIENCE, V118, P253, DOI 10.1016/S0306-4522(02)00908-9; Gabela V, 2015, BEHAV BRAIN RES, V281, P258, DOI 10.1016/j.bbr.2014.12.043; Gaggioni G, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00126; Genno H, 1997, INT J IND ERGONOM, V19, P161, DOI 10.1016/S0169-8141(96)00011-X; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Huiberts LM, 2015, BEHAV BRAIN RES, V294, P234, DOI 10.1016/j.bbr.2015.07.045; Huiberts LM, 2016, PHYSIOL BEHAV, V164, P129, DOI 10.1016/j.physbeh.2016.05.035; JENNINGS JR, 1976, PSYCHOPHYSIOLOGY, V13, P277; Kaida K, 2013, SLEEP BIOL RHYTHMS, V11, P125, DOI 10.1111/sbr.12013; Krauchi K, 1999, NATURE, V401, P36, DOI 10.1038/43366; Kretschmer V, 2012, LIGHTING RES TECHNOL, V44, P316, DOI 10.1177/1477153511418769; Lara T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088820; Lockley SW, 2006, SLEEP, V29, P161; Lucas RJ, 2014, TRENDS NEUROSCI, V37, P1, DOI 10.1016/j.tins.2013.10.004; Or Calvin K. L., 2007, Occupational Ergonomics, V7, P83; Phipps-Nelson J, 2009, CHRONOBIOL INT, V26, P891, DOI 10.1080/07420520903044364; Rahman SA, 2014, SLEEP, V37, P271, DOI 10.5665/sleep.3396; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Santhi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079688; Schneider W., 2002, E PRIME USERS GUIDE; Seli P, 2012, CAN J EXP PSYCHOL, V66, P44, DOI 10.1037/a0025111; Smolders KCHJ, 2012, PHYSIOL BEHAV, V107, P7, DOI 10.1016/j.physbeh.2012.04.028; Smolders KCHJ, 2014, J ENVIRON PSYCHOL, V39, P77, DOI 10.1016/j.jenvp.2013.12.010; van Diepen HC, 2014, EUR J NEUROSCI, V40, P3504, DOI 10.1111/ejn.12715; Vandewalle G, 1991, CEREB CORTEX N Y N, V17, P2788; Vandewalle G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001247; Vandewalle G, 2013, NEUROIMAGING OF SLEEP AND SLEEP DISORDERS, P171; Vandewalle G, 2011, J BIOL RHYTHM, V26, P249, DOI 10.1177/0748730411401736; Vandewalle G, 2009, TRENDS COGN SCI, V13, P429, DOI 10.1016/j.tics.2009.07.004; Wright KP, 1997, J SLEEP RES, V6, P26, DOI 10.1046/j.1365-2869.1997.00022.x; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	41	16	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0164945	10.1371/journal.pone.0164945	http://dx.doi.org/10.1371/journal.pone.0164945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB8BB	27820822	Green Submitted, Green Published, gold			2022-12-26	WOS:000387614800004
J	Lee, J; Horan, WP; Wynn, JK; Green, MF				Lee, Junghee; Horan, William P.; Wynn, Jonathan K.; Green, Michael F.			Neural Correlates of Belief and Emotion Attribution in Schizophrenia	PLOS ONE			English	Article							SOCIAL COGNITION; BRAIN IMAGES; MIND; FMRI; METAANALYSIS; EMPATHY; ROBUST; OPTIMIZATION; REGISTRATION; IMPAIRMENT	Impaired mental state attribution is a core social cognitive deficit in schizophrenia. With functional magnetic resonance imaging (fMRI), this study examined the extent to which the core neural system of mental state attribution is involved in mental state attribution, focusing on belief attribution and emotion attribution. Fifteen schizophrenia outpatients and 14 healthy controls performed two mental state attribution tasks in the scanner. In a Belief Attribution Task, after reading a short vignette, participants were asked infer either the belief of a character (a false belief condition) or a physical state of an affair (a false photograph condition). In an Emotion Attribution Task, participants were asked either to judge whether character(s) in pictures felt unpleasant, pleasant, or neutral emotion (other condition) or to look at pictures that did not have any human characters (view condition). fMRI data were analyzing focusing on a priori regions of interest (ROIs) of the core neural systems of mental state attribution: the medial prefrontal cortex (mPFC), temporoparietal junction (TPJ) and precuneus. An exploratory whole brain analysis was also performed. Both patients and controls showed greater activation in all four ROIs during the Belief Attribution Task than the Emotion Attribution Task. Patients also showed less activation in the precuneus and left TPJ compared to controls during the Belief Attribution Task. No significant group difference was found during the Emotion Attribution Task in any of ROIs. An exploratory whole brain analysis showed a similar pattern of neural activations. These findings suggest that while schizophrenia patients rely on the same neural network as controls do when attributing beliefs of others, patients did not show reduced activation in the key regions such as the TPJ. Further, this study did not find evidence for aberrant neural activation during emotion attribution or recruitment of compensatory brain regions in schizophrenia.	[Lee, Junghee; Horan, William P.; Wynn, Jonathan K.; Green, Michael F.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Lee, Junghee; Horan, William P.; Wynn, Jonathan K.; Green, Michael F.] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Lee, J (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA.; Lee, J (corresponding author), VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA.	jungheelee@ucla.edu	Wynn, Jonathan/H-3749-2014; Lee, Junghee/AAX-6124-2021; Lee, Junghee/C-5226-2014; Horan, William/V-7495-2019	Wynn, Jonathan/0000-0002-1763-8540; Lee, Junghee/0000-0001-9567-8700; Lee, Junghee/0000-0001-9567-8700; 	Department of Veterans Affairs, Desert Pacific Mental Illness Research, Education and Clinical Center (MIRECC) PALA Pilot Grant; National Institute of Mental Health [MH43292, MH065707]; Brain Mapping Medical Research Organization; Brain Mapping Support Foundation; Pierson-Lovelace Foundation; Tamkin Foundation; Jennifer Jones-Simon Foundation; Capital Group Companies Charitable Foundation; Robson Family; Northstar Fund	Department of Veterans Affairs, Desert Pacific Mental Illness Research, Education and Clinical Center (MIRECC) PALA Pilot Grant; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brain Mapping Medical Research Organization; Brain Mapping Support Foundation; Pierson-Lovelace Foundation; Tamkin Foundation; Jennifer Jones-Simon Foundation; Capital Group Companies Charitable Foundation; Robson Family; Northstar Fund	This study is supported by Department of Veterans Affairs, Desert Pacific Mental Illness Research, Education and Clinical Center (MIRECC) PALA Pilot Grant (PI: JL), and National Institute of Mental Health Grants MH43292 and MH065707 (PI: MFG). For generous support, we would like to thank the Brain Mapping Medical Research Organization, the Brain Mapping Support Foundation, the Pierson-Lovelace Foundation, the Tamkin Foundation, the Jennifer Jones-Simon Foundation, the Capital Group Companies Charitable Foundation, the Robson Family and the Northstar Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Benedetti F, 2009, SCHIZOPHR RES, V114, P154, DOI 10.1016/j.schres.2009.06.021; Bora E, 2009, SCHIZOPHR RES, V109, P1, DOI 10.1016/j.schres.2008.12.020; Brune M, 2011, NEUROIMAGE, V55, P329, DOI 10.1016/j.neuroimage.2010.12.018; Brune M, 2005, SCHIZOPHRENIA BULL, V31, P21, DOI 10.1093/schbul/sbi002; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Chung YS, 2011, SCHIZOPHRENIA BULL, V37, P1048, DOI 10.1093/schbul/sbq012; Das P, 2012, SCHIZOPHR RES, V134, P158, DOI 10.1016/j.schres.2011.08.019; Derntl B, 2012, SCHIZOPHR RES, V136, P70, DOI 10.1016/j.schres.2011.12.018; Derntl B, 2009, SCHIZOPHR RES, V108, P197, DOI 10.1016/j.schres.2008.11.009; First M.B., 2014, STRUCTURED CLIN INTE; First M. B., 1997, STRUCTURED CLIN INTE; Frith CD, 1992, COGNITIVE NEUROPSYCH; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Green MF, 2015, NAT REV NEUROSCI, V16, P620, DOI 10.1038/nrn4005; Greenwald M.K., 1993, INT AFFECTIVE PICTUR; Harvey PO, 2013, SCHIZOPHRENIA BULL, V39, P617, DOI 10.1093/schbul/sbs042; Herve PY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054400; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kern RS, 2009, PSYCHOL MED, V39, P645, DOI 10.1017/S0033291708003966; Lee J, 2011, PSYCHOL MED, V41, P2297, DOI 10.1017/S0033291711000614; Lee J, 2011, SOC NEUROSCI-UK, V6, P569, DOI 10.1080/17470919.2011.620774; Lee SJ, 2010, PSYCHIAT RES-NEUROIM, V181, P121, DOI 10.1016/j.pscychresns.2009.08.003; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Savla GN, 2013, SCHIZOPHRENIA BULL, V39, P979, DOI 10.1093/schbul/sbs080; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Schurz M, 2014, NEUROSCI BIOBEHAV R, V42, P9, DOI 10.1016/j.neubiorev.2014.01.009; Sebastian CL, 2012, SOC COGN AFFECT NEUR, V7, P53, DOI 10.1093/scan/nsr023; Seghier ML, 2013, NEUROSCIENTIST, V19, P43, DOI 10.1177/1073858412440596; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sparks A, 2010, SCHIZOPHR RES, V122, P172, DOI 10.1016/j.schres.2010.06.011; van Veluw SJ, 2014, BRAIN IMAGING BEHAV, V8, P24, DOI 10.1007/s11682-013-9266-8; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Walter H, 2009, SOC COGN AFFECT NEUR, V4, P166, DOI 10.1093/scan/nsn047; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; Zaitchik D, 2010, NEUROPSYCHOLOGIA, V48, P2528, DOI 10.1016/j.neuropsychologia.2010.04.031	41	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165546	10.1371/journal.pone.0165546	http://dx.doi.org/10.1371/journal.pone.0165546			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812142	Green Published, Green Submitted, gold			2022-12-26	WOS:000386910000035
J	Morales, M; Sentchilo, V; Bertelli, C; Komljenovic, A; Kryuchkova-Mostacci, N; Bourdilloud, A; Linke, B; Goesmann, A; Harshman, K; Segers, F; Delapierre, F; Fiorucci, D; Seppey, M; Trofimenco, E; Berra, P; El Taher, A; Loiseau, C; Roggero, D; Sulfiotti, M; Etienne, A; Buendia, GR; Pillard, L; Escoriza, A; Moritz, R; Schneider, C; Alfonso, E; Ben Jeddou, F; Selmoni, O; Resch, G; Greub, G; Emery, O; Dubey, M; Pillonel, T; Robinson-Rechavi, M; van der Meer, JR				Morales, Marian; Sentchilo, Vladimir; Bertelli, Claire; Komljenovic, Andrea; Kryuchkova-Mostacci, Nadezda; Bourdilloud, Audrey; Linke, Burkhard; Goesmann, Alexander; Harshman, Keith; Segers, Francisca; Delapierre, Fabien; Fiorucci, Damien; Seppey, Mathieu; Trofimenco, Evgeniya; Berra, Pauline; El Taher, Athimed; Loiseau, Chloe; Roggero, Dejan; Sulfiotti, Madeleine; Etienne, Angela; Buendia, Gustavo Ruiz; Pillard, Loic; Escoriza, Angelique; Moritz, Roxane; Schneider, Cedric; Alfonso, Esteban; Ben Jeddou, Fatma; Selmoni, Oliver; Resch, Gregory; Greub, Gilbert; Emery, Olivier; Dubey, Manupriyam; Pillonel, Trestan; Robinson-Rechavi, Marc; van der Meer, Jan Roelof			The Genome of the Toluene-Degrading Pseudomonas veronii Strain 1YdBTEX2 and Its Differential Gene Expression in Contaminated Sand	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; TOXIN-ANTITOXIN LOCI; WIDE ANALYSIS; KDP-ATPASE; BACTERIA; BIODEGRADATION; BIOREMEDIATION; DIVERSITY; VISUALIZATION; METABOLISM	The natural restoration of soils polluted by aromatic hydrocarbons such as benzene, toluene, ethylbenzene and m-and p-xylene (BTEX) may be accelerated by inoculation of specific biodegraders (bioaugmentation). Bioaugmentation mainly involves introducing bacteria that deploy their metabolic properties and adaptation potential to survive and propagate in the contaminated environment by degrading the pollutant. In order to better understand the adaptive response of cells during a transition to contaminated material, we analyzed here the genome and short-term (1 h) changes in genome-wide gene expression of the BTEX-degrading bacterium Pseudomonas veronii 1YdBTEX2 in non-sterile soil and liquid medium, both in presence or absence of toluene. We obtained a gapless genome sequence of P. veronii 1YdBTEX2 covering three individual replicons with a total size of 8 Mb, two of which are largely unrelated to current known bacterial replicons. One-hour exposure to toluene, both in soil and liquid, triggered massive transcription (up to 208-fold induction) of multiple gene clusters, such as toluene degradation pathway(s), chemotaxis and toluene efflux pumps. This clearly underlines their key role in the adaptive response to toluene. In comparison to liquid medium, cells in soil drastically changed expression of genes involved in membrane functioning (e.g., lipid composition, lipid metabolism, cell fatty acid synthesis), osmotic stress response (e.g., polyamine or trehalose synthesis, uptake of potassium) and putrescine metabolism, highlighting the immediate response mechanisms of P. veronii 1YdBTEX2 for successful establishment in polluted soil.	[Morales, Marian; Sentchilo, Vladimir; Resch, Gregory; Emery, Olivier; Dubey, Manupriyam; van der Meer, Jan Roelof] Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland; [Bertelli, Claire; Greub, Gilbert; Pillonel, Trestan] Univ Hosp Ctr, Inst Microbiol, Lausanne, Switzerland; [Bertelli, Claire; Greub, Gilbert; Pillonel, Trestan] Univ Lausanne, Lausanne, Switzerland; [Komljenovic, Andrea; Kryuchkova-Mostacci, Nadezda; Robinson-Rechavi, Marc] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Bourdilloud, Audrey; Segers, Francisca; Delapierre, Fabien; Fiorucci, Damien; Seppey, Mathieu; Trofimenco, Evgeniya; Berra, Pauline; El Taher, Athimed; Loiseau, Chloe; Roggero, Dejan; Sulfiotti, Madeleine; Etienne, Angela; Buendia, Gustavo Ruiz; Pillard, Loic; Escoriza, Angelique; Moritz, Roxane; Schneider, Cedric; Alfonso, Esteban; Ben Jeddou, Fatma; Selmoni, Oliver] Univ Lausanne, Mol Life Sci, Lausanne, Switzerland; [Linke, Burkhard; Goesmann, Alexander] Justus Liebig Univ, Bioinformat & Syst Biol, Giessen, Germany; [Harshman, Keith] Univ Lausanne, Ctr Integrat Genom, Lausanne Genom Technol Facil, CH-1015 Lausanne, Switzerland; [Bertelli, Claire; Komljenovic, Andrea; Kryuchkova-Mostacci, Nadezda; Robinson-Rechavi, Marc] SIB, Lausanne, Switzerland	University of Lausanne; University of Lausanne; University of Lausanne; University of Lausanne; Justus Liebig University Giessen; University of Lausanne; Swiss Institute of Bioinformatics	van der Meer, JR (corresponding author), Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland.	janroelof.vandermeer@unil.ch	van der Meer, Jan Roelof/G-6610-2012; Greub, Gilbert GG/K-5804-2017; Bertelli, Claire/H-9609-2015; Robinson-Rechavi, Marc/E-9727-2011	van der Meer, Jan Roelof/0000-0003-1485-3082; Greub, Gilbert GG/0000-0001-9529-3317; Bertelli, Claire/0000-0003-0550-8981; Robinson-Rechavi, Marc/0000-0002-3437-3329; Trofimenko, Evgeniya/0000-0003-4910-5324; Selmoni, Oliver/0000-0003-0904-5486; Goesmann, Alexander/0000-0002-7086-2568; Loiseau, Chloe/0000-0003-4889-2784; Pillonel, Trestan/0000-0002-5725-7929	SystemsX.ch; Swiss Initiative in Systems Biology	SystemsX.ch; Swiss Initiative in Systems Biology	The study was funded by SystemsX.ch'http://SystemsX.ch', the Swiss Initiative in Systems Biology (http://www.systemsx.ch), to Marian Morales, Manupriyam Dubey and Jan R. van der Meer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Backman A, 2004, APPL ENVIRON MICROB, V70, P2952, DOI 10.1128/AEM.70.5.2952-2958.2004; Ballal A, 2007, J BIOSCIENCES, V32, P559, DOI 10.1007/s12038-007-0055-7; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bertelli C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00101; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Chang WS, 2007, J BACTERIOL, V189, P8290, DOI 10.1128/JB.00727-07; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Coronado E, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00300; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Cunliffe M, 2006, FEMS MICROBIOL ECOL, V58, P364, DOI 10.1111/j.1574-6941.2006.00167.x; Darling AE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000128; de Lima-Morales D, 2013, GENOME ANNOUNCEMENTS, V1, DOI [10.1128/genomeA.00258-13, DOI 10.1128/GEN0MEA.00258-13]; de Lima-Morales D, 2016, APPL ENVIRON MICROB, V82, P167, DOI 10.1128/AEM.03026-15; Dhillon BK, 2015, NUCLEIC ACIDS RES, V43, pW104, DOI 10.1093/nar/gkv401; Fivian-Hughes AS, 2010, J BACTERIOL, V192, P4348, DOI 10.1128/JB.00454-10; Freeman BC, 2013, J BACTERIOL, V195, P4742, DOI 10.1128/JB.00787-13; Gerhardt P, 1981, MANUAL METHODS GEN B; Gordon D, 2013, BIOINFORMATICS, V29, P2936, DOI 10.1093/bioinformatics/btt515; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Haghollahi A, 2016, J ENVIRON MANAGE, V180, P197, DOI 10.1016/j.jenvman.2016.05.038; Haritash AK, 2009, J HAZARD MATER, V169, P1, DOI 10.1016/j.jhazmat.2009.03.137; He ZL, 2010, APPL ENVIRON MICROB, V76, P1574, DOI 10.1128/AEM.02141-09; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jeon CO, 2013, CURR OPIN BIOTECH, V24, P474, DOI 10.1016/j.copbio.2012.09.001; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Junca H, 2004, ENVIRON MICROBIOL, V6, P95, DOI 10.1046/j.1462-2920.2003.00541.x; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Lan DD, 2015, MAR POLLUT BULL, V96, P220, DOI 10.1016/j.marpolbul.2015.05.023; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Malli R, 1998, J BACTERIOL, V180, P5102, DOI 10.1128/JB.180.19.5102-5108.1998; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; Martinez-Garcia E, 2014, ENVIRON MICROBIOL, V16, P291, DOI 10.1111/1462-2920.12309; Martinez-Garcia E, 2011, ENVIRON MICROBIOL, V13, P2702, DOI 10.1111/j.1462-2920.2011.02538.x; Megharaj M, 2011, ENVIRON INT, V37, P1362, DOI 10.1016/j.envint.2011.06.003; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Miyazaki R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002818; Moreno-Forero SK, 2016, ENV MICROBIOL REP, V8, P91, DOI 10.1111/1758-2229.12356; Moreno-Forero SK, 2015, ISME J, V9, P150, DOI 10.1038/ismej.2014.101; Mrozik A, 2010, MICROBIOL RES, V165, P363, DOI 10.1016/j.micres.2009.08.001; Mukherjee S, 2014, ISME J, V8, P2131, DOI 10.1038/ismej.2014.151; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Parales RE, 2000, APPL ENVIRON MICROB, V66, P4098, DOI 10.1128/AEM.66.9.4098-4104.2000; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rojas A, 2001, J BACTERIOL, V183, P3967, DOI 10.1128/JB.183.13.3967-3973.2001; Samanta SK, 2002, TRENDS BIOTECHNOL, V20, P243, DOI 10.1016/S0167-7799(02)01943-1; Sevin EW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r155; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Singer AC, 2005, TRENDS BIOTECHNOL, V23, P74, DOI 10.1016/j.tibtech.2004.12.012; Witzig R, 2006, APPL ENVIRON MICROB, V72, P3504, DOI 10.1128/AEM.72.5.3504-3514.2006; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	59	9	9	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165850	10.1371/journal.pone.0165850	http://dx.doi.org/10.1371/journal.pone.0165850			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812150	Green Published, Green Submitted, gold			2022-12-26	WOS:000386910000071
J	Sanagavarapu, K; Weiffert, T; Ni Mhurchu, N; O'Connell, D; Linse, S				Sanagavarapu, Kalyani; Weiffert, Tanja; Ni Mhurchu, Niamh; O'Connell, David; Linse, Sara			Calcium Binding and Disulfide Bonds Regulate the Stability of Secretagogin towards Thermal and Urea Denaturation	PLOS ONE			English	Article							CA2+-BINDING PROTEIN; PARVALBUMIN; CALMODULIN; EXPRESSION; TARGET; TAU	Secretagogin is a calcium-sensor protein with six EF-hands. It is widely expressed in neurons and neuro-endocrine cells of a broad range of vertebrates including mammals, fishes and amphibia. The protein plays a role in secretion and interacts with several vesicle-associated proteins. In this work, we have studied the contribution of calcium binding and disulfide-bond formation to the stability of the secretagogin structure towards thermal and urea denaturation. SDS-PAGE analysis of secretagogin in reducing and non-reducing conditions identified a tendency of the protein to form dimers in a redox-dependent manner. The denaturation of apo and Calcium-loaded secretagogin was studied by circular dichroism and fluorescence spectroscopy under conditions favoring monomer or dimer or a 1: 1 monomer: dimer ratio. This analysis reveals significantly higher stability towards urea denaturation of Calcium-loaded secretagogin compared to the apo protein. The secondary and tertiary structure of the Calcium-loaded form is not completely denatured in the presence of 10 M urea. Reduced and Calcium-loaded secretagogin is found to refold reversibly after heating to 95 degrees C, while both oxidized and reduced apo secretagogin is irreversibly denatured at this temperature. Thus, calcium binding greatly stabilizes the structure of secretagogin towards chemical and heat denaturation.	[Sanagavarapu, Kalyani; Weiffert, Tanja; Linse, Sara] Lund Univ, Dept Biochem & Struct Biol, Lund, Sweden; [Ni Mhurchu, Niamh; O'Connell, David] Univ Coll Dublin, Conway Inst, Sch Biomol & Biomed Sci, Dublin, Ireland	Lund University; University College Dublin	Sanagavarapu, K; Linse, S (corresponding author), Lund Univ, Dept Biochem & Struct Biol, Lund, Sweden.	Kalyani.Sanagavarapu@biochemistry.lu.se; Sara.Linse@biochemistry.lu.se		O'Connell, David/0000-0002-6461-7750	Swedish Research Council VR; SFI Investigators Programme [12/IP/1620]	Swedish Research Council VR(Swedish Research Council); SFI Investigators Programme(Science Foundation Ireland)	This work was funded by the Swedish Research Council VR (SL) and the SFI Investigators Programme 12/IP/1620 (DOC).	Attems J, 2006, CLIN NEUROPATHOL, V25, P265; Bauer M, 2011, METHODS MOL BIOL, V781, P47, DOI 10.1007/978-1-61779-276-2_3; Bitto E, 2009, PROTEINS, V76, P477, DOI 10.1002/prot.22362; Cedervall T, 2005, BIOCHEMISTRY-US, V44, P684, DOI 10.1021/bi049232r; Choi S, 2010, J PROTEOME RES, V9, P626, DOI 10.1021/pr900771r; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Gartner W, 2001, CEREB CORTEX, V11, P1161, DOI 10.1093/cercor/11.12.1161; Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248; Karki R, 2013, EXPERT OPIN THER TAR, V17, P461, DOI 10.1517/14728222.2013.766170; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; LINSE S, 1993, PROTEIN SCI, V2, P985, DOI 10.1002/pro.5560020612; Maj M, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00084; Maj M, 2010, J ENDOCRINOL, V205, P25, DOI 10.1677/JOE-09-0341; Masino L, 2000, PROTEIN SCI, V9, P1519, DOI 10.1110/ps.9.8.1519; MATSUMURA M, 1991, METHOD ENZYMOL, V202, P336; McClenaghan NH, 1996, DIABETES, V45, P1132, DOI 10.2337/diabetes.45.8.1132; Mulder J, 2009, P NATL ACAD SCI USA, V106, P22492, DOI 10.1073/pnas.0912484106; Pauls TL, 1996, BBA-GENE STRUCT EXPR, V1306, P39, DOI 10.1016/0167-4781(95)00221-9; PERMYAKOV EA, 1982, BIOPHYS CHEM, V15, P19, DOI 10.1016/0301-4622(82)87013-0; Permyakoy SE, 2008, PROTEINS, V72, P822, DOI 10.1002/prot.21974; Rogstam A, 2007, BIOCHEM J, V401, P353, DOI 10.1042/BJ20060918; Romanov RA, 2015, EMBO J, V34, P36, DOI 10.15252/embj.201488977; SMITH L, 1994, J BIOL CHEM, V269, P9857; TIDOR B, 1993, PROTEINS, V15, P71, DOI 10.1002/prot.340150109; Tidow H, 2013, FEBS J, V280, P5551, DOI 10.1111/febs.12296; Venyaminov SY, 2004, ANAL BIOCHEM, V334, P97, DOI 10.1016/j.ab.2004.07.032; Wagner L, 2000, J BIOL CHEM, V275, P24740, DOI 10.1074/jbc.M001974200; WALTERSSON Y, 1993, BIOCHEMISTRY-US, V32, P7866, DOI 10.1021/bi00082a005; Wijeyesakere SJ, 2011, J BIOL CHEM, V286, P8771, DOI 10.1074/jbc.M110.169193; Zierhut B, 2005, BIOCHEM BIOPH RES CO, V329, P1193, DOI 10.1016/j.bbrc.2005.02.093	31	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165709	10.1371/journal.pone.0165709	http://dx.doi.org/10.1371/journal.pone.0165709			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812162	Green Published, Green Submitted, gold			2022-12-26	WOS:000386910000050
J	Yao, LL; Lu, PF; Ling, EA				Yao, Linli; Lu, Pengfei; Ling, Eng-Ang			Melatonin Suppresses Toll Like Receptor 4-Dependent Caspase-3 Signaling Activation Coupled with Reduced Production of Proinflammatory Mediators in Hypoxic Microglia	PLOS ONE			English	Article							PERIVENTRICULAR WHITE-MATTER; BRAIN-INJURY; APOPTOSIS; CELLS; CYTOKINES; PATHWAY; RATS	Microglia activation and associated inflammatory response play pivotal roles in the pathogenesis of different neurodegenerative diseases including neonatal hypoxic brain injury. Here we show that caspase3 expression was upregulated in activated microglia after hypoxic exposure, and remarkably, the cell viability remained unaffected alluding to the possibility of a non-apoptotic role of caspase3 in activated microglia. Chemical inhibition of caspase3 suppressed microglia activation as evident by an obvious reduction in expression of proinflammatory mediators and NF-kappa B signaling activation. Hypoxia induced caspase3 activation was TLR4 dependent as supported by the fact that caspase3 activation was hindered in cells with TLR4 knockdown. Interestingly, melatonin treatment significantly suppressed caspase3 activation. More importantly, melatonin also inhibited the increase in TLR4 protein and mRNA expression in hypoxic microglia. Inhibition of TLR4 expression by melatonin was also found in microglia of postnatal rats subjected to hypoxic exposure. Taken together, it is concluded that melatonin could inhibit TLR4 expression in hypoxic microglia followed by suppression of caspase3 activation leading to decrease in production of proinflammatory mediators.	[Yao, Linli; Lu, Pengfei] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Yao, Linli] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Ling, Eng-Ang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore, Singapore	ShanghaiTech University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; National University of Singapore	Ling, EA (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore, Singapore.	antlea@nus.edu.sg			National University of Singapore [R-181-000-140-592]	National University of Singapore(National University of Singapore)	This study was supported by grant No. R-181-000-140-592 from the National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alconada D, 2012, HISTOL HISTOPATHOL, V27, P771, DOI 10.14670/HH-27.771; Bonestroo HJC, 2015, DEV NEUROSCI-BASEL, V37, P78, DOI 10.1159/000368770; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Chen JY, 2014, J PINEAL RES, V57, P340, DOI 10.1111/jpi.12173; Deng YY, 2008, BRAIN PATHOL, V18, P387, DOI 10.1111/j.1750-3639.2008.00138.x; Gonzalez-Rodriguez PJ, 2014, NEUROBIOL DIS, V65, P172, DOI 10.1016/j.nbd.2014.01.020; da Silva DGH, 2015, J PINEAL RES, V58, P178, DOI 10.1111/jpi.12204; Kadhim H, 2002, NEUROLOGY, V58, P1125; Kang JW, 2012, J PINEAL RES, V53, P67, DOI 10.1111/j.1600-079X.2012.00972.x; Kaur C, 2010, J PINEAL RES, V48, P185, DOI 10.1111/j.1600-079X.2009.00740.x; Kaur C, 2009, PROG NEUROBIOL, V87, P264, DOI 10.1016/j.pneurobio.2009.01.003; Kaur C, 2013, J NEUROIMMUNE PHARM, V8, P66, DOI 10.1007/s11481-012-9347-2; Kim SY, 2010, IMMUNOLOGY, V129, P516, DOI 10.1111/j.1365-2567.2009.03203.x; Mesri Alamdari N, 2015, HORM METAB RES, V47, P504, DOI 10.1055/s-0034-1384587; Ozyener F, 2012, RESTOR NEUROL NEUROS, V30, P435, DOI 10.3233/RNN-2012-120217; Park SY, 2010, J PINEAL RES, V48, P178, DOI 10.1111/j.1600-079X.2009.00742.x; Pertsov S. S., 2015, Biomeditsinskaya Khimiya, V61, P394, DOI 10.18097/PBMC20156103394; Phiphatwatcharaded C, 2014, DRUG DEVELOP RES, V75, P235, DOI 10.1002/ddr.21177; Qi JH, 2015, APOPTOSIS, V20, P523, DOI 10.1007/s10495-014-1076-y; Rathnasamy G, 2011, J NEUROSCI, V31, P17982, DOI 10.1523/JNEUROSCI.2250-11.2011; Schulz JB, 1998, CELL DEATH DIFFER, V5, P847, DOI 10.1038/sj.cdd.4400420; Shan H, 2015, J TRACE ELEM MED BIO, V31, P85, DOI 10.1016/j.jtemb.2015.03.005; Suzumura Akio, 2014, Rinsho Shinkeigaku, V54, P1119, DOI 10.5692/clinicalneurol.54.1119; Venero JL, 2011, CELL DEATH DIFFER, V18, P1679, DOI 10.1038/cdd.2011.107; Wang L, 2015, PHYTOMEDICINE, V22, P1079, DOI 10.1016/j.phymed.2015.08.009; Yang JY, 2014, PHARMACOL THERAPEUT, V144, P321, DOI 10.1016/j.pharmthera.2014.07.002; Yao LL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-23	27	24	25	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166010	10.1371/journal.pone.0166010	http://dx.doi.org/10.1371/journal.pone.0166010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812200	Green Published, gold, Green Submitted			2022-12-26	WOS:000386910000091
J	Zhang, Y; Cao, Y; Zhang, RW; Zhang, XX; Lu, HY; Wu, CH; Huo, N; Xu, XY				Zhang, Yu; Cao, Ying; Zhang, Renwen; Zhang, Xiaxia; Lu, Haiying; Wu, Chihong; Huo, Na; Xu, Xiaoyuan			Pre-Existing HCV Variants Resistant to DAAs and Their Sensitivity to PegIFN/RBV in Chinese HCV Genotype 1b Patients	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; VIRUS NS3/4A PROTEASE; IN-VITRO; NS5A INHIBITOR; POLYMERASE INHIBITORS; PREVALENCE; MUTATIONS; BMS-790052; PROFILE	Background The efficacy of direct-acting antiviral agents (DAAs) could be attenuated by the presence of resistance-associated variants (RAVs). The aim of this study was to investigate the natural prevalence of RAVs among Chinese HCV genotype 1b patients and analyze the efficacy of pegylated interferon (PegIFN)/ribavirin (RBV) therapy in patients with and without RAVs at baseline. Methods Direct sequencing of the HCV NS3, NS5A and NS5B regions was performed in baseline serum samples of 117 DAAs-naive subjects infected with HCV genotype 1b. The efficacy of PegIFN/RBV therapy in patients with and without RAVs at baseline was analyzed by comparing the response rates between patients with RAVs and patients with wild type virus. Results The incidence of RAVs was 8.00% (8/100) in the NS3 region (T54S, n = 1, 1.00%; R117H, n = 5, 5.00%; S122T, n = 1, 1.00%; S174F, n = 1, 1.00%), 29.91% (32/107) in the NS5A region (L28M, n = 12, 11.21%; R30Q, n = 10, 9.35%; L31M, n = 1, 0.93%; P58S, n = 4, 3.74%; Y93H, n = 8, 7.48%) and 98.15% (106/108) in the NS5B region (L159F, n = 1, 0.93%; C316N, n = 103, 95.37%; A421V, n = 6, 5.56%). The response rates to PegIFN/RBV treatment did not differ between patients with or without RAVs in the NS5A region. Conclusions Pre-existing RAVs, including key RAVs, were detected in Chinese DAAs-naive patients infected with HCV genotype 1b. IFN-based therapy could be a good option for patients with RAVs, especially key RAVs, at baseline.	[Zhang, Yu; Cao, Ying; Zhang, Renwen; Zhang, Xiaxia; Lu, Haiying; Wu, Chihong; Huo, Na; Xu, Xiaoyuan] Peking Univ, Dept Infect Dis, Hosp 1, Beijing, Peoples R China	Peking University	Xu, XY (corresponding author), Peking Univ, Dept Infect Dis, Hosp 1, Beijing, Peoples R China.	xiaoyuanxu6@163.com			12th Five-Year Plan of the National Major Project for Infectious Diseases Control [2012ZX10002003]; National Natural Science Foundation of China [81373056]; Beijing Municipal Science and Technology Commission [D141100000314002, D141100000314005]; Postdoctoral Programs Foundation of China [2014M560859]	12th Five-Year Plan of the National Major Project for Infectious Diseases Control; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Postdoctoral Programs Foundation of China	This study was supported by the 12th Five-Year Plan of the National Major Project for Infectious Diseases Control (no. 2012ZX10002003), National Natural Science Foundation of China (no. 81373056), Beijing Municipal Science and Technology Commission of major projects (no. D141100000314002 and D141100000314005) and the Postdoctoral Programs Foundation of China (no. 2014M560859). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai L, 2009, CHINESE MED J-PEKING, V122, P5, DOI 10.3760/cma.j.issn.0366-6999.2009.01.002; Bartels DJ, 2013, J VIROL, V87, P1544, DOI 10.1128/JVI.02294-12; European Association for the Study of the Liver, 2014, Journal of Hepatology, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Fridell RA, 2011, HEPATOLOGY, V54, P1924, DOI 10.1002/hep.24594; Fridell RA, 2010, ANTIMICROB AGENTS CH, V54, P3641, DOI 10.1128/AAC.00556-10; Geneva WHO, 2014, GUID SCREEN CAR TREA; Itakura Jun, 2015, PLoS One, V10, pe0138060, DOI 10.1371/journal.pone.0138060; Itakura J, 2015, HEPATOL RES, V45, pE115, DOI 10.1111/hepr.12474; Ju W, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0341-1; Krishnan P, 2015, ANTIMICROB AGENTS CH, V59, P979, DOI 10.1128/AAC.04226-14; Larousse JA, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0318-0; Larousse JA, 2014, J MED VIROL, V86, P1350, DOI 10.1002/jmv.23958; Lawitz EJ, 2012, J HEPATOL, V57, P24, DOI 10.1016/j.jhep.2011.12.029; Lenz O, 2010, ANTIMICROB AGENTS CH, V54, P1878, DOI 10.1128/AAC.01452-09; Lontok E, 2015, HEPATOLOGY, V62, P1623, DOI 10.1002/hep.27934; Manns M, 2014, LANCET, V384, P1597, DOI 10.1016/S0140-6736(14)61059-X; Paolucci S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-355; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Peres-da-Silva A, 2015, J ANTIMICROB CHEMOTH, V70, P726, DOI 10.1093/jac/dku462; Peres-da-Silva A, 2010, ARCH VIROL, V155, P807, DOI 10.1007/s00705-010-0642-z; Poveda E, 2014, ANTIVIR RES, V108, P181, DOI 10.1016/j.antiviral.2014.05.015; Rao HY, 2014, J GASTROEN HEPATOL, V29, P545, DOI 10.1111/jgh.12398; Sarrazin C., 2016, IMPORTANCE RESISTANC, V2, P486, DOI [10.1016/j.jhep.2015.09.011, DOI 10.1016/J.JHEP.2015.09.011]; Summa V, 2012, ANTIMICROB AGENTS CH, V56, P4161, DOI 10.1128/AAC.00324-12; Tong X, 2014, J INFECT DIS, V209, P668, DOI 10.1093/infdis/jit562; Vicenti I, 2012, J ANTIMICROB CHEMOTH, V67, P984, DOI 10.1093/jac/dkr581; Wang L, 2011, CHINESE MED J-PEKING, V124, P4264, DOI 10.3760/cma.j.issn.0366-6999.2011.24.025; Zeminian LB, 2013, MEM I OSWALDO CRUZ, V108, P13, DOI 10.1590/S0074-02762013000100002	28	5	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165658	10.1371/journal.pone.0165658	http://dx.doi.org/10.1371/journal.pone.0165658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812165	Green Published, gold, Green Submitted			2022-12-26	WOS:000386910000043
J	Eulenburg, C; Suling, A; Neuser, P; Reuss, A; Canzler, U; Fehm, T; Luyten, A; Hellriegel, M; Woelber, L; Mahner, S				Eulenburg, Christine; Suling, Anna; Neuser, Petra; Reuss, Alexander; Canzler, Ulrich; Fehm, Tanja; Luyten, Alexander; Hellriegel, Martin; Woelber, Linn; Mahner, Sven			Propensity Scoring after Multiple Imputation in a Retrospective Study on Adjuvant Radiation Therapy in Lymph-Node Positive Vulvar Cancer	PLOS ONE			English	Article							MARGINAL STRUCTURAL MODELS; CAUSAL INFERENCE; MISSING VALUES; BIAS REDUCTION; SURVIVAL; ADJUSTMENT; REGRESSION	Propensity scoring (PS) is an established tool to account for measured confounding in non-randomized studies. These methods are sensitive to missing values, which are a common problem in observational data. The combination of multiple imputation of missing values and different propensity scoring techniques is addressed in this work. For a sample of lymph node-positive vulvar cancer patients, we re-analyze associations between the application of radiotherapy and disease-related and non-related survival. Inverse-probability-of-treatment-weighting (IPTW) and PS stratification are applied after multiple imputation by chained equation (MICE). Methodological issues are described in detail. Interpretation of the results and methodological limitations are discussed.	[Eulenburg, Christine] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Med Stat & Decis Making, Groningen, Netherlands; [Suling, Anna] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Neuser, Petra; Reuss, Alexander] KKS Philipps Univ Marburg, Marburg, Germany; [Canzler, Ulrich] Univ Dresden, Dept Gynecol & Obstet, Dresden, Germany; [Fehm, Tanja] Univ Med Ctr Duesseldorf, Dept Gynecol, Dusseldorf, Germany; [Fehm, Tanja] Univ Hosp Tuebingen, Dept Gynecol & Obstet, Tubingen, Germany; [Luyten, Alexander] Klinikum Wolfsburg, Dept Gynecol Obstet & Gynecol Oncol, Wolfsburg, Germany; [Hellriegel, Martin] Univ Gottingen, Dept Gynecol, Gottingen, Germany; [Woelber, Linn] Univ Med Ctr Hamburg Eppendorf, Dept Gynecol & Gynecol Oncol, Hamburg, Germany; [Mahner, Sven] Univ Munich, Dept Gynecol & Obstet, Munich, Germany	University of Groningen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Philipps University Marburg; Technische Universitat Dresden; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich	Eulenburg, C (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Med Stat & Decis Making, Groningen, Netherlands.	c.h.zu.eulenburg@umcg.nl		Fehm, Tanja/0000-0002-4926-0108	Medac oncology company	Medac oncology company	The AGO-CaRE 1 study was partially supported by Medac oncology company without any influence in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of this manuscript; and decision to submit the manuscript for publication.	[Anonymous], 2015, PBALCHK CHECKING COV; [Anonymous], 2014, PSMATCH2 STATA MODUL; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Baser O, 2006, VALUE HEALTH, V9, P377, DOI 10.1111/j.1524-4733.2006.00130.x; Becker SO, 2002, STATA J, V2, P358, DOI 10.1177/1536867X0200200403; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Brookhart MA, 2013, CIRC-CARDIOVASC QUAL, V6, P604, DOI 10.1161/CIRCOUTCOMES.113.000359; Crowson C.S., 2013, BASICS PROPENSITY SC; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dehejia RH, 1999, J AM STAT ASSOC, V94, P1053, DOI 10.2307/2669919; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; Greenland S, 2011, INT STAT REV, V79, P401, DOI 10.1111/j.1751-5823.2011.00158.x; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; Lunt M., 2011, GUIDE IMPUTING MISSI; Mahner S, 2015, J NATL CANC I, V107; Mertens BJ, 2014, STAT METHODS MED RES; Mitra R, 2012, STAT METHODS MED RES; Qu YM, 2009, STAT MED, V28, P1402, DOI 10.1002/sim.3549; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rosenbaum P, 2014, J AM STAT ASSOC, V79, P516; ROSENBAUM PR, 1987, J AM STAT ASSOC, V82, P387, DOI 10.2307/2289440; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Royston P, 2005, STATA J, V5, P1; Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; Royston P, 2009, STATA J, V9, P252, DOI 10.1177/1536867X0900900205; RUBIN DB, 1980, BIOMETRICS, V36, P293, DOI 10.2307/2529981; RUBIN DB, 1979, J AM STAT ASSOC, V74, P318, DOI 10.2307/2286330; Rubin DB, 2004, MULTIPLE IMPUTATION; Rubin DB, 2010, AM J OPHTHALMOL, V149, P7, DOI 10.1016/j.ajo.2009.08.024; Seaman S, 2014, COMMUN STAT-THEOR M, V43, P3499, DOI 10.1080/03610926.2012.700371; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Westreich D, 2010, J CLIN EPIDEMIOL, V63, P826, DOI 10.1016/j.jclinepi.2009.11.020; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	40	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165705	10.1371/journal.pone.0165705	http://dx.doi.org/10.1371/journal.pone.0165705			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802342	Green Submitted, Green Published, gold			2022-12-26	WOS:000386714200041
J	Malecka-Massalska, T; Mlak, R; Smolen, A; Brzozowska, A; Surtel, W; Morshed, K				Malecka-Massalska, Teresa; Mlak, Radoslaw; Smolen, Agata; Brzozowska, Anna; Surtel, Wojciech; Morshed, Kamal			Capacitance of Membrane As a Prognostic Indicator of Survival in Head and Neck Cancer	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; TISSUE ELECTRICAL-PROPERTIES; HEALTHY-HUMAN SUBJECTS; QUALITY-OF-LIFE; PHASE-ANGLE; CLINICAL-PRACTICE; MALNUTRITION; PREVALENCE; TUMORS	Background Evaluation of prognostic value of capacitance of membrane (Cm), parameter measured by bioelectrical impedance (BIA) as an alternative to known clinical factors in patients with Head and Neck Cancer (HNC). Methods A cohort of 75 stage IIIB and IV HNC patients treated in Department of Otolaryngology, Head and Neck Surgery, Medical University of Lublin, Poland were prospectively evaluated. Cm measurements were performed in all patients using a bioelectrical impedance analyzer that was set on a frequency of 50 kHz. Results of Cm measurements were presented in nF. Survival differences were estimated using Kaplan-Meier method. Results Significantly higher Cm median was noted in well-nourished(n = 45) compared to malnourished (n = 30) patients (1.41 vs 1.01 respectively; p = 0.0009). Established in ROC curves analysis cut-off value (0.743) was characterized by 98% specificity and 37% sensitivity in the detection of malnutrition. Median overall survival (mOS) in the cohort was 32months. At the time of analysis deaths were recorded in 47 cases (62.7%). In patients who had Cm below the level of 0.743 risk of OS shortening was significantly higher than in other patients (12.1 and 43.4 months respectively; HR = 8.47, 95% CI: 2.91 - 24.66; chi(2) = 15.38, p = 0.0001). Conclusion Cm is a strong, independent prognostic factor in head and neck cancer.	[Malecka-Massalska, Teresa; Mlak, Radoslaw] Med Univ Lublin, Dept Human Physiol, Lublin, Poland; [Smolen, Agata; Morshed, Kamal] Med Univ Lublin, Dept Epidemiol & Methodol Clin Res, Lublin, Poland; [Brzozowska, Anna] Med Univ Lublin, Dept Oncol, Lublin, Poland; [Surtel, Wojciech] Tech Univ Lublin, Inst Elect & Informat Technol, Lublin, Poland	Medical University of Lublin; Medical University of Lublin; Medical University of Lublin; Lublin University of Technology	Malecka-Massalska, T (corresponding author), Med Univ Lublin, Dept Human Physiol, Lublin, Poland.	t.malecka@gmail.com	Miak, Radoslaw/I-9994-2019	Miak, Radoslaw/0000-0001-7399-8340; Malecka-Massalska, Teresa/0000-0003-3384-0324; Morshed, Kamal/0000-0003-0061-0362; Brzozowska, Anna/0000-0002-8883-5816				[Anonymous], [No title captured]; Barbosa-Silva MCG, 2003, NUTRITION, V19, P422, DOI 10.1016/S0899-9007(02)00932-2; Blad B, 1996, PHYSIOL MEAS, V17, pA105, DOI 10.1088/0967-3334/17/4A/015; Davis MP, 2009, AM J HOSP PALLIAT ME, V26, P180, DOI 10.1177/1049909108330028; De Luis DA, 2006, ANN NUTR METAB, V50, P7, DOI 10.1159/000089484; Desport JC, 2003, AM J CLIN NUTR, V77, P1179, DOI 10.1093/ajcn/77.5.1179; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108; FRICKE HUGO, 1926, JOUR CANCER RES, V10, P340; Garcia-Peris P, 2007, CLIN NUTR, V26, P710, DOI 10.1016/j.clnu.2007.08.006; Grundmann O, 2015, EUROPEAN J CLIN NUTR, P1; Guo CB, 2007, BRIT J ORAL MAX SURG, V45, P467, DOI 10.1016/j.bjoms.2006.11.014; Gupta D, 2004, AM J CLIN NUTR, V80, P1634, DOI 10.1093/ajcn/80.6.1634; Health and Social Care Information Centre, 2014, NAT HEAD NECK CANC A; Hui D, 2014, CANCER-AM CANCER SOC, V120, P2207, DOI 10.1002/cncr.28624; Kumar S, 2012, IRAN J BASIC MED SCI, V15, P1180; Leandro-Merhi VA, 2014, CLINNUTR, V14, pS0261; Lee SY, 2014, KOREAN J FAM MED, V35, P251, DOI 10.4082/kjfm.2014.35.5.251; Liboff AR, 1997, BIOELECTROMAGNETICS, V18, P85, DOI 10.1002/(SICI)1521-186X(1997)18:1<85::AID-BEM13>3.0.CO;2-P; Maggiore Q, 1996, KIDNEY INT, V50, P2103, DOI 10.1038/ki.1996.535; Malecka-Massalska T, 2014, INDIAN J CANCER, V51, P209, DOI 10.4103/0019-509X.146717; Malecka-Massalska T, 2013, HEAD NECK-J SCI SPEC, V35, P1101, DOI 10.1002/hed.23091; Norman K, 2010, AM J CLIN NUTR, V92, P612, DOI 10.3945/ajcn.2010.29215; OTT M, 1995, J ACQ IMMUN DEF SYND, V9, P20; Pencharz PB, 1996, AM J CLIN NUTR, V64, P485; Santarpia L, 2009, NUTRITION, V25, P930, DOI 10.1016/j.nut.2009.01.015; Schwenk A, 2000, AM J CLIN NUTR, V72, P496; Segura A, 2005, CLIN NUTR, V24, P801, DOI 10.1016/j.clnu.2005.05.001; Selberg O, 2002, EUR J APPL PHYSIOL, V86, P509, DOI 10.1007/s00421-001-0570-4; SIMONS JPFHA, 1995, AM J CLIN NUTR, V61, P741, DOI 10.1093/ajcn/61.4.741; Stern RG, 1999, MED HYPOTHESES, V52, P367, DOI 10.1054/mehy.1997.0657; SZENTGYORGYI A, 1968, SCIENCE, V161, P988, DOI 10.1126/science.161.3845.988; ZAROWITZ BJ, 1989, DICP ANN PHARMAC, V23, P548, DOI 10.1177/1060028089023007-803	32	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165809	10.1371/journal.pone.0165809	http://dx.doi.org/10.1371/journal.pone.0165809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802349	Green Published, gold, Green Submitted			2022-12-26	WOS:000386714200056
J	Laan, LC; Williams, AR; Stavenhagen, K; Giera, M; Kooij, G; Vlasakov, I; Kalay, H; Kringel, H; Nejsum, P; Thamsborg, SM; Wuhrer, M; Dijkstra, CD; Cummings, RD; van Die, I				Laan, Lisa C.; Williams, Andrew R.; Stavenhagen, Kathrin; Giera, Martin; Kooij, Gijs; Vlasakov, Iliyan; Kalay, Hakan; Kringel, Helene; Nejsum, Peter; Thamsborg, Stig M.; Wuhrer, Manfred; Dijkstra, Christine D.; Cummings, Richard D.; van Die, Irma			The whipworm (Trichuris suis) secretes prostaglandin E2 to suppress proinflammatory properties in human dendritic cells	FASEB JOURNAL			English	Article						multiple sclerosis; inflammatory bowel disease; helminth therapy; immune regulation; lipids	OESOPHAGOSTOMUM-DENTATUM; INFLAMMATORY RESPONSES; EICOSANOID PRODUCTION; IMMUNE-RESPONSES; SOLUBLE PRODUCTS; LIPID MEDIATORS; RECEPTOR; DIFFERENTIATION; MODULATION; HELMINTHS	Clinical trials have shown that administration of the nematode Trichuris suis can be beneficial in treating various immune disorders. To provide insight into the mechanisms by which this worm suppresses inflammatory responses, an active component was purified from T. suis soluble products (TsSPs) that suppress TNF and IL-12 secretion from LPS-activated human dendritic cells (DCs). Analysis by liquid chromatography tandem mass spectrometry identified this compound as prostaglandin (PG)E2. The purified compound showed similar properties compared with TsSPs and commercial PGE2 in modulating LPS-induced expression of many cytokines and chemokines and in modulating Rab7B and P2RX7 expression in human DCs. Furthermore, the TsSP-induced reduction of TNF secretion from DCs is reversed by receptor antagonists for EP2 and EP4, indicating PGE2 action. T. suis secretes extremely high amounts of PGE2 (45-90 ng/mg protein) within their excretory/secretory products but few related lipid mediators as established by metabololipidomic analysis. Culture of T. suis with several cyclooxygenase (COX) inhibitors that inhibit mammalian prostaglandin synthesis affected the worm's motility but did not inhibit PGE2 secretion, suggesting that the worms can synthesize PGE2 via a COX-independent pathway. We conclude that T. suis secretes PGE2 to suppress proinflammatory responses in human DCs, thereby modulating the host's immune response.	[Laan, Lisa C.; Kooij, Gijs; Kalay, Hakan; Dijkstra, Christine D.; van Die, Irma] Vrije Univ, Med Ctr Amsterdam, Dept Mol Cell Biol & Immunol, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Williams, Andrew R.; Kringel, Helene; Nejsum, Peter; Thamsborg, Stig M.] Univ Copenhagen, Dept Vet Dis Biol, Sect Parasitol Hlth & Dev, DK-1168 Copenhagen, Denmark; [Stavenhagen, Kathrin; Wuhrer, Manfred] Vrije Univ Amsterdam, Div BioAnalyt Chem, Amsterdam, Netherlands; [Stavenhagen, Kathrin; Giera, Martin; Wuhrer, Manfred] Leiden Univ, Med Ctr, Ctr Prote & Metabol, Leiden, Netherlands; [Kooij, Gijs; Vlasakov, Iliyan] Brigham & Womens Hosp, Harvard Inst Med, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA; [Kooij, Gijs; Vlasakov, Iliyan] Harvard Med Sch, Boston, MA USA; [Cummings, Richard D.] Harvard Med Sch, Ctr Glycosci, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA USA	Vrije Universiteit Amsterdam; University of Copenhagen; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	van Die, I (corresponding author), Dept Mol Cell Biol & Immunol, OI2 Bldg,Room 11 E 41,POB 7057, NL-1007 MB Amsterdam, Netherlands.	im.vandie@vumc.nl	Giera, Martin/Y-2413-2018; Kringel, Helene/Z-2392-2019; Kooij, Gijs/AAA-4268-2020; Wuhrer, Manfred/ABE-9168-2020; Williams, Andrew R/A-3057-2013	Giera, Martin/0000-0003-1684-1894; Kringel, Helene/0000-0003-4682-1114; Wuhrer, Manfred/0000-0002-0814-4995; Williams, Andrew R/0000-0002-8231-282X; Nejsum, Peter/0000-0002-6673-8505; Kooij, Gijs/0000-0002-9488-2918	DutchMS [multiple sclerosis] Research Foundation [MS11-771, MS14-878]; U.S. National Institute of Health (NIH) National Institute of Allergy and Infectious Diseases [AI101982]; Lundbeck Foundation [14-3670A]; NIH National Institute of General Medical Sciences Grant [P01GM095467]; Lundbeck Foundation [R171-2014-309] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467] Funding Source: NIH RePORTER	DutchMS [multiple sclerosis] Research Foundation; U.S. National Institute of Health (NIH) National Institute of Allergy and Infectious Diseases; Lundbeck Foundation(Lundbeckfonden); NIH National Institute of General Medical Sciences Grant; Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the DutchMS [multiple sclerosis] Research Foundation (MS11-771 to I.V.D. and C.D.) and (MS14-878 to G.K.), and from the U.S. National Institute of Health (NIH) National Institute of Allergy and Infectious Diseases (Grant AI101982 to R.D.C.). A.R.W. was supported by the Lundbeck Foundation (Grant 14-3670A). The authors thank Dr. Paul Norris and Charles N. Serhan (NIH National Institute of General Medical Sciences Grant P01GM095467 (Center for Experimental Therapeutics and Reperfusion Injury, Harvard Institutes of Medicine, Brigham and Women's Hospital and Harvard Medical School) for help in metabololipidomic analysis and editorial assistance. The authors declare no conflicts of interest.	Alvarado R, 2015, IMMUNOBIOLOGY, V220, P262, DOI 10.1016/j.imbio.2014.11.008; Bager P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022346; BELLEY A, 1995, PARASITOL TODAY, V11, P327, DOI 10.1016/0169-4758(95)80185-5; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Cohn SM, 1997, J CLIN INVEST, V99, P1367, DOI 10.1172/JCI119296; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; Daugschies A, 1998, INT J PARASITOL, V28, P355, DOI 10.1016/S0020-7519(97)00153-7; De Keijzer S, 2013, INT J MOL SCI, V14, P6542, DOI 10.3390/ijms14046542; Duffin R, 2016, SCIENCE, V351, P1333, DOI 10.1126/science.aad9903; Ebner F, 2014, ALLERGY, V69, P1489, DOI 10.1111/all.12496; Esaki Y, 2010, P NATL ACAD SCI USA, V107, P12233, DOI 10.1073/pnas.0915112107; Everts B, 2010, EUR J IMMUNOL, V40, P1525, DOI 10.1002/eji.200940109; Fleming JO, 2015, PARASITE IMMUNOL, V37, P277, DOI 10.1111/pim.12175; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; FUSCO AC, 1985, EXP PARASITOL, V59, P44, DOI 10.1016/0014-4894(85)90055-4; Garg SK, 2014, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD009400.PUB2; Grencis RK, 2015, ANNU REV IMMUNOL, V33, P201, DOI 10.1146/annurev-immunol-032713-120218; Hansen TVA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002752; Harn DA, 2009, IMMUNOL REV, V230, P247, DOI 10.1111/j.1600-065X.2009.00799.x; Harnett MM, 2008, ANN RHEUM DIS, V67, P518, DOI 10.1136/ard.2007.073502; Hiemstra IH, 2014, MOL IMMUNOL, V60, P1, DOI 10.1016/j.molimm.2014.03.003; Hoang HD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003271; Hoeksema MA, 2016, FASEB J, V30, P2826, DOI 10.1096/fj.201600343R; Iizuka Y, 2014, J PHYSIOL SCI, V64, P85, DOI 10.1007/s12576-013-0295-2; Joachim A, 2001, PARASITOL INT, V50, P211, DOI 10.1016/S1383-5769(01)00077-0; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kapsenberg ML, 1999, CLIN EXP ALLERGY, V29, P33, DOI 10.1046/j.1365-2222.1999.00006.x-i2; Khan WI, 2004, PARASITE IMMUNOL, V26, P319, DOI 10.1111/j.0141-9838.2004.00715.x; Kihara Y, 2009, P NATL ACAD SCI USA, V106, P21807, DOI 10.1073/pnas.0906891106; Klaver EJ, 2015, GENES IMMUN, V16, P378, DOI 10.1038/gene.2015.18; Klaver EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124089; Klaver EJ, 2013, INT J PARASITOL, V43, P191, DOI 10.1016/j.ijpara.2012.10.021; Kooij G, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0223-1; Kradin RL, 2006, ARCH PATHOL LAB MED, V130, P718; Kringel H, 2002, ACTA VET SCAND, V43, P185; Kuijk LM, 2012, MOL IMMUNOL, V51, P210, DOI 10.1016/j.molimm.2012.03.020; LEID RW, 1983, PROSTA LEUKOTR MED, V11, P317, DOI 10.1016/0262-1746(83)90043-4; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; LIU LX, 1990, J EXP MED, V172, P993, DOI 10.1084/jem.172.3.993; Maizels Rick M., 2008, V94, P112, DOI 10.1159/000154944; Nakanishi M, 2013, SEMIN IMMUNOPATHOL, V35, P123, DOI 10.1007/s00281-012-0342-8; Nyame AK, 2003, EXP PARASITOL, V104, P1, DOI 10.1016/S0014-4894(03)00110-3; Ottow MK, 2014, GENES IMMUN, V15, P477, DOI 10.1038/gene.2014.38; PAPPO R, 1956, J ORG CHEM, V21, P478, DOI 10.1021/jo01110a606; Pineda MA, 2015, LUPUS, V24, P400, DOI 10.1177/0961203314560004; Poloso NJ, 2013, MOL IMMUNOL, V54, P284, DOI 10.1016/j.molimm.2012.12.010; Schlegel M, 2016, HEPATOLOGY, V63, P1689, DOI 10.1002/hep.28347; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Stavenhagen K, 2015, ANAL CHEM, V87, P11691, DOI 10.1021/acs.analchem.5b02366; van Die I, 2010, GLYCOBIOLOGY, V20, P2, DOI 10.1093/glycob/cwp140; Weinstock JV, 2014, J IMMUNOL, V193, P3239, DOI 10.4049/jimmunol.1400927; Williams AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097053; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Zhang YY, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2340	54	34	34	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					719	731		10.1096/fj.201600841R	http://dx.doi.org/10.1096/fj.201600841R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27806992	Green Published			2022-12-26	WOS:000394235400024
J	Cividini, F; Scott, BT; Dai, AZ; Han, WL; Suarez, J; Diaz-Juarez, J; Diemer, T; Casteel, DE; Dillmann, WH				Cividini, Federico; Scott, Brian T.; Dai, Anzhi; Han, Wenlong; Suarez, Jorge; Diaz-Juarez, Julieta; Diemer, Tanja; Casteel, Darren E.; Dillmann, Wolfgang H.			O-GlcNAcylation of 8-Oxoguanine DNA Glycosylase (Ogg1) Impairs Oxidative Mitochondrial DNA Lesion Repair in Diabetic Hearts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINIDASE; GLCNAC TRANSFERASE; TETRATRICOPEPTIDE REPEATS; CYTOSOLIC PROTEINS; CARDIAC MYOCYTES; LINKED GLCNAC; HIGH-GLUCOSE; DAMAGE; NUCLEAR; REPLICATION	mtDNA damage in cardiac myocytes resulting from increased oxidative stress is emerging as an important factor in the pathogenesis of diabetic cardiomyopathy. A prevalent lesion that occurs in mtDNA damage is the formation of 8-hydroxy-2'-deoxyguanosine (8-OHdG), which can cause mutations when not repaired properly by 8-oxoguanine DNA glycosylase (Ogg1). Although the mtDNA repair machinery has been described in cardiac myocytes, the regulation of this repair has been incompletely investigated. Here we report that the hearts of type 1 diabetic mice, despite having increased Ogg1 protein levels, had significantly lower Ogg1 activity than the hearts of control, non-type 1 diabetic mice. In diabetic hearts, we further observed increased levels of 8-OHdG and an increased amount of mtDNA damage. Interestingly, Ogg1 was found to be highly O-GlcNAcylated in diabetic mice compared with controls. In vitro experiments demonstrated that O-GlcNAcylation inhibits Ogg1 activity, which could explain the mtDNA lesion accumulation observed in vivo. Reducing Ogg1 O-GlcNAcylation in vivo by introducing a dominant negative O-GlcNAc transferase mutant (F460A) restored Ogg1 enzymatic activity and, consequently, reduced 8-OHdG and mtDNA damage despite the adverse hyperglycemic milieu. Taken together, our results implicate hyperglycemia-induced O-GlcNAcylation of Ogg1 in increased mtDNA damage and, therefore, provide a new plausible biochemical mechanism for diabetic cardiomyopathy.	[Cividini, Federico; Scott, Brian T.; Dai, Anzhi; Han, Wenlong; Suarez, Jorge; Diemer, Tanja; Casteel, Darren E.; Dillmann, Wolfgang H.] Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Diaz-Juarez, Julieta] Inst Nacl Cardiol, Dept Pharmacol, Juan Badiano 41, Tlalpan 14080, DF, Mexico	University of California System; University of California San Diego	Cividini, F; Dillmann, WH (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	fcividini@ucsd.edu; wdillmann@ucsd.edu		Scott, Brian/0000-0002-1321-7204; Cividini, Federico/0000-0001-6312-6514	National Institutes of Health [HL066941, NS047101]; P. Robert Majumder Charitable Foundation; University of California Institute for Mexico; United States (UC MEXUS); Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACYT) [CN 15-1489]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); P. Robert Majumder Charitable Foundation; University of California Institute for Mexico; United States (UC MEXUS); Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants HL066941 (to W. H. D., PI project 3) and NS047101, and a grant from the P. Robert Majumder Charitable Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by the University of California Institute for Mexico and the United States (UC MEXUS) and the Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACYT) (CN 15-1489).	Aguilar H, 2014, AM J PHYSIOL-CELL PH, V306, pC794, DOI 10.1152/ajpcell.00251.2013; ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348; Anson RM, 2000, FASEB J, V14, P355, DOI 10.1096/fasebj.14.2.355; Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960; Banerjee PS, 2015, P NATL ACAD SCI USA, V112, P6050, DOI 10.1073/pnas.1424017112; Barja G, 2004, BIOL REV, V79, P235, DOI 10.1017/S1464793103006213; Bennett CE, 2013, LIFE SCI, V92, P657, DOI 10.1016/j.lfs.2012.09.007; Bhakat KK, 2006, MOL CELL BIOL, V26, P1654, DOI 10.1128/MCB.26.5.1654-1665.2006; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Costa RAP, 2011, J BIOENERG BIOMEMBR, V43, P25, DOI 10.1007/s10863-011-9329-8; Dizdaroglu M, 2002, FREE RADICAL BIO MED, V32, P1102, DOI 10.1016/S0891-5849(02)00826-2; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fricovsky ES, 2012, AM J PHYSIOL-REG I, V303, pR689, DOI 10.1152/ajpregu.00548.2011; Fulop N, 2007, AM J PHYSIOL-HEART C, V292, pH2227, DOI 10.1152/ajpheart.01091.2006; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Gawlowski T, 2012, J BIOL CHEM, V287, P30024, DOI 10.1074/jbc.M112.390682; GIULIVI C, 1995, ARCH BIOCHEM BIOPHYS, V316, P909, DOI 10.1006/abbi.1995.1122; Gredilla R, 2010, EXP GERONTOL, V45, P478, DOI 10.1016/j.exger.2010.01.017; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Halliwell B, 2011, TRENDS PHARMACOL SCI, V32, P125, DOI 10.1016/j.tips.2010.12.002; Hsueh W, 2007, CIRC RES, V100, P1415, DOI 10.1161/01.RES.0000266449.37396.1f; Hu JP, 2005, NUCLEIC ACIDS RES, V33, P3271, DOI 10.1093/nar/gki636; Hu Y, 2005, CIRC RES, V96, P1006, DOI 10.1161/01.RES.0000165478.06813.58; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Kovalenko Olga A, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1901s62; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lazarus BD, 2005, J BIOL CHEM, V280, P35537, DOI 10.1074/jbc.M504948200; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Macauley MS, 2012, J BIOL CHEM, V287, P28882, DOI 10.1074/jbc.M112.363721; Marsh SA, 2014, J BIOL CHEM, V289, P34449, DOI 10.1074/jbc.R114.585984; Marsh SA, 2013, LIFE SCI, V92, P648, DOI 10.1016/j.lfs.2012.06.011; Marsh SA, 2011, AMINO ACIDS, V40, P819, DOI 10.1007/s00726-010-0699-8; Mirbahai L, 2010, DNA REPAIR, V9, P144, DOI 10.1016/j.dnarep.2009.11.009; Nakabeppu Y, 2004, ANN NY ACAD SCI, V1011, P101, DOI 10.1196/annals.1293.011; Ngoh GA, 2010, CIRC RES, V107, P171, DOI 10.1161/CIRCRESAHA.110.224675; Redza-Dutordoir M, 2016, BBA-MOL CELL RES, V1863, P2977, DOI 10.1016/j.bbamcr.2016.09.012; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Rolo AP, 2006, TOXICOL APPL PHARM, V212, P167, DOI 10.1016/j.taap.2006.01.003; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Sikorsky JA, 2007, BIOCHEM BIOPH RES CO, V355, P431, DOI 10.1016/j.bbrc.2007.01.169; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Tyrberg Bjorn, 2002, BMC Endocr Disord, V2, P2, DOI 10.1186/1472-6823-2-2; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200	48	30	31	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26515	26528		10.1074/jbc.M116.754481	http://dx.doi.org/10.1074/jbc.M116.754481			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27816939	Green Published, hybrid			2022-12-26	WOS:000391568200024
J	Park, T; Koptyra, M; Curran, T				Park, Taeju; Koptyra, Mateusz; Curran, Tom			Fibroblast Growth Requires CT10 Regulator of Kinase (Crk) and Crk-like (CrkL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAPTER PROTEIN CRK; EPITHELIAL OVARIAN CARCINOMAS; KEY SIGNALING INTEGRATORS; CELL-PROLIFERATION; JNK ACTIVATION; MESENCHYMAL TRANSITION; ENDOTHELIAL-CELLS; MALIGNANT FEATURE; GASTRIC-CANCER; MESSENGER-RNA	CT10 regulator of kinase (Crk) and Crk-like (CrkL) are the cellular counterparts of the viral oncogene v-Crk. Elevated levels of Crk and CrkL have been observed in many human cancers; inhibition of Crk and CrkL expression reduced the tumor-forming potential of cancer cell lines. Despite a close relationship between the Crk family proteins and tumorigenesis, how Crk and CrkL contribute to cell growth is unclear. We ablated endogenous Crk and CrkL from cultured fibroblasts carrying floxed alleles of Crk and CrkL by transfection with synthetic Cre mRNA (synCre). Loss of Crk and CrkL induced by synCre transfection blocked cell proliferation and caused shrinkage of the cytoplasm and the nucleus, formation of adherens junctions, and reduced cell motility. Ablation of Crk or CrkL alone conferred a much more modest reduction in cell proliferation. Reintroduction of CrkI, CrkII, or CrkL individually rescued cell proliferation in the absence of the endogenous Crk and CrkL, suggesting that Crk and CrkL play overlapping functions in regulating fibroblast growth. Serum and basic FGF induced phosphorylation of Akt, MAP kinases, and S6 kinase and Fos expression in the absence of Crk and CrkL, suggesting that cells lacking Crk and CrkL are capable of initiating major signal transduction pathways in response to extracellular stimuli. Furthermore, cell cycle and cell death analyses demonstrated that fibroblasts lacking Crk and CrkL become arrested at the G1-S transition and undergo a modest apoptosis. Taken together, our results suggest that Crk and CrkL play essential overlapping roles in fibroblast growth.	[Park, Taeju; Koptyra, Mateusz; Curran, Tom] Childrens Mercy Kansas City, Childrens Res Inst, Kansas City, MO 64108 USA	Children's Mercy Hospital	Park, T (corresponding author), Childrens Mercy Kansas City, Childrens Res Inst, Kansas City, MO 64108 USA.	tjpark@cmh.edu	Curran, Tom/F-5234-2018; Curran, Thomas/AAE-7631-2019	Curran, Tom/0000-0003-1444-7551; Curran, Thomas/0000-0003-1444-7551; Koptyra, Mateusz/0000-0002-3857-6633; Park, Taeju/0000-0003-3897-3994				Antoku S, 2009, J CELL SCI, V122, P4228, DOI 10.1242/jcs.054627; Batt DB, 1998, J BIOL CHEM, V273, P3408, DOI 10.1074/jbc.273.6.3408; Bell Emily S, 2012, Genes Cancer, V3, P341, DOI 10.1177/1947601912459951; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Cheng SM, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0494-1; Cheng SM, 2015, TUMOR BIOL, V36, P915, DOI 10.1007/s13277-014-2724-0; Deng YP, 2008, J CELL BIOCHEM, V105, P1172, DOI 10.1002/jcb.21829; Elmansuri AZ, 2016, ONCOTARGET, V7, P27094, DOI 10.18632/oncotarget.8314; Fathers KE, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3183; George B, 2014, KIDNEY INT, V85, P1382, DOI 10.1038/ki.2013.556; Hallock PT, 2010, GENE DEV, V24, P2451, DOI 10.1101/gad.1977710; Han G, 2015, CYTOKINE, V76, P163, DOI 10.1016/j.cyto.2015.05.009; Huang S, 2002, EXP CELL RES, V275, P255, DOI 10.1006/excr.2002.5504; Huang S, 1998, MOL BIOL CELL, V9, P3179, DOI 10.1091/mbc.9.11.3179; Huang YP, 2015, J CLIN INVEST, V125, P1019, DOI 10.1172/JCI77278; Isakov N, 2008, TRENDS IMMUNOL, V29, P388, DOI 10.1016/j.it.2008.04.006; Ishimaru S, 2004, EMBO J, V23, P3984, DOI 10.1038/sj.emboj.7600417; Kodama H, 2003, HYPERTENSION, V41, P1372, DOI 10.1161/01.HYP.0000069698.11814.F4; Koptyra M, 2016, MOL CARCINOGEN, V55, P97, DOI 10.1002/mc.22262; Kuhn AN, 2012, CURR GENE THER, V12, P347; Kumar S, 2014, J CELL BIOCHEM, V115, P819, DOI 10.1002/jcb.24749; Lamorte L, 2000, ONCOGENE, V19, P5973, DOI 10.1038/sj.onc.1203977; Lamorte L, 2002, MOL BIOL CELL, V13, P1449, DOI 10.1091/mbc.01-10-0477; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Li FF, 2012, EUR J PHARMACOL, V678, P1, DOI 10.1016/j.ejphar.2011.12.018; Linghu H, 2006, ONCOGENE, V25, P3547, DOI 10.1038/sj.onc.1209398; Lohez OD, 2003, J CELL BIOL, V161, P67, DOI 10.1083/jcb.200208140; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Magdaleno S, 2002, NEURON, V33, P573, DOI 10.1016/S0896-6273(02)00582-2; MATSUDA M, 1992, MOL CELL BIOL, V12, P3482, DOI 10.1128/MCB.12.8.3482; Matsumoto R, 2015, CANCER SCI, V106, P709, DOI 10.1111/cas.12662; MAYER BJ, 1988, COLD SPRING HARB SYM, V53, P907, DOI 10.1101/SQB.1988.053.01.104; Miller CT, 2003, ONCOGENE, V22, P7950, DOI 10.1038/sj.onc.1206529; Mochizuki N, 2000, J BIOL CHEM, V275, P12667, DOI 10.1074/jbc.275.17.12667; Mortazavi F, 2011, CLIN EXP METASTAS, V28, P391, DOI 10.1007/s10585-011-9378-8; Nishihara H, 2002, CANCER LETT, V180, P55, DOI 10.1016/S0304-3835(01)00763-7; Park TJ, 2014, ONCOGENE, V33, P5121, DOI 10.1038/onc.2013.453; Park TJ, 2006, MOL CELL BIOL, V26, P6272, DOI 10.1128/MCB.00472-06; Park TJ, 2008, J NEUROSCI, V28, P13551, DOI 10.1523/JNEUROSCI.4323-08.2008; Paski SC, 2002, CAN J PHYSIOL PHARM, V80, P790, DOI 10.1139/Y02-101; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Rodrigues GA, 1997, EMBO J, V16, P2634, DOI 10.1093/emboj/16.10.2634; Rodrigues SP, 2005, MOL CANCER RES, V3, P183; Salameh A, 2005, BLOOD, V106, P3423, DOI 10.1182/blood-2005-04-1388; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Senechal K, 1996, J BIOL CHEM, V271, P23255, DOI 10.1074/jbc.271.38.23255; Sriram Ganapathy, 2010, Genes Cancer, V1, P1132, DOI 10.1177/1947601910397188; Takino T, 2003, CANCER RES, V63, P2335; Tanaka S, 1997, P NATL ACAD SCI USA, V94, P2356, DOI 10.1073/pnas.94.6.2356; Tsuda Masumi, 2012, Genes Cancer, V3, P334, DOI 10.1177/1947601912458687; Wang J, 2011, MOL CARCINOGEN, V50, P506, DOI 10.1002/mc.20745; Wang JQ, 2013, CHEM-BIOL INTERACT, V206, P230, DOI 10.1016/j.cbi.2013.09.003; Wang L, 2007, BIOCHEM BIOPH RES CO, V362, P976, DOI 10.1016/j.bbrc.2007.08.106; Wang Y, 2013, MOL CARCINOGEN, V52, P890, DOI 10.1002/mc.21935; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Watanabe T, 2006, MOL CANCER RES, V4, P499, DOI 10.1158/1541-7786.MCR-05-0141; Yamada S, 2011, CANCER LETT, V303, P84, DOI 10.1016/j.canlet.2011.01.004; Yanagi H, 2012, BIOCHEM BIOPH RES CO, V418, P104, DOI 10.1016/j.bbrc.2011.12.142; Yeung CL, 2013, ONCOGENE, V32, P5429, DOI 10.1038/onc.2012.590	59	12	12	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26273	26290		10.1074/jbc.M116.764613	http://dx.doi.org/10.1074/jbc.M116.764613			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27807028	Green Published, hybrid			2022-12-26	WOS:000391568200004
J	Mazzei, M; Fronte, B; Sagona, S; Carrozza, ML; Forzan, M; Pizzurro, F; Bibbiani, C; Miragliotta, V; Abramo, F; Millanta, F; Bagliacca, M; Poli, A; Felicioli, A				Mazzei, Maurizio; Fronte, Baldassare; Sagona, Simona; Carrozza, Maria Luisa; Forzan, Mario; Pizzurro, Federica; Bibbiani, Carlo; Miragliotta, Vincenzo; Abramo, Francesca; Millanta, Francesca; Bagliacca, Marco; Poli, Alessandro; Felicioli, Antonio			Effect of 1,3-1,6 beta-Glucan on Natural and Experimental Deformed Wing Virus Infection in Newly Emerged Honeybees (Apis mellifera ligustica)	PLOS ONE			English	Article							PROPHENOLOXIDASE; IMMUNITY; REPLICATION; EXPRESSION; DROSOPHILA; PATHWAYS; SYSTEM; BEES	The Western Honeybee is a key pollinator for natural as well as agricultural ecosystems. In the last decade massive honeybee colony losses have been observed worldwide, the result of a complex syndrome triggered by multiple stress factors, with the RNA virus Deformed Wing Virus (DWV) and the mite Varroa destructor playing crucial roles. The mite supports replication of DWV to high titers, which exert an immunosuppressive action and correlate with the onset of the disease. The aim of this study was to investigate the effect of 1,3-1,6 beta-glucan, a natural innate immune system modulator, on honeybee response to low-titer natural and high-titer experimental DWV infection. As the effects exerted by beta-glucans can be remarkably different, depending on the target organism and the dose administered, two parallel experiments were performed, where 1,3-1,6 beta-glucan at a concentration of 0.5% and 2% respectively, was added to the diet of three cohorts of newly emerged honeybees, which were sampled from a Varroa-free apiary and harboured a low endogenous DWV viral titer. Each cohort was subjected to one of the following experimental treatments: no injection, injection of a high-copy number DWV suspension into the haemocel (experimental DWV infection) or injection of PBS into the haemocoel (physical injury). Control bees fed a beta-glucan-free diet were subjected to the same treatments. Viral load, survival rate, haemocyte populations and phenoloxidase activity of each experimental group were measured and compared. The results indicated that oral administration of 0.5% beta-glucan to naturally infected honeybees was associated with a significantly decrease of the number of infected bees and viral load they carried, and with a significant increase of the survival rate, suggesting that this natural immune modulator molecule might contribute to increase honeybee resistance to viral infection.	[Mazzei, Maurizio; Fronte, Baldassare; Sagona, Simona; Forzan, Mario; Pizzurro, Federica; Bibbiani, Carlo; Miragliotta, Vincenzo; Abramo, Francesca; Millanta, Francesca; Bagliacca, Marco; Poli, Alessandro; Felicioli, Antonio] Univ Pisa, Dept Vet Sci, Pisa, Italy; [Carrozza, Maria Luisa] Scuola Normale Super Pisa, Pisa, Italy	University of Pisa; Scuola Normale Superiore di Pisa	Mazzei, M (corresponding author), Univ Pisa, Dept Vet Sci, Pisa, Italy.	maurizio.mazzei@unipi.it	sagona, simona/GXH-0254-2022; Felicioli, Antonio/AAT-2167-2021; Miragliotta, Vincenzo/K-7361-2015; Pizzurro, Federica/D-8325-2017; Bibbiani, Carlo/D-6477-2017; Sagona, Simona/AAT-8969-2021; Mazzei, Maurizio/H-5788-2016	Miragliotta, Vincenzo/0000-0001-7896-5695; Pizzurro, Federica/0000-0003-3875-6148; Bibbiani, Carlo/0000-0002-9730-9498; Mazzei, Maurizio/0000-0003-3797-8320; FRONTE, BALDASSARE/0000-0002-8480-318X; Poli, Alessandro/0000-0003-1254-5772; Forzan, Mario/0000-0003-2474-8219	University of Pisa (PROGETTI DI RICERCA DI ATENEO PRA) [0053]	University of Pisa (PROGETTI DI RICERCA DI ATENEO PRA)	This research was supported by a grant from the University of Pisa (PROGETTI DI RICERCA DI ATENEO PRA 2015 n. 0053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Boman HG, 1986, ANTIBACTERIAL IMMUNE, P63, DOI [10.1007/978-3-642-70768-1_6, DOI 10.1007/978-3-642-70768-1_6]; Brutscher LM, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/941897; Bull JC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003083; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; El Mohandes S. S., 2010, J BIOL SCI, V3, P213; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Giusti M, 2016, APIDOLOGIE, V47, P688, DOI 10.1007/s13592-015-0417-3; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Guselle NJ, 2007, J FISH DIS, V30, P111, DOI 10.1111/j.1365-2761.2007.00781.x; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hudson LN, 2014, ECOL EVOL, V4, P4701, DOI 10.1002/ece3.1303; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Kingsolver MB, 2013, J MOL BIOL, V425, P4921, DOI 10.1016/j.jmb.2013.10.006; Lourenco AP, 2005, INSECT BIOCHEM MOLEC, V35, P541, DOI 10.1016/j.ibmb.2005.01.013; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Mazzei M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113448; Merkling SH, 2013, J INSECT PHYSIOL, V59, P159, DOI 10.1016/j.jinsphys.2012.07.004; Mockel N, 2011, J GEN VIROL, V92, P370, DOI 10.1099/vir.0.025940-0; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Nazzi F, 2014, TRENDS PARASITOL, V30, P556, DOI 10.1016/j.pt.2014.09.006; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Pathak K, 2014, CURRENT PHARM CLIN, V4, P71; Patil U.S., 2012, INT J PHARM PHARM SC, V4, P30, DOI DOI 10.5455/NJPPP.2017.7.0203808032017; Potts SG, 2011, J APICULT RES, V50, P152, DOI 10.3896/IBRA.1.50.2.07; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Ryabov EV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004230; Sabcaliu A, 2010, B UASVM, V67, P313; SAS INSTITUTE, 2008, JMP STAT GRAPH GUID; Schmid MR, 2008, J INSECT PHYSIOL, V54, P439, DOI 10.1016/j.jinsphys.2007.11.002; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Shiao SH, 2001, INSECT MOL BIOL, V10, P315, DOI 10.1046/j.0962-1075.2001.00268.x; Soltanian S, 2009, CRIT REV MICROBIOL, V35, P109, DOI 10.1080/10408410902753746; Szymas B, 2003, APIDOLOGIE, V34, P97, DOI 10.1051/apido:2003012; THEODORSSONNORHEIM E, 1986, COMPUT METH PROG BIO, V23, P57, DOI 10.1016/0169-2607(86)90081-7; Underwood R., 2007, BEE CULTURE, V35, P13; Van Wettere Arnaud, 2007, Veterinary Clinics of North America Exotic Animal Practice, V10, P235, DOI 10.1016/j.cvex.2006.11.003; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Zioni N, 2011, VIROLOGY, V417, P106, DOI 10.1016/j.virol.2011.05.009	47	20	20	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166297	10.1371/journal.pone.0166297	http://dx.doi.org/10.1371/journal.pone.0166297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829027	Green Published, gold			2022-12-26	WOS:000387724300104
J	Guo, QY; Miller, D; An, HY; Wang, H; Lopez, J; Lough, D; He, L; Kumar, A				Guo, Qiongyu; Miller, Devin; An, Hongying; Wang, Howard; Lopez, Joseph; Lough, Denver; He, Ling; Kumar, Anand			Controlled Heat Stress Promotes Myofibrillogenesis during Myogenesis	PLOS ONE			English	Article							SKELETAL-MUSCLE REGENERATION; MITOCHONDRIAL BIOGENESIS; MYOBLAST FUSION; DIFFERENTIATION; GENE; HYPERTHERMIA; ACTIVATION; EXPRESSION; ATROPHY; CELLS	Hyperthermia therapy has recently emerged as a clinical modality used to finely tune heat stress inside the human body for various biomedical applications. Nevertheless, little is known regarding the optimal timing or temperature of heat stress that is needed to achieve favorable results following hyperthermia therapy for muscle regeneration purposes. The regeneration of skeletal muscle after injury is a highly complex and coordinated process that involves a multitude of cellular mechanisms. The main objective of this study was to characterize the effects of hyperthermal therapy on the overall behavior of myoblasts during myogenic differentiation. Various cellular processes, including myogenesis, myofibrillogenesis, hypertrophy/atrophy, and mitochondrial biogenesis, were studied using systematic cellular, morphological, and pathway-focused high-throughput gene expression profiling analyses. We found that C2C12 myoblasts exhibited distinctive time and temperature-dependence in biosynthesis and regulatory events during myogenic differentiation. Specifically, we for the first time observed that moderate hyperthermia at 39 degrees C favored the growth of sarcomere in myofibrils at the late stage of myogenesis, showing universal up-regulation of characteristic myofibril proteins. Characteristic myofibrillogenesis genes, including heavy polypeptide 1 myosin, heavy polypeptide 2 myosin, alpha 1 actin, nebulin and titin, were all significantly upregulated (p<0.01) after C2C12 cells differentiated at 39 degrees C over 5 days compared with the control cells cultured at 37 degrees C. Furthermore, moderate hyperthermia enhanced myogenic differentiation, with nucleus densities per myotube showing 2.2-fold, 1.9-fold and 1.6-fold increases when C2C12 cells underwent myogenic differentiation at 39 E C over 24 hours, 48 hours and 72 hours, respectively, as compared to the myotubes that were not exposed to heat stress. Yet, atrophy genes were sensitive even to moderate hyperthermia, indicating that strictly controlled heat stress is required to minimize the development of atrophy in myotubes. In addition, mitochondrial biogenesis was enhanced following thermal induction of myoblasts, suggesting a subsequent shift toward anabolic demand requirements for energy production. This study offers a new perspective to understand and utilize the time and temperature-sensitive effects of hyperthermal therapy on muscle regeneration.	[Guo, Qiongyu; Miller, Devin; Wang, Howard; Lopez, Joseph; Lough, Denver; Kumar, Anand] Johns Hopkins Univ, Sch Med, Dept Plast & Reconstruct Surg, Baltimore, MD 21218 USA; [An, Hongying; He, Ling] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Metab, Baltimore, MD 21205 USA; [An, Hongying; He, Ling] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Endocrinol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Kumar, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Plast & Reconstruct Surg, Baltimore, MD 21218 USA.	akumar40@jhu.edu	Guo, Qiongyu/J-3118-2014; Lopez, Joseph/AAD-7424-2020	Guo, Qiongyu/0000-0002-1916-9100; Lopez, Joseph/0000-0001-8723-6347; Kumar, Anand/0000-0002-4429-0236	Johns Hopkins School of Medicine Faculty Start Up Research Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107641] Funding Source: NIH RePORTER	Johns Hopkins School of Medicine Faculty Start Up Research Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by Johns Hopkins School of Medicine Faculty Start Up Research Grant (AK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Bartoli M, 2005, INT J BIOCHEM CELL B, V37, P2115, DOI 10.1016/j.biocel.2004.12.012; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Castellani JW, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12777; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Charrasse S, 2006, MOL BIOL CELL, V17, P749, DOI 10.1091/mbc.E05-04-0284; Chatterjee DK, 2011, THER DELIV, V2, P1001, DOI 10.4155/TDE.11.72; Cleveland BM, 2010, COMP BIOCHEM PHYS B, V157, P248, DOI 10.1016/j.cbpb.2010.06.010; Crawford Garland L, 2011, Biophys Rev, V3, P25, DOI 10.1007/s12551-011-0043-x; Duguez S, 2002, AM J PHYSIOL-ENDOC M, V282, pE802, DOI 10.1152/ajpendo.00343.2001; Foulstone EJ, 2003, J CELL PHYSIOL, V195, P70, DOI 10.1002/jcp.10227; Gagan J, 2012, J BIOL CHEM, V287, P40360, DOI 10.1074/jbc.M112.378414; Giombini A, 2007, BRIT MED BULL, V83, P379, DOI 10.1093/bmb/ldm020; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Hatade T, 2014, J MUSCULOSKEL NEURON, V14, P325; Hauerslev S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-43; He L, 2016, J BIOL CHEM, V291, P10562, DOI 10.1074/jbc.M116.719666; Hubbard SR, 2013, BBA-PROTEINS PROTEOM, V1834, P2166, DOI 10.1016/j.bbapap.2013.02.034; Hwang PM, 2015, NAT REV DRUG DISCOV, V14, P313, DOI 10.1038/nrd4554; Ikeda K, 2017, J TISSUE ENG REGEN M, V11, P1322, DOI 10.1002/term.2030; Jones NC, 2001, J CELL PHYSIOL, V186, P104, DOI 10.1002/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0; Kim KI, 2006, ARTERIOSCL THROM VAS, V26, P91, DOI 10.1161/01.ATV.0000193569.12490.4b; Kislinger T, 2005, MOL CELL PROTEOMICS, V4, P887, DOI 10.1074/mcp.M400182-MCP200; Kumar CSSR, 2011, ADV DRUG DELIVER REV, V63, P789, DOI 10.1016/j.addr.2011.03.008; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; Li J, 2006, BIOCHEM BIOPH RES CO, V345, P1425, DOI 10.1016/j.bbrc.2006.05.051; Lima GA, 2009, AM J PHYSIOL-ENDOC M, V296, pE132, DOI 10.1152/ajpendo.90548.2008; Liu CT, 2012, J APPL PHYSIOL, V112, P354, DOI 10.1152/japplphysiol.00989.2011; Melkani GC, 2006, J MOL BIOL, V358, P635, DOI 10.1016/j.jmb.2006.02.043; Montesano A, 2013, INT J BIOL SCI, V9, P391, DOI 10.7150/ijbs.4729; Oishi Y, 2015, MUSCLE NERVE, V52, P1047, DOI 10.1002/mus.24686; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Qazi TH, 2015, BIOMATERIALS, V53, P502, DOI 10.1016/j.biomaterials.2015.02.110; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sanger JW, 2009, CELL MOTIL CYTOSKEL, V66, P556, DOI 10.1002/cm.20365; Sanger JW, 2002, CLIN ORTHOP RELAT R, pS153, DOI 10.1097/01.blo.0000031973.69509.21; Schoneich C, 2014, APOPTOSIS, V19, P42, DOI 10.1007/s10495-013-0922-7; Takeuchi K, 2014, ACTA HISTOCHEM, V116, P327, DOI 10.1016/j.acthis.2013.08.010; Welc SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148927; Welc SS, 2013, AM J PHYSIOL-CELL PH, V305, pC406, DOI 10.1152/ajpcell.00084.2013; Yamaguchi T, 2010, AM J PHYSIOL-CELL PH, V298, pC140, DOI 10.1152/ajpcell.00050.2009; Yusuf F, 2012, HISTOCHEM CELL BIOL, V138, P187, DOI 10.1007/s00418-012-0972-x	42	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166294	10.1371/journal.pone.0166294	http://dx.doi.org/10.1371/journal.pone.0166294			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824934	gold, Green Published			2022-12-26	WOS:000387615200082
J	Liu, WY; Lin, SG; Zhu, GQ; Van Poucke, S; Braddock, M; Zhang, ZH; Mao, Z; Shen, FX; Zheng, MH				Liu, Wen-Yue; Lin, Shi-Gang; Zhu, Gui-Qi; Van Poucke, Sven; Braddock, Martin; Zhang, Zhongheng; Mao, Zhi; Shen, Fei-Xia; Zheng, Ming-Hua			Establishment and Validation of GV-SAPS II Scoring System for Non-Diabetic Critically Ill Patients	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; GLUCOSE VARIABILITY; GLYCEMIC CONTROL; HOSPITAL MORTALITY; ASSOCIATION; ICU	Background and Aims Recently, glucose variability (GV) has been reported as an independent risk factor for mortality in non-diabetic critically ill patients. However, GV is not incorporated in any severity scoring system for critically ill patients currently. The aim of this study was to establish and validate a modified Simplified Acute Physiology Score II scoring system (SAPS II), integrated with GV parameters and named GV-SAPS II, specifically for non-diabetic critically ill patients to predict short-term and long-term mortality. Methods Training and validation cohorts were exacted from the Multiparameter Intelligent Monitoring in Intensive Care database III version 1.3 (MIMIC-III v1.3). The GV-SAPS II score was constructed by Cox proportional hazard regression analysis and compared with the original SAPS II, Sepsis-related Organ Failure Assessment Score (SOFA) and Elixhauser scoring systems using area under the curve of the receiver operator characteristic (auROC) curve. Results 4,895 and 5,048 eligible individuals were included in the training and validation cohorts, respectively. The GV-SAPS II score was established with four independent risk factors, including hyperglycemia, hypoglycemia, standard deviation of blood glucose levels (Glu(SD)), and SAPS II score. In the validation cohort, the auROC values of the new scoring system were 0.824 (95% CI: 0.813-0.834, P<0.001) and 0.738 (95% CI: 0.725-0.750, P<0.001), respectively for 30 days and 9 months, which were significantly higher than other models used in our study (all P<0.001). Moreover, Kaplan-Meier plots demonstrated significantly worse outcomes in higher GV-SAPS II score groups both for 30-day and 9-month mortality endpoints (all P<0.001). Conclusions We established and validated a modified prognostic scoring system that integrated glucose variability for non-diabetic critically ill patients, named GV-SAPS II. It demonstrated a superior prognostic capability and may be an optimal scoring system for prognostic evaluation in this patient group.	[Liu, Wen-Yue; Shen, Fei-Xia] Wenzhou Med Univ, Dept Endocrinol, Affiliated Hosp 1, Wenzhou 325000, Peoples R China; [Lin, Shi-Gang; Zhu, Gui-Qi] Wenzhou Med Univ, Sch Clin Med Sci 1, Wenzhou 325000, Peoples R China; [Zhu, Gui-Qi; Zheng, Ming-Hua] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, Liver Res Ctr, Wenzhou 325000, Peoples R China; [Van Poucke, Sven] Ziekenhuis Oost Limburg, Dept Anesthesiol Intens Care Emergency Med & Pain, Genk, Belgium; [Braddock, Martin] AstraZeneca R&D, Global Med Dev, Loughborough, Leics, England; [Zhang, Zhongheng] Zhejiang Univ, Jinhua Hosp, Jinhua Municipal Cent Hosp, Dept Crit Care Med, Jinhua 321000, Peoples R China; [Mao, Zhi] Chinese Peoples Liberat Army Gen Hosp, Dept Crit Care Med, Beijing, Peoples R China; [Zheng, Ming-Hua] Wenzhou Med Univ, Inst Hepatol, Wenzhou 325000, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; East Limburg Hospital; AstraZeneca; Zhejiang University; Chinese People's Liberation Army General Hospital; Wenzhou Medical University	Shen, FX (corresponding author), Wenzhou Med Univ, Dept Endocrinol, Affiliated Hosp 1, Wenzhou 325000, Peoples R China.; Zheng, MH (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, Liver Res Ctr, Wenzhou 325000, Peoples R China.; Zheng, MH (corresponding author), Wenzhou Med Univ, Inst Hepatol, Wenzhou 325000, Peoples R China.	327654951@qq.com; blueman1320@163.com	Zhu, Gui-Qi/H-9265-2017; Zhang, Zhongheng/E-1282-2011; Zheng, Ming-Hua/H-5584-2019; zhang, zh/GWV-4677-2022; Van Poucke, Sven/K-5999-2016	Zhu, Gui-Qi/0000-0001-5089-6923; Zhang, Zhongheng/0000-0002-2336-5323; Zheng, Ming-Hua/0000-0003-4984-2631; Van Poucke, Sven/0000-0001-8070-8786	National Natural Science Foundation of China [81500665]; Zhejiang Provincial Natural Science Foundation [Y14H070034]; High Level Creative Talents from Department of Public Health in Zhejiang Province; Project of New Century 551 Talent Nurturing in Wenzhou; AstraZeneca RD	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); High Level Creative Talents from Department of Public Health in Zhejiang Province; Project of New Century 551 Talent Nurturing in Wenzhou; AstraZeneca RD(AstraZeneca)	This work was supported by grants from National Natural Science Foundation of China (81500665), Zhejiang Provincial Natural Science Foundation (Y14H070034), High Level Creative Talents from Department of Public Health in Zhejiang Province and Project of New Century 551 Talent Nurturing in Wenzhou. AstraZeneca R&D provided support in the form of salaries for author Martin Braddock, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha A, 2002, CHIRURG, V73, P439, DOI 10.1007/s00104-001-0374-4; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Bagshaw SM, 2009, CRIT CARE MED, V37, P463, DOI 10.1097/CCM.0b013e318194b097; Deane AM, 2013, DIABETES OBES METAB, V15, P792, DOI 10.1111/dom.12078; Donati A, 2014, CRIT CARE RESUSC, V16, P13; Egi M, 2006, ANESTHESIOLOGY, V105, P244, DOI 10.1097/00000542-200608000-00006; Eslami S, 2011, INTENS CARE MED, V37, P583, DOI 10.1007/s00134-010-2129-5; Falciglia M, 2009, CRIT CARE MED, V37, P3001, DOI 10.1097/CCM.0b013e3181b083f7; Farrokhi F, 2014, ENDOCR PRACT, V20, P41, DOI 10.4158/EP13131.OR; Farrokhi F, 2011, BEST PRACT RES CL EN, V25, P813, DOI 10.1016/j.beem.2011.05.004; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Hermanides J, 2010, CRIT CARE MED, V38, P838, DOI 10.1097/CCM.0b013e3181cc4be9; Kavanagh BP, 2010, NEW ENGL J MED, V363, P2540, DOI 10.1056/NEJMcp1001115; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lheureux O, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0571-4; Lipska KJ, 2012, CIRC-CARDIOVASC QUAL, V5, P550, DOI 10.1161/CIRCOUTCOMES.111.963298; Metnitz PGH, 2005, INTENS CARE MED, V31, P1336, DOI 10.1007/s00134-005-2762-6; Meyfroidt G, 2010, CRIT CARE MED, V38, P1021, DOI 10.1097/CCM.0b013e3181cf710e; Ooi YC, 2012, NEUROSURGERY, V71, P692, DOI 10.1227/NEU.0b013e3182631eb4; Pisarchik AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046582; Risso A, 2001, AM J PHYSIOL-ENDOC M, V281, pE924, DOI 10.1152/ajpendo.2001.281.5.E924; Saeed M, 2011, CRIT CARE MED, V39, P952, DOI 10.1097/CCM.0b013e31820a92c6; SCHLICHTING P, 1983, HEPATOLOGY, V3, P889; Schuster HP, 1997, INTENS CARE MED, V23, P1056, DOI 10.1007/s001340050456; Sechterberger MK, 2013, CRIT CARE, V17, DOI 10.1186/cc12572; Sekulic AD, 2015, MED SCI MONITOR, V21, DOI 10.12659/MSM.894153; Siegelaar SE, 2011, BEST PRACT RES CL EN, V25, P825, DOI 10.1016/j.beem.2011.03.004; Todi S, 2014, INDIAN J CRIT CARE M, V18, P285, DOI [10.4103/0972-5229.132484, 10.4103/0972-5229.130574]; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wunsch H, 2010, JAMA-J AM MED ASSOC, V303, P849, DOI 10.1001/jama.2010.216; Yan Chiu-Lan, 2013, Acta Anaesthesiol Taiwan, V51, P67, DOI 10.1016/j.aat.2013.06.004; Zimmerman JE, 2013, CRIT CARE, V17, DOI 10.1186/cc12695	34	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166085	10.1371/journal.pone.0166085	http://dx.doi.org/10.1371/journal.pone.0166085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824941	Green Submitted, Green Published, gold			2022-12-26	WOS:000387615200060
J	Zhang, C; Li, XM; Liu, Y; Qiao, S; Zhou, YJ; Shen, ZY; Chen, Y				Zhang, Chen; Li, Xiaoming; Liu, Yu; Qiao, Shan; Zhou, Yuejiao; Shen, Zhiyong; Chen, Yi			Substance Use and Psychosocial Status among People Living with HIV/AIDS Who Encountered HIV Stigma in China: Stratified Analyses by Socio-Economic Status	PLOS ONE			English	Article							MENTAL-HEALTH; ASSOCIATION; SES	This study examined whether the impact of HIV stigma on psychosocial status and substance use among people living with HIV/AIDS (PLWHA) differed by their socio-economic status (SES) in a Chinese setting. A total of 2,987 PLWHA were recruited from 12 sites with the highest number of cumulative HIV incidence in Guangxi, China. Participants were asked to provide information regarding their psychosocial status (e.g., depression, anxiety), history of substance use (e.g., tobacco, alcohol and drug) and SES (e.g., education, monthly income, residence type, and job category). By employing stratified multivariate regression analyses, we assessed stratum-specific impacts of HIV stigma on PLWHA's psychosocial status and behaviors of substance use based upon participants' SES. The impact of HIV stigma differed significantly on psychosocial status across SES gradients. Psychosocial status among people with higher education was more sensitive to HIV stigma compared with PLWHA who were less educated. The odds of substance use behaviors were higher among people with better monthly income than their low-income peers. Our study is the first paper to document the paucity of SES stratified analyses between HIV stigma and psychosocial status and substance use among PLWHA in China. We call for tailored intervention programs to target PLWHA with different backgrounds and characteristics in order to help them to better manage their seropositivity.	[Zhang, Chen; Liu, Yu] Vanderbilt Univ, Div Epidemiol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Li, Xiaoming; Qiao, Shan] Univ South Carolina, Arnold Sch Publ Hlth, Dept Hlth Promot Educ & Behav, Columbia, SC USA; [Zhou, Yuejiao; Shen, Zhiyong; Chen, Yi] Guangxi CDC, Dept HIV STD Prevent, Nanning, Guangxi, Peoples R China	Vanderbilt University; University of South Carolina System; University of South Carolina Columbia	Zhang, C (corresponding author), Vanderbilt Univ, Div Epidemiol, 221 Kirkland Hall, Nashville, TN 37235 USA.	chen.zhang.1@vanderbilt.edu	Li, Xiaoming/AAF-1362-2019	Li, Xiaoming/0000-0002-5555-9034; Zhang, Chen/0000-0002-8771-561X	National Institute of Child and Human Development Grant [R01HD074221]	National Institute of Child and Human Development Grant	The study was supported by the National Institute of Child and Human Development Grant (#R01HD074221) (https://www.nichd.nih.gov/Pages/index.aspx). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Child and Human Development.	Ahsan Ullah A K M, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P97, DOI 10.1177/1545109710381926; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; China Government, 2006, COMP ED ACT PEOPL RE; Dray J, 2016, CHILD ADOL PSYCH MEN, V10, DOI 10.1186/s13034-016-0120-9; Earnshaw VA, 2013, AIDS BEHAV, V17, P1785, DOI 10.1007/s10461-013-0437-9; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Foster G, 2007, AIDS CARE, V19, pS54, DOI 10.1080/09540120601114469; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Guangxi CDC, 2011, UPD HIV AIDS EP GUAN; Guangxi CDC, 2014, GUANGX HIV SURV REP; Guangxi Statistic Bureau, 2011, REP 6 POP CENS SURV; Kuria EN, 2010, PUBLIC HEALTH NUTR, V13, P475, DOI 10.1017/S1368980009990826; Lepiece Brice, 2015, Psychiatr Danub, V27 Suppl 1, pS92; Link B, 2001, ANNU REV SOCIOL, V27, P418; Milloy MJ, 2012, CURR HIV-AIDS REP, V9, P364, DOI 10.1007/s11904-012-0137-5; Oakes JM, 2003, SOC SCI MED, V56, P769, DOI 10.1016/S0277-9536(02)00073-4; Park S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2731-8; Probst C, 2016, TROP MED INT HEALTH, V21, P846, DOI 10.1111/tmi.12712; Qian HZ, 2007, AIDS CARE, V19, P1283, DOI 10.1080/09540120701402814; Qiao S, 2015, AIDS CARE, V27, P28, DOI 10.1080/09540121.2015.1034648; Qiao Shan, 2015, AIDS, V29 Suppl 1, pS25, DOI 10.1097/QAD.0000000000000670; Queen S, 2012, 2012 NAT C HLTH STAT; Reich WA, 2010, PSYCHOL HEALTH MED, V15, P135, DOI 10.1080/13548501003623930; Ritte S A, 2012, East Afr J Public Health, V9, P33; Siegfried N, 2010, INT J EPIDEMIOL, V39, P1556, DOI 10.1093/ije/dyq198; Sugiyama T, 2016, HEALTH PLACE, V38, P16, DOI 10.1016/j.healthplace.2016.01.002; Tam C L, 2011, East Asian Arch Psychiatry, V21, P73; Tsai AC, 2017, AIDS BEHAV, V21, P248, DOI 10.1007/s10461-015-1285-6; Veenstra G, 2000, SOC SCI MED, V50, P619, DOI 10.1016/S0277-9536(99)00307-X; WACC, 2014, PEER ED HIV AIDS STI; World Health Organization, 2016, GLOB HLTH OBS GHO DA; Wu LY, 2013, HEALTH PSYCHOL BEHAV, V1, P31, DOI 10.1080/21642850.2013.822798; Yi SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121461; Zhang C, 2016, PLOS ONE IN PRESS; Zhang C, 2016, AIDS CARE, V28, P124, DOI 10.1080/09540121.2016.1146206	35	7	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165624	10.1371/journal.pone.0165624	http://dx.doi.org/10.1371/journal.pone.0165624			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB8BE	27824948	Green Published, Green Submitted, gold			2022-12-26	WOS:000387615200023
J	Kerviel, A; Dash, S; Moncorge, O; Panthu, B; Prchal, J; Decimo, D; Ohlmann, T; Lina, B; Favard, C; Decroly, E; Ottmann, M; Roingeard, P; Muriaux, D				Kerviel, Adeline; Dash, Shantoshini; Moncorge, Olivier; Panthu, Baptiste; Prchal, Jan; Decimo, Didier; Ohlmann, Theophile; Lina, Bruno; Favard, Cyril; Decroly, Etienne; Ottmann, Michele; Roingeard, Philippe; Muriaux, Delphine			Involvement of an Arginine Triplet in M1 Matrix Protein Interaction with Membranes and in M1 Recruitment into Virus-Like Particles of the Influenza A(H1N1)pdm09 Virus	PLOS ONE			English	Article							A VIRUS; QUANTITATIVE-ANALYSIS; NS1 PROTEIN; BINDING; ASSOCIATION; GLYCOPROTEINS; DOMAINS; RNA; OLIGOMERIZATION; HEMAGGLUTININ	The influenza A(H1N1) pdm09 virus caused the first influenza pandemic of the 21st century. In this study, we wanted to decipher the role of conserved basic residues of the viral M1 matrix protein in virus assembly and release. M1 plays many roles in the influenza virus replication cycle. Specifically, it participates in viral particle assembly, can associate with the viral ribonucleoprotein complexes and can bind to the cell plasma membrane and/or the cytoplasmic tail of viral transmembrane proteins. M1 contains an N-terminal domain of 164 amino acids with two basic domains: the nuclear localization signal on helix 6 and an arginine triplet (R76/77/78) on helix 5. To investigate the role of these two M1 basic domains in influenza A(H1N1) pdm09 virus molecular assembly, we analyzed M1 attachment to membranes, virus-like particle (VLP) production and virus infectivity. In vitro, M1 binding to large unilamellar vesicles (LUVs), which contain negatively charged lipids, decreased significantly when the M1 R76/77/78 motif was mutated. In cells, M1 alone was mainly observed in the nucleus (47%) and in the cytosol (42%). Conversely, when co-expressed with the viral proteins NS1/NEP and M2, M1 was relocated to the cell membranes (55%), as shown by subcellular fractionation experiments. This minimal system allowed the production of M1 containing-VLPs. However, M1 with mutations in the arginine triplet accumulated in intracellular clusters and its incorporation in VLPs was strongly diminished. M2 over-expression was essential for M1 membrane localization and VLP production, whereas the viral transmembrane proteins HA and NA seemed dispensable. These results suggest that the M1 arginine triplet participates in M1 interaction with membranes. This R76/77/78 motif is essential for M1 incorporation in virus particles and the importance of this motif was confirmed by reverse genetic demonstrating that its mutation is lethal for the virus. These results highlight the molecular mechanism of M1-membrane interaction during the formation of influenza A(H1N1)pdm09 virus particles which is essential for infectivity.	[Kerviel, Adeline; Dash, Shantoshini; Moncorge, Olivier; Prchal, Jan; Favard, Cyril; Muriaux, Delphine] CNRS, Ctr Etud Agents Pathogenes & Biotechnol Sante CPB, Montpellier, France; [Kerviel, Adeline; Dash, Shantoshini; Moncorge, Olivier; Prchal, Jan; Favard, Cyril; Muriaux, Delphine] Univ Montpellier, Montpellier, France; [Panthu, Baptiste; Decimo, Didier; Ohlmann, Theophile] CIRI, INSERM U 1111, Lyon, France; [Panthu, Baptiste; Decimo, Didier; Ohlmann, Theophile] ENS Lyon, Lyon, France; [Lina, Bruno; Ottmann, Michele] Univ Lyon 1, Fac Med Lyon Est, Lab Virol & Pathol Humaine, EA 4610, Lyon, France; [Roingeard, Philippe] Univ Tours, INSERM U966, Tours, France; [Roingeard, Philippe] CHRU Tours, Tours, France; [Decroly, Etienne] Aix Marseille Univ, 163 Ave Luminy, F-13288 Marseille 09, France; [Decroly, Etienne] CNRS, AFMB UMR 7257, 163 Ave Luminy, F-13288 Marseille 09, France; [Prchal, Jan] Inst Chem Technol, Lab NMR Spect, Tech 5, Prague 16628, Czech Republic	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Ecole Normale Superieure de Lyon (ENS de LYON); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); University of Chemistry & Technology, Prague	Muriaux, D (corresponding author), CNRS, Ctr Etud Agents Pathogenes & Biotechnol Sante CPB, Montpellier, France.; Muriaux, D (corresponding author), Univ Montpellier, Montpellier, France.	delphine.muriaux@cpbs.cnrs.fr	Ohlmann, Theophile/H-6522-2016; lina, bruno/N-3663-2019; Prchal, Jan/H-9756-2014; Moncorge, Olivier/E-3233-2017; Favard, Cyril/P-6392-2016; Carmen, Team2/Y-7383-2019; ohlmann, Theophile/M-4463-2014	lina, bruno/0000-0002-8959-2123; Prchal, Jan/0000-0002-3398-5059; Moncorge, Olivier/0000-0003-0512-1824; Favard, Cyril/0000-0002-8304-2980; Carmen, Team2/0000-0001-9867-5724; ohlmann, Theophile/0000-0002-2001-8916; Decimo, Didier/0000-0002-0390-1205; Kerviel, Adeline/0000-0002-1315-9841; DECROLY, Etienne/0000-0002-6046-024X; ottmann, michele/0000-0002-6911-0705; Lab, Carmen/0000-0002-5935-3236	ENS Lyon; IHU Infectiopole Sud Mediterranee Fondation; French National Research Agency [ANR 13-BSV5-0006-01]; CNRS; French Ministry/ENS Lyon	ENS Lyon; IHU Infectiopole Sud Mediterranee Fondation; French National Research Agency(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministry/ENS Lyon	AK received doctoral fellowship support from French Minister/ENS Lyon. SD received a fellowship from IHU Infectiopole Sud Mediterranee Fondation. DM received grant funding from the French National Research Agency (ANR 13-BSV5-0006-01) and the CNRS.; We thank Prof W. Weissenhorn (Grenoble, France) and members of his laboratory, especially Jens Radzimanowski, for scientific exchanges during this work. We thank the MRI microscopy facility (Montpellier), and Dr Olivier Coux (CRBM, CNRS Montpellier, France) for technical suggestions concerning M1 protein purification. We thank Juliette Rousseau and Fabienne Arcanger for technical assistance with EM sections. Our data were obtained with the assistance of the IBiSA Electron Microscopy Facility of Francois Rabelais University. AK had a PhD studentship from the French Ministry/ENS Lyon, and SD from the IHU Infectiopole Sud Mediterranee Fondation. We are thankful to Elisabetta Andermarcher MD, PhD (Cantab) for editing the manuscript. This work was supported by grants from the French National Research Agency (ANR 13-BSV5-0006-01) and CNRS.	Akarsu H, 2003, EMBO J, V22, P4646, DOI 10.1093/emboj/cdg449; Ali A, 2000, J VIROL, V74, P8709, DOI 10.1128/JVI.74.18.8709-8719.2000; Arzt S, 2004, VIRUS RES, V99, P115, DOI 10.1016/j.virusres.2003.10.010; Avalos RT, 1997, J VIROL, V71, P2947, DOI 10.1128/JVI.71.4.2947-2958.1997; Barman S, 2001, VIRUS RES, V77, P61, DOI 10.1016/S0168-1702(01)00266-0; Baudin F, 2001, VIROLOGY, V281, P102, DOI 10.1006/viro.2000.0804; Chen BJ, 2008, J VIROL, V82, P10059, DOI 10.1128/JVI.01184-08; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; Chlanda P, 2015, J VIROL, V89, P8957, DOI 10.1128/JVI.00592-15; Das SC, 2012, J VIROL, V86, P1522, DOI 10.1128/JVI.06230-11; Elster C, 1997, J GEN VIROL, V78, P1589, DOI 10.1099/0022-1317-78-7-1589; ENAMI K, 1994, J VIROL, V68, P1432, DOI 10.1128/JVI.68.3.1432-1437.1994; Enami M, 1996, J VIROL, V70, P6653, DOI 10.1128/JVI.70.10.6653-6657.1996; Gerl MJ, 2012, J CELL BIOL, V196, P213, DOI 10.1083/jcb.201108175; Gomez-Puertas P, 2000, J VIROL, V74, P11538, DOI 10.1128/JVI.74.24.11538-11547.2000; Hamard-Peron E, 2010, J VIROL, V84, P503, DOI 10.1128/JVI.01134-09; Hilsch M, 2014, BIOPHYS J, V107, P912, DOI 10.1016/j.bpj.2014.06.042; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hutchinson EC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5816; Kretzschmar E, 1996, VIROLOGY, V220, P37, DOI 10.1006/viro.1996.0283; Leser GP, 2005, VIROLOGY, V342, P215, DOI 10.1016/j.virol.2005.09.049; LU Y, 1994, GENE DEV, V8, P1817, DOI 10.1101/gad.8.15.1817; McCown MF, 2006, J VIROL, V80, P8178, DOI 10.1128/JVI.00627-06; Momose F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021123; Nayak DP, 2009, VIRUS RES, V143, P147, DOI 10.1016/j.virusres.2009.05.010; Noton SL, 2007, J GEN VIROL, V88, P2280, DOI 10.1099/vir.0.82809-0; RICHARDSON JC, 1991, ARCH VIROL, V116, P69, DOI 10.1007/BF01319232; Robb NC, 2012, J GEN VIROL, V93, P113, DOI 10.1099/vir.0.035485-0; Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Ruigrok RWH, 2000, VIROLOGY, V267, P289, DOI 10.1006/viro.1999.0134; Ruigrok RWH, 2000, J MOL BIOL, V300, P103, DOI 10.1006/jmbi.2000.3822; Safo MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109510; Sha BD, 1997, NAT STRUCT BIOL, V4, P239, DOI 10.1038/nsb0397-239; Shimizu T, 2011, FEBS LETT, V585, P41, DOI 10.1016/j.febslet.2010.11.017; Shtykova EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082431; Soni SP, 2013, BIOPHYS J, V104, P1940, DOI [10.1016/j.bpj.2013.03.021, 10.1016/j.bPj.2013.03.021]; Thaa B, 2009, VIROLOGY, V383, P150, DOI 10.1016/j.virol.2008.10.001; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Wang C, 2010, IEEE INFOCOM SER, DOI 10.1109/PEDG.2010.5545769; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; YE ZP, 1995, J VIROL, V69, P1964, DOI 10.1128/JVI.69.3.1964-1970.1995; Zhang J, 2000, J VIROL, V74, P4634, DOI 10.1128/JVI.74.10.4634-4644.2000; Zhang J, 1996, VIROLOGY, V225, P255, DOI 10.1006/viro.1996.0599; Zhang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037786	45	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165421	10.1371/journal.pone.0165421	http://dx.doi.org/10.1371/journal.pone.0165421			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814373	Green Published, Green Submitted, gold			2022-12-26	WOS:000386911100011
J	Arriagada, F; Correa, O; Gunther, G; Nonell, S; Mura, F; Olea-Azar, C; Morales, J				Arriagada, Francisco; Correa, Olosmira; Gunther, German; Nonell, Santi; Mura, Francisco; Olea-Azar, Claudio; Morales, Javier			Morin Flavonoid Adsorbed on Mesoporous Silica, a Novel Antioxidant Nanomaterial	PLOS ONE			English	Article							RADICAL SCAVENGING ACTIVITY; OXIDATIVE STRESS; SINGLET OXYGEN; GAMMA-AMINOPROPYLTRIETHOXYSILANE; FUNDAMENTAL PROPERTIES; AQUEOUS-SOLUTION; DRUG-DELIVERY; NANOPARTICLES; KINETICS; ADSORPTION	Morin (2' A, 3, 4' , 5,7-pentahydroxyflavone) is a flavonoid with several beneficial health effects. However, its poor water solubility and it sensitivity to several environmental factors avoid its use in applications like pharmaceutical and cosmetic. In this work, we synthetized morinmodified mesoporous silica nanoparticles (AMSNPs-MOR) as useful material to be used as potential nanoantioxidant. To achieve this, we characterized its adsorption kinetics, isotherm and the antioxidant capacity as hydroxyl radical (HO center dot) scavenger and singlet oxygen (O-1(2)) quencher. The experimental data could be well fitted with Langmuir, Freundlich and Temkin isotherm models, besides the pseudo-second order kinetics model. The total quenching rate constant obtained for singlet oxygen deactivation by AMSNPs-MOR was one order of magnitude lower than the morin rate constant reported previously in neat solvents and lipid membranes. The AMSNPs-MOR have good antioxidant properties by itself and exhibit a synergic effect with morin on the antioxidant property against hydroxyl radical. This effect, in the range of concentrations studied, was increased when the amount of morin adsorbed increased.	[Arriagada, Francisco; Correa, Olosmira; Morales, Javier] Univ Chile, Dept Ciencias & Tecnol Farmaceut, Fac Ciencias Quim & Farmaceut, Sergio Livingstone,1007,Independencia, Santiago, Chile; [Gunther, German] Univ Chile, Dept Quim Organ & Fisicoquim, Fac Ciencias Quim & Farmaceut, Sergio Livingstone,1007,Independencia, Santiago, Chile; [Nonell, Santi] Univ Ramon Llull, IQS, Via Augusta 390, Barcelona 08017, Spain; [Mura, Francisco; Olea-Azar, Claudio] Univ Chile, Dept Quim Inorgan & Analit, Fac Ciencias Quim & Farmaceut, Sergio Livingstone,1007,Independencia, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universitat Ramon Llull; Institut Quimic de Sarria; Universidad de Chile	Morales, J (corresponding author), Univ Chile, Dept Ciencias & Tecnol Farmaceut, Fac Ciencias Quim & Farmaceut, Sergio Livingstone,1007,Independencia, Santiago, Chile.	javiermv@ciq.uchile.cl	Gunther, German/I-1028-2013; OLEA AZAR, CLAUDIO/I-1605-2013	Gunther, German/0000-0002-4733-8426; OLEA AZAR, CLAUDIO/0000-0001-5805-0746; Mura Mardones, Francisco/0000-0003-0463-1814; Morales Valenzuela, Javier Eduardo/0000-0002-9880-2567	FONDECYT [1160757]; CONICYT [21160932, 21120376]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by FONDECYT (grant 1160757 to JM), CONICYT (grant 21160932 to FA) and CONICYT (grant 21120376 to FM).	Amic A, 2014, FOOD CHEM, V152, P578, DOI 10.1016/j.foodchem.2013.12.025; Anbia M, 2012, DYES PIGMENTS, V94, P1, DOI 10.1016/j.dyepig.2011.10.016; Anbia M, 2010, DESALINATION, V261, P61, DOI 10.1016/j.desal.2010.05.030; Anbia M, 2010, APPL SURF SCI, V256, P3228, DOI 10.1016/j.apsusc.2009.12.010; Azizian S, 2004, J COLLOID INTERF SCI, V276, P47, DOI 10.1016/j.jcis.2004.03.048; Beganskiene A., 2004, MAT SCI, V10, P287; Berlier G, 2013, INT J PHARMACEUT, V457, P177, DOI 10.1016/j.ijpharm.2013.09.018; Berneburg M, 1999, J BIOL CHEM, V274, P15345, DOI 10.1074/jbc.274.22.15345; Bhattacharya K, 2015, SCI REP-UK, V5, DOI 10.1038/srep17072; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; BOYD GE, 1947, J AM CHEM SOC, V69, P2836, DOI 10.1021/ja01203a066; Chandran PR, 2015, GOLD NANOPARTICLES C, P221; Chen YP, 2013, J AM CHEM SOC, V135, P1516, DOI 10.1021/ja3105208; Chen YY, 2014, CHEM ENG J, V254, P579, DOI 10.1016/j.cej.2014.05.120; DARR D, 1994, J INVEST DERMATOL, V102, P671, DOI 10.1111/1523-1747.ep12374036; Deligiannakis Y, 2012, ACS APPL MATER INTER, V4, P6609, DOI 10.1021/am301751s; Devasagayam Thomas P. A., 2002, Indian Journal of Experimental Biology, V40, P680; Doane T, 2013, ADV DRUG DELIVER REV, V65, P607, DOI 10.1016/j.addr.2012.05.012; Elliott J, 2006, MRS BULL, V31, P869, DOI 10.1557/mrs2006.205; Endo N, 2009, J CLIN BIOCHEM NUTR, V45, P193, DOI 10.3164/jcbn.08-265; Eriksson M, 1997, J APPL PHYS, V82, P3143, DOI 10.1063/1.366158; FINKELSTEIN E, 1980, J AM CHEM SOC, V102, P4994, DOI 10.1021/ja00535a029; Foo KY, 2010, CHEM ENG J, V156, P2, DOI 10.1016/j.cej.2009.09.013; Gao ZP, 2013, J FOOD ENG, V116, P195, DOI 10.1016/j.jfoodeng.2012.10.037; Ghaedi M, 2014, J IND ENG CHEM, V20, P17, DOI 10.1016/j.jiec.2013.04.031; Goldstein S, 2007, ENVIRON SCI TECHNOL, V41, P7486, DOI 10.1021/es071379t; Govindasamy C, 2014, J AM COLL CARDIOL, V64, pC56, DOI 10.1016/j.jacc.2014.06.271; Gunther G, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0129749, DOI 10.1371/J0URNAL.P0NE.0129749]; Guo YY, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/6/065102; HALL KR, 1966, IND ENG CHEM FUND, V5, P212, DOI 10.1021/i160018a011; Ho YS, 2005, PROCESS BIOCHEM, V40, P3455, DOI 10.1016/j.procbio.2005.02.017; Ho YS, 1998, CHEM ENG J, V70, P115, DOI 10.1016/S0923-0467(98)00076-1; Hulchanskyy TY, 2007, NANO LETT, V7, P2835, DOI 10.1021/nl0714637; HUSAIN SR, 1987, PHYTOCHEMISTRY, V26, P2489, DOI 10.1016/s0031-9422(00)83860-1; Iglesias CV, 2005, TOXICON, V46, P751, DOI 10.1016/j.toxicon.2005.07.017; Kamiya H, 2000, J AM CERAM SOC, V83, P287; Kumar R, 2008, ACS NANO, V2, P449, DOI 10.1021/nn700370b; Kupetz E, 2014, J CONTROL RELEASE, V189, P54, DOI 10.1016/j.jconrel.2014.06.007; Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002; Langmuir I, 1917, J AM CHEM SOC, V39, P1848, DOI 10.1021/ja02254a006; Lee GH, 2016, COLLOIDS SURFACES B; Lee J, 2014, INT J RADIAT BIOL, V90, P20, DOI 10.3109/09553002.2013.835502; Liberman A, 2014, SURF SCI REP, V69, P132, DOI 10.1016/j.surfrep.2014.07.001; Limousin G, 2007, APPL GEOCHEM, V22, P249, DOI 10.1016/j.apgeochem.2006.09.010; Liu WY, 2008, MOL PHARMACEUT, V5, P588, DOI 10.1021/mp7001413; Liu Y, 2008, SEP PURIF TECHNOL, V61, P229, DOI 10.1016/j.seppur.2007.10.002; Markovic Z, 2012, FOOD CHEM, V135, P2070, DOI 10.1016/j.foodchem.2012.05.119; Masood F, 2016, MAT SCI ENG C-MATER, V60, P569, DOI 10.1016/j.msec.2015.11.067; Mehnert W, 2012, ADV DRUG DELIVER REV, V64, P83, DOI 10.1016/j.addr.2012.09.021; Mladenka P, 2011, J INORG BIOCHEM, V105, P693, DOI 10.1016/j.jinorgbio.2011.02.003; Morales J, 2012, PLOS ONE, P7; Morales J, 2009, AFINIDAD, V539, P56; Mortera R, 2010, CHEM ENG J, V156, P184, DOI 10.1016/j.cej.2009.10.018; Mura F, 2014, FREE RADICAL RES, V48, P1473, DOI 10.3109/10715762.2014.965702; Musialik M, 2009, J ORG CHEM, V74, P2699, DOI 10.1021/jo802716v; Nagai S, 2005, J PHYS CHEM B, V109, P4234, DOI 10.1021/jp0451389; OGILBY PR, 1992, MACROMOLECULES, V25, P3399, DOI 10.1021/ma00039a014; Parisi O.I., 2014, POLYPHENOLS HUMAN HL, P29, DOI DOI 10.1016/B978-0-12-398456-2.00004-9; Park JT, 2010, J IND ENG CHEM, V16, P517, DOI 10.1016/j.jiec.2010.03.030; Pasternack RM, 2008, LANGMUIR, V24, P12963, DOI 10.1021/la8024827; Pena-Alonso R, 2007, J MATER SCI, V42, P595, DOI 10.1007/s10853-006-1138-9; Peppas NA, 2006, MRS BULL, V31, P888, DOI 10.1557/mrs2006.208; Prahalathan P, 2012, METABOLISM, V61, P1087, DOI 10.1016/j.metabol.2011.12.012; Pu YY, 2012, CHINESE CHEM LETT, V23, P1201, DOI 10.1016/j.cclet.2012.07.010; Qiao B, 2015, APPL SURFACE SCI; Qiu H, 2009, J ZHEJIANG UNIV-SC A, V10, P716, DOI 10.1631/jzus.A0820524; Queiroz RG, 2016, INT J BIOL MACROMOL, V85, P82, DOI 10.1016/j.ijbiomac.2015.12.074; Rahman IA, 2009, CERAM INT, V35, P1883, DOI 10.1016/j.ceramint.2008.10.028; Rai M, 2015, INT J PHARMACEUT, V496, P159, DOI 10.1016/j.ijpharm.2015.10.059; Rao BVB, 2014, MAT SCI ENG C-MATER, V34, P9, DOI 10.1016/j.msec.2013.10.002; Schlipf DM, 2015, COLLOID SURFACE A, V478, P15, DOI 10.1016/j.colsurfa.2015.03.039; Shah P, 2006, MRS BULL, V31, P894, DOI 10.1557/mrs2006.209; Shetty PK, 2015, INT J NANOMED, V10, P6477, DOI 10.2147/IJN.S90964; Sivaramakrishnan V, 2010, CHEM-BIOL INTERACT, V183, P284, DOI 10.1016/j.cbi.2009.11.011; Sposito G., 2008, CHEM SOILS, V2nd; STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Sun XX, 2011, J AM CHEM SOC, V133, P18554, DOI 10.1021/ja2080168; Tang L, 2013, NANO TODAY, V8, P290, DOI 10.1016/j.nantod.2013.04.007; Tien C, 2014, SEP PURIF TECHNOL, V136, P303, DOI 10.1016/j.seppur.2014.08.013; Tseng RL, 2010, J TAIWAN INST CHEM E, V41, P661, DOI 10.1016/j.jtice.2010.01.014; Uppal A, 2011, PHOTOCHEM PHOTOBIOL, V87, P1146, DOI 10.1111/j.1751-1097.2011.00967.x; Vasiliu S, 2011, CARBOHYD POLYM, V85, P376, DOI 10.1016/j.carbpol.2011.02.039; VENUGOPAL J, 2013, PHARMACOGNOSY J, V5, P123, DOI DOI 10.1016/j.phcgj.2013.04.006; Vergara-Castaneda H, 2016, J COLLOID INTERF SCI, V466, P44, DOI 10.1016/j.jcis.2015.12.011; Wang X, 2014, COMPOS SCI TECHNOL, V104, P1, DOI 10.1016/j.compscitech.2014.08.027; Wang Y, 2015, NANOMED-NANOTECHNOL, V11, P313, DOI 10.1016/j.nano.2014.09.014; WU TW, 1995, BIOCHEM PHARMACOL, V49, P537, DOI 10.1016/0006-2952(94)00446-S; Yue H, 2015, VACCINE, V33, P5927, DOI 10.1016/j.vaccine.2015.07.100; Zelenak V, 2008, CHEM ENG J, V144, P336, DOI 10.1016/j.cej.2008.07.025; Zhang B, 2008, SCI CHINA SER B, V51, P145, DOI 10.1007/s11426-007-0104-y; Zhang R, 2009, CHEM-BIOL INTERACT, V177, P21, DOI 10.1016/j.cbi.2008.08.009; Zhou H, 2013, MATER CHEM PHYS, V140, P148, DOI 10.1016/j.matchemphys.2013.03.013; Zhou QH, 2009, SPECTROCHIM ACTA A, V72, P110, DOI 10.1016/j.saa.2008.08.012	94	35	35	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164507	10.1371/journal.pone.0164507	http://dx.doi.org/10.1371/journal.pone.0164507			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812111	Green Submitted, Green Published, gold			2022-12-26	WOS:000386910000009
J	Brophy, JC; Hawkes, MT; Mwinjiwa, E; Mateyu, G; Sodhi, SK; Chan, AK				Brophy, Jason C.; Hawkes, Michael T.; Mwinjiwa, Edson; Mateyu, Gabriel; Sodhi, Sumeet K.; Chan, Adrienne K.			Survival Outcomes in a Pediatric Antiretroviral Treatment Cohort in Southern Malawi	PLOS ONE			English	Article							HIV-INFECTED CHILDREN; FOLLOW-UP; OBSERVATIONAL DATABASE; TREATMENT PROGRAMS; CLINICAL-OUTCOMES; THERAPY; MORTALITY; CARE; LOST; TUBERCULOSIS	Background Pediatric uptake and outcomes in antiretroviral treatment (ART) programmes have lagged behind adult programmes. We describe outcomes from a population-based pediatric ART cohort in rural southern Malawi. Methods Data were analyzed on children who initiated ART from October/2003-September/2011. Demographics and diagnoses were described and survival analyses conducted to assess the impact of age, presenting features at enrolment, and drug selection. Results The cohort consisted of 2203 children <15 years of age. Age at entry was <1 year for 219 (10%), 1-1.9 years for 343 (16%), 2-4.9 years for 584 (27%), and 5-15 years for 1057 (48%) patients. Initial clinical diagnoses of tuberculosis and wasting were documented for 409 (19%) and 523 (24%) patients, respectively. Median follow-up time was 1.5 years (range 0-8 years), with 3900 patient-years of follow-up. Over the period of observation, 134 patients (6%) died, 1324 (60%) remained in the cohort, 345 (16%) transferred out, and 387 (18%) defaulted. Infants <1 year of age accounted for 19% of deaths, with a 2.7-fold adjusted mortality hazard ratio relative to 5-15 year olds; median time to death was also shorter for infants (60 days) than older children (108 days). Survival analysis demonstrated younger age at ART initiation, more advanced HIV stage, and presence of tuberculosis to each be associated with shorter survival time. Among children <5 years, severe wasting (weight-for-height z-score </=-3.0) was also associated with reduced survival. Conclusions Cumulative incidence of mortality was 5.2%, 7.1% and 7.7% after 1, 3, and 5 years, respectively, with disproportionate mortality in infants <1 year of age and those presenting with tuberculosis. These findings reinforce the urgent need for early diagnosis and treatment in this population, but also demonstrate that provision of pediatric care in a rural setting can yield outcomes comparable to more resourced urban settings of poor countries.	[Brophy, Jason C.; Mateyu, Gabriel; Sodhi, Sumeet K.; Chan, Adrienne K.] Dignitas Int, Zomba, Malawi; [Brophy, Jason C.] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON, Canada; [Hawkes, Michael T.] Univ Alberta, Stollery Childrens Hosp, Dept Pediat, Edmonton, AB, Canada; [Mwinjiwa, Edson] Minist Hlth, Zomba Cent Hosp, Zomba, Malawi; [Sodhi, Sumeet K.] Univ Toronto, Univ Hlth Network, Dept Family & Community Med, Toronto, ON, Canada; [Chan, Adrienne K.] Univ Toronto, Sunnybrook Hosp, Dept Med, Toronto, ON, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; Stollery Children's Hospital; University of Alberta; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Brophy, JC (corresponding author), Dignitas Int, Zomba, Malawi.; Brophy, JC (corresponding author), Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON, Canada.	jbrophy@cheo.on.ca	, Michael/AAP-3049-2020		Canadian Institutes for Health Research-Operating Grant-PA: HIV/AIDS Res Initiative-HIth Svs/Population HIth Stream; USAID-Malawi: APS [M/OAA/GRO/ EGAS - 09-232]	Canadian Institutes for Health Research-Operating Grant-PA: HIV/AIDS Res Initiative-HIth Svs/Population HIth Stream; USAID-Malawi: APS(United States Agency for International Development (USAID))	Support was provided by: Canadian Institutes for Health Research-Operating Grant-PA: HIV/AIDS Res Initiative-HIth Svs/Population HIth Stream. "Assessing the Impact of HIV/AIDS Service Delivery in Zomba District, Malawi: The Zomba District Observational Cohort Study [to SS]; and USAID-Malawi: APS No: M/OAA/GRO/ EGAS - 09-232 "Support for Health Systems Strengthening and HIV/AIDS Service Delivery in Malawi's South-East Zone. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakeera-Kitaka S, 2011, INT J TUBERC LUNG D, V15, P1082, DOI 10.5588/ijtld.10.0538; Binagwaho A, 2013, J PUBLIC HEALTH POL, V34, P2, DOI 10.1057/jphp.2012.62; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Bong CN, 2007, INT J TUBERC LUNG D, V11, P534; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Chan AK, 2010, TROP MED INT HEALTH, V15, P90, DOI 10.1111/j.1365-3156.2010.02503.x; Davies MA, 2009, SAMJ S AFR MED J, V99, P730; Edmonds A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001044; Fenner L, 2010, JAIDS-J ACQ IMM DEF, V54, P524, DOI 10.1097/QAI.0b013e3181e0c4cf; Gray B., 2014, PACKAGE CMPRSK SUBDI; Hansudewechakul R, 2010, JAIDS-J ACQ IMM DEF, V55, P503, DOI 10.1097/QAI.0b013e3181f5379a; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Kabue MM, 2012, PEDIATRICS, V130, pE591, DOI 10.1542/peds.2011-1187; Malawi Ministry of Health, 2008, GUID US ANT THER MAL; Malawi Ministry of Health, 2014, MAL HIV PROGR DAT Q4; McNairy ML, 2013, JAIDS-J ACQ IMM DEF, V62, pE70, DOI 10.1097/QAI.0b013e318278bcb0; National Statistical Office, 2013, 2008 POP HOUS CENS R; Palmer D, 2006, REPROD HEALTH MATTER, V14, P27, DOI 10.1016/S0968-8080(06)27244-6; Peacock-Villada E, 2011, PEDIATRICS, V127, pE423, DOI 10.1542/peds.2009-2701; Phongsamart W, 2014, INT J INFECT DIS, V22, P19, DOI 10.1016/j.ijid.2013.12.011; Preidis GA, 2011, J PEDIATR-US, V159, P484, DOI 10.1016/j.jpeds.2011.02.033; Rasschaert F, 2011, JAIDS-J ACQ IMM DEF, V57, pS109, DOI 10.1097/QAI.0b013e31821f9b69; Scrucca L, 2007, BONE MARROW TRANSPL, V40, P381, DOI 10.1038/sj.bmt.1705727; Sengayi M, 2013, GLOBAL HEALTH ACTION, V6, P169, DOI 10.3402/gha.v6i0.19248; Tene G, 2013, PEDIATR INFECT DIS J, V32, pE341, DOI 10.1097/INF.0b013e31828c2744; Therneau T, 2012, PACKAGE SURVIVAL ANA; Therneau TG, 2002, MODELING SURVIVAL DA, P85; Torpey K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042859; Waning B, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-74; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; Weigel R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-31; WHO, 2013, GLOB UPD HIV TREATM; World Health Organization, 2010, ANT THER HIV INF INF; World Health Organization and United Nations Children's Fund, 2009, WHO CHILD GROWTH STA; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	36	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165772	10.1371/journal.pone.0165772	http://dx.doi.org/10.1371/journal.pone.0165772			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812166	Green Published, gold, Green Submitted			2022-12-26	WOS:000386910000056
J	Chan, ASH; Jonas, AB; Qiu, X; Ottoson, NR; Walsh, RM; Gorden, KB; Harrison, B; Maimonis, PJ; Leonardo, SM; Ertelt, KE; Danielson, ME; Michel, KS; Nelson, M; Graff, JR; Patchen, ML; Bose, N				Chan, Anissa S. H.; Jonas, Adria Bykowski; Qiu, Xiaohong; Ottoson, Nadine R.; Walsh, Richard M.; Gorden, Keith B.; Harrison, Ben; Maimonis, Peter J.; Leonardo, Steven M.; Ertelt, Kathleen E.; Danielson, Michael E.; Michel, Kyle S.; Nelson, Mariana; Graff, Jeremy R.; Patchen, Myra L.; Bose, Nandita			Imprime PGG-Mediated Anti-Cancer Immune Activation Requires Immune Complex Formation	PLOS ONE			English	Article							FC-GAMMA RECEPTORS; YEAST BETA-GLUCAN; CHRONIC LYMPHOCYTIC-LEUKEMIA; DENGUE VIRUS-INFECTION; HUMAN-NEUTROPHILS; MONOCLONAL-ANTIBODY; XENOGRAFT MODELS; OXIDATIVE BURST; HUMAN MONOCYTES; IGG SUBCLASSES	Imprime PGG (Imprime), an intravenously-administered, soluble beta-glucan, has shown compelling efficacy in multiple phase 2 clinical trials with tumor targeting or anti-angiogenic antibodies. Mechanistically, Imprime acts as pathogen-associated molecular pattern (PAMP) directly activating innate immune effector cells, triggering a coordinated anti-cancer immune response. Herein, using whole blood from healthy human subjects, we show that Imprime-induced anti-cancer functionality is dependent on immune complex formation with naturally-occurring, anti-beta glucan antibodies (ABA). The formation of Imprime-ABA complexes activates complement, primarily via the classical complement pathway, and is opsonized by iC3b. Immune complex binding depends upon Complement Receptor 3 and Fcg Receptor IIa, eliciting phenotypic activation of, and enhanced chemokine production by, neutrophils and monocytes, enabling these effector cells to kill antibody-opsonized tumor cells via the generation of reactive oxygen species and antibody-dependent cellular phagocytosis. Importantly, these innate immune cell changes were not evident in subjects with low ABA levels but could be rescued with exogenous ABA supplementation. Together, these data indicate that pre-existing ABA are essential for Imprime-mediated anti-cancer immune activation and suggest that pre-treatment ABA levels may provide a plausible patient selection biomarker to delineate patients most likely to benefit from Imprime-based therapy.	[Chan, Anissa S. H.; Jonas, Adria Bykowski; Qiu, Xiaohong; Ottoson, Nadine R.; Walsh, Richard M.; Gorden, Keith B.; Harrison, Ben; Maimonis, Peter J.; Leonardo, Steven M.; Ertelt, Kathleen E.; Danielson, Michael E.; Michel, Kyle S.; Nelson, Mariana; Graff, Jeremy R.; Patchen, Myra L.; Bose, Nandita] Biothera Pharmaceut Inc, Eagan, MN 55121 USA		Bose, N (corresponding author), Biothera Pharmaceut Inc, Eagan, MN 55121 USA.	nbose@biothera.com			Biothera Pharmaceuticals Inc.	Biothera Pharmaceuticals Inc.	Biothera Pharmaceuticals Inc. provided support in the form of salaries for authors (Anissa S.H. Chan, Adria Bykowski Jonas, Xiaohong Qiu, Nadine R. Ottoson, Richard M. Walsh, Keith B. Gorden, Ben Harrison, Peter J. Maimonis, Steven Leonardo, Kathleen E. Ertelt, Michael E. Danielson, Kyle S. Michel, Mariana Nelson, Jeremy R. Graff, Myra L. Patchen and Nandita Bose), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BARRETT DJ, 1986, CLIN EXP IMMUNOL, V63, P127; Boruchov AM, 2005, J CLIN INVEST, V115, P2914, DOI 10.1172/JCI24772; Bose N, 2014, GLYCOBIOLOGY, V24, P379, DOI 10.1093/glycob/cwu005; Bose N, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00230; Brandsma AM, 2015, IMMUNOL REV, V268, P74, DOI 10.1111/imr.12332; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; CHESON BD, 1981, INT ARCH ALLER A IMM, V66, P48, DOI 10.1159/000232798; Chiani P, 2009, VACCINE, V27, P513, DOI 10.1016/j.vaccine.2008.11.030; DANIELS RH, 1992, IMMUNOLOGY, V75, P157; Leoratti FMD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001710; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; EMBER JA, 1994, AM J PATHOL, V144, P393; Fortunati E, 2009, CLIN EXP IMMUNOL, V155, P559, DOI 10.1111/j.1365-2249.2008.03791.x; Fukuoka Y, 2001, CURR EYE RES, V23, P320, DOI 10.1076/ceyr.23.5.320.5437; Geller MA, 2010, CANCER IMMUNOL IMMUN, V59, P1877, DOI 10.1007/s00262-010-0914-1; Ghosh TK, 2006, CELL IMMUNOL, V243, P48, DOI 10.1016/j.cellimm.2006.12.002; Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Halstenson CE, 2016, INVEST NEW DRUG, V34, P202, DOI 10.1007/s10637-016-0325-z; Hao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038317; Hood JD, 2010, HUM VACCINES, V6, P322, DOI 10.4161/hv.6.4.10866; Huang ZY, 2011, J BIOL CHEM, V286, P160, DOI 10.1074/jbc.M110.163030; Hunniger K, 2015, J IMMUNOL, V194, P1199, DOI 10.4049/jimmunol.1401845; Ishibashi K, 2013, INT J MED MUSHROOMS, V15, P115, DOI 10.1615/IntJMedMushr.v15.i2.10; Li B, 2007, CANCER RES, V67, P7421, DOI 10.1158/0008-5472.CAN-07-1465; Li B, 2006, J IMMUNOL, V177, P1661, DOI 10.4049/jimmunol.177.3.1661; Masuzawa S, 2003, DRUG DEVELOP RES, V58, P179, DOI 10.1002/ddr.10158; Milton DK, 2001, APPL ENVIRON MICROB, V67, P5420, DOI 10.1128/AEM.67.12.5420-5424.2001; Mollnes TE, 2002, BLOOD, V100, P1869; PARREN PWHI, 1992, J CLIN INVEST, V90, P1537, DOI 10.1172/JCI116022; Perkins H, 2012, J CLIN IMMUNOL, V32, P1082, DOI 10.1007/s10875-012-9687-y; PETTY HR, 1993, J LEUKOCYTE BIOL, V54, P492, DOI 10.1002/jlb.54.5.492; Qi CJ, 2011, BLOOD, V117, P6825, DOI 10.1182/blood-2011-02-339812; Ravetch JV, 2002, J CLIN INVEST, V110, P1759, DOI 10.1172/JCI200217349; Rigby KM, 2012, SEMIN IMMUNOPATHOL, V34, P237, DOI 10.1007/s00281-011-0295-3; SALMON JE, 1992, J CLIN INVEST, V89, P1274, DOI 10.1172/JCI115712; Salvador C, 2008, CLIN CANCER RES, V14, P1239, DOI 10.1158/1078-0432.CCR-07-1669; Schaeffer V, 2007, SHOCK, V27, P623, DOI 10.1097/SHK.0b013e31802fa0bd; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; Schwarzer E, 1998, INFECT IMMUN, V66, P1601, DOI 10.1128/IAI.66.4.1601-1606.1998; Segal NH, 2016, J CLIN COLO IN PRESS; Shankar G, 2007, NAT BIOTECHNOL, V25, P555, DOI 10.1038/nbt1303; SIPKA S, 1985, INT J IMMUNOPHARMACO, V7, P747, DOI 10.1016/0192-0561(85)90161-4; Taylor A, 2015, IMMUNOL REV, V268, P340, DOI 10.1111/imr.12367; Tsuboi N, 2011, ARTHRITIS RHEUM-US, V63, P467, DOI 10.1002/art.30141; VALIM YML, 1991, CLIN EXP IMMUNOL, V84, P1, DOI 10.1111/j.1365-2249.1991.tb08115.x; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wang LY, 2010, CLIN IMMUNOL, V137, P157, DOI 10.1016/j.clim.2010.05.012; WARMERDAM PAM, 1991, J IMMUNOL, V147, P1338; Zent CS, 2008, CANCER, V113, P2110, DOI 10.1002/cncr.23824; Zent CS, 2015, LEUKEMIA LYMPHOMA, V56, P2373, DOI 10.3109/10428194.2015.1016932; Zhong WJ, 2009, J IMMUNOTHER, V32, P703, DOI 10.1097/CJI.0b013e3181ad3fcf; ZHOU MJ, 1994, J CELL BIOL, V125, P1407, DOI 10.1083/jcb.125.6.1407	56	30	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165909	10.1371/journal.pone.0165909	http://dx.doi.org/10.1371/journal.pone.0165909			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812183	Green Submitted, Green Published, gold			2022-12-26	WOS:000386910000078
J	Jiang, ZB; Yang, Q				Jiang, Zi-Bin; Yang, Qiong			A Discrete Fruit Fly Optimization Algorithm for the Traveling Salesman Problem	PLOS ONE			English	Article							INVENTORY CONTROL-PROBLEM; NETWORK	The fruit fly optimization algorithm (FOA) is a newly developed bio-inspired algorithm. The continuous variant version of FOA has been proven to be a powerful evolutionary approach to determining the optima of a numerical function on a continuous definition domain. In this study, a discrete FOA (DFOA) is developed and applied to the traveling salesman problem (TSP), a common combinatorial problem. In the DFOA, the TSP tour is represented by an ordering of city indices, and the bio-inspired meta-heuristic search processes are executed with two elaborately designed main procedures: the smelling and tasting processes. In the smelling process, an effective crossover operator is used by the fruit fly group to search for the neighbors of the best-known swarm location. During the tasting process, an edge intersection elimination (EXE) operator is designed to improve the neighbors of the non-optimum food location in order to enhance the exploration performance of the DFOA. In addition, benchmark instances from the TSPLIB are classified in order to test the searching ability of the proposed algorithm. Furthermore, the effectiveness of the proposed DFOA is compared to that of other meta-heuristic algorithms. The results indicate that the proposed DFOA can be effectively used to solve TSPs, especially large-scale problems.	[Jiang, Zi-Bin; Yang, Qiong] Hunan Univ, Coll Business Adm, Changsha, Hunan, Peoples R China	Hunan University	Jiang, ZB (corresponding author), Hunan Univ, Coll Business Adm, Changsha, Hunan, Peoples R China.	jiangzibin@hnu.edu.cn			Doctoral Program Foundation of the Institutions of Higher Education of China [20100161120006]; Humanities and Social Sciences Foundation of the Ministry of Education of China [11YJC630078]; China Scholarship Council [201306135011]	Doctoral Program Foundation of the Institutions of Higher Education of China; Humanities and Social Sciences Foundation of the Ministry of Education of China(Ministry of Education, China); China Scholarship Council(China Scholarship Council)	This research was partially supported by the Doctoral Program Foundation of the Institutions of Higher Education of China (No.20100161120006), the Humanities and Social Sciences Foundation of the Ministry of Education of China (No. 11YJC630078), and the China Scholarship Council (No. 201306135011).	Baraglia R, 2001, IEEE T EVOLUT COMPUT, V5, P613, DOI 10.1109/4235.974843; Burkard RE, 1998, SIAM REV, V40, P496, DOI 10.1137/S0036144596297514; Choubey N.-S., 2014, INT J COMPUTER APPL, V107, P22, DOI [10.5120/18851-0385, DOI 10.5120/18851-0385]; CLARKE G, 1964, OPER RES, V12, P568, DOI 10.1287/opre.12.4.568; Dorigo M, 1997, BIOSYSTEMS, V43, P73, DOI 10.1016/S0303-2647(97)01708-5; Duan Yanming, 2016, Computer Engineering and Applications, V52, P144, DOI 10.3778/j.issn.1002-8331.1404-0468; Goldberg DE, 1985, INT C GENETIC ALGORI, V12, P154; Grefenstette J., 1985, PROC 1 INT C GENET A, V160, P160; Gutin G., 2007, COMBINATORIAL OPTIMI, V12, DOI [10.1007/b101971, DOI 10.1007/B101971]; Johnson D. S., 1997, LOCAL SEARCH COMBINA, P215, DOI DOI 10.1108/01445150910987763; Karthikeyan S, 2015, INT J BIO-INSPIR COM, V7, P386, DOI 10.1504/IJBIC.2015.073165; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Wu L, 2016, INT J COMPUT INT SYS, V9, P80, DOI 10.1080/18756891.2016.1144155; Lei XJ, 2016, KNOWL-BASED SYST, V105, P270, DOI 10.1016/j.knosys.2016.05.019; Li HZ, 2013, KNOWL-BASED SYST, V37, P378, DOI 10.1016/j.knosys.2012.08.015; Li HY, 2014, IEEE INT C INFORM AU, V58, P58, DOI [10.1109/ICInfA.2014.6932728, DOI 10.1109/ICINFA.2014.6932728]; LIN S, 1973, OPER RES, V21, P498, DOI 10.1287/opre.21.2.498; Lin SM, 2013, NEURAL COMPUT APPL, V22, P783, DOI 10.1007/s00521-011-0769-1; Mousavi SM, 2016, SOFT COMPUT, V20, P2281, DOI 10.1007/s00500-015-1641-5; Mousavi SM, 2015, COMPUT IND ENG, V87, P543, DOI 10.1016/j.cie.2015.05.022; Mousavi SM, 2014, INFORM SCIENCES, V276, P42, DOI 10.1016/j.ins.2014.02.046; Mousavi SM, 2014, INT J ADV MANUF TECH, V70, P1739, DOI 10.1007/s00170-013-5378-y; Nguyen HD, 2007, IEEE T SYST MAN CY B, V37, P92, DOI 10.1109/TSMCB.2006.880136; Oncan T, 2009, COMPUT OPER RES, V36, P637, DOI 10.1016/j.cor.2007.11.008; Orman AJ, 2007, ADV COMPUT MANAG SCI, V9, P91; Osaba E, 2016, ENG APPL ARTIF INTEL, V48, P59, DOI 10.1016/j.engappai.2015.10.006; Pan QK, 2014, KNOWL-BASED SYST, V62, P69, DOI 10.1016/j.knosys.2014.02.021; Pan WT, 2012, KNOWL-BASED SYST, V26, P69, DOI 10.1016/j.knosys.2011.07.001; Pasandideh SHR, 2013, INT J ADV MANUF TECH, V69, P1671, DOI 10.1007/s00170-013-5130-7; Shan D, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/108768; Shi XH, 2007, INFORM PROCESS LETT, V103, P169, DOI 10.1016/j.ipl.2007.03.010; Spanos AC, 2014, INT T OPER RES, V21, P479, DOI 10.1111/itor.12056; Wang FR, 2015, MATEC WEB CONF, V22, DOI 10.1051/matecconf/20152201040; Wang Ke-fu, 2014, Computer Engineering and Design, V35, P2789; Wang L, 2016, KNOWL-BASED SYST, V97, P158, DOI 10.1016/j.knosys.2016.01.006; Wang L, 2013, KNOWL-BASED SYST, V48, P17, DOI 10.1016/j.knosys.2013.04.003; WHITLEY D, 1989, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P133; Yin LJ, 2016, 2016 EIGHTH INTERNATIONAL CONFERENCE ON ADVANCED COMPUTATIONAL INTELLIGENCE (ICACI), P21, DOI 10.1109/ICACI.2016.7449797; Zhang P, 2014, CHIN CONTR CONF, P7466, DOI 10.1109/ChiCC.2014.6896242; Zheng XL, 2014, KNOWL-BASED SYST, V57, P95, DOI 10.1016/j.knosys.2013.12.011; Zhou YQ, 2015, NEUROCOMPUTING, V151, P1227, DOI 10.1016/j.neucom.2014.01.078	42	11	11	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165804	10.1371/journal.pone.0165804	http://dx.doi.org/10.1371/journal.pone.0165804			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812175	Green Published, gold, Green Submitted			2022-12-26	WOS:000386910000061
J	Daan, NMP; Koster, MPH; de Wilde, MA; Dalmeijer, GW; Evelein, AMV; Fauser, BCJM; de Jager, W				Daan, Nadine M. P.; Koster, Maria P. H.; de Wilde, Marlieke A.; Dalmeijer, Gerdien W.; Evelein, Annemieke M. V.; Fauser, Bart C. J. M.; de Jager, Wilco			Biomarker Profiles in Women with PCOS and PCOS Offspring; A Pilot Study	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; JUVENILE IDIOPATHIC ARTHRITIS; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; MULTIPLEX IMMUNOASSAY; S100 PROTEINS; ADIPONECTIN; METAANALYSIS; CHILDREN; LEPTIN	Objective To study metabolic/inflammatory biomarker risk profiles in women with PCOS and PCOS offspring. Design Cross-sectional comparison of serum biomarkers. Setting University Medical Center Utrecht. Patients Hyperandrogenic PCOS women (HA-PCOS, n = 34), normoandrogenic PCOS women (NA-PCOS, n = 34), non-PCOS reference population (n = 32), PCOS offspring (n = 14, age 6-8 years), and a paedriatic reference population (n = 30). Main Outcome Measure(s) Clustering profile of adipocytokines (IL-1b, IL-6, IL-13, IL-17, IL-18, TNF-alpha, adiponectin, adipsin, leptin, chemerin, resistin, RBP4, DPP-IV/sCD26, CCL2/MCP-1), growth factors (PIGF, VEGF, sVEGF-R1), soluble cell adhesion molecules (sICAM-1/sCD54, sVCAM-1/sCD106), and other inflammatory related proteases (MMP-9, S100A8, Cathepsin S). Differences in median biomarker concentrations between groups, and associations with the free androgen index (FAI; Testosterone/SHBG x100). Results The cluster analysis identified leptin, RBP-4, DPP-IV and adiponectin as potential discriminative markers for HA-PCOS with a specifically strong correlation in cases with increased BMI. Leptin (R-2 = 0.219) and adiponectin ((R2) = 0.182) showed the strongest correlation with the FAI. When comparing median protein concentrations adult PCOS women with or without hyperandrogenemia, the most profound differences were observed for leptin (P < 0.001), DPP-IV (P = 0.005), and adiponectin (P < 0.001). Adjusting for age, BMI and multiple testing attenuated all differences. In PCOS offspring, MMP-9 (P = 0.001) and S100A8 (P < 0.001) concentrations were significantly higher compared to a healthy matched reference population, even after correcting for age and BMI and adjustment for multiple testing. Conclusion In this preliminary investigation we observed significant differences in adipocytokines between women with or without hyperandrogenic PCOS and non-PCOS controls, mostly influenced by BMI. Leptin and adiponectin showed the strongest correlation with the FAI in adult women with PCOS. In PCOS offspring other inflammatory biomarkers (MMP-9, S100A8) were increased, suggesting that these children may exhibit increased chronic low-grade inflammation. Additional research is required to confirm results of the current exploratory investigation.	[Daan, Nadine M. P.; Koster, Maria P. H.; de Wilde, Marlieke A.; Fauser, Bart C. J. M.] Univ Med Ctr Utrecht, Dept Reprod Med & Gynecol, Utrecht, Netherlands; [Dalmeijer, Gerdien W.; Evelein, Annemieke M. V.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Jager, Wilco] Wilhelmina Childrens Hosp, Div Pediat, Lab Translat Immunol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Daan, NMP (corresponding author), Univ Med Ctr Utrecht, Dept Reprod Med & Gynecol, Utrecht, Netherlands.	n.m.p.daan@umcutrecht.nl		de Jager, Wilco/0000-0002-0014-0682	Dutch Heart Foundation [2013T083]; Dutch Technology Foundation STW, Netherlands Organisation for Scientific Research (NWO) [11679]; Ministry of Economic Affairs; Actavis; COGI; Euroscreen; Ferring; Finox; Genovum; Gedeon-Richter; Merck-Serono; OvaScience; Pantharei Bioscience; PregLem; Roche; Uteron; Watson laboratories; Child Health research programme of the University Medical Center Utrecht; Netherlands Organisation for Health Research and Development [2100.0095]; Dutch Asthma Foundation; Glaxo Smith Kline; ReumaFonds [LLP-10] Funding Source: researchfish	Dutch Heart Foundation(Netherlands Heart Foundation); Dutch Technology Foundation STW, Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs; Actavis; COGI; Euroscreen; Ferring(Ferring Pharmaceuticals); Finox; Genovum; Gedeon-Richter; Merck-Serono(Merck & Company); OvaScience; Pantharei Bioscience; PregLem; Roche(Roche Holding); Uteron; Watson laboratories; Child Health research programme of the University Medical Center Utrecht; Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Dutch Asthma Foundation; Glaxo Smith Kline(GlaxoSmithKline); ReumaFonds	N.M.P. Daan has received funding from the Dutch Heart Foundation, grant number 2013T083. W. de Jager is supported by the Dutch Technology Foundation STW (project 11679), which is part of the Netherlands Organisation for Scientific Research (NWO), and which is partly funded by the Ministry of Economic Affairs. During the recent 5 year period B.C.J.M. Fauser has received fees and grant support from the following companies (in alphabetic order); Actavis, COGI, Euroscreen, Ferring, Finox, Genovum, Gedeon-Richter, Merck-Serono, OvaScience, Pantharei Bioscience, PregLem, Roche, Uteron, and Watson laboratories. This funding is unrelated to the current investigation. The Children follow-up study from women with PCOS (CHOPS) was funded in part by the Child Health research programme of the University Medical Center Utrecht. A.M.V. Evelein being part of the Wheezing Illnesses Study Leidsche Rijn (WHISTLER) Study group received funding from The Netherlands Organisation for Health Research and Development, grant number 2100.0095 (ZonMw), the Dutch Asthma Foundation and from Glaxo Smith Kline (no personal grant). None of the funders stated above of any of the authors had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIEL SA, 1991, J CLIN ENDOCR METAB, V72, P277, DOI 10.1210/jcem-72-2-277; Ardawi MSM, 2005, FERTIL STERIL, V83, P1708, DOI 10.1016/j.fertnstert.2004.11.077; Atiomo W, 2009, BJOG-INT J OBSTET GY, V116, P137, DOI 10.1111/j.1471-0528.2008.02041.x; Battaglia C, 2009, FERTIL STERIL, V92, P240, DOI 10.1016/j.fertnstert.2008.05.018; Cassar S, 2015, CLIN ENDOCRINOL, V83, P50, DOI 10.1111/cen.12619; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Chen CI, 2015, GYNECOL ENDOCRINOL, V31, P264, DOI 10.3109/09513590.2014.984676; Cohen B, 1996, SCIENCE, V274, P1185, DOI 10.1126/science.274.5290.1185; Daan NM, 2014, FERTIL STERIL; de Jager W, 2005, J IMMUNOL METHODS, V300, P124, DOI 10.1016/j.jim.2005.03.009; de Jager W, 2007, ANN RHEUM DIS, V66, P589, DOI 10.1136/ard.2006.061853; Diamanti-Kandarakis E, 2012, ENDOCR REV, V33, P981, DOI 10.1210/er.2011-1034; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Eikendal ALM, 2014, ATHEROSCLEROSIS, V236, P270, DOI 10.1016/j.atherosclerosis.2014.07.018; Escobar-Morreale HF, 2006, HUM REPROD, V21, P2257, DOI 10.1093/humrep/del146; Escobar-Morreale HF, 2011, FERTIL STERIL, V95, P1048, DOI 10.1016/j.fertnstert.2010.11.036; Escobar-Morreale HF, 2004, J CLIN ENDOCR METAB, V89, P806, DOI 10.1210/jc.2003-031365; Fauser BCJM, 2012, FERTIL STERIL, V97, P28, DOI 10.1016/j.fertnstert.2011.09.024; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Geerts CC, 2012, ANN MED, V44, P350, DOI 10.3109/07853890.2011.558520; Glintborg D, 2009, CLIN ENDOCRINOL, V71, P652, DOI 10.1111/j.1365-2265.2009.03523.x; Goldman S, 2004, FRONT BIOSCI-LANDMRK, V9, P2474, DOI 10.2741/1409; Hart R, 2015, J CLIN ENDOCR METAB, V100, P911, DOI 10.1210/jc.2014-3886; Huet C, 1997, BIOL REPROD, V56, P1025, DOI 10.1095/biolreprod56.4.1025; Jacobs HS, 1999, HUM REPROD UPDATE, V5, P166, DOI 10.1093/humupd/5.2.166; Kent SC, 2008, J CLIN ENDOCR METAB, V93, P1662, DOI 10.1210/jc.2007-1958; Khurana R, 2005, CIRCULATION, V112, P1813, DOI 10.1161/CIRCULATIONAHA.105.535294; Kofla-Dlubacz A, 2014, ADV CLIN EXP MED, V23, P103, DOI 10.17219/acem/37031; Lewandowski KC, 2006, J CLIN ENDOCR METAB, V91, P1173, DOI 10.1210/jc.2005-0648; Lim SS, 2012, HUM REPROD UPDATE, V18, P618, DOI 10.1093/humupd/dms030; Lyon CJ, 2003, ENDOCRINOLOGY, V144, P2195, DOI 10.1210/en.2003-0285; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Montaner J, 2001, STROKE, V32, P2762, DOI 10.1161/hs1201.99512; Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001; Plati E, 2010, FERTIL STERIL, V94, P1451, DOI 10.1016/j.fertnstert.2009.04.055; Price DT, 1999, AM J MED, V107, P85, DOI 10.1016/S0002-9343(99)00153-9; Rath T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115847; Samy N, 2009, DIS MARKERS, V26, P163, DOI [10.3233/DMA-2009-0627, 10.1155/2009/465203]; Sarray S, 2015, FERTIL STERIL; Schipper HS, 2010, CLIN CHEM, V56, P1320, DOI 10.1373/clinchem.2010.146118; Spranger J, 2004, CLIN ENDOCRINOL, V61, P738, DOI 10.1111/j.1365-2265.2004.02159.x; Svendsen PF, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.03.056; Teng Z, 2015, J CELL PHYSIOL, V230, P2998, DOI 10.1002/jcp.25032; Toulis KA, 2009, HUM REPROD UPDATE, V15, P297, DOI 10.1093/humupd/dmp006; Toulis KA, 2011, HUM REPROD UPDATE, V17, P741, DOI 10.1093/humupd/dmr025; Turkeli A, 2015, RESP MED, V109, P680, DOI 10.1016/j.rmed.2015.04.004; van den Ham HJ, 2009, RHEUMATOLOGY, V48, P899, DOI 10.1093/rheumatology/kep125; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666	51	38	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165033	10.1371/journal.pone.0165033	http://dx.doi.org/10.1371/journal.pone.0165033			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806063	gold, Green Published, Green Submitted			2022-12-26	WOS:000386715500018
J	Libedinsky, C; So, R; Xu, ZM; Kyar, TK; Ho, DC; Lim, C; Chan, L; Chua, Y; Yao, L; Cheong, JH; Lee, JH; Vishal, KV; Guo, YX; Chen, ZN; Lim, LK; Li, P; Liu, L; Zou, XD; Ang, KK; Gao, Y; Ng, WH; Han, BS; Chng, K; Guan, C; Je, M; Yen, SC				Libedinsky, Camilo; So, Rosa; Xu, Zhiming; Kyar, Toe K.; Ho, Duncun; Lim, Clement; Chan, Louiza; Chua, Yuanwei; Yao, Lei; Cheong, Jia Hao; Lee, Jung Hyup; Vishal, Kulkarni Vinayak; Guo, Yongxin; Chen, Zhi Ning; Lim, Lay K.; Li, Peng; Liu, Lei; Zou, Xiaodan; Ang, Kai K.; Gao, Yuan; Ng, Wai Hoe; Han, Boon Siew; Chng, Keefe; Guan, Cuntai; Je, Minkyu; Yen, Shih-Cheng			Independent Mobility Achieved through a Wireless Brain-Machine Interface	PLOS ONE			English	Article							CORTICAL CONTROL; NEURAL-CONTROL; ARM; TETRAPLEGIA; WHEELCHAIR; VELOCITY; GRASP	Individuals with tetraplegia lack independent mobility, making them highly dependent on others to move from one place to another. Here, we describe how two macaques were able to use a wireless integrated system to control a robotic platform, over which they were sitting, to achieve independent mobility using the neuronal activity in their motor cortices. The activity of populations of single neurons was recorded using multiple electrode arrays implanted in the arm region of primary motor cortex, and decoded to achieve brain control of the platform. We found that free-running brain control of the platform (which was not equipped with any machine intelligence) was fast and accurate, resembling the performance achieved using joystick control. The decoding algorithms can be trained in the absence of joystick movements, as would be required for use by tetraplegic individuals, demonstrating that the non-human primate model is a good pre-clinical model for developing such a cortically-controlled movement prosthetic. Interestingly, we found that the response properties of some neurons differed greatly depending on the mode of control (joystick or brain control), suggesting different roles for these neurons in encoding movement intention and movement execution. These results demonstrate that independent mobility can be achieved without first training on prescribed motor movements, opening the door for the implementation of this technology in persons with tetraplegia.	[Libedinsky, Camilo] Natl Univ Singapore, Dept Psychol, Singapore, Singapore; [Libedinsky, Camilo; Lim, Clement; Yen, Shih-Cheng] Natl Univ Singapore, Singapore Inst Neurotechnol, Singapore, Singapore; [Libedinsky, Camilo; Chan, Louiza; Chng, Keefe] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [So, Rosa; Xu, Zhiming; Kyar, Toe K.; Chua, Yuanwei; Lee, Jung Hyup; Vishal, Kulkarni Vinayak; Chen, Zhi Ning; Ang, Kai K.; Han, Boon Siew; Guan, Cuntai] ASTAR, Inst Infocomm Res, Singapore, Singapore; [Ho, Duncun; Ng, Wai Hoe] Natl Neurosci Inst, Singapore, Singapore; [Yao, Lei; Cheong, Jia Hao; Lim, Lay K.; Li, Peng; Liu, Lei; Zou, Xiaodan; Gao, Yuan; Je, Minkyu] ASTAR, Inst Microelect, Singapore, Singapore; [Guo, Yongxin; Chen, Zhi Ning; Yen, Shih-Cheng] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore, Singapore; [Guan, Cuntai] Nanyang Technol Univ, Sch Comp Sci & Engn, Singapore, Singapore; [Guan, Cuntai] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R); National Neuroscience Institute (NNI); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Microelectronics (IME); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Yen, SC (corresponding author), Natl Univ Singapore, Singapore Inst Neurotechnol, Singapore, Singapore.; Yen, SC (corresponding author), Natl Univ Singapore, Dept Elect & Comp Engn, Singapore, Singapore.	shihcheng@nus.edu.sg	Je, Minkyu/P-5960-2019; Chen, Zhi Ning/AAD-4349-2019; Je, Minkyu/Q-9864-2018; Guan, Cuntai/G-7835-2016; Je, Minkyu/G-3056-2016; Ang, Kai Keng/F-1626-2016; Gao, Yuan/E-4502-2011; Libedinsky, Camilo/AAZ-8543-2020; Yen, Shih-Cheng/AAU-6487-2021	Je, Minkyu/0000-0003-4580-2771; Chen, Zhi Ning/0000-0002-3617-6468; Guan, Cuntai/0000-0002-0872-3276; Ang, Kai Keng/0000-0002-3053-6311; Gao, Yuan/0000-0002-0832-2982; Libedinsky, Camilo/0000-0003-4980-4088; Yen, Shih-Cheng/0000-0001-7723-0072; Guo, Yongxin/0000-0001-8842-5609	A*STAR SERC grant [1021710167]	A*STAR SERC grant(Agency for Science Technology & Research (A*STAR))	This work was funded by A*STAR SERC grant (ID 1021710167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Cheng KW, 2012, IEEE ASIAN SOLID STA, P185; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Collinger JL, 2013, J SPINAL CORD MED, V36, P258, DOI 10.1179/2045772313Y.0000000128; Ethier C, 2012, NATURE, V485, P368, DOI 10.1038/nature10987; Gilja V, 2012, NAT NEUROSCI, V15, P1752, DOI 10.1038/nn.3265; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Ifft PJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006159; Iturrate I, 2009, IEEE T ROBOT, V25, P614, DOI 10.1109/TRO.2009.2020347; Kim SP, 2008, J NEURAL ENG, V5, P455, DOI 10.1088/1741-2560/5/4/010; Lebedev MA, 2005, J NEUROSCI, V25, P4681, DOI 10.1523/JNEUROSCI.4088-04.2005; Millan JDR, 2009, ANN INT C IEEE; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Rebsamen B, 2010, IEEE T NEUR SYS REH, V18, P590, DOI 10.1109/TNSRE.2010.2049862; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Zou X, 2013, INVENTORSA RECORDING; Zou XD, 2013, IEEE T CIRCUITS-I, V60, P2584, DOI 10.1109/TCSI.2013.2249175	20	23	23	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165773	10.1371/journal.pone.0165773	http://dx.doi.org/10.1371/journal.pone.0165773			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802344	Green Submitted, Green Published, gold			2022-12-26	WOS:000386714200052
J	Goyama, S; Shrestha, M; Schibler, J; Rosenfeldt, L; Miller, W; O'Brien, E; Mizukawa, B; Kitamura, T; Palumbo, JS; Mulloy, JC				Goyama, S.; Shrestha, M.; Schibler, J.; Rosenfeldt, L.; Miller, W.; O'Brien, E.; Mizukawa, B.; Kitamura, T.; Palumbo, J. S.; Mulloy, J. C.			Protease-activated receptor-1 inhibits proliferation but enhances leukemia stem cell activity in acute myeloid leukemia	ONCOGENE			English	Article							THROMBIN RECEPTOR; SELF-RENEWAL; PROGENITOR CELLS; CANCER GENOMICS; UP-REGULATION; IN-VIVO; PROMOTES; EXPRESSION; ADHESION; AML1-ETO	Eradication of leukemia stem cells (LSCs) is the ultimate goal of treating acute myeloid leukemia (AML). We recently showed that the combined loss of Runx1/Cbfb inhibited the development of MLL-AF9-induced AML. However, c-Kit(+)/Gr-1(-)cells remained viable in Runx1/Cbfb-deleted cells, indicating that suppressing RUNX activity may not eradicate the most immature LSCs. In this study, we found upregulation of several hemostasis-related genes, including the thrombin-activatable receptor PAR- 1 (protease-activated receptor-1), in Runx1/Cbfb-deleted MLL-AF9 cells. Similar to the effect of Runx1/Cbfb deletion, PAR- 1 overexpression induced CDKN1A/p21 expression and attenuated proliferation in MLL-AF9 cells. To our surprise, PAR- 1 deficiency also prevented leukemia development induced by a small number of MLL-AF9 leukemia stem cells (LSCs) in vivo. PAR- 1 deficiency also reduced leukemogenicity of AML1-ETO-induced leukemia. Re-expression of PAR- 1 in PAR-1-deficient cells combined with a limiting-dilution transplantation assay demonstrated the cell-dose-dependent role of PAR- 1 in MLL-AF9 leukemia: PAR- 1 inhibited rapid leukemic proliferation when there were a large number of LSCs, while a small number of LSCs required PAR- 1 for their efficient growth. Mechanistically, PAR- 1 increased the adherence properties of MLL-AF9 cells and promoted their engraftment to bone marrow. Taken together, these data revealed a multifaceted role for PAR- 1 in leukemogenesis, and highlight this receptor as a potential target to eradicate primitive LSCs in AML.	[Goyama, S.; Shrestha, M.; Schibler, J.; Rosenfeldt, L.; Miller, W.; O'Brien, E.; Mizukawa, B.; Palumbo, J. S.; Mulloy, J. C.] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA; [Goyama, S.; Shrestha, M.; Schibler, J.; Rosenfeldt, L.; Miller, W.; O'Brien, E.; Mizukawa, B.; Palumbo, J. S.; Mulloy, J. C.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Goyama, S.; Kitamura, T.] Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Tokyo, Japan	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Tokyo	Palumbo, JS; Mulloy, JC (corresponding author), Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA.	Joe.Palumbo@cchmc.org; james.mulloy@cchmc.org	Kitamura, Toshio/AAA-2071-2021		Institutional Clinical and Translational Science Award; NIH/NCRR Grant [1UL1RR026314-01]; Translational Trials Development and Support Laboratory award (USPHS Grant) [MO1 RR 08084]; Center of Excellence in Molecular Hematology P30 award [DK090971];  [CA176907]; NATIONAL CANCER INSTITUTE [R01CA204058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER	Institutional Clinical and Translational Science Award; NIH/NCRR Grant; Translational Trials Development and Support Laboratory award (USPHS Grant); Center of Excellence in Molecular Hematology P30 award; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank Dr J Trejo and Dr M Onodera for plasmids. We also thank the Flow Cytometry Core and the Mouse Core at Cincinnati Children's Hospital Medical Center for their help. This work was supported by an Institutional Clinical and Translational Science Award, NIH/NCRR Grant Number 1UL1RR026314-01, Translational Trials Development and Support Laboratory award (USPHS Grant Number MO1 RR 08084), CA176907 (JCM) and a Center of Excellence in Molecular Hematology P30 award (DK090971). JCM is a Leukemia and Lymphoma Society Scholar.	Aronovich A, 2013, BLOOD, V122, P2562, DOI 10.1182/blood-2012-08-447458; Austin KM, 2013, BLOOD, V121, P431, DOI 10.1182/blood-2012-09-355958; Auvergne R, 2016, ONCOGENE, V35, P3817, DOI 10.1038/onc.2015.452; Baumer N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094993; BOWER M, 1994, BLOOD, V84, P3776, DOI 10.1182/blood.V84.11.3776.bloodjournal84113776; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chou FS, 2012, BLOOD, V120, P709, DOI 10.1182/blood-2012-01-403212; COHEN SG, 2015, NAT MED, V21, P1307; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Darrow AL, 1996, THROMB HAEMOSTASIS, V76, P860; Degen JL, 2012, THROMB RES, V129, pS1, DOI 10.1016/S0049-3848(12)70143-3; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goyama S, 2016, LEUKEMIA, V30, P728, DOI 10.1038/leu.2015.275; Goyama S, 2015, BLOOD, V125, P2630, DOI 10.1182/blood-2014-11-570218; Goyama S, 2013, J CLIN INVEST, V123, P3876, DOI 10.1172/JCI68557; Heider I, 2004, ONCOL RES, V14, P475, DOI 10.3727/0965040042380496; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huang YQ, 2000, J BIOL CHEM, V275, P6462, DOI 10.1074/jbc.275.9.6462; ISHII K, 1993, J BIOL CHEM, V268, P9780; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Kanemaru M, 2012, HEPATO-GASTROENTEROL, V59, P1614, DOI 10.5754/hge10036; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Martin CB, 2001, ONCOGENE, V20, P1953, DOI 10.1038/sj.onc.1204281; Mendler JH, 2012, J CLIN ONCOL, V30, P3109, DOI 10.1200/JCO.2011.40.6652; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mulloy JC, 2008, CELL CYCLE, V7, P3314, DOI 10.4161/cc.7.21.6951; Mulloy JC, 2003, BLOOD, V102, P4369, DOI 10.1182/blood-2003-05-1762; Mulloy JC, 2002, BLOOD, V99, P15, DOI 10.1182/blood.V99.1.15; Nakahara F, 2014, BLOOD, V123, P3932, DOI 10.1182/blood-2013-01-476747; NIERODZIK ML, 1991, J CLIN INVEST, V87, P229, DOI 10.1172/JCI114976; Pagel CN, 2009, BONE, V44, P813, DOI 10.1016/j.bone.2008.12.031; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Song SJ, 2005, AM J PATHOL, V166, P857, DOI 10.1016/S0002-9440(10)62306-1; Tanaka Y, 2012, DEV BIOL, V366, P404, DOI 10.1016/j.ydbio.2012.03.024; Tellez C, 2003, ONCOGENE, V22, P3130, DOI 10.1038/sj.onc.1206453; Veiga CDB, 2011, BLOOD CELL MOL DIS, V46, P230, DOI 10.1016/j.bcmd.2010.12.005; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Wunderlich M, 2006, BLOOD, V108, P1690, DOI 10.1182/blood-2005-12-012773; Wunderlich Mark, 2009, V538, P263, DOI 10.1007/978-1-59745-418-6_13; Yang E, 2016, ONCOGENE, V35, P1529, DOI 10.1038/onc.2015.217; Ye M, 2015, CELL STEM CELL, V17, P611, DOI 10.1016/j.stem.2015.08.011; Yue R, 2012, DEV CELL, V22, P1092, DOI 10.1016/j.devcel.2012.01.025; Zhong JF, 2005, P NATL ACAD SCI USA, V102, P2448, DOI 10.1073/pnas.0409459102	46	12	12	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 4	2017	36	18					2589	2598		10.1038/onc.2016.416	http://dx.doi.org/10.1038/onc.2016.416			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET9AN	27819671	Green Accepted			2022-12-26	WOS:000400597300009
J	Guo, JY; Hsu, HS; Tyan, SW; Li, FY; Shew, JY; Lee, WH; Chen, JY				Guo, J-Y; Hsu, H-S; Tyan, S-W; Li, F-Y; Shew, J-Y; Lee, W-H; Chen, J-Y			Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; CD44; FIBROBLASTS; EXPRESSION; OVEREXPRESSION; ACTIVATION; ADHESION; PROTEOGLYCAN	Tumor microenvironment (TME) plays an active role in promoting tumor progression. To further understand the communication between TME and tumor cells, this study aimed at investigating the involvement of CD44, a type I cell surface receptor, in the crosstalk between tumor cells and TME. We have previously shown that chondroitin sulfate proteoglycan serglycin (SRGN), a CD44-interacting factor, was preferentially secreted by cancer-associated fibroblasts (CAFs) for promoting tumor growth in breast cancer patients. In this study, we show that SRGN is overexpressed in primary non-small cell lung cancers (NSCLCs), by both carcinoma and stromal cells. Using gain-of-function and loss-of-function approaches, we show that SRGN promotes NSCLC cell migration and invasion as well as colonization in the lung and liver in a CD44-dependent manner. SRGN induces lung cancer cell stemness, as demonstrated by its ability to enhance NSCLC cell sphere formation via Nanog induction, accompanied with increased chemoresistance and anoikis-resistance. SRGN promotes epithelial-mesenchymal transition by enhancing vimentin expression via CD44/NF-kappa B/claudin-1(CLDN1) axis. In support, CLDN1 and SRGN expression are tightly linked together in primary NSCLC. Most importantly, increased expression of SRGN and/or CLDN1 predicts poor prognosis in primary lung adenocarcinomas. In summary, we demonstrate that SRGN secreted by tumor cells and stromal components in the TME promotes malignant phenotypes through interacting with tumor cell receptor CD44, suggesting that a combined therapy targeting both CD44 and its ligands in the TME may be an attractive approach for cancer therapy.	[Guo, J-Y; Chen, J-Y] Acad Sinica, Inst Biomed Sci, 128 Acad Rd,Sect 2, Taipei 115, Taiwan; [Hsu, H-S] Taipei Vet Gen Hosp, Dept Thorac Surg, Taipei, Taiwan; [Tyan, S-W] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan; [Li, F-Y] Taipei Vet Gen Hosp, Dept Pathol, Taipei, Taiwan; [Shew, J-Y; Lee, W-H] Acad Sinica, Genom Res Ctr, Taipei, Taiwan; [Lee, W-H] China Med Univ, Inst Clin Med, Taichung, Taiwan; [Chen, J-Y] Natl Yang Ming Univ, Dept Life Sci, Taipei, Taiwan; [Chen, J-Y] Natl Yang Ming Univ, Inst Genome Sci, Taipei, Taiwan	Academia Sinica - Taiwan; Taipei Veterans General Hospital; Chia Nan University of Pharmacy & Science; Taipei Veterans General Hospital; Academia Sinica - Taiwan; China Medical University Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chen, JY (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Acad Rd,Sect 2, Taipei 115, Taiwan.	bmchen@ibms.sinica.edu.tw	Chen, Joanne Jeou-Yuan/S-7022-2018		Academia Sinica and Ministry of Science and Technology [MOST 104-0210-01-09-02, MOST-104-2320-B-001-010]; Academia Sinica, Taiwan	Academia Sinica and Ministry of Science and Technology; Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This research was supported by Academia Sinica and Ministry of Science and Technology (MOST 104-0210-01-09-02 and MOST-104-2320-B-001-010 to JYC), and a post-doctoral fellowship to JYG from Academia Sinica, Taiwan.	Bourguignon LYW, 2012, ONCOGENE, V31, P149, DOI 10.1038/onc.2011.222; Chao YC, 2009, AM J RESP CRIT CARE, V179, P123, DOI 10.1164/rccm.200803-456OC; Chen Hong-Chen, 2004, V294, P15; Chen WJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4472; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; dos Reis PP, 2008, CANCER-AM CANCER SOC, V113, P3169, DOI 10.1002/cncr.23934; Edlund K, 2012, INT J CANCER, V131, P2264, DOI 10.1002/ijc.27518; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Fitzgerald KA, 2000, J IMMUNOL, V164, P2053, DOI 10.4049/jimmunol.164.4.2053; Giannoni E, 2011, ANTIOXID REDOX SIGN, V14, P2361, DOI 10.1089/ars.2010.3727; Giannoni E, 2010, CANCER RES, V70, P6945, DOI 10.1158/0008-5472.CAN-10-0785; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hassona Y, 2013, CARCINOGENESIS, V34, P1286, DOI 10.1093/carcin/bgt035; He J, 2014, WORLD J GASTROENTERO, V20, P3025, DOI 10.3748/wjg.v20.i11.3025; He L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0707-4; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kinugasa Y, 2014, STEM CELLS, V32, P145, DOI 10.1002/stem.1556; Korpetinou A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078157; Lee JC, 2008, NCM 2008: 4TH INTERNATIONAL CONFERENCE ON NETWORKED COMPUTING AND ADVANCED INFORMATION MANAGEMENT, VOL 2, PROCEEDINGS, P28, DOI 10.1109/NCM.2008.203; Lee J, 2007, IEEE ASIAN SOLID STA, P67, DOI 10.1109/ASSCC.2007.4425733; Leotlela PD, 2007, ONCOGENE, V26, P3846, DOI 10.1038/sj.onc.1210155; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Li HC, 2007, J CELL BIOCHEM, V101, P805, DOI 10.1002/jcb.21159; Li XJ, 2011, CANCER RES, V71, P3162, DOI 10.1158/0008-5472.CAN-10-3557; LIN H, 2013, MATH PROBL ENG, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0060516; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Liu CA, 2004, ONCOGENE, V23, P8731, DOI 10.1038/sj.onc.1208106; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Orian-Rousseau V, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00154; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Purushothaman A, 2014, J BIOL CHEM, V289, P5499, DOI 10.1074/jbc.M113.532143; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Shiozaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038049; Singh A. K., 2012, J ENV SCI TOXICOL FO, V1, P1, DOI DOI 10.1016/J.BMC.2011.09.022; Singh AB, 2011, GASTROENTEROLOGY, V141, P2140, DOI 10.1053/j.gastro.2011.08.038; Skliris A, 2013, FEBS J, V280, P2342, DOI 10.1111/febs.12179; Sudhir PR, 2015, SCI REP-UK, V5, DOI 10.1038/srep09633; Suh Y, 2013, ONCOGENE, V32, P4873, DOI 10.1038/onc.2012.505; Swisshelm K, 2005, ADV DRUG DELIVER REV, V57, P919, DOI 10.1016/j.addr.2005.01.006; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; ToyamaSorimachi N, 1997, J BIOL CHEM, V272, P26714, DOI 10.1074/jbc.272.42.26714; TOYAMASORIMACHI N, 1995, J BIOL CHEM, V270, P7437, DOI 10.1074/jbc.270.13.7437; Tuck AB, 2007, J CELL BIOCHEM, V102, P859, DOI 10.1002/jcb.21520; Tyan SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035128; Tyan SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015313; Vered M, 2010, INT J CANCER, V127, P1356, DOI 10.1002/ijc.25358; Volz Y, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150093	53	72	75	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 27	2017	36	17					2457	2471		10.1038/onc.2016.404	http://dx.doi.org/10.1038/onc.2016.404			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET4QE	27819672	Green Published, hybrid			2022-12-26	WOS:000400268900011
J	Mitani, Y; Vagnozzi, RJ; Millay, DP				Mitani, Yasuyuki; Vagnozzi, Ronald J.; Millay, Douglas P.			In vivo myomaker-mediated heterologous fusion and nuclear reprogramming	FASEB JOURNAL			English	Article						cell therapy; membrane fusion; muscular dystrophy	DUCHENNE MUSCULAR-DYSTROPHY; HEMATOPOIETIC STEM-CELLS; SKELETAL-MUSCLE REGENERATION; MESENCHYMAL STROMAL CELLS; MDX MOUSE; GLYCOPROTEIN COMPLEX; MYOBLAST FUSION; SATELLITE CELLS; GENE-THERAPY; EXPRESSION	Knowledge regarding cellular fusion and nuclear reprogramming may aid in cell therapy strategies for skeletal muscle diseases. An issue with cell therapy approaches to restore dystrophin expression in muscular dystrophy is obtaining a sufficient quantity of cells that normally fuse with muscle. Here we conferred fusogenic activity without transdifferentiation to multiple non-muscle cell types and tested dystrophin restoration inmouse models of muscular dystrophy. We previously demonstrated that myomaker, a skeletal muscle-specific transmembrane protein necessary for myoblast fusion, is sufficient to fuse 10T 1/2 fibroblasts to myoblasts in vitro. Whether myomaker-mediated heterologous fusion is functional in vivo and whether the newly introduced nonmuscle nuclei undergoes nuclear reprogramming has not been investigated. We showed that mesenchymal stromal cells, cortical bone stem cells, and tail-tip fibroblasts fuse to skeletal muscle when they express myomaker. These cells restored dystrophin expression in a fraction of dystrophin-deficient myotubes after fusion in vitro. However, dystrophin restoration was not detected in vivo although nuclear reprogramming of the muscle-specific myosin light chain promoter did occur. Despite the lack of detectable dystrophin reprogramming by immunostaining, this study indicated that myomaker could be used in nonmuscle cells to induce fusion with muscle in vivo, thereby providing a platform to deliver therapeutic material.-Mitani, Y., Vagnozzi, R. J., Millay, D. P. In vivo myomaker-mediated heterologous fusion and nuclear reprogramming.	[Mitani, Yasuyuki; Vagnozzi, Ronald J.; Millay, Douglas P.] Cincinnati Childrens Hosp Med Ctr, Dept Mol Cardiovasc Biol, 240 Albert Sabin Way,MLC 7020, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Millay, DP (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Mol Cardiovasc Biol, 240 Albert Sabin Way,MLC 7020, Cincinnati, OH 45229 USA.	douglas.millay@cchmc.org	Vagnozzi, Ronald/AAR-6891-2020	Vagnozzi, Ronald/0000-0002-8027-1809	Cincinnati Children's Hospital Research Foundation; U.S. National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR068286]; Muscular Dystrophy Association; Pew Charitable Trusts; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068286] Funding Source: NIH RePORTER	Cincinnati Children's Hospital Research Foundation; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Muscular Dystrophy Association(Muscular Dystrophy Association); Pew Charitable Trusts; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank J. Cancelas (Cincinnati Children's Hospital Medical Center) for mouse MSCs. This work was supported, in part, by grants to D.P.M. from the Cincinnati Children's Hospital Research Foundation, U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR068286), the Muscular Dystrophy Association, and Pew Charitable Trusts.	Bajek A, 2015, CRIT REV EUKAR GENE, V25, P1, DOI 10.1615/CritRevEukaryotGeneExpr.2015011074; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; CHIU CP, 1984, CELL, V37, P879, DOI 10.1016/0092-8674(84)90423-9; Chretien F, 2005, AM J PATHOL, V166, P1741, DOI 10.1016/S0002-9440(10)62484-4; Corbel SY, 2003, NAT MED, V9, P1528, DOI 10.1038/nm959; Cossu G, 2015, EMBO MOL MED, V7, P1513, DOI 10.15252/emmm.201505636; Duan DS, 2016, CURR OPIN VIROL, V21, P16, DOI 10.1016/j.coviro.2016.07.006; Dumont NA, 2015, COMPR PHYSIOL, V5, P1027, DOI 10.1002/cphy.c140068; Duran JM, 2013, CIRC RES, V113, P539, DOI 10.1161/CIRCRESAHA.113.301202; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Filareto A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2550; Folker ES, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00363; Godfrey C, 2015, HUM MOL GENET, V24, P4225, DOI 10.1093/hmg/ddv155; Gonzalez-Nieto D, 2012, BLOOD, V119, P5144, DOI 10.1182/blood-2011-07-368506; Gregorevic P, 2008, MOL THER, V16, P657, DOI 10.1038/mt.2008.28; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hoogduijn MJ, 2014, CURR OPIN ORGAN TRAN, V19, P41, DOI 10.1097/MOT.0000000000000036; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559; Lapidos KA, 2004, J CLIN INVEST, V114, P1577, DOI 10.1172/JCI200423071; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Li DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015286; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026381; Looney TJ, 2014, GENOME RES, V24, P267, DOI 10.1101/gr.143891.112; Millay DP, 2016, P NATL ACAD SCI USA, V113, P2116, DOI 10.1073/pnas.1600101113; Millay DP, 2014, GENE DEV, V28, P1641, DOI 10.1101/gad.247205.114; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Miller RG, 1997, MUSCLE NERVE, V20, P469, DOI 10.1002/(SICI)1097-4598(199704)20:4<469::AID-MUS10>3.3.CO;2-1; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; Muir LA, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.25; Najar M, 2016, CYTOTHERAPY, V18, P160, DOI 10.1016/j.jcyt.2015.10.011; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Patel SA, 2008, ARCH IMMUNOL THER EX, V56, P1, DOI 10.1007/s00005-008-0001-x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pomerantz JH, 2009, J CELL SCI, V122, P1045, DOI 10.1242/jcs.041376; Quattrocelli M, 2015, J CLIN INVEST, V125, P4463, DOI 10.1172/JCI82735; Rinaldi F, 2014, TRANSL RES, V163, P409, DOI 10.1016/j.trsl.2013.11.006; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Sanges D, 2013, CELL REP, V4, P271, DOI 10.1016/j.celrep.2013.06.015; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shimizu-Motohashi Y, 2016, AM J TRANSL RES, V8, P2471; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Young CS, 2016, CELL STEM CELL, V18, P533, DOI 10.1016/j.stem.2016.01.021; Yue YP, 2003, CIRCULATION, V108, P1626, DOI 10.1161/01.CIR.0000089371.11664.27; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238	50	11	14	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					400	+		10.1096/fj.201600945R	http://dx.doi.org/10.1096/fj.201600945R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27825107	Green Published			2022-12-26	WOS:000392177600037
J	Rivera-Colon, Y; Maguire, A; Liszczak, GP; Olia, AS; Marmorstein, R				Rivera-Colon, Yadilette; Maguire, Andrew; Liszczak, Glen P.; Olia, Adam S.; Marmorstein, Ronen			Molecular Basis for Cohesin Acetylation by Establishment of Sister Chromatid Cohesion N-Acetyltransferase ESCO1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASE; STRUCTURE VALIDATION; CATALYTIC MECHANISM; KINETIC MECHANISM; ROBERTS-SYNDROME; DNA-BINDING; PROTEIN; ALPHA-TAT1; SWITCH; ECO1	Protein acetylation is a prevalent posttranslational modification that is regulated by diverse acetyltransferase enzymes. Although histone acetyltransferases (HATs) have been well characterized both structurally and mechanistically, far less is known about non-histone acetyltransferase enzymes. The human ESCO1 and ESCO2 paralogs acetylate the cohesin complex subunit SMC3 to regulate the separation of sister chromatids during mitosis and meiosis. Missense mutations within the acetyltransferase domain of these proteins correlate with diseases, including endometrial cancers and Roberts syndrome. Despite their biological importance, the mechanisms underlying acetylation by the ESCO proteins are not understood. Here, we report the X-ray crystal structure of the highly conserved zinc finger-acetyltransferase moiety of ESCO1 with accompanying structure-based mutagenesis and biochemical characterization. We find that the ESCO1 acetyltransferase core is structurally homologous to the Gcn5 HAT, but contains unique additional features including a zinc finger and an similar to 40-residue loop region that appear to play roles in protein stability and SMC3 substrate binding. We identify key residues that play roles in substrate binding and catalysis, and rationalize the functional consequences of disease-associated mutations. Together, these studies reveal the molecular basis for SMC3 acetylation by ESCO1 and have broader implications for understanding the structure/function of non-histone acetyltransferases.	[Rivera-Colon, Yadilette; Maguire, Andrew; Liszczak, Glen P.; Olia, Adam S.; Marmorstein, Ronen] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Maguire, Andrew; Liszczak, Glen P.; Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Marmorstein, R (corresponding author), Univ Penn, Perelman Sch Med, 421 Curie Blvd,Biomed Res Bldg 2-3,Rm 454, Philadelphia, PA 19104 USA.	marmor@mail.med.upenn.edu			National Institutes of Health [R01 GM060293, R35 GM118090, P01 AG031862, T32 GM098910, K12 GM081259]; NATIONAL CANCER INSTITUTE [P30CA016520, P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098910, R35GM118090, K12GM081259, R01GM060293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01 GM060293, R35 GM118090, and P01 AG031862 (to R. M.), T32 GM098910 (to G. P. L.), and K12 GM081259 (to Y. R-C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Carretero M, 2013, EMBO J, V32, P2938, DOI 10.1038/emboj.2013.230; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; DELATORRE JG, 1992, ANAL ULTRACENTRIFUGA, P333; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Friedmann DR, 2013, FEBS J, V280, P5570, DOI 10.1111/febs.12373; Friedmann DR, 2012, P NATL ACAD SCI USA, V109, P19655, DOI 10.1073/pnas.1209357109; Gordillo M., 2006, ROBERTS SYNDROME GEN; Gordillo M, 2008, HUM MOL GENET, V17, P2172, DOI 10.1093/hmg/ddn116; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Jeppsson K, 2014, NAT REV MOL CELL BIO, V15, P601, DOI 10.1038/nrm3857; Kouznetsova E, 2016, STRUCTURE, V24, P789, DOI 10.1016/j.str.2016.03.021; Lau OD, 2000, J BIOL CHEM, V275, P21953, DOI 10.1074/jbc.M003219200; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Li AG, 2007, MOL CELL, V28, P408, DOI 10.1016/j.molcel.2007.09.006; Liszczak G, 2013, NAT STRUCT MOL BIOL, V20, P1098, DOI 10.1038/nsmb.2636; Liszczak G, 2011, J BIOL CHEM, V286, P37002, DOI 10.1074/jbc.M111.282863; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Marmorstein R, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018762; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pramanik KC, 2014, MOL CANCER THER, V13, P687, DOI 10.1158/1535-7163.MCT-13-0863; Price JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063313; Rahman S, 2015, P NATL ACAD SCI USA, V112, P11270, DOI 10.1073/pnas.1505323112; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Sutton A, 2003, J BIOL CHEM, V278, P16887, DOI 10.1074/jbc.M210709200; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tanner KG, 2000, J BIOL CHEM, V275, P22048, DOI 10.1074/jbc.M002893200; Tanner KG, 2000, BIOCHEMISTRY-US, V39, P11961, DOI 10.1021/bi001272h; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wang L, 2008, CURR OPIN STRUC BIOL, V18, P741, DOI 10.1016/j.sbi.2008.09.004; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Zhang SY, 2016, TUMOR BIOL, V37, P5165, DOI 10.1007/s13277-015-4375-1	47	11	13	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26468	26477		10.1074/jbc.M116.752220	http://dx.doi.org/10.1074/jbc.M116.752220			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27803161	Green Published, hybrid			2022-12-26	WOS:000391568200020
J	Cherubin, P; Garcia, MC; Curtis, D; Britt, CBT; Craft, JW; Burress, H; Berndt, C; Reddy, S; Guyette, J; Zheng, TY; Huo, Q; Quinones, B; Briggs, JM; Teter, K				Cherubin, Patrick; Garcia, Maria Camila; Curtis, David; Britt, Christopher B. T.; Craft, John W., Jr.; Burress, Helen; Berndt, Chris; Reddy, Srikar; Guyette, Jessica; Zheng, Tianyu; Huo, Qun; Quinones, Beatriz; Briggs, James M.; Teter, Ken			Inhibition of Cholera Toxin and Other AB Toxins by Polyphenolic Compounds	PLOS ONE			English	Article							ENTEROHEMORRHAGIC ESCHERICHIA-COLI; INDUCED FLUID ACCUMULATION; ENDOPLASMIC-RETICULUM; SHIGA TOXIN; ADP-RIBOSYLTRANSFERASE; DEGRADATION PATHWAY; PLANT POLYPHENOLS; A1 POLYPEPTIDE; TARGET-CELLS; VERO CELLS	Cholera toxin (CT) is an AB-type protein toxin that contains a catalytic A1 subunit, an A2 linker, and a cell-binding B homopentamer. The CT holotoxin is released into the extracellular environment, but CTA1 attacks a target within the cytosol of a host cell. We recently reported that grape extract confers substantial resistance to CT. Here, we used a cell culture system to identify twelve individual phenolic compounds from grape extract that inhibit CT. Additional studies determined the mechanism of inhibition for a subset of the compounds: two inhibited CT binding to the cell surface and even stripped CT from the plasma membrane of a target cell; two inhibited the enzymatic activity of CTA1; and four blocked cytosolic toxin activity without directly affecting the enzymatic function of CTA1. Individual polyphenolic compounds from grape extract could also generate cellular resistance to diphtheria toxin, exotoxin A, and ricin. We have thus identified individual toxin inhibitors from grape extract and some of their mechanisms of inhibition against CT.	[Cherubin, Patrick; Garcia, Maria Camila; Curtis, David; Britt, Christopher B. T.; Burress, Helen; Berndt, Chris; Reddy, Srikar; Guyette, Jessica; Teter, Ken] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Craft, John W., Jr.; Briggs, James M.] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Zheng, Tianyu; Huo, Qun] Univ Cent Florida, NanoSci Technol Ctr, Orlando, FL 32816 USA; [Zheng, Tianyu; Huo, Qun] Univ Cent Florida, Dept Chem, Orlando, FL 32816 USA; [Quinones, Beatriz] USDA ARS, Produce Safety & Microbiol Res Unit, Western Reg Res Ctr, Albany, CA USA; [Curtis, David] Valencia Coll, Orlando, FL USA	State University System of Florida; University of Central Florida; University of Houston System; University of Houston; State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; United States Department of Agriculture (USDA)	Teter, K (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	kteter@mail.ucf.edu		Briggs, James/0000-0001-5863-8945; Cherubin, Patrick/0000-0002-3567-836X; Craft, John/0000-0002-5679-5629; Quinones, Beatriz/0000-0001-5010-9889; Teter, Ken/0000-0003-4176-9361	U.S. Department of Agriculture, Agricultural Research Service [2030-42000-051-00D, 58-5325-4-024]; ARS [ARS-0430420] Funding Source: Federal RePORTER	U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This material is based upon work supported by the U.S. Department of Agriculture, Agricultural Research Service (www.ars.usda.gov/)-CRIS project no. 2030-42000-051-00D under the Non-Assistance Cooperative Agreement (NACA) no. 58-5325-4-024 to KT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee T, 2014, MOL MICROBIOL, V94, P898, DOI 10.1111/mmi.12807; Barth H, 2011, N-S ARCH PHARMACOL, V383, P237, DOI 10.1007/s00210-010-0581-y; Brijesh S, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-47; Burress H, 2014, J BIOL CHEM, V289, P33644, DOI 10.1074/jbc.M114.609800; Charlton AJ, 2002, J AGR FOOD CHEM, V50, P1593, DOI 10.1021/jf010897z; Cho JA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00051; Choi O, 2007, MICROB PATHOGENESIS, V42, P215, DOI 10.1016/j.micpath.2007.01.007; Friedman M, 2014, J AGR FOOD CHEM, V62, P6025, DOI 10.1021/jf501266s; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; Jobling MG, 2015, TOXINS, V7, P919, DOI 10.3390/toxins7030919; Kimura R, 2000, APPL ENVIRON MICROB, V66, P2513, DOI 10.1128/AEM.66.6.2513-2519.2000; Majoul I, 1997, FEBS LETT, V401, P104, DOI 10.1016/S0014-5793(96)01447-0; Massey S, 2011, METHODS MOL BIOL, V739, P49, DOI 10.1007/978-1-61779-102-4_5; Miyamoto T, 2014, FOOD CONTROL, V42, P263, DOI 10.1016/j.foodcont.2014.02.017; Morinaga N, 2005, J BIOL CHEM, V280, P23303, DOI 10.1074/JBC.M502093200; Morinaga N, 2010, TOXICON, V56, P29, DOI 10.1016/j.toxicon.2010.03.009; Muanprasat C, 2013, FUTURE MED CHEM, V5, P781, DOI [10.4155/FMC.13.42, 10.4155/fmc.13.42]; Murphy JR, 2011, TOXINS, V3, P294, DOI 10.3390/toxins3030294; Oi H, 2002, P NATL ACAD SCI USA, V99, P3042, DOI 10.1073/pnas.052709499; Orlandi PA, 1997, J BIOL CHEM, V272, P4591; Quinones B, 2009, APPL ENVIRON MICROB, V75, P1410, DOI 10.1128/AEM.02230-08; Ray S, 2012, J BIOL CHEM, V287, P30395, DOI 10.1074/jbc.M112.385575; Reddy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073390; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Saha P, 2013, ANTIMICROB AGENTS CH, V57, P4373, DOI 10.1128/AAC.00122-13; Saito T, 2002, MICROBIOL IMMUNOL, V46, P249, DOI 10.1111/j.1348-0421.2002.tb02693.x; Sandvig K, 2002, ANNU REV CELL DEV BI, V18, P1, DOI 10.1146/annurev.cellbio.18.011502.142107; Seal BS, 2013, ANIM HEALTH RES REV, V14, P78, DOI 10.1017/S1466252313000030; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Shi John, 2003, Journal of Medicinal Food, V6, P291, DOI 10.1089/109662003772519831; SOMAN G, 1986, BIOCHEMISTRY-US, V25, P4113, DOI 10.1021/bi00362a019; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Taylor M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003925; Taylor M, 2010, J BIOL CHEM, V285, P31261, DOI 10.1074/jbc.M110.148981; Teter K, 2004, INFECT IMMUN, V72, P6826, DOI 10.1128/IAI.72.12.6826-6835.2004; Teter K, 2002, INFECT IMMUN, V70, P6166, DOI 10.1128/IAI.70.11.6166-6171.2002; Teter K., 2013, MOONLIGHTING CELL ST, P323; Teter K, 2013, BIOMOLECULES, V3, P997, DOI 10.3390/biom3040997; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Verhelst R, 2013, VET MICROBIOL, V163, P319, DOI 10.1016/j.vetmic.2012.12.039; Wallace RJ, 2010, BRIT POULTRY SCI, V51, P461, DOI 10.1080/00071668.2010.506908; WELSH CF, 1994, MOL CELL BIOCHEM, V138, P157, DOI 10.1007/BF00928458; Windisch W, 2008, J Anim Sci, V86, pE140; Xia EQ, 2010, INT J MOL SCI, V11, P622, DOI 10.3390/ijms11020622; Yoshino N, 2009, VACCINE, V27, P4808, DOI 10.1016/j.vaccine.2009.05.081	45	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166477	10.1371/journal.pone.0166477	http://dx.doi.org/10.1371/journal.pone.0166477			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829022	Green Published, Green Submitted, gold			2022-12-26	WOS:000387724300110
J	Imran, M; Tang, K; Liu, JY				Imran, Muhammad; Tang, Kai; Liu, Jin-Yuan			Comparative Genome-Wide Analysis of the Malate Dehydrogenase Gene Families in Cotton	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; FIBER; ARABIDOPSIS; GROWTH; PLANT; EXPRESSION; NAD; MECHANISMS; ISOENZYMES; OXIDATION	Malate dehydrogenases (MDHs) play crucial roles in the physiological processes of plant growth and development. In this study, 13 and 25 MDH genes were identified from Gossypium raimondii and Gossypium hirsutum, respectively. Using these and 13 previously reported Gossypium arboretum MDH genes, a comparative molecular analysis between identified MDH genes from G. raimondii, G. hirsutum, and G. arboretum was performed. Based on multiple sequence alignments, cotton MDHs were divided into five subgroups: mitochondrial MDH, peroxisomal MDH, plastidial MDH, chloroplastic MDH and cytoplasmic MDH. Almost all of the MDHs within the same subgroup shared similar gene structure, amino acid sequence, and conserved motifs in their functional domains. An analysis of chromosomal localization suggested that segmental duplication played a major role in the expansion of cotton MDH gene families. Additionally, a selective pressure analysis indicated that purifying selection acted as a vital force in the evolution of MDH gene families in cotton. Meanwhile, an expression analysis showed the distinct expression profiles of GhMDHs in different vegetative tissues and at different fiber developmental stages, suggesting the functional diversification of these genes in cotton growth and fiber development. Finally, a promoter analysis indicated redundant but typical cis-regulatory elements for the potential functions and stress activity of many MDH genes. This study provides fundamental information for a better understanding of cotton MDH gene families and aids in functional analyses of the MDH genes in cotton fiber development.	[Imran, Muhammad; Tang, Kai; Liu, Jin-Yuan] Tsinghua Univ, Sch Life Sci, Ctr Plant Biol, Plant Mol Biol Lab, Beijing 100084, Peoples R China	Tsinghua University	Liu, JY (corresponding author), Tsinghua Univ, Sch Life Sci, Ctr Plant Biol, Plant Mol Biol Lab, Beijing 100084, Peoples R China.	liujy@mail.tsinghua..edu.cn	Imran, Muhammad/AEK-4305-2022	Imran, Muhammad/0000-0001-7552-8326	National Transgenic Animals and Plants Research Project [2011ZX08005-003, 2011ZX08009-003]	National Transgenic Animals and Plants Research Project	This work was supported by grants from the National Transgenic Animals and Plants Research Project (2011ZX08005-003 and 2011ZX08009-003). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amemiya T, 2006, PLANTA, V223, P1272, DOI 10.1007/s00425-005-0176-x; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Basra AS, 1999, GROWTH REGULATION CO, P47; Beeler S, 2014, PLANT PHYSIOL, V164, P1175, DOI 10.1104/pp.113.233866; BIRKTOFT JJ, 1983, J BIOL CHEM, V258, P472; Bjorklund AK, 2006, PLOS COMPUT BIOL, V2, P959, DOI 10.1371/journal.pcbi.0020114; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Cao XF, 2015, SCI CHINA LIFE SCI, V58, P515, DOI 10.1007/s11427-015-4862-z; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Chi YH, 2011, DNA RES, V18, P1, DOI 10.1093/dnares/dsq031; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Cosgrove DJ, 1997, PLANTA, V203, pS130, DOI 10.1007/PL00008101; Cronn RC, 1999, P NATL ACAD SCI USA, V96, P14406, DOI 10.1073/pnas.96.25.14406; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DHINDSA RS, 1975, PLANT PHYSIOL, V56, P394, DOI 10.1104/pp.56.3.394; Ding Y, 2004, BIOCHIMIE, V86, P509, DOI 10.1016/j.biochi.2004.07.011; Drawid A, 2000, TRENDS GENET, V16, P426, DOI 10.1016/S0168-9525(00)02108-9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferguson DL, 1996, J AGR FOOD CHEM, V44, P4022, DOI 10.1021/jf9602028; Fricke W, 2006, PLANT CELL MONOGR, P7; GIETL C, 1982, PLANT PHYSIOL, V70, P483, DOI 10.1104/pp.70.2.483; GIETL C, 1992, BIOCHIM BIOPHYS ACTA, V1100, P217, DOI 10.1016/0167-4838(92)90476-T; Gu ZL, 2002, MOL BIOL EVOL, V19, P256, DOI 10.1093/oxfordjournals.molbev.a004079; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Heazlewood JL, 2004, PLANT CELL, V16, P241, DOI 10.1105/tpc.016055; Hebbelmann I, 2012, J EXP BOT, V63, P1445, DOI 10.1093/jxb/err386; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Imran M, 2016, PAK J BOT, V48, P1081; JOURNET EP, 1981, PLANT PHYSIOL, V67, P467, DOI 10.1104/pp.67.3.467; Kim Yu Jin, 2008, [KOREAN JOURNAL OF MEDICINAL CROP SCIENCE, 한국약용작물학회지], V16, P261; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li QF, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01180; Li W, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00732; Li XR, 2010, J EXP BOT, V61, P287, DOI 10.1093/jxb/erp299; Liu FL, 2005, PLANT PHYSIOL, V137, P1115, DOI 10.1104/pp.104.055475; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LONGO GP, 1969, P NATL ACAD SCI USA, V62, P104, DOI 10.1073/pnas.62.1.104; Martin C, 2010, PLANT PHYSIOL, V154, P506, DOI 10.1104/pp.110.161331; Menckhoff L, 2013, J PROTEOMICS, V80, P66, DOI 10.1016/j.jprot.2012.12.015; Musrati RA, 1998, GEN PHYSIOL BIOPHYS, V17, P193; NICHOLLS DJ, 1992, BIOCHEM BIOPH RES CO, V189, P1057, DOI 10.1016/0006-291X(92)92311-K; Nunes-Nesi A, 2005, PLANT PHYSIOL, V137, P611, DOI 10.1104/pp.104.055566; Pracharoenwattana I, 2007, PLANT J, V50, P381, DOI 10.1111/j.1365-313X.2007.03055.x; Pu L, 2008, GENETICS, V180, P811, DOI 10.1534/genetics.108.093070; Rudrappa T, 2008, PLANT PHYSIOL, V148, P1547, DOI 10.1104/pp.108.127613; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Scheibe R, 2004, PHYSIOL PLANTARUM, V120, P21, DOI 10.1111/j.0031-9317.2004.0222.x; Seagull R. W., 2004, Journal of Cotton Science, V8, P105; Selinski J, 2014, MOL PLANT, V7, P170, DOI 10.1093/mp/sst151; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Sunilkumar G, 2006, P NATL ACAD SCI USA, V103, P18054, DOI 10.1073/pnas.0605389103; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tesfaye M, 2001, PLANT PHYSIOL, V127, P1836, DOI 10.1104/pp.010376; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Todeschini AL, 2014, TRENDS GENET, V30, P211, DOI 10.1016/j.tig.2014.04.002; Tomaz T, 2010, PLANT PHYSIOL, V154, P1143, DOI 10.1104/pp.110.161612; Tripathi AK, 2004, EUR J BIOCHEM, V271, P3488, DOI 10.1111/j.1432-1033.2004.04281.x; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang ZA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10343; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Weiner J, 2006, FEBS J, V273, P2037, DOI 10.1111/j.1742-4658.2006.05220.x; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; Xiao YH, 2010, J PLANT PHYSIOL, V167, P829, DOI 10.1016/j.jplph.2010.01.003; Yao YX, 2011, PLANT PHYSIOL BIOCH, V49, P257, DOI 10.1016/j.plaphy.2010.12.009; YUEH AY, 1989, BIOCHEM J, V258, P221, DOI 10.1042/bj2580221; Zhang M, 2011, NAT BIOTECHNOL, V29, P453, DOI 10.1038/nbt.1843; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhu YX, 2013, J INTEGR PLANT BIOL, V55, P570, DOI 10.1111/jipb.12076	79	12	13	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166341	10.1371/journal.pone.0166341	http://dx.doi.org/10.1371/journal.pone.0166341			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829020	gold, Green Submitted, Green Published			2022-12-26	WOS:000387724300106
J	Pal, K; Ngin, C; Tuot, S; Chhoun, P; Ly, C; Chhim, S; Luong, MA; Tatomir, B; Yi, SY				Pal, Khuondyla; Ngin, Chanrith; Tuot, Sovannary; Chhoun, Pheak; Ly, Cheaty; Chhim, Srean; Minh-Anh Luong; Tatomir, Brent; Yi, Siyan			Acceptability Study on HIV Self-Testing among Transgender Women, Men who Have Sex with Men, and Female Entertainment Workers in Cambodia: A Qualitative Analysis	PLOS ONE			English	Article							FEASIBILITY	Background In Cambodia, HIV prevalence is high while HIV testing rates remain low among transgender women (TG women), men who have sex with men (MSM), and female entertainment workers (FEW). Introducing self-testing for HIV to these key populations (KPs) could potentially overcome the under-diagnosis of HIV and significantly increase testing rates and receipt of the results, and thus could decrease transmission. Therefore, this study aimed to determine the acceptability of HIV self-testing (HIVST) among these three categories of KPs. Methods This study was conducted through focus group discussions (FGDs) with TG women, MSM, and FEW in Phnom Penh city, Kampong Cham, Battambang, and Siem Reap provinces of Cambodia. Convenience sampling was used to recruit the participants. Two FGDs (six participants in each FGD) were conducted in each target group in each study site, totaling 24 FGDs (144 participants). Thematic analysis was performed to identify common or divergent patterns across the target groups. Results Almost all participants among the three groups (TG women, MSM, and FEW) had not heard about HIVST, but all of them expressed willingness to try it. They perceived HIVST as confidential, convenient, time-saving, and high-tech. Barriers to obtaining HIVST included cost, access, administration technique, embarrassment, and fear of pain. The majority preferred counseling before and after testing. Conclusions Participants showed high willingness to use and acceptability of HIVST due to its confidentiality/privacy and convenience even if it is not linked to a confirmatory test or care and treatment. Notwithstanding, to increase HIVST, the target groups would need affordable self-test kits, education about how to perform HIVST and read results, assurance about accuracy and reliability of HIVST, and provision of post-test counseling and facilitation of linkage to care and treatment.	[Pal, Khuondyla; Ngin, Chanrith; Tuot, Sovannary; Chhoun, Pheak; Yi, Siyan] KHANA Ctr Populat Hlth Res, Phnom Penh, Cambodia; [Minh-Anh Luong; Tatomir, Brent; Yi, Siyan] Touro Univ Calif, Publ Hlth Program, Ctr Global Hlth Res, Vallejo, CA USA; [Ly, Cheaty] PSK, Phnom Penh, Cambodia; [Chhim, Srean] FHI 360, Phnom Penh, Cambodia	Touro University California	Pal, K (corresponding author), KHANA Ctr Populat Hlth Res, Phnom Penh, Cambodia.	pkhuondyla@khana.org.kh	Chhoun, Pheak/AAR-3361-2021; Chhim, Srean/E-8829-2016	Chhoun, Pheak/0000-0001-6369-0190; Chhim, Srean/0000-0003-1558-1875	United States Agency for International Development (USAID)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This study was supported by the United States Agency for International Development (USAID). The funder had no role in study design, data collection and analysis, decisioin to publish, or preparation of the manuscript.; This study was supported by the United States Agency for International Development (USAID). The authors thank KHANA's senior management for their guidance and support. We gratefully acknowledge the support from our research assistants, implementing partners, outreach workers, and the participants in the data collection and provision.	Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Campbell CH, 1997, AIDS EDUC PREV, V9, P92; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P512; Rosales-Statkus ME, 2014, ENFERM INFEC MICR CL, V32, P302, DOI 10.1016/j.eimc.2013.12.004; Figueroa C, 2015, AIDS BEHAV; Gaydos CA, 2011, ANN EMERG MED, V58, pS74, DOI 10.1016/j.annemergmed.2011.03.029; HIV/AIDS,, 2014, 90 90 90 AMB TREATM; Hutchinson AB, 2006, AIDS, V20, P1597, DOI 10.1097/01.aids.0000238405.93249.16; Joint United Nations Programme on HIV/AIDS (UNAIDS) & the National AIDS Authority (NAA), 2015, CAMB COUNTR PROGR RE; Kassler WJ, 1998, INT J STD AIDS, V9, P134, DOI 10.1258/0956462981921882; Katz DA, 2012, 19 C RETR OPP INF MA; Keenan PA, 2005, POSTGRAD MED, V117, P47, DOI 10.3810/pgm.2005.03.1600; Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735; Lee VJ, 2007, JAIDS-J ACQ IMM DEF, V45, P449, DOI 10.1097/QAI.0b013e318095a3f3; Menard D, 2005, J VIROL METHODS, V126, P75, DOI 10.1016/j.jviromet.2005.01.023; National Center for HIV/AIDS Dermatology and STD (NCHADS) & KHANA, NAT POP SIZ EST HIV; Pai NP, 2014, AIDS RES TREAT, V2014, DOI 10.1155/2014/747619; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Phalkun M, 2013, BEHAV SENTINEL SURVE; Spielberg F, 1996, ANN INTERN MED, V125, P509, DOI 10.7326/0003-4819-125-6-199609150-00014; Spielberg F, 2004, LANCET INFECT DIS, V4, P640, DOI 10.1016/S1473-3099(04)01150-8; World Health Organisation, 2013, WHO CONS GUID US ANT; Wright AA, 2006, NEW ENGL J MED, V354, P437, DOI 10.1056/NEJMp058302	23	37	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166129	10.1371/journal.pone.0166129	http://dx.doi.org/10.1371/journal.pone.0166129			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829064	Green Published, gold, Green Submitted			2022-12-26	WOS:000387724300086
J	Shi, HH; Zhang, JF; Zhu, RR; Hu, N; Lu, H; Yang, M; Qin, B; Shi, J; Guan, HJ				Shi, Haihong; Zhang, Junfang; Zhu, Rongrong; Hu, Nan; Lu, Hong; Yang, Mei; Qin, Bai; Shi, Jian; Guan, Huaijin			Primary Angle Closure and Sequence Variants within MicroRNA Binding Sites of Genes Involved in Eye Development	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; PROTEIN MFRP; GLAUCOMA; MECHANISM; HOMOCYSTEINE; BIOGENESIS; RECEPTOR; CHINA	Purpose The formation of primary angle closure (PAC) and primary angle closure glaucoma (PACG) is regulated by a tissue remodeling pathway that plays a critical role in eye development. MicroRNAs (miRNAs) are powerful gene expression regulators and may exert their effects on tissue remodeling genes. This study investigated the associations between gene variants (single-nucleotide polymorphism, SNP) in miRNA binding sites in the 3'-UTR region of genes involved in eye development and PAC. Methods The sample consisted of 232 PAC subjects and 306 controls obtained from a population-based cohort in the Funing District of Jiangsu, China. The markers include 9 SNPs in the COL11A1, PCMTD1, ZNRF3, MTHFR, and ALPPL2 genes respectively. SNP genotyping was performed with a TaqMan-MGB probe using an RT-PCR system. Results Of the 9 SNPs studied, the frequency of the minor A allele of COL11A1 rs1031820 was higher in the PAC group than in the control group in allele analysis (p = 0.047). The genotype analysis indicated that MTHFR rs1537514 is marginally associated with PAC (p = 0.014). The CC genotype of rs1537514 was present solely in the PAC group. However, the differences lost significance after Bonferroni correction. Conclusion Our study reveals a possible association of COL11A1 and MTHFR with PAC in the Han Chinese population. These results will contribute to an improved understanding of the genetic basis of PACG.	[Shi, Haihong; Zhang, Junfang; Zhu, Rongrong; Hu, Nan; Lu, Hong; Yang, Mei; Qin, Bai; Shi, Jian; Guan, Huaijin] Nantong Univ, Inst Eye, Affiliated Hosp, Nantong, Peoples R China	Nantong University	Guan, HJ (corresponding author), Nantong Univ, Inst Eye, Affiliated Hosp, Nantong, Peoples R China.	guanhjeye@163.com						Annunen S, 1999, AM J HUM GENET, V65, P974, DOI 10.1086/302585; Aung T, 2008, MOL VIS, V14, P1313; Aung T, 2008, J GLAUCOMA, V17, P257, DOI 10.1097/IJG.0b013e31815c3aa5; Ayub H, 2010, MOL VIS, V16, P18; Barathi VA, 2009, VISION RES, V49, P383, DOI 10.1016/j.visres.2008.11.005; Barkana Y, 2007, ARCH OPHTHALMOL-CHIC, V125, P1331, DOI 10.1001/archopht.125.10.1331; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheng CY, 2013, AM J HUM GENET, V93, P264, DOI 10.1016/j.ajhg.2013.06.016; Cong YH, 2009, MOL VIS, V15, P1412; Day AC, 2013, BRIT J OPHTHALMOL, V97, P704, DOI 10.1136/bjophthalmol-2012-302969; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Foster PJ, 2000, BRIT J OPHTHALMOL, V84, P186, DOI 10.1136/bjo.84.2.186; Foster PJ, 2001, BRIT J OPHTHALMOL, V85, P1277, DOI 10.1136/bjo.85.11.1277; Fuhrmann Sabine, 2008, Organogenesis, V4, P60; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Kahler RA, 2008, MATRIX BIOL, V27, P330, DOI 10.1016/j.matbio.2008.01.002; Khor CC, 2016, NAT GENET, V48, P556, DOI 10.1038/ng.3540; Michael I, 2008, INVEST OPHTH VIS SCI, V49, P3981, DOI 10.1167/iovs.08-1674; Michael S, 2008, MOL VIS, V14, P661; Mujumdar VS, 2002, AM J PHYSIOL-CELL PH, V282, pC1009, DOI 10.1152/ajpcell.00353.2001; Nongpiur ME, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004089; Patel V, 2012, CURR OPIN NEPHROL HY, V21, P410, DOI 10.1097/MNH.0b013e328354e559; Shi HH, 2013, MOL VIS, V19, P128; Sihota R, 2000, CLIN EXP OPHTHALMOL, V28, P253, DOI 10.1046/j.1442-9071.2000.00324.x; Tyagi SC, 1998, AM J PHYSIOL-CELL PH, V274, pC396, DOI 10.1152/ajpcell.1998.274.2.C396; Vettori Serena, 2012, Open Rheumatol J, V6, P130, DOI 10.2174/1874312901206010130; Vithana EN, 2012, NAT GENET, V44, P1142, DOI 10.1038/ng.2390; Wang IJ, 2008, MOL VIS, V14, P1673; Wang IJ, 2006, MOL VIS, V12, P1223	31	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166055	10.1371/journal.pone.0166055	http://dx.doi.org/10.1371/journal.pone.0166055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824919	Green Published, Green Submitted, gold			2022-12-26	WOS:000387615200058
J	Teshima, T; Matsumoto, H; Okusa, T; Uchiyama, R; Koyama, H				Teshima, Takahiro; Matsumoto, Hirotaka; Okusa, Tomoko; Uchiyama, Rion; Koyama, Hidekazu			Carbenoxolone Disodium Treatment for Canine Pituitary-Dependent Hyperadrenocorticism	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2; ADRENOCORTICOTROPIC HORMONE; DOGS; TRILOSTANE; EXPRESSION; ADENOMAS; CORTISOL	Pituitary-dependent hyperadrenocorticism (PDH) is mainly caused by pituitary corticotroph tumors in dogs. A characteristic feature of corticotroph tumors is their resistance to negative feedback by glucocorticoids. In some animal species, including dogs, the aberrant expression of 11 beta-hydroxysteroid dehydrogenase (11HSD), a cortisol metabolic enzyme, is observed in corticotroph tumors. We previously reported that carbenoxolone (CBX), an inhibitor of 11HSD, suppressed ACTH secretion from the pituitary gland, and decreased cortisol concentrations in healthy dogs. Therefore, the aim of this study was to investigate the therapeutic effects of CBX on dogs with PDH. Six dogs with PDH were treated with 60 to 80 mg/kg/day of CBX for 6 weeks, followed by trilostane, which is a commonly used agent for canine PDH. CBX treatment led to a gradual decrease in both basal and in corticotropic releasing hormone (CRH)-stimulated plasma ACTH concentrations and CRH-stimulated serum cortisol concentrations, without side effects. However, basal and stimulated ACTH and cortisol concentrations remained higher than those of healthy dogs, and clinical symptoms such as polydipsia and polyuria were not ameliorated. After a 2-week wash-out interval, trilostane was administered for 2 weeks. Although basal plasma ACTH concentrations were higher after trilostane treatment than CBX treatment, polydipsia and polyuria resolved in all six dogs. The reason for the lack of improvement in polydipsia and polyuria with CBX treatment is unclear. Other mechanisms, in addition to a partial decrease in ACTH secretion, are likely to be involved. In conclusion, this is the first study to report the in vivo effects of CBX in dogs with PDH. The findings suggest that CBX inhibits ACTH secretion from canine pituitary tumors, resulting in lower cortisol concentrations.	[Teshima, Takahiro; Matsumoto, Hirotaka; Okusa, Tomoko; Uchiyama, Rion; Koyama, Hidekazu] Nippon Vet & Life Sci Univ, Sch Vet Med, Div Therapeut Sci 1, Fac Vet Sci,Dept Vet Clin Med, 1-7-1 Kyonan Cho, Musashino, Tokyo 1808602, Japan	Nippon Veterinary & Life Science University	Teshima, T (corresponding author), Nippon Vet & Life Sci Univ, Sch Vet Med, Div Therapeut Sci 1, Fac Vet Sci,Dept Vet Clin Med, 1-7-1 Kyonan Cho, Musashino, Tokyo 1808602, Japan.	teshima63@nviu.ac.jp						Bell R, 2006, VET REC, V159, P277, DOI 10.1136/vr.159.9.277; BIEWENGA WJ, 1991, ACTA ENDOCRINOL-COP, V124, P583, DOI 10.1530/acta.0.1240583; Fracassi F, 2007, DOMEST ANIM ENDOCRIN, V32, P43, DOI 10.1016/j.domaniend.2005.12.009; KEMPPAINEN RJ, 1984, J ENDOCRINOL, V103, P219, DOI 10.1677/joe.0.1030219; Kemppainen RJ, 1997, VET CLIN N AM-SMALL, V27, P173, DOI 10.1016/S0195-5616(97)50026-X; Kooistra HS, 1997, J ENDOCRINOL, V152, P113, DOI 10.1677/joe.0.1520113; Korbonits M, 2001, J CLIN ENDOCR METAB, V86, P2728, DOI 10.1210/jc.86.6.2728; Ma X, 2011, TOXICOLOGY, V285, P83, DOI 10.1016/j.tox.2011.04.007; Nigawara T, 2006, ENDOCRINOLOGY, V147, P769, DOI 10.1210/en.2005-0544; PAPANEK PE, 1994, AM J PHYSIOL, V266, pR1744, DOI 10.1152/ajpregu.1994.266.6.R1744; Peterson ME, 1997, VET CLIN N AM-SMALL, V27, P255, DOI 10.1016/S0195-5616(97)50030-1; Pineiro MIR, 2009, J VET INTERN MED, V23, P850, DOI 10.1111/j.1939-1676.2009.0328.x; Rabbitt E, 2003, ONCOGENE, V22, P1663, DOI 10.1038/sj.onc.1206293; Ramsey IK, 2010, VET CLIN N AM-SMALL, V40, P269, DOI 10.1016/j.cvsm.2009.10.008; Teshima T, 2009, DOMEST ANIM ENDOCRIN, V36, P3, DOI 10.1016/j.domaniend.2008.08.002; Teshima T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135516; Teshima T, 2014, VET J, V200, P452, DOI 10.1016/j.tvjl.2014.03.022; Witt AL, 2004, VET REC, V154, P399, DOI 10.1136/vr.154.13.399	18	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166267	10.1371/journal.pone.0166267	http://dx.doi.org/10.1371/journal.pone.0166267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824928	gold, Green Submitted, Green Published			2022-12-26	WOS:000387615200079
J	Javor, A; Ransmayr, G; Struhal, W; Riedl, R				Javor, Andrija; Ransmayr, Gerhard; Struhal, Walter; Riedl, Rene			Parkinson Patients' Initial Trust in Avatars: Theory and Evidence	PLOS ONE			English	Article							IMMERSIVE VIRTUAL ENVIRONMENTS; RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; BASAL GANGLIA; FACIAL EXPRESSIONS; CLINICAL-DIAGNOSIS; NEURAL CIRCUITRY; DECISION-MAKING; LEWY BODY; DISEASE	Parkinson's disease (PD) is a neurodegenerative disease that affects the motor system and cognitive and behavioral functions. Due to these impairments, PD patients also have problems in using the computer. However, using computers and the Internet could help these patients to overcome social isolation and enhance information search. Specifically, avatars (defined as virtual representations of humans) are increasingly used in online environments to enhance human-computer interaction by simulating face-to-face interaction. Our laboratory experiment investigated how PD patients behave in a trust game played with human and avatar counterparts, and we compared this behavior to the behavior of age, income, education and gender matched healthy controls. The results of our study show that PD patients trust avatar faces significantly more than human faces. Moreover, there was no significant difference between initial trust of PD patients and healthy controls in avatar faces, while PD patients trusted human faces significantly less than healthy controls. Our data suggests that PD patients' interaction with avatars may constitute an effective way of communication in situations in which trust is required (e.g., a physician recommends intake of medication). We discuss the implications of these results for several areas of human-computer interaction and neurological research.	[Javor, Andrija; Ransmayr, Gerhard; Struhal, Walter] Johannes Kepler Univ Linz, Kepler Univ Clin, Dept Neurol 2, Linz, Austria; [Riedl, Rene] Univ Appl Sci Upper Austria, Sch Management, Steyr, Austria; [Riedl, Rene] Johannes Kepler Univ Linz, Dept Business Informat Informat Engn, Linz, Austria	Johannes Kepler University Linz; Kepler University Hospital; Johannes Kepler University Linz	Javor, A (corresponding author), Johannes Kepler Univ Linz, Kepler Univ Clin, Dept Neurol 2, Linz, Austria.	javor@gmx.at			Internet Foundation Austria [688]	Internet Foundation Austria	This study was supported by a research grant from the Internet Foundation Austria (Call 8 - No. 688), https://www.netidee.at. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2010, BRAIN PATHOL, V20, P633, DOI 10.1111/j.1750-3639.2009.00369.x; Achey M, 2014, MOVEMENT DISORD, V29, P871, DOI 10.1002/mds.25903; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Alesina A, 2002, J PUBLIC ECON, V85, P207, DOI 10.1016/S0047-2727(01)00084-6; Arias P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030021; Arsalidou M, 2013, HUM BRAIN MAPP, V34, P3031, DOI 10.1002/hbm.22124; Bailenson JN, 2006, PRESENCE-VIRTUAL AUG, V15, P359, DOI 10.1162/pres.15.4.359; Bailenson JN, 2005, PRESENCE-VIRTUAL AUG, V14, P379, DOI 10.1162/105474605774785235; Bailenson JN, 2003, PERS SOC PSYCHOL B, V29, P819, DOI 10.1177/0146167203029007002; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Begnum MEN, 2010, LECT NOTES COMPUT SC, V6179, P292, DOI 10.1007/978-3-642-14097-6_47; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Berger CR, 1975, HUM COMMUN RES, V1, P99, DOI [10.1111/j.1468-2958.1975.tb00258.x, DOI 10.1111/J.1468-2958.1975.TB00258.X]; Bertrand JA, 2012, MOVEMENT DISORD, V27, P1781, DOI 10.1002/mds.25272; Bessiere K, 2007, CYBERPSYCHOL BEHAV, V10, P530, DOI 10.1089/cpb.2007.9994; Bhatt M, 2005, GAME ECON BEHAV, V52, P424, DOI 10.1016/j.geb.2005.03.007; Biswas P, 2008, ACCESSIBLE DESIGN DI; Bodden ME, 2010, MOVEMENT DISORD, V25, P13, DOI 10.1002/mds.22818; BRAAK H, 1994, ACTA NEUROPATHOL, V88, P493, DOI 10.1007/BF00296485; Braak H, 2006, MOVEMENT DISORD, V21, P2042, DOI 10.1002/mds.21065; Brand M, 2004, BEHAV NEUROL, V15, P77, DOI 10.1155/2004/578354; Bromiley P., 1995, RES NEGOTIATION ORG, V5, P219; Carrasco E, 2008, NATURAL INTERACTION, P38; Chevalier JA, 2006, J MARKETING RES, V43, P345, DOI 10.1509/jmkr.43.3.345; Coleman J., 1994, FDN SOCIAL THEORY; Cotten SR, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2306; Cunningham L M, 2009, Technol Health Care, V17, P269, DOI 10.3233/THC-2009-0547; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Donath J, 2007, SCIENCE, V317, P53, DOI 10.1126/science.1142770; Mendes FAD, 2012, PHYSIOTHERAPY, V98, P217, DOI 10.1016/j.physio.2012.06.001; DuBois T., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P418, DOI 10.1109/PASSAT/SocialCom.2011.56; Dujardin K, 2004, NEUROPSYCHOLOGIA, V42, P239, DOI 10.1016/S0028-3932(03)00154-4; Ernst M, 2005, BIOL PSYCHIAT, V58, P597, DOI 10.1016/j.biopsych.2005.06.004; Fabri M, 2007, LECT NOTES COMPUT SC, V4552, P275; Fahn S., 1987, RECENT DEV PARKINSON, P153; Fehr E, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P215, DOI 10.1016/B978-0-12-374176-9.00015-4; Fehr E, 2009, J EUR ECON ASSOC, V7, P235, DOI 10.1162/JEEA.2009.7.2-3.235; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fong K. N., 2010, J NEUROENG REHABIL, V30, P7; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Gambetta D., 1988, TRUST MAKING BREAKIN, P213; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198; Goodwin VA, 2008, MOVEMENT DISORD, V23, P631, DOI 10.1002/mds.21922; Grenci RT, 2002, COMMUN ACM, V45, P64, DOI 10.1145/504729.504730; Grujic Z, 2009, CONTEL 2009: PROCEEDINGS OF THE 10TH INTERNATIONAL CONFERENCE ON TELECOMMUNICATIONS, P185; Hamm MP, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002819; Harding AJ, 2002, BRAIN, V125, P2431, DOI 10.1093/brain/awf251; Hartzband P, 2010, NEW ENGL J MED, V362, P1063, DOI 10.1056/NEJMp0911938; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Holzwarth M, 2006, J MARKETING, V70, P19, DOI 10.1509/jmkg.70.4.19; Hughes AJ, 2001, NEUROLOGY, V57, P1497, DOI 10.1212/WNL.57.8.1497; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; Hum NJ, 2011, COMPUT HUM BEHAV, V27, P1828, DOI 10.1016/j.chb.2011.04.003; Javor A, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0374-5; Javor A, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-13; Karlsen KH, 2000, J NEUROL NEUROSUR PS, V69, P584, DOI 10.1136/jnnp.69.5.584; Keates S, 2005, P 7 INT ACM SIGACCES, P68; KELLEY HH, 1950, J PERS, V18, P431, DOI 10.1111/j.1467-6494.1950.tb01260.x; Kim E, 2009, PROG NEURO-PSYCHOPH, V33, P1409, DOI 10.1016/j.pnpbp.2009.07.019; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Klinger E, 2006, CYBERPSYCHOL BEHAV, V9, P342, DOI 10.1089/cpb.2006.9.342; Kopton I. M., 2013, P INT C INF SYST; Koscik TR, 2011, NEUROPSYCHOLOGIA, V49, P602, DOI 10.1016/j.neuropsychologia.2010.09.023; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Krueger F, 2007, P NATL ACAD SCI USA, V104, P20084, DOI 10.1073/pnas.0710103104; Lee M, 2013, INTERNET RES, V23, P116, DOI 10.1108/10662241311313277; Lee SJ, 2007, EDUC STUD-UK, V33, P209, DOI 10.1080/03055690601068477; Lewis SJG, 2003, J NEUROSCI, V23, P6351, DOI 10.1523/jneurosci.23-15-06351.2003; Lowe BP, 2001, GESUNDHEITSFRAGEBOGE; Lundqvist D, 1998, DATABASE KAROLINSKA; Maasland E, 2007, ACTA NEUROL SCAND, V115, P41, DOI 10.1111/j.1600-0404.2006.00722.x; MacDorman KF, 2009, COMPUT HUM BEHAV, V25, P695, DOI 10.1016/j.chb.2008.12.026; MAES P, 1994, COMMUN ACM, V37, P31, DOI 10.1145/176789.176792; Manderson L, 2010, QUAL HEALTH RES, V20, P1418, DOI [10.1177/1049732310373105, DOI 10.1177/1049732310373105]; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; McCabe KA, 2000, P NATL ACAD SCI USA, V97, P3777, DOI 10.1073/pnas.040577397; McCabe KA, 2003, J ECON BEHAV ORGAN, V52, P267, DOI 10.1016/S0167-2681(03)00003-9; Monahan T, 2008, COMPUT EDUC, V50, P1339, DOI 10.1016/j.compedu.2006.12.008; MONTGOMERY EB, 1994, AM J MED, V97, P429, DOI 10.1016/0002-9343(94)90322-0; Moser E, 2007, J NEUROSCI METH, V161, P126, DOI 10.1016/j.jneumeth.2006.10.016; Newbold KB, 2011, MEDIA SOCIAL MEDIA P; Nombela Cristina, 2011, Front Neurol, V2, P82, DOI 10.3389/fneur.2011.00082; Noy D, 2013, MULTIMODAL END 2 END, P135; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Park IH, 2009, PSYCHIATRY, V72, P79, DOI 10.1521/psyc.2009.72.1.79; Pavlou P.A., 2007, MIS Q, V31, P1; Poletti M, 2012, J NEUROL, V259, P1029, DOI 10.1007/s00415-011-6302-8; Riedl R., 2011, P 32 INT C INF SYST, P1; Riedl R, 2014, J MANAGE INFORM SYST, V30, P83, DOI 10.2753/MIS0742-1222300404; Riedl R, 2012, J NEUROSCI PSYCHOL E, V5, P63, DOI 10.1037/a0026318; Riedl R, 2010, MIS QUART, V34, P397; Rizzo A A, 1997, Stud Health Technol Inform, V39, P22; Robert LP, 2009, J MANAGE INFORM SYST, V26, P241, DOI 10.2753/MIS0742-1222260210; Rolls ET, 2015, CORTEX, V62, P119, DOI 10.1016/j.cortex.2013.12.005; Rousseau DM, 1998, ACAD MANAGE REV, V23, P393, DOI 10.5465/AMR.1998.926617; Ruiz JG, 2012, FED PRACT, V29, P25; Rust RT, 2003, COMMUN ACM, V46, P36, DOI 10.1145/777313.777336; Saenz A, 2013, EUR J NEUROL, V20, P571, DOI 10.1111/ene.12040; Schneider David, 1979, PERSON PERCEPTION; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Sockeel P, 2006, J NEUROL NEUROSUR PS, V77, P579, DOI 10.1136/jnnp.2005.075929; Tinaz S, 2011, MOVEMENT DISORD, V26, P436, DOI 10.1002/mds.23453; van der Vegt JPM, 2013, BRAIN, V136, P1192, DOI 10.1093/brain/awt027; Vasalou A, 2008, INT J HUM-COMPUT ST, V66, P801, DOI 10.1016/j.ijhcs.2008.08.002; von der Putten AM, 2010, COMPUT HUM BEHAV, V26, P1641, DOI 10.1016/j.chb.2010.06.012; WALTHER JB, 1992, COMMUN RES, V19, P52, DOI 10.1177/009365092019001003; Weintraub D, 2009, MOVEMENT DISORD, V24, P1461, DOI 10.1002/mds.22571; Wenhui Yu, 2011, Virtual and Mixed Reality - Systems and Applications. Proceedings International Conference, Virtual and Mixed Reality 2011. Held as Part of HCI International 2011, P129, DOI 10.1007/978-3-642-22024-1_15; WILLIAMSON OE, 1993, J LAW ECON, V36, P453, DOI 10.1086/467284; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Wu T, 2012, NEUROSCI LETT, V524, P55, DOI 10.1016/j.neulet.2012.07.012; Yu RL, 2013, TRANSL NEURODEGENER, V2, DOI 10.1186/2047-9158-2-7; Zak P., 2011, ECON J, V111, P295, DOI [10.111114680297.00609, DOI 10.1111/1468-0297.00609]; Zak PJ, 2004, ANN NY ACAD SCI, V1032, P224, DOI 10.1196/annals.1314.025; Zgaljardic Dennis J, 2003, Cogn Behav Neurol, V16, P193, DOI 10.1097/00146965-200312000-00001	118	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165998	10.1371/journal.pone.0165998	http://dx.doi.org/10.1371/journal.pone.0165998			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB8BB	27820864	Green Submitted, gold, Green Published			2022-12-26	WOS:000387614800028
J	Kotajima-Murakami, H; Narumi, S; Yuzaki, M; Yanagihara, D				Kotajima-Murakami, Hiroko; Narumi, Sakae; Yuzaki, Michisuke; Yanagihara, Dai			Involvement of GluD2 in Fear-Conditioned Bradycardia in Mice	PLOS ONE			English	Article							ANTERIOR CEREBELLAR VERMIS; DELTA-2 GLUTAMATE-RECEPTOR; LONG-TERM DEPRESSION; MOTOR COORDINATION; SYNAPTIC CHANGES; RESPONSES; LTD; EXPRESSION; AMYGDALA; SUBUNIT	Lesions in the cerebellar vermis abolish acquisition of fear-conditioned bradycardia in animals and human patients. The delta 2 glutamate receptor (GluD2) is predominantly expressed in cerebellar Purkinje cells. The mouse mutant ho15J carries a spontaneous mutation in GluD2 and these mice show a primary deficiency in parallel fiber-Purkinje cell synapses, multiple innervations of Purkinje cells by climbing fibers, and impairment of long-term depression. In the present study, we used ho15J mice to investigate the role of the cerebellum in fear-conditioned bradycardia. We recorded changes in heart rate of ho15J mice induced by repeated pairing of an acoustic (conditioned) stimulus (CS) with an aversive (unconditioned) stimulus (US). The mice acquired conditioned bradycardia on Day 1 of the CS-US phase, similarly to wild-type mice. However, the magnitude of the conditioned bradycardia was not stable in the mutant mice, but rather was exaggerated on Days 2-5 of the CS-US phase. We examined the effects of reversibly inactivating the cerebellum by injection of an antagonist against the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor (AMPAR). The antagonist abolished expression of conditioned responses in both wild-type and ho15J mice. We conclude that the GluD2 mutation in the ho15J mice affects stable retention of the acquired conditioned bradycardia.	[Kotajima-Murakami, Hiroko; Yanagihara, Dai] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan; [Narumi, Sakae; Yuzaki, Michisuke] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo, Japan; [Kotajima-Murakami, Hiroko] Sch Sci & Engn, Dept Biosci, Utsunomiya, Tochigi, Japan; [Kotajima-Murakami, Hiroko] Tokyo Metropolitan Inst Med Sci, Addict Subst Project, Setagaya Ku, Tokyo, Japan	University of Tokyo; Keio University; Tokyo Metropolitan Institute of Medical Science	Yanagihara, D (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan.	dai-y@idaten.c.u-tokyo.ac.jp	Yuzaki, Michisuke/K-5328-2013; Murakami-Kotajima, Hiroko/AAY-6913-2020	Yuzaki, Michisuke/0000-0002-5750-3544; 	Sasakawa Scientific Research; Japan Science Society; Grants-in-Aid for Scientific Research [15K01498] Funding Source: KAKEN	Sasakawa Scientific Research; Japan Science Society; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by: Grants in Aid for Scientific Research (C), https://www.jsps.go.jp/english/e-grants/, Sasakawa Scientific Research, Grant from The Japan Science Society, www.jss.or.jp/ikusei/sasakawa/.	ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; ARAKI K, 1993, BIOCHEM BIOPH RES CO, V197, P1267, DOI 10.1006/bbrc.1993.2614; Attwell PJE, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0003.1999; BRADLEY DJ, 1991, NEUROSCI RES, V12, P45, DOI 10.1016/0168-0102(91)90099-K; Emi K, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00180; Hills LB, 2013, NEUROLOGY, V81, P1378, DOI 10.1212/WNL.0b013e3182a841a3; Hirai H, 2003, NAT NEUROSCI, V6, P869, DOI 10.1038/nn1086; Kakegawa W, 2011, NAT NEUROSCI, V14, P603, DOI 10.1038/nn.2791; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kim J, 2007, P NATL ACAD SCI USA, V104, P20955, DOI 10.1073/pnas.0710548105; Kohda K, 2013, P NATL ACAD SCI USA, V110, pE948, DOI 10.1073/pnas.1218380110; Kotajima H, 2014, NEUROREPORT, V25, P556, DOI 10.1097/WNR.0000000000000135; Maier A, 2014, MUSCLE NERVE, V49, P289, DOI 10.1002/mus.24096; Maschke M, 2002, J NEUROL NEUROSUR PS, V72, P116, DOI 10.1136/jnnp.72.1.116; Matsuda K, 2010, SCIENCE, V328, P363, DOI 10.1126/science.1185152; Matsuda S, 2002, EUR J NEUROSCI, V16, P1507, DOI 10.1046/j.1460-9568.2002.02219.x; Motohashi J, 2007, BRAIN RES, V1140, P153, DOI 10.1016/j.brainres.2006.03.068; Nisimaru N, 2004, JPN J PHYSIOL, V54, P431, DOI 10.2170/jjphysiol.54.431; NISIMARU N, 1984, JPN J PHYSIOL, V34, P539, DOI 10.2170/jjphysiol.34.539; Sacchetti B, 2005, NEUROSCIENTIST, V11, P217, DOI 10.1177/1073858405276428; Sacchetti B, 2004, NEURON, V42, P973, DOI 10.1016/j.neuron.2004.05.012; Sacchetti B, 2007, EUR J NEUROSCI, V25, P2875, DOI 10.1111/j.1460-9568.2007.05508.x; Schonewille M, 2010, NEURON, V67, P618, DOI 10.1016/j.neuron.2010.07.009; Schonewille M, 2011, NEURON, V70, P43, DOI 10.1016/j.neuron.2011.02.044; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; SUPPLE WF, 1993, NEUROREPORT, V4, P975, DOI 10.1097/00001756-199307000-00035; SUPPLE WF, 1993, J NEUROSCI, V13, P3705; SUPPLE WF, 1990, BRAIN RES, V509, P17, DOI 10.1016/0006-8993(90)90303-S; Takayama C, 1996, DEV BRAIN RES, V92, P147, DOI 10.1016/0165-3806(95)00212-X; Takeuchi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047553; Thompson RF, 2009, NEUROSCIENCE, V162, P732, DOI 10.1016/j.neuroscience.2009.01.041; Utine GE, 2013, J CHILD NEUROL, V28, P926, DOI 10.1177/0883073813484967; Yoshida M, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-52; Yuzaki M, 2013, NEURAL NETWORKS, V47, P36, DOI 10.1016/j.neunet.2012.07.001	34	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166144	10.1371/journal.pone.0166144	http://dx.doi.org/10.1371/journal.pone.0166144			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820843	Green Published, Green Submitted, gold			2022-12-26	WOS:000387614800035
J	LoMauro, A; Aliverti, A; Mastella, C; Arnoldi, MT; Banfi, P; Baranello, G				LoMauro, A.; Aliverti, A.; Mastella, C.; Arnoldi, M. T.; Banfi, P.; Baranello, G.			Spontaneous Breathing Pattern as Respiratory Functional Outcome in Children with Spinal Muscular Atrophy (SMA)	PLOS ONE			English	Article							LUNG-FUNCTION; PULMONARY-FUNCTION; REFERENCE VALUES; MUSCLE ATROPHY; VENTILATION; TRIAL; PLETHYSMOGRAPHY; SALBUTAMOL; SPIROMETRY; SCOLIOSIS	Introduction SMA is characterised by progressive motor and respiratory muscle weakness. We aimed to verify if in SMA children 1) each form is characterized by specific ventilatory and thoracoabdominal pattern(VTAp) during quiet breathing(QB); 2) VTAp is affected by salbutamol therapy, currently suggested as standard treatment, or by the natural history(NH) of SMA; 3) the severity of global motor impairment linearly correlates with VTAp. Materials and methods VTAp was analysed on 32 SMA type I (SMA1, the most severe form), 51 type II (SMA2, the moderate), 8 type III (SMA3, the mildest) and 20 healthy (HC) using opto-electronic plethysmography. Spirometry, cough and motor function were measured in a subgroup of patients. Results In SMA1, a normal ventilation is obtained in supine position by rapid and shallow breathing with paradoxical ribcage motion. In SMA2, ventilation is within a normal range in seated position due to an increased respiratory rate(p<0.05) with reduced tidal volume(p<0.05) secondary to a poor contribution of pulmonary ribcage(%Delta V-RC,(P), p<0.001). Salbutamol therapy had no effect on VTAp during QB(p>0.05) while tachypnea occurred in type I NH. A linear correlation(p<0.001) was found between motor function scales and VTAp. Conclusion A negative or reduced %Delta V-RC,V- P,V- indicative of ribcage muscle weakness, is a distinctive feature of SMA1 and SMA2 since infancy. Its quantitative assessment represents a non-invasive, non-volitional index that can be obtained in all children, even uncollaborative, and provides useful information on the action of ribcage muscles that are known to be affected by the disease. Low values of motor function scales indicate impairment of motor but also of respiratory function.	[LoMauro, A.; Aliverti, A.] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Milan, Italy; [Mastella, C.] Osped Policlin Maggiore Mangiagalli, SAPRE, Milan, Italy; [Mastella, C.] Regina Elena Fdn, Milan, Italy; [Arnoldi, M. T.; Baranello, G.] Carlo Besta Neurol Res Inst Fdn, Dev Neurol Unit, Milan, Italy; [Banfi, P.] Pulm Rehabil Fdn Don Carlo Gnocchi, Milan, Italy	Polytechnic University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico	LoMauro, A (corresponding author), Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Milan, Italy.	antonella.lomauro@polimi.it	Arnoldi, Maria Teresa/AAJ-2217-2021; Andrea, Aliverti/A-3901-2015	Arnoldi, Maria Teresa/0000-0002-3920-5869; Andrea, Aliverti/0000-0002-2950-0231; LoMauro, Antonella/0000-0002-1408-6971	Associazione Famiglie SMA ONLUS	Associazione Famiglie SMA ONLUS	The consumables of the study (markers and ipoallergenic adhesive tapes to fix the markers to the skin) were supported by Associazione Famiglie SMA ONLUS. There was no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliverti A, 2001, ANN BIOMED ENG, V29, P60, DOI 10.1114/1.1332084; Bach JR, 2012, AM J PHYS MED REHAB, V91, P487, DOI 10.1097/PHM.0b013e31824fa5dd; Bach JR, 2008, PAEDIATR RESPIR REV, V9, P45, DOI 10.1016/j.prrv.2007.11.003; Bach JR, 2007, AM J PHYS MED REHAB, V86, P339, DOI 10.1097/PHM.0b013e31804a8505; Bach JR, 1996, CHEST, V110, P1566, DOI 10.1378/chest.110.6.1566; BERMAN S, 1991, ARCH DIS CHILD, V66, P81, DOI 10.1136/adc.66.1.81; Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST; Bianchi C, 2008, AM J PHYS MED REHAB, V87, P461, DOI 10.1097/PHM.0b013e318174e4c7; Bushby K, 2004, Neuromuscul Disord, V14, P526, DOI 10.1016/j.nmd.2004.05.006; Cala SJ, 1996, J APPL PHYSIOL, V81, P2680, DOI 10.1152/jappl.1996.81.6.2680; Chng SY, 2003, J PAEDIATR CHILD H, V39, P673, DOI 10.1046/j.1440-1754.2003.00266.x; Darras BT, 2015, PEDIATR CLIN N AM, V62, P743, DOI 10.1016/j.pcl.2015.03.010; De Troyer A, 2005, PHYSIOL REV, V85, P717, DOI 10.1152/physrev.00007.2004; De Troyer A, 2012, J APPL PHYSIOL, V112, P529, DOI 10.1152/japplphysiol.01067.2011; Dellaca RL, 2010, PEDIATR RES, V67, P11, DOI 10.1203/PDR.0b013e3181c0b184; DETROYER A, 1985, J CLIN INVEST, V75, P850, DOI 10.1172/JCI111782; DUBOWITZ V, 1995, NEUROMUSCULAR DISORD, V5, P3, DOI 10.1016/0960-8966(94)00075-K; Dubowitz V, 2009, NEUROMUSCULAR DISORD, V19, P69, DOI 10.1016/j.nmd.2008.10.004; Fauroux B, 2008, CHEST, V133, P161, DOI 10.1378/chest.07-1615; Fauroux B, 2015, CHEST, V147, P552, DOI 10.1378/chest.14-0819; Finkel R, 2015, NEUROMUSCULAR DISORD, V25, P593, DOI 10.1016/j.nmd.2015.04.009; Finkel RS, 2014, PEDIATR PULM, V49, P1234, DOI 10.1002/ppul.22997; Fujak A, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-283; GAULTIER C, 1981, RESP PHYSIOL, V46, P71, DOI 10.1016/0034-5687(81)90069-4; Glanzman AM, 2010, NEUROMUSCULAR DISORD, V20, P155, DOI 10.1016/j.nmd.2009.11.014; Glanzman AM, 2011, PEDIATR PHYS THER, V23, P322, DOI 10.1097/PEP.0b013e3182351f04; Gormley MC, 2014, J NEUROSCI NURS, V46, pE33, DOI 10.1097/JNN.0000000000000080; Ioos C, 2004, CHEST, V126, P831, DOI 10.1378/chest.126.3.831; Kaufmann P, 2011, ARCH NEUROL-CHICAGO, V68, P779, DOI 10.1001/archneurol.2010.373; Khirani S, 2013, EUR J PAEDIATR NEURO, V17, P552, DOI 10.1016/j.ejpn.2013.04.004; Kinali M, 2002, NEUROLOGY, V59, P609, DOI 10.1212/WNL.59.4.609; KUZUHARA S, 1981, ANN NEUROL, V9, P506, DOI 10.1002/ana.410090515; Leduc D, 2013, J APPL PHYSIOL, V114, P941, DOI 10.1152/japplphysiol.01392.2012; Lewelt A, 2012, CURR NEUROL NEUROSCI, V12, P42, DOI 10.1007/s11910-011-0240-9; Lissoni A, 1996, AM J PHYS MED REHAB, V75, P332, DOI 10.1097/00002060-199609000-00005; LoMauro A, 2014, RESP PHYSIOL NEUROBI, V197, P1, DOI 10.1016/j.resp.2014.03.001; LUMB AB, 1991, ANESTH ANALG, V73, P422; MACKLEM PT, 1980, CHEST, V78, P753, DOI 10.1378/chest.78.5.753; Mayer OH, 2003, CHEST, V124, P1812, DOI 10.1378/chest.124.5.1812; Mazzone E, 2011, NEUROMUSCULAR DISORD, V21, P406, DOI 10.1016/j.nmd.2011.02.014; Mercuri E, 2016, NEUROMUSCULAR DISORD, V26, P126, DOI 10.1016/j.nmd.2015.10.006; Mercuri E, 2012, NEUROMUSCULAR DISORD, V22, P1105, DOI [10.1016/j.nmd.2012.11.001, 10.1016/j.nmd.2012.06.006]; Miske LJ, 2004, CHEST, V125, P1406, DOI 10.1378/chest.125.4.1406; Nicot F, 2006, AM J RESP CRIT CARE, V174, P67, DOI 10.1164/rccm.200512-1841OC; Nugent JK, 2016, PEDIAT NURS, V7, P18; Nugent JK, 2016, PEDIAT NURS, V7, P18; Numa AH, 1996, J APPL PHYSIOL, V80, P1485, DOI 10.1152/jappl.1996.80.5.1485; Ogino S, 2004, EUR J HUM GENET, V12, P1015, DOI 10.1038/sj.ejhg.5201288; Ogino S, 2002, HUM GENET, V111, P477, DOI 10.1007/s00439-002-0828-x; Pane M, 2008, NEUROMUSCULAR DISORD, V18, P536, DOI 10.1016/j.nmd.2008.05.004; Perez A, 1996, CHEST, V110, P454, DOI 10.1378/chest.110.2.454; Petrone A, 2007, AM J PHYS MED REHAB, V86, P216, DOI 10.1097/PHM.0b013e31802ef774; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Quanjer PH, 2012, EUR RESPIR J, V40, P190, DOI 10.1183/09031936.00161011; Reinaux CMA, 2016, PEDIAT PULMONOL; Romei M, 2010, RESP PHYSIOL NEUROBI, V172, P184, DOI 10.1016/j.resp.2010.05.018; RUSCONI F, 1994, PEDIATRICS, V94, P350; Sansone VA, 2015, NEUROMUSCUL DISORD; Schroth MK, 2009, PEDIATRICS, V123, pS245, DOI 10.1542/peds.2008-2952K; SIMOES EAF, 1991, ARCH DIS CHILD, V66, P1199, DOI 10.1136/adc.66.10.1199; Takazakura R, 2004, J MAGN RESON IMAGING, V19, P605, DOI 10.1002/jmri.20051; Tangsrud SE, 2001, ARCH DIS CHILD, V84, P521, DOI 10.1136/adc.84.6.521; Tiziano FD, 2010, J MED GENET, V47, P856, DOI 10.1136/jmg.2010.080366; Van Meerbeke JP, 2011, DISCOV MED, V12, P291; Vieira DSR, 2013, RESP PHYSIOL NEUROBI, V189, P473, DOI 10.1016/j.resp.2013.08.023; Wang CH, 2007, J CHILD NEUROL, V22, P1027, DOI 10.1177/0883073807305788	66	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165818	10.1371/journal.pone.0165818	http://dx.doi.org/10.1371/journal.pone.0165818			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820869	Green Published, Green Submitted, gold			2022-12-26	WOS:000387614800022
J	An, HQ; Zhu, QK; Pei, W; Fan, J; Liang, Y; Cui, YH; Lv, N; Wang, WJ				An, Hongqiang; Zhu, Qiankun; Pei, Wei; Fan, Jing; Liang, Yi; Cui, Yihui; Lv, Nan; Wang, Wanjun			Whole-Transcriptome Selection and Evaluation of Internal Reference Genes for Expression Analysis in Protocorm Development of Dendrobium officinale Kimura et Migo	PLOS ONE			English	Article							TIME RT-PCR; POLYMERASE CHAIN-REACTION; MESSENGER-RNA LEVELS; BETA-ACTIN; HOUSEKEEPING GENES; QUANTITATIVE PCR; ABIOTIC STRESS; SEED MASS; NORMALIZATION; ARABIDOPSIS	Dendrobium officinale Kimu et Migo has increased many researchers' interest for its high medical and horticultural values and the molecular mechanism of its protocorm development remains unclear. In this study, 19 genes from 26 most stably expressed genes in whole transcriptome of protocorms and 5 housekeeping genes were used as candidate reference genes and screened with 4 application softwares (geNorm, NormFinder, BestKeeper and RefFinder). The results showed that a few reference genes could effectively normalize expression level of specific genes in protocorm development and the optimal top 2 reference genes were ASS and APH1L. Meanwhile, validation of GNOM, AP2 and temperature induced gene (TIL) for normalization demonstrates the usefulness of the validated candidate reference genes. The expression profiles of these genes varied under protocorms and temperature stress according to the stablest and unstablest reference genes, which proved the importance of the choice of appropriate reference genes. The first systematic evaluation of stably expressed genes will be very useful in the future analysis of specific genes expression in D. officinale.	[An, Hongqiang; Zhu, Qiankun; Pei, Wei; Fan, Jing; Liang, Yi; Cui, Yihui; Lv, Nan; Wang, Wanjun] Southwest Jiaotong Univ, Sch Life Sci & Engn, Chengdu 610031, Peoples R China	Southwest Jiaotong University	Wang, WJ (corresponding author), Southwest Jiaotong Univ, Sch Life Sci & Engn, Chengdu 610031, Peoples R China.	wanjunwang@home.swjtu.edu.cn		Zhu, Qiankun/0000-0003-4727-8969	National Natural Science Foundation of China [31371232]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Grant (NO. 31371232) from National Natural Science Foundation of China, the urls was(https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list). WW achieved the funding for the study of "Molecular Mechanisms with Specific NAC Family Genes on Promeristem of Protocorm in Dendrobium candidum Wall ex Lindl." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Goidin D, 2001, ANAL BIOCHEM, V295, P17, DOI 10.1006/abio.2001.5171; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Han X, 2012, PLOS ONE, V7; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jofuku KD, 2005, P NATL ACAD SCI USA, V102, P3117, DOI 10.1073/pnas.0409893102; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; Kim S, 2006, MOL BIOL EVOL, V23, P107, DOI 10.1093/molbev/msj014; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Li QF, 2010, PLANT MOL BIOL REP, V28, P49, DOI 10.1007/s11105-009-0124-1; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Ohto M, 2005, P NATL ACAD SCI USA, V102, P3123, DOI 10.1073/pnas.0409858102; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Provenzano M, 2005, EUREKAH BIOSCIENCE, V1, P510; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; RICHARDSON KA, 1992, CAN J BOT, V70, P291, DOI 10.1139/b92-040; Riechmann JL, 1998, BIOL CHEM, V379, P633; Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376; SHEVELL DE, 1994, CELL, V77, P1051, DOI 10.1016/0092-8674(94)90444-8; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xi GangJun, 2012, Medicinal Plant, V3, P67; Xie F., 2012, PLANT MOL BIOL; Xu Huaisheng, 2015, BMC Res Notes, V8, P58, DOI 10.1186/s13104-015-0973-7; Yan L, 2015, MOL PLANT, V8, P922, DOI 10.1016/j.molp.2014.12.011; Yan X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104124; Zelmer Carla D., 1996, Mycoscience, V37, P439, DOI 10.1007/BF02461001; Zhao P, 2008, IN VITRO CELL DEV-PL, V44, P178, DOI 10.1007/s11627-007-9101-2; Zhao P, 2011, PLANT CELL TISS ORG, V107, P151, DOI 10.1007/s11240-011-9968-9	44	12	15	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0163478	10.1371/journal.pone.0163478	http://dx.doi.org/10.1371/journal.pone.0163478			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814359	Green Submitted, Green Published, gold			2022-12-26	WOS:000386911100003
J	Ianniello, RG; Zotta, T; Matera, A; Genovese, F; Parente, E; Ricciardi, A				Ianniello, Rocco G.; Zotta, Teresa; Matera, Attilio; Genovese, Francesco; Parente, Eugenio; Ricciardi, Annamaria			Investigation of Factors Affecting Aerobic and Respiratory Growth in the Oxygen-Tolerant Strain Lactobacillus casei N87	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; CYTOCHROME BD OXIDASE; LACTOCOCCUS-LACTIS; OXIDATIVE STRESS; ELECTRON-TRANSPORT; PLANTARUM WCFS1; PYRUVATE OXIDASE; METABOLISM; AERATION; SURVIVAL	Aerobic and respiratory cultivations provide benefits for some lactic acid bacteria (LAB). Growth, metabolites, enzymatic activities (lactate dehydrogenase; pyruvate and NADH oxidases, NADH peroxidase; catalase), antioxidant capability and stress tolerance of Lactobacillus casei N87 were evaluated in anaerobic, aerobic and respiratory (aerobiosis with heme and menaquinone supplementation) batch cultivations with different dissolved oxygen (DO) concentrations. The expression of pox (pyruvate oxidase) and cydABCD operon (cytochrome bd oxidase complex) was quantified by quantitative Real Time polymerase chain reaction. Respiration increased biomass production compared to anaerobiosis and unsupplemented aerobiosis, and altered the central metabolism rerouting pyruvate away from lactate accumulation. All enzymatic activities, except lactate dehydrogenase, were higher in respiratory cultures, while unsupplemented aerobiosis with 60% of DO promoted H2O2 and free radical accumulation. Respiration improved the survival to oxidative and freeze-drying stresses, while significant numbers of dead, damaged and viable but not cultivable cells were found in unsupplemented aerobic cultures (60% DO). Analysis of gene expression suggested that the activation of aerobic and respiratory pathways occurred during the exponential growth phase, and that O-2 and hemin induced, respectively, the transcription of pox and cydABCD genes. Respiratory cultivation might be a natural strategy to improve functional and technological properties of L. casei.	[Ianniello, Rocco G.; Matera, Attilio; Genovese, Francesco; Ricciardi, Annamaria] Univ Basilicata, Scuola Sci Agr Forestali Alimentari & Ambientali, Potenza, Italy; [Zotta, Teresa] CNR, Ist Sci Alimentaz, Avellino, Italy; [Parente, Eugenio] Univ Basilicata, Dipartimento Sci, Potenza, Italy	University of Basilicata; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); University of Basilicata	Zotta, T (corresponding author), CNR, Ist Sci Alimentaz, Avellino, Italy.	teresa.zotta@isa.cnr.it	GENOVESE, FRANCESCO/AAB-7694-2020; Matera, Attilio/GOK-0930-2022; Parente, Eugenio/B-3809-2014	GENOVESE, FRANCESCO/0000-0002-9326-1183; Matera, Attilio/0000-0003-4372-1564; Parente, Eugenio/0000-0002-5716-2348; Zotta, Teresa/0000-0001-8228-6804	Ministero dell'Istruzione, dell'Universita e della Ricerca, Rome, Italy, FIRB [RBFR107VML]	Ministero dell'Istruzione, dell'Universita e della Ricerca, Rome, Italy, FIRB	This work was funded by Ministero dell'Istruzione, dell'Universita e della Ricerca, Rome, Italy, FIRB n. RBFR107VML.	Arioli S, 2013, APPL ENVIRON MICROB, V79, P376, DOI 10.1128/AEM.02734-12; BARANYI J, 1994, INT J FOOD MICROBIOL, V23, P277, DOI 10.1016/0168-1605(94)90157-0; BARANYI J., 1996, DMFIT MANUAL VERSION; Borisov VB, 2013, FEBS LETT, V587, P2214, DOI 10.1016/j.febslet.2013.05.047; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Brooijmans RJW, 2007, J BACTERIOL, V189, P5203, DOI 10.1128/JB.00361-07; Brooijmans RJW, 2009, APPL ENVIRON MICROB, V75, P3580, DOI 10.1128/AEM.00147-09; Brooijmans R, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-28; Cesselin B., 2010, JPN J LACT ACID BACT, V21, P10, DOI [10.4109/jslab.21.10, DOI 10.4109/JSLAB.21.10]; de Felipe FL, 2009, APPL MICROBIOL BIOT, V82, P1115, DOI 10.1007/s00253-009-1897-8; Duwat P, 2001, J BACTERIOL, V183, P4509, DOI 10.1128/JB.183.15.4509-4516.2001; Forte E, 2016, SCI REP-UK, V6, DOI 10.1038/srep23788; Giuffre A, 2012, FEBS LETT, V586, P622, DOI 10.1016/j.febslet.2011.07.035; Goffin P, 2006, APPL ENVIRON MICROB, V72, P7933, DOI 10.1128/AEM.00659-06; Guidone A, 2013, WORLD J MICROB BIOT, V29, P1713, DOI 10.1007/s11274-013-1334-0; Iacumin L, 2015, FOOD MICROBIOL, V46, P357, DOI 10.1016/j.fm.2014.08.007; Ianniello RG, 2015, J APPL MICROBIOL, V119, P763, DOI 10.1111/jam.12853; Ianniello RG, 2015, LWT-FOOD SCI TECHNOL, V60, P817, DOI 10.1016/j.lwt.2014.10.020; Lechardeur D, 2011, CURR OPIN BIOTECH, V22, P143, DOI 10.1016/j.copbio.2010.12.001; Lorquet F, 2004, J BACTERIOL, V186, P3749, DOI 10.1128/JB.186.12.3749-3759.2004; Pedersen MB, 2012, ANNU REV FOOD SCI T, V3, P37, DOI 10.1146/annurev-food-022811-101255; Pedersen MB, 2005, FEMS MICROBIOL REV, V29, P611, DOI 10.1016/j.femsre.2005.04.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puri-Taneja A, 2007, J BACTERIOL, V189, P3348, DOI 10.1128/JB.00050-07; Quatravaux S, 2006, J APPL MICROBIOL, V101, P903, DOI 10.1111/j.1365-2672.2006.02955.x; Rezaiki L, 2004, MOL MICROBIOL, V53, P1331, DOI 10.1111/j.1365-2958.2004.04217.x; Ricciardi A, 2015, ANN MICROBIOL, V65, P1639, DOI 10.1007/s13213-014-1003-z; Ricciardi A, 2014, ANN MICROBIOL, V64, P1861, DOI 10.1007/s13213-014-0819-x; Stevens MJA, 2008, APPL ENVIRON MICROB, V74, P4776, DOI 10.1128/AEM.00136-08; Wang AN, 2009, J APPL MICROBIOL, V107, P1140, DOI 10.1111/j.1365-2672.2009.04294.x; Watanabe M, 2012, MICROBIOL-SGM, V158, P293, DOI 10.1099/mic.0.051250-0; Zotta T, 2014, J APPL MICROBIOL, V116, P632, DOI 10.1111/jam.12398; Zotta T, 2013, J APPL MICROBIOL, V115, P848, DOI 10.1111/jam.12285; Zotta T, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00348-16; Zotta T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099189; Zotta T, 2012, INT J FOOD MICROBIOL, V155, P51, DOI 10.1016/j.ijfoodmicro.2012.01.017	36	27	29	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164065	10.1371/journal.pone.0164065	http://dx.doi.org/10.1371/journal.pone.0164065			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812097	Green Published, gold, Green Submitted			2022-12-26	WOS:000386910000006
J	Kyeremeh, IA; Charles, CJ; Rout, SP; Laws, AP; Humphreys, PN				Kyeremeh, Isaac A.; Charles, Christopher J.; Rout, Simon P.; Laws, Andrew P.; Humphreys, Paul N.			Microbial Community Evolution Is Significantly Impacted by the Use of Calcium Isosaccharinic Acid as an Analogue for the Products of Alkaline Cellulose Degradation	PLOS ONE			English	Article							SP-NOV.; RNA; ACINETOBACTER; ENVIRONMENTS; BACTERIA; SLUDGE	Diasteriomeric isosaccharinic acid (ISA) is an important consideration within safety assessments for the disposal of the United Kingdoms' nuclear waste legacy, where it may potentially influence radionuclide migration. Since the intrusion of micro-organisms may occur within a disposal concept, the impact of ISA may be impacted by microbial metabolism. Within the present study we have established two polymicrobial consortia derived from a hyperalkaline soil. Here, alpha-ISA and a diatereomeric mix of ISAs' were used as a sole carbon source, reflecting two common substrates appearing within the literature. The metabolism of ISA within these two consortia was similar, where ISA degradation resulted in the acetogenesis and hydrogenotrophic methanogenesis. The chemical data obtained confirm that the diastereomeric nature of ISA is likely to have no impact on its metabolism within alkaline environments. High throughput sequencing of the original soil showed a diverse community which, in the presence of ISA allowed for the dominance the Clostridiales associated taxa with Clostridium clariflavum prevalent. Further taxonomic investigation at the genus level showed that there was in fact a significant difference (p = 0.004) between the two community profiles. Our study demonstrates that the selection of carbon substrate is likely to have a significant impact on microbial community composition estimations, which may have implications with respect to a safety assessment of an ILW-GDF.	[Kyeremeh, Isaac A.; Charles, Christopher J.; Rout, Simon P.; Laws, Andrew P.; Humphreys, Paul N.] Univ Huddersfield, Dept Biol, Sch Appl Sci, Huddersfield, W Yorkshire, England	University of Huddersfield	Humphreys, PN (corresponding author), Univ Huddersfield, Dept Biol, Sch Appl Sci, Huddersfield, W Yorkshire, England.	p.n.humphreys@hud.ac.uk		Rout, Simon/0000-0001-5778-6145; Humphreys, Paul/0000-0003-3431-7930				B.S.I, 2005, 148532005 BSIISO; Bassil NM, 2015, ISME J, V9, P310, DOI 10.1038/ismej.2014.125; BM W, 1963, METHODS CARBOHYDRATE, V2; Burke IT, 2012, GEOMICROBIOL J, V29, P769, DOI 10.1080/01490451.2011.619638; Charles CJ, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv085; Cowper M, SERCO CONTRACTORS RE; DEINEMA MH, 1985, WATER SCI TECHNOL, V17, P119, DOI 10.2166/wst.1985.0226; Doulgeris C, 2015, MINERALOGIC IN PRESS; FARROW JAE, 1995, INT J SYST BACTERIOL, V45, P436, DOI 10.1099/00207713-45-3-436; Glaus MA, 1999, ANAL CHIM ACTA, V398, P111, DOI 10.1016/S0003-2670(99)00371-2; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Hattori S, 2008, MICROBES ENVIRON, V23, P118, DOI 10.1264/jsme2.23.118; Izquierdo JA, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0136-4; Jung JY, 2011, APPL ENVIRON MICROB, V77, P2264, DOI 10.1128/AEM.02157-10; Kato S, 2004, INT J SYST EVOL MICR, V54, P2043, DOI 10.1099/ijs.0.63148-0; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Knill CJ, 2003, CARBOHYD POLYM, V51, P281, DOI 10.1016/S0144-8617(02)00183-2; Kuippers G, 2015, MINERAL MAG, V79, P1443, DOI 10.1180/minmag.2015.079.6.19; Lawson PA, 2004, INT J SYST EVOL MICR, V54, P413, DOI 10.1099/ijs.0.02653-0; LOTTER LH, 1986, WATER SA, V12, P203; NDA, 2010, GAS STAT REP NUCL DE; NDA, 2010, NEAR FIELD EV STAT R; Oksanen J., 2007, COMMUNITY ECOL PACKA, V10; Racine JS, 2012, J APPL ECONOMET, V27, P167, DOI 10.1002/jae.1278; Randall M, 2013, ASSESSMENT EFFECTS C; Rout SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107433; Rout SP, 2015, PLOS ONE, V10; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shiratori H, 2009, INT J SYST EVOL MICR, V59, P1764, DOI 10.1099/ijs.0.003483-0; Singleton DR, 2001, APPL ENVIRON MICROB, V67, P4374, DOI 10.1128/AEM.67.9.4374-4376.2001; Van Dyke MI, 2002, APPL ENVIRON MICROB, V68, P2049, DOI 10.1128/AEM.68.4.2049-2053.2002; Vercammen K, 2001, RADIOCHIM ACTA, V89, P393, DOI 10.1524/ract.2001.89.6.393; WORAKIT S, 1986, INT J SYST BACTERIOL, V36, P380, DOI 10.1099/00207713-36-3-380	34	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165832	10.1371/journal.pone.0165832	http://dx.doi.org/10.1371/journal.pone.0165832			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806095	Green Published, Green Submitted, gold			2022-12-26	WOS:000386715500059
J	Natisvili, T; Yandim, C; Silva, R; Emanuelli, G; Krueger, F; Nageshwaran, S; Festenstein, R				Natisvili, Theona; Yandim, Cihangir; Silva, Raquel; Emanuelli, Giulia; Krueger, Felix; Nageshwaran, Sathiji; Festenstein, Richard			Transcriptional Activation of Pericentromeric Satellite Repeats and Disruption of Centromeric Clustering upon Proteasome Inhibition	PLOS ONE			English	Article							RNA-POLYMERASE-II; STRESS-INDUCED TRANSCRIPTION; HEAT-SHOCK RESPONSE; CELL-CYCLE; HISTONE H3; HETEROCHROMATIN FORMATION; PROTEIN-DEGRADATION; 26S PROTEASOME; HUMAN GENOME; CHROMATIN MODIFICATIONS	Heterochromatinisation of pericentromeres, which in mice consist of arrays of major satellite repeats, are important for centromere formation and maintenance of genome stability. The dysregulation of this process has been linked to genomic stress and various cancers. Here we show in mice that the proteasome binds to major satellite repeats and proteasome inhibition by MG132 results in their transcriptional de-repression; this de-repression is independent of cell-cycle perturbation. The transcriptional activation of major satellite repeats upon proteasome inhibition is accompanied by delocalisation of heterochromatin protein 1 alpha ( HP1 alpha) from chromocentres, without detectable change in the levels of histone H3K9me3, H3K4me3, H3K36me3 and H3 acetylation on the major satellite repeats. Moreover, inhibition of the proteasome was found to increase the number of chromocentres per cell, reflecting destabilisation of the chromocentre structures. Our findings suggest that the proteasome plays a role in maintaining heterochromatin integrity of pericentromeres.	[Natisvili, Theona; Yandim, Cihangir; Silva, Raquel; Emanuelli, Giulia; Nageshwaran, Sathiji; Festenstein, Richard] Imperial Coll London, Hammersmith Hosp, Gene Control Mech & Dis Grp, Dept Med,Div Brain Sci, London, England; [Natisvili, Theona; Yandim, Cihangir; Silva, Raquel; Emanuelli, Giulia; Nageshwaran, Sathiji; Festenstein, Richard] Imperial Coll London, Hammersmith Hosp, MRC Clin Sci Ctr, London, England; [Krueger, Felix] Babraham Inst, Bioinformat Grp, Cambridge, England; [Yandim, Cihangir] Inst Canc Res, 15 Cotswold Rd, London, England; [Silva, Raquel] UCL, Inst Ophthalmol, 11-43 Bath St, London, England; [Emanuelli, Giulia] Kings Coll London, James Black Ctr, Cardiovasc Div, Denmark Hill Campus, London, England	Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; University College London; University of London; King's College London	Festenstein, R (corresponding author), Imperial Coll London, Hammersmith Hosp, Gene Control Mech & Dis Grp, Dept Med,Div Brain Sci, London, England.; Festenstein, R (corresponding author), Imperial Coll London, Hammersmith Hosp, MRC Clin Sci Ctr, London, England.	r.festenstein@imperial.ac.uk	Krueger, Felix/J-3340-2019; YANDIM, Cihangir/AAA-2250-2021	YANDIM, Cihangir/0000-0002-2050-6186; Silva, Raquel/0000-0002-1455-3082; Emanuelli, Giulia/0000-0001-8899-6110; Krueger, Felix/0000-0002-5513-3324	MRC (UK) Wellcome Trust Fellowship [48935]; Biotechnology and Biological Sciences Research Council [BB/M003760/1] Funding Source: researchfish; Medical Research Council [MC_U120081321, MR/J007943/1] Funding Source: researchfish; BBSRC [BB/M003760/1] Funding Source: UKRI; MRC [MC_U120081321, MR/J007943/1] Funding Source: UKRI	MRC (UK) Wellcome Trust Fellowship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MRC (UK) Wellcome Trust Fellowship 48935. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 1999, CANCER RES, V59, P2615; Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Azzaz AM, 2014, J BIOL CHEM, V289, P6850, DOI 10.1074/jbc.M113.512137; Banfalvi G, 2008, NAT PROTOC, V3, P663, DOI 10.1038/nprot.2008.34; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bonvini P, 2007, LEUKEMIA, V21, P838, DOI 10.1038/sj.leu.2404528; Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Braun S, 2011, CELL, V144, P41, DOI 10.1016/j.cell.2010.11.051; Bulut-Karslioglu A, 2012, NAT STRUCT MOL BIOL, V19, P1023, DOI 10.1038/nsmb.2382; Bush KT, 1997, J BIOL CHEM, V272, P9086; Catic A, 2013, CELL, V155, P1380, DOI 10.1016/j.cell.2013.11.016; Chaves S, 2010, MOL CELL BIOL, V30, P5284, DOI 10.1128/MCB.00952-10; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Dillon N, 2002, TRENDS GENET, V18, P252, DOI 10.1016/S0168-9525(02)02648-3; Enukashvily NI, 2007, CYTOGENET GENOME RES, V118, P42, DOI 10.1159/000106440; Eymery A, 2010, EXP CELL RES, V316, P1845, DOI 10.1016/j.yexcr.2010.02.002; Eymery A, 2009, NUCLEIC ACIDS RES, V37, P6340, DOI 10.1093/nar/gkp639; Fatyol K, 2008, BBA-GENE REGUL MECH, V1779, P850, DOI 10.1016/j.bbagrm.2008.08.010; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Ferdous A, 2007, GENE DEV, V21, P112, DOI 10.1101/gad.1493207; Ferri F, 2009, NUCLEIC ACIDS RES, V37, P5071, DOI 10.1093/nar/gkp529; Geng FQ, 2012, P NATL ACAD SCI USA, V109, P6060, DOI 10.1073/pnas.1200854109; Gillette TG, 2004, P NATL ACAD SCI USA, V101, P5904, DOI 10.1073/pnas.0305411101; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Hassan KMA, 2001, HUM GENET, V109, P452; Javerzat JP, 1999, MOL CELL BIOL, V19, P5155; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jolly C, 2004, J CELL BIOL, V164, P25, DOI 10.1083/jcb.200306104; Jung T, 2013, REDOX BIOL, V1, P178, DOI 10.1016/j.redox.2013.01.004; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Kawazoe Y, 1998, EUR J BIOCHEM, V255, P356, DOI 10.1046/j.1432-1327.1998.2550356.x; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kinyamu HK, 2007, MOL CELL BIOL, V27, P4891, DOI 10.1128/MCB.02162-06; Kitagawa T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4597; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Lee KB, 2002, P NATL ACAD SCI USA, V99, P4239, DOI 10.1073/pnas.072068399; Ling YH, 2003, CLIN CANCER RES, V9, P1145; Lu J, 2007, J CELL BIOL, V179, P411, DOI 10.1083/jcb.200706176; Machiels BM, 1997, CYTOMETRY, V28, P243; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Mateos-Langerak J, 2007, MOL BIOL CELL, V18, P1464, DOI 10.1091/mbc.E06-01-0025; Mathew A, 1998, MOL CELL BIOL, V18, P5091, DOI 10.1128/MCB.18.9.5091; Mengual E, 1996, J NEUROSCI, V16, P6331; Metz A, 2004, J CELL SCI, V117, P4551, DOI 10.1242/jcs.01329; Millanes-Romero A, 2013, MOL CELL, V52, P746, DOI 10.1016/j.molcel.2013.10.015; MINIOU P, 1994, HUM MOL GENET, V3, P2093, DOI 10.1093/hmg/3.12.2093; Mosch K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015894; Nalley K, 2006, NATURE, V442, P1054, DOI 10.1038/nature05067; Narayan A, 1998, INT J CANCER, V77, P833, DOI 10.1002/(SICI)1097-0215(19980911)77:6<833::AID-IJC6>3.0.CO;2-V; Nickell S, 2009, P NATL ACAD SCI USA, V106, P11943, DOI 10.1073/pnas.0905081106; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Oliva J, 2009, WORLD J GASTROENTERO, V15, P705, DOI 10.3748/wjg.15.705; PALMER A, 1994, EUR J CELL BIOL, V64, P163; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; PETERS JM, 1994, J BIOL CHEM, V269, P7709; Probst AV, 2010, DEV CELL, V19, P625, DOI 10.1016/j.devcel.2010.09.002; Qu GZ, 1999, MUTAT RES-FUND MOL M, V423, P91, DOI 10.1016/S0027-5107(98)00229-2; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; RIVETT AJ, 1992, J HISTOCHEM CYTOCHEM, V40, P1165, DOI 10.1177/40.8.1619280; Rizzi N, 2004, MOL BIOL CELL, V15, P543, DOI 10.1091/mbc.E03-07-0487; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Saksouk N, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-3; Santenard A, 2010, NAT CELL BIOL, V12, P853, DOI 10.1038/ncb2089; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Sulahian R, 2006, NUCLEIC ACIDS RES, V34, P1351, DOI 10.1093/nar/gkl012; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Valgardsdottir R, 2008, NUCLEIC ACIDS RES, V36, P423, DOI 10.1093/nar/gkm1056; WOJCIK C, 1995, EUR J CELL BIOL, V68, P191; Yuan CM, 2004, CYTOM PART B-CLIN CY, V58B, P47, DOI 10.1002/cyto.b.20000; Zhang HS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004202; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371	83	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165873	10.1371/journal.pone.0165873	http://dx.doi.org/10.1371/journal.pone.0165873			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806100	Green Published, Green Submitted, gold			2022-12-26	WOS:000386715500065
J	Pal, A; Rhoads, DB; Tavakkoli, A				Pal, Atanu; Rhoads, David B.; Tavakkoli, Ali			Effect of Portal Glucose Sensing on Systemic Glucose Levels in SD and ZDF Rats	PLOS ONE			English	Article							HEPATIC NERVES; CONSCIOUS DOG; DELIVERY; SENSOR; METABOLISM; CAPSAICIN; INFUSION; LIVER	Background The global epidemic of Type-2-Diabetes (T2D) highlights the need for novel therapeutic targets and agents. Roux-en-Y-Gastric-Bypass (RYGB) is the most effective treatment. Studies investigating the mechanisms of RYGB suggest a role for post-operative changes in portal glucose levels. We investigate the impact of stimulating portal glucose sensors on systemic glucose levels in health and T2D, and evaluated the role of sodium-glucose-cotransporter-3 (SGLT3) as the possible sensor. Methods Systemic glucose and hormone responses to portal stimulation were measured. In Sprague-Dawley (SD) rats, post-prandial state was simulated by infusing glucose into the portal vein. The SGLT3 agonist, alpha-methyl-glucopyranoside (alpha MG), was then added to further stimulate the portal sensor. To elucidate the neural pathway, vagotomy or portal denervation was followed by alpha MG+glucose co-infusion. The therapeutic potential of portal glucose sensor stimulation was investigated by alpha MG-only infusion (vs. saline) in SD and Zucker Diabetic-Fatty (ZDF) rats. Hepatic mRNA expression was also measured. Results alpha MG+glucose co-infusion reduced peak systemic glucose (vs. glucose alone), and lowered hepatic G6Pase expression. Portal denervation, but not vagotomy, abolished this effect. alpha MG-only infusion lowered systemic glucose levels. This glucose-lowering effect was more pronounced in ZDF rats, where portal alpha MG infusion increased insulin, C-peptide and GIP levels compared to saline infusions. Conclusions The portal vein is capable of sensing its glucose levels, and responds by altering hepatic glucose handling. The enhanced effect in T2D, mediated through increased GIP and insulin, highlights a therapeutic target that could be amenable to pharmacological modulation or minimally-invasive surgery.	[Pal, Atanu; Tavakkoli, Ali] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA; [Pal, Atanu; Rhoads, David B.; Tavakkoli, Ali] Harvard Med Sch, 25 Shattuck St, Boston, MA 02115 USA; [Rhoads, David B.] MassGen Hosp Children, Pediat Endocrine Unit, 55 Fruit St, Boston, MA 02114 USA; [Tavakkoli, Ali] Brigham & Womens Hosp, Ctr Weight Management & Metab Surg, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Tavakkoli, A (corresponding author), Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA.; Tavakkoli, A (corresponding author), Harvard Med Sch, 25 Shattuck St, Boston, MA 02115 USA.; Tavakkoli, A (corresponding author), Brigham & Womens Hosp, Ctr Weight Management & Metab Surg, 75 Francis St, Boston, MA 02115 USA.	atavakkoli@partners.org			National Institutes of Health [1 R01 DK084064]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant 1 R01 DK084064 (AT).	ADKINS BA, 1987, J CLIN INVEST, V79, P557, DOI 10.1172/JCI112847; ADKINSMARSHALL B, 1992, AM J PHYSIOL, V262, pE679, DOI 10.1152/ajpendo.1992.262.5.E679; Baird JP, 1997, AM J PHYSIOL-REG I, V272, pR1454, DOI 10.1152/ajpregu.1997.272.5.R1454; Berthoud HR, 2004, ANAT REC PART A, V280A, P827, DOI 10.1002/ar.a.20088; Boubaker J, 2012, J NEUROENDOCRINOL, V24, P1096, DOI 10.1111/j.1365-2826.2012.02326.x; Burcelin R, 2000, DIABETES, V49, P1635, DOI 10.2337/diabetes.49.10.1635; Burcelin R, 2000, DIABETES, V49, P1643, DOI 10.2337/diabetes.49.10.1643; Chan OW, 2014, DIABETES, V63, P2617, DOI 10.2337/db14-0755; Coate KC, 2013, DIABETES, V62, P392, DOI 10.2337/db12-0417; Delaere F, 2013, MOL METAB, V2, P47, DOI 10.1016/j.molmet.2012.11.003; DiCostanzo CA, 2007, METABOLISM, V56, P814, DOI 10.1016/j.metabol.2007.01.012; Diez-Sampedro A, 2003, P NATL ACAD SCI USA, V100, P11753, DOI 10.1073/pnas.1733027100; Diez-Sampedro A, 2001, AM J PHYSIOL-RENAL, V280, pF278, DOI 10.1152/ajprenal.2001.280.2.F278; Holzer P, 1998, AM J PHYSIOL-GASTR L, V275, pG8, DOI 10.1152/ajpgi.1998.275.1.G8; IMAMURA M, 1984, TOHOKU J EXP MED, V143, P335, DOI 10.1620/tjem.143.335; Johansen SL, 2015, AUTON NEUROSCI-BASIC, V193, P51, DOI 10.1016/j.autneu.2015.07.002; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; McCrate F, 2010, CAN FAM PHYSICIAN, V56, pE13; PAGLIASSOTTI MJ, 1992, DIABETES, V41, P1247, DOI 10.2337/diabetes.41.10.1247; Pal A, 2015, DIABETES; Saeidi N, 2013, SCIENCE, V341, P406, DOI 10.1126/science.1235103; Shiota Masakazu, 2012, Methods Mol Biol, V933, P103, DOI 10.1007/978-1-62703-068-7_8; Stearns AT, 2012, DIGEST DIS SCI, V57, P1281, DOI 10.1007/s10620-011-1968-4; Stearns AT, 2008, AM J PHYSIOL-GASTR L, V294, pG1078, DOI 10.1152/ajpgi.00591.2007; Tanaka Tadashi, 2005, J Anesth, V19, P277, DOI 10.1007/s00540-005-0341-1	25	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165592	10.1371/journal.pone.0165592	http://dx.doi.org/10.1371/journal.pone.0165592			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806092	Green Published, gold, Green Submitted			2022-12-26	WOS:000386715500039
J	Park, HR; Lee, JM; Kim, JW; Han, JH; Chung, HT; Han, MH; Kim, DG; Paek, SH				Park, Hye Ran; Lee, Jae Meen; Kim, Jin Wook; Han, Jung-Ho; Chung, Hyun-Tai; Han, Moon Hee; Kim, Dong Gyu; Paek, Sun Ha			Time-Staged Gamma Knife Stereotactic Radiosurgery for Large Cerebral Arteriovenous Malformations: A Preliminary Report	PLOS ONE			English	Article							NATURAL-HISTORY; GRADING SYSTEM; HEMORRHAGE; MANAGEMENT; OUTCOMES; BRAIN; RISK; COMPLICATIONS; OBLITERATION; THERAPY	Objective We retrospectively analyzed our experience with time-staged gamma knife stereotactic radiosurgery (GKS) in treating large arteriovenous malformation(AVM) s; >= 10 cm(3)). Methods Forty-five patients who underwent time-staged GKS (2-stage, n = 37; 3-stage, n = 8) between March 1998 and December 2011 were included. The mean volume treated was 20.42 +/- 6.29 cm(3) (range, 10.20-38.50 cm(3)). Obliteration rates of AVMs and the associated complications after GKS were evaluated. Results Mean AVM volume (and median marginal dose) at each GKS session in the 37 patients who underwent 2-stage GKS was 19.67 +/- 6.08 cm(3) (13 Gy) at session 1 and 6.97 +/- 6.92 cm(3) (17 Gy) at session 2. The median interval period was 39 months. After follow-up period of 37 months, the complete obliteration rate was 64.9%. The mean AVM volume (and median marginal dose) at each GKS session in the 8 patients who underwent 3-stage GKS was 23.90 +/- 6.50 cm(3) (12.25 Gy), 19.43 +/- 7.46 cm(3) (13.5 Gy), 7.48 +/- 6.86 cm(3) (15.5 Gy) at session 1, 2, and 3, respectively. The median interval duration between each GKS session was 37.5 and 38 months, respectively. After a median follow-up period of 47.5 months, 5 patients (62.5%) achieved complete obliteration. Postradiosurgical hemorrhage developed in 5 patients (11.1%) including one case of major bleeding and 4 cases of minor bleeding. No patient suffered from clinically symptomatic radiation necrosis following radiation. Conclusion Time-staged GKS could be an effective and safe treatment option in the management of large AVMs.	[Park, Hye Ran] Soonchunhyang Univ Hosp, Dept Neurosurg, Seoul, South Korea; [Lee, Jae Meen; Kim, Jin Wook; Chung, Hyun-Tai; Kim, Dong Gyu; Paek, Sun Ha] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul, South Korea; [Han, Jung-Ho] Seoul Natl Univ, Bundang Hosp, Dept Neurosurg, Seoul, South Korea; [Han, Moon Hee] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea	Soonchunhyang University; Soonchunhyang University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Paek, SH (corresponding author), Seoul Natl Univ Hosp, Dept Neurosurg, Seoul, South Korea.	paeksh@snu.ac.kr	Lee, Jeong Min/V-3429-2019	Lee, Jeong Min/0000-0003-0561-8777	Korea Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries, Republic of Korea [311011-05-3-SB020]; Korea Healthcare Technology R&D Project - Ministry of Health & Welfare, Republic of Korea [HI11C21100200]; Technology Innovation Program (Business Model Development for Personalized Medicine Based on Integrated Genome and Clinical Information) - Ministry of Trade, Industry & Energy (MI, Korea) [10050154]; Bio & Medical Technology Development Program of the NRF - Korean government, MSIP [2015M3C7A1028926]	Korea Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries, Republic of Korea; Korea Healthcare Technology R&D Project - Ministry of Health & Welfare, Republic of Korea; Technology Innovation Program (Business Model Development for Personalized Medicine Based on Integrated Genome and Clinical Information) - Ministry of Trade, Industry & Energy (MI, Korea); Bio & Medical Technology Development Program of the NRF - Korean government, MSIP	SHP received these fundings: This study was supported by the Korea Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries, Republic of Korea (311011-05-3-SB020), by the Korea Healthcare Technology R&D Project (HI11C21100200) funded by Ministry of Health & Welfare, Republic of Korea, by the Technology Innovation Program (10050154, Business Model Development for Personalized Medicine Based on Integrated Genome and Clinical Information) funded by the Ministry of Trade, Industry & Energy (MI, Korea), and by the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIP (2015M3C7A1028926). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen CJ, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.6.FOCUS1454; COLOMBO F, 1994, NEUROSURGERY, V34, P14; Ding DL, 2014, BRIT J NEUROSURG, V28, P666, DOI 10.3109/02688697.2013.872227; Duffner F, 2000, STEREOT FUNCT NEUROS, V75, P27, DOI 10.1159/000048380; Fleetwood IG, 2002, LANCET, V359, P863, DOI 10.1016/S0140-6736(02)07946-1; Flickinger JC, 2002, RADIOTHER ONCOL, V63, P347, DOI 10.1016/S0167-8140(02)00103-2; Foote KD, 2003, J NEUROSURG, V98, P337, DOI 10.3171/jns.2003.98.2.0337; Han PP, 2003, J NEUROSURG, V98, P3, DOI 10.3171/jns.2003.98.1.0003; Hernesniemi JA, 2008, NEUROSURGERY, V63, P823, DOI 10.1227/01.NEU.0000330401.82582.5E; Izawa M, 2005, J NEUROSURG, V102, P34, DOI 10.3171/jns.2005.102.s_supplement.0034; Kano H, 2012, J NEUROSURG, V116, P54, DOI 10.3171/2011.9.JNS11177; Kjellberg R, 1979, ISOEFFECTIVE DOSE PA; KJELLBERG RN, 1983, NEW ENGL J MED, V309, P269, DOI 10.1056/NEJM198308043090503; Liscak R, 2007, NEUROSURGERY, V60, P1005, DOI 10.1227/01.NEU.0000255474.60505.4A; Maesawa S, 2000, J NEUROSURG, V92, P961, DOI 10.3171/jns.2000.92.6.0961; Maruyama K, 2005, NEW ENGL J MED, V352, P146, DOI 10.1056/NEJMoa040907; Mohr JP, 2014, LANCET, V383, P614, DOI 10.1016/S0140-6736(13)62302-8; Moosa S, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.5.FOCUS14205; Ogilvy CS, 2001, CIRCULATION, V103, P2644; Pollock BE, 2000, INT J RADIAT ONCOL, V48, P817, DOI 10.1016/S0360-3016(00)00696-9; Pollock BE, 1998, NEUROSURGERY, V42, P1239, DOI 10.1097/00006123-199806000-00020; Pollock BE, 2002, J NEUROSURG, V96, P79, DOI 10.3171/jns.2002.96.1.0079; Pollock BE, 1996, NEUROSURGERY, V38, P652, DOI 10.1227/00006123-199604000-00004; Pollock BE, 2008, NEUROSURGERY, V63, P239, DOI 10.1227/01.NEU.0000315861.24920.92; Regis J, 2002, GAMMA KNIFE SURGERY; Schneider BF, 1997, J NEUROSURG, V87, P352, DOI 10.3171/jns.1997.87.3.0352; Sirin S, 2006, NEUROSURGERY, V58, P17, DOI 10.1227/01.NEU.0000190653.42970.6B; Spetzler R F, 1978, Clin Neurosurg, V25, P651; Yamamoto M, 1999, NEUROSURG CLIN N AM, V10, P181, DOI 10.1016/S1042-3680(18)30189-X; Yang SY, 2009, ACTA NEUROCHIR, V151, P113, DOI 10.1007/s00701-008-0173-5; YU H, 2010, J NEUROSURG, V113, P2, DOI [10.3171/3171/2010.7.GKS101043, DOI 10.3171/3171/2010.7.GKS101043]	31	5	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165783	10.1371/journal.pone.0165783	http://dx.doi.org/10.1371/journal.pone.0165783			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806123	Green Published, gold, Green Submitted			2022-12-26	WOS:000386715500054
J	Berthenet, K; Bokhari, A; Lagrange, A; Marcion, G; Boudesco, C; Causse, S; De Thonel, A; Svrcek, M; Goloudina, AR; Dumont, S; Hammann, A; Biard, DS; Demidov, ON; Seigneuric, R; Duval, A; Collura, A; Jego, G; Garrido, C				Berthenet, K.; Bokhari, A'dem; Lagrange, A.; Marcion, G.; Boudesco, C.; Causse, S.; De Thonel, A.; Svrcek, M.; Goloudina, A. R.; Dumont, S.; Hammann, A.; Biard, D. S.; Demidov, O. N.; Seigneuric, R.; Duval, A.; Collura, A.; Jego, G.; Garrido, C.			HSP110 promotes colorectal cancer growth through STAT3 activation	ONCOGENE			English	Article							MICROSATELLITE INSTABILITY; EXPRESSION; HSP70; GENE; PROTEINS; SURVIVAL; CELLS; CD1D; RNA	Heat shock protein 110 (HSP110) is induced by different stresses and, through its anti-apoptotic and chaperoning properties, helps cells survive these adverse situations. In colon cancers, HSP110 is abnormally abundant. We have recently shown that colorectal cancer patients with microsatellite instability (MSI) had an improved response to chemotherapy because they harbor an HSP110-inactivating mutation (HSP110DE9). In this work, we used patient biopsies, human colorectal cancer cells grown in vitro and in vivo (xenografts), and intestinal crypts to demonstrate that HSP110 is also involved in colon cancer growth. We showed that HSP110 induces colon cancer cell proliferation and that this effect is associated with STAT3 activation, specifically an increase in STAT3 phosphorylation, nuclear translocation and transcription factor activity. STAT3 inhibition blocks the proliferative effect of HSP110. From a molecular standpoint, we demonstrated that HSP110 directly binds to STAT3, thereby facilitating its phosphorylation by JAK2. Finally, we showed a correlation between HSP110 expression and STAT3 phosphorylation in colon cancer patient samples. Thus, the expression of HSP110 in colon cancer contributes to STAT3-dependent tumor growth and the frequent inactivating mutation of this chaperone is probably an important event underlying the improved prognosis in colon cancer displaying MSI.	[Berthenet, K.; Marcion, G.; Boudesco, C.; Causse, S.; Goloudina, A. R.; Hammann, A.; Demidov, O. N.; Seigneuric, R.; Jego, G.; Garrido, C.] Univ Bourgogne Franche Comte, INSERM, UMR866, Fac Sci Sante, 7 Blvd Jeanne dArc, F-21079 Dijon, France; [Berthenet, K.; Marcion, G.; Boudesco, C.; Causse, S.; Goloudina, A. R.; Hammann, A.; Demidov, O. N.; Seigneuric, R.; Jego, G.; Garrido, C.] Equipe Labellisee Ligue Natl Canc, INSERM, LNC UMR866, Dijon, France; [Bokhari, A'dem; Lagrange, A.; Svrcek, M.; Duval, A.; Collura, A.] Equipe Labellisee Ligue Natl Canc, INSERM, UMR 938, Dijon, France; [Bokhari, A'dem; Lagrange, A.; Svrcek, M.; Duval, A.; Collura, A.] Univ Pierre & Marie Curie Paris 6, Paris, France; [De Thonel, A.] CNRS, Epigenet & Cell Fate UMR7216, Paris, France; [Dumont, S.] Hop St Antoine, AP HP, Serv Anat Pathol, Paris, France; [Biard, D. S.] Ctr Etude Atom, Paris, France; [Garrido, C.] CGFL, Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Jego, G; Garrido, C (corresponding author), Univ Bourgogne Franche Comte, INSERM, UMR866, Fac Sci Sante, 7 Blvd Jeanne dArc, F-21079 Dijon, France.	gaetan.jego@u-bourgogne.fr; cgarrido@u-bourgogne.fr	Goloudina, Anastasia/T-4989-2019; jego, gaetan/N-7226-2018; Causse, Sebastien Zwe/AAZ-7365-2021; Demidov, Oleg/AAC-4462-2021; Demidov, Oleg/U-2050-2017; Garrido, Carolina/GWM-5557-2022; Garrido, carmen/G-1633-2018	jego, gaetan/0000-0003-0376-9299; Demidov, Oleg/0000-0003-4323-7174; Demidov, Oleg/0000-0003-4323-7174; Garrido, carmen/0000-0003-1368-1493; Berthenet, Kevin/0000-0001-7345-4837; Causse, Sebastien/0000-0003-3246-3491; Marcion, Guillaume/0000-0002-3634-6316; BIARD, Denis Serge Francois/0000-0001-9697-4392; de Thonel, Aurelie/0000-0003-0405-0745	Institut National du Cancer, Agence Nationale de la Recherche, Ligue Nationale Contre le Cancer; Association pour la Recherche sur le Cancer (ARC); Conseil Regional de Bourgogne; program 'Investissements d'Avenir' [ANR-11-LABX-0021-01-LipSTIC LabEx]; FEDER; La Ligue Nationale Contre le Cancer; La Foundation pour la Recherche Medicale	Institut National du Cancer, Agence Nationale de la Recherche, Ligue Nationale Contre le Cancer(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); program 'Investissements d'Avenir'(French National Research Agency (ANR)); FEDER(European Commission); La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); La Foundation pour la Recherche Medicale	This work was supported by grants from the Institut National du Cancer, Agence Nationale de la Recherche, Ligue Nationale Contre le Cancer ('Labeled teams' to CG and AD), the Association pour la Recherche sur le Cancer (ARC), the Conseil Regional de Bourgogne, the program 'Investissements d'Avenir' ANR-11-LABX-0021-01-LipSTIC LabEx. We thank the FEDER for their support. KB and SC have a doctoral fellowship from La Ligue Nationale Contre le Cancer and KB from La Foundation pour la Recherche Medicale. We thank Prof. Dr Ibrahim M. Adham, Institut fur Humangenetik, University of Gottingen for kindly providing the HSP110 KO mice and P Bastable (CHU, Dijon) for the English correction of the manuscript.	Berthenet K, ONCOIMMUNOL IN PRESS; Biard DSF, 2005, MOL CANCER RES, V3, P519, DOI 10.1158/1541-7786.MCR-05-0044; Boissiere-Michot F, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.29256; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Colgan SP, 2003, J CLIN INVEST, V112, P745, DOI 10.1172/JC1200317241; Collura A, 2014, GASTROENTEROLOGY, V146, P401, DOI 10.1053/j.gastro.2013.10.054; Dorard C, 2011, NAT MED, V17, P1283, DOI 10.1038/nm.2457; Duval A, 2011, ONCOTARGET, V2, P826, DOI 10.18632/oncotarget.353; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Henics T, 1999, J BIOL CHEM, V274, P17318, DOI 10.1074/jbc.274.24.17318; Jego G, 2014, LEUKEMIA, V28, P1676, DOI 10.1038/leu.2014.63; Jego G, 2013, CANCER LETT, V332, P275, DOI 10.1016/j.canlet.2010.10.014; Lanneau D, 2008, J CELL MOL MED, V12, P743, DOI 10.1111/j.1582-4934.2008.00273.x; Mattoo RUH, 2013, J BIOL CHEM, V288, P21399, DOI 10.1074/jbc.M113.479253; Olszak T, 2014, NATURE, V509, P497, DOI 10.1038/nature13150; Prinsloo E, 2012, IUBMB LIFE, V64, P266, DOI 10.1002/iub.607; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Sato N, 2003, BIOCHEM BIOPH RES CO, V300, P847, DOI 10.1016/S0006-291X(02)02941-8; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; Slaby O, 2009, ONCOL REP, V21, P1235, DOI 10.3892/or_00000346; Waldner MJ, 2012, INT J BIOL SCI, V8, P1248, DOI 10.7150/ijbs.4614; Yamagishi N, 2009, FEBS J, V276, P5870, DOI 10.1111/j.1742-4658.2009.07311.x; Yu N, 2015, MOL CELL BIOL, V35, P1390, DOI 10.1128/MCB.01307-14; Zappasodi R, 2015, BLOOD, V125, P1768, DOI 10.1182/blood-2014-07-590034; Zappasodi R, 2011, BLOOD, V118, P4421, DOI 10.1182/blood-2011-06-364570	25	44	45	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 20	2017	36	16					2328	2336		10.1038/onc.2016.403	http://dx.doi.org/10.1038/onc.2016.403			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ES8DM	27819670				2022-12-26	WOS:000399782700013
J	Nyirenda, M; Omori, R; Tessmer, HL; Arimura, H; Ito, K				Nyirenda, Mayumbo; Omori, Ryosuke; Tessmer, Heidi L.; Arimura, Hiroki; Ito, Kimihito			Estimating the Lineage Dynamics of Human Influenza B Viruses	PLOS ONE			English	Article							SEASONAL INFLUENZA; EPIDEMIC MODEL; CROSS-IMMUNITY; SELECTION; VACCINE	The prediction of the lineage dynamics of influenza B viruses for the next season is one of the largest obstacles for constructing an appropriate influenza trivalent vaccine. Seasonal fluctuation of transmissibility and epidemiological interference between the two major influenza B lineages make the lineage dynamics complicated. Here we construct a parsimonious model describing the lineage dynamics while taking into account seasonal fluctuation of transmissibility and epidemiological interference. Using this model we estimated the epidemiological and evolutional parameters with the time-series data of the lineage specific isolates in Japan from the 2010-2011 season to the 2014-2015 season. The basic reproduction number is similar between Victoria and Yamagata, with a minimum value during one year as 0.82 (95% highest posterior density (HPD): 0.77-0.87) for the Yamagata and 0.83 (95% HPD: 0.74-0.92) for Victoria, the amplitude of seasonal variation of the basic reproduction number is 0.77 (95% HPD: 0.66-0.87) for Yamagata and 1.05 (95% HPD: 0.89-1.02) for Victoria. The duration for which the acquired immunity is effective against infection by the Yamagata lineage is shorter than the acquired immunity for Victoria, 424.1days (95% HPD: 317.4-561.5days). The reduction rate of susceptibility due to immune cross-reaction is 0.51 (95% HPD: 0.084-0.92) for the immunity obtained from the infection with Yamagata against the infection with Victoria and 0.62 (95% HPD: 0.42-0.80) for the immunity obtained from the infection with Victoria against the infection with Yamagata. Using estimated parameters, we predicted the dominant lineage in 2015-2016 season. The accuracy of this prediction is 68.8% if the emergence timings of the two lineages are known and 61.4% if the emergence timings are unknown. Estimated seasonal variation of the lineage specific reproduction number can narrow down the range of emergence timing, with an accuracy of 64.6% if the emergence times are assumed to be the time at which the estimated reproduction number exceeds one.	[Nyirenda, Mayumbo; Arimura, Hiroki] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido, Japan; [Omori, Ryosuke; Tessmer, Heidi L.; Ito, Kimihito] Hokkaido Univ, Div Bioinformat, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Omori, Ryosuke] JST, PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan	Hokkaido University; Hokkaido University; Japan Science & Technology Agency (JST)	Omori, R (corresponding author), Hokkaido Univ, Div Bioinformat, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan.; Omori, R (corresponding author), JST, PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan.	omori@czc.hokudai.ac.jp	Ito, Kimihito/E-9975-2012	Ito, Kimihito/0000-0003-4986-1795	CREST, Japan Science and Technology Agency; PRESTO, Japan Science and Technology Agency; PRESTO, JST; Grants-in-Aid for Scientific Research [16J02715] Funding Source: KAKEN	CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); PRESTO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); PRESTO, JST(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by CREST, Japan Science and Technology Agency (http:// www.jst.go.jp/kisoken/crest/en/index.html) to RO and KI; PRESTO, Japan Science and Technology Agency (http://www.jst.go.jp/kisoken/presto/en/ index.html) to RO.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by CREST, Japan Science and Technology Agency (JST) to RO and KI, PRESTO, JST to RO. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedford T, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-38; CASTILLOCHAVEZ C, 1989, J MATH BIOL, V27, P233, DOI 10.1007/BF00275810; Glezen WP, 2014, CLIN INFECT DIS, V59, P1525, DOI 10.1093/cid/ciu668; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604; Gupta S, 1998, SCIENCE, V280, P912, DOI 10.1126/science.280.5365.912; Hopping AM, 2016, VACCINE, V34, P1617, DOI 10.1016/j.vaccine.2016.01.042; Ito K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025953; Kamo M, 2002, PHYSICA D, V165, P228, DOI 10.1016/S0167-2789(02)00389-5; Kryazhimskiy S, 2007, PLOS COMPUT BIOL, V3, P1513, DOI 10.1371/journal.pcbi.0030159; Luksza M, 2014, NATURE, V507, P57, DOI 10.1038/nature13087; Minayev P, 2009, J R SOC INTERFACE, V6, P509, DOI 10.1098/rsif.2008.0333; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Omori R, 2013, J THEOR BIOL, V329, P32, DOI 10.1016/j.jtbi.2013.03.027; Rohani P, 1998, P ROY SOC B-BIOL SCI, V265, P2033, DOI 10.1098/rspb.1998.0537; SCHWARTZ IB, 1983, J MATH BIOL, V18, P233, DOI 10.1007/BF00276090; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Skowronski DM, 2011, PEDIATRICS, V128, pE276, DOI 10.1542/peds.2010-2777; Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638; Sunnaker M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002803; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tria F, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/07/P07008; Vijaykrishna D, 2015, ELIFE, V4, DOI 10.7554/eLife.05055; Xu CL, 2015, AM J EPIDEMIOL, V182, P705, DOI 10.1093/aje/kwv110	25	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166107	10.1371/journal.pone.0166107	http://dx.doi.org/10.1371/journal.pone.0166107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829058	Green Submitted, gold, Green Published			2022-12-26	WOS:000387724300081
J	Ward, CS; Huang, TW; Herrera, JA; Samaco, RC; Pitcher, MR; Herron, A; Skinner, SA; Kaufmann, WE; Glaze, DG; Percy, AK; Neul, JL				Ward, Christopher S.; Huang, Teng-Wei; Herrera, Jose A.; Samaco, Rodney C.; Pitcher, Meagan R.; Herron, Alan; Skinner, Steven A.; Kaufmann, Walter E.; Glaze, Daniel G.; Percy, Alan K.; Neul, Jeffrey L.			Loss of MeCP2 Causes Urological Dysfunction and Contributes to Death by Kidney Failure in Mouse Models of Rett Syndrome	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; URINARY-TRACT SYMPTOMS; RESPIRATORY PHENOTYPES; OBSTRUCTIVE UROPATHY; GENETIC BACKGROUNDS; BLADDER DYSFUNCTION; CEREBRAL-PALSY; MICE; RETENTION; MUTATIONS	Rett Syndrome (RTT) is a neurodevelopmental disorder characterized by loss of acquired skills during development, autonomic dysfunction, and an increased risk for premature lethality. Clinical experience identified a subset of individuals with RTT that present with urological dysfunction including individuals with frequent urinary tract infections, kidney stones, and urine retention requiring frequent catheterization for bladder voiding. To determine if urologic dysfunction is a feature of RTT, we queried the Rett Syndrome Natural History Study, a repository of clinical data from over 1000 individuals with RTT and found multiple instances of urological dysfunction. We then evaluated urological function in a mouse model of RTT and found an abnormal pattern of micturition. Both male and female mice possessing Mecp2 mutations show a decrease in urine output per micturition event. Furthermore, we identified signs of kidney failure secondary to urethral obstruction. Although genetic strain background significantly affects both survival and penetrance of the urethral obstruction phenotype, survival and penetrance of urethral obstruction do not directly correlate. We have identified an additional phenotype caused by loss of MeCP2, urological dysfunction. Furthermore, we urge caution in the interpretation of survival data as an endpoint in preclinical studies, especially where causes of mortality are poorly characterized.	[Ward, Christopher S.; Glaze, Daniel G.; Neul, Jeffrey L.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Ward, Christopher S.; Samaco, Rodney C.; Neul, Jeffrey L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Huang, Teng-Wei; Neul, Jeffrey L.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Huang, Teng-Wei; Neul, Jeffrey L.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Herrera, Jose A.; Samaco, Rodney C.; Pitcher, Meagan R.; Neul, Jeffrey L.] Baylor Coll Med, Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Herron, Alan] Baylor Coll Med, Ctr Comparat Med, Houston, TX 77030 USA; [Skinner, Steven A.; Kaufmann, Walter E.] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Kaufmann, Walter E.] Boston Childrens Hosp, Boston, MA 02115 USA; [Percy, Alan K.] Univ Alabama Birmingham, Birmingham, AL 35294 USA; [Neul, Jeffrey L.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Neul, Jeffrey L.] Univ Calif San Diego, Dept Neurosci, 9500 Gilman Dr,M-C 0626, La Jolla, CA 92093 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Greenwood Genetic Center; Harvard University; Boston Children's Hospital; University of Alabama System; University of Alabama Birmingham; Baylor College of Medicine; University of California System; University of California San Diego	Neul, JL (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.; Neul, JL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Neul, JL (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.; Neul, JL (corresponding author), Baylor Coll Med, Program Translat Biol & Mol Med, Houston, TX 77030 USA.; Neul, JL (corresponding author), Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA.; Neul, JL (corresponding author), Univ Calif San Diego, Dept Neurosci, 9500 Gilman Dr,M-C 0626, La Jolla, CA 92093 USA.	jneul@ucsd.edu	Neul, Jeffrey/AAF-5324-2020	Samaco, Rodney/0000-0001-5636-5314; Huang, Teng-Wei/0000-0002-8604-1262; Neul, Jeffrey/0000-0002-5628-5872; Ward, Christopher/0000-0002-3445-6327	International Rett Syndrome Foundation; NIH [HD062553, DP50D009134, HD024064, HD061222, NS066601]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064, R01HD062553, U54HD061222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS066601, T32NS043124] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009134] Funding Source: NIH RePORTER	International Rett Syndrome Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	International Rett Syndrome Foundation (JLN) and NIH grants HD062553 (JLN), DP50D009134 (RCS), HD024064 (BCM IDDRC), HD061222 (AKP), NS066601 (CSW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the generous contributions of Yaling Sun, Diana Parra and E. Melissa Arvide for technical help and assistance in generating the animals used for this study. This work was supported by funding from the International Rett Syndrome Foundation (JLN), NIH grants HD062553 (JLN), DP50D009134 (RCS), HD024064 (BCM IDDRC), HD061222 (AKP), NS066601 (CSW). The Rett Syndrome Natural History Study (U54 HD061222) is a part of the National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR) at the National Center for Advancing Translational Science (NCATS). The Rett Syndrome Natural History Study is funded through collaboration between NCATS, and the Eunice Kennedy Shriver Child Health and Human Development Institute (NICHD). The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Development of the National Institutes of Health.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Anigilaje EA, 2013, INT J NEPHROL, V2013, DOI 10.1155/2013/937268; BENDELE AM, 1986, LAB ANIM SCI, V36, P282; Bilbault Heloise, 2016, World J Nephrol, V5, P189, DOI 10.5527/wjn.v5.i2.189; Bissonnete JM, 2006, PEDIATR RES, V59, P513, DOI 10.1203/01.pdr.0000203157.31924.4a; Bissonnette JM, 2014, NEUROSCIENCE, V267, P166, DOI 10.1016/j.neuroscience.2014.02.043; Buchovecky CM, 2013, NAT GENET, V45, P1013, DOI 10.1038/ng.2714; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chicoine B, 2015, J AM BOARD FAM MED, V28, P115, DOI 10.3122/jabfm.2015.01.140065; Clayton-Smith J, 2009, EUR J HUM GENET, V17, P434, DOI 10.1038/ejhg.2008.192; Conway PH, 2007, JAMA-J AM MED ASSOC, V298, P179, DOI 10.1001/jama.298.2.179; Curhan GC, 1997, ANN INTERN MED, V126, P497, DOI 10.7326/0003-4819-126-7-199704010-00001; Silva JAF, 2014, J PEDIATR UROL, V10, P413, DOI 10.1016/j.jpurol.2013.07.004; FISCHER CP, 1978, J UROLOGY, V120, P328, DOI 10.1016/S0022-5347(17)57158-X; FITZGERALD PM, 1990, MOVEMENT DISORD, V5, P195, DOI 10.1002/mds.870050303; Geerdink N, 2002, NEUROPEDIATRICS, V33, P33, DOI 10.1055/s-2002-23598; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; HAGBERG B, 1985, BRAIN DEV-JPN, V7, P277, DOI 10.1016/S0387-7604(85)80028-0; Hong CC, 1978, LAB ANIMALS, V12; JOTKOWITZ S, 1976, JAMA-J AM MED ASSOC, V235, P2586, DOI 10.1001/jama.1976.03260500014014; Kerr AM, 1997, EUR CHILD ADOLES PSY, V6, P71; KLARSKOV P, 1987, SCAND J UROL NEPHROL, V21, P29, DOI 10.3109/00365598709180286; KUNSTYR I, 1982, LAB ANIM, V16, P151, DOI 10.1258/002367782781110205; Leary S., 2013, AVMA GUIDELINES FOR; Lieske JC, 2006, KIDNEY INT, V69, P760, DOI 10.1038/sj.ki.5000150; Marild S, 1998, ACTA PAEDIATR, V87, P549, DOI 10.1080/08035259850158272; McCauley MD, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002982; Neul JL, 2008, NEUROLOGY, V70, P1313, DOI 10.1212/01.wnl.0000291011.54508.aa; Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124; Ninomiya H, 1999, J VET MED SCI, V61, P53, DOI 10.1292/jvms.61.53; Ogier M, 2007, J NEUROSCI, V27, P10912, DOI 10.1523/JNEUROSCI.1869-07.2007; Percy AK, 2010, ANN NEUROL, V68, P951, DOI 10.1002/ana.22154; Ransmayr GN, 2008, NEUROLOGY, V70, P299, DOI 10.1212/01.wnl.0000296826.61499.26; Rao C N, 1987, Lab Anim Sci, V37, P8; REID CJD, 1993, ARCH DIS CHILD, V68, P739, DOI 10.1136/adc.68.6.739; Roux JC, 2007, EUR J NEUROSCI, V25, P1915, DOI 10.1111/j.1460-9568.2007.05466.x; Samaco RC, 2013, HUM MOL GENET, V22, P96, DOI 10.1093/hmg/dds406; Samijn B, 2017, NEUROUROL URODYNAM, V36, P541, DOI 10.1002/nau.22982; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SOKOLOFF L, 1962, AM J PATHOL, V41, P233; Sugino Y, 2008, NEUROUROL URODYNAM, V27, P548, DOI 10.1002/nau.20552; Todorova MT, 2003, EPILEPSIA, V44, P25, DOI 10.1046/j.1528-1157.2003.11402.x; Viemari JC, 2005, J NEUROSCI, V25, P11521, DOI 10.1523/JNEUROSCI.4373-05.2005; Ward CS, 2011, J NEUROSCI, V31, P10359, DOI 10.1523/JNEUROSCI.0057-11.2011; Weese-Mayer DE, 2006, PEDIATR RES, V60, P443, DOI 10.1203/01.pdr.0000238302.84552.d0; Wells S, 2009, J AM ASSOC LAB ANIM, V48, P296; WHEELER JS, 1985, BRIT J UROL, V57, P63, DOI 10.1111/j.1464-410X.1985.tb08987.x; Yu WQ, 2014, AM J PHYSIOL-RENAL, V306, pF1296, DOI 10.1152/ajprenal.00074.2014	49	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165550	10.1371/journal.pone.0165550	http://dx.doi.org/10.1371/journal.pone.0165550			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828991	Green Published, gold			2022-12-26	WOS:000387724300050
J	Biesbroek, JM; Weaver, NA; Hilal, S; Kuijf, HJ; Ikram, MK; Xu, X; Tan, BY; Venketasubramanian, N; Postman, A; Biessels, GJ; Chen, CPLH				Biesbroek, J. Matthijs; Weaver, Nick A.; Hilal, Saima; Kuijf, Hugo J.; Ikram, Mohammad Kamran; Xu, Xin; Tan, Boon Yeow; Venketasubramanian, Narayanaswamy; Postman, Albert; Biessels, Geert Jan; Chen, Christopher P. L. H.			Impact of Strategically Located White Matter Hyperintensities on Cognition in Memory Clinic Patients with Small Vessel Disease	PLOS ONE			English	Article							PROCESSING SPEED DEFICITS; ALZHEIMERS-DISEASE; CEREBRAL MICROBLEEDS; SUNNYBROOK DEMENTIA; EXECUTIVE FUNCTION; VASCULAR DEMENTIA; LESION LOCATION; ROTTERDAM SCAN; RISK-FACTORS; IMPAIRMENT	Background and Purpose Studies on the impact of small vessel disease (SVD) on cognition generally focus on white matter hyperintensity (WMH) volume. The extent to which WMH location relates to cognitive performance has received less attention, but is likely to be functionally important. We examined the relation between WMH location and cognition in a memory clinic cohort of patients with sporadic SVD. Methods A total of 167 patients with SVD were recruited from memory clinics. Assumption-free region of interest-based analyses based on major white matter tracts and voxel-wise analyses were used to determine the association between WMH location and executive functioning, visuomotor speed and memory. Results Region of interest-based analyses showed that WMHs located particularly within the anterior thalamic radiation and forceps minor were inversely associated with both executive functioning and visuomotor speed, independent of total WMH volume. Memory was significantly associated with WMH volume in the forceps minor, independent of total WMH volume. An independent assumption-free voxel-wise analysis identified strategic voxels in these same tracts. Region of interest-based analyses showed that WMH volume within the anterior thalamic radiation explained 6.8% of variance in executive functioning, compared to 3.9% for total WMH volume; WMH volume within the forceps minor explained 4.6% of variance in visuomotor speed and 4.2% of variance in memory, compared to 1.8% and 1.3% respectively for total WMH volume. Conclusions Our findings identify the anterior thalamic radiation and forceps minor as strategic white matter tracts in which WMHs are most strongly associated with cognitive impairment in memory clinic patients with SVD. WMH volumes in individual tracts explained more variance in cognition than total WMH burden, emphasizing the importance of lesion location when addressing the functional consequences of WMHs.	[Biesbroek, J. Matthijs; Weaver, Nick A.; Ikram, Mohammad Kamran; Biessels, Geert Jan] Univ Med Ctr Utrecht, Dept Neurol, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Hilal, Saima; Ikram, Mohammad Kamran; Xu, Xin; Chen, Christopher P. L. H.] Natl Univ Hlth Syst, Memory Aging & Cognit Ctr, Singapore, Singapore; [Hilal, Saima; Xu, Xin; Chen, Christopher P. L. H.] Natl Univ Singapore, Dept Pharmacol, Singapore, Singapore; [Kuijf, Hugo J.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Ikram, Mohammad Kamran] Natl Univ Singapore, Acad Med Res Inst, Duke NUS Grad Med Sch, Singapore, Singapore; [Tan, Boon Yeow] St Lukes Hosp, Singapore, Singapore; [Venketasubramanian, Narayanaswamy] Raffles Hosp, Raffles Neurosci Ctr, Singapore, Singapore; [Postman, Albert] Univ Utrecht, Helmholtz Inst, Expt Psychol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; National University of Singapore; National University of Singapore; Utrecht University; Utrecht University Medical Center; National University of Singapore; Raffles Hospital; Utrecht University	Biessels, GJ (corresponding author), Univ Med Ctr Utrecht, Dept Neurol, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.	g.j.biessels@umcutrecht.nl	Venketasubramanian, Narayanaswamy/GPP-5948-2022; Xu, Xin/S-6074-2016; Kuijf, Hugo J/G-2711-2013; Weaver, Nick A./AAA-8756-2019; Hilal, Saima/D-6028-2016; Chen, Christopher/E-7023-2013	Xu, Xin/0000-0002-4639-6480; Kuijf, Hugo J/0000-0001-6997-9059; Hilal, Saima/0000-0001-5434-5635; Chen, Christopher/0000-0002-1047-9225; Biesbroek, Matthijs/0000-0001-7017-2148; Weaver, Nick/0000-0001-8425-8436; Ikram, Mohammad Kamran/0000-0003-0173-9571	National Medical Council of Singapore Centre Grant [NMRC/CG/013/2013]; project Brainbox (Quantitative analysis of MR brain images for cerebrovascular disease management); Netherlands Organisation for Health Research and Development (ZonMw) [104002002]	National Medical Council of Singapore Centre Grant; project Brainbox (Quantitative analysis of MR brain images for cerebrovascular disease management); Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	The Memory Aging and Cognition Centre is funded by a National Medical Council of Singapore Centre Grant (NMRC/CG/013/2013). Hugo J. Kuijf was financially supported by the project Brainbox (Quantitative analysis of MR brain images for cerebrovascular disease management), funded by the Netherlands Organisation for Health Research and Development (ZonMw) in the framework of the research programme IMDI (Innovative Medical Devices Initiative); project 104002002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Biesbroek JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060541; Biffi A, 2011, J CLIN NEUROL, V7, P1, DOI 10.3988/jcn.2011.7.1.1; Bolandzadeh N, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-126; Burton EJ, 2004, STROKE, V35, P1270, DOI 10.1161/01.STR.0000126041.99024.86; Carew TG, 1997, NEUROPSYCHOLOGY, V11, P400, DOI 10.1037/0894-4105.11.3.400; Chabriat H, 2016, STROKE, V47, P4, DOI 10.1161/STROKEAHA.115.010696; Charlton RA, 2006, NEUROLOGY, V66, P1523, DOI 10.1212/01.wnl.0000216270.02610.7e; Cordonnier C, 2009, STROKE, V40, P94, DOI 10.1161/STROKEAHA.108.526996; Diller L., 1974, STUDIES COGNITION RE; Dong YH, 2013, J NEUROL SCI, V333, P5, DOI 10.1016/j.jns.2013.05.011; Duering M, 2015, NEUROLOGY, V84, P1685, DOI 10.1212/WNL.0000000000001502; Duering M, 2014, NEUROLOGY, V82, P1946, DOI 10.1212/WNL.0000000000000475; Duering M, 2013, NEUROIMAGE, V66, P177, DOI 10.1016/j.neuroimage.2012.10.084; Duering M, 2011, BRAIN, V134, P2366, DOI 10.1093/brain/awr169; Elia LF, 1996, COLOR TRAILS TEST PR; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fonov V., 2009, NEUROIMAGE, V47, pS102, DOI [DOI 10.1016/S1053-8119(09)70884-5, 10.1016/s1053-8119(09)70884-5]; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kloppenborg RP, 2014, NEUROLOGY, V82, P2127, DOI 10.1212/WNL.0000000000000505; Kuijf HJ, 2013, THESIS; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McNeely AA, 2015, J ALZHEIMERS DIS, V43, P785, DOI 10.3233/JAD-140588; Mega MS, 2005, NEUROIMAGE, V26, P1009, DOI 10.1016/j.neuroimage.2005.03.031; O'Brien JT, 2002, ANN NY ACAD SCI, V977, P436, DOI 10.1111/j.1749-6632.2002.tb04849.x; Poels MMF, 2010, STROKE, V41, pS103, DOI 10.1161/STROKEAHA.110.595181; Porteus SD., 1959, MAZE TEST CLIN PSYCH; Prins ND, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.10; Ramirez J, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt279; Reijmer YD, 2013, NEUROLOGY, V80, P1370, DOI 10.1212/WNL.0b013e31828c2ee5; Ritter F, 2011, IEEE PULSE, V2, P60, DOI 10.1109/MPUL.2011.942929; Rorden C, 2004, NAT REV NEUROSCI, V5, P813, DOI 10.1038/nrn1521; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Sahadevan S., 1997, Annals Academy of Medicine Singapore, V26, P271; Sepehry AA, 2016, AM J NEURORADIOL, V37, P215, DOI 10.3174/ajnr.A4525; Smith A., 1982, SYMBOL DIGIT MODALIT; Smith EE, 2011, NEUROLOGY, V76, P1492, DOI 10.1212/WNL.0b013e318217e7c8; van Norden AGW, 2012, J ALZHEIMERS DIS, V32, P667, DOI 10.3233/JAD-2012-120784; Vernooij MW, 2008, NEUROLOGY, V70, P1208, DOI 10.1212/01.wnl.0000307750.41970.d9; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wiederkehr S, 2008, J NEUROPSYCH CLIN N, V20, P150, DOI 10.1176/appi.neuropsych.20.2.150	44	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166261	10.1371/journal.pone.0166261	http://dx.doi.org/10.1371/journal.pone.0166261			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824925	Green Published, Green Submitted, gold			2022-12-26	WOS:000387615200078
J	Ellmers, TJ; Cocks, AJ; Doumas, M; Williams, AM; Young, WR				Ellmers, Toby J.; Cocks, Adam J.; Doumas, Michail; Williams, A. Mark; Young, William R.			Gazing into Thin Air: The Dual-Task Costs of Movement Planning and Execution during Adaptive Gait	PLOS ONE			English	Article							WORKING-MEMORY RESOURCES; AGE-RELATED DECLINE; VISUAL RISK-FACTORS; OLDER-ADULTS; COGNITIVE PERFORMANCE; GAZE BEHAVIOR; STOPS WALKING; FALL-RISK; REINVESTMENT; ATTENTION	We examined the effect of increased cognitive load on visual search behavior and measures of gait performance during locomotion. Also, we investigated how personality traits, specifically the propensity to consciously control or monitor movements (trait movement 'reinvestment'), impacted the ability to maintain effective gaze under conditions of cognitive load. Healthy young adults traversed a novel adaptive walking path while performing a secondary serial subtraction task. Performance was assessed using correct responses to the cognitive task, gaze behavior, stepping accuracy, and time to complete the walking task. When walking while simultaneously carrying out the secondary serial subtraction task, participants visually fixated on task-irrelevant areas 'outside' the walking path more often and for longer durations of time, and fixated on task-relevant areas 'inside' the walkway for shorter durations. These changes were most pronounced in high-trait-reinvesters. We speculate that reinvestment-related processes placed an additional cognitive demand upon working memory. These increased task-irrelevant 'outside' fixations were accompanied by slower completion rates on the walking task and greater gross stepping errors. Findings suggest that attention is important for the maintenance of effective gaze behaviors, supporting previous claims that the maladaptive changes in visual search observed in high-risk older adults may be a consequence of inefficiencies in attentional processing. Identifying the underlying attentional processes that disrupt effective gaze behaviour during locomotion is an essential step in the development of rehabilitation, with this information allowing for the emergence of interventions that reduce the risk of falling.	[Ellmers, Toby J.; Cocks, Adam J.; Young, William R.] Brunel Univ London, Dept Life Sci, Uxbridge, Middx, England; [Doumas, Michail] Queens Univ Belfast, Sch Psychol, Belfast, Antrim, North Ireland; [Williams, A. Mark] Univ Utah, Coll Heath, Salt Lake City, UT USA; [Young, William R.] Brunel Univ London, Coll Hlth & Life Sci, Ctr Cognit Neurosci, Uxbridge, Middx, England; [Young, William R.] Brunel Univ London, Inst Environm Hlth & Soc, Uxbridge, Middx, England	Brunel University; Queens University Belfast; Utah System of Higher Education; University of Utah; Brunel University; Brunel University	Ellmers, TJ (corresponding author), Brunel Univ London, Dept Life Sci, Uxbridge, Middx, England.	toby.ellmers@brunel.ac.uk	Doumas, M/A-4494-2009	Doumas, M/0000-0002-5323-6258; Young, William/0000-0002-5064-8601; Ellmers, Toby/0000-0001-9595-6360; Cocks, Adam/0000-0001-7793-3827	Royal Society [IE131576]; British Academy [SG132820]	Royal Society(Royal Society of London); British Academy	This research was partially supported by grants awarded to author WRY from The Royal Society (grant number:IE131576, URL: www.royalsociety.org) and British Academy (grant number: SG132820, URL: www.brriac.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon M, 2014, CLIN INTERV AGING, V9, P477, DOI 10.2147/CIA.S54978; Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; [Anonymous], 2013, NICE GUIDELINES FALL; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Beauchet O, 2009, EUR J NEUROL, V16, P786, DOI 10.1111/j.1468-1331.2009.02612.x; Beurskens R, 2013, HUM MOVEMENT SCI, V32, P1456, DOI 10.1016/j.humov.2013.07.013; Beurskens R, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/131608; Beurskens R, 2012, EXP BRAIN RES, V217, P117, DOI 10.1007/s00221-011-2978-3; Bialoszewski Dariusz, 2008, Ortop Traumatol Rehabil, V10, P441; Bock O, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-27; Chapman GJ, 2007, GAIT POSTURE, V26, P59, DOI 10.1016/j.gaitpost.2006.07.010; Chapman GJ, 2006, EXP BRAIN RES, V174, P613, DOI 10.1007/s00221-006-0507-6; De Rammelaere S, 1999, PSYCHOL RES-PSYCH FO, V62, P72, DOI 10.1007/s004260050041; De Rammelaere S, 2001, MEM COGNITION, V29, P267, DOI 10.3758/BF03194920; De Rammelaere S., 2001, CURRENT PSYCHOL LETT, V2, P79; Derakshan N, 2009, EUR PSYCHOL, V14, P168, DOI 10.1027/1016-9040.14.2.168; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Henry L., 2011, DEV WORKING MEMORY C; Higuchi T, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00277; Hollands MA, 2001, J MOTOR BEHAV, V33, P205, DOI 10.1080/00222890109603151; HOLLANDS MA, 1995, J MOTOR BEHAV, V27, P155, DOI 10.1080/00222895.1995.9941707; Hollands MA, 1996, EXP BRAIN RES, V109, P343; Hyman Ira E Jr, 2014, Front Psychol, V5, P356, DOI 10.3389/fpsyg.2014.00356; Hyman IE, 2010, APPL COGNITIVE PSYCH, V24, P597, DOI 10.1002/acp.1638; Imbo I, 2007, EUR J COGN PSYCHOL, V19, P910, DOI 10.1080/09541440601051571; Jackson RC, 2006, J SPORT EXERCISE PSY, V28, P49, DOI 10.1123/jsep.28.1.49; Lord SR, 2001, J AM GERIATR SOC, V49, P508, DOI 10.1046/j.1532-5415.2001.49107.x; Lord SR, 2006, AGE AGEING, V35, P42, DOI 10.1093/ageing/afl085; LundinOlsson L, 1997, LANCET, V349, P617, DOI 10.1016/S0140-6736(97)24009-2; Masters R., 2008, INT REV SPORT EXER P, V1, P160, DOI [10.1080/17509840802287218, DOI 10.1080/17509840802287218]; Masters R. S. W., 2005, INT SOC SPORT PSYCHO; MCDOWD JM, 1986, J GERONTOL, V41, P764, DOI 10.1093/geronj/41.6.764; Muhaidat J, 2013, PHYSIOTHER THEOR PR, V29, P351, DOI 10.3109/09593985.2012.752056; Muir SW, 2012, AGE AGEING, V41, P299, DOI 10.1093/ageing/afs012; Muir-Hunter SW, 2016, PHYSIOTHERAPY, V102, P29, DOI 10.1016/j.physio.2015.04.011; Nagamatsu LS, 2011, PSYCHOL AGING, V26, P253, DOI 10.1037/a0022929; National Center for Injury Prevention and Control, 2013, WEB BAS INJ STAT QUE; Patla AE, 1997, NEUROREPORT, V8, P3661, DOI 10.1097/00001756-199712010-00002; Schwebel DC, 2012, ACCIDENT ANAL PREV, V45, P266, DOI 10.1016/j.aap.2011.07.011; Seitz K, 2000, EUR J COGN PSYCHOL, V12, P552, DOI 10.1080/095414400750050231; Stavrinos D, 2011, J SAFETY RES, V42, P101, DOI 10.1016/j.jsr.2011.01.004; Strayer DL, 2003, J EXP PSYCHOL-APPL, V9, P23, DOI 10.1037/1076-898X.9.1.23; Strayer DL, 2004, P HUM FACTORS ERGON, V48, P2213; Terrier P, 2013, J NEUROL SCI, V333, pe570; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; Uiga L, 2015, COGN PROCESS, V16, pS421, DOI 10.1007/s10339-015-0685-x; Uiga L, 2015, AGEING RES REV, V20, P24, DOI 10.1016/j.arr.2014.12.005; Veltman JA, 1996, BIOL PSYCHOL, V42, P323, DOI 10.1016/0301-0511(95)05165-1; Wong WL, 2008, NEUROREHAB NEURAL RE, V22, P410, DOI 10.1177/1545968307313510; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Young WR, 2016, EXP BRAIN RES, V234, P161, DOI 10.1007/s00221-015-4445-z; Young WR, 2015, GAIT POSTURE, V41, P7, DOI 10.1016/j.gaitpost.2014.09.006; Young WR, 2012, GAIT POSTURE, V36, P477, DOI 10.1016/j.gaitpost.2012.04.009; Young WR, 2012, J GERONTOL B-PSYCHOL, V67, P43, DOI 10.1093/geronb/gbr074; Young WR, 2010, EXP BRAIN RES, V204, P103, DOI 10.1007/s00221-010-2300-9; Young WR, 2007, PLOS ONE, V7; Zaback M, 2015, HUM MOVEMENT SCI, V40, P393, DOI 10.1016/j.humov.2015.01.015; Zettel JL, 2007, NEUROSCI LETT, V422, P207, DOI 10.1016/j.neulet.2007.06.020; Zijlstra F. R. H., 1993, EFFICIENCY WORK BEHA	60	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166063	10.1371/journal.pone.0166063	http://dx.doi.org/10.1371/journal.pone.0166063			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB8BE	27824937	Green Published, Green Submitted, gold			2022-12-26	WOS:000387615200059
J	Marzi, C; Holdt, LM; Fiorito, G; Tsai, PC; Kretschmer, A; Wahl, S; Guarrera, S; Teupser, D; Spector, TD; Iacoviello, L; Sacerdote, C; Strauch, K; Lee, S; Thasler, WE; Peters, A; Thorand, B; Wolf, P; Prokisch, H; Tumino, R; Gieger, C; Krogh, V; Panico, S; Bell, JT; Matullo, G; Waldenberger, M; Grallert, H; Koenig, W				Marzi, Carola; Holdt, Lesca M.; Fiorito, Giovanni; Tsai, Pei-Chien; Kretschmer, Anja; Wahl, Simone; Guarrera, Simonetta; Teupser, Daniel; Spector, Tim D.; Iacoviello, Licia; Sacerdote, Carlotta; Strauch, Konstantin; Lee, Serene; Thasler, Wolfgang E.; Peters, Annette; Thorand, Barbara; Wolf, Petra; Prokisch, Holger; Tumino, Rosario; Gieger, Christian; Krogh, Vittorio; Panico, Salvatore; Bell, Jordana T.; Matullo, Giuseppe; Waldenberger, Melanie; Grallert, Harald; Koenig, Wolfgang			Epigenetic Signatures at AQP3 and SOCS3 Engage in Low-Grade Inflammation across Different Tissues	PLOS ONE			English	Article							C-REACTIVE PROTEIN; DNA METHYLATION PATTERNS; PROMOTES CELL-GROWTH; CARDIOVASCULAR-DISEASE; CANCER; AQUAPORIN-3; BLOOD; ATHEROSCLEROSIS; MECHANISMS; LEUKOCYTES	Background Elevated levels of C-reactive protein (CRP, determined by a high-sensitivity assay) indicate low-grade inflammation which is implicated in many age-related disorders. Epigenetic studies on CRP might discover molecular mechanisms underlying CRP regulation. We aimed to identify DNA methylation sites related to CRP concentrations in cells and tissues regulating low-grade inflammation. Results Genome-wide DNA methylation was measured in peripheral blood in 1,741 participants of the KORA F4 study using Illumina HumanMethylation450 BeadChip arrays. Four CpG sites (located at BCL3, AQP3, SOCS3, and cg19821297 intergenic at chromosome 19p13.2, P <= 1.01E-07) were significantly hypomethylated at high CRP concentrations independent of various confounders including age, sex, BMI, smoking, and white blood cell composition. Findings were not sex-specific. CRP-related top genes were enriched in JAK/STAT pathways (Benjamini-Hochberg corrected P < 0.05). Results were followed-up in three studies using DNA from peripheral blood (EPICOR, n = 503) and adipose tissue (TwinsUK, n = 368) measured as described above and from liver tissue (LMU liver cohort, n = 286) measured by MALDI-TOF mass spectrometry using EpiTYPER. CpG sites at the AQP3 locus (significant p-values in peripheral blood = 1.72E-03 and liver tissue = 1.51E-03) and the SOCS3 locus (p-values in liver < 2.82E-05) were associated with CRP in the validation panels. Conclusions Epigenetic modifications seem to engage in low-grade inflammation, possibly via JAK/STAT mediated pathways. Results suggest a shared relevance across different tissues at the AQP3 locus and highlight a role of DNA methylation for CRP regulation at the SOCS3 locus.	[Marzi, Carola; Kretschmer, Anja; Wahl, Simone; Gieger, Christian; Waldenberger, Melanie; Grallert, Harald] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Res Unit Mol Epidemiol, Neuherberg, Germany; [Marzi, Carola; Thorand, Barbara; Grallert, Harald] German Ctr Diabet Res DZD eV, Neuherberg, Germany; [Holdt, Lesca M.; Teupser, Daniel] Ludwig Maximilians Univ Munchen, Inst Lab Med, Munich, Germany; [Fiorito, Giovanni; Guarrera, Simonetta] Human Genet Fdn HuGeF Torino, Turin, Italy; [Fiorito, Giovanni; Guarrera, Simonetta] Univ Turin, Dept Med Sci, Turin, Italy; [Tsai, Pei-Chien; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Iacoviello, Licia] IRCCS Ist Neurol Mediterraneo Neuromed, Dept Epidemiol & Prevent, Pozzilli, IS, Italy; [Sacerdote, Carlotta] Univ Turin, Citta Salute Sci Hosp, Canc Epidemiol Unit, Turin, Italy; [Sacerdote, Carlotta] CPO, Turin, Italy; [Strauch, Konstantin] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Genet Epidemiol, Neuherberg, Germany; [Strauch, Konstantin] Ludwig Maximilians Univ Munchen, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Lee, Serene; Thasler, Wolfgang E.] Ludwig Maximilians Univ Munchen, Dept Surg, Munich, Germany; [Peters, Annette; Thorand, Barbara] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Wolf, Petra; Prokisch, Holger] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Human Genet, Neuherberg, Germany; [Wolf, Petra; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Tumino, Rosario] Civile MP Arezzo Hosp, ASP 7, Canc Registry, Ragusa, Italy; [Tumino, Rosario] Civile MP Arezzo Hosp, ASP 7, Histopathol Unit, Ragusa, Italy; [Krogh, Vittorio] Fdn IRCSS Ist Nazl Tumori, Epidemiol & Prevent Unit, Milan, Italy; [Panico, Salvatore] Univ Naples Federico II, Dept Clin & Med & Surg, Naples, Italy; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, Ulm, Germany; [Koenig, Wolfgang] Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany; [Koenig, Wolfgang] Munich Heart Alliance, DZHK German Ctr Cardiovasc Res, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Turin; University of London; King's College London; IRCCS Neuromed; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Civile M.P. Arezzo Hospital; Civile M.P. Arezzo Hospital; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Naples Federico II; Ulm University; German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance	Marzi, C (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Res Unit Mol Epidemiol, Neuherberg, Germany.; Marzi, C (corresponding author), German Ctr Diabet Res DZD eV, Neuherberg, Germany.	carolamarzi@helmholtz-muenchen.de	Thorand, Barbara/B-5349-2014; Iacoviello, Licia/K-4676-2016; Guarrera, Simonetta/AAB-8482-2022; Waldenberger, Melanie/B-5355-2014; Grallert, Harald/B-3424-2013; Krogh, Vittorio/K-2628-2016; Krogh, Vittorio/AAA-9171-2019; Peters, Annette/A-6117-2011; Siani, Alfonso/B-7925-2015; Bell, Jordana/AAH-7312-2019; Iacoviello, Licia/AGX-7071-2022; MATULLO, Giuseppe/K-6383-2016; bisconti, alessandro/I-8016-2018	Thorand, Barbara/0000-0002-8416-6440; Iacoviello, Licia/0000-0003-0514-5885; Waldenberger, Melanie/0000-0003-0583-5093; Krogh, Vittorio/0000-0003-0122-8624; Krogh, Vittorio/0000-0003-0122-8624; Peters, Annette/0000-0001-6645-0985; Iacoviello, Licia/0000-0003-0514-5885; tumino, rosario/0000-0003-2666-414X; Lee, Serene/0000-0001-5231-0607; TSAI, PEI-CHIEN/0000-0003-1575-9020; MATULLO, Giuseppe/0000-0003-0674-7757; Prokisch, Holger/0000-0003-2379-6286; Sacerdote, Carlotta/0000-0002-8008-5096; Fiorito, Giovanni/0000-0002-7651-5452; Koenig, Wolfgang/0000-0002-2064-9603; Bell, Jordana/0000-0002-3858-5986; bisconti, alessandro/0000-0002-8474-5733	Helmholtz Zentrum MuEnchen - German Research Center for Environmental Health; German Federal Ministry of Education and Research (BMBF); State of Bavaria; Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LM Uinnovativ; Helmholtz Association (Helmholtz-Russia Joint Research Group 310); European Union's Seventh Framework Programme (FP7) [261433, 603288, HEALTH-F2-2013-602736]; European Union's Seventh Framework Programme [FP7-Health-F5-2012, 305280]; BMBF [01ZX1313A-2014]; German Center for Diabetes Research (DZD) - BMBF; German National Genome Research Network (NGFNplus) [01GS0834]; University of Ulm; Compagnia di San Paolo for the EPIC-Italy; EPICOR; MIUR ex60% grant; Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan) [IG2013 N.14410]; European Research Council [250157]; Economic and Social Research council [ES/N000404/1]; Twins UK; Wellcome Trust; European Community's Seventh Framework Programme (FP7); National Institute for Health Research (NIHR)- BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London; ERC Advanced Principal Investigator award [ERC 250157]; Human Genetics Foundation-HuGeF; Economic and Social Research Council [ES/N000404/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10027] Funding Source: researchfish; ESRC [ES/N000404/1] Funding Source: UKRI	Helmholtz Zentrum MuEnchen - German Research Center for Environmental Health; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Bavaria; Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LM Uinnovativ; Helmholtz Association (Helmholtz-Russia Joint Research Group 310); European Union's Seventh Framework Programme (FP7); European Union's Seventh Framework Programme(European Commission); BMBF(Federal Ministry of Education & Research (BMBF)); German Center for Diabetes Research (DZD) - BMBF(Federal Ministry of Education & Research (BMBF)); German National Genome Research Network (NGFNplus); University of Ulm; Compagnia di San Paolo for the EPIC-Italy(Compagnia di San Paolo); EPICOR; MIUR ex60% grant(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan)(Fondazione AIRC per la ricerca sul cancro); European Research Council(European Research Council (ERC)European Commission); Economic and Social Research council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Twins UK; Wellcome Trust(Wellcome TrustEuropean Commission); European Community's Seventh Framework Programme (FP7)(European Commission); National Institute for Health Research (NIHR)- BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London; ERC Advanced Principal Investigator award(European Research Council (ERC)); Human Genetics Foundation-HuGeF; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The KORA study was initiated and financed by the Helmholtz Zentrum MuEnchen - German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Furthermore, KORA research was supported with in the Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LM Uinnovativ. The research leading to these results has received funding from the Helmholtz Association (Helmholtz-Russia Joint Research Group 310), the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreements number 261433 (BioSHaRE-EU), number 603288 (SysVasc) and HEALTH-F2-2013-602736 (PAIN-OMICS), as well as the European Union's Seventh Framework Programme (FP7-Health-F5-2012) under grant agreement number305280 (MIMOmics) and BMBF e:Med project: e:AtheroSysMedD-Systems medicine of myocardial infarction and stroke, grant number 01ZX1313A-2014. In addition, part of this work was financed by the German Center for Diabetes Research (DZD) funded by the BMBF, by the German National Genome Research Network (NGFNplus, project number 01GS0834), and through additional funds from the University of Ulm. EPICOR: This work was supported by the Compagnia di San Paolo for the EPIC-Italy and EPICOR projects (to SP, VK, RT, LI, CS, GM), the Human Genetics Foundation-HuGeF (to GM), and the MIUR ex60% grant (to GM). EPIC-Italy is further supported by grant number IG2013 N.14410 from the Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan) (to SP, CS). Twins UK: Funding support for this project was obtained from the European Research Council (project number 250157), the Economic and Social Research council (grant number ES/N000404/1), and in part by Twins UK, which is funded by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013). The study also receives support from the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. Laboratory work was performed by The Wellcome Trust Sanger Institute and National Eye Institute via NIH/CIDR. TDS is the holder of an ERC Advanced Principal Investigator award (ERC 250157). LMU liver cohort: We acknowledge the support of the non-profit foundation HTCR, which holds human tissue on trust, making it broadly available for research on an ethical and legal basis.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Arnaud C, 2005, ARTERIOSCL THROM VAS, V25, P1231, DOI 10.1161/01.ATV.0000163840.63685.0c; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Ballestar E, 2011, NAT REV RHEUMATOL, V7, P264, DOI 10.1038/nrrheum.2011.16; Bell JT, 2012, PLOS GENET, V8, P189, DOI 10.1371/journal.pgen.1002629; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Burrell AM, 2011, DISCOV MED, V11, P187; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Durham A, 2010, EPIGENOMICS-UK, V2, P523, DOI 10.2217/EPI.10.27; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; El-Maarri O, 2007, HUM GENET, V122, P505, DOI 10.1007/s00439-007-0430-3; Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x; Gentilini D, 2013, AGE, V35, P1961, DOI 10.1007/s11357-012-9463-1; Grimaldi V, 2015, CURR ATHEROSCLER REP, V17, DOI 10.1007/s11883-014-0476-3; Hara-Chikuma M, 2008, J MOL MED-JMM, V86, P221, DOI 10.1007/s00109-007-0272-4; Ho SM, 2010, J ALLERGY CLIN IMMUN, V126, P453, DOI 10.1016/j.jaci.2010.07.030; Holdt LM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003588; Horie I, 2009, BIOCHEM BIOPH RES CO, V387, P564, DOI 10.1016/j.bbrc.2009.07.077; Houseman EA, 2014, BIOINFORMATICS, V30, P1431, DOI 10.1093/bioinformatics/btu029; Isomoto H, 2007, GASTROENTEROLOGY, V132, P384, DOI 10.1053/j.gastro.2006.10.037; Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Karsli-Ceppioglu S, 2014, EPIGENOMICS-UK, V6, P651, DOI [10.2217/EPI.14.59, 10.2217/epi.14.59]; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Kiu H, 2012, GROWTH FACTORS, V30, P88, DOI 10.3109/08977194.2012.660936; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Kucukali CI, 2014, NEUROMOLECULAR MED; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; MacGregor AJ, 2004, CLIN CHEM, V50, P130, DOI 10.1373/clinchem.2003.028258; Marchini G, 2003, PEDIATR DERMATOL, V20, P377, DOI 10.1046/j.1525-1470.2003.20501.x; Mei W. X., 2010, J CHIN INTEGR MED, V8, P111, DOI [10.3736/jcim20100203, DOI 10.3736/JCIM20100203]; Molavi O, 2013, BRIT J HAEMATOL, V161, P348, DOI 10.1111/bjh.12262; Nakahigashi K, 2011, J INVEST DERMATOL, V131, P865, DOI 10.1038/jid.2010.395; Niwa Y, 2005, ONCOGENE, V24, P6406, DOI 10.1038/sj.onc.1208788; Pfeiffer L, 2015, CIRC-CARDIOVASC GENE, V8, P334, DOI 10.1161/CIRCGENETICS.114.000804; Pierconti F, 2011, PROSTATE, V71, P318, DOI 10.1002/pros.21245; Sarter B, 2005, HUM GENET, V117, P402, DOI 10.1007/s00439-005-1317-9; Stenvinkel P, 2007, J INTERN MED, V261, P488, DOI 10.1111/j.1365-2796.2007.01777.x; Sun YV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073480; Tancharoen S, 2008, J CELL PHYSIOL, V217, P338, DOI 10.1002/jcp.21506; Tischoff I, 2007, GUT, V56, P1047, DOI 10.1136/gut.2006.111633; Wang J, 2014, J MOL MED, V92, P1257, DOI 10.1007/s00109-014-1184-8; Wang XL, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-87; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812	49	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166015	10.1371/journal.pone.0166015	http://dx.doi.org/10.1371/journal.pone.0166015			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824951	Green Published, Green Submitted, gold			2022-12-26	WOS:000387615200053
J	Fan, X; Xiao, M; Liu, P; Chen, SR; Kong, FR; Wang, H; Zhang, L; Hou, X; Xu, YC				Fan, Xin; Xiao, Meng; Liu, Ping; Chen, Sharon; Kong, Fanrong; Wang, He; Zhang, Li; Hou, Xin; Xu, Ying-Chun			Novel Polymorphic Multilocus Microsatellite Markers to Distinguish Candida tropicalis Isolates	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; HOSPITAL STAY; FLUCONAZOLE; SURVEILLANCE; POPULATION; INFECTIONS; RESISTANCE; MORTALITY; OUTBREAK; CHINA	Candida tropicalis is an important pathogen. Here we developed and evaluated a polymorphic multilocus microsatellite scheme employing novel genetic markers for genotyping of C. tropicalis. Using 10 isolates from 10 unique (separate) patients to screen over 4000 tandem repeats from the C. tropicalis genome (strain MYA-3404), six new candidate microsatellite loci (ctm1, ctm3, ctm8, ctm18, ctm24 and ctm26) were selected according to amplification success, observed polymorphisms and stability of flanking regions by preliminary testing. Two known microsatellite loci CT14 and URA3 were also studied. The 6-locus scheme was then tested against a set of 82 different isolates from 32 patients. Microsatellite genotypes of isolates from the same patient (two to five isolates per patient) were identical. The six loci produced eight to 17 allele types and identified 11 to 24 genotypes amongst 32 patients' isolates, achieving a discriminatory power (DP) of 0.76 to 0.97 (versus 0.78 for both CT14 and URA3 loci, respectively). Testing of a combination of only three loci, ctm1, ctm3 and ctm24, also achieved maximum typing efficiency (DP = 0.99, 29 genotypes). The microsatellite typing scheme had good correlation compared with pulsed-field gel electrophoresis, although was slightly less discriminatory. The new sixlocus microsatellite typing scheme is a potentially valuable tool for genotyping and investigating microevolution of C. tropicalis.	[Fan, Xin; Xiao, Meng; Wang, He; Zhang, Li; Hou, Xin; Xu, Ying-Chun] Chinese Acad Med Sci, Dept Clin Lab, Peking Union Med Coll Hosp, Beijing, Peoples R China; [Fan, Xin; Hou, Xin] Chinese Acad Med Sci, Grad Sch, Peking Union Med Coll, Beijing, Peoples R China; [Liu, Ping] Tianjin First Ctr Hosp, Dept Clin Lab, Tianjin, Peoples R China; [Chen, Sharon; Kong, Fanrong] Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, Darcy Rd, Westmead, NSW, Australia	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Sydney	Xu, YC (corresponding author), Chinese Acad Med Sci, Dept Clin Lab, Peking Union Med Coll Hosp, Beijing, Peoples R China.	xycpumch@139.com	Xiao, Meng/J-6518-2017	Xiao, Meng/0000-0003-2103-7008	Research Special Fund for Public Welfare Industry of Health [201402001]	Research Special Fund for Public Welfare Industry of Health	YCX received funding from The Research Special Fund for Public Welfare Industry of Health, Grant Number 201402001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almirante B, 2005, J CLIN MICROBIOL, V43, P1829, DOI 10.1128/JCM.43.4.1829-1835.2005; Amouri I, 2012, J MED MICROBIOL, V61, P1091, DOI 10.1099/jmm.0.043992-0; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Chakrabarti A, 2015, INTENS CARE MED, V41, P285, DOI 10.1007/s00134-014-3603-2; Magri MMC, 2013, J CLIN MICROBIOL, V51, P268, DOI 10.1128/JCM.02366-12; Chen KW, 2009, INFECT GENET EVOL, V9, P912, DOI 10.1016/j.meegid.2009.06.011; Chou HH, 2007, DIAGN MICR INFEC DIS, V58, P427, DOI 10.1016/j.diagmicrobio.2007.03.014; Chou HH, 2007, DIAGN MICR INFEC DIS, V57, P451, DOI 10.1016/j.diagmicrobio.2006.09.009; Chowdhary A, 2003, MYCOSES, V46, P287, DOI 10.1046/j.1439-0507.2003.00883.x; Desnos-Ollivier M, 2008, EMERG INFECT DIS, V14, P557, DOI 10.3201/eid1404.071083; DOEBBELING BN, 1991, J CLIN MICROBIOL, V29, P1268, DOI 10.1128/JCM.29.6.1268-1270.1991; Fan X, 2014, CHINESE MED J-PEKING, V127, P4226, DOI 10.3760/cma.j.issn.0366-6999.20142048; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jang SJ, 2005, JPN J INFECT DIS, V58, P263; Kothavade RJ, 2010, J MED MICROBIOL, V59, P873, DOI 10.1099/jmm.0.013227-0; Metwally L, 2008, J MED MICROBIOL, V57, P296, DOI 10.1099/jmm.0.47617-0; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Morgan J, 2005, INFECT CONT HOSP EP, V26, P540, DOI 10.1086/502581; Munoz P, 2011, CLIN MICROBIOL INFEC, V17, P1538, DOI 10.1111/j.1469-0691.2010.03338.x; Pfaller MA, 2010, J CLIN MICROBIOL, V48, P1366, DOI 10.1128/JCM.02117-09; Pfaller MA, 2015, DIAGN MICR INFEC DIS, V82, P303, DOI DOI 10.1016/J.DIAGMICR0BI0.2015.04.008; Rho J, 2004, J MICROBIOL, V42, P80; Sabino R, 2010, J CLIN MICROBIOL, V48, P1677, DOI 10.1128/JCM.02151-09; Saghrouni F, 2013, J APPL MICROBIOL, V114, P1559, DOI 10.1111/jam.12132; Sheng WH, 2005, J HOSP INFECT, V59, P205, DOI 10.1016/j.jhin.2004.06.003; Tavanti A, 2005, J CLIN MICROBIOL, V43, P5593, DOI 10.1128/JCM.43.11.5593-5600.2005; Wang H, 2012, J CLIN MICROBIOL, V50, P3952, DOI 10.1128/JCM.01130-12; Wu Y, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0245-z; Xiao M, 2015, J ANTIMICROB CHEMOTH, V70, P802, DOI 10.1093/jac/dku460; Zhang L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1086-6	30	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166156	10.1371/journal.pone.0166156	http://dx.doi.org/10.1371/journal.pone.0166156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820850	Green Published, Green Submitted, gold			2022-12-26	WOS:000387614800038
J	Liu, Z; Sun, CJ; Qu, L; Wang, KH; Yang, N				Liu, Zhuang; Sun, Congjiao; Qu, Liang; Wang, Kehua; Yang, Ning			Genome-Wide Detection of Selective Signatures in Chicken through High Density SNPs	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; REVEALS LOCI; ASSOCIATION; SCAN; SIGNALS; DIFFERENTIATION; VARIANTS; MODEL; TOOL	Chicken is recognized as an excellent model for studies of genetic mechanism of phenotypic and genomic evolution, with large effective population size and strong human-driven selection. In the present study, we performed Extended Haplotype Homozygosity (EHH) tests to identify significant core regions employing 600K SNP Chicken chip in an F2 population of 1,534 hens, which was derived from reciprocal crosses between White Leghorn and Dongxiang chicken. Results indicated that a total of 49,151 core regions with an average length of 9.79 Kb were identified, which occupied approximately 52.15% of genome across all autosomes, and 806 significant core regions attracted us mostly. Genes in candidate regions may experience positive selection and were considered to have possible influence on beneficial economic traits. A panel of genes including AASDHPPT, GDPD5, PAR3, SOX6, GPC1 and a signal pathway of AKT1 were detected with the most extreme P-values. Further enrichment analyses indicated that these genes were associated with immune function, sensory organ development and neurogenesis, and may have experienced positive selection in chicken. Moreover, some of core regions exactly overlapped with genes excavated in our previous GWAS, suggesting that these genes have undergone positive selection may affect egg production. Findings in our study could draw a comparatively integrate genome-wide map of selection signature in the chicken genome, and would be worthy for explicating the genetic mechanisms of phenotypic diversity in poultry breeding.	[Liu, Zhuang; Sun, Congjiao; Yang, Ning] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Beijing 100193, Peoples R China; [Liu, Zhuang; Sun, Congjiao; Yang, Ning] China Agr Univ, MOA Key Lab Anim Genet & Breeding, Coll Anim Sci & Technol, Beijing 100193, Peoples R China; [Qu, Liang; Wang, Kehua] Jiangsu Inst Poultry Sci, Yangzhou 225125, Jiangsu, Peoples R China	China Agricultural University; China Agricultural University	Yang, N (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Beijing 100193, Peoples R China.; Yang, N (corresponding author), China Agr Univ, MOA Key Lab Anim Genet & Breeding, Coll Anim Sci & Technol, Beijing 100193, Peoples R China.	nyang@cau.edu.cn		Liu, Zhuang/0000-0001-8938-0086; Yang, Ning/0000-0001-5772-3320	National High Technology Research and Development Program of China [2013AA102501]; National Natural Science Foundation of China [31320103905]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1191]; China Agriculture Research Systems [CARS-41]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); China Agriculture Research Systems	This work was funded by National High Technology Research and Development Program of China (2013AA102501), National Natural Science Foundation of China (31320103905), Program for Changjiang Scholars and Innovative Research Team in University (IRT1191), and China Agriculture Research Systems (CARS-41).	Aburto MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030790; Afonso C, 2006, J CELL SCI, V119, P4293, DOI 10.1242/jcs.03170; Antao EM, 2008, MICROB PATHOGENESIS, V45, P361, DOI 10.1016/j.micpath.2008.08.005; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Benevolo M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-132; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dorval KM, 2005, J BIOL CHEM, V280, P10100, DOI 10.1074/jbc.M412676200; Enard D, 2014, GENOME RES, V24, P885, DOI 10.1101/gr.164822.113; Feng SZ, 2011, J GEN VIROL, V92, P1688, DOI 10.1099/vir.0.030866-0; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Harris MP, 2004, DEV DYNAM, V231, P22, DOI 10.1002/dvdy.20096; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Kim Y, 2004, GENETICS, V167, P1513, DOI 10.1534/genetics.103.025387; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Lee KE, 2014, P NATL ACAD SCI USA, V111, P2794, DOI 10.1073/pnas.1308758111; LEWONTIN RC, 1973, GENETICS, V74, P175; Li DF, 2012, POULTRY SCI, V91, P1804, DOI 10.3382/ps.2012-02275; Mann ZF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4839; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Pan DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060440; Park S, 2013, SCIENCE, V339, P324, DOI 10.1126/science.1231921; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qanbari S, 2010, ANIM GENET, V41, P377, DOI 10.1111/j.1365-2052.2009.02016.x; Qanbari S, 2014, LIVEST SCI, V166, P133, DOI 10.1016/j.livsci.2014.05.003; Roux C, 2013, MOL BIOL EVOL, V30, P435, DOI 10.1093/molbev/mss246; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Shi LH, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/354094; Shiau CE, 2010, DEV BIOL, V348, P107, DOI 10.1016/j.ydbio.2010.09.017; Smith J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-49; Tako E, 2010, POULTRY SCI, V89, P514, DOI 10.3382/ps.2009-00326; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Velleman SG, 2004, POULTRY SCI, V83, P1020, DOI 10.1093/ps/83.6.1020; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Walsh EC, 2006, HUM GENET, V119, P92, DOI 10.1007/s00439-005-0090-0; Wang ZH, 2005, HUM MOL GENET, V14, P2075, DOI 10.1093/hmg/ddi212; Wang Z, 2014, ANIM GENET, V45, P808, DOI 10.1111/age.12229; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yi GQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1945-y; Yuan J, 2015, PLOS ONE, V10; Yuan JW, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0161-1; Zhang C, 2006, BIOINFORMATICS, V22, P2122, DOI 10.1093/bioinformatics/btl365; Zhang H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-704	49	6	6	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166146	10.1371/journal.pone.0166146	http://dx.doi.org/10.1371/journal.pone.0166146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820849	Green Submitted, Green Published, gold			2022-12-26	WOS:000387614800036
J	Seiter, M; Schausberger, P				Seiter, Michael; Schausberger, Peter			Constitutive and Operational Variation of Learning in Foraging Predatory Mites	PLOS ONE			English	Article							AMBLYSEIUS-SWIRSKII; NATURAL VARIATION; MEMORY; FOOD; BEHAVIOR; ABILITY; COST; REPRODUCTION; DYNAMICS; THRIPS	Learning is widely documented across animal taxa but studies stringently scrutinizing the causes of constitutive or operational variation of learning among populations and individuals are scarce. The ability to learn is genetically determined and subject to constitutive variation while the performance in learning depends on the immediate circumstances and is subject to operational variation. We assessed variation in learning ability and performance of plant-inhabiting predatory mites, Amblyseius swirskii, caused by population origin, rearing diet, and type of experience. Using an early learning foraging paradigm, we determined that homogeneous single prey environments did not select for reduced learning ability, as compared to natural prey-diverse environments, whereas a multi-generational pollen diet resulted in loss of learning, as compared to a diet of live prey. Associative learning produced stronger effects than non-associative learning but both types of experience produced persistent memory. Our study represents a key example of environmentally caused variation in learning ability and performance.	[Seiter, Michael; Schausberger, Peter] Univ Nat Resources & Life Sci, Dept Crop Sci, Grp Arthropod Ecol & Behav, Vienna, Austria; [Schausberger, Peter] Univ Vienna, Dept Behav Biol, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Vienna	Schausberger, P (corresponding author), Univ Nat Resources & Life Sci, Dept Crop Sci, Grp Arthropod Ecol & Behav, Vienna, Austria.; Schausberger, P (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.	peter.schausberger@univie.ac.at		Schausberger, Peter/0000-0002-1529-3198	Austrian Science Fund (FWF) [P 25876-B25]; Austrian Science Fund (FWF) [P 25876] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The study was supported by a grant from the Austrian Science Fund (FWF; P 25876-B25) to PS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar Y, 2003, J INSECT BEHAV, V16, P811, DOI 10.1023/B:JOIR.0000018322.45068.a9; Akman C, 2004, EPILEPSY BEHAV, V5, P446, DOI 10.1016/j.yebeh.2004.03.008; ALCOCK J, 2005, ANIMAL BEHAV EVOLUTI; ALLOWAY TM, 1972, ANNU REV ENTOMOL, V17, P43, DOI 10.1146/annurev.en.17.010172.000355; Barron AB, 2015, TRENDS NEUROSCI, V38, P405, DOI 10.1016/j.tins.2015.04.008; BATESON P, 1979, ANIM BEHAV, V27, P470, DOI 10.1016/0003-3472(79)90184-2; Bernays EA, 1998, AM NAT, V151, P451, DOI 10.1086/286132; Bolckmans K.J.F., 2006, WO Patent, Patent No. [WO/2006/057552, 2006057552]; Brydges NM, 2008, ANIM BEHAV, V75, P935, DOI 10.1016/j.anbehav.2007.08.005; Burger JMS, 2010, AGING CELL, V9, P327, DOI 10.1111/j.1474-9726.2010.00560.x; Christiansen IC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23571; Colombelli-Negrel D, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1154; Darmaillacq AS, 2006, BIOL LETTERS, V2, P345, DOI 10.1098/rsbl.2006.0477; De Boer JG, 2006, ANIM BIOL, V56, P143, DOI 10.1163/157075606777304221; Drukker B, 2000, EXP APPL ACAROL, V24, P881, DOI 10.1023/A:1010645720829; Nguyen DT, 2013, BIOCONTROL, V58, P369, DOI 10.1007/s10526-012-9502-y; Dudai Y., 1989, NEUROBIOLOGY MEMORY; Dukas R, 2000, BEHAV ECOL, V11, P536, DOI 10.1093/beheco/11.5.536; Ferreira F. R., 2006, Bioscience Journal, V22, P91; Fidgett M.J., 2008, WO patent, Patent No. [WO2008/015393, 2008015393]; Franks NR, 2006, NATURE, V439, P153, DOI 10.1038/439153a; Gandolfi M, 2003, J CHEM ECOL, V29, P1871, DOI 10.1023/A:1024854312528; Giurfa M, 2004, LEARN MEMORY, V11, P294, DOI 10.1101/lm.63604; Goleva I, 2013, EXP APPL ACAROL, V61, P259, DOI 10.1007/s10493-013-9700-z; GOODENOUGH J, 2001, PERSPECTIVES ANIMAL; Hebets EA, 2003, P NATL ACAD SCI USA, V100, P13390, DOI 10.1073/pnas.2333262100; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; Hoedjes KM, 2011, P ROY SOC B-BIOL SCI, V278, P889, DOI 10.1098/rspb.2010.2199; IMMELMANN K, 1975, ANNU REV ECOL SYST, V6, P15, DOI 10.1146/annurev.es.06.110175.000311; Calvo FJ, 2015, EXP APPL ACAROL, V65, P419, DOI 10.1007/s10493-014-9873-0; Kaiser L, 2003, ANIM BEHAV, V66, P1077, DOI 10.1006/anbe.2003.2302; Kawecki TJ, 2010, POPUL ECOL, V52, P15, DOI 10.1007/s10144-009-0174-0; Kolss M, 2008, ECOL ENTOMOL, V33, P583, DOI 10.1111/j.1365-2311.2008.01007.x; LEVINS R, 1969, Ecology (Washington D C), V50, P910, DOI 10.2307/1933709; McMurtry JA, 1997, ANNU REV ENTOMOL, V42, P291, DOI 10.1146/annurev.ento.42.1.291; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Mery F, 2002, P NATL ACAD SCI USA, V99, P14274, DOI 10.1073/pnas.222371199; Mery F, 2003, P ROY SOC B-BIOL SCI, V270, P2465, DOI 10.1098/rspb.2003.2548; Mery F, 2004, ANIM BEHAV, V68, P589, DOI 10.1016/j.anbehav.2003.12.005; Mery F, 2007, P NATL ACAD SCI USA, V104, P13051, DOI 10.1073/pnas.0702923104; Mery F, 2013, CURR OPIN NEUROBIOL, V23, P52, DOI 10.1016/j.conb.2012.09.001; Messelink GJ, 2008, BIOL CONTROL, V44, P372, DOI 10.1016/j.biocontrol.2007.10.017; Mogensen J, 2003, PHARMACOL BIOCHEM BE, V76, P197, DOI 10.1016/S0091-3057(03)00220-X; Papaj D.R., 1993, INSECT LEARNING ECOL; Pearce J. M., 2008, ANIMAL LEARNING COGN, V3rd; Peralta Quesada PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053229; Pereira S, 2012, J NEUROSCI, V32, P9035, DOI 10.1523/JNEUROSCI.4221-11.2012; Potting RPJ, 1997, ANIM BEHAV, V53, P1211, DOI 10.1006/anbe.1996.0382; Punzo F, 2002, BEHAV PROCESS, V58, P177, DOI 10.1016/S0376-6357(02)00031-1; Rahmani H, 2009, BEHAV ECOL, V20, P946, DOI 10.1093/beheco/arp081; Rowe C, 2014, BEHAV ECOL, V25, P1287, DOI 10.1093/beheco/aru090; Sabelis M.W., 1985, P43; Schausberger P, 1997, EXP APPL ACAROL, V21, P131, DOI 10.1023/A:1018478418010; Schausberger P, 2007, BEHAV ECOL SOCIOBIOL, V62, P119, DOI 10.1007/s00265-007-0444-9; Schausberger P, 2010, BEHAVIOUR, V147, P883, DOI 10.1163/000579510X495799; Segura DF, 2007, ANIM BEHAV, V74, P131, DOI 10.1016/j.anbehav.2006.12.005; Snell-Rood EC, 2011, BEHAV ECOL, V22, P291, DOI 10.1093/beheco/arq169; Stephens D.W., 1986, pi; Stireman JO, 2002, J INSECT BEHAV, V15, P689, DOI 10.1023/A:1020752024329; Strodl MA, 2013, OIKOS, V122, P1217, DOI 10.1111/j.1600-0706.2012.20833.x; Strodl MA, 2012, NATURWISSENSCHAFTEN, V99, P303, DOI 10.1007/s00114-012-0903-7; Vangansbeke D, 2016, PEST MANAG SCI, V72, P466, DOI 10.1002/ps.4000; Walzer A, 2011, ANIM BEHAV, V81, P177, DOI 10.1016/j.anbehav.2010.09.031; Walzer A, 2009, OIKOS, V118, P934, DOI 10.1111/j.1600-0706.2008.17299.x; Xia SZ, 1997, PHYSIOL BEHAV, V62, P263, DOI 10.1016/S0031-9384(97)00113-3; Yanai S, 2004, NEUROBIOL AGING, V25, P325, DOI 10.1016/S0197-4580(03)00115-5	66	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166334	10.1371/journal.pone.0166334	http://dx.doi.org/10.1371/journal.pone.0166334			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814380	Green Published, Green Submitted, gold			2022-12-26	WOS:000386911100038
J	Fong-ngern, K; Vinaiphat, A; Thongboonkerd, V				Fong-ngern, Kedsarin; Vinaiphat, Arada; Thongboonkerd, Visith			Microvillar injury in renal tubular epithelial cells induced by calcium oxalate crystal and the protective role of epigallocatechin-3-gallate	FASEB JOURNAL			English	Article						EGCG; ezrin; kidney stone; microvilli; oxidative stress	KIDNEY-STONE FORMATION; OXIDATIVE STRESS; MONOHYDRATE CRYSTAL; PROXIMAL TUBULE; DIFFERENTIATED PROPERTIES; PROTEOMIC-ANALYSIS; ENDOTHELIAL-CELLS; APICAL MEMBRANE; LINE MDCK; EZRIN	Pathogenic mechanisms of kidney stone disease remained unclear. This study investigated its initial cellular/molecular mechanisms when calcium oxalate monohydrate (COM) crystal adhered to renal tubular cells. Transmission electron microscopy revealed decreased length and density of microvilli, whereas Western blot analysis showed that whole-cell ezrin (a microvillus-stabilizing protein), not beta-actin, was decreased in COM-treated cells. Immunofluorescence staining, followed by laser-scanning confocal microscopy and subcellular fractionations, revealed decreases in both ezrin and F-/beta-actin at apical membrane. Cytoskeletal extraction by Triton X-100 showed reduced cytoskeleton-associated ezrin, consistent with colocalization data of ezrin/F-actin. Thr(567)-phosphorylated ezrin and RhoA increased in COM-treated cells. A protein oxidation blot assay showed an increase in oxidized proteins in COM-treated cells that could be prevented by epigallocatechin-3-gallate (EGCG), which also preserved the whole-cell ezrin level, stabilized apical membrane ezrin/F-actin colocalization, and maintained microvillar structure in COM-treated and H2O2-treated cells. Our data clearly demonstrated the reduction of ezrin and actin expression at the apical membrane of COM-treated cells, most likely because of oxidative stress, which could be prevented by EGCG. These findings provide a novel approach to better understanding of the pathogenesis of kidney stone disease in its initial phase and offer potential preventive strategy against microvillar injury induced by COM crystals in patients with kidney stones.-Fong-ngern, K., Vinaiphat, A., Thongboonkerd, V. Microvillar injury in renal tubular epithelial cells induced by calcium oxalate crystal and the protective role of epigallocatechin-3-gallate.	Siriraj Hosp, Med Prote Unit, Off Res & Dev, Fac Med, Bangkok, Thailand; Mahidol Univ, Ctr Res Complex Syst Sci, Bangkok, Thailand	Mahidol University; Mahidol University	Thongboonkerd, V (corresponding author), Mahidol Univ, Med Prote Unit, Off Res & Dev, Siriraj Hosp, 6th Floor,SiMR Bldg,2 Wanglang Rd, Bangkok 10700, Thailand.	thongboonkerd@dr.com	Thongboonkerd, Visith/C-6920-2009	Thongboonkerd, Visith/0000-0001-7865-0765	Mahidol University; Office of the Higher Education Commission; Mahidol University, under the National Research Universities Initiative; Thailand Research Fund [RTA5680004, TRG5680008]; "Chalermphrakiat" grant; Faculty of Medicine, Siriraj Hospital	Mahidol University; Office of the Higher Education Commission; Mahidol University, under the National Research Universities Initiative; Thailand Research Fund(Thailand Research Fund (TRF)); "Chalermphrakiat" grant; Faculty of Medicine, Siriraj Hospital	The authors thank Ms. Nusara Chomanee (Faculty of Medicine Siriraj Hospital) for technical support. This study was supported by a Mahidol University research grant; the Office of the Higher Education Commission and Mahidol University, under the National Research Universities Initiative; and Thailand Research Fund Grants RTA5680004 and TRG5680008. V.T. is supported by a "Chalermphrakiat" grant, and K.F.-N. is supported by a research staff grant from the Faculty of Medicine, Siriraj Hospital. The authors declare no conflicts of interest.	BERRYMAN M, 1993, J CELL SCI, V105, P1025; Bonfili L, 2011, BIOCHIMIE, V93, P931, DOI 10.1016/j.biochi.2011.02.003; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Brown D, 1997, AM J PHYSIOL-RENAL, V273, pF1003, DOI 10.1152/ajprenal.1997.273.6.F1003; Brown JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009406; Casaletto JB, 2011, P NATL ACAD SCI USA, V108, P11924, DOI 10.1073/pnas.1103418108; Chaiyarit S, 2012, J PROTEOME RES, V11, P3269, DOI 10.1021/pr300018c; Coe FL, 2010, UROL RES, V38, P147, DOI 10.1007/s00240-010-0271-8; Davalos M, 2010, J ENDOUROL, V24, P339, DOI 10.1089/end.2009.0205; Evan AP, 2015, UROLITHIASIS, V43, pS19, DOI 10.1007/s00240-014-0701-0; Evan AP, 2003, J CLIN INVEST, V111, P607, DOI 10.1172/JCI200317038; Fidalgo M, 2012, J BIOL CHEM, V287, P11556, DOI 10.1074/jbc.M111.320259; Fong-ngern K, 2011, J PROTEOME RES, V10, P4463, DOI 10.1021/pr2006878; Fong-ngern K, 2009, ANAL BIOCHEM, V395, P25, DOI 10.1016/j.ab.2009.08.007; Grune T, 2002, FASEB J, V16, P1602, DOI 10.1096/fj.02-0015com; Hirose M, 2008, UROL RES, V36, P139, DOI 10.1007/s00240-008-0143-7; Hirose M, 2010, INT J UROL, V17, P83, DOI 10.1111/j.1442-2042.2009.02410.x; Hobbs G.A., 2014, SMALL GTPASES, V5; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; Khan SR, 2014, TRANSL ANDROL UROL, V3, P256, DOI 10.3978/j.issn.2223-4683.2014.06.04; Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022; KOK DJ, 1994, KIDNEY INT, V46, P847, DOI 10.1038/ki.1994.341; Lieske JC, 1999, J AM SOC NEPHROL, V10, pS422; LIESKE JC, 1994, P NATL ACAD SCI USA, V91, P6987, DOI 10.1073/pnas.91.15.6987; Parks JH, 1997, KIDNEY INT, V51, P894, DOI 10.1038/ki.1997.126; Parnell E, 2015, BBA-MOL CELL RES, V1853, P1749, DOI 10.1016/j.bbamcr.2015.04.009; Rabinovich YI, 2006, J COLLOID INTERF SCI, V300, P131, DOI 10.1016/j.jcis.2006.03.070; Randall A, 1937, ANN SURG, V105, P1009, DOI 10.1097/00000658-193706000-00014; RINDLER MJ, 1979, J CELL BIOL, V81, P635, DOI 10.1083/jcb.81.3.635; SAIER MH, 1981, AM J PHYSIOL, V240, pC106, DOI 10.1152/ajpcell.1981.240.3.C106; Semangoen T, 2008, PROTEOM CLIN APPL, V2, P1099, DOI 10.1002/prca.200780136; Tang FQ, 2009, J BIOL CHEM, V284, P27456, DOI 10.1074/jbc.M109.033795; Thongboonkerd V, 2006, CLIN CHIM ACTA, V367, P120, DOI 10.1016/j.cca.2005.11.033; Thongboonkerd V, 2008, J PROTEOME RES, V7, P4689, DOI 10.1021/pr8002408; Thongboonkerd V, 2008, CONTRIB NEPHROL, V160, P142, DOI 10.1159/000125972; Thongboonkerd V, 2008, J UROLOGY, V179, P1615, DOI 10.1016/j.juro.2007.11.041; Tsujihata M, 2008, INT J UROL, V15, P115, DOI 10.1111/j.1442-2042.2007.01953.x; White P, 2000, AM J PHYSIOL-RENAL, V278, pF886, DOI 10.1152/ajprenal.2000.278.6.F886; Worcester EM, 2013, AM J PHYSIOL-RENAL, V305, pF1574, DOI 10.1152/ajprenal.00382.2013; Wu YX, 2000, J CELL BIOCHEM, V79, P311, DOI 10.1002/1097-4644(20001101)79:2<311::AID-JCB140>3.0.CO;2-Z; Xiao YJ, 2014, RHEUMATOLOGY, V53, P1291, DOI 10.1093/rheumatology/keu013; Xiong Y, 2007, PLANT PHYSIOL, V143, P291, DOI 10.1104/pp.106.092106; Zhai W, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-228; Zwaenepoel I, 2012, MOL BIOL CELL, V23, P1080, DOI 10.1091/mbc.E11-07-0588	44	22	23	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					120	131		10.1096/fj.201600543R	http://dx.doi.org/10.1096/fj.201600543R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27825102				2022-12-26	WOS:000392177600014
J	Koblitz, JC; Stilz, P; Rasmussen, MH; Laidre, KL				Koblitz, Jens C.; Stilz, Peter; Rasmussen, Marianne H.; Laidre, Kristin L.			Highly Directional Sonar Beam of Narwhals (Monodon monoceros) Measured with a Vertical 16 Hydrophone Array	PLOS ONE			English	Article							DOLPHINS TURSIOPS-TRUNCATUS; HIGH-FREQUENCY CLICKS; ECHOLOCATION CLICKS; SOURCE PARAMETERS; HARBOR PORPOISES; NARROW-BAND; SIGNALS; PATTERN; BEHAVIOR; SOUND	Recordings of narwhal (Monodon monoceros) echolocation signals were made using a linear 16 hydrophone array in the pack ice of Baffin Bay, West Greenland in 2013 at eleven sites. An average-3 dB beam width of 5.0 degrees makes the narwhal click the most directional biosonar signal reported for any species to date. The beam shows a dorsal-ventral asymmetry with a narrower beam above the beam axis. This may be an evolutionary advantage for toothed whales to reduce echoes from the water surface or sea ice surface. Source level measurements show narwhal click intensities of up to 222 dB pp re 1 mu Pa, with a mean apparent source level of 215 dB pp re 1 mu Pa. During ascents and descents the narwhals perform scanning in the vertical plane with their sonar beam. This study provides valuable information for reference sonar parameters of narwhals and for the use of acoustic monitoring in the Arctic.	[Koblitz, Jens C.] Bioacoust Network, Neuss, Germany; [Stilz, Peter] Bioacoust Network, Hechingen, Germany; [Rasmussen, Marianne H.] Univ Iceland, Res Ctr Husavik, Husavik, Iceland; [Laidre, Kristin L.] Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA	University of Iceland; University of Washington; University of Washington Seattle	Koblitz, JC (corresponding author), Bioacoust Network, Neuss, Germany.; Laidre, KL (corresponding author), Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA.	Jens.Koblitz@gmail.com; klaidre@uw.edu			ONR [N00014-11-1-0201]	ONR(Office of Naval Research)	ONR funded the study on a grant to K. Laidre (N00014-11-1-0201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ONR funded the study on a grant to K.L. Laidre (N00014-11-1-0201). Mikkel Villium Jensen assisted in the field, and skilled flying was conducted by our pilot Geir Akse of Air Greenland. People of the community of Niaqornat are thanked for their generosity and assistance. Greenland Institute of Natural Resource provided housing. The University of Tubingen and the German Oceanographic Museum Stralsund provided recording equipment. Support from CAE Software & Systems is highly appreciated. Two reviewers improved the manuscript.	AMSA, 2009, ARCT MAR SHIPP ASS 2; AROYAN JL, 1992, J ACOUST SOC AM, V92, P2539, DOI 10.1121/1.404424; Au WWL, 2012, J ACOUST SOC AM, V131, P569, DOI 10.1121/1.3662077; Au WWL, 2010, J ACOUST SOC AM, V128, P1426, DOI 10.1121/1.3372643; Au WWL, 2003, NATURE, V423, P861, DOI 10.1038/nature01727; Au WWL, 2003, J ACOUST SOC AM, V113, P598, DOI 10.1121/1.1518980; AU WWL, 1978, J ACOUST SOC AM, V64, P411, DOI 10.1121/1.382015; AU WWL, 1986, J ACOUST SOC AM, V80, P688, DOI 10.1121/1.394012; AU WWL, 1995, J ACOUST SOC AM, V98, P51, DOI 10.1121/1.413643; AU WWL, 1987, J ACOUST SOC AM, V82, P807, DOI 10.1121/1.395278; Baumann-Pickering S, 2013, J ACOUST SOC AM, V134, P2293, DOI 10.1121/1.4817832; Baumann-Pickering S, 2010, J ACOUST SOC AM, V128, P2212, DOI 10.1121/1.3479549; de Freitas M, 2015, J ACOUST SOC AM, V137, P3033, DOI 10.1121/1.4921277; Dietz Rune, 2007, BMC Ecology, V7, P14, DOI 10.1186/1472-6785-7-14; Finley K.J., 1990, Canadian Bulletin of Fisheries and Aquatic Sciences, V224, P97; Finneran JJ, 2014, J ACOUST SOC AM, V136, P2025, DOI 10.1121/1.4895682; FISHER FH, 1977, J ACOUST SOC AM, V62, P558, DOI 10.1121/1.381574; FORD JKB, 1978, CAN J ZOOL, V56, P552, DOI 10.1139/z78-079; Heide-Jorgensen MP, 2010, J MAMMAL, V91, P1135, DOI 10.1644/09-MAMM-A-198.1; Heide-Jorgensen MP, 2002, POLAR BIOL, V25, P331, DOI 10.1007/s00300-001-0347-6; Innes Stuart, 2002, NAMMCO Scientific Publications, V4, P169; Jensen FH, 2009, J EXP BIOL, V212, P1078, DOI 10.1242/jeb.025619; Jensen FH, 2015, J EXP BIOL, V218, P1314, DOI 10.1242/jeb.116285; Jensen FH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059284; Johnson M, 2009, MAR ECOL PROG SER, V395, P55, DOI 10.3354/meps08255; Koblitz JC, 2012, J ACOUST SOC AM, V131, P2315, DOI 10.1121/1.3683254; Kyhn LA, 2010, J EXP BIOL, V213, P1940, DOI 10.1242/jeb.042440; Kyhn LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063763; Kyhn LA, 2009, J ACOUST SOC AM, V125, P1783, DOI 10.1121/1.3075600; Ladegaard M, 2015, J EXP BIOL, V218, P3091, DOI 10.1242/jeb.120501; Laidre KL, 2004, MAR BIOL, V145, P821, DOI 10.1007/s00227-004-1371-1; Laidre KL, 2004, ICES J MAR SCI, V61, P430, DOI 10.1016/j.icesjms.2004.02.002; Laidre KL, 2003, MAR ECOL PROG SER, V261, P269, DOI 10.3354/meps261269; Laidre KL, 2008, ECOL APPL, V18, pS97, DOI 10.1890/06-0546.1; Laidre KL, 2015, CONSERV BIOL, V29, P724, DOI 10.1111/cobi.12474; Lurton X., 2002, INTRO UNDERWATER ACO; Madsen PT, 2010, J EXP BIOL, V213, P3105, DOI 10.1242/jeb.044420; Madsen PT, 2004, J EXP BIOL, V207, P1811, DOI 10.1242/jeb.00966; Marcoux M, 2012, MAR MAMMAL SCI, V28, P649, DOI 10.1111/j.1748-7692.2011.00514.x; MILLER LA, 1995, MAR MAMMAL SCI, V11, P491, DOI 10.1111/j.1748-7692.1995.tb00672.x; Mohl B, 2003, J ACOUST SOC AM, V114, P1143, DOI 10.1121/1.1586258; MOHL B, 1990, NATO ADV SCI I A-LIF, V196, P295; Mohl B, 2000, J ACOUST SOC AM, V107, P638, DOI 10.1121/1.428329; Moore PW, 2008, J ACOUST SOC AM, V124, P3324, DOI 10.1121/1.2980453; NORRIS KS, 1961, BIOL BULL, V120, P163, DOI 10.2307/1539374; Overland JE, 2013, GEOPHYS RES LETT, V40, P2097, DOI 10.1002/grl.50316; Rasmussen MH, 2015, AQUAT MAMM, V41, P256, DOI 10.1578/AM.41.3.2015.256; Rasmussen MH, 2004, J ACOUST SOC AM, V116, P1826, DOI 10.1121/1.1775274; Rasmussen MH, 2002, J ACOUST SOC AM, V111, P1122, DOI 10.1121/1.1433814; Reeves RR, 2014, MAR POLICY, V44, P375, DOI 10.1016/j.marpol.2013.10.005; Richard PR, 2010, ARCTIC, V63, P85; Roch MA, 2011, J ACOUST SOC AM, V129, P467, DOI 10.1121/1.3514383; SCHEVILL WILLIAM E., 1956, BREVIORA MUS COMP ZOOL [HARVARD], V53, P1; Seibert AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060752; Shaffer JW, 2013, J ACOUST SOC AM, V133, P1770, DOI 10.1121/1.4776177; Soldevilla MS, 2008, J ACOUST SOC AM, V124, P609, DOI 10.1121/1.2932059; Stafford KM, 2012, MAR MAMMAL SCI, V28, pE197, DOI 10.1111/j.1748-7692.2011.00500.x; Surlykke A, 2009, J EXP BIOL, V212, P1011, DOI 10.1242/jeb.024620; Villadsgaard A, 2007, J EXP BIOL, V210, P56, DOI 10.1242/jeb.02618; Wahlberg M, 2001, J ACOUST SOC AM, V109, P397, DOI 10.1121/1.1329619; Wahlberg M, 2014, SPRINGER HANDB AUDIT, V51, P107, DOI 10.1007/978-1-4614-9146-0_4; Wahlberg M, 2011, J ACOUST SOC AM, V130, P2263, DOI 10.1121/1.3624822; WATKINS WA, 1971, J ACOUST SOC AM, V49, P595, DOI 10.1121/1.1912391; Wei C, 2014, J ACOUST SOC AM, V136, P423, DOI 10.1121/1.4883597; Wisniewska DM, 2015, ELIFE, V4, DOI 10.7554/eLife.05651; Wisniewska DM, 2012, J EXP BIOL, V215, P4358, DOI 10.1242/jeb.074013; Yovel Y, 2010, SCIENCE, V327, P701, DOI 10.1126/science.1183310; Zimmer WMX, 2005, J ACOUST SOC AM, V117, P3919, DOI 10.1121/1.1910225	68	14	14	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0162069	10.1371/journal.pone.0162069	http://dx.doi.org/10.1371/journal.pone.0162069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828956	Green Published, gold, Green Submitted			2022-12-26	WOS:000387724300004
J	Taylor, M; Gozen, I; Patel, S; Jesorka, A; Bertoldi, K				Taylor, Michael; Gozen, Irep; Patel, Samir; Jesorka, Aldo; Bertoldi, Katia			Peridynamic Modeling of Ruptures in Biomembranes	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; CRACK-PROPAGATION; MEMBRANE-FLUIDITY; LIPID-BILAYERS; ELASTICITY; FRACTURE; CALCIUM; PORES	We simulate the formation of spontaneous ruptures in supported phospholipid double bilayer membranes, using peridynamic modeling. Experiments performed on spreading double bilayers typically show two distinct kinds of ruptures, floral and fractal, which form spontaneously in the distal (upper) bilayer at late stages of double bilayer formation on high energy substrates. It is, however, currently unresolved which factors govern the occurrence of either rupture type. Variations in the distance between the two bilayers, and the occurrence of interconnections ("pinning sites") are suspected of contributing to the process. Our new simulations indicate that the pinned regions which form, presumably due to Ca2+ ions serving as bridging agent between the distal and the proximal bilayer, act as nucleation sites for the ruptures. Moreover, assuming that the pinning sites cause a non-zero shear modulus, our simulations also show that they change the rupture mode from floral to fractal. At zero shear modulus the pores appear to be circular, subsequently evolving into floral pores. With increasing shear modulus the pore edges start to branch, favoring fractal morphologies. We conclude that the pinning sites may indirectly determine the rupture morphology by contributing to shear stress in the distal membrane.	[Taylor, Michael] Santa Clara Univ, Dept Mech Engn, Santa Clara, CA 95053 USA; [Gozen, Irep; Patel, Samir; Bertoldi, Katia] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Jesorka, Aldo] Chalmers, Dept Chem & Chem Engn, Gothenburg, Sweden	Santa Clara University; Harvard University; Chalmers University of Technology	Bertoldi, K (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	bertoldi@seas.harvard.edu		Gozen, Irep/0000-0002-5379-3273; Taylor, Michael/0000-0002-3702-4191	Santa Clara University; Vetenskapsradet [637-2013-414]; Horizon [664786]; National Science Foundation; Harvard MRSEC [DMR1420570]	Santa Clara University; Vetenskapsradet(Swedish Research Council); Horizon; National Science Foundation(National Science Foundation (NSF)); Harvard MRSEC(National Science Foundation (NSF))	This work was made possible through financial support obtained from the Start-up Funding from the Santa Clara University (MT); Vetenskapsradet 637-2013-414 (IG); Horizon 2020 664786 (AJ), National Science Foundation and Harvard MRSEC DMR1420570 (KB).	Agwai A, 2011, INT J FRACTURE, V171, P65, DOI 10.1007/s10704-011-9628-4; Akashi K, 1998, BIOPHYS J, V74, P2973, DOI 10.1016/S0006-3495(98)78004-X; Ayton G, 2002, BIOPHYS J, V82, P1226, DOI 10.1016/S0006-3495(02)75479-9; Bobaru F, 2012, CENTEURJENG, V2, P551, DOI [10.2478/s13531-012-0020-6, DOI 10.2478/S13531-012-0020-6]; Braverman B, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/262931; Dimova R, 2000, BIOPHYS J, V79, P340, DOI 10.1016/S0006-3495(00)76296-5; Espinosa G, 2011, P NATL ACAD SCI USA, V108, P6008, DOI 10.1073/pnas.1018572108; Falconer K., 2014, FRACTAL GEOMETRY MAT; Fan HF, 2016, INT J IMPACT ENG, V87, P14, DOI 10.1016/j.ijimpeng.2015.08.006; Gerstle W, 2007, NUCL ENG DES, V237, P1250, DOI 10.1016/j.nucengdes.2006.10.002; Gozen I, 2013, SOFT MATTER, V9, P2787, DOI 10.1039/c3sm27429b; Gozen I, 2014, EUR PHYS J-SPEC TOP, V223, P1813, DOI 10.1140/epjst/e2014-02228-5; Gozen I, 2012, SOFT MATTER, V8, P6220, DOI 10.1039/c2sm25629k; Gozen I, 2010, NAT MATER, V9, P908, DOI [10.1038/NMAT2854, 10.1038/nmat2854]; Ha Y, 2010, INT J FRACTURE, V162, P229, DOI 10.1007/s10704-010-9442-4; Hu WK, 2012, COMPUT METHOD APPL M, V217, P247, DOI 10.1016/j.cma.2012.01.016; Hu WK, 2011, INT J MULTISCALE COM, V9, P707, DOI 10.1615/IntJMultCompEng.2011002651; Huang D, 2011, SCI CHINA TECHNOL SC, V54, P591, DOI 10.1007/s11431-011-4306-3; Jadidi Tayebeh, 2014, Front Bioeng Biotechnol, V2, P8, DOI 10.3389/fbioe.2014.00008; Janssen JZ M., 2004, FRACTURE MECH, DOI DOI 10.1529/BIOPHYSJ.107; Kilic B, 2010, THEOR APPL FRACT MEC, V53, P194, DOI 10.1016/j.tafmec.2010.08.001; Lai X, 2015, INT J NUMER ANAL MET, V39, P1304, DOI 10.1002/nag.2356; Liu W, 2012, DISCRETIZED BOND BAS; Liu WY, 2012, INT J NUMER METH ENG, V89, P1028, DOI 10.1002/nme.3278; Madenci E., 2013, PERIDYNAMIC THEORY I; Oterkus E, 2012, OPEN ENG, V2, P523, DOI 10.2478/s13531-012-0025-1; Oterkus E, 2012, J MECH MATER STRUCT, V7, P45, DOI 10.2140/jomms.2012.7.45; Oterkus S, 2014, 55 AIAA ASEM ASCE AH; Pabst G, 2007, BIOPHYS J, V93, P2688, DOI 10.1529/biophysj.107.112615; Parks ML, 2008, COMPUT PHYS COMMUN, V179, P777, DOI 10.1016/j.cpc.2008.06.011; Parks ML, 2011, SANDIA REPORT 2011 8; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Saintyves B, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.047801; Seleson P, 2009, MULTISCALE MODEL SIM, V8, P204, DOI 10.1137/09074807X; Silling SA, 2007, J ELASTICITY, V88, P151, DOI 10.1007/s10659-007-9125-1; Silling SA, 2005, COMPUT STRUCT, V83, P1526, DOI 10.1016/j.compstruc.2004.11.026; Silling SA, 2005, INT J NONLIN MECH, V40, P395, DOI 10.1016/j.ijnonlinmec.2004.08.004; Silling SA, 2000, J MECH PHYS SOLIDS, V48, P175, DOI 10.1016/S0022-5096(99)00029-0; Silling SA., COMPUTATIONAL FLUID, P641; Sinn CG, 2006, COLLOID SURFACE A, V282, P410, DOI 10.1016/j.colsurfa.2005.10.014; Smith TG, 1996, J NEUROSCI METH, V69, P123, DOI 10.1016/S0165-0270(96)00080-5; Taylor M, 2015, MATH MECH SOLIDS, V20, P998, DOI 10.1177/1081286513512925; Tupek MR, 2014, J MECH PHYS SOLIDS, V65, P82, DOI 10.1016/j.jmps.2013.12.012; WATANABE H, 1990, FREE RADICAL BIO MED, V8, P507, DOI 10.1016/0891-5849(90)90150-H; Weckner O, 2013, APPL MATH COMPUT, V219, P6039, DOI 10.1016/j.amc.2012.11.090; Zohdi T., 2007, INTRO MODELING SIMUL	46	12	12	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165947	10.1371/journal.pone.0165947	http://dx.doi.org/10.1371/journal.pone.0165947			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829001	Green Submitted, gold, Green Published			2022-12-26	WOS:000387724300068
J	Walther, S; Tietze, M; Czerny, CP; Konig, S; Diesterbeck, US				Walther, Stefanie; Tietze, Manfred; Czerny, Claus-Peter; Koenig, Sven; Diesterbeck, Ulrike S.			Development of a Bioinformatics Framework for the Detection of Gene Conversion and the Analysis of Combinatorial Diversity in Immunoglobulin Heavy Chains in Four Cattle Breeds	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; COMPLEMENTARITY-DETERMINING REGION-3; VARIABLE REGION; SOMATIC DIVERSIFICATION; IG; REPERTOIRE; CHICKEN; GERMLINE; FAMILY; REARRANGEMENT	We have developed a new bioinformatics framework for the analysis of rearranged bovine heavy chain immunoglobulin (Ig) variable regions by combining and refining widely used alignment algorithms. This bioinformatics framework allowed us to investigate alignments of heavy chain framework regions (FRHs) and the separate alignments of FRHs and heavy chain complementarity determining regions (CDRHs) to determine their germline origin in the four cattle breeds Aubrac, German Black Pied, German Simmental, and Holstein Friesian. Now it is also possible to specifically analyze Ig heavy chains possessing exceptionally long CDR3Hs. In order to gain more insight into breed specific differences in Ig combinatorial diversity, somatic hypermutations and putative gene conversions of IgG, we compared the dominantly transcribed variable (IGHV), diversity (IGHD), and joining (IGHJ) segments and their recombination in the four cattle breeds. The analysis revealed the use of 15 different IGHV segments, 21 IGHD segments, and two IGHJ segments with significant different transcription levels within the breeds. Furthermore, there are preferred rearrangements within the three groups of CDR3H lengths. In the sequences of group 2 (CDR3H lengths (L) of 11-47 amino acid residues (aa)) a higher number of recombination was observed than in sequences of group 1 (L <= 10 aa) and 3 (L >= 48 aa). The combinatorial diversity of germline IGHV, IGHD, and IGHJ-segments revealed 162 rearrangements that were significantly different. The few preferably rearranged gene segments within group 3 CDR3H regions may indicate specialized antibodies because this length is unique in cattle. The most important finding of this study, which was enabled by using the bioinformatics framework, is the discovery of strong evidence for gene conversion as a rare event using pseudogenes fulfilling all definitions for this particular diversification mechanism.	[Walther, Stefanie; Czerny, Claus-Peter; Diesterbeck, Ulrike S.] Georg August Univ Goettingen, Inst Vet Med, Fac Agr Sci, Dept Anim Sci,Div Microbiol & Anim Hyg, Gottingen, Germany; [Tietze, Manfred; Koenig, Sven] Univ Kassel, Dept Anim Breeding, Witzenhausen, Germany; [Diesterbeck, Ulrike S.] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA	University of Gottingen; Universitat Kassel; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Diesterbeck, US (corresponding author), Georg August Univ Goettingen, Inst Vet Med, Fac Agr Sci, Dept Anim Sci,Div Microbiol & Anim Hyg, Gottingen, Germany.; Diesterbeck, US (corresponding author), NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.	ulrike.diesterbeck@nih.gov			Georg-August University Goettingen [GAUGIVM9100010893]; German Research Foundation (DFG); Open Access Publication Funds of the Gottingen University	Georg-August University Goettingen; German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Funds of the Gottingen University	Stefanie Walther was supported by a scholarship provided by the Georg-August University Goettingen (GAUGIVM9100010893). We acknowledge support by the German Research Foundation (DFG) and the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; BECKER RS, 1990, CELL, V63, P987, DOI 10.1016/0092-8674(90)90502-6; Berens SJ, 1997, INT IMMUNOL, V9, P189, DOI 10.1093/intimm/9.1.189; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Dufour V, 1996, J IMMUNOL, V156, P2163; EDELMAN GM, 1973, SCIENCE, V180, P830, DOI 10.1126/science.180.4088.830; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gaeta BA, 2007, BIOINFORMATICS, V23, P1580, DOI 10.1093/bioinformatics/btm147; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Hosseini A, 2004, INT IMMUNOL, V16, P843, DOI 10.1093/intimm/dxh085; KABAT EA, 2006, SEQUENCES PROTEINS I; Koti M, 2008, DEV BIOLOGICALS, V132, P307, DOI 10.1159/000317176; Koti M, 2010, MOL IMMUNOL, V47, P2119, DOI 10.1016/j.molimm.2010.02.014; Larsen PA, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-52; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Liljavirta J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099808; Lucier MR, 1998, J IMMUNOL, V161, P5438; MILLER JR, 1992, ANIM GENET, V23, P51, DOI 10.1111/j.1365-2052.1992.tb00017.x; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Niku M, 2012, DEV COMP IMMUNOL, V37, P457, DOI 10.1016/j.dci.2012.02.006; Parng CL, 1996, J IMMUNOL, V157, P5478; Retter I, 2005, NUCLEIC ACIDS RES, V33, pD671, DOI 10.1093/nar/gki088; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; REYNAUD CA, 1985, CELL, V40, P283, DOI 10.1016/0092-8674(85)90142-4; REYNAUD CA, 1995, CELL, V80, P115, DOI 10.1016/0092-8674(95)90456-5; REYNAUD CA, 1994, ADV IMMUNOL, V57, P353, DOI 10.1016/S0065-2776(08)60676-8; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; Saini SS, 1997, MOL IMMUNOL, V34, P641, DOI 10.1016/S0161-5890(97)00055-2; Saini SS, 2003, INT IMMUNOL, V15, P845, DOI 10.1093/intimm/dxg083; Saini SS, 1999, J IMMUNOL, V162, P5624; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Scaviner D, 1999, EXP CLIN IMMUNOGENET, V16, P234, DOI 10.1159/000019115; Shojaei F, 2003, MOL IMMUNOL, V40, P61, DOI 10.1016/S0161-5890(03)00098-1; Sinclair MC, 1997, J IMMUNOL, V159, P3883; Souto-Carneiro MM, 2004, J IMMUNOL, V172, P6790, DOI 10.4049/jimmunol.172.11.6790; SUN J, 1994, J IMMUNOL, V153, P5618; Sun Y, 2010, DEV COMP IMMUNOL, V34, P1009, DOI 10.1016/j.dci.2010.05.003; Tallmadge RL, 2014, DEV COMP IMMUNOL, V46, P171, DOI 10.1016/j.dci.2014.04.001; Tallmadge RL, 2013, DEV COMP IMMUNOL, V41, P33, DOI 10.1016/j.dci.2013.03.020; THOMPSON CB, 1987, CELL, V48, P369, DOI 10.1016/0092-8674(87)90188-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Wagner SD, 1996, ANNU REV IMMUNOL, V14, P441, DOI 10.1146/annurev.immunol.14.1.441; Walther S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064234; Wang F, 2013, CELL, V153, P1379, DOI 10.1016/j.cell.2013.04.049; Wang Y, 2008, IMMUNOL CELL BIOL, V86, P111, DOI 10.1038/sj.icb.7100144; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Zhao YF, 2003, J BIOL CHEM, V278, P35024, DOI 10.1074/jbc.M301337200	51	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0164567	10.1371/journal.pone.0164567	http://dx.doi.org/10.1371/journal.pone.0164567			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828971	Green Published, gold, Green Submitted			2022-12-26	WOS:000387724300018
J	Abraham, A; Alabdali, M; Alsulaiman, A; Breiner, A; Barnett, C; Katzberg, HD; Lovblom, LE; Perkins, BA; Bril, V				Abraham, Alon; Alabdali, Majed; Alsulaiman, Abdulla; Breiner, Ari; Barnett, Carolina; Katzberg, Hans D.; Lovblom, Leif E.; Perkins, Bruce A.; Bril, Vera			Laser Doppler Flare Imaging and Quantitative Thermal Thresholds Testing Performance in Small and Mixed Fiber Neuropathies	PLOS ONE			English	Article							SYMPTOMS; DENSITY	Introduction Small fiber neuropathy might be a part of typical mixed small and large fiber neuropathy, or a distinct entity, affecting exclusively small nerve fibers. Objectives Explore the utility of small nerve fiber testing in patients with clinical presentation suggesting small fiber neuropathy, with and without evidence for concomitant large fiber neuropathy. Methods Patients attending the neuromuscular clinic from 2012 to 2015 with a clinical presentation suggesting small nerve fiber impairment, who had Laser Doppler flare imaging (LDIFlare) and quantitative thermal testing (QTT) were evaluated for this study. Patients with clinical or electrophysiological evidence for concomitant large fiber neuropathy were not excluded. Results The sensitivities of LDIFlare, cooling and heat threshold testing were 64%, 36%, and 0% respectively for clinically highly suggestive small fiber neuropathy, 64%, 56%, and 19% respectively for mixed fiber neuropathy, and 86%, 79%, and 29% respectively for diabetic mixed fiber neuropathy. Discussion LDIFlare and cooling thresholds testing are non-invasive small nerve fiber testing modalities, with moderate performance in patients with small and mixed fiber neuropathy, and excellent performance in diabetic mixed fiber neuropathy.	[Abraham, Alon; Breiner, Ari; Barnett, Carolina; Katzberg, Hans D.; Bril, Vera] Univ Toronto, Dept Med, Div Neurol, Univ Hlth Network,Ellen & Martin Prosserman Ctr N, Toronto, ON, Canada; [Alabdali, Majed; Alsulaiman, Abdulla] Univ Dammam, King Fahad Hosp Univ, Dept Neurol, Dammam, Saudi Arabia; [Lovblom, Leif E.; Perkins, Bruce A.] Univ Toronto, Div Endocrinol & Metab, Dept Med, Mt Sinai Hosp, Toronto, ON, Canada; [Lovblom, Leif E.; Perkins, Bruce A.] Univ Toronto, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Imam Abdulrahman Bin Faisal University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Bril, V (corresponding author), Univ Toronto, Dept Med, Div Neurol, Univ Hlth Network,Ellen & Martin Prosserman Ctr N, Toronto, ON, Canada.	vera.bril@utoronto.ca	Perkins, Bruce A/L-3726-2017; Abraham, Alon/H-9343-2019; Barnett, Carolina/AFM-9470-2022; BRIL, vera/ABA-6509-2020	Abraham, Alon/0000-0002-9020-2399; Lovblom, Leif Erik/0000-0002-6774-8924; Barnett, Carolina/0000-0001-5546-0221				Almurdhi MM, 2017, DIABETIC MED, V34, P356, DOI 10.1111/dme.13163; Bolton CF, 2000, CANADIAN J NEUROLOGI, P288; Breiner A, 2014, DIABETES CARE, V37, P1418, DOI 10.2337/dc13-2005; CLAUS D, 1993, MUSCLE NERVE, V16, P757, DOI 10.1002/mus.880160711; Devigili G, 2008, BRAIN, V131, P1912, DOI 10.1093/brain/awn093; Ebadi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042208; Green AQ, 2009, MUSCLE NERVE, V40, P985, DOI 10.1002/mus.21333; Hagander LG, 2000, CLIN NEUROPHYSIOL, V111, P17, DOI 10.1016/S1388-2457(99)00192-3; Holland NR, 1998, ANN NEUROL, V44, P47, DOI 10.1002/ana.410440111; Huang CS, 2012, MICROVASC RES, V84, P351, DOI 10.1016/j.mvr.2012.07.003; Lacomis D, 2002, MUSCLE NERVE, V26, P173, DOI 10.1002/mus.10181; Lauria G, 2010, EUR J NEUROL, V17, P903, DOI 10.1111/j.1468-1331.2010.03023.x; Lefaucheur J-P, 2015, NEUROPHYSIOL CLIN; Lysy Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106995; Nabavi Nouri M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034807, DOI 10.1371/JOURNAL.PONE.0034807]; Provitera V, 2016, EUR J NEUROL, V23, P333, DOI 10.1111/ene.12842; Vas PRJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069920; Walk D, 2007, J NEUROL SCI, V255, P23, DOI 10.1016/j.jns.2007.01.052	18	25	26	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165731	10.1371/journal.pone.0165731	http://dx.doi.org/10.1371/journal.pone.0165731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824912	Green Published, gold, Green Submitted			2022-12-26	WOS:000387615200030
J	Singh, R; Teel, C; Sabus, C; McGinnis, P; Kluding, P				Singh, Rupali; Teel, Cynthia; Sabus, Carla; McGinnis, Patricia; Kluding, Patricia			Fatigue in Type 2 Diabetes: Impact on Quality of Life and Predictors	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; GLYCEMIC CONTROL; NATIONAL SAMPLE; CANCER-PATIENTS; SLEEP QUALITY; 6-MINUTE WALK; DEPRESSION; MELLITUS; HEALTH; SYMPTOMS	Fatigue is a persistent symptom, impacting quality of life (QoL) and functional status in people with type 2 diabetes, yet the symptom of fatigue has not been fully explored. The purpose of this study was to explore the relationship between fatigue, QoL functional status and to investigate the predictors of fatigue. These possible predictors included body mass index (BMI), Hemoglobin A1C (HbA1C), sleep quality, pain, number of complications from diabetes, years since diagnosis and depression. Forty-eight individuals with type 2 diabetes (22 females, 26 males; 59.66 +/- 7.24 years of age; 10.45 +/- 7.38 years since diagnosis) participated in the study. Fatigue was assessed by using Multidimensional Fatigue Inventory (MFI-20). Other outcomes included: QoL (Audit of Diabetes Dependent QoL), and functional status (6 minute walk test), BMI, HbA1c, sleep (Pittsburg sleep quality index, PSQI), pain (Visual Analog Scale), number of complications, years since diagnosis, and depression (Beck's depression Inventory-2). The Pearson correlation analysis followed by multivariable linear regression model was used. Fatigue was negatively related to quality of life and functional status. Multivariable linear regression analysis revealed sleep, pain and BMI as the independent predictors of fatigue signaling the presence of physiological (sleep, pain, BMI) phenomenon that could undermine health outcomes.	[Singh, Rupali] Sage Coll, Dept Phys Therapy, Troy, NY 12180 USA; [Teel, Cynthia] Univ Kansas, Med Ctr, Sch Nursing, Kansas City, KS 66103 USA; [Sabus, Carla; Kluding, Patricia] Univ Kansas, Med Ctr, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66103 USA; [McGinnis, Patricia] Stockton Univ, Dept Phys Therapy, Galloway, NJ USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Singh, R (corresponding author), Sage Coll, Dept Phys Therapy, Troy, NY 12180 USA.	singhr@sage.edu		Singh, Rupali/0000-0002-8747-3999				Aaronson L S, 1999, Image J Nurs Sch, V31, P45; Aistars J, 1987, Oncol Nurs Forum, V14, P25; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Anderson RM, 1997, DIABETES CARE, V20, P299, DOI 10.2337/diacare.20.3.299; Benbow SJ, 1998, QJM-INT J MED, V91, P733, DOI 10.1093/qjmed/91.11.733; Bonora E, 2001, DIABETES CARE, V24, P2023, DOI 10.2337/diacare.24.12.2023; Bonora E, 2001, DIABETOLOGIA, V44, P2107, DOI 10.1007/s001250100020; Borneman Tami, 2012, Clin J Oncol Nurs, V16, pE26, DOI 10.1188/12.CJON.E26-E32; Bradley C, 2002, DIABETES-METAB RES, V18, pS64, DOI 10.1002/dmrr.279; Bradley C, 1999, QUAL LIFE RES, V8, P79, DOI 10.1023/A:1026485130100; Brown GC, 2000, J DIABETES COMPLICAT, V14, P18, DOI 10.1016/S1056-8727(00)00061-1; BRUNO RL, 1993, ARCH PHYS MED REHAB, V74, P1061, DOI 10.1016/0003-9993(93)90062-F; Bulpitt CJ, 1998, DIABETES CARE, V21, P111, DOI 10.2337/diacare.21.1.111; Buysse D J, 1989, Psychiatry Res, V28, P193; Chasens ER, 2013, DIABETES EDUCATOR, V39, P74, DOI 10.1177/0145721712467683; Coleman EA, 2011, CANCER NURS, V34, P219, DOI 10.1097/NCC.0b013e3181f9904d; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Cuellar NG, 2008, J CLIN SLEEP MED, V4, P50; du Bois RM, 2014, EUR RESPIR J, V43, P1421, DOI 10.1183/09031936.00131813; Egede LE, 2003, DIABETES CARE, V26, P104, DOI 10.2337/diacare.26.1.104; Field A, 2013, DISCOVERING STAT USI; Fritschi C, 2012, DIABETES EDUCATOR, V38, P662, DOI 10.1177/0145721712450925; Funk S, 1989, PROJECT DNR KEY ASPE, DOI [10.1111/J.1365-2702.2006.01349.X, DOI 10.1111/J.1365-2702.2006.01349.X]; Garber CE, 2003, NEUROLOGY, V60, P1119, DOI 10.1212/01.WNL.0000055868.06222.AB; GIBSON H, 1985, SPORTS MED, V2, P120, DOI 10.2165/00007256-198502020-00004; Glasgow RE, 1997, DIABETES CARE, V20, P562, DOI 10.2337/diacare.20.4.562; Goldman MD, 2008, MULT SCLER J, V14, P383, DOI 10.1177/1352458507082607; Goldney RD, 2004, DIABETES CARE, V27, P1066, DOI 10.2337/diacare.27.5.1066; Hamilton D M, 2000, J Cardiopulm Rehabil, V20, P156, DOI 10.1097/00008483-200005000-00003; HERMANN LS, 1979, DIABETES METAB, V5, P233; Huibers MJH, 2007, J PSYCHOSOM RES, V63, P137, DOI 10.1016/j.jpsychores.2007.02.014; Hume C, 2010, DIABETES EDUCATOR, V36, P495, DOI 10.1177/0145721710368326; Ingle L, 2006, J AM COLL CARDIOL, V47, P1909, DOI 10.1016/j.jacc.2006.02.005; Kanade RV, 2006, DIABETOLOGIA, V49, P1747, DOI 10.1007/s00125-006-0309-1; Katon W, 2004, DIABETES CARE, V27, P914, DOI 10.2337/diacare.27.4.914; Khurana R, 2010, POSTGRAD MED J, V86, P371, DOI 10.1136/hrt.2009.173773; Knutson KL, 2006, ARCH INTERN MED, V166, P1768, DOI 10.1001/archinte.166.16.1768; Kong DL, 2011, DIABETES RES CLIN PR, V94, P45, DOI 10.1016/j.diabres.2011.05.026; Lasselin J, 2012, PSYCHONEUROENDOCRINO, V37, P1468, DOI 10.1016/j.psyneuen.2012.01.016; Lin Jin-Mann S, 2009, Popul Health Metr, V7, P18, DOI 10.1186/1478-7954-7-18; Magnusson K, 1999, EUR J CANCER CARE, V8, P224; Morrato EH, 2007, DIABETES CARE, V30, P203, DOI 10.2337/dc06-1128; Morsch CM, 2006, J CLIN NURS, V15, P498, DOI 10.1111/j.1365-2702.2006.01349.x; Nortvedt MW, 1999, MULT SCLER, V5, P317, DOI 10.1177/135245859900500503; Park H, 2015, J ADV NURS, V71, P1650, DOI 10.1111/jan.12632; Portenoy R K, 1999, Oncologist, V4, P1; Rayburn WF, 1997, J REPROD MED, V42, P585; Ream E, 1996, INT J NURS STUD, V33, P519, DOI 10.1016/0020-7489(96)00004-1; Redeker N S, 2000, Sch Inq Nurs Pract, V14, P275; Resnick HE, 2003, DIABETES CARE, V26, P702, DOI 10.2337/diacare.26.3.702; Resnick HE, 2006, J CLIN SLEEP MED, V2, P163; Rijken PM, 1998, DISABIL REHABIL, V20, P330, DOI 10.3109/09638289809166090; Rose L, 1998, J ADV NURS, V28, P295, DOI 10.1046/j.1365-2648.1998.00789.x; Ryerson B, 2003, DIABETES CARE, V26, P206, DOI 10.2337/diacare.26.1.206; Sachedina N, 2003, DIABETIC MED, V20, P1012, DOI 10.1046/j.1464-5491.2003.01037.x; Siegel K, 2012, J PAIN SYMPTOM MANAG, V44, P52, DOI 10.1016/j.jpainsymman.2011.07.013; Singh R, 2013, DIABETES EDUCATOR, V39, P320, DOI 10.1177/0145721713479144; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Soon SS, 2010, APPL HEALTH ECON HEA, V8, P239, DOI 10.2165/11313920-000000000-00000; St Pierre B A, 1992, Oncol Nurs Forum, V19, P419; STEWART AL, 1994, J CLIN EPIDEMIOL, V47, P719, DOI 10.1016/0895-4356(94)90169-4; Surani S, 2015, WORLD J DIABETES, V6, P868, DOI 10.4239/wjd.v6.i6.868; Testa MA, 1998, JAMA-J AM MED ASSOC, V280, P1490, DOI 10.1001/jama.280.17.1490; Thomas N, 2004, POSTGRAD MED J, V80, P287, DOI 10.1136/pgmj.2003.010553; Trendall J, 2000, J ADV NURS, V32, P1126, DOI 10.1046/j.1365-2648.2000.01583.x; van Weert E, 2006, ONCOLOGIST, V11, P184, DOI 10.1634/theoncologist.11-2-184; VanderDoes FEE, 1996, DIABETES CARE, V19, P204, DOI 10.2337/diacare.19.3.204; Vigg A, 2003, J Assoc Physicians India, V51, P479; Visser MRM, 1998, SUPPORT CARE CANCER, V6, P101, DOI 10.1007/s005200050142; WALKER GC, 1991, ARCH PHYS MED REHAB, V72, P469; Wandell PE, 1997, SCAND J PRIM HEALTH, V15, P97, DOI 10.3109/02813439709018495; Warren RE, 2003, DIABETES-METAB RES, V19, P408, DOI 10.1002/dmrr.396; Watkins K, 2004, PHARMACOECONOMICS, V22, P1109, DOI 10.2165/00019053-200422170-00002; Wei M, 2000, ANN INTERN MED, V132, P605, DOI 10.7326/0003-4819-132-8-200004180-00002; Weijman I, 2004, J OCCUP ENVIRON MED, V46, P828, DOI 10.1097/01.jom.0000135605.62330.ca; Weijman I, 2003, OCCUP ENVIRON MED, V60, P93; Wilmoth MC, 2004, ONCOL NURS FORUM, V31, P1069, DOI 10.1188/04.ONF.1069-1075; Winningham M L, 1994, Oncol Nurs Forum, V21, P23; Wu MS, 2010, INT J NURS STUD, V47, P49, DOI 10.1016/j.ijnurstu.2009.05.026	79	30	30	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165652	10.1371/journal.pone.0165652	http://dx.doi.org/10.1371/journal.pone.0165652			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB8BE	27824886	Green Published, Green Submitted, gold			2022-12-26	WOS:000387615200026
J	Sugiura, Y; Tanimoto, Y; Imbe, A; Inaba, Y; Sakai, S; Shishikura, K; Tanimoto, K; Hanafusa, T				Sugiura, Yumiko; Tanimoto, Yoshimi; Imbe, Ayumi; Inaba, Yuiko; Sakai, Satoshi; Shishikura, Kanako; Tanimoto, Keiji; Hanafusa, Toshiaki			Association between Functional Capacity Decline and Nutritional Status Based on the Nutrition Screening Initiative Checklist: A 2-Year Cohort Study of Japanese Community-Dwelling Elderly	PLOS ONE			English	Article							OLDER-ADULTS; HEALTH; INDEX; NSI	Aim To assess whether nutritional status based on the Nutrition Screening Initiative Checklist is useful for predicting functional capacity decline in community-dwelling Japanese elderly. Methods This two-year observational cohort study included 536 community-dwelling Japanese (65 years and older at baseline) who were independent in both activities and instrumental activities of daily living. Demographic attributes, chronic illness, lifestyle-related habits, nutritional status, functional capacity, and anthropometric measurements were assessed, with decline in functional capacity used as the outcome measure. Results Subjects were classified into three groups as follows based on the Nutrition Screening Initiative Checklist: low (59.5%), moderate (23.7%), and high (16.8%) nutritional risk. Significant differences were found between nutritional status and the following four baseline variables: age, hypertension, cerebrovascular diseases, and current smoking. However, no significant differences were evident between nutritional status and sex, body mass index, diabetes, drinking habit, or exercise habit. Logistic regression analysis adjusted for age, sex, body mass index, hypertension, cerebrovascular diseases and smoking habit showed that the high nutritional risk group was significantly associated with a decline in both activities of daily living (odds ratio: 4.96; 95% confidence interval (CI): 1.59-15.50) and instrumental activities of daily living (OR: 2.58; 95% CI: 1.31-5.06) compared with the low nutritional risk group. Conclusions Poor nutritional status based on the Nutrition Screening Initiative Checklist was associated with a decline in functional capacity over a 2-year period in community-dwelling Japanese elderly. These results suggest that the Nutrition Screening Initiative Checklist is a suitable tool for predicting functional capacity decline in community-dwelling elderly.	[Sugiura, Yumiko] Med Corp Hatsunekai, Sugiura Clin, Kariya, Aichi, Japan; [Tanimoto, Yoshimi; Imbe, Ayumi; Inaba, Yuiko; Sakai, Satoshi; Shishikura, Kanako; Tanimoto, Keiji; Hanafusa, Toshiaki] Osaka Med Coll, Dept Internal Med 1, Takatsuki, Osaka, Japan	Osaka Medical College	Tanimoto, Y (corresponding author), Osaka Med Coll, Dept Internal Med 1, Takatsuki, Osaka, Japan.	hyg022@osaka-med.ac.jp			Japan Society for the Promotion of Science KAKENHI Grant [24590823]	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 24590823.	Aida J, 2012, J AM GERIATR SOC, V60, P338, DOI 10.1111/j.1532-5415.2011.03791.x; BARROCAS A, 1995, J AM DIET ASSOC, V95, P647, DOI 10.1016/S0002-8223(95)00177-8; Bartlett S, 1997, GERIATRIC NUTR HDB, P27; Cabinet Office Government of Japan, 2013, WHIT PAP AG SOC VERS; Chen CCH, 2007, J CLIN NURS, V16, P2015, DOI 10.1111/j.1365-2702.2006.01867.x; de Groot LCPGM, 1998, EUR J CLIN NUTR, V52, P877, DOI 10.1038/sj.ejcn.1600658; Fujiwara Y, 2008, GERONTOLOGY, V54, P373, DOI 10.1159/000151221; Ishizaki T, 2002, ARCH GERONTOL GERIAT, V35, P107, DOI 10.1016/S0167-4943(02)00002-X; Kamo T, 2014, GERIATR GERONTOL INT, V14, P799, DOI 10.1111/ggi.12169; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Keller HH, 2004, J GERONTOL A-BIOL, V59, P68; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Kumagai Shu, 2003, Nihon Koshu Eisei Zasshi, V50, P1117; Kusabiraki Toshiyuki, 2014, Bulletin of the Osaka Medical College, V60, P27; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Alvarenga MRM, 2010, REV ESC ENFERM USP, V44, P1041; Nutrition Screening Initiative, 1991, REP NUTR SCREEN 1 CO; Okamura T, 2008, J AM GERIATR SOC, V56, P529, DOI 10.1111/j.1532-5415.2007.01549.x; Phillips MB, 2010, ASIA PAC J CLIN NUTR, V19, P440; POSNER BM, 1993, AM J PUBLIC HEALTH, V83, P972, DOI 10.2105/AJPH.83.7.972; REUBEN DB, 1995, J AM GERIATR SOC, V43, P415, DOI 10.1111/j.1532-5415.1995.tb05818.x; Rowe JW, 1997, GERONTOLOGIST, V37, P433, DOI 10.1093/geront/37.4.433; Sherina M S Jr, 2004, Malays J Nutr, V10, P149; Simsek H, 2014, GERIATR GERONTOL INT, V14, P960, DOI 10.1111/ggi.12166; Takahashi Ryutaro, 2006, Nihon Ronen Igakkai Zasshi, V43, P375; WHITE JV, 1991, J AM DIET ASSOC, V91, P783; Yap K. B., 2007, SMJ Singapore Medical Journal, V48, P911	27	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166037	10.1371/journal.pone.0166037	http://dx.doi.org/10.1371/journal.pone.0166037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB8BE	27824916	Green Published, gold, Green Submitted			2022-12-26	WOS:000387615200056
J	Li, CM; Lim, S; Braunewell, KH; Ames, JB				Li, Congmin; Lim, Sunghyuk; Braunewell, Karl H.; Ames, James B.			Structure and Calcium Binding Properties of a Neuronal Calcium-Myristoyl Switch Protein, Visinin-Like Protein 3	PLOS ONE			English	Article							GUANYLYL CYCLASE; SENSOR PROTEINS; SUBCELLULAR-LOCALIZATION; MOLECULAR-STRUCTURE; APO-CALMODULIN; IQ MOTIF; VILIP-1; HIPPOCALCIN; FAMILY; DREAM	Visinin-like protein 3 (VILIP-3) belongs to a family of Ca2+-myristoyl switch proteins that regulate signal transduction in the brain and retina. Here we analyze Ca2+ binding, characterize Ca2+-induced conformational changes, and determine the NMR structure of myristoylated VILIP-3. Three Ca2+ bind cooperatively to VILIP-3 at EF2, EF3 and EF4 (K-D = 0.52 mu M and Hill slope of 1.8). NMR assignments, mutagenesis and structural analysis indicate that the covalently attached myristoyl group is solvent exposed in Ca2+-bound VILIP-3, whereas Ca2+-free VILIP-3 contains a sequestered myristoyl group that interacts with protein residues (E26, Y64, V68), which are distinct from myristate contacts seen in other Ca2+-myristoyl switch proteins. The myristoyl group in VILIP-3 forms an unusual L-shaped structure that places the C-14 methyl group inside a shallow protein groove, in contrast to the much deeper myristoyl binding pockets observed for recoverin, NCS-1 and GCAP1. Thus, the myristoylated VILIP-3 protein structure determined in this study is quite different from those of other known myristoyl switch proteins (recoverin, NCS-1, and GCAP1). We propose that myristoylation serves to fine tune the three-dimensional structures of neuronal calcium sensor proteins as a means of generating functional diversity.	[Li, Congmin; Lim, Sunghyuk; Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Braunewell, Karl H.] Ruhr Univ Bochum, Fac Med, Dept Neurophysiol, Bochum, Germany	University of California System; University of California Davis; Ruhr University Bochum	Ames, JB (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.	jbames@ucdavis.edu			NIH [EY012347]; NATIONAL EYE INSTITUTE [R01EY012347] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by NIH grant EY012347.	Adams PJ, 2014, CELL, V159, P608, DOI 10.1016/j.cell.2014.09.047; Ames JB, 2012, BBA-GEN SUBJECTS, V1820, P1205, DOI 10.1016/j.bbagen.2011.10.003; AMES JB, 1995, J BIOL CHEM, V270, P4526, DOI 10.1074/jbc.270.9.4526; Ames JB, 1995, J BIOL CHEM, V270, P30909, DOI 10.1074/jbc.270.52.30909; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Badger J, 1999, PROTEINS, V35, P25, DOI 10.1002/(SICI)1097-0134(19990401)35:1<25::AID-PROT3>3.3.CO;2-M; BAGBY S, 1994, STRUCTURE, V2, P107, DOI 10.1016/S0969-2126(00)00013-7; Bernstein HG, 1999, J NEUROCYTOL, V28, P655, DOI 10.1023/A:1007056731551; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Chagot B, 2011, J MOL BIOL, V406, P106, DOI 10.1016/j.jmb.2010.11.046; Chen KC, 2009, J PEPT SCI, V15, P89, DOI 10.1002/psc.1097; Clore GM, 1997, NAT STRUCT BIOL, V4, P849; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; DIZHOOR AM, 1993, SCIENCE, V259, P829, DOI 10.1126/science.8430337; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Feldkamp MD, 2011, STRUCTURE, V19, P733, DOI 10.1016/j.str.2011.02.009; Gomez-Villafuertes R, 2005, J NEUROSCI, V25, P10822, DOI 10.1523/JNEUROSCI.3912-05.2005; Hoffman L, 2014, J BIOL CHEM, V289, P14644, DOI 10.1074/jbc.M114.560656; Johny MB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2727; Kim KS, 2012, BIOPHYS J, V103, P2446, DOI 10.1016/j.bpj.2012.11.002; KOBAYASHI M, 1993, J BIOL CHEM, V268, P18898; LADANT D, 1995, J BIOL CHEM, V270, P3179; Li CM, 2014, BIOMOL NMR ASSIGN, V8, P63, DOI 10.1007/s12104-012-9453-3; Li CM, 2011, J BIOL CHEM, V286, P6354, DOI 10.1074/jbc.M110.173724; Lim S, 2016, J BIOL CHEM, V291, P4429, DOI 10.1074/jbc.M115.696161; Lim S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208868; Liu ZH, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00038; NILGES M, 1988, PROTEIN ENG, V2, P27, DOI 10.1093/protein/2.1.27; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Osawa M, 2001, J BIOL CHEM, V276, P41005, DOI 10.1074/jbc.M105842200; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Paterlini M, 2000, NEUROSCIENCE, V99, P205, DOI 10.1016/S0306-4522(00)00201-3; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Scsucova S, 2005, NUCLEIC ACIDS RES, V33, P2269, DOI 10.1093/nar/gki503; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Spilker C, 2000, NEUROSCIENCE, V96, P121, DOI 10.1016/S0306-4522(99)00536-9; Spilker C, 2003, MOL CELL NEUROSCI, V24, P766, DOI 10.1016/S1044-7431(03)00242-2; Spilker C, 2002, BBA-PROTEINS PROTEOM, V1600, P118, DOI 10.1016/S1570-9639(02)00452-1; Spilker C, 2002, J NEUROSCI, V22, P7331; Stephen R, 2007, STRUCTURE, V15, P1392, DOI 10.1016/j.str.2007.09.013; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; Tiruppathi C, 2014, NAT IMMUNOL, V15, P239, DOI 10.1038/ni.2823; Tzingounis AV, 2007, NEURON, V53, P487, DOI 10.1016/j.neuron.2007.01.011; Wingard JN, 2005, J BIOL CHEM, V280, P37461, DOI 10.1074/jbc.M508541200; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569	51	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165921	10.1371/journal.pone.0165921	http://dx.doi.org/10.1371/journal.pone.0165921			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820860	Green Submitted, gold, Green Published			2022-12-26	WOS:000387614800026
J	Babiker, F; Al-Jarallah, A; Joseph, S				Babiker, Fawzi; Al-Jarallah, Aishah; Joseph, Shaji			The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ISCHEMIA-REPERFUSION INJURY; MYOCARDIAL-INFARCTION; TYPE-1 RECEPTOR; II FORMATION; CHYMASE; HEART; STRESS; INHIBITION; MECHANISMS	Background Accumulating evidence suggests a cardioprotective role of pacing postconditioning (PPC) maneuvers in animal models and more recently in humans. The procedure however remains to be optimized and its interaction with physiological systems remains to be further explored. The renin angiotensin system (RAS) plays a dual role in ischemia/reperfusion (I/R) injury. The interaction between RAS and PPC induced cardiac protection is however not clearly understood. We have recently demonstrated that angiotensin (1-7) via Mas receptor played a significant role in PPC mediated cardiac protection against I/R injury. Objective The objective of this study was to investigate the role of angiotensin converting enzyme (ACE) D chymase D angiotensin II (Ang II) D angiotensin receptor 1 (AT1) axes of RAS in PPC mediated cardiac protection. Methods Isolated rat hearts were subjected to I/R (control) or PPC in the presence or absence of Ang II, chymostatin (inhibitor of locally produced Ang II), ACE blocker (captopril) or AT1 antagonist (irbesartan). Hemodynamics data was computed digitally and infarct size was determined histologically using TTC staining and biochemically by measuring creatine kinase (CK) and lactate dehydrogenase levels. Results Cardiac hemodynamics were significantly (P<0.001) improved and infarct size and cardiac enzymes were significantly (P<0.001) reduced in hearts subjected to PPC relative to hearts subjected to I/R injury. Exogenous administration of Ang II did not affect I/R injury or PPC mediated protection. Nonetheless inhibition of endogenously synthesized Ang II protected against I/R induced cardiac damage yet did not block or augment the protective effects of PPC. The administration of AT1 antagonist did not alleviate I/R induced damage. Interestingly it abrogated PPC induced cardiac protection in isolated rat hearts. Finally, PPC induced protection and blockade of locally produced Ang II involved enhanced activation of ERK1/2 and Akt components of the reperfusion injury salvage kinase (RISK) pathway. Conclusions This study demonstrate a novel role of endogenously produced Ang II in mediating I/R injury and highlights the significance of AT1 signaling in PPC mediated cardiac protection in isolated rodents hearts ex vivo. The interaction between Ang II-AT1 and PPC appears to involve alterations in the activation state of ERK1/2 and Akt components of the RISK pathway.	[Babiker, Fawzi; Joseph, Shaji] Kuwait Univ, Dept Physiol, Fac Med, Hlth Sci Ctr, Jabriya, Kuwait; [Al-Jarallah, Aishah] Kuwait Univ, Dept Biochem, Fac Med, Hlth Sci Ctr, Jabriya, Kuwait	Kuwait University; Kuwait University	Babiker, F (corresponding author), Kuwait Univ, Dept Physiol, Fac Med, Hlth Sci Ctr, Jabriya, Kuwait.	Fawzi.b@hsc.edu.kw			Research Administration Kuwait University grant [MY 02/ 10]	Research Administration Kuwait University grant	This work is supported by Research Administration, Kuwait University, grant #MY 02/ 10.	Abwainy A, 2016, AM J PHYSIOL-HEART C, V310, pH104, DOI 10.1152/ajpheart.00121.2015; Babiker FA, 2006, ARTERIOSCL THROM VAS, V26, P1524, DOI 10.1161/01.ATV.0000223344.11128.23; Babiker FA, 2014, J PHYSIOL BIOCHEM, V70, P151, DOI 10.1007/s13105-013-0289-9; Babiker FA, 2010, BASIC RES CARDIOL, V105, P523, DOI 10.1007/s00395-010-0095-2; Bice JS, 2015, BRIT J PHARMACOL, V172, P1933, DOI 10.1111/bph.12976; Bouhidel JO, 2014, FRONT BIOSCI-LANDMRK, V19, P566, DOI 10.2741/4227; Carey RM, 2003, ENDOCR REV, V24, P261, DOI 10.1210/er.2003-0001; Cat AND, 2012, CURR OPIN NEPHROL HY, V21, P147, DOI 10.1097/MNH.0b013e32834fb25b; Clausmeyer S, 2000, ENDOCRINOLOGY, V141, P2963, DOI 10.1210/en.141.8.2963; Daugherty A, 2004, TRENDS CARDIOVAS MED, V14, P117, DOI 10.1016/j.tcm.2004.01.002; De Mello WC, 2011, PEPTIDES, V32, P1774, DOI 10.1016/j.peptides.2011.06.018; De Mello WC, 2003, REGUL PEPTIDES, V115, P31, DOI 10.1016/S0167-0115(03)00128-9; de Oliveira UO, 2012, FUND CLIN PHARMACOL, V26, P679, DOI 10.1111/j.1472-8206.2011.00995.x; Dell'Italia LJ, 2002, CURR OPIN CARDIOL, V17, P374, DOI 10.1097/00001573-200207000-00009; DOSTAL DE, 1992, AM J PHYSIOL, V263, pC851, DOI 10.1152/ajpcell.1992.263.4.C851; Ernsberger P, 2007, CURR OPIN PHARMACOL, V7, P140, DOI 10.1016/j.coph.2006.11.008; Ferdinandy P, 2007, PHARMACOL REV, V59, P418, DOI 10.1124/pr.107.06002; Ferrera R, 2009, CARDIOVASC DRUG THER, V23, P327, DOI 10.1007/s10557-009-6176-5; Fleming I, 2006, CIRC RES, V98, P887, DOI 10.1161/01.RES.0000217340.40936.53; Freixa X, 2012, EUR HEART J, V33, P103, DOI 10.1093/eurheartj/ehr297; Garcia RA, 2005, AM J PHYSIOL-HEART C, V288, pH1080, DOI 10.1152/ajpheart.00860.2004; Hahn JY, 2013, CIRCULATION, V128, P1889, DOI 10.1161/CIRCULATIONAHA.113.001690; Hausenloy DJ, 2007, PHARMACOL THERAPEUT, V116, P173, DOI 10.1016/j.pharmthera.2007.06.005; Hausenloy DJ, 2009, ATHEROSCLEROSIS, V204, P334, DOI 10.1016/j.atherosclerosis.2008.10.029; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; Heusch G, 2008, CIRCULATION, V118, P1915, DOI 10.1161/CIRCULATIONAHA.108.805242; Ihara M, 1999, HYPERTENSION, V33, P1399, DOI 10.1161/01.HYP.33.6.1399; Ihara M, 2000, CARDIOLOGY, V94, P247, DOI 10.1159/000047325; Jandeleit-Dahm K, 2006, ENDOCRIN METAB CLIN, V35, P469, DOI 10.1016/j.ecl.2006.06.007; Kumar R, 2012, AM J PHYSIOL-REG I, V302, pR510, DOI 10.1152/ajpregu.00512.2011; Kurdi M, 2005, INT J BIOCHEM CELL B, V37, P1357, DOI 10.1016/j.biocel.2005.01.012; Limalanathan S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000679; Lonborg JT, 2015, HEART, V101, P1612, DOI 10.1136/heartjnl-2015-307804; Messadi-Laribi E, 2007, J PHARMACOL EXP THER, V323, P210, DOI 10.1124/jpet.107.124859; Nishimoto M, 2001, J THORAC CARDIOV SUR, V121, P729, DOI 10.1067/mtc.2001.112467; Pagliaro P, 2005, CARDIOVASC DRUG THER, V19, P77, DOI 10.1007/s10557-005-6900-8; Penna C, 2008, J CELL MOL MED, V12, P435, DOI 10.1111/j.1582-4934.2007.00210.x; Pipicz M, 2015, BRIT J PHARMACOL, V172, P3472, DOI 10.1111/bph.13154; Prosser HCG, 2009, CARDIOVASC RES, V82, P40, DOI 10.1093/cvr/cvp003; Schupp M, 2004, CIRCULATION, V109, P2054, DOI 10.1161/01.CIR.0000127955.36250.65; Sharma A, 2000, PHARMACOL RES, V41, P635, DOI 10.1006/phrs.1999.0631; Singh VP, 2008, DIABETES, V57, P3297, DOI 10.2337/db08-0805; Tsang A, 2004, CIRC RES, V95, P230, DOI 10.1161/01.RES.0000138303.76488.fe; Uehara Y, 2002, CARDIOVASC RES, V55, P870, DOI 10.1016/S0008-6363(02)00458-3; Urata H, 2000, J Renin Angiotensin Aldosterone Syst, V1, pS35; Vanagt WY, 2007, J AM COLL CARDIOL, V49, P1813, DOI 10.1016/j.jacc.2007.01.070; Vanagt WY, 2006, CIRCULATION, V114, pI264, DOI 10.1161/CIRCULATIONAHA.105.000893; Vilardaga JP, 2005, NAT CHEM BIOL, V1, P25, DOI 10.1038/nchembio705; Waltenberger J, 2014, JACC-CARDIOVASC IMAG, V7, P620, DOI 10.1016/j.jcmg.2014.01.017; Yasuda N, 2008, EMBO REP, V9, P179, DOI 10.1038/sj.embor.7401157; Yetgin T, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0403-3; Zablocki D, 2011, CURR HYPERTENS REP, V13, P129, DOI 10.1007/s11906-011-0180-4; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	54	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165777	10.1371/journal.pone.0165777	http://dx.doi.org/10.1371/journal.pone.0165777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814397	Green Published, Green Submitted, gold			2022-12-26	WOS:000386911100018
J	Ohno, Y; Fujita, K; Toyofuku, T; Nakamaura, T				Ohno, Yoshikazu; Fujita, Kazuhiko; Toyofuku, Takashi; Nakamaura, Takashi			Cytological Observations of the Large Symbiotic Foraminifer Amphisorus kudakajimensis Using Calcein Acetoxymethyl Ester	PLOS ONE			English	Article							BENTHIC FORAMINIFERA; ALLOGROMIA-LATICOLLARIS; RETICULOPODIAL NETWORK; INTRACELLULAR PH; CELLS; CALCIFICATION; MICROTUBULES; PHYLOGENY; MOTILITY; PROTOZOA	Large benthic foraminifera are unicellular calcifying reef organisms that can form symbiotic relationships with a range of different microalgae. However, the cellular functions, such as symbiosis and calcification, and other aspects of cellular physiology in large benthic foraminifera are not fully understood. Amphisorus kudakajimensis was used as a model to determine the detailed cellular characteristics of large benthic foraminifera. We used calcein acetoxymethyl ester (calcein AM) as a fluorescent indicator for live confocal imaging. We demonstrated that calcein AM is a useful fluorescent indicator to stain the fine network of reticulopodia and the cytoplasm in living A. kudakajimensis. We showed that at least two types of reticulopodia exist in A. kudakajimensis: the straight bundle of reticulopodia that spreads from the aperture and the fine reticulopodia along the surface of the aperture and chamber walls. The cytoplasm in outer chambers was highly branched and contained a few dinoflagellates. In contrast, the inner chamberlets contained condensed cytoplasm and many dinoflagellates, suggesting that the cytoplasm of A. kudakajimensis performs different functions based on its location within the large test. Our confocal detailed image analysis provides real-time cellular morphology and cell physiology of living foraminifera.	[Ohno, Yoshikazu] Univ Ryukyus, Grad Sch Engn & Sci, Marine & Environm Sci Course, Senbaru 1, Nishihara, Okinawa 9030213, Japan; [Fujita, Kazuhiko] Univ Ryukyus, Fac Sci, Dept Phys & Earth Sci, Senbaru 1, Nishihara, Okinawa 9030213, Japan; [Fujita, Kazuhiko; Nakamaura, Takashi] Univ Ryukyus, Trop Biosphere Res Ctr, Senbaru 1, Nishihara, Okinawa 9030213, Japan; [Toyofuku, Takashi] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Marine Biodivers Res B DIVE, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan; [Nakamaura, Takashi] Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, Senbaru 1, Nishihara, Okinawa 9030213, Japan; [Nakamaura, Takashi] Japan Sci & Technol Agcy JST, Japan Int Cooperat Agcy JICA SATREPS, Chiyoda Ku, 8th Floor,Ks Gobancho 7, Tokyo 1020076, Japan	University of the Ryukyus; University of the Ryukyus; University of the Ryukyus; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of the Ryukyus; Japan Science & Technology Agency (JST)	Ohno, Y (corresponding author), Univ Ryukyus, Grad Sch Engn & Sci, Marine & Environm Sci Course, Senbaru 1, Nishihara, Okinawa 9030213, Japan.	yoshikazu.ohno7@gmail.com	Ohno, Yoshikazu/AAU-9366-2021; Takashi, Toyofuku/E-4441-2011	Takashi, Toyofuku/0000-0001-8095-6077; Kazuhiko, Fujita/0000-0002-9833-007X; Ohno, Yoshikazu/0000-0002-6179-0363	KAKENHI [24340131];  [15J04797]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); 	This work was supported by KAKENHI (24340131), Grant-in-Aid for JSPS Fellows (15J04797), URL: https//www.jsps.go.jp/english/e-grants/; and The International Research Hub Project for Climate Change, and Coral Reef/Island Dynamics Department of the University of the Ryukyus, and the University of the Ryukyus Foundation, URL: http://www.u-ryukyu.ac.jp/en.	Allen R. D., 1964, PRIMITIVE MOTILE SYS, P407; Bentov S, 2005, GEOLOGY, V33, P841, DOI 10.1130/G21800.1; Bentov S, 2009, P NATL ACAD SCI USA, V106, P21500, DOI 10.1073/pnas.0906636106; BERNHARD JM, 1992, MAR ECOL PROG SER, V83, P263, DOI 10.3354/meps083263; Bernhard JM, 2004, J FORAMIN RES, V34, P96, DOI 10.2113/0340096; Bernhard JM, 1996, J MICROPALAEONTOL, V15, P68, DOI 10.1144/jm.15.1.68; Bernhard JM, 2000, MICROPALEONTOLOGY, V46, P38; Bernhard JM, 2008, J EUKARYOT MICROBIOL, V55, P135, DOI 10.1111/j.1550-7408.2008.00318.x; Bernhard JM, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2006PA001290; BOWSER SS, 1985, TISSUE CELL, V17, P823, DOI 10.1016/0040-8166(85)90039-4; Bowser SS, 2002, J FORAMIN RES, V32, P440, DOI 10.2113/0320440; BOWSER SS, 1988, J CELL SCI, V89, P297; CALLEWAERT DM, 1991, CYTOMETRY, V12, P666, DOI 10.1002/cyto.990120711; Cavalier-Smith T, 2003, EUR J PROTISTOL, V39, P338, DOI 10.1078/0932-4739-00002; Cedhagen T, 2002, J FORAMIN RES, V32, P434, DOI 10.2113/0320434; de Nooijer LJ, 2009, BIOGEOSCIENCES, V6, P2669, DOI 10.5194/bg-6-2669-2009; de Nooijer LJ, 2008, LIMNOL OCEANOGR-METH, V6, P610, DOI 10.4319/lom.2008.6.610; de Nooijer LJ, 2009, P NATL ACAD SCI USA, V106, P15374, DOI 10.1073/pnas.0904306106; DECLERCK LS, 1994, J IMMUNOL METHODS, V172, P115, DOI 10.1016/0022-1759(94)90384-0; DENHOLM EM, 1995, CYTOKINE, V7, P436, DOI 10.1006/cyto.1995.0059; Dissard D, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002417; Fujita K, 2000, MAR MICROPALEONTOL, V38, P267, DOI 10.1016/S0377-8398(99)00042-0; GUDMUNDSSON G, 1994, MICROPALEONTOLOGY, V40, P101, DOI 10.2307/1485772; Hamann S, 2002, J FLUORESC, V12, P139, DOI 10.1023/A:1016832027325; Hemleben C., 1989, MODERN PLANKTONIC FO, DOI [DOI 10.1016/S0016-6995(89)80108-1, DOI 10.1007/978-1-4612-3544-6_2]; Knight R., 1986, Journal of Micropalaeontology, V5, P83; Kruger R, 1997, ARCH PROTISTENKD, V147, P307; Kurtarkar SR, 2015, MAR MICROPALEONTOL, V114, P36, DOI 10.1016/j.marmicro.2014.10.001; Lee JJ, 1997, J FORAMIN RES, V27, P254, DOI 10.2113/gsjfr.27.4.254; Lee JJ, 1991, BIOL FORAMINIFERA, P91; Lee JJ, 2006, SYMBIOSIS, V42, P63; LEUTENEGGER S, 1979, MAR BIOL, V54, P11, DOI 10.1007/BF00387046; LIPPS JH, 1973, ANNU REV MICROBIOL, V27, P471, DOI 10.1146/annurev.mi.27.100173.002351; Lipps JH, 1993, FOSSIL PROKARYOTES A; MULLERMERZ E, 1976, J PROTOZOOL, V23, P390, DOI 10.1111/j.1550-7408.1976.tb03793.x; Neri S, 2001, CLIN DIAGN LAB IMMUN, V8, P1131, DOI 10.1128/CDLI.8.6.1131-1135.2001; Orokos DD, 2000, CELL MOTIL CYTOSKEL, V47, P296, DOI 10.1002/1097-0169(200012)47:4<296::AID-CM4>3.0.CO;2-4; ROTTGER R, 1974, MAR BIOL, V26, P5, DOI 10.1007/BF00389081; SAVIN SM, 1975, GEOL SOC AM BULL, V86, P1499, DOI 10.1130/0016-7606(1975)86<1499:TMP>2.0.CO;2; Tawakoli PN, 2013, CLIN ORAL INVEST, V17, P841, DOI 10.1007/s00784-012-0792-3; Toyofuku T, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001772; TRAVIS JL, 1983, J CELL BIOL, V97, P1668, DOI 10.1083/jcb.97.6.1668; TRAVIS JL, 1981, J CELL BIOL, V90, P211, DOI 10.1083/jcb.90.1.211; Tyszka J, 2005, STUD GEOL POLON, V124, P143; Vogel N, 2012, J EXP MAR BIOL ECOL, V424, P15, DOI 10.1016/j.jembe.2012.05.008; West CA, 2001, J HISTOCHEM CYTOCHEM, V49, P511, DOI 10.1177/002215540104900411; Zachos JC, 1986, PALEOCEANOGRAPHY, V1, P5, DOI 10.1029/PA001i001p00005	47	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165844	10.1371/journal.pone.0165844	http://dx.doi.org/10.1371/journal.pone.0165844			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812157	Green Published, Green Submitted, gold			2022-12-26	WOS:000386910000070
J	Wang, JJ; Yang, YP; Sun, H; Wen, J; Deng, T; Nie, ZL; Meng, Y				Wang, Jia-Jian; Yang, Yong-Ping; Sun, Hang; Wen, Jun; Deng, Tao; Nie, Ze-Long; Meng, Ying			The Biogeographic South-North Divide of Polygonatum (Asparagaceae Tribe Polygonateae) within Eastern Asia and Its Recent Dispersals in the Northern Hemisphere	PLOS ONE			English	Article							HISTORICAL BIOGEOGRAPHY; MOLECULAR PHYLOGENETICS; DNA-SEQUENCES; EVOLUTION; TERTIARY; AMERICA; DIVERSIFICATION; DISJUNCT; ANGIOSPERMS; CHINA	Eastern Asia (EA) is a key region for the diversification of flowering plants in the Northern Hemisphere, but few studies have focused on the biogeographic history within EA in the context of the other northern continents. Polygonatum is an important medicinal genus widely distributed in the Northern Hemisphere with its highest species richness in EA, and it represents an excellent model for studying the evolution of biogeographic patterns in this region. Divergence time estimation was used to examine the biogeographic history of Polygonatum based on nuclear ITS and four plastid sequences (rbcL, matK, psbA-trnH and trnC-petN) from 30 Polygonatum species and 35 outgroup taxa. The ancestral area of Polygonatum and subsequent dispersal routes were inferred using Bayes-Lagrange. Polygonatum was estimated to have originated in southern EA during the middle Miocene (14.34-13.57 Ma) with subsequent south-to-north expansion in the late Miocene. Multiple intercontinental dispersal events were inferred between EA and Europe or North America, and all of them have occurred recently in the late Miocene to Pliocene. The separation of Polygonatum into the south and north lineages and their subsequent diversifications in the late Miocene supports the existence of a biogeographic divide between the northern and southern parts of EA that also coincides with the retreat and redevelopment of the arid zone in EA in the Neogene. Our results demonstrate the complexity of biogeographic history of Polygonatum in the Northern Hemisphere including early vicariance followed by frequent and recent dispersals in the Neogene.	[Wang, Jia-Jian; Nie, Ze-Long; Meng, Ying] Jishou Univ, Coll Biol & Environm Sci, Key Lab Plant Resources Conservat & Utilizat, Jishou 416000, Hunan, Peoples R China; [Yang, Yong-Ping; Sun, Hang; Deng, Tao] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog E Asia, Kunming 650201, Yunnan, Peoples R China; [Wen, Jun] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, MRC 166, Washington, DC 20013 USA	Jishou University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Smithsonian Institution; Smithsonian National Museum of Natural History	Nie, ZL; Meng, Y (corresponding author), Jishou Univ, Coll Biol & Environm Sci, Key Lab Plant Resources Conservat & Utilizat, Jishou 416000, Hunan, Peoples R China.	zelongnie@163.com; mengyingnie@163.com	Wang, Jiajian/I-4126-2019	Nie, Ze-Long/0000-0001-8065-3981	Natural Sciences Foundation of China [NSFC31270273, 31570211, 31590823]; Laboratory of Analytical Biology of the National Museum of Natural History; Smithsonian Institution; Small Grants Program of the National Museum of Natural History	Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Laboratory of Analytical Biology of the National Museum of Natural History; Smithsonian Institution(Smithsonian Institution); Small Grants Program of the National Museum of Natural History	This study was supported by grants from Natural Sciences Foundation of China (NSFC31270273, 31570211, 31590823). This work was also partially supported by the Laboratory of Analytical Biology of the National Museum of Natural History, Smithsonian Institution, as well as the Small Grants Program of the National Museum of Natural History, the Smithsonian Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1967, BERING LAND BRIDGE; Bai WN, 2016, NEW PHYTOL, V209, P1757, DOI 10.1111/nph.13711; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Beaulieu JM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-80; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Buerki S, 2013, ANN BOT-LONDON, V111, P361, DOI 10.1093/aob/mcs286; Buerki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039377; BUSH BENJAMIN FRANKLIN, 1927, AMER MIDLAND NAT, V10, P385, DOI 10.2307/2993208; Chen S.C., 2000, FLORA CHINA, V24, P223; Chen SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059472; Deng XY, 2009, BOT J LINN SOC, V159, P245, DOI 10.1111/j.1095-8339.2008.00944.x; Donoghue MJ, 2008, P NATL ACAD SCI USA, V105, P11549, DOI 10.1073/pnas.0801962105; Donoghue MJ, 2004, PHILOS T R SOC B, V359, P1633, DOI 10.1098/rstb.2004.1538; Donoghue MJ, 2001, INT J PLANT SCI, V162, pS41, DOI 10.1086/323278; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Forest F, 2009, ANN BOT-LONDON, V104, P789, DOI 10.1093/aob/mcp192; Friis E. M., 2011, EARLY FLOWERS ANGIOS; Gandolfo MA, 2002, AM J BOT, V89, P1940, DOI 10.3732/ajb.89.12.1940; Guo ZT, 2008, CLIM PAST, V4, P153, DOI 10.5194/cp-4-153-2008; Hertweck KL, 2015, BOT J LINN SOC, V178, P375, DOI 10.1111/boj.12260; Huang WP, 2013, BOT J LINN SOC, V171, P395, DOI 10.1111/j.1095-8339.2012.01321.x; Iles WJD, 2015, BOT J LINN SOC, V178, P346, DOI 10.1111/boj.12233; Jang C.G., 2002, STAPFIA, V80, P333; JEFFREY C, 1982, Kew Bulletin, V37, P335, DOI 10.2307/4109978; JEFFREY C, 1980, Kew Bulletin, V34, P435, DOI 10.2307/4109822; Judd Walter S., 2003, Harvard Papers in Botany, V7, P93; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kim JH, 2010, ANN BOT-LONDON, V106, P775, DOI 10.1093/aob/mcq167; LI HUI-LIN, 1948, TAIWANIA, V1, P1; Manos PS, 2001, INT J PLANT SCI, V162, pS77, DOI 10.1086/323280; Meng Y, 2008, MOL PHYLOGENET EVOL, V49, P424, DOI 10.1016/j.ympev.2008.07.017; Meng Y, 2014, BOT J LINN SOC, V176, P435, DOI 10.1111/boj.12218; Milne RI, 2002, ADV BOT RES, V38, P281, DOI 10.1016/S0065-2296(02)38033-9; Milne RI, 2006, ANN BOT-LONDON, V98, P465, DOI 10.1093/aob/mcl148; Nie ZL, 2006, AM J BOT, V93, P1343, DOI 10.3732/ajb.93.9.1343; Nie ZL, 2006, MOL PHYLOGENET EVOL, V40, P155, DOI 10.1016/j.ympev.2006.03.012; Nie ZL, 2016, NEW PHYTOL, V209, P1795, DOI 10.1111/nph.13740; Nie ZL, 2010, AM J BOT, V97, P1342, DOI 10.3732/ajb.1000085; Quandt D, 2010, PHYDE PHYLOGENETIC D; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Rudall PJ, 2000, BOT J LINN SOC, V134, P73, DOI 10.1006/bojl.2000.0365; SHINWARI ZK, 1994, PLANT SYST EVOL, V192, P263, DOI 10.1007/BF00986256; Suchard M.A., 2014, TRACER V1 6; Sun XJ, 2005, PALAEOGEOGR PALAEOCL, V222, P181, DOI 10.1016/j.palaeo.2005.03.005; Tamura M. N., 1997, Feddes Repertorium, V108, P159; Tang T., 1978, FLORA REIPUBLICAE PO, V15, P52; TIDWELL WD, 1990, REV PALAEOBOT PALYNO, V62, P79, DOI 10.1016/0034-6667(90)90018-E; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P243, DOI 10.5962/bhl.part.13183; Tiffney BH, 2001, INT J PLANT SCI, V162, pS3, DOI 10.1086/323880; Wang P X., 1997, CHANGING FACE E ASIA, P263; WANG PX, 1990, PALAEOGEOGR PALAEOCL, V77, P315, DOI 10.1016/0031-0182(90)90183-8; Wang W.-T., 1992, ACTA PHYTOTAXONOMICA, V30, P97; WANG WT, 1992, ACTA PHYTOTAXON SIN, V30, P1, DOI DOI 10.4324/9780429500190-1; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Wen J., 2010, DARWINS HERITAGE TOD, P252; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wu ZY., 1998, P 1 INT S FLOR CHAR, P3; Xiang QYJ, 2004, EVOLUTION, V58, P2175, DOI 10.1111/j.0014-3820.2004.tb01596.x; Xiang QYJ, 2001, INT J PLANT SCI, V162, pS29, DOI 10.1086/323332; Xie L, 2009, MOL PHYLOGENET EVOL, V53, P995, DOI 10.1016/j.ympev.2009.09.009; Yu Y, 2015, MOL PHYLOGENET EVOL, V87, P46, DOI 10.1016/j.ympev.2015.03.008; Zhu WD, 2013, BOT J LINN SOC, V171, P377, DOI 10.1111/j.1095-8339.2012.01318.x	64	13	14	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166134	10.1371/journal.pone.0166134	http://dx.doi.org/10.1371/journal.pone.0166134			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812188	Green Published, Green Submitted, gold			2022-12-26	WOS:000386910000104
J	Xiao, GJ; Jiang, SW; Qian, LL; Cai, CB; Wang, QQ; Ma, DZ; Li, B; Xie, SS; Cui, WT; Li, K				Xiao, Gao-Jun; Jiang, Sheng-Wang; Qian, Li-Li; Cai, Chun-Bo; Wang, Qing-Qing; Ma, De-Zun; Li, Biao; Xie, Shan-Shan; Cui, Wen-Tao; Li, Kui			A 90-Day Feeding Study in Rats to Assess the Safety of Genetically Engineered Pork	PLOS ONE			English	Article							GENE; GUIDANCE; CATTLE	Our laboratory recently produced genetically engineered (GE) Meishan pigs containing a ZFN-edited myostatin loss-of-function mutant. These GE pigs develop and grow as normal as wild type pigs but produce pork with greater lean yield and lower fat mass. To assess any potential subchronic toxicity risks of this GE pork, a 90-day feeding study was conducted in Sprague-Dawley rats. Rats were randomly divided into five groups, and fed for 90 days with basic diet and basic diets formulated with low dose and high dose pork prepared from wild type pigs and GE pigs, respectively. Animal behaviors and clinical signs were monitored twice daily, and body weight and food consumption were measured and recorded weekly. At days 45 and 90, blood tests (lipid panel, electrolytes, parameters related to liver and kidney functions, and complete blood counts) were performed. Additionally, gross pathology and histopathological analyses were performed for major organs in each group. Data analysis shows that there were no significant differences in growth rate, food consumption, and blood test parameters between rat groups fed with GE pork and wild type pork. Although differences in some liver function parameters (such as aspartate aminotransferase, total proteins, albumin, and alkaline phosphatase) and white blood cell counts (such as lymphocyte percentage and monocyte percentage) were observed between rats fed with high dose GE pork and basic diet, all test results in rats fed with GE pork are in the normal range. Additionally, there are no apparent lesions noted in all organs isolated from rats in all five feeding groups on days 45 and 90. Overall, our results clearly indicate that food consumption of GE pork produced by ZFN-edited myostatin loss-of-function mutant pigs did not have any long-term adverse effects on the health status in rats.	[Xiao, Gao-Jun; Jiang, Sheng-Wang; Cai, Chun-Bo; Wang, Qing-Qing; Ma, De-Zun; Li, Biao; Xie, Shan-Shan; Cui, Wen-Tao; Li, Kui] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China; [Qian, Li-Li; Cai, Chun-Bo] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; China Agricultural University	Cui, WT (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China.	cuiwentao@caas.cn	钱, 钱丽丽/GWV-8162-2022; xie, shanshan/GSM-8999-2022		National Transgenic Project of China [2011ZX08006-003]; Agricultural Science and Technology Innovation Program [ASTIP-IA505]; Safety Evaluation Project of Transgenic Animals and Feeding Materials [2011-G11]	National Transgenic Project of China; Agricultural Science and Technology Innovation Program; Safety Evaluation Project of Transgenic Animals and Feeding Materials	This work was supported by the National Transgenic Project of China (2011ZX08006-003) the Agricultural Science and Technology Innovation Program (ASTIP-IA505), and Safety Evaluation Project of Transgenic Animals and Feeding Materials (2011-G11). K.L. received the above funding. The funding agents had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson HC, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2501; Antunovic B, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2438; Bai H, 2015, PLOS ONE, V10; Beumer KJ, 2008, P NATL ACAD SCI USA, V105, P19821, DOI 10.1073/pnas.0810475105; CHINA SAOTPSRO, 2003, DET AM AC FOODS, p6P; CHINA SAOTPSRO, 2003, DET FAT FOODS, p4P; CHINA SAOTPSRO, 2006, FEED STUFF DET CRUD, p12P; CHINA SAOTPSRO, 2010, NAT FOOD SAF STAND D, p6P; CHINA SAOTPSRO, 2010, NAT FOOD SAF STAND D, p9P; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Ge K. Y Y, 2008, ACTA NUTRIMENTA SINI, V30, P1; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gupta RM, 2014, J CLIN INVEST, V124, P4154, DOI 10.1172/JCI72992; Hashimoto W, 1999, BIOSCI BIOTECH BIOCH, V63, P1942, DOI 10.1271/bbb.63.1942; Hatada I, 2016, ENDOCR J, V63, P105, DOI 10.1507/endocrj.EJ15-0716; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Liu S, 2013, FOOD CHEM TOXICOL, V57, P314, DOI 10.1016/j.fct.2013.04.003; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Qian LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14435; Ramirez CL, 2012, NUCLEIC ACIDS RES, V40, P5560, DOI 10.1093/nar/gks179; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Song H, 2015, TRANSGENIC RES, V24, P295, DOI 10.1007/s11248-014-9844-6; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zhang F, 2010, P NATL ACAD SCI USA, V107, P12028, DOI 10.1073/pnas.0914991107; Zhu YX, 2013, FOOD CHEM TOXICOL, V51, P280, DOI 10.1016/j.fct.2012.09.008	37	5	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165843	10.1371/journal.pone.0165843	http://dx.doi.org/10.1371/journal.pone.0165843			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812153	Green Submitted, Green Published, gold			2022-12-26	WOS:000386910000069
J	Aasted, CM; Yucel, MA; Steele, SC; Peng, K; Boas, DA; Becerra, L; Borsook, D				Aasted, Christopher M.; Yucel, Meryem A.; Steele, Sarah C.; Peng, Ke; Boas, David A.; Becerra, Lino; Borsook, David			Frontal Lobe Hemodynamic Responses to Painful Stimulation: A Potential Brain Marker of Nociception	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; FUNCTIONAL CONNECTIVITY; RATING-SCALES; HUMAN CORTEX; INTENSITY; DISTRACTION; HUMANS; GYRUS	The purpose of this study was to use functional near-infrared spectroscopy (fNIRS) to examine patterns of both activation and deactivation that occur in the frontal lobe in response to noxious stimuli. The frontal lobe was selected because it has been shown to be activated by noxious stimuli in functional magnetic resonance imaging studies. The brain region is located behind the forehead which is devoid of hair, providing a relative ease of placement for fNIRS probes on this area of the head. Based on functional magnetic resonance imaging studies showing blood-oxygenation-level dependent changes in the frontal lobes, we evaluated functional near-infrared spectroscopy measures in response to two levels of electrical pain in awake, healthy human subjects (n = 10; male = 10). Each subject underwent two recording sessions separated by a 30-minute resting period. Data collected from 7 subjects were analyzed, containing a total of 38/36 low/high intensity pain stimuli for the first recording session and 27/31 pain stimuli for the second session. Our results show that there is a robust and significant deactivation in sections of the frontal cortices. Further development and definition of the specificity and sensitivity of the approach may provide an objective measure of nociceptive activity in the brain that can be easily applied in the surgical setting.	[Aasted, Christopher M.; Steele, Sarah C.; Peng, Ke; Becerra, Lino; Borsook, David] Harvard Med Sch, Ctr Pain & Brain, Boston, MA 02115 USA; [Aasted, Christopher M.; Steele, Sarah C.; Peng, Ke; Becerra, Lino; Borsook, David] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Aasted, Christopher M.; Yucel, Meryem A.; Steele, Sarah C.; Peng, Ke; Boas, David A.; Becerra, Lino; Borsook, David] Harvard Med Sch, Boston, MA 02115 USA; [Aasted, Christopher M.; Yucel, Meryem A.; Steele, Sarah C.; Peng, Ke; Boas, David A.; Becerra, Lino; Borsook, David] Massachusetts Gen Hosp, Dept Radiol, Martinos Ctr Biomed Imaging, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Borsook, D (corresponding author), Harvard Med Sch, Ctr Pain & Brain, Boston, MA 02115 USA.; Borsook, D (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA.; Borsook, D (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Borsook, D (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Martinos Ctr Biomed Imaging, Boston, MA 02114 USA.	david.borsook@childrens.harvard.edu		YUCEL, MERYEM/0000-0002-4291-2847	Mayday Foundation; Anesthesia Research Distinguished Trailblazer Award; National Institute of General Medical Science of the National Institutes of Health [R01GM104986]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104986] Funding Source: NIH RePORTER	Mayday Foundation; Anesthesia Research Distinguished Trailblazer Award; National Institute of General Medical Science of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this article was supported by the Mayday Foundation, the Anesthesia Research Distinguished Trailblazer Award, and the National Institute of General Medical Science of the National Institutes of Health under award number R01GM104986. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anticevic A, 2010, COGN AFFECT BEHAV NE, V10, P159, DOI 10.3758/CABN.10.2.159; Barati Z, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.11.117007; Barati Z, 2013, ANN BIOMED ENG, V41, P223, DOI 10.1007/s10439-012-0642-0; Becerra L, 2008, NEUROIMAGE, V41, P252, DOI 10.1016/j.neuroimage.2008.01.047; Becerra L, 2016, PAIN, V157, P840, DOI 10.1097/j.pain.0000000000000446; Bonhomme V, 2016, ANESTHESIOLOGY, V125, P873, DOI 10.1097/ALN.0000000000001275; Cauda F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004542; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Gohil K, 2016, SCI REP-UK, V6, DOI 10.1038/srep22317; Gold AL, 2015, BIOL PSYCHIAT, V77, P394, DOI 10.1016/j.biopsych.2014.03.030; Hautvast RWM, 1997, EUR J NEUROSCI, V9, P1178, DOI 10.1111/j.1460-9568.1997.tb01472.x; Hjermstad MJ, 2011, J PAIN SYMPTOM MANAG, V41, P1073, DOI 10.1016/j.jpainsymman.2010.08.016; Kucyi A, 2014, J NEUROSCI, V34, P3969, DOI 10.1523/JNEUROSCI.5055-13.2014; Kussman BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158975; Lee CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075360; Lenz FA, 1998, J NEUROPHYSIOL, V79, P2231, DOI 10.1152/jn.1998.79.4.2231; Lobanov OV, 2013, PAIN, V154, P1758, DOI 10.1016/j.pain.2013.05.030; MANTYH PW, 1982, J COMP NEUROL, V206, P146, DOI 10.1002/cne.902060205; Minamoto T, 2015, CORTEX, V71, P277, DOI 10.1016/j.cortex.2015.07.025; Moayedi M, 2015, BRAIN STRUCT FUNCT, V220, P2603, DOI 10.1007/s00429-014-0809-6; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Ploghaus A, 2000, P NATL ACAD SCI USA, V97, P9281, DOI 10.1073/pnas.160266497; Porro CA, 1998, J NEUROPHYSIOL, V80, P3312, DOI 10.1152/jn.1998.80.6.3312; Pourshoghi A, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0190-9; Sakuma S, 2014, NEUROSCI LETT, V575, P74, DOI 10.1016/j.neulet.2014.05.040; Simons LE, 2014, HUM BRAIN MAPP, V35, P527, DOI 10.1002/hbm.22199; Svensson P, 1997, J NEUROPHYSIOL, V78, P450, DOI 10.1152/jn.1997.78.1.450; Symonds LL, 2006, J NEUROPHYSIOL, V95, P3823, DOI 10.1152/jn.01162.2005; Wheelock MD, 2014, NEUROIMAGE, V102, P904, DOI 10.1016/j.neuroimage.2014.08.005; Williamson A, 2005, J CLIN NURS, V14, P798, DOI 10.1111/j.1365-2702.2005.01121.x; Yucel MA, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.3.035005; Yucel MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09469	32	26	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165226	10.1371/journal.pone.0165226	http://dx.doi.org/10.1371/journal.pone.0165226			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806119	Green Published, Green Submitted, gold			2022-12-26	WOS:000386715500022
J	de Moraes, AV; Carvalho, CDS; Carneiro, CC; do Vale, CR; Lima, DCD; Carvalho, WF; Vieira, TB; Silva, DDE; Cunha, KS; Chen-Chen, L				de Moraes Filho, Aroldo Vieira; Silva Carvalho, Claudia de Jesus; Carneiro, Cristiene Costa; do Vale, Camila Regina; da Silva Lima, Debora Cristina; Carvalho, Wanessa Fernandes; Vieira, Thiago Bernardi; de Melo e Silva, Daniela; Cunha, Kenya Silva; Chen-Chen, Lee			Genotoxic and Cytotoxic Effects of Antiretroviral Combinations in Mice Bone Marrow	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; TENOFOVIR DISOPROXIL FUMARATE; HPRT LYMPHOCYTE MUTANTS; COMET ASSAY; MICRONUCLEUS ASSAY; LYMPHOBLASTOID-CELLS; GENETIC-DAMAGE; DNA-DAMAGE; ZIDOVUDINE; LAMIVUDINE	Commonly used guidelines for the management of human immunodeficiency virus (HIV) infection (highly active antiretroviral therapy, HAART) include drug combinations such as tenofovir disoproxil fumarate (TDF) + lamivudine (3TC) and combivir [zidovudine (AZT) + 3TC] + efavirenz (EFV). These combinations may enhance the genotoxic effects induced by such drugs individually, since the therapy requires lifelong adherence and the drugs have unknown effects during treatment. Thus, the evaluation of the benefits and risks of HAART is of great importance. In order to assess the cytotoxic and genotoxic potential of three concentrations of each of the antiretroviral combinations TDF + 3TC (800 + 400, 1600 + 800, and 3200 + 1600 mg/kg body weight, BW) and combivir + EFV (200 + 100 + 400, 400 + 200 + 800, and 800 + 400 + 1600 mg/kg BW) after two exposure periods (24 h and 48 h), in the present study the in vivo comet assay (single-cell gel electrophoresis) and the mouse bone marrow micronucleus test were used. Neither TDF + 3TC nor combivir + EFV induced DNA damage at any concentrations tested after 24 h or 48 h using the comet assay. After 24 h, both combinations increased the micronucleus frequency at all concentrations tested. After 48 h, combivir + EFV increased the micronucleated polychromatic erythrocyte (MNPCE) frequency at the two highest concentrations tested. Polychromatic erythrocytes (PCE)/normochromatic erythrocytes (NCE) ratio was high for both combinations, suggesting that they can be mitogenic. Since genotoxicity may be related to carcinogenesis, it is necessary to conduct further studies to verify the long-term mutagenic effects of these drugs.	[de Moraes Filho, Aroldo Vieira; Silva Carvalho, Claudia de Jesus; Carneiro, Cristiene Costa; do Vale, Camila Regina; da Silva Lima, Debora Cristina; Carvalho, Wanessa Fernandes; de Melo e Silva, Daniela; Cunha, Kenya Silva; Chen-Chen, Lee] Univ Fed Goias, ICB, Dept Genet, Lab Radiobiol & Mutagenese, Campus Samambaia,Caixa Postal 131, BR-74001970 Goiania, Go, Brazil; [Vieira, Thiago Bernardi] Univ Estado Mato Grosso, Programa Posgrad Ecol & Conservacao, Campus Univ Nova Xavantina,BR 158,Caixa Postal 8, BR-78690000 Nova Xavantina, MT, Brazil	Universidade Federal de Goias; Universidade do Estado de Mato Grosso	de Moraes, AV (corresponding author), Univ Fed Goias, ICB, Dept Genet, Lab Radiobiol & Mutagenese, Campus Samambaia,Caixa Postal 131, BR-74001970 Goiania, Go, Brazil.	aroldodemoraes@gmail.com	Chen-Chen, Lee/Q-9797-2019; Filho, Aroldo Moraes/AAQ-5257-2021; Vieira, Thiago Bernardi/H-4520-2017; Vieira, Thiago Bernardi/P-5233-2015; Chen, Lee Chen/B-1668-2013	Chen-Chen, Lee/0000-0002-0386-247X; Vieira, Thiago Bernardi/0000-0003-1762-8294; Vieira, Thiago Bernardi/0000-0003-1762-8294; Chen, Lee Chen/0000-0002-0386-247X; Carvalho, Wanessa Fernandes/0000-0003-4297-5191	CAPES Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior	CAPES Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by CAPES Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior.	Anderson PL, 2003, AIDS, V17, P2159, DOI 10.1097/00002030-200310170-00003; Attia SM, 2014, MUTAGENESIS, V29, P55, DOI 10.1093/mutage/get063; Barditch-Crovo P, 2001, ANTIMICROB AGENTS CH, V45, P2733, DOI 10.1128/AAC.45.10.2733-2739.2001; Bayram S, 2008, ENVIRON MOL MUTAGEN, V49, P328, DOI 10.1002/em.20393; Bialkowska A, 2000, CARCINOGENESIS, V21, P1059, DOI 10.1093/carcin/21.5.1059; Bishop JB, 2004, ENVIRON MOL MUTAGEN, V43, P3, DOI 10.1002/em.10210; Bisset LR, 2002, ANTIVIR RES, V53, P35, DOI 10.1016/S0166-3542(01)00190-5; Bonassi S, 2007, CARCINOGENESIS, V28, P625, DOI 10.1093/carcin/bgl177; Brambilla G, 2011, MUTAGENESIS, P1, DOI [10.1093/mutage/ger052, DOI 10.1093/MUTAGE/GER052]; Brambilla G, 2012, MUTAT RES-REV MUTAT, V750, P1, DOI 10.1016/j.mrrev.2011.09.002; Carter MM, 2007, ENVIRON MOL MUTAGEN, V48, P239, DOI 10.1002/em.20282; Cihlar T, 2002, ANTIVIR RES, V54, P37, DOI 10.1016/S0166-3542(01)00210-8; COLEGIO BRASILEIRO DE EXPERIMENTACAO ANIMAL-COBEA, 1991, PRINC ET EXP AN; Collins A, 2014, MUTAT RES-REV MUTAT, V759, P27, DOI 10.1016/j.mrrev.2013.10.001; Collins AR, 2014, BBA-GEN SUBJECTS, V1840, P794, DOI 10.1016/j.bbagen.2013.04.022; de Baar MP, 2007, ANTIVIR RES, V76, P68, DOI 10.1016/j.antiviral.2007.05.004; de Oliveira HM, 2014, ENVIRON TOXICOL PHAR, V37, P390, DOI 10.1016/j.etap.2013.12.011; Decordier I, 2002, MUTAGENESIS, V17, P337, DOI 10.1093/mutage/17.4.337; Decordier I, 2008, MUTAT RES-GEN TOX EN, V651, P30, DOI 10.1016/j.mrgentox.2007.10.016; Diaz-Delfin J, 2011, ANTIVIR RES, V91, P112, DOI 10.1016/j.antiviral.2011.04.018; Duan CY, 2001, J INFECT DIS, V184, P1336, DOI 10.1086/323995; Ehteshami M, 2008, J BIOL CHEM, V283, P29904, DOI 10.1074/jbc.M804882200; Escobar PA, 2007, ENVIRON MOL MUTAGEN, V48, P330, DOI 10.1002/em.20285; Friedrich A, 2011, REGUL TOXICOL PHARM, V60, P225, DOI 10.1016/j.yrtph.2011.04.001; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Godschalk RWL, 2013, MUTAT RES-GEN TOX EN, V757, P60, DOI 10.1016/j.mrgentox.2013.06.020; Guimaraes NN, 2013, FOOD CHEM TOXICOL, V53, P299, DOI 10.1016/j.fct.2012.12.005; Hartmann A, 2004, MUTAGENESIS, V19, P51, DOI 10.1093/mutage/geg038; HAYASHI M, 1994, MUTAT RES, V312, P293, DOI 10.1016/0165-1161(94)90039-6; Hecht M, 2013, AIDS, V27, P2031, DOI 10.1097/QAD.0b013e3283625444; HEDDLE JA, 1973, MUTAT RES, V18, P187, DOI 10.1016/0027-5107(73)90035-3; Herd O., 2014, Journal of AIDS and Clinical Research, V5, P397; Krishna G, 2000, MUTAT RES-FUND MOL M, V455, P155, DOI 10.1016/S0027-5107(00)00117-2; Lei FX, 2011, CHIN J ANTIBIOT; Lourenco ED, 2010, GENET MOL BIOL, V33, P756, DOI 10.1590/S1415-47572010005000084; MACGREGOR JT, 1987, MUTAT RES, V189, P103, DOI 10.1016/0165-1218(87)90016-4; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2016, GUIDELINES USE ANTIR; Pozniak AL, 2006, JAIDS-J ACQ IMM DEF, V43, P535; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ribaudo HJ, 2006, CLIN INFECT DIS, V42, P401, DOI 10.1086/499364; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; SCHILLING BE, 1995, CURR THER RES CLIN E, V56, P201, DOI 10.1016/0011-393X(95)85025-2; SCHLEGEL R, 1984, MUTAT RES, V127, P169, DOI 10.1016/0027-5107(84)90018-6; SHAFIK HM, 1991, ANTIVIR RES, V16, P205, DOI 10.1016/0166-3542(91)90026-N; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Tripathi DN, 2008, MUTAT RES-GEN TOX EN, V653, P134, DOI 10.1016/j.mrgentox.2008.03.004; Von Tungeln LS, 2007, ENVIRON MOL MUTAGEN, V48, P258, DOI 10.1002/em.20237; Von Tungeln LS, 2002, CARCINOGENESIS, V23, P1427, DOI 10.1093/carcin/23.9.1427; Walker DM, 2009, ENVIRON MOL MUTAGEN, V50, P460, DOI 10.1002/em.20482; Wu KM, 2012, INT J TOXICOL, V31, P211, DOI 10.1177/1091581812439585; Xiang GG, 2013, FOOD CHEM TOXICOL, V53, P352, DOI 10.1016/j.fct.2012.12.020	51	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165706	10.1371/journal.pone.0165706	http://dx.doi.org/10.1371/journal.pone.0165706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806085	Green Published, gold, Green Submitted			2022-12-26	WOS:000386715500051
J	Nagata, JM; Gippetti, J; Wager, S; Chavez, A; Wise, PH				Nagata, Jason M.; Gippetti, James; Wager, Stefan; Chavez, Alejandro; Wise, Paul H.			Prevalence and Predictors of Malnutrition among Guatemalan Children at 2 Years of Age	PLOS ONE			English	Article							TZUTUJIL MAYA; INTERVENTIONS; CHILDHOOD; SUPPLEMENTATION; PATTERNS; WATER	Objective To identify the prevalence and predictors of malnutrition among 2-year old children in the Western Highlands of Guatemala. Methods Prospective cohort of 852 Guatemalan children in San Lucas Toliman, Guatemala followed from birth to age 2 from May 2008 to December 2013. Socio-demographic, anthropometric, and health data of children was collected at 2 month intervals. Results Among the 402 males and 450 females in the cohort, mean weight-for-age Z-score (WAZ) declined from -0.67 +/- 1.01 at 1 year to -1.07 +/- 0.87 at 2 years, while mean height-for-age Z-score (HAZ) declined from -1.88 +/- 1.19 at 1 year to -2.37 +/- 0.99 at 2 years. Using multiple linear regression modeling, number of children <5 years old, vomiting in the past week, fever in the past week, and WAZ at 1 year were significant predictors of WAZ at 2 years. Significant predictors of HAZ at 2 years included household size, number of children <5 years old, diarrhea in the past week, WAZ at 1 year, and HAZ at 1 year. Vomiting in the past week and WAZ at 1 year were significant predictors of weight-for-height z-score (WHZ) at 2 years. Conclusions Number of children <5 years old, symptoms such as vomiting or diarrhea in the previous week, and prior nutritional status were the most significant predictors of malnutrition in this cohort. Future research may focus on the application of models to develop predictive algorithms for mobile device technology, as well as the identification of other predictors of malnutrition that are not well characterized such as the interaction of environmental exposures with protein consumption and epigenetics.	[Nagata, Jason M.; Wise, Paul H.] Stanford Univ, Dept Pediat, Palo Alto, CA 94304 USA; [Gippetti, James; Chavez, Alejandro; Wise, Paul H.] Stanford Univ, Ctr Hlth Policy, Palo Alto, CA 94304 USA; [Gippetti, James; Chavez, Alejandro; Wise, Paul H.] Stanford Univ, Ctr Primary Care & Outcomes Res, Palo Alto, CA 94304 USA; [Wager, Stefan] Stanford Univ, Grad Sch Business, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Stanford University	Nagata, JM (corresponding author), Stanford Univ, Dept Pediat, Palo Alto, CA 94304 USA.	jasonmnagata@gmail.com		Nagata, Jason/0000-0002-6541-0604	Mary Duke Biddle Clinical Scholars Program at Stanford University	Mary Duke Biddle Clinical Scholars Program at Stanford University	JMN was supported by the Mary Duke Biddle Clinical Scholars Program at Stanford University, http://globalhealth.stanford.edu/field-service/mary-duke.html. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrman JR, 2009, AM J CLIN NUTR, V90, P1372, DOI 10.3945/ajcn.2009.27524; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berngard SC, 2013, EARLY HUM DEV, V89, P967, DOI 10.1016/j.earlhumdev.2013.09.008; Bhaskaram P, 2002, NUTR REV, V60, pS40, DOI 10.1301/00296640260130722; Brown K, 2014, MATERN CHILD NUTR; Chanani S., 2016, FOOD NUTR B; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Frongillo EA, 1997, J NUTR, V127, P2302, DOI 10.1093/jn/127.12.2302; HABICHT JP, 1995, J NUTR, V125, pS1042; Hien Nguyen Ngoc, 2008, J Prev Med Public Health, V41, P232, DOI 10.3961/jpmph.2008.41.4.232; Islam MM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-11; Kinyoki DK, 2015, PUBLIC HEALTH NUTR, P1; Lakkam M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099632; Lundeen EA, 2014, AM J CLIN NUTR, V100, P821, DOI 10.3945/ajcn.114.084368; Maleta K, 2003, PAEDIATR PERINAT EP, V17, P384, DOI 10.1046/j.1365-3016.2003.00519.x; Nagahori C, 2015, NURS HEALTH SCI, V17, P229, DOI 10.1111/nhs.12176; Nagata JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091403; Nagata JM, 2013, DIABETES TECHNOL THE, V15, P606, DOI 10.1089/dia.2013.0058; Nagata JM, 2011, ECOL FOOD NUTR, V50, P297, DOI 10.1080/03670244.2011.568911; Nagata JM, 2011, REV PANAM SALUD PUBL, V29, P9; Nagata JM, 2009, ECON HUM BIOL, V7, P96, DOI 10.1016/j.ehb.2009.02.002; Nandy S, 2005, B WORLD HEALTH ORGAN, V83, P210; Oruamabo RS, 2015, ARCH DIS CHILD, V100, pS19, DOI 10.1136/archdischild-2013-305384; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; Rice AL, 2000, B WORLD HEALTH ORGAN, V78, P1207; Schrezenmeir J, 2004, CLIN PEDIATR, V43, P239, DOI 10.1177/000992280404300305; Stein AD, 2010, AM J HUM BIOL, V22, P353, DOI 10.1002/ajhb.20998; United Nations, 2014, MILL DEV GOALS REP 2; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA	31	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0164772	10.1371/journal.pone.0164772	http://dx.doi.org/10.1371/journal.pone.0164772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806066	gold, Green Published, Green Submitted			2022-12-26	WOS:000386715500012
J	Dimitrova, N; Nagaraj, AB; Razi, A; Singh, S; Kamalakaran, S; Banerjee, N; Joseph, P; Mankovich, A; Mittal, P; DiFeo, A; Varadan, V				Dimitrova, N.; Nagaraj, A. B.; Razi, A.; Singh, S.; Kamalakaran, S.; Banerjee, N.; Joseph, P.; Mankovich, A.; Mittal, P.; Difeo, A.; Varadan, V.			InFlo: a novel systems biology framework identifies cAMP-CREB1 axis as a key modulator of platinum resistance in ovarian cancer	ONCOGENE			English	Article							REVEALS; PHOSPHORYLATION; SENSITIVITY; PATHWAYS; BINDING; TARGET; ALPHA; FOXM1	Characterizing the complex interplay of cellular processes in cancer would enable the discovery of key mechanisms underlying its development and progression. Published approaches to decipher driver mechanisms do not explicitly model tissue-specific changes in pathway networks and the regulatory disruptions related to genomic aberrations in cancers. We therefore developed InFlo, a novel systems biology approach for characterizing complex biological processes using a unique multidimensional framework integrating transcriptomic, genomic and/or epigenomic profiles for any given cancer sample. We show that InFlo robustly characterizes tissue-specific differences in activities of signalling networks on a genome scale using unique probabilistic models of molecular interactions on a per-sample basis. Using large-scale multi-omics cancer datasets, we show that InFlo exhibits higher sensitivity and specificity in detecting pathway networks associated with specific disease states when compared to published pathway network modelling approaches. Furthermore, InFlo's ability to infer the activity of unmeasured signalling network components was also validated using orthogonal gene expression signatures. We then evaluated multi-omics profiles of primary high-grade serous ovarian cancer tumours (N = 357) to delineate mechanisms underlying resistance to frontline platinumbased chemotherapy. InFlo was the only algorithm to identify hyperactivation of the cAMP-CREB1 axis as a key mechanism associated with resistance to platinum-based therapy, a finding that we subsequently experimentally validated. We confirmed that inhibition of CREB1 phosphorylation potently sensitized resistant cells to platinum therapy and was effective in killing ovarian cancer stem cells that contribute to both platinum-resistance and tumour recurrence. Thus, we propose InFlo to be a scalable and widely applicable and robust integrative network modelling framework for the discovery of evidence-based biomarkers and therapeutic targets.	[Dimitrova, N.; Kamalakaran, S.; Banerjee, N.; Mankovich, A.] Philips Res North Amer, Dept Clin Informat Solut & Serv, Briarcliff Manor, NY USA; [Nagaraj, A. B.; Razi, A.; Singh, S.; Joseph, P.; Difeo, A.; Varadan, V.] Case Western Reserve Univ, Case Comprehens Canc Ctr, 2103 Cornell Rd,WRB 3125, Cleveland, OH 44106 USA; [Mittal, P.] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA	Philips; Philips Research; Case Western Reserve University; Princeton University	DiFeo, A; Varadan, V (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, 2103 Cornell Rd,WRB 3125, Cleveland, OH 44106 USA.	analisa.difeo@case.edu; vinay.varadan@case.edu	Varadan, Vinay/AAC-2520-2020; Nagaraj, Anil Belur/V-7779-2019; Singh, Salendra/AAG-8574-2019	Singh, Salendra/0000-0002-4903-9868; DiFeo, Analisa/0000-0001-8319-6763	PHS award: Career Development Program of Case GI SPORE [P50 CA150964]; PHS award: Career Development Program in Computational Genomic Epidemiology of Cancer [R25T CA094186]; Philips Healthcare; Rosalie and Morton Cohen Family Memorial Genomics Fund of University Hospitals; Ohio Cancer Research award; VelaSano Bike for Cure Funds; Norma I and Al G Geller Endowment in Ovarian Cancer Research (Analisa DiFeo); NATIONAL CANCER INSTITUTE [P50CA150964, R25CA094186] Funding Source: NIH RePORTER	PHS award: Career Development Program of Case GI SPORE; PHS award: Career Development Program in Computational Genomic Epidemiology of Cancer; Philips Healthcare; Rosalie and Morton Cohen Family Memorial Genomics Fund of University Hospitals; Ohio Cancer Research award; VelaSano Bike for Cure Funds; Norma I and Al G Geller Endowment in Ovarian Cancer Research (Analisa DiFeo); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported, in part, by PHS awards: Career Development Program of Case GI SPORE (P50 CA150964) award to Vinay Varadan; Career Development Program in Computational Genomic Epidemiology of Cancer (R25T CA094186) award to Vinay Varadan In addition, this research was supported, in part, by research funding from Philips Healthcare to Vinay Varadan: the Rosalie and Morton Cohen Family Memorial Genomics Fund of University Hospitals to Vinay Varadan: Ohio Cancer Research award to Vinay Varadan: VelaSano Bike for Cure Funds award to Analisa DiFeo and Vinay Varadan: and the Norma I and Al G Geller Endowment in Ovarian Cancer Research (Analisa DiFeo).	Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Benedetti V, 2008, MOL CANCER THER, V7, P679, DOI 10.1158/1535-7163.MCT-07-0450; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Efroni S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000425; Figueroa JD, 2010, BREAST CANCER RES TR, V121, P727, DOI 10.1007/s10549-009-0590-z; Greenblum SI, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-133; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kuroda T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065158; Latifi A, 2011, J CELL BIOCHEM, V112, P2850, DOI 10.1002/jcb.23199; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu J.S., 2001, MONTE CARLO STRATEGI; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Michael LF, 2000, MOL CELL BIOL, V20, P1596, DOI 10.1128/MCB.20.5.1596-1603.2000; Millour J, 2010, ONCOGENE, V29, P2983, DOI 10.1038/onc.2010.47; Mutation C, 2015, NAT METHODS, V12, P615, DOI DOI 10.1038/NMETH.3440; Nagaraj AB, 2015, ONCOTARGET, V6, P23720, DOI 10.18632/oncotarget.4690; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sanders DA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r6; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Steg AD, 2012, CLIN CANCER RES, V18, P869, DOI 10.1158/1078-0432.CCR-11-2188; Varadan V, 2012, IEEE SIGNAL PROC MAG, V29, P35, DOI 10.1109/MSP.2011.943037; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Wessels LFA, 2005, BIOINFORMATICS, V21, P3755, DOI 10.1093/bioinformatics/bti429; Xie Y, 2014, MOL MED REP, V10, P2346, DOI 10.3892/mmr.2014.2490; Yang S, 2009, ANESTH ANALG, V108, P964, DOI 10.1213/ane.0b013e318192442c; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	27	14	16	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 27	2017	36	17					2472	2482		10.1038/onc.2016.398	http://dx.doi.org/10.1038/onc.2016.398			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET4QE	27819677	Green Published, hybrid			2022-12-26	WOS:000400268900012
J	Wang, L; Ren, J; Li, G; Moorman, JP; Yao, ZQ; Ning, S				Wang, L.; Ren, J.; Li, G.; Moorman, J. P.; Yao, Z. Q.; Ning, S.			LMP1 signaling pathway activates IRF4 in latent EBV infection and a positive circuit between PI3K and Src is required	ONCOGENE			English	Article							EPSTEIN-BARR-VIRUS; PHOSPHATIDYLINOSITOL 3-KINASE/AKT PATHWAY; NF-KAPPA-B; CHRONIC LYMPHOCYTIC-LEUKEMIA; MEMBRANE-PROTEIN 1; MULTIPLE-MYELOMA; CELL-SURVIVAL; REGULATORY FACTOR-4; FAMILY-MEMBER; TARGET GENES	Interferon (IFN) regulatory factors (IRFs) have crucial roles in immune regulation and oncogenesis. We have recently shown that IRF4 is activated through c-Src-mediated tyrosine phosphorylation in virus-transformed cells. However, the intracellular signaling pathway triggering Src activation of IRF4 remains unknown. In this study, we provide evidence that Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) promotes IRF4 phosphorylation and markedly stimulates IRF4 transcriptional activity, and that Src mediates LMP1 activation of IRF4. As to more precise mechanism, we show that LMP1 physically interacts with c-Src, and the phosphatidylinositol 3 kinase (PI3K) subunit P85 mediates their interaction. Depletion of P85 by P85-specific short hairpin RNAs disrupts their interaction and diminishes IRF4 phosphorylation in EBV-transformed cells. Furthermore, we show that Src is upstream of PI3K for activation of both IRF4 and Akt. In turn, inhibition of PI3K kinase activity by the PI3K-speicfic inhibitor LY294002 impairs Src activity. Our results show that LMP1 signaling is responsible for IRF4 activation, and further characterize the IRF4 regulatory network that is a promising therapeutic target for specific hematological malignancies.	[Wang, L.; Ren, J.; Li, G.; Moorman, J. P.; Yao, Z. Q.; Ning, S.] East Tennessee State Univ, Div Infect Dis, Dept Internal Med, Quillen Coll Med, Johnson City, TN 37614 USA; [Wang, L.; Ren, J.; Li, G.; Moorman, J. P.; Yao, Z. Q.; Ning, S.] East Tennessee State Univ, Ctr Excellence Inflammat Infect Dis & Immun, Quillen Coll Med, Johnson City, TN 37614 USA; [Moorman, J. P.; Yao, Z. Q.] James H Quillen VA Med Ctr, Hepatitis HCV HIV Program, Johnson City, TN USA	East Tennessee State University; East Tennessee State University	Ning, S (corresponding author), East Tennessee State Univ, Div Infect Inflammatory & Immunol Dis, Dept Internal Med, Quillen Coll Med, Johnson City, TN 37614 USA.	nings1@etsu.edu	Ning, Shunbin/AAC-6895-2021; Ning, Shunbin/I-3961-2019	Ning, Shunbin/0000-0001-5484-5779	NIH NIDDK grant [R01DK093526]; NIH NIAID grant [R01AI114748]; American Society of Hematology Scholar Award; NIH grant [C06RR0306551]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093526] Funding Source: NIH RePORTER	NIH NIDDK grant; NIH NIAID grant(CGIAR); American Society of Hematology Scholar Award; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an NIH NIDDK grant to ZQY/JPM (R01DK093526), an NIH NIAID grant to ZQY/JPM (R01AI114748), the American Society of Hematology Scholar Award to SN, and in part by the NIH grant C06RR0306551. We thank Dr Bill Sugden for providing pSV2-LMP1 and its deletion mutant pSV2-LMP1.(12-20). This publication is the result of work supported with resources and the use of facilities at the James H Quillen Veterans Affairs Medical Center. The contents in this publication do not represent the views of the Department of Veterans Affairs or the United States Government.	Alvarez RH, 2006, CANCER-AM CANCER SOC, V107, P1918, DOI 10.1002/cncr.22215; Arron JR, 2001, J BIOL CHEM, V276, P30011, DOI 10.1074/jbc.M100414200; Banerjee S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003314; Biswas PS, 2010, IMMUNOL REV, V233, P79, DOI 10.1111/j.0105-2896.2009.00864.x; Bloss T, 1999, J GEN VIROL, V80, P3227, DOI 10.1099/0022-1317-80-12-3227; Boshoff C, 2002, NAT REV CANCER, V2, P373, DOI 10.1038/nrc797; Cahir-McFarland ED, 2004, J VIROL, V78, P4108, DOI 10.1128/JVI.78.8.4108-4119.2004; Carbone A, 2008, ONCOLOGIST, V13, P577, DOI 10.1634/theoncologist.2008-0036; Chang CC, 2002, BLOOD, V100, P4671, DOI 10.1182/blood-2002-01-0104; Davies CC, 2005, MOL CELL BIOL, V25, P9806, DOI 10.1128/MCB.25.22.9806-9819.2005; Dawson CW, 2012, SEMIN CANCER BIOL, V22, P144, DOI 10.1016/j.semcancer.2012.01.004; Dawson CW, 2003, J BIOL CHEM, V278, P3694, DOI 10.1074/jbc.M209840200; Deregibus MC, 2003, J BIOL CHEM, V278, P18008, DOI 10.1074/jbc.M300711200; Feldman AL, 2009, LEUKEMIA, V23, P574, DOI 10.1038/leu.2008.320; Fukuda M, 2004, J VIROL, V78, P1697, DOI 10.1128/JVI.78.4.1697-1705.2004; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Gu TL, 2010, LEUKEMIA, V24, P861, DOI 10.1038/leu.2009.293; Hatton O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042610; Havelange V, 2011, BLOOD, V118, P2827, DOI 10.1182/blood-2011-04-350579; Huye LE, 2007, MOL CELL BIOL, V27, P2910, DOI 10.1128/MCB.02256-06; Iida S, 1997, NAT GENET, V17, P226, DOI 10.1038/ng1097-226; Kieser A., 2007, SIGNAL TRANSDUCTION, V7, P20, DOI [10.1002/sita.200600116, DOI 10.1002/SITA.200600116]; Kieser A, 2015, CURR TOP MICROBIOL, V391, P119, DOI 10.1007/978-3-319-22834-1_4; Li HP, 2003, J BIOMED SCI, V10, P490, DOI 10.1159/000072376; Mamane Y, 2002, J INTERF CYTOK RES, V22, P135, DOI 10.1089/107999002753452746; Martin HJ, 2007, J VIROL, V81, P9748, DOI 10.1128/JVI.01122-07; Middeldorp JM, 2008, SEMIN CANCER BIOL, V18, P388, DOI 10.1016/j.semcancer.2008.10.004; Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21; Ning S, 2013, J ONCOBIOMARKERS, V1, P6; Ning SB, 2008, MOL CELL BIOL, V28, P6536, DOI 10.1128/MCB.00785-08; Pagano JS, 2004, SEMIN CANCER BIOL, V14, P453, DOI 10.1016/j.semcancer.2004.06.009; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; Portis T, 2004, ONCOGENE, V23, P8619, DOI 10.1038/sj.onc.1207905; Ramos JC, 2007, BLOOD, V109, P3060, DOI 10.1182/blood-2006-07-036368; Rui LX, 2011, NAT IMMUNOL, V12, P933, DOI 10.1038/ni.2094; Saddawi-Konefka R, 2010, J NEUROIMMUNE PHARM, V5, P387, DOI 10.1007/s11481-010-9204-0; Scholle F, 2000, J VIROL, V74, P10681, DOI 10.1128/JVI.74.22.10681-10689.2000; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shaffer AL, 2009, CLIN CANCER RES, V15, P2954, DOI 10.1158/1078-0432.CCR-08-1845; Sharma S, 2002, J IMMUNOL, V169, P3120, DOI 10.4049/jimmunol.169.6.3120; So T, 2011, J IMMUNOL, V186, P3547, DOI 10.4049/jimmunol.1003156; Soni V, 2007, ADV EXP MED BIOL, V597, P173; Spender LC, 2006, J GEN VIROL, V87, P2859, DOI 10.1099/vir.0.82128-0; St-Germain JR, 2009, P NATL ACAD SCI USA, V106, P20127, DOI 10.1073/pnas.0910957106; Stunz LL, 2014, CRIT REV IMMUNOL, V34, P177, DOI 10.1615/CritRevImmunol.2014010041; Sundram U, 2003, MODERN PATHOL, V16, P802, DOI 10.1097/01.MP.0000081726.49886.CF; Swart R, 2000, J VIROL, V74, P10838, DOI 10.1128/JVI.74.22.10838-10845.2000; Thornburg NJ, 2006, ONCOGENE, V25, P288, DOI 10.1038/sj.onc.1209023; Wang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106788; Wang L, 2013, J VIROL, V87, P9672, DOI 10.1128/JVI.01435-13; Wang L, 2011, J VIROL, V85, P8328, DOI 10.1128/JVI.00570-11; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Xu DS, 2008, J VIROL, V82, P6251, DOI 10.1128/JVI.00163-08; Zhang BC, 2012, CELL, V148, P739, DOI 10.1016/j.cell.2011.12.031; Zhang LW, 2004, J VIROL, V78, P12987, DOI 10.1128/JVI.78.23.12987-12995.2004	55	11	11	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 20	2017	36	16					2265	2274		10.1038/onc.2016.380	http://dx.doi.org/10.1038/onc.2016.380			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ES8DM	27819673	Green Submitted, Green Accepted			2022-12-26	WOS:000399782700007
J	Lee, H; Park, JJ; Nguyen, N; Park, JS; Hong, J; Kim, SH; Song, WY; Kim, HJ; Choi, K; Cho, S; Lee, JS; Kim, BW; Ko, YG				Lee, Hyun; Park, Jung-Jin; Nga Nguyen; Park, Jun Sub; Hong, Jin; Kim, Seung-Hyeob; Song, Woon Young; Kim, Hak Joong; Choi, Kwangman; Cho, Sungchan; Lee, Jae-Seon; Kim, Bong-Woo; Ko, Young-Gyu			MG53-IRS-1 (Mitsugumin 53-Insulin Receptor Substrate-1) Interaction Disruptor Sensitizes Insulin Signaling in Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE REPAIR; MUSCULAR-DYSTROPHY; MG53; INJURY; MYOGENESIS; OBESITY; KINASE; TRIM72	Mitsugumin 53 (MG53) is an E3 ligase that interacts with and ubiquitinates insulin receptor substrate-1 (IRS-1) in skeletal muscle; thus, an MG53-IRS-1 interaction disruptor (MID), which potentially sensitizes insulin signaling with an elevated level of IRS-1 in skeletal muscle, is an excellent candidate for treating insulin resistance. To screen for an MID, we developed a bimolecular luminescence complementation system using an N-terminal luciferase fragment fused with IRS-1 and a C-terminal luciferase fragment fused with an MG53 C14A mutant that binds to IRS-1 but does not have E3 ligase activity. An MID, which was discovered using the bimolecular luminescence complementation system, disrupted the molecular association of MG53 with IRS-1, thus abolishing MG53-mediated IRS-1 ubiquitination and degradation. Thus, the MID sensitized insulin signaling and increased insulin-elicited glucose uptake with an elevated level of IRS-1 in C2C12 myotubes. These data indicate that this MID holds promise as a drug candidate for treating insulin resistance.	[Lee, Hyun; Park, Jung-Jin; Nga Nguyen; Park, Jun Sub; Hong, Jin; Kim, Seung-Hyeob; Kim, Bong-Woo; Ko, Young-Gyu] Korea Univ, Div Life Sci, 145 Anam Ro, Seoul 02841, South Korea; [Song, Woon Young; Kim, Hak Joong] Korea Univ, Dept Chem, Seoul 02841, South Korea; [Choi, Kwangman; Cho, Sungchan] Korea Res Inst Biosci & Biotechnol, Targeted Med Res Ctr, Daejeon 34141, South Korea; [Lee, Jae-Seon] Inha Univ, Dept Biomed Sci, Coll Med, Inchon 22212, South Korea	Korea University; Korea University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Inha University	Ko, YG (corresponding author), Korea Univ, Div Life Sci, 145 Anam Ro, Seoul 02841, South Korea.; Kim, BW (corresponding author), Korea Univ, Tunneling Nanotube Res Ctr, 145 Anam Ro, Seoul 02841, South Korea.	kbw96@korea.ac.kr; ygko@korea.ac.kr	Song, Woon Young/AAC-5895-2019		Korea of Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health and Welfare, Republic of Korea [HI14C2739]; Korea University	Korea of Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea University	This work was supported by a grant from the Korea of Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (HI14C2739; to Y.-G. K.). This work was also supported in part by a Korea University grant (to J.-J. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Duann P, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010755; He B, 2012, MOL THER, V20, P727, DOI 10.1038/mt.2012.5; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Jia YL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5387; Jung SY, 2010, BIOCHEM BIOPH RES CO, V396, P238, DOI 10.1016/j.bbrc.2010.04.072; Kim SC, 2014, AM J PHYSIOL-LUNG C, V307, pL449, DOI 10.1152/ajplung.00172.2014; Kim S, 2012, BMB REP, V45, P26, DOI 10.5483/BMBRep.2012.45.1.26; Lee CS, 2010, CELL DEATH DIFFER, V17, P1254, DOI 10.1038/cdd.2010.1; Lee H, 2016, BMB REP, V49, P116, DOI 10.5483/BMBRep.2016.49.2.232; Lemckert FA, 2016, CARDIOVASC RES, V110, P178, DOI 10.1093/cvr/cvw017; Li HC, 2015, J BIOL CHEM, V290, P24592, DOI 10.1074/jbc.M115.680074; Lin PH, 2012, FASEB J, V26, P1875, DOI 10.1096/fj.11-188599; Nguyen N, 2014, J BIOL CHEM, V289, P3209, DOI 10.1074/jbc.M113.525154; Paulmurugan R, 2007, ANAL CHEM, V79, P2346, DOI 10.1021/ac062053q; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Song RS, 2013, NATURE, V494, P375, DOI 10.1038/nature11834; Tan T, 2016, BMB REP, V49, P414, DOI 10.5483/BMBRep.2016.49.8.079; Wang XH, 2010, CIRC RES, V107, P76, DOI 10.1161/CIRCRESAHA.109.215822; Weisleder N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003921; Yi JS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3354; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhu H, 2011, J BIOL CHEM, V286, P12820, DOI 10.1074/jbc.C111.221440	25	9	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26627	26635		10.1074/jbc.M116.754424	http://dx.doi.org/10.1074/jbc.M116.754424			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27810898	Green Published, hybrid			2022-12-26	WOS:000391571400004
J	Ko, YH; Domingo-Vidal, M; Roche, M; Lin, Z; Whitaker-Menezes, D; Seifert, E; Capparelli, C; Tuluc, M; Birbe, RC; Tassone, P; Curry, JM; Navarro-Sabate, A; Manzano, A; Bartrons, R; Caro, J; Martinez-Outschoorn, U				Ko, Ying-Hui; Domingo-Vidal, Marina; Roche, Megan; Lin, Zhao; Whitaker-Menezes, Diana; Seifert, Erin; Capparelli, Claudia; Tuluc, Madalina; Birbe, Ruth C.; Tassone, Patrick; Curry, Joseph M.; Navarro-Sabate, Aurea; Manzano, Anna; Bartrons, Ramon; Caro, Jaime; Martinez-Outschoorn, Ubaldo			TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-GROWTH; GLIOMA-CELLS; GLUCOSE-METABOLISM; FIBROBLASTS; AUTOPHAGY; HYPOXIA; PFKFB3; ROS; MITOCHONDRIA; MODULATION	A subgroup of breast cancers has several metabolic compartments. The mechanisms by which metabolic compartmentalization develop in tumors are poorly characterized. TP53 inducible glycolysis and apoptosis regulator (TIGAR) is a bisphosphatase that reduces glycolysis and is highly expressed in carcinoma cells in the majority of human breast cancers. Hence we set out to determine the effects of TIGAR expression on breast carcinoma and fibroblast glycolytic phenotype and tumor growth. The overexpression of this bisphosphatase in carcinoma cells induces expression of enzymes and transporters involved in the catabolism of lactate and glutamine. Carcinoma cells overexpressing TIGAR have higher oxygen consumption rates and ATP levels when exposed to glutamine, lactate, or the combination of glutamine and lactate. Coculture of TIGAR overexpressing carcinoma cells and fibroblasts compared with control cocultures induce more pronounced glycolytic differences between carcinoma and fibroblast cells. Carcinoma cells overexpressing TIGAR have reduced glucose uptake and lactate production. Conversely, fibroblasts in coculture with TIGAR overexpressing carcinoma cells induce HIF (hypoxia-inducible factor) activation with increased glucose uptake, increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3), and lactate dehydrogenase-A expression. We also studied the effect of this enzyme on tumor growth. TIGAR overexpression in carcinoma cells increases tumor growth in vivo with increased proliferation rates. However, a catalytically inactive variant of TIGAR did not induce tumor growth. Therefore, TIGAR expression in breast carcinoma cells promotes metabolic compartmentalization and tumor growth with a mitochondrial metabolic phenotype with lactate and glutamine catabolism. Targeting TIGAR warrants consideration as a potential therapy for breast cancer.	[Ko, Ying-Hui; Domingo-Vidal, Marina; Roche, Megan; Lin, Zhao; Whitaker-Menezes, Diana; Martinez-Outschoorn, Ubaldo] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Med Oncol, Philadelphia, PA 19107 USA; [Seifert, Erin; Tuluc, Madalina] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Capparelli, Claudia] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA; [Tassone, Patrick; Curry, Joseph M.] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Otolaryngol, Philadelphia, PA 19107 USA; [Birbe, Ruth C.] Cooper Univ Hosp, Dept Pathol, Camden, NJ 08103 USA; [Navarro-Sabate, Aurea; Manzano, Anna; Bartrons, Ramon] Univ Barcelona, Dept Physiol Sci, Barcelona 08907, Spain; [Caro, Jaime] Thomas Jefferson Univ, Cardeza Fdn Hematol Res, Dept Med, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University; Jefferson University; Cooper University Hospital; University of Barcelona; Jefferson University	Martinez-Outschoorn, U (corresponding author), Sidney Kimmel Canc Ctr, Dept Med Oncol, 233 S 10th St Suite 909, Philadelphia, PA 19107 USA.	ubaldo.martinez-outschoorn@jefferson.edu	Tassone, Patrick/AAL-1306-2020; Navarro-Sabaté, Aurea/K-6329-2018; Manzano, Anna/ABG-3422-2020	Navarro-Sabaté, Aurea/0000-0002-8286-9732; Manzano, Anna/0000-0002-9106-3132; Birbe, Ruth/0000-0002-0651-2360; Curry, Joseph/0000-0001-9507-4237; Martinez-Outschoorn, Ubaldo/0000-0003-1483-4551	National Institutes of Health [NCI K08-CA175193, NCI 5 P30 CA 56036]; Instituto de Salud Carlos III-FIS [PI13/0096]; Fondo Europeo de Desarrollo Regional (FEDER); NATIONAL CANCER INSTITUTE [K08CA175193, P30CA056036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Instituto de Salud Carlos III-FIS(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants NCI K08-CA175193 and NCI 5 P30 CA 56036. This work was also supported by Instituto de Salud Carlos III-FIS (PI13/0096) and Fondo Europeo de Desarrollo Regional (FEDER). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Atsumi T, 2002, CANCER RES, V62, P5881; Augsten M, 2014, CANCER RES, V74, P2999, DOI 10.1158/0008-5472.CAN-13-2740; Bartrons R, 2007, J BIOENERG BIOMEMBR, V39, P223, DOI 10.1007/S10863-007-9080-3; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bensaad K, 2009, EMBO J, V28, P3015, DOI 10.1038/emboj.2009.242; Chen SS, 2015, CELL PHYSIOL BIOCHEM, V35, P997, DOI 10.1159/000369755; Cheung EC, 2013, DEV CELL, V25, P463, DOI 10.1016/j.devcel.2013.05.001; Cheung EC, 2012, P NATL ACAD SCI USA, V109, P20491, DOI 10.1073/pnas.1206530109; Chiavarina B, 2012, CELL CYCLE, V11, P3280, DOI 10.4161/cc.21643; Curry JM, 2016, LARYNGOSCOPE, V126, P2410, DOI 10.1002/lary.25799; DeNicola GM, 2015, MOL CELL, V60, P514, DOI 10.1016/j.molcel.2015.10.018; Farmaki Elena, 2012, Genes Cancer, V3, P592, DOI 10.1177/1947601912474002; Gerin I, 2014, BIOCHEM J, V458, P439, DOI 10.1042/BJ20130841; Hanai J, 2002, J BIOL CHEM, V277, P16464, DOI 10.1074/jbc.M112274200; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kumar B, 2015, BIOCHIMIE, V118, P26, DOI 10.1016/j.biochi.2015.07.016; Lee P, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.205; Lee P, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-1; Li L, 2012, FREE RADICAL BIO MED, V53, P1399, DOI 10.1016/j.freeradbiomed.2012.07.011; Lui VWY, 2011, ONCOGENE, V30, P1127, DOI 10.1038/onc.2010.490; Martinez-Outschoorn UE, 2015, NAT REV CANCER, V15, P225, DOI 10.1038/nrc3915; Martinez-Outschoorn UE, 2014, SEMIN CANCER BIOL, V25, P47, DOI 10.1016/j.semcancer.2014.01.005; Martinez-Outschoorn UE, 2012, CELL METAB, V15, P4, DOI 10.1016/j.cmet.2011.12.011; Martinez-Outschoorn UE, 2011, CANCER BIOL THER, V12, P924, DOI 10.4161/cbt.12.10.17780; Migneco G, 2010, CELL CYCLE, V9, P2412, DOI 10.4161/cc.9.12.11989; Novellasdemunt L, 2013, BIOCHEM J, V452, P531, DOI 10.1042/BJ20121886; Obach M, 2004, J BIOL CHEM, V279, P53562, DOI 10.1074/jbc.M406096200; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; OSBORNE CK, 1985, CANCER RES, V45, P584; Patocs A, 2007, NEW ENGL J MED, V357, P2543, DOI 10.1056/NEJMoa071825; Pena-Rico MA, 2011, RADIOTHER ONCOL, V101, P132, DOI 10.1016/j.radonc.2011.07.002; Pusapati RV, 2016, CANCER CELL, V29, P548, DOI 10.1016/j.ccell.2016.02.018; Quaegebeur A, 2016, CELL METAB, V23, P280, DOI 10.1016/j.cmet.2015.12.007; Rarnanathan A, 2005, P NATL ACAD SCI USA, V102, P5992, DOI 10.1073/pnas.0502267102; Sanchez-Alvarez R, 2013, CELL CYCLE, V12, P172, DOI 10.4161/cc.23058; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Shekhar MPV, 2007, AM J PATHOL, V170, P1546, DOI 10.2353/ajpath.2007.061004; Simon-Molas H, 2016, FEBS LETT, V590, P2915, DOI 10.1002/1873-3468.12338; Sinha S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.128; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Sotgia F, 2012, CELL CYCLE, V11, P4390, DOI 10.4161/cc.22777; Sun ML, 2015, NEUROCHEM INT, V80, P99, DOI 10.1016/j.neuint.2014.09.006; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wanka C, 2012, J BIOL CHEM, V287, P33436, DOI 10.1074/jbc.M112.384578; Won KY, 2012, HUM PATHOL, V43, P221, DOI 10.1016/j.humpath.2011.04.021; Xie JM, 2014, CANCER RES, V74, P5127, DOI 10.1158/0008-5472.CAN-13-3517; Ye L, 2013, BIOCHEM BIOPH RES CO, V437, P300, DOI 10.1016/j.bbrc.2013.06.072; Zhao M, 2016, INT J ONCOL, V48, P756, DOI 10.3892/ijo.2015.3297; Zhou X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080576; Zou SB, 2012, MOL CELL BIOCHEM, V359, P17, DOI 10.1007/s11010-011-0993-0	53	46	48	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26291	26303		10.1074/jbc.M116.740209	http://dx.doi.org/10.1074/jbc.M116.740209			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27803158	Green Published, hybrid			2022-12-26	WOS:000391568200005
J	Kreko-Pierce, T; Azpurua, J; Mahoney, RE; Eaton, BA				Kreko-Pierce, Tabita; Azpurua, Jorge; Mahoney, Rebekah E.; Eaton, Benjamin A.			Extension of Health Span and Life Span in Drosophila by S107 Requires the calstabin Homologue FK506-BP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR CALCIUM LEAK; OXIDATIVE DAMAGE THEORY; NAKED MOLE-RAT; CAENORHABDITIS-ELEGANS; SUPEROXIDE-DISMUTASE; RELEASE CHANNEL; STRESS; LONGEVITY; MELANOGASTER; RESVERATROL	The accumulation of oxidative damage is strongly linked to age-dependent declines in cell function, but the contribution of oxidative damage to morbidity is still debated. Many organisms seem to tolerate oxidative damage, and the extension of health span and life span by augmenting antioxidant activity has been inconsistent. Here we use the Drosophila model system to investigate the relationship among oxidative stress, health span, and life span. The oxidation-dependent dissociation of the Calstabin protein from the ryanodine receptor has been shown to result in reduced muscle function in mammals. The S107 molecule is able to reestablish this binding resulting in improved muscle function. We find that S107 is able to restore motor function in aging Drosophila to young levels, and this effect of S107 is absent in calstabin (FK506-BP2) mutants. Interestingly, FK506-BP2 mutant flies have reduced sensitivity to the effects of age and oxidative stress on motor function between 7 and 35 days of age. Muscle expression of FK506-BP2 in FK506-BP2 mutants completely restores the sensitivity of motor function to both age and oxidative stress, supporting the idea that the age-dependent decline in motor function in Drosophila requires FK506-BP2 function within the muscle. Although FK506-BP2 mutant flies are found to have less sensitivity to oxidative stress, FK506-BP2 mutants do not live longer than wild type. These results demonstrate that the deleterious effects of oxidation on motor function early in life are the result of a singular event that does not compromise survival.	[Kreko-Pierce, Tabita; Azpurua, Jorge; Mahoney, Rebekah E.; Eaton, Benjamin A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Integrat & Cellular Physiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Eaton, BA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Integrat & Cellular Physiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	eatonb@uthscsa.edu			NIA, National Institutes of Health [P30-AG-013283]; National Institutes of Health [P40OD018537]	NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge the Drosophila Aging Core of the Nathan Shock Center of Excellence in the Biology of Aging (which is supported in part by NIA, National Institutes of Health Grant P30-AG-013283) and the Bloomington Drosophila Stock Center (which is supported in part by National Institutes of Health Grant P40OD018537) for providing resources. Select immune reagents were also obtained from the Developmental Studies Hybridoma Bank, created by the NICHD, National Institutes of Health, and maintained at the University of Iowa Department of Biology.	Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; Andziak B, 2005, MECH AGEING DEV, V126, P1206, DOI 10.1016/j.mad.2005.06.009; Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; Betzenhauser MJ, 2010, PFLUG ARCH EUR J PHY, V460, P467, DOI 10.1007/s00424-010-0794-4; Brown-Borg HM, 2000, EXP GERONTOL, V35, P199, DOI 10.1016/S0531-5565(00)00079-6; Brunet-Rossinni AK, 2004, MECH AGEING DEV, V125, P11, DOI 10.1016/j.mad.2003.09.003; Canistro D, 2015, J GERONTOL A-BIOL, V70, P936, DOI 10.1093/gerona/glu160; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Duttaroy A, 2003, GENETICS, V165, P2295; Edrey YH, 2014, FREE RADICAL BIO MED, V71, P368, DOI 10.1016/j.freeradbiomed.2014.03.038; Epel ES, 2014, J GERONTOL A-BIOL, V69, pS10, DOI 10.1093/gerona/glu055; Gaburjakova M, 2001, J BIOL CHEM, V276, P16931, DOI 10.1074/jbc.M100856200; Gao SY, 2013, ANESTHESIOLOGY, V118, P587, DOI 10.1097/ALN.0b013e31827e52c6; Gems D, 2009, CELL CYCLE, V8, P1681, DOI 10.4161/cc.8.11.8595; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Grimes KM, 2014, AM J PHYSIOL-HEART C, V307, pH284, DOI 10.1152/ajpheart.00305.2014; Haas J, 2015, EUR HEART J, V36, P1123, DOI 10.1093/eurheartj/ehu301; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; Kirby K, 2002, P NATL ACAD SCI USA, V99, P16162, DOI 10.1073/pnas.252342899; Krivoruchko A, 2010, OXID MED CELL LONGEV, V3, P186, DOI 10.4161/oxim.3.3.12356; Lehnart SE, 2006, P NATL ACAD SCI USA, V103, P7906, DOI 10.1073/pnas.0602133103; Lewis KN, 2013, ANTIOXID REDOX SIGN, V19, P1388, DOI 10.1089/ars.2012.4911; Magwere T, 2006, MECH AGEING DEV, V127, P356, DOI 10.1016/j.mad.2005.12.009; Mahoney RE, 2014, J NEUROSCI, V34, P2111, DOI 10.1523/JNEUROSCI.3556-13.2014; Mei YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054208; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Montgomery MK, 2012, EXP GERONTOL, V47, P211, DOI 10.1016/j.exger.2011.11.014; Ondrias K, 1998, ANN NY ACAD SCI, V853, P149, DOI 10.1111/j.1749-6632.1998.tb08263.x; ORR WC, 1993, ARCH BIOCHEM BIOPHYS, V301, P34, DOI 10.1006/abbi.1993.1111; Parker JD, 2004, P NATL ACAD SCI USA, V101, P3486, DOI 10.1073/pnas.0400222101; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Perez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003; Rawson JM, 2012, AGING CELL, V11, P418, DOI 10.1111/j.1474-9726.2012.00799.x; Siegel MP, 2013, AGING CELL, V12, P763, DOI 10.1111/acel.12102; Tong MM, 2016, CURR MOL PHARMACOL, V9, P48, DOI 10.2174/1874467208666150519113541; Toroser D, 2007, BIOCHEM BIOPH RES CO, V363, P418, DOI 10.1016/j.bbrc.2007.08.193; Umanskaya A, 2014, P NATL ACAD SCI USA, V111, P15250, DOI 10.1073/pnas.1412754111; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109; WANG TW, 1994, SCIENCE, V265, P674, DOI 10.1126/science.7518616; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Wu SW, 2006, BRAIN, V129, P1470, DOI 10.1093/brain/awl077; Yan LJ, 2014, REDOX BIOL, V2, P165, DOI 10.1016/j.redox.2014.01.002; Zheng JY, 2005, AGING CELL, V4, P209, DOI 10.1111/j.1474-9726.2005.00159.x	49	8	8	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26045	26055		10.1074/jbc.M116.758839	http://dx.doi.org/10.1074/jbc.M116.758839			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27803160	Green Published, hybrid			2022-12-26	WOS:000390345200024
J	Hall, SE; Schubert, E; Wilson, SJ				Hall, Sarah E.; Schubert, Emery; Wilson, Sarah J.			The Role of Trait and State Absorption in the Enjoyment of Music	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; EVERYDAY LIFE; LOVED MUSIC; SAD MUSIC; RESPONSES; EXPERIENCES; PREFERENCES; EMOTIONS; OPENNESS; SCALE	Little is known about the role of state versus trait characteristics on our enjoyment of music. The aim of this study was to investigate the influence of state and trait absorption upon preference for music, particularly preference for music that evokes negative emotions. The sample consisted of 128 participants who were asked to listen to two pieces of self-selected music and rate the music on variables including preference and felt and expressed emotions. Participants completed a brief measure of state absorption after listening to each piece, and a trait absorption inventory. State absorption was strongly positively correlated with music preference, whereas trait absorption was not. Trait absorption was related to preference for negative emotions in music, with chi-square analyses demonstrating greater enjoyment of negative emotions in music among individuals with high trait absorption. This is the first study to show that state and trait absorption have separable and distinct effects on a listener's music experience, with state characteristics impacting music enjoyment in the moment, and trait characteristics influencing music preference based on its emotional content.	[Hall, Sarah E.; Wilson, Sarah J.] Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic, Australia; [Schubert, Emery] Univ New South Wales, Sch Arts & Media, Sydney, NSW, Australia	University of Melbourne; University of New South Wales Sydney	Schubert, E (corresponding author), Univ New South Wales, Sch Arts & Media, Sydney, NSW, Australia.	e.schubert@unsw.edu.au		Hall, Sarah/0000-0002-3000-5975; Schubert, Emery/0000-0002-6541-8083	Australian Research Council [FT120100053]	Australian Research Council(Australian Research Council)	This study was supported by the Australian Research Council (http://www.arc.gov.au/future-fellowships), FT120100053 held by ES.; This research was supported by the Australian Research Council (FT120100053).	Agarwal R, 2000, MIS QUART, V24, P665, DOI 10.2307/3250951; [Anonymous], 1999, C1 CTR RES PSYCH, DOI DOI 10.1002/PER.2410010304; Csikszentmihalyi M., 1991, FLOW PSYCHOL OPTIMAL; Eerola T., 2015, PSYCHOMUSICOLOGY MUS, V25, P116, DOI [DOI 10.1037/PMU0000096, 10.1037/pmu0000096]; FINNAS L, 1989, B COUN RES MUSIC ED, P1; Gabrielsson Alf, 2011, STRONG EXPERIENCES M; Garrido S, 2011, MUSIC PERCEPT, V28, P279, DOI 10.1525/MP.2011.28.3.279; GLISKY ML, 1993, INT J CLIN EXP HYP, V41, P112, DOI 10.1080/00207149308414542; Herbert R, 2012, MUSIC SCI, V16, P41, DOI 10.1177/1029864911423161; Honing H, 2008, EMPIR MUSICOL REV, V3, P4, DOI 10.18061/1811/31692; Hunter PG, 2008, COGNITION EMOTION, V22, P327, DOI 10.1080/02699930701438145; Hunter PG, 2010, SPRINGER HANDB AUDIT, V36, P129, DOI 10.1007/978-1-4419-6114-3_5; Huron D, 2011, MUSIC SCI, V15, P146, DOI 10.1177/1029864911401171; Jackson SA, 1996, J SPORT EXERCISE PSY, V18, P17, DOI 10.1123/jsep.18.1.17; Jameson E, 2011, PAIN RES MANAG, V16, P27, DOI 10.1155/2011/856014; Jamieson GA, EMPIRICAL TEST UNPUB; Jamieson GrahamA., 2005, AUST J CLIN EXP HYPN, V33, P119, DOI DOI 10.1037/T14465-000; Juslin PN, 2013, PHYS LIFE REV, V10, P235, DOI 10.1016/j.plrev.2013.05.008; Kreutz G, 2008, PSYCHOL MUSIC, V36, P101, DOI 10.1177/0305735607082623; Lowis MJ, 2002, CREATIVITY RES J, V14, P351, DOI 10.1207/S15326934CRJ1434_6; McCrae R.R., 1993, IMAGIN COGN PERS, V13, P39, DOI [10.2190/H8H6-QYKR-KEU8-GAQ0, DOI 10.2190/H8H6-QYKR-KEU8-GAQ0]; Menard S.W., 1995, APPL LOGISTIC REGRES, V2nd ed.; North AC, 2004, MUSIC PERCEPT, V22, P41, DOI 10.1525/mp.2004.22.1.41; North AC, 1996, J ENVIRON PSYCHOL, V16, P55, DOI 10.1006/jevp.1996.0005; PEKALA RJ, 1985, J PERS SOC PSYCHOL, V48, P125, DOI 10.1037/0022-3514.48.1.125; Pekala RJ, 1991, QUANTIFYING CONSCIOU; Plutchik R., 1962, EMOTIONS FACTS THEOR; Rentfrow PJ, 2003, J PERS SOC PSYCHOL, V84, P1236, DOI 10.1037/0022-3514.84.6.1236; RHODES LA, 1988, PERCEPT MOTOR SKILL, V66, P737, DOI 10.2466/pms.1988.66.3.737; Rickard N.S., 2004, PSYCHOL MUSIC, V32, P371, DOI [DOI 10.1177/0305735604046096, 10.1177%2F0305735604046096]; ROCHE SM, 1990, J PERS SOC PSYCHOL, V59, P91, DOI 10.1037/0022-3514.59.1.91; RUSSELL JA, 1989, J PERS SOC PSYCHOL, V57, P493, DOI 10.1037/0022-3514.57.3.493; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Salimpoor VN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007487; Schubert E, 2012, P 30 ISME WORLD C MU; Schubert E., 1996, PSYCHOL MUSIC, V24, P18, DOI [10.1177/0305735696241003, DOI 10.1177/0305735696241003]; Schubert E., 2007, PSYCHOL MUSIC, V35, P499, DOI [10.1177/0305735607072657, DOI 10.1177/0305735607072657]; Schubert E, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00312; Schubert E, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00837; Schubert E, 2013, MUSIC SCI, V17, P11, DOI 10.1177/1029864912461321; Schubert E, 2010, PSYCHOL AESTHET CREA, V4, P36, DOI 10.1037/a0016316; Smuts A, 2007, J AESTHET EDUC, V41, P59, DOI 10.1353/jae.2007.0029; TELLEGEN A, 1974, J ABNORM PSYCHOL, V83, P268, DOI 10.1037/h0036681; Vuoskoski JK, 2012, MUSIC PERCEPT, V29, P311, DOI 10.1525/MP.2012.29.3.311; WILD TC, 1995, J PERS SOC PSYCHOL, V69, P569; Yorke M, 2001, BRIT EDUC RES J, V27, P171, DOI 10.1080/01411920120037126; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848	47	14	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0164029	10.1371/journal.pone.0164029	http://dx.doi.org/10.1371/journal.pone.0164029			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9OG	27828970	Green Published, gold			2022-12-26	WOS:000387724300012
J	Hensch, NR; Karim, ZA; Druey, KM; Tansey, MG; Khasawneh, FT				Hensch, Nicole R.; Karim, Zubair A.; Druey, Kirk M.; Tansey, Malu G.; Khasawneh, Fadi T.			RGS10 Negatively Regulates Platelet Activation and Thrombogenesis	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; OUTSIDE-IN; THROMBUS FORMATION; VASCULAR INJURY; KAPPA-B; AGONISTS; PHOSPHORYLATION; SECRETION; NEURONS; COMPLEX	Regulators of G protein signaling (RGS) proteins act as GTPase activating proteins to negatively regulate G protein-coupled receptor (GPCR) signaling. Although several RGS proteins including RGS2, RGS16, RGS10, and RGS18 are expressed in human and mouse platelets, the respective unique function(s) of each have not been fully delineated. RGS10 is a member of the D/R12 subfamily of RGS proteins and is expressed in microglia, macrophages, megakaryocytes, and platelets. We used a genetic approach to examine the role (s) of RGS10 in platelet activation in vitro and hemostasis and thrombosis in vivo. GPCRinduced aggregation, secretion, and integrin activation was much more pronounced in platelets from Rgs10(-/-) mice relative to wild type (WT). Accordingly, these mice had markedly reduced bleeding times and were more susceptible to vascular injury-associated thrombus formation than control mice. These findings suggest a unique, non-redundant role of RGS10 in modulating the hemostatic and thrombotic functions of platelets in mice. RGS10 thus represents a potential therapeutic target to control platelet activity and/or hypercoagulable states.	[Hensch, Nicole R.; Karim, Zubair A.; Khasawneh, Fadi T.] Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA 91766 USA; [Druey, Kirk M.] NIAID, Mol Signal Transduct Sect, Lab Allerg Dis, NIH, 10 Ctr Dr,Room 11S244B, Bethesda, MD 20892 USA; [Tansey, Malu G.] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA; [Karim, Zubair A.; Khasawneh, Fadi T.] Univ Texas El Paso, Sch Pharm, Dept Pharmaceut Sci, 1101 N Campbell St, El Paso, TX 79902 USA	Western University of Health Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University; University of Texas System; University of Texas El Paso	Khasawneh, FT (corresponding author), Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA 91766 USA.; Khasawneh, FT (corresponding author), Univ Texas El Paso, Sch Pharm, Dept Pharmaceut Sci, 1101 N Campbell St, El Paso, TX 79902 USA.	khasawneh@westemu.edu		Hensch, Nicole/0000-0001-9946-0995	College of Pharmacy, Western University of Health Sciences, Pomona, CA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000746] Funding Source: NIH RePORTER	College of Pharmacy, Western University of Health Sciences, Pomona, CA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from the College of Pharmacy, Western University of Health Sciences, Pomona, CA (to F.T.K.).	Alshbool FZ, 2015, BIOCHEM BIOPH RES CO, V462, P378, DOI 10.1016/j.bbrc.2015.04.143; Banno F, 2012, J THROMB HAEMOST, V10, P309, DOI 10.1111/j.1538-7836.2011.04575.x; Budnik I, 2015, THROMB RES, V135, P114, DOI 10.1016/j.thromres.2014.10.005; Burgon PG, 2001, J BIOL CHEM, V276, P32828, DOI 10.1074/jbc.M100960200; Delesque-Touchard N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113215; Flor PJ, 2012, BIOCHEM PHARMACOL, V84, P414, DOI 10.1016/j.bcp.2012.04.013; Fong KP, 2016, J BIOL CHEM, V291, P11706, DOI 10.1074/jbc.M116.716613; Gagnon AW, 2002, CELL SIGNAL, V14, P595, DOI 10.1016/S0898-6568(02)00012-8; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; Karim ZA, 2016, BBA-MOL CELL RES, V1863, P314, DOI 10.1016/j.bbamcr.2015.11.028; Karim ZA, 2015, ARTERIOSCL THROM VAS, V35, P637, DOI 10.1161/ATVBAHA.114.304509; Karim ZA, 2013, BLOOD, V121, P4567, DOI 10.1182/blood-2012-11-470468; Khoury E, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00068; Kim SD, 2006, PLATELETS, V17, P493, DOI 10.1080/09537100600758123; LAU LF, 1994, BIOCHEM J, V303, P391, DOI 10.1042/bj3030391; Lee JK, 2008, J NEUROSCI, V28, P8517, DOI 10.1523/JNEUROSCI.1806-08.2008; Lee JK, 2015, PROG MOL BIOL TRANSL, V133, P153, DOI 10.1016/bs.pmbts.2015.01.005; Lee JK, 2011, J NEUROSCI, V31, P11879, DOI 10.1523/JNEUROSCI.1002-11.2011; Lee JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084256; Lin OA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087026; Louwette S, 2012, J THROMB HAEMOST, V10, P2215, DOI 10.1111/j.1538-7836.2012.04903.x; Ma PS, 2012, BLOOD, V119, P1935, DOI 10.1182/blood-2011-10-387910; Mao YJ, 2014, PHARMAZIE, V69, P371, DOI 10.1691/ph.2014.3833; Mehrbod M, 2013, BIOPHYS J, V105, P1304, DOI 10.1016/j.bpj.2013.07.055; Mohr K, 2013, ANGEW CHEM INT EDIT, V52, P508, DOI 10.1002/anie.201205315; Mumford AD, 2015, THROMB HAEMOSTASIS, V114, P14, DOI 10.1160/TH14-11-0999; Murad JP, 2012, BIOCHEM BIOPH RES CO, V421, P456, DOI 10.1016/j.bbrc.2012.04.011; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Signarvic RS, 2010, BLOOD, V116, P6092, DOI 10.1182/blood-2010-05-283846; Sjogren B, 2010, MOL PHARMACOL, V78, P550, DOI 10.1124/mol.110.065219; Tu YP, 2001, J BIOL CHEM, V276, P20160, DOI 10.1074/jbc.M101599200; Vemana HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125764; Weiss EJ, 2002, BLOOD, V100, P3240, DOI 10.1182/blood-2002-05-1470; Xie ZH, 2016, AAPS J, V18, P294, DOI 10.1208/s12248-015-9847-0	34	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165984	10.1371/journal.pone.0165984	http://dx.doi.org/10.1371/journal.pone.0165984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829061	Green Published, gold, Green Submitted			2022-12-26	WOS:000387724300071
J	Marongiu, L; Shain, E; Drumright, L; Lillestol, R; Somasunderam, D; Curran, MD				Marongiu, Luigi; Shain, Eric; Drumright, Lydia; Lillestol, Reidun; Somasunderam, Donald; Curran, Martin D.			Analysis of TaqMan Array Cards Data by an Assumption-Free Improvement of the maxRatio Algorithm Is More Accurate than the Cycle-Threshold Method	PLOS ONE			English	Article							REAL-TIME PCR; VALIDATION; AGREEMENT	Quantitative PCR diagnostic platforms are moving towards increased sample throughput, with instruments capable of carrying out thousands of reactions at once already in use. The need for a computational tool to reliably assist in the validation of the results is therefore compelling. In the present study, 328 residual clinical samples provided by the Public Health England at Addenbrooke's Hospital (Cambridge, UK) were processed by TaqMan Array Card assay, generating 15 744 reactions from 54 targets. The amplification data were analysed by the conventional cycle-threshold (CT) method and an improvement of the maxRatio (MR) algorithm developed to filter out the reactions with irregular amplification profiles. The reactions were also independently validated by three raters and a consensus was generated from their classification. The inter-rater agreement by Fleiss' kappa was 0.885; the agreement between either CT or MR with the raters gave Fleiss' kappa 0.884 and 0.902, respectively. Based on the consensus classification, the CT and MR methods achieved an assay accuracy of 0.979 and 0.987, respectively. These results suggested that the assumption-free MR algorithm was more reliable than the CT method, with clear advantages for the diagnostic settings.	[Marongiu, Luigi; Drumright, Lydia; Lillestol, Reidun] Univ Cambridge, Dept Med, Cambridge CB2 0QQ, Cambs, England; [Shain, Eric] Grove St Technol LLC, 459 Grove St, Glencoe, IL 60022 USA; [Somasunderam, Donald; Curran, Martin D.] Addenbrookes Hosp, Clin Microbiol & Publ Hlth Lab, Publ Hlth England, Hills Rd, Cambridge CB2 0QW, Cambs, England; [Marongiu, Luigi] Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland; [Marongiu, Luigi] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH8 9YL, Midlothian, Scotland	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Public Health England; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Marongiu, L (corresponding author), Univ Cambridge, Dept Med, Cambridge CB2 0QQ, Cambs, England.; Marongiu, L (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland.; Marongiu, L (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH8 9YL, Midlothian, Scotland.	luigi.marongiu@ed.ac.uk	Marongiu, Luigi/O-9964-2014	Marongiu, Luigi/0000-0003-4720-7087; Drumright, Lydia/0000-0002-3361-8080	National Institute for Health Research Cambridge Biomedical Research Centre (NIHR-BRC) [CDF-2011-04-017]; Isaac Newton / Wellcome Trust / University of Cambridge Joint Research Grant; NIHR-BRC; National Institute for Health Research [CDF-2011-04-017] Funding Source: researchfish	National Institute for Health Research Cambridge Biomedical Research Centre (NIHR-BRC); Isaac Newton / Wellcome Trust / University of Cambridge Joint Research Grant; NIHR-BRC; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the National Institute for Health Research Cambridge Biomedical Research Centre (NIHR-BRC) [CDF-2011-04-017] and Isaac Newton / Wellcome Trust / University of Cambridge Joint Research Grant. Funding for open access charge: NIHR-BRC. Grove Street Technology LLC provided support in the form of salaries for authors LM RL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Benaglia T, 2009, J STAT SOFTW, V32, P1; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Darragh TM, 2013, CANCER CYTOPATHOL, V121, P72, DOI 10.1002/cncy.21218; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Fardy John M., 2009, V473, P127, DOI 10.1007/978-1-59745-385-1_7; Gasparic MB, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-26; Gisev N, 2013, RES SOC ADMIN PHARM, V9, P330, DOI 10.1016/j.sapharm.2012.04.004; Goll R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-107; Guescini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068481; Guescini M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-326; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Juzenas S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132327; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; Kodani M, 2011, J CLIN MICROBIOL, V49, P2175, DOI 10.1128/JCM.02270-10; Krzywinski M, 2014, NAT METHODS, V11, P119, DOI 10.1038/nmeth.2813; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Leamon JH, 2003, ELECTROPHORESIS, V24, P3769, DOI 10.1002/elps.200305646; Linnet K, 2012, CLIN CHEM, V58, P1292, DOI 10.1373/clinchem.2012.182543; Liu J, 2013, J CLIN MICROBIOL, V51, P472, DOI 10.1128/JCM.02658-12; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; Magalang UJ, 2013, SLEEP, V36, P591, DOI 10.5665/sleep.2552; Morrison T, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl639; Mucci B, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20130245; Ounpraseuth Songthip, 2012, BMC Res Notes, V5, P656, DOI 10.1186/1756-0500-5-656; Pripuzova N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043246; Qi YH, 2014, VIRUSES-BASEL, V6, P1823, DOI 10.3390/v6041823; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rutledge RG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh177; Schlesinger J, 2010, METHODS, V50, pS19, DOI 10.1016/j.ymeth.2010.01.007; Shain EB, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn408; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Tichopad A, 2010, METHODS, V50, P308, DOI 10.1016/j.ymeth.2010.01.028; Wiland HO, 2013, AM J CLIN PATHOL, V139, P730, DOI 10.1309/AJCPG8AYN9MUWJXV; Wilhelm J, 2003, ANAL BIOCHEM, V317, P218, DOI 10.1016/S0003-2697(03)00167-2; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Zaas AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006280; Zhao YL, 2010, J NEMATOL, V42, P166	41	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165282	10.1371/journal.pone.0165282	http://dx.doi.org/10.1371/journal.pone.0165282			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828987	gold, Green Published, Green Submitted			2022-12-26	WOS:000387724300036
J	Martinez-Martinez, E; Ibarrola, J; Calvier, L; Fernandez-Celis, A; Leroy, C; Cachofeiro, V; Rossignol, P; Lopez-Andres, N				Martinez-Martinez, Ernesto; Ibarrola, Jaime; Calvier, Laurent; Fernandez-Celis, Amaya; Leroy, Celine; Cachofeiro, Victoria; Rossignol, Patrick; Lopez-Andres, Natalia			Galectin-3 Blockade Reduces Renal Fibrosis in Two Normotensive Experimental Models of Renal Damage	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; VALVE-REPLACEMENT; INHIBITION; OUTCOMES; FAILURE; OBESITY; INJURY; PROTEINURIA; PROGRESSION; RISK	Background Galectin-3 (Gal-3), a beta-galactoside-binding lectin, is increased in kidney injury and its pharmacological blockade reduces renal damage in acute kidney injury, hyperaldosteronism or hypertensive nephropathy. We herein investigated the effects of pharmacological Gal-3 inhibition by modified citrus pectin (MCP) in early renal damage associated with obesity and aortic stenosis (AS). Results Gal-3 was upregulated in kidneys from high fat diet (HFD) rats and in animals with partial occlusion of ascending aorta (AS). Urinary and plasma neutrophil gelatinase-associated lipocalin (NGAL) and urinary albumin were enhanced in HFD and AS rats. In kidney from obese rats, fibrotic markers (collagen, TFG-beta), epithelial-mesenchymal transition molecules (a-smooth muscle actin, E-cadherin), inflammatory mediator (osteopontin) and kidney injury marker (kidney injury molecule-1) were modified. In kidney from AS rats, fibrotic markers (collagen, CTGF), epithelial-mesenchymal transition molecules (fibronectin, alpha-smooth muscle actin, beta-catenin, E-cadherin) and kidney injury markers (NGAL, kidney injury molecule 1) were altered. Histologic observations of obese and AS rat kidneys revealed tubulointerstitial fibrosis. The pharmacological inhibition of Gal-3 with MCP normalized renal Gal-3 levels as well as functional, histological and molecular alterations in obese and AS rats. Conclusions In experimental models of mild kidney damage, the increase in renal Gal-3 expression paralleled with renal fibrosis, inflammation and damage, while these alterations were prevented by Gal-3 blockade. These data suggest that Gal-3 could be a new player in renal molecular, histological and functional alterations at early stages of kidney damage.	[Martinez-Martinez, Ernesto; Ibarrola, Jaime; Fernandez-Celis, Amaya; Lopez-Andres, Natalia] Miguel Servet Fdn, Inst Invest Sanitaria Navarra IdiSNA, Cardiovasc Translat Res Navarrabiomed, Pamplona, Spain; [Calvier, Laurent; Leroy, Celine; Rossignol, Patrick; Lopez-Andres, Natalia] Univ Lorraine, CHRU Nancy, UMR 1116, INSERM,Ctr Invest Clin Plurithemat 1433,French Cl, Nancy, France; [Cachofeiro, Victoria] Univ Complutense, Sch Med, Dept Physiol, IiSGM, Madrid, Spain	Navarrabiomed; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Complutense University of Madrid	Lopez-Andres, N (corresponding author), Miguel Servet Fdn, Inst Invest Sanitaria Navarra IdiSNA, Cardiovasc Translat Res Navarrabiomed, Pamplona, Spain.; Lopez-Andres, N (corresponding author), Univ Lorraine, CHRU Nancy, UMR 1116, INSERM,Ctr Invest Clin Plurithemat 1433,French Cl, Nancy, France.	Natalia.lopez.andres@navarra.es	Lopez-Andres, Natalia/B-1276-2017; Martinez-Martinez, Ernesto/M-1376-2017	Lopez-Andres, Natalia/0000-0003-3728-2606; Martinez-Martinez, Ernesto/0000-0002-3011-2041; Ibarrola, Jaime/0000-0003-0604-9289; Fernandez-Celis, Amaya/0000-0002-5627-7653; Cachofeiro, Victoria/0000-0001-6959-6293; Calvier, Laurent/0000-0001-6437-2119	Miguel Servet from the "Instituto de Salud Carlos III-FEDER" [CP13/00221]; Fondo de Investigaciones Sanitarias [P115/02160]; FIBROTARGETS project [602904]; Red de Investigacion Cardiovascular del ISCIII (RIC) [RD12/0042/0033]; Plan Estatal I+D+I; RHU Fight-HF by French National Research Agency (ANR), second "Investissements d'Avenir" programme [ANR-15-RHUS-0004]	Miguel Servet from the "Instituto de Salud Carlos III-FEDER"; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); FIBROTARGETS project; Red de Investigacion Cardiovascular del ISCIII (RIC); Plan Estatal I+D+I; RHU Fight-HF by French National Research Agency (ANR), second "Investissements d'Avenir" programme(French National Research Agency (ANR))	This work was supported by Miguel Servet contract CP13/00221 from the "Instituto de Salud Carlos III-FEDER", Fondo de Investigaciones Sanitarias [P115/02160] "One way to make Europe", FIBROTARGETS project (Grant agreement number FP7 #602904), Red de Investigacion Cardiovascular del ISCIII (RIC; RD12/0042/0033), Plan Estatal I+D+I 2013-2016. PR was supported by the RHU Fight-HF, a public grant overseen by the French National Research Agency (ANR) as part of the second "Investissements d'Avenir" programme (reference: ANR-15-RHUS-0004).	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Anderson S, 2009, J AM SOC NEPHROL, V20, P1199, DOI 10.1681/ASN.2008080860; Aregger F, 2009, NEPHROL DIAL TRANSPL, V24, P2175, DOI 10.1093/ndt/gfp036; Becker GJ, 2000, CURR OPIN NEPHROL HY, V9, P133, DOI 10.1097/00041552-200003000-00006; Calvier L, 2015, JACC-HEART FAIL, V3, P59, DOI 10.1016/j.jchf.2014.08.002; Chen S.Y., 2016, INT J MOL SCI, V17; Bertocchi APF, 2008, TRANSPL INT, V21, P999, DOI 10.1111/j.1432-2277.2008.00705.x; Fragiadaki M, 2011, INT J EXP PATHOL, V92, P143, DOI 10.1111/j.1365-2613.2011.00775.x; Frenay ARS, 2015, AM J PHYSIOL-RENAL, V308, pF500, DOI 10.1152/ajprenal.00461.2014; Henderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Kolatsi-Joannou M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018683; Lee HS, 2010, BIOCHEM BIOPH RES CO, V395, P553, DOI 10.1016/j.bbrc.2010.04.065; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Liu HY, 2008, WORLD J GASTROENTERO, V14, P7386, DOI 10.3748/wjg.14.7386; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; MacKinnon AC, 2012, AM J RESP CRIT CARE, V185, P537, DOI 10.1164/rccm.201106-0965OC; Martinez-Martinez E, 2016, INT J OBESITY, V40, P1034, DOI 10.1038/ijo.2016.19; Martinez-Martinez E, 2015, HYPERTENSION, V66, P961, DOI 10.1161/HYPERTENSIONAHA.115.06032; Martinez-Martinez E, 2015, HYPERTENSION, V66, P767, DOI 10.1161/HYPERTENSIONAHA.115.05876; McClellan WM, 2003, J AM SOC NEPHROL, V14, pS65, DOI 10.1097/01.ASN.0000070147.10399.9E; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Najjar M, 2015, INTERACT CARDIOV TH, V21, P499, DOI 10.1093/icvts/ivv196; Nishiyama J, 2000, AM J PATHOL, V157, P815, DOI 10.1016/S0002-9440(10)64595-6; O'Seaghdha CM, 2013, J AM SOC NEPHROL, V24, P1470, DOI 10.1681/ASN.2012090909; Okamura DM, 2011, AM J PHYSIOL-RENAL, V300, pF245, DOI 10.1152/ajprenal.00326.2010; Pugliese G, 2001, FASEB J, V15, P2471, DOI 10.1096/fj.01-0006com; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Tang WHW, 2011, AM J CARDIOL, V108, P385, DOI 10.1016/j.amjcard.2011.03.056; Traber PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075361; Wicks SE, 2016, BIOCHIMIE, V124, P65, DOI 10.1016/j.biochi.2015.08.001; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	32	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166272	10.1371/journal.pone.0166272	http://dx.doi.org/10.1371/journal.pone.0166272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829066	Green Submitted, gold, Green Published			2022-12-26	WOS:000387724300102
J	Sove, RJ; Fraser, GM; Goldman, D; Ellis, CG				Sove, Richard J.; Fraser, Graham M.; Goldman, Daniel; Ellis, Christopher G.			Finite Element Model of Oxygen Transport for the Design of Geometrically Complex Microfluidic Devices Used in Biological Studies	PLOS ONE			English	Article							DEFORMATION-INDUCED RELEASE; RED-BLOOD-CELLS; ATP RELEASE; IN-VITRO; RESISTANCE VESSELS; ENDOTHELIAL-CELLS; VASCULAR-TONE; ERYTHROCYTES; GRADIENTS; CULTURE	Red blood cells play a crucial role in the local regulation of oxygen supply in the microcirculation through the oxygen dependent release of ATP. Since red blood cells serve as an oxygen sensor for the circulatory system, the dynamics of ATP release determine the effectiveness of red blood cells to relate the oxygen levels to the vessels. Previous work has focused on the feasibility of developing a microfluidic system to measure the dynamics of ATP release. The objective was to determine if a steep oxygen gradient could be developed in the channel to cause a rapid decrease in hemoglobin oxygen saturation in order to measure the corresponding levels of ATP released from the red blood cells. In the present study, oxygen transport simulations were used to optimize the geometric design parameters for a similar system which is easier to fabricate. The system is composed of a microfluidic device stacked on top of a large, gas impermeable flow channel with a hole to allow gas exchange. The microfluidic device is fabricated using soft lithography in polydimethyl-siloxane, an oxygen permeable material. Our objective is twofold: (1) optimize the parameters of our system and (2) develop a method to assess the oxygen distribution in complex 3D microfluidic device geometries. 3D simulations of oxygen transport were performed to simulate oxygen distribution throughout the device. The simulations demonstrate that micro fluidic device geometry plays a critical role in molecule exchange, for instance, changing the orientation of the short wide microfluidic channel results in a 97.17% increase in oxygen exchange. Since microfluidic devices have become a more prominent tool in biological studies, understanding the transport of oxygen and other biological molecules in microfluidic devices is critical for maintaining a physiologically relevant environment. We have also demonstrated a method to assess oxygen levels in geometrically complex microfluidic devices.	[Sove, Richard J.; Fraser, Graham M.; Goldman, Daniel; Ellis, Christopher G.] Western Univ, Dept Med Biophys, London, ON, Canada; [Fraser, Graham M.] Mem Univ St Johns, Div Biomed Sci, Cardiovasc Res Grp, Fac Med, St Johns, NF, Canada	Western University (University of Western Ontario); Memorial University Newfoundland	Sove, RJ (corresponding author), Western Univ, Dept Med Biophys, London, ON, Canada.	rsove@uwo.ca	Ellis, Christopher G/AAV-2325-2020; Goldman, Daniel/CAF-8020-2022	Goldman, Daniel/0000-0002-8707-5536	Natural Sciences and Engineering Research Council of Canada [R1379A13]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research is funded by the Natural Sciences and Engineering Research Council of Canada (R1379A13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci HE, 2012, BIOTECHNOL APPL BIOC, V59, P97, DOI 10.1002/bab.1010; Abhyankar VV, 2006, LAB CHIP, V6, P389, DOI 10.1039/b514133h; Bateman RM, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1102-7; BERGFELD GR, 1992, CARDIOVASC RES, V26, P40, DOI 10.1093/cvr/26.1.40; BJERKVIG R, 1992, UNDERSEA BIOMED RES, V19, P415; Chen YA, 2011, LAB CHIP, V11, P3626, DOI 10.1039/c1lc20325h; COKELET GR, 1993, MICROVASC RES, V46, P394, DOI 10.1006/mvre.1993.1062; Dertinger SKW, 2001, ANAL CHEM, V73, P1240, DOI 10.1021/ac001132d; Dietrich HH, 1996, AM J PHYSIOL-HEART C, V271, pH1109, DOI 10.1152/ajpheart.1996.271.3.H1109; Dietrich HH, 2000, AM J PHYSIOL-HEART C, V278, pH1294, DOI 10.1152/ajpheart.2000.278.4.H1294; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Ellis CG, 2012, MICROCIRCULATION, V19, P440, DOI 10.1111/j.1549-8719.2012.00196.x; Ellis CG, 2010, AM J PHYSIOL-HEART C, V298, pH1661, DOI 10.1152/ajpheart.01239.2009; Ellsworth ML, 2009, PHYSIOLOGY, V24, P107, DOI 10.1152/physiol.00038.2008; Ellsworth ML, 1995, AM J PHYSIOL-HEART C, V269, pH2155, DOI 10.1152/ajpheart.1995.269.6.H2155; Fischer DJ, 2003, ANALYST, V128, P1163, DOI 10.1039/b308225n; Geuzaine C, 2009, INT J NUMER METH ENG, V79, P1309, DOI 10.1002/nme.2579; Ghaemmaghami AM, 2012, DRUG DISCOV TODAY, V17, P173, DOI 10.1016/j.drudis.2011.10.029; Ghonaim NW, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00260; Ghonaim NW, 2011, MICROCIRCULATION, V18, P646, DOI 10.1111/j.1549-8719.2011.00132.x; Hellums JD, 1996, ANN BIOMED ENG, V24, P1, DOI 10.1007/BF02770991; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Inamdar NK, 2011, CURR OPIN BIOTECH, V22, P681, DOI 10.1016/j.copbio.2011.05.512; Jagger JE, 2001, AM J PHYSIOL-HEART C, V280, pH2833, DOI 10.1152/ajpheart.2001.280.6.H2833; Jiang XY, 2005, ANAL CHEM, V77, P2338, DOI 10.1021/ac048440m; JORNOT L, 1987, J APPL PHYSIOL, V63, P457, DOI 10.1152/jappl.1987.63.2.457; Kang TY, 2013, LANGMUIR, V29, P701, DOI 10.1021/la303552m; Kim MC, 2013, MICROFLUID NANOFLUID, V15, P285, DOI 10.1007/s10404-013-1142-8; Li CY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155921; Light DB, 1999, AM J PHYSIOL-CELL PH, V277, pC480, DOI 10.1152/ajpcell.1999.277.3.C480; Moehlenbrock MJ, 2006, ANALYST, V131, P930, DOI 10.1039/b605136g; Oppegard SC, 2013, BIOMED MICRODEVICES, V15, P407, DOI 10.1007/s10544-013-9737-0; PATANKAR SV, 1972, INT J HEAT MASS TRAN, V15, P1787, DOI 10.1016/0017-9310(72)90054-3; Price AK, 2004, ANAL CHEM, V76, P4849, DOI 10.1021/ac0495992; Quinn DJ, 2011, ANN BIOMED ENG, V39, P1041, DOI 10.1007/s10439-010-0232-y; Reddy J.N., 2010, FINITE ELEMENT METHO; SAAD Y, 1986, SIAM J SCI STAT COMP, V7, P856, DOI 10.1137/0907058; SANDERS SP, 1993, J CLIN INVEST, V91, P46, DOI 10.1172/JCI116198; Shevkoplyas SS, 2003, MICROVASC RES, V65, P132, DOI 10.1016/S0026-2862(02)00034-1; Sove RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081537; Sprague RS, 2006, DIABETES, V55, P3588, DOI 10.2337/db06-0555; Wan JD, 2008, P NATL ACAD SCI USA, V105, P16432, DOI 10.1073/pnas.0805779105; Wang L, 2013, LAB CHIP, V13, P695, DOI [10.1039/c2lc40661f, 10.1039/C2LC40661F]; Weller HG, 1998, COMPUT PHYS, V12, P620, DOI 10.1063/1.168744; Wu HK, 2006, J AM CHEM SOC, V128, P4194, DOI 10.1021/ja058530o; Zahorodny-Burke M, 2011, CHEM ENG SCI, V66, P6244, DOI 10.1016/j.ces.2011.09.007	47	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166289	10.1371/journal.pone.0166289	http://dx.doi.org/10.1371/journal.pone.0166289			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829071	Green Published, Green Submitted, gold			2022-12-26	WOS:000387724300103
J	Wilcox, RC; Fletcher, RJ				Wilcox, Rebecca C.; Fletcher, Robert J., Jr.			Experimental Test of Preferences for an Invasive Prey by an Endangered Predator: Implications for Conservation	PLOS ONE			English	Article							SNAIL KITE; IMPACTS; DIET; CONSEQUENCES; SPECIALIST; DEMOGRAPHY; SELECTION; BEHAVIOR; HABITAT; MODEL	Identifying impacts of exotic species on native populations is central to ecology and conservation. Although the effects of exotic predators on native prey have received much attention, the role of exotic prey on native predators is poorly understood. Determining if native predators actively prefer invasive prey over native prey has implications for interpreting invasion impacts, identifying the presence of evolutionary traps, and predator persistence. One of the world's most invasive species, Pomacea maculata, has recently established in portions of the endangered Everglade snail kite's (Rostrhamus sociabilis plumbeus) geographic range. Although these exotic snails could provide additional prey resources, they are typically much larger than the native snail, which can lead to lower foraging success and the potential for diminished energetic benefits in comparison to native snails. Nonetheless, snail kites frequently forage on exotic snails. We used choice experiments to evaluate snail kite foraging preference in relation to exotic species and snail size. We found that snail kites do not show a preference for native or exotic snails. Rather, snail kites generally showed a preference for medium-sized snails, the sizes reflective of large native snails. These results suggest that while snail kites frequently forage on exotic snails in the wild, this behavior is likely driven simply by the abundance of exotic snails rather than snail kites preferring exotics. This lack of preference offers insights to hypotheses regarding effects of exotic species, guidance regarding habitat and invasive species management, and illustrates how native-exotic relationships can be misleading in the absence of experimental tests of such interactions.	[Wilcox, Rebecca C.; Fletcher, Robert J., Jr.] Univ Florida, Dept Wildlife Ecol & Conservat, 110 Newins Zeigler Hall, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Fletcher, RJ (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, 110 Newins Zeigler Hall, Gainesville, FL 32611 USA.	robert.fletcher@ufl.edu			USGS's Greater Everglades Priority Ecosystems Science (GEPES); U.S. Army Corps of Engineers; U.S. Fish and Wildlife Service	USGS's Greater Everglades Priority Ecosystems Science (GEPES); U.S. Army Corps of Engineers(United States Department of DefenseUnited States Army); U.S. Fish and Wildlife Service(US Fish & Wildlife Service)	This project was funded by USGS's Greater Everglades Priority Ecosystems Science (GEPES), the U.S. Army Corps of Engineers, and U.S. Fish and Wildlife Service.; We thank Wiley Kitchens, Peter Frederick, Ellen Robertson and three anonymous reviewers for providing comments on earlier versions of this manuscript. This project was funded by USGS's Greater Everglades Priority Ecosystems Science (GEPES), the U.S. Army Corps of Engineers, and U.S. Fish and Wildlife Service.	Barber NA, 2008, ECOLOGY, V89, P2678, DOI 10.1890/08-0395.1; Barnes MA, 2008, J N AM BENTHOL SOC, V27, P738, DOI 10.1899/08-013.1; BEISSINGER SR, 1994, OECOLOGIA, V100, P54, DOI 10.1007/BF00317130; BEISSINGER SR, 1983, AUK, V100, P84, DOI 10.1093/auk/100.1.84; Bennetts RE, 2000, OIKOS, V91, P459, DOI 10.1034/j.1600-0706.2000.910306.x; Berger-Tal O, 2014, BEHAV ECOL SOCIOBIOL, V68, P1769, DOI 10.1007/s00265-014-1785-9; Bompard A, 2013, POPUL ECOL, V55, P433, DOI 10.1007/s10144-013-0371-8; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; CARACO T, 1981, BEHAV ECOL SOCIOBIOL, V8, P213, DOI 10.1007/BF00299833; Carlsson NOL, 2009, FRONT ECOL ENVIRON, V7, P525, DOI 10.1890/080093; Cattau CE, 2016, ECOL APPL, V26, P1952, DOI 10.1890/15-1020.1; Cattau CE, 2014, J WILDLIFE MANAGE, V78, P620, DOI 10.1002/jwmg.706; Cattau CE, 2010, BIOL CONSERV, V143, P513, DOI 10.1016/j.biocon.2009.11.022; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; D'Amore A, 2009, HERPETOL CONSERV BIO, V4, P325; Darby Philip C., 2007, Florida Field Naturalist, V35, P79; Darby PC, 2008, WETLANDS, V28, P204, DOI 10.1672/07-115.1; Darby PC, 2015, LANDSCAPE ECOL, V30, P1497, DOI 10.1007/s10980-015-0205-5; Donovan TM, 2001, ECOL APPL, V11, P871; ELLIS JE, 1976, J THEOR BIOL, V60, P93, DOI 10.1016/0022-5193(76)90157-0; ELNER RW, 1978, J ANIM ECOL, V47, P103, DOI 10.2307/3925; Fletcher RJ, 2015, P ROY SOC B-BIOL SCI, V282, P40, DOI 10.1098/rspb.2015.1545; Fletcher RJ, 2012, P ROY SOC B-BIOL SCI, V279, P2546, DOI 10.1098/rspb.2012.0139; Hutto R.L., 1990, Studies in Avian Biology, P20; Jaworski CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082231; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; LI KT, 1985, ECOLOGY, V66, P1729, DOI 10.2307/2937368; Li YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024299; Martin Julien, 2008, Endangered Species Research, V6, P25, DOI 10.3354/esr00119; Martin J, 2007, CONSERV BIOL, V21, P472, DOI 10.1111/j.1523-1739.2006.00613.x; OSENBERG CW, 1989, ECOL MONOGR, V59, P405, DOI 10.2307/1943074; Overton CT, 2014, BIOL INVASIONS, V16, P1897, DOI 10.1007/s10530-013-0634-5; Paxton EH, 2011, CONDOR, V113, P255, DOI 10.1525/cond.2011.090226; Pearson DE, 2008, ECOL APPL, V18, P321, DOI 10.1890/07-0766.1; Pias KE, 2012, WATERBIRDS, V35, P347, DOI 10.1675/063.035.0217; Pintor LM, 2015, ECOL LETT, V18, P1174, DOI 10.1111/ele.12496; R Core Team, 2021, R LANGUAGE ENV STAT; Rawlings TA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-97; Reed JM, 1999, CONSERV BIOL, V13, P232, DOI 10.1046/j.1523-1739.1999.013002232.x; Reichert B. E., 2015, SNAIL KITE ROSTRHAMU; Reichert BE, 2016, J ANIM ECOL, V85, P1563, DOI 10.1111/1365-2656.12571; Reichert BE, 2012, ECOLOGY, V93, P2580, DOI 10.1890/12-0233.1; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; Robertson BA, 2013, TRENDS ECOL EVOL, V28, P552, DOI 10.1016/j.tree.2013.04.004; Rodriguez LF, 2006, BIOL INVASIONS, V8, P927, DOI 10.1007/s10530-005-5103-3; Saul WC, 2015, ECOL LETT, V18, P236, DOI 10.1111/ele.12408; Schlaepfer MA, 2005, ECOL LETT, V8, P241, DOI 10.1111/j.1461-0248.2005.00730.x; SNYDER NFR, 1983, AUK, V100, P93, DOI 10.1093/auk/100.1.93; SYKES P W JR, 1987, Colonial Waterbirds, V10, P84, DOI 10.2307/1521235; Sykes PW, 1995, BIRDS N AM, P1; TAKEKAWA JE, 1989, CONSERV BIOL, V3, P302, DOI 10.1111/j.1523-1739.1989.tb00090.x; THOMAS DL, 1990, J WILDLIFE MANAGE, V54, P322, DOI 10.2307/3809050; TINBERGEN L., 1960, ARCH NEERLAND ZOOL, V13, P265; van Gils JA, 2003, AM NAT, V161, P777, DOI 10.1086/374205	54	8	8	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165427	10.1371/journal.pone.0165427	http://dx.doi.org/10.1371/journal.pone.0165427			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829031	gold, Green Submitted, Green Published			2022-12-26	WOS:000387724300045
J	Ibrahim, A; Souissi, A; Leray, A; Heliot, L; Vandenbunder, B; Souissi, S				Ibrahim, Ali; Souissi, Anissa; Leray, Aymeric; Heliot, Laurent; Vandenbunder, Bernard; Souissi, Sami			Myofibril Changes in the Copepod Pseudodiaptomus marinus Exposed to Haline and Thermal Stresses	PLOS ONE			English	Article							EURYTEMORA-AFFINIS COPEPODA; SKINNED MUSCLE-FIBERS; BEHAVIORAL-RESPONSES; SWIMMING BEHAVIOR; ESTUARINE COPEPOD; SALINITY; CALANOIDA; TEMPERATURE; EXPRESSION; MICROSCOPY	Copepods are small crustaceans capable to survive in various aquatic environments. Their responses to changes in different external factors such as salinity and temperature can be observed at different integration levels from copepod genes to copepod communities. Until now, no thorough observation of the temperature or salinity effect stresses on copepods has been done by optical microscopy. In this study, we used autofluorescence to visualize these effects on the morphology of the calanoid copepod Pseudodiaptomus marinus maintained during several generations in the laboratory at favorable and stable conditions of salinity (30 psu) and temperature (18 degrees C). Four different stress experiments were conducted: at a sharp decrease in temperature (18 to 4 degrees C), a moderate decrease in salinity (from 30 to 15 psu), a major decrease in salinity (from 30 to 0 psu), and finally a combined stress with a decrease in both temperature and salinity (from 18 degrees C and 30 psu to 4 degrees C and 0 psu). After these stresses, images acquired by confocal laser scanning microscopy (CLSM) revealed changes in copepod cuticle and muscle structure. Low salinity and/or temperature stresses affected both the detection of fluorescence emitted by muscle sarcomeres and the distance between them. In the remaining paper we will use the term sarcomeres to describe the elements located within sarcomeres and emitted autofluorescence signals. Quantitative study showed an increase in the average distance between two consecutive sarcomeres from 2.06 +/- 0.11 mu m to 2.44 +/- 0.42 mu m and 2.88 +/- 0.45 mu m after the exposure to major haline stress (18 degrees C, 0 psu) and the combined stress (4 degrees C, 0 psu), respectively. These stresses also caused cuticle cracks which often occurred at the same location, suggesting the cuticle as a sensitive area for osmoregulation. Our results suggest the use of cuticular and muscle autofluorescence as new biomarkers of stress detectable in formalin-preserved P. marinus individuals. Our label-free method can be easily applied to a large number of other copepod species or invertebrates with striated musculature.	[Ibrahim, Ali; Leray, Aymeric; Heliot, Laurent; Vandenbunder, Bernard] Univ Lille, CNRS, Interdisciplinary Res Inst, USR 3078, Parc Sci Haute Borne, F-59650 Villeneuve Dascq, France; [Ibrahim, Ali; Souissi, Anissa; Souissi, Sami] Univ Littoral Cote dOpale, Univ Lille, CNRS, UMR LOG 8187,Lab Oceanol & Geosci, F-62930 Wimereux, France; [Leray, Aymeric] Univ Bourgogne France Comte, Lab Interdisciplinaire Carnot Bourgogne ICB, CNRS, UMR 6303, F-21078 Dijon, France; [Heliot, Laurent; Vandenbunder, Bernard] Univ Lille, CNRS, UMR 8523, Lab Phys Lasers Atomes & Mol, Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; Universite du Littoral-Cote-d'Opale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Bourgogne; Universite de Technologie de Belfort-Montbeliard (UTBM); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); CNRS - Institute of Physics (INP); Universite de Lille - ISITE; Universite de Lille	Souissi, S (corresponding author), Univ Littoral Cote dOpale, Univ Lille, CNRS, UMR LOG 8187,Lab Oceanol & Geosci, F-62930 Wimereux, France.	Sami.Souissi@univ-lille1.fr	Souissi, Sami/C-5146-2018	Souissi, Sami/0000-0002-6720-0096; Souissi, Anissa/0000-0001-6999-0178	University of Lille 1; GIP Seine-Aval (grant ZOOGLOBAL); Nord-Pas de Calais Regional Council; CNRS; FEDER (UE); GDR2588 ("Functional microscopy for life")	University of Lille 1; GIP Seine-Aval (grant ZOOGLOBAL); Nord-Pas de Calais Regional Council(Region Hauts-de-France); CNRS(Centre National de la Recherche Scientifique (CNRS)); FEDER (UE)(European Commission); GDR2588 ("Functional microscopy for life")	University of Lille 1 provided a PhD scholarship (salary) to AI. The GIP Seine-Aval provided a research grant to SS to study the habitats and role of zooplankton in estuaries (grant ZOOGLOBAL). Nord-Pas de Calais Regional Council provided a grant (salary) to AS for the project COPEFISH. This grant to SS allowed them to maintain copepod cultures during several generations. CNRS provided a grant in 2010 called "Risk taking support" CNRS Interdisciplinary Program to LH. Nord-Pas de Calais Regional Council and FEDER (UE) supported LH through the CPER 2007-2013 project. The GDR2588 ("Functional microscopy for life") provided support to LH.	Agarkova I, 2003, J MUSCLE RES CELL M, V24, P191, DOI 10.1023/A:1026094924677; Bayly IAE, 2009, HYDROBIOLOGIA, V630, P39, DOI 10.1007/s10750-009-9797-6; Beaugrand G, 2003, FISH OCEANOGR, V12, P270, DOI 10.1046/j.1365-2419.2003.00248.x; Bhandiwad A, 2011, J EXP BIOL, V214, P709, DOI 10.1242/jeb.049296; Bollmohr S, 2009, ECOTOX ENVIRON SAFE, V72, P756, DOI 10.1016/j.ecoenv.2008.08.003; BRADLEY BP, 1988, HYDROBIOLOGIA, V167, P197, DOI 10.1007/BF00026305; Brylinski JM, 2012, AQUAT INVASIONS, V7, P577, DOI 10.3391/ai.2012.7.4.014; Buttino I, 2003, MICROSC RES TECHNIQ, V60, P458, DOI 10.1002/jemt.10284; Buttino I, 2011, CHEM ECOL, V27, P97, DOI 10.1080/02757540.2011.625944; Cailleaud K, 2007, COMP BIOCHEM PHYS A, V147, P841, DOI 10.1016/j.cbpa.2006.09.012; Cailleaud K, 2009, ENVIRON POLLUT, V157, P64, DOI 10.1016/j.envpol.2008.07.026; Devreker D, 2004, J EXP MAR BIOL ECOL, V303, P31, DOI 10.1016/j.jembe.2003.11.002; Devreker D, 2010, ESTUAR COAST SHELF S, V89, P245, DOI 10.1016/j.ecss.2010.07.010; Devreker D, 2008, J PLANKTON RES, V30, P1329, DOI 10.1093/plankt/fbn086; FLEMINGER A, 1988, MAR BIOL, V98, P535, DOI 10.1007/BF00391545; Gislason A, 2012, ICES J MAR SCI, V69, P1263, DOI 10.1093/icesjms/fss070; GODT RE, 1977, BIOPHYS J, V19, P103, DOI 10.1016/S0006-3495(77)85573-2; Hansen BW, 2012, J COMP PHYSIOL B, V182, P613, DOI 10.1007/s00360-012-0646-y; Ibrahim A, 2015, J STRUCT BIOL, V191, P224, DOI 10.1016/j.jsb.2015.06.004; Jackson KA, 2004, STEM CELLS, V22, P180, DOI 10.1634/stemcells.22-2-180; Jiang ZB, 2008, J THERM BIOL, V33, P419, DOI 10.1016/j.jtherbio.2008.06.008; Johnson KE, 2014, PHYSIOL BIOCHEM ZOOL, V87, P310, DOI 10.1086/674319; Kiernan DA, 2006, EVOL DEV, V8, P537, DOI 10.1111/j.1525-142X.2006.00126.x; Lauritano C, 2012, MAR ENVIRON RES, V76, P22, DOI 10.1016/j.marenvres.2011.09.015; Lee HW, 2003, J PLANKTON RES, V25, P261, DOI 10.1093/plankt/25.3.261; Li CL, 2009, THESCIENTIFICWORLDJO, V9, P866, DOI 10.1100/tsw.2009.96; MAUGHAN DW, 1979, BIOPHYS J, V28, P391, DOI 10.1016/S0006-3495(79)85188-7; Michalec FG, 2013, AQUAT TOXICOL, V138, P129, DOI 10.1016/j.aquatox.2013.05.007; Michalec FG, 2012, J EXP MAR BIOL ECOL, V438, P24, DOI 10.1016/j.jembe.2012.09.013; Michalec FG, 2010, J PLANKTON RES, V32, P805, DOI 10.1093/plankt/fbq006; Michels J, 2007, J MICROSC-OXFORD, V227, P1, DOI 10.1111/j.1365-2818.2007.01787.x; Monici M, 2005, BIOTECHNOL ANN REV, V11, P227, DOI 10.1016/S1387-2656(05)11007-2; Pereira VM, 2012, NEUROTOXICOLOGY, V33, P469, DOI 10.1016/j.neuro.2012.03.005; Pfeffer CP, 2011, BIOMED OPT EXPRESS, V2, P1366, DOI 10.1364/BOE.2.001366; Poulet SA, 2003, MAR BIOL, V143, P889, DOI 10.1007/s00227-003-1142-4; Powers SK, 2005, AM J PHYSIOL-REG I, V288, pR337, DOI 10.1152/ajpregu.00469.2004; Rajakaruna H, 2012, BIOL INVASIONS, V14, P633, DOI 10.1007/s10530-011-0104-x; Recher G, 2009, OPT EXPRESS, V17, P19763, DOI 10.1364/OE.17.019763; Sabia L, 2014, ZOOL STUD, V53, DOI 10.1186/s40555-014-0049-8; Silva C, 2013, MAR ENVIRON RES, V90, P39, DOI 10.1016/j.marenvres.2013.05.010; Souissi S, 2007, J PLANKTON RES, V29, pI1, DOI 10.1093/plankt/fbm026; Souissi S, 2010, J PLANKTON RES, V32, P1227, DOI 10.1093/plankt/fbq059; Vehmaa A, 2013, ECOL EVOL, V3, P4548, DOI 10.1002/ece3.839; Wallace SJ, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3027970; Xu MG, 2000, APPL OPTICS, V39, P6312, DOI 10.1364/AO.39.006312; Xuereb B, 2012, CELL STRESS CHAPERON, V17, P457, DOI 10.1007/s12192-012-0323-9; Yu JG, 2005, J HISTOCHEM CYTOCHEM, V53, P839, DOI 10.1369/jhc.4A6608.2005; Zirbel MJ, 2007, LIMNOL OCEANOGR-METH, V5, P106, DOI 10.4319/lom.2007.5.106	48	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0164770	10.1371/journal.pone.0164770	http://dx.doi.org/10.1371/journal.pone.0164770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824880	Green Submitted, gold, Green Published			2022-12-26	WOS:000387615200006
J	Iguchi, T; Nambara, S; Masuda, T; Komatsu, H; Ueda, M; Kidogami, S; Ogawal, Y; Hu, QJ; Sato, K; Saito, T; Hirata, H; Sakimura, S; Uchi, R; Hayashi, N; Ito, S; Eguchi, H; Sugimachi, K; Maehara, Y; Mimori, K				Iguchi, Tomohiro; Nambara, Sho; Masuda, Takaaki; Komatsu, Hisateru; Ueda, Masami; Kidogami, Shinya; Ogawal, Yushi; Hu, Qingjiang; Sato, Kuniaki; Saito, Tomoko; Hirata, Hidenari; Sakimura, Shotaro; Uchi, Ryutaro; Hayashi, Naoki; Ito, Shuhei; Eguchi, Hidetoshi; Sugimachi, Keishi; Maehara, Yoshihiko; Mimori, Koshi			miR-146a Polymorphism (rs2910164) Predicts Colorectal Cancer Patients' Susceptibility to Liver Metastasis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; FUNCTIONAL POLYMORPHISM; GASTRIC-CANCER; EXPRESSION; MICRORNAS; RISK; SUPPRESSION; INHIBITION; SURVIVAL; GENE	miR-146a plays important roles in cancer as it directly targets NUMB, an inhibitor of Notch signaling. miR-146a is reportedly regulated by a G>C polymorphism (SNP; rs2910164). This polymorphism affects various cancers, including colorectal cancer (CRC). However, the clinical significance of miR-146a polymorphism in CRC remains unclear. A total of 59 patients with CRC were divided into 2 groups: a CC/CG genotype (n = 32) and a GG genotype (n = 27), based on the miR-146a polymorphism. cDNA microarray analysis was performed using 59 clinical samples. Significantly enriched gene sets in each genotype were extracted using GSEA. We also investigated the association between miR-146a polymorphism and miR-146a, NUMB expression or migratory response in CRC cell lines. The CC/CG genotype was associated with significantly more synchronous liver metastasis (p = 0.007). A heat map of the two genotypes showed that the expression profiles were clearly stratified. GSEA indicated that Notch signaling and JAK/STAT3 signaling were significantly associated with the CC/CG genotype (p = 0.004 and p = 0.023, respectively). CRC cell lines with the pre-miR-146a/C revealed significantly higher miR-146a expression (p = 0.034) and higher NUMB expression and chemotactic activity. In CRC, miR-146a polymorphism is involved in liver metastasis. Identification of this polymorphism could be useful to identify patients with a high risk of liver metastasis in CRC.	[Iguchi, Tomohiro; Nambara, Sho; Masuda, Takaaki; Komatsu, Hisateru; Ueda, Masami; Kidogami, Shinya; Ogawal, Yushi; Hu, Qingjiang; Sato, Kuniaki; Saito, Tomoko; Hirata, Hidenari; Sakimura, Shotaro; Uchi, Ryutaro; Hayashi, Naoki; Ito, Shuhei; Eguchi, Hidetoshi; Sugimachi, Keishi; Mimori, Koshi] Kyushu Univ, Beppu Hosp, Dept Surg, 4546 Tsurumihara, Beppu, Oita 8740838, Japan; [Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan	Kyushu University; Kyushu University	Mimori, K (corresponding author), Kyushu Univ, Beppu Hosp, Dept Surg, 4546 Tsurumihara, Beppu, Oita 8740838, Japan.	kmimori@beppu.kyushu-u.ac.jp	Sato, Kuniaki/AAD-2565-2020	Mimori, Koshi/0000-0003-3897-9974; Hu, Qingjiang/0000-0002-8313-5861; Sato, Kuniaki/0000-0001-6014-1911	MEXT [26461980, 15H04921, 15K10168, 15K10170]; RIKEN Advanced Institute for Computational Science through the HPCI System Research project [hp140230]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN Advanced Institute for Computational Science through the HPCI System Research project	This work was supported by Grants-in-Aid for Scientific Research of MEXT (26461980, 15H04921, 15K10168, 15K10170) (https://www.isps.go.jp/english/e-grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; d This work was supported by the following grants and foundations: Grants-in-Aid for Scientific Research of MEXT (26461980, 15H04921, 15K10168, 15K10170). This research used computational resources of the K computer provided by the RIKEN Advanced Institute for Computational Science through the HPCI System Research project (Project ID: hp140230). Computation time was also provided by the Supercomputer System, Human Genome Center, Institute of Medical Science, University of Tokyo (http://sc.hgc.jp/shirokane.html). We appreciate the technical support of Ms. Kazumi Oda, Michiko Kasagi, Sachiko Sakuma, Noriko Mishima and Tomoko Kawano.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chae YS, 2013, ANTICANCER RES, V33, P3233; Chen G, 2013, PLOS ONE, DOI [10.1371/journal.pone.0060317, DOI 10.1371/JOURNAL.PONE.0060317PMID:23555954]; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Forloni M, 2014, ELIFE, V3, DOI 10.7554/eLife.01460; Gayyed MF, 2015, J GASTROINTEST ONCOL, V6, P618, DOI 10.3978/j.issn.2078-6891.2015.072; Hezova R, 2012, WORLD J GASTROENTERO, V18, P2827, DOI 10.3748/wjg.v18.i22.2827; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Hung PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079926; Hwang WL, 2014, NAT CELL BIOL, V16, P268, DOI 10.1038/ncb2910; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jia H, 2016, BBA-GEN SUBJECTS, V1860, P1417, DOI 10.1016/j.bbagen.2016.04.007; Kang J, 2013, J BIOL CHEM, V288, P27343, DOI 10.1074/jbc.M113.490482; Kogo R, 2011, CLIN CANCER RES, V17, P4277, DOI 10.1158/1078-0432.CCR-10-2866; Kuang W, 2009, BIOCHEM BIOPH RES CO, V378, P259, DOI 10.1016/j.bbrc.2008.11.041; Kumaraswamy E, 2015, ONCOGENE, V34, P4333, DOI 10.1038/onc.2014.363; Landau DA, 2011, SEMIN ONCOL, V38, P743, DOI 10.1053/j.seminoncol.2011.08.003; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Ma L, 2013, ARCH TOXICOL, V87, P825, DOI 10.1007/s00204-012-1004-2; Mimori K, 1999, P NATL ACAD SCI USA, V96, P7456, DOI 10.1073/pnas.96.13.7456; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Shen J, 2008, CARCINOGENESIS, V29, P1963, DOI 10.1093/carcin/bgn172; Shinden Y, 2015, MOL CLIN ONCOL, V3, P919, DOI 10.3892/mco.2015.565; Slaby O, 2012, J CELL MOL MED, V16, P8, DOI 10.1111/j.1582-4934.2011.01359.x; Sonoshita M, 2011, CANCER CELL, V19, P125, DOI 10.1016/j.ccr.2010.11.008; Sugimachi K, 2014, ANN SURG ONCOL, V21, pS515, DOI 10.1245/s10434-013-3468-6; Sun XX, 2015, CELL CYCLE, V14, P243, DOI 10.4161/15384101.2014.977112; Ueda M, 2015, ANN SURG ONCOL, V22, pS1490, DOI 10.1245/s10434-015-4652-7; Vinci S, 2013, METHODS, V59, P138, DOI 10.1016/j.ymeth.2012.09.002; Wang C, 2016, BRIT J CANCER, V114, P290, DOI 10.1038/bjc.2015.463; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Washington MK, 2008, ARCH PATHOL LAB MED, V132, P1600, DOI 10.1043/1543-2165(2008)132[1600:CCSIIP]2.0.CO;2; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Xu B, 2010, PROSTATE, V70, P467, DOI 10.1002/pros.21080; Xu T, 2008, CARCINOGENESIS, V29, P2126, DOI 10.1093/carcin/bgn195; Yao QY, 2013, CANCER LETT, V335, P219, DOI 10.1016/j.canlet.2013.02.031; Yu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079137; Yumimoto K, 2015, J CLIN INVEST, V125, P621, DOI 10.1172/JCI78782; Zeng Changqing, 2014, Nan Fang Yi Ke Da Xue Xue Bao, V34, P396; Zhong WM, 1997, DEVELOPMENT, V124, P1887	44	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165912	10.1371/journal.pone.0165912	http://dx.doi.org/10.1371/journal.pone.0165912			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824903	gold, Green Published, Green Submitted			2022-12-26	WOS:000387615200043
J	Pereira, N; Cozzubbo, T; Cheung, S; Rosenwaks, Z; Palermo, GD; Neri, QV				Pereira, Nigel; Cozzubbo, Tyler; Cheung, Stephanie; Rosenwaks, Zev; Palermo, Gianpiero D.; Neri, Queenie V.			Identifying Maternal Constraints on Fetal Growth and Subsequent Perinatal Outcomes Using a Multiple Embryo Implantation Model	PLOS ONE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGY; IN-VITRO FERTILIZATION; INTRACYTOPLASMIC SPERM INJECTION; INFANT DEVELOPMENT-II; LOW-BIRTH-WEIGHT; STAGES QUESTIONNAIRES; BAYLEY SCALES; FOLLOW-UP; PRETERM; AGES	Introduction Although the majority of singleton births after in vitro fertilization (IVF) are uncomplicated, studies have suggested that IVF pregnancies may be independently associated with low birth weight (LBW), preterm birth (PTB), and perinatal mortality. These outcomes complicate multiple gestations as expected, but have also been reported in singletons. A multiple embryo implantation model allows for assessment of the early in utero environment, and therefore, assessment of any maternal constraints on developing fetuses. We question whether adverse perinatal outcomes associated with assisted reproductive techniques (ART) occur as a result of maternal physiologic adaptations. Patients and Methods This is a retrospective, single center study of ART cycles, specifically intracytoplasmic sperm injection (ICSI) cycles during a 16-year period. For each positive pregnancy test 9-11 days after embryo transfer, an ultrasonogram was performed at 7 weeks of gestation to record the number of implanted fetal poles with cardiac activity. Controlled ovarian stimulation (COS), hCG trigger, oocyte retrieval and sperm injection were performed as per our standard protocols. First trimester implantation sites that resulted in live births were defined as "true" to distinguish them from those that spontaneously reduced called "virtual". Birth outcomes analyzed included birth weight and gestational age at delivery. Results A total of 17,415 cycles were analyzed. The average maternal age was 36.9 (+/- 5.0) years. An overall fertilization rate of 73.4% generated approximately 48,708 good quality cleavage-stage embryos. In most patients (92.8%), an average of 3 embryos were transferred. The clinical pregnancy rate was 39.2% (n = 6,281). The overall occurrence of multiple gestations was 38.2% (n = 2,608) consisting of 2,038 twin, 511 triplet, and 59 quadruplet pregnancies. Of these multiple gestations, 18.6% of twin, 54.2% of triplet and 76.3% of quadruplet gestations spontaneously reduced. Failure of the implanted embryo to progress was not related to maternal age. Singleton newborns resulting from multiple implantation sites had lower birth weights (P<0.01) and shorter gestational ages (P<0.01) than those from a single implanted embryo. The number of embryos transferred did not affect the gestational length of singleton newborns. Although the birth weights of singletons from multiple implantation sites (virtual singletons) were lower than true singletons, the birth weight of virtual singletons were comparable to the birth weights of true twin, triplet, and quadruplet live births. Multiple logistic regression revealed that virtual singletons were an independent risk factor for PTB (odds ratio: 4.55, 95% CI 2.23-9.29) and LBW (odds ratio: 3.61, 95% CI 1.78-7.32), even after controlling for the number of oocytes, stimulation protocol type, sperm source, total gonadotropins administered, age, embryo quality, and day of embryo transfer. Conclusions Our study highlights that embryonic implantation sites during early gestation set the growth profile of each embryo, dictating later growth patterns. Specifically, spontaneous reduction of an embryo after multiple embryo implantations can confer greater perinatal risk in the form of LBW and PTB to the surviving fetus. Our findings suggest that maternal constraints or physiologic adaptations maybe one of the mechanisms mediating adverse perinatal outcomes when multiple embryo implantation occurs.	[Pereira, Nigel; Cozzubbo, Tyler; Cheung, Stephanie; Rosenwaks, Zev; Palermo, Gianpiero D.; Neri, Queenie V.] Weill Cornell Med Coll, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA	Cornell University	Palermo, GD (corresponding author), Weill Cornell Med Coll, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA.	gdpaterm@med.cornell.edu		Palermo, Gianpiero D./0000-0001-8440-4560; Cheung, Stephanie/0000-0002-2092-7001				Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Allen WR, 2002, REPRODUCTION, V123, P445, DOI 10.1530/rep.0.1230445; [Anonymous], 2010, WHO LAB MAN EX PROC; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; BROOKS AA, 1995, EARLY HUM DEV, V42, P29, DOI 10.1016/0378-3782(95)01637-I; Buckler JMH, 2004, ANN HUM BIOL, V31, P311, DOI 10.1080/03014460410001670120; Bulletti C, 2005, CURR OPIN OBSTET GYN, V17, P265, DOI 10.1097/01.gco.0000169104.85128.0e; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Ceelen M, 2008, J CLIN ENDOCR METAB, V93, P1682, DOI 10.1210/jc.2007-2432; Chen Q, 2011, J BIOL CHEM, V286, P4349, DOI 10.1074/jbc.M110.197202; COGSWELL ME, 1995, SEMIN PERINATOL, V19, P222, DOI 10.1016/S0146-0005(05)80028-X; De Sutter P, 2006, HUM REPROD, V21, P2633, DOI 10.1093/humrep/del247; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Dickey RP, 2004, HUM REPROD, V19, P783, DOI 10.1093/humrep/deh181; Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378; Gluckman PD, 2003, J NUTR, V133, p1741S, DOI 10.1093/jn/133.5.1741S; Gluckman Peter D, 2004, Semin Fetal Neonatal Med, V9, P419, DOI 10.1016/j.siny.2004.03.001; Gosden LV, 2014, METHODS MOL BIOL, V1154, P343, DOI 10.1007/978-1-4939-0659-8_16; Hama K, 2007, BIOL REPROD, V77, P954, DOI 10.1095/biolreprod.107.060293; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Huang JYJ, 2014, METHODS MOL BIOL, V1154, P171, DOI 10.1007/978-1-4939-0659-8_8; Ishihara O, 2015, FERTIL STERIL, V103, P402, DOI 10.1016/j.fertnstert.2014.11.004; Kwong WY, 2000, DEVELOPMENT, V127, P4195; Kwun Y, 2015, J KOREAN MED SCI, V30, P450, DOI 10.3346/jkms.2015.30.4.450; La Sala GB, 2006, FERTIL STERIL, V86, P247, DOI 10.1016/j.fertnstert.2005.11.073; Luke B, 2009, FERTIL STERIL, V91, P2578, DOI 10.1016/j.fertnstert.2008.03.068; McGovern PG, 2004, FERTIL STERIL, V82, P1514, DOI 10.1016/j.fertnstert.2004.06.038; Neri QV, 2014, METHODS MOL BIOL, V1154, P91, DOI 10.1007/978-1-4939-0659-8_5; PALERMO GD, 1995, FERTIL STERIL, V63, P1231, DOI 10.1016/S0015-0282(16)57603-1; Palermo GD, 2014, FERTIL STERIL, V102, P1508, DOI 10.1016/j.fertnstert.2014.10.008; Palermo GD, 2008, REPROD BIOMED ONLINE, V17, P820, DOI 10.1016/S1472-6483(10)60411-7; Pandey S, 2012, HUM REPROD UPDATE, V18, P485, DOI 10.1093/humupd/dms018; Petrini AC, 2016, WOMENS HEALTH, V12, P420, DOI 10.1177/1745505716658898; Saadeldin IM, 2015, STEM CELLS CLONING, V8, P103, DOI 10.2147/SCCAA.S84991; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; Schieve LA, 2004, OBSTET GYNECOL, V103, P1144, DOI 10.1097/01.AOG.0000127037.12652.76; Shebl O, 2008, FERTIL STERIL, V90, P310, DOI 10.1016/j.fertnstert.2007.06.048; Shevell T, 2005, OBSTET GYNECOL, V106, P1039, DOI 10.1097/01.AOG.0000183593.24583.7c; Simard MN, 2012, PEDIATRICS, V130, pE108, DOI 10.1542/peds.2011-3532; Spong CY, 2011, OBSTET GYNECOL, V118, P323, DOI 10.1097/AOG.0b013e3182255999; Squires J, 2003, FERTIL STERIL, V79, P453, DOI 10.1016/S0015-0282(02)04685-X; Squires J, 1997, J PEDIATR PSYCHOL, V22, P313, DOI 10.1093/jpepsy/22.3.313; Steel AJ, 2009, HUM FERTIL, V12, P21, DOI 10.1080/14647270802499201; Stojnic J, 2013, CLIN EXP OBSTET GYN, V40, P277; Sunderam S, 2015, MMWR SURVEILL SUMM, V64, P1; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Woodward BJ, 2011, J PERINATOL, V31, P641, DOI 10.1038/jp.2011.1	47	7	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166222	10.1371/journal.pone.0166222	http://dx.doi.org/10.1371/journal.pone.0166222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824942	gold, Green Published, Green Submitted			2022-12-26	WOS:000387615200073
J	Rush, D; Osborne, KA; Birgel, D; Kappler, A; Hirayama, H; Peckmann, J; Poulton, SW; Nickel, JC; Mangelsdorf, K; Kalyuzhnaya, M; Sidgwick, FR; Talbot, HM				Rush, Darci; Osborne, Kate A.; Birgel, Daniel; Kappler, Andreas; Hirayama, Hisako; Peckmann, Joern; Poulton, Simon W.; Nickel, Julia C.; Mangelsdorf, Kai; Kalyuzhnaya, Marina; Sidgwick, Frances R.; Talbot, Helen M.			The Bacteriohopanepolyol Inventory of Novel Aerobic Methane Oxidising Bacteria Reveals New Biomarker Signatures of Aerobic Methanotrophy in Marine Systems	PLOS ONE			English	Article							SUBMARINE HYDROTHERMAL SYSTEM; CARBON ISOTOPIC FRACTIONATION; SUSPENDED PARTICULATE MATTER; MOSBY MUD VOLCANO; LIPID BIOMARKERS; WATER COLUMN; BLACK-SEA; SEDIMENTARY BACTERIOHOPANEPOLYOLS; MICROBIAL COMMUNITIES; HYDROCARBON SEEPS	Aerobic methane oxidation (AMO) is one of the primary biologic pathways regulating the amount of methane (CH4) released into the environment. AMO acts as a sink of CH4, converting it into carbon dioxide before it reaches the atmosphere. It is of interest for (paleo) climate and carbon cycling studies to identify lipid biomarkers that can be used to trace AMO events, especially at times when the role of methane in the carbon cycle was more pronounced than today. AMO bacteria are known to synthesise bacteriohopanepolyol (BHP) lipids. Preliminary evidence pointed towards 35-aminobacteriohopane-30,31,32,33,34-pentol (aminopentol) being a characteristic biomarker for Type I methanotrophs. Here, the BHP compositions were examined for species of the recently described novel Type I methanotroph bacterial genera Methylomarinum and Methylomarinovum, as well as for a novel species of a Type I Methylomicrobium. Aminopentol was the most abundant BHP only in Methylomarinovum caldicuralii, while Methylomicrobium did not produce aminopentol at all. In addition to the expected regular aminotriol and aminotetrol BHPs, novel structures tentatively identified as methylcarbamate lipids related to C-35 amino-BHPs (MCBHPs) were found to be synthesised in significant amounts by some AMO cultures. Subsequently, sediments and authigenic carbonates from methane-influenced marine environments were analysed. Most samples also did not contain significant amounts of aminopentol, indicating that aminopentol is not a useful biomarker for marine aerobic methanotophic bacteria. However, the BHP composition of the marine samples do point toward the novel MC-BHPs components being potential new biomarkers for AMO.	[Rush, Darci; Osborne, Kate A.; Sidgwick, Frances R.; Talbot, Helen M.] Newcastle Univ, Sch Civil Engn & Geosci, Drummond Bldg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Birgel, Daniel; Peckmann, Joern] Univ Hamburg, Inst Geol, Hamburg, Germany; [Kappler, Andreas] Univ Tubingen, Ctr Appl Geosci, Tubingen, Germany; [Kappler, Andreas] Ctr Geomicrobiol, Dept Biosci, Ny Munkegade 116, DK-8000 Aarhus C, Denmark; [Hirayama, Hisako] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Subsurface Geobiol Anal & Res, Yokosuka, Kanagawa, Japan; [Peckmann, Joern] Univ Vienna, Dept Geodynam & Sedimentol, A-1090 Vienna, Austria; [Poulton, Simon W.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Nickel, Julia C.; Mangelsdorf, Kai] GFZ German Res Ctr Geosci, D-14473 Potsdam, Germany; [Kalyuzhnaya, Marina] San Diego State Univ, Fac Biol, 5500 Campanile Dr, San Diego, CA 92182 USA	Newcastle University - UK; University of Hamburg; Eberhard Karls University of Tubingen; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Vienna; University of Leeds; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; California State University System; San Diego State University	Rush, D (corresponding author), Newcastle Univ, Sch Civil Engn & Geosci, Drummond Bldg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	darci.rush@nioz.nl		Kappler, Andreas/0000-0002-3558-9500; Peckmann, Jorn/0000-0002-8572-0060; Poulton, Simon/0000-0001-7621-189X; Sidgwick, Frances/0000-0001-8792-1096; Rush, Darci/0000-0002-6567-4116	European Research Council [258734]; Lundin Petroleum	European Research Council(European Research Council (ERC)European Commission); Lundin Petroleum	The work was funded by a Starting Grant (No. 258734) awarded to HMT for project AMOPROX, from the European Research Council. KM and JCN thank Lundin Petroleum for financial support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baco AR, 2010, MAR GEOL, V272, P251, DOI 10.1016/j.margeo.2009.06.015; Banta AB, 2015, P NATL ACAD SCI USA, V112, P13478, DOI 10.1073/pnas.1511482112; Berndmeyer C, 2013, ORG GEOCHEM, V55, P103, DOI 10.1016/j.orggeochem.2012.11.010; Birgel D, 2015, GEOBIOLOGY, V13, P245, DOI 10.1111/gbi.12130; Birgel D, 2011, CHEM GEOL, V285, P82, DOI 10.1016/j.chemgeo.2011.03.004; Birgel D, 2008, ORG GEOCHEM, V39, P1659, DOI 10.1016/j.orggeochem.2008.01.023; Bischoff J, 2016, BIOGEOSCIENCES, V13, P4899, DOI 10.5194/bg-13-4899-2016; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blumenberg M, 2013, BIOGEOSCIENCES, V10, P2725, DOI 10.5194/bg-10-2725-2013; Blumenberg M, 2007, ORG GEOCHEM, V38, P84, DOI 10.1016/j.orggeochem.2006.08.011; Blumenberg M, 2006, ENVIRON MICROBIOL, V8, P1220, DOI 10.1111/j.1462-2920.2006.01014.x; Blumenberg M, 2013, ORG GEOCHEM, V55, P55, DOI 10.1016/j.orggeochem.2012.11.004; Blumenberg M, 2012, ORG GEOCHEM, V49, P1, DOI 10.1016/j.orggeochem.2012.05.003; Blumenberg M, 2010, ORG GEOCHEM, V41, P1119, DOI 10.1016/j.orggeochem.2010.06.005; Blumenberg M, 2009, GEOCHIM COSMOCHIM AC, V73, P750, DOI 10.1016/j.gca.2008.11.005; Blumenberg M, 2009, FEMS MICROBIOL LETT, V293, P73, DOI 10.1111/j.1574-6968.2009.01520.x; BOUVIER P, 1976, BIOCHEM J, V159, P267, DOI 10.1042/bj1590267; Bradley AS, 2010, ORG GEOCHEM, V41, P1075, DOI 10.1016/j.orggeochem.2010.07.003; Chand S, 2012, EARTH PLANET SC LETT, V331, P305, DOI 10.1016/j.epsl.2012.03.021; COLLISTER JW, 1992, ORG GEOCHEM, V19, P265, DOI 10.1016/0146-6380(92)90042-V; Cooke MP, 2008, ORG GEOCHEM, V39, P1347, DOI 10.1016/j.orggeochem.2008.05.003; Cooke MP, 2008, ORG GEOCHEM, V39, P965, DOI 10.1016/j.orggeochem.2008.03.009; Cooke MP, 2009, ORG GEOCHEM, V40, P1151, DOI 10.1016/j.orggeochem.2009.07.014; Cooke MP, 2011, THESIS; Coolen MJL, 2008, ENVIRON MICROBIOL, V10, P1783, DOI 10.1111/j.1462-2920.2008.01601.x; Cre Amiere A, 2016, NAT COMMUN, V7, P1; Crespo-Medina M, 2014, NAT GEOSCI, V7, P423, DOI [10.1038/ngeo2156, 10.1038/NGEO2156]; Crossman ZM, 2001, ORG GEOCHEM, V32, P359, DOI 10.1016/S0146-6380(00)00178-9; Cvejic JH, 2000, FEMS MICROBIOL LETT, V182, P361; De Jonge C, 2016, GEOCHIM COSMOCHIM AC, V174, P85, DOI 10.1016/j.gca.2015.11.008; Dedysh SN, 2009, MICROBIOLOGY+, V78, P655, DOI 10.1134/S0026261709060010; Dickens GR, 1997, GEOLOGY, V25, P259, DOI 10.1130/0091-7613(1997)025<0259:ABOGIT>2.3.CO;2; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Dunfield PF, 2007, NATURE, V450, P879, DOI 10.1038/nature06411; Elvert M, 2000, ORG GEOCHEM, V31, P1175, DOI 10.1016/S0146-6380(00)00111-X; Elvert M, 2008, ORG GEOCHEM, V39, P167, DOI 10.1016/j.orggeochem.2007.11.006; Farrimond P, 2000, GEOCHIM COSMOCHIM AC, V64, P2985, DOI 10.1016/S0016-7037(00)00404-X; Farrimond P, 2004, GEOCHIM COSMOCHIM AC, V68, P3873, DOI 10.1016/j.gca.2004.04.011; Farrimond P., 1998, ANCIENT BIOMOLECULES, V2, P147; Felden J, 2013, BIOGEOSCIENCES, V10, P3269, DOI 10.5194/bg-10-3269-2013; Felden J, 2010, LIMNOL OCEANOGR, V55, P2366, DOI 10.4319/lo.2010.55.6.2366; Fuse H, 1998, BIOSCI BIOTECH BIOCH, V62, P1925, DOI 10.1271/bbb.62.1925; Gibson RA, 2008, ORG GEOCHEM, V39, P1020, DOI 10.1016/j.orggeochem.2008.04.014; Gibson RA, 2014, ORG GEOCHEM, V69, P61, DOI 10.1016/j.orggeochem.2014.02.004; Hamersley MR, 2007, LIMNOL OCEANOGR, V52, P923, DOI 10.4319/lo.2007.52.3.0923; Handley L, 2008, EARTH PLANET SC LETT, V275, P17, DOI 10.1016/j.epsl.2008.07.030; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Himmler T, 2015, CHEM GEOL, V415, P102, DOI 10.1016/j.chemgeo.2015.09.016; Hinrichs KU, 2001, GEOCHEM GEOPHY GEOSY, V2, part. no.; Hirayama H, 2007, APPL ENVIRON MICROB, V73, P7642, DOI 10.1128/AEM.01258-07; Hirayama H, 2014, INT J SYST EVOL MICR, V64, P989, DOI 10.1099/ijs.0.058172-0; Hirayama H, 2013, INT J SYST EVOL MICR, V63, P1073, DOI 10.1099/ijs.0.040568-0; Hofle ST, 2015, ORG GEOCHEM, V88, P1, DOI 10.1016/j.orggeochem.2015.08.002; Hovland M, 2005, MAR GEOL, V218, P191, DOI 10.1016/j.margeo.2005.04.005; Inglis GN, 2015, PALAEOGEOGR PALAEOCL, V438, P245, DOI 10.1016/j.palaeo.2015.08.001; Islam T, 2008, P NATL ACAD SCI USA, V105, P300, DOI 10.1073/pnas.0704162105; Jahnke LL, 1999, GEOCHIM COSMOCHIM AC, V63, P79, DOI 10.1016/S0016-7037(98)00270-1; JAHNKE LL, 1995, APPL ENVIRON MICROB, V61, P576, DOI 10.1128/AEM.61.2.576-582.1995; Jensen S, 2008, FEMS MICROBIOL ECOL, V66, P320, DOI 10.1111/j.1574-6941.2008.00575.x; Joyeux C, 2004, FEMS MICROBIOL ECOL, V47, P371, DOI 10.1016/S0168-6496(03)00302-7; Kalyuzhnaya MG, 2008, INT J SYST EVOL MICR, V58, P591, DOI 10.1099/ijs.0.65317-0; Kellermann MY, 2012, ORG GEOCHEM, V43, P112, DOI 10.1016/j.orggeochem.2011.10.005; Kessler JD, 2011, SCIENCE, V331, P312, DOI 10.1126/science.1199697; Kharbush JJ, 2013, APPL ENVIRON MICROB, V79, P7491, DOI 10.1128/AEM.02367-13; Kim JH, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003364; Lelieveld J, 1998, TELLUS B, V50, P128, DOI 10.1034/j.1600-0889.1998.t01-1-00002.x; LIDSTROM ME, 1988, A VAN LEEUW J MICROB, V54, P189, DOI 10.1007/BF00443577; Losekann T, 2007, APPL ENVIRON MICROB, V73, P3348, DOI 10.1128/AEM.00016-07; Mastalerz V, 2009, GEOCHIM COSMOCHIM AC, V73, P3849, DOI 10.1016/j.gca.2008.12.030; McDonald IR, 2005, FEMS MICROBIOL LETT, V250, P287, DOI 10.1016/j.femsle.2005.07.016; McInerney FA, 2011, ANNU REV EARTH PL SC, V39, P489, DOI 10.1146/annurev-earth-040610-133431; Mondamert L, 2011, BIOFOULING, V27, P21, DOI 10.1080/08927014.2010.536614; Moussard H, 2009, ENV MICROBIOL REP, V1, P424, DOI 10.1111/j.1758-2229.2009.00063.x; NEUNLIST S, 1985, BIOCHEM J, V231, P635, DOI 10.1042/bj2310635; Nickel JC, 2012, MAR GEOL, V332, P152, DOI 10.1016/j.margeo.2012.02.002; Niemann H, 2006, NATURE, V443, P854, DOI 10.1038/nature05227; Osborne KA, 2015, THESIS; OURISSON G, 1992, ACCOUNTS CHEM RES, V25, P398, DOI 10.1021/ar00021a003; Pancost RD, 2000, GEOLOGY, V28, P663, DOI 10.1130/0091-7613(2000)28<663:CVARDO>2.0.CO;2; Pancost RD, 2005, PALAEOGEOGR PALAEOCL, V227, P48, DOI 10.1016/j.palaeo.2005.04.035; Pancost RD, 2000, APPL ENVIRON MICROB, V66, P1126, DOI 10.1128/AEM.66.3.1126-1132.2000; Paulmier A, 2009, PROG OCEANOGR, V80, P113, DOI 10.1016/j.pocean.2008.08.001; Pol A, 2007, NATURE, V450, P874, DOI 10.1038/nature06222; Redmond MC, 2010, APPL ENVIRON MICROB, V76, P6412, DOI 10.1128/AEM.00271-10; Redshaw CH, 2008, J SOIL SEDIMENT, V8, P217, DOI 10.1007/s11368-008-0024-2; Rethemeyer J, 2010, ORG GEOCHEM, V41, P1130, DOI 10.1016/j.orggeochem.2010.06.004; Ricci JN, 2014, ISME J, V8, P675, DOI 10.1038/ismej.2013.191; ROHMER M, 1984, J GEN MICROBIOL, V130, P1137; Ruff SE, 2015, P NATL ACAD SCI USA, V112, P4015, DOI 10.1073/pnas.1421865112; Ruff SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072627; Rush D, 2014, GEOCHIM COSMOCHIM AC, V140, P50, DOI 10.1016/j.gca.2014.05.014; Saenz JP, 2011, ORG GEOCHEM, V42, P1351, DOI 10.1016/j.orggeochem.2011.08.016; Saenz JP, 2011, ORG GEOCHEM, V42, P774, DOI 10.1016/j.orggeochem.2011.05.006; Sassen R, 2004, CHEM GEOL, V205, P195, DOI 10.1016/j.chemgeo.2003.12.032; Sauter LM, 2012, SYST APPL MICROBIOL, V35, P198, DOI 10.1016/j.syapm.2011.10.006; Schaeffer P, 2008, ORG GEOCHEM, V39, P1479, DOI 10.1016/j.orggeochem.2008.07.007; Selver AD, 2015, ORG GEOCHEM, V83-84, P16, DOI 10.1016/j.orggeochem.2015.01.005; Selver AD, 2012, ORG GEOCHEM, V51, P63, DOI 10.1016/j.orggeochem.2012.08.002; Sharp CE, 2014, ENVIRON MICROBIOL, V16, P1867, DOI 10.1111/1462-2920.12454; SIEBURTH JM, 1987, CURR MICROBIOL, V14, P285, DOI 10.1007/BF01568138; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Spencer-Jones CL, 2015, ORG GEOCHEM, V89-90, P1, DOI 10.1016/j.orggeochem.2015.09.003; Spencer-Jones CL, 2016, THESIS; SUMMONS RE, 1994, GEOCHIM COSMOCHIM AC, V58, P2853, DOI 10.1016/0016-7037(94)90119-8; Talbot HM, 2008, ORG GEOCHEM, V39, P232, DOI 10.1016/j.orggeochem.2007.08.006; Talbot HM, 2007, ORG GEOCHEM, V38, P1212, DOI 10.1016/j.orggeochem.2007.04.006; Talbot HM, 2007, RAPID COMMUN MASS SP, V21, P880, DOI 10.1002/rcm.2911; Talbot HM, 2016, ORG GEOCHEM, V97, P95, DOI 10.1016/j.orggeochem.2016.04.011; Talbot HM, 2016, ORG GEOCHEM, V96, P77, DOI 10.1016/j.orggeochem.2016.03.006; Talbot HM, 2014, GEOCHIM COSMOCHIM AC, V133, P387, DOI 10.1016/j.gca.2014.02.035; Talbot HM, 2003, ORG GEOCHEM, V34, P1353, DOI 10.1016/S0146-6380(03)00159-1; Talbot HM, 2001, J CHROMATOGR A, V921, P175, DOI 10.1016/S0021-9673(01)00871-8; Tavormina PL, 2008, APPL ENVIRON MICROB, V74, P3985, DOI 10.1128/AEM.00069-08; Taylor KA, 2011, ORG GEOCHEM, V42, P487, DOI 10.1016/j.orggeochem.2011.03.012; Thiel V, 2001, MAR CHEM, V73, P97, DOI 10.1016/S0304-4203(00)00099-2; van Teeseling MCF, 2014, APPL ENVIRON MICROB, V80, P6782, DOI 10.1128/AEM.01838-14; van Winden JF, 2012, ORG GEOCHEM, V53, P73, DOI 10.1016/j.orggeochem.2012.07.001; van Winden JF, 2012, GEOCHIM COSMOCHIM AC, V77, P52, DOI 10.1016/j.gca.2011.10.026; van Winden JF, 2010, ORG GEOCHEM, V41, P1040, DOI 10.1016/j.orggeochem.2010.04.015; Wagner T, 2014, ORG GEOCHEM, V67, P85, DOI 10.1016/j.orggeochem.2013.12.003; Wakeham SG, 2007, ORG GEOCHEM, V38, P2070, DOI 10.1016/j.orggeochem.2007.08.003; Wakeham SG, 2012, DEEP-SEA RES PT I, V63, P133, DOI 10.1016/j.dsr.2012.01.005; Wasmund K, 2009, FEMS MICROBIOL ECOL, V68, P142, DOI 10.1111/j.1574-6941.2009.00667.x; Watson DF, 2002, THESIS; Welander PV, 2012, P NATL ACAD SCI USA, V109, P12905, DOI 10.1073/pnas.1208255109; Wild Christian, 2015, Galaxea - Tokyo, V17, P13; Xu YP, 2009, ORG GEOCHEM, V40, P79, DOI 10.1016/j.orggeochem.2008.09.003; Yan TF, 2006, FEMS MICROBIOL ECOL, V57, P251, DOI 10.1111/j.1574-6941.2006.00122.x; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004; Zhang CL, 2007, GEOMICROBIOL J, V24, P519, DOI 10.1080/01490450701572515; Zhu C, 2011, LIMNOL OCEANOGR, V56, P1850, DOI 10.4319/lo.2011.56.5.1850; Zhu C, 2010, ORG GEOCHEM, V41, P1056, DOI 10.1016/j.orggeochem.2010.03.015; Zink KG, 2004, ANAL BIOANAL CHEM, V380, P798, DOI 10.1007/s00216-004-2828-2; ZUNDEL M, 1985, EUR J BIOCHEM, V150, P23, DOI 10.1111/j.1432-1033.1985.tb08980.x	134	25	27	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165635	10.1371/journal.pone.0165635	http://dx.doi.org/10.1371/journal.pone.0165635			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824887	Green Published, gold			2022-12-26	WOS:000387615200024
J	Rigo-Adrover, MD; Franch, A; Castell, M; Perez-Cano, FJ				del Mar Rigo-Adrover, Maria; Franch, Angels; Castell, Margarida; Jose Perez-Cano, Francisco			Preclinical Immunomodulation by the Probiotic Bifidobacterium breve M-16V in Early Life	PLOS ONE			English	Article							IMMUNE-SYSTEM; ALLERGIC SYMPTOMS; SMALL-INTESTINE; T-LYMPHOCYTES; SYNBIOTICS; ADHESION; MODEL; OLIGOSACCHARIDES; INTERVENTION; MODULATION	This study aimed to investigate the effect of supplementation with the probiotic Bifidobacterium breve M-16V on the maturation of the intestinal and circulating immune system during suckling. In order to achieve this purpose, neonatal Lewis rats were supplemented with the probiotic strain from the 6th to the 18th day of life. The animals were weighed during the study, and faecal samples were obtained and evaluated daily. On day 19, rats were euthanized and intestinal wash samples, mesenteric lymph node (MLN) cells, splenocytes and intraepithelial lymphocytes (IEL) were obtained. The probiotic supplementation in early life did not modify the growth curve and did not enhance the systemic immune maturation. However, it increased the proportion of cells bearing TLR4 in the MLN and IEL, and enhanced the percentage of the integrin alpha E beta 7+ and CD62L+ cells in the MLN and that of the integrin alpha E beta 7+ cells in the IEL, suggesting an enhancement of the homing process of naive T lymphocytes to the MLN, and the retention of activated lymphocytes in the intraepithelial compartment. Interestingly, B. breve M-16V enhanced the intestinal IgA synthesis. In conclusion, supplementation with the probiotic strain B. breve M-16V during suckling improves the development of mucosal immunity in early life.	[del Mar Rigo-Adrover, Maria; Franch, Angels; Castell, Margarida; Jose Perez-Cano, Francisco] Univ Barcelona, Dept Bioquim & Fisiol, Fac Farm & Ciencies Alimentacio, Barcelona, Spain; [del Mar Rigo-Adrover, Maria; Franch, Angels; Castell, Margarida; Jose Perez-Cano, Francisco] Inst Recerca Nutr & Seguretat Alimentaria INSA, Barcelona, Spain	University of Barcelona; University of Barcelona	Perez-Cano, FJ (corresponding author), Univ Barcelona, Dept Bioquim & Fisiol, Fac Farm & Ciencies Alimentacio, Barcelona, Spain.; Perez-Cano, FJ (corresponding author), Inst Recerca Nutr & Seguretat Alimentaria INSA, Barcelona, Spain.	franoiscoperez@ub.edu	Franch, Àngels/G-5669-2019; Castell, Margarida/G-9078-2015; Perez-Cano, Francisco J/G-6516-2019	Franch, Àngels/0000-0002-2362-1374; Castell, Margarida/0000-0001-5408-0593; Perez-Cano, Francisco J/0000-0001-6243-9164				Agace W, 2010, IMMUNOL LETT, V128, P21, DOI 10.1016/j.imlet.2009.09.012; Agace WW, 2008, TRENDS IMMUNOL, V29, P514, DOI 10.1016/j.it.2008.08.003; Amit-Romach E, 2010, MOL NUTR FOOD RES, V54, P277, DOI 10.1002/mnfr.200800591; Aureli P, 2011, PHARMACOL RES, V63, P366, DOI 10.1016/j.phrs.2011.02.006; Bermudez-Brito M, 2012, ANN NUTR METAB, V61, P160, DOI 10.1159/000342079; Bernardo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036262; Bertelsen RJ, 2016, BEST PRACT RES CL GA, V30, P39, DOI 10.1016/j.bpg.2016.01.001; Bodera P, 2009, RECENT PATENTS INFLA, V3, P58, DOI 10.2174/187221309787158461; Borruel N, 2002, GUT, V51, P659, DOI 10.1136/gut.51.5.659; Carasi P, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/361604; Carol M, 2006, J LEUKOCYTE BIOL, V79, P917, DOI 10.1189/jlb.0405188; Castillo NA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-177; Cauley LS, 2013, MUCOSAL IMMUNOL, V6, P14, DOI 10.1038/mi.2012.96; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Chu ZX, 2010, DIGEST DIS SCI, V55, P2505, DOI 10.1007/s10620-009-1063-2; de Kivit S, 2012, ALLERGY, V67, P343, DOI 10.1111/j.1398-9995.2011.02771.x; de Vrese M, 2008, ADV BIOCHEM ENG BIOT, V111, P1, DOI 10.1007/10_2008_097; Delcenserie V, 2008, CURR ISSUES MOL BIOL, V10, P37; Escribano E, 2014, ARCH DIS CHILD; FAO/WHO, 2006, PROB FOOD HLTH NUTR; Frei R, 2015, CURR OPIN GASTROEN, V31, P153, DOI 10.1097/MOG.0000000000000151; Fukushima Y, 1998, INT J FOOD MICROBIOL, V42, P39, DOI 10.1016/S0168-1605(98)00056-7; Galdeano CM, 2007, CLIN VACCINE IMMUNOL, V14, P485, DOI 10.1128/CVI.00406-06; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Guarner F, 2012, J CLIN GASTROENTEROL, V46, P468, DOI 10.1097/MCG.0b013e3182549092; Gueimonde M, 2006, J PEDIATR GASTR NUTR, V42, P604, DOI 10.1097/01.mpg.0000221897.45910.d3; Hashemi A, 2016, FOOD FUNCT, V7, P1752, DOI [10.1039/C5FO01148E, 10.1039/c5fo01148e]; Hong M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117451; Hougee S, 2010, INT ARCH ALLERGY IMM, V151, P107, DOI 10.1159/000236000; Hu GZ, 2016, EXP THER MED, V11, P33, DOI 10.3892/etm.2015.2854; Ivetic A, 2013, INT J BIOCHEM CELL B, V45, P550, DOI 10.1016/j.biocel.2012.12.023; Kaplan JL, 2011, PEDIATR RES, V69, P465, DOI 10.1203/PDR.0b013e318217638a; Kick AR, 2012, J ANIM SCI, V90, P649, DOI 10.2527/jas.2010-3470; Kilshaw PJ, 1999, J CLIN PATHOL-MOL PA, V52, P203, DOI 10.1136/mp.52.4.203; Knight SC, 2016, DIGEST DIS, V34, P51, DOI 10.1159/000442926; Kotzamanidis C, 2010, INT J FOOD MICROBIOL, V140, P154, DOI 10.1016/j.ijfoodmicro.2010.04.004; Liu YY, 2012, AM J PHYSIOL-GASTR L, V302, pG608, DOI 10.1152/ajpgi.00266.2011; Macfarlane GT, 2011, J CLIN GASTROENTEROL, V45, pS120, DOI 10.1097/MCG.0b013e31822fecfe; Majamaa H, 1997, J ALLERGY CLIN IMMUN, V99, P179, DOI 10.1016/S0091-6749(97)70093-9; Mann ER, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/573576; Marin-Gallen S, 2008, DEV COMP IMMUNOL, V32, P1405, DOI 10.1016/j.dci.2008.06.011; Martin R, 2010, BENEF MICROBES, V1, P367, DOI 10.3920/BM2010.0027; Park JH, 2002, CELL IMMUNOL, V219, P22, DOI 10.1016/S0008-8749(02)00579-8; Partty A, 2015, PEDIATR RES, V77, P823, DOI 10.1038/pr.2015.51; Perez-Cano FJ, 2005, PEDIATR RES, V58, P885, DOI 10.1203/01.pdr.0000182187.88505.49; Perez-Cano FJ, 2005, PEDIATR RES, V58, P164, DOI 10.1203/01.PDR.0000156367.60769.36; Perez-Cano FJ, 2007, DEV COMP IMMUNOL, V31, P1264, DOI 10.1016/j.dci.2007.03.004; Perez-Cano FJ, 2007, BRIT J NUTR, V98, pS80, DOI 10.1017/S0007114507838074; Perez-Cano FJ, 2007, PEDIATR RES, V62, P658, DOI 10.1203/PDR.0b013e318159a273; Perez-Cano FJ, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/537310; Perez-Cano FJ, 2010, IMMUNOBIOLOGY, V215, P996, DOI 10.1016/j.imbio.2010.01.004; Ramos-Romero S, 2012, BRIT J NUTR, V107, P378, DOI 10.1017/S0007114511003035; Rigo-Adrover M, 2017, EUR J NUTR, V56, P1657, DOI 10.1007/s00394-016-1213-1; Salvatore S, 2010, BIOACTIVE FOODS IN PROMOTING HEALTH: PROBIOTICS AND PREBIOTICS, P181, DOI 10.1016/B978-0-12-374938-3.00013-X; Serazin Andrew C, 2010, Nat Immunol, V11, P769, DOI 10.1038/ni0910-769; Smelt MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068952; van de Pol MA, 2011, ALLERGY, V66, P39, DOI 10.1111/j.1398-9995.2010.02454.x; Veereman-Wauters G, 2011, J PEDIATR GASTR NUTR, V52, P763, DOI 10.1097/MPG.0b013e3182139f39; Verheijden KAT, 2016, EUR J NUTR, V55, P1141, DOI 10.1007/s00394-015-0928-8; Westerbeek EAM, 2011, ACTA PAEDIATR, V100, P1426, DOI 10.1111/j.1651-2227.2011.02295.x; Yan F, 2011, CURR OPIN GASTROEN, V27, P496, DOI 10.1097/MOG.0b013e32834baa4d; Yang X, 2013, J HUAZHONG U SCI-MED, V33, P661, DOI 10.1007/s11596-013-1177-9	63	15	17	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166082	10.1371/journal.pone.0166082	http://dx.doi.org/10.1371/journal.pone.0166082			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820846	gold, Green Published, Green Submitted			2022-12-26	WOS:000387614800031
J	Moens, SJB; van Leuven, SI; Zheng, KH; Havik, SR; Versloot, MV; van Duivenvoorde, LM; Hahne, M; Stroes, ESG; Baeten, DL; Hamers, AAJ				Moens, Sophie J. Bernelot; van Leuven, Sander I.; Zheng, Kang H.; Havik, Stefan R.; Versloot, Miranda V.; van Duivenvoorde, Leonie M.; Hahne, Michael; Stroes, Erik S. G.; Baeten, Dominique L.; Hamers, Anouk A. J.			Impact of the B Cell Growth Factor APRIL on the Qualitative and Immunological Characteristics of Atherosclerotic Plaques	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; NATURAL ANTIBODIES; IMMUNOGLOBULIN-M; BAFF; MICE; IGM; MACROPHAGE; FAMILY; LIGAND	Studies on the role of B lymphocytes in atherosclerosis development, have yielded contradictory results. Whereas B lymphocyte-deficiency aggravates atherosclerosis in mice; depletion of mature B lymphocytes reduces atherosclerosis. These observations led to the notion that distinct B lymphocyte subsets have different roles. B1a lymphocytes exert an atheroprotective effect, which has been attributed to secretion of IgM, which can be deposited in atherosclerotic lesions thereby reducing necrotic core formation. Tumor necrosis factor (TNF)-family member 'A Proliferation-Inducing Ligand' (APRIL, also known as TNFSF13) was previously shown to increase serum IgM levels in a murine model. In this study, we investigated the effect of APRIL overexpression on advanced lesion formation and composition, IgM production and B cell phenotype. We crossed APRIL transgenic (APRIL-Tg) mice with ApoE knockout (ApoE(-/-)) mice. After a 12-week Western Type Diet, ApoE(-/-) APRIL-Tg mice and ApoE(-/-) littermates showed similar increases in body weight and lipid levels. Histologic evaluation showed no differences in lesion size, stage or necrotic area. However, smooth muscle cell (a-actin stain) content was increased in ApoE(-/-) APRIL-Tg mice, implying more stable lesions. In addition, increases in both plaque IgM deposition and plasma IgM levels were found in ApoE(-/-) APRIL-Tg mice compared with ApoE(-/-) mice. Flow cytometry revealed a concomitant increase in peritoneal B1a lymphocytes in ApoE(-/-) APRIL-Tg mice. This study shows that ApoE(-/-) APRIL-Tg mice have increased oxLDL-specific serum IgM levels, potentially mediated via an increase in B1a lymphocytes. Although no differences in lesion size were found, transgenic ApoE(-/-) APRIL-Tg mice do show potential plaque stabilizing features in advanced atherosclerotic lesions.	[Moens, Sophie J. Bernelot; Zheng, Kang H.; Stroes, Erik S. G.] Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [van Leuven, Sander I.; van Duivenvoorde, Leonie M.; Baeten, Dominique L.] Acad Med Ctr, Amsterdam Rheumatol & Immunol Ctr, Dept Clin Immunol & Rheumatol, Amsterdam, Netherlands; [Versloot, Miranda V.; Hamers, Anouk A. J.] Acad Med Ctr, Dept Expt Vasc Med, Amsterdam, Netherlands; [van Duivenvoorde, Leonie M.; Baeten, Dominique L.] Acad Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands; [Hahne, Michael] Univ Montpellier, CNRS, Inst Genet Mol Montpellier, Montpellier, France	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Moens, SJB (corresponding author), Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands.	s.j.bernelotmoens@amc.uva.nl	/AAF-6018-2020; van Leuven, Sander I/R-7844-2017	Bernelot Moens, Sophie/0000-0001-6915-521X; Zheng, Kang He/0000-0001-8954-1337; van Leuven, Sander/0000-0003-1432-069X	Netherlands Heart Foundation (Generating the best evidence-based pharmaceutical targets for atherosclerosis (GENIUS) [CVON 2011/ B019]; ReumaFonds [LLP-2] Funding Source: researchfish	Netherlands Heart Foundation (Generating the best evidence-based pharmaceutical targets for atherosclerosis (GENIUS); ReumaFonds	This research is supported by The Netherlands Heart Foundation (CVON 2011/ B019: Generating the best evidence-based pharmaceutical targets for atherosclerosis (GENIUS).	Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155; Binder CJ, 2005, J LIPID RES, V46, P1353, DOI 10.1194/jlr.R500005-JLR200; Cesena FHY, 2012, ATHEROSCLEROSIS, V220, P59, DOI 10.1016/j.atherosclerosis.2011.10.002; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; DAVIES MJ, 1993, BRIT HEART J, V69, P377; de Waard Vivian, 2012, Curr Protoc Mouse Biol, V2, P317, DOI 10.1002/9780470942390.mo120069; Fernandez L, 2013, ANN RHEUM DIS, V72, P1367, DOI 10.1136/annrheumdis-2012-202382; Gower RM, 2011, ARTERIOSCL THROM VAS, V31, P160, DOI 10.1161/ATVBAHA.110.215434; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Huan TX, 2013, ARTERIOSCL THROM VAS, V33, P1427, DOI 10.1161/ATVBAHA.112.300112; Karvonen J, 2003, CIRCULATION, V108, P2107, DOI 10.1161/01.CIR.0000092891.55157.A7; Kolodgie FD, 2001, CURR OPIN CARDIOL, V16, P285, DOI 10.1097/00001573-200109000-00006; Kyaw T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029371; Kyaw T, 2011, CIRC RES, V109, P830, DOI 10.1161/CIRCRESAHA.111.248542; Kyaw T, 2010, J IMMUNOL, V185, P4410, DOI 10.4049/jimmunol.1000033; Lewis MJ, 2009, CIRCULATION, V120, P417, DOI 10.1161/CIRCULATIONAHA.109.868158; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Major AS, 2002, ARTERIOSCL THROM VAS, V22, P1892, DOI 10.1161/01.ATV.0000039169.47943.EE; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; Perry HM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00373; Planelles L, 2004, CANCER CELL, V6, P399, DOI 10.1016/j.ccr.2004.08.033; Rincon-Arevalo H, 2016, ATHEROSCLEROSIS, V247, P118, DOI 10.1016/j.atherosclerosis.2015.12.022; Rong JX, 2001, CIRCULATION, V104, P2447, DOI 10.1161/hc4501.098952; Rosenfeld SM, 2015, CIRC RES, V117, pE28, DOI 10.1161/CIRCRESAHA.117.306044; Sage AP, 2012, ARTERIOSCL THROM VAS, V32, P1573, DOI 10.1161/ATVBAHA.111.244731; Sandberg WJ, 2009, THROMB HAEMOSTASIS, V102, P704, DOI 10.1160/TH08-10-0665; Schneider P, 2005, CURR OPIN IMMUNOL, V17, P282, DOI 10.1016/j.coi.2005.04.005; Stein JV, 2002, J CLIN INVEST, V109, P1587, DOI 10.1172/JCI200215034; Tsiantoulas D, 2014, CIRC RES, V114, P1743, DOI 10.1161/CIRCRESAHA.113.301145; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P2218, DOI 10.1016/j.jacc.2012.08.979; Turpeinen H, 2011, ATHEROSCLEROSIS, V219, P799, DOI 10.1016/j.atherosclerosis.2011.08.011	31	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0164690	10.1371/journal.pone.0164690	http://dx.doi.org/10.1371/journal.pone.0164690			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820817	Green Submitted, Green Published, gold			2022-12-26	WOS:000387614800002
J	Sadeghinejad, L; Cvitkovitch, DG; Siqueira, WL; Santerre, JP; Finer, Y				Sadeghinejad, Lida; Cvitkovitch, Dennis G.; Siqueira, Walter L.; Santerre, J. Paul; Finer, Yoav			Triethylene Glycol Up-Regulates Virulence-Associated Genes and Proteins in Streptococcus mutans	PLOS ONE			English	Article							TERMINAL HALF PART; BIOFILM FORMATION; DENTAL COMPOSITE; POSTERIOR RESTORATIONS; SALIVARY ESTERASE; SIGNALING SYSTEM; EXPRESSION; AMALGAM; BIODEGRADATION; LONGEVITY	Triethylene glycol dimethacrylate (TEGDMA) is a diluent monomer used pervasively in dental composite resins. Through hydrolytic degradation of the composites in the oral cavity it yields a hydrophilic biodegradation product, triethylene glycol (TEG), which has been shown to promote the growth of Streptococcus mutans, a dominant cariogenic bacterium. Previously it was shown that TEG up-regulated gtfB, an important gene contributing to polysaccharide synthesis function in biofilms. However, molecular mechanisms related to TEG's effect on bacterial function remained poorly understood. In the present study, S. mutans UA159 was incubated with clinically relevant concentrations of TEG at pH 5.5 and 7.0. Quantitative real-time PCR, proteomics analysis, and glucosyltransferase enzyme (GTF) activity measurements were employed to identify the bacterial phenotypic response to TEG. A S. mutans vicK isogenic mutant (SM Delta vicK1) and its associated complemented strain (SM Delta vicK1C), an important regulatory gene for biofilm-associated genes, were used to determine if this signaling pathway was involved in modulation of the S. mutans virulence-associated genes. Extracted proteins from S. mutans biofilms grown in the presence and absence of TEG were subjected to mass spectrometry for protein identification, characterization and quantification. TEG up-regulated gtfB/C, gbpB, comC, comD and comE more significantly in biofilms at cariogenic pH (5.5) and defined concentrations. Differential response of the vicK knock-out (SM Delta vicK1) and complemented strains (SM Delta vicK1C) implicated this signalling pathway in TEG-modulated cellular responses. TEG resulted in increased GTF enzyme activity, responsible for synthesizing insoluble glucans involved in the formation of cariogenic biofilms. As well, TEG increased protein abundance related to biofilm formation, carbohydrate transport, acid tolerance, and stress-response. Proteomics data was consistent with gene expression findings for the selected genes. These findings demonstrate a mechanistic pathway by which TEG derived from commercial resin materials in the oral cavity promote S. mutans pathogenicity, which is typically associated with secondary caries.	[Sadeghinejad, Lida; Cvitkovitch, Dennis G.; Santerre, J. Paul; Finer, Yoav] Univ Toronto, Dent Res Inst, Fac Dent, Toronto, ON, Canada; [Sadeghinejad, Lida; Cvitkovitch, Dennis G.; Santerre, J. Paul; Finer, Yoav] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Siqueira, Walter L.] Univ Western Ontario, Schulich Dent, London, ON, Canada; [Siqueira, Walter L.] Univ Western Ontario, Dept Biochem, London, ON, Canada	University of Toronto; University of Toronto; Western University (University of Western Ontario); Western University (University of Western Ontario)	Finer, Y (corresponding author), Univ Toronto, Dent Res Inst, Fac Dent, Toronto, ON, Canada.; Finer, Y (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	yoav.finer@dentistry.utoronto.ca	Siqueira, Walter/ABE-8924-2020; Siqueira, Walter/ABE-4069-2021; Cvitkovitch, Dennis/AAF-9311-2020	Siqueira, Walter/0000-0003-1921-3658; 	National Institute of Dental & Craniofacial Research [R01DE021385]; Canadian Institute of Health Research [MOP115113, 97577]; Canada Foundation for Innovation [25116]; CIHR [97577]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021385] Funding Source: NIH RePORTER	National Institute of Dental & Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institute of Dental & Craniofacial Research R01DE021385 (YF); Canadian Institute of Health Research MOP115113 (YF); Canadian Institute of Health Research grant #97577 (WLS); and Canada Foundation for Innovation grant #25116 (WLS).; The authors thank Dr. Shida Wang, Kirsten Krastel, Yizhi Xiao and Eduardo B. Moffa, for their technical assistance. This investigation was funded by National Institute of Dental & Craniofacial Research R01DE021385; Canadian Institute of Health Research MOP115113, CIHR grant # 97577 and Canada Foundation for Innovation grant # 25116. This is an independent study free of conflict of interest.	Abranches J, 2003, APPL ENVIRON MICROB, V69, P4760, DOI 10.1128/AEM.69.8.4760-4769.2003; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; [Anonymous], 2007, ADA SURV DENT SERV R; Ballantyne B, 2007, J APPL TOXICOL, V27, P291, DOI 10.1002/jat.1220; Beazoglou T, 2007, PUBLIC HEALTH REP, V122, P657, DOI 10.1177/003335490712200513; BENDER GR, 1986, INFECT IMMUN, V53, P331, DOI 10.1128/IAI.53.2.331-338.1986; Bernardo M, 2007, J AM DENT ASSOC, V138, P775, DOI 10.14219/jada.archive.2007.0265; BIGG E, 1945, AM J PUBLIC HEALTH, V35, P788; Bourbia M, 2013, J DENT RES, V92, P989, DOI 10.1177/0022034513504436; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Brooun A, 2000, ANTIMICROB AGENTS CH, V44, P640, DOI 10.1128/AAC.44.3.640-646.2000; Casal M, 2016, ADV EXP MED BIOL, V892, P229, DOI 10.1007/978-3-319-25304-6_9; Chattoraj P, 2010, J BACTERIOL, V192, P1312, DOI 10.1128/JB.01350-09; CHIRIFE J, 1983, ANTIMICROB AGENTS CH, V24, P409, DOI 10.1128/AAC.24.3.409; Chrysanthakopoulos Nikolaos Andreas, 2011, J Dent Res Dent Clin Dent Prospects, V5, P87; Cvitkovitch DG, 2003, J CLIN INVEST, V112, P1626, DOI 10.1172/JCI200320430; Duque C, 2011, INFECT IMMUN, V79, P786, DOI 10.1128/IAI.00725-10; Englemann J, 2001, J DENT RES, V80, P869, DOI 10.1177/00220345010800030501; Erbse A, 2004, BIOCHEM SOC T, V32, P617, DOI 10.1042/BST0320617; Falsetta ML, 2012, ANTIMICROB AGENTS CH, V56, P6201, DOI 10.1128/AAC.01381-12; Ferracane JL, 2011, DENT MATER, V27, P29, DOI 10.1016/j.dental.2010.10.020; FINCHER EL, 1962, APPL MICROBIOL, V10, P542, DOI 10.1128/AEM.10.6.542-547.1962; Finer Y, 2007, J BIOMED MATER RES A, V81A, P75, DOI 10.1002/jbm.a.31004; Finer Y, 2004, J BIOMED MATER RES A, V69A, P233, DOI 10.1002/jbm.a.30000; Finer Y, 2004, J DENT RES, V83, P22, DOI 10.1177/154405910408300105; Finer Y, 2003, J BIOMAT SCI-POLYM E, V14, P837, DOI 10.1163/156856203768366558; Fozo EA, 2004, APPL ENVIRON MICROB, V70, P929, DOI 10.1128/AEM.70.2.929-936.2004; Frost Peter M, 2002, Prim Dent Care, V9, P31, DOI 10.1308/135576102322547548; Fujita K, 2011, ARCH ORAL BIOL, V56, P258, DOI 10.1016/j.archoralbio.2010.09.018; Geurtsen W, 2001, J DENT RES, V80, P2046, DOI 10.1177/00220345010800120401; Gordan VV, 2012, J AM DENT ASSOC, V143, P593, DOI 10.14219/jada.archive.2012.0238; HAMBURGER M, 1945, J INFECT DIS, V77, P177, DOI 10.1093/infdis/77.3.177; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Inagaki S, 2009, ORAL MICROBIOL IMMUN, V24, P104, DOI 10.1111/j.1399-302X.2008.00480.x; Inagaki S, 2013, SCI WORLD J, DOI 10.1155/2013/405075; Jaffer F, 2002, BIOMATERIALS, V23, P1707, DOI 10.1016/S0142-9612(01)00298-8; JAYARAMAN GC, 1995, FEMS MICROBIOL LETT, V131, P255; Ji CH, 2014, J GEN PHYSIOL, V144, P257, DOI 10.1085/jgp.201411243; Kajfasz JK, 2009, J BACTERIOL, V191, P2060, DOI 10.1128/JB.01609-08; KAWAI F, 1978, APPL ENVIRON MICROB, V35, P679, DOI 10.1128/AEM.35.4.679-684.1978; Kawai F, 2002, APPL MICROBIOL BIOT, V58, P30, DOI 10.1007/s00253-001-0850-2; Kermanshahi S, 2010, J DENT RES, V89, P996, DOI 10.1177/0022034510372885; Khalichi P, 2004, BIOMATERIALS, V25, P5467, DOI 10.1016/j.biomaterials.2003.12.056; Khalichi P, 2009, BIOMATERIALS, V30, P452, DOI 10.1016/j.biomaterials.2008.09.053; Klein MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045795; Koo H, 2006, ANTIMICROB AGENTS CH, V50, P542, DOI 10.1128/AAC.50.2.542-546.2006; Koo H, 2003, J ANTIMICROB CHEMOTH, V52, P782, DOI 10.1093/jac/dkg449; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; Kopperud SE, 2012, EUR J ORAL SCI, V120, P539, DOI 10.1111/eos.12004; Lau PCY, 2002, J MICROBIOL METH, V49, P193, DOI 10.1016/S0167-7012(01)00369-4; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Lemos JAC, 2005, CURR ISSUES MOL BIOL, V7, P95; Lemos JA, 2007, J BACTERIOL, V189, P1582, DOI 10.1128/JB.01655-06; Len ACL, 2004, MICROBIOL-SGM, V150, P1339, DOI 10.1099/mic.0.27008-0; Len ACL, 2003, PROTEOMICS, V3, P627, DOI 10.1002/pmic.200300391; Len MCL, 2004, MICROBIOL-SGM, V150, P1353, DOI 10.1099/mic.0.26888-0; LESTER W, 1949, AM J HYG, V50, P175, DOI 10.1093/oxfordjournals.aje.a119352; Li YH, 2002, J BACTERIOL, V184, P6333, DOI 10.1128/JB.184.22.6333-6342.2002; Li YH, 2001, J BACTERIOL, V183, P897, DOI 10.1128/JB.183.3.897-908.2001; Li YH, 2002, J BACTERIOL, V184, P2699, DOI 10.1128/JB.184.10.2699-2708.2002; Li YH, 2012, SENSORS-BASEL, V12, P2519, DOI 10.3390/s120302519; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Loo CY, 2003, J BACTERIOL, V185, P6241, DOI 10.1128/JB.185.21.6241-6254.2003; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Mattos-Graner RO, 2006, J BACTERIOL, V188, P3813, DOI 10.1128/JB.01845-05; Moraschini V, 2015, J DENT, V43, P1043, DOI 10.1016/j.jdent.2015.06.005; MUNRO C, 1991, INFECT IMMUN, V59, P2316, DOI 10.1128/IAI.59.7.2316-2323.1991; Nedeljkovic I, 2015, DENT MATER, V31, pE247, DOI 10.1016/j.dental.2015.09.001; Opdam NJM, 2007, DENT MATER, V23, P2, DOI 10.1016/j.dental.2005.11.036; Palotie U, 2012, ACTA ODONTOL SCAND, V70, P485, DOI 10.3109/00016357.2011.640274; QUIVEY RG, 1995, FEMS MICROBIOL LETT, V126, P257, DOI 10.1016/0378-1097(95)00019-2; Rho YJ, 2013, OPER DENT, V38, P572, DOI 10.2341/12-432-C; ROBERTSON OH, 1948, J INFECT DIS, V83, P124, DOI 10.1093/infdis/83.2.124; ROBERTSON OH, 1951, AM J HYG, V53, P69, DOI 10.1093/oxfordjournals.aje.a119437; ROSEBURY T, 1947, J EXP MED, V85, P65, DOI 10.1084/jem.85.1.65; Roumanas Eleni D, 2010, J Evid Based Dent Pract, V10, P23, DOI 10.1016/j.jebdp.2009.11.009; Santerre JP, 2001, CRIT REV ORAL BIOL M, V12, P136, DOI 10.1177/10454411010120020401; SCHROEDER VA, 1989, INFECT IMMUN, V57, P3560, DOI 10.1128/IAI.57.11.3560-3569.1989; Sciotti MA, 1997, ADV EXP MED BIOL, V418, P699; Sciotti MA, 1997, FEMS MICROBIOL LETT, V153, P439, DOI 10.1016/S0378-1097(97)00287-5; Senadheera D, 2009, J BACTERIOL, V191, P6415, DOI 10.1128/JB.00793-09; Senadheera DB, 2012, J BACTERIOL, V194, P1307, DOI 10.1128/JB.06071-11; Senadheera MD, 2007, J BACTERIOL, V189, P1451, DOI 10.1128/JB.01161-06; Senadheera MD, 2005, J BACTERIOL, V187, P4064, DOI 10.1128/JB.187.12.4064-4076.2005; Shemesh M, 2007, MICROBIOL-SGM, V153, P1307, DOI 10.1099/mic.0.2006/002030-0; Shokati B, 2010, J BIOMED MATER RES B, V94B, P230, DOI 10.1002/jbm.b.31645; Simecek JW, 2009, J AM DENT ASSOC, V140, P200, DOI 10.14219/jada.archive.2009.0134; Siqueira WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042204; Smith AMV, 2007, CARIES RES, V41, P445, DOI 10.1159/000107930; Smith Daniel J, 2003, J Dent Educ, V67, P1130; Smith DJ, 1996, INFECT IMMUN, V64, P3069, DOI 10.1128/IAI.64.8.3069-3073.1996; Soncini JA, 2007, J AM DENT ASSOC, V138, P763, DOI 10.14219/jada.archive.2007.0264; Spencer P, 2014, J DENT RES, V93, P1243, DOI 10.1177/0022034514550039; Stipp RN, 2008, ORAL MICROBIOL IMMUN, V23, P466, DOI 10.1111/j.1399-302X.2008.00451.x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sunnegardh-Gronberg K, 2009, J DENT, V37, P673, DOI 10.1016/j.jdent.2009.04.010; Svensater G, 2001, FEMS MICROBIOL LETT, V205, P139, DOI 10.1111/j.1574-6968.2001.tb10937.x; Tamura H, 2014, GENES GENET SYST, V89, P41, DOI 10.1266/ggs.89.41; Terao Y, 2009, ORAL MICROBIOL IMMUN, V24, P211, DOI 10.1111/j.1399-302X.2008.00497.x; Van den Bogert B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083418; Wolman A, 1947, AM J PUBLIC HEALTH N, V37, P189; Xiao J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002623; YAMASHITA Y, 1993, INFECT IMMUN, V61, P3811, DOI 10.1128/IAI.61.9.3811-3817.1993	103	28	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165760	10.1371/journal.pone.0165760	http://dx.doi.org/10.1371/journal.pone.0165760			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820867	Green Published, Green Submitted, gold			2022-12-26	WOS:000387614800019
J	Tusch, ES; Alperin, BR; Holcomb, PJ; Daffner, KR				Tusch, Erich S.; Alperin, Brittany R.; Holcomb, Phillip J.; Daffner, Kirk R.			Increased Early Processing of Task-Irrelevant Auditory Stimuli in Older Adults	PLOS ONE			English	Article							AGE-RELATED-CHANGES; DOWN SUPPRESSION DEFICIT; WORKING-MEMORY LOAD; NEURAL ACTIVITY; SELECTIVE ATTENTION; INDIVIDUAL-DIFFERENCES; COGNITIVE CONTROL; ANTERIOR SHIFT; INVOLUNTARY ATTENTION; EXECUTIVE FUNCTIONS	The inhibitory deficit hypothesis of cognitive aging posits that older adults' inability to adequately suppress processing of irrelevant information is a major source of cognitive decline. Prior research has demonstrated that in response to task-irrelevant auditory stimuli there is an age-associated increase in the amplitude of the N1 wave, an ERP marker of early perceptual processing. Here, we tested predictions derived from the inhibitory deficit hypothesis that the age-related increase in N1 would be 1) observed under an auditory-ignore, but not auditory-attend condition, 2) attenuated in individuals with high executive capacity (EC), and 3) augmented by increasing cognitive load of the primary visual task. ERPs were measured in 114 well-matched young, middle-aged, young-old, and old-old adults, designated as having high or average EC based on neuropsychological testing. Under the auditory- ignore (visual-attend) task, participants ignored auditory stimuli and responded to rare target letters under low and high load. Under the auditory-attend task, participants ignored visual stimuli and responded to rare target tones. Results confirmed an age-associated increase in N1 amplitude to auditory stimuli under the auditory-ignore but not auditory-attend task. Contrary to predictions, EC did not modulate the N1 response. The load effect was the opposite of expectation: the N1 to task-irrelevant auditory events was smaller under high load. Finally, older adults did not simply fail to suppress the N1 to auditory stimuli in the task-irrelevant modality; they generated a larger response than to identical stimuli in the task-relevant modality. In summary, several of the study's findings do not fit the inhibitory- deficit hypothesis of cognitive aging, which may need to be refined or supplemented by alternative accounts.	[Tusch, Erich S.; Daffner, Kirk R.] Harvard Med Sch, Brigham & Womens Hosp, Ctr Brain Mind Med, Div Cognit & Behav Neurol,Dept Neurol, 221 Longwood Ave, Boston, MA 02115 USA; [Alperin, Brittany R.] Oregon Hlth & Sci Univ, Dept Psychol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Holcomb, Phillip J.] Tufts Univ, Dept Psychol, 490 Boston Ave, Medford, MA 02155 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Oregon Health & Science University; Tufts University	Daffner, KR (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Ctr Brain Mind Med, Div Cognit & Behav Neurol,Dept Neurol, 221 Longwood Ave, Boston, MA 02115 USA.	kdaffner@partners.org		Tusch, Erich/0000-0003-1434-101X	NIH / NIA grant [R01 AG017935]; Wimberly family; Muss family; Mortimer/Grubman family	NIH / NIA grant; Wimberly family; Muss family; Mortimer/Grubman family	This research was funded in part by NIH / NIA grant R01 AG017935 (https://www.nia.nih.gov/) and by generous support from the Wimberly family, the Muss family, and the Mortimer/Grubman family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Lisa Walker, MHA, for her guidance in conducting the audiological evaluations, Sarah Fackler, MA, for her excellent administrative assistance, and Sharon Sanz Simon, BA, for her valuable input. The authors would also like to thank the Wimberly family, the Muss family, and the Mortimer/Grubman family for their generous support of our Lab.	Alain C, 1999, PSYCHOL AGING, V14, P507, DOI 10.1037/0882-7974.14.3.507; Alain C, 2012, HEARING RES, V283, P126, DOI 10.1016/j.heares.2011.10.007; ALHO K, 1994, ELECTROEN CLIN NEURO, V91, P353, DOI 10.1016/0013-4694(94)00173-1; Alperin BR, 2014, NEUROSCI LETT, V577, P6, DOI 10.1016/j.neulet.2014.05.049; Alperin BR, 2014, PSYCHOPHYSIOLOGY, V51, P620, DOI 10.1111/psyp.12206; Alperin BR, 2013, J COGNITIVE NEUROSCI, V25, P2189, DOI 10.1162/jocn_a_00456; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andres P, 2006, NEUROPSYCHOLOGIA, V44, P2564, DOI 10.1016/j.neuropsychologia.2006.05.005; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Benoni H, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00522; Berti S, 2003, EUR J NEUROSCI, V17, P1119, DOI 10.1046/j.1460-9568.2003.02527.x; Berti S, 2013, BRAIN RES, V1491, P156, DOI 10.1016/j.brainres.2012.11.009; Bialystok E, 2004, PSYCHOL AGING, V19, P290, DOI 10.1037/0882-7974.19.2.290; Bidelman GM, 2014, NEUROBIOL AGING, V35, P2526, DOI 10.1016/j.neurobiolaging.2014.05.006; Budd TW, 1998, INT J PSYCHOPHYSIOL, V31, P51, DOI 10.1016/S0167-8760(98)00040-3; CARLSON MC, 1995, PSYCHOL AGING, V10, P427, DOI 10.1037/0882-7974.10.3.427; Castel AD, 2007, MEM COGNITION, V35, P689, DOI 10.3758/BF03193307; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chao LL, 1997, CEREB CORTEX, V7, P63, DOI 10.1093/cercor/7.1.63; Correa-Jaraba KS, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00129; Daffner K. R., 2014, DEMENTIA COMPREHENSI; Daffner KR, 2006, J COGNITIVE NEUROSCI, V18, P1759, DOI 10.1162/jocn.2006.18.10.1759; Daffner KR, 2015, BIOL PSYCHOL, V105, P83, DOI 10.1016/j.biopsycho.2015.01.002; Daffner KR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00167; Daffner KR, 2011, J COGNITIVE NEUROSCI, V23, P1298, DOI 10.1162/jocn.2010.21540; Daffner KR, 2011, NEUROIMAGE, V54, P427, DOI 10.1016/j.neuroimage.2010.08.006; Daselaar S. M., 2005, COGNITIVE NEUROSCIEN, P325; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; de Fockert Jan W, 2005, Sci Aging Knowledge Environ, V2005, ppe34, DOI 10.1126/sageke.2005.44.pe34; de Fockert JW, 2009, BRAIN RES, V1282, P67, DOI 10.1016/j.brainres.2009.05.060; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; Delis DC, 2001, DELIS KAPLAN EXECUTI; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DEMPSTER FN, 1992, DEV REV, V12, P45, DOI 10.1016/0273-2297(92)90003-K; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dien J, 2003, COGNITIVE BRAIN RES, V17, P637, DOI 10.1016/S0926-6410(03)00188-5; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Fabiani M, 2006, J COGNITIVE NEUROSCI, V18, P637, DOI 10.1162/jocn.2006.18.4.637; FABIANI M, 1995, PSYCHOPHYSIOLOGY, V32, P579, DOI 10.1111/j.1469-8986.1995.tb01234.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friedman D, 1998, PSYCHOPHYSIOLOGY, V35, P508, DOI 10.1017/S0048577298970664; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Gazzaley A., 2007, HUMAN FRONTAL LOBES, P187; Gazzaley A, 2008, P NATL ACAD SCI USA, V105, P13122, DOI 10.1073/pnas.0806074105; Getzmann S, 2013, NEUROBIOL AGING, V34, P1952, DOI 10.1016/j.neurobiolaging.2013.02.014; Grady CL, 2008, CEREB CORTEX, V18, P189, DOI 10.1093/cercor/bhm045; Grady CL, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00024; GRADY CL, 1994, J NEUROSCI, V14, P1450, DOI 10.1523/JNEUROSCI.14-03-01450.1994; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Guerreiro MJS, 2014, J COGNITIVE NEUROSCI, V26, P2827, DOI 10.1162/jocn_a_00685; Guerreiro MJS, 2010, PSYCHOL BULL, V136, P975, DOI 10.1037/a0020731; Haring AE, 2013, BRAIN RES, V1499, P69, DOI 10.1016/j.brainres.2013.01.003; Helfer KS, 2008, EAR HEARING, V29, P87, DOI 10.1097/AUD.0b013e31815d638b; Ivnik RJ, 1996, CLIN NEUROPSYCHOL, V10, P262, DOI 10.1080/13854049608406689; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Kappenman E. S., 2012, OXFORD HDB EVENT REL, P3, DOI DOI 10.1093/OXFORDHB/9780195374148.013.0014; Konstantinou N, 2014, ATTEN PERCEPT PSYCHO, V76, P1985, DOI 10.3758/s13414-014-0742-z; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Leung AWS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068892; Li KZH, 1998, PSYCHOL AGING, V13, P574, DOI 10.1037/0882-7974.13.4.574; LINDENBERGER U, 2014, SCI ENG ETHICS, V18, P7, DOI DOI 10.1016/J.TICS.2013.10.006; Lopez-Calderon J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00213; Lustig C., 2007, INHIBITION COGNITION, P145, DOI [DOI 10.1037/11587-008, 10.1037/11587-008]; Madden DJ, 2004, CEREB CORTEX, V14, P143, DOI 10.1093/cercor/bhg113; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Murphy G, 2016, PSYCHON B REV, V23, P1316, DOI 10.3758/s13423-015-0982-5; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Porto FHG, 2016, NEUROIMAGE, V130, P115, DOI 10.1016/j.neuroimage.2016.01.035; RABBITT P, 1965, J GERONTOL, V20, P233, DOI 10.1093/geronj/20.2.233; Reitan RM, 1985, HALSTEAD REITAN NEUR; Riis JL, 2008, NEUROIMAGE, V39, P441, DOI 10.1016/j.neuroimage.2007.08.034; Riis JL, 2009, BIOL PSYCHOL, V82, P33, DOI 10.1016/j.biopsycho.2009.05.003; Rissman J, 2009, NEUROPSYCHOLOGIA, V47, P1637, DOI 10.1016/j.neuropsychologia.2009.01.036; Ross B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010101; Ross B, 2009, NEUROIMAGE, V47, P678, DOI 10.1016/j.neuroimage.2009.04.051; Rugg MD, 2005, COGNITIVE NEUROSCIEN, P132; Rutman AM, 2010, J COGNITIVE NEUROSCI, V22, P1224, DOI 10.1162/jocn.2009.21257; Ryan J.J., 1992, CLIN NEUROPSYCHOL, V6, P53, DOI DOI 10.1080/; Sandhu R, 2016, EXP BRAIN RES, V234, P1279, DOI 10.1007/s00221-015-4517-0; Sawaki R, 2008, J VISION, V8, DOI 10.1167/8.15.4; Simon SS, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00380; Sommers MS, 1999, PSYCHOL AGING, V14, P458, DOI 10.1037/0882-7974.14.3.458; Sorqvist P, 2015, CURR DIR PSYCHOL SCI, V24, P267, DOI 10.1177/0963721415577356; Sorqvist P, 2014, PSYCH J, V3, P42, DOI 10.1002/pchj.47; Spreen O, 1998, EXECUTIVE FUNCTION A, P171; Townsend J, 2006, NEUROIMAGE, V31, P1682, DOI 10.1016/j.neuroimage.2006.01.045; Tun PA, 2002, PSYCHOL AGING, V17, P453, DOI 10.1037//0882-7974.17.3.453; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Wechsler D., 2012, WAIS 4 KASIKIRJA; West R, 1998, PSYCHOL AGING, V13, P206, DOI 10.1037/0882-7974.13.2.206; West R, 1999, MEM COGNITION, V27, P1064, DOI 10.3758/BF03201235; WOODS DL, 1986, ELECTROEN CLIN NEURO, V65, P297, DOI 10.1016/0168-5597(86)90008-0; Woods DL, 1995, EEG CL N SU, P102; Wurm LH, 2004, PSYCHOL AGING, V19, P523, DOI 10.1037/0882-7974.19.3.523; Yucel G, 2005, NEUROREPORT, V16, P1031, DOI 10.1097/00001756-200507130-00001	97	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165645	10.1371/journal.pone.0165645	http://dx.doi.org/10.1371/journal.pone.0165645			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6DJ	27806081	Green Published, gold, Green Submitted			2022-12-26	WOS:000386715500046
J	Wan, T; Han, QX; Xian, L; Cao, Y; Andrew, AA; Pan, XJ; Li, W; Liu, F				Wan, Tao; Han, Qingxiang; Xian, Ling; Cao, Yu; Andrew, Apudo A.; Pan, Xiaojie; Li, Wei; Liu, Fan			Reproductive Allocation in Three Macrophyte Species from Different Lakes with Variable Eutrophic Conditions	PLOS ONE			English	Article							AQUATIC PLANT; HISTORICAL BIOGEOGRAPHY; MYRIOPHYLLUM SPICATUM; SUBMERSED MACROPHYTES; GENERIC PHYLOGENY; CLONAL GROWTH; DISPERSAL; NITROGEN; WATER; PHOTOSYNTHESIS	Reproductive allocation is a key process in the plant life cycle and aquatic plants exhibit great diversity in their reproductive systems. In the present study, we conduct a field investigation of three aquatic macrophytes: Stuckenia pectinata, Myriophyllum spicatum, and Potamogeton perfoliatus. Our results showed that widespread species, including S. pectinata and M. spicatum had greater plasticity in their allocation patterns in the form of increased sexual and asexual reproduction, and greater potential to set seeds and increase fitness in more eutrophic environments. P. perfoliatus also exhibited a capacity to adopt varied sexual reproductive strategies such as setting more offspring for the future, although only in clear conditions with low nutrient levels. Our results establish strategies and mechanisms of some species for tolerating and surviving in varied eutrophic lake conditions.	[Wan, Tao] Fairy Lake Bot Garden, Key Lab Southern Subtrop Plant Divers, Shenzhen, Peoples R China; [Wan, Tao] Chinese Acad Sci, Shenzhen 518004, Peoples R China; [Wan, Tao; Andrew, Apudo A.; Liu, Fan] Chinese Acad Sci, Sino Africa Joint Res Ctr, Wuhan 430074, Peoples R China; [Xian, Ling; Cao, Yu; Andrew, Apudo A.; Li, Wei; Liu, Fan] Chinese Acad Sci, Key Lab Aquat Bot & Watershed Ecol, Wuhan 430074, Peoples R China; [Han, Qingxiang] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto 6068501, Japan; [Pan, Xiaojie] MWR&CAS, Key Lab Ecol Impacts Hydraul Projects & Restorat, Minist Water Resources, Inst Hydroecol, Wuhan 430074, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; Kyoto University; Chinese Academy of Sciences; Ministry of Water Resources	Liu, F (corresponding author), Chinese Acad Sci, Sino Africa Joint Res Ctr, Wuhan 430074, Peoples R China.; Liu, F (corresponding author), Chinese Acad Sci, Key Lab Aquat Bot & Watershed Ecol, Wuhan 430074, Peoples R China.	fanliu@wbgcas.cn			National Natural Science Foundation of China [31370262, 31670369, 31200270]; Project of Sino-Africa Joint Research Center [CAS SAJC201326, CAS SAJC201304]; Strategic Pilot Science and Technology Projects of the Chinese Academy of Sciences [XDAO5090305]; Open fundation of CAS Key Laboratory of Aquatic Botany and Watershed Ecology [Y452711s03]; Three Gorges Follow-up Research Project [2013HXKY2-3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Sino-Africa Joint Research Center; Strategic Pilot Science and Technology Projects of the Chinese Academy of Sciences; Open fundation of CAS Key Laboratory of Aquatic Botany and Watershed Ecology; Three Gorges Follow-up Research Project	The work was supported by the following: FL National Natural Science Foundation of China 31370262, http://www.nsfc.gov.cn; FL National Natural Science Foundation of China 31670369, http://www.nsfc.gov.cn; YC National Natural Science Foundation of China 31200270, http://www.nsfc.gov.cn; FL Project of Sino-Africa Joint Research Center, CAS SAJC201326, http://www.wbgcas.cn; TW Project of Sino-Africa Joint Research Center, CAS SAJC201304, http://www.wbgcas.cn; FL The Strategic Pilot Science and Technology Projects of the Chinese Academy of Sciences XDAO5090305, http://www.cas.cn/; TW Open fundation of CAS Key Laboratory of Aquatic Botany and Watershed Ecology Y452711s03, http://www.wbgcas.cn; XP The Three Gorges Follow-up Research Project, 2013HXKY2-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apudo AA, 2016, ENVIRON EXP BOT, V130, P79, DOI 10.1016/j.envexpbot.2016.05.009; BARRETT SCH, 1993, AQUAT BOT, V44, P105, DOI 10.1016/0304-3770(93)90068-8; Best E. P. H., 1988, HDB VEGETATION SCI, V15-1, P155; Cao T, 2007, MAR FRESHWATER RES, V58, P581, DOI 10.1071/MF06090; Cao T, 2011, FRESHWATER BIOL, V56, P1620, DOI 10.1111/j.1365-2427.2011.02601.x; Chen LY, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-30; Chen LY, 2012, MOL PHYLOGENET EVOL, V63, P407, DOI 10.1016/j.ympev.2012.01.016; CNEMC, 2001, EV CLASS EUTR LAK; Cook C.D.K., 1990, AQUATIC PLANT BOOK; DENDENE MA, 1993, AQUAT BOT, V46, P301, DOI 10.1016/0304-3770(93)90010-T; Eckert CG, 2001, EVOL ECOL, V15, P501, DOI 10.1023/A:1016005519651; Eriksson O, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P211; Grant V., 1981, PLANT SPECIATION; Gusewell S, 2002, PERSPECT PLANT ECOL, V5, P37, DOI 10.1078/1433-8319-0000022; Havens KE, 2004, AQUAT BOT, V78, P67, DOI 10.1016/j.aquabot.2003.09.005; HOUSSARD C, 1991, OECOLOGIA, V86, P236, DOI 10.1007/BF00317536; Ikegami M, 2008, ECOL MODEL, V213, P156, DOI 10.1016/j.ecolmodel.2007.11.016; Jeppesen E., 1998, STRUCTURING ROLE SUB; Karlsson P. Staffan, 2005, P1, DOI 10.1016/B978-012088386-8/50001-6; Les DH, 2003, INT J PLANT SCI, V164, P917, DOI 10.1086/378650; Li W, 2014, AQUAT BOT, V118, P62, DOI 10.1016/j.aquabot.2014.07.008; Liu F, 2013, J PLANT ECOL, V6, P499, DOI 10.1093/jpe/rtt021; Liu F, 2013, J SYST EVOL, V51, P461, DOI 10.1111/j.1759-6831.2012.00242.x; Maberly SC, 2014, AQUAT BOT, V118, P4, DOI 10.1016/j.aquabot.2014.06.014; Maurer DA, 2002, OECOLOGIA, V131, P279, DOI 10.1007/s00442-002-0886-8; Nimptsch J, 2007, CHEMOSPHERE, V66, P708, DOI 10.1016/j.chemosphere.2006.07.064; Philbrick CT, 1996, BIOSCIENCE, V46, P813, DOI 10.2307/1312967; Reekie EG, 2005, REPROD ALLOCATION PL; Riis T, 2009, AQUAT BOT, V90, P209, DOI 10.1016/j.aquabot.2008.08.005; Roff Derek A., 1992; Rolland T, 1995, ACTA BOT GALLICA, V142, P733, DOI 10.1080/12538078.1995.10515297; Santamaria L, 2002, ACTA OECOL, V23, P137, DOI 10.1016/S1146-609X(02)01146-3; Scheffer M., 1998, ECOLOGY SHALLOW LAKE; Strand JA, 2001, J ECOL, V89, P166, DOI 10.1046/j.1365-2745.2001.00530.x; Sun XZ, 1992, FLORA REIPUBLICAE PO, P40; Thompson FL, 2004, J EVOLUTION BIOL, V17, P581, DOI 10.1111/j.1420-9101.2004.00701.x; Vari A, 2013, FUND APPL LIMNOL, V183, P15, DOI 10.1127/1863-9135/2013/0328; Xiao KY, 2007, HYDROBIOLOGIA, V589, P265, DOI 10.1007/s10750-007-0740-4; Yu Q, 2015, WATER RES, V83, P385, DOI 10.1016/j.watres.2015.06.053; Zhang L, 2013, ECOL ENG, V58, P91, DOI 10.1016/j.ecoleng.2013.06.006	40	2	2	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165234	10.1371/journal.pone.0165234	http://dx.doi.org/10.1371/journal.pone.0165234			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806122	Green Published, gold, Green Submitted			2022-12-26	WOS:000386715500023
J	Gong, YX; Zhang, Y; Feng, SL; Liu, XF; Lu, SQ; Long, M				Gong, Yixin; Zhang, Yan; Feng, Shiliang; Liu, Xiaofeng; Lu, Shouqin; Long, Mian			Dynamic contributions of P- and E-selectins to beta(2)-integrin-induced neutrophil transmigration	FASEB JOURNAL			English	Article						PSGL-1; CD44; synergic mechanisms	CELL-ADHESION; CONFORMATIONAL-CHANGES; GLYCOPROTEIN LIGAND-1; CYTOSKELETAL REGULATION; 2-DIMENSIONAL KINETICS; VASCULAR ENDOTHELIUM; LEUKOCYTE ADHESION; CYTOPLASMIC DOMAIN; CATCH BONDS; ICAM-1	Leukocyte transendothelial migrationis a key step in their recruitment to sites of inflammation. However, synergic regulation of endothelium-expressed selectins on leukocyte transmigration remains unclear. In this study, an in vitro model was developed to investigate the dynamic contributions of P- and E-selectin to polymorphonuclear neutrophil (PMN) transmigration under static conditions. Human umbilical vein endothelial cells (HUVECs) were treated with LPS for 4 or 12 h to induce different expression of selectins and intercellular adhesion molecule (ICAM)-1. PMN transmigration was increased significantly by LPS stimulation, which was higher on 4-h than on 12-h LPS treated HUVECs. Blocking and competitive tests indicated that P-selectin engages PSGL-1 to activate beta(2)-integrin and initiate PMN transmigration within the first 15 min, whereas E-selectin engages CD44 to influence PMN transmigration after 15 min. P-and E-selectin-induced beta(2)-integrin activation is likely conducted through the spleen tyrosine kinase signaling pathway. Complicated complementary and competitive mechanisms are involved in the interaction of P-/E-selectins and their ligands to promote PMN transmigration. These results provide direct evidence of the distinct and dynamic contribution of P- and E-selectins inmediating PMN transmigration and give new insight into PMN interaction with the vessel wall.-Gong, Y., Zhang, Y., Feng, S., Liu, X., Lu, S., Long, M. Dynamic contributions of P-and E-selectins to beta(2)-integrin-induced neutrophil transmigration.	[Gong, Yixin; Zhang, Yan; Feng, Shiliang; Liu, Xiaofeng; Lu, Shouqin; Long, Mian] Chinese Acad Sci, Ctr Biomech & Bioengn, 15 North 4th Ring Rd, Beijing 100190, Peoples R China; [Gong, Yixin; Zhang, Yan; Feng, Shiliang; Liu, Xiaofeng; Lu, Shouqin; Long, Mian] Chinese Acad Sci, Key Lab Micrograv, Natl Micrograv Lab, Beijing, Peoples R China; [Gong, Yixin; Zhang, Yan; Feng, Shiliang; Liu, Xiaofeng; Lu, Shouqin; Long, Mian] Chinese Acad Sci, Inst Mech, Beijing Key Lab Engn Construct & Mechanobiol, Beijing, Peoples R China; [Zhang, Yan; Lu, Shouqin; Long, Mian] Univ Chinese Acad Sci, Sch Engn Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Long, M (corresponding author), Chinese Acad Sci, Ctr Biomech & Bioengn, 15 North 4th Ring Rd, Beijing 100190, Peoples R China.; Long, M (corresponding author), Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Natl Micrograv Lab, 15 North 4th Ring Rd, Beijing 100190, Peoples R China.	mlong@imech.ac.cn		gong, yixin/0000-0001-7681-9619	National Natural Science Foundation of China [31230027, 91539119, 31270994]; National Key Basic Research Foundation of China [2011CB710904]; Strategic Priority Research Program Grant [XDA01030102]; National High Technology Research and Development Program of China [2011AA020109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Foundation of China(National Basic Research Program of China); Strategic Priority Research Program Grant; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China Grants 31230027, 91539119 and 31270994; National Key Basic Research Foundation of China Grant 2011CB710904; Strategic Priority Research Program Grant XDA01030102; and National High Technology Research and Development Program of China Grant 2011AA020109. The authors declare no conflicts of interest.	Adamson P, 1999, J IMMUNOL, V162, P2964; Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; Alon R, 2003, MICROCIRCULATION, V10, P297, DOI 10.1038/sj.mn.7800195; Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; BEVILACQUA MP, 1994, ANNU REV MED, V45, P361, DOI 10.1146/annurev.med.45.1.361; Borau C, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/6/066008; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; Chatterjee A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/579830; Dokukina IV, 2010, BIOPHYS J, V98, P2794, DOI 10.1016/j.bpj.2010.03.026; Elosegui-Artola A, 2014, NAT MATER, V13, P631, DOI [10.1038/NMAT3960, 10.1038/nmat3960]; Eutamene H, 2005, EUR RESPIR J, V25, P789, DOI 10.1183/09031936.05.00064704; Feng D, 2004, J HISTOCHEM CYTOCHEM, V52, P87, DOI 10.1177/002215540405200109; Ghibaudo M, 2008, SOFT MATTER, V4, P1836, DOI 10.1039/b804103b; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KAPLANSKI G, 1994, J CELL SCI, V107, P2449; Katayama Y, 2005, J EXP MED, V201, P1183, DOI 10.1084/jem.20042014; Kelly M, 2007, J ALLERGY CLIN IMMUN, V120, P3, DOI 10.1016/j.jaci.2007.05.017; Kong D, 2010, J BIOMECH, V43, P2524, DOI 10.1016/j.jbiomech.2010.05.019; Laszik Z, 1996, BLOOD, V88, P3010, DOI 10.1182/blood.V88.8.3010.bloodjournal8883010; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Li N, 2013, J IMMUNOL, V190, P4371, DOI 10.4049/jimmunol.1201374; Lorenzon P, 1998, J CELL BIOL, V142, P1381, DOI 10.1083/jcb.142.5.1381; Lou O, 2007, J IMMUNOL, V178, P1136, DOI 10.4049/jimmunol.178.2.1136; Ma YQ, 2004, BLOOD, V104, P2549, DOI 10.1182/blood-2004-03-1108; Mao DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024188; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; MCEVER RP, 1994, CURR OPIN IMMUNOL, V6, P75, DOI 10.1016/0952-7915(94)90037-X; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; Milstone DS, 1998, MICROCIRCULATION-LON, V5, P153, DOI 10.1080/713773857; Miner JJ, 2008, BLOOD, V112, P2035, DOI 10.1182/blood-2008-04-149468; MULLER WA, 1995, J LEUKOCYTE BIOL, V57, P523, DOI 10.1002/jlb.57.4.523; Nacher M, 2011, AM J PATHOL, V178, P2437, DOI 10.1016/j.ajpath.2011.01.039; NORMAN KE, 1995, BLOOD, V86, P4417, DOI 10.1182/blood.V86.12.4417.bloodjournal86124417; O'Brien CD, 2003, BLOOD, V101, P2816, DOI 10.1182/blood-2002-08-2396; Ohno N, 1997, INFLAMMATION, V21, P313, DOI 10.1023/A:1027349900279; Roca-Cusachs P, 2012, J CELL SCI, V125, P3025, DOI 10.1242/jcs.095794; Roldan V, 2003, THROMB HAEMOSTASIS, V90, P1007, DOI 10.1160/TH02-09-0083; Sans E, 2001, J IMMUNOL, V166, P544, DOI 10.4049/jimmunol.166.1.544; Schwarz US, 2006, BIOSYSTEMS, V83, P225, DOI 10.1016/j.biosystems.2005.05.019; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; SIMON SI, 1995, J IMMUNOL, V155, P1502; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Wang HB, 2007, NAT IMMUNOL, V8, P882, DOI 10.1038/ni1491; Wang Y, 2014, J BIOL CHEM, V289, P35159, DOI 10.1074/jbc.M114.600767; Williams M, 2003, CRIT CARE MED, V31, pA45; Wittchen ES, 2009, FRONT BIOSCI-LANDMRK, V14, P2522, DOI 10.2741/3395; Wu L, 2007, J BIOL CHEM, V282, P9846, DOI 10.1074/jbc.M609219200; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; Yago T, 2010, P NATL ACAD SCI USA, V107, P9204, DOI 10.1073/pnas.1003110107; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Yoshida M, 1996, J CELL BIOL, V133, P445, DOI 10.1083/jcb.133.2.445; Zarbock A, 2008, J EXP MED, V205, P2339, DOI 10.1084/jem.20072660; Zarbock A, 2012, J MOL MED, V90, P353, DOI 10.1007/s00109-011-0835-2; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566; Zhang F, 2005, J BIOL CHEM, V280, P42207, DOI 10.1074/jbc.M510407200; Zhong Y, 2014, EUR PHYS J-SPEC TOP, V223, P1373, DOI 10.1140/epjst/e2014-02196-8; Zhu C, 2005, BIORHEOLOGY, V42, P443	58	18	18	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					212	+		10.1096/fj.201600398RRR	http://dx.doi.org/10.1096/fj.201600398RRR			24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27825101	Green Submitted			2022-12-26	WOS:000392177600022
J	Park, JK; Peng, H; Yang, WD; Katsnelson, J; Volpert, O; Lavker, RM				Park, Jong Kook; Peng, Han; Yang, Wending; Katsnelson, Julia; Volpert, Olga; Lavker, Robert M.			miR-184 exhibits angiostatic properties via regulation of Akt and VEGF signaling pathways	FASEB JOURNAL			English	Article						corneal epithelium; limbal epithelium; FOG2; PDGF-beta; PPAP2B	EPITHELIAL STEM-CELLS; LIPID PHOSPHATASE SHIP2; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR; GLYCOGEN-METABOLISM; BASAL-CELLS; EXPRESSION; ANGIOGENESIS; KERATOCONUS; MICRORNAS	Corneal a vascularity is critical for achieving transparency necessary for proper transmission of light to the lens and visual acuity. Although much is known about angiogenesis and angiostasis, the precise regulation of these processes in the cornea is unclear. MicroRNA (miR)-184, the most abundant corneal epithelial miRNA, has been suggested to function in corneal angiostasis by altering VEGF signaling; however, the mechanism(s) underlying this regulation have not been addressed. Using a combination of in vitro and in vivo assays to evaluate angiogenesis, we demonstrated that human limbal epithelial keratinocytes (HLEKs) engineered to overexpress miR-184 secreted lower amounts of angiogenic mitogens. Human dermal microvascular cells exposedto conditioned medium from miR-184-overexpressing HLEKs were less proliferative and failed to seal linear scratch wounds. The in vivo Matrigel plug assay showed that conditioned medium from miR-184-expressing HLEKs elicited a lesser degree of neovascularization compared with controls. We found that miR-184 directly targets and represses the proangiogenic factors, friend of Gata 2 (FOG2), platelet-derived growth factor (PDGF)-b, and phosphatidic acid phosphatase 2b (PPAP2B). FOG2 regulates VEGF expression, whereas PDGF-band PPAP2B regulate Akt activity. By attenuating both VEGF and Akt signaling, miR-184 acts as a broad-spectrum negative regulator of corneal angiogenesis.Park, J. K., Peng, H., Yang, W., Katsnelson, J., Volpert, O., Lavker, R. M. miR-184 exhibits angiostatic properties via regulation of Akt and VEGF signaling pathways.	[Park, Jong Kook; Peng, Han; Yang, Wending; Lavker, Robert M.] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, 303 E Chicago Ave.,Ward 9-124, Chicago, IL 60611 USA; [Volpert, Olga] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Katsnelson, Julia] New York Metropolitan Hosp, Dept Dermatol, New York, NY USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Lavker, RM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Dermatol, 303 E Chicago Ave.,Ward 9-124, Chicago, IL 60611 USA.	r-lavker@northwestern.edu		Park, Jong Kook/0000-0002-3946-5687; Peng, Han/0000-0002-1105-8254	U.S. National Institutes of Health (NIH) National Eye Institute [EY017536, EY019463]; NIH National Cancer Institute [CA172669]; Dermatology Foundation; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR057216]; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA172669] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY017536, R01EY019463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057216] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dermatology Foundation; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by U.S. National Institutes of Health (NIH) National Eye Institute Grants EY017536 and EY019463 (to R.M.L.), EY019463 (to O.V.), and NIH National Cancer Institute Grant CA172669 (to O.V.); and by a Dermatology Foundation Career Development Award (to H.P.). The NU-SDRC is supported by NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR057216. The authors thank Drs. Spiro Getsios and Nihal Kaplan (Northwestern University) for helpful discussions.	Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Amitai-Lange A, 2015, STEM CELLS, V33, P230, DOI 10.1002/stem.1840; An JH, 2015, INVEST OPHTH VIS SCI, V56, P3673, DOI 10.1167/iovs.15-16467; Balasubramanian SA, 2010, CURR EYE RES, V35, P185, DOI 10.3109/02713680903477824; CINTRON C, 1983, INVEST OPHTH VIS SCI, V24, P543; Collier SA, 2000, CURR EYE RES, V21, P662, DOI 10.1076/0271-3683(200008)21:2;1-V;FT662; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Davidson AE, 2014, EYE, V28, P189, DOI 10.1038/eye.2013.278; DILLY PN, 1985, T OPHTHAL SOC UK, V104, P381; Dimmeler S, 2000, CIRC RES, V86, P4, DOI 10.1161/01.RES.86.1.4; Ecoiffier T, 2010, INVEST OPHTH VIS SCI, V51, P2436, DOI 10.1167/iovs.09-4505; Foley NH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-83; Funari VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084425; Getsios S, 2009, J CELL BIOL, V185, P1243, DOI 10.1083/jcb.200809044; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Hoffmann A, 2012, MOL MED, V18, P528, DOI 10.2119/molmed.2011.00463; Hughes AE, 2011, AM J HUM GENET, V89, P628, DOI 10.1016/j.ajhg.2011.09.014; Humtsoe JO, 2003, EMBO J, V22, P1539, DOI 10.1093/emboj/cdg165; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Kymionis GD, 2012, SEMIN OPHTHALMOL, V27, P19, DOI 10.3109/08820538.2011.588646; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lavker RM, 2004, EXP EYE RES, V78, P433, DOI 10.1016/j.exer.2003.09.008; Lechner J, 2013, INVEST OPHTH VIS SCI, V54, P5266, DOI 10.1167/iovs.13-12035; Ljubimov AV, 2015, PROG RETIN EYE RES, V49, P17, DOI 10.1016/j.preteyeres.2015.07.002; Malzkorn B, 2010, BRAIN PATHOL, V20, P539, DOI 10.1111/j.1750-3639.2009.00328.x; Morgan CP, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-22; National Eye Institute, 2012, VIS RES NEEDS GAPS O; Panchatcharam M, 2014, ARTERIOSCL THROM VAS, V34, P837, DOI 10.1161/ATVBAHA.113.302335; Peng H, 2015, STEM CELLS, V33, P1642, DOI 10.1002/stem.1962; Peng H, 2013, INVEST OPHTH VIS SCI, V54, P2781, DOI 10.1167/iovs.12-11512; Peng H, 2012, P NATL ACAD SCI USA, V109, P14030, DOI 10.1073/pnas.1111292109; Peng H, 2012, FASEB J, V26, P3140, DOI 10.1096/fj.11-198515; Phua YW, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0593-0; Raza A, 2010, AM J HEMATOL, V85, P593, DOI 10.1002/ajh.21745; Risinger GM, 2006, J BIOL CHEM, V281, P25915, DOI 10.1074/jbc.M513513200; Ryan D, 2006, MOL VIS, V12, P1175; Salido-Guadarrama I, 2014, ONCOTARGETS THER, V7, P1327, DOI 10.2147/OTT.S61562; Sasaoka T, 2003, ENDOCRINOLOGY, V144, P4204, DOI 10.1210/en.2003-0190; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Shah S., 1989, INT CONTACT LENS CLI, V25, P128; Shalom-Feuerstein R, 2012, STEM CELLS, V30, P898, DOI 10.1002/stem.1068; Sharrard RM, 2007, CELL SIGNAL, V19, P129, DOI 10.1016/j.cellsig.2006.05.029; Sleeman MW, 2005, NAT MED, V11, P199, DOI 10.1038/nm1178; Tevosian SG, 2000, CELL, V101, P729, DOI 10.1016/S0092-8674(00)80885-5; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wecker T, 2016, INVEST OPHTH VIS SCI, V57, P1706, DOI 10.1167/iovs.15-17828; WEI ZG, 1993, INVEST OPHTH VIS SCI, V34, P1814; Yu J, 2010, FASEB J, V24, P3950, DOI 10.1096/fj.10-157404; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; Zhang DL, 2004, J BIOL CHEM, V279, P19683, DOI 10.1074/jbc.M313145200; Zhang DL, 2003, ONCOGENE, V22, P974, DOI 10.1038/sj.onc.1206197; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zhou B, 2009, J CLIN INVEST, V119, P1462, DOI 10.1172/JCI38723; Zhou MY, 2006, J BIOL CHEM, V281, P19600, DOI 10.1074/jbc.M600777200; Zhuang GL, 2012, EMBO J, V31, P3513, DOI 10.1038/emboj.2012.183; Zong RR, 2016, INVEST OPHTH VIS SCI, V57, P1398, DOI 10.1167/iovs.15-17417	59	35	38	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					257	+		10.1096/fj.201600746R	http://dx.doi.org/10.1096/fj.201600746R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27825105	Green Published			2022-12-26	WOS:000392177600025
J	Young, MK; Isaak, DJ; McKelvey, KS; Wilcox, TM; Bingham, DM; Pilgrim, KL; Carim, KJ; Campbell, MR; Corsi, MP; Horan, DL; Nagel, DE; Schwartz, MK				Young, Michael K.; Isaak, Daniel J.; McKelvey, Kevin S.; Wilcox, Taylor M.; Bingham, Daniel M.; Pilgrim, Kristine L.; Carim, Kellie J.; Campbell, Matthew R.; Corsi, Matthew P.; Horan, Dona L.; Nagel, David E.; Schwartz, Michael K.			Climate, Demography, and Zoogeography Predict Introgression Thresholds in Salmonid Hybrid Zones in Rocky Mountain Streams	PLOS ONE			English	Article							WESTSLOPE CUTTHROAT TROUT; INTRODUCED RAINBOW-TROUT; ONCORHYNCHUS-CLARKI-LEWISI; BIOLOGICAL INVASIONS; STEELHEAD TROUT; TRADE-OFFS; O-MYKISS; HYBRIDIZATION; RIVER; POPULATIONS	Among the many threats posed by invasions of nonnative species is introgressive hybridization, which can lead to the genomic extinction of native taxa. This phenomenon is regarded as common and perhaps inevitable among native cutthroat trout and introduced rainbow trout in western North America, despite that these taxa naturally co-occur in some locations. We conducted a synthetic analysis of 13,315 genotyped fish from 558 sites by building logistic regression models using data from geospatial stream databases and from 12 published studies of hybridization to assess whether environmental covariates could explain levels of introgression between westslope cutthroat trout and rainbow trout in the U. S. northern Rocky Mountains. A consensus model performed well (AUC, 0.78-0.86; classification success, 72-82%; 10-fold cross validation, 70-82%) and predicted that rainbow trout introgression was significantly associated with warmer water temperatures, larger streams, proximity to warmer habitats and to recent sources of rainbow trout propagules, presence within the historical range of rainbow trout, and locations further east. Assuming that water temperatures will continue to rise in response to climate change and that levels of introgression outside the historical range of rainbow trout will equilibrate with those inside that range, we applied six scenarios across a 55,234-km stream network that forecast 9.574.7% declines in the amount of habitat occupied by westslope cutthroat trout populations of conservation value, but not the wholesale loss of such populations. We conclude that introgression between these taxa is predictably related to environmental conditions, many of which can be manipulated to foster largely genetically intact populations of westslope cutthroat trout and help managers prioritize conservation activities.	[Young, Michael K.; McKelvey, Kevin S.; Wilcox, Taylor M.; Bingham, Daniel M.; Pilgrim, Kristine L.; Carim, Kellie J.; Schwartz, Michael K.] US Forest Serv, Natl Genom Ctr Wildlife & Fish Conservat, Rocky Mt Res Stn, USDA, Missoula, MT 59812 USA; [Isaak, Daniel J.; Horan, Dona L.; Nagel, David E.] US Forest Serv, Rocky Mt Res Stn, Boise, ID USA; [Wilcox, Taylor M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Campbell, Matthew R.] Idaho Dept Fish & Game, Eagle Fish Genet Lab, Eagle, ID USA; [Corsi, Matthew P.] Idaho Dept Fish & Game, Coeur Dalene, ID USA; [Bingham, Daniel M.] Rogue Biol Consultants, Vancouver, WA USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; University of Montana System; University of Montana	Young, MK (corresponding author), US Forest Serv, Natl Genom Ctr Wildlife & Fish Conservat, Rocky Mt Res Stn, USDA, Missoula, MT 59812 USA.	mkyoung@fs.fed.us	Corsi, Matthew/AAK-8502-2021; Wilcox, Taylor/P-7064-2019	Wilcox, Taylor/0000-0003-3341-7374	Region 1 of the U.S. Forest Service; Rocky Mountain Research Station; U.S. Forest Service Washington Office	Region 1 of the U.S. Forest Service; Rocky Mountain Research Station(United States Department of Agriculture (USDA)United States Forest Service); U.S. Forest Service Washington Office	Funding for this work was provided by Region 1 of the U.S. Forest Service. The funder provided support in the form of salaries for authors [DMB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; Funding for this work was provided by Region 1 of the U.S. Forest Service. Institutional support was provided by the National Genomics Center for Wildlife and Fish Conservation, supported by the Rocky Mountain Research Station and U.S. Forest Service Washington Office.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Aboim MA, 2010, J EVOLUTION BIOL, V23, P817, DOI 10.1111/j.1420-9101.2010.01953.x; Al-Chokhachy R, 2014, N AM J FISH MANAGE, V34, P642, DOI 10.1080/02755947.2014.901259; ALLENDORF F W, 1988, Conservation Biology, V2, P170, DOI 10.1111/j.1523-1739.1988.tb00168.x; Allendorf FW, 2004, CONSERV BIOL, V18, P1203, DOI 10.1111/j.1523-1739.2004.00305.x; Allendorf FW, CONSERVATION GENETIC, V2; Araki H, 2008, EVOL APPL, V1, P342, DOI 10.1111/j.1752-4571.2008.00026.x; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; Bean PT, 2013, T AM FISH SOC, V142, P681, DOI 10.1080/00028487.2012.758170; Behnke RJ, 2002, TROUT SALMON N AM; Bennett SN, 2010, ECOL APPL, V20, P263, DOI 10.1890/08-0441.1; Bingham DM, 2016, N AM J FISH MANAGE, V36, P590, DOI 10.1080/02755947.2016.1165765; Bossu CM, 2013, GENETICA, V141, P75, DOI 10.1007/s10709-013-9707-8; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Boyer MC, 2008, CAN J FISH AQUAT SCI, V65, P658, DOI 10.1139/F08-001; Buehrens TW, 2013, T AM FISH SOC, V142, P221, DOI 10.1080/00028487.2012.728165; Calcagno V, 2013, GLMULTI MODEL SELECT; Carim K, 2015, N AM J FISH MANAGE, V35, P337, DOI 10.1080/02755947.2015.1007182; Childs MR, 1996, EVOLUTION, V50, P2014, DOI 10.1111/j.1558-5646.1996.tb03588.x; Cooter W, 2010, ENVIRON MANAGE, V46, P510, DOI 10.1007/s00267-010-9526-y; Corse E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142592; Corsi MP, 2013, CAN J FISH AQUAT SCI, V70, P895, DOI 10.1139/cjfas-2012-0312; Crete-Lafreniere A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046662; Culumber ZW, 2012, J EVOLUTION BIOL, V25, P1800, DOI 10.1111/j.1420-9101.2012.02562.x; Culumber ZW, 2011, MOL ECOL, V20, P342, DOI 10.1111/j.1365-294X.2010.04949.x; Curran CE, 2016, BLOOMSBURY ACAD COLL, P1; Curry CM, 2014, AM MIDL NAT, V171, P271, DOI 10.1674/0003-0031-171.2.271; DeHaan PW, 2010, CONSERV GENET, V11, P935, DOI 10.1007/s10592-009-9937-6; DeRito JN, 2010, N AM J FISH MANAGE, V30, P866, DOI 10.1577/M09-006.1; Dunham JB, 2004, FISHERIES, V29, P18, DOI 10.1577/1548-8446(2004)29[18:ATCONT]2.0.CO;2; Dunnigan JL, 1997, THESIS; Duvernell DD, 2014, EVOL ECOL, V28, P37, DOI 10.1007/s10682-013-9653-z; DWYER WP, 1975, T AM FISH SOC, V104, P552, DOI 10.1577/1548-8659(1975)104<552:TIOTOS>2.0.CO;2; Elsner MM, 2010, CLIMATIC CHANGE, V102, P225, DOI 10.1007/s10584-010-9855-0; Epifanio J, 2000, REV FISH BIOL FISHER, V10, P339, DOI 10.1023/A:1016673331459; Fausch KD, 2009, CONSERV BIOL, V23, P859, DOI 10.1111/j.1523-1739.2008.01159.x; FERGUSON MM, 1988, CAN J ZOOL, V66, P1389, DOI 10.1139/z88-204; Finstad AG, 2011, GLOBAL CHANGE BIOL, V17, P1703, DOI 10.1111/j.1365-2486.2010.02335.x; Foster G, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/044022; Gresswell RE, 2011, N AM J FISH MANAGE, V31, P782, DOI 10.1080/02755947.2011.608980; Gunnell K, 2008, CONSERV GENET, V9, P49, DOI 10.1007/s10592-007-9302-6; Haak AL, 2012, N AM J FISH MANAGE, V32, P387, DOI 10.1080/02755947.2012.678963; Henderson Richard, 2000, North American Journal of Fisheries Management, V20, P584, DOI 10.1577/1548-8675(2000)020&lt;0584:TALOSB&gt;2.3.CO;2; Hitt NP, 2003, CAN J FISH AQUAT SCI, V60, P1440, DOI 10.1139/F03-125; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Isaak DJ, 2016, P NATL ACAD SCI USA, V113, P4374, DOI 10.1073/pnas.1522429113; Isaak DJ, 2015, GLOBAL CHANGE BIOL, V21, P2540, DOI 10.1111/gcb.12879; Isaak DJ, 2013, GLOBAL CHANGE BIOL, V19, P742, DOI 10.1111/gcb.12073; Isaak DJ, 2010, ECOL APPL, V20, P1350, DOI 10.1890/09-0822.1; Kaeding LR, 2003, FED REGISTER, V68, P46989; Kendall NW, 2015, CAN J FISH AQUAT SCI, V72, P319, DOI 10.1139/cjfas-2014-0192; KINDSCHI GA, 1994, PROG FISH CULT, V56, P13, DOI 10.1577/1548-8640(1994)056<0013:PAOCOS>2.3.CO;2; Kovach R. P., 2015, P ROY SOC LOND B BIO, V282, P2014; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Loxterman JL, 2014, CAN J FISH AQUAT SCI, V71, P1050, DOI 10.1139/cjfas-2013-0424; Maindonald J. H., 2015, DAAG DATA ANAL GRAPH; McKay L, 2012, NHDPLUS VERSION 2 US; McKelvey KS, 2016, ECOL EVOL, V6, P688, DOI 10.1002/ece3.1887; Meraner A, 2013, MOL ECOL, V22, P5295, DOI 10.1111/mec.12470; Miller LM, 2004, MOL ECOL, V13, P3379, DOI 10.1111/j.1365-294X.2004.02347.x; Moyle PB, 1996, BIOL CONSERV, V78, P149, DOI 10.1016/0006-3207(96)00024-9; Muhlfeld CC, 2015, N AM J FISH MANAGE, V35, P31, DOI 10.1080/02755947.2014.951807; Muhlfeld CC, 2014, NAT CLIM CHANGE, V4, P620, DOI [10.1038/NCLIMATE2252, 10.1038/nclimate2252]; Muhlfeld CC, 2009, T AM FISH SOC, V138, P1036, DOI 10.1577/T08-235.1; Ostberg CO, 2011, T AM FISH SOC, V140, P334, DOI 10.1080/00028487.2011.567866; Ostberg CO, 2012, NORTHWEST SCI, V86, P198, DOI 10.3955/046.086.0305; Ostberg CO, 2004, MOL ECOL, V13, P2773, DOI 10.1111/j.1365-294X.2004.02268.x; Pereira RJ, 2016, MOL ECOL, V25, P1551, DOI 10.1111/mec.13575; Perrier C, 2013, ECOL EVOL, V3, P2334, DOI 10.1002/ece3.629; Peterson DP, 2014, ECOL FRESHW FISH, V23, P556, DOI 10.1111/eff.12108; Poisot T, 2016, ECOGRAPHY, V39, P402, DOI 10.1111/ecog.01941; Quinn TP, 2004, REV FISH BIOL FISHER, V14, P421, DOI 10.1007/s11160-005-0802-5; R Core Team, 2013, R LANG ENV STAT COMP; Rahel FJ, 2002, ANNU REV ECOL SYST, V33, P291, DOI 10.1146/annurev.ecolsys.33.010802.150429; Rasmussen JB, 2012, BIOL J LINN SOC, V105, P56, DOI 10.1111/j.1095-8312.2011.01768.x; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Rieman BE, 2000, ECOL FRESHW FISH, V9, P51, DOI 10.1034/j.1600-0633.2000.90106.x; Rubidge EM, 2005, CONSERV GENET, V6, P369, DOI 10.1007/s10592-005-4972-4; Servedio MR, 2004, PLOS BIOL, V2, P2032, DOI 10.1371/journal.pbio.0020420; Shepard BB, 2005, N AM J FISH MANAGE, V25, P1426, DOI 10.1577/M05-004.1; Sloat MR, 2014, CAN J FISH AQUAT SCI, V71, P491, DOI 10.1139/cjfas-2013-0366; Splendiani A, 2016, BIOL INVASIONS, V18, P2029, DOI 10.1007/s10530-016-1149-7; Stoffels RJ, 2016, OECOLOGIA, V180, P45, DOI 10.1007/s00442-015-3463-7; Taylor EB, 2003, EVOLUTION ILLUMINATED: SALMON AND THEIR RELATIVES, P232; Taylor SA, 2015, TRENDS ECOL EVOL, V30, P398, DOI 10.1016/j.tree.2015.04.010; Utah Division of Wildlife Resources, 2000, UT DIV PUBL; Valiquette E, 2014, EVOL APPL, V7, P625, DOI 10.1111/eva.12160; Van Leeuwen TE, 2011, J ANIM ECOL, V80, P1012, DOI 10.1111/j.1365-2656.2011.01841.x; Vonlanthen P, 2009, J EVOLUTION BIOL, V22, P498, DOI 10.1111/j.1420-9101.2008.01670.x; Wang IJ, 2014, MOL ECOL, V23, P5649, DOI 10.1111/mec.12938; Weigel DE, 2003, ECOL APPL, V13, P38, DOI 10.1890/1051-0761(2003)013[0038:IHBNCT]2.0.CO;2; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; Wenger SJ, 2011, CAN J FISH AQUAT SCI, V68, P988, DOI [10.1139/F2011-034, 10.1139/f2011-034]; Wenger SJ, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008839; Williams I, 2007, T AM FISH SOC, V136, P926, DOI 10.1577/T06-214.1; Winkler KA, 2011, MOL ECOL, V20, P456, DOI 10.1111/j.1365-294X.2010.04961.x; Yau MM, 2013, CONSERV GENET, V14, P885, DOI 10.1007/s10592-013-0485-8; Young MK, 2011, CAN J FISH AQUAT SCI, V68, P941, DOI 10.1139/F2011-023	100	29	29	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0163563	10.1371/journal.pone.0163563	http://dx.doi.org/10.1371/journal.pone.0163563			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828980	Green Submitted, Green Published, gold			2022-12-26	WOS:000387724300007
J	Zahran, R; Leal, JIR; Rodriguez Valverde, MA; Vilchez, MAC				Zahran, R.; Rosales Leal, J. I.; Rodriguez Valverde, M. A.; Cabrerizo Vilchez, M. A.			Effect of Hydrofluoric Acid Etching Time on Titanium Topography, Chemistry, Wettability, and Cell Adhesion	PLOS ONE			English	Article							OSTEOBLAST-LIKE CELLS; SURFACE-TOPOGRAPHY; PROTEIN-SYNTHESIS; POLYMER SURFACES; IMPLANT SURFACES; BONE-FORMATION; IN-VIVO; DIFFERENTIATION; ROUGHNESS; OSSEOINTEGRATION	Titanium implant surface etching has proven an effective method to enhance cell attachment. Despite the frequent use of hydrofluoric (HF) acid, many questions remain unresolved, including the optimal etching time and its effect on surface and biological properties. The objective of this study was to investigate the effect of HF acid etching time on Ti topography, surface chemistry, wettability, and cell adhesion. These data are useful to design improved acid treatment and obtain an improved cell response. The surface topography, chemistry, dynamic wetting, and cell adhesiveness of polished Ti surfaces were evaluated after treatment with HF acid solution for 0, 2; 3, 5, 7, or 10 min, revealing a time-dependent effect of HF acid on their topography, chemistry, and wetting. Roughness and wetting increased with longer etching time except at 10 min, when roughness increased but wetness decreased. Skewness became negative after etching and kurtosis tended to 3 with longer etching time. Highest cell adhesion was achieved after 5-7 min of etching time. Wetting and cell adhesion were reduced on the highly rough surfaces obtained after 10-min etching time.	[Zahran, R.; Rosales Leal, J. I.] Univ Granada, Sch Dent, Dept Prosthodont, Granada, Spain; [Zahran, R.; Rosales Leal, J. I.] Univ Granada, Stomatognat Physiopathol & Prosthodont Res Grp CT, Granada, Spain; [Rosales Leal, J. I.] Univ Granada, Inst Invest Biosanitariaibs GRANADA, Granada, Spain; [Rodriguez Valverde, M. A.; Cabrerizo Vilchez, M. A.] Univ Granada, Sch Sci, Dept Appl Phys, Granada, Spain; [Rodriguez Valverde, M. A.; Cabrerizo Vilchez, M. A.] Univ Granada, Fluid & Biocolloid Phys Res Grp, Granada, Spain	University of Granada; University of Granada; University of Granada; University of Granada; University of Granada	Leal, JIR (corresponding author), Univ Granada, Sch Dent, Dept Prosthodont, Granada, Spain.; Leal, JIR (corresponding author), Univ Granada, Stomatognat Physiopathol & Prosthodont Res Grp CT, Granada, Spain.; Leal, JIR (corresponding author), Univ Granada, Inst Invest Biosanitariaibs GRANADA, Granada, Spain.	irosales@ugr.es	Rodriguez-Valverde, Miguel A/B-7938-2009	Rodriguez-Valverde, Miguel A/0000-0003-4361-6721	Ministerio Espanol de Economia y Competitividad [MAT2014-60615-R]; Junta de Andalucia, Spain [CTS 974]	Ministerio Espanol de Economia y Competitividad(Spanish Government); Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission)	This study was supported by the "Ministerio Espanol de Economia y Competitividad" (project MAT2014-60615-R) and by Research Group #CTS 974 (Junta de Andalucia, Spain).r This study was supported by the "Ministerio Espanol de Economia y Competitividad" (project MAT2014-60615-R) and by Research Group #CTS 974 (Junta de Andalucia, Spain). The authors thank Richard Davies for editorial assistance.	Abrahamsson I, 2004, CLIN ORAL IMPLAN RES, V15, P381, DOI 10.1111/j.1600-0501.2004.01082.x; Bachle M, 2004, CLIN ORAL IMPLAN RES, V15, P683, DOI 10.1111/j.1600-0501.2004.01054.x; Blanco J, 2011, CLIN ORAL IMPLAN RES, V22, P92, DOI 10.1111/j.1600-0501.2010.02009.x; Canabarro A, 2012, SCANNING, V34, P378, DOI 10.1002/sca.21020; Chappard D, 2003, BIOMATERIALS, V24, P1399, DOI 10.1016/S0142-9612(02)00524-0; Cooper LF, 2006, BIOMATERIALS, V27, P926, DOI 10.1016/j.biomaterials.2005.07.009; Dahotre NB, 2010, PHILOS T R SOC A, V368, P1863, DOI 10.1098/rsta.2010.0003; Galdelmawla ES, 2002, J MATER PROCESS TECH, V123, P133; Gittens RA, 2014, ACTA BIOMATER, V10, P3363, DOI 10.1016/j.actbio.2014.03.037; Gittens RA, 2013, ACTA BIOMATER, V9, P6268, DOI 10.1016/j.actbio.2012.12.002; Guo J, 2007, BIOMATERIALS, V28, P5418, DOI 10.1016/j.biomaterials.2007.08.032; Ha SW, 1997, J MATER SCI-MATER M, V8, P891, DOI 10.1023/A:1018562023599; He FM, 2010, ORAL SURG ORAL MED O, V110, pE13, DOI 10.1016/j.tripleo.2010.03.044; Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009; Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O; Korotin D. M., 2012, J BIOMATER NANOBIOTE, V3, P87, DOI DOI 10.4236/JBNB.2012.31011; Kubiak KJ, 2011, SCANNING, V33, P370, DOI 10.1002/sca.20289; Kwon T, 2014, J DENT, V2014, DOI [10.1016/j.jdent, DOI 10.1016/J.JDENT.2014;05-016]; Lamolle SF, 2009, J BIOMED MATER RES A, V88A, P581, DOI 10.1002/jbm.a.31898; Lamolle SF, 2009, BIOMATERIALS, V30, P736, DOI 10.1016/j.biomaterials.2008.10.052; Li YF, 2010, BIOMATERIALS, V31, P3266, DOI 10.1016/j.biomaterials.2010.01.028; Maldelbrot BB, 1983, FRACTAL GEOMETRY NAT; MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314; Monjo M, 2008, BIOMATERIALS, V29, P3771, DOI 10.1016/j.biomaterials.2008.06.001; Ruiz-Cabello FJM, 2011, J ADHES SCI TECHNOL, V25, P2039, DOI 10.1163/016942410X544848; MORRA M, 1990, ADV COLLOID INTERFAC, V32, P79, DOI 10.1016/0001-8686(90)80012-O; Nakagawa M, 2001, Dent Mater J, V20, P305; Park J, 2009, SMALL, V5, P666, DOI 10.1002/smll.200801476; Rauscher M, 2008, PHENOMENA NANOFLUIDI, P38; Rodriguez Valverde MA, 1978, MICROSCOPY BOOK SERI, V3; Rodriguez- Rius D, 2005, MED ORAL PATOL ORAL, V10, P58; Rosales Leal JI, 2010, PHYSICOCHEM ENG ASPE, V365, P222; Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518; Wennerberg A, 1996, BIOMATERIALS, V17, P15, DOI 10.1016/0142-9612(96)80750-2; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024	35	31	34	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165296	10.1371/journal.pone.0165296	http://dx.doi.org/10.1371/journal.pone.0165296			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824875	Green Published, Green Submitted, gold			2022-12-26	WOS:000387615200016
J	Bartels, MF; Winterhalter, PR; Yu, J; Liu, Y; Lommel, M; Mohrlen, F; Hu, HY; Feizi, T; Westerlind, U; Ruppert, T; Strahl, S				Bartels, Markus F.; Winterhalter, Patrick R.; Yu, Jin; Liu, Yan; Lommel, Mark; Moehrlen, Frank; Hu, Huaiyu; Feizi, Ten; Westerlind, Ulrika; Ruppert, Thomas; Strahl, Sabine			Protein O-Mannosylation in the Murine Brain: Occurrence of Mono-O-Mannosyl Glycans and Identification of New Substrates	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; DYSTROPHIN-GLYCOPROTEIN COMPLEX; CONGENITAL MUSCULAR-DYSTROPHIES; REDUCTIVE ALKALINE-HYDROLYSIS; WALKER-WARBURG-SYNDROME; ALPHA-DYSTROGLYCAN; BASEMENT-MEMBRANE; MUCIN DOMAIN; MOUSE-BRAIN; MUSCLE	Protein O-mannosylation is a post-translational modification essential for correct development of mammals. In humans, deficient O-mannosylation results in severe congenital muscular dystrophies often associated with impaired brain and eye development. Although various O-mannosylated proteins have been identified in the recent years, the distribution of O-mannosyl glycans in the mammalian brain and target proteins are still not well defined. In the present study, rabbit monoclonal antibodies directed against the O-mannosylated peptide YAT(alpha 1-Man) AV were generated. Detailed characterization of clone RKU-1-3-5 revealed that this monoclonal antibody recognizes O-linked mannose also in different peptide and protein contexts. Using this tool, we observed that mono-O-mannosyl glycans occur ubiquitously throughout the murine brain but are especially enriched at inhibitory GABAergic neurons and at the perineural nets. Using a mass spectrometry-based approach, we further identified glycoproteins from the murine brain that bear single O-mannose residues. Among the candidates identified are members of the cadherin and plexin superfamilies and the perineural net protein neurocan. In addition, we identified neurexin 3, a cell adhesion protein involved in synaptic plasticity, and inter-alpha-trypsin inhibitor 5, a protease inhibitor important in stabilizing the extracellular matrix, as new O-mannosylated glycoproteins.	[Bartels, Markus F.; Winterhalter, Patrick R.; Lommel, Mark; Strahl, Sabine] Heidelberg Univ, Dept Cell Chem, Ctr Organismal Studies, Heidelberg, Germany; [Winterhalter, Patrick R.; Ruppert, Thomas] Heidelberg Univ, Ctr Mol Biol Heidelberg ZMBH, Core Facil Mass Spectrometry & Prote, Heidelberg, Germany; [Yu, Jin; Westerlind, Ulrika] ISAS Leibniz Inst Analyt Sci, Gesell Forderung Analyt Wissensch eV, Dortmund, Germany; [Liu, Yan; Feizi, Ten] Imperial Coll London, Dept Med, Glycosci Lab, Hammersmith Campus, London, England; [Moehrlen, Frank] Heidelberg Univ, Dept Anim Mol Physiol, Ctr Organismal Studies, Heidelberg, Germany; [Hu, Huaiyu] Upstate Med Univ, Inst Human Performance, Dept Neurosci & Physiol, New York, NY USA	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); Imperial College London; Ruprecht Karls University Heidelberg; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Strahl, S (corresponding author), Heidelberg Univ, Dept Cell Chem, Ctr Organismal Studies, Heidelberg, Germany.	sabine.strahl@cos.uni-heidelberg.de	Lommel, Mark/E-3836-2014; Liu, Yan/D-9117-2013; Ruppert, Thomas/AAC-2467-2021	Ruppert, Thomas/0000-0001-9152-2266; Lommel, Mark/0000-0001-6954-3714; Liu, Yan/0000-0002-2566-6867	Deutsche Forschungsgemeinschaft, Sonderforschungsbereich [1036, 11]; Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen; Senatsverwaltung fur Wirtschaft, Technologie und Forschung des Landes Berlin; Bundesministerium for Bildung and Forschung; Wellcome Trust [WT093378MA, WT099197MA, 108430/Z/15/Z]	Deutsche Forschungsgemeinschaft, Sonderforschungsbereich(German Research Foundation (DFG)); Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen; Senatsverwaltung fur Wirtschaft, Technologie und Forschung des Landes Berlin; Bundesministerium for Bildung and Forschung; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 1036, project 11 (to S.S.). S.S. is a member of the excellence cluster CellNetworks. Financial support by the Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen, the Senatsverwaltung fur Wirtschaft, Technologie und Forschung des Landes Berlin, and the Bundesministerium for Bildung and Forschung is gratefully acknowledged (to U.W.). Supported by Wellcome Trust Grants WT093378MA, WT099197MA and 108430/Z/15/Z (to T.F.).	Abbott KL, 2008, J BIOL CHEM, V283, P33026, DOI 10.1074/jbc.M803646200; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Beedle AM, 2012, J CLIN INVEST, V122, P3330, DOI 10.1172/JCI63004; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Bleckmann C, 2009, BIOL CHEM, V390, P627, DOI 10.1515/BC.2009.044; Bonnemann CG, 2014, NEUROMUSCULAR DISORD, V24, P289, DOI 10.1016/j.nmd.2013.12.011; Breloy I, 2008, J BIOL CHEM, V283, P18832, DOI 10.1074/jbc.M802834200; Breloy I, 2012, BIOL CHEM, V393, P709, DOI 10.1515/hsz-2012-0214; Cabrera PV, 2012, J BIOL CHEM, V287, P22759, DOI 10.1074/jbc.M111.334581; Chai WG, 1999, EUR J BIOCHEM, V263, P879, DOI 10.1046/j.1432-1327.1999.00572.x; Che MI, 2014, ONCOTARGET, V5, P3673, DOI 10.18632/oncotarget.1981; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dwyer CA, 2012, NEUROSCIENCE, V220, P47, DOI 10.1016/j.neuroscience.2012.06.026; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FINNE J, 1979, J BIOL CHEM, V254, P295; Friedel RH, 2007, J NEUROSCI, V27, P3921, DOI 10.1523/JNEUROSCI.4710-06.2007; Goddeeris MM, 2013, NATURE, V503, P136, DOI 10.1038/nature12605; HARTIG W, 1992, NEUROREPORT, V3, P869; Himmelfarb M, 2004, CANCER LETT, V204, P69, DOI 10.1016/j.canlet.2003.09.011; Howell MD, 2012, NEUROSCIENCE, V217, P6, DOI 10.1016/j.neuroscience.2012.05.034; Hu HY, 2007, J COMP NEUROL, V501, P168, DOI 10.1002/cne.21238; Hu HY, 2011, J COMP NEUROL, V519, P1320, DOI 10.1002/cne.22572; Judas M, 2009, NEUROPEDIATRICS, V40, P6, DOI 10.1055/s-0029-1224099; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; Kogelberg H, 2001, CARBOHYD RES, V331, P393, DOI 10.1016/S0008-6215(01)00051-9; Liu JM, 2006, MECH DEVELOP, V123, P228, DOI 10.1016/j.mod.2005.12.003; Loibl M, 2013, BBA-MOL CELL RES, V1833, P2438, DOI 10.1016/j.bbamcr.2013.02.008; Lommel M, 2013, P NATL ACAD SCI USA, V110, P21024, DOI 10.1073/pnas.1316753110; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Mo KF, 2011, J AM CHEM SOC, V133, P14418, DOI 10.1021/ja205473q; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Neubert P, 2016, MOL CELL PROTEOMICS, V15, P1323, DOI 10.1074/mcp.M115.057505; Pacharra S, 2013, J PROTEOME RES, V12, P1764, DOI 10.1021/pr3011028; Pacharra S, 2012, J PROTEOME RES, V11, P3955, DOI 10.1021/pr200996y; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Praissman JL, 2014, BIOCHEMISTRY-US, V53, P3066, DOI 10.1021/bi500153y; Pribiag H, 2014, P NATL ACAD SCI USA, V111, P6810, DOI 10.1073/pnas.1321774111; Sambrook J., 2001, MOL CLONING LAB MANU; Sassoe-Pognetto M, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00004; Stalnaker SH, 2011, J BIOL CHEM, V286, P21180, DOI 10.1074/jbc.M110.203281; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; SUGIYAMA J, 1994, NEURON, V13, P103, DOI 10.1016/0896-6273(94)90462-6; Tanaka M, 2003, J NEUROSCI, V23, P2804, DOI 10.1523/jneurosci.23-07-02804.2003; Tolu S, 2010, FASEB J, V24, P723, DOI 10.1096/fj.09-139790; Trinidad JC, 2013, MOL CELL PROTEOMICS, V12, P3474, DOI 10.1074/mcp.M113.030007; Vester-Christensen MB, 2013, P NATL ACAD SCI USA, V110, P21018, DOI 10.1073/pnas.1313446110; Waite A, 2012, TRENDS NEUROSCI, V35, P487, DOI 10.1016/j.tins.2012.04.004; Whitney ER, 2008, J NEUROSCI METH, V168, P42, DOI 10.1016/j.jneumeth.2007.09.009; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Willer T, 2004, P NATL ACAD SCI USA, V101, P14126, DOI 10.1073/pnas.0405899101; Winterhalter PR, 2013, FEBS LETT, V587, P3715, DOI 10.1016/j.febslet.2013.09.041; Wright KM, 2012, NEURON, V76, P931, DOI 10.1016/j.neuron.2012.10.009; Yoshida-Moriguchi T, 2015, GLYCOBIOLOGY, V25, P702, DOI 10.1093/glycob/cwv021; Yuen CT, 1997, J BIOL CHEM, V272, P8924	57	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166119	10.1371/journal.pone.0166119	http://dx.doi.org/10.1371/journal.pone.0166119			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812179	Green Published, gold, Green Submitted			2022-12-26	WOS:000386910000103
J	Sarri, CA; Markantoni, M; Stamatis, C; Papa, A; Tsakris, A; Pervanidou, D; Baka, A; Politis, C; Billinis, C; Hadjichristodoulou, C; Mamuris, Z				Sarri, Constantina A.; Markantoni, Maria; Stamatis, Costas; Papa, Anna; Tsakris, Athanasios; Pervanidou, Danai; Baka, Agoritsa; Politis, Constantina; Billinis, Charalambos; Hadjichristodoulou, Christos; Mamuris, Zissis		MALWEST Project	Genetic Contribution of MHC Class II Genes in Susceptibility to West Nile Virus Infection	PLOS ONE			English	Article							T-CELL RESPONSES; NEUROINVASIVE DISEASE; DENGUE-FEVER; HLA; POPULATION; ASSOCIATION; FREQUENCIES; SELECTION; EPIDEMIC; EUROPE	WNV is a zoonotic neurotropic flavivirus that has recently emerged globally as a significant cause of viral encephalitis. The last five years, 624 incidents of WNV infection have been reported in Greece. The risk for severe WNV disease increases among immunosuppressed individuals implying thus the contribution of the MHC locus to the control of WNV infection. In order to investigate a possible association of MHC class II genes, especially HLA-DPA1, HLA-DQA1, HLA-DRB1, we examined 105 WNV patients, including 68 cases with neuroinvasive disease and 37 cases with mild clinical phenotype, collected during the period from 2010 to 2013, and 100 control individuals selected form the Greek population. Typing was performed for exon 2 for all three genes. DQA1*01: 01 was considered to be "protective" against WNV infection (25.4% vs 40.1%, P = 0.004) while DQA1*01: 02 was associated with increased susceptibility (48.0% vs 32.1%, P = 0.003). Protection against neuroinvasion was associated with the presence of DRB1* 11: 02 (4.99% vs 0.0%, P = 0.018). DRB1*16: 02 was also absent from the control cohort (P = 0.016). Three additional population control groups were used in order to validate our results. No statistically significant association with the disease was found for HLA-DPA alleles. The results of the present study provide some evidence that MHC class II is involved in the response to WNV infection, outlining infection "susceptibility" and "CNS-high-risk" candidates. Furthermore, three new alleles were identified while the frequency of all alleles in the study was compared with worldwide data. The characterization of the MHC locus could help to estimate the risk for severe WNV cases in a country.	[Sarri, Constantina A.; Markantoni, Maria; Stamatis, Costas; Mamuris, Zissis] Univ Thessaly, Dept Biochem & Biotechnol, Lab Genet Comparat & Evolutionary Biol, Larisa, Greece; [Papa, Anna] Aristotle Univ Thessaloniki, Arboviruses Reference Lab, Microbiol Lab 1, Thessaloniki, Greece; [Tsakris, Athanasios] Univ Athens, Sch Med, Microbiol Lab, Athens, Greece; [Pervanidou, Danai; Baka, Agoritsa] HCDCP, Attika, Greece; [Politis, Constantina] HCDCP, Hellen Coordinating Hemovigilance Ctr, Attika, Greece; [Billinis, Charalambos] Univ Thessaly, Lab Microbiol & Parasitol, Fac Vet Med, Kardhitsa, Greece; [Hadjichristodoulou, Christos] Univ Thessaly, Lab Hyg & Epidemiol, Fac Med, Larisa, Greece	University of Thessaly; Aristotle University of Thessaloniki; Athens Medical School; National & Kapodistrian University of Athens; University of Thessaly; University of Thessaly	Mamuris, Z (corresponding author), Univ Thessaly, Dept Biochem & Biotechnol, Lab Genet Comparat & Evolutionary Biol, Larisa, Greece.	zmamur@bio.uth.gr	Mamuris, Zissis/AAN-2576-2021	Markantoni, Maria/0000-0002-3616-4344; Hadjichristodoulou, Christos/0000-0002-4769-8376	"Integrated surveillance and control programme for West Nile virus and malaria in Greece" (MALWEST) through the Operational Programme "Human Resources Development" of National Strategic Reference Framework (NSRF)	"Integrated surveillance and control programme for West Nile virus and malaria in Greece" (MALWEST) through the Operational Programme "Human Resources Development" of National Strategic Reference Framework (NSRF)	This work was funded by "Integrated surveillance and control programme for West Nile virus and malaria in Greece" (MALWEST) through the Operational Programme "Human Resources Development" of National Strategic Reference Framework (NSRF) 2007-2013.	Ashraf U, 2015, VIRUSES-BASEL, V7, P219, DOI 10.3390/v7010219; Bigham AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024745; Cangussu LOF, 2011, SCAND J IMMUNOL, V74, P282, DOI 10.1111/j.1365-3083.2011.02568.x; Carson PJ, 2012, EMERG INFECT DIS, V18, P684, DOI 10.3201/eid1804.111313; Davis LE, 2006, ANN NEUROL, V60, P286, DOI 10.1002/ana.20959; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Iacovakis C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074360; James EA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005375; Janeway CA., 2001, IMMUNOBIOLOGY IMMUNE; Kaabinejadian S, 2014, J IMMUNOL S, V192, P43; Koutsogiannouli EA, 2009, MOL ECOL, V18, P4631, DOI 10.1111/j.1365-294X.2009.04394.x; Kumar D, 2004, AM J TRANSPLANT, V4, P1883, DOI 10.1111/j.1600-6143.2004.00592.x; LaFleur C, 2002, HUM IMMUNOL, V63, P1039, DOI 10.1016/S0198-8859(02)00682-1; Lan NTP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000304; Lanteri MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022948; Lim JK, 2010, J INFECT DIS, V201, P178, DOI 10.1086/649426; Louis C, 2012, EMERG INFECT DIS, V18, P78, DOI 10.3201/eid1801.110191; Marka A, 2013, INT J ENV RES PUB HE, V10, P6534, DOI 10.3390/ijerph10126534; Netland J, 2013, VIRUSES-BASEL, V5, P2573, DOI 10.3390/v5102573; O'Leary DR, 2004, VECTOR-BORNE ZOONOT, V4, P61, DOI 10.1089/153036604773083004; Ovsyannikova IG, 2007, VIROLOGY, V364, P87, DOI 10.1016/j.virol.2007.02.028; Panoutsopoulou K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6345; Polizel JR, 2004, MEM I OSWALDO CRUZ, V99, P559, DOI 10.1590/S0074-02762004000600003; Pradier S, 2012, REV SCI TECH OIE, V31, P829; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; Ranasinghe S, 2013, NAT MED, V19, P930, DOI 10.1038/nm.3229; Rubicz R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003147; Sanchez-Mazas A, 2011, IMMUNOLOGY, V133, P143, DOI 10.1111/j.1365-2567.2011.03438.x; Sarri CA, HLA; Sarri CA, COMPLETE EXON 2 SEQU; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Sierra B, 2007, HUM IMMUNOL, V68, P531, DOI 10.1016/j.humimm.2007.03.001; Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06; Spiroski M, 2013, HUM IMMUNOL, V74, P389, DOI 10.1016/j.humimm.2012.11.015; TAKAHATA N, 1990, GENETICS, V124, P967; Tamori A, 2013, WORLD J GASTROENTERO, V19, P5395, DOI 10.3748/wjg.v19.i33.5395; THOMPSON J, 2005, GEOGRAPHIC MOSAIC CO, P31, DOI DOI 10.1117/12.604911; Wedekind C, 2005, GENETICS, V170, P1427, DOI 10.1534/genetics.105.040683	39	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165952	10.1371/journal.pone.0165952	http://dx.doi.org/10.1371/journal.pone.0165952			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812212	gold, Green Published			2022-12-26	WOS:000386910000084
J	Guiducci, L; Razghandi, K; Bertinetti, L; Turcaud, S; Ruggeberg, M; Weaver, JC; Fratzl, P; Burgert, I; Dunlop, JWC				Guiducci, Lorenzo; Razghandi, Khashayar; Bertinetti, Luca; Turcaud, Sebastien; Rueggeberg, Markus; Weaver, James C.; Fratzl, Peter; Burgert, Ingo; Dunlop, John W. C.			Honeycomb Actuators Inspired by the Unfolding of Ice Plant Seed Capsules	PLOS ONE			English	Article							CELLULOSE FIBRILS; PINE-CONES; SYSTEMS; MESEMBRYANTHEMUM; POMERIDIANA; DISPERSAL; FRUITS; BR	Plant hydro-actuated systems provide a rich source of inspiration for designing autonomously morphing devices. One such example, the pentagonal ice plant seed capsule, achieves complex mechanical actuation which is critically dependent on its hierarchical organization. The functional core of this actuation system involves the controlled expansion of a highly swellable cellulosic layer, which is surrounded by a non-swellable honeycomb framework. In this work, we extract the design principles behind the unfolding of the ice plant seed capsules, and use two different approaches to develop autonomously deforming honeycomb devices as a proof of concept. By combining swelling experiments with analytical and finite element modelling, we elucidate the role of each design parameter on the actuation of the prototypes. Through these approaches, we demonstrate potential pathways to design/develop/construct autonomously morphing systems by tailoring and amplifying the initial material's response to external stimuli through simple geometric design of the system at two different length scales.	[Guiducci, Lorenzo; Razghandi, Khashayar; Bertinetti, Luca; Turcaud, Sebastien; Fratzl, Peter; Dunlop, John W. C.] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany; [Guiducci, Lorenzo; Razghandi, Khashayar] Humboldt Univ, Cluster Excellence Image Knowledge, Berlin, Germany; [Weaver, James C.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Rueggeberg, Markus; Burgert, Ingo] ETHZ, Inst Bldg Mat IfB, Zurich, Switzerland; [Rueggeberg, Markus; Burgert, Ingo] Empa, Appl Wood Mat Lab, Dubendorf, Switzerland	Max Planck Society; Humboldt University of Berlin; Harvard University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Guiducci, L; Razghandi, K (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany.; Guiducci, L; Razghandi, K (corresponding author), Humboldt Univ, Cluster Excellence Image Knowledge, Berlin, Germany.	lorenzo.guiducci@mpikg.mpg.de; khashayar.razghandi@mpikg.mpg.de	Bertinetti, Luca/M-8242-2016; Weaver, James C./AAE-7870-2019; Dunlop, John W C/A-1997-2012; Fratzl, Peter/H-9095-2012	Bertinetti, Luca/0000-0002-4666-9610; Dunlop, John W C/0000-0003-2741-6383; Fratzl, Peter/0000-0003-4437-7830; Razghandi, Khashayar/0000-0003-3419-4870	Max Planck Institute of Colloids and Interfaces of Potsdam; DFG Deutsche Forschungsgemeinschaft through Priority Program: "Biomimetic Materials Research: Functionality by Hierarchical Structuring of Materials" [SPP1420]; "Image Knowledge Gestaltung: An Interdisciplinary Laboratory" Cluster of Excellence at the Humboldt University of Berlin through DFG contract [EXC1027/1]; ETHZ, Institute for Building Materials (IfB) of Zurich, Switzerland; Empa, Applied Wood Materials Laboratory of Dubendorf, Switzerland	Max Planck Institute of Colloids and Interfaces of Potsdam; DFG Deutsche Forschungsgemeinschaft through Priority Program: "Biomimetic Materials Research: Functionality by Hierarchical Structuring of Materials"; "Image Knowledge Gestaltung: An Interdisciplinary Laboratory" Cluster of Excellence at the Humboldt University of Berlin through DFG contract; ETHZ, Institute for Building Materials (IfB) of Zurich, Switzerland; Empa, Applied Wood Materials Laboratory of Dubendorf, Switzerland	This work was financially supported by Max Planck Institute of Colloids and Interfaces of Potsdam, the DFG Deutsche Forschungsgemeinschaft through SPP1420 Priority Program: "Biomimetic Materials Research: Functionality by Hierarchical Structuring of Materials," "Image Knowledge Gestaltung: An Interdisciplinary Laboratory" Cluster of Excellence at the Humboldt University of Berlin through DFG contract EXC1027/1, ETHZ, Institute for Building Materials (IfB) of Zurich, Switzerland, and Empa, Applied Wood Materials Laboratory of Dubendorf, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertinetti L, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.238001; Brown R, 2006, PHYS TESTING RUBBERS; Burgert I, 2009, PHILOS T R SOC A, V367, P1541, DOI 10.1098/rsta.2009.0003; Burgert I, 2009, INTEGR COMP BIOL, V49, P69, DOI 10.1093/icb/icp026; Caulfield DF, 1988, 1988 PAPER PRESERVAT; Dawson J, 1997, NATURE, V390, P668, DOI 10.1038/37745; Elbaum R, 2008, J STRUCT BIOL, V164, P101, DOI 10.1016/j.jsb.2008.06.008; Erb RM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2666; Fratzl P, 2008, FARADAY DISCUSS, V139, P275, DOI 10.1039/b716663j; Fratzl P, 2009, NATURE, V462, P442, DOI 10.1038/nature08603; Garside S, 1930, ANN BOT-LONDON, V44, P639, DOI 10.1093/oxfordjournals.aob.a090241; Guiducci L, 2014, THESIS; Guiducci L, 2015, ADV MATER INTERFACES, V2, DOI 10.1002/admi.201500011; Guiducci L, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0458; Harrington MJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1336; Ionov L, 2013, ADV FUNCT MATER, V23, P4555, DOI 10.1002/adfm.201203692; Kang MK, 2010, J APPL MECH-T ASME, V77, DOI 10.1115/1.4001715; Lockyer S, 1932, ANN BOT-LONDON, V46, P323, DOI 10.1093/oxfordjournals.aob.a090325; Ma MM, 2013, SCIENCE, V339, P186, DOI 10.1126/science.1230262; Neuhaus FH, 1981, ELASTIZITATSZAHLEN V; Rafsanjani A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08064; Razghandi K, 2015, THESIS; Razghandi K, 2014, BIOINSPIR BIOMIM NAN, V3, P169, DOI 10.1680/bbn.14.00016; Reyssat E, 2009, J R SOC INTERFACE, V6, P951, DOI 10.1098/rsif.2009.0184; Ruggeberg M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120718; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHAHINPOOR M, 1995, MAT SCI ENG C-BIOMIM, V2, P229, DOI 10.1016/0928-4931(95)00105-0; Shepherd RF, 2011, P NATL ACAD SCI USA, V108, P20400, DOI 10.1073/pnas.1116564108; Sinibaldi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102461; Teraoka I, 1996, PROG POLYM SCI, V21, P89, DOI 10.1016/0079-6700(95)00018-6; Timoshenko S, 1925, J OPT SOC AM REV SCI, V11, P233, DOI 10.1364/JOSA.11.000233; Treloar LRG, 1949, THE PHYSICS OF RUBBE; Turcaud S, 2011, INT J MATER RES, V102, P607, DOI 10.3139/146.110517	33	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0163506	10.1371/journal.pone.0163506	http://dx.doi.org/10.1371/journal.pone.0163506			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806052	Green Published, Green Submitted, gold			2022-12-26	WOS:000386715500006
J	Li, XF; Wu, Y; Ren, XQ; Deng, SY; Hu, GF; Yu, SY; Tang, SX				Li, Xiufen; Wu, Yue; Ren, Xuqi; Deng, Shuyun; Hu, Guifang; Yu, Shouyi; Tang, Shixing			Characterization of Humoral Immune Responses against Capsid Protein p24 and Transmembrane Glycoprotein gp41 of Human Immunodeficiency Virus Type 1 in China	PLOS ONE			English	Article							B-CELL EPITOPES; MONOCLONAL-ANTIBODIES; HIV; ASSAYS; SEROCONVERSION; INFECTION	The objective of this study was to extend our previous research and to further characterize the humoral immune responses against HIV-1 p24, gp41 and the specific peptides carrying the immunodominant epitopes (IDEs) that react with human serum samples from HIV-1-infected individuals in China. We found that the majority (90.45%, 180/199) of the samples did not react with any of the three HIV-1 p24 peptides carrying IDEs, but did react with the recombinant full-length p24, suggesting that these samples tested in China were primarily directed against the conformational epitopes of HIV-1 p24. In contrast, 84.54% (164/194) of the samples reacted with at least one HIV-1 linear gp41 peptide, in particular the gp41p1 peptide (amino acids 560-616). Both recently and long-term HIV-1-infected individuals displayed similar humoral immune responses against the recombinant gp41. However, samples from long-term HIV-1-infected subjects but not from recently infected subjects, showed a very strong reaction against the gp41-p1 peptide. The different response patterns observed for the two groups against the gp41 and the peptide gp41-p1 were statistically significant (P<0.01, Chi-square test). These results have direct relevance and importance for design of improved HIV-1 p24 detection assays and the gp41-based immunoassay that can be used to reliably distinguish recent and long-term HIV-1 infection.	[Li, Xiufen; Wu, Yue; Hu, Guifang; Yu, Shouyi; Tang, Shixing] Southern Med Univ, Sch Publ Hlth, Dept Epidemiol, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Guangdong, Peoples R China; [Ren, Xuqi] Guangdong Prov Skin Dis & STD Control Ctr, Dept Sexually Transmitted Dis, Guangzhou, Guangdong, Peoples R China; [Deng, Shuyun] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, State Key Lab Organ Failure Res,Guangdong Prov Ke, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Yu, SY; Tang, SX (corresponding author), Southern Med Univ, Sch Publ Hlth, Dept Epidemiol, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Guangdong, Peoples R China.	qingchen@smu.edu.cn; tamgshixing@smu.edu.cn	Ren, Xu-Qi/GRX-4131-2022		Guangzhou Science and Technology Program - Bureau of Science and Information Technology of Guangzhou Municipality [201508020018]; Guangdong Province Public Welfare Research and Capacity Building Project - Guangdong Provincial Department of Science and Technology [20146020212007]	Guangzhou Science and Technology Program - Bureau of Science and Information Technology of Guangzhou Municipality; Guangdong Province Public Welfare Research and Capacity Building Project - Guangdong Provincial Department of Science and Technology	This research is supported by Guangzhou Science and Technology Program sponsored by Bureau of Science and Information Technology of Guangzhou Municipality (no. 201508020018). This research is also supported by Guangdong Province Public Welfare Research and Capacity Building Project sponsored by Guangdong Provincial Department of Science and Technology (no. 20146020212007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. rly.	Atun R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001045; BARIN F, 1985, SCIENCE, V228, P1094, DOI 10.1126/science.2986291; Bentsen C, 2011, J CLIN VIROL, V52, pS57, DOI 10.1016/j.jcv.2011.09.023; Brookmeyer R, 2013, AM J EPIDEMIOL, V177, P264, DOI 10.1093/aje/kws436; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Chen S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048747, 10.1371/journal.pone.0046703, 10.1371/journal.pone.0029579, 10.1371/journal.pone.0050850]; Cohen MS, 2010, J INFECT DIS, V202, pS270, DOI 10.1086/655651; Dosenovic P, 2009, J IMMUNOL, V183, P3373, DOI 10.4049/jimmunol.0900407; Friedman DS, 2017, INT J STD AIDS, V28, P693, DOI 10.1177/0956462416664674; GAINES H, 1987, LANCET, V1, P1249; Gao ZY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161183; Hauser A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098038; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; JANVIER B, 1990, J VIROL, V64, P4258, DOI 10.1128/JVI.64.9.4258-4263.1990; Janvier B, 1996, AIDS RES HUM RETROV, V12, P519, DOI 10.1089/aid.1996.12.519; Kassanjee R, 2014, AIDS, V28, P2439, DOI 10.1097/QAD.0000000000000429; Kirkpatrick AR, 2016, AIDS RES HUM RETROV, V32, P756, DOI [10.1089/AID.2015.0198, 10.1089/aid.2015.0198]; Liu GJ, 2005, CELL MOL IMMUNOL, V2, P289; Liu GJ, 2007, CELL MOL IMMUNOL, V4, P203; Longosz AF, 2014, AIDS RES HUM RETROV, V30, P339, DOI [10.1089/aid.2013.0169, 10.1089/AID.2013.0169]; Mastro Timothy D, 2010, J HIV AIDS Surveill Epidemiol, V2, P1; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mehandru S, 2004, J VIROL, V78, P14039, DOI 10.1128/JVI.78.24.14039-14042.2004; Moyo S, 2015, VIRUSES-BASEL, V7, P5508, DOI 10.3390/v7102887; Nabel GJ, 2005, SCIENCE, V308, P1878, DOI 10.1126/science.1114854; Parekh BS, 2011, AIDS RES HUM RETROV, V27, P265, DOI 10.1089/aid.2010.0159; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Powers KA, 2007, AIDS, V21, P2237, DOI 10.1097/QAD.0b013e3282f08b4d; Ragupathy V, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-185; Rosenberg NE, 2015, CURR OPIN HIV AIDS, V10, P61, DOI 10.1097/COH.0000000000000121; Serhir B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156023; Tang SX, 2010, CLIN VACCINE IMMUNOL, V17, P1244, DOI 10.1128/CVI.00066-10; Wang Ning, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P541; Wei XR, 2010, AIDS RES HUM RETROV, V26, P61, DOI 10.1089/aid.2009.0133; Wu JLW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001865; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991; Yusim K, 2016, LAUR1622283 LANL	37	2	2	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165874	10.1371/journal.pone.0165874	http://dx.doi.org/10.1371/journal.pone.0165874			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802337	Green Submitted, Green Published, gold			2022-12-26	WOS:000386714200064
J	Hirai, Y; Hirano, Y; Matsuda, A; Hiraoka, Y; Honda, T; Tomonaga, K				Hirai, Yuya; Hirano, Yasuhiro; Matsuda, Atsushi; Hiraoka, Yasushi; Honda, Tomoyuki; Tomonaga, Keizo			Borna Disease Virus Assembles Porous Cage-like Viral Factories in the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURED-ILLUMINATION MICROSCOPY; INFECTED-CELLS; POLYMERASE COMPLEX; PROTEIN; RESOLUTION; NUCLEOPROTEIN; RNA; PHOSPHOPROTEIN; REPLICATION; LOCALIZATION	Animal-derived RNA viruses frequently generate viral factories in infected cells. However, the details of how RNA viruses build such intracellular structures are poorly understood. In this study, we examined the structure and formation of the viral factories, called viral speckle of transcripts (vSPOTs), that are produced in the nuclei of host cells by Borna disease virus (BDV). Super-resolution microscopic analysis showed that BDV assembled vSPOTs as intranuclear cage-like structures with 59-180-nm pores. The viral nucleoprotein formed the exoskeletons of vSPOTs, whereas the other viral proteins appeared to be mainly localized within these structures. In addition, stochastic optical reconstruction microscopy revealed that filamentous structures resembling viral ribonucleoprotein complexes (RNPs) appeared to protrude from the outer surfaces of the vSPOTs. We also found that vSPOTs disintegrated into RNPs concurrently with the breakdown of the nuclear envelope during mitosis. These observations demonstrated that BDV generates viral replication factories whose shape and formation are regulated, suggesting the mechanism of the integrity of RNA virus persistent infection in the nucleus.	[Hirai, Yuya] Osaka Dent Univ, Dept Biol, Hirakata, Osaka 5731121, Japan; [Hirai, Yuya; Honda, Tomoyuki; Tomonaga, Keizo] Kyoto Univ, Inst Frontier Life & Med Sci InFRONT, Dept Virus Res, Kyoto 6068507, Japan; [Tomonaga, Keizo] Kyoto Univ, Dept Mol Virol, Grad Sch Med, Kyoto 6068507, Japan; [Tomonaga, Keizo] Kyoto Univ, Mammalian Regulatory Network, Grad Sch Biostudies, Kyoto 6068507, Japan; [Hirano, Yasuhiro; Matsuda, Atsushi; Hiraoka, Yasushi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Matsuda, Atsushi; Hiraoka, Yasushi] Natl Inst Informat & Commun Technol, Adv ICT Res Inst Kobe, Kobe, Hyogo 6512492, Japan	Kyoto University; Kyoto University; Kyoto University; Osaka University; National Institute of Information & Communications Technology (NICT) - Japan	Tomonaga, K (corresponding author), Kyoto Univ, Inst Frontier Life & Med Sci InFRONT, Dept Virus Res, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	tomonaga@virus.kyoto-u.ac.jp	Hirano, Yasuhiro/AAN-4617-2021; Hiraoka, Yasushi/B-5111-2009	Hiraoka, Yasushi/0000-0001-9407-8228; Hirano, Yasuhiro/0000-0001-7339-4053; Hirai, Yuya/0000-0001-8571-080X; Matsuda, Atsushi/0000-0003-0510-213X	Japan Society for the Promotion of Science (JSPS)/The Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [JP26253027, JP15H01259, JP16H06429, JP16K21723, JP16H06430, JP26870286, JP25840008, JP16H01440, JP15K14500, JP26116511]; JSPS Core-to-Core Program A, the Advanced Research Networks; Basic Science and Platform Technology Program for Innovative Biological Medicine; Japanese Agency for Medical Research and Development (AMED); Takeda Science Foundation; Grants-in-Aid for Scientific Research [16H01309, 15K14500, 16H01440] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)/The Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI; JSPS Core-to-Core Program A, the Advanced Research Networks(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Basic Science and Platform Technology Program for Innovative Biological Medicine; Japanese Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science (JSPS)/The Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grant Numbers JP26253027, JP15H01259, JP16H06429, JP16K21723, JP16H06430 (to K. T.), JP26870286 (to Y. Hirai), JP25840008 (to Y. Hirano), JP16H01440, JP15K14500 (to A. M.), and JP26116511 (to Y. Hiraoka), and JSPS Core-to-Core Program A, the Advanced Research Networks (to K. T.), the Basic Science and Platform Technology Program for Innovative Biological Medicine (to K. T.) from the Japanese Agency for Medical Research and Development (AMED), and a grant from the Takeda Science Foundation (to K. T.). The authors declare that they have no conflicts of interest with the contents of this article.	BRIESE T, 1992, P NATL ACAD SCI USA, V89, P11486, DOI 10.1073/pnas.89.23.11486; Charlier CM, 2013, J VIROL, V87, P12339, DOI 10.1128/JVI.01127-13; Chase G, 2007, J VIROL, V81, P743, DOI 10.1128/JVI.01351-06; GARCIA J, 1993, VIROLOGY, V195, P243, DOI 10.1006/viro.1993.1366; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Heinrich BS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000958; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Hirai Y, 2015, J GEN VIROL, V96, P3198, DOI 10.1099/jgv.0.000273; Holden SJ, 2011, NAT METHODS, V8, P279, DOI 10.1038/nmeth0411-279; Knoops K, 2012, J VIROL, V86, P2474, DOI 10.1128/JVI.06677-11; Knoops K, 2008, PLOS BIOL, V6, P1957, DOI 10.1371/journal.pbio.0060226; Kobayashi T, 2003, J VIROL, V77, P8099, DOI 10.1128/JVI.77.14.8099-8107.2003; Kobayashi T, 2001, J VIROL, V75, P3404, DOI 10.1128/JVI.75.7.3404-3412.2001; Lahaye X, 2009, J VIROL, V83, P7948, DOI 10.1128/JVI.00554-09; Lang T, 2010, PHYSIOLOGY, V25, P116, DOI 10.1152/physiol.00044.2009; Ludwig H, 2000, REV SCI TECH OIE, V19, P259, DOI 10.20506/rst.19.1.1217; Matsuda A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8753; Matsuda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012768; Matsumoto Y, 2012, CELL HOST MICROBE, V11, P492, DOI 10.1016/j.chom.2012.04.009; Matsunaga S, 2012, CELL REP, V1, P299, DOI 10.1016/j.celrep.2012.02.005; Nakamura Y, 2000, J VIROL, V74, P4601, DOI 10.1128/JVI.74.10.4601-4611.2000; Nanbo A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01206; Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32; Perez M, 2003, J GEN VIROL, V84, P3099, DOI 10.1099/vir.0.19467-0; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schneider U, 2005, VIRUS RES, V111, P148, DOI 10.1016/j.virusres.2005.04.006; Schneider U, 2003, J VIROL, V77, P11781, DOI 10.1128/JVI.77.21.11781-11789.2003; Staudt T, 2007, MICROSC RES TECHNIQ, V70, P1, DOI 10.1002/jemt.20396; Tomonaga K, 2002, MICROBES INFECT, V4, P491, DOI 10.1016/S1286-4579(02)01564-2; Vaughan JC, 2012, NAT METHODS, V9, P1181, DOI [10.1038/NMETH.2214, 10.1038/nmeth.2214]; Watanabe M, 2000, MICROBIOL IMMUNOL, V44, P765, DOI 10.1111/j.1348-0421.2000.tb02561.x; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; ZAJAC BA, 1970, J VIROL, V6, P243, DOI 10.1128/JVI.6.2.243-252.1970	35	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25789	25798		10.1074/jbc.M116.746396	http://dx.doi.org/10.1074/jbc.M116.746396			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27803166	Green Published, hybrid			2022-12-26	WOS:000390345200003
J	Archidona-Yuste, A; Navas-Cortes, JA; Cantalapiedra-Navarrete, C; Palomares-Rius, JE; Castillo, P				Archidona-Yuste, Antonio; Navas-Cortes, Juan A.; Cantalapiedra-Navarrete, Carolina; Palomares-Rius, Juan E.; Castillo, Pablo			Remarkable Diversity and Prevalence of Dagger Nematodes of the Genus Xiphinema Cobb, 1913 (Nematoda: Longidoridae) in Olives Revealed by Integrative Approaches	PLOS ONE			English	Article							SP-N NEMATODA; AMERICANUM-GROUP; COMPLEX NEMATODA; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR CHARACTERIZATION; SPECIES DELIMITATION; PARASITIC NEMATODES; IDENTIFICATION; PACHTAICUM; POPULATIONS	The genus Xiphinema includes a remarkable group of invertebrates of the phylum Nematoda comprising ectoparasitic animals of many wild and cultivated plants. Damage is caused by direct feeding on root cells and by vectoring nepoviruses that cause diseases on several crops. Precise identification of Xiphinema species is critical for launching appropriate control measures. We make available the first detailed information on the diversity and distribution of Xiphinema species infesting wild and cultivated olive in a wide-region in southern Spain that included 211 locations from which 453 sampling sites were analyzed. The present study identified thirty-two Xiphinema spp. in the rhizosphere of olive trees, ten species belonging to Xiphinema americanum-group, whereas twenty-two were attributed to Xiphinema non-americanum-group. These results increase our current knowledge on the biodiversity of Xiphinema species identified in olives and include the description of four new species (Xiphinema andalusiense sp. nov., Xiphinema celtiense sp. nov., Xiphinema iznajarense sp. nov., and Xiphinema mengibarense sp. nov.), and two new records for cultivate olives (X. cadavalense and X. conurum). We also found evidence of remarkable prevalence of Xiphinema spp. in olive trees, viz. 85.0% (385 out of 453 sampling sites), and they were widely distributed in both wild and cultivated olives, with 26 and 17 Xiphinema spp., respectively. Diversity indexes (Richness, Hill 's diversity, Hill 's reciprocal of D and Hill' s evenness) were significantly affected by olive type. We also developed a comparative morphological and morphometrical study together with molecular data from three nuclear ribosomal RNA genes (D2-D3 expansion segments of 28S, ITS1, and partial 18S). Molecular characterization and phylogenetic analyses allowed the delimitation and discrimination of four new species of the genus described herein and three known species. Phylogenetic analyses of Xiphinema spp. resulted in a general consensus of these species groups. This study is the most complete phylogenetic analysis for Xiphinema non-americanum-group species to date.	[Archidona-Yuste, Antonio; Navas-Cortes, Juan A.; Cantalapiedra-Navarrete, Carolina; Palomares-Rius, Juan E.; Castillo, Pablo] CSIC, IAS, Ave Menendez Pidal S-N, Cordoba 14004, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Castillo, P (corresponding author), CSIC, IAS, Ave Menendez Pidal S-N, Cordoba 14004, Spain.	p.castillo@csic.es	Navas-Cortes, Juan A/H-3381-2014; , Antonio/ABF-4935-2020; Archidona-Yuste, Antonio/GRS-2729-2022; Castillo, Pablo/L-3397-2019; Navas-Cortes, Juan A./M-2060-2019; Castillo, Pablo/A-1445-2011; Archidona-Yuste, Antonio/C-2406-2018; Palomares-Rius, Juan/K-8004-2015	Navas-Cortes, Juan A/0000-0001-6480-1104; , Antonio/0000-0003-4446-0642; Archidona-Yuste, Antonio/0000-0003-4446-0642; Castillo, Pablo/0000-0001-6657-6385; Castillo, Pablo/0000-0003-0256-876X; Archidona-Yuste, Antonio/0000-0003-4446-0642; Palomares-Rius, Juan/0000-0003-1776-8131	Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia [P12-AGR-1486]; Institute Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) [219262]; 'Ministerio de Economia y Competitividad' of Spain [AGL-2012-37521]; FEDER from the European Union	Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia; Institute Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)(Instituto de Investigacion Agropecuaria (INIA)); 'Ministerio de Economia y Competitividad' of Spain; FEDER from the European Union	Financial support was received by Project P12-AGR-1486 from 'Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia, the grant 219262 ArimNET_ERANET FP7 2012-2015 Project PESTOLIVE 'Contribution of olivehistory for the management of soilborne parasites in the Mediterranean basin' from Institute Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA), Project AGL-2012-37521 from 'Ministerio de Economia y Competitividad' of Spain, and FEDER financial support from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archidona-Yuste A, 2016, INVERTEBR SYST, V30, P547, DOI 10.1071/IS16002; Archidona-Yuste A, 2016, ZOOL J LINN SOC-LOND, V176, P231, DOI 10.1111/zoj.12316; Archidona-Yuste A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147689; ARIAS M, 1987, Revue de Nematologie, V10, P377; Arias M., 1973, Nematologia Mediterranea, V1, P28; Bongers T, 1999, TRENDS ECOL EVOL, V14, P224, DOI 10.1016/S0169-5347(98)01583-3; Brown D.J.F., 1994, Nematologia Mediterranea, V22, P253; Brown D.J.F., 1993, Nematologia Mediterranea, V20, P251; Cantalapiedra-Navarrete C, 2013, ZOOL ANZ, V252, P246, DOI 10.1016/j.jcz.2012.08.002; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cherry T, 1997, J NEMATOL, V29, P23; Cobb N. A., 1913, J Acad Sci, V3; COOMANS A, 1985, AGR ECOSYST ENVIRON, V12, P335, DOI 10.1016/0167-8809(85)90006-4; Coomans A, 2000, NEMATOLOGY, V2, P3, DOI 10.1163/156854100508845; Coomans A, 2001, ANN SCI ZOOLOGIQUES, V287, P1; Coomans August, 1996, Russian Journal of Nematology, V4, P51; Dalmasso A., 1969, MEMOIRES MUSEUM NATL, VLXI; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Decaens T, 2006, EUR J SOIL BIOL, V42, pS23, DOI 10.1016/j.ejsobi.2006.07.001; Decraemer W, 2006, PLANT NEMATOLOGY, P3, DOI [10.1079/9781845930561.0003, 10.1079/9781780641515.0003]; Decraemer W, 2007, J NEMATOL, V39, P295; Groza M, 2013, HELMINTHOLOGIA, V50, P215, DOI 10.2478/s11687-013-0133-3; Guesmi-Mzoughi I, 2017, EUR J PLANT PATHOL, V147, P389, DOI 10.1007/s10658-016-1011-x; Gutierrez-Gutierrez C, 2013, ZOOL J LINN SOC-LOND, V169, P548, DOI 10.1111/zoj.12071; Gutierrez-Gutierrez C, 2012, EUR J PLANT PATHOL, V134, P561, DOI 10.1007/s10658-012-0039-9; Gutierrez-Gutierrez C, 2011, PHYTOPATHOLOGY, V101, P1168, DOI 10.1094/PHYTO-07-10-0194; Gutierrez-Gutierrez C, 2011, EUR J PLANT PATHOL, V129, P427, DOI 10.1007/s10658-010-9705-y; Gutierrez-Gutierrez C, 2010, ZOOL SCR, V39, P483, DOI 10.1111/j.1463-6409.2010.00437.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hashim Z., 1979, Nematologia Mediterranea, V7, P177; Hashim Z., 1983, Nematologia Mediterranea, V11, P27; He Y, 2005, NEMATOLOGY, V7, P111, DOI 10.1163/1568541054192108; HEYNS J, 1971, Phytophylactica, V3, P107; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kirjanova E. S, 1951, TRUDY ZOOL INST AKAD, V9, P625; Koenning SR, 1999, J NEMATOL, V31, P587; Lal A., 1982, Nematologia Mediterranea, V10, P217; Lamberti F., 2004, Nematologia Mediterranea, V32, P53; Lamberti F., 1993, Nematologia Mediterranea, V21, P215; Lamberti F., 1983, Nematologia Mediterranea, V11, P49; Lamberti F, 2000, RUSS J NEMATOL, V8, P65; Lamberti F., 1992, Nematologia Mediterranea, V20, P125; Lamberti F., 1986, Nematologia Mediterranea, V14, P101; Lamberti F., 1993, EPPO B, V23, P481, DOI DOI 10.1111/J.1365-2338.1993.TB01356.X; Lamberti F, 1979, NEMATOLOGIA MEDITERR, V7, P51; Lamberti F, 1990, NEMATOLOGIA MEDITERR, V17, P115; Linnaeus C, 1766, SYSTEMA NATURAE REGN; LOOF PAA, 1990, SYST PARASITOL, V16, P35, DOI 10.1007/BF00009600; LOOF PAA, 1972, NEMATOLOGICA, V18, P92, DOI 10.1163/187529272X00458; LUC M, 1985, Revue de Nematologie, V8, P85; LUC M, 1982, Revue de Nematologie, V5, P233; Luc M., 1964, Nematologica, V10, P151; Luc M., TROIS NOUVEAUX XIPHI; Macfarlane SA, 2003, MOL PLANT PATHOL, V4, P211, DOI 10.1046/j.1364-3703.2003.00164.x; MacFarlane SA, 2002, ADV BOT RES, V36, P169, DOI 10.1016/S0065-2296(02)36063-4; Martelli GP, 1990, ADV DIS VECTOR RES, V6, P144; MCELROY FD, 1972, J NEMATOL, V4, P16; Meyl AH., 1953, Z MORPHOLOGIE OKOL T; MICOLETZKY H., 1927, ZOOL ANZEIGER, V73, P113; NAVAS A, 1988, NEMATOLOGICA, V34, P314, DOI 10.1163/002825988X00170; Navas A., 1993, Nematologia Mediterranea, V21, P71; Navas A., 1990, Nematologia Mediterranea, V18, P103; Oliveira CMG, 2006, J NEMATOL, V38, P418; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palomares-Rius JE, 2008, NEMATOLOGY, V10, P87, DOI 10.1163/156854108783360186; Palomares-Rius JE, 2016, MOL ECOL, V25, P6225, DOI 10.1111/mec.13904; Palomares-Rius JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116890; Palomares-Rius JE, 2014, NEMATOLOGY, V16, P1105, DOI 10.1163/15685411-00002831; Palomares-Rius JE, 2012, SOIL BIOL BIOCHEM, V45, P168, DOI 10.1016/j.soilbio.2011.11.009; PENA-SANTIAGO R, 1990, Revue de Nematologie, V13, P113; Pereira M. J., 1992, NEMATOLOGICA, V38, P428; Robbins Robert T., 1996, Russian Journal of Nematology, V4, P163; ROBBINS RT, 1995, SYST PARASITOL, V32, P33, DOI 10.1007/BF00009466; ROCA F, 1994, FUND APPL NEMATOL, V17, P79; ROCA F, 1993, FUND APPL NEMATOL, V16, P543; ROCA F, 1993, FUND APPL NEMATOL, V16, P515; ROCA F, 1991, Revue de Nematologie, V14, P597; ROCA F, 1993, FUND APPL NEMATOL, V16, P455; Roca F., 1988, Nematologia Mediterranea, V16, P87; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanchez-Moreno S, 2015, AGRON SUSTAIN DEV, V35, P691, DOI 10.1007/s13593-014-0266-x; Sasanelli N., 1999, Nematologia Mediterranea, V27, P253; Schindler AF, 1957, MARYLAND FLORIST, V47, P1; Schuurmans Stekhoven Jr JH, 1938, NEMATODES LIBRES TER; Siddiqi M. R., 1961, Zeitschrift fuer Parasitenkunde, V20, P457, DOI 10.1007/BF00572848; Siddiqi M. R., 2000, TYLENCHIDA PARASITES; STURHAN D, 1983, NEMATOLOGICA, V29, P270, DOI 10.1163/187529283X00032; STURHAN D, 1984, NEMATOLOGICA, V30, P305, DOI 10.1163/187529284X00211; STURHAN D, 1978, NEMATOLOGICA, V24, P19, DOI 10.1163/187529278X00029; Subbotin SA, 2006, PLANT NEMATOLOGY, P33, DOI 10.1079/9781845930561.0033; Tarjan A. C., 1964, FAO PLANT PROTECTION, V12, P49; Taylor C.E., 1997, NEMATODE VECTORS PLA; Teliz D, 2007, PLANT DIS, V91, P1147, DOI 10.1094/PDIS-91-9-1147; Thome G., 1939, V Proc helminth Soc Washington, V6, P30; THORNE G, 1950, P HELM SOC WASH, V17, P27; THORNE GERALD, 1935, PROC HELMINTH SOC WASHINGTON, V2, P96; Tulaganov A. T, 1938, T UZBEKSKOGO GOSUDAR, V12, P1; Tzortzakakis EA, 2015, NEMATOLOGY, V17, P231, DOI 10.1163/15685411-00002865; Tzortzakakis EA, 2014, EUR J PLANT PATHOL, V140, P563, DOI 10.1007/s10658-014-0488-4; WILLIAMS TD, 1961, CAN J ZOOLOG, V39, P407, DOI 10.1139/z61-044; Wolters V, 2001, EUR J SOIL BIOL, V37, P221, DOI 10.1016/S1164-5563(01)01088-3; Wyss U, 1997, DEV PLANT PATHOL, V10, P5; Ye WM, 2004, J NEMATOL, V36, P14; Yeates GW, 1999, AGR ECOSYST ENVIRON, V74, P113, DOI 10.1016/S0167-8809(99)00033-X	105	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165412	10.1371/journal.pone.0165412	http://dx.doi.org/10.1371/journal.pone.0165412			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829048	Green Published, gold, Green Submitted			2022-12-26	WOS:000387724300043
J	Czernekova, M; Jonsson, KI				Czernekova, Michaels; Jonsson, K. Ingemar			Experimentally Induced Repeated Anhydrobiosis in the Eutardigrade Richtersius coronifer	PLOS ONE			English	Article							STORAGE-CELLS; TARDIGRADES; CRYPTOBIOSIS; TOLERANCE; SURVIVAL; LIFE; MACROBIOTIDAE; EVOLUTION	Tardigrades represent one of the main animal groups with anhydrobiotic capacity at any stage of their life cycle. The ability of tardigrades to survive repeated cycles of anhydrobiosis has rarely been studied but is of interest to understand the factors constraining anhydrobiotic survival. The main objective of this study was to investigate the patterns of survival of the eutardigrade Richtersius coronifer under repeated cycles of desiccation, and the potential effect of repeated desiccation on size, shape and number of storage cells. We also analyzed potential change in body size, gut content and frequency of mitotic storage cells. Specimens were kept under non-cultured conditions and desiccated under controlled relative humidity. After each desiccation cycle 10 specimens were selected for analysis of morphometric characteristics and mitosis. The study demonstrates that tardigrades may survive up to 6 repeated desiccations, with declining survival rates with increased number of desiccations. We found a significantly higher proportion of animals that were unable to contract properly into a tun stage during the desiccation process at the 5th and 6th desiccations. Also total number of storage cells declined at the 5th and 6th desiccations, while no effect on storage cell size was observed. The frequency of mitotic storage cells tended to decline with higher number of desiccation cycles. Our study shows that the number of consecutive cycles of anhydrobiosis that R. coronifer may undergo is limited, with increased inability for tun formation and energetic constraints as possible causal factors.	[Czernekova, Michaels; Jonsson, K. Ingemar] Kristianstad Univ, Sch Educ & Environm, Kristianstad, Sweden; [Czernekova, Michaels] Acad Sci Czech Republic, Inst Physiol, Prague, Czech Republic; [Czernekova, Michaels] Charles Univ Prague, Fac Med, Prague, Czech Republic	Kristianstad University; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague	Czernekova, M (corresponding author), Kristianstad Univ, Sch Educ & Environm, Kristianstad, Sweden.; Czernekova, M (corresponding author), Acad Sci Czech Republic, Inst Physiol, Prague, Czech Republic.; Czernekova, M (corresponding author), Charles Univ Prague, Fac Med, Prague, Czech Republic.	Czernekovam@seznam.cz			Academy of Sciences of the Czech Republic [RVO: 67985823]; Mobility Fund, Charles University in Prague; Kristianstad University Sweden	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Mobility Fund, Charles University in Prague; Kristianstad University Sweden	MC received funding from the Academy of Sciences of the Czech Republic (RVO: 67985823) and the Mobility Fund, Charles University in Prague (http://wvw.cuni.cz/ukeng-49-version1.txt). MC and KIJ received funding from Kristianstad University Sweden (www.hkr.se).	Alpert P, 2006, J EXP BIOL, V209, P1575, DOI 10.1242/jeb.02179; Alpert P, 2005, INTEGR COMP BIOL, V45, P685, DOI 10.1093/icb/45.5.685; Baumann H., 1922, Zoologische Jahrbuecher Jena Abteilungen f Systematik, V45, P501; Clegg JS, 2001, COMP BIOCHEM PHYS B, V128, P613, DOI 10.1016/S1096-4959(01)00300-1; CROWE J H, 1975, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V32, P37; Czernekova M, 2016, ZOOL J LINN SOC-LOND, V178, P888, DOI 10.1111/zoj.12440; Guidetti R, 2002, J ZOOL, V257, P181, DOI 10.1017/S095283690200078X; Hengherr S, 2008, J ZOOL, V275, P216, DOI 10.1111/j.1469-7998.2008.00427.x; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Jonsson KI, 2005, INTEGR COMP BIOL, V45, P764, DOI 10.1093/icb/45.5.764; Jonsson KI, 2005, INT J RADIAT BIOL, V81, P649, DOI 10.1080/09553000500368453; Jonsson KI, 2001, ZOOL ANZ, V240, P419, DOI 10.1078/0044-5231-00050; Jonsson KI, 2002, J EXP ZOOL, V293, P578, DOI 10.1002/jez.10186; KEILIN D, 1959, PROC R SOC SER B-BIO, V150, P149, DOI 10.1098/rspb.1959.0013; Lance D., 1896, THESIS; Mobjerg N, 2007, J LIMNOL, V66, P132, DOI 10.4081/jlimnol.2007.s1.132; Nelson DR, 2002, INTEGR COMP BIOL, V42, P652, DOI 10.1093/icb/42.3.652; Neumann S, 2009, COMP BIOCHEM PHYS A, V153, P425, DOI 10.1016/j.cbpa.2009.04.611; Pilato G., 1981, Animalia (Catania), V8, P51; Puhlev I, 2001, CRYOBIOLOGY, V42, P207, DOI 10.1006/cryo.2001.2324; Rebecchi L, 2003, INVERTEBR BIOL, V122, P19; REBECCHI L, 1991, CARYOLOGIA, V44, P301, DOI 10.1080/00087114.1991.10797195; Reuner A, 2010, CURR ZOOL, V56, P259, DOI 10.1093/czoolo/56.2.259; Schill RO, 2009, BIOTECHNOL ADV, V27, P348, DOI 10.1016/j.biotechadv.2009.01.011; Weglarska B., 1994, ACTA BIOL CRACOV, VXXXVI, P41; Wolkers WF, 2002, COMP BIOCHEM PHYS A, V131, P535, DOI 10.1016/S1095-6433(01)00505-0; Wright JC, 2001, ZOOL ANZ, V240, P563, DOI 10.1078/0044-5231-00068; WRIGHT JC, 1992, BIOL REV, V67, P1, DOI 10.1111/j.1469-185X.1992.tb01657.x	28	11	12	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0164062	10.1371/journal.pone.0164062	http://dx.doi.org/10.1371/journal.pone.0164062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828978	gold, Green Published			2022-12-26	WOS:000387724300013
J	Hamedi, Y; Sharifi-Sarasiabi, K; Dehghan, F; Safari, R; To, S; Handayuni, I; Trimarsanto, H; Price, RN; Auburn, S				Hamedi, Yaghoob; Sharifi-Sarasiabi, Khojasteh; Dehghan, Farzaneh; Safari, Reza; To, Sheren; Handayuni, Irene; Trimarsanto, Hidayat; Price, Ric N.; Auburn, Sarah			Molecular Epidemiology of P. vivax in Iran: High Diversity and Complex Sub-Structure Using Neutral Markers, but No Evidence of Y976F Mutation at pvmdr1	PLOS ONE			English	Article							RESISTANT PLASMODIUM-VIVAX; SINGLE-NUCLEOTIDE POLYMORPHISMS; LOCAL-POPULATION STRUCTURE; MALARIA CONTROL; TRANSMISSION DYNAMICS; GENETIC DIVERSITY; CRT-O; AREAS; INFECTIONS; MYANMAR	Background Malaria remains endemic at low levels in the south-eastern provinces of Iran bordering Afghanistan and Pakistan, with the majority of cases attributable to P. vivax. The national guidelines recommend chloroquine (CQ) as blood-stage treatment for uncomplicated P. vivax, but the large influx of imported cases enhances the risk of introducing CQ resistance (CQR). Methodology and Principal Findings The genetic diversity at pvmdr1, a putative modulator of CQR, and across nine putatively neutral short tandem repeat (STR) markers were assessed in P. vivax clinical isolates collected between April 2007 and January 2013 in Hormozgan Province, south-eastern Iran. One hundred blood samples were collected from patients with microscopy-confirmed P. vivax enrolled at one of five district clinics. In total 73 (73%) were autochthonous cases, 23 (23%) imported cases from Afghanistan or Pakistan, and 4 (4%) with unknown origin. 97% (97/100) isolates carried the F1076L mutation, but none carried the Y976F mutation. STR genotyping was successful in 71 (71%) isolates, including 57(57%) autochthonous and 11 (11%) imported cases. Analysis of population structure revealed 2 major sub-populations, K1 and K2, with further sub-structure within K2. The K1 sub-population had markedly lower diversity than K2 (H-E = 0.06 vs H-E = 0.82) suggesting that the sub-populations were sustained by distinct reservoirs with differing transmission dynamics, possibly reflecting local versus imported/introduced populations. No notable separation was observed between the local and imported cases although the sample size was limited. Conclusions The contrasting low versus high diversity in the two sub-populations (K1 and K2) infers that a combination of local transmission and cross-border malaria from higher transmission regions shape the genetic make-up of the P. vivax population in south-eastern Iran. There was no molecular evidence of CQR amongst the local or imported cases, but ongoing clinical surveillance is warranted.	[Hamedi, Yaghoob; Sharifi-Sarasiabi, Khojasteh] Hormozgan Univ Med Sci, Infect & Trop Dis Res Ctr, Bandar Abbas, Hormozgan Provi, Iran; [Dehghan, Farzaneh] Hormozgan Univ Med Sci, Mol Med Res Ctr, Bandar Abbas, Hormozgan Provi, Iran; [Safari, Reza] Hormozgan Univ Med Sci, Bandar Abbas, Hormozgan Provi, Iran; [To, Sheren; Handayuni, Irene; Price, Ric N.; Auburn, Sarah] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [To, Sheren; Handayuni, Irene; Price, Ric N.; Auburn, Sarah] Charles Darwin Univ, Darwin, NT, Australia; [Trimarsanto, Hidayat] Eijkman Inst Mol Biol, Bioinformat Lab, Jakarta, Indonesia; [Trimarsanto, Hidayat] Minist Res & Technol RISTEK, Jakarta, Indonesia; [Trimarsanto, Hidayat] Agcy Assessment & Applicat Technol, Jakarta, Indonesia; [Price, Ric N.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England	Charles Darwin University; Menzies School of Health Research; Charles Darwin University; Eijkman Institute; Agency for the Assessment & Application of Technology (BPPT); University of Oxford	Sharifi-Sarasiabi, K (corresponding author), Hormozgan Univ Med Sci, Infect & Trop Dis Res Ctr, Bandar Abbas, Hormozgan Provi, Iran.; Auburn, S (corresponding author), Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia.; Auburn, S (corresponding author), Charles Darwin Univ, Darwin, NT, Australia.	Shariisarasiabi@gmail.com; Sarah.Aubum@menzies.edu.au	Sharifi-Sarasiabi, Khojasteh/G-2037-2017; Hamedi, Yaghoob/G-7447-2017; Auburn, Sarah/N-2266-2013	Sharifi-Sarasiabi, Khojasteh/0000-0003-3615-5285; Hamedi, Yaghoob/0000-0003-4224-3118; Price, Richard/0000-0003-2000-2874; Auburn, Sarah/0000-0002-4638-536X; Trimarsanto, Hidayat/0000-0003-2436-8283	Infectious and Tropical Disease Research Center, Hormozgan University of Medical Sciences, Iran; Wellcome Trust [091625]	Infectious and Tropical Disease Research Center, Hormozgan University of Medical Sciences, Iran; Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported financially by the Infectious and Tropical Disease Research Center, Hormozgan University of Medical Sciences, Iran. SA and RNP were supported by the Wellcome Trust; Senior Fellowship in Clinical Science awarded to RNP (091625). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082553; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Barry AE, 2015, PATHOG GLOB HEALTH, V109, P142, DOI 10.1179/2047773215Y.0000000012; Basseri H R, 2010, Bull Soc Pathol Exot, V103, P340, DOI 10.1007/s13149-010-0050-3; Battle KE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-144; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Brega S, 2005, J INFECT DIS, V191, P272, DOI 10.1086/426830; Chavshin Ali Reza, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P47, DOI 10.1016/S2221-1691(14)60207-0; Chenet SM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-412; Cui LW, 2003, TRENDS PARASITOL, V19, P220, DOI 10.1016/S1471-4922(03)00085-0; del Carmen R, 2012, AM J TROP MED HYG, V87, P813, DOI 10.4269/ajtmh.2012.12-0094; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Edrissian G., 2006, IRAN J PARASITOL, P1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685; Getachew S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140780; Gray KA, 2013, SOLOMON ISLANDS MALA, V12, P429, DOI DOI 10.1186/1475-2875-12-429; Gunawardena S, 2014, PARASITOLOGY, V141, P880, DOI 10.1017/S0031182013002278; Gunawardena S, 2010, AM J TROP MED HYG, V82, P235, DOI 10.4269/ajtmh.2010.09-0588; Hamedi Y., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P512; Hastings IM, 1996, PARASITOLOGY, V112, P155, DOI 10.1017/S0031182000084717; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Imwong M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0906-x; Imwong M, 2014, J CLIN MICROBIOL, V52, P3303, DOI 10.1128/JCM.01057-14; Karunaweera ND, 2008, GENE, V410, P105, DOI 10.1016/j.gene.2007.11.022; Karyana M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-148; Kim JY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151514; Koepfli C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003872; Koepfli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066041; Koepfli C, 2009, J INFECT DIS, V199, P1074, DOI 10.1086/597303; Marfurt J, 2008, J INFECT DIS, V198, P409, DOI 10.1086/589882; Nateghpour M, 2007, IRAN J PUBLIC HEALTH, V36, P60; Noviyanti R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003739; Orjuela-Sanchez P, 2009, ANTIMICROB AGENTS CH, V53, P3561, DOI 10.1128/AAC.00004-09; PALMQUIST EE, 1954, PUBLIC HEALTH REP, V69, P976, DOI 10.2307/4588935; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pava Z, 2016, ANTIMICROB AGENTS CH, V60, P361, DOI 10.1128/AAC.02207-15; Price RN, 2014, LANCET INFECT DIS, V14, P982, DOI 10.1016/S1473-3099(14)70855-2; Price RN, 2012, TRENDS PARASITOL, V28, P522, DOI 10.1016/j.pt.2012.08.005; Pritchard JK, 2000, GENETICS, V155, P945; Raeisi A, 2013, IRAN J PUBLIC HEALTH, V42, P326; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schousboe ML, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-392; Suwanarusk R, 2008, J INFECT DIS, V198, P1558, DOI 10.1086/592451; Suwanarusk R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001089; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Van den Eede P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-151; Van den Eede P, 2010, AM J TROP MED HYG, V82, P223, DOI 10.4269/ajtmh.2010.09-0458; Wangchuk S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1320-8; Wangdi K, 2015, ADV PARASIT, V89, P79, DOI 10.1016/bs.apar.2015.04.002; White NJ, 2012, ADV PARASIT, V80, P113, DOI 10.1016/B978-0-12-397900-1.00002-5; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2015, WORLD MAL REP 2015; ZAIM M, 1987, J AM MOSQUITO CONTR, V3, P392; Zakeri S, 2006, AM J TROP MED HYG, V74, P394, DOI 10.4269/ajtmh.2006.74.394; Zakeri S, 2010, PARASITOL INT, V59, P15, DOI 10.1016/j.parint.2009.06.006	57	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166124	10.1371/journal.pone.0166124	http://dx.doi.org/10.1371/journal.pone.0166124			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829067	Green Published, Green Submitted, gold			2022-12-26	WOS:000387724300085
J	Scheicher, B; Lorenzer, C; Gegenbauer, K; Partlic, J; Andreae, F; Kirsch, AH; Rosenkranz, AR; Werzer, O; Zimmer, A				Scheicher, Bernhard; Lorenzer, Cornelia; Gegenbauer, Katrin; Partlic, Julia; Andreae, Fritz; Kirsch, Alexander H.; Rosenkranz, Alexander R.; Werzer, Oliver; Zimmer, Andreas			Manufacturing of a Secretoneurin Drug Delivery System with Self-Assembled Protamine Nanoparticles by Titration	PLOS ONE			English	Article							IN-VITRO; OLIGONUCLEOTIDE-NANOPARTICLES; PHYSICOCHEMICAL CHARACTERIZATION; ALBUMIN NANOPARTICLES; GOLD NANOPARTICLES; ENDOTHELIAL-CELLS; SECRETOGRANIN-II; BASIC FGF; ANGIOGENESIS; NEUROPEPTIDE	Since therapeutic peptides and oligonucleotides are gathering interests as active pharmaceutical ingredients (APIs), nanoparticulate drug delivery systems are becoming of great importance. Thereby, the possibility to design drug delivery systems according to the therapeutic needs of APIs enhances clinical implementation. Over the last years, the focus of our group was laid on protamine-oligonucleotide-nanoparticles (so called proticles), however, the possibility to modify the size, zeta potential or loading efficiencies was limited. Therefore, at the present study we integrated a stepwise addition of protamine (titration) into the formation process of proticles loaded with the angiogenic neuropeptide secretoneurin (SN). A particle size around 130 nm was determined when proticles were assembled by the commonly used protamine addition at once. Through application of the protamine titration process it was possible to modify and adjust the particle size between approx. 120 and 1200 nm (dependent on mass ratio) without influencing the SN loading capacity. Dynamic light scattering pointed out that the difference in particle size was most probably the result of a secondary aggregation. Initially-formed particles of early stages in the titration process aggregated towards bigger assemblies. Atomic-force-microscopy images also revealed differences in morphology along with different particle size. In contrast, the SN loading was only influenced by the applied mass ratio, where a slight saturation effect was observable. Up to 65% of deployed SN could be imbedded into the proticle matrix. An in-vivo biodistribution study (i.m.) showed a retarded distribution of SN from the site of injection after the application of a SN-proticle formulation. Further, it was demonstrated that SN loaded proticles can be successfully freeze-dried and resuspended afterwards. To conclude, the integration of the protamine titration process offers new possibilities for the formulation of proticles in order to address key parameters of drug delivery systems as size, API loading or modified drug release.	[Scheicher, Bernhard; Lorenzer, Cornelia; Gegenbauer, Katrin; Partlic, Julia; Werzer, Oliver; Zimmer, Andreas] Graz Univ, Inst Pharmaceut Sci, Dept Pharmaceut Technol, Graz, Austria; [Andreae, Fritz] PiCHEM, Kahngasse 20, Graz, Austria; [Kirsch, Alexander H.; Rosenkranz, Alexander R.] Med Univ Graz, Dept Internal Med, Clin Div Nephrol, Auenbruggerpl 27, Graz, Austria	University of Graz; Medical University of Graz	Zimmer, A (corresponding author), Graz Univ, Inst Pharmaceut Sci, Dept Pharmaceut Technol, Graz, Austria.	andreas.zimmer@uni-graz.at	; Zimmer, Andreas/C-7290-2012; Werzer, Oliver/A-2752-2014	Kirsch, Alexander/0000-0001-6711-7834; Zimmer, Andreas/0000-0003-3127-287X; Werzer, Oliver/0000-0003-0732-4422	CEO of piCHEM	CEO of piCHEM	Dr. Fritz Andreae is the owner and CEO of piCHEM, who provided financial support in the form of salary for Dr. Andreae. piCHEM was the manufacturer of the peptides in this study. piCHEM did not have any additional role in the study design, data collection and analysis as well as the decision to publish our data.	Albrecht-Schgoer K, 2014, ANGIOGENESIS, V17, P27, DOI 10.1007/s10456-013-9375-4; Albrecht-Schgoer K, 2012, CIRCULATION, V126, P2491, DOI 10.1161/CIRCULATIONAHA.111.076950; Almer G, 2014, INT J NANOMED, V9, P4211, DOI 10.2147/IJN.S66830; Bartczak D, 2013, ACS NANO, V7, P5628, DOI 10.1021/nn402111z; Bartczak D, 2012, SMALL, V8, P122, DOI 10.1002/smll.201101422; Bastiat G, 2013, J CONTROL RELEASE, V170, P334, DOI 10.1016/j.jconrel.2013.06.014; Brannon-Peppas L, 2004, ADV DRUG DELIVER REV, V56, P1649, DOI 10.1016/j.addr.2004.02.014; Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3; Budhian A, 2008, INT J PHARMACEUT, V346, P151, DOI 10.1016/j.ijpharm.2007.06.011; Dinauer N, 2004, J CONTROL RELEASE, V96, P497, DOI 10.1016/j.jconrel.2004.02.020; Egger M, 2007, FASEB J, V21, P2906, DOI 10.1096/fj.06-7440com; El-Shabouri MH, 2002, INT J PHARM, V249, P101, DOI 10.1016/S0378-5173(02)00461-1; Essa S, 2011, INT J PHARMACEUT, V411, P178, DOI 10.1016/j.ijpharm.2011.02.039; FINSY R, 1991, PART PART SYST CHAR, V8, P187, DOI 10.1002/ppsc.19910080135; Fischer-Colbrie R, 2005, CURR PROTEIN PEPT SC, V6, P373, DOI 10.2174/1389203054546334; Foged C, 2005, INT J PHARMACEUT, V298, P315, DOI 10.1016/j.ijpharm.2005.03.035; He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065; Henk M., 2009, PARTICLE SIZE MEASUR; Hiemenz PC, 1986, PRINCIPLES COLLOID S, DOI 10.1201/9781315274287; Hoffmann J A, 1990, Protein Expr Purif, V1, P127, DOI 10.1016/1046-5928(90)90005-J; HOFLEHNER J, 1995, FEBS LETT, V360, P294, DOI 10.1016/0014-5793(95)00127-U; Junghans M, 2001, BBA-PROTEIN STRUCT M, V1544, P177, DOI 10.1016/S0167-4838(00)00219-3; Junghans M, 2000, Nucleic Acids Res, V28, pE45, DOI 10.1093/nar/28.10.e45; Kerkmann M, 2006, OLIGONUCLEOTIDES, V16, P313, DOI 10.1089/oli.2006.16.313; Kirchmair R, 2004, CIRCULATION, V110, P1121, DOI 10.1161/01.CIR.0000139884.81390.56; Kirchmair R, 2004, CIRCULATION, V109, P777, DOI 10.1161/01.CIR.0000112574.07422.C1; KIRCHMAIR R, 1993, NEUROSCIENCE, V53, P359, DOI 10.1016/0306-4522(93)90200-Y; Lochmann D, 2005, EUR J PHARM BIOPHARM, V59, P419, DOI 10.1016/j.ejpb.2004.04.001; Lochmann D, 2004, J MICROENCAPSUL, V21, P625, DOI 10.1080/02652040400000504; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Mayer G, 2005, J CONTROL RELEASE, V106, P181, DOI 10.1016/j.jconrel.2005.04.019; Mori Y, 2010, INT J NANOMED, V5, P147; Pali-Scholl I, 2013, EUR J PHARM BIOPHARM, V85, P656, DOI 10.1016/j.ejpb.2013.03.003; Sadeghi R, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2565-1; Schatz C, 2004, BIOMACROMOLECULES, V5, P1882, DOI 10.1021/bm049786+; Scheicher B, 2015, EUR J PHARM SCI, V75, P54, DOI 10.1016/j.ejps.2015.04.009; Schgoer W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074029; Schgoer W, 2009, CIRC RES, V105, P994, DOI 10.1161/CIRCRESAHA.109.199513; Takikawa M, 2015, J SURG RES, V196, P247, DOI 10.1016/j.jss.2015.03.022; Tilley AJ, 2013, J COLLOID INTERF SCI, V392, P288, DOI 10.1016/j.jcis.2012.09.051; Vogel V, 2005, J CONTROL RELEASE, V103, P99, DOI 10.1016/j.jconrel.2004.11.029; Wernig K, 2008, J CONTROL RELEASE, V130, P192, DOI 10.1016/j.jconrel.2008.06.005	42	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0164149	10.1371/journal.pone.0164149	http://dx.doi.org/10.1371/journal.pone.0164149			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828968	Green Submitted, Green Published, gold			2022-12-26	WOS:000387724300014
J	Maharaj, KA; Que, NLS; Hong, F; Huck, JD; Gill, SK; Wu, S; Li, ZH; Gewirth, DT				Maharaj, Kevin A.; Que, Nanette L. S.; Hong, Feng; Huck, John D.; Gill, Sabrina K.; Wu, Shuang; Li, Zihai; Gewirth, Daniel T.			Exploring the Functional Complementation between Grp94 and Hsp90	PLOS ONE			English	Article							ESCHERICHIA-COLI HSP90; TOLL-LIKE RECEPTORS; HEAT-SHOCK-PROTEIN; MOLECULAR CHAPERONE; ENDOPLASMIC-RETICULUM; CONFORMATIONAL-CHANGES; STRUCTURAL-ANALYSIS; STEROID-RECEPTOR; IN-VIVO; IMMUNOGLOBULIN-CHAINS	Grp94 and Hsp90 are the ER and cytoplasmic paralog members, respectively, of the hsp90 family of molecular chaperones. The structural and biochemical differences between Hsp90 and Grp94 that allow each paralog to efficiently chaperone its particular set of clients are poorly understood. The two paralogs exhibit a high degree of sequence similarity, yet also display significant differences in their quaternary conformations and ATPase activity. In order to identify the structural elements that distinguish Grp94 from Hsp90, we characterized the similarities and differences between the two proteins by testing the ability of Hsp90/Grp94 chimeras to functionally substitute for the wild-type chaperones in vivo. We show that the N-terminal domain or the combination of the second lobe of the Middle domain plus the C-terminal domain of Grp94 can functionally substitute for their yeast Hsp90 counterparts but that the equivalent Hsp90 domains cannot functionally replace their counterparts in Grp94. These results also identify the interface between the Middle and C-terminal domains as an important structural unit within the Hsp90 family.	[Maharaj, Kevin A.; Que, Nanette L. S.; Huck, John D.; Gill, Sabrina K.; Gewirth, Daniel T.] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; [Maharaj, Kevin A.; Huck, John D.; Gewirth, Daniel T.] Univ Buffalo, Dept Biol Struct, Buffalo, NY 14228 USA; [Hong, Feng; Wu, Shuang; Li, Zihai] Med Univ South Carolina, Dept Microbiol & Immunol, Hollings Canc Ctr, Charleston, SC USA	Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Medical University of South Carolina	Gewirth, DT (corresponding author), Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA.; Gewirth, DT (corresponding author), Univ Buffalo, Dept Biol Struct, Buffalo, NY 14228 USA.	gewirth@hwi.buffalo.edu			National Cancer Institute [R01-CA095130, P01-CA186866]; National Institute of General Medical Sciences [F31-GM086120]; Richard and Mae Stone Goode Foundation of Buffalo; NATIONAL CANCER INSTITUTE [R01CA095130, P01CA186866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM086120] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Richard and Mae Stone Goode Foundation of Buffalo; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by the National Cancer Institute, R01-CA095130 [www.cancer.gov] to DTG; National Cancer Institute, P01-CA186866 [www.cancer.gov] to DTG; National Institute of General Medical Sciences, F31-GM086120 [www.nigms.nih.gov] to KAM; and Richard and Mae Stone Goode Foundation of Buffalo to DTG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; BOHEN SP, 1993, P NATL ACAD SCI USA, V90, P11424, DOI 10.1073/pnas.90.23.11424; CHANG HCJ, 1994, J BIOL CHEM, V269, P24983; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Dollins DE, 2005, J BIOL CHEM, V280, P30438, DOI 10.1074/jbc.M503761200; Echeverria PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026044; Fang L, 2006, P NATL ACAD SCI USA, V103, P18487, DOI 10.1073/pnas.0609163103; FERGUSON J, 1986, NUCLEIC ACIDS RES, V14, P6681, DOI 10.1093/nar/14.16.6681; Hagn F, 2011, NAT STRUCT MOL BIOL, V18, P1086, DOI 10.1038/nsmb.2114; Harris SF, 2004, STRUCTURE, V12, P1087, DOI 10.1016/j.str.2004.03.020; Hartson SD, 2012, BBA-MOL CELL RES, V1823, P656, DOI 10.1016/j.bbamcr.2011.08.013; Immormino RM, 2004, J BIOL CHEM, V279, P46162, DOI 10.1074/jbc.M405253200; Immormino RM, 2009, J MOL BIOL, V388, P1033, DOI 10.1016/j.jmb.2009.03.071; Kiianitsa K, 2003, ANAL BIOCHEM, V321, P266, DOI 10.1016/S0003-2697(03)00461-5; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; Krukenberg KA, 2009, J MOL BIOL, V390, P278, DOI 10.1016/j.jmb.2009.04.080; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Li J, 2011, NAT STRUCT MOL BIOL, V18, P61, DOI 10.1038/nsmb.1965; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Liu B, 2013, P NATL ACAD SCI USA, V110, P6877, DOI 10.1073/pnas.1302933110; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; MELNICK J, 1992, J BIOL CHEM, V267, P21303; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Meyer P, 2004, EMBO J, V23, P511, DOI 10.1038/sj.emboj.7600060; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; MINAMI Y, 1994, MOL CELL BIOL, V14, P1459, DOI 10.1128/MCB.14.2.1459; Morales C, 2009, J IMMUNOL, V183, P5121, DOI 10.4049/jimmunol.0900811; Morra G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002433; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; NEMOTO T, 1995, EUR J BIOCHEM, V233, P1, DOI 10.1111/j.1432-1033.1995.001_1.x; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Onuoha SC, 2008, J MOL BIOL, V379, P732, DOI 10.1016/j.jmb.2008.02.013; Ostrovsky O, 2009, MOL BIOL CELL, V20, P1855, DOI 10.1091/mbc.E08-04-0346; PALMER G, 1995, MOL BIOCHEM PARASIT, V70, P199, DOI 10.1016/0166-6851(95)00007-N; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Piper PW, 2003, GENE, V302, P165, DOI 10.1016/S0378-1119(02)01102-2; Pursell NW, 2012, EUKARYOT CELL, V11, P1033, DOI 10.1128/EC.00099-12; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; REED SI, 1980, GENETICS, V95, P561; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Rosenbaum M, 2014, GENE DEV, V28, P1165, DOI 10.1101/gad.240762.114; Samant RS, 2012, CELL CYCLE, V11, P1301, DOI 10.4161/cc.19722; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023; Street TO, 2011, MOL CELL, V42, P96, DOI 10.1016/j.molcel.2011.01.029; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Verba KA, 2016, BIORXIV, DOI [10.1101/040907, DOI 10.1101/040907]; Wayne N, 2007, J BIOL CHEM, V282, P35386, DOI 10.1074/jbc.M703844200; Wayne N, 2010, J MOL BIOL, V401, P931, DOI 10.1016/j.jmb.2010.06.066; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wider D, 2009, MOL BIOCHEM PARASIT, V164, P147, DOI 10.1016/j.molbiopara.2008.12.011; Wu S, 2012, J BIOL CHEM, V287, P6735, DOI 10.1074/jbc.M111.309526; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Yue L, 1999, GENETICS, V151, P1065; Zhang YL, 2015, J CLIN INVEST, V125, P859, DOI 10.1172/JCI79014	65	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166271	10.1371/journal.pone.0166271	http://dx.doi.org/10.1371/journal.pone.0166271			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824935	Green Published, Green Submitted, gold			2022-12-26	WOS:000387615200081
J	Imada, Y; Kato, M				Imada, Yume; Kato, Makoto			Bryophyte-Feeders in a Basal Brachyceran Lineage (Diptera: Rhagionidae: Spaniinae): Adult Oviposition Behavior and Changes in the Larval Mouthpart Morphology Accompanied with the Diet Shifts	PLOS ONE			English	Article								Dipteran larval morphology exhibits overwhelming variety, affected by their diverse feeding habits and habitat use. In particular, larval mouthpart morphology is associated with feeding behavior, providing key taxonomic traits. Despite most larval Brachycera being carnivorous, a basal brachyceran family, Rhagionidae, contains bryophyte-feeding taxa with multiple feeding habits. To elucidate the life history, biology, and morphological evolution of the bryophyte-feeding rhagionids, the larval feeding behavior and morphology, and the adult oviposition behavior of four species belonging to three genera of Spaniinae (Spania Meigen, Litoleptis Chillcott and Ptiolina Zetterstedt) are described. Moreover, changes of the larval morphology associated with the evolution of bryophyte-feeding are traced by molecular phylogenetic analyses. Spania and Litoleptis (thallus-miners of thallose liverworts) share a toothed form of apical mandibular sclerite with an orifice on its dorsal surface, which contrasts to those of the other members of Rhagionidae possessing a blade-like mandibular hook with an adoral groove; whereas, Ptiolina (stem borer of mosses) exhibits a weak groove on the adoral surface of mandible and highly sclerotized maxilla with toothed projections. Based on the larval feeding behavior of the thallus-miners, it is inferred that the toothed mandibles with the dorsal orifice facilitate scraping plant tissue and then imbibing it with a great deal of the sap. A phylogeny indicated that the bryophyte-feeding genera formed a clade with Spaniopsis and was sister to Symphoromyia, which presumably are detritivores. This study indicates that the loss or reduction of adoral mandibular groove and mandibular brush is coincident with the evolution of bryophyte-feeding, and it is subsequently followed by the occurrence of dorsal mandibular orifice and the loss of creeping welts accompanying the evolution of thallus-mining.	[Imada, Yume; Kato, Makoto] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Yoshidanihonmatsu Cho, Kyoto 6068501, Japan	Kyoto University	Imada, Y (corresponding author), Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Yoshidanihonmatsu Cho, Kyoto 6068501, Japan.	imayume.ac@gmail.com	Imada, Yume/AAT-6011-2020	Imada, Yume/0000-0003-2173-7389	Ministry of Education, Science, Sports and Culture [15H02420]; Japan Society for the Promotion of Science [26-160]; Grants-in-Aid for Scientific Research [14J00160] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was partly supported by Ministry of Education, Science, Sports and Culture (http://www.mext.go.jp/english/), Grant-in-Aid for Scientific Research (B) 2015-2020 (15H02420) to MK and also by Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html), Grant-in-Aid for JSPS Fellows (No. 26-160) to YI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Brauer OF, 1883, DENKSCHRIFTEN KAI MN, V47, P1; BRINDLE ALLAN, 1959, ENT REC, V71, P126; Chandler PJ, 2010, A DIPTERISTS HDB, P442; COOK E. F., 1949, MICROENTOMOLOGY, V14, P1; Courtney Gregory W., 2000, P85; De Meijere JHC, 1916, ZOOL ANZ, V46, P241; Drummond A.J., MOL EVOLUTION PHYLOG; Friedrich M, 1997, SYST BIOL, V46, P674, DOI 10.2307/2413500; Gibson JF, 2011, ANN ENTOMOL SOC AM, V104, P976, DOI 10.1603/AN10153; Grimaldi D, 2005, EVOLUTION INSECTS, P514; Hennig W, 1973, HDB ZOOLOGIE, VIV, P564; Hernandez MC, 2008, ANN ENTOMOL SOC AM, V101, P1041, DOI 10.1603/0013-8746-101.6.1041; HINTON H. E., 1955, TRANS ROY ENT SOC LONDON, V106, P455; Hobby BM, 1961, ENTOMOL MON MAG, V97, P190; Imada Y, 2016, ZOOTAXA, V4097, P41, DOI 10.11646/zootaxa.4097.1.2; Ingrouille M, 2006, PLANTS DIVERSITY EVO, P197; Kerr PH, 2010, ZOOTAXA, P1; Kovalev VG, 1981, PALEONTOL ZH, V15, P84; Krivosheina MG, 2007, ENTOMOL REV, V87, P1090; LANE RS, 1982, J MED ENTOMOL, V19, P104, DOI 10.1093/jmedent/19.1.104; Mik J, 1896, WEINER ENTOMOLOGISCH, V15, P241; Mostovski MB, 2000, P GEOLOGIST ASSOC, V111, P153, DOI 10.1016/S0016-7878(00)80005-X; Nagatomi A., 1958, Mushi Fukuoka, V32, P33; NAGATOMI A, 1982, J NAT HIST, V16, P31, DOI 10.1080/00222938200770041; Nagatomi Akira, 1998, Entomologist's Monthly Magazine, V134, P95; Nartshuk Emilia P., 1995, Acta Zoologica Fennica, V199, P17; ROBERTS MJ, 1969, J ZOOL, V159, P381; Rotheray GE, 2008, ZOOL J LINN SOC-LOND, V153, P287, DOI 10.1111/j.1096-3642.2008.00395.x; SCHREMMER FRITZ, 1951, OESTERREICH ZOOL ZEITSCHR, V3, P326; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SINCLAIR BJ, 1992, SYST ENTOMOL, V17, P233, DOI 10.1111/j.1365-3113.1992.tb00335.x; SOMMERMAN KATHRYN M., 1962, MOSQUITO NEWS, V22, P116; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stuckenberg Brian R., 2001, Studia Dipterologica, V8, P3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Teskey H.J., 1981, Canada Department of Agriculture Research Branch Monograph, P65; TESKEY HJ, 1970, CAN ENTOMOL, V102, P1130, DOI 10.4039/Ent1021130-9; TSACAS LEONIDAS, 1962, MEM MUS NAT HIST NATUR NOUV SER SER A ZOOL, V27, P147; Wiegmann BM, 2000, ANN ENTOMOL SOC AM, V93, P1031, DOI 10.1603/0013-8746(2000)093[1031:MAROTT]2.0.CO;2; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Woodley N.E., 1989, Agriculture Canada Monograph, P1371; Zhang JF, 2010, GEOBIOS-LYON, V43, P663, DOI 10.1016/j.geobios.2010.06.004	44	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165808	10.1371/journal.pone.0165808	http://dx.doi.org/10.1371/journal.pone.0165808			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812169	gold, Green Published, Green Submitted			2022-12-26	WOS:000386910000063
J	Nakamura, T; Matsumoto, J; Nishimaru, H; Bretas, RV; Takamura, Y; Hori, E; Ono, T; Nishijo, H				Nakamura, Tomoya; Matsumoto, Jumpei; Nishimaru, Hiroshi; Bretas, Rafael Vieira; Takamura, Yusaku; Hori, Etsuro; Ono, Taketoshi; Nishijo, Hisao			A Markerless 3D Computerized Motion Capture System Incorporating a Skeleton Model for Monkeys	PLOS ONE			English	Article							FACIAL EMOTION RECOGNITION; NONHUMAN-PRIMATES; RHESUS-MONKEYS; METHAMPHETAMINE; BEHAVIOR; ANXIETY; PSYCHOPATHOLOGY; SCHIZOPHRENIA; DEFICITS; AMYGDALA	In this study, we propose a novel markerless motion capture system (MCS) for monkeys, in which 3D surface images of monkeys were reconstructed by integrating data from four depth cameras, and a skeleton model of the monkey was fitted onto 3D images of monkeys in each frame of the video. To validate the MCS, first, estimated 3D positions of body parts were compared between the 3D MCS-assisted estimation and manual estimation based on visual inspection when a monkey performed a shuttling behavior in which it had to avoid obstacles in various positions. The mean estimation error of the positions of body parts (3-14 cm) and of head rotation (35-43 degrees) between the 3D MCS-assisted and manual estimation were comparable to the errors between two different experimenters performing manual estimation. Furthermore, the MCS could identify specific monkey actions, and there was no false positive nor false negative detection of actions compared with those in manual estimation. Second, to check the reproducibility of MCS-assisted estimation, the same analyses of the above experiments were repeated by a different user. The estimation errors of positions of most body parts between the two experimenters were significantly smaller in the MCS-assisted estimation than in the manual estimation. Third, effects of methamphetamine (MAP) administration on the spontaneous behaviors of four monkeys were analyzed using the MCS. MAP significantly increased head movements, tended to decrease locomotion speed, and had no significant effect on total path length. The results were comparable to previous human clinical data. Furthermore, estimated data following MAP injection (total path length, walking speed, and speed of head rotation) correlated significantly between the two experimenters in the MCS-assisted estimation (r = 0.863 to 0.999). The results suggest that the presented MCS in monkeys is useful in investigating neural mechanisms underlying various psychiatric disorders and developing pharmacological interventions.	[Nakamura, Tomoya; Matsumoto, Jumpei; Nishimaru, Hiroshi; Bretas, Rafael Vieira; Takamura, Yusaku; Hori, Etsuro; Ono, Taketoshi; Nishijo, Hisao] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Syst Emot Sci, Toyama 9300194, Japan; [Nakamura, Tomoya] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Anat, Toyama 9300194, Japan; [Hori, Etsuro] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Behav Sci, Toyama 9300194, Japan	University of Toyama; University of Toyama; University of Toyama	Nishijo, H (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Syst Emot Sci, Toyama 9300194, Japan.	nishijo@med.u-toyama.ac.jp		Matsumoto, Jumpei/0000-0003-4729-2816	Hokuriku Bank, Toyama, Japan; Japan Society for Promotion of Science (JSPS), Japan [16H04652]	Hokuriku Bank, Toyama, Japan; Japan Society for Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported partly by Young researcher funds (J.M.) from Hokuriku Bank (http://www.hokugin.co.jp/index.html), Toyama, Japan and Grant-in-Aid for Scientific Research (B) (16H04652) (H.Nishijo) from Japan Society for Promotion of Science (JSPS) (https://www.jsps.go.jp/english/index.html), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caligiuri MP, 2005, NEUROPSYCHOPHARMACOL, V30, P2125, DOI 10.1038/sj.npp.1300859; Capitanio JP, 2008, LANCET, V371, P1126, DOI 10.1016/S0140-6736(08)60489-4; CHAMOVE A S, 1984, Primates, V25, P319, DOI 10.1007/BF02382270; Chan SS, 2006, J NEURAL ENG, V3, P327, DOI 10.1088/1741-2560/3/4/010; Coleman K, 2014, ILAR J, V55, P333, DOI 10.1093/ilar/ilu019; Curtis B, 2015, ENVIRON HEALTH PERSP, V123, P579, DOI 10.1289/ehp.1408257; de Gelder B, 2009, NEUROREPORT, V20, P642, DOI 10.1097/WNR.0b013e32832a1e56; DesJardin JT, 2013, J NEUROSCI, V33, P150, DOI 10.1523/JNEUROSCI.2924-12.2013; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Dziobek D, 2015, BRAIN DISORD THER, V4, pe118; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Feczko EJ, 2016, PLOS ONE, V11; Fitzsimmons NA, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.003.2009; Foster JD, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046020; Gilja V, 2010, CURR OPIN NEUROBIOL, V20, P676, DOI 10.1016/j.conb.2010.06.007; Grant KM, 2012, J NEUROIMMUNE PHARM, V7, P113, DOI 10.1007/s11481-011-9288-1; Hall DA, 2008, PSYCHOPHARMACOLOGY, V195, P469, DOI 10.1007/s00213-007-0923-8; Hart CL, 2008, NEUROPSYCHOPHARMACOL, V33, P1847, DOI 10.1038/sj.npp.1301578; Hung CC, 2012, NEURON, V74, P1099, DOI 10.1016/j.neuron.2012.04.029; Izquierdo A, P NATL ACAD SCI, V104, P14128; Ji XF, 2010, IEEE T SYST MAN CY C, V40, P13, DOI 10.1109/TSMCC.2009.2027608; JOHANSON CE, 1979, PHARMACOL BIOCHEM BE, V11, P273, DOI 10.1016/0091-3057(79)90134-5; Kalin NH, 2003, ANN NY ACAD SCI, V1008, P189, DOI 10.1196/annals.1301.021; Kalin NH, 2004, J NEUROSCI, V24, P5506, DOI 10.1523/JNEUROSCI.0292-04.2004; Kalin NH, 2001, J NEUROSCI, V21, P2067, DOI 10.1523/JNEUROSCI.21-06-02067.2001; Lee SJ, 2010, PSYCHIAT INVEST, V7, P291, DOI 10.4306/pi.2010.7.4.291; Liu YB, 2013, IEEE T PATTERN ANAL, V35, P2720, DOI 10.1109/TPAMI.2013.47; Lu HJ, 2010, J VISION, V10, DOI 10.1167/10.12.13; MACHIYAMA Y, 1992, SCHIZOPHRENIA BULL, V18, P107, DOI 10.1093/schbul/18.1.107; Martin LA, 2008, BRAIN BEHAV IMMUN, V22, P806, DOI 10.1016/j.bbi.2007.12.007; Matsumoto J, 2014, BEHAV BRAIN RES, V272, P16, DOI 10.1016/j.bbr.2014.06.047; Matsumoto J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078460; Moeslund TB, 2006, COMPUT VIS IMAGE UND, V104, P90, DOI 10.1016/j.cviu.2006.08.002; Nelson EE, 2009, NEUROPSYCHOPHARMACOL, V34, P90, DOI 10.1038/npp.2008.150; Oram MW, 1996, J NEUROPHYSIOL, V76, P109, DOI 10.1152/jn.1996.76.1.109; Peikon ID, 2009, J NEUROSCI METH, V180, P224, DOI 10.1016/j.jneumeth.2009.03.010; REISBICK S, 1994, PHYSIOL BEHAV, V55, P231, DOI 10.1016/0031-9384(94)90128-7; Ruby S, 2015, AM J PRIMATOL, V77, P1097, DOI 10.1002/ajp.22444; Sellers WI, 2014, BIOL OPEN; Singh RAK, 2012, PHARMACOL BIOCHEM BE, V103, P230, DOI 10.1016/j.pbb.2012.08.013; Smith MJL, 2010, NEUROPSYCHOLOGIA, V48, P2777, DOI 10.1016/j.neuropsychologia.2010.03.008; Takushiro A., 1998, KITAKANTO MED J, V48, P127; Troisi A, 2002, STRESS, V5, P46, DOI 10.1080/10253890290012378; Van Mao C, 2008, REV NEUROSCIENCE, V19, P83; Vargas-Irwin CE, 2010, J NEUROSCI, V30, P9659, DOI 10.1523/JNEUROSCI.5443-09.2010; Watson KK, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-21; Wright MJ, 2012, BRIT J PHARMACOL, V167, P1342, DOI 10.1111/j.1476-5381.2012.02091.x	48	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166154	10.1371/journal.pone.0166154	http://dx.doi.org/10.1371/journal.pone.0166154			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812205	gold, Green Published, Green Submitted			2022-12-26	WOS:000386910000105
J	Xiao, YQ; Brauer, J; Lauckner, M; Zhai, HC; Jia, FC; Margulies, DS; Friederici, AD				Xiao, Yaqiong; Brauer, Jens; Lauckner, Mark; Zhai, Hongchang; Jia, Fucang; Margulies, Daniel S.; Friederici, Angela D.			Development of the Intrinsic Language Network in Preschool Children from Ages 3 to 5 Years	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; HUMAN BRAIN; PERISYLVIAN ACTIVATION; TEMPORAL CORTEX; DEFAULT NETWORK; SPEECH; ARCHITECTURE; PERCEPTION; PATTERNS; STREAMS	Resting state studies of spontaneous fluctuations in the functional magnetic resonance imaging (fMRI) blood oxygen level dependent signal have shown great potential in mapping the intrinsic functional connectivity of the human brain underlying cognitive functions. The aim of the present study was to explore the developmental changes in functional networks of the developing human brain exemplified with the language network in typically developing preschool children. To this end, resting-sate fMRI data were obtained from native Chinese children at ages of 3 and 5 years, 15 in each age group. Resting-state functional connectivity (RSFC) was analyzed for four regions of interest; these are the left and right anterior superior temporal gyrus (aSTG), left posterior superior temporal gyrus (pSTG), and left inferior frontal gyrus (IFG). The comparison of these RSFC maps between 3- and 5-year-olds revealed that RSFC decreases in the right aSTG and increases in the left hemisphere between aSTG seed and IFG, between pSTG seed and IFG, as well as between IFG seed and posterior superior temporal sulcus. In a subsequent analysis, functional asymmetry of the language network seeding in aSTG, pSTG and IFG was further investigated. The results showed an increase of left lateralization in both RSFC of pSTG and of IFG from ages 3 to 5 years. The IFG showed a leftward lateralized trend in 3-year-olds, while pSTG demonstrated rightward asymmetry in 5-year-olds. These findings suggest clear developmental trajectories of the language network between 3- and 5-year-olds revealed as a function of age, characterized by increasing long-range connections and dynamic hemispheric lateralization with age. Our study provides new insights into the developmental changes of a well-established functional network in young children and also offers a basis for future cross-culture and cross-age studies of the resting-state language network.	[Xiao, Yaqiong; Brauer, Jens; Friederici, Angela D.] Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany; [Lauckner, Mark; Margulies, Daniel S.] Max Planck Inst Human Cognit & Brain Sci, Max Planck Res Grp Neuroanat & Connect, Leipzig, Germany; [Zhai, Hongchang] Guangzhou Univ, Coll Educ, Guangzhou, Guangdong, Peoples R China; [Jia, Fucang] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China	Max Planck Society; Max Planck Society; Guangzhou University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Xiao, YQ (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany.; Zhai, HC (corresponding author), Guangzhou Univ, Coll Educ, Guangzhou, Guangdong, Peoples R China.	xiao@cbs.mpg.de; zhaihongchang@126.com	Xiao, Yaqiong/L-5548-2019; Xiao, Yaqiong/AAS-4384-2021; Margulies, Daniel/L-4719-2016	XIAO, YAQIONG/0000-0001-8719-5418; Margulies, Daniel/0000-0002-8880-9204				Antonenko D, 2013, NEUROIMAGE, V83, P513, DOI 10.1016/j.neuroimage.2013.07.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Brauer J, 2008, NEUROIMAGE, V41, P1484, DOI 10.1016/j.neuroimage.2008.03.027; Brauer J, 2007, J COGNITIVE NEUROSCI, V19, P1609, DOI 10.1162/jocn.2007.19.10.1609; Brauer J, 2011, CEREB CORTEX, V21, P459, DOI 10.1093/cercor/bhq108; Cao M, 2017, CEREB CORTEX, V27, P1949, DOI 10.1093/cercor/bhw038; Chan MY, 2014, P NATL ACAD SCI USA, V111, pE4997, DOI 10.1073/pnas.1415122111; Chang HW, 1986, LINGUISTIC PSYCHOL C; Crinion JT, 2009, HUM BRAIN MAPP, V30, P4108, DOI 10.1002/hbm.20832; Croft LJ, 2014, BRAIN, V137, P2245, DOI 10.1093/brain/awu154; de Bie HMA, 2012, HUM BRAIN MAPP, V33, P1189, DOI 10.1002/hbm.21280; Dehaene-Lambertz G, 2015, NEURON, V88, P93, DOI 10.1016/j.neuron.2015.09.026; Dehaene-Lambertz G, 2006, P NATL ACAD SCI USA, V103, P14240, DOI 10.1073/pnas.0606302103; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2007, P NATL ACAD SCI USA, V104, P15531, DOI 10.1073/pnas.0704380104; Fransson P, 2011, CEREB CORTEX, V21, P145, DOI 10.1093/cercor/bhq071; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Friederici AD, 2012, TRENDS COGN SCI, V16, P262, DOI 10.1016/j.tics.2012.04.001; Friederici Angela D, 2012, Front Evol Neurosci, V4, P3, DOI 10.3389/fnevo.2012.00003; Friederici AD, 2011, PHYSIOL REV, V91, P1357, DOI 10.1152/physrev.00006.2011; Friederici AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020726; Friederici AD, 2009, NEUROREPORT, V20, P563, DOI 10.1097/WNR.0b013e3283297dee; Fukunaga M, 2006, MAGN RESON IMAGING, V24, P979, DOI 10.1016/j.mri.2006.04.018; Gandour J, 2004, NEUROIMAGE, V23, P344, DOI 10.1016/j.neuroimage.2004.06.004; Gao W, 2009, P NATL ACAD SCI USA, V106, P6790, DOI 10.1073/pnas.0811221106; Ge JQ, 2015, P NATL ACAD SCI USA, V112, P2972, DOI 10.1073/pnas.1416000112; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Holland SK, 2007, INT J AUDIOL, V46, P533, DOI 10.1080/14992020701448994; Holland SK, 2001, NEUROIMAGE, V14, P837, DOI 10.1006/nimg.2001.0875; Jeng L, 1991, CHINESE J PSYCHOL; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kinno R, 2008, HUM BRAIN MAPP, V29, P1015, DOI 10.1002/hbm.20441; Knoll LJ, 2012, NEUROIMAGE, V62, P207, DOI 10.1016/j.neuroimage.2012.05.014; Liu HS, 2009, P NATL ACAD SCI USA, V106, P20499, DOI 10.1073/pnas.0908073106; Liu WC, 2008, BRAIN RES, V1223, P42, DOI 10.1016/j.brainres.2008.05.054; Lohmann G, 2010, CEREB CORTEX, V20, P1286, DOI 10.1093/cercor/bhp190; Luo H, 2006, P NATL ACAD SCI USA, V103, P19558, DOI 10.1073/pnas.0607065104; Mesgarani N, 2014, SCIENCE, V343, P1006, DOI 10.1126/science.1245994; Muller AM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00228; Nan Y, 2013, HUM BRAIN MAPP, V34, P2045, DOI 10.1002/hbm.22046; Obleser J, 2011, NEUROIMAGE, V56, P2310, DOI 10.1016/j.neuroimage.2011.03.035; Perani D, 2011, P NATL ACAD SCI USA, V108, P16056, DOI 10.1073/pnas.1102991108; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Shu H, 2008, DEVELOPMENTAL SCI, V11, P171, DOI 10.1111/j.1467-7687.2007.00654.x; Skeide MA, 2016, CEREB CORTEX, V26, P2127, DOI 10.1093/cercor/bhv042; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Szaflarski JP, 2006, HUM BRAIN MAPP, V27, P202, DOI 10.1002/hbm.20177; Tomasi D, 2012, MOL PSYCHIATR, V17, P841, DOI 10.1038/mp.2011.177; Tomasi D, 2012, CEREB CORTEX, V22, P1455, DOI 10.1093/cercor/bhr230; Turken AU, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00001; van den Heuvel MP, 2015, CEREB CORTEX, V25, P3000, DOI 10.1093/cercor/bhu095; Vigneau M, 2011, NEUROIMAGE, V54, P577, DOI 10.1016/j.neuroimage.2010.07.036; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Weiss-Croft LJ, 2015, NEUROIMAGE, V123, P269, DOI 10.1016/j.neuroimage.2015.07.046; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Xiang HD, 2010, CEREB CORTEX, V20, P549, DOI 10.1093/cercor/bhp119; Xiao YQ, 2016, BRAIN IMAGING BEHAV, V10, P50, DOI 10.1007/s11682-015-9362-z; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yan H, 2009, NEUROIMAGE, V47, P1579, DOI 10.1016/j.neuroimage.2009.05.080; Zatorre RJ, 2008, PHILOS T R SOC B, V363, P1087, DOI 10.1098/rstb.2007.2161; Zheng Y, 2009, INT J AUDIOL, V48, P718, DOI 10.1080/14992020902902658; Zheng Y, 2009, EAR HEARING, V30, P600, DOI 10.1097/AUD.0b013e3181b4aba8; Zhu LL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085880, 10.1371/journal.pone.0102471, 10.1371/journal.pone.0097178]	74	11	11	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165802	10.1371/journal.pone.0165802	http://dx.doi.org/10.1371/journal.pone.0165802			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812160	Green Published, Green Submitted, gold			2022-12-26	WOS:000386910000060
J	Cho, YY; Sidorenkov, G; Denig, P				Cho, Yeon Young; Sidorenkov, Grigory; Denig, Petra			Role of Patient and Practice Characteristics in Variance of Treatment Quality in Type 2 Diabetes between General Practices	PLOS ONE			English	Article							PRIMARY-CARE; CARDIOVASCULAR-DISEASE; HEART-DISEASE; PRACTICE SIZE; OF-CARE; ADHERENCE; IMPACT; COMORBIDITY; MEDICATION; GUIDELINES	Background Accounting for justifiable variance is important for fair comparisons of treatment quality. The variance between general practices in treatment quality of type 2 diabetes (T2DM) patients may be attributed to the underlying patient population and practice characteristics. The objective of this study is to describe the between practice differences in treatment, and identify patient and practice level characteristics that may explain these differences. Methods The data of 24,607 T2DM patients from 183 general practices in the Netherlands were used. Treatment variance was assessed in a cross- sectional manner for: glucose- lowering drugs/metformin, lipid- lowering drugs/statins, blood pressure- lowering drugs/ACE- inhibitor or ARB. Patient characteristics tested were age, gender, diabetes duration, comorbidity, comedication. Practice characteristics were number of T2DM patients, practice type, diabetes assistant available. Multilevel logistic regression was used to examine the between practice variance in treatment and the effect of characteristics on this variance. Results Treatment rates varied considerably between practices (IQR 9.5-13.9). The variance at practice level was 7.5% for glucose- lowering drugs, 3.6% for metformin, 3.1% for lipid- lowering drugs, 10.3% for statins, 8.6% for blood pressure- lowering drugs, and 3.9% for ACEinhibitor/ARB. Patient and practice characteristics explained 19.0%, 7.5%, 20%, 6%, 9.9%, and 13.4% of the variance respectively. Age, multiple chronic drugs, and >= 3 glucose- lowering drugs were the most relevant patient characteristics. Number of T2DM patients per practice was the most relevant practice characteristic. Discussion Considerable differences exist between practices in treatment rates. Patients' age was identified as characteristic that may account for justifiable differences in especially lipid- lowering treatment. Other patient or practice characteristics either do not explain or do not justify the differences.	[Cho, Yeon Young; Sidorenkov, Grigory; Denig, Petra] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands; [Cho, Yeon Young] Seoul Natl Univ, Grad Sch Publ Hlth, Dept Epidemiol, Seoul, South Korea	University of Groningen; Seoul National University (SNU)	Sidorenkov, G (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands.	g.sidorenkov@umcg.nl	Denig, Petra/L-9865-2014	Denig, Petra/0000-0002-7929-4739; Sidorenkov, Grigory/0000-0002-1926-8862	Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, the Netherlands	Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, the Netherlands	The study was funded by the Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded by the Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab E, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-24; Booth GL, 2006, LANCET, V368, P29, DOI 10.1016/S0140-6736(06)68967-8; Botsis T, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-11; Calsbeek H, 2016, AM J MANAG CARE, V22, pE45; Campmans-Kuijpers MJE, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-129; Chen Szu-chi, 2013, Rev Diabet Stud, V10, P88, DOI 10.1900/RDS.2013.10.88; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Dijkstra RF, 2004, DIABETIC MED, V21, P586, DOI 10.1111/j.1464-5491.2004.01195.x; Gnavi R, 2007, EUR J PUBLIC HEALTH, V17, P492, DOI 10.1093/eurpub/ckm005; Greving JP, 2006, SOC SCI MED, V63, P2890, DOI 10.1016/j.socscimed.2006.07.019; Gulliford MC, 2005, J HUM HYPERTENS, V19, P111, DOI 10.1038/sj.jhh.1001787; Hansen DG, 2007, PHARMACOEPIDEM DR S, V16, P458, DOI 10.1002/pds.1364; Health & Social Care Information Centre, QUAL OUTC FRAM QOF 2; Hira Ravi S, 2015, J Am Coll Cardiol, V65, P111, DOI 10.1016/j.jacc.2014.10.035; Hong CS, 2010, JAMA-J AM MED ASSOC, V304, P1107, DOI 10.1001/jama.2010.1287; Ickowicz E, 2003, J AM GERIATR SOC, V51, pS265; Instituut voor Verantwoord Medicijngebruik [Dutch Institute for Rational Use of Medicine], MON VOORSCHR HUIS; Inzucchi SE, 2014, JAMA-J AM MED ASSOC, V312, P2668, DOI 10.1001/jama.2014.15298; Janssen PGH, 2008, SCAND J PRIM HEALTH, V26, P160, DOI 10.1080/08037050802117924; Kramer HU, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-88; Kralewski J, 2015, HEALTH SERV RES, V50, P710, DOI 10.1111/1475-6773.12242; Krein SL, 2002, HEALTH SERV RES, V37, P1159, DOI 10.1111/1475-6773.01102; Lovaglio PG, 2011, INT J MENT HEALTH SY, V5, DOI 10.1186/1752-4458-5-20; Manteuffel M, 2014, J WOMENS HEALTH, V23, P112, DOI 10.1089/jwh.2012.3972; Mathew Elizabeth Mampally, 2013, J Basic Clin Pharm, V5, P15, DOI 10.4103/0976-0105.128251; McGinn J, 2006, DIABETES RES CLIN PR, V72, P162, DOI 10.1016/j.diabres.2005.10.023; Mohammed MA, 2012, MED DECIS MAKING, V32, P498, DOI 10.1177/0272989X12437246; National Committee of Quality Assurance, HEDIS QUAL RAT SYST; National Health Service (NHS), INTR ATL VAR HEALTHC; Nederlands Huisartsengenootschap, 2012, HUISARTS WET, V55, P14; Ng CWL, 2013, BRIT J GEN PRACT, V63, pE604, DOI 10.3399/bjgp13X671588; O'Connor Patrick J, 2008, Prev Chronic Dis, V5, pA15; Parnes BL, 2004, DIABETES CARE, V27, P13, DOI 10.2337/diacare.27.1.13; Pentakota SR, 2012, DIABETES CARE, V35, P1285, DOI 10.2337/dc11-1569; Peyrot M, 2012, DIABETIC MED, V29, P682, DOI 10.1111/j.1464-5491.2012.03605.x; Piette JD, 2006, DIABETES CARE, V29, P725, DOI 10.2337/diacare.29.03.06.dc05-2078; Satman I, 2012, DIABETES RES CLIN PR, V98, P75, DOI 10.1016/j.diabres.2012.05.003; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Simmons RK, 2014, DIABETIC MED, V31, P1577, DOI 10.1111/dme.12574; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Struijs JN, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-84; Tahrani AA, 2008, BRIT J GEN PRACT, V58, P576, DOI 10.3399/bjgp08X319729; The Dutch College of General Practitioners [Nederlands Huisartsen Genootschap (NHG)], 2016, QUAL IND PRIM CAR PA; van den Berg MJ, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-1; Van den Bruel A, 2015, FAM PRACT, V32, P127, DOI 10.1093/fampra/cmv008; van Hateren KJJ, 2011, INT J CLIN PRACT, V65, P415, DOI 10.1111/j.1742-1241.2010.02596.x; van Hateren KJJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001387; van Loenen T, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0458-3; Voorham J, 2007, J AM MED INFORM ASSN, V14, P349, DOI 10.1197/jamia.M2128; Woodard LD, 2011, MED CARE, V49, P605, DOI 10.1097/MLR.0b013e31820f0ed0	50	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0166012	10.1371/journal.pone.0166012	http://dx.doi.org/10.1371/journal.pone.0166012			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6DJ	27806107	gold, Green Published, Green Submitted			2022-12-26	WOS:000386715500077
J	Dabrowski-Tumanski, P; Stasiak, A; Sulkowska, JI				Dabrowski-Tumanski, Pawel; Stasiak, Andrzej; Sulkowska, Joanna I.			In Search of Functional Advantages of Knots in Proteins	PLOS ONE			English	Article							SLIPKNOTTING PATTERNS; ACTIVE-SITE; BINDING; METHYLTRANSFERASE; CONSERVATION; FRUSTRATION; MECHANISM; SURFACES; ENZYME; SPOUT	We analysed the structure of deeply knotted proteins representing three unrelated families of knotted proteins. We looked at the correlation between positions of knotted cores in these proteins and such local structural characteristics as the number of intra-chain contacts, structural stability and solvent accessibility. We observed that the knotted cores and especially their borders showed strong enrichment in the number of contacts. These regions showed also increased thermal stability, whereas their solvent accessibility was decreased. Interestingly, the active sites within these knotted proteins preferentially located in the regions with increased number of contacts that also have increased thermal stability and decreased solvent accessibility. Our results suggest that knotting of polypeptide chains provides a favourable environment for the active sites observed in knotted proteins. Some knotted proteins have homologues without a knot. Interestingly, these unknotted homologues form local entanglements that retain structural characteristics of the knotted cores.	[Dabrowski-Tumanski, Pawel; Sulkowska, Joanna I.] Ctr New Technol, Banacha 2c, PL-02097 Warsaw, Poland; [Dabrowski-Tumanski, Pawel; Sulkowska, Joanna I.] Univ Warsaw, Fac Chem, Pasteura 1, PL-02093 Warsaw, Poland; [Dabrowski-Tumanski, Pawel; Stasiak, Andrzej] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Stasiak, Andrzej] SIB Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland	University of Warsaw; University of Warsaw; University of Lausanne; Swiss Institute of Bioinformatics	Sulkowska, JI (corresponding author), Ctr New Technol, Banacha 2c, PL-02097 Warsaw, Poland.; Sulkowska, JI (corresponding author), Univ Warsaw, Fac Chem, Pasteura 1, PL-02093 Warsaw, Poland.; Stasiak, A (corresponding author), Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.; Stasiak, A (corresponding author), SIB Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland.	Andrzej.Stasiak@unil.ch; jsulkowska@chem.uw.edu.pl	Dabrowski-Tumanski, Pawel/O-2581-2019; Dabrowski-Tumanski, Pawel/J-6836-2015; Stasiak, Andrzej/E-5551-2010	Dabrowski-Tumanski, Pawel/0000-0001-9412-1716; Dabrowski-Tumanski, Pawel/0000-0001-9412-1716; Stasiak, Andrzej/0000-0002-0398-1989; Sulkowska, Joanna/0000-0003-2452-0724	National Science Centre Poland [2012/07/E/NZ1/01900]; EMBO Installation Grant [2057]; Swiss National Science Foundation [31003A_166684]; Leverhulme Trust [RP2013-K-017]; University of Warsaw, Faculty of Chemistry [120000-501/86-DSM-112 700]	National Science Centre Poland(National Science Centre, Poland); EMBO Installation Grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Leverhulme Trust(Leverhulme Trust); University of Warsaw, Faculty of Chemistry	This work was supported by National Science Centre Poland #2012/07/E/NZ1/01900 (JIS) https:/www.ncn.gov.pl; EMBO Installation Grant #2057 (JIS) http://www.embo.org/; Swiss National Science Foundation 31003A_166684 (AS) http://www.snf.ch; and the Leverhulme Trust RP2013-K-017 (AS) https://www.leverhulme.ac.uk/; University of Warsaw, Faculty of Chemistry 120000-501/86-DSM-112 700 (PD-T) http://www.chem.uw.edu.pl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MT, 2002, FEBS LETT, V519, P35, DOI 10.1016/S0014-5793(02)02693-5; Anantharaman V, 2002, J MOL MICROB BIOTECH, V4, P71; Bolinger D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000731; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; COLLIER CD, 1990, J BACTERIOL, V172, P3918, DOI 10.1128/jb.172.7.3918-3924.1990; Dabrowski-Tumanski P, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/35/354109; Ferreiro DU, 2007, P NATL ACAD SCI USA, V104, P19819, DOI 10.1073/pnas.0709915104; Jamroz M, 2015, NUCLEIC ACIDS RES, V43, pD306, DOI 10.1093/nar/gku1059; Jenik M, 2012, NUCLEIC ACIDS RES, V40, pW348, DOI 10.1093/nar/gks447; King NP, 2007, J MOL BIOL, V373, P153, DOI 10.1016/j.jmb.2007.07.042; Lim K, 2003, PROTEINS, V51, P56, DOI 10.1002/prot.10323; Liu RJ, 2013, NUCLEIC ACIDS RES, V41, P7828, DOI 10.1093/nar/gkt568; Mallam AL, 2007, STRUCTURE, V15, P111, DOI 10.1016/j.str.2006.11.007; Mallam AL, 2012, NAT CHEM BIOL, V8, P147, DOI 10.1038/nchembio.742; Millett KC, 2013, BIOCHEM SOC T, V41, P533, DOI 10.1042/BST20120339; Nureki O, 2004, STRUCTURE, V12, P593, DOI 10.1016/j.str.2004.03.003; Nureki O, 2002, ACTA CRYSTALLOGR D, V58, P1129, DOI 10.1107/S0907444902006601; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potestio R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000864; Prakash S, 2004, TRENDS BIOCHEM SCI, V29, P593, DOI 10.1016/j.tibs.2004.09.011; Prlic A, 2010, BIOINFORMATICS, V26, P2983, DOI 10.1093/bioinformatics/btq572; Rawdon EJ, 2013, BIOCHEM SOC T, V41, P538, DOI 10.1042/BST20120329; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Sayre TC, 2011, PROTEIN ENG DES SEL, V24, P627, DOI 10.1093/protein/gzr024; Shi DS, 2006, PROTEINS, V64, P532, DOI 10.1002/prot.21013; Sulkowska J, 2012, PROTEIN SCI, V21, P222; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, P17783, DOI 10.1073/pnas.1201804109; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, pE1715, DOI 10.1073/pnas.1205918109; Sulkowska JI, 2009, P NATL ACAD SCI USA, V106, P3119, DOI 10.1073/pnas.0811147106; Sulkowska JI, 2008, P NATL ACAD SCI USA, V105, P19714, DOI 10.1073/pnas.0805468105; Taylor WR, 2007, COMPUT BIOL CHEM, V31, P151, DOI 10.1016/j.compbiolchem.2007.03.002; Taylor WR, 2000, NATURE, V406, P916, DOI 10.1038/35022623; Tkaczuk KL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-73; Tubiana L, 2011, PROG THEOR PHYS SUPP, P192; van Roon AMM, 2008, P NATL ACAD SCI USA, V105, P9621, DOI 10.1073/pnas.0802494105; Virnau P, 2006, PLOS COMPUT BIOL, V2, P1074, DOI 10.1371/journal.pcbi.0020122; Virnau P, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/3/033101; Yang XJ, 2015, STRUCTURE, V23, P1179, DOI 10.1016/j.str.2015.04.022; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086	39	37	37	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165986	10.1371/journal.pone.0165986	http://dx.doi.org/10.1371/journal.pone.0165986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806097	Green Submitted, gold, Green Published			2022-12-26	WOS:000386715500076
J	Henquin, JC; Nenquin, M				Henquin, Jean-Claude; Nenquin, Myriam			Dynamics and Regulation of Insulin Secretion in Pancreatic Islets from Normal Young Children	PLOS ONE			English	Article							PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA; HUMAN-FETAL; ACTIVATING MUTATIONS; CELL PROLIFERATION; BETA-CELLS; B-CELL; GLUCOSE; MATURATION; INFANT; GLUCOKINASE	Insulin secretion has only exceptionally been investigated in pancreatic islets from healthy young children. It remains unclear whether those islets behave like adult islets despite substantial differences in cellular composition and higher beta-cell replication rates. Islets were isolated from 5 infants/toddlers (11-36 month-old) and perifused to characterize their dynamics of insulin secretion when subjected to various stimuli and inhibitors. Their insulin responses were compared to those previously reported for similarly treated adult islets. Qualitatively, infant islets responded like adult islets to stimulation by glucose, tolbutamide, forskolin (to increase cAMP), arginine and the combination of leucine and glutamine, and to inhibition by diazoxide and CaCl2 omission. This similarity included the concentration-dependency and biphasic pattern of glucose-induced insulin secretion, the dynamics of the responses to non- glucose stimuli and metabolic amplification of these responses. The insulin content was not different, but fractional insulin secretion rates were lower in infant than adult islets irrespective of the stimulus. However, the stimulation index was similar because basal secretion rates were also lower in infant islets. In conclusion, human beta-cells are functionally mature by the age of one year, before expansion of their mass is complete. Their responsiveness (stimulation index) to all stimuli is not smaller than that of adult beta-cells. Yet, under basal and stimulated conditions, they secrete smaller proportions of their insulin stores in keeping with smaller in vivo insulin needs during infancy.	[Henquin, Jean-Claude; Nenquin, Myriam] Univ Louvain, Fac Med, Unit Endocrinol & Metab, Brussels, Belgium	Universite Catholique Louvain	Henquin, JC (corresponding author), Univ Louvain, Fac Med, Unit Endocrinol & Metab, Brussels, Belgium.	jean-claude.henquin@uclouvain.be			Directorate for Scientific Research of the French Community of Belgium [05/10-328]	Directorate for Scientific Research of the French Community of Belgium	This work was funded by Directorate for Scientific Research of the French Community of Belgium (ARC 05/10-328). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN A, 1980, Diabetes, V29, P64; Arslanian S, 1997, J CLIN ENDOCR METAB, V82, P1923, DOI 10.1210/jc.82.6.1923; Atiya A W, 1997, J Gastrointest Surg, V1, P251, DOI 10.1016/S1091-255X(97)80117-5; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Balamurugan AN, 2006, DIABETOLOGIA, V49, P1845, DOI 10.1007/s00125-006-0318-0; CAPRIO S, 1989, J PEDIATR-US, V114, P963, DOI 10.1016/S0022-3476(89)80438-X; CAREL JC, 1993, J CLIN INVEST, V92, P509, DOI 10.1172/JCI116595; Chase HP, 2001, J PEDIATR-US, V138, P244, DOI 10.1067/mpd.2001.111274; Detimary P, 1996, ENDOCRINOLOGY, V137, P4671, DOI 10.1210/en.137.11.4671; Dhawan S, 2015, J CLIN INVEST, V125, P2851, DOI 10.1172/JCI79956; Dunne MJ, 2004, PHYSIOL REV, V84, P239, DOI 10.1152/physrev.00022.2003; FALORNI A, 1974, DIABETES, V23, P172, DOI 10.2337/diab.23.3.172; GRASSO S, 1973, DIABETES, V22, P349, DOI 10.2337/diab.22.5.349; Gregg BE, 2012, J CLIN ENDOCR METAB, V97, P3197, DOI 10.1210/jc.2012-1206; Hattersley AT, 2005, DIABETES, V54, P2503, DOI 10.2337/diabetes.54.9.2503; Hauge-Evans AC, 2009, DIABETES, V58, P403, DOI 10.2337/db08-0792; HAWDON JM, 1993, ARCH DIS CHILD-FETAL, V68, P274, DOI 10.1136/adc.68.3_Spec_No.274; Henquin JC, 2006, DIABETES, V55, P3470, DOI 10.2337/db06-0868; Henquin JC, 2015, AM J PHYSIOL-ENDOC M, V309, pE640, DOI 10.1152/ajpendo.00251.2015; Henquin JC, 2013, DIABETES, V62, P1689, DOI 10.2337/db12-1414; Henquin JC, 2011, J CLIN INVEST, V121, P3932, DOI 10.1172/JCI58400; HOFFMAN L, 1982, DIABETOLOGIA, V23, P426; Ishiyama N, 2006, AM J PHYSIOL-ENDOC M, V290, pE540, DOI 10.1152/ajpendo.00032.2005; Jacovetti C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9084; Jaffe R, 1982, Perspect Pediatr Pathol, V7, P137; JAHR H, 1981, DIABETES METAB, V7, P71; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Keskinen P, 2002, DIABETOLOGIA, V45, P1639, DOI 10.1007/s00125-002-0981-8; Manning Fox JE, 2013, ENDOCRINOLOGY, V154, P1392; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Mericq V, 2005, DIABETOLOGIA, V48, P2609, DOI 10.1007/s00125-005-0036-z; MILNER RDG, 1972, J ENDOCRINOL, V52, P497, DOI 10.1677/joe.0.0520497; OTONKOSKI T, 1988, DIABETES, V37, P286, DOI 10.2337/diabetes.37.3.286; OTONKOSKI T, 1995, J CLIN ENDOCR METAB, V80, P3779, DOI 10.1210/jc.80.12.3779; RAHIER J, 1981, DIABETOLOGIA, V20, P540; REITANO G, 1971, J CLIN ENDOCR METAB, V33, P924, DOI 10.1210/jcem-33-6-924; Richardson CC, 2007, DIABETOLOGIA, V50, P1000, DOI 10.1007/s00125-007-0644-x; ROBERT JJ, 1991, DIABETES CARE, V14, P718, DOI 10.2337/diacare.14.8.718; Sato Y, 1999, ENDOCRINOLOGY, V140, P2252, DOI 10.1210/en.140.5.2252; Sempoux C, 1998, MODERN PATHOL, V11, P444; Stanley CA, 2016, J CLIN ENDOCR METAB, V101, P815, DOI 10.1210/jc.2015-3651; STEFAN Y, 1983, DIABETES, V32, P293, DOI 10.2337/diabetes.32.4.293; Stolovich-Rain M, 2015, DEV CELL, V32, P535, DOI 10.1016/j.devcel.2015.01.002; Stumpp C, 2014, PEDIATR DIABETES, V15, P528, DOI 10.1111/pedi.12122; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; Tu J, 1997, J CLIN ENDOCR METAB, V82, P943, DOI 10.1210/jc.82.3.943; WIRDNAM PK, 1981, EARLY HUM DEV, V5, P299, DOI 10.1016/0378-3782(81)90037-2	47	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165961	10.1371/journal.pone.0165961	http://dx.doi.org/10.1371/journal.pone.0165961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806105	Green Submitted, gold, Green Published			2022-12-26	WOS:000386715500073
J	Dagdeviren, S; Jung, DY; Friedline, RH; Noh, HL; Kim, JH; Patel, PR; Tsitsilianos, N; Inashima, K; Tran, DA; Hu, XD; Loubato, MM; Craige, SM; Kwon, JY; Lee, KW; Kim, JK				Dagdeviren, Sezin; Jung, Dae Young; Friedline, Randall H.; Noh, Hye Lim; Kim, Jong Hun; Patel, Payal R.; Tsitsilianos, Nicholas; Inashima, Kunikazu; Tran, Duy A.; Hu, Xiaodi; Loubato, Marilia M.; Craige, Siobhan M.; Kwon, Jung Yeon; Lee, Ki Won; Kim, Jason K.			IL-10 prevents aging-associated inflammation and insulin resistance in skeletal muscle	FASEB JOURNAL			English	Article						cytokines; interleukins; aging; type 2 diabetes; glucose metabolism	CYTOKINE PRODUCTION; ADIPOSE-TISSUE; IN-VIVO; OBESITY; INTERLEUKIN-10; MICE; AGE; DISEASE; HUMANS; CELLS	Altered energy balance and insulin resistance are important characteristics of aging. Skeletal muscle is a major site of glucose disposal, and the role of aging-associated inflammation in skeletal muscle insulin resistance remains unclear. To investigate, we examined glucose metabolism in 18-mo-old transgenic mice with muscle-specific overexpression of IL-10 (M-IL10) and in wild-type mice during hyperinsulinemic-euglycemic clamping. Despite similar fat mass and energy balance, M-IL10 mice were protected from aging-associated insulin resistance with significant increases in glucose infusion rates, whole-body glucose turnover, and skeletal muscle glucose uptake (similar to 60%; P < 0.05), as compared to age-matched WT mice. This protective effect was associated with decreased muscle inflammation, but no changes in adipose tissue inflammation in aging M-IL10 mice. These results demonstrate the importance of skeletal muscle inflammation in aging-mediated insulin resistance, and our findings further implicate a potential therapeutic role of anti-inflammatory cytokine in the treatment of aging-mediated insulin resistance.	[Dagdeviren, Sezin; Jung, Dae Young; Friedline, Randall H.; Noh, Hye Lim; Kim, Jong Hun; Patel, Payal R.; Tsitsilianos, Nicholas; Inashima, Kunikazu; Tran, Duy A.; Hu, Xiaodi; Loubato, Marilia M.; Kwon, Jung Yeon; Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Mol Med, Worcester, MA 01655 USA; [Craige, Siobhan M.] Univ Massachusetts, Sch Med, Div Cardiovasc Med, Worcester, MA 01655 USA; [Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Worcester, MA 01655 USA; [Kim, Jong Hun; Kwon, Jung Yeon; Lee, Ki Won] Seoul Natl Univ, Adv Inst Convergence Technol, Wellness Emergence Ctr, Suwon, South Korea; [Lee, Ki Won; Kim, Jason K.] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Seoul National University (SNU); Seoul National University (SNU)	Kim, JK (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 368 Plantat St,AS9-1041, Worcester, MA 01605 USA.	jason.kim@umassmed.edu	Dagdeviren, Sezin/CAI-5833-2022; Dagdeviren, Sezin/I-9277-2019; Lee, Ki Won/M-4114-2018	Kim, Jason/0000-0002-7185-042X	Institute of Diabetes and Digestive and Kidney Diseases [R01-DK080756, R01-DK079999, R24-DK0909, UC2-DK09300063]; American Diabetes Association Research Award [707-RA-80]; South Korean Midcareer Researcher Program Grant from the National Research Foundation, Ministry of Science, Information and Communications Technology, and Future Planning [2015R1A2A1A10053567]; High Value-Added Food Technology Development Program Grant through Korean Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries,Ministry of Agriculture, Food and Rural Affairs [116030-3]; U.S. National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK093000, R01DK080756, R01DK079999, R24DK090963, U24DK093000] Funding Source: NIH RePORTER	Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association Research Award(American Diabetes Association); South Korean Midcareer Researcher Program Grant from the National Research Foundation, Ministry of Science, Information and Communications Technology, and Future Planning; High Value-Added Food Technology Development Program Grant through Korean Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries,Ministry of Agriculture, Food and Rural Affairs; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by U.S. National Institutes of Health, Institute of Diabetes and Digestive and Kidney Diseases Grants R01-DK080756, R01-DK079999, R24-DK090963, and UC2-DK093000 (to J.K.K.); American Diabetes Association Research Award 707-RA-80 (to J.K.K.); South Korean Midcareer Researcher Program Grant 2015R1A2A1A10053567 from the National Research Foundation, Ministry of Science, Information and Communications Technology, and Future Planning (to K.W.L.); High Value-Added Food Technology Development Program Grant 116030-3 through the Korean Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries, Ministry of Agriculture, Food and Rural Affairs (to K.W.L.).	Akki A, 2014, AGE, V36, P21, DOI 10.1007/s11357-013-9540-0; Alvarez B, 2002, CANCER LETT, V175, P181, DOI 10.1016/S0304-3835(01)00717-0; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Bernstein ED, 1998, VACCINE, V16, P1722, DOI 10.1016/S0264-410X(98)00140-6; Brett JO, 2014, CURR OPIN GENET DEV, V26, P33, DOI 10.1016/j.gde.2014.05.004; Bruunsgaard H, 2000, CLIN EXP IMMUNOL, V119, P433, DOI 10.1046/j.1365-2249.2000.01146.x; Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5; Conley KE, 2000, J PHYSIOL-LONDON, V526, P211, DOI 10.1111/j.1469-7793.2000.00211.x; Dagdeviren S, 2011, J ORTHOP RES, V29, P275, DOI 10.1002/jor.21226; FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Gonzalez-Rodriguez A, 2012, AGING CELL, V11, P284, DOI 10.1111/j.1474-9726.2011.00786.x; Hacham M, 2004, EUR CYTOKINE NETW, V15, P37; Hawkins SA, 2003, SPORTS MED, V33, P877, DOI 10.2165/00007256-200333120-00002; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134; Houtkooper RH, 2010, CELL, V142, P9, DOI 10.1016/j.cell.2010.06.029; Karakelides H, 2010, DIABETES, V59, P89, DOI 10.2337/db09-0591; Khabour OF, 2010, INT J IMMUNOGENET, V37, P293, DOI 10.1111/j.1744-313X.2010.00925.x; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Kim JK, 2009, METHODS MOL BIOL, V560, P221, DOI 10.1007/978-1-59745-448-3_15; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; KREISBERG RA, 1987, AM J MED, V82, P54, DOI 10.1016/0002-9343(87)90272-5; Leclercq IA, 2007, J HEPATOL, V47, P142, DOI 10.1016/j.jhep.2007.04.002; Levast B, 2015, CYTOKINE, V75, P291, DOI 10.1016/j.cyto.2014.11.027; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Llorente L, 1997, SCAND J IMMUNOL, V45, P401, DOI 10.1046/j.1365-3083.1997.d01-409.x; Meador BM, 2008, J APPL PHYSIOL, V104, P991, DOI 10.1152/japplphysiol.01079.2007; Mittal SK, 2015, CURR OPIN IMMUNOL, V34, P22, DOI 10.1016/j.coi.2014.12.009; Moller N, 1998, J CLIN ENDOCR METAB, V83, P931, DOI 10.1210/jc.83.3.931; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Rajala MW, 2003, J CLIN INVEST, V111, P225, DOI 10.1172/JCI200316521; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Sziksz E, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/764641; van der Geest KSM, 2016, EXP GERONTOL, V75, P24, DOI 10.1016/j.exger.2015.12.009; Wang JL, 2001, DIABETES, V50, P2786, DOI 10.2337/diabetes.50.12.2786; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zhou XH, 2004, COMPARATIVE MED, V54, P176	42	74	75	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					701	710		10.1096/fj.201600832R	http://dx.doi.org/10.1096/fj.201600832R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27811060	Green Published			2022-12-26	WOS:000394235400022
J	Iracheta-Vellve, A; Petrasek, J; Gyongyosi, B; Satishchandran, A; Lowe, P; Kodys, K; Catalano, D; Calenda, CD; Kurt-Jones, EA; Fitzgerald, KA; Szabo, G				Iracheta-Vellve, Arvin; Petrasek, Jan; Gyongyosi, Benedek; Satishchandran, Abhishek; Lowe, Patrick; Kodys, Karen; Catalano, Donna; Calenda, Charles D.; Kurt-Jones, Evelyn A.; Fitzgerald, Katherine A.; Szabo, Gyongyi			Endoplasmic Reticulum Stress-induced Hepatocellular Death Pathways Mediate Liver Injury and Fibrosis via Stimulator of Interferon Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; INNATE IMMUNITY; CARBON-TETRACHLORIDE; MOLECULAR-MECHANISMS; HEPATOCYTE APOPTOSIS; HEPATIC-FIBROSIS; DANGER SIGNALS; ER STRESS; RAT-LIVER; URIC-ACID	Fibrosis, driven by inflammation, marks the transition from benign to progressive stages of chronic liver diseases. Although inflammation promotes fibrogenesis, it is not known whether other events, such as hepatocyte death, are required for the development of fibrosis. Interferon regulatory factor 3 (IRF3) regulates hepatocyte apoptosis and production of type I IFNs. In the liver, IRF3 is activated via Toll-like receptor 4 (TLR4) signaling or the endoplasmic reticulum (ER) adapter, stimulator of interferon genes (STING). We hypothesized that IRF3-mediated hepatocyte death is an independent determinant of chemically induced liver fibrogenesis. To test this, we performed acute or chronic CCl4 administration to WT and IRF3-, Toll/Interleukin-1R (TIR) domain-containing adapter-inducing interferon-beta (TRIF)-, TRIF-related adaptor molecule (TRAM)-, and STING-deficient mice. We report that acute CCl4 administration to WT mice resulted in early ER stress, activation of IRF3, and type I IFNs, followed by hepatocyte apoptosis and liver injury, accompanied by liver fibrosis upon repeated administration of CCl4. Deficiency of IRF3 or STING prevented hepatocyte death and fibrosis both in acute or chronic CCl4. In contrast, mice deficient in type I IFN receptors or in TLR4 signaling adaptors, TRAM or TRIF, upstream of IRF3, were not protected from hepatocyte death and/or fibrosis, suggesting that the proapoptotic role of IRF3 is independent of TLR signaling in fibrosis. Hepatocyte death is required for liver fibrosis with causal involvement of STING and IRF3. Thus, our results identify that IRF3, by its association with STING in the presence of ER stress, couples hepatocyte apoptosis with liver fibrosis and indicate that innate immune signaling regulates outcomes of liver fibrosis via modulation of hepatocyte death in the liver.	[Iracheta-Vellve, Arvin; Petrasek, Jan; Gyongyosi, Benedek; Satishchandran, Abhishek; Lowe, Patrick; Kodys, Karen; Catalano, Donna; Calenda, Charles D.; Kurt-Jones, Evelyn A.; Fitzgerald, Katherine A.; Szabo, Gyongyi] Univ Massachusetts, Sch Med, Dept Med, LRB208,364 Plantat St, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Szabo, G (corresponding author), Univ Massachusetts, Sch Med, Dept Med, LRB208,364 Plantat St, Worcester, MA 01605 USA.	gyongyi.szabo@umassmed.edu	Fitzgerald, Katherine/ABE-6317-2020; Iracheta-Vellve, Arvin/K-6140-2014	Iracheta-Vellve, Arvin/0000-0002-6635-3904; Fitzgerald, Kate/0000-0003-3175-609X	National Institute on Alcohol Abuse and Alcoholism [AA017729, PA-12-149, F31AA025545]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA025545, R01AA020744, R01AA017729] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institute on Alcohol Abuse and Alcoholism Grants AA017729 (to G. S.) and PA-12-149 (to A. I.-V.), and National Institute on Alcohol Abuse and Alcoholism Award F31AA025545 (to A. I.-V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe T, 2013, MOL CELL, V50, P5, DOI 10.1016/j.molcel.2013.01.039; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chattopadhyay S, 2013, J VIROL, V87, P16, DOI 10.1128/JVI.01853-12; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Deminice R, 2016, AMINO ACIDS, V48, P1983, DOI 10.1007/s00726-016-2183-6; Fox S, 2010, J INNATE IMMUN, V2, P216, DOI 10.1159/000284367; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Hu FL, 2011, EUR J IMMUNOL, V41, P1086, DOI 10.1002/eji.201040831; Iracheta-Vellve A, 2015, J HEPATOL, V63, P1147, DOI 10.1016/j.jhep.2015.06.013; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Knockaert L, 2012, LAB INVEST, V92, P396, DOI 10.1038/labinvest.2011.193; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Liu YP, 2012, J IMMUNOL, V189, P4630, DOI 10.4049/jimmunol.1102737; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Maurel M, 2014, TRENDS BIOCHEM SCI, V39, P245, DOI 10.1016/j.tibs.2014.02.008; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Petrasek J, 2015, J LEUKOCYTE BIOL, V98, P249, DOI 10.1189/jlb.3AB1214-590R; Petrasek J, 2013, P NATL ACAD SCI USA, V110, P16544, DOI 10.1073/pnas.1308331110; Petrasek J, 2011, HEPATOLOGY, V53, P649, DOI 10.1002/hep.24059; Plumb R, 2015, ELIFE, V4, DOI 10.7554/eLife.07426; Rivera CA, 2001, AM J PHYSIOL-GASTR L, V281, pG200, DOI 10.1152/ajpgi.2001.281.1.G200; Roh YS, 2014, HEPATOLOGY, V60, P237, DOI 10.1002/hep.26981; Roychowdhury S, 2012, ALCOHOL CLIN EXP RES, V36, P1139, DOI 10.1111/j.1530-0277.2011.01720.x; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Servant MJ, 2002, J INTERF CYTOK RES, V22, P49, DOI 10.1089/107999002753452656; Shi JL, 1998, AM J PATHOL, V153, P515, DOI 10.1016/S0002-9440(10)65594-0; Smith JA, 2008, EUR J IMMUNOL, V38, P1194, DOI 10.1002/eji.200737882; Soares JB, 2010, HEPATOL INT, V4, P659, DOI 10.1007/s12072-010-9219-x; Sun F, 2001, BBA-MOL BASIS DIS, V1535, P186, DOI 10.1016/S0925-4439(00)00098-3; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang X, 2011, CELL DEATH DIFFER, V18, P38, DOI 10.1038/cdd.2010.68; Xia TL, 2016, CELL REP, V14, P282, DOI 10.1016/j.celrep.2015.12.029; Zakim D., 2002, HEPATOLOGY TXB LIVER, P746; Zhou Z, 2016, CELL MOL IMMUNOL, V13, P301, DOI 10.1038/cmi.2015.97	42	85	91	4	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26794	26805		10.1074/jbc.M116.736991	http://dx.doi.org/10.1074/jbc.M116.736991			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27810900	Green Published, hybrid			2022-12-26	WOS:000391571400018
J	Niu, NN; Shao, R; Yan, G; Zou, WG				Niu, Ningning; Shao, Rui; Yan, Guang; Zou, Weiguo			Bromodomain and Extra-terminal (BET) Protein Inhibitors Suppress Chondrocyte Differentiation and Restrain Bone Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE-INHIBITION; THERAPEUTIC STRATEGY; STEM-CELLS; P-TEFB; CANCER; TRANSCRIPTION; BRD4; RESISTANCE; KINASE; MICE	Small molecule inhibitors for bromodomain and extra-terminal (BET) proteins have recently emerged as potential therapeutic agents in clinical trials for various cancers. However, to date, it is unknown whether these inhibitors have side effects on bone structures. Here, we report that inhibition of BET bromodomain proteins may suppress chondrocyte differentiation and restrain bone growth. We generated a luciferase reporter system using the chondrogenic cell line ATDC5 in which the luciferase gene was driven by the promoter of Col2a1, an elementary collagen of the chondrocyte. The Col2a1-luciferase ATDC5 system was used for rapidly screening both activators and repressors of human collagen Col2a1 gene expression, and we found that BET bromodomain inhibitors reduce the Col2a1-luciferase. Consistent with the luciferase assay, BET inhibitors decrease the expression of Col2a1. Furthermore, we constructed a zebrafish line in which the enhanced green fluorescent protein (EGFP) expression was driven by col2a1 promoter. The transgenic (col2a1-EGFP) zebrafish line demonstrated that BET inhibitors I-BET151 and (+)-JQ1 may affect EGFP expression in zebrafish. Furthermore, we found that I-BET151 and (+)-JQ1 may affect chondrocyte differentiation in vitro and inhibit zebrafish growth in vivo. Mechanistic analysis revealed that BET inhibitors influenced the depletion of RNA polymerase II from the Col2a1 promoter. Collectively, these results suggest that BET bromodomain inhibition may have side effects on skeletal bone structures.	[Niu, Ningning; Shao, Rui; Yan, Guang; Zou, Weiguo] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol,Ctr Excellence Mol Cell S, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zou, WG (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, 320 Yue Yang Rd,SIBCB Bldg,Rm 1401, Shanghai 200031, Peoples R China.	zouwg94@sibcb.ac.cn		Yan, Guang/0000-0001-6784-0010	973 Program from the Chinese Ministry of Science and Technology [2015CB964503, 2014CB964704]; National Natural Science Foundation of China [31371463, 31501170]; National Science Fund for Excellent Young Scholars [81322027]	973 Program from the Chinese Ministry of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Excellent Young Scholars	This work was supported in part by 973 Program from the Chinese Ministry of Science and Technology Grants 2015CB964503 and 2014CB964704 and National Natural Science Foundation of China Grants 31371463 and 31501170. The authors declare that they have no conflicts of interest with the contents of this article.; A scholar of the National 1000 Young Talents Program of China and the National Science Fund for Excellent Young Scholars (Grant 81322027). To whom correspondence should be addressed: Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue Yang Rd., SIBCB Bldg., Rm. 1401, Shanghai 200031, China. Tel.: 86-21-54921320; Fax: 86-21-54921279; E-mail: zouwg94@sibcb.ac.cn.	Adamo A, 2011, NAT CELL BIOL, V13, P652, DOI 10.1038/ncb2246; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bianco P, 1998, MATRIX BIOL, V17, P185, DOI 10.1016/S0945-053X(98)90057-9; Ceribelli M, 2014, P NATL ACAD SCI USA, V111, P11365, DOI 10.1073/pnas.1411701111; Chaidos A, 2014, BLOOD, V123, P697, DOI 10.1182/blood-2013-01-478420; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Fenaroli F, 2014, ACS NANO, V8, P7014, DOI 10.1021/nn5019126; Feng Q, 2014, CELL RES, V24, P809, DOI 10.1038/cr.2014.71; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fisher S, 2003, DEV BIOL, V264, P64, DOI 10.1016/S0012-1606(03)00399-3; Fiskus W, 2014, MOL CANCER THER, V13, P2315, DOI 10.1158/1535-7163.MCT-14-0258; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; Fu LL, 2015, ONCOTARGET, V6, P5501, DOI 10.18632/oncotarget.3551; Huang MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23770; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157; Jung M, 2015, EPIGENOMICS-UK, V7, P487, DOI 10.2217/epi.14.91; Kan A, 2009, ARTHRITIS RHEUM-US, V60, P3314, DOI 10.1002/art.24878; Korb E, 2015, NAT NEUROSCI, V18, P1464, DOI 10.1038/nn.4095; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lamoureux F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4511; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Liu Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11149; Mackie EJ, 2011, J ENDOCRINOL, V211, P109, DOI 10.1530/JOE-11-0048; Montenegro RC, 2016, ONCOTARGET, V7, P43997, DOI 10.18632/oncotarget.9766; Park-Min KH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6418; Seghatoleslami MR, 1995, MATRIX BIOL, V14, P753, DOI 10.1016/S0945-053X(05)80018-6; Stratikopoulos EE, 2015, CANCER CELL, V27, P837, DOI 10.1016/j.ccell.2015.05.006; Sullivan JM, 2015, J EXP MED, V212, P1771, DOI 10.1084/jem.20151271; Tang YJ, 2014, NAT MED, V20, P732, DOI 10.1038/nm.3613; Wei X, 2016, J DENT RES, V95, P1221, DOI 10.1177/0022034516651823; Wein MN, 2012, P NATL ACAD SCI USA, V109, P8173, DOI 10.1073/pnas.1205848109; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yapp C, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1053-7; Zhang WS, 2012, J BIOL CHEM, V287, P43137, DOI 10.1074/jbc.M112.413047; Zhou G, 1998, J BIOL CHEM, V273, P14989, DOI 10.1074/jbc.273.24.14989	40	14	14	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26647	26657		10.1074/jbc.M116.749697	http://dx.doi.org/10.1074/jbc.M116.749697			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27821592	Green Published, hybrid			2022-12-26	WOS:000391571400006
J	Wang, X; Jia, YY; Fei, C; Song, XM; Li, L				Wang, Xin; Jia, Yingying; Fei, Cong; Song, Xiaomin; Li, Lin			Activation/Proliferation-associated Protein 2 (Caprin-2) Positively Regulates CDK14/Cyclin Y-mediated Lipoprotein Receptor-related Protein 5 and 6 (LRP5/6) Constitutive Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CONTROL; LRP6 PHOSPHORYLATION; BETA-CATENIN; WNT PATHWAY; STEM-CELLS; IDENTIFICATION; ACTIVATION; EXPRESSION; STABILIZATION; DROSOPHILA	Low-density lipoprotein receptor-related proteins 5 and 6 (LRP5/6) are co-receptors for Wnt ligands. Upon ligand binding, LRP5/6 undergo glycogen synthase kinase 3 (GSK3)/casein kinase I (CKI)-mediated phosphorylation at multiple PPP(S/T) P motifs in the intracellular domain, which is essential for canonical Wnt signal transduction. On the other hand, in the Wnt-off state, the mitosis-specific CDK14-Cyclin Y kinase complex phosphorylates Ser-1490 of LRP5/6 at G(2)/M, thereby priming the receptor for Wnt-induced phosphorylation. However, it remains unclear how CDK14/Cyclin Y is recruited to LRP5/6 and whether there are other cofactors involved in this process. Previously, we identified Caprin-2 as a positive regulator of canonical Wnt signaling by promoting GSK3-depedent LRP5/6 phosphorylation upon Wnt stimulation. Here we uncovered that Caprin-2 positively regulates constitutive LRP5/6 Ser-1490 phosphorylation by complexing with CDK14/Cyclin Y. Caprin-2-mediated LRP5/6 phosphorylation is cell cycle-dependent in a pattern similar to that of CDK14/Cyclin Y-dependent LRP5/6 phosphorylation. Moreover, knockdown of Caprin-2 disrupts not only the interaction between CDK14 and Cyclin Y but also the interaction between CDK14/Cyclin Y and LRP6. Overall, our findings revealed an unrecognized role of Caprin-2 in facilitating LRP5/6 constitutive phosphorylation at G(2)/M through forming a quaternary complex with CDK14, Cyclin Y, and LRP5/6.	[Wang, Xin; Jia, Yingying; Fei, Cong; Song, Xiaomin; Li, Lin] Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Innovat Ctr Cell Signaling Network, State Key Lab Mol Biol,Inst Biochem & Cell Biol,S, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Song, XM; Li, L (corresponding author), Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Innovat Ctr Cell Signaling Network, State Key Lab Mol Biol,Inst Biochem & Cell Biol,S, Shanghai 200031, Peoples R China.	lli@sibs.ac.cn	li, li/HII-4157-2022; Li, Li/AEM-3636-2022; LI, LI/GVS-5344-2022		National Natural Science Foundation of China [31530094, 31230044, 31100532]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19000000, XDA12010301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (Grants 31530094, 31230044 and 31100532) and the Strategic Priority Research Program of the Chinese Academy of Sciences (Grants XDB19000000 and XDA12010301). The authors declare that they have no conflicts of interest with the contents of this article.	Acebron SP, 2014, MOL CELL, V54, P663, DOI 10.1016/j.molcel.2014.04.014; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Davidson G, 2009, DEV CELL, V17, P788, DOI 10.1016/j.devcel.2009.11.006; Ding Y, 2008, J CELL BIOL, V182, P865, DOI 10.1083/jcb.200803147; Feng Q, 2015, J CELL PHYSIOL, V230, P1170, DOI 10.1002/jcp.24853; Hadjihannas MV, 2012, EMBO REP, V13, P347, DOI 10.1038/embor.2012.12; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Holland JD, 2013, CURR OPIN CELL BIOL, V25, P254, DOI 10.1016/j.ceb.2013.01.004; Huang YL, 2015, P NATL ACAD SCI USA, V112, P5732, DOI 10.1073/pnas.1423533112; Jiang M, 2009, FEBS LETT, V583, P2171, DOI 10.1016/j.febslet.2009.06.010; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Kim NG, 2009, P NATL ACAD SCI USA, V106, P5165, DOI 10.1073/pnas.0810185106; Koch S, 2015, CELL, V163, P1225, DOI 10.1016/j.cell.2015.10.029; Li M, 2010, J BIOL CHEM, V285, P13397, DOI 10.1074/jbc.M109.083246; Liu DM, 2010, GENETICS, V184, P1025, DOI 10.1534/genetics.110.114017; Loren CE, 2009, DIFFERENTIATION, V77, P386, DOI 10.1016/j.diff.2008.11.003; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Miao HF, 2014, J BIOL CHEM, V289, P34104, DOI 10.1074/jbc.M114.591636; Olmeda D, 2003, MOL BIOL CELL, V14, P2844, DOI 10.1091/mbc.E03-01-0865; Pan WJ, 2008, SCIENCE, V321, P1350, DOI 10.1126/science.1160741; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Semenov MV, 2008, J BIOL CHEM, V283, P21427, DOI 10.1074/jbc.M800014200; Shiina N, 2010, J BIOL CHEM, V285, P24260, DOI 10.1074/jbc.M110.108944; Stolz A, 2015, EMBO REP, V16, P490, DOI 10.15252/embr.201439410; Stowers RS, 2000, DEV BIOL, V221, P23, DOI 10.1006/dbio.2000.9685; Tanneberger K, 2011, EMBO J, V30, P1433, DOI 10.1038/emboj.2011.28; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Verkaar F, 2011, DRUG DISCOV TODAY, V16, P35, DOI 10.1016/j.drudis.2010.11.007; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yang T, 2001, GENE, V267, P165, DOI 10.1016/S0378-1119(01)00391-2; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zi ZZ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005485	38	11	15	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26427	26434		10.1074/jbc.M116.744607	http://dx.doi.org/10.1074/jbc.M116.744607			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27821587	Green Published, hybrid			2022-12-26	WOS:000391568200016
J	Christensen, MA; Bettencourt, L; Kaye, L; Moturu, ST; Nguyen, KT; Olgin, JE; Pletcher, MJ; Marcus, GM				Christensen, Matthew A.; Bettencourt, Laura; Kaye, Leanne; Moturu, Sai T.; Nguyen, Kaylin T.; Olgin, Jeffrey E.; Pletcher, Mark J.; Marcus, Gregory M.			Direct Measurements of Smartphone Screen-Time: Relationships with Demographics and Sleep	PLOS ONE			English	Article							DURATION; SEVERITY; RISK; METAANALYSIS; TECHNOLOGY; DEPRESSION; VALIDITY; QUALITY; LIGHT	Background Smartphones are increasingly integrated into everyday life, but frequency of use has not yet been objectively measured and compared to demographics, health information, and in particular, sleep quality. Aims The aim of this study was to characterize smartphone use by measuring screen-time directly, determine factors that are associated with increased screen-time, and to test the hypothesis that increased screen-time is associated with poor sleep. Methods We performed a cross-sectional analysis in a subset of 653 participants enrolled in the Health eHeart Study, an internet-based longitudinal cohort study open to any interested adult (>= 18 years). Smartphone screen-time (the number of minutes in each hour the screen was on) was measured continuously via smartphone application. For each participant, total and average screen-time were computed over 30-day windows. Average screen-time specifically during self-reported bedtime hours and sleeping period was also computed. Demographics, medical information, and sleep habits (Pittsburgh Sleep Quality Index-PSQI) were obtained by survey. Linear regression was used to obtain effect estimates. Results Total screen-time over 30 days was a median 38.4 hours (IQR 21.4 to 61.3) and average screen-time over 30 days was a median 3.7 minutes per hour (IQR 2.2 to 5.5). Younger age, self-reported race/ethnicity of Black and "Other" were associated with longer average screen-time after adjustment for potential confounders. Longer average screen-time was associated with shorter sleep duration and worse sleep-efficiency. Longer average screen-times during bedtime and the sleeping period were associated with poor sleep quality, decreased sleep efficiency, and longer sleep onset latency. Conclusions These findings on actual smartphone screen-time build upon prior work based on self-report and confirm that adults spend a substantial amount of time using their smartphones. Screen-time differs across age and race, but is similar across socio-economic strata suggesting that cultural factors may drive smartphone use. Screen-time is associated with poor sleep. These findings cannot support conclusions on causation. Effect-cause remains a possibility: poor sleep may lead to increased screen-time. However, exposure to smartphone screens, particularly around bedtime, may negatively impact sleep.	[Christensen, Matthew A.; Nguyen, Kaylin T.; Olgin, Jeffrey E.; Marcus, Gregory M.] Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA; [Bettencourt, Laura; Pletcher, Mark J.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Kaye, Leanne; Moturu, Sai T.] Ginger Io Inc, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Marcus, GM (corresponding author), Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA.	marcusg@medicine.ucsf.edu	Marcus, Gregory/AAN-8584-2021	Marcus, Gregory/0000-0001-5197-7696; Christensen, Matthew/0000-0002-6021-8680; Kaye, Leanne/0000-0002-5345-7026	Office of Behavioral Social Sciences (OBSSR); National Institute of Biomedical Imaging and Bioengineering (NIBIB); National Institute of Neurological Disorders and Stroke (NINDS); National Heart Lung and Blood Institute (NHLBI); National Institute on Alcohol Abuse and Alcoholism (NIAAA) of the National Institutes of Health [1U2CEB021881]; Sarnoff Cardiovascular Research Foundation; National Institute on Minority Health and Health Disparities (NIM HD) [R25MD006832]	Office of Behavioral Social Sciences (OBSSR); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Alcohol Abuse and Alcoholism (NIAAA) of the National Institutes of Health; Sarnoff Cardiovascular Research Foundation; National Institute on Minority Health and Health Disparities (NIM HD)	Research reported in this publication was supported by the Office of Behavioral Social Sciences (OBSSR), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institute of Neurological Disorders and Stroke (NINDS), National Heart Lung and Blood Institute (NHLBI), and National Institute on Alcohol Abuse and Alcoholism (NIAAA) of the National Institutes of Health under award number 1U2CEB021881 (https://grants.nih.govigrants/oer.htm). MAC is a research fellow supported by the Sarnoff Cardiovascular Research Foundation (http://samofffoundation.com). KTN is a fellow supported by National Institute on Minority Health and Health Disparities (NIM HD) under award number R25MD006832 (http.//www.nimhd.nih.gov/). Ginger.io Incorporated (https://ginger.io) provided support in the form of salaries for authors LK and STM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors (LK, STM) are articulated in the 'author contributions' section. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buysse DJ, 1989, RES PSYCHIAT, V193, P213, DOI DOI 10.1016/0165-1781(89)90047-4; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Cajochen C, 2011, J APPL PHYSIOL, V110, P1432, DOI 10.1152/japplphysiol.00165.2011; Calamaro CJ, 2009, PEDIATRICS, V123, pE1005, DOI 10.1542/peds.2008-3641; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Chang A. - M., 2014, P NATL ACAD SCI USA, V112; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Demirci K, 2015, J BEHAV ADDICT, V4, P85, DOI 10.1556/2006.4.2015.010; Dixit S, 2016, HEART RHYTHM, V13, P3, DOI 10.1016/j.hrthm.2015.08.004; Duffy JF, 2009, SLEEP MED CLIN, V4, P165, DOI 10.1016/j.jsmc.2009.01.004; Falbe J, 2015, PEDIATRICS, V135, pE367, DOI 10.1542/peds.2014-2306; Gibss N., 2012, YOUR LIFE IS FULLY M; Gradisar M, 2013, J CLIN SLEEP MED, V9, P1291, DOI 10.5664/jcsm.3272; Grandner Michael A, 2006, Sleep Biol Rhythms, V4, P129, DOI 10.1111/j.1479-8425.2006.00207.x; Grandner MA, 2012, J SLEEP RES, V21, P427, DOI 10.1111/j.1365-2869.2011.00990.x; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hixon T., 2014, FORBES; Holzman DC, 2010, ENVIRON HEALTH PERSP, V118, pA22, DOI 10.1289/ehp.118-a22; Howden LM, 2011, AGE SEX COMPOSITION, P1; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Knutson KL, 2006, SLEEP, V29, P1503, DOI 10.1093/sleep/29.11.1503; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lin YH, 2015, J PSYCHIATR RES, V65, P139, DOI 10.1016/j.jpsychires.2015.04.003; Patyar S, 2015, J STROKE CEREBROVASC, V24, P905, DOI 10.1016/j.jstrokecerebrovasdis.2014.12.038; Saeb S, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4273; Smith A, 2011, 35 AM ADULTS OWN SMA; Smith A., 2015, SMARTPHONE DIFFERENC; Smith A., 2013, SMARTPHONE OWNERSHIP	28	101	107	7	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165331	10.1371/journal.pone.0165331	http://dx.doi.org/10.1371/journal.pone.0165331			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829040	gold, Green Submitted, Green Published			2022-12-26	WOS:000387724300038
J	Lindstrand, A; Kalyango, J; Alfven, T; Darenberg, J; Kadobera, D; Bwanga, F; Peterson, S; Henriques-Normark, B; Kallander, K				Lindstrand, Ann; Kalyango, Joan; Alfven, Tobias; Darenberg, Jessica; Kadobera, Daniel; Bwanga, Freddie; Peterson, Stefan; Henriques-Normark, Birgitta; Kallander, Karin			Pneumococcal Carriage in Children under Five Years in Uganda-Will Present Pneumococcal Conjugate Vaccines Be Appropriate?	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; ANTIBIOTIC-RESISTANCE; SEROTYPE DISTRIBUTION; INVASIVE-DISEASE; PREVALENCE; SURVEILLANCE; VACCINATION; POPULATION	Background Pneumonia is the major cause of death in children globally, with more than 900,000 deaths annually in children under five years of age. Streptococcus pneumoniae causes most deaths, most often in the form of community acquired pneumonia. Pneumococcal conjugate vaccines (PCVs) are currently being implemented in many low-income countries. PCVs decrease vaccine-type pneumococcal carriage, a prerequisite for invasive pneumococcal disease, and thereby affects pneumococcal disease and transmission. In Uganda, PCV was launched in 2014, but baseline data is lacking for pneumococcal serotypes in carriage. Objectives To study pneumococcal nasopharyngeal carriage and serotype distribution in children under 5 years of age prior to PCV introduction in Uganda Methods Three cross-sectional pneumococcal carriage surveys were conducted in 2008, 2009 and 2011, comprising respectively 150, 587 and 1024 randomly selected children aged less than five years from the lganga/Mayuge Health and Demographic Surveillance Site. The caretakers were interviewed about illness history of the child and 1723 nasopharyngeal specimens were collected. From these, 927 isolates of S. pneumoniae were serotyped. Results Overall, the carriage rate of S. pneumoniae was 56% (957/1723). Pneumococcal carriage was associated with illness on the day of the interview (OR = 1.50, p = 0.04). The most common pneumococcal serotypes were in descending order 19F (16%), 23F (9%), 6A (8%), 29 (7%) and 6B (7%). One percent of the strains were non-typeable. The potential serotype coverage rate for PCV10 was 42% and 54% for PCV13. Conclusion About half of circulating pneumococcal serotypes in carriage in the Ugandan under-five population studied was covered by available PCVs.	[Lindstrand, Ann; Alfven, Tobias; Peterson, Stefan; Kallander, Karin] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Lindstrand, Ann; Darenberg, Jessica; Henriques-Normark, Birgitta] Publ Hlth Agcy Sweden, Stockholm, Sweden; [Kalyango, Joan; Kadobera, Daniel; Peterson, Stefan; Kallander, Karin] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Alfven, Tobias] Sachs Children & Youth Hosp, Stockholm, Sweden; [Bwanga, Freddie] Makerere Univ, Fac Med, Kampala, Uganda; [Henriques-Normark, Birgitta] Karolinska Inst, Dept Microbiol Tumor & Cellbiol, Stockholm, Sweden; [Henriques-Normark, Birgitta] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden; [Kallander, Karin] Malaria Consortium, London, England; [Peterson, Stefan] Uppsala Univ, Dept Int Maternal & Child Hlth Womens & Childrens, Uppsala, Sweden; [Kadobera, Daniel] Minist Hlth, Kampala, Uganda; [Kadobera, Daniel] Hlth & Demog Surveillance Site, Iganga Mayuge, Uganda	Karolinska Institutet; Public Health Agency of Sweden; Makerere University; Makerere University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Uppsala University	Lindstrand, A (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.; Lindstrand, A (corresponding author), Publ Hlth Agcy Sweden, Stockholm, Sweden.	Ann.Lindstrand@folkhalsomyndigheten.se		Kallander, Karin/0000-0002-5778-5780; Lindstrand, Ann/0000-0002-8271-9486; Alfven, Tobias/0000-0002-2328-3512	Swedish International Development Agency [SWE-2008-228]; Karolinska Institutet (KI) Strategic Research Program in Epidemiology; KI Public International Health Network (KIPIH) [228/2008-607]	Swedish International Development Agency; Karolinska Institutet (KI) Strategic Research Program in Epidemiology; KI Public International Health Network (KIPIH)	This study was funded by the Swedish International Development Agency (SWE-2008-228) (www.sida.se), the Karolinska Institutet (KI) Strategic Research Program in Epidemiology (http://ki.se/en/research/the-strategic-research-area-in-epidemiology-sfoepi), the KI Public International Health Network (228/2008-607) (KIPIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103293; Ba F, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0627-8; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Biesbroek G, 2014, EMERG INFECT DIS, V20, P201, DOI 10.3201/eid2002.131220; Blossom DB, 2006, INT J INFECT DIS, V10, P458, DOI 10.1016/j.ijid.2006.05.010; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Donkor ES, 2013, INT J GEN MED, V6, P757, DOI 10.2147/IJGM.S45842; Galanis I, 2016, EUR RESPIR J, V47, P1208, DOI 10.1183/13993003.01451-2015; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; Goldblatt D, 2013, VACCINE, V32, P146, DOI 10.1016/j.vaccine.2013.06.040; Hackel M, 2013, VACCINE, V31, P4881, DOI 10.1016/j.vaccine.2013.07.054; Hammitt LL, 2014, LANCET GLOB HEALTH, V2, pE397, DOI 10.1016/S2214-109X(14)70224-4; Hammitt LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085459; Hausdorff WP, 2007, VACCINE, V25, P2406, DOI 10.1016/j.vaccine.2006.09.009; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Kallander K, 2016, LANCET GLOB HEALTH, V4, pE12, DOI 10.1016/S2214-109X(15)00272-7; Kalyango JN, 2012, AM J TROP MED HYG, V87, P36, DOI 10.4269/ajtmh.2012.11-0733; Kisakye A, 2009, CLIN INFECT DIS, V48, pS153, DOI 10.1086/596495; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Mackenzie GA, 2016, LANCET INFECT DIS; Mudhune S, 2009, CLIN INFECT DIS, V48, pS147, DOI 10.1086/596494; Muema DM, 2015, CLIN EXP IMMUNOL, V181, P297, DOI 10.1111/cei.12637; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nantanda R, 2008, ANN TROP PAEDIATR, V28, P253, DOI 10.1179/146532808X375404; Normark BH, 2003, MICROB DRUG RESIST, V9, P337, DOI 10.1089/107662903322762761; Normark BH, 2001, SCAND J INFECT DIS, V33, P848, DOI 10.1080/713933757; Nunes MC, 2013, PEDIATR INFECT DIS J, V32, pE192, DOI 10.1097/INF.0b013e31828683a3; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Oliwa JN, PAEDIAT RESP REV; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Rutebemberwa E, 2015, UPSALA J MED SCI, V120, P249, DOI 10.3109/03009734.2015.1072606; Rutebemberwa E, 2009, TROP MED INT HEALTH, V14, P472, DOI 10.1111/j.1365-3156.2009.02237.x; Sa-Leao R, 2011, J CLIN MICROBIOL, V49, P1369, DOI 10.1128/JCM.01763-10; Sankoh O, 2012, INT J EPIDEMIOL, V41, P579, DOI 10.1093/ije/dys081; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Sharma D, 2013, PEDIATR INFECT DIS J, V32, pE45, DOI 10.1097/INF.0b013e3182788fdd; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Tate JE, 2011, VACCINE, V29, P3329, DOI 10.1016/j.vaccine.2010.12.122; Usuf E, 2015, TROP MED INT HLTH; Usuf E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085001; Valles X, 2006, TROP MED INT HEALTH, V11, P358, DOI 10.1111/j.1365-3156.2006.01565.x; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914; Weinberger DM, 2013, AM J EPIDEMIOL, V178, P1488, DOI 10.1093/aje/kwt156; World Health Organization, 2003, MANUAL LAB IDENTIFIC; World Health Organization, 2015, HLTH 2015 MDGS MILL, DOI 10.1007/BF01918387	48	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166018	10.1371/journal.pone.0166018	http://dx.doi.org/10.1371/journal.pone.0166018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829063	Green Published, Green Submitted, gold			2022-12-26	WOS:000387724300075
J	Cunningham, DJ; Shearer, DA; Drawer, S; Pollard, B; Eager, R; Taylor, N; Cook, CJ; Kilduff, LP				Cunningham, Daniel J.; Shearer, David A.; Drawer, Scott; Pollard, Ben; Eager, Robin; Taylor, Neil; Cook, Christian J.; Kilduff, Liam P.			Movement Demands of Elite Under-20s and Senior International Rugby Union Players	PLOS ONE			English	Article							CREATINE-KINASE RESPONSES; TEAM SOCCER MATCH; PHYSICAL DEMANDS; MOTION ANALYSIS; PLAYING LEVEL; PERFORMANCE; POWER; JUNIOR; SPEED; TIME	This study compared the movement demands of elite international Under-20 age grade (U20s) and senior international rugby union players during competitive tournament match play. Forty elite professional players from an U20 and 27 elite professional senior players from international performance squads were monitored using 10Hz global positioning systems (GPS) during 15 (U20s) and 8 (senior) international tournament matches during the 2014 and 2015 seasons. Data on distances, velocities, accelerations, decelerations, high metabolic load (HML) distance and efforts, and number of sprints were derived. Data files from players who played over 60 min (n = 258) were separated firstly into Forwards and Backs, and more specifically into six positional groups; FR-Front Row (prop & hooker), SR-Second Row, BR-Back Row (Flankers & No. 8), HB-Half Backs (scrum half & outside half), MF-Midfield (centres), B3-Back Three (wings & full back) for match analysis. Linear mixed models revealed significant differences between U20 and senior teams in both the forwards and backs. In the forwards the seniors covered greater HML distance (736.4 +/- 280.3 vs 701.3 +/- 198.7m, p = 0.01) and severe decelerations (2.38 +/- 2.2 vs 2.28 +/- 1.65, p = 0.05) compared to the U20s, but performed less relative HSR (3.1 +/- 1.6 vs 3.2 +/- 1.5, p < 0.01), moderate (19.4 +/- 10.5 vs 23.6 +/- 10.5, p = 0.01) and high accelerations (2.2 +/- 1.9 vs 4.3-2.7, p < 0.01) and sprint center dot min(-1) (0.11 +/- 0.06 vs 0.11 +/- 0.05, p < 0.01). Senior backs covered a greater relative distance (73.3 +/- 8.1 vs 69.1 +/- 7.6 m center dot min(-1), p < 0.01), greater High Metabolic Load (HML) distance (1138.0 +/- 233.5 vs 1060.4 +/- 218.1m, p < 0.01), HML efforts (112.7 +/- 22.2 vs 98.8 +/- 21.7, p < 0.01) and heavy decelerations (9.9 +/- 4.3 vs 9.5 +/- 4.4, p = 0.04) than the U20s backs. However, the U20s backs performed more relative HSR (7.3 +/- 2.1 vs 7.2 +/- 2.1, p < 0.01) and sprint center dot min(-1) (0.26 +/- 0.07 vs 0.25 +/- 0.07, p < 0.01). Further investigation highlighted differences between the 6 positional groups of the teams. The positional groups that differed the most on the variables measured were the FR and MF groups, with the U20s FR having higher outputs on HSR, moderate & high accelerations, moderate, high & severe decelerations, HML distance, HML efforts, and sprints center dot min(-1). For the MF group the senior players produced greater values for relative distance covered,HSR, moderate decelerations, HML distance and sprint center dot min(-1). The BR position group was most similar with the only differences seen on heavy accelerations (U20s higher) and moderate decelerations (seniors higher). Findings demonstrate that U20s internationals appear to be an adequate 'stepping stone' for preparing players for movement characteristics found senior International rugby, however, the current study highlight for the first time that certain positional groups may require more time to be able to match the movement demands required at a higher playing level than others. Conditioning staff must also bear in mind that the U20s players whilst maintaining or improving match movement capabilities may require to gain substantial mass in some positions to match their senior counterparts.	[Cunningham, Daniel J.; Cook, Christian J.; Kilduff, Liam P.] Swansea Univ, Coll Engn, Appl Sport Technol Exercise & Med Res Ctr A STEM, Swansea, W Glam, Wales; [Shearer, David A.] Univ South Wales, Sch Psychol & Therapeut Studies, Pontypridd, Wales; [Shearer, David A.; Kilduff, Liam P.] Swansea Univ, Coll Engn, Welsh Inst Performance Sci, Swansea, W Glam, Wales; [Drawer, Scott; Pollard, Ben; Eager, Robin; Taylor, Neil] Rugby Football Union, Greater London, England	Swansea University; University of South Wales; Swansea University	Kilduff, LP (corresponding author), Swansea Univ, Coll Engn, Appl Sport Technol Exercise & Med Res Ctr A STEM, Swansea, W Glam, Wales.; Kilduff, LP (corresponding author), Swansea Univ, Coll Engn, Welsh Inst Performance Sci, Swansea, W Glam, Wales.	l.kilduff@swansea.ac.uk	Shearer, David/K-8025-2019	Shearer, David/0000-0002-5877-8160; Cunningham, Dan/0000-0002-5249-0609; Cook, Christian/0000-0001-9677-0306	Rugby Football Union	Rugby Football Union	The author(s) received no specific funding for this work and no authors have any financial or other interest in the products or distributor of the products named in the study. The Rugby Football Union provided support in the form of salaries for authors Scott Drawer, Robin Eager, Ben Pollard and Neil Taylor, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson L, 2016, INT J SPORT PHYSIOL, V11, P1038, DOI 10.1123/ijspp.2015-0672; Anderson L, 2016, J SPORT SCI, V34, P1250, DOI 10.1080/02640414.2015.1106574; Argus CK, 2012, J STRENGTH COND RES, V26, P2698, DOI 10.1519/JSC.0b013e318241382a; Austin DJ, 2013, J STRENGTH COND RES, V27, P14, DOI 10.1519/JSC.0b013e31824e108c; Barr MJ, 2014, J STRENGTH COND RES, V28, P2724, DOI 10.1519/JSC.0000000000000364; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Cahill N, 2013, J SPORT SCI, V31, P229, DOI 10.1080/02640414.2012.727456; Castellano J, 2011, J SPORT SCI MED, V10, P233; Clarke AC, 2017, J STRENGTH COND RES, V31, P1116, DOI 10.1519/JSC.0000000000001576; Cunniffe B, 2011, J SPORT MED PHYS FIT, V51, P329; Cunniffe B, 2010, EUR J APPL PHYSIOL, V108, P113, DOI 10.1007/s00421-009-1200-9; Cunniffe B, 2009, J STRENGTH COND RES, V23, P1195, DOI 10.1519/JSC.0b013e3181a3928b; Cunningham D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153275; Darrall-Jones JD, 2015, J STRENGTH COND RES, V29, P2086, DOI 10.1519/JSC.0000000000000872; Deutsch MU, 2007, J SPORT SCI, V25, P461, DOI 10.1080/02640410600631298; Duthie G, 2005, J SPORT SCI, V23, P523, DOI 10.1080/02640410410001730188; Eaton C, 2006, PHYS THER SPORT, V7, P22, DOI 10.1016/j.ptsp.2005.08.006; Gabbett TJ, 2016, BRIT J SPORT MED, V50, P273, DOI 10.1136/bjsports-2015-095788; Gabbett TJ, 2013, J STRENGTH COND RES, V27, P1623, DOI 10.1519/JSC.0b013e318274f2af; Gabbett TJ, 2002, BRIT J SPORT MED, V36, P334, DOI 10.1136/bjsm.36.5.334; Gannon EA, 2016, INT J SPORT PHYSIOL, V11, P381, DOI 10.1123/ijspp.2015-0337; Hansen KT, 2011, J STRENGTH COND RES, V25, P2382, DOI 10.1519/JSC.0b013e318201bf48; Harley JA, 2010, J SPORT SCI, V28, P1391, DOI 10.1080/02640414.2010.510142; Higham DG, 2012, J SCI MED SPORT, V15, P277, DOI 10.1016/j.jsams.2011.11.256; Jennings DH, 2012, J STRENGTH COND RES, V26, P947, DOI 10.1519/JSC.0b013e31822e5913; Jones MR, 2015, EUR J SPORT SCI, V15, P488, DOI 10.1080/17461391.2015.1010106; Jones MR, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-38; Jones NMP, 2008, J SPORT SCI, V26, P691, DOI 10.1080/02640410701815170; Lacome M, 2014, J SPORT SCI, V32, P290, DOI 10.1080/02640414.2013.823225; Lindsay A, 2015, EUR J SPORT SCI, V15, P480, DOI 10.1080/17461391.2015.1025858; Lombard WP, 2015, J STRENGTH COND RES, V29, P980, DOI 10.1519/JSC.0000000000000724; McLean DA, 1992, J SPORT SCI, V10, P285, DOI 10.1080/02640419208729927; McLellan CP, 2013, J STRENGTH COND RES, V27, P3266, DOI 10.1519/JSC.0b013e31828f1d74; McLellan CP, 2011, J STRENGTH COND RES, V25, P1703, DOI 10.1519/JSC.0b013e3181ddf678; Mohr M, 2003, J SPORT SCI, V21, P519, DOI 10.1080/0264041031000071182; Olds T, 2001, J SPORT SCI, V19, P253, DOI 10.1080/026404101750158312; Owen SM, 2015, J SPORT SCI, V33, P2061, DOI 10.1080/02640414.2015.1028086; Preatoni E, 2013, SCAND J MED SCI SPOR, V23, pe178, DOI 10.1111/sms.12048; Quarrie KL, 2013, J SCI MED SPORT, V16, P353, DOI 10.1016/j.jsams.2012.08.005; Reardon C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133410; Roberts SP, 2008, J SPORT SCI, V26, P825, DOI 10.1080/02640410801942122; Russell M, 2016, HUM MOVEMENT SCI, V45, P96, DOI 10.1016/j.humov.2015.11.011; Russell M, 2015, J SPORT SCI, V33, P2133, DOI 10.1080/02640414.2015.1064153; Russell M, 2016, J STRENGTH COND RES, V30, P2839, DOI 10.1519/JSC.0000000000000805; Sirotic AC, 2009, J SPORT SCI, V27, P203, DOI 10.1080/02640410802520802; Tierney PJ, 2016, HUM MOVEMENT SCI, V49, P1, DOI 10.1016/j.humov.2016.05.007; Varley MC, 2012, J SPORT SCI, V30, P121, DOI 10.1080/02640414.2011.627941	47	20	20	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0164990	10.1371/journal.pone.0164990	http://dx.doi.org/10.1371/journal.pone.0164990			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824865	gold, Green Published, Green Submitted			2022-12-26	WOS:000387615200010
J	Embrey, M; Vialle-Valentin, C; Dillip, A; Kihiyo, B; Mbwasi, R; Semali, IA; Chalker, JC; Liana, J; Lieber, R; Johnson, K; Rutta, E; Kimatta, S; Shekalaghe, E; Valimba, R; Ross-Degnan, D				Embrey, Martha; Vialle-Valentin, Catherine; Dillip, Angel; Kihiyo, Bernard; Mbwasi, Romuald; Semali, Innocent A.; Chalker, John C.; Liana, Jafary; Lieber, Rachel; Johnson, Keith; Rutta, Edmund; Kimatta, Suleiman; Shekalaghe, Elizabeth; Valimba, Richard; Ross-Degnan, Dennis			Understanding the Role of Accredited Drug Dispensing Outlets in Tanzania's Health System	PLOS ONE			English	Article							MALARIA TREATMENT; COMMUNITY; KNOWLEDGE; ACCESS; FEVER; CARE	Introduction People in many low-income countries access medicines from retail drug shops. In Tanzania, a public-private partnership launched in 2003 used an accreditation approach to improve access to quality medicines and pharmaceutical services in underserved areas. The government scaled up the accredited drug dispensing outlet (ADDO) program nationally, with over 9,000 shops now accredited. This study assessed the relationships between community members and their sources of health care and medicines, particularly antimicrobials, with a specific focus on the role ADDOs play in the health care system. Methods Using mixed methods, we collected data in four regions. We surveyed 1,185 households and audited 96 ADDOs and 84 public/nongovernmental health facilities using a list of 17 tracer drugs. To determine practices in health facilities, we interviewed 1,365 exiting patients. To assess dispensing practices, mystery shoppers visited 306 ADDOs presenting one of three scenarios (102 each) about a child's respiratory symptoms. Results and Discussion Of 614 household members with a recent acute illness, 73% sought outside care-30% at a public facility and 31% at an ADDO. However, people bought medicines more often at ADDOs no matter who recommended the treatment; of the 581 medicines that people had received, 49% came from an ADDO. Although health facilities and ADDOs had similar availability of antimicrobials, ADDOs had more pediatric formulations available (p<0.001). The common perception was that drugs from ADDOs are more expensive, but the difference in the median cost to treat pneumonia was relatively minimal (US$0.26 in a public facility and US$0.30 in an ADDO). Over 20% of households said they had someone with a chronic condition, with 93% taking medication, but ADDOs are allowed to sell very few chronic care-related medicines. ADDO dispensers are trained to refer complicated cases to a health facility, and notably, 99% of mystery shoppers presenting a pneumonia scenario received an antimicrobial (54%), a referral (90%), or both (45%), which are recommended practices for managing pediatric pneumonia. However, one-third of the dispensers needlessly sold antibiotics for cold symptoms, and 85% sold an antibiotic on request. In addition, the pneumonia scenario elicited more advice on handling the illness than the cold symptoms scenario (61% vs. 15%; p<0.0001), but overall, only 44% of the dispensers asked any of the shoppers about danger signs potentially associated with pneumonia in a child. Conclusion ADDOs are the principal source of medicines in Tanzania and an important part of a multifaceted health care system. Poor prescribing in health facilities, poor dispensing at ADDOs, and inappropriate patient demand continue to contribute to inappropriate medicines use. Therefore, while accreditation has attempted to address the quality of pharmaceutical services in private sector drug outlets, efforts to improve access to and use of medicines in Tanzania need to target ADDOs, public/nongovernmental health facilities, and the public to be effective.	[Embrey, Martha; Chalker, John C.; Lieber, Rachel; Johnson, Keith; Rutta, Edmund] Management Sci Hlth, Pharmaceut & Hlth Technol Grp, Arlington, VA 22203 USA; [Vialle-Valentin, Catherine; Ross-Degnan, Dennis] Harvard Med Sch, Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Drug Policy Res Grp, Boston, MA USA; [Dillip, Angel] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Kihiyo, Bernard] Tanzania Consumer Advocacy Soc, Dar Es Salaam, Tanzania; [Mbwasi, Romuald] St Johns Univ Dodoma, Apotheker Consultancy Ltd T, Dodoma, Tanzania; [Semali, Innocent A.] Muhimbili Univ Hlth & Allied Sci, Sch Publ Hlth, Dar Es Salaam, Tanzania; [Liana, Jafary; Kimatta, Suleiman; Valimba, Richard] Management Sci Hlth, Pharmaceut & Hlth Technol Grp, Dar Es Salaam, Tanzania; [Shekalaghe, Elizabeth] Pharm Council Tanzania, Dar Es Salaam, Tanzania	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Ifakara Health Institute; Muhimbili University of Health & Allied Sciences	Embrey, M (corresponding author), Management Sci Hlth, Pharmaceut & Hlth Technol Grp, Arlington, VA 22203 USA.	membrey@msh.org		Embrey, Martha/0000-0002-2556-6487	Bill & Melinda Gates Foundation [OPP1017439]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was supported by the Bill & Melinda Gates Foundation, www.gatesfoundation.org/, under grant OPP1017439 to KJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Romuald Mbwasi is employed by Apotheker Consultancy (T) Limited. Apotheker Consultancy (T) Limited provided support in the form of salary for author RM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Alba S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-163; [Anonymous], 2013, 6610 WHA; Awor P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115440; Battersby A, 2003, IMPROVING SUPPLY DIS; Beyeler N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117165; Bigdeli M, 2014, MED HLTH SYSTEMS ADV, P74; Center for Pharmaceutical Management, 2001, ACC ESS MED TANZ 200; Chalker JC, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0075-2; Chipwaza B, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-252; Chipwaza B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002896; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; Dillip A, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0073-4; East Africa Drug Seller Initiative, 2011, EV REP; Geldsetzer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093427; Goodman C, 2007, AM J TROP MED HYG, V77, P203, DOI 10.4269/ajtmh.2007.77.203; Goodman C, 2007, HEALTH POLICY PLANN, V22, P393, DOI 10.1093/heapol/czm033; Hertz JT, 2013, TROP MED INT HEALTH, V18, P1406, DOI 10.1111/tmi.12191; Lagomarsino H, 2009, PUBLIC STEWARDSHIP P; Madden JM, 1997, SOC SCI MED, V45, P1465, DOI 10.1016/S0277-9536(97)00076-2; Management Sciences for Health, 2008, ACCR DRUG DISP OUTL; Metta E, 2014, GLOBAL HEALTH ACTION, V7, P148, DOI 10.3402/gha.v7.23439; Mikkelsen-Lopez I, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-444; Ministry of Health and Social Welfare, 2013, STANDARD TREATMENT G; Ministry of Health and Social Welfare Reproductive and Child Health Section, 2010, NAT FAM PLANN COST I; National Malaria Control Program and Clinton Health Access Initiative. mRDTs, 2014, ADDO PROGR STAK M AR; Rutta D, 2009, PROG COMM HLTH PARTN, p[3, 145], DOI [10.1353/cpr.0.0063PMID: 20208262, DOI 10.1353/CPR.0.0063]; Rutta E, 2014, INT J TUBERC LUNG D, V18, P1108, DOI 10.5588/ijtld.14.0020; Rutta E, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-22; Shah NM, 2011, HEALTH POLICY PLANN, V26, P275, DOI 10.1093/heapol/czq074; The United Republic of Tanzania, 2008, HLTH SECT STRAT PLAN; Tumwikirize W A, 2004, East Afr Med J, VSuppl, pS33; WHO, 2013, WORLD MALARIA REPORT 2013, P1; World Health Organization, GLOB HLTH OBS DAT RE; World Health Organization, 2014, NONC DIS COUNTR PROF; World Health Organization Department of Child Adolescent Health World Health Organization and UNICEF, 2005, HDB IMCI INT MAN CHI	35	24	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0164332	10.1371/journal.pone.0164332	http://dx.doi.org/10.1371/journal.pone.0164332			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824876	Green Published, Green Submitted, gold			2022-12-26	WOS:000387615200005
J	Lee, N; Ryu, HG; Kwon, JH; Kim, DK; Kim, SR; Wang, HJ; Kim, KT; Choi, KY				Lee, Namgyu; Ryu, Hye Guk; Kwon, Jung-Hee; Kim, Dae-Kyum; Kim, Sae Rom; Wang, Hee Jung; Kim, Kyong-Tai; Choi, Kwan Yong			SIRT6 Depletion Suppresses Tumor Growth by Promoting Cellular Senescence Induced by DNA Damage in HCC	PLOS ONE			English	Article							HISTONE DEACETYLASE SIRT6; HEPATOCELLULAR-CARCINOMA; TELOMERE DYSFUNCTION; CANCER-CELLS; REPAIR; EXPRESSION; METABOLISM; RESISTANCE; MUTATIONS; APOPTOSIS	The role of Sirtuin 6 (SIRT6) as a tumor suppressor or oncogene in liver cancer remains controversial. Thus, we identified the specific role of SIRT6 in the progression of hepatocellular carcinoma (HCC). SIRT6 expression was significantly higher in HCC cell lines and HCC tissues from 138 patients than in an immortalized hepatocyte cell line, THLE-2 and non-tumor tissues, respectively. SIRT6 knockdown by shRNA suppressed the growth of HCC cells and inhibited HCC tumor growth in vivo. In addition, SIRT6 silencing significantly prevented the growth of HCC cell lines by inducing cellular senescence in the p16/Rb- and p53/p21-pathway independent manners. Microarray analysis revealed that the expression of genes involved in nucleosome assembly was apparently altered in SIRT6-depleted Hep3B cells. SIRT6 knockdown promoted G2/M phase arrest and downregulation of genes encoding histone variants associated with nucleosome assembly, which could be attributed to DNA damage. Taken together, our findings suggest that SIRT6 acts as a tumor promoter by preventing DNA damage and cellular senescence, indicating that SIRT6 represents a potential therapeutic target for the treatment of HCC.	[Lee, Namgyu; Ryu, Hye Guk; Kim, Sae Rom; Kim, Kyong-Tai; Choi, Kwan Yong] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, Gyeongbuk, South Korea; [Kwon, Jung-Hee] Cbs Biosci Inc, Daejeon, South Korea; [Kim, Dae-Kyum] Univ Toronto, Donnelly Ctr, Dept Mol Genet, Toronto, ON, Canada; [Kim, Dae-Kyum] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Kim, Dae-Kyum] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Wang, Hee Jung] Ajou Univ, Sch Med, Dept Surg, Suwon, South Korea; [Kim, Kyong-Tai; Choi, Kwan Yong] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, Gyeongbuk, South Korea; [Lee, Namgyu] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA	Pohang University of Science & Technology (POSTECH); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Ajou University; Pohang University of Science & Technology (POSTECH); University of Massachusetts System; University of Massachusetts Worcester	Choi, KY (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang, Gyeongbuk, South Korea.; Choi, KY (corresponding author), Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, Gyeongbuk, South Korea.	kchoi@postech.ac.kr		KIM, KYONG-TAI/0000-0001-7292-2627; Kim, Dae-Kyum/0000-0003-4568-8278; Lee, Namgyu/0000-0002-2980-2758	National Research Foundation of Korea (NRF) grant - Korea government (MEST) [2014R1A2A2A01002931]; Next Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ011216012016]; CbsBioscience	National Research Foundation of Korea (NRF) grant - Korea government (MEST)(National Research Foundation of KoreaMinistry of Education, Science & Technology (MEST), Republic of Korea); Next Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea; CbsBioscience	This study was supported by a grant from the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (2014R1A2A2A01002931) and the Next Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea (PJ011216012016). The funders provided support in the form of salaries for authors [NL, KYC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. JHK is employees of CbsBioscience, whose company provided support in the form of salary for her, but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2014, HEPATOLOGY, V60, P1972, DOI 10.1002/hep.27198; Bauer I, 2012, J BIOL CHEM, V287, P40924, DOI 10.1074/jbc.M112.405837; de Jesus BB, 2012, CIRC RES, V111, P97, DOI 10.1161/CIRCRESAHA.111.247866; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cardus A, 2013, CARDIOVASC RES, V97, P571, DOI 10.1093/cvr/cvs352; Chen QM, 2000, BIOCHEM J, V347, P543, DOI 10.1042/0264-6021:3470543; Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245; DiPaola RS, 2002, CLIN CANCER RES, V8, P3311; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Feng XX, 2015, CANCER SCI, V106, P559, DOI 10.1111/cas.12632; Feser J, 2011, FEBS LETT, V585, P2041, DOI 10.1016/j.febslet.2010.11.016; Feser J, 2010, MOL CELL, V39, P724, DOI 10.1016/j.molcel.2010.08.015; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Hengstschlager M, 1999, MUTAT RES-REV MUTAT, V436, P1, DOI 10.1016/S1383-5742(98)00022-2; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jia GX, 2012, MOL CELL BIOCHEM, V364, P345, DOI 10.1007/s11010-012-1236-8; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Khongkow M, 2013, CARCINOGENESIS, V34, P1476, DOI 10.1093/carcin/bgt098; Kugel S, 2015, CELL REP, V13, P479, DOI 10.1016/j.celrep.2015.09.022; Kwon JH, 2010, CLIN CANCER RES, V16, P5511, DOI 10.1158/1078-0432.CCR-10-0825; Lee N, 2015, ONCOTARGET, V6, P30130, DOI 10.18632/oncotarget.4967; Lee N, 2014, PROTEOMICS, V14, P1610, DOI 10.1002/pmic.201400001; Liu R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/470393; Lombard DB, 2008, J INTERN MED, V263, P128, DOI 10.1111/j.1365-2796.2007.01902.x; Lombard DB, 2009, AGING-US, V1, P12, DOI 10.18632/aging.100014; Lopez MF, 2012, AGING-US, V4, P823, DOI 10.18632/aging.100507; Mao ZY, 2012, P NATL ACAD SCI USA, V109, P11800, DOI 10.1073/pnas.1200583109; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Marquardt JU, 2013, HEPATOLOGY, V58, P1054, DOI 10.1002/hep.26413; McCord RA, 2009, AGING-US, V1, P109, DOI 10.18632/aging.100011; Min LH, 2012, NAT CELL BIOL, V14, P1203, DOI 10.1038/ncb2590; Minagawa S, 2011, AM J PHYSIOL-LUNG C, V300, pL391, DOI 10.1152/ajplung.00097.2010; Nagai K, 2015, OSTEOARTHR CARTILAGE, V23, P1412, DOI 10.1016/j.joca.2015.03.024; Oberdoerffer P, 2010, NAT CELL BIOL, V12, P1029, DOI 10.1038/ncb1110-1029; Ran LK, 2016, CLIN CANCER RES, V22, P3372, DOI 10.1158/1078-0432.CCR-15-1638; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Sociali G, 2015, EUR J MED CHEM, V102, P530, DOI 10.1016/j.ejmech.2015.08.024; Takasaka N, 2014, J IMMUNOL, V192, P958, DOI 10.4049/jimmunol.1302341; Thirumurthi U, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005076; Wang D, 2014, DNA CELL BIOL, V33, P581, DOI 10.1089/dna.2013.2257	42	32	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165835	10.1371/journal.pone.0165835	http://dx.doi.org/10.1371/journal.pone.0165835			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824900	Green Published, Green Submitted, gold			2022-12-26	WOS:000387615200036
J	Fullston, T; Ohlsson-Teague, EMC; Print, CG; Sandeman, LY; Lane, M				Fullston, Tod; Ohlsson-Teague, E. Maria C.; Print, Cristin G.; Sandeman, Lauren Y.; Lane, Michelle			Sperm microRNA Content Is Altered in a Mouse Model of Male Obesity, but the Same Suite of microRNAs Are Not Altered in Offspring's Sperm	PLOS ONE			English	Article							BODY-MASS INDEX; DIET-INDUCED OBESITY; HIGH-FAT DIET; DNA METHYLTRANSFERASES 3A; SLOW GROWTH PERIOD; PATERNAL OBESITY; TRANSGENERATIONAL INHERITANCE; SUBSEQUENT GENERATIONS; METABOLIC SYNDROME; SPERMATOZOAL RNAS	The prevalence of obesity is increasing worldwide and has tripled in men of reproductive age since the 1970s. Concerningly, obesity is not only comorbid with other chronic diseases, but there is mounting evidence that it increases the non-communicable disease load in their children (eg mortality, obesity, autism). Animal studies have demonstrated that paternal obesity increases the risk of metabolic (eg glucose metabolism defects, obesity) and reproductive disorders in offspring. Epigenetic changes within sperm are clear mechanistic candidates that are associated with both changes to the father's environment and offspring phenotype. Specifically there is emerging evidence that a father's sperm microRNA content both responds to paternal environmental cues and alters the gene expression profile and subsequent development of the early embryo. We used a mouse model of high fat diet (HFD) induced obesity to investigate whether male obesity could modulate sperm microRNA content. We also investigated whether this alteration to a father's sperm microRNA content lead to a similar change in the sperm of male offspring. Our investigations were initially guided by a Taqman PCR array, which indicated the differential abundance of 28 sperm borne microRNAs in HFD mice. qPCR confirmation in a much larger cohort of founder males demonstrated that 13 of these microRNAs were differentially abundant (11 up-regulated; 2 down-regulated) due to HFD feeding. Despite metabolic and reproductive phenotypes also being observed in grand-offspring fathered via the male offspring lineage, there was no evidence that any of the 13 microRNAs were also dysregulated in male offspring sperm. This was presumably due to the variation seen within both groups of offspring and suggests other mechanisms might act between offspring and grand-offspring. Thus 13 sperm borne microRNAs are modulated by a father's HFD and the presumed transfer of this altered microRNA payload to the embryo at fertilisation potentially acts to alter the embryonic molecular makeup post-fertilisation, altering its growth trajectory, ultimately affecting adult offspring phenotype and may contribute to paternal programming.	[Fullston, Tod; Ohlsson-Teague, E. Maria C.; Sandeman, Lauren Y.; Lane, Michelle] Univ Adelaide, Discipline Obstet & Gynaecol, Sch Med, Robinson Res Inst, Adelaide, SA 5005, Australia; [Fullston, Tod; Lane, Michelle] Univ Adelaide, Freemasons Fdn Ctr Mens Hlth, Adelaide, SA 5005, Australia; [Print, Cristin G.] Univ Auckland, Dept Mol Med & Pathol, Auckland 1142, New Zealand; [Print, Cristin G.] Univ Auckland, New Zealand Bioinformat Inst, Auckland 1142, New Zealand; [Lane, Michelle] Monash IVF Grp, Melbourne, Vic 3168, Australia	Robinson Research Institute; University of Adelaide; University of Adelaide; University of Auckland; University of Auckland	Fullston, T (corresponding author), Univ Adelaide, Discipline Obstet & Gynaecol, Sch Med, Robinson Res Inst, Adelaide, SA 5005, Australia.; Fullston, T (corresponding author), Univ Adelaide, Freemasons Fdn Ctr Mens Hlth, Adelaide, SA 5005, Australia.	tod.fullston@adelaide.edu.au		Print, Cristin/0000-0001-8345-7812	Senior Research Fellowship - National Health and Medical Research Council [APP1042089]; Project Grant - National Health and Medical Research Council [APP1022882]; National Health and Medical Research Council [APP1036561]; Robinson Research Institute	Senior Research Fellowship - National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Project Grant - National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Robinson Research Institute	ML was funded by a Senior Research Fellowship (APP1042089) and a Project Grant (APP1022882) awarded by the National Health and Medical Research Council (www.nhmrc.gov.au) to undertake this research TF was awarded an Early Career Fellowship (APP1036561) by the National Health and Medical Research Council (www.nhmrc.gov.au) to undertake this research TF was subsequently awarded a Robinson Research Institute (www.adelaide.edu.au/robinson-research-institute) Career Development Fellowship to undertake this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Bakos HW, 2011, INT J ANDROL, V34, P402, DOI 10.1111/j.1365-2605.2010.01092.x; Bakos HW, 2011, FERTIL STERIL, V95, P1700, DOI 10.1016/j.fertnstert.2010.11.044; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Belleannee C, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110486; Binder NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052304; Bogazzi F, 2013, ENDOCRINOLOGY, V154, P4226, DOI 10.1210/en.2013-1220; Bohacek J, 2015, NAT REV GENET, V16, P641, DOI 10.1038/nrg3964; Bygren LO, 2001, ACTA BIOTHEOR, V49, P53, DOI 10.1023/A:1010241825519; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chen Q, 2016, SCIENCE, V351, P397, DOI 10.1126/science.aad7977; Chiang PH, 2009, WORLD J GASTROENTERO, V15, P5334, DOI 10.3748/wjg.15.5334; Dadoune JP, 2009, MICROSC RES TECHNIQ, V72, P536, DOI 10.1002/jemt.20697; Danielzik S, 2002, EUR J NUTR, V41, P132, DOI 10.1007/s00394-002-0367-1; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Dong HF, 2013, CHEM REV, V113, P6207, DOI 10.1021/cr300362f; Erel CT, 2009, CURR OPIN OBSTET GYN, V21, P228, DOI 10.1097/GCO.0b013e32832aee96; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Foygel K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004109; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; Freeman E, 2012, INT J OBESITY, V36, P12, DOI 10.1038/ijo.2011.198; Fullston T, 2012, HUM REPROD, V27, P1391, DOI 10.1093/humrep/des030; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Gapp K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6466; Grandjean V, 2015, SCI REP-UK, V5, DOI 10.1038/srep18193; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Holland ML, 2013, BIOCHEM SOC T, V41, P769, DOI 10.1042/BST20130043; Huang Q, 2014, CELL BIOL INT, V38, P1384, DOI 10.1002/cbin.10334; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Katzmarzyk PT, 2004, CAN J PUBLIC HEALTH, V95, P16, DOI 10.1007/BF03403627; Kawano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044542; Li L, 2009, AM J CLIN NUTR, V89, P551, DOI 10.3945/ajcn.2008.26759; Li Y, 2012, GENE, V497, P330, DOI 10.1016/j.gene.2012.01.038; Liu WM, 2012, P NATL ACAD SCI USA, V109, P490, DOI 10.1073/pnas.1110368109; Mar JC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-110; McPherson NO, 2014, FERTIL STERIL, V101, P1458, DOI 10.1016/j.fertnstert.2013.12.057; McPherson NO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071459; McPherson NO, 2015, AM J PHYSIOL-ENDOC M; Mitchell M, 2011, FERTIL STERIL, V95, P1349, DOI 10.1016/j.fertnstert.2010.09.038; Murphy SK, 2014, NAT REV ENDOCRINOL, V10, P389, DOI 10.1038/nrendo.2014.81; Ng EKO, 2009, BRIT J CANCER, V101, P699, DOI 10.1038/sj.bjc.6605195; Ng EKO, 2014, TUMOR BIOL, V35, P2591, DOI 10.1007/s13277-013-1341-7; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014; Nilsson EE, 2015, TRANSL RES, V165, P12, DOI 10.1016/j.trsl.2014.02.003; Nixon B, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.132209; Nixon B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135605; Ostermeier GC, 2005, J ANDROL, V26, P70; Ostermeier GC, 2004, NATURE, V429, P154, DOI 10.1038/429154a; Palmer NO, 2012, AM J PHYSIOL-ENDOC M, V302, pE768, DOI 10.1152/ajpendo.00401.2011; Palmer NO, 2011, REPROD FERT DEVELOP, V23, P929, DOI 10.1071/RD10326; Pang RTK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027878; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Rato L, 2014, OBES REV, V15, P996, DOI 10.1111/obr.12226; Rodgers AB, 2015, P NATL ACAD SCI US; Rodgers AB, 2013, J NEUROSCI, V33, P9003, DOI 10.1523/JNEUROSCI.0914-13.2013; Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x; Shayeb AG, 2011, REPROD BIOMED ONLINE, V23, P717, DOI 10.1016/j.rbmo.2011.07.018; Shen JZ, 2014, ONCOL REP, V31, P2035, DOI 10.3892/or.2014.3078; Suren P, 2014, PEDIATRICS, V133, pE1128, DOI 10.1542/peds.2013-3664; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Takanabe R, 2008, BIOCHEM BIOPH RES CO, V376, P728, DOI 10.1016/j.bbrc.2008.09.050; Tamashiro KL, 2011, STRESS, V14, P468, DOI 10.3109/10253890.2011.606341; Tunc O, 2011, ANDROLOGIA, V43, P121, DOI 10.1111/j.1439-0272.2009.01032.x; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Wahlqvist ML, 2014, ECOL FOOD NUTR, V53, P81, DOI 10.1080/03670244.2013.772512; Wang Y, 2007, NAT PROTOC, V2, P972, DOI 10.1038/nprot.2007.144; Whitaker KL, 2010, AM J CLIN NUTR, V91, P1560, DOI 10.3945/ajcn.2009.28838; Wilson J.S., 2010, WHO LAB MAN EX PROC; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yahagi N, 2003, J BIOL CHEM, V278, P25395, DOI 10.1074/jbc.M302364200; Zhao S, 2011, ARTHRITIS RHEUM-US, V63, P1376, DOI 10.1002/art.30196	74	57	59	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166076	10.1371/journal.pone.0166076	http://dx.doi.org/10.1371/journal.pone.0166076			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814400	Green Submitted, gold, Green Published			2022-12-26	WOS:000386911100030
J	Grgic, RG; Crespi, SA; De'Sperati, C				Grgic, Regina Gregori; Crespi, Sofia Allegra; de'Sperati, Claudio			Assessing Self-Awareness through Gaze Agency	PLOS ONE			English	Article							TELEOLOGICAL EXPLANATIONS; SENSORY CONSEQUENCES; VOLUNTARY ACTION; NEURAL REUSE; ATTENTION; AUTISM; SCHIZOPHRENIA; MODEL; PREFERENCE; INTENTION	We define gaze agency as the awareness of the causal effect of one's own eye movements in gaze-contingent environments, which might soon become a widespread reality with the diffusion of gaze-operated devices. Here we propose a method for measuring gaze agency based on self-monitoring propensity and sensitivity. In one task, naif observers watched bouncing balls on a computer monitor with the goal of discovering the cause of concurrently presented beeps, which were generated in real-time by their saccades or by other events (Discovery Task). We manipulated observers' self-awareness by pre-exposing them to a condition in which beeps depended on gaze direction or by focusing their attention to their own eyes. These manipulations increased propensity to agency discovery. In a second task, which served to monitor agency sensitivity at the sensori-motor level, observers were explicitly asked to detect gaze agency (Detection Task). Both tasks turned out to be well suited to measure both increases and decreases of gaze agency. We did not find evident oculomotor correlates of agency discovery or detection. A strength of our approach is that it probes self-monitoring propensity-difficult to evaluate with traditional tasks based on bodily agency. In addition to putting a lens on this novel cognitive function, measuring gaze agency could reveal subtle self-awareness deficits in pathological conditions and during development.	[Grgic, Regina Gregori; Crespi, Sofia Allegra; de'Sperati, Claudio] Univ Vita Salute San Raffaele, Fac Psychol, Via Olgettina 58, I-20132 Milan, Italy; [Grgic, Regina Gregori; Crespi, Sofia Allegra; de'Sperati, Claudio] Univ Vita Salute San Raffaele, Lab Act Percept Cognit, Via Olgettina 58, I-20132 Milan, Italy; [Grgic, Regina Gregori; Crespi, Sofia Allegra; de'Sperati, Claudio] IRCCS San Raffaele Sci Inst, Div Neurosci, Expt Psychol Unit, Via Olgettina 60, I-20132 Milan, Italy; [Crespi, Sofia Allegra] IRCCS San Raffaele Sci Inst, Neuroradiol Dept, CERMAC, Via Olgettina 60, I-20132 Milan, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	De'Sperati, C (corresponding author), Univ Vita Salute San Raffaele, Fac Psychol, Via Olgettina 58, I-20132 Milan, Italy.; De'Sperati, C (corresponding author), Univ Vita Salute San Raffaele, Lab Act Percept Cognit, Via Olgettina 58, I-20132 Milan, Italy.	desperati.claudio@hsr.it		de'sperati, claudio/0000-0002-7322-2240	Futuro in ricerca [RBFR1332DJ]; Ministero dell'Istruzione dell'Universita e della Ricerca, SAC	Futuro in ricerca; Ministero dell'Istruzione dell'Universita e della Ricerca, SAC	This work was supported by Futuro in ricerca 2013, http://firb.miur.it/, grant number: RBFR1332DJ; Ministero dell'Istruzione dell'Universita e della Ricerca, SAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht B, 2008, BIOL PSYCHIAT, V64, P615, DOI 10.1016/j.biopsych.2007.12.016; Anderson ML, 2016, DEV MED CHILD NEUROL, V58, P3, DOI 10.1111/dmcn.13039; Anderson ML, 2010, BEHAV BRAIN SCI, V33, P245, DOI 10.1017/S0140525X10000853; Bandura A, 2006, PERSPECT PSYCHOL SCI, V1, P164, DOI 10.1111/j.1745-6916.2006.00011.x; Berger A, 2000, NEUROSCI BIOBEHAV R, V24, P3, DOI 10.1016/S0149-7634(99)00046-9; BRIDGEMAN B, 1994, BEHAV BRAIN SCI, V17, P247, DOI 10.1017/S0140525X00034361; Brown GS, 2005, BEHAV RES METHODS, V37, P436, DOI 10.3758/BF03192712; Cavazzana Annachiara, 2014, Front Hum Neurosci, V8, P651, DOI 10.3389/fnhum.2014.00651; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Crespi S, 2012, J VISION, V12, DOI 10.1167/12.11.30; Daprati E, 1997, COGNITION, V65, P71, DOI 10.1016/S0010-0277(97)00039-5; de'Sperati C, 2003, J COGNITIVE NEUROSCI, V15, P1244, DOI 10.1162/089892903322598184; De'Sperati C, 2008, J NEUROSCI, V28, P4317, DOI 10.1523/JNEUROSCI.0352-08.2008; Deubel H, 2008, PSYCHOL RES-PSYCH FO, V72, P630, DOI 10.1007/s00426-008-0165-3; Dewey JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110118; Dewey JA, 2013, CONSCIOUS COGN, V22, P155, DOI 10.1016/j.concog.2012.12.004; Duchowski A. T., 2006, EYE TRACKING METHODO; Elias DO, 2006, J COMP PHYSIOL A, V192, P785, DOI 10.1007/s00359-006-0116-7; Farb NAS, 2013, CEREB CORTEX, V23, P114, DOI 10.1093/cercor/bhr385; FRITH C. D., 1992, COGNITIVE NEUROPSYCH; Frith CD, 2000, BRAIN RES REV, V31, P357, DOI 10.1016/S0165-0173(99)00052-1; Fukushima H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072267; Gallagher S, 2004, PSYCHOPATHOLOGY, V37, P8, DOI 10.1159/000077014; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Gentsch A, 2012, BIOL PSYCHIAT, V71, P652, DOI 10.1016/j.biopsych.2011.12.022; Gergely G, 1999, EARLY SOCIAL COGNITION, P101; Gibson J.J., 1986, ECOLOGICAL APPROACH; Gibson J.J., 1966, SENSES CONSIDERED PE; Grainger C, 2014, J AUTISM DEV DISORD, V44, P1193, DOI 10.1007/s10803-013-1987-4; Gregori Grgic R, 2015, 16 INT MULTISENSORY; Haggard P, 2005, TRENDS COGN SCI, V9, P290, DOI 10.1016/j.tics.2005.04.012; Haggard P, 2003, NEUROREPORT, V14, P1081, DOI 10.1097/01.wnr.0000073684.00308.c0; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Herwig A, 2015, ANN NY ACAD SCI, V1339, P97, DOI 10.1111/nyas.12672; Herwig A, 2014, J EXP PSYCHOL GEN, V143, P1903, DOI 10.1037/a0036781; Herwig A, 2011, PSYCHON B REV, V18, P531, DOI 10.3758/s13423-011-0063-3; Hill EL, 2002, INFANT CHILD DEV, V11, P159, DOI 10.1002/icd.303; Huestegge L, 2012, PSYCHON B REV, V19, P198, DOI 10.3758/s13423-011-0215-5; Ilg UJ, 1997, PROG NEUROBIOL, V53, P293, DOI 10.1016/S0301-0082(97)00039-7; Jackson P, 2012, J AUTISM DEV DISORD, V42, P697, DOI 10.1007/s10803-011-1296-8; Jeannerod M, 2009, EXP BRAIN RES, V192, P527, DOI 10.1007/s00221-008-1533-3; KALNINS IV, 1973, PERCEPTION, V2, P307, DOI 10.1068/p020307; Keehn B, 2013, NEUROSCI BIOBEHAV R, V37, P164, DOI 10.1016/j.neubiorev.2012.11.014; Kelemen D, 1999, DEV PSYCHOL, V35, P1440, DOI 10.1037/0012-1649.35.6.1440; Khalighinejad N, 2016, P NATL ACAD SCI USA, V113, P8867, DOI 10.1073/pnas.1521223113; Kilbourn K, 2007, 6 NORDC SEM WORKSH D; Limerick H, 2014, FRONT HUM NEUROSCI, V8, DOI [10.3389/tnhurn.2014.00643, 10.3389/fnhum.2014.00643]; Lindner A, 2005, CURR BIOL, V15, P1119, DOI 10.1016/j.cub.2005.05.049; Lombrozo T, 2007, PSYCHOL SCI, V18, P999, DOI 10.1111/j.1467-9280.2007.02015.x; Macmillan NA, 2005, DETECTION THEORY USE; Majaranta P., 2014, ADV PHYSL COMPUTING, P39, DOI DOI 10.1007/978-1-4471-6392-3_3; Martinez-Conde S, 2006, PROG BRAIN RES, V154, P151; MENDELSON MJ, 1982, DEV PSYCHOL, V18, P222, DOI 10.1037/0012-1649.18.2.222; Metcalfe J, 2010, COGNITION, V116, P267, DOI 10.1016/j.cognition.2010.05.009; Moore JW, 2012, CONSCIOUS COGN, V21, P59, DOI 10.1016/j.concog.2011.08.010; Moore JW, 2012, CONSCIOUS COGN, V21, P546, DOI 10.1016/j.concog.2011.12.002; Moore JW, 2010, NEUROPSYCHOLOGIA, V48, P1125, DOI 10.1016/j.neuropsychologia.2009.12.014; Mundy P, 2009, AUTISM RES, V2, P2, DOI 10.1002/aur.61; Neisser U., 1976, COGNITION REALITY; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939, DOI 10.1017/S0140525X01000115; Repp BH, 2007, J EXP PSYCHOL HUMAN, V33, P469, DOI 10.1037/0096-1523.33.2.469; Robino C, 2012, P S EYE TRACK RES AP, P181; Roda C, 2006, COMPUT HUM BEHAV, V22, P557, DOI 10.1016/j.chb.2005.12.005; Roda Claudia, 2011, HUMAN ATTENTION DIGI; ROVEECOLLIER CK, 1980, SCIENCE, V208, P1159, DOI 10.1126/science.7375924; Russell J, 2001, J CHILD PSYCHOL PSYC, V42, P317, DOI 10.1111/1469-7610.00725; Russell J, 1998, J AUTISM DEV DISORD, V28, P177, DOI 10.1023/A:1026009203333; Salvucci DD, 2008, PSYCHOL REV, V115, P101, DOI 10.1037/0033-295X.115.1.101; Sato A, 2005, COGNITION, V94, P241, DOI 10.1016/j.cognition.2004.04.003; Shimojo S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00196; Synofzik M, 2008, CONSCIOUS COGN, V17, P219, DOI 10.1016/j.concog.2007.03.010; Synofzik M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00127; Tops M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00429; van Elk M, 2015, COGNITION, V145, P1, DOI 10.1016/j.cognition.2015.08.004; Verschoor SA, 2013, DEVELOPMENTAL SCI, V16, P801, DOI 10.1111/desc.12085; Viviani P, 1990, Rev Oculomot Res, V4, P353; Wang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030884; Weiss C, 2011, COGNITION, V121, P207, DOI 10.1016/j.cognition.2011.06.011; Williams D, 2009, J AUTISM DEV DISORD, V39, P251, DOI 10.1007/s10803-008-0619-x	80	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164682	10.1371/journal.pone.0164682	http://dx.doi.org/10.1371/journal.pone.0164682			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812138	Green Published, Green Submitted, gold			2022-12-26	WOS:000386910000012
J	Kallio, A				Kallio, Aleksi			Properties of Fixed-Fixed Models and Alternatives in Presence-Absence Data Analysis	PLOS ONE			English	Article							NULL MODEL; NESTEDNESS; ALGORITHM	Assessing the significance of patterns in presence-absence data is an important question in ecological data analysis, e.g., when studying nestedness. Significance testing can be performed with the commonly used fixed-fixed models, which preserve the row and column sums while permuting the data. The manuscript considers the properties of fixed-fixed models and points out how their strict constraints can lead to limited randomizability. The manuscript considers the question of relaxing row and column sun constraints of the fixed-fixed models. The Rasch models are presented as an alternative with relaxed constraints and sound statistical properties. Models are compared on presence-absence data and surprisingly the fixed-fixed models are observed to produce unreasonably optimistic measures of statistical significance, giving interesting insight into practical effects of limited randomizability.	[Kallio, Aleksi] Aalto Univ, Dept Comp Sci, Espoo, Finland; [Kallio, Aleksi] CSC IT Ctr Sci, Espoo, Finland	Aalto University	Kallio, A (corresponding author), Aalto Univ, Dept Comp Sci, Espoo, Finland.; Kallio, A (corresponding author), CSC IT Ctr Sci, Espoo, Finland.	aleksi.kallio@csc.fi						Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; Araujo AIL, 2010, PHYSICA A, V389, P1405, DOI 10.1016/j.physa.2009.11.030; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Cobb GW, 2003, AM MATH MON, V110, P265, DOI 10.2307/3647877; CONNOR EF, 1983, OIKOS, V41, P455, DOI 10.2307/3544105; CONNOR EF, 1979, ECOLOGY, V60, P1132, DOI 10.2307/1936961; De Bie T, 2011, DATA MIN KNOWL DISC, V23, P407, DOI 10.1007/s10618-010-0209-3; DIAMOND J M, 1976, Emu, V76, P187; Diamond J. M., 1975, ECOLOGY EVOLUTION CO, V342, P444; DIAMOND JM, 1982, OECOLOGIA, V52, P64, DOI 10.1007/BF00349013; Fortelius M., 2007, NEOGENE OLD WORLD DA; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 2001, GLOBAL ECOL BIOGEOGR, V10, P337, DOI 10.1046/j.1466-822X.2001.00249.x; Kallio A, 2011, PALAEONTOL ELECTRON, V14; Krause S, 2009, BEHAV ECOL SOCIOBIOL, V63, P1089, DOI 10.1007/s00265-009-0746-1; Maher SP, 2014, METHODS ECOL EVOL, V5, P761, DOI 10.1111/2041-210X.12222; Manceur AM, 2014, METHODS ECOL EVOL, V5, P739, DOI 10.1111/2041-210X.12224; Mannila H, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P480; Moore JE, 2007, OECOLOGIA, V152, P763, DOI 10.1007/s00442-007-0696-0; Navarro-Alberto JA, 2009, POPUL ECOL, V51, P505, DOI 10.1007/s10144-008-0137-x; Rodriguez-Girones MA, 2006, J BIOGEOGR, V33, P924, DOI 10.1111/j.1365-2699.2006.01444.x; Ryser H. J., 1960, B AM MATH SOC, V66, P442, DOI [DOI 10.1090/S0002-9904-1960-10494-6, 10.1090/S0002-9904-1960-10494-6]; Sanderson JG, 1998, OECOLOGIA, V116, P275, DOI 10.1007/s004420050589; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Tsaparas, 2007, ACM T KNOWL DISCOV D, V1, P4, DOI [10.1145/1217299.1217303, DOI 10.1145/1217299.1217303]; Ulrich W, 2006, NESTEDNESS FORTRAN P; Ulrich W, 2012, ECOGRAPHY, V35, P865, DOI 10.1111/j.1600-0587.2012.07671.x; Ulrich W, 2012, ECOL MODEL, V244, P20, DOI 10.1016/j.ecolmodel.2012.06.030; WRIGHT DH, 1992, OECOLOGIA, V92, P416, DOI 10.1007/BF00317469	29	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165456	10.1371/journal.pone.0165456	http://dx.doi.org/10.1371/journal.pone.0165456			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812126	Green Published, Green Submitted, gold			2022-12-26	WOS:000386910000030
J	Kittinger, C; Lipp, M; Folli, B; Kirschner, A; Baumert, R; Galler, H; Grisold, AJ; Luxner, J; Weissenbacher, M; Farnleitner, AH; Zarfel, G				Kittinger, Clemens; Lipp, Michaela; Folli, Bettina; Kirschner, Alexander; Baumert, Rita; Galler, Herbert; Grisold, Andrea J.; Luxner, Josefa; Weissenbacher, Melanie; Farnleitner, Andreas H.; Zarfel, Gernot			Enterobacteriaceae Isolated from the River Danube: Antibiotic Resistances, with a Focus on the Presence of ESBL and Carbapenemases	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; WATER TREATMENT PLANTS; NDM-1-PRODUCING KLEBSIELLA-PNEUMONIAE; EXTENDED-SPECTRUM; ESCHERICHIA-COLI; WASTE-WATER; CTX-M; ANTIMICROBIAL RESISTANCE; AQUATIC ENVIRONMENT; BACTERIA	In a clinical setting it seems to be normal these days that a relevant proportion or even the majority of different bacterial species has already one or more acquired antibiotic resistances. Unfortunately, the overuse of antibiotics for livestock breeding and medicine has also altered the wild-type resistance profiles of many bacterial species in different environmental settings. As a matter of fact, getting in contact with resistant bacteria is no longer restricted to hospitals. Beside food and food production, the aquatic environment might also play an important role as reservoir and carrier. The aim of this study was the assessment of the resistance patterns of Escherichia coli and Klebsiella spp. out of surface water without prior enrichment and under non-selective culture conditions (for antibiotic resistance). In addition, the presence of clinically important extended spectrum beta lactamase (ESBL) and carbapenmase harboring Enterobacteriaceae should be investigated. During Joint Danube Survey 3 (2013), water samples were taken over the total course of the River Danube. Resistance testing was performed for 21 different antibiotics. Samples were additionally screened for ESBL or carbapenmase harboring Enterobacteriaceae. 39% of all isolated Escherichia coli and 15% of all Klebsiella spp. from the river Danube had at least one acquired resistance. Resistance was found against all tested antibiotics except tigecycline. Taking a look on the whole stretch of the River Danube the proportion of multiresistances did not differ significantly. In total, 35 ESBL harboring Enterobacteriaceae, 17 Escherichia coli, 13 Klebsiella pneumoniae and five Enterobacter spp. were isolated. One Klebsiella pneumoniae harboring NMD-1 carbapenmases and two Enterobacteriaceae with KPC-2 could be identified. Human generated antibiotic resistance is very common in E. coli and Klebsiella spp. in the River Danube. Even isolates with resistance patterns normally associated with intensive care units are present.	[Kittinger, Clemens; Lipp, Michaela; Folli, Bettina; Baumert, Rita; Galler, Herbert; Grisold, Andrea J.; Luxner, Josefa; Weissenbacher, Melanie; Zarfel, Gernot] Med Univ Graz, Inst Hyg Microbiol & Environm Med, Graz, Austria; [Kirschner, Alexander] Med Univ Vienna, Inst Hyg & Appl Immunol, Water Hyg, Vienna, Austria; [Kirschner, Alexander; Farnleitner, Andreas H.] Vienna Univ Technol, Interuniv Cooperat Ctr Water & Hlth, Vienna, Austria; [Farnleitner, Andreas H.] Vienna Univ Technol, Inst Chem Engn, Res Grp Environm Microbiol & Mol Ecol, Vienna, Austria	Medical University of Graz; Medical University of Vienna; Technische Universitat Wien; Technische Universitat Wien	Zarfel, G (corresponding author), Med Univ Graz, Inst Hyg Microbiol & Environm Med, Graz, Austria.	gernot.zarfel@medunigraz.at	Kittinger, Clemens/AAK-4360-2020	Kittinger, Clemens/0000-0001-8472-2155; Grisold, Andrea/0000-0002-6937-521X; Zarfel, Gernot/0000-0003-1592-4559; Kirschner, Alexander/0000-0002-9797-3073; Farnleitner, Andreas/0000-0002-0542-5425	Austrian Science Fund (FWF) [P25817-B22]; Austrian Science Fund (FWF) [P 25817] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The study was supported by the Austrian Science Fund (FWF), project nr P25817-B22.	Baker-Austin C, 2006, TRENDS MICROBIOL, V14, P176, DOI 10.1016/j.tim.2006.02.006; Belmonte O, 2010, PATHOL BIOL, V58, P18, DOI 10.1016/j.patbio.2009.07.021; Blaak H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127752; Bouki C, 2013, ECOTOX ENVIRON SAFE, V91, P1, DOI 10.1016/j.ecoenv.2013.01.016; Boyen F, 2010, VET MICROBIOL, V144, P359, DOI 10.1016/j.vetmic.2010.01.010; Bradford PA, 2004, CLIN INFECT DIS, V39, P55, DOI 10.1086/421495; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Carattoli A, 2008, CLIN MICROBIOL INFEC, V14, P117, DOI 10.1111/j.1469-0691.2007.01851.x; Clinical and Laboratory Standards Institute (CLSI), 2008, AUSTRALIA; Davison J, 1999, PLASMID, V42, P73, DOI 10.1006/plas.1999.1421; Del Franco M, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0597-z; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Dissanayake DRA, 2014, VET MICROBIOL, V168, P403, DOI 10.1016/j.vetmic.2013.11.028; Eckert C, 2004, ANTIMICROB AGENTS CH, V48, P1249, DOI 10.1128/AAC.48.4.1249-1255.2004; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Gales AC, 2001, J CLIN MICROBIOL, V39, P183, DOI 10.1128/JCM.39.1.183-190.2001; Galler H, 2013, CLIN MICROBIOL INFEC; Hammerum AM, 2010, LANCET INFECT DIS, V10, P829, DOI 10.1016/S1473-3099(10)70276-0; Iredell J, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6420; JDS 3. Joint Danube Survey 3, 2015, JDS 3 JOINT DAN SURV; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kiratisin P, 2008, ANTIMICROB AGENTS CH, V52, P2818, DOI 10.1128/AAC.00171-08; Korzeniewska E, 2013, J ENVIRON MANAGE, V128, P904, DOI 10.1016/j.jenvman.2013.06.051; Kummerer K, 2009, CHEMOSPHERE, V75, P417, DOI 10.1016/j.chemosphere.2008.11.086; Kummerer K, 2009, CHEMOSPHERE, V75, P435, DOI 10.1016/j.chemosphere.2008.12.006; Lee K, 2001, CLIN MICROBIOL INFEC, V7, P88, DOI 10.1046/j.1469-0691.2001.00204.x; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Livermore DM, 2012, INT J ANTIMICROB AG, V39, P283, DOI 10.1016/j.ijantimicag.2011.12.012; Luczkiewicz A, 2010, WATER RES, V44, P5089, DOI 10.1016/j.watres.2010.08.007; Markovska R, 2015, APMIS, V123, P887, DOI 10.1111/apm.12433; Mathers AJ, 2015, ADV APPL MICROBIOL, V90, P109, DOI 10.1016/bs.aambs.2014.09.002; Mazzariol A, 2012, EMERG INFECT DIS, V18, P532, DOI [10.3201/eid1803.110389, 10.3201/eid1803.1103890]; Muller A, 2016, SCI TOTAL ENVIRON, V541, P667, DOI 10.1016/j.scitotenv.2015.09.135; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; Novovic K, 2015, SCI TOTAL ENVIRON, V511, P393, DOI 10.1016/j.scitotenv.2014.12.072; Ojer-Usoz E, 2014, WATER RES, V56, P37, DOI 10.1016/j.watres.2014.02.041; Paterson DL, 2006, AM J MED, V119, pS20, DOI 10.1016/j.amjmed.2006.03.013; Pietsch M, 2015, VET MICROBIOL; Pignato S, 2010, FOODBORNE PATHOG DIS, V7, P945, DOI 10.1089/fpd.2009.0504; Pitout JDD, 2003, J CLIN MICROBIOL, V41, P3933, DOI 10.1128/JCM.41.8.3933-3935.2003; Poirel L, 2012, ANTIMICROB AGENTS CH, V56, P1662, DOI 10.1128/AAC.05850-11; Poonia Shubra, 2014, Indian J Community Med, V39, P156, DOI 10.4103/0970-0218.137152; Rahube TO, 2012, J APPL MICROBIOL, V112, P1123, DOI 10.1111/j.1365-2672.2012.05301.x; Reinthaler FF, 2013, J WATER HEALTH, V11, P13, DOI 10.2166/wh.2012.207; Reuland EA, 2013, CLIN MICROBIOL INFEC, V19, P542, DOI 10.1111/j.1469-0691.2012.03947.x; Rice LB, 2009, CURR OPIN MICROBIOL, V12, P476, DOI 10.1016/j.mib.2009.08.001; Rizzo L, 2013, SCI TOTAL ENVIRON, V447, P345, DOI 10.1016/j.scitotenv.2013.01.032; Schaefer AM, 2009, ECOHEALTH, V6, P33, DOI 10.1007/s10393-009-0221-5; Sola-Gines M, 2015, APPL ENVIRON MICROB, V81, P3604, DOI 10.1128/AEM.04252-14; Taylor NGH, 2011, TRENDS ECOL EVOL, V26, P278, DOI 10.1016/j.tree.2011.03.004; Titilawo Y, 2015, ENVIRON SCI POLLUT R, V22, P10969, DOI 10.1007/s11356-014-3887-3; Torneke K, 2015, J VET PHARMACOL THER, V38, P519, DOI 10.1111/jvp.12226; Toth A, 2010, EUR J CLIN MICROBIOL, V29, P765, DOI 10.1007/s10096-010-0921-3; Viens AM, 2015, PUBLIC HEALTH ETH-UK, V8, P255, DOI 10.1093/phe/phv015; Voulgari E, 2014, J ANTIMICROB CHEMOTH, V69, P2091, DOI 10.1093/jac/dku105; World Health Organization, 2014, SURVEILLANCE ANTIMIC; Zarfel G, 2013, ENVIRON POLLUT, V173, P192, DOI 10.1016/j.envpol.2012.09.019; Zarfel G, 2011, CLIN MICROBIOL INFEC, V17, pE5, DOI 10.1111/j.1469-0691.2011.03659.x; Zhang HN, 2015, ENVIRON SCI POLLUT R, V22, P11488, DOI 10.1007/s11356-015-4387-9; Zhang XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111026; Zheng SL, 2011, CHEMOSPHERE, V84, P1677, DOI 10.1016/j.chemosphere.2011.04.076; Zurfluh K, 2013, APPL ENVIRON MICROB, V79, P3021, DOI 10.1128/AEM.00054-13	62	47	50	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165820	10.1371/journal.pone.0165820	http://dx.doi.org/10.1371/journal.pone.0165820			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812159	Green Published, Green Submitted, gold			2022-12-26	WOS:000386910000065
J	Lahesaare, A; Ainelo, H; Teppo, A; Kivisaar, M; Heipieper, HJ; Teras, R				Lahesaare, Andrio; Ainelo, Hanna; Teppo, Annika; Kivisaar, Maia; Heipieper, Hermann J.; Teras, Riho			LapF and Its Regulation by Fis Affect the Cell Surface Hydrophobicity of Pseudomonas putida	PLOS ONE			English	Article							BIOFILM FORMATION; ESCHERICHIA-COLI; GENE-EXPRESSION; ADHESION; BACTERIA; PROTEIN; MUTANT; IDENTIFICATION; COLONIZATION; ATTACHMENT	The ability of bacteria to regulate cell surface hydrophobicity is important for the adaptation to different environmental conditions. The hydrophobicity of cell surface can be determined by several factors, including outer membrane and surface proteins. In this study, we report that an adhesin LapF influences cell surface hydrophobicity of Pseudomonas putida. Cells lacking LapF are less hydrophobic than wild-type cells in stationary growth phase. Moreover, the overexpression of the global regulator Fis decreases surface hydrophobicity by repressing the expression of lapF. Flow cytometry analysis revealed that bacteria producing LapF are more viable when confronted with methanol (a hydrophilic compound) but are more susceptible to 1-octanol (a hydrophobic compound). Thus, these results revealed that LapF is the hydrophobicity factor for the cell surface of P. putida.	[Lahesaare, Andrio; Ainelo, Hanna; Teppo, Annika; Kivisaar, Maia; Teras, Riho] Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia; [Heipieper, Hermann J.] UFZ Helmholtz Ctr Environm Res, Dept Environm Biotechnol, Leipzig, Germany	University of Tartu; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Teras, R (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia.	riho.teras@ut.ee	Heipieper, Hermann/D-1864-2010; Teras, Riho/ABA-8761-2021	Heipieper, Hermann/0000-0002-3723-9600; Ainelo, Hanna/0000-0003-3340-9120	Targeted Financing Project [SF0180031s08]; Institutional Research Funding from Estonian Ministry of Education and Research [IUT20-19]; European Commission within Project BACSIN [211684]; FEMS Grants [FEMS-RG-2014-0003.R1, FEMS-RG-2015-0051.R1]	Targeted Financing Project; Institutional Research Funding from Estonian Ministry of Education and Research; European Commission within Project BACSIN; FEMS Grants	This work was supported by the funding of the Targeted Financing Project SF0180031s08; the Institutional Research Funding IUT20-19 from Estonian Ministry of Education and Research; the European Commission within its Seventh Framework Program Project BACSIN (Contract No. 211684); and by the FEMS Grants ID #FEMS-RG-2014-0003.R1 and ID #FEMS-RG-2015-0051.R1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adav SS, 2008, BIOTECHNOL ADV, V26, P411, DOI 10.1016/j.biotechadv.2008.05.002; Ali Y., 2001, DISINFECTION STERILI, P229; Baumgarten T, 2012, APPL ENVIRON MICROB, V78, P6217, DOI 10.1128/AEM.01525-12; Bodelon G, 2013, FEMS MICROBIOL REV, V37, P204, DOI 10.1111/j.1574-6976.2012.00347.x; Boyd CD, 2014, J BACTERIOL, V196, P2775, DOI 10.1128/JB.01629-14; Bradley MD, 2007, MICROBIOL-SGM, V153, P2922, DOI 10.1099/mic.0.2007/008565-0; Browning DF, 2010, CURR OPIN MICROBIOL, V13, P773, DOI 10.1016/j.mib.2010.09.013; Corpe WA, 1980, ADSORPTION MICROORGA, P105; Dalgaard P, 2001, J MICROBIOL METH, V43, P183, DOI 10.1016/S0167-7012(00)00219-0; Dekkers LC, 1998, MOL PLANT MICROBE IN, V11, P763, DOI 10.1094/MPMI.1998.11.8.763; DELORENZO V, 1993, J BACTERIOL, V175, P6902, DOI 10.1128/jb.175.21.6902-6907.1993; Dulla GFJ, 2010, ENVIRON MICROBIOL, V12, P1762, DOI 10.1111/j.1462-2920.2010.02261.x; FINKEL SE, 1992, MOL MICROBIOL, V6, P3257, DOI 10.1111/j.1365-2958.1992.tb02193.x; Fuqua C, 2010, MOL MICROBIOL, V77, P533, DOI 10.1111/j.1365-2958.2010.07250.x; Gjermansen M, 2010, MOL MICROBIOL, V75, P815, DOI 10.1111/j.1365-2958.2009.06793.x; Goulter RM, 2009, LETT APPL MICROBIOL, V49, P1, DOI 10.1111/j.1472-765X.2009.02591.x; Haussler S, 2010, J BACTERIOL, V192, P2941, DOI 10.1128/JB.00332-10; Heipieper HJ, 2007, APPL MICROBIOL BIOT, V74, P961, DOI 10.1007/s00253-006-0833-4; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Higashi JM, 1998, J BIOMED MATER RES, V39, P341, DOI 10.1002/(SICI)1097-4636(19980305)39:3<341::AID-JBM1>3.0.CO;2-J; Hinsa SM, 2003, MOL MICROBIOL, V49, P905, DOI 10.1046/j.1365-2958.2003.03615.x; Isberg RR, 2002, CELL, V110, P1, DOI 10.1016/S0092-8674(02)00821-8; Jahn A, 1999, BIOFOULING, V14, P49, DOI 10.1080/08927019909378396; Jakovleva J, 2012, MICROBIOL-SGM, V158, P708, DOI 10.1099/mic.0.053355-0; Kobayashi H, 1999, J BACTERIOL, V181, P4493, DOI 10.1128/JB.181.15.4493-4498.1999; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lahesaare A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115901; Liu XW, 2009, BIOTECHNOL ADV, V27, P1061, DOI 10.1016/j.biotechadv.2009.05.020; Lugtenberg BJ, 2014, MICROBIAL PHENAZINES, P163; Lugtenberg BJJ, 2004, PSEUDOMONAS, VOL 1: GENOMICS, LIFE STYLE AND MOLECULAR ARCHITECTURE, P403; Martinez-Gil M, 2014, J BACTERIOL, V196, P1484, DOI 10.1128/JB.01287-13; Martinez-Gil M, 2010, MOL MICROBIOL, V77, P549, DOI 10.1111/j.1365-2958.2010.07249.x; Matilla MA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r179; Montag D, 2012, BIOFOULING, V28, P315, DOI 10.1080/08927014.2012.673219; Moor H, 2014, MICROBIOL-SGM, V160, P2681, DOI 10.1099/mic.0.082503-0; Morath S, 2005, J ENDOTOXIN RES, V11, P348, DOI 10.1179/096805105X67328; Neumann G, 2006, APPL ENVIRON MICROB, V72, P4232, DOI 10.1128/AEM.02904-05; Nolvak H, 2012, SCI TOTAL ENVIRON, V426, P351, DOI 10.1016/j.scitotenv.2012.03.054; Ojangu EL, 2000, J BACTERIOL, V182, P6707, DOI 10.1128/JB.182.23.6707-6713.2000; OSUNA R, 1995, J BACTERIOL, V177, P2021, DOI 10.1128/jb.177.8.2021-2032.1995; PAVEL H, 1994, J BACTERIOL, V176, P7550, DOI 10.1128/JB.176.24.7550-7557.1994; Rodrigues DF, 2009, BIOFOULING, V25, P401, DOI 10.1080/08927010902833443; ROSENBERG M, 1986, ADV MICROB ECOL, V9, P353; Ruhs PA, 2014, COLLOID SURFACE B, V117, P174, DOI 10.1016/j.colsurfb.2014.02.023; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Segura A, 1999, ENVIRON MICROBIOL, V1, P191, DOI 10.1046/j.1462-2920.1999.00033.x; Sharma RC, 1996, BIOTECHNIQUES, V20, P42; Sidhu MS, 1997, MICROBIOL-SGM, V143, P1039, DOI 10.1099/00221287-143-4-1039; Teras R, 2009, MICROBIOL-SGM, V155, P1203, DOI 10.1099/mic.0.022830-0; Torres S, 2011, BIOTECHNOL ADV, V29, P442, DOI 10.1016/j.biotechadv.2011.04.002; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; XU JM, 1995, J BACTERIOL, V177, P938, DOI 10.1128/jb.177.4.938-947.1995; Yeung ATY, 2009, J BACTERIOL, V191, P5592, DOI 10.1128/JB.00157-09; Zahringer U, 1995, Prog Clin Biol Res, V392, P113; Zavialov AV, 2003, CELL, V113, P587, DOI 10.1016/S0092-8674(03)00351-9	57	13	13	8	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166078	10.1371/journal.pone.0166078	http://dx.doi.org/10.1371/journal.pone.0166078			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812186	Green Published, gold, Green Submitted			2022-12-26	WOS:000386910000100
J	Damiens, D; Lebon, C; Wilkinson, DA; Dijoux-Millet, D; Le Goff, G; Bheecarry, A; Gouagna, LC				Damiens, David; Lebon, Cyrille; Wilkinson, David A.; Dijoux-Millet, Damien; Le Goff, Gilbert; Bheecarry, Ambicadutt; Gouagna, Louis Clement			Cross-Mating Compatibility and Competitiveness among Aedes albopictus Strains from Distinct Geographic Origins Implications for Future Application of SIT Programs in the South West Indian Ocean Islands	PLOS ONE			English	Article							STANDARD OPERATING PROCEDURES; STERILE INSECT TECHNIQUE; WING SHAPE; DIPTERA-CULICIDAE; AEGYPTI MOSQUITOS; POPULATIONS; SIZE; VECTORS; RELEASE; DENGUE	The production of large numbers of males needed for a sustainable sterile insect technique (SIT) control program requires significant developmental and operational costs. This may constitute a significant economic barrier to the installation of large scale rearing facilities in countries that are undergoing a transition from being largely dependent on insecticide use to be in a position to integrate the SIT against Aedes albopictus. Alternative options available for those countries could be to rely on outsourcing of sterile males from a foreign supplier, or for one centralised facility to produce mosquitoes for several countries, thus increasing the efficiency of the mass-rearing effort. However, demonstration of strain compatibility is a prerequisite for the export of mosquitoes for transborder SIT applications. Here, we compared mating compatibility among Ae. albopictus populations originating from three islands of the South Western Indian Ocean, and assessed both insemination rates and egg fertility in all possible cross-mating combinations. Furthermore, competitiveness between irradiated and non-irradiated males from the three studied strains, and the subsequent effect on female fertility were also examined. Although morphometric analysis of wing shapes suggested phenoptypic differences between Ae. albopictus strains, perfect reproductive compatibility between them was observed. Furthermore, irradiated males from the different islands demonstrated similar levels of competitiveness and induced sterility when confronted with fertile males from any of the other island populations tested. In conclusion, despite the evidence of inter-strain differences based on male wing morphology, collectively, our results provide a new set of expectations for the use of a single candidate strain of mass-reared sterile males for area-wide scale application of SIT against Ae. albopictus populations in different islands across the South Western Indian Ocean. Cross-mating competitiveness tests such as those applied here are necessary to assess the quality of mass reared strains for the trans-border application of sterile male release programs.	[Damiens, David; Le Goff, Gilbert; Gouagna, Louis Clement] IRD, Unite Mixte Rech MIVEGEC, IRD CNRS 5290 UM1 UM2 224, Montpellier, France; [Damiens, David; Lebon, Cyrille; Le Goff, Gilbert; Gouagna, Louis Clement] IRD La Reunion, Plateforme Rech CYROI, St Clotilde, Reunion, France; [Wilkinson, David A.] Univ La Reunion, UMR PIMIT, INSERM U1187 CNRS9192 IRD249, Plateforme Rech CYROI, St Denis, Reunion, France; [Dijoux-Millet, Damien] Univ La Reunion, Inst Univ Technol, Dept Genie Biol, St Pierre, Reunion, France; [Bheecarry, Ambicadutt] Minist Hlth & Qual Life, Vector Biol & Control Div, SSR Bot Garden Rd, Curepipe, Mauritius	Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); University of La Reunion; University of La Reunion	Gouagna, LC (corresponding author), IRD, Unite Mixte Rech MIVEGEC, IRD CNRS 5290 UM1 UM2 224, Montpellier, France.; Gouagna, LC (corresponding author), IRD La Reunion, Plateforme Rech CYROI, St Clotilde, Reunion, France.	louis-clement.gouagna@ird.fr		Le Goff, Gilbert/0000-0001-9913-8736; Gouagna, Louis Clement/0000-0003-0957-4484; Wilkinson, David/0000-0002-9986-6212	Regional SIT feasibility programme [2013-33857]; French Ministry of Health on the phase II SIT program in Reunion Island	Regional SIT feasibility programme; French Ministry of Health on the phase II SIT program in Reunion Island	This work has been performed as part of the "Regional SIT feasibility programme" under the Contract No. 2013-33857 with the European Regional Development Fund (ERDF) within the 2007-2013 European Territorial Cooperation Program on Sustainable Development and Environment. We also gratefully acknowledge the financial contribution of the French Ministry of Health on the phase II SIT program in Reunion Island.	[Anonymous], 2013, INT J BIOCH BIOINFOR; Armbruster P, 2006, ANN ENTOMOL SOC AM, V99, P1234, DOI 10.1603/0013-8746(2006)99[1234:GVOLGI]2.0.CO;2; Atyame CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146834; Ayres C, 2002, MEM I OSWALDO CRUZ, V97, P871, DOI 10.1590/S0074-02762002000600022; Azevedo RBR, 1998, EVOLUTION, V52, P1353, DOI [10.1111/j.1558-5646.1998.tb02017.x, 10.2307/2411305]; Balestrino F, 2014, J MED ENTOMOL, V51, P155, DOI 10.1603/ME13130; Balestrino F, 2012, J MED ENTOMOL, V49, P595, DOI 10.1603/ME11188; Balestrino F, 2010, J MED ENTOMOL, V47, P581, DOI 10.1603/ME09272; Bellini R., 2007, P505, DOI 10.1007/978-1-4020-6059-5_47; Bellini R, 2013, J MED ENTOMOL, V50, P317, DOI 10.1603/ME12048; Bellini R, 2013, J MED ENTOMOL, V50, P94, DOI 10.1603/ME11058; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; BLACK WC, 1988, HEREDITY, V61, P439, DOI 10.1038/hdy.1988.136; BLACK WC, 1989, J MED ENTOMOL, V26, P260, DOI 10.1093/jmedent/26.4.260; Bourtzis K, 1996, GENETICS, V144, P1063; Bourtzis K, 2003, CONT T ENT, P217; Bourtzis K., 2006, INSECT SYMBIOSIS VOL, V2, P225, DOI DOI 10.1201/9781420005936.CH14; Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004; Boyer S, 2011, MED VET ENTOMOL, V25, P454, DOI 10.1111/j.1365-2915.2011.00962.x; Burney DA, 2004, J HUM EVOL, V47, P25, DOI 10.1016/j.jhevol.2004.05.005; BUSHLAND RC, 1955, SCIENCE, V122, P287, DOI 10.1126/science.122.3163.287; BUSHLAND RC, 1953, J ECON ENTOMOL, V46, P648, DOI 10.1093/jee/46.4.648; COSGROVE JB, 1994, J AM MOSQUITO CONTR, V10, P434; Dame D. A., 1981, CYTOGENETICS GENETIC, P231; Dame DA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S2; Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649; Delatte H, 2011, INFECT GENET EVOL, V11, P1769, DOI 10.1016/j.meegid.2011.07.016; Dowell RV, 2021, STERILE INSECT TECHNIQUE, 2 EDITION, P441, DOI 10.1007/1-4020-4051-2_11; Enkerlin W. R., 2004, Proceedings of the 6th International Symposium on fruit flies of economic importance, Stellenbosch, South Africa, 6-10 May 2002, P203; Food and Agriculture Organisation of the United Nations (FAO) / International Atomic Energy Agency (IAEA), 2001, DISCUSSION PAPER ON; Food and Agriculture Organization of the United Nations FAO, 1992, THE NEW WORLD SCREWW; FRIED M, 1971, J ECON ENTOMOL, V64, P869, DOI 10.1093/jee/64.4.869; Gilchrist AS, 2000, EVOL DEV, V2, P114, DOI 10.1046/j.1525-142x.2000.00041.x; Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350; HARRIS E J, 1986, Proceedings of the Hawaiian Entomological Society, V26, P77; Hidalgo K, 2015, ACTA TROP, V143, P79, DOI 10.1016/j.actatropica.2014.12.014; Higgs S, 2006, VECTOR-BORNE ZOONOT, V6, P115, DOI 10.1089/vbz.2006.6.115; Hoffmann AA, 2002, EVOLUTION, V56, P1068, DOI 10.1111/j.0014-3820.2002.tb01418.x; Houle D, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-25; IMASHEVA AG, 1995, GENETICA, V96, P303, DOI 10.1007/BF01439584; Iyaloo DP, 2014, ACTA TROP, V132, pS140, DOI 10.1016/j.actatropica.2013.11.011; Jeratthitikul E, 2014, ENTOMOL SCI, V17, P342, DOI 10.1111/ens.12068; Kamgang B, 2010, MED VET ENTOMOL, V24, P132, DOI 10.1111/j.1365-2915.2010.00869.x; Kamgang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020257; Kean JM, AREA WIDE CONTROL IN, P211; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P3, DOI 10.1007/1-4020-4051-2_1; KNIPLING EF, 1968, B WORLD HEALTH ORGAN, V38, P421; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Kolliker-Ott UM, 2003, OIKOS, V100, P563, DOI 10.1034/j.1600-0706.2003.12063.x; Krafsur ES, 1998, J AGR ENTOMOL, V15, P303; Leisnham PT, 2008, J MED ENTOMOL, V45, P210, DOI 10.1603/0022-2585(2008)45[210:GVIASA]2.0.CO;2; Lindquist DA, 1993, MANAGEMENT INSECT PE, P319; Lougnon A, 1958, SOUS LE SIGNE DE LA; Lounibos LP, 2003, ANN ENTOMOL SOC AM, V96, P512, DOI 10.1603/0013-8746(2003)096[0512:AEOPDI]2.0.CO;2; LOWE RE, 1980, AM J TROP MED HYG, V29, P695, DOI 10.4269/ajtmh.1980.29.695; Mesbah RA., 2015, J CROP PROT, V4, P207; Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627; O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797; O'Donnell D, 2009, ANN ENTOMOL SOC AM, V102, P1135, DOI 10.1603/008.102.0623; Oliva CF, 2013, ACTA TROP, V125, P287, DOI 10.1016/j.actatropica.2012.11.010; Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414; POZZA GD, 1992, J AM MOSQUITO CONTR, V8, P318; POZZA GLD, 1994, J AM MOSQUITO CONTR, V10, P589; Puggioli A, 2013, J MED ENTOMOL, V50, P819, DOI 10.1603/ME13011; Robinson AS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S1; Roff Derek, 2002, pi; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rossler Y, 2000, CROP PROT, V19, P733, DOI 10.1016/S0261-2194(00)00097-1; Sadeghi S, 2009, ODONATOLOGICA, V38, P341; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Stearns S.C., 1992, pi; Urbanelli S, 2000, HEREDITY, V84, P331, DOI 10.1046/j.1365-2540.2000.00676.x; Usmani-Brown S, 2009, ANN ENTOMOL SOC AM, V102, P144, DOI 10.1603/008.102.0116; VARGAS RI, 1995, J ECON ENTOMOL, V88, P1279, DOI 10.1093/jee/88.5.1279; Vera MT, 2006, ANN ENTOMOL SOC AM, V99, P387, DOI 10.1603/0013-8746(2006)099[0387:MIAPOT]2.0.CO;2; Villasenor A., 2000, Area-wide control of fruit flies and other insect pests. Joint proceedings of the international conference on area-wide control of insect pests, 28 May-2 June, 1998 and the Fifth International Symposium on Fruit Flies of Economic Importance, Penang, Malaysia, 1-5 June, 1998, P361; Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123; Walters M. L., 2000, Area-wide control of fruit flies and other insect pests. Joint proceedings of the international conference on area-wide control of insect pests, 28 May-2 June, 1998 and the Fifth International Symposium on Fruit Flies of Economic Importance, Penang, Malaysia, 1-5 June, 1998, P201; Wyss JH, 2000, PROCEEDINGS AREA WID; Yeap HL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-58; Yeap HL, 2013, AM J TROP MED HYG, V89, P78, DOI 10.4269/ajtmh.12-0719; Zhang DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151864; Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135194; Zheng ML, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0951-x; Zheng ML, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0631-2	85	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0163788	10.1371/journal.pone.0163788	http://dx.doi.org/10.1371/journal.pone.0163788			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806056	gold, Green Submitted, Green Published			2022-12-26	WOS:000386715500007
J	Torres, LS; Okumura, JV; Silva, DGH; Mimura, KKO; Belini, E; Oliveira, RG; Lobo, CLC; Oliani, SM; Bonini-Domingos, CR				Torres, Lidiane S.; Okumura, Jessika V.; Silva, Danilo G. H.; Mimura, Kallyne K. O.; Belini-Junior, Edis; Oliveira, Renan G.; Lobo, Clarisse L. C.; Oliani, Sonia M.; Bonini-Domingos, Claudia R.			Inflammation in Sickle Cell Disease: Differential and Down-Expressed Plasma Levels of Annexin A1 Protein	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION; CLUSTER HAPLOTYPES; ANEMIA; NEUTROPHILS; INJURY; ELECTROPHORESIS; ACTIVATION; RESOLUTION; MEDIATORS	Sickle cell disease (SCD) is an inherited hemolytic anemia whose pathophysiology is driven by polymerization of the hemoglobin S (Hb S), leading to hemolysis and vaso-occlusive events. Inflammation is a fundamental component in these processes and a continuous inflammatory stimulus can lead to tissue damages. Thus, pro-resolving pathways emerge in order to restore the homeostasis. For example there is the annexin A1 (ANXA1), an endogenous anti-inflammatory protein involved in reducing neutrophil-endothelial interactions, accelerating neutrophil apoptosis and stimulating macrophage efferocytosis. We investigated the expression of ANXA1 in plasma of SCD patients and its relation with anemic, hemolytic and inflammatory parameters of the disease. Three SCD genotypes were considered: the homozygous inheritance for Hb S (Hb SS) and the association between Hb S and the hemoglobin variants D-Punjab (Hb SD) and C (Hb SC). ANXA1 and proinflammatory cytokines were quantified by ELISA in plasma of SCD patients and control individuals without hemoglobinopathies. Hematological and biochemical parameters were analyzed by flow cytometry and spectrophotometer. The plasma levels of ANXA1 were about threefold lesser in SCD patients compared to the control group, and within the SCD genotypes the most elevated levels were found in Hb SS individuals (approximately three-fold higher). Proinflammatory cytokines were higher in SCD groups than in the control individuals. Anemic and hemolytic markers were higher in Hb SS and Hb SD genotypes compared to Hb SC patients. White blood cells and platelets count were higher in Hb SS genotype and were positively correlated to ANXA1 levels. We found that ANXA1 is down-regulated and differentially expressed within the SCD genotypes. Its expression seems to depend on the inflammatory, hemolytic and vaso-occlusive characteristics of the diseased. These data may lead to new biological targets for therapeutic intervention in SCD.	[Torres, Lidiane S.; Okumura, Jessika V.; Silva, Danilo G. H.; Belini-Junior, Edis; Oliveira, Renan G.; Bonini-Domingos, Claudia R.] Sao Paulo State Univ UNESP, Dept Biol, Lab Hemoglobin & Hematol Genet Dis, Sao Paulo, Brazil; [Mimura, Kallyne K. O.; Oliani, Sonia M.] Sao Paulo State Univ UNESP, Dept Biol, Lab Immunomorphol, Sao Paulo, Brazil; [Lobo, Clarisse L. C.] Inst Hematol Arthur de Siqueira Cavalcanti HEMORI, Rio De Janeiro, Rio De Janeiro, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Torres, LS (corresponding author), Sao Paulo State Univ UNESP, Dept Biol, Lab Hemoglobin & Hematol Genet Dis, Sao Paulo, Brazil.; Oliani, SM (corresponding author), Sao Paulo State Univ UNESP, Dept Biol, Lab Immunomorphol, Sao Paulo, Brazil.	lidiane.unesp@gmail.com; smoliani@ibilce.unesp.br	Bonini-Domingos, Claudia Regina/Y-4077-2019; Torres, Lidiane S./GQH-1725-2022; Belini, Edis/ABG-3748-2021; Torres, Lidiane/AAL-4450-2020; Belini, Edis/G-4427-2012; Silva, Danilo GH/G-6833-2012; da Silva, Danilo Grünig Humberto/AAI-4688-2021; Bonini-Domingos, Claudia R/F-4964-2012; Oliani, Sonia Maria/E-3476-2012; Mimura, Kallyne/G-6096-2015	Bonini-Domingos, Claudia Regina/0000-0002-4603-9467; Torres, Lidiane S./0000-0002-4598-1899; Belini, Edis/0000-0001-6478-8173; Torres, Lidiane/0000-0002-4598-1899; Belini, Edis/0000-0001-6478-8173; Silva, Danilo GH/0000-0002-5500-9403; da Silva, Danilo Grünig Humberto/0000-0002-5500-9403; Bonini-Domingos, Claudia R/0000-0002-4603-9467; Oliani, Sonia Maria/0000-0003-0918-2130; Mimura, Kallyne/0000-0003-1398-2413	State of Sao Paulo Research Foudation (FAPESP), Brazil [2012/21603-2, 2012/19653-1]; National Council for Scientific and Technological Development (CNPq), Brazil [308144/2014-7]	State of Sao Paulo Research Foudation (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the State of Sao Paulo Research Foudation (FAPESP; grants 2012/21603-2 SMO and 2012/19653-1 LST) and by the National Council for Scientific and Technological Development (CNPq; grant 308144/2014-7 SMO), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI K, 1988, J BIOL CHEM, V263, P5607; Aggarwal BB, 2012, BLOOD, V3, P745; Ballas SK, 2012, SCI WORLD J, DOI 10.1100/2012/949535; Ballas SK, 2012, AM J HEMATOL, V87, P338, DOI 10.1002/ajh.22259; Conran N, 2009, HEMOGLOBIN, V33, P1, DOI 10.1080/03630260802625709; D'Acunto CW, 2014, CELL SIGNAL, V26, P173, DOI 10.1016/j.cellsig.2013.09.020; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Facio FN, 2011, J MOL MED, V89, P51, DOI 10.1007/s00109-010-0684-4; Gastardelo TS, 2009, AM J PATHOL, V174, P177, DOI 10.2353/ajpath.2009.080342; Headland SE, 2015, SEMIN IMMUNOL, V27, P149, DOI 10.1016/j.smim.2015.03.014; Hebbel RP, 2014, HEMATOL ONCOL CLIN N, V28, P181, DOI 10.1016/j.hoc.2013.11.005; Hoppe CC, 2014, HEMATOL ONCOL CLIN N, V28, P265, DOI 10.1016/j.hoc.2013.11.006; Silva DGH, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-108; Kato Gregory J, 2009, Am J Hematol, V84, P618, DOI 10.1002/ajh.21475; La M, 2001, FASEB J, V15, P2247, DOI 10.1096/fj.01-0196com; Lanaro C, 2009, J LEUKOCYTE BIOL, V85, P235, DOI 10.1189/jlb.0708445; Leal MC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00053; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; MARENGOROWE AJ, 1965, J CLIN PATHOL, V18, P790, DOI 10.1136/jcp.18.6.790; Monaco C, 2015, INT IMMUNOL, V27, P55, DOI 10.1093/intimm/dxu102; NAGEL R L, 1984, Einstein Quarterly Journal of Biology and Medicine, V2, P53; Nourale M, 2013, HAEMATOLOGICA, V98, P464, DOI 10.3324/haematol.2012.068965; Oliani SM, 2001, AM J PATHOL, V158, P603, DOI 10.1016/S0002-9440(10)64002-3; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Palomo J, 2015, CYTOKINE, V76, P25, DOI 10.1016/j.cyto.2015.06.017; Patel S, 2014, PEDIATR BLOOD CANCER, V61, P1341, DOI 10.1002/pbc.25004; Perretti M, 2004, J LEUKOCYTE BIOL, V76, P25, DOI 10.1189/jlb.1103552; Perretti M, 1997, TRENDS PHARMACOL SCI, V18, P418; POWARS D, 1993, AM J DIS CHILD, V147, P1197, DOI 10.1001/archpedi.1993.02160350071011; POWARS DR, 1991, HEMATOL ONCOL CLIN N, V5, P475, DOI 10.1016/S0889-8588(18)30426-X; Qari MH, 2012, CLIN APPL THROMB-HEM, V18, P195, DOI 10.1177/1076029611420992; Qin CX, 2015, PHARMACOL THERAPEUT, V148, P47, DOI 10.1016/j.pharmthera.2014.11.012; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Rifkind JM, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00500; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sarray S, 2015, CYTOKINE, V72, P43, DOI 10.1016/j.cyto.2014.11.030; Sena A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076969; Serjeant GR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011783; Steinberg MH, 2009, THESCIENTIFICWORLDJO, V9, P46, DOI 10.1100/tsw.2009.10; Sugimoto MA, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/8239258; SUTTON M, 1989, AM J HEMATOL, V32, P66, DOI 10.1002/ajh.2830320113; Torres Lidiane de Souza, 2015, Rev. Bras. Hematol. Hemoter., V37, P120, DOI 10.1016/j.bjhh.2015.02.007; Tsai WH, 2013, J CHIN MED ASSOC, V76, P486, DOI 10.1016/j.jcma.2013.05.004; VELLA F, 1968, AM J CLIN PATHOL, V49, P440, DOI 10.1093/ajcp/49.3_ts.440; Zhang DC, 2016, BLOOD, V127, P801, DOI 10.1182/blood-2015-09-618538	45	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165833	10.1371/journal.pone.0165833	http://dx.doi.org/10.1371/journal.pone.0165833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802331	Green Published, Green Submitted, gold			2022-12-26	WOS:000386714200060
J	Sugiyama, Y; Nakamura, A; Matsumoto, M; Kanbe, A; Sakanaka, M; Higashi, K; Igarashi, K; Katayama, T; Suzuki, H; Kurihara, S				Sugiyama, Yuta; Nakamura, Atsuo; Matsumoto, Mitsuharu; Kanbe, Ayaka; Sakanaka, Mikiyasu; Higashi, Kyohei; Igarashi, Kazuei; Katayama, Takane; Suzuki, Hideyuki; Kurihara, Shin			A Novel Putrescine Exporter SapBCDF of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; UTILIZATION PATHWAY; GAMMA-AMINOBUTYRATE; POTASSIUM CHANNEL; TRANSPORT-SYSTEM; POLYAMINES; K-12; SPERMIDINE; PROTEIN; CONTRIBUTES	Recent research has suggested that polyamines (putrescine, spermidine, and spermine) in the intestinal tract impact the health of animals either negatively or positively. The concentration of polyamines in the intestinal tract results from the balance of uptake and export of the intestinal bacteria. However, the mechanism of polyamine export from bacterial cells to the intestinal lumen is still unclear. In Escherichia coli, PotE was previously identified as a transporter responsible for putrescine excretion in an acidic growth environment. We observed putrescine concentration in the culture supernatant was increased from 0 to 50 mu M during growth of E. coli under neutral conditions. Screening for the unidentified putrescine exporter was performed using a gene knock-out collection of E. coli, and deletion of sapBCDF significantly decreased putrescine levels in the culture supernatant. Complementation of the deletion mutant with the sapBCDF genes restored putrescine levels in the culture supernatant. Additionally, the Delta sapBCDF strain did not facilitate uptake of putrescine from the culture supernatant. Quantification of stable isotope-labeled putrescine derived from stable isotope-labeled arginine supplemented in the medium revealed that SapBCDF exported putrescine from E. coli cells to the culture supernatant. It was previously reported that SapABCDF of Salmonella enterica sv. typhimurium and Haemophilus influenzae conferred resistance to antimicrobial peptides; however, the E. coli Delta sapBCDF strain did not affect resistance to antimicrobial peptide LL-37. These results strongly suggest that the natural function of the SapBCDF proteins is the export of putrescine.	[Sugiyama, Yuta; Sakanaka, Mikiyasu; Katayama, Takane; Kurihara, Shin] Ishikawa Prefectural Univ, Grad Sch Bioresources & Environm Sci, Div Appl Life Sci, Nonoichi, Ishikawa 9218836, Japan; [Nakamura, Atsuo; Matsumoto, Mitsuharu] Kyodo Milk Ind Co Ltd, Dairy Sci & Technol Inst, Tokyo 1900182, Japan; [Kanbe, Ayaka; Suzuki, Hideyuki] Kyoto Inst Technol, Div Appl Biol, Kyoto 6068585, Japan; [Higashi, Kyohei] Chiba Univ, Grad Sch Pharmaceut Sci, Div Biopharmaceut Sci, Chiba 2608675, Japan; [Igarashi, Kazuei] Chiba Univ, Amine Pharma Res Inst, Innovat Plaza, Chiba 2600856, Japan; [Katayama, Takane] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Sakyo Ku, Kyoto 6068502, Japan	Ishikawa Prefecture University; Kyoto Institute of Technology; Chiba University; Chiba University; Kyoto University	Kurihara, S (corresponding author), Ishikawa Prefectural Univ, 1-308 Suematsu, Nonoichi, Ishikawa 9218836, Japan.	kuri711@ishikawa-pu.ac.jp	Matsumoto, Mitsuharu/AHB-4023-2022	Higashi, Kyohei/0000-0002-2622-4825; Matsumoto, Mitsuharu/0000-0002-0378-3077; Igarashi, Kazuei/0000-0003-3751-3187	Institute for Fermentation, Osaka, Japan; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry by the Bio-oriented Technology Research Advancement Institution (BRAIN), Japan	Institute for Fermentation, Osaka, Japan(Institute for Fermentation (IFO)); Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry by the Bio-oriented Technology Research Advancement Institution (BRAIN), Japan	This work was supported by grants-in-aid from the Institute for Fermentation, Osaka, Japan, and in part by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry by the Bio-oriented Technology Research Advancement Institution (BRAIN), Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Babbar N, 2011, RECENT RESULTS CANC, V188, P49, DOI 10.1007/978-3-642-10858-7_4; Chen GG, 2009, J MASS SPECTROM, V44, P1203, DOI 10.1002/jms.1597; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dubin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10391; FURUCHI T, 1991, J BIOL CHEM, V266, P20928; Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108; Grenier F, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01038-14; Harms C, 2001, MICROBIOL-SGM, V147, P2991, DOI 10.1099/00221287-147-11-2991; HARWIG SSL, 1994, METHOD ENZYMOL, V236, P160; Higashi K, 2008, J BACTERIOL, V190, P872, DOI 10.1128/JB.01505-07; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; KASHIWAGI K, 1991, J BIOL CHEM, V266, P20922; Kashiwagi K, 1997, J BIOL CHEM, V272, P6318, DOI 10.1074/jbc.272.10.6318; KASHIWAGI K, 1992, P NATL ACAD SCI USA, V89, P4529, DOI 10.1073/pnas.89.10.4529; Kibe R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04548; Kurihara S, 2006, FEMS MICROBIOL LETT, V256, P318, DOI 10.1111/j.1574-6968.2006.00137.x; Kurihara S, 2005, J BIOL CHEM, V280, P4602, DOI 10.1074/jbc.M411114200; Kurihara S, 2008, J BIOL CHEM, V283, P19981, DOI 10.1074/jbc.M800133200; Kurihara S, 2013, J BIOL CHEM, V288, P15668, DOI 10.1074/jbc.M113.454090; Kurihara S, 2010, J BACTERIOL, V192, P4582, DOI 10.1128/JB.00308-10; Kurihara S, 2009, J BACTERIOL, V191, P2776, DOI 10.1128/JB.01314-08; Leuzzi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136744; Liu K, 2000, PLANT PHYSIOL, V124, P1315, DOI 10.1104/pp.124.3.1315; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Mason KM, 2006, MOL MICROBIOL, V62, P1357, DOI 10.1111/j.1365-2958.2006.05460.x; Mason KM, 2005, INFECT IMMUN, V73, P599, DOI 10.1128/IAI.73.1.599-608.2005; Matsumoto M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00233; Matsumoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023652; Miller J. H., 1972, SHORT COURSE BACTERI, p[263, 437]; Nemoto N, 2012, J BACTERIOL, V194, P3437, DOI 10.1128/JB.00097-12; PARRALOPEZ C, 1993, EMBO J, V12, P4053, DOI 10.1002/j.1460-2075.1993.tb06089.x; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; PISTOCCHI R, 1993, J BIOL CHEM, V268, P146; Sakanaka M, 2016, AMINO ACIDS, V48, P2443, DOI 10.1007/s00726-016-2233-0; Sasahara A, 2011, J BIOL CHEM, V286, P29044, DOI 10.1074/jbc.M111.260224; Schiller D, 2000, J BACTERIOL, V182, P6247, DOI 10.1128/JB.182.21.6247-6249.2000; Shelton CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002360; Soda K, 2009, EXP GERONTOL, V44, P727, DOI 10.1016/j.exger.2009.08.013; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Thompson PA, 2010, GASTROENTEROLOGY, V139, P797, DOI 10.1053/j.gastro.2010.06.005; Tiburcio AF, 2014, PLANTA, V240, P1, DOI 10.1007/s00425-014-2055-9; Vandenberg CA, 2008, P NATL ACAD SCI USA, V105, P7109, DOI 10.1073/pnas.0803231105; Woolridge DP, 1997, J BIOL CHEM, V272, P8864; Wortham BW, 2007, ADV EXP MED BIOL, V603, P106	46	32	37	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26343	26351		10.1074/jbc.M116.762450	http://dx.doi.org/10.1074/jbc.M116.762450			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27803167	hybrid, Green Published			2022-12-26	WOS:000391568200009
J	Bacchi, E; Bonin, C; Zanolin, ME; Zambotti, F; Livornese, D; Dona, S; Tosi, F; Baldisser, G; Ihnatava, T; Di Sarra, D; Sonora, E; Moghetti, P				Bacchi, Elisabetta; Bonin, Cecilia; Zanolin, Maria Elisabetta; Zambotti, Francesca; Livornese, Dario; Dona, Silvia; Tosi, Flavia; Baldisser, Giulia; Ihnatava, Tatsiana; Di Sarra, Daniela; Sonora, Enzo; Moghetti, Paolo			Physical Activity Patterns in Normal-Weight and Overweight/Obese Pregnant Women	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; RISK; PREECLAMPSIA	The aims of the present study were to assess the volume of physical activity (PA) throughout pregnancy in normal-weight vs overweight/obese women, and to investigate which factors may predict compliance to PA recommendations in these women throughout gestation. In 236 pregnant women, 177 normal-weight and 59 overweight/obese (median [IQR] BMI 21.2[19.9-22.8] vs 26.5[25.5-29.0] kg/m2, respectively), medical history, anthropometry and clinical data, including glucose tolerance, were recorded. In addition, pre-pregnancy PA was estimated by the Kaiser questionnaire, while total, walking and fitness/sport PA during pregnancy were assessed by the Physical Activity Scale for the Elderly (PASE) modified questionnaire, at 14-16, 24-28 and 30-32 weeks of gestation. PA volume was very low in the first trimester of pregnancy in both groups of women. However, it increased in the second and third trimester in normal-weight, but not in overweight/ obese subjects. Higher pre-pregnancy PA was a statistically significant predictor of being physically active (>150 minutes of PA per week) during all trimesters of gestation. In conclusion, physical activity volume is low in pregnant women, especially in overweight/obese subjects. PA volume increases during pregnancy only in normal-weight women. Pre-pregnancy PA is an independent predictor of achieving a PA volume of at least 150 min per week during pregnancy.	[Bacchi, Elisabetta; Zambotti, Francesca; Livornese, Dario; Dona, Silvia; Tosi, Flavia; Baldisser, Giulia; Di Sarra, Daniela; Sonora, Enzo; Moghetti, Paolo] Univ Verona, Dept Med, Endocrinol Diabet & Metab, Verona, Italy; [Bacchi, Elisabetta; Zambotti, Francesca; Livornese, Dario; Dona, Silvia; Tosi, Flavia; Baldisser, Giulia; Di Sarra, Daniela; Sonora, Enzo; Moghetti, Paolo] AOUI Verona, Verona, Italy; [Bonin, Cecilia; Ihnatava, Tatsiana] AOUI Verona, Miniinvas Pelv Surg Unit, Verona, Italy; [Zanolin, Maria Elisabetta] Univ Verona, Dept Diagnost & Publ Hlth, Epidemiol & Med Stat, Verona, Italy	University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona	Moghetti, P (corresponding author), Univ Verona, Dept Med, Endocrinol Diabet & Metab, Verona, Italy.; Moghetti, P (corresponding author), AOUI Verona, Verona, Italy.	paolo.moghetti@univr.it	Moghetti, Paolo/K-1138-2016; Tosi, Flavia/AAB-4855-2022	Moghetti, Paolo/0000-0003-3951-0297; Tosi, Flavia/0000-0003-3495-4411				Aune D, 2014, EPIDEMIOLOGY, V25, P331, DOI 10.1097/EDE.0000000000000036; Campbell CG, 2012, J DEV ORIG HLTH DIS, V3, P159, DOI 10.1017/S2040174412000025; Comm Obstet Practice, 2015, OBSTET GYNECOL, V126, pe135, DOI 10.1097/AOG.0000000000001214; Domingues MR, 2007, REV SAUDE PUBL, V41, P173, DOI 10.1590/s0034-89102007000200002; Evenson KR, 2014, AM J LIFESTYLE MED, V8, P102, DOI 10.1177/1559827613498204; Evenson KR, 2004, PAEDIATR PERINAT EP, V18, P400, DOI 10.1111/j.1365-3016.2004.00595.x; Hegaard HK, 2007, ACTA OBSTET GYN SCAN, V86, P1290, DOI 10.1080/00016340701647341; Hegaard HK, 2011, MATERN CHILD HLTH J, V15, P806, DOI 10.1007/s10995-010-0647-y; Liu JH, 2011, EUR J EPIDEMIOL, V26, P237, DOI 10.1007/s10654-010-9538-1; Lof M, 2006, BRIT J NUTR, V95, P296, DOI 10.1079/BJN20051497; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Nascimento SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128953; Ning Y, 2003, J Matern Fetal Neonatal Med, V13, P385, DOI 10.1080/713605926; Pivarnik JM, 2006, MED SCI SPORT EXER, V38, P989, DOI 10.1249/01.mss.0000218147.51025.8a; Renault K, 2010, ACTA OBSTET GYN SCAN, V89, P956, DOI 10.3109/00016341003792459; Rousham EK, 2006, EUR J CLIN NUTR, V60, P393, DOI 10.1038/sj.ejcn.1602329; Schmidt MD, 2006, MED SCI SPORT EXER, V38, P42, DOI 10.1249/01.mss.0000181301.07516.d6; Sui ZX, 2013, HEALTH PROMOT J AUST, V24, P206, DOI 10.1071/HE13054; Tobias DK, 2011, DIABETES CARE, V34, P223, DOI 10.2337/dc10-1368; Walsh JM, 2011, INT J GYNECOL OBSTET, V114, P154, DOI 10.1016/j.ijgo.2011.02.016; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Zhang CL, 2006, ARCH INTERN MED, V166, P543, DOI 10.1001/archinte.166.5.543	23	23	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166254	10.1371/journal.pone.0166254	http://dx.doi.org/10.1371/journal.pone.0166254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829017	Green Submitted, gold, Green Published			2022-12-26	WOS:000387724300100
J	Dalhatu, I; Onotu, D; Odafe, S; Abiri, O; Debem, H; Agolory, S; Shiraishi, RW; Auld, AF; Swaminathan, M; Dokubo, K; Ngige, E; Asadu, C; Abatta, E; Ellerbrock, TV				Dalhatu, Ibrahim; Onotu, Dennis; Odafe, Solomon; Abiri, Oseni; Debem, Henry; Agolory, Simon; Shiraishi, Ray W.; Auld, Andrew F.; Swaminathan, Mahesh; Dokubo, Kainne; Ngige, Evelyn; Asadu, Chukwuemeka; Abatta, Emmanuel; Ellerbrock, Tedd V.			Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; TERM IMMUNOLOGICAL RESPONSE; FOLLOW-UP; PATIENTS LOST; CELL COUNT; 1ST YEAR; THERAPY; MORTALITY; CD4; COHORT	Background The Nigerian Antiretroviral therapy (ART) program started in 2004 and now ranks among the largest in Africa. However, nationally representative data on outcomes have not been reported. Methods We evaluated retrospective cohort data from a nationally representative sample of adults aged >= 15 years who initiated ART during 2004 to 2012. Data were abstracted from 3,496 patient records at 35 sites selected using probability-proportional-to-size (PPS) sampling. Analyses were weighted and controlled for the complex survey design. The main outcome measures were mortality, loss to follow-up (LTFU), and retention (the proportion alive and on ART). Potential predictors of attrition were assessed using competing risk regression models. Results At ART initiation, 66.4 percent (%) were females, median age was 33 years, median weight 56 kg, median CD4 count 161 cells/mm(3), and 47.1% had stage III/IV disease. The percentage of patients retained at 12, 24, 36 and 48 months was 81.2%, 74.4%, 67.2%, and 61.7%, respectively. Over 10,088 person-years of ART, mortality, LTFU, and overall attrition (mortality, LTFU, and treatment stop) rates were 1.1 (95% confidence interval (CI): 0.7-1.8), 12.3 (95% CI: 8.9-17.0), and 13.9 (95% CI: 10.4-18.5) per 100 person-years (py) respectively. Highest attrition rates of 55.4/100py were witnessed in the first 3 months on ART. Predictors of LTFU included: lower-than-secondary level education (reference: Tertiary), care in North-East and South-South regions (reference: North-Central), presence of moderate/severe anemia, symptomatic functional status, and baseline weight <45kg. Predictor of mortality was WHO stage higher than stage I. Male sex, severe anemia, and care in a small clinic were associated with both mortality and LTFU. Conclusion Moderate/Advanced HIV disease was predictive of attrition; earlier ART initiation could improve program outcomes. Retention interventions targeting men and those with lower levels of education are needed. Further research to understand geographic and clinic size variations with outcome is warranted.	[Dalhatu, Ibrahim; Onotu, Dennis; Odafe, Solomon; Debem, Henry] US Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Abuja, Nigeria; [Abiri, Oseni; Dokubo, Kainne] Univ Texas Houston, Sch Biomed Informat, Houston, TX USA; [Agolory, Simon; Shiraishi, Ray W.; Auld, Andrew F.; Swaminathan, Mahesh; Ellerbrock, Tedd V.] US Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Atlanta, GA USA; [Ngige, Evelyn; Asadu, Chukwuemeka; Abatta, Emmanuel] Fed Minist Hlth, Natl AIDS & STIs Control Program, Abuja, Nigeria	University of Texas System; University of Texas Health Science Center Houston; Centers for Disease Control & Prevention - USA	Odafe, S (corresponding author), US Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Abuja, Nigeria.	wsp7@cdc.gov	Odafe, Solomon/AAJ-2390-2020	Shiraishi, Ray/0000-0001-7640-0666; Auld, Andrew/0000-0001-5089-9163	President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Centers for Disease Control and Prevention (CDC)	President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Centers for Disease Control and Prevention (CDC)	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) (http://www.pepfar.gov/) through the United States Centers for Disease Control and Prevention (CDC) (http://www.cdc.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam RR, 2015, T ROY SOC TROP MED H, V109, P325, DOI 10.1093/trstmh/trv018; Anguzu R, 2015, VALUE HEALTH, V18, pA590, DOI 10.1016/j.jval.2015.09.1515; Auld AF, 2015, MMWR-MORBID MORTAL W, V64, P1281, DOI 10.15585/mmwr.mm6446a2; Auld AF, 2014, MMWR-MORBID MORTAL W, V63, P1097; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Bognounou R, 2015, Bull Soc Pathol Exot, V108, P197, DOI 10.1007/s13149-015-0424-7; Bonner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113813; Bonner K, 2013, JAIDS-J ACQ IMM DEF, V64, P74, DOI 10.1097/QAI.0b013e31829f05ac; Bonnet F, 2005, HIV MED, V6, P198, DOI 10.1111/j.1468-1293.2005.00290.x; Boulle A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001718; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Charurat M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010584; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Eddings W, 2012, STATA J, V12, P353, DOI 10.1177/1536867X1201200301; Federal Ministry of Health, 2010, TECHN REP 2010 NAT H, P16; Federal Ministry of Health (FMOH), 2007, NAT GUID HIV AIDS TR, P12; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Ferradini L, 2007, AIDS, V21, P2293, DOI 10.1097/QAD.0b013e32828cc8b7; Fine J, 1991, JAMSTATASSOC, V94, P496; FMOH, 2010, NAT GUID HIV AIDS TR, P12; FMOH, 2007, NAT GUID HIV AIDS TR, P65; FMOH, 2014, INT NAT GUIEL HIV PR, P1; Ford N, 2015, LANCET INFECT DIS, V15, P241, DOI 10.1016/S1473-3099(14)70896-5; Gazzard B, 2014, J INT AIDS SOC, V17, P167, DOI 10.7448/IAS.17.4.19767; Gonzalez PJ, 2016, F1000RESEARCH, V5, P983, DOI [10.7490/f1000research.1111966.1, DOI 10.7490/F1000RESEARCH.1111966.1]; Hao Lianzheng, 2014, Zhonghua Yu Fang Yi Xue Za Zhi, V48, P466; Harries AD, 2010, TROP MED INT HEALTH, V15, P70, DOI 10.1111/j.1365-3156.2010.02506.x; Imaz A, 2013, ANTIVIR THER, V18, P125, DOI 10.3851/IMP2249; Ioannidis JPA, 1997, J ACQ IMMUN DEF SYND, V16, P22, DOI 10.1097/00042560-199709010-00004; Kaufmann GR, 2000, AIDS, V14, P959, DOI 10.1097/00002030-200005260-00007; Kousignian I, 2008, CLIN INFECT DIS, V46, P296, DOI 10.1086/524753; Landman R, 2014, ANTIVIR THER, V19, P51, DOI 10.3851/IMP2675; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Marazzi MC, 2008, AIDS RES HUM RETROV, V24, P555, DOI 10.1089/aid.2007.0217; Mdege ND, 2013, HEALTH POLICY PLANN, V28, P223, DOI 10.1093/heapol/czs058; Meloni ST, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu055; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Nasidi A, 1986, 2 INT C AIDS JUN 23; National Agency for the Control of AIDS (NACA), 2007, STRAT PLANN RES, P20; National Agency for the Control of AIDS (NACA), 2014, GLOB AIDS RESP COUNT, P14; National Agency for the Control of AIDS (NACA) Federal Republic of Nigeria, 2012, GLOB AIDS RESP COUNT; National Centre for AIDS and STD Control, 2020, RETENTION HIV CARE N; Nuesch Reto, 2009, Open AIDS J, V3, P38, DOI 10.2174/1874613600903010038; Odafe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051254; Odafe S, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17424; Oladepo DK, 2009, CLIN VACCINE IMMUNOL, V16, P1374, DOI 10.1128/CVI.00378-08; Olsen CH, 2007, HIV MED, V8, P96, DOI 10.1111/j.1468-1293.2007.00436.x; Palacios R, 2009, EUR J CLIN MICROBIOL, V28, P399, DOI 10.1007/s10096-008-0636-x; Patrick Royston, 2011, J STAT SOFTWARE, V45; Ramjan R, 2014, TROP MED INT HEALTH, V19, P501, DOI 10.1111/tmi.12297; Reepalu A, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu039; Renaud-Thery F, ADULT ANTIRETROVIRAL; Reynolds SJ, 2014, AIDS PATIENT CARE ST, V28, P575, DOI 10.1089/apc.2014.0086; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rubin DB, 2004, MULTIPLE IMPUTATION; Sabapathy K, 2012, JAIDS-J ACQ IMM DEF, V60, pE53, DOI 10.1097/QAI.0b013e31824d5689; Schaubel DE, 2005, STAT MED, V24, P3037, DOI 10.1002/sim.2157; Smith CJ, 2004, J INFECT DIS, V190, P1860, DOI 10.1086/425075; StataCorp, 2013, REL 13 STAT SOFTW REL 13 STAT SOFTW; StataCorp, 2013, TEST TEST LIN HYP ES; StataCorp, 2013, IT LIF TABL SURV DAT; StataCorp, 2013, STPTIM CALC PERS TIM; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Tafese Zelalem, 2012, Ethiop Med J, V50, P75; Takarinda KC, 2015, INT J INFECT DIS, V30, P98, DOI 10.1016/j.ijid.2014.11.009; Takuva S, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18651; Tweya H, 2014, TROP MED INT HEALTH, V19, P1360, DOI 10.1111/tmi.12369; Ugbena R, 2012, CLIN INFECT DIS, V54, pS375, DOI 10.1093/cid/cir1064; UNAIDS, 2014, HIV AIDS EST; UNAIDS, 2012, NIG HIV AIDS EST; Verguet S, 2013, J INFECT DIS, V207, P72, DOI 10.1093/infdis/jis635; Walker AS, 2008, AIDS, V22, P237, DOI 10.1097/QAD.0b013e3282f2d760; Wandeler G, 2012, JAIDS-J ACQ IMM DEF, V59, pE9, DOI 10.1097/QAI.0b013e31823edb6a; Wang HL, 2012, AIDS, V26, P1755, DOI 10.1097/QAD.0b013e328355ced2; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WHO, 2011, WHO UNICEF EST ROT C, P2; *WHO, TEXTB 7 3 MON RESP A; WHO, 2004, SUBST MAINT THER MAN, P11; WHO, 2013, GLOB UPD HIV TREATM; WHO Scientific Group on the Assessment of Osteoporosis at Primary Health Care Level, 2004, STRAT FRAM MAL PREV, P9; World Health Organization (WHO) HIV/AIDS, 2006, PAT MON GUID HIV CAR, P30; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	86	36	36	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165528	10.1371/journal.pone.0165528	http://dx.doi.org/10.1371/journal.pone.0165528			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9OG	27829033	Green Published, gold, Green Submitted			2022-12-26	WOS:000387724300048
J	Hernandez-Trejo, M; Garcia-Rivas, G; Torres-Quintanilla, A; Laresgoiti-Servitje, E				Hernandez-Trejo, Maria; Garcia-Rivas, Gerardo; Torres-Quintanilla, Alejandro; Laresgoiti-Servitje, Estibalitz			Relationship between Irisin Concentration and Serum Cytokines in Mother and Newborn	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; CORD BLOOD IRISIN; CIRCULATING IRISIN; SKELETAL-MUSCLE; OXIDATIVE STRESS; WEIGHT-LOSS; EXERCISE; FETAL; PREGNANCY; FAT	Introduction Irisin is considered to be a myokine and adipokine that may also participate in reproductive functions, as it increases significantly throughout pregnancy. However, the regulation of circulating irisin and its relationship with other cytokines has not been assessed thus far in pregnant women and their offspring. Objective The aim of this study was to evaluate differences in irisin and cytokine concentrations between women at the end of pregnancy and their offspring, as well as the relationship between maternal and newborn irisin and maternal and newborn biomarkers. Methods Twenty-eight mother/newborn pairs were included in this study. The following biomarkers were evaluated in maternal venous and arterial umbilical cord blood samples: irisin, 27 cytokine panel, total antioxidant capacity (TAC), total plasma protein, and free fatty acid concentration. Results The newborns had significantly lower irisin concentrations compared to their mothers (p = 0.03), but this difference was present only in babies born from mothers without labor prior to cesarean section delivery (p = 0.01). No significant differences in maternal and newborn irisin concentrations were found between diabetic and non-diabetic mothers or between overweight/obese and normal weight mothers. A significant positive correlation was found between TAC level and irisin concentration in newborns. Maternal and newborn interleukin (IL)-1 beta, IL-1RA, IL-5, IL-7, and interferon gamma-induced protein (IP)-10 levels were significantly positively correlated with irisin concentrations in both study groups. In addition, maternal IL1 beta, IL-5, IL-7, and IP-10 levels positively predicted maternal irisin concentrations. Furthermore, arterial cord blood TAC and IL-1 beta and IL1-RA levels positively predicted newborn irisin concentrations. Multiple regression analyses showed that maternal IL-13 negatively predicted offspring irisin levels (p = 0.03) and that maternal IL-1 beta positively predicted newborn irisin concentrations (p = 0.046). Conclusion No evidence was found that serum irisin concentrations in mothers at pregnancy termination or those of their newborns correlated with maternal body mass index, the presence of diabetes mellitus, or free fatty acid levels. However, the results of this study indicated that cytokines might predict irisin concentration in mothers and their offspring, although interactions between irisin levels during pregnancy and the newborn have not yet been fully elucidated.	[Hernandez-Trejo, Maria] Inst Nacl Perinatol, Neurobiol Dev, Mexico City, DF, Mexico; [Garcia-Rivas, Gerardo; Torres-Quintanilla, Alejandro] Tecnol Monterrey, Escuela Nacl Med, Catedra Cardiol, Monterrey, Mexico; [Garcia-Rivas, Gerardo] Tecnol Monterrey, Hosp Zambrano Hell, Ctr Invest Biomed, San Pedro Garza Garcia, Mexico; [Laresgoiti-Servitje, Estibalitz] Tecnol Monterrey, TEC ABC Sch Med, Basic Med Sci, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Tecnologico de Monterrey; Tecnologico de Monterrey; Tecnologico de Monterrey	Laresgoiti-Servitje, E (corresponding author), Tecnol Monterrey, TEC ABC Sch Med, Basic Med Sci, Mexico City, DF, Mexico.	estibalitz.laresgoiti@itesm.mx	Torres-Quintanilla, Alejandro/X-3336-2019; Torres Quintanilla, Alejandro Daniel/GXV-9386-2022; García-Rivas, Gerardo/A-9691-2011; Hernandez-Trejo, Maria/AAG-4276-2020; Laresgoiti-Servitje, Estibalitz/B-7658-2014	Torres-Quintanilla, Alejandro/0000-0002-7145-1840; Torres Quintanilla, Alejandro Daniel/0000-0002-7145-1840; García-Rivas, Gerardo/0000-0003-4731-3293; Laresgoiti-Servitje, Estibalitz/0000-0002-3271-9955	National Institute of Perinatology, Mexico [(384) 212250-22651]; CONACYT-Mexico [151136]	National Institute of Perinatology, Mexico; CONACYT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was supported by the National Institute of Perinatology, Mexico, Reg (384) 212250-22651 (Maria Hernandez-Trejo). Irisin ELISA detection kits used in this study were supported by CONACYT-Mexico grant 151136.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Daghri NM, 2015, EUR J CLIN INVEST, V45, P775, DOI 10.1111/eci.12468; Al-Daghri NM, 2014, CLIN SCI, V126, P837, DOI 10.1042/CS20130426; Albrecht E, 2015, SCI REP-UK, V5, DOI 10.1038/srep08889; Apak R, 2005, FREE RADICAL RES, V39, P949, DOI 10.1080/10715760500210145; Aydin S, 2014, PEPTIDES, V61, P130, DOI 10.1016/j.peptides.2014.09.014; Baka S, 2015, METABOLISM, V64, P1515, DOI 10.1016/j.metabol.2015.07.020; Bakal U, 2016, BIOCHEM INSIGHTS, V9, P11, DOI [10.4137/BCICI.S39671, 10.4137/BCI.S39671]; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Briana D, 2014, ARCH DIS CHILD, V99, pA126, DOI [10.1136/archdischild-2014-307384.336, DOI 10.1136/ARCHDISCHILD-2014-307384.336]; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Caglar M, 2014, J ENDOCRINOL INVEST, V37, P619, DOI 10.1007/s40618-014-0078-5; Choi YK, 2013, DIABETES RES CLIN PR, V100, P96, DOI 10.1016/j.diabres.2013.01.007; Crujeiras AB, 2015, CLIN ENDOCRINOL, V82, P467, DOI 10.1111/cen.12627; Dong J, 2016, INT J OBESITY, V40, P434, DOI 10.1038/ijo.2015.200; Dun SL, 2013, NEUROSCIENCE, V240, P155, DOI 10.1016/j.neuroscience.2013.02.050; DUNCOMBE WG, 1964, CLIN CHIM ACTA, V9, P122, DOI 10.1016/0009-8981(64)90004-X; Ebert T, 2014, CYTOKINE, V65, P153, DOI 10.1016/j.cyto.2013.11.009; Eckardt K, 2014, DIABETOLOGIA, V57, P1087, DOI 10.1007/s00125-014-3224-x; Erickson HP, 2013, ADIPOCYTE, V2, P289, DOI 10.4161/adip.26082; Erol O, 2016, J MATERN-FETAL NEO M, V29, P3590, DOI 10.3109/14767058.2016.1142967; Garces MF, 2014, J CLIN ENDOCR METAB, V99, P2113, DOI 10.1210/jc.2013-4127; Hauguel-de Mouzon S, 2006, PLACENTA, V27, P794, DOI 10.1016/j.placenta.2005.08.009; Huh JY, 2014, J CLIN ENDOCR METAB, V99, pE2154, DOI 10.1210/jc.2014-1437; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Hung TH, 2010, REPROD SCI, V17, P401, DOI 10.1177/1933719109359704; Jedrychowski MP, 2015, CELL METAB, V22, P734, DOI 10.1016/j.cmet.2015.08.001; Jiang LQ, 2013, AM J PHYSIOL-ENDOC M, V305, pE1359, DOI 10.1152/ajpendo.00236.2013; JONES CM, 1982, AM J OBSTET GYNECOL, V144, P149, DOI 10.1016/0002-9378(82)90616-0; Kurdiova T, 2014, J PHYSIOL-LONDON, V592, P1091, DOI 10.1113/jphysiol.2013.264655; Kuzmicki M, 2014, GYNECOL ENDOCRINOL, V30, P636, DOI 10.3109/09513590.2014.920006; Liu J-J, J DIABETES COMPLICAT, V27, P365, DOI [10.1016/j.jdiaccmp.2013.003.002, DOI 10.1016/J.JDIACCMP.2013.003.002]; Lopez-Legarrea P, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x; Pantham P, 2015, PLACENTA, V36, P709, DOI 10.1016/j.placenta.2015.04.006; Park KH, 2013, J CLIN ENDOCR METAB, V98, P4899, DOI 10.1210/jc.2013-2373; Park MJ, 2015, CELL SIGNAL, V27, P1831, DOI 10.1016/j.cellsig.2015.04.010; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; PERKINS SL, 1993, CLIN CHEM, V39, P1041; Phoenix Pharmaceuticals I, IRISIN PROTEINS ANTI; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Raschke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073680; Raschke S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/320724; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Sykes L, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/967629; Timmons JA, 2012, NATURE, V488, pE9, DOI 10.1038/nature11364; Toescu V, 2002, CLIN ENDOCRINOL, V57, P609, DOI 10.1046/j.1365-2265.2002.01638.x; Vaughan RA, 2015, J PHYSIOL BIOCHEM, V71, P679, DOI 10.1007/s13105-015-0433-9; Wang C, 2015, ENDOCRINE, V49, P90, DOI 10.1007/s12020-014-0458-9; Wawrusiewicz-Kurylonek N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131171; Williams TJ, 2000, J ALLERGY CLIN IMMUN, V105, P951, DOI 10.1067/mai.2000.106211; Yuksel MA, 2014, DIABETES RES CLIN PR, V104, P171, DOI 10.1016/j.diabres.2013.12.025; Zhao L, 2015, ENDOCR J, V62, P921, DOI 10.1507/endocrj.EJ15-0230	53	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165229	10.1371/journal.pone.0165229	http://dx.doi.org/10.1371/journal.pone.0165229			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828992	Green Published, gold, Green Submitted			2022-12-26	WOS:000387724300033
J	Karat, AS; Omar, T; von Gottberg, A; Tlali, M; Chihota, VN; Churchyard, GJ; Fielding, KL; Johnson, S; Martinson, NA; McCarthy, K; Wolter, N; Wong, EB; Charalambous, S; Grant, AD				Karat, Aaron S.; Omar, Tanvier; von Gottberg, Anne; Tlali, Mpho; Chihota, Violet N.; Churchyard, Gavin J.; Fielding, Katherine L.; Johnson, Suzanne; Martinson, Neil A.; McCarthy, Kerrigan; Wolter, Nicole; Wong, Emily B.; Charalambous, Salome; Grant, Alison D.			Autopsy Prevalence of Tuberculosis and Other Potentially Treatable Infections among Adults with Advanced HIV Enrolled in Out-Patient Care in South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; POSTMORTEM BACTERIOLOGY; HOSPITALIZED ADULTS; DEATH; MORTALITY; TB; VALIDATION; ROUTINE; PEOPLE; NEED	Background Early mortality among HIV-positive adults starting antiretroviral therapy (ART) remains high in resource-limited settings, with tuberculosis (TB) the leading cause of death. However, current methods to estimate TB-related deaths are inadequate and most autopsy studies do not adequately represent those attending primary health clinics (PHCs). This study aimed to determine the autopsy prevalence of TB and other infections in adults enrolled at South African PHCs in the context of a pragmatic trial of empiric TB treatment ("TB Fast Track"). Methods and Findings Adults with CD4 <= 150 cells/mu L, not on ART or TB treatment, were enrolled to TB Fast Track and followed up for at least six months. Minimally invasive autopsy (MIA) was conducted as soon as possible after death. Lungs, liver, and spleen were biopsied; blood, CSF, and urine aspirated; and bronchoalveolar lavage fluid obtained. Samples underwent mycobacterial, bacterial, and fungal culture; molecular testing (including Xpert (R) MTB/RIF); and histological examination. 34 MIAs were conducted: 18 (53%) decedents were female; median age was 39 (interquartile range 33-44) years; 25 (74%) deaths occurred in hospitals; median time from death to MIA was five (IQR 3-6) days. 16/34 (47%) had evidence of TB (14/16 [88%] with extrapulmonary disease; 6/16 [38%] not started on treatment antemortem); 23 (68%) had clinically important bacterial infections; four (12%) cryptococcal disease; three (9%) non-tuberculous mycobacterial disease; and two (6%) Pneumocystis pneumonia. Twenty decedents (59%) had evidence of two or more concurrent infections; 9/ 16 (56%) individuals with TB had evidence of bacterial disease and two (13%) cryptococcal disease. Conclusions TB, followed by bacterial infections, were the leading findings at autopsy among adults with advanced HIV enrolled from primary care clinics. To reduce mortality, strategies are needed to identify and direct those at highest risk into a structured pathway that includes expedited investigation and/or treatment of TB and other infections.	[Karat, Aaron S.; Churchyard, Gavin J.; Fielding, Katherine L.; Grant, Alison D.] London Sch Hyg & Trop Med, TB Ctr, London, England; [Omar, Tanvier] Natl Hlth Lab Serv, Dept Anat Pathol, Johannesburg, South Africa; [Omar, Tanvier] Univ Witwatersrand, Johannesburg, South Africa; [von Gottberg, Anne; Wolter, Nicole] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [von Gottberg, Anne; Wolter, Nicole] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa; [Tlali, Mpho; Chihota, Violet N.; Churchyard, Gavin J.; McCarthy, Kerrigan; Charalambous, Salome] Aurum Inst, Johannesburg, South Africa; [Chihota, Violet N.; Churchyard, Gavin J.; Fielding, Katherine L.; McCarthy, Kerrigan; Charalambous, Salome; Grant, Alison D.] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Johnson, Suzanne] Fdn Profess Dev, Pretoria, South Africa; [Martinson, Neil A.] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Martinson, Neil A.] Univ Witwatersrand, Med Res Council, Soweto Matlosana Collaborating Ctr HIV AIDS & TB, Johannesburg, South Africa; [Martinson, Neil A.] Johns Hopkins Univ, Ctr TB Res, Baltimore, MD USA; [Martinson, Neil A.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn, Ctr Excellence Biomed TB Res, Johannesburg, South Africa; [McCarthy, Kerrigan] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Div Publ Hlth Surveillance & Response, Johannesburg, South Africa; [Wong, Emily B.] Africa Hlth Res Inst, Durban, South Africa; [Wong, Emily B.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Grant, Alison D.] Univ KwaZulu Natal, Durban, South Africa	University of London; London School of Hygiene & Tropical Medicine; National Health Laboratory Service; University of Witwatersrand; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; South African Medical Research Council; University of Witwatersrand; Johns Hopkins University; National Research Foundation - South Africa; University of Witwatersrand; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); Africa Health Research Institute; Harvard University; Massachusetts General Hospital; University of Kwazulu Natal	Karat, AS (corresponding author), London Sch Hyg & Trop Med, TB Ctr, London, England.	aaron.karat@lshtm.ac.uk	Chihota, Violet/DWH-9372-2022	Karat, Aaron/0000-0001-9643-664X; McCarthy, Kerrigan/0000-0001-8958-9795; Tlali, Mpho/0000-0003-0283-2022; Charalambous, Salome/0000-0001-7143-1009; von Gottberg, Anne/0000-0002-0243-7455; Churchyard, Gavin/0000-0002-4269-3699; Chihota, Violet/0000-0003-1444-9266	Bill and Melinda Gates Foundation [OPP1083118]; Medical Research Council [MR/K012126/1, G1100689] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI118538] Funding Source: NIH RePORTER; MRC [G1100689] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Bill and Melinda Gates Foundation (Global Health Grant number OPP1083118; http://www.gatesfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett I V., 2016, JAIDS J ACQUIR I APR; Bates M, 2015, LANCET INFECT DIS, V3099, P1; Burger EH, 2012, J CLIN EPIDEMIOL, V65, P309, DOI 10.1016/j.jclinepi.2011.08.007; Cain KP, 2015, INT J TUBERC LUNG D, V19, P1270, DOI 10.5588/ijtld.15.0782; Christoffersen S, 2015, FORENSIC SCI INT, V250, P27, DOI 10.1016/j.forsciint.2015.02.020; Cox JA, 2014, JAIDS-J ACQ IMM DEF, V67, P169, DOI 10.1097/QAI.0000000000000290; Cox JA, 2011, TROP MED INT HEALTH, V16, P1015, DOI 10.1111/j.1365-3156.2011.02798.x; Fielding KL, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0650-0; Ford N, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20714; Garcia-Basteiro AL, 2016, SCI REP-UK, V6, DOI 10.1038/srep20703; Gerston KF, 2004, HUM PATHOL, V35, P571, DOI 10.1016/j.humpath.2004.01.009; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Guerra I, 2001, PATHOL RES PRACT, V197, P165, DOI 10.1078/0344-0338-00028; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Gupta RK, 2015, AIDS, V29, P1987, DOI 10.1097/QAD.0000000000000802; Hanifa Y, 2012, INT J TUBERC LUNG D, V16, P1252, DOI 10.5588/ijtld.11.0733; Karat AS, 2015, 22 C RETR OPP INF; Kufa T, 2012, JAIDS-J ACQ IMM DEF, V60, pE22, DOI 10.1097/QAI.0b013e318251ae0b; Lawn SD, 2008, AIDS, V22; Lawn SD, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0432-2; Liu TT, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/937013; Lucas S., 2007, CURR DIAGN PATHOL, V13, P375, DOI DOI 10.1016/J.CDIP.2007.06.001; Martinez MJ, 2016, DIAGN MICR INFEC DIS, V84, P80, DOI 10.1016/j.diagmicrobio.2015.10.002; Martinson NA, 2007, AIDS, V21, P2043, DOI 10.1097/QAD.0b013e3282eea47f; Maujean G, 2013, J FORENSIC SCI, V58, P1069, DOI 10.1111/1556-4029.12155; Morris JA, 2006, J CLIN PATHOL, V59, P1, DOI 10.1136/jcp.2005.028183; Morris JA, 2007, CURR DIAGN PATHOL, V13, P65, DOI DOI 10.1016/J.CDIP.2006.07.005; Mudenda V, 2012, J INFECT DIS, V205, pS340, DOI 10.1093/infdis/jir859; Murithi S, 2015, 46 UN WORLD C LUNG H; Omar T, 2015, INT J TUBERC LUNG D, V19, P1320, DOI 10.5588/ijtld.15.0222; Palmiere C, 2015, J FORENSIC LEG MED, V30, P21, DOI 10.1016/j.jflm.2014.12.012; Popovic T, 2011, INT J EPIDEMIOL, P71; Pretorius MA, 2012, J INFECT DIS, V206, pS159, DOI 10.1093/infdis/jis538; South African National Department of Health, 2014, NAT TUB MAN GUID; Statistics South Africa, 2015, MORT CAUS DEATH S AF; Streatfield PK, 2014, GLOB HLTH ACTION, P1; Tatti KM, 2011, J CLIN MICROBIOL, V49, P4059, DOI 10.1128/JCM.00601-11; Thurman KA, 2011, DIAGN MICR INFEC DIS, V70, P1, DOI 10.1016/j.diagmicrobio.2010.11.014; Tsokos M, 2001, Leg Med (Tokyo), V3, P15, DOI 10.1016/S1344-6223(01)00002-5; Wang X, 2012, J CLIN MICROBIOL, V50, P702, DOI 10.1128/JCM.06087-11; Weber MA, 2010, FORENSIC SCI INT, V198, P121, DOI 10.1016/j.forsciint.2010.02.002; Weustink AC, 2009, RADIOLOGY, V250, P897, DOI 10.1148/radiol.2503080421; WHO, 2015, END TB STRAT GLOB ST; WHO, 2007, IMPR DIAGN TREATM SM; Wong EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047542; World Health Organization, 2015, IMPL TUB DIAGN POL F; World Health Organization, 2016, CONS GUID US ANT DRU	47	37	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166158	10.1371/journal.pone.0166158	http://dx.doi.org/10.1371/journal.pone.0166158			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829072	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000387724300092
J	Reznikov, LR; Meyerholz, DK; Adam, RJ; Abou Alaiwa, M; Jaffer, O; Michalski, AS; Powers, LS; Price, MP; Stoltz, DA; Welsh, MJ				Reznikov, Leah R.; Meyerholz, David K.; Adam, Ryan J.; Abou Alaiwa, Mahmoud; Jaffer, Omar; Michalski, Andrew S.; Powers, Linda S.; Price, Margaret P.; Stoltz, David A.; Welsh, Michael J.			Acid-Sensing Ion Channel 1 alpha Contributes to Airway Hyperreactivity in Mice	PLOS ONE			English	Article							TACHYKININ NK1 RECEPTOR; SMOOTH-MUSCLE; MURINE MODEL; SUBSTANCE-P; ASIC1 CONTRIBUTES; BREATH CONDENSATE; INFLAMMATION; HYPERRESPONSIVENESS; ASTHMA; ACIDIFICATION	Neurons innervating the airways contribute to airway hyperreactivity (AHR), a hallmark feature of asthma. Several observations suggested that acid-sensing ion channels (ASICs), neuronal cation channels activated by protons, might contribute to AHR. For example, ASICs are found in vagal sensory neurons that innervate airways, and asthmatic airways can become acidic. Moreover, airway acidification activates ASIC currents and depolarizes neurons innervating airways. We found ASIC1a protein in vagal ganglia neurons, but not airway epithelium or smooth muscle. We induced AHR by sensitizing mice to ovalbumin and found that ASIC1a(-/-) mice failed to exhibit AHR despite a robust inflammatory response. Loss of ASIC1a also decreased bronchoalveolar lavage fluid levels of substance P, a sensory neuropeptide secreted from vagal sensory neurons that contributes to AHR. These findings suggest that ASIC1a is an important mediator of AHR and raise the possibility that inhibiting ASIC channels might be beneficial in asthma.	[Reznikov, Leah R.; Adam, Ryan J.; Abou Alaiwa, Mahmoud; Jaffer, Omar; Michalski, Andrew S.; Powers, Linda S.; Price, Margaret P.; Stoltz, David A.; Welsh, Michael J.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Meyerholz, David K.] Univ Iowa, Dept Pathol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Stoltz, David A.; Welsh, Michael J.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Reznikov, Leah R.; Adam, Ryan J.; Abou Alaiwa, Mahmoud; Powers, Linda S.; Price, Margaret P.; Stoltz, David A.; Welsh, Michael J.] Univ Iowa, Pappajohn Biomed Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Adam, Ryan J.; Stoltz, David A.] Univ Iowa, Coll Engn, Dept Biomed Engn, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Welsh, MJ (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.; Welsh, MJ (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.; Welsh, MJ (corresponding author), Univ Iowa, Pappajohn Biomed Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.; Welsh, MJ (corresponding author), Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	michael-welsh@uiowa.edu	Reznikov, Leah R./J-4314-2019; Meyerholz, David/J-8131-2019	Reznikov, Leah R./0000-0002-4074-9070; Meyerholz, David/0000-0003-1552-3253; Welsh, Michael/0000-0002-1646-6206; Abou Alaiwa, Mahmoud/0000-0003-4525-0217; Stoltz, David/0000-0003-0893-9015; Adam, Ryan/0000-0001-8602-8263	National Institutes of Health [1K99HL119560-01A1, 1P01HL091842]; America Asthma Foundation; Roy J Carver Charitable Trust; Gilead Sciences Research Scholars Program in Cystic Fibrosis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL119560, T32HL007638, P01HL091842, K99HL119560, P01HL051670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); America Asthma Foundation; Roy J Carver Charitable Trust; Gilead Sciences Research Scholars Program in Cystic Fibrosis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was in part supported by the National Institutes of Health 1K99HL119560-01A1 (LRR) and 1P01HL091842 (MJW), the America Asthma Foundation (DAS), and by the Roy J Carver Charitable Trust. DAS was funded by the Gilead Sciences Research Scholars Program in Cystic Fibrosis. MJW is an Investigator of the Howard Hughes Medical Institute.	Adam RJ, 2013, AM J RESP CRIT CARE, V188, P1434, DOI 10.1164/rccm.201307-1268OC; Allen GB, 2009, J APPL PHYSIOL, V107, P1763, DOI 10.1152/japplphysiol.00572.2009; ANTONACCIO MJ, 1973, EUR J PHARMACOL, V23, P311, DOI 10.1016/0014-2999(73)90102-7; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Brunetti L, 2008, ALLERGY ASTHMA PROC, V29, P461, DOI 10.2500/aap.2008.29.3152; Canning B KM, 2013, FASEB FASEB J; Carr MJ, 2001, BRIT J PHARMACOL, V133, P1255, DOI 10.1038/sj.bjp.0704197; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Cheng CF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/709159; Cohn L, 1999, J EXP MED, V190, P1309, DOI 10.1084/jem.190.9.1309; Crimi E, 1998, AM J RESP CRIT CARE, V157, P4, DOI 10.1164/ajrccm.157.1.9703002; Diochot S, 2007, TOXICON, V49, P271, DOI 10.1016/j.toxicon.2006.09.026; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Du JY, 2014, P NATL ACAD SCI USA, V111, P8961, DOI 10.1073/pnas.1407018111; Dusenkova S, 2014, AM J PHYSIOL-GASTR L, V307, pG922, DOI 10.1152/ajpgi.00129.2014; El-Hashim AZ, 2005, EUR J PHARMACOL, V513, P125, DOI 10.1016/j.ejphar.2005.02.007; Erle DJ, 2014, J CELL BIOL, V205, P621, DOI 10.1083/jcb.201401050; Escoubas P, 2003, PROTEIN SCI, V12, P1332, DOI 10.1110/ps.0307003; Faisy C, 2007, LIFE SCI, V81, P1094, DOI 10.1016/j.lfs.2007.08.026; FEATHERSTONE RL, 1988, EUR RESPIR J, V1, P839; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Gibson-Corley KN, 2013, VET PATHOL, V50, P1007, DOI 10.1177/0300985813485099; Gu QH, 2006, AM J PHYSIOL-LUNG C, V291, pL58, DOI 10.1152/ajplung.00517.2005; Gu QH, 2011, CURR OPIN PHARMACOL, V11, P238, DOI 10.1016/j.coph.2011.04.005; GUSTAFSSON PM, 1990, ARCH DIS CHILD, V65, P1255, DOI 10.1136/adc.65.11.1255; Hoka S, 1988, J Anesth, V2, P207, DOI 10.1007/s0054080020207; Hunt JF, 2000, AM J RESP CRIT CARE, V161, P694, DOI 10.1164/ajrccm.161.3.9911005; Jernigan NL, 2009, AM J PHYSIOL-LUNG C, V297, pL271, DOI 10.1152/ajplung.00020.2009; Jia YL, 2007, BBA-MOL BASIS DIS, V1772, P915, DOI 10.1016/j.bbadis.2007.01.013; Johnson JR, 2015, AM J PHYSIOL-LUNG C, V308, pL658, DOI 10.1152/ajplung.00286.2014; Kang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035225; Kearley J, 2007, J EXP MED, V204, P1289, DOI 10.1084/jem.20062093; Kodric M, 2007, AM J RESP CRIT CARE, V175, P905, DOI 10.1164/rccm.200607-940OC; Kollarik M, 2002, J PHYSIOL-LONDON, V543, P591, DOI 10.1113/jphysiol.2002.022848; Kollarik M, 2007, PULM PHARMACOL THER, V20, P402, DOI 10.1016/j.pupt.2006.11.010; Kostikas K, 2002, AM J RESP CRIT CARE, V165, P1364, DOI 10.1164/rccm.200111-068OC; Lee LY, 2013, PULM PHARMACOL THER, V26, P491, DOI 10.1016/j.pupt.2013.03.010; Lopes FDTQS, 2002, J APPL PHYSIOL, V93, P842, DOI 10.1152/japplphysiol.00013.2002; Lu YJ, 2009, NEURON, V64, P885, DOI 10.1016/j.neuron.2009.11.007; LUNDBERG JM, 1983, ACTA PHYSIOL SCAND, V119, P49, DOI 10.1111/j.1748-1716.1983.tb07304.x; MANZINI S, 1992, BRIT J PHARMACOL, V105, P968, DOI 10.1111/j.1476-5381.1992.tb09086.x; Mazzone Stuart B, 2005, Cough, V1, P2, DOI 10.1186/1745-9974-1-2; Meyerholz DK, 2010, AM J PATHOL, V176, P1377, DOI 10.2353/ajpath.2010.090849; Mhanna MJ, 1999, AM J PHYSIOL-LUNG C, V276, pL51, DOI 10.1152/ajplung.1999.276.1.L51; MURLAS CG, 1993, LUNG, V171, P109, DOI 10.1007/BF00542338; Nassenstein C, 2008, J PHYSIOL-LONDON, V586, P1595, DOI 10.1113/jphysiol.2007.148379; Nenan S, 2001, EUR J PHARMACOL, V421, P201, DOI 10.1016/S0014-2999(01)01036-6; Nitta CH, 2014, AM J PHYSIOL-HEART C, V306, pH41, DOI 10.1152/ajpheart.00269.2013; Padrid PA, 1998, AM J RESP CELL MOL, V18, P453, DOI 10.1165/ajrcmb.18.4.3055; Page AJ, 2004, GASTROENTEROLOGY, V127, P1739, DOI 10.1053/j.gastro.2004.08.061; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Ricciardolo FLM, 2001, AM J MED, V111, P18, DOI 10.1016/S0002-9343(01)00816-6; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Sanders PN, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006135; Schuiling M, 1999, CLIN EXP ALLERGY, V29, P48; Schuiling M, 1999, AM J RESP CRIT CARE, V159, P423, DOI 10.1164/ajrccm.159.2.9804125; SCHULTZ HD, 1987, CIRC RES, V60, P337, DOI 10.1161/01.RES.60.3.337; Shah VS, 2016, SCIENCE, V351, P503, DOI 10.1126/science.aad5589; Sluka KA, 2013, ARTHRITIS RHEUM-US, V65, P1194, DOI 10.1002/art.37862; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Thiesse J, 1985, J APPL PHYSIOL, V109, P1960, DOI 10.1152/japplphysiol.01322.2009; Tong J, 2011, J IMMUNOL, V186, P3686, DOI 10.4049/jimmunol.1001346; Tournoy KG, 2003, EUR RESPIR J, V21, P3, DOI 10.1183/09031936.03.00007803; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; Vysotskaya ZV, 2014, LUNG, V192, P927, DOI 10.1007/s00408-014-9634-1; Walder RY, 2010, J PAIN, V11, P210, DOI 10.1016/j.jpain.2009.07.004; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Wilder JA, 1999, AM J RESP CELL MOL, V20, P1326, DOI 10.1165/ajrcmb.20.6.3561; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Xiao Lan, 2012, J Allergy (Cairo), V2012, P423612, DOI 10.1155/2012/423612; Yasumitsu R, 1996, EUR J PHARMACOL, V300, P215, DOI 10.1016/0014-2999(95)00881-0; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	73	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166089	10.1371/journal.pone.0166089	http://dx.doi.org/10.1371/journal.pone.0166089			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820848	gold, Green Published, Green Submitted			2022-12-26	WOS:000387614800032
J	Haegele, S; Reiter, S; Wanek, D; Offensperger, F; Pereyra, D; Stremitzer, S; Fleischmann, E; Brostjan, C; Gruenberger, T; Starlinger, P				Haegele, Stefanie; Reiter, Silvia; Wanek, David; Offensperger, Florian; Pereyra, David; Stremitzer, Stefan; Fleischmann, Edith; Brostjan, Christine; Gruenberger, Thomas; Starlinger, Patrick			Perioperative Non-Invasive Indocyanine Green-Clearance Testing to Predict Postoperative Outcome after Liver Resection	PLOS ONE			English	Article							FOR-SIZE SYNDROME; TRANSIENT ELASTOGRAPHY; STIFFNESS MEASUREMENT; DISEASE; CLASSIFICATION; HEPATECTOMY; SURGERY; MODEL	Background Postoperative liver dysfunction may lead to morbidity and mortality after liver resection. Preoperative liver function assessment is critical to identify preexisting liver dysfunction in patients prior to resection. The aim of this study was to evaluate the predictive potential of perioperative indocyanine green (ICG)-clearance testing to prevent postoperative liver dysfunction and morbidity using standardized outcome parameters in a routine Western-clinical-setting. Study Design 137 patients undergoing partial hepatectomy between 2011 and 2013, at the general hospital of Vienna, were included. ICG-clearance was recorded one day prior to surgery as well as on the first and fifth postoperative day. Postoperative liver dysfunction was defined according to the International Study Group of Liver Surgery and evaluation of morbidity was based on the Dindo-Clavien classification. Statistical analyses were based on non-parametric tests. Results Preoperative reduced ICG-plasma disappearance rate (PDR) as well as increased ICG-retention rate at 15 min (R15) were able to significantly predict postoperative liver dysfunction (Area under the curve = PDR: 0.716, P = 0.018; R15: 0.719, P = 0.016). Furthermore, PDR <17%/min.or R15 >8%, were able to accurately predict postoperative complications prior to surgery. In addition to this, ICG-clearance on postoperative day 1 comparably predicted postoperative liver dysfunction (Area under the curve = PDR: 0.895; R15: 0.893; both P < 0.001), specifically, PDR < 10%/min or R15 > 20% on postoperative day 1 predicted poor postoperative outcome. Conclusion PDR and R15 may represent useful parameters to distinguish preoperative high and low risk patients in a Western collective as well as on postoperative day 1, to identify patients who require closer monitoring for potential complications.	[Haegele, Stefanie; Reiter, Silvia; Wanek, David; Offensperger, Florian; Pereyra, David; Stremitzer, Stefan; Brostjan, Christine; Starlinger, Patrick] Med Univ Vienna, Gen Hosp, Dept Surg, Vienna, Austria; [Fleischmann, Edith] Med Univ Vienna, Gen Hosp, Dept Anesthesiol, Vienna, Austria; [Gruenberger, Thomas] Rudolfstiftung Hosp, Dept Surg 1, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Rudolfstiftung Hospital	Starlinger, P (corresponding author), Med Univ Vienna, Gen Hosp, Dept Surg, Vienna, Austria.; Gruenberger, T (corresponding author), Rudolfstiftung Hosp, Dept Surg 1, Vienna, Austria.	tgruenberger@icloud.com; patrick.starlinger@meduniwien.ac.at	Gruenberger, Thomas/ABA-1661-2020	Gruenberger, Thomas/0000-0002-2671-0540; Pereyra, David/0000-0001-6700-9163; Brostjan, Christine/0000-0003-1462-5397				Akita H, 2008, WORLD J SURG, V32, P2668, DOI 10.1007/s00268-008-9752-0; Carino ND, 2009, EJSO-EUR J SURG ONC, V35, P957, DOI 10.1016/j.ejso.2009.02.003; CHERRICK GR, 1960, J CLIN INVEST, V39, P592, DOI 10.1172/JCI104072; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; Dahm F, 2005, AM J TRANSPLANT, V5, P2605, DOI 10.1111/j.1600-6143.2005.01081.x; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Fan ST, 2010, J HEPATO-BIL-PAN SCI, V17, P380, DOI 10.1007/s00534-009-0229-9; Fung J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072306; Gruttadauria S, 2010, WORLD J GASTROENTERO, V16, P5011, DOI 10.3748/wjg.v16.i40.5011; Jiao LR, 2000, BRIT J SURG, V87, P568, DOI 10.1046/j.1365-2168.2000.01399.x; Krieger PM, 2011, ANN SURG ONCOL, V18, P1644, DOI 10.1245/s10434-010-1494-1; Lisotti A, 2014, HEPATOLOGY, V59, P643, DOI 10.1002/hep.26700; MAKUUCHI M, 1993, SEMIN SURG ONCOL, V9, P298, DOI 10.1002/ssu.2980090404; Manizate F, 2010, J HEPATO-BIL-PAN SCI, V17, P385, DOI 10.1007/s00534-009-0228-x; Okochi O, 2002, J SURG RES, V103, P109, DOI 10.1006/jsre.2001.6328; Pang W., 2002, HPB, V4, P100; Pang YY, 2002, HPB, V4, P99, DOI [DOI 10.1080/136518202760378489, 10.1016/S1365-182X(17)30755-4, DOI 10.1016/S1365-182X(17)30755-4]; Quintero J, 2014, LIVER INT, V34, P689, DOI 10.1111/liv.12298; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; Sakka SG, 2007, CURR OPIN CRIT CARE, V13, P207, DOI 10.1097/MCC.0b013e328012b268; Starlinger P, 2014, HEPATOLOGY, V60, P257, DOI 10.1002/hep.26950; Stauber RE, 2009, LIVER INT, V29, P1516, DOI 10.1111/j.1478-3231.2009.02104.x; Stockmann M, 2009, ANN SURG, V250, P119, DOI 10.1097/SLA.0b013e3181ad85b5; Tucker ON, 2005, CURR OPIN CRIT CARE, V11, P150, DOI 10.1097/01.ccx.0000157080.11117.45; Wakiya T, 2014, ANN SURG ONCOL, V21, P167, DOI 10.1245/s10434-013-3203-3; Wong GLH, 2011, J GASTROEN HEPATOL, V26, P300, DOI 10.1111/j.1440-1746.2010.06510.x; Wong JSW, 2013, ANN SURG, V257, P922, DOI 10.1097/SLA.0b013e318269d2ec; Yokoyama Y, 2010, BRIT J SURG, V97, P1260, DOI 10.1002/bjs.7084; Zipprich A, 2010, GUT, V59, P963, DOI 10.1136/gut.2010.208595	29	29	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165481	10.1371/journal.pone.0165481	http://dx.doi.org/10.1371/journal.pone.0165481			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812143	gold, Green Published, Green Submitted			2022-12-26	WOS:000386910000031
J	Hussain, A; Yadav, MK; Bose, S; Wang, JH; Lim, D; Song, YK; Ko, SG; Kim, H				Hussain, Ahtesham; Yadav, Mukesh Kumar; Bose, Shambhunath; Wang, Jing-Hua; Lim, Dongwoo; Song, Yun-Kyung; Ko, Seong-Gyu; Kim, Hojun			Daesiho-Tang Is an Effective Herbal Formulation in Attenuation of Obesity in Mice through Alteration of Gene Expression and Modulation of Intestinal Microbiota	PLOS ONE			English	Article							DIET-INDUCED OBESITY; GUT-MICROBIOTA; INSULIN-RESISTANCE; ADIPOSE-TISSUE; FAT; POLYSACCHARIDES; CONTRIBUTES; NPC1L1	Background Obesity has become a major global health challenge due to its increasing prevalence, and the associated health risk. It is the main cause of various metabolic diseases including diabetes, hypertension, cardiovascular disease, stroke and certain forms of cancer. Methods and Results In the present study we evaluated the anti-obesity property of Daesiho-tang (DSHT), an herbal medicine, using high fat diet (HFD)-induced obese mice as a model. Our results showed that DSHT ameliorated body weight gain, decreased total body fat, regulated expression of leptin and adiponectin genes of adipose tissue and exerted an anti-diabetic effect by attenuating fasting glucose level and serum insulin level in HFD-fed animals. In addition, DSHT-treatment significantly reduced total cholesterol (TC), triglycerides (TG) and increased high density lipoprotein-cholesterol (HDL), glutamic pyruvic transaminase (GPT) and glutamic oxaloacetic transaminase (GOT) levels in serum and reduced deposition of fat droplets in liver. DSHT treatment resulted in significantly increased relative abundance of bacteria including Bacteroidetes, Bacteroidetes/ Firmicutes ratio, Akkermansia Bifidobacterium., Lactobacillus, and decreased the level of Firmicutes. Using RT2 profiler PCR array, 39 (46%) genes were found to be differentially expressed in HFD-fed mice compared to normal control. However, normal gene expressions were restored in 36 (92%) genes of HFD-fed mice, when co-exposed to DSHT. Conclusion/Major Findings The results of this study demonstrated that DSHT is an effective herbal formulation in attenuation of obesity in HFD-fed mice through alteration of gene expressions and modulation of intestinal microbiota.	[Hussain, Ahtesham; Wang, Jing-Hua; Kim, Hojun] Dongguk Univ, Dept Rehabil Med Korean Med, Goyang, South Korea; [Yadav, Mukesh Kumar] Korea Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea; [Yadav, Mukesh Kumar] Korea Univ, Inst Med Device Clin Trials, Coll Med, Seoul, South Korea; [Bose, Shambhunath] Appl Surface Technol Inc, Adv Inst Convergence Technol, 11th Floor,Bldg A, Suwon 16229, Gyeonggi Do, South Korea; [Wang, Jing-Hua] Anhui Univ Tradit Chinese Med, Key Lab Xinan Med, Minist Educ, Meishan Rd 103, Hefei, Anhui, Peoples R China; [Lim, Dongwoo] Dongguk Univ, Dept Pathol, Coll Korean Med, Goyang, South Korea; [Song, Yun-Kyung] Gachon Univ, Dept Korean Rehabil Med, Coll Korean Med, Inchon, South Korea; [Ko, Seong-Gyu] Kyung Hee Univ, Dept Prevent Med, Coll Korean Med, Seoul, South Korea	Dongguk University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Anhui University of Chinese Medicine; Dongguk University; Gachon University; Kyung Hee University	Kim, H (corresponding author), Dongguk Univ, Dept Rehabil Med Korean Med, Goyang, South Korea.	kimklar@dongguk.ac.kr	Yadav, Mukesh Kumar/M-9154-2015; Wang, Jing-hua/AAO-2350-2020; Lim, Dongwoo/GLU-0640-2022; Kim, Hojun/AAB-8405-2020	Yadav, Mukesh Kumar/0000-0002-4703-8554; Wang, Jing-hua/0000-0002-2034-7429; Bose, Shambunath/0000-0003-0737-5713; Lim, Dongwoo/0000-0002-3179-9439; Kim, Hojun/0000-0003-1038-0142	Traditional Korean Medicine R&D Project, Ministry for Health & Welfare & Family Affairs, Republic of Korea [HI13C0530]	Traditional Korean Medicine R&D Project, Ministry for Health & Welfare & Family Affairs, Republic of Korea	This study was supported by a grant from the Traditional Korean Medicine R&D Project, Ministry for Health & Welfare & Family Affairs, Republic of Korea (HI13C0530). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella V, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/343746; Aguirre M, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0472-4; [Anonymous], 1996, GUIDE CARE USE LAB A; Bajzer M, 2006, NATURE, V444, P1009, DOI 10.1038/4441009a; Betters JL, 2010, FEBS LETT, V584, P2740, DOI 10.1016/j.febslet.2010.03.030; Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2; Bray GA, 2000, NUTRITION, V16, P953, DOI 10.1016/S0899-9007(00)00424-X; Bullo M, 2005, OBES SURG, V15, P382, DOI 10.1381/0960892053576776; Butsch WS, 2015, CURR OPIN ENDOCRINOL, V22, P360, DOI 10.1097/MED.0000000000000192; Cani PD, 2013, BRIEF FUNCT GENOMICS, V12, P381, DOI 10.1093/bfgp/elt014; Cani PD, 2009, CURR OPIN PHARMACOL, V9, P737, DOI 10.1016/j.coph.2009.06.016; Cox AJ, 2015, LANCET DIABETES ENDO, V3, P207, DOI 10.1016/S2213-8587(14)70134-2; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; Diamant M, 2011, OBES REV, V12, P272, DOI 10.1111/j.1467-789X.2010.00797.x; DiBaise JK, 2012, AM J GASTROENTEROL S, V1, P22, DOI [10.1038/ajgsup.2012.5, DOI 10.1038/AJGSUP.2012.5]; Dwivedi S, 2014, ELECTRON J BIOTECHN, V17, P238, DOI 10.1016/j.ejbt.2014.07.004; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Everard A, 2013, BEST PRACT RES CL GA, V27, P73, DOI 10.1016/j.bpg.2013.03.007; Fu JY, 2015, CIRC RES, V117, P817, DOI 10.1161/CIRCRESAHA.115.306807; Fuentes-Zaragoza E, 2011, STARCH-STARKE, V63, P406, DOI 10.1002/star.201000099; Ganesh BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074963; Cano PG, 2013, OBESITY, V21, P2310, DOI 10.1002/oby.20330; Gerard P, 2016, CELL MOL LIFE SCI, V73, P147, DOI 10.1007/s00018-015-2061-5; Guerciolini R, 1997, INT J OBESITY, V21, pS12; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Han K, 2015, FOOD FUNCT, V6, P2684, DOI 10.1039/c5fo00232j; Jeffery E, 2015, NAT CELL BIOL, V17, P376, DOI 10.1038/ncb3122; Jeong EJ, 2016, BIOL PHARM BULL, V39, P409, DOI 10.1248/bpb.b15-00849; 여운홍, 2005, [Journal of Physiology & Pathology in Korean Medicine, 동의생리병리학회지], V19, P1573; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Karimi G, 2015, FOOD NUTR RES, V59, DOI 10.3402/fnr.v59.29273; Kim C.H., 2004, KOREAN J ORIENT MED, V12, P139; Kim JH, 2001, J KOREAN ORI MED, V22, P63; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Kzhyshkowska J, 2006, J CELL MOL MED, V10, P635, DOI 10.1111/j.1582-4934.2006.tb00425.x; Lecomte V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126931; Lee SJ, 2014, CLIN NUTR, V33, P973, DOI 10.1016/j.clnu.2013.12.006; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; LONNQVIST F, 1995, NAT MED, V1, P950, DOI 10.1038/nm0995-950; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Miserez AR, 2002, ATHEROSCLEROSIS, V164, P15, DOI 10.1016/S0021-9150(01)00762-6; Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017; Moreno-Indias I, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00190; Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Park S.D., 2001, KOREAN J ORIENT MED, V9, P289; Patterson E, 2016, POSTGRAD MED J, V92, P286, DOI 10.1136/postgradmedj-2015-133285; Pichiah PBT, 2012, NUTR RES, V32, P856, DOI 10.1016/j.nutres.2012.09.015; Rha YG, 1991, J ORINT MED PATHOL, V6, P1; Sahin M, 2007, CLIN ENDOCRINOL, V67, P346, DOI 10.1111/j.1365-2265.2007.02888.x; Sanz Y, 2013, PHARMACOL RES, V69, P144, DOI 10.1016/j.phrs.2012.10.021; Shen J, 2013, MOL ASPECTS MED, V34, P39, DOI 10.1016/j.mam.2012.11.001; Su ML, 2016, MOLECULES, V21, DOI 10.3390/molecules21080976; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Tsai Franklin, 2009, Curr Gastroenterol Rep, V11, P307, DOI 10.1007/s11894-009-0045-z; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Van den Ende W, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00247; Wang J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087451, 10.1371/journal.pone.0107012]; Wang JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep08391; World Health Organization,, 2015, OB OV; Yang L, 2015, JAMA INTERN MED, V175, P1412, DOI 10.1001/jamainternmed.2015.2405; Yoo HD, 2012, BIOMOL THER, V20, P371, DOI 10.4062/biomolther.2012.20.4.371; Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011; Zhang ZJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-62; Zhou SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep22474	75	41	45	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165483	10.1371/journal.pone.0165483	http://dx.doi.org/10.1371/journal.pone.0165483			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812119	Green Published, Green Submitted, gold			2022-12-26	WOS:000386910000032
J	Marathe, NP; Shetty, SA; Shouche, YS; Larsson, DGJ				Marathe, Nachiket P.; Shetty, Sudarshan A.; Shouche, Yogesh S.; Larsson, D. G. Joakim			Limited Bacterial Diversity within a Treatment Plant Receiving Antibiotic-Containing Waste from Bulk Drug Production	PLOS ONE			English	Article							WATER TREATMENT-PLANT; MICROBIAL DIVERSITY; GENERATION; DEGRADATION; COMMUNITIES	Biological treatment of waste water from bulk drug production, contaminated with high levels of fluoroquinolone antibiotics, can lead to massive enrichment of antibiotic resistant bacteria, resistance genes and associated mobile elements, as previously shown. Such strong selection may be boosted by the use of activated sludge (AS) technology, where microbes that are able to thrive on the chemicals within the wastewater are reintroduced at an earlier stage of the process to further enhance degradation of incoming chemicals. The microbial community structure within such a treatment plant is, however, largely unclear. In this study, Illumina-based 16S rRNA amplicon sequencing was applied to investigate the bacterial communities of different stages from an Indian treatment plant operated by Patancheru Environment Technology Limited (PETL) in Hyderabad, India. The plant receives waste water with high levels of fluoroquinolones and applies AS technology. A total of 1,019,400 sequences from samples of different stages of the treatment process were analyzed. In total 202, 303, 732, 652, 947 and 864 operational taxonomic units (OTUs) were obtained at 3% distance cutoff in the equilibrator, aeration tanks 1 and 2, settling tank, secondary sludge and old sludge samples from PETL, respectively. Proteobacteria was the most dominant phyla in all samples with Gammaproteobacteria and Betaproteobacteria being the dominant classes. Alcaligenaceae and Pseudomonadaceae, bacterial families from PETL previously reported to be highly multidrug resistant, were the dominant families in aeration tank samples. Despite regular addition of human sewage (approximately 20%) to uphold microbial activity, the bacterial diversity within aeration tanks from PETL was considerably lower than corresponding samples from seven, regular municipal waste water treatment plants. The strong selection pressure from antibiotics present may be one important factor in structuring the microbial community in PETL, which may affect not only resistance promotion but also general efficiency of the waste treatment process.	[Marathe, Nachiket P.; Larsson, D. G. Joakim] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden; [Marathe, Nachiket P.; Larsson, D. G. Joakim] Univ Gothenburg, Ctr Antibiot Resistance Res CARe, Gothenburg, Sweden; [Shetty, Sudarshan A.] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands; [Shouche, Yogesh S.] Natl Ctr Cell Sci, MCC, Pune, Maharashtra, India	University of Gothenburg; University of Gothenburg; Wageningen University & Research; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Larsson, DGJ (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden.; Larsson, DGJ (corresponding author), Univ Gothenburg, Ctr Antibiot Resistance Res CARe, Gothenburg, Sweden.	joakim.larsson@fysiologi.gu.se	Shetty, Sudarshan A/N-6785-2014; Larsson, D.G. Joakim/E-5243-2011; Marathe, Nachiket/AAJ-3565-2021	Shetty, Sudarshan A/0000-0001-7280-9915; Larsson, D.G. Joakim/0000-0002-5496-0328; Marathe, Nachiket/0000-0003-2955-3402	Department of Biotechnology (DBT, Government of India); University for Potential Excellence (UPE-II); DBT India under MCC project [BT/PR10054/NDB/52/94/2007]; Swedish Research Council VR; Swedish Research Council FORMAS	Department of Biotechnology (DBT, Government of India)(Department of Biotechnology (DBT) India); University for Potential Excellence (UPE-II); DBT India under MCC project; Swedish Research Council VR(Swedish Research Council); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	The work was funded by the Department of Biotechnology (DBT, Government of India) and University for Potential Excellence (UPE-II) phase program and DBT India under the MCC project grant no. BT/PR10054/NDB/52/94/2007; as well as Swedish Research Councils VR and FORMAS.	Arora PK, 2016, J CHEM-NY, V2016, DOI 10.1155/2016/7589068; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bengtsson-Palme J, 2014, FRONT MICROBIOL, V5; Bintrim SB, 1997, P NATL ACAD SCI USA, V94, P277, DOI 10.1073/pnas.94.1.277; Borneman J, 1996, APPL ENVIRON MICROB, V62, P1935, DOI 10.1128/AEM.62.6.1935-1943.1996; Bramucci M, 2003, APPL MICROBIOL BIOT, V62, P594, DOI 10.1007/s00253-003-1372-x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Central Pollution Control Board India, REP TITL FIN ACT PLA; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; Deng YQ, 2012, ENVIRON SCI TECHNOL, V46, P795, DOI 10.1021/es2025998; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Fick J, 2009, ENVIRON TOXICOL CHEM, V28, P2522, DOI 10.1897/09-073.1; Gothwal R, 2016, J HAZARDOUS TOXIC RA; Hernandez-Raquet G, 2013, ENV MICROBIOL REP, V5, P588, DOI 10.1111/1758-2229.12053; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Jain RK, 2005, CURR SCI INDIA, V89, P101; Jang JH, 2006, J BIOSCI BIOENG, V102, P53, DOI 10.1263/jbb.102.53; Johnning A, 2013, APPL ENVIRON MICROB, V79, P7256, DOI 10.1128/AEM.02141-13; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Larsson DGJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0571; Larsson DGJ, 2010, J HAZARD MATER, V148, P751; Li D, 2010, APPL ENVIRON MICROB, V76, P3444, DOI 10.1128/AEM.02964-09; Li D, 2009, ENVIRON MICROBIOL, V11, P1506, DOI 10.1111/j.1462-2920.2009.01878.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marathe N, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-222; Marathe NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077310; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Mizrahi-Man O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053608; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Neumann G, 2004, APPL ENVIRON MICROB, V70, P1907, DOI 10.1128/AEM.70.4.1907-1912.2004; Sanapareddy N, 2009, APPL ENVIRON MICROB, V75, P1688, DOI 10.1128/AEM.01210-08; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SEILER H, 1982, EUR J APPL MICROBIOL, V14, P97, DOI 10.1007/BF00498010; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Vasileiadis S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042671; Wagner M, 2002, CURR OPIN BIOTECH, V13, P218, DOI 10.1016/S0958-1669(02)00315-4; Wang XH, 2012, APPL ENVIRON MICROB, V78, P7042, DOI 10.1128/AEM.01617-12; Ye L, 2013, APPL MICROBIOL BIOT, V97, P2681, DOI 10.1007/s00253-012-4082-4; Yu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038183; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188	42	6	8	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165914	10.1371/journal.pone.0165914	http://dx.doi.org/10.1371/journal.pone.0165914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812209	Green Published, Green Submitted, gold			2022-12-26	WOS:000386910000080
J	Vallabhaneni, KC; Hassler, MY; Abraham, A; Whitt, J; Mo, YY; Atfi, A; Pochampally, R				Vallabhaneni, Krishna C.; Hassler, Meeves-Yoni; Abraham, Anu; Whitt, Jason; Mo, Yin-Yuan; Atfi, Azeddine; Pochampally, Radhika			Mesenchymal Stem/Stromal Cells under Stress Increase Osteosarcoma Migration and Apoptosis Resistance via Extracellular Vesicle Mediated Communication	PLOS ONE			English	Article							STEM-CELLS; TUMOR STROMA; PULMONARY METASTASIS; MCT1 EXPRESSION; DOWN-REGULATION; BONE-MARROW; CANCER; GROWTH; PROLIFERATION; MICRORNA	Studies have shown that mesenchymal stem/stromal cells (MSCs) from bone marrow are involved in the growth and metastasis of solid tumors but the mechanism remains unclear in osteosarcoma (OS). Previous studies have raised the possibility that OS cells may receive support from associated MSCs in the nutrient deprived core of the tumors through the release of supportive macromolecules and growth factors either in vesicular or non-vesicular forms. In the present study, we used stressed mesenchymal stem cells (SD-MSCs), control MSCs and OS cells to examine the hypothesis that tumor-associated MSCs in nutrient deprived core provide pro-proliferative, anti-apoptotic, and metastatic support to nearby tumor cells. Assays to study of the effects of SD-MSC conditioned media revealed that OS cells maintained proliferation when compared to OS cells grown under serum-starved conditions alone. Furthermore, OS cells in MSCs and SD-MSC conditioned media were significantly resistant to apoptosis and an increased wound healing rate was observed in cells exposed to either conditioned media or EVs from MSCs and SD-MSCs. RT-PCR assays of OS cells incubated with extracellular vesicles (EVs) from SD-MSCs revealed microRNAs that could potentially target metabolism and metastasis associated genes as predicted by in silico algorithms, including monocarboxylate transporters, bone morphogenic receptor type 2, fibroblast growth factor 7, matrix metalloproteinase-1, and focal adhesion kinase-1. Changes in the expression levels of focal adhesion kinase, STK11 were confirmed by quantitative PCR assays. Together, these data indicate a tumor supportive role of MSCs in osteosarcoma growth that is strongly associated with the miRNA content of the EVs released from MSCs under conditions that mimic the nutrient deprived core of solid tumors.	[Vallabhaneni, Krishna C.; Hassler, Meeves-Yoni; Abraham, Anu; Whitt, Jason; Mo, Yin-Yuan; Atfi, Azeddine; Pochampally, Radhika] Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA; [Vallabhaneni, Krishna C.] Univ Mississippi, Med Ctr, Dept Radiat Oncol, Jackson, MS 39216 USA; [Mo, Yin-Yuan] Univ Mississippi, Med Ctr, Dept Pharmacol Toxicol, Jackson, MS 39216 USA; [Atfi, Azeddine; Pochampally, Radhika] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Pochampally, R (corresponding author), Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA.; Pochampally, R (corresponding author), Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA.	rpochampally@umc.edu	Mo, Yin-Yuan/R-8255-2019		National Cancer Institute [CA151851]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR059070]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Cancer Institute CA151851 and National Institute of Arthritis and Musculoskeletal and Skin Diseases R01AR059070.	Alexandrova AY, 2006, EXP CELL RES, V312, P2066, DOI 10.1016/j.yexcr.2006.03.004; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Beckermann BM, 2008, BRIT J CANCER, V99, P622, DOI 10.1038/sj.bjc.6604508; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Boidot R, 2012, CANCER RES, V72, P939, DOI 10.1158/0008-5472.CAN-11-2474; Boisen MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109430; Bonuccelli G, 2014, ONCOTARGET, V5, P7575, DOI 10.18632/oncotarget.2243; Cai HK, 2015, J SURG RES, V194, P505, DOI 10.1016/j.jss.2014.11.025; De Saedeleer CJ, 2014, ONCOGENE, V33, P4060, DOI 10.1038/onc.2013.454; Ell Brian, 2014, Bonekey Rep, V3, P549, DOI 10.1038/bonekey.2014.44; Geng S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091566; Gong C, 2014, CANCER RES, V74, P4341, DOI 10.1158/0008-5472.CAN-14-0125; Husmann K, 2013, BBA-MOL BASIS DIS, V1832, P347, DOI 10.1016/j.bbadis.2012.11.006; Ji F, 2013, BONE, V56, P220, DOI 10.1016/j.bone.2013.05.020; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Ma WL, 2014, TUMOR BIOL, V35, P12467, DOI 10.1007/s13277-014-2565-x; Mizuno Y, 2009, FEBS LETT, V583, P2263, DOI 10.1016/j.febslet.2009.06.006; Naito Y, 2014, ONCOL REP, V32, P1720, DOI 10.3892/or.2014.3333; Oskowitz AZ, 2008, P NATL ACAD SCI USA, V105, P18372, DOI 10.1073/pnas.0809807105; Pavlides S, 2010, CELL CYCLE, V9, P3485, DOI 10.4161/cc.9.17.12721; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pochampally RR, 2004, BLOOD, V103, P1647, DOI 10.1182/blood-2003-06-1967; Qiao L, 2008, CELL RES, V18, P500, DOI 10.1038/cr.2008.40; Ramasamy R, 2007, LEUKEMIA, V21, P304, DOI 10.1038/sj.leu.2404489; Ren K, 2015, ONCOTARGET, DOI 10.18632/oncotarget.5044; Rubio R, 2014, STEM CELLS, V32, P1136, DOI 10.1002/stem.1647; Satoh H, 2010, CARCINOGENESIS, V31, P1833, DOI 10.1093/carcin/bgq105; Shinagawa K, 2010, INT J CANCER, V127, P2323, DOI 10.1002/ijc.25440; Sung L, 2004, EUR J CANCER, V40, P1878, DOI 10.1016/j.ejca.2004.04.005; Suomi S, 2008, GENE REGUL SYST BIO, V2, P177; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Tu B, 2014, EXP CELL RES, V320, P164, DOI 10.1016/j.yexcr.2013.10.013; Tu B, 2012, CANCER LETT, V325, P80, DOI 10.1016/j.canlet.2012.06.006; Tu YT, 2015, CELL REP, V10, P854, DOI 10.1016/j.celrep.2015.01.033; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vallabhaneni KC, 2015, ONCOTARGET, V6, P4953, DOI 10.18632/oncotarget.3211; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; Xu HD, 2014, CELL PHYSIOL BIOCHEM, V33, P1547, DOI 10.1159/000358718; Xu WT, 2009, CANCER LETT, V281, P32, DOI 10.1016/j.canlet.2009.02.022; YAN GC, 1993, MOL CELL BIOL, V13, P4513, DOI 10.1128/MCB.13.8.4513; Yoo KH, 2009, CELL IMMUNOL, V259, P150, DOI 10.1016/j.cellimm.2009.06.010; Yui Y, 2010, CLIN EXP METASTAS, V27, P619, DOI 10.1007/s10585-010-9352-x; Zhao ZQ, 2014, CANCER LETT, V342, P150, DOI 10.1016/j.canlet.2013.08.042; Zhu Y, 2009, LEUKEMIA, V23, P925, DOI 10.1038/leu.2008.384	48	51	52	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166027	10.1371/journal.pone.0166027	http://dx.doi.org/10.1371/journal.pone.0166027			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812189	Green Submitted, Green Published, gold			2022-12-26	WOS:000386910000097
J	Zheng, WB; Zhang, XX; Ma, JG; Li, FC; Zhao, Q; Huang, SY; Zhu, XQ				Zheng, Wen-Bin; Zhang, Xiao-Xuan; Ma, Jian-Gang; Li, Fa-Cai; Zhao, Quan; Huang, Si-Yang; Zhu, Xing-Quan			Molecular Detection and Genetic Characterization of Toxoplasma gondii in Farmed Minks (Neovison vison) in Northern China by PCR-RFLP	PLOS ONE			English	Article							RISK-FACTORS; GENOTYPIC CHARACTERIZATION; NORTHEASTERN CHINA; STRAY CATS; INFECTION; PREVALENCE; PROVINCE; SEROPREVALENCE; IDENTIFICATION; DIVERSITY	Toxoplasma gondii is a worldwide prevalent parasite, affecting a wide range of mammals and human beings. Little information is available about the distribution of genetic diversity of T. gondii infection in minks (Neovison vison). This study was conducted to estimate the prevalence and genetic characterization of T. gondii isolates from minks in China. A total of 418 minks brain tissue samples were collected from Jilin and Hebei provinces, northern China. Genomic DNA were extracted and assayed for T. gondii infection by semi-nested PCR of B1 gene. The positive DNA samples were typed at 10 genetic markers (SAG1, SAG2 (5'+3' SAG2, alter. SAG2), SAG3, BTUB, GRA6, c22-8, c29-2, L358, PK1, and Apico) using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technology. 36 (8.6%) of 418 DNA samples were overall positive for T. gondii. Among them, 5 samples were genotyped at all loci, and 1 sample was genotyped for 9 loci. In total, five samples belong to ToxoDB PCR-RFLP genotype#9, one belong to ToxoDB genotye#3. To our knowledge, this is the first report of genetic characterization of T. gondii in minks in China. Meanwhile, these results revealed a distribution of T. gondii infection in minks in China. These data provided base-line information for controlling T. gondii infection in minks.	[Zheng, Wen-Bin; Zhang, Xiao-Xuan; Ma, Jian-Gang; Li, Fa-Cai; Huang, Si-Yang; Zhu, Xing-Quan] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China; [Zheng, Wen-Bin; Zhang, Xiao-Xuan; Ma, Jian-Gang; Zhao, Quan; Zhu, Xing-Quan] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin Province, Peoples R China; [Huang, Si-Yang; Zhu, Xing-Quan] Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Jilin Agricultural University; Yangzhou University	Huang, SY (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.; Huang, SY (corresponding author), Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.	siyang.huang@hotmail.com		Zheng, Wen-Bin/0000-0001-7621-4628	National Natural Science Foundation of China [31230073]; Natural Science Foundation of Gansu Province for Distinguished Young Scholars [1506RJDA133]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Gansu Province for Distinguished Young Scholars	Project support was provided by the National Natural Science Foundation of China (Grant No. 31230073), and Natural Science Foundation of Gansu Province for Distinguished Young Scholars (Grant No. 1506RJDA133).	Ahlers AA, 2015, J WILDLIFE DIS, V51, P488, DOI 10.7589/2014-03-071; Burrells A, 2013, PARASITOLOGY, V140, P1768, DOI 10.1017/S0031182013001169; Chen YM, 1988, CHINESE JOURNAL OF V, V5, P38; Cheng WS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2106-z; Commodaro AG, 2016, EMERG INFECT DIS, V22, P691, DOI 10.3201/eid2204.141819; Cong W, 2016, INFECT GENET EVOL, V39, P9, DOI 10.1016/j.meegid.2016.01.005; Cong W, 2015, CANCER LETT, V359, P307, DOI 10.1016/j.canlet.2015.01.036; Cong W, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-152; Cong W, 2013, KOREAN J PARASITOL, V51, P363, DOI 10.3347/kjp.2013.51.3.363; da Silva MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141700; Dubey JP, 2007, VET PARASITOL, V145, P352, DOI 10.1016/j.vetpar.2006.12.016; Dubey JP., 2022, TOXOPLASMOSIS ANIMAL, V3rd, P1; Findal G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145519; Furtado JM, 2011, J GLOB INFECT DIS, V3, P281, DOI 10.4103/0974-777X.83536; Hill DE, 2006, VET PARASITOL, V141, P9, DOI 10.1016/j.vetpar.2006.05.008; Jiang HH, 2014, VET PARASITOL, V203, P318, DOI 10.1016/j.vetpar.2014.04.016; Jiang HH, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-227; Jung BK, 2015, KOREAN J PARASITOL, V53, P259, DOI 10.3347/kjp.2015.53.3.259; Kannan G, 2010, FOLIA PARASIT, V57, P151, DOI 10.14411/fp.2010.019; Li XR, 2010, J VET DIAGN INVEST, V22, P442, DOI 10.1177/104063871002200318; Qian WF, 2012, VET PARASITOL, V187, P408, DOI 10.1016/j.vetpar.2012.01.026; Qin SY, 2015, VET PARASITOL, V211, P300, DOI 10.1016/j.vetpar.2015.05.015; Qin SY, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0558-7; Rajendran C, 2012, INFECT GENET EVOL, V12, P359, DOI 10.1016/j.meegid.2011.12.010; Rong G, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0459-9; Sepulveda MA, 2011, VET PARASITOL, V175, P60, DOI 10.1016/j.vetpar.2010.09.020; Shwab EK, 2014, PARASITOLOGY, V141, P453, DOI 10.1017/S0031182013001844; Smielewska-Los E, 2004, VET PARASITOL, V122, P201, DOI 10.1016/j.vetpar.2004.02.003; SMITH DD, 1995, J WILDLIFE DIS, V31, P15, DOI 10.7589/0090-3558-31.1.15; Su C, 2006, INT J PARASITOL, V36, P841, DOI 10.1016/j.ijpara.2006.03.003; Su C, 2010, PARASITOLOGY, V137, P1, DOI 10.1017/S0031182009991065; Tian YM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-178; Zhang FK, 2015, PARASITOL INT, V64, P576, DOI 10.1016/j.parint.2015.08.008; Zhang XX, 2014, J PARASITOL, V100, P692, DOI 10.1645/13-381.1; Zhou P, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-165; Zhou P, 2009, PARASITOL INT, V58, P193, DOI 10.1016/j.parint.2009.01.006	36	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165308	10.1371/journal.pone.0165308	http://dx.doi.org/10.1371/journal.pone.0165308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806069	Green Submitted, Green Published, gold			2022-12-26	WOS:000386715500026
J	Tacharoenmuang, R; Komoto, S; Guntapong, R; Ide, T; Sinchai, P; Upachai, S; Yoshikawa, T; Tharmaphornpilas, P; Sangkitporn, S; Taniguchi, K				Tacharoenmuang, Ratana; Komoto, Satoshi; Guntapong, Ratigorn; Ide, Tomihiko; Sinchai, Phakapun; Upachai, Sompong; Yoshikawa, Tetsushi; Tharmaphornpilas, Piyanit; Sangkitporn, Somchai; Taniguchi, Koki			Full Genome Characterization of Novel DS-1-Like G8P[8] Rotavirus Strains that Have Emerged in Thailand: Reassortment of Bovine and Human Rotavirus Gene Segments in Emerging DS-1-Like Intergenogroup Reassortant Strains	PLOS ONE			English	Article							GROUP-A ROTAVIRUS; PROVIDES EVIDENCE; EQUINE-LIKE; PORCINE; GASTROENTERITIS; IDENTIFICATION; CONSTELLATION; PREDOMINANCE; PREVALENCE; DIVERSITY	The emergence and rapid spread of unusual DS-1-like intergenogroup reassortant rotavirus strains have been recently reported in Asia, Australia, and Europe. During rotavirus surveillance in Thailand in 2013 - 2014, novel DS-1-like intergenogroup reassortant strains having G8P[8] genotypes (i.e., strains KKL-17, PCB-79, PCB-84, PCB-85, PCB-103, SKT-107, SWL-12, NP-130, PCB-656, SKT-457, SSKT-269, and SSL-55) were identified in stool samples from hospitalized children with severe diarrhea. In this study, we determined and characterized the complete genomes of these 12 strains (seven strains, KKL-17, PCB-79, PCB-84, PCB-85, PCB-103, SKT-107, and SWL-12, found in 2013 (2013 strains), and five, NP-130, PCB-656, SKT-457, SSKT-269, and SSL-55, in 2014 (2014 strains)). On full genomic analysis, all 12 strains showed a unique genotype constellation comprising a mixture of genogroup 1 and 2 genes: G8-P[8]-I2-R2-C2-M2-A2-N2-T2-E2-H2. With the exception of the G genotype, the unique genotype constellation of the 12 strains (P[8]-I2-R2-C2M2- A2-N2-T2-E2-H2) was found to be shared with DS-1-like intergenogroup reassortant strains. On phylogenetic analysis, six of the 11 genes of the 2013 strains (VP4, VP2, VP3, NSP1, NSP3, and NSP5) appeared to have originated from DS-1-like intergenogroup reassortant strains, while the remaining four (VP7, VP6, VP1, and NSP2) and one (NSP4) gene appeared to be of bovine and human origin, respectively. Thus, the 2013 strains appeared to be reassortant strains as to DS-1-like intergenogroup reassortant, bovine, bovine-like human, and/or human rotaviruses. On the other hand, five of the 11 genes of the 2014 strains (VP4, VP2, VP3, NSP1, and NSP3) appeared to have originated from DS-1-like intergenogroup reassortant strains, while three (VP7, VP1, and NSP2) and one (NSP4) were assumed to be of bovine and human origin, respectively. Notably, the remaining two genes, VP6 and NSP5, of the 2014 strains appeared to have originated from locally circulating DS-1-like G2P[4] human rotaviruses. Thus, the 2014 strains were assumed to be multiple reassortment strains as to DS-1-like intergenogroup reassortant, bovine, bovine-like human, human, and/or locally circulating DS-1-like G2P[4] human rotaviruses. Overall, the great genomic diversity among the DS-1-like intergenogroup reassortant strains seemed to have been generated through additional reassortment events involving animal and human strains. Moreover, all the 11 genes of three of the 2014 strains, NP-130, PCB-656, and SSL-55, were very closely related to those of Vietnamese DS-1-like G8P[8] strains that emerged in 2014-2015, indicating the derivation of these DS-1-like G8P[8] strains from a common ancestor. To our knowledge, this is the first report on full genome-based characterization of DS-1-like G8P[8] strains that have emerged in Thailand. Our observations will add to our growing understanding of the evolutionary patterns of emerging DS-1-like intergenogroup reassortant strains.	[Tacharoenmuang, Ratana; Guntapong, Ratigorn; Sinchai, Phakapun; Upachai, Sompong; Sangkitporn, Somchai] Natl Inst Hlth, Dept Med Sci, Nonthaburi, Thailand; [Komoto, Satoshi; Ide, Tomihiko; Taniguchi, Koki] Fujita Hlth Univ, Dept Virol & Parasitol, Sch Med, Toyoake, Aichi, Japan; [Yoshikawa, Tetsushi] Fujita Hlth Univ, Dept Pediat, Sch Med, Toyoake, Aichi, Japan; [Tharmaphornpilas, Piyanit] Minist Publ Hlth, Dept Dis Control, Nonthaburi, Thailand	Ministry of Public Health - Thailand; Fujita Health University; Fujita Health University; Ministry of Public Health - Thailand	Komoto, S (corresponding author), Fujita Hlth Univ, Dept Virol & Parasitol, Sch Med, Toyoake, Aichi, Japan.	satoshik@fujita-hu.ac.jp			Research Program on Emerging and Re-emerging Infectious Diseases of the Japan Agency for Medical Research and Development, AMED; Original Rotavirus Vaccine Effectiveness Study Program of the Ministry of Public Health of Thailand	Research Program on Emerging and Re-emerging Infectious Diseases of the Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Original Rotavirus Vaccine Effectiveness Study Program of the Ministry of Public Health of Thailand	This study was supported in part by the Research Program on Emerging and Re-emerging Infectious Diseases of the Japan Agency for Medical Research and Development, AMED (KT), and the Original Rotavirus Vaccine Effectiveness Study Program of the Ministry of Public Health of Thailand (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbemabiese CA, 2015, INFECT GENET EVOL, V35, P184, DOI 10.1016/j.meegid.2015.07.033; Arana A, 2016, INFECT GENET EVOL, V44, P137, DOI 10.1016/j.meegid.2016.06.048; Chieochansin T, 2016, INFECT GENET EVOL, V37, P129, DOI 10.1016/j.meegid.2015.11.011; Cowley D, 2016, J GEN VIROL, V97, P403, DOI 10.1099/jgv.0.000352; Delogu R, 2013, J CLIN MICROBIOL, V51, P1583, DOI 10.1128/JCM.00396-13; Dennis FE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100699; Doro R, 2016, ACTA MICROBIOL IMM H, V63, P243, DOI 10.1556/030.63.2016.2.8; El Sherif M, 2011, INFECT GENET EVOL, V11, P1436, DOI 10.1016/j.meegid.2011.05.012; Estes M.K., 2013, FIELDS VIROLOGY, V6th, P1347; Fujii Y, 2014, INFECT GENET EVOL, V28, P426, DOI 10.1016/j.meegid.2014.08.001; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; Ghosh S, 2007, ARCH VIROL, V152, P423, DOI 10.1007/s00705-006-0848-2; Ghosh S, 2015, VET MICROBIOL, V180, P286, DOI 10.1016/j.vetmic.2015.09.017; Ghosh S, 2011, FUTURE MICROBIOL, V6, P1049, DOI [10.2217/FMB.11.90, 10.2217/fmb.11.90]; Guntapong R, 2016, J MED VIROL IN PRESS; Heiman EM, 2008, J VIROL, V82, P11106, DOI 10.1128/JVI.01402-08; Hoa-Tran TN, 2016, ARCH VIROL, V161, P479, DOI 10.1007/s00705-015-2682-x; Ide T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124965; Kahn G, 2012, INDIAN PEDIATR, V49, P467, DOI 10.1007/s13312-012-0076-7; Komoto S, 2016, INFECT GENET EVOL, V43, P424, DOI 10.1016/j.meegid.2016.06.023; Komoto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148416; Komoto S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141739; Komoto S, 2014, VET MICROBIOL, V174, P577, DOI 10.1016/j.vetmic.2014.09.033; Komoto S, 2014, INFECT GENET EVOL, V27, P277, DOI 10.1016/j.meegid.2014.08.002; Kuzuya M, 2014, J MED VIROL, V86, P1056, DOI 10.1002/jmv.23746; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2006, J CLIN MICROBIOL, V44, P1801, DOI 10.1128/JCM.44.5.1801-1809.2006; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137; McDonald SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000634; Papp H, 2013, VET MICROBIOL, V165, P190, DOI 10.1016/j.vetmic.2013.03.020; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Solberg OD, 2009, VIROLOGY, V385, P58, DOI 10.1016/j.virol.2008.11.026; Tacharoenmuang R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139381; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; Yamamoto SP, 2014, EMERG INFECT DIS, V20, P1030, DOI 10.3201/eid2006.131326	40	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165826	10.1371/journal.pone.0165826	http://dx.doi.org/10.1371/journal.pone.0165826			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802339	gold, Green Submitted, Green Published			2022-12-26	WOS:000386714200059
J	Nickerson, ML; Das, S; Im, KM; Turan, S; Berndt, SI; Li, H; Lou, H; Brodie, SA; Billaud, JN; Zhang, T; Bouk, AJ; Butcher, D; Wang, Z; Sun, L; Misner, K; Tan, W; Esnakula, A; Esposito, D; Huang, WY; Hoover, RN; Tucker, MA; Keller, JR; Boland, J; Brown, K; Anderson, SK; Moore, LE; Isaacs, WB; Chanock, SJ; Yeager, M; Dean, M; Andresson, T				Nickerson, M. L.; Das, S.; Im, K. M.; Turan, S.; Berndt, S. I.; Li, H.; Lou, H.; Brodie, S. A.; Billaud, J. N.; Zhang, T.; Bouk, A. J.; Butcher, D.; Wang, Z.; Sun, L.; Misner, K.; Tan, W.; Esnakula, A.; Esposito, D.; Huang, W. Y.; Hoover, R. N.; Tucker, M. A.; Keller, J. R.; Boland, J.; Brown, K.; Anderson, S. K.; Moore, L. E.; Isaacs, W. B.; Chanock, S. J.; Yeager, M.; Dean, M.; Andresson, T.			TET2 binds the androgen receptor and loss is associated with prostate cancer	ONCOGENE			English	Article							GENE; MUTATIONS; LANDSCAPE; HYDROXYMETHYLATION; IDENTIFICATION; HOMEODOMAIN; PREDICTION; INSIGHT; GENOME	Genetic alterations associated with prostate cancer (PCa) may be identified by sequencing metastatic tumour genomes to identify molecular markers at this lethal stage of disease. Previously, we characterized somatic alterations in metastatic tumours in the methylcytosine dioxygenase ten-eleven translocation 2 (TET2), which is altered in 5-15% of myeloid, kidney, colon and PCas. Genome-wide association studies previously identified non-coding risk variants associated with PCa and melanoma. We perform fine-mapping of PCa risk across TET2 using genotypes from the PEGASUS case-control cohort and identify six new risk variants in introns 1 and 2. Oligonucleotides containing two risk variants are bound by the transcription factor octamer-binding protein 1 (Oct1/POU2F1) and TET2 and Oct1 expression are positively correlated in prostate tumours. TET2 is expressed in normal prostate tissue and reduced in a subset of tumours from the Cancer Genome Atlas (TCGA). Small interfering RNA-mediated TET2 knockdown (KD) increases LNCaP cell proliferation, migration and wound healing, verifying loss drives a cancer phenotype. Endogenous TET2 bound the androgen receptor (AR) and AR-coactivator proteins in LNCaP cell extracts, and TET2 KD increases prostate-specific antigen (KLK3/PSA) expression. Published data reveal TET2 binding sites and hydroxymethylcytosine proximal to KLK3. A gene co-expression network identified using TCGA prostate tumour RNA-sequencing identifies co-regulated cancer genes associated with 2-oxoglutarate (2-OG) and succinate metabolism, including TET2, lysine demethylase (KDM) KDM6A, BRCA1-associated BAP1, and citric acid cycle enzymes IDH1/2, SDHA/B, and FH. The co-expression signature is conserved across 31 TCGA cancers suggesting a putative role for TET2 as an energy sensor (of 2-OG) that modifies aspects of androgen-AR signalling. Decreased TET2 mRNA expression in TCGA PCa tumours is strongly associated with reduced patient survival, indicating reduced expression in tumours may be an informative biomarker of disease progression and perhaps metastatic disease.	[Nickerson, M. L.; Turan, S.; Li, H.; Lou, H.; Misner, K.; Tan, W.; Anderson, S. K.; Dean, M.] NCI, Canc & Inflammat Program, NIH, Frederick, MD 21701 USA; [Das, S.; Andresson, T.] Leidos Biomed Res Inc, Prot Characterizat Lab, Canc Res Technol Program, Frederick Natl Lab Canc Res, Frederick, MD USA; [Im, K. M.] Data Sci Genom, Ellicott City, MD USA; [Berndt, S. I.; Brodie, S. A.; Bouk, A. J.; Wang, Z.; Huang, W. Y.; Hoover, R. N.; Tucker, M. A.; Boland, J.; Moore, L. E.; Chanock, S. J.; Yeager, M.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Li, H.; Lou, H.] Leidos Biomed Res Inc, Basic Res Program, Frederick Natl Lab Canc Res, Frederick, MD USA; [Brodie, S. A.; Boland, J.; Yeager, M.] Leidos Biomed Res Inc, Canc Genom Res, Frederick Natl Lab Canc Res, Frederick, MD USA; [Billaud, J. N.] Ingenu Syst Inc, Redwood City, CA USA; [Nickerson, M. L.; Zhang, T.; Brown, K.; Dean, M.] NCI, Lab Translat Genom, 8717 Grovemont Circle,Rm 225C, Bethesda, MD 20892 USA; [Butcher, D.] Leidos Biomed Res Inc, Pathol & Histotechnol Lab, Frederick Natl Lab Canc Res, Frederick, MD USA; [Sun, L.; Keller, J. R.] NCI, Mouse Canc Genet Program, NIH, Frederick, MD 21701 USA; [Esnakula, A.] Howard Univ, Coll Med, Dept Pathol, Howard Univ Hosp, Washington, DC USA; [Esposito, D.] Leidos Biomed Res Inc, Prot Express Lab, Frederick Natl Lab Canc Res, Frederick, MD USA; [Isaacs, W. B.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University	Nickerson, ML (corresponding author), NCI, Lab Translat Genom, 8717 Grovemont Circle,Rm 225C, Bethesda, MD 20892 USA.	nickersonml@mail.nih.gov	Brodie, Seth/U-9035-2019; Dean, Michael C/G-8172-2012; Anderson, Stephen K/B-1727-2012; Dean, Michael/R-7501-2019; Keller, Jonathan R./O-6677-2018; Yeager, Meredith/AAA-5322-2020	Dean, Michael C/0000-0003-2234-0631; Anderson, Stephen K/0000-0002-7856-4266; Esposito, Dominic/0000-0002-9987-1687	Intramural Research Program of the National Institutes of Health; National Cancer Institute; Leidos Biomedical Research, Inc. [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC010001] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leidos Biomedical Research, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by the Intramural Research Program of the National Institutes of Health, the National Cancer Institute and by Leidos Biomedical Research, Inc., under contract # HHSN261200800001E.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Dong XS, 2007, MOL CELL BIOL, V27, P4863, DOI 10.1128/MCB.02144-06; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Fu LJ, 2014, J AM CHEM SOC, V136, P11582, DOI 10.1021/ja505305z; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; Hsieh CL, 2014, P NATL ACAD SCI USA, V111, P7319, DOI 10.1073/pnas.1324151111; Hu LL, 2015, NATURE, V527, P118, DOI 10.1038/nature15713; Hu LL, 2013, CELL, V155, P1545, DOI 10.1016/j.cell.2013.11.020; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Lilja H, 2008, NAT REV CANCER, V8, P268, DOI 10.1038/nrc2351; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Loy CJ, 2003, P NATL ACAD SCI USA, V100, P4562, DOI 10.1073/pnas.0736237100; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Metzeler KH, 2011, J CLIN ONCOL, V29, P1373, DOI 10.1200/JCO.2010.32.7742; Nickerson ML, 2014, CLIN CANCER RES, V20, P4935, DOI 10.1158/1078-0432.CCR-14-0330; Nickerson ML, 2013, HUM MUTAT, V34, P1231, DOI 10.1002/humu.22346; Norris JD, 2009, MOL CELL, V36, P405, DOI 10.1016/j.molcel.2009.10.020; Obinata D, 2012, INT J CANCER, V130, P1021, DOI 10.1002/ijc.26043; Passon DM, 2012, P NATL ACAD SCI USA, V109, P4846, DOI 10.1073/pnas.1120792109; Pena-Llopis S, 2013, CANCER RES, V73, P4173, DOI 10.1158/0008-5472.CAN-13-0360; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Pomerantz MM, 2011, CANCER PREV RES, V4, P719, DOI 10.1158/1940-6207.CAPR-10-0292; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Saint-Martin C, 2009, BLOOD, V114, P1628, DOI 10.1182/blood-2009-01-197525; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Scopim-Ribeiro R, 2015, EUR J HAEMATOL, V94, P413, DOI 10.1111/ejh.12445; SEGIL N, 1991, SCIENCE, V254, P1814, DOI 10.1126/science.1684878; Serandour AA, 2012, NUCLEIC ACIDS RES, V40, P8255, DOI 10.1093/nar/gks595; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Setiawan VW, 2014, CARCINOGENESIS, V35, P2068, DOI 10.1093/carcin/bgu107; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Song FJ, 2014, CARCINOGENESIS, V35, P2097, DOI 10.1093/carcin/bgu140; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Takayama K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9219; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tonin P, 1996, NAT MED, V2, P1179, DOI 10.1038/nm1196-1179; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	53	33	34	0	16	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 13	2017	36	15					2172	2183		10.1038/onc.2016.376	http://dx.doi.org/10.1038/onc.2016.376			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ES8DK	27819678	Green Accepted			2022-12-26	WOS:000399782500012
J	Parker, A; Maclaren, OJ; Fletcher, AG; Muraro, D; Kreuzaler, PA; Byrne, HM; Maini, PK; Watson, AJM; Pin, C				Parker, Aimee; Maclaren, Oliver J.; Fletcher, Alexander G.; Muraro, Daniele; Kreuzaler, Peter A.; Byrne, Helen M.; Maini, Philip K.; Watson, Alastair J. M.; Pin, Carmen			Cell proliferation within small intestinal crypts is the principal driving force for cell migration on villi	FASEB JOURNAL			English	Article						mathematical model; epithelium; small intestine	CYTOSINE-ARABINOSIDE; EPITHELIAL RESTITUTION; STEM-CELLS; GASTROINTESTINAL-TRACT; POPULATION KINETICS; FEEDBACK-CONTROL; DNA-SYNTHESIS; MOUSE; MODEL; MICE	The functional integrity of the intestinal epithelial barrier relies on tight coordination of cell proliferation and migration, with failure to regulate these processes resulting in disease. It is not known whether cell proliferation is sufficient to drive epithelial cell migration during homoeostatic turnover of the epithelium. Nor is it known precisely how villus cell migration is affected when proliferation is perturbed. Some reports suggest that proliferation and migration may not be related while other studies support a direct relationship. We used established cell-tracking methods based on thymine analog cell labeling and developed tailored mathematical models to quantify cell proliferation and migration under normal conditions and when proliferation is reduced and when it is temporarily halted. We found that epithelial cell migration velocities along the villi are coupled to cell proliferation rates within the crypts in all conditions. Furthermore, halting and resuming proliferation results in the synchronized response of cell migration on the villi. We conclude that cell proliferation within the crypt is the primary force that drives cell migration along the villus. This methodology can be applied to interrogate intestinal epithelial dynamics and characterize situations in which processes involved in cell turnover become uncoupled, including pharmacological treatments and disease models.	[Parker, Aimee; Pin, Carmen] Inst Food Res, Gut Hlth & Food Safety Res Programme, Norwich NR4 7UA, Norfolk, England; [Maclaren, Oliver J.; Fletcher, Alexander G.; Muraro, Daniele; Byrne, Helen M.; Maini, Philip K.] Univ Oxford, Math Inst, Wolfson Ctr Math Biol, Oxford OX1 2JD, England; [Fletcher, Alexander G.] Univ Sheffield, Sch Math & Stat, Sheffield S10 2TN, S Yorkshire, England; [Fletcher, Alexander G.] Univ Sheffield, Bateson Ctr, Sheffield S10 2TN, S Yorkshire, England; [Kreuzaler, Peter A.] Univ Cambridge, Dept Biochem, Cambridge CB2 1TN, England; [Watson, Alastair J. M.] Univ East Anglia, Sch Med, Norwich NR4 7TJ, Norfolk, England; [Maclaren, Oliver J.] Univ Auckland, Dept Engn Sci, Auckland, New Zealand	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Oxford; University of Sheffield; University of Sheffield; University of Cambridge; University of East Anglia; University of Auckland	Pin, C (corresponding author), Inst Food Res, Gut Hlth & Food Safety Res Programme, Norwich NR4 7UA, Norfolk, England.	carmen.pin@ifr.ac.uk	Fletcher, Alexander/C-8908-2013	Fletcher, Alexander/0000-0003-0525-4336; Byrne, Helen/0000-0003-1771-5910; Parker, Aimee/0000-0003-1765-9656; Kreuzaler, Peter/0000-0001-8684-9424	Biotechnology and Biological Sciences Research Council (BBSRC)-UK [BB/K018256/1, BB/K017578/1, BB/K017144/1, BB/J004529/1]; EPSRC-UK [EP/I017909]; Biotechnology and Biological Sciences Research Council [BB/K017578/1, BBS/E/F/00044446, BB/K018256/1, BB/K017144/1] Funding Source: researchfish; BBSRC [BBS/E/F/00044446, BB/K017578/1, BB/K017144/1, BB/K018256/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)-UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC-UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank Gerard Evan and Trevor Littlewood (both from the University of Cambridge) for helpful discussions on cell biology and for kindly providing the Omomyc mouse model. This work was funded by Biotechnology and Biological Sciences Research Council (BBSRC)-UK projects BB/K018256/1, BB/K017578/1, BB/K017144/1, and BB/J004529/1 and the EPSRC-UK project EP/I017909. The authors declare no conflicts of interest.	ALDEWACHI HS, 1980, VIRCHOWS ARCH B, V34, P299, DOI 10.1007/BF02892427; ALNAFUSSI AI, 1982, VIRCHOWS ARCH B, V40, P63, DOI 10.1007/BF02932851; ANILKUMAR TV, 1992, BRIT J CANCER, V65, P552, DOI 10.1038/bjc.1992.113; Balakrishnan A, 2010, EXP CELL RES, V316, P3512, DOI 10.1016/j.yexcr.2010.07.007; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BARTHOLD SW, 1979, CANCER RES, V39, P24; BOARDER TA, 1976, CELL TISSUE KINET, V9, P589, DOI 10.1111/j.1365-2184.1976.tb01308.x; BRITTON NF, 1982, J THEOR BIOL, V98, P531, DOI 10.1016/0022-5193(82)90135-7; Carothers AM, 2001, J BIOL CHEM, V276, P39094, DOI 10.1074/jbc.M103450200; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Dunn SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080516; EASTWOOD GL, 1981, CELL TISSUE KINET, V14, P405, DOI 10.1111/j.1365-2184.1981.tb00547.x; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FEIL W, 1989, GASTROENTEROLOGY, V97, P685, DOI 10.1016/0016-5085(89)90640-9; GALJAARD H, 1972, EXP CELL RES, V73, P197, DOI 10.1016/0014-4827(72)90120-6; Gallagher AM, 2001, AM J PHYSIOL-GASTR L, V281, pG681, DOI 10.1152/ajpgi.2001.281.3.G681; Ghaleb AM, 2011, DEV BIOL, V349, P310, DOI 10.1016/j.ydbio.2010.11.001; GRAHAM FL, 1970, CANCER RES, V30, P2627; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; HAGEMANN RF, 1970, AM J ANAT, V129, P41, DOI 10.1002/aja.1001290104; HAGEMANN RF, 1975, BRIT J RADIOL, V48, P545, DOI 10.1259/0007-1285-48-571-545; HAGEMANN RF, 1973, J NATL CANCER I, V50, P467, DOI 10.1093/jnci/50.2.467; Heath JP, 1996, CELL BIOL INT, V20, P139, DOI 10.1006/cbir.1996.0018; HIRSCHMAN SZ, 1969, INT J CANCER, V4, P671, DOI 10.1002/ijc.2910040513; KAUR P, 1986, CELL TISSUE KINET, V19, P591, DOI 10.1111/j.1365-2184.1986.tb00760.x; KAUR P, 1986, CELL TISSUE KINET, V19, P611, DOI 10.1111/j.1365-2184.1986.tb00762.x; KLEIN RM, 1978, CELL TISSUE RES, V195, P239; LACY ER, 1988, J CLIN GASTROENTEROL, V10, pS72, DOI 10.1097/00004836-198812001-00012; LENAZ L, 1970, CANCER RES, V30, P1961; LENAZ L, 1969, CANCER RES, V29, P1790; Mahmoud NN, 1997, CANCER RES, V57, P5045; Meineke FA, 2001, CELL PROLIFERAT, V34, P253, DOI 10.1046/j.0960-7722.2001.00216.x; Mirams GR, 2012, J THEOR BIOL, V312, P143, DOI 10.1016/j.jtbi.2012.08.002; MOORE R, 1989, LAB INVEST, V60, P237; Moss SF, 1996, GUT, V39, P811, DOI 10.1136/gut.39.6.811; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Osborne JM, 2010, PHILOS T R SOC A, V368, P5013, DOI 10.1098/rsta.2010.0173; Pignatelli M, 1996, YALE J BIOL MED, V69, P131; Pin C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037115; Potten P. K. C., 1986, CELL TISSUE KINET, V19, P611; Rasband W., 2006, IMAGEJ; RICHARDS TC, 1981, ANAT RECORD, V200, P299, DOI 10.1002/ar.1092000309; RIJKE RPC, 1976, GASTROENTEROLOGY, V71, P786; SATO F, 1972, CELL TISSUE KINET, V5, P227, DOI 10.1111/j.1365-2184.1972.tb00361.x; Soucek L, 1998, ONCOGENE, V17, P2463, DOI 10.1038/sj.onc.1202199; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; SYMONS LEA, 1965, GASTROENTEROLOGY, V49, P158; TSUBOUCHI S, 1983, CELL TISSUE KINET, V16, P441; van Leeuwen IMM, 2009, CELL PROLIFERAT, V42, P617, DOI 10.1111/j.1365-2184.2009.00627.x; VERBIN RS, 1972, CANCER RES, V32, P1476; Watson AJM, 2009, ANN NY ACAD SCI, V1165, P135, DOI 10.1111/j.1749-6632.2009.04027.x; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; WRIGHT NA, 1982, CELL TISSUE KINET, V15, P611, DOI 10.1111/j.1365-2184.1982.tb01067.x; Wright NA, 1984, BIOL EPITHELIAL CELL, V2	54	45	46	2	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					636	649		10.1096/fj.201601002	http://dx.doi.org/10.1096/fj.201601002			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27811059	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000394235400017
J	Panagoulias, I; Georgakopoulos, T; Aggeletopoulou, I; Agelopoulos, M; Thanos, D; Mouzaki, A				Panagoulias, Ioannis; Georgakopoulos, Tassos; Aggeletopoulou, Ioanna; Agelopoulos, Marios; Thanos, Dimitris; Mouzaki, Athanasia			Transcription Factor Ets-2 Acts as a Preinduction Repressor of Interleukin-2 (IL-2) Transcription in Naive T Helper Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; CELL-ACTIVATION; PROMOTER; PROLIFERATION; PROTEINS; FAMILY; ARCHITECTURE; SPECIFICITY; MODULATION; APOPTOSIS	IL-2 is the first cytokine produced when naive T helper (Th) cells are activated and differentiate into dividing pre-Th0 proliferating precursors. IL-2 expression is blocked in naive, but not activated or memory, Th cells by the transcription factor Ets-2 that binds to the antigen receptor response element (ARRE)-2 of the proximal IL-2 promoter. Ets-2 acts as an independent pre-induction repressor in naive Th cells and does not interact physically with the transcription factor NFAT (nuclear factor of activated T-cells) that binds to the ARRE-2 in activated Th cells. In naive Th cells, Ets-2 mRNA expression, Ets-2 protein levels, and Ets-2 binding to ARRE-2 decrease upon cell activation followed by the concomitant expression of IL-2. Cyclosporine Astabilizes Ets-2 mRNA and protein when the cells are activated. Ets-2 silences directly constitutive or induced IL-2 expression through the ARRE-2. Conversely, Ets-2 silencing allows for constitutive IL-2 expression in unstimulated cells. Ets-2 binding to ARRE-2 in chromatin is stronger in naive compared with activated or memory Th cells; in the latter, Ets-2 participates in a change of the IL-2 promoter architecture, possibly to facilitate a quick response when the cells re-encounter antigen. We propose that Ets-2 expression and protein binding to the ARRE-2 of the IL-2 promoter are part of a strictly regulated process that results in a physiological transition of naive Th cells to Th0 cells upon antigenic stimulation. Malfunction of such a repression mechanism at the molecular level could lead to a disturbance of later events in Th cell plasticity, leading to autoimmune diseases or other pathological conditions.	[Panagoulias, Ioannis; Georgakopoulos, Tassos; Aggeletopoulou, Ioanna; Mouzaki, Athanasia] Univ Patras, Fac Med, Dept Internal Med, Div Hematol, GR-26500 Patras, Greece; [Agelopoulos, Marios; Thanos, Dimitris] Acad Athens, Biomed Res Fdn, Inst Mol Biol Genet & Biotechnol, GR-11527 Athens, Greece	University of Patras; Academy of Athens	Mouzaki, A (corresponding author), Univ Patras, Sch Hlth Sci, Fac Med, Lab Immunohematol,Div Hematol,Dept Internal Med, GR-26500 Patras, Greece.	mouzaki@upatras.gr	panagoulias, ioannis/ABA-7915-2020; Thanos, Dimitris/AAE-5720-2019; aggeletopoulou, ioanna/P-4129-2016	Aggeletopoulou, Ioanna/0000-0003-4489-1485	European Union (European Social Fund); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework-Research Funding Program Heracleitus II Grant [D.276.001.020]; K. Karatheodoris Grant, University of Patras [B407]	European Union (European Social Fund)(European Social Fund (ESF)); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework-Research Funding Program Heracleitus II Grant; K. Karatheodoris Grant, University of Patras	This work was co-supported by the European Union (European Social Fund) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework-Research Funding Program Heracleitus II Grant D.276.001.020 and K. Karatheodoris Grant B407, University of Patras (to A. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson MK, 1999, DEVELOPMENT, V126, P3131; Argyropoulos C, 2004, GENES IMMUN, V5, P16, DOI 10.1038/sj.gene.6364034; Baker KM, 2003, J BIOL CHEM, V278, P17876, DOI 10.1074/jbc.M209480200; BHAT NK, 1990, P NATL ACAD SCI USA, V87, P3723, DOI 10.1073/pnas.87.10.3723; Blumenthal SG, 1999, J BIOL CHEM, V274, P12910, DOI 10.1074/jbc.274.18.12910; Bunting K, 2006, VITAM HORM, V74, P105, DOI 10.1016/S0083-6729(06)74005-5; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; FIRPO EJ, 1994, MOL CELL BIOL, V14, P4889, DOI 10.1128/MCB.14.7.4889; Gallant S, 2006, ARCH IMMUNOL THER EX, V54, P149, DOI 10.1007/s00005-006-0017-z; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Irvin BJ, 2003, J BIOL CHEM, V278, P46378, DOI 10.1074/jbc.M305189200; Jia Y., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0097999; Lin L, 2004, SCIENCE, V303, P1017, DOI 10.1126/science.1093889; Liu Jun O, 2005, Sci STKE, V2005, pre1; Lomvardas S, 2002, CELL, V110, P261, DOI 10.1016/S0092-8674(02)00822-X; Lopez R, 1999, J BIOL CHEM, V274, P30132, DOI 10.1074/jbc.274.42.30132; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mavrothalassitis G, 2000, ONCOGENE, V19, P6524, DOI 10.1038/sj.onc.1204045; MOUZAKI A, 1994, BLOOD, V84, P2612; MOUZAKI A, 1991, EMBO J, V10, P1399, DOI 10.1002/j.1460-2075.1991.tb07660.x; Mouzaki A, 2002, BLOOD, V100, P1774, DOI 10.1182/blood.V100.5.1774.h81702001774_1774_1779; Mouzaki A, 2000, MOL MED, V6, P377, DOI 10.1007/BF03401782; MOUZAKI A, 1993, EUR J IMMUNOL, V23, P1469, DOI 10.1002/eji.1830230711; Naito T, 2011, INT IMMUNOL, V23, P661, DOI 10.1093/intimm/dxr078; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Savignac M, 2005, EMBO J, V24, P3555, DOI 10.1038/sj.emboj.7600810; Senger K, 2000, MOL CELL, V6, P931, DOI 10.1016/S1097-2765(05)00081-X; SERFLING E, 1995, BBA-GENE STRUCT EXPR, V1263, P181, DOI 10.1016/0167-4781(95)00112-T; Shore P, 1996, MOL CELL BIOL, V16, P3338; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sussan TE, 2008, NATURE, V451, P73, DOI 10.1038/nature06446; THOMPSON CB, 1992, MOL CELL BIOL, V12, P1043, DOI 10.1128/MCB.12.3.1043; Travers P., 2001, IMMUNOBIOLOGY IMMUNE, P323; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Wolvetang EJ, 2003, HUM MOL GENET, V12, P247, DOI 10.1093/hmg/ddg015; Yamanaka Y, 2008, J ORTHOP RES, V26, P1577, DOI 10.1002/jor.20714; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Zaldumbide A, 2002, J IMMUNOL, V169, P4873, DOI 10.4049/jimmunol.169.9.4873	38	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26707	26721		10.1074/jbc.M116.762179	http://dx.doi.org/10.1074/jbc.M116.762179			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27815505	Green Published, hybrid			2022-12-26	WOS:000391571400011
J	Johnson, ML; Saffrey, MJ; Taylor, VJ				Johnson, Michelle L.; Saffrey, M. Jill; Taylor, Victoria J.			Plasma Ghrelin Concentrations Were Altered with Oestrous Cycle Stage and Increasing Age in Reproductively Competent Wistar Females	PLOS ONE			English	Article							MESSENGER-RNA; RATS; EXPRESSION; ESTRADIOL; APPETITE; STOMACH	Changes in appetite occur during the ovarian cycle in female mammals. Research on appetite -regulatory gastrointestinal peptides in females is limited, because reproductive changes in steroid hormones present additional experimental factors to control for. This study aimed to explore possible changes in the orexigenic (appetite-stimulating) gastrointestinal peptide hormone ghrelin during the rodent oestrous cycle. Fed and fasted plasma and stomach tissue samples were taken from female Wistar rats (32-44 weeks of age) at each stage of the oestrous cycle for total ghrelin quantification using radioimmunoassay. Sampling occurred during the dark phase when most eating takes place in rats. Statistical analysis was by paired-samples t-test, one-way ANOVA on normally distributed data, with Tukey post-hoc tests, or Kruskal-Wallis if not. GLM univariate analysis was used to assess main effects and interactions in ghrelin concentrations in the fed or fasted state and during different stages of the ovarian cycle, with age as a covariate. No consistent fed to fasted ghrelin increases were measured in matched plasma samples from the same animals, contrary to expectations. Total ghrelin concentrations did not significantly change between cycle stages with ANOVA, in either fed or fasted plasma or in stomach tissue. This was despite significantly decreased fasted stomach contents at oestrus (P= 0.028), suggesting decreased food intake. There was however a significant interaction in ghrelin plasma concentrations between fed and fasted proestrus rats and a direct effect of age with rats over 37 weeks old having lower circulating concentrations of ghrelin in both fed and fasted states. The biological implications of altered ghrelin plasma concentrations from 37 weeks of age are as yet unknown, but warrant further investigation. Exploring peripheral ghrelin regulatory factor changes with increasing age in reproductively competent females may bring to light potential effects on offspring development and nutritional metabolic programming.	[Johnson, Michelle L.; Saffrey, M. Jill; Taylor, Victoria J.] Open Univ, Sch Life Hlth & Chem Sci, Fac Sci Technol Engn & Math, Milton Keynes, Bucks, England; [Johnson, Michelle L.] Univ Leeds, Leeds Inst Canc & Pathol, Fac Med & Hlth, Leeds, W Yorkshire, England	Open University - UK; University of Leeds	Taylor, VJ (corresponding author), Open Univ, Sch Life Hlth & Chem Sci, Fac Sci Technol Engn & Math, Milton Keynes, Bucks, England.	vicky.taylor@open.ac.uk	Taylor, Victoria Jane/AAE-2568-2021	Taylor, Victoria Jane/0000-0001-9864-4979; Johnson, Michelle/0000-0002-6252-610X	Department of Life, Health and Chemical Sciences (LHCS), The Open University	Department of Life, Health and Chemical Sciences (LHCS), The Open University	This work was funded by the Department of Life, Health and Chemical Sciences (LHCS), The Open University. The Open University had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asarian L, 2006, PHILOS T R SOC B, V361, P1251, DOI 10.1098/rstb.2006.1860; Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Butera PC, 2010, PHYSIOL BEHAV, V99, P175, DOI 10.1016/j.physbeh.2009.06.010; Clegg DJ, 2007, DIABETES, V56, P1051, DOI 10.2337/db06-0015; Dye L, 1997, HUM REPROD, V12, P1142; Eckel LA, 2000, PHYSIOL BEHAV, V70, P397, DOI 10.1016/S0031-9384(00)00278-X; Fang FG, 2012, SYST BIOL REPROD MED, V58, P116, DOI 10.3109/19396368.2011.637607; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Martin JR, 2011, ENDOCRINOLOGY, V152, P2060, DOI 10.1210/en.2010-1485; Sakata I, 2006, J ENDOCRINOL, V190, P749, DOI 10.1677/joe.1.06808; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Slupecka M, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/5739763; Spivak H, 2012, SURG ENDOSC, V26, P1909, DOI 10.1007/s00464-011-2125-z; Stengel A, 2009, ENDOCRINOLOGY, V150, P5113, DOI 10.1210/en.2009-0697; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; WHO, OB OV 2015; Zhao Z, 2008, J ENDOCRINOL, V196, P529, DOI 10.1677/JOE-07-0300	19	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166229	10.1371/journal.pone.0166229	http://dx.doi.org/10.1371/journal.pone.0166229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829021	Green Accepted, Green Published, gold			2022-12-26	WOS:000387724300097
J	Labandeira, CC; Kustatscher, E; Wappler, T				Labandeira, Conrad C.; Kustatscher, Evelyn; Wappler, Torsten			Floral Assemblages and Patterns of Insect Herbivory during the Permian to Triassic of Northeastern Italy	PLOS ONE			English	Article							PRA-DELLA-VACCA; FOREST-NATIONAL-PARK; NORTH-CENTRAL TEXAS; PLANT-ARTHROPOD INTERACTIONS; NEW-SOUTH-WALES; COAL MEASURES; SEED-FERNS; TREE FERN; MIDDLE; DOLOMITES	To discern the effect of the end-Permian (P-Tr) ecological crisis on land, interactions between plants and their insect herbivores were examined for four time intervals containing ten major floras from the Dolomites of northeastern Italy during a Permian-Triassic interval. These floras are: (i) the Kungurian Tregiovo Flora; (ii) the Wuchiapingian Bletterbach Flora; (iii) three Anisian floras; and (iv) five Ladinian floras. Derived plant-insect interactional data is based on 4242 plant specimens (1995 Permian, 2247 Triassic) allocated to 86 fossil taxa (32 Permian, 56 Triassic), representing lycophytes, sphenophytes, pteridophytes, pterido-sperms, ginkgophytes, cycadophytes and coniferophytes from 37 million-year interval (23 m. yr. Permian, 14 m. yr. Triassic). Major Kungurian herbivorized plants were unaffiliated taxa and pteridosperms; later during the Wuchiapingian cycadophytes were predominantly consumed. For the Anisian, pteridosperms and cycadophytes were preferentially consumed, and subordinately pteridophytes, lycophytes and conifers. Ladinian herbivores overwhelming targeted pteridosperms and subordinately cycadophytes and conifers. Throughout the interval the percentage of insect-damaged leaves in bulk floras, as a proportion of total leaves examined, varied from 3.6% for the Kungurian (N = 464 leaves), 1.95% for the Wuchiapingian (N = 1531), 11.65% for the pooled Anisian (N = 1324), to 10.72% for the pooled Ladinian (N = 923), documenting an overall herbivory rise. The percentage of generalized consumption, equivalent to external foliage feeding, consistently exceeded the level of specialized consumption from internal feeding. Generalized damage ranged from 73.6% (Kungurian) of all feeding damage, to 79% (Wuchiapingian), 65.5% (pooled Anisian) and 73.2% (pooled Ladinian). Generalized-to-specialized ratios show minimal change through the interval, although herbivore component community structure (herbivore species feeding on a single plant-host species) increasingly was partitioned from Wuchiapingian to Ladinian. The Paleozoic plant with the richest herbivore component community, the coniferophyte Pseudovoltzia liebeana, harbored four damage types (DTs), whereas its Triassic parallel, the pteridosperm Scytophyllum bergeri housed 11 DTs, almost four times that of P. liebeana. Although generalized DTs of P. liebeana were similar to S. bergeri, there was expansion of Triassic specialized feeding types, including leaf mining. Permian-Triassic generalized herbivory remained relatively constant, but specialized herbivores more finely partitioned plant- host tissues via new feeding modes, especially in the Anisian. Insect-damaged leaf percentages for Dolomites Kungurian and Wuchiapingian floras were similar to those of lower Permian, north-central Texas, but only one-third that of southeastern Brazil. Global herbivore patterns for Early Triassic plant-insect interactions remain unknown.	[Labandeira, Conrad C.] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA; [Labandeira, Conrad C.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Labandeira, Conrad C.] Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China; [Kustatscher, Evelyn] Museum Nat South Tyrol, Bindergasse 1, I-39100 Bozen Bolzano, Italy; [Kustatscher, Evelyn] Ludwig Maximilians Univ & Bayer Staatssammlung Pa, Dept Geo & Umweltwissensch, Palaontol & Geobiol, Richard Wagner Str 10, D-80333 Munich, Germany; [Wappler, Torsten] Univ Bonn, Steinmann Inst, Nussallee 8, D-53115 Bonn, Germany	Smithsonian Institution; Smithsonian National Museum of Natural History; University System of Maryland; University of Maryland College Park; Capital Normal University; University of Munich; University of Bonn	Wappler, T (corresponding author), Univ Bonn, Steinmann Inst, Nussallee 8, D-53115 Bonn, Germany.	twappler@uni-bonn.de	Wappler, Torsten/P-6831-2019; Kustatscher, Evelyn/I-3085-2019	Wappler, Torsten/0000-0003-1592-0988; 	Deutsche Forschungsgemeinschaft (DFG) [WA 1496/8-1]; Promotion of Educational Policies, University; Research Department of the Autonomous Province of Bolzano-South Tyrol; Euregio Tirol-SiAtirol-Trentino Science Fund	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Promotion of Educational Policies, University; Research Department of the Autonomous Province of Bolzano-South Tyrol; Euregio Tirol-SiAtirol-Trentino Science Fund	This research was possible thanks to grants of the Deutsche Forschungsgemeinschaft (DFG, Heisenberg grant WA 1496/8-1) to TW. The study of the material has been partly carried out within the project "The Permian-Triassic ecological crisis in the Dolomites: extinction and recovery dynamics in Terrestrial Ecosystems" financed by the Promotion of Educational Policies, University and Research Department of the Autonomous Province of Bolzano-South Tyrol and by the "The end-Permian mass extinction in the Southern and Eastern Alps: extinction rates vs taphonomic biases in different depositional environments" financed by the Euregio Tirol-SiAtirol-Trentino Science Fund.	Adami-Rodrigues K, 2008, SIMPOSIO BRASILEIRO, V12, P1; Adami-Rodrigues Karen, 2004, Fossils and Strata, V51, P106; Adami-Rodrigues Karen, 2004, Revista Brasileira de Paleontologia, V7, P93; Anderson JM, 2016, EVOL STUD I IN PRESS, V1; [Anonymous], 1997, J AUST GEOL GEOPHYS; Araya Jaime E., 2000, Boletin de Sanidad Vegetal Plagas, V26, P65; Aristov DS, 2013, PALEONTOL J+, V47, P641, DOI 10.1134/S0031030113070010; Ash S, 1996, LETHAIA, V29, P237, DOI 10.1111/j.1502-3931.1996.tb01657.x; Ash S, 1999, INT J PLANT SCI, V160, P208, DOI 10.1086/314115; Ash S, 2000, J PALEONTOL, V74, P1065, DOI 10.1666/0022-3360(2000)074<1065:EOOMHI>2.0.CO;2; ASH S R, 1972, Palaeontology (Oxford), V15, P598; Ash Sidney, 2005, Paleobios, V25, P17; Ash S, 2009, PALAEONTOGR ABT B, V282, P1; Ash SR, 2004, IAWA J, V25, P349, DOI 10.1163/22941932-90000371; Avanzini M., 2004, STUD TRENT SCI NAT A, V79, P1; Avanzini M, 2011, EARTH AND ENVIRONMENTAL SCIENCES, P591; Bambach RK, 2004, PALEOBIOLOGY, V30, P522, DOI 10.1666/0094-8373(2004)030<0522:OEAMDO>2.0.CO;2; Banerjee M, 1988, IND BIOL, V30, P58; Bauer K, 2014, RIV ITAL PALEONTOL S, V120, P271, DOI 10.13130/2039-4942/6071; Beattie R, 2007, AFR INVERTEBR, V48, P41; Beck AL, 1998, PALAEOGEOGR PALAEOCL, V142, P139, DOI 10.1016/S0031-0182(98)00060-1; Bethoux O, 2008, J IBER GEOL, V34, P109; Blanckenhorn M., 1885, PALAEONTOGRAPHICA, V32, P117; CALANCHI N, 1978, TSCHER MINER PETROG, V25, P131, DOI 10.1007/BF01082858; Calanchi N, 1977, MINEROLOGICA PETROGR, V21, P221; Cariglino B, 2011, AMEGHINIANA, V48, P103, DOI 10.5710/AMGH.v48i1(321); Carpenter FM, 1969, P 1 N AM PAL CONV CH, V2, P1236; Cassinis G., 1999, FIELD TRIP GUID INT; Cassinis G, 2012, INT J EARTH SCI, V101, P129, DOI 10.1007/s00531-011-0642-6; CEOLONI P, 1988, Z GEOL WISSENSCHAFT, V16, P895; CHALONER WG, 1991, PHILOS T ROY SOC B, V333, P177, DOI 10.1098/rstb.1991.0066; CHAUHAN D K, 1985, Bionature, V5, P5; Clement-Westerhof J.A, 1986, FORSCHUNGSINSTITUT S, V86, P89; CLEMENTW.JA, 1974, REV PALAEOBOT PALYNO, V17, P63, DOI 10.1016/0034-6667(74)90092-X; CLEMENTWESTERHOF JA, 1984, REV PALAEOBOT PALYNO, V41, P51, DOI 10.1016/0034-6667(84)90043-5; CLEMENTWESTERHOF JA, 1987, REV PALAEOBOT PALYNO, V52, P375, DOI 10.1016/0034-6667(87)90066-2; Conti M. A., 1975, MEMORIE GEOPALEONTOL, V3, P141; Conti MA, 1977, PALAEONTOGR ITAL, V70, P1; Conti MA, 1979, MEM SOC GEOL ITAL, V20, P357; Creber GT, 2004, PALAEONTOLOGY, V47, P21, DOI 10.1111/j.0031-0239.2004.00345.x; D'Rozario A, 2011, PALAEOGEOGR PALAEOCL, V306, P127, DOI 10.1016/j.palaeo.2011.04.009; Pinheiro ERD, 2012, REV PALAEOBOT PALYNO, V174, P113, DOI 10.1016/j.revpalbo.2012.01.002; De Zanche V., 1993, MEM SCI GEOL, V45, P1; Delfrati L., 2000, CARTA GEOLOGICA DITA, V3, P89; DEZANCHE V, 1992, ECLOGAE GEOL HELV, V85, P127; ECALE CL, 1995, ENTOMOL EXP APPL, V77, P121, DOI 10.1007/BF02383025; Erwin D. H., 2006, EXTINCTION LIFE EART; Feng Z, 2014, GEOLOGY, V42, P407, DOI 10.1130/G35369.1; Feng Z, 2010, PALAEOGEOGR PALAEOCL, V288, P54, DOI 10.1016/j.palaeo.2010.01.035; Fischer TC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-337; Florin, 1945, PALAEONTOGR ABT B, V85, P1, DOI [10.1515/9783111561752-001, DOI 10.1515/9783111561752-001]; Fois E., 1984, Palaeontographica Americana, P191; Frentzen K., 1933, PALAEONTOL Z, V15, P30; Gallego J, 2014, GEOBIOS-LYON, V47, P101, DOI 10.1016/j.geobios.2014.01.002; Gallego O., 2003, COMUNICACIONES CIENT; Gastaldo RA, 2005, PALAIOS, V20, P479, DOI 10.2110/palo.2004.P04-62; Geyer G., 1987, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V174, P331; Ghosh AK, 2015, ALCHERINGA, V39, P92, DOI 10.1080/03115518.2015.958285; Gianolla P, 1999, THESIS; Glasspool I, 2003, REV PALAEOBOT PALYNO, V127, P125, DOI 10.1016/S0034-6667(03)00107-6; Gnaedinger SC, 2014, GEOBIOS-LYON, V47, P221, DOI 10.1016/j.geobios.2014.06.003; Goth Kurt, 1992, Senckenbergiana Lethaea, V72, P1; Grauvogel-Stamm Lea, 1996, Paleontologia Lombarda, V5, P5; Guerra-Sommer M, FITOFAGIA GLOSSOPTER; Hering EM, 1951, BIOL LEAF MINERS; Hilton J, 2002, REV PALAEOBOT PALYNO, V120, P301, DOI 10.1016/S0034-6667(02)00084-2; Hilton J, 2001, PALAEONTOLOGY, V44, P811, DOI 10.1111/1475-4983.00202; Hoernes R., 1912, SITZUNGSBERICHTE KON, V121, P3; Holmes W. B. K., 1995, GLOBAL ENV DIVERSIFI, P123; Holmes WBK, 2003, P LINN SOC N S W, V124, P53; Hudspith V, 2012, INT J COAL GEOL, V89, P13, DOI 10.1016/j.coal.2011.07.009; Ikeuchi M, 2013, PLANT CELL, V25, P3159, DOI 10.1105/tpc.113.116053; Isaias R.M.S., 2014, NEOTROPICAL INSECT G, P51; Italian International Geological Correlation Program Project 203 Group, 1986, FIELD GUID FIELD C S, P91; Josten, 1973, COMPT REND SEPT C IN, V2, P2, DOI [10.1007/s15033-021-2690-3, DOI 10.1134/S0031030107020116]; Kelber K.A., 1988, NEUE FORSCHUNGEN ERD, V1, P166; Kelber K.P., 1989, COURIER FORSCHUNGSIN, V109, P165; Kelber KP., 1999, TRIAS GANZ ANDERE WE, P355; Knoll AH, 2007, EARTH PLANET SC LETT, V256, P295, DOI 10.1016/j.epsl.2007.02.018; Konijnenburg-Van Cittert JAV, 2006, PALAEONTOLOGY, V49, P943; Krassilov Valentin, 2008, Alavesia, V2, P247; Krassilov V, 2009, PALAEOGEOGR PALAEOCL, V284, P326, DOI 10.1016/j.palaeo.2009.10.012; Kustatscher E, 2006, REV PALAEOBOT PALYNO, V140, P79, DOI 10.1016/j.revpalbo.2006.03.003; Kustatscher E., 2005, GEO ALP, V2, P31; Kustatscher E., 2004, GEOL ALPINE, V1, P57; Kustatscher E., 2004, ACTA NATURALIA ALTEN, V40, P95; Kustatscher E, 2007, PALAEONTOLOGY, V50, P1277, DOI 10.1111/j.1475-4983.2007.00707.x; Kustatscher E, 2006, MICROPALEONTOLOGY, V52, P223, DOI 10.2113/gsmicropal.52.3.223; Kustatscher E, 2014, ACTA PALAEONTOL POL, V59, P741, DOI 10.4202/app.2012.0076; Kustatscher E, 2014, REV PALAEOBOT PALYNO, V208, P65, DOI 10.1016/j.revpalbo.2014.05.003; Kustatscher E, 2014, PALAEOBIO PALAEOENV, V94, P237, DOI 10.1007/s12549-014-0161-0; Kustatscher E, 2012, REV PALAEOBOT PALYNO, V183, P32, DOI 10.1016/j.revpalbo.2012.06.011; Kustatscher E, 2012, REV PALAEOBOT PALYNO, V182, P1, DOI 10.1016/j.revpalbo.2012.06.001; Kustatscher E, 2010, PALAEOGEOGR PALAEOCL, V290, P71, DOI 10.1016/j.palaeo.2009.07.001; Kustatscher E, 2010, PALAEONTOLOGY, V53, P595, DOI 10.1111/j.1475-4983.2010.00948.x; Labandeira CC, 1997, PALAIOS, V12, P319, DOI 10.2307/3515334; Labandeira CC, 2012, GEOL SOC AM ABSTR, p[44, 290]; Labandeira CC, 2007, GUIDE INSECTS OTHER; Labandeira Conrad, 2006, Arthropod Systematics & Phylogeny, V64, P53; Labandeira CC, 2007, PALAEOGEOGR PALAEOCL, V247, P197, DOI 10.1016/j.palaeo.2006.10.015; Labandeira CC, 2013, NATURWISSENSCHAFTEN, V100, P355, DOI 10.1007/s00114-013-1035-4; Labandeira CC, 2014, INT J PALEOPATHOL, V4, P1, DOI 10.1016/j.ijpp.2013.10.002; Labandeira CC, 2013, ANNU REV EARTH PL SC, V41, P287, DOI 10.1146/annurev-earth-050212-124139; Labandeira Conrad C., 2012, P269; Labandeira Conrad C., 2005, American Entomologist, V51, P14; Labandeira Conrad C., 2002, P26; Leonardi P, FLORA PERMIANA ORTIS; Leonardi P., 1968, DOLOMITI GEOLOGIA MO; Linck O., 1949, Neues Jahrbuch fuer Mineralogie Geologie und Palaeontologie Stuttgart B, V4-6, P180; Loriga CB, 2002, RIV ITAL PALEONTOL S, V108, P381, DOI 10.13130/2039-4942/5483; Lozovsky VR, 2016, STRATIGR GEO CORREL+, V24, P364, DOI 10.1134/S0869593816040043; Lucchini F., 1982, GUIDA GEOLOGIA SUDAL, P221; Maheshwari H.K., 1990, Geophytology, V20, P45; Marchetti L, 2015, PALAEOGEOGR PALAEOCL, V440, P180, DOI 10.1016/j.palaeo.2015.08.021; Marocchi M, 2008, J GEOL, V116, P480, DOI 10.1086/590135; Massari F., 1988, SCI GEOL MEM U PADOV, V60, P229; Massari F., 1994, SCI GEOL MEM U PADOV, V46, P119; Massari F., 1999, STRATIGRAPHY FACIES, P111; McLoughlin S., 1994, PALAEONTOGR ABT B, V228, P105; McLoughlin Stephen, 1992, Palaeontographica Abteilung B Palaeophytologie, V228, P105; McLoughlin Stephen, 1994, Palaeontographica Abteilung B Palaeophytologie, V231, P1; McLoughlin S, 2011, AUST J BOT, V59, P156, DOI 10.1071/BT10297; Meller B, 2011, PALAEONTOLOGY, V54, P97, DOI 10.1111/j.1475-4983.2010.01009.x; Mendonca Jr M. S., 2014, NEOTROPICAL INSECT G, P221; Mietto P, 1995, B SOC GEOL FR, V166, P539; MITTER C, 1988, AM NAT, V132, P107, DOI 10.1086/284840; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; Morelli C., 2007, MITT OSTERR MINER GE, V153, P195; Naugolnykh SV, 2010, PALEONTOL J+, V44, P468, DOI 10.1134/S0031030110040131; Noll R., 2005, VEROFF MUS NATURK CH, V28, P29; Ori G.C., 1988, PERMIAN PERMIAN TRIA, V34, P155; Pant D D, 1995, P INT C GLOB ENV DIV, P317; Pinheiro E.R.S., 2012, Palaeobotanist (Lucknow), V61, P67; Pisa G, 1978, MEM SOC GEOL ITAL, V18, P63; PLUMSTEAD EDNA P., 1963, S AFRICAN JOUR SCI, V59, P147; Ponomarenko AG, 2016, PALEONTOL J+, V50, P174, DOI 10.1134/S0031030116020052; Pott C, 2008, J PALEONTOL, V82, P778, DOI 10.1666/06-094.1; Prevec R, 2009, REV PALAEOBOT PALYNO, V156, P454, DOI 10.1016/j.revpalbo.2009.04.012; Remy W., 1978, ARGUMENTA PALAEOBOT, V5, P57; Roopnarine PD, 2007, P ROY SOC B-BIOL SCI, V274, P2077, DOI 10.1098/rspb.2007.0515; Rossler R, 2000, REV PALAEOBOT PALYNO, V108, P55, DOI 10.1016/S0034-6667(99)00033-0; Rossler R, 2011, VEROFF MUS NATURK CH, V37, P55; Rossler R., 1996, VEROFFENTLICHUNGEN M, V19, P27; ROZEFELDS AC, 1987, ALCHERINGA, V11, P51, DOI 10.1080/03115518708618979; Schachat SR, 2015, PALAEOGEOGR PALAEOCL, V440, P830, DOI 10.1016/j.palaeo.2015.10.001; Schachat SR, 2015, SCI NAT-HEIDELBERG, V102, DOI 10.1007/s00114-015-1266-7; Schachat SR, 2014, INT J PLANT SCI, V175, P855, DOI 10.1086/677679; Schmidt G, 2000, J TROP ECOL, V16, P829, DOI 10.1017/S0266467400001747; Scott AC, 2004, J GEOL SOC LONDON, V161, P401, DOI 10.1144/0016-764903-118; Senowbari-Daryan B, 1933, FACIES, V28, P181; Shcherbakov DE, 2008, PALEONTOL J+, V42, P15, DOI 10.1134/S0031030108010036; Shcherbakov Dmitry E., 2009, Russian Entomological Journal, V18, P7; Sidor CA, 2013, P NATL ACAD SCI USA, V110, P8129, DOI 10.1073/pnas.1302323110; Sidorchuk EA, 2015, J SYST PALAEONTOL, V13, P129, DOI 10.1080/14772019.2013.867373; Slater BJ, 2012, PALAEOGEOGR PALAEOCL, V363, P109, DOI 10.1016/j.palaeo.2012.08.018; Smith DM, 2004, BIOTROPICA, V36, P318, DOI 10.1111/j.1744-7429.2004.tb00323.x; Srivastava AK, 2011, PALEONTOL J+, V45, P200, DOI 10.1134/S0031030111020171; Srivastava A.K., 1987, PALAEOBOTANIST, V36, P138; Srivastava AK, 1996, GONDWANA NINE - NINTH INTERNATIONAL GONDWANA SYMPOSIUM, VOLS 1 AND 2, P549; Stull GW, 2013, J PALEONTOL, V87, P217, DOI 10.1666/12-063R.1; Tapanila L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031668; Testa B, 2013, GEOHERITAGE, V5, P151, DOI 10.1007/s12371-013-0079-3; Tillyard R. J., 1922, Proceedings of the Linnean Society of New South Wales, V47, P447; Todesco Rossana, 2008, Geo.Alp, V5, P121; Uhl D, 2005, PALAEOGEOGR PALAEOCL, V218, P205, DOI 10.1016/j.palaeo.2004.12.015; Uhl D, 2014, PALAEOBIO PALAEOENV, V94, P271, DOI 10.1007/s12549-014-0155-y; Uhl D, 2012, RIV ITAL PALEONTOL S, V118, P223, DOI 10.13130/2039-4942/6002; Vasilenko DV, 2007, PALEONTOL J+, V41, P207, DOI 10.1134/S0031030107020116; VIEL G, 1979, Rivista Italiana di Paleontologia e Stratigrafia, V85, P297; Viel G., 1979, RIV ITAL PALEONTOL S, V85, P85; VINCENT JFV, 1990, ADV BOT RES, V17, P235, DOI 10.1016/S0065-2296(08)60135-4; Visscher H., 2001, REGIONAL REPORTS COR, V25, P117; Walker JD, 2013, GEOL SOC AM BULL, V125, P259, DOI 10.1130/B30712.1; WALKER M. V., 1938, PROC U S NATION MUS, V85, P137; Wang J, 2009, REV PALAEOBOT PALYNO, V156, P277, DOI 10.1016/j.revpalbo.2009.03.006; Wappler T, 2015, PEERJ, V3, DOI 10.7717/peerj.921; WEBB JA, 1982, ALCHERINGA, V6, P79, DOI 10.1080/03115518208566988; Wilf P, 1999, SCIENCE, V284, P2153, DOI 10.1126/science.284.5423.2153; Wopfner H, 1999, SCHLERN, V73, P23; Wopfner H., 1988, MEM SOC GEOL ITAL, V34, P161; ZAVADA MS, 1992, AM MIDL NAT, V127, P1, DOI 10.2307/2426316	181	34	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165205	10.1371/journal.pone.0165205	http://dx.doi.org/10.1371/journal.pone.0165205			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829032	Green Submitted, Green Published, gold			2022-12-26	WOS:000387724300031
J	Crowcombe, J; Dhillon, SS; Hurst, RM; Egginton, S; Muller, F; Sik, A; Tarte, E				Crowcombe, James; Dhillon, Sundeep Singh; Hurst, Rhiannon Mary; Egginton, Stuart; Mueller, Ferenc; Sik, Attila; Tarte, Edward			3D Finite Element Electrical Model of Larval Zebrafish ECG Signals	PLOS ONE			English	Article							ACTION-POTENTIAL PROPAGATION; CARDIAC ELECTROPHYSIOLOGY; HEART FIELD; ION-CHANNEL; MEMBRANE; ELECTROCARDIOGRAM; TOMOGRAPHY; SIMULATION; DYNAMICS; PLATFORM	Assessment of heart function in zebrafish larvae using electrocardiography (ECG) is a potentially useful tool in developing cardiac treatments and the assessment of drug therapies. In order to better understand how a measured ECG waveform is related to the structure of the heart, its position within the larva and the position of the electrodes, a 3D model of a 3 days post fertilisation (dpf) larval zebrafish was developed to simulate cardiac electrical activity and investigate the voltage distribution throughout the body. The geometry consisted of two main components; the zebrafish body was modelled as a homogeneous volume, while the heart was split into five distinct regions (sinoatrial region, atrial wall, atrioventricular band, ventricular wall and heart chambers). Similarly, the electrical model consisted of two parts with the body described by Laplace's equation and the heart using a bidomain ionic model based upon the Fitzhugh-Nagumo equations. Each region of the heart was differentiated by action potential (AP) parameters and activation wave conduction velocities, which were fitted and scaled based on previously published experimental results. ECG measurements in vivo at different electrode recording positions were then compared to the model results. The model was able to simulate action potentials, wave propagation and all the major features (P wave, R wave, T wave) of the ECG, as well as polarity of the peaks observed at each position. This model was based upon our current understanding of the structure of the normal zebrafish larval heart. Further development would enable us to incorporate features associated with the diseased heart and hence assist in the interpretation of larval zebrafish ECGs in these conditions.	[Crowcombe, James; Tarte, Edward] Univ Birmingham, Sch Engn, Birmingham, W Midlands, England; [Dhillon, Sundeep Singh; Hurst, Rhiannon Mary; Mueller, Ferenc] Univ Birmingham, Coll Med & Dent Sci, Inst Canc & Genom Sci, Birmingham, W Midlands, England; [Dhillon, Sundeep Singh; Hurst, Rhiannon Mary; Sik, Attila] Univ Birmingham, Inst Clin Sci, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Egginton, Stuart] Univ Leeds, Sch Biomed Sci, Fac Biol Sci, Leeds, W Yorkshire, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Leeds	Crowcombe, J (corresponding author), Univ Birmingham, Sch Engn, Birmingham, W Midlands, England.; Sik, A (corresponding author), Univ Birmingham, Inst Clin Sci, Coll Med & Dent Sci, Birmingham, W Midlands, England.	james.crowcombe@gmail.com; a.sik@bham.ac.uk		mueller, ferenc/0000-0002-0996-774X; Egginton, Stuart/0000-0002-3084-9692	British Heart Foundation [NH/12/3/29636]; Engineering and Physical Sciences Research Council studentship	British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council studentship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study was funded by the British Heart Foundation (https://www.bhf.org.uk/) awarded to AS, ET, FM and SE (NH/12/3/29636) and JC was funded by an Engineering and Physical Sciences Research Council studentship awarded to the University of Birmingham (https://www.epsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeniran I., 2013, J BIOMED SCI ENG, V6, P47, DOI DOI 10.4236/JBISE.2013.612A007; Arrenberg AB, 2010, SCIENCE, V330, P971, DOI 10.1126/science.1195929; Berenfeld O, 1996, MED ENG PHYS, V18, P615, DOI 10.1016/S1350-4533(96)00028-8; Berghmans Stephane, 2008, Journal of Pharmacological and Toxicological Methods, V58, P59, DOI 10.1016/j.vascn.2008.05.130; Boulakia M, 2010, ANN BIOMED ENG, V38, P1071, DOI 10.1007/s10439-009-9873-0; Bruce D, 2012, ELECTRON PROC THEOR, P1, DOI 10.4204/EPTCS.92.1; Bryson-Richardson RJ, 2004, METHOD CELL BIOL, V76, P37; Butters TD, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0067; Chi NC, 2008, PLOS BIOL, V6, P1006, DOI 10.1371/journal.pbio.0060109; Clayton RH, 2011, PROG BIOPHYS MOL BIO, V104, P22, DOI 10.1016/j.pbiomolbio.2010.05.008; CLERC L, 1976, J PHYSIOL-LONDON, V255, P335, DOI 10.1113/jphysiol.1976.sp011283; Dhillon SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060552; Dietrich AC, 2014, DEV CELL, V30, P367, DOI 10.1016/j.devcel.2014.06.020; Dokos S, 2007, P 29 ANN INT C IEEE; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Forouhar AS, 2004, P 26 ANN INT C IEEE; Garny A, 2004, ANN NY ACAD SCI, V1015, P133, DOI 10.1196/annals.1302.011; Grimes AC, 2008, TOXICOL SCI, V106, P193, DOI 10.1093/toxsci/kfn154; Gurev V, 2010, BIOPHYS J, V99, P745, DOI 10.1016/j.bpj.2010.05.028; Gurev V, 2011, BIOMECH MODEL MECHAN, V10, P295, DOI 10.1007/s10237-010-0235-5; Hami D, 2011, DEVELOPMENT, V138, P2389, DOI 10.1242/dev.061473; Harrild DM, 2000, CIRC RES, V87, pE25; Hecker L, 2008, ZEBRAFISH, V5, P319, DOI 10.1089/zeb.2008.0550; Henriquez CS, 2014, IEEE T BIO-MED ENG, V61, P1457, DOI 10.1109/TBME.2014.2310515; Jensen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044231; Johnston BM, 2015, MATH BIOSCI, V266, P15, DOI 10.1016/j.mbs.2015.05.008; Just S, 2011, CIRCULATION, V124, P324, DOI 10.1161/CIRCULATIONAHA.110.003301; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kochova P, 2015, J THEOR BIOL, V373, P12, DOI 10.1016/j.jtbi.2015.03.014; Lee JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084256; Liebling M, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2061567; Lin E, 2014, AM J PHYSIOL-REG I, V306, pR823, DOI 10.1152/ajpregu.00002.2014; Lines G. T., 2003, Computing and Visualization in Science, V5, P215, DOI 10.1007/s00791-003-0101-4; MacLeod R., 2010, COMPREHENSIVE ELECTR, P247, DOI [10.1007/978-1-84882-046-3_8, DOI 10.1007/978-1-84882-046-3_8]; Malmivuo P., 1995, BIOELECTROMAGNETISM, DOI [DOI 10.1093/ACPROF:OSO/9780195058239.001.0001, 10.1093/acprof:oso/9780195058239.001.0001]; Mickoleit M, 2014, NAT METHODS, V11, P919, DOI [10.1038/NMETH.3037, 10.1038/nmeth.3037]; Milan DJ, 2006, AM J PHYSIOL-HEART C, V291, pH269, DOI 10.1152/ajpheart.00960.2005; Mitchell CC, 2003, B MATH BIOL, V65, P767, DOI 10.1016/S0092-8240(03)00041-7; Nakazaki T, 2003, NATURE, V421, P170, DOI 10.1038/nature01219; Nemtsas P, 2010, J MOL CELL CARDIOL, V48, P161, DOI 10.1016/j.yjmcc.2009.08.034; NOBLE D, 1962, J PHYSIOL-LONDON, V160, P317, DOI 10.1113/jphysiol.1962.sp006849; Okada JI, 2013, PACE, V36, P309, DOI 10.1111/pace.12057; Panakova D, 2010, NATURE, V466, P874, DOI 10.1038/nature09249; Peralta M, 2014, J DEV BIOL, V2, P101, DOI 10.3390/jdb2020101; Potse M, 2006, IEEE T BIO-MED ENG, V53, P2425, DOI 10.1109/TBME.2006.880875; Renz M, 2015, DEV CELL, V32, P181, DOI 10.1016/j.devcel.2014.12.016; ROBERTS DE, 1979, CIRC RES, V44, P701, DOI 10.1161/01.RES.44.5.701; Roberts DE, 1982, CIRCULATION, V50; ROGERS JM, 1994, IEEE T BIO-MED ENG, V41, P743, DOI 10.1109/10.310090; Rohr S, 2004, CARDIOVASC RES, V62, P309, DOI 10.1016/j.cardiores.2003.11.035; Rottbauer W, 2001, DEV CELL, V1, P265, DOI 10.1016/S1534-5807(01)00023-5; Salgao D, ZEBRAFISH ANATOMY PO; Sedmera D, 2003, AM J PHYSIOL-HEART C, V284, pH1152, DOI 10.1152/ajpheart.00870.2002; Sovilj S, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/134208; SPACH MS, 1981, CIRC RES, V48, P39, DOI 10.1161/01.RES.48.1.39; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Stinstra J, 2010, ANN BIOMED ENG, V38, P1399, DOI 10.1007/s10439-009-9883-y; Stinstra JG, 2005, ANN BIOMED ENG, V33, P1743, DOI 10.1007/s10439-005-7257-7; Sun P, 2009, ANN BIOMED ENG, V37, P890, DOI 10.1007/s10439-009-9668-3; Takeuchi JK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1187; Taylor CA, 2013, J AM COLL CARDIOL, V61, P2233, DOI 10.1016/j.jacc.2012.11.083; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Thomas NA, 2008, DEVELOPMENT, V135, P3789, DOI 10.1242/dev.024083; Trayanova NA, 2011, CIRC RES, V108, P113, DOI 10.1161/CIRCRESAHA.110.223610; Tsai CT, 2011, CLIN CHIM ACTA, V412, P1963, DOI 10.1016/j.cca.2011.07.002; Verkerk AO, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00255; Wang J, 2011, DEVELOPMENT, V138; Yu F, 2010, ZEBRAFISH, V7, P325, DOI 10.1089/zeb.2010.0658; Zemzemi N, 2013, BRIT J PHARMACOL, V168, P718, DOI 10.1111/j.1476-5381.2012.02200.x; Zhang RL, 2013, NATURE, V498, P497, DOI 10.1038/nature12322; Zhang X, 2014, MICR MECH SYST MEMS; Zhou Y, 2011, NATURE, V474, P645, DOI 10.1038/nature10094	73	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165655	10.1371/journal.pone.0165655	http://dx.doi.org/10.1371/journal.pone.0165655			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824910	Green Published, gold			2022-12-26	WOS:000387615200027
J	Milanovich, JR; Barrett, K; Crawford, JA				Milanovich, Joseph R.; Barrett, Kyle; Crawford, John A.			Detritus Quality and Locality Determines Survival and Mass, but Not Export, of Wood Frogs at Metamorphosis	PLOS ONE			English	Article							LARVAL AMPHIBIANS; BIOMASS EXPORT; CLIMATE-CHANGE; RECIPROCAL SUBSIDIES; EXPERIMENTAL ECOLOGY; SECONDARY COMPOUNDS; EXPERIMENTAL VENUE; SPECIES CHANGES; FOOD WEBS; PONDS	Single-site experiments have demonstrated detritus quality in wetlands can have strongly negative, neutral, and even positive influences on wildlife. However, an examination of the influence of detritus quality across several regions is lacking and can provide information on whether impacts from variation in detritus quality are consistent across species with wide ranges. To address this gap in regional studies we examined effects of emergent and allochthonous detritus of different nutrient qualities on amphibians and assessed a mechanism that may contribute to potential impacts. We used aquatic mesocosms to raise wood frogs (Rana sylvatica) from two regions of the United States with whole plants from purple loosestrife (Lythrum salicaria), leaf litter from native hardwood trees, and a mixture of both. We examined several metrics of amphibian fitness and life history, including survival, number of days to metamorphosis, and size at metamorphosis. Further, we quantified whether the effects of detritus type could translate to variation in anuran biomass or standing stock of nitrogen or phosphorus export. Our results show detritus with high nutrient quality (purple loosestrife) negatively influenced survival of wood frogs, but increased size of metamorphic individuals in two different regions of the United States. Despite the decrease in survival, the increase in size of post-metamorphic anurans raised with high quality detritus resulted in anuran biomass and standing stock of N and P export being similar across treatments at both locations. These results further demonstrate the role of plant quality in shaping wet-land ecosystem dynamics, and represent the first demonstration that effects are consistent within species across ecoregional boundaries.	[Milanovich, Joseph R.] Loyola Univ, Dept Biol, Chicago, IL 60626 USA; [Barrett, Kyle] Clemson Univ, Dept Forestry & Environm Conservat, Clemson, SC USA; [Crawford, John A.] Lindenwood Univ, Dept Biol Sci, St Charles, MO USA; [Crawford, John A.] Natl Great Rivers Res & Educ Ctr, East Alton, IL USA	Loyola University Chicago; Clemson University	Milanovich, JR (corresponding author), Loyola Univ, Dept Biol, Chicago, IL 60626 USA.	jmilanovich@luc.edu			Clemson University Research Grants Committee	Clemson University Research Grants Committee	This project was partially supported by an award from the Clemson University Research Grants Committee to K. Barrett.	Alvarez M. R., 2016, COMPUTATIONAL SOCIAL; Boggs CL, 2005, OECOLOGIA, V144, P353, DOI 10.1007/s00442-005-0076-6; Burkett V, 2000, J AM WATER RESOUR AS, V36, P313, DOI 10.1111/j.1752-1688.2000.tb04270.x; Capps KA, 2015, FRESHWATER BIOL, V60, P500, DOI 10.1111/fwb.12470; Cecala Kristen K., 2007, Herpetological Review, V38, P63; Cohen JS, 2012, ECOL APPL, V22, P218, DOI 10.1890/11-0078.1; Corlett RT, 2013, TRENDS ECOL EVOL, V28, P482, DOI 10.1016/j.tree.2013.04.003; Cothran RD, 2011, J N AM BENTHOL SOC, V30, P893, DOI 10.1899/11-011.1; Earl JE, 2014, OECOLOGIA, V175, P209, DOI 10.1007/s00442-013-2870-x; Earl JE, 2012, OECOLOGIA, V170, P1077, DOI 10.1007/s00442-012-2361-5; Earl JE, 2011, FRESHWATER BIOL, V56, P2473, DOI 10.1111/j.1365-2427.2011.02672.x; Gosner K. L., 1960, Herpetologica, V16, P183; Hautier Y, 2015, SCIENCE, V348, P336, DOI 10.1126/science.aaa1788; HerreraSilveira JA, 1996, LIMNOL OCEANOGR, V41, P1018, DOI 10.4319/lo.1996.41.5.1018; Hocking DJ, 2014, HERPETOL CONSERV BIO, V9, P1; ILLIUS AW, 1992, OECOLOGIA, V89, P428, DOI 10.1007/BF00317422; Kiesecker JM, 2001, ECOLOGY, V82, P1956, DOI 10.1890/0012-9658(2001)082[1956:EODAPD]2.0.CO;2; Leary S, 2013, AVMA GUIDELINES EUTH; Maerz JC, 2005, FUNCT ECOL, V19, P970, DOI 10.1111/j.1365-2435.2005.01054.x; Maerz JC, 2010, FRESHWATER BIOL, V55, P1694, DOI 10.1111/j.1365-2427.2010.02404.x; Magurran AE, 2016, SCIENCE, V351, P448, DOI 10.1126/science.aad6758; Martin LJ, 2015, OIKOS, V124, P871, DOI 10.1111/oik.01745; Martin LJ, 2013, OECOLOGIA, V173, P449, DOI 10.1007/s00442-013-2624-9; Parris MJ, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P526; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; Regester KJ, 2006, OECOLOGIA, V147, P303, DOI 10.1007/s00442-005-0266-2; Richter-Boix A, 2007, J ANIM ECOL, V76, P607, DOI 10.1111/j.1365-2656.2007.01232.x; RIHA VF, 1991, COPEIA, P209, DOI 10.2307/1446264; Rohr JR, 2010, P NATL ACAD SCI USA, V107, P8269, DOI 10.1073/pnas.0912883107; Rosa E. A., 2015, CLIMATE CHANGE SOC S; Rubbo MJ, 2008, HYDROBIOLOGIA, V605, P37, DOI 10.1007/s10750-008-9298-z; Rubbo MJ, 2004, ECOLOGY, V85, P2519, DOI 10.1890/03-0653; Schiesari L, 2009, FRESHWATER BIOL, V54, P572, DOI 10.1111/j.1365-2427.2008.02134.x; Schmider E., 2010, METHODOLOGY; Schriever TA, 2013, FRESHWATER BIOL, V58, P223, DOI 10.1111/fwb.12044; SEALE DB, 1980, ECOLOGY, V61, P1531, DOI 10.2307/1939059; Selwood KE, 2015, BIOL REV, V90, P837, DOI 10.1111/brv.12136; Short FT, 2016, AQUATIC BOT; Skelly DK, 2002, ECOLOGY, V83, P2097, DOI 10.1890/0012-9658(2002)083[2097:EVAEOI]2.0.CO;2; Skelly DK, 2002, ECOLOGY, V83, P983, DOI 10.1890/0012-9658(2002)083[0983:FCATPO]2.0.CO;2; Stephens JP, 2013, FRESHWATER BIOL, V58, P1631, DOI 10.1111/fwb.12155; Stoler AB, 2016, ECOLOGY, V97, P1783, DOI 10.1890/15-1786.1; Stoler AB, 2015, OECOLOGIA, V179, P667, DOI 10.1007/s00442-015-3387-2; Stoler AB, 2013, ECOLOGY, V94, P1594, DOI 10.1890/12-2087.1; Stoler AB, 2011, OIKOS, V120, P862, DOI 10.1111/j.1600-0706.2010.18625.x; Watling JI, 2011, OECOLOGIA, V165, P153, DOI 10.1007/s00442-010-1777-z; Watling JI, 2011, OIKOS, V120, P735, DOI 10.1111/j.1600-0706.2010.19255.x; Wilbur HM, 1997, ECOLOGY, V78, P2279, DOI 10.1890/0012-9658(1997)078[2279:EEOFWC]2.0.CO;2; Winkler JD, 2012, FUNCT ECOL, V26, P513, DOI 10.1111/j.1365-2435.2012.01965.x; Zhu K, 2012, GLOBAL CHANGE BIOL, V18, P1042, DOI 10.1111/j.1365-2486.2011.02571.x	51	6	6	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166296	10.1371/journal.pone.0166296	http://dx.doi.org/10.1371/journal.pone.0166296			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824915	Green Published, gold, Green Submitted			2022-12-26	WOS:000387615200084
J	He, F; Akbari, P; Mo, R; Zhang, JJ; Hui, CC; Kim, PC; Farhat, WA				He, Fei; Akbari, Pedram; Mo, Rong; Zhang, Jennifer J.; Hui, Chi-Chung; Kim, Peter C.; Farhat, Walid A.			Adult Gli2(+/-);Gli3(Delta 699/+) Male and Female Mice Display a Spectrum of Genital Malformation	PLOS ONE			English	Article							EXTERNAL GENITALIA; ANORECTAL-MALFORMATIONS; MOUSE; CRYPTORCHIDISM; HYPOSPADIAS; SURGERY; TESTIS	Disorders of sexual development (DSD) encompass a broad spectrum of urogenital malformations and are amongst the most common congenital birth defects. Although key genetic factors such as the hedgehog (Hh) family have been identified, a unifying postnatally viable model displaying the spectrum of male and female urogenital malformations has not yet been reported. Since human cases are diagnosed and treated at various stages postnatally, equivalent mouse models enabling analysis at similar stages are of significant interest. Additionally, all non-Hh based genetic models investigating DSD display normal females, leaving female urogenital development largely unknown. Here, we generated compound mutant mice, Gli2(+/-);Gli3 Delta(699/+), which exhibit a spectrum of urogenital malformations in both males and females upon birth, and also carried them well into adulthood. Analysis of embryonic day (E) 18.5 and adult mice revealed shortened anogenital distance (AGD), open ventral urethral groove, incomplete fusion of scrotal sac, abnormal penile size and structure, and incomplete testicular descent with hypoplasia in male mice, whereas female mutant mice displayed reduced AGD, urinary incontinence, and a number of uterine anomalies such as vaginal duplication. Male and female fertility was also investigated via breeding cages, and it was identified that male mice were infertile while females were unable to deliver despite becoming impregnated. We propose that Gli2(+/-);Gli3 Delta(699/+) mice can serve as a genetic mouse model for common DSD such as cryptorchidism, hypospadias, and incomplete fusion of the scrotal sac in males, and a spectrum of uterine and vaginal abnormalities along with urinary incontinence in females, which could prove essential in revealing new insights into their equivalent diseases in humans.	[He, Fei; Akbari, Pedram; Mo, Rong; Zhang, Jennifer J.; Hui, Chi-Chung; Farhat, Walid A.] Hosp Sick Children, Res Inst, Program Dev & Stem Cell Biol, Toronto, ON, Canada; [Hui, Chi-Chung] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Kim, Peter C.] Childrens Natl Hlth Syst, Sheikh Zayed Inst Pediat Surg Innovat, Washington, DC USA; [Farhat, Walid A.] Univ Toronto, Hosp Sick Children, Div Urol, Dept Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Children's National Health System; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Farhat, WA (corresponding author), Hosp Sick Children, Res Inst, Program Dev & Stem Cell Biol, Toronto, ON, Canada.; Farhat, WA (corresponding author), Univ Toronto, Hosp Sick Children, Div Urol, Dept Surg, Toronto, ON, Canada.	Walid.farhat@sickkids.ca	Farhat, Walid/AAM-4580-2021		Canadian Institutes of Health Research [FRN: 86628]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work is supported by an operating grant (FRN: 86628) from the Canadian Institutes of Health Research (PCK).	Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; Blaschko SD, 2012, DIFFERENTIATION, V84, P261, DOI 10.1016/j.diff.2012.06.003; Bose J, 2002, HUM MOL GENET, V11, P1129, DOI 10.1093/hmg/11.9.1129; Cheng W, 2008, J UROLOGY, V180, P1543, DOI 10.1016/j.juro.2008.06.003; Clark AM, 2000, BIOL REPROD, V63, P1825, DOI 10.1095/biolreprod63.6.1825; Haraguchi R, 2001, DEVELOPMENT, V128, P4241; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Kimmel SG, 2000, J PEDIATR SURG, V35, P227, DOI 10.1016/S0022-3468(00)90014-9; Klonisch T, 2004, DEV BIOL, V270, P1, DOI 10.1016/j.ydbio.2004.02.018; Kokorowski PJ, 2010, PEDIATRICS, V126, pE576, DOI 10.1542/peds.2010-0747; Levitt MA, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-33; Lin CX, 2009, DEVELOPMENT, V136, P3959, DOI 10.1242/dev.039768; Marrocco G, 2004, PEDIATR SURG INT, V20, P200, DOI 10.1007/s00383-004-1147-1; Miyagawa S, 2011, ENDOCRINOLOGY, V152, P2894, DOI 10.1210/en.2011-0263; Mo R, 2001, AM J PATHOL, V159, P765, DOI 10.1016/S0002-9440(10)61747-6; Nahum GG, 1998, J REPROD MED, V43, P877; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; Nitti V W, 2001, Rev Urol, V3 Suppl 1, pS2; Perriton CL, 2002, DEV BIOL, V247, P26, DOI 10.1006/dbio.2002.0668; Pohl HG, 2007, J UROLOGY, V177, P1646, DOI 10.1016/j.juro.2007.01.058; Rodriguez E, 2011, BIOL REPROD, V85, P1216, DOI 10.1095/biolreprod.111.091504; Ruggeri G, 2012, PEDIATR SURG INT, V28, P797, DOI 10.1007/s00383-012-3121-7; Runck LA, 2014, DIS MODEL MECH, V7, P483, DOI 10.1242/dmm.014530; Tannour-Louet M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015392; Warne SA, 2011, ARCH DIS CHILD, V96, P1072, DOI 10.1136/adc.2009.175034; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399; Yong WD, 2007, J BIOL CHEM, V282, P5026, DOI 10.1074/jbc.M609360200	27	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165958	10.1371/journal.pone.0165958	http://dx.doi.org/10.1371/journal.pone.0165958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814383	Green Submitted, gold, Green Published			2022-12-26	WOS:000386911100022
J	Deiuliis, JA; Syed, R; Duggineni, D; Rutsky, J; Rengasamy, P; Zhang, J; Huang, K; Needleman, B; Mikami, D; Perry, K; Hazey, J; Rajagopalan, S				Deiuliis, Jeffrey A.; Syed, Rafay; Duggineni, Dheeraj; Rutsky, Jessica; Rengasamy, Palanivel; Zhang, Jie; Huang, Kun; Needleman, Bradley; Mikami, Dean; Perry, Kyle; Hazey, Jeffrey; Rajagopalan, Sanjay			Visceral Adipose MicroRNA 223 Is Upregulated in Human and Murine Obesity and Modulates the Inflammatory Phenotype of Macrophages	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; TISSUE INFLAMMATION; EXPRESSION; ACTIVATION; TLR4	Obesity in humans and mice is typified by an activated macrophage phenotype in the visceral adipose tissue (VAT) leading to increased macrophage-mediated inflammation. microRNAs (miRNAs) play an important role in regulating inflammatory pathways in macrophages, and in this study we compared miRNA expression in the VAT of insulin resistant morbidly obese humans to a non-obese cohort with normal glucose tolerance. miR-223-3p was found to be significantly upregulated in the whole omental tissue RNA of 12 human subjects, as were 8 additional miRNAs. We then confirmed that miR-223 upregulation was specific to the stromal vascular cells of human VAT, and found that miR-223 levels were unchanged in adipocytes and circulating monocytes of the non-obese and obese. miR-223 ablation increased basal / unstimulated TLR4 and STAT3 expression and LPS-stimulated TLR4, STAT3, and NOS2 expression in primary macrophages. Conversely, miR-223 mimics decreased TLR4 expression in primary macrophage, at the same time it negatively regulated FBXW7 expression, a well described suppressor of Toll-like receptor 4 (TLR4) signaling. We concluded that the abundance of miR-223 in macrophages significantly modulates macrophage phenotype / activation state and response to stimuli via effects on the TLR4/FBXW7 axis.	[Deiuliis, Jeffrey A.; Syed, Rafay; Rengasamy, Palanivel; Rajagopalan, Sanjay] Univ Maryland, Dept Med, Div Cardiovasc Med, Baltimore, MD 21201 USA; [Deiuliis, Jeffrey A.; Duggineni, Dheeraj; Rutsky, Jessica; Rajagopalan, Sanjay] Ohio State Univ, Coll Med, Dorothy Davis Heart & Lung Inst, Columbus, OH 43210 USA; [Zhang, Jie; Huang, Kun] Ohio State Univ, Coll Med, Dept Biomed Informat, Columbus, OH 43210 USA; [Needleman, Bradley; Mikami, Dean; Perry, Kyle; Hazey, Jeffrey] Ohio State Univ, Coll Med, Dept Surg, Columbus, OH 43210 USA	University System of Maryland; University of Maryland Baltimore; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Deiuliis, JA (corresponding author), Univ Maryland, Dept Med, Div Cardiovasc Med, Baltimore, MD 21201 USA.; Deiuliis, JA (corresponding author), Ohio State Univ, Coll Med, Dorothy Davis Heart & Lung Inst, Columbus, OH 43210 USA.	jeffrey.deiuliis@gmail.com	RENGASAMY, PALANIVEL/GMW-4099-2022	Perry, Kyle/0000-0003-4391-3259; Needleman, Bradley/0000-0002-9186-4028; Syed, Rafay/0000-0001-7831-3005; Deiuliis, Jeffrey/0000-0002-5665-8894				Balamurugan K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2677; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Carvalho MA, 2009, DIABETOLOGIA, V52, P2425, DOI 10.1007/s00125-009-1498-1; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chen QY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037149, 10.1371/journal.pone.0042971]; Deiuliis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016376; Deiuliis JA, 2012, AM J PHYSIOL-LUNG C, V302, pL399, DOI 10.1152/ajplung.00261.2011; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Haneklaus M, 2012, J IMMUNOL, V189, P3795, DOI 10.4049/jimmunol.1200312; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Li JH, 2012, J CANCER RES CLIN, V138, P763, DOI 10.1007/s00432-012-1154-x; Matsumoto A, 2006, BIOCHEM BIOPH RES CO, V350, P114, DOI 10.1016/j.bbrc.2006.09.003; Matsumoto A, 2011, CANCER SCI, V102, P749, DOI 10.1111/j.1349-7006.2011.01851.x; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Noronha BT, 2005, DIABETES, V54, P1082, DOI 10.2337/diabetes.54.4.1082; Odegaard JI, 2008, NAT CLIN PRACT ENDOC, V4, P619, DOI 10.1038/ncpendmet0976; Onoyama I, 2011, J CLIN INVEST, V121, P342, DOI 10.1172/JCI40725; Pescador N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077251; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Tu KS, 2012, MOL MED REP, V6, P525, DOI 10.3892/mmr.2012.953; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Xu YF, 2010, J BIOL CHEM, V285, P34439, DOI 10.1074/jbc.M110.152306; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817	25	39	39	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165962	10.1371/journal.pone.0165962	http://dx.doi.org/10.1371/journal.pone.0165962			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812198	Green Submitted, Green Published, gold			2022-12-26	WOS:000386910000085
J	Pellicelli, M; Picard, C; Wang, DS; Lavigne, P; Moreau, A				Pellicelli, Martin; Picard, Cynthia; Wang, DaShen; Lavigne, Patrick; Moreau, Alain			E2F1 and TFDP1 Regulate PITX1 Expression in Normal and Osteoarthritic Articular Chondrocytes	PLOS ONE			English	Article							ENDOCHONDRAL OSSIFICATION; TRANSCRIPTION FACTORS; DNA-DAMAGE; APOPTOSIS; P53; ACCUMULATION; SENESCENCE; FAMILY; GENES; DP-1	We previously reported a loss-of-PITX1 expression in patients suffering of knee/hip osteo-arthritis (OA). Search for the mechanism underlying this event led us to discover that PITX1 repression was triggered by the aberrant nuclear accumulation of Prohibitin (PHB1), an E2F1 co-repressor, in OA articular chondrocytes. In the current study, we assessed in details the involvement of E2F transcription factors in regulating PITX1 expression. We also analyzed other genes that are similarly regulated by E2F in regard to osteoarthritis. The transcriptional regulation of the PITX1 promoter by E2F1 was analyzed with the luciferase reporter assay, and chromatin immunoprecipitation assays, which confirmed direct E2F1-PITX1 interactions. The probable binding sites for E2F1 in the PITX1 promoter were identified by DNA pulldown experiments. In silico and in vitro analyses show that the PITX1 proximal promoter region contains 2 specific sequences that are bound by E2F1. Overexpression of E2F1 enhances PITX1 promoter activity and mRNA transcription. In primary control and osteoarthritis chondrocytes, real time RT-PCR was used to measure the mRNA expression levels of candidate genes under E2F1 transcriptional control. Transcription Factor Dp-1 (TFDP1) knockdown experiments confirmed that the E2F1-TFDP1 complex regulates PITX1. Knockdown of TFDP1, an E2F1 dimerization partner, inhibits the activating effect of E2F1 and reduces both PITX1 promoter activity and mRNA transcription. Real time RT-PCR results reveal reduced expression of TFDP1 and a similar downregulation of their targets PITX1, BRCA1, CDKN1A, and RAD51 in mid-stage OA chondrocytes. Collectively, our data define a previously uncharacterized role for E2F1 and TFDP1 in the transcriptional regulation of PITX1 in articular chondrocytes. Additional E2F1 targets may be affected in OA pathogenesis.	[Pellicelli, Martin; Picard, Cynthia; Wang, DaShen; Moreau, Alain] St Justine Univ, Hosp Res Ctr, Viscogliosi Lab Mol Genet Musculoskeletal Dis, Montreal, PQ, Canada; [Pellicelli, Martin; Picard, Cynthia; Moreau, Alain] Univ Montreal, Dept Biochem & Mol Med, Fac Med, Montreal, PQ, Canada; [Lavigne, Patrick] Maisonneuve Rosemont Hosp, Orthoped Div, Montreal, PQ, Canada; [Lavigne, Patrick] Univ Montreal, Dept Surg, Fac Med, Montreal, PQ, Canada; [Moreau, Alain] Univ Montreal, Dept Stomatol, Fac Dent, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Moreau, A (corresponding author), St Justine Univ, Hosp Res Ctr, Viscogliosi Lab Mol Genet Musculoskeletal Dis, Montreal, PQ, Canada.; Moreau, A (corresponding author), Univ Montreal, Dept Biochem & Mol Med, Fac Med, Montreal, PQ, Canada.; Moreau, A (corresponding author), Univ Montreal, Dept Stomatol, Fac Dent, Montreal, PQ, Canada.	alain.moreau@recherche-ste-justine.qc.ca		Picard, Cynthia/0000-0003-1107-6839	Canadian Institute of Health Research [MOP-62791]; RSBO-FRSQ; Canadian Institute of Health Research/MENTOR; Fonds de la recherche en sante du Quebec	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); RSBO-FRSQ; Canadian Institute of Health Research/MENTOR; Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by a research grant from The Canadian Institute of Health Research (MOP-62791) to Dr. Moreau. Dr. Martin Pellicelli is a recipient of the RSBO-FRSQ doctoral scholarship. Dr. Cynthia Picard is a recipient of the Canadian Institute of Health Research/MENTOR training program PhD Scholarship and is also a recipient of the Fonds de la recherche en sante du Quebec doctoral scholarship.	Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; DeGregori J, 2002, BBA-REV CANCER, V1602, P131, DOI 10.1016/S0304-419X(02)00051-3; Ding M, 2012, J CELL PHYSIOL, V227, P3446, DOI 10.1002/jcp.24045; Fei Q, 2016, JOINT BONE SPINE, V83, P545, DOI 10.1016/j.jbspin.2015.09.001; Finger F, 2003, ARTHRITIS RHEUM-US, V48, P3395, DOI 10.1002/art.11341; Gibson G, 1998, MICROSC RES TECHNIQ, V43, P191, DOI 10.1002/(SICI)1097-0029(19981015)43:2<191::AID-JEMT10>3.0.CO;2-T; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kowalik TF, 1998, CELL GROWTH DIFFER, V9, P113; Lanctot C, 1999, DEVELOPMENT, V126, P1805; Liu DX, 2007, CELL DEATH DIFFER, V14, P1893, DOI 10.1038/sj.cdd.4402209; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Perlman H, 2003, J IMMUNOL, V170, P838, DOI 10.4049/jimmunol.170.2.838; Picard C, 2007, CLIN ORTHOP RELAT R, P59, DOI 10.1097/BLO0b013e3180d09d9c; Picard C, 2013, ARTHRITIS RHEUM-US, V65, P993, DOI 10.1002/art.37837; Qin YL, 2012, AM J CANCER RES, V2, P540; Raderschall E, 2002, J CELL SCI, V115, P153; Rose J, 2012, OSTEOARTHR CARTILAGE, V20, P1020, DOI 10.1016/j.joca.2012.05.009; Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sesselmann S, 2009, OSTEOARTHR CARTILAGE, V17, P507, DOI 10.1016/j.joca.2008.09.006; Sorensen TS, 1996, MOL CELL BIOL, V16, P5888; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Zamli Z, 2011, INT J RHEUM DIS, V14, P159, DOI 10.1111/j.1756-185X.2011.01618.x	25	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165951	10.1371/journal.pone.0165951	http://dx.doi.org/10.1371/journal.pone.0165951			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802335	gold, Green Published, Green Submitted			2022-12-26	WOS:000386714200071
J	Richter, MJ; Tiede, SL; Sommer, N; Schmidt, T; Seeger, W; Ghofrani, HA; Schermuly, R; Gall, H				Richter, Manuel Jonas; Tiede, Svenja Lena; Sommer, Natascha; Schmidt, Thomas; Seeger, Werner; Ghofrani, Hossein Ardeschir; Schermuly, Ralph; Gall, Henning			Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CONGESTIVE-HEART-FAILURE; ARTERIAL-HYPERTENSION; PLASMA ANGIOPOIETIN-1; RECEPTOR TIE-2; MARKER; ANGIOGENESIS; PATHWAY; TRANSPLANTATION; ASSOCIATION	Background Circulating angiopoietin-1 (Ang-1) has been linked to pulmonary hypertension (PH) in experimental studies. However, the clinical relevance of Ang-1 as a biomarker in PH remains unknown. We aimed to investigate the prognostic and clinical significance of Ang-1 in PH using data from the prospectively recruiting Giessen PH Registry. Methods Patients with suspected PH (without previous specific pulmonary arterial hypertension [PAH] therapy) who underwent initial right heart catheterization (RHC) in our national referral center between July 2003 and May 2012 and who agreed to optional biomarker analysis were included if they were diagnosed with idiopathic PAH, connective tissue disease-associated PAH (CTD-PAH), PH due to left heart disease (PH-LHD), or chronic thromboembolic PH (CTEPH), or if PH was excluded by RHC (non-PH controls). The association of Ang-1 levels with disease severity (6-minute walk distance and pulmonary hemodynamics) was assessed using linear regression, and the impact of Ang-1 levels on transplant-free survival (primary endpoint)and clinical worsening was assessed using Kaplan-Meier curves, receiver operating characteristic (ROC) analyses, and Cox regression. Results 151 patients (39, 39, 32, and 41 with idiopathic PAH, CTD-PAH, PH-LHD, and CTEPH, respectively) and 41 non-PH controls were included. Ang-1 levels showed no significant difference between groups (p = 0.8), and no significant associations with disease severity in PH subgroups (p >= 0.07). In Kaplan-Meier analyses, Ang-1 levels (stratified by quartile) had no significant impact on transplant-free survival (p >= 0.27) or clinical worsening (p >= 0.51) in PH subgroups. Regression models found no significant association between Ang-1 levels and outcomes (p >= 0.31). ROC analyses found no significant cut-off that would maximize sensitivity and specificity. Conclusions Despite a strong pathophysiological association in experimental studies, this first comprehensive analysis of Ang-1 in PH subgroups suggests that Ang-1 is not a predictive and clinically relevant biomarker in PH.	[Richter, Manuel Jonas; Tiede, Svenja Lena; Sommer, Natascha; Schmidt, Thomas; Seeger, Werner; Ghofrani, Hossein Ardeschir; Schermuly, Ralph; Gall, Henning] Univ Giessen, Dept Internal Med, UGMLC, Giessen, Germany; [Richter, Manuel Jonas; Tiede, Svenja Lena; Sommer, Natascha; Schmidt, Thomas; Seeger, Werner; Ghofrani, Hossein Ardeschir; Schermuly, Ralph; Gall, Henning] German Ctr Lung Res DZL, Giessen, Germany; [Richter, Manuel Jonas; Ghofrani, Hossein Ardeschir] Kerckhoff Heart Rheuma & Thorac Ctr, Dept Pneumol, Bad Nauheim, Germany; [Ghofrani, Hossein Ardeschir] Imperial Coll London, Dept Med, London, England	Justus Liebig University Giessen; Kerckhoff Clinic; Imperial College London	Gall, H (corresponding author), Univ Giessen, Dept Internal Med, UGMLC, Giessen, Germany.; Gall, H (corresponding author), German Ctr Lung Res DZL, Giessen, Germany.	Henning.Gall@innere.med.uni-giessen.de	Ghofrani, Ardeschir/AAD-5293-2020; Sommer, Natascha/AAD-5406-2020; Ghofrani, Hossein Ardeschir/AAD-2856-2022	Ghofrani, Ardeschir/0000-0002-2029-4419; Schermuly, Ralph/0000-0002-5167-6970; Seeger, Werner/0000-0003-1946-0894; Sommer, Natascha/0000-0002-8915-7762				Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Belly MJ, 2012, J HEART LUNG TRANSPL, V31, P1109, DOI 10.1016/j.healun.2012.08.014; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Caine GJ, 2003, EUR J CLIN INVEST, V33, P883, DOI 10.1046/j.1365-2362.2003.01243.x; Chong AY, 2004, J AM COLL CARDIOL, V43, P423, DOI 10.1016/j.jacc.2003.08.042; Chong AY, 2004, EUR J CLIN INVEST, V34, P9, DOI 10.1111/j.1365-2362.2004.01284.x; Chu D, 2004, ANN THORAC SURG, V77, P449, DOI 10.1016/S0003-4975(03)01350-X; David S, 2009, AM J KIDNEY DIS, V53, P770, DOI 10.1053/j.ajkd.2008.11.030; Dewachter L, 2006, AM J RESP CRIT CARE, V174, P1025, DOI 10.1164/rccm.200602-304OC; Du Lingling, 2003, New England Journal of Medicine, V348, P500, DOI 10.1056/NEJMoa021650; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Gashouta MA, 2014, PRESSE MED, V43, pE293, DOI 10.1016/j.lpm.2014.06.007; Gouw ASH, 2010, HEPATOLOGY, V52, P540, DOI 10.1002/hep.23700; Hampole CV, 2009, AM J CARDIOL, V104, P868, DOI 10.1016/j.amjcard.2009.05.016; Hassoun PM, 2015, AM J RESP CRIT CARE, V192, P1102, DOI 10.1164/rccm.201507-1398OC; Hato T, 2009, BIOCHEM BIOPH RES CO, V381, P218, DOI 10.1016/j.bbrc.2009.02.030; Hoeper MM, 2007, EUR RESPIR J, V29, P944, DOI 10.1183/09031936.00134506; Hughes DP, 2003, CIRC RES, V92, P630, DOI 10.1161/01.RES.0000063422.38690.DC; Kasztelan-Szczerbinska B, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/673032; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Kim Won, 2008, Electrolyte Blood Press, V6, P22, DOI 10.5049/EBP.2008.6.1.22; Kumpers P, 2010, EUR HEART J, V31, P2291, DOI 10.1093/eurheartj/ehq226; Kugathasan L, 2005, CHEST, V128, p633S, DOI 10.1378/chest.128.6_suppl.633S; Kugathasan L, 2009, J EXP MED, V206, P2221, DOI 10.1084/jem.20090389; Lee KW, 2004, CIRCULATION, V110, P2355, DOI 10.1161/01.CIR.0000138112.90641.7F; Leuchte HH, 2007, CHEST, V131, P402, DOI 10.1378/chest.06-1758; Lukasz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066861; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mandriota SJ, 1998, CIRC RES, V83, P852, DOI 10.1161/01.RES.83.8.852; McLaughlin VV, 2013, J AM COLL CARDIOL, V62, pD73, DOI 10.1016/j.jacc.2013.10.034; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Nadar SK, 2004, J INTERN MED, V256, P331, DOI 10.1111/j.1365-2796.2004.01367.x; Oh H, 1999, J BIOL CHEM, V274, P15732, DOI 10.1074/jbc.274.22.15732; Olsson KM, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0194-6; Pepke-Zaba J, 2011, CIRCULATION, V124, P1973, DOI 10.1161/CIRCULATIONAHA.110.015008; Poss J, 2015, CLIN RES CARDIOL, V104, P380, DOI 10.1007/s00392-014-0787-y; Post S, 2008, J VASC RES, V45, P244, DOI 10.1159/000112939; Puri MC, 1999, DEVELOPMENT, V126, P4569; RICKHAM PP, 1964, BRIT MED J, V2, P173; Rubens C, 2001, CHEST, V120, P1562, DOI 10.1378/chest.120.5.1562; Shah SJ, 2008, CIRCULATION, V117, P2475, DOI 10.1161/CIRCULATIONAHA.107.719500; Singh S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158908; Sitbon O, 2010, EUR RESPIR REV, V19, P272, DOI 10.1183/09059180.00008210; Sullivan CC, 2003, P NATL ACAD SCI USA, V100, P12331, DOI 10.1073/pnas.1933740100; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Thistlethwaite PA, 2001, J THORAC CARDIOV SUR, V122, P65, DOI 10.1067/mtc.2001.113753; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Tiede SL, 2015, EUR RESPIR J, V46, P1390, DOI 10.1183/13993003.00187-2015; Torbicki A, 2003, CIRCULATION, V108, P844, DOI 10.1161/01.CIR.0000084544.54513.E2; van der Plas MN, 2010, ANN THORAC SURG, V89, P347, DOI 10.1016/j.athoracsur.2009.08.001; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Woolf AS, 2009, J AM SOC NEPHROL, V20, P239, DOI 10.1681/ASN.2008020243; Zhao YD, 2003, CIRC RES, V92, P984, DOI 10.1161/01.RES.0000070587.79937.F0	54	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165982	10.1371/journal.pone.0165982	http://dx.doi.org/10.1371/journal.pone.0165982			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802345	Green Published, Green Submitted, gold			2022-12-26	WOS:000386714200073
J	Tang, R; Zhang, G; Chen, SY				Tang, Rui; Zhang, Gui; Chen, Shi-You			Smooth Muscle Cell Proangiogenic Phenotype Induced by Cyclopentenyl Cytosine Promotes Endothelial Cell Proliferation and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE RECEPTORS; TGF-BETA; CAROTID ARTERIES; LESION FORMATION; ANGIOGENESIS; PDGF; INHIBITION; PLASTICITY; PERICYTES; GROWTH	Vascular smooth muscle cells (SMCs) and endothelial cells (ECs) are in close contact with blood vessels. SMC phenotypes can be altered during pathological vascular remodeling. However, how SMC phenotypes affect EC properties remains largely unknown. In this study, we found that PDGF-BB-induced synthetic SMCs suppressed EC proliferation and migration while exhibiting increased expression of anti-angiogenic factors, such as endostatin, and decreased pro-angiogenic factors, including CXC motif ligand 1 (CXCL1). Cyclopentenyl cytosine (CPEC), a CTP synthase inhibitor that has been reported previously to inhibit SMC proliferation and injury-induced neointima formation, induced SMC redifferentiation. Interestingly, CPEC-conditioned SMC culture medium promoted EC proliferation and migration because of an increase in CXCL1 along with decreased endostatin production in SMCs. Addition of recombinant endostatin protein or blockade of CXCL1 with a neutralizing antibody suppressed the EC proliferation and migration induced by CPEC-conditioned SMC medium. Mechanistically, CPEC functions as a cytosine derivate to stimulate adenosine receptors A1 and A2a, which further activate downstream cAMP and Akt signaling, leading to the phosphorylation of cAMP response element binding protein and, consequently, SMC redifferentiation. These data provided proof of a novel concept that synthetic SMC exhibits an anti-angiogenic SMC phenotype, whereas contractile SMC shows a pro-angiogenic phenotype. CPEC appears to be a potent stimulator for switching the anti-angiogenic SMC phenotype to the pro-angiogenic phenotype, which may be essential for CPEC to accelerate re-endothelialization for vascular repair during injury-induced vascular wall remodeling.	[Tang, Rui; Zhang, Gui; Chen, Shi-You] Univ Georgia, Dept Physiol & Pharmacol, 501 DW Brooks Dr, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Chen, SY (corresponding author), Univ Georgia, Dept Physiol & Pharmacol, 501 DW Brooks Dr, Athens, GA 30602 USA.	sc229@uga.edu			National Institute of Health [HL123302, HL119053]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123302, R01HL119053] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institute of Health Grants HL123302 and HL119053. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANTONELLIORLIDGE A, 1989, P NATL ACAD SCI USA, V86, P4544, DOI 10.1073/pnas.86.12.4544; Apovian CM, 2008, ARTERIOSCL THROM VAS, V28, P1654, DOI 10.1161/ATVBAHA.108.170316; Beech DJ, 2007, BIOCHEM SOC T, V35, P890, DOI 10.1042/BST0350890; Brigstock David R., 2002, Angiogenesis, V5, P153, DOI 10.1023/A:1023823803510; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chang SF, 2014, P NATL ACAD SCI USA, V111, P1855, DOI 10.1073/pnas.1323761111; Cidad P, 2010, ARTERIOSCL THROM VAS, V30, P1203, DOI 10.1161/ATVBAHA.110.205187; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Feoktistov I, 2004, HYPERTENSION, V44, P649, DOI 10.1161/01.HYP.0000144800.21037.a5; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Fillinger MF, 1997, J SURG RES, V67, P169, DOI 10.1006/jsre.1996.4978; FINGERLE J, 1990, ARTERIOSCLEROSIS, V10, P1082, DOI 10.1161/01.ATV.10.6.1082; FISHMAN JA, 1975, LAB INVEST, V32, P339; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; Halka AT, 2008, CARDIOVASC PATHOL, V17, P98, DOI 10.1016/j.carpath.2007.03.001; Hatch GM, 1996, J BIOL CHEM, V271, P25810, DOI 10.1074/jbc.271.42.25810; Hayashi K, 1999, J CELL BIOL, V145, P727, DOI 10.1083/jcb.145.4.727; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; HOOVER GA, 1989, ARTERIOSCLEROSIS, V9, P76, DOI 10.1161/01.ATV.9.1.76; Iyemere VP, 2006, J INTERN MED, V260, P192, DOI 10.1111/j.1365-2796.2006.01692.x; Jaschke B, 2005, CARDIOVASC RES, V68, P483, DOI 10.1016/j.cardiores.2005.06.029; JONZON B, 1985, J CELL PHYSIOL, V124, P451, DOI 10.1002/jcp.1041240314; Kipshidze N, 2004, J AM COLL CARDIOL, V44, P733, DOI 10.1016/j.jacc.2004.04.048; Klemm DJ, 2001, J BIOL CHEM, V276, P46132, DOI 10.1074/jbc.M104769200; LANGILLE BL, 1986, SCIENCE, V231, P405, DOI 10.1126/science.3941904; Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; Miyake M, 2013, LAB INVEST, V93, P768, DOI 10.1038/labinvest.2013.71; Miyazawa K, 1995, ATHEROSCLEROSIS, V118, P213, DOI 10.1016/0021-9150(95)05607-6; MOTRO B, 1990, P NATL ACAD SCI USA, V87, P3092, DOI 10.1073/pnas.87.8.3092; Nadal JA, 2002, AM J PHYSIOL-HEART C, V282, pH739, DOI 10.1152/ajpheart.00656.2001; Natori T, 2002, BIOCHEM BIOPH RES CO, V297, P1058, DOI 10.1016/S0006-291X(02)02335-5; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Olson LE, 2011, DEV CELL, V20, P815, DOI 10.1016/j.devcel.2011.04.019; ORLIDGE A, 1987, J CELL BIOL, V105, P1455, DOI 10.1083/jcb.105.3.1455; Rehn M, 2001, P NATL ACAD SCI USA, V98, P1024, DOI 10.1073/pnas.031564998; REIDY MA, 1981, LAB INVEST, V44, P301; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Sakao S, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-95; Shigematsu Satoshi, 1999, Endocrine Journal, V46, pS59, DOI 10.1507/endocrj.46.Suppl_S59; Shryock JC, 1997, AM J CARDIOL, V79, P2, DOI 10.1016/S0002-9149(97)00256-7; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Tang R, 2013, ARTERIOSCL THROM VAS, V33, P2336, DOI 10.1161/ATVBAHA.113.301561; Tang R, 2012, CELL RES, V22, P504, DOI 10.1038/cr.2011.137; Tuszynski GP, 1996, BIOESSAYS, V18, P71, DOI 10.1002/bies.950180113; Virmani R, 1999, CURR OPIN LIPIDOL, V10, P499, DOI 10.1097/00041433-199912000-00004; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Wang JN, 2011, ARTERIOSCL THROM VAS, V31, pE19, DOI 10.1161/ATVBAHA.111.230706; Wong J, 1997, CIRCULATION, V96, P1631, DOI 10.1161/01.CIR.96.5.1631; Xie WB, 2011, J BIOL CHEM, V286, P15050, DOI 10.1074/jbc.M110.202747; Yilmaz MS, 2008, EUR J PHARMACOL, V584, P125, DOI 10.1016/j.ejphar.2008.01.044; Zhong HY, 2004, AM J RESP CELL MOL, V30, P118, DOI 10.1165/rcmb.2003-0118OC	55	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26913	26921		10.1074/jbc.M116.741967	http://dx.doi.org/10.1074/jbc.M116.741967			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27821588	Green Published, hybrid			2022-12-26	WOS:000391571400027
J	St Gelais, C; Kim, SH; Ding, LM; Yount, JS; Ivanov, D; Spearman, P; Wu, L				St Gelais, Corine; Kim, Sun Hee; Ding, Lingmei; Yount, Jacob S.; Ivanov, Dmitri; Spearman, Paul; Wu, Li			A Putative Cyclin-binding Motif in Human SAMHD1 Contributes to Protein Phosphorylation, Localization, and Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AICARDI-GOUTIERES-SYNDROME; RESTRICTION FACTOR SAMHD1; DEOXYNUCLEOSIDE TRIPHOSPHATE TRIPHOSPHOHYDROLASE; IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; HIV-1 RESTRICTION; DENDRITIC CELLS; RIBONUCLEASE-ACTIVITY; DEPENDENT KINASES; NUCLEASE ACTIVITY	SAMHD1 (sterile alpha motif and HD domain-containing protein 1) is a mammalian protein that regulates intracellular dNTP levels through its hydrolysis of dNTPs. SAMHD1 functions as an important retroviral restriction factor through a mechanism relying on its dNTPase activity. We and others have reported that human SAMHD1 interacts with the cell cycle regulatory proteins cyclin A, CDK1, and CDK2, which mediates phosphorylation of SAMHD1 at threonine 592, a post-translational modification that has been implicated in abrogating SAMHD1 restriction function and ability to form stable tetramers. Utilizing co-immunoprecipitation and co-localization approaches, we show that endogenous SAMHD1 is able to interact with the cyclin A-CDK1-CDK2 complex in monocytic THP-1 cells and primary monocyte-derived macrophages. Sequence analysis of SAMHD1 identifies a putative cyclin-binding motif found in many cyclin-CDK complex substrates. Using a mutagenesis-based approach, we demonstrate that the conserved residues in the putative cyclin-binding motif are important for protein expression, protein half-life, and optimal phosphorylation of SAMHD1 at Thr(592). Furthermore, we observed that SAMHD1 mutants of the cyclin-binding motif mislocalized to a nuclear compartment and had reduced ability to interact with cyclin A-CDK complexes and to form the tetramer. These findings help define the mechanisms by which SAMHD1 is phosphorylated and suggest the contribution of cyclin binding to SAMHD1 expression and stability in dividing cells.	[St Gelais, Corine; Kim, Sun Hee; Wu, Li] Ohio State Univ, Dept Vet Biosci, Ctr Retrovirus Res, 1900 Coffey Rd, Columbus, OH 43210 USA; [Yount, Jacob S.; Wu, Li] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Ding, Lingmei; Spearman, Paul] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Spearman, Paul] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Ivanov, Dmitri] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Emory University; Children's Healthcare of Atlanta (CHOA); University of Texas System; University of Texas Health San Antonio	Wu, L (corresponding author), Ohio State Univ, Dept Vet Biosci, Ctr Retrovirus Res, 1900 Coffey Rd, Columbus, OH 43210 USA.	wu.840@osu.edu	Wu, Li/ABB-2813-2020; Wu, Li/E-4330-2011; Ivanov, Dmitri/B-4600-2011	Wu, Li/0000-0002-5468-2487; Wu, Li/0000-0002-5468-2487; Yount, Jacob/0000-0002-6128-4575	National Institutes of Health [GM111027, AI104483, CA181997, AI120209, AI127667]; Public Health Preparedness for Infectious Diseases Program of the Ohio State University; NATIONAL CANCER INSTITUTE [R21CA181997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104476, R01AI104483, R56AI127667, R01AI120209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Preparedness for Infectious Diseases Program of the Ohio State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM111027 (to P. S.) and AI104483, CA181997, AI120209, and AI127667 (to L. W.) and in part by the Public Health Preparedness for Infectious Diseases Program of the Ohio State University (to L. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 1996, MOL CELL BIOL, V16, P6623; Antonucci JM, 2016, NAT MED, V22, P1072, DOI 10.1038/nm.4163; Arnold LH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005194; Arnold LH, 2015, ANTIMICROB AGENTS CH, V59, P186, DOI 10.1128/AAC.03903-14; Badia R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005829; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Beloglazova N, 2013, J BIOL CHEM, V288, P8101, DOI 10.1074/jbc.M112.431148; Bonifati S, 2016, VIROLOGY, V495, P92, DOI 10.1016/j.virol.2016.05.002; Brandariz-Nunez A, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-131; Brandariz-Nunez A, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-49; Chen JJ, 1996, MOL CELL BIOL, V16, P4673; Chen ZM, 2014, BIOCHEM BIOPH RES CO, V450, P1462, DOI 10.1016/j.bbrc.2014.07.023; Choi J, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0174-4; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Dong CS, 2007, J VIROL, V81, P11352, DOI 10.1128/JVI.01081-07; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Gelais CS, 2014, J VIROL, V88, P5834, DOI 10.1128/JVI.00155-14; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goncalves A, 2012, HUM MUTAT, V33, P1116, DOI 10.1002/humu.22087; Goutieres F, 2005, BRAIN DEV-JPN, V27, P201, DOI 10.1016/j.braindev.2003.12.011; Gramberg T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-26; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Jackman M, 2002, MOL BIOL CELL, V13, P1030, DOI 10.1091/mbc.01-07-0361; Ji XY, 2013, NAT STRUCT MOL BIOL, V20, P1304, DOI 10.1038/nsmb.2692; Jiang W, 1999, P NATL ACAD SCI USA, V96, P6193, DOI 10.1073/pnas.96.11.6193; Kim ET, 2013, J VIROL, V87, P12949, DOI 10.1128/JVI.02291-13; Kohnken R, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0446-6; Kretschmer S, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204845; Kyei GB, 2015, CELL HOST MICROBE, V17, P98, DOI 10.1016/j.chom.2014.11.009; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Li N, 2000, IMMUNOL LETT, V74, P221, DOI 10.1016/S0165-2478(00)00276-5; Liu F, 1999, MOL CELL BIOL, V19, P5113; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma TL, 1999, P NATL ACAD SCI USA, V96, P382, DOI 10.1073/pnas.96.2.382; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Pauls E, 2014, J IMMUNOL, V193, P1988, DOI 10.4049/jimmunol.1400873; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Ruiz A, 2015, CELL CYCLE, V14, P1657, DOI 10.1080/15384101.2015.1030558; Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626; Seamon KJ, 2015, NUCLEIC ACIDS RES, V43, P6486, DOI 10.1093/nar/gkv633; St Gelais C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-105; Tang CX, 2015, J BIOL CHEM, V290, P26352, DOI 10.1074/jbc.M115.677435; Tungler V, 2013, J MOL MED, V91, P759, DOI 10.1007/s00109-013-0995-3; Welbourn S, 2013, J VIROL, V87, P11516, DOI 10.1128/JVI.01642-13; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; White TE, 2013, VIROLOGY, V436, P81, DOI 10.1016/j.virol.2012.10.029; Wittmann S, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0229-6; Wohlschlegel JA, 2001, MOL CELL BIOL, V21, P4868, DOI 10.1128/MCB.21.15.4868-4874.2001; XU M, 1994, MOL CELL BIOL, V14, P8420, DOI 10.1128/MCB.14.12.8420; Yan JP, 2015, J BIOL CHEM, V290, P13279, DOI 10.1074/jbc.M115.646588; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Zhou Pengbo, 2004, Methods Mol Biol, V284, P67; Zhu CF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3722	56	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26332	26342		10.1074/jbc.M116.753947	http://dx.doi.org/10.1074/jbc.M116.753947			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27815502	Green Published, hybrid			2022-12-26	WOS:000391568200008
J	Chen, YL; Guo, HF; Terajima, M; Banerjee, P; Liu, X; Yu, J; Momin, AA; Katayama, H; Hanash, SM; Burns, AR; Fields, GB; Yamauchi, M; Kurie, JM				Chen, Yulong; Guo, Houfu; Terajima, Masahiko; Banerjee, Priyam; Liu, Xin; Yu, Jiang; Momin, Amin A.; Katayama, Hiroyuki; Hanash, Samir M.; Burns, Alan R.; Fields, Gregg B.; Yamauchi, Mitsuo; Kurie, Jonathan M.			Lysyl Hydroxylase 2 Is Secreted by Tumor Cells and Can Modify Collagen in the Extracellular Space	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME-OSTEOGENESIS IMPERFECTA; BRUCK-SYNDROME; CROSS-LINKING; LYSINE HYDROXYLATION; FKBP10 CAUSE; I COLLAGEN; MUTATIONS; TISSUE; METASTASIS; EXPRESSION	Lysyl hydroxylase 2 (LH2) catalyzes the hydroxylation of lysine residues in the telopeptides of fibrillar collagens, which leads to the formation of stable collagen cross-links. Recently we reported that LH2 enhances the metastatic propensity of lung cancer by increasing the amount of stable hydroxylysine aldehyde-derived collagen cross-links (HLCCs), which generate a stiffer tumor stroma (Chen, Y., et al. (2015) J. Clin. Invest. 125, 125, 1147-1162). It is generally accepted that LH2 modifies procollagen alpha chains on the endoplasmic reticulum before the formation of triple helical procollagen molecules. Herein, we report that LH2 is also secreted and modifies collagen in the extracellular space. Analyses of lung cancer cell lines demonstrated that LH2 is present in the cell lysates and the conditioned media in a dimeric, active form in both compartments. LH2 co-localized with collagen fibrils in the extracellular space in human lung cancer specimens and in orthotopic lung tumors generated by injection of a LH2-expressing human lung cancer cell line into nude mice. LH2 depletion in MC3T3 osteoblastic cells impaired the formation of HLCCs, resulting in an increase in the unmodified lysine aldehyde-derived collagen cross-link (LCC), and the addition of recombinant LH2 to the media of LH2-deficient MC3T3 cells was sufficient to rescue HLCC formation in the extracellular matrix. The finding that LH2 modifies collagen in the extracellular space challenges the current view that LH2 functions solely on the endoplasmic reticulum and could also have important implications for cancer biology.	[Chen, Yulong; Guo, Houfu; Banerjee, Priyam; Liu, Xin; Yu, Jiang; Kurie, Jonathan M.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Terajima, Masahiko; Yamauchi, Mitsuo] Univ N Carolina, Sch Dent, Oral & Craniofacial Hlth Sci, Chapel Hill, NC 27599 USA; [Momin, Amin A.; Katayama, Hiroyuki; Hanash, Samir M.] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [Burns, Alan R.] Univ Houston, Coll Optometry, Houston, TX 77004 USA; [Fields, Gregg B.] Florida Atlantic Univ, Dept Chem & Biochem, Jupiter, FL 33458 USA	University of Texas System; UTMD Anderson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; UTMD Anderson Cancer Center; University of Houston System; University of Houston; State University System of Florida; Florida Atlantic University	Yamauchi, M (corresponding author), Univ N Carolina, Sch Dent, Oral & Craniofacial Hlth Sci, Chapel Hill, NC 27599 USA.; Kurie, JM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Unit 432, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mitsuo_yamauchi@unc.edu; jkurie@mdanderson.org	Banerjee, Priyam/D-2363-2011	Banerjee, Priyam/0000-0001-9398-9345; Guo, Hou-Fu/0000-0002-3659-9399	National Institutes of Health [R21AR060978, R01CA105155]; Elza A. and Ina S. Freeman Professorship in Lung Cancer; MD Anderson Cancer Center [CA016672]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elza A. and Ina S. Freeman Professorship in Lung Cancer; MD Anderson Cancer Center	This work was supported, in whole or in part, by National Institutes of Health Grants R21AR060978 (NIAMS; to M. Y.) and R01CA105155 (NCI; to J. M. K. and M. Y.). This work was also supported by the Elza A. and Ina S. Freeman Professorship in Lung Cancer (to J. M. K.) and MD Anderson Cancer Center Support Grant CA016672. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blanco MA, 2012, CELL RES, V22, P1339, DOI 10.1038/cr.2012.89; Cao Y, 2013, CANCER RES, V73, P4579, DOI 10.1158/0008-5472.CAN-13-0529; Chen YL, 2015, J CLIN INVEST, V125, P1147, DOI 10.1172/JCI74725; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; Eisinger-Mathason TSK, 2013, CANCER DISCOV, V3, P1190, DOI 10.1158/2159-8290.CD-13-0118; Gilkes DM, 2013, MOL CANCER RES, V11, P456, DOI 10.1158/1541-7786.MCR-12-0629; Ha-Vinh R, 2004, AM J MED GENET A, V131A, P115, DOI 10.1002/ajmg.a.30231; Heikkinen J, 2011, MATRIX BIOL, V30, P27, DOI 10.1016/j.matbio.2010.10.002; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kelley BP, 2011, J BONE MINER RES, V26, P666, DOI 10.1002/jbmr.250; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Mercer DK, 2003, BIOCHEM BIOPH RES CO, V307, P803, DOI 10.1016/S0006-291X(03)01262-2; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Pornprasertsuk S, 2005, J BONE MINER RES, V20, P81, DOI 10.1359/JBMR.041026; Pornprasertsuk S, 2004, J BONE MINER RES, V19, P1349, DOI 10.1359/JBMR.040323; Remst DFG, 2013, OSTEOARTHR CARTILAGE, V21, P157, DOI 10.1016/j.joca.2012.10.002; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Robertson D, 2011, METHODS MOL BIOL, V724, P69, DOI 10.1007/978-1-61779-055-3_4; Sada M, 2016, CANCER LETT, V372, P210, DOI 10.1016/j.canlet.2016.01.016; Salo AM, 2006, J CELL PHYSIOL, V207, P644, DOI 10.1002/jcp.20596; Salo AM, 2006, MATRIX BIOL, V25, P475, DOI 10.1016/j.matbio.2006.08.260; Schliekelman MJ, 2015, CANCER RES, V75, P1789, DOI 10.1158/0008-5472.CAN-14-2535; Schwarze U, 2013, HUM MOL GENET, V22, P1, DOI 10.1093/hmg/dds371; Shaheen R, 2011, AM J MED GENET A, V155A, P1448, DOI 10.1002/ajmg.a.34025; SIEGEL RC, 1974, P NATL ACAD SCI USA, V71, P4826, DOI 10.1073/pnas.71.12.4826; Sricholpech M, 2011, J BIOL CHEM, V286, P8846, DOI 10.1074/jbc.M110.178509; Suokas M, 2000, J BIOL CHEM, V275, P17863, DOI 10.1074/jbc.M908025199; Takaluoma K, 2007, MATRIX BIOL, V26, P396, DOI 10.1016/j.matbio.2007.01.002; TANZER ML, 1973, J BIOL CHEM, V248, P393; Puig-Hervas MT, 2012, HUM MUTAT, V33, P1444, DOI 10.1002/humu.22133; Uzawa K, 1999, J BONE MINER RES, V14, P1272, DOI 10.1359/jbmr.1999.14.8.1272; Valtavaara M, 1997, J BIOL CHEM, V272, P6831, DOI 10.1074/jbc.272.11.6831; van der Slot AJ, 2005, BBA-MOL BASIS DIS, V1741, P95, DOI 10.1016/j.bbadis.2004.09.009; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; Wang CG, 2012, J CELL PHYSIOL, V227, P668, DOI 10.1002/jcp.22774; YAMAUCHI M, 1987, J BIOL CHEM, V262, P11428; Yamauchi Mitsuo, 2008, V446, P95, DOI 10.1007/978-1-60327-084-7_7; Yamauchi M, 2012, ESSAYS BIOCHEM, V52, P113, DOI [10.1042/BSE0520113, 10.1042/bse0520113]	40	46	46	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25799	25808		10.1074/jbc.M116.759803	http://dx.doi.org/10.1074/jbc.M116.759803			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27803159	Green Published, hybrid			2022-12-26	WOS:000390345200004
J	Balaraman, S; Schafer, JJ; Tseng, AM; Wertelecki, W; Yevtushok, L; Zymak-Zakutnya, N; Chambers, CD; Miranda, RC				Balaraman, Sridevi; Schafer, Jordan J.; Tseng, Alexander M.; Wertelecki, Wladimir; Yevtushok, Lyubov; Zymak-Zakutnya, Natalya; Chambers, Christina D.; Miranda, Rajesh C.			Plasma miRNA Profiles in Pregnant Women Predict Infant Outcomes following Prenatal Alcohol Exposure	PLOS ONE			English	Article							MATERNAL RISK-FACTORS; ACID ETHYL-ESTERS; ETHANOL EXPOSURE; MICRORNA EXPRESSION; MESSENGER-RNA; SPECTRUM DISORDERS; ENDOTHELIAL-CELLS; FETAL; RAT; PREVALENCE	Fetal alcohol spectrum disorders (FASD) are difficult to diagnose since many heavily exposed infants, at risk for intellectual disability, do not exhibit craniofacial dysmorphology or growth deficits. Consequently, there is a need for biomarkers that predict disability. In both animal models and human studies, alcohol exposure during pregnancy resulted in significant alterations in circulating microRNAs (miRNAs) in maternal blood. In the current study, we asked if changes in plasma miRNAs in alcohol-exposed pregnant mothers, either alone or in conjunction with other clinical variables, could predict infant outcomes. Sixtyeight pregnant women at two perinatal care clinics in western Ukraine were recruited into the study. Detailed health and alcohol consumption histories, and 2nd and 3rd trimester blood samples were obtained. Birth cohort infants were assessed by a geneticist and classified as unexposed (UE), heavily prenatally exposed and affected (HEa) or heavily exposed but apparently unaffected (HEua). MiRNAs were assessed in plasma samples using qRT-PCR arrays. ANOVA models identified 11 miRNAs that were all significantly elevated in maternal plasma from the HEa group relative to HEua and UE groups. In a random forest analysis classification model, a combination of high variance miRNAs, smoking history and socioeconomic status classified membership in HEa and UE groups, with a misclassification rate of 13%. The RFA model also classified 17% of the HEua group as UE-like, whereas 83% were HEa-like, at least at one stage of pregnancy. Collectively our data indicate that maternal plasma miRNAs predict infant outcomes, and may be useful to classify difficult-to-diagnose FASD subpopulations.	[Balaraman, Sridevi; Tseng, Alexander M.; Miranda, Rajesh C.] Texas A&M Hlth Sci Ctr, Dept Neurosci & Expt Therapeut, Coll Med, Bryan, TX USA; [Schafer, Jordan J.; Wertelecki, Wladimir; Chambers, Christina D.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Wertelecki, Wladimir; Yevtushok, Lyubov; Zymak-Zakutnya, Natalya] Omni Net Ukraine Birth Defects Prevent Program, Rivne, Ukraine; [Yevtushok, Lyubov] Rivne Prov Med Diagnost Ctr, Rivne, Ukraine; [Yevtushok, Lyubov] OMNI Net Ctr, Rivne, Ukraine; [Zymak-Zakutnya, Natalya] Khmelnytsky City Perinatal Ctr, Khmelnytsky, Ukraine; [Zymak-Zakutnya, Natalya] OMNI Net Ctr, Khmelnytsky, Ukraine; [Chambers, Christina D.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Wertelecki, Wladimir; Yevtushok, Lyubov; Zymak-Zakutnya, Natalya; Chambers, Christina D.; Miranda, Rajesh C.] CIFASD, San Diego, CA 92120 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of California System; University of California San Diego; University of California System; University of California San Diego	Miranda, RC (corresponding author), Texas A&M Hlth Sci Ctr, Dept Neurosci & Expt Therapeut, Coll Med, Bryan, TX USA.; Miranda, RC (corresponding author), CIFASD, San Diego, CA 92120 USA.	Miranda@medicine.tamhsc.edu		Miranda, Rajesh/0000-0002-8359-892X; Chambers, Christina D/0000-0003-4675-7722	NIH Office of Dietary Supplements;  [NIH-U01AA014835];  [R01AA013440];  [NIH-U24AA014811]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U24AA014811, U01AA014835, R01AA013440] Funding Source: NIH RePORTER	NIH Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by NIH-U01AA014835 and the NIH Office of Dietary Supplements to CDC, and by R01AA013440 and a pilot grant subcontract from CIFASD.org (from NIH-U24AA014811) to RCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, Obstet Gynecol, V118, P383, DOI 10.1097/AOG.0b013e31822c9906; Baer JS, 2003, ARCH GEN PSYCHIAT, V60, P377, DOI 10.1001/archpsyc.60.4.377; Bakhireva LN, 2013, ALCOHOL CLIN EXP RES, V37, P1008, DOI 10.1111/acer.12045; Bala S, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/498232; Balaraman S, 2014, ALCOHOL CLIN EXP RES, V38, P1390, DOI 10.1111/acer.12378; Balaraman S, 2012, ALCOHOL CLIN EXP RES, V36, P1669, DOI 10.1111/j.1530-0277.2012.01793.x; Bearer CF, 2005, J PEDIATR-US, V146, P824, DOI 10.1016/j.jpeds.2005.01.048; Beninson LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108748; BONTHIUS DJ, 1990, ALCOHOL CLIN EXP RES, V14, P107, DOI 10.1111/j.1530-0277.1990.tb00455.x; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; BRELJE TC, 1993, ENDOCRINOLOGY, V132, P879, DOI 10.1210/en.132.2.879; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Chambers CD, 2014, ALCOHOL CLIN EXP RES, V38, P1012, DOI 10.1111/acer.12318; Chen CY, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131250; Chiu RWK, 2006, CLIN CHEM, V52, P313, DOI 10.1373/clinchem.2005.059691; Coles Claire D, 2015, Matern Child Health J, V19, P2605, DOI 10.1007/s10995-015-1779-x; Corbacho AM, 2002, J ENDOCRINOL, V173, P219, DOI 10.1677/joe.0.1730219; Dhahbi JM, 2013, PHYSIOL GENOMICS, V45, P990, DOI 10.1152/physiolgenomics.00129.2013; Diwadkar VA, 2013, HUM BRAIN MAPP, V34, P1931, DOI 10.1002/hbm.22042; Dolganiuc A, 2009, ALCOHOL CLIN EXP RES, V33, P1704, DOI 10.1111/j.1530-0277.2009.01007.x; Dutton PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039784; Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575; Gardiner AS, 2016, ALCOHOL CLIN EXP RES, V40, P826, DOI 10.1111/acer.13026; Gidlof O, 2013, BLOOD, V121, P3908, DOI 10.1182/blood-2012-10-461798; Go Attie T. J. J., 2008, V444, P291, DOI 10.1007/978-1-59745-066-9_23; Goldman-Wohl D, 2004, PLACENTA, V25, P623, DOI 10.1016/j.placenta.2004.01.016; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gundogan F, 2015, PLACENTA, V36, P523, DOI 10.1016/j.placenta.2015.02.010; Gundogan F, 2010, ALCOHOL CLIN EXP RES, V34, P415, DOI 10.1111/j.1530-0277.2009.01106.x; Guo YQ, 2012, ALCOHOL CLIN EXP RES, V36, P1058, DOI 10.1111/j.1530-0277.2011.01689.x; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Hellemans KGC, 2010, NEUROSCI BIOBEHAV R, V34, P791, DOI 10.1016/j.neubiorev.2009.06.004; Hoyme HE, 2005, PEDIATRICS, V115, P39, DOI 10.1542/peds.2004-0259; Hu YL, 2009, CLIN CHEM LAB MED, V47, P923, DOI 10.1515/CCLM.2009.228; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Ignacio C, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00103; Jacobson SW, 2008, ALCOHOL CLIN EXP RES, V32, P365, DOI 10.1111/j.1530-0277.2007.00585.x; Jacobson SW, 2002, PEDIATRICS, V109, P815, DOI 10.1542/peds.109.5.815; James J, 2015, INTRO STAT LEARNING; Jong HL, 2013, PHYSIOL GENOMICS, V45, P256, DOI 10.1152/physiolgenomics.00071.2012; Kambe S, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121616; Kokkinos MI, 2010, PLACENTA, V31, P747, DOI 10.1016/j.placenta.2010.06.017; Laffont B, 2013, BLOOD, V122, P253, DOI 10.1182/blood-2013-03-492801; Lewohl JM, 2011, ALCOHOL CLIN EXP RES, V35, P1928, DOI 10.1111/j.1530-0277.2011.01544.x; Lucas A, 2015, CARDIOVASC RES, V108, P254, DOI 10.1093/cvr/cvv219; Matlow JN, 2012, J POPUL THER CLIN PH, V19, pE473; May PA, 2005, AM J PUBLIC HEALTH, V95, P1190, DOI 10.2105/AJPH.2003.037093; May PA, 2004, AM J MED GENET C, V127C, P10, DOI 10.1002/ajmg.c.30011; Meng FY, 2012, AM J PATHOL, V181, P804, DOI 10.1016/j.ajpath.2012.06.010; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; MURPHY JF, 1971, AM J OBSTET GYNECOL, V111, P22, DOI 10.1016/0002-9378(71)90920-3; O'Connor MJ, 2009, DEV DISABIL RES REV, V15, P225, DOI 10.1002/ddrr.74; Pappalardo-Carter DL, 2013, ALCOHOL CLIN EXP RES, V37, P1657, DOI 10.1111/acer.12139; Peterson J, 2008, J PEDIATR, V152, P788, DOI 10.1016/j.jpeds.2007.11.009; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Poon LLM, 2000, CLIN CHEM, V46, P1832; Popova S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043024; RUSSELL CS, 1968, BRIT J PREV SOC MED, V22, P119; Sampson HW, 2011, EXP BIOL MED, V236, P1389, DOI 10.1258/ebm.2011.011207; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Sathyan P, 2007, J NEUROSCI, V27, P8546, DOI 10.1523/JNEUROSCI.1269-07.2007; Schneider ML, 2002, PSYCHONEUROENDOCRINO, V27, P285, DOI 10.1016/S0306-4530(01)00050-6; Selvamani A, 2014, CLIN SCI, V127, P77, DOI 10.1042/CS20130565; SOBELL LC, 1988, BRIT J ADDICT, V83, P393; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; Srinivas SK, 2009, J PERINATOL, V29, P680, DOI 10.1038/jp.2009.83; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; Tapocik JD, 2013, PHARMACOGENOMICS J, V13, P286, DOI 10.1038/tpj.2012.17; Tsai PC, 2014, BIOL OPEN, V3, P741, DOI 10.1242/bio.20147765; Tsui Nancy B. Y., 2006, V336, P123; Turchinovich A., 2013, Frontiers in Genetics, V4, P119, DOI 10.3389/fgene.2013.00119; van Steenwyk G, 2013, BRAIN SCI, V3, P744, DOI 10.3390/brainsci3020744; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Williams JF, 2015, PEDIATRICS, V136, pE1395, DOI 10.1542/peds.2015-3113; Yadav S, 2011, J BIOL CHEM, V286, P37347, DOI 10.1074/jbc.M111.235531; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zhou M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081232; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007	82	37	39	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165081	10.1371/journal.pone.0165081	http://dx.doi.org/10.1371/journal.pone.0165081			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828986	gold, Green Published, Green Submitted			2022-12-26	WOS:000387724300030
J	Holmes, IA; Mautz, WJ; Rabosky, ARD				Holmes, Iris A.; Mautz, William J.; Rabosky, Alison R. Davis			Historical Environment Is Reflected in Modern Population Genetics and Biogeography of an Island Endemic Lizard (Xantusia riversiana reticulata)	PLOS ONE			English	Article							SAN-CLEMENTE-ISLAND; BAJA-CALIFORNIA; NIGHT LIZARDS; R-PACKAGE; DIVERSITY; ERADICATION; LIKELIHOOD; EVOLUTION; SOFTWARE; PROGRAMS	The restricted distribution and isolation of island endemics often produces unique genetic and phenotypic diversity of conservation interest to management agencies. However, these isolated species, especially those with sensitive life history traits, are at high risk for the adverse effects of genetic drift and habitat degradation by non-native wildlife. Here, we study the population genetic diversity, structure, and stability of a classic "island giant" (Xantusia riversiana, the Island Night Lizard) on San Clemente Island, California following the removal of feral goats. Using DNA microsatellites, we found that this population is reasonably genetically robust despite historical grazing, with similar effective population sizes and genetic diversity metrics across all sampling locations irrespective of habitat type and degree of degradation. However, we also found strong site-specific patterns of genetic variation and low genetic diversity compared to mainland congeners, warranting continued special management as an island endemic. We identify both high and low elevation areas that remain valuable repositories of genetic diversity and provide a case study for other low-dispersal coastal organisms in the face of future climate change.	[Holmes, Iris A.; Rabosky, Alison R. Davis] Univ Michigan, Dept Ecol & Evolutionary Biol, 1109 Geddes Ave, Ann Arbor, MI 48103 USA; [Mautz, William J.] Univ Hawaii, Dept Biol, Hilo, HI 96720 USA; [Rabosky, Alison R. Davis] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, 1156 High St, Santa Cruz, CA 95064 USA	University of Michigan System; University of Michigan; University of Hawaii System; University Hawaii Hilo; University of California System; University of California Santa Cruz	Rabosky, ARD (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, 1109 Geddes Ave, Ann Arbor, MI 48103 USA.; Rabosky, ARD (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, 1156 High St, Santa Cruz, CA 95064 USA.	ardr@umich.edu		Holmes, Iris/0000-0001-6150-6150	STEPS Institute for Innovation in Environmental Research at the University of California; University of Michigan	STEPS Institute for Innovation in Environmental Research at the University of California; University of Michigan(University of Michigan System)	Funding for molecular work was provided by the STEPS Institute for Innovation in Environmental Research at the University of California (http://www1.ucsc.edu/currents/01-02/04-08/institute.html, Davis2012) Santa Cruz and by start-up funds from the University of Michigan to ARDR (https://www.lsa.umich.edu/eeb/, Davis2014).; We thank the U.S. Department of the Navy for supporting field collection and for granting access to San Clemente Island. Funding for molecular work was provided by the STEPS Institute for Innovation in Environmental Research at the University of California, Santa Cruz and by start-up funds from the University of Michigan to ARDR. WJM is contracted as a Biological Consultant for San Clemente Island by the U.S. Navy.	Bezy RL, 1980, CALIFORNIA ISLANDS, P565; COBLENTZ BE, 1978, BIOL CONSERV, V13, P279, DOI 10.1016/0006-3207(78)90038-1; Crouch JK, 1979, GEOLOGICAL SOC AM B, V90, P3; Culver M, 2008, ANIM CONSERV, V11, P104, DOI 10.1111/j.1469-1795.2007.00154.x; Davis AR, 2012, BEHAV ECOL, V23, P18, DOI 10.1093/beheco/arr144; Davis AR, 2011, P ROY SOC B-BIOL SCI, V278, P1507, DOI 10.1098/rspb.2010.1703; Davis Alison R., 2007, Herpetological Review, V38, P402; Dent R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036889, 10.1371/journal.pone.0037135]; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Eaton DAR, 2014, BIOINFORMATICS, V30, P1844, DOI 10.1093/bioinformatics/btu121; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frankham R, 2015, MOL ECOL, V24, P2610, DOI 10.1111/mec.13139; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gow JL, 2006, MOL ECOL NOTES, V6, P873, DOI 10.1111/j.1471-8286.2006.01382.x; Grueber CE, 2013, MOL ECOL, V22, P4470, DOI 10.1111/mec.12404; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Haasl RJ, 2010, MOL BIOL EVOL, V27, P2702, DOI 10.1093/molbev/msq164; Hastie T., 2015, GAM GEN ADDITIVE MOD; Hauksson E, 2014, GEOPHYS J INT, V196, P1619, DOI 10.1093/gji/ggt467; Hedrick PW, 2010, CONSERV GENET, V11, P615, DOI 10.1007/s10592-009-9999-5; Hijmans RJ, 2015, **DATA OBJECT**, DOI DOI 10.HTTPS://CRAN.R-PROJECT.ORG/WEB/PACKAGES/RASTER/INDEX.HTML; Holland R.F., 1986, PRELIMINARY DESCRIPT; Horton BP, 2014, QUATERNARY SCI REV, V84, P1, DOI 10.1016/j.quascirev.2013.11.002; Imad H.H., 2015, EGPT J FOREN SCI, V5, P150; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kappes PJ, 2014, BIODIVERS CONSERV, V23, P503, DOI 10.1007/s10531-013-0608-z; KEEGAN DR, 1994, WILDLIFE SOC B, V22, P56; Kimmel M, 1998, GENETICS, V148, P1921; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Langkilde T, 2006, J EXP BIOL, V209, P1035, DOI 10.1242/jeb.02112; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Lusini I, 2014, CONSERV GENET, V15, P283, DOI 10.1007/s10592-013-0537-0; Martiinez-Cabrera HI, 2006, REV PALAEOBOT PALYNO, V138, P141, DOI 10.1016/j.revpalbo.2006.01.001; Mautz William J., 1993, P417; MAUTZ WJ, 1987, AM ZOOL, V27, pA147; Mautz WJ., 2007, ISLAND NIGHT LIZARD; McRae B., 2013, NAT CONSERV; MERIFIEL.PM, 1971, GEOL SOC AM BULL, V82, P1989, DOI 10.1130/0016-7606(1971)82[1989:GOCSCI]2.0.CO;2; Monks JM, 2014, BIOL INVASIONS, V16, P167, DOI 10.1007/s10530-013-0511-2; Mouret V, 2011, J BIOGEOGR, V38, P1717, DOI 10.1111/j.1365-2699.2011.02514.x; MUHS DR, 1983, QUATERNARY RES, V20, P322, DOI 10.1016/0033-5894(83)90016-9; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nachman MW, 2000, GENETICS, V156, P297; National Geophysical Data Center, 2012, US COAST REL MOD SO; Noel F, 2013, BIOL CONSERV, V158, P167, DOI 10.1016/j.biocon.2012.07.029; Noonan BP, 2013, MOL PHYLOGENET EVOL, V69, P109, DOI 10.1016/j.ympev.2013.05.017; Paolucci EM, 2013, DIVERS DISTRIB, V19, P988, DOI 10.1111/ddi.12073; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Porcasi P., 1999, PACIFIC COAST ARCHAE, V35, P1; Powell TWR, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/025024; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ringsby TH, 2006, CONSERV BIOL, V20, P1761, DOI 10.1111/j.1523-1739.2006.00568.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Rumeu B, 2014, DIVERS DISTRIB, V20, P272, DOI 10.1111/ddi.12163; Sinclair EA, 2004, AM NAT, V164, P396, DOI 10.1086/381404; Spatz DR, 2014, CONSERV BIOL, V28, P1282, DOI 10.1111/cobi.12279; STOCK JM, 1994, TECTONICS, V13, P1472, DOI 10.1029/94TC01808; Sun JX, 2012, NAT GENET, V44, P1161, DOI 10.1038/ng.2398; Tabak MA, 2014, BIOL INVASIONS, V16, P341, DOI 10.1007/s10530-013-0524-x; van Oosterhout C, 2006, MOL ECOL NOTES, V6, P255, DOI 10.1111/j.1471-8286.2005.01082.x; Vicario S, 2003, MOL PHYLOGENET EVOL, V26, P243, DOI 10.1016/S1055-7903(02)00313-5; Ward SN, 1996, GEOPHYS J INT, V126, P712, DOI 10.1111/j.1365-246X.1996.tb04699.x; Wilson GA, 2003, GENETICS, V163, P1177; Wright S, 1931, GENETICS, V16, P0097; Wylie J., 2012, VEGETATION CHANGE SA	69	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0163738	10.1371/journal.pone.0163738	http://dx.doi.org/10.1371/journal.pone.0163738			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828958	Green Submitted, Green Published, gold			2022-12-26	WOS:000387724300010
J	Wei, XL; McCune, B; Lumbsch, HT; Li, H; Leavitt, S; Yamamoto, Y; Tchabanenko, S; Wei, JC				Wei, Xinli; McCune, Bruce; Lumbsch, H. Thorsten; Li, Hui; Leavitt, Steven; Yamamoto, Yoshikazu; Tchabanenko, Svetlana; Wei, Jiangchun			Limitations of Species Delimitation Based on Phylogenetic Analyses: A Case Study in the Hypogymnia hypotrypa Group (Parmeliaceae, Ascomycota)	PLOS ONE			English	Article							PAIR CONCEPT; SEQUENCE ALIGNMENT; RIBOSOMAL DNA; BETA-TUBULIN; MOLECULAR PHYLOGENY; GENE FLOW; INFERENCE; EVOLUTION; LICHENS; NUCLEAR	Delimiting species boundaries among closely related lineages often requires a range of independent data sets and analytical approaches. Similar to other organismal groups, robust species circumscriptions in fungi are increasingly investigated within an empirical framework. Here we attempt to delimit species boundaries in a closely related Glade of lichen-forming fungi endemic to Asia, the Hypogymnia hypotrypa group (Parmeliaceae). In the current classification, the Hypogymnia hypotrypa group includes two species: H. hypotrypa and H. flavida, which are separated based on distinctive reproductive modes, the former producing soredia but absent in the latter. We reexamined the relationship between these two species using phenotypic characters and molecular sequence data (ITS, GPD, and MCM7sequences) to address species boundaries in this group. In addition to morphological investigations, we used Bayesian clustering to identify potential genetic groups in the H. hypotrypa/H. flavida Glade. We also used a variety of empirical, sequence-based species delimitation approaches, including: the "Automatic Barcode Gap Discovery" (ABGD), the Poisson tree process model (PTP), the General Mixed Yule Coalescent (GMYC), and the multispecies coalescent approach BPP. Different species delimitation scenarios were compared using Bayes factors delimitation analysis, in addition to comparisons of pairwise genetic distances, pairwise fixation indices (FST). The majority of the species delimitation analyses implemented in this study failed to support H. hypotrypa and H. flavida as distinct lineages, as did the Bayesian clustering analysis. However, strong support for the evolutionary independence of H. hypotrypa and H. flavida was inferred using BPP and further supported by Bayes factor delimitation. In spite of rigorous morphological comparisons and a wide range of sequence-based approaches to delimit species, species boundaries in the H. hypotrypa group remain uncertain. This study reveals the potential limitations of relying on distinct reproductive strategies as diagnostic taxonomic characters for Hypogymnia and also the challenges of using popular sequence-based species delimitation methods in groups with recent diversification histories.	[Wei, Xinli; Li, Hui; Wei, Jiangchun] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [McCune, Bruce] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Lumbsch, H. Thorsten] Field Museum, Sci & Educ, Chicago, IL USA; [Li, Hui] Univ Chinese Acad Sci, Beijing, Peoples R China; [Leavitt, Steven] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Yamamoto, Yoshikazu] Akita Prefectural Univ, Fac Bioresource Sci, Dept Bioprod Sci, Akita, Japan; [Tchabanenko, Svetlana] Sakhalin Bot Garden, Yuzhno Sakhalinsk, Russia	Chinese Academy of Sciences; Institute of Microbiology, CAS; Oregon State University; Field Museum of Natural History (Chicago); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Brigham Young University; Akita Prefectural University; Russian Academy of Sciences; Botanical Garden Institute of the Far Eastern Branch of the Russian Academy of Sciences	Wei, XL; Wei, JC (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China.	weixl@im.ac.cn; weijc2004@126.com	Leavitt, Steven D./AAC-6462-2021; wei, jiang/GRX-7907-2022	Leavitt, Steven D./0000-0002-5034-9724; Lumbsch, Thorsten/0000-0003-1512-835X	National Natural Science Foundation of China [31200018]; Ministry of Science and Technology of China [2012FY111600, 2014FY120100]; Youth Innovation Promotion Association, Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Youth Innovation Promotion Association, Chinese Academy of Sciences	Support was provided by: the National Natural Science Foundation of China (31200018; http://www.nsfc.gov.cn; XLW); Ministry of Science and Technology of China (2012FY111600, 2014FY120100; http://www.most.gov.cn; XLW); the Youth Innovation Promotion Association, Chinese Academy of Sciences (http://www.yicas. cry, XLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello A, 2007, BIOL J LINN SOC, V91, P455, DOI 10.1111/j.1095-8312.2007.00810.x; Articus K, 2002, MYCOL RES, V106, P412, DOI 10.1017/S0953756202005786; ASAHINA YASUHIKO, 1950, ACTA PHYTOTAX ET GEOBOT, V14, P33; AWASTHI D D, 1984, Kavaka, V12, P87; Bitter G., 1901, HEDWIGIA, V40, P171; Buschbom J, 2006, MOL BIOL EVOL, V23, P574, DOI 10.1093/molbev/msj063; Crespo A, 2007, MOL PHYLOGENET EVOL, V44, P812, DOI 10.1016/j.ympev.2006.11.029; Crespo A, 2010, IMA FUNGUS, V1, P167, DOI 10.5598/imafungus.2010.01.02.09; Crespo A, 2010, TAXON, V59, P1735, DOI 10.1002/tax.596008; Crespo A, 2009, AN JARDIN BOT MADRID, V66, P71, DOI 10.3989/ajbm.2225; Cubero OF, 2004, MYCOL RES, V108, P498, DOI 10.1017/s095375620400975x; CULBERSON CF, 1972, J CHROMATOGR, V72, P113, DOI 10.1016/0021-9673(72)80013-X; CULBERSON CF, 1970, J CHROMATOGR, V46, P85, DOI 10.1016/S0021-9673(00)83967-9; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Molina MD, 2011, LICHENOLOGIST, V43, P585, DOI 10.1017/S0024282911000521; Del-Prado R, 2010, MOL PHYLOGENET EVOL, V56, P125, DOI 10.1016/j.ympev.2010.04.014; Divakar PK, 2005, LICHENOLOGIST, V37, P37, DOI 10.1017/S0024282904014641; Divakar PK, 2010, FUNGAL DIVERS, V42, P47, DOI 10.1007/s13225-010-0027-3; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Falush D, 2003, GENETICS, V164, P1567; Ferencova Z, 2010, LICHENOLOGIST, V42, P449, DOI 10.1017/S0024282909990739; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Galloway DJ, 2008, LICHEN BIOLOGY, 2ND EDITION, P315, DOI 10.1017/CBO9780511790478.017; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grishkan I, 2003, P ROY SOC B-BIOL SCI, V270, P13, DOI 10.1098/rspb.2002.2194; Grummer JA, 2014, SYST BIOL, V63, P119, DOI 10.1093/sysbio/syt069; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hey J, 1997, GENETICS, V145, P833; Hodkinson BP, 2011, BIBL LICHENOL, V106, P115; HUDSON RR, 1992, GENETICS, V132, P583; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kis-Papo T, 2003, P NATL ACAD SCI USA, V100, P14970, DOI 10.1073/pnas.2036284100; Lai M. J, 1980, Q J TAIWAN MUSEUM, V33, P209; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leavitt S.D., 2015, RECENT ADV LICHENOLO, P11, DOI 10.1007/978-81-322-2235-4_2; Leavitt SD, 2016, SCI REP-UK, V6, DOI 10.1038/srep22262; Leavitt SD, 2011, AM J BOT, V98, P175, DOI 10.3732/ajb.1000230; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lohtander K, 1998, BRYOLOGIST, V101, P404; Lohtander K, 1998, LICHENOLOGIST, V30, P341, DOI 10.1006/lich.1998.0154; Lumbsch HT, 2011, FUNGAL DIVERS, V50, P59, DOI 10.1007/s13225-011-0123-z; Martinez I, 2012, FUNGAL BIOL-UK, V116, P1192, DOI 10.1016/j.funbio.2012.09.005; MasonGamer RJ, 1996, SYST BIOL, V45, P524, DOI 10.1093/sysbio/45.4.524; MATTSSON JE, 1989, TAXON, V38, P238, DOI 10.2307/1220840; McCune B, 2001, MYCOTAXON, V79, P23; Miadlikowska J, 2011, BRYOLOGIST, V114, P392, DOI 10.1639/0007-2745-114.2.392; Miller M.A., 2010, P GAT COMP ENV WORKS; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Monte M., 1993, Aerobiologia, V9, P169, DOI 10.1007/BF02066258; Myllys L, 2002, LICHENOLOGIST, V34, P237, DOI 10.1006/lich.2002.0390; Myllys L, 2001, MYCOLOGIA, V93, P335, DOI 10.2307/3761655; Ott S, 2004, LICHENOLOGIST, V36, P227, DOI 10.1017/S0024282904014306; Parnmen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052245; Pino-Bodas R, 2012, LICHENOLOGIST, V44, P121, DOI 10.1017/S002428291100065X; Pino-Bodas R, 2012, MYCOL PROG, V11, P269, DOI 10.1007/s11557-011-0746-1; POELT J., 1963, PHYTON ANN REI BOT, V10, P206; Poelt J., 1970, NEUE FOLGE, V4, P187; POELT VJ, 1972, BOT NOTISER, V125, P77; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Prieto M, 2012, AM J BOT, V99, P23, DOI 10.3732/ajb.1100239; Pritchard JK, 2000, GENETICS, V155, P945; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rannala B, 2013, GENETICS, V194, P245, DOI 10.1534/genetics.112.149039; Rassadina KA, 1967, BOT MAT NOT SYST SEC, V20, P297; Rassadina KA, 1960, BOT MAT OTD SPOROV B, V13, P23; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Seymour Fabian A., 2005, Mycologist, V19, P51, DOI 10.1017/S0269915X05002016; Spribille T, 2011, MOL PHYLOGENET EVOL, V59, P603, DOI 10.1016/j.ympev.2011.03.021; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; TEHLER A, 1982, TAXON, V31, P708, DOI 10.2307/1219689; Tehler A, 2009, TAXON, V58, P438, DOI 10.1002/tax.582010; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tolpysheva T. Yu., 2008, Moscow University Biological Sciences Bulletin, V63, P170, DOI 10.3103/S0096392508040068; Velmala S, 2009, LICHENOLOGIST, V41, P231, DOI 10.1017/S0024282909008573; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Vondrak J, 2009, LICHENOLOGIST, V41, P571, DOI 10.1017/S0024282909008317; Wei J.C., 1991, ENUMERATION LICHENS; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wirtz N, 2012, ORG DIVERS EVOL, V12, P17, DOI 10.1007/s13127-011-0066-y; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Yang ZH, 2015, CURR ZOOL, V61, P854, DOI 10.1093/czoolo/61.5.854; Yang ZH, 2014, MOL BIOL EVOL, V31, P3125, DOI 10.1093/molbev/msu279; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yoshimura I., 1974, LICHEN FLORA JAPAN C; ZAHLBRUCKNER A., 1934, HEDWIGIA, V74, P195; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zhao JD, 1964, ACTA PHYTOTAXONOMICA, V9, P139; [No title captured]	91	14	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0163664	10.1371/journal.pone.0163664	http://dx.doi.org/10.1371/journal.pone.0163664			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828951	Green Submitted, Green Published, gold			2022-12-26	WOS:000387724300009
J	Zhou, Q; Long, L; Zhou, T; Tian, J; Zhou, B				Zhou, Qiao; Long, Li; Zhou, Ting; Tian, Juan; Zhou, Bin			Demethylation of MicroRNA-124a Genes Attenuated Proliferation of Rheumatoid Arthritis Derived Fibroblast-Like Synoviocytes and Synthesis of Tumor Necrosis Factor-alpha	PLOS ONE			English	Article							DNA METHYLATION; SECRETION; CELLS	Objective To examine the impact of 5-Aza-2'-deoxycytidine (5-AzadC) on methylation status of miR-124a genes in rheumatoid arthritis (RA) associated fibroblast-like synoviocytes (FLS) and its effect on RA-FLS proliferation and TNF-alpha expression. Materials and Methods FLS were isolated from seven RA-derived synovial tissues and cultured in vitro. The expression of miR-124a was measured by real time quantitative polymerase chain reaction (PCR) in FLS with or without 5-AzadC treatment. MiR-124a gene methylation was detected by methylation-specific PCR. FLS were divided into three groups as control, IL-1 beta and IL-1 beta/5 5-AzadC, respectively. The cells in the IL-1 beta group were treated with 5 mu g/L of IL-1 beta for 24 hours, whereas the cells in the IL-1 beta/5-AzadC group were first treated with IL-1 beta exactly as those in the IL-1 beta group for 24 h but further treated with 1 mu M 5-AzadC for additional 3 days. The cell growth was estimated based on absorbance at UV450nm. Secreted TNF-alpha from the cells was evaluated by enzyme-linked immunosorbent assay. After that, RA-FLS treated with IL-1 beta plus 5-AzadC were further transfected with miR-124a inhibitor or scrambled control. After culturing for 3 days, cell growth and TNF-a concentrations were measured. Results After 5-AzadC treatment, the expression of miR-124a was significantly increased compared with the control group (1.545 +/- 0.189 vs 0.836 +/- 0.166, p = 0.001). On the other hand, 5-AzadC significantly reduced IL-1 beta-mediated cell proliferation by nearly 2.5 fold (p = 0.006). Also, the level of TNF-alpha secreted from the cells treated with IL-1 beta plus 5-AzadC was considerably less than that from the cells treated with IL-1 beta alone (324.99 +/- 22.73 ng/L vs 387.91 +/- 58.51 ng/L, p = 0.022). After transfection with miR-124a inhibitor in RA-FLS treated with IL-1 beta plus 5-AzadC, the cell proliferation was increased by 18.2% and the TNF-alpha expression was increased by 19.0% (p = 0.001 and 0.011, respectively). Conclusion Methylation of miR-124a genes contributed to IL-1 beta-mediated RA-FLS proliferation and TNF-alpha expression.	[Zhou, Qiao] Sichuan Acad Med Sci, Dept Rheumatol & Immunol, 1st Ring Rd, Chengdu 610072, Sichuan, Peoples R China; Sichuan Prov Peoples Hosp, 1st Ring Rd, Chengdu 610072, Sichuan, Peoples R China	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Zhou, Q (corresponding author), Sichuan Acad Med Sci, Dept Rheumatol & Immunol, 1st Ring Rd, Chengdu 610072, Sichuan, Peoples R China.	22922934@qq.com	Zhou, Qiao/HDN-2716-2022	Zhou, Qiao/0000-0003-2666-2283	Doctoral Foundation of Sichuan Provincial People's Hospital [30305030587191]	Doctoral Foundation of Sichuan Provincial People's Hospital	The study was funded by the Doctoral Foundation of Sichuan Provincial People's Hospital (No.30305030587191, http://www.samsph.com/news_hos/27/16394/1/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett FC, 1987, ARTHR RHEUM, V1988, P315, DOI DOI 10.1002/ART.1780310302; Ballestar E, 2011, NAT REV RHEUMATOL, V7, P264, DOI 10.1038/nrrheum.2011.16; Chen XY, 2013, INVEST OPHTH VIS SCI, V54, P2248, DOI 10.1167/iovs.12-10977; Cooles FAH, 2011, CURR OPIN RHEUMATOL, V23, P233, DOI 10.1097/BOR.0b013e32834518a3; Firestein GS, 1996, ARTHRITIS RHEUM, V39, P1781, DOI 10.1002/art.1780391103; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Miao CG, 2013, CELL SIGNAL, V25, P1118, DOI 10.1016/j.cellsig.2013.01.024; Motegi K, 2005, LAB INVEST, V85, P342, DOI 10.1038/labinvest.3700234; Nakamachi Y, 2009, ARTHRITIS RHEUM-US, V60, P1294, DOI 10.1002/art.24475; Nakano K, 2013, ANN RHEUM DIS, V72, P110, DOI 10.1136/annrheumdis-2012-201526; Nervi C, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0157-2; Qiao Z, 2013, ABSTR APPL ANAL, DOI 10.1155/2013/207987; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Yang S, 2013, CELL RES, V23, P1270, DOI [10.1038/cr.2013.116, DOI 10.1038/CR.2013.116]	14	12	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0164207	10.1371/journal.pone.0164207	http://dx.doi.org/10.1371/journal.pone.0164207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824863	Green Published, Green Submitted, gold			2022-12-26	WOS:000387615200002
J	Delaney, JT; Moranz, RA; Debinski, DM; Engle, DM; Miller, JR				Delaney, John T.; Moranz, Raymond A.; Debinski, Diane M.; Engle, David M.; Miller, James R.			Exotic-Dominated Grasslands Show Signs of Recovery with Cattle Grazing and Fire	PLOS ONE			English	Article							BRITISH BUTTERFLIES; ECOSYSTEM PROCESSES; MOTH COMMUNITIES; PLANT COMMUNITY; ALIEN PLANTS; MANAGEMENT; BIODIVERSITY; RESTORATION; RESPONSES; DEGRADATION	In grasslands, overgrazing by domestic livestock, fertilization, and introduction of exotic forage species leads to plant communities consisting of a mixture of native and exotic species. These degraded grasslands present a problem for land managers, farmers, and restoration ecologists concerned with improving biodiversity while continuing to use the land for livestock production. Here we assessed the response of butterfly and plant community composition to the use of fire and moderate grazing by domestic cattle on degraded grasslands dominated by exotic plants. We evaluated change by comparing experimental pastures to two reference sites that were grasslands dominated by native plants. We used two burning and grazing treatments: 1) patch-burn graze, a heterogeneously managed treatment, where one third of the pasture is burned each year and cattle have free access to the entire pasture, and 2) graze-and-burn, a homogenously managed treatment, where the entire pasture is grazed each year and burned in its entirety every three years. We tested for change in the butterfly and plant community composition over seven years using Bray-Curtis dissimilarity measures. Over the course of seven years, degraded pastures in both treatments became more similar to reference sites with respect to the butterfly and plant communities. Only two butterfly species and two plant functional guilds exhibited significant linear trends over time, with varying responses. Compositional changes in both the butterfly and plant communities indicate that the use of moderate grazing and fire may shift butterfly and plant communities of exotic-dominated grasslands to be more similar to reference tall-grass prairies over time.	[Delaney, John T.; Debinski, Diane M.] Iowa State Univ, Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Moranz, Raymond A.; Engle, David M.] Oklahoma State Univ, Nat Resource Ecol & Management, Stillwater, OK 74078 USA; [Miller, James R.] Univ Illinois, Nat Resources & Environm Sci, Urbana, IL USA	Iowa State University; Oklahoma State University System; Oklahoma State University - Stillwater; University of Illinois System; University of Illinois Urbana-Champaign	Delaney, JT (corresponding author), Iowa State Univ, Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	johntdelaney@gmail.com		Delaney, John/0000-0003-1038-0265	Oklahoma Agricultural Experiment Station; Iowa Department of Natural Resources; Iowa Agricultural and Home Economics Experiment Station; Iowa State Wildlife Grants program [T-1-R-15, U-2-R-1]; U.S. Fish and Wildlife Service, Wildlife and Sport Fish Restoration Program	Oklahoma Agricultural Experiment Station; Iowa Department of Natural Resources; Iowa Agricultural and Home Economics Experiment Station; Iowa State Wildlife Grants program; U.S. Fish and Wildlife Service, Wildlife and Sport Fish Restoration Program	This research was supported by the Oklahoma Agricultural Experiment Station, Iowa Department of Natural Resources, and the Iowa Agricultural and Home Economics Experiment Station. Partial funding for this project was through the Iowa State Wildlife Grants program grants T-1-R-15 and U-2-R-1 in cooperation with the U.S. Fish and Wildlife Service, Wildlife and Sport Fish Restoration Program.; This research was supported by the Oklahoma Agricultural Experiment Station, Iowa Department of Natural Resources, and the Iowa Agricultural and Home Economics Experiment Station. Partial funding for this project was through the Iowa State Wildlife Grants program grants T-1-R-15 and U-2-R-1 in cooperation with the U.S. Fish and Wildlife Service, Wildlife and Sport Fish Restoration Program. We wish to thank Jason Burkum, Anna Holtermann, Meghan Kirkwood, Jacob Mortensen, Ben Nagel, Matthew Nielsen, Calla Olson, Toni Pro escholdt, Michael Rausch, Shannon Rusk, and Laura Winkler for their work in the field, and special thanks to Ryan Harr for managing almost every field aspect of our research project. Finally, we pay our respects to the late Sheri Svehla for initiating our work in the field and the lab.	Archibald S, 2004, INT J WILDLAND FIRE, V13, P377, DOI 10.1071/WF03070; BELSKY JA, 1992, J VEG SCI, V3, P187, DOI 10.2307/3235679; Biondini ME, 1998, ECOL APPL, V8, P469, DOI 10.1890/1051-0761(1998)008[0469:GIAEPI]2.0.CO;2; Boggs C., 2003, BUTTERFLIES ECOLOGY; Brereton T, 2011, J INSECT CONSERV, V15, P139, DOI 10.1007/s10841-010-9333-z; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cummings DC, 2007, RANGELAND ECOL MANAG, V60, P253, DOI 10.2111/1551-5028(2007)60[253:IAGSOI]2.0.CO;2; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; De Bruijn SL, 2006, BIOL CONTROL, V36, P305, DOI 10.1016/j.biocontrol.2005.10.007; Debinski DM, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00226.1; Delaney JT, 2014, UTILIZING NOVEL GRAS; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Engst K, 2016, J APPL ECOL, V53, P751, DOI 10.1111/1365-2664.12623; Erhardt A., 1991, Symposia of the Royal Entomological Society of London, P213; Ewel JJ, 2004, FRONT ECOL ENVIRON, V2, P354, DOI 10.1890/1540-9295(2004)002[0354:apfasi]2.0.co;2; FIRN J, 2013, ECOL PROCESS, V2, pNIL1, DOI DOI 10.1186/2192-1709-2-26; Foster D, 2003, BIOSCIENCE, V53, P77, DOI 10.1641/0006-3568(2003)053[0077:TIOLUL]2.0.CO;2; Fuhlendorf SD, 2004, J APPL ECOL, V41, P604, DOI 10.1111/j.0021-8901.2004.00937.x; Fuhlendorf SD, 2001, BIOSCIENCE, V51, P625, DOI 10.1641/0006-3568(2001)051[0625:RHOREM]2.0.CO;2; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Gardener M. R., 2005, Plant Protection Quarterly, V20, P36; Gioria M, 2010, BIOL CONSERV, V143, P1125, DOI 10.1016/j.biocon.2010.02.007; Graves SD, 2003, BIOL CONSERV, V110, P413, DOI 10.1016/S0006-3207(02)00233-1; Hadar L, 1999, J VEG SCI, V10, P673, DOI 10.2307/3237082; Hickman KR, 2004, J RANGE MANAGE, V57, P58, DOI 10.2307/4003955; Hill JK, 2003, J TROP ECOL, V19, P35, DOI 10.1017/S0266467403003055; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; Isbell FI, 2011, PLANT ECOL, V212, P1663, DOI 10.1007/s11258-011-9939-6; Kristensen NP, 2007, ZOOTAXA, V1668, pe747; Maccherini S, 2009, ACTA OECOL, V35, P311, DOI 10.1016/j.actao.2008.12.002; Maes D, 2001, BIOL CONSERV, V99, P263, DOI 10.1016/S0006-3207(00)00182-8; Martin LM, 2014, OECOLOGIA, V175, P687, DOI 10.1007/s00442-014-2911-0; Mascaro J, 2012, ECOL MONOGR, V82, P221, DOI 10.1890/11-1014.1; McGranahan DA, 2011, SPECIES RICHNESS FIR; McGranahan DA, 2012, NAT AREA J, V32, P208, DOI 10.3375/043.032.0214; McGranahan DA, 2013, LAND-BASEL, V2, P328, DOI 10.3390/land2030328; Memmott J, 2002, P ROY SOC B-BIOL SCI, V269, P2395, DOI 10.1098/rspb.2002.2174; New TR, 1997, J INSECT CONSERV, V1, P5, DOI 10.1023/A:1018433406701; Novotny V, 2003, ECOL ENTOMOL, V28, P704, DOI 10.1111/j.1365-2311.2003.00558.x; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Olson BE, 1997, WEED TECHNOL, V11, P176, DOI 10.1017/S0890037X00041543; Papanastasis VP, 2009, RESTOR ECOL, V17, P441, DOI 10.1111/j.1526-100X.2009.00567.x; Pieper R. D., 1994, Ecological implications of herbivory in the west.., P177; Pillsbury FC, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00154.1; Pinheiro J, 2020, R PACKAGE VERSION 31; POLLARD E, 1988, J APPL ECOL, V25, P819, DOI 10.2307/2403748; Pollard E, 1977, BIOL CONSERV, V12, P115; Popay I, 1996, WEED TECHNOL, V10, P217, DOI 10.1017/S0890037X00045942; Poyry J, 2004, ECOL APPL, V14, P1656, DOI 10.1890/03-5151; Pywell RF, 2010, GRASS FORAGE SCI, V65, P159, DOI 10.1111/j.1365-2494.2010.00735.x; Scasta JD, 2014, IMPLICATIONS PYRIC H; Schaffers AP, 2008, ECOLOGY, V89, P782, DOI 10.1890/07-0361.1; Seastedt TR, 2008, FRONT ECOL ENVIRON, V6, P547, DOI 10.1890/070046; Shapiro AM, 2002, DIVERS DISTRIB, V8, P31, DOI 10.1046/j.1366-9516.2001.00120.x; Shuey JA, 2012, AM MIDL NAT, V167, P273, DOI 10.1674/0003-0031-167.2.273; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; Sivicek VA, 2011, ECOL INDIC, V11, P1251, DOI 10.1016/j.ecolind.2011.01.003; Stahlheber KA, 2013, BIOL CONSERV, V157, P300, DOI 10.1016/j.biocon.2012.09.008; Sternberg M, 2000, J APPL ECOL, V37, P224, DOI 10.1046/j.1365-2664.2000.00491.x; Stohlgren TJ, 1998, J RANGE MANAGE, V51, P164, DOI 10.2307/4003202; Su JC, 2004, CONSERV BIOL, V18, P167, DOI 10.1111/j.1523-1739.2004.00337.x; Swengel SR, 2011, J INSECT CONSERV, V15, P327, DOI 10.1007/s10841-010-9323-1; The Nature Conservancy, 2008, GRAND RIVER IN PRESS; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; TILMAN D, 1989, P136; TNC-Missouri, 2012, GRAND RIV GRASSL PRA; van Swaay C, 2006, J INSECT CONSERV, V10, P189, DOI 10.1007/s10841-006-6293-4; Vermeire LT, 2004, J RANGE MANAGE, V57, P248, DOI 10.2307/4003792; WallisDeVries MF, 2001, RESTOR ECOL, V9, P179, DOI 10.1046/j.1526-100x.2001.009002179.x; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Wenzel M, 2006, BIOL CONSERV, V128, P542, DOI 10.1016/j.biocon.2005.10.022; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilsey BJ, 2011, PERSPECT PLANT ECOL, V13, P265, DOI 10.1016/j.ppees.2011.07.002; Wilsey BJ, 2009, ECOL LETT, V12, P432, DOI 10.1111/j.1461-0248.2009.01298.x; Woodcock BA, 2012, BIOL CONSERV, V155, P50, DOI 10.1016/j.biocon.2012.05.013; Woodcock BA, 2011, J APPL ECOL, V48, P1070, DOI 10.1111/j.1365-2664.2011.02029.x; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	78	10	10	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165758	10.1371/journal.pone.0165758	http://dx.doi.org/10.1371/journal.pone.0165758			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820838	Green Published, gold, Green Submitted			2022-12-26	WOS:000387614800017
J	Lundquist, I; Al-Amily, IM; Abaraviciene, SM; Salehi, A				Lundquist, Ingmar; Al-Amily, Israa Mohammed; Abaraviciene, Sandra Meidute; Salehi, Albert			Metformin Ameliorates Dysfunctional Traits of Glibenclamide- and Glucose-Induced Insulin Secretion by Suppression of Imposed Overactivity of the Islet Nitric Oxide Synthase-NO System	PLOS ONE			English	Article							PROTEIN S-NITROSYLATION; HUMAN PANCREATIC-ISLETS; BETA-CELL DYSFUNCTION; CHRONIC EXPOSURE; TYROSINE NITRATION; HORMONE-RELEASE; RAT ISLETS; EXPRESSION; GLP-1; ROSIGLITAZONE	Metformin lowers diabetic blood glucose primarily by reducing hepatic gluconeogenesis and increasing peripheral glucose uptake. However, possible effects by metformin on beta-cell function are incompletely understood. We speculated that metformin might positively influence insulin secretion through impacting the beta-cell nitric oxide synthase (NOS)-NO system, a negative modulator of glucose-stimulated insulin release. In short-time incubations with isolated murine islets either glibenclamide or high glucose augmented insulin release associated with increased NO production from both neural and inducible NOS. Metformin addition suppressed the augmented NO generation coinciding with amplified insulin release. Islet culturing with glibenclamide or high glucose revealed pronounced fluorescence of inducible NOS in the beta-cells being abolished by metformin co-culturing. These findings were reflected in medium nitrite-nitrate levels. A glucose challenge following islet culturing with glibenclamide or high glucose revealed markedly impaired insulin response. Metformin co-culturing restored this response. Culturing murine islets and human islets from controls and type 2 diabetics with high glucose or high glucose + glibenclamide induced a pronounced decrease of cell viability being remarkably restored by metformin co-culturing. We show here, that imposed overactivity of the beta-cell NOS-NO system by glibenclamide or high glucose leads to insulin secretory dysfunction and reduced cell viability and also, importantly, that these effects are relieved by metformin inhibiting beta-cell NO overproduction from both neural and inducible NOS thus ameliorating a concealed negative influence by NO induced by sulfonylurea treatment and/or high glucose levels. This double-edged effect of glibenclamide on the beta-cellsuggests sulfonylurea monotherapy in type 2 diabetes being avoided.	[Lundquist, Ingmar; Al-Amily, Israa Mohammed; Abaraviciene, Sandra Meidute; Salehi, Albert] Lund Univ, Div Islet Cell Physiol, SUS, Dept Clin Sci, Malmo, Sweden; [Lundquist, Ingmar] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Abaraviciene, Sandra Meidute] Vilnius Univ, Dept Physiol Biochem Microbiol & Lab Med, Vilnius, Lithuania; [Abaraviciene, Sandra Meidute] Ctr Innovat Med, State Res Inst, Dept Regenerat Med, Vilnius, Lithuania; [Salehi, Albert] Univ Gothenburg, Metab Res Unit, Dept Neurosci & Physiol, Gothenburg, Sweden	Lund University; Lund University; Vilnius University; State Research Institute Centre for Innovative Medicine; University of Gothenburg	Salehi, A (corresponding author), Lund Univ, Div Islet Cell Physiol, SUS, Dept Clin Sci, Malmo, Sweden.; Salehi, A (corresponding author), Univ Gothenburg, Metab Res Unit, Dept Neurosci & Physiol, Gothenburg, Sweden.	S_Albert.Salehi@med.lu.se	Salehi, Albert/F-7768-2018	Salehi, Albert/0000-0001-6120-3539				Abaraviciene SM, 2008, CELL MOL LIFE SCI, V65, P2256, DOI 10.1007/s00018-008-8100-8; Akesson B, 1999, J ENDOCRINOL, V163, P39, DOI 10.1677/joe.0.1630039; Akesson B, 1999, ENDOCRINE, V11, P99, DOI 10.1385/ENDO:11:1:99; Akesson B, 1996, DIABETES RES, V31, P91; Alm P, 1999, DIABETOLOGIA, V42, P978, DOI 10.1007/s001250051256; Berglund LM, 2016, DIABETES, V65, P239, DOI 10.2337/db15-0122; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buse JB, 2016, DIABETES CARE, V39, P198, DOI 10.2337/dc15-0488; Butler PC, 2013, DIABETES CARE, V36, P2118, DOI 10.2337/dc12-2713; Chang-Chen KJ, 2008, REV ENDOCR METAB DIS, V9, P329, DOI 10.1007/s11154-008-9101-5; Cho YM, 2011, DIABETOLOGIA, V54, P219, DOI 10.1007/s00125-010-1986-3; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Drews G, 2010, PFLUG ARCH EUR J PHY, V460, P703, DOI 10.1007/s00424-010-0862-9; Eizirik DL, 1996, DIABETOLOGIA, V39, P875; Fu A, 2013, MOL CELL ENDOCRINOL, V366, P127, DOI 10.1016/j.mce.2012.06.020; Gale EAM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1263; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Henningsson R, 2002, AM J PHYSIOL-CELL PH, V283, pC296, DOI 10.1152/ajpcell.00537.2001; Henningsson R, 2001, AM J PHYSIOL-CELL PH, V280, pC1242, DOI 10.1152/ajpcell.2001.280.5.C1242; Henningsson R, 2000, AM J PHYSIOL-ENDOC M, V279, pE95, DOI 10.1152/ajpendo.2000.279.1.E95; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Holst JJ, 2012, CLIN DRUG INVEST, V32, P1, DOI 10.2165/11595370-000000000-00000; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jimenez-Feltstrom J, 2005, CELL TISSUE RES, V319, P221, DOI 10.1007/s00441-004-1013-4; Jimenez-Feltstrom J, 2011, REGUL PEPTIDES, V170, P43, DOI 10.1016/j.regpep.2011.04.011; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Koeck T, 2009, ARCH BIOCHEM BIOPHYS, V484, P221, DOI 10.1016/j.abb.2009.01.021; Lajoix AD, 2001, DIABETES, V50, P1311, DOI 10.2337/diabetes.50.6.1311; Maida A, 2011, DIABETOLOGIA, V54, P339, DOI 10.1007/s00125-010-1937-z; Marchetti P, 2004, J CLIN ENDOCR METAB, V89, P5535, DOI 10.1210/jc.2004-0150; Marshak S, 1999, DIABETES, V48, P1230, DOI 10.2337/diabetes.48.6.1230; Masini M, 2014, DIABETES RES CLIN PR, V104, P163, DOI 10.1016/j.diabres.2013.12.031; Mezghenna K, 2011, DIABETOLOGIA, V54, P2856, DOI 10.1007/s00125-011-2264-8; Mosen H, 2008, REGUL PEPTIDES, V151, P139, DOI 10.1016/j.regpep.2008.07.002; Muhammed SJ, 2012, DIABETES OBES METAB, V14, P1010, DOI 10.1111/j.1463-1326.2012.01632.x; Patane G, 2000, DIABETES, V49, P735, DOI 10.2337/diabetes.49.5.735; Salehi A, 1996, AM J PHYSIOL-CELL PH, V270, pC1634, DOI 10.1152/ajpcell.1996.270.6.C1634; Salehi A, 2001, ENDOCRINE, V16, P97, DOI 10.1385/ENDO:16:2:097; Salehi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002165; Shimabukuro M, 1997, J CLIN INVEST, V100, P290, DOI 10.1172/JCI119534; Takahashi T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004581; Takamura T, 1998, J BIOL CHEM, V273, P2493, DOI 10.1074/jbc.273.5.2493; Tsuura Y, 1998, BIOCHEM BIOPH RES CO, V252, P34, DOI 10.1006/bbrc.1998.9601; Wiseman DA, 2012, CURR DIABETES REV, V8, P303, DOI 10.2174/157339912800840514	47	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165668	10.1371/journal.pone.0165668	http://dx.doi.org/10.1371/journal.pone.0165668			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820841	gold, Green Published			2022-12-26	WOS:000387614800015
J	Tan, MK; Raman, H; Chambers, G; Sharma, I; Chen, ZL; Deshpande, N; Wilkins, MR				Tan, Mui-Keng; Raman, Harsh; Chambers, Grant; Sharma, Indu; Chen, Zhiliang; Deshpande, Nandan; Wilkins, Marc R.			Characterization of SNP and Structural Variations in the Mitochondrial Genomes of Tilletia indica and Its Closely Related Species Formed Basis for a Simple Diagnostic Assay	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; GROUP-I INTRONS; KARNAL BUNT; RIBOSOMAL-RNA; LARGE SUBUNIT; WHEAT; RISK; LAMP	Tilletia indica causes the disease Karnal bunt in wheat. The disease is under international quarantine regulations. Comparative mitochondrial (mt) genome analysis of T. indica (KX394364 and DQ993184) and T. walkeri (EF536375) has found 325 to 328 SNPs, 57 to 60 short InDels (from 1 to 13 nt), two InDels (30 and 61 nt) and five (>200 nt) presence/absence variations (PAVs) between the two species. The mt genomes of both species have identical gene order. The numbers of SNPs and InDels between the mt genomes of the two species are approximately nine times of the corresponding numbers between the two T. indica isolates. There are eight SNPs between T. indica and T. walkeri that resulted in amino acid substitutions in the mt genes of cob, nad2 and nad5. In contrast, there is no amino acid substitution in the mt genes of the T. indica isolates from the SNPs found. The five PAVs present in T. indica (DQ993184) are absent in T. walkeri. Four PAVs are more than 1 kb and are not present in every T. indica isolate. Analysis of their presence and absence separates a collection of T. indica isolates into 11 subgroups. Two PAVs have ORFs for the LAGLIDAG endonuclease and two have ORFs for the GIY-YIG endonuclease family, which are representatives of homing endonuclease genes (HEGs). These intronencoded HEGs confer intron mobility and account for their fluid distribution in T. indica isolates. The small PAV of 221 bp, present in every T. indica isolate and unique to the species, was used as the genetic fingerprint for the successful development of a rapid, highly sensitive and specific loop mediated isothermal amplification (LAMP) assay. The simple procedure of the LAMP assay and the easy detection formats will enable the assay to be automated for high throughput diagnosis.	[Tan, Mui-Keng; Chambers, Grant] Elizabeth Macarthur Agr Inst, NSW Dept Primary Ind, Menangle, NSW, Australia; [Raman, Harsh] Wagga Wagga Agr Res Inst, NSW Dept Primary Ind, Wagga Wagga, NSW, Australia; [Sharma, Indu] Punjab Agr Univ, Dept Plant Breeding Genet & Biotechnol, Ludhiana, Punjab, India; [Chen, Zhiliang; Deshpande, Nandan; Wilkins, Marc R.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Kensington, NSW, Australia; [Wilkins, Marc R.] Univ New South Wales, Ramaciotti Ctr Genom, Kensington, NSW, Australia	NSW Department of Primary Industries; NSW Department of Primary Industries; Punjab Agricultural University; University of New South Wales Sydney; University of New South Wales Sydney	Tan, MK (corresponding author), Elizabeth Macarthur Agr Inst, NSW Dept Primary Ind, Menangle, NSW, Australia.	mui-keng.tan@dpi.nsw.gov.au	RAMAN, HARSH/N-8891-2016	RAMAN, HARSH/0000-0001-9761-1518	New South Wales Department of Primary Industries and Bioplatforms Australia, New South Wales, Australia; Australian Federal Government NCRIS; New South Wales State Government RAAP; University of New South Wales	New South Wales Department of Primary Industries and Bioplatforms Australia, New South Wales, Australia; Australian Federal Government NCRIS(Australian GovernmentDepartment of Industry, Innovation and Science); New South Wales State Government RAAP; University of New South Wales	This research was financially supported by New South Wales Department of Primary Industries and Bioplatforms Australia, New South Wales, Australia. Our funding for the bioinformatics team comes from the Australian Federal Government NCRIS scheme, New South Wales State Government RAAP scheme, and the University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan JP, 2004, P 48 ANN C AUSTR AGR; Castlebury LA, 2005, MYCOLOGIA, V97, P888, DOI 10.3852/mycologia.97.4.888; Castlebury LA, 1999, MYCOLOGIA, V91, P121, DOI 10.2307/3761200; Chevalier BS, 2001, NUCLEIC ACIDS RES, V29, P3757, DOI 10.1093/nar/29.18.3757; Da Luz WC, 1993, FITOPATOLOGIA BRAS S, V18, P329; DURAN R, 1972, CAN J BOT, V50, P2569, DOI 10.1139/b72-329; Gao Y, 2016, AUSTRALAS PLANT PATH, V45, P361, DOI 10.1007/s13313-016-0422-7; Hafi A, 2015, 152 ABARES DEP AGR; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Hausner G, 2003, APPLIED MYCOLOGY AND BIOTECHNOLOGY, VOL 3, P101; Holst-Jensen A, 1999, MOL BIOL EVOL, V16, P114, DOI 10.1093/oxfordjournals.molbev.a026031; LAMBOWITZ AM, 1993, ANNU REV BIOCHEM, V62, P587, DOI 10.1146/annurev.bi.62.070193.003103; Levy L, 2001, PHYTOPATHOLOGY, V91, P935, DOI 10.1094/PHYTO.2001.91.10.935; Mitra M, 1931, ANN APPL BIOL, V18, P178, DOI 10.1111/j.1744-7348.1931.tb02294.x; Mitra M, 1935, INDIAN J AGR SCI, V5, P51; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Murray GM, 1998, AUSTRALAS PLANT PATH, V27, P212, DOI 10.1071/AP98024; Niessen L, 2010, INT J FOOD MICROBIOL, V140, P183, DOI 10.1016/j.ijfoodmicro.2010.03.036; Nosek J, 1998, TRENDS GENET, V14, P184, DOI 10.1016/S0168-9525(98)01443-7; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Owens SR, 2002, EMBO REP, V3, P111, DOI 10.1093/embo-reports/kvf043; Rigano LA, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-86; Sansford C, 2006, PEST RISK ANAL TILLE; Sansford CE, 2008, PLANT PATHOL, V57, P603, DOI 10.1111/j.1365-3059.2008.01825.x; Schoch CL, 2001, PLANT DIS, V85, P941, DOI [10.1094/PDIS.2001.85.9.941, 10.1094/PDIS.2001.85.5.561B]; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan MK, 2006, MYCOL RES, V110, P203, DOI 10.1016/j.mycres.2005.08.006; Tan MK, 1997, J MOL EVOL, V44, P637, DOI 10.1007/PL00006187; Tan Mui-Keng, 2014, Mycology, V5, P52; Tan MK, 2013, AUSTRALAS PLANT PATH, V42, P95, DOI 10.1007/s13313-012-0176-9; Tana MK, 2009, AUSTRALAS PLANT PATH, V38, P101, DOI 10.1071/AP08088; Thiery O, 2010, MOL PHYLOGENET EVOL, V55, P599, DOI 10.1016/j.ympev.2010.02.013; Torarbi M., 1996, Seed and Plant, V12, P8; VISSER W, 1995, ANTON LEEUW INT J G, V67, P243, DOI 10.1007/BF00873688; WARHAM EJ, 1986, TROP PEST MANAGE, V32, P229; Wei-chuan Z, 2010, J PLANT PATHOL, V92, P367; Ykema RE, 1996, PLANT DIS, V80, P1207, DOI 10.1094/PD-80-1207B	38	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166086	10.1371/journal.pone.0166086	http://dx.doi.org/10.1371/journal.pone.0166086			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814391	gold, Green Submitted, Green Published			2022-12-26	WOS:000386911100032
J	Speidel, A; Felk, S; Reinhardt, P; Sterneckert, J; Gillardon, F				Speidel, Anna; Felk, Sandra; Reinhardt, Peter; Sterneckert, Jared; Gillardon, Frank			Leucine-Rich Repeat Kinase 2 Influences Fate Decision of Human Monocytes Differentiated from Induced Pluripotent Stem Cells	PLOS ONE			English	Article							DISEASE-ASSOCIATED MUTATIONS; GENOME-WIDE ASSOCIATION; PARKINSONS-DISEASE; MICROGLIAL ACTIVATION; BLOOD MONOCYTES; IN-VIVO; G2019S MUTATION; GENE-EXPRESSION; LRRK2 MUTATION; IMMUNE	Mutations in Leucine-rich repeat kinase 2 (LRRK2) are strongly associated with familial Parkinson's disease (PD). High expression levels in immune cells suggest a role of LRRK2 in regulating the immune system. In this study, we investigated the effect of the LRRK2 (G2019S) mutation in monocytes, using a human stem cell-derived model expressing LRRK2 at endogenous levels. We discovered alterations in the differentiation pattern of LRRK2 mutant, compared to non-mutant isogenic controls, leading to accelerated monocyte production and a reduction in the non-classical CD14+ CD16+ monocyte subpopulation in the LRRK2 mutant cells. LPS-treatment of the iPSC-derived monocytes significantly increased the release of pro-inflammatory cytokines, demonstrating a functional response without revealing any significant differences between the genotypes. Assessment of the migrational capacity of the differentiated monocytes revealed moderate deficits in LRRK2 mutant cells, compared to their respective controls. Our findings indicate a pivotal role of LRRK2 in hematopoietic fate decision, endorsing the involvement of the immune system in the development of PD.	[Speidel, Anna; Felk, Sandra; Gillardon, Frank] Boehringer Ingelheim Pharma GmbH & Co KG, CNS Dis Res, Biberach, Germany; [Reinhardt, Peter; Sterneckert, Jared] CRTD DFG Ctr Regenerat Therapies Dresden, Dresden, Germany	Boehringer Ingelheim; Technische Universitat Dresden	Gillardon, F (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, CNS Dis Res, Biberach, Germany.	frank.gillardon@boehringer-ingelheim.com		Sterneckert, Jared/0000-0002-7688-3124	Boehringer Ingelheim Pharma GmbH Co. KG.	Boehringer Ingelheim Pharma GmbH Co. KG.(Boehringer Ingelheim)	This work was supported by Boehringer Ingelheim Pharma GmbH & Co. KG. The funder provided financial support in the form of authors' salaries [Anna Speidel, Sandra Felk and Frank Gillardon] and research materials, but did not have any additional role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ackermann M, 2015, EMBO MOL MED, V7, P1388, DOI 10.15252/emmm.201505301; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Azzinnari D, 2014, NEUROPHARMACOLOGY, V85, P328, DOI 10.1016/j.neuropharm.2014.05.039; Blesa J, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00091; Caesar M, 2014, GLIA, V62, P1075, DOI 10.1002/glia.22663; Choi I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9255; Daher JPL, 2014, P NATL ACAD SCI USA, V111, P9289, DOI 10.1073/pnas.1403215111; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dzamko N, 2015, NEUROSCIENCE, V302, P89, DOI 10.1016/j.neuroscience.2014.10.028; Dzamko N, 2012, BIOCHEM SOC T, V40, P1134, DOI 10.1042/BST20120119; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Funk N, 2013, MOVEMENT DISORD, V28, P392, DOI 10.1002/mds.25300; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Gillardon F, 2012, NEUROSCIENCE, V208, P41, DOI 10.1016/j.neuroscience.2012.02.001; Goldwurm S, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.035568; Greggio E, 2012, BIOCHEM SOC T, V40, P1058, DOI 10.1042/BST20120054; Grozdanov V, 2014, ACTA NEUROPATHOL, V128, P651, DOI 10.1007/s00401-014-1345-4; Gullo F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00361; Hakimi M, 2011, J NEURAL TRANSM, V118, P795, DOI 10.1007/s00702-011-0653-2; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Infante J, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.026; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Kim B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034693; Kubo M, 2010, J NEUROIMMUNOL, V229, P123, DOI 10.1016/j.jneuroim.2010.07.021; Kwan W, 2012, J CLIN INVEST, V122, P4737, DOI 10.1172/JCI64484; Lewis PA, 2012, BIOCHEM SOC T, V40, P1039, DOI 10.1042/BST20120178; Liu XH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/431232; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marker DF, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-261; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Menk M, 2015, INFLAMMATION, V38, P1690, DOI 10.1007/s10753-015-0146-9; Moehle MS, 2015, HUM MOL GENET, V24, P4250, DOI 10.1093/hmg/ddv157; Moehle MS, 2012, J NEUROSCI, V32, P1602, DOI 10.1523/JNEUROSCI.5601-11.2012; Muffat J, 2016, NAT MED; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Niwa A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022261; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Panicker LM, 2014, STEM CELLS, V32, P2338, DOI 10.1002/stem.1732; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Reinhardt P, 2013, CELL STEM CELL, V12, P354, DOI 10.1016/j.stem.2013.01.008; Reynolds A, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00054; Rideout HJ, 2014, NEUROCHEM RES, V39, P576, DOI 10.1007/s11064-013-1073-5; Russo I, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0449-7; Russo I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-52; Saeki K, 2009, STEM CELLS, V27, P59, DOI 10.1634/stemcells.2007-0980; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Schulz C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020820; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Sgambato JA, 2015, STEM CELL TRANSL MED, V4, P878, DOI 10.5966/sctm.2014-0213; Sheng WW, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-121; Sheng ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004485; Sulahian TH, 2001, J IMMUNOL METHODS, V252, P25, DOI 10.1016/S0022-1759(01)00328-3; Thevenet J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021519; van Wilgenburg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071098; Wandu WS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128906; Waschbisch A, 2016, J IMMUNOL, V196, P1558, DOI 10.4049/jimmunol.1501960; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Yanagimachi MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059243; Ziegler-Heitbrock HWL, 2000, J LEUKOCYTE BIOL, V67, P603, DOI 10.1002/jlb.67.5.603; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	65	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165949	10.1371/journal.pone.0165949	http://dx.doi.org/10.1371/journal.pone.0165949			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812199	Green Published, gold, Green Submitted			2022-12-26	WOS:000386910000083
J	Su, CH; Lin, IH; Tzeng, TY; Hsieh, WT; Hsu, MT				Su, Chia-Hsin; Lin, I-Hsuan; Tzeng, Tsai-Yu; Hsieh, Wen-Ting; Hsu, Ming-Ta			Regulation of IL-20 Expression by Estradiol through KMT2B-Mediated Epigenetic Modification	PLOS ONE			English	Article							NF-KAPPA-B; BREAST-CANCER; ESTROGEN-RECEPTOR; TGF-BETA; T-CELLS; ALPHA; GENE; MLL; ACTIVATION; CYTOKINES	Cytokines are low molecular weight regulatory proteins, or glycoproteins, with both tumorpromoting and inhibitory effects on breast cancer growth. Different cytokines play important roles in breast cancer initiation and progression. Here, we show that of the 39 interleukin (IL) genes, IL-20 is the only gene over-expressed in MCF-7 cells treated with estradiol (E2) and that induction of IL-20 expression by estrogen was epigenetically regulated. Methylation of histone H3K4 in the IL-20 promoter was shown to occur via the specific recruitment of KMT2B by estrogen receptor alpha (ER alpha), but not by other members of the mixed-lineage leukemia (MLL) family of histone methyltransferases. Depletion of KMT2B, or IL-20, disrupts estrogen signaling, attenuates cell proliferation, reduces colony formation, and results in cell cycle arrest. Furthermore, we demonstrated that KMT2B-mediated epigenetic modification also affected the expression of several ER alpha target genes. IL-20 and KMT2B expression were also associated with ER alpha-positive breast cancer tissues. We have revealed an important role for KMT2B in the epigenetic transcriptional regulation of cytokine IL-20, and other ER alpha-responsive genes, in breast cancer cells. Inhibition of IL-20 and KMT2B may have therapeutic benefits in ER alpha-positive breast cancer.	[Su, Chia-Hsin; Hsieh, Wen-Ting; Hsu, Ming-Ta] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Sch Life Sci, Taipei 11221, Taiwan; [Lin, I-Hsuan] Taipei Med Univ, Ctr Translat Med, Taipei, Taiwan; [Tzeng, Tsai-Yu] Natl Yang Ming Univ, Univ Syst Taiwan, VYM Genome Res Ctr, Taipei 11221, Taiwan; [Hsu, Ming-Ta] Chien Tien Hsu Canc Res Fdn, Taipei 11221, Taiwan	National Yang Ming Chiao Tung University; Taipei Medical University; National Yang Ming Chiao Tung University	Hsu, MT (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, Sch Life Sci, Taipei 11221, Taiwan.; Hsu, MT (corresponding author), Chien Tien Hsu Canc Res Fdn, Taipei 11221, Taiwan.	mth@ym.edu.tw	Lin, I-Hsuan/N-6501-2013	Lin, I-Hsuan/0000-0002-6207-1299; Hsieh, Wen-Ting/0000-0003-3201-7547; Tzeng, Tsai-Yu/0000-0001-7334-6270	Ministry of Education, Aim for the Top University Plan	Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This work was supported by a grant from the Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari KI, 2012, BRIT J CANCER, V107, P315, DOI 10.1038/bjc.2012.263; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Blot E, 2003, BRIT J CANCER, V88, P1207, DOI 10.1038/sj.bjc.6600872; Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648; Chen YY, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/294320; Cho YA, 2013, CANCER RES TREAT, V45, P210, DOI 10.4143/crt.2013.45.3.210; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Esquivel-Velazquez M, 2015, J INTERF CYTOK RES, V35, P1, DOI 10.1089/jir.2014.0026; Ferrari F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-446; Gaughan L, 2013, NUCLEIC ACIDS RES, V41, P6892, DOI 10.1093/nar/gkt469; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hsu YH, 2012, J IMMUNOL, V188, P1981, DOI 10.4049/jimmunol.1102843; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kashiwagi S, 2010, BRIT J CANCER, V103, P249, DOI 10.1038/sj.bjc.6605735; KOBAYASHI Y, 1993, BLOOD, V82, P3220; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Liu H, 2009, CANCER BIOL THER, V8, P1204, DOI 10.4161/cbt.8.13.8924; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nicolini A, 2006, CYTOKINE GROWTH F R, V17, P325, DOI 10.1016/j.cytogfr.2006.07.002; Nicolini A, 2006, BIOMED PHARMACOTHER, V60, P548, DOI 10.1016/j.biopha.2006.07.086; PRIGOGINA EL, 1986, HUM GENET, V73, P137, DOI 10.1007/BF00291604; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Reed JR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2246; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rivas MA, 2008, EXP CELL RES, V314, P509, DOI 10.1016/j.yexcr.2007.10.005; Ross-Innes CS, 2010, GENE DEV, V24, P171, DOI 10.1101/gad.552910; Rutz S, 2014, NAT REV IMMUNOL, V14, P783, DOI 10.1038/nri3766; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Schraets D, 2003, ONCOGENE, V22, P3655, DOI 10.1038/sj.onc.1206438; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Singh G, 2010, J BIOL CHEM, V285, P27241, DOI 10.1074/jbc.M110.100438; Strehl S, 2003, ONCOGENE, V22, P157, DOI 10.1038/sj.onc.1206042; Su CH, 2014, NUCLEIC ACIDS RES, V42, P3073, DOI 10.1093/nar/gkt1341; Svotelis A, 2011, EMBO J, V30, P3947, DOI 10.1038/emboj.2011.284; Tan G, 2016, BIOINFORMATICS, V32, P1555, DOI 10.1093/bioinformatics/btw024; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Vega VB, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r82; Wade MA, 2015, NUCLEIC ACIDS RES, V43, P196, DOI 10.1093/nar/gku1298; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Yang J, 2014, HISTOCHEM CELL BIOL, V142, P401, DOI 10.1007/s00418-014-1222-1; Zou JX, 2014, MOL CANCER RES, V12, P539, DOI 10.1158/1541-7786.MCR-13-0459	47	12	12	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0166090	10.1371/journal.pone.0166090	http://dx.doi.org/10.1371/journal.pone.0166090			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806114	gold, Green Published, Green Submitted			2022-12-26	WOS:000386715500082
J	Zhai, YM; Yang, Q; Wu, YY				Zhai, Yaming; Yang, Qian; Wu, Yunyu			Soil Salt Distribution and Tomato Response to Saline Water Irrigation under Straw Mulching	PLOS ONE			English	Article							BLOSSOM-END ROT; DRIP-IRRIGATION; DEFICIT IRRIGATION; PROCESSING TOMATO; USE EFFICIENCY; FRUIT-QUALITY; GROWN TOMATO; ROOT-ZONE; YIELD; CALCIUM	To investigate better saline water irrigation scheme for tomatoes that scheduling with the compromise among yield (Y-t), quality, irrigation water use efficiency (IWUE) and soil salt residual, an experiment with three irrigation quotas and three salinities of irrigation water was conducted under straw mulching in northern China. The irrigation quota levels were 280 mm (W1), 320 mm (W2) and 360 mm (W3), and the salinity levels were 1.0 dS/m (F), 3.0 dS/m (S1) and 5.0 dS/m (S2). Compared to freshwater, saline water irrigations decreased the maximum leaf area index (LAI(m)) of tomatoes, and the LAI(m) presented a decline tendency with higher salinity and lower irrigation quota. The best overall quality of tomato was obtained by S2W1, with the comprehensive quality index of 3.61. A higher salinity and lower irrigation quota resulted in a decrease of individual fruit weight and an increase of the blossom-end rot incidence, finally led to a reduction in the tomato Yt and marketable yield (Y-m). After one growth season of tomato, the mass fraction of soil salt in plough layer under S2W1 treatment was the highest, and which presented a decline trend with an increasing irrigation quota. Moreover, compared to W1, soil salts had a tendency to move to the deeper soil layer when using W2 and W3 irrigation quota. According to the calculation results of projection pursuit model, S1W3 was the optimal treatment that possessed the best comprehensive benefit (tomato overall quality, Y-t, Y-m, IWUE and soil salt residual), and was recommended as the saline water irrigation scheme for tomatoes in northern China.	[Zhai, Yaming; Wu, Yunyu] Hohai Univ, Key Lab Efficient Irrigat Drainage & Agr Soil Wat, Nanjing 210098, Jiangsu, Peoples R China; [Zhai, Yaming; Wu, Yunyu] Hohai Univ, Coll Water Conservancy & Hydropower, Nanjing 210098, Jiangsu, Peoples R China; [Yang, Qian] Henan Vocat Coll Agr, Dept Gardening, Zhengzhou, Peoples R China	Hohai University; Hohai University	Wu, YY (corresponding author), Hohai Univ, Key Lab Efficient Irrigat Drainage & Agr Soil Wat, Nanjing 210098, Jiangsu, Peoples R China.; Wu, YY (corresponding author), Hohai Univ, Coll Water Conservancy & Hydropower, Nanjing 210098, Jiangsu, Peoples R China.	njwuyunyu@126.com			Natural Science Foundation of Jiangsu province [BK20130838]; Natural Science Foundation of China [51409086]	Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financed by Natural Science Foundation of Jiangsu province (BK20130838) and Natural Science Foundation of China (51409086), received by Zhai, http://www.jstd.gov.cn/, http//www.nsfc.gov.cn/.; This work was financed by Natural Science Foundation of Jiangsu province (BK20130838) and Natural Science Foundation of China (51409086).	ADAMS P, 1993, PLANT SOIL, V154, P127, DOI 10.1007/BF00011081; Akhtar SS, 2014, AGR WATER MANAGE, V138, P37, DOI 10.1016/j.agwat.2014.02.016; Beckles DM, 2012, POSTHARVEST BIOL TEC, V63, P129, DOI 10.1016/j.postharvbio.2011.05.016; CHALMERS DJ, 1975, ANN BOT-LONDON, V39, P423, DOI 10.1093/oxfordjournals.aob.a084956; Chen LJ, 2014, AGR WATER MANAGE, V146, P24, DOI 10.1016/j.agwat.2014.07.021; Conesa MA, 2014, POSTHARVEST BIOL TEC, V93, P114, DOI 10.1016/j.postharvbio.2014.02.014; de Marsily Ghislain, 2007, Ecohydrology & Hydrobiology, V7, P147; DEKOCK PC, 1982, J SCI FOOD AGR, V33, P509, DOI 10.1002/jsfa.2740330603; Dorais M., 2001, Horticultural Reviews, V26, P239; EHRET DL, 1986, ANN BOT-LONDON, V58, P679, DOI 10.1093/oxfordjournals.aob.a087230; Gao XB, 2013, PROCED EARTH PLAN SC, V7, P280, DOI 10.1016/j.proeps.2013.03.052; Gawad GA, 2005, AGR WATER MANAGE, V78, P39, DOI 10.1016/j.agwat.2005.04.024; Hou MM, 2012, J FOOD AGRIC ENVIRON, V10, P1284; Hou MM, 2017, ARCH AGRON SOIL SCI, V63, P74, DOI 10.1080/03650340.2016.1182159; Hou MM, 2016, ZEMDIRBYSTE, V103, P221, DOI 10.13080/z-a.2016.103.029; Hou MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154799; Hou MM, 2014, SCI WORLD J, DOI 10.1155/2014/953675; Huang Z, 2010, AGR SCI CHINA, V9, P1150, DOI 10.1016/S1671-2927(09)60202-9; Incrocci L, 2006, SCI HORTIC-AMSTERDAM, V107, P365, DOI 10.1016/j.scienta.2005.12.001; Jensen CR, 2010, AGR WATER MANAGE, V98, P403, DOI 10.1016/j.agwat.2010.10.018; Kanzari S, 2012, COMPUT ELECTRON AGR, V86, P34, DOI 10.1016/j.compag.2011.09.010; Katerji N, 1998, AGR WATER MANAGE, V38, P59, DOI 10.1016/S0378-3774(98)00051-1; Kumar P, 2015, AGR WATER MANAGE, V148, P72, DOI 10.1016/j.agwat.2014.09.014; Kuscu H, 2014, AGR WATER MANAGE, V133, P92, DOI 10.1016/j.agwat.2013.11.008; Li CJ, 2015, SOIL TILL RES, V146, P99, DOI 10.1016/j.still.2014.03.013; Li XB, 2015, SOIL TILL RES, V146, P159, DOI 10.1016/j.still.2014.10.005; Li YL, 2002, SCI HORTIC-AMSTERDAM, V93, P267, DOI 10.1016/S0304-4238(01)00329-6; Liu JG, 2013, GLOBAL ENVIRON CHANG, V23, P633, DOI 10.1016/j.gloenvcha.2013.02.002; Lu ShaoWei, 2012, China Vegetables, P56; Maggio A, 2004, EUR J AGRON, V21, P149, DOI 10.1016/S1161-0301(03)00092-3; Malash N, 2005, AGR WATER MANAGE, V78, P25, DOI 10.1016/j.agwat.2005.04.016; Mohamed A. A. K., 1989, Mesopotamia Journal of Agriculture, V21, P65; Nebauer SG, 2013, PLANT PHYSIOL BIOCH, V63, P61, DOI 10.1016/j.plaphy.2012.11.006; Nonami H, 1995, ACTA HORTIC, P107, DOI 10.17660/ActaHortic.1995.396.11; Olle M, 2009, J HORTIC SCI BIOTECH, V84, P577, DOI 10.1080/14620316.2009.11512568; OShaughnessy S.A., 2014, ENCY AGR FOOD SYSTEM, P521, DOI [10.1016/B978-0-444-52512-3.00235-7, DOI 10.1016/B978-0-444-52512-3.00235-7]; Patane C, 2011, SCI HORTIC-AMSTERDAM, V129, P590, DOI 10.1016/j.scienta.2011.04.030; Qiu RJ, 2013, AGR WATER MANAGE, V130, P44, DOI 10.1016/j.agwat.2013.08.013; Reina-Sanchez A, 2005, AGR WATER MANAGE, V78, P54, DOI 10.1016/j.agwat.2005.04.021; Sanchez-Rodriguez E, 2012, PLANT SCI, V188, P89, DOI 10.1016/j.plantsci.2011.12.019; Saure MC, 2001, SCI HORTIC-AMSTERDAM, V90, P193, DOI 10.1016/S0304-4238(01)00227-8; Selby, 1896, OHIO AGR EXP STA B, V73, P146; Shao GC, 2014, SCI WORLD J, DOI 10.1155/2014/457937; Shao GC, 2014, EUR J AGRON, V53, P1, DOI 10.1016/j.eja.2013.10.005; Shao HB, 2007, COLLOID SURFACE B, V55, P251, DOI 10.1016/j.colsurfb.2006.12.001; Shao X, 2013, RES CROP, V14, P1159; Shao XH, 2012, ENRGY PROCED, V16, P747, DOI 10.1016/j.egypro.2012.01.120; Sperry W. J., 1996, HortTechnology, V6, P21; Subramanian KS, 2006, SCI HORTIC-AMSTERDAM, V107, P245, DOI 10.1016/j.scienta.2005.07.006; Taylor MD, 2004, HORTSCIENCE, V39, P1110, DOI 10.21273/HORTSCI.39.5.1110; Tomato R., 1998, SCI HORTICULTURAE, V78, P83; Topcu S, 2007, EUR J AGRON, V26, P64, DOI 10.1016/j.eja.2006.08.004; Tuna AL, 2007, ENVIRON EXP BOT, V59, P173, DOI 10.1016/j.envexpbot.2005.12.007; Wan SQ, 2007, AGR WATER MANAGE, V90, P63, DOI 10.1016/j.agwat.2007.02.011; Wan SQ, 2010, AGR WATER MANAGE, V98, P105, DOI 10.1016/j.agwat.2010.08.003; Wang CT, 2011, PROCEDIA ENVIRON SCI, V10, P1595, DOI 10.1016/j.proenv.2011.09.253; Wang D, 2007, AGR WATER MANAGE, V87, P180, DOI 10.1016/j.agwat.2006.06.021; Wang GD, 2014, PLANT PHYSIOL BIOCH, V82, P95, DOI 10.1016/j.plaphy.2014.05.011; Wang HX, 2002, ADV AGRON, V75, P135; Wang RS, 2014, AGR WATER MANAGE, V131, P41, DOI 10.1016/j.agwat.2013.09.011; [王伟娜 Wang Weina], 2014, [河海大学学报. 自然科学版, Journal of Hohai University. Natural Sciences], V42, P372; Wang YR, 2007, PEDOSPHERE, V17, P303, DOI 10.1016/S1002-0160(07)60037-X; Wang Yu, 2012, WATER SAVING IRRIGAT, V18, P2060; Wu Y, 2015, WATER SAVING IRRIGAT, V7, P21; Yang JianGuo, 2010, Acta Agriculturae Zhejiangensis, V22, P813; Yao RJ, 2014, AGR WATER MANAGE, V131, P115, DOI 10.1016/j.agwat.2013.09.014; Yi LL, 2011, J ENVIRON SCI-CHINA, V23, P1585, DOI 10.1016/S1001-0742(10)60627-4; Zhai YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142204; Zhou J, 2013, FOREST ECOL MANAG, V300, P33, DOI 10.1016/j.foreco.2013.01.007; Zotarelli L, 2009, AGR WATER MANAGE, V96, P23, DOI 10.1016/j.agwat.2008.06.007	70	11	11	6	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165985	10.1371/journal.pone.0165985	http://dx.doi.org/10.1371/journal.pone.0165985			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806098	Green Submitted, Green Published, gold			2022-12-26	WOS:000386715500075
J	McCurdy, SR; Pacal, M; Ahmad, M; Bremner, R				McCurdy, S. R.; Pacal, M.; Ahmad, M.; Bremner, R.			A CDK2 activity signature predicts outcome in CDK2-low cancers	ONCOGENE			English	Article							CYCLIN-DEPENDENT KINASES; TERMINAL DOMAIN CTD; CELL-CYCLE; TUMOR SUPPRESSION; TARGET GENES; IDENTIFICATION; PHOSPHORYLATION; CARCINOMA; MICE; RETINOBLASTOMA	The role of cyclin-dependent kinase 2 (CDK2) in cancer is controversial. A major hurdle is the availability of tools to easily assess its activity across many samples. Here, we introduce a transcriptional signature to specifically track CDK2 activity. It responds to genetic and chemical perturbations in the CDK-RB-E2F axis, correlates with mitotic rate in vitro and in vivo and reacts rapidly to changes in CDK2 activity during cell cycle progression. We find that CDK2 activity is specifically elevated in human testes, mirroring its critical function in mice, and report very distinct profiles across human cancers. Increased CDK2 activity decreases risk in colon cancer, but elevates poor outcome two-to fivefold in specific tumors, including low grade glioma, kidney, thyroid, adrenocortical and prostate cancer. These are typically 'CDK2-low' cancers, suggesting that above a certain threshold CDK2 promotes progression, but further increases do not influence outcome. Multivariate analysis revealed that the CDK2 signature is the most important predictive feature in these cancers versus dozens of other clinical parameters, such as tumor grade or mitotic index. Thus, transcriptome data provides a novel, straightforward method to monitor CDK2 activity, implicates key roles for the kinase in a subset of human tissues and tumors and enhances cancer risk prediction. The strategy used here for CDK2 could be applied to other kinases that influence transcription.	[McCurdy, S. R.; Pacal, M.; Ahmad, M.; Bremner, R.] Sinai Hlth Syst, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Room 840 600 Univ Ave, Toronto, ON M5G 1X5, Canada; [McCurdy, S. R.; Bremner, R.] Univ Toronto, Dept Lab Med & Pathobiol, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Bremner, R (corresponding author), Sinai Hlth Syst, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Room 840 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	bremner@lunenfeld.ca	Bremner, Rod/I-6490-2012	Bremner, Rod/0000-0001-9184-7212	Canadian Institutes for Health Research (CIHR); Foundation Fighting Blindness Canada; Ontario Institute for Cancer Research through Government of Ontario; Terry Fox Research Institute; Peterborough KM Hunter Foundation; CIHR (Vanier Graduate Scholarship); CIHR Biological Therapeutics Program; Krembil Foundation	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Foundation Fighting Blindness Canada; Ontario Institute for Cancer Research through Government of Ontario; Terry Fox Research Institute; Peterborough KM Hunter Foundation; CIHR (Vanier Graduate Scholarship)(Canadian Institutes of Health Research (CIHR)); CIHR Biological Therapeutics Program(Canadian Institutes of Health Research (CIHR)); Krembil Foundation	We thank G Bader, F Roth and J Wrana for helpful comments. This project was funded by grants to RB from the Canadian Institutes for Health Research (CIHR), Foundation Fighting Blindness Canada, Krembil Foundation, Ontario Institute for Cancer Research through funding provided by the Government of Ontario and the Terry Fox Research Institute. SRM was supported by scholarships from Peterborough KM Hunter Foundation, CIHR (Vanier Graduate Scholarship) and the CIHR Biological Therapeutics Program.	Adler AS, 2012, CANCER RES, V72, P2129, DOI 10.1158/0008-5472.CAN-11-3886; Akli S, 2011, CANCER RES, V71, P3377, DOI 10.1158/0008-5472.CAN-10-4086; Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Asghar U, 2015, NAT REV DRUG DISCOV, V14, P130, DOI 10.1038/nrd4504; Assie G, 2014, NAT GENET, V46, P607, DOI 10.1038/ng.2953; Berkofsky-Fessler W, 2009, MOL CANCER THER, V8, P2517, DOI 10.1158/1535-7163.MCT-09-0083; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; Chi Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r149; Cline MS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02652; Deng LW, 2002, J BIOL CHEM, V277, P33922, DOI 10.1074/jbc.M111349200; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Galbraith MD, 2013, CELL, V153, P1327, DOI 10.1016/j.cell.2013.04.048; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gillam MP, 2014, ONCOGENE, V124, P1056; Heaton JH, 2012, AM J PATHOL, V181, P1017, DOI 10.1016/j.ajpath.2012.05.026; Hongo F, 2014, UROL ONCOL-SEMIN ORI, V32, P1240, DOI 10.1016/j.urolonc.2014.05.006; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishihara H, 2005, BBA-MOL BASIS DIS, V1741, P226, DOI 10.1016/j.bbadis.2005.06.001; Kim SJ, 2008, ANN ONCOL, V19, P68, DOI 10.1093/annonc/mdm358; Kim SJ, 2012, ANN ONCOL, V23, P891, DOI 10.1093/annonc/mdr340; Kronja I, 2011, PHILOS T R SOC B, V366, P3638, DOI 10.1098/rstb.2011.0084; Kubo H, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-755; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Li JQ, 2001, HUM PATHOL, V32, P945, DOI 10.1053/hupa.2001.27116; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Macias E, 2007, CANCER RES, V67, P9713, DOI 10.1158/0008-5472.CAN-07-2119; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Martin A, 2005, CANCER CELL, V7, P591, DOI 10.1016/j.ccr.2005.05.006; Molenaar JJ, 2009, P NATL ACAD SCI USA, V106, P12968, DOI 10.1073/pnas.0901418106; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; Nekhai S, 2002, BIOCHEM J, V364, P649, DOI 10.1042/BJ20011191; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Padmakumar VC, 2009, MOL CELL BIOL, V29, P2582, DOI 10.1128/MCB.00952-08; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Puyol M, 2010, CANCER CELL, V18, P63, DOI 10.1016/j.ccr.2010.05.025; Ray D, 2011, NEOPLASIA, V13, P439, DOI 10.1593/neo.101704; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sangwan M, 2012, ONCOGENE, V31, P5019, DOI 10.1038/onc.2011.654; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062; Stojadinovic A, 2003, MODERN PATHOL, V16, P742, DOI 10.1097/01.MP.0000081730.72305.81; Stojadinovic A, 2002, J CLIN ONCOL, V20, P941, DOI 10.1200/JCO.2002.20.4.941; Tsutsui T, 2011, GENES CELLS, V16, P1208, DOI 10.1111/j.1365-2443.2011.01565.x; Wang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034247; WEISS LM, 1989, AM J SURG PATHOL, V13, P202, DOI 10.1097/00000478-198903000-00004; WEISS LM, 1984, AM J SURG PATHOL, V8, P163, DOI 10.1097/00000478-198403000-00001; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Zhang W, 2006, MOL CANCER RES, V4, P935, DOI 10.1158/1541-7786.MCR-06-0253; Zhu JC, 2009, NAT METHODS, V6, P239, DOI 10.1038/nmeth0409-239	59	23	24	0	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 4	2017	36	18					2491	2502		10.1038/onc.2016.409	http://dx.doi.org/10.1038/onc.2016.409			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET9AN	27819669				2022-12-26	WOS:000400597300001
J	Martin, EE; Huang, W; Anwar, T; Arellano-Garcia, C; Burman, B; Guan, JL; Gonzalez, ME; Kleer, CG				Martin, E. E.; Huang, W.; Anwar, T.; Arellano-Garcia, C.; Burman, B.; Guan, J-L; Gonzalez, M. E.; Kleer, C. G.			MMTV-cre; Ccn6 knockout mice develop tumors recapitulating human metaplastic breast carcinomas	ONCOGENE			English	Article							TO-MESENCHYMAL TRANSITION; P63 EXPRESSION; MAMMARY-TUMORS; CANCER; WISP3; CELLS; INVASION; GENE; METASTASIS; INVOLUTION	Metaplastic breast carcinoma is an aggressive form of invasive breast cancer with histological evidence of epithelial to mesenchymal transition (EMT). However, the defining molecular events are unknown. Here we show that CCN6 (WISP3), a secreted matricellular protein of the CCN (CYR61/CTGF/NOV) family, is significantly downregulated in clinical samples of human spindle cell metaplastic breast carcinoma. We generated a mouse model of mammary epithelial-specific Ccn6 deletion by developing a floxed Ccn6 mouse which was bred with an MMTV-Cre mouse. Ccn6(fl/fl); MMTV-Cre mice displayed severe defects in ductal branching and abnormal age-related involution compared to littermate controls. Ccn6(fl/fl); MMTV-Cre mice developed invasive high grade mammary carcinomas with bona fide EMT, histologically similar to human metaplastic breast carcinomas. Global gene expression profiling of Ccn6(fl/fl) mammary carcinomas and comparison of orthologous genes with a human metaplastic carcinoma signature revealed a significant overlap of 87 genes (P = 5x10(-11)). Among the shared deregulated genes between mouse and human are important regulators of epithelial morphogenesis including Cdh1, Ck19, Cldn3 and 4, Ddr1, and Wnt10a. These results document a causal role for Ccn6 deletion in the pathogenesis of metaplastic carcinomas with histological and molecular similarities with human disease. We provide a platform to study new targets in the diagnosis and treatment of human metaplastic carcinomas, and a new disease relevant model in which to test new treatment strategies.	[Martin, E. E.; Huang, W.; Anwar, T.; Arellano-Garcia, C.; Burman, B.; Gonzalez, M. E.; Kleer, C. G.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Martin, E. E.; Huang, W.; Anwar, T.; Arellano-Garcia, C.; Burman, B.; Gonzalez, M. E.; Kleer, C. G.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Anwar, T.] Univ Michigan, Med Scientist Training Program, Ann Arbor, MI 48109 USA; [Anwar, T.] Univ Michigan, Mol & Cellular Pathol Grad Program, Ann Arbor, MI 48109 USA; [Arellano-Garcia, C.] Univ Michigan, Postbaccalaureate Res Educ Program, Ann Arbor, MI 48109 USA; [Guan, J-L] Univ Cincinnati, Dept Canc Biol, Cincinnati, OH USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Ohio; University of Cincinnati	Kleer, CG (corresponding author), Univ Michigan, Dept Pathol, Comprehens Canc Ctr 4217, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	kleer@umich.edu		Arellano-Garcia, Caroline/0000-0002-4103-4042	National Institutes of Health (NIH) grant [R01CA125577, R01CA107469, F30CA196084, R25GM086262]; University of Michigan's Cancer Center [5 P30 CA46592]; NATIONAL CANCER INSTITUTE [R01CA125577, K08CA090876, P30CA046592, F30CA196084, R01CA107469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM086262] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan's Cancer Center(University of Michigan System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) grant R01CA125577 and R01CA107469 (C.G.K), F30CA196084 (T.A), R25GM086262 (PREP program, C.A-G), and the University of Michigan's Cancer Center Support grant 5 P30 CA46592. We thank Dr Stephen Weiss for the MMTV-Cre line A mice in FVB background, and members of the Kleer lab for critical review of the manuscript.	Anwar TE, 2013, HUM PATHOL, V44, P1457, DOI 10.1016/j.humpath.2013.01.005; Bae SY, 2011, BREAST CANCER RES TR, V126, P471, DOI 10.1007/s10549-011-1359-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardo GM, 2012, BIOSCIENCE REP, V32, P113, DOI 10.1042/BSR20110046; Blackburn AC, 2007, AM J PATHOL, V170, P2030, DOI 10.2353/ajpath.2007.060512; Burstein MD, 2015, CLIN CANCER RES, V21, P1688, DOI 10.1158/1078-0432.CCR-14-0432; Ferguson BW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036618; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hayes MJ, 2008, CLIN CANCER RES, V14, P4038, DOI 10.1158/1078-0432.CCR-07-4379; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Hennessy BT, 2006, ANN ONCOL, V17, P605, DOI 10.1093/annonc/mdl006; Huang W, 2008, AM J PATHOL, V172, P893, DOI 10.2353/ajpath.2008.070899; Huang W, 2016, ONCOTARGET, V7, P25180, DOI 10.18632/oncotarget.7734; Huang W, 2010, CANCER RES, V70, P3340, DOI 10.1158/0008-5472.CAN-09-4225; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Hurvitz JR, 1999, NAT GENET, V23, P94, DOI 10.1038/12699; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JONES L P, 2011, J CANC SCI THER S, V2, P1, DOI [DOI 10.4172/1948-5956.S2-004, 10.4172/1948-5956]; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Kleer CG, 2004, NEOPLASIA, V6, P179, DOI 10.1593/neo.03316; Kleer CG, 2002, ONCOGENE, V21, P3172, DOI 10.1038/sj.onc.1205462; Koker MM, 2004, AM J SURG PATHOL, V28, P1506, DOI 10.1097/01.pas.0000138183.97366.fd; Kutz WE, 2005, MOL CELL BIOL, V25, P414, DOI 10.1128/MCB.25.1.414-421.2005; Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3; Li Y, 2015, ONCOTARGET, V6, P32656, DOI 10.18632/oncotarget.5328; Lorenzatti G, 2011, J CELL SCI, V124, P1752, DOI 10.1242/jcs.084194; Luini A, 2007, BREAST CANCER RES TR, V101, P349, DOI 10.1007/s10549-006-9301-1; McAllister KA, 2002, CANCER RES, V62, P990; Milanese TR, 2006, J NATL CANCER I, V98, P1600, DOI 10.1093/jnci/djj439; Mollenhauer J, 1997, NAT GENET, V17, P32, DOI 10.1038/ng0997-32; Morishita A, 2013, CANCER RES, V73, P4289, DOI 10.1158/0008-5472.CAN-12-3848; OBERMAN HA, 1987, AM J SURG PATHOL, V11, P918, DOI 10.1097/00000478-198712000-00002; Pal A, 2012, NEOPLASIA, V14, P1067, DOI 10.1593/neo.121322; Pal A, 2012, CANCER RES, V72, P4818, DOI 10.1158/0008-5472.CAN-12-0154; Parr C, 2006, INT J CANCER, V119, P1176, DOI 10.1002/ijc.21881; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Radisky DC, 2009, J MAMMARY GLAND BIOL, V14, P181, DOI 10.1007/s10911-009-9123-y; Rakha EA, 2015, BRIT J CANCER, V112, P283, DOI 10.1038/bjc.2014.592; Reis JS, 2005, BREAST CANCER RES, V7, pR1028, DOI 10.1186/bcr1341; Reis JS, 2003, APPL IMMUNOHISTO M M, V11, P1, DOI 10.1097/00022744-200303000-00001; Reis JS, 2003, HISTOPATHOLOGY, V42, P94, DOI 10.1046/j.1365-2559.2003.01513_2.x; Ritchie ME, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-261; Rungta S, 2012, ARCH PATHOL LAB MED, V136, P896, DOI 10.5858/arpa.2012-0166-CR; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tchatchou S, 2010, HUM MUTAT, V31, P60, DOI 10.1002/humu.21134; Toy KA, 2015, BREAST CANCER RES TR, V150, P9, DOI 10.1007/s10549-015-3285-7; van Golen KL, 1999, CLIN CANCER RES, V5, P2511; Weigelt B, 2015, MODERN PATHOL, V28, P340, DOI 10.1038/modpathol.2014.142; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Zhang YH, 2012, MODERN PATHOL, V25, P178, DOI 10.1038/modpathol.2011.167; Zhang YH, 2005, BREAST CANCER RES, V7, pR1080, DOI 10.1186/bcr1351; Zhou ZN, 2014, ONCOGENE, V33, P3784, DOI 10.1038/onc.2013.363	52	17	17	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 20	2017	36	16					2275	2285		10.1038/onc.2016.381	http://dx.doi.org/10.1038/onc.2016.381			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ES8DM	27819674	Green Accepted			2022-12-26	WOS:000399782700008
J	Tang, Y; Liu, MY; Wu, JH				Tang, Yi; Liu, Ming-yu; Wu, Jin-hua			Effects of Thinning and Water Supply Manipulation on the Productivity of Pinus sylvestris var. mongolica in Northeastern China	PLOS ONE			English	Article							EUROPEAN BEECH; SEED NUMBER; IMPACTS; FORESTS; STANDS; MODEL	Management is an effective tool for increasing the productivity of Mongolian pine (Pinus sylvestris var. mongolica). This species has been widely planted in China, especially in sandy lands. However, optimization of management practices had not been fully explored. We established a system dynamic model to evaluate the effects of thinning and of manipulation of water supply on the productivity and population density of a Mongolian pine forest (17 scenarios in total). Different levels of thinning increased the mean biomass of Mongolian pine over no-management to a range from 202 to 256 t.ha(-1). Increasing water supply decreased the mean biomass of Mongolian pine to a range from 176 to 199 t.ha(-1). These results indicated that thinning at different levels may lead to an increase in biomass accumulation, while manipulating water supply may decrease biomass. Further, thinning appeared more effective than increasing water supply in efforts at maintaining high productivity of Mongolian pine forests. Moreover, the highest biomass occurred in a scenario with a thinning intensity of 30% in over-mature trees, indicating that this thinning intensity was the most effective choice for to the maintenance of the highest biomass in Mongolian pine forests. This study informs about the interactions between Mongolian pine and forest management, and provides guidelines for the practice of management of this forest type.	[Tang, Yi; Liu, Ming-yu; Wu, Jin-hua] Liaoning Univ, Sch Life Sci, Shenyang, Peoples R China	Liaoning University	Tang, Y (corresponding author), Liaoning Univ, Sch Life Sci, Shenyang, Peoples R China.	tangyi@lnu.edu.cn	Tang, Yi/AAG-3642-2021	Tang, Yi/0000-0002-4374-6334	National Basic Research Program of China [2013CB429905]; National Natural Science Foundation of China [41201052]; Scientific Research Program of the education department of Liaoning province [LYB201613]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Program of the education department of Liaoning province	This work was supported by the National Basic Research Program of China (2013CB429905), the National Natural Science Foundation of China (41201052) and the Scientific Research Program of the education department of Liaoning province (LYB201613).	Armolaitis K, 2013, BIOMASS BIOENERG, V54, P250, DOI 10.1016/j.biombioe.2013.03.034; Carvajal DE, 2015, AM J BOT, V102, P1552, DOI 10.3732/ajb.1500097; Chu Jian-min, 2011, Shengtaixue Zazhi, V30, P2672; Cienciala E, 2006, TREES-STRUCT FUNCT, V20, P483, DOI 10.1007/s00468-006-0064-4; Dulamsuren C, 2013, PLANT ECOL, V214, P139, DOI 10.1007/s11258-012-0152-z; Dyck W. J., 1994, IMPACTS FOREST HARVE; Forrester DI, 2013, FOREST ECOL MANAG, V288, P21, DOI 10.1016/j.foreco.2011.11.024; Gambin BL, 2010, ANN APPL BIOL, V156, P91, DOI 10.1111/j.1744-7348.2009.00367.x; Guo H, 2010, J ECOL, V98, P1232, DOI 10.1111/j.1365-2745.2010.01688.x; Huang XH., 2012, RUAL PRACT TECH INFO, V18, P39; Jiang F, 1996, MANAGEMENT REASONABL; Jiao ShuRen, 2001, Scientia Silvae Sinicae, V37, P131; [康宏樟 Kang Hongzhang], 2005, [生态学杂志, Chinese Journal of Ecology], V24, P799; [李华 Li Hua], 2010, [生态学报, Acta Ecologica Sinica], V21, P3654; Lopez-Serrano FR, 2015, EUR J FOREST RES, V134, P167, DOI 10.1007/s10342-014-0841-3; Luan KZ, 2012, FOREST SCI TECH, V37, P35; Luo L. Y., 2008, THESIS; McKnight US, 2013, ENVIRON MODELL SOFTW, V40, P35, DOI 10.1016/j.envsoft.2012.07.007; Molina AJ, 2012, FOREST ECOL MANAG, V269, P206, DOI 10.1016/j.foreco.2011.12.037; Nzunda EF, 2011, PLANT ECOL, V212, P1991, DOI 10.1007/s11258-011-9991-2; Pretzsch H, 2013, EUR J FOREST RES, V132, P263, DOI 10.1007/s10342-012-0673-y; Sharma RP, 2016, FOREST ECOL MANAG, V366, P208, DOI 10.1016/j.foreco.2016.01.040; Song LN, 2015, AGROFOREST SYST, V89, P477, DOI 10.1007/s10457-014-9784-4; Tang Y, 2018, AGROFOREST SYST, V92, P1, DOI 10.1007/s10457-016-0004-2; Tang Y, 2015, BIOCELL, V39, P15; Wang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043531; Wang QF, 2009, THE SYSTEM DYNAMICS; Wei SK, 2012, EUR J OPER RES, V221, P248, DOI 10.1016/j.ejor.2012.03.014; Wei X, 2000, FOREST ECOL MANAG, V133, P217, DOI 10.1016/S0378-1127(99)00234-0; Wu CR, 2003, PROTECTION FOREST SC, V1, P59; Wu YX, 1997, J LIAONING FOREST SC, V24, P27; Xu Wei, 2008, Journal of Zhejiang University (Agriculture and Life Sciences), V34, P649; You GC, 2002, PROTECT FOREST SCI T, V10, P11; Zeng DH, 2000, ACTA ECOL SIN, V20, P235, DOI DOI 10.3321/J.ISSN:1000-0933.2000.02.011; Zhang ZJ., 2014, PROTECT FOREST SCI T, V23, P73; Zheng DeHui, 1996, Chinese Journal of Applied Ecology, V7, P134; Zheng X, 2012, AGR WATER MANAGE, V109, P94, DOI 10.1016/j.agwat.2012.02.010; Zhu Jiao-jun, 2003, Journal of Forestry Research (Harbin), V14, P103, DOI 10.1007/BF02856774; Zhu JJ, 2006, J FOREST RES-JPN, V11, P319, DOI 10.1007/s10310-006-0214-y	40	2	2	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166109	10.1371/journal.pone.0166109	http://dx.doi.org/10.1371/journal.pone.0166109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829012	gold, Green Submitted, Green Published			2022-12-26	WOS:000387724300082
J	Chen, WJ; Kinsler, VA; Macmillan, D; Di, WL				Chen, Wenjie; Kinsler, Veronica A.; Macmillan, Derek; Di, Wei-Li			Tissue Kallikrein Inhibitors Based on the Sunflower Trypsin Inhibitor Scaffold - A Potential Therapeutic Intervention for Skin Diseases	PLOS ONE			English	Article							PROTEINASE-ACTIVATED RECEPTOR-2; AMINO-ACID-SEQUENCE; NETHERTON-SYNDROME; SERINE-PROTEASE; STRATUM-CORNEUM; ALPHA-CHYMOTRYPSIN; ACYL TRANSFER; GENE-THERAPY; MECHANISM; SFTI-1	Tissue kallikreins (KLKs), in particular KLK5, 7 and 14 are the major serine proteases in the skin responsible for skin shedding and activation of inflammatory cell signaling. In the normal skin, their activities are controlled by an endogenous protein protease inhibitor encoded by the SPINK5 gene. Loss-of-function mutations in SPINK5 leads to enhanced skin kallikrein activities and cause the skin disease Netherton Syndrome (NS). We have been developing inhibitors based on the Sunflower Trypsin Inhibitor 1 (SFTI-1) scaffold, a 14 amino acids head-to-tail bicyclic peptide with a disulfide bond. To optimize a previously reported SFTI-1 analogue (I10H), we made five analogues with additional substitutions, two of which showed improved inhibition. We then combined those substitutions and discovered a variant (Analogue 6) that displayed dual inhibition of KLK5 (tryptic) and KLK7 (chymotryptic). Analogue 6 attained a tenfold increase in KLK5 inhibition potency with an Isothermal Titration Calorimetry (ITC) K-d of 20nM. Furthermore, it selectively inhibits KLK5 and KLK14 over seven other serine proteases. Its biological function was ascertained by full suppression of KLK5-induced Protease-Activated Receptor 2 (PAR-2) dependent intracellular calcium mobilization and postponement of Interleukin-8 (IL-8) secretion in cell model. Moreover, Analogue 6 permeates through the cornified layer of in vitro organotypic skin equivalent culture and inhibits protease activities therein, providing a potential drug lead for the treatment of NS.	[Chen, Wenjie; Di, Wei-Li] UCL GOS Inst Child Hlth, Immunobiol Sect, Infect Immun & Inflammat Programme, London, England; [Kinsler, Veronica A.] UCL GOS Inst Child Hlth, Genet & Genom Med Programme, London, England; [Macmillan, Derek] UCL, Dept Chem, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Di, WL (corresponding author), UCL GOS Inst Child Hlth, Immunobiol Sect, Infect Immun & Inflammat Programme, London, England.	w.di@ucl.ac.uk	陈, 文杰·/HHN-5495-2022; Kinsler, Veronica A./AAO-8195-2021	陈, 文杰·/0000-0003-0556-7391; 	UK charity Sparks [13ICH03]; Ichthyosis Support Group; Sparks Charity [13ICH03] Funding Source: researchfish	UK charity Sparks; Ichthyosis Support Group; Sparks Charity	WC received support from the UK charity Sparks www.sparks.org.uk (Grant Number 13ICH03) and Ichthyosis Support Group www.ichthyosis.org.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bin Saif G, 2007, INT J DERMATOL, V46, P290; BIRK Y, 1967, BIOCHIM BIOPHYS ACTA, V147, P402, DOI 10.1016/0005-2795(67)90424-2; BIRK Y, 1961, BIOCHIM BIOPHYS ACTA, V54, P378, DOI 10.1016/0006-3002(61)90387-0; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; CHAPMAN SJ, 1991, ARCH DERMATOL RES, V283, P167, DOI 10.1007/BF00372057; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cowper B, 2015, ORG BIOMOL CHEM, V13, P7469, DOI 10.1039/c5ob01029b; de Veer SJ, 2015, J MED CHEM, V58, P8257, DOI 10.1021/acs.jmedchem.5b01148; de Veer SJ, 2015, BIOCHEM J, V469, P243, DOI 10.1042/BJ20150412; de Veer SJ, 2013, BIOPOLYMERS, V100, P510, DOI [10.1002/bip.22231, 10.1002/peps.22231]; de Veer SJ, 2016, BIOL CHEM; Debela M, 2007, J MOL BIOL, V373, P1017, DOI 10.1016/j.jmb.2007.08.042; Debowski D, 2016, J THERM ANAL CALORIM, V123, P807, DOI 10.1007/s10973-015-4993-2; Deraison C, 2007, MOL BIOL CELL, V18, P3607, DOI 10.1091/mbc.E07-02-0124; Di WL, 2013, HUM GENE THER CL DEV, V24, P182, DOI 10.1089/humc.2013.195; Di WL, 2011, MOL THER, V19, P408, DOI 10.1038/mt.2010.201; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Flohr S, 2010, Kallikrein 7 modulators, Patent No. [US 2010/0256144 A1, 20100256144]; Fontao L, 2011, J INVEST DERMATOL, V131, P1947, DOI 10.1038/jid.2011.124; Furio L, 2014, J EXP MED, V211, P499, DOI 10.1084/jem.20131797; GILFIX BM, 1984, J CELL PHYSIOL, V119, P172, DOI 10.1002/jcp.1041190205; Goettig P, 2010, BIOCHIMIE, V92, P1546, DOI 10.1016/j.biochi.2010.06.022; Hou L, 1998, IMMUNOLOGY, V94, P356, DOI 10.1046/j.1365-2567.1998.00528.x; Hovnanian A, 2015, patent WO, Patent No. [2015/114144A1.2015, 2015114144]; Jendrny C, 2016, CHEMBIOCHEM, V17, P719, DOI 10.1002/cbic.201500539; Komatsu N, 2007, BRIT J DERMATOL, V156, P875, DOI 10.1111/j.1365-2133.2006.07743.x; Komatsu N, 2007, EXP DERMATOL, V16, P513, DOI 10.1111/j.1600-0625.2007.00562.x; Krastel P., 2009, Cyclic Depsipeptides, Patent No. [US 2009/0156472 A1, 20090156472, 2009/0156472A1]; Long YQ, 2001, BIOORG MED CHEM LETT, V11, P2515, DOI 10.1016/S0960-894X(01)00493-0; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; Macmillan D, 2011, CHEMBIOCHEM, V12, P2133, DOI 10.1002/cbic.201100364; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Meyer-Hoffert U, 2011, J INVEST DERM SYMP P, V15, P16, DOI 10.1038/jidsymp.2011.2; Michael IP, 2005, J BIOL CHEM, V280, P14628, DOI 10.1074/jbc.M408132200; Mitsudo K, 2003, BIOCHEMISTRY-US, V42, P3874, DOI 10.1021/bi027029v; Mulvenna JP, 2005, J BIOL CHEM, V280, P32245, DOI 10.1074/jbc.M506060200; ODANI S, 1977, J BIOCHEM-TOKYO, V82, P1523, DOI 10.1093/oxfordjournals.jbchem.a131846; ODANI S, 1971, P JPN ACAD, V47, P621, DOI 10.2183/pjab1945.47.621; Oliveira JPC, 2014, ACS MED CHEM LETT, V5, P128, DOI 10.1021/ml4003698; Prassas I, 2015, NAT REV DRUG DISCOV, V14, P183, DOI 10.1038/nrd4534; Renner ED, 2009, J ALLERGY CLIN IMMUN, V124, P536, DOI 10.1016/j.jaci.2009.06.009; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Shariff L, 2014, TETRAHEDRON, V70, P7675, DOI 10.1016/j.tet.2014.06.059; Shpacovitch VM, 2002, J INVEST DERMATOL, V118, P380, DOI 10.1046/j.0022-202x.2001.01658.x; Stefansson K, 2008, J INVEST DERMATOL, V128, P18, DOI 10.1038/sj.jid.5700965; Swedberg JE, 2009, CHEM BIOL, V16, P633, DOI 10.1016/j.chembiol.2009.05.008; Tan X, 2015, J MED CHEM, V58, P598, DOI 10.1021/jm500988d; Tan X, 2013, BIOORG MED CHEM LETT, V23, P4547, DOI 10.1016/j.bmcl.2013.06.039; Vasileiou Z, 2010, BIOPOLYMERS, V94, P339, DOI 10.1002/bip.21376; Voegeli R, 2009, BRIT J DERMATOL, V161, P70, DOI 10.1111/j.1365-2133.2009.09142.x; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Yoshida N, 2007, INT J MOL MED, V19, P335; Zablotna E, 2002, LETT PEPT SCI, V9, P131	58	27	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166268	10.1371/journal.pone.0166268	http://dx.doi.org/10.1371/journal.pone.0166268			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824929	Green Published, gold, Green Submitted			2022-12-26	WOS:000387615200080
J	Christensen, AP; Akyuz, N; Corey, DP				Christensen, Adam P.; Akyuz, Nurunisa; Corey, David P.			The Outer Pore and Selectivity Filter of TRPA1	PLOS ONE			English	Article							ION-CHANNEL TRPA1; COVALENT MODIFICATION; DIRECT ACTIVATION; CALCIUM-IONS; PERMEATION; TRPV1; CA2+; COLD; PERMEABILITY; CONDUCTANCE	TRPA1 ((t) under bar ransient-(r) under bar eceptor-(p) under bar otential-related ion channel with ankyrin domains) is a direct receptor or indirect effector for a wide variety of nociceptive signals, and thus is a compelling target for development of analgesic pharmaceuticals such as channel blockers. Recently, the structure of TRPA1 was reported, providing insights into channel assembly and pore architecture. Here we report whole-cell and single-channel current recordings of wild-type human TRPA1 as well as TRPA1 bearing point mutations of key charged residues in the outer pore. These measurements demonstrate that the glutamate at position 920 plays an important role in collecting cations into the mouth of the pore, by changing the effective surface potential by similar to 16 mV, while acidic residues further out have little effect on permeation. Electrophysiology experiments also confirm that the aspartate residue at position 915 represents a constriction site of the TRPA1 pore and is critical in controlling ion permeation.	[Christensen, Adam P.; Corey, David P.] Harvard Med Sch, Program Neurosci, 220 Longwood Ave, Boston, MA 02115 USA; [Christensen, Adam P.; Akyuz, Nurunisa; Corey, David P.] Harvard Med Sch, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA; [Christensen, Adam P.; Akyuz, Nurunisa; Corey, David P.] Harvard Med Sch, Howard Hughes Med Inst, 220 Longwood Ave, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Corey, DP (corresponding author), Harvard Med Sch, Program Neurosci, 220 Longwood Ave, Boston, MA 02115 USA.; Corey, DP (corresponding author), Harvard Med Sch, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.; Corey, DP (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, 220 Longwood Ave, Boston, MA 02115 USA.	dcorey@hms.harvarrd.edu		Akyuz, Nurunisa/0000-0002-6340-1915; Corey, David/0000-0003-4497-6016	NIH [R01-DC000304]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000304] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was supported by NIH grant R01-DC000304 to DPC.; Authors would like to thank David Clapham, Gary Yellen and Marcos Sotomayor for critical reading of the manuscript. Supported by R01-DC000304 to DPC. NA is an Associate and DPC is an Investigator of the Howard Hughes Medical Institute.	ADAMS DJ, 1980, J GEN PHYSIOL, V75, P493, DOI 10.1085/jgp.75.5.493; Alam A, 2007, P NATL ACAD SCI USA, V104, P15334, DOI 10.1073/pnas.0707324104; ALMERS W, 1984, J PHYSIOL-LONDON, V353, P585, DOI 10.1113/jphysiol.1984.sp015352; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Banke TG, 2010, AM J PHYSIOL-CELL PH, V298, pC1457, DOI 10.1152/ajpcell.00489.2009; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Bobkov YV, 2011, BBA-BIOMEMBRANES, V1808, P1120, DOI 10.1016/j.bbamem.2010.12.024; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Carvacho I, 2008, J GEN PHYSIOL, V131, P147, DOI 10.1085/jgp.200709862; Cavanaugh EJ, 2008, NEUROSCIENCE, V154, P1467, DOI 10.1016/j.neuroscience.2008.04.048; Chen J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-3; Darre L, 2015, J MOL BIOL, V427, P537, DOI 10.1016/j.jmb.2014.11.016; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Farris HE, 2004, J PHYSIOL-LONDON, V558, P769, DOI 10.1113/jphysiol.2004.061267; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; GREEN WN, 1991, ANNU REV PHYSIOL, V53, P341, DOI 10.1146/annurev.ph.53.030191.002013; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; JORDAN PC, 1987, BIOPHYS J, V51, P297, DOI 10.1016/S0006-3495(87)83336-2; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Karashima Y, 2010, BIOPHYS J, V98, P773, DOI 10.1016/j.bpj.2009.11.007; Kukic P, 2013, J AM CHEM SOC, V135, P16968, DOI 10.1021/ja406995j; Kwan KY, 2009, J GEN PHYSIOL, V133, P251, DOI 10.1085/jgp.200810146; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; LLC. Schrodinger, PYMOL MOL GRAPH SYST; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8092, DOI 10.1021/bi00446a020; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; Macpherson LJ, 2007, J NEUROSCI, V27, P11412, DOI 10.1523/JNEUROSCI.3600-07.2007; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; Mathias RT, 1992, ELECTRIFIED INTERFAC, V355, P473; MCCLESKEY EW, 1985, P NATL ACAD SCI USA, V82, P7149, DOI 10.1073/pnas.82.20.7149; Meyers JR, 2003, J NEUROSCI, V23, P4054; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Samad A, 2011, BIOCHEM J, V433, P197, DOI 10.1042/BJ20101256; Shi N, 2006, NATURE, V440, P570, DOI 10.1038/nature04508; STANFIELD PR, 1983, REV PHYSIOL BIOCH P, V97, P1, DOI 10.1007/BFb0035345; Stepanyan RS, 2011, JARO-J ASSOC RES OTO, V12, P729, DOI 10.1007/s10162-011-0288-x; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; TANG SQ, 1993, NEURON, V11, P1013, DOI 10.1016/0896-6273(93)90215-D; Taylor-Clark TE, 2009, MOL PHARMACOL, V75, P820, DOI 10.1124/mol.108.054445; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Voets T, 2004, J BIOL CHEM, V279, P15223, DOI 10.1074/jbc.M312076200; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	58	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166167	10.1371/journal.pone.0166167	http://dx.doi.org/10.1371/journal.pone.0166167			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824920	Green Published, gold, Green Submitted			2022-12-26	WOS:000387615200065
J	Gong, AGW; Huang, VY; Wang, HY; Lin, HQ; Dong, TTX; Tsim, KWK				Gong, Amy G. W.; Huang, Vincent Y.; Wang, Huai Y.; Lin, Huang Q.; Dong, Tina T. X.; Tsim, Karl W. K.			Ferulic Acid Orchestrates Anti-Oxidative Properties of Danggui Buxue Tang, an Ancient Herbal Decoction: Elucidation by Chemical Knock-Out Approach	PLOS ONE			English	Article							RADIX ANGELICAE SINENSIS; OXIDATIVE STRESS; ASTRAGALI RADIX; CARDIOVASCULAR-DISEASE; SIGNALING PATHWAY; INDUCED APOPTOSIS; ANGIOTENSIN-II; NITRIC-OXIDE; ACTIVATION; CELLS	Ferulic acid, a phenolic acid derived mainly from a Chinese herb Angelica Sinensis Radix (ASR), was reported to reduce the formation of free radicals. Danggui Buxue Tang (DBT), a herbal decoction composing of Astragali Radix (AR) and ASR, has been utilized for more than 800 years in China having known anti-oxidative property. Ferulic acid is a major active ingredient in DBT; however, the role of ferulic acid within the herbal mixture has not been resolved. In order to elucidate the function of ferulic acid within this herbal decoction, a ferulic acid-depleted herbal decoction was created and named as DBT Delta fa. The anti-oxidative properties of chemically modified DBT decoction were systemically compared in cultured H9C2 rat cardiomyoblast cell line. The application of DBT and DBT Delta fa into the cultures showed functions in (i) decreasing the reactive oxygen species (ROS) formation, detected by laser confocal; (ii) increasing of the activation of Akt; (iii) increasing the transcriptional activity of anti-oxidant response element (ARE); and (iv) increasing the expressions of antioxidant enzymes, i.e. NQO1 and GCLM. In all scenario, the aforementioned anti-oxidative properties of DBT Delta fa in H9C2 cells were significantly reduced, as compared to authentic DBT. Thus, ferulic acid could be an indispensable chemical in DBT to orchestrate multicomponents of DBT as to achieve maximal anti-oxidative functions.	[Gong, Amy G. W.; Huang, Vincent Y.; Wang, Huai Y.; Lin, Huang Q.; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Div Life Sci, Clear Water Bay, Hong Kong, Peoples R China; [Gong, Amy G. W.; Huang, Vincent Y.; Wang, Huai Y.; Lin, Huang Q.; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Ctr Chinese Med, Clear Water Bay, Hong Kong, Peoples R China; [Wang, Huai Y.] HKUST Shenzhen Res Inst, Hitech Pk, Shenzhen 518000, Guangdong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Clear Water Bay, Hong Kong, Peoples R China.; Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Ctr Chinese Med, Clear Water Bay, Hong Kong, Peoples R China.	botsim@ust.hk		Wang, Huai-You/0000-0003-1407-9912	Hong Kong Research Grants Council Theme-based Research Scheme [T13-607/12R]; ITF [UIM/254]; GRF [663012, 662713, M-HKUST604/13, TUYF15SC01]; Hong Kong Jockey Club Charities Trust [HKJCCT12SC01]; Foundation of The Awareness of Nature [TAON12SC01]	Hong Kong Research Grants Council Theme-based Research Scheme(Hong Kong Research Grants Council); ITF; GRF; Hong Kong Jockey Club Charities Trust; Foundation of The Awareness of Nature	Supported by Hong Kong Research Grants Council Theme-based Research Scheme (T13-607/12R), ITF (UIM/254), GRF (663012, 662713, M-HKUST604/13), TUYF15SC01, The Hong Kong Jockey Club Charities Trust (HKJCCT12SC01) and Foundation of The Awareness of Nature (TAON12SC01) to Karl Tsim.	Alam B, 2013, AVICENNA J PHYTOMEDI, V3, P112; Cai Zhiyou, 2013, J Biochem Pharmacol Res, V1, P15; Carlsen MH, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-37; Chan PH, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/567893; Chen KJ, 1999, CHINESE MED J-PEKING, V112, P934; Cui L, 2015, J CHEM INF MODEL, V55, P2455, DOI 10.1021/acs.jcim.5b00449; Cutler D, 2006, J ECON PERSPECT, V20, P97, DOI 10.1257/jep.20.3.97; Dong TTX, 2006, J AGR FOOD CHEM, V54, P2767, DOI 10.1021/jf053163l; Fang B, 2014, BIOCHEM BIOPH RES CO, V448, P443, DOI 10.1016/j.bbrc.2014.04.123; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Gan XT, 2012, MOL CELL BIOCHEM, V363, P323, DOI 10.1007/s11010-011-1185-7; Giugliano D, 2000, NUTR METAB CARDIOVAS, V10, P38; Gong AGW, 2016, PLANTA MED, V82, P418, DOI 10.1055/s-0035-1558332; Gong AGW, 2015, J ETHNOPHARMACOL, V168, P150, DOI 10.1016/j.jep.2015.03.033; Hou YZ, 2004, EUR J PHARMACOL, V499, P85, DOI 10.1016/j.ejphar.2004.07.107; Huang CY, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-358; Joung EJ, 2007, ANTIOXID REDOX SIGN, V9, P2087, DOI 10.1089/ars.2007.1827; Jun HO, 2011, EXP MOL MED, V43, P53, DOI 10.3858/emm.2011.43.1.006; Kris-Etherton PM, 2002, AM J MED, V113, P71, DOI 10.1016/S0002-9343(01)00995-0; Kumar SVR, 2014, NAT REV NEPHROL, V10, P545, DOI 10.1038/nrneph.2014.156; Li SM, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/459264; Li XC, 2009, MOLECULES, V14, P5349, DOI 10.3390/molecules14125349; Ma XQ, 2002, J AGR FOOD CHEM, V50, P4861, DOI 10.1021/jf0202279; Maiwulanjiang M, 2014, J ETHNOPHARMACOL, V153, P491, DOI 10.1016/j.jep.2014.03.010; Mak DHF, 2006, PHYTOTHER RES, V20, P561, DOI 10.1002/ptr.1904; Mathew S, 2004, CRIT REV BIOTECHNOL, V24, P59, DOI 10.1080/07388550490491467; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Alok SP, 2007, J MOL CELL CARDIOL, V43, P580, DOI 10.1016/j.yjmcc.2007.08.003; Song ZH, 2004, PLANTA MED, V70, P1222, DOI 10.1055/s-2004-835855; Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004; Tan Yong, 2013, Zhongguo Zhong Xi Yi Jie He Za Zhi, V33, P1412; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Wang Xiao-ling, 2011, Zhongguo Zhong Xi Yi Jie He Za Zhi, V31, P1093; Wen XD, 2008, J CHROMATOGR B, V865, P99, DOI 10.1016/j.jchromb.2008.02.024; Xin YF, 2007, BASIC CLIN PHARMACOL, V101, P421, DOI 10.1111/j.1742-7843.2007.00144.x; Yu CL, 2016, MOL NEUROBIOL, V53, P6489, DOI 10.1007/s12035-015-9555-x; Zhan JYX, 2013, PLANTA MED, V79, P533, DOI 10.1055/s-0032-1328261; Zhang AH, 2010, PLANTA MED, V76, P2026, DOI 10.1055/s-0030-1250542; Zhang WDL, 2013, PHYTOMEDICINE, V20, P1076, DOI 10.1016/j.phymed.2013.04.016; Zhao KJ, 2003, J AGR FOOD CHEM, V51, P2576, DOI 10.1021/jf026178h	40	12	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165486	10.1371/journal.pone.0165486	http://dx.doi.org/10.1371/journal.pone.0165486			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824860	Green Published, gold, Green Submitted			2022-12-26	WOS:000387615200019
J	Ivliev, AE; 't Hoen, PAC; Borisevich, D; Nikolsky, Y; Sergeeva, MG				Ivliev, Alexander E.; 't Hoen, Peter A. C.; Borisevich, Dmitrii; Nikolsky, Yuri; Sergeeva, Marina G.			Drug Repositioning through Systematic Mining of Gene Coexpression Networks in Cancer	PLOS ONE			English	Article							BREAST-CANCER; TUMOR MICROENVIRONMENT; EXPRESSION PROFILES; BRAIN TRANSCRIPTOME; MICROARRAY DATA; SIGNATURES; DISEASE; SENSITIVITY; PATHWAYS; PACKAGE	Gene coexpression network analysis is a powerful "data-driven" approach essential for understanding cancer biology and mechanisms of tumor development. Yet, despite the completion of thousands of studies on cancer gene expression, there have been few attempts to normalize and integrate co-expression data from scattered sources in a concise "meta-analysis" framework. We generated such a resource by exploring gene coexpression networks in 82 microarray datasets from 9 major human cancer types. The analysis was conducted using an elaborate weighted gene coexpression network (WGCNA) methodology and identified over 3,000 robust gene coexpression modules. The modules covered a range of known tumor features, such as proliferation, extracellular matrix remodeling, hypoxia, inflammation, angiogenesis, tumor differentiation programs, specific signaling pathways, genomic alterations, and biomarkers of individual tumor subtypes. To prioritize genes with respect to those tumor features, we ranked genes within each module by connectivity, leading to identification of module-specific functionally prominent hub genes. To showcase the utility of this network information, we positioned known cancer drug targets within the coexpression networks and predicted that Anakinra, an anti-rheumatoid therapeutic agent, may be promising for development in colorectal cancer. We offer a comprehensive, normalized and well documented collection of >3000 gene coexpression modules in a variety of cancers as a rich data resource to facilitate further progress in cancer research.	[Ivliev, Alexander E.; Sergeeva, Marina G.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Ivliev, Alexander E.] Thomson Reuters, IP & Sci, Boston, MA USA; ['t Hoen, Peter A. C.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Borisevich, Dmitrii] Lomonosov Moscow State Univ, Fac Bioengn & Bioinformat, Moscow, Russia; [Nikolsky, Yuri] Inst Gen Genet, Moscow, Russia; [Nikolsky, Yuri] George Mason Univ, Fairfax, VA 22030 USA; [Nikolsky, Yuri] Prosapia Genet, Solana Beach, CA USA	Lomonosov Moscow State University; Clarivate; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Lomonosov Moscow State University; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; George Mason University	Ivliev, AE (corresponding author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia.; Ivliev, AE (corresponding author), Thomson Reuters, IP & Sci, Boston, MA USA.	ivliev.alexa@gmail.com	Sergeeva, Marina/G-3439-2012; Hoen, Peter A 't/D-3950-2018	Hoen, Peter A 't/0000-0003-4450-3112; Borisevich, Dmitrii/0000-0002-1686-3578; Sergeeva, Marina/0000-0003-3424-6431	Russian Science Foundation [16-15-10298]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Science Foundation, grant #16-15-10298 (M. Sergeeva and D. Borisevich). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Russian Science Foundation, grant #16-15-10298 (M. Sergeeva and D. Borisevich).	Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Choi JK, 2005, BIOINFORMATICS, V21, P4348, DOI 10.1093/bioinformatics/bti722; Dinarello CA, 2010, CANCER METAST REV, V29, P317, DOI 10.1007/s10555-010-9229-0; Ducray F, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-41; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elaraj DM, 2006, CLIN CANCER RES, V12, P1088, DOI 10.1158/1078-0432.CCR-05-1603; Emig D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060618; Fang H, 2013, CANCER RES, V73, P4965, DOI 10.1158/0008-5472.CAN-13-0661; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Ivliev AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035618; Ivliev AE, 2010, CANCER RES, V70, P10060, DOI 10.1158/0008-5472.CAN-10-2465; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee YS, 2015, CANCER GENOM PROTEOM, V12, P153; Liang Y, 2005, BMC CLIN PATHOL, V5, DOI 10.1186/1472-6890-5-6; Mertens M, 2009, J RHEUMATOL, V36, P1118, DOI 10.3899/jrheum.090074; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Nayak RR, 2009, GENOME RES, V19, P1953, DOI 10.1101/gr.097600.109; Penrod NM, 2014, GENOME MED, V6, DOI 10.1186/gm550; Pikor L, 2013, CANCER METAST REV, V32, P341, DOI 10.1007/s10555-013-9429-5; Rhodes DR, 2009, P NATL ACAD SCI USA, V106, P10284, DOI 10.1073/pnas.0900351106; Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Sounni NE, 2013, CLIN CHEM, V59, P85, DOI 10.1373/clinchem.2012.185363; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Tan TZ, 2013, EMBO MOL MED, V5, P1051, DOI 10.1002/emmm.201201823; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; Vitucci M, 2011, BRIT J CANCER, V104, P545, DOI 10.1038/sj.bjc.6606031; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang C, 2014, NAT BIOTECHNOL, V32, P926, DOI 10.1038/nbt.3001; Watari K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099568; Weigelt B, 2010, J PATHOL, V220, P263, DOI 10.1002/path.2648; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002656	50	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165059	10.1371/journal.pone.0165059	http://dx.doi.org/10.1371/journal.pone.0165059			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824868	Green Published, gold, Green Submitted			2022-12-26	WOS:000387615200013
J	Jaime-Acuna, OE; Meza-Villezcas, A; Vasquez-Pena, M; Raymond-Herrera, O; Villavicencio-Garcia, H; Petranovskii, V; Vazquez-Duhalt, R; Huerta-Saquero, A				Jaime-Acuna, O. E.; Meza-Villezcas, A.; Vasquez-Pena, M.; Raymond-Herrera, O.; Villavicencio-Garcia, H.; Petranovskii, V.; Vazquez-Duhalt, R.; Huerta-Saquero, A.			Synthesis and Complete Antimicrobial Characterization of CEOBACTER, an Ag-Based Nanocomposite	PLOS ONE			English	Article							SILVER NANOPARTICLES; ESCHERICHIA-COLI; ANTIBACTERIAL ACTIVITY; BACTERICIDAL ACTION; ZEOLITE; COMPOSITES; IONS; MECHANISMS; MORDENITE; EFFICACY	The antimicrobial activity of silver nanoparticles (AgNPs) is currently used as an alternative disinfectant with diverse applications, ranging from decontamination of aquatic environments to disinfection of medical devices and instrumentation. However, incorporation of AgNPs to the environment causes collateral damage that should be avoided. In this work, a novel Ag-based nanocomposite (CEOBACTER) was successfully synthetized. It showed excellent antimicrobial properties without the spread of AgNPs into the environment. The complete CEOBACTER antimicrobial characterization protocol is presented herein. It is straightforward and reproducible and could be considered for the systematic characterization of antimicrobial nanomaterials. CEOBACTER showed minimal bactericidal concentration of 3 mu g/ml, bactericidal action time of 2 hours and re-use capacity of at least five times against E. coli cultures. The bactericidal mechanism is the release of Ag ions. CEOBACTER displays potent bactericidal properties, long lifetime, high stability and re-use capacity, and it does not dissolve in the solution. These characteristics point to its potential use as a bactericidal agent for decontamination of aqueous environments.	[Jaime-Acuna, O. E.; Meza-Villezcas, A.; Vasquez-Pena, M.; Raymond-Herrera, O.; Villavicencio-Garcia, H.; Petranovskii, V.; Vazquez-Duhalt, R.; Huerta-Saquero, A.] Univ Nacl Autonoma Mexico, Ctr Nanociencias & Nanotecnol, Ensenada, Baja California, Mexico	Universidad Nacional Autonoma de Mexico	Huerta-Saquero, A (corresponding author), Univ Nacl Autonoma Mexico, Ctr Nanociencias & Nanotecnol, Ensenada, Baja California, Mexico.	saquero@cnyn.unam.mx	Huerta-Saquero, Alejandro/P-3499-2019; Saquero, Alejandro Huerta/E-2734-2016; Vazquez-Duhalt, Rafael/AGO-6764-2022; Vazquez-Duhalt, Rafael/E-2751-2016; Herrera, Oscar Raymond/E-3329-2016	Huerta-Saquero, Alejandro/0000-0002-0156-6773; Saquero, Alejandro Huerta/0000-0002-0156-6773; Vazquez-Duhalt, Rafael/0000-0003-1612-2996; Vazquez-Duhalt, Rafael/0000-0003-1612-2996; Herrera, Oscar Raymond/0000-0001-7832-1486; Petranovskii, Vitalii/0000-0002-8794-0593; Meza-Villezcas, Anaid/0000-0003-4993-3656	Matematike Grant [1010/295/2014 C-477/2014]; Direccion General de Asuntos del Personal Academic (DGAPA) [RN204815, IN110315]	Matematike Grant; Direccion General de Asuntos del Personal Academic (DGAPA)	This work was supported by Matematike Grant 1010/295/2014 C-477/2014 to AMV, and Direccion General de Asuntos del Personal Academic (DGAPA) Grants RN204815 to AH-S and IN110315 to OR-H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri S, 2014, RSC ADV, V4, P3974, DOI 10.1039/c3ra44507k; Agnihotri S, 2013, NANOSCALE, V5, P7328, DOI 10.1039/c3nr00024a; Akhigbe L, 2014, ENVIRON SCI POLLUT R, V21, P10940, DOI 10.1007/s11356-014-2888-6; Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089; Chen ZH, 2013, J PHYS CHEM C, V117, P19346, DOI 10.1021/jp406508y; Crist B.V., 2000, HDB MONOCHROMATIC XP; Dong B, 2014, NANOSCALE, V6, P10859, DOI 10.1039/c4nr03169e; Ferreira L, 2012, MICROPOR MESOPOR MAT, V160, P126, DOI 10.1016/j.micromeso.2012.05.006; Finberg RW, 2004, CLIN INFECT DIS, V39, P1314, DOI 10.1086/425009; FIZ Karlsruhe, 2015, VERSION 3 3 0; Greulich C, 2012, RSC ADV, V2, P6981, DOI 10.1039/c2ra20684f; Guerra R, 2012, MICROPOR MESOPOR MAT, V147, P267, DOI 10.1016/j.micromeso.2011.06.031; Harry Robson, 2001, VERIFIED SYNTHESES Z; Hedberg J, 2014, ENVIRON SCI TECHNOL, V48, P7314, DOI 10.1021/es500234y; Hoflund GB, 2000, PHYS REV B, V62, P11126, DOI 10.1103/PhysRevB.62.11126; Hsueh YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144306; Ivask A, 2014, ACS NANO, V8, P374, DOI 10.1021/nn4044047; Jaime-Acuna OE, 2016, CATAL COMMUN, V75, P103, DOI 10.1016/j.catcom.2015.11.009; Jaime-Acuna OE, 2014, CHEM MATER, V26, P6152, DOI 10.1021/cm5024585; Jiraroj D, 2014, POWDER TECHNOL, V264, P418, DOI 10.1016/j.powtec.2014.05.049; Lalueza P, 2011, MATER RES BULL, V46, P2070, DOI 10.1016/j.materresbull.2011.06.041; Lalueza P, 2011, CHEM COMMUN, V47, P680, DOI 10.1039/c0cc03905e; Lin JJ, 2013, ACS APPL MATER INTER, V5, P433, DOI 10.1021/am302534k; Lv M, 2010, ADV MATER, V22, P5463, DOI 10.1002/adma.201001934; Maillard JY, 2013, CRIT REV MICROBIOL, V39, P373, DOI 10.3109/1040841X.2012.713323; Matsumura Y, 2003, APPL ENVIRON MICROB, V69, P4278, DOI 10.1128/AEM.69.7.4278-4281.2003; MBITHI JN, 1993, J CLIN MICROBIOL, V31, P2988, DOI 10.1128/JCM.31.11.2988-2995.1993; McFarland J, 1907, J AMER MED ASSOC, V49, P1176; McQuillan JS, 2014, NANOTOXICOLOGY, V8, P177, DOI 10.3109/17435390.2013.870243; Michael T, 2014, BROCK BIOL MICROORGA; Mock JJ, 2002, J CHEM PHYS, V116, P6755, DOI 10.1063/1.1462610; Pankey GA, 2004, CLIN INFECT DIS, V38, P864, DOI 10.1086/381972; Patrick Murray, 2012, MED MICROBIOLOGY; Rai M, 2015, STRATEGIC ROLE SELEC; Raymond O, 2003, MAT SCI ENG A-STRUCT, V360, P202, DOI 10.1016/S0921-5093(03)00463-5; Raymond-Herrera O, 2014, SINTESIS NANOCOMPUES, p1/62; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Shameli K, 2015, RES CHEM INTERMEDIAT, V41, P251, DOI 10.1007/s11164-013-1188-y; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Sotiriou GA, 2010, ENVIRON SCI TECHNOL, V44, P5649, DOI 10.1021/es101072s; Su HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021125; Vilaca N, 2011, J MATER SCI, V46, P7511, DOI 10.1007/s10853-011-5722-2; Yang SY, 2014, EXPRESS POLYM LETT, V8, P425, DOI 10.3144/expresspolymlett.2014.46; Zhang Y, 2014, CHEM SOC REV, V43, P3762, DOI 10.1039/c3cs60338e; Zhou YZ, 2014, RSC ADV, V4, P5283, DOI 10.1039/c3ra44750b	45	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166205	10.1371/journal.pone.0166205	http://dx.doi.org/10.1371/journal.pone.0166205			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824932	Green Published, gold, Green Submitted			2022-12-26	WOS:000387615200071
J	Oyama, K; Kawada-Matsuo, M; Oogai, Y; Hayashi, T; Nakamura, N; Komatsuzawa, H				Oyama, Kentaro; Kawada-Matsuo, Miki; Oogai, Yuichi; Hayashi, Tetsuya; Nakamura, Norifumi; Komatsuzawa, Hitoshi			Antibacterial Effects of Glycyrrhetinic Acid and Its Derivatives on Staphylococcus aureus	PLOS ONE			English	Article							REDUCED VANCOMYCIN SUSCEPTIBILITY; GLYCYRRHIZIC ACID; LICORICE; INFECTIONS; EMERGENCE; VIRULENCE	Staphylococcus aureus is a major pathogen in humans and causes serious problems due to antibiotic resistance. We investigated the antimicrobial effect of glycyrrhetinic acid (GRA) and its derivatives against 50 clinical S. aureus strains, including 18 methicillin-resistant strains. The minimum inhibitory concentrations (MICs) of GRA, dipotassium glycyrrhizate, disodium succinoyl glycyrrhetinate (GR-SU), stearyl glycyrrhetinate and glycyrrhetinyl stearate were evaluated against various S. aureus strains. Additionally, we investigated the bactericidal effects of GRA and GR-SU against two specific S. aureus strains. DNA microarray analysis was also performed to clarify the mechanism underlying the antibacterial activity of GR-SU. We detected the antimicrobial activities of five agents against S. aureus strains. GRA and GR-SU showed strong antibacterial activities compared to the other three agents tested. At a higher concentration (above 2x MIC), GRA and GR-SU showed bactericidal activity, whereas at a concentration of 1x MIC, they showed a bacteriostatic effect. Additionally, GRA and GR-SU exhibited a synergistic effect with gentamicin. The expression of a large number of genes (including transporters) and metabolic factors (carbohydrates and amino acids) was altered by the addition of GR-SU, suggesting that the inhibition of these metabolic processes may influence the degree of the requirement for carbohydrates or amino acids. In fact, the requirement for carbohydrates or amino acids was increased in the presence of either GRA or GR-SU. GRA and GR-SU exhibited strong antibacterial activity against several S. aureus strains, including MRSA. This activity may be partly due to the inhibition of several pathways involved in carbohydrate and amino acid metabolism.	[Oyama, Kentaro; Kawada-Matsuo, Miki; Oogai, Yuichi; Komatsuzawa, Hitoshi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Microbiol, Kagoshima, Japan; [Oyama, Kentaro; Nakamura, Norifumi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral maxillofacial Surg, Kagoshima, Japan; [Hayashi, Tetsuya] Kyushu Univ, Dept Bacteriol, Fac Med Sci, Fukuoka, Japan	Kagoshima University; Kagoshima University; Kyushu University	Komatsuzawa, H (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Microbiol, Kagoshima, Japan.	hkomatsu@dent.kagoshima-u.ac.jp	Hayashi, Tetsuya/ABA-1074-2020; Komatsuzawa, Hitoshi/AAC-7731-2019		Ministry of Education, Culture, Sports, Sciences, and Technology of Japan [25462868]	Ministry of Education, Culture, Sports, Sciences, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Grants-in-Aid for Scientific Research (C) (Grant No: 25462868) from the Ministry of Education, Culture, Sports, Sciences, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Kaori Yasuda, Cell Innovator Inc. for assistance with microarray data acquisition. This study was supported in part by Grants-in-Aid for Scientific Research (C) (Grant No: 25462868) from the Ministry of Education, Culture, Sports, Sciences, and Technology of Japan.	Chung KT, 1998, CRIT REV FOOD SCI, V38, P421, DOI 10.1080/10408699891274273; CORTHOUT J, 1994, PLANTA MED, V60, P460, DOI 10.1055/s-2006-959532; Deurenberg RH, 2007, CLIN MICROBIOL INFEC, V13, P222, DOI 10.1111/j.1469-0691.2006.01573.x; Finks J, 2009, EMERG INFECT DIS, V15, P943, DOI 10.3201/eid1506.081312; FINNEY RSH, 1958, J PHARM PHARMACOL, V10, P613, DOI 10.1111/j.2042-7158.1958.tb10349.x; Foster TJ, 2004, J CLIN INVEST, V114, P1693, DOI 10.1172/JCI200423825; Fukai T, 2002, FITOTERAPIA, V73, P536, DOI 10.1016/S0367-326X(02)00168-5; Green AE, 2012, FEMS MICROBIOL LETT, V333, P54, DOI 10.1111/j.1574-6968.2012.02598.x; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Hatano T, 2005, PHYTOCHEMISTRY, V66, P2047, DOI 10.1016/j.phytochem.2005.01.013; Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135; Hoever G, 2005, J MED CHEM, V48, P1256, DOI 10.1021/jm0493008; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Iino S, 2001, HEPATOL RES, V19, P31, DOI 10.1016/S1386-6346(00)00079-6; INOUE H, 1989, BRIT J PHARMACOL, V96, P204, DOI 10.1111/j.1476-5381.1989.tb11801.x; INOUE H, 1993, J PHARM PHARMACOL, V45, P1067, DOI 10.1111/j.2042-7158.1993.tb07182.x; Kao TC, 2010, J AGR FOOD CHEM, V58, P8623, DOI 10.1021/jf101841r; Kim JK, 2006, BIOCHEM BIOPH RES CO, V345, P1215, DOI 10.1016/j.bbrc.2006.05.035; Komatsuzawa H, 2004, MOL MICROBIOL, V53, P1221, DOI 10.1111/j.1365-2958.2004.04200.x; Kumada H, 2002, ONCOLOGY-BASEL, V62, P94, DOI 10.1159/000048283; Li HE, 2012, FITOTERAPIA, V83, P241, DOI 10.1016/j.fitote.2011.10.018; Long DR, 2013, ANTIMICROB AGENTS CH, V57, P241, DOI 10.1128/AAC.01023-12; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Manders SM, 1998, J AM ACAD DERMATOL, V39, P383, DOI 10.1016/S0190-9622(98)70314-7; Marty FM, 2006, J CLIN MICROBIOL, V44, P595, DOI 10.1128/JCM.44.2.595-597.2006; Ming LJ, 2013, NAT PROD COMMUN, V8, P415; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Park HY, 2004, ARCH PHARM RES, V27, P57, DOI 10.1007/BF02980047; Shimada K, 1995, JPN J CHEMOTHER, V43, P1048; Taleb H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00198; Taylor Peter W, 2005, Food Sci Technol Bull, V2, P71, DOI 10.1616/1476-2137.14184; THYAGARAJAN SP, 2002, J GASTROEN HEPATOL, V17, P370, DOI DOI 10.1046/J.1440-1746.17.S3.30.X; Wang LQ, 2015, ACTA PHARM SIN B, V5, P310, DOI [10.1016/j.apsb.2015.05.005, 10.1016//j.apsb.2015.05.005]; YANO S, 1989, CHEM PHARM BULL, V37, P2500, DOI 10.1248/cpb.37.2500; Yarwood JM, 2003, J CLIN INVEST, V112, P1620, DOI 10.1172/JCI200320442	36	31	31	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165831	10.1371/journal.pone.0165831	http://dx.doi.org/10.1371/journal.pone.0165831			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820854	Green Published, Green Submitted, gold			2022-12-26	WOS:000387614800024
J	Harris, JC; Martinez, JM; Grozdanov, PN; Bergeson, SE; Grammas, P; MacDonald, CC				Harris, Jaryse C.; Martinez, Joseph M.; Grozdanov, Petar N.; Bergeson, Susan E.; Grammas, Paula; MacDonald, Clinton C.			The Cstf2t Polyadenylation Gene Plays a Sex-Specific Role in Learning Behaviors in Mice	PLOS ONE			English	Article							PRE-MESSENGER-RNA; B-CELL DIFFERENTIATION; ALTERNATIVE POLYADENYLATION; PROTEIN TAU-CSTF-64; BINDING PROTEINS; WATER-MAZE; CSTF-64; MEMORY; BRAIN; SPERMATOGENESIS	Polyadenylation is an essential mechanism for the processing of mRNA 30 ends. CstF-64 (the 64,000 M-r subunit of the cleavage stimulation factor; gene symbol Cstf2) is an RNA-binding protein that regulates mRNA polyadenylation site usage. We discovered a paralogous form of CstF-64 called tau CstF-64 (Cstf2t). The Cstf2t gene is conserved in all eutherian mammals including mice and humans, but the tCstF-64 protein is expressed only in a subset of mammalian tissues, mostly testis and brain. Male mice that lack Cstf2t (Cstf2(-/-) mice) experience disruption of spermatogenesis and are infertile, although female fertility is unaffected. However, a role for tCstF-64 in the brain has not yet been determined. Given the importance of RNA polyadenylation and splicing in neuronal gene expression, we chose to test the hypothesis that tCstF-64 is important for brain function. Male and female 185-day old wild type and Cstf2t(-/-) mice were examined for motor function, general activity, learning, and memory using rotarod, open field activity, 8-arm radial arm maze, and Morris water maze tasks. Male wild type and Cstf2t(-/-) mice did not show differences in learning and memory. However, female Cstf2t(-/-) mice showed significantly better retention of learned maze tasks than did female wild type mice. These results suggest that tCstf-64 is important in memory function in female mice. Interestingly, male Cstf2t (-/-) mice displayed less thigmotactic behavior than did wild type mice, suggesting that Cstf2t may play a role in anxiety in males. Taken together, our studies highlight the importance of mRNA processing in cognition and behavior as well as their established functions in reproduction.	[Harris, Jaryse C.; Grozdanov, Petar N.; MacDonald, Clinton C.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA; [Martinez, Joseph M.; Bergeson, Susan E.] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA; [Grammas, Paula] Univ Rhode Isl, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; University of Rhode Island	MacDonald, CC (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA.	clint.macdonald@ttuhsc.edu		MacDonald, Clinton/0000-0003-3209-1982	Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health [HD037109]; Laura W. Bush Institute for Women's Health; National Institutes of Health [AG020569, AG028367]; Wilson Foundation, Dallas, Texas; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020569, R01AG028367] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Laura W. Bush Institute for Women's Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wilson Foundation, Dallas, Texas; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health under award number HD037109, the Laura W. Bush Institute for Womens Health (to CCM), the National Institutes of Health (AG020569 and AG028367), and the Wilson Foundation, Dallas, Texas (to PG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARA SG, 1984, MOL CELL BIOL, V4, P2151, DOI 10.1128/MCB.4.10.2151; Anthony K, 2010, BRAIN RES, V1338, P67, DOI 10.1016/j.brainres.2010.03.008; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Chan SL, 2014, GENE DEV, V28, P2370, DOI 10.1101/gad.250993.114; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Costessi L, 2006, NUCLEIC ACIDS RES, V34, P243, DOI 10.1093/nar/gkj425; Costessi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058879; Dass B, 2002, GENOMICS, V80, P509, DOI 10.1006/geno.2002.6862; Dass B, 2001, J BIOL CHEM, V276, P8044, DOI 10.1074/jbc.M009091200; Dass B, 2007, P NATL ACAD SCI USA, V104, P20374, DOI 10.1073/pnas.0707589104; Davis MJ, 2012, BEHAV BRAIN RES, V229, P21, DOI 10.1016/j.bbr.2011.12.037; Deka P, 2005, J MOL BIOL, V347, P719, DOI 10.1016/j.jmb.2005.01.046; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; FOULKES NS, 1993, NATURE, V362, P264, DOI 10.1038/362264a0; Frick KM, 2000, NEUROSCIENCE, V95, P293; Gillies GE, 2010, PHARMACOL REV, V62, P155, DOI 10.1124/pr.109.002071; Grozdanov PN, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.134684; Hartley CA, 2012, P NATL ACAD SCI USA, V109, P5493, DOI 10.1073/pnas.1202044109; Hockert JA, 2010, J BIOL CHEM, V285, P695, DOI 10.1074/jbc.M109.061705; Hockert KJ, 2011, J REPROD IMMUNOL, V89, P26, DOI 10.1016/j.jri.2011.01.018; Huang YS, 2002, EMBO J, V21, P2139, DOI 10.1093/emboj/21.9.2139; Huber Z, 2005, ANN NY ACAD SCI, V1061, P163, DOI 10.1196/annals.1336.017; Hwang HW, 2016, CELL REP, V15, P423, DOI 10.1016/j.celrep.2016.03.023; Idler RK, 2012, J ANDROL, V33, P309, DOI 10.2164/jandrol.111.014167; Ivshina M, 2014, ANNU REV CELL DEV BI, V30, P393, DOI 10.1146/annurev-cellbio-101011-155831; Kleene KC, 2013, REPRODUCTION, V146, pR1, DOI 10.1530/REP-12-0362; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048373; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lutz CS, 2011, WIRES RNA, V2, P22, DOI 10.1002/wrna.47; MACDONALD CC, 1994, MOL CELL BIOL, V14, P6647, DOI 10.1128/MCB.14.10.6647; MacDonald CC, 2010, WIRES RNA, V1, P494, DOI 10.1002/wrna.29; Maldonado R, 1999, P NATL ACAD SCI USA, V96, P14094, DOI 10.1073/pnas.96.24.14094; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; Martincic K, 1998, P NATL ACAD SCI USA, V95, P11095, DOI 10.1073/pnas.95.19.11095; Miura P, 2013, GENOME RES, V23, P812, DOI 10.1101/gr.146886.112; Mizuno K, 2010, TRENDS NEUROSCI, V33, P285, DOI 10.1016/j.tins.2010.03.001; Monarez RR, 2007, BIOCHEM J, V401, P651, DOI 10.1042/BJ20061097; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nazim M, 2017, NUCLEIC ACIDS RES, V45, P1455, DOI 10.1093/nar/gkw823; OLTON DS, 1979, AM PSYCHOL, V34, P583, DOI 10.1037/0003-066X.34.7.583; Parks CL, 1998, P NATL ACAD SCI USA, V95, P10734, DOI 10.1073/pnas.95.18.10734; Reimann-Philipp U, 2001, J NEUROSCI RES, V64, P654, DOI 10.1002/jnr.1119; Rouget C, 2006, J BIOL CHEM, V281, P28687, DOI 10.1074/jbc.M601116200; Ruepp MD, 2011, MOL BIOL CELL, V22, P91, DOI 10.1091/mbc.E10-06-0543; Sartini BL, 2008, BIOL REPROD, V78, P472, DOI 10.1095/biolreprod.107.064774; Schonemann L, 2014, GENE DEV, V28, P2381, DOI 10.1101/gad.250985.114; Seil FJ, 2014, NEUROSCI BIOBEHAV R, V45, P212, DOI 10.1016/j.neubiorev.2014.06.003; Shankarling GS, 2013, GENE, V529, P220, DOI 10.1016/j.gene.2013.08.007; Shankarling GS, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-22; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; TAKAGAKI Y, 1992, P NATL ACAD SCI USA, V89, P1403, DOI 10.1073/pnas.89.4.1403; Takagaki Y, 1998, MOL CELL, V2, P761, DOI 10.1016/S1097-2765(00)80291-9; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Taliaferro JM, 2016, MOL CELL, V61, P821, DOI 10.1016/j.molcel.2016.01.020; Tardif S, 2010, BIOL REPROD, V83, P464, DOI 10.1095/biolreprod.109.083238; Tian B, 2012, WIRES RNA, V3, P385, DOI 10.1002/wrna.116; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Van Epps H, 2010, DEVELOPMENT, V137, P2237, DOI 10.1242/dev.049692; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wallace AM, 2004, BIOL REPROD, V70, P1080, DOI 10.1095/biolreprod.103.022947; Wallace AM, 1999, P NATL ACAD SCI USA, V96, P6763, DOI 10.1073/pnas.96.12.6763; Wang H, 2006, BIOL REPROD, V75, P318, DOI 10.1095/biolreprod.106.052209; Wang L, 2014, BIOESSAYS, V36, P39, DOI 10.1002/bies.201300100; WATZMAN N, 1964, J PHARM SCI, V53, P1429, DOI 10.1002/jps.2600531142; Wolfer DP, 1998, NEWS PHYSIOL SCI, V13, P118, DOI 10.1152/physiologyonline.1998.13.3.118; Yao CG, 2013, RNA, V19, P1781, DOI 10.1261/rna.042317.113; Yao CG, 2012, P NATL ACAD SCI USA, V109, P18773, DOI 10.1073/pnas.1211101109; Youngblood BA, 2014, NUCLEIC ACIDS RES, V42, P8330, DOI 10.1093/nar/gku551; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	74	10	10	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165976	10.1371/journal.pone.0165976	http://dx.doi.org/10.1371/journal.pone.0165976			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812195	Green Published, Green Submitted, gold			2022-12-26	WOS:000386910000086
J	Lachmair, M; Fernandez, SR; Bury, NA; Gerjets, P; Fischer, MH; Bock, OL				Lachmair, Martin; Fernandez, Susana Ruiz; Bury, Nils-Alexander; Gerjets, Peter; Fischer, Martin H.; Bock, Otmar L.			How Body Orientation Affects Concepts of Space, Time and Valence: Functional Relevance of Integrating Sensorimotor Experiences during Word Processing	PLOS ONE			English	Article							MENTAL TIMELINE; COGNITION; LANGUAGE; REPRESENTATION; HYPOTHESIS; MECHANISMS; FUTURE; FLIES; LINE; MIND	The aim of the present study was to test the functional relevance of the spatial concepts UP or DOWN for words that use these concepts either literally (space) or metaphorically (time, valence). A functional relevance would imply a symmetrical relationship between the spatial concepts and words related to these concepts, showing that processing words activate the related spatial concepts on one hand, but also that an activation of the concepts will ease the retrieval of a related word on the other. For the latter, the rotation angle of participant's body position was manipulated either to an upright or a head-down tilted body position to activate the related spatial concept. Afterwards participants produced in a within-subject design previously memorized words of the concepts space, time and valence according to the pace of a metronome. All words were related either to the spatial concept UP or DOWN. The results including Bayesian analyses show (1) a significant interaction between body position and words using the concepts UP and DOWN literally, (2) a marginal significant interaction between body position and temporal words and (3) no effect between body position and valence words. However, post-hoc analyses suggest no difference between experiments. Thus, the authors concluded that integrating sensorimotor experiences is indeed of functional relevance for all three concepts of space, time and valence. However, the strength of this functional relevance depends on how close words are linked to mental concepts representing vertical space.	[Lachmair, Martin; Fernandez, Susana Ruiz; Gerjets, Peter] Leibniz Knowledge Media Res Ctr, Tubingen, Germany; [Bury, Nils-Alexander; Bock, Otmar L.] German Sport Univ Cologne, Inst Physiol & Anat, Cologne, Germany; [Fischer, Martin H.] Univ Potsdam, Dept Psychol, Potsdam, Germany	Leibniz Institut fur Wissensmedien; German Sport University Cologne; University of Potsdam	Lachmair, M (corresponding author), Leibniz Knowledge Media Res Ctr, Tubingen, Germany.	m.lachmair@iwm-tuebingen.de	Lachmair, Martin/HCH-2667-2022; Gerjets, Peter/AAD-2017-2020; Fischer, Martin H./D-9965-2017	Fischer, Martin H./0000-0003-3818-7272; Lachmair, Martin/0000-0002-0469-9168				Ansorge U, 2010, COGNITION, V116, P303, DOI 10.1016/j.cognition.2010.05.010; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Bonato M, 2012, NEUROSCI BIOBEHAV R, V36, P2257, DOI 10.1016/j.neubiorev.2012.08.007; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Casasanto D, 2010, COGNITIVE SCI, V34, P387, DOI 10.1111/j.1551-6709.2010.01094.x; Dudschig C, 2012, MEM COGNITION, V40, P1081, DOI 10.3758/s13421-012-0201-9; Just MA, 2013, COGNITIVE PROCESSES; Lachmair M, 2014, ACTA PSYCHOL, V148, P107, DOI 10.1016/j.actpsy.2013.12.004; Lachmair M, 2011, PSYCHON B REV, V18, P1180, DOI 10.3758/s13423-011-0158-x; LAKOFF G, 1980, COGNITIVE SCI, V4, P195, DOI 10.1207/s15516709cog0402_4; Loetscher T, 2008, CURR BIOL, V18, pR60, DOI 10.1016/j.cub.2007.11.015; Mahon BZ, 2008, J PHYSIOL-PARIS, V102, P59, DOI 10.1016/j.jphysparis.2008.03.004; Masson MEJ, 2003, CAN J EXP PSYCHOL, V57, P203, DOI 10.1037/h0087426; Matlock T., 2013, P 35 ANN C COGN SCI, P3789; Meier BP, 2004, PSYCHOL SCI, V15, P243, DOI 10.1111/j.0956-7976.2004.00659.x; Morey Richard D., 2015, BAYESFACTOR COMPUTAT; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; RISKIND JH, 1983, SOC COGNITION, V2, P62, DOI 10.1521/soco.1983.2.1.62; Rolke B, 2013, COGN PROCESS, V14, P231, DOI 10.1007/s10339-013-0537-5; Rouder JN, 2016, PSYCHOL METHODS; Ruiz Fernandez S., 2014, P 6 INT C MED SPAC E; Santiago J, 2007, PSYCHON B REV, V14, P512, DOI 10.3758/BF03194099; Setic M, 2007, LANG COGNITIVE PROC, V22, P297, DOI 10.1080/01690960600732430; Ulrich R, 2012, MEM COGNITION, V40, P483, DOI 10.3758/s13421-011-0162-4; Ulrich R, 2010, COGNITION, V117, P126, DOI 10.1016/j.cognition.2010.08.001; Weger UW, 2008, PSYCHON B REV, V15, P426, DOI 10.3758/PBR.15.2.426; Zwaan RolfA., 2005, GROUNDING COGNITION, P224, DOI DOI 10.1017/CBO9780511499968.010	29	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165795	10.1371/journal.pone.0165795	http://dx.doi.org/10.1371/journal.pone.0165795			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812155	Green Submitted, gold, Green Published			2022-12-26	WOS:000386910000057
J	Tang, FR; Wang, JW; Tang, Z; Kang, M; Deng, QL; Yu, JM				Tang, Furong; Wang, Jiwei; Tang, Zheng; Kang, Mei; Deng, Qinglong; Yu, Jinming			Quality of Life and Its Association with Physical Activity among Different Types of Cancer Survivors	PLOS ONE			English	Article							COMORBID CHRONIC DISEASES; BREAST-CANCER; CLINICAL-TRIALS; LUNG-CANCER; INTERVENTION; SUPPORT; COHORT	Purpose The main goal of this study was to compare the quality of life (QOL) and its association with physical activity (PA) among patients diagnosed with different types of cancer. Based on the results, we tentatively present suggestions for the cancer health care model. Method A cross-sectional study was conducted with 2915 cancer survivors recruited from multi-community cancer rehabilitation centers, all of which were affiliated with the Shanghai Cancer Rehabilitation Club. We collected data including socio-demographic characteristics and information about PA. All the subjects included were asked to complete the European Organization for Research and Treatment Quality of Life Questionnaires (EORTC QLQ-C30) and Functional Assessment of Cancer Therapy-General Questionnaire (FACT-G). Multiple linear regression models were employed to control the potential confounding factors. Results Lung cancer survivors reported the worst dyspnea. Colorectal cancer survivors claimed the highest level of constipation and diarrhea. Liver cancer survivors indicated greatest loss of appetite and financial difficulties. Generally, survivors with PA tended to reported better QOL, although these associations among liver cancer survivors were not statistically significant. Moreover, survivors of all cancer types who performed PA did not report significant lower level of constipation or diarrhea. The relationship between PA frequency and QOL among cancer survivors remained unexplored. Conclusions Both QOL and its association with PA vary among survivors of different cancer types. The detailed results can assist clinicians and public health practitioners with improving health care management.	[Tang, Furong; Wang, Jiwei; Tang, Zheng; Kang, Mei; Deng, Qinglong; Yu, Jinming] Fudan Univ, Inst Epidemiol & Hlth Stat, Sch Publ Hlth, Shanghai, Peoples R China	Fudan University	Yu, JM (corresponding author), Fudan Univ, Inst Epidemiol & Hlth Stat, Sch Publ Hlth, Shanghai, Peoples R China.	jmy@fudan.edu.cn						AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Akin S, 2008, EUR J ONCOL NURS, V12, P449, DOI 10.1016/j.ejon.2008.07.006; Angevaren M, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005381.pub3, 10.1002/14651858.CD005381.pub2]; Aziz NM, 2007, ACTA ONCOL, V46, P417, DOI 10.1080/02841860701367878; Bairamov R B, 2013, Klin Khir, P18; Chui PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139952; Friedenreich CM, 2001, CANCER EPIDEM BIOMAR, V10, P287; Fu MR, 2015, J PERS MED, V5, P229, DOI 10.3390/jpm5030229; Ganti AK, 2016, AM J CLIN ONCOL-CANC, V39, P142, DOI 10.1097/COC.0000000000000040; Hamidou Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096848; Joly F, 2014, INT J GYNECOL CANCER, V24, P1693, DOI 10.1097/IGC.0000000000000299; Jordhoy MS, 2001, BRIT J CANCER, V85, P1478, DOI 10.1054/bjoc.2001.2116; Kao HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139252; Kim AR, 2012, ANN SURG, V256, P1008, DOI 10.1097/SLA.0b013e31827661c9; Knols R, 2005, J CLIN ONCOL, V23, P3830, DOI 10.1200/JCO.2005.02.148; Kumar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089851; Lin Tsai-Rung, 2013, Hu Li Za Zhi, V60, P68, DOI 10.6224/JN.60.6.68; Mishra SI, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007566.pub2; Moro-Valdezate D, 2014, BREAST CANCER-TOKYO, V21, P442, DOI 10.1007/s12282-012-0402-x; Moseholm E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148463; Ramadas Amutha, 2015, Asian Pac J Cancer Prev, V16, P1479; Sajjad S, 2016, EUR J ONCOL NURS, V21, P75, DOI 10.1016/j.ejon.2016.01.006; Sheean P, 2015, J ACAD NUTR DIET, V115, P1690, DOI 10.1016/j.jand.2015.03.017; Smits A, 2015, GYNECOL ONCOL, V139, P546, DOI 10.1016/j.ygyno.2015.10.002; Turgay AS, 2008, CANCER NURS, V31, pE19, DOI 10.1097/01.NCC.0000339248.37829.c2; van Roekel EH, 2015, MED SCI SPORT EXER, V47, P2493, DOI 10.1249/MSS.0000000000000698; Wang JW, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2240-1; Wang JW, 2015, SUPPORT CARE CANCER, V23, P1383, DOI 10.1007/s00520-014-2494-7; World Health Organization, 2000, WHO TECH REP SER, V894, p[i, 1]; Yi M, 2011, J CLIN ONCOL, V29, P4654, DOI 10.1200/JCO.2011.38.3174; Zackrisson S, 2007, J MED SCREEN, V14, P138, DOI 10.1258/096914107782066239; Zhang B, 2000, HEPATO-GASTROENTEROL, V47, P414	33	17	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164971	10.1371/journal.pone.0164971	http://dx.doi.org/10.1371/journal.pone.0164971			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812130	Green Published, Green Submitted, gold			2022-12-26	WOS:000386910000018
J	Eissa, MM; Mostafa, DK; Ghazy, AA; El Azzouni, MZ; Boulos, LM; Younis, LK				Eissa, Maha M.; Mostafa, Dalia K.; Ghazy, Amany A.; El Azzouni, Mervat Z.; Boulos, Laila M.; Younis, Layla K.			Anti-Arthritic Activity of Schistosoma mansoni and Trichinella spiralis Derived-Antigens in Adjuvant Arthritis in Rats: Role of FOXP3(+) Treg Cells	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; REGULATORY T-CELLS; RHEUMATOID-ARTHRITIS; AUTOIMMUNE ARTHRITIS; HELMINTH INFECTIONS; HYGIENE HYPOTHESIS; ALLERGIC DISEASES; FREUNDS-ADJUVANT; REDUCES SEVERITY; MECHANISMS	A growing body of evidence supports the concept of helminths therapy in a variety of autoimmune diseases. Here, we aimed to investigate the protective effects of autoclaved Schistosoma mansoni antigen (ASMA) and Trichinella spiralis antigen (ATSA) on the clinical and immunopathological features of rheumatoid arthritis (RA). Adjuvant arthritis was induced by subcutaneous and intradermal injections of complete Freund's adjuvant into the plantar surface of the right hind paw and the root of the tail, respectively. Rats were randomly assigned to serve as normal control, untreated arthritis, ASMA or ATSA-treated arthritis groups. Antigens were given by intradermal injection in two doses, two weeks apart. The development, progression of arthritic features, and the impact on animals' gait and body weight were followed up for 4 weeks. The associated changes in serum cytokines (IL-17, IFN-gamma and IL-10), joints' histopathology and immunohistochemistry of Foxp3(+) T regulatory cells (Tregs) were evaluated at the end of the study. Treatment with either ASMA or ATSA attenuated the progression of clinical features of polyarthritis, improved gait and body weight gain, reduced the elevated serum IL-17 and further increased both IFN-gamma and IL-10. Histopathologically, this was associated with a remarkable regression of paws' inflammation that was limited only to the subcutaneous tissue, and a significant increase in the number of Foxp3+ cells versus the untreated arthritis group. In conclusion, both Schistosoma mansoni and Trichinella spiralis derived antigens exerted protective effect against adjuvant arthritis with better effect achieved by ASMA treatment. This anti-arthritic activity is attributed to upregulation of the Foxp3(+) Tregs, with subsequent favorable modulation of both pro-and anti-inflammatory cytokines. The use of autoclaved parasitic antigens excludes the deleterious effects of imposing helminthic infection by using live parasites, which may pave the way to a new therapeutic modality in treating RA.	[Eissa, Maha M.; El Azzouni, Mervat Z.; Boulos, Laila M.] Univ Alexandria, Dept Med Parasitol, Fac Med, Alexandria, Egypt; [Mostafa, Dalia K.] Univ Alexandria, Dept Clin Pharmacol, Fac Med, Alexandria, Egypt; [Ghazy, Amany A.] Kafrelsheikh Univ, Dept Med Microbiol & Immunol, Fac Med, Kafrelsheikh, Egypt; [Younis, Layla K.] Univ Alexandria, Dept Pathol, Fac Med, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Kafrelsheikh University; Egyptian Knowledge Bank (EKB); Alexandria University	Mostafa, DK (corresponding author), Univ Alexandria, Dept Clin Pharmacol, Fac Med, Alexandria, Egypt.	dalia.kashishy@alexmed.edu.eg	Ghazy, Amany/AAP-9170-2021; Ghazy, Amany/ABC-7510-2020; Mostafa, Dalia/AAL-9118-2021; Eissa, M M/S-4230-2019	Ghazy, Amany/0000-0002-5603-1303; Mostafa, Dalia/0000-0002-5057-2491; Eissa, M M/0000-0003-4723-6427; Eissa, Maha/0000-0001-9572-2820				Alunno A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/751793; Ashour DS, 2014, J HELMINTHOL, V88, P210, DOI 10.1017/S0022149X13000059; Ashour DS, 2013, EXPERT REV CLIN IMMU, V9, P669, DOI 10.1586/1744666X.2013.811187; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Beiting DP, 2007, J IMMUNOL, V178, P1039, DOI 10.4049/jimmunol.178.2.1039; Bendele A. M., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P377; Bevaart L, 2010, ARTHRITIS RHEUM-US, V62, P2192, DOI 10.1002/art.27503; Boissier MC, 2009, JOINT BONE SPINE, V76, P10, DOI 10.1016/j.jbspin.2008.08.002; Cetre C, 1999, INFECT IMMUN, V67, P2713; Chabaud M, 2001, ARTHRITIS RES, V3, P168, DOI 10.1186/ar294; Cooles FAH, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0352-0; Darani HY, 1997, PARASITOLOGY, V115, P237, DOI 10.1017/S0031182097001303; Darwish SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079284; Dief AE, 2015, EUR REV MED PHARMACO, V19, P1537; Doodes PD, 2010, J IMMUNOL, V184, P1552, DOI 10.4049/jimmunol.0902907; Drury R.A, 1980, CARLETONS HISTOLOGIC; Eissa MM, 2012, EXP PARASITOL, V131, P310, DOI 10.1016/j.exppara.2012.05.001; Eissa Maha M., 2003, Journal of the Egyptian Society of Parasitology, V33, P541; El Aswad BEW, 2011, IMMUNOBIOLOGY, V216, P379, DOI 10.1016/j.imbio.2010.06.014; El-Malky M, 2011, PARASITE IMMUNOL, V33, P589, DOI 10.1111/j.1365-3024.2011.01324.x; Finlay CM, 2016, J IMMUNOL, V196, P703, DOI 10.4049/jimmunol.1501820; Fleming JO, 2015, PARASITE IMMUNOL, V37, P277, DOI 10.1111/pim.12175; Greenwood BM, 1986, LANCET, V2, P380; Gruden-Movsesijan A, 2010, PARASITE IMMUNOL, V32, P450, DOI 10.1111/j.1365-3024.2010.01207.x; Hawkins P, 2015, INFLAMMOPHARMACOLOGY, V23, P131, DOI 10.1007/s10787-015-0241-4; He Y, 2010, BMC IMMUNOL, V11, P128; Ilic N, 2011, PARASITE IMMUNOL, V33, P572, DOI 10.1111/j.1365-3024.2011.01322.x; Kondrashova A, 2013, APMIS, V121, P478, DOI 10.1111/apm.12023; Krakowski M, 1996, EUR J IMMUNOL, V26, P1641, DOI 10.1002/eji.1830260735; Lee SY, 2016, IMMUNOL LETT, V172, P56, DOI 10.1016/j.imlet.2016.02.011; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Maizels RM, 2016, CLIN MICROBIOL INFEC, V22, P481, DOI 10.1016/j.cmi.2016.04.024; Matisz Chelsea E., 2011, Journal of Parasitology Research, P942616, DOI 10.1155/2011/942616; Matthys P, 1999, J IMMUNOL, V163, P3503; McGrath JC, 2015, BRIT J PHARMACOL, V172, P1179, DOI 10.1111/bph.13008; Mellor AL, 2011, J IMMUNOL, V186, P4535, DOI 10.4049/jimmunol.1002937; Sempere-Ortells JM, 2009, AUTOIMMUNITY, V42, P636, DOI 10.3109/08916930903061491; Moudgil KD, 2011, CURR RHEUMATOL REP, V13, P456, DOI 10.1007/s11926-011-0200-z; Ngoi SM, 2011, DISCOV MED, V12, P405; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Osada Y, 2009, INT J PARASITOL, V39, P457, DOI 10.1016/j.ijpara.2008.08.007; Park HK, 2011, EXP PARASITOL, V127, P539, DOI 10.1016/j.exppara.2010.10.004; Pellegrino J, 1968, Adv Parasitology, V6, P233, DOI 10.1016/S0065-308X(08)60475-3; Pica-Mattoccia L, 2004, INT J PARASITOL, V34, P527, DOI 10.1016/j.ijpara.2003.12.003; Rajaiah R, 2011, J BIOL CHEM, V286, P2817, DOI 10.1074/jbc.M110.187013; Romano A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004306; Rzepecka J, 2015, J AUTOIMMUN, V60, P59, DOI 10.1016/j.jaut.2015.04.005; Saunders KA, 2007, INFECT IMMUN, V75, P397, DOI 10.1128/IAI.00664-06; Sega Y, 2015, HAREFUAH, V154, P469; Sega Y, 2015, HAREFUAH, V154, P470; Sega Yahel, 2015, Harefuah, V154, P428; Sun X, 2010, PARASITE IMMUNOL, V32, P739, DOI 10.1111/j.1365-3024.2010.01240.x; Wang SS, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-015-1288-1; Wang T, 2015, ANN RHEUM DIS, V74, P1293, DOI 10.1136/annrheumdis-2013-204228; Wang XL, 2009, VET PARASITOL, V159, P249, DOI 10.1016/j.vetpar.2008.10.052; WASSOM DL, 1988, J PARASITOL, V74, P283, DOI 10.2307/3282457; Weinstock JV, 2002, J LAB CLIN MED, V139, P334, DOI 10.1067/mlc.2002.124343; Weng L, 2010, ANN RHEUM DIS, V69, P1519, DOI 10.1136/ard.2009.121111; Wu HX, 2016, JOINT BONE SPINE, V83, P525, DOI 10.1016/j.jbspin.2015.09.002; Yang XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096454; Zaccone P, 2006, PARASITE IMMUNOL, V28, P515, DOI 10.1111/j.1365-3024.2006.00879.x	62	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165916	10.1371/journal.pone.0165916	http://dx.doi.org/10.1371/journal.pone.0165916			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802332	gold, Green Published			2022-12-26	WOS:000386714200067
J	Caron-Lormier, G; Harvey, ND; England, GCW; Asher, L				Caron-Lormier, Geoffrey; Harvey, Naomi D.; England, Gary C. W.; Asher, Lucy			A New Metric for Quantifying the Relative Impact of Risk Factors on Loss of Working Life Illustrated in a Population of Working Dogs	PLOS ONE			English	Article							QUALITY-OF-LIFE; ACVD TASK-FORCE; SEPARATION ANXIETY; GUIDE DOGS; EPIDEMIOLOGY; BEHAVIOR	In a resource-limited world, organisations attempting to reduce the impact of health or behaviour issues need to choose carefully how to allocate resources for the highest overall impact. However, such choices may not always be obvious. Which has the biggest impact? A large change to a small number of individuals, or a small change to a large number of individuals? The challenge is identifying the issues that have the greatest impact on the population so potential interventions can be prioritised. We addressed this by developing a score to quantify the impact of health conditions and behaviour problems in a population of working guide dogs using data from Guide Dogs, UK. The cumulative incidence of different issues was combined with information about their impact, in terms of reduction in working life, to create a work score. The work score was created at population-level to illustrate issues with the greatest impact on the population and to understand contributions of breeds or crossbreeds to the workforce. An individual work deficit score was also created and means of this score used to illustrate the impact on working life within a subgroup of the population such as a breed, or crossbreed generation. The work deficit scores showed that those removed for behavioural issues had a greater impact on the overall workforce than those removed for health reasons. Additionally trends over time illustrated the positive influence of interventions Guide Dogs have made to improve their workforce. Information highlighted by these scores is pertinent to the effort of Guide Dogs to ensure partnerships are lasting. Recognising that the scores developed here could be transferable to a wide variety of contexts and species, most notably human work force decisions; we discuss possible uses and adaptations such as reduction in lifespan, quality of life and yield in production animals.	[Caron-Lormier, Geoffrey; Harvey, Naomi D.; England, Gary C. W.] Univ Nottingham, Sch Vet Med & Sci, Sutton Bonington Campus, Nottingham, Leics, England; [Asher, Lucy] Newcastle Univ, Ctr Behav & Evolut, Henry Wellcome Bldg, Newcastle Upon Tyne, Tyne & Wear, England	University of Nottingham; Newcastle University - UK	Harvey, ND (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Sutton Bonington Campus, Nottingham, Leics, England.	Naomi.Harvey@nottingham.ac.uk	PAN, ZEQIANG/X-6341-2018; Harvey, Naomi D./H-6435-2019; England, Gary C.W./G-5432-2011	Harvey, Naomi D./0000-0002-9208-7734; Asher, Lucy/0000-0001-9729-7856; England, Gary/0000-0001-5800-3106	Guide Dogs, UK [CR2012-01a]	Guide Dogs, UK	This study was supported by Guide Dogs, UK (www.guideclogs.org.uk), Grant Code: CR2012-01a. The funders provided access to the data (no new data was collected) and approved of the project through ethical review. The funders approved this manuscript for publication but had no role in study design, analysis or manuscript preparation.r We would like to thank Guide Dogs UK for funding this study, for their cooperation throughout the project and for comments on earlier versions of this manuscript.	Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P38; Arvelius P, 2014, J VET BEHAV, V9, P281, DOI 10.1016/j.jveb.2014.06.008; Belshaw Z, 2015, VET J, V206, P203, DOI 10.1016/j.tvjl.2015.07.016; Caron-Lormier G, 2016, VET J, V207, P124, DOI 10.1016/j.tvjl.2015.10.046; Caron-Lormier G, 2016, SCI REP-UK, V6, DOI 10.1038/srep23860; Cohen JD, 2006, J HEALTHC MANAG, V51, P233, DOI 10.1097/00115514-200607000-00006; Collins LM, 2010, ANIM WELFARE, V19, P67; Collins LM, 2011, VET J, V189, P147, DOI 10.1016/j.tvjl.2011.06.012; Devinsky O, 1999, EPILEPSIA, V40, P1715, DOI 10.1111/j.1528-1157.1999.tb01588.x; Flannigan G, 2001, J AM VET MED ASSOC, V219, P460, DOI 10.2460/javma.2001.219.460; German AJ, 2006, J NUTR, V136, p1940S, DOI 10.1093/jn/136.7.1940S; Green LE, 2002, J DAIRY SCI, V85, P2250, DOI 10.3168/jds.S0022-0302(02)74304-X; Grierson J, 2011, VET COMP ORTHOPAED, V24, P192, DOI 10.3415/VCOT-10-03-0030; Hill PB, 2001, VET IMMUNOL IMMUNOP, V81, P169, DOI 10.1016/S0165-2427(01)00298-7; King JN, 2000, APPL ANIM BEHAV SCI, V67, P255, DOI 10.1016/S0168-1591(99)00127-6; Konok V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118375; Langford FM, 2012, ANIM WELFARE, V21, P41, DOI 10.7120/096272812X13345905673647; Macht M, 2013, CRIT CARE, V17, DOI 10.1186/cc12791; Nielsen TD, 2014, VET REC; Pierce JP, 2007, J CLIN ONCOL, V25, P2345, DOI 10.1200/JCO.2006.08.6819; Robinson NJ, 2015, VET REC, V176, P463, DOI 10.1136/vr.102751; SIMON GE, 1995, ARCH GEN PSYCHIAT, V52, P850; Sousa CA, 2001, VET IMMUNOL IMMUNOP, V81, P153, DOI 10.1016/S0165-2427(01)00297-5; Takeuchi Y, 2001, APPL ANIM BEHAV SCI, V70, P297, DOI 10.1016/S0168-1591(00)00156-8; WHITEHAIR JG, 1993, J AM VET MED ASSOC, V203, P1016; Wilsson E, 2012, APPL ANIM BEHAV SCI, V141, P158, DOI 10.1016/j.applanim.2012.08.012	26	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165414	10.1371/journal.pone.0165414	http://dx.doi.org/10.1371/journal.pone.0165414			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829045	Green Published, gold			2022-12-26	WOS:000387724300044
J	Fritz, J; Fritz, B; Dellon, AL				Fritz, Jan; Fritz, Benjamin; Dellon, A. Lee			Sacrotuberous Ligament Healing following Surgical Division during Transgluteal Pudendal Nerve Decompression: A 3-Tesla MR Neurography Study	PLOS ONE			English	Article							TRANSVERSE CARPAL LIGAMENT; MAGNETIC-RESONANCE NEUROGRAPHY; TUNNEL-SYNDROME; PELVIC LIGAMENTS; PAIN; ENTRAPMENT; RELEASE; TRANSPOSITION; NEUROLYSIS; NEURALGIA	Pelvic pain due to chronic pudendal nerve (PN) compression, when treated surgically, is approached with a transgluteal division of the sacrotuberous ligament (STL). Controversy exists as to whether the STL heals spontaneously or requires grafting. Therefore, the aim of this study was to determine how surgically divided and unrepaired STL heal. A retrospective evaluation of 10 patients who had high spatial resolution 3-Tesla magnetic resonance imaging (3T MRI) exams of the pelvis was done using an IRB-approved protocol. Each patient was referred for residual pelvic pain after a transgluteal STL division for chronic pudendal nerve pain. Of the 10 patients, 8 had the STL divided and not repaired, while 2 had the STL divided and reconstructed with an allograft tendon. Of the 8 that were left unrepaired, 6 had bilateral surgery. Outcome variables included STL integrity and thickness. Normative data for the STL were obtained through a control group of 20 subjects. STL integrity and thickness were measured directly on 3 T MR Neurography images, by two independent Radiologists. The integrity and thickness of the post-surgical STL was evaluated 39 months (range, 9-55) after surgery. Comparison was made with the native contra-lateral STL in those who had unilateral STL division, and with normal, non-divided STL of subjects of the control group. The normal STL measured 3 mm (minimum and maximum of absolute STL thickness, 2-3 mm). All post-operative STL were found to be continuous regardless of the surgical technique used. Measured at level of Alcock's canal in the same plane as the obturator internus tendon posterior to the ischium, the mean anteroposterior STL diameter was 5 mm (range, 4-5 mm) in the group of prior STL division without repair and 8 mm (range, 8-9 mm) in the group with the STL reconstructed with grafts (p<0.05). The group of healed STLs were significantly thicker than the normal STL (p<0.05). We conclude that a surgically divided STL will heal spontaneously and will be significantly thicker after healing.	[Fritz, Jan] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, 600 N Wolfe St, Baltimore, MD 21287 USA; [Fritz, Benjamin] Orthoped Univ, Hosp Balgrist, Dept Radiol, Forchstr 340, CH-8008 Zurich, Switzerland; [Dellon, A. Lee] Johns Hopkins Univ, Sch Med, Dept Plast & Reconstruct Surg, 600 N Wolfe St, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University	Dellon, AL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Plast & Reconstruct Surg, 600 N Wolfe St, Baltimore, MD 21287 USA.	aldellon@dellon.com	Fritz, Benjamin/AAW-1140-2021	Fritz, Benjamin/0000-0001-8733-131X				Abdelfattah A, 2014, INJURY, V45, P1599, DOI 10.1016/j.injury.2014.05.026; Citron ND, 1997, J HAND SURG-BRIT EUR, V22B, P317, DOI 10.1016/S0266-7681(97)80393-2; Conza NE, 2007, J BIOMECH, V40, P1599, DOI 10.1016/j.jbiomech.2006.07.001; Dellon AL, 2015, J RECONSTR MICROSURG, V31, P283, DOI 10.1055/s-0034-1396896; Filler Aaron G, 2009, Neurosurg Focus, V26, pE9, DOI 10.3171/FOC.2009.26.2.E9; Fritz J, 2008, AM J ROENTGENOL, V191, P1717, DOI 10.2214/AJR.08.1075; Fritz J, 2015, MAGN RESON IMAGING C, V23, P533, DOI 10.1016/j.mric.2015.05.010; Fritz J, 2014, NEUROIMAG CLIN N AM, V24, P211, DOI 10.1016/j.nic.2013.03.028; Hibner M, 2012, J MINIM INVAS GYN, V19, P325, DOI 10.1016/j.jmig.2011.12.022; Hibner M, 2010, J MINIM INVAS GYN, V17, P148, DOI 10.1016/j.jmig.2009.11.003; JAKAB E, 1991, J HAND SURG-AM, V16A, P202, DOI 10.1016/S0363-5023(10)80097-8; Karlsson MK, 1997, SCAND J PLAST RECONS, V31, P65, DOI 10.3109/02844319709010507; Kluge W, 1996, J HAND SURG-BRIT EUR, V21B, P205, DOI 10.1016/S0266-7681(96)80098-2; Loukas M, 2006, SURG RADIOL ANAT, V28, P163, DOI 10.1007/s00276-006-0082-3; Mauillon J, 1999, DIS COLON RECTUM, V42, P186, DOI 10.1007/BF02237125; Popeney C, 2007, NEUROUROL URODYNAM, V26, P820, DOI 10.1002/nau.20421; RICHMAN JA, 1989, J HAND SURG-AM, V14A, P852, DOI 10.1016/S0363-5023(89)80089-9; Robert R, 2005, EUR UROL, V47, P403, DOI 10.1016/j.eururo.2004.09.003; Robert R, 2007, ADV TECH STAND NEURO, V32, P41, DOI 10.1007/978-3-211-47423-5_3; Sayegh ET, 2015, CLIN ORTHOP RELAT R, V473, P1120, DOI 10.1007/s11999-014-3835-z; SIMONIAN PT, 1994, CLIN ORTHOP RELAT R, P245; Varga E, 2008, INJURY, V39, P858, DOI 10.1016/j.injury.2008.01.017; VRAHAS M, 1995, ORTHOPEDICS, V18, P271	23	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165239	10.1371/journal.pone.0165239	http://dx.doi.org/10.1371/journal.pone.0165239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828983	Green Submitted, Green Published, gold			2022-12-26	WOS:000387724300034
J	Hornigold, K; Lake, I; Dolman, P				Hornigold, Karen; Lake, Iain; Dolman, Paul			Recreational Use of the Countryside: No Evidence that High Nature Value Enhances a Key Ecosystem Service	PLOS ONE			English	Article							BIODIVERSITY; BENEFITS; TOURISM; AREAS	In Western Europe, recreational amenity is presented as an important cultural ecosystem service that, along with other values, helps justify policies to conserve biodiversity. However, whether recreational use by the public is enhanced at protected areas designated for nature conservation is unknown. This is the first study to model outdoor recreation at a national scale, examining habitat preferences with statutory designation (Site of Special Scientific Interest) as an indicator of nature conservation importance. Models were based on a massive, three year national household survey providing spatially-referenced recreational visits to the natural environment. Site characteristics including land cover were compared between these observed visit sites (n = 31,502) and randomly chosen control sites (n = 63,000). Recreationists preferred areas of coast, freshwater, broadleaved woodland and higher densities of footpaths and avoided arable, coniferous woodland and lowland heath. Although conservation designation offers similar or greater public access than undesignated areas of the same habitat, statutory designation decreased the probability of visitation to coastal and freshwater sites and gave no effect for broadleaved woodland. Thus general recreational use by the public did not represent an important ecosystem service of protected high-nature-value areas, so that intrinsic and existence values remain as the primary justifications for conservation of high nature value areas. Management of 'green infrastructure' sites of lower conservation value that offer desirable habitats and enhanced provision of footpaths, could mitigate recreational impacts on nearby valuable conservation areas.	[Hornigold, Karen; Lake, Iain; Dolman, Paul] Univ East Anglia, Sch Environm Sci, Norwich, Norfolk, England	University of East Anglia	Hornigold, K (corresponding author), Univ East Anglia, Sch Environm Sci, Norwich, Norfolk, England.	K.Hornigold@uea.ac.uk	lake, iain r/C-9917-2011; Dolman, Paul M./AAK-3914-2020	Lake, Iain Richard/0000-0003-4407-5357; Dolman, Paul/0000-0002-9340-2791	Natural Environment Research Council (NERC) [NE/K500896/1]; Natural Environment Research Council [1210123] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	KH was funded by a Natural Environment Research Council (NERC) Research Studentship (Directed) NE/K500896/1 (http://www.nerc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Monitor of the Engagement with the Natural Environment teams at Natural England and TNS for providing the MENE data and to the Centre for Ecology and Hydrology for the licence to use the LCM2007 25m Raster. We also thank all participants in the MENE survey and all contributors to OpenStreetMap. We are grateful to Alastair Grant for comments on an earlier version of the manuscript. This work was supported by the Natural Environment Research Council [grant number NE/K500896/1]. We are grateful for comments from anonymous reviewers and the editor that helped us improve an earlier version of the manuscript.	[Anonymous], 2013, CONT ORD SURV DAT CR; [Anonymous], 2013, OS MERIDIAN 2 CONTAI; Balmford A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000144; Beyer H.L., GEOSPATIAL MODELLING; Boughey KL, 2011, BIOL CONSERV, V144, P2300, DOI 10.1016/j.biocon.2011.06.008; Clarke RT, 2006, VISITOR ACCESS PATTE; Committee of Public Accounts, DEFRA NAT ENGL ROL; Dallimer M, 2012, BIOSCIENCE, V62, P47, DOI 10.1525/bio.2012.62.1.9; Defra, 2007, CONS BIOD THE UK APP; Defra, 2011, BIOD 2020 STRAT ENGL; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dolman P., 2000, ENV SCI ENV MANAGEME, P119; Eigenbrod F, 2009, P ROY SOC B-BIOL SCI, V276, P2903, DOI 10.1098/rspb.2009.0528; GADM, 2013, DAT GLOB ADM AR; Gimingham C.H., 1972, ECOLOGY HEATHLANDS; Hill GW, 2006, FORESTRY, V79, P185, DOI 10.1093/forestry/cpl005; Jones A., 2010, Sustainability, V2, P684; Keniger LE, 2013, INT J ENV RES PUB HE, V10, P913, DOI 10.3390/ijerph10030913; Liley D, 2005, VISITOR ACCESS PATTE; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; Manly B.F.J., 2002, RESOURCE SELECTION A; MEA (Millennium Ecosystem Assessment), 2005, EC HUM WELL BEING DE; Molloy D, 2011, RSPB RESERVES AND LO; Morton D., 2011, 1107NERC CTR EC HYDR; Naidoo R, 2005, ENVIRON DEV ECON, V10, P159, DOI 10.1017/S1355770X0400186X; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; National Records of Scotland, CENS EST US RES POP; Natural England, 2012, NE356; Natural England, 2011, NE3062011; Natural England, GIS DIG BOUND DAT CO; Natural England, 2012, 0952012 NECR; Office for National Statistics, 2011, 2011 CENS HEADC HOUS; OpenStreetMap, LIC OP DAT COMM OP D; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pickering CM, 2007, J ENVIRON MANAGE, V85, P791, DOI 10.1016/j.jenvman.2006.11.021; Ratcliffe DA, 1977, NATURE CONSERVATION, V1; Reed SE, 2008, CONSERV LETT, V1, P146, DOI 10.1111/j.1755-263X.2008.00019.x; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sandifer PA, 2015, ECOSYST SERV, V12, P1, DOI 10.1016/j.ecoser.2014.12.007; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Sen A, 2014, ENVIRON RESOUR ECON, V57, P233, DOI 10.1007/s10640-013-9666-7; Siikamaki P, 2015, BIODIVERS CONSERV, V24, P2521, DOI 10.1007/s10531-015-0941-5; UKDS, 2013, POSTC DIR; Vickery Juliet, 1995, P42	45	13	14	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165043	10.1371/journal.pone.0165043	http://dx.doi.org/10.1371/journal.pone.0165043			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828990	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000387724300026
J	McFadden, BR				McFadden, Brandon R.			Examining the Gap between Science and Public Opinion about Genetically Modified Food and Global Warming	PLOS ONE			English	Article							CLIMATE-CHANGE; COGNITIVE REFLECTION; INFORMATION; RISK; KNOWLEDGE; GENDER; BIASES	There is great uncertainty due to challenges of escalating population growth and climate change. Public perception that diverges from the scientific community may decrease the effectiveness of scientific inquiry and innovation as tools to solve these challenges. The objective of this study was to identify the factors associated with the divergence of public opinion from scientific consensus regarding the safety of genetically modified (GM) foods and human involvement in global warming (GW). Results indicate that the effects of knowledge on public opinion are complex and non-uniform across types of knowledge (i.e., perceived and actual) or issues. Political affiliation affects agreement with science; Democrats were more likely to agree that GM food is safe and human actions cause GW. Respondents who had relatively higher cognitive function or held illusionary correlations about GM food or GW were more likely to have an opinion that differed from the scientific community.	[McFadden, Brandon R.] Univ Florida, Dept Food & Resource Econ, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	McFadden, BR (corresponding author), Univ Florida, Dept Food & Resource Econ, Gainesville, FL 32611 USA.	brandon.mcfadden@ufl.edu						Bensaude-Vincent B, 2001, PUBLIC UNDERST SCI, V10, P99, DOI 10.1088/0963-6625/10/1/307; Bord RJ, 2000, PUBLIC UNDERST SCI, V9, P205, DOI 10.1088/0963-6625/9/3/301; CHAPMAN LJ, 1967, J VERB LEARN VERB BE, V6, P151, DOI 10.1016/S0022-5371(67)80066-5; Davidson DJ, 1996, ENVIRON BEHAV, V28, P302, DOI 10.1177/0013916596283003; DeStefano F, 2013, J PEDIATR-US, V163, P561, DOI 10.1016/j.jpeds.2013.02.001; Douglas M, 1983, RISK CULTURE ESSAY S; Dunlap RE, 2008, ENVIRONMENT, V50, P26, DOI 10.3200/ENVT.50.5.26-35; EVANS G, 1995, PUBLIC UNDERST SCI, V0004; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Funk C., 2015, PUBLIC SCI VIEWS SCI; Greene H., 2003, ECONOMETRIC ANAL; Gross A. G., 1994, PUBLIC UNDERST SCI, V3, P3, DOI DOI 10.1088/0963-6625/3/1/001; Hallman W. K, 2003, PUBLIC PERCEPTIONS G; Hamilton LC, 2012, POLAR GEOGR, V35, P155, DOI 10.1080/1088937X.2012.684155; Hamilton LC, 2011, CLIMATIC CHANGE, V104, P231, DOI 10.1007/s10584-010-9957-8; Hoppe EI, 2011, ECON LETT, V110, P97, DOI 10.1016/j.econlet.2010.11.015; Hossain F, 2003, J INT FOOD AGRIBUS M, V15, P53; Kahan D.M., 2012, HDB RISK THEORY EPIS, P725, DOI [DOI 10.1007/978-94-007-1433-5_28, 10.1007/978-94-007-1433-5_28]; Kahneman D, 2003, AM ECON REV, V93, P1449, DOI 10.1257/000282803322655392; Malka A, 2009, RISK ANAL, V29, P633, DOI 10.1111/j.1539-6924.2009.01220.x; McCright AM, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044029; McCright AM, 2010, POPUL ENVIRON, V32, P66, DOI 10.1007/s11111-010-0113-1; McFadden BR, 2015, FOOD POLICY, V54, P35, DOI 10.1016/j.foodpol.2015.04.010; McMillan GS, 2000, RES POLICY, V29, P1, DOI 10.1016/s0048-7333(99)00030-x; Mooney C., 2012, REPUBLICAN BRAIN SCI; Mooney Chris, 2005, REPUBLICAN WAR SCI; Narin F, 1997, RES POLICY, V26, P317, DOI 10.1016/S0048-7333(97)00013-9; Owens S, 2000, ENVIRON PLANN A, V32, P1141, DOI 10.1068/a3330; Phillips DM, 2013, PSYCHOL MARKET, V30, P739, DOI 10.1002/mar.20642; Rabin M, 1999, Q J ECON, V114, P37, DOI 10.1162/003355399555945; Shaw A, 2002, PUBLIC UNDERST SCI, V11, P273, DOI 10.1088/0963-6625/11/3/305; Shenhav A, 2012, J EXP PSYCHOL GEN, V141, P423, DOI 10.1037/a0025391; Shwom RachaelL., 2015, CLIMATE CHANGE SOC S, P269, DOI 10.1093/acprof:oso/9780199356102.003.0009; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Toplak ME, 2011, MEM COGNITION, V39, P1275, DOI 10.3758/s13421-011-0104-1; Wynne B., 1992, PUBLIC UNDERST SCI, V1, P281, DOI [10.1088/0963-6625/1/3/004, DOI 10.1088/0963-6625/1/3/004]; ZIMAN J, 1991, SCI TECHNOL HUM VAL, V16, P99, DOI 10.1177/016224399101600106	37	29	29	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166140	10.1371/journal.pone.0166140	http://dx.doi.org/10.1371/journal.pone.0166140			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9OG	27829008	Green Submitted, Green Published, gold			2022-12-26	WOS:000387724300088
J	Nolte, A; Gawalek, P; Koerte, S; Wei, H; Schumann, R; Werckenthin, A; Krieger, J; Stengl, M				Nolte, Andreas; Gawalek, Petra; Koerte, Sarah; Wei, HongYing; Schumann, Robin; Werckenthin, Achim; Krieger, Juergen; Stengl, Monika			No Evidence for Ionotropic Pheromone Transduction in the Hawkmoth Manduca sexta	PLOS ONE			English	Article							OLFACTORY RECEPTOR NEURONS; DROSOPHILA ODORANT RECEPTORS; SENSITIVE TRICHOID SENSILLA; ION CHANNELS; AMILORIDE DERIVATIVES; ANTHERAEA-POLYPHEMUS; MEMBRANE TOPOLOGY; CATION CHANNELS; ANTENNA; CURRENTS	Insect odorant receptors (ORs) are 7-transmembrane receptors with inverse membrane topology. They associate with the conserved ion channel Orco. As chaperon, Orco maintains ORs in cilia and, as pacemaker channel, Orco controls spontaneous activity in olfactory receptor neurons. Odorant binding to ORs opens OR-Orco receptor ion channel complexes in heterologous expression systems. It is unknown, whether this also occurs in vivo. As an alternative to this ionotropic transduction, experimental evidence is accumulating for metabotropic odor transduction, implicating that insect ORs couple to G-proteins. Resulting second messengers gate various ion channels. They generate the sensillum potential that elicits phasic-tonic action potentials (APs) followed by late, long-lasting pheromone responses. Because it is still unclear how and when Orco opens after odor-OR-binding, we used tip recordings to examine in vivo the effects of the Orco antagonist OLC15 and the amilorides MIA and HMA on bombykal transduction in the hawkmoth Manduca sexta. In contrast to OLC15 both amilorides decreased the pheromone-dependent sensillum potential amplitude and the frequency of the phasic AP response. Instead, OLC15 decreased spontaneous activity, increased latencies of phasic-, and decreased frequencies of late, long-lasting pheromone responses Zeitgebertime-dependently. Our results suggest no involvement for Orco in the primary transduction events, in contrast to amiloride-sensitive channels. Instead of an odor-gated ionotropic receptor, Orco rather acts as a voltage- and apparently second messenger-gated pacemaker channel controlling the membrane potential and hence threshold and kinetics of the pheromone response.	[Nolte, Andreas; Gawalek, Petra; Koerte, Sarah; Wei, HongYing; Schumann, Robin; Werckenthin, Achim; Stengl, Monika] Univ Kassel, Dept Anim Physiol, FB Biol 10, Heinrich Plett Str 40, D-34132 Kassel, Germany; [Krieger, Juergen] Martin Luther Univ Halle Wittenberg, Dept Anim Physiol, Inst Biol Zool, Hoher Weg 8, D-06108 Halle, Saale, Germany; [Koerte, Sarah] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Hans Knoell Str 8, D-07749 Jena, Germany	Universitat Kassel; Martin Luther University Halle Wittenberg; Max Planck Society	Stengl, M (corresponding author), Univ Kassel, Dept Anim Physiol, FB Biol 10, Heinrich Plett Str 40, D-34132 Kassel, Germany.	stengl@uni-kassel.de			Deutsche Forschungsgesellschaft [STE531/20-1, STE531/20-2, SPP 1392]	Deutsche Forschungsgesellschaft(German Research Foundation (DFG))	The work was supported by grants from the Deutsche Forschungsgesellschaft STE531/20-1,2 and SPP 1392 to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahk S, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0306-x; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2007, TRENDS NEUROSCI, V30, P512, DOI 10.1016/j.tins.2007.07.004; Bobkov YV, 2007, CHEM SENSES, V32, P149, DOI 10.1093/chemse/bjl041; BOEKHOFF I, 1993, INSECT BIOCHEM MOLEC, V23, P757, DOI 10.1016/0965-1748(93)90063-X; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Dolzer J, 2003, J EXP BIOL, V206, P1575, DOI 10.1242/jeb.00302; Dolzer J, 2001, J EXP BIOL, V204, P2781; Dolzer J, 2008, CHEM SENSES, V33, P803, DOI 10.1093/chemse/bjn043; Elmore T, 2003, J NEUROSCI, V23, P9906; Flecke C, 2010, J EXP BIOL, V213, P842, DOI 10.1242/jeb.032839; Getahun MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058889; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Krannich S, 2008, J NEUROPHYSIOL, V100, P2866, DOI 10.1152/jn.01400.2007; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Martin JP, 2011, PROG NEUROBIOL, V95, P427, DOI 10.1016/j.pneurobio.2011.09.007; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Nolte A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062648; Pask GM, 2013, CHEM SENSES, V38, P221, DOI 10.1093/chemse/bjs100; Sargsyan V, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00005; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schendzielorz T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121230; Schuckel J, 2007, CELL TISSUE RES, V330, P271, DOI 10.1007/s00441-007-0471-x; SCHWEITZER ES, 1976, J INSECT PHYSIOL, V22, P955, DOI 10.1016/0022-1910(76)90078-0; STENGL M, 1993, J EXP BIOL, V178, P125; Stengl M, 2001, CELL TISSUE RES, V304, P409, DOI 10.1007/s004410000336; STENGL M, 1990, J NEUROSCI, V10, P837; STENGL M, 1994, J COMP PHYSIOL A, V174, P187; Stengl M, 1990, THESIS; Stengl M, 2013, J COMP PHYSIOL A, V199, P897, DOI 10.1007/s00359-013-0837-3; Stengl M, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00133; Szyszka P, 2014, P NATL ACAD SCI USA, V111, P16925, DOI 10.1073/pnas.1412051111; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wei HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108757; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906; ZIEGELBERGER G, 1990, J NEUROSCI, V10, P1217; ZUFALL F, 1991, J EXP BIOL, V161, P455	49	16	16	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166060	10.1371/journal.pone.0166060	http://dx.doi.org/10.1371/journal.pone.0166060			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829053	Green Published, Green Submitted, gold			2022-12-26	WOS:000387724300076
J	Ribeiro, BR; Sales, LP; De Marco, P; Loyola, R				Ribeiro, Bruno R.; Sales, Lilian P.; De Marco, Paulo, Jr.; Loyola, Rafael			Assessing Mammal Exposure to Climate Change in the Brazilian Amazon	PLOS ONE			English	Article							RANGE SHIFTS; DISTRIBUTIONS; VULNERABILITY; BIODIVERSITY; IMPACTS; CONSERVATION; GEOGRAPHY; BEHAVIOR; HEAT; SIZE	Human-induced climate change is considered a conspicuous threat to biodiversity in the 21st century. Species' response to climate change depends on their exposition, sensitivity and ability to adapt to novel climates. Exposure to climate change is however uneven within species' range, so that some populations may be more at risk than others. Identifying the regions most exposed to climate change is therefore a first and pivotal step on determining species' vulnerability across their geographic ranges. Here, we aimed at quantifying mammal local exposure to climate change across species' ranges. We identified areas in the Brazilian Amazon where mammals will be critically exposed to non-analogue climates in the future with different variables predicted by 15 global circulation climate forecasts. We also built a null model to assess the effectiveness of the Amazon protected areas in buffering the effects of climate change on mammals, using an innovative and more realistic approach. We found that 85% of species are likely to be exposed to non-analogue climatic conditions in more than 80% of their ranges by 2070. That percentage is even higher for endemic mammals; almost all endemic species are predicted to be exposed in more than 80% of their range. Exposure patterns also varied with different climatic variables and seem to be geographically structured. Western and northern Amazon species are more likely to experience temperature anomalies while northeastern species will be more affected by rainfall abnormality. We also observed an increase in the number of critically-exposed species from 2050 to 2070. Overall, our results indicate that mammals might face high exposure to climate change and that protected areas will probably not be efficient enough to avert those impacts.	[Ribeiro, Bruno R.; Sales, Lilian P.; Loyola, Rafael] Univ Fed Goias, Dept Ecol, Lab Biogeog Conservacao, Goiania, Go, Brazil; [Ribeiro, Bruno R.; Sales, Lilian P.] Univ Fed Goias, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil; [De Marco, Paulo, Jr.] Univ Fed Goias, Lab Metacomunidades & Ecol Paisagens, Dept Ecol, Goiania, Go, Brazil; [De Marco, Paulo, Jr.; Loyola, Rafael] Inst Nacl Pesquisas Espaciais, Brazilian Res Network Climate Change Rede Clima, Sao Jose Dos Campos, SP, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias; Instituto Nacional de Pesquisas Espaciais (INPE)	Loyola, R (corresponding author), Univ Fed Goias, Dept Ecol, Lab Biogeog Conservacao, Goiania, Go, Brazil.; Loyola, R (corresponding author), Inst Nacl Pesquisas Espaciais, Brazilian Res Network Climate Change Rede Clima, Sao Jose Dos Campos, SP, Brazil.	loyola@ufg.br	Sales, Lillian P./C-2300-2016; Loyola, Rafael/S-3978-2019; Loyola, Rafael/A-4425-2008; De Marco, Paulo/B-2209-2009; Ribeiro, Bruno R./Z-2123-2018	Sales, Lillian P./0000-0003-1159-6412; Loyola, Rafael/0000-0001-5323-2735; Loyola, Rafael/0000-0001-5323-2735; De Marco, Paulo/0000-0002-3628-6405; Ribeiro, Bruno R./0000-0002-7755-6715	Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico; Coordenagao de Aperfeicoamento de Nivel Superior; CNPq [308532/2014-7, 479959/2013-7, 407094/2013-0, 563621/2010-9, 437167/2016-0]; O Boticario Group Foundation for the Protection of Nature [PROG_0008_2013]; CNCFlora; FINEP [01.13.0353.00]	Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Coordenagao de Aperfeicoamento de Nivel Superior; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); O Boticario Group Foundation for the Protection of Nature; CNCFlora; FINEP(Financiadora de Inovacao e Pesquisa (Finep))	BRR and LPS are supported by Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico (www.cnpq.br) and Coordenagao de Aperfeicoamento de Nivel Superior (www.capes.gov.br) scholarships, respectively. RL research has been constantly funded by CNPq (grants #308532/2014-7, 479959/2013-7, 407094/2013-0, 563621/2010-9), O Boticario Group Foundation for the Protection of Nature (grant #PROG_0008_2013), and CNCFlora. This paper is a contribution of the Brazilian Network on Global Climate Change Research funded by CNPq (grant #437167/2016-0) and FINEP (grant #01.13.0353.00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Juarez EIAY, 2013, CONSERV LETT, V6, P145, DOI 10.1111/j.1755-263X.2012.00306.x; Juarez EIAY, 2012, TRENDS ECOL EVOL, V27, P272, DOI 10.1016/j.tree.2011.11.005; Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Berry Pam, 2013, Biology - Basel, V2, P872, DOI 10.3390/biology2030872; Bozinovic F, 2011, ANNU REV ECOL EVOL S, V42, P155, DOI 10.1146/annurev-ecolsys-102710-145055; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Brando PM, 2014, P NATL ACAD SCI USA, V111, P6347, DOI 10.1073/pnas.1305499111; Buckley LB, 2012, GLOBAL ECOL BIOGEOGR, V21, P873, DOI 10.1111/j.1466-8238.2011.00737.x; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Cruz-McDonnell KK, 2016, GLOBAL CHANGE BIOL, V22, P237, DOI 10.1111/gcb.13092; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Diffenbaugh NS, 2013, SCIENCE, V341, P486, DOI 10.1126/science.1237123; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; Ferro VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107792; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Garcia RA, 2014, SCIENCE, V344, P486, DOI 10.1126/science.1247579; Grinnell J, 1924, ECOLOGY, V5, P225, DOI 10.2307/1929447; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Huey RB, 2012, PHILOS T R SOC B, V367, P1665, DOI 10.1098/rstb.2012.0005; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Khaliq I, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1097; Lemes P, 2014, BIODIVERS CONSERV, V23, P357, DOI 10.1007/s10531-013-0605-2; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lovejoy TE, 2006, TRENDS ECOL EVOL, V21, P329, DOI 10.1016/j.tree.2006.04.005; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Mantyka-Pringle CS, 2012, GLOBAL CHANGE BIOL, V18, P1239, DOI 10.1111/j.1365-2486.2011.02593.x; Mccain CM, 2014, GLOBAL CHANGE BIOL, V20, P1760, DOI 10.1111/gcb.12499; McCain CM, 2009, ECOL LETT, V12, P550, DOI 10.1111/j.1461-0248.2009.01308.x; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; Oswald SA, 2011, J BIOGEOGR, V38, P430, DOI 10.1111/j.1365-2699.2010.02435.x; Pacifici M, 2015, NAT CLIM CHANGE, V5, P215, DOI 10.1038/NCLIMATE2448; Paglia A.P., 2012, OCCASIONAL PAPERS CO, V2nd; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Peters GP, 2012, NAT CLIM CHANGE, V2, P2, DOI 10.1038/nclimate1332; R Core Team, 2013, R LANG ENV STAT COMP; Schloss CA, 2012, P NATL ACAD SCI USA, V109, P8606, DOI 10.1073/pnas.1116791109; Sheth SN, 2014, EVOLUTION, V68, P2917, DOI 10.1111/evo.12494; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Standards IUCN and Subcommittee Petitions, 2016, GUIDELINES FOR USING, V12; Stocker T.F., 2013, CLIMATE CHANGE 2013; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Verissimo A, 2011, PROTECTED AREAS BRAZ, V92; Vilela B, 2015, METHODS ECOL EVOL, V6, P1229, DOI 10.1111/2041-210X.12401; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104	54	30	30	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165073	10.1371/journal.pone.0165073	http://dx.doi.org/10.1371/journal.pone.0165073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829036	gold, Green Published, Green Submitted			2022-12-26	WOS:000387724300029
J	Topczewska, JM; Shoela, RA; Tomaszewski, JP; Mirmira, RB; Gosain, AK				Topczewska, Jolanta M.; Shoela, Ramy A.; Tomaszewski, Joanna P.; Mirmira, Rupa B.; Gosain, Arun K.			The Morphogenesis of Cranial Sutures in Zebrafish	PLOS ONE			English	Article							MOUSE CORONAL SUTURE; OSTEOBLAST DIFFERENTIATION; CRANIOFACIAL DEVELOPMENT; SKULL VAULT; COLLAGEN-FIBERS; CALVARIAL BONE; MODEL SYSTEM; DANIO-RERIO; CRANIOSYNOSTOSIS; EXPRESSION	Using morphological, histological, and TEM analyses of the cranium, we provide a detailed description of bone and suture growth in zebrafish. Based on expression patterns and localization, we identified osteoblasts at different degrees of maturation. Our data confirm that, unlike in humans, zebrafish cranial sutures maintain lifelong patency to sustain skull growth. The cranial vault develops in a coordinated manner resulting in a structure that protects the brain. The zebrafish cranial roof parallels that of higher vertebrates and contains five major bones: one pair of frontal bones, one pair of parietal bones, and the supraoccipital bone. Parietal and frontal bones are formed by intramembranous ossification within a layer of mesenchyme positioned between the dermal mesenchyme and meninges surrounding the brain. The supraoccipital bone has an endochondral origin. Cranial bones are separated by connective tissue with a distinctive architecture of osteogenic cells and collagen fibrils. Here we show RNA in situ hybridization for col1a1a, col2a1a, col10a1, bglap/osteocalcin, fgfr1a, fgfr1b, fgfr2, fgfr3, foxq1, twist2, twist3, runx2a, runx2b, sp7/osterix, and spp1/osteopontin, indicating that the expression of genes involved in suture development in mammals is preserved in zebrafish. We also present methods for examining the cranium and its sutures, which permit the study of the mechanisms involved in suture patency as well as their pathological obliteration. The model we develop has implications for the study of human disorders, including craniosynostosis, which affects 1 in 2,500 live births.	[Topczewska, Jolanta M.; Shoela, Ramy A.; Tomaszewski, Joanna P.; Mirmira, Rupa B.; Gosain, Arun K.] Northwestern Univ, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Div Pediat Plast Surg,Stanley Manne Childrens Res, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine	Topczewska, JM (corresponding author), Northwestern Univ, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Div Pediat Plast Surg,Stanley Manne Childrens Res, Chicago, IL 60611 USA.	j-topczewska@northwestern.edu		Topczewska, Jolanta M/0000-0003-1876-5039	AO Foundation [S-09-102G]	AO Foundation	AO Foundation supported this work through No. S-09-102G [https://www.aeans.aotoundation.org/Structure/research/research-funding/Pages/Start-up-agrants.aspx].	Avaron F, 2006, DEV DYNAM, V235, P478, DOI 10.1002/dvdy.20619; Bhat A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025990; Bieller A, 2001, DNA CELL BIOL, V20, P555, DOI 10.1089/104454901317094963; Boonrungsiman S, 2012, P NATL ACAD SCI USA, V109, P14170, DOI 10.1073/pnas.1208916109; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; Boskey AL, 2002, CALCIFIED TISSUE INT, V71, P145, DOI 10.1007/s00223-001-1121-z; Clendenning DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036789; Cohen MM, 2012, J CRANIOFAC SURG, V23, P338, DOI 10.1097/SCS.0b013e318241dbc4; Cubbage CC, 1996, J MORPHOL, V229, P121, DOI 10.1002/(SICI)1097-4687(199608)229:2<121::AID-JMOR1>3.0.CO;2-4; DeLaurier A, 2010, GENESIS, V48, P505, DOI 10.1002/dvg.20639; DOLBER PC, 1993, J HISTOCHEM CYTOCHEM, V41, P465, DOI 10.1177/41.3.7679127; Eames BF, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-27; Feng WG, 2013, GENESIS, V51, P677, DOI 10.1002/dvg.22416; Filipek-Gorniok B, 2013, DEV DYNAM, V242, P964, DOI 10.1002/dvdy.23981; FURUYA Y, 1984, J NEUROSURG, V61, P53, DOI 10.3171/jns.1984.61.1.0053; Geurtzen K, 2014, DEVELOPMENT, V141, P2225, DOI 10.1242/dev.105817; Hatch NE, 2010, CRIT REV EUKAR GENE, V20, P295, DOI 10.1615/CritRevEukarGeneExpr.v20.i4.20; Hermann CD, 2012, CALCIFIED TISSUE INT, V91, P255, DOI 10.1007/s00223-012-9632-3; Irie K, 1998, ANAT RECORD, V252, P554; Iseki S, 1999, DEVELOPMENT, V126, P5611; Ishii M, 2015, CURR TOP DEV BIOL, V115, P131, DOI 10.1016/bs.ctdb.2015.07.004; Jacob AL, 2006, DEV BIOL, V296, P315, DOI 10.1016/j.ydbio.2006.05.031; Jasinoski SC, 2010, J BIOMECH, V43, P3104, DOI 10.1016/j.jbiomech.2010.08.007; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Johnson D, 2000, MECH DEVELOP, V91, P341, DOI 10.1016/S0925-4773(99)00278-6; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kabbani H, 2004, AM FAM PHYSICIAN, V69, P2863; Kague E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047394; Kapp-Simon KA, 2016, J NEUROSURG PEDIAT, P1, DOI [DOI 10.3171/2015.9.PEDS15238, 10.3171/2015.9.PEDS15238]; Karsenty G, 2001, ENDOCRINOLOGY, V142, P2731, DOI 10.1210/en.142.7.2731; Khonsari RH, 2012, AM J MED GENET A, V158A, P2797, DOI 10.1002/ajmg.a.35598; Kimmel CB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009475; Knopf F, 2011, DEV CELL, V20, P713, DOI 10.1016/j.devcel.2011.04.014; Kolar JC, 2011, J CRANIOFAC SURG, V22, P47, DOI 10.1097/SCS.0b013e3181f6c2fb; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Levi B, 2012, J CRANIOFAC SURG, V23, P13, DOI 10.1097/SCS.0b013e318240c6c0; Li N, 2009, DEV DYNAM, V238, P459, DOI 10.1002/dvdy.21838; McGee-Lawrence ME, 2013, J BIOL CHEM, V288, P5291, DOI 10.1074/jbc.M112.414995; Merrill AE, 2006, HUM MOL GENET, V15, P1319, DOI 10.1093/hmg/ddl052; Morriss-Kay GM, 2005, J ANAT, V207, P637, DOI 10.1111/j.1469-7580.2005.00475.x; Moursi AM, 2002, CLEFT PALATE-CRAN J, V39, P487, DOI 10.1597/1545-1569(2002)039<0487:FGFIIC>2.0.CO;2; Muenke M, 2011, MONOGR HUM GENET, V19, P1; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Narisawa S, 2013, J BONE MINER RES, V28, P1587, DOI 10.1002/jbmr.1901; Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; PUCHTLER H, 1973, BEITR PATHOL, V150, P174, DOI 10.1016/S0005-8165(73)80016-2; Quarto N, 2005, CELLS TISSUES ORGANS, V181, P109, DOI 10.1159/000091100; Renn J, 2013, DEV BIOL, V381, P134, DOI 10.1016/j.ydbio.2013.05.030; Rice DPC, 2003, EUR J ORTHODONT, V25, P139, DOI 10.1093/ejo/25.2.139; Rice DPC, 2000, DEVELOPMENT, V127, P1845; Sabaliauskas NA, 2006, METHODS, V39, P246, DOI 10.1016/j.ymeth.2006.03.001; Sinha KM, 2013, J CELL BIOCHEM, V114, P975, DOI 10.1002/jcb.24439; Slater BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003914; Sousa S, 2012, BIOL OPEN, V1, P915, DOI 10.1242/bio.2012877; Spiesz EM, 2011, J STRUCT BIOL, V176, P302, DOI 10.1016/j.jsb.2011.09.009; Szabo-Rogers HL, 2010, DEV BIOL, V341, P84, DOI 10.1016/j.ydbio.2009.11.021; Twigg SRF, 2015, HUM MOL GENET, V24, pR50, DOI 10.1093/hmg/ddv228; Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Warren SM, 2008, J CRANIOFAC SURG, V19, P198, DOI 10.1097/scs.0b013e31815c8a9a; Wei JW, 2015, CELL, V161, P1576, DOI 10.1016/j.cell.2015.05.029; Wilkie AOM, 1997, HUM MOL GENET, V6, P1647, DOI 10.1093/hmg/6.10.1647; Yelick PC, 2002, CRIT REV ORAL BIOL M, V13, P308, DOI 10.1177/154411130201300402; Yoshida T, 2005, J ANAT, V206, P437, DOI 10.1111/j.1469-7580.2005.00411.x; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007	68	27	27	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165775	10.1371/journal.pone.0165775	http://dx.doi.org/10.1371/journal.pone.0165775			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829009	Green Submitted, gold, Green Published			2022-12-26	WOS:000387724300058
J	Butler, DC; Joshi, SN; De Genst, E; Baghel, AS; Dobson, CM; Messer, A				Butler, David C.; Joshi, Shubhada N.; De Genst, Erwin; Baghel, Ankit S.; Dobson, Christopher M.; Messer, Anne			Bifunctional Anti-Non-Amyloid Component alpha-Synuclein Nanobodies Are Protective In Situ	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; MUTANT HUNTINGTIN AGGREGATION; IMPAIRS MACROAUTOPHAGY; INTRABODY; DISEASE; EXPRESSION; MODELS; OVEREXPRESSION; NEUROTOXICITY; INCLUSIONS	Misfolding, abnormal accumulation, and secretion of alpha-Synuclein (alpha-Syn) are closely associated with synucleinopathies, including Parkinson's disease (PD). VH14 is a human single domain intrabody selected against the non-amyloid component (NAC) hydrophobic interaction region of alpha-Syn, which is critical for initial aggregation. Using neuronal cell lines, we show that as a bifunctional nanobody fused to a proteasome targeting signal, VH14PEST can counteract heterologous proteostatic effects of mutant alpha-Syn on mutant huntingtin Exon1 and protect against alpha-Syn toxicity using propidium iodide or Annexin V readouts. We compared this anti-NAC candidate to NbSyn87, which binds to the C-terminus of alpha-Syn. NbSyn87PEST degrades alpha-Syn as well or better than VH14PEST. However, while both candidates reduced toxicity, VH14PEST appears more effective in both proteostatic stress and toxicity assays. These results show that the approach of reducing intracellular monomeric targets with novel antibody engineering technology should allow in vivo modulation of proteostatic pathologies.	[Butler, David C.; Messer, Anne] Neural Stem Cell Inst, Rensselaer, NY 12144 USA; [Butler, David C.; Messer, Anne] SUNY Albany, Dept Biomed Sci, Albany, NY 12208 USA; [Butler, David C.; Joshi, Shubhada N.; Baghel, Ankit S.; Messer, Anne] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12208 USA; [De Genst, Erwin; Dobson, Christopher M.] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England; [Baghel, Ankit S.] Stanford Univ, Palo Alto, CA 94304 USA; [De Genst, Erwin] AstraZeneca UK Ltd, Cambridge CB2 0AA, England	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; Wadsworth Center; University of Cambridge; Stanford University; AstraZeneca	Messer, A (corresponding author), Neural Stem Cell Inst, Rensselaer, NY 12144 USA.; Messer, A (corresponding author), SUNY Albany, Dept Biomed Sci, Albany, NY 12208 USA.; Messer, A (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12208 USA.	annemesser@neuralsci.org		Baghel, Ankit/0000-0001-7853-1109	Michael J Fox Foundation; NIH/NINDS [NS053912, NS073415, NS061257]; Albany Medical College; Medical Research Council [MRC G1002272]; MRC [G1002272] Funding Source: UKRI	Michael J Fox Foundation; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Albany Medical College; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Work by AM and DCB was supported by the Michael J Fox Foundation, and NIH/NINDS [NS053912, NS073415 and NS061257]. Student stipend for SNJ was provided by Albany Medical College during portions of this work. EDG and CMD are grateful for support obtained by the Medical Research Council (MRC G1002272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029199; Chanez-Cardenas Maria Elena, 2012, J Biophys, V2012, P606172, DOI 10.1155/2012/606172; Corrochano S, 2012, AUTOPHAGY, V8, P431, DOI 10.4161/auto.19259; Corrochano S, 2012, HUM MOL GENET, V21, P485, DOI 10.1093/hmg/ddr477; da Fonseca TL, 2015, BIOMOLECULES, V5, P435, DOI 10.3390/biom5020435; De Genst E, 2014, BBA-PROTEINS PROTEOM, V1844, P1907, DOI 10.1016/j.bbapap.2014.08.016; De Genst EJ, 2010, J MOL BIOL, V402, P326, DOI 10.1016/j.jmb.2010.07.001; Ehrlich ME, 2001, EXP NEUROL, V167, P215, DOI 10.1006/exnr.2000.7551; El-Turk F, 2016, BIOCHEMISTRY-US, V55, P3116, DOI 10.1021/acs.biochem.6b00149; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Furlong RA, 2000, BIOCHEM J, V346, P577, DOI 10.1042/0264-6021:3460577; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Guilliams T, 2013, J MOL BIOL, V425, P2397, DOI 10.1016/j.jmb.2013.01.040; Hornykiewicz O, 1998, NEUROLOGY, V51, pS2, DOI 10.1212/WNL.51.2_Suppl_2.S2; Huston J S, 1993, Int Rev Immunol, V10, P195, DOI 10.3109/08830189309061696; Jach G, 2006, NAT METHODS, V3, P597, DOI 10.1038/NMETH901; Joshi SN, 2012, MABS-AUSTIN, V4, P686, DOI 10.4161/mabs.21696; Khoshnan A, 2002, P NATL ACAD SCI USA, V99, P1002, DOI 10.1073/pnas.022631799; Kvam E, 2010, PROTEIN ENG DES SEL, V23, P489, DOI 10.1093/protein/gzq022; Kvam E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005727; Lea A, 2014, P NATL ACAD SCI USA, V111, P12486, DOI 10.1073/pnas.1402012111; Lecerf JM, 2001, P NATL ACAD SCI USA, V98, P4764, DOI 10.1073/pnas.071058398; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lynch SM, 2008, J MOL BIOL, V377, P136, DOI 10.1016/j.jmb.2007.11.096; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; Messer A, 2013, NEUROTHERAPEUTICS, V10, P447, DOI 10.1007/s13311-013-0193-6; Mezey E, 1998, MOL PSYCHIATR, V3, P493, DOI 10.1038/sj.mp.4000446; Muyldermans S, 2001, J Biotechnol, V74, P277; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; Pinotsi D, 2016, P NATL ACAD SCI USA, V113, P3815, DOI 10.1073/pnas.1516546113; Pocas GM, 2015, HUM MOL GENET, V24, P1898, DOI 10.1093/hmg/ddu606; Ravikumar B, 2004, NEUROREPORT, V15, P2443, DOI 10.1097/00001756-200411150-00001; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Tomas-Zapico C, 2012, HUM MOL GENET, V21, P495, DOI 10.1093/hmg/ddr507; Valera E, 2016, NEUROTHERAPEUTICS, V13, P179, DOI 10.1007/s13311-015-0397-z; van Genderen H, 2006, NAT PROTOC, V1, P363, DOI 10.1038/nprot.2006.55; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Xin W, 2015, BIOMOLECULES, V5, P1634, DOI 10.3390/biom5031634; Yan JQ, 2014, MOL NEUROBIOL, V50, P685, DOI 10.1007/s12035-014-8738-1; Yerbury JJ, 2016, J NEUROCHEM, V137, P489, DOI 10.1111/jnc.13575; Zhao XN, 1999, METHOD ENZYMOL, V302, P32, DOI 10.1016/S0076-6879(99)02006-6; Zhou C, 2004, MOL THER, V10, P1023, DOI 10.1016/j.ymthe.2004.08.019	48	37	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165964	10.1371/journal.pone.0165964	http://dx.doi.org/10.1371/journal.pone.0165964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824888	Green Published, gold, Green Submitted			2022-12-26	WOS:000387615200051
J	Ebner, L; Walti, LN; Rauch, A; Furrer, H; Cusini, A; Meyer, AMJ; Weiler, S; Huynh-Do, U; Heverhagen, J; Arampatzis, S; Christe, A				Ebner, Lukas; Walti, Laura N.; Rauch, Andri; Furrer, Hansjakob; Cusini, Alexia; Meyer, Andreas M. J.; Weiler, Stefan; Huynh-Do, Uyen; Heverhagen, Johannes; Arampatzis, Spyridon; Christe, Andreas			Clinical Course, Radiological Manifestations, and Outcome of Pneumocystis jirovecii Pneumonia in HIV Patients and Renal Transplant Recipients	PLOS ONE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; HIGH-RESOLUTION CT; CARINII-PNEUMONIA; AIDS PATIENTS; INFECTION; ACCURACY; PATTERNS; FEATURES	Background Pneumocystis jirovecii pneumonia (PCP) is a frequent opportunistic infection in immuno-compromised patients. In literature, presentation and outcome of PCP differs between patients with human immunodeficiency virus (HIV) infection and renal transplant recipients (RTRs). Methods We conducted a cross-sectional study of patients with PCP based on the HIV and renal transplant registries at our institution. Radiological and clinical data from all confirmed PCP cases between 2005 and 2012 were compared. Results Forty patients were included: 16 with HIV and 24 RTRs. Radiologically, HIV patients had significantly more areas of diffuse lung affection (81% HIV vs. 25% RTR; p = 0.02), more ground glass nodules 5-10 mm (69% vs. 4%; p = <0.001) and enlarged hilar lymph nodes were found only in HIV patients (44%). Cough and dyspnea were the most common clinical signs (>80%) in both groups. Duration from illness onset to hospital presentation was longer in the HIV patients (median of 18 vs. 10 days (p = 0.02)), implying a less fulminant clinical course. Sixty percent of PCP cases in RTRs occurred >12 months after transplantation. Lengths of hospitalization, admission rates to the intensive care unit, and requirements for mechanical ventilation were similar. Outcome in both groups was favourable. Conclusions While important differences in radiological presentation of PCP between HIV patients and RTRs were found, clinical presentation was similar. PCP only rarely presented with fulminant respiratory symptoms requiring ICU admission, with similar results and outcomes for HIV patients and RTRs. Early diagnosis and treatment is mandatory for clinical success.	[Ebner, Lukas; Heverhagen, Johannes; Christe, Andreas] Univ Bern, Univ Hosp Bern, Inselspital, Dept Diagnost Intervent & Pediat Radiol, Bern, Switzerland; [Walti, Laura N.; Rauch, Andri; Furrer, Hansjakob; Cusini, Alexia] Univ Bern, Univ Hosp Bern, Inselspital, Dept Infect Dis, Bern, Switzerland; [Meyer, Andreas M. J.; Weiler, Stefan; Huynh-Do, Uyen; Arampatzis, Spyridon] Univ Bern, Univ Hosp Bern, Inselspital, Dept Hypertens Nephrol & Clin Pharmacol, Bern, Switzerland; [Ebner, Lukas] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; [Weiler, Stefan] Univ Zurich Hosp, Dept Clin Pharmacol & Toxicol, Zurich, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Duke University; University of Zurich; University Zurich Hospital	Arampatzis, S (corresponding author), Univ Bern, Univ Hosp Bern, Inselspital, Dept Hypertens Nephrol & Clin Pharmacol, Bern, Switzerland.	spiros.arampatzis@insel.ch	weiler, stefan/ABE-8932-2021; Furrer, Hansjakob/G-6768-2013; Walti, Laura/ABD-8601-2020; Rauch, Andri/E-9948-2017	Furrer, Hansjakob/0000-0002-1375-3146; Rauch, Andri/0000-0001-5297-6062; Ebner, Lukas/0000-0001-5117-6047; Walti, Laura Naemi/0000-0002-7048-6590; Arampatzis, Spyridon/0000-0002-6959-0411; Heverhagen, Johannes/0000-0002-5416-6650				Catherinot E, 2010, INFECT DIS CLIN N AM, V24, P107, DOI 10.1016/j.idc.2009.10.010; Christe A, 2013, EUR J RADIOL, V82, pE142, DOI 10.1016/j.ejrad.2012.09.025; Denis B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094183; Fritzsche C, 2013, NEPHROLOGY, V18, P382, DOI 10.1111/nep.12054; Fujii Takeshi, 2007, Journal of Infection and Chemotherapy, V13, P1, DOI 10.1007/s10156-006-0484-5; GERRARD JG, 1995, MED J AUSTRALIA, V162, P233, DOI 10.5694/j.1326-5377.1995.tb139873.x; Goto N, 2011, TRANSPL INFECT DIS, V13, P551, DOI 10.1111/j.1399-3062.2011.00691.x; Gruden JF, 1997, AM J ROENTGENOL, V169, P967, DOI 10.2214/ajr.169.4.9308446; Hardak E, 2010, LUNG, V188, P159, DOI 10.1007/s00408-009-9214-y; HARTMAN TE, 1994, AM J ROENTGENOL, V162, P547, DOI 10.2214/ajr.162.3.8109494; Hidalgo A, 2003, EUR RADIOL, V13, P1179, DOI 10.1007/s00330-002-1641-6; Kanne JP, 2012, AM J ROENTGENOL, V198, pW555, DOI 10.2214/AJR.11.7329; KOVACS JA, 1984, ANN INTERN MED, V100, P663, DOI 10.7326/0003-4819-100-5-663; Mansharamani NG, 2000, CHEST, V118, P704, DOI 10.1378/chest.118.3.704; McCaughan JA, 2012, NEPHROL DIAL TRANSPL, V27, P13, DOI 10.1093/ndt/gfr444; Morris A, 2008, CLIN INFECT DIS, V46, P634, DOI 10.1086/526779; Neff RT, 2009, TRANSPLANTATION, V88, P135, DOI 10.1097/TP.0b013e3181aad256; Nuesch R, 1999, CLIN INFECT DIS, V29, P1519, DOI 10.1086/313534; Radisic M, 2003, Transpl Infect Dis, V5, P84, DOI 10.1034/j.1399-3062.2003.00018.x; SEPKOWITZ KA, 1992, JAMA-J AM MED ASSOC, V267, P832, DOI 10.1001/jama.267.6.832; Tasaka S, 2010, INTERNAL MED, V49, P273, DOI 10.2169/internalmedicine.49.2871; Walzer PD, 2008, CLIN INFECT DIS, V46, P625, DOI 10.1086/526778; Wang EHZ, 2012, TRANSPL INFECT DIS, V14, P519, DOI 10.1111/j.1399-3062.2012.00740.x; Yale SH, 1996, MAYO CLIN PROC, V71, P5, DOI 10.4065/71.1.5	24	19	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0164320	10.1371/journal.pone.0164320	http://dx.doi.org/10.1371/journal.pone.0164320			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824870	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000387615200004
J	Kemleu, S; Guelig, D; Moukoko, CE; Essangui, E; Diesburg, S; Mouliom, A; Melingui, B; Manga, J; Donkeu, C; Epote, A; Texier, G; LaBarre, P; Burton, R; Ayong, L				Kemleu, Sylvie; Guelig, Dylan; Moukoko, Carole Eboumbou; Essangui, Estelle; Diesburg, Steven; Mouliom, Abas; Melingui, Bernard; Manga, Jeanne; Donkeu, Christiane; Epote, Annie; Texier, Gaetan; LaBarre, Paul; Burton, Robert; Ayong, Lawrence			A Field-Tailored Reverse Transcription Loop-Mediated Isothermal Assay for High Sensitivity Detection of Plasmodium falciparum Infections	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; SEQUENCE-BASED AMPLIFICATION; REAL-TIME PCR; MALARIA ELIMINATION; ASYMPTOMATIC MALARIA; BLOOD-DONORS; DNA; CHALLENGES; PARASITES; STRATEGIES	Highly sensitive and field deployable molecular diagnostic tools are critically needed for detecting submicroscopic, yet transmissible levels of malaria parasites prevalent in malaria endemic countries worldwide. A reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay was developed and evaluated in comparison with thick blood smear microscopy, an antigen-based rapid diagnostic test (RDT), and an in-house RT-PCR targeting the same RT-LAMP transcript. The optimized assay detected Plasmodium falciparum infections in as little as 0.25ng of total parasite RNA, and exhibited a detection limit of 0.08 parasites/mu L when tested directly on infected whole blood lysates, or similar to 0.0008 parasites/mu L when using RNA extracts. Assay positivity was observed as early as eight minutes from initiation of the RT-LAMP and in most cases the reaction was complete before twenty minutes. Clinical evaluation of the assay on 132 suspected malaria cases resulted in a positivity rate of 90% for RT-LAMP using extracted RNA, and 85% when using whole blood lysates. The positivity rates were 70% for P. falciparum-specific RDT, 83% for RT-PCR, and 74% for thick blood smear microscopy (Mean parasite density = 36,986 parasites/mu L). Concordance rates between the developed RT-LAMP and comparator tests were greater than 75%, the lowest being with light microscopy (78%, McNemar's test: P = 0.0002), and the highest was with RT-PCR (87%, McNemar's test: P = 0.0523). Compared to reference RT-PCR, assay sensitivity was 90% for RT-LAMP on whole blood, and 96% for RT-LAMP using corresponding RNA extracts. Electricity-free heaters were further developed and evaluated in comparison with a battery-operated isothermal amplification machine for use with the developed test in resource-limited settings. Taken together, the data highlight the benefits of targeting high abundant RNA transcripts in molecular diagnosis, as well as the potential usefulness of the developed RT-LAMP-assay in malaria diagnosis in low to high parasite density settings.	[Kemleu, Sylvie; Moukoko, Carole Eboumbou; Essangui, Estelle; Donkeu, Christiane; Ayong, Lawrence] Ctr Pasteur Cameroun, Malaria Res Unit, Yaounde, Cameroon; [Guelig, Dylan; Diesburg, Steven; Burton, Robert] PATH, Seattle, WA USA; [Moukoko, Carole Eboumbou] Univ Douala, Fac Med & Pharmaceut Sci, Douala, Cameroon; [Essangui, Estelle] Univ Douala, Fac Sci, Douala, Cameroon; [Mouliom, Abas; Melingui, Bernard; Manga, Jeanne; Epote, Annie] Ctr Pasteur Cameroun, Hematol Unit, Yaounde, Cameroon; [Texier, Gaetan] Ctr Pasteur Cameroun, Publ Hlth & Epidemiol Unit, Yaounde, Cameroon	Centre Pasteur du Cameroun; Centre Pasteur du Cameroun; Centre Pasteur du Cameroun	Ayong, L (corresponding author), Ctr Pasteur Cameroun, Malaria Res Unit, Yaounde, Cameroon.	layong05@yahoo.co.uk		MANGA MESSINA MBETI, JEANNE/0000-0002-6108-3140	Institut Pasteur International Division [G4]; NIH [R01EB012641-01A1]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012641] Funding Source: NIH RePORTER	Institut Pasteur International Division; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded through a Capacity Building and Training grant (G4 Award) from the Institut Pasteur International Division to LA and an NIH grant R01EB012641-01A1 to RB.	Abdullah S, 2016, PARASITOL RES, V115, P35, DOI 10.1007/s00436-015-4808-1; Amoah LE, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1159-z; Aydin-Schmidt B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103905; Baker J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-129; Baltzell KA, 2013, AM J TROP MED HYG, V88, P289, DOI 10.4269/ajtmh.2012.12-0095; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Britton S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1158-0; Chander Y, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00395; Connolly Michael A, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot4104; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Curtis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031432; Douamba Zoenabo, 2014, Malar Res Treat, V2014, P390513, DOI 10.1155/2014/390513; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Gillet P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002180; Guerin PJ, 2002, LANCET INFECT DIS, V2, P564, DOI 10.1016/S1473-3099(02)00372-9; Hayashida K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003578; Hodgson SH, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0541-6; Hofmann N, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001788; Houze S, 2011, J CLIN MICROBIOL, V49, P2694, DOI 10.1128/JCM.00281-11; Houze S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-211; Hoyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045797; Kamau E, 2011, J CLIN MICROBIOL, V49, P2946, DOI 10.1128/JCM.00276-11; Karunaweera ND, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-59; Kitchen AD, 2014, VOX SANG, V107, P123, DOI 10.1111/vox.12142; Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665; Kubota Ryo, 2011, Biol Eng Trans, V4, P69; Kumar N, 2013, ACTA TROP, V125, P119, DOI 10.1016/j.actatropica.2012.09.015; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau YL, 2016, AM J TROP MED HYG, V94, P336, DOI 10.4269/ajtmh.15-0569; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lee JH, 2014, J CLIN MICROBIOL, V52, P3784, DOI 10.1128/JCM.01797-14; Leshem E, 2011, J CLIN MICROBIOL, V49, P2331, DOI 10.1128/JCM.00307-11; Li Y, 2013, J MOL DIAGN, V15, P634, DOI 10.1016/j.jmoldx.2013.05.005; Lin JT, 2014, TRENDS PARASITOL, V30, P183, DOI 10.1016/j.pt.2014.02.004; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733; Luchavez J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-286; Maltha J, 2013, CLIN MICROBIOL INFEC, V19, P399, DOI 10.1111/1469-0691.12151; McCutchan TF, 2008, EMERG INFECT DIS, V14, P1750, DOI 10.3201/eid1411.080840; Meatherall B, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-377; Mohan A, 2014, NATL MED J INDIA, V27, P297; Mohon A, 2016, DIAGN MICR INFEC DIS, V85, P149, DOI 10.1016/j.diagmicrobio.2015.11.009; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Moya-Alvarez V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-271; Murphy SC, 2012, AM J TROP MED HYG, V86, P383, DOI 10.4269/ajtmh.2012.10-0658; Nakao R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-296; Newby G, 2015, AM J TROP MED HYG, V93, P125, DOI 10.4269/ajtmh.14-0254; Nkouawa A, 2010, J CLIN MICROBIOL, V48, P3350, DOI 10.1128/JCM.00697-10; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; O'Brien SF, 2015, TRANSFUS MED REV, V29, P162, DOI 10.1016/j.tmrv.2015.03.004; Oladeinde BH, 2014, IRAN J PARASITOL, V9, P415; Olawumi Hannah O, 2015, Afr J Infect Dis, V9, P10, DOI 10.4314/ajid.v9i1.3; Oriero EC, 2015, J ANTIMICROB CHEMOTH, V70, P2, DOI 10.1093/jac/dku343; Oriero EC, 2015, EXPERT REV MOL DIAGN, V15, P1419, DOI 10.1586/14737159.2015.1090878; Polley SD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-62; Polley SD, 2010, J CLIN MICROBIOL, V48, P2866, DOI 10.1128/JCM.00355-10; Rio DC., 2010, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot5439, DOI 10.1101/PDB.PROT5439]; Schneider P, 2005, J CLIN MICROBIOL, V43, P402, DOI 10.1128/JCM.43.1.402-405.2005; Schoone GJ, 2000, J CLIN MICROBIOL, V38, P4072, DOI 10.1128/JCM.38.11.4072-4075.2000; Sema M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0559-9; Shah Sajid Ali, 2015, J Ayub Med Coll Abbottabad, V27, P721; Shakely D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072912; Singleton J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113693; Singleton J, 2013, PROC SPIE, V8615, DOI 10.1117/12.2005928; Slater HC, 2015, NATURE, V528, pS94, DOI 10.1038/nature16040; Stresman G, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-353; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; Xiao Hui-hui, 2014, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V32, P474	70	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165506	10.1371/journal.pone.0165506	http://dx.doi.org/10.1371/journal.pone.0165506			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824866	Green Published, Green Submitted, gold			2022-12-26	WOS:000387615200020
J	Irum, B; Khan, SY; Ali, M; Kaul, H; Kabir, F; Rauf, B; Fatima, F; Nadeem, R; Khan, AO; Al Obaisi, S; Naeem, MA; Nasir, IA; Khan, SN; Husnain, T; Riazuddin, S; Akram, J; Eghrari, AO; Riazuddin, SA				Irum, Bushra; Khan, Shahid Y.; Ali, Muhammad; Kaul, Haiba; Kabir, Firoz; Rauf, Bushra; Fatima, Fareeha; Nadeem, Raheela; Khan, Arif O.; Al Obaisi, Saif; Naeem, Muhammad Asif; Nasir, Idrees A.; Khan, Shaheen N.; Husnain, Tayyab; Riazuddin, Sheikh; Akram, Javed; Eghrari, Allen O.; Riazuddin, S. Amer			Mutation in LIM2 Is Responsible for Autosomal Recessive Congenital Cataracts	PLOS ONE			English	Article							INTRINSIC MEMBRANE-PROTEIN; CONSANGUINEOUS PAKISTANI FAMILIES; NONSENSE MUTATION; MISSENSE MUTATION; BOVINE LENS; LOCUS; GENE; MP19; IDENTIFICATION; LOCALIZATION	Purpose To identify the molecular basis of non-syndromic autosomal recessive congenital cataracts (arCC) in a consanguineous family. Methods All family members participating in the study received a comprehensive ophthalmic examination to determine their ocular phenotype and contributed a blood sample, from which genomic DNA was extracted. Available medical records and interviews with the family were used to compile the medical history of the family. The symptomatic history of the individuals exhibiting cataracts was confirmed by slit-lamp biomicroscopy. A genome-wide linkage analysis was performed to localize the disease interval. The candidate gene, LIM2 (lens intrinsic membrane protein 2), was sequenced bi-directionally to identify the disease-causing mutation. The physical changes caused by the mutation were analyzed in silico through homology modeling, mutation and bioinformatic algorithms, and evolutionary conservation databases. The physiological importance of LIM2 to ocular development was assessed in vivo by real-time expression analysis of Lim2 in a mouse model. Results Ophthalmic examination confirmed the diagnosis of nuclear cataracts in the affected members of the family; the inheritance pattern and cataract development in early infancy indicated arCC. Genome-wide linkage analysis localized the critical interval to chromosome 19q with a two-point logarithm of odds (LOD) score of 3.25. Bidirectional sequencing identified a novel missense mutation, c.233G> A (p.G78D) in LIM2. This mutation segregated with the disease phenotype and was absent in 192 ethnically matched control chromosomes. In silico analysis predicted lower hydropathicity and hydrophobicity but higher polarity of the mutant LIM2-encoded protein (MP19) compared to the wild-type. Moreover, these analyses predicted that the mutation would disrupt the secondary structure of a transmembrane domain of MP19. The expression of Lim2, which was detected in the mouse lens as early as embryonic day 15 (E15) increased after birth to a level that was sustained through the postnatal time points. Conclusion A novel missense mutation in LIM2 is responsible for autosomal recessive congenital cataracts.	[Irum, Bushra; Khan, Shahid Y.; Ali, Muhammad; Kaul, Haiba; Kabir, Firoz; Rauf, Bushra; Eghrari, Allen O.; Riazuddin, S. Amer] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA; [Irum, Bushra; Rauf, Bushra; Fatima, Fareeha; Nadeem, Raheela; Naeem, Muhammad Asif; Nasir, Idrees A.; Khan, Shaheen N.; Husnain, Tayyab; Riazuddin, Sheikh] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore 53700, Pakistan; [Khan, Arif O.; Al Obaisi, Saif] King Khalid Eye Specialist Hosp, Riyadh 12329, Saudi Arabia; [Riazuddin, Sheikh; Akram, Javed] Univ Hlth Sci, Allama Iqbal Med Coll, Lahore 54550, Pakistan; [Riazuddin, Sheikh; Akram, Javed] Shaheed Zulfiqar Ali Bhutto Med Univ, Natl Ctr Genet Dis, Islamabad 44000, Pakistan; [Riazuddin, S. Amer] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; King Khaled Eye Specialist Hospital; University of Health Science - Pakistan; Johns Hopkins University	Riazuddin, SA (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA.; Riazuddin, SA (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	riazuddin@jhmi.edu	Eghrari, Allen/AAI-9282-2021; Eghrari, Allen/ABH-4964-2020; Husnain, Tayyab/AAE-9033-2019; Nasir, Idrees Ahmad/T-7695-2019	Eghrari, Allen/0000-0003-2798-038X; Naeem, Muhammad Asif/0000-0001-8547-6419; Kaul, Haiba/0000-0001-8257-4128; Alobaisi, Saif/0000-0002-5493-8315	National Eye Institute [R01EY022714]; Knights Templar Eye Foundation grant; King Khaled Eye Specialist Hospital-Johns Hopkins University collaboration grant; National Academy of Sciences, Washington DC USA; Higher Education Commission, Islamabad Pakistan; NATIONAL EYE INSTITUTE [R01EY022714] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Knights Templar Eye Foundation grant; King Khaled Eye Specialist Hospital-Johns Hopkins University collaboration grant; National Academy of Sciences, Washington DC USA; Higher Education Commission, Islamabad Pakistan(Higher Education Commission of Pakistan); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported in part by the National Eye Institute, grant R01EY022714 (SAR), the Knights Templar Eye Foundation grant (SAR), King Khaled Eye Specialist Hospital-Johns Hopkins University collaboration grant (SAR), the National Academy of Sciences, Washington DC USA, and the Higher Education Commission, Islamabad Pakistan.	Abu Safieh L, 2009, MOL VIS, V15, P980; Aldahmesh MA, 2012, HUM MUTAT, V33, P960, DOI 10.1002/humu.22071; Arneson ML, 1998, EXP EYE RES, V66, P495, DOI 10.1006/exer.1998.0477; Butt T, 2007, MOL VIS, V13, P1635; Chen JJ, 2011, AM J HUM GENET, V88, P827, DOI 10.1016/j.ajhg.2011.05.008; Chen T, 2002, MOL VIS, V8, P372; Cohen D, 2007, INVEST OPHTH VIS SCI, V48, P2208, DOI 10.1167/iovs.06-1019; GUTEKUNST KA, 1990, CURR EYE RES, V9, P955, DOI 10.3109/02713689009069931; Heon E, 2001, AM J HUM GENET, V68, P772, DOI 10.1086/318798; Jiao XD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157005; Jiaox X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137973; Kaul H, 2010, MOL VIS, V16, P511; Kaul H, 2010, MOL VIS, V16, P240; Khan SY, 2015, INVEST OPHTH VIS SCI, V56, P4919, DOI 10.1167/iovs.14-16253; Lachke SA, 2011, SCIENCE, V331, P1571, DOI 10.1126/science.1195970; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LOUIS CF, 1989, J BIOL CHEM, V264, P19967; Maher GJ, 2012, EXP EYE RES, V103, P115, DOI 10.1016/j.exer.2011.08.006; MERIN S, 1971, CAN J OPHTHALMOLOGY, V6, P178; MULDERS JWM, 1988, CURR EYE RES, V7, P207, DOI 10.3109/02713688808995750; Ponnam SPG, 2008, MOL VIS, V14, P1204; Ponnam SPG, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.050138; Pras E, 2000, INVEST OPHTH VIS SCI, V41, P3511; Pras E, 2004, INVEST OPHTH VIS SCI, V45, P1940, DOI 10.1167/iovs.03-1117; Pras E, 2002, AM J HUM GENET, V70, P1363, DOI 10.1086/340318; Pras E, 2001, ISR MED ASSOC J, V3, P559; Ramachandran RD, 2007, HUM GENET, V121, P475, DOI 10.1007/s00439-006-0319-6; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P2100, DOI 10.1167/iovs.04-1481; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P623, DOI 10.1167/iovs.04-0955; ROBINSON GC, 1987, AM J DIS CHILD, V141, P1321, DOI 10.1001/archpedi.1987.04460120087041; Sabir N, 2010, MOL VIS, V16, P2911; Sabir N, 2010, MOL VIS, V16, P2634; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Shi YR, 2011, INVEST OPHTH VIS SCI, V52, P7332, DOI 10.1167/iovs.11-7724; Shiels A, 2007, ARCH OPHTHALMOL-CHIC, V125, P165, DOI 10.1001/archopht.125.2.165; Smaoui N, 2004, INVEST OPHTH VIS SCI, V45, P2716, DOI 10.1167/iovs.03-1370; Steele E C Jr, 1997, Mol Vis, V3, P5; TENBROEK E, 1992, J CELL SCI, V103, P245; Yasmeen A, 2010, MOL VIS, V16, P682; Zhao L, 2015, NATURE, V523, P607, DOI 10.1038/nature14650; Zhou L, 2001, MOL VIS, V7, P79	41	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0162620	10.1371/journal.pone.0162620	http://dx.doi.org/10.1371/journal.pone.0162620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814360	gold, Green Published, Green Submitted			2022-12-26	WOS:000386911100002
J	Mank, A; van Zanten, HA; Meyer, MP; Pauws, S; Lopriore, E; te Pas, AB				Mank, Arenda; van Zanten, Henriette A.; Meyer, Michael P.; Pauws, Steffen; Lopriore, Enrico; te Pas, Arjan B.			Hypothermia in Preterm Infants in the First Hours after Birth: Occurrence, Course and Risk Factors	PLOS ONE			English	Article							WEIGHT INFANTS; TEMPERATURE; NEWBORNS; CARE; ADMISSION; OUTCOMES; DEATH	Background Hypothermia is associated with increased morbidity and mortality rates. Preterm infants frequently have hypothermia when they are admitted to the NICU, but there is no data on the occurrence of hypothermia during the first hours after admission. Objective To investigate the occurrence of hypothermia in preterm infants in the first three hours of admission and to identify risk factors. Methods Infants < 32 weeks of gestation included in a randomized trial with admission temperature as primary outcome were retrospectively analyzed for the occurrence of hypothermia (< 36.5 E degrees C) in the first three hours after admission. Risk factors were identified using linear regression analysis and logistic regression. Results In total 80 infants were included with a median (IQR) gestational age at birth of 29 (27-30) weeks. In 93% of the infants hypothermia occurred in the first three hours after admission. The median (IQR) duration of hypothermia was 101 (34-162) minutes, of which 24 (7-52) minutes the hypothermia was mild, 45 (4-111) minutes moderate, severe hypothermia hardly occurred. Gestational age and the occurrence of hypothermia at birth were independent risk factors for the occurrence of moderate and severe hypothermia and significantly correlated with duration of hypothermia. Conclusions Hypothermia occurred often and for a long period in preterm infants in the first three hours of life, low gestational age and admission temperature were independent risk factors	[Mank, Arenda; van Zanten, Henriette A.; Lopriore, Enrico; te Pas, Arjan B.] Leiden Univ, Med Ctr, Dept Pediat, Div Neonatol, Leiden, Netherlands; [Meyer, Michael P.] Middlemore Hosp, Div Neonatol, Dept Pediat, Auckland, New Zealand; [Pauws, Steffen] Philips Res Healthcare, Eindhoven, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Philips; Philips Healthcare	te Pas, AB (corresponding author), Leiden Univ, Med Ctr, Dept Pediat, Div Neonatol, Leiden, Netherlands.	a.b.te_pas@lumc.nl	Lopriore, Enrico/ABE-3576-2021; pas, arjan te/AAA-9019-2020	Lopriore, Enrico/0000-0002-3513-5066; pas, arjan te/0000-0001-7831-8797				de Almeida MFB, 2014, J PEDIATR-US, V164, P271, DOI 10.1016/j.jpeds.2013.09.049; Costeloe K, 2000, PEDIATRICS, V106, P659, DOI 10.1542/peds.106.4.659; DAGA AS, 1991, J TROP PEDIATRICS, V37, P53, DOI 10.1093/tropej/37.2.53; Gentles TL, 1997, J THORAC CARDIOV SUR, V114, P392, DOI 10.1016/S0022-5223(97)70184-3; Helder OK, 2012, ACTA PAEDIATR, V101, pe240, DOI 10.1111/j.1651-2227.2011.02583.x; JOHANSON RB, 1992, ACTA PAEDIATR, V81, P859, DOI 10.1111/j.1651-2227.1992.tb12123.x; Laptook AR, 2007, PEDIATRICS, V119, pE643, DOI 10.1542/peds.2006-0943; McCall EM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004210.pub4; Meyer MP, 2001, PEDIATRICS, V108, P395, DOI 10.1542/peds.108.2.395; Miller SS, 2011, J PERINATOL, V31, pS49, DOI 10.1038/jp.2010.177; Pas ABT, 2010, PEDIATRICS, V125, pE1427, DOI 10.1542/peds.2009-2656; Perlman JM, 2006, PEDIATRICS, V117, pE978, DOI 10.1542/ped.2006-0350; SARMAN I, 1989, ARCH DIS CHILD, V64, P687, DOI 10.1136/adc.64.5.687; Silveira SMD, 2003, J TROP PEDIATRICS, V49, P115, DOI 10.1093/tropej/49.2.115; *WHO, 1993, THERM CONTR NEWB PRA	15	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164817	10.1371/journal.pone.0164817	http://dx.doi.org/10.1371/journal.pone.0164817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812148	Green Submitted, gold, Green Published			2022-12-26	WOS:000386910000013
J	Aw-Yong, KL; Sam, IC; Koh, MT; Chan, YF				Aw-Yong, Kam Leng; Sam, I-Ching; Koh, Mia Tuang; Chan, Yoke Fun			Immunodominant IgM and IgG Epitopes Recognized by Antibodies Induced in Enterovirus A71-Associated Hand, Foot and Mouth Disease Patients	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODY; 71 VACCINE; SYNTHETIC PEPTIDE; INFECTION; IDENTIFICATION; PROTECTION; CHILDREN; MALAYSIA	Enterovirus A71 (EV-A71) is one of the main causative agents of hand, foot and mouth disease (HFMD). Unlike other enteroviruses that cause HFMD, EV-A71 is more frequently associated with severe neurological complications and fatality. To date, no effective licensed antivirals are available to combat EV-A71 infection. Little is known about the immunogenicity of viral non-structural proteins in humans. Previous studies have mainly focused on characterization of epitopes of EV-A71 structural proteins by using immunized animal antisera. In this study, we have characterized human antibody responses against the structural and non-structural proteins of EV-A71. Each viral protein was cloned and expressed in either bacterial or mammalian systems, and tested with antisera by western blot. Results revealed that all structural proteins (VP1-4), and non-structural proteins 2A, 3C and 3D were targets of EV-A71 IgM, whereas EV-A71 IgG recognized all the structural and non-structural proteins. Sixty three synthetic peptides predicted to be immunogenic in silico were synthesized and used for the characterization of EV-A71 linear B-cell epitopes. In total, we identified 22 IgM and four IgG dominant epitopes. Synthetic peptide PEP27, corresponding to residues 142 - 156 of VP1, was identified as the EV-A71 IgM-specific immunodominant epitope. PEP23, mapped to VP1 41 - 55, was recognized as the EV-A71 IgG cross-reactive immunodominant epitope. The structural protein VP1 is the major immunodominant site targeted by anti-EV-A71 IgM and IgG antibodies, but epitopes against non-structural proteins were also detected. These data provide new understanding of the immune response to EV-A71 infection, which benefits the development of diagnostic tools, potential therapeutics and subunit vaccine candidates.	[Aw-Yong, Kam Leng; Sam, I-Ching; Chan, Yoke Fun] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia; [Koh, Mia Tuang] Univ Malaya, Fac Med, Dept Paediat, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya	Chan, YF (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia.	chanyf@ummc.edu.my	Sam, Jamal I-Ching/B-8688-2010; KOH, MIA TUANG/B-8797-2010; abubakar, sazaly/B-3957-2010; Chan, Yoke Fun/B-5351-2010; Ibrahim, Essam Hassan/G-1960-2018	Sam, Jamal I-Ching/0000-0002-1296-7898; abubakar, sazaly/0000-0002-9267-1420; Chan, Yoke Fun/0000-0001-7089-0510; Ibrahim, Essam Hassan/0000-0003-0130-2257; Aw-Yong, Kam Leng/0000-0002-6418-7287	University of Malaya [E000013-20001, RG522-13HTM, PG036-2013B]	University of Malaya(Universiti Malaya)	This study was supported by grants from the University of Malaya (High Impact Research Grant E000013-20001, University Malaya Research Grant RG522-13HTM and Postgraduate Research Grant PG036-2013B).	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; AbuBakar S, 2009, EMERG INFECT DIS, V15, P79, DOI 10.3201/eid1501.080264; Aw-Yong KL, 2016, TROP BIOMED, V33, P238; Bergmann IE, 2003, ARCH VIROL, V148, P891, DOI 10.1007/s00705-002-0965-5; Bronsvoort Barend M deC, 2006, BMC Vet Res, V2, P30, DOI 10.1186/1746-6148-2-30; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Cao RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064024; Cao RY, 2010, CLIN INFECT DIS, V50, P125, DOI 10.1086/649012; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan YF, 2011, NEUROL ASIA, V16, P1; Chang HW, 2011, J VIROL METHODS, V173, P189, DOI 10.1016/j.jviromet.2011.02.003; Clavijo A, 2004, VET J, V167, P9, DOI 10.1016/S1090-0233(03)00087-X; Deng YQ, 2015, APPL MICROBIOL BIOT, V99, P7663, DOI 10.1007/s00253-015-6652-8; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Foo DGW, 2008, VIRAL IMMUNOL, V21, P215, DOI 10.1089/vim.2007.0089; Foo DGW, 2007, MICROBES INFECT, V9, P1299, DOI 10.1016/j.micinf.2007.06.002; Gao F, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-26; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; HAGIWARA A, 1978, INTERVIROLOGY, V9, P60, DOI 10.1159/000148922; Hofmeister Y, 2011, J VIROL, V85, P1896, DOI 10.1128/JVI.02155-10; Hosoya M, 2006, PEDIATR INFECT DIS J, V25, P691, DOI 10.1097/01.inf.0000227959.89339.c3; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Jiang LP, 2015, VACCINE, V33, P6596, DOI 10.1016/j.vaccine.2015.10.104; Kam YW, 2012, J VIROL, V86, P13005, DOI 10.1128/JVI.01780-12; Kiener TK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002895; Kiener TK, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-55; Lee H, 2013, J VIROL, V87, P11363, DOI 10.1128/JVI.01926-13; Li RC, 2014, NEW ENGL J MED, V370, P829, DOI 10.1056/NEJMoa1303224; Li XL, 2009, BIOCHEM BIOPH RES CO, V390, P1126, DOI 10.1016/j.bbrc.2009.09.103; Lim XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029751; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Ma LN, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-419; NikNadia NMN, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004562; NikNadia NMN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148767; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rodrigo WWSI, 2009, VIROLOGY, V394, P175, DOI 10.1016/j.virol.2009.09.024; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shingler KL, 2015, J VIROL, V89, P1900, DOI 10.1128/JVI.03098-14; Sorensen KJ, 2005, ARCH VIROL, V150, P805, DOI 10.1007/s00705-004-0455-z; Tan CW, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-14; Tan SG, 2013, J IMMUNOL, V191, P1637, DOI 10.4049/jimmunol.1301439; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Xu LF, 2014, THERANOSTICS, V4, P498, DOI 10.7150/thno.7457; YANG C, 2011, BMC BIOINFORMATICS, V12, DOI DOI 10.1186/1743-422X-8-306; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu FC, 2013, LANCET, V381, P2024, DOI 10.1016/S0140-6736(13)61049-1; Zhu FC, 2014, NEW ENGL J MED, V370, P818, DOI 10.1056/NEJMoa1304923	49	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165659	10.1371/journal.pone.0165659	http://dx.doi.org/10.1371/journal.pone.0165659			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806091	Green Published, gold, Green Submitted			2022-12-26	WOS:000386715500047
J	Raffray, L; Giry, C; Vandroux, D; Kuli, B; Randrianjohany, A; Pequin, AM; Renou, F; Jaffar-Bandjee, MC; Gasque, P				Raffray, Loic; Giry, Claude; Vandroux, David; Kuli, Barbara; Randrianjohany, Andry; Pequin, Anne-Marie; Renou, Frederic; Jaffar-Bandjee, Marie-Christine; Gasque, Philippe			Major Neutrophilia Observed in Acute Phase of Human Leptospirosis Is Not Associated with Increased Expression of Granulocyte Cell Activation Markers	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; CHEMOKINE RECEPTOR; INFLAMMATION; LEUKOCYTES; MIGRATION; CORRELATE; CXCR2	It has long been known that pathogenic Leptospira can mobilize the immune system but the specific contribution of neutrophils to control the infectious challenge remains to be clarified. We herein analyzed the phenotype of circulating neutrophils of patients with leptospirosis and healthy controls for the expression of toll-like receptor (TLR) type 2 (TLR2, to sense the leptospiral LPS) and several activation markers: interleukin 8 chemokine receptor CD182 (CXCR2), CD11b of the integrin/opsonin complement receptor type 3 (CR3) and CD15 (ligand of the selectin). The plasmatic level of the main CD182 ligand, interleukin 8 (CXCL8), was measured by ELISA. Hospitalized leptospirosis cases showed marked neutrophilia, particularly in the most severe cases. Interestingly, TLR2 was significantly increased in leptospirosis but identical levels of CD182 and CD11b were detected when compared to controls. CD15 was significantly decreased on neutrophils in leptospirosis but returned to normal within 1 month. Basal levels of IL-8 were measured in control subjects and were not increased in leptospirosis cases at the initial stage of the disease. In conclusion, we observed that neutrophils failed to regulate the expression of several of the receptors involved in cell activation and recruitment. This study further emphasizes the paradigm that neutrophils may be impaired in their overall capacity to thwart bacterial infection in leptospirosis patients.	[Raffray, Loic; Giry, Claude; Jaffar-Bandjee, Marie-Christine; Gasque, Philippe] Univ La Reunion, Unite Mixte Proc Infectieux Milieu Insulaire Trop, Plateforme Technol CYROI, CNRS 9192,INSERM U1187,IRD 249,CHU La Reunion, St Clotilde, Reunion, France; [Raffray, Loic; Gasque, Philippe] CHU La Reunion Site Felix Guyon, Lab Immunol Clin & Expt ZOI LICE OI, St Denis, Reunion, France; [Raffray, Loic; Renou, Frederic] CHU La Reunion Site Felix Guyon, Internal Med Unit, St Denis, Reunion, France; [Giry, Claude; Jaffar-Bandjee, Marie-Christine] CHU La Reunion Site Felix Guyon, Microbiol Virol Lab, St Denis, Reunion, France; [Vandroux, David] CHU La Reunion Site Felix Guyon, Intens Care Unit, St Denis, Reunion, France; [Kuli, Barbara] CHU La Reunion Site Felix Guyon, Infect Dis Unit, St Denis, Reunion, France; [Randrianjohany, Andry] GHER Hosp, Internal Med Unit, St Benoit, Reunion, France; [Pequin, Anne-Marie] CHU La Reunion Site Felix Guyon, Hematol Lab, St Denis, Reunion, France	CHU Reunion; Institut National de la Sante et de la Recherche Medicale (Inserm); University of La Reunion; CHU Reunion; CHU Reunion; CHU Reunion; CHU Reunion; CHU Reunion; CHU Reunion	Raffray, L (corresponding author), Univ La Reunion, Unite Mixte Proc Infectieux Milieu Insulaire Trop, Plateforme Technol CYROI, CNRS 9192,INSERM U1187,IRD 249,CHU La Reunion, St Clotilde, Reunion, France.; Raffray, L (corresponding author), CHU La Reunion Site Felix Guyon, Lab Immunol Clin & Expt ZOI LICE OI, St Denis, Reunion, France.; Raffray, L (corresponding author), CHU La Reunion Site Felix Guyon, Internal Med Unit, St Denis, Reunion, France.	loic.raffray@chu-reunion.fr	Vandroux, David/AAK-2574-2020		"Contrat de Projets Etat-Region/Fonds Europeen de Developpement Regional" (CPER/FEDER) [32648]	"Contrat de Projets Etat-Region/Fonds Europeen de Developpement Regional" (CPER/FEDER)	This study was supported financially by "Contrat de Projets Etat-Region/Fonds Europeen de Developpement Regional" (CPER/FEDER), grant number 32648 coordinated by PG.	Alves JC, 2008, SHOCK, V30, P3, DOI 10.1097/SHK.0b013e3181818466; Alves JC, 2009, P NATL ACAD SCI USA, V106, P4018, DOI 10.1073/pnas.0900196106; Araujo AM, 2014, AM J TROP MED HYG, V90, P719, DOI 10.4269/ajtmh.13-0667; Atzingen MV, 2009, J INFECTION, V59, P264, DOI 10.1016/j.jinf.2009.07.010; Bernardi FD, 2012, HUM PATHOL, V43, P1601, DOI 10.1016/j.humpath.2011.11.017; Cedola M, 2015, ACTA TROP, V146, P73, DOI 10.1016/j.actatropica.2015.03.007; Chishti AD, 2004, INTENS CARE MED, V30, P605, DOI 10.1007/s00134-004-2175-y; CINCO M, 1993, J GEN MICROBIOL, V139, P2959, DOI 10.1099/00221287-139-12-2959; Cinco M, 2000, J MOL MICROB BIOTECH, V2, P575; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; Craig SB, 2013, TROP BIOMED, V30, P579; Craig SB, 2009, ANN TROP MED PARASIT, V103, P333, DOI 10.1179/136485909X435058; Cummings CJ, 1999, J IMMUNOL, V162, P2341; De Silva Nipun Lakshitha, 2014, Int Arch Med, V7, P31, DOI 10.1186/1755-7682-7-31; DOBRINA A, 1995, INFECT IMMUN, V63, P2995, DOI 10.1128/IAI.63.8.2995-2999.1995; Fortunati E, 2009, CLIN EXP IMMUNOL, V155, P559, DOI 10.1111/j.1365-2249.2008.03791.x; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; Goeijenbier M, 2015, J INFECTION, V71, P437, DOI 10.1016/j.jinf.2015.05.016; Goris MGA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018279; Harter L, 2004, SHOCK, V22, P403, DOI 10.1097/01.shk.0000142256.23382.5d; Januszkiewicz A, 2002, CLIN EXP IMMUNOL, V130, P263, DOI 10.1046/j.1365-2249.2002.01983.x; Jean-Baptiste Eddy, 2007, J Intensive Care Med, V22, P63, DOI 10.1177/0885066606297123; Kyriakidis I, 2011, CYTOKINE, V54, P117, DOI 10.1016/j.cyto.2011.01.014; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Levett PN, 2005, J MED MICROBIOL, V54, P45, DOI 10.1099/jmm.0.45860-0; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Meri T, 2005, MICROB PATHOGENESIS, V39, P139, DOI 10.1016/j.micpath.2005.07.003; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Murgia R, 2002, INFECT IMMUN, V70, P7172, DOI 10.1128/IAI.70.12.7172-7175.2002; Papa A, 2015, T ROY SOC TROP MED H, V109, P749, DOI 10.1093/trstmh/trv095; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Raffray L, 2015, MICROBES INFECT, V17, P451, DOI 10.1016/j.micinf.2015.04.001; Reis EAG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002457; Remick DG, 2005, CRIT CARE MED, V33, pS466, DOI 10.1097/01.CCM.0000186783.34908.18; Rizvi M, 2011, ANN TROP MED PARASIT, V105, P499, DOI 10.1179/1364859411Y.0000000041; Russwurm S, 2002, SHOCK, V17, P263, DOI 10.1097/00024382-200204000-00004; Sabroe I, 2005, CLIN INFECT DIS, V41, pS421, DOI 10.1086/431992; Sabroe I, 2005, IMMUNOLOGY, V115, P90, DOI 10.1111/j.1365-2567.2005.02133.x; Sabroe I, 2002, J IMMUNOL, V168, P4701, DOI 10.4049/jimmunol.168.9.4701; Scharrig E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003927; SCOCCHI M, 1993, INFECT IMMUN, V61, P3081, DOI 10.1128/IAI.61.7.3081-3083.1993; Stadtmann A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00263; Troxell B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084625; Wagenaar JFP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000453; WANG B, 1984, INFECT IMMUN, V44, P459, DOI 10.1128/IAI.44.2.459-464.1984; Weinschenk NP, 2000, J PEDIATR-US, V137, P345, DOI 10.1067/mpd.2000.107846; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354	48	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165716	10.1371/journal.pone.0165716	http://dx.doi.org/10.1371/journal.pone.0165716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802348	Green Submitted, Green Published, gold			2022-12-26	WOS:000386714200044
J	Lopata, A; Leveles, I; Bendes, AA; Viskolcz, B; Vertessy, BG; Jojart, B; Toth, J				Lopata, Anna; Leveles, Ibolya; Bendes, Abris Adam; Viskolcz, Bela; Vertessy, Beata G.; Jojart, Balazs; Toth, Judit			A Hidden Active Site in the Potential Drug Target Mycobacterium tuberculosis dUTPase Is Accessible through Small Amplitude Protein Conformational Changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PHOSPHATE ESTER HYDROLYSIS; INFECTIOUS-ANEMIA VIRUS; ESCHERICHIA-COLI; CATALYTIC MECHANISM; RANDOM ACCELERATION; C-TERMINUS; CYTOCHROME P450CAM; TRIMERIC DUTPASES; COUPLED RECEPTOR	dUTPases catalyze the hydrolysis of dUTP into dUMP and pyrophosphate to maintain the proper nucleotide pool for DNA metabolism. Recent evidence suggests that dUTPases may also represent a selective drug target in mycobacteria because of the crucial role of these enzymes in maintaining DNA integrity. Nucleotide-hydrolyzing enzymes typically harbor a buried ligand-binding pocket at interdomain or intersubunit clefts, facilitating proper solvent shielding for the catalyzed reaction. The mechanism by which substrate binds this hidden pocket and product is released in dUTPases is unresolved because of conflicting crystallographic and spectroscopic data. We sought to resolve this conflict by using a combination of random acceleration molecular dynamics (RAMD) methodology and structural and biochemical methods to study the dUTPase from Mycobacterium tuberculosis. In particular, the RAMD approach used in this study provided invaluable insights into the nucleotide dissociation process that reconciles all previous experimental observations. Specifically, our data suggest that nucleotide binding takes place as a small stretch of amino acids transiently slides away and partially uncovers the active site. The in silico data further revealed a new dUTPase conformation on the pathway to a relatively open active site. To probe this model, we developed the Trp(21) reporter and collected crystallographic, spectroscopic, and kinetic data that confirmed the interaction of Trp(21) with the active site shielding C-terminal arm, suggesting that the RAMD method is effective. In summary, our computational simulations and spectroscopic results support the idea that small loop movements in dUTPase allow the shuttling of the nucleotides between the binding pocket and the solvent.	[Lopata, Anna; Leveles, Ibolya; Bendes, Abris Adam; Vertessy, Beata G.; Toth, Judit] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Magyar Tudosok Korutja 2, H-1117 Budapest, Hungary; [Viskolcz, Bela] Univ Miskolc, Inst Chem, H-3529 Miskolc, Hungary; [Vertessy, Beata G.] Budapest Univ Technol & Econ, Dept Appl Biotechnol, H-1111 Budapest, Hungary; [Jojart, Balazs] Univ Szeged, Dept Chem Informat, H-6725 Szeged, Hungary; [Lopata, Anna] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Lopata, Anna] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Bendes, Abris Adam] Univ Oulu, Fac Biochem & Mol Med, Oulu 90014, Finland; [Bendes, Abris Adam] Univ Oulu, Bioctr Oulu, Oulu 90014, Finland	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Miskolc; Budapest University of Technology & Economics; Szeged University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Leeds; University of Oulu; University of Oulu	Toth, J (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Magyar Tudosok Korutja 2, H-1117 Budapest, Hungary.	toth.judit@ttk.mta.hu	Viskolcz, Bela/R-3927-2017; Viskolcz, Béla/Q-6225-2019; Vertessy, Beata G/H-6202-2012	Viskolcz, Bela/0000-0002-0777-9569; Viskolcz, Béla/0000-0002-0777-9569; Vertessy, Beata G./0000-0002-1288-2982; Bendes, Abris Adam/0000-0002-1335-6183	National Institutes of Health [1R01TW008130]; National Research, Development and Innovation Office Hungarian Scientific Research Fund Grants OTKA [K109486, K115993, K119493]; Hungarian Academy of Sciences MedInProt Program; International Centre for Genetic Engineering and Biotechnology (ICGEB) Research Grant [CRP/HUN14-01]; Hungarian Scientific Research Funds; Hungarian Academy of Sciences; FOGARTY INTERNATIONAL CENTER [R01TW008130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research, Development and Innovation Office Hungarian Scientific Research Fund Grants OTKA; Hungarian Academy of Sciences MedInProt Program; International Centre for Genetic Engineering and Biotechnology (ICGEB) Research Grant; Hungarian Scientific Research Funds(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by National Institutes of Health Grant 1R01TW008130; National Research, Development and Innovation Office Hungarian Scientific Research Fund Grants OTKA K109486, K115993, and K119493; the Hungarian Academy of Sciences MedInProt Program; International Centre for Genetic Engineering and Biotechnology (ICGEB) Research Grant CRP/HUN14-01; and Hungarian Scientific Research Funds. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Recipient of the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. To whom correspondence should be addressed: Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Magyar tudosok korutja 2, Budapest, Hungary, H1117. Tel.: 36-1-3826707; Fax: 36-1-4631401; E-mail: toth.judit@ttk.mta.hu.	Tormo-Mas MA, 2010, NATURE, V465, P779, DOI 10.1038/nature09065; Barabas O, 2004, J BIOL CHEM, V279, P42907, DOI 10.1074/jbc.M406135200; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Chan S, 2004, J MOL BIOL, V341, P503, DOI 10.1016/j.jmb.2004.06.028; Cojocaru V, 2012, CURR DRUG METAB, V13, P143, DOI 10.2174/138920012798918462; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dror RO, 2013, NATURE, V503, P295, DOI 10.1038/nature12595; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fiser A, 2000, BIOCHEM BIOPH RES CO, V279, P534, DOI 10.1006/bbrc.2000.3994; Freeman L, 2009, J BIOL CHEM, V284, P25280, DOI 10.1074/jbc.M109.019315; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Gao M, 2002, J MOL BIOL, V323, P939, DOI 10.1016/S0022-2836(02)01001-X; Garcia-Nafria J, 2010, ACTA CRYSTALLOGR D, V66, P953, DOI 10.1107/S0907444910026272; Gervasio FL, 2006, J MOL BIOL, V361, P390, DOI 10.1016/j.jmb.2006.06.034; Gonzalez A, 2001, ACTA CRYSTALLOGR D, V57, P767, DOI 10.1107/S0907444901004255; Grazioso G, 2012, J AM CHEM SOC, V134, P453, DOI 10.1021/ja208485w; Hill RLL, 2016, J MOL BIOL, V428, P142, DOI 10.1016/j.jmb.2015.11.009; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kalyaanamoorthy S, 2012, J CHEM INF MODEL, V52, P589, DOI 10.1021/ci200584f; Klvana M, 2009, J MOL BIOL, V392, P1339, DOI 10.1016/j.jmb.2009.06.076; Larsson G, 1996, J BIOL CHEM, V271, P24010, DOI 10.1074/jbc.271.39.24010; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Ludemann SK, 2000, J MOL BIOL, V303, P813, DOI 10.1006/jmbi.2000.4155; Ludemann SK, 2000, J MOL BIOL, V303, P797, DOI 10.1006/jmbi.2000.4154; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mol CD, 1996, STRUCTURE, V4, P1077, DOI 10.1016/S0969-2126(96)00114-1; Muha V, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002738; Nemeth-Pongracz V, 2007, NUCLEIC ACIDS RES, V35, P495, DOI 10.1093/nar/gkl1074; Niu YZ, 2016, PHYS CHEM CHEM PHYS, V18, P5622, DOI 10.1039/c5cp06257h; Nord J, 2001, FEBS LETT, V492, P228, DOI 10.1016/S0014-5793(01)02257-8; Nord J, 2000, FEBS LETT, V472, P312, DOI 10.1016/S0014-5793(00)01453-8; Pecsi I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037461; Pecsi I, 2011, P NATL ACAD SCI USA, V108, P14437, DOI 10.1073/pnas.1013872108; Pecsi I, 2010, NUCLEIC ACIDS RES, V38, P7179, DOI 10.1093/nar/gkq584; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pietra F, 2013, CHEM BIODIVERS, V10, P556, DOI 10.1002/cbdv.201200434; Prasad GS, 2000, ACTA CRYSTALLOGR D, V56, P1100, DOI 10.1107/S0907444900009197; Sablin EP, 2001, CURR OPIN STRUC BIOL, V11, P716, DOI 10.1016/S0959-440X(01)00265-2; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; Shan YB, 2011, J AM CHEM SOC, V133, P9181, DOI 10.1021/ja202726y; Shao H, 1997, BBA-PROTEIN STRUCT M, V1339, P181, DOI 10.1016/S0167-4838(96)00229-4; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; Szabo JE, 2014, NUCLEIC ACIDS RES, V42, P11912, DOI 10.1093/nar/gku882; Takacs E, 2010, FEBS LETT, V584, P3047, DOI 10.1016/j.febslet.2010.05.018; Takacs E, 2009, FEBS LETT, V583, P865, DOI 10.1016/j.febslet.2009.02.011; Tarbouriech N, 2005, STRUCTURE, V13, P1299, DOI 10.1016/j.str.2005.06.009; Thomas T, 2016, J CHEM INF MODEL, V56, P308, DOI 10.1021/acs.jcim.5b00457; Toth J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706230200; Varga B, 2008, BIOCHEM BIOPH RES CO, V373, P8, DOI 10.1016/j.bbrc.2008.05.130; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Vertessy BG, 2009, ACCOUNTS CHEM RES, V42, P97, DOI 10.1021/ar800114w; Vertessy BG, 1997, PROTEINS, V28, P568, DOI 10.1002/(SICI)1097-0134(199708)28:4<568::AID-PROT10>3.0.CO;2-E; Vertessy BG, 1998, FEBS LETT, V421, P83, DOI 10.1016/S0014-5793(97)01545-7; Wang T, 2007, J AM CHEM SOC, V129, P6970, DOI 10.1021/ja0691977; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang SW, 2016, BBA-PROTEINS PROTEOM, V1864, P42, DOI 10.1016/j.bbapap.2015.10.007; Zhang JQ, 2015, SOFT MATTER, V11, P6633, DOI 10.1039/c5sm01028d; Zhuang SL, 2013, J MOL GRAPH MODEL, V44, P155, DOI 10.1016/j.jmgm.2013.06.001	66	7	7	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26320	26331		10.1074/jbc.M116.734012	http://dx.doi.org/10.1074/jbc.M116.734012			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27815500	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000391568200007
J	Cheok, J; Pressey, RL; Weeks, R; Andrefouet, S; Moloney, J				Cheok, Jessica; Pressey, Robert L.; Weeks, Rebecca; Andrefouet, Serge; Moloney, James			Sympathy for the Devil: Detailing the Effects of Planning-Unit Size, Thematic Resolution of Reef Classes, and Socioeconomic Costs on Spatial Priorities for Marine Conservation	PLOS ONE			English	Article							PROTECTED AREAS; BIODIVERSITY CONSERVATION; OPPORTUNITY COSTS; RESERVE SELECTION; LAND CLASSES; SCALE; REPRESENTATION; ECOREGIONS; SURROGATES; DESIGN	Spatial data characteristics have the potential to influence various aspects of prioritising bio-diversity areas for systematic conservation planning. There has been some exploration of the combined effects of size of planning units and level of classification of physical environments on the pattern and extent of priority areas. However, these data characteristics have yet to be explicitly investigated in terms of their interaction with different socioeconomic cost data during the spatial prioritisation process. We quantify the individual and interacting effects of three factors-planning-unit size, thematic resolution of reef classes, and spatial variability of socioeconomic costs-on spatial priorities for marine conservation, in typical marine planning exercises that use reef classification maps as a proxy for biodiversity. We assess these factors by creating 20 unique prioritisation scenarios involving combinations of different levels of each factor. Because output data from these scenarios are analogous to ecological data, we applied ecological statistics to determine spatial similarities between reserve designs. All three factors influenced prioritisations to different extents, with cost variability having the largest influence, followed by planning-unit size and thematic resolution of reef classes. The effect of thematic resolution on spatial design depended on the variability of cost data used. In terms of incidental representation of conservation objectives derived from finer-resolution data, scenarios prioritised with uniform cost outperformed those prioritised with variable cost. Following our analyses, we make recommendations to help maximise the spatial and cost efficiency and potential effectiveness of future marine conservation plans in similar planning scenarios. We recommend that planners: employ the smallest planning-unit size practical; invest in data at the highest possible resolution; and, when planning across regional extents with the intention of incidentally representing fine-resolution features, prioritise the whole region with uniform costs rather than using coarse-resolution data on variable costs.	[Cheok, Jessica; Pressey, Robert L.; Weeks, Rebecca] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Andrefouet, Serge] Univ Reunion, CNRS, Inst Rech Dev, Lab Excellence CORAIL,UMR ENTROPIE 9220, Noumea, New Caledonia; [Cheok, Jessica; Moloney, James] James Cook Univ, Coll Sci & Engn, Townsville, Qld 4811, Australia	James Cook University; Institut de Recherche pour le Developpement (IRD); James Cook University	Cheok, J (corresponding author), James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.; Cheok, J (corresponding author), James Cook Univ, Coll Sci & Engn, Townsville, Qld 4811, Australia.	jessica.cheok@my.jcu.edu.au		Weeks, Rebecca/0000-0002-0867-1007	Australian Research Council; James Cook University; US National Aeronautics and Space Administration (NASA); University of South Florida (USF, Institute for Marine Remote Sensing); Institut de Recherche Pour le Developpement (IRD) [UMR 9220 ENTROPIE]	Australian Research Council(Australian Research Council); James Cook University; US National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); University of South Florida (USF, Institute for Marine Remote Sensing); Institut de Recherche Pour le Developpement (IRD)	This study was funded by the Australian Research Council, and James Cook University. Millennium mapping products were funded by the US National Aeronautics and Space Administration (NASA), University of South Florida (USF, Institute for Marine Remote Sensing) and by Institut de Recherche Pour le Developpement (IRD, UMR 9220 ENTROPIE). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JC thanks Phil Bright from the Secretariat of the Pacific Community (SPC) for access to invaluable district-level population data and GIS shapefiles of census areas, Collin Storlie for help and advice on using the High Performance Computing facility at James Cook University, and Loic Thibaut for statistical advice. RLP and RW acknowledge funding from the Australian Research Council.	Adams VM, 2011, BIOL CONSERV, V144, P350, DOI 10.1016/j.biocon.2010.09.012; Adams VM, 2010, BIOL CONSERV, V143, P439, DOI 10.1016/j.biocon.2009.11.011; Alpine JE, 2007, MAR FRESHWATER RES, V58, P558, DOI 10.1071/MF06214; Andrefouet S., 2006, P 10 INT COR REEF S; [Anonymous], 2013, SPARCL PERFORM SPARS; [Anonymous], 2014, R LANG ENV STAT COMP; Ardron JA, 2010, CJ MARXAN GOOD PRACT, P165; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Ban NC, 2013, FRONT ECOL ENVIRON, V11, P194, DOI 10.1890/110205; Ban NC, 2009, MAR POLICY, V33, P794, DOI 10.1016/j.marpol.2009.02.011; Ban NC, 2009, CONSERV BIOL, V23, P899, DOI 10.1111/j.1523-1739.2009.01185.x; Ban NC, 2009, CONSERV LETT, V2, P206, DOI 10.1111/j.1755-263X.2009.00071.x; Beger M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9208; Bode M, 2008, P NATL ACAD SCI USA, V105, P6498, DOI 10.1073/pnas.0710705105; Bridge TCL, 2016, CONSERV BIOL, V30, P154, DOI 10.1111/cobi.12557; Carwardine J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002586; CNMI Department of Commerce, 2010, NO MAR ISL 2010 CENS; Dalleau M, 2010, CONSERV BIOL, V24, P541, DOI 10.1111/j.1523-1739.2009.01394.x; Deas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097409; Delavenne J, 2012, ICES J MAR SCI, V69, P75, DOI 10.1093/icesjms/fsr180; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Federated States of Micronesia Division of Statistics, 2010, 2010 CENS POP HOUS; Fiji Bureau of Statistics, 2007, 2007 CENS POP; Fjeldsa J, 2007, CONSERV BIOL, V21, P659, DOI 10.1111/j.1523-1739.2007.00706.x; Giakoumi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076449; Green A., 2013, DESIGNING MARINE PRO; Green A, 2009, ORYX, V43, P488, DOI 10.1017/S0030605309990342; Hamel MA, 2013, CONSERV LETT, V6, P46, DOI 10.1111/j.1755-263X.2012.00285.x; Horigue V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135789; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Justus J, 2008, CONSERV BIOL, V22, P673, DOI 10.1111/j.1523-1739.2008.00928.x; Juutinen A, 2004, FOREST SCI, V50, P527; KIRKPATRICK JB, 1994, CONSERV BIOL, V8, P217, DOI 10.1046/j.1523-1739.1994.08010217.x; Klein CJ, 2008, CONSERV BIOL, V22, P691, DOI 10.1111/j.1523-1739.2008.00896.x; Klein C, 2009, ECOL APPL, V19, P206, DOI 10.1890/07-1684.1; Klein CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012431; Larsen FW, 2003, BIODIVERS CONSERV, V12, P599, DOI 10.1023/A:1022448928753; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lombard AT, 2003, BIOL CONSERV, V112, P45, DOI 10.1016/S0006-3207(02)00422-6; Margules CR, 2002, J BIOSCIENCES, V27, P309, DOI 10.1007/BF02704962; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mazor T, 2014, ECOL APPL, V24, P1115, DOI 10.1890/13-1249.1; Miclat EFB, 2006, OCEAN COAST MANAGE, V49, P597, DOI 10.1016/j.ocecoaman.2006.06.019; Mills M, 2010, CONSERV LETT, V3, P291, DOI 10.1111/j.1755-263X.2010.00134.x; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Nhancale BA, 2011, BIODIVERS CONSERV, V20, P1821, DOI 10.1007/s10531-011-0063-7; Office of Planning and Statistics, 2005, 2005 CENS POP HOUS R; Oksanen J., **DATA OBJECT**; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Payet K, 2010, AUSTRAL ECOL, V35, P121, DOI 10.1111/j.1442-9993.2009.02014.x; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Poiani KA, 2000, BIOSCIENCE, V50, P133, DOI 10.1641/0006-3568(2000)050[0133:BCAMSF]2.3.CO;2; Pressey RL, 1998, BIOL CONSERV, V85, P305, DOI 10.1016/S0006-3207(97)00146-8; Pressey RL, 1995, CONSERV BIOL, V9, P1506, DOI 10.1046/j.1523-1739.1995.09061506.x; Pressey RL, 1999, J BIOGEOGR, V26, P179, DOI 10.1046/j.1365-2699.1999.00258.x; Pressey RL, 2013, BIOL CONSERV, V166, P155, DOI 10.1016/j.biocon.2013.06.025; Pressey RL, 2009, ORYX, V43, P464, DOI 10.1017/S0030605309990500; Republic of the Marshall Islands, 1999, CENS POP HOUS; Richardson EA, 2006, CONSERV BIOL, V20, P1191, DOI 10.1111/j.1523-1739.2006.00426.x; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Rouget M, 2006, CONSERV BIOL, V20, P549, DOI 10.1111/j.1523-1739.2006.00297.x; Rouget M, 2003, BIOL CONSERV, V112, P217, DOI 10.1016/S0006-3207(02)00415-9; Scholes RJ, 2013, CURR OPIN ENV SUST, V5, P16, DOI 10.1016/j.cosust.2013.01.004; Schroter M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112557; Selig ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082898; Shriner SA, 2006, ECOL APPL, V16, P1660, DOI 10.1890/1051-0761(2006)016[1660:RNBORH]2.0.CO;2; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; U.S. Census Bureau, 2010, 2010 CENS FOR GUAM; Van Wynsberge S, 2015, OCEAN COAST MANAGE, V116, P37, DOI 10.1016/j.ocecoaman.2015.06.031; Venter O, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001891; Warman LD, 2004, CONSERV BIOL, V18, P655, DOI 10.1111/j.1523-1739.2004.00538.x; Watson J.E.M., 2011, CONSERVATION BIOGEOG, P136, DOI [DOI 10.1002/9781444390001.CH6, 10.1002/9781444390001.ch6]; Weeks R, 2010, CONSERV LETT, V3, P445, DOI 10.1111/j.1755-263X.2010.00131.x; Weeks R, 2010, BIOL CONSERV, V143, P1236, DOI 10.1016/j.biocon.2010.02.031	77	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0164869	10.1371/journal.pone.0164869	http://dx.doi.org/10.1371/journal.pone.0164869			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829042	Green Published, Green Accepted, gold			2022-12-26	WOS:000387724300021
J	McNabb, RW; Womble, JN; Prakash, A; Gens, R; Haselwimmer, CE				McNabb, Robert W.; Womble, Jamie N.; Prakash, Anupma; Gens, Rudiger; Haselwimmer, Christian E.			Quantification and Analysis of Icebergs in a Tidewater Glacier Fjord Using an Object-Based Approach	PLOS ONE			English	Article							BAY NATIONAL-PARK; ALASKA; IMAGERY; ABUNDANCE; CLASSIFICATION; CONSERVATION	Tidewater glaciers are glaciers that terminate in, and calve icebergs into, the ocean. In addition to the influence that tidewater glaciers have on physical and chemical oceanography, floating icebergs serve as habitat for marine animals such as harbor seals (Phoca vitulina richardii). The availability and spatial distribution of glacier ice in the fjords is likely a key environmental variable that influences the abundance and distribution of selected marine mammals; however, the amount of ice and the fine-scale characteristics of ice in fjords have not been systematically quantified. Given the predicted changes in glacier habitat, there is a need for the development of methods that could be broadly applied to quantify changes in available ice habitat in tidewater glacier fjords. We present a case study to describe a novel method that uses object-based image analysis (OBIA) to classify floating glacier ice in a tidewater glacier fjord from high-resolution aerial digital imagery. Our objectives were to (i) develop workflows and rule sets to classify high spatial resolution airborne imagery of floating glacier ice; (ii) quantify the amount and fine-scale characteristics of floating glacier ice; (iii) and develop processes for automating the object-based analysis of floating glacier ice for large number of images from a representative survey day during June 2007 in Johns Hopkins Inlet (JHI), a tidewater glacier fjord in Glacier Bay National Park, southeastern Alaska. On 18 June 2007, JHI was comprised of brash ice ((x) over bar = 45.2%, SD = 41.5%), water ((x) over bar = 52.7%, SD = 42.3%), and icebergs ((x) over bar = 2.1%, SD = 1.4%). Average iceberg size per scene was 5.7 m(2) (SD = 2.6 m(2)). We estimate the total area (+/- uncertainty) of iceberg habitat in the fjord to be 455,400 +/- 123,000 m(2). The method works well for classifying icebergs across scenes (classification accuracy of 75.6%); the largest classification errors occur in areas with densely-packed ice, low contrast between neighboring ice cover, or dark or sediment-covered ice, where icebergs may be misclassified as brash ice about 20% of the time. OBIA is a powerful image classification tool, and the method we present could be adapted and applied to other ice habitats, such as sea ice, to assess changes in ice characteristics and availability.	[McNabb, Robert W.; Prakash, Anupma; Gens, Rudiger; Haselwimmer, Christian E.] Univ Alaska Fairbanks, Inst Geophys, Fairbanks, AK 99775 USA; [Womble, Jamie N.] Natl Pk Serv, Glacier Bay Field Stn, Juneau, AK 99801 USA; [McNabb, Robert W.] Univ Oslo, Dept Geosci, Oslo, Norway; [Haselwimmer, Christian E.] Chevron Energy Technol Co, San Ramon, CA USA	University of Alaska System; University of Alaska Fairbanks; United States Department of the Interior; University of Oslo; Chevron	Womble, JN (corresponding author), Natl Pk Serv, Glacier Bay Field Stn, Juneau, AK 99801 USA.	jamie_womble@nps.gov	Gens, Rudiger/ABE-8762-2021	Womble, Jamie/0000-0002-6635-1490; McNabb, Robert/0000-0003-0016-493X	Glacier Bay National Park [H991080028]; National Science Foundation grant [OIA-1208927]; National Park Service Coastal Cluster Program; Endeavour Fellowship Program; Alaska EPSCoR NSF award [OIA-1208927]	Glacier Bay National Park; National Science Foundation grant(National Science Foundation (NSF)); National Park Service Coastal Cluster Program; Endeavour Fellowship Program; Alaska EPSCoR NSF award	This study was supported by the Glacier Bay National Park Cooperative Ecosystem Studies Unit grant #H991080028 and National Science Foundation grant OIA-1208927. JNW was supported in part by the National Park Service Coastal Cluster Program and by the Endeavour Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded and supported by Glacier Bay National Park (GLBA) (CESU Award Number H991080028) and the National Park Service Coastal Cluster Program. Prakash would like to acknowledge the additional support from Alaska EPSCoR NSF award #OIA-1208927 and the state of Alaska. We would like to thank John Jansen (NOAA-NMML) for assistance in the implementation of the aerial survey method in Glacier Bay and for thoughtful discussions regarding harbor seals in tidewater glacier fjords. We are greatly appreciative to Avery Gast for safely conducting aerial surveys and assistance with acquiring airborne imagery. Evelina Augustsson (University of Karlstad) assisted with data processing and Chris Waigl (University of Alaska Fairbanks) provided assistance with plotting data. We would like to acknowledge Lisa Etherington and Scott Gende for supporting this project and John Jansen and Jay Ver Hoef for discussions related to harbor seals and ice.	Amundson JM, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001405; Arendt A, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000436; Arendt AA, 2002, SCIENCE, V297, P382, DOI 10.1126/science.1072497; Arimitsu ML, 2012, FISH OCEANOGR, V21, P148, DOI 10.1111/j.1365-2419.2012.00616.x; Barclay DJ, 2009, QUATERNARY SCI REV, V28, P2034, DOI 10.1016/j.quascirev.2009.01.016; Berthier E, 2010, NAT GEOSCI, V3, P92, DOI 10.1038/NGEO737; Blaschke T, 2010, ISPRS J PHOTOGRAMM, V65, P2, DOI 10.1016/j.isprsjprs.2009.06.004; Blaschke T, 2014, ISPRS J PHOTOGRAMM, V87, P180, DOI 10.1016/j.isprsjprs.2013.09.014; Blundell GM, 2011, MAR ECOL PROG SER, V429, P277, DOI 10.3354/meps09073; Bock Michael, 2005, Journal for Nature Conservation (Jena), V13, P75, DOI 10.1016/j.jnc.2004.12.002; CALAMBOKIDIS J, 1987, CAN J ZOOL, V65, P1391, DOI 10.1139/z87-219; Clift PD., 2011, EOS T AM GEOPHYS UN, V92, P205, DOI [10.1029/2011EO240006, DOI 10.1029/2011EO240006, 10.1029/2011EO370001, DOI 10.1029/2011EO370001]; Congalton R.G., 2008, ASSESSING ACCURACY R, V2nd, DOI [10.1201/9781420055139, DOI 10.1201/9781420055139]; Council NR, 2001, MAR PROT AR TOOLS SU; Evans W, 2014, BIOGEOSCIENCES, V11, P365, DOI 10.5194/bg-11-365-2014; Field WO, 1947, GEOGR REV, V37, P369, DOI 10.2307/211127; Goebel ME, 2015, POLAR BIOL, V38, P619, DOI 10.1007/s00300-014-1625-4; HALL DK, 1995, PHYS GEOGR, V16, P27, DOI 10.1080/02723646.1995.10642541; Hodgson AB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059561, 10.1371/journal.pone.0079556]; Hoef JMV, 2015, J AGR BIOL ENVIR ST, V20, P1, DOI 10.1007/s13253-014-0192-z; Hoover AA, 1983, BEHAV ECOLOGY HARBOR; Hoover-Miller A, 2011, MAR ECOL PROG SER, V424, P259, DOI 10.3354/meps08987; Jansen JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129798; Jansen JK, 2015, MAR MAMMAL SCI, V31, P66, DOI 10.1111/mms.12140; Kobler A, 2006, ECOL MODEL, V191, P83, DOI 10.1016/j.ecolmodel.2005.08.002; Laidre KL, 2015, CONSERV BIOL, V29, P724, DOI 10.1111/cobi.12474; Larsen CF, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000586; Larue MA, 2014, CONSERV BIOL, V28, P1731, DOI 10.1111/cobi.12367; LaRue MA, 2011, POLAR BIOL, V34, P1727, DOI 10.1007/s00300-011-1023-0; Lydersen C, 2014, J MARINE SYST, V129, P452, DOI 10.1016/j.jmarsys.2013.09.006; Mallinis G, 2008, ISPRS J PHOTOGRAMM, V63, P237, DOI 10.1016/j.isprsjprs.2007.08.007; Mathews EA, 2006, MAR MAMMAL SCI, V22, P167, DOI 10.1111/j.1748-7692.2006.00011.x; McMahon CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092613; McNabb RW, 2015, J GEOPHYS RES-EARTH, V120, P120, DOI 10.1002/2014JF003276; McNabb RW, 2014, J GEOPHYS RES-EARTH, V119, P153, DOI 10.1002/2013JF002915; O'Neel S, 2015, BIOSCIENCE, V65, P499, DOI 10.1093/biosci/biv027; Pfeffer WT, 2014, J GLACIOL, V60, P537, DOI 10.3189/2014JoG13J176; Soh LK, 1999, IEEE T GEOSCI REMOTE, V37, P780, DOI 10.1109/36.752194; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; Sweeney KL, 2016, J UNMANNED VEH SYST, V4, P70, DOI 10.1139/juvs-2015-0010; Ver Hoef Jay M., 2007, ENVIRONMETRICS, V18, P697, DOI DOI 10.1002/ENV.873; Womble JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055386; Womble JN, 2010, MAR MAMMAL SCI, V26, P686, DOI 10.1111/j.1748-7692.2009.00360.x; Zohmann M, 2013, ECOL MODEL, V254, P22, DOI 10.1016/j.ecolmodel.2013.01.008	44	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0164444	10.1371/journal.pone.0164444	http://dx.doi.org/10.1371/journal.pone.0164444			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828967	Green Published, gold, Green Submitted			2022-12-26	WOS:000387724300016
J	Padder, BA; Kamfwa, K; Awale, HE; Kelly, JD				Padder, Bilal A.; Kamfwa, Kelvin; Awale, Halima E.; Kelly, James D.			Transcriptome Profiling of the Phaseolus vulgaris - Colletotrichum lindemuthianum Pathosystem	PLOS ONE			English	Article							WESTERN HIMALAYAN REGION; ANTHRACNOSE RESISTANCE; MOLECULAR DIVERSITY; GENE-EXPRESSION; BZIP PROTEIN; NEMATODE RESISTANCE; DEFENSE RESPONSES; BASAL RESISTANCE; HIMACHAL-PRADESH; CO-4 LOCUS	Bean (Phaseolus vulgaris) anthracnose caused by the hemi-biotrophic pathogen Colletotrichum lindemuthianum is a major factor limiting production worldwide. Although sources of resistance have been identified and characterized, the early molecular events in the host-pathogen interface have not been investigated. In the current study, we conducted a comprehensive transcriptome analysis using Illumina sequencing of two near isogenic lines (NILs) differing for the presence of the Co-1 gene on chromosome Pv01 during a time course following infection with race 73 of C. lindemuthianum. From this, we identified 3,250 significantly differentially expressed genes (DEGs) within and between the NILs over the time course of infection. During the biotrophic phase the majority of DEGs were up regulated in the susceptible NIL, whereas more DEGs were up-regulated in the resistant NIL during the necrotrophic phase. Various defense related genes, such as those encoding PR proteins, peroxidases, lipoxygenases were up regulated in the resistant NIL. Conversely, genes encoding sugar transporters were up-regulated in the susceptible NIL during the later stages of infection. Additionally, numerous transcription factors (TFs) and candidate genes within the vicinity of the Co-1 locus were differentially expressed, suggesting a global reprogramming of gene expression in and around the Co-1 locus. Through this analysis, we reduced the previous number of candidate genes reported at the Co-1 locus from eight to three. These results suggest the dynamic nature of P. vulgaris-C. lindemuthianum interaction at the transcriptomic level and reflect the role of both pathogen and effector triggered immunity on changes in plant gene expression.	[Padder, Bilal A.; Kamfwa, Kelvin; Awale, Halima E.; Kelly, James D.] Michigan State Univ, Dept Plant Soil & Microbial Sci, 1066 Bogue St, E Lansing, MI 48824 USA; [Padder, Bilal A.] Sher E Kashmir Univ Agr Sci & Technol Kashmir, Srinagar 190025, Jammu & Kashmir, India; [Kamfwa, Kelvin] Univ Zambia, Sch Agr Sci, Dept Plant Sci, POB 32379,Great East Rd, Lusaka, Zambia	Michigan State University; Sher-e-Kashmir University of Agricultural Sciences & Technology of Kashmir (SKUAST Kashmir); University of Zambia	Kelly, JD (corresponding author), Michigan State Univ, Dept Plant Soil & Microbial Sci, 1066 Bogue St, E Lansing, MI 48824 USA.	kellyj@msu.edu		Padder, Bilal A/0000-0001-8842-2432	MSU AgBioResearch Project GREEEN [GR15-015]; University Grants Commission, India	MSU AgBioResearch Project GREEEN; University Grants Commission, India(University Grants Commission, India)	Research was supported by MSU AgBioResearch Project GREEEN Proposal #GR15-015, with financial support acknowledged from the University Grants Commission, India for providing RAMAN Fellowship to BAP.	AFANADOR LK, 1994, THEOR APPL GENET, V88, P337, DOI 10.1007/BF00223642; Albani D, 1997, PLANT CELL, V9, P171, DOI 10.1105/tpc.9.2.171; Alkan N, 2015, NEW PHYTOL, V205, P801, DOI 10.1111/nph.13087; Alves MS, 2015, FUNCT INTEGR GENOMIC, V15, P685, DOI 10.1007/s10142-015-0445-0; Alves MS, 2013, INT J MOL SCI, V14, P7815, DOI 10.3390/ijms14047815; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews S., 2010, FASTQC QUALITY CONTR; Balardin RS, 1997, PHYTOPATHOLOGY, V87, P1184, DOI 10.1094/PHYTO.1997.87.12.1184; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Borges A, 2012, J PLANT PHYSIOL, V169, P1216, DOI 10.1016/j.jplph.2012.04.003; Brown SH, 2008, MOL PLANT PATHOL, V9, P171, DOI 10.1111/J.1364-3703.2007.00454.X; Burkhardt A, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.08.0069; Burt AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139450; Cai DG, 1997, SCIENCE, V275, P832, DOI 10.1126/science.275.5301.832; Camehl I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002051; Campa A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-115; Carpita NC, 2001, PLANT PHYSIOL, V127, P551, DOI 10.1104/pp.010146; Casado-Diaz A, 2006, PHYSIOL PLANTARUM, V128, P633, DOI 10.1111/j.1399-3054.2006.00798.x; Chern MS, 1996, PLANT J, V10, P135, DOI 10.1046/j.1365-313X.1996.10010135.x; Chuang CF, 1999, GENE DEV, V13, P334, DOI 10.1101/gad.13.3.334; De Cremer K, 2013, PLANT CELL ENVIRON, V36, P1992, DOI 10.1111/pce.12106; Denance N, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00155; Devarenne TP, 2006, EMBO J, V25, P255, DOI 10.1038/sj.emboj.7600910; Dongfang YF, 2008, CAN J PLANT SCI, V88, P771, DOI 10.4141/CJPS07145; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dufresne M, 2000, PLANT CELL, V12, P1579, DOI 10.1105/tpc.12.9.1579; Fernandez MT, 2000, EUPHYTICA, V114, P143, DOI 10.1023/A:1003937812700; Ferreira JJ, TRANSLATIONAL GENOMI, VI, P151; FOUILLOUX G, 1976, ANN AMELIOR PLANT, V26, P443; Fountain JC, 2015, PHYSIOL MOL PLANT P, V89, P31, DOI 10.1016/j.pmpp.2014.11.005; Fraire-Velazquez S, 2003, PHYSIOL MOL PLANT P, V63, P79, DOI 10.1016/j.pmpp.2003.10.004; Fu ZQ, 2013, ANNU REV PLANT BIOL, V64, P839, DOI 10.1146/annurev-arplant-042811-105606; Fukazawa J, 2000, PLANT CELL, V12, P901, DOI 10.1105/tpc.12.6.901; Gao QM, 2011, PLANT PHYSIOL, V155, P464, DOI 10.1104/pp.110.166876; Garcia AV, 2012, CELL MOL LIFE SCI, V69, P3259, DOI 10.1007/s00018-012-1093-3; Geffroy V, 2008, THEOR APPL GENET, V116, P407, DOI 10.1007/s00122-007-0678-y; Gonzalez AM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00141; Goodwin PH, 2004, PLANT SCI, V167, P481, DOI 10.1016/j.plantsci.2004.04.014; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Herbert C, 2004, FUNGAL GENET BIOL, V41, P140, DOI 10.1016/j.fgb.2003.09.008; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Journot-Catalino N, 2006, PLANT CELL, V18, P3289, DOI 10.1105/tpc.106.044149; Kadota Y, 2010, TRENDS BIOCHEM SCI, V35, P199, DOI 10.1016/j.tibs.2009.12.005; Kawahara Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049423; KELLY JD, 1994, PLANT DIS, V78, P892, DOI 10.1094/PD-78-0892; Kelly JD, 2004, HORTSCIENCE, V39, P1196, DOI 10.21273/HORTSCI.39.6.1196; Kelly JD, 2001, CROP SCI, V41, P1647, DOI 10.2135/cropsci2001.4151647x; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim KC, 2008, PLANT CELL, V20, P2357, DOI 10.1105/tpc.107.055566; Kim KC, 2006, PLANT PHYSIOL, V142, P1180, DOI 10.1104/pp.106.082487; Kim KH, 2004, PHYTOPATHOLOGY, V94, P1295, DOI 10.1094/PHYTO.2004.94.12.1295; Li Chun-Yu, 2012, BMC Genomics, V13, P374, DOI 10.1186/1471-2164-13-374; Li GJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002767; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lingner U, 2011, J BIOL CHEM, V286, P20913, DOI 10.1074/jbc.M110.213678; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lowe RGT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103098; Ludwig N, 2014, MOL PLANT MICROBE IN, V27, P315, DOI 10.1094/MPMI-09-13-0267-R; Mahuku GS, 2004, EUR J PLANT PATHOL, V110, P253, DOI 10.1023/B:EJPP.0000019795.18984.74; Mahuku GS, 2002, PLANT DIS, V86, P1383, DOI 10.1094/PDIS.2002.86.12.1383; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matsui H, 2010, PLANT CELL PHYSIOL, V51, P1731, DOI 10.1093/pcp/pcq132; Melotto M, 2001, THEOR APPL GENET, V103, P508, DOI 10.1007/s001220100609; MENEZES JR, 1988, PHYTOPATHOLOGY, V78, P650, DOI 10.1094/Phyto-78-650; Meziadi C, 2016, PLANT SCI, V242, P351, DOI 10.1016/j.plantsci.2015.09.006; Miles TD, 2011, MOL PLANT PATHOL, V12, P463, DOI 10.1111/j.1364-3703.2010.00687.x; Muencha S, 2008, J PLANT PHYSIOL, V165, P41, DOI 10.1016/j.jplph.2007.06.008; Nakagawa H, 1996, PLANT J, V9, P217, DOI 10.1046/j.1365-313X.1996.09020217.x; Oblessuc PR, 2015, THEOR APPL GENET, V128, P1193, DOI 10.1007/s00122-015-2500-6; Oblessuc PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043161; Padder BA, 2007, PHYSIOL MOL PLANT P, V70, P8, DOI 10.1016/j.pmpp.2007.05.003; Padder BA, 2008, APPL BIOL RES, V10, P6; Padder B. A., 2009, Archives of Phytopathology and Plant Protection, V42, P610, DOI 10.1080/03235400701287305; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; PASTOR-CORRALES M A, 1991, Phytopathology, V81, P694; Pastor-Corrales M.A., 1989, BEAN PRODUCTION PROB, P77; PASTORCORRALES MA, 1995, PLANT DIS, V79, P63, DOI 10.1094/PD-79-0063; Pathania A, 2006, EUPHYTICA, V149, P97, DOI 10.1007/s10681-005-9057-4; Pereira MF, 2013, J MICROBIOL, V51, P70, DOI 10.1007/s12275-013-2393-5; Perfect SE, 1999, FUNGAL GENET BIOL, V27, P186, DOI 10.1006/fgbi.1999.1143; Prusky D, 2000, COLLETOTRICHUM, P232; Que YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106476; Richard MMS, 2014, THEOR APPL GENET, V127, P1653, DOI 10.1007/s00122-014-2328-5; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; SHAO FM, 1985, TROP PEST MANAGE, V31, P60, DOI 10.1080/09670878509370947; Sharma PN, 2007, AUSTRALAS PLANT PATH, V36, P191, DOI 10.1071/AP07013; Sharma P. N., 2008, Indian Phytopathology, V61, P323; Sharma PN, 1999, J PHYTOPATHOL, V147, P41, DOI 10.1046/j.1439-0434.1999.147001041.x; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Thurau T, 2003, PLANT MOL BIOL, V52, P643, DOI 10.1023/A:1024887516581; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van Ooijen G, 2010, PLANT J, V63, P563, DOI 10.1111/j.1365-313X.2010.04260.x; Vazin MA, 2014, ANN REPT BEAN IMPROV, V57, P161; Vos P, 1998, NAT BIOTECHNOL, V16, P1365, DOI 10.1038/4350; Wang N., 2016, PLANT GENE, V5, P22, DOI [10.1016/j.plgene.2015.11.003, DOI 10.1016/J.PLGENE.2015.11.003]; WIJESUNDERA RLC, 1989, PHYSIOL MOL PLANT P, V34, P403, DOI 10.1016/0885-5765(89)90067-2; Yin YH, 1997, EMBO J, V16, P5247, DOI 10.1093/emboj/16.17.5247; Zhuang XF, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-668; Zuiderveen GH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156391	99	27	27	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165823	10.1371/journal.pone.0165823	http://dx.doi.org/10.1371/journal.pone.0165823			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829044	gold, Green Published, Green Submitted			2022-12-26	WOS:000387724300062
J	Thieler, ER; Zeigler, SL; Winslow, LA; Hines, MK; Read, JS; Walker, JI				Thieler, E. Robert; Zeigler, Sara L.; Winslow, Luke A.; Hines, Megan K.; Read, Jordan S.; Walker, Jordan I.			Smartphone-Based Distributed Data Collection Enables Rapid Assessment of Shorebird Habitat Suitability	PLOS ONE			English	Article							BAYESIAN NETWORK; PIPING PLOVERS; ASSISTED GPS; ECOLOGY; CONSERVATION; ACCURACY	Understanding and managing dynamic coastal landscapes for beach-dependent species requires biological and geological data across the range of relevant environments and habitats. It is difficult to acquire such information; data often have limited focus due to resource constraints, are collected by non-specialists, or lack observational uniformity. We developed an open-source smartphone application called iPlover that addresses these difficulties in collecting biogeomorphic information at piping plover (Charadrius melodus) nest sites on coastal beaches. This paper describes iPlover development and evaluates data quality and utility following two years of collection (n = 1799 data points over 1500 km of coast between Maine and North Carolina, USA). We found strong agreement between field user and expert assessments and high model skill when data were used for habitat suitability prediction. Methods used here to develop and deploy a distributed data collection system have broad applicability to interdisciplinary environmental monitoring and modeling.	[Thieler, E. Robert; Zeigler, Sara L.] US Geol Survey, Woods Hole, MA 02543 USA; [Winslow, Luke A.; Hines, Megan K.; Read, Jordan S.; Walker, Jordan I.] US Geol Survey, Middleton, WI USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Thieler, ER (corresponding author), US Geol Survey, Woods Hole, MA 02543 USA.	rthieler@usgs.gov		Zeigler, Sara/0000-0002-5472-769X; thieler, e/0000-0003-4311-9717	North Atlantic Landscape Conservation Cooperative; U.S. Geological Survey Coastal and Marine Geology Program	North Atlantic Landscape Conservation Cooperative; U.S. Geological Survey Coastal and Marine Geology Program(United States Geological Survey)	This work was supported by the North Atlantic Landscape Conservation Cooperative through the U.S. Department of the Interior Hurricane Sandy recovery program under the Disaster Relief Appropriations Act of 2013, and the U.S. Geological Survey Coastal and Marine Geology Program.; This work was supported by the North Atlantic Landscape Conservation Cooperative through the U.S. Department of the Interior Hurricane Sandy recovery program under the Disaster Relief Appropriations Act of 2013, and the U.S. Geological Survey Coastal and Marine Geology Program.	Aanensen DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006968; Anel JA, 2011, COMMUN ACM, V54, P40, DOI 10.1145/1941487.1941502; BAYES T, 1958, BIOMETRIKA, V45, P296; Boccardo P, 2015, SENSORS-BASEL, V15, P15717, DOI 10.3390/s150715717; BURGER J, 1987, CONDOR, V89, P811, DOI 10.2307/1368529; Cohen JB, 2009, WILDLIFE MONOGR, P1, DOI 10.2193/2007-553; Cubasch U., 2013, CLIMATE CHANGE 2013; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Faundeen JL, 2013, USGS OPEN-FILE REP, P4, DOI [10.3133/ofr20131265, DOI 10.3133/ofr20131265]; Galbraith H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108899; Gieder KD, 2014, ECOL MODEL, V276, P38, DOI 10.1016/j.ecolmodel.2014.01.005; Godfrey P., 1976, TECHN P 1976 BARR IS, P5; Gregory R., 2012, STRUCTURED DECISION, DOI [DOI 10.1002/9781444398557, 10.1002/9781444398557]; Gutierrez BT, 2015, J GEOPHYS RES-EARTH, V120, P2452, DOI 10.1002/2015JF003671; Gutierrez BT, 2011, J GEOPHYS RES-EARTH, V116, DOI [10.1029/20101F001891, 10.1029/2010JF001891]; Hecht A, 2009, WATERBIRDS, V32, P64, DOI 10.1675/063.032.0107; Hermoso V, 2015, J BIOGEOGR, V42, P218, DOI 10.1111/jbi.12393; Jensen F. V., 2007, BAYESIAN NETWORKS DE, DOI DOI 10.1007/978-0-387-68282-2; Karlen W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099266; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Martin J, 2009, ECOL APPL, V19, P1079, DOI 10.1890/08-0255.1; Martin R.C., 2003, AGILE SOFTWARE DEV P, V2; Moser S. C., 2014, CLIMATE CHANGE IMPAC, P579, DOI DOI 10.7930/J0MS3QNW; Sturdivant E., 2016, **DATA OBJECT**, DOI 10.5066/F70V89X3; Takeuchi K, 2010, COMPUT GEOSCI-UK, V36, P573, DOI 10.1016/j.cageo.2009.09.012; Teacher AGF, 2013, ECOL EVOL, V3, P5268, DOI 10.1002/ece3.888; U.S. Fish and Wildlife Service, 1996, PIP PLOV CHAR MEL AT; U.S. Fish and Wildlife Service, 2015, PREL 2012 ATL COAST; U.S. Fish and Wildlife Service [USFWS], 1985, FED REGISTER, V50, P50726; Vogels W, 2009, COMMUN ACM, V52, P40, DOI 10.1145/1435417.1435432; WILCOX LEROY, 1959, AUK, V76, P129; Wong PP, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P361; Zandbergen PA, 2011, J NAVIGATION, V64, P381, DOI 10.1017/S0373463311000051; Zandbergen PA, 2009, T GIS, V13, P5, DOI 10.1111/j.1467-9671.2009.01152.x	35	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0164979	10.1371/journal.pone.0164979	http://dx.doi.org/10.1371/journal.pone.0164979			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828974	Green Submitted, Green Published, gold			2022-12-26	WOS:000387724300023
J	Yamauchi, H; Bando, M; Baba, T; Kataoka, K; Yamada, Y; Yamamoto, H; Miyamoto, A; Ikushima, S; Johkoh, T; Sakai, F; Terasaki, Y; Hebisawa, A; Kawabata, Y; Sugiyama, Y; Ogura, T				Yamauchi, Hiroyoshi; Bando, Masashi; Baba, Tomohisa; Kataoka, Kensuke; Yamada, Yoshihito; Yamamoto, Hiroshi; Miyamoto, Atsushi; Ikushima, Soichiro; Johkoh, Takeshi; Sakai, Fumikazu; Terasaki, Yasuhiro; Hebisawa, Akira; Kawabata, Yoshinori; Sugiyama, Yukihiko; Ogura, Takashi			Clinical Course and Changes in High Resolution Computed Tomography Findings in Patients with Idiopathic Pulmonary Fibrosis without Honeycombing	PLOS ONE			English	Article							NONSPECIFIC INTERSTITIAL PNEUMONIA; CT FINDINGS; CLASSIFICATION; DIAGNOSIS; SOCIETY; DISEASE; PATTERN	Some patients with idiopathic pulmonary fibrosis (IPF) do not have honeycombing on high resolution computed tomography (HRCT) at their initial evaluation. The clinical course and sequential changes in HRCT findings in these patients are not fully understood. We reviewed the cases of 43 patients with IPF without honeycombing on initial HRCT from institutions throughout Japan. All patients were diagnosed with IPF based on a surgical lung biopsy. Multidisciplinary discussions were held five times between 2011 and 2014, to exclude alternative etiologies. We evaluated the sequential changes in HRCT findings in 30 patients with IPF. We classified these 30 patients into three groups based on their HRCT patterns and clarified the clinical characteristics and prognosis among the groups. The patterns of all 30 patients on initial HRCT corresponded to a possible usual interstitial pneumonia (UIP) pattern which was described in the 2011 International Statement. On long-term follow-up (71.0 +/- 38.7 standard deviation [SD] months), honeycombing was seen in 16 patients (53%, the HoneyCo group); traction bronchiectasis or cysts without honeycombing was observed in 12 patients (40%, the NoHoneyCo group), and two patients showed no interval change (7%, the NoChange group) on HRCT. The mean survival periods of the HoneyCo and NoHoneyCo groups were 67.1 and 61.2 months, respectively (p = 0.76). There are some patients with IPF whose conditions chronically progress without honeycombing on HRCT. The appearance of honeycombing on HRCT during the follow-up might not be related to prognosis.	[Yamauchi, Hiroyoshi; Bando, Masashi; Sugiyama, Yukihiko] Jichi Med Univ, Dept Med, Shimotsuke, Tochigi, Japan; [Baba, Tomohisa; Ogura, Takashi] Kanagawa Cardiovasc & Resp Ctr, Dept Resp Med, Yokohama, Kanagawa, Japan; [Kataoka, Kensuke] Tosei Gen Hosp, Dept Resp Med & Allergy, Seto, Aichi, Japan; [Yamada, Yoshihito] East Japan Railway Co, JR Tokyo Gen Hosp, Dept Resp Med, Tokyo, Japan; [Yamamoto, Hiroshi] Shinshu Univ, Sch Med, Dept Internal Med 1, Nagano, Japan; [Miyamoto, Atsushi] Toranomon Gen Hosp, Dept Resp Med, Tokyo, Japan; [Ikushima, Soichiro] Japanese Red Cross Med Ctr, Dept Resp Med, Tokyo, Japan; [Johkoh, Takeshi] Mutual Aid Assoc Publ Sch Teachers, Kinki Cent Hosp, Dept Radiol, Itami, Hyogo, Japan; [Sakai, Fumikazu] Saitama Med Univ, Dept Diagnost Radiol, Int Med Ctr, Moroyama, Saitama, Japan; [Terasaki, Yasuhiro] Nippon Med Sch, Dept Analyt Human Pathol, Tokyo, Japan; [Hebisawa, Akira] Natl Hosp Org, Dept Clin Res, Tokyo Natl Hosp, Tokyo, Japan; [Kawabata, Yoshinori] Saitama Prefectural Cardiovasc & Resp Ctr, Div Diagnost Pathol, Kumagaya, Saitama, Japan	Jichi Medical University; Kanagawa Cardiovascular & Respiratory Center; Tosei General Hospital; Shinshu University; Toranomon Hospital; Japanese Red Cross Medical Center; University of Tokyo; Saitama Medical University; Nippon Medical School	Bando, M (corresponding author), Jichi Med Univ, Dept Med, Shimotsuke, Tochigi, Japan.	bando034@jichi.ac.jp		Terasaki, Yasuhiro/0000-0003-4495-7982				Akira M, 2011, THORAX, V66, P61, DOI 10.1136/thx.2010.140574; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Bando M, 2015, RESPIR INVESTIG, V53, P51, DOI 10.1016/j.resinv.2014.11.001; Battista Giuseppe, 2003, Radiol Med, V105, P2; Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; Flaherty KR, 2002, EUR RESPIR J, V19, P275, DOI 10.1183/09031936.02.00182002; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Kazerooni EA, 1997, AM J ROENTGENOL, V169, P977, DOI 10.2214/ajr.169.4.9308447; Lee HY, 2012, AM J ROENTGENOL, V199, P982, DOI 10.2214/AJR.11.8192; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; RAGHU G, 1987, CHEST, V92, P148, DOI 10.1378/chest.92.1.148; Raghu G, 2014, LANCET RESP MED, V2, P566, DOI 10.1016/S2213-2600(14)70101-8; Raghu G, 2014, LANCET RESP MED, V2, P277, DOI 10.1016/S2213-2600(14)70011-6; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Schettino IAL, 2002, PATHOL RES PRACT, V198, P347, DOI 10.1078/0344-0338-00265; Selman M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000482; Silva CIS, 2008, RADIOLOGY, V247, P251, DOI 10.1148/radiol.2471070369; Sumikawa H, 2014, RADIOLOGY, V272, P549, DOI 10.1148/radiol.14130853; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Tristan JH, 2015, RESP INVESTIG, V53, P88; Vancheri C, 2010, EUR RESPIR J, V35, P496, DOI 10.1183/09031936.00077309	22	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166168	10.1371/journal.pone.0166168	http://dx.doi.org/10.1371/journal.pone.0166168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829068	Green Published, Green Submitted, gold			2022-12-26	WOS:000387724300093
J	Leyvraz, M; Rohner, F; Konan, AG; Esso, LJCE; Woodruff, BA; Norte, A; Adiko, AF; Bonfoh, B; Aaron, GJ				Leyvraz, Magali; Rohner, Fabian; Konan, Amoin G.; Esso, Lasme J. C. E.; Woodruff, Bradley A.; Norte, Augusto; Adiko, Adiko F.; Bonfoh, Bassirou; Aaron, Grant J.			High Awareness but Low Coverage of a Locally Produced Fortified Complementary Food in Abidjan, Cote d'Ivoire: Findings from a Cross-Sectional Survey	PLOS ONE			English	Article							ANEMIA; INFANT	Poor complementary feeding practices among infants and young children in Cote d'Ivoire are major contributing factors to the country's high burden of malnutrition. As part of a broad effort to address this issue, an affordable, nutritious, and locally produced fortified complementary food product was launched in the Cote d'Ivoire in 2011. The objective of the current research was to assess various levels of coverage of the program and to identify coverage barriers. A cross-sectional household survey was conducted among caregivers of children less than 2-years of age living in Abidjan, Cote d'Ivoire. Four measures of coverage were assessed: "message coverage" (i.e., has the caregiver ever heard of the product?), "contact coverage" (i.e., has the caregiver ever fed the child the product?), "partial coverage" (i.e., has the caregiver fed the child the product in the previous month?), and "effective coverage" (i.e., has the caregiver fed the child the product in the previous 7 days?). A total of 1,113 caregivers with children between 0 and 23 months of age were interviewed. Results showed high message coverage (85.0%), moderate contact coverage (37.8%), and poor partial and effective coverages (8.8% and 4.6%, respectively). Product awareness was lower among caregivers from poorer households, but partial and effective coverages were comparable in both poor and non-poor groups. Infant and young child feeding (IYCF) practices were generally poor and did not appear to have improved since previous assessments. In conclusion, the results from the present study indicate that availability on the market and high awareness among the target population is not sufficient to achieve high and effective coverage. With market-based delivery models, significant efforts are needed to improve demand. Moreover, given the high prevalence of malnutrition and poor IYCF practices, additional modes of delivering IYCF interventions and improving IYCF practices should be considered.	[Leyvraz, Magali; Aaron, Grant J.] Global Alliance Improved Nutr, Geneva, Switzerland; [Rohner, Fabian; Woodruff, Bradley A.; Norte, Augusto] GroundWork, Flasch, Switzerland; [Konan, Amoin G.; Esso, Lasme J. C. E.; Adiko, Adiko F.; Bonfoh, Bassirou] Ctr Suisse Rech Sci Cote Divoire, Abidjan, Cote Ivoire; [Konan, Amoin G.; Esso, Lasme J. C. E.; Adiko, Adiko F.] Univ Felix Houphouet Boigny, Abidjan, Cote Ivoire; [Bonfoh, Bassirou] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute	Leyvraz, M (corresponding author), Global Alliance Improved Nutr, Geneva, Switzerland.	magali.leyvraz@gmail.com	Rohner, Fabian/I-5088-2019	Rohner, Fabian/0000-0003-0579-6952; Rios-Leyvraz, Magali/0000-0003-0455-197X	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron GJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163176; Aaron GJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162462; Alkire S, 2014, WORLD DEV, V59, P251; [Anonymous], 2014, RECH FORM PRAT AL NO; [Anonymous], 2011, HOUSEHOLD HUNGER SCA; Cameron AC, 2008, REV ECON STAT, V90, P414, DOI 10.1162/rest.90.3.414; Daelmans B, 2009, FOOD NUTR BULL, V30, pS256, DOI 10.1177/15648265090302S210; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; FAO, 2013, STATE HUNGER BUILDIN; Glinz D, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0872-3; Global Alliance for Improved Nutrition, 2014, CAS STUD INV COT IV; Guevarra E, 2014, FIELD EXCHANGE, V47; Institut National de la Statistique (INS) ICF International, DEM SANT IND MULT CO; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003517.pub2; Lauritsen JM, 2004, EPIDATA ENTRY V3 1 C; Meinzen-Derr JK, 2006, J NUTR, V136, P452, DOI 10.1093/jn/136.2.452; Rohner F, 2014, PUBLIC HEALTH NUTR, V17, P2016, DOI 10.1017/S136898001300222X; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; United Nations High Commissioner for Refugees World Food Programme, 2011, GUID SEL FEED MAN MA; Wijnhoven TMA, 2009, COLLATE REV DATA COM	21	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166295	10.1371/journal.pone.0166295	http://dx.doi.org/10.1371/journal.pone.0166295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824917	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000387615200083
J	Li, QF; Lu, YQ; Pan, CL; Yao, MM; Zhang, JP; Yang, XM; Liu, WH; Li, XQ; Xi, YJ; Li, LH				Li, Qingfeng; Lu, Yuqing; Pan, Cuili; Yao, Miaomiao; Zhang, Jinpeng; Yang, Xinming; Liu, Weihua; Li, Xiuquan; Xi, Yajun; Li, Lihui			Chromosomal Localization of Genes Conferring Desirable Agronomic Traits from Wheat-Agropyron cristatum Disomic Addition Line 5113	PLOS ONE			English	Article							RESISTANCE GENE; RUST RESISTANCE; COMMON WHEAT; BARLEY; IDENTIFICATION; GENOME; HYBRIDS; 6P	Creation of wheat-alien disomic addition lines and localization of desirable genes on alien chromosomes are important for utilization of these genes in genetic improvement of common wheat. In this study, wheat-Agropyron cristatum derivative line 5113 was characterized by genomic in situ hybridization (GISH) and specific-locus amplified fragment sequencing (SLAF-seq), and was demonstrated to be a novel wheat-A. cristatum disomic-6P addition line. Compared with its parent Fukuhokomugi (Fukuho), 5113 displayed multiple elite agronomic traits, including higher uppermost internode/plant height ratio, larger flag leaf, longer spike length, elevated grain number per spike and spikelet number per spike, more kernel number in the middle spikelet, more fertile tiller number per plant, and enhanced resistance to powdery mildew and leaf rust. Genes conferring these elite traits were localized on the A. cristatum 6P chromosome by using SLAF-seq markers and biparental populations (F-1, BC1F1 and BC1F2 populations) produced from the crosses between Fukuho and 5113. Taken together, chromosomal localization of these desirable genes will facilitate transferring of high-yield and high-resistance genes from A. cristatum into common wheat, and serve as the foundation for the utilization of 5113 in wheat breeding.	[Li, Qingfeng; Xi, Yajun] Northwest A&F Univ, Coll Agron, Yangling 712100, Shaanxi, Peoples R China; [Li, Qingfeng; Lu, Yuqing; Pan, Cuili; Yao, Miaomiao; Zhang, Jinpeng; Yang, Xinming; Liu, Weihua; Li, Xiuquan; Li, Lihui] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China	Northwest A&F University - China; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Xi, YJ (corresponding author), Northwest A&F Univ, Coll Agron, Yangling 712100, Shaanxi, Peoples R China.; Li, LH (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China.	xiyajun2002@126.com; lilihui@caas.cn			National Key Technology Support Program of China [2013BAD01B02]; National Natural Science Foundation of China [31271714]; CMS Innovation Team Project	National Key Technology Support Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CMS Innovation Team Project	This work was funded by the National Key Technology Support Program of China (No. 2013BAD01B02), the National Natural Science Foundation of China (No. 31271714), and the CMS Innovation Team Project.; This work was funded by the National Key Technology Support Program of China (No. 2013BAD01B02), the National Natural Science Foundation of China (No. 31271714), and the CAAS Innovation Team Project.	Allen GC, 2006, NAT PROTOC, V1, P2320, DOI 10.1038/nprot.2006.384; Bilgic H, 2007, GENOME, V50, P898, DOI 10.1139/G07-059; CAI XW, 1989, THEOR APPL GENET, V77, P81, DOI 10.1007/BF00292320; Cao ZJ, 2008, PLANT SCI, V174, P544, DOI 10.1016/j.plantsci.2008.02.007; Chen Q, 1996, THEOR APPL GENET, V93, P679, DOI 10.1007/BF00224062; Chen SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065122; Chen SY, 2004, PLANT SCI, V167, P773, DOI 10.1016/j.plantsci.2004.05.010; Darko E, 2015, EUPHYTICA, V203, P491, DOI 10.1007/s10681-014-1245-7; Dewey DR, 1984, GENOMIC SYSTEM CLASS; Dolezel J, 2004, CHROMOSOME RES, V12, P77, DOI 10.1023/B:CHRO.0000009293.15189.e5; DONG YS, 1992, HEREDITAS, V116, P175, DOI 10.1111/j.1601-5223.1992.tb00224.x; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; Han HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091066; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; Jauhar PP, 2006, PLANT BREEDING, V125, P19, DOI 10.1111/j.1439-0523.2006.01176.x; Khlestkina EK, 2011, CEREAL RES COMMUN, V39, P465, DOI 10.1556/CRC.39.2011.4.1; Kishii M, 2004, THEOR APPL GENET, V109, P255, DOI 10.1007/s00122-004-1631-y; Li GR, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0202-z; Li HJ, 2002, PLANT DIS, V86, P423, DOI 10.1094/PDIS.2002.86.4.423; Li L.H., 1997, ACTA GENET SIN, V24, P154; Li Li-hui, 1998, Acta Genetica Sinica, V25, P538; Li M, 2016, J GENET GENOMICS, V43, P209, DOI 10.1016/j.jgg.2015.11.005; Li QF, 2016, CROP SCI, V56, P2390, DOI 10.2135/cropsci2015.10.0638; Li RD, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0331-4; Lu Y.T., 2016, IEEE MTT S INT MICRO, P1, DOI [10.1109/iccs.2016.7833643, DOI 10.1109/ICCS.2016.7833643]; Maestra B, 2002, CHROMOSOME RES, V10, P655, DOI 10.1023/A:1021564327226; Murai K, 1997, EUPHYTICA, V96, P281, DOI 10.1023/A:1003025501591; Niu ZX, 2011, GENETICS, V187, P1011, DOI 10.1534/genetics.110.123588; Qi LL, 2007, CHROMOSOME RES, V15, P3, DOI 10.1007/s10577-006-1108-8; Qi LL, 1996, GENOME, V39, P191, DOI 10.1139/g96-025; Qi ZJ, 2010, THEOR APPL GENET, V121, P589, DOI 10.1007/s00122-010-1332-7; Qi ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104871; RILEY R, 1968, NATURE, V217, P383, DOI 10.1038/217383a0; Rubiales D, 2001, EUPHYTICA, V122, P369, DOI 10.1023/A:1012952819255; Schneider A, 2008, EUPHYTICA, V163, P1, DOI 10.1007/s10681-007-9624-y; SHENG BQ, 1991, BEIJING AGR SCI, V1, P38; Song LQ, 2016, THEOR APPL GENET, V129, P1023, DOI 10.1007/s00122-016-2680-8; Stakman E.C., 1962, E617 USDAARS; Suchankova P, 2006, THEOR APPL GENET, V113, P651, DOI 10.1007/s00122-006-0329-8; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Nguyen V, 2015, THEOR APPL GENET, V128, P953, DOI 10.1007/s00122-015-2482-4; Xu SS, 2005, CHROMOSOME RES, V13, P559, DOI 10.1007/s10577-005-0981-x; Ye XL, 2015, THEOR APPL GENET, V128, P797, DOI 10.1007/s00122-015-2466-4; Zhang PX, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/376527; Zhang QP, 2005, EUPHYTICA, V145, P317, DOI 10.1007/s10681-005-1743-8; Zhang RQ, 2015, THEOR APPL GENET, V128, P2415, DOI 10.1007/s00122-015-2596-8; Zhang Y., 2013, MATH PROB ENG, V2013, DOI DOI 10.4018/JIIT.2013010101; Zhang Y, 2015, PLANTA, V242, P1335, DOI 10.1007/s00425-015-2372-7; Zhao PanPan, 2013, Journal of Henan Agricultural Sciences, V42, P91; Zhao TT, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0737-0; Zhou Jingyu, 2014, ScientificWorldJournal, V2014, P530942, DOI 10.1155/2014/530942	51	9	11	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165957	10.1371/journal.pone.0165957	http://dx.doi.org/10.1371/journal.pone.0165957			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824906	Green Submitted, Green Published, gold			2022-12-26	WOS:000387615200050
J	Panda, S; Jena, S; Sharma, S; Dhawan, B; Nath, G; Singh, DV				Panda, Sasmita; Jena, Smrutiti; Sharma, Savitri; Dhawan, Benu; Nath, Gopal; Singh, Durg Vijai			Identification of Novel Sequence Types among Staphylococcus haemolyticus Isolated from Variety of Infections in India	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; GENOME; METHICILLIN; RESISTANCE; UNIT	The aim of this study was to determine sequence types of 34 S. haemolyticus strains isolated from a variety of infections between 2013 and 2016 in India by MLST. The MEGA5.2 software was used to align and compare the nucleotide sequences. The advanced cluster analysis was performed to define the clonal complexes. MLST analysis showed 24 new sequence types (ST) among S. haemolyticus isolates, irrespective of sources and place of isolation. The finding of this study allowed to set up an MLST database on the PubMLST. org website using BIGSdb software and made available at http://pubmlst.org/shaemolyticus/. The data of this study thus suggest that MLST can be used to study population structure and diversity among S. haemolyticus isolates.	[Panda, Sasmita; Jena, Smrutiti; Singh, Durg Vijai] Inst Life Sci, Infect Dis Biol, Nalco Sq, Bhubaneswar 751023, Orissa, India; [Sharma, Savitri] LV Prasad Eye Inst, Jhaveri Microbiol Ctr, Kellam Anji Reddy Campus,LV Prasad Marg, Hyderabad 500034, Andhra Pradesh, India; [Dhawan, Benu] All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India; [Nath, Gopal] Banaras Hindu Univ, Inst Med Sci, Dept Microbiol, Varanasi 221005, Uttar Pradesh, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); L. V. Prasad Eye Institute; All India Institute of Medical Sciences (AIIMS) New Delhi; Banaras Hindu University (BHU)	Singh, DV (corresponding author), Inst Life Sci, Infect Dis Biol, Nalco Sq, Bhubaneswar 751023, Orissa, India.	durg_singh@yahoo.co.in	Singh, Durg Vijai/ADU-5699-2022; Singh, Durg Vijai/C-3336-2009; NATH, GOPAL/GSN-5212-2022	Singh, Durg Vijai/0000-0002-9258-073X; NATH, GOPAL/0000-0003-2722-1308	Science and Engineering Research Board, New Delhi [SB/SO/HS-0203/2012]; Indian Council of Medical Research, New Delhi; Department of Science and Technology, New Delhi	Science and Engineering Research Board, New Delhi; Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR)); Department of Science and Technology, New Delhi(Department of Science & Technology (India))	DVS was supported by a grant from Science and Engineering Research Board, New Delhi (Grant no. SB/SO/HS-0203/2012). SP and SJ were supported by Senior Research Fellowships from Indian Council of Medical Research, New Delhi and Department of Science and Technology, New Delhi. The funder had no role in study design, data collection, and analysis, decision to publish or preparation of the manuscript.	Pereira PMA, 2014, DIAGN MICR INFEC DIS, V78, P85, DOI 10.1016/j.diagmicrobio.2013.06.026; Barros EM, 2012, J CLIN MICROBIOL, V50, P166, DOI 10.1128/JCM.05563-11; Cavanagh JP, 2012, J MICROBIOL METH, V89, P159, DOI 10.1016/j.mimet.2012.03.014; FROGGATT JW, 1989, ANTIMICROB AGENTS CH, V33, P460, DOI 10.1128/AAC.33.4.460; Hirotaki S, 2011, J CLIN MICROBIOL, V49, P3627, DOI 10.1128/JCM.00488-11; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Makki AR, 2011, INVEST OPHTH VIS SCI, V52, P9018, DOI 10.1167/iovs.11-7777; Mehta G, 1997, ANN TROP PAEDIATR, V17, P15, DOI 10.1080/02724936.1997.11747857; Panda S, 2014, FEMS MICROBIOL LETT, V352, P114, DOI 10.1111/1574-6968.12383; Takeuchi F, 2005, J BACTERIOL, V187, P7292, DOI 10.1128/JB.187.21.7292-7308.2005	10	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166193	10.1371/journal.pone.0166193	http://dx.doi.org/10.1371/journal.pone.0166193			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824930	Green Published, Green Submitted, gold			2022-12-26	WOS:000387615200069
J	Askari, A; Naghizadeh, MM; Homayounfar, R; Shahi, A; Afsarian, MH; Paknahad, A; Kennedy, D; Ataollahi, MR				Askari, Alireza; Naghizadeh, Mohammad Mehdi; Homayounfar, Reza; Shahi, Abbas; Afsarian, Mohammad Hosein; Paknahad, Abbas; Kennedy, Derek; Ataollahi, Mohammad Reza			Increased Serum Levels of IL-17A and IL-23 Are Associated with Decreased Vitamin D3 and Increased Pain in Osteoarthritis	PLOS ONE			English	Article							INTERLEUKIN-17; CHONDROCYTES; CARTILAGE; KNEE; ACTIVATION; CYTOKINES	Introduction Osteoarthritis (OA) is the most common type of arthritis and proinflammatory cytokines have been considered as the main etiologic factor in the pathogenesis of the disease. Serum levels of cytokines, that are associated with innate immunity and TH1 cells, have been analyzed in OA patients, however, there is limited research that profiles cytokines associated with Th17 cells and their relation to vitamin D3 and pain. Material and methods The sera from 131 patients with OA and 262 healthy controls were evaluated for serum levels of IL-17A, IL-21, IL-23 and vitamin D3 using ELISA. Results Serum levels of IL-17A, and IL-23 were statistically higher in OA patients than in healthy controls, while IL-21 and vitamin D3 were significantly lower in OA patients when compared to controls. A significant positive correlation was found between the serum levels of IL-17A and IL-23 using WOMAC pain scores and vitamin D3 serum levels. Discussion The results suggest that IL-17A plays a significant role in OA pathogenesis and the induction of pain. Decreased serum levels of vitamin D3 may reflect a positive role played by the factor in the regulation of immune responses in OA patients.	[Askari, Alireza; Naghizadeh, Mohammad Mehdi; Homayounfar, Reza; Afsarian, Mohammad Hosein; Ataollahi, Mohammad Reza] Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran; [Shahi, Abbas] Fasa Univ Med Sci, Student Res Comm, Fasa, Iran; [Paknahad, Abbas] Hormozgan Univ Med Sci, Student Res Comm, Bandar Abbas, Iran; [Kennedy, Derek] Griffith Univ Nathan, Eskitis Inst Drug Discovery, Sch Nat Sci, Nathan, Qld, Australia	Griffith University	Homayounfar, R; Ataollahi, MR (corresponding author), Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran.	r_homayounfar@yahoo.com; ataollahim@gmail.com	Homayounfar, R/L-8813-2017; Askari, Alireza/Z-2099-2019; Afsariyan, Mohammad Hossein/N-3153-2017; Ataollahi, MohammadReza/P-9042-2017; Kennedy, Hendrick/A-7635-2010; Naghizadeh, Mohammad Mehdi/O-4889-2017	Homayounfar, R/0000-0001-5398-9519; Afsariyan, Mohammad Hossein/0000-0003-3444-9319; Kennedy, Hendrick/0000-0001-7937-3069; Naghizadeh, Mohammad Mehdi/0000-0001-5562-103X; Ataollahi, Mohammadreza/0000-0001-8007-4736	Fasa University of Medical Sciences [93165]	Fasa University of Medical Sciences	This study has been financially supported by grant number 93165 from the Fasa University of Medical Sciences.	ALSALAMEH S, 1990, ARTHRITIS RHEUM, V33, P1477, DOI 10.1002/art.1780331004; Arababadi MK, 2014, ARCH VIROL, V159, P1883, DOI 10.1007/s00705-014-2002-x; Arababadi MK, 2010, HEPAT MON, V10, P31; Benderdour M, 2002, J RHEUMATOL, V29, P1262; Felson DT, 2006, NEW ENGL J MED, V354, P841, DOI 10.1056/NEJMcp051726; Goula T, 2015, J ORTHOP TRAUMATOL, V16, P35, DOI 10.1007/s10195-014-0322-y; Honorati MC, 2002, OSTEOARTHR CARTILAGE, V10, P799, DOI 10.1053/joca.2002.0829; Imamura M, 2015, INT J INFLAMM, V2015, DOI 10.1155/2015/329792; Jamali Z, 2013, CLIN LAB, V59, P407, DOI 10.7754/Clin.Lab.2012.120908; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kim J, 2013, ANN LAB MED, V33, P52, DOI 10.3343/alm.2013.33.1.52; Koga T, 2017, CLIN IMMUNOL, V185, P95, DOI 10.1016/j.clim.2016.04.010; Laslett LL, 2014, ANN RHEUM DIS, V73, P697, DOI 10.1136/annrheumdis-2012-202831; Li JK, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0833-9; Lories RJ, 2011, NAT REV RHEUMATOL, V7, P43, DOI 10.1038/nrrheum.2010.197; Lubberts E, 2000, ARTHRITIS RHEUM-US, V43, P1300, DOI 10.1002/1529-0131(200006)43:6<1300::AID-ANR12>3.0.CO;2-D; Martel-Pelletier J, 1999, ARTHRITIS RHEUM-US, V42, P2399, DOI 10.1002/1529-0131(199911)42:11<2399::AID-ANR19>3.0.CO;2-Y; Massicotte F, 2002, OSTEOARTHR CARTILAGE, V10, P491, DOI 10.1053/joca.2002.0528; Onuora S, 2016, NATURE REV RHEUMATOL, V12, P252; Pacquelet S, 2002, J RHEUMATOL, V29, P2602; Upala S, 2016, PHOTODERMATOL PHOTO, V32, P181, DOI 10.1111/phpp.12241; Wang X, 2015, INT J ENDOCRINOL, V2015, DOI DOI 10.1155/2015/28529026681939; Wojdasiewicz P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/561459; Wu CW, 2005, SEMINARS ARTHRITIS R; Zhu S, 2012, CLIN SCI, V122, P487, DOI 10.1042/CS20110496	25	34	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0164757	10.1371/journal.pone.0164757	http://dx.doi.org/10.1371/journal.pone.0164757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820818	gold, Green Submitted, Green Published			2022-12-26	WOS:000387614800003
J	De Samber, B; Niemiec, MJ; Laforce, B; Garrevoet, J; Vergucht, E; De Rycke, R; Cloetens, P; Urban, CF; Vincze, L				De Samber, Bjorn; Niemiec, Maria J.; Laforce, Brecht; Garrevoet, Jan; Vergucht, Eva; De Rycke, Riet; Cloetens, Peter; Urban, Constantin F.; Vincze, Laszlo			Probing Intracellular Element Concentration Changes during Neutrophil Extracellular Trap Formation Using Synchrotron Radiation Based X-Ray Fluorescence	PLOS ONE			English	Article							MICRO-XRF; QUANTIFICATION; PATHOGENESIS; LIBRARY; NETOSIS; REVEAL	High pressure frozen (HPF), cryo-substituted microtome sections of 2 mu m thickness containing human neutrophils (white blood cells) were analyzed using synchrotron radiation based X-ray fluorescence (SR nano-XRF) at a spatial resolution of 50 nm. Besides neutrophils from a control culture, we also analyzed neutrophils stimulated for 1-2 h with phorbol myristate acetate (PMA), a substance inducing the formation of so-called Neutrophil Extracellular Traps (or NETs), a defense system again pathogens possibly involving proteins with metal chelating properties. In order to gain insight in metal transport during this process, precise local evaluation of elemental content was performed reaching limits of detection (LODs) of 1 ppb. Mean weight fractions within entire neutrophils, their nuclei and cytoplasms were determined for the three main elements P, S and Cl, but also for the 12 following trace elements: K, Ca, Mn, Fe, Co, Ni, Cu, Zn, Se, Br, Sr and Pb. Statistical analysis, including linear regression provided objective analysis and a measure for concentration changes. The nearly linear Ca and Cl concentration changes in neutrophils could be explained by already known phenomena such as the induction of Ca channels and the uptake of Cl under activation of NET forming neutrophils. Linear concentration changes were also found for P, S, K, Mn, Fe, Co and Se. The observed linear concentration increase for Mn could be related to scavenging of this metal from the pathogen by means of the neutrophil protein calprotectin, whereas the concentration increase of Se may be related to its antioxidant function protecting neutrophils from the reactive oxygen species they produce against pathogens. We emphasize synchrotron radiation based nanoscopic X-ray fluorescence as an enabling analytical technique to study changing (trace) element concentrations throughout cellular processes, provided accurate sample preparation and data-analysis.	[De Samber, Bjorn; Laforce, Brecht; Vergucht, Eva; Vincze, Laszlo] Univ Ghent, Dept Analyt Chem, Ghent, Belgium; [Niemiec, Maria J.; Urban, Constantin F.] Umea Univ, Dept Clin Microbiol, MIMS, Umea, Sweden; [Niemiec, Maria J.] Leibniz Inst Nat Prod Res & Infect Biol, Microbial Immunol Res Grp, Hans Knoll Inst, Jena, Germany; [Garrevoet, Jan] DESY, Hamburg, Germany; [De Rycke, Riet] Univ Ghent VIB, Inflammat Res Ctr, Ghent, Belgium; [De Rycke, Riet] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [De Rycke, Riet] Univ Ghent VIB, Dept Plant Syst Biol, Ghent, Belgium; [De Rycke, Riet] Univ Ghent, Dept Plant Biotechnol & Bioinformat, Ghent, Belgium; [Cloetens, Peter] European Synchrotron Radiat Facil, Grenoble, France	Ghent University; Umea University; Hans Knoll Institute (HKI); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; European Synchrotron Radiation Facility (ESRF)	De Samber, B (corresponding author), Univ Ghent, Dept Analyt Chem, Ghent, Belgium.	Bjorn.DeSamber@UGent.be	Laforce, Brecht/AAF-9215-2021; Vincze, Laszlo/AAP-3914-2020; Urban, Constantin/H-5121-2019; Laforce, Brecht/GPX-2175-2022; Cloetens, Peter/AAJ-6131-2020; De Samber, Bjorn/K-9636-2015	Urban, Constantin/0000-0003-1438-1134; Cloetens, Peter/0000-0002-4129-9091; Niemiec, Maria Joanna/0000-0001-5667-6032; De Samber, Bjorn/0000-0002-6759-4195	FWO Vlaanderen [1263313N]; FWO grant [V.4.114.10.N.00]; J.C. Kempe Memorial Fund; Flemish Institute for the Promotion of Scientific and Technological Research in Industry (IWT Flanders, Belgium); Swedish Research Council [521-2014-2281]; Medical Faculty Umea University; Ake Wiberg Foundation [M15-0108]	FWO Vlaanderen(FWO); FWO grant(FWO); J.C. Kempe Memorial Fund; Flemish Institute for the Promotion of Scientific and Technological Research in Industry (IWT Flanders, Belgium); Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Faculty Umea University; Ake Wiberg Foundation	Bjorn De Samber acknowledges his postdoctoral research grant from FWO Vlaanderen (application nr. 1263313N), FWO grant for a long stay abroad (application nr. V.4.114.10.N.00) and statistical consult from Ghent University FIRE (Fostering Innovative Research based on Evidence). Maria J. Niemiec acknowledges financial support from the J.C. Kempe Memorial Fund. Eva Vergucht, Brecht Laforce and Jan Garrevoet were funded by a PhD grant from the Flemish Institute for the Promotion of Scientific and Technological Research in Industry (IWT Flanders, Belgium). Constantin F. Urban acknowledges support from the Swedish Research Council (521-2014-2281), Medical Faculty Umea University and the Ake Wiberg Foundation (M15-0108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akong-Moore K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042984; Almyroudis NG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00045; Aron AT, 2015, ACCOUNTS CHEM RES, V48, P2434, DOI 10.1021/acs.accounts.5b00221; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Brophy MB, 2015, ACS CHEM BIOL, V10, P641, DOI 10.1021/cb500792b; Brunetti A, 2004, SPECTROCHIM ACTA B, V59, P1725, DOI 10.1016/j.sab.2004.03.014; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; de Jonge MD, 2010, P NATL ACAD SCI USA, V107, P15676, DOI 10.1073/pnas.1001469107; De Samber B, 2008, ANAL BIOANAL CHEM, V390, P267, DOI 10.1007/s00216-007-1694-0; De Samber B, 2013, ANAL BIOANAL CHEM, V405, P6061, DOI 10.1007/s00216-013-7019-6; De Samber B, 2010, J ANAL ATOM SPECTROM, V25, P544, DOI 10.1039/b918624g; Douda DN, 2015, P NATL ACAD SCI USA, V112, P2817, DOI 10.1073/pnas.1414055112; Ellwanger Joel H., 2016, AN ACAD BRAS CIENC; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Germain RN, 2004, NAT MED, V10, P1307, DOI 10.1038/nm1159; Giewekemeyer K, 2014, J SYNCHROTRON RADIAT, V21, P1167, DOI 10.1107/S1600577514013411; Gupta AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097088; Haas KL, 2009, CHEM REV, V109, P4921, DOI 10.1021/cr900134a; Hemonnot CYJ, 2016, ACS NANO, V10, P3553, DOI 10.1021/acsnano.5b07871; Hyman LM, 2012, COORDIN CHEM REV, V256, P2333, DOI 10.1016/j.ccr.2012.03.009; Kempenaers L, 2000, SPECTROCHIM ACTA B, V55, P651, DOI 10.1016/S0584-8547(00)00207-X; Krenkel M, 2014, P SPIE, V9212; Krenkel M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09973; LCPW R. R., 1979, MICR AN BIOL; Martinez-Criado G, 2012, J SYNCHROTRON RADIAT, V19, P10, DOI 10.1107/S090904951104249X; McRae R, 2009, CHEM REV, V109, P4780, DOI 10.1021/cr900223a; Moore KL, 2014, NEW PHYTOL, V201, P104, DOI 10.1111/nph.12497; Niemiec MJ, 2015, METALLOMICS, V7, P996, DOI 10.1039/c4mt00346b; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Piazza V, 2014, ACS NANO, V8, P12228, DOI 10.1021/nn5041526; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Schoonjans T, 2011, P SPIE; Schoonjans T, 2013, SPECTROCHIM ACTA B, V82, P36, DOI 10.1016/j.sab.2012.12.011; Schoonjans T, 2012, SPECTROCHIM ACTA B, V70, P10, DOI 10.1016/j.sab.2012.03.011; Schoonjans T, 2012, SPECTROCHIM ACTA B, V67, P32, DOI 10.1016/j.sab.2011.12.006; Schoonjans T, 2011, SPECTROCHIM ACTA B, V66, P776, DOI 10.1016/j.sab.2011.09.011; Schropp A, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4729942; SHERMAN J, 1955, SPECTROCHIM ACTA, V7, P283, DOI 10.1016/0371-1951(55)80081-1; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Van Malderen SJM, 2015, J ANAL ATOM SPECTROM, V30, P119, DOI 10.1039/c4ja00137k; VEKEMANS B, 1994, X-RAY SPECTROM, V23, P278, DOI 10.1002/xrs.1300230609; Wartha F, 2007, CURR OPIN MICROBIOL, V10, P52, DOI 10.1016/j.mib.2006.12.005; YAROM R, 1976, P NATL ACAD SCI USA, V73, P3690, DOI 10.1073/pnas.73.10.3690	45	12	12	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165604	10.1371/journal.pone.0165604	http://dx.doi.org/10.1371/journal.pone.0165604			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812122	Green Published, Green Submitted, gold			2022-12-26	WOS:000386910000037
J	Liu, G; Dong, CP; Liu, L				Liu, Gang; Dong, Chuanpeng; Liu, Lei			Integrated Multiple "-omics" Data Reveal Subtypes of Hepatocellular Carcinoma	PLOS ONE			English	Article							EXPRESSION; GENE; MIR-203; H19	Hepatocellular carcinoma is one of the most heterogeneous cancers, as reflected by its multiple grades and difficulty to subtype. In this study, we integrated copy number variation, DNA methylation, mRNA, and miRNA data with the developed "cluster of cluster" method and classified 256 HCC samples from TCGA (The Cancer Genome Atlas) into five major subgroups (S1-S5). We observed that this classification was associated with specific mutations and protein expression, and we detected that each subgroup had distinct molecular signatures. The subclasses were associated not only with survival but also with clinical observations. S1 was characterized by bulk amplification on 8q24, TP53 mutation, low lipid metabolism, highly expressed onco-proteins, attenuated tumor suppressor proteins and a worse survival rate. S2 and S3 were characterized by telomere hypomethylation and a low expression of TERT and DNMT1/3B. Compared to S2, S3 was associated with less copy number variation and some good prognosis biomarkers, including CRP and CYP2E1. In contrast, the mutation rate of CTNNB1 was higher in S3. S4 was associated with bulk amplification and various molecular characteristics at different biological levels. In summary, we classified the HCC samples into five subgroups using multiple "-omics" data. Each subgroup had a distinct survival rate and molecular signature, which may provide information about the pathogenesis of subtypes in HCC.	[Liu, Gang; Dong, Chuanpeng; Liu, Lei] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China	Fudan University	Liu, L (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China.	liulei_sibs@163.com			National High-tech R&D Program (863 Program) [2015AA020104, 2012AA02A602]; National Science and Technology Major Project [2012ZX10002010]	National High-tech R&D Program (863 Program)(National High Technology Research and Development Program of China); National Science and Technology Major Project	This work was supported by National High-tech R&D Program (863 Program) 2015AA020104 to Lei Liu; National High-tech R&D Program (863 Program) 2012AA02A602 to Lei Liu; and National Science and Technology Major Project 2012ZX10002010 to Lei Liu.	Austinat M, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-21; Borel F, 2012, J HEPATOL, V56, P1371, DOI 10.1016/j.jhep.2011.11.026; Brisbin AG, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-156; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Dong H, 2015, GENOM DATA, V6, P1, DOI 10.1016/j.gdata.2015.07.018; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Hsu HC, 2000, AM J PATHOL, V157, P763, DOI 10.1016/S0002-9440(10)64590-7; Iizuka N, 2004, ANTICANCER RES, V24, P4085; Inokawa Y, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-65; Kim JM, 2013, WORLD J SURG ONCOL, V11; Kim KS, 1997, CANCER LETT, V119, P143, DOI 10.1016/S0304-3835(97)00264-4; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Laurent-Puig P, 2001, GASTROENTEROLOGY, V120, P1763, DOI 10.1053/gast.2001.24798; Liu YR, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0214-0; Man XB, 2004, WORLD J GASTROENTERO, V10, P1565, DOI 10.3748/wjg.v10.i11.1565; Marquardt Jens U, 2012, Biology (Basel), V1, P383, DOI 10.3390/biology1020383; Matter MS, 2014, J HEPATOL, V60, P855, DOI 10.1016/j.jhep.2013.11.031; Morishita A, 2015, HEPATOL RES, V45, P128, DOI 10.1111/hepr.12386; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pei YF, 2009, ACTA BIOCH BIOPH SIN, V41, P1, DOI 10.1093/abbs/gmn001; Shen J, 2012, HEPATOLOGY, V55, P1799, DOI 10.1002/hep.25569; Song JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110074; Therneau T.M., 2000, MODELING SURVIVAL DA; Wang Z, 2015, MOL CLIN ONCOL, V3, P936, DOI 10.3892/mco.2015.569; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Xu HT, 2015, J CANCER, V6, P247, DOI 10.7150/jca.10747; Yang H, 2010, EXP BIOL MED, V235, P32, DOI 10.1258/ebm.2009.009252; Zhang F, 2014, CANCER LETT, V342, P121, DOI 10.1016/j.canlet.2013.08.037; Zhang HE, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-244; Zheng ZY, 2013, INT J MED SCI, V10, P653, DOI 10.7150/ijms.6050	34	17	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165457	10.1371/journal.pone.0165457	http://dx.doi.org/10.1371/journal.pone.0165457			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806083	gold, Green Published, Green Submitted			2022-12-26	WOS:000386715500030
J	Mertens, C; Akam, EA; Rehwald, C; Brune, B; Tomat, E; Jung, M				Mertens, Christina; Akam, Eman Abureida; Rehwald, Claudia; Bruene, Bernhard; Tomat, Elisa; Jung, Michaela			Intracellular Iron Chelation Modulates the Macrophage Iron Phenotype with Consequences on Tumor Progression	PLOS ONE			English	Article							BREAST-CANCER; SALMONELLA-TYPHIMURIUM; MEDIATED REGULATION; HOMEOSTASIS; METABOLISM; CARCINOMA; CELLS; LIPOCALIN-2; ACTIVATION; FERRITIN	A growing body of evidence suggests that macrophage polarization dictates the expression of iron-regulated genes. Polarization towards iron sequestration depletes the microenvironment, whereby extracellular pathogen growth is limited and inflammation is fostered. In contrast, iron release contributes to cell proliferation, which is important for tissue regeneration. Moreover, macrophages constitute a major component of the infiltrates in most solid tumors. Considering the pivotal role of macrophages for iron homeostasis and their presence in association with poor clinical prognosis in tumors, we approached the possibility to target macrophages with intracellular iron chelators. Analyzing the expression of iron-regulated genes at mRNA and protein level in primary human macrophages, we found that the iron-release phenotype is a characteristic of polarized macrophages that, in turn, stimulate tumor cell growth and progression. The application of the intracellular iron chelator (TC3-S)(2) shifted the macrophage phenotype from iron release towards sequestration, as determined by the iron-gene profile and atomic absorption spectroscopy (AAS). Moreover, whereas the addition of macrophage supernatants to tumor cells induced tumor growth and metastatic behavior, the supernatant of chelator-treated macrophages reversed this effect. Iron chelators demonstrated potent anti-neoplastic properties in a number of cancers, both in cell culture and in clinical trials. Our results suggest that iron chelation could affect not only cancer cells but also the tumor microenvironment by altering the iron-release phenotype of tumor-associated macrophages (TAMs). The study of iron chelators in conjunction with the effect of TAMs on tumor growth could lead to an improved understanding of the role of iron in cancer biology and to novel therapeutic avenues for iron chelation approaches.	[Mertens, Christina; Rehwald, Claudia; Bruene, Bernhard; Jung, Michaela] Goethe Univ Frankfurt, Inst Biochem 1, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Akam, Eman Abureida; Tomat, Elisa] Univ Arizona, Dept Chem & Biochem, 1306 E,Univ Blvd, Tucson, AZ 85721 USA	Goethe University Frankfurt; University of Arizona	Jung, M (corresponding author), Goethe Univ Frankfurt, Inst Biochem 1, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.; Tomat, E (corresponding author), Univ Arizona, Dept Chem & Biochem, 1306 E,Univ Blvd, Tucson, AZ 85721 USA.	tomat@email.arizona.edu; m.jung@biochem.uni-frankfurt.de	Tomat, Elisa/M-9802-2018	Tomat, Elisa/0000-0002-7075-9501; Mertens, Christina/0000-0002-0767-4759	Fritz Thyssen Stiftung [Az.10.12.2.156]; Goethe-University Frankfurt; Doktor Robert Pfleger Stiftung; University of Arizona Office of Research and Development; University of Arizona Global Initiatives; Deutsche Krebshilfe [111578]	Fritz Thyssen Stiftung; Goethe-University Frankfurt; Doktor Robert Pfleger Stiftung; University of Arizona Office of Research and Development; University of Arizona Global Initiatives; Deutsche Krebshilfe(Deutsche Krebshilfe)	The study was supported by the Fritz Thyssen Stiftung (Az.10.12.2.156 to MJ), Goethe-University Frankfurt (Focus Line B to MJ), and the Doktor Robert Pfleger Stiftung (awarded to MJ). We thank the University of Arizona Office of Research and Development for financial support (New Faculty Start-Up Funds to ET) and University of Arizona Global Initiatives for travel funds to initiate collaborative research work. Additional funding came from Deutsche Krebshilfe (111578 to BB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akam EA, 2014, METALLOMICS, V6, P1905, DOI 10.1039/c4mt00153b; Alkhateeb AA, 2013, BREAST CANCER RES TR, V137, P733, DOI 10.1007/s10549-012-2405-x; Baby SM, 2003, HISTOCHEM CELL BIOL, V120, P343, DOI 10.1007/s00418-003-0588-2; BLATT J, 1991, LEUKEMIA RES, V15, P391, DOI 10.1016/0145-2126(91)90015-L; Bories G, 2013, CIRC RES, V113, P1196, DOI 10.1161/CIRCRESAHA.113.301656; Cairo G, 2011, TRENDS IMMUNOL, V32, P241, DOI 10.1016/j.it.2011.03.007; Cairo G, 2010, HAEMATOL-HEMATOL J, V95, P1801, DOI 10.3324/haematol.2010.030239; Chang TM, 2013, DALTON T, V42, P7846, DOI 10.1039/c3dt50824b; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Coombs GS, 2012, ONCOGENE, V31, P213, DOI 10.1038/onc.2011.228; Corna G, 2010, HAEMATOL-HEMATOL J, V95, P1814, DOI 10.3324/haematol.2010.023879; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; DORNER MH, 1980, SCIENCE, V209, P1019, DOI 10.1126/science.6967622; Freitas I, 2007, ANTICANCER RES, V27, P3059; Habashy HO, 2010, BREAST CANCER RES TR, V119, P283, DOI 10.1007/s10549-009-0345-x; Hatcher HC, 2009, FUTURE MED CHEM, V1, P1643, DOI 10.4155/FMC.09.121; Jezequel P, 2012, INT J CANCER, V131, P426, DOI 10.1002/ijc.26397; Jian JL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-307; Jiang XP, 2010, ANTICANCER RES, V30, P759; Jung M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21950; Jung M, 2015, IMMUNOBIOLOGY, V220, P295, DOI 10.1016/j.imbio.2014.09.011; Jung M, 2012, KIDNEY INT, V81, P969, DOI 10.1038/ki.2011.446; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Labonte AC, 2014, MOL CELLS, V37, P275, DOI 10.14348/molcells.2014.2374; LEONARDI E, 1992, J CLIN PATHOL, V45, P416, DOI 10.1136/jcp.45.5.416; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Ludwiczek S, 2003, BLOOD, V101, P4148, DOI 10.1182/blood-2002-08-2459; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Marques O, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2228-y; Miller LD, 2011, CANCER RES, V71, P6728, DOI 10.1158/0008-5472.CAN-11-1870; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nairz M, 2008, EUR J IMMUNOL, V38, P1923, DOI 10.1002/eji.200738056; Nairz M, 2015, EUR J IMMUNOL, V45, P3073, DOI 10.1002/eji.201545569; Nairz M, 2013, J EXP MED, V210, P855, DOI 10.1084/jem.20121946; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; Niewiadomska H, 1998, J EXP CLIN CANC RES, V17, P503; Pinnix ZK, 2010, SCI TRANSL MED, V2, DOI [10.1126/scitranslmed.3001127, 10.1126/scisignal.3001127]; Pogribny IP, 2013, INT J ONCOL, V42, P1822, DOI 10.3892/ijo.2013.1855; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Recalcati S, 2012, SEMIN IMMUNOL, V24, P393, DOI 10.1016/j.smim.2013.01.001; Recalcati S, 2012, AUTOIMMUN REV, V11, P883, DOI 10.1016/j.autrev.2012.03.003; Recalcati S, 2010, ANTIOXID REDOX SIGN, V13, P1593, DOI 10.1089/ars.2009.2983; Recalcati S, 2010, EUR J IMMUNOL, V40, P824, DOI 10.1002/eji.200939889; Richardson DR, 2009, BBA-GEN SUBJECTS, V1790, P702, DOI 10.1016/j.bbagen.2008.04.003; ROSSIELLO R, 1984, J CLIN PATHOL, V37, P51, DOI 10.1136/jcp.37.1.51; Ruffell B, 2012, P NATL ACAD SCI USA, V109, P2796, DOI 10.1073/pnas.1104303108; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Siddiq A, 2007, NEUROCHEM RES, V32, P931, DOI 10.1007/s11064-006-9268-7; Sola A, 2011, J PATHOL, V225, P597, DOI 10.1002/path.2982; Tchekmedyian NS, 2002, ONCOLOGY-NY, V16, P17; Torti Suzy V., 2013, Critical Reviews in Oncogenesis, V18, P435; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Wang W, 2014, CANCER RES, V74, P497, DOI 10.1158/0008-5472.CAN-13-1224; Weiss G, 2005, BEST PRACT RES CL HA, V18, P183, DOI 10.1016/j.beha.2004.09.001; Yu Y, 2007, CELL CYCLE, V6, P1982, DOI 10.4161/cc.6.16.4603; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076147	56	53	55	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0166164	10.1371/journal.pone.0166164	http://dx.doi.org/10.1371/journal.pone.0166164			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806101	gold, Green Published, Green Submitted			2022-12-26	WOS:000386715500083
J	Lee, D; Park, SM				Lee, Donghoon; Park, Sang Min			Cost-Effectiveness Analysis of Hepatitis B Vaccination Strategies to Prevent Perinatal Transmission in North Korea: Selective Vaccination vs. Universal Vaccination	PLOS ONE			English	Article							VERTICAL TRANSMISSION; ECONOMIC-EVALUATION; VIRUS HBV; E-ANTIGEN; IMMUNIZATION; IMMUNOPROPHYLAXIS; AFFORDABILITY; EXPERIENCE; MOZAMBIQUE; INFECTION	Background To tackle the high prevalence of Hepatitis B virus (HBV) infection in North Korea, it is essential that birth doses of HBV vaccines should be administered within 24 hours of birth. As the country fails to provide a Timely Birth Dose (TBD) of HBV vaccine, the efforts of reducing the high prevalence of HBV have been significantly hampered. Methods To examine the cost-effectiveness of vaccination strategies to prevent perinatal transmission of HBV in North Korea, we established a decision tree with a Markov model consisting of selective, universal, and the country's current vaccination program against HBV. The cost-effectiveness analysis was performed from societal and payer's perspectives and evaluated by Disability Adjusted Life Year (DALY). Results The results suggest that introducing the universal vaccination would prevent 1,866 cases of perinatal infections per 100,000 of the birth cohort of 2013. Furthermore, 900 cases of perinatal infections per 100,000 could be additionally averted if switching to the selective vaccination. The current vaccination is a dominated strategy both from the societal and payer's perspective. The Incremental Cost-Effectiveness Ratio (ICER) between universal and selective vaccination is $267 from the societal perspective and is reported as $ 273 from the payer's perspective. Conclusion Based on the assumption that the 2012 Gross Domestic Product (GDP) per capita in North Korea, $582.6 was set for cost-effectiveness criteria, the result of this study indicates that selective vaccination may be a highly cost-effective strategy compared to universal vaccination.	[Lee, Donghoon] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea; [Park, Sang Min] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Park, Sang Min] Seoul Natl Univ, Coll Med, Dept Family Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Park, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.; Park, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Family Med, Seoul, South Korea.	smpark_snuh@gmail.com	Park, Sang Min/V-9194-2019					Adibi P, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-31; Amnesty International, 2010, CRUMBL STAT HLTH CAR; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P405; [Anonymous], GLOB BURD DIS 2004 U; BEASLEY RP, 1977, AM J EPIDEMIOL, V105, P94, DOI 10.1093/oxfordjournals.aje.a112370; Chen HL, 2012, GASTROENTEROLOGY, V142, P773, DOI 10.1053/j.gastro.2011.12.035; Chen SCC, 2013, PEDIATRICS, V131, pE1135, DOI 10.1542/peds.2012-1262; Choi HR, 1999, J KOREAN ACAD FAM ME, V20, P1778; Edejer T.T.-T., 2003, MAKING CHOICES HLTH, V1; Edmunds WJ, 1996, EPIDEMIOL INFECT, V117, P313, DOI 10.1017/S0950268800001497; Evans AA, 2015, VACCINE, V33, P3010, DOI 10.1016/j.vaccine.2015.01.054; Fan L, 2014, OBSTET GYNECOL, V123, P929, DOI 10.1097/AOG.0000000000000124; GHENDON Y, 1987, J VIROL METHODS, V17, P69, DOI 10.1016/0166-0934(87)90070-X; Global Alliance for Vaccines and Immunization, 2002, PROP HEP B MON VACC; Global Alliance for Vaccines and Immunization, 2011, COMPR MULT PLAN IMM; Global Alliance for Vaccines and Immunization, ALL COUNTR COMM AND; Global Alliance for Vaccines and Immunization, 2011, PROP DTP HEPB HIB PE; Goe LC, 2005, PUBLIC HEALTH, V119, P347, DOI 10.1016/j.puhe.2004.05.024; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Griffiths UK, 2005, HEALTH POLICY PLANN, V20, P50, DOI 10.1093/heapol/czi006; Grundy J, 2009, INT J HEALTH PLAN M, V24, P113, DOI 10.1002/hpm.958; Hutton DW, 2007, ANN INTERN MED, V147, P460, DOI 10.7326/0003-4819-147-7-200710020-00004; Jeong EC., 2012, THESIS KYUNGPOOK NAT; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Kim SY, 2007, B WORLD HEALTH ORGAN, V85, P833, DOI 10.2471/BLT.06.038893; Klingler C, 2012, VACCINE, V31, P252, DOI 10.1016/j.vaccine.2012.08.007; Lu SQ, 2013, VACCINE, V31, P1864, DOI 10.1016/j.vaccine.2013.01.020; MARGOLIS HS, 1995, JAMA-J AM MED ASSOC, V274, P1201, DOI 10.1001/jama.274.15.1201; Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8; SEHGAL A, 1992, J TROP PEDIATRICS, V38, P247, DOI 10.1093/tropej/38.5.247; Sendi PP, 2001, HEALTH ECON, V10, P675; Siddiqui MR, 2011, VACCINE, V29, P466, DOI 10.1016/j.vaccine.2010.10.075; STEVENS CE, 1975, NEW ENGL J MED, V292, P771, DOI 10.1056/NEJM197504102921503; Stouthard MEA, 1997, DISABILITY WEIGHTS D; Tandon A, 2002, MEASURING HLTH SYSTE; Tu Hong Anh T, 2012, Value Health Reg Issues, V1, P7, DOI 10.1016/j.vhri.2012.03.007; UNICEF Supplies and Logistics, VACC PRIC DAT DTP HE; United Nations, UN DAT DPR KOR; Vaccines and Immunization, 2014, ANN PROGR REP 2013 K; Vimolket Thosporn, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P693; WHEELEY SM, 1991, J MED VIROL, V35, P212, DOI 10.1002/jmv.1890350312; *WHO, 2009, WHO COUNTR COOP STRA; WHO Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E; Wiseman E, 2009, MED J AUSTRALIA, V190, P489, DOI 10.5694/j.1326-5377.2009.tb02524.x; WONG VCW, 1984, LANCET, V1, P921; World Health Organization, 2013, EPI FACTSH DPR KOR 2; World Health Organization, GLOB HLTH OBS DAT RE; World Health Organization, 2001, HEPATITIS B SURFACE; World Health Organization, 2003, WHO COUNTR COOP STRA; ZANETTI AR, 1986, J MED VIROL, V18, P327, DOI 10.1002/jmv.1890180405; ZANETTI AR, 1983, DEV BIOLOGICALS, V54, P383	51	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165879	10.1371/journal.pone.0165879	http://dx.doi.org/10.1371/journal.pone.0165879			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802340	Green Submitted, Green Published, gold			2022-12-26	WOS:000386714200065
J	Han, HY; Liang, XM; Ekberg, M; Kritikou, JS; Brunnstrom, A; Pelcman, B; Matl, M; Miao, XY; Andersson, M; Yuan, XT; Schain, F; Parvin, S; Melin, E; Sjoberg, J; Xu, DW; Westerberg, LS; Bjorkholm, M; Claesson, HE				Han, Hongya; Liang, Xiuming; Ekberg, Monica; Kritikou, Joanna S.; Brunnstrom, Asa; Pelcman, Benjamin; Matl, Maria; Miao, Xinyan; Andersson, Margareta; Yuan, Xiaotian; Schain, Frida; Parvin, Selina; Melin, Eva; Sjoberg, Jan; Xu, Dawei; Westerberg, Lisa S.; Bjorkholm, Magnus; Claesson, Hans-Erik			Human 15-lipoxygenase-1 is a regulator of dendritic-cell spreading and podosome formation	FASEB JOURNAL			English	Article						arachidonic acid; cell migration; dermatitis; endocytosis	PRORESOLVING MEDIATORS; SURFACE EXPRESSION; UP-REGULATION; SOLUBLE FORM; CD83; 12/15-LIPOXYGENASE; ACID; INFLAMMATION; EOXINS; PROSTAGLANDIN-E2	Dendritic cells (DCs) involved in proinflammatory immune responses derive mainly from peripheral monocytes, and the cells subsequently mature and migrate into the inflammatory micromilieu. Here we report that suppressing of 15-lipoxygenase-1 led to a substantial reduction in DC spreading and podosome formation in vitro. The surface expression of CD83 was significantly lower in both sh-15-lipoxygenase-1 (15-LOX-1)-transduced cells and DCs cultivated in the presence of a novel specific 15-LOX-1 inhibitor. The T-cell response against tetanus-pulsed DCs was only affected to a minor extent on inhibition of 15-LOX-1. In contrast, endocytosis and migration ability of DCs were significantly suppressed on 15-LOX-1 inhibition. The expression of 15-LOX-1 in DCs was also demonstrated in affected human skin in atopic and contact dermatitis, showing that the enzyme is indeed expressed in inflammatory diseases in vivo. This study demonstrated that inhibiting 15-LOX-1 led to an impaired podosome formation in DCs, and consequently suppressed antigen uptake and migration capacity. These results indicated that 15-LOX-1 is a potential target for inhibiting the trafficking of DCs to lymphoid organs and inflamed tissues and decreasing the inflammatory response attenuating symptoms of certain immunologic and inflammatory disorders such as dermatitis.-Han, H., Liang, X., Ekberg, M., Kritikou, J. S., Brunnstro " m, angstrom., Pelcman, B., Matl, M., Miao, X., Andersson, M., Yuan, X., Schain, F., Parvin, S., Melin, E., Sjoberg, J., Xu, D., Westerberg, L. S., Bjorkholm, M., Claesson, H.- E. Human 15-lipoxygenase- 1 is a regulator of dendritic-cell spreading and podosome formation.	[Han, Hongya] Karolinska Univ, Huddinge Hosp, Ctr Hematol & Regenerat Med, Karolinska Inst,Dept Med, Stockholm, Sweden; [Han, Hongya; Liang, Xiuming; Ekberg, Monica; Brunnstrom, Asa; Andersson, Margareta; Yuan, Xiaotian; Schain, Frida; Parvin, Selina; Sjoberg, Jan; Xu, Dawei; Bjorkholm, Magnus; Claesson, Hans-Erik] Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Med,Div Hematol, Stockholm, Sweden; [Matl, Maria] Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Med,Clin Immunol & Allergy Unit, Stockholm, Sweden; [Miao, Xinyan] Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Med,Clin Pharmacol Grp, Stockholm, Sweden; [Kritikou, Joanna S.; Westerberg, Lisa S.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Pelcman, Benjamin] Uppsala Univ, Dept Med Chem, Organ Pharmaceut Chem, Uppsala, Sweden; [Melin, Eva] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Uppsala University; Danderyds Hospital; Karolinska Institutet	Han, HY (corresponding author), Karolinska Univ, Huddinge Hosp, Ctr Hematol & Regenerat Med, Karolinska Inst,Dept Med, Halsovagen 7, Huddinge, Sweden.	ya.han@ki.se	Melin, Eva/AAF-8222-2020; Westerberg, Lisa/AAB-3808-2019	Claesson, Hans-Erik/0000-0002-1960-6542; Westerberg, Lisa/0000-0003-2943-2192	Cancer Foundation; Swedish Cancer Society; Lars Hiertas Foundation; Karolinska Institutet	Cancer Foundation; Swedish Cancer Society(Swedish Cancer Society); Lars Hiertas Foundation; Karolinska Institutet(Karolinska Institutet)	The authors thank A. Cimarelli (INSERM Unite 1111, Lyon, France), for providing the plasmid SIV3<SUP>+</SUP>. The authors also thank S. Ganesan (Karolinska Institutet, Karolinska University Hospital Huddinge) for helpful discussion. This work was supported, in part, by the Cancer Foundation, Swedish Cancer Society, the Lars Hiertas Foundation, and the Karolinska Institutet.	Andersson CK, 2008, AM J RESP CELL MOL, V39, P648, DOI 10.1165/rcmb.2007-0443OC; Berger G, 2011, NAT PROTOC, V6, P806, DOI 10.1038/nprot.2011.327; Brunnstrom A, 2015, PROSTAG OTH LIPID M, V121, P83, DOI 10.1016/j.prostaglandins.2015.04.010; Claesson HE, 2008, FEBS J, V275, P4222, DOI 10.1111/j.1742-4658.2008.06570.x; Claesson HE, 2009, PROSTAG OTH LIPID M, V89, P120, DOI 10.1016/j.prostaglandins.2008.12.003; CONRAD DJ, 1992, P NATL ACAD SCI USA, V89, P217, DOI 10.1073/pnas.89.1.217; Deschamps JD, 2006, BIOORGAN MED CHEM, V14, P4295, DOI 10.1016/j.bmc.2006.01.057; Feltenmark S, 2008, P NATL ACAD SCI USA, V105, P680, DOI 10.1073/pnas.0710127105; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Gulliksson M, 2007, BBA-MOL CELL BIOL L, V1771, P1156, DOI 10.1016/j.bbalip.2007.06.001; Hajek AR, 2008, J ALLERGY CLIN IMMUN, V122, P633, DOI 10.1016/j.jaci.2008.06.021; Han H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091499; Han HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085085; Heydeck D, 1998, BLOOD, V92, P2503, DOI 10.1182/blood.V92.7.2503.2503_2503_2510; Hock BD, 2001, INT IMMUNOL, V13, P959, DOI 10.1093/intimm/13.7.959; Hsieh Chia-Jung, 2007, Clin Mol Allergy, V5, P5, DOI 10.1186/1476-7961-5-5; Hunger RE, 2004, J CLIN INVEST, V113, P701, DOI 10.1172/JCI200419655; Ivanov I, 2015, GENE, V573, P1, DOI 10.1016/j.gene.2015.07.073; James A, 2013, INT ARCH ALLERGY IMM, V162, P37, DOI 10.1159/000351422; Kotzor N, 2004, IMMUNOBIOLOGY, V209, P129, DOI 10.1016/j.imbio.2004.04.003; Kruse M, 2000, J EXP MED, V191, P1581, DOI 10.1084/jem.191.9.1581; Kuhn H, 1999, LIPIDS, V34, pS273, DOI 10.1007/BF02562317; Kumar J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111759; Lechmann M, 2002, TRENDS IMMUNOL, V23, P273, DOI 10.1016/S1471-4906(02)02214-7; Lechmann M, 2001, J EXP MED, V194, P1813, DOI 10.1084/jem.194.12.1813; Liu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052703; Liu C, 2012, EXP CELL RES, V318, P169, DOI 10.1016/j.yexcr.2011.10.017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Miller YI, 2001, J BIOL CHEM, V276, P19431, DOI 10.1074/jbc.M011276200; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Norgauer J, 2003, INT J MOL MED, V12, P83; Prechtel AT, 2007, J IMMUNOL, V178, P5454, DOI 10.4049/jimmunol.178.9.5454; Rice RL, 1998, INT J CANCER, V77, P271, DOI 10.1002/(SICI)1097-0215(19980717)77:2<271::AID-IJC17>3.0.CO;2-E; Rothe T, 2015, J CLIN INVEST, V125, P1944, DOI 10.1172/JCI78490; Sacharzewska E, 2016, ADV MED SCI-POLAND, V61, P141, DOI 10.1016/j.advms.2015.11.001; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Satoh Takeshi, 2013, Methods Mol Biol, V960, P401, DOI 10.1007/978-1-62703-218-6_30; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Schwartz S, 2005, PSYCHOACTIVE HERBS IN VETERINARY BEHAVIOR MEDICINE, P1, DOI 10.1002/9780470344644; SCHWENK U, 1992, J BIOL CHEM, V267, P12482; Senechal B, 2004, BLOOD, V103, P4207, DOI 10.1182/blood-2003-12-4350; Spanbroek R, 2001, P NATL ACAD SCI USA, V98, P5152, DOI 10.1073/pnas.091076998; Sreeramkumar V, 2016, IMMUNOL CELL BIOL, V94, P39, DOI 10.1038/icb.2015.62; Stein K, 2016, J LEUKOCYTE BIOL, V99, P231, DOI 10.1189/jlb.3HI0515-189R; Tang K, 1997, ADV EXP MED BIOL, V422, P71; Wilson NS, 2004, IMMUNOL CELL BIOL, V82, P91, DOI 10.1111/j.1440-1711.2004.01216.x; Yamada T, 2011, FASEB J, V25, P561, DOI 10.1096/fj.10-170027; Zhan YF, 2012, MOL IMMUNOL, V52, P30, DOI 10.1016/j.molimm.2012.04.009; Zhao JM, 2011, P NATL ACAD SCI USA, V108, P14246, DOI 10.1073/pnas.1018075108; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588; Zinser E, 2004, J EXP MED, V200, P345, DOI 10.1084/jem.20030973	52	11	14	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					491	504		10.1096/fj.201600679RR	http://dx.doi.org/10.1096/fj.201600679RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27825104				2022-12-26	WOS:000394235400006
J	Chiara, DC; Jounaidi, Y; Zhou, XJ; Savechenkov, PY; Bruzik, KS; Miller, KW; Cohen, JB				Chiara, David C.; Jounaidi, Youssef; Zhou, Xiaojuan; Savechenkov, Pavel Y.; Bruzik, Karol S.; Miller, Keith W.; Cohen, Jonathan B.			General Anesthetic Binding Sites in Human alpha 4 beta 3 delta gamma-Aminobutyric Acid Type A Receptors (GABAARs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRASYNAPTIC GABA(A) RECEPTORS; DELTA-SUBUNIT; INTRAVENOUS ANESTHETICS; TRANSMEMBRANE DOMAIN; ALLOSTERIC MODULATION; FUNCTIONAL-PROPERTIES; ETOMIDATE; STOICHIOMETRY; PROPOFOL; ALPHA-1-BETA-3-DELTA	Extrasynaptic gamma-aminobutyric acid type A receptors (GABA(A)Rs), which contribute generalized inhibitory tone to the mammalian brain, are major targets for general anesthetics. To identify anesthetic binding sites in an extrasynaptic GABA(A)R, we photolabeled human alpha 4 beta 3 delta GABA(A)Rs purified in detergent with [H-3]azietomidate and a barbiturate, [H-3]R-mTFD-MPAB, photoreactive anesthetics that bind with high selectivity to distinct but homologous intersubunit binding sites in the transmembrane domain of synaptic alpha 1 beta 3 gamma 2 GABA(A)Rs. Based upon H-3 incorporation into receptor subunits resolved by SDS-PAGE, there was etomidate-inhibitable labeling by [H-3] azietomidate in the alpha 4 and beta 3 subunits and barbiturate-inhibitable labeling by [H-3] R-mTFD-MPAB in the beta 3 subunit. These sites did not bind the anesthetic steroid alphaxalone, which enhanced photolabeling, or DS-2, a delta subunit-selective positive allosteric modulator, which neither enhanced nor inhibited photolabeling. The amino acids labeled by [H-3] azietomidate or [H-3] R-mTFD-MPAB were identified by N-terminal sequencing of fragments isolated by HPLC fractionation of enzymatically digested subunits. No evidence was found for a delta subunit contribution to an anesthetic binding site. [H-3] azietomidate photolabeling of beta 3Met-286 in beta M3 and alpha 4Met-269 in alpha M1 that was inhibited by etomidate but not by R-mTFD-MPAB established that etomidate binds to a site at the alpha 3(+)-alpha 4(-) interface equivalent to its site in alpha 1 beta 3 gamma 2 GABA(A)Rs. [H-3] Azietomidate and [H-3] R-mTFD-MPAB photolabeling of beta 3Met-227 in beta M1 established that these anesthetics also bind to a homologous site, most likely at the beta 3(+)-beta 3(-) interface, which suggests a subunit arrangement of beta 3 alpha 4 beta 3 delta beta 3.	[Chiara, David C.; Cohen, Jonathan B.] Harvard Med Sch, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA; [Miller, Keith W.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Jounaidi, Youssef; Zhou, Xiaojuan; Miller, Keith W.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Savechenkov, Pavel Y.; Bruzik, Karol S.] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL 60612 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cohen, JB (corresponding author), Harvard Med Sch, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	jonathan_cohen@hms.harvard.edu			National Institutes of Health [GM-58448]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-58448. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amlong CA, 2016, ANESTH ANALG, V123, P1241, DOI 10.1213/ANE.0000000000001358; Barrera NP, 2008, MOL PHARMACOL, V73, P960, DOI 10.1124/mol.107.042481; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; Bieda MC, 2009, ANESTH ANALG, V108, P484, DOI 10.1213/ane.0b013e3181904571; Botzolakis EJ, 2016, J BIOL CHEM, V291, P20440, DOI 10.1074/jbc.M115.698860; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Chiara DC, 2013, J BIOL CHEM, V288, P19343, DOI 10.1074/jbc.M113.479725; Chiara DC, 2012, BIOCHEMISTRY-US, V51, P836, DOI 10.1021/bi201772m; Dostalova Z, 2014, PROTEIN SCI, V23, P157, DOI 10.1002/pro.2401; Drexler B, 2011, CAN J ANESTH, V58, P178, DOI 10.1007/s12630-010-9414-1; Eaton MM, 2014, MOL PHARMACOL, V86, P647, DOI 10.1124/mol.114.094813; Estrada-Mondragon A, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00055; Feng HJ, 2014, BRIT J PHARMACOL, V171, P789, DOI 10.1111/bph.12507; Feng HJ, 2010, J BIOL CHEM, V285, P23614, DOI 10.1074/jbc.M110.122564; Forman SA, 2015, NEUROPHARMACOLOGY, V96, P169, DOI 10.1016/j.neuropharm.2014.10.002; Gauci S, 2009, ANAL CHEM, V81, P4493, DOI 10.1021/ac9004309; Hartiadi LY, 2016, BIOCHEM PHARMACOL, V103, P98, DOI 10.1016/j.bcp.2015.12.021; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Jayakar SS, 2015, J BIOL CHEM, V290, P23432, DOI 10.1074/jbc.M115.672006; Jayakar SS, 2014, J BIOL CHEM, V289, P27456, DOI 10.1074/jbc.M114.581728; Jensen ML, 2013, BRIT J PHARMACOL, V168, P1118, DOI 10.1111/bph.12001; Jia F, 2008, J PHARMACOL EXP THER, V324, P1127, DOI 10.1124/jpet.107.134569; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Kaur KH, 2009, J BIOL CHEM, V284, P7889, DOI 10.1074/jbc.M806484200; Krasowski MD, 2001, NEUROPHARMACOLOGY, V41, P952, DOI 10.1016/S0028-3908(01)00141-1; Kretschmannova K, 2013, J NEUROSCI, V33, P7264, DOI 10.1523/JNEUROSCI.5475-12.2013; Lambert Jeremy J, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS48, DOI 10.1016/j.psyneuen.2009.08.009; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Liao M, 2005, ANESTH ANALG, V101, P131, DOI 10.1213/01.ANE.0000153011.64764.6F; Maldifassi MC, 2016, NEUROPHARMACOLOGY, V105, P207, DOI 10.1016/j.neuropharm.2016.01.003; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Nourmahnad A, 2016, ANESTHESIOLOGY, V125, P1144, DOI 10.1097/ALN.0000000000001390; Patel B, 2014, BRIT J PHARMACOL, V171, P985, DOI 10.1111/bph.12514; Patel P.M., 2011, GOODMAN GILMANS PHAR, P527; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Puthenkalam R, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00044; Reynolds DS, 2003, J NEUROSCI, V23, P8608; Sauguet L, 2015, BBA-GEN SUBJECTS, V1850, P511, DOI 10.1016/j.bbagen.2014.05.007; Savechenkov PY, 2012, J MED CHEM, V55, P6554, DOI 10.1021/jm300631e; Sieghart W, 2015, ADV PHARMACOL, V72, P53, DOI 10.1016/bs.apha.2014.10.002; Siegwart R, 2002, J NEUROCHEM, V80, P140, DOI 10.1046/j.0022-3042.2001.00682.x; Sigel E., 2005, BENZODIAZEPINE RECOG; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Stewart D, 2008, MOL PHARMACOL, V74, P1687, DOI 10.1124/mol.108.050500; Stewart DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111470; Stewart DS, 2013, J BIOL CHEM, V288, P30373, DOI 10.1074/jbc.M113.494583; Wagoner KR, 2010, J BIOL CHEM, V285, P14187, DOI 10.1074/jbc.M110.104257; Wongsamitkul N, 2016, J BIOL CHEM, V291, P18474, DOI 10.1074/jbc.M116.738906; Ziebell MR, 2004, J BIOL CHEM, V279, P17640, DOI 10.1074/jbc.M313886200	50	16	16	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26529	26539		10.1074/jbc.M116.753335	http://dx.doi.org/10.1074/jbc.M116.753335			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27821594	Green Published, hybrid			2022-12-26	WOS:000391568200025
J	Huang, Z; Zhong, XJ; He, J; Jin, SH; Quo, HD; Yu, XF; Zhou, YJ; Li, X; Ma, MD; Chen, QB; Long, H				Huang, Zhuo; Zhong, Xiao-Juan; He, Jiao; Jin, Si-Han; Quo, Han-Du; Yu, Xiao-Fang; Zhou, Yu-Jue; Li, Xi; Ma, Ming-Dong; Chen, Qi-Bing; Long, Hai			Genome-Wide Identification, Characterization, and Stress-Responsive Expression Profiling of Genes Encoding LEA (Late Embryogenesis Abundant) Proteins in Moso Bamboo (Phyllostachys edulis)	PLOS ONE			English	Article							FREEZING TOLERANCE; WATER-DEFICIT; ARABIDOPSIS; DROUGHT; FAMILY; SALT; PHYLOGENY; EVOLUTION; SEQUENCE; ELEMENTS	Late embryogenesis abundant (LEA) proteins have been identified in a wide range of organisms and are believed to play a role in the adaptation of plants to stress conditions. In this study, we performed genome-wide identification of LEA proteins and their coding genes in Moso bamboo (Phyllostachys edulis) of Poaceae. A total of 23 genes encoding LEA proteins (PeLEAs) were found in P. edulis that could be classified to six groups based on Pfam protein family and homologous analysis. Further in silico analyses of the structures, gene amount, and biochemical characteristics were conducted and compared with those of O. sativa (OsLEAs), B. distachyon (BdLEAs), Z. mays (ZmLEAs), S. bicolor (SbLEAs), Arabidopsis, and Populus trichocarpa. The less number of PeLEAs was found. Evolutionary analysis revealed orthologous relationship and colinearity between P. edulis, O. sativa, B. distachyon, Z. mays, and S. bicolor. Analyses of the non-synonymous (Ka) and synonymous (Ks) substitution rates and their ratios indicated that the duplication of PeLEAs may have occurred around 18.8 million years ago (MYA), and divergence time of LEA family among the P. edulis-O. sativa and P. edulis-B. distachyon, P. edulis-S. bicolor, and P. edulis-Z. mays was approximately 30 MYA, 36 MYA, 48 MYA, and 53 MYA, respectively. Almost all PeLEAs contain ABA-and (or) stress-responsive regulatory elements. Further RNA-seq analysis revealed approximately 78% of PeLEAs could be up-regulated by dehydration and cold stresses. The present study makes insights into the LEA family in P. edulis and provides inventory of stress-responsive genes for further functional validation and transgenic research aiming to plant genetic improvement of abiotic stress tolerance.	[Huang, Zhuo; Zhong, Xiao-Juan; He, Jiao; Jin, Si-Han; Quo, Han-Du; Yu, Xiao-Fang; Zhou, Yu-Jue; Li, Xi; Ma, Ming-Dong; Chen, Qi-Bing] Sichuan Agr Univ, Coll Landscape Architecture, 211 Huimin Rd, Chengdu 611130, Sichuan, Peoples R China; [Long, Hai] Chinese Acad Sci, Chengdu Inst Biol, Chengdu 610041, Sichuan, Peoples R China	Sichuan Agricultural University; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Huang, Z (corresponding author), Sichuan Agr Univ, Coll Landscape Architecture, 211 Huimin Rd, Chengdu 611130, Sichuan, Peoples R China.; Long, H (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu 610041, Sichuan, Peoples R China.	duoduo609@sina.com; hailong@cib.ac.cn		Qibing, Chen/0000-0001-6466-2618	Department of Science and Technology of Sichuan Province, China [2015JY0085]; Science and Technology Support Project of Sichuan Province, China [16ZC2871]	Department of Science and Technology of Sichuan Province, China; Science and Technology Support Project of Sichuan Province, China	This work was Financially supported by Department of Science and Technology of Sichuan Province, China (2015JY0085) and Science and Technology Support Project of Sichuan Province, China (16ZC2871).	BAKER J, 1988, PLANT MOL BIOL, V11, P277, DOI 10.1007/BF00027385; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Battaglia M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00190; Bies-Etheve N, 2008, PLANT MOL BIOL, V67, P107, DOI 10.1007/s11103-008-9304-x; Brini F, 2007, PLANT CELL REP, V26, P2017, DOI 10.1007/s00299-007-0412-x; DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033; DURE L, 1989, PLANT MOL BIOL, V12, P475, DOI 10.1007/BF00036962; Filiz E, 2013, PLANT OMICS, V6, P433; GALAU GA, 1993, PLANT PHYSIOL, V101, P695, DOI 10.1104/pp.101.2.695; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Imai R, 1996, GENE, V170, P243, DOI 10.1016/0378-1119(95)00868-3; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Ismail AM, 1999, PLANT PHYSIOL, V120, P237, DOI 10.1104/pp.120.1.237; Kim HS, 2005, GENE, V344, P115, DOI 10.1016/j.gene.2004.09.012; Kimura M, 2003, PHOTOCHEM PHOTOBIOL, V77, P226, DOI 10.1562/0031-8655(2003)077&lt;0226:IOAGRB&gt;2.0.CO;2; Lan T, 2013, TREE GENET GENOMES, V9, P253, DOI 10.1007/s11295-012-0551-2; Liang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083056; Liang JJ, 2012, MOL BREEDING, V30, P441, DOI 10.1007/s11032-011-9633-3; Liu Y, 2013, PLANT CELL PHYSIOL, V54, P944, DOI 10.1093/pcp/pct047; Lobovikov M., 2007, WORLD BAMBOO RESOURC, VVolume 18; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; MAITRA N, 1994, PLANT PHYSIOL, V106, P805, DOI 10.1104/pp.106.2.805; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nylander M, 2001, PLANT MOL BIOL, V45, P263, DOI 10.1023/A:1006469128280; Park SC, 2011, PLANTA, V233, P621, DOI 10.1007/s00425-010-1326-3; Peng ZH, 2013, NAT GENET, V45, P456, DOI 10.1038/ng.2569; PIATKOWSKI D, 1990, PLANT PHYSIOL, V94, P1682, DOI 10.1104/pp.94.4.1682; Shih MD, 2008, ADV BOT RES, V48, P211, DOI 10.1016/S0065-2296(08)00404-7; Sivamani E, 2000, PLANT SCI, V155, P1, DOI 10.1016/S0168-9452(99)00247-2; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang MZ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0290-7; Wang XS, 2007, PLANT SCI, V172, P414, DOI 10.1016/j.plantsci.2006.10.004; Wu HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126657; Wu ZQ, 2012, MOL PHYLOGENET EVOL, V62, P573, DOI 10.1016/j.ympev.2011.10.019; Xu DP, 1996, PLANT PHYSIOL, V110, P249, DOI 10.1104/pp.110.1.249; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yang ZF, 2008, J MOL EVOL, V67, P266, DOI 10.1007/s00239-008-9143-z; Zegzouti H, 1997, PLANT MOL BIOL, V35, P847, DOI 10.1023/A:1005860302313; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	46	32	37	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165953	10.1371/journal.pone.0165953	http://dx.doi.org/10.1371/journal.pone.0165953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829056	gold, Green Published, Green Submitted			2022-12-26	WOS:000387724300069
J	Li, LJ; Velumian, AA; Samoilova, M; Fehlings, MG				Li, Lijun; Velumian, Alexander A.; Samoilova, Marina; Fehlings, Michael G.			A Novel Approach for Studying the Physiology and Pathophysiology of Myelinated and Non-Myelinated Axons in the CNS White Matter	PLOS ONE			English	Article							SPINAL-CORD AXONS; COMPOUND ACTION-POTENTIALS; VISUAL CALLOSAL AXONS; CORPUS-CALLOSUM; ISCHEMIC-INJURY; ANOXIC INJURY; IMPULSE CONDUCTION; UNMYELINATED AXONS; RAT; BRAIN	Advances in brain connectomics set the need for detailed knowledge of functional properties of myelinated and non-myelinated (if present) axons in specific white matter pathways. The corpus callosum (CC), a major white matter structure interconnecting brain hemispheres, is extensively used for studying CNS axonal function. Unlike another widely used CNS white matter preparation, the optic nerve where all axons are myelinated, the CC contains also a large population of non-myelinated axons, making it particularly useful for studying both types of axons. Electrophysiological studies of optic nerve use suction electrodes on nerve ends to stimulate and record compound action potentials (CAPs) that adequately represent its axonal population, whereas CC studies use microelectrodes (MEs), recording from a limited area within the CC. Here we introduce a novel robust isolated "whole" CC preparation comparable to optic nerve. Unlike ME recordings where the CC CAP peaks representing myelinated and non-myelinated axons vary broadly in size, "whole" CC CAPs show stable reproducible ratios of these two main peaks, and also reveal a third peak, suggesting a distinct group of smaller caliber non-myelinated axons. We provide detailed characterization of "whole" CC CAPs and conduction velocities of myelinated and non-myelinated axons along the rostro-caudal axis of CC body and show advantages of this preparation for comparing axonal function in wild type and dysmyelinated shiverer mice, studying the effects of temperature dependence, bath-applied drugs and ischemia modeled by oxygen-glucose deprivation. Due to the isolation from gray matter, our approach allows for studying CC axonal function without possible "contamination" by reverberating signals from gray matter. Our analysis of "whole" CC CAPs revealed higher complexity of myelinated and non-myelinated axonal populations, not noticed earlier. This preparation may have a broad range of applications as a robust model for studying myelinated and non-myelinated axons of the CNS in various experimental models.	[Li, Lijun; Velumian, Alexander A.; Samoilova, Marina; Fehlings, Michael G.] Univ Hlth Network, Krembil Res Inst, Div Genet & Dev, Toronto, ON, Canada; [Velumian, Alexander A.; Fehlings, Michael G.] Univ Hlth Network, Div Neurosurg, Toronto, ON, Canada; [Fehlings, Michael G.] Univ Hlth Network, Krembil Neurosci Ctr, Toronto, ON, Canada; [Velumian, Alexander A.] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON, Canada; [Velumian, Alexander A.; Fehlings, Michael G.] Univ Toronto, Fac Med, Dept Surg, Toronto, ON, Canada	Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Fehlings, MG (corresponding author), Univ Hlth Network, Krembil Res Inst, Div Genet & Dev, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Hlth Network, Div Neurosurg, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Hlth Network, Krembil Neurosci Ctr, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Toronto, Fac Med, Dept Surg, Toronto, ON, Canada.	michael.fehlings@uhn.ca		Fehlings, Michael/0000-0002-5722-6364	Ontario Brain Institute; NeuroDevNet Canadian Network of Centres of Excellence; Halbert Chair in Neural Repair and Regeneration; DeZwirek Foundation	Ontario Brain Institute; NeuroDevNet Canadian Network of Centres of Excellence; Halbert Chair in Neural Repair and Regeneration; DeZwirek Foundation	No specific funding was received for this work but Michael G. Fehlings is supported by the Ontario Brain Institute, NeuroDevNet Canadian Network of Centres of Excellence, Halbert Chair in Neural Repair and Regeneration and the DeZwirek Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboitiz F, 2003, BRAZ J MED BIOL RES, V36, P409, DOI 10.1590/S0100-879X2003000400002; ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Agrawal SK, 1997, J NEUROSCI, V17, P1055; Alix JJP, 2009, ANN NEUROL, V66, P682, DOI 10.1002/ana.21767; Allen L, 2006, J NEUROPHYSIOL, V95, P1917, DOI 10.1152/jn.00637.2005; Baker AJ, 2002, J NEUROTRAUM, V19, P587, DOI 10.1089/089771502753754064; Bakker R, 2015, NEUROINFORMATICS, V13, P353, DOI 10.1007/s12021-014-9258-x; Baltan Selva, 2006, Critical Reviews in Neurobiology, V18, P95; Baltan S, 2008, J NEUROSCI, V28, P1479, DOI 10.1523/JNEUROSCI.5137-07.2008; Baltan S, 2010, J NEUROSCI, V30, P5644, DOI 10.1523/JNEUROSCI.5956-09.2010; Bando Y, 2008, EUR J NEUROSCI, V28, P1731, DOI 10.1111/j.1460-9568.2008.06474.x; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; BERGJOHNSEN J, 1992, BRAIN RES, V576, P319, DOI 10.1016/0006-8993(92)90696-7; BERRY RL, 1990, J NEUROSCI METH, V33, P171, DOI 10.1016/0165-0270(90)90021-7; Black JA, 2002, MOL BRAIN RES, V105, P19, DOI 10.1016/S0169-328X(02)00385-6; Bolton Sally, 2005, Journal of Pharmacological and Toxicological Methods, V51, P221, DOI 10.1016/j.vascn.2004.08.010; Calabrese E, 2015, CEREB CORTEX, V25, P4628, DOI 10.1093/cercor/bhv121; Caminiti R, 2013, J NEUROSCI, V33, P14501, DOI 10.1523/JNEUROSCI.0761-13.2013; Colley BS, 2010, EXP NEUROL, V224, P241, DOI 10.1016/j.expneurol.2010.03.026; Crawford DK, 2009, NEUROSCIENCE, V164, P1407, DOI 10.1016/j.neuroscience.2009.09.069; Crawford DK, 2009, J NEUROSCI METH, V182, P25, DOI 10.1016/j.jneumeth.2009.05.013; Devaux J, 2003, J NEUROSCI, V23, P4509; Devaux J, 2008, J CELL BIOL, V183, P909, DOI 10.1083/jcb.200808034; DiLeonardi AM, 2012, J NEUROPATHOLOGY EXP, V71; Eftekharpour E, 2005, EXP NEUROL, V193, P334, DOI 10.1016/j.expneurol.2005.01.019; Eftekharpour E, 2007, J NEUROSCI, V27, P3416, DOI 10.1523/JNEUROSCI.0273-07.2007; Etxeberria A, 2010, NAT NEUROSCI, V13, P287, DOI 10.1038/nn.2500; Fame RM, 2011, TRENDS NEUROSCI, V34, P41, DOI 10.1016/j.tins.2010.10.002; Fehlings MG, 1997, J NEUROSCI METH, V71, P215, DOI 10.1016/S0165-0270(96)00147-1; FERN R, 1995, J NEUROPHYSIOL, V74, P369, DOI 10.1152/jn.1995.74.1.369; Fern R, 1998, J NEUROPHYSIOL, V79, P95, DOI 10.1152/jn.1998.79.1.95; Fornito A, 2015, NAT REV NEUROSCI, V16, P159, DOI 10.1038/nrn3901; FOSTER RE, 1982, DEV BRAIN RES, V3, P371, DOI 10.1016/0165-3806(82)90005-0; Fu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006705; Goncharenko K, 2014, J NEUROPHYSIOL, V112, P2067, DOI 10.1152/jn.00037.2013; HILDEBRAND C, 1993, PROG NEUROBIOL, V40, P319, DOI 10.1016/0301-0082(93)90015-K; Huff TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017176; Innocenti GM, 2014, CEREB CORTEX, V24, P2178, DOI 10.1093/cercor/bht070; Jbabdi S, 2015, NAT NEUROSCI, V18, P1546, DOI 10.1038/nn.4134; Jensen JM, 2003, J NEUROPHYSIOL, V90, P2334, DOI 10.1152/jn.00868.2002; KOCSIS JD, 1985, EXP BRAIN RES, V57, P620; Larsen PH, 2006, J NEUROSCI, V26, P2207, DOI 10.1523/JNEUROSCI.1880-05.2006; LEE MR, 1993, EXP NEUROL, V119, P140, DOI 10.1006/exnr.1993.1015; Li SX, 2000, J NEUROSCI, V20, P1190, DOI 10.1523/JNEUROSCI.20-03-01190.2000; Mitchell BD, 2005, J COMP NEUROL, V482, P17, DOI 10.1002/cne.20428; Moore S, 2014, J NEUROSCI RES, V92, P1621, DOI 10.1002/jnr.23440; Nashmi R, 2000, EUR J NEUROSCI, V12, P491, DOI 10.1046/j.1460-9568.2000.00926.x; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Olmos-Serrano JL, 2016, NEURON, V89, P1208, DOI 10.1016/j.neuron.2016.01.042; Ouardouz M, 2006, J PHYSL LOND, V577, P191; Park E, 2013, NEUROBIOL DIS, V52, P150, DOI 10.1016/j.nbd.2012.12.002; Park E, 2011, J NEUROTRAUM, V28, P343, DOI 10.1089/neu.2009.1050; Patel R, 2013, BRAIN PATHOL, V23, P462, DOI 10.1111/bpa.12029; Pinto V, 2008, J NEUROPHYSIOL, V99, P617, DOI 10.1152/jn.00944.2007; PRESTON RJ, 1983, EXP NEUROL, V79, P808, DOI 10.1016/0014-4886(83)90044-4; Pryor J, 2006, SPINAL CORD, V44, P653, DOI 10.1038/sj.sc.3101901; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Reeves TM, 2012, SPRINGER PROTOCOLS H, P313, DOI DOI 10.1007/978-1-61779-782-8_30; REMAHL S, 1990, J NEUROCYTOL, V19, P313, DOI 10.1007/BF01188401; REMAHL S, 1982, J NEUROL SCI, V54, P33, DOI 10.1016/0022-510X(82)90216-7; Ritter JS, 2012, THESIS; Ruff CA, 2013, J NEUROSCI, V33, P11899, DOI 10.1523/JNEUROSCI.1131-13.2013; Sahel A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00077; Schultke E, 2005, J NEUROTRAUM, V22, P1475, DOI 10.1089/neu.2005.22.1475; Shi R, 1996, J NEUROPHYSIOL, V76, P1572, DOI 10.1152/jn.1996.76.3.1572; Sinha K, 2005, J NEUROTRAUM, V22, P1239; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Stidworthy MF, 2003, BRAIN PATHOL, V13, P329; STURROCK RR, 1980, NEUROPATH APPL NEURO, V6, P415, DOI 10.1111/j.1365-2990.1980.tb00219.x; STYS PK, 1992, J CEREBR BLOOD F MET, V12, P977, DOI 10.1038/jcbfm.1992.135; STYS PK, 1990, P NATL ACAD SCI USA, V87, P4212, DOI 10.1073/pnas.87.11.4212; STYS PK, 1991, BRAIN RES, V546, P18, DOI 10.1016/0006-8993(91)91154-S; SWADLOW HA, 1976, EXP NEUROL, V53, P128, DOI 10.1016/0014-4886(76)90288-0; SWADLOW HA, 1975, P NATL ACAD SCI USA, V72, P5156, DOI 10.1073/pnas.72.12.5156; SWADLOW HA, 1978, EXP BRAIN RES, V33, P455; Swanson L, 2016, ANN REV NEUROSCI; Swanson TH, 1998, BRAIN RES, V784, P188, DOI 10.1016/S0006-8993(97)01323-1; Tekkok SB, 2005, NEUROSCI LETT, V382, P275, DOI 10.1016/j.neulet.2005.03.054; Tekkok SB, 2004, NEUROCHEM RES, V29, P2163; Tekkok SB, 2001, J NEUROSCI, V21, P4237, DOI 10.1523/JNEUROSCI.21-12-04237.2001; Tekkok SB, 2003, J CEREBR BLOOD F MET, V23, P1340, DOI 10.1097/01.WCB.0000091763.61714.B7; Van Essen DC, 2013, NEURON, V80, P775, DOI 10.1016/j.neuron.2013.10.027; Velumian AA, 2011, J NEUROPHYSIOL, V105, P929, DOI 10.1152/jn.00435.2010; Velumian AA, 2010, J NEUROSCI METH, V187, P33, DOI 10.1016/j.jneumeth.2009.12.006; Vincze A, 2008, INT J DEV NEUROSCI, V26, P575, DOI 10.1016/j.ijdevneu.2008.05.003; VOGT BA, 1982, J NEUROPHYSIOL, V48, P1257, DOI 10.1152/jn.1982.48.6.1257; WAXMAN SG, 1976, BRAIN RES, V113, P179, DOI 10.1016/0006-8993(76)90017-2; WAXMAN SG, 1990, ANN NEUROL, V28, P335, DOI 10.1002/ana.410280306; WAXMAN SG, 1977, PROG NEUROBIOL, V8, P297, DOI 10.1016/0301-0082(77)90009-0; Xie MQ, 2010, J NEUROPATH EXP NEUR, V69, P704, DOI 10.1097/NEN.0b013e3181e3de90; Zhang CL, 2004, J NEUROPHYSIOL, V91, P1025, DOI 10.1152/jn.00769.2003; Zhang JD, 2013, J NEUROSCI RES, V91, P240, DOI 10.1002/jnr.23150; Zhou J, 2013, P NATL ACAD SCI USA, V110, pE2714, DOI 10.1073/pnas.1310233110; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	94	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165637	10.1371/journal.pone.0165637	http://dx.doi.org/10.1371/journal.pone.0165637			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829055	Green Published, Green Submitted, gold			2022-12-26	WOS:000387724300053
J	Myhrvold, NP				Myhrvold, Nathan P.			Dinosaur Metabolism and the Allometry of Maximum Growth Rate	PLOS ONE			English	Article							BODY TEMPERATURES; PATTERNS; EVOLUTION; REPRODUCTION; FALLACY; MASS; CURVATURE; MODELS; BIRDS; POWER	The allometry of maximum somatic growth rate has been used in prior studies to classify the metabolic state of both extant vertebrates and dinosaurs. The most recent such studies are reviewed, and their data is reanalyzed. The results of allometric regressions on growth rate are shown to depend on the choice of independent variable; the typical choice used in prior studies introduces a geometric shear transformation that exaggerates the statistical power of the regressions. The maximum growth rates of extant groups are found to have a great deal of overlap, including between groups with endothermic and ectothermic metabolism. Dinosaur growth rates show similar overlap, matching the rates found for mammals, reptiles and fish. The allometric scaling of growth rate with mass is found to have curvature (on a log-log scale) for many groups, contradicting the prevailing view that growth rate allometry follows a simple power law. Reanalysis shows that no correlation between growth rate and basal metabolic rate (BMR) has been demonstrated. These findings drive a conclusion that growth rate allometry studies to date cannot be used to determine dinosaur metabolism as has been previously argued.	[Myhrvold, Nathan P.] Intellectual Ventures, Bellevue, WA 98005 USA	Intellectual Ventures	Myhrvold, NP (corresponding author), Intellectual Ventures, Bellevue, WA 98005 USA.	nathanm@intven.com		Myhrvold, Nathan/0000-0003-3994-5143				Agutter PS, 2004, THEOR BIOL MED MODEL, V1, P1, DOI DOI 10.1186/1742-4682-1-13; Apanius V., 1998, AVIAN GROWTH DEV EVO; Botelho JF, 2015, EVOL DEV, V17, P221, DOI 10.1111/ede.12126; Brusatte SL, 2015, CURR BIOL, V25, pR888, DOI 10.1016/j.cub.2015.08.003; Bueno J, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00061; Burnham KP, 2003, MODEL SELECTION INFE; Bybee PJ, 2006, J MORPHOL, V267, P347, DOI 10.1002/jmor.10406; CALDER WA, 1982, J ZOOL, V198, P215; Calder WA., 1984, SIZE FUNCTION LIFE H; Capellini I, 2010, ECOLOGY, V91, P2783, DOI 10.1890/09-0817.1; Carey N, 2013, J EXP MAR BIOL ECOL, V439, P7, DOI 10.1016/j.jembe.2012.10.013; CASE TJ, 1978, PALEOBIOLOGY, V4, P320, DOI 10.1017/S0094837300006023; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Centers for Disease Control and Prevention, NHANES 2013 2014; Chinsamy Anusuya, 1993, Modern Geology, V18, P319; Clarke A, 2010, BIOL REV, V85, P703, DOI 10.1111/j.1469-185X.2010.00122.x; Cubo J, 2008, EVOL DEV, V10, P217, DOI 10.1111/j.1525-142X.2008.00229.x; D'Emic MD, 2015, SCIENCE, V348, DOI [10.1126/science.1260061, 10.1126/science.1260410]; Dodds PS, 2001, J THEOR BIOL, V209, P9, DOI 10.1006/jtbi.2000.2238; Eagle RA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9296; Ehnes RB, 2011, ECOL LETT, V14, P993, DOI 10.1111/j.1461-0248.2011.01660.x; Elftman H, 1946, AM J PHYS ANTHROP-NE, V4, P116, DOI 10.1002/ajpa.1330040117; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2000, ZOOL J LINN SOC-LOND, V130, P551, DOI 10.1006/zjls.2000.0243; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Erickson GM, 2014, ANNU REV EARTH PL SC, V42, P675, DOI 10.1146/annurev-earth-060313-054858; Erickson GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007390; Erickson GM, 2009, ANAT REC, V292, P1514, DOI 10.1002/ar.20992; Glazier DS, 2009, COMP BIOCHEM PHYS A, V153, P403, DOI 10.1016/j.cbpa.2009.03.020; Grady JM, 2015, SCIENCE, V348, DOI 10.1126/science.1260299; Grady JM, 2014, SCIENCE, V344, P1268, DOI 10.1126/science.1253143; HAYSSEN V, 1985, COMP BIOCHEM PHYS A, V81, P741, DOI 10.1016/0300-9629(85)90904-1; Jasienski M, 1999, OIKOS, V84, P321, DOI 10.2307/3546729; Kaitaniemi P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001932; KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511; Kleiber M., 1961, FIRE LIFE, DOI DOI 10.1002/JPS.2600510525; Kolokotrones T, 2010, NATURE, V464, P753, DOI 10.1038/nature08920; Langford E, 2001, AM STAT, V55, P322, DOI 10.1198/000313001753272286; Lee AH, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P217; Legendre L., 2015, DID CROCODILES BECOM; Legendre LJ, 2016, SOC SYST BIOL, P1; Lehman TM, 2008, PALEOBIOLOGY, V34, P264, DOI 10.1666/0094-8373(2008)034[0264:MGRFSD]2.0.CO;2; Lovegrove BG, 2009, J COMP PHYSIOL B, V179, P391, DOI 10.1007/s00360-008-0322-4; Lucas J, 2014, J FISH BIOL, V84, P1171, DOI 10.1111/jfb.12306; Marquet PA, 2005, J EXP BIOL, V208, P1749, DOI 10.1242/jeb.01588; McNab B.K., 2012, EXTREME MEASURES ECO; Moran D, 2007, COMP BIOCHEM PHYS A, V148, P611, DOI 10.1016/j.cbpa.2007.08.006; Muller DWH, 2012, OIKOS, V121, P102, DOI 10.1111/j.1600-0706.2011.19505.x; Myhrvold NP, 2015, ANAT REC, V298, P489, DOI 10.1002/ar.23101; Myhrvold NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081917; Nespolo RF, 2005, BIOL RES, V38, P27, DOI 10.4067/S0716-97602005000100004; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; PIANTADOSI S, 1988, AM J EPIDEMIOL, V127, P893, DOI 10.1093/oxfordjournals.aje.a114892; Portnov BA, 2007, J EXPO SCI ENV EPID, V17, P106, DOI 10.1038/sj.jes.7500533; Prondvai E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031392; Reid R.E.H., 1990, Modern Geology, V15, P19; RICKLEFS RE, 1984, ECOLOGY, V65, P1602, DOI 10.2307/1939139; RICKLEFS RE, 1973, IBIS, V115, P177, DOI 10.1111/j.1474-919X.1973.tb02636.x; RICKLEFS RE, 1969, ECOLOGY, V50, P1031, DOI 10.2307/1936894; RICKLEFS RE, 1968, IBIS, V110, P419, DOI 10.1111/j.1474-919X.1968.tb00058.x; Robinson WS, 2011, INT J EPIDEMIOL, V40, P1134, DOI [10.1093/ije/dyn357, 10.1093/ije/dyr082]; Sander PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078573; Savage VM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000171; Seebacher F, 2003, PALEOBIOLOGY, V29, P105, DOI 10.1666/0094-8373(2003)029<0105:DBTTOO>2.0.CO;2; Seymour RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069361; Seymour RS, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1051, DOI 10.1086/422766; WELSH AH, 1988, AM NAT, V132, P277, DOI 10.1086/284850; Werner J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088834; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; White CR, 2007, ECOLOGY, V88, P315, DOI 10.1890/05-1883; White CR, 2014, COMPR PHYSIOL, V4, P231, DOI 10.1002/cphy.c110049; White CR, 2011, AM NAT, V178, P746, DOI 10.1086/662666; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; ZULLINGER EM, 1984, J MAMMAL, V65, P607, DOI 10.2307/1380844	77	11	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0163205	10.1371/journal.pone.0163205	http://dx.doi.org/10.1371/journal.pone.0163205			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828977	Green Published, Green Submitted, gold			2022-12-26	WOS:000387724300006
J	Poizot-Martin, I; Allavena, C; Duvivier, C; Cano, CE; de Salvador, FG; Rey, D; Dellamonica, P; Cuzin, L; Cheret, A; Hoen, B				Poizot-Martin, Isabelle; Allavena, Clotilde; Duvivier, Claudine; Cano, Carla Eliana; de Salvador, Francine Guillouet; Rey, David; Dellamonica, Pierre; Cuzin, Lise; Cheret, Antoine; Hoen, Bruno		Dat'AIDS Study Grp	CMV plus Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART	PLOS ONE			English	Article							T-CELL-ACTIVATION; ANTIRETROVIRAL THERAPY; CD4/CD8 RATIO; LARGE COHORT; INFLAMMATION; INDIVIDUALS; MORTALITY; RECOVERY; CD4(+)	Cytomegalovirus (CMV) infection is common among HIV-infected patients but its repercussion on the course of CD4+ and CD8+ T cells after cART initiation remains elusive. The French Dat'AIDS cohort enrolled 5,688 patients on first-line cART, from which we selected patients who achieved HIV suppression for at least 12 months without modification of cART, and for whom CMV serostatus was available. Five hundred and three patients fulfilled the selection criteria (74% male, median age 43 yrs, 15.5% CDC stage C), of whom 444 (88.3%) were seropositive for CMV (CMV+). Multivariate analyses using mixed-linear models adjusted for the time from HIV suppression, sex, age, transmission risk group, duration of HIV follow-up, the interaction between time from HIV suppression and CMV+ serology, and the nadir CD4 count revealed a negative correlation between CMV+ and CD4: CD8 ratio (coeff. = -0.16; p = 0.001). This correlation was also observed among patients displaying optimal CD4 recovery (>= 500 cells/mm3 at M12; coeff. = -0.24; p = 0.002). Hence, CMV+ serostatus antagonizes normalization of the CD4: CD8 ratio, although further analyses of the impact of co-morbidities that associate with CMV serostatus, like HCV infection, are needed to elucidate this antagonism formally. However, this might reflect a premature T cell senescence, thus advocating for a close monitoring of T cells in CMV co-infected patients. In addition, our results raise the question of the benefit of treatment for asymptomatic CMV co-infection in HIV-infected patients.	[Poizot-Martin, Isabelle; Cano, Carla Eliana] Aix Marseille Univ, APHM Hop St Marguerite, Immunohematol Clin, Marseille, France; [Poizot-Martin, Isabelle] INSERM, U912, SESSTIM, Marseille, France; [Allavena, Clotilde] CHU Hotel Dieu, Serv Malad Infect, Nantes, France; [Duvivier, Claudine] Univ Paris 05, IHU Imagine Paris, AP HP, Hop Necker,Serv Malad Infect & Trop,Ctr Infectiol, Paris, France; [Duvivier, Claudine] Inst Pasteur, Ctr Med, Ctr Infectiol Necker Pasteur, Paris, France; [Duvivier, Claudine] Univ Paris 05, Sorbonne Paris Cite, EA7327, Paris, France; [de Salvador, Francine Guillouet] CHU Archet 1, Serv Malad Infect & Trop, Nice, France; [Rey, David] Hop Univ Strasbourg, Ctr HIV Care, Strasbourg, France; [Dellamonica, Pierre] Univ Nice Sophia Antipolis, CHU Nice, Dept Infect Dis, Nice, France; [Cuzin, Lise] Toulouse III Univ, INSERM, CHU Toulouse, COREVIH Toulouse,UMR 1027, F-31000 Toulouse, France; [Cheret, Antoine] Paris Descartes Univ, Sorbonne Paris Cite, EA 3620, Paris, France; [Cheret, Antoine] Necker Enfants Malades Hosp, Virol Lab, Paris, France; [Hoen, Bruno] Univ Antilles, Fac Med Hyacinthe Bastaraud, EA 4537, Pointe A Pitre, Guadeloupe, France; [Hoen, Bruno] CHU Pointe a Pitre, INSERM, Serv Malad Infect & Trop, CIC1424,Dermatol,Med Interne, Pointe A Pitre, Guadeloupe, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; CHU Nice; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite des Antilles; CHU Guadeloupe; Institut National de la Sante et de la Recherche Medicale (Inserm)	Poizot-Martin, I (corresponding author), Aix Marseille Univ, APHM Hop St Marguerite, Immunohematol Clin, Marseille, France.; Poizot-Martin, I (corresponding author), INSERM, U912, SESSTIM, Marseille, France.	isabelle.poizot@ap-hm.fr	Allavena, Clotilde/AAH-4310-2019	Poizot-Martin, Isabelle/0000-0002-5676-5411				Appay V, 2011, AIDS, V25, P1813, DOI 10.1097/QAD.0b013e32834640e6; Barrett L, 2014, AIDS, V28, P2045, DOI 10.1097/QAD.0000000000000405; Battegay M, 2006, LANCET INFECT DIS, V6, P280, DOI 10.1016/S1473-3099(06)70463-7; BOWEN DL, 1985, ANN INTERN MED, V103, P704, DOI 10.7326/0003-4819-103-5-704; Buggert M, 2014, J IMMUNOL, V192, P2099, DOI 10.4049/jimmunol.1302596; Effros RB, 2005, IMMUNOL REV, V205, P147, DOI 10.1111/j.0105-2896.2005.00259.x; Helleberg M, 2015, J INFECT DIS, V211, P1726, DOI 10.1093/infdis/jiu669; Hunt PW, 2012, CURR HIV-AIDS REP, V9, P139, DOI 10.1007/s11904-012-0118-8; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Kapetanovic S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120474; Lee SA, 2014, J INFECT DIS, V210, P374, DOI 10.1093/infdis/jiu109; Lichtner M, 2015, J INFECT DIS, V211, P178, DOI 10.1093/infdis/jiu417; Ndumbi P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117039; Pugliese P, 2003, PRESSE MED, V32, P299; Pugliese P, 2009, HIV MED, V10, P504, DOI 10.1111/j.1468-1293.2009.00719.x; Roberts ET, 2010, AM J EPIDEMIOL, V172, P363, DOI 10.1093/aje/kwq177; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Serrano-Villar S, 2013, J INFECTION, V66, P57, DOI 10.1016/j.jinf.2012.09.013; Tassiopoulos K, 2012, J INFECT DIS, V205, P1730, DOI 10.1093/infdis/jis260; Turner JE, 2014, AGE, V36, P287, DOI 10.1007/s11357-013-9557-4; WIKBY A, 1994, EXP GERONTOL, V29, P531, DOI 10.1016/0531-5565(94)90036-1	21	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165774	10.1371/journal.pone.0165774	http://dx.doi.org/10.1371/journal.pone.0165774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824907	Green Submitted, Green Published, gold			2022-12-26	WOS:000387615200032
J	De Regge, N; Cay, B				De Regge, Nick; Cay, Brigitte			Comparison of PRRSV Nucleic Acid and Antibody Detection in Pen-Based Oral Fluid and Individual Serum Samples in Three Different Age Categories of Post-Weaning Pigs from Endemically Infected Farms	PLOS ONE			English	Article							RESPIRATORY-SYNDROME-VIRUS; POLYMERASE CHAIN-REACTION; SPECIMENS; COLLECTION; SURVEILLANCE; EUROPE; ASSAYS; WILD; PCR	Background Porcine reproductive and respiratory syndrome virus (PRRSV) is the causative agent of an economically important disease in swine. Since it has been shown that PRRSV and PRRSV specific antibodies can be detected in oral fluid, many different aspects have been studied to show that oral fluid could be a worthy alternative diagnostic sample to serum for monitoring and surveillance of this disease. Thorough field evaluations are however missing to convincingly show its usefulness under representative field conditions. Methodology Pen-based oral fluid samples and serum samples from all individual pigs in the corresponding pens were collected from post-weaning pigs of three different age categories in eight endemically PRRSV infected farms and one PRRSV free farm in Belgium. All samples were tested by quantitative reverse transcription polymerase chain reaction (qRT-PCR) and ELISA to detect PRRSV RNA and PRRSV specific antibodies, respectively. Results While the relative specificity of PRRSV detection by qRT-PCR in pen-based oral fluid compared to serum collected from individual pigs was high in all age categories (>90%), the relative sensitivity decreased with the age of the pigs (89, 93 and 10% in 8-12w, 16-20w and 24-28w old pigs, respectively). The latter correlated with a lower percentage of PRRSV positive pigs in serum/pen in the different age categories (55, 29 and 6%, respectively). Irrespective of the age category, pen-based oral fluid samples were always found PCR positive when at least 30% of the individual pigs were positive in serum. PRRSV specific antibody detection in oral fluid by ELISA showed a 100% relative sensitivity to detection in serum since oral fluid samples were always positive as soon as one pig in the pen was positive in serum. On the other hand, two false positive oral fluid samples in 11 pens without serum positive pigs were found, resulting in a relative specificity of 82%. Indications are however present that the oral fluid result indicated the correct infection status but the absence of a golden standard test makes it difficult to define definitive test characteristics. Conclusions Overall it can be concluded that oral fluid seems to be a useful matrix for diagnosis of PRRSV under field conditions and that differences in kinetics of PRRSV and PRRSV specific antibody detection in oral fluid and serum of individual pigs can also be reflected in pen-based oral fluid results.	[De Regge, Nick; Cay, Brigitte] CODA CERVA, Operat Direct Viral Dis, Enzoot & Reemerging Dis, Groeselenberg 99, B-1180 Uccle, Belgium		De Regge, N (corresponding author), CODA CERVA, Operat Direct Viral Dis, Enzoot & Reemerging Dis, Groeselenberg 99, B-1180 Uccle, Belgium.	nick.deregge@coda-cerva.be			Federal Public Service of Health, Food Chain Safety and Environment, Belgium [RF 10/6235]	Federal Public Service of Health, Food Chain Safety and Environment, Belgium	This study was funded by the Federal Public Service of Health, Food Chain Safety and Environment (RF 10/6235), Belgium. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albina E, 1997, VET MICROBIOL, V55, P309, DOI 10.1016/S0378-1135(96)01322-3; Balka G, 2015, VIRUS RES, V200, P1, DOI 10.1016/j.virusres.2015.01.014; Chittick WA, 2011, J VET DIAGN INVEST, V23, P248, DOI 10.1177/104063871102300208; Decorte I, 2015, J VET DIAGN INVEST, V27, P47, DOI 10.1177/1040638714561252; Decorte I, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-134; Decorte I, 2013, VET J, V197, P224, DOI 10.1016/j.tvjl.2013.02.001; Gerber PF, 2013, J CLIN MICROBIOL, V51, P547, DOI 10.1128/JCM.02685-12; Kittawornrat A, 2014, VET MICROBIOL, V168, P331, DOI 10.1016/j.vetmic.2013.11.035; Kittawornrat A, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-61; Kittawornrat A, 2012, J VET DIAGN INVEST, V24, P262, DOI 10.1177/1040638711435679; Kittawornrat A, 2010, VIRUS RES, V154, P170, DOI 10.1016/j.virusres.2010.07.025; Kuiek AM, 2015, TROP ANIM HEALTH PRO, V47, P1337, DOI 10.1007/s11250-015-0868-6; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Langenhorst RJ, 2012, CLIN VACCINE IMMUNOL, V19, P180, DOI 10.1128/CVI.05372-11; Linhares DCL, 2012, J VET DIAGN INVEST, V24, P328, DOI 10.1177/1040638711429492; Trang NT, 2014, J VET SCI, V15, P361, DOI 10.4142/jvs.2014.15.3.361; Nodelijk G, 1997, VET MICROBIOL, V56, P21, DOI 10.1016/S0378-1135(96)01349-1; Olsen C, 2013, VET J, V198, P158, DOI 10.1016/j.tvjl.2013.06.014; Olsen C, 2013, J VET DIAGN INVEST, V25, P328, DOI 10.1177/1040638713481471; Ouyang K, 2013, CLIN VACCINE IMMUNOL, V20, P1305, DOI 10.1128/CVI.00276-13; Pepin BJ, 2015, TRANSBOUND EMERG DIS, V62, P295, DOI 10.1111/tbed.12135; Prickett J, 2008, J VET DIAGN INVEST, V20, P156, DOI 10.1177/104063870802000203; Prickett JR, 2010, J SWINE HEALTH PROD, V18, P187; Ramirez A, 2012, PREV VET MED, V104, P292, DOI 10.1016/j.prevetmed.2011.11.008; Sattler T, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0388-7; Seddon YM, 2012, VET J, V193, P180, DOI 10.1016/j.tvjl.2011.11.008; Stadejek T, 2013, VET MICROBIOL, V165, P21, DOI 10.1016/j.vetmic.2013.02.029; Steinrigl A, 2014, BERL MUNCH TIERARZTL, V127, P216, DOI 10.2376/0005-9366-127-216; Wills RW, 1997, VET MICROBIOL, V57, P69, DOI 10.1016/S0378-1135(97)00079-5	29	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166300	10.1371/journal.pone.0166300	http://dx.doi.org/10.1371/journal.pone.0166300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820859	Green Published, gold, Green Submitted			2022-12-26	WOS:000387614800044
J	Bartholomaus, A; Wibberg, D; Winkler, A; Puhler, A; Schluter, A; Varrelmann, M				Bartholomaeus, Anika; Wibberg, Daniel; Winkler, Anika; Puehler, Alfred; Schlueter, Andreas; Varrelmann, Mark			Deep Sequencing Analysis Reveals the Mycoviral Diversity of the Virome of an Avirulent Isolate of Rhizoctonia solani AG-2-2 IV	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; MOLECULAR CHARACTERIZATION; GENOME SEQUENCE; ROSELLINIA-NECATRIX; VEGETATIVE GROWTH; CHESTNUT BLIGHT; VIRUSES; HYPOVIRULENCE; VIRULENCE; MEGABIRNAVIRUS	Rhizoctonia solani represents an important plant pathogenic Basidiomycota species complex and the host of many different mycoviruses, as indicated by frequent detection of dsRNA elements in natural populations of the fungus. To date, eight different mycoviruses have been characterized in Rhizoctonia and some of them have been reported to modulate its virulence. DsRNA extracts of the avirulent R. solani isolate DC17 (AG2-2-IV) displayed a diverse pattern, indicating multiple infections with mycoviruses. Deep sequencing analysis of the dsRNA extract, converted to cDNA, revealed that this isolate harbors at least 17 different mycovirus species. Based on the alignment of the conserved RNA-dependent RNApolymerase (RdRp) domain, this viral community included putative members of the families Narnaviridae, Endornaviridae, Partitiviridae and Megabirnaviridae as well as of the order Tymovirales. Furthermore, viruses, which could not be assigned to any existing family or order, but showed similarities to so far unassigned species like Sclerotinia sclerotiorum RNA virus L, Rhizoctonia solani dsRNA virus 1, Aspergillus foetidus slow virus 2 or Rhizoctonia fumigata virus 1, were identified. This is the first report of a fungal isolate infected by 17 different viral species and a valuable study case to explore the diversity of mycoviruses infecting R. solani.	[Bartholomaeus, Anika; Varrelmann, Mark] Inst Sugar Beet Res, D-37077 Gottingen, Germany; [Wibberg, Daniel; Winkler, Anika; Puehler, Alfred; Schlueter, Andreas] Univ Bielefeld, CeBiTec, Inst Genome Res & Syst Biol, D-33501 Bielefeld, Germany	University of Bielefeld	Bartholomaus, A; Varrelmann, M (corresponding author), Inst Sugar Beet Res, D-37077 Gottingen, Germany.	bartholomaeus@ifz-goettingen.de; varrelmann@ifz-goettingen.de		Schluter, Andreas/0000-0003-4830-310X; Puhler, Alfred/0000-0003-4723-2960				Anees M, 2010, SOIL BIOL BIOCHEM, V42, P1661, DOI 10.1016/j.soilbio.2010.05.013; BANDY BP, 1990, AM POTATO J, V67, P189, DOI 10.1007/BF02987071; Bharathan N, 2005, PLANT PATHOL, V54, P196, DOI 10.1111/j.1365-3059.2005.01159.x; BHARATHAN N, 1990, PHYTOPATHOLOGY, V80, P631, DOI 10.1094/Phyto-80-631; Boehr DD, 2014, NUCLEIC ACIDS MOL BI, V30, P309, DOI 10.1007/978-3-642-39796-7_14; Bruenn JA, 2003, NUCLEIC ACIDS RES, V31, P1821, DOI 10.1093/nar/gkg277; Cerny J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096070; Chiba S, 2009, J VIROL, V83, P12801, DOI 10.1128/JVI.01830-09; CHOI GH, 1992, SCIENCE, V257, P800, DOI 10.1126/science.1496400; Cubeta MA, 1997, PHYTOPATHOLOGY, V87, P480, DOI 10.1094/PHYTO.1997.87.4.480; Darissa O, 2012, EUR J PLANT PATHOL, V134, P181, DOI 10.1007/s10658-012-9977-5; Das S, 2014, FUNGAL BIOL-UK, V118, P924, DOI 10.1016/j.funbio.2014.08.003; Dawe AL, 2001, ANNU REV GENET, V35, P1, DOI 10.1146/annurev.genet.35.102401.085929; FROUSSARD P, 1992, NUCLEIC ACIDS RES, V20, P2900, DOI 10.1093/nar/20.11.2900; Ghabrial SA, 2015, VIROLOGY, V479, P356, DOI 10.1016/j.virol.2015.02.034; Garcia VG, 2006, SPAN J AGRIC RES, V4, P55; Hillman BI, 2013, ADV VIRUS RES, V86, P149, DOI 10.1016/B978-0-12-394315-6.00006-4; Howitt RLJ, 2006, ARCH VIROL, V151, P563, DOI 10.1007/s00705-005-0621-y; Howitt RLJ, 2001, J GEN VIROL, V82, P67, DOI 10.1099/0022-1317-82-1-67; Jian JH, 1997, MOL PLANT MICROBE IN, V10, P1002, DOI 10.1094/MPMI.1997.10.8.1002; Jian JH, 1998, MOL PLANT MICROBE IN, V11, P601, DOI 10.1094/MPMI.1998.11.7.601; Kanematsu S, 2014, VIROLOGY, V450, P308, DOI 10.1016/j.virol.2013.12.002; Kanematsu S, 2010, PHYTOPATHOLOGY, V100, P922, DOI 10.1094/PHYTO-100-9-0922; Kim JM, 2015, VIRUS RES, V197, P8, DOI 10.1016/j.virusres.2014.11.016; Kim SO, 1996, FEMS MICROBIOL LETT, V141, P203, DOI 10.1016/0378-1097(96)00222-4; King A.M.Q., 2011, VIRUS TAXONOMY, V1st ed; Kitahara R, 2014, ARCH VIROL, V159, P2157, DOI 10.1007/s00705-014-1999-1; Koonin EV, 2015, VIROLOGY, V479, P2, DOI 10.1016/j.virol.2015.02.039; Koonin EV, 2014, MICROBIOL MOL BIOL R, V78, P278, DOI 10.1128/MMBR.00049-13; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; Kozlakidis Z, 2013, ARCH VIROL, V158, P2625, DOI 10.1007/s00705-013-1779-3; Lakshman DK, 1998, P NATL ACAD SCI USA, V95, P6425, DOI 10.1073/pnas.95.11.6425; Li W, 2014, ARCH VIROL, V159, P1213, DOI 10.1007/s00705-013-1893-2; Li YQ, 2015, ARCH VIROL, V160, P2371, DOI 10.1007/s00705-015-2483-2; Liu HQ, 2009, J VIROL, V83, P1981, DOI 10.1128/JVI.01897-08; Marquez LM, 2007, SCIENCE, V315, P513, DOI 10.1126/science.1136237; Marzano SYL, 2016, J VIROL, V90, P6846, DOI 10.1128/JVI.00357-16; Marzano SYL, 2016, VIRUS RES, V219, P11, DOI 10.1016/j.virusres.2016.05.012; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Nerva L, 2016, VIRUS RES, V219, P22, DOI 10.1016/j.virusres.2015.10.028; Nuss DL, 2005, NAT REV MICROBIOL, V3, P632, DOI 10.1038/nrmicro1206; Okubara PA, 2014, PLANT SCI, V228, P61, DOI 10.1016/j.plantsci.2014.02.001; Pearson MN, 2009, MOL PLANT PATHOL, V10, P115, DOI 10.1111/j.1364-3703.2008.00503.x; Roossinck MJ, 2015, PHYTOPATHOLOGY, V105, P716, DOI 10.1094/PHYTO-12-14-0356-RVW; Roossinck MJ, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00767; Roossinck MJ, 2011, J GEN VIROL, V92, P2674, DOI 10.1099/vir.0.034702-0; Rosario K, 2011, CURR OPIN VIROL, V1, P289, DOI 10.1016/j.coviro.2011.06.004; Sasaki A, 2016, VIRUS RES, V219, P73, DOI 10.1016/j.virusres.2015.12.009; Simmonds P, 2015, J GEN VIROL, V96, P1193, DOI 10.1099/jgv.0.000016; SNEH B, 1989, CAN J BOT, V67, P2135, DOI 10.1139/b89-270; Son M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005172; Soueidan H, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00739; Strauss EE, 2000, J GEN VIROL, V81, P549, DOI 10.1099/0022-1317-81-2-549; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; te Velthuis AJW, 2014, CELL MOL LIFE SCI, V71, P4403, DOI 10.1007/s00018-014-1695-z; Urayama S, 2010, J GEN VIROL, V91, P3085, DOI 10.1099/vir.0.025411-0; Vainio EJ, 2015, J GEN VIROL, V96, P714, DOI 10.1099/jgv.0.000003; VALVERDE RA, 1990, PLANT DIS, V74, P255; van Diepeningen AD, 2006, FUNGAL GENET BIOL, V43, P446, DOI 10.1016/j.fgb.2006.01.014; Wang MH, 2015, J VIROL, V89, P8567, DOI 10.1128/JVI.00243-15; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wibberg D, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2561-1; Wibberg D, 2011, J BIOTECHNOL, V155, P50, DOI 10.1016/j.jbiotec.2011.01.010; Xie J, 2006, J GEN VIROL, V87, P241, DOI 10.1099/vir.0.81522-0; Xie JT, 2014, ANNU REV PHYTOPATHOL, V52, P45, DOI 10.1146/annurev-phyto-102313-050222; Xu X, 2003, NUCLEIC ACIDS RES, V31, P7117, DOI 10.1093/nar/gkg916; Yu X, 2013, P NATL ACAD SCI USA, V110, P1452, DOI 10.1073/pnas.1213755110; Zanotto PMD, 1996, J VIROL, V70, P6083, DOI 10.1128/JVI.70.9.6083-6096.1996; ZANZINGER DH, 1984, J GEN VIROL, V65, P1601, DOI 10.1099/0022-1317-65-9-1601; Zhang R, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.1, 10.1038/nmicrobiol.2015.1]; Zhang T, 2015, ARCH VIROL, V160, P1815, DOI 10.1007/s00705-015-2431-1; Zheng L, 2014, VIROLOGY, V456, P220, DOI 10.1016/j.virol.2014.03.029; Zheng L, 2013, ARCH VIROL, V158, P1609, DOI 10.1007/s00705-013-1637-3; Zhong J, 2015, VIRUS GENES, V51, P167, DOI 10.1007/s11262-015-1219-4	75	39	40	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165965	10.1371/journal.pone.0165965	http://dx.doi.org/10.1371/journal.pone.0165965			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814394	gold, Green Published, Green Submitted			2022-12-26	WOS:000386911100023
J	Khan, MI; Czarnecka, AM; Lewicki, S; Helbrecht, I; Brodaczewska, K; Koch, I; Zdanowski, R; Krol, M; Szczylik, C				Khan, Mohammed I.; Czarnecka, Anna M.; Lewicki, Slawomir; Helbrecht, Igor; Brodaczewska, Klaudia; Koch, Irena; Zdanowski, Robert; Krol, Magdalena; Szczylik, Cezary			Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; INTEGRIN-LINKED KINASE; FACTOR-ALPHA; THERAPEUTIC TARGET; INITIATING ABILITY; PROGENITOR CELLS; ENDOGLIN CD105; RESISTANCE	Background Recent advancement in cancer research has shown that tumors are highly heterogeneous, and multiple phenotypically different cell populations are found in a single tumor. Cancer development and tumor growth are driven by specific types of cells-stem cell-like cancer cells (SCLCCs)-which are also responsible for metastatic spread and drug resistance. This research was designed to verify the presence of SCLCCs in renal cell cancer cell lines. Subsequently, we aimed to characterize phenotype and cell biology of CD105+ cells, defined previously as renal cell carcinoma tumor-initiating cells. The main goal of the project was to describe the gene-expression profile of stem cell-like cancer cells of primary tumor and metastatic origin. Materials and Methods Real-time PCR analysis of stemness genes (Oct-4, Nanog and Ncam) and soft agar colony formation assay were conducted to check the stemness properties of renal cell carcinoma (RCC) cell lines. FACS analysis of CD105+ and CD133+ cells was performed on RCC cells. Isolated CD105+ cells were verified for expression of mesenchymal markers-CD24, CD146, CD90, CD73, CD44, CD11b, CD19, CD34, CD45, HLA-DR and alkaline phosphatase. Hanging drop assay was used to investigate CD105+ cell-cell cohesion. Analysis of free-floating 3D spheres formed by isolated CD105+ was verified, as spheres have been hypothesized to contain undifferentiated multipotent progenitor cells. Finally, CD105+ cells were sorted from primary (Caki-2) and metastatic (ACHN) renal cell cancer cell lines. Gene-expression profiling of sorted CD105+ cells was performed with Agilent's human GE 4x44K v2 microarrays. Differentially expressed genes were further categorized into canonical pathways. Network analysis and downstream analysis were performed with Ingenuity Pathway Analysis. Results Metastatic RCC cell lines (ACHN and Caki-1) demonstrated higher colony-forming ability in comparison to primary RCC cell lines. Metastatic RCC cell lines harbor numerous CD105+ cell subpopulations and have higher expression of stemness genes (Oct-4 and Nanog). CD105+ cells adopt 3D grape-like floating structures under handing drop conditions. Sorted CD105+ cells are positive for human mesenchymal stem cell (MSC) markers CD90, CD73, CD44, CD146, and alkaline phosphatase activity, but not for CD24 and hematopoietic lineage markers CD34, CD11b, CD19, CD45, and HLA-DR. 1411 genes are commonly differentially expressed in CD105+ cells (both from primary [Caki-2] and metastatic RCC [ACHN] cells) in comparison to a healthy kidney epithelial cell line (ASE-5063). TGF-beta, Wnt/beta-catenine, epithelial-mesenchymal transition (EMT), Rap1 signaling, PI3K-Akt signaling, and Hippo signaling pathway are deregulated in CD105+ cells. TGFB1, ERBB2, and TNF are the most significant transcriptional regulators activated in these cells. Conclusions All together, RCC-CD105+ cells present stemlike properties. These stem cell-like cancer cells may represent a novel target for therapy. A unique gene-expression profile of CD105+ cells could be used as initial data for subsequent functional studies and drug design.	[Khan, Mohammed I.; Czarnecka, Anna M.; Helbrecht, Igor; Brodaczewska, Klaudia; Szczylik, Cezary] Mil Inst Med, Dept Oncol, Mol Oncol Lab, Warsaw, Poland; [Lewicki, Slawomir; Zdanowski, Robert] Mil Inst Hyg & Epidemiol, Dept Regenerat Med, Warsaw, Poland; [Krol, Magdalena] WULS, Dept Physiol Sci, Fac Vet Med, Warsaw, Poland; [Helbrecht, Igor] Warsaw Univ, Inst Genet & Biotechnol, Fac Biol, Warsaw, Poland; [Koch, Irena] Inst Mother & Child Hlth, Dept Pathomorphol, Warsaw, Poland	Military Institute of Aviation Medicine; Military Institute of Hygiene & Epidemiology (MIHE); Warsaw University of Life Sciences; University of Warsaw	Khan, MI; Czarnecka, AM (corresponding author), Mil Inst Med, Dept Oncol, Mol Oncol Lab, Warsaw, Poland.	mkhan@wim.mil.pl; aczarnecka@wim.mil.pl	Khan, Mohammed I/I-9621-2017; Lewicki, Sławomir/AAZ-4709-2020; Czarnecka, Anna M/A-1388-2009; Koch, Irena/Z-1092-2018; Krol, Magdalena/A-5554-2019	Khan, Mohammed I/0000-0003-3020-1324; Lewicki, Sławomir/0000-0002-0539-0680; Czarnecka, Anna M/0000-0002-2107-3810; Szczylik, Cezary/0000-0002-2524-2810; Helbrecht, Igor/0000-0002-8078-3935; Koch, Irena/0000-0003-3546-9469; Krol, Magdalena/0000-0003-0421-5167; Zdanowski, Robert/0000-0003-0455-1072; Brodaczewska, Klaudia K./0000-0003-2374-3600	Foundation for Polish Science project [TEAM/2010-6/8]	Foundation for Polish Science project	This work was supported by the Foundation for Polish Science project TEAM/2010-6/8. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorno-Cruz V, 2015, CANCER RES, V75, P924, DOI 10.1158/0008-5472.CAN-14-3225; Bachmeier BE, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-129; Banerjee M, 2006, CYTOTECHNOLOGY, V51, P1, DOI 10.1007/s10616-006-9001-z; Bertazza L, 2010, CURR MED CHEM, V17, P3337, DOI 10.2174/092986710793176339; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; BORDER WA, 1995, KIDNEY INT, V47, pS59; Bruno S, 2006, AM J PATHOL, V169, P2223, DOI 10.2353/ajpath.2006.060498; Buczek M, 2014, BBA-REV CANCER, V1845, P31, DOI 10.1016/j.bbcan.2013.10.001; Buhring HJ, 2009, ANN NY ACAD SCI, V1176, P124, DOI 10.1111/j.1749-6632.2009.04564.x; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; Bussolati B, 2008, FASEB J, V22, P3696, DOI 10.1096/fj.08-102590; Canis M, 2013, TUMOR BIOL, V34, P437, DOI 10.1007/s13277-012-0568-z; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; Cho RW, 2008, CURR OPIN GENET DEV, V18, P48, DOI 10.1016/j.gde.2008.01.017; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Costa LJ, 2007, ONCOLOGIST, V12, P1404, DOI 10.1634/theoncologist.12-12-1404; Czarnecka AM, 2013, CURR SIGNAL TRANSD T, V8, P203; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Duff SE, 2003, FASEB J, V17, P984, DOI 10.1096/fj.02-0634rev; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Escudier B, 2009, J CLIN ONCOL, V27, P3312, DOI 10.1200/JCO.2008.19.5511; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Ferrajoli A, 2002, BLOOD, V100, P1215, DOI 10.1182/blood.V100.4.1215.h81602001215_1215_1219; Flanigan Robert C, 2003, Curr Treat Options Oncol, V4, P385, DOI 10.1007/s11864-003-0039-2; Fonsatti E, 2003, ONCOGENE, V22, P6557, DOI 10.1038/sj.onc.1206813; Foty R, 2011, JOVE-J VIS EXP, DOI 10.3791/2720; Galleggiante V, 2014, J UROLOGY, V192, P1831, DOI 10.1016/j.juro.2014.06.070; Garcia-Tunon I, 2006, CANCER SCI, V97, P1044, DOI 10.1111/j.1349-7006.2006.00277.x; Gargett CE, 2010, MOL HUM REPROD, V16, P818, DOI 10.1093/molehr/gaq061; Garner JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125838; Gassenmaier M, 2013, STEM CELLS, V31, P1467, DOI 10.1002/stem.1407; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Grosse-Gehling P, 2013, J PATHOL, V229, P355, DOI 10.1002/path.4086; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hara S, 2005, ANN ONCOL, V16, P928, DOI 10.1093/annonc/mdi182; Ho MY, 2012, MOL CANCER RES, V10, P1109, DOI 10.1158/1541-7786.MCR-12-0160; Hong BX, 2015, INT J CANCER, V136, P34, DOI 10.1002/ijc.28958; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Khan MI, 2016, AM J PHYSIOL-RENAL, V311, pF424, DOI 10.1152/ajprenal.00138.2016; Khan MI, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0177-z; Khan MI, 2013, CURR SIGNAL TRANSD T, V8, P240; Kim GR, 2015, ONCOL LETT, V9, P1641, DOI 10.3892/ol.2015.2918; Kim K, 2011, ONCOL LETT, V2, P1095, DOI 10.3892/ol.2011.368; Kim SY, 2013, CELL SIGNAL, V25, P961, DOI 10.1016/j.cellsig.2013.01.007; Kim YH, 2012, STEM CELLS DEV, V21, P2958, DOI 10.1089/scd.2011.0349; Klein U, 2011, CANCER CELL, V20, P556, DOI 10.1016/j.ccr.2011.10.026; Knoefel B, 1997, J INTERF CYTOK RES, V17, P95, DOI 10.1089/jir.1997.17.95; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lee SH, 2012, BIOCHEM BIOPH RES CO, V424, P58, DOI 10.1016/j.bbrc.2012.06.065; Lin TT, 2006, CELL RES, V16, P857, DOI 10.1038/sj.cr.7310107; Liu XQ, 2015, CURR PHARM DESIGN, V21, P1279, DOI 10.2174/1381612821666141211115611; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Lu JZ, 2013, ONCOL LETT, V5, P1903, DOI 10.3892/ol.2013.1270; LYONS RM, 1990, EUR J BIOCHEM, V187, P467, DOI 10.1111/j.1432-1033.1990.tb15327.x; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Michalaki V, 2004, BRIT J CANCER, V90, P2312, DOI 10.1038/sj.bjc.6601814; Micucci C, 2015, BRIT J CANCER, V113, P1178, DOI 10.1038/bjc.2015.338; Miles FL, 2008, CLIN EXP METASTAS, V25, P305, DOI 10.1007/s10585-007-9098-2; Mitropoulos D, 2004, UROL RES, V32, P317, DOI 10.1007/s00240-003-0360-z; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2014, LANCET ONCOL, V15, P286, DOI 10.1016/S1470-2045(14)70030-0; Nassiri F, 2011, ANTICANCER RES, V31, P2283; Nishizawa S, 2012, CANCER RES, V72, P2844, DOI 10.1158/0008-5472.CAN-11-3062; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Pfeiffer MJ, 2010, EUR UROL, V57, P246, DOI 10.1016/j.eururo.2009.01.015; Rahman MT, 2012, AM J CLIN PATHOL, V138, P535, DOI 10.1309/AJCPKDLRQ8F3EWNS; Raimondi C, 2011, BREAST CANCER RES TR, V130, P449, DOI 10.1007/s10549-011-1373-x; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Roemer A, 2004, J UROLOGY, V172, P2162, DOI 10.1097/01.ju.0000144602.01322.49; Saroufim A, 2014, BRIT J CANCER, V110, P1778, DOI 10.1038/bjc.2014.71; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serrano I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3976; Sjolund J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023057; Sobiesiak M, 2010, STEM CELLS DEV, V19, P669, DOI 10.1089/scd.2009.0290; Stankiewicz AM, 2014, BMC NEUROSCI, V15, DOI 10.1186/s12868-014-0130-6; Stefkova K, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/628368; Sturm I, 2003, CELL DEATH DIFFER, V10, P477, DOI 10.1038/sj.cdd.4401194; Szlosarek PW, 2006, MOL CANCER THER, V5, P382, DOI 10.1158/1535-7163.MCT-05-0303; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Torisawa YS, 2007, BIOMATERIALS, V28, P559, DOI 10.1016/j.biomaterials.2006.08.054; Tsukada S, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt168; Ueda K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075463; Varna M, 2015, CLIN CANCER RES, V21, P916, DOI 10.1158/1078-0432.CCR-14-0666; Walther MM, 1998, J UROLOGY, V159, P718, DOI 10.1016/S0022-5347(01)63709-1; Wang L, 2011, CANCER RES, P71, DOI [10.1158/1538-7445.Am2011-293, DOI 10.1158/1538-7445.AM2011-293]; Wang L, 2015, J CANCER RES CLIN, V141, P1013, DOI 10.1007/s00432-014-1883-0; Wang X, 2008, ACTA PHARMACOL SIN, V29, P1275, DOI 10.1111/j.1745-7254.2008.00889.x; Wu ST, 2011, EXP BIOL MED, V236, P1022, DOI 10.1258/ebm.2011.011058; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Yu DH, 2000, BIOESSAYS, V22, P673, DOI 10.1002/1521-1878(200007)22:7<673::AID-BIES10>3.0.CO;2-A; Zecchini S, 2011, EMBO MOL MED, V3, P480, DOI 10.1002/emmm.201100152	102	36	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165718	10.1371/journal.pone.0165718	http://dx.doi.org/10.1371/journal.pone.0165718			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812180	Green Published, Green Submitted, gold			2022-12-26	WOS:000386910000052
J	Lee, BJ; Kim, JY				Lee, Bum Ju; Kim, Jong Yeol			Identification of Hemoglobin Levels Based on Anthropometric Indices in Elderly Koreans	PLOS ONE			English	Article							WAIST CIRCUMFERENCE; IRON-DEFICIENCY; ANEMIA; OLDER; PREVALENCE; OBESITY; INDICATORS; FEMALES; GENDER; HEALTH	Objectives Anemia is independently and strongly associated with an increased risk of mortality in older people and is also strongly associated with obesity. The objectives of the present study were to examine the associations between the hemoglobin level and various anthropometric indices, to predict low and normal hemoglobin levels using combined anthropometric indices, and to assess differences in the hemoglobin level and anthropometric indices between Korean men and women. Methods A total of 7,156 individuals ranging in age from 53-90 years participated in this retrospective cross-sectional study. Binary logistic regression (LR) and naive Bayes (NB) models were used to identify significant differences in the anthropometric indices between subjects with low and normal hemoglobin levels and to assess the predictive power of these indices for the hemoglobin level. Results Among all of the variables, age displayed the strongest association with the hemoglobin level in both men (p < 0.0001, odds ratio [OR] = 0.487, area under the receiver operating characteristic curve based on the LR [LR-AUC] = 0.702, NB-AUC = 0.701) and women (p < 0.0001, OR = 0.636, LR-AUC = 0.625, NB-AUC = 0.624). Among the anthropometric indices, weight and body mass index (BMI) were the best predictors of the hemoglobin level. The predictive powers of all of the variables were higher in men than in women. The AUC values for the NB-Wrapper and LR-Wrapper predictive models generated using combined anthropometric indices were 0.734 and 0.723, respectively, for men and 0.649 and 0.652, respectively, for women. The use of combined anthropometric indices may improve the predictive power for the hemoglobin level. Discussion Among the various anthropometric indices, with the exception of age, we did not identify any indices that were better predictors than weight and BMI for low and normal hemoglobin levels. In addition, none of the ratios between pairs of indices were good indicators of the hemoglobin level. Finally, the Korean men tended to have higher associations between the anthropometric indices and anemia than the women.	[Lee, Bum Ju; Kim, Jong Yeol] Korea Inst Oriental Med, KM Fundamental Res Div, Deajeon, South Korea	Korea Institute of Oriental Medicine (KIOM)	Lee, BJ (corresponding author), Korea Inst Oriental Med, KM Fundamental Res Div, Deajeon, South Korea.	bjlee@kiom.re.kr	Yeol, Kim Jong/AAP-5998-2020	Lee, Bum Ju/0000-0003-2682-5716	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2006-2005173, NRF-2012-0009830, NRF-2009-0090900]; Bio & Medical Technology Development Program of the NRF - Korean government, MSIP [NRF-2015M3A9B6027139]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Bio & Medical Technology Development Program of the NRF - Korean government, MSIP	This research was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (No. 2006-2005173, NRF-2012-0009830, and NRF-2009-0090900). This research was also supported by the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIP (NRF-2015M3A9B6027139).	Al-Hashem FH, 2007, SAUDI MED J, V28, P41; Ausk KJ, 2008, OBESITY, V16, P2356, DOI 10.1038/oby.2008.353; Cepeda-Lopez AC, 2011, AM J CLIN NUTR, V93, P975, DOI 10.3945/ajcn.110.005439; Cesari M, 2004, J GERONTOL A-BIOL, V59, P249; Choi CW, 2004, AM J HEMATOL, V77, P26, DOI 10.1002/ajh.20140; Esmaillzadeh A, 2004, INT J OBESITY, V28, P1325, DOI 10.1038/sj.ijo.0802757; Frith-Terhune AL, 2000, AM J CLIN NUTR, V72, P963; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Izaks GJ, 1999, JAMA-J AM MED ASSOC, V281, P1714, DOI 10.1001/jama.281.18.1714; Jang E, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/604842; KARIO K, 1992, AM J HEMATOL, V41, P252, DOI 10.1002/ajh.2830410406; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Lee BJ, 2014, IEEE J BIOMED HEALTH, V19, P1618; Lee BJ, 2015, COMPUT BIOL MED, V57, P201, DOI 10.1016/j.compbiomed.2014.12.005; Lee BJ, 2014, IEEE J BIOMED HEALTH, V18, P555, DOI 10.1109/JBHI.2013.2264509; Lee BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084897; Lee HyunSook, 2004, Korean Journal of Community Nutrition, V9, P589; LIPSCHITZ DA, 1981, AM J HEMATOL, V11, P47, DOI 10.1002/ajh.2830110106; MARTI B, 1989, ATHEROSCLEROSIS, V75, P111, DOI 10.1016/0021-9150(89)90167-6; Neymotin F, 2011, OBESITY, V19, P191, DOI 10.1038/oby.2010.112; Odagiri K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088873; Patel KV, 2008, SEMIN HEMATOL, V45, P210, DOI 10.1053/j.seminhematol.2008.06.006; Qin Y, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-10; SALIVE ME, 1992, J AM GERIATR SOC, V40, P489, DOI 10.1111/j.1532-5415.1992.tb02017.x; Semba RD, 2009, EUR J CLIN NUTR, V63, P93, DOI 10.1038/sj.ejcn.1602889; Snijder MB, 2004, INT J OBESITY, V28, P402, DOI 10.1038/sj.ijo.0802567; Takeda M, 2011, GERIATR GERONTOL INT, V11, P377, DOI 10.1111/j.1447-0594.2011.00736.x; TIMIRAS ML, 1987, J AM GERIATR SOC, V35, P639, DOI 10.1111/j.1532-5415.1987.tb04340.x; Vuong J, 2014, AM J HEMATOL, V89, P671, DOI 10.1002/ajh.23713; Wasikowski M, 2010, IEEE T KNOWL DATA EN, V22, P1388, DOI 10.1109/TKDE.2009.187; Wu JL, 2010, MED CARE, V48, pS106, DOI 10.1097/MLR.0b013e3181de9e17; Zakai NA, 2005, ARCH INTERN MED, V165, P2214, DOI 10.1001/archinte.165.19.2214	35	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165622	10.1371/journal.pone.0165622	http://dx.doi.org/10.1371/journal.pone.0165622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812118	gold, Green Published, Green Submitted			2022-12-26	WOS:000386910000039
J	Bartholome, J; Bink, MCAM; van Heerwaarden, J; Chancerel, E; Boury, C; Lesur, I; Isik, F; Bouffier, L; Plomion, C				Bartholome, Jerome; Bink, Marco C. A. M.; van Heerwaarden, Joost; Chancerel, Emilie; Boury, Christophe; Lesur, Isabelle; Isik, Fikret; Bouffier, Laurent; Plomion, Christophe			Linkage and Association Mapping for Two Major Traits Used in the Maritime Pine Breeding Program: Height Growth and Stem Straightness	PLOS ONE			English	Article							WOOD PROPERTY TRAITS; CANDIDATE GENES; TAEDA L.; COMPLEX TRAITS; PINASTER AIT.; FOREST TREES; ADAPTIVE TRAIT; QTL ANALYSIS; GENETICS; SELECTION	Background Increasing our understanding of the genetic architecture of complex traits, through analyses of genotype-phenotype associations and of the genes/polymorphisms accounting for trait variation, is crucial, to improve the integration of molecular markers into forest tree breeding. In this study, two full-sib families and one breeding population of maritime pine were used to identify quantitative trait loci (QTLs) for height growth and stem straightness, through linkage analysis (LA) and linkage disequilibrium (LD) mapping approaches. Results The populations used for LA consisted of two unrelated three-generation full-sib families (n = 197 and n = 477). These populations were assessed for height growth or stem straightness and genotyped for 248 and 217 markers, respectively. The population used for LD mapping consisted of 661 founders of the first and second generations of the breeding program. This population was phenotyped for the same traits and genotyped for 2,498 single-nucleotide polymorphism (SNP) markers corresponding to 1,652 gene loci. The gene-based reference genetic map of maritime pine was used to localize and compare the QTLs detected by the two approaches, for both traits. LA identified three QTLs for stem straightness and two QTLs for height growth. The LD study yielded seven significant associations (P <= 0.001): four for stem straightness and three for height growth. No colocalisation was found between QTLs identified by LA and SNPs detected by LD mapping for the same trait. Conclusions This study provides the first comparison of LA and LD mapping approaches in maritime pine, highlighting the complementary nature of these two approaches for deciphering the genetic architecture of two mandatory traits of the breeding program.	[Bartholome, Jerome; Chancerel, Emilie; Boury, Christophe; Lesur, Isabelle; Bouffier, Laurent; Plomion, Christophe] Univ Bordeaux, INRA, BIOGECO, F-33610 Cestas, France; [Bink, Marco C. A. M.; van Heerwaarden, Joost] Univ Wageningen & Res Ctr, Biometris, NL-6700 AC Wageningen, Netherlands; [Lesur, Isabelle] HelixVenture, Merignac, France; [Isik, Fikret] North Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC USA	INRAE; UDICE-French Research Universities; Universite de Bordeaux; Wageningen University & Research; University of North Carolina; North Carolina State University	Plomion, C (corresponding author), Univ Bordeaux, INRA, BIOGECO, F-33610 Cestas, France.	christophe.plomion@inra.fr	Isik, Fikret/AAR-1220-2020; van Heerwaarden, Joost/A-1424-2014; Bartholomé, Jérôme/S-9333-2019	Isik, Fikret/0000-0003-2833-7919; van Heerwaarden, Joost/0000-0002-4959-3914; Bartholomé, Jérôme/0000-0002-0855-3828; plomion, christophe/0000-0002-3176-2767	Agence national de la recherche (ERANET SUSTAINPINE project, the COTE Cluster of Excellence) [ANR-10-LABX-45]; European Union [211868, 289841]; Conseil General des Landes; Conseil Regional d'Aquitaine [20030304002FA, 20040305003FA]; European Union, FEDER [2003227]; Investissements d'avenir [ANR-10-EQPX-16-01]; Conseil Regional d'Aquitaine; Direction Regionale de l'Alimentation, de l'Agriculture et de la Foret d'Aquitaine	Agence national de la recherche (ERANET SUSTAINPINE project, the COTE Cluster of Excellence)(French National Research Agency (ANR)); European Union(European Commission); Conseil General des Landes(Region Nouvelle-Aquitaine); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); European Union, FEDER(European Commission); Investissements d'avenir(French National Research Agency (ANR)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Direction Regionale de l'Alimentation, de l'Agriculture et de la Foret d'Aquitaine	This study was carried out with financial support from the Agence national de la recherche (http://www.agence-nationale-recherche.fr/, ERANET SUSTAINPINE project, the COTE Cluster of Excellence, ANR-10-LABX-45), the European Union Sixth and Seventh Framework Programmes (https://ec.europa.eu/research/fp7/index_en.cfm, Noveltree (no. 211868) and Procogen (no. 289841)). JB was supported by a postdoctoral fellowship from the Conseil General des Landes. The F2 mapping population was genotyped at the Genomic and Transcriptomic Facility of Bordeaux (grants from the Conseil Regional d'Aquitaine, nos. 20030304002FA and 20040305003FA, the European Union, FEDER no. 2003227 and Investissements d'avenir, ANR-10-EQPX-16-01). The public funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. IL is employed by the commercial company: HelixVenture. This funder provided support in the form of salaries for author IL, but did not have any additional role in the study design, data collection, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; We thank J Brach, D Charon and the staff of the experimental unit of INRA Pierroton (especially C Gauvrit, L Severin, H Lataillade, N Cheval, and B Issenhuth) for the experimental follow-up of the F2 and G2 mapping populations. The authors are thankful to GIS Groupe Pin Maritime du Futur for installing and measuring progeny tests. The Groupe Pin Maritime du Futur is supported by the Conseil Regional d'Aquitaine and by the Direction Regionale de l'Alimentation, de l'Agriculture et de la Foret d'Aquitaine.	Cabezas JA, 2015, TREE PHYSIOL, V35, P1000, DOI 10.1093/treephys/tpv050; Arcade A, 2004, BIOINFORMATICS, V20, P2324, DOI 10.1093/bioinformatics/bth230; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Beaulieu J, 2011, GENETICS, V188, P197, DOI 10.1534/genetics.110.125781; Beavis WD, 1998, MOL DISSECTION COMPL, P145, DOI DOI 10.1093/MP/SSR111; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouffier L, 2008, HEREDITY, V101, P156, DOI 10.1038/hdy.2008.41; Brautigam K, 2013, ECOL EVOL, V3, P399, DOI 10.1002/ece3.461; Brendel O, 2002, PLANT CELL ENVIRON, V25, P945, DOI 10.1046/j.1365-3040.2002.00872.x; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Broman KW, 2011, GUIDE QTL MAPPING R; Budde KB, 2014, NEW PHYTOL, V201, P230, DOI 10.1111/nph.12483; Canales J, 2014, PLANT BIOTECHNOL J, V12, P286, DOI 10.1111/pbi.12136; Cappa EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081267; Carvalho Ana, 2013, Mol Biol Int, V2013, P974324, DOI 10.1155/2013/974324; Chagne D, 2002, ANN FOREST SCI, V59, P627, DOI 10.1051/forest:2002048; Chancerel E, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-50; Chancerel E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-368; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Chhatre VE, 2013, TREE GENET GENOMES, V9, P1161, DOI 10.1007/s11295-013-0624-x; Costa P, 1996, CAN J FOREST RES, V26, P1209, DOI 10.1139/x26-135; Cumbie WP, 2011, HEREDITY, V107, P105, DOI 10.1038/hdy.2010.168; DANJON F, 1994, THEOR APPL GENET, V89, P911, DOI 10.1007/BF00224517; de Miguel M, 2015, GENOME BIOL EVOL, V7, P2799, DOI 10.1093/gbe/evv185; de Miguel M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-464; Devey ME, 2004, THEOR APPL GENET, V108, P516, DOI 10.1007/s00122-003-1471-1; Dillon SK, 2010, GENETICS, V185, P1477, DOI 10.1534/genetics.110.116582; Du QZ, 2016, NEW PHYTOL, V209, P1067, DOI 10.1111/nph.13695; Durel C, 1995, REVUE FRANCAISE, P5, DOI [10.4267/2042.26674, DOI 10.4267/2042.26674]; Eckert AJ, 2012, NEW PHYTOL, V193, P890, DOI 10.1111/j.1469-8137.2011.03976.x; Emebiri LC, 1998, THEOR APPL GENET, V97, P1053, DOI 10.1007/s001220050991; Endelman JB, 2014, BIOINFORMATICS, V30, P1623, DOI 10.1093/bioinformatics/btu091; Eu-ahsunthornwattana J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004445; Evans LM, 2014, NAT GENET, V46, P1089, DOI 10.1038/ng.3075; Eveno E, 2008, MOL BIOL EVOL, V25, P417, DOI 10.1093/molbev/msm272; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Gion JM, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0795-0; Gonzalez-Martinez S. C., 2011, Genetics, genomics and breeding of conifers, P239; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Grattapaglia D, 2009, CURR OPIN PLANT BIOL, V12, P148, DOI 10.1016/j.pbi.2008.12.008; Heuertz M, 2006, GENETICS, V174, P2095, DOI 10.1534/genetics.106.065102; Holliday JA, 2010, NEW PHYTOL, V188, P501, DOI 10.1111/j.1469-8137.2010.03380.x; Illy G, 1966, ANN SCI FORESTIERES; Ingvarsson PK, 2011, NEW PHYTOL, V189, P909, DOI 10.1111/j.1469-8137.2010.03593.x; Isik F, 2016, PLANT SCI, V242, P108, DOI 10.1016/j.plantsci.2015.08.006; Jaramillo-Correa JP, 2015, ADV BOT RES, V74, P265, DOI 10.1016/bs.abr.2015.04.003; Kaya Z, 1999, THEOR APPL GENET, V98, P586, DOI 10.1007/s001220051108; Khan MA, 2012, J EXP BOT, V63, P4045, DOI 10.1093/jxb/ers105; Korte A, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-29; KREMER A, 1981, ANN SCI FOREST, V38, P331, DOI 10.1051/forest:19810303; Lepoittevin C, 2012, TREE GENET GENOMES, V8, P113, DOI 10.1007/s11295-011-0426-y; Lepoittevin C, 2011, ANN FOREST SCI, V68, P873, DOI 10.1007/s13595-011-0084-0; Mackay J, 2012, PLANT MOL BIOL, V80, P555, DOI 10.1007/s11103-012-9961-7; Manichaikul A, 2006, GENETICS, V174, P481, DOI 10.1534/genetics.106.061549; Marguerit E, 2014, J EXP BOT, V65, P4757, DOI 10.1093/jxb/eru226; Markussen T, 2003, SILVAE GENET, V52, P8; Mather K, 1941, J GENET, V41, P159, DOI 10.1007/BF02983019; Moritsuka E, 2012, GENETICS, V190, P1145, DOI 10.1534/genetics.111.136697; Muranty H, 2014, TREE GENET GENOMES, V10, P1491, DOI 10.1007/s11295-014-0790-5; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Neale DB, 2004, TRENDS PLANT SCI, V9, P325, DOI 10.1016/j.tplants.2004.05.006; Neves LG, 2013, PLANT J, V75, P146, DOI 10.1111/tpj.12193; Nuzhdin SV, 2012, TRENDS GENET, V28, P421, DOI 10.1016/j.tig.2012.06.003; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Parchman TL, 2012, MOL ECOL, V21, P2991, DOI 10.1111/j.1365-294X.2012.05513.x; Pavy N, 2012, HEREDITY, V108, P273, DOI 10.1038/hdy.2011.72; Pelgas B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-145; Perez P, 2010, PLANT GENOME-US, V3, P106, DOI 10.3835/plantgenome2010.04.0005; Plomion C, 2016, MOL ECOL RESOUR, V16, P574, DOI 10.1111/1755-0998.12464; Plomion C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-171; Pot D, 2005, NEW PHYTOL, V167, P101, DOI 10.1111/j.1469-8137.2005.01417.x; Pot D, 2006, TREE GENET GENOMES, V2, P10, DOI 10.1007/s11295-005-0026-9; Prunier J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-368; Ritland K., 2011, Genetics, genomics and breeding of conifers, P196; Shepherd M, 2002, ANN FOR SCI, V59, P617, DOI 10.1051/forest:2002047; Stich B, 2008, GENETICS, V178, P1745, DOI 10.1534/genetics.107.079707; Svishcheva GR, 2012, NAT GENET, V44, P1166, DOI 10.1038/ng.2410; Thavamanikumar S, 2014, TREE GENET GENOMES, V10, P1661, DOI [10.1007/s11295-01, 10.1007/s11295-014-0787-0]; Thavamanikumar S, 2013, TREE GENET GENOMES, V9, P627, DOI 10.1007/s11295-013-0594-z; Tocquard K, 2014, SPRINGER SER WOOD, P107, DOI 10.1007/978-3-642-10814-3_4; Uchiyama K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079866; Ukrainetz NK, 2008, TREE GENET GENOMES, V4, P159, DOI 10.1007/s11295-007-0097-x; Van Ooijen, 2011, JOINMAP 4 1 SOFTWARE; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wegrzyn JL, 2014, GENETICS, V196, P891, DOI 10.1534/genetics.113.159996; Westbrook JW, 2013, NEW PHYTOL, V199, P89, DOI 10.1111/nph.12240; Wilcox P. L., 2007, Association mapping in plants, P211, DOI 10.1007/978-0-387-36011-9_10; Wimmer V, 2012, BIOINFORMATICS, V28, P2086, DOI 10.1093/bioinformatics/bts335; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Xu SZ, 2003, GENETICS, V165, P2259; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	94	18	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165323	10.1371/journal.pone.0165323	http://dx.doi.org/10.1371/journal.pone.0165323			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806077	Green Published, gold, Green Submitted			2022-12-26	WOS:000386715500027
J	Cong, ME; Pau, CP; Heneine, W; Garcia-Lerma, JG				Cong, Mian-er; Pau, Chou-Pong; Heneine, Walid; Garcia-Lerma, J. Gerardo			Antiretroviral Drug Activity in Macaques Infected during Pre-Exposure Prophylaxis Has a Transient Effect on Cell-Associated SHIV DNA Reservoirs	PLOS ONE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; PRIMARY HIV-1 INFECTION; IMMUNODEFICIENCY-VIRUS; AFRICAN WOMEN; TRANSMISSION; EMTRICITABINE; SHIVSF162P3; EFFICACY; THERAPY; VIREMIA	Background Pre-exposure prophylaxis (PrEP) with emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) is a novel HIV prevention strategy. Suboptimal PrEP adherence and HIV infection creates an opportunity for continued antiretroviral drug activity during undiagnosed infection. We previously showed that macaques infected with SHIV during PrEP with FTC/TDF display reduced acute plasma viremias and limited virus diversity. We investigated the effect of PrEP on acute SHIV DNA dynamics and on the size of the persistent virus reservoir in lymphoid tissues. Design Cell-associated SHIV DNA levels in PBMCs were measured in 8 macaques infected during PrEP with FTC/TDF or single-agent TAF and was compared to those seen in untreated infections (n = 10). PrEP breakthrough infections continued treatment with 1-2 weekly drug doses to model suboptimal drug exposure during undiagnosed HIV infection in humans. SHIV DNA was also measured in lymphoid tissues collected from FTC/TDF PrEP breakthroughs after 1 year of infection. Results Compared to untreated controls, PrEP infections had reduced plasma RNA viremias both at peak and throughout weeks 1-12 (p<0.005). SHIV DNA levels were also reduced at peak and during the first 12 weeks of infection (p<0.043) but not throughout weeks 12-20. At 1 year, SHIV DNA reservoirs in lymphoid tissues were similar in size among macaques that received PrEP or placebo. Conclusions Antiviral drug activity due to PrEP limits acute SHIV replication but has only a transient effect on cell-associated SHIV DNA levels. Our model suggests that suboptimal drug exposure in persons that are taking PrEP and become infected with HIV may not be sufficient to reduce the pool of HIV-infected cells, and that treatment intensification may be needed to sustain potential virological benefits from the PrEP regimen.	[Cong, Mian-er; Pau, Chou-Pong; Heneine, Walid; Garcia-Lerma, J. Gerardo] Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Garcia-Lerma, JG (corresponding author), Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA.	GGarcia-Lerma@cdc.gov			CDC intramural funds	CDC intramural funds	This work was supported by CDC intramural funds.	Amico KR, 2014, CLIN INFECT DIS, V59, pS55, DOI 10.1093/cid/ciu266; Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; Anderson PL, 2014, J ANTIMICROB CHEMOTH, V69, P2470, DOI 10.1093/jac/dku162; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Cheret A, 2014, TOP ANTIVIR MED, V22, P189; Donnell D, 2014, JAIDS-J ACQ IMM DEF, V66, P340, DOI 10.1097/QAI.0000000000000172; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Garcia-Lerma JG, 2011, J VIROL, V85, P6610, DOI 10.1128/JVI.00311-11; Garcia-Lerma JG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000391; Gianella S, 2011, ANTIVIR THER, V16, P535, DOI 10.3851/IMP1776; Harouse JM, 1999, SCIENCE, V284, P816, DOI 10.1126/science.284.5415.816; Harouse JM, 2001, J VIROL, V75, P1990, DOI 10.1128/JVI.75.4.1990-1995.2001; Henning TR, 2014, AIDS RES HUM RETROV, V30, P1125, DOI 10.1089/aid.2014.0238; Kersh EN, 2012, J INFECT DIS, V206, P770, DOI 10.1093/infdis/jis422; Laanani M, 2015, CLIN INFECT DIS, V60, P1715, DOI 10.1093/cid/civ171; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Massud I, 2013, J VIROL, V87, P8952, DOI 10.1128/JVI.01204-13; Pau CP, 2010, J VIROL METHODS, V164, P55, DOI 10.1016/j.jviromet.2009.11.027; Radzio J, 2014, AIDS, V28, P1431, DOI 10.1097/QAD.0000000000000294; Radzio J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050632; Ruone S, 2016, JAIDS-J ACQ IMM DEF, V72, P129, DOI 10.1097/QAI.0000000000000921; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594; Zheng Q, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-40	26	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0164821	10.1371/journal.pone.0164821	http://dx.doi.org/10.1371/journal.pone.0164821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806064	Green Published, Green Submitted, gold			2022-12-26	WOS:000386715500014
J	Duncan, CA; Ingram, TGJ; Mansfield, A; Byrne, JM; McIlroy, WE				Duncan, Carolyn A.; Ingram, Tony G. J.; Mansfield, Avril; Byrne, Jeannette M.; McIlroy, William E.			Population Differences in Postural Response Strategy Associated with Exposure to a Novel Continuous Perturbation Stimuli: Would Dancers Have Better Balance on a Boat?	PLOS ONE			English	Article							UPRIGHT STANCE; MOVEMENTS	Central or postural set theory suggests that the central nervous system uses short term, trial to trial adaptation associated with repeated exposure to a perturbation in order to improve postural responses and stability. It is not known if longer-term prior experiences requiring challenging balance control carryover as long-term adaptations that influence ability to react in response to novel stimuli. The purpose of this study was to determine if individuals who had long-term exposure to balance instability, such as those who train on specific skills that demand balance control, will have improved ability to adapt to complex continuous multidirectional perturbations. Healthy adults from three groups: 1) experienced maritime workers (n = 14), 2) novice individuals with no experience working in maritime environments (n = 12) and 3) individuals with training in dance (n = 13) participated in the study. All participants performed a stationary standing task while being exposed to five 6 degree of freedom motions designed to mimic the motions of a ship at sea. The balance reactions (change-in-support (CS) event occurrences and characteristics) were compared between groups. Results indicate dancers demonstrated significantly fewer CS events than novices during the first trial, but did not perform as well as those with offshore experience. Linear trend analyses revealed that short-term adaptation across all five trials was dependent on the nature of participant experience, with dancers achieving postural stability earlier than novices, but later than those with offshore experience. These results suggest that long term previous experiences also have a significant influence on the neural control of posture and balance in the development of compensatory responses.	[Duncan, Carolyn A.; McIlroy, William E.] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Duncan, Carolyn A.; Mansfield, Avril; McIlroy, William E.] Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada; [Ingram, Tony G. J.; Mansfield, Avril] Dalhousie Univ, Lab Brain Recovery & Funct, Halifax, NS, Canada; [Mansfield, Avril; McIlroy, William E.] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada; [McIlroy, William E.] Sunnybrook Res Inst, Hurvitz Brain Sci Res Program, Evaluat Clin Sci, Toronto, ON, Canada; [Byrne, Jeannette M.] Mem Univ, Sch Human Kinet & Recreat, St John, NF, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Waterloo; Dalhousie University; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Memorial University Newfoundland	Duncan, CA (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada.; Duncan, CA (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada.	carolyn.duncan@mun.ca	Mansfield, Avril/B-8589-2013	Mansfield, Avril/0000-0002-0396-5815; Ingram, Tony/0000-0003-1213-7920; McIlroy, William/0000-0003-2319-1746	MITACS Accelerate [IT02671]; Petroleum Research Board and Newfoundland and Labrador (MITACS grant); SLEIPNIR LIFT Management (MITACS grant)	MITACS Accelerate; Petroleum Research Board and Newfoundland and Labrador (MITACS grant); SLEIPNIR LIFT Management (MITACS grant)	This work was funded by MITACS Accelerate IT02671 (www.maws.ca), Petroleum Research Board and Newfoundland and Labrador (as industry partner for the MITACS grant) (http:IIpr-ac.ca/), and SLEIPNIR LIFT Management (as industry partner for the MITACS grant) (http://www.sleipnirlogistics.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkin AL, 2008, NEUROSCI LETT, V435, P120, DOI 10.1016/j.neulet.2008.02.018; Asseman F, 2004, NEUROSCI LETT, V358, P83, DOI 10.1016/j.neulet.2003.12.102; BOX GEP, 1953, BIOMETRIKA, V40, P318, DOI 10.1093/biomet/40.3-4.318; Bruyneel AV, 2010, NEUROSCI LETT, V485, P228, DOI 10.1016/j.neulet.2010.09.017; Chapman DW, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2006.033688; COHEN J, 1962, J ABNORM PSYCHOL, V65, P145, DOI 10.1037/h0045186; Duncan CA, 2014, WORLD C BIOM BOST MA; Duncan CA, 2014, INT J IND ERGONOM, V44, P874, DOI 10.1016/j.ergon.2014.06.005; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; Gerbino PG, 2007, GAIT POSTURE, V26, P501, DOI 10.1016/j.gaitpost.2006.11.205; Glass G. V., 1981, METAANALYSIS SOCIAL; Hedges L. V., 1981, J ED STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Horak FB, 1997, PHYS THER, V77, P517, DOI 10.1093/ptj/77.5.517; HORAK FB, 1989, J NEUROPHYSIOL, V62, P841, DOI 10.1152/jn.1989.62.4.841; Jacobs JV, 2007, J NEURAL TRANSM, V114, P1339, DOI 10.1007/s00702-007-0657-0; Jakobsen MD, 2011, EUR J APPL PHYSIOL, V111, P521, DOI 10.1007/s00421-010-1669-2; JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.1093/biomet/41.1-2.133; Keller M, 2012, SCAND J MED SCI SPOR, V22, P471, DOI 10.1111/j.1600-0838.2010.01268.x; Kiefer Adam W, 2013, J Dance Med Sci, V17, P126; Langlois RG, 2009, INT J MARITIME ENG, V151; Lloyd ARJM., 1993, SEAKEEPING SHIP BEHA; Maki BE, 1997, PHYS THER, V77, P488, DOI 10.1093/ptj/77.5.488; Maki BE, 2003, IEEE ENG MED BIOL, V22, P20, DOI 10.1109/MEMB.2003.1195691; Mansfield A, 2010, PHYS THER, V90, P476, DOI 10.2522/ptj.20090070; MCILROY WE, 1994, NEUROSCI LETT, V175, P13, DOI 10.1016/0304-3940(94)91066-9; MCILROY WE, 1993, BRAIN RES, V616, P30, DOI 10.1016/0006-8993(93)90188-S; MCILROY WE, 1995, GAIT POSTURE, V3, P43; Mochizuki G, 2008, CLIN NEUROPHYSIOL, V119, P1626, DOI 10.1016/j.clinph.2008.03.020; NASHNER LM, 1981, EXP BRAIN RES, V43, P395; PROCHAZKA A, 1989, PROG NEUROBIOL, V33, P281, DOI 10.1016/0301-0082(89)90004-X; Schmidt R. A, 2011, MOTOR CONTROL LEARNI; Simmons RW, 2005, INT J NEUROSCI, V115, P1193, DOI 10.1080/00207450590914572; Stoffregen TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066949; Terpstra T, 1952, INDAGATIONES MATHEMA, V14, P327; Zhang JG, 2008, GAIT POSTURE, V27, P697, DOI 10.1016/j.gaitpost.2007.09.004	36	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165735	10.1371/journal.pone.0165735	http://dx.doi.org/10.1371/journal.pone.0165735			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806129	Green Submitted, Green Published, gold			2022-12-26	WOS:000386715500053
J	Sacamano, PL; Farley, JE				Sacamano, Paul L.; Farley, Jason E.			Behavioral and Other Characteristics Associated with HIV Viral Load in an Outpatient Clinic	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; RISK BEHAVIORS; UNITED-STATES; DRUG-USERS; MOLECULAR EPIDEMIOLOGY; ANTIRETROVIRAL THERAPY; MEDICATION ADHERENCE; SEXUAL-BEHAVIOR; CARE; TRANSMISSION	Persons living with HIV (PLWH) who are engaged in care, yet not virally suppressed, represent a risk for transmission and opportunity for risk reduction interventions. This study describes characteristics of an outpatient clinic cohort of PLWH by laboratory confirmed viral suppression status and examines associations with demographics and sexual and drug use behaviors gathered through questionnaire. From a sample of 500 clinic patients, 438 were prescribed antiretroviral treatment (ART) and 62 were not. Among the 438 on ART, 72 (16.4%) were not virally suppressed at the most recent lab draw. Compared to individuals with a suppressed viral load, those that were unsuppressed were more likely to: be black (79.2% vs. 64.2%; p = 0.014); earn below $ 25,000/year (88.9% vs. 65.0%; p < 0.001); be of a younger age (47.8 vs. 50.0 mean years; p = 0.009); be on opiate substitution (14.1% vs. 6.3%; p = 0.023); and acknowledge poly-substance (38.9% vs. 24.4%; p = 0.012) and excessive alcohol use (13.9% vs. 6.0%; p = 0.019). Conversely, a smaller proportion of those with an unsuppressed viral load had multiple sex partners in the previous 30 days (39.8% vs. 58.5%; p = 0.003). In multivariable regression of those on ART, the prevalence of an unsuppressed viral load was 3% lower with each increasing year of age (aPR: 0.97; 95% CI: 0.95, 0.99) and 47% lower with income over $ 25,000/year (aPR: 0.33; 95% CI: 0.16, 0.70). In a separate analysis of all 500 subjects, ART was less frequently prescribed to blacks compared to whites, heterosexuals, those with lower education and income, and persons with active substance use. Findings confirm that a large proportion of PLWH and engaged in care were not virally suppressed and continued behaviors that risk transmission, indicating the need for screening, prevention counseling and access to ancillary services to lower the incidence of HIV infections.	[Sacamano, Paul L.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA; [Farley, Jason E.] Johns Hopkins Univ, Sch Nursing, Dept Community & Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Sacamano, PL (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.	psacama1@jhu.edu		Farley, Jason/0000-0002-6896-0134; Sacamano, Paul/0000-0002-7709-8283	Johns Hopkins Institute for Clinical and Translational Research (ICTR); National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH); NIH Roadmap for Medical Research; Johns Hopkins ICTR; NCATS or NIH; Robert Wood Johnson Foundation Nurse Faculty Scholars Program [70324]	Johns Hopkins Institute for Clinical and Translational Research (ICTR); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins ICTR; NCATS or NIH; Robert Wood Johnson Foundation Nurse Faculty Scholars Program(Robert Wood Johnson Foundation (RWJF))	This publication was made possible by the Johns Hopkins Institute for Clinical and Translational Research (ICTR); the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH); and NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the Johns Hopkins ICTR, NCATS or NIH. The Robert Wood Johnson Foundation Nurse Faculty Scholars Program (Grant # 70324) provided support for the parent study.	[Anonymous], GUIDELINES USE ANTIR; Arnsten JH, 2002, J GEN INTERN MED, V17, P377, DOI 10.1007/s11606-002-0044-3; Bradley H, 2014, MMWR-MORBID MORTAL W, V63, P1113; Celentano DD, 2007, CLIN INFECT DIS, V45, pS318, DOI 10.1086/522557; Celentano David D, 2008, Curr HIV/AIDS Rep, V5, P212, DOI 10.1007/s11904-008-0030-4; Centers for Disease Control and Prevention, 2010, 9 CDCP; Centers for Disease Control and Prevention, 2011, HIV SURV REP, P23; Centers for Disease Control and Prevention Health Resources and Services Administration National Institutes of Health American Academy of HIV Medicine Association of Nurses in AIDS Care International Association of Providers of AIDS Care the National Minority AIDS Council Urban Coalition for HIV/AIDS Prevention Services, 2014, REC HIV PREV AD AD H, V2014; Crepaz N, 2006, AIDS, V20, P143, DOI 10.1097/01.aids.0000196166.48518.a0; Farley JE, 2008, AM J INFECT CONTROL, V36, P644, DOI 10.1016/j.ajic.2008.05.005; Farley JE, 2015, AM J INFECT CONTROL, V43, P329, DOI 10.1016/j.ajic.2014.12.024; Farley JE, 2013, AM J INFECT CONTROL, V41, P199, DOI 10.1016/j.ajic.2012.03.028; Flickinger TE, 2013, AIDS PATIENT CARE ST, V27, P416, DOI 10.1089/apc.2012.0426; Hall HI, 2013, AIDS BEHAV, V17, P1632, DOI 10.1007/s10461-013-0426-z; Hasse B, 2010, CLIN INFECT DIS, V51, P1314, DOI 10.1086/656809; Hazelton PT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090306; Hinkin CH, 2007, AIDS BEHAV, V11, P185, DOI 10.1007/s10461-006-9152-0; Kalichman SC, 2014, INT J BEHAV MED, V21, P811, DOI 10.1007/s12529-013-9353-7; Kalichman SC, 2011, AM J PUBLIC HEALTH, V101, P531, DOI 10.2105/AJPH.2010.197608; Kerr T, 2012, DRUG ALCOHOL DEPEN, V124, P108, DOI 10.1016/j.drugalcdep.2011.12.019; Malta M, 2008, ADDICTION, V103, P1242, DOI 10.1111/j.1360-0443.2008.02269.x; Maranda MJ, 2004, J PSYCHOACTIVE DRUGS, V36, P315, DOI 10.1080/02791072.2004.10400032; Maryland Department of Health and Mental Hygiene, 2012, HIV BALT CIT EP PROF; McCarty-Caplan D, 2014, AIDS BEHAV, V18, P1339, DOI 10.1007/s10461-013-0622-x; Mellins CA, 2009, AIDS CARE, V21, P168, DOI 10.1080/09540120802001705; Mizuno Y, 2014, AIDS, V28, P407, DOI 10.1097/QAD.0000000000000057; Morin SF, 2007, JAIDS-J ACQ IMM DEF, V44, P213, DOI 10.1097/QAI.0b013e31802c0cae; Newville H, 2010, AIDS CARE, V22, P1259, DOI 10.1080/09540121003615111; Ojikutu B, 2014, AIDS CARE, V26, P731, DOI 10.1080/09540121.2013.855299; Purcell DW, 2006, J URBAN HEALTH, V83, P656, DOI 10.1007/s11524-006-9066-1; Seth P, 2011, WOMEN HEALTH ISS, V21, P130, DOI 10.1016/j.whi.2010.10.005; Vosburgh HW, 2012, AIDS BEHAV, V16, P1394, DOI 10.1007/s10461-011-0131-8	32	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0166016	10.1371/journal.pone.0166016	http://dx.doi.org/10.1371/journal.pone.0166016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6DJ	27806109	Green Published, Green Submitted, gold			2022-12-26	WOS:000386715500078
J	Prokesch, A; Graef, FA; Madl, T; Kahlhofer, J; Heidenreich, S; Schumann, A; Moyschewitz, E; Pristoynik, P; Blaschitz, A; Knauer, M; Muenzner, M; Bogner-Strauss, JG; Dohr, G; Schulz, TJ; Schupp, M				Prokesch, Andreas; Graef, Franziska A.; Madl, Tobias; Kahlhofer, Jennifer; Heidenreich, Steffi; Schumann, Anne; Moyschewitz, Elisabeth; Pristoynik, Petra; Blaschitz, Astrid; Knauer, Miriam; Muenzner, Matthias; Bogner-Strauss, Juliane G.; Dohr, Gottfried; Schulz, Tim J.; Schupp, Michael			Liver p53 is stabilized upon starvation and required for amino acid catabolism and gluconeogenesis	FASEB JOURNAL			English	Article						AMPK; hepatic steatosis; liver metabolism; nutrient deprivation; fasting	HUMAN HEPATOCELLULAR-CARCINOMA; LIPID-METABOLISM; MICE; NUTRIENT; CELLS; RESPIRATION; GLYCOLYSIS; EXPRESSION; REGULATOR; OXIDATION	The ability to adapt cellular metabolism to nutrient availability is critical for survival. The liver plays a central role in the adaptation to starvation by switching from glucose-consuming processes and lipid synthesis to providing energy substrates like glucose to the organism. Here we report a previously unrecognized role of the tumor suppressor p53 in the physiologic adaptation to food withdrawal. We found that starvation robustly increases p53 protein in mouse liver. This induction was posttranscriptional and mediated by a hepatocyte-autonomous and AMP-activated protein kinase-dependent mechanism. p53 stabilization was required for the adaptive expression of genes involved in amino acid catabolism. Indeed, acute deletion of p53 in livers of adult mice impaired hepatic glycogen storage and induced steatosis. Upon food withdrawal, p53-deleted mice became hypoglycemic and showed defects in the starvation-associated utilization of hepatic amino acids. In summary, we provide novel evidence for a p53-dependent integration of acute changes of cellular energy status and the metabolic adaptation to starvation. Because of its tumor suppressor function, p53 stabilization by starvation could have implications for both metabolic and oncological diseases of the liver.	[Prokesch, Andreas; Kahlhofer, Jennifer; Moyschewitz, Elisabeth; Pristoynik, Petra; Blaschitz, Astrid; Dohr, Gottfried] Med Univ Graz, Inst Cell Biol Histol & Embryol, Harrachgasse 21-7, A-8010 Graz, Austria; [Madl, Tobias] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria; [Graef, Franziska A.; Heidenreich, Steffi; Schumann, Anne; Knauer, Miriam; Muenzner, Matthias; Schupp, Michael] Charite, Cardiovasc Res Ctr, Inst Pharmacol, Hess Str 3-4, D-10115 Berlin, Germany; [Bogner-Strauss, Juliane G.] Graz Univ Technol, Inst Biochem, Graz, Austria; [Schulz, Tim J.] German Inst Human Nutr, Dept Adipocyte Dev & Nutr, Potsdam, Germany; [Schulz, Tim J.] German Ctr Diabet Res DZD, Munich, Germany	Medical University of Graz; Medical University of Graz; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Graz University of Technology; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Prokesch, A (corresponding author), Med Univ Graz, Inst Cell Biol Histol & Embryol, Harrachgasse 21-7, A-8010 Graz, Austria.; Schupp, M (corresponding author), Charite, Cardiovasc Res Ctr, Inst Pharmacol, Hess Str 3-4, D-10115 Berlin, Germany.	andreas.prokesch@medunigraz.at; michael.schupp@charite.de	Schulz, Tim/F-4842-2013; Madl, Tobias/B-1682-2012; Dohr, Gottfried/E-8070-2010; PROKESCH, ANDREAS/B-6786-2019	Schulz, Tim/0000-0002-8413-3972; Madl, Tobias/0000-0002-9725-5231; Graef, Franziska/0000-0002-7492-4447; PROKESCH, ANDREAS/0000-0002-8487-7103; Schupp, Michael/0000-0003-3720-1052	Franz-Lanyar grant, a starting grant of the Medical University Graz [389]; Austrian Science Fund (FWF) [P29328-B26]; German Research Foundation (DFG; Emmy Noether Grant) [SCHU 2546/1-1]; Career Integration grant from the European Union (CIG) [291867]; German Research Foundation [SCHU 2445/2-1]; European Research Council [ERC-StG-2012-311082]; German Center for Diabetes Research (DZD)	Franz-Lanyar grant, a starting grant of the Medical University Graz; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); German Research Foundation (DFG; Emmy Noether Grant)(German Research Foundation (DFG)); Career Integration grant from the European Union (CIG); German Research Foundation(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); German Center for Diabetes Research (DZD)	A.P. was supported by a Franz-Lanyar grant (389), a starting grant of the Medical University Graz, and a grant from the Austrian Science Fund (FWF; P29328-B26). M.S. was supported by the German Research Foundation (DFG; Emmy Noether Grant SCHU 2546/1-1) and a Career Integration grant from the European Union (CIG; 291867). T.J.S. was supported by the German Research Foundation (SCHU 2445/2-1), the European Research Council (ERC-StG-2012-311082), and the German Center for Diabetes Research (DZD). A. P. is grateful to D. Kummer for help with bioinformatic quantification of histology images, to R. Malli (both from Medical University Graz) for providing AMPK siRNAs, and to QPS Hepatic Biosciences for provision of primary human hepatocytes.	Aguilar V, 2010, EMBO MOL MED, V2, P338, DOI 10.1002/emmm.201000089; AIKAWA T, 1973, J BIOCHEM, V74, P1003; Allen MA, 2014, ELIFE, V3, DOI 10.7554/eLife.02200; Armata HL, 2010, MOL CELL BIOL, V30, P5787, DOI 10.1128/MCB.00347-10; BAQUET A, 1991, BIOCHEM J, V273, P57, DOI 10.1042/bj2730057; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019; BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Fajas L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00004; Fischer M, 2014, CELL CYCLE, V13, P3037, DOI 10.4161/15384101.2014.949083; Goldstein I, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-9; Goldstein I, 2012, TRENDS ENDOCRIN MET, V23, P567, DOI 10.1016/j.tem.2012.06.007; Goldstein I, 2012, J HEPATOL, V56, P656, DOI 10.1016/j.jhep.2011.08.022; Guan HP, 2009, J BIOL CHEM, V284, P24644, DOI 10.1074/jbc.M109.034397; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Katz S. F., 2012, GASTROENTEROLOGY, V142; Kung CP, 2016, CELL REP, V14, P2413, DOI 10.1016/j.celrep.2016.02.037; Lee JM, 2014, NATURE, V516, P112, DOI 10.1038/nature13961; LEVITAN IB, 1980, BRAIN RES, V187, P415, DOI 10.1016/0006-8993(80)90212-7; Liu K, 2013, CELL DEATH DIFFER, V20, P3, DOI 10.1038/cdd.2012.63; Liu Y, 2014, P NATL ACAD SCI USA, V111, pE2414, DOI 10.1073/pnas.1315605111; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Ma WZ, 2007, J BIOENERG BIOMEMBR, V39, P243, DOI 10.1007/s10863-007-9083-0; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; Marino S, 2000, GENE DEV, V14, P994; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Perry ME, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000968; Prokesch A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23723; Ristow M, 2003, J CLIN INVEST, V112, P527, DOI 10.1172/JCI200318107; Schupp M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-758; Schupp M, 2009, J BIOL CHEM, V284, P9458, DOI 10.1074/jbc.M809498200; Sermeus A, 2013, J CELL PHYSIOL, V228, P2365, DOI 10.1002/jcp.24409; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tschaharganeh DF, 2016, CELL, V165, P1546, DOI 10.1016/j.cell.2016.05.058; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang WG, 2011, CANCER BIOL THER, V12, P229, DOI 10.4161/cbt.12.3.17033; Wang XW, 2013, J MOL CELL BIOL, V5, P147, DOI 10.1093/jmcb/mjs064; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wilson CG, 2010, ENDOCRINOLOGY, V151, P5174, DOI 10.1210/en.2010-0379; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zhang P, 2014, P NATL ACAD SCI USA, V111, P10684, DOI 10.1073/pnas.1411026111	53	46	46	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					732	742		10.1096/fj.201600845R	http://dx.doi.org/10.1096/fj.201600845R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27811061	Green Published, hybrid			2022-12-26	WOS:000394235400025
J	Bouillet, S; Genest, O; Jourlin-Castelli, C; Fons, M; Mejean, V; Iobbi-Nivol, C				Bouillet, Sophie; Genest, Olivier; Jourlin-Castelli, Cecile; Fons, Michel; Mejean, Vincent; Iobbi-Nivol, Chantal			The General Stress Response sigma(S) Is Regulated by a Partner Switch in the Gram-negative Bacterium Shewanella oneidensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; BIOFILM FORMATION; RNA-POLYMERASE; III SECRETION; RPOS; RSSB; STABILITY; COLONIZATION; DEGRADATION; SYSTEM	Here, we show that a partner-switching system of the aquatic Proteobacterium Shewanella oneidensis regulates post-translationally sigma(S) (also called RpoS), the general stress response sigma factor. Genes SO2118 and SO2119 encode CrsA and CrsR, respectively. CrsR is a three-domain protein comprising a receiver, a phosphatase, and a kinase/anti-sigma domains, and CrsA is an anti-sigma antagonist. In vitro, CrsR sequesters sigma(S) and possesses kinase and phosphatase activities toward CrsA. In turn, dephosphorylated CrsA binds the anti-sigma domain of CrsR to allow the release of sigma(S). This study reveals a novel pathway that post-translationally regulates the general stress response sigma factor differently than what was described for other proteobacteria like Escherichia coli. We argue that this pathway allows probably a rapid bacterial adaptation.	[Bouillet, Sophie; Genest, Olivier; Jourlin-Castelli, Cecile; Fons, Michel; Mejean, Vincent; Iobbi-Nivol, Chantal] Aix Marseille Univ, CNRS, BIP UMR7281, F-13402 Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Iobbi-Nivol, C (corresponding author), CNRS, BIP IMM, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	iobbi@imm.cnrs.fr	Genest, Olivier/GQZ-3215-2022	Genest, Olivier/0000-0003-1240-2827; Fons, Michel/0000-0001-8263-3669; Mejean, Vincent/0000-0001-6533-5846	Centre National de la Recherche Scientifique; Aix-Marseille Universite; Ministere de l'enseignement superieur et de la recherche fellowship	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite; Ministere de l'enseignement superieur et de la recherche fellowship	This work was supported by the Centre National de la Recherche Scientifique and Aix-Marseille Universite. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a Ministere de l'enseignement superieur et de la recherche fellowship and Aix-Marseille Universite.	ALPER S, 1994, CELL, V77, P195, DOI 10.1016/0092-8674(94)90312-3; Baraquet C, 2009, MOL MICROBIOL, V73, P278, DOI 10.1111/j.1365-2958.2009.06770.x; Battesti A, 2012, J BACTERIOL, V194, P2470, DOI 10.1128/JB.00132-12; Battesti A, 2015, P NATL ACAD SCI USA, V112, P5159, DOI 10.1073/pnas.1504639112; Battesti A, 2013, GENE DEV, V27, P2722, DOI 10.1101/gad.229617.113; Battesti A, 2012, METHODS, V58, P325, DOI 10.1016/j.ymeth.2012.07.018; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Becker G, 2000, MOL MICROBIOL, V35, P657, DOI 10.1046/j.1365-2958.2000.01736.x; Bhuwan M, 2012, J BIOL CHEM, V287, P1903, DOI 10.1074/jbc.M111.256586; Bordi C, 2003, J BACTERIOL, V185, P2042, DOI 10.1128/JB.185.6.2042-2045.2003; Bougdour A, 2006, GENE DEV, V20, P884, DOI 10.1101/gad.1400306; Bougdour A, 2008, MOL MICROBIOL, V68, P298, DOI 10.1111/j.1365-2958.2008.06146.x; de Been M, 2011, MICROBIOL-SGM, V157, P3, DOI 10.1099/mic.0.045740-0; Delumeau O, 2002, J BACTERIOL, V184, P5583, DOI 10.1128/JB.184.20.5583-5589.2002; Dong T, 2010, INFECT IMMUN, V78, P887, DOI 10.1128/IAI.00882-09; DUFOUR A, 1994, J BACTERIOL, V176, P1813, DOI 10.1128/jb.176.7.1813-1820.1994; Dufour A, 1996, J BACTERIOL, V178, P3701, DOI 10.1128/jb.178.13.3701-9sigma.1996; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Fiebig A, 2015, ANNU REV GENET, V49, P603, DOI 10.1146/annurev-genet-112414-054813; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Fimlaid KA, 2015, CURR OPIN MICROBIOL, V24, P88, DOI 10.1016/j.mib.2015.01.006; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Gao HC, 2004, J BACTERIOL, V186, P7796, DOI 10.1128/JB.186.22.7796-7803.2004; Gottesman S, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P59; Hau HH, 2007, ANNU REV MICROBIOL, V61, P237, DOI 10.1146/annurev.micro.61.080706.093257; Hengge R, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P251; Hengge R, 2009, RES MICROBIOL, V160, P667, DOI 10.1016/j.resmic.2009.08.014; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Houot L, 2012, MICROBIOL-SGM, V158, P1964, DOI 10.1099/mic.0.057059-0; Hryckowian AJ, 2014, MBIO, V5, DOI 10.1128/mBio.01043-14; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kinoshita E, 2011, PROTEOMICS, V11, P319, DOI 10.1002/pmic.201000472; Kozak NA, 2005, J BACTERIOL, V187, P5665, DOI 10.1128/JB.187.16.5665-5676.2005; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Landini P, 2014, ENV MICROBIOL REP, V6, P1, DOI 10.1111/1758-2229.12112; Larsen MR, 2001, PROTEOMICS, V1, P223; Lucchini S, 2009, MOL MICROBIOL, V74, P1169, DOI 10.1111/j.1365-2958.2009.06929.x; Magnin T, 1997, J BACTERIOL, V179, P3922, DOI 10.1128/jb.179.12.3922-3927.1997; Mattoo S, 2004, MOL MICROBIOL, V52, P1201, DOI 10.1111/j.1365-2958.2004.04053.x; Mika F, 2005, GENE DEV, V19, P2770, DOI 10.1101/gad.353705; Mika F, 2014, RNA BIOL, V11, P494, DOI 10.4161/rna.28867; Moreno M, 2000, J MOL MICROB BIOTECH, V2, P245; Morris AR, 2013, MOL MICROBIOL, V87, P509, DOI 10.1111/mmi.12109; Morris AR, 2011, MOL MICROBIOL, V82, P114, DOI 10.1111/j.1365-2958.2011.07800.x; Morris AR, 2010, ENVIRON MICROBIOL, V12, P2051, DOI 10.1111/j.1462-2920.2010.02269.x; Muffler A, 1996, EMBO J, V15, P1333, DOI 10.1002/j.1460-2075.1996.tb00475.x; Nair S, 2004, J BACTERIOL, V186, P4192, DOI 10.1128/JB.186.13.4192-4198.2004; Osterberg S, 2011, ANNU REV MICROBIOL, V65, P37, DOI 10.1146/annurev.micro.112408.134219; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; Park YH, 2013, P NATL ACAD SCI USA, V110, P21142, DOI 10.1073/pnas.1316629111; Pesavento C, 2012, NUCLEIC ACIDS RES, V40, P4783, DOI 10.1093/nar/gks055; Pratt LA, 1996, P NATL ACAD SCI USA, V93, P2488, DOI 10.1073/pnas.93.6.2488; Price CW, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P301; Sharma AK, 2011, CELL PHYSIOL BIOCHEM, V28, P407, DOI 10.1159/000335104; Sheldon JR, 2012, APPL ENVIRON MICROB, V78, P8331, DOI 10.1128/AEM.02149-12; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Thompson CC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005125; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Zhou YN, 2001, GENE DEV, V15, P627, DOI 10.1101/gad.864401	61	13	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26151	26163		10.1074/jbc.M116.751933	http://dx.doi.org/10.1074/jbc.M116.751933			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27810894	Green Published, hybrid			2022-12-26	WOS:000390345200032
J	Jakobs, A; Steinmann, S; Henrich, SM; Schmidt, TJ; Klempnauer, KH				Jakobs, Anke; Steinmann, Simone; Henrich, Sarah Marie; Schmidt, Thomas J.; Klempnauer, Karl-Heinz			Helenalin Acetate, a Natural Sesquiterpene Lactone with Anti-inflammatory and Anti-cancer Activity, Disrupts the Cooperation of CCAAT Box/Enhancer-binding Protein beta (C/EBP beta) and Co-activator p300	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-MYB; TRANSCRIPTION FACTORS; GENE-EXPRESSION; MIM-1 GENE; SYNERGISTIC ACTIVATION; MESSENGER-RNA; MYELOID GENES; CANCER CELLS; KAPPA-B; NF-M	Recent work has demonstrated pro-oncogenic functions of the transcription factor CCAAT box/enhancer-binding protein beta (C/EBP beta) in various tumors, implicating C/EBP beta as an interesting target for the development of small-molecule inhibitors. We have previously discovered that the sesquiterpene lactone helenalin acetate, a natural compound known to inhibit NF-kappa B, is a potent C/EBP beta inhibitor. We have now examined the inhibitory mechanism of helenalin acetate in more detail. We demonstrate that helenalin acetate is a significantly more potent inhibitor of C/EBP beta than of NF-kappa B. Our work shows that helenalin acetate inhibits C/EBP beta by binding to the N-terminal part of C/EBP beta, thereby disrupting the cooperation of C/EBP beta with the co-activator p300. C/EBP beta is expressed in several isoforms from alternative translational start codons. We have previously demonstrated that helenalin acetate selectively inhibits only the full-length (liver-enriched activating protein* (LAP*)) isoform but not the slightly shorter (LAP) isoform. Consistent with this, helenalin acetate binds to the LAP* but not to the LAP isoform, explaining why its inhibitory activity is selective for LAP*. Although helenalin acetate contains reactive groups that are able to interact covalently with cysteine residues, as exemplified by its effect on NF-kappa B, the inhibition of C/EBP beta by helenalin acetate is not due to irreversible reaction with cysteine residues of C/EBP beta. In summary, helenalin acetate is the first highly active small-molecule C/EBP beta inhibitor that inhibits C/EBP beta by a direct binding mechanism. Its selectivity for the LAP* isoform also makes helenalin acetate an interesting tool to dissect the functions of the LAP* and LAP isoforms.	[Jakobs, Anke; Steinmann, Simone; Henrich, Sarah Marie; Klempnauer, Karl-Heinz] Westfal Wilhelms Univ, Inst Biochem, D-48149 Munster, Germany; [Schmidt, Thomas J.] Westfal Wilhelms Univ, Inst Pharmaceut Biol & Phytochem, D-48149 Munster, Germany	University of Munster; University of Munster	Klempnauer, KH (corresponding author), Westfal Wilhelms Univ Munster, Inst Biochem, Wilhelm Klemm Str 2, D-48149 Munster, Germany.	klempna@uni-muenster.de	Schmidt, Thomas J/M-1678-2016	Schmidt, Thomas J/0000-0003-2634-9705	Deutsche Krebshilfe; Graduate School of Chemistry at the University of Munster (GSC-MS)	Deutsche Krebshilfe(Deutsche Krebshilfe); Graduate School of Chemistry at the University of Munster (GSC-MS)	This work was supported by the Deutsche Krebshilfe. This work was also supported by a fellowship from the Graduate School of Chemistry at the University of Munster (GSC-MS) (to S. M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar-Morante D, 2011, NEUROSCIENCE, V176, P110, DOI 10.1016/j.neuroscience.2010.12.025; Aguilar-Morante D, 2015, ONCOTARGET, V6, P4369, DOI 10.18632/oncotarget.2976; Anastasov N, 2010, HAEMATOL-HEMATOL J, V95, P760, DOI 10.3324/haematol.2009.014050; Bhaumik P, 2014, ACTA CRYSTALLOGR D, V70, P1914, DOI 10.1107/S1399004714009262; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Buchele B, 2010, ANAL BIOCHEM, V401, P30, DOI 10.1016/j.ab.2010.02.020; BURK O, 1993, EMBO J, V12, P2027, DOI 10.1002/j.1460-2075.1993.tb05852.x; Calkhoven CF, 2000, GENE DEV, V14, P1920; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Cesena TI, 2008, MOL CELL ENDOCRINOL, V289, P94, DOI 10.1016/j.mce.2008.03.009; Cesena TI, 2007, J BIOL CHEM, V282, P956, DOI 10.1074/jbc.M511451200; Chayka O, 2005, MOL CELL BIOL, V25, P499, DOI 10.1128/MCB.25.1.499-511.2005; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Eaton EM, 2003, J BIOL CHEM, V278, P33416, DOI 10.1074/jbc.M305680200; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Hadaschik D, 2003, J VIROL, V77, P5253, DOI 10.1128/JVI.77.9.5253-5265.2003; Homma J, 2006, ONCOL REP, V15, P595; Huber R, 2012, CELL SIGNAL, V24, P1287, DOI 10.1016/j.cellsig.2012.02.007; Jakobs A, 2016, LEUKEMIA, V30, P1612, DOI 10.1038/leu.2016.16; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Joo M, 2004, J BIOL CHEM, V279, P6658, DOI 10.1074/jbc.M306267200; Kim MH, 2009, PROSTATE, V69, P1435, DOI 10.1002/pros.20993; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Kowenz-Leutz E, 2010, EMBO J, V29, P1105, DOI 10.1038/emboj.2010.3; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; Lyss G, 1998, J BIOL CHEM, V273, P33508, DOI 10.1074/jbc.273.50.33508; Mink S, 1996, MOL CELL BIOL, V16, P1316; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; NESS SA, 1993, GENE DEV, V7, P749, DOI 10.1101/gad.7.5.749; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Piva R, 2006, J CLIN INVEST, V116, P3171, DOI 10.1172/JCI29401; Pless O, 2008, J BIOL CHEM, V283, P26357, DOI 10.1074/jbc.M802132200; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rask K, 2000, INT J CANCER, V86, P337, DOI 10.1002/(SICI)1097-0215(20000501)86:3<337::AID-IJC6>3.3.CO;2-V; Schmidt TJ, 1997, BIOORGAN MED CHEM, V5, P645, DOI 10.1016/S0968-0896(97)00003-5; Schmidt TJ, 1999, BIOORGAN MED CHEM, V7, P2849, DOI 10.1016/S0968-0896(99)00234-5; Schomburg C, 2013, EUR J MED CHEM, V63, P313, DOI 10.1016/j.ejmech.2013.02.018; Schwartz C, 2003, EMBO J, V22, P882, DOI 10.1093/emboj/cdg076; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; Steinmann S, 2009, ONCOGENE, V28, P2446, DOI 10.1038/onc.2009.90; Steinmann S, 2013, J BIOL CHEM, V288, P22257, DOI 10.1074/jbc.M113.487769; Su WC, 2003, J BIOL CHEM, V278, P51150, DOI 10.1074/jbc.M305501200; Wethmar K, 2010, BIOESSAYS, V32, P885, DOI 10.1002/bies.201000037; Xu M, 2003, EMBO J, V22, P893, DOI 10.1093/emboj/cdg094	49	24	26	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26098	26108		10.1074/jbc.M116.748129	http://dx.doi.org/10.1074/jbc.M116.748129			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27803164	hybrid, Green Published			2022-12-26	WOS:000390345200028
J	Cramer, CA; de Sousa, LM				Cramer, Christian Andreas; de Sousa, Leandro Melo			A New Species of Tiger Pleco Panaqolus (Siluriformes: Loricariidae) from the Xingu Basin, Brazil	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; DIVERSIFICATION; IDENTIFICATION; GENERA	Panaqolus tankei is described from the Xingu River, Brazil. The new species is diagnosed from P. albomaculatus, P. dentex, P. nix, P. nocturnus, and P. koko by its color pattern consisting of dark and light diagonal bars on the body and bands on the fins (vs. body and fins without bars or bands); from P. albivermis, P. maccus, and P. purusiensis by the width of the dark bars being more or less the same of the light bars (vs. dark bars at least two or three times wider than light bars) and from P. changae by the absence of vermiculation on the head (vs. vermiculation present on head). The new species differs from P. gnomus by the orientation of the bars from posterodorsal to anteroventral direction (vs. anterodorsal to posteroventral direction), and from P. claustellifer by the orientation of the bands in the dorsal fin that are not parallel to the margin (vs. parallel to the margin). The barcoding region (COI) was sequenced for the new species, sequences were deposited in GenBank and were compared with congeners from other drainages. With regard to the current construction of a hydroelectric power plant (a so-called mega dam) in the Xingu River, herewith we increase knowledge of the river Xingu's ichthyofauna and, thus improve the assessment of the impacts of that construction on the river.	[Cramer, Christian Andreas] Philipps Univ Marburg, Ctr Human Genet, Fac Med, Marburg, Germany; [Cramer, Christian Andreas] Univ Fed Rondonia, Dept Biol, Lab Ictiol & Pesca, Porto Velho, Rondonia, Brazil; [de Sousa, Leandro Melo] Fed Univ Para, Fac Ciencias Biol, Lab Ictiol, Altamira, Para, Brazil	Philipps University Marburg; Universidade Federal de Rondonia; Universidade Federal do Para	Cramer, CA (corresponding author), Philipps Univ Marburg, Ctr Human Genet, Fac Med, Marburg, Germany.; Cramer, CA (corresponding author), Univ Fed Rondonia, Dept Biol, Lab Ictiol & Pesca, Porto Velho, Rondonia, Brazil.	Cramerc@gmx.de	de Sousa, Leandro Melo/I-6108-2012	de Sousa, Leandro Melo/0000-0002-0793-9737	CAC Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [350674/2010-8]; Three-years-studentship; LMS Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [486376/2013-3]; Xingu River; NSF [DEB-1257813]	CAC Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Three-years-studentship; LMS Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Xingu River; NSF(National Science Foundation (NSF))	This work was supported by CAC Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cupq.br), No. 350674/2010-8, Three-years-studentship, LMS Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br), No. 486376/2013-3, and Research-grant for fieldwork at the Xingu River, Fieldwork supported in part by NSF DEB-1257813 (CoPI Mark Sabaj Perez).	Camargo M, 2013, LORICARIIDS MIDDLE X; Costa-Silva GJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135075; Cramer CA, NEOTROPICAL IN PRESS; Cramer CA, 2014, NEOTROP ICHTHYOL, V12, P61, DOI 10.1590/S1679-62252014000100006; Cramer CA, 2011, MOL PHYLOGENET EVOL, V59, P43, DOI 10.1016/j.ympev.2011.01.002; Fisch-Muller S, 2012, CYBIUM, V36, P163; Garcia-Davilla C, 2013, GENETICA, V141, P347, DOI 10.1007/s10709-013-9734-5; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubert N, 2007, MOL ECOL, V16, P2115, DOI 10.1111/j.1365-294X.2007.03267.x; Lucena CAS, 2013, B SOC BRAS ICTIOL, V105, P20; Lujan NK, 2015, MOL PHYLOGENET EVOL, V82, P269, DOI 10.1016/j.ympev.2014.08.020; Lujan NK, 2013, ZOOTAXA, V3691, P192, DOI 10.11646/zootaxa.3691.1.8; Lujan NK, 2010, COPEIA, P676, DOI 10.1643/CI-09-185; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Montoya-Burgos JI, 2003, MOL ECOL, V12, P1855, DOI 10.1046/j.1365-294X.2003.01857.x; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Ribeiro ED, 2013, DIVERSIDADE MOL ANCI; Roxo FF, 2015, ZOOKEYS, P109, DOI 10.3897/zookeys.481.8755; Sabaj Perez MH, 2013, STANDARD SYMBOLIC CO; Stawikowski R, 1998, AQUARIEN TERRARIEN Z, V51, P686; Stawikowski R, 1988, AQUARIEN TERRARIEN Z, V41, P556; Stawikowski R, 1994, AQUARIEN TERRARIEN Z, V47, P416; Stawikowski R, 1990, AQUARIEN TERRARIEN Z, V43, P647; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan M, 2016, NEOTROP ICHTHYOL, V14, DOI 10.1590/1982-0224-20150033; Tanke A, 2013, AQUARIEN TERRARIEN Z, V66, P28; Tanke A, 2009, AQUARIEN TERRARIEN Z, V62, P22; TAYLOR W R, 1985, Cybium, V9, P107; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Werner A, 2005, AQUARIEN TERRARIEN Z, V58, P56; Werner A, 2005, AQUARIEN TERRARIEN Z, V58, P32; Wong EHK, 2009, MOL ECOL RESOUR, V9, P243, DOI 10.1111/j.1755-0998.2009.02653.x	34	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165388	10.1371/journal.pone.0165388	http://dx.doi.org/10.1371/journal.pone.0165388			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828981	gold, Green Submitted, Green Published			2022-12-26	WOS:000387724300041
J	Das, P; Bansal, A; Rao, SN; Deodhar, K; Mahantshetty, U; Shrivastava, SK; Sivaraman, K; Mulherkar, R				Das, Poulami; Bansal, Akanksha; Rao, Sudha Narayan; Deodhar, Kedar; Mahantshetty, Umesh; Shrivastava, Shyam K.; Sivaraman, Karthikeyan; Mulherkar, Rita			Somatic Variations in Cervical Cancers in Indian Patients	PLOS ONE			English	Article							MUTATIONS; GENOME; GENE; ACTIVATION; HETEROGENEITY; PATHWAY; BREAST; TUMORS; RISK; HPV	There are very few reports that describe the mutational landscape of cervical cancer, one of the leading cancers in Indian women. The aim of the present study was to investigate the somatic mutations that occur in cervical cancer. Whole exome sequencing of 10 treatment naive tumour biopsies with matched blood samples, from a cohort of Indian patients with locally advanced disease, was performed. The data revealed missense mutations across 1282 genes, out of 1831 genes harbouring somatic mutations. These missense mutations (nonsynonymous + stop-gained) when compared with pre-existing mutations in the COSMIC database showed that 272 mutations in 250 genes were already reported although from cancers other than cervical cancer. More than 1000 novel somatic variations were obtained in matched tumour samples. Pathways / genes that are frequently mutated in various other cancers were found to be mutated in cervical cancers. A significant enrichment of somatic mutations in the MAPK pathway was observed, some of which could be potentially targetable. This is the first report of whole exome sequencing of well annotated cervical cancer samples from Indian women and helps identify trends in mutation profiles that are found in an Indian cohort of cervical cancer.	[Das, Poulami; Bansal, Akanksha; Mulherkar, Rita] Tata Mem Hosp, ACTREC, Mulherkar Lab, Kharghar 410210, Navi Mumbai, India; [Rao, Sudha Narayan] Genotyp Technol Pvt Ltd, 259 Apoorva 4th Cross,80 Ft Rd,RMV 2 Stage, Bengaluru 560094, India; [Deodhar, Kedar] Tata Mem Hosp, Dept Pathol, Bombay 400012, Maharashtra, India; [Mahantshetty, Umesh; Shrivastava, Shyam K.] Tata Mem Hosp, Dept Radiat Oncol, Bombay 400012, Maharashtra, India; [Sivaraman, Karthikeyan] Dhiti Technol Pvt Ltd, 2-10,5th Floor,80 Feet Rd,RMV 2nd Stage, Bengaluru 560094, Karnataka, India; [Das, Poulami] Univ Texas Austin, Ctr Infect Dis, Dept Mol Biosci, Austin, TX 78712 USA; [Mulherkar, Rita] A 103,Pk Dew,Sect 20, Kharghar 410210, Navi Mumbai, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital; University of Texas System; University of Texas Austin	Mulherkar, R (corresponding author), Tata Mem Hosp, ACTREC, Mulherkar Lab, Kharghar 410210, Navi Mumbai, India.; Mulherkar, R (corresponding author), A 103,Pk Dew,Sect 20, Kharghar 410210, Navi Mumbai, India.	rmulherkar@gmail.com	DAS, POULAMI/ABC-6544-2020	Bansal, Akanksha/0000-0002-4501-2094; DAS, POULAMI/0000-0002-8100-7962	Department of Science and Technology (DST) [SR/SO/HS-22/2009]; Genotypic Technology Pvt. Ltd.; Dhitiomics Technologies Pvt. Ltd.	Department of Science and Technology (DST)(Department of Science & Technology (India)); Genotypic Technology Pvt. Ltd.; Dhitiomics Technologies Pvt. Ltd.	The work was funded by Department of Science and Technology (DST No: SR/SO/HS-22/2009), a grant sanctioned to RM. Genotypic Technology Pvt. Ltd. and Dhitiomics Technologies Pvt. Ltd. provided support in the form of salaries/consultation fees for authors SNR and KS respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. SNR provided services which included exomesequencing using Illumina platform and providing the raw data. KS, an independent consultant, was specifically brought in by Dhitiomics Technologies Pvt. Ltd., for handling the data analysis part. The specific roles of these authors are articulated in the 'author contributions' section.	Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Chandrani P, 2015, BRIT J CANCER, V112, P1958, DOI 10.1038/bjc.2015.121; Christiansen IK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119566; Chung TK, 2015, INT J CANC; Courts C, 2008, J NEUROPATH EXP NEUR, V67, P720, DOI 10.1097/NEN.0b013e31817dd02d; Cui B, 2009, INT J ONCOL, V34, P409, DOI 10.3892/ijo_00000164; Das P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041012; EllingerZiegelbauer H, 1997, J BIOL CHEM, V272, P2668, DOI 10.1074/jbc.272.5.2668; FRIEDMAN E, 1993, NAT GENET, V5, P242, DOI 10.1038/ng1193-242; GLOBOCAN, 2012, SECT CANC SURV; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hildesheim A, 1998, CANCER EPIDEM BIOMAR, V7, P1035; HILKENS J, 1992, TRENDS BIOCHEM SCI, V17, P359, DOI 10.1016/0968-0004(92)90315-Z; Horvath A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02256; Huang A, 2005, CANCER RES, V65, P5607, DOI 10.1158/0008-5472.CAN-05-0500; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lou H, 2015, CLIN CANCER RES, V21, P5360, DOI 10.1158/1078-0432.CCR-14-1837; Madeleine MM, 2002, J INFECT DIS, V186, P1565, DOI 10.1086/345285; Muller E, 2015, CANCER MED-US, V4, P1484, DOI 10.1002/cam4.492; Narayan G, 2010, FUTURE ONCOL, V6, P1643, DOI 10.2217/FON.10.114; Nichols Anthony C, 2012, ISRN Oncol, V2012, P809370, DOI 10.5402/2012/809370; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Ouyang LM, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-2; Parfenov M, 2014, P NATL ACAD SCI USA, V111, P15544, DOI 10.1073/pnas.1416074111; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rusan M, 2015, CLIN CANCER RES, V21, P2009, DOI 10.1158/1078-0432.CCR-14-1101; Sanz G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085110; Sharma V, 2011, CANCER RES, V71, P6438, DOI 10.1158/0008-5472.CAN-11-1645; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Storey A, 1998, NATURE, V393, P229, DOI 10.1038/30400; TOMMERUP N, 1995, GENOMICS, V27, P259, DOI 10.1006/geno.1995.1040; Torkamani A, 2008, CANCER RES, V68, P1675, DOI 10.1158/0008-5472.CAN-07-5283; Wang WP, 2012, HUM MUTAT, V33, P480, DOI 10.1002/humu.22014; Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137; WONG YF, 1995, CANCER LETT, V95, P29, DOI 10.1016/0304-3835(95)03857-S; Xu L, 2015, CANCER-AM CANCER SOC, V121, P2367, DOI 10.1002/cncr.29381; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496	40	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165878	10.1371/journal.pone.0165878	http://dx.doi.org/10.1371/journal.pone.0165878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829003	Green Submitted, Green Published, gold			2022-12-26	WOS:000387724300064
J	Ip, V; Toth, Z; Chibnall, J; McBride-Gagyi, S				Ip, Victoria; Toth, Zacharie; Chibnall, John; McBride-Gagyi, Sarah			Remnant Woven Bone and Calcified Cartilage in Mouse Bone: Differences between Ages/Sex and Effects on Bone Strength	PLOS ONE			English	Article							RAT CORTICAL BONE; MECHANICAL-PROPERTIES; LONG BONES; MICE; AGE; RESISTANCE; SENESCENCE; INTEGRITY; FRACTURE; GROWTH	Introduction Mouse models are used frequently to study effects of bone diseases and genetic determinates of bone strength. Murine bones have an intracortical band of woven bone that is not present in human bones. This band is not obvious under brightfield imaging and not typically analyzed. Due to the band's morphology and location it has been theorized to be remnant bone from early in life. Furthermore, lamellar and woven bone are well known to have differing mechanical strengths. The purpose of this study was to determine (i) if the band is from early life and (ii) if the woven bone or calcified cartilage contained within the band affect whole bone strength. Woven Bone Origin Studies In twelve to fourteen week old mice, doxycycline was used to label bone formed prior to 3 weeks old. Doxycycline labeling and woven bone patterns on contralateral femora matched well and encompassed an almost identical cross-sectional area. Also, we highlight for the first time in mice the presence of calcified cartilage exclusively within the band. However, calcified cartilage could not be identified on high resolution cone-beam microCT scans when examined visually or by thresholding methods. Mechanical Strength Studies Subsequently, three-point bending was used to analyze the effects of woven bone and calcified cartilage on whole bone mechanics in a cohort of male and female six and 13 week old Balb/C mice. Three-point bending outcomes were correlated with structural and compositional measures using multivariate linear regression. Woven bone composed a higher percent of young bones than older bones. However, calcified cartilage in older bones was twice that of younger bones, which was similar when normalized by area. Area and/or tissue mineral density accounted for >75% of variation for most strength outcomes. Percent calcified cartilage added significant predictive power to maximal force and bending stress. Calcified cartilage and woven bone could have more influence in genetic models where calcified cartilage percent is double our highest value.	[Ip, Victoria] Cornell Univ, Sch Operat Res & Informat Engn, Ithaca, NY USA; [Toth, Zacharie; McBride-Gagyi, Sarah] St Louis Univ, Dept Orthopaed Surg, St Louis, MO 63103 USA; [Chibnall, John] St Louis Univ, Dept Psychiat, St Louis, MO 63103 USA	Cornell University; Saint Louis University; Saint Louis University	McBride-Gagyi, S (corresponding author), St Louis Univ, Dept Orthopaed Surg, St Louis, MO 63103 USA.	smcbrid9@slu.edu			NIAMS NIH HHS [P30 AR057235] Funding Source: Medline	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bach-Gansmo FL, 2013, CALCIFIED TISSUE INT, V92, P330, DOI 10.1007/s00223-012-9682-6; BECK TJ, 1993, CALCIFIED TISSUE INT, V53, pS41, DOI 10.1007/BF01673401; DANIELSEN CC, 1992, CALCIFIED TISSUE INT, V50, P169, DOI 10.1007/BF00298796; DANIELSEN CC, 1993, CALCIFIED TISSUE INT, V52, P26, DOI 10.1007/BF00675623; FAULKNER KG, 1993, J BONE MINER RES, V8, P1211, DOI 10.1002/jbmr.5650081008; Ferguson VL, 2003, BONE, V33, P387, DOI 10.1016/S8756-3282(03)00199-6; Hayer PS, 2016, J CLIN DIAGN RES, V10, pRC9, DOI 10.7860/JCDR/2016/19267.7629; Jepsen KJ, 2015, J BONE MINER RES, V30, P951, DOI 10.1002/jbmr.2539; Kerschnitzki M, 2011, J STRUCT BIOL, V173, P303, DOI 10.1016/j.jsb.2010.11.014; Long FX, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008334; McBride-Gagyi SH, 2015, BONE, V81, P533, DOI 10.1016/j.bone.2015.09.003; Pautke C, 2010, J ORAL MAXIL SURG, V68, P125, DOI 10.1016/j.joms.2009.05.442; Price C, 2005, J BONE MINER RES, V20; Shipov A, 2013, J STRUCT BIOL, V183, P132, DOI 10.1016/j.jsb.2013.04.010; Silva MJ, 2006, J BONE MINER RES, V21, P78, DOI 10.1359/JBMR.050909; Silva MJ, 2002, J BONE MINER RES, V17, P1597, DOI 10.1359/jbmr.2002.17.9.1597; Tang SY, 2012, J BONE MINER RES, V27, P1936, DOI 10.1002/jbmr.1646; Tseng KF, 1996, J ORTHOPAED RES, V14, P598, DOI 10.1002/jor.1100140414; Vanleene M, 2008, MED ENG PHYS, V30, P1049, DOI 10.1016/j.medengphy.2007.12.010; Vardakastani V, 2014, INCREASED INTRACORTI, V69; Willinghamm MD, 2010, CALCIFIED TISSUE INT, V86, P470, DOI 10.1007/s00223-010-9359-y; Zimmermann EA, 2015, J BONE MINER RES, V30, P264, DOI 10.1002/jbmr.2340	22	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166476	10.1371/journal.pone.0166476	http://dx.doi.org/10.1371/journal.pone.0166476			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829059	Green Published, Green Submitted, gold			2022-12-26	WOS:000387724300109
J	O'Dea, MA; Jackson, B; Jackson, C; Xavier, P; Warren, K				O'Dea, Mark A.; Jackson, Bethany; Jackson, Carol; Xavier, Pally; Warren, Kristin			Discovery and Partial Genomic Characterisation of a Novel Nidovirus Associated with Respiratory Disease in Wild Shingleback Lizards (Tiliqua rugosa)	PLOS ONE			English	Article							VIRUS; POPULATION; INFECTIONS; REPTILES; IDENTIFICATION; TRANSMISSION; SALMONELLA; TORTOISES	A respiratory disease syndrome has been observed in large numbers of wild shingleback lizards (Tiliqua rugosa) admitted to wildlife care facilities in the Perth metropolitan region of Western Australia. Mortality rates are reportedly high without supportive treatment and care. Here we used next generation sequencing techniques to screen affected and unaffected individuals admitted to Kanyana Wildlife Rehabilitation Centre in Perth between April and December 2015, with the resultant discovery of a novel nidovirus significantly associated with cases of respiratory disease according to a case definition based on clinical signs. Interestingly this virus was also found in 12% of apparently healthy individuals, which may reflect testing during the incubation period or a carrier status, or it may be that this agent is not causative in the disease process. This is the first report of a nidovirus in lizards globally. In addition to detection of this virus, characterisation of a 23,832 nt segment of the viral genome revealed the presence of characteristic nidoviral genomic elements providing phylogenetic support for the inclusion of this virus in a novel genus alongside Ball Python nidovirus, within the Torovirinae sub-family of the Coronaviridae. This study highlights the importance of next generation sequencing technologies to detect and describe emerging infectious diseases in wildlife species, as well as the importance of rehabilitation centres to enhance early detection mechanisms through passive and targeted health surveillance. Further development of diagnostic tools from these findings will aid in detection and control of this agent across Australia, and potentially in wild lizard populations globally.	[O'Dea, Mark A.; Jackson, Bethany; Xavier, Pally; Warren, Kristin] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA, Australia; [Jackson, Carol] Kanyana Wildlife Rehabil Ctr, 120 Gilchrist Rd, Lesmurdie, WA, Australia	Murdoch University	O'Dea, MA (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA, Australia.	m.odea@murdoch.edu.au		Jackson, Bethany/0000-0002-8622-8035; O'Dea, Mark/0000-0002-2757-7585; Warren, Kristin/0000-0002-9328-2013	Murdoch University School of Veterinary and Life Sciences; National Significant Disease Investigation Program	Murdoch University School of Veterinary and Life Sciences; National Significant Disease Investigation Program	This work was supported using funds provided by the Murdoch University School of Veterinary and Life Sciences, and through the National Significant Disease Investigation Program, managed by Animal Health Australia with assistance from Wildlife Health Australia and DAFWA.	Abbas MD, 2011, VET MICROBIOL, V150, P70, DOI 10.1016/j.vetmic.2011.01.010; Aiello CM, 2014, ANIM CONSERV, V17, P27, DOI 10.1111/acv.12147; Allender MC, 2015, FUNGAL ECOL, V17, P187, DOI 10.1016/j.funeco.2015.05.003; Benton CH, 2015, EUR J WILDLIFE RES, V61, P1, DOI 10.1007/s10344-014-0882-4; Bermingham A, 2012, EUROSURVEILLANCE, V17, P6; Bodewes R, 2014, J GEN VIROL, V95, P2480, DOI 10.1099/vir.0.068700-0; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; Bouma MJ, 2007, PARASITOL RES, V100, P949, DOI 10.1007/s00436-006-0379-5; Braun J, 2014, J WILDLIFE DIS, V50, P757, DOI 10.7589/2013-09-231; Bruniche-Olsen A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147875; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Bull CM, 2012, MOL ECOL, V21, P4386, DOI 10.1111/j.1365-294X.2012.05653.x; Chen Y, 2009, P NATL ACAD SCI USA, V106, P3484, DOI 10.1073/pnas.0808790106; Cogger H.G., 1975, P1; Cox-Witton K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095127; Dunowska M, 2012, VET MICROBIOL, V156, P418, DOI 10.1016/j.vetmic.2011.11.013; Giles J, 2016, VIROLOGY, V491, P20, DOI 10.1016/j.virol.2016.01.005; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Grange ZL, 2016, MICROB ECOL, V71, P1020, DOI 10.1007/s00248-015-0721-5; Guthrie AL, 2016, J WILDLIFE DIS, V52, P143, DOI 10.7589/2015-04-093.1; Gyawali P., 2013, International Journal of Veterinary Science, V2, P17; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hyndman T, 2011, AUST VET J, V89, P232, DOI 10.1111/j.1751-0813.2011.00712.x; Hyndman TH, 2013, VET MICROBIOL, V165, P200, DOI 10.1016/j.vetmic.2013.04.002; Hyndman TH, 2012, VET MICROBIOL, V161, P77, DOI 10.1016/j.vetmic.2012.07.030; Jackson B, 2014, NEW ZEAL VET J, V62, P297, DOI 10.1080/00480169.2014.909750; Jacobson ER, 2014, VET J, V201, P257, DOI 10.1016/j.tvjl.2014.05.039; Kanyana Wildlife Centre, 2015, 2014 2015 ANN REP; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; King A. M. Q., 2012, 9 INT COMM TAX VIR; Lamirande EW, 1999, VIRUS RES, V63, P135, DOI 10.1016/S0168-1702(99)00067-2; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Levinson J, 2013, EMERG INFECT DIS, V19, P743, DOI 10.3201/eid1905.121042; Luis AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2753; Marschang RE, 2002, J ZOO WILDLIFE MED, V33, P317, DOI 10.1638/1042-7260(2002)033[0317:PARIIW]2.0.CO;2; Miller KA, 2012, CONSERV BIOL, V26, P790, DOI 10.1111/j.1523-1739.2012.01902.x; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Ng TFF, 2015, J VIROL, V89, P5340, DOI 10.1128/JVI.00064-15; Origgi FC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134897; Parsons SK, 2015, APPL ENVIRON MICROB, V81, P5804, DOI 10.1128/AEM.00997-15; Pees M, 2007, DEUT TIERARZTL WOCH, V114, P388, DOI 10.2377/0341-6593-114-388; Randall N., 2011, THESIS; Read JL, 2015, J HERPETOL, V49, P64, DOI 10.1670/13-208; Rivas AE, 2014, HUM-WILDL INTERACT, V8, P78; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Schumacher J, 2006, J EXOT PET MED, V15, P18, DOI 10.1053/j.jepm.2005.11.004; Schumacher Juergen, 2011, Veterinary Clinics of North America Exotic Animal Practice, V14, P207, DOI 10.1016/j.cvex.2011.03.010; Smallridge CJ, 2000, PARASITOL RES, V86, P655, DOI 10.1007/PL00008547; Smyth AK, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140257; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sperry SM, 2005, J VIROL, V79, P3391, DOI 10.1128/JVI.79.6.3391-3400.2005; Stenglein MD, 2014, MBIO, V5, DOI 10.1128/mBio.01484-14; Stohr AC, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-84; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tokarz R, 2015, J GEN VIROL, V96, P2188, DOI 10.1099/vir.0.000166; Uccellini L, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-144; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang RC, 2013, EXP PARASITOL, V133, P144, DOI 10.1016/j.exppara.2012.11.012	59	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165209	10.1371/journal.pone.0165209	http://dx.doi.org/10.1371/journal.pone.0165209			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828982	Green Submitted, gold, Green Published			2022-12-26	WOS:000387724300032
J	Ahlers, LRH; Bastos, RG; Hiroyasu, A; Goodman, AG				Ahlers, Laura R. H.; Bastos, Reginaldo G.; Hiroyasu, Aoi; Goodman, Alan G.			Invertebrate Iridescent Virus 6, a DNA Virus, Stimulates a Mammalian Innate Immune Response through RIG-I-Like Receptors	PLOS ONE			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; VESICULAR STOMATITIS-VIRUS; CYCLIC GMP-AMP; ANTIVIRAL IMMUNITY; ENDOPLASMIC-RETICULUM; GROWTH ARREST; CYTOSOLIC DNA; INTERFERON; HELICASE	Insects are not only major vectors of mammalian viruses, but are also host to insect-restricted viruses that can potentially be transmitted to mammals. While mammalian innate immune responses to arboviruses are well studied, less is known about how mammalian cells respond to viruses that are restricted to infect only invertebrates. Here we demonstrate that IIV-6, a DNA virus of the family Iridoviridae, is able to induce a type I interferondependent antiviral immune response in mammalian cells. Although IIV-6 is a DNA virus, we demonstrate that the immune response activated during IIV-6 infection is mediated by the RIG-I-like receptor 9RLR) pathway, and not the canonical DNA sensing pathway via cGAS/STING. We further show that RNA polymerase III is required for maximal IFN-beta secretion, suggesting that viral DNA is transcribed by this enzyme into an RNA species capable of activating the RLR pathway. Finally, we demonstrate that the RLR-driven mammalian innate immune response to IIV-6 is functionally capable of protecting cells from subsequent infection with the arboviruses Vesicular Stomatitis virus and Kunjin virus. These results represent a novel example of an invertebrate DNA virus activating a canonically RNA sensing pathway in the mammalian innate immune response, which reduces viral load of ensuing arboviral infection.	[Ahlers, Laura R. H.; Bastos, Reginaldo G.; Hiroyasu, Aoi; Goodman, Alan G.] Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA; [Ahlers, Laura R. H.] Washington State Univ, NIH Prot Biotechnol Grad Training Program, Pullman, WA 99164 USA	Washington State University; Washington State University	Goodman, AG (corresponding author), Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA.	agoodman@vetmed.wsu.edu	Goodman, Alan/AAQ-1108-2020	Goodman, Alan/0000-0001-6394-332X	National Institutes of Health [R00 AI106963]; National Institutes of Health/National Institute of General Medical Sciences [T32 GM008336]; Washington State University; NIH [R00 AI106963]; NIH/NIGMS [T32 GM008336]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI106963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Washington State University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health Grant R00 AI106963 to A. G. Goodman, National Institutes of Health/National Institute of General Medical Sciences-funded pre-doctoral fellowship T32 GM008336 to L. R. H. Ahlers, and funds from Washington State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by NIH Grant R00 AI106963 to A.G. Goodman, NIH/NIGMS-funded pre-doctoral fellowship T32 GM008336 to L.R.H. Ahlers, and funds from Washington State University.	Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; Benitez AA, 2015, CELL REP, V13, P1456, DOI 10.1016/j.celrep.2015.10.020; Bogerd HP, 2014, J VIROL, V88, P8065, DOI 10.1128/JVI.00985-14; Bronkhorst AW, 2012, P NATL ACAD SCI USA, V109, pE3604, DOI 10.1073/pnas.1207213109; Brunette RL, 2012, J EXP MED, V209, P1969, DOI 10.1084/jem.20121960; Burgess DJ, 2013, NAT REV GENET, V14, P821, DOI 10.1038/nrg3616; Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; Chinchar VG, 2002, ARCH VIROL, V147, P447, DOI 10.1007/s007050200000; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cui YZ, 2001, GENOMICS, V78, P129, DOI 10.1006/geno.2001.6661; Cullen BR, 2013, CELL HOST MICROBE, V14, P374, DOI 10.1016/j.chom.2013.09.011; D'Costa SM, 2012, ARCH VIROL, V157, P2171, DOI 10.1007/s00705-012-1417-5; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13; Freaney JE, 2013, CELL REP, V4, P959, DOI 10.1016/j.celrep.2013.07.043; Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398; FUKAYA M, 1966, Applied Entomology and Zoology, V1, P69; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gitlin L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000734; Goodman AG, 2010, J VIROL, V84, P2027, DOI 10.1128/JVI.01595-09; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; HOWE JG, 1989, CELL, V57, P825, DOI 10.1016/0092-8674(89)90797-6; Huang F, 1999, GENE, V236, P125, DOI 10.1016/S0378-1119(99)00244-9; Huang F, 1999, ONCOGENE, V18, P3546, DOI 10.1038/sj.onc.1202715; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jakob NJ, 2001, VIROLOGY, V286, P182, DOI 10.1006/viro.2001.0963; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Johnson KN, 1999, J INVERTEBR PATHOL, V73, P248, DOI 10.1006/jipa.1998.4830; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486; Kim K, 2006, COLD SPRING HARB SYM, V71, P39, DOI 10.1101/sqb.2006.71.008; Kranzusch PJ, 2015, MOL CELL, V59, P891, DOI 10.1016/j.molcel.2015.07.022; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lam E, 2014, J VIROL, V88, P974, DOI 10.1128/JVI.02702-13; Lau L, 2015, SCIENCE, V350, P568, DOI 10.1126/science.aab3291; Lee E, 2000, J VIROL, V74, P8867, DOI 10.1128/JVI.74.19.8867-8875.2000; Levy DE, 2002, J INTERF CYTOK RES, V22, P87, DOI 10.1089/107999002753452692; Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Ma Z, 2015, P NATL ACAD SCI USA, V112, pE4306, DOI 10.1073/pnas.1503831112; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Minamitani T, 2011, J VIROL, V85, P4035, DOI 10.1128/JVI.02160-10; Mueller S, 2010, P NATL ACAD SCI USA, V107, P19390, DOI 10.1073/pnas.1014378107; Mukherjee S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-127; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Pan X., 2012, P NATL ACAD SCI USA, V109, pE23, DOI DOI 10.1073/pnas.1116932108; Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109; Pastorino B, 2010, ANTIVIR RES, V87, P281, DOI 10.1016/j.antiviral.2010.04.014; Perry AK, 2005, CELL RES, V15, P407, DOI 10.1038/sj.cr.7290309; Pfeffer LM, 2004, J BIOL CHEM, V279, P31304, DOI 10.1074/jbc.M308975200; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Rustagi A, 2013, METHODS, V59, P225, DOI 10.1016/j.ymeth.2012.05.011; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712; Sarkar D, 2008, P NATL ACAD SCI USA, V105, P17040, DOI 10.1073/pnas.0804956105; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun YW, 1997, RIG I HUMAN HOMOLOG; Takeuchi O, 2008, NAT IMMUNOL, V9, P1327, DOI 10.1038/ni1208-1327; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Williams T, 2008, NEOTROP ENTOMOL, V37, P615, DOI 10.1590/S1519-566X2008000600001; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yamaguchi T, 2010, P NATL ACAD SCI USA, V107, P17286, DOI 10.1073/pnas.1009823107; Yoneda M., 2016, J IMMUNOL; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	84	22	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166088	10.1371/journal.pone.0166088	http://dx.doi.org/10.1371/journal.pone.0166088			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824940	Green Published, Green Submitted, gold			2022-12-26	WOS:000387615200061
J	Jin, HJ; Fang, W; Zhu, ML; Yu, ZZ; Fang, Y; Yan, H; Zhang, MF; Wang, Q; Che, XJ; Xie, YY; Huang, JY; Hu, CH; Zhang, HF; Mou, S; Ni, ZH				Jin, Haijiao; Fang, Wei; Zhu, Mingli; Yu, Zanzhe; Fang, Yan; Yan, Hao; Zhang, Minfang; Wang, Qin; Che, Xiajing; Xie, Yuanyuan; Huang, Jiaying; Hu, Chunhua; Zhang, Haifen; Mou, Shan; Ni, Zhaohui			Urgent-Start Peritoneal Dialysis and Hemodialysis in ESRD Patients: Complications and Outcomes	PLOS ONE			English	Article							BREAK-IN PERIOD; ACCESS; ASSOCIATIONS; MORTALITY; OPTION	Background Several studies have suggested that urgent-start peritoneal dialysis (PD) is a feasible alternative to hemodialysis (HD) in patients with end-stage renal disease (ESRD), but the impact of the dialysis modality on outcome, especially on short-term complications, in urgent-start dialysis has not been directly evaluated. The aim of the current study was to compare the complications and outcomes of PD and HD in urgent-start dialysis ESRD patients. Methods In this retrospective study, ESRD patients who initiated dialysis urgently without a preestablished functional vascular access or PD catheter at a single center from January 2013 to December 2014 were included. Patients were grouped according to their dialysis modality (PD and HD). Each patient was followed for at least 30 days after catheter insertion (until January 2016). Dialysis-related complications and patient survival were compared between the two groups. Results Our study enrolled 178 patients (56.2% male), of whom 96 and 82 patients were in the PD and HD groups, respectively. Compared with HD patients, PD patients had more cardiovascular disease, less heart failure, higher levels of serum potassium, hemoglobin, serum albumin, serum pre-albumin, and lower levels of brain natriuretic peptide. There were no significant differences in gender, age, use of steroids, early referral to a nephrologist, prevalence of primary renal diseases, prevalence of co-morbidities, and other laboratory characteristics between the groups. The incidence of dialysis-related complications during the first 30 days was significantly higher in HD than PD patients. HD patients had a significantly higher probability of bacteremia compared to PD patients. HD was an independent predictor of short-term (30-day) dialysis-related complications. There was no significant difference between PD and HD patients with respect to patient survival rate. Conclusion In an experienced center, PD is a safe and feasible dialysis alternative to HD for ESRD patients with an urgent need for dialysis.	[Jin, Haijiao; Fang, Wei; Zhu, Mingli; Yu, Zanzhe; Fang, Yan; Yan, Hao; Zhang, Minfang; Wang, Qin; Che, Xiajing; Xie, Yuanyuan; Huang, Jiaying; Hu, Chunhua; Zhang, Haifen; Mou, Shan; Ni, Zhaohui] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Nephrol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Ni, ZH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Nephrol, Shanghai, Peoples R China.	profnizh@126.com		mou, shan/0000-0003-4160-1681	National Natural Science Foundation of China [81370794]; National "Twelfth Five-Year" Plan for Science and Technology [2011BAI10B08]; Research Project of Health Public Welfare Industry in China [201502023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National "Twelfth Five-Year" Plan for Science and Technology; Research Project of Health Public Welfare Industry in China	This work was supported by the National Natural Science Foundation of China (81370794, http://www.nsfc.gov.cn) and the National "Twelfth Five-Year" Plan for Science and Technology (2011BAI10B08, http://prograrm.most.gov.cn) to Dr Ni, as well as the Research Project of Health Public Welfare Industry in China (201502023, http://www.moh.gov.cn) to Dr Lin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (grant No. 81370794), the National "Twelfth Five-Year" Plan for Science & Technology (grant No. 2011BAI10B08), and the Research Project of Health Public Welfare Industry in China (grant No. 201502023).	Alkatheeri AMA, 2016, PERITON DIALYSIS INT, V36, P171, DOI 10.3747/pdi.2014.00148; [Anonymous], 2001, AM J KIDNEY DIS, V37, p137 ; Dean D, 2016, SEMIN DIAL; Dias DB, 2016, INT UROL NEPHROL, V48, P901, DOI 10.1007/s11255-016-1243-x; Dombros N., 2005, NEPHROL DIAL TRANSPL, V20, pix8, DOI DOI 10.1093/NDT/GFI1117; Figueiredo A, 2010, PERITON DIALYSIS INT, V30, P424, DOI 10.3747/pdi.2010.00087; Ghaffari A, 2012, AM J KIDNEY DIS, V59, P400, DOI 10.1053/j.ajkd.2011.08.034; Johnson DW, 2009, AM J KIDNEY DIS, V53, P290, DOI 10.1053/j.ajkd.2008.06.032; Koch M, 2012, NEPHROL DIAL TRANSPL, V27, P375, DOI 10.1093/ndt/gfr262; Lee T, 2005, AM J KIDNEY DIS, V46, P501, DOI 10.1053/j.ajkd.2005.05.024; Liangos O, 2006, SEMIN DIALYSIS, V19, P158, DOI 10.1111/j.1525-139X.2006.00143.x; Liu FX, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000293; Liu YR, 2014, PERITON DIALYSIS INT, V34, P49, DOI 10.3747/pdi.2012.00293; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Lobbedez T, 2008, NEPHROL DIAL TRANSPL, V23, P3290, DOI 10.1093/ndt/gfn213; Lok CE, 2013, CLIN J AM SOC NEPHRO, V8, P1213, DOI 10.2215/CJN.01690213; Lorenzo V, 2004, AM J KIDNEY DIS, V43, P999, DOI 10.1053/j.ajkd.2004.02.012; Povlsen JV, 2006, NEPHROL DIAL TRANSPL, V21, DOI 10.1093/ndt/gfl192; Ravani P, 2013, J AM SOC NEPHROL, V24, P465, DOI 10.1681/ASN.2012070643; Rehman R, 2009, CLIN J AM SOC NEPHRO, V4, P456, DOI 10.2215/CJN.03840808; Sharma AP, 2008, NEPHROLOGY, V13, P672, DOI 10.1111/j.1440-1797.2008.01000.x; United States Renal Data System, 2014, USRDS 2014 ANN DAT R, V2; United States Renal Data System, 2015, USRDS 2015 ANN DAT R, V2; United States Renal Data System, 2014, USRDS 2014 ANN DAT R, V1; US Renal Data System, 2011, AM J KIDNEY DIS, V57, P1, DOI [10.1053/j.ajkd.2010.11.005, DOI 10.1053/J.AJKD.2010.11.005]	25	45	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166181	10.1371/journal.pone.0166181	http://dx.doi.org/10.1371/journal.pone.0166181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824950	Green Published, Green Submitted, gold			2022-12-26	WOS:000387615200067
J	Lee, L; Cui, JZ; Cua, M; Esfandiarei, M; Sheng, XY; Chui, WA; Xu, MH; Sarunic, MV; Beg, MF; van Breemen, C; Sandor, GGS; Tibbits, GF				Lee, Ling; Cui, Jason Z.; Cua, Michelle; Esfandiarei, Mitra; Sheng, Xiaoye; Chui, Winsey Audrey; Xu, Michael Haoying; Sarunic, Marinko V.; Beg, Mirza Faisal; van Breemen, Cornelius; Sandor, George G. S.; Tibbits, Glen F.			Aortic and Cardiac Structure and Function Using High-Resolution Echocardiography and Optical Coherence Tomography in a Mouse Model of Marfan Syndrome	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; LEFT-VENTRICULAR FUNCTION; AXIS SYSTOLIC FUNCTION; BIOPHYSICAL PROPERTIES; DIASTOLIC DYSFUNCTION; ARTERIAL STIFFNESS; THORACIC AORTA; YOUNG-ADULTS; ANEURYSM; MICE	Marfan syndrome (MFS) is an autosomal-dominant disorder of connective tissue caused by mutations in the fibrillin-1 (FBN1) gene. Mortality is often due to aortic dissection and rupture. We investigated the structural and functional properties of the heart and aorta in a [Fbn1(C1039G/+)] MFS mouse using high-resolution ultrasound (echo) and optical coherence tomography (OCT). Echo was performed on 6- and 12-month old wild type (WT) and MFS mice (n = 8). In vivo pulse wave velocity (PWV), aortic root diameter, ejection fraction, stroke volume, left ventricular (LV) wall thickness, LV mass and mitral valve early and atrial velocities (E/A) ratio were measured by high resolution echocardiography. OCT was performed on 12-month old WT and MFS fixed mouse hearts to measure ventricular volume and mass. The PWV was significantly increased in 6-mo MFS vs. WT (366.6 +/- 19.9 vs. 205.2 +/- 18.1 cm/s; p = 0.003) and 12-mo MFS vs. WT (459.5 +/- 42.3 vs. 205.3 +/- 30.3 cm/s; p< 0.0001). PWV increased with age in MFS mice only. We also found a significantly enlarged aortic root and decreased E/A ratio in MFS mice compared with WT for both age groups. The [Fbn1(C1039G/+)] mouse model of MFS replicates many of the anomalies of Marfan patients including significant aortic dilation, central aortic stiffness, LV systolic and diastolic dysfunction. This is the first demonstration of the direct measurement in vivo of pulse wave velocity non-invasively in the aortic arch of MFS mice, a robust measure of aortic stiffness and a critical clinical parameter for the assessment of pathology in the Marfan syndrome.	[Lee, Ling; Cui, Jason Z.; Esfandiarei, Mitra; Sheng, Xiaoye; Xu, Michael Haoying; van Breemen, Cornelius; Sandor, George G. S.; Tibbits, Glen F.] Child & Family Res Inst, Dept Cardiovasc Sci, Vancouver, BC, Canada; [Lee, Ling; Sheng, Xiaoye; Tibbits, Glen F.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada; [Cua, Michelle; Chui, Winsey Audrey; Sarunic, Marinko V.; Beg, Mirza Faisal] Simon Fraser Univ, Sch Engn Sci, Burnaby, BC, Canada; [Esfandiarei, Mitra; van Breemen, Cornelius] Univ British Columbia, Fac Med, Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada; [Cui, Jason Z.; Sandor, George G. S.] Univ British Columbia, Dept Pediat, Div Cardiol, Vancouver, BC, Canada; [Esfandiarei, Mitra] Midwestern Univ, Dept Biomed Sci, Glendale, AZ USA	Child & Family Research Institute; Simon Fraser University; Simon Fraser University; University of British Columbia; University of British Columbia; Midwestern University	Tibbits, GF (corresponding author), Child & Family Res Inst, Dept Cardiovasc Sci, Vancouver, BC, Canada.; Tibbits, GF (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada.	tibbits@sfu.ca	Esfandiarei, Mitra/R-9903-2019; Esfandiarei, Mitra/V-1258-2019	Esfandiarei, Mitra/0000-0003-3218-7781; Sandor, George/0000-0002-9930-5140; Beg, Mirza Faisal/0000-0001-6706-8630; Sarunic, Marinko/0000-0002-5636-9056	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research, www.cihr-irsc.gc.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpendurada F, 2010, EUR J HEART FAIL, V12, P1085, DOI 10.1093/eurjhf/hfq127; Angtuaco MJ, 2012, J ULTRAS MED, V31, P1609; Arnlov J, 2004, EUR HEART J, V25, P2220, DOI 10.1016/j.ehj.2004.10.021; Bradley TJ, 2005, AM J CARDIOL, V96, P1317, DOI 10.1016/j.amjcard.2005.06.080; Campens L, 2015, PEDIATR RES, V78, P256, DOI 10.1038/pr.2015.110; Chatrath R, 2003, AM J CARDIOL, V91, P914, DOI 10.1016/S0002-9149(03)00039-0; Child AH, 2004, MED INTELL UNIT, P13; Chung AWY, 2007, BRIT J PHARMACOL, V152, P305, DOI 10.1038/sj.bjp.0707391; Chung AWY, 2007, BRIT J PHARMACOL, V150, P1075, DOI 10.1038/sj.bjp.0707181; Chung AWY, 2007, CIRC RES, V101, P512, DOI 10.1161/CIRCRESAHA.107.157776; Cook JR, 2014, J CLIN INVEST, V124, P1329, DOI 10.1172/JCI71059; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Cua M, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.11.116007; Cui JZ, 2014, J STRUCT BIOL, V187, P242, DOI 10.1016/j.jsb.2014.07.003; Das BB, 2006, PEDIATR CARDIOL, V27, P256, DOI 10.1007/s00246-005-1139-5; Di Lascio N, 2014, ATHEROSCLEROSIS, V237, P31, DOI 10.1016/j.atherosclerosis.2014.08.033; Dietz HC, 2005, AM J MED GENET C, V139C, P4, DOI 10.1002/ajmg.c.30068; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; El-Hamamsy I, 2009, NAT REV CARDIOL, V6, P771, DOI 10.1038/nrcardio.2009.191; FREED C, 1977, WESTERN J MED, V126, P87; Gao Shumin, 2011, Curr Protoc Mouse Biol, V1, P71; Groenink M, 2001, RADIOLOGY, V219, P535, DOI 10.1148/radiology.219.2.r01ma01535; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hartley CJ, 1997, AM J PHYSIOL-HEART C, V273, pH494, DOI 10.1152/ajpheart.1997.273.1.H494; HIRATA K, 1991, J AM COLL CARDIOL, V18, P57, DOI 10.1016/S0735-1097(10)80218-9; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Hucker WJ, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2975826; JEREMY RW, 1994, AM J CARDIOL, V74, P369, DOI 10.1016/0002-9149(94)90405-7; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; KAINULAINEN K, 1994, NAT GENET, V6, P64, DOI 10.1038/ng0194-64; Kass DA, 2004, CIRC RES, V94, P1533, DOI 10.1161/01.RES.0000129254.25507.d6; Keane MG, 2008, CIRCULATION, V117, P2802, DOI 10.1161/CIRCULATIONAHA.107.693523; Kiotsekoglou A, 2008, EUR J ECHOCARDIOGR, V9, P605, DOI 10.1093/ejechocard/jen003; Kiotsekoglou A, 2011, ECHOCARDIOGR-J CARD, V28, P29, DOI 10.1111/j.1540-8175.2010.01241.x; Kiotsekoglou A, 2010, HELL J CARDIOL, V51, P501; Kroner ESJ, 2013, INT J CARDIOL, V167, P2977, DOI 10.1016/j.ijcard.2012.08.057; Laurent S, 2003, STROKE, V34, P1203, DOI 10.1161/01.STR.0000065428.03209.64; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Leloup AJA, 2014, HYPERTENSION, V64, P195, DOI 10.1161/HYPERTENSIONAHA.114.03312; Little WC, 2009, CIRCULATION, V120, P802, DOI 10.1161/CIRCULATIONAHA.109.869602; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Nollen GJ, 2004, EUR HEART J, V25, P1146, DOI 10.1016/j.ehj.2004.04.033; Okamura H, 2014, CIRC-CARDIOVASC IMAG, V7, P690, DOI 10.1161/CIRCIMAGING.114.001658; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Rabben SI, 2004, J BIOMECH, V37, P1615, DOI 10.1016/j.jbiomech.2003.12.031; Ram R, 2011, AM J PHYSIOL-HEART C, V301, pH1765, DOI 10.1152/ajpheart.00559.2011; Rhoades R, 2013, MED PHYSL PRINCIPLES, pxvi; Roth DM, 2002, AM J PHYSIOL-HEART C, V282, pH2134, DOI 10.1152/ajpheart.00845.2001; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Syyong HT, 2009, BRIT J PHARMACOL, V158, P1597, DOI 10.1111/j.1476-5381.2009.00439.x; Tae HJ, 2015, AM J PHYSIOL-HEART C, DOI [10.1152/ajpheart.00354.2015ajpheart.00354.2015, DOI 10.1152/AJPHEART.00354.2015AJPHEART]; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Westenberg JJM, 2011, J MAGN RESON IMAGING, V34, P526, DOI 10.1002/jmri.22646; Williams R, 2007, ULTRASOUND MED BIOL, V33, P1368, DOI 10.1016/j.ultrasmedbio.2007.03.012; Yetman AT, 2003, J AM COLL CARDIOL, V41, P329, DOI 10.1016/S0735-1097(02)02699-2	59	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0164778	10.1371/journal.pone.0164778	http://dx.doi.org/10.1371/journal.pone.0164778			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824871	Green Submitted, Green Published, gold			2022-12-26	WOS:000387615200007
J	Sugita, N				Sugita, Norimasa			Homosexual Fellatio: Erect Penis Licking between Male Bonin Flying Foxes Pteropus pselaphon	PLOS ONE			English	Article							BEHAVIOR; BATS; ETHOGRAM; ALECTO	A recent focus of interest has been on the functional significance of genital licking (fellatio and cunnilingus) in relation to sexual selection in Pteropodid bats. In the present paper, a form of fellatio in wild Bonin flying foxes, Pteropus pselaphon, performed between adult males has been reported. During the mating season, adult flying foxes roost in same-sex groups, forming ball-shaped clusters which provide warmth. The female clusters may also contain a few males. Unassociated with allogrooming, same-sex genital licking occurred among males in the all male clusters. As such, male-male fellatio can be considered as homosexual behavior, two functional explanations could account for this behavior; the social bonding and the social tension regulation hypotheses suggested in a previous review. Given that neither the simpler alternative that in all male groups such fellatio may represent misdirected sexual behavior, nor the two previously proposed functional hypotheses were supported by the data, I propose another functional hypothesis. Homosexual fellatio in this species could help males solve inconsistent situations in the roost when there are conflicts between cooperative behavior for social thermoregulation and competition for mating.	[Sugita, Norimasa] Rikkyo Univ, Coll Sci, Toshima Ku, Tokyo, Japan; [Sugita, Norimasa] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki, Japan	Rikkyo University; National Museum of Nature and Science	Sugita, N (corresponding author), Rikkyo Univ, Coll Sci, Toshima Ku, Tokyo, Japan.; Sugita, N (corresponding author), Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki, Japan.	nsugita@rikkyo.ac.jp		Sugita, Norimasa/0000-0002-5239-9872				Bagemihl B, 1999, BIOL EXUBERANCE; Bailey NW, 2009, TRENDS ECOL EVOL, V24, P439, DOI 10.1016/j.tree.2009.03.014; Courts SE, 1996, DODO, V32, P15; DEWAAL FBM, 1995, CHIC SEX HIST SOC, P37; EAST ML, 1993, BEHAV ECOL SOCIOBIOL, V33, P355; Gebhard Paul H., 1979, KINSEY DATA MARGINAL; Grant Gilbert S., 1999, Australian Mammalogy, V21, P111; Greenhall A. M., 1965, Mammalia, V29, P441, DOI 10.1515/mamm.1965.29.4.441; Inaba M., 2005, OGASAWARA RES, V30, P15; Ishii N., 2008, 2008 IUCN RED LIST T; Kinjo K, 1829, WILD MAMMALS JAPAN, P56; MacFarlane GR, 2016, BEHAV PROCESS, V126, P21, DOI 10.1016/j.beproc.2016.02.016; Markus N, 2002, ACTA CHIROPTEROL, V4, P137, DOI 10.3161/001.004.0203; Markus N, 2002, ACTA CHIROPTEROL, V4, P153, DOI 10.3161/001.004.0204; Maruthupandian J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059743; NELSON JE, 1965, ANIM BEHAV, V13, P544, DOI 10.1016/0003-3472(65)90118-1; Ogawa H., 2006, WILY MONKEYS SOCIAL; R Development Core Team, 2016, R LANG ENV STAT COMP; Riccucci M, 2011, HYSTRIX, V22, P139, DOI 10.4404/Hystrix-22.1-4478; Sugita N, 2014, MAMM STUDY, V39, P185, DOI 10.3106/041.039.0301; Sugita N, 2013, MAMM BIOL, V78, P455, DOI 10.1016/j.mambio.2013.07.078; Sugita N, 2013, MAMM STUDY, V38, P225, DOI 10.3106/041.038.0301; Sugita N, 2009, J MAMMAL, V90, P195, DOI 10.1644/07-MAMM-A-368.1; Tan M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007595; Vasey P. L., 2006, HOMOSEXUAL BEHAV ANI, P3; Vasey PL, 2006, ARCH SEX BEHAV, V35, P523, DOI 10.1007/s10508-006-9111-x	26	7	9	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166024	10.1371/journal.pone.0166024	http://dx.doi.org/10.1371/journal.pone.0166024			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824953	Green Published, gold, Green Submitted			2022-12-26	WOS:000387615200054
J	Zheng, LZ; Lin, VC; Mu, YG				Zheng, Liangzhen; Lin, Valerie Chunling; Mu, Yuguang			Exploring Flexibility of Progesterone Receptor Ligand Binding Domain Using Molecular Dynamics	PLOS ONE			English	Article							FREE-ENERGY LANDSCAPE; CATION-PI INTERACTIONS; NORMAL-MODE ANALYSIS; CRYSTAL-STRUCTURE; RETINOIC ACID; MAMMARY-GLAND; FORCE-FIELD; C-TERMINUS; PROTEIN; SIMULATIONS	Progesterone receptor (PR), a member of nuclear receptor (NR) superfamily, plays a vital role for female reproductive tissue development, differentiation and maintenance. PR ligand, such as progesterone, induces conformation changes in PR ligand binding domain (LBD), thus mediates subsequent gene regulation cascades. PR LBD may adopt different conformations upon an agonist or an antagonist binding. These different conformations would trigger distinct transcription events. Therefore, the dynamics of PR LBD would be of general interest to biologists for a deep understanding of its structure-function relationship. However, no apo-form (non-ligand bound) of PR LBD model has been proposed either by experiments or computational methods so far. In this study, we explored the structural dynamics of PR LBD using molecular dynamics simulations and advanced sampling tools in both ligand-bound and the apo-forms. Resolved by the simulation study, helix 11, helix 12 and loop 895-908 (the loop between these two helices) are quite flexible in antagonistic conformation. Several residues, such as Arg899 and Glu723, could form salt-bridging interaction between helix 11 and helix 3, and are important for the PR LBD dynamics. And we also propose that helix 12 in apo-form PR LBD, not like other NR LBDs, such as human estrogen receptor a (ER alpha) LBD, may not adopt a totally extended conformation. With the aid of umbrella sampling and meta-dynamics simulations, several stable conformations of apo-form PR LBD have been sampled, which may work as critical structural models for further large scale virtual screening study to discover novel PR ligands for therapeutic application.	[Zheng, Liangzhen; Lin, Valerie Chunling; Mu, Yuguang] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Mu, YG (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	ygmu@ntu.edu.sg	Liangzhen, ZHENG/CAJ-5666-2022; Zheng, Liangzhen/AAA-6885-2020		Nanyang Technological University [RG 138/15]	Nanyang Technological University(Nanyang Technological University)	The authors recevied fund from Nanyang Technological University, fund name is Tier 1 Grant RG 138/15. Funder's website: http://www.ntu.edu.sg/Pages/home.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is supported and financed by Nanyang Technological University Tier 1 Grant RG 138/15.	Allen M. P., 1989, COMPUTER SIMULATION, DOI DOI 10.1093/OSO/9780198803195.001.0001; Arora K, 2007, P NATL ACAD SCI USA, V104, P18496, DOI 10.1073/pnas.0706443104; Awuni Y, 2015, MOLECULES, V20, P5152, DOI 10.3390/molecules20035152; Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Baker ME, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-24; Banavali NK, 2005, J AM CHEM SOC, V127, P6866, DOI 10.1021/ja050482k; Banerjee S, 2011, J AM SOC MASS SPECTR, V22, P1707, DOI 10.1007/s13361-011-0188-7; Barducci A, 2006, J AM CHEM SOC, V128, P2705, DOI 10.1021/ja057076l; Barducci A, 2013, P NATL ACAD SCI USA, V110, pE4708, DOI 10.1073/pnas.1320077110; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Batista MRB, 2013, BIOPHYS J, V105, P1670, DOI 10.1016/j.bpj.2013.07.032; Bellance C, 2013, MOL BIOL CELL, V24, P1363, DOI 10.1091/mbc.E12-11-0807; Blondel A, 1999, J MOL BIOL, V291, P101, DOI 10.1006/jmbi.1999.2879; Bonomi M, 2009, J COMPUT CHEM, V30, P1615, DOI 10.1002/jcc.21305; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Branduardi D, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2432340; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Bussi G, 2006, J AM CHEM SOC, V128, P13435, DOI 10.1021/ja062463w; Case D.A., 2022, AMBER 2020; Celik L, 2007, BIOCHEMISTRY-US, V46, P1743, DOI 10.1021/bi061656t; Chiu CC, 2013, BIOPHYS J, V105, P1227, DOI 10.1016/j.bpj.2013.07.029; Cohen RN, 2001, MOL ENDOCRINOL, V15, P1049, DOI 10.1210/me.15.7.1049; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Favia AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025375; Fernandez-Valdivia R, 2005, SEMIN REPROD MED, V23, P22, DOI 10.1055/s-2005-864031; Frisch M., 2009, GAUSSIAN 09 REVISION, P200; Fujii S, 2014, EUR J MED CHEM, V84, P264, DOI 10.1016/j.ejmech.2014.07.034; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; GUIOCHONMANTEL A, 1989, CELL, V57, P1147, DOI 10.1016/0092-8674(89)90052-4; Harvey S.C., 1988, DYNAMICS PROTEINS NU; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hill KK, 2012, MOL CELL ENDOCRINOL, V348, P418, DOI 10.1016/j.mce.2011.07.017; Hsin Jen, 2008, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0507s24; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaplan W, 2001, Brief Bioinform, V2, P195, DOI 10.1093/bib/2.2.195; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Khan JA, 2013, MOL ENDOCRINOL, V27, P909, DOI 10.1210/me.2012-1328; Kozakov D, 2015, NAT PROTOC, V10, P733, DOI 10.1038/nprot.2015.043; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601; LANZ RB, 1994, ENDOCRINOLOGY, V135, P2183, DOI 10.1210/en.135.5.2183; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Leonhardt SA, 2003, STEROIDS, V68, P761, DOI 10.1016/S0039-128X(03)00129-6; Letz M, 1999, BBA-PROTEIN STRUCT M, V1429, P391, DOI 10.1016/S0167-4838(98)00249-0; Limongelli V, 2012, P NATL ACAD SCI USA, V109, P1467, DOI 10.1073/pnas.1112181108; LobaccaroHenri C, 1996, J STEROID BIOCHEM, V59, P63, DOI 10.1016/S0960-0760(96)00091-X; Lusher SJ, 2012, J BIOL CHEM, V287, P20333, DOI 10.1074/jbc.M111.308403; Madauss KP, 2007, MOL ENDOCRINOL, V21, P1066, DOI 10.1210/me.2006-0524; Madauss KP, 2004, J MED CHEM, V47, P3381, DOI 10.1021/jm030640n; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mecozzi S, 1996, P NATL ACAD SCI USA, V93, P10566, DOI 10.1073/pnas.93.20.10566; MEYER ME, 1990, EMBO J, V9, P3923, DOI 10.1002/j.1460-2075.1990.tb07613.x; Miao YL, 2014, CHEM BIOL DRUG DES, V83, P237, DOI 10.1111/cbdd.12233; Mu YG, 2005, PROTEINS, V58, P45, DOI 10.1002/prot.20310; Nettles KW, 2008, NAT CHEM BIOL, V4, P241, DOI 10.1038/nchembio.76; Palmer D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0696; Perryman AL, 2004, PROTEIN SCI, V13, P1108, DOI 10.1110/ps.03468904; Petit-Topin I, 2014, J STEROID BIOCHEM, V144, P427, DOI 10.1016/j.jsbmb.2014.08.008; Petit-Topin I, 2009, MOL PHARMACOL, V75, P1317, DOI 10.1124/mol.108.054312; Pfaendtner J, 2009, P NATL ACAD SCI USA, V106, P12723, DOI 10.1073/pnas.0902092106; Piana S, 2007, J PHYS CHEM B, V111, P4553, DOI 10.1021/jp067873l; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Pietrucci F, 2009, J CHEM THEORY COMPUT, V5, P2197, DOI 10.1021/ct900202f; Pronk S., 2013, BIOINFORMATICS; Raaijmakers HCA, 2009, J BIOL CHEM, V284, P19572, DOI 10.1074/jbc.M109.007872; Lopez-Blanco JR, 2011, BIOINFORMATICS, V27, P2843, DOI 10.1093/bioinformatics/btr497; Recouvreux MS, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-2240; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Rho YA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002524; Richer JK, 2002, J BIOL CHEM, V277, P5209, DOI 10.1074/jbc.M110090200; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schapira M, 2003, J MED CHEM, V46, P3045, DOI 10.1021/jm0300173; Schnecke V, 1999, Proc Int Conf Intell Syst Mol Biol, P242; Seeber M, 2007, BIOINFORMATICS, V23, P2625, DOI 10.1093/bioinformatics/btm378; Seeber M, 2011, J COMPUT CHEM, V32, P1183, DOI 10.1002/jcc.21688; Soderhjelm P, 2012, P NATL ACAD SCI USA, V109, P5170, DOI 10.1073/pnas.1201940109; Spitz IM, 2003, EXPERT OPIN INV DRUG, V12, P1693, DOI 10.1517/eoid.12.10.1693.21837; Sutto L, 2013, P NATL ACAD SCI USA, V110, P10616, DOI 10.1073/pnas.1221953110; Takimoto GS, 2003, J STEROID BIOCHEM, V85, P209, DOI 10.1016/S0960-0760(03)00197-3; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; Tiwary P, 2015, J PHYS CHEM B, V119, P736, DOI 10.1021/jp504920s; VEGETO E, 1992, CELL, V69, P703, DOI 10.1016/0092-8674(92)90234-4; Wang JN, 2014, J PHYS CHEM B, V118, P134, DOI 10.1021/jp4105129; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Xu JM, 1996, P NATL ACAD SCI USA, V93, P12195, DOI 10.1073/pnas.93.22.12195; Zhang SM, 1996, MOL ENDOCRINOL, V10, P24, DOI 10.1210/me.10.1.24	92	10	10	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165824	10.1371/journal.pone.0165824	http://dx.doi.org/10.1371/journal.pone.0165824			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824891	Green Submitted, gold, Green Published			2022-12-26	WOS:000387615200034
J	Gregorio, AC; Fonseca, NA; Moura, V; Lacerda, M; Figueiredo, P; Simoes, S; Diaz, S; Moreira, JN				Gregorio, Ana C.; Fonseca, Nuno A.; Moura, Vera; Lacerda, Manuela; Figueiredo, Paulo; Simoes, Sergio; Diaz, Sergio; Moreira, Joao Nuno			Inoculated Cell Density as a Determinant Factor of the Growth Dynamics and Metastatic Efficiency of a Breast Cancer Murine Model	PLOS ONE			English	Article							MOUSE MAMMARY-TUMOR; PEGYLATED LIPOSOMAL DOXORUBICIN; MONITORING TREATMENT RESPONSE; SOLID TUMORS; IN-VIVO; CARCINOMA; MICROENVIRONMENT; INHIBITION; CHALLENGES; NECROSIS	4T1 metastatic breast cancer model have been widely used to study stage IV human breast cancer. However, the frequent inoculation of a large number of cells, gives rise to fast growing tumors, as well as to a surprisingly low metastatic take rate. The present work aimed at establishing the conditions enabling high metastatic take rate of the triple-negative murine 4T1 syngeneic breast cancer model. An 87% 4T1 tumor incidence was observed when as few as 500 cancer cells were implanted. 4T1 cancer cells colonized primarily the lungs with 100% efficiency, and distant lesions were also commonly identified in the mesentery and pancreas. The drastic reduction of the number of inoculated cells resulted in increased tumor doubling times and decreased specific growth rates, following a Gompertzian tumor expansion. The established conditions for the 4T1 mouse model were further validated in a therapeutic study with peguilated liposomal doxorubicin, in clinical used in the setting of metastatic breast cancer. Inoculated cell density was proven to be a key methodological aspect towards the reproducible development of macrometastases in the 4T1 mouse model and a more reliable pre-clinical assessment of antimetastatic therapies.	[Gregorio, Ana C.; Fonseca, Nuno A.; Moura, Vera; Simoes, Sergio; Moreira, Joao Nuno] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Gregorio, Ana C.] Univ Coimbra, UC Inst Interdisciplinary Res, Coimbra, Portugal; [Fonseca, Nuno A.; Simoes, Sergio; Moreira, Joao Nuno] Univ Coimbra, FFUC Fac Pharm, Polo Ciencias Saude, Coimbra, Portugal; [Moura, Vera] TREAT U SA, Coimbra, Portugal; [Lacerda, Manuela] Univ Porto, IPATIMUP Inst Mol Pathol & Immunol, Oporto, Portugal; [Figueiredo, Paulo] IPOFG EPE Portuguese Inst Oncol Francisco Gentil, Coimbra, Portugal; [Diaz, Sergio] Univ Lisbon, IMM, Fac Med, Lisbon, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade do Porto; Universidade de Coimbra; Universidade de Lisboa	Moreira, JN (corresponding author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal.; Moreira, JN (corresponding author), Univ Coimbra, FFUC Fac Pharm, Polo Ciencias Saude, Coimbra, Portugal.	jmoreira@ff.uc.pt	Fonseca, Nuno/AAF-1747-2020; Moreira, João Nuno/F-3180-2010; Dias, Sergio/L-1250-2014	Moreira, João Nuno/0000-0003-3449-0522; Moura, Vera/0000-0001-5820-9964; Gregorio, Ana/0000-0001-7265-0019; Simoes, Sergio/0000-0002-8898-7625; Fonseca, Nuno A. C./0000-0003-4970-7288; Dias, Sergio/0000-0002-7603-4616	Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/51190/2010]; FCT [PTDC/SAU-BMA/121028/2010]; FEDER/COMPETE [UID/NEU/04539/2013]; TREAT U	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER/COMPETE(European Commission); TREAT U	Ana Cristina Gregorio is a student of the international PhD program in Experimental Biology and Biomedicine (PDBEB) from the Institute for Interdisciplinary Research, University of Coimbra and recipient of the fellowship SFRH/BD/51190/2010 from the Portuguese Foundation for Science and Technology (FCT). The work was supported by the grants PTDC/SAU-BMA/121028/2010 (FCT) and UID/NEU/04539/2013 (FEDER/COMPETE 2020/FCT). TREAT U provided support in the form of salaries for author VM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abu N, 2015, DRUG DES DEV THER, V9, P1401, DOI 10.2147/DDDT.S67976; Adler EP, 2003, IMMUNOL LETT, V90, P187, DOI 10.1016/j.imlet.2003.09.013; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bailey-Downs LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098624; Benzekry S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003800; Bos PD, 2010, CURR OPIN PHARMACOL, V10, P571, DOI 10.1016/j.coph.2010.06.003; BURTON AC, 1966, GROWTH, V30, P157; Carballido EM, 2014, CURR ONCOL REP, V16, DOI 10.1007/s11912-014-0404-2; Carstens E, 2000, ILAR J, V41, P62; Charrois GJR, 2003, J PHARMACOL EXP THER, V306, P1058, DOI 10.1124/jpet.103.053413; Chen F, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0278-7; Comen E, 2011, NAT REV CLIN ONCOL, V8, P369, DOI 10.1038/nrclinonc.2011.64; DEXTER DL, 1978, CANCER RES, V38, P3174; Dupre SA, 2007, INT J EXP PATHOL, V88, P351, DOI 10.1111/j.1365-2613.2007.00539.x; duPre' SA, 2007, EXP MOL PATHOL, V82, P12, DOI 10.1016/j.yexmp.2006.06.007; Dupre SA, 2008, EXP MOL PATHOL, V85, P174, DOI 10.1016/j.yexmp.2008.05.002; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Ferrari-Amorotti G, 2014, NEOPLASIA, V16, P1047, DOI 10.1016/j.neo.2014.10.006; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Gabizon A, 1998, J CONTROL RELEASE, V53, P275, DOI 10.1016/S0168-3659(97)00261-7; Gabizon A, 1997, DRUGS, V54, P15, DOI 10.2165/00003495-199700544-00005; Gao ZG, 2011, J CONTROL RELEASE, V152, P84, DOI 10.1016/j.jconrel.2011.01.021; Gould SE, 2015, NAT MED, V21, P431, DOI 10.1038/nm.3853; Haddad TC, 2008, MICE WOMEN IS THIS A, DOI [10.1200/JCO.2007.14.9062, DOI 10.1200/JCO.2007.14.9062]; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Heimburg J, 2006, NEOPLASIA, V8, P939, DOI 10.1593/neo.06493; HIRANO T, 2011, INHIBITION TUMOR GRO; Hori K, 2014, CANCER SCI, V105, P1196, DOI 10.1111/cas.12477; Huang Y, 2015, ONCOTARGET; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Kim EJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2927; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kurt RA, 2001, CELL IMMUNOL, V207, P81, DOI 10.1006/cimm.2000.1754; Leek RD, 1999, BRIT J CANCER, V79, P991, DOI 10.1038/sj.bjc.6690158; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Nguyen L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-522; Lirdprapamongkol K, 2005, EUR J PHARM SCI, V25, P57, DOI 10.1016/j.ejps.2005.01.015; LUDDEN TM, 1994, J PHARMACOKINET BIOP, V22, P431, DOI 10.1007/BF02353864; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3; McKeown E, 2014, J CANCER, V5, P31, DOI 10.7150/jca.7987; Mehrara E, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-31; MILLER FR, 1983, INVAS METAST, V3, P22; Nasti TH, 2015, LIFE SCI, V131, P11, DOI 10.1016/j.lfs.2015.02.025; NORTON L, 1988, CANCER RES, V48, P7067; Parham F, 2005, WILEY SER PROBAB ST, P239; Pastorino F, 2008, CLIN CANCER RES, V14, P7320, DOI 10.1158/1078-0432.CCR-08-0804; Peiris PM, 2015, J PHARM SCI-US, V104, P2600, DOI 10.1002/jps.24518; Poeschinger T, 2013, MOL IMAGING BIOL, V15, P28, DOI 10.1007/s11307-012-0559-x; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Proskuryakov SY, 2010, CURR PHARM DESIGN, V16, P56, DOI 10.2174/138161210789941793; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Quang CT, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.14; Samant RS, 2006, CANCER LETT, V235, P260, DOI 10.1016/j.canlet.2005.04.032; Sato M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126483; Singh M, 2012, NAT BIOTECHNOL, V30, P648, DOI 10.1038/nbt.2286; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; Tevaarwerk AJ, 2013, CANCER-AM CANCER SOC, V119, P1140, DOI 10.1002/cncr.27819; Vakkila J, 2004, NAT REV IMMUNOL, V4, P641, DOI 10.1038/nri1415; Vitiello PF, 2004, IMMUNOL LETT, V91, P239, DOI 10.1016/j.imlet.2003.12.009; Waight JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027690; Wallace TJ, 2014, J CANCER, V5, P3, DOI 10.7150/jca.7709; Weber GF, 2013, CANCER LETT, V328, P207, DOI 10.1016/j.canlet.2012.09.025; Welch DR, 1997, CLIN EXP METASTAS, V15, P272, DOI 10.1023/A:1018477516367; Weng DS, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3102; Wenzel J, 2010, CLIN EXP METASTAS, V27, P25, DOI 10.1007/s10585-009-9299-y; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Yan HH, 2010, CANCER RES, V70, P6139, DOI 10.1158/0008-5472.CAN-10-0706; Yokoi K, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.SABCS14-P1-07-13; Zhou R, 2002, CANCER RES, V62, P2561	72	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165817	10.1371/journal.pone.0165817	http://dx.doi.org/10.1371/journal.pone.0165817			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820870	gold, Green Published, Green Submitted			2022-12-26	WOS:000387614800021
J	Li, XS; Wang, GB; Sun, Y; Liu, W; He, YZ; Wang, FC; Jiang, YR; Qin, L				Li, Xi-Sheng; Wang, Guo-Bao; Sun, Ying; Liu, Wei; He, Ying-Zi; Wang, Feng-Cheng; Jiang, Yi-Ren; Qin, Li			Transcriptome Analysis of the Midgut of the Chinese Oak Silkworm Antheraea pernyi Infected with Antheraea pernyi Nucleopolyhedrovirus	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; CYTOPLASMIC POLYHEDROSIS-VIRUS; RNA-SEQ DATA; GENE-EXPRESSION; SERINE PROTEASES; REFERENCE GENOME; DROSOPHILA; HOST; QUANTIFICATION; MICROARRAY	The Antheraea pernyi nucleopolyhedrovirus (ApNPV) is an exclusive pathogen of A. pernyi. The intense interactions between ApNPV and A. pernyi cause a series of physiological and pathological changes to A. pernyi. However, no detailed report exists regarding the molecular mechanisms underlying the interactions between ApNPV and A. pernyi. In this study, four cDNA libraries of the A. pernyi midgut, including two ApNPV-infected groups and two control groups, were constructed for transcriptomic analysis to provide new clues regarding the molecular mechanisms that underlie these interactions. The transcriptome of the A. pernyi midgut was de novo assembled using the Trinity platform because of the lack of a genome resource for A. pernyi. Compared with the controls, a total of 5,172 differentially expressed genes (DEGs) were identified, including 2,183 up-regulated and 2,989 down-regulated candidates, of which 2,965 and 911 DEGs were classified into different GO categories and KEGG pathways, respectively. The DEGs involved in A. pernyi innate immunity were classified into several categories, including heat-shock proteins, apoptosis-related proteins, serpins, serine proteases and cytochrome P450s. Our results suggested that these genes were related to the immune response of the A. pernyi midgut to ApNPV infection via their essential roles in regulating a variety of physiological processes. Our results may serve as a basis for future research not only on the molecular mechanisms of ApNPV invasion but also on the anti-ApNPV mechanism of A. pernyi.	[Li, Xi-Sheng; Sun, Ying; Qin, Li] Shenyang Agr Univ, Coll Plant Protect, Shenyang 110866, Peoples R China; [Li, Xi-Sheng; Wang, Guo-Bao; Sun, Ying; Liu, Wei; Jiang, Yi-Ren; Qin, Li] Shenyang Agr Univ, Liaoning Engn & Technol Res Ctr Insect Resources, Coll Biosci & Biotechnol, Shenyang, Peoples R China; [Li, Xi-Sheng; He, Ying-Zi; Wang, Feng-Cheng] Sericulture Res Inst Liaoning Prov, Fengcheng 118100, Peoples R China	Shenyang Agricultural University; Shenyang Agricultural University	Qin, L (corresponding author), Shenyang Agr Univ, Coll Plant Protect, Shenyang 110866, Peoples R China.; Jiang, YR; Qin, L (corresponding author), Shenyang Agr Univ, Liaoning Engn & Technol Res Ctr Insect Resources, Coll Biosci & Biotechnol, Shenyang, Peoples R China.	jiangyiren56@126.com; qinli1963@163.com			National Modern Agriculture Industry Technology System Construction Project; Magnitude Science and Technology Projects of Liaoning Province; Cultivation Plan for Youth Agricultural Science and Technology Innovative Talents of Liaoning Province [2014040]; Scientific Research Project for the Education Department of Liaoning Province [L2014255]	National Modern Agriculture Industry Technology System Construction Project; Magnitude Science and Technology Projects of Liaoning Province; Cultivation Plan for Youth Agricultural Science and Technology Innovative Talents of Liaoning Province; Scientific Research Project for the Education Department of Liaoning Province	This work was supported by the National Modern Agriculture Industry Technology System Construction Project (Silkworm and Mulberry) and the Magnitude Science and Technology Projects of Liaoning Province to LQ; the Cultivation Plan for Youth Agricultural Science and Technology Innovative Talents of Liaoning Province (2014040) and the Scientific Research Project for the Education Department of Liaoning Province (L2014255) to YRJ.	Ahmad ST, 2009, P NATL ACAD SCI USA, V106, P12168, DOI 10.1073/pnas.0903134106; Bao YY, 2009, GENOMICS, V94, P138, DOI 10.1016/j.ygeno.2009.04.003; Brackney DE, 2008, AM J TROP MED HYG, V79, P267, DOI 10.4269/ajtmh.2008.79.267; Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Gao K, 2014, J INVERTEBR PATHOL, V115, P8, DOI 10.1016/j.jip.2013.10.016; Goley ED, 2006, SCIENCE, V314, P464, DOI 10.1126/science.1133348; Gorman MJ, 2001, INSECT BIOCHEM MOLEC, V31, P257, DOI 10.1016/S0965-1748(00)00145-4; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRANADOS RR, 1981, VIROLOGY, V108, P297, DOI 10.1016/0042-6822(81)90438-4; HAAS AL, 1998, THE FASEB JOURNAL, V11, P1257; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Kolliopoulou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121447; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liew KJL, 2006, J VIROL METHODS, V131, P47, DOI 10.1016/j.jviromet.2005.07.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McTaggart SJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1499-z; Merrill AH, 1999, CHEM PHYS LIPIDS, V102, P131, DOI 10.1016/S0009-3084(99)00081-X; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Narayanan K, 2004, CURR SCI INDIA, V86, P800; Pederson T, 2005, MOL BIOL CELL, V16, P5055, DOI 10.1091/mbc.E05-07-0656; Pockley AG, 2003, LANCET, V362, P469, DOI 10.1016/S0140-6736(03)14075-5; Provost B, 2011, INSECT BIOCHEM MOLEC, V41, P582, DOI 10.1016/j.ibmb.2011.03.010; Reichhart JM, 2005, TRENDS CELL BIOL, V15, P659, DOI 10.1016/j.tcb.2005.10.001; Ren XX, 2014, PEERJ, V2, DOI 10.7717/peerj.584; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Smartt CT, 2009, AM J TROP MED HYG, V81, P258, DOI 10.4269/ajtmh.2009.81.258; Tang H, 2008, DEV CELL, V15, P617, DOI 10.1016/j.devcel.2008.08.017; Tezel G, 2004, BRAIN RES BULL, V62, P473, DOI 10.1016/S0361-9230(03)00074-1; Thiem SM, 2009, IN VITRO CELL DEV-AN, V45, P111, DOI 10.1007/s11626-008-9170-5; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Wang GB, 2015, J INVERTEBR PATHOL, V128, P37, DOI 10.1016/j.jip.2015.04.001; Wu P, 2011, MOL BIOL REP, V38, P333, DOI 10.1007/s11033-010-0112-4	36	8	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165959	10.1371/journal.pone.0165959	http://dx.doi.org/10.1371/journal.pone.0165959			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820844	Green Published, gold, Green Submitted			2022-12-26	WOS:000387614800027
J	Osorio, R; Alfonso-Rodriguez, CA; Medina-Castillo, AL; Alaminos, M; Toledano, M				Osorio, Raquel; Andres Alfonso-Rodriguez, Camilo; Medina-Castillo, Antonio L.; Alaminos, Miguel; Toledano, Manuel			Bioactive Polymeric Nanoparticles for Periodontal Therapy	PLOS ONE			English	Article							EXTRACELLULAR CALCIUM; DEPENDENT PATHWAY; ALVEOLAR BONE; PHOSPHATE; CYTOTOXICITY; EXPRESSION; PARTICLES; FIBROBLAST; COMPOSITE; DENTIN	Aims to design calcium and zinc-loaded bioactive and cytocompatible nanoparticles for the treatment of periodontal disease. Methods PolymP-nActive nanoparticles were zinc or calcium loaded. Biomimetic calcium phosphate precipitation on polymeric particles was assessed after 7 days immersion in simulated body fluid, by scanning electron microscopy attached to an energy dispersive analysis system. Amorphous mineral deposition was probed by X-ray diffraction. Cell viability analysis was performed using oral mucosa fibroblasts by: 1) quantifying the liberated deoxyribonucleic acid from dead cells, 2) detecting the amount of lactate dehydrogenase enzyme released by cells with damaged membranes, and 3) by examining the cytoplasmic esterase function and cell membranes integrity with a fluorescence-based method using the Live/Dead commercial kit. Data were analyzed by Kruskal-Wallis and Mann-Whitney tests. Results Precipitation of calcium and phosphate on the nanoparticles surfaces was observed in calcium- loaded nanoparticles. Non-loaded nanoparticles were found to be non-toxic in all the assays, calcium and zinc-loaded particles presented a dose dependent but very low cytotoxic effect. Conclusions The ability of calcium- loaded nanoparticles to promote precipitation of calcium phosphate deposits, together with their observed non-toxicity may offer new strategies for periodontal disease treatment.	[Osorio, Raquel; Toledano, Manuel] Univ Granada, Colegio Maximo, Dent Sch, Campus Cartuja S-N, Granada 18017, Spain; [Andres Alfonso-Rodriguez, Camilo; Alaminos, Miguel] Univ Granada, Dept Histol, Tissue Engn Grp, Granada 18012, Spain; [Medina-Castillo, Antonio L.] NanoMyP Spin Off Enterprise Univ Granada, Edificio BIC Granada,Av Innovac 1, Granada 18016, Spain	University of Granada; University of Granada	Osorio, R (corresponding author), Univ Granada, Colegio Maximo, Dent Sch, Campus Cartuja S-N, Granada 18017, Spain.	rosorio@ugr.es	Toledano, Manuel/E-7923-2017; Osorio, Raquel/E-7913-2017; Medina-Castillo, Antonio L/E-9799-2018; Castillo, Antonio Luis Medina/ABD-7194-2020; ALAMINOS, MIGUEL/N-9960-2016	Toledano, Manuel/0000-0002-2172-7896; Osorio, Raquel/0000-0001-7679-6840; Medina-Castillo, Antonio L/0000-0002-0308-9878; ALAMINOS, MIGUEL/0000-0003-4876-2672	Ministry of Economy and Competitiveness; European Regional Development Fund [MAT2014-52036-P]	Ministry of Economy and Competitiveness; European Regional Development Fund(European Commission)	This work was supported by the Ministry of Economy and Competitiveness and European Regional Development Fund, Grant: MAT2014-52036-P to MT, RO, ALMC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Al Machot E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/786353; [Anonymous], 233172012 ISO; Arzate H, 2015, PERIODONTOL 2000, V67, P211, DOI 10.1111/prd.12062; Bartold PM, 2016, J PERIODONTAL RES, V51, P1, DOI 10.1111/jre.12275; Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10622; Besinis A, 2012, DENT MATER, V28, P1012, DOI 10.1016/j.dental.2012.05.007; Bizenjima T, 2016, CLIN ORAL IMPLAN RES, V27, P1360, DOI 10.1111/clr.12744; Breitwieser GE, 2008, INT J BIOCHEM CELL B, V40, P1467, DOI 10.1016/j.biocel.2008.01.019; Chai YC, 2012, ACTA BIOMATER, V8, P3876, DOI 10.1016/j.actbio.2012.07.002; Chiara G, 2012, INT J MOL SCI, V13, P737, DOI 10.3390/ijms13010737; Elangovan S, 2013, J PERIODONTOL, V84, P117, DOI 10.1902/jop.2012.120012; Feuser PE, 2014, MACROMOL SYMP, V343, P65, DOI 10.1002/masy.201300194; Gamal AY, 2013, J PERIODONTOL, V84, P1730, DOI 10.1902/jop.2013.120701; Hadjicharalambous C, 2015, J BIOMED MATER RES A, V103, P3834, DOI 10.1002/jbm.a.35527; Hashimoto M, 2016, J BIOMED MATER RES B, V104, P241, DOI 10.1002/jbm.b.33377; Hong L, 2006, MATER LETT, V60, P1710, DOI 10.1016/j.matlet.2005.12.004; Jain RK, 2014, J CLIN DIAGN RES, V8, pZC21, DOI [10.7860/JCDR/2014/9535.5047, 10.7860/JCDR/2014/8339.4554]; Kanaya S, 2013, BONE, V56, P398, DOI 10.1016/j.bone.2013.06.031; Kanaya S, 2010, BONE, V47, P564, DOI 10.1016/j.bone.2010.05.042; Leonor IB, 2009, J BIOMED MATER RES B, V91B, P239, DOI 10.1002/jbm.b.31395; Li JH, 2013, BIOMATERIALS, V34, P6738, DOI 10.1016/j.biomaterials.2013.05.046; Liu HW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007330; Liu Y, 2011, J DENT RES, V90, P953, DOI 10.1177/0022034510391799; Lopez-Lopez MT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133878; Medina-Castillo AL, 2012, J POLYM SCI POL CHEM, V50, P3944, DOI 10.1002/pola.26203; Medina-Castillo AL, 2010, MACROMOLECULES, V43, P5804, DOI 10.1021/ma100841c; Munchow EA, 2015, DENT MATER, V31, P1038, DOI 10.1016/j.dental.2015.06.004; Munchow EA, 2016, CLIN ORAL INVEST, V20, P1921, DOI 10.1007/s00784-015-1671-5; Nandakumar A, 2010, LANGMUIR, V26, P7380, DOI 10.1021/la904406b; Osorio R, 2014, J DENT RES, V93, P1258, DOI 10.1177/0022034514551608; Osorio R, 2011, J DENT, V39, P148, DOI 10.1016/j.jdent.2010.11.005; Osorio R, 2016, CLIN ORAL INVEST, V20, P2411, DOI 10.1007/s00784-016-1738-y; PAGE RC, 1991, J PERIODONTAL RES, V26, P230, DOI 10.1111/j.1600-0765.1991.tb01649.x; Pietak AM, 2007, BIOMATERIALS, V28, P4023, DOI 10.1016/j.biomaterials.2007.05.003; Quan CY, 2016, J BIOMED MATER RES B, V104, P576, DOI 10.1002/jbm.b.33428; Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039; Riss TL, 2004, ASSAY DRUG DEV TECHN, V2, P51, DOI 10.1089/154065804322966315; Sanz M, 2011, J CLIN PERIODONTOL, V38, P3, DOI 10.1111/j.1600-051X.2010.01681.x; Sariibrahimoglu K, 2015, J BIOMED MATER RES A, V103, P1930, DOI 10.1002/jbm.a.35327; Seker S, 2014, TOXICOL IN VITRO, V28, P1349, DOI 10.1016/j.tiv.2014.06.016; Seol YJ, 2010, J BIOMED MATER RES A, V94A, P649, DOI 10.1002/jbm.a.32738; Shimauchi H, 2013, JPN DENT SCI REV, V49, P118, DOI 10.1016/j.jdsr.2013.05.001; Song J, 2003, J AM CHEM SOC, V125, P1236, DOI 10.1021/ja028559h; Suarez P, 2013, MACROMOL BIOSCI, V13, P1174, DOI 10.1002/mabi.201300141; Sugino A, 2008, J MATER SCI-MATER M, V19, P2269, DOI 10.1007/s10856-007-3327-8; Sundaram MN, 2016, J BIOMED MATER RES B, V104, P761, DOI 10.1002/jbm.b.33480; Suto M, 2013, ARCH ORAL BIOL, V58, P1021, DOI 10.1016/j.archoralbio.2013.02.014; Suzuki O, 2010, ACTA BIOMATER, V6, P3379, DOI 10.1016/j.actbio.2010.04.002; Szivek JA, 2007, J BIOMED MATER RES A, V81A, P939, DOI 10.1002/jbm.a.31116; Tada H, 2010, BIOCHEM BIOPH RES CO, V394, P1093, DOI 10.1016/j.bbrc.2010.03.135; Wilhelmi V, 2012, TOXICOL IN VITRO, V26, P323, DOI 10.1016/j.tiv.2011.12.006; Yamauchi K, 2010, INT J ORAL MAX SURG, V39, P1000, DOI 10.1016/j.ijom.2010.05.008; Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019	53	38	38	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166217	10.1371/journal.pone.0166217	http://dx.doi.org/10.1371/journal.pone.0166217			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820866	Green Published, Green Submitted, gold			2022-12-26	WOS:000387614800041
J	Annequin, M; Lert, F; Spire, B; Dray-Spira, R				Annequin, Margot; Lert, France; Spire, Bruno; Dray-Spira, Rosemary		ANRS-Vespa2 Study Grp	Increase in Unemployment over the 2000's: Comparison between People Living with HIV and the French General Population	PLOS ONE			English	Article							EMPLOYMENT STATUS; CHRONICALLY ILL; HEALTH-STATUS; FRANCE; INFECTION; CHANCES; DISEASE; ILLNESS; IMPACT; ERA	Background Despite improved health, unemployment has increased among people living with HIV (PlwHIV) over the last decade. However, since the economic recession of 2008, unemployment also increased in the French general population. This paper aimed to determine if the increase in the unemployment rate in the HIV population was higher than that in the French general population. Methods We used data from the ANRS-Vespa study, a repeated cross-sectional survey among two national representative samples of PlwHIV followed at hospitals in France in 2003 and 2011. We compared employment and unemployment rates between HIV-infected people (overall and according to period of HIV diagnosis) and the French general population in 2003 and 2011, using multivariate Poisson regressions adjusted for individual sociodemographic characteristics. Results The employment rate among PlwHIV was consistently lower than that in the general population in 2003 and 2011. In contrast, there was a trend of an increasing unemployment rate difference between PlwHIV and the general population: PlwHIV's unemployment rate was 1.48 (95% confidence interval [CI]: 1.16-1.90) times higher than that of the general population in 2003, versus 1.62 (95% CI: 1.34-1.96) times higher in 2011. This unemployment rate difference was the highest for PlwHIV diagnosed in or after 2008 (adjusted prevalence rate ratio: 2.06; 95% CI: 1.59-2.67). Conclusions These results suggest that in time of economic recession, an increasing proportion of PlwHIV may be excluded from the labor market although they are willing to re-enter it. This constitutes a major issue relative to social consequences of chronic disease.	[Annequin, Margot; Dray-Spira, Rosemary] UPMC Univ Paris 06, Sorbonne Univ, INSERM,Dept Social Epidemiol, Inst Pierre Louis Epidemiol & Sante Publ IPLES UM, F-75012 Paris, France; [Lert, France] Ctr Res Epidemiol & Populat Hlth, INSERM, U1018, Villejuif, France; [Spire, Bruno] INSERM, UMR912, Econ & Social Sci Appl Hlth & Anal Med Informat S, Marseille, France; [Spire, Bruno] Aix Marseille Univ, UMR S912, IRD, Marseille, France; [Spire, Bruno] Southeastern Hlth Reg Observ, ORS PACA, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Annequin, M (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, INSERM,Dept Social Epidemiol, Inst Pierre Louis Epidemiol & Sante Publ IPLES UM, F-75012 Paris, France.; Annequin, M (corresponding author), INSERM, U1136, 27 Rue Chaligny, F-75571 Paris 12, France.	margot.annequin@inserm.fr	Spire, Bruno/F-5546-2013	Spire, Bruno/0000-0002-3546-8020; Dray-Spira, Rosemary/0000-0001-7646-3667; Carrieri, Patrizia/0000-0002-6794-4837	ANRS (Agence Nationale de Recherches sur le SIDA et les Hepatites Virales); EHESP (Ecole des Hautes Etudes en Sante Publique [School of Public Health]), Rennes	ANRS (Agence Nationale de Recherches sur le SIDA et les Hepatites Virales)(ANRSFrench National Research Agency (ANR)); EHESP (Ecole des Hautes Etudes en Sante Publique [School of Public Health]), Rennes	The ANRS-Vespal and ANRS-Vespa2 surveys were sponsored and funded by the ANRS (Agence Nationale de Recherches sur le SIDA et les Hepatites Virales). Margot Annequin is the recipient of a PhD grant from the EHESP (Ecole des Hautes Etudes en Sante Publique [School of Public Health]), Rennes.	Annequin M, 2015, AIDS, V29, P1537, DOI 10.1097/QAD.0000000000000722; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bartley M, 2004, J EPIDEMIOL COMMUN H, V58, P501, DOI 10.1136/jech.2003.009878; BARTLEY M, 1994, J EPIDEMIOL COMMUN H, V48, P333, DOI 10.1136/jech.48.4.333; Berkman LF, 2014, INT J EPIDEMIOL, V43, P1517, DOI 10.1093/ije/dyu110; Burstrom B, 2000, INT J HEALTH SERV, V30, P435, DOI 10.2190/6PP1-TDEQ-H44D-4LJQ; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Castagnone E, 2013, 26 MAFE, V26, P43; de Boer AGEM, 2009, JAMA-J AM MED ASSOC, V301, P753, DOI 10.1001/jama.2009.187; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Del Amo J, 2011, EUR J PUBLIC HEALTH, V21, P620, DOI 10.1093/eurpub/ckq150; Dray-Spira R, 2008, OCCUP ENVIRON MED, V65, P112, DOI 10.1136/oem.2007.034363; Dray-Spira R, 2006, EUR J PUBLIC HEALTH, V16, P89, DOI 10.1093/eurpub/cki153; Dray-Spira R, 2003, AIDS CARE, V15, P739, DOI 10.1080/09540120310001618595; Dray-Spira R, 2007, AM J PUBLIC HEALTH, V97, P552, DOI 10.2105/AJPH.2005.081083; Dray-Spira R, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000255082.31728.52; Dray-Spira R, 2012, AIDS, V26, P207, DOI 10.1097/QAD.0b013e32834dcf61; Duguet E, 2014, REV ECON POLIT, V124, P437, DOI 10.3917/redp.243.0437; Evans-Lacko S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069792; Goldman DP, 2004, HEALTH SERV RES, V39, P1691, DOI 10.1111/j.1475-6773.2004.00313.x; Gross M, 2016, INT J PUBLIC HEALTH, V61, P593, DOI 10.1007/s00038-015-0750-3; Hamers FF, 2004, LANCET, V364, P83, DOI 10.1016/S0140-6736(04)16594-X; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; Heggebo K, 2015, SOC SCI MED, V130, P115, DOI 10.1016/j.socscimed.2015.02.010; Holland P, 2011, INT J HEALTH SERV, V41, P395, DOI 10.2190/HS.41.3.a; INSEE, 2011, EMPL CONT VERS FPR 2; INSEE, 2016, CONT LAB FORC SURV 2; Kaye HS, 2010, MON LABOR REV, V133, P19; Le Barbanchon T, 2013, 142 ILO, V142, P45; Legarth R, 2014, AIDS, V28, P1489, DOI 10.1097/QAD.0000000000000257; Marsicano E, 2014, AIDS CARE, V26, pS97, DOI 10.1080/09540121.2014.907385; Minton JW, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2316; Morlat P., 2013, MED CARE PEOPLE LIVI; Morlat P, 2014, AIDS, V28, P1181, DOI 10.1097/QAD.0000000000000222; Nadal J-M, 1997, B EPIDEMIOL HEBD, V23, P107; Peretti-Watel P, 2005, POPULATION, V60, P525, DOI 10.2307/4150781; Rabkin JG, 2004, PSYCHOSOM MED, V66, P72, DOI 10.1097/01.PSY.0000108083.43147.6D; Rijken M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-803; Roelfs DJ, 2011, SOC SCI MED, V72, P840, DOI 10.1016/j.socscimed.2011.01.005; Schuring M, 2013, SCAND J WORK ENV HEA, V39, P134, DOI 10.5271/sjweh.3321; Tron L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107451; van der Wel KA, 2011, SOC SCI MED, V73, P1608, DOI 10.1016/j.socscimed.2011.09.012; Velche D, 2009, THEMATIC REPORT IMPL; Virtanen P, 2013, PUBLIC HEALTH, V127, P46, DOI 10.1016/j.puhe.2012.10.016	44	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165634	10.1371/journal.pone.0165634	http://dx.doi.org/10.1371/journal.pone.0165634			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8TH	27814374	Green Published, Green Submitted, gold			2022-12-26	WOS:000386911100012
J	Pohjoismaki, JLO; Kahanpaa, J; Mutanen, M				Pohjoismaki, Jaakko L. O.; Kahanpaa, Jere; Mutanen, Marko			DNA Barcodes for the Northern European Tachinid Flies (Diptera: Tachinidae)	PLOS ONE			English	Article							OSTRINIA-NUBILALIS; EVOLUTION; COMMUNITY; GENUS; CLASSIFICATION; LEPIDOPTERA; PARASITOIDS; DIVERSITY; ECOLOGY; BIOLOGY	This data release provides COI barcodes for 366 species of parasitic flies (Diptera: Tachinidae), enabling the DNA based identification of the majority of northern European species and a large proportion of Palearctic genera, regardless of the developmental stage. The data will provide a tool for taxonomists and ecologists studying this ecologically important but challenging parasitoid family. A comparison of minimum distances between the nearest neighbors revealed the mean divergence of 5.52% that is approximately the same as observed earlier with comparable sampling in Lepidoptera, but clearly less than in Coleoptera. Full barcode-sharing was observed between 13 species pairs or triplets, equaling to 7.36% of all species. Delimitation based on Barcode Index Number (BIN) system was compared with traditional classification of species and interesting cases of possible species oversplits and cryptic diversity are discussed. Overall, DNA barcodes are effective in separating tachinid species and provide novel insight into the taxonomy of several genera.	[Pohjoismaki, Jaakko L. O.] Univ Eastern Finland, Dept Environm & Biol Sci, POB 111, Joensuu 80101, Finland; [Kahanpaa, Jere] Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland; [Mutanen, Marko] Univ Oulu, Dept Genet & Physiol, POB 3000, Oulu 90014, Finland	University of Eastern Finland; University of Helsinki; University of Oulu	Pohjoismaki, JLO (corresponding author), Univ Eastern Finland, Dept Environm & Biol Sci, POB 111, Joensuu 80101, Finland.	Jaakko.Pohjoismaki@uef.fi	Pohjoismaeki, Jaakko L. O./AAC-7995-2019	Pohjoismaeki, Jaakko L. O./0000-0002-1185-3610; Kahanpaa, Jere/0000-0003-1485-5272	Koneen Saatio [2011/12]; Suomen Kulttuurirahasto [27/02/2013]; Suomen Akatemia [277984]; Government of Canada through Genome Canada; Ontario Genomics Institute	Koneen Saatio; Suomen Kulttuurirahasto; Suomen Akatemia; Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute	This work was supported by Koneen Saatio (Grant Number 2011/12), Suomen Kulttuurirahasto (Grant Number 27/02/2013), Suomen Akatemia (Grant Number 277984). In addition, the Barcode of Life Project, funded by the Government of Canada through Genome Canada and the Ontario Genomics Institute contributed to the sequencing costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen Stig, 1996, Fauna Entomologica Scandinavica, V33, P1; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Cerretti P, 2012, ZOOKEYS, P5, DOI 10.3897/zookeys.205.3409; Davey JL, 2010, BRIEF FUNCT GENOMICS, V9, P416, DOI 10.1093/bfgp/elq031; de Jong Yde, 2014, Biodivers Data J, pe4034, DOI 10.3897/BDJ.2.e4034; DeWaard Jeremy R., 2008, V410, P275; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; GODWIN PA, 1984, ENVIRON ENTOMOL, V13, P1059, DOI 10.1093/ee/13.4.1059; Hara J.E., 2004, MEMOIRS ENTOMOLOGY I, V18; Hausmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084518; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Herting B, 1993, CATALOGUE PALAEARCTI, p[118, 624]; Inclan DJ, 2014, LANDSCAPE ECOL, V29, P879, DOI 10.1007/s10980-014-0024-0; Kress WJ, 2015, TRENDS ECOL EVOL, V30, P25, DOI 10.1016/j.tree.2014.10.008; Lutovinovas E, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.13901; Maczey N, 2016, BIOCONTROL SCI TECHN, V26, P447, DOI 10.1080/09583157.2015.1123675; Mesnil LP, 1975, LARVAEVORINAE LARVAV; Mesnil LP, 1944, LARVAEVORINAE SALMAC; Mesnil LP, 1956, LARVAEVORINAE PHOROC; Mitterboeck TF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1128; Mutanen M, 2016, SYST BIOL, V65, P1024, DOI 10.1093/sysbio/syw044; O'Hara JE, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.316.5132; Pentinsaari M, 2016, UTILITY DNA BARCODES; Pentinsaari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108651; Peris D, 2016, GEOSCIENCE IN PRESS; Pohjoismaki J, 2015, ZOOTAXA, V4059, P581, DOI 10.11646/zootaxa.4059.3.9; Pohjoismaki J, 2014, ZOOKEYS, P383, DOI 10.3897/zookeys.441.7252; QUEDNAU FW, 1993, CAN ENTOMOL, V125, P749, DOI 10.4039/Ent125749-4; Rahal Y, 1995, ENTOMOPHAGA, V40, P329, DOI 10.1007/BF02373720; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; SANDLAN KP, 1983, ENVIRON ENTOMOL, V12, P174, DOI 10.1093/ee/12.1.174; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Stireman JO, 2006, P ROY SOC B-BIOL SCI, V273, P523, DOI 10.1098/rspb.2005.3363; Stireman JO, 2006, ANNU REV ENTOMOL, V51, P525, DOI 10.1146/annurev.ento.51.110104.151133; Stireman JO, 2008, ANN ENTOMOL SOC AM, V101, P362, DOI 10.1603/0013-8746(2008)101[362:ADOATP]2.0.CO;2; Stireman JO, 2016, CURR OPIN INSECT SCI, V14, P87, DOI 10.1016/j.cois.2016.02.002; Tachi T, 2013, MOL PHYLOGENET EVOL, V66, P401, DOI 10.1016/j.ympev.2012.10.017; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tschorsnig Hans-Peter, 1994, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V506, P1; Whitworth TL, 2007, P ROY SOC B-BIOL SCI, V274, P1731, DOI 10.1098/rspb.2007.0062; Winkler IS, 2015, MOL PHYLOGENET EVOL, V88, P38, DOI 10.1016/j.ympev.2015.03.021; Wirta H, 2015, MOL ECOL RESOUR; Wirta HK, 2015, ECOL EVOL, V5, P3842, DOI 10.1002/ece3.1647; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	45	14	16	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0164933	10.1371/journal.pone.0164933	http://dx.doi.org/10.1371/journal.pone.0164933			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814365	Green Published, Green Submitted, gold			2022-12-26	WOS:000386911100005
J	Deliens, T; Deforche, B; Annemans, L; De Bourdeaudhuij, I; Clarys, P				Deliens, Tom; Deforche, Benedicte; Annemans, Lieven; De Bourdeaudhuij, Ilse; Clarys, Peter			Effectiveness of Pricing Strategies on French Fries and Fruit Purchases among University Students: Results from an On-Campus Restaurant Experiment	PLOS ONE			English	Article							COLLEGE-STUDENTS; FOOD CHOICES; WEIGHT-GAIN; DETERMINANTS; CONSUMPTION; EDUCATION; FRESHMAN; BEHAVIORS; SUBSIDIES; PATTERNS	Objectives This study examined the effect of a 10 and 20% meal price increase when choosing French fries and a 10 and 20% meal price reduction when choosing fruit for dessert on university students' purchasing behaviour in an on-campus restaurant. The moderating effect of gender was also investigated. Secondly, this study aimed at gaining further insight into reasons why these price manipulations did or did not change students' purchasing behaviour. Materials and Methods This two-phased mixed-methods study was conducted in a Belgian on-campus university restaurant with approximately 1200 to 1300 student visitors per day. In a first phase (French fries experiment), data were collected during a control week (no price manipulation) and two separate intervention weeks (10 and 20% meal price increase when students chose French fries). In a second phase (fruit experiment), following the same protocol but carried out a few weeks later, meal prices were reduced by 10 and 20% when students chose fruit for dessert. French fries and fruit sale counts relative to the total number of items sold were used as outcome measure. Short interviews were conducted in convenient subsamples of student customers to assess influences on food choice. Key findings Increasing the meal price by 10 and 20% when choosing French fries was associated with respective 10.9 and 21.8% absolute reductions in French fries purchases, while reducing the meal price by 10 and 20% when choosing fruit for dessert was associated with absolute increases in fruit purchases of respectively 25.1 and 42.4% (all p<0.001). No moderating effect of gender was detected. Besides price, food/taste preference, eating habits, health, availability and accessibility, and body satisfaction influenced students' food choices, with taste being the most frequently mentioned factor. Significance Pricing may be a promising strategy to improve university students' eating behaviour. The likelihood of intervention success may increase when combining pricing strategies with offering healthy, tasty and meal matching starchy alternatives to French fries and offering a variety of fresh and appealing fruits.	[Deliens, Tom; Deforche, Benedicte; Clarys, Peter] Vrije Univ Brussel, Dept Movement & Sport Sci, Brussels, Belgium; [Deforche, Benedicte; Annemans, Lieven] Univ Ghent, Dept Publ Hlth, Ghent, Belgium; [De Bourdeaudhuij, Ilse] Univ Ghent, Dept Movement & Sports Sci, Ghent, Belgium	Vrije Universiteit Brussel; Ghent University; Ghent University	Deliens, T (corresponding author), Vrije Univ Brussel, Dept Movement & Sport Sci, Brussels, Belgium.	Tom.Deliens@vub.ac.be	De+Bourdeaudhuij, Ilse/AAC-5528-2019	De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; Deliens, Tom/0000-0002-8165-4617				An RP, 2013, PUBLIC HEALTH NUTR, V16, P1215, DOI 10.1017/S1368980012004715; Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; Block JP, 2010, AM J PUBLIC HEALTH, V100, P1427, DOI 10.2105/AJPH.2009.175687; Crombie AP, 2009, NUTR REV, V67, P83, DOI 10.1111/j.1753-4887.2008.00143.x; Deforche B, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0173-9; Deliens T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-53; Deliens T, 2013, APPETITE, V65, P111, DOI 10.1016/j.appet.2013.01.024; Epstein LH, 2012, AM J CLIN NUTR, V95, P789, DOI 10.3945/ajcn.111.024380; Epstein LH, 2010, PSYCHOL SCI, V21, P406, DOI 10.1177/0956797610361446; Giesen JCAH, 2011, AM J CLIN NUTR, V93, P689, DOI 10.3945/ajcn.110.008193; Greaney ML, 2009, J NUTR EDUC BEHAV, V41, P281, DOI 10.1016/j.jneb.2008.04.354; Cardenas MK, 2015, PUBLIC HEALTH NUTR, V18, P2742, DOI 10.1017/S1368980014002730; LaCaille LJ, 2011, J AM COLL HEALTH, V59, P531, DOI 10.1080/07448481.2010.523855; Lachat CK, 2009, BRIT J NUTR, V102, P1030, DOI 10.1017/S000711450930389X; Michels KB, 2008, J AM COLL NUTR, V27, P6, DOI 10.1080/07315724.2008.10719669; Nederkoorn C, 2011, APPETITE, V56, P760, DOI 10.1016/j.appet.2011.03.002; Nelson MC, 2009, J NUTR EDUC BEHAV, V41, P287, DOI 10.1016/j.jneb.2008.05.005; Niebylski ML, 2015, NUTRITION, V31, P787, DOI 10.1016/j.nut.2014.12.010; Racette SB, 2005, J AM COLL HEALTH, V53, P245, DOI 10.3200/JACH.53.6.245-251; Silverman D., 2004, QUALITATIVE RES THEO, V2; Steenhuis IHM, 2011, PUBLIC HEALTH NUTR, V14, P2220, DOI 10.1017/S1368980011001637; Stok FM, 2015, PUBLIC HEALTH NUTR, V18, P1044, DOI 10.1017/S1368980014001268; Vella-Zarb RA, 2009, J AM COLL HEALTH, V58, P161, DOI 10.1080/07448480903221392; Waterlander WE, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-59; Waterlander WE, 2013, AM J CLIN NUTR, V97, P886, DOI 10.3945/ajcn.112.041632; Waterlander WE, 2014, APPETITE, V78, P32, DOI 10.1016/j.appet.2014.03.012	26	19	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165298	10.1371/journal.pone.0165298	http://dx.doi.org/10.1371/journal.pone.0165298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812123	Green Published, gold, Green Submitted			2022-12-26	WOS:000386910000026
J	Jaruthamsophon, K; Sriplung, H; Charalsawadi, C; Limprasert, P				Jaruthamsophon, Kanoot; Sriplung, Hutcha; Charalsawadi, Chariyawan; Limprasert, Pornprot			Maternal Age-Specific Rates for Trisomy 21 and Common Autosomal Trisomies in Fetuses from a Single Diagnostic Center in Thailand	PLOS ONE			English	Article							LIVE BIRTH PREVALENCE; DOWN-SYNDROME RISK; ABNORMALITIES; AMNIOCENTESIS; ASCERTAINMENT; GESTATION; OLDER	To provide maternal age-specific rates for trisomy 21 (T21) and common autosomal trisomies (including trisomies 21, 18 and 13) in fetuses. We retrospectively reviewed prenatal cytogenetic results obtained between 1990 and 2009 in Songklanagarind Hospital, a university teaching hospital, in southern Thailand. Maternal age-specific rates of T21 and common autosomal trisomies were established using different regression models, from which only the fittest models were used for the study. A total of 17,819 records were included in the statistical analysis. The fittest models for predicting rates of T21 and common autosomal trisomies were regression models with 2 parameters (Age and Age 2). The rate of T21 ranged between 2.67 per 1,000 fetuses at the age of 34 and 71.06 per 1,000 at the age of 48. The rate of common autosomal trisomies ranged between 4.54 per 1,000 and 99.65 per 1,000 at the same ages. This report provides the first maternal age-specific rates for T21 and common autosomal trisomies fetuses in a Southeast Asian population and the largest case number of fetuses have ever been reported in Asians.	[Jaruthamsophon, Kanoot; Charalsawadi, Chariyawan; Limprasert, Pornprot] Prince Songkla Univ, Dept Pathol, Human Genet Unit, Fac Med, Hat Yai, Songkhla, Thailand; [Sriplung, Hutcha] Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Songkhla, Thailand	Prince of Songkla University; Prince of Songkla University	Limprasert, P (corresponding author), Prince Songkla Univ, Dept Pathol, Human Genet Unit, Fac Med, Hat Yai, Songkhla, Thailand.	Lpornpro@medicine.psu.ac.th	Limprasert, Pornprot/L-1820-2013; Limprasert, Pornprot/N-5236-2019	Limprasert, Pornprot/0000-0001-5022-5361; Limprasert, Pornprot/0000-0001-5022-5361; Jaruthamsophon, Kanoot/0000-0003-1563-0024; Charalsawadi, Chariyawan/0000-0002-3841-3818				Barch MJ, 1997, AGT CYTOGENETICS LAB; Bray I, 1998, PRENATAL DIAG, V18, P9, DOI 10.1002/(SICI)1097-0223(199801)18:1<9::AID-PD210>3.3.CO;2-6; FERGUSONSMITH MA, 1984, PRENATAL DIAG, V4, P5, DOI 10.1002/pd.1970040704; Hecht CA, 1996, AM J MED GENET, V62, P376, DOI 10.1002/(SICI)1096-8628(19960424)62:4<376::AID-AJMG10>3.0.CO;2-L; HOOK EB, 1983, JAMA-J AM MED ASSOC, V249, P2034, DOI 10.1001/jama.249.15.2034; Huether CA, 1998, J MED GENET, V35, P482, DOI 10.1136/jmg.35.6.482; Kim Young Joo, 2013, Obstet Gynecol Sci, V56, P160, DOI 10.5468/ogs.2013.56.3.160; Leoncini E, 2010, AM J MED GENET A, V152A, P1670, DOI 10.1002/ajmg.a.33493; Metneki J, 2005, EUR J EPIDEMIOL, V20, P525, DOI 10.1007/s10654-005-4261-z; Morris JK, 2005, PRENATAL DIAG, V25, P275, DOI 10.1002/pd.1059; Morris JK, 2002, J MED SCREEN, V9, P2, DOI 10.1136/jms.9.1.2; Park IY, 2010, FETAL DIAGN THER, V27, P214, DOI 10.1159/000309136; Pighin S, 2015, PRENATAL DIAG, V35, P777, DOI 10.1002/pd.4606; Savva GM, 2010, PRENATAL DIAG, V30, P57, DOI 10.1002/pd.2403; Sheu BC, 1998, PRENATAL DIAG, V18, P675; Snijders RJM, 1999, ULTRASOUND OBST GYN, V13, P167, DOI 10.1046/j.1469-0705.1999.13030167.x; Yaegashi N, 1998, J HUM GENET, V43, P85, DOI 10.1007/s100380050046	17	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165859	10.1371/journal.pone.0165859	http://dx.doi.org/10.1371/journal.pone.0165859			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812158	Green Submitted, gold, Green Published			2022-12-26	WOS:000386910000072
J	Kessel, KA; Lettner, S; Kessel, C; Bier, H; Biedermann, T; Friess, H; Herrschbach, P; Gschwend, JE; Meyer, B; Peschel, C; Schmid, R; Schwaiger, M; Wolff, KD; Combs, SE				Kessel, Kerstin A.; Lettner, Sabrina; Kessel, Carmen; Bier, Henning; Biedermann, Tilo; Friess, Helmut; Herrschbach, Peter; Gschwend, Juergen E.; Meyer, Bernhard; Peschel, Christian; Schmid, Roland; Schwaiger, Markus; Wolff, Klaus-Dietrich; Combs, Stephanie E.			Use of Complementary and Alternative Medicine (CAM) as Part of the Oncological Treatment: Survey about Patients' Attitude towards CAM in a University-Based Oncology Center in Germany	PLOS ONE			English	Article							COMPREHENSIVE CANCER CENTER; RADIATION-THERAPY; DIETARY ANTIOXIDANTS; INCREASE SURVIVAL; CHEMOTHERAPY; ACUPUNCTURE; RADIOTHERAPY; AUSTRALIA; NUTRIENTS; WOMEN	Introduction To understand if and which patients would be open-minded to Complementary and Alternative Medicine (CAM) use parallel to their oncological treatment. Moreover, we sought to determine which methods are most accepted and which are the primary motivators to use CAM. Methods We developed and anonymously conducted a questionnaire for patients in the oncology center (TU Munich). Questions focus on different CAM methods, previous experiences, and willingness to apply or use CAM when offered in a university-based setting. Results A total of 171 of 376 patients (37.4% women, 62.0% men, 0.6% unknown) participated. This corresponds to a return rate of 45%. Median age was 64 years (17-87 years). Of all participants, 15.2% used CAM during their oncological therapy; 32.7% have used it in the past. The majority (81.9%) was not using CAM during therapy; 55.5% have not used CAM in the past respectively. The analysis revealed a significant correlation between education and CAM use during therapy (r = 0.18; p = 0.02), and CAM use in the past (r = 0.17; p = 0.04). Of all patients using CAM during therapy, favored methods were food supplements (42.3%), vitamins/minerals (42.3%), massage (34.6%). Motivations are especially the reduction of side effect and stress, the positive effect of certain CAM-treatments on the immune system and tumor therapy. Results showed no difference between women and men. Most patients not having had any experience with CAM complain about the deficiency of information by their treating oncologist (31.4%) as well as missing treatment possibilities (54.3%). Conclusion Since many patients believe in study results demonstrating the efficacy of CAM, it stresses our task to develop innovative study protocols to investigate the outcomes of certain CAM on symptom reduction or other endpoints. Thus, prospective trials and innovative evidence-based treatment concepts to include CAM into high-end oncology is what patients demand and what a modern oncology center should offer.	[Kessel, Kerstin A.; Lettner, Sabrina; Kessel, Carmen; Combs, Stephanie E.] TUM, Dept Radiat Oncol, Ismaninger Str 22, Munich, Germany; [Kessel, Kerstin A.; Combs, Stephanie E.] Helmholtz Zentrum Munchen, Inst Innovat Radiotherapy IRT, Ingolstadter Landstr 1, Neuherberg, Germany; [Kessel, Carmen; Combs, Stephanie E.] TUM, Onkol Zentrum, RHCCC, Klinikum Rechts Isar, Ismaninger Str 22, Munich, Germany; [Bier, Henning] TUM, Dept Otorhinolaryngol, Ismaninger Str 22, Munich, Germany; [Biedermann, Tilo] TUM, Dept Dermatol & Allergy Biederstein, Biedersteiner Str 29, Munich, Germany; [Friess, Helmut] TUM, Dept Surg, Ismaninger Str 22, Munich, Germany; [Herrschbach, Peter] TUM, Roman Herzog Krebszentrum Comprehens Canc Ctr RHC, Trogerstr 26, Munich, Germany; [Gschwend, Juergen E.] TUM, Dept Urol, Ismaninger Str 22, Munich, Germany; [Meyer, Bernhard] TUM, Dept Neurosurg, Ismaninger Str 22, Munich, Germany; [Peschel, Christian] TUM, Dept Internal Med 3, Ismaninger Str 22, Munich, Germany; [Schmid, Roland] TUM, Dept Internal Med 2, Ismaninger Str 22, Munich, Germany; [Schwaiger, Markus] TUM, Dept Nucl Med, Ismaninger Str 22, Munich, Germany; [Wolff, Klaus-Dietrich] TUM, Dept Oral & Maxillofacial Surg, Ismaninger Str 22, Munich, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Munich; Technical University of Munich; Technical University of Munich; University of Munich; Technical University of Munich	Kessel, KA (corresponding author), TUM, Dept Radiat Oncol, Ismaninger Str 22, Munich, Germany.; Kessel, KA (corresponding author), Helmholtz Zentrum Munchen, Inst Innovat Radiotherapy IRT, Ingolstadter Landstr 1, Neuherberg, Germany.	Kerstin.Kessel@tum.de		Biedermann, Tilo/0000-0002-5352-5105; Kessel, Carmen/0000-0002-3791-0206				Abdallah R, 2015, INT J GYNECOL CANCER, V25, P1724, DOI 10.1097/IGC.0000000000000549; Adams J, 2015, INTEGR CANCER THER, V14, P359, DOI 10.1177/1534735415583555; Akpunar Dercan, 2015, Asian Pac J Cancer Prev, V16, P7847; AlBedah Abdullah M, 2015, Asian Pac J Cancer Prev, V16, P6799; Asadpour R, 2016, ADV RAD ONCOLOGY; Barnes P., 2007, COMPLEMENTARY ALTERN; Begbie SD, 1996, MED J AUSTRALIA, V165, P545, DOI 10.5694/j.1326-5377.1996.tb138639.x; Burstein HJ, 1999, NEW ENGL J MED, V340, P1733, DOI 10.1056/NEJM199906033402206; Cassileth BR, 2001, CANCER, V91, P1390, DOI 10.1002/1097-0142(20010401)91:7<1390::AID-CNCR1143>3.0.CO;2-C; Correa-Velez I, 2003, PALLIATIVE MED, V17, P695, DOI 10.1191/0269216303pm834oa; D'Andrea GM, 2005, CA-CANCER J CLIN, V55, P319, DOI 10.3322/canjclin.55.5.319; Enblom A, 2012, ANN ONCOL, V23, P1353, DOI 10.1093/annonc/mdr402; Endres HG, 2005, SCHMERZ, V19, P201, DOI 10.1007/s00482-004-0345-z; Endres HG, 2007, AKUPUNKTUR BEI CHRON; Gunawan S, 2016, PEDIATR BLOOD CANCER, V63, P118, DOI 10.1002/pbc.25689; Haake M, 2007, ARCH INTERN MED, V167, P1892, DOI 10.1001/archinte.167.17.1892; Horneber M, 2012, INTEGR CANCER THER, V11, P187, DOI 10.1177/1534735411423920; Huebner J, 2009, ONKOLOGE, DOI [10.1007/s00761-009-1764-3, DOI 10.1007/S00761-009-1764-3]; Huebner J, 2014, ONCOL RES TREAT, V37, DOI 10.1159/000362616; Hyodo I, 2005, J CLIN ONCOL, V23, P2645, DOI 10.1200/JCO.2005.04.126; Knight Aishah, 2015, Asian Pac J Cancer Prev, V16, P3125; Labriola D, 1999, ONCOLOGY-NY, V13, P1003; Lawenda BD, 2008, JNCI-J NATL CANCER I, V100, P773, DOI 10.1093/jnci/djn148; Magi T, 2015, USE COMPLEMENTARY AL, V10, DOI [10.1371/journal.pone.0145787, DOI 10.1371/JOURNAL.PONE.0145787]; Mani J, 2015, USE COMPLEMENTARY AL, P1407, DOI [10.2147/PPA.S90061, DOI 10.2147/PPA.S90061]; Micke O, 2009, EUR J INTEGR MED, V1, P19, DOI 10.1016/j.eujim.2009.02.001; Molassiotis A, 2005, ANN ONCOL, V16, P655, DOI 10.1093/annonc/mdi110; Molassiotis A, 2006, EUROPEAN J, DOI [10.1111/j.1365-2354.2005.00615.x/pdf, DOI 10.1111/J.1365-2354.2005.00615.X/PDF]; Montazeri A, 2007, EUR J CANCER CARE, V16, P144, DOI 10.1111/j.1365-2354.2006.00722.x; Montazeri A, 2005, SUPPORT CARE CANCER, V13, P339, DOI 10.1007/s00520-004-0709-z; Naja F, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0969-9; Nakayama A, 2011, CANCER INVEST, V29, P655, DOI 10.3109/07357907.2011.626479; National Institutes of Health Bethesda MD (US), 2002, ACT HUM GEN NOM COMM, DOI [10.2172/804185, DOI 10.2172/804185]; Nazik E, 2012, ASIAN PAC J CANCER P, V13, P21, DOI 10.7314/APJCP.2012.13.1.021; Nissen N, 2012, FORSCH KOMPLEMENTMED, V19, P9, DOI 10.1159/000342710; Ojukwu M, 2015, INTEGR CANCER THER, V14, P503, DOI 10.1177/1534735415589347; Paul M, 2013, J CANCER RES CLIN, V139, P1515, DOI 10.1007/s00432-013-1460-y; Rausch SM, 2011, SUPPORT CARE CANCER, V19, P521, DOI 10.1007/s00520-010-0846-5; Richardson MA, 2000, J CLIN ONCOL, V18, P2505, DOI 10.1200/JCO.2000.18.13.2505; Risberg T, 2003, QUAL LIFE RES, V12, P539, DOI 10.1023/A:1025063705413; Robotin M, 2012, COMPLEMENT THER MED, V20, P345, DOI 10.1016/j.ctim.2012.04.001; Shumer G, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-360; Simcock R, 2013, ANN ONCOL, V24, P776, DOI 10.1093/annonc/mds515; Simone CB, 2007, ALTERN THER HEALTH M, V13, P40; Simone CB, 2007, ALTERN THER HEALTH M, V13, P22; Sullivan A, 2015, INTEGR CANCER THER, V14, P350, DOI 10.1177/1534735415580679; Ustundag S, 2015, HOLIST NURS PRACT, V29, P357, DOI 10.1097/HNP.0000000000000113; Vickers A, 2004, HEALTH TECHNOL ASSES, V8, DOI [10.3310/hta8480, DOI 10.3310/HTA8480]; Vickers AJ, 2004, J CLIN ONCOL, V22, P1731, DOI 10.1200/JCO.2004.04.102; Yates JS, 2005, SUPPORT CARE CANCER, V13, P806, DOI 10.1007/s00520-004-0770-7; Yeung K Simon, 2007, J Soc Integr Oncol, V5, P113, DOI 10.2310/7200.2007.008; Yidirim Y, 2006, EUR J GYNAECOL ONCOL, V27, P81	52	33	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165801	10.1371/journal.pone.0165801	http://dx.doi.org/10.1371/journal.pone.0165801			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812163	gold, Green Submitted, Green Published			2022-12-26	WOS:000386910000059
J	Bong, IW; Felker, ME; Maryudi, A				Bong, Indah Waty; Felker, Mary Elizabeth; Maryudi, Ahmad			How Are Local People Driving and Affected by Forest Cover Change? Opportunities for Local Participation in REDD plus Measurement, Reporting and Verification	PLOS ONE			English	Article							TROPICAL FORESTS; CO-BENEFITS; TRADE-OFFS; DEFORESTATION; MANAGEMENT; SUSTAINABILITY; SAFEGUARDS; INDONESIA; PROJECTS; BORNEO	Deforestation and forest degradation are complex and dynamic processes that vary from place to place. They are driven by multiple causes. Local communities are, to some extent, driving and also affected by some of these processes. Can their knowledge aid and add to place-specific assessment and monitoring of Deforestation and forest Degradation (DD) drivers? Our research was conducted in seven villages across three provinces of Indonesia (Papua, West Kalimantan and Central Java). Household surveys and focus group discussions were used to investigate how local community knowledge of DD drivers contributes to place-specific assessment and monitoring of DD drivers. We analyzed the link between drivers and local livelihoods to see how attempts to address deforestation and forest degradation might affect local communities and how this link might influence their participation in climate change mitigation measures such as Reducing Emissions from Deforestation and Forest Degradation (REDD+) and Measuring, Reporting and Verifying (MRV) activities. We found that local knowledge is fundamental to capturing the variety of drivers particularly in countries like Indonesia where forest and socio-economic conditions are diverse. Better understanding of drivers and their importance for local livelihoods will not only contribute to a more locally appropriate design of REDD+ and monitoring systems but will also foster local participation.	[Bong, Indah Waty; Felker, Mary Elizabeth] Ctr Int Forestry Res, Jl CIFOR, Bogor 16115, Indonesia; [Maryudi, Ahmad] Univ Gadjah Mada, Fac Forestry, Bulaksumur 55281, Yogyakarta, Indonesia	CGIAR; Center for International Forestry Research (CIFOR); Gadjah Mada University	Bong, IW (corresponding author), Ctr Int Forestry Res, Jl CIFOR, Bogor 16115, Indonesia.	i.waty@cgiar.org	Maryudi, Ahmad/T-8029-2019	Maryudi, Ahmad/0000-0001-5051-7217	U.S. Agency for International Development (USAID) [MT0069018]; Norwegian Agency for Development Cooperation (NORAD) [GL0-3945, QZA 12/0882]	U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); Norwegian Agency for Development Cooperation (NORAD)	Our research is funded by :1. The U.S. Agency for International Development (USAID), grant number MT0069018, http://www.usaid.gov/; 2. The Norwegian Agency for Development Cooperation (NORAD), grant number GL0-3945, QZA 12/0882, http://www.norad.no/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blom B, 2010, ENVIRON SCI POLICY, V13, P164, DOI 10.1016/j.envsci.2010.01.002; Boissiere M, 2014, FORESTS, V5, P1855, DOI 10.3390/f5081855; Brewster J, 2012, COMMUNITY BASED MONI; Byron N, 1999, WORLD DEV, V27, P789, DOI 10.1016/S0305-750X(99)00025-X; Chhatre A, 2012, CURR OPIN ENV SUST, V4, P654, DOI 10.1016/j.cosust.2012.08.006; Chhatre A, 2009, P NATL ACAD SCI USA, V106, P17667, DOI 10.1073/pnas.0905308106; Christie P, 2005, OCEAN COAST MANAGE, V48, P468, DOI 10.1016/j.ocecoaman.2005.04.006; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Danielsen F, 2011, CONSERV LETT, V4, P158, DOI 10.1111/j.1755-263X.2010.00159.x; Dharmadi Hawthorne S., 2014, LIT REV PARTICIPATOR; Fisher RJ, 1997, ASIA PACIFIC FORESTR; Force RT, 2012, STRAT IMPL PLAN REDD; Fraser EDG, 2006, J ENVIRON MANAGE, V78, P114, DOI 10.1016/j.jenvman.2005.04.009; Fry B, 2011, ENVIRON SCI POLICY, V14, P181, DOI 10.1016/j.envsci.2010.12.004; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Holck MH, 2008, BIODIVERS CONSERV, V17, P2023, DOI 10.1007/s10531-007-9273-4; Hosonuma N, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044009; Houghton RA, 2012, CURR OPIN ENV SUST, V4, P597, DOI 10.1016/j.cosust.2012.06.006; Huang R., RQDA R BASED QUALITA; Indrabudi H, 1998, LAND DEGRAD DEV, V9, P311, DOI 10.1002/(SICI)1099-145X(199807/08)9:4<311::AID-LDR294>3.0.CO;2-X; Indrarto GB, 2012, CONTEXT REDD INDONE; Joseph S, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034038; Kissinger G., 2012, SYNTHESIS REPORT RED, V48; Kothari CR, 2011, REMETHODOLOGY METH; Langner A, 2007, GLOBAL CHANGE BIOL, V13, P2329, DOI 10.1111/j.1365-2486.2007.01442.x; Larrazabal A, 2012, CURR OPIN ENV SUST, V4, P707, DOI 10.1016/j.cosust.2012.10.008; Lawlor K, 2010, GLOBAL ENVIRON POLIT, V10, P1, DOI 10.1162/GLEP_a_00028; Lederer M, 2011, ECOL ECON, V70, P1900, DOI 10.1016/j.ecolecon.2011.02.003; McCall K., 2010, LOCAL PARTICIPATION; Microsoft, 2010, MICR EXC; Mukama K, 2012, INT J FORESTRY RES, V2011; Murdiyarso D., 2008, ECOHYDROLOGY MAMBERA; Olander LP, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/2/025011; Peres CA, 2006, TRENDS ECOL EVOL, V21, P227, DOI 10.1016/j.tree.2006.03.007; Peters-Guarin G, 2010, COMMUNITY CARBON FOR; Pratihast AK, 2013, CARBON MANAG, V4, P91, DOI [10.4155/cmt.12.75, 10.4155/CMT.12.75]; Rana EB, 2008, INITIATION, V2, P91; Romijn E, 2013, ENVIRON SCI POLICY, V33, P246, DOI 10.1016/j.envsci.2013.06.002; Salvini G, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/7/074004; Sanchez-Azofeifa GA, 2009, ECOL APPL, V19, P480, DOI 10.1890/08-1149.1; Skutsch M, 2011, COMMUNITY FOREST MON; Skutsch M, 2009, COMMUNITY MONITORING, P101; Skutsch M.M., 2009, CASE STUDIES MEASURI; Skutsch Margaret M, 2011, Carbon Balance Manag, V6, P16, DOI 10.1186/1750-0680-6-16; Skutsch MM, 2005, CLIM POLICY, V5, P433; Verplanke J., 2009, FIELD GUIDE ASSESSIN; Visseren-Hamakers IJ, 2012, CURR OPIN ENV SUST, V4, P646, DOI 10.1016/j.cosust.2012.10.005	48	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0145330	10.1371/journal.pone.0145330	http://dx.doi.org/10.1371/journal.pone.0145330			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806044	Green Published, Green Submitted, gold			2022-12-26	WOS:000386715500001
J	Han, YJ; Zhang, J; Zheng, YL; Huo, DZ; Olopade, OI				Han, Yoo-Jeong; Zhang, Jing; Zheng, Yonglan; Huo, Dezheng; Olopade, Olufunmilayo I.			Genetic and Epigenetic Regulation of TOX3 Expression in Breast Cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; AFRICAN ANCESTRY; RISK; WOMEN; METHYLATION; VARIANTS	Genome wide association studies (GWAS) have identified low penetrance and high frequency single nucleotide polymorphisms (SNPs) that contribute to genetic susceptibility of breast cancer. The SNPs at 16q12, close to the TOX3 and CASC16 genes, represent one of the susceptibility loci identified by GWAS, showing strong evidence for breast cancer association across various populations. To examine molecular mechanisms of TOX3 regulation in breast cancer, we investigated both genetic and epigenetic factors using cell lines and datasets derived from primary breast tumors available through The Cancer Genome Atlas (TCGA). TOX3 expression is highly up-regulated in luminal subtype tumors compared to normal breast tissues or basal-like tumors. Expression quantitative trait loci (eQTL) analyses revealed significant associations of rs3803662 and rs4784227 genotypes with TOX3 expression in breast tumors. Bisulfite sequencing of four CpG islands in the TOX3 promoter showed a clear difference between luminal and basal-like cancer cell lines. 5-Aza-2'-deoxy-cytidine treatment of a basal-like cancer cell line increased expression of TOX3. TCGA dataset verified significantly lower levels of methylation of the promoter in luminal breast tumors with an inverse correlation between methylation and expression of TOX3. Methylation QTL (mQTL) analyses showed a weak or no correlation of rs3803662 or rs4784227 with TOX3 promoter methylation in breast tumors, indicating an independent relationship between the genetic and epigenetic events. These data suggest a complex system of TOX3 regulation in breast tumors, driven by germline variants and somatic epigenetic modifications in a subtype specific manner.	[Han, Yoo-Jeong; Zhang, Jing; Zheng, Yonglan; Olopade, Olufunmilayo I.] Univ Chicago, Dept Med, Ctr Clin Canc Genet & Global Hlth, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Han, Yoo-Jeong; Zhang, Jing; Zheng, Yonglan; Olopade, Olufunmilayo I.] Univ Chicago, Dept Med, Sect Hematol & Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Huo, Dezheng] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Han, YJ; Olopade, OI (corresponding author), Univ Chicago, Dept Med, Ctr Clin Canc Genet & Global Hlth, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Han, YJ; Olopade, OI (corresponding author), Univ Chicago, Dept Med, Sect Hematol & Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	yjhan@medicine.bsd.uchicago.edu; folopade@medicine.bsd.uchicago.edu	Zheng, Yonglan/O-4112-2019	Zheng, Yonglan/0000-0001-6597-7072	NIH [R01 CM 42996-01]; NIH Specialized Program of Research Excellence in Breast Cancer [P50 CA125183]; Breast Cancer Research Foundation; Ralph and Marion Falk Medical Research Trust; NATIONAL CANCER INSTITUTE [R01CA142996, P50CA125183] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Specialized Program of Research Excellence in Breast Cancer; Breast Cancer Research Foundation; Ralph and Marion Falk Medical Research Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH R01 CM 42996-01 (OIO), NIH Specialized Program of Research Excellence in Breast Cancer P50 CA125183 (OIO), Breast Cancer Research Foundation (YH and OIO), and the Ralph and Marion Falk Medical Research Trust (OIO). OIO is American Cancer Society Clinical Research Professor.; The authors thank Dr. Charles M. Perou (University of North Carolina, Chapel Hill, NC) for generously providing the University of North Carolina dataset and Dr. Albert C. Yeh (University of Chicago) for critically reviewing the manuscript. We also thank Dr. Tatyana Grushko and Ms. Maria Gomez for assistance with FISH experiments and data interpretation, and Ms. Mariann Coyle for assistance with the cell culturing. This work was supported by NIH R01 CA142996-01 (OIO), NIH Specialized Program of Research Excellence in Breast Cancer P50 CA125183 (OIO), Breast Cancer Research Foundation (YH and OIO), and the Ralph and Marion Falk Medical Research Trust (OIO). OK) is American Cancer Society Clinical Research Professor.	Baumgartner A, 2006, J HISTOCHEM CYTOCHEM, V54, P1363, DOI 10.1369/jhc.6A6974.2006; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Chen F, 2011, HUM MOL GENET, V20, P4491, DOI 10.1093/hmg/ddr367; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Dittmer S, 2011, J CELL SCI, V124, P252, DOI 10.1242/jcs.068759; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Gudmundsdottir ET, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-621; Han W, 2011, CANCER EPIDEM BIOMAR, V20, P793, DOI 10.1158/1055-9965.EPI-10-1282; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Huo DZ, 2012, CARCINOGENESIS, V33, P835, DOI 10.1093/carcin/bgs093; Jones JO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074102; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Long JR, 2010, CANCER EPIDEM BIOMAR, V19, P2357, DOI 10.1158/1055-9965.EPI-10-0054; Long JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001002; Mavaddat N, 2010, MOL ONCOL, V4, P174, DOI 10.1016/j.molonc.2010.04.011; Michailidou K, 2015, NAT GENET, V47, P373, DOI 10.1038/ng.3242; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Millis RM, 2011, CURR HYPERTENS REP, V13, P21, DOI 10.1007/s11906-010-0173-8; O'Flaherty E, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-13; Riaz M, 2012, BREAST CANCER RES TR, V133, P843, DOI 10.1007/s10549-011-1663-3; Ruiz-Narvaez EA, 2010, CANCER EPIDEM BIOMAR, V19, P1320, DOI 10.1158/1055-9965.EPI-09-1250; Shan JX, 2013, CANCER RES, V73, P2840, DOI 10.1158/0008-5472.CAN-12-4313; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Vo AT, 2012, OBSTET GYNECOL INT, V2012, DOI [10.1156/2012/6022720, DOI 10.1156/2012/6022720]; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; Wei MJ, 2005, CANCER RES, V65, P10692, DOI 10.1158/0008-5472.CAN-05-1277; Zheng YL, 2013, CARCINOGENESIS, V34, P1520, DOI 10.1093/carcin/bgt090	28	19	19	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165559	10.1371/journal.pone.0165559	http://dx.doi.org/10.1371/journal.pone.0165559			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806084	gold, Green Published, Green Submitted			2022-12-26	WOS:000386715500037
J	Ebner-Karestinos, D; Thonnard, JL; Bleyenheuft, Y				Ebner-Karestinos, Daniela; Thonnard, Jean-Louis; Bleyenheuft, Yannick			Precision Grip Control while Walking Down a Stair Step	PLOS ONE			English	Article							OBJECT TRANSPORT; ARM MOVEMENTS; GENDER-DIFFERENCES; FINGERTIP FORCES; LOAD FORCE; GAIT; COORDINATION; PERFORMANCE; STABILITY; CHILDREN	The aim of this study was to determine whether the internal model regulating grip force (GF)/load force (LF) coordination during a brisk load increase is preserved when the lower extremities produce a perturbation during a single step-down task. We observed the coordination of the vertical ground reaction force (vGRF), GF and LF while holding a handheld object during a single step-down task. The 3 forces (vGRF, GF and LF) decreased during the start of the task. While the subject was descending, LF and GF became dissociated from vGRF and increased in value, probably to anticipate the first foot contact. Coordination of LF and GF was maintained until the maximal vGRF (knee extension). LF peaked in the same time window as vGRF, whereas GF peaked about 70 ms later. This desynchronization, which was previously observed in direct load increase on a handheld object, was interpreted to be a predictive action to ensure the smooth management of the brisk increase in load induced by the lower extremities. Incidentally, in this group, kinematic and dynamic differences were observed between men and women, which may highlight a gender-specific strategy to perform the step-down task. In conclusion, these results suggest that the internal model of precision grip is able to integrate a brisk load change, whatever its origin, and regulate the forces to provide an ideal GF to dampen a brisk load increase and secure the object.	[Ebner-Karestinos, Daniela; Thonnard, Jean-Louis; Bleyenheuft, Yannick] Catholic Univ Louvain, Inst Neurosci, Brussels, Belgium; [Thonnard, Jean-Louis] Catholic Univ Louvain, Phys & Rehabil Med Dept, Clin Univ St Luc, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Bleyenheuft, Y (corresponding author), Catholic Univ Louvain, Inst Neurosci, Brussels, Belgium.	yannick.bleyenheuft@uclouvain.be	Bleyenheuft, Yannick/ABA-1472-2021	Bleyenheuft, Yannick/0000-0002-6688-932X; Ebner Karestinos, Daniela/0000-0002-5941-8706				Augurelle AS, 2003, J NEUROPHYSIOL, V89, P665, DOI 10.1152/jn.00249.2002; Bleyenheuft Y, 2010, J MOTOR BEHAV, V42, P169, DOI 10.1080/00222891003765843; Bleyenheuft Y, 2010, NEUROREHAB NEURAL RE, V24, P318, DOI 10.1177/1545968309353327; Bleyenheuft Y, 2009, J MOTOR BEHAV, V41, P411, DOI 10.3200/35-08-084; DAVIS BL, 1993, J BIOMECH, V26, P593, DOI 10.1016/0021-9290(93)90020-F; Delevoye-Turrell YN, 2003, Q J EXP PSYCHOL-A, V56, P1113, DOI 10.1080/02724980245000025; Descoins M, 2006, EXP BRAIN RES, V172, P331, DOI 10.1007/s00221-005-0340-3; Dierick F, 2004, GAIT POSTURE, V20, P299, DOI 10.1016/j.gaitpost.2003.11.001; Diermayr G, 2008, EXP BRAIN RES, V190, P337, DOI 10.1007/s00221-008-1476-8; Ferber R, 2003, CLIN BIOMECH, V18, P350, DOI 10.1016/S0268-0033(03)00025-1; FLANAGAN JR, 1995, EXP BRAIN RES, V105, P455; FLANAGAN JR, 1993, EXP BRAIN RES, V95, P131; FLANAGAN JR, 1993, NEUROSCI LETT, V152, P53, DOI 10.1016/0304-3940(93)90481-Y; Gysin P, 2003, EXP BRAIN RES, V149, P371, DOI 10.1007/s00221-003-1380-1; Gysin P, 2009, SENSORIMOTOR CONTROL, P219; Gysin P, 2008, J NEUROPHYSIOL, V100, P2477, DOI 10.1152/jn.90561.2008; Hamel KA, 2004, J AM GERIATR SOC, V52, P563, DOI 10.1111/j.1532-5415.2004.52162.x; Hollman JH, 2011, AM J MENS HEALTH, V5, P11, DOI 10.1177/1557988309357232; Hsue BJ, 2014, ARCH PHYS MED REHAB, V95, P1860, DOI 10.1016/j.apmr.2014.05.001; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P72; LACQUANITI F, 1993, J NEUROPHYSIOL, V69, P1443, DOI 10.1152/jn.1993.69.5.1443; LACQUANITI F, 1992, J NEUROSCI, V12, P1750; Marasovic Tea, 2009, WSEAS Transactions on Systems, V8, P1105; Oh-Park M, 2013, AGING CLIN EXP RES, V25, P99, DOI 10.1007/s40520-013-0014-0; Prabhu SB, 2011, DEV MED CHILD NEUROL, V53, P865, DOI 10.1111/j.1469-8749.2011.04061.x; Turrell YN, 1999, EXP BRAIN RES, V128, P86, DOI 10.1007/s002210050822; WESTLING G, 1984, EXP BRAIN RES, V53, P277; White O, 2005, EXP BRAIN RES, V163, P324, DOI 10.1007/s00221-004-2175-8; White O, 2011, NEUROSCIENCE, V189, P269, DOI 10.1016/j.neuroscience.2011.04.055; White O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044291; Witney AG, 1999, J NEUROPHYSIOL, V82, P2039, DOI 10.1152/jn.1999.82.5.2039; Yan J, 2007, HDB BIOMECHANICS HUM, P565; Yan JH, 1995, J COMP PE SPORT, V17, P38; Yogev-Seligmann G, 2010, PHYS THER, V90, P177, DOI 10.2522/ptj.20090043; ZACHAZEWSKI JE, 1993, J REHABIL RES DEV, V30, P412	35	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165549	10.1371/journal.pone.0165549	http://dx.doi.org/10.1371/journal.pone.0165549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802343	Green Published, gold, Green Submitted			2022-12-26	WOS:000386714200026
J	Meng, Z; Ma, X; Du, J; Wang, X; He, M; Gu, Y; Zhang, J; Han, W; Fang, Z; Gan, X; Van Ness, C; Fu, X; Schones, DE; Xu, R; Huang, W				Meng, Z.; Ma, X.; Du, J.; Wang, X.; He, M.; Gu, Y.; Zhang, J.; Han, W.; Fang, Z.; Gan, X.; Van Ness, C.; Fu, X.; Schones, D. E.; Xu, R.; Huang, W.			CAMK2 gamma antagonizes mTORC1 activation during hepatocarcinogenesis	ONCOGENE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; PROTEIN-KINASE-II; NF-KAPPA-B; FARNESOID-X RECEPTOR; HEPATOCELLULAR-CARCINOMA; LIVER-CANCER; PEPTIDE ARRAYS; CHEMICAL HEPATOCARCINOGENESIS; SIGNAL INTEGRATION; CRITICAL REGULATOR	Hepatocellular carcinoma (HCC) is one of the most deadly cancers that still lacks effective treatments. Dysregulation of kinase signaling has frequently been reported to contribute to HCC. In this study, we used bioinformatic approaches to identify kinases that regulate gene expression changes in human HCCs and two murine HCC models. We identified a role for calcium/calmodulin-dependent protein kinases II gamma isoform (CAMK2 gamma) in hepatocarcinogenesis. CAMK2 gamma(-/-) mice displayed severely enhanced chemical-induced hepatocarcinogenesis compared with wild-type controls. Mechanistically, CAMK2 gamma deletion potentiates hepatic activation of mechanistic target of rapamycin complex 1 (mTORC1), which results in hyperproliferation of hepatocytes. Inhibition of mTORC1 by rapamycin effectively attenuates the compensatory proliferation of hepatocytes in CAMK2 gamma(-/-) livers. We further demonstrated that CAMK2 gamma suppressed growth factor-or insulin-induced mTORC1 activation by inhibiting IRS1/AKT signaling. Taken together, our results reveal a novel mechanism by which CAMK2 gamma antagonizes mTORC1 activation during hepatocarcinogenesis.	[Meng, Z.; Ma, X.; Du, J.; Wang, X.; Gu, Y.; Zhang, J.; Gan, X.; Van Ness, C.; Fu, X.; Schones, D. E.; Xu, R.; Huang, W.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet Complicat & Metab, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Ma, X.; Du, J.; Schones, D. E.; Huang, W.] City Hope Natl Med Ctr, Beckman Res Inst, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA; [He, M.] Guangxi Med Univ, Sch Publ Hlth, Nanning, Guangxi, Peoples R China; [Gu, Y.; Xu, R.] Zhejiang Univ, China Natl Minist Educ, Key Lab Canc Prevent & Intervent, Dept Hematol, Hangzhou, Zhejiang, Peoples R China; [Zhang, J.; Xu, R.] Zhejiang Univ, Canc Inst, Sch Med, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China; [Han, W.; Fang, Z.] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Med Oncol, Coll Med, Hangzhou, Zhejiang, Peoples R China; [Fu, X.] Sichuan Univ, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China; [Fu, X.] Sichuan Univ, Canc Ctr, Collaborat Innovat Ctr Biotherapy, West China Hosp,West China Med Sch, Chengdu, Sichuan, Peoples R China	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Guangxi Medical University; Zhejiang University; Zhejiang University; Zhejiang University; Sichuan University; Sichuan University	Xu, R; Huang, W (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet Complicat & Metab, 1500 E Duarte Rd, Duarte, CA 91010 USA.	zrxyk10@zju.edu.cn; whuang@coh.org	Ma, Xiaoxiao/AFB-9086-2022	Ma, Xiaoxiao/0000-0001-8661-5660; Fang, Zhipeng/0000-0001-5720-1709; Fu, Xianghui/0000-0001-9808-3892	NCI [1R01-CA139158]; National Natural Science Foundation of China [81270601, 81328016]; NATIONAL CANCER INSTITUTE [R01CA139158, P30CA033572] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Johannes Backs for providing the Camk2 gamma KO mice. We also thank Dr Richard Ermel and the Animal Resource center for the technique support in animal experiments. Similarly, we thank Dr Yun Yen and Yafan Wang and the Translational Research Core for providing reagents. This work is supported in part by NCI 1R01-CA139158 and the National Natural Science Foundation of China (81270601 and 81328016).	Abdul-Ghani R, 2006, ONCOGENE, V25, P1743, DOI 10.1038/sj.onc.1209201; Arsenault R, 2011, PROTEOMICS, V11, P4595, DOI 10.1002/pmic.201100296; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Azeloglu EU, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004621; Bhat M, 2013, HEPATOLOGY, V58, P810, DOI 10.1002/hep.26323; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Chen EY, 2012, BIOINFORMATICS, V28, P105, DOI 10.1093/bioinformatics/btr625; Chen WM, 2013, BIOINFORMATICS, V29, P2435, DOI 10.1093/bioinformatics/btt387; Cretich M, 2006, BIOMOL ENG, V23, P77, DOI 10.1016/j.bioeng.2006.02.001; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; DeFea K, 1997, BIOCHEMISTRY-US, V36, P12939, DOI 10.1021/bi971157f; DEGROOT RP, 1993, EMBO J, V12, P3903, DOI 10.1002/j.1460-2075.1993.tb06068.x; DeVries TA, 2004, J BIOL CHEM, V279, P45603, DOI 10.1074/jbc.M407448200; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Ella E, 2014, ONCOTARGET, V5, P10318, DOI 10.18632/oncotarget.2515; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Feng GS, 2012, CANCER CELL, V21, P150, DOI 10.1016/j.ccr.2012.01.001; Florian MC, 2013, NATURE, V503, P392, DOI 10.1038/nature12631; Goldman A, 2014, MOL CELL, V55, P422, DOI 10.1016/j.molcel.2014.05.012; Gu Y, 2012, BLOOD, V120, P4829, DOI 10.1182/blood-2012-06-434894; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Hell JW, 2014, NEURON, V81, P249, DOI 10.1016/j.neuron.2013.12.024; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Huang WD, 2005, MOL ENDOCRINOL, V19, P1646, DOI 10.1210/me.2004-0520; Illario M, 2009, CELL SIGNAL, V21, P786, DOI 10.1016/j.cellsig.2009.01.022; Ishiguro K, 2006, MOL CELL BIOL, V26, P5497, DOI 10.1128/MCB.02469-05; Kenerson HL, 2013, GASTROENTEROLOGY, V144, P1055, DOI 10.1053/j.gastro.2013.01.053; Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249; Kim MS, 2016, PROTEOMICS, V16, P700, DOI 10.1002/pmic.201500355; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Lachmann A, 2009, BIOINFORMATICS, V25, P684, DOI 10.1093/bioinformatics/btp026; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li Z, 2012, CELL, V148, P72, DOI 10.1016/j.cell.2011.11.026; Liu NA, 2012, MOL ENDOCRINOL, V26, P775, DOI 10.1210/me.2011-1383; Liu Y, 2014, COMPUT STRUCT BIOTEC, V10, P90, DOI 10.1016/j.csbj.2014.07.003; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Maluccio M, 2012, CA-CANCER J CLIN, V62, P394, DOI 10.3322/caac.21161; Matter MS, 2014, J HEPATOL, V60, P855, DOI 10.1016/j.jhep.2013.11.031; Meng ZP, 2013, MOL CANCER THER, V12, P2067, DOI 10.1158/1535-7163.MCT-13-0314; Meng ZP, 2012, J HEPATOL, V57, P1004, DOI 10.1016/j.jhep.2012.06.016; Menon S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002739; Midorikawa R, 2006, CELL, V125, P371, DOI 10.1016/j.cell.2006.02.039; Mothe I, 1996, J BIOL CHEM, V271, P11222, DOI 10.1074/jbc.271.19.11222; Nair JS, 2002, P NATL ACAD SCI USA, V99, P5971, DOI 10.1073/pnas.052159099; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Ozcan L, 2013, CELL METAB, V18, P803, DOI 10.1016/j.cmet.2013.10.011; Ozcan L, 2012, CELL METAB, V15, P739, DOI 10.1016/j.cmet.2012.03.002; Papa S, 2008, J CLIN INVEST, V118, P1911, DOI 10.1172/JCI33913; Patsenker E, 2011, J HEPATOL, V55, P388, DOI 10.1016/j.jhep.2010.10.044; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Rabinowitz KM, 2013, GASTROENTEROLOGY, V144, P601, DOI 10.1053/j.gastro.2012.12.001; Ravichandran LV, 2001, J BIOL CHEM, V276, P3543, DOI 10.1074/jbc.M007231200; Reimer U, 2002, CURR OPIN BIOTECH, V13, P315, DOI 10.1016/S0958-1669(02)00339-7; Rexer BN, 2011, ONCOGENE, V30, P4163, DOI 10.1038/onc.2011.130; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Satow R, 2010, CLIN CANCER RES, V16, P2518, DOI 10.1158/1078-0432.CCR-09-2214; Si JT, 2008, CANCER RES, V68, P3733, DOI 10.1158/0008-5472.CAN-07-2509; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soliman GA, 2010, J BIOL CHEM, V285, P7866, DOI 10.1074/jbc.M109.096222; Swaminathan PD, 2011, J CLIN INVEST, V121, P3277, DOI 10.1172/JCI57833; Thomas MB, 2005, J CLIN ONCOL, V23, P2892, DOI 10.1200/JCO.2005.03.196; Timmins JM, 2009, J CLIN INVEST, V119, P2925, DOI 10.1172/JCI38857; Vasudevan HN, 2014, DEV CELL, V31, P332, DOI 10.1016/j.devcel.2014.10.005; Volarevic S, 2000, SCIENCE, V288, P2045, DOI 10.1126/science.288.5473.2045; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang ZJ, 2012, J CLIN ENDOCR METAB, V97, P2347, DOI 10.1210/jc.2012-1267; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	77	12	12	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 27	2017	36	17					2446	2456		10.1038/onc.2016.400	http://dx.doi.org/10.1038/onc.2016.400			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET4QE	27819676	Green Accepted			2022-12-26	WOS:000400268900010
J	Gao, Y; Mruk, D; Chen, HQ; Lui, WY; Lee, WM; Cheng, CY				Gao, Ying; Mruk, Dolores; Chen, Haiqi; Lui, Wing-Yee; Lee, Will M.; Cheng, C. Yan			Regulation of the blood-testis barrier by a local axis in the testis: role of laminin 2 in the basement membrane	FASEB JOURNAL			English	Article						spermatogenesis; ectoplasmic specialization; spermatid adhesion; Sertoli cell adhesion	CONGENITAL MUSCULAR-DYSTROPHY; ADULT-RAT TESTES; SEMINIFEROUS EPITHELIUM; EXTRACELLULAR-MATRIX; ALPHA-2 CHAIN; SERTOLI-CELLS; IN-VITRO; ECTOPLASMIC SPECIALIZATION; TRAFFICKING EVENTS; JUNCTION DYNAMICS	Laminin 2 is one of the constituent components of the basement membrane (BM) in adult rat testes. Earlier studies that used a mouse genetic model have shown that a deletion of laminin 2 impedes male fertility by disrupting ectoplasmic specialization (ES; a testis-specific, actin-rich anchoring junction) function along the length of Sertoli cell in the testis. This includes ES at the Sertoli cell-elongating/elongated spermatid interface, which is known as apical ES and possibly the Sertoli-Sertoli cell interface, known as basal ES, at the blood-testis barrier (BTB). Studies have also illustrated that there is a local regulatory axis that functionally links cellular events of spermiation that occur near the luminal edge of tubule lumen at the apical ES and the basal ES/BTB remodeling near the BM at opposite ends of the seminiferous epithelium during the epithelial cycle, known as the apical ES-BTB-BM axis. However, the precise role of BM in this axis remains unknown. Here, we show that laminin 2 in the BM serves as the crucial regulator in this axis as laminin 2, likely its 80-kDa fragment from the C terminus, was found to be transported across the seminiferous epithelium at stages VIII-IX of the epithelial cycle, from the BM to the luminal edge of the tubule, possibly being used to modulate apical ES restructuring at these stages. Of more importance, a knockdown of laminin 2 in Sertoli cells was shown to induce the Sertoli cell tight junction permeability barrier disruption via changes in localization of adhesion proteins at the tight junction and basal ES at the Sertoli cell BTB. These changes were found to be mediated by a disruption of F-actin organization that was induced by changes in the spatiotemporal expression of actin binding/regulatory proteins. Furthermore, laminin 2 knockdown also perturbed microtubule (MT) organization by considerable down-regulation of MT polymerization via changes in the spatiotemporal expression of EB1 (end-binding protein 1), a +TIP (MT plus-end tracking protein). In short, laminin 2 in the BM seems to play a crucial role in the BTB-BM axis by modulating BTB dynamics during spermatogenesis.	[Gao, Ying; Mruk, Dolores; Chen, Haiqi; Cheng, C. Yan] Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA; [Lui, Wing-Yee; Lee, Will M.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	Population Council; University of Hong Kong	Cheng, CY (corresponding author), Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA.	y-cheng@popcbr.rockefeller.edu	Chen, Haiqi/J-7468-2019; Lui, Wing Yee/A-2743-2010	Chen, Haiqi/0000-0001-7179-3229; Cheng, C Yan/0000-0003-3117-3791; Lui, Wing Yee/0000-0002-3096-1158	U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01-HD056034, U54-HD029990]; Hong Kong Research Grants Council (RGC) [GRF774213M, GRF11004516, GRF771513]; RGC/National Natural Science Foundation of China Joint Research Scheme [N_HKU 717/12]; Hong Kong University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD029990, R01HD056034] Funding Source: NIH RePORTER	U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Hong Kong Research Grants Council (RGC)(Hong Kong Research Grants Council); RGC/National Natural Science Foundation of China Joint Research Scheme; Hong Kong University(University of Hong Kong); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Grants R01-HD056034 (to C.Y.C.) and U54-HD029990 Project 5 (to C.Y.C.); Hong Kong Research Grants Council (RGC) (GRF774213M and GRF11004516 to W.Y.L., and GRF771513 to W.M.L.); RGC/National Natural Science Foundation of China Joint Research Scheme (N_HKU 717/12 to W.M.L.); and Hong Kong University Seed Funding (to W.Y.L. and W.M.L.).	Allamand V, 1997, HUM MOL GENET, V6, P747, DOI 10.1093/hmg/6.5.747; Brunden KR, 2014, BIOORGAN MED CHEM, V22, P5040, DOI 10.1016/j.bmc.2013.12.046; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Cheng CY, 2010, NAT REV ENDOCRINOL, V6, P380, DOI 10.1038/nrendo.2010.71; Cheng CY, 2009, CRIT REV BIOCHEM MOL, V44, P245, DOI 10.1080/10409230903061207; Cohn RD, 1998, NEUROLOGY, V51, P94, DOI 10.1212/WNL.51.1.94; Durbeej M, 1998, J HISTOCHEM CYTOCHEM, V46, P449, DOI 10.1177/002215549804600404; DYM M, 1994, ENDOCR REV, V15, P102, DOI 10.1210/er.15.1.102; EHRIG K, 1990, P NATL ACAD SCI USA, V87, P3264, DOI 10.1073/pnas.87.9.3264; Ekblom P, 1996, CURR OPIN CELL BIOL, V8, P700, DOI 10.1016/S0955-0674(96)80112-8; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; GALDIERI M, 1981, J ANDROL, V2, P249; Gao Y, 2016, THESIS; Granger E, 2014, SEMIN CELL DEV BIOL, V31, P20, DOI 10.1016/j.semcdb.2014.04.011; Grima J, 1997, J BIOL CHEM, V272, P6499, DOI 10.1074/jbc.272.10.6499; Guo LT, 2003, NEUROMUSCULAR DISORD, V13, P207, DOI 10.1016/s0960-8966(02)00266-3; HADLEY MA, 1985, J CELL BIOL, V101, P1511, DOI 10.1083/jcb.101.4.1511; Hager M, 2005, AM J PATHOL, V167, P823, DOI 10.1016/S0002-9440(10)62054-8; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Holmberg J, 2013, CELL ADHES MIGR, V7, P111, DOI 10.4161/cam.22618; Jones KJ, 2001, J MED GENET, V38, P649, DOI 10.1136/jmg.38.10.649; Koch M, 1999, J CELL BIOL, V145, P605, DOI 10.1083/jcb.145.3.605; Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705; Lee NPY, 2004, J ANDROL, V25, P200; Li MWM, 2009, INT J BIOCHEM CELL B, V41, P2302, DOI 10.1016/j.biocel.2009.05.016; Li N, 2016, ENDOCRINOLOGY, V157, P2894, DOI 10.1210/en.2016-1133; Margolis RL, 1998, BIOESSAYS, V20, P830, DOI 10.1002/(SICI)1521-1878(199810)20:10<830::AID-BIES8>3.0.CO;2-N; Menezes MJ, 2014, J NEUROSCI, V34, P15260, DOI 10.1523/JNEUROSCI.3678-13.2014; Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7; Miyagoe-Suzuki Y, 2000, MICROSC RES TECHNIQ, V48, P181, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<181::AID-JEMT6>3.0.CO;2-Q; Mok KW, 2015, ENDOCRINOLOGY, V156, P1900, DOI 10.1210/en.2014-1791; Mruk Dolores D, 2011, Spermatogenesis, V1, P121; Mruk DD, 2011, METHODS MOL BIOL, V763, P237, DOI 10.1007/978-1-61779-191-8_16; Naom I, 2000, BRAIN, V123, P31, DOI 10.1093/brain/123.1.31; Neto FTL, 2016, SEMIN CELL DEV BIOL, V59, P10, DOI 10.1016/j.semcdb.2016.04.009; O'Donnell L, 2014, SEMIN CELL DEV BIOL, V30, P45, DOI 10.1016/j.semcdb.2014.01.003; Oberlies NH, 2004, J NAT PROD, V67, P129, DOI 10.1021/np030498t; Pelletier RM, 2011, PROG HISTOCHEM CYTO, V46, P49, DOI 10.1016/j.proghi.2011.05.001; RUSSELL LD, 1989, TISSUE CELL, V21, P361, DOI 10.1016/0040-8166(89)90051-7; Schlatt S, 2014, SEMIN CELL DEV BIOL, V29, P2, DOI 10.1016/j.semcdb.2014.03.007; Sewry CA, 1997, NEUROMUSCULAR DISORD, V7, P169, DOI 10.1016/S0960-8966(97)00425-2; Siu MKY, 2005, J BIOL CHEM, V280, P25029, DOI 10.1074/jbc.M501049200; Siu MKY, 2004, BIOESSAYS, V26, P978, DOI 10.1002/bies.20099; Siu MKY, 2004, BIOL REPROD, V70, P945, DOI 10.1095/biolreprod.103.023606; Siu MKY, 2003, ENDOCRINOLOGY, V144, P371, DOI 10.1210/en.2002-220786; Smith BE, 2012, SCIENCE, V338, P798, DOI 10.1126/science.1219969; Su LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16271; Su LL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2171; Su LL, 2010, EXP CELL RES, V316, P2945, DOI 10.1016/j.yexcr.2010.07.018; SUNADA Y, 1994, J BIOL CHEM, V269, P13729; Talts JF, 1998, FEBS LETT, V426, P71, DOI 10.1016/S0014-5793(98)00312-3; Tang EI, 2016, SEMIN CELL DEV BIOL, V59, P35, DOI 10.1016/j.semcdb.2016.01.004; Tang EI, 2016, ENDOCRINOLOGY, V157, P1644, DOI 10.1210/en.2015-1962; Tang EI, 2015, CELL POLARITY 1: BIOLOGICAL ROLE AND BASIC MECHANISMS, P303, DOI 10.1007/978-3-319-14463-4_13; Tang EI, 2015, ENDOCRINOLOGY, V156, P680, DOI 10.1210/en.2014-1720; Tang EI, 2013, J ENDOCRINOL, V217, pR13, DOI 10.1530/JOE-12-0586; TUNG PS, 1986, DEV BIOL, V113, P119, DOI 10.1016/0012-1606(86)90114-4; TUNG PS, 1993, J CELL PHYSIOL, V156, P1, DOI 10.1002/jcp.1041560102; Tzu J, 2008, INT J BIOCHEM CELL B, V40, P199, DOI 10.1016/j.biocel.2007.07.015; Vogl AW, 2008, ADV EXP MED BIOL, V636, P186, DOI 10.1007/978-0-387-09597-4_11; Wong EWP, 2010, P NATL ACAD SCI USA, V107, P11399, DOI 10.1073/pnas.1001077107; Wong EW, 2013, SPERMATOGENESIS, V3, DOI DOI 10.4161/SPMG.25465; Xiao X, 2014, AM J PHYSIOL-ENDOC M, V307, pE553, DOI 10.1152/ajpendo.00176.2014; Xiao X, 2014, PHYSIOLOGY, V29, P286, DOI 10.1152/physiol.00001.2014; Xiao XA, 2011, INT J BIOCHEM CELL B, V43, P651, DOI 10.1016/j.biocel.2011.01.008; Yan HHN, 2008, P NATL ACAD SCI USA, V105, P8950, DOI 10.1073/pnas.0711264105; Yan HHN, 2008, FASEB J, V22, P1945, DOI 10.1096/fj.06-070342; Yan HHN, 2008, CURR TOP DEV BIOL, V80, P57, DOI 10.1016/S0070-2153(07)80002-0; Yan HHN, 2007, BIOESSAYS, V29, P36, DOI 10.1002/bies.20513; Yan HHN, 2006, J BIOL CHEM, V281, P17286, DOI 10.1074/jbc.M513218200; Yao PL, 2010, BIOL REPROD, V82, P516, DOI 10.1095/biolreprod.109.080374; Yao PL, 2009, BIOL REPROD, V80, P581, DOI 10.1095/biolreprod.108.073122	74	35	40	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					584	597		10.1096/fj.201600870R	http://dx.doi.org/10.1096/fj.201600870R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27815338	Green Published			2022-12-26	WOS:000394235400013
J	Gerbier, R; Alvear-Perez, R; Margathe, JF; Flahault, A; Couvineau, P; Gao, J; De Mota, N; Dabire, H; Li, B; Ceraudo, E; Hus-Citharel, A; Esteoulle, L; Bisoo, C; Hibert, M; Berdeaux, A; Iturrioz, X; Bonnet, D; Llorens-Cortes, C				Gerbier, Romain; Alvear-Perez, Rodrigo; Margathe, Jean-Francois; Flahault, Adrien; Couvineau, Pierre; Gao, Ji; De Mota, Nadia; Dabire, Hubert; Li, Bo; Ceraudo, Emilie; Hus-Citharel, Annette; Esteoulle, Lucie; Bisoo, Cynthia; Hibert, Marcel; Berdeaux, Alain; Iturrioz, Xavier; Bonnet, Dominique; Llorens-Cortes, Catherine			Development of original metabolically stable apelin-17 analogs with diuretic and cardiovascular effects	FASEB JOURNAL			English	Article						vascular reactivity; blood pressure; cardiac contractility; vasopressin and diuresis	HUMAN APJ RECEPTOR; HEART-FAILURE; IN-VIVO; ENDOGENOUS LIGAND; BLOOD-PRESSURE; RAT-BRAIN; PEPTIDE; SYSTEM; BINDING; IDENTIFICATION	Apelin, a (neuro)vasoactive peptide, plays a prominent role in controlling cardiovascular functions and water balance. Because the in vivo apelin half-life is in the minute range, we aimed to identify metabolically stable apelin-17 (K17F) analogs. We generated P92 by classic chemical substitutions and LIT01-196 by original addition of a fluorocarbon chain to the N terminus of K17F. Both analogs were much more stable in plasma (half-life >24 h for LIT01-196) than K17F (4.6 min). Analogs displayed a subnanomolar affinity for the apelin receptor and behaved as full agonists with regard to cAMP production, ERK phosphorylation, and apelin receptor internalization. Ex vivo, these compounds induced vasorelaxation of rat aortas and glomerular arterioles, respectively, precontracted with norepinephrine and angiotensin II, and increased cardiac contractility. In vivo, after intracerebroventricular administration in water-deprived mice, P92 and LIT01-196 were 6 and 160 times, respectively, more efficient at inhibiting systemic vasopressin release than K17F. Administered intravenously (nmol/kg range) in normotensive rats, these analogs potently increased urine output and induced a profound and sustained decrease in arterial blood pressure. In summary, these new compounds, which favor diuresis and improve cardiac contractility while reducing vascular resistances, represent promising candidates for the treatment of heart failure and water retention/hyponatremic disorders.	[Gerbier, Romain; Alvear-Perez, Rodrigo; Flahault, Adrien; Couvineau, Pierre; Gao, Ji; De Mota, Nadia; Li, Bo; Ceraudo, Emilie; Hus-Citharel, Annette; Bisoo, Cynthia; Iturrioz, Xavier; Llorens-Cortes, Catherine] Coll France, INSERM, Ctr Natl Rech Sci,Unite 1050,Unit Mixte Rech, Ctr Interdisciplinary Res Biol,Lab Cent Neuropept, Paris, France; [Margathe, Jean-Francois; Esteoulle, Lucie; Hibert, Marcel; Bonnet, Dominique] Univ Strasbourg, Fac Pharm, Ctr Natl Rech Sci, Lab Therapeut Innovat,Unite Mixte Rech 7200, Illkirch Graffenstaden, France; [Berdeaux, Alain] Univ Paris Est, INSERM, Fac Med, Unite 955, Creteil, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Llorens-Cortes, C (corresponding author), Coll France, INSERM, CNRS, U1050,UMR 7241,Lab Cent Neuropeptides Regulat Bod, 11 Pl Marcelin Berthelot, F-75005 Paris, France.	c.llorens-cortes@college-de-france.fr	DABIRE, Hubert/G-5488-2018; Bonnet, Dominique/N-7275-2014; GERBIER, Romain/ABF-2481-2020; Iturrioz, Xavier/AAS-3555-2020; Llorens-Cortès, catherine/AAL-3893-2021; Llorens-Cortes, Catherine/E-5839-2016; Flahault, Adrien/Q-4576-2017; ITURRIOZ, Xavier/Q-4406-2017	DABIRE, Hubert/0000-0002-5829-2718; Bonnet, Dominique/0000-0002-8252-9199; Iturrioz, Xavier/0000-0001-7143-8323; Llorens-Cortès, catherine/0000-0002-7667-0401; Llorens-Cortes, Catherine/0000-0002-7667-0401; Flahault, Adrien/0000-0003-4632-6332; ITURRIOZ, Xavier/0000-0001-7143-8323; DE MOTA, Nadia/0000-0003-3754-3722; Couvineau, Pierre/0000-0002-4905-7740; Gerbier, Romain/0000-0003-4617-4850	INSERM; Centre National de la Recherche Scientifique; Universite de Strasbourg; College de France; Agence Nationale pour la Recherche "Physique et Chimie du Vivant"; "Cardiovasculaire-Obesite-Rein-Diabete" (Region Ile-de-France); Fondation Lefoulon-Delalande; French "Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche."	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; College de France; Agence Nationale pour la Recherche "Physique et Chimie du Vivant"(French National Research Agency (ANR)); "Cardiovasculaire-Obesite-Rein-Diabete" (Region Ile-de-France); Fondation Lefoulon-Delalande; French "Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche."	The authors thank Julie Sapa for the editing the article, Jeremie Teillon (Center for Interdisciplinary Research in Biology for Microscopy Core Facility), Patrick Gizzi (TechMedILL Platform, Illkirch, France), and Nicolas Humbert and Hugues de Rocquigny (Laboratory of Biophotonics and Pharmacology, Illkirch, France) for peptides synthesis. This work was supported by INSERM (through financial support for Proof of Concept, CoPoC, in particular), the Centre National de la Recherche Scientifique, the Universite de Strasbourg, the College de France, and the Agence Nationale pour la Recherche "Physique et Chimie du Vivant 2009." R.G., J.G., E.C., and L.E were supported by fellowships from " Cardiovasculaire-Obesite-Rein-Diabete" (Region Ile-de-France), Fondation Lefoulon-Delalande, and the French "Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche."	Ashley EA, 2005, CARDIOVASC RES, V65, P73, DOI 10.1016/j.cardiores.2004.08.018; Azizi M, 2008, J AM SOC NEPHROL, V19, P1015, DOI 10.1681/ASN.2007070816; Barnes GD, 2013, CIRC-HEART FAIL, V6, P482, DOI 10.1161/CIRCHEARTFAILURE.111.000077; Berry MF, 2004, CIRCULATION, V110, pII187, DOI 10.1161/01.CIR.0000138382.57325.5c; Blanchard A, 2013, J CLIN ENDOCR METAB, V98, P2084, DOI 10.1210/jc.2012-3794; Brame AL, 2015, HYPERTENSION, V65, P834, DOI 10.1161/HYPERTENSIONAHA.114.05099; Ceraudo E, 2014, J BIOL CHEM, V289, P24599, DOI 10.1074/jbc.M113.541698; Dabire H, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0240-6; De Mota N, 2000, NEUROENDOCRINOLOGY, V72, P400, DOI 10.1159/000054609; De Mota N, 2004, P NATL ACAD SCI USA, V101, P10464, DOI 10.1073/pnas.0403518101; Evans NA, 2001, J NEUROCHEM, V77, P476, DOI 10.1046/j.1471-4159.2001.00269.x; Fan XJ, 2003, BIOCHEMISTRY-US, V42, P10163, DOI 10.1021/bi030049s; Folino A, 2015, HEART FAIL REV, V20, P505, DOI 10.1007/s10741-015-9475-x; Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003; Gerbier R, 2015, FASEB J, V29, P314, DOI 10.1096/fj.14-256339; Habata Y, 1999, BBA-MOL CELL RES, V1452, P25, DOI 10.1016/S0167-4889(99)00114-7; Hamada J, 2008, INT J MOL MED, V22, P547, DOI 10.3892/ijmm_00000054; Hus-Citharel A, 2008, KIDNEY INT, V74, P486, DOI 10.1038/ki.2008.199; Hus-Citharel A, 2014, ENDOCRINOLOGY, V155, P4483, DOI 10.1210/en.2014-1257; Ishida J, 2004, J BIOL CHEM, V279, P26274, DOI 10.1074/jbc.M404149200; Iturrioz X, 2010, FASEB J, V24, P1506, DOI 10.1096/fj.09-140715; Japp AG, 2010, CIRCULATION, V121, P1818, DOI 10.1161/CIRCULATIONAHA.109.911339; Japp AG, 2008, J AM COLL CARDIOL, V52, P908, DOI 10.1016/j.jacc.2008.06.013; Japp AG, 2008, BIOCHEM PHARMACOL, V75, P1882, DOI 10.1016/j.bcp.2007.12.015; Jia ZQ, 2012, PEPTIDES, V38, P181, DOI 10.1016/j.peptides.2012.09.003; Katugampola SD, 2002, CAN J PHYSIOL PHARM, V80, P369, DOI 10.1139/Y02-029; Krieg E, 2014, J AM CHEM SOC, V136, P9443, DOI 10.1021/ja503906p; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Lee DK, 2000, J NEUROCHEM, V74, P34, DOI 10.1046/j.1471-4159.2000.0740034.x; Llorens-Cortes C., 2016, Patent, Patent No. [WO2016102648 A1, 2016102648]; Masri B, 2004, FASEB J, V18, P1909, DOI 10.1096/fj.04-1930fje; McKeown SC, 2014, BIOORG MED CHEM LETT, V24, P4871, DOI 10.1016/j.bmcl.2014.08.045; Messari SE, 2004, J NEUROCHEM, V90, P1290, DOI 10.1111/j.1471-4159.2004.02591.x; Mitra A, 2006, PHYSIOL BEHAV, V89, P221, DOI 10.1016/j.physbeh.2006.06.006; Murza A, 2015, J MED CHEM, V58, P2431, DOI 10.1021/jm501916k; Murza A, 2014, BIOPOLYMERS, V102, P297, DOI 10.1002/bip.22498; Murza A, 2012, CHEMMEDCHEM, V7, P318, DOI 10.1002/cmdc.201100492; O'Carroll AM, 2000, BBA-GENE STRUCT EXPR, V1492, P72, DOI 10.1016/S0167-4781(00)00072-5; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Reaux A, 2001, J NEUROCHEM, V77, P1085, DOI 10.1046/j.1471-4159.2001.00320.x; Reaux A, 2002, NEUROSCIENCE, V113, P653, DOI 10.1016/S0306-4522(02)00192-6; Reaux A, 1999, P NATL ACAD SCI USA, V96, P13415, DOI 10.1073/pnas.96.23.13415; Reaux-Le Goazigo A, 2004, ENDOCRINOLOGY, V145, P4392, DOI 10.1210/en.2004-0384; Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wang W, 2016, HYPERTENSION, V68, P365, DOI 10.1161/HYPERTENSIONAHA.115.06892; Wang W, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000249; Zhang YY, 2014, BIOORGAN MED CHEM, V22, P2992, DOI 10.1016/j.bmc.2014.04.001	49	34	37	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					687	700		10.1096/fj.201600784R	http://dx.doi.org/10.1096/fj.201600784R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27815337				2022-12-26	WOS:000394235400021
J	Cai, SB; Bodle, JC; Mathieu, PS; Amos, A; Hamouda, M; Bernacki, S; McCarty, G; Loboa, EG				Cai, Shaobo; Bodle, Josephine C.; Mathieu, Pattie S.; Amos, Alison; Hamouda, Mehdi; Bernacki, Susan; McCarty, Greg; Loboa, Elizabeth G.			Primary cilia are sensors of electrical field stimulation to induce osteogenesis of human adipose-derived stem cells	FASEB JOURNAL			English	Article						polycystin-1; intraflagellar protein-88; siRNA knockdown; signal transduction; calcium oscillations	MESENCHYMAL STROMAL CELLS; VERTEBRATE DEVELOPMENT; SIGNAL-TRANSDUCTION; OSTEOBLAST GROWTH; BONE-CELLS; CALCIUM; TISSUE; DIFFERENTIATION; POLYCYSTIN-1; REGENERATION	In this study, we report for the first time that the primary ciliumacts as a crucial sensor for electrical field stimulation (EFS)-enhanced osteogenic response in osteoprogenitor cells. In addition, primary cilia seem to functionally modulate effects of EFS-induced cellular calcium oscillations. Primary cilia are organelles that have recently been implicated to play a crucial sensor role for many mechanical and chemical stimuli on stem cells. Here, we investigate the role of primary cilia in EFS-enhanced osteogenic response of human adipose-derived stem cells (hASCs) by knocking down 2 primary cilia structural proteins, polycystin-1 and intraflagellar protein-88. Our results indicate that structurally integrated primary cilia are required for detection of electrical field signals in hASCs. Furthermore, by measuring changes of cytoplasmic calcium concentration in hASCs during EFS, our findings also suggest that primary cilia may potentially function as a crucial calcium-signaling nexus in hASCs during EFS.-Cai, S., Bodle, J. C., Mathieu, P. S., Amos, A., Hamouda, M., Bernacki, S., McCarty, G., Loboa, E. G. Primary cilia are sensors of electrical field stimulation to induce osteogenesis of human adipose-derived stem cells.	[Cai, Shaobo] North Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC USA; [Bodle, Josephine C.; Mathieu, Pattie S.; Amos, Alison; Hamouda, Mehdi; Bernacki, Susan; McCarty, Greg; Loboa, Elizabeth G.] North Carolina State Univ, Joint Dept Biomed Engn, Raleigh, NC USA; [Bodle, Josephine C.; Mathieu, Pattie S.; Amos, Alison; Hamouda, Mehdi; Bernacki, Susan; McCarty, Greg; Loboa, Elizabeth G.] Univ North Carolina Chapel Hill, Raleigh, NC USA; [Loboa, Elizabeth G.] Univ Missouri, Coll Engn, W1051 Thomas & Nell Laferre Hall, Columbia, MO 65211 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of Missouri System; University of Missouri Columbia	Loboa, EG (corresponding author), Univ Missouri, Coll Engn, W1051 Thomas & Nell Laferre Hall, Columbia, MO 65211 USA.	egloboa@missouri.edu	Cai, Shaobo/AAQ-4306-2020	Cai, Shaobo/0000-0003-0165-9846	U.S. National Science Foundation/Chemical, Bioengineering, Environmental, and Transport Systems Grant [1133427]; National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering Grant [1R03-EB008790]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB008790] Funding Source: NIH RePORTER; Directorate For Engineering [1133427] Funding Source: National Science Foundation	U.S. National Science Foundation/Chemical, Bioengineering, Environmental, and Transport Systems Grant; National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering Grant; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by U.S. National Science Foundation/Chemical, Bioengineering, Environmental, and Transport Systems Grant 1133427 and National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering Grant 1R03-EB008790.	Balint R, 2013, TISSUE ENG PART B-RE, V19, P48, DOI [10.1089/ten.teb.2012.0183, 10.1089/ten.TEB.2012.0183]; Banks TA, 2015, INTEGR BIOL-UK, V7, P693, DOI 10.1039/c4ib00297k; Basten Sander G, 2013, Cilia, V2, P2, DOI 10.1186/2046-2530-2-2; Bergh JJ, 2004, ENDOCRINOLOGY, V145, P426, DOI 10.1210/en.2003-0319; Bernacki SH, 2008, METHOD CELL BIOL, V86, P257, DOI 10.1016/S0091-679X(08)00011-3; Bijlsma MF, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002798; Bimonte S, 2011, DEV BIOL, V349, P179, DOI 10.1016/j.ydbio.2010.09.020; Bodle JC, 2014, TISSUE ENG PART C-ME, V20, P972, DOI [10.1089/ten.tec.2013.0683, 10.1089/ten.TEC.2013.0683]; Bodle JC, 2011, TISSUE ENG PART B-RE, V17, P195, DOI 10.1089/ten.teb.2010.0738; Bodle JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062554; Brighton CT, 2001, J BONE JOINT SURG AM, V83A, P1514, DOI 10.2106/00004623-200110000-00009; Brownell WE, 2010, BIOPHYS J, V99, P845, DOI 10.1016/j.bpj.2010.05.025; Delling M, 2013, NATURE, V504, P311, DOI 10.1038/nature12833; Delmas P, 2002, J BIOL CHEM, V277, P11276, DOI 10.1074/jbc.M110483200; Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66; Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI 10.1038/NNANO.2010.246; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Hart FX, 2010, BIOELECTROMAGNETICS, V31, P77, DOI 10.1002/bem.20525; Hierck BP, 2008, DEV DYNAM, V237, P725, DOI 10.1002/dvdy.21472; Hoerner C, 2013, CELL, V155, P271, DOI 10.1016/j.cell.2013.09.027; Hoey DA, 2011, BIOCHEM BIOPH RES CO, V412, P182, DOI 10.1016/j.bbrc.2011.07.072; Hronik-Tupaj M, 2012, TISSUE ENG PART B-RE, V18, P167, DOI [10.1089/ten.teb.2011.0244, 10.1089/ten.TEB.2011.0244]; Hu WW, 2014, MAT SCI ENG C-MATER, V37, P28, DOI 10.1016/j.msec.2013.12.019; Hwang SJ, 2012, TISSUE ENG PT A, V18, P432, DOI [10.1089/ten.tea.2010.0752, 10.1089/ten.TEA.2010.0752]; Jin XJ, 2014, CELL MOL LIFE SCI, V71, P2165, DOI 10.1007/s00018-013-1483-1; Khatib L, 2004, FASEB J, V18, P1903, DOI 10.1096/fj.04-1814fje; Kim IS, 2009, TISSUE ENG PT A, V15, P2411, DOI 10.1089/ten.tea.2008.0554; Kleene SJ, 2014, BIOSCIENCE, V64, P1092, DOI 10.1093/biosci/biu181; Lee Kristen L, 2015, Cilia, V4, P7, DOI 10.1186/s13630-015-0016-y; Li JKJ, 2006, ULTRASOUND MED BIOL, V32, P769, DOI 10.1016/j.ultrasmedbio.2006.01.017; Lim JH, 2013, CELL REPROGRAM, V15, P405, DOI 10.1089/cell.2013.0001; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; McCullen SD, 2010, TISSUE ENG PART C-ME, V16, P1377, DOI [10.1089/ten.tec.2009.0751, 10.1089/ten.TEC.2009.0751]; McGlashan SR, 2010, CELL BIOL INT, V34, P441, DOI 10.1042/CBI20090094; Moore NM, 2011, ACTA BIOMATER, V7, P2091, DOI 10.1016/j.actbio.2011.01.019; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nguyen AM, 2013, BONE, V54, P196, DOI 10.1016/j.bone.2012.11.016; Ozkucur N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006131; Oh EC, 2012, DEVELOPMENT, V139, P443, DOI 10.1242/dev.050054; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Riehl BD, 2012, TISSUE ENG PART B-RE, V18, P288, DOI [10.1089/ten.teb.2011.0465, 10.1089/ten.TEB.2011.0465]; Saadoun S, 2011, J NEUROL NEUROSUR PS, V82, DOI 10.1136/jnnp.2010.232371; Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045; Sun S, 2007, FASEB J, V21, P1472, DOI 10.1096/fj.06-7153com; Temiyasathit S, 2010, ANN NY ACAD SCI, V1192, P422, DOI 10.1111/j.1749-6632.2009.05243.x; Tummala P, 2010, CELL MOL BIOENG, V3, P207, DOI 10.1007/s12195-010-0127-x; Wann AKT, 2012, CELL MOL LIFE SCI, V69, P2967, DOI 10.1007/s00018-012-0980-y; Xiao ZS, 2010, ANN NY ACAD SCI, V1192, P410, DOI 10.1111/j.1749-6632.2009.05239.x; Xu J, 2009, OSTEOARTHR CARTILAGE, V17, P397, DOI 10.1016/j.joca.2008.07.001; Yan JL, 2015, MOL CELL ENDOCRINOL, V404, P132, DOI 10.1016/j.mce.2015.01.031; Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675; Zhang JY, 2016, ACTA BIOMATER, V32, P46, DOI 10.1016/j.actbio.2015.12.024; Zhang JY, 2013, BIOTECHNOL BIOENG, V110, P1466, DOI 10.1002/bit.24796; Zhou J, 2009, ANNU REV PHYSIOL, V71, P83, DOI 10.1146/annurev.physiol.70.113006.100621	54	15	15	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					346	355		10.1096/fj.201600560R	http://dx.doi.org/10.1096/fj.201600560R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27825103	Green Published			2022-12-26	WOS:000392177600032
J	Imamura, M; Tabeta, N; Kato, N; Matsuura, Y; Iwamaru, Y; Yokoyama, T; Murayama, Y				Imamura, Morikazu; Tabeta, Naoko; Kato, Nobuko; Matsuura, Yuichi; Iwamaru, Yoshifumi; Yokoyama, Takashi; Murayama, Yuichi			Heparan Sulfate and Heparin Promote Faithful Prion Replication in Vitro by Binding to Normal and Abnormal Prion Proteins in Protein Misfolding Cyclic Amplification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; PRESYMPTOMATIC DETECTION; CHONDROITIN SULFATE; ALZHEIMERS-DISEASE; CULTURED-CELLS; SCRAPIE; AGGREGATION; BRAIN; PRPSC; GLYCOSAMINOGLYCAN	The precise mechanism underlying the conversion of normal prion protein (PrPC) into abnormal prion protein (PrPSc) remains unclear. Protein misfolding cyclic amplification (PMCA), an in vitro technique used for amplifying PrPSc, results in PrPSc replication that preserves the strain-specific characteristics of the input PrPSc; thus, PMCA mimics the process of in vivo PrPSc replication. Previous work has demonstrated that in PMCA, nucleic acids are critical for PrPSc amplification, but little information has been reported on glycosaminoglycan (GAG) participation in PrPSc replication in vitro. Here, we investigated whether GAGs play a role in the faithful replication of PrPSc by using a modified PMCA performed with baculovirus-derived recombinant PrP (Bac-PrP) as a substrate. The addition of heparan sulfate (HS) or its analog heparin (HP) restored the conversion efficiency in PMCA that was inhibited through nucleic acid depletion. Moreover, the PMCA products obtained under these conditions were infectious and preserved the properties of the input PrPSc. These data suggest that HS and HP play the same role as nucleic acids in facilitating faithful replication of prions in PMCA. Furthermore, we showed that HP binds to both Bac-PrP and Bac-PrPSc through the sulfated groups present on HP and that the N-terminal domain of Bac-PrPSc might potentially not be involved in the binding to HP. These results suggest that the interaction of GAGs such as HS and HP with PrPC and/or PrPSc through their sulfate groups is critical for the faithful replication of prions.	[Imamura, Morikazu; Tabeta, Naoko; Kato, Nobuko; Matsuura, Yuichi; Iwamaru, Yoshifumi; Yokoyama, Takashi; Murayama, Yuichi] Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Tsukuba, Ibaraki 3050856, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Imamura, M (corresponding author), Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Tsukuba, Ibaraki 3050856, Japan.	imamuram@affrc.go.jp	Matsuura, Yuichi/AAF-3170-2021	Matsuura, Yuichi/0000-0003-3383-7918	JSPS [25460575]; BSE Control Project of the Ministry of Agriculture, Forestry, and Fisheries of Japan	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); BSE Control Project of the Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This study was supported by JSPS KAKENHI Grant 25460575 and a grant-in-aid from the BSE Control Project of the Ministry of Agriculture, Forestry, and Fisheries of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Abid K, 2010, FEBS LETT, V584, P2409, DOI 10.1016/j.febslet.2010.04.040; Aono S, 2006, ADV PHARMACOL, V53, P323, DOI 10.1016/S1054-3589(05)53015-1; Avram S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/642798; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; CAUGHEY B, 1994, J VIROL, V68, P2135, DOI 10.1128/JVI.68.4.2135-2141.1994; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; DebBurman SK, 1997, P NATL ACAD SCI USA, V94, P13938, DOI 10.1073/pnas.94.25.13938; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Deleault NR, 2010, BIOCHEMISTRY-US, V49, P3928, DOI 10.1021/bi100370b; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Ellett LJ, 2015, GLYCOBIOLOGY, V25, P745, DOI 10.1093/glycob/cwv014; GABIZON R, 1993, J CELL PHYSIOL, V157, P319, DOI 10.1002/jcp.1041570215; Imamura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082538; Kazlauskaite J, 2003, BIOCHEMISTRY-US, V42, P3295, DOI 10.1021/bi026872q; Klajnert B, 2006, BIOCHEM BIOPH RES CO, V339, P577, DOI 10.1016/j.bbrc.2005.11.053; Kwok JCF, 2012, INT J BIOCHEM CELL B, V44, P582, DOI 10.1016/j.biocel.2012.01.004; Lawson VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012351; Leucht C, 2003, EMBO REP, V4, P290, DOI 10.1038/sj.embor.embor768; Ma JY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002589; Maeda N, 2011, NEUROCHEM RES, V36, P1228, DOI 10.1007/s11064-010-0324-y; Mayer-Sonnenfeld T, 2005, NEUROBIOL DIS, V20, P738, DOI 10.1016/j.nbd.2005.05.009; Mays CE, 2010, FASEB J, V24, P5102, DOI 10.1096/fj.10-163600; Murayama Y, 2016, BIOCHEM BIOPH RES CO, V470, P563, DOI 10.1016/j.bbrc.2016.01.105; Murayama Y, 2007, J GEN VIROL, V88, P2890, DOI 10.1099/vir.0.82786-0; PERLMUTTER LS, 1991, J NEUROSCI RES, V30, P673, DOI 10.1002/jnr.490300411; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Saa P, 2012, J VIROL, V86, P10494, DOI 10.1128/JVI.01286-12; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; SNOW AD, 1994, AM J PATHOL, V144, P337; SNOW AD, 1990, LAB INVEST, V63, P601; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Yokoyama T, 2011, NEUROSCI LETT, V498, P119, DOI 10.1016/j.neulet.2011.04.072	40	19	19	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26478	26486		10.1074/jbc.M116.745851	http://dx.doi.org/10.1074/jbc.M116.745851			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27821590	Green Published, hybrid			2022-12-26	WOS:000391568200021
J	El-Battrawy, I; Lang, S; Zhao, Z; Akin, I; Yucel, G; Meister, S; Patocskai, B; Behnes, M; Rudic, B; Tulumen, E; Liebe, V; Tiburcy, M; Dworacek, J; Zimmermann, WH; Utikal, J; Wieland, T; Borggrefe, M; Zhou, XB				El-Battrawy, Ibrahim; Lang, Siegfried; Zhao, Zhihan; Akin, Ibrahim; Yuecel, Goekhan; Meister, Sophie; Patocskai, Bence; Behnes, Michael; Rudic, Boris; Tueluemen, Erol; Liebe, Volker; Tiburcy, Malte; Dworacek, Jennifer; Zimmermann, Wolfram-Hubertus; Utikal, Jochen; Wieland, Thomas; Borggrefe, Martin; Zhou, Xiao-Bo			Hyperthermia Influences the Effects of Sodium Channel Blocking Drugs in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes	PLOS ONE			English	Article							BRUGADA-SYNDROME; MOLECULAR CHARACTERIZATION; ATRIAL-FIBRILLATION; LIDOCAINE; CURRENTS; FEVER; TEMPERATURE; RANOLAZINE; MUTATION; DEPENDENCE	Introduction Fever can increase the susceptibility to supraventricular and ventricular arrhythmias, in which sodium channel dysfunction has been implicated. Whether fever influences the efficacy of sodium channel blocking drugs is unknown. The current study was designed to investigate the temperature dependent effects of distinct sodium channel blocking drugs on the sodium currents in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). Methods and Results hiPSC-CMs were generated from human skin fibroblasts of a healthy donor. The peak and late sodium currents (I-Na), steady-state activation, inactivation and recovery from inactivation of INa in hiPSC-CMs were analyzed using the whole-cell patch clamp technique. The effects of different concentrations of the antiarrhythmic drugs flecainide, lidocaine, ajmaline and the antianginal drug ranolazine on INa were tested at 36 degrees C and 40 degrees C. Increasing the temperature of the bath solution from 36 degrees C to 40 degrees C enhanced the inhibition of peak INa but reduced the inhibition of late INa by flecainide and lidocaine. By contrast, increasing the temperature reduced the effect of ajmaline and ranolazine on the peak INa but not late INa. None of the tested drugs showed temperature-dependent effects on the steady-state activation and inactivation as well as on the recovery from inactivation of INa in hiPSC-CMs. Conclusions Temperature variation from the physiological to the febrile range apparently influences the effects of sodium channel blockers on the sodium currents. This may influence their antiarrhythmic efficacy in patients suffering from fever.	[El-Battrawy, Ibrahim; Lang, Siegfried; Zhao, Zhihan; Akin, Ibrahim; Yuecel, Goekhan; Meister, Sophie; Patocskai, Bence; Behnes, Michael; Rudic, Boris; Tueluemen, Erol; Liebe, Volker; Borggrefe, Martin; Zhou, Xiao-Bo] Heidelberg Univ, Med Fac Mannheim, Dept Med 1, Mannheim, Germany; [El-Battrawy, Ibrahim; Lang, Siegfried; Akin, Ibrahim; Yuecel, Goekhan; Patocskai, Bence; Behnes, Michael; Rudic, Boris; Tueluemen, Erol; Tiburcy, Malte; Dworacek, Jennifer; Zimmermann, Wolfram-Hubertus; Utikal, Jochen; Wieland, Thomas; Borggrefe, Martin; Zhou, Xiao-Bo] DZHK German Ctr Cardiovasc Res, Heidelberg, Germany; [El-Battrawy, Ibrahim; Lang, Siegfried; Akin, Ibrahim; Yuecel, Goekhan; Patocskai, Bence; Behnes, Michael; Rudic, Boris; Tueluemen, Erol; Tiburcy, Malte; Dworacek, Jennifer; Zimmermann, Wolfram-Hubertus; Utikal, Jochen; Wieland, Thomas; Borggrefe, Martin; Zhou, Xiao-Bo] DZHK German Ctr Cardiovasc Res, Gottingen, Germany; [Tiburcy, Malte; Zimmermann, Wolfram-Hubertus] Univ Gottingen, Inst Pharmacol & Toxicol, Gottingen, Germany; [Dworacek, Jennifer; Utikal, Jochen] German Canc Res Ctr, Skin Canc Unit, Heidelberg, Germany; [Dworacek, Jennifer; Utikal, Jochen] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol Venereol & Allergol, Mannheim, Germany; [Wieland, Thomas] Heidelberg Univ, Med Fac Mannheim, Inst Expt & Clin Pharmacol & Toxicol, Mannheim, Germany; [Zhou, Xiao-Bo] Southwest Med Univ, Inst Cardiovasc Res, Luzhou, Sichuan, Peoples R China	Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research; German Centre for Cardiovascular Research; University of Gottingen; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Southwest Medical University	El-Battrawy, I; Zhou, XB (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Med 1, Mannheim, Germany.; El-Battrawy, I; Zhou, XB (corresponding author), DZHK German Ctr Cardiovasc Res, Heidelberg, Germany.; El-Battrawy, I; Zhou, XB (corresponding author), DZHK German Ctr Cardiovasc Res, Gottingen, Germany.; Zhou, XB (corresponding author), Southwest Med Univ, Inst Cardiovasc Res, Luzhou, Sichuan, Peoples R China.	lbrahim.El-Battrawy@medma.uni-heidelberg.de; Xiaoba.zhou@medma.uni-heidelberg.de	Tulumen, Erol/AAI-2331-2019; Zimmermann, Wolfram-Hubertus H/I-6838-2012; Rudic, Boris/AAG-9404-2020; Akin, Ibrahim/AAF-1356-2020; Wieland, Thomas/Q-1506-2019; Zhou, Xiaobo/AAH-4320-2019; Yücel, Gökhan/GZL-1223-2022; Wieland, Thomas/G-1772-2012; Rudic, Boris/X-6703-2019	Zimmermann, Wolfram-Hubertus H/0000-0003-1190-4040; Wieland, Thomas/0000-0001-8262-8261; Wieland, Thomas/0000-0001-8262-8261; Rudic, Boris/0000-0002-2275-7149; Utikal, Jochen/0000-0001-5316-0241; Yucel, Gokhan/0000-0002-1803-2663; El-Battrawy, Ibrahim/0000-0002-0139-1045	DZHK (German Center for Cardiovascular Research); BMBF (German Ministry of Education and Research)	DZHK (German Center for Cardiovascular Research); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF))	This study was supported by the DZHK (German Center for Cardiovascular Research), the BMBF (German Ministry of Education and Research) (grants to MB, JU, TW and WZ).	Amin AS, 2005, ACTA PHYSIOL SCAND, V185, P291, DOI 10.1111/j.1365-201X.2005.01496.x; Antzelevitch C, 2002, PACE, V25, P1537, DOI 10.1046/j.1460-9592.2002.01537.x; Barajas-Martinez HM, 2008, CIRC RES, V103, P396, DOI 10.1161/CIRCRESAHA.108.172619; Bebarova M, 2005, GEN PHYSIOL BIOPHYS, V24, P311; Benito B, 2008, PROG CARDIOVASC DIS, V51, P1, DOI 10.1016/j.pcad.2008.05.002; Berne P, 2012, CIRC J, V76, P1563, DOI 10.1253/circj.CJ-12-0717; Brugada R, 2000, CIRCULATION, V101, P510, DOI 10.1161/01.CIR.101.5.510; Burrell Christopher, 2007, J Infect, V54, pe13, DOI 10.1016/j.jinf.2006.03.020; Chaitman BR, 2006, CIRCULATION, V113, P2462, DOI 10.1161/CIRCULATIONAHA.105.597500; Dumaine R, 1999, CIRC RES, V85, P803, DOI 10.1161/01.RES.85.9.803; Fuster V, 2006, EUROPACE, V8, P651, DOI 10.1093/europace/eul097; Germanguz I, 2011, J CELL MOL MED, V15, P38, DOI 10.1111/j.1582-4934.2009.00996.x; Hoekstra M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00346; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; JOHNS JA, 1989, J CARDIOVASC PHARM, V13, P826, DOI 10.1097/00005344-198906000-00004; Kane C, 2016, BIOPHYS J, V110, P281, DOI 10.1016/j.bpj.2015.08.052; Keller DI, 2005, CARDIOVASC RES, V67, P510, DOI 10.1016/j.cardiores.2005.03.024; Larribere L, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12369; LEE HC, 1993, J CLIN INVEST, V91, P693, DOI 10.1172/JCI116250; Ma JY, 2011, AM J PHYSIOL-HEART C, V301, pH2006, DOI 10.1152/ajpheart.00694.2011; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; MAKIELSKI JC, 1991, AM J PHYSIOL, V260, pH681, DOI 10.1152/ajpheart.1991.260.3.H681; MANZ M, 1988, DEUT MED WOCHENSCHR, V113, P1317, DOI 10.1055/s-2008-1067813; Matsa E, 2011, EUR HEART J, V32, P952, DOI 10.1093/eurheartj/ehr073; Mok NS, 2003, J CARDIOVASC ELECTR, V14, P407, DOI 10.1046/j.1540-8167.2003.02379.x; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Morita H, 2002, J CARDIOVASC ELECTR, V13, P816, DOI 10.1046/j.1540-8167.2002.00816.x; Novak A, 2012, J CELL MOL MED, V16, P468, DOI 10.1111/j.1582-4934.2011.01476.x; Pasquie JL, 2004, J CARDIOVASC ELECTR, V15, P1271, DOI 10.1046/j.1540-8167.2004.04388.x; Polytarchou Kali, 2015, Cardiovascular & Hematological Agents in Medicinal Chemistry, V13, P31; Porres JM, 2002, PACE, V25, P1646, DOI 10.1046/j.1460-9592.2002.01646.x; Saura D, 2002, PACE, V25, P856, DOI 10.1046/j.1460-9592.2002.t01-1-00856.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shimizu W, 2000, J CARDIOVASC ELECTR, V11, P1320, DOI 10.1046/j.1540-8167.2000.01320.x; Sossalla S, 2010, J AM COLL CARDIOL, V55, P2330, DOI 10.1016/j.jacc.2009.12.055; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tiburcy M, 2014, TRENDS CARDIOVAS MED, V24, P7, DOI 10.1016/j.tcm.2013.05.003; WANG ZG, 1995, J PHARMACOL EXP THER, V272, P184; WELLENS HJJ, 1980, AM J CARDIOL, V45, P130, DOI 10.1016/0002-9149(80)90230-1; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	43	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166143	10.1371/journal.pone.0166143	http://dx.doi.org/10.1371/journal.pone.0166143			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829006	Green Published, gold, Green Submitted			2022-12-26	WOS:000387724300089
J	Gupta, J; Misra, S; Misra-Bhattacharya, S				Gupta, Jyoti; Misra, Sweta; Misra-Bhattacharya, Shailja			Immunization with Brugia malayi Myosin as Heterologous DNA Prime Protein Boost Induces Protective Immunity against B-malayi Infection in Mastomys coucha	PLOS ONE			English	Article							LYMPHATIC FILARIASIS; MULTIVALENT VACCINE; ANTIGEN-B; RESPONSES; CHALLENGE; LARVAE; PARAMYOSIN; CANDIDATE; GENE; TROPOMYOSIN	The current control strategies employing chemotherapy with diethylcarbamazine, ivermectin and albendazole have reduced transmission in some filaria-endemic areas, there is growing interest for complementary approaches, such as vaccines especially in light of threat of parasite developing resistance to mainstay drugs. We earlier demonstrated recombinant heavy chain myosin of B. malayi (Bm-Myo) as a potent vaccine candidate whose efficacy was enhanced by heterologous DNA prime/protein boost (Myo-pcD+Bm-Myo) vaccination in BALB/c mice. BALB/c mouse though does not support the full developmental cycle of B. malayi, however, the degree of protection may be studied in terms of transformation of challenged infective larvae (L3) to next stage (L4) with an ease of delineating the generated immunological response of host. In the current investigation, DNA vaccination with Bm-Myo was therefore undertaken in susceptible rodent host, Mastomys coucha (M. coucha) which sustains the challenged L3 and facilitates their further development to sexually mature adult parasites with patent microfilaraemia. Immunization schedule consisted of Myo-pcD and Myo-pcD+Bm-Myo followed by B. malayi L3 challenge and the degree of protection was evaluated by observing microfilaraemia as well as adult worm establishment. Myo-pcD+Bm-Myo immunized animals not only developed 78.5% reduced blood microfilarial density but also decreased adult worm establishment by 75.3%. In addition, 75.4% of the recovered live females revealed sterilization over those of respective control animals. Myo-pcD+BmMyo triggered higher production of specific IgG and its isotypes which induced marked cellular adhesion and cytotoxicity (ADCC) to microfilariae (mf) and L3 in vitro. Both Th1 and Th2 cytokines were significantly up-regulated displaying a mixed immune response conferring considerable protection against B. malayi establishment by engendering a long-lasting effective immune response and therefore emerges as a potential vaccination method against LF.	[Gupta, Jyoti; Misra, Sweta; Misra-Bhattacharya, Shailja] Cent Drug Res Inst, CSIR, Div Parasitol, BS 10-1,Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India; [Gupta, Jyoti; Misra, Sweta; Misra-Bhattacharya, Shailja] Acad Sci & Innovat Res, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Academy of Scientific & Innovative Research (AcSIR)	Misra-Bhattacharya, S (corresponding author), Cent Drug Res Inst, CSIR, Div Parasitol, BS 10-1,Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India.; Misra-Bhattacharya, S (corresponding author), Acad Sci & Innovat Res, New Delhi, India.	shailja_bhattacharya@cdri.res.in			Council of Scientific and Industrial Research (CSIR), New Delhi; CSIR-Network project SPIenDID	Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India); CSIR-Network project SPIenDID	The financial support was received in the form of research fellowship from Council of Scientific and Industrial Research (CSIR), New Delhi, to JG, SM. Authors also wish to acknowledge funding support provided to SMB via the CSIR-Network project SPIenDID. The funders have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alekseeva Ekaterina, 2009, Genet Vaccines Ther, V7, P7, DOI 10.1186/1479-0556-7-7; Arumugam S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-43; Babayan SA, 2006, INT J PARASITOL, V36, P903, DOI 10.1016/j.ijpara.2006.04.013; Babu S, 2006, J IMMUNOL, V176, P3248, DOI 10.4049/jimmunol.176.5.3248; Babu S, 2014, PARASITE IMMUNOL, V36, P338, DOI 10.1111/pim.12081; Bergquist NR, 1998, PARASITOL TODAY, V14, P99, DOI 10.1016/S0169-4758(97)01207-6; Cassataro J, 2007, CLIN VACCINE IMMUNOL, V14, P869, DOI 10.1128/CVI.00472-06; Catmull J, 1999, VACCINE, V17, P31, DOI 10.1016/S0264-410X(98)00147-9; CHANDRASHEKAR R, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P15; CHANDRASHEKAR R, 1985, PARASITE IMMUNOL, V7, P633, DOI 10.1111/j.1365-3024.1985.tb00107.x; Dakshinamoorthy G, 2013, VACCINE, V32, P19, DOI 10.1016/j.vaccine.2013.10.083; Dakshinamoorthy G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034077; Diefenbach A, 1998, IMMUNITY, V8, P77, DOI 10.1016/S1074-7613(00)80460-4; Dimock KA, 1996, INFECT IMMUN, V64, P2962, DOI 10.1128/IAI.64.8.2962-2967.1996; Dunachie SJ, 2003, J EXP BIOL, V206, P3771, DOI 10.1242/jeb.00642; ELSON LH, 1995, J INFECT DIS, V171, P652, DOI 10.1093/infdis/171.3.652; FINKELMAN FD, 1988, J IMMUNOL, V140, P1022; Fonseca Cristina Toscano, 2012, J Parasitol Res, V2012, P541268, DOI 10.1155/2012/541268; Gobert GN, 1998, PARASITOL TODAY, V14, P115, DOI 10.1016/S0169-4758(97)01205-2; Gregory WF, 2000, INFECT IMMUN, V68, P4174, DOI 10.1128/IAI.68.7.4174-4179.2000; Gupta J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142548; Harrison RA, 1999, VACCINE, V18, P647, DOI 10.1016/S0264-410X(99)00274-1; Harrison RA, 2000, PARASITE IMMUNOL, V22, P249, DOI 10.1046/j.1365-3024.2000.00304.x; Jenkins RE, 1998, P NATL ACAD SCI USA, V95, P7550, DOI 10.1073/pnas.95.13.7550; Kalyanasundaram R, 2011, RES REP TROP MED, V2, P45, DOI 10.2147/RRTM.S13679; Kushwaha S, 2012, PARASITE IMMUNOL, V34, P199, DOI 10.1111/j.1365-3024.2012.01352.x; Kushwaha S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072585; Kushwaha S, 2012, MICROBES INFECT, V14, P1330, DOI 10.1016/j.micinf.2012.08.006; LACLETTE JP, 1987, J PARASITOL, V73, P121, DOI 10.2307/3282356; LACLETTE JP, 1991, MOL BIOCHEM PARASIT, V44, P287, DOI 10.1016/0166-6851(91)90015-X; Li BW, 1999, VACCINE, V18, P76, DOI 10.1016/S0264-410X(99)00182-6; Liang R, 2005, VACCINE, V23, P5252, DOI 10.1016/j.vaccine.2005.06.025; Linehan LA, 1998, J IMMUNOL, V161, P302; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loukas A, 2001, INFECT IMMUN, V69, P3646, DOI 10.1128/IAI.69.6.3646-3651.2001; Marcilla A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045974; Martin JE, 2006, CLIN VACCINE IMMUNOL, V13, P1267, DOI 10.1128/CVI.00162-06; Nag JK, 2013, COMP IMMUNOL MICROB, V36, P25, DOI 10.1016/j.cimid.2012.09.004; Ramachandran S, 2004, MICROBIOL IMMUNOL, V48, P945, DOI 10.1111/j.1348-0421.2004.tb03624.x; Ramshaw IA, 2000, IMMUNOL TODAY, V21, P163, DOI 10.1016/S0167-5699(00)01612-1; Saeftel M, 2003, INFECT IMMUN, V71, P6978, DOI 10.1128/IAI.71.12.6978-6985.2003; Shakya S, 2009, PARASITOL INT, V58, P346, DOI 10.1016/j.parint.2009.07.007; Shrivastava N, 2013, COMP IMMUNOL MICROB, V36, P507, DOI 10.1016/j.cimid.2013.05.003; SIM BKL, 1982, T ROY SOC TROP MED H, V76, P362, DOI 10.1016/0035-9203(82)90191-2; Singh M, 2012, J BIOTECHNOL, V157, P351, DOI 10.1016/j.jbiotec.2011.12.003; Singh PK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/590281; Specht S, 2004, INFECT IMMUN, V72, P6287, DOI 10.1128/IAI.72.11.6287-6293.2004; TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0; Taylor MJ, 1996, PARASITE IMMUNOL, V18, P219, DOI 10.1046/j.1365-3024.1996.d01-93.x; Thirugnanam S, 2007, EXP PARASITOL, V116, P483, DOI 10.1016/j.exppara.2007.02.017; Vaine M, 2010, VACCINE, V28, P2999, DOI 10.1016/j.vaccine.2010.02.006; Vanam U, 2009, AM J TROP MED HYG, V80, P319, DOI 10.4269/ajtmh.2009.80.319; Vedi S, 2008, VACCINE, V26, P5997, DOI 10.1016/j.vaccine.2008.08.073; Veerapathran A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000457	54	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0164991	10.1371/journal.pone.0164991	http://dx.doi.org/10.1371/journal.pone.0164991			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828973	Green Published, Green Submitted, gold			2022-12-26	WOS:000387724300024
J	Landsheer, JA				Landsheer, Johannes A.			Interval of Uncertainty: An Alternative Approach for the Determination of Decision Thresholds, with an Illustrative Application for the Prediction of Prostate Cancer	PLOS ONE			English	Article							LOGISTIC-REGRESSION; DIAGNOSTIC-TESTS; MODELS; ZONE	Often, for medical decisions based on test scores, a single decision threshold is determined and the test results are dichotomized into positive and negative diagnoses. It is therefore important to identify the decision threshold with the least number of misclassifications. The proposed method uses trichotomization: it defines an Uncertain Interval around the point of intersection between the two distributions of individuals with and without the targeted disease. In this Uncertain Interval the diagnoses are intermixed and the numbers of correct and incorrect diagnoses are (almost) equal. This Uncertain Interval is considered to be a range of test scores that is inconclusive and does not warrant a decision. It is expected that defining such an interval with some precision, prevents a relatively large number of false decisions, and therefore results in an increased accuracy or correct classifications rate (CCR) for the test scores outside this Uncertain Interval. Clinical data and simulation results confirm this. The results show that the CCR is systematically higher outside the Uncertain Interval when compared to the CCR of the decision threshold based on the maximized You den index. For strong tests with a very small overlap between the two distributions, it can be difficult to determine an Uncertain Interval. In simulations, the comparison with an existing method for test-score trichotomization, the Two-graph Receiver Operating Characteristic (TG-ROC), showed smaller differences between the two distributions for the Uncertain Interval than for TG-ROC's Intermediate Range and consequently a more improved CCR outside the Uncertain Interval. The main conclusion is that the Uncertain Interval method offers two advantages: 1. Identification of patients for whom the test results are inconclusive; 2. A higher estimated rate of correct decisions for the remaining patients.	[Landsheer, Johannes A.] Univ Utrecht, Dept Methodol & Stat, Utrecht, Netherlands	Utrecht University	Landsheer, JA (corresponding author), Univ Utrecht, Dept Methodol & Stat, Utrecht, Netherlands.	j.a.landsheer@uu.nl		Landsheer, Hans/0000-0001-5117-7031	University of Utrecht	University of Utrecht	All costs were covered by the author's employer, the University of Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayer T, 2010, RADIOGRAPHICS, V30, P13, DOI 10.1148/rg.301095057; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Brasil P, 2010, DIAGNOSISMED DIAGNOS; Briggs WM, 2008, BIOMETRICS, V64, P250, DOI 10.1111/j.1541-0420.2007.00781_1.x; Cammann H, 2011, CLIN CHEM, V57, P1490, DOI 10.1373/clinchem.2011.166959; Coste J, 2003, INT J EPIDEMIOL, V32, P304, DOI 10.1093/ije/dyg054; Coste J, 2006, CLIN CHEM, V52, P2229, DOI 10.1373/clinchem.2006.072280; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P109, DOI 10.1016/0895-4356(90)90064-V; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; FREI H, 1988, MUTAT RES, V203, P297, DOI 10.1016/0165-1161(88)90019-2; Goncalves L, 2014, REVSTAT-STAT J, V12, P1; Greiner M, 1996, J IMMUNOL METHODS, V191, P93, DOI 10.1016/0022-1759(96)00013-0; GREINER M, 1995, J IMMUNOL METHODS, V185, P145, DOI 10.1016/0022-1759(95)00078-O; GREINER M, 1995, J IMMUNOL METHODS, V185, P123, DOI 10.1016/0022-1759(95)00121-P; HANLEY JA, 1988, MED DECIS MAKING, V8, P197, DOI 10.1177/0272989X8800800308; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Lopez-Raton M, 2014, J STAT SOFTW, V61, P1; R Development Core Team, 2014, R LANG ENV STAT COMP; Shinkins B, 2013, BRIT J GEN PRACT, V63, P122, DOI 10.3399/bjgp13X664090; Simundic AM, 2008, MED BIOL SCI, V22, P61; SOMOZA E, 1994, MED DECIS MAKING, V14, P157, DOI 10.1177/0272989X9401400208; Tjur T, 2009, AM STAT, V63, P366, DOI 10.1198/tast.2009.08210; Tyagi A, 2015, INT J MED RES HEALTH, V4, P208, DOI 10.5958/2319-5886.2015.00034.X; Woolever Donald R, 2008, Fam Pract Manag, V15, P31	25	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166007	10.1371/journal.pone.0166007	http://dx.doi.org/10.1371/journal.pone.0166007			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829010	Green Published, gold, Green Submitted			2022-12-26	WOS:000387724300074
J	Liu, W; Zhu, W; Liao, B; Chen, XT				Liu, Wei; Zhu, Wen; Liao, Bo; Chen, Xiangtao			Gene Regulatory Network Inferences Using a Maximum-Relevance and Maximum-Significance Strategy	PLOS ONE			English	Article							BAYESIAN NETWORK; BOOLEAN NETWORKS; EXPRESSION DATA; ALGORITHM; TOPOLOGY; MODEL	Recovering gene regulatory networks from expression data is a challenging problem in systems biology that provides valuable information on the regulatory mechanisms of cells. A number of algorithms based on computational models are currently used to recover network topology. However, most of these algorithms have limitations. For example, many models tend to be complicated because of the "large p, small n" problem. In this paper, we propose a novel regulatory network inference method called the maximum-relevance and maximum-significance network (MRMSn) method, which converts the problem of recovering networks into a problem of how to select the regulator genes for each gene. To solve the latter problem, we present an algorithm that is based on information theory and selects the regulator genes for a specific gene by maximizing the relevance and significance. A first-order incremental search algorithm is used to search for regulator genes. Eventually, a strict constraint is adopted to adjust all of the regulatory relationships according to the obtained regulator genes and thus obtain the complete network structure. We performed our method on five different datasets and compared our method to five state-of-the-art methods for network inference based on information theory. The results confirm the effectiveness of our method.	[Liu, Wei; Zhu, Wen; Liao, Bo; Chen, Xiangtao] Hunan Univ, Coll Informat Sci & Engn, Changsha 410082, Hunan, Peoples R China	Hunan University	Liao, B (corresponding author), Hunan Univ, Coll Informat Sci & Engn, Changsha 410082, Hunan, Peoples R China.	dragonbw@163.com		chen, xiangtao/0000-0002-5102-1472	National Nature Science Foundation of China [11171369, 61272395, 61370171, 61300128, 61472127, 61572178]; National Nature Science Foundation of Hunan Province [12JJ2041]; Planned Science and Technology Project of Hunan Province [2014FJ3079]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nature Science Foundation of Hunan Province; Planned Science and Technology Project of Hunan Province	This study is supported by the National Nature Science Foundation of China (Grant Nos. 11171369, 61272395, 61370171, 61300128, 61472127 and 61572178), National Nature Science Foundation of Hunan Province (Grant No. 12JJ2041) and the Planned Science and Technology Project of Hunan Province (Grant Nos. 2014FJ3079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acid S, 2004, ARTIF INTELL MED, V30, P215, DOI 10.1016/j.artmed.2003.11.002; Aijo T, 2009, BIOINFORMATICS, V25, P2937, DOI 10.1093/bioinformatics/btp511; Banga JR, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-47; Bashan A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1705; Butte A J, 2000, Pac Symp Biocomput, P418; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; Chen CC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S19; Chen XW, 2008, IEEE T KNOWL DATA EN, V20, P628, DOI 10.1109/TKDE.2007.190732; De Campos LM, 1998, J EXP THEOR ARTIF IN, V10, P511, DOI 10.1080/095281398146743; de Campos LM, 2000, INT J APPROX REASON, V24, P11, DOI 10.1016/S0888-613X(99)00042-0; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman N, 1998, NATO ADV SCI I D-BEH, V89, P421; Gardner TS, 2005, PHYS LIFE REV, V2, P65, DOI 10.1016/j.plrev.2005.01.001; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Iba H, 2002, INFORM SCIENCES, V145, P225, DOI 10.1016/S0020-0255(02)00234-7; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; KAUFFMAN S, 1974, J THEOR BIOL, V44, P167, DOI 10.1016/S0022-5193(74)80037-8; Keedwell E, 2005, IEEE ACM T COMPUT BI, V2, P231, DOI 10.1109/TCBB.2005.40; Lee WP, 2009, BRIEF BIOINFORM, V10, P408, DOI 10.1093/bib/bbp028; Longabaugh WJR, 2005, DEV BIOL, V283, P1, DOI 10.1016/j.ydbio.2005.04.023; Luo WJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-467; Maetschke SR, 2014, BRIEF BIOINFORM, V15, P195, DOI 10.1093/bib/bbt034; Maji P, 2011, INT J APPROX REASON, V52, P408, DOI 10.1016/j.ijar.2010.09.006; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; Meyer P, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-13; Meyer PE, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/79879; Ocone A, 2013, BIOINFORMATICS, V29, P910, DOI 10.1093/bioinformatics/btt069; Pal R, 2005, BIOINFORMATICS, V21, P4021, DOI 10.1093/bioinformatics/bti664; Ronen M, 2002, P NATL ACAD SCI USA, V99, P10555, DOI 10.1073/pnas.152046799; Samoilov M., 1997, THESIS; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Steck H., 2012, ARXIV12063287; Vasic B, 2012, IEEE ACM T COMPUT BI, V9, P52, DOI 10.1109/TCBB.2011.61; Villaverde AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096732; Villaverde Alejandro F, 2013, Cells, V2, P306, DOI 10.3390/cells2020306; Wai Lam, 1994, Computational Intelligence, V10, P269, DOI 10.1111/j.1467-8640.1994.tb00166.x; Wang Y, 2006, BIOINFORMATICS, V22, P2413, DOI 10.1093/bioinformatics/btl396; Watanabe Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S12; Zhang XJ, 2012, BIOINFORMATICS, V28, P98, DOI 10.1093/bioinformatics/btr626	42	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166115	10.1371/journal.pone.0166115	http://dx.doi.org/10.1371/journal.pone.0166115			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829000	gold, Green Published, Green Submitted			2022-12-26	WOS:000387724300083
J	Markovic, D; Nikolic, N; Glinwood, R; Seisenbaeva, G; Ninkovic, V				Markovic, Dimitrije; Nikolic, Neda; Glinwood, Robert; Seisenbaeva, Gulaim; Ninkovic, Velemir			Plant Responses to Brief Touching: A Mechanism for Early Neighbour Detection?	PLOS ONE			English	Article							GLANDULAR TRICHOMES; VOLATILE COMMUNICATION; PHENOTYPIC PLASTICITY; BIOMASS ALLOCATION; PUBESCENCE DENSITY; LEAVES; STRESS; WIND; HERBIVORES; RESISTANCE	In natural habitats plants can be exposed to brief and light contact with neighbouring plants. This mechanical stimulus may represent a cue that induces responses to nearby plants. However, little is known about the effect of touching on plant growth and interaction with insect herbivores. To simulate contact between plants, a soft brush was used to apply light and brief mechanical stimuli to terminal leaves of potato Solanum tuberosum L. The number of non-glandular trichomes on the leaf surface was counted on images made by light microscope while glandular trichomes and pavement cells were counted on images made under scanning electronic microscope. Volatile compounds were identified and quantified using coupled gas chromatography-mass spectrometry (GC-MS). Treated plants changed their pattern of biomass distribution; they had lower stem mass fraction and higher branch and leaf mass fraction than untouched plants. Size, weight and number of tubers were not significantly affected. Touching did not cause trichome damage nor change their total number on touched terminal leaves. However, on primary leaves the number of glandular trichomes and pavement cells was significantly increased. Touching altered the volatile emission of treated plants; they released higher quantities of the sesquiterpenes (E)-beta-caryophyllene, germacrene D-4-ol and (E)-nerolidol, and lower quantities of the terpenes (E)-ocimene and linalool, indicating a systemic effect of the treatment. The odour of touched plants was significantly less preferred by the aphids Macrosiphum euphorbiae and Myzus persicae compared to odour of untouched plants. The results suggest that light contact may have a potential role in the detection of neighbouring plants and may affect plant-insect interactions.	[Markovic, Dimitrije; Nikolic, Neda; Glinwood, Robert; Ninkovic, Velemir] Swedish Univ Agr Sci, Dept Crop Prod Ecol, Uppsala, Sweden; [Markovic, Dimitrije] Univ Banja Luka, Fac Agr, Banja Luka, Bosnia & Herceg; [Seisenbaeva, Gulaim] Swedish Univ Agr Sci, Dept Chem & Biotechnol, Uppsala, Sweden	Swedish University of Agricultural Sciences; University of Banja Luka (UNIBL); Swedish University of Agricultural Sciences	Ninkovic, V (corresponding author), Swedish Univ Agr Sci, Dept Crop Prod Ecol, Uppsala, Sweden.	velemir.ninkovic@slu.se	Seisenbaeva, Gulaim/Y-8024-2019; Ninkovic, Velemir/E-7677-2011; Markovic, Dimitrije/A-2513-2019	Seisenbaeva, Gulaim/0000-0003-0072-6082; Ninkovic, Velemir/0000-0001-9276-7169; Markovic, Dimitrije/0000-0003-3030-4155; Glinwood, Robert/0000-0001-5082-5076	Swedish Research Council [2012-581]; Svenska Forskningsradet Formas [2014-225]; Carl Tryggers Foundation for Scientific Research [CTS KF14:7]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Svenska Forskningsradet Formas(Swedish Research Council Formas); Carl Tryggers Foundation for Scientific Research	This study was financially supported by the Swedish Research Council (Formas) grants 2012-581 (Dr. Gulaim Seisenbaeva) and Svenska Forskningsradet Formas 2014-225 Dr. Velemir Ninkovic. This work was also supported by Carl Tryggers Foundation for Scientific Research, grant CTS KF14:7 (Dr. Velemir Ninkovic). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; [Anonymous], 2010, CORELDRAW X5; Anten NPR, 2010, NEW PHYTOL, V188, P554, DOI 10.1111/j.1469-8137.2010.03379.x; Anten NPR, 2005, AM NAT, V166, P650, DOI 10.1086/497442; AVE DA, 1987, ENTOMOL EXP APPL, V44, P131, DOI 10.1007/BF00367620; Baldwin IT, 2010, CURR BIOL, V20, pR392, DOI 10.1016/j.cub.2010.02.052; Benikhlef L, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-133; Benz BW, 2006, J PLANT PHYSIOL, V163, P648, DOI 10.1016/j.jplph.2005.05.008; Biedrzycki Meredith L, 2010, Commun Integr Biol, V3, P28; Braam J, 2005, NEW PHYTOL, V165, P373, DOI 10.1111/j.1469-8137.2004.01263.x; BRAAM J, 1990, CELL, V60, P357, DOI 10.1016/0092-8674(90)90587-5; Chehab EW, 2012, CURR BIOL, V22, P701, DOI 10.1016/j.cub.2012.02.061; Choh Y, 2004, J CHEM ECOL, V30, P1305, DOI 10.1023/B:JOEC.0000037741.13402.19; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Coutand C, 2008, ANN BOT-LONDON, V101, P1421, DOI 10.1093/aob/mcn054; Dahlin I, 2013, J APPL ECOL, V50, P1281, DOI 10.1111/1365-2664.12115; de Wit M, 2012, P NATL ACAD SCI USA, V109, P14705, DOI 10.1073/pnas.1205437109; Defauw S.L., 2012, SUSTAINABLE POTATO P, P3, DOI [10.1007/978-94-007-4104-1_1, DOI 10.1007/978-94-007-4104-1_1]; Dell Inc, 2015, DELL STAT VERS; ELLER BM, 1977, OECOLOGIA, V29, P179, DOI 10.1007/BF00345796; Falster DS, 2003, TRENDS ECOL EVOL, V18, P337, DOI 10.1016/S0169-5347(03)00061-2; Farmer EE, 2014, LEAF DEFENCE, P47; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; Gagliano M, 2012, TRENDS PLANT SCI, V17, P323, DOI 10.1016/j.tplants.2012.03.002; Galmes J, 2007, ENVIRON EXP BOT, V60, P105, DOI 10.1016/j.envexpbot.2006.08.001; Glas JJ, 2012, INT J MOL SCI, V13, P17077, DOI 10.3390/ijms131217077; Glinwood R, 2011, PHYTOCHEMISTRY, V72, P1683, DOI 10.1016/j.phytochem.2011.02.010; Gonzalez WL, 2008, ACTA OECOL, V33, P128, DOI 10.1016/j.actao.2007.10.004; Holeski LM, 2007, J EVOLUTION BIOL, V20, P2092, DOI 10.1111/j.1420-9101.2007.01434.x; Izaguirre MM, 2006, P NATL ACAD SCI USA, V103, P7170, DOI 10.1073/pnas.0509805103; Jaffe MJ, 2002, AM J BOT, V89, P375, DOI 10.3732/ajb.89.3.375; Jeffries C., 2006, HDB POTATO PRODUCTIO, P387; Kaplan I, 2009, ECOL APPL, V19, P864, DOI 10.1890/07-1566.1; Karban R, 2014, ECOL LETT, V17, P44, DOI 10.1111/ele.12205; Kegge W, 2015, ANN BOT-LONDON, V115, P961, DOI 10.1093/aob/mcv036; Kollner TG, 2008, PLANT CELL, V20, P482, DOI 10.1105/tpc.107.051672; Kos M, 2013, PEST MANAG SCI, V69, P302, DOI 10.1002/ps.3391; Liu Y, 2007, ANN BOT-LONDON, V99, P121, DOI 10.1093/aob/mcl230; Markovic D, 2014, ARTHROPOD-PLANT INTE, V8, P171, DOI 10.1007/s11829-014-9303-6; Montgomery JA, 2004, J AM SOC HORTIC SCI, V129, P339, DOI 10.21273/JASHS.129.3.0339; Moran PJ, 1999, J PHYTOPATHOL, V147, P313, DOI 10.1046/j.1439-0434.1999.147005313.x; Moulia B, 2006, AM J BOT, V93, P1477, DOI 10.3732/ajb.93.10.1477; Niklas KJ, 1998, ANN BOT-LONDON, V82, P147, DOI 10.1006/anbo.1998.0658; Ninkovic V, 2003, J EXP BOT, V54, P1931, DOI 10.1093/jxb/erg192; Ninkovic V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069431; Peiffer M, 2009, NEW PHYTOL, V184, P644, DOI 10.1111/j.1469-8137.2009.03002.x; Perez-Estrada LB, 2000, TREE PHYSIOL, V20, P629; Pettersson J, 2007, APHIDS AS CROP PESTS, P87, DOI 10.1079/9780851998190.0087; Pickett JA, 2007, APHIDS AS CROP PESTS, P235, DOI 10.1079/9780851998190.0235; Pieczynski M, 2013, PLANT BIOTECHNOL J, V11, P459, DOI 10.1111/pbi.12032; Pigliucci M, 2002, INT J PLANT SCI, V163, P399, DOI 10.1086/339158; Poorter H, 2015, NEW PHYTOL, V208, P736, DOI 10.1111/nph.13571; Read J, 2006, AM J BOT, V93, P1546, DOI 10.3732/ajb.93.10.1546; Ren Q, 2000, EUPHYTICA, V111, P191, DOI 10.1023/A:1003833230859; Saidi I, 2010, PLANT SIGNAL BEHAV, V5, P122, DOI 10.4161/psb.5.2.10302; Salter MG, 2003, NATURE, V426, P680, DOI 10.1038/nature02174; Sato Y, 2014, EVOL ECOL, V28, P545, DOI 10.1007/s10682-013-9686-3; Stolarz M, 2009, PLANT SIGNAL BEHAV, V4, P380, DOI 10.4161/psb.4.5.8293; Szafranek B, 2005, J AGR FOOD CHEM, V53, P2817, DOI 10.1021/jf040437g; Telewski FW, 2006, AM J BOT, V93, P1466, DOI 10.3732/ajb.93.10.1466; Traw MB, 2002, ENVIRON ENTOMOL, V31, P714, DOI 10.1603/0046-225X-31.4.714; Valkama E, 2005, TREES-STRUCT FUNCT, V19, P191, DOI 10.1007/s00468-004-0380-5; Webster B, 2012, PHYSIOL ENTOMOL, V37, P10, DOI 10.1111/j.1365-3032.2011.00791.x; Weissbecker B, 2000, J CHEM ECOL, V26, P1433, DOI 10.1023/A:1005535708866; Whippo CW, 2006, PLANT CELL, V18, P1110, DOI 10.1105/tpc.105.039669; WOODMAN RL, 1991, OIKOS, V60, P11, DOI 10.2307/3544986; ZHANG JH, 1992, CROP SCI, V32, P641, DOI 10.2135/cropsci1992.0011183X003200030013x; Zhang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082256	69	18	19	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165742	10.1371/journal.pone.0165742	http://dx.doi.org/10.1371/journal.pone.0165742			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828995	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000387724300057
J	Palm, MM; Dallinga, MG; van Dijk, E; Klaassen, I; Schlingemann, RO; Merks, RMH				Palm, Margriet M.; Dallinga, Marchien G.; van Dijk, Erik; Klaassen, Ingeborg; Schlingemann, Reinier O.; Merks, Roeland M. H.			Computational Screening of Tip and Stalk Cell Behavior Proposes a Role for Apelin Signaling in Sprout Progression	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; IN-VITRO; UP-REGULATION; VASCULAR DEVELOPMENT; ANGIOGENIC FACTOR; BLOOD-VESSELS; TUMOR-GROWTH; NOTCH; VEGF; EXPRESSION	Angiogenesis involves the formation of new blood vessels by sprouting or splitting of existing blood vessels. During sprouting, a highly motile type of endothelial cell, called the tip cell, migrates from the blood vessels followed by stalk cells, an endothelial cell type that forms the body of the sprout. To get more insight into how tip cells contribute to angiogenesis, we extended an existing computational model of vascular network formation based on the cellular Potts model with tip and stalk differentiation, without making a priori assumptions about the differences between tip cells and stalk cells. To predict potential differences, we looked for parameter values that make tip cells (a) move to the sprout tip, and (b) change the morphology of the angiogenic networks. The screening predicted that if tip cells respond less effectively to an endothelial chemoattractant than stalk cells, they move to the tips of the sprouts, which impacts the morphology of the networks. A comparison of this model prediction with genes expressed differentially in tip and stalk cells revealed that the endothelial chemoattractant Apelin and its receptor APJ may match the model prediction. To test the model prediction we inhibited Apelin signaling in our model and in an in vitro model of angiogenic sprouting, and found that in both cases inhibition of Apelin or of its receptor APJ reduces sprouting. Based on the prediction of the computational model, we propose that the differential expression of Apelin and APJ yields a "self-generated" gradient mechanisms that accelerates the extension of the sprout.	[Palm, Margriet M.; van Dijk, Erik; Merks, Roeland M. H.] Ctr Wiskunde & Informat, Life Sci Grp, Amsterdam, Netherlands; [Dallinga, Marchien G.; Klaassen, Ingeborg; Schlingemann, Reinier O.] Acad Med Ctr, Ocular Angiogenesis Grp, Amsterdam, Netherlands; [Merks, Roeland M. H.] Leiden Univ, Math Inst, Leiden, Netherlands; [Palm, Margriet M.] Leiden Univ, LACDR, Div Toxicol, Leiden, Netherlands; [van Dijk, Erik] Vrije Univ Amsterdam, Ctr Integrat Bioinformat, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	Merks, RMH (corresponding author), Ctr Wiskunde & Informat, Life Sci Grp, Amsterdam, Netherlands.; Merks, RMH (corresponding author), Leiden Univ, Math Inst, Leiden, Netherlands.	merks@cwi.nl	Klaassen, Ingeborg/F-7333-2015; Merks, Roeland/A-2249-2008; Palm, Margriet/H-4077-2019	Merks, Roeland/0000-0002-6152-687X; Klaassen, Ingeborg/0000-0003-1695-9403; van Dijk, Erik/0000-0002-6272-2039	Netherlands Consortium for Systems Biology (NCSB); Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO); programme "Innovational Research Incentives Scheme Vidi Cross-divisional ALW" [864.10.009]; Netherlands Organisation for Scientific Research (NWO); Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (ANWB); Stichting Blinden-Penning; Landelijke Stichting voor Blinden en Slechtzienden (LSBS); Stichting MD fonds [UitZicht2012-17]; Nederlandse Vereniging ter Verbetering van het Lot der Blinden; Rotterdamse Stichting Blindenbelangen; Stichting voor Ooglijders; Stichting Nederlands Oogheelkundig Onderzoek	Netherlands Consortium for Systems Biology (NCSB); Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); programme "Innovational Research Incentives Scheme Vidi Cross-divisional ALW"; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (ANWB); Stichting Blinden-Penning; Landelijke Stichting voor Blinden en Slechtzienden (LSBS); Stichting MD fonds; Nederlandse Vereniging ter Verbetering van het Lot der Blinden; Rotterdamse Stichting Blindenbelangen; Stichting voor Ooglijders; Stichting Nederlands Oogheelkundig Onderzoek	This work was financed by the Netherlands Consortium for Systems Biology (NCSB), which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO). The work is part of the research programme "Innovational Research Incentives Scheme Vidi Cross-divisional 2010 ALW" with project number 864.10.009, which is (partly) financed by the Netherlands Organisation for Scientific Research (NWO). The in vitro work was supported by grants from the following Dutch eye funds: Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (ANWB), Stichting Blinden-Penning, Landelijke Stichting voor Blinden en Slechtzienden (LSBS), Stichting MD fonds (all together cooperated by UitZicht, project # UitZicht2012-17), Nederlandse Vereniging ter Verbetering van het Lot der Blinden, Rotterdamse Stichting Blindenbelangen, Stichting voor Ooglijders and the Stichting Nederlands Oogheelkundig Onderzoek. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2010, ENCYCL RES, V2, P897; Angelini TE, 2011, P NATL ACAD SCI USA, V108, P4714, DOI 10.1073/pnas.1010059108; Arima S, 2011, DEVELOPMENT, V138, P4763, DOI 10.1242/dev.068023; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Artel A, 2011, TISSUE ENG PT A, V17, P2133, DOI [10.1089/ten.tea.2010.0571, 10.1089/ten.TEA.2010.0571]; Bauer AL, 2007, BIOPHYS J, V92, P3105, DOI 10.1529/biophysj.106.101501; Bauer AL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000445; Bautch VL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006452; Benedito R, 2012, NATURE, V484, P110, DOI 10.1038/nature10908; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bentley K, 2008, J THEOR BIOL, V250, P25, DOI 10.1016/j.jtbi.2007.09.015; Bentley K, 2014, NAT CELL BIOL, V16, P309, DOI 10.1038/ncb2926; Bentley K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000549; Boas SEM, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0222-7; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Califano JP, 2008, CELL MOL BIOENG, V1, P122, DOI 10.1007/s12195-008-0022-x; Caolo V, 2010, J BIOL CHEM, V285, P40681, DOI 10.1074/jbc.M110.176065; Claxton S, 2004, GENE EXPR PATTERNS, V5, P123, DOI 10.1016/j.modgep.2004.05.004; Coelho L.P., 2013, JORS, V1, pe3, DOI [10.5334/jors.ac, DOI 10.5334/JORS.AC]; Cox CM, 2006, DEV BIOL, V296, P177, DOI 10.1016/j.ydbio.2006.04.452; del Toro R, 2010, BLOOD, V116, P4025, DOI 10.1182/blood-2010-02-270819; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dona E, 2013, NATURE, V503, P285, DOI 10.1038/nature12635; Dougherty ER, 2003, SPIE TUTORIAL TEXTS; Eyries M, 2008, CIRC RES, V103, P432, DOI 10.1161/CIRCRESAHA.108.179333; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; Franco M, 2011, BLOOD, V118, P2906, DOI 10.1182/blood-2011-01-331694; Funahashi Yasuhiro, 2010, J Angiogenes Res, V2, P3, DOI 10.1186/2040-2384-2-3; Gamba A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.118101; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; Graham R. L., 1972, Information Processing Letters, V1, P132, DOI 10.1016/0020-0190(72)90045-2; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Guidolin D, 2004, MICROVASC RES, V67, P117, DOI 10.1016/j.mvr.2003.11.002; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Hainaud P, 2006, CANCER RES, V66, P8501, DOI 10.1158/0008-5472.CAN-05-4226; Hara C, 2013, INVEST OPHTH VIS SCI, V54, P4321, DOI 10.1167/iovs.13-11611; Harrington LS, 2008, MICROVASC RES, V75, P144, DOI 10.1016/j.mvr.2007.06.006; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Jackson T, 2010, B MATH BIOL, V72, P830, DOI 10.1007/s11538-009-9471-1; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Jakobsson L, 2009, BIOCHEM SOC T, V37, P1233, DOI 10.1042/BST0371233; Kalin RE, 2007, DEV BIOL, V305, P599, DOI 10.1016/j.ydbio.2007.03.004; Kasai A, 2004, BIOCHEM BIOPH RES CO, V325, P395, DOI 10.1016/j.bbrc.2004.10.042; Kasai A, 2008, ARTERIOSCL THROM VAS, V28, P1717, DOI 10.1161/ATVBAHA.108.163402; Kasai A, 2013, ANGIOGENESIS, V16, P723, DOI 10.1007/s10456-013-9349-6; Kidoya H, 2008, EMBO J, V27, P522, DOI 10.1038/sj.emboj.7601982; Kleinstreuer N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002996; Kohn-Luque A, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/6/066007; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Long BL, 2013, J THEOR BIOL, V326, P43, DOI 10.1016/j.jtbi.2012.11.030; Manoussaki D, 1996, ACTA BIOTHEOR, V44, P271, DOI 10.1007/BF00046533; MCCUTCHEON M, 1946, PHYSIOL REV, V26, P319, DOI 10.1152/physrev.1946.26.3.319; Mehdizadeh H, 2013, BIOMATERIALS, V34, P2875, DOI 10.1016/j.biomaterials.2012.12.047; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Merks RMH, 2006, DEV BIOL, V289, P44, DOI 10.1016/j.ydbio.2005.10.003; Merks RMH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000163; Milde F, 2008, BIOPHYS J, V95, P3146, DOI 10.1529/biophysj.107.124511; Namy P, 2004, J THEOR BIOL, V227, P103, DOI 10.1016/j.jtbi.2003.10.015; Palm MM, 2015, METHODS MOL BIOL, V1189, P301, DOI 10.1007/978-1-4939-1164-6_20; Palm MM, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012725; PARK JE, 1994, J BIOL CHEM, V269, P25646; Parsa H, 2011, P NATL ACAD SCI USA, V108, P5133, DOI 10.1073/pnas.1007508108; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Qutub AA, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-13; Rahimi N, 2000, J BIOL CHEM, V275, P16986, DOI 10.1074/jbc.M000528200; Reinhart-King CA, 2008, BIOPHYS J, V95, P6044, DOI 10.1529/biophysj.107.127662; Ribatti D, 2011, INT J DEV BIOL, V55, P261, DOI 10.1387/ijdb.103167dr; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Sainson RCA, 2005, FASEB J, V19, P1027, DOI 10.1096/fj.04-3172fje; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Salvucci O, 2002, BLOOD, V99, P2703, DOI 10.1182/blood.V99.8.2703; Savill NJ, 1997, J THEOR BIOL, V184, P229, DOI 10.1006/jtbi.1996.0237; Scehnet JS, 2007, BLOOD, V109, P4753, DOI 10.1182/blood-2006-12-063933; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; Serini G, 2003, EMBO J, V22, P1771, DOI 10.1093/emboj/cdg176; Shirinifard A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002440; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Siemerink MJ, 2012, ANGIOGENESIS, V15, P151, DOI 10.1007/s10456-011-9251-z; Strasser GA, 2010, BLOOD, V115, P5102, DOI 10.1182/blood-2009-07-230284; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Swat MH, 2012, METHOD CELL BIOL, V110, P325, DOI 10.1016/B978-0-12-388403-9.00013-8; Szabo A, 2010, MATH MODEL NAT PHENO, V5, P106, DOI 10.1051/mmnp/20105105; Szabo A, 2008, BIOPHYS J, V95, P2702, DOI 10.1529/biophysj.108.129668; Szabo A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.038102; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Taylor KL, 2002, MICROVASC RES, V64, P372, DOI 10.1006/mvre.2002.2443; Tranqui L, 2000, CR ACAD SCI III-VIE, V323, P31, DOI 10.1016/S0764-4469(00)00110-4; Travasso RDM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019989; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; van Oers RFM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003774; vanHengel J, 1997, J CELL BIOL, V137, P1103, DOI 10.1083/jcb.137.5.1103; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000	104	18	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0159478	10.1371/journal.pone.0159478	http://dx.doi.org/10.1371/journal.pone.0159478			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828952	Green Published, gold, Green Submitted			2022-12-26	WOS:000387724300002
J	Veljkovic, V; Veljkovic, N; Paessler, S; Goeijenbier, M; Perovic, V; Glisic, S; Muller, CP				Veljkovic, Veljko; Veljkovic, Nevena; Paessler, Slobodan; Goeijenbier, Marco; Perovic, Vladimir; Glisic, Sanja; Muller, Claude P.			Predicted Enhanced Human Propensity of Current Avian-Like H1N1 Swine Influenza Virus from China	PLOS ONE			English	Article							H5N1; HEMAGGLUTININ; CONSEQUENCES; INFECTION; EVOLUTION	Influenza A virus (IAV) subtypes against which little or no pre-existing immunity exists in humans represent a serious threat to global public health. Monitoring of IAV in animal hosts is essential for early and rapid detection of potential pandemic IAV strains to prevent their spread. Recently, the increased pandemic potential of the avian-like swine H1N1 IAV A/swine/Guangdong/104/2013 has been suggested. The virus is infectious in humans and the general population seems to lack neutralizing antibodies against this virus. Here we present an in silico analysis that shows a strong human propensity of this swine virus further confirming its pandemic potential. We suggest mutations which would further enhance its human propensity. We also propose conserved antigenic determinants which could serve as a component of a prepandemic vaccine. The bioinformatics tool, which can be used to further monitor the evolution of swine influenza viruses towards a pandemic virus, are described here and are made publically available (http://www.vin.bg.ac.rs/180/tools/iav_ mon.php;http://www.biomedprotection.com/iav_mon.php).	[Veljkovic, Veljko; Veljkovic, Nevena; Perovic, Vladimir; Glisic, Sanja] Univ Belgrade, Inst Nucl Sci Vince, Ctr Multidisciplinary Res, Mihajla Petrovica 12-14, Belgrade 11001, Serbia; [Paessler, Slobodan] Univ Texas Med Branch, Dept Pathol, Galveston Natl Lab, 301 Univ Blvd, Galveston, TX 77555 USA; [Goeijenbier, Marco] Erasmus Univ, Med Ctr Rotterdam, Dept Virosci, Rotterdam, Netherlands; [Muller, Claude P.] Luxembourg Inst Hlth, Dept Infect & Immun, 29 Rue Henri Koch, L-4534 Esch Sur Alzette, Grand Duchy Of, Luxembourg	University of Belgrade; University of Texas System; University of Texas Medical Branch Galveston; Erasmus University Rotterdam; Erasmus MC; Luxembourg Institute of Health	Veljkovic, V (corresponding author), Univ Belgrade, Inst Nucl Sci Vince, Ctr Multidisciplinary Res, Mihajla Petrovica 12-14, Belgrade 11001, Serbia.	vv@vinca.rs	Glisic, Sanja/AAE-8590-2019	Glisic, Sanja/0000-0001-5691-1055; Goeijenbier, Marco/0000-0002-3165-8193; Perovic, Vladimir/0000-0002-3700-6452; Veljkovic, Nevena/0000-0001-6562-5800	Ministry of Education, Science and Technological Development of the Republic of Serbia [173001]	Ministry of Education, Science and Technological Development of the Republic of Serbia	This work was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Grant no. 173001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Grant no. 173001).	Fineberg HV, 2014, NEW ENGL J MED, V370, P1335, DOI 10.1056/NEJMra1208802; Perovic VR, 2013, J MATH CHEM, V51, P2238, DOI 10.1007/s10910-013-0212-1; Perovic VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061572; Schmier S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11434; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Veljkovic N, 2008, CURR PROTEIN PEPT SC, V9, P493, DOI 10.2174/138920308785915245; Veljkovic V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01456; Veljkovic V, 2014, VACCINE, V32, P6569, DOI 10.1016/j.vaccine.2014.07.007; Veljkovic V, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-62; Veljkovic V, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-21; Wang DY, 2013, EMERG INFECT DIS, V19, P1709, DOI 10.3201/eid1910.130420; Yang HL, 2016, P NATL ACAD SCI USA, V113, P392, DOI 10.1073/pnas.1522643113	12	0	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165451	10.1371/journal.pone.0165451	http://dx.doi.org/10.1371/journal.pone.0165451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828989	Green Submitted, Green Published, gold			2022-12-26	WOS:000387724300047
J	Becker-Bense, S; Buchholz, HG; Baier, B; Schreckenberger, M; Bartenstein, P; Zwergal, A; Brandt, T; Dieterich, M				Becker-Bense, Sandra; Buchholz, Hans-Georg; Baier, Bernhard; Schreckenberger, Mathias; Bartenstein, Peter; Zwergal, Andreas; Brandt, Thomas; Dieterich, Marianne			Functional Plasticity after Unilateral Vestibular Midbrain Infarction in Human Positron Emission Tomography	PLOS ONE			English	Article							BRAIN-STEM; INTERSTITIAL NUCLEUS; THALAMIC ASTASIA; OCULAR TORSION; COMPENSATION; LESION; TILT; CONNECTIVITY; SUBSTITUTION; STIMULATION	The aim of the study was to uncover mechanisms of central compensation of vestibular function at brainstem, cerebellar, and cortical levels in patients with acute unilateral midbrain infarctions presenting with an acute vestibular tone imbalance. Eight out of 17 patients with unilateral midbrain infarctions were selected on the basis of signs of a vestibular tone imbalance, e.g., graviceptive (tilts of perceived verticality) and oculomotor dysfunction (skew deviation, ocular torsion) in F18-fluordeoxyglucose (FDG)-PET at two time points: A) in the acute stage, and B) after recovery 6 months later. Lesion-behavior mapping analyses with MRI verified the exact structural lesion sites. Group subtraction analyses and comparisons with healthy controls were performed with Statistic Parametric Mapping for the PET data. A comparison of PET A of acute-stage patients with that of healthy controls showed increases in glucose metabolism in the cerebellum, motion-sensitive visual cortex areas, and inferior temporal lobe, but none in vestibular cortex areas. At the supratentorial level bilateral signal decreases dominated in the thalamus, frontal eye fields, and anterior cingulum. These decreases persisted after clinical recovery in contrast to the increases. The transient activations can be attributed to ocular motor and postural recovery (cerebellum) and sensory substitution of vestibular function for motion perception (visual cortex). The persisting deactivation in the thalamic nuclei and frontal eye fields allows alternative functional interpretations of the thalamic nuclei: either a disconnection of ascending sensory input occurs or there is a functional mismatch between expected and actual vestibular activity. Our data support the view that both thalami operate separately for each hemisphere but receive vestibular input from ipsilateral and contralateral midbrain integration centers. Normally they have gatekeeper functions for multisensory input to the cortex and automatic motor output to subserve balance and locomotion, as well as sensorimotor integration.	[Becker-Bense, Sandra; Zwergal, Andreas; Dieterich, Marianne] Univ Munich, Dept Neurol, Munich, Germany; [Becker-Bense, Sandra; Bartenstein, Peter; Zwergal, Andreas; Brandt, Thomas; Dieterich, Marianne] Univ Munich, German Ctr Vertigo & Balance Disorders IFB, Munich, Germany; [Buchholz, Hans-Georg; Schreckenberger, Mathias] Johannes Gutenberg Univ Mainz, Dept Nucl Med, Mainz, Germany; [Baier, Bernhard] Johannes Gutenberg Univ Mainz, Dept Neurol, Mainz, Germany; [Bartenstein, Peter] Univ Munich, Dept Nucl Med, Munich, Germany; [Bartenstein, Peter; Dieterich, Marianne] Univ Munich, Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Brandt, Thomas] Univ Munich, Inst Clin Neurosci, Munich, Germany	University of Munich; University of Munich; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Munich; University of Munich; University of Munich	Becker-Bense, S (corresponding author), Univ Munich, Dept Neurol, Munich, Germany.; Becker-Bense, S (corresponding author), Univ Munich, German Ctr Vertigo & Balance Disorders IFB, Munich, Germany.	sandra.bense@med.uni-muenchen.de			German Research Foundation (Deutsche Forschungsgemeinschaft) [DI 379/4-3]; Foundation "Stiftung Rheinland-Pfalz fur Innovation" [961-386261 /759]; German Federal Ministry of Education and Research [01 EO 0901, 01 EO 1401]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Foundation "Stiftung Rheinland-Pfalz fur Innovation"; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The study is not industry-sponsored. This work was undertaken at the University Hospitals in Mainz and Munich. The study is supported by the German Research Foundation (Deutsche Forschungsgemeinschaft DI 379/4-3), the Foundation "Stiftung Rheinland-Pfalz fur Innovation" (961-386261 /759), and the German Federal Ministry of Education and Research (grant code 01 EO 0901 and 01 EO 1401 IFB LMU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandrini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057596; Alessandrini M, 2009, EUR ARCH OTO-RHINO-L, V266, P1547, DOI 10.1007/s00405-009-0953-4; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; [Anonymous], 2014, BRAIN STRUCT FUNCT, V221, P159, DOI 10.1007/s00429-014-0899-1; Baier B, 2016, NEUROLOGY, V86, P134, DOI 10.1212/WNL.0000000000002238; Baier B, 2012, J NEUROSCI, V32, P14854, DOI 10.1523/JNEUROSCI.0770-12.2012; BARTLETT EJ, 1988, J CEREBR BLOOD F MET, V8, P502, DOI 10.1038/jcbfm.1988.91; Becker-Bense S, 2014, BRAIN STRUCT FUNCT, V219, P1355, DOI 10.1007/s00429-013-0573-z; Becker-Bense S, 2013, NEUROLOGY, V80, P1103, DOI 10.1212/WNL.0b013e31828868a6; Bense S, 2004, ANN NEUROL, V56, P624, DOI 10.1002/ana.20244; Beraneck Mathieu, 2012, Front Neurol, V3, P25, DOI 10.3389/fneur.2012.00025; BERTHOZ A, 1986, PROG BRAIN RES, V64, P325; Brandt T, 1997, ADV NEUROL, V73, P297; Brandt T, 1998, BRAIN, V121, P1749, DOI 10.1093/brain/121.9.1749; Brandt T, 2002, ANN NY ACAD SCI, V956, P230, DOI 10.1111/j.1749-6632.2002.tb02822.x; BRANDT T, 1994, ANN NEUROL, V36, P337, DOI 10.1002/ana.410360304; Brandt T, 1999, LANCET, V354, P746, DOI 10.1016/S0140-6736(99)03179-7; Brandt T, 1998, NEURO-OPHTHALMOLOGY, V19, P83, DOI 10.1076/noph.19.2.83.3944; Brandt T, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00047; Brodoehl S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10515; Buttner-Ennever J.A., 2014, OLSZEWSKI BAXTERS CY; BUTTNERENNEVER JA, 1982, BRAIN, V105, P125, DOI 10.1093/brain/105.1.125; Carrera E, 2004, STROKE, V35, P2826, DOI 10.1161/01.STR.0000147039.49252.2f; Chen AH, 2011, J NEUROSCI, V31, P3082, DOI 10.1523/JNEUROSCI.4476-10.2011; Choi JW, 2015, EUR ARCH OTO-RHINO-L, V272, P1613, DOI 10.1007/s00405-014-2952-3; Cutfield NJ, 2014, NEUROIMAGE-CLIN, V4, P274, DOI 10.1016/j.nicl.2013.12.013; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Diedrichsen J, 2006, NEUROIMAGE, V33, P127, DOI 10.1016/j.neuroimage.2006.05.056; DIETERICH M, 1992, ANN NEUROL, V31, P399, DOI 10.1002/ana.410310409; Dieterich M, 2005, BRAIN, V128, P2052, DOI 10.1093/brain/awh551; DIETERICH M, 1993, ANN NEUROL, V33, P292, DOI 10.1002/ana.410330311; Dieterich M, 2008, BRAIN, V131, P2538, DOI 10.1093/brain/awn042; Dieterich M, 2007, BRAIN, V130, P2108, DOI 10.1093/brain/awm130; Dieterich M, 2015, ANN NY ACAD SCI, V1343, P10, DOI 10.1111/nyas.12585; Dutia MB, 2010, CURR OPIN OTOLARYNGO, V18, P420, DOI 10.1097/MOO.0b013e32833de71f; Elwischger K, 2012, NEUROLOGY, V78, P146, DOI 10.1212/WNL.0b013e31823efc82; Eulenburg PZ, 2012, NEUROIMAGE, V60, P162, DOI 10.1016/j.neuroimage.2011.12.032; Eulenburg PZ, 2010, ANN NEUROL, V68, P241, DOI 10.1002/ana.22063; Frank SM, 2014, J NEUROPHYSIOL, V112, P2481, DOI 10.1152/jn.00078.2014; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1990, HUM BRAIN MAPP, V13, P1038; Gottlich M, 2014, NEUROIMAGE-CLIN, V4, P488, DOI 10.1016/j.nicl.2014.03.003; Guillery RW, 2002, PHILOS T R SOC B, V357, P1809, DOI 10.1098/rstb.2002.1171; Helmchen C, 2002, NEUROLOGY, V59, P1956, DOI 10.1212/01.WNL.0000038387.90128.8D; Helmchen C, 2011, J NEUROL NEUROSUR PS, V82, P309, DOI 10.1136/jnnp.2010.204925; Helmchen C, 2009, ANN NY ACAD SCI, V1164, P104, DOI 10.1111/j.1749-6632.2008.03745.x; Horn AKE, 2000, J COMP NEUROL, V420, P19, DOI 10.1002/(SICI)1096-9861(20000424)420:1<19::AID-CNE2>3.0.CO;2-D; Hufner K, 2011, HIPPOCAMPUS, V21, P855, DOI 10.1002/hipo.20801; Jahn K, 2008, NEUROIMAGE, V39, P786, DOI 10.1016/j.neuroimage.2007.09.047; JONGKEES L B, 1962, Pract Otorhinolaryngol (Basel), V24, P65; Kirsch V, 2016, BRAIN STRUCT FUNCT, V221, P1291, DOI 10.1007/s00429-014-0971-x; Kokkoroyannis T, 1996, J NEUROPHYSIOL, V75, P725, DOI 10.1152/jn.1996.75.2.725; Lopez C., 2012, NEUROSCIENCE, V60, P162; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; MASDEU JC, 1988, ANN NEUROL, V23, P596, DOI 10.1002/ana.410230612; Mossmann S, 1997, NEUROLOGY, V49, P1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rorden C, 2009, NEUROIMAGE, V44, P1355, DOI 10.1016/j.neuroimage.2008.09.031; SALMASO D, 1985, CORTEX, V21, P533, DOI 10.1016/S0010-9452(58)80003-9; Schaltenbrandt G, 1977, ATLAS STEREOTAXY HUM; Schmahmann JD, 2000, MRI ATLAS HUMAN BRAI; Schroeter M, 2009, J CEREBR BLOOD F MET, V29, P1216, DOI 10.1038/jcbfm.2009.36; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Shinder ME, 2014, J NEUROPHYSIOL, V111, P2445, DOI 10.1152/jn.00731.2013; Smith AT, 2012, CEREB CORTEX, V22, P1068, DOI 10.1093/cercor/bhr179; Varrone A, 2009, EUR J NUCL MED MOL I, V36, P2103, DOI 10.1007/s00259-009-1264-0; WESTHEIMER G, 1975, EXP BRAIN RES, V24, P89; WIENHARD K, 1992, J COMPUT ASSIST TOMO, V16, P804, DOI 10.1097/00004728-199209000-00024; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Wuehr M, 2013, GAIT POSTURE, V37, P214, DOI 10.1016/j.gaitpost.2012.07.003; Yang TH, 2014, NEUROLOGY, V82, P1968, DOI 10.1212/WNL.0000000000000480; Zwergal A, 2016, BRAIN STRUCT FUNCT, V221, P159, DOI 10.1007/s00429-014-0899-1; Zwergal A, 2013, NEUROLOGY, V80, P634, DOI 10.1212/WNL.0b013e318281cc43	74	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165935	10.1371/journal.pone.0165935	http://dx.doi.org/10.1371/journal.pone.0165935			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824897	gold, Green Published, Green Submitted			2022-12-26	WOS:000387615200046
J	Racovita, RC; Jetter, R				Racovita, Radu C.; Jetter, Reinhard			Identification of In-Chain-Functionalized Compounds and Methyl-Branched Alkanes in Cuticular Waxes of Triticum aestivum cv. Bethlehem	PLOS ONE			English	Article							SECONDARY ALCOHOLS; BETA-DIKETONES; LEAF WAX; EPICUTICULAR WAX; ESTERS; LEAVES; BIOSYNTHESIS; KETONES; HYDROCARBONS; DERIVATIVES	In this work, cuticular waxes from flag leaf blades and peduncles of Triticum aestivum cv.Bethlehem were investigated in search for novel wax compounds. Seven wax compound classes were detected that had previously not been reported, and their structures were elucidated using gas chromatography-mass spectrometry of various derivatives. Six of the classes were identified as series of homologs differing by two methylene units, while the seventh was a homologous series with homologs with single methylene unit differences. In the waxes of flag leaf blades, secondary alcohols (predominantly C-27 and C-33), primary/secondary diols (predominantly C-28) and esters of primary/secondary diols (predominantly C-50, combining C-28 diol with C-22 acid) were found, all sharing similar secondary hydroxyl group positions at and around C-12 or omega-12. 7- and 8-hydroxy-2-alkanol esters (predominantly C-35), 7- and 8-oxo-2-alkanol esters (predominantly C-35), and 4-alkylbutan-4-olides (predominantly C28) were found both in flag leaf and peduncle wax mixtures. Finally, a series of even- and odd-numbered alkane homologs was identified in both leaf and peduncle waxes, with an internal methyl branch preferentially on C-11 and C-13 of homologs with even total carbon number and on C-12 of odd-numbered homologs. Biosynthetic pathways are suggested for all compounds, based on common structural features and matching chain length profiles with other wheat wax compound classes.	[Racovita, Radu C.; Jetter, Reinhard] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Jetter, Reinhard] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Jetter, R (corresponding author), Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada.; Jetter, R (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada.	reinhard.jetter@botany.ubc.ca	Racovita, Radu C/Q-8089-2016	Racovita, Radu C/0000-0002-6396-9869	Natural Sciences and Engineering Research Council (Canada) [262461]	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by the Natural Sciences and Engineering Research Council (Canada) Discovery grant #262461 to RJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski NM, 2013, PLANT J, V74, P989, DOI 10.1111/tpj.12185; Ali M, 2001, INDIAN J CHEM B, V40, P698; Basas-Jaumandreu J, 2014, PHYTOCHEM LETT, V10, P240, DOI 10.1016/j.phytol.2014.10.009; BIANCHI G, 1992, PHYTOCHEMISTRY, V31, P3503, DOI 10.1016/0031-9422(92)83716-C; BIANCHI G, 1977, PHYTOCHEMISTRY, V16, P943, DOI 10.1016/S0031-9422(00)86700-X; Buschhaus C, 2013, PHYTOCHEMISTRY, V91, P249, DOI 10.1016/j.phytochem.2012.07.018; Busta L, 2016, PHYTOCHEMISTRY, V121, P38, DOI 10.1016/j.phytochem.2015.10.007; DIEKMAN J, 1967, J ORG CHEM, V32, P3904, DOI 10.1021/jo01287a040; DIERICKX PJ, 1973, PHYTOCHEMISTRY, V12, P1498, DOI 10.1016/0031-9422(73)80597-7; Dong XQ, 2012, HORTIC ENVIRON BIOTE, V53, P288, DOI 10.1007/s13580-012-0036-0; EVANS D, 1975, PHYTOCHEMISTRY, V14, P2447, DOI 10.1016/0031-9422(75)80362-1; Greer S, 2007, PLANT PHYSIOL, V145, P653, DOI 10.1104/pp.107.107300; Hen-Avivi S, 2016, PLANT CELL, V28, P1440, DOI 10.1105/tpc.16.00197; HORN DHS, 1964, AUST J CHEM, V17, P464, DOI 10.1071/CH9640464; HUSSAIN RA, 1982, PHYTOCHEMISTRY, V21, P1393, DOI 10.1016/0031-9422(82)80149-0; Jenks MA, 2002, HORTSCIENCE, V37, P673, DOI 10.21273/HORTSCI.37.4.673; Jetter R, 1999, PHYTOCHEMISTRY, V50, P1359, DOI 10.1016/S0031-9422(98)00369-0; Jetter R, 2000, J CHEM ECOL, V26, P399, DOI 10.1023/A:1005409405771; Jetter R, 2000, PHYTOCHEMISTRY, V55, P169, DOI 10.1016/S0031-9422(00)00274-0; Jetter R, 1996, CAN J BOT, V74, P419, DOI 10.1139/b96-052; Jetter R, 1999, PHYTOCHEMISTRY, V52, P907, DOI 10.1016/S0031-9422(99)00309-X; Jetter R, 2006, ANNU PLANT REV, V23, P145; Ji XF, 2008, PHYTOCHEMISTRY, V69, P1197, DOI 10.1016/j.phytochem.2007.12.008; KINGSTON DG, 1974, CHEM REV, V74, P215, DOI 10.1021/cr60288a004; KOLATTUKUDY PE, 1970, LIPIDS, V5, P259, DOI 10.1007/BF02532477; Kunst L, 2006, ANNU PLANT REV, V23, P182; MANHEIM BS, 1978, PHYTOCHEMISTRY, V17, P1799, DOI 10.1016/S0031-9422(00)88704-X; Mata R, 2003, PHYTOCHEMISTRY, V64, P285, DOI 10.1016/S0031-9422(03)00217-6; MCCLOSKEY JA, 1968, ANAL CHEM, V40, P233, DOI 10.1021/ac60257a071; MCFADDEN WH, 1965, ANAL CHEM, V37, P89, DOI 10.1021/ac60220a022; Mejanelle L, 2003, ORG GEOCHEM, V34, P527, DOI 10.1016/S0146-6380(02)00246-2; MIKKELSEN JD, 1978, ARCH BIOCHEM BIOPHYS, V188, P172, DOI 10.1016/0003-9861(78)90370-3; Millet E, 2013, EUPHYTICA, V190, P1, DOI 10.1007/s10681-012-0725-x; MOLD JD, 1966, BIOCHEMISTRY-US, V5, P455, DOI 10.1021/bi00866a009; Nawrath C, 2006, CURR OPIN PLANT BIOL, V9, P281, DOI 10.1016/j.pbi.2006.03.001; NELSON DR, 1975, J LIPID RES, V16, P12; NETTING AG, 1976, ARCH BIOCHEM BIOPHYS, V174, P613, DOI 10.1016/0003-9861(76)90390-8; NORDBY HE, 1994, J AGR FOOD CHEM, V42, P708, DOI 10.1021/jf00039a021; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; Racovita RC, 2016, PHYTOCHEMISTRY, V130, P182, DOI 10.1016/j.phytochem.2016.05.003; Racovita RC, 2015, PHYTOCHEMISTRY, V113, P183, DOI 10.1016/j.phytochem.2014.08.005; RIEDERER M, 1989, PHYSIOL PLANTARUM, V77, P373, DOI 10.1111/j.1399-3054.1989.tb05656.x; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Schneider LM, 2016, J EXP BOT, V67, P2715, DOI 10.1093/jxb/erw105; Speelman EN, 2009, ORG GEOCHEM, V40, P628, DOI 10.1016/j.orggeochem.2009.02.001; STRANSKY K, 1970, COLLECT CZECH CHEM C, V35, P882, DOI 10.1135/cccc19700882; TANTISEWIE B, 1969, Pharmaceutisch Weekblad, V104, P1341; TULLOCH AP, 1969, CAN J CHEMISTRY, V47, P3119, DOI 10.1139/v69-516; TULLOCH AP, 1973, PHYTOCHEMISTRY, V12, P2217, DOI 10.1016/0031-9422(73)85123-4; TULLOCH AP, 1971, PHYTOCHEMISTRY, V10, P871, DOI 10.1016/S0031-9422(00)97158-9; Vermeer CP, 2003, PHYTOCHEMISTRY, V62, P433, DOI 10.1016/S0031-9422(02)00560-5; von Wettstein-Knowles P, 2012, PLANT WAXES ELS, P1; von Wettstein-Knowles P, 2007, PLANT J, V49, P250, DOI 10.1111/j.1365-313X.2006.02956.x; VONWETTSTEINKNOWLES P, 1976, CARLSBERG RES COMMUN, V41, P225, DOI 10.1007/BF02906259; VONWETTSTEINKNOWLES P, 1984, CARLSBERG RES COMMUN, V49, P611, DOI 10.1007/BF02907493; VONWETTSTEINKNOWLES P, 1984, CARLSBERG RES COMMUN, V49, P57, DOI 10.1007/BF02913965; VONWETTSTEINKNOWLES P, 1976, LIPIDS, V11, P478, DOI 10.1007/BF02532839; Wang Y., 2015, J NANOMATER, V2015, P1, DOI DOI 10.1038/SREP18296; Wen M, 2007, PHYTOCHEMISTRY, V68, P2563, DOI 10.1016/j.phytochem.2007.05.029; Wen M, 2006, PHYTOCHEMISTRY, V67, P2494, DOI 10.1016/j.phytochem.2006.08.016; Wen M, 2009, J EXP BOT, V60, P1811, DOI 10.1093/jxb/erp061; Zhao XY, 2015, J NANOMATER, V2015, DOI 10.1155/2015/104193	62	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165827	10.1371/journal.pone.0165827	http://dx.doi.org/10.1371/journal.pone.0165827			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820857	Green Published, gold, Green Submitted			2022-12-26	WOS:000387614800023
J	Schreurs, TJL; Hectors, SJ; Jacobs, I; Grull, H; Nicolay, K; Strijkers, GJ				Schreurs, Tom J. L.; Hectors, Stefanie J.; Jacobs, Igor; Grull, Holger; Nicolay, Klaas; Strijkers, Gustav J.			Quantitative Multi-Parametric Magnetic Resonance Imaging of Tumor Response to Photodynamic Therapy	PLOS ONE			English	Article							DIFFUSION-WEIGHTED MRI; PROSTATE-CANCER; MULTICENTER; ABLATION	Objective The aim of this study was to characterize response to photodynamic therapy (PDT) in a mouse cancer model using a multi-parametric quantitative MRI protocol and to identify MR parameters as potential biomarkers for early assessment of treatment outcome. Methods CT26.WT colon carcinoma tumors were grown subcutaneously in the hind limb of BALB/c mice. Therapy consisted of intravenous injection of the photosensitizer Bremachlorin, followed by 10 min laser illumination (200 mW/cm(2)) of the tumor 6 h post injection. MRI at 7 T was performed at baseline, directly after PDT, as well as at 24 h, and 72 h. Tumor relaxation time constants (T-1 and T-2) and apparent diffusion coefficient (ADC) were quantified at each time point. Additionally, Gd-DOTA dynamic contrast-enhanced (DCE) MRI was performed to estimate transfer constants (K trans) and volume fractions of the extravascular extracellular space (V-e) using standard Tofts-Kermode tracer kinetic modeling. At the end of the experiment, tumor viability was characterized by histology using NADH-diaphorase staining. Results The therapy induced extensive cell death in the tumor and resulted in significant reduction in tumor growth, as compared to untreated controls. Tumor T-1 and T2 relaxation times remained unchanged up to 24 h, but decreased at 72 h after treatment. Tumor ADC values significantly increased at 24 h and 72 h. DCE-MRI derived tracer kinetic parameters displayed an early response to the treatment. Directly after PDT complete vascular shutdown was observed in large parts of the tumors and reduced uptake (decreased K trans) in remaining tumor tissue. At 24 h, contrast uptake in most tumors was essentially absent. Out of 5 animals that were monitored for 2 weeks after treatment, 3 had tumor recurrence, in locations that showed strong contrast uptake at 72 h. Conclusion DCE-MRI is an effective tool for visualization of vascular effects directly after PDT. Endogenous contrast parameters T-1, T-2, and ADC, measured at 24 to 72 h after PDT, are also potential biomarkers for evaluation of therapy outcome.	[Schreurs, Tom J. L.; Jacobs, Igor; Grull, Holger; Nicolay, Klaas] Eindhoven Univ Technol, Biomed NMR, Biomed Engn, Eindhoven, Netherlands; [Hectors, Stefanie J.] Icahn Sch Med Mt Sinai, Dept Radiol, Translat & Mol Imaging Inst, New York, NY 10029 USA; [Grull, Holger] Philips Res, Dept Oncol Solut, Eindhoven, Netherlands; [Strijkers, Gustav J.] Acad Med Ctr, Biomed Engn & Phys, Amsterdam, Netherlands	Eindhoven University of Technology; Icahn School of Medicine at Mount Sinai; Philips; Philips Research; University of Amsterdam; Academic Medical Center Amsterdam	Schreurs, TJL (corresponding author), Eindhoven Univ Technol, Biomed NMR, Biomed Engn, Eindhoven, Netherlands.	t.j.l.schreurs@tue.nl		Hectors, Stefanie/0000-0001-9457-6606; Strijkers, Gustav/0000-0001-6700-5058; Grull, Holger/0000-0002-0993-9300	NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands; project Molecular Imaging [T3-C-2.1]	NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands; project Molecular Imaging	This work was supported by NanoNextNL (www.nanonextnl.nl), a micro and nanotechnology consortium of the Government of the Netherlands and 130 partners, project Molecular Imaging (grant T3-C-2.1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author HG was employed by a commercial company (PhilipsResearch). The funder provided support in the form of salaries for author HG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section; We kindly thank Arno Ras (Philips Research, The Netherlands) for providing technical support for the custom laser treatment setup. This work is supported by NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands and 130 partners.	Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Anderson JK, 2007, J ENDOUROL, V21, P223, DOI 10.1089/end.2005.1128; D'Cruz AK, 2004, HEAD NECK-J SCI SPEC, V26, P232, DOI 10.1002/hed.10372; DEICHMANN R, 1992, J MAGN RESON, V96, P608, DOI 10.1016/0022-2364(92)90347-A; DODD NJF, 1989, BRIT J CANCER, V60, P164, DOI 10.1038/bjc.1989.244; DOUGHERTY TJ, 1975, J NATL CANCER I, V55, P115, DOI 10.1093/jnci/55.1.115; Douillard S, 2009, PHOTOCH PHOTOBIO SCI, V8, P405, DOI 10.1039/b817175k; Dowell NG, 2007, MAGN RESON MED, V58, P622, DOI 10.1002/mrm.21368; Fei B, 2007, P SPIE MED IMAGING P, V6511, P1; Fei BW, 2007, LASER SURG MED, V39, P723, DOI 10.1002/lsm.20576; Fingar V H, 1996, J Clin Laser Med Surg, V14, P323; Fruytier AC, 2014, MAGN RESON MED, V72, P602, DOI 10.1002/mrm.25297; Haider MA, 2007, RADIOLOGY, V244, P196, DOI 10.1148/radiol.2441060398; Hamstra DA, 2007, J CLIN ONCOL, V25, P4104, DOI 10.1200/JCO.2007.11.9610; Hectors SJCG, 2016, MAGN RESON MED, V75, P302, DOI 10.1002/mrm.25758; Hectors SJCG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099936; Huang Z, 2006, LASER SURG MED, V38, P672, DOI 10.1002/lsm.20375; Jacobs I, 2015, NMR BIOMED, V28, P1443, DOI 10.1002/nbm.3406; KENNEDY SD, 1994, MAGNET RESON MED, V31, P292, DOI 10.1002/mrm.1910310308; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; LEVITT MH, 1981, J MAGN RESON, V43, P65, DOI 10.1016/0022-2364(81)90082-2; LIU YH, 1995, MAGN RESON IMAGING, V13, P251, DOI 10.1016/0730-725X(94)00107-E; Morton C, 2006, ARCH DERMATOL, V142, P729, DOI 10.1001/archderm.142.6.729; Mroz Pawel, 2011, Cancers (Basel), V3, P2516, DOI 10.3390/cancers3022516; Overholt BF, 2005, GASTROINTEST ENDOSC, V62, P488, DOI 10.1016/j.gie.2005.06.047; Park EK, 2008, IMMUNOLOGY, V124, P461, DOI 10.1111/j.1365-2567.2007.02797.x; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Trachtenberg J, 2008, BJU INT, V102, P556, DOI 10.1111/j.1464-410X.2008.07753.x; VACHA J, 1975, PHYSIOL BOHEMOSLOV, V24, P413; Vander Elst L, 2013, P INT SOC MAG RESON, P746; Wang HS, 2010, J MAGN RESON IMAGING, V32, P409, DOI 10.1002/jmri.22247; Winsborrow BG, 1997, PHOTOCHEM PHOTOBIOL, V66, P847, DOI 10.1111/j.1751-1097.1997.tb03236.x; Yankeelov TE, 2014, NAT REV CLIN ONCOL, V11, P670, DOI 10.1038/nrclinonc.2014.134; Zilberstein J, 2001, PHOTOCHEM PHOTOBIOL, V73, P257, DOI 10.1562/0031-8655(2001)073<0257:ATOSMT>2.0.CO;2	34	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165759	10.1371/journal.pone.0165759	http://dx.doi.org/10.1371/journal.pone.0165759			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820832	Green Submitted, Green Published, gold			2022-12-26	WOS:000387614800018
J	Stene-Johansen, K; Yaqoob, N; Overbo, J; Aberra, H; Desalegn, H; Berhe, N; Johannessen, A				Stene-Johansen, Kathrine; Yaqoob, Nadeem; Overbo, Joakim; Aberra, Hanna; Desalegn, Hailemichael; Berhe, Nega; Johannessen, Asgeir			Dry Blood Spots a Reliable Method for Measurement of Hepatitis B Viral Load in Resource-Limited Settings	PLOS ONE			English	Article							C VIRUS-RNA; DRIED BLOOD; ENTECAVIR THERAPY; PLASMA; INFECTION; CIRRHOSIS; SAMPLES; LEVEL; RISK; DNA	Background & Aims Hepatitis B virus (HBV) quantification is essential in the management of chronic hepatitis B, both to determine treatment eligibility and in the monitoring of treatment effect. This test, however, is rarely available in resource-limited settings due to high costs and stringent requirements for shipment and storage of plasma. Dried Blood Spots (DBS) can be a convenient alternative to plasma, but its use for HBV monitoring has not been investigated under real-life conditions in Africa. Methods The performance of DBS in HBV quantification was investigated using a modified commercial test (Abbott RealTime HBV assay). Paired DBS and plasma samples were collected from an HBV positive cohort in Addis Ababa, Ethiopia. DBS were stored at ambient temperature for 4-39 days before shipment to the laboratory. Results Twenty-six paired samples were selected covering the total range of quantification, from 2.14 log IU/ml to >7 log IU/ml. HBV was detected in 21 of 21 (100%) DBS from patients with a corresponding plasma viral load above 2.70 log IU/ml. The mean difference between plasma and DBS was 0.59 log IU/ml, and the correlation was strong (R2 = 0.92). In stability studies there was no significant change in DBS viral load after storage at room temperature for up to 12 weeks. Conclusions This study suggests that DBS can be a feasible and reliable alternative to plasma for quantification of HBV in resource-limited settings. DBS can expand access to antiviral treatment for patients in low-and middle-income countries.	[Stene-Johansen, Kathrine; Yaqoob, Nadeem; Overbo, Joakim] Norwegian Inst Publ Hlth, Dept Virol, Oslo, Norway; [Aberra, Hanna; Desalegn, Hailemichael] St Pauls Hosp Millennium Med Coll, Dept Med, Addis Ababa, Ethiopia; [Berhe, Nega] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Berhe, Nega; Johannessen, Asgeir] Oslo Univ Hosp, Ctr Imported & Trop Dis, Oslo, Norway; [Johannessen, Asgeir] Vestre Viken HF, Dept Microbiol, Baerum, Norway	Norwegian Institute of Public Health (NIPH); Addis Ababa University; University of Oslo	Johannessen, A (corresponding author), Oslo Univ Hosp, Ctr Imported & Trop Dis, Oslo, Norway.; Johannessen, A (corresponding author), Vestre Viken HF, Dept Microbiol, Baerum, Norway.	johannessen.asgeir@gmail.com		Johannessen, Asgeir/0000-0001-5966-7166	Norwegian Research Council [220622/H10]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was funded in part by The Norwegian Research Council (www.forskningsradet.no), through a postdoc grant to AJ (grant number 220622/H10). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alidjinou EK, 2014, DIAGN MICR INFEC DIS, V78, P229, DOI 10.1016/j.diagmicrobio.2013.09.019; Bennett S, 2012, J CLIN VIROL, V54, P106, DOI 10.1016/j.jcv.2012.02.004; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brambilla D, 2003, J CLIN MICROBIOL, V41, P1888, DOI 10.1128/JCM.41.5.1888-1893.2003; Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Garrido C, 2009, J CLIN MICROBIOL, V47, P1031, DOI 10.1128/JCM.02099-08; GE Life Sciences GHL, 2016, 903 PROT SAV CARD 20; Gish RG, 2007, GASTROENTEROLOGY, V133, P1437, DOI 10.1053/j.gastro.2007.08.025; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Jardi R, 2004, HEPATOLOGY, V40, P133, DOI 10.1002/hep.20275; Johannessen A, 2009, CLIN INFECT DIS, V49, P976, DOI 10.1086/605502; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Lira R, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-153; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Mei JV, 2001, J NUTR, V131, p1631S, DOI 10.1093/jn/131.5.1631S; Mohamed S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061077; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Santos C, 2012, J VIROL METHODS, V179, P17, DOI 10.1016/j.jviromet.2011.06.012; Tuaillon E, 2010, HEPATOLOGY, V51, P752, DOI 10.1002/hep.23407; Vinikoor MJ, 2015, J CLIN VIROL, V72, P20, DOI 10.1016/j.jcv.2015.08.019; WHO, 2015, WHO GUID PREV CAR TR	23	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166201	10.1371/journal.pone.0166201	http://dx.doi.org/10.1371/journal.pone.0166201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820845	Green Accepted, gold, Green Submitted, Green Published			2022-12-26	WOS:000387614800040
J	Tonosu, J; Inanami, H; Oka, H; Katsuhira, J; Takano, Y; Koga, H; Yuzawa, Y; Shiboi, R; Oshima, Y; Baba, S; Tanaka, S; Matsudaira, K				Tonosu, Juichi; Inanami, Hirohiko; Oka, Hiroyuki; Katsuhira, Junji; Takano, Yuichi; Koga, Hisashi; Yuzawa, Yohei; Shiboi, Ryutaro; Oshima, Yasushi; Baba, Satoshi; Tanaka, Sakae; Matsudaira, Ko			Diagnosing Discogenic Low Back Pain Associated with Degenerative Disc Disease Using a Medical Interview	PLOS ONE			English	Article							LUMBAR INTERVERTEBRAL DISC; 10-YEAR MATCHED COHORT; PROVOCATIVE DISCOGRAPHY; PREVALENCE; INDIVIDUALS	Purposes To evaluate the usefulness of our original five questions in a medical interview for diagnosing discogenic low back pain (LBP), and to establish a support tool for diagnosing discogenic LBP. Materials and Methods The degenerative disc disease (DDD) group (n = 42) comprised patients diagnosed with discogenic LBP associated with DDD, on the basis of magnetic resonance imaging findings and response to analgesic discography (discoblock). The control group (n = 30) comprised patients with LBP due to a reason other than DDD. We selected patients from those who had been diagnosed with lumbar spinal stenosis and had undergone decompression surgery without fusion. Of them, those whose postoperative LBP was significantly decreased were included in the control group. We asked patients in both groups whether they experienced LBP after sitting too long, while standing after sitting too long, squirming in a chair after sitting too long, while washing one's face, and in the standing position with flexion. We analyzed the usefulness of our five questions for diagnosing discogenic LBP, and performed receiver operating characteristic (ROC) curve analysis to develop a diagnostic support tool. Results There were no significant differences in baseline characteristics, except age, between the groups. There were significant differences between the groups for all five questions. In the age-adjusted analyses, the odds ratios of LBP after sitting too long, while standing after sitting too long, squirming in a chair after sitting too long, while washing one's face, and in standing position with flexion were 10.5, 8.5, 4.0, 10.8, and 11.8, respectively. The integer scores were 11, 9, 4, 11, and 12, respectively, and the sum of the points of the five scores ranged from 0 to 47. Results of the ROC analysis were as follows: cut-off value, 31 points; area under the curve, 0.92302; sensitivity, 100%; and specificity, 71.4%. Conclusions All five questions were useful for diagnosing discogenic LBP. We established the scoring system as a support tool for diagnosing discogenic LBP.	[Tonosu, Juichi] Kanto Rosai Hosp, Dept Orthoped Surg, Kawasaki, Kanagawa, Japan; [Inanami, Hirohiko; Takano, Yuichi; Koga, Hisashi; Yuzawa, Yohei] Inanami Spine & Joint Hosp, Dept Orthoped Surg, Tokyo, Japan; [Inanami, Hirohiko; Takano, Yuichi; Koga, Hisashi; Yuzawa, Yohei; Shiboi, Ryutaro; Baba, Satoshi] Iwai Orthopaed Med Hosp, Dept Orthoped Surg, Tokyo, Japan; [Oka, Hiroyuki; Matsudaira, Ko] Univ Tokyo, Dept Med Res & Management Musculoskeletal Pain, 22nd Century Med & Res Ctr, Fac Med, Tokyo, Japan; [Oka, Hiroyuki; Oshima, Yasushi; Matsudaira, Ko] Univ Tokyo, Dept Orthoped Surg, Fac Med, Tokyo, Japan; [Katsuhira, Junji] Niigata Univ Hlth & Welf, Fac Med Technol, Dept Prosthet & Orthot & Assist Technol, Niigata, Japan	University of Tokyo; University of Tokyo; Niigata University	Tonosu, J (corresponding author), Kanto Rosai Hosp, Dept Orthoped Surg, Kawasaki, Kanagawa, Japan.	juichitohnosu@yahoo.co.jp	Takano, Yuichi/GVU-0109-2022; Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414; BABA, SATOSHI/0000-0003-3606-8587				ADAMS MA, 1983, SPINE, V8, P665, DOI 10.1097/00007632-198309000-00013; Carragee EJ, 2000, SPINE, V25, P1373, DOI 10.1097/00007632-200006010-00009; Carragee EJ, 2006, SPINE, V31, P2115, DOI 10.1097/01.brs.0000231436.30262.dd; Carragee EJ, 2009, SPINE, V34, P2338, DOI 10.1097/BRS.0b013e3181ab5432; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Cuellar JM, 2016, SPINE J, V16, P273, DOI 10.1016/j.spinee.2015.06.051; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94; Eck JC, 2014, J NEUROSURG-SPINE, V21, P37, DOI 10.3171/2014.4.SPINE14269; Endean A, 2011, SPINE, V36, P160, DOI 10.1097/BRS.0b013e3181cd9adb; Fairbank J C, 1980, Physiotherapy, V66, P271; Fujii T, 2013, EUR SPINE J, V22, P432, DOI 10.1007/s00586-012-2439-0; Fujiwara A, 2003, SPINE, V28, P1601, DOI 10.1097/00007632-200307150-00023; Grotle M, 2013, ACTA ORTHOP, V84, P196, DOI [10.3109/17453674.2013.786634, DOI 10.3109/1743674.2013.786634]; Jones ADR, 2014, EUR SPINE J, V23, P135, DOI 10.1007/s00586-013-2964-5; Kjaer P, 2005, SPINE, V30, P1173, DOI 10.1097/01.brs.0000162396.97739.76; Krismer M, 2007, BEST PRACT RES CL RH, V21, P77, DOI 10.1016/j.berh.2006.08.004; Manchikanti Laxmaiah, 2013, Pain Physician, V16, pSE55; McMillan DW, 1996, ANN RHEUM DIS, V55, P880, DOI 10.1136/ard.55.12.880; NACHEMSON A., 1966, CLIN ORTHO RELAT RES, V45, P107; Nachemson A, 1970, Scand J Rehabil Med Suppl, V1, P1; NACHEMSON AL, 1981, SPINE, V6, P93, DOI 10.1097/00007632-198101000-00020; Neckelmann G, 2013, SKELETAL RADIOL, V42, P1593, DOI [10.1007/s00256-013-1077-x, DOI 10.1007/S00256-013-1700-23982421]; Ohtori Seiji, 2009, Spine (Phila Pa 1976), V34, P1345, DOI 10.1097/BRS.0b013e3181a401bf; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Sato K, 1999, SPINE, V24, P2468, DOI 10.1097/00007632-199912010-00008; SCHWARZER AC, 1995, SPINE, V20, P1878, DOI 10.1097/00007632-199509000-00007; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005; Young Sharon, 2003, Spine J, V3, P460, DOI 10.1016/S1529-9430(03)00151-7	30	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166031	10.1371/journal.pone.0166031	http://dx.doi.org/10.1371/journal.pone.0166031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820861	Green Published, gold, Green Submitted			2022-12-26	WOS:000387614800029
J	Armstead, MY; Bitzer-Creathers, L; Wilson, M				Armstead, Mindy Yeager; Bitzer-Creathers, Leah; Wilson, Mandee			The Effects of Elevated Specific Conductivity on the Chronic Toxicity of Mining Influenced Streams Using Ceriodaphnia dubia	PLOS ONE			English	Article							METAL TOXICITY; MAJOR IONS; SULFATE; SENSITIVITY; SALINITY; CHLORIDE; EFFLUENTS; HARDNESS; FIELD; PH	Salinization of freshwater ecosystems as a result of human activities has markedly increased in recent years. Much attention is currently directed at evaluating the effects of increased salinity on freshwater biota. In the Central Appalachian region of the eastern United States, specific conductance from alkaline discharges associated with mountain top mining practices has been implicated in macroinvertebrate community declines in streams receiving coal mining discharges. Whole effluent toxicity testing of receiving stream water was used to test the hypothesis that mine discharges are toxic to laboratory test organisms and further, that toxicity is related to ionic concentrations as indicated by conductivity. Chronic toxicity testing using Ceriodaphnia dubia was conducted by contract laboratories at 72 sites with a total of 129 tests over a 3.5 year period. The database was evaluated to determine the ionic composition of mine effluent dominated streams and whether discharge constituents were related to toxicity in C. dubia. As expected, sulfate was found to be the dominant anion in streams receiving mining discharges with bicarbonate variable and sometimes a substantial component of the dissolved solids. Overall, the temporal variability in conductance was low at each site which would indicate fairly stable water quality conditions. Results of the toxicity tests show no relationship between conductance and survival of C. dubia in the mining influenced streams with the traditional toxicity test endpoints. However, consideration of the entire dataset revealed a significant inverse relationship between conductivity and neonate production. While conductivity explained very little of the high variability in the offspring production (r(2) = 0.1304), the average numbers of offspring were consistently less than 20 neonates at the highest conductivities.	[Armstead, Mindy Yeager; Bitzer-Creathers, Leah; Wilson, Mandee] Marshall Univ, Dept Integrated Sci & Technol, Huntington, WV 25755 USA; [Armstead, Mindy Yeager; Bitzer-Creathers, Leah] Potesta & Associates Inc, Charleston, WV USA	Marshall University	Armstead, MY (corresponding author), Marshall Univ, Dept Integrated Sci & Technol, Huntington, WV 25755 USA.; Armstead, MY (corresponding author), Potesta & Associates Inc, Charleston, WV USA.	m.armstead@marshall.edu			Marshall University; Potesta & Associates, Inc.; Appalachian Research Initiative for Environmental Sciences (ARIES), an industrial affiliates program at Virginia Tech; Norfolk Southern Corporation; Patriot Coal Corporation; TECO Coal Corporation; Natural Resource Partners; Arch Coal; Alpha Natural Resources	Marshall University; Potesta & Associates, Inc.; Appalachian Research Initiative for Environmental Sciences (ARIES), an industrial affiliates program at Virginia Tech; Norfolk Southern Corporation; Patriot Coal Corporation; TECO Coal Corporation; Natural Resource Partners; Arch Coal; Alpha Natural Resources	The study was funded by Marshall University. Potesta & Associates, Inc. provided support in the form of salaries for the authors (MYA, LBC) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The authors, recognizing the need for evaluating ecological risks and the availability of the toxicity data, conceived the study independently and sought cooperation from the mining companies involved and the funding agency. Two mining companies, Alpha Natural Resources and Patriot Mining, were required to collect toxicity data from high ionic strength discharges pursuant to United States Environmental Protection Agency agreements. These data were made available to the authors at our request. Researchers' (MYA and MW) time for conducting the evaluation and preparing the manuscript was supported by the Appalachian Research Initiative for Environmental Sciences (ARIES), an industrial affiliates program at Virginia Tech, which is supported by members that include companies in the energy sector (Norfolk Southern Corporation, Patriot Coal Corporation, TECO Coal Corporation, Natural Resource Partners, Arch Coal and Alpha Natural Resources). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Beketov MA, 2013, P NATL ACAD SCI USA, V110, P11039, DOI 10.1073/pnas.1305618110; Bernhardt ES, 2011, ANN NY ACAD SCI, V1223, P39, DOI 10.1111/j.1749-6632.2011.05986.x; Bryant G, 2003, SURVEY WATER QUALITY; Canedo-Arguelles M, 2013, ENVIRON POLLUT, V173, P157, DOI 10.1016/j.envpol.2012.10.011; Dow CL, 2000, ENVIRON MANAGE, V26, P437, DOI 10.1007/s002670010101; Eaton A.D., 1998, STANDARD METHODS EXA, V20th; Elphick JR, 2011, ENVIRON TOXICOL CHEM, V30, P247, DOI 10.1002/etc.363; Elphick JRF, 2011, ENVIRON TOXICOL CHEM, V30, P239, DOI 10.1002/etc.365; Fritz KM, 2010, J N AM BENTHOL SOC, V29, P673, DOI 10.1899/09-060.1; Goodfellow WL, 2000, ENVIRON TOXICOL CHEM, V19, P175, DOI 10.1002/etc.5620190121; Horning W. B., 1985, EPA600485014, P58; Jaeger KL, 2015, GEOMORPHOLOGY, V236, P25, DOI 10.1016/j.geomorph.2015.02.007; Kefford BJ, 2006, CAN J FISH AQUAT SCI, V63, P1865, DOI 10.1139/F06-080; Kefford BJ, 2011, ENVIRON POLLUT, V159, P302, DOI 10.1016/j.envpol.2010.08.025; Kefford BJ, 2004, ENVIRON POLLUT, V129, P355, DOI 10.1016/j.envpol.2003.12.005; Kennedy AJ, 2005, ARCH ENVIRON CON TOX, V49, P155, DOI 10.1007/s00244-004-0034-z; Kennedy AJ, 2003, ARCH ENVIRON CON TOX, V44, P324, DOI 10.1007/s00244-002-2062-x; Kratzer EB, 2006, J N AM BENTHOL SOC, V25, P954, DOI 10.1899/0887-3593(2006)025[0954:MDIRTL]2.0.CO;2; Kunz JL, 2013, ENVIRON TOXICOL CHEM, V32, P2826, DOI 10.1002/etc.2391; Lasier PJ, 2010, ENVIRON TOXICOL CHEM, V29, P347, DOI 10.1002/etc.29; Lindberg TT, 2011, P NATL ACAD SCI USA, V108, P20929, DOI 10.1073/pnas.1112381108; Merricks TC, 2007, ENVIRON MONIT ASSESS, V129, P359, DOI 10.1007/s10661-006-9369-4; Mount DR, 1997, ENVIRON TOXICOL CHEM, V16, P2009, DOI 10.1002/etc.5620161005; PAGENKOPF GK, 1983, ENVIRON SCI TECHNOL, V17, P342, DOI 10.1021/es00112a007; PARSONS JD, 1968, ARCH HYDROBIOL, V65, P25; Pickering QH, 1996, ENVIRON TOXICOL CHEM, V15, P353, DOI [10.1897/1551-5028(1996)015&lt;0353:SSOOFA&gt;2.3.CO;2, 10.1002/etc.5620150320]; Pond GJ, 2008, J N AM BENTHOL SOC, V27, P717, DOI 10.1899/08-015.1; Pond GJ, 2010, HYDROBIOLOGIA, V641, P185, DOI 10.1007/s10750-009-0081-6; Poteat MD, 2014, ENVIRON SCI TECHNOL, V48, P887, DOI 10.1021/es405529n; Soucek DJ, 2011, ENVIRON TOXICOL CHEM, V30, P930, DOI 10.1002/etc.454; Soucek DJ, 2007, ENVIRON TOXICOL CHEM, V26, P773, DOI 10.1897/06-229R.1; Soucek DJ, 2005, ENVIRON TOXICOL CHEM, V24, P1204, DOI 10.1897/04-142.1; Struewing KA, 2015, CHEMOSPHERE, V139, P597, DOI 10.1016/j.chemosphere.2014.04.096; van Dam RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106857; van Dam RA, 2010, ENVIRON TOXICOL CHEM, V29, P410, DOI 10.1002/etc.56; WARNER R W, 1971, Ohio Journal of Science, V71, P202; Wiley J. B, 2003, 03133 US DEP INT US	38	13	13	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165683	10.1371/journal.pone.0165683	http://dx.doi.org/10.1371/journal.pone.0165683			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814378	gold, Green Published, Green Submitted			2022-12-26	WOS:000386911100015
J	Korrodi-Gregorio, L; Soto-Cerrato, V; Vitorino, R; Fardilha, M; Perez-Tomas, R				Korrodi-Gregorio, Luis; Soto-Cerrato, Vanessa; Vitorino, Rui; Fardilha, Margarida; Perez-Tomas, Ricardo			From Proteomic Analysis to Potential Therapeutic Targets: Functional Profile of Two Lung Cancer Cell Lines, A549 and SW900, Widely Studied in Pre-Clinical Research	PLOS ONE			English	Article							GENE-EXPRESSION; NEDD8-ACTIVATING ENZYME; NUCLEAR ANTIGEN; PROGNOSTIC-SIGNIFICANCE; SURVIVIN EXPRESSION; CASEIN KINASE-2; PROTEIN; CARCINOMA; TISSUE; P53	Lung cancer is a serious health problem and the leading cause of cancer death worldwide. The standard use of cell lines as in vitro pre-clinical models to study the molecular mechanisms that drive tumorigenesis and access drug sensitivity/effectiveness is of undisputable importance. Label-free mass spectrometry and bioinformatics were employed to study the proteomic profiles of two representative lung cancer cell lines and to unravel the specific biological processes. Adenocarcinoma A549 cells were enriched in proteins related to cellular respiration, ubiquitination, apoptosis and response to drug/hypoxia/oxidative stress. In turn, squamous carcinoma SW900 cells were enriched in proteins related to translation, apoptosis, response to inorganic/organic substances and cytoskeleton organization. Several proteins with differential expression were related to cancer transformation, tumor resistance, proliferation, migration, invasion and metastasis. Combined analysis of proteome and interactome data highlighted key proteins and suggested that adenocarcinoma might be more prone to PI3K/Akt/mTOR and topoisomerase IIa inhibitors, and squamous carcinoma to Ck2 inhibitors. Moreover, ILF3 overexpression in adenocarcinoma, and PCNA and NEDD8 in squamous carcinoma shows them as promising candidates for therapeutic purposes. This study highlights the functional proteomic differences of two main subtypes of lung cancer models and hints several targeted therapies that might assist in this type of cancer.	[Korrodi-Gregorio, Luis; Soto-Cerrato, Vanessa; Perez-Tomas, Ricardo] Univ Barcelona, Canc Cell Biol Res Grp, Dept Pathol & Expt Therapeut, Fac Med, Campus Bellvitge,Feixa Llarga S-N, Lhospitalet De Llobregat 08907, Spain; [Korrodi-Gregorio, Luis; Fardilha, Margarida] Univ Aveiro, Lab Signal Transduct, Dept Med Sci, Inst Res Biomed iBiMED,Hlth Sci Program, Campus Santiago, P-3810193 Aveiro, Portugal; [Vitorino, Rui] Univ Aveiro, Dept Med Sci, Hlth Sci Program, Inst Res Biomed iBiMED, Campus Santiago, P-3810193 Aveiro, Portugal; [Vitorino, Rui] Univ Porto, Dept Physiol & Cardiothorac Surg, Fac Med, P-4200319 Oporto, Portugal	University of Barcelona; Universidade de Aveiro; Universidade de Aveiro; Universidade do Porto	Perez-Tomas, R (corresponding author), Univ Barcelona, Canc Cell Biol Res Grp, Dept Pathol & Expt Therapeut, Fac Med, Campus Bellvitge,Feixa Llarga S-N, Lhospitalet De Llobregat 08907, Spain.; Fardilha, M (corresponding author), Univ Aveiro, Lab Signal Transduct, Dept Med Sci, Inst Res Biomed iBiMED,Hlth Sci Program, Campus Santiago, P-3810193 Aveiro, Portugal.	mfardilha@ua.pt; rperez@ub.edu	Fardilha, Margarida/G-3182-2010; Vitorino, Rui/G-7356-2014; Soto-Cerrato, Vanessa/AAB-4392-2020; Korrodi-Gregório, Luís/N-6796-2013; Vitorino, Rui/AAJ-3621-2021	Fardilha, Margarida/0000-0001-7459-9173; Vitorino, Rui/0000-0003-3636-5805; Soto-Cerrato, Vanessa/0000-0001-5835-3595; Korrodi-Gregório, Luís/0000-0002-2811-8081; Vitorino, Rui/0000-0003-3636-5805; Perez-Tomas, Ricardo/0000-0003-3226-1240	Spanish Government; EU funds [FIS PI13/ 00089]; La Marato de TV3 Foundation [20132730]; FCT (Fundacao para a Ciencia e a Tecnologia) [UID/BIM/04501/2013]; Proteostasis COST Action [BM1307]; FCT [SFRH/BPD/91766/2012]	Spanish Government(Spanish GovernmentEuropean Commission); EU funds; La Marato de TV3 Foundation; FCT (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology); Proteostasis COST Action; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by grants from the Spanish Government and EU funds (FIS PI13/ 00089), from La Marato de TV3 Foundation (20132730) and from FCT (Fundacao para a Ciencia e a Tecnologia), to the RNEM (Portuguese Mass Spectrometry Network) through the project UID/BIM/04501/2013 and Proteostasis COST Action (BM1307). This work was also supported by an individual grant from FCT to Luis Korrodi-Gregorio (SFRH/BPD/91766/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Lizarbe MA, 2013, INT J MOL SCI, V14, P2652, DOI 10.3390/ijms14022652; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Balbin OA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3617; Bantscheff M, 2012, ANAL BIOANAL CHEM, V404, P939, DOI 10.1007/s00216-012-6203-4; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Cantor JM, 2012, J CELL SCI, V125, P1373, DOI 10.1242/jcs.096040; Capo-chichi CD, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-28; Chernyavsky AI, 2015, INT IMMUNOPHARMACOL, V29, P36, DOI 10.1016/j.intimp.2015.05.033; Chung LY, 2012, CLIN CANCER RES, V18, P4037, DOI 10.1158/1078-0432.CCR-11-3348; Cleator S, 2006, BREAST CANCER RES TR, V95, P229, DOI 10.1007/s10549-005-9009-7; DAYAMAKIN M, 1994, CANCER RES, V54, P2262; De Petris L, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-9; Deng SS, 2013, ONCOL LETT, V5, P107, DOI 10.3892/ol.2012.959; Dixit D, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.10; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; EBINA M, 1994, CANCER RES, V54, P2496; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Ertel A, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-55; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Forbus J, 2006, PROTEOMICS, V6, P2656, DOI 10.1002/pmic.200500652; Gaudio E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078610; Gellert P, 2010, BIOINFORMATICS, V26, P2328, DOI 10.1093/bioinformatics/btq417; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Gottschling S, 2012, LUNG CANCER, V75, P45, DOI 10.1016/j.lungcan.2011.05.020; Grossi F, 2003, EUR J CANCER, V39, P1242, DOI 10.1016/S0959-8049(03)00232-6; Guan DY, 2008, MOL CELL BIOL, V28, P4629, DOI 10.1128/MCB.00120-08; Guo NL, 2008, CLIN CANCER RES, V14, P8213, DOI 10.1158/1078-0432.CCR-08-0095; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Han SW, 2006, CANCER RES, V66, P315, DOI 10.1158/0008-5472.CAN-05-2367; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsu YL, 2013, CARCINOGENESIS, V34, P1370, DOI 10.1093/carcin/bgt040; Inada H, 2001, J CELL BIOL, V155, P415, DOI 10.1083/jcb.200103078; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; KASAHARA K, 1992, J NATL CANCER I, V84, P113, DOI 10.1093/jnci/84.2.113; Kidd ME, 2014, AM J RESP CELL MOL, V50, P1, DOI 10.1165/rcmb.2013-0314TR; Kikuchi T, 2012, MOL CELL PROTEOMICS, V11, P916, DOI 10.1074/mcp.M111.015370; Kim TY, 2013, P NATL ACAD SCI USA, V110, P16868, DOI 10.1073/pnas.1306358110; Kumar M, 2015, MOL ASPECTS MED, V45, P55, DOI 10.1016/j.mam.2015.06.009; Langevin SM, 2015, TRANSL RES, V165, P74, DOI 10.1016/j.trsl.2014.03.001; Li JH, 2016, TUMOR BIOL, V37, P2387, DOI 10.1007/s13277-015-4017-7; Li LH, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju083; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; LONG BH, 1986, CANCER RES, V46, P3809; Lu HY, 2015, BIOMATERIALS, V42, P30, DOI 10.1016/j.biomaterials.2014.11.029; Luo ZG, 2012, CANCER RES, V72, P3360, DOI 10.1158/0008-5472.CAN-12-0388; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Mahoney CL, 2009, BRIT J CANCER, V100, P370, DOI 10.1038/sj.bjc.6604886; Matsuzaki S, 2014, EXPERT OPIN THER TAR, V18, P403, DOI 10.1517/14728222.2014.882323; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Nakamura N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013243; Nawrocki ST, 2012, EXPERT OPIN INV DRUG, V21, P1563, DOI 10.1517/13543784.2012.707192; Nguyen VN, 2000, ACTA HISTOCHEM, V102, P323, DOI 10.1078/S0065-1281(04)70039-2; Nie W, 2015, LAB INVEST, V95, P56, DOI 10.1038/labinvest.2014.124; Ning JF, 2013, ONCOL RES, V21, P67, DOI 10.3727/096504013X13747716581417; Oji Y, 2014, INT J ONCOL, V44, P1461, DOI 10.3892/ijo.2014.2318; Okano T, 2006, PROTEOMICS, V6, P3938, DOI 10.1002/pmic.200500883; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Olsten MEK, 2004, BIOCHEM CELL BIOL, V82, P681, DOI 10.1139/O04-116; Orvis T, 2014, CANCER RES, V74, P6486, DOI 10.1158/0008-5472.CAN-14-0061; Pagano MA, 2008, BIOCHEM J, V415, P353, DOI 10.1042/BJ20080309; Patel VJ, 2009, J PROTEOME RES, V8, P3752, DOI 10.1021/pr900080y; Porebska Irena, 2010, Cancer Genomics & Proteomics, V7, P331; Recchi C, 2012, BIOCHEM SOC T, V40, P1398, DOI 10.1042/BST20120199; Rubporn Atchara, 2009, Cancer Genomics & Proteomics, V6, P229; Salton M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023882; Sandberg R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r65; Schaefer MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031826; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SHAPIRO GI, 1995, CANCER RES, V55, P6200; Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stolimenov I, 2009, BIOCHEM SOC T, V37, P605, DOI 10.1042/BST0370605; Sun PL, 2013, VIRCHOWS ARCH, V463, P427, DOI 10.1007/s00428-013-1462-9; Sun QL, 2011, J CANCER RES CLIN, V137, P521, DOI 10.1007/s00432-010-0913-9; Sun RF, 2015, TUMOR BIOL, V36, P7195, DOI 10.1007/s13277-015-3361-y; Tanaka T, 2012, MOL ONCOL, V6, P267, DOI 10.1016/j.molonc.2012.01.003; Travis WD, 2012, MODERN PATHOL, V25, pS18, DOI 10.1038/modpathol.2011.150; Tuncbag N, 2012, NUCLEIC ACIDS RES, V40, pW505, DOI 10.1093/nar/gks445; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Virtanen C, 2002, P NATL ACAD SCI USA, V99, P12357, DOI 10.1073/pnas.192240599; Wang XH, 2010, AM J PATHOL, V177, P586, DOI 10.2353/ajpath.2010.091217; Watson IR, 2011, CANCER CELL, V19, P168, DOI 10.1016/j.ccr.2011.01.002; Wei YH, 2011, J PROTEOME RES, V10, P161, DOI 10.1021/pr100491e; WIETHEGE T, 1995, J CANCER RES CLIN, V121, P371, DOI 10.1007/BF01225691; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Wistuba II, 1999, CLIN CANCER RES, V5, P991; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xiao ZX, 2013, CANCER CELL, V23, P527, DOI 10.1016/j.ccr.2013.03.009; Yang SY, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-83; Yang XQ, 2011, PHYSIOL GENOMICS, V43, P457, DOI 10.1152/physiolgenomics.00178.2010; Yonesaka K, 2016, ONCOGENE, V35, P878, DOI 10.1038/onc.2015.142; Yoon YK, 2010, MOL CARCINOGEN, V49, P353, DOI 10.1002/mc.20607; Yu GC, 2011, MOL BIOSYST, V7, P472, DOI 10.1039/c0mb00055h; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zhang W, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-74; Zhang W, 2014, PROTEOMICS, V14, P795, DOI 10.1002/pmic.201300382; Zhao HJ, 2011, MOL CANCER THER, V10, P29, DOI 10.1158/1535-7163.MCT-10-0778; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	103	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165973	10.1371/journal.pone.0165973	http://dx.doi.org/10.1371/journal.pone.0165973			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814385	Green Published, Green Submitted, gold			2022-12-26	WOS:000386911100024
J	Alvaro-Meca, A; Diaz, A; Diez, JDM; Resino, R; Resino, S				Alvaro-Meca, Alejandro; Diaz, Asuncion; de Miguel Diez, Javier; Resino, Rosa; Resino, Salvador			Environmental Factors Related to Pulmonary Tuberculosis in HIV-Infected Patients in the Combined Antiretroviral Therapy (cART) Era	PLOS ONE			English	Article							CASE-CROSSOVER DESIGN; VITAMIN-D LEVELS; AIR-POLLUTION; SEASONAL-VARIATION; DISEASE; RISK; STATISTICS; PARTICLES; DIAGNOSIS; SUNLIGHT	The aim of our study was to evaluate the seasonal variations and whether short-term exposure to environmental risk factors, such as climate and air pollution, is associated with PTB-related hospital admissions in human immunodeficiency virus (HIV)-infected patients in Spain during the era of combined antiretroviral therapy (cART). A retrospective study was carried out using data from the Minimum Basic Data Set (MBDS) and the State Meteorological Agency (AEMET) of Spain. The primary outcome variable was hospital admissions with PTB diagnosis. The environmental risk factors evaluated were season, temperature, humidity, NO2, SO2, O-3, PM10, and CO. Overall, HIV-infected patients had a lower frequency of PTB-related hospital admissions in summer (22.8%) and autumn (22.4%), but higher values in winter (26.6%) and spring (28.2%). Using a Bayesian temporal model, PTB-related hospital admissions were less frequent in summer-autumn and more abundant in winter-spring during the first years of follow-up. During the later years of follow-up, the seasonal trends continued resulting in the lowest values in autumn and the highest in spring. When considering short-term exposure to environmental risk factors, lower temperatures at 1 week (odds ratio (OR) = 1.03; p = 0.008), 1.5 weeks (OR = 1.03; p< 0.001), 2 weeks (OR = 1.04; p< 0.001), and 3 weeks (OR = 1.03; p< 0.001) prior to PTB admission. In addition, higher concentration of NO2 at the time of admission were significantly associated with higher likelihoods of PTB-related hospital admission in HIV-infected patients when 1.5 weeks (OR = 1.1; p = 0.044) and 2 weeks (OR = 1.21; p< 0.001) were used as controls. Finally, higher concentration of SO2 at 1.5 weeks prior to PTB admission was significantly associated with a higher likelihood of PTB-related hospital admissions (OR = 0.92; p = 0.029). In conclusion, our data suggest an apparent seasonal variation in hospital admissions of HIV-infected patients with a PTB diagnosis (summer/autumn vs. winter/spring), as well as a link to short-term exposure to environmental risk factors, such as temperature and ambient NO2 and SO2.	[Alvaro-Meca, Alejandro] Rey Juan Carlos Univ, Dept Prevent Med & Publ Hlth, Madrid, Spain; [Diaz, Asuncion] Inst Hlth Carlos III, Natl Ctr Epidemiol, Unit HIV Surveillance & Behav Monitoring, Madrid, Spain; [Diaz, Asuncion] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Network Biomed Res Ctr Epidemiol & Publ Hlth, Madrid, Spain; [de Miguel Diez, Javier] Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Serv Pneumol, Madrid, Spain; [Resino, Rosa] Univ Complutense Madrid, Fac Geog & Hist, Dept Human Geog, Madrid, Spain; [Resino, Salvador] Inst Hlth Carlos III, Natl Ctr Microbiol, Unit Viral Infect & Immun, Madrid, Spain	Universidad Rey Juan Carlos; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Complutense University of Madrid; General University Gregorio Maranon Hospital; Complutense University of Madrid; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Alvaro-Meca, A (corresponding author), Rey Juan Carlos Univ, Dept Prevent Med & Publ Hlth, Madrid, Spain.; Resino, S (corresponding author), Inst Hlth Carlos III, Natl Ctr Microbiol, Unit Viral Infect & Immun, Madrid, Spain.	alejandro.alvaro@urjc.es; sresino@isciii.es	Resino, Salvador/B-2430-2008; Diaz, Asuncion/Q-6016-2017	Resino, Salvador/0000-0001-8783-0450; Diaz, Asuncion/0000-0002-8309-4270; de Miguel-Diez, Javier/0000-0003-4543-573X; Alvaro-Meca, Alejandro/0000-0003-1315-4386; RESINO GARCIA, ROSA/0000-0002-9324-6397	Instituto de Salud Carlos III [PI14CIII/00011, PI12/00019]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work has been supported by a grant from "Instituto de Salud Carlos III" (Ref. PI14CIII/00011 to SR and PI12/00019 to AAM) (http://www.isciii.es).	Alvaro-Meca A, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19906; Atun RA, 2005, EUR J PUBLIC HEALTH, V15, P350, DOI 10.1093/eurpub/cki018; Bauer RN, 2012, J ALLERGY CLIN IMMUN, V129, P14, DOI 10.1016/j.jaci.2011.11.004; Boura M, 2014, J INT AIDS SOC, V17, P204, DOI 10.7448/IAS.17.4.19826; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; Dangor Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091464; Delfosse VC, 2015, ENVIRON TOXICOL, V30, P589, DOI 10.1002/tox.21936; ECDC/WHO, 2011, HIV AIDS SURV EUR 20; ECDC/WHO, 2013, TUB SURV MON EUR 201; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2014, TUB SURV MON EUR 201; Fares A, 2013, INT J PREVENTIVE MED, V4, P128; Fares A, 2011, J GLOB INFECT DIS, V3, P46, DOI 10.4103/0974-777X.77296; Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001; Gomez-Barroso D, 2013, INT J TUBERC LUNG D, V17, P745, DOI 10.5588/ijtld.12.0702; Griffin AT, 2012, AIDS PATIENT CARE ST, V26, P516, DOI 10.1089/apc.2012.0145; Grupo de Trabajo de la Encuesta Hospitalaria. [Working Group of the Hospital Survey], 2014, ENC HOSP PAC CON VIH, P1; Guzman-Fulgencio M, 2014, J INFECTION, V68, P176, DOI 10.1016/j.jinf.2013.10.011; Hildebrandt K, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-25; Hwang SS, 2014, KOREAN J INTERN MED, V29, P183, DOI 10.3904/kjim.2014.29.2.183; Iwai K, 2005, ENVIRON RES, V99, P106, DOI 10.1016/j.envres.2004.11.004; Jaakkola JJK, 2003, EUR RESPIR J, V21, p81S, DOI 10.1183/09031936.03.00402703; Jassal MS, 2013, PUBLIC HEALTH, V127, P268, DOI 10.1016/j.puhe.2012.12.030; Jiang RW, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0071-3; Kavasery R, 2009, JAIDS-J ACQ IMM DEF, V50, P360, DOI 10.1097/QAI.0b013e318198a800; Koh GCKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057752; Laumbach RJ, 2012, J ALLERGY CLIN IMMUN, V129, P3, DOI 10.1016/j.jaci.2011.11.021; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; MacLachlan JH, 2012, EMERG INFECT DIS, V18, P1879, DOI 10.3201/eid1811.120456; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Martineaua AR, 2011, P NATL ACAD SCI USA, V108, P19013, DOI 10.1073/pnas.1111825108; Muga R, 2007, AIDS, V21, P2521, DOI 10.1097/QAD.0b013e3282f1c933; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; Oliva J, 2014, GAC SANIT, V28, P116, DOI 10.1016/j.gaceta.2013.06.009; Oliva J, 2010, ENFERM INFEC MICR CL, V28, P583, DOI 10.1016/j.eimc.2010.02.013; Onozuka D, 2015, INT J BIOMETEOROL, V59, P1107, DOI 10.1007/s00484-014-0924-3; Organization WH, 2009, GLOB HLTH RISKS MORT; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Portilla J, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18945; R Core Team, 2011, R LANG ENV STAT COMP; Rice MB, 2013, AM J RESP CRIT CARE, V188, P1351, DOI 10.1164/rccm.201308-1414OC; Rios M, 2000, EUR J EPIDEMIOL, V16, P483, DOI 10.1023/A:1007653329972; Rodger A, 2003, BRIT MED J, V326, P909, DOI 10.1136/bmj.326.7395.909; Ronacher K, 2015, IMMUNOL REV, V264, P121, DOI 10.1111/imr.12257; Rue H., 2014, INLA FUNCTIONS WHICH; Santos LG, 2012, TUBERCULOSIS, V92, P293, DOI 10.1016/j.tube.2012.03.006; Sarkar S, 2012, J IMMUNOL, V188, P2778, DOI 10.4049/jimmunol.1101380; Shilova M V, 2004, Probl Tuberk Bolezn Legk, P17; Smith G.S., 2016, ENV HLTH PERSPECT; Smith GS, 2014, INT J ENVIRON HEAL R, V24, P103, DOI 10.1080/09603123.2013.800959; TB Stop partnership, 2011, GLOB PLAN STOP TB 20; Thorpe LE, 2004, LANCET, V364, P1613, DOI 10.1016/S0140-6736(04)17316-9; Tremblay GA, 2007, INT J TUBERC LUNG D, V11, P722; Vallecillo G, 2010, CURR HIV RES, V8, P641, DOI 10.2174/157016210794088272; Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]; Wingfield T, 2014, J INFECT DIS, V210, P774, DOI 10.1093/infdis/jiu121; World Health Organization, 2015, GLOB TUB REP 2015; Yang XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108369	58	26	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165944	10.1371/journal.pone.0165944	http://dx.doi.org/10.1371/journal.pone.0165944			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812194	Green Submitted, Green Published, gold			2022-12-26	WOS:000386910000082
J	Clare, DS; Spencer, M; Robinson, LA; Frid, CLJ				Clare, David S.; Spencer, Matthew; Robinson, Leonie A.; Frid, Christopher L. J.			Species-Specific Effects on Ecosystem Functioning Can Be Altered by Interspecific Interactions	PLOS ONE			English	Article							AMPHIPOD COROPHIUM-VOLUTATOR; NEREIS-DIVERSICOLOR MULLER,O.F.; RAGWORM HEDISTE-DIVERSICOLOR; POPULATION-DYNAMICS; TEMPORAL VARIATION; NORTH-ATLANTIC; EAST ENGLAND; BIODIVERSITY; SEDIMENT; COMMUNITIES	Biological assemblages are constantly undergoing change, with species being introduced, extirpated and experiencing shifts in their densities. Theory and experimentation suggest that the impacts of such change on ecosystem functioning should be predictable based on the biological traits of the species involved. However, interspecific interactions could alter how species affect functioning, with the strength and sign of interactions potentially depending on environmental context (e.g. homogenous vs. heterogeneous conditions) and the function considered. Here, we assessed how concurrent changes to the densities of two common marine benthic invertebrates, Corophium volutator and Hediste diversicolor, affected the ecological functions of organic matter consumption and benthic-pelagic nutrient flux. Complementary experiments were conducted within homogenous laboratory microcosms and naturally heterogeneous field plots. When the densities of the species were increased within microcosms, interspecific interactions enhanced effects on organic matter consumption and reduced effects on nutrient flux. Trait-based predictions of how each species would affect functioning were only consistently supported when the density of the other species was low. In field plots, increasing the density of either species had a positive effect on organic matter consumption (with no significant interspecific interactions) but no effect on nutrient flux. Our results indicate that species-specific effects on ecosystem functioning can be altered by interspecific interactions, which can be either facilitative (positive) or antagonistic (negative) depending on the function considered. The impacts of biodiversity change may therefore not be predictable based solely on the biological traits of the species involved. Possible explanations for why interactions were detected in microcosms but not in the field are discussed.	[Clare, David S.; Spencer, Matthew; Robinson, Leonie A.; Frid, Christopher L. J.] Univ Liverpool, Sch Environm Sci, Brownlow St, Liverpool L69 3GP, Merseyside, England; [Frid, Christopher L. J.] Griffith Univ, Griffith Sch Environm, Gold Coast Campus,G24 Parklands Dr, Southport, Qld 4222, Australia	University of Liverpool; Griffith University	Clare, DS (corresponding author), Univ Liverpool, Sch Environm Sci, Brownlow St, Liverpool L69 3GP, Merseyside, England.	David.Clare@liverpool.ac.uk		Frid, Christopher/0000-0002-7565-635X	University of Liverpool	University of Liverpool	This work was funded by the University of Liverpool as part of David Clare's PhD research.	Auguie B, 2017, GRIDEXTRA MISCELLANE; Barbeau MA, 2009, J CRUSTACEAN BIOL, V29, P491, DOI 10.1651/08-3067.1; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Braeckman U, 2010, MAR ECOL PROG SER, V399, P173, DOI 10.3354/meps08336; Bremner J, 2003, MAR ECOL PROG SER, V254, P11, DOI 10.3354/meps254011; Bremner J, 2008, J EXP MAR BIOL ECOL, V366, P37, DOI 10.1016/j.jembe.2008.07.007; Bulling M, 2008, OECOLOGIA, V158, P511, DOI 10.1007/s00442-008-1160-5; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cesar CP, 2012, MAR ECOL PROG SER, V466, P35, DOI 10.3354/meps09938; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; CHEVENET F, 1994, FRESHWATER BIOL, V31, P295, DOI 10.1111/j.1365-2427.1994.tb01742.x; Clare DS, 2016, MAR ECOL PROG SER, V547, P149, DOI 10.3354/meps11650; Clare DS, 2015, MAR ENVIRON RES, V107, P24, DOI 10.1016/j.marenvres.2015.03.012; de Deckere EMGT, 2000, HYDROBIOLOGIA, V426, P37, DOI 10.1023/A:1003978714382; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; Ehlers A, 2008, MAR ECOL PROG SER, V355, P1, DOI 10.3354/meps07369; Einfeldt AL, 2015, BIOL J LINN SOC, V115, P288, DOI 10.1111/bij.12507; Einfeldt AL, 2014, INVERTEBR BIOL, V133, P232, DOI 10.1111/ivb.12060; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Gamenick I, 1996, MAR ECOL PROG SER, V144, P73, DOI 10.3354/meps144073; Gaston KJ, 2010, SCIENCE, V327, P154, DOI 10.1126/science.1182818; GERDOL V, 1994, MAR ECOL PROG SER, V114, P103, DOI 10.3354/meps114103; Godbold JA, 2011, P ROY SOC B-BIOL SCI, V278, P2510, DOI 10.1098/rspb.2010.2414; Godbold JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007423; Godbold JA, 2009, OIKOS, V118, P77, DOI 10.1111/j.1600-0706.2008.17072.x; Graham PH, 2003, PLANT PHYSIOL, V131, P872, DOI 10.1104/pp.017004; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Hale R, 2014, SCI REP-UK, V4, DOI 10.1038/srep06463; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes RG, 1997, ESTUAR COAST SHELF S, V44, P621, DOI 10.1006/ecss.1996.0146; Inger R, 2015, ECOL LETT, V18, P28, DOI 10.1111/ele.12387; JACKSON D, 1985, OECOLOGIA, V65, P406, DOI 10.1007/BF00378916; Jousset A, 2011, ECOL LETT, V14, P537, DOI 10.1111/j.1461-0248.2011.01613.x; Kristensen E., 1988, SCOPE, V33, P275; Maestre FT, 2010, PHILOS T R SOC B, V365, P2057, DOI 10.1098/rstb.2010.0016; McGill BJ, 2015, TRENDS ECOL EVOL, V30, P104, DOI 10.1016/j.tree.2014.11.006; MEADOWS PS, 1966, J ZOOL, V150, P387; Mouillot D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017476; MURDOCH MH, 1986, J EXP MAR BIOL ECOL, V103, P235, DOI 10.1016/0022-0981(86)90143-7; Nixon SW, 1981, ESTUARIES NUTRIENTS, P111, DOI DOI 10.1007/978-1-4612-5826-1_6; OLAFSSON EB, 1986, J EXP MAR BIOL ECOL, V103, P103, DOI 10.1016/0022-0981(86)90135-8; Orvain F, 2006, J SEA RES, V55, P54, DOI 10.1016/j.seares.2005.10.002; PELEGRI SP, 1994, MAR ECOL PROG SER, V105, P285, DOI 10.3354/meps105285; Pereira HM, 2012, ANNU REV ENV RESOUR, V37, P25, DOI 10.1146/annurev-environ-042911-093511; Peres CA, 2000, OECOLOGIA, V122, P175, DOI 10.1007/PL00008845; Polley HW, 2003, ECOL LETT, V6, P248, DOI 10.1046/j.1461-0248.2003.00422.x; RIISGARD HU, 1991, MAR ECOL PROG SER, V70, P29, DOI 10.3354/meps070029; RONN C, 1988, J EXP MAR BIOL ECOL, V116, P143, DOI 10.1016/0022-0981(88)90052-4; Scaps P, 2002, HYDROBIOLOGIA, V470, P203, DOI 10.1023/A:1015681605656; Schuckel U, 2013, ESTUAR COAST SHELF S, V117, P210, DOI 10.1016/j.ecss.2012.11.008; Schumacher J, 1930, HELGOLAND MAR RES, V68, P289; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Strong JA, 2015, ESTUAR COAST SHELF S, V161, P46, DOI 10.1016/j.ecss.2015.04.008; Tilman D, 2014, ANNU REV ECOL EVOL S, V45, P471, DOI 10.1146/annurev-ecolsys-120213-091917; Tiunov AV, 2005, ECOL LETT, V8, P618, DOI 10.1111/j.1461-0248.2005.00757.x; Tornroos A, 2015, J EXP MAR BIOL ECOL, V472, P32, DOI 10.1016/j.jembe.2015.06.015; Venables WN., 2002, MODERN APPL STAT S 4; Widdows J, 1998, ESTUARIES, V21, P552, DOI 10.2307/1353294; Ysebaert T, 2005, HYDROBIOLOGIA, V540, P197, DOI 10.1007/s10750-004-7144-5; Ysebaert T, 2002, MAR ECOL PROG SER, V244, P105, DOI 10.3354/meps244105	65	7	7	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165739	10.1371/journal.pone.0165739	http://dx.doi.org/10.1371/journal.pone.0165739			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812164	Green Published, Green Submitted, gold			2022-12-26	WOS:000386910000054
J	Dodo, Y; Murakami, T; Unoki, N; Ogino, K; Uji, A; Yoshitake, S; Yoshimura, N				Dodo, Yoko; Murakami, Tomoaki; Unoki, Noriyuki; Ogino, Ken; Uji, Akihito; Yoshitake, Shin; Yoshimura, Nagahisa			White Dots as a Novel Marker of Diabetic Retinopathy Severity in Ultrawide Field Imaging	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; COHERENCE TOMOGRAPHIC CHARACTERISTICS; MICROANEURYSMS; PREVALENCE; TRIAL; RISK	Purpose To characterize white dots in diabetic retinopathy (DR) and their association with disease severity using ultra-wide-field scanning laser ophthalmoscopy. Methods We randomly selected 125 eyes of 77 patients (25 eyes from individual categories of the international classification of DR severity) for which ultrawide field photographs were obtained. We characterized white dots, which were delineated by higher signal levels on green but not red laser images, and evaluated the relationship between the number of white dots and the international severity scale of DR. Results Most white dots were located in nonperfused areas, and the number of total white dots was significantly correlated to that of dots in nonperfused areas. White dots corresponded to microaneurysms around the boundary between nonperfused areas and perfused areas or unknown lesions in nonperfused areas. Eyes with DR had significantly more white dots than those with no apparent retinopathy. The numbers of white dots in moderate nonproliferative diabetic retinopathy (NPDR) or more severe grades were significantly higher than in mild NPDR. The area under the receiver operating characteristics curve (AROC) analyses demonstrated that the number of white dots had the significance in the diagnosis of DR (0.908-0.986) and moderate NPDR or more severe grades (0.888-0.974). Conclusions These data suggest the clinical relevance of white dots seen on ultrawide field images in the diagnosis of the severity of DR.	[Dodo, Yoko; Murakami, Tomoaki; Unoki, Noriyuki; Ogino, Ken; Uji, Akihito; Yoshitake, Shin; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan	Kyoto University	Murakami, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan.	mutomo@kuhp.kyoto-u.ac.jp			Japan Society for the Promotion of Sciences	Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research of Japan Society for the Promotion of Sciences. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; [Anonymous], 1991, OPHTHALMOLOGY, V98, P786; [Anonymous], 1991, OPHTHALMOLOGY, V98, P823; [Anonymous], 1976, AM J OPHTHALMOL, V81, P383; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Arichika S, 2013, INVEST OPHTH VIS SCI, V54, P4394, DOI 10.1167/iovs.12-11138; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; BEK T, 1994, ACTA OPHTHALMOL, V72, P409; Bolz M, 2009, OPHTHALMOLOGY, V116, P914, DOI 10.1016/j.ophtha.2008.12.039; BRESNICK GH, 1977, ARCH OPHTHALMOL-CHIC, V95, P1215, DOI 10.1001/archopht.1977.04450070113010; Byeon SH, 2009, OPHTHALMOLOGY, V116, P1949, DOI 10.1016/j.ophtha.2009.06.066; Cunningham ET, 2005, OPHTHALMOLOGY, V112, P1747, DOI 10.1016/j.ophtha.2005.06.007; De Venecia G, 1976, Arch Ophthalmol, V94, P1766; Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678; Gardner TW, 2002, SURV OPHTHALMOL, V47, pS253, DOI 10.1016/S0039-6257(02)00387-9; Horii T, 2010, AM J OPHTHALMOL, V150, P840, DOI 10.1016/j.ajo.2010.06.015; Ito H, 2013, RETINA-J RET VIT DIS, V33, P732, DOI 10.1097/IAE.0b013e31826b0bd7; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; KLEIN R, 1995, ARCH OPHTHALMOL-CHIC, V113, P1386, DOI 10.1001/archopht.1995.01100110046024; Kohner EM, 1999, DIABETOLOGIA, V42, P1107, DOI 10.1007/s001250051278; Mackenzie PJ, 2007, RETINA-J RET VIT DIS, V27, P1119, DOI 10.1097/IAE.0b013e3180592b5c; Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; Murakami T, 2012, DIABETES, V61, P1573, DOI 10.2337/db11-1367; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Shin YU, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.036; Silva PS, 2013, OPHTHALMOLOGY, V120, P2587, DOI 10.1016/j.ophtha.2013.05.004; Vujosevic S, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/491835; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wilson PJ, 2010, OPHTHALMOLOGICA, V224, P251, DOI 10.1159/000284351; Yanoff M, 1984, SURV OPHTHALMOL S, V28, P505; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909	32	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165906	10.1371/journal.pone.0165906	http://dx.doi.org/10.1371/journal.pone.0165906			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812207	Green Published, gold, Green Submitted			2022-12-26	WOS:000386910000076
J	Komatsu, H; Inui, A; Umetsu, S; Tsunoda, T; Sogo, T; Konishi, Y; Fujisawa, T				Komatsu, Haruki; Inui, Ayano; Umetsu, Shuichiro; Tsunoda, Tomoyuki; Sogo, Tsuyoshi; Konishi, Yasuhiro; Fujisawa, Tomoo			Evaluation of the G145R Mutant of the Hepatitis B Virus as a Minor Strain in Mother-to-Child Transmission	PLOS ONE			English	Article							REAL-TIME PCR; PERIPHERAL-BLOOD LEUKOCYTES; NUCLEIC-ACID PROBES; SURFACE-ANTIGEN; S GENE; IMMUNOPROPHYLAXIS FAILURE; IMMUNE GLOBULIN; POSTNATAL IMMUNOPROPHYLAXIS; INFANT TRANSMISSION; VACCINE FAILURE	The role of the hepatitis B virus (HBV) mutant G145R, with a single change in amino acid 145 of the surface protein, as a minor population remains unknown in mother-to-child transmission. The minor strain as well as the major strain of the G145R mutant were evaluated in three cohorts using a locked nucleic acid probe-based real-time PCR. The breakthrough cohort consisted of children who were born to HBV carrier mothers and became HBV carriers despite immnoprophylaxis (n = 25). The control cohort consisted of HBV carriers who had no history of receiving the hepatitis B vaccine, hepatitis B immunoglobulin or antiviral treatment (n = 126). The pregnant cohort comprised pregnant women with chronic HBV infection (n = 31). In the breakthrough cohort, 6 showed positive PCR results (major, 2; minor, 4). In the control cohort, 13 showed positive PCR results (major, 0; minor, 13). HBeAg-positive patients were prone to have the G145R mutant as a minor population. Deep sequencing was performed in a total of 32 children (PCR positive, n = 13; negative, n = 19). In the breakthrough cohort, the frequency of the G145R mutant ranged from 0.54% to 6.58%. In the control cohort, the frequency of the G145R mutant ranged from 0.42% to 4.1%. Of the 31 pregnant women, 4 showed positive PCR results (major, n = 0; minor, n = 4). All of the pregnant women were positive for HBeAg and showed a high viral load. Three babies born to 3 pregnant women with the G145R mutant were evaluated. After the completion of immunoprophylaxis, 2 infants became negative for HBsAg. The remaining infant became negative for HBsAg after the first dose of HB vaccine. G145R was detected in one-fourth of the children with immunoprophylaxis failure. However, the pre-existence of the G145R mutant as a minor population in pregnant women does not always cause breakthrough infection in infants.	[Komatsu, Haruki] Toho Univ, Dept Pediat, Sakura Med Ctr, Chiba, Japan; [Komatsu, Haruki; Inui, Ayano; Umetsu, Shuichiro; Tsunoda, Tomoyuki; Sogo, Tsuyoshi; Fujisawa, Tomoo] Eastern Yokohama Hosp, Dept Pediat Hepatol & Gastroenterol, Yokohama, Kanagawa, Japan; [Konishi, Yasuhiro] Eastern Yokohama Hosp, Dept Obstet & Gynecol, Yokohama, Kanagawa, Japan	Toho University	Komatsu, H (corresponding author), Toho Univ, Dept Pediat, Sakura Med Ctr, Chiba, Japan.; Komatsu, H (corresponding author), Eastern Yokohama Hosp, Dept Pediat Hepatol & Gastroenterol, Yokohama, Kanagawa, Japan.	haruki-komatsu@chive.ocn.ne.jp			JSPS KAKENHI [15K09701]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI (Grant-in-Aid for Scientific Research) grant number 15K09701.	Ayres A, 2014, J VIRAL HEPATITIS, V21, P809, DOI 10.1111/jvh.12212; BEASLEY RP, 1983, LANCET, V2, P1099; Buchanan C, 2010, CLIN LIVER DIS, V14, P495, DOI 10.1016/j.cld.2010.05.008; Bzowej Natalie H, 2010, Curr Hepat Rep, V9, P197, DOI 10.1007/s11901-010-0059-x; CARMAN WF, 1990, LANCET, V336, P325, DOI 10.1016/0140-6736(90)91874-A; Chakravarty R, 2002, VIRUS RES, V90, P133, DOI 10.1016/S0168-1702(02)00147-8; Cooreman MP, 2001, J BIOMED SCI, V8, P237, DOI 10.1007/BF02256597; Datta S, 2009, J VIROL, V83, P9983, DOI 10.1128/JVI.01905-08; Dunkelberg JC, 2014, J PERINATOL, V34, P882, DOI 10.1038/jp.2014.167; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; Francois G, 2001, VACCINE, V19, P3799, DOI 10.1016/S0264-410X(01)00108-6; Gambarin-Gelwan Maya, 2007, Clin Liver Dis, V11, P945, DOI 10.1016/j.cld.2007.08.004; Hige S, 2010, J CLIN MICROBIOL, V48, P4487, DOI 10.1128/JCM.00731-10; HINO K, 1995, DIGEST DIS SCI, V40, P566, DOI 10.1007/BF02064370; Hsu HY, 2013, J INFECT DIS, V207, P1047, DOI 10.1093/infdis/jis943; Hsu HY, 2004, GUT, V53, P1499, DOI 10.1136/gut.2003.034223; Hsu HY, 1997, HEPATOLOGY, V26, P786, DOI 10.1053/jhep.1997.v26.pm0009303514; Jonas MM, 2009, LIVER INT, V29, P133, DOI 10.1111/j.1478-3231.2008.01933.x; Kitab B, 2011, J INFECTION, V63, P66, DOI 10.1016/j.jinf.2011.05.007; Komatsu H, 2002, J MED VIROL, V66, P28, DOI 10.1002/jmv.2107; Komatsu Haruki, 2012, BMC Res Notes, V5, P22, DOI 10.1186/1756-0500-5-22; Kumar A, 2012, INDIAN J GASTROENTER, V31, P43, DOI 10.1007/s12664-012-0174-4; Lada O, 2006, J VIROL, V80, P2968, DOI 10.1128/JVI.80.6.2968-2975.2006; Lazarevic I, 2010, J MED VIROL, V82, P1160, DOI 10.1002/jmv.21810; Lee PI, 1997, J INFECT DIS, V176, P427, DOI 10.1086/514060; Liu Y, 2007, J CLIN MICROBIOL, V45, P553, DOI 10.1128/JCM.00709-06; Liu Y, 2012, J MICROBIOL METH, V91, P483, DOI 10.1016/j.mimet.2012.10.002; Matsumoto T, 1997, J MED VIROL, V53, P255, DOI 10.1002/(SICI)1096-9071(199711)53:3<255::AID-JMV13>3.0.CO;2-G; MITAMURA K, 1991, PROG CLIN BIOL RES, V364, P81; Miyake Y, 1996, TOHOKU J EXP MED, V180, P233, DOI 10.1620/tjem.180.233; Nainan OV, 2002, J MED VIROL, V68, P319, DOI 10.1002/jmv.10206; Ngui SL, 1997, J INFECT DIS, V176, P1360, DOI 10.1086/514133; Ntziora F, 2013, J CLIN MICROBIOL, V51, P2893, DOI 10.1128/JCM.00936-13; Ogura Y, 1999, J INFECT DIS, V180, P1444, DOI 10.1086/315094; OKAMOTO H, 1992, PEDIATR RES, V32, P264, DOI 10.1203/00006450-199209000-00002; OKAMOTO H, 1987, JPN J EXP MED, V57, P231; Osiowy C, 2002, J CLIN MICROBIOL, V40, P2566, DOI 10.1128/JCM.40.7.2566-2571.2002; Osiowy C, 2006, J VIROL, V80, P10307, DOI 10.1128/JVI.00996-06; Pan CVQ, 2012, CLIN GASTROENTEROL H, V10, P452, DOI 10.1016/j.cgh.2011.10.041; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Patton H, 2014, NAT REV GASTRO HEPAT, V11, P402, DOI 10.1038/nrgastro.2014.30; Rodriguez-Frias F, 1999, LIVER, V19, P177, DOI 10.1111/j.1478-3231.1999.tb00032.x; Rodriguez-Frias F, 2013, WORLD J GASTROENTERO, V19, P6995, DOI 10.3748/wjg.v19.i41.6995; Sa-nguanmoo P, 2012, J MED VIROL, V84, P1177, DOI 10.1002/jmv.23260; Singh AE, 2011, J VIRAL HEPATITIS, V18, P468, DOI 10.1111/j.1365-2893.2010.01333.x; Song BC, 2005, J MED VIROL, V76, P194, DOI 10.1002/jmv.20354; Sun Z, 2007, GENOMICS, V89, P151, DOI 10.1016/j.ygeno.2006.07.011; Tadokoro K, 2006, J VIROL METHODS, V138, P30, DOI 10.1016/j.jviromet.2006.07.014; Terrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156; Wang Q, 2012, EXP THER MED, V3, P503, DOI 10.3892/etm.2011.442; Warshawsky I, 2011, J CLIN PATHOL, V64, P905, DOI 10.1136/jclinpath-2011-200086; World Health Organization (WHO), 2016, MED CTR HEP B; Xu HM, 2006, J INFECT DIS, V193, P88, DOI 10.1086/498573; Zhang L, 2014, EUR J PEDIATR, V173, P1161, DOI 10.1007/s00431-014-2305-7; Zhang M, 2002, HEPATOLOGY, V36, P723, DOI 10.1053/jhep.2002.35346; Zou H, 2012, J VIRAL HEPATITIS, V19, pE18, DOI 10.1111/j.1365-2893.2011.01492.x	56	9	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165674	10.1371/journal.pone.0165674	http://dx.doi.org/10.1371/journal.pone.0165674			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812178	gold, Green Published, Green Submitted			2022-12-26	WOS:000386910000047
J	Liu, BY; Tai, Y; Caceres, AI; Achanta, S; Balakrishna, S; Shao, XM; Fang, JF; Jordt, SE				Liu, Boyi; Tai, Yan; Caceres, Ana I.; Achanta, Satyanarayana; Balakrishna, Shrilatha; Shao, Xiaomei; Fang, Junfan; Jordt, Sven-Eric			Oxidized Phospholipid OxPAPC Activates TRPA1 and Contributes to Chronic Inflammatory Pain in Mice	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; RECEPTOR POTENTIAL A1; COVALENT MODIFICATION; HYDROGEN-PEROXIDE; PROSTAGLANDIN E-2; OXIDATIVE STRESS; ION CHANNELS; LUNG INJURY; IN-VITRO; IDENTIFICATION	Oxidation products of the naturally occurring phospholipid 1-palmitoyl-2-arachidonoyl-sn-glycerol-3-phosphatidylcholine (PAPC), which are known as OxPAPC, accumulate in atherosclerotic lesions and at other sites of inflammation in conditions such as septic inflammation and acute lung injury to exert pro-or anti-inflammatory effects. It is currently unknown whether OxPAPC also contributes to inflammatory pain and peripheral neuronal excitability in these conditions. Here, we observed that OxPAPC dose-dependently and selectively activated human TRPA1 nociceptive ion channels expressed in HEK293 cells in vitro, without any effect on other TRP channels, including TRPV1, TRPV4 and TRPM8. OxPAPC agonist activity was dependent on essential cysteine and lysine residues within the N-terminus of the TRPA1 channel protein. OxPAPC activated calcium influx into a subset of mouse sensory neurons which were also sensitive to the TRPA1 agonist mustard oil. Neuronal OxPAPC responses were largely abolished in neurons isolated from TRPA1-deficient mice. Intraplantar injection of OxPAPC into the mouse hind paw induced acute pain and persistent mechanical hyperalgesia and this effect was attenuated by the TRPA1 inhibitor, HC-030031. More importantly, we found levels of OxPAPC to be significantly increased in inflamed tissue in a mouse model of chronic inflammatory pain, identified by the binding of an OxPAPC-specific antibody. These findings suggest that TRPA1 is a molecular target for OxPAPC and OxPAPC may contribute to chronic inflammatory pain through TRPA1 activation. Targeting against OxPAPC and TRPA1 signaling pathway may be promising in inflammatory pain treatment.	[Liu, Boyi; Shao, Xiaomei; Fang, Junfan] Zhejiang Chinese Med Univ, Clin Med Coll 3, Dept Neurobiol & Acupuncture Res, Hangzhou, Zhejiang, Peoples R China; [Tai, Yan] Zhejiang Chinese Med Univ, Dept Lab & Equipment Adm, Hangzhou, Zhejiang, Peoples R China; [Tai, Yan; Caceres, Ana I.; Achanta, Satyanarayana; Jordt, Sven-Eric] Duke Univ, Sch Med, Dept Anesthesiol, Durham, NC 27703 USA; [Balakrishna, Shrilatha] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Duke University; Yale University	Jordt, SE (corresponding author), Duke Univ, Sch Med, Dept Anesthesiol, Durham, NC 27703 USA.	sven.jordt@duke.edu	Jordt, Sven-Eric/ABE-6517-2020; Achanta, Satyanarayana/I-8440-2017; tai, yh/GRR-4574-2022; Caceres, Ana I/E-5542-2012	Jordt, Sven-Eric/0000-0001-6171-5622; Achanta, Satyanarayana/0000-0001-7121-5445; Caceres, Ana I/0000-0001-7219-8851	National Institute of Environmental Health Sciences [U01 ES015674]; National Institute of Arthritis and Musculoskeletal and Skin Disease [R21 AR070554]; National Center for Advancing Translational Sciences [UL1TR001117]; Duke Anesthesiology Dream Innovation Grant [2015-DIG LIU]; National Natural Science Foundation of China [81603676]; Zhejiang Provincial Natural Science Funds for Distinguished Young Scholars [LR17H270001]; Zhejiang Chinese Medical University Starting-up Funding [722223A08301/001/004]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR070554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES015674] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Arthritis and Musculoskeletal and Skin Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Duke Anesthesiology Dream Innovation Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Funds for Distinguished Young Scholars; Zhejiang Chinese Medical University Starting-up Funding; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project is supported by funding from the National Institute of Environmental Health Sciences U01 ES015674 (http://www.niehs.nih.gov/), National Institute of Arthritis and Musculoskeletal and Skin Disease R21 AR070554 (http://www.niams.nih.gov/) to S.E.J. and from National Center for Advancing Translational Sciences UL1TR001117 (https://ncats.nih.gov), Duke Anesthesiology Dream Innovation Grant 2015-DIG LIU (http://anesthesia.mc.dke.edu/), National Natural Science Foundation of China 81603676 (http://www.nsfc.gov.cn/), Zhejiang Provincial Natural Science Funds for Distinguished Young Scholars LR17H270001 (http://www.zjnsf.gov.cn/index.aspx), Zhejiang Chinese Medical University Starting-up Funding 722223A08301/001/004 (http://www.zcmu.edu.cn/) to B.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	af Forselles KJ, 2011, BRIT J PHARMACOL, V164, P1847, DOI 10.1111/j.1476-5381.2011.01495.x; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Asgar J, 2015, NEUROSCIENCE, V310, P206, DOI 10.1016/j.neuroscience.2015.09.042; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Awasthi D, 2016, FREE RADICAL BIO MED, V93, P190, DOI 10.1016/j.freeradbiomed.2016.01.004; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; Bellono NW, 2013, P NATL ACAD SCI USA, V110, P2383, DOI 10.1073/pnas.1215555110; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Bessac BF, 2009, FASEB J, V23, P1102, DOI 10.1096/fj.08-117812; Birukov KG, 2004, MICROVASC RES, V67, P18, DOI 10.1016/j.mvr.2003.09.004; Bluml S, 2005, J IMMUNOL, V175, P501, DOI 10.4049/jimmunol.175.1.501; Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; Bochkov VN, 2002, BLOOD, V99, P199, DOI 10.1182/blood.V99.1.199; da Costa DSM, 2010, PAIN, V148, P431, DOI 10.1016/j.pain.2009.12.002; Dall'Acqua MC, 2014, LIFE SCI, V105, P7, DOI 10.1016/j.lfs.2014.02.031; Earley S, 2009, CIRC RES, V104, P987, DOI 10.1161/CIRCRESAHA.108.189530; Erridge C, 2008, J BIOL CHEM, V283, P24748, DOI 10.1074/jbc.M800352200; Fernandes ES, 2011, ARTHRITIS RHEUM-US, V63, P819, DOI 10.1002/art.30150; Fruhwirth GO, 2007, BBA-MOL BASIS DIS, V1772, P718, DOI 10.1016/j.bbadis.2007.04.009; Furnkranz A, 2005, ARTERIOSCL THROM VAS, V25, P633, DOI 10.1161/01.ATV.0000153106.03644.a0; Grace M, 2012, THORAX, V67, P891, DOI 10.1136/thoraxjnl-2011-201443; Gruber F, 2007, J BIOL CHEM, V282, P16934, DOI 10.1074/jbc.M702523200; Gruber F, 2010, FASEB J, V24, P39, DOI 10.1096/fj.09-133520; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Horkko S, 1999, J CLIN INVEST, V103, P117, DOI 10.1172/JCI4533; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Kadl A, 2011, FREE RADICAL BIO MED, V51, P1903, DOI 10.1016/j.freeradbiomed.2011.08.026; Kadl A, 2009, ARTHRITIS RHEUM-US, V60, P1362, DOI 10.1002/art.24448; KEERY RJ, 1988, BRIT J PHARMACOL, V94, P745, DOI 10.1111/j.1476-5381.1988.tb11584.x; Li RS, 2006, CIRC RES, V98, P642, DOI 10.1161/01.RES.0000207394.39249.fc; Liu BY, 2013, PAIN, V154, P2169, DOI 10.1016/j.pain.2013.06.043; Liu BY, 2013, FASEB J, V27, P3549, DOI 10.1096/fj.13-229948; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Meliton AY, 2015, AM J PHYSIOL-LUNG C, V308, pL550, DOI 10.1152/ajplung.00248.2014; Nassini R, 2014, REV PHYSIOL BIOCH P, V167, P1, DOI 10.1007/112_2014_18; Nassini R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042454; Oskolkova OV, 2010, J IMMUNOL, V185, P7706, DOI 10.4049/jimmunol.0903594; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Pitcher GM, 1999, J NEUROSCI METH, V87, P185, DOI 10.1016/S0165-0270(99)00004-7; Romanoski CE, 2011, CIRC RES, V109, pE27, DOI 10.1161/CIRCRESAHA.111.241869; Springstead JR, 2012, J LIPID RES, V53, P1304, DOI 10.1194/jlr.M025320; Subbanagounder G, 2000, ARTERIOSCL THROM VAS, V20, P2248, DOI 10.1161/01.ATV.20.10.2248; Thimmulappa RK, 2012, BIOCHEM BIOPH RES CO, V426, P253, DOI 10.1016/j.bbrc.2012.08.076; Trevisan G, 2016, BRAIN; Trevisan G, 2014, FREE RADICAL BIO MED, V72, P200, DOI 10.1016/j.freeradbiomed.2014.04.021; Trevisan G, 2013, ARTHRITIS RHEUM-US, V65, P2984, DOI 10.1002/art.38112; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; VILE GF, 1995, FREE RADICAL BIO MED, V18, P721, DOI 10.1016/0891-5849(94)00192-M; WOODWARD DF, 1995, BIOCHEM PHARMACOL, V50, P1731, DOI 10.1016/0006-2952(95)02035-7; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692	51	34	35	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165200	10.1371/journal.pone.0165200	http://dx.doi.org/10.1371/journal.pone.0165200			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812120	gold, Green Published, Green Submitted			2022-12-26	WOS:000386910000023
J	Niedz, RP				Niedz, Randall P.			ARS-Media for Excel: A Spreadsheet Tool for Calculating Media Recipes Based on Ion-Specific Constraints	PLOS ONE			English	Article							TISSUE-CULTURE MEDIUM; IN-VITRO CULTURE; MINERAL-COMPOSITION; OLIVE TREES; MICROPROPAGATION; POTASSIUM; GROWTH; SODIUM; CULTIVARS; NUTRITION	ARS-Media for Excel is an ion solution calculator that uses "Microsoft Excel" to generate recipes of salts for complex ion mixtures specified by the user. Generating salt combinations (recipes) that result in pre-specified target ion values is a linear programming problem. Excel's Solver add-on solves the linear programming equation to generate a recipe. Calculating a mixture of salts to generate exact solutions of complex ionic mixtures is required for at least 2 types of problems-1) formulating relevant ecological/biological ionic solutions such as those from a specific lake, soil, cell, tissue, or organ and, 2) designing ion confounding-free experiments to determine ion-specific effects where ions are treated as statistical factors. Using ARS-Media for Excel to solve these two problems is illustrated by 1) exactly reconstructing a soil solution representative of a loamy agricultural soil and, 2) constructing an ion-based experiment to determine the effects of substituting Na+ for K+ on the growth of a Valencia sweet orange nonembryogenic cell line.	[Niedz, Randall P.] ARS, USDA, US Hort Res Lab, Ft Pierce, FL 34945 USA	United States Department of Agriculture (USDA)	Niedz, RP (corresponding author), ARS, USDA, US Hort Res Lab, Ft Pierce, FL 34945 USA.	randall.niedz@ars.usda.gov						Anderson M.J., 2016, RSM SIMPLIFIED OPTIM; ANGLE JS, 1991, APPL ENVIRON MICROB, V57, P3674, DOI 10.1128/AEM.57.12.3674-3676.1991; [Anonymous], 2003, MINEQL CHEM EQUILIBR; Ashrafi EN, 2010, J FOOD AGRIC ENVIRON, V8, P325; Erel R, 2015, J PLANT PHYSIOL, V177, P1, DOI 10.1016/j.jplph.2015.01.005; Erel R, 2014, TREE PHYSIOL, V34, P1102, DOI 10.1093/treephys/tpu081; Evens TJ, 2008, SCHOLARLY RES EXCHAN, DOI [10.3814/2008/761829, DOI 10.3814/2008/761829]; Goncalves S, 2005, BIOL PLANTARUM, V49, P277, DOI 10.1007/s10535-005-7280-4; Oberschelp GPJ, 2015, IN VITRO CELL DEV-PL, V51, P626, DOI 10.1007/s11627-015-9715-8; Krishnasamy K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00631; LITVAY JD, 1981, I PAPER CHEM TECH PA, V115, P1; Monteiro ACBD, 2000, IN VITRO CELL DEV-PL, V36, P527, DOI 10.1007/s11627-000-0094-3; Morard P, 1998, J PLANT NUTR, V21, P1565, DOI 10.1080/01904169809365504; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; MURASHIGE T., 1969, Proceedings 1st int. Citrus Symp., Univ. California, Riverside 1968., V3, P1155; Nas MN, 2013, TURK J BOT, V37, P1134, DOI 10.3906/bot-1302-49; Nas MN, 2004, SCI HORTIC-AMSTERDAM, V101, P189, DOI 10.1016/j.scienta.2003.10.004; Niedz RP, 2007, IN VITRO CELL DEV-PL, V43, P370, DOI 10.1007/s11627-007-9062-5; Niedz RP, 2006, NAT METHODS, V3, P417, DOI 10.1038/nmeth0606-417; Smith EJ, 2002, WATER RES, V36, P1286, DOI 10.1016/S0043-1354(01)00341-4; Staikidou I, 2006, J HORTIC SCI BIOTECH, V81, P537, DOI 10.1080/14620316.2006.11512100; Wakeel A, 2011, CRIT REV PLANT SCI, V30, P401, DOI 10.1080/07352689.2011.587728	22	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166025	10.1371/journal.pone.0166025	http://dx.doi.org/10.1371/journal.pone.0166025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812202	gold, Green Submitted, Green Published			2022-12-26	WOS:000386910000095
J	Ushie, BA; Ugal, DB; Ingwu, JA				Ushie, Boniface Ayanbekongshie; Ugal, David Betelwhobel; Ingwu, Justin Agorye			Overdependence on For-Profit Pharmacies: A Descriptive Survey of User Evaluation of Medicines Availability in Public Hospitals in Selected Nigerian States	PLOS ONE			English	Article							HEALTH-CARE; AFFORDABILITY; VENDORS; ACCESS; INCOME; DRUGS; URBAN	Objective Lower availability of medicines in Nigerian public health facilities D the most affordable option for the masses D undermines global health reforms to improve access to health for all, especially the chronically ill and poor. Thus, a sizeable proportion of healthcare users, irrespective of purchasing power, buy medicines at higher costs from for-profit pharmacies. We examined user evaluation of medicine availability in public facilities and how this influences their choice of where to buy medicines in selected states D Cross River, Enugu and Oyo D in Nigeria. Methods We approached and interviewed 1711 healthcare users using a semi-structured, interviewer-administered questionnaire as they exited for-profit pharmacies after purchasing medicines. This ensured that both clients who had presented at health facilities (private/public) and those who did not were included. Information was collected on why respondents could not buy medicines at the hospitals they attended, their views of medicine availability and whether their choice of where to buy medicines is influenced by non-availability. Principal Findings Respondents' mean age was 37.7 +/- 14.4 years; 52% were males, 59% were married, 82% earned >= NGN18, 000 (US$57.19) per month, and 72% were not insured. Majority (66%) had prescriptions; of this, 70% were from public facilities. Eighteen percent of all respondents indicated that all their medicines were usually available at the public facilities, most (29%), some (44%) and not always available (10%). Reasons for using for-profit pharmacies included: health workers attitudes (43%), referral by providers (43%); inadequate money to purchase all prescribed drugs (42%) and cumbersome processes for obtaining medicines. Conclusions Lower availability of medicines has serious implications for healthcare behavior, especially because of poverty. It is crucial for government to fulfill its mandate of equitable access to care for all by making medicines available and cheap through reviving and sustaining the drug revolving fund scheme and encouraging the prescription of generic drugs in all public health facilities.	[Ushie, Boniface Ayanbekongshie] Univ Ibadan, Inst Child Hlth, Coll Med, Ibadan, Nigeria; [Ugal, David Betelwhobel] Fed Univ Lafia, Dept Sociol, Lafia, Nigeria; [Ingwu, Justin Agorye] Univ Nigeria, Dept Nursing Sci, Nsukka, Nigeria	University of Ibadan; University of Nigeria	Ushie, BA (corresponding author), Univ Ibadan, Inst Child Hlth, Coll Med, Ibadan, Nigeria.	boniface.ushie@gmail.com		Ushie, Boniface Ayanbekongshie/0000-0001-6579-6327	Tertiary Education Trust Fund; Federal Government of Nigeria	Tertiary Education Trust Fund; Federal Government of Nigeria	The authors received funding for this work from the Tertiary Education Trust Fund, which is provided by the Federal Government of Nigeria; http://www.tetfund.gov.ng/.	Abegunde K. A., 2013, J COMMUNITY MED PRIM, V26, P1; Adesina, 2002, CURRENTS PERSPECTIVE, P212; Alubo O, 2001, HEALTH POLICY PLANN, V16, P313, DOI 10.1093/heapol/16.3.313; Alubo S. O., 1999, SOC SCI MED, V38, P97; Babar ZUD, 2013, PHARMACOECONOMICS, V31, P1063, DOI 10.1007/s40273-013-0095-9; Bigdeli M, 2013, HEALTH POLICY PLANN, V28, P692, DOI 10.1093/heapol/czs108; Brieger WR, 2004, HEALTH POLICY PLANN, V19, P177, DOI 10.1093/heapol/czh021; Brinda EM, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-5; BROCK DW, 1987, J MED PHILOS, V12, P1; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Chandler CIR, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-13; Eke Christopher Bismarck, 2014, BMC Res Notes, V7, P800, DOI 10.1186/1756-0500-7-800; Fadare J. O., 2015, EXPERT REV PHARM OUT, P1; FMOH, 2005, INV HLTH FAC NIG; Foster S.D., 1990, IMPROVING SUPPLY USE; Garg CC, 2009, HEALTH POLICY PLANN, V24, P116, DOI 10.1093/heapol/czn046; Iloh GUP, 2012, NIGER J CLIN PRACT, V15, P469, DOI 10.4103/1119-3077.104529; Iyioha IO, 2016, COMP HLTH LAW POLICY; Jitta J, 2003, HEALTH POLICY, V65, P167, DOI 10.1016/S0168-8510(03)00003-4; Johnson O. E., 2015, J COMMUNITY MED PRIM, V27, P73; Kotwani A, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-285; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; Muhammed KA, 2013, J PUBLIC HEALTH AFR, V4, P64, DOI 10.4081/jphia.2013.e13; NHA, 2006, NAT HLTH ACC NHA 200; Niens LM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000333; Odusanya O. O., 1999, NIGERIAN Q J HOSP ME, V9, DOI [10.4314/nqjhm.v9i4.12397, DOI 10.4314/NQJHM.V9I4.12397]; Odusanya OO, 2004, J COMMUNITY MED PRIM, V16, P21; Okafor C., 2015, AFRICAN RES REV, V9, P333; Oparah C. A., 2001, INT J PHARM PRACT, V9, P191; Orem JN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-175; OSHINAME FO, 1992, SOC SCI MED, V35, P1477, DOI 10.1016/0277-9536(92)90050-Z; Pecoul B, 1999, JAMA-J AM MED ASSOC, V281, P361, DOI 10.1001/jama.281.4.361; Sado E, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0572-3; Salako L. A., 2004, J CLIN EPIDEMIOL, V45, P15; Shabangu K, 2015, AFR J PRIM HEALTH CA, V7, DOI [10.4102/phcfm.v7i1.829, 10.4102/PHCFM.V7I1.829]; Uche I., 2014, ACAD J INTERDISCIPLI, V3, P501; Umoru A, 2016, VALUE HEALTH, V19, pA35, DOI 10.1016/j.jval.2016.03.380; UNDP, 2007, HUMAN DEV REPORT; Uzochukwu B, 2005, HEALTH POLICY, V75, P1, DOI 10.1016/j.healthpol.2005.01.019; Wang Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116897; WHO, 2004, WORLD MED SITUATION; Wirtz VJ, 2012, VALUE HEALTH, V15, P593, DOI 10.1016/j.jval.2012.01.006; World Health Organization, 2004, EQ ACC ESS MED FRAM	43	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165707	10.1371/journal.pone.0165707	http://dx.doi.org/10.1371/journal.pone.0165707			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812177	Green Submitted, Green Published, gold			2022-12-26	WOS:000386910000049
J	Nashta-ali, D; Motahari, SA; Hosseinkhalaj, B				Nashta-ali, Damoun; Motahari, Seyed Abolfazl; Hosseinkhalaj, Babak			Breaking Lander-Waterman's Coverage Bound	PLOS ONE			English	Article							NANOPORE	Lander-Waterman's coverage bound establishes the total number of reads required to cover the whole genome of size G bases. In fact, their bound is a direct consequence of the well-known solution to the coupon collector's problem which proves that for such genome, the total number of bases to be sequenced should be O(G ln G). Although the result leads to a tight bound, it is based on a tacit assumption that the set of reads are first collected through a sequencing process and then are processed through a computation process, i.e., there are two different machines: one for sequencing and one for processing. In this paper, we present a significant improvement compared to Lander-Waterman's result and prove that by combining the sequencing and computing processes, one can re-sequence the whole genome with as low as O(G) sequenced bases in total. Our approach also dramatically reduces the required computational power for the combined process. Simulation results are performed on real genomes with different sequencing error rates. The results support our theory predicting the log G improvement on coverage bound and corresponding reduction in the total number of bases required to be sequenced.	[Nashta-ali, Damoun; Hosseinkhalaj, Babak] Sharif Univ Technol, Dept Elect Engn, Tehran, Iran; [Motahari, Seyed Abolfazl] Sharif Univ Technol, Dept Comp Engn, Tehran, Iran	Sharif University of Technology; Sharif University of Technology	Hosseinkhalaj, B (corresponding author), Sharif Univ Technol, Dept Elect Engn, Tehran, Iran.	khalaj@sharif.edu	Khalaj, Babak/AAP-6223-2020; Motahari, Seyed Abolfazl/ABB-2459-2020	Khalaj, Babak/0000-0002-9289-2338; 				Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Ku CS, 2013, EXPERT REV MED DEVIC, V10, P1, DOI [10.1586/erd.12.63, 10.1586/ERD.12.63]; LANDER E S, 1988, Genomics, V2, P231; Meller A, 2002, ELECTROPHORESIS, V23, P2583, DOI 10.1002/1522-2683(200208)23:16<2583::AID-ELPS2583>3.0.CO;2-H; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Nashta-ali D, 2016, BIORXIV	7	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0164888	10.1371/journal.pone.0164888	http://dx.doi.org/10.1371/journal.pone.0164888			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806058	Green Submitted, gold, Green Published			2022-12-26	WOS:000386715500016
J	Wittwer, M; Luo, Q; Kaila, VRI; Dames, SA				Wittwer, Matthias; Luo, Qi; Kaila, Ville R. I.; Dames, Sonja A.			Oxidative Unfolding of the Rubredoxin Domain and the Natively Disordered N-terminal Region Regulate the Catalytic Activity of Mycobacterium tuberculosis Protein Kinase G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGENIC MYCOBACTERIA; MOLECULAR-DYNAMICS; DIPOLAR COUPLINGS; STRUCTURAL BASIS; STRESS-RESPONSE; AMINO-ACIDS; NMR; SURVIVAL; ZINC; PKNG	Mycobacterium tuberculosis escapes killing in human macrophages by secreting protein kinase G (PknG). PknG intercepts host signaling to prevent fusion of the phagosome engulfing the mycobacteria with the lysosome and, thus, their degradation. The N-terminal NORS (no regulatory secondary structure) region of PknG (approximately residues 1-75) has been shown to play a role in PknG regulation by (auto) phosphorylation, whereas the following rubredoxin-like metal-binding motif (RD, residues similar to 74-147) has been shown to interact tightly with the subsequent catalytic domain (approximately residues 148-420) to mediate its redox regulation. Deletions or mutations in NORS or the redox-sensitive RD significantly decrease PknG survival function. Based on combined NMR spectroscopy, in vitro kinase assay, and molecular dynamics simulation data, we provide novel insights into the regulatory roles of the N-terminal regions. The NORS region is indeed natively disordered and rather dynamic. Consistent with most earlier data, autophosphorylation occurs in our assays only when the NORS region is present and, thus, in the NORS region. Phosphorylation of it results only in local conformational changes and does not induce interactions with the subsequent RD. Although the reduced, metal-bound RD makes tight interactions with the following catalytic domain in the published crystal structures, it can also fold in its absence. Our data further suggest that oxidation-induced unfolding of the RD regulates substrate access to the catalytic domain and, thereby, PknG function under different redox conditions, e.g. when exposed to increased levels of reactive oxidative species in host macrophages.	[Wittwer, Matthias; Dames, Sonja A.] Tech Univ Munich, Dept Chem, Biomol NMR Spect, Lichtenbergstr 4, D-85747 Garching, Germany; [Luo, Qi; Kaila, Ville R. I.] Tech Univ Munich, Dept Chem, Computat Biocatalysis, Lichtenbergstr 4, D-85747 Garching, Germany; [Luo, Qi] Zhejiang Univ, Soft Matter Res Ctr, Hangzhou 310027, Zhejiang, Peoples R China; [Luo, Qi] Zhejiang Univ, Dept Chem, Hangzhou 310027, Zhejiang, Peoples R China; [Dames, Sonja A.] Helmholtz Zentrum Munchen, Inst Biol Struct, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany	Technical University of Munich; Technical University of Munich; Zhejiang University; Zhejiang University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Dames, SA (corresponding author), Tech Univ Munich, Dept Chem, Biomol NMR Spect, Lichtenbergstr 4, D-85747 Garching, Germany.; Dames, SA (corresponding author), Helmholtz Zentrum Munchen, Inst Biol Struct, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	sonja.dames@tum.de	Kaila, Ville R. I./E-1449-2014	Kaila, Ville/0000-0003-4464-6324; Dames, Sonja/0000-0001-7495-6943	German Research Foundation (Deutsche Forschungsgemeinschaft) [SFB1035]; Gauss Centre for Supercomputing/Leibniz Supercomputing Centre [pr84pa]; China Scholarship Council; Technische Universitat Munchen (TUM) Diversity and Talent Management Office; Helmholtz portfolio theme "Metabolic Dysfunction and Common Disease" of the Helmholtz Zentrum Munchen	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Gauss Centre for Supercomputing/Leibniz Supercomputing Centre; China Scholarship Council(China Scholarship Council); Technische Universitat Munchen (TUM) Diversity and Talent Management Office; Helmholtz portfolio theme "Metabolic Dysfunction and Common Disease" of the Helmholtz Zentrum Munchen	This work was supported by grants from the German Research Foundation (Deutsche Forschungsgemeinschaft) (SFB1035, Project B04 and SFB1035, Project B12) (to S. A. D. and V. R. I. K., respectively). Computer resources were provided in part by the Gauss Centre for Supercomputing/Leibniz Supercomputing Centre (Grant pr84pa to V. R. I. K.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the China Scholarship Council.r Supported by the Technische Universitat Munchen (TUM) Diversity and Talent Management Office and the Helmholtz portfolio theme "Metabolic Dysfunction and Common Disease" of the Helmholtz Zentrum Munchen.	Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Bah A, 2015, NATURE, V519, P106, DOI 10.1038/nature13999; Bhat SA, 2012, FREE RADICAL BIO MED, V53, P1625, DOI 10.1016/j.freeradbiomed.2012.08.008; Bourles E, 2011, CHEM-EUR J, V17, P13762, DOI 10.1002/chem.201101913; Campbell EA, 2007, MOL CELL, V27, P793, DOI 10.1016/j.molcel.2007.07.009; Chaurasiya SK, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-271; Chim N, 2014, J INORG BIOCHEM, V133, P118, DOI 10.1016/j.jinorgbio.2013.11.003; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; Dames SA, 2011, J BIOL CHEM, V286, P36907, DOI 10.1074/jbc.M111.225052; Dames SA, 2006, J AM CHEM SOC, V128, P13508, DOI 10.1021/ja063606h; Dauter Z, 1996, P NATL ACAD SCI USA, V93, P8836, DOI 10.1073/pnas.93.17.8836; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dunker AK, 2015, SEMIN CELL DEV BIOL, V37, P44, DOI 10.1016/j.semcdb.2014.09.025; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Gamiz-Hernandez AP, 2009, J CHEM THEORY COMPUT, V5, P2898, DOI 10.1021/ct900328c; Gil M, 2013, FREE RADICAL BIO MED, V65, P150, DOI 10.1016/j.freeradbiomed.2013.06.021; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iannuzzi C, 2014, PROTEIN SCI, V23, P1208, DOI 10.1002/pro.2501; Jayakumar D, 2008, CELL MICROBIOL, V10, P365, DOI 10.1111/j.1462-5822.2007.01049.x; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kumar A, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002079; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Li J, 2000, J CELL SCI, V113, P4143; Lisa MN, 2015, STRUCTURE, V23, P1039, DOI 10.1016/j.str.2015.04.001; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Park ST, 2008, P NATL ACAD SCI USA, V105, P13105, DOI 10.1073/pnas.0801143105; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104; Scherr N, 2009, J BACTERIOL, V191, P4546, DOI 10.1128/JB.00245-09; Shen Y, 2010, J BIOMOL NMR, V48, P13, DOI 10.1007/s10858-010-9433-9; SIEKER LC, 1994, METHOD ENZYMOL, V243, P203; Sureka K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008590; Thakur KG, 2010, J MOL BIOL, V397, P1199, DOI 10.1016/j.jmb.2010.02.026; Tharun IM, 2015, ACS CHEM BIOL, V10, P475, DOI 10.1021/cb5007097; Tiwari D, 2009, J BIOL CHEM, V284, P27467, DOI 10.1074/jbc.M109.036095; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Walsh JD, 2010, BIOPHYS J, V99, P2636, DOI 10.1016/j.bpj.2010.08.036; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wittwer M, 2016, BIOMOL NMR ASSIGN, V10, P401, DOI 10.1007/s12104-016-9708-5; Wittwer M, 2015, PROTEIN EXPRES PURIF, V111, P68, DOI 10.1016/j.pep.2015.03.015; Zdanowski K, 2006, BIOCHEMISTRY-US, V45, P8294, DOI 10.1021/bi060711v; Zheng P, 2014, ANGEW CHEM INT EDIT, V53, P14060, DOI 10.1002/anie.201408105; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	52	14	12	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27062	27072		10.1074/jbc.M116.747089	http://dx.doi.org/10.1074/jbc.M116.747089			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27810897	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000391576300008
J	Berchtold, MW; Zacharias, T; Kulej, K; Wang, K; Torggler, R; Jespersen, T; Chen, JN; Larsen, MR; la Cour, JM				Berchtold, Martin W.; Zacharias, Triantafyllos; Kulej, Katarzyna; Wang, Kevin; Torggler, Raffaela; Jespersen, Thomas; Chen, Jau-Nian; Larsen, Martin R.; la Cour, Jonas M.			The Arrhythmogenic Calmodulin Mutation D129G Dysregulates Cell Growth, Calmodulin-dependent Kinase II Activity, and Cardiac Function in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; PROTEIN-KINASE; HEART-FAILURE; CAMKII ACTIVITY; CALCIUM; ION; DEATH; CALM1; CA2+/CALMODULIN; CHROMATOGRAPHY	Calmodulin (CaM) is a Ca2+ binding protein modulating multiple targets, several of which are associated with cardiac pathophysiology. Recently, CaM mutations were linked to heart arrhythmia. CaM is crucial for cell growth and viability, yet the effect of the arrhythmogenic CaM mutations on cell viability, as well as heart rhythm, remains unknown, and only a few targets with relevance for heart physiology have been analyzed for their response to mutant CaM. We show that the arrhythmia-associated CaM mutants support growth and viability of DT40 cells in the absence of WT CaM except for the long QT syndrome mutant CaM D129G. Of the six CaM mutants tested (N53I, F89L, D95V, N97S, D129G, and F141L), three showed a decreased activation of Ca2+/CaM-dependent kinase II, most prominently the D129G CaM mutation, which was incapable of stimulating Thr(286) autophosphorylation. Furthermore, the CaM D129G mutation led to bradycardia in zebrafish and an arrhythmic phenotype in a subset of the analyzed zebrafish.	[Berchtold, Martin W.; Zacharias, Triantafyllos; Torggler, Raffaela; la Cour, Jonas M.] Univ Copenhagen, Dept Biol, Univ Pk 13, DK-2100 Copenhagen, Denmark; [Jespersen, Thomas] Univ Copenhagen, Danish Arrhythmia Res Ctr, DK-2100 Copenhagen, Denmark; [Kulej, Katarzyna; Larsen, Martin R.] Univ Southern Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [Wang, Kevin; Chen, Jau-Nian] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of Copenhagen; University of Copenhagen; University of Southern Denmark; University of California System; University of California Los Angeles	Berchtold, MW; la Cour, JM (corresponding author), Univ Copenhagen, Dept Biol, Univ Pk 13, DK-2100 Copenhagen, Denmark.	mabe@bio.ku.dk; jonas@bio.ku.dk	Chen, Jau-Nian/AAM-7808-2020; Berchtold, Martin W./L-1695-2014; la Cour, Jonas/M-5088-2016	Berchtold, Martin W./0000-0001-8995-9047; Jespersen, Thomas/0000-0001-6575-360X; la Cour, Jonas/0000-0002-1588-0608	Danish Heart Foundation; AP Moller Laegefonden; Nilssons Foundation; Marshall Foundation; Willumsen Foundation; Danielsen Foundation; Danish Research Council [FSS4004-00560]; Villum Fonden [00007292] Funding Source: researchfish	Danish Heart Foundation; AP Moller Laegefonden; Nilssons Foundation; Marshall Foundation; Willumsen Foundation; Danielsen Foundation; Danish Research Council(Det Frie Forskningsrad (DFF)); Villum Fonden(Villum Fonden)	This work was supported by funds from the Danish Heart Foundation (to J. M. L. C. and M. W. B.), AP Moller Laegefonden (to J. M. L. C.), and the Nilssons, Marshall, Willumsen, and Danielsen Foundations (to M. W. B.) and by Danish Research Council Grant FSS4004-00560 (to M. W. B. and J. M. L. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Barcomb K, 2014, FASEB J, V28, P3810, DOI 10.1096/fj.14-250407; Berchtold MW, 2014, BBA-MOL CELL RES, V1843, P398, DOI 10.1016/j.bbamcr.2013.10.021; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; BERCHTOLD MW, 1993, GENOMICS, V16, P461, DOI 10.1006/geno.1993.1211; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Bers DM, 2011, HEART RHYTHM, V8, P1101, DOI 10.1016/j.hrthm.2011.01.030; Bers DM, 2009, J CARDIOVASC PHARM, V54, P180, DOI 10.1097/FJC.0b013e3181a25078; Boczek NJ, 2016, CIRC-CARDIOVASC GENE, V9, P136, DOI 10.1161/CIRCGENETICS.115.001323; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Coultrap SJ, 2010, J BIOL CHEM, V285, P17930, DOI 10.1074/jbc.M109.069351; Crotti L, 2013, CIRCULATION, V127, P1009, DOI 10.1161/CIRCULATIONAHA.112.001216; DeGrande S, 2012, HEART RHYTHM, V9, P2034, DOI 10.1016/j.hrthm.2012.08.026; Engholm-Keller K, 2011, J PROTEOME RES, V10, P5383, DOI 10.1021/pr200641x; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Erickson JR, 2011, PHYSIOL REV, V91, P889, DOI 10.1152/physrev.00018.2010; Gomez-Hurtado N, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.116.004161; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Hund TJ, 2015, TRENDS CARDIOVAS MED, V25, P392, DOI 10.1016/j.tcm.2014.12.001; Hwang HS, 2014, CIRC RES, V114, P1114, DOI 10.1161/CIRCRESAHA.114.303391; Kopp R, 2005, J EXP BIOL, V208, P2123, DOI 10.1242/jeb.01620; Kwok S, 2008, BIOCHEM BIOPH RES CO, V369, P519, DOI 10.1016/j.bbrc.2008.02.070; Langenbacher AD, 2012, DEV BIOL, V362, P263, DOI 10.1016/j.ydbio.2011.12.004; Leong IUS, 2010, BIOCHEM BIOPH RES CO, V396, P817, DOI 10.1016/j.bbrc.2010.04.157; Limpitikul WB, 2014, J MOL CELL CARDIOL, V74, P115, DOI 10.1016/j.yjmcc.2014.04.022; Luo M, 2013, CIRC RES, V113, P690, DOI 10.1161/CIRCRESAHA.113.301651; Maier LS, 2007, CARDIOVASC RES, V73, P631, DOI 10.1016/j.cardiores.2006.11.005; Makita N, 2014, CIRC-CARDIOVASC GENE, V7, P466, DOI 10.1161/CIRCGENETICS.113.000459; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; Marsman RF, 2014, J AM COLL CARDIOL, V63, P259, DOI 10.1016/j.jacc.2013.07.091; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; Mower AF, 2011, P NATL ACAD SCI USA, V108, P21241, DOI 10.1073/pnas.1108261109; Nyegaard M, 2012, AM J HUM GENET, V91, P703, DOI 10.1016/j.ajhg.2012.08.015; Panina S, 2012, J BIOL CHEM, V287, P18173, DOI 10.1074/jbc.M112.339382; Pipilas DC, 2016, HEART RHYTHM, V13, P2012, DOI 10.1016/j.hrthm.2016.06.038; Racioppi L, 2012, J BIOL CHEM, V287, P31658, DOI 10.1074/jbc.R112.356485; Reed GJ, 2015, HEART RHYTHM, V12, P419, DOI 10.1016/j.hrthm.2014.10.035; Roden DM, 2006, CIRC RES, V98, P979, DOI 10.1161/01.RES.0000221822.22971.8c; Schmalzigaug R, 2001, IMMUNOLOGY, V103, P332, DOI 10.1046/j.1365-2567.2001.01259.x; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Shifman JM, 2006, P NATL ACAD SCI USA, V103, P13968, DOI 10.1073/pnas.0606433103; Shimizu J, 2016, RHEUMATOLOGY, V55, P583, DOI 10.1093/rheumatology/kev320; Sorensen AB, 2013, FEBS J, V280, P5511, DOI 10.1111/febs.12337; Toutenhoofd SL, 2002, BBA-PROTEINS PROTEOM, V1600, P95, DOI 10.1016/S1570-9639(02)00449-1; Vincent O, 2003, MOL CELL BIOL, V23, P1647, DOI 10.1128/MCB.23.5.1647-1655.2003; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5	48	18	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26636	26646		10.1074/jbc.M116.758680	http://dx.doi.org/10.1074/jbc.M116.758680			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27815504	Green Published, hybrid			2022-12-26	WOS:000391571400005
J	Yang, Y; Davis, I; Ha, U; Wang, YF; Shin, I; Liu, AM				Yang, Yu; Davis, Ian; Ha, Uyen; Wang, Yifan; Shin, Inchul; Liu, Aimin			A Pitcher-and-Catcher Mechanism Drives Endogenous Substrate Isomerization by a Dehydrogenase in Kynurenine Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL ALDEHYDE DEHYDROGENASE; 4-OXALOCROTONATE TAUTOMERASE; DECARBOXYLASE ACMSD; CRYSTAL-STRUCTURE; ACTIVE-SITE; TRYPTOPHAN; PATHWAY; ACID; DEGRADATION; CATALYSIS	Aldehyde dehydrogenase typically performs oxidation of aldehydes to their corresponding carboxylic acid while reducing NAD(P)(+) to NAD(P) H via covalent catalysis mediated by an active-site cysteine residue. One member of this superfamily, the enzyme 2-aminomuconate-6-semialdehyde dehydrogenase (AMSDH), is a component of the kynurenine pathway, which catabolizes tryptophan in mammals and certain bacteria. AMSDH catalyzes the NAD(+)-dependent oxidation of 2-aminomuconate semialdehyde to 2-aminomuconate. We recently determined the first crystal structure of AMSDH and several catalytic cycle intermediates. A conserved asparagine in the oxyanion hole, Asn-169, is found to be H-bonded to substrate-derived intermediates in the active site of AMSDH during catalysis, including both the covalently bound thiohemiacetal and thioacyl intermediates. To better interrogate the significance of the hydrogen bond provided by Asn-169 to the reaction mechanism of AMSDH, we created Ala, Ser, Asp, and Gln mutants and studied them using biochemical, kinetic, crystallographic, and computational studies. The in crystallo chemical reaction of the primary substrate with the co-crystalized complex of the N169D mutant and NAD(+) led to the successful trapping of a new catalytic intermediate that was not previously seen. The structural and computational data are consistent with a substrate imine/enol tautomer intermediate being formed prior to the formation of the covalent bond between the substrate and the active-site cysteine. Thus, AMSDH surprisingly includes an isomerization process within its known catalytic mechanism. These data establish a hidden intrinsic isomerization activity of the dehydrogenase and allow us to propose a pitcher-catcher type of catalytic mechanism for the isomerization.	[Yang, Yu; Davis, Ian; Wang, Yifan; Shin, Inchul; Liu, Aimin] Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA; [Davis, Ian; Ha, Uyen; Liu, Aimin] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA	University of Texas System; University of Texas at San Antonio (UTSA); University System of Georgia; Georgia State University	Liu, AM (corresponding author), Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA.; Liu, AM (corresponding author), Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA.	Feradical@utsa.edu	Liu, Aimin/C-1572-2017	Liu, Aimin/0000-0002-4182-8176; Wang, Yifan/0000-0003-0378-2469; Yang, Yu/0000-0001-5305-2435; Davis, Ian/0000-0002-1566-4972	National Institutes of Health [MH107985]; National Science Foundation [CHE-1623856]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH107985] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1623856] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the National Institutes of Health Grant MH107985 and the National Science Foundation Grant CHE-1623856. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Burks EA, 2011, BIOCHEMISTRY-US, V50, P7600, DOI 10.1021/bi200947w; Burks EA, 2010, BIOCHEMISTRY-US, V49, P5016, DOI 10.1021/bi100502z; CHEN LH, 1992, J BIOL CHEM, V267, P17716; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cobessi D, 2000, J MOL BIOL, V300, P141, DOI 10.1006/jmbi.2000.3824; Colabroy KL, 2005, J AM CHEM SOC, V127, P840, DOI 10.1021/ja0446395; D'Ambrosio K, 2006, BIOCHEMISTRY-US, V45, P2978, DOI 10.1021/bi0515117; Davis I, 2015, EXPERT REV NEUROTHER, V15, P719, DOI 10.1586/14737175.2015.1049999; Dazzi C, 2001, J CHROMATOGR B, V751, P61, DOI 10.1016/S0378-4347(00)00450-3; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI 10.1038/hr.2014.17; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; FARRES J, 1995, BIOCHEMISTRY-US, V34, P2592, DOI 10.1021/bi00008a025; Frisch M.J., 2016, GAUSSIAN16 REV B01; Huddleston JP, 2014, ARCH BIOCHEM BIOPHYS, V564, P189, DOI 10.1016/j.abb.2014.08.019; Huo L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6935; Huo L, 2015, PROTEINS, V83, P178, DOI 10.1002/prot.24722; Huo L, 2013, J BIOL CHEM, V288, P30862, DOI 10.1074/jbc.M113.496869; ICHIYAMA A, 1965, J BIOL CHEM, V240, P740; Li TF, 2005, J AM CHEM SOC, V127, P12282, DOI 10.1021/ja0532234; Li TF, 2007, J AM CHEM SOC, V129, P9278, DOI 10.1021/ja073648l; Li TF, 2006, BIOCHEMISTRY-US, V45, P6628, DOI 10.1021/bi060108c; Metanis N, 2004, J AM CHEM SOC, V126, P12726, DOI 10.1021/ja0463841; Muraki T, 2003, APPL ENVIRON MICROB, V69, P1564, DOI 10.1128/AEM.69.3.1564-1572.2003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park J, 2013, J BIOL CHEM, V288, P15760, DOI 10.1074/jbc.M113.460428; Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; Taylor AB, 1998, BIOCHEMISTRY-US, V37, P14692, DOI 10.1021/bi981607j; Terrell CR, 2013, ARCH BIOCHEM BIOPHYS, V537, P113, DOI 10.1016/j.abb.2013.06.016; WANG XP, 1995, BIOCHEMISTRY-US, V34, P237, DOI 10.1021/bi00001a028	34	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26252	26261		10.1074/jbc.M116.759712	http://dx.doi.org/10.1074/jbc.M116.759712			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27810899	hybrid, Green Published			2022-12-26	WOS:000391568200002
J	Morzelle, MC; Salgado, JM; Telles, M; Mourelle, D; Bachiega, P; Buck, HS; Viel, TA				Morzelle, Maressa Caldeira; Salgado, Jocelem Mastrodi; Telles, Milena; Mourelle, Danilo; Bachiega, Patricia; Buck, Hudson Sousa; Viel, Tania Araujo			Neuroprotective Effects of Pomegranate Peel Extract after Chronic Infusion with Amyloid-beta Peptide in Mice	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; IN-VITRO; COGNITIVE IMPAIRMENT; RAT-BRAIN; ANTIBACTERIAL ACTIVITY; SUPEROXIDE-DISMUTASE; NEUROTROPHIC FACTOR; TRANSGENIC MOUSE; OXIDATIVE DAMAGE; FREE-RADICALS	Alzheimer's disease is a chronic and degenerative condition that had no treatment until recently. The current therapeutic strategies reduce progression of the disease but are expensive and commonly cause side effects that are uncomfortable for treated patients. Functional foods to prevent and/or treat many conditions, including neurodegenerative diseases, represent a promising field of study currently gaining attention. To this end, here we demonstrate the effects of pomegranate (Punica granatum) peel extract (PPE) regarding spatial memory, biomarkers of neuroplasticity, oxidative stress and inflammation in a mouse model of neurodegeneration. Male C57Bl/6 mice were chronically infused for 35 days with amyloid-beta peptide 1-42 (A beta) or vehicle (control) using mini-osmotic pumps. Another group, also infused with A beta, was treated with PPE (p.o. -beta A+PPE, 800 mg/kg/day). Spatial memory was evaluated in the Barnes maze. Animals treated with PPE and in the control group exhibited a reduction in failure to find the escape box, a finding that was not observed in the A beta group. The consumption of PPE reduced amyloid plaque density, increased the expression of neurotrophin BDNF and reduced the activity of acetylcholinesterase enzyme. A reduction in lipid peroxidation and in the concentration of the pro-inflammatory cytokine TNF-alpha was also observed in the PPE group. No hepatic lesions were observed in animals treated with PPE. In conclusion, administration of pomegranate peel extract has neuroprotective effects involving multiple mechanisms to prevent establishment and progression of the neurodegenerative process induced by infusion with amyloid-beta peptide in mice.	[Morzelle, Maressa Caldeira; Salgado, Jocelem Mastrodi; Bachiega, Patricia] Univ Sao Paulo, Dept Agrifood Ind Food & Nutr, Luiz de Queiroz Coll Agr, Padua Dias Ave,POB 9, BR-13418900 Piracicaba, SP, Brazil; [Telles, Milena; Mourelle, Danilo; Viel, Tania Araujo] Univ Sao Paulo, Inst Biomed Sci, Grad Course Pharmacol, Ave Prof Lineu Prestes 1524, BR-05508900 Sao Paulo, Brazil; [Buck, Hudson Sousa] Santa Casa Sao Paulo Sch Med Sci, Dept Physiol Sci, R Dr Cesario Motta Jr 61,111 Andar, BR-01221020 Sao Paulo, SP, Brazil; [Viel, Tania Araujo] Univ Sao Paulo, Sch Arts Sci & Humanities, Av Arlindo Bettio 1000, BR-03828080 Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Viel, TA (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Grad Course Pharmacol, Ave Prof Lineu Prestes 1524, BR-05508900 Sao Paulo, Brazil.; Viel, TA (corresponding author), Univ Sao Paulo, Sch Arts Sci & Humanities, Av Arlindo Bettio 1000, BR-03828080 Sao Paulo, SP, Brazil.	taniaviel@usp.br	Morzelle, Maressa C/N-4461-2015; Viel, Tania/K-2909-2016; Buck, Hudson/E-7664-2013	Viel, Tania/0000-0002-4015-785X; Buck, Hudson/0000-0002-1867-2441; Bachiega, Patricia/0000-0002-6517-5464	Sao Paulo Research Foundation [2013/0898-1, 2013/13656-1, 2012/12917-3]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Sao Paulo Research Foundation 2013/0898-1, 2013/13656-1 and 2012/12917-3 (www.fapesp.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademosun AO, 2012, J MED FOOD, V15, P428, DOI 10.1089/jmf.2011.0226; Ahmed S, 2005, J NUTR, V135, P2096, DOI 10.1093/jn/135.9.2096; Ahmed T, 2014, PHYTOTHER RES, V28, P517, DOI 10.1002/ptr.5030; Akhtar S, 2015, FOOD CHEM, V174, P417, DOI 10.1016/j.foodchem.2014.11.035; ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; Allen SJ, 2011, CURR NEUROPHARMACOL, V9, P559, DOI 10.2174/157015911798376190; Amaral FA, 2010, NEUROPEPTIDES, V44, P93, DOI 10.1016/j.npep.2009.10.006; BALAZS L, 1994, NEUROCHEM RES, V19, P1131, DOI 10.1007/BF00965146; Baraldi T, 2013, EXP GERONTOL, V48, P831, DOI 10.1016/j.exger.2013.05.055; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Benamar H, 2010, J BIOL SCI, V10, P100; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10256; Choi SJ, 2011, J MED FOOD, V14, P695, DOI 10.1089/jmf.2010.1452; Essa MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120964; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Franklin K., 2007, MOUSE BRAIN STEREOTA; Frautschy SA, 1998, J NEUROSCI, V18, P8311; Gao YL, 2012, ENVIRON TOXICOL PHAR, V33, P304, DOI 10.1016/j.etap.2011.12.022; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Gomez-Pinilla F, 2012, NUTR NEUROSCI, V15, P127, DOI 10.1179/1476830511Y.0000000035; Gullon B, 2016, FOOD CONTROL, V59, P94, DOI 10.1016/j.foodcont.2015.05.025; Hartman RE, 2006, NEUROBIOL DIS, V24, P506, DOI 10.1016/j.nbd.2006.08.006; Hu SQ, 2015, J MOL NEUROSCI, V55, P1014, DOI 10.1007/s12031-014-0458-5; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; Iores-Marcal LM, 2006, PEPTIDES, V27, P3363, DOI 10.1016/j.peptides.2006.08.012; Johanningsmeier SD, 2011, ANNU REV FOOD SCI T, V2, P181, DOI 10.1146/annurev-food-030810-153709; Kreutz F, 2013, NEUROCHEM RES, V38, P2342, DOI 10.1007/s11064-013-1145-6; Kwak HM, 2005, ARCH PHARM RES, V28, P1328, DOI 10.1007/BF02977896; LEVIMONTALCINI R, 1987, BIOSCIENCE REP, V7, P681, DOI 10.1007/BF01116861; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Lindholm D, 1996, EUR J NEUROSCI, V8, P1452, DOI 10.1111/j.1460-9568.1996.tb01607.x; LOVELL MA, 1995, NEUROLOGY, V45, P1594, DOI 10.1212/WNL.45.8.1594; Luque-Rodriguez JM, 2007, BIORESOURCE TECHNOL, V98, P2705, DOI 10.1016/j.biortech.2006.09.019; Lyras L, 1997, J NEUROCHEM, V68, P2061; Mahboubi A, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0887-x; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Morris MC, 2005, AM J CLIN NUTR, V81, P508; Nunes MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142267; Oh MH, 2004, PHYTOMEDICINE, V11, P544, DOI 10.1016/j.phymed.2004.03.001; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ono K, 2004, BBA-MOL BASIS DIS, V1690, P193, DOI 10.1016/j.bbadis.2004.06.008; Ozcankaya R, 2002, CROAT MED J, V43, P28; Pervin M, 2014, MOLECULES, V19, P9403, DOI 10.3390/molecules19079403; Qu W, 2009, T ASABE, V52, P1997, DOI 10.13031/2013.29196; Rezai-Zadeh K, 2005, J NEUROSCI, V25, P8807, DOI 10.1523/JNEUROSCI.1521-05.2005; RICHARDSON JS, 1993, ANN NY ACAD SCI, V695, P73, DOI 10.1111/j.1749-6632.1993.tb23031.x; Rojanathammanee L, 2013, J NUTR, V143, P597, DOI 10.3945/jn.112.169516; Ryu HW, 2012, FOOD CHEM, V132, P1244, DOI 10.1016/j.foodchem.2011.11.093; Salgado JM, 2012, PLANT FOOD HUM NUTR, V67, P39, DOI 10.1007/s11130-011-0264-y; Schrag M, 2013, NEUROBIOL DIS, V59, P100, DOI 10.1016/j.nbd.2013.07.005; Schubert SY, 1999, J ETHNOPHARMACOL, V66, P11, DOI 10.1016/S0378-8741(98)00222-0; Schulz V, 2003, PHYTOMEDICINE, V10, P74, DOI 10.1078/1433-187X-00302; Seeram N, 2005, SEP PURIF TECHNOL, V41, P49, DOI 10.1016/j.seppur.2004.04.003; Small SA, 2000, MICROSC RES TECHNIQ, V51, P101, DOI 10.1002/1097-0029(20001001)51:1<101::AID-JEMT11>3.0.CO;2-H; Sorensen G, 1996, Z LEBENSM UNTERS FOR, V202, P205, DOI 10.1007/BF01263541; Spencer JPE, 2009, ARCH BIOCHEM BIOPHYS, V492, P1, DOI 10.1016/j.abb.2009.10.003; Subash S, 2015, NUTRITION, V31, P223, DOI 10.1016/j.nut.2014.06.004; Szwajgier D, 2014, POL J FOOD NUTR SCI, V64, P59, DOI 10.2478/v10222-012-0089-x; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vardin H, 2012, INT J FOOD SCI TECH, V47, P167, DOI 10.1111/j.1365-2621.2011.02823.x; Venkatesan R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/814068; Viel TA, 2012, CURR ALZHEIMER RES, V2011; Viel TA, 2008, NEUROBIOL AGING, V29, P1805, DOI 10.1016/j.neurobiolaging.2007.04.019; Wang DL, 2012, BIOL PHARM BULL, V35, P2128, DOI 10.1248/bpb.b12-00238; Xu BJ, 2007, J FOOD SCI, V72, pS159, DOI 10.1111/j.1750-3841.2006.00260.x; Yang JP, 2016, FOOD CHEM, V194, P1300, DOI 10.1016/j.foodchem.2015.08.099; Yu TX, 2015, INT J CLIN EXP PATHO, V8, P6740; ZEMLAN FP, 1989, BRAIN RES, V476, P160, DOI 10.1016/0006-8993(89)91550-3; Zhang JS, 2016, NEUROSCIENCE, V325, P1, DOI 10.1016/j.neuroscience.2016.03.024	72	45	46	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166123	10.1371/journal.pone.0166123	http://dx.doi.org/10.1371/journal.pone.0166123			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829013	Green Published, gold, Green Submitted			2022-12-26	WOS:000387724300084
J	Silva, KR; Rezende, RA; Pereira, FDAS; Gruber, P; Stuart, MP; Ovsianikov, A; Brakke, K; Kasyanov, V; da Silva, JVL; Granjeiro, JM; Baptista, LS; Mironov, V				Silva, Karina R.; Rezende, Rodrigo A.; Pereira, Frederico D. A. S.; Gruber, Peter; Stuart, Mellannie P.; Ovsianikov, Aleksandr; Brakke, Ken; Kasyanov, Vladimir; da Silva, Jorge V. L.; Granjeiro, Jose M.; Baptista, Leandra S.; Mironov, Vladimir			Delivery of Human Adipose Stem Cells Spheroids into Lockyballs	PLOS ONE			English	Article							2-PHOTON POLYMERIZATION; CULTURE; SHRINKAGE; CARTILAGE; MATRICES	Adipose stem cells (ASCs) spheroids show enhanced regenerative effects compared to single cells. Also, spheroids have been recently introduced as building blocks in directed self assembly strategy. Recent efforts aim to improve long-term cell retention and integration by the use of microencapsulation delivery systems that can rapidly integrate in the implantation site. Interlockable solid synthetic microscaffolds, so called lockyballs, were recently designed with hooks and loops to enhance cell retention and integration at the implantation site as well as to support spheroids aggregation after transplantation. Here we present an efficient methodology for human ASCs spheroids biofabrication and lockyballs cellularization using micro-molded non-adhesive agarose hydrogel. Lockyballs were produced using two-photon polymerization with an estimated mechanical strength. The Young's modulus was calculated at level 0.1362 +/-0.009 MPa. Interlocking in vitro test demonstrates high level of loading induced interlockability of fabricated lockyballs. Diameter measurements and elongation coefficient calculation revealed that human ASCs spheroids biofabricated in resections of micro-molded non-adhesive hydrogel had a more regular size distribution and shape than spheroids biofabricated in hanging drops. Cellularization of lockyballs using human ASCs spheroids did not alter the level of cells viability (p > 0,999) and gene fold expression for SOX-9 and RUNX2 (p> 0,195). The biofabrication of ASCs spheroids into lockyballs represents an innovative strategy in regenerative medicine, which combines solid scaffold-based and directed self-assembly approaches, fostering opportunities for rapid in situ biofabrication of 3D building-blocks.	[Silva, Karina R.; Stuart, Mellannie P.; Granjeiro, Jose M.; Baptista, Leandra S.; Mironov, Vladimir] Natl Inst Metrol Qual & Technol Inmetro, Lab Tissue Bioengn, Rio De Janeiro, Brazil; [Silva, Karina R.; Baptista, Leandra S.] Fed Univ Rio de Janeiro Xerem, Nucleus Multidisciplinary Res Biol Numpex Bio, Rio De Janeiro, Brazil; [Rezende, Rodrigo A.; Pereira, Frederico D. A. S.; da Silva, Jorge V. L.; Mironov, Vladimir] Renato Archer Ctr Informat Technol CTI, Div Technol 3D, Campinas, SP, Brazil; [Gruber, Peter; Ovsianikov, Aleksandr] TU Wien, Inst Mat Sci & Technol, Vienna, Austria; [Brakke, Ken] Susquehanna Univ, Dept Math, Selinsgrove, PA USA; [Kasyanov, Vladimir] Riga Stradins Univ, Riga, Latvia; [Kasyanov, Vladimir] Riga Tech Univ, Riga, Latvia; [Granjeiro, Jose M.] Univ Fed Fluminense, Bioengn Lab, Rio De Janeiro, Brazil	Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Technische Universitat Wien; Susquehanna University; Riga Stradins University; Riga Technical University; Universidade Federal Fluminense	Baptista, LS; Mironov, V (corresponding author), Natl Inst Metrol Qual & Technol Inmetro, Lab Tissue Bioengn, Rio De Janeiro, Brazil.; Baptista, LS (corresponding author), Fed Univ Rio de Janeiro Xerem, Nucleus Multidisciplinary Res Biol Numpex Bio, Rio De Janeiro, Brazil.; Mironov, V (corresponding author), Renato Archer Ctr Informat Technol CTI, Div Technol 3D, Campinas, SP, Brazil.	leandra.baptista@gmail.com; vladmir.mironov54@gmail.com	Mironov, Vladimir/AAC-5926-2022; da Silva, Jorge Vicente Lopes/C-8502-2012; Baptista, Leandra/D-4259-2013; Granjeiro, Jose/D-8289-2012; Ovsianikov, Aleksandr/K-8128-2015	da Silva, Jorge Vicente Lopes/0000-0002-2347-5215; Baptista, Leandra/0000-0001-9998-8044; Granjeiro, Jose/0000-0002-8027-8293; Kasyanovs, Vladimirs/0000-0003-4411-1020; Ribeiro Silva, Karina/0000-0001-7394-2494; Ovsianikov, Aleksandr/0000-0001-5846-0198	MCTI/CNPq/CT-Saude/CT-Biotecnologia/MS/SCTIE/DECIT-Novas Terapias Portadoras de Futuro [CNPq-457541/2013-0-47/2013]; European Research Council [307701]; CNPq Regenerative Medicine [467643/2014-8]; Brazilian Institute of Biofabrication (INCT-BIOFABRIS) [08/57860-3]	MCTI/CNPq/CT-Saude/CT-Biotecnologia/MS/SCTIE/DECIT-Novas Terapias Portadoras de Futuro; European Research Council(European Research Council (ERC)European Commission); CNPq Regenerative Medicine; Brazilian Institute of Biofabrication (INCT-BIOFABRIS)	This work was funded by CNPq-457541/2013-0-Chamada No 47/2013 MCTI/CNPq/CT-Saude/CT-Biotecnologia/MS/SCTIE/DECIT-Novas Terapias Portadoras de Futuro to JMG; European Research Council (Starting Grant 307701) to AO; CNPq Regenerative Medicine project 467643/2014-8 to JVLS; and Brazilian Institute of Biofabrication (INCT-BIOFABRIS) 08/57860-3 to JVLS.	Achilli TM, 2014, MOL PHARMACEUT, V11, P2071, DOI 10.1021/mp500002y; Achilli TM, 2012, EXPERT OPIN BIOL TH, V12, P1347, DOI 10.1517/14712598.2012.707181; Al Kindi AH, 2011, EUR J CARDIO-THORAC, V39, P241, DOI 10.1016/j.ejcts.2010.03.066; Baptista LS, 2009, CYTOTHERAPY, V11, P706, DOI 10.3109/14653240902981144; Baraniak PR, 2012, J MECH BEHAV BIOMED, V11, P63, DOI 10.1016/j.jmbbm.2012.02.018; Baraniak PR, 2012, CELL TISSUE RES, V347, P701, DOI 10.1007/s00441-011-1215-5; Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107; Bhang SH, 2011, BIOMATERIALS, V32, P2734, DOI 10.1016/j.biomaterials.2010.12.035; Caplan AI, 2015, STEM CELL TRANSL MED, V4, P695, DOI 10.5966/sctm.2014-0291; Casteilla Louis, 2011, World J Stem Cells, V3, P25, DOI 10.4252/wjsc.v3.i4.25; Danilevicius P, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4922646; De Francesco F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006537; Frith JE, 2010, TISSUE ENG PART C-ME, V16, P735, DOI 10.1089/ten.TEC.2009.0432; Guven S, 2015, TRENDS BIOTECHNOL, V33, P269, DOI 10.1016/j.tibtech.2015.02.003; Kelm JM, 2010, ADV DRUG DELIVER REV, V62, P753, DOI 10.1016/j.addr.2010.02.003; Kelm JM, 2010, J BIOTECHNOL, V148, P46, DOI 10.1016/j.jbiotec.2010.03.002; Kinney MA, 2014, ANN BIOMED ENG, V42, P352, DOI 10.1007/s10439-013-0953-9; Kirn TG, 2010, ADV FUNCT MATER, V20, P2303, DOI 10.1002/adfm.201000458; Liu XH, 2011, NAT MATER, V10, P398, DOI [10.1038/NMAT2999, 10.1038/nmat2999]; Malda J, 2006, TRENDS BIOTECHNOL, V24, P299, DOI 10.1016/j.tibtech.2006.04.009; Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084; Napolitano AP, 2007, BIOTECHNIQUES, V43, P494, DOI 10.2144/000112591; Oliveira MB, 2011, BIOTECHNOL PROGR, V27, P897, DOI 10.1002/btpr.618; Oubaha M, 2011, J MATER SCI, V46, P400, DOI 10.1007/s10853-010-4853-1; Ovsianikov A, 2012, EXPERT REV MED DEVIC, V9, P613, DOI [10.1586/ERD.12.48, 10.1586/erd.12.48]; Ovsianikov A, 2008, ACS NANO, V2, P2257, DOI 10.1021/nn800451w; Ovsianikov A, 2009, OPT EXPRESS, V17, P2143, DOI 10.1364/OE.17.002143; Paul A, 2009, REGEN MED, V4, P733, DOI 10.2217/RME.09.43; Przybyt E, 2013, CURR STEM CELL RES T, V8, P270, DOI 10.2174/1574888X11308040002; Rago AP, 2009, BIOTECHNOL BIOENG, V102, P1231, DOI 10.1002/bit.22162; Raimondi MT, 2013, ACTA BIOMATER, V9, P4579, DOI 10.1016/j.actbio.2012.08.022; Raimondi MT, 2012, J APPL BIOMATER FUNC, V10, P56, DOI 10.5301/JABFM.2012.9278; Rezende RA, 2012, VIRTUAL PHYS PROTOTY, V7, P287, DOI 10.1080/17452759.2012.740877; Schon BS, 2012, CELL TISSUE RES, V347, P629, DOI 10.1007/s00441-011-1311-6; Svoronos AA, 2014, TISSUE ENG PT A, V20, P1134, DOI [10.1089/ten.TEA.2013.0297, 10.1089/ten.tea.2013.0297]; Wang HA, 2012, TISSUE ENG PART B-RE, V18, P24, DOI [10.1089/ten.teb.2011.0184, 10.1089/ten.TEB.2011.0184]	36	28	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166073	10.1371/journal.pone.0166073	http://dx.doi.org/10.1371/journal.pone.0166073			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829016	Green Published, Green Submitted, gold			2022-12-26	WOS:000387724300079
J	Yoon, S; Kim, SY; Nam, D				Yoon, Sora; Kim, Seon-Young; Nam, Dougu			Improving Gene-Set Enrichment Analysis of RNA-Seq Data with Small Replicates	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; BIOCONDUCTOR PACKAGE; NORMALIZATION; TOOLS	Deregulated pathways identified from transcriptome data of two sample groups have played a key role in many genomic studies. Gene-set enrichment analysis (GSEA) has been commonly used for pathway or functional analysis of microarray data, and it is also being applied to RNA-seq data. However, most RNA-seq data so far have only small replicates. This enforces to apply the gene-permuting GSEA method (or preranked GSEA) which results in a great number of false positives due to the inter-gene correlation in each gene-set. We demonstrate that incorporating the absolute gene statistic in one-tailed GSEA considerably improves the false-positive control and the overall discriminatory ability of the gene-permuting GSEA methods for RNA-seq data. To test the performance, a simulation method to generate correlated read counts within a gene-set was newly developed, and a dozen of currently available RNA-seq enrichment analysis methods were compared, where the proposed methods outperformed others that do not account for the inter-gene correlation. Analysis of real RNA-seq data also supported the proposed methods in terms of false positive control, ranks of true positives and biological relevance. An efficient R package (AbsFilterG-SEA) coded with C++ (Rcpp) is available from CRAN.	[Yoon, Sora; Nam, Dougu] Ulsan Natl Inst Sci & Technol, Sch Life Sci, Ulsan, South Korea; [Kim, Seon-Young] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Daejeon, South Korea; [Kim, Seon-Young] Univ Sci & Technol, Dept Bioinformat, Daejeon, South Korea; [Nam, Dougu] Ulsan Natl Inst Sci & Technol, Dept Math Sci, Ulsan, South Korea	Ulsan National Institute of Science & Technology (UNIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Ulsan National Institute of Science & Technology (UNIST)	Nam, D (corresponding author), Ulsan Natl Inst Sci & Technol, Sch Life Sci, Ulsan, South Korea.; Nam, D (corresponding author), Ulsan Natl Inst Sci & Technol, Dept Math Sci, Ulsan, South Korea.	dougnam@unist.ac.kr	Nam, Dougu/F-5057-2010; Nam, Dougu/AAC-7173-2019; Nam, Dougu/AAA-4046-2019	Nam, Dougu/0000-0003-0239-2899; Nam, Dougu/0000-0003-0239-2899; Yoon, Sora/0000-0002-0107-0057	National Research Foundation (NRF) - Ministry of Science, ICT, and Future Planning, KRIBB Research Initiative [NRF-2014M3C9A3068554, 2014M3C9A3068555]; Basic Science Research Program through a National Research Foundation (NRF) - Korean government (MOE) [2014R1A1A2056353]	National Research Foundation (NRF) - Ministry of Science, ICT, and Future Planning, KRIBB Research Initiative; Basic Science Research Program through a National Research Foundation (NRF) - Korean government (MOE)	The genomics programs (NRF-2014M3C9A3068554 and 2014M3C9A3068555) of the National Research Foundation (NRF, http://www.nrf.re.kr/) of Korea, funded by the Ministry of Science, ICT, and Future Planning, the KRIBB Research Initiative. Basic Science Research Program through a National Research Foundation (NRF) grants funded by the Korean government (MOE) (2014R1A1A2056353). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barry WT, 2008, ANN APPL STAT, V2, P286, DOI 10.1214/07-AOAS146; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Eddelbuettel D, 2011, J STAT SOFTW, V40, P1; Feng JX, 2012, BIOINFORMATICS, V28, P2782, DOI 10.1093/bioinformatics/bts515; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Gray KA, 2015, NUCLEIC ACIDS RES, V43, pD1079, DOI 10.1093/nar/gku1071; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jiang H, 2001, BIOTECHNIQUES, V31, P38, DOI 10.2144/01311bm05; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kovalchik S., 2015, RISmed: Download Content from NCBI Databases. R package version 2.1.5; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lee C, 2016, BIOINFORMATICS, V32, P1100, DOI 10.1093/bioinformatics/btv694; Li H, 2008, P NATL ACAD SCI USA, V105, P20179, DOI 10.1073/pnas.0807121105; Li HL, 2014, ONCOTARGET, V5, P587, DOI 10.18632/oncotarget.1782; Li J, 2013, STAT METHODS MED RES, V22, P519, DOI 10.1177/0962280211428386; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nam D, 2008, BRIEF BIOINFORM, V9, P189, DOI 10.1093/bib/bbn001; Nam D, 2017, STAT METHODS MED RES, V26, P1248, DOI 10.1177/0962280215574014; Nam D, 2010, BIOINFORMATICS, V26, pi511, DOI 10.1093/bioinformatics/btq380; Nam D, 2010, NUCLEIC ACIDS RES, V38, pW749, DOI 10.1093/nar/gkq428; Newton MA, 2007, ANN APPL STAT, V1, P85, DOI 10.1214/07-AOAS104; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; R Core Team, 2013, R LANG ENV STAT COMP; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saxena V, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl766; Schwarz JK, 2012, CLIN CANCER RES, V18, P1464, DOI 10.1158/1078-0432.CCR-11-2485; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Song S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-502; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang X, 2014, BIOINFORMATICS, V30, P1777, DOI 10.1093/bioinformatics/btu090; Wang X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S16; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Xiong Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep06347; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	48	9	9	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165919	10.1371/journal.pone.0165919	http://dx.doi.org/10.1371/journal.pone.0165919			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829002	Green Published, Green Submitted, gold			2022-12-26	WOS:000387724300067
J	Holder, A; Mella, S; Palmer, DB; Aspinall, R; Catchpole, B				Holder, Angela; Mella, Stephanie; Palmer, Donald B.; Aspinall, Richard; Catchpole, Brian			An Age-Associated Decline in Thymic Output Differs in Dog Breeds According to Their Longevity	PLOS ONE			English	Article							RECEPTOR EXCISION CIRCLES; T-CELL POOL; LIFE-SPAN; AGING RESEARCH; BODY-SIZE; INVOLUTION; DELETION; BLOOD; YOUNG; GENE	The age associated decline in immune function is preceded in mammals by a reduction in thymic output. Furthermore, there is increasing evidence of a link between immune competence and lifespan. One approach to determining thymic output is to quantify signal joint T cell receptor excision circles (sj-TRECs), a method which has been developed and used in several mammalian species. Life expectancy and the rate of aging vary in dogs depending upon their breed. In this study, we quantified sj-TRECs in blood samples from dogs of selected breeds to determine whether there was a relationship between longevity and thymic output. In Labrador retrievers, a breed with a median expected lifespan of 11 years, there was an age-associated decline in sj-TREC values, with the greatest decline occurring before 5 years of age, but with sj-TREC still detectable in some geriatric animals, over 13 years of age. In large short-lived breeds (Burnese mountain dogs, Great Danes and Dogue de Bordeaux), the decline in sj-TREC values began earlier in life, compared with small long-lived breeds (Jack Russell terriers and Yorkshire terriers), and the presence of animals with undetectable sj-TRECs occurred at a younger age in the short-lived breeds. The study findings suggest that age-associated changes in canine sj-TRECs are related to breed differences in longevity, and this research highlights the use of dogs as a potential model of immunosenescence.	[Holder, Angela; Mella, Stephanie; Catchpole, Brian] Royal Vet Coll, Dept Pathol & Pathogen Biol, N Mymms, Herts, England; [Palmer, Donald B.] Royal Vet Coll, Dept Comparat Biomed Sci, London, England; [Aspinall, Richard] Anglia Ruskin Univ, Postgrad Med Inst, Hlth & Wellbeing Acad, Chelmsford, Essex, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; Anglia Ruskin University	Catchpole, B (corresponding author), Royal Vet Coll, Dept Pathol & Pathogen Biol, N Mymms, Herts, England.	bcatchpole@rvc.ac.uk		Aspinall, Richard/0000-0002-1648-1887	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J011800/1]; Biotechnology and Biological Sciences Research Council [1233476] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) (http://www.bbsrc.ac.uk/) grant number: BB/J011800/1 to BC, DBP, RA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VJ, 2010, J SMALL ANIM PRACT, V51, P512, DOI 10.1111/j.1748-5827.2010.00974.x; Andrew D, 2002, EXP GERONTOL, V37, P455, DOI 10.1016/S0531-5565(01)00213-3; Aspinall R, 2010, J COMP PATHOL, V141, pS111, DOI 10.1016/j.jcpa.2009.10.022; Aspinall R, 2001, Dev Immunol, V8, P95, DOI 10.1155/2001/17064; Aw D, 2007, IMMUNOLOGY, V120, P435, DOI 10.1111/j.1365-2567.2007.02555.x; Aw D, 2012, BIOGERONTOLOGY, V13, P77, DOI 10.1007/s10522-011-9349-0; Aw D, 2011, AGING DIS, V2, P437; Berryman DE, 2008, GROWTH HORM IGF RES, V18, P455, DOI 10.1016/j.ghir.2008.05.005; Betjes MGH, 2011, KIDNEY INT, V80, P209, DOI 10.1038/ki.2011.110; Cicin-Sain L, 2010, J IMMUNOL, V184, P6739, DOI 10.4049/jimmunol.0904193; Day MJ, 2010, J COMP PATHOL, V141, pS60, DOI [10.1016/j.jepa.2009.10.011, 10.1016/j.jcpa.2009.10.011]; DEVILLARTAY JP, 1988, NATURE, V335, P170, DOI 10.1038/335170a0; Diesel G, 2010, VET REC, V166, P455, DOI 10.1136/vr.b4798; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Favier RP, 2001, J ENDOCRINOL, V170, P479, DOI 10.1677/joe.0.1700479; Ferrando-Martinez S, 2013, AGE, V35, P251, DOI 10.1007/s11357-011-9341-2; Fick LJ, 2012, CELL REP, V2, P1530, DOI 10.1016/j.celrep.2012.11.021; Fleming JM, 2011, J VET INTERN MED, V25, P187, DOI 10.1111/j.1939-1676.2011.0695.x; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Geenen V, 2003, J ENDOCRINOL, V176, P305, DOI 10.1677/joe.0.1760305; Gilmore KM, 2015, EXP GERONTOL, V71, P14, DOI 10.1016/j.exger.2015.08.008; Greer KA, 2011, AGE, V33, P475, DOI 10.1007/s11357-010-9182-4; Hart BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102241; Hazenberg MD, 2003, NAT IMMUNOL, V4, P97, DOI 10.1038/ni0203-97; Hince M, 2008, CELL IMMUNOL, V252, P122, DOI 10.1016/j.cellimm.2007.10.007; HOCKETT RD, 1988, P NATL ACAD SCI USA, V85, P9694, DOI 10.1073/pnas.85.24.9694; Hoffman JM, 2013, J VET INTERN MED, V27, P747; Ito G, 2015, VET IMMUNOL IMMUNOP, V166, P1, DOI 10.1016/j.vetimm.2015.05.003; Kilpatrick RD, 2008, J IMMUNOL, V180, P1499, DOI 10.4049/jimmunol.180.3.1499; Kong FK, 1999, P NATL ACAD SCI USA, V96, P1536, DOI 10.1073/pnas.96.4.1536; Kraus C, 2013, AM NAT, V181, P492, DOI 10.1086/669665; Lang PO, 2011, J IMMUNOL METHODS, V369, P133, DOI 10.1016/j.jim.2011.05.002; Lynch HE, 2009, TRENDS IMMUNOL, V30, P366, DOI 10.1016/j.it.2009.04.003; Michell AR, 1999, VET REC, V145, P625, DOI 10.1136/vr.145.22.625; Mitchell WA, 2010, CLIN EXP IMMUNOL, V161, P497, DOI 10.1111/j.1365-2249.2010.04209.x; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; Pido-Lopez J, 2001, CLIN EXP IMMUNOL, V125, P409, DOI 10.1046/j.1365-2249.2001.01640.x; Ploemen JPHTM, 2003, TOXICOL PATHOL, V31, P214, DOI 10.1080/01926230390183706; Prelog M, 2008, ARTHRITIS RHEUM-US, V58, P2153, DOI 10.1002/art.23599; Savino W, 2002, SCAND J IMMUNOL, V55, P442, DOI 10.1046/j.1365-3083.2002.01077.x; Seksenyan A, 2010, J CELL MOL MED, V14, P2470, DOI 10.1111/j.1582-4934.2009.00863.x; Sempowski GD, 2002, MOL IMMUNOL, V39, P379, DOI 10.1016/S0161-5890(02)00112-8; Shanley DP, 2009, TRENDS IMMUNOL, V30, P374, DOI 10.1016/j.it.2009.05.001; Sodora DL, 2000, EUR J IMMUNOL, V30, P1145, DOI 10.1002/(SICI)1521-4141(200004)30:4<1145::AID-IMMU1145>3.0.CO;2-7; Sutherland JS, 2005, J IMMUNOL, V175, P2741, DOI 10.4049/jimmunol.175.4.2741; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Targonski PV, 2007, VACCINE, V25, P3066, DOI 10.1016/j.vaccine.2007.01.025; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Vallabhajosyula P, 2011, TRANSPLANTATION, V92, P634, DOI 10.1097/TP.0b013e31822b9287; Vallejo AN, 2009, P NATL ACAD SCI USA, V106, P11252, DOI 10.1073/pnas.0807025106; Waters DJ, 2011, ILAR J, V52, P97, DOI 10.1093/ilar.52.1.97; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140; YANG TJ, 1989, LAB ANIM, V23, P143, DOI 10.1258/002367789780863619; Zhang LQ, 1999, J EXP MED, V190, P725, DOI 10.1084/jem.190.5.725	54	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165968	10.1371/journal.pone.0165968	http://dx.doi.org/10.1371/journal.pone.0165968			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824893	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000387615200052
J	Kwok, MK; Leung, GM; Schooling, CM				Kwok, Man Ki; Leung, Gabriel M.; Schooling, C. Mary			Glucose-6-Phosphate Dehydrogenase Deficiency and Physical and Mental Health until Adolescence	PLOS ONE			English	Article							X-CHROMOSOME MARKERS; MANIC-DEPRESSIVE ILLNESS; SICKLE-CELL TRAIT; DIABETES-MELLITUS; BLOOD-PRESSURE; BIPOLAR DISORDER; GENETIC-LINKAGE; CHINESE; METAANALYSIS; IMPUTATION	Background To examine the association of glucose-6-phosphate dehydrogenase (G6PD) deficiency with adolescent physical and mental health, as effects of G6PD deficiency on health are rarely reported. Methods In a population-representative Chinese birth cohort: "Children of 1997" (n = 8,327), we estimated the adjusted associations of G6PD deficiency with growth using generalized estimating equations, with pubertal onset using interval censored regression, with hospitalization using Cox proportional hazards regression and with size, blood pressure, pubertal maturation and mental health using linear regression with multiple imputation and inverse probability weighting. Results Among 5,520 screened adolescents (66% follow-up), 4.8% boys and 0.5% girls had G6PD deficiency. G6PD-deficiency was not associated with birth weight-for-gestational age or length/height gain into adolescence, but was associated with lower childhood body mass index (BMI) gain (-0.38 z-score, 95% confidence interval (CI) -0.57, -0.20), adjusted for sex and parental education, and later onset of pubic hair development (time ratio = 1.029, 95% CI 1.007, 1.050). G6PD deficiency was not associated with blood pressure, height, BMI or mental health in adolescence, nor with serious infectious morbidity until adolescence. Conclusions G6PD deficient adolescents had broadly similar physical and mental health indicators, but transiently lower BMI gain and later pubic hair development, whose long-term implications warrant investigation.	[Kwok, Man Ki; Leung, Gabriel M.; Schooling, C. Mary] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Schooling, C. Mary] CUNY, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA	University of Hong Kong; City University of New York (CUNY) System	Schooling, CM (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.; Schooling, CM (corresponding author), CUNY, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA.	cms1l@hku.hk		Schooling, Mary/0000-0001-9933-5887; Leung, Gabriel/0000-0002-2503-6283; Kwok, Man Ki/0000-0003-3777-4766	Health Care and Promotion Fund, Health and Welfare Bureau, Government of the Hong Kong SAR [HCPF] [216106]; Health and Health Services Research Fund [HHSRF] [03040771]; University Research Committee Strategic Research Theme (SRT) of Public Health, The University of Hong Kong; Health and Health Services Research Fund [HHSRF], Government of the Hong Kong SAR [07080841, 07080751, 08090761, 09101061]	Health Care and Promotion Fund, Health and Welfare Bureau, Government of the Hong Kong SAR [HCPF]; Health and Health Services Research Fund [HHSRF]; University Research Committee Strategic Research Theme (SRT) of Public Health, The University of Hong Kong(University of Hong Kong); Health and Health Services Research Fund [HHSRF], Government of the Hong Kong SAR	This work was a sub-study of the "Children of 1997" birth cohort which was initially supported by the Health Care and Promotion Fund, Health and Welfare Bureau, Government of the Hong Kong SAR [HCPF Grant # 216106] and re-established in 2005 funded by the Health and Health Services Research Fund [HHSRF Grant # 03040771] and the University Research Committee Strategic Research Theme (SRT) of Public Health, The University of Hong Kong. This sub-study was funded by the Health and Health Services Research Fund [HHSRF Grants # 07080841, # 07080751, # 08090761 and # 09101061], Government of the Hong Kong SAR. The study sponsors have no role in: (1) study design; (2) the collection, analysis, and interpretation of data; (3) the writing of the report; and (4) the decision to submit the paper for publication. The authors have no conflict of interest, financial or otherwise. No honorarium, grant, or other form of payment was given to the authors to produce the manuscript.	[Anonymous], 1989, B WORLD HEALTH ORGAN, V67, P601; BARON M, 1987, NATURE, V326, P289, DOI 10.1038/326289a0; BARON M, 1993, NAT GENET, V3, P49, DOI 10.1038/ng0193-49; BARON M, 1994, NAT GENET, V7, P461, DOI 10.1038/ng0894-461a; Battle J., 1992, CULTURE FREE SELF ES; BERRETTINI WH, 1990, ARCH GEN PSYCHIAT, V47, P366; BOCCHETTA A, 1994, NAT GENET, V6, P224, DOI 10.1038/ng0394-224; Bocchetta Alberto, 2003, Ann Gen Hosp Psychiatry, V2, P6, DOI 10.1186/1475-2832-2-6; Cai X, 2014, ASIAN J ANDROL, V16, P146, DOI 10.4103/1008-682X.122346; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Cocco P, 2008, QJM-INT J MED, V101, P161, DOI 10.1093/qjmed/hcm129; Cocco P, 1998, BLOOD, V91, P706, DOI 10.1182/blood.V91.2.706.706_706_709; DELISI LE, 1991, BRIT J PSYCHIAT, V158, P630, DOI 10.1192/bjp.158.5.630; DELZOMPO M, 1984, ACTA PSYCHIAT SCAND, V70, P282; DERN RJ, 1963, J LAB CLIN MED, V62, P319; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Euling SY, 2008, PEDIATRICS, V121, pS172, DOI 10.1542/peds.2007-1813D; FIEVE RR, 1965, J PSYCHIAT RES, V3, P255, DOI 10.1016/0022-3956(65)90006-3; Fok TF, 2003, ARCH DIS CHILD-FETAL, V88, pF229, DOI 10.1136/fn.88.3.F229; Health Canada, 2014, SUMM SAF REV TEST RE; HELLER P, 1979, NEW ENGL J MED, V300, P1001, DOI 10.1056/NEJM197905033001801; Heymann Anthony D, 2012, Diabetes Care, V35, pe58, DOI 10.2337/dc11-2527; Kwok MK, 2013, J HYPERTENS, V31, P1785, DOI 10.1097/HJH.0b013e3283622ea0; Lam S. T. S, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P73; Lee W, 2008, BODY DISSATISFACTION; Lo KS, 2011, HUM GENET, V129, P307, DOI 10.1007/s00439-010-0925-1; Meloni L, 2008, J INHERIT METAB DIS, V31, P412, DOI 10.1007/s10545-008-0704-5; MENDLEWICZ J, 1980, BRIT J PSYCHIAT, V137, P337, DOI 10.1192/bjp.137.4.337; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Muntoni S, 2008, J NUTRIGENET NUTRIGE, V1, P49, DOI 10.1159/000109874; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; NIAZI GA, 1991, INT J HEMATOL, V54, P295; NWANKWO MU, 1990, GENET EPIDEMIOL, V7, P211, DOI 10.1002/gepi.1370070305; PETO R, 1973, ROY STAT SOC C-APP, V22, P86; Pinna A, 2013, INT J MED SCI, V10, P1907, DOI 10.7150/ijms.6776; Reriani MK, 2011, EUR J CARDIOV PREV R, V18, P704, DOI 10.1177/1741826711398430; Saeed T K, 1985, Diabet Med, V2, P110; SAHA N, 1979, J MED GENET, V16, P431, DOI 10.1136/jmg.16.6.431; Santana MS, 2014, AM J TROP MED HYG, V91, P74, DOI 10.4269/ajtmh.13-0032; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schooling CM, 2012, INT J EPIDEMIOL, V41, P611, DOI 10.1093/ije/dyq243; Seaman SR, 2012, BIOMETRICS, V68, P129, DOI 10.1111/j.1541-0420.2011.01666.x; Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017; Swerdlow DI, 2015, LANCET, V385, P351, DOI 10.1016/S0140-6736(14)61183-1; Utriainen P, 2013, J CLIN ENDOCR METAB, V98, pE87, DOI 10.1210/jc.2012-2783; WHO, 2007, WHO GROWTH REF 5 19; WIESENFELD SL, 1970, NEW ENGL J MED, V282, P1001, DOI 10.1056/NEJM197004302821804; WONG CK, 1988, ACTA PSYCHIAT SCAND, V78, P11, DOI 10.1111/j.1600-0447.1988.tb06295.x; World Health Organization, 2005, WHO CHILD GROWTH STA; World Health Organization (WHO) & Vietnam Ministry of Health of, 2012, HLTH SERV DEL PROF; Worthman CM, 2005, AM J HUM BIOL, V17, P95, DOI 10.1002/ajhb.20096	51	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166192	10.1371/journal.pone.0166192	http://dx.doi.org/10.1371/journal.pone.0166192			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824927	gold, Green Published			2022-12-26	WOS:000387615200068
J	Juste, RA; Alonso-Hearn, M; Garrido, JM; Abendano, N; Sevilla, IA; Gortazar, C; de la Fuente, J; Dominguez, L				Juste, Ramon A.; Alonso-Hearn, Marta; Garrido, Joseba M.; Abendano, Naiara; Sevilla, Iker A.; Gortazar, Christian; de la Fuente, Jose; Dominguez, Lucas			Increased Lytic Efficiency of Bovine Macrophages Trained with Killed Mycobacteria	PLOS ONE			English	Article							CALMETTE-GUERIN VACCINE; TUBERCULOSIS; PHAGOCYTOSIS; IMMUNITY; CATTLE	Innate immunity is evolutionarily conserved in multicellular organisms and was considered to lack memory until very recently. One of its more characteristic mechanisms is phagocytosis, the ability of cells to engulf, process and eventually destroy any injuring agent. We report the results of an ex vivo experiment in bovine macrophages in which improved clearance of Mycobacterium bovis (M. bovis) was induced by pre-exposure to a heat killed M. bovis preparation. The effects were independent of humoral and cellular adaptive immune responses and lasted up to six months. Specifically, our results demonstrate the existence of a training effect in the lytic phase of phagocytosis that can be activated by killed mycobacteria, thus suggesting a new mechanism of vaccine protection. These findings are compatible with the recently proposed concept of trained immunity, which was developed to explain the observation that innate immune responses provide unspecific protection against pathogens including other than those that originally triggered the immune response.	[Juste, Ramon A.; Alonso-Hearn, Marta; Garrido, Joseba M.; Abendano, Naiara; Sevilla, Iker A.] NEIKER Tecnalia, Dept Anim Hlth, Berreaga 1, Derio 48160, Bizkaia, Spain; [Gortazar, Christian; de la Fuente, Jose] UCLM, JCCM, CSIC, SaBio,Inst Invest Recursos Cineget,IREC, Ciudad Real 13071, Spain; [de la Fuente, Jose] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, 250 McElroy Hall, Stillwater, OK 74078 USA; [Dominguez, Lucas] Univ Complutense, Ctr Vigilancia Sanitaria Vet VISAVET, Ave Puerta Hierro, E-28040 Madrid, Spain; [Juste, Ramon A.] SERIDA, Carretera Oviedo, Villaviciosa 33300, Asturias, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Oklahoma State University System; Oklahoma State University - Stillwater; Complutense University of Madrid; Servicio Regional Investigacion Desarrollo Agroalimentario - SERIDA	Juste, RA (corresponding author), NEIKER Tecnalia, Dept Anim Hlth, Berreaga 1, Derio 48160, Bizkaia, Spain.; Juste, RA (corresponding author), SERIDA, Carretera Oviedo, Villaviciosa 33300, Asturias, Spain.	rajuste@serida.org	Sevilla, Iker A/O-6060-2014; Abendaño, Naiara/L-3535-2017; Dominguez Rodriguez, Lucas/B-9668-2014; Gortazar, Christian/E-7918-2012	Sevilla, Iker A/0000-0003-3968-3390; Abendaño, Naiara/0000-0001-9719-0688; Dominguez Rodriguez, Lucas/0000-0001-8843-0010; Joseba M., Garrido/0000-0002-7559-0653; Alonso-Hearn, Marta/0000-0001-5979-347X; Gortazar, Christian/0000-0003-0012-4006	EU project WildTBVac [613799]; Institute Nacional de Investigacion y Tencologia Agraria y alimentaria (INIA) [RTA2011-00049]; Ministry of Science (MINECO) [AGL2014-56305]; European Funds Regional Development (FEDER)	EU project WildTBVac; Institute Nacional de Investigacion y Tencologia Agraria y alimentaria (INIA)(Instituto de Investigacion Agropecuaria (INIA)); Ministry of Science (MINECO); European Funds Regional Development (FEDER)	Funding for these studies was provided by the EU project WildTBVac (Contract #613799) and by grants from the Institute Nacional de Investigacion y Tencologia Agraria y alimentaria (INIA, RTA2011-00049) and the Ministry of Science (MINECO, AGL2014-56305) and European Funds Regional Development (FEDER).	Aaby P, 2012, P NATL ACAD SCI USA, V109, P17317, DOI 10.1073/pnas.1215761109; Abendano N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104238; Abendano N, 2013, VET MICROBIOL, V163, P325, DOI 10.1016/j.vetmic.2012.12.042; Alonso-Hearn M, 2012, J DAIRY SCI, V95, P618, DOI 10.3168/jds.2009-2860; Andersen A, 2013, VACCINE, V31, P2137, DOI 10.1016/j.vaccine.2013.02.050; [Anonymous], 2011, ROITTS ESSENTIAL IMM; Beltran-Beck B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098048; Billau A, 2011, J LEUKOCYTE BIOL, V70, P849; Buffen K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004485; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; De la Fuente IM, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00016; De La Fuente J, 2016, EXPERT REV VACCINES, V15, P275, DOI 10.1586/14760584.2016.1125294; Galagan JE, 2014, NAT REV GENET, V15, P307, DOI 10.1038/nrg3664; Garrido JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024905; Good M., 2010, VET HDB HERD MANAGEM; Gordon S, 2016, IMMUNITY, V44, P463, DOI 10.1016/j.immuni.2016.02.026; Hollm-Delgado MG, 2014, PEDIATRICS, V133, pE73, DOI 10.1542/peds.2013-2218; Naranjo V, 2006, FEMS IMMUNOL MED MIC, V46, P298, DOI 10.1111/j.1574-695X.2005.00035.x; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Ritz N, 2013, VACCINE, V31, P3098, DOI 10.1016/j.vaccine.2013.03.059; Roth O, 2009, DEV COMP IMMUNOL, V33, P1151, DOI 10.1016/j.dci.2009.04.005; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086	22	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165607	10.1371/journal.pone.0165607	http://dx.doi.org/10.1371/journal.pone.0165607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820836	Green Published, gold, Green Submitted			2022-12-26	WOS:000387614800014
J	Nandi, D; Balakrishnan, R				Nandi, Diptarup; Balakrishnan, Rohini			Spatio-Temporal Dynamics of Field Cricket Calling Behaviour: Implications for Female Mate Search and Mate Choice	PLOS ONE			English	Article							SEXUAL SELECTION; GRYLLUS-CAMPESTRIS; TELEOGRYLLUS-COMMODUS; POPULATION-DENSITIES; CHORUS TENURE; COMPONENTS; SIGNALS; DETERMINANTS; ORTHOPTERA; STRATEGIES	Amount of calling activity (calling effort) is a strong determinant of male mating success in species such as orthopterans and anurans that use acoustic communication in the context of mating behaviour. While many studies in crickets have investigated the determinants of calling effort, patterns of variability in male calling effort in natural choruses remain largely unexplored. Within-individual variability in calling activity across multiple nights of calling can influence female mate search and mate choice strategies. Moreover, calling site fidelity across multiple nights of calling can also affect the female mate sampling strategy. We therefore investigated the spatio-temporal dynamics of acoustic signaling behaviour in a wild population of the field cricket species Plebeiogryllus guttiventris. We first studied the consistency of calling activity by quantifying variation in male calling effort across multiple nights of calling using repeatability analysis. Callers were inconsistent in their calling effort across nights and did not optimize nightly calling effort to increase their total number of nights spent calling. We also estimated calling site fidelity of males across multiple nights by quantifying movement of callers. Callers frequently changed their calling sites across calling nights with substantial displacement but without any significant directionality. Finally, we investigated trade-offs between within-night calling effort and energetically expensive calling song features such as call intensity and chirp rate. Calling effort was not correlated with any of the calling song features, suggesting that energetically expensive song features do not constrain male calling effort. The two key features of signaling behaviour, calling effort and call intensity, which determine the duration and spatial coverage of the sexual signal, are therefore uncorrelated and function independently.	[Nandi, Diptarup; Balakrishnan, Rohini] Indian Inst Sci, Ctr Ecol Sci, Bangalore, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Nandi, D; Balakrishnan, R (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bangalore, Karnataka, India.	diptarup@ces.iisc.ernet.in; rohini@ces.iisc.ernet.in	Balakrishnan, Rohini/Z-5881-2019		Council of Scientific and Industrial Research, Government of India [CSIR/HRD/37 (1434)/10 EMR-II]; Department of Biotechnology, Ministry of Science & Technology, Government of India	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Ministry of Science & Technology, Government of India(Department of Biotechnology (DBT) India)	This project was supported by funding received by RB from the Council of Scientific and Industrial Research, Government of India, (No. CSIR/HRD/37 (1434)/10 EMR-II) and the Department of Biotechnology, Ministry of Science & Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arak A., 1983, P181; BAILEY WJ, 1993, J EXP BIOL, V178, P21; Bertram SM, 2011, ANIM BEHAV, V82, P1255, DOI 10.1016/j.anbehav.2011.08.021; Bertram SM, 2005, ANIM BEHAV, V70, P477, DOI 10.1016/j.anbehav.2004.09.024; Bertram SM, 2012, ECOL EVOL, V2, P181, DOI 10.1002/ece3.76; Bevier CR, 1997, HERPETOLOGICA, V53, P297; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Burt John M., 2005, P320, DOI 10.1017/CBO9780511610363.019; CADE WH, 1992, ANIM BEHAV, V43, P49, DOI 10.1016/S0003-3472(05)80070-3; Callander S, 2013, BEHAV ECOL, V24, P1251, DOI 10.1093/beheco/art059; CAMPBELL DJ, 1990, ANIM BEHAV, V39, P1051, DOI 10.1016/S0003-3472(05)80777-8; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Castellano S, 2011, J THEOR BIOL, V274, P161, DOI 10.1016/j.jtbi.2011.01.001; Chopard L., 1969, FAUNA INDIA ADJACENT; Crawley M.J., 2007, R BOOK; Deb R, 2014, BEHAV ECOL, V25, P967, DOI 10.1093/beheco/aru072; Deb R, 2012, ANIM BEHAV, V84, P137, DOI 10.1016/j.anbehav.2012.04.020; Falconer D. S., 1996, INTRO QUANTITATIVE G; FORREST T G, 1991, Bioacoustics, V3, P93; FORREST TG, 1994, BEHAV ECOL, V5, P293, DOI 10.1093/beheco/5.3.293; FRENCH BW, 1989, J INSECT BEHAV, V2, P105, DOI 10.1007/BF01053621; FRENCH BW, 1987, BEHAV ECOL SOCIOBIOL, V21, P157, DOI 10.1007/BF00303205; Friedl TWP, 2005, ANIM BEHAV, V70, P1141, DOI 10.1016/j.anbehav.2005.01.017; Gerhardt HC, 1996, BEHAV ECOL, V7, P7, DOI 10.1093/beheco/7.1.7; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; GREEN AJ, 1990, ANIM BEHAV, V39, P620, DOI 10.1016/S0003-3472(05)80373-2; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; HISSMANN K, 1990, ECOL ENTOMOL, V15, P281, DOI 10.1111/j.1365-2311.1990.tb00810.x; Holzer B, 2003, BEHAV ECOL, V14, P353, DOI 10.1093/beheco/14.3.353; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; Hunt J, 2005, AM NAT, V166, P79, DOI 10.1086/430672; JANETOS AC, 1980, BEHAV ECOL SOCIOBIOL, V7, P107, DOI 10.1007/BF00299515; Johnstone RA, 1996, PHILOS T R SOC B, V351, P329, DOI 10.1098/rstb.1996.0026; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Luttbeg B, 1996, BEHAV ECOL, V7, P451, DOI 10.1093/beheco/7.4.451; Mazalov V, 1996, AM NAT, V148, P123, DOI 10.1086/285914; McClelland BE, 1996, J EXP BIOL, V199, P1907; Mhatre N, 2008, J EXP BIOL, V211, P2779, DOI 10.1242/jeb.017756; Mhatre N, 2007, J EXP BIOL, V210, P3661, DOI 10.1242/jeb.003764; Mhatre N, 2006, ANIM BEHAV, V72, P1045, DOI 10.1016/j.anbehav.2006.02.022; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; Morris GK, 2002, CAN J ZOOL, V80, P271, DOI 10.1139/z02-003; Murphy CG, 1998, EVOLUTION, V52, P8, DOI 10.1111/j.1558-5646.1998.tb05133.x; MURPHY CG, 1994, BEHAV ECOL SOCIOBIOL, V34, P285; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nandi D, 2013, ANIM BEHAV, V86, P1003, DOI 10.1016/j.anbehav.2013.09.003; Nityananda V, 2008, ANIM BEHAV, V76, P723, DOI 10.1016/j.anbehav.2008.04.015; Parker G.A., 1983, P141; PRESTWICH KN, 1994, AM ZOOL, V34, P625, DOI 10.1093/icb/34.6.625; R Development Core Team, 2014, R LANG ENV STAT COMP; REAL L, 1990, AM NAT, V136, P376, DOI 10.1086/285103; Ritz MS, 2007, ECOL ENTOMOL, V32, P384, DOI 10.1111/j.1365-2311.2007.00887.x; Ritz MS, 2010, EVOL ECOL, V24, P985, DOI 10.1007/s10682-009-9328-y; Rodriguez-Munoz R, 2010, SCIENCE, V328, P1269, DOI 10.1126/science.1188102; Rodriguez-Munoz R, 2011, CURR BIOL, V21, P1716, DOI 10.1016/j.cub.2011.08.053; ROST R, 1987, BEHAV ECOL SOCIOBIOL, V21, P279, DOI 10.1007/BF00299965; Scheuber H, 2003, P ROY SOC B-BIOL SCI, V270, P1779, DOI 10.1098/rspb.2003.2449; Scheuber H, 2004, P ROY SOC B-BIOL SCI, V271, P2453, DOI 10.1098/rspb.2004.2907; Scheuber H, 2003, ANIM BEHAV, V65, P721, DOI 10.1006/anbe.2003.2083; Segev O, 2012, ACTA HERPETOL, V7, P331; Sokal RR., 2011, BIOMETRY; TEJEDO M, 1992, ANIM BEHAV, V44, P557, DOI 10.1016/0003-3472(92)90065-H; WAGNER WE, 1995, ANIM BEHAV, V49, P305, DOI 10.1006/anbe.1995.0044; Wagner WE, 1999, ANIM BEHAV, V57, P89, DOI 10.1006/anbe.1998.0964; Wells K.D., 2006, HEARING SOUND COMMUN, P44, DOI [10.1007/978-0-387-47796-1_3, DOI 10.1007/978-0-387-47796-1]; WELLS KD, 1977, ANIM BEHAV, V25, P666, DOI 10.1016/0003-3472(77)90118-X; Whattam EM, 2011, ANIM BEHAV, V81, P135, DOI 10.1016/j.anbehav.2010.09.024; Wiegmann DD, 2007, J THEOR BIOL, V249, P654, DOI 10.1016/j.jtbi.2007.08.027; Wittenberger J.F., 1983, P435; Zajitschek F, 2009, AM NAT, V173, P792, DOI 10.1086/598486; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	72	4	3	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165807	10.1371/journal.pone.0165807	http://dx.doi.org/10.1371/journal.pone.0165807			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820868	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000387614800020
J	Abbasi, SA; Shah, RV; McNulty, SE; Hernandez, AF; Semigran, MJ; Lewis, GD; Jerosch-Herold, M; Kim, RJ; Redfield, MM; Kwong, RY				Abbasi, Siddique A.; Shah, Ravi V.; McNulty, Steven E.; Hernandez, Adrian F.; Semigran, Marc J.; Lewis, Gregory D.; Jerosch-Herold, Michael; Kim, Raymond J.; Redfield, Margaret M.; Kwong, Raymond Y.			Left Atrial Structure and Function in Heart Failure with Preserved Ejection Fraction: A RELAX Substudy	PLOS ONE			English	Article							EXERCISE CAPACITY; CARDIAC STRUCTURE; TRIAL; VOLUME	Given the emerging recognition of left atrial structure and function as an important marker of disease in heart failure with preserved ejection fraction (HF-pEF), we investigated the association between left atrial volume and function with markers of disease severity and cardiac structure in HF-pEF. We studied 100 patients enrolled in the PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial who underwent cardiac magnetic resonance (CMR), cardiopulmonary exercise testing, and blood collection before randomization. Maximal left atrial volume index (LAVi; N = 100), left atrial emptying fraction (LAEF; N = 99; including passive and active components (LAEF(P), LAEF(A); N = 80, 79, respectively) were quantified by CMR. After adjustment for multiple testing, maximal LAVi was only associated with age (rho = 0.39), transmitral filling patterns (medial E/e' rho = 0.43), and N-terminal pro-BNP (NT-proBNP; rho = 0.65; all p< 0.05). Lower LAEF was associated with older age, higher transmitral E/A ratio and higher NT-proBNP. Peak VO2 and V-E/VCO2 slope were not associated with left atrial structure or function. After adjustment for age, sex, transmitral E/A ratio, CMR LV mass, LV ejection fraction, and creatinine clearance, NT-proBNP remained associated with maximal LAVi (beta = 0.028, p = 0.0007) and total LAEF (beta = -0.033, p = 0.001). Passive and active LAEF were most strongly associated with age and NT-proBNP, but not gas exchange or other markers of ventricular structure or filling properties. Left atrial volume and emptying function are associated most strongly with NT-proBNP and diastolic filling properties, but not significantly with gas exchange, in HFpEF. Further research to explore the relevance of left atrial structure and function in HF-pEF is warranted.	[Abbasi, Siddique A.; Jerosch-Herold, Michael; Kwong, Raymond Y.] Brigham & Womens Hosp, Noninvas Cardiovasc Imaging Sect, 75 Francis St, Boston, MA 02115 USA; [Shah, Ravi V.; Semigran, Marc J.; Lewis, Gregory D.] Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02114 USA; [McNulty, Steven E.; Hernandez, Adrian F.] Duke Clin Res Inst, Durham, NC USA; [Kim, Raymond J.] Duke Univ, Med Ctr, Duke Cardiovasc Magnet Resonance Ctr, Durham, NC USA; [Redfield, Margaret M.] Mayo Clin Rochester, Rochester, MN USA; [Abbasi, Siddique A.] Providence VA Med Ctr, Div Cardiol, Providence, RI USA; [Abbasi, Siddique A.] Brown Univ, Alpert Med Sch, Cardiovasc Inst, Providence, RI 02912 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Duke University; Duke University; Mayo Clinic; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University	Kwong, RY (corresponding author), Brigham & Womens Hosp, Noninvas Cardiovasc Imaging Sect, 75 Francis St, Boston, MA 02115 USA.	rykwong@partners.org	Kwong, Raymond Y/R-1925-2016; Kim, Raymond J/B-1426-2008; Jerosch-Herold, Michael/R-9824-2019; Hernandez, Adrian F/A-7818-2016; Abbasi, Siddique/B-8425-2016	Kwong, Raymond Y/0000-0001-8212-0759; Hernandez, Adrian F/0000-0003-3387-9616; Abbasi, Siddique/0000-0002-9601-7565	National Heart, Lung, and Blood Institute [U10HL084904, U10HL084861, U10HL084875, U10HL084877, U10HL084889, U10HL084890, U10HL084891, U10HL084899, U10HL084907, U10HL084931]; Heart Failure National Institutes of Health Clinical Research Network [U01-HL084877]; National Institutes of Health [5T32HL094301-04]; NIH [5R01HL091157]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL110337, K23HL127099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103652] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Heart Failure National Institutes of Health Clinical Research Network; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants U10HL084904 (for the data coordinating center), and U10HL084861, U10HL084875, U10HL084877, U10HL084889, U10HL084890, U10HL084891, U10HL084899, U10HL084907, and U10HL084931 (for the clinical centers) from the National Heart, Lung, and Blood Institute. Dr. Shah was supported by a training grant from the Heart Failure National Institutes of Health Clinical Research Network (U01-HL084877). Dr. Abbasi was supported by a T32 training grant (5T32HL094301-04) from the National Institutes of Health. Dr. Kwong was supported by NIH 5R01HL091157. Pfizer provided study drug (sildenafil and matched placebo). All other authors have no financial disclosures relevant to the content of this manuscript.	Abhayaratna WP, 2008, AM J CARDIOL, V101, P1626, DOI 10.1016/j.amjcard.2008.01.051; Barclay JL, 2006, AM J CARDIOL, V98, P98, DOI 10.1016/j.amjcard.2006.01.057; Edelmann F, 2013, INT J CARDIOL, V169, P408, DOI 10.1016/j.ijcard.2013.10.018; Gelsomino S, 2014, ANN CARDIOTHORAC SUR, V3, P70, DOI 10.3978/j.issn.2225-319X.2013.12.03; Hoit BD, 2014, J AM COLL CARDIOL, V63, P493, DOI 10.1016/j.jacc.2013.10.055; Hundley WG, 2001, J AM COLL CARDIOL, V38, P796, DOI 10.1016/S0735-1097(01)01447-4; Kadappu KK, 2012, EUR HEART J-CARD IMG, V13, P1016, DOI 10.1093/ehjci/jes084; Kramer CM, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-35; Maeder MT, 2009, RESP MED, V103, P1337, DOI 10.1016/j.rmed.2009.03.015; Mazzone C, 2014, ECHOCARDIOGR-J CARD, V31, P123, DOI 10.1111/echo.12325; Melenovsky V, 2015, CIRC HEART FAIL; Redfield MM, 2012, CIRC-HEART FAIL, V5, P653, DOI 10.1161/CIRCHEARTFAILURE.112.969071; Shah AM, 2014, CIRC-HEART FAIL, V7, P104, DOI 10.1161/CIRCHEARTFAILURE.113.000887; Shah AM, 2012, EUR HEART J, V33, P1716, DOI 10.1093/eurheartj/ehs124; Trojnarska O, 2010, INT J CARDIOL, V139, P241, DOI 10.1016/j.ijcard.2008.10.025; Zakeri R, 2014, CIRC-HEART FAIL, V7, P123, DOI 10.1161/CIRCHEARTFAILURE.113.000568; Zile MR, 2011, CIRCULATION, V124, P2491, DOI 10.1161/CIRCULATIONAHA.110.011031	17	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164914	10.1371/journal.pone.0164914	http://dx.doi.org/10.1371/journal.pone.0164914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812147	Green Published, Green Submitted, gold			2022-12-26	WOS:000386910000017
J	Thiebaut, R; Esmiol, S; Lecine, P; Mahfouz, B; Hermant, A; Nicoletti, C; Parnis, S; Perroy, J; Borg, JP; Pascoe, L; Hugot, JP; Ollendorff, V				Thiebaut, Raphaele; Esmiol, Sophie; Lecine, Patrick; Mahfouz, Batoul; Hermant, Aurelie; Nicoletti, Cendrine; Parnis, Stephane; Perroy, Julie; Borg, Jean-Paul; Pascoe, Leigh; Hugot, Jean-Pierre; Ollendorff, Vincent			Characterization and Genetic Analyses of New Genes Coding for NOD2 Interacting Proteins	PLOS ONE			English	Article							NF-KAPPA-B; GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; PROTEOME-SCALE MAP; CROHNS-DISEASE; OLIGOMERIZATION DOMAIN-2; SUSCEPTIBILITY LOCI; INTERACTION NETWORK; PANCREATIC-CANCER; MURAMYL DIPEPTIDE	NOD2 contributes to the innate immune response and to the homeostasis of the intestinal mucosa. In response to its bacterial ligand, NOD2 interacts with RICK and activates the NF-.B and MAPK pathways, inducing gene transcription and synthesis of proteins required to initiate a balanced immune response. Mutations in NOD2 have been associated with an increased risk of Crohn's Disease (CD), a disabling inflammatory bowel disease (IBD). Because NOD2 signaling plays a key role in CD, it is important to further characterize the network of protein interacting with NOD2. Using yeast two hybrid (Y2H) screens, we identified new NOD2 interacting proteins (NIP). The primary interaction was confirmed by coimmunoprecipitation and/or bioluminescence resonance energy transfer (BRET) experiments for 11 of these proteins (ANKHD1, CHMP5, SDCCAG3, TRIM41, LDOC1, PPP1R12C, DOCK7, VIM, KRT15, PPP2R3B, and C10Orf67). These proteins are involved in diverse functions, including endosomal sorting complexes required for transport (ESCRT), cytoskeletal architecture and signaling regulation. Additionally, we show that the interaction of 8 NIPs is compromised with the 3 main CD associated NOD2 mutants (R702W, G908R and 1007fs). Furthermore, to determine whether these NOD2 protein partners could be encoded by IBD susceptibility genes, a transmission disequilibrium test (TDT) was performed on 101 single nucleotide polymorphisms (SNPs) and the main corresponding haplotypes in genes coding for 15 NIPs using a set of 343 IBD families with 556 patients. Overall this work did not increase the number of IBD susceptibility genes but extends the NOD2 protein interaction network and suggests that NOD2 interactome and signaling depend upon the NOD2 mutation profile in CD.	[Esmiol, Sophie; Ollendorff, Vincent] Univ Montpellier, INRA, DMEM, UMR866, Montpellier, France; [Thiebaut, Raphaele; Mahfouz, Batoul; Hugot, Jean-Pierre] INSERM, UMR1149, F-75018 Paris, France; [Thiebaut, Raphaele; Mahfouz, Batoul; Hugot, Jean-Pierre] Univ Paris Diderot, Sorbonne Paris Cite, F-75018 Paris, France; [Hugot, Jean-Pierre] Hop Robert Debre, AP HP, Serv Gastroenterol Pediat, F-75019 Paris, France; [Lecine, Patrick; Hermant, Aurelie; Borg, Jean-Paul] Aix Marseille Univ, CNRS, INSERM,Inst Paoli Calmettes,CRCM, Cell Polar Cell Signaling & Canc Equipe Labellise, Marseille, France; [Nicoletti, Cendrine; Parnis, Stephane] Aix Marseille Univ, CNRS, Cent Marseille, ISM2 UMR7313, F-13397 Marseille, France; [Perroy, Julie] CNRS, UMR 5203, Inst Genom Fonct, F-34094 Montpellier, France; [Perroy, Julie] INSERM, U1191, F-34094 Montpellier, France; [Perroy, Julie] Univ Montpellier, UMR 5203, F-34094 Montpellier, France; [Pascoe, Leigh] Fdn Jean Dausset, CEPH, Paris, France; [Esmiol, Sophie] Aix Marseille Univ, APHM, Dept Pediat Hematol Oncol, La Timone Hosp, Marseille, France; [Lecine, Patrick] BIOASTER, 40 Ave Tony Gamier, F-69007 Lyon, France	INRAE; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Foundation Jean Dausset-CEPH; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Ollendorff, V (corresponding author), Univ Montpellier, INRA, DMEM, UMR866, Montpellier, France.	vincent.ollendorff@supagro.inra.fr	Lecine, Patrick/H-9338-2016; Borg, Jean-Paul/AAX-8096-2020	Borg, Jean-Paul/0000-0001-8418-3382; Hugot, Jean-Pierre/0000-0002-8446-6056; Ollendorff, Vincent/0000-0001-9751-2202; Lecine, Patrick/0000-0002-8091-7286; perroy, julie/0000-0001-6199-0448; Cendrine, Nicoletti/0000-0002-0086-6707	INRA; INSERM; Agence National pour la Recherche, Investissements d'Avenir programme Sorbonne-Paris-Cite Laboratoire d'excellence INFLAMEX [ANR-11-IDEX-0005-02]; Universite Paris-Diderot; Broad Medical Research Program; Association Francois Aupetit; Mairie de Paris; French Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale; INCa (Marseille Proteomics platform); Institut Paoli-Calmettes	INRA; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence National pour la Recherche, Investissements d'Avenir programme Sorbonne-Paris-Cite Laboratoire d'excellence INFLAMEX(French National Research Agency (ANR)); Universite Paris-Diderot; Broad Medical Research Program; Association Francois Aupetit; Mairie de Paris(Region Ile-de-France); French Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); INCa (Marseille Proteomics platform); Institut Paoli-Calmettes	Financial support was provided by INRA, INSERM, Agence National pour la Recherche, Investissements d'Avenir programme ANR-11-IDEX-0005-02 Sorbonne-Paris-Cite Laboratoire d'excellence INFLAMEX, Universite Paris-Diderot, the Broad Medical Research Program, the Association Francois Aupetit, and the Mairie de Paris. R. Thiebaut and S. Esmiol received a grant from the French Ministere de l'Enseignement Superieur et de la Recherche. R. Thiebaut was the recipient of a fellowship from the Fondation pour la Recherche Medicale. JPB is funded by INCa (Marseille Proteomics platform), and Institut Paoli-Calmettes.	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Alvarez C, 2001, J BIOL CHEM, V276, P2693, DOI 10.1074/jbc.M007957200; Barnich N, 2005, J BIOL CHEM, V280, P19021, DOI 10.1074/jbc.M413776200; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Boyle JP, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140178; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Chen D, 2007, J BIOL CHEM, V282, P33776, DOI 10.1074/jbc.M703320200; Ciruela F, 2010, TRENDS BIOTECHNOL, V28, P407, DOI 10.1016/j.tibtech.2010.05.002; Claes AK, 2015, PHYSIOLOGY, V30, P241, DOI 10.1152/physiol.00025.2014; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eitel J, 2008, J IMMUNOL, V181, P2664, DOI 10.4049/jimmunol.181.4.2664; Fenner BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008799; Franke A, 2008, GASTROENTEROLOGY, V135, P1207, DOI 10.1053/j.gastro.2008.07.017; Fukuyama H, 2013, P NATL ACAD SCI USA, V110, P10717, DOI 10.1073/pnas.1304380110; Greenblatt MB, 2015, J EXP MED, V212, P1283, DOI 10.1084/jem.20150407; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hofer-Warbinek R, 2004, CELL DEATH DIFFER, V11, P1317, DOI 10.1038/sj.cdd.4401502; Homer CR, 2012, J BIOL CHEM, V287, P25565, DOI 10.1074/jbc.M111.326835; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Kufer TA, 2006, INFECT IMMUN, V74, P3115, DOI 10.1128/IAI.00035-06; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Lambert JC, 2010, J ALZHEIMERS DIS, V20, P1107, DOI 10.3233/JAD-2010-100018; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Lavelle EC, 2010, MUCOSAL IMMUNOL, V3, P17, DOI 10.1038/mi.2009.124; Lecine P, 2007, J BIOL CHEM, V282, P15197, DOI 10.1074/jbc.M606242200; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Li ST, 2006, MOL CELL, V24, P497, DOI 10.1016/j.molcel.2006.10.015; Magenta A, 2008, MOL CELL BIOL, V28, P873, DOI 10.1128/MCB.00480-07; Maminska A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad0848; McDonald C, 2005, J BIOL CHEM, V280, P40301, DOI 10.1074/jbc.M508538200; McGough IJ, 2014, J CELL SCI, V127, P4940, DOI 10.1242/jcs.156299; Menning M, 2013, FEBS LETT, V587, P2137, DOI 10.1016/j.febslet.2013.05.037; Minin AA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1453, DOI 10.1134/S0006297908130063; Nagasaki K, 2003, INT J CANCER, V105, P454, DOI 10.1002/ijc.11122; Nakamura N, 2014, NATURE, V509, P240, DOI 10.1038/nature13133; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Neznanov N, 2005, DNA CELL BIOL, V24, P777, DOI 10.1089/dna.2005.24.777; Nimmo ER, 2011, GASTROENTEROLOGY, V141, P972, DOI 10.1053/j.gastro.2011.05.043; Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; ORRWEAVER TL, 1983, P NATL ACAD SCI-BIOL, V80, P4417, DOI 10.1073/pnas.80.14.4417; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Raelson JV, 2007, P NATL ACAD SCI USA, V104, P14747, DOI 10.1073/pnas.0706645104; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rosenstiel P, 2009, SEMIN IMMUNOL, V21, P334, DOI 10.1016/j.smim.2009.10.001; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salazar JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000444; Sellge G, 2015, SEMIN IMMUNOL, V27, P75, DOI 10.1016/j.smim.2015.03.009; Seok J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-78; Shim JH, 2006, J CELL BIOL, V172, P1045, DOI 10.1083/jcb.200509041; Shim S, 2008, MOL BIOL CELL, V19, P2661, DOI 10.1091/mbc.E07-12-1263; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stevens C, 2013, GUT, V62, P695, DOI 10.1136/gutjnl-2011-301775; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Thalappilly S, 2008, PROTEOMICS, V8, P3071, DOI 10.1002/pmic.200701157; Theibaut R, 2011, INFLAMM BOWEL DIS, V17, P1055, DOI 10.1002/ibd.21406; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Wang J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.67; Warner N, 2014, J BIOL CHEM, V289, P28213, DOI 10.1074/jbc.M114.574756; Warner N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003305; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JC133145, 10.1172/JCI33145]; Watanabe T, 2006, IMMUNITY, V25, P473, DOI 10.1016/j.immuni.2006.06.018; Yamamoto-Furusho JK, 2006, J BIOL CHEM, V281, P36060, DOI 10.1074/jbc.M602383200; Zhernakova A, 2008, AM J HUM GENET, V82, P1202, DOI 10.1016/j.ajhg.2008.03.016; Zurek B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041255	77	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165420	10.1371/journal.pone.0165420	http://dx.doi.org/10.1371/journal.pone.0165420			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812135	gold, Green Published, Green Submitted			2022-12-26	WOS:000386910000029
J	Bragazzi, NL; Dini, G; Toletone, A; Brigo, F; Durando, P				Bragazzi, Nicola Luigi; Dini, Guglielmo; Toletone, Alessandra; Brigo, Francesco; Durando, Paolo			Leveraging Big Data for Exploring Occupational Diseases-Related Interest at the Level of Scientific Community, Media Coverage and Novel Data Streams: The Example of Silicosis as a Pilot Study	PLOS ONE			English	Article							EBOLA RESEARCH; UNITED-STATES; WEB; INFORMATION; INTERNET; SCIENCE; TRENDS; SURVEILLANCE; WIKIPEDIA; MEDICINE	Objective Silicosis is an untreatable but preventable occupational disease, caused by exposure to silica. It can progressively evolve to lung impairment, respiratory failure and death, even after exposure has ceased. However, little is known about occupational diseases-related interest at the level of scientific community, media coverage and web behavior. This article aims at filling in this gap of knowledge, taking the silicosis as a case study. Methods We investigated silicosis-related web-activities using Google Trends (GT) for capturing the Internet behavior worldwide in the years 2004-2015. GT-generated data were, then, compared with the silicosis-related scientific production (i.e., PubMed and Google Scholar), the media coverage (i.e., Google news), the Wikipedia traffic (i.e, Wikitrends) and the usage of new media (i.e., YouTube and Twitter). Results A peak in silicosis-related web searches was noticed in 2010-2011: interestingly, both scientific articles production and media coverage markedly increased after these years in a statistically significant way. The public interest and the level of the public engagement were witnessed by an increase in likes, comments, hashtags, and re-tweets. However, it was found that only a small fraction of the posted/uploaded material contained accurate scientific information. Conclusions GT could be useful to assess the reaction of the public and the level of public engagement both to novel risk-factors associated to occupational diseases, and possibly related changes in disease natural history, and to the effectiveness of preventive workplace practices and legislative measures adopted to improve occupational health. Further, occupational clinicians should become aware of the topics most frequently searched by patients and proactively address these concerns during the medical examination. Institutional bodies and organisms should be more present and active in digital tools and media to disseminate and communicate scientifically accurate information. This manuscript should be intended as preliminary, exploratory communication, paving the way for further studies.	[Bragazzi, Nicola Luigi] Univ Genoa, Postgrad Sch Publ Hlth, Dept Hlth Sci, Genoa, Italy; [Dini, Guglielmo; Toletone, Alessandra; Durando, Paolo] Univ Genoa, Dept Hlth Sci, Postgrad Sch Occupat Med, Genoa, Italy; [Brigo, Francesco] Franz Tappeiner Hosp, Dept Neurol, Merano, Italy; [Brigo, Francesco] Univ Verona, Dept Neurol Biomed & Movement Sci, Verona, Italy; [Durando, Paolo] IRCCS AOU San Martino IST, Occupat Med Unit, Genoa, Italy	University of Genoa; University of Genoa; Ospedale Franz Tappeiner; University of Verona; University of Genoa; IRCCS AOU San Martino IST	Dini, G (corresponding author), Univ Genoa, Dept Hlth Sci, Postgrad Sch Occupat Med, Genoa, Italy.	guglielmo.dini@edu.unige.it	Bragazzi, Nicola Luigi/G-1672-2011; Brigo, Francesco/H-6513-2013	Bragazzi, Nicola Luigi/0000-0001-8409-868X; Brigo, Francesco/0000-0003-0928-1577				Alicino C, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0090-9; Althouse BM, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0054-0; Althouse BM, 2014, AM J PREV MED, V46, P166, DOI 10.1016/j.amepre.2013.10.008; Ayers John W, 2016, JMIR Public Health Surveill, V2, pe16, DOI 10.2196/publichealth.5304; Ayers JW, 2016, JAMA INTERN MED, V176, P552, DOI 10.1001/jamainternmed.2016.0003; Ayers JW, 2014, JAMA-J AM MED ASSOC, V311, P1399, DOI 10.1001/jama.2014.1505; Bakan ND, 2011, CHEST, V140, P1300, DOI 10.1378/chest.10-1856; Bang KM, 2015, MMWR-MORBID MORTAL W, V64, P117; Bowman S., 2003, WE MEDIA AUDIENCES S; Bragazzi NL, 2014, PSYCHOL RES BEHAV MA, V7, P1, DOI 10.2147/PRBM.S44084; Bragazzi NL, 2013, PATIENT PREFER ADHER, V7, P353, DOI 10.2147/PPA.S38578; Brigo F, 2015, EPILEPTIC DISORD, V17, P460, DOI 10.1684/epd.2015.0772; Brigo F, 2015, J CLIN NEUROSCI, V22, P1170, DOI 10.1016/j.jocn.2015.02.006; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Chaplin E, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008055; Cruz-Calderon S, 2015, TRAVEL MED INFECT DI, V13, P202, DOI 10.1016/j.tmaid.2015.02.007; Cullinan P, 2013, PRIM CARE RESP J, V22, P249, DOI 10.4104/pcrj.2013.00055; Curti S, 2016, OCCUP ENVIRON MED, V73, P353, DOI 10.1136/oemed-2015-103209; Delgado CK, 2015, RESP CARE, V60, P1276, DOI 10.4187/respcare.03716; Dove ES, 2013, EMBO REP, V14, P113, DOI 10.1038/embor.2012.205; Duplaga M, 2013, TELEMED E-HEALTH, V19, P683, DOI 10.1089/tmj.2012.0306; Eysenbach G, 1998, BRIT MED J, V316, P72, DOI 10.1136/bmj.316.7124.72; Filios MS, 2015, MMWR-MORBID MORTAL W, V62, P81, DOI 10.15585/mmwr.mm6254a6; FREUND E, 1989, JAMA-J AM MED ASSOC, V262, P3041, DOI 10.1001/jama.262.21.3041; Freund E, 1990, MMWR Recomm Rep, V39, P19; Friedman GK, 2015, MMWR-MORBID MORTAL W, V64, P129; Hinkle D.E., 2003, APPL STAT BEHAV SCI; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Leas EC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159885; Leung CC, 2012, LANCET, V379, P2008, DOI 10.1016/S0140-6736(12)60235-9; Manzoli L, 2015, EPIDEMIOL PREV, V39, P81; Nelson G, 2010, ENVIRON HEALTH PERSP, V118, P421, DOI 10.1289/ehp.0900918; Noar Seth M., 2013, Journal of the National Cancer Institute Monographs, P188, DOI 10.1093/jncimonographs/lgt017; Nuti SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109583; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Paolucci Valentina, 2015, Arch Bronconeumol, V51, pe57, DOI 10.1016/j.arbres.2014.12.010; Peters HP, 2013, P NATL ACAD SCI USA, V110, P14102, DOI 10.1073/pnas.1212745110; Santillana M, 2014, AM J PREV MED, V47, P341, DOI 10.1016/j.amepre.2014.05.020; Segev E, 2016, PUBLIC UNDE IN PRESS; Steenland K, 2014, CA-CANCER J CLIN, V64, P63, DOI 10.3322/caac.21214; Strekalova YA, 2016, HLTH ED BEH IN PRESS; ter Meulen J, 2015, J CLIN VIROL, V64, P107, DOI 10.1016/j.jcv.2014.12.008; Thomas CR, 2010, ENVIRON HEALTH INSIG, V4, P21; Voncken-Brewster V, 2015, INT J CHRONIC OBSTR, V10, P1061, DOI 10.2147/COPD.S81295; Wildevuur SE, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3687; Wilson K, 2009, CAN MED ASSOC J, V180, P829, DOI [10.1503/cmaj.090215, 10.1503/cmaj.1090215]; Winandy M, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.4480; Yi Fengyun, 2016, BMC Res Notes, V9, P221, DOI 10.1186/s13104-016-2026-2	48	27	30	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0166051	10.1371/journal.pone.0166051	http://dx.doi.org/10.1371/journal.pone.0166051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806115	gold, Green Submitted, Green Published			2022-12-26	WOS:000386715500080
J	Goodall, KJ; Finch-Edmondson, ML; van Vuuren, J; Yeoh, GC; Gentle, IE; Vince, JE; Ekert, PG; Vaux, DL; Callus, BA				Goodall, Katharine J.; Finch-Edmondson, Megan L.; van Vuuren, Joanne; Yeoh, George C.; Gentle, Ian E.; Vince, James E.; Ekert, Paul G.; Vaux, David L.; Callus, Bernard A.			Cycloheximide Can Induce Bax/Bak Dependent Myeloid Cell Death Independently of Multiple BH3-Only Proteins	PLOS ONE			English	Article							PROSURVIVAL BCL-2 PROTEINS; SIGNALING PATHWAY; DOWN-REGULATION; APOPTOSIS; MCL-1; PUMA; BIM; BAK; PHOSPHORYLATION; FAMILY	Apoptosis mediated by Bax or Bak is usually thought to be triggered by BH3-only members of the Bcl-2 protein family. BH3-only proteins can directly bind to and activate Bax or Bak, or indirectly activate them by binding to anti-apoptotic Bcl-2 family members, thereby relieving their inhibition of Bax and Bak. Here we describe a third way of activation of Bax/Bak dependent apoptosis that does not require triggering by multiple BH3-only proteins. In factor dependent myeloid (FDM) cell lines, cycloheximide induced apoptosis by a Bax/Bak dependent mechanism, because Bax(-/-)Bak(-/-) lines were profoundly resistant, whereas FDM lines lacking one or more genes for BH3-only proteins remained highly sensitive. Addition of cycloheximide led to the rapid loss of Mcl-1 but did not affect the expression of other Bcl-2 family proteins. In support of these findings, similar results were observed by treating FDM cells with the CDK inhibitor, roscovitine. Roscovitine reduced Mcl-1 abundance and caused Bax/Bak dependent cell death, yet FDM lines lacking one or more genes for BH3-only proteins remained highly sensitive. Therefore Bax/Bak dependent apoptosis can be regulated by the abundance of anti-apoptotic Bcl-2 family members such as Mcl-1, independently of several known BH3-only proteins.	[Goodall, Katharine J.; Gentle, Ian E.; Vince, James E.; Ekert, Paul G.; Vaux, David L.; Callus, Bernard A.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Bundoora, Vic, Australia; [Finch-Edmondson, Megan L.; Yeoh, George C.; Callus, Bernard A.] Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia; [van Vuuren, Joanne; Yeoh, George C.] QEII Med Ctr, Harry Perkins Inst Med Res, Nedlands, WA, Australia; [van Vuuren, Joanne; Yeoh, George C.] Univ Western Australia, Med Res Ctr, Crawley, WA, Australia; [Gentle, Ian E.] Inst Med Microbiol & Hyg, Hermann Herder Str 11, D-79104 Freiburg, Germany; [Vince, James E.; Ekert, Paul G.; Vaux, David L.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Vince, James E.; Vaux, David L.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Ekert, Paul G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Callus, Bernard A.] Univ Notre Dame Australia, Sch Hlth Sci, Fremantle, WA, Australia	La Trobe University; University of Western Australia; Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia; Walter & Eliza Hall Institute; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Notre Dame Australia	Goodall, KJ (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Bundoora, Vic, Australia.	katharine.goodall@monash.edu	Vaux, David L/C-7249-2013; Ekert, Paul/Q-1842-2015; Gentle, Ian/X-2888-2019; Finch-Edmondson, Megan/S-7340-2017	Vaux, David L/0000-0003-2703-1651; Ekert, Paul/0000-0002-2976-8617; Gentle, Ian/0000-0002-6707-7809; Finch-Edmondson, Megan/0000-0002-9628-5842; Goodall, Katharine/0000-0001-5812-8515	Association of International Cancer Research project [09-0084]; Cancer Council of WA project [1010749, 1067515]; National Health and Medical Research Council (Canberra, Australia) [384404, 1016701, 461221]; Australian Government IRISS; Victorian State Government OIS	Association of International Cancer Research project; Cancer Council of WA project(Cancer Council Western Australia); National Health and Medical Research Council (Canberra, Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australian Government IRISS(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government OIS	This work was supported by an Association of International Cancer Research project grant (09-0084) and Cancer Council of WA project grants (1010749 and 1067515) and fellowship to BAC, and National Health and Medical Research Council (Canberra, Australia) Project grant (384404), fellowship (1016701), and Program Grant (461221) to DLV, and operational infrastructure grants through the Australian Government IRISS and the Victorian State Government OIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by an Association of International Cancer Research project grant (09-0084) and Cancer Council of WA project grants (1010749 and 1067515) and fellowship to BAC, and National Health and Medical Research Council (Canberra, Australia) Project grant (384404), fellowship (1016701), and Program Grant (461221) to DLV, and operational infrastructure grants through the Australian Government IRISS and the Victorian State Government OIS. We generously thank Andreas Strasser for providing Bcl-2 antibody, Lorraine O'Reilly for providing Bcl-w and Bcl-xL antibodies, David Huang for providing A1 antibody and Mcl-1 and Bcl-2 cDNAs and Doug Fairlie for providing BimS2A cDNA.	Adams KW, 2007, J BIOL CHEM, V282, P6192, DOI 10.1074/jbc.M610643200; Callus BA, 2008, J MOL BIOL, V384, P313, DOI 10.1016/j.jmb.2008.09.041; Chen HC, 2015, NAT CELL BIOL, V17, P1270, DOI 10.1038/ncb3236; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Coultas L, 2004, MOL CELL BIOL, V24, P1570, DOI 10.1128/MCB.24.4.1570-1581.2004; Coultas L, 2007, J CELL SCI, V120, P2044, DOI 10.1242/jcs.002063; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; De Biasio A, 2007, J BIOL CHEM, V282, P23919, DOI 10.1074/jbc.M700938200; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Ekert PG, 2006, BLOOD, V108, P1461, DOI 10.1182/blood-2006-03-014209; GILDEN RV, 1966, J BACTERIOL, V91, P1295, DOI 10.1128/JB.91.3.1295-1297.1966; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; Ink B, 1997, MOL CELL BIOL, V17, P2468, DOI 10.1128/MCB.17.5.2468; Jabbour AM, 2009, CELL DEATH DIFFER, V16, P555, DOI 10.1038/cdd.2008.179; Labi V, 2008, J EXP MED, V205, P641, DOI 10.1084/jem.20071658; Lee EF, 2008, J CELL BIOL, V180, P341, DOI 10.1083/jcb.200708096; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lindqvist LM, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.149; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; Michalak EM, 2008, CELL DEATH DIFFER, V15, P1019, DOI 10.1038/cdd.2008.16; Muer A, 2012, J BIOL CHEM, V287, P17343, DOI 10.1074/jbc.M111.314898; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; O'Neill KL, 2016, GENE DEV, V30, P973, DOI 10.1101/gad.276725.115; PERKINS AC, 1993, EMBO J, V12, P3835, DOI 10.1002/j.1460-2075.1993.tb06062.x; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Shimazu T, 2007, GENE DEV, V21, P929, DOI 10.1101/gad.1522007; Stewart DP, 2010, MOL CELL BIOL, V30, P3099, DOI 10.1128/MCB.01266-09; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; VAUX DL, 1993, MOL CELL BIOL, V13, P7000, DOI 10.1128/MCB.13.11.7000; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Willis SN, 2005, GENE DEV, V18, P18; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	43	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0164003	10.1371/journal.pone.0164003	http://dx.doi.org/10.1371/journal.pone.0164003			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806040	Green Published, gold			2022-12-26	WOS:000386715500009
J	Itthitaetrakool, U; Pinlaor, P; Pinlaor, S; Chomvarin, C; Dangtakot, R; Chaidee, A; Wilailuckana, C; Sangka, A; Lulitanond, A; Yongvanit, P				Itthitaetrakool, Upsornsawan; Pinlaor, Porntip; Pinlaor, Somchai; Chomvarin, Chariya; Dangtakot, Rungtiwa; Chaidee, Apisit; Wilailuckana, Chotechana; Sangka, Arunnee; Lulitanond, Aroonlug; Yongvanit, Puangrat			Chronic Opisthorchis viverrini Infection Changes the Liver Microbiome and Promotes Helicobacter Growth	PLOS ONE			English	Article							SYRIAN-HAMSTERS; SP NOV.; PYLORI; SEQUENCES; BACTERIA; CANCER; SPP.; METAGENOMICS; CARCINOMA; BILE	Adults of Opisthorchis viverrini reside in the biliary system, inducing inflammation of bile ducts and cholangitis, leading to hepatobiliary disease (HBD) including cholangiocarcinoma. O. viverrini infection also has major implications for the bacterial community in bile ducts and liver. To investigate this in chronic O. viverrini infection (>= 8 months p.i.), bacterial genomic DNA from livers of hamsters and from worms was investigated using culture techniques, PCR for Helicobacter spp. and high-throughput next-generation sequencing targeting the V3-V4 hypervariable regions of prokaryotic 16S rRNA gene. Of a total of 855,046 DNA sequence reads, 417,953 were useable after filtering. Metagenomic analyses assigned these to 93 operational taxonomic units (OTUs) consisting of 80 OTUs of bacteria, including 6 phyla and 42 genera. In the chronic O. viverrini-infected group, bacterial community composition and diversity were significantly increased compared to controls. Sequences of Fusobacterium spp. were the most common (13.81%), followed by Streptococcus luteciae (10.76%), Escherichia coli (10.18%), and Bifidobacterium spp. (0.58%). In addition, Helicobacter pylori (0.17% of sequences) was also identified in the liver of chronic O. viverrini infections, but not in normal liver. The presence of H. pylori was confirmed by PCR and by use of an antibody against bacterial antigen, supporting the metagenomics data. The identities of bacteria cultured for enrichment suggested that chronic O. viverrini infection changes the liver microbiome and promotes Helicobacter spp. growth. There may be synergy between O. viverrini and the liver microbiome in enhancing immune response-mediated hepatobiliary diseases.	[Itthitaetrakool, Upsornsawan] Khon Kaen Univ, Grad Sch, Program Biomed Sci, Khon Kaen, Thailand; [Itthitaetrakool, Upsornsawan; Pinlaor, Porntip; Dangtakot, Rungtiwa; Wilailuckana, Chotechana; Sangka, Arunnee; Lulitanond, Aroonlug] Khon Kaen Univ, Fac Associated Med Sci, Ctr Res & Dev, Med Diagnost Labs, Khon Kaen 40002, Thailand; [Pinlaor, Somchai; Chaidee, Apisit] Khon Kaen Univ, Fac Med, Dept Parasitol, Khon Kaen 40002, Thailand; [Dangtakot, Rungtiwa] Khon Kaen Univ, Sci Program Med Technol, Fac Associated Med Sci, Khon Kaen 40002, Thailand; [Chomvarin, Chariya] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen 40002, Thailand; [Yongvanit, Puangrat] Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen 40002, Thailand; [Itthitaetrakool, Upsornsawan; Pinlaor, Porntip; Pinlaor, Somchai; Chomvarin, Chariya; Dangtakot, Rungtiwa; Chaidee, Apisit; Yongvanit, Puangrat] Khon Kaen Univ, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen 40002, Thailand	Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University	Pinlaor, P (corresponding author), Khon Kaen Univ, Fac Associated Med Sci, Ctr Res & Dev, Med Diagnost Labs, Khon Kaen 40002, Thailand.; Pinlaor, P (corresponding author), Khon Kaen Univ, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen 40002, Thailand.	porawa@kku.ac.th	Lulitanond, Aroonlug/W-1278-2019; /ABI-5967-2020; Chaidee, Apisit/ABH-6755-2020	Lulitanond, Aroonlug/0000-0002-4735-5074; /0000-0001-6495-0951; Pinlaor, Somchai/0000-0002-8187-7247	grant of The Thailand Research Fund; Khon Kaen University Research Foundation, Thailand [TRG5680032]; Higher Education Research Promotion and National Research University Project of Thailand; Office of the Higher Education Commission, through the Health Cluster (SHeP-GMS); National Research Project of Khon Kaen University, Thailand [NRU580216]	grant of The Thailand Research Fund; Khon Kaen University Research Foundation, Thailand; Higher Education Research Promotion and National Research University Project of Thailand; Office of the Higher Education Commission, through the Health Cluster (SHeP-GMS); National Research Project of Khon Kaen University, Thailand	This work was supported by a grant of The Thailand Research Fund and Khon Kaen University Research Foundation, Thailand (TRG5680032), and the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission, through the Health Cluster (SHeP-GMS), The National Research Project of Khon Kaen University, Thailand (NRU580216).	Abu Al-Soud W, 2008, DIGEST LIVER DIS, V40, P126, DOI 10.1016/j.dld.2007.09.011; Akinsanya MA, 2015, GENOM DATA, V6, P159, DOI 10.1016/j.gdata.2015.09.004; Andersen LP, 2001, DIGEST DIS, V19, P112, DOI 10.1159/000050664; Aviles-Jimenez F, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.10.008; Boonyanugomol W, 2012, HPB, V14, P177, DOI 10.1111/j.1477-2574.2011.00423.x; Bragazzi MC., 2011, TRANSL GASTROINTEST, V1, P21; Bragg L, 2014, METHODS MOL BIOL, V1096, P183, DOI 10.1007/978-1-62703-712-9_15; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carpenter HA, 1998, MAYO CLIN PROC, V73, P473; Catalano OA, 2009, RADIOGRAPHICS, V29, P2059, DOI 10.1148/rg.297095051; Charoensuk L, 2014, FOLIA PARASIT, V61, P512, DOI 10.14411/fp.2014.063; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Deenonpoe Raksawan, 2015, Asian Pac J Cancer Prev, V16, P1751; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fox JG, 2009, J CLIN MICROBIOL, V47, P3673, DOI 10.1128/JCM.00879-09; Franklin CL, 1996, J CLIN MICROBIOL, V34, P2952, DOI 10.1128/JCM.34.12.2952-2958.1996; Fukugaiti MH, 2015, BRAZ J MICROBIOL, V46, P1135, DOI 10.1590/S1517-838246420140665; Goldman CG, 2010, HELICOBACTER, V15, P69, DOI 10.1111/j.1523-5378.2010.00780.x; Hsieh PS, 2012, HELICOBACTER, V17, P466, DOI 10.1111/j.1523-5378.2012.00992.x; IARC, 2012, IARC MONOGR EVAL C B, V100, P341; Keku TO, 2013, TRENDS MICROBIOL, V21, P506, DOI 10.1016/j.tim.2013.08.004; Khuntikeo N, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1475-7; Kirchner GI, 2011, INT J CLIN EXP MED, V4, P26; Landis SH, 1998, CA-CANCER J CLIN, V48, P6, DOI 10.3322/canjclin.48.1.6; Li QR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034939; Maeda H, 1998, Gan To Kagaku Ryoho, V25, P1474; MAIRIANG E, 1993, T ROY SOC TROP MED H, V87, P194, DOI 10.1016/0035-9203(93)90489-D; Manolis EN, 2008, J GASTROINTEST LIVER, V17, P179; Morgan XC, 2013, TRENDS GENET, V29, P51, DOI 10.1016/j.tig.2012.09.005; Murano A, 1999, MICROBIOL IMMUNOL, V43, P1009, DOI 10.1111/j.1348-0421.1999.tb01230.x; Ong SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060811; Pace F, 2015, MINERVA GASTROENTERO, V61, P273; Patterson MM, 2000, J CLIN MICROBIOL, V38, P3722, DOI 10.1128/JCM.38.10.3722-3728.2000; Pinlaor S, 2013, KOREAN J PARASITOL, V51, P703, DOI 10.3347/kjp.2013.51.6.703; Plieskatt JL, 2013, FASEB J, V27, P4572, DOI 10.1096/fj.13-232751; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schneeberger PHH, 2016, INFECT GENET EVOL, V40, P389, DOI 10.1016/j.meegid.2015.08.044; Simmons JH, 2000, J CLIN MICROBIOL, V38, P1811, DOI 10.1128/JCM.38.5.1811-1817.2000; Sirica AE, 2012, NAT REV GASTRO HEPAT, V9, P44, DOI 10.1038/nrgastro.2011.222; Sithithaworn P, 2012, PARASITOL INT, V61, P10, DOI 10.1016/j.parint.2011.08.014; Sripa B, 2012, TRENDS PARASITOL, V28, P395, DOI 10.1016/j.pt.2012.07.006; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Worku ML, 2004, J MED MICROBIOL, V53, P807, DOI 10.1099/jmm.0.45636-0; Zenner L, 1999, COMP IMMUNOL MICROB, V22, P41, DOI 10.1016/S0147-9571(98)00018-6	48	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165798	10.1371/journal.pone.0165798	http://dx.doi.org/10.1371/journal.pone.0165798			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806126	gold, Green Published, Green Submitted			2022-12-26	WOS:000386715500057
J	Mercurio, P; Mueller, JF; Eaglesham, G; O'Brien, J; Flores, F; Negri, AP				Mercurio, Philip; Mueller, Jochen F.; Eaglesham, Geoff; O'Brien, Jake; Flores, Florita; Negri, Andrew P.			Degradation of Herbicides in the Tropical Marine Environment: Influence of Light and Sediment	PLOS ONE			English	Article							GREAT-BARRIER-REEF; PESTICIDE DEGRADATION; WATER; EXPOSURE; ATRAZINE; LAGOON; DIURON; FATE; TRANSFORMATION; PERSISTENCE	Widespread contamination of nearshore marine systems, including the Great Barrier Reef (GBR) lagoon, with agricultural herbicides has long been recognised. The fate of these contaminants in the marine environment is poorly understood but the detection of photosystem II (PSII) herbicides in the GBR year-round suggests very slow degradation rates. Here, we evaluated the persistence of a range of commonly detected herbicides in marine water under field-relevant concentrations and conditions. Twelve-month degradation experiments were conducted in large open tanks, under different light scenarios and in the presence and absence of natural sediments. All PSII herbicides were persistent under control conditions (dark, no sediments) with half-lives of 300 d for atrazine, 499 d diuron, 1994 d hexazinone, 1766 d tebuthiuron, while the non-PSII herbicides were less persistent at 147 d for metolachlor and 59 d for 2,4-D. The degradation of herbicides was 2-10 fold more rapid in the presence of a diurnal light cycle and coastal sediments; apart from 2,4-D which degraded more slowly in the presence of light. Despite the more rapid degradation observed for most herbicides in the presence of light and sediments, the half-lives remained > 100 d for the PS II herbicides. The effects of light and sediments on herbicide persistence were likely due to their influence on microbial community composition and its ability to utilise the herbicides as a carbon source. These results help explain the year-round presence of PSII herbicides in marine systems, including the GBR, but more research on the transport, degradation and toxicity on a wider range of pesticides and their transformation products is needed to improve their regulation in sensitive environments.	[Mercurio, Philip; Flores, Florita; Negri, Andrew P.] Australian Inst Marine Sci, Townsville, Qld, Australia; [Mercurio, Philip; Mueller, Jochen F.; Eaglesham, Geoff; O'Brien, Jake] Univ Queensland, Natl Res Ctr Environm Toxicol, Coopers Plains, Qld, Australia	Australian Institute of Marine Science; University of Queensland	Mercurio, P (corresponding author), Australian Inst Marine Sci, Townsville, Qld, Australia.; Mercurio, P (corresponding author), Univ Queensland, Natl Res Ctr Environm Toxicol, Coopers Plains, Qld, Australia.	pmercurio@gmail.com	Negri, Andrew P/G-9909-2017; O'Brien, Jake William/C-4749-2015; O'Brien, Jake William/AAD-9103-2019; Mueller, Jochen F/C-6241-2008	Negri, Andrew P/0000-0003-1388-7395; O'Brien, Jake William/0000-0001-9336-9656; Mueller, Jochen/0000-0002-0000-1973	Australian Government's National Environmental Research Program NERP Tropical Ecosystems Hub Project [4.2]; Australian Government's Caring; ARC future fellowship [FF120100546]; National Environmental Research Program (NERP)	Australian Government's National Environmental Research Program NERP Tropical Ecosystems Hub Project(Australian Government); Australian Government's Caring(Australian Government); ARC future fellowship(Australian Research Council); National Environmental Research Program (NERP)	This research was conducted with the support of funding from the Australian Government's National Environmental Research Program (http://www.environment.gov.au/index.html) NERP Tropical Ecosystems Hub Project 4.2 and the Australian Government's Caring for our Country initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Scott Turner from Queensland Health for advice on sediment extraction and Cassandra Thompson for technical assistance. Jochen F. Mueller acknowledges funding by an ARC future fellowship (FF120100546). We also thank the three anonymous reviewers whose constructive comments helped improve the paper. This project was co-funded through the National Environmental Research Program (NERP) and the Australian Government's Caring for our Country initiative.	Ahtiainen J, 2003, CHEMOSPHERE, V51, P529, DOI 10.1016/S0045-6535(02)00861-5; Angly FE, 2016, PEERJ, V4, DOI 10.7717/peerj.1758; ATLAS RM, 1981, MICROBIOL REV, V45, P180, DOI 10.1128/MMBR.45.1.180-209.1981; Barcelo D., 1997, TRACE DETERMINATION, V19, P1; Bentley C, 2012, PESTICIDE MONITORING, P1; Beulke S, 2001, BIOL FERT SOILS, V33, P558, DOI 10.1007/s003740100364; Bocquene G, 2005, MAR POLLUT BULL, V51, P612, DOI 10.1016/j.marpolbul.2005.06.026; Cessna AJ, 2008, TRIAZINE HERBICIDES: 50 YEARS REVOLUTIONIZING AGRICULTURE, P329, DOI 10.1016/B978-044451167-6.50026-X; CROSBY DG, 1966, J AGR FOOD CHEM, V14, P596, DOI 10.1021/jf60148a012; Davies-Colley RJ, 2001, J AM WATER RESOUR AS, V37, P1085, DOI 10.1111/j.1752-1688.2001.tb03624.x; Davis AM, 2014, SCI TOTAL ENVIRON, V490, P81, DOI 10.1016/j.scitotenv.2014.04.005; Davis AM, 2012, MAR POLLUT BULL, V65, P182, DOI 10.1016/j.marpolbul.2011.08.025; Devlin MJ, 2012, MAR POLLUT BULL, V65, P224, DOI 10.1016/j.marpolbul.2012.03.001; Egli T, 2010, WATER RES, V44, P4826, DOI 10.1016/j.watres.2010.07.023; Fenner K, 2013, SCIENCE, V341, P752, DOI 10.1126/science.1236281; Flores F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075798; Ganapathy C, 1996, ENV FATE HEXAZINONE, P1; GBRMPA, 2009, REEF WATER QUALITY P; GBRMPA, 2010, **NON-TRADITIONAL**; HORVATH RS, 1972, BACTERIOL REV, V36, P146, DOI 10.1128/MMBR.36.2.146-155.1972; Howard PH, 1991, HANDBOOK OF ENVIRONM, VIII; KEMP WM, 1983, MAR TECHNOL SOC J, V17, P78; Kennedy K, 2012, MAR POLLUT BULL, V64, P1495, DOI 10.1016/j.marpolbul.2012.05.014; Kennedy K, 2012, MAR POLLUT BULL, V65, P292, DOI 10.1016/j.marpolbul.2011.10.029; King J, 2013, AGR ECOSYST ENVIRON, V180, P54, DOI 10.1016/j.agee.2012.07.001; Kroon FJ, 2012, MAR POLLUT BULL, V65, P167, DOI 10.1016/j.marpolbul.2011.10.018; Laabs V, 2007, CHEMOSPHERE, V67, P975, DOI 10.1016/j.chemosphere.2006.10.067; Lazartigues A, 2013, CHEMOSPHERE, V91, P530, DOI 10.1016/j.chemosphere.2012.12.032; Lewis SE, 2012, MAR POLLUT BULL, V65, P280, DOI 10.1016/j.marpolbul.2011.11.009; Lewis SE, 2009, ENVIRON POLLUT, V157, P2470, DOI 10.1016/j.envpol.2009.03.006; Lin CH, 2008, J ENVIRON QUAL, V37, P196, DOI 10.2134/jeq2006.0503; Magnusson M, 2008, MAR POLLUT BULL, V56, P1545, DOI 10.1016/j.marpolbul.2008.05.023; Magnusson M, 2012, MAR POLLUT BULL, V65, P363, DOI 10.1016/j.marpolbul.2011.09.029; Mandelbaum RT, 2008, TRIAZINE HERBICIDES: 50 YEARS REVOLUTIONIZING AGRICULTURE, P301, DOI 10.1016/B978-044451167-6.50025-8; Mercurio P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136391; Mercurio P, 2014, MAR POLLUT BULL, V85, P385, DOI 10.1016/j.marpolbul.2014.01.021; Moncada A., 2004, ENVIRONMENTAL FATE O, P1; Navarro S, 2004, SCI TOTAL ENVIRON, V329, P87, DOI 10.1016/j.scitotenv.2004.03.013; Negri AP, 2015, AQUAT TOXICOL, V165, P73, DOI 10.1016/j.aquatox.2015.05.007; O'Brien DS, 2013, REPORT TO THE REEF R; OECD, 1992, ORGAN EC COOP DEV, P1; OECD, 2000, OECD GUID TEST CHEM, DOI DOI 10.1787/9789264069602-EN; Okamura H, 2002, CHEMOSPHERE, V48, P43, DOI 10.1016/S0045-6535(02)00025-5; Packett R, 2009, MAR POLLUT BULL, V58, P976, DOI 10.1016/j.marpolbul.2009.02.017; Pathiratne A, 2016, ENVIRON TOXICOL CHEM, V35, P419, DOI 10.1002/etc.3199; Potter TL, 2013, MAR POLLUT BULL, V67, P36, DOI 10.1016/j.marpolbul.2012.12.004; Rice PJ, 2004, ENVIRON TOXICOL CHEM, V23, P1145, DOI 10.1897/03-110; Salvat B, 2015, ENV SCI POLLUT R, P1, DOI [10.1007/s11356-015-4396-9, DOI 10.1007/S11356-015-4396-9]; Santilio A, 2011, J ENVIRON SCI HEAL B, V46, P535, DOI 10.1080/03601234.2011.583876; Schaffelke B, 2012, MAR POLLUT BULL, V65, P249, DOI 10.1016/j.marpolbul.2011.10.031; Shaw CM, 2008, MAR POLLUT BULL, V57, P473, DOI 10.1016/j.marpolbul.2008.04.002; Shaw M, 2010, MAR POLLUT BULL, V60, P113, DOI 10.1016/j.marpolbul.2009.08.026; Smith R, 2012, MAR POLLUT BULL, V65, P117, DOI 10.1016/j.marpolbul.2011.08.010; Starner K., 1999, P TECHN M CHARL SC, P89; Stasinakis AS, 2009, WATER RES, V43, P1471, DOI 10.1016/j.watres.2008.12.040; Steen RJCA, 2000, J ENVIRON MONITOR, V2, P597, DOI 10.1039/b004734l; Thouand G, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00164; Zepp RG, 2003, COMP SER PHOTOCHEM, V1, P137	58	26	27	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165890	10.1371/journal.pone.0165890	http://dx.doi.org/10.1371/journal.pone.0165890			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806103	gold, Green Published, Green Submitted			2022-12-26	WOS:000386715500069
J	Senguttuvan, NB; Kumar, S; Lee, WS; Mishra, S; Cho, JH; Kwon, JE; Hyeon, SH; Jeong, YS; Won, H; Shin, SY; Lee, KJ; Kim, TH; Kim, CJ; Kim, SW				Senguttuvan, Nagendra Boopathy; Kumar, Sharath; Lee, Wang-Soo; Mishra, Sundeep; Cho, Jun Hwan; Kwon, Jee Eun; Hyeon, Seong Hyeop; Jeong, Yun Sang; Won, Hoyoun; Shin, Seung Yong; Lee, Kwang Je; Kim, Tae Ho; Kim, Chee Jeong; Kim, Sang-Wook			Plaque Vulnerability as Assessed by Radiofrequency Intravascular Ultrasound in Patients with Valvular Calcification	PLOS ONE			English	Article							MITRAL ANNULAR CALCIFICATION; AORTIC-VALVE CALCIFICATION; CORONARY-ARTERY-DISEASE; RISK-FACTORS; CALCIFIED ATHEROSCLEROSIS; CARDIOVASCULAR MORBIDITY; MORTALITY; HEART; ANGIOGRAPHY; HYPERCHOLESTEROLEMIA	Background Cardiac valvular calcification is associated with the overall coronary plaque burden and considered an independent cardiovascular risk and prognostic factor. The purpose of this study was to evaluate the relationship between the presence of valvular calcification and plaque morphology and/or vulnerability. Methods Transthoracic echocardiography was used to assess valvular calcification in 280 patients with coronary artery disease who underwent radiofrequency intravascular ultrasound (Virtual Histology IVUS, VH-IVUS). A propensity score-matched cohort of 192 patients (n = 96 in each group) was analyzed. Thin-capped fibroatheroma (TCFA) was defined as a necrotic core (NC) >10% of the plaque area with a plaque burden >40% and NC in contact with the lumen for >= 3 image slices. A remodeling index (lesion/reference vessel area) >1.05 was considered to be positive. Results Patients were divided into two groups: any calcification in at least one valve (152 patients) vs. no detectable valvular calcification (128 patients). Groups were similar in terms of age, risk factors, clinical diagnosis, and angiographic analysis after propensity score-matched analysis. Gray-scale IVUS analysis showed that the vessel size, plaque burden, minimal lumen area, and remodeling index were similar. By VH-IVUS, % NC and % dense calcium (DC) were greater in patients with valvular calcification (p = 0.024, and p = 0.016, respectively). However, only % DC was higher at the maximal NC site by propensity scorematched analysis (p = 0.029). The frequency of VH-TCFA occurrence was higher depending on the complexity (p = 0.0064) and severity (p = 0.013) of valvular calcification. Conclusions There is a significant relationship between valvular calcifications and VH-IVUS assessment of TCFAs. Valvular calcification indicates a greater atherosclerosis disease complexity (increased calcification of the coronary plaque) and vulnerable coronary plaques (higher incidence of VH-TCFA).	[Senguttuvan, Nagendra Boopathy; Kumar, Sharath; Lee, Wang-Soo; Cho, Jun Hwan; Kwon, Jee Eun; Hyeon, Seong Hyeop; Jeong, Yun Sang; Won, Hoyoun; Shin, Seung Yong; Lee, Kwang Je; Kim, Tae Ho; Kim, Chee Jeong; Kim, Sang-Wook] Chung Ang Univ Hosp, Heart Res Inst, Seoul 06973, South Korea; [Mishra, Sundeep] All India Inst Med Sci, New Delhi 110029, India	Chung Ang University; Chung Ang University Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi	Lee, WS (corresponding author), Chung Ang Univ Hosp, Heart Res Inst, Seoul 06973, South Korea.	wslee1227@cau.ac.kr	Shin, Seung Yong/AAF-7226-2019; Lee, Wang-Soo/AAS-1477-2021	Lee, Wang-Soo/0000-0002-8264-0866; Kim, Sang-Wook/0000-0002-7208-8596; Shin, Seung Yong/0000-0002-3408-6899; SENGUTTUVAN, NAGENDRA BOOPATHY/0000-0003-4979-596X				Adler Y, 1998, AM J CARDIOL, V82, P1183, DOI 10.1016/S0002-9149(98)00596-7; Allison MA, 2006, CIRCULATION, V113, P861, DOI 10.1161/CIRCULATIONAHA.105.552844; Allison MA, 2012, ARTERIOSCL THROM VAS, V32, P140, DOI 10.1161/ATVBAHA.111.235234; Barasch E, 2006, AM J CARDIOL, V97, P1281, DOI 10.1016/j.amjcard.2005.11.065; Boon A, 1997, HEART, V78, P472, DOI 10.1136/hrt.78.5.472; Bozbas H, 2008, ATHEROSCLEROSIS, V198, P115, DOI 10.1016/j.atherosclerosis.2007.09.044; Chaves Paulo H M, 2004, Am J Geriatr Cardiol, V13, P137, DOI 10.1111/j.1076-7460.2004.02120.x; Cheitlin MD, 2003, J AM COLL CARDIOL, V42, P954, DOI 10.1016/S0735-1097(03)01065-9; Corciu AI, 2010, INT J CARDIOL, V142, P288, DOI 10.1016/j.ijcard.2009.01.021; Dawber TR, 1951, AM J PUBLIC HEALTH N, V41, P279, DOI 10.2105/ajph.41.3.279; Fox CS, 2003, CIRCULATION, V107, P1492, DOI 10.1161/01.CIR.0000058168.26163.BC; Hoshino T, 2009, AM J PHYSIOL-HEART C, V297, pH802, DOI 10.1152/ajpheart.00318.2009; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Katz R, 2006, CIRCULATION, V113, P2113, DOI 10.1161/CIRCULATIONAHA.105.598086; Kohsaka S, 2008, JACC-CARDIOVASC IMAG, V1, P617, DOI 10.1016/j.jcmg.2008.07.006; Messika-Zeitoun D, 2007, ARTERIOSCL THROM VAS, V27, P642, DOI 10.1161/01.ATV.0000255952.47980.c2; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Nair Anuja, 2007, EuroIntervention, V3, P113; Schoenhagen P, 2000, CIRCULATION, V101, P598, DOI 10.1161/01.CIR.101.6.598; Simon A, 1997, CIRCULATION, V96, P2449; Taniguchi H, 2004, AM HEART J, V148, P137, DOI 10.1016/j.ahj.2004.03.008; Tonstad S, 1996, ARTERIOSCL THROM VAS, V16, P984, DOI 10.1161/01.ATV.16.8.984; Utsunomiya H, 2010, ATHEROSCLEROSIS, V213, P166, DOI 10.1016/j.atherosclerosis.2010.08.070; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Volzke H, 2010, ATHEROSCLEROSIS, V209, P606, DOI 10.1016/j.atherosclerosis.2009.10.030; Wasserman BA, 2008, STROKE, V39, P329, DOI 10.1161/STROKEAHA.107.498634; WEISSMAN NJ, 1994, AM J CARDIOL, V73, P1080, DOI 10.1016/0002-9149(94)90287-9	28	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165885	10.1371/journal.pone.0165885	http://dx.doi.org/10.1371/journal.pone.0165885			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806099	gold, Green Published, Green Submitted			2022-12-26	WOS:000386715500068
J	Zea, L; Prasad, N; Levy, SE; Stodieck, L; Jones, A; Shrestha, S; Klaus, D				Zea, Luis; Prasad, Nripesh; Levy, Shawn E.; Stodieck, Louis; Jones, Angela; Shrestha, Shristi; Klaus, David			A Molecular Genetic Basis Explaining Altered Bacterial Behavior in Space	PLOS ONE			English	Article							ESCHERICHIA-COLI; ACID RESISTANCE; CELL-DENSITY; MICROGRAVITY; EXPRESSION; FLIGHT; TRANSPORT; SYSTEMS; PH; ANTIBIOTICS	Bacteria behave differently in space, as indicated by reports of reduced lag phase, higher final cell counts, enhanced biofilm formation, increased virulence, and reduced susceptibility to antibiotics. These phenomena are theorized, at least in part, to result from reduced mass transport in the local extracellular environment, where movement of molecules consumed and excreted by the cell is limited to diffusion in the absence of gravity-dependent convection. However, to date neither empirical nor computational approaches have been able to provide sufficient evidence to confirm this explanation. Molecular genetic analysis findings, conducted as part of a recent spaceflight investigation, support the proposed model. This investigation indicated an overexpression of genes associated with starvation, the search for alternative energy sources, increased metabolism, enhanced acetate production, and other systematic responses to acidity-all of which can be associated with reduced extracellular mass transport.	[Zea, Luis; Stodieck, Louis; Klaus, David] Univ Colorado, Dept Aerosp Engn Sci, BioServe Space Technol, Boulder, CO 80309 USA; [Prasad, Nripesh; Levy, Shawn E.; Jones, Angela; Shrestha, Shristi] HudsonAlpha Inst Biotechnol, Genom Serv Lab, Huntsville, AL USA; [Shrestha, Shristi] Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA	University of Colorado System; University of Colorado Boulder; HudsonAlpha Institute for Biotechnology; University of Alabama System; University of Alabama Huntsville	Zea, L (corresponding author), Univ Colorado, Dept Aerosp Engn Sci, BioServe Space Technol, Boulder, CO 80309 USA.	Luis.Zea@Colorado.edu		Shrestha, Shristi/0000-0003-4519-1712; Levy, Shawn/0000-0002-1369-5740	International Space Station (ISS) National Laboratory through the Center for the Advancement of Science in Space, Inc. (CASIS) [GA-2014-146]; NASA [NNH11CD70A]; German Academic Exchange Service (DAAD); German Aerospace Center (DLR); DLR Aerospace Medicine Institute	International Space Station (ISS) National Laboratory through the Center for the Advancement of Science in Space, Inc. (CASIS); NASA(National Aeronautics & Space Administration (NASA)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German Aerospace Center (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); DLR Aerospace Medicine Institute	The data analysis effort for this investigation was funded under Grant Agreement (GA-2014-146) as part of the International Space Station (ISS) National Laboratory through the Center for the Advancement of Science in Space, Inc. (CASIS) in accordance with NASA Cooperative Agreement No. NNH11CD70A (http://www.iss-casis.org/). LZ's work in Germany was funded by the German Academic Exchange Service (DAAD) and the German Aerospace Center (DLR) for their support through the DAAD Research Fellowship for Doctoral Candidates and Young Scientists (https://www.daad.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Luis Zea thanks the German Academic Exchange Service (DAAD) and the German Aerospace Center (DLR) for their support through the DAAD Research Fellowship for Doctoral Candidates and Young Scientists. The authors would like to thank Paul Koenig, and Christine Fanchiang from BioServe for their assistance with the payload hardware preparation, Mark Rupert, Shankini Doraisingam, Chris Nie and Kirstyn Johnson, for their support with the operation activities, and Vale Zins for his help with the pH measurements; Jolien Tyler for her advice with light microscopy; Megan Leahy for her graphic design of the biomolecular process; Dr. Ralf Moller, Dr. Gunther Reitz, Andrea Schroder, Stefan Leuko and Vanessa Neumann from the DLR Aerospace Medicine Institute for their support; NASA astronauts Rick Mastracchio and Mike Hopkins for conducting the AES-1 operations onboard the ISS, and everybody in the space program that made this experiment possible.	Albrecht-Buehler G, 1991, GRAVIT SPACE RES, V4; ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; ANDREWS JC, 1985, J BACTERIOL, V161, P484, DOI 10.1128/JB.161.2.484-492.1985; Arnold C. N., J BACTERIO, V183, P2178; Benoit M, 2005, MICROBIOL-SGM, V151, P69, DOI 10.1099/mic.0.27062-0; Benoit MR, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/4/046007; Benoit MR, 2007, ADV SPACE RES, V39, P1225, DOI 10.1016/j.asr.2006.10.009; Benoit MR, 2006, APPL MICROBIOL BIOT, V70, P403, DOI 10.1007/s00253-005-0098-3; BERTRAND K, 1976, J MOL BIOL, V103, P319, DOI 10.1016/0022-2836(76)90315-6; Bjorkman T., 1988, NASA C PUBLICATION; Brown R.B, 1999, THESIS U COLORADO BO; Brown RB, 2002, MICROGRAVITY SCI TEC, V13, P24, DOI 10.1007/BF02881678; Buchanan R.E, 1975, BERGEYS MANUAL DETER; Chang Y.-Y., MOL MICROBIO, V11, P1019; CIFERRI O, 1986, NATURWISSENSCHAFTEN, V73, P418, DOI 10.1007/BF00367284; Crabbe A, 2011, APPL ENVIRON MICROB, V77, P1221, DOI 10.1128/AEM.01582-10; FERENCI T, 1980, J BACTERIOL, V144, P7, DOI 10.1128/JB.144.1.7-11.1980; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gigliobianco T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-148; GORGP, 2015, PANTHER GEN LIST AN; Hoehn Alexander, 2004, J Gravit Physiol, V11, P39; Hommais F., MICROBIO, V150, P61; Horneck G, 2010, MICROBIOL MOL BIOL R, V74, P121, DOI 10.1128/MMBR.00016-09; Ilyin VK, 2005, ACTA ASTRONAUT, V56, P839, DOI 10.1016/j.actaastro.2005.01.009; Johnson J, 2003, J CLIN MICROBIOL, V41, P5798, DOI 10.1128/JCM.41.12.5798-5802.2003; Juergensmeyer MA, 1999, MICROGRAVITY SCI TEC, V12, P41; Kacena MA, 1999, APPL MICROBIOL BIOT, V51, P229, DOI 10.1007/s002530051386; KELLERMANN O, 1974, EUR J BIOCHEM, V47, P139, DOI 10.1111/j.1432-1033.1974.tb03677.x; Kim W, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-241; Kim W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062437; Kitts C., 2007, 21 ANN AIAA USU C SM; Kitts C., 2009, P 23 ANN AIAA USU C; Klaus D, 1997, MICROBIOL-SGM, V143, P449, DOI 10.1099/00221287-143-2-449; Klaus D, J GRAVIT PHYSIO, V11, P17; Klaus D, 2001, P C MICR TRANSP PROC, VII, P527; Klaus DM, 1998, TRENDS BIOTECHNOL, V16, P369, DOI 10.1016/S0167-7799(98)01197-4; LAPCHINE L, 1986, DRUG EXP CLIN RES, V12, P933; Leonardi R, 2004, J BIOL CHEM, V279, P17054, DOI 10.1074/jbc.M312714200; Liu MZ, 2005, J BIOL CHEM, V280, P15921, DOI 10.1074/jbc.M414050200; Liu P, 2012, COMPUT STRUCT BIOTEC, V3, DOI 10.5936/csbj.201210011; Ma Z., MOL MICROBIO, V49, P1309; MARNETT LJ, 1985, MUTAT RES, V148, P25; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; McLean RJC, 2001, FEMS MICROBIOL LETT, V195, P115, DOI 10.1016/S0378-1097(00)00549-8; Minelli G., 2008, P 22 ANN AIAA USU C; MOATTI N, 1986, NATURWISSENSCHAFTEN, V73, P413, DOI 10.1007/BF00367282; Moreau PL, 2007, J BACTERIOL, V189, P2249, DOI 10.1128/JB.01306-06; Nicholson WL, 2011, ASTROBIOLOGY, V11, P951, DOI 10.1089/ast.2011.0714; Novikova ND, 2004, MICROB ECOL, V47, P127, DOI 10.1007/s00248-003-1055-2; Owen RB, 2002, APPL OPTICS, V41, P3927, DOI 10.1364/AO.41.003927; Parra M., 2008, GRAVIT SPACE BIOL, V21, P9; POLLARD EC, 1965, J THEOR BIOL, V8, P113, DOI 10.1016/0022-5193(65)90097-4; Price SB, 2004, APPL ENVIRON MICROB, V70, P4792, DOI 10.1128/AEM.70.8.4792-4799.2004; Ricco A., 2010, 2010 SOLID STATE SEN, P110; Ricco A. J., 2007, SOL STAT SENS ACT MI, P33; Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004; Shin S, 2001, MOL MICROBIOL, V41, P1133, DOI 10.1046/j.1365-2958.2001.02570.x; TIXADOR R, 1985, AVIAT SPACE ENVIR MD, V56, P748; TIXADOR R, 1985, ACTA ASTRONAUT, V12, P131, DOI 10.1016/0094-5765(85)90082-7; TIXADOR R, 1994, AVIAT SPACE ENVIR MD, V65, P551; Tucker DL, 2002, J BACTERIOL, V184, P6551, DOI 10.1128/JB.184.23.6551-6558.2002; VANDERHORN PB, 1993, J BACTERIOL, V175, P982, DOI 10.1128/JB.175.4.982-992.1993; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wang YF, 1997, J MOL BIOL, V272, P56, DOI 10.1006/jmbi.1997.1224; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104; YEE L, 1992, BIO-TECHNOL, V10, P1550, DOI 10.1038/nbt1292-1550; Zea L., 2015, 66 INT ASTR C JER IS; Zea L., 2015, THESIS	69	37	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0164359	10.1371/journal.pone.0164359	http://dx.doi.org/10.1371/journal.pone.0164359			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806055	Green Published, Green Submitted, gold			2022-12-26	WOS:000386715500010
J	Rosado, D; Gramegna, G; Cruz, A; Lira, BS; Freschi, L; de Setta, N; Rossi, M				Rosado, Daniele; Gramegna, Giovanna; Cruz, Aline; Lira, Bruno Silvestre; Freschi, Luciano; de Setta, Nathalia; Rossi, Magdalena			Phytochrome Interacting Factors (PIFs) in Solanum lycopersicum: Diversity, Evolutionary History and Expression Profiling during Different Developmental Processes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; LEAF SENESCENCE; GENE DUPLICATION; MOLECULAR CLOCK; TOMATO; ARABIDOPSIS; BIOSYNTHESIS; GROWTH; DEPHYTYLATION; METABOLISM	Although the importance of light for tomato plant yield and edible fruit quality is well known, the PHYTOCHROME INTERACTING FACTORS (PIFs), main components of phytochrome-mediated light signal transduction, have been studied almost exclusively in Arabidopsis thaliana. Here, the diversity, evolution and expression profile of PIF gene subfamily in Solanum lycopersicum was characterized. Eight tomato PIF loci were identified, named SlPIF1a, SlPIF1b, SlPIF3, SlPIF4, SlPIF7a, SlPIF7b, SlPIF8a and SlPIF8b. The duplication of SlPIF1, SlPIF7 and SlPIF8 genes were dated and temporally coincided with the whole-genome triplication event that preceded tomato and potato divergence. Different patterns of mRNA accumulation in response to light treatments were observed during seedling deetiolation, dark-induced senescence, diel cycle and fruit ripening. SlPIF4 showed similar expression profile as that reported for A. thaliana homologs, indicating an evolutionary conserved function of PIF4 clade. A comprehensive analysis of the evolutionary and transcriptional data allowed proposing that duplicated SlPIFs have undergone sub- and neofunctionalization at mRNA level, pinpointing the importance of transcriptional regulation for the maintenance of duplicated genes. Altogether, the results indicate that genome polyploidization and functional divergence have played a major role in diversification of the Solanum PIF gene subfamily.	[Rosado, Daniele; Gramegna, Giovanna; Cruz, Aline; Lira, Bruno Silvestre; Freschi, Luciano; Rossi, Magdalena] Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, SP, Brazil; [de Setta, Nathalia] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil	Universidade de Sao Paulo; Universidade Federal do ABC (UFABC)	Rossi, M (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, SP, Brazil.	mmrossi@usp.br	Freschi, Luciano/B-3807-2008; Lira, Bruno Silvestre/G-2874-2017; de Setta, Nathalia/C-6069-2012; Rossi, Magdalena/B-7847-2012	Freschi, Luciano/0000-0002-0737-3438; Lira, Bruno Silvestre/0000-0002-0820-6682; de Setta, Nathalia/0000-0002-4807-5410; Rossi, Magdalena/0000-0003-3650-772X; Rosado, Daniele/0000-0002-9319-9041; GRAMEGNA, GIOVANNA/0000-0001-8585-7801	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo, Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	DR and MR were recipients of fellowships from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br/), Brazil. DR, GG and BL were recipients of fellowships from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br/), Sao Paulo, Brazil. This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azari R, 2010, BIOTECHNOL ADV, V28, P108, DOI 10.1016/j.biotechadv.2009.10.003; Bell CD, 2005, EVOLUTION, V59, P1245, DOI 10.1111/j.0014-3820.2005.tb01775.x; Bino RJ, 2005, NEW PHYTOL, V166, P427, DOI 10.1111/j.1469-8137.2005.01362.x; Chow CN, 2016, NUCLEIC ACIDS RES, V44, pD1154, DOI 10.1093/nar/gkv1035; Cordeiro AM, 2016, BBA-GENE REGUL MECH, V1859, P393, DOI 10.1016/j.bbagrm.2015.12.008; Di Rienzo J, 2012, FGSTATISTICS STAT SO; Force A, 1999, AM ZOOL, V39, p78A; Fujisawa M, 2012, PLANTA, V235, P1107, DOI 10.1007/s00425-011-1561-2; Groszmann M, 2011, PLANT J, V68, P816, DOI 10.1111/j.1365-313X.2011.04732.x; Gupta SK, 2014, PLANT CELL ENVIRON, V37, P1688, DOI 10.1111/pce.12279; Guyer L, 2014, PLANT PHYSIOL, V166, P44, DOI 10.1104/pp.114.239541; Hauser BA, 1995, PLANT MOL BIOL, V29, P1143, DOI 10.1007/BF00020458; Husaineid SSH, 2007, J EXP BOT, V58, P615, DOI 10.1093/jxb/erl253; Inoue K, 2016, PLANT CELL, V28, P1406, DOI 10.1105/tpc.15.01063; Kamenetzky L, 2010, PLANT PHYSIOL, V152, P1772, DOI 10.1104/pp.109.150532; Khanna R, 2004, PLANT CELL, V16, P3033, DOI 10.1105/tpc.104.025643; Kidokoro S, 2009, PLANT PHYSIOL, V151, P2046, DOI 10.1104/pp.109.147033; Kumar I, 2016, J EXP BOT, V67, P4231, DOI 10.1093/jxb/erw217; Lee CM, 2012, P NATL ACAD SCI USA, V109, P15054, DOI 10.1073/pnas.1211295109; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Leivar P, 2014, PLANT CELL, V26, P56, DOI 10.1105/tpc.113.120857; Leivar P, 2011, TRENDS PLANT SCI, V16, P19, DOI 10.1016/j.tplants.2010.08.003; Lira BS, 2016, PLANT CELL PHYSIOL, V57, P642, DOI 10.1093/pcp/pcw021; Lira BS, 2014, GENE, V546, P359, DOI 10.1016/j.gene.2014.05.051; Liu YS, 2004, P NATL ACAD SCI USA, V101, P9897, DOI 10.1073/pnas.0400935101; Llorente B, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00263; Llorente B, 2016, PLANT J, V85, P107, DOI 10.1111/tpj.13094; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Melo NKG, 2016, PLANT PHYSIOL, V170, P2278, DOI 10.1104/pp.16.00023; Mohan V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152907; Monte E, 2004, P NATL ACAD SCI USA, V101, P16091, DOI 10.1073/pnas.0407107101; Moon J, 2008, P NATL ACAD SCI USA, V105, P9433, DOI 10.1073/pnas.0803611105; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pedmale UV, 2016, CELL, V164, P233, DOI 10.1016/j.cell.2015.12.018; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pires N, 2010, PLANT SIGNAL BEHAV, V5, P911, DOI 10.4161/psb.5.7.12100; Powell ALT, 2012, SCIENCE, V336, P1711, DOI 10.1126/science.1222218; Pulquerio MJF, 2007, TRENDS ECOL EVOL, V22, P180, DOI 10.1016/j.tree.2006.11.013; Quadrana L, 2013, PLANT MOL BIOL, V81, P309, DOI 10.1007/s11103-012-0001-4; Rensing SA, 2014, CURR OPIN PLANT BIOL, V17, P43, DOI 10.1016/j.pbi.2013.11.002; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sakuraba Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5636; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Song Y, 2014, MOL PLANT, V7, P1776, DOI 10.1093/mp/ssu109; Soy J, 2014, J EXP BOT, V65, P2925, DOI 10.1093/jxb/ert465; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teufel AI, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0616-1; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Toledo-Ortiz G, 2010, P NATL ACAD SCI USA, V107, P11626, DOI 10.1073/pnas.0914428107; Wang Y, 2008, GENETICS, V180, P391, DOI 10.1534/genetics.108.087981; Weaver LM, 1998, PLANT MOL BIOL, V37, P455, DOI 10.1023/A:1005934428906; Weller JL, 2000, PLANT J, V24, P345, DOI 10.1046/j.1365-313x.2000.00879.x; Wilke T, 2009, AM MALACOL BULL, V27, P25, DOI 10.4003/006.027.0203; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060781, 10.1371/journal.pone.0053931, 10.1371/journal.pone.0061922]; Zhang YQ, 2015, PLANT SCI, V237, P57, DOI 10.1016/j.plantsci.2015.05.010	56	30	37	6	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165929	10.1371/journal.pone.0165929	http://dx.doi.org/10.1371/journal.pone.0165929			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802334	Green Published, gold			2022-12-26	WOS:000386714200070
J	Hazawa, M; Lin, DC; Handral, H; Xu, L; Chen, Y; Jiang, YY; Mayakonda, A; Ding, LW; Meng, X; Sharma, A; Samuel, S; Movahednia, MM; Wong, RW; Yang, H; Tong, C; Koeffler, HP				Hazawa, M.; Lin, D-C; Handral, H.; Xu, L.; Chen, Y.; Jiang, Y-Y; Mayakonda, A.; Ding, L-W; Meng, X.; Sharma, A.; Samuel, S.; Movahednia, M. M.; Wong, R. W.; Yang, H.; Tong, C.; Koeffler, H. P.			ZNF750 is a lineage-specific tumour suppressor in squamous cell carcinoma	ONCOGENE			English	Article								ZNF750 controls epithelial homeostasis by regulating epidermal-differentiation genes, a role underscored by its pathogenic mutations in esophageal squamous cell cancers (SCCs). However, the precise role of ZNF750 in SCC cell biology remains unclear. In this study, we report that ZNF750 is exclusively deleted, mutated and underexpressed in human SCCs, and low ZNF750 expression is associated with poor survival. Restoration of wildtype, but not mutant ZNF750 protein uniquely inhibited the malignant phenotypes of SCC cells both in vitro and in vivo. Notably, ZNF750 promoted the expression of a long non-coding RNA (TINCR), which mediated both cancer-inhibition and differentiation-induction effects of ZNF750. In addition, ZNF750 potently suppressed cell migration by directly inhibiting the transactivation of LAMC2. Together, our findings characterize ZNF750 as a crucial SCC-specific suppressor and uncover its novel anticancer-associated functions.	[Hazawa, M.; Lin, D-C; Xu, L.; Chen, Y.; Jiang, Y-Y; Mayakonda, A.; Ding, L-W; Meng, X.; Sharma, A.; Samuel, S.; Yang, H.; Koeffler, H. P.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore; [Hazawa, M.; Wong, R. W.] Kanazawa Univ, Inst Frontier Sci Initiat, Cell Bion Res Unit, Innovat Integrated Biores Core, Kanazawa, Ishikawa, Japan; [Lin, D-C; Koeffler, H. P.] Univ Calif Los Angeles, Sch Med, Div Hematol Oncol, Cedars Sinai Med Ctr, Los Angeles, CA 90024 USA; [Handral, H.; Movahednia, M. M.; Tong, C.] Natl Univ Singapore, Dept Oral & Maxillofacial Surg, Fac Dent, Singapore, Singapore; [Koeffler, H. P.] Natl Univ Hlth Syst, Natl Univ Canc Inst, Singapore, Singapore; [Koeffler, H. P.] Natl Univ Singapore, Singapore, Singapore	National University of Singapore; Kanazawa University; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National University of Singapore; National University of Singapore; National University of Singapore	Hazawa, M (corresponding author), Kanazawa Univ, Inst Frontier Sci Initiat, Kanazawa, Ishikawa 9201192, Japan.; Lin, DC (corresponding author), Los Angeles Sch Med, Los Angeles, CA 90048 USA.	masaharu.akj@gmail.com; dchlin11@gmail.com	Ding, Ling-Wen/H-6916-2019; HANDRAL, HARISH/AAM-6564-2020; HAZAWA, Masaharu/A-6520-2016; Xu, Liang/I-9877-2014; Tong CAO, iHuman/B-1008-2008; Hazawa, M/AAA-2712-2021; Wong, Richard W./E-9155-2011; SHARMA, ARJUN/U-5920-2019	Ding, Ling-Wen/0000-0003-0022-1551; HANDRAL, HARISH/0000-0002-3892-3316; Xu, Liang/0000-0002-2700-4840; Tong CAO, iHuman/0000-0002-7994-9627; Sharma, ARJUN/0000-0002-5705-5470; Wong, Richard/0000-0002-2131-6595	Singapore Ministry of Health's National Medical Research Council (NMRC) under its Singapore Translational Research (STaR) Investigator Award; NMRC Individual Research Grant [NMRC/1311/2011]; NMRC Centre Grant; American Society of Hematology Fellow Scholar Award; Donna and Jesse Garber Awards for Cancer Research, National Center for Advancing Translational Sciences UCLA CTSI Grant [UL1TR000124]; RNA Biology Center at the Cancer Science Institute of Singapore, NUS, under the Singapore Ministry of Education's Tier 3 grants [MOE2014-T3-1-006]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER	Singapore Ministry of Health's National Medical Research Council (NMRC) under its Singapore Translational Research (STaR) Investigator Award(Ministry of Health-SingaporeNational Medical Research Council, Singapore); NMRC Individual Research Grant; NMRC Centre Grant(National Medical Research Council, Singapore); American Society of Hematology Fellow Scholar Award; Donna and Jesse Garber Awards for Cancer Research, National Center for Advancing Translational Sciences UCLA CTSI Grant; RNA Biology Center at the Cancer Science Institute of Singapore, NUS, under the Singapore Ministry of Education's Tier 3 grants(Ministry of Education, SingaporeNational University of Singapore); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the Singapore Ministry of Health's National Medical Research Council (NMRC) under its Singapore Translational Research (STaR) Investigator Award to HPK, NMRC Individual Research Grant (NMRC/1311/2011) and the NMRC Centre Grant awarded to National University Cancer Institute of Singapore, the National Research Foundation Singapore and the Singapore Ministry of Education under its Research Centres of Excellence initiatives. D-C.L was supported by American Society of Hematology Fellow Scholar Award, Donna and Jesse Garber Awards for Cancer Research, National Center for Advancing Translational Sciences UCLA CTSI Grant UL1TR000124. This study was partially supported by a generous donation from the Melamed family. This research was also supported by the RNA Biology Center at the Cancer Science Institute of Singapore, NUS, as part of funding under the Singapore Ministry of Education's Tier 3 grants, grant number MOE2014-T3-1-006.	American Cancer Society, 2011, CANC FACTS FIG 2011; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Boxer LD, 2014, GENE DEV, V28, P2013, DOI 10.1101/gad.246579.114; Brooks YS, 2014, J CLIN INVEST, V124, P2260, DOI 10.1172/JCI72718; Degen M, 2012, AM J PATHOL, V180, P2462, DOI 10.1016/j.ajpath.2012.02.028; Garg M, 2014, EXPERT OPIN THER TAR, V18, P979, DOI 10.1517/14728222.2014.934814; Garg M, 2014, J CLIN ENDOCR METAB, V99, pE62, DOI 10.1210/jc.2013-2994; Hamasaki H, 2011, BRIT J CANCER, V6, P824; Hlubek F, 2001, CANCER RES, V61, P8089; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Khammanivong A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069395; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Kypriotou M, 2012, EXP DERMATOL, V21, P643, DOI 10.1111/j.1600-0625.2012.01472.x; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; Lopez-Pajares V, 2015, DEV CELL, V32, P693, DOI 10.1016/j.devcel.2015.01.028; Ohashi S, 2015, GASTROENTEROLOGY, V149, P1700, DOI 10.1053/j.gastro.2015.08.054; Ono Y, 1999, CANCER, V85, P2315, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2315::AID-CNCR3>3.0.CO;2-Y; Rothenberg SM, 2012, J CLIN INVEST, V122, P1951, DOI 10.1172/JCI59889; Sen GL, 2012, DEV CELL, V22, P669, DOI 10.1016/j.devcel.2011.12.001; Tugizov S, 2005, J VIROL, V79, P1099, DOI 10.1128/JVI.79.2.1099-1112.2005; Xu TP, 2015, ONCOGENE, V34, P5648, DOI 10.1038/onc.2015.18; Yamamoto H, 2001, CLIN CANCER RES, V7, P896; Zhang L, 2015, AM J HUM GENET, V96, P597, DOI 10.1016/j.ajhg.2015.02.017; Zhong XL, 2012, CELL SIGNAL, V24, P393, DOI 10.1016/j.cellsig.2011.10.005	24	70	74	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 20	2017	36	16					2243	2254		10.1038/onc.2016.377	http://dx.doi.org/10.1038/onc.2016.377			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ES8DM	27819679	Green Published, hybrid			2022-12-26	WOS:000399782700005
J	Liu, H; Dong, SY; Sun, DY; Liu, W; Gu, FW; Liu, YZ; Guo, T; Wang, H; Wang, JF; Chen, ZQ				Liu, Hao; Dong, Shuangyu; Sun, Dayuan; Liu, Wei; Gu, Fengwei; Liu, Yongzhu; Guo, Tao; Wang, Hui; Wang, Jiafeng; Chen, Zhiqiang			CONSTANS-Like 9 (OsCOL9) Interacts with Receptor for Activated C-Kinase 1(OsRACK1) to Regulate Blast Resistance through Salicylic Acid and Ethylene Signaling Pathways	PLOS ONE			English	Article							NAC TRANSCRIPTION FACTORS; DISEASE RESISTANCE; MOLECULAR CHARACTERIZATION; STRESS TOLERANCE; RICE; GENE; EXPRESSION; ARABIDOPSIS; FAMILY; TRANSFORMATION	In a previous transcriptome analysis of early response genes in rice during Magnaporthe oryzae infection, we identified a CONSTANS-like (COL) gene OsCOL9. In the present study, we investigated the functional roles of OsCOL9 in blast resistance. OsCOL9 belonged to group II of the COL protein family, and it contained a BB-box and a C-terminal CCT (CONSTANS, COL and TOC1) domain. OsCOL9 was found in the nucleus of rice cells, and it exerted transcriptional activation activities through its middle region (MR). Magnaporthe oryzae infection induced OsCOL9 expression, and transgenic OsCOL9 knock-out rice plants showed increased pathogen susceptibility. OsCOL9 was a critical regulator of pathogen-related genes, especially PR1b, which were also activated by exogenous salicylic acid (SA) and 1-aminocyclopropane-1-carboxylicacid (ACC), the precursor of ethylene (ET). Further analysis indicated that OsCOL9 over-expression increased the expressions of phytohormone biosynthetic genes, NPR1, WRKY45, OsACO1 and OsACS1, which were related to SA and ET biosynthesis. Interestingly, we found that OsCOL9 physically interacted with the scaffold protein OsRACK1 through its CCT domain, and the OsRACK1 expression was induced in response to exogenous SA and ACC as well as M. oryzae infection. Taken together, these results indicated that the COL protein OsCOL9 interacted with OsRACK1, and it enhanced the rice blast resistance through SA and ET signaling pathways.	[Liu, Hao; Dong, Shuangyu; Liu, Wei; Gu, Fengwei; Liu, Yongzhu; Guo, Tao; Wang, Hui; Wang, Jiafeng; Chen, Zhiqiang] South China Agr Univ, Natl Engn Res Ctr Plant Space Breeding, Guangzhou 510642, Guangdong, Peoples R China; [Sun, Dayuan] Guangdong Acad Agr Sci, Plant Protect Res Inst, Guangdong Prov Key Lab High Technol Plant Protect, Guangzhou 510640, Guangdong, Peoples R China	South China Agricultural University; Guangdong Academy of Agricultural Sciences	Wang, JF; Chen, ZQ (corresponding author), South China Agr Univ, Natl Engn Res Ctr Plant Space Breeding, Guangzhou 510642, Guangdong, Peoples R China.	bcjfwang@gmail.com; chenlin.@scau.edu.cn	guo, tao/AAI-2936-2020		"863" High Technology Research and Development Program of China (863 Program) [2011AA10A101]; Specialized Research Fund for the Doctoral Program of Higher Education [20124404120007]	"863" High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by two fundings: "863" High Technology Research and Development Program of China (863 Program) (2011AA10A101),Zhicliang Chen received the funding; and Specialized Research Fund for the Doctoral Program of Higher Education (20124404120007), Jiafeng Wang received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2000, BIOCHEM BIOPH RES CO, V278, P290, DOI 10.1006/bbrc.2000.3781; Agrawal GK, 2000, BIOCHEM BIOPH RES CO, V274, P157, DOI 10.1006/bbrc.2000.3114; Alves MS, 2013, INT J MOL SCI, V14, P7815, DOI 10.3390/ijms14047815; Andolfo G, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00987; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bu QY, 2008, CELL RES, V18, P756, DOI 10.1038/cr.2008.53; Buscaill P, 2014, CURR OPIN PLANT BIOL, V20, P35, DOI 10.1016/j.pbi.2014.04.004; Cao YF, 2006, J PLANT PHYSIOL, V163, P1167, DOI 10.1016/j.jplph.2005.11.004; Chae HS, 2000, PLANT CELL PHYSIOL, V41, P354, DOI 10.1093/pcp/41.3.354; Chen HD, 2010, PLANT CELL, V22, P108, DOI 10.1105/tpc.109.065490; Chen J, 2012, GENE, V496, P110, DOI 10.1016/j.gene.2012.01.008; Cheng XF, 2005, PLANT J, V43, P758, DOI 10.1111/j.1365-313X.2005.02491.x; Chuio T, 2007, BBA-GENE STRUCT EXPR, V1769, P497, DOI 10.1016/j.bbaexp.2007.04.006; Crocco CD, 2013, GENE, V531, P44, DOI 10.1016/j.gene.2013.08.037; Gangappa SN, 2014, TRENDS PLANT SCI, V19, P460, DOI 10.1016/j.tplants.2014.01.010; Gao H, 2014, P NATL ACAD SCI USA, V111, P16337, DOI 10.1073/pnas.1418204111; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Holm M, 2001, EMBO J, V20, P118, DOI 10.1093/emboj/20.1.118; Inoue H, 2013, P NATL ACAD SCI USA, V110, P9577, DOI 10.1073/pnas.1222155110; Iwai T, 2006, PLANT PHYSIOL, V142, P1202, DOI 10.1104/pp.106.085258; Iwamoto M, 2010, PLANT CELL ENVIRON, V33, P805, DOI 10.1111/j.1365-3040.2009.02106.x; Jiang CH, 2016, J EXP BOT, V67, P157, DOI 10.1093/jxb/erv445; Johansson M, 2015, J EXP BOT, V66, P719, DOI 10.1093/jxb/eru441; Kim SG, 2011, MOL CELLS, V31, P25, DOI 10.1007/s10059-011-0004-z; Lin J, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005867; Luo DP, 2013, NAT GENET, V45, P573, DOI 10.1038/ng.2570; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Min JH, 2015, J INTEGR PLANT BIOL, V57, P313, DOI 10.1111/jipb.12246; Mitsuhara I, 2008, MOL GENET GENOMICS, V279, P415, DOI 10.1007/s00438-008-0322-9; Nakano T, 2006, PLANT CELL PHYSIOL, V47, P554, DOI 10.1093/pcp/pcj017; Nakashima A, 2008, PLANT CELL, V20, P2265, DOI 10.1105/tpc.107.054395; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Onate-Sanchez L, 2007, PLANT PHYSIOL, V143, P400, DOI 10.1104/pp.106.086637; Ouyang YD, 2012, BMC GENOMICS, V13, DOI [10.1186/1471-2164-13-100, 10.1186/1471-2164-14-396]; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Shrestha R, 2014, ANN BOT-LONDON, V114, P1445, DOI 10.1093/aob/mcu032; Singh RP, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00937; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Sun YD, 2015, PLANT CELL REP, V34, P1295, DOI 10.1007/s00299-015-1787-8; Tao Z, 2011, J EXP BOT, V62, P4863, DOI 10.1093/jxb/err144; Thurow C, 2005, PLANT J, V44, P100, DOI 10.1111/j.1365-313X.2005.02513.x; van Loon LC, 2006, TRENDS PLANT SCI, V11, P184, DOI 10.1016/j.tplants.2006.02.005; Xiao WM, 2011, MOL BREEDING, V28, P303, DOI 10.1007/s11032-010-9481-6; Yang JW, 2014, PLANT MOL BIOL REP, V32, P153, DOI 10.1007/s11105-013-0633-9; Yuan YX, 2007, PLANT BIOTECHNOL J, V5, P313, DOI 10.1111/j.1467-7652.2007.00243.x; Zhai C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098067; Zhang DP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103747, 10.1371/journal.pone.0097120]; Zhang J, 2008, CELL RES, V18, P508, DOI 10.1038/cr.2007.104; Zhang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep07663; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30; Zhu XY, 2015, PLANT J, V84, P597, DOI 10.1111/tpj.13030	55	22	29	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166249	10.1371/journal.pone.0166249	http://dx.doi.org/10.1371/journal.pone.0166249			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829023	Green Published, gold, Green Submitted			2022-12-26	WOS:000387724300099
J	Lauritzen, HB; Larose, TL; Oien, T; Odland, JO; van de Bor, M; Jacobsen, GW; Sandanger, TM				Lauritzen, Hilde B.; Larose, Tricia L.; Oien, Torbjorn; Odland, Jon O.; van de Bor, Margot; Jacobsen, Geir W.; Sandanger, Torkjel M.			Factors Associated with Maternal Serum Levels of Perfluoroalkyl Substances and Organochlorines: A Descriptive Study of Parous Women in Norway and Sweden	PLOS ONE			English	Article							POLYCHLORINATED-BIPHENYLS PCBS; POLYFLUOROALKYL SUBSTANCES; PLASMA-CONCENTRATIONS; PREGNANT-WOMEN; HUMAN-MILK; PERFLUORINATED CHEMICALS; DIETARY EXPOSURE; BIRTH-WEIGHT; FETAL-GROWTH; TIME TRENDS	Introduction Perfluoroalkyl substances (PFASs) and organochlorines (OCs) are ubiquitous and persistent in the environment and proposed endocrine disrupting chemicals (EDCs). They can be transferred across the placenta during pregnancy, and studies suggest that the prenatal period may be particularly sensitive for influences on fetal growth and development. Several studies have investigated socio-demographic and pregnancy related factors associated with maternal serum PFAS and OC levels, but few studies have been conducted in time periods with increasing emissions of PFASs and recent emissions of OCs. Methods Serum from 424 pregnant women participating in the NICHD Scandinavian Successive Small-for-gestational Age (SGA) births study was collected in 1986-1988, and analyses of two PFASs and six OCs were conducted. Associations between EDCs and geographic, time dependent, socio-demographic and pregnancy related variables were evaluated by using multivariable linear regression models. Results Previous breastfeeding duration, time since last breastfeeding period, sampling date and country of residence were important factors associated with serum levels of PFOS and PFOA. Smoking status and pre-pregnancy BMI were negatively associated with PFOS, and maternal height was borderline negatively associated with PFOS and PFOA. Glomerular filtration rate (GFR) was negatively associated with PFOS in a sub-sample. Maternal serum levels of OCs were positively associated with maternal age, and negatively associated with previous breastfeeding duration and sampling date. Smoking had a consistently negative association with PCB 118 in a dose-dependent manner. Education level, pre-pregnancy BMI and alcohol consumption varied in importance according to the compound under study. Conclusions Several maternal factors, including potentially modifiable factors, markers of pregnancy physiology and factors also related to perinatal outcomes were associated with EDC levels. Results from this study are relevant to populations with still high PFAS and OC levels, i.e. developing countries. Moreover, we can use this knowledge about associated factors on emerging EDCs with similar properties.	[Lauritzen, Hilde B.; Larose, Tricia L.; Oien, Torbjorn; Jacobsen, Geir W.] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, Trondheim, Norway; [Odland, Jon O.; Sandanger, Torkjel M.] Arctic Univ Norway, Univ Tromso, Dept Community Med, Tromso, Norway; [van de Bor, Margot] Vrije Univ, Sect Hlth & Life Sci, Amsterdam, Netherlands; [Odland, Jon O.] Univ Pretoria, Sch Hlth Syst & Publ Hlth, Pretoria, South Africa; [Sandanger, Torkjel M.] NILU Norwegian Inst Air Res, Tromso, Norway	Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; Vrije Universiteit Amsterdam; University of Pretoria; Norwegian Institute for Air Research	Lauritzen, HB (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, Trondheim, Norway.	hilde.b.lauritzen@ntnu.no	Odland, Jon Oyvind/L-5096-2017	Odland, Jon Oyvind/0000-0002-2756-0732	Liaison Committee	Liaison Committee	This work was funded by grants from the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAP, 2015, AMAP ASS 2015 HUM HL; Apelberg BJ, 2007, ENVIRON HEALTH PERSP, V115, P1670, DOI 10.1289/ehp.10334; Bach CC, 2015, CRIT REV TOXICOL, V45, P53, DOI 10.3109/10408444.2014.952400; BAKKETEIG LS, 1993, ACTA OBSTET GYN SCAN, V72, P273, DOI 10.3109/00016349309068037; Barr DB, 2007, REPROD TOXICOL, V23, P260, DOI 10.1016/j.reprotox.2007.03.003; Berg V, 2015, ENVIRON INT, V77, P63, DOI 10.1016/j.envint.2015.01.007; Berg V, 2014, ENVIRON INT, V69, P58, DOI 10.1016/j.envint.2014.04.010; Boekelheide K, 2012, ENVIRON HEALTH PERSP, V120, P1353, DOI 10.1289/ehp.1204934; Brantsaeter AL, 2013, ENVIRON INT, V54, P74, DOI 10.1016/j.envint.2012.12.014; Brouwer A, 1999, ENVIRON HEALTH PERSP, V107, P639, DOI 10.2307/3434557; Butenhoff JL, 2006, ENVIRON HEALTH PERSP, V114, P1776, DOI 10.1289/ehp.9060; Conde-Agudelo A, 2006, JAMA-J AM MED ASSOC, V295, P1809, DOI 10.1001/jama.295.15.1809; Covaci A, 2006, SCI TOTAL ENVIRON, V366, P361, DOI 10.1016/j.scitotenv.2006.03.006; Deutch B, 2003, ARCH ENVIRON HEALTH, V58, P30, DOI 10.3200/AEOH.58.1.30-36; Dewailly E, 1999, ENVIRON HEALTH PERSP, V107, P823, DOI 10.2307/3454581; Dirtu AC, 2013, ENVIRON SCI TECHNOL, V47, P12441, DOI 10.1021/es400657t; Domingo JL, 2012, ENVIRON INT, V40, P187, DOI 10.1016/j.envint.2011.08.001; Faniband M, 2014, ASIAN J ANDROL, V16, P5, DOI 10.4103/1008-682X.122197; Faupel-Badger JM, 2007, CANCER EPIDEM BIOMAR, V16, P1720, DOI 10.1158/1055-9965.EPI-07-0311; Fei CY, 2007, ENVIRON HEALTH PERSP, V115, P1677, DOI 10.1289/ehp.10506; Glynn A, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-2; Glynn A, 2012, ENVIRON SCI TECHNOL, V46, P9071, DOI 10.1021/es301168c; Govarts E, 2012, ENVIRON HEALTH PERSP, V120, P162, DOI 10.1289/ehp.1103767; Grandjean P, 2008, BASIC CLIN PHARMACOL, V102, P94, DOI 10.1111/j.1742-7843.2007.00167.x; Gyllenhammar I, 2015, ENVIRON RES, V140, P673, DOI 10.1016/j.envres.2015.05.019; Hagmar L, 2006, CHEMOSPHERE, V64, P1507, DOI 10.1016/j.chemosphere.2005.12.054; Halldorsson TI, 2008, ENVIRON SCI TECHNOL, V42, P8971, DOI 10.1021/es801907r; Hansen S, 2014, ENVIRON INT, V68, P41; Hanssen L, 2013, SCI TOTAL ENVIRON, V447, P430, DOI 10.1016/j.scitotenv.2013.01.029; Hardell E, 2010, SCI TOTAL ENVIRON, V408, P4412, DOI 10.1016/j.scitotenv.2010.06.029; HOVINGA ME, 1992, ARCH ENVIRON CON TOX, V22, P362, DOI 10.1007/BF00212554; Kato K, 2014, ENVIRON SCI TECHNOL, V48, P9600, DOI 10.1021/es501811k; Kato K, 2011, ENVIRON SCI TECHNOL, V45, P8037, DOI 10.1021/es1043613; Kim SK, 2011, ENVIRON POLLUT, V159, P169, DOI 10.1016/j.envpol.2010.09.008; Koetje PMJL, 2011, REPROD SCI, V18, P456, DOI 10.1177/1933719110387831; KOOPMANESSEBOOM C, 1994, CHEMOSPHERE, V28, P1721, DOI 10.1016/0045-6535(94)90428-6; Lackmann Gerd-Michael, 2006, Int J Biomed Sci, V2, P178; Laden F, 1999, ENVIRON HEALTH PERSP, V107, P75, DOI 10.2307/3434292; Larsen JC, 2006, MOL NUTR FOOD RES, V50, P885, DOI 10.1002/mnfr.200500247; Lee DH, 2014, ENDOCR REV, V35, P557, DOI 10.1210/er.2013-1084; Lehmler HJ, 2005, CHEMOSPHERE, V58, P1471, DOI 10.1016/j.chemosphere.2004.11.078; Lim JS, 2011, INT J OBESITY, V35, P744, DOI 10.1038/ijo.2010.188; Milbrath MO, 2009, ENVIRON HEALTH PERSP, V117, P417, DOI 10.1289/ehp.11781; Morken NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101897; Natland ST, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-179; Nost TH, 2014, ENVIRON INT, V67, P43, DOI 10.1016/j.envint.2014.02.011; Nost TH, 2013, ENVIRON HEALTH PERSP, V121, P1292, DOI 10.1289/ehp.1206317; Ode A, 2013, ENVIRON SCI POLLUT R, V20, P7970, DOI 10.1007/s11356-013-1573-5; Olsen GW, 2007, ENVIRON HEALTH PERSP, V115, P1298, DOI 10.1289/ehp.10009; PHILLIPS DL, 1989, ARCH ENVIRON CON TOX, V18, P495, DOI 10.1007/BF01055015; Powley CR, 2005, ANAL CHEM, V77, P6353, DOI 10.1021/ac0508090; Richardson DB, 2007, EPIDEMIOLOGY, V18, P441, DOI 10.1097/EDE.0b013e318060d25c; ROGAN WJ, 1986, AM J PUBLIC HEALTH, V76, P172, DOI 10.2105/AJPH.76.2.172; Rylander L, 1997, SCI TOTAL ENVIRON, V207, P55, DOI 10.1016/S0048-9697(97)00245-3; Sagiv SK, 2015, ENVIRON SCI TECHNOL, V49, P11849, DOI 10.1021/acs.est.5b02489; Sandanger TM, 2003, J ENVIRON MONITOR, V5, P689, DOI 10.1039/b302025h; Sandanger TM, 2007, ENVIRON HEALTH PERSP, V115, P1429, DOI 10.1289/ehp.10303; SVENSSON BG, 1995, SCAND J WORK ENV HEA, V21, P96, DOI 10.5271/sjweh.16; Uehara R, 2007, CHEMOSPHERE, V68, P915, DOI 10.1016/j.chemosphere.2007.01.050; van den Berg M, 2017, ARCH TOXICOL, V91, P83, DOI 10.1007/s00204-016-1802-z; Verner MA, 2015, ENVIRON HEALTH PERSP, V123, P1317, DOI 10.1289/ehp.1408837; Vestergren R, 2012, ENVIRON INT, V49, P120, DOI 10.1016/j.envint.2012.08.016; WHO/UNEP, 2013, TOXICOL LETT, DOI DOI 10.1016/J.TOXLET.2012.03.020; Wolff MS, 2007, CANCER EPIDEM BIOMAR, V16, P1925, DOI 10.1158/1055-9965.EPI-07-0394	64	28	28	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166127	10.1371/journal.pone.0166127	http://dx.doi.org/10.1371/journal.pone.0166127			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824939	Green Published, gold, Green Submitted			2022-12-26	WOS:000387615200063
J	Patankar, HV; Assaha, DVM; Al-Yahyai, R; Sunkar, R; Yaish, MW				Patankar, Himanshu V.; Assaha, Dekoum V. M.; Al-Yahyai, Rashid; Sunkar, Ramanjulu; Yaish, Mahmoud W.			Identification of Reference Genes for Quantitative Real-Time PCR in Date Palm (Phoenix dactylifera L.) Subjected to Drought and Salinity	PLOS ONE			English	Article							HOUSEKEEPING GENES; RT-PCR; INTERNAL CONTROL; SALT-TOLERANCE; NORMALIZATION; EXPRESSION; STRESS; VALIDATION; AQUAPORINS; RESPONSES	Date palm is an important crop plant in the arid and semi-arid regions supporting human population in the Middle East and North Africa. These areas have been largely affected by drought and salinity due to insufficient rainfall and improper irrigation practices. Date palm is a relatively salt-and drought-tolerant plant and more recently efforts have been directed to identifying genes and pathways that confer stress tolerance in this species. Quantitative real-time PCR (qPCR) is a promising technique for the analysis of stress-induced differential gene expression, which involves the use of stable reference genes for normalizing gene expression. In an attempt to find the best reference genes for date palm's drought and salinity research, we evaluated the stability of 12 most commonly used reference genes using the geNorm, NormFinder, BestKeeper statistical algorithms and the comparative.CT method. The comprehensive results revealed that HEAT SHOCK PROTEIN (HSP), UBIQUITIN (UBQ) and YTH domain-containing family protein (YT521) were stable in drought-stressed leaves whereas GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (GAPDH), ACTIN and TUBULIN were stable in drought-stressed roots. On the other hand, SMALL SUBUNIT RIBOSOMAL RNA (25S), YT521 and 18S ribosomal RNA (18S); and UBQ, ACTIN and ELONGATION FACTOR 1-ALPHA (eEF1a) were stable in leaves and roots, respectively, under salt stress. The stability of these reference genes was verified by using the abiotic stress-responsive CYTOSOLIC Cu/Zn SUPEROXIDE DISMUTASE (Cyt-Cu/Zn SOD), an ABA RECEPTOR, and a PROLINE TRANSPORTER 2 (PRO) genes. A combination of top 2 or 3 stable reference genes were found to be suitable for normalization of the target gene expression and will facilitate gene expression analysis studies aimed at identifying functional genes associated with drought and salinity tolerance in date palm.	[Patankar, Himanshu V.; Assaha, Dekoum V. M.; Yaish, Mahmoud W.] Sultan Qaboos Univ, Dept Biol, Coll Sci, Muscat, Oman; [Al-Yahyai, Rashid] Sultan Qaboos Univ, Dept Crop Sci, Coll Agr & Marine Sci, Muscat, Oman; [Sunkar, Ramanjulu] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Sultan Qaboos University; Sultan Qaboos University; Oklahoma State University System; Oklahoma State University - Stillwater	Yaish, MW (corresponding author), Sultan Qaboos Univ, Dept Biol, Coll Sci, Muscat, Oman.	myaish@squ.edu.om	Patankar, Himanshu/L-9643-2019; Al-Yahyai, Rashid/B-9273-2011; Yaish, Mahmoud W/F-7168-2014; Assaha, Dekoum/AAM-3386-2020	Patankar, Himanshu/0000-0001-6739-2895; Al-Yahyai, Rashid/0000-0001-7628-6218; Yaish, Mahmoud W/0000-0002-5171-3014; Assaha, Dekoum/0000-0001-8352-8000	Research Council of Oman [151]	Research Council of Oman(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman)	Support was provided by The Research Council of Oman number 151.	Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Al-Mssallem IS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3274; Al-Yahyai R., 2015, DATE PALM GENETIC RE, P207, DOI [10.1007/978-94-017-9707-8_6, DOI 10.1007/978-94-017-9707-8_6]; Amil-Ruiz F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070603; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chao CT, 2007, HORTSCIENCE, V42, P1077, DOI 10.21273/HORTSCI.42.5.1077; Close TJ, 1997, PHYSIOL PLANTARUM, V100, P291, DOI 10.1034/j.1399-3054.1997.1000210.x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; El-Juhany L.I., 2010, AUST J BASIC APPL SC, V4, P3998, DOI DOI 10.1016/J.RADPHYSCHEM.2006.10.004; Ellis Danielle R., 2004, BMC Plant Biology, V4, P1, DOI 10.1186/1471-2229-4-1; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Gargouri-Bouzid R, 2009, MOL BIOTECHNOL, V41, P63, DOI [10.1007/s12033-008-9104-1, DOI 10.1007/S12033-008-914-1]; Gimeno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091474; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; Hazzouri KM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9824; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Javot H, 2002, ANN BOT-LONDON, V90, P301, DOI 10.1093/aob/mcf199; Liu CL, 2012, EXTREMOPHILES, V16, P419, DOI 10.1007/s00792-012-0441-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maathuis FJM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00467; Malash NM, 2008, IRRIGATION SCI, V26, P313, DOI 10.1007/s00271-007-0095-7; Mathur P. B., 2004, International Arachis Newsletter, P33; Maurel C, 2002, INT REV CYTOL, V215, P105; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radwan O, 2015, TROP PLANT BIOL, V8, P74, DOI 10.1007/s12042-015-9155-y; Reddy DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078555; Sah SK, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00571; Saha P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106308; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sinha P, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls.2015.01071, 10.3389/fpls.2015.01065]; Sinha P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122847; STANGER G, 1985, AGR WATER MANAGE, V9, P269, DOI 10.1016/0378-3774(85)90038-1; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2011, BIOCHEM BIOPH RES CO, V416, P24, DOI 10.1016/j.bbrc.2011.10.105; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Wang X, 2015, MOLECULES, V20, P4833, DOI 10.3390/molecules20034833; Wen LZ, 2018, CANCER RES, V78, P4680, DOI 10.1158/0008-5472.CAN-17-3896; Xiao Y, 2012, PLANT OMICS, V5, P584; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yaish MW, 2015, GENET MOL RES, V14, P9943, DOI 10.4238/2015.August.19.30; Yaish MW, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00946; Yaish MW, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00348; Yang ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119569; Zhao TJ, 2006, J BIOL CHEM, V281, P10752, DOI 10.1074/jbc.M510535200; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	52	17	21	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166216	10.1371/journal.pone.0166216	http://dx.doi.org/10.1371/journal.pone.0166216			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824922	Green Published, Green Submitted, gold			2022-12-26	WOS:000387615200072
J	Vesselinova, N; Alexandrov, BS; Wall, ME				Vesselinova, Neda; Alexandrov, Boian S.; Wall, Michael E.			Dynamical Model of Drug Accumulation in Bacteria: Sensitivity Analysis and Experimentally Testable Predictions	PLOS ONE			English	Article							ESCHERICHIA-COLI; EFFLUX; RESISTANCE; PERMEABILITY; SPECIFICITY; AGENTS	We present a dynamical model of drug accumulation in bacteria. The model captures key features in experimental time courses on ofloxacin accumulation: initial uptake; two-phase response; and long-term acclimation. In combination with experimental data, the model provides estimates of import and export rates in each phase, the time of entry into the second phase, and the decrease of internal drug during acclimation. Global sensitivity analysis, local sensitivity analysis, and Bayesian sensitivity analysis of the model provide information about the robustness of these estimates, and about the relative importance of different parameters in determining the features of the accumulation time courses in three different bacterial species: Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. The results lead to experimentally testable predictions of the effects of membrane permeability, drug efflux and trapping (e.g., by DNA binding) on drug accumulation. A key prediction is that a sudden increase in ofloxacin accumulation in both E. coli and S. aureus is accompanied by a decrease in membrane permeability.	[Vesselinova, Neda; Alexandrov, Boian S.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; [Vesselinova, Neda] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Wall, Michael E.] Los Alamos Natl Lab, Comp Computat & Stat Sci Div, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California Los Angeles; United States Department of Energy (DOE); Los Alamos National Laboratory	Wall, ME (corresponding author), Los Alamos Natl Lab, Comp Computat & Stat Sci Div, Los Alamos, NM 87545 USA.	mewall@lanl.gov	Alexandrov, Boian/D-2488-2010	Alexandrov, Boian/0000-0001-8636-4603; Wall, Michael/0000-0003-1000-688X	US Department of Energy [DE-AC52-06NA25396]	US Department of Energy(United States Department of Energy (DOE))	This study was supported by the US Department of Energy under Contract DE-AC52-06NA25396 through the Laboratory-Directed Research and Development Program at Los Alamos National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the reviewers for their comments, which led to substantial improvements in the paper. This study was performed under the auspices of the Laboratory-Directed Research and Development Program at Los Alamos National Laboratory, which is managed for the US Department of Energy by Los Alamos National Security, LLC under contract DE-AC52-06NA25396.	ASUQUO AE, 1993, J ANTIMICROB CHEMOTH, V31, P865, DOI 10.1093/jac/31.6.865; BRATBAK G, 1984, APPL ENVIRON MICROB, V48, P755, DOI 10.1128/AEM.48.4.755-757.1984; Brown DG, 2014, J MED CHEM, V57, P10144, DOI 10.1021/jm501552x; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Campos M, 2014, CELL, V159, P1433, DOI 10.1016/j.cell.2014.11.022; Demchick P, 1996, J BACTERIOL, V178, P768, DOI 10.1128/jb.178.3.768-773.1996; DIVER JM, 1990, J ANTIMICROB CHEMOTH, V25, P319, DOI 10.1093/jac/25.3.319; Gustafson P, 1995, BAYESIAN STAT, V5, P631; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; Kourtesi Christina, 2013, Open Microbiol J, V7, P34, DOI 10.2174/1874285801307010034; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; Lim SP, 2010, ANTIMICROB AGENTS CH, V54, P1800, DOI 10.1128/AAC.01714-09; Nagano K, 2009, P NATL ACAD SCI USA, V106, P5854, DOI 10.1073/pnas.0901695106; NIKAIDO H, 1987, MOL MICROBIOL, V1, P29, DOI 10.1111/j.1365-2958.1987.tb00523.x; NIKAIDO H, 1993, ANTIMICROB AGENTS CH, V37, P1393, DOI 10.1128/AAC.37.7.1393; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Oakley JE, 2004, J R STAT SOC B, V66, P751, DOI 10.1111/j.1467-9868.2004.05304.x; SALTELLI A, 1993, COMPUT STAT DATA AN, V15, P211, DOI 10.1016/0167-9473(93)90193-W; Saltelli A., 2008, GLOBAL SENSITIVITY A; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Savageau M.A., 2013, QUANTITATIVE BIOL MO, P23; SHEN LL, 1989, BIOCHEMISTRY-US, V28, P3879, DOI 10.1021/bi00435a038; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Sobol I.M., 1990, MAT MODEL, V2, P112, DOI DOI 10.18287/0134-2452-2015-39-4-459-461; SOBOL IM, 1993, COMP MATH MATH PHYS+, V33, P1391; THANASSI DG, 1995, J BACTERIOL, V177, P998, DOI 10.1128/jb.177.4.998-1007.1995; Vasquez-Laslop N, 2001, J BACTERIOL, V183, P2399, DOI 10.1128/JB.183.8.2399-2404.2001; Vihola M, 2012, STAT COMPUT, P22; Weiss R, 1996, J ROY STAT SOC B MET, V58, P739	29	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165899	10.1371/journal.pone.0165899	http://dx.doi.org/10.1371/journal.pone.0165899			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824914	Green Published, Green Submitted, gold			2022-12-26	WOS:000387615200041
J	Kamura, Y; Iwata, M; Maede, S; Shinmura, S; Koshimizu, Y; Honoki, H; Fukuda, K; Ishiki, M; Usui, I; Fukushima, Y; Takano, A; Kato, H; Murakami, S; Higuchi, K; Kobashi, C; Tobe, K				Kamura, Yutaka; Iwata, Minoru; Maede, Shiro; Shinmura, Satomi; Koshimizu, Yukiko; Honoki, Hisae; Fukuda, Kazuhito; Ishiki, Manabu; Usui, Isao; Fukushima, Yasuo; Takano, Atsuko; Kato, Hiromi; Murakami, Shihou; Higuchi, Kiyohiro; Kobashi, Chikaaki; Tobe, Kazuyuki			FTO Gene Polymorphism Is Associated with Type 2 Diabetes through Its Effect on Increasing the Maximum BMI in Japanese Men	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; OBESITY-ASSOCIATED GENE; BODY-FAT DISTRIBUTION; WEIGHT-GAIN; EARLY-ONSET; RISK; MASS; VARIANT; GENOTYPE; CHILDREN	Aim Several studies have demonstrated that polymorphisms within the fat-mass and obesity-associated gene (FTO) are associated with type 2 diabetes (T2D). However, whether the effects of the FTO locus on T2D susceptibility are independent of fat-mass increases remains controversial. To investigate this issue, we examined the association of FTO variants with T2D and various aspects of BMI history during adult life in a Japanese population. Methods We genotyped SNPs within FTO (rs1121980 and rs1558902) in 760 Japanese patients with T2D who had reached a lifetime maximum BMI (BMImax) before or at the time of diagnosis and 693 control individuals with information regarding their BMImax. Results The BMImax showed the strongest association with T2D risk among the BMIs evaluated in this study. In the sex-combined analysis, FTO SNPs were not associated with any of the BMI variables or with T2D, but in sex-stratified analyses, both SNPs were significantly associated with the BMImax and rs1558902 was associated with T2D in men. The association of the SNPs with T2D remained significant after adjustments for the current BMI and age, whereas the T2D association of the SNP was no longer significant after adjustments for BMImax and age. Conclusions These results suggest that the effects of FTO polymorphisms on T2D susceptibility in Japanese men are mediated through their effect on increasing the BMImax before or at the time of diagnosis.	[Kamura, Yutaka; Iwata, Minoru; Shinmura, Satomi; Koshimizu, Yukiko; Honoki, Hisae; Fukuda, Kazuhito; Ishiki, Manabu; Usui, Isao; Tobe, Kazuyuki] Toyama Univ, Fac Med, Dept Internal Med 1, Toyama, Japan; [Iwata, Minoru] Toyama Univ, Hlth Adm Ctr, Toyama, Japan; [Maede, Shiro] RIKEN Ctr Genom Med, Lab Endocrinol & Metab, Yokohama, Kanagawa, Japan; [Maede, Shiro] Univ Ryukyus, Grad Sch Med, Dept Adv Genom & Lab Med, Okinawa, Japan; [Maede, Shiro] Univ Ryukyus Hosp, Div Clin Lab & Blood Transfus, Okinawa, Japan; [Fukushima, Yasuo] Asahi Gen Hosp, Dept Internal Med, Asahi, Toyama, Japan; [Takano, Atsuko] Saiseikai Takaoka Hosp, Dept Internal Med, Div Endocrinol & Metab, Takaoka, Toyama, Japan; [Kato, Hiromi] Takaoka Fushiki Hosp, Japan Community Hlth Care Org, Dept Internal Med, Div Endocrinol & Metab, Takaoka, Toyama, Japan; [Murakami, Shihou] Toyama Rosai Hosp, Dept Internal Med, Div Endocrinol & Metab, Uozu, Toyama, Japan; [Higuchi, Kiyohiro] Kouseiren Itoigawa Gen Hosp, Dept Internal Med, Itoigawa, Niigata, Japan; [Kobashi, Chikaaki] Kamiichi Gen Hosp, Dept Internal Med, Kamiichi, Toyama, Japan	University of Toyama; University of Toyama; RIKEN; University of the Ryukyus; University of the Ryukyus	Iwata, M (corresponding author), Toyama Univ, Fac Med, Dept Internal Med 1, Toyama, Japan.; Iwata, M (corresponding author), Toyama Univ, Hlth Adm Ctr, Toyama, Japan.	iwamino-tym@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [24510276]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan (approved number 24510276). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2010, DIABETES RES CLIN PR, V89, P309, DOI 10.1016/j.diabres.2010.04.012; Aschard H, 2015, AM J HUM GENET, V96, P329, DOI 10.1016/j.ajhg.2014.12.021; CASEY VA, 1991, AM J CLIN NUTR, V53, P1493, DOI 10.1093/ajcn/53.6.1493; CLINE MG, 1989, HUM BIOL, V61, P415; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; FUJIMOTO WY, 1991, INT J OBESITY, V15, P111; Gavin JR, 1999, DIABETES CARE, V22, pS5; Han LY, 2014, BIOMED REP, V2, P681, DOI 10.3892/br.2014.293; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Hertel JK, 2011, DIABETES, V60, P1637, DOI 10.2337/db10-1340; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Horikawa Y, 2008, J CLIN ENDOCR METAB, V93, P3136, DOI 10.1210/jc.2008-0452; Horikoshi M, 2007, DIABETOLOGIA, V50, P2461, DOI 10.1007/s00125-007-0827-5; Hotta K, 2008, J HUM GENET, V53, P546, DOI 10.1007/s10038-008-0283-1; Iwata M, 2012, DIABETES CARE, V35, P1763, DOI 10.2337/dc11-2006; Jacobsson JA, 2008, BIOCHEM BIOPH RES CO, V368, P476, DOI 10.1016/j.bbrc.2008.01.087; Jacobsson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020158; KADOWAKI T, 1984, DIABETOLOGIA, V26, P44, DOI 10.1007/BF00252262; Karasawa S, 2010, ENDOCR J, V57, P293, DOI 10.1507/endocrj.K09E-305; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Kring SII, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002958; Li H, 2012, DIABETOLOGIA, V55, P981, DOI 10.1007/s00125-011-2370-7; Liu Y, 2010, OBESITY, V18, P1619, DOI 10.1038/oby.2009.469; Maeda S, 2005, J HUM GENET, V50, P283, DOI 10.1007/s10038-005-0253-9; Masunari N, 2007, OSTEOPOROSIS INT, V18, P1493, DOI 10.1007/s00198-007-0392-2; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meyre D, 2012, DIABETOLOGIA, V55, P873, DOI 10.1007/s00125-012-2478-4; Miyake K, 2009, J HUM GENET, V54, P236, DOI 10.1038/jhg.2009.17; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Ng MCY, 2010, J CLIN ENDOCR METAB, V95, P2418, DOI 10.1210/jc.2009-2077; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Park JY, 1997, DIABETES RES CLIN PR, V35, P49, DOI 10.1016/S0168-8227(96)01363-0; Qi L, 2008, DIABETES, V57, P3145, DOI 10.2337/db08-0006; Qian Y, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-86; Sanghera DK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-59; Scott RA, 2010, EUR J HUM GENET, V18, P1339, DOI 10.1038/ejhg.2010.131; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Shahid A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/324093; Shimaoka I, 2010, HYPERTENS RES, V33, P214, DOI 10.1038/hr.2009.215; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tabara Y, 2009, INT J OBESITY, V33, P1243, DOI 10.1038/ijo.2009.161; Takeuchi F, 2011, DIABETOLOGIA, V54, P1350, DOI 10.1007/s00125-011-2086-8; Tamakoshi K, 2003, INT J OBESITY, V27, P247, DOI 10.1038/sj.ijo.802195; Tanaka M, 2012, J ATHEROSCLER THROMB, V19, P633, DOI 10.5551/jat.11940; Tanaka S, 2011, J ATHEROSCLER THROMB, V18, P115, DOI 10.5551/jat.5926; Xi B, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-107; Xi B, 2009, BIOMED ENVIRON SCI, V22, P449, DOI 10.1016/S0895-3988(10)60001-3; Yajnik CS, 2009, DIABETOLOGIA, V52, P247, DOI 10.1007/s00125-008-1186-6; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401; Yoshizawa S, 2014, DIABETIC MED, V31, P1378, DOI 10.1111/dme.12471; Zhang XM, 2012, DIABETES, V61, P3005, DOI 10.2337/db11-1799	53	22	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165523	10.1371/journal.pone.0165523	http://dx.doi.org/10.1371/journal.pone.0165523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820839	Green Published, Green Submitted, gold			2022-12-26	WOS:000387614800011
J	Bu, Y; Liu, F; Jia, QA; Yu, SN				Bu, Yang; Liu, Fang; Jia, Qing-An; Yu, Song-Ning			Decreased Expression of TMEM173 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							CYCLIC-DI-GMP; I IFN; CANCER; SENSOR; CELLS; ACTIVATION; IMMUNITY; AMP; DNA	Hepatocellular carcinoma (HCC) is one of the most lethal cancer types, and chronic infection with Hepatitis B Virus (HBV) is identified as the strongest risk factor for HCC. Transmembrane Protein 173 (TMEM173) is a pattern recognition receptor which functions as a major regulator of the innate immune response to viral and bacterial infections. However, the prognostic value of TMEM173 in HCC remains elusive. Thus, we aimed to evaluate the potential prognostic significance of TMEM173 expression in HCC patients following curative resection. Immunohistochemistry was used to detect TMEM173 expression in 96 HCC patients. We found that TMEM173 protein expression was remarkably decreased in tumor tissues compared to non-tumor tissues, and that TMEM173 staining intensity was inversely correlated with tumor size, tumor invasion TNM stage and overall survival (OS) in HCC patients. Multivariate analysis supported TMEM173 as an independent prognostic factor, and identified that combining TMEM173 expression with TNM stage showed better prognostic efficiency for OS in HCC patients. In summary, TMEM173 was discovered having an independent prognostic value and may serve as a potential immunotherapeutic target for HCC.	[Bu, Yang; Yu, Song-Ning] Ningxia Med Univ, Gen Hosp, Hepatobiliary Surg, Yinchuan, Peoples R China; [Liu, Fang] Ningxia Med Univ, Gen Hosp, Med Examinat Ctr, Yinchuan, Peoples R China; [Jia, Qing-An] Xi An Jiao Tong Univ, Affiliated Hosp 1, Hepatobiliary Surg, Xian, Peoples R China	Ningxia Medical University; Ningxia Medical University; Xi'an Jiaotong University	Yu, SN (corresponding author), Ningxia Med Univ, Gen Hosp, Hepatobiliary Surg, Yinchuan, Peoples R China.	YSN_NXYC@163.com			Ningxia Natural Science Foundation [NZ15130]; National Natural Science Foundation of China [81502694]; Postdoctoral Science Foundation of China [2015M570330]	Ningxia Natural Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This research project was supported by Key project of Ningxia Natural Science Foundation (NZ15130) for YB, and The National Natural Science Foundation of China (81502694) and Postdoctoral Science Foundation of China (2015M570330) for Q-AJ. YB was in charge of study design, data collection and analysis and preparation of the manuscript. Q-AJ was in charge of preparation of the manuscript.	Anghelina D, 2016, J VIROL, V90, P5915, DOI 10.1128/JVI.00500-16; Blaauboer SM, 2014, J IMMUNOL, V192, P492, DOI 10.4049/jimmunol.1301812; Bruix J, 2016, GASTROENTEROLOGY, V150, P835, DOI 10.1053/j.gastro.2015.12.041; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Camp JT, 2011, MOL CANCER RES, V9, P3, DOI 10.1158/1541-7786.MCR-10-0372; Chan SL, 2016, J CLIN ONCOL, V34, P83, DOI 10.1200/JCO.2015.61.5724; Ho SSW, 2016, IMMUNITY, V44, P1177, DOI 10.1016/j.immuni.2016.04.010; Huitzil-Melendez FD, 2010, J CLIN ONCOL, V28, P2889, DOI 10.1200/JCO.2009.25.9895; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Karimi-Googheri M, 2015, ARCH IRAN MED, V18, P351, DOI 015186/AIM.005; Melkil I, 2015, CURR OPIN IMMUNOL, V37, P1, DOI 10.1016/j.coi.2015.07.008; Nakamura T, 2015, J CONTROL RELEASE, V216, P149, DOI 10.1016/j.jconrel.2015.08.026; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Su YC, 2012, ACTA CRYSTALLOGR F, V68, P906, DOI 10.1107/S1744309112024372; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Tang CHA, 2016, CANCER RES, V76, P2137, DOI 10.1158/0008-5472.CAN-15-1885; Villa E, 2016, GUT, V65, P861, DOI 10.1136/gutjnl-2014-308483; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xia TL, 2016, CELL REP, V14, P282, DOI 10.1016/j.celrep.2015.12.029; Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845	23	39	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165681	10.1371/journal.pone.0165681	http://dx.doi.org/10.1371/journal.pone.0165681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814372	Green Submitted, gold, Green Published			2022-12-26	WOS:000386911100014
J	Patel, MC; Wang, W; Pletneva, LM; Rajagopala, SV; Tan, Y; Hartert, TV; Boukhvalova, MS; Vogel, SN; Das, SR; Blanco, JCG				Patel, Mira C.; Wang, Wei; Pletneva, Lioubov M.; Rajagopala, Seesandra V.; Tan, Yi; Hartert, Tina V.; Boukhvalova, Marina S.; Vogel, Stefanie N.; Das, Suman R.; Blanco, Jorge C. G.			Enterovirus D-68 Infection, Prophylaxis, and Vaccination in a Novel Permissive Animal Model, the Cotton Rat (Sigmodon hispidus)	PLOS ONE			English	Article							RESPIRATORY-INFECTIONS; HUMAN RHINOVIRUS-87; 2014 OUTBREAK; D68; EMERGENCE; CHILDREN; REPLICATION; CHALLENGE; SEROTYPE; PROVIDES	In recent years, there has been a significant increase in detection of Enterovirus D-68 (EV-D68) among patients with severe respiratory infections worldwide. EV-D68 is now recognized as a re-emerging pathogen; however, due to lack of a permissive animal model for EV-D68, a comprehensive understanding of the pathogenesis and immune response against EV-D68 has been hampered. Recently, it was shown that EV-D68 has a strong affinity for alpha 2,6-linked sialic acids (SAs) and we have shown previously that a2,6-linked SAs are abundantly present in the respiratory tract of cotton rats (Sigmodon hispidus). Thus, we hypothesized that cotton rats could be a potential model for EV-D68 infection. Here, we evaluated the ability of two recently isolated EV-D68 strains (VANBT/1 and MO/14/49), along with the historical prototype Fermon strain (ATCC), to infect cotton rats. We found that cotton rats are permissive to EV-D68 infection without virus adaptation. The different strains of EV-D68 showed variable infection profiles and the ability to produce neutralizing antibody (NA) upon intranasal infection or intramuscular immunization. Infection with the VANBT/1 resulted in significant induction of pulmonary cytokine gene expression and lung pathology. Intramuscular immunization with live VANBT/1 or MO/14/49 induced strong homologous antibody responses, but a moderate heterologous NA response. We showed that passive prophylactic administration of serum with high content of NA against VANBT/1 resulted in an efficient antiviral therapy. VANBT/1-immunized animals showed complete protection from VANBT/1 challenge, but induced strong pulmonary Th1 and Th2 cytokine responses and enhanced lung pathology, indicating the generation of exacerbated immune response by immunization. In conclusion, our data illustrate that the cotton rat is a powerful animal model that provides an experimental platform to investigate pathogenesis, immune response, anti-viral therapies and vaccines against EV-D68 infection.	[Patel, Mira C.; Pletneva, Lioubov M.; Boukhvalova, Marina S.; Blanco, Jorge C. G.] Sigmovir Biosyst Inc, Rockville, MD 20850 USA; [Patel, Mira C.; Vogel, Stefanie N.] Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Wang, Wei; Rajagopala, Seesandra V.; Tan, Yi; Das, Suman R.] J Craig Venter Inst, Infect Dis Grp, Rockville, MD 20850 USA; [Hartert, Tina V.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA	University System of Maryland; University of Maryland Baltimore; J. Craig Venter Institute; Vanderbilt University	Blanco, JCG (corresponding author), Sigmovir Biosyst Inc, Rockville, MD 20850 USA.; Das, SR (corresponding author), J Craig Venter Inst, Infect Dis Grp, Rockville, MD 20850 USA.; Das, SR (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Ctr Translat Immunol & Infect Dis, Nashville, TN USA.	suman.r.das@vanderbilt.edu; j.blanco@sigmovir.com	Das, Suman/ABB-7273-2020; Blanco, Jorge/AAW-3752-2020	Das, Suman/0000-0003-2496-9724; Rajagopala, Seesandra/0000-0001-7176-5770; Blanco, Jorge/0000-0002-6173-0213	Sigmovir Biosystems Inc. (SBI); NIH [R01AI104541, AI104541]; J. Craig Venter Institute; NIAID/NIH Genomic Centers for Infectious Diseases (GCID) program [U19-AI110819]; SBI;  [AI110819]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI077930, U19AI110819] Funding Source: NIH RePORTER	Sigmovir Biosystems Inc. (SBI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J. Craig Venter Institute; NIAID/NIH Genomic Centers for Infectious Diseases (GCID) program; SBI(Indian Council of Agricultural Research (ICAR)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by Sigmovir Biosystems Inc.'s (SBI) corporate funds, NIH grants R01AI104541 (to SNV at the University of Maryland and JCGB at SBI). This work was also partly supported by J. Craig Venter Institute internal funding and the sequence characterization of the viruses used in this study was supported by the NIAID/NIH Genomic Centers for Infectious Diseases (GCID) program (U19-AI110819 to SRD). MCP, LMP, MSB, JCGB have affiliation and are supported by SBI and NIH grant AI104541. WW, SVR, YT, SRD were partially supported by AI110819. SBI, through JCGB, MCP, and MSB has been involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. All other SBI's funders did not have any role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. SBI has provided support in the form of authors' salaries for MCP, LMP, MSB, and JCGB, as well as for research animals and materials.	ARMSTRONG CHARLES, 1939, PUBL HEALTH REPTS, V54, P2302, DOI 10.2307/4583135; Baggen J, 2016, P NATL ACAD SCI USA, V113, P1399, DOI 10.1073/pnas.1524498113; Blanco JCG, 2004, J INTERF CYTOK RES, V24, P21, DOI 10.1089/107999004772719873; Blanco JCG, 2015, VACCINE, V33, P5371, DOI 10.1016/j.vaccine.2015.08.071; Blanco Jorge C G, 2014, Trials Vaccinol, V3, P52; Blanco JCG, 2013, J VIROL, V87, P2036, DOI 10.1128/JVI.00638-12; Blomqvist S, 2002, J CLIN MICROBIOL, V40, P4218, DOI 10.1128/JCM.40.11.4218-4223.2002; Boukhvalova M, 2016, BONE MARROW TRANSPL, V51, P119, DOI 10.1038/bmt.2015.212; Boukhvalova M, 2015, J VIROL, V89, P9825, DOI 10.1128/JVI.01387-15; Boukhvalova MS, 2007, J VIROL, V81, P9443, DOI 10.1128/JVI.00102-07; Boukhvalova MS, 2006, VACCINE, V24, P5027, DOI 10.1016/j.vaccine.2006.03.064; Boukhvalova MS, 2013, CURR TOP MICROBIOL, V372, P347, DOI 10.1007/978-3-642-38919-1_17; Boukhvalova MS, 2009, BIOLOGICALS, V37, P152, DOI 10.1016/j.biologicals.2009.02.017; CHATTERJEE S, 1970, BRIT J OPHTHALMOL, V54, P628, DOI 10.1136/bjo.54.9.628; Connor E, 1997, PEDIATRICS, V99, P93; Du J, 2015, PLOS ONE, V10, DOI [10.13717journal.pone.0144208, DOI 10.13717JOUMAL.PONE.0144208]; Eichelberger MC, 2006, CELL IMMUNOL, V243, P67, DOI 10.1016/j.cellimm.2006.12.005; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Furuse Y, 2015, J CLIN MICROBIOL, V53, P1015, DOI 10.1128/JCM.03362-14; Greninger AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9; Harvala H, 2014, J GEN VIROL, V95, P403, DOI 10.1099/vir.0.059048-0; Harvala H, 2011, J VIROL, V85, P4480, DOI 10.1128/JVI.02285-10; Holm-Hansen CC, 2016, LANCET INFECT DIS, V16, pE64, DOI 10.1016/S1473-3099(15)00543-5; Huang WH, 2015, SCI REP-UK, V5, DOI 10.1038/srep15223; Ikeda T, 2012, MICROBIOL IMMUNOL, V56, P139, DOI 10.1111/j.1348-0421.2012.00411.x; Imamura T, 2015, REV MED VIROL, V25, P102, DOI 10.1002/rmv.1820; Imamura T, 2014, J VIROL, V88, P2374, DOI 10.1128/JVI.03070-13; Imamura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074221; Imamura T, 2011, EMERG INFECT DIS, V17, P1430, DOI 10.3201/eid1708.101328; Ishiko H, 2002, INTERVIROLOGY, V45, P136, DOI 10.1159/000065866; Junttila N, 2007, J MED VIROL, V79, P393, DOI 10.1002/jmv.20825; Kaida A, 2011, EMERG INFECT DIS, V17, P1494, DOI 10.3201/eid1708.110028; Khetsuriani N, 2006, MMWR SURVEILL SUMM, V55, P1, DOI DOI 10.1016/j.alit.2017.04.003; KONO R, 1972, LANCET, V1, P1191; KOROLEVA GA, 1980, VOP VIRUSOL+, P185; Kreuter JD, 2011, ARCH PATHOL LAB MED, V135, P793, DOI 10.1043/2010-0174-CR.1; Lang M, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.44.20952; Lauinger IL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036005; Linsuwanon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035190; Liu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9865; Lu QB, 2014, J MED MICROBIOL, V63, P408, DOI 10.1099/jmm.0.068247-0; Lyon GM, 2014, NEW ENGL J MED, V371, P2402, DOI 10.1056/NEJMoa1409838; Meijer A, 2014, EURO SURVEILL, V19; Meijer A, 2012, VIROLOGY, V423, P49, DOI 10.1016/j.virol.2011.11.021; Messacar K, 2015, LANCET, V385, P1662, DOI 10.1016/S0140-6736(14)62457-0; Midgley Claire M, 2014, MMWR Morb Mortal Wkly Rep, V63, P798; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0; Ottolini MG, 2000, VIRAL IMMUNOL, V13, P231, DOI 10.1089/vim.2000.13.231; Ottolini MG, 2005, J GEN VIROL, V86, P2823, DOI 10.1099/vir.0.81145-0; Pfeiffer HC, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.10.21062; Pfeuffer J, 2003, J VIROL, V77, P150, DOI 10.1128/JVI.77.1.150-158.2003; Piralla A, 2014, J MED VIROL, V86, P1590, DOI 10.1002/jmv.23821; Pletneva LM, 2008, J GEN VIROL, V89, P261, DOI 10.1099/vir.0.83294-0; Pletneva LM, 2006, J INTERF CYTOK RES, V26, P914, DOI 10.1089/jir.2006.26.914; Royston L, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8010016; SCHIEBLE JH, 1967, AM J EPIDEMIOL, V85, P297, DOI 10.1093/oxfordjournals.aje.a120693; Schuster JE, 2015, J CLIN VIROL, V70, P77, DOI 10.1016/j.jcv.2015.07.298; Sejvar JJ, 2016, CLIN INFECT DIS; Smura TP, 2007, J GEN VIROL, V88, P849, DOI 10.1099/vir.0.82510-0; Straight TM, 2006, VACCINE, V24, P6264, DOI 10.1016/j.vaccine.2006.05.092; Sun YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep34299; Tan Y, 2016, J VIROL, V90, P1997, DOI 10.1128/JVI.02418-15; Tokarz R, 2012, J GEN VIROL, V93, P1952, DOI 10.1099/vir.0.043935-0; Verhelst J, 2013, MICROBIOL MOL BIOL R, V77, P551, DOI 10.1128/MMBR.00024-13; Waghmare A, 2015, BLOOD, V125, P1724, DOI 10.1182/blood-2014-12-616516; Wang Z, 2010, MICROB ECOL, V59, P623, DOI 10.1007/s00248-010-9636-3; WYDE PR, 1992, P SOC EXP BIOL MED, V201, P80, DOI 10.3181/00379727-201-43483; Yim KC, 2005, J VIROL, V79, P14632, DOI 10.1128/JVI.79.23.14632-14639.2005	69	17	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166336	10.1371/journal.pone.0166336	http://dx.doi.org/10.1371/journal.pone.0166336			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814404	gold, Green Published, Green Submitted			2022-12-26	WOS:000386911100039
J	Sawano, S; Komiya, Y; Ichitsubo, R; Ohkawa, Y; Nakamura, M; Tatsumi, R; Ikeuchi, Y; Mizunoya, W				Sawano, Shoko; Komiya, Yusuke; Ichitsubo, Riho; Ohkawa, Yasuyuki; Nakamura, Mako; Tatsumi, Ryuichi; Ikeuchi, Yoshihide; Mizunoya, Wataru			A One-Step Immunostaining Method to Visualize Rodent Muscle Fiber Type within a Single Specimen	PLOS ONE			English	Article							HEAVY-CHAIN ISOFORMS; MYOFIBRILLAR ATPASE ACTIVITY; SOLEUS MUSCLE; MYOSIN; ANTIBODIES; EXPRESSION; ANTIGENS; PROTOCOL	In this study, we present a quadruple immunostaining method for rapid muscle fiber typing of mice and rats using antibodies specific to the adult myosin heavy chain (MyHC) isoforms MyHC1, 2A, 2X, and 2B, which are common marker proteins of distinct muscle fiber types. We developed rat monoclonal antibodies specific to each MyHC isoform and conjugated these four antibodies to fluorophores with distinct excitation and emission wavelengths. By mixing the four types of conjugated antibodies, MyHC1, 2A, 2X, and 2B could be distinguished within a single specimen allowing for facile delineation of skeletal muscle fiber types. Furthermore, we could observe hybrid fibers expressing MyHC2X and MyHC2B together in single longitudinal muscle sections from mice and rats, that was not attained in previous techniques. This staining method is expected to be applied to study muscle fiber type transition in response to environmental factors, and to ultimately develop techniques to regulate animal muscle fiber types.	[Sawano, Shoko; Komiya, Yusuke; Ichitsubo, Riho; Nakamura, Mako; Tatsumi, Ryuichi; Ikeuchi, Yoshihide; Mizunoya, Wataru] Kyushu Univ, Dept Bioresource Sci, Fac Agr, Fukuoka, Japan; [Ohkawa, Yasuyuki] Kyushu Univ, Med Inst Bioregulat, Div Transcript, Fukuoka, Japan; [Ohkawa, Yasuyuki] JST, CREST, Saitama, Japan; [Sawano, Shoko] Fukuoka Womens Jr Coll, Dept Food Nutr, Dazaifu, Japan	Kyushu University; Kyushu University; Japan Science & Technology Agency (JST)	Mizunoya, W (corresponding author), Kyushu Univ, Dept Bioresource Sci, Fac Agr, Fukuoka, Japan.	mizunoya.wataru.185@m.kyushu-u.ac.jp	Ohkawa, Yasuyuki/ABG-1839-2021; Mizunoya, Wataru/W-1674-2019	Ohkawa, Yasuyuki/0000-0001-6440-9954; Mizunoya, Wataru/0000-0002-2258-1964; Komiya, Yusuke/0000-0003-3225-2491; Nakamura, Mako/0000-0002-6129-7560	Japan Society for the Promotion of Science (JSPS) KAKENHI [26712023, 22580136, 20404056, 26850083, 14J40234, 11J40017]; Faculty of Agriculture, Kyushu University; Grants-in-Aid for Scientific Research [16H02585, 26450391] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Faculty of Agriculture, Kyushu University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by Japan Society for the Promotion of Science (JSPS; http://www.jsps.go.jp/english/e-grants/index.html) KAKENHI #26712023, 22580136, and 20404056 to WM, and #26850083, 14J40234, and 11J40017 to SS. The cost of English proofreading service was supported by a Research Grant for Young Investigators of Faculty of Agriculture, Kyushu University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augusto V, 2004, BRAZ J MORPHOL SCIS, V21, P89; BILLETER R, 1980, HISTOCHEMISTRY, V65, P249, DOI 10.1007/BF00493174; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; BROOKE MH, 1970, ARCH NEUROL-CHICAGO, V23, P369, DOI 10.1001/archneur.1970.00480280083010; Caiozzo VJ, 1997, AM J PHYSIOL-CELL PH, V273, pC944, DOI 10.1152/ajpcell.1997.273.3.C944; D'Amico A, 2008, CURR NEUROL NEUROSCI, V8, P73, DOI 10.1007/s11910-008-0012-3; DRABER P, 1995, J IMMUNOL METHODS, V181, P37, DOI 10.1016/0022-1759(94)00326-R; Ellefsen S, 2014, SCAND J MED SCI SPOR, V24, pE332, DOI 10.1111/sms.12185; Engel WK, 2015, BBA-MOL BASIS DIS, V1852, P563, DOI 10.1016/j.bbadis.2014.11.015; FITZSIMONS DP, 1990, J APPL PHYSIOL, V68, P1950, DOI 10.1152/jappl.1990.68.5.1950; Goding J., 1986, MONOCLONAL ANTIBODIE, P108; Gregorevic P, 2008, MUSCLE NERVE, V37, P104, DOI 10.1002/mus.20877; IZUMO S, 1986, SCIENCE, V231, P597, DOI 10.1126/science.3945800; Jackson KA, 2004, STEM CELLS, V22, P180, DOI 10.1634/stemcells.22-2-180; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; KISHIRO Y, 1995, CELL STRUCT FUNCT, V20, P151, DOI 10.1247/csf.20.151; Komiya Y, 2015, ANAL BIOCHEM, V482, P22, DOI 10.1016/j.ab.2015.03.034; Korn ED, 2000, P NATL ACAD SCI USA, V97, P12559, DOI 10.1073/pnas.230441597; Lucas CA, 2000, BIOCHEM BIOPH RES CO, V272, P303, DOI 10.1006/bbrc.2000.2768; Mizunoya W, 2008, ANAL BIOCHEM, V377, P111, DOI 10.1016/j.ab.2008.02.021; Mizunoya W, 2014, ANIM SCI J, V85, P293, DOI 10.1111/asj.12143; Mizunoya W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080152; Mundegar RR, 2008, J HISTOCHEM CYTOCHEM, V56, P969, DOI 10.1369/jhc.2008.950105; Pette D, 1998, ACTA PHYSIOL SCAND, V162, P367, DOI 10.1046/j.1365-201X.1998.0296e.x; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Rayment I, 1996, J BIOL CHEM, V271, P15850, DOI 10.1074/jbc.271.27.15850; Ribaric S, 2013, CELLS TISSUES ORGANS, V197, P312, DOI 10.1159/000345424; Rivero JLL, 1999, HISTOCHEM CELL BIOL, V111, P277, DOI 10.1007/s004180050358; SADO Y, 1995, HISTOCHEM CELL BIOL, V104, P267, DOI 10.1007/BF01464322; SALMONS S, 1976, NATURE, V263, P30, DOI 10.1038/263030a0; Sato Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1748, DOI 10.1271/bbb.90085; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; SIMONEAU JA, 1989, AM J PHYSIOL, V257, pE567, DOI 10.1152/ajpendo.1989.257.4.E567; SMERDU V, 1994, AM J PHYSIOL-CELL PH, V267, pC1723, DOI 10.1152/ajpcell.1994.267.6.C1723; STARON RS, 1986, HISTOCHEMISTRY, V86, P19, DOI 10.1007/BF00492341; Talmadge RJ, 2004, BIOCHEM BIOPH RES CO, V325, P296, DOI 10.1016/j.bbrc.2004.10.030; Talmadge RJ, 1985, J APPL PHYSIOL, V78, P1256; Tang XB, 2007, J NEUROSCI, V27, P5837, DOI 10.1523/JNEUROSCI.5048-06.2007; Toniolo L, 2005, J EXP BIOL, V208, P4243, DOI 10.1242/jeb.01904; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Yoshihara H, 2006, J NUTR SCI VITAMINOL, V52, P183, DOI 10.3177/jnsv.52.183; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	43	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166080	10.1371/journal.pone.0166080	http://dx.doi.org/10.1371/journal.pone.0166080			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814384	Green Published, Green Submitted, gold			2022-12-26	WOS:000386911100031
J	Douguet, L; Cherfils-Vicini, J; Bod, L; Lengagne, R; Gilson, E; Prevost-Blondel, A				Douguet, Laetitia; Cherfils-Vicini, Julien; Bod, Lloyd; Lengagne, Renee; Gilson, Eric; Prevost-Blondel, Armelle			Nitric Oxide Synthase 2 Improves Proliferation and Glycolysis of Peripheral gamma delta T Cells	PLOS ONE			English	Article							SUPPRESSOR-CELLS; LYMPHOCYTES; SURVIVAL; RECOGNITION; METABOLISM; INDUCTION; INFECTION; APOPTOSIS; IMMUNITY; RELEASE	gamma delta T cells play critical roles in host defense against infections and cancer. Although advances have been made in identifying gamma delta TCR ligands, it remains essential to understand molecular mechanisms responsible for in vivo expansion of gamma delta T cells in periphery. Recent findings identified the expression of the inducible NO synthase (NOS2) in lymphoid cells and highlighted novel immunoregulatory functions of NOS2 in alpha beta T cell differentiation and B cell survival. In this context, we wondered whether NOS2 exerts an impact on gamma delta T cell properties. Here, we show that gamma delta T cells express NOS2 not only in vitro after TCR triggering, but also directly ex vivo. Nos2 deficient mice have fewer gamma delta T cells in peripheral lymph nodes (pLNs) than their wild-type counterparts, and these cells exhibit a reduced ability to produce IL-2. Using chemical NOS inhibitors and Nos2 deficient gamma delta T cells, we further evidence that the inactivation of endogenous NOS2 significantly reduced gamma delta T cell proliferation and glycolysis metabolism that can be restored in presence of exogenous IL-2. Collectively, we demonstrate the crucial role of endogenous NOS2 in promoting optimal IL-2 production, proliferation and glycolysis of gamma delta T cells that may contribute to their regulation at steady state.	[Douguet, Laetitia; Bod, Lloyd; Lengagne, Renee; Prevost-Blondel, Armelle] Inst Cochin, INSERM, U1016, Paris, France; [Douguet, Laetitia; Bod, Lloyd; Lengagne, Renee; Prevost-Blondel, Armelle] CNRS, UMR8104, Paris, France; [Douguet, Laetitia; Bod, Lloyd; Lengagne, Renee; Prevost-Blondel, Armelle] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Cherfils-Vicini, Julien; Gilson, Eric] Univ Nice, Inst Rech Canc & Vieillissement, CNRS UMR7284, INSERM U1081, Nice, France; [Cherfils-Vicini, Julien; Gilson, Eric] CHU Nice, Hop Archet, Dept Genet Med, Nice, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice	Prevost-Blondel, A (corresponding author), Inst Cochin, INSERM, U1016, Paris, France.; Prevost-Blondel, A (corresponding author), CNRS, UMR8104, Paris, France.; Prevost-Blondel, A (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.	armelle.blondel@inserm.fr	Prevost-Blondel, Armelle/N-7643-2017; Cherfils-Vicini, Julien/L-1997-2019; Bod, Lloyd/AAG-2345-2020	Cherfils-Vicini, Julien/0000-0001-7813-1527; Bod, Lloyd/0000-0003-3663-2571; Douguet, Laetitia/0000-0003-4319-491X; Prevost-Blondel, Armelle/0000-0002-7268-5905	SI LAB Jean Paufique foundation; "Ligue contre le Cancer"; Paris VII University; "Fondation de France"; french fondation "ARC" for the Cancer Research; Comite "Ile de France" from Ligue contre le Cancer; Conseil general, FEDER, le Ministere de l'Enseignement Superieur, la Region PACA; INSERM	SI LAB Jean Paufique foundation; "Ligue contre le Cancer"(Ligue nationale contre le cancer); Paris VII University; "Fondation de France"(Fondation de France); french fondation "ARC" for the Cancer Research; Comite "Ile de France" from Ligue contre le Cancer; Conseil general, FEDER, le Ministere de l'Enseignement Superieur, la Region PACA(Region Provence-Alpes-Cote d'Azur); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by the SI LAB Jean Paufique foundation. LD was supported by the "Ligue contre le Cancer" and Paris VII University. JCV was supported by the "Fondation de France". APB's team is supported by the french fondation "ARC" for the Cancer Research and Comite "Ile de France" from Ligue contre le Cancer. CytoMed were supported by le Conseil general, FEDER, le Ministere de l'Enseignement Superieur, la Region PACA and INSERM.	Atre N, 2006, INT J CANCER, V119, P1368, DOI 10.1002/ijc.21966; Bogdan C, 2015, TRENDS IMMUNOL, V36, P161, DOI 10.1016/j.it.2015.01.003; CARDING SR, 1990, GENE DEV, V4, P1304, DOI 10.1101/gad.4.8.1304; Chang CH, 2016, NAT IMMUNOL, V17, P364, DOI 10.1038/ni.3415; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Cidad P, 2004, BIOCHEM J, V384, P629, DOI 10.1042/BJ20040886; Coloff JL, 2011, J BIOL CHEM, V286, P5921, DOI 10.1074/jbc.M110.179101; Crowley MP, 1997, J EXP MED, V185, P1223, DOI 10.1084/jem.185.7.1223; Douguet L, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1208878; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gao YF, 2003, J EXP MED, V198, P433, DOI 10.1084/jem.20030584; Jayaraman P, 2012, J IMMUNOL, V188, P5365, DOI 10.4049/jimmunol.1103553; Lanca T, 2013, J IMMUNOL, V190, P6673, DOI 10.4049/jimmunol.1300434; Lukacs-Kornek V, 2011, NAT IMMUNOL, V12, P1096, DOI 10.1038/ni.2112; MacIver NJ, 2008, J LEUKOCYTE BIOL, V84, P949, DOI 10.1189/jlb.0108024; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; MATIS LA, 1989, SCIENCE, V245, P746, DOI 10.1126/science.2528206; McVay LD, 1996, J IMMUNOL, V157, P2873; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Niedbala W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5575; Obermajer N, 2013, J EXP MED, V210, P1433, DOI 10.1084/jem.20121277; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ribot JC, 2012, J IMMUNOL, V189, P1202, DOI 10.4049/jimmunol.1200268; Saini AS, 2014, NAT IMMUNOL, V15, P275, DOI 10.1038/ni.2806; Sciorati C, 1997, J BIOL CHEM, V272, P23211, DOI 10.1074/jbc.272.37.23211; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Sheridan BS, 2013, IMMUNITY, V39, P184, DOI 10.1016/j.immuni.2013.06.015; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Siegert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027618; Silva-Santos B, 2015, NAT REV IMMUNOL, V15, P683, DOI 10.1038/nri3904; STUEHR DJ, 1985, P NATL ACAD SCI USA, V82, P7738, DOI 10.1073/pnas.82.22.7738; Tumurkhuu G, 2010, CELL IMMUNOL, V261, P122, DOI 10.1016/j.cellimm.2009.11.009; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Wang T, 2006, J IMMUNOL, V177, P1825, DOI 10.4049/jimmunol.177.3.1825; Yang JJ, 2013, J EXP MED, V210, P1447, DOI 10.1084/jem.20122494	38	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165639	10.1371/journal.pone.0165639	http://dx.doi.org/10.1371/journal.pone.0165639			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812136	Green Published, gold, Green Submitted			2022-12-26	WOS:000386910000042
J	Janssen, KJH; Hoebe, CJPA; Dukers-Muijrers, NHTM; Eppings, L; Lucchesi, M; Wolffs, PFG				Janssen, Kevin J. H.; Hoebe, Christian J. P. A.; Dukers-Muijrers, Nicole H. T. M.; Eppings, Lisanne; Lucchesi, Mayk; Wolffs, Petra F. G.			Viability-PCR Shows That NAAT Detects a High Proportion of DNA from Non-Viable Chlamydia trachomatis	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PROPIDIUM MONOAZIDE; GENITAL-INFECTION; PERFORMANCE; TIME; DIAGNOSIS; ASSAYS	Objectives According to the current guidelines for laboratory diagnosis of sexually transmitted infections (STIs), nucleic acid amplification tests (NAATs) are the preferred diagnostic method for Chlamydia trachomatis (CT) infections. However, NAATs amplify the available target DNA without discriminating between DNA originating from viable or non-viable CT. Assessing CT viability will provide more insights in the clinical and public health relevance of a CT positive test result. The aim of this study was to technically validate and implement viability-PCR (V-PCR) to asses CT viability. Methods Technical validation of V-PCR was performed by the assessment of predefined viability ratios of CT. Samples were subjected to V-PCR which consisted of propidium monoazide (PMA) treatment prior to DNA extraction followed by quantitative PCR (qPCR) targeting the ompA gene for the detection of CT DNA. Finally, V-PCR was applied to vaginal swabs of 50 CT positive patients, as indicated by routine NAAT, collected at our outpatient STD clinics before antimicrobial treatment. Results Technical validation of V-PCR showed that PMA treatment of heat-inactivated CT culture resulted in an almost complete loss of qPCR signal. PMA treated samples of the fresh viable CT culture showed no marked reduction of PCR signal, indicating that all DNA from viable CT could be detected. Applying V-PCR to clinical samples showed that in 36% of samples (18/50) less than 1% of CT DNA originated from viable bacteria. Conclusions V-PCR showed to be a fast and easy method to assess CT viability in clinical samples, without the need of traditional challenging cell culture methods. Furthermore, V-PCR results of clinical samples have indicated that a substantial amount of the amplified CT DNA originated from non-viable cells. Although results might be influenced by cell death during transport, this study suggests that there is a potential overestimation of quantitative CT positivity by currently used NAATs.	[Janssen, Kevin J. H.; Hoebe, Christian J. P. A.; Dukers-Muijrers, Nicole H. T. M.; Eppings, Lisanne; Lucchesi, Mayk; Wolffs, Petra F. G.] Maastricht Univ, Med Ctr MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Med Microbiol, Maastricht, Netherlands; [Hoebe, Christian J. P. A.; Dukers-Muijrers, Nicole H. T. M.; Eppings, Lisanne] South Limburg Publ Hlth Serv GGD South Limburg, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	Wolffs, PFG (corresponding author), Maastricht Univ, Med Ctr MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Med Microbiol, Maastricht, Netherlands.	p.wolffs@mumc.nl	Dukers-Muijrers, Nicole/M-7178-2014	Wolffs, Petra/0000-0002-5326-3985; Janssen, Kevin J.H./0000-0001-5521-0521; Eppings, Lisanne/0000-0001-7501-8801				Black CM, 1997, CLIN MICROBIOL REV, V10, P160, DOI 10.1128/CMR.10.1.160; Dirks JAMC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145693; Dirks JAMC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121433; Dukers-Muijrers NHTM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1721-x; Dukers-Muijrers NHTM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081236; Gaydos CA, 1998, J INFECT DIS, V177, P417, DOI 10.1086/514207; Gaydos CA, 2013, J CLIN MICROBIOL, V51, P1666, DOI 10.1128/JCM.03461-12; Geelen Tanja H, 2013, Diagn Microbiol Infect Dis, V77, P101, DOI 10.1016/j.diagmicrobio.2013.06.020; Geisler WM, 2013, J INFECT DIS, V207, P1850, DOI 10.1093/infdis/jit094; Geisler WM, 2010, J INFECT DIS, V201, pS104, DOI 10.1086/652402; Henley SJ, 2014, MMWR-MORBID MORTAL W, V63, P1; Jalal H, 2006, J CLIN MICROBIOL, V44, P206, DOI 10.1128/JCM.44.1.206-213.2006; Kobayashi H, 2009, J ORTHOP RES, V27, P1243, DOI 10.1002/jor.20872; Lanjouw E, 2016, INT J STD AIDS, V27, P333, DOI 10.1177/0956462415618837; Liang NJ, 2011, J FOOD SCI, V76, pM234, DOI 10.1111/j.1750-3841.2011.02123.x; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Nocker A, 2006, APPL ENVIRON MICROB, V72, P1997, DOI 10.1128/AEM.72.3.1997-2004.2006; Nocker A, 2007, J MICROBIOL METH, V70, P252, DOI 10.1016/j.mimet.2007.04.014; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Nogva HK, 2003, BIOTECHNIQUES, V34, P804, DOI 10.2144/03344rr02; Nwokolo NC, 2016, INT J STD AIDS, V27, P251, DOI 10.1177/0956462415615443; Renault CA, 2011, SEX HEALTH, V8, P69, DOI 10.1071/SH10030; Trembizki E, 2015, PATHOLOGY, V47, P219, DOI 10.1097/PAT.0000000000000239; Van Der Pol B, 2012, J CLIN MICROBIOL, V50, P2244, DOI 10.1128/JCM.06481-11; van Dommelen L, 2010, SEX TRANSM INFECT, V86, P355, DOI 10.1136/sti.2010.042598; Varma M, 2009, WATER RES, V43, P4790, DOI 10.1016/j.watres.2009.05.031; Vodstrcil LA, 2015, J INFECT DIS, V211, P1628, DOI 10.1093/infdis/jiu670; VOGELS WHM, 1993, J CLIN MICROBIOL, V31, P1103, DOI 10.1128/JCM.31.5.1103-1107.1993; Williams JA, 2014, SEX TRANSM DIS, V41, P215, DOI 10.1097/OLQ.0000000000000102; WORKOWSKI KA, 1993, JAMA-J AM MED ASSOC, V270, P2071, DOI 10.1001/jama.270.17.2071	30	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165920	10.1371/journal.pone.0165920	http://dx.doi.org/10.1371/journal.pone.0165920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812208	Green Submitted, Green Published, gold			2022-12-26	WOS:000386910000081
J	Muscella, A; Vetrugno, C; Cossa, LG; Antonaci, G; De Nuccio, F; De Pascali, SA; Fanizzi, FP; Marsigliante, S				Muscella, Antonella; Vetrugno, Carla; Cossa, Luca Giulio; Antonaci, Giovanna; De Nuccio, Francesco; De Pascali, Sandra Angelica; Fanizzi, Francesco Paolo; Marsigliante, Santo			In Vitro and In Vivo Antitumor Activity of [Pt (O,O'-acac)(gamma-acac)(DMS)] in Malignant Pleural Mesothelioma	PLOS ONE			English	Article							CISPLATIN-INDUCED APOPTOSIS; ACTIVATED PROTEIN-KINASE; XENOGRAFT MODEL; CELL-LINES; C-DELTA; PT(O,O'-ACAC)(GAMMA-ACAC)(DMS); BCL-2; PT(O,O-ACAC)(GAMMA-ACAC)(DMS); INVOLVEMENT; CASPASE	Malignant pleural mesothelioma (MPM) is an aggressive malignancy highly resistant to chemotherapy. There is an urgent need for effective therapy inasmuch as resistance, intrinsic and acquired, to conventional therapies is common. Among Pt(II) antitumor drugs, [Pt (O,O'-acac)(gamma-acac)(DMS)] (Ptac2S) has recently attracted considerable attention due to its strong in vitro and in vivo antiproliferative activity and reduced toxicity. The purpose of this study was to examine the efficacy of Ptac2S treatment in MPM. We employed the ZL55 human mesothelioma cell line in vitro and in a murine xenograft model in vivo, to test the antitumor activity of Ptac2S. Cytotoxicity assays and Western blottings of different apoptosis and survival proteins were thus performed. Ptac2S increases MPM cell death in vitro and in vivo compared with cisplatin. Ptac2S was more efficacious than cisplatin also in inducing apoptosis characterized by: (a) mitochondria depolarization, (b) increase of bax expression and its cytosol-to-mitochondria translocation and decrease of Bcl-2 expression, (c) activation of caspase-7 and -9. Ptac2S activated full-length PKC-delta and generated a PKC-delta fragment. Full-length PKC-delta translocated to the nucleus and membrane, whilst PKC-delta fragment concentrated to mitochondria. Ptac2S was also responsible for the PKC-epsilon activation that provoked phosphorylation of p38. Both PKC-delta and PKC-epsilon inhibition (by PKC-siRNA) reduced the apoptotic death of ZL55 cells. Altogether, our results confirm that Ptac2S is a promising therapeutic agent for malignant mesothelioma, providing a solid starting point for its validation as a suitable candidate for further pharmacological testing.	[Muscella, Antonella; Vetrugno, Carla] Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, Lab Cell Pathol, Lecce, Italy; [Cossa, Luca Giulio; Antonaci, Giovanna; Marsigliante, Santo] Univ Salento, DiSTeBA, Lab Cell Physiol, Lecce, Italy; [De Nuccio, Francesco] Univ Salento, DiSTeBA, Lab Human Anat & Neurosci, Lecce, Italy; [De Pascali, Sandra Angelica; Fanizzi, Francesco Paolo] Univ Salento, DiSTeBA, Inorgan Chem Lab, Lecce, Italy	University of Salento; University of Salento; University of Salento; University of Salento	Muscella, A (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, Lab Cell Pathol, Lecce, Italy.	antonella.muscella@unisalento.it	De Nuccio, Francesco/GSD-5516-2022; Muscella, Antonella/AAE-8075-2019; Fanizzi, Francesco Paolo/K-5766-2012	Muscella, Antonella/0000-0002-2822-9929; Fanizzi, Francesco Paolo/0000-0003-3073-5772; De Nuccio, Francesco/0000-0003-2041-0149; MARSIGLIANTE, Santo/0000-0001-6535-3286	Ministero dell'Istruzione, dell'Universita e della Ricerca [FIRB CAROMICS RBAP11B2SX_008]; Consorzio Interuniversitario di Ricerca in Chimica dei Metalli nei Sistemi Biologici (CIRCMSB), Bari, Italy	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Consorzio Interuniversitario di Ricerca in Chimica dei Metalli nei Sistemi Biologici (CIRCMSB), Bari, Italy	This work was supported by the Ministero dell'Istruzione, dell'Universita e della Ricerca (FIRB CAROMICS RBAP11B2SX_008) and by the Consorzio Interuniversitario di Ricerca in Chimica dei Metalli nei Sistemi Biologici (CIRCMSB), Bari, Italy.	Allen RT, 1998, CELL MOL LIFE SCI, V54, P427, DOI 10.1007/s000180050171; Barbieri F, 2011, BIOCHEM PHARMACOL, V82, P1467, DOI 10.1016/j.bcp.2011.07.073; Basu A, 2001, CELL DEATH DIFFER, V8, P899, DOI 10.1038/sj.cdd.4400885; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Colussi PA, 1998, J BIOL CHEM, V273, P26566, DOI 10.1074/jbc.273.41.26566; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; De Pascali SA, 2005, EUR J INORG CHEM, P788, DOI 10.1002/ejic.200400665; De Pascali SA, 2009, DALTON T, P7786, DOI 10.1039/b909209a; Delgermaa V, 2011, B WORLD HEALTH ORGAN, V89, P716, DOI 10.2471/BLT.11.086678; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Fan MY, 2001, DRUG RESIST UPDATE, V4, P253, DOI 10.1054/drup.2001.0214; Favoni RE, 2011, TRENDS PHARMACOL SCI, V32, P463, DOI 10.1016/j.tips.2011.03.011; Fennell DA, 2004, LANCET ONCOL, V5, P354, DOI 10.1016/S1470-2045(04)01492-5; Galan A, 2000, J BIOL CHEM, V275, P11418, DOI 10.1074/jbc.275.15.11418; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Grimaldi M, 2016, HISTOCHEM CELL BIOL, V145, P587, DOI 10.1007/s00418-015-1396-1; Henkels KM, 1999, CANCER RES, V59, P3077; Kindler HL, 2008, CURR TREAT OPTION ON, V9, P171, DOI 10.1007/s11864-008-0071-3; Ko HW, 2000, J NEUROCHEM, V74, P2455, DOI 10.1046/j.1471-4159.2000.0742455.x; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Mujoomdar AA, 2010, J THORAC CARDIOV SUR, V140, P352, DOI 10.1016/j.jtcvs.2009.11.072; Muscella A, 2008, BRIT J PHARMACOL, V153, P34, DOI 10.1038/sj.bjp.0707576; Muscella A, 2016, BRIT J PHARMACOL, V173, P2633, DOI 10.1111/bph.13543; Muscella A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.554; Muscella A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.315; Muscella A, 2007, BIOCHEM PHARMACOL, V74, P28, DOI 10.1016/j.bcp.2007.03.027; Muscella A, 2015, BIOCHEM PHARMACOL, V98, P29, DOI 10.1016/j.bcp.2015.08.103; Muscella A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112186; Muscella A, 2011, BIOCHEM PHARMACOL, V81, P1271, DOI 10.1016/j.bcp.2011.03.007; Muscella A, 2011, BIOCHEM PHARMACOL, V81, P91, DOI 10.1016/j.bcp.2010.09.012; Muscella A, 2010, BRIT J PHARMACOL, V160, P1362, DOI 10.1111/j.1476-5381.2010.00782.x; Narasimhan SR, 1998, AM J PHYSIOL-LUNG C, V275, pL165, DOI 10.1152/ajplung.1998.275.1.L165; Nowak G, 2002, J BIOL CHEM, V277, P43377, DOI 10.1074/jbc.M206373200; Orengo AM, 1999, EUR RESPIR J, V13, P527, DOI 10.1183/09031936.99.13352799; SCHMITTER D, 1992, INT J CANCER, V51, P296, DOI 10.1002/ijc.2910510220; Soini Y, 1999, CLIN CANCER RES, V5, P3508; Urso L, 2005, BIOCHEM BIOPH RES CO, V337, P297, DOI 10.1016/j.bbrc.2005.09.046; Vetrugno C, 2014, BRIT J PHARMACOL, V171, P5139, DOI 10.1111/bph.12831; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Wust AP, 2003, INT J CANCER, V106, P1660; Zhuang SG, 2000, J BIOL CHEM, V275, P25939, DOI 10.1074/jbc.M001185200	42	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165154	10.1371/journal.pone.0165154	http://dx.doi.org/10.1371/journal.pone.0165154			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806086	Green Published, Green Submitted, gold			2022-12-26	WOS:000386715500020
J	Song, FL; Wang, Y; Jiang, DW; Wang, TC; Zhang, YQ; Ma, H; Kang, YF				Song, Fanglong; Wang, Yi; Jiang, Dawei; Wang, Tianchen; Zhang, Yinquan; Ma, Hui; Kang, Yifan			Cyclic Compressive Stress Regulates Apoptosis in Rat Osteoblasts: Involvement of PI3K/Akt and JNK MAPK Signaling Pathways	PLOS ONE			English	Article							CELL-DEATH; BONE; CANCER; INHIBITION; ACTIVATION; EXPRESSION; SURVIVAL; RECEPTOR; KINASE; LIGAND	It is widely accepted that physiological mechanical stimulation suppresses apoptosis and induces synthesis of extracellular matrix by osteoblasts; however, the effect of stress overloading on osteoblasts has not been fully illustrated. In the present study, we investigated the effect of cyclic compressive stress on rat osteoblasts apoptosis, using a novel liquid drop method to generate mechanical stress on osteoblast monolayers. After treatment with different levels of mechanical stress, apoptosis of osteoblasts and activations of mitogenactivated protein kinases (MAPKs) and PI3-kinase (PI3K)/Akt signaling pathways were investigated. Osteoblasts apoptosis was observed after treated with specific inhibitors prior to mechanical stimulation. Protein levels of Bax/Bcl-2/caspase-3 signaling were determined using western blot with or without inhibitors of PI3K/Akt and phosphorylation of c-jun N- terminal kinase (JNK) MAPK. Results showed that mechanical stimulation led to osteoblasts apoptosis in a dose-dependent manner and a remarkable activation of MAPKs and PI3K/Akt signaling pathways. Activation of PI3K/Akt protected against apoptosis, whereas JNK MAPK increased apoptosis via regulation of Bax/Bcl-2/caspase-3 activation. In summary, the PI3K/Akt and JNK MAPK signaling pathways played opposing roles in osteoblasts apoptosis, resulting in inhibition of apoptosis upon small-magnitude stress and increased apoptosis upon large-magnitude stress.	[Song, Fanglong; Wang, Yi; Jiang, Dawei; Wang, Tianchen; Zhang, Yinquan; Ma, Hui; Kang, Yifan] PLA Second Mil Med Univ, Affiliated Hosp 3, Dept Orthoped, Shanghai 200433, Peoples R China	Naval Medical University	Kang, YF (corresponding author), PLA Second Mil Med Univ, Affiliated Hosp 3, Dept Orthoped, Shanghai 200433, Peoples R China.	kangyf11@163.com	Wang, Yi/AAH-8970-2020	Wang, Yi/0000-0003-3489-5183; Kang, Yifan/0000-0002-5856-6643	National Natural Science Foundation of China [81371974]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81371974).	Ackler S, 2010, CANCER CHEMOTH PHARM, V66, P869, DOI 10.1007/s00280-009-1232-1; Aisha MD, 2015, EXP CELL RES, V337, P87, DOI 10.1016/j.yexcr.2015.07.002; Bakker AD, 2016, J CELL PHYSIOL, V231, P1283, DOI 10.1002/jcp.25228; Bucaro MA, 2004, ANN NY ACAD SCI, V1027, P64, DOI 10.1196/annals.1324.007; Cheng WP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123235; Chuang WL, 2016, MOLECULES, V21, DOI 10.3390/molecules21040460; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davis WJ, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00024; Geng B, 2016, EXP CELL RES, V343, P208, DOI 10.1016/j.yexcr.2016.03.014; Geng B, 2015, BIOCHEM BIOPH RES CO, V466, P117, DOI 10.1016/j.bbrc.2015.08.117; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Green DR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a006080; HILLSLEY MV, 1994, BIOTECHNOL BIOENG, V43, P573, DOI 10.1002/bit.260430706; Iura A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141345; Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793; Jilka RL, 2014, J BONE MINER RES, V29, P103, DOI 10.1002/jbmr.2007; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kim EK, 2015, ARCH TOXICOL, V89, P867, DOI 10.1007/s00204-015-1472-2; Koff JL, 2015, INT J MOL SCI, V16, P2942, DOI 10.3390/ijms16022942; Kong DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069403; Matsui H, 2014, J BIOL CHEM, V289, P6438, DOI 10.1074/jbc.M113.536300; Nithianandarajah-Jones GN, 2012, CELL SIGNAL, V24, P2187, DOI 10.1016/j.cellsig.2012.07.007; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; Pavalko FM, 2003, J CELL PHYSIOL, V194, P194, DOI 10.1002/jcp.10221; Plotkin LI, 2015, J BIOL CHEM, V290, P18934, DOI 10.1074/jbc.M115.642090; Roymans D, 2001, EUR J BIOCHEM, V268, P487, DOI 10.1046/j.1432-1327.2001.01936.x; Shoham N, 2012, AM J PHYSIOL-CELL PH, V302, pC429, DOI 10.1152/ajpcell.00167.2011; Song HH, 2016, CELL BIOL INT, V40, P832, DOI 10.1002/cbin.10622; Srivastava K, 2013, PHYTOMEDICINE, V20, P470, DOI 10.1016/j.phymed.2012.12.021; Tahimic CGT, 2016, J BIOL CHEM, V291, P8140, DOI 10.1074/jbc.M115.693598; Takeda K, 2011, ANTIOXID REDOX SIGN, V15, P719, DOI 10.1089/ars.2010.3392; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Vazquez M, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00208; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075973; Yanagisawa M, 2008, ARCH ORAL BIOL, V53, P214, DOI 10.1016/j.archoralbio.2007.08.012; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yu DD, 2015, INT J MOL MED, V36, P345, DOI 10.3892/ijmm.2015.2258; Yuan L, 2013, FOOD CHEM TOXICOL, V53, P62, DOI [10.1016/j.fct.2013.02.003, 10.1016/j.fct.2012.11.048]; Zhang K, 2016, APOPTOSIS, V21, P13, DOI 10.1007/s10495-015-1180-7; Zhang L, 2013, TRENDS BIOCHEM SCI, V38, P612, DOI 10.1016/j.tibs.2013.10.001; Zheng DW, 2015, ONCOL LETT, V10, P182, DOI 10.3892/ol.2015.3218; Zhong W, 2008, ORAL DIS, V14, P270, DOI 10.1111/j.1601-0825.2007.01375.x	42	24	28	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165845	10.1371/journal.pone.0165845	http://dx.doi.org/10.1371/journal.pone.0165845			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806136	Green Published, Green Submitted, gold			2022-12-26	WOS:000386715500061
J	Zhang, N; McHale, LK; Finer, JJ				Zhang, Ning; McHale, Leah K.; Finer, John J.			A Leader Intron of a Soybean Elongation Factor 1A (eEF1A) Gene Interacts with Proximal Promoter Elements to Regulate Gene Expression in Synthetic Promoters	PLOS ONE			English	Article							NONSENSE-MEDIATED DECAY; IN-VITRO; ARABIDOPSIS-THALIANA; FUNCTIONAL-ANALYSIS; TUBULIN GENE; SPLICE SITES; 1ST INTRONS; ENHANCEMENT; MAIZE; SIGNALS	Introns, especially the first intron in the 5' untranslated region (5'UTR), can significantly impact gene expression via intron-mediated enhancement (IME). In this study, we demonstrate the leader intron of a soybean elongation factor 1A (eEF1A) gene (GmScreamM8) was essential for the high activity of the native promoter. Furthermore, the interaction of the GmScreamM8 leader intron with regulatory element sequences from several soybean eEF1A promoters was studied using synthetic promoters, which consisted of element tetramers upstream of a core promoter used to regulate a green fluorescent protein (gfp) reporter gene. Element tetramers, placed upstream of a GmScreamM8 core promoter, showed very high activity using both transient expression in lima bean cotyledons and stable expression in soybean hairy roots, only if the native leader intron was included, suggesting an interaction between intronic sequences and promoter elements. Partial deletions of the leader intron showed that a 222 bp intronic sequence significantly contributed to very high levels of GFP expression. Generation of synthetic intron variants with a monomeric or trimeric repeat of the 222 bp intronic sequence, yielded almost two-fold higher expression compared to the original intron, while partial deletion of the 222 bp intronic repeated sequence significantly decreased gene expression, indicating that this intronic sequence was essential for the intron-element interaction enhancement.	[Zhang, Ning; Finer, John J.] Ohio State Univ, Dept Hort & Crop Sci, Wooster, OH 44691 USA; [McHale, Leah K.] Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Finer, JJ (corresponding author), Ohio State Univ, Dept Hort & Crop Sci, Wooster, OH 44691 USA.	finer.1@osu.edu	Finer, John/N-4713-2014	Finer, John/0000-0001-8004-5468	United Soybean Board [RC371-252/4353848]; State and Federal funds; OARDC Director's Associateship Program	United Soybean Board; State and Federal funds; OARDC Director's Associateship Program	Salaries and research support were provided by the United Soybean Board (grant #RC371-252/4353848), and by State and Federal funds appropriated to The Ohio State University/Ohio Agricultural Research and Development Center.; We thank Drs. Feng Qu and Esther van der Knaap for critically reviewing this manuscript. We also thank the OARDC Director's Associateship Program for support to NZ. Mention of trademark or proprietary products does not constitute a guarantee or warranty of the product by OSU/OARDC and also does not imply approval to the exclusion of other products that may also be suitable. Department of Horticulture and Crop Science journal article tracking No HCS-16-23.	Barrett LW, 2012, CELL MOL LIFE SCI, V69, P3613, DOI 10.1007/s00018-012-0990-9; Bianchi M, 2009, GENE, V448, P88, DOI 10.1016/j.gene.2009.08.013; CALLIS J, 1987, GENE DEV, V1, P1183, DOI 10.1101/gad.1.10.1183; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chiera JM, 2007, PLANT CELL REP, V26, P1501, DOI 10.1007/s00299-007-0359-y; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Chung Eunsook, 2009, Journal of Plant Biotechnology, V36, P255; Clancy M, 2002, PLANT PHYSIOL, V130, P918, DOI 10.1104/pp.008235; CURIE C, 1993, MOL GEN GENET, V238, P428, DOI 10.1007/BF00292002; De La Torre CM, 2015, PLANT CELL REP, V34, P111, DOI 10.1007/s00299-014-1691-7; DONATH M, 1995, PLANT MOL BIOL, V28, P667, DOI 10.1007/BF00021192; DURSO NA, 1994, PROTOPLASMA, V180, P99, DOI 10.1007/BF01507846; Fincher K.L., 2006, U.S. Patent, Patent No. [No. 7,141,722, 7141722]; Finer J. J., 2011, Plant transformation technologies, P109; Finer J.J., 2008, HDB NEW TECHNOLOGIES, P103; FINER JJ, 1992, PLANT CELL REP, V11, P323, DOI 10.1007/BF00233358; Finer JE, 2007, PLANT CELL TISS ORG, V91, P299, DOI 10.1007/s11240-007-9292-6; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; FU HY, 1995, PLANT CELL, V7, P1395, DOI 10.1105/tpc.7.9.1395; Furger A, 2002, GENE DEV, V16, P2792, DOI 10.1101/gad.983602; Gallegos JE, 2015, PLANT SCI, V237, P8, DOI 10.1016/j.plantsci.2015.04.017; GOODALL GJ, 1990, PLANT MOL BIOL, V14, P727, DOI 10.1007/BF00016505; Hernandez-Garcia CM, 2016, PLANT CELL REP, V35, P303, DOI 10.1007/s00299-015-1885-7; Hernandez-Garcia Carlos M, 2010, J Vis Exp, DOI 10.3791/1733; Hernandez-Garcia CM, 2014, PLANT SCI, V217, P109, DOI 10.1016/j.plantsci.2013.12.007; Hernandez-Garcia CM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-237; Jeon JS, 2000, PLANT PHYSIOL, V123, P1005, DOI 10.1104/pp.123.3.1005; Jeong YM, 2006, PLANT PHYSIOL, V140, P196, DOI 10.1104/pp.105.071316; Kertesz S, 2006, NUCLEIC ACIDS RES, V34, P6147, DOI 10.1093/nar/gkl737; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li ZY, 1999, ACTA BOT SIN, V41, P800; LIU K, 1995, P NATL ACAD SCI USA, V92, P7724, DOI 10.1073/pnas.92.17.7724; LUEHRSEN KR, 1994, PLANT MOL BIOL, V24, P449, DOI 10.1007/BF00024113; MASCARENHAS D, 1990, PLANT MOL BIOL, V15, P913, DOI 10.1007/BF00039430; Mattick JS, 2001, MOL BIOL EVOL, V18, P1611, DOI 10.1093/oxfordjournals.molbev.a003951; MORELLI JK, 1994, PLANT PHYSIOL, V106, P897, DOI 10.1104/pp.106.3.897; Morello L, 2008, CURR GENOMICS, V9, P227, DOI 10.2174/138920208784533629; Morello L, 2006, PLANTA, V223, P479, DOI 10.1007/s00425-005-0105-z; Morello L, 2002, PLANT J, V29, P33, DOI 10.1046/j.0960-7412.2001.01192.x; Ott CJ, 2009, J CELL MOL MED, V13, P680, DOI 10.1111/j.1582-4934.2008.00621.x; Park SG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-526; Parra G, 2011, NUCLEIC ACIDS RES, V39, P5328, DOI 10.1093/nar/gkr043; Qi XT, 2007, BIOCHEM BIOPH RES CO, V356, P273, DOI 10.1016/j.bbrc.2007.02.124; Rasband W., 2006, IMAGEJ; Remans T, 2005, BIOTECHNIQUES, V38, P209, DOI 10.2144/05382ST01; RIIS B, 1990, TRENDS BIOCHEM SCI, V15, P420, DOI 10.1016/0968-0004(90)90279-K; Rose AB, 2008, CURR TOP MICROBIOL, V326, P277; Rose AB, 2004, PLANT J, V40, P744, DOI 10.1111/j.1365-313X.2004.02247.x; Rose AB, 2000, PLANT PHYSIOL, V122, P535, DOI 10.1104/pp.122.2.535; Rose AB, 2008, PLANT CELL, V20, P543, DOI 10.1105/tpc.107.057190; Rushton PJ, 2002, PLANT CELL, V14, P749, DOI 10.1105/tpc.010412; Salgueiro S, 2000, PLANT MOL BIOL, V42, P615, DOI 10.1023/A:1006331831858; SAMBROOK J, 1977, NATURE, V268, P101, DOI 10.1038/268101a0; Sasikumar AN, 2012, WIRES RNA, V3, P543, DOI 10.1002/wrna.1118; Shin D, 2009, PLANT SCI, V177, P156, DOI 10.1016/j.plantsci.2009.05.003; SINIBALDI RM, 1992, PROG NUCLEIC ACID RE, V42, P229, DOI 10.1016/S0079-6603(08)60577-2; Stewart CN, 2001, PLANT CELL REP, V20, P376, DOI 10.1007/s002990100346; Szczesniak MW, 2013, PLANT CELL PHYSIOL, V54, pE10, DOI 10.1093/pcp/pct001; URSIN VM, 1991, PLANT CELL, V3, P583, DOI 10.1105/tpc.3.6.583; Vain P, 1996, PLANT CELL REP, V15, P489, DOI 10.1007/BF00232980; Wu CL, 2008, IN VITRO CELL DEV-PL, V44, P540, DOI 10.1007/s11627-008-9126-1; Xu YF, 1999, BIOTECHNIQUES, V26, P639, DOI 10.2144/99264bm10; Zhang N, 2015, PLANT SCI, V241, P189, DOI 10.1016/j.plantsci.2015.10.010	64	6	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0166074	10.1371/journal.pone.0166074	http://dx.doi.org/10.1371/journal.pone.0166074			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806110	Green Published, gold, Green Submitted			2022-12-26	WOS:000386715500081
J	de Jeude, JFV; Meijer, BJ; Wielenga, MCB; Spaan, CN; Baan, B; Rosekrans, SL; Meisner, S; Shen, YH; Lee, AS; Paton, JC; Paton, AW; Muncan, V; van den Brink, GR; Heijmans, J				de Jeude, J. F. van Lidth; Meijer, B. J.; Wielenga, M. C. B.; Spaan, C. N.; Baan, B.; Rosekrans, S. L.; Meisner, S.; Shen, Y. H.; Lee, A. S.; Paton, J. C.; Paton, A. W.; Muncan, V.; van den Brink, G. R.; Heijmans, J.			Induction of endoplasmic reticulum stress by deletion of Grp78 depletes Apc mutant intestinal epithelial stem cells	ONCOGENE			English	Article							RAPID LOSS; IN-VIVO; EXPRESSION; DIFFERENTIATION; TUMORIGENESIS; CANCER; COLON; GENE; APOPTOSIS; ADENOMA	Intestinal epithelial stem cells are highly sensitive to differentiation induced by endoplasmic reticulum (ER) stress. Colorectal cancer develops from mutated intestinal epithelial stem cells. The most frequent initiating mutation occurs in Apc, which results in hyperactivated Wnt signalling. This causes hyperproliferation and reduced sensitivity to chemotherapy, but whether these mutated stem cells are sensitive to ER stress induced differentiation remains unknown. Here we examined this by generating mice in which both Apc and ER stress repressor chaperone Grp78 can be conditionally deleted from the intestinal epithelium. For molecular studies, we used intestinal organoids derived from these mice. Homozygous loss of Apc alone resulted in crypt elongation, activation of the Wnt signature and accumulation of intestinal epithelial stem cells, as expected. This phenotype was however completely rescued on activation of ER stress by additional deletion of Grp78. In these Apc-Grp78 double mutant animals, stem cells were rapidly lost and repopulation occurred by non-mutant cells that had escaped recombination, suggesting that Apc-Grp78 double mutant stem cells had lost self-renewal capacity. Although in Apc-Grp78 double mutant mice the Wnt signature was lost, these intestines exhibited ubiquitous epithelial presence of nuclear beta-catenin. This suggests that ER stress interferes with Wnt signalling downstream of nuclear beta-catenin. In conclusion, our findings indicate that ER stress signalling results in loss of Apc mutated intestinal epithelial stem cells by interference with the Wnt signature. In contrast to many known inhibitors of Wnt signalling, ER stress acts downstream of beta-catenin. Therefore, ER stress poses a promising target in colorectal cancers, which develop as a result of Wnt activating mutations.	[de Jeude, J. F. van Lidth; Meijer, B. J.; Wielenga, M. C. B.; Spaan, C. N.; Baan, B.; Rosekrans, S. L.; Meisner, S.; Shen, Y. H.; Muncan, V.; van den Brink, G. R.; Heijmans, J.] Acad Med Ctr, Tygat Inst Liver & Intestinal Res, Amsterdam, Netherlands; [de Jeude, J. F. van Lidth; Meijer, B. J.; Wielenga, M. C. B.; Spaan, C. N.; Baan, B.; Rosekrans, S. L.; Meisner, S.; Shen, Y. H.; Lee, A. S.; Muncan, V.; van den Brink, G. R.; Heijmans, J.] Acad Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [Lee, A. S.] Univ Southern Calif, USC Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Keck Sch Med, Los Angeles, CA USA; [Paton, J. C.; Paton, A. W.] Univ Adelaide, Res Ctr Infect Dis, Dept Mol & Cellular Biol, Sch Biol Sci, Adelaide, SA, Australia; [Heijmans, J.] Acad Med Ctr, Dept Internal Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Southern California; University of Adelaide	Heijmans, J (corresponding author), Acad Med Ctr, Dept Internal Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.heijmans@amc.nl	Meijer, Bartolomeus/AAU-5300-2021	Heijmans, Jarom/0000-0001-9615-7851; Lee, Amy/0000-0002-0378-5443	VENI grant from the Dutch Organisation for Scientific Research (NWO); Dutch Cancer Foundation (KWF)	VENI grant from the Dutch Organisation for Scientific Research (NWO); Dutch Cancer Foundation (KWF)(KWF Kankerbestrijding)	This work was supported by a VENI grant from the Dutch Organisation for Scientific Research (NWO) and by a research stipendium from the Dutch Cancer Foundation (KWF).	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; Heijmans J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022620; Heijmans J, 2013, CELL REP, V3, P1128, DOI 10.1016/j.celrep.2013.02.031; Holik AZ, 2013, STEM CELLS, V31, P2457, DOI 10.1002/stem.1498; Huels DJ, 2015, BRIT J CANCER, V113, P1, DOI 10.1038/bjc.2015.214; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Niederreiter L, 2013, J EXP MED, V210, P2041, DOI 10.1084/jem.20122341; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Rizvi AZ, 2006, P NATL ACAD SCI USA, V103, P6321, DOI 10.1073/pnas.0508593103; ROBINE S, 1993, J BIOL CHEM, V268, P11426; Rosekrans SL, 2015, GUT, V64, P195, DOI 10.1136/gutjnl-2013-306347; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Dop WA, 2010, GASTROENTEROLOGY, V139, P1665, DOI 10.1053/j.gastro.2010.07.045; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; van Galen P, 2014, NATURE, V510, P268, DOI 10.1038/nature13228; Vermeulen L, 2014, NAT REV CANCER, V14, P468, DOI 10.1038/nrc3744; Verras M, 2008, MOL CELL BIOL, V28, P7212, DOI 10.1128/MCB.00947-08; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wielenga MCB, 2015, CELL REP, V13, P489, DOI 10.1016/j.celrep.2015.09.016; Wolfson JJ, 2008, CELL MICROBIOL, V10, P1775, DOI 10.1111/j.1462-5822.2008.01164.x; Yang WC, 2005, AM J PATHOL, V166, P1239, DOI 10.1016/S0002-9440(10)62342-5	44	19	19	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 15	2017	36	24					3397	3405		10.1038/onc.2016.326	http://dx.doi.org/10.1038/onc.2016.326			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EX6GL	27819675	Green Accepted, hybrid			2022-12-26	WOS:000403340700004
J	Liu, Q; Tang, Y; Chen, L; Liu, N; Lang, FF; Liu, H; Wang, P; Sun, XL				Liu, Qiang; Tang, Yu; Chen, Long; Liu, Na; Lang, Fangfang; Liu, Heng; Wang, Pin; Sun, Xiulian			E3 Ligase SCF beta TrCP-induced DYRK1A Protein Degradation Is Essential for Cell Cycle Progression in HEK293 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME PROTEOLYTIC PATHWAY; DOWN-SYNDROME; UBIQUITIN LIGASE; KINASE DYRK1A; NEURONAL DIFFERENTIATION; INHIBITS PROLIFERATION; DEPENDENT DEGRADATION; COGNITIVE DEFICITS; ALZHEIMER-DISEASE; FUNCTIONAL-LINK	DYRK1A, located on the Down syndrome (DS) critical region of chromosome 21, was found to be overexpressed in brains of DS and Alzheimer's disease individuals. DYRK1A was considered to play important roles in the pathogenesis of DS and Alzheimer's disease; however, the degradation mechanism of DYRK1A was still unclear. In this study, we found that DYRK1A was degraded through the ubiquitin-proteasome pathway in HEK293 cells. The N terminus of DYRK1A that was highly unstable in HEK293 cells contributed to proteolysis of DYRK1A. E3 ligase SCF beta TrCP mediated ubiquitination and promoted degradation of DYRK1A through an unconserved binding motif ((49)SDQQVSALS(57)) lying in the N terminus. Any Ser-Ala substitution in this motif could decrease the binding between DYRK1A and beta-transducin repeat containing protein (beta TrCP), resulting in stabilization of DYRK1A. We also found DYRK1Aprotein was elevated in theG0/G1 phase and decreased in the S and G(2)/M phase, which was negatively correlated to beta TrCP levels in the HEK293 cell cycle. Knockdown of beta TrCP caused arrest of the G(0)/G(1) phase, which could be partly rescued by down-regulation of DYRK1A. Our study uncovered a new regulatory mechanism of DYRK1A degradation by SCF beta TrCP in HEK293 cell cycle progression.	[Liu, Qiang; Sun, Xiulian] Shandong Univ, Qilu Hosp, Brain Res Inst, 107 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Tang, Yu] Shandong Univ, Qilu Hosp, Dept Neurol, Jinan 250012, Peoples R China; [Chen, Long; Liu, Heng; Wang, Pin; Sun, Xiulian] Shandong Univ, Qilu Hosp, Natl Key Lab Otolaryngol, Jinan 250012, Peoples R China; [Liu, Na] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250012, Peoples R China; [Liu, Qiang] Shandong Univ, Shandong Prov Qianfoshan Hosp, Med Res Ctr, 10766 Jingshi Rd, Jinan 250014, Peoples R China; [Lang, Fangfang] Shandong Univ, Jinan Cent Hosp, Dept Gynecol & Obstet, 105 Jiefang Rd, Jinan 250013, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Sun, XL (corresponding author), Shandong Univ, Qilu Hosp, Brain Res Inst, 107 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	xiulians@gmail.com			National Natural Science Foundation of China [81171030]; Fundamental Research Funds of Shandong University [2015JC035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds of Shandong University	This work was supported by National Natural Science Foundation of China Grant 81171030 (to X. S.) and Fundamental Research Funds of Shandong University Grant 2015JC035 (to X. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Chakrabarti L, 2007, J NEUROSCI, V27, P11483, DOI 10.1523/JNEUROSCI.3406-07.2007; Chen JY, 2013, MOL CELL, V52, P87, DOI 10.1016/j.molcel.2013.09.009; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Contestabile A, 2007, HIPPOCAMPUS, V17, P665, DOI 10.1002/hipo.20308; Dierssen M, 2006, THESCIENTIFICWORLDJO, V6, P1911, DOI 10.1100/tsw.2006.319; Dowjat WK, 2007, NEUROSCI LETT, V413, P77, DOI 10.1016/j.neulet.2006.11.026; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Ferrer I, 2005, NEUROBIOL DIS, V20, P392, DOI 10.1016/j.nbd.2005.03.020; Ferron SR, 2010, CELL STEM CELL, V7, P367, DOI 10.1016/j.stem.2010.06.021; Fong A, 2002, J BIOL CHEM, V277, P22111, DOI 10.1074/jbc.C200151200; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gao DM, 2011, MOL CELL, V44, P290, DOI 10.1016/j.molcel.2011.08.030; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gockler N, 2009, FEBS J, V276, P6324, DOI 10.1111/j.1742-4658.2009.07346.x; Guidi S, 2008, BRAIN PATHOL, V18, P180, DOI 10.1111/j.1750-3639.2007.00113.x; Hammerle B, 2011, DEVELOPMENT, V138, P2543, DOI 10.1242/dev.066167; Hattori K, 1999, J BIOL CHEM, V274, P29641, DOI 10.1074/jbc.274.42.29641; Ishihara K, 2010, CEREB CORTEX, V20, P1131, DOI 10.1093/cercor/bhp176; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Larsen KB, 2008, ANN ANAT, V190, P421, DOI 10.1016/j.aanat.2008.05.007; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Limon-Mortes MC, 2008, J CELL SCI, V121, P1825, DOI 10.1242/jcs.020552; Litovchick L, 2011, GENE DEV, V25, P801, DOI 10.1101/gad.2034211; Liu F, 2008, FASEB J, V22, P3224, DOI 10.1096/fj.07-104539; Liu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098853; Lott IT, 2010, LANCET NEUROL, V9, P623, DOI 10.1016/S1474-4422(10)70112-5; Low TY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005882; Lu M, 2011, J BIOL CHEM, V286, P10755, DOI 10.1074/jbc.M110.174540; Park J, 2010, J BIOL CHEM, V285, P31895, DOI 10.1074/jbc.M110.147520; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Ryoo SR, 2008, J NEUROCHEM, V104, P1333, DOI 10.1111/j.1471-4159.2007.05075.x; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Seki A, 2008, J CELL BIOL, V181, P65, DOI 10.1083/jcb.200712027; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Song YC, 2004, BIOCHEM BIOPH RES CO, V317, P128, DOI 10.1016/j.bbrc.2004.03.019; Soppa U, 2014, CELL CYCLE, V13, P2084, DOI 10.4161/cc.29104; Tanzi RE, 1996, NAT MED, V2, P31, DOI 10.1038/nm0196-31; Tudzarova S, 2011, P NATL ACAD SCI USA, V108, P5278, DOI 10.1073/pnas.1102247108; Uchida S, 2011, J CELL SCI, V124, P2816, DOI 10.1242/jcs.083931; van Kerkhof P, 2007, J BIOL CHEM, V282, P20475, DOI 10.1074/jbc.M702610200; Vicari S, 2006, BEHAV GENET, V36, P355, DOI 10.1007/s10519-006-9057-8; Vingtdeux V, 2005, NEUROBIOL DIS, V20, P625, DOI 10.1016/j.nbd.2005.05.004; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Wei S, 2008, J BIOL CHEM, V283, P26759, DOI 10.1074/jbc.M802160200; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; WISNIEWSKI KE, 1990, AM J MED GENET, P274; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Yabut O, 2010, J NEUROSCI, V30, P4004, DOI 10.1523/JNEUROSCI.4711-09.2010	53	11	12	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26399	26409		10.1074/jbc.M116.717553	http://dx.doi.org/10.1074/jbc.M116.717553			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27807027	Green Published, hybrid			2022-12-26	WOS:000391568200014
J	Canelon, SP; Wallace, JM				Canelon, Silvia P.; Wallace, Joseph M.			beta-Aminopropionitrile-Induced Reduction in Enzymatic Crosslinking Causes In Vitro Changes in Collagen Morphology and Molecular Composition	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURES; BRTL MOUSE MODEL; NANOSCALE MORPHOLOGY; BONE; EXPRESSION; MECHANICS; MUTATION; FIBRILS; ALTERS	Type I collagen morphology can be characterized using fibril D-spacing, a metric which describes the periodicity of repeating bands of gap and overlap regions of collagen molecules arranged into collagen fibrils. This fibrillar structure is stabilized by enzymatic crosslinks initiated by lysyl oxidase (LOX), a step which can be disrupted using P-aminopropionitrile (BAPN). Murine in vivo studies have confirmed effects of BAPN on collagen nano structure and the objective of this study was to evaluate the mechanism of these effects in vitro by measuring D-spacing, evaluating the ratio of mature to immature crosslinks, and quantifying gene expression of type I collagen and LOX. Osteoblasts were cultured in complete media, and differentiated using ascorbic acid, in the presence or absence of 0.25mM BAPN-fumarate. The matrix produced was imaged using atomic force microscopy (AFM) and 2D Fast Fourier transforms were performed to extract D-spacing from individual fibrils. The experiment was repeated for quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Fourier Transform infrared spectroscopy (FTIR) analyses. The D-spacing distribution of collagen produced in the presence of BAPN was shifted toward higher D spacing values, indicating BAPN affects the morphology of collagen produced in vitro, supporting aforementioned in vivo experiments. In contrast, no difference in gene expression was found for any target gene, suggesting LOX inhibition does not upregulate the LOX gene to compensate for the reduction in aldehyde formation, or regulate expression of genes encoding type I collagen. Finally, the mature to immature crosslink ratio decreased with BAPN treatment and was linked to a reduction in peak percent area of mature crosslink hydroxylysylpyridinoline (HP). In conclusion, in vitro treatment of osteoblasts with low levels of BAPN did not induce changes in genes encoding LOX or type I collagen, but led to an increase in collagen D-spacing as well as a decrease in mature crosslinks.	[Canelon, Silvia P.; Wallace, Joseph M.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Wallace, Joseph M.] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Wallace, Joseph M.] Indiana Univ Sch Med, Dept Orthopaed Surg, Indianapolis, IN 46202 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington	Wallace, JM (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.; Wallace, JM (corresponding author), Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA.; Wallace, JM (corresponding author), Indiana Univ Sch Med, Dept Orthopaed Surg, Indianapolis, IN 46202 USA.	jmwalla@iupui.edu	Wallace, Joseph Michael/G-7906-2012	Wallace, Joseph Michael/0000-0001-6077-8058	NIH [1K25AR067221-01A1]; IUPUI departmental start-up funds; IUPUI Office of the Vice Chancellor for Research; IUPUI Biomechanics and Biomaterials Research Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K25AR067221] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IUPUI departmental start-up funds; IUPUI Office of the Vice Chancellor for Research; IUPUI Biomechanics and Biomaterials Research Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by funding from the NIH (1K25AR067221-01A1), IUPUI departmental start-up funds, Research Support Funds Grant from the IUPUI Office of the Vice Chancellor for Research and funding from the IUPUI Biomechanics and Biomaterials Research Center.	Avery Nicholas C., 2009, V522, P103, DOI 10.1007/978-1-59745-413-1_6; Becker S, 2008, BALLOON KYPHOPLASTY, V16, P1, DOI DOI 10.1007/978-3-211-74221-1_1; Boskey AL, 1999, J BONE MINER RES, V14, P330, DOI 10.1359/jbmr.1999.14.3.330; Burr D.B., 2013, BASIC APPL BONE BIOL; Burr DB, 2002, BONE, V31, P8, DOI 10.1016/S8756-3282(02)00815-3; BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433; Byler DM, EXAMINATION SECONDAR, DOI [10.1002/bip.360250307, DOI 10.1002/BIP.360250307]; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178, DOI 10.1093/oxfordjournals.epirev.a036281; DASLER W, 1954, SCIENCE, V120, P307, DOI 10.1126/science.120.3112.307; DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022; Erickson B, 2013, BIOTECHNOL J, V8, P117, DOI 10.1002/biot.201200174; Eyre DR, 2005, TOP CURR CHEM, V247, P207, DOI 10.1007/b103828; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Farlay D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028736; Fernandes H, 2008, BONE, V42, pS21, DOI 10.1016/j.bone.2007.12.020; Fernandes H, 2009, TISSUE ENG PT A, V15, P3857, DOI 10.1089/ten.tea.2009.0011; GERSTENFELD LC, 1988, J CELL BIOL, V106, P979, DOI 10.1083/jcb.106.3.979; Gonzalez AD, 2014, J BIOMECH, V47, P681, DOI 10.1016/j.jbiomech.2013.11.045; Hammond MA, 2016, BONE, V88, P85, DOI 10.1016/j.bone.2016.04.021; Hammond MA, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.12; Hodge A, 1963, ASPECTS PROTEIN STRU, P289; HULMES DJS, 1973, J MOL BIOL, V79, P137, DOI 10.1016/0022-2836(73)90275-1; Jepsen KJ, 1997, J BIOMECH, V30, P1141, DOI 10.1016/S0021-9290(97)00088-2; Kadler KE, 1996, BIOCHEM J, V316, P1; Kemp AD, 2012, J STRUCT BIOL, V180, P428, DOI 10.1016/j.jsb.2012.09.012; Lazarev YA, INFRARED SPECTRA STR; LEES S, 1994, J BONE MINER RES, V9, P1377; McNerny EMB, 2015, J BONE MINER RES, V30, P446, DOI 10.1002/jbmr.2356; Nagan Narasimhan, 1998, Frontiers in Bioscience, V3, pA23; NIMNI ME, 1977, P ROY SOC MED, V70, P65, DOI 10.1177/00359157770700S322; Ottani V, 2002, MICRON, V33, P587, DOI 10.1016/S0968-4328(02)00033-1; Paschalis EP, 2015, CALCIFIED TISSUE INT, V96, P18, DOI 10.1007/s00223-014-9933-9; Paschalis EP, 2011, BONE, V49, P1232, DOI 10.1016/j.bone.2011.08.027; Paschalis EP, 2001, J BONE MINER RES, V16, P1821, DOI 10.1359/jbmr.2001.16.10.1821; Paschalis EP, 2004, J BONE MINER RES, V19, P2000, DOI 10.1359/JBMR.040820; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; SIEGEL RC, 1977, J BIOL CHEM, V252, P254; Thaler R, 2010, BONE, V46, P703, DOI 10.1016/j.bone.2009.10.038; TRACKMAN PC, 1979, J BIOL CHEM, V254, P7831; Turecek C, 2008, CALCIFIED TISSUE INT, V82, P392, DOI 10.1007/s00223-008-9136-3; Varga F, 2010, BIOCHEM BIOPH RES CO, V402, P180, DOI 10.1016/j.bbrc.2010.08.022; Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9; Wallace JM, 2015, CONNECT TISSUE RES, V56, P68, DOI 10.3109/03008207.2015.1005209; Wallace JM, 2011, J STRUCT BIOL, V173, P146, DOI 10.1016/j.jsb.2010.08.003; Wallace JM, 2010, LANGMUIR, V26, P7349, DOI 10.1021/la100006a; Wallace JM, 2010, BONE, V46, P1349, DOI 10.1016/j.bone.2009.11.020; Wallace JM, 2009, J BONE MINER RES, V24, P1002, DOI [10.1359/jbmr.081259, 10.1359/JBMR.081259]; WHO, 1994, WHO TECH REP SER, V843, DOI [10.1007/BF01622200, DOI 10.1007/BF01622200]; Yang HY, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2015.024	53	13	13	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166392	10.1371/journal.pone.0166392	http://dx.doi.org/10.1371/journal.pone.0166392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829073	gold, Green Published, Green Submitted			2022-12-26	WOS:000387724300107
J	Budak, F; Bal, SH; Tezcan, G; Guvenc, F; Akalin, EH; Goral, G; Deniz, G; Oral, HB				Budak, Ferah; Bal, S. Haldun; Tezcan, Gulcin; Guvenc, Furkan; Akalin, E. Halis; Goral, Guher; Deniz, Gunnur; Oral, H. Barbaros			MicroRNA Expression Patterns of CD8+T Cells in Acute and Chronic Brucellosis	PLOS ONE			English	Article							T-LYMPHOCYTES; UP-REGULATION; DIFFERENTIAL EXPRESSION; PROSTATE-CANCER; DOWN-REGULATION; POOR-PROGNOSIS; SERUM MIRNAS; HEPATITIS-B; PROLIFERATION; MELITENSIS	Although our knowledge about Brucella virulence factors and the host response increase rapidly, the mechanisms of immune evasion by the pathogen and causes of chronic disease are still unknown. Here, we aimed to investigate the immunological factors which belong to CD8+ T cells and their roles in the transition of brucellosis from acute to chronic infection. Using miRNA microarray, more than 2000 miRNAs were screened in CD8+ T cells of patients with acute or chronic brucellosis and healthy controls that were sorted from peripheral blood with flow cytometry and validated through qRT-PCR. Findings were evaluated using GeneSpring GX (Agilent) 13.0 software and KEGG pathway analysis. Expression of two miRNAs were determined to display a significant fold change in chronic group when compared with acute or control groups. Both miRNAs (miR-126-5p and miR-47533p) were decreased (p <0.05 or fold change > 2). These miRNAs have the potential to be the regulators of CD8+ T cell-related marker genes for chronic brucellosis infections. The differentially expressed miRNAs and their predicted target genes are involved in MAPK signaling pathway, cytokine-cytokine receptor interactions, endocytosis, regulation of actin cytoskeleton, and focal adhesion indicating their potential roles in chronic brucellosis and its progression. It is the first study of miRNA expression analysis of human CD8+ T cells to clarify the mechanism of inveteracy in brucellosis.	[Budak, Ferah; Bal, S. Haldun; Oral, H. Barbaros] Uludag Univ, Dept Immunol, Fac Med, Bursa, Turkey; [Tezcan, Gulcin] Uludag Univ, Fac Med, Dept Med Biol, Bursa, Turkey; [Guvenc, Furkan] Univ Toronto, Fac Med, Dept Mol Genet, Toronto, ON, Canada; [Akalin, E. Halis] Uludag Univ, Fac Med, Dept Clin Microbiol & Infect Dis, Bursa, Turkey; [Goral, Guher] Uludag Univ, Dept Med Microbiol, Fac Med, Bursa, Turkey; [Deniz, Gunnur] Istanbul Univ, Aziz Sancar Inst Expt Med, Dept Immunol, Istanbul, Turkey	Uludag University; Uludag University; University of Toronto; Uludag University; Uludag University; Istanbul University	Oral, HB (corresponding author), Uludag Univ, Dept Immunol, Fac Med, Bursa, Turkey.	oralb@uludag.edu.tr	Tezcan, Gulcin/F-8554-2017; Deniz, Gunnur/AAC-2909-2020; Budak, Ferah/F-4657-2014; Tezcan, Gulcin/AAH-3843-2020; Akalin, Halis/AAU-8952-2020; ORAL, HALUK BARBAROS Haluk/K-7285-2012	ORAL, HALUK BARBAROS Haluk/0000-0003-0463-6818; Guvenc, Furkan/0000-0002-6978-8217; Tezcan, Gulcin/0000-0002-5956-8755	Uludag University, Bursa, Turkey [UAP(T)-2011/15]	Uludag University, Bursa, Turkey(Uludag University)	This work was supported by the grant from Uludag University, Bursa, Turkey (grant number UAP(T)-2011/15).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ander BP, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0029-9; Araj GF, 2010, INT J ANTIMICROB AG, V36, pS12, DOI 10.1016/j.ijantimicag.2010.06.014; ARIZA J, 1992, CLIN INFECT DIS, V14, P131, DOI 10.1093/clinids/14.1.131; Asahchop EL, 2016, AIDS, V30, P2021, DOI 10.1097/QAD.0000000000001160; Atluri VL, 2011, ANNU REV MICROBIOL, V65, P523, DOI 10.1146/annurev-micro-090110-102905; Aygen B, 2002, MED MALADIES INFECT, V32, P485, DOI 10.1016/S0399-077X(02)00403-1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Budak F, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/4591468; Cassataro J, 2005, INFECT IMMUN, V73, P6537, DOI 10.1128/IAI.73.10.6537-6546.2005; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cheng JW, 2016, ONCOTARGET, V7, P30702, DOI [10.18632/oncotarget.8930, 10.16632/oncotarget.8930]; Choi Y, 2001, EUR J IMMUNOL, V31, P2179, DOI 10.1002/1521-4141(200107)31:7<2179::AID-IMMU2179>3.0.CO;2-X; Chowdhari S, 2014, J CELL PHYSIOL, V229, P1630, DOI 10.1002/jcp.24608; Das K, 2013, TUBERCULOSIS, V93, pS47, DOI 10.1016/S1472-9792(13)70010-6; de Figueiredo P, 2015, AM J PATHOL, V185, P1505, DOI 10.1016/j.ajpath.2015.03.003; Doganay Mehmet, 2003, International Journal of Infectious Diseases, V7, P173, DOI 10.1016/S1201-9712(03)90049-X; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Durward M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034925; Durward MA, 2010, INFECT IMMUN, V78, P168, DOI 10.1128/IAI.00994-09; Durward-Diloia M, 2015, INFECT IMMUN, V83, P4759, DOI 10.1128/IAI.01184-15; Ferooz Jonathan, 2010, BMC Res Notes, V3, P333, DOI 10.1186/1756-0500-3-333; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; Fricke A, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0424-z; GALDIERO M, 1995, RES MICROBIOL, V146, P507, DOI 10.1016/0923-2508(96)80296-8; Galinska EM, 2013, ANN AGR ENV MED, V20, P233; Geyik MF, 2002, SWISS MED WKLY, V132, P98, DOI 10.57187/smw.2002.09900; Hamam R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25997; He YQ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00002; Hu R, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176099; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Jin BX, 2015, SCI REP-UK, V5, DOI 10.1038/srep15026; Jinushi T, 2014, CANCER MED-US, V3, P1544, DOI 10.1002/cam4.309; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim JH, 2013, THER ADV MUSCULOSKEL, V5, P13, DOI 10.1177/1759720X12466608; Kojima M, 2015, PLOS ONE, V10; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lee KH, 2014, BBA-MOL CELL RES, V1843, P2055, DOI 10.1016/j.bbamcr.2014.06.001; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li J, 2015, BIO-MED MATER ENG, V26, pS1985, DOI 10.3233/BME-151502; Li L, 2016, CANCER LETT, V373, P234, DOI 10.1016/j.canlet.2016.01.028; MEYERSON M, 1994, MOL CELL BIOL, V14, P2077, DOI 10.1128/MCB.14.3.2077; Moreno-Lafont MC, 2002, T ROY SOC TROP MED H, V96, P340, DOI 10.1016/S0035-9203(02)90119-7; MORENOLAFONT MC, 1995, CLIN DIAGN LAB IMMUN, V2, P377, DOI 10.1128/CDLI.2.3.377-380.1995; Murphy EA, 2001, FEMS IMMUNOL MED MIC, V32, P85, DOI 10.1111/j.1574-695X.2001.tb00536.x; Mutlu S, 2015, EUR REV MED PHARMACO, V19, P2384; Norman FF, 2016, TRAVEL MED INFECT DI, V14, P182, DOI 10.1016/j.tmaid.2016.05.005; OLIVEIRA SC, 1995, EUR J IMMUNOL, V25, P2551, DOI 10.1002/eji.1830250922; Pu Q, 2016, THORAC CANCER, V7, P348, DOI 10.1111/1759-7714.12317; Sallustio F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068296; Scian R, 2012, INFECT IMMUN, V80, P2333, DOI 10.1128/IAI.00208-12; Shan L, 2007, CELL HOST MICROBE, V1, P167, DOI 10.1016/j.chom.2007.04.008; Shen YH, 2015, TUMOR BIOL, V36, P4525, DOI 10.1007/s13277-015-3097-8; Shibayama Y, 2015, ONCOL REP, V33, P2176, DOI 10.3892/or.2015.3839; Shrivastava S, 2013, HEPATOLOGY, V58, P863, DOI 10.1002/hep.26296; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Skendros P, 2013, REV SCI TECH OIE, V32, P137; Skendros P, 2007, J INFECTION, V54, P192, DOI 10.1016/j.jinf.2006.04.001; Solera J, 2010, INT J ANTIMICROB AG, V36, pS18, DOI 10.1016/j.ijantimicag.2010.06.015; Song CJ, 2015, PROSTATE, V75, P500, DOI 10.1002/pros.22936; Takahashi K, 2014, DRUG METAB PHARMACOK, V29, P333, DOI 10.2133/dmpk.DMPK-13-RG-114; Tan YW, 2015, CLIN CHIM ACTA, V451, P232, DOI 10.1016/j.cca.2015.10.002; Thirion M, 2013, VIRUSES-BASEL, V5, P2690, DOI 10.3390/v5112690; Ulu-Kilic Aysegul, 2013, Recent Pat Antiinfect Drug Discov, V8, P34; Veiga-Fernandes H, 2004, NAT IMMUNOL, V5, P31, DOI 10.1038/ni1015; Vosa U, 2013, INT J CANCER, V132, P2884, DOI 10.1002/ijc.27981; Wahlquist C, 2014, NATURE, V508, P531, DOI 10.1038/nature13073; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang ZH, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0577-9; Warnecke-Eberz U, 2015, TUMOR BIOL, V36, P4643, DOI 10.1007/s13277-015-3112-0; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu ZP, 2014, BIOCHEM BIOPH RES CO, V443, P944, DOI 10.1016/j.bbrc.2013.12.075; Xavier MN, 2009, J COMP PATHOL, V140, P149, DOI 10.1016/j.jcpa.2008.10.004; Xia ZY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/624037; Xu C, 2016, ONCOL REP, V35, P497, DOI 10.3892/or.2015.4392; Xun M, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0288-2; Yabushita S, 2012, PANCREAS, V41, P1013, DOI 10.1097/MPA.0b013e31824ac3a5; Yamaguchi T, 1996, J BIOCHEM-TOKYO, V120, P494; Young EJ., 2005, PRINCIPLES PRACTICE, V6; Yu CR, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/359674; Yu T, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-64; Yuan ZL, 2004, MOL CELL BIOL, V24, P9390, DOI 10.1128/MCB.24.21.9390-9400.2004; Yuce A, 2006, KLIMIK J, V19, P87; Zhang YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17942; Zheng GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083025; Zheng HY, 2016, ONCOTARGET, V7, P4647, DOI 10.18632/oncotarget.6615; Zheng K, 2012, INT J BIOL SCI, V8, P1013, DOI 10.7150/ijbs.3836; Zheng ZH, 2013, J VIROL, V87, P5645, DOI 10.1128/JVI.02655-12; Zhou W, 2014, BONE, V66, P267, DOI 10.1016/j.bone.2014.06.021	90	12	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165138	10.1371/journal.pone.0165138	http://dx.doi.org/10.1371/journal.pone.0165138			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824867	Green Published, Green Submitted, gold			2022-12-26	WOS:000387615200014
J	Lo, WC; Arsenescu, V; Arsenescu, RI; Friedman, A				Lo, Wing-Cheong; Arsenescu, Violeta; Arsenescu, Razvan I.; Friedman, Avner			Inflammatory Bowel Disease: How Effective Is TNF-alpha Suppression?	PLOS ONE			English	Article							REGULATORY T-CELLS; INTERFERON-GAMMA-PRODUCTION; BLOOD MONONUCLEAR-CELLS; CYTOKINE PRODUCTION; MATHEMATICAL-MODEL; TH1; EXPRESSION; IL-2; SARCOIDOSIS; TOLERANCE	Crohn's Disease (CD) results from inappropriate response toward commensal flora. Earlier studies described CD as a Th1 mediated disease. Current models view both phenotypes as a continuum of various permutations between Th1, Th2 and Th17 pathways compounded by a range of Treg disfunctions. In the present paper, we develop a mathematical model, by a system of differential equations, which describe the dynamic relations among these T cells and their cytokines. The model identities four groups of CD patients according to up/down regulation of Th1 and Th2. The model simulations show that immunosuppression by TNF-alpha blockage benefits the group with Th1(High)/Th2(Low) while, by contrast, the group with Th1(Low)/Th2(High) will benefit from immune activation.	[Lo, Wing-Cheong] City Univ Hong Kong, Dept Math, Hong Kong, Hong Kong, Peoples R China; [Arsenescu, Violeta] Armedica LLC, Dublin, OH USA; [Arsenescu, Razvan I.] Morristown Med Ctr, Ctr Inflammatory Bowel Dis, Digest Hlth Inst, Morristown, NJ USA; [Friedman, Avner] Ohio State Univ, Dept Math, Math Biosci Inst, 231 W 18th Ave, Columbus, OH 43210 USA	City University of Hong Kong; Atlantic Health System; University System of Ohio; Ohio State University	Lo, WC (corresponding author), City Univ Hong Kong, Dept Math, Hong Kong, Hong Kong, Peoples R China.	wingclo@cityu.edu.hk			Mathematical Biosciences Institute; National Science Foundation [DMS 0931642]; CityU StUp Grant [7200437]	Mathematical Biosciences Institute; National Science Foundation(National Science Foundation (NSF)); CityU StUp Grant	This research has been supported by the Mathematical Biosciences Institute and the National Science Foundation under Grant DMS 0931642. WCL was partially supported by a grant from a CityU StUp Grant (No. 7200437). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research has been supported by the Mathematical Biosciences Institute and the National Science Foundation under Grant DMS 0931642. WCL was partially supported by a grant from a CityU StUp Grant (No. 7200437).	Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bhatia S, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-2; Brooks DG, 2010, P NATL ACAD SCI USA, V107, P3018, DOI 10.1073/pnas.0914500107; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Conlon P J, 1989, Biotechnol Ther, V1, P31; Coquet JM, 2008, J IMMUNOL, V180, P7097, DOI 10.4049/jimmunol.180.11.7097; Crouser ED, 2009, AM J RESP CRIT CARE, V179, P929, DOI 10.1164/rccm.200803-490OC; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; Grassegger A, 2004, CLIN EXP DERMATOL, V29, P584, DOI 10.1111/j.1365-2230.2004.01652.x; Hao WR, 2014, P NATL ACAD SCI USA, V111, P16065, DOI 10.1073/pnas.1417789111; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Hong T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002122; HuLi J, 1997, P NATL ACAD SCI USA, V94, P3189, DOI 10.1073/pnas.94.7.3189; Hwang ES, 2005, J EXP MED, V202, P1289, DOI 10.1084/jem.20051044; Kaminska B, 2005, ACTA BIOCHIM POL, V52, P329; Le T, 1997, BLOOD, V89, P4112, DOI 10.1182/blood.V89.11.4112; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Liu C, 2013, CLIN EXP IMMUNOL, V173, P102, DOI 10.1111/cei.12084; Lo WC, 2013, B MATH BIOL, V75, P1417, DOI 10.1007/s11538-013-9853-2; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Marino A, 2008, NEPHROL DIAL TRANSPL, V23, P1460, DOI 10.1093/ndt/gfm856; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Matinez FO, 2014, F1000PRIME REP, V6, P6; Mizoguchi A, 2010, CURR OPIN PHARMACOL, V10, P578, DOI 10.1016/j.coph.2010.05.007; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; OLIVER JC, 1993, LYMPHOKINE CYTOK RES, V12, P115; Osugi Y, 1997, BLOOD, V89, P4100, DOI 10.1182/blood.V89.11.4100; PUERINGER RJ, 1993, CHEST, V103, P832, DOI 10.1378/chest.103.3.832; Rao BM, 2004, MOL PHARMACOL, V66, P864, DOI 10.1124/mol.66.4.864; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Shim JO, 2013, PEDIATR GASTROENTERO, V16, P17, DOI 10.5223/pghn.2013.16.1.17; Stummvoll GH, 2008, J IMMUNOL, V181, P1908, DOI 10.4049/jimmunol.181.3.1908; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Targan SR, 2009, CURR GASTROENTEROL R, V11, P473; Toossi Z, 1996, J IMMUNOL, V156, P3461; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Viallard JF, 1999, CLIN EXP IMMUNOL, V115, P189; WALLACE WAH, 1992, THORAX, V47, P437, DOI 10.1136/thx.47.6.437; Wang YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S6-S21; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Zenewicz LA, 2009, TRENDS MOL MED, V15, P199, DOI 10.1016/j.molmed.2009.03.002; Zhang JD, 2014, HYPERTENSION, V64, P1275, DOI 10.1161/HYPERTENSIONAHA.114.03863	44	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165782	10.1371/journal.pone.0165782	http://dx.doi.org/10.1371/journal.pone.0165782			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824890	Green Submitted, Green Published, gold			2022-12-26	WOS:000387615200033
J	Wang, YH; Vlasova, A; Velasquez, DE; Saif, LJ; Kandasamy, S; Kochba, E; Levin, Y; Jiang, BM				Wang, Yuhuan; Vlasova, Anastasia; Velasquez, Daniel E.; Saif, Linda J.; Kandasamy, Sukumar; Kochba, Efrat; Levin, Yotam; Jiang, Baoming			Skin Vaccination against Rotavirus Using Microneedles: Proof of Concept in Gnotobiotic Piglets	PLOS ONE			English	Article							ADULTS 18-64 YEARS; IMMUNE-RESPONSES; INTRADERMAL VACCINATION; REASSORTANT ROTAVIRUS; PROTECTIVE IMMUNITY; INFLUENZA VACCINES; RANDOMIZED-TRIAL; INDIAN INFANTS; IMMUNOGENICITY; INFECTION	Live-attenuated oral rotavirus (RV) vaccines have lower efficacy in low income countries, and additionally are associated with a rare but severe adverse event, intussusception. We have been pursuing the development of an inactivated rotavirus vaccine (IRV) using the human rotavirus strain CDC-9 (G1P[8]) through parenteral immunization and previously demonstrated dose sparing and enhanced immunogenicity of intradermal (ID) unadjuvanted IRV using a coated microneedle patch in comparison with intramuscular (IM) administration in mice. The aim of this study was to evaluate the immune response and protection against RV infection and diarrhea conferred by the administration of the ID unadjuvanted IRV using the microneedle device MicronJet600 (R) in neonatal gnotobiotic (Gn) piglets challenged with virulent Wa G1P[8] human RV. Three doses of 5 mu g IRV when administered intradermally and 5 mu g IRV formulated with aluminum hydroxide [Al(OH)(3)] when administered intramuscularly induced comparable rotavirus-specific antibody titers of IgA, IgG, IgG avidity index and neutralizing activity in sera of neonatal piglets. Both IRV vaccination regimens protected against RV antigen shedding in stools, and reduced the cumulative diarrhea scores in the piglets. This study demonstrated that the ID and IM administrations of IRV are immunogenic and protective against RV-induced diarrhea in neonatal piglets. Our findings highlight the potential value of an adjuvant sparing effect of the IRV ID delivery route.	[Wang, Yuhuan; Velasquez, Daniel E.; Jiang, Baoming] Ctr Dis Control & Prevent, Div Viral Dis, Gastroenteritis & Resp Viruses Lab Branch, Atlanta, GA USA; [Vlasova, Anastasia; Saif, Linda J.; Kandasamy, Sukumar] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA; [Kochba, Efrat; Levin, Yotam] NanoPass Technol Ltd, Ness Ziona, Israel	Centers for Disease Control & Prevention - USA; University System of Ohio; Ohio State University	Jiang, BM (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, Gastroenteritis & Resp Viruses Lab Branch, Atlanta, GA USA.	bxj4@cdc.gov			NanoPass Technologies Limited	NanoPass Technologies Limited	NanoPass Technologies Limited provided support in the form of salaries for authors [YL and EK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ali SA, 2014, J INFECT DIS, V210, P1772, DOI 10.1093/infdis/jiu335; Angel J, 1999, J INTERF CYTOK RES, V19, P655, DOI 10.1089/107999099313802; Angel J, 2014, HUM VACC IMMUNOTHER, V10, P3659, DOI 10.4161/hv.34361; Angel J, 2012, CURR OPIN VIROL, V2, P419, DOI 10.1016/j.coviro.2012.05.003; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Boom JA, 2012, J INFECT DIS, V206, P1275, DOI 10.1093/infdis/jis490; Bowen MD, 2012, EXPERT REV VACCINES, V11, P1311, DOI [10.1586/erv.12.114, 10.1586/ERV.12.114]; CONNER ME, 1993, J VIROL, V67, P6633, DOI 10.1128/JVI.67.11.6633-6641.1993; Conner ME, 1996, ARCH VIROL, P199; DEBOISSIEU D, 1993, J PEDIATR GASTR NUTR, V16, P29; Della Cioppa G, 2014, HUM VACC IMMUNOTHER, V10, P1701, DOI 10.4161/hv.28618; Esona MD, 2010, HUMAN VACCINES, V6; Feng N, 2008, J VIROL, V82, P7578, DOI 10.1128/JVI.00391-08; FLYNN PM, 1994, CHEST, V106, P1463, DOI 10.1378/chest.106.5.1463; Gonzalez AM, 2010, IMMUNOLOGY, V131, P242, DOI 10.1111/j.1365-2567.2010.03298.x; Gorse GJ, 2013, VACCINE, V31, P6034, DOI 10.1016/j.vaccine.2013.09.012; Gorse GJ, 2013, VACCINE, V31, P2358, DOI 10.1016/j.vaccine.2013.03.008; Greenberg HB, 2011, NEW ENGL J MED, V364, P2354, DOI 10.1056/NEJMe1105302; Groome MJ, 2014, B WORLD HEALTH ORGAN, V92, P238, DOI 10.2471/BLT.13.128066; Hemming M, 2014, PEDIATR INFECT DIS J, V33, P655, DOI 10.1097/INF.0000000000000221; Hung IFN, 2012, VACCINE, V30, P6427, DOI 10.1016/j.vaccine.2012.08.014; Jiang BM, 2008, HUM VACCINES, V4, P143, DOI 10.4161/hv.4.2.5263; Jiang BM, 2013, HUM VACC IMMUNOTHER, V9, P1634, DOI 10.4161/hv.24958; Jiang BM, 1999, VACCINE, V17, P1005, DOI 10.1016/S0264-410X(98)00317-X; Jiang V, 2010, HUM VACCINES, V6, P532, DOI 10.4161/hv.6.7.11278; Kompithra RZ, 2014, VACCINE, V32, pA129, DOI 10.1016/j.vaccine.2014.03.002; LECCE J G, 1990, Molecular Biotherapy, V2, P211; Levin Y, 2015, HUM VACC IMMUNOTHER, V11, P991, DOI 10.1080/21645515.2015.1010871; Levin Y, 2014, VACCINE, V32, P4249, DOI 10.1016/j.vaccine.2014.03.024; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Madhusudana SN, 2014, EXPERT REV VACCINES, V13, P641, DOI 10.1586/14760584.2014.901893; Mankeshwar R, 2014, Nepal Med Coll J, V16, P68; Moon S, 2013, VACCINE, V31, P3396, DOI 10.1016/j.vaccine.2012.11.027; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Premkumar P, 2014, VACCINE, V32, pA55, DOI 10.1016/j.vaccine.2014.04.077; Rongsen-Chandola T, 2014, VACCINE, V32, pA134, DOI 10.1016/j.vaccine.2014.04.078; Rose TL, 2013, EMERG INFECT DIS, V19, P1843, DOI 10.3201/eid1911.121407; Roy A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4643; Saif L, 1997, ADV EXP MED BIOL, V412, P397; Saif LJ, 1996, ARCH VIROL, P153; SCHWERS A, 1985, ANN RECH VET, V16, P213; Su F., 2016, HUM VACC IMMUNOTHER, P1, DOI DOI 10.1080/21645515.2015.1114195; Tarnow K, 2004, APPL NURS RES, V17, P275, DOI 10.1016/S0897-1897(04)00079-5; Troy SB, 2015, J INFECT DIS, V211, P1969, DOI 10.1093/infdis/jiu841; Velasquez DE, 2015, HUM VACC IMMUNOTHER, V11, P531, DOI 10.4161/21645515.2014.988553; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wang YH, 2010, VACCINE, V28, P5432, DOI 10.1016/j.vaccine.2010.06.006; Yuan LJ, 2002, VET IMMUNOL IMMUNOP, V87, P147, DOI 10.1016/S0165-2427(02)00046-6; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6	49	24	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166038	10.1371/journal.pone.0166038	http://dx.doi.org/10.1371/journal.pone.0166038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824918	Green Submitted, Green Published, gold			2022-12-26	WOS:000387615200057
J	Reisig, G; Kreinest, M; Richter, W; Wagner-Ecker, M; Dinter, D; Attenberger, U; Schneider-Wald, B; Fickert, S; Schwarz, ML				Reisig, Gregor; Kreinest, Michael; Richter, Wiltrud; Wagner-Ecker, Mechthild; Dinter, Dietmar; Attenberger, Ulrike; Schneider-Wald, Barbara; Fickert, Stefan; Schwarz, Markus L.			Osteoarthritis in the Knee Joints of Gottingen Minipigs after Resection of the Anterior Cruciate Ligament? Missing Correlation of MRI, Gene and Protein Expression with Histological Scoring	PLOS ONE			English	Article							OSTEOCHONDRAL DEFECT REPAIR; ARTICULAR-CARTILAGE; IN-VIVO; ANIMAL-MODELS; COLLAGEN DEGRADATION; GUINEA-PIG; POND-NUKI; HYALINE CARTILAGE; PROFILING REVEALS; ACL TRANSECTION	Introduction The Gottingen Minipig (GM) is used as large animal model in articular cartilage research. The aim of the study was to introduce osteoarthritis (OA) in the GM by resecting the anterior cruciate ligament (ACLR) according to Pond and Nuki, verified by histological and magnetic resonance imaging (MRI) scoring as well as analysis of gene and protein expression. Materials and Methods The eight included skeletally mature female GM were assessed after ACLR in the left and a sham operation in the right knee, which served as control. 26 weeks after surgery the knee joints were scanned using a 3-Tesla high-field MR tomography unit with a 3 TCP Large Flex Coil. Standard proton-density weighted fat saturated sequences in coronal and sagittal direction with a slice thickness of 3 mm were used. The MRI scans were assessed by two radiologists according to a modified WORMS-score, the X-rays of the knee joints by two evaluators. Osteochondral plugs with a diameter of 4mm were taken for histological examination from either the main loading zone or the macroscopic most degenerated parts of the tibia plateau or condyle respectively. The histological sections were blinded and scored by three experts according to Little et al. Gene expression analysis was performed from surrounding cartilage. Expression of adamts4, adamts5, acan, col1A1, col2, il-beta, mmp1, mmp3, mmp13, vegf was determined by qRT-PCR. Immunohistochemical staining (IH) of Col I and II was performed. IH was scored using a 4 point grading (0-no staining; 3-intense staining). Results and Discussion Similar signs of OA were evident both in ACLR and sham operated knee joints with the histological scoring result of the ACLR joints with 6.48 +/- 5.67 points and the sham joints with 6.86 +/- 5.84 points (p = 0.7953) The MRI scoring yielded 0.34 +/- 0.89 points for the ACLR and 0.03 +/- 0.17 for the sham knee joints. There was no correlation between the histological and MRI scores (r = 0.10021). The gene expression profiles as well as the immunohistochemical findings showed no significant differences between ACLR and sham knee joints. In conclusion, both knee joints showed histological signs of OA after 26 weeks irrespective of whether the ACL was resected or not. As MRI results did not match the histological findings, MRI was obviously unsuitable to diagnose the OA in GM. The analysis of the expression patterns of the 10 genes could not shed light on the question, whether sham operation also induced cartilage erosion or if the degeneration was spontaneous. The modified Pond-Nuki model may be used with reservation in the adult minipig to induce an isolated osteoarthritis.	[Reisig, Gregor; Kreinest, Michael; Schneider-Wald, Barbara; Fickert, Stefan; Schwarz, Markus L.] Heidelberg Univ, Med Fac Mannheim, Dept Expt Orthopaed & Trauma Surg, Orthopaed & Trauma Surg Ctr OUZ, Mannheim, Germany; [Richter, Wiltrud; Wagner-Ecker, Mechthild] Orthopaed Univ Hosp Heidelberg, Res Ctr Expt Orthopaed, Heidelberg, Germany; [Dinter, Dietmar; Attenberger, Ulrike] Univ Med Ctr Mannheim, Inst Clin Radiol & Nucl Med, Mannheim, Germany; [Kreinest, Michael] BG Trauma Ctr Ludwigshafen, Dept Trauma Surg & Orthopaed Surg, Ludwigshafen, Germany; [Fickert, Stefan] Sporthopaedicum, Straubing, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Schwarz, ML (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Expt Orthopaed & Trauma Surg, Orthopaed & Trauma Surg Ctr OUZ, Mannheim, Germany.	Markus.Schwarz@medma.uni-heidelberg.de	Kreinest, Michael/ABI-7282-2020; Richter, Wiltrud/V-3217-2017; Attenberger, Ulrike/ABD-8541-2020; Attenberger, Ulrike/HDN-2286-2022	Richter, Wiltrud/0000-0003-4694-2768; Attenberger, Ulrike/0000-0002-8123-5447; Attenberger, Ulrike/0000-0002-8123-5447	Medical Faculty Mannheim, Heidelberg University, Germany; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg, Germany	Medical Faculty Mannheim, Heidelberg University, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg, Germany	This study was supported by the Medical Faculty Mannheim, Heidelberg University, Germany and the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg, Germany within the funding programme Open Access Publishing.	Ahern BJ, 2009, OSTEOARTHR CARTILAGE, V17, P705, DOI 10.1016/j.joca.2008.11.008; Aigner T, 2004, REJUV RES, V7, P134, DOI 10.1089/1549168041552964; Aigner T, 2001, ARTHRITIS RHEUM-US, V44, P2777, DOI 10.1002/1529-0131(200112)44:12<2777::AID-ART465>3.0.CO;2-H; Aigner T, 2006, ARTHRITIS RHEUM-US, V54, P3533, DOI 10.1002/art.22174; ALTMAN RD, 1989, SEMIN ARTHRITIS RHEU, V18, P1, DOI 10.1016/0049-0172(89)90007-3; Appleton CTG, 2007, ARTHRITIS RHEUM-US, V56, P1854, DOI 10.1002/art.22711; Attia E, 2010, AM J SPORT MED, V38, P348, DOI 10.1177/0363546509348052; Bachmann G, 1997, ROFO-FORTSCHR RONTG, V166, P429, DOI 10.1055/s-2007-1015453; Barley RDC, 2010, VIRCHOWS ARCH, V456, P561, DOI 10.1007/s00428-010-0890-z; Batiste DL, 2004, OSTEOARTHR CARTILAGE, V12, P986, DOI 10.1016/j.joca.2004.08.010; Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; Bernstein P, 2009, J BIOMED MATER RES A, V91A, P910, DOI 10.1002/jbm.a.32308; Bittersohl B, 2009, EUR J RADIOL, V70, P561, DOI 10.1016/j.ejrad.2008.02.031; Bittersohl B, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006895; Blackman AJ, 2013, AM J SPORT MED, V41, P1426, DOI 10.1177/0363546513485931; Boulocher C, 2007, OSTEOARTHR CARTILAGE, V15, P1378, DOI 10.1016/j.joca.2007.04.012; Bowers ME, 2008, OSTEOARTHR CARTILAGE, V16, P1167, DOI 10.1016/j.joca.2008.03.005; Calvo E, 2004, OSTEOARTHR CARTILAGE, V12, P878, DOI 10.1016/j.joca.2004.07.007; Carlson CS, 1996, J BONE MINER RES, V11, P1209; Casula V, 2014, KNEE SURG SPORTS TRA; Chaganti RK, 2011, CURR REV MUSCULOSKE, V4, P99, DOI 10.1007/s12178-011-9088-5; Chen BL, 2013, BIO-MED MATER ENG, V23, P263, DOI 10.3233/BME-130750; Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]; Cook JL, 2010, OSTEOARTHR CARTILAGE, V18, pS66, DOI 10.1016/j.joca.2010.04.017; Costa-Paz M, 2012, CLIN ORTHOP RELAT R, V470, P979, DOI 10.1007/s11999-011-1933-8; Cruz R, 2015, PATHOL RES PRACT, V211, P829, DOI 10.1016/j.prp.2015.07.012; Curzer HJ, 2016, SCI ENG ETHICS, V22, P549, DOI 10.1007/s11948-015-9659-8; Eckstein F, 2006, ANN RHEUM DIS, V65, P433, DOI 10.1136/ard.2005.039370; Eckstein F, 2006, NMR BIOMED, V19, P822, DOI 10.1002/nbm.1063; Elsaid KA, 2012, OSTEOARTHR CARTILAGE, V20, P940, DOI 10.1016/j.joca.2012.04.021; Eltawil NM, 2009, OSTEOARTHR CARTILAGE, V17, P695, DOI 10.1016/j.joca.2008.11.003; Evangelopoulos DS, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20140542; Fan ZY, 2005, ARTHRITIS RHEUM-US, V52, P136, DOI 10.1002/art.20725; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Fischbach F, 2005, ACTA RADIOL, V46, P67, DOI 10.1080/02841850510012625; Flannery CR, 2009, ARTHRITIS RHEUM-US, V60, P840, DOI 10.1002/art.24304; Fleming Braden C, 2005, Curr Opin Orthop, V16, P354, DOI 10.1097/01.bco.0000176423.07865.d2; Foldager CB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-94; Frost-Christensen LN, 2008, OSTEOARTHR CARTILAGE, V16, P1327, DOI 10.1016/j.joca.2008.03.013; Fukui N, 2008, ARTHRITIS RHEUM, V58, P3843, DOI 10.1002/art.24036; Gavenis K, 2014, J BIOMATER APPL, V28, P1008, DOI 10.1177/0885328213491440; Gerwin N, 2010, OSTEOARTHR CARTILAGE, V18, pS24, DOI 10.1016/j.joca.2010.05.030; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goranov NV, 2007, VET CLIN PATH, V36, P192, DOI 10.1111/j.1939-165X.2007.tb00208.x; Gotterbarm T, 2008, LAB ANIM-UK, V42, P71, DOI 10.1258/la.2007.06029e; Gray P, 1954, BLAKISTON, V43, P403; Grcevic D, 2010, J RHEUMATOL, V37, P246, DOI 10.3899/jrheum.090167; Gredes T, 2007, THESIS; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x; Hanashi Daisuke, 2002, J Orthop Sci, V7, P672, DOI 10.1007/s007760200119; Haslauer CM, 2013, OSTEOARTHR CARTILAGE, V21, P1950, DOI 10.1016/j.joca.2013.09.003; Haywood J, 2016, OSTEOARTHR CARTILAGE, V24, P942, DOI 10.1016/j.joca.2015.11.020; Heijink A, 2012, KNEE SURG SPORT TR A, V20, P423, DOI 10.1007/s00167-011-1818-0; Herzog W, 1993, Osteoarthritis Cartilage, V1, P243, DOI 10.1016/S1063-4584(05)80330-9; Hissnauer TN, 2010, OSTEOARTHR CARTILAGE, V18, P1630, DOI 10.1016/j.joca.2010.10.002; Huang CY, 2011, RHEUMATOLOGY, V50, P1379, DOI 10.1093/rheumatology/ker134; Huebner JL, 2009, OSTEOARTHR CARTILAGE, V17, P1056, DOI 10.1016/j.joca.2009.02.015; Huebner JL, 2002, OSTEOARTHR CARTILAGE, V10, P758, DOI 10.1053/joca.2002.0821; Hulmes DJS, 2004, OSTEOARTHR CARTILAGE, V12, P232, DOI 10.1016/j.joca.2003.11.007; Inoue K, 2005, RHEUMATOL INT, V26, P93, DOI 10.1007/s00296-004-0513-6; JACKSON DW, 1992, AM J SPORT MED, V20, P644, DOI 10.1177/036354659202000605; Jacquet R, 2005, ANAL BIOCHEM, V337, P22, DOI 10.1016/j.ab.2004.09.033; Jay GD, 2010, ARTHRITIS RHEUM-US, V62, P2382, DOI 10.1002/art.27550; Jefferies D, 2002, VET RES, V33, P383, DOI 10.1051/vetres:2002024; Jimenez PA, 1997, LAB ANIM SCI, V47, P598; Jung M, 2009, CELL TRANSPLANT, V18, P923, DOI 10.3727/096368909X471297; Kaab MJ, 1998, J ANAT, V193, P23, DOI 10.1046/j.1469-7580.1998.19310023.x; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Kraus VB, 2010, OSTEOARTHR CARTILAGE, V18, pS35, DOI 10.1016/j.joca.2010.04.015; Kreinest M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159331; Kuyinu EL, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-016-0346-5; LAFEBER FPJG, 1992, AM J PATHOL, V140, P1421; Lasch P, 2001, J BIOL CHEM, V276, P9492, DOI 10.1074/jbc.M008528200; Laverty S, 2010, OSTEOARTHR CARTILAGE, V18, pS53, DOI 10.1016/j.joca.2010.05.029; Le Graverand MPH, 2002, J ORTHOP RES, V20, P535, DOI 10.1016/S0736-0266(01)00126-7; Libicher M, 2005, EUR RADIOL, V15, P390, DOI 10.1007/s00330-004-2486-y; Little CB, 2010, OSTEOARTHR CARTILAGE, V18, pS80, DOI 10.1016/j.joca.2010.04.016; Liu WH, 2003, J ORTHOP RES, V21, P730, DOI 10.1016/S0736-0266(03)00002-0; Lorenz H, 2005, ARTHRITIS RES THER, V7, pR156, DOI 10.1186/ar1471; Lukas VA, 2015, J ORTHOP RES, V33, P640, DOI 10.1002/jor.22810; Makela JTA, 2014, OSTEOARTHR CARTILAGE, V22, P869, DOI 10.1016/j.joca.2014.04.010; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; MATYAS JR, 1995, ARTHRITIS RHEUM, V38, P420, DOI 10.1002/art.1780380320; McCoy AM, 2015, VET PATHOL, V52, P803, DOI 10.1177/0300985815588611; MCDEVITT C, 1977, J BONE JOINT SURG BR, V59, P24, DOI 10.1302/0301-620X.59B1.576611; McIlwraith CW, 2010, OSTEOARTHR CARTILAGE, V18, pS93, DOI 10.1016/j.joca.2010.05.031; McNulty AL, 2011, CONNECT TISSUE RES, V52, P523, DOI 10.3109/03008207.2011.597902; Miyatake K, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1094-8; Moriyama H, 2012, BIOGERONTOLOGY, V13, P369, DOI 10.1007/s10522-012-9381-8; Murray MM, 2007, J ORTHOP RES, V25, P81, DOI 10.1002/jor.20282; Nebelung W, 2005, ARTHROSCOPY, V21, P696, DOI 10.1016/j.arthro.2005.03.010; Nielsen RH, 2008, BIOMARKERS, V13, P79, DOI 10.1080/13547500701615108; Niemietz T, 2014, CELL TISSUE RES, V358, P749, DOI 10.1007/s00441-014-1982-x; O'Brien EJO, 2013, J ORTHOP RES, V31, P35, DOI 10.1002/jor.22187; Oppermann A, 2016, COMMUNICATION; Orth P, 2015, PROG HISTOCHEM CYTO, V50, P19, DOI 10.1016/j.proghi.2015.10.001; Palmer AJR, 2013, BONE JOINT J, V95B, P738, DOI 10.1302/0301-620X.95B6.31414; Peterfy CG, 2004, OSTEOARTHR CARTILAGE, V12, P177, DOI 10.1016/j.joca.2003.11.003; Pond M J, 1973, Ann Rheum Dis, V32, P387, DOI 10.1136/ard.32.4.387; Prieto-Alhambra D, 2014, ANN RHEUM DIS, V73, P1659, DOI 10.1136/annrheumdis-2013-203355; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Rehnitz C, 2014, OSTEOARTHR CARTILAGE, V22, P1732, DOI 10.1016/j.joca.2014.04.020; ROSENTHAL AK, 1994, MECH AGEING DEV, V75, P35, DOI 10.1016/0047-6374(94)90026-4; Ruehe B, 2009, ORAL SURG ORAL MED O, V108, P699, DOI 10.1016/j.tripleo.2009.06.037; Saadat E, 2008, EUR RADIOL, V18, P2292, DOI 10.1007/s00330-008-0989-7; SAKAKIBARA Y, 1994, CLIN ORTHOP RELAT R, P282; Salzmann GM, 2014, AM J SPORT MED, V42, P1832, DOI 10.1177/0363546514536682; Schwarz ML, 2010, SCAND J LAB ANIM SCI, V37, P13; Sharma L, 1999, ARTHRITIS RHEUM, V42, P861, DOI 10.1002/1529-0131(199905)42:5<861::AID-ANR4>3.0.CO;2-N; Steck E, 2012, J MOL MED, V90, P1185, DOI 10.1007/s00109-012-0895-y; Steck E, 2009, STEM CELLS DEV, V18, P969, DOI 10.1089/scd.2008.0213; Stoker Aaron M, 2006, J Orthop Surg Res, V1, P8, DOI 10.1186/1749-799X-1-8; Stoop R, 2001, OSTEOARTHR CARTILAGE, V9, P308, DOI 10.1053/joca.2000.0390; Streitparth F, 2009, ACTA RADIOL, V50, P765, DOI 10.1080/02841850902980272; Tayade C, 2006, J IMMUNOL, V176, P148, DOI 10.4049/jimmunol.176.1.148; Tiraloche G, 2005, ARTHRITIS RHEUM-US, V52, P1118, DOI 10.1002/art.20951; Tsai PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076658; van Meer BL, 2015, BR J SPORTS MED; Vasara AI, 2006, OSTEOARTHR CARTILAGE, V14, P1066, DOI 10.1016/j.joca.2006.04.003; Verzijl N, 2002, ARTHRITIS RHEUM, V46, P114, DOI 10.1002/1529-0131(200201)46:1<114::AID-ART10025>3.0.CO;2-P; VILENSKY JA, 1994, J ELECTROMYOGR KINES, V4, P181, DOI 10.1016/1050-6411(94)90019-1; Visco DM, 1996, OSTEOARTHR CARTILAGE, V4, P9, DOI 10.1016/S1063-4584(96)80003-3; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; von Engelhardt LV, 2007, ARTHROSCOPY, V23, P496, DOI 10.1016/j.arthro.2006.12.027; Wachsmuth L, 2003, OSTEOARTHR CARTILAGE, V11, P891, DOI 10.1016/j.joca.2003.08.008; Wei B, 2015, J MAGN RESON IMAGING; Wei L, 2010, J ORTHOP RES, V28, P900, DOI 10.1002/jor.21093; Wenz W, 1998, Z ORTHOP GRENZGEB, V136, P298, DOI 10.1055/s-2008-1053741; Yin J, 2011, CHINESE MED J-PEKING, V124, P4245, DOI 10.3760/cma.j.issn.0366-6999.2011.24.022; Zayed N, 2008, ARTHRITIS RHEUM-US, V58, P3530, DOI 10.1002/art.23958; Zeni P, 2007, AM J PHYSIOL-CELL PH, V293, pC855, DOI 10.1152/ajpcell.00470.2006; Zhou QY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-337; Zou LJ, 2008, J ORTHOP RES, V26, P56, DOI 10.1002/jor.20467	136	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165897	10.1371/journal.pone.0165897	http://dx.doi.org/10.1371/journal.pone.0165897			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820852	Green Published, Green Submitted, gold			2022-12-26	WOS:000387614800025
J	Brachs, S; Winkel, AF; Polack, J; Tang, H; Brachs, M; Margerie, D; Brunner, B; Jahn-Hofmann, K; Ruetten, H; Spranger, J; Schmoll, D				Brachs, Sebastian; Winkel, Angelika F.; Polack, James; Tang, Hui; Brachs, Maria; Margerie, Daniel; Brunner, Bodo; Jahn-Hofmann, Kerstin; Ruetten, Hartmut; Spranger, Joachim; Schmoll, Dieter			Chronic Activation of Hepatic Nrf2 Has No Major Effect on Fatty Acid and Glucose Metabolism in Adult Mice	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; KEAP1/NRF2 PATHWAY; INSULIN-RESISTANCE; LIPID-METABOLISM; GENE-EXPRESSION; IN-VIVO; DELETION; STEATOSIS; DIET; LIVER	The transcription factor NF-E2-related factor 2 (Nrf2) induces cytoprotective genes, but has also been linked to the regulation of hepatic energy metabolism. In order to assess the pharmacological potential of hepatic Nrf2 activation in metabolic disease, Nrf2 was activated over 7 weeks in mice on Western diet using two different siRNAs against kelch-like ECH-associated protein 1 (Keap1), the inhibitory protein of Nrf2. Whole genome expression analysis followed by pathway analysis demonstrated successful knock-down of Keap1 expression and induction of Nrf2-dependent genes involved in anti-oxidative stress defense and biotransformation, proving the activation of Nrf2 by the siRNAs against Keap1. Neither the expression of fatty acid-nor carbohydrate-handling proteins was regulated by Keap1 knock-down. Metabolic profiling of the animals did also not show effects on plasma and hepatic lipids, energy expenditure or glucose tolerance. The data indicate that hepatic Keap1/Nrf2 is not a major regulator of glucose or lipid metabolism in mice.	[Brachs, Sebastian; Polack, James; Tang, Hui; Brachs, Maria; Spranger, Joachim] Charite, Sch Med, Ctr Cardiovasc Res, Dept Endocrinol Diabet & Nutr, Berlin, Germany; [Brachs, Sebastian; Polack, James; Tang, Hui; Brachs, Maria; Spranger, Joachim] German Ctr Cardiovasc Res, DZHK Partner Site Berlin, Berlin, Germany; [Winkel, Angelika F.; Margerie, Daniel; Brunner, Bodo; Jahn-Hofmann, Kerstin; Ruetten, Hartmut; Schmoll, Dieter] Sanofi Aventis Deutschland GmbH, Ind Pk Hoechst, Frankfurt, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; Sanofi-Aventis	Spranger, J (corresponding author), Charite, Sch Med, Ctr Cardiovasc Res, Dept Endocrinol Diabet & Nutr, Berlin, Germany.; Spranger, J (corresponding author), German Ctr Cardiovasc Res, DZHK Partner Site Berlin, Berlin, Germany.	joachim.spranger@charite.de		Brachs, Sebastian/0000-0002-6336-3939; Venkatasubramanian, Siddharth/0000-0002-5860-0768	Charite Deutschland GmbH; Sanofi-Aventis Deutschland GmbH; DZHK (BMBF); DZHK	Charite Deutschland GmbH; Sanofi-Aventis Deutschland GmbH(Sanofi-Aventis); DZHK (BMBF); DZHK	This work was supported by a collaboration between Charite and Sanofi-Aventis Deutschland GmbH and SB, JP, HT, MB and JS were supported by the DZHK (BMBF). Sanofi-Aventis Deutschland GmbH provided support in the form of salaries for authors [AFW, DM, BB, KJ-H, HR, and DS] and a research grant to SB and JS. DS was involved in study design and experiments were partially carried out in the labs of Sanofi-Aventis Deutschland GmbH. The specific roles of the authors are articulated in the 'author contributions' section. However Sanofi-Aventis Deutschland GmbH as funding organization did not have any further role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder did not directly benefit from the study and the study did not involve a product the funder sells. JS is PI of the German Center for Cardiovascular Research (DZHK) and this study was supported by resources of the DZHK. The DZHK provided salaries for authors [HT, MB], but the DZHK did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaucage SL, 2008, CURR OPIN DRUG DISC, V11, P203; Broering R, 2014, INT IMMUNOL, V26, P35, DOI 10.1093/intimm/dxt040; Camer D, 2015, MOL CELL ENDOCRINOL, V412, P36, DOI 10.1016/j.mce.2015.05.018; Chartoumpekis DV, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/340731; Chartoumpekis DV, 2013, CURR DIABETES REV, V9, P137, DOI 10.2174/1573399811309020005; Gao B, 2014, CLIN PHARMACOL-ADV A, V6, P19, DOI 10.2147/CPAA.S35078; Glien M, 2011, HORM METAB RES, V43, P601, DOI 10.1055/s-0031-1283138; Gonzalez-Rodriguez A, 2014, DIS MODEL MECH, V7, P1093, DOI 10.1242/dmm.015537; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Herling AW, 1999, EUR J PHARMACOL, V386, P75, DOI 10.1016/S0014-2999(99)00748-7; Kitteringham NR, 2010, J PROTEOMICS, V73, P1612, DOI 10.1016/j.jprot.2010.03.018; Kulkarni SR, 2013, PHARM RES-DORDR, V30, P2221, DOI 10.1007/s11095-013-1138-9; Meakin PJ, 2014, MOL CELL BIOL, V34, P3305, DOI [10.1128/MCB.00677-14, 10.1128/MCB.00677-1]; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; More VR, 2013, FREE RADICAL BIO MED, V61, P85, DOI 10.1016/j.freeradbiomed.2013.03.007; Muller S, 2004, CURR ORG SYNTH, V1, P293, DOI 10.2174/1570179043366675; Okada K, 2008, AM J PHYSIOL-GASTR L, V295, pG735, DOI 10.1152/ajpgi.90321.2008; Okada K, 2013, J GASTROENTEROL, V48, P620, DOI 10.1007/s00535-012-0659-z; Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185; Ramadori P, 2016, FREE RADICAL BIO MED, V91, P114, DOI 10.1016/j.freeradbiomed.2015.12.014; Richter M, 2014, J TOXICOL SCI, V39, P353, DOI 10.2131/jts.39.353; Saha PK, 2010, J BIOL CHEM, V285, P40581, DOI 10.1074/jbc.M110.176545; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022; Slocum SL, 2016, ARCH BIOCHEM BIOPHYS, V591, P57, DOI 10.1016/j.abb.2015.11.040; Sugimoto H, 2010, AM J PHYSIOL-GASTR L, V298, pG283, DOI 10.1152/ajpgi.00296.2009; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Tanaka Y, 2012, J GASTROEN HEPATOL, V27, P1711, DOI 10.1111/j.1440-1746.2012.07180.x; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Uruno A, 2015, ARCH BIOCHEM BIOPHYS, V566, P76, DOI 10.1016/j.abb.2014.12.012; Wang CH, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-165; Weerachayaphorn J, 2014, J HEPATOL, V60, P160, DOI 10.1016/j.jhep.2013.08.015; Winkel AF, 2015, J BIOL CHEM, V290, P28446, DOI 10.1074/jbc.M115.678136; Xu JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079841; Xu JL, 2012, DIABETES, V61, P3208, DOI 10.2337/db11-1716; Yu Z, 2011, DIABETOLOGIA, V54, P922, DOI 10.1007/s00125-010-2001-8; Zhang DD, 2013, ANTIOXID REDOX SIGN, V19, P517, DOI 10.1089/ars.2012.5118; Zhang P., 2012, BIO-PROTOCOL, V2, pe186	38	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166110	10.1371/journal.pone.0166110	http://dx.doi.org/10.1371/journal.pone.0166110			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814396	gold, Green Published, Green Submitted			2022-12-26	WOS:000386911100033
J	Diaz-Gutierrez, J; Martinez-Gonzalez, MA; Izquierdo, JJ; Gonzalez-Muniesa, P; Martinez, J; Bes-Rastrollo, M				Diaz-Gutierrez, Jesus; Martinez-Gonzalez, Miguel Angel; Pons Izquierdo, Juan Jose; Gonzalez-Muniesa, Pedro; Alfredo Martinez, J.; Bes-Rastrollo, Maira			Living at Higher Altitude and Incidence of Overweight/Obesity: Prospective Analysis of the SUN Cohort	PLOS ONE			English	Article							NORMOBARIC SHAM HYPOXIA; SERUM LEPTIN LEVELS; UNITED-STATES; SOCIOECONOMIC DIFFERENCES; INTERMITTENT HYPOXIA; OBESE SUBJECTS; BODY-WEIGHT; ASSOCIATION; EXERCISE; EXPOSURE	Background Residence at high altitude has been associated with lower obesity rates probably due to hypoxia conditions. However, there is no evidence of this association in a free-living population. Objectives We assessed the association between the altitude where each participant of a Spanish cohort (the SUN Project) was living and the incidence of overweight/obesity. Methods The SUN Project is a dynamic, prospective, multipurpose cohort of Spanish university graduates with a retention rate of 89%. We included in the analysis 9 365 participants free of overweight/obesity at baseline. At the baseline questionnaire, participants reported their postal code and the time they had been living in their city/village. We imputed the altitude of each postal code according to the data of the Spanish National Cartographic Institute and categorized participants in tertiles. We used Cox regression models to adjust for potential confounding variables. Results During a median follow-up of 10 years, we identified 2 156 incident cases of overweight/obesity. After adjusting for sex, age, time of residence at current city, baseline body mass index, physical activity, sedentarism and years of education (<= 3 years, >= 4 years, Master/PhD), those participants in the third tertile (> 456 m) exhibited a statistically significant 14% reduction in the risk of developing overweight/obesity in comparison to those in the first tertile (< 124 m) (adjusted HR = 0.86; 95% CI: 0.77, 0.96). Conclusions Living in cities of higher altitude was inversely associated with the risk of developing overweight/ obesity in a cohort of Spanish university graduates.	[Diaz-Gutierrez, Jesus; Martinez-Gonzalez, Miguel Angel; Bes-Rastrollo, Maira] Univ Navarra, Sch Med, Dept Prevent Med & Publ Hlth, Pamplona, Spain; [Martinez-Gonzalez, Miguel Angel; Gonzalez-Muniesa, Pedro; Alfredo Martinez, J.; Bes-Rastrollo, Maira] IDISNA Navarras Hlth Res Inst, Pamplona, Spain; [Martinez-Gonzalez, Miguel Angel; Gonzalez-Muniesa, Pedro; Alfredo Martinez, J.; Bes-Rastrollo, Maira] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Madrid, Spain; [Martinez-Gonzalez, Miguel Angel] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Pons Izquierdo, Juan Jose] Univ Navarra, Sch Humanities & Social Sci, Dept Hist Art Hist & Geog, Pamplona, Spain; [Gonzalez-Muniesa, Pedro; Alfredo Martinez, J.] Univ Navarra, Sch Pharm, Dept Nutr & Food Sci & Physiol, Pamplona, Spain	University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Harvard University; Harvard T.H. Chan School of Public Health; University of Navarra; University of Navarra	Bes-Rastrollo, M (corresponding author), Univ Navarra, Sch Med, Dept Prevent Med & Publ Hlth, Pamplona, Spain.; Bes-Rastrollo, M (corresponding author), IDISNA Navarras Hlth Res Inst, Pamplona, Spain.; Bes-Rastrollo, M (corresponding author), Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Madrid, Spain.	mbes@unav.es	Izquierdo, Juan José Pons/AAB-2991-2019; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Díaz-Gutiérrez, Jesús/O-2525-2016; González-Muniesa, Pedro/H-2158-2015; San-Miguel, Jesús F./V-8977-2018; Bes-Rastrollo, Maira/A-1329-2009	Izquierdo, Juan José Pons/0000-0002-5623-1591; Díaz-Gutiérrez, Jesús/0000-0003-0351-4018; González-Muniesa, Pedro/0000-0002-3130-2496; San-Miguel, Jesús F./0000-0002-9183-4857; Bes-Rastrollo, Maira/0000-0002-9139-4206; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808	Spanish Ministry of Health; European Regional Development Fund (FEDER) [PI10/02993, PI10/02658, PI13/00615, PI14/01668, PI14/01798, PI14/1764, RD06/0045, G03/140]; Navarra Regional Government [45/2011, 122/2014]; University of Navarra	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); European Regional Development Fund (FEDER)(European Commission); Navarra Regional Government; University of Navarra	The Seguimiento Universidad de Navarra (SUN) study has received funding from the Spanish Ministry of Health and European Regional Development Fund (FEDER) (Grants PI10/02993, PI10/02658, PI13/00615, PI14/01668, PI14/01798, PI14/1764, RD06/0045, G03/140), the Navarra Regional Government (45/2011, 122/2014), and the University of Navarra. Funding sources had no role in study design, data collection, analysis, interpretation of results, and in the writing of the manuscript. All authors were and are independent from funders.	Bailey D M, 2000, High Alt Med Biol, V1, P9, DOI 10.1089/152702900320649; Bes-Rastrollo M., 2005, REV ESP OBES, V3, P352; Cruickshank S., 2004, CONTIN ED ANAESTH CR, V4, P24, DOI [10.1093/bjaceaccp/mkh008, DOI 10.1093/BJACEACCP/MKH008]; De Irala-Estevez J, 2000, EUR J CLIN NUTR, V54, P706, DOI 10.1038/sj.ejcn.1601080; Donat-Vargas C, 2014, J EPIDEMIOL COMMUN H, V68, P834, DOI 10.1136/jech-2013-203752; Gatterer H, 2015, OBESITY FACTS, V8, P200, DOI 10.1159/000431157; Gonzalez-Muniesa P, 2015, J PHYSIOL BIOCHEM, V71, P589, DOI 10.1007/s13105-015-0410-3; Hartmann G, 2000, CYTOKINE, V12, P246, DOI 10.1006/cyto.1999.0533; Holtcamp W, 2012, ENVIRON HEALTH PERSP, V120, pA62, DOI 10.1289/ehp.120-a62; Kayser B, 2013, OBES REV, V14, P579, DOI 10.1111/obr.12034; KAYSER B, 1994, SPORTS MED, V17, P309, DOI 10.2165/00007256-199417050-00004; Kong ZW, 2014, SLEEP BREATH, V18, P591, DOI 10.1007/s11325-013-0922-4; Lippl FJ, 2010, OBESITY, V18, P675, DOI 10.1038/oby.2009.509; Little BB, 2013, AM J PHYS ANTHROPOL, V152, P1, DOI 10.1002/ajpa.22326; Martinez-Gonzalez MA, 2005, PUBLIC HEALTH NUTR, V8, p920e7; National Institute of Statistics, 2012, ENC NAC SAL ESP 2011; Netzer N, 2013, J TRAVEL MED, V20, P247, DOI 10.1111/jtm.12017; Netzer NC, 2008, SLEEP BREATH, V12, P129, DOI 10.1007/s11325-007-0149-3; Nielsen HB, 2003, SCAND J MED SCI SPOR, V13, P339, DOI 10.1046/j.1600-0838.2003.00325.x; Quintero P, 2010, MED HYPOTHESES, V74, P901, DOI 10.1016/j.mehy.2009.10.022; Raff H, 2008, J APPL PHYSIOL, V105, P1686, DOI 10.1152/japplphysiol.zdg-8233-vpcomm.2008; Roos E, 1996, EUR J CLIN NUTR, V50, P753; Rose G., 2008, ROSES STRATEGY PREVE; Segui-Gomez M, 2006, INT J EPIDEMIOL, V35, P1417, DOI 10.1093/ije/dyl223; Sherpa LY, 2010, INT J ENV RES PUB HE, V7, P1670, DOI 10.3390/ijerph7041670; Shukla V, 2005, NUTR NEUROSCI, V8, P161, DOI 10.1080/10284150500132823; Sierra-Johnson J, 2008, J APPL PHYSIOL, V105, P1684, DOI 10.1152/japplphysiol.01284.2007; Singh SN, 2001, NUTR NEUROSCI, V4, P323, DOI 10.1080/1028415X.2001.11747372; Trayhurn P, 2014, ANNU REV NUTR, V34, P207, DOI 10.1146/annurev-nutr-071812-161156; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Vafeiadi M, 2015, ENVIRON HEALTH PERSP, V123, P1015, DOI 10.1289/ehp.1409062; Vats P, 2013, HIGH ALT MED BIOL, V14, P45, DOI 10.1089/ham.2012.1071; Voss JD, 2013, INT J OBESITY, V37, P1407, DOI 10.1038/ijo.2013.5; Voss JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093493; Wasse LK, 2012, J APPL PHYSIOL, V112, P552, DOI 10.1152/japplphysiol.00090.2011; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Woolcott OO, 2002, HIGH ALT MED BIOL, V3, P245, DOI 10.1089/15270290260131975; Woolcott OO, 2014, OBESITY, V22, P2080, DOI 10.1002/oby.20800; Zaccaria M, 2004, EUR J APPL PHYSIOL, V92, P249, DOI 10.1007/s00421-004-1070-0; Zheutlin AR, 2014, ENVIRON INT, V73, P111, DOI 10.1016/j.envint.2014.07.012	40	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164483	10.1371/journal.pone.0164483	http://dx.doi.org/10.1371/journal.pone.0164483			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812092	Green Submitted, gold, Green Published			2022-12-26	WOS:000386910000008
J	Larsson, M; Pettersson, KO; Kashiha, J; Ross, MW; Agardh, A				Larsson, Markus; Pettersson, Karen Odberg; Kashiha, John; Ross, Michael W.; Agardh, Anette			Stretching the Boundaries: Tanzanian Pharmacy Workers' Views and Experiences of Providing STI Services for Men Who Have Sex with Men	PLOS ONE			English	Article							DAR-ES-SALAAM; PRIVATE PHARMACIES; MALARIA TREATMENT; CARE; URETHRITIS; HIV/AIDS; BEHAVIOR; ISSUES; HANOI	Objective To explore the views and experiences of providing assistance and treatment of sexually transmitted infections to same-sex practicing male clients among service providers at pharmacies and drugstores in Dar es Salaam, Tanzania. Previous research suggests that sexually transmitted infections are an increasing concern for this population. Due to stigma and discrimination, men who have sex with men face limited access to treatment, which might contribute to increased self-medication. However, limited research has been conducted on the role of the pharmaceutical service provider with regards to this population in sub-Saharan Africa. Method In January 2016, 16 service providers at private pharmacies and drugstores with previous experience of providing services to this population were purposively selected for open-ended face-to-face interviews. The analysis was guided by the grounded theory approach. Results The process that emerged was labelled "Stretching Boundaries for Pharmaceutical Responsibilities". This reflected informants' perceptions of themselves as being involved in a transition from having limited engagement in the care of same-sex practicing male clients to becoming regular service-providers to this group. Findings further revealed that the emotional commitment they developed for clients through this process led to a transgression of provider-client boundaries, which undermined objective decision-making when clients lacked prescription. Financial interests also emerged as an underlying motivation for providing incomplete or inaccurate drug dosages. Conclusions Further studies are required to better address incentives related to unregulated sale of drugs. Inter-professional networks between pharmacy and healthcare workers could support the development of targeted treatment for men who have sex with men and other key populations.	[Larsson, Markus; Pettersson, Karen Odberg; Agardh, Anette] Lund Univ, Dept Clin Sci Malmo, Div Social Med & Global Hlth, Malmo, Sweden; [Kashiha, John] Community Hlth Educ Serv & Advocacy CHESA, Dar Es Salaam, Tanzania; [Ross, Michael W.] Univ Minnesota, Sch Med, Dept Family Med & Community Hlth, Programme Human Sexual, Minneapolis, MN 55455 USA	Lund University; University of Minnesota System; University of Minnesota Twin Cities	Larsson, M (corresponding author), Lund Univ, Dept Clin Sci Malmo, Div Social Med & Global Hlth, Malmo, Sweden.	markus.larsson@med.lu.se		Ross, Michael/0000-0002-5718-9989	Swedish Research Council [2014-2649]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by grants from the Swedish Research Council (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html), project grant number 2014-2649 (AA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman D, 2007, CULT HEALTH SEX, V9, P153, DOI 10.1080/13691050601040480; Allport G. W., 1954, NATURE PREJUDICE; Anderson AM, 2015, AIDS CARE, V27, P63, DOI 10.1080/09540121.2014.951597; [Anonymous], 2012, 2012 FIP GLOB PHARM; [Anonymous], ACCR DRUG DISP OUTL; BENNER P, 1982, AM J NURS, V82, P402, DOI 10.2307/3462928; Benner P., 1984, NOVICE EXPERT EXCELL; Chalker JC, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0075-2; Chuc NTK, 1999, EUR J CLIN PHARMACOL, V55, P325, DOI 10.1007/s002280050636; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Crabbe F, 1996, GENITOURIN MED, V72, P220; Enhancing Nigeria's HIV/AIDS Response (ENR) Programme, 2010, PREV SEX TRANSM INF; Fonck K, 2001, SEX TRANSM DIS, V28, P367, DOI 10.1097/00007435-200107000-00002; GABBARD GO, 1995, JAMA-J AM MED ASSOC, V273, P1445, DOI 10.1001/jama.273.18.1445; Goel P, 1996, SOC SCI MED, V42, P1155, DOI 10.1016/0277-9536(95)00388-6; Goodman C, 2007, HEALTH POLICY PLANN, V22, P393, DOI 10.1093/heapol/czm033; Hart CA, 1998, BRIT MED J, V317, P647, DOI 10.1136/bmj.317.7159.647; Hawthorne N, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-48; Herek GM, 1998, AIDS PUBLIC POLICY J, V13, P36; Hetzel MW, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-157; Kagashe Godeliver A B, 2011, Int J Pharm Pract, V19, P30, DOI 10.1111/j.2042-7174.2010.00075.x; King R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082937; King RC, 2010, INT J HEALTH PLAN M, V25, P30, DOI 10.1002/hpm.982; KITCHENER KS, 1988, J COUNS DEV, V67, P217, DOI 10.1002/j.1556-6676.1988.tb02586.x; Kvale S., 2009, INTERVIEWS LEARNING; Kwena Z A, 2008, East Afr Med J, V85, P419; Larsson M, 2016, INT J SEX HEALTH, V28, P163, DOI 10.1080/19317611.2016.1158763; Leshabari M, 2013, PREVALENCE HUMAN IMM; Lincoln Y.S., 1985, NATURALISTIC INQUIRY, DOI DOI 10.1016/0147-1767(85)90062-8; Magesa Daniel J, 2014, Tanzan J Health Res, V16, P118; Mhamba R, 2010, DRUGS IND ACCESS ESS; Ministry of Health and Social Welfare National AIDS Control Programme, 2012, NAT GUID MAN HIV AID; Mshana SE, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-28; Mugo PM, 2013, SEX TRANSM INFECT, V89, P583, DOI 10.1136/sextrans-2012-050979; Nadelson C, 2002, THEOR MED BIOETH, V23, P191, DOI 10.1023/A:1020899425668; National Bureau of Statistics Ministry of Finance Dar es Saaam Office of Chief Government Statistician President's Office Finance Economy and Development Planning Zanzibar, 2013, POP DISTR SEX AG; Niang CI, 2003, CULT HEALTH SEX, V5, P499, DOI 10.1080/1369105031000152715; Nyanzi S, 2013, CULT HEALTH SEX, V15, P952, DOI 10.1080/13691058.2013.798684; Nyoni J, 2012, SEX TRANSM INFECT, V88, P483, DOI 10.1136/sextrans-2012-050661; Okanlawon K, 2013, CULT HEALTH SEX, V15, P22, DOI 10.1080/13691058.2012.754053; Olsson E, 2002, J CLIN PHARM THER, V27, P273, DOI 10.1046/j.1365-2710.2002.00421.x; Paswa B, 1992, Int Q Community Health Educ, V13, P317, DOI 10.2190/7P6M-C4A4-4Y62-HW8B; Reamer FG, 2003, SOC WORK, V48, P121, DOI 10.1093/sw/48.1.121; Ross MW, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen-2014-006175, 10.1136/bmjopen-2012-001928]; Ross MW., 2014, RES SOCIAL SCI STUDY, V25, P160, DOI [DOI 10.1163/9789004272385_, 10.1163/9789004272385_010, DOI 10.1163/9789004272385_010]; Rutta Edmund, 2015, J Pharm Policy Pract, V8, P23, DOI 10.1186/s40545-015-0044-4; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Tanzania Food and Drugs Authority, 2010, TRAIN MAN ACCR DRUG; Torn A, 1998, J ADV NURS, V27, P1202, DOI 10.1046/j.1365-2648.1998.00648.x; VANDERGEEST S, 1987, SOC SCI MED, V25, P293, DOI 10.1016/0277-9536(87)90232-2; Ventola C Lee, 2015, P T, V40, P277; Viberg N, 2009, SEX TRANSM INFECT, V85, P300, DOI 10.1136/sti.2008.032888; Zahn R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147156	54	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166019	10.1371/journal.pone.0166019	http://dx.doi.org/10.1371/journal.pone.0166019			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812206	gold, Green Published, Green Submitted			2022-12-26	WOS:000386910000093
J	Mas-y-Mas, S; Barbon, M; Teyssier, C; Demene, H; Carvalho, JE; Bird, LE; Lebedev, A; Fattori, J; Schubert, M; Dumas, C; Bourguet, W; le Maire, A				Mas-y-Mas, Sarah; Barbon, Marta; Teyssier, Catherine; Demene, Helene; Carvalho, Joao E.; Bird, Louise E.; Lebedev, Andrey; Fattori, Juliana; Schubert, Michael; Dumas, Christian; Bourguet, William; le Maire, Albane			The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; H3K4 METHYLATION; HISTONE H3; EXPRESSION; HOMOLOG; COMPLEX; BINDING; FAMILY; SERVER	Mixed Lineage Leukemia 5 (MLL5) plays a key role in hematopoiesis, spermatogenesis and cell cycle progression. Chromatin binding is ensured by its plant homeodomain (PHD) through a direct interaction with the N-terminus of histone H3 (H3). In addition, MLL5 contains a Su(var) 3-9, Enhancer of zeste, Trithorax (SET) domain, a protein module that usually displays histone lysine methyltransferase activity. We report here the crystal structure of the unliganded SET domain of human MLL5 at 2.1 resolution. Although it shows most of the canonical features of other SET domains, both the lack of key residues and the presence in the SET-I subdomain of an unusually large loop preclude the interaction of MLL5 SET with its cofactor and substrate. Accordingly, we show that MLL5 is devoid of any in vitro methyltransferase activity on full-length histones and histone H3 peptides. Hence, the three dimensional structure of MLL5 SET domain unveils the structural basis for its lack of methyltransferase activity and suggests a new regulatory mechanism.	[Mas-y-Mas, Sarah; Barbon, Marta; Demene, Helene; Dumas, Christian; Bourguet, William; le Maire, Albane] INSERM, U1054, Ctr Biochim Struct, Montpellier, France; [Mas-y-Mas, Sarah; Barbon, Marta; Demene, Helene; Dumas, Christian; Bourguet, William; le Maire, Albane] CNRS, UMR5048, Ctr Biochim Struct, Montpellier, France; [Mas-y-Mas, Sarah; Barbon, Marta; Teyssier, Catherine; Demene, Helene; Dumas, Christian; Bourguet, William; le Maire, Albane] Univ Montpellier, Montpellier, France; [Teyssier, Catherine] IRCM, Montpellier, France; [Carvalho, Joao E.; Schubert, Michael] UPMC Univ Paris 06, Sorbonne Univ, CNRS, Lab Biol Dev Villefranche Sur Mer,Observ Oceanol, Villefranche Sur Mer, France; [Bird, Louise E.] Rutherford Appleton Lab, Res Complex Harwell, OPPF UK, Didcot OX11 0FA, Oxon, England; [Lebedev, Andrey] Rutherford Appleton Lab, Res Complex Harwell, CCP4, Didcot OX11 0FA, Oxon, England; [Fattori, Juliana; le Maire, Albane] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Campinas, SP, Brazil; [Barbon, Marta] Imperial Coll, Inst Clin Sci, DNA Replicat Grp, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Imperial College London	le Maire, A (corresponding author), INSERM, U1054, Ctr Biochim Struct, Montpellier, France.; le Maire, A (corresponding author), CNRS, UMR5048, Ctr Biochim Struct, Montpellier, France.; le Maire, A (corresponding author), Univ Montpellier, Montpellier, France.; le Maire, A (corresponding author), Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Campinas, SP, Brazil.	albane.lemaire@cbs.cnrs.fr	Bourguet, William/I-5569-2013; Fattori, Juliana/M-4021-2019; Déméné, Hélène/AAZ-1691-2021; Bourguet, William/Y-6600-2019; Schubert, Michael/C-1875-2008; Teyssier, Catherine/AAC-2395-2020; Carvalho, João E/AAQ-1456-2020	Bourguet, William/0000-0002-0643-7719; Fattori, Juliana/0000-0002-5865-0183; Déméné, Hélène/0000-0002-7531-4309; Bourguet, William/0000-0002-0643-7719; Schubert, Michael/0000-0002-2341-712X; Teyssier, Catherine/0000-0003-4937-6503; Carvalho, João E/0000-0002-7770-4351; le Maire, Albane/0000-0003-3336-2158; Barbon, Marta/0000-0003-0891-5507; Bird, Louise/0000-0002-9846-5716	Association pour la Recherche sur le Cancer (ARC); FCT [SFRH/BD/86878/2012]; Medical Research Council [MR/K018779/1] Funding Source: researchfish; MRC [MR/K018779/1] Funding Source: UKRI	Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a research grant from the Association pour la Recherche sur le Cancer (ARC) (to A.I.M). J.E.C. is a FCT doctoral fellow (SFRH/BD/86878/2012).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ali M, 2013, P NATL ACAD SCI USA, V110, P11296, DOI 10.1073/pnas.1310156110; Antonysamy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084147; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deng LW, 2004, P NATL ACAD SCI USA, V101, P757, DOI 10.1073/pnas.2036345100; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Emerling BM, 2002, ONCOGENE, V21, P4849, DOI 10.1038/sj.onc.1205615; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Heuser M, 2009, BLOOD, V113, P1432, DOI [10.1182/blood-2008-02-162263, 10.1182/blood-2008-06-162263]; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horowitz S, 2011, J BIOL CHEM, V286, P18658, DOI 10.1074/jbc.M111.232876; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Justin N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11316; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lemak A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077020; Li YJ, 2016, NATURE, V530, P447, DOI 10.1038/nature16952; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Madan V, 2009, BLOOD, V113, P1444, DOI 10.1182/blood-2008-02-142638; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Mark P, 2001, J PHYS CHEM A, V105, P9954, DOI 10.1021/jp003020w; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Pons JL, 1996, J BIOMOL NMR, V8, P445, DOI 10.1007/BF00228146; Rincon-Arano H, 2012, CELL, V151, P1214, DOI 10.1016/j.cell.2012.11.009; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sali A., 2008, STRUCTURE, P779; Sebastian S, 2009, P NATL ACAD SCI USA, V106, P4719, DOI 10.1073/pnas.0807136106; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Tiwari SP, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0427-6; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Whelan S, 2001, TRENDS GENET, V17, P262, DOI 10.1016/S0168-9525(01)02272-7; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083737; Wu J, 2012, J BIOMOL SCREEN, V17, P237, DOI 10.1177/1087057111414903; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Yap DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027127; Zhang P, 2012, NUCLEIC ACIDS RES, V40, P4237, DOI 10.1093/nar/gkr1235; Zhang Y, 2009, BLOOD, V113, P1455, DOI 10.1182/blood-2008-05-159905; Zheng WH, 2012, J AM CHEM SOC, V134, P18004, DOI 10.1021/ja307060p; Zhou PP, 2013, J BIOL CHEM, V288, P17532, DOI 10.1074/jbc.M112.439729	56	21	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165139	10.1371/journal.pone.0165139	http://dx.doi.org/10.1371/journal.pone.0165139			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812132	gold, Green Published, Green Submitted			2022-12-26	WOS:000386910000022
J	Mayo, C; Shelley, C; MacLachlan, NJ; Gardner, I; Hartley, D; Barker, C				Mayo, Christie; Shelley, Courtney; MacLachlan, N. James; Gardner, Ian; Hartley, David; Barker, Christopher			A Deterministic Model to Quantify Risk and Guide Mitigation Strategies to Reduce Bluetongue Virus Transmission in California Dairy Cattle	PLOS ONE			English	Article							CULICOIDES-VARIIPENNIS DIPTERA; SONORENSIS DIPTERA; RECENT EMERGENCE; CERATOPOGONIDAE; INFECTION; ABUNDANCE; SEROTYPE; VECTORS; CLIMATE; DISEASE	The global distribution of bluetongue virus (BTV) has been changing recently, perhaps as a result of climate change. To evaluate the risk of BTV infection and transmission in a BTV-endemic region of California, sentinel dairy cows were evaluated for BTV infection, and populations of Culicoides vectors were collected at different sites using carbon dioxide. A deterministic model was developed to quantify risk and guide future mitigation strategies to reduce BTV infection in California dairy cattle. The greatest risk of BTV transmission was predicted within the warm Central Valley of California that contains the highest density of dairy cattle in the United States. Temperature and parameters associated with Culicoides vectors (transmission probabilities, carrying capacity, and survivorship) had the greatest effect on BTV's basic reproduction number, R-0. Based on these analyses, optimal control strategies for reducing BTV infection risk in dairy cattle will be highly reliant upon early efforts to reduce vector abundance during the months prior to peak transmission.	[Mayo, Christie] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Shelley, Courtney; MacLachlan, N. James; Barker, Christopher] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Gardner, Ian] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Charlottetown, PE, Canada; [Hartley, David] Cincinnati Childrens Hosp Med Ctr, James M Anderson Ctr Hlth Syst Excellence, Cincinnati, OH 45229 USA	Colorado State University; University of California System; University of California Davis; University of Prince Edward Island; Cincinnati Children's Hospital Medical Center	Mayo, C (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Christie.Mayo@colostate.edu	Shelley, Courtney/AAD-6527-2021	Hartley, David/0000-0003-2589-2538	Agriculture and Food Research Initiative from U.S. Department of Agriculture-National Institute of Food and Agriculture [2012-67015-19527]; Center for Food Animal Health at University of California Davis; US Department of Agriculture; Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health	Agriculture and Food Research Initiative from U.S. Department of Agriculture-National Institute of Food and Agriculture; Center for Food Animal Health at University of California Davis; US Department of Agriculture(United States Department of Agriculture (USDA)); Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	These studies were supported by funds provided by the Agriculture and Food Research Initiative competitive grant 2012-67015-19527 from the U.S. Department of Agriculture-National Institute of Food and Agriculture, and the Center for Food Animal Health at University of California Davis, the US Department of Agriculture under the Animal Health Act, 1977, Public Law 95-113. Additional support was received from the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security and Fogarty International Center, National Institutes of Health.	Baylis M, 2009, VET J, V182, P140, DOI 10.1016/j.tvjl.2009.08.014; Bonneau KR, 2001, J VIROL, V75, P8298, DOI 10.1128/JVI.75.17.8298-8305.2001; Boyer TC, 2007, AM J VET RES, V68, P1212, DOI 10.2460/ajvr.68.11.1212; Brenner J, 2010, EMERG INFECT DIS, V16, P2003, DOI 10.3201/eid1612.100239; BRENNER RJ, 1984, MOSQ NEWS, V44, P343; Burgin LE, 2013, TRANSBOUND EMERG DIS, V60, P263, DOI 10.1111/j.1865-1682.2012.01345.x; Calistri P, 2004, VETER ITAL SER, V40, P243; Cameron A R, 2004, Vet Ital, V40, P693; Carpenter S, 2011, VET REC, V168, P238, DOI 10.1136/vr.d1385; CHANEY RW, 1949, P NATL ACAD SCI USA, V35, P356, DOI 10.1073/pnas.35.7.356; Charron MVP, 2011, J THEOR BIOL, V291, P1, DOI 10.1016/j.jtbi.2011.08.041; Cheng Xu, 2002, Yingyong Shengtai Xuebao, V13, P1503; Eagles D, 2013, PREV VET MED, V110, P312, DOI 10.1016/j.prevetmed.2013.02.022; Eagles D, 2012, MED VET ENTOMOL, V26, P334, DOI 10.1111/j.1365-2915.2011.01005.x; Gerry AC, 2000, J MED ENTOMOL, V37, P675, DOI 10.1603/0022-2585-37.5.675; Gerry AC, 2001, J MED ENTOMOL, V38, P197, DOI 10.1603/0022-2585-38.2.197; Gerry AC, 2009, J MED ENTOMOL, V46, P615, DOI 10.1603/033.046.0329; GIBBS EPJ, 1983, AM J VET RES, V44, P2226; GIBBS EPJ, 1994, COMP IMMUNOL MICROB, V17, P207, DOI 10.1016/0147-9571(94)90044-2; Giovannini A, 2004, VETER ITAL SER, V40, P369; Gloster J, 2007, VET REC, V160, P54, DOI 10.1136/vr.160.2.54; Green AL, 2005, AM J VET RES, V66, P853, DOI 10.2460/ajvr.2005.66.853; Gubbins S, 2012, PREV VET MED, V105, P297, DOI 10.1016/j.prevetmed.2012.02.016; Gubbins S, 2008, J R SOC INTERFACE, V5, P363, DOI 10.1098/rsif.2007.1110; Guis H, 2012, J R SOC INTERFACE, V9, P339, DOI 10.1098/rsif.2011.0255; Holbrook F.R., 1985, Progress in Clinical and Biological Research, V178, P607; HOLBROOK FR, 1995, J MED ENTOMOL, V32, P413, DOI 10.1093/jmedent/32.4.413; Hoyle A, 2007, MATH BIOSCI, V210, P1, DOI 10.1016/j.mbs.2007.06.001; Kirkland PD, 2004, VETER ITAL SER, V40, P47; Maclachlan NJ, 2015, REV SCI TECH OIE, V34, P329, DOI 10.20506/rst.34.2.2360; Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003; Maclachlan NJ, 2013, ANTIVIR RES, V99, P79, DOI 10.1016/j.antiviral.2013.04.021; Maclachlan NJ, 2013, EMERG INFECT DIS, V19, P665, DOI 10.3201/eid1904.120347; MacLachlan NJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010007; Maclachlan NJ, 2010, VET CLIN N AM-FOOD A, V26, P163, DOI 10.1016/j.cvfa.2009.10.012; MacLachlan NJ, 2006, JAVMA-J AM VET MED A, V228, P1346, DOI 10.2460/javma.228.9.1346; MACLACHLAN NJ, 1994, ARCH VIROL, V136, P1, DOI 10.1007/BF01538812; Mayo CE, 2010, TRANSBOUND EMERG DIS, V57, P277, DOI 10.1111/j.1865-1682.2010.01149.x; Mayo CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106975; Mayo CE, 2012, VET PARASITOL, V187, P295, DOI 10.1016/j.vetpar.2012.01.004; Mayo CE, 2012, VET MICROBIOL, V155, P158, DOI 10.1016/j.vetmic.2011.08.029; McDermott EG, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1062-4; Mellor PS, 2008, PREV VET MED, V87, P4, DOI 10.1016/j.prevetmed.2008.06.002; Monteiro DMS, 2012, PREV VET MED, V105, P17, DOI 10.1016/j.prevetmed.2012.01.011; MULLENS BA, 1991, J AM MOSQUITO CONTR, V7, P588; Mullens BA, 1998, J MED ENTOMOL, V35, P245, DOI 10.1093/jmedent/35.3.245; Mullens BA, 2004, VETER ITAL SER, V40, P160; MULLENS BA, 1989, J MED ENTOMOL, V26, P566, DOI 10.1093/jmedent/26.6.566; Napp S, 2013, MED VET ENTOMOL, V27, P19, DOI 10.1111/j.1365-2915.2012.01016.x; Nunamaker RA, 1997, J MED ENTOMOL, V34, P18, DOI 10.1093/jmedent/34.1.18; O'Connell L., 2002, THESIS U BRISTOL, P176; OROURKE MJ, 1983, MOSQ NEWS, V43, P147; Ortega J, 2010, J VET DIAGN INVEST, V22, P134, DOI 10.1177/104063871002200129; Osborne CJ, 2015, J MED ENTOMOL, V52, P274, DOI 10.1093/jme/tju063; OSBURN BI, 1981, AM J VET RES, V42, P884; PRISM Climate Group. Oregon State University, 2004, STATE; Purse BV, 2006, MED VET ENTOMOL, V20, P335, DOI 10.1111/j.1365-2915.2006.00636.x; Purse BV, 2012, MED VET ENTOMOL, V26, P168, DOI 10.1111/j.1365-2915.2011.00991.x; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Roug A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050600; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Schmidtmann ET, 2000, J MED ENTOMOL, V37, P58, DOI 10.1603/0022-2585-37.1.58; Singer RS, 2001, J VET DIAGN INVEST, V13, P43, DOI 10.1177/104063870101300109; Spreull J, 1905, J COMP PATHOL, V18, P321, DOI DOI 10.1016/S0368-1742(05)80073-6; STALLKNECHT DE, 1991, J WILDLIFE DIS, V27, P668, DOI 10.7589/0090-3558-27.4.668; STOTT J L, 1985, P571; Szmaragd C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007741; Turner J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00319; Tuya F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020190; UHAA IJ, 1990, VET RES COMMUN, V14, P99; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Velthuis AGJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019612; Verwoerd D. W., 2004, Infectious diseases of livestock. Volume Two, P1201; Walton TE, 2004, VETER ITAL SER, V40, P31; Ward MP, 1997, PREV VET MED, V29, P299, DOI 10.1016/S0167-5877(96)01081-1; Zuliani A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130294	76	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165806	10.1371/journal.pone.0165806	http://dx.doi.org/10.1371/journal.pone.0165806			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812161	gold, Green Published, Green Submitted			2022-12-26	WOS:000386910000062
J	Rand, MK; Rentsch, S				Rand, Miya K.; Rentsch, Sebastian			Eye-Hand Coordination during Visuomotor Adaptation with Different Rotation Angles: Effects of Terminal Visual Feedback	PLOS ONE			English	Article							REAL SLIDING LEVERS; SENSORIMOTOR ADAPTATION; MOTOR TRANSFORMATIONS; EXPLICIT STRATEGY; MOVEMENTS; TARGET; GAZE; TASK; IMPLICIT; ERROR	This study examined adaptive changes of eye-hand coordination during a visuomotor rotation task under the use of terminal visual feedback. Young adults made reaching movements to targets on a digitizer while looking at targets on a monitor where the rotated feedback (a cursor) of hand movements appeared after each movement. Three rotation angles (30 degrees, 75 degrees and 150 degrees) were examined in three groups in order to vary the task difficulty. The results showed that the 30 degrees group gradually reduced direction errors of reaching with practice and adapted well to the visuomotor rotation. The 75 degrees group made large direction errors of reaching, and the 150 degrees group applied a 180 degrees reversal shift from early practice. The 75 degrees and 150 degrees groups, however, overcompensated the respective rotations at the end of practice. Despite these group differences in adaptive changes of reaching, all groups gradually adapted gaze directions prior to reaching from the target area to the areas related to the final positions of reaching during the course of practice. The adaptive changes of both hand and eye movements in all groups mainly reflected adjustments of movement directions based on explicit knowledge of the applied rotation acquired through practice. Only the 30 degrees group showed small implicit adaptation in both effectors. The results suggest that by adapting gaze directions from the target to the final position of reaching based on explicit knowledge of the visuomotor rotation, the oculomotor system supports the limb-motor system to make precise preplanned adjustments of reaching directions during learning of visuomotor rotation under terminal visual feedback.	[Rand, Miya K.; Rentsch, Sebastian] Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Rand, MK (corresponding author), Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.	rand@ifado.de			German Research Foundation (DFG) [Ra 2183/1-3]	German Research Foundation (DFG)(German Research Foundation (DFG))	This research was supported by grant Ra 2183/1-3 of the German Research Foundation (DFG) to MKR, http://www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeele S, 2001, EXP BRAIN RES, V140, P407, DOI 10.1007/s002210100846; ABRAMS RA, 1990, J EXP PSYCHOL HUMAN, V16, P248, DOI 10.1037/0096-1523.16.2.248; Adam JJ, 2012, J EXP PSYCHOL HUMAN, V38, P891, DOI 10.1037/a0027592; Benson BL, 2011, J NEUROPHYSIOL, V105, P2843, DOI 10.1152/jn.00002.2011; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bernier PM, 2005, EXP BRAIN RES, V167, P292, DOI 10.1007/s00221-005-0063-5; Bowman M, 2009, EXP BRAIN RES, V195, P273, DOI 10.1007/s00221-009-1781-x; Crawford JD, 2004, J NEUROPHYSIOL, V92, P10, DOI 10.1152/jn.00117.2004; CUNNINGHAM HA, 1989, J EXP PSYCHOL HUMAN, V15, P493, DOI 10.1037/0096-1523.15.3.493; de Boor C, 1978, A PRACTICAL GUIDE TO; ELLIOTT D, 1988, CAN J PSYCHOL, V42, P57, DOI 10.1037/h0084172; Ferrel C, 2001, EXP BRAIN RES, V138, P313, DOI 10.1007/s002210100697; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Gaveau V, 2008, NEUROPSYCHOLOGIA, V46, P475, DOI 10.1016/j.neuropsychologia.2007.08.028; Gaveau V, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00880; GEORGOPOULOS AP, 1987, EXP BRAIN RES, V65, P361; Ghez C, 2007, J NEUROPHYSIOL, V98, P3614, DOI 10.1152/jn.00652.2007; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; Granek JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0086138; Granek JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046619; Hayhoe MM, 2003, J VISION, V3, P49, DOI 10.1167/3.1.6; Hegele M, 2010, CONSCIOUS COGN, V19, P906, DOI 10.1016/j.concog.2010.05.005; Heuer H., 2013, AGE DIFFERENTIATED W, P369, DOI DOI 10.1007/978-3-642-35057-3_16; Heuer H, 2008, J MOTOR BEHAV, V40, P368, DOI 10.3200/JMBR.40.5.368-379; Heuer H, 2008, PSYCHOL AGING, V23, P190, DOI 10.1037/0882-7974.23.1.190; Heuer H, 2008, EXP BRAIN RES, V185, P101, DOI 10.1007/s00221-007-1135-5; Heuer H, 2012, HUM MOVEMENT SCI, V31, P1056, DOI 10.1016/j.humov.2012.01.004; Hinder MR, 2008, EXP BRAIN RES, V191, P143, DOI 10.1007/s00221-008-1513-7; Hinder MR, 2010, EXP BRAIN RES, V201, P191, DOI 10.1007/s00221-009-2025-9; IMAMIZU H, 1995, J EXP PSYCHOL HUMAN, V21, P719, DOI 10.1037/0096-1523.21.4.719; Ishihara S, 2005, ISHIHARA TESTS FOR C; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Lunenburger L, 2000, EUR J NEUROSCI, V12, P4107, DOI 10.1046/j.1460-9568.2000.00298.x; Martin TA, 1996, BRAIN, V119, P1199, DOI 10.1093/brain/119.4.1199; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Michel C, 2007, J COGNITIVE NEUROSCI, V19, P341, DOI 10.1162/jocn.2007.19.2.341; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; Paillard J., 1982, ANAL VISUAL BEHAV, P367; Peled A, 2012, J MOTOR BEHAV, V44, P185, DOI 10.1080/00222895.2012.672349; Pisella L, 2009, NEUROPSYCHOLOGIA, V47, P3033, DOI 10.1016/j.neuropsychologia.2009.06.020; PRABLANC C, 1986, EXP BRAIN RES, V62, P293; PRABLANC C, 1979, BIOL CYBERN, V35, P113, DOI 10.1007/BF00337436; Rand MK, 2015, J NEUROPHYSIOL, V113, P88, DOI 10.1152/jn.00044.2014; Rand MK, 2014, EXP BRAIN RES, V232, P2753, DOI 10.1007/s00221-014-3951-8; Rand MK, 2010, EXP BRAIN RES, V207, P197, DOI 10.1007/s00221-010-2456-3; Redding GM, 1996, J EXP PSYCHOL HUMAN, V22, P379, DOI 10.1037/0096-1523.22.2.379; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; Rentsch S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109819; Sailer U, 2005, J NEUROSCI, V25, P8833, DOI 10.1523/JNEUROSCI.2658-05.2005; Saunders JA, 2004, J NEUROSCI, V24, P3223, DOI 10.1523/JNEUROSCI.4319-03.2004; Scheidt RA, 2007, J NEUROPHYSIOL, V98, P3600, DOI 10.1152/jn.00121.2007; Shabbott BA, 2010, EXP BRAIN RES, V203, P75, DOI 10.1007/s00221-010-2209-3; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Sulzenbruck S, 2012, EXP BRAIN RES, V218, P283, DOI 10.1007/s00221-012-3011-1; Sulzenbruck S, 2012, Z PSYCHOL, V220, P3, DOI 10.1027/2151-2604/a000084; Sulzenbruck S, 2011, ERGONOMICS, V54, P34, DOI 10.1080/00140139.2010.535023; Sulzenbruck S, 2010, EXP BRAIN RES, V201, P549, DOI 10.1007/s00221-009-2071-3; Sulzenbruck S, 2009, EXP BRAIN RES, V195, P153, DOI 10.1007/s00221-009-1764-y; Taylor JA, 2014, J NEUROSCI, V34, P3023, DOI 10.1523/JNEUROSCI.3619-13.2014; Taylor JA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001096; TEASDALE N, 1993, J MOTOR BEHAV, V25, P97, DOI 10.1080/00222895.1993.9941644; Walsh CM, 2009, ACAD MED, V84, pS54, DOI 10.1097/ACM.0b013e3181b38daf; Werner S, 2007, EXP BRAIN RES, V178, P554, DOI 10.1007/s00221-007-0925-0; Winer BJ., 1971, STAT PRINCIPLES EXPT, V2nd ed	64	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164602	10.1371/journal.pone.0164602	http://dx.doi.org/10.1371/journal.pone.0164602			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812093	Green Submitted, Green Published, gold			2022-12-26	WOS:000386910000010
J	Sekine, Y; Zyryanova, A; Crespillo-Casado, A; Amin-Wetzel, N; Harding, HP; Ron, D				Sekine, Yusuke; Zyryanova, Alisa; Crespillo-Casado, Ana; Amin-Wetzel, Niko; Harding, Heather P.; Ron, David			Paradoxical Sensitivity to an Integrated Stress Response Blocking Mutation in Vanishing White Matter Cells	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; TRANSLATIONAL CONTROL; EIF2B; PHOSPHORYLATION; REPRESSION; DISORDERS; DISEASE; TARGET; GENES; GCN4	The eukaryotic translation initiation factor eIF2B promotes mRNA translation as a guanine nucleotide exchange factor (GEF) for translation initiation factor 2 (eIF2). Endoplasmic reticulum (ER) stress-mediated activation of the kinase PERK and the resultant phosphorylation of eIF2's alpha subunit (eIF2 alpha) attenuates eIF2B GEF activity thereby inducing an integrated stress response (ISR) that defends against protein misfolding in the ER. Mutations in all five subunits of human eIF2B cause an inherited leukoencephalopathy with vanishing white matter (VWM), but the role of the ISR in its pathogenesis remains unclear. Using CRISPR-Cas9 genome editing we introduced the most severe known VWM mutation, EIF2B4 A391D, into CHO cells. Compared to isogenic wildtype cells, GEF activity of cells with the VWM mutation was impaired and the mutant cells experienced modest enhancement of the ISR. However, despite their enhanced ISR, imposed by the intrinsic defect in eIF2B, disrupting the inhibitory effect of phosphorylated eIF2 alpha on GEF by a contravening EIF2S1/eIF2 alpha(S51A) mutation that functions upstream of eIF2B, selectively enfeebled both EIF2B4(A391D) and the related severe VWM EIF2B4(R483W) cells. The basis for paradoxical dependence of cells with the VWM mutations on an intact eIF2 alpha genotype remains unclear, as both translation rates and survival from stressors that normally activate the ISR were not reproducibly affected by the VWM mutations. Nonetheless, our findings support an additional layer of complexity in the development of VWM, beyond a hyperactive ISR.	[Sekine, Yusuke; Zyryanova, Alisa; Crespillo-Casado, Ana; Amin-Wetzel, Niko; Harding, Heather P.; Ron, David] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Sekine, Yusuke] NHLBI, Ctr Mol Med, NIH, Bldg 10, Bethesda, MD 20892 USA	University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Sekine, Y; Ron, D (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Cambridge, England.; Sekine, Y (corresponding author), NHLBI, Ctr Mol Med, NIH, Bldg 10, Bethesda, MD 20892 USA.	yusuke.sekine@nih.gov; dr360@medschl.cam.ac.uk	Sekine, Yusuke/AHI-8340-2022	Harding, Heather P/0000-0002-7359-7974; Amin-Wetzel, Niko/0000-0002-4640-3724; Sekine, Yusuke/0000-0003-0345-1416; Ron, David/0000-0002-3014-5636	Wellcome Trust [200848/Z/16/Z, 100140]; European Commission (EU FP7 Beta-Bat) [277713]; Medical Research Council; Medical Research Council [1358405] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); European Commission (EU FP7 Beta-Bat); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from the Wellcome Trust (Wellcome 200848/Z/16/Z) and the European Commission (EU FP7 Beta-Bat No: 277713) and, a Wellcome Trust Strategic Award for core facilities to the Cambridge Institute for Medical Research (Wellcome 100140). YS is a Japanese Society for the Promotion of Science Postdoctoral Fellow for Research Abroad. NAW is a Medical Research Council supported PhD student. DR is a Wellcome Trust Principal Research Fellow. Wellcome Trust URL; http://www.wellcome.ac.uk, JSPS URL; https://www.jsps.go.jp, MRC URL; http://www.mrc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Fogli A, 2006, BIOCHEM SOC T, V34, P22, DOI 10.1042/BST0340022; Fogli A, 2003, AM J HUM GENET, V72, P1544, DOI 10.1086/375404; HARASHIMA S, 1986, MOL CELL BIOL, V6, P3990, DOI 10.1128/MCB.6.11.3990; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Kantor L, 2005, HUM GENET, V118, P99, DOI 10.1007/s00439-005-0024-x; Li W, 2004, MOL CELL BIOL, V24, P3295, DOI 10.1128/MCB.24.8.3295-3306.2004; Lin WS, 2009, NAT NEUROSCI, V12, P379, DOI 10.1038/nn.2273; Liu R, 2011, HUM MUTAT, V32, P1036, DOI 10.1002/humu.21535; Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486; Maletkovic J, 2008, J CHILD NEUROL, V23, P205, DOI 10.1177/0883073807308705; Mohammad-Qureshi SS, 2008, BIOCHEM SOC T, V36, P658, DOI 10.1042/BST0360658; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Pavitt GD, 2009, BIOCHEM SOC T, V37, P1298, DOI 10.1042/BST0371298; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ron D, 2007, TRANSLATIONAL CONTRO, P345; Ronda C, 2014, BIOTECHNOL BIOENG, V111, P1604, DOI 10.1002/bit.25233; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; SCORSONE KA, 1987, J BIOL CHEM, V262, P14538; Sekine Y, 2015, SCIENCE, V348, P1027, DOI 10.1126/science.aaa6986; van der Knaap MS, 2003, AM J HUM GENET, V73, P1199, DOI 10.1086/379524; van der Knapp MS, 2006, LANCET NEUROL, V5, P413, DOI 10.1016/S1474-4422(06)70440-9; van Kollenburg B, 2006, NEUROBIOL DIS, V21, P496, DOI 10.1016/j.nbd.2005.08.009	28	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166278	10.1371/journal.pone.0166278	http://dx.doi.org/10.1371/journal.pone.0166278			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812215	Green Published, gold, Green Submitted			2022-12-26	WOS:000386910000107
J	Wang, JC; Shi, GF; Baptiste, S; Yarotska, M; Sindhu, H; Wong, C; Kalavar, M; Gotlieb, V; Bandarchuk, A; Chen, H				Wang, Jen C.; Shi, Guanfang; Baptiste, Stacey; Yarotska, Maryna; Sindhu, Hemant; Wong, Ching; Kalavar, Madhumati; Gotlieb, Vladimir; Bandarchuk, Andrei; Chen, Hui			Quantification of IGF-1 Receptor May Be Useful in Diagnosing Polycythemia Vera-Suggestion to Be Added to Be One of the Minor Criterionle	PLOS ONE			English	Article							CIRCULATING ERYTHROID PROGENITORS; BONE-MARROW; ESSENTIAL THROMBOCYTHEMIA; MYELOPROLIFERATIVE NEOPLASMS; HISTOLOGICAL CRITERIA; MONONUCLEAR-CELLS; COLONY FORMATION; IN-VITRO; ERYTHROPOIETIN; MYELOFIBROSIS	Endogenous erythroid colony (EEC) formation is one of the minor criteria for diagnosing polycythemia vera (PV) according to 2008 WHO diagnostic criteria. But EEC requires bone marrow aspiration and sophisticated laboratory procedures; therefore, practically it is rarely used to diagnose PV. Insulin-like growth factor 1 receptor (IGF-1R) was found to be constitutively phosphorylated and was responsible for the EEC formation in PV; therefore, we measured IGF-1R levels in the peripheral blood of 26 PV patients and compared them with those of 33 patients with secondary polycythemia and 29 normal controls. Among the PV patients, 16 were treated with only phlebotomy, 9 received hydroxyurea, and 1 was treated with ruxolinitinib. We found that PV patients treated with only phlebotomy had significantly higher IGF-1R levels than did those PV patients treated with hydroxyurea or ruxolinitinib. None of the secondary PV patients or normal controls had elevated IGR-1R levels, while 14 of 16 (87%) PV patients had significantly elevated IGF-1R levels. The new 2016 WHO has eliminated EEC as a minor criterion for diagnosing PV, but there are still some cases that cannot be definitively diagnosed by the current criteria. Therefore, we suggest that quantifying the IGF-1R level in peripheral blood by flow cytometry to replace EEC as the minor criterion for diagnosing PV.	[Wang, Jen C.; Shi, Guanfang; Baptiste, Stacey; Yarotska, Maryna; Sindhu, Hemant; Wong, Ching; Kalavar, Madhumati; Gotlieb, Vladimir; Bandarchuk, Andrei; Chen, Hui] Brookdale Univ Hosp Med Ctr, Div Hematol Oncol, Brooklyn, NY 11212 USA		Wang, JC (corresponding author), Brookdale Univ Hosp Med Ctr, Div Hematol Oncol, Brooklyn, NY 11212 USA.	jcwang0005@Gmail.com			Celgen Corp.	Celgen Corp.	JCW received grants from Celgen Corp. The other authors declare no competing financial interests. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Larran A, 2014, BRIT J HAEMATOL, V166, P911, DOI 10.1111/bjh.12990; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Barbui T, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.64; Barbui T, 2014, AM J HEMATOL, V89, P52, DOI 10.1002/ajh.23585; CORREA PN, 1994, BLOOD, V83, P99; EAVES CJ, 1978, BLOOD, V52, P1196; ELLIS JT, 1986, SEMIN HEMATOL, V23, P144; Gianelli U, 2008, AM J CLIN PATHOL, V130, P336, DOI 10.1309/6BQ5K8LHVYAKUAF4; Gianelli U, 2014, MODERN PATHOL, V27, P814, DOI 10.1038/modpathol.2013.196; Kim HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052518; Kvasnicka HM, 2010, AM J HEMATOL, V85, P62, DOI 10.1002/ajh.21543; LACOMBE C, 1980, BRIT J HAEMATOL, V44, P189, DOI 10.1111/j.1365-2141.1980.tb01201.x; LUTTON JD, 1979, ACTA HAEMATOL-BASEL, V62, P94, DOI 10.1159/000207547; MIRZA AM, 1995, BLOOD, V86, P877; Mossuz P, 2004, HAEMATOLOGICA, V89, P1194; Pardanani A, 2007, LEUKEMIA, V21, P1960, DOI 10.1038/sj.leu.2404810; PRCHAL JF, 1974, NEW ENGL J MED, V290, P1382; Silver RT, 2013, BLOOD, V122, P1881, DOI 10.1182/blood-2013-06-508416; Spivak JL, 2002, BLOOD, V100, P4272, DOI 10.1182/blood-2001-12-0349; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Tefferi A, 2007, BLOOD, V110, P1092, DOI 10.1182/blood-2007-04-083501; Thiele J, 2005, ACTA HAEMATOL-BASEL, V113, P213, DOI 10.1159/000084673; Thiele J, 2005, ANN HEMATOL, V84, P362, DOI 10.1007/s00277-005-1030-8; Thiele J, 2005, HISTOL HISTOPATHOL, V20, P317, DOI 10.14670/HH-20.317; Vannucchi AM, 2008, LEUKEMIA, V22, pCP5, DOI 10.1038/leu.2008.113; WEINBERG RS, 1989, LEUKEMIA RES, V13, P331, DOI 10.1016/0145-2126(89)90070-2; Wilkins BS, 2008, BLOOD, V111, P60, DOI 10.1182/blood-2007-05-091850; ZANJANI ED, 1977, J CLIN INVEST, V59, P841, DOI 10.1172/JCI108706	28	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165299	10.1371/journal.pone.0165299	http://dx.doi.org/10.1371/journal.pone.0165299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812134	gold, Green Submitted, Green Published			2022-12-26	WOS:000386910000027
J	Qi, XQ; Zhang, K; Xu, T; Yamaki, VN; Wei, ZS; Huang, MF; Rose, GM; Cai, X				Qi, Xiaoqiang; Zhang, Ke; Xu, Ting; Yamaki, Vitor Nagai; Wei, Zhisheng; Huang, Mingfa; Rose, Gregory M.; Cai, Xiang			Sex Differences in Long-Term Potentiation at Temporoammonic-CA1 Synapses: Potential Implications for Memory Consolidation	PLOS ONE			English	Article							ENHANCED SYNAPTIC PLASTICITY; WATER MAZE PERFORMANCE; RAT ESTROUS-CYCLE; SPATIAL NAVIGATION; WORKING-MEMORY; POSTERIOR HIPPOCAMPUS; RETROGRADE-AMNESIA; GENDER-DIFFERENCES; PYRAMIDAL CELLS; RODENT MODELS	Sex differences in spatial memory have long been observed in humans, non-human primates and rodents, but the underlying cellular and molecular mechanisms responsible for these differences remain obscure. In the present study we found that adolescent male rats outperformed female rats in 7 d and 28 d retention probes, but not in learning trials and immediate probes, in the Morris water maze task. Male rats also had larger long-term potentiation (LTP) at hippocampal temproammonic-CA1 (TA-CA1) synapses, which have been implicated to play a key role in place field and memory consolidation, when protocols designed to elicit late-stage LTP (LLTP) were used. Interestingly, the ratio of evoked AMPA/NMDA currents was found to be smaller at TA-CA1 synapses in male rats compared to female rats. Protein biotinylation experiments showed that male rats expressed more surface GluN1 receptors in hippocampal CA1 stratum lacunosum-moleculare (SLM) than female rats, although GluA1 expression was also slightly higher in male rats. Taken together, our results suggest that differences in the expression of AMPA and NMDA receptors may affect LTP expression at TA-CA1 synapses in adolescent male and female rats, and thus possibly contribute to the observed sex difference in spatial memory.	[Qi, Xiaoqiang; Zhang, Ke; Yamaki, Vitor Nagai; Cai, Xiang] Southern Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA; [Xu, Ting; Wei, Zhisheng; Huang, Mingfa; Cai, Xiang] Guangzhou Med Univ, Affiliated Hosp 2, Inst Neurosci, Key Lab Neurogenet & Channelopathies Guangdong Pr, Guangzhou, Guangdong, Peoples R China; [Xu, Ting; Wei, Zhisheng; Huang, Mingfa; Cai, Xiang] Guangzhou Med Univ, Affiliated Hosp 2, Minist Educ China, Guangzhou, Guangdong, Peoples R China; [Rose, Gregory M.] Southern Illinois Univ, Sch Med, Dept Anat, Carbondale, IL USA; [Rose, Gregory M.; Cai, Xiang] Southern Illinois Univ, Sch Med, Neurosci Res Ctr, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University; Guangzhou Medical University; Guangzhou Medical University; Ministry of Education, China; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Cai, X (corresponding author), Southern Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA.; Cai, X (corresponding author), Guangzhou Med Univ, Affiliated Hosp 2, Inst Neurosci, Key Lab Neurogenet & Channelopathies Guangdong Pr, Guangzhou, Guangdong, Peoples R China.; Cai, X (corresponding author), Guangzhou Med Univ, Affiliated Hosp 2, Minist Educ China, Guangzhou, Guangdong, Peoples R China.; Cai, X (corresponding author), Southern Illinois Univ, Sch Med, Neurosci Res Ctr, Carbondale, IL 62901 USA.	cai001@siu.edu	Cai, Xiang/AAD-8012-2021	cai, xiang/0000-0003-0222-553X	NIMH [R01 (NIHMH086828)]; SIU School of Medicine startup funds; NARSAD Young Investigator Awards	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); SIU School of Medicine startup funds; NARSAD Young Investigator Awards(NARSAD)	This study was supported by NIMH R01 (NIHMH086828) (ST and XC); SIU School of Medicine startup funds (XC); NARSAD Young Investigator Awards (XC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astur RS, 1998, BEHAV BRAIN RES, V93, P185, DOI 10.1016/S0166-4328(98)00019-9; Blokland A, 2006, BEHAV BRAIN RES, V171, P216, DOI 10.1016/j.bbr.2006.03.033; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Cai X, 2013, NAT NEUROSCI, V16, P464, DOI 10.1038/nn.3355; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Clark RE, 2002, J NEUROSCI, V22, P4663, DOI 10.1523/JNEUROSCI.22-11-04663.2002; Cooke BM, 2003, HORM BEHAV, V43, P336, DOI 10.1016/S0018-506X(02)00047-8; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Daniel JM, 1999, PHYSIOL BEHAV, V66, P11, DOI 10.1016/S0031-9384(98)00272-8; Duff SJ, 2001, BRAIN COGNITION, V47, P470, DOI 10.1006/brcg.2001.1326; Foy MR, 1999, J NEUROPHYSIOL, V81, P925, DOI 10.1152/jn.1999.81.2.925; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Giedd JN, 1996, J COMP NEUROL, V366, P223, DOI 10.1002/(SICI)1096-9861(19960304)366:2<223::AID-CNE3>3.0.CO;2-7; Gron G, 2000, NAT NEUROSCI, V3, P404, DOI 10.1038/73980; Gupta RR, 2001, BRAIN RES, V888, P356, DOI 10.1016/S0006-8993(00)03116-4; Harte-Hargrove LC, 2015, J NEUROSCI, V35, P1723, DOI 10.1523/JNEUROSCI.0820-14.2015; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; JEFFERY KJ, 1993, HIPPOCAMPUS, V3, P133, DOI 10.1002/hipo.450030205; Jonasson Z, 2005, NEUROSCI BIOBEHAV R, V28, P811, DOI 10.1016/j.neubiorev.2004.10.006; KEATING MB, 1986, CHILD DEV, V57, P115, DOI 10.2307/1130643; Kosaki Y, 2014, HIPPOCAMPUS, V24, P1633, DOI 10.1002/hipo.22343; Leon I, 2014, NEUROPSYCHOLOGY, V28, P485, DOI 10.1037/neu0000054; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MAREN S, 1994, BRAIN RES, V661, P25, DOI 10.1016/0006-8993(94)91176-2; MAREN S, 1995, NEUROSCI LETT, V196, P177, DOI 10.1016/0304-3940(95)11869-X; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Mendez-Lopez M, 2009, NEUROSCI RES, V65, P28, DOI 10.1016/j.neures.2009.05.001; Monfort P, 2015, ACS CHEM NEUROSCI, V6, P1420, DOI 10.1021/acschemneuro.5b00096; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Murphy DGM, 1996, ARCH GEN PSYCHIAT, V53, P585; Newhouse P, 2007, BEHAV BRAIN RES, V183, P1, DOI 10.1016/j.bbr.2007.05.011; Otmakhova NA, 2002, J NEUROSCI, V22, P1199, DOI 10.1523/JNEUROSCI.22-04-01199.2002; Persson J, 2014, NEUROIMAGE, V99, P215, DOI 10.1016/j.neuroimage.2014.05.038; Pruessner JC, 2001, J NEUROSCI, V21, P194, DOI 10.1523/JNEUROSCI.21-01-00194.2001; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; Rizk-Jackson AM, 2006, BEHAV BRAIN RES, V173, P181, DOI 10.1016/j.bbr.2006.06.029; Russell NA, 2003, J NEUROSCI, V23, P6490; Sandstrom NJ, 1998, COGNITIVE BRAIN RES, V6, P351, DOI 10.1016/S0926-6410(98)00002-0; Saucier DM, 2008, ANIM COGN, V11, P129, DOI 10.1007/s10071-007-0096-1; Saucier DM, 2002, BEHAV NEUROSCI, V116, P403, DOI 10.1037//0735-7044.116.3.403; Scharfman HE, 2003, J NEUROSCI, V23, P11641; Schmidt B, 2009, HORM BEHAV, V56, P199, DOI 10.1016/j.yhbeh.2009.04.004; Shah DS, 2013, BEHAV BRAIN RES, V257, P90, DOI 10.1016/j.bbr.2013.09.027; Sherry DF, 1997, TRENDS COGN SCI, V1, P50, DOI 10.1016/S1364-6613(97)01015-2; Smith CC, 2005, J NEUROSCI, V25, P7780, DOI 10.1523/JNEUROSCI.0762-05.2005; Smith CC, 2015, HIPPOCAMPUS; Sneider JT, 2015, BEHAV PROCESS, V111, P42, DOI 10.1016/j.beproc.2014.11.015; Speed HE, 2009, HIPPOCAMPUS, V19, P187, DOI 10.1002/hipo.20496; Spellman T, 2015, NATURE, V522, P309, DOI 10.1038/nature14445; Squire LR, 2011, ANNU REV NEUROSCI, V34, P259, DOI 10.1146/annurev-neuro-061010-113720; Stavnezer AJ, 2000, BEHAV BRAIN RES, V112, P135, DOI 10.1016/S0166-4328(00)00174-1; Sutherland RJ, 2010, NEUROPSYCHOLOGIA, V48, P2357, DOI 10.1016/j.neuropsychologia.2010.04.015; Tan A, 2016, NEUROIMAGE, V124, P350, DOI 10.1016/j.neuroimage.2015.08.050; Taniike N, 2008, ACTA MED OKAYAMA, V62, P21; Tropp J, 2005, HIPPOCAMPUS, V15, P154, DOI 10.1002/hipo.20042; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Warren SG, 1997, BEHAV NEUROSCI, V111, P259, DOI 10.1037/0735-7044.111.2.259; Warren SG, 1995, BRAIN RES, V703, P26, DOI 10.1016/0006-8993(95)01059-9; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; WILLIAMS CL, 1991, PSYCHONEUROENDOCRINO, V16, P155, DOI 10.1016/0306-4530(91)90076-6; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; Woolley DG, 2010, BEHAV BRAIN RES, V208, P408, DOI 10.1016/j.bbr.2009.12.019; Yang DW, 2004, LIFE SCI, V75, P119, DOI 10.1016/j.lfs.2003.12.004; Zhang SJ, 2013, SCIENCE, V340, P44, DOI 10.1126/science.1232627	69	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165891	10.1371/journal.pone.0165891	http://dx.doi.org/10.1371/journal.pone.0165891			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806108	gold, Green Published, Green Submitted			2022-12-26	WOS:000386715500070
J	Torbeyns, T; de Geus, B; Bailey, S; De Pauw, K; Decroix, L; Van Cutsem, J; Meeusen, R				Torbeyns, Tine; de Geus, Bas; Bailey, Stephen; De Pauw, Kevin; Decroix, Lieselot; Van Cutsem, Jeroen; Meeusen, Romain			Cycling on a Bike Desk Positively Influences Cognitive Performance	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; TASK-PERFORMANCE; WORKSTATIONS; EXERCISE; WALKING; RELIABILITY; INTENSITY; CONFLICT; ERP	Purpose Cycling desks as a means to reduce sedentary time in the office has gained interest as excessive sitting has been associated with several health risks. However, the question rises if people will still be as efficient in performing their desk-based office work when combining this with stationary cycling. Therefore, the effect of cycling at 30% Wmax on typing, cognitive performance and brain activity was investigated. Methods After two familiarisation sessions, 23 participants performed a test battery [typing test, Rey auditory verbal learning test (RAVLT), Stroop test and Rosvold continuous performance test (RCPT)] with electroencephalography recording while cycling and sitting on a conventional chair. Results Typing performance, performance on the RAVLT and accuracy on the Stroop test and the RCPT did not differ between conditions. Reaction times on the Stroop test and the RCPT were shorter while cycling relative to sitting (p < 0.05). N200, P300, N450 and conflict SP latency and amplitude on the Stroop test and N200 and P300 on the RCPT did not differ between conditions. Conclusions This study showed that typing performance and short-term memory are not deteriorated when people cycle at 30% Wmax. Furthermore, cycling had a positive effect on response speed across tasks requiring variable amounts of attention and inhibition.	[Torbeyns, Tine; de Geus, Bas; De Pauw, Kevin; Decroix, Lieselot; Van Cutsem, Jeroen; Meeusen, Romain] Vrije Univ Brussel, Human Physiol Res Grp, Brussels, Belgium; [Bailey, Stephen] Elon Univ, Dept Phys Therapy Educ, Elon, NC USA; [Meeusen, Romain] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld, Australia	Vrije Universiteit Brussel; Elon University; James Cook University	Meeusen, R (corresponding author), Vrije Univ Brussel, Human Physiol Res Grp, Brussels, Belgium.; Meeusen, R (corresponding author), James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld, Australia.	rmeeusen@vub.ac.be	Van Cutsem, Jeroen/AAZ-6281-2021; De Pauw, Kevin/E-8937-2018; de Geus, Bas/F-5335-2011; Van Cutsem, Jeroen/AAZ-7325-2021	de Geus, Bas/0000-0001-7447-0230; De Pauw, Kevin/0000-0002-6901-7199; Van Cutsem, Jeroen/0000-0001-6122-7629				Alderman BL, 2014, J PHYS ACT HEALTH, V11, P752, DOI 10.1123/jpah.2012-0097; Audiffren M, 2008, ACTA PSYCHOL, V129, P410, DOI 10.1016/j.actpsy.2008.09.006; Chen AT, 2011, INT J PSYCHOPHYSIOL, V80, P129, DOI 10.1016/j.ijpsycho.2011.02.012; Commissaris DACM, 2014, APPL ERGON, V45, P1570, DOI 10.1016/j.apergo.2014.05.003; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Dunstan DW, 2012, DIABETES RES CLIN PR, V97, P368, DOI 10.1016/j.diabres.2012.05.020; Elmer SJ, 2014, APPL ERGON, V45, P1240, DOI 10.1016/j.apergo.2014.03.001; Erickson KI, 2012, ARCH MED RES, V43, P615, DOI 10.1016/j.arcmed.2012.09.008; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Funk RE, 2012, PERCEPT MOTOR SKILL, V115, P309, DOI 10.2466/06.23.26.PMS.115.4.309-318; Gajewski PD, 2015, BRAIN COGNITION, V98, P87, DOI 10.1016/j.bandc.2015.06.004; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Hruby T, 2003, ACTA NEUROBIOL EXP, V63, P55; JASPER HH, 1958, ELECTROENCEPHALOGRAP, V10, P370, DOI DOI 10.1016/0013-4694(58)90053-1; John D, 2009, J PHYS ACT HEALTH, V6, P617, DOI 10.1123/jpah.6.5.617; Kamijo K, 2007, INT J PSYCHOPHYSIOL, V65, P114, DOI 10.1016/j.ijpsycho.2007.04.001; Koren K, 2016, APPL ERGON, V54, P83, DOI 10.1016/j.apergo.2015.11.013; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Larson MJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00723; Larson MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121309; Larson MJ, 2014, INT J PSYCHOPHYSIOL, V93, P283, DOI 10.1016/j.ijpsycho.2014.06.007; Ma JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095198; Ohlinger CM, 2011, J PHYS ACT HEALTH, V8, P119, DOI 10.1123/jpah.8.1.119; Patel Salil H, 2005, Int J Med Sci, V2, P147; Pedersen SJ, 2014, WORK, V49, P289, DOI 10.3233/WOR-131644; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pontifex MB, 2007, CLIN NEUROPHYSIOL, V118, P570, DOI 10.1016/j.clinph.2006.09.029; Riccio CA, 2002, ARCH CLIN NEUROPSYCH, V17, P235, DOI 10.1016/S0887-6177(01)00111-1; Sedentary Behaviour Research Network, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/h2012-024, DOI 10.1139/H2012-024]; Straker LM, 2009, HUM FACTORS, V51, P831, DOI 10.1177/0018720810362079; Strauss E., 2006, A COMPENDIUM OF NEUR; Torbeyns T, 2014, SPORTS MED, V44, P1261, DOI 10.1007/s40279-014-0202-x; World Health Organization, 2014, HEALTH TOPICS PHYSIC; World Health Organization, 2010, GLOBAL RECOMMENDATIO; World Health Organization, 2006, PHYSICAL ACTIVITY AN; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931; Yuan JJ, 2011, BIOL PSYCHOL, V87, P17, DOI 10.1016/j.biopsycho.2011.01.004	39	25	25	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165510	10.1371/journal.pone.0165510	http://dx.doi.org/10.1371/journal.pone.0165510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6DJ	27806079	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000386715500033
J	Shi, N; Zhang, J; Chen, SY				Shi, Ning; Zhang, Jing; Chen, Shi-You			Runx2, a novel regulator for goblet cell differentiation and asthma development	FASEB JOURNAL			English	Article						mucus overproduction; airway epithelial remodeling; transcriptional activation; SPDEF	MUCIN GENE-EXPRESSION; TRANSCRIPTION FACTORS; AIRWAY EPITHELIUM; CANCER CELLS; HYPERPLASIA; METAPLASIA; INFLAMMATION; MUCUS; ABNORMALITIES	Airway goblet cell differentiation and related mucus overproduction are critical processes in the development of respiratory diseases, including asthma. The underlying mechanisms, however, are not fully understood. We identified Runt-related transcription factor 2 (Runx2) as a novel regulator for goblet cell differentiation. Runx2 was up-regulated by 6.4-fold during IL-13-induced goblet cell differentiation of human bronchial epithelial cells. Knockdown of Runx2 attenuated the IL-13-induced differentiation/mucus production by 67%. Mechanistically, Runx2 bound to the promoter of SAM-pointed domain-containing Ets-like factor (SPDEF), a known factor for goblet cell differentiation, resulting in an activation of SPDEF transcription. In vivo, Runx2 was induced by 6.2-fold in pulmonary epithelium of house dust mite-challenged mice. Blockade of Runx2 inhibited the house dust mite-induced goblet cell differentiation with a 75% reduction in mucus overproduction while improving airway responsiveness to methacholine by 41%. More importantly, a 12.3-fold increase in Runx2 expression was observed in human asthma lung epithelium, underlying the potential clinical importance of these findings.-Shi, N., Zhang, J., Chen, S.-Y. Runx2, a novel regulator for goblet cell differentiation and asthma development.	[Shi, Ning; Zhang, Jing; Chen, Shi-You] Univ Georgia, Dept Physiol & Pharmacol, 501 DW Brooks Dr, Athens, GA 30602 USA; [Zhang, Jing] Hubei Univ Med, Taihe Hosp, Dept Resp Med, Shiyan, Hubei, Peoples R China	University System of Georgia; University of Georgia; Hubei University of Medicine	Chen, SY (corresponding author), Univ Georgia, Dept Physiol & Pharmacol, 501 DW Brooks Dr, Athens, GA 30602 USA.	sc229@uga.edu			U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL123302, HL119053]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123302, R01HL119053] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, by grants from the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (HL123302 and HL119053).	Atherton HC, 2003, AM J PHYSIOL-LUNG C, V285, pL730, DOI 10.1152/ajplung.00089.2003; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; Coffman JA, 2003, CELL BIOL INT, V27, P315, DOI 10.1016/S1065-6995(03)00018-0; Curran DR, 2010, AM J RESP CELL MOL, V42, P268, DOI 10.1165/rcmb.2009-0151TR; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Fahy JV, 2002, CHEST, V122, p320S, DOI 10.1378/chest.122.6_suppl.320S; Haley KJ, 2011, AM J PHYSIOL-LUNG C, V301, pL693, DOI 10.1152/ajplung.00348.2010; Ito Y, 2015, NAT REV CANCER, V15, P81, DOI 10.1038/nrc3877; Kanoh S, 2011, CLIN EXP ALLERGY, V41, P1747, DOI 10.1111/j.1365-2222.2011.03852.x; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Laoukili J, 2001, J CLIN INVEST, V108, P1817, DOI 10.1172/JCI13557; Lim M, 2010, LAB INVEST, V90, P222, DOI 10.1038/labinvest.2009.128; Long AJ, 2006, AM J RESP CELL MOL, V35, P357, DOI 10.1165/rcmb.2005-0451OC; Ordonez CL, 2001, AM J RESP CRIT CARE, V163, P517, DOI 10.1164/ajrccm.163.2.2004039; Pain M, 2014, EUR RESPIR REV, V23, P118, DOI 10.1183/09059180.00004413; Park KS, 2007, J CLIN INVEST, V117, P978, DOI 10.1172/JCI29176; Rajavelu P, 2015, J CLIN INVEST, V125, P2021, DOI 10.1172/JCI79422; Ren XM, 2013, MOL CELL BIOL, V33, P371, DOI 10.1128/MCB.00934-12; Rogers DF, 2002, CLIN EXP ALLERGY, V32, P1124, DOI 10.1046/j.1365-2745.2002.01474.x; Rogers DF, 2001, RESP PHYSIOL, V125, P129, DOI 10.1016/S0034-5687(00)00209-7; Rose MC, 2000, J AEROSOL MED, V13, P245, DOI 10.1089/jam.2000.13.245; Tandon M, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-27; Tesfaigzi Y, 2008, CURR MOL MED, V8, P408, DOI 10.2174/156652408785160961; Thavagnanam S, 2011, PEDIATR RES, V69, P95, DOI 10.1203/PDR.0b013e318204edb5; Tsao PN, 2011, DEVELOPMENT, V138, P3533, DOI 10.1242/dev.063727; Wang Y, 2004, AM J PHYSIOL-LUNG C, V286, pL1188, DOI 10.1152/ajplung.00288.2003	27	15	16	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					412	420		10.1096/fj.201600954R	http://dx.doi.org/10.1096/fj.201600954R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27825108	Green Published			2022-12-26	WOS:000392177600038
J	Bondo, KJ; Pearl, DL; Janecko, N; Boerlin, P; Reid-Smith, RJ; Parmley, J; Jardine, CM				Bondo, Kristin J.; Pearl, David L.; Janecko, Nicol; Boerlin, Patrick; Reid-Smith, Richard J.; Parmley, Jane; Jardine, Claire M.			Epidemiology of Antimicrobial Resistance in Escherichia coli Isolates from Raccoons (Procyon lotor) and the Environment on Swine Farms and Conservation Areas in Southern Ontario	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; EXTENDED-SPECTRUM; CLOACAL SWABS; WILD BIRDS; SALMONELLA; PREVALENCE; BACTERIA; SUSCEPTIBILITY; SEROTYPES; PATTERNS	Antimicrobial resistance is a global threat to livestock, human and environmental health. Although resistant bacteria have been detected in wildlife, their role in the epidemiology of antimicrobial resistance is not clear. Our objective was to investigate demographic, temporal and climatic factors associated with carriage of antimicrobial resistant Escherichia coli in raccoons and the environment. We collected samples from raccoon paws and feces and from soil, manure pit and dumpsters on five swine farms and five conservation areas in Ontario, Canada once every five weeks from May to November, 2011-2013 and tested them for E. coli and susceptibility to 15 antimicrobials. Of samples testing positive for E. coli, resistance to >= 1 antimicrobials was detected in 7.4% (77/1044; 95% CI, 5.9-9.1) of raccoon fecal samples, 6.3% (23/365; 95% CI, 4.0-9.3) of paw samples, 9.6% (121/1260; 8.0-11.4) of soil samples, 57.4% (31/54; 95% CI, 43.2-70.8) of manure pit samples, and 13.8% (4/29; 95% CI, 3.9-31.7) of dumpster samples. Using univariable logistic regression, there was no significant difference in the occurrence of resistant E. coli in raccoon feces on conservation areas versus farms; however, E. coli isolates resistant to >= 1 antimicrobials were significantly less likely to be detected from raccoon paw samples on swine farms than conservation areas and significantly more likely to be detected in soil samples from swine farms than conservation areas. Resistant phenotypes and genotypes that were absent from the swine farm environment were detected in raccoons from conservation areas, suggesting that conservation areas and swine farms may have different exposures to resistant bacteria. However, the similar resistance patterns and genes in E. coli from raccoon fecal and environmental samples from the same location types suggest that resistant bacteria may be exchanged between raccoons and their environment.	[Bondo, Kristin J.; Boerlin, Patrick; Reid-Smith, Richard J.; Parmley, Jane; Jardine, Claire M.] Univ Guelph, Dept Pathobiol, Guelph, ON, Canada; [Pearl, David L.; Janecko, Nicol; Reid-Smith, Richard J.] Univ Guelph, Dept Populat Med, Guelph, ON, Canada; [Janecko, Nicol; Reid-Smith, Richard J.; Parmley, Jane] Publ Hlth Agcy Canada, Ctr Foodborne Environm & Zoonot Infect Dis, Guelph, ON, Canada; [Janecko, Nicol] Univ Vet & Pharmaceut Sci Brno, Dept Biol & Wildlife Dis, Brno, Czech Republic; [Parmley, Jane; Jardine, Claire M.] Univ Guelph, Dept Pathobiol, Canadian Wildlife Hlth Cooperat, Guelph, ON, Canada	University of Guelph; University of Guelph; Public Health Agency of Canada; University of Veterinary Sciences Brno; University of Guelph	Jardine, CM (corresponding author), Univ Guelph, Dept Pathobiol, Guelph, ON, Canada.; Jardine, CM (corresponding author), Univ Guelph, Dept Pathobiol, Canadian Wildlife Hlth Cooperat, Guelph, ON, Canada.	cjardi01@uoguelph.ca			National Science and Engineering Research Council (NSERC); United States Department of Agriculture (USDA); Ontario Graduate Scholarship (OGS)	National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Ontario Graduate Scholarship (OGS)(Ontario Graduate Scholarship)	Funding was provided by the National Science and Engineering Research Council (NSERC) and the United States Department of Agriculture (USDA). KJB also received support through an Ontario Graduate Scholarship (OGS). In-kind support was provided by the Public Health Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agga GE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132586; Ahmed Lubna N, 2015, BMC Res Notes, V8, P137, DOI 10.1186/s13104-015-1103-2; Allen SE, 2011, APPL ENVIRON MICROB, V77, P882, DOI 10.1128/AEM.01111-10; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Bondo KJ, 2016, ZOONOSES PUBLIC HLTH, V63, P303, DOI 10.1111/zph.12232; Bondo KJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161497; Bonnedahl J, 2008, POLAR BIOL, V31, P759, DOI 10.1007/s00300-008-0430-3; Byappanahalli MN, 2006, ENVIRON MICROBIOL, V8, P504, DOI 10.1111/j.1462-2920.2005.00916.x; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Carlson JC, 2015, VET MICROBIOL, V179, P60, DOI 10.1016/j.vetmic.2015.04.009; Cole D, 2005, EMERG INFECT DIS, V11, P935; Cristobal-Azkarate J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107719; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Dierikx CM, 2012, J ANTIMICROB CHEMOTH, V67, P1368, DOI 10.1093/jac/dks049; Dohoo IR, 2009, VET EPIDEMIOLOGIC RE, P151; Gilliver MA, 1999, NATURE, V401, P233, DOI 10.1038/45724; GOODLIFFE L, 2014, AMMI ANN C VICT CAN; GOVERNMENT OF CANADA, 2014, CAN INT PROGR ANT RE; Government of Canada, 2013, OV FOODNET CAN FORM; Government of Canada, 2012, CAN INT PROGR ANT RE; GOVERNMENT OF CANADA, 2015, CAN INT PROGR ANT RE; Grand River Conservation Authority, 2008, GRAND RIV WAT CHAR R; Guenther S, 2010, ENV MICROBIOL REP, V2, P641, DOI 10.1111/j.1758-2229.2010.00148.x; Guenther S, 2010, SCI TOTAL ENVIRON, V408, P3519, DOI 10.1016/j.scitotenv.2010.05.005; Human K., 2005, CLIN INFECT DIS, V41, P1613, DOI [10.1086/497599, DOI 10.1086/497599]; Jardine CM, 2012, APPL ENVIRON MICROB, V78, P3873, DOI 10.1128/AEM.00705-12; Jobbins SE, 2015, J WILDLIFE DIS, V51, P811, DOI 10.7589/2014-11-257; Kobayashi H, 2007, J VET MED SCI, V69, P309, DOI 10.1292/jvms.69.309; Kozak GK, 2009, APPL ENVIRON MICROB, V75, P559, DOI 10.1128/AEM.01821-08; Kummerer K, 2009, CHEMOSPHERE, V75, P435, DOI 10.1016/j.chemosphere.2008.12.006; Maal-Bared R, 2013, SCI TOTAL ENVIRON, V443, P315, DOI 10.1016/j.scitotenv.2012.10.106; Madsen M, 1998, J ZOO WILDLIFE MED, V29, P31; Miranda CD, 2001, MAR POLLUT BULL, V42, P1096, DOI 10.1016/S0025-326X(01)00093-5; Nhung NT, 2015, APPL ENVIRON MICROB, V81, P812, DOI 10.1128/AEM.03366-14; Osterblad M, 2001, NATURE, V409, P37, DOI 10.1038/35051173; Palmgren H, 2000, EPIDEMIOL INFECT, V125, P257, DOI 10.1017/S0950268899004586; Procter TD, 2014, ZOONOSES PUBLIC HLTH, V61, P250, DOI 10.1111/zph.12064; ROLLAND RM, 1985, APPL ENVIRON MICROB, V49, P791, DOI 10.1128/AEM.49.4.791-794.1985; Rosatte R, 2010, J MAMMAL, V91, P122, DOI 10.1644/08-MAMM-A-201R2.1; Sayah RS, 2005, APPL ENVIRON MICROB, V71, P1394, DOI 10.1128/AEM.71.3.1394-1404.2005; Schaufler K, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv155; Schaufler Katharina, 2015, Infection Ecology & Epidemiology, V5, P25334, DOI 10.3402/iee.v5.25334; Schroeder CM, 2003, INT J FOOD MICROBIOL, V85, P197, DOI 10.1016/S0168-1605(02)00508-1; Skurnik D, 2006, J ANTIMICROB CHEMOTH, V57, P1215, DOI 10.1093/jac/dkl122; SONENSHINE DE, 1972, J WILDLIFE MANAGE, V36, P838, DOI 10.2307/3799438; Sulzner K, 2014, J ZOO WILDLIFE MED, V45, P931, DOI 10.1638/2012-0217.1; Taylor NGH, 2011, TRENDS ECOL EVOL, V26, P278, DOI 10.1016/j.tree.2011.03.004; Thaller MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008989; Travis RM, 2006, J ANTIMICROB CHEMOTH, V58, P173, DOI 10.1093/jac/dkl207; Veterinary Drugs Directorate, 2009, CAT ANT DRUGS BAS IM; Vigo GB, 2011, POLAR BIOL, V34, P675, DOI 10.1007/s00300-010-0923-8; Watkinson AJ, 2007, APPL ENVIRON MICROB, V73, P5667, DOI 10.1128/AEM.00763-07; Williams NJ, 2011, J APPL MICROBIOL, V110, P962, DOI 10.1111/j.1365-2672.2011.04952.x; Witte W, 1998, SCIENCE, V279, P996, DOI 10.1126/science.279.5353.996	54	19	19	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165303	10.1371/journal.pone.0165303	http://dx.doi.org/10.1371/journal.pone.0165303			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829035	Green Published, Green Submitted, gold			2022-12-26	WOS:000387724300037
J	Chen, S; Chen, X; Sun, KX; Xiu, YL; Liu, BL; Feng, MX; Sang, XB; Zhao, Y				Chen, Shuo; Chen, Xi; Sun, Kai-Xuan; Xiu, Yin-Ling; Liu, Bo-Liang; Feng, Miao-Xiao; Sang, Xiu-Bo; Zhao, Yang			MicroRNA-93 Promotes Epithelial-Mesenchymal Transition of Endometrial Carcinoma Cells	PLOS ONE			English	Article							BREAST-CANCER CELLS; LUNG ADENOCARCINOMA; METASTASIS; SUPPRESSES; INVASION; GROWTH; FOXA1; OVEREXPRESSION; RECEPTOR; PATHWAY	MicroRNA-93, derived from a paralog (miR-106b-25) of the miR-17-92 cluster, is involved in the tumorigenesis and progression of many cancers such as breast, colorectal, hepatocellular, lung, ovarian, and pancreatic cancer. However, the role of miR-93 in endometrial carcinoma and the potential molecular mechanisms involved remain unknown. Our results showed that miR-93 was overexpressed in endometrial carcinoma tissues than normal endometrial tissues. The endometrial carcinoma cell lines HEC-1B and Ishikawa were transfected with miR-93-5P, after which cell migration and invasion ability and the expression of relevant molecules were detected. MiR-93 overexpression promoted cell migration and invasion, and downregulated E-cadherin expression while increasing N-cadherin expression. Dual-luciferase reporter assay showed that miR-93 may directly bind to the 30 untranslated region of forkhead box A1 (FOXA1); furthermore, miR-93 overexpression downregulated FOXA1 expression while miR-93 inhibitor transfection upregulated FOXA1 expression at both mRNA and protein level. In addition, transfection with the most effective FOXA1 small interfering RNA promoted both endometrial cancer cell migration and invasion, and downregulated E-cadherin expression while upregulating N-cadherin expression. Therefore, we suggest that miR-93 may promote the process of epithelial-mesenchymal transition in endometrial carcinoma cells by targeting FOXA1.	[Chen, Shuo; Chen, Xi; Sun, Kai-Xuan; Xiu, Yin-Ling; Liu, Bo-Liang; Feng, Miao-Xiao; Sang, Xiu-Bo; Zhao, Yang] China Med Univ, Affiliated Hosp 1, Dept Gynecol, Shenyang, Liaoning, Peoples R China	China Medical University	Zhao, Y (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Gynecol, Shenyang, Liaoning, Peoples R China.	yida.zhaoyang@163.com		Shuo, Chen/0000-0002-5122-3656; Zhao, Yang/0000-0003-3226-8127	National Natural Science Foundation of China [81202049, 81472440, 81602266]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Yang Zhao, Nos. 81202049, 81472440; and Shuo Chen, No. 81602266).	Azmi AS, 2015, SCI REP-UK, V5, DOI 10.1038/srep16077; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chakrabarti R, 2012, NAT CELL BIOL, V14, P1212, DOI 10.1038/ncb2607; Chen SP, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1738-3; Chen X, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0304-6; Cheng CW, 2015, ONCOTARGET, V6, P44222, DOI 10.18632/oncotarget.5826; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; De Mattos-Arruda L, 2015, ONCOTARGET, V6, P37269, DOI 10.18632/oncotarget.5495; Dong PX, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0231-0; Dong PX, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/130362; Ghahhari NM, 2015, EUR J CANCER, V51, P1638, DOI 10.1016/j.ejca.2015.04.021; Gou WF, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-477; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Huang JZ, 2016, J PATHOL, V239, P186, DOI 10.1002/path.4716; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Jin HJ, 2013, CANCER RES, V73, P3725, DOI 10.1158/0008-5472.CAN-12-3468; Lin YC, 2014, J CELL SCI, V127, P85, DOI 10.1242/jcs.132779; Liu TM, 2015, MOL MED REP, V12, P7403, DOI 10.3892/mmr.2015.4374; Liu YN, 2012, MOL CELL BIOL, V32, P941, DOI 10.1128/MCB.06306-11; Long HX, 2015, ONCOTARGET, V6, P38705, DOI 10.18632/oncotarget.5478; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Meng X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.32; Mitra A, 2015, ONCOTARGET, V6, P10697, DOI 10.18632/oncotarget.4037; Qiu MT, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-78; Qu JJ, 2015, INT J ONCOL, V47, P2141, DOI 10.3892/ijo.2015.3187; Song Y, 2010, CANCER RES, V70, P2115, DOI 10.1158/0008-5472.CAN-09-2979; Wang JY, 2014, ONCOL REP, V31, P1225, DOI 10.3892/or.2014.2982; Wang L, 2015, ONCOTARGET, V6, P35978, DOI 10.18632/oncotarget.5427; Wang SS, 2015, ONCOTARGETS THER, V8, P2973, DOI 10.2147/OTT.S91863; Wu S, 2016, BIOL CHEM, V397, P75, DOI 10.1515/hsz-2015-0215; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang WN, 2014, J GYNECOL ONCOL, V25, P36, DOI 10.3802/jgo.2014.25.1.36; Ye ZX, 2015, INT J GYNECOL CANCER, V25, P1574, DOI 10.1097/IGC.0000000000000546; Yeramian A, 2013, ONCOGENE, V32, P403, DOI 10.1038/onc.2012.76; Zhang XL, 2015, ARCH BIOCHEM BIOPHYS, V585, P10, DOI 10.1016/j.abb.2015.09.006; Zhao MY, 2015, ONCOTARGET, V6, P15610, DOI 10.18632/oncotarget.3639	37	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165776	10.1371/journal.pone.0165776	http://dx.doi.org/10.1371/journal.pone.0165776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829043	Green Published, Green Submitted, gold			2022-12-26	WOS:000387724300059
J	Xu, J; Spitale, RC; Guan, LN; Flynn, RA; Torre, EA; Li, R; Reber, I; Qu, K; Kern, D; Knaggs, HE; Chang, HY; Chang, ALS				Xu, Jin; Spitale, Robert C.; Guan, Linna; Flynn, Ryan A.; Torre, Eduardo A.; Li, Rui; Reber, Inbar; Qu, Kun; Kern, Dale; Knaggs, Helen E.; Chang, Howard Y.; Chang, Anne Lynn S.			Novel Gene Expression Profile of Women with Intrinsic Skin Youthfulness by Whole Transcriptome Sequencing	PLOS ONE			English	Article							AGED HUMAN SKIN; IMMUNE-RESPONSES; T-CELLS; RNA; GENOME; LONGEVITY; REVEALS; INSIGHTS; HAS2	While much is known about genes that promote aging, little is known about genes that protect against or prevent aging, particularly in human skin. The main objective of this study was to perform an unbiased, whole transcriptome search for genes that associate with intrinsic skin youthfulness. To accomplish this, healthy women (n = 122) of European descent, ages 18-89 years with Fitzpatrick skin type I/II were examined for facial skin aging parameters and clinical covariates, including smoking and ultraviolet exposure. Skin youthfulness was defined as the top 10% of individuals whose assessed skin aging features were most discrepant with their chronological ages. Skin biopsies from sun-protected inner arm were subjected to 3'-end sequencing for expression quantification, with results verified by quantitative reverse transcriptase-polymerase chain reaction. Unbiased clustering revealed gene expression signatures characteristic of older women with skin youthfulness (n = 12) compared to older women without skin youthfulness (n = 33), after accounting for gene expression changes associated with chronological age alone. Gene set analysis was performed using Genomica open-access software. This study identified a novel set of candidate skin youthfulness genes demonstrating differences between SY and non-SY group, including pleckstrin homology like domain family A member 1 (PHLDA1) (p = 2.4x10(-5)), a follicle stem cell marker, and hyaluronan synthase 2-anti-sense 1 (HAS2-AS1) (p = 0.00105), a non-coding RNA that is part of the hyaluronan synthesis pathway. We show that immunologic gene sets are the most significantly altered in skin youthfulness (with the most significant gene set p = 2.4x10(-5)), suggesting the immune system plays an important role in skin youthfulness, a finding that has not previously been recognized. These results are a valuable resource from which multiple future studies may be undertaken to better understand the mechanisms that promote skin youthfulness in humans.	[Xu, Jin; Guan, Linna; Flynn, Ryan A.; Torre, Eduardo A.; Li, Rui; Reber, Inbar; Qu, Kun; Chang, Howard Y.; Chang, Anne Lynn S.] Stanford Univ, Sch Med, Dept Dermatol, Redwood City, CA 94063 USA; [Spitale, Robert C.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA USA; [Kern, Dale; Knaggs, Helen E.] Nu Skin Int, Provo, UT USA	Stanford University; University of California System; University of California Irvine	Chang, ALS (corresponding author), Stanford Univ, Sch Med, Dept Dermatol, Redwood City, CA 94063 USA.	alschang@stanford.edu	Qu, Kun/G-3359-2012; Xu, Jin/M-9532-2016	Xu, Jin/0000-0003-0944-9835	Nuskin International; Nu Skin; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER	Nuskin International; Nu Skin; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by a research award from Nuskin International to Anne Lynn S. Chang, the clinical investigator. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank John Coller, PhD, at the Stanford Functional Genomics Facility for whole transcriptome sequencing, and Gefei Alex Zhu, Rashmi Tarhalkar and Hoa Nguyen for assistance with clinical data acquisition and curation. This study was funded by a research award from Nu Skin to the principal investigator Anne Lynn S. Chang, MD.	Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507; Agius E, 2009, J EXP MED, V206, P1929, DOI 10.1084/jem.20090896; Arijs I, 2009, GUT, V58, P1612, DOI 10.1136/gut.2009.178665; Atzmon G, 2009, J CLIN ENDOCR METAB, V94, P4768, DOI 10.1210/jc.2009-0808; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Beck AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008768; Borlon C, 2008, BIOGERONTOLOGY, V9, P197, DOI 10.1007/s10522-008-9127-9; Chang ALS, 2014, J INVEST DERMATOL, V134, P651, DOI 10.1038/jid.2013.381; Chang ALS, 2013, J INVEST DERMATOL, V133, P394, DOI 10.1038/jid.2012.287; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Glass D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r75; Gorbunova V, 2014, NAT REV GENET, V15, P531, DOI 10.1038/nrg3728; Guinot C, 2002, ARCH DERMATOL, V138, P1454, DOI 10.1001/archderm.138.11.1454; Haq K, 2014, CURR OPIN IMMUNOL, V29, P38, DOI 10.1016/j.coi.2014.03.008; Kim C, 2017, CLIN EXP IMMUNOL, V187, P71, DOI 10.1111/cei.12829; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; Kretz M, 2012, GENE DEV, V26, P338, DOI 10.1101/gad.182121.111; Lages CS, 2008, J IMMUNOL, V181, P1835, DOI 10.4049/jimmunol.181.3.1835; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Lener T, 2006, EXP GERONTOL, V41, P387, DOI 10.1016/j.exger.2006.01.012; Lennox KA, 2016, NUCLEIC ACIDS RES, V44, P863, DOI 10.1093/nar/gkv1206; Li Y, 2012, INT J CLIN EXP PATHO, V5, P624; Lu L, 2010, J BIOL CHEM, V285, P9373, DOI 10.1074/jbc.M109.094425; Mayer D, 2012, J AM ACAD DERMATOL, V66, pE9, DOI 10.1016/j.jaad.2010.10.002; Oh JH, 2011, EXP DERMATOL, V20, P455, DOI 10.1111/j.1600-0625.2011.01258.x; Papakonstantinou E, 2012, DERM-ENDOCRINOL, V4, DOI 10.4161/derm.21923; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Rilla K, 2002, J CELL SCI, V115, P3633, DOI 10.1242/jcs.00042; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; Sakthianandeswaren A, 2011, CANCER RES, V71, P3709, DOI 10.1158/0008-5472.CAN-10-2342; Schulz AR, 2015, J IMMUNOL, V195, P4699, DOI 10.4049/jimmunol.1500598; Sellheyer K, 2011, BRIT J DERMATOL, V164, P141, DOI 10.1111/j.1365-2133.2010.10045.x; Singh P, 2012, FRONT GENET, P3; Swindell WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033204; Tariq MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr547; Toyoshima Y, 2004, J BIOL CHEM, V279, P25898, DOI 10.1074/jbc.M400661200; Vachiramon V, 2011, DERMATOLOGIST; Vigetti D, 2014, J BIOL CHEM, V289, P28816, DOI 10.1074/jbc.M114.597401; Vukmanovic-Stejic M, 2011, CURR OPIN IMMUNOL, V23, P525, DOI 10.1016/j.coi.2011.05.008; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Weinberger B, 2008, CLIN INFECT DIS, V46, P1078, DOI 10.1086/529197; Yu SG, 1997, MECH AGEING DEV, V94, P103, DOI 10.1016/S0047-6374(97)01868-X; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; Zhu GFA, 2016, BMC DERMATOL, V16, DOI 10.1186/s12895-016-0038-1	50	6	6	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165913	10.1371/journal.pone.0165913	http://dx.doi.org/10.1371/journal.pone.0165913			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829007	Green Published, gold			2022-12-26	WOS:000387724300066
J	El-Ansary, A; Hassan, WM; Qasem, H; Das, UN				El-Ansary, Afaf; Hassan, Wail M.; Qasem, Hanan; Das, Undurti N.			Identification of Biomarkers of Impaired Sensory Profiles among Autistic Patients	PLOS ONE			English	Article							DIAGNOSTIC INTERVIEW; CHILDREN; PERFORMANCE; DISORDER; RELEASE; BRAIN	Background Autism is a neurodevelopmental disorder that displays significant heterogeneity. Comparison of subgroups within autism, and analyses of selected biomarkers as measure of the variation of the severity of autistic features such as cognitive dysfunction, social interaction impairment, and sensory abnormalities might help in understanding the pathophysiology of autism. Methods and Participants In this study, two sets of biomarkers were selected. The first included 7, while the second included 6 biomarkers. For set 1, data were collected from 35 autistic and 38 healthy control participants, while for set 2, data were collected from 29 out of the same 35 autistic and 16 additional healthy subjects. These markers were subjected to a principal components analysis using either covariance or correlation matrices. Moreover, libraries composed of participants categorized into units were constructed. The biomarkers used include, PE (phosphatidyl ethanolamine), PS (phosphatidyl serine), PC (phosphatidyl choline), MAP2K1 (Dual specificity mitogen-activated protein kinase kinase 1), IL-10 (interleukin-10), IL-12, NF-kappa B (nuclear factor-kappa appa B); PGE2 (prostaglandin E2), PGE2-EP2, mPGES-1 (microsomal prostaglandin synthase E-1), cPLA2 (cytosolic phospholipase A2), 8-isoprostane, and COX-2 (cyclo-oxygenase-2). Results While none of the studied markers correlated with CARS and SRS as measure of cognitive and social impairments, six markers significantly correlated with sensory profiles of autistic patients. Multiple regression analysis identifies a combination of PGES, mPGES-1, and PE as best predictors of the degree of sensory profile impairment. Library identification resulted in 100% correct assignments of both autistic and control participants based on either set 1 or 2 biomarkers together with a satisfactory rate of assignments in case of sensory profile impairment using different sets of biomarkers. Conclusion The two selected sets of biomarkers were effective to separate autistic from healthy control subjects, demonstarting the possibility to accurately predict the severity of autism using the selected biomarkers. The effectiveness of the identified libraries lied in the fact that they were helpful in correctly assigning the study population as control or autistic patients and in classifying autistic patients with different degree of sensory profile impairment.	[El-Ansary, Afaf] King Saud Univ, Ctr Female Sci & Med Coll, Cent Lab, Riyadh, Saudi Arabia; [Qasem, Hanan] King Saud Univ, Coll Sci, Dept Biochem, Riyadh, Saudi Arabia; [El-Ansary, Afaf] Natl Res Ctr, Therapuet Chem Dept, Cairo, Egypt; [Hassan, Wail M.] Univ Wisconsin, Coll Hlth Sci, Dept Biomed Sci, Milwaukee, WI 53201 USA; [Das, Undurti N.] UND Life Sci, 2020 S 360th St,K-202,Fed Way, Washington, DC 98003 USA; [Das, Undurti N.] BioSci Res Ctr, GVP Coll Engn Campus, Visakhapatnam 530048, Andhra Pradesh, India	King Saud University; King Saud University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); University of Wisconsin System; University of Wisconsin Milwaukee	Das, UN (corresponding author), UND Life Sci, 2020 S 360th St,K-202,Fed Way, Washington, DC 98003 USA.; Das, UN (corresponding author), BioSci Res Ctr, GVP Coll Engn Campus, Visakhapatnam 530048, Andhra Pradesh, India.	undurti@hotmail.com	Hassan, Wail/R-5045-2019	Hassan, Wail/0000-0002-2960-3927	Center for Female Scientific and Medical Collegesat King Saud University [2015-G3]	Center for Female Scientific and Medical Collegesat King Saud University	This research project was supported by a grant from the research center of the Center for Female Scientific and Medical Colleges at King Saud University. UND is employed by UND Life Sciences but UND Life Sciences did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This research project was supported by a grant from the research center of the Center for Female Scientific and Medical Colleges at King Saud University. Competing Interests: This does not alter our adherence to PLOS ONE policies on sharing data and materials. Financial Disclosure: This research project was supported by a grant from the research center of the Center for Female Scientific and Medical Colleges at King Saud University. Funding Information: Funder Name: The research center of the Center for Female Scientific and Medical Colleges at King Saud University Grant Number: 2015-G3 Grant Recipient: Afaf El-Ansary UND is employed by UND Life Sciences but UND Life Sciences did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Ahmad SF, 2016, MOL NEUROBIOLOGY; Ashwood P, 2006, J LEUKOCYTE BIOL, V80, P1, DOI 10.1189/jlb.1205707; Baranek GT, 2002, J AUTISM DEV DISORD, V32, P397, DOI 10.1023/A:1020541906063; Bell JG, 2004, PROSTAG LEUKOTR ESS, V71, P201, DOI 10.1016/j.plefa.2004.03.008; Bezzi P, 2001, CURR OPIN NEUROBIOL, V11, P387, DOI 10.1016/S0959-4388(00)00223-3; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Breece E, 2013, BRAIN BEHAV IMMUN, V31, P69, DOI 10.1016/j.bbi.2012.10.006; Connolly AM, 1999, J PEDIATR-US, V134, P607, DOI 10.1016/S0022-3476(99)70248-9; Constantino J. N., 2007, SOCIAL RESPONSIVENES; Das UN, 2013, NUTRITION, V29, P1175, DOI 10.1016/j.nut.2013.01.012; Das UN, 2013, NUTRITION, V29, P1066, DOI 10.1016/j.nut.2012.11.013; Dubois A, 2010, PAIN RES MANAG, V15, P245, DOI 10.1155/2010/749275; Dunn W, 1997, AM J OCCUP THER, V51, P25, DOI 10.5014/ajot.51.1.25; Dunn W, 2001, AM J OCCUP THER, V55, P608, DOI 10.5014/ajot.55.6.608; Dunn W., 1999, SENSORY PROFILE EXAM; Filipek PA, 2000, NEUROLOGY, V55, P468, DOI 10.1212/WNL.55.4.468; Gadad Bharathi S, 2013, Autism Res Treat, V2013, P731935, DOI 10.1155/2013/731935; Ganz M, 2006, UNDERSTANDING AUTISM; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; Gillberg C, 2000, BIOL AUTISTIC SYNDRO, V3rd; Gorrindo P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068444; Gorrindo P, 2012, AUTISM RES, V5, P101, DOI 10.1002/aur.237; Hu VW, 2009, AUTISM RES, V2, P67, DOI 10.1002/aur.72; Kientz MA, 1997, AM J OCCUP THER, V51, P530, DOI 10.5014/ajot.51.7.530; Kohane IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033224; Lawrence G. D., 2010, FATS LIFE ESSENTIAL; LECOUTEUR A, 1989, J AUTISM DEV DISORD, V19, P363, DOI 10.1007/BF02212936; Mandell D, 2011, AUTISM, V15, P259, DOI 10.1177/1362361311410808; Mostafa GA, 2010, J NEUROIMMUNOL, V219, P114, DOI 10.1016/j.jneuroim.2009.12.003; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; Perry A, 2005, J AUTISM DEV DISORD, V35, P625, DOI 10.1007/s10803-005-0006-9; Qasem H, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0298-0; Silver WG, 2012, PEDIATR CLIN N AM, V59, P45, DOI 10.1016/j.pcl.2011.10.010; Subramanian M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.2015.00313, 10.3339/fnins.2015.00373]; Szatmari P, 2011, BMJ, V342; Tomchek SD, 2007, AM J OCCUP THER, V61, P190, DOI 10.5014/ajot.61.2.190; Tostes MHFS, 2012, PHARMACOPSYCHIATRY, V45, P241, DOI 10.1055/s-0032-1301914; Wallace JL, 2001, GASTROENTEROL CLIN N, V30, P971, DOI 10.1016/S0889-8553(05)70223-5; Watling RL, 2001, AM J OCCUP THER, V55, P416, DOI 10.5014/ajot.55.4.416; Yao YM, 2006, ARCH NEUROL-CHICAGO, V63, P1161, DOI 10.1001/archneur.63.8.1161; Zonta M, 2003, J PHYSIOL-LONDON, V553, P407, DOI 10.1113/jphysiol.2003.046706	43	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0164153	10.1371/journal.pone.0164153	http://dx.doi.org/10.1371/journal.pone.0164153			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824861	gold, Green Published, Green Submitted			2022-12-26	WOS:000387615200001
J	Fontes, J; Semmens, B; Caselle, JE; Santos, RS; Prakya, R				Fontes, Jorge; Semmens, Brice; Caselle, Jennifer E.; Santos, Ricardo S.; Prakya, R.			Ocean Productivity May Predict Recruitment of the Rainbow Wrasse (Coris julis)	PLOS ONE			English	Article							TROPICAL REEF FISH; TEMPERATURE; VARIABILITY; PLANKTON; GROWTH; LARVAE; SIZE; INFORMATION; SETTLEMENT; CLIMATE	Predicting recruitment fluctuations of fish populations remains the Holy Grail of fisheries science. While previous work has linked recruitment of reef fish to environmental variables including temperature, the demonstration of a robust relationship with productivity remains elusive. Despite decades of research, empirical evidence to support this critical link remains limited. Here we identify a consistent and strong relationship between recruitment of a temperate wrasse Coris julis, from temperate reefs in the mid-Atlantic region, with Chlorophyll, over contrasting scales, across multiple years. Additionally, we find that the correlation between Chlorophyll and recruitment is not simply masking a temperature-recruitment relationship. Understanding the potential mechanisms underlying recruitment variability, particularly as it relates to changing climate and ocean regimes, is a critical first step towards characterizing species' vulnerability to mismatches between pulsed planktonic production and early pelagic life stages.	[Fontes, Jorge; Santos, Ricardo S.; Prakya, R.] Univ Azores IMAR UAz, Marine & Environm Sci Ctr MARE, Dept Oceanog & Fisheries, P-9901862 Horta, Portugal; [Fontes, Jorge; Santos, Ricardo S.; Prakya, R.] Univ Azores IMAR UAz, Inst Marine Res, Dept Oceanog & Fisheries, P-9901862 Horta, Portugal; [Semmens, Brice] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92023 USA; [Caselle, Jennifer E.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA	Universidade dos Acores; Universidade dos Acores; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California Santa Barbara	Fontes, J (corresponding author), Univ Azores IMAR UAz, Marine & Environm Sci Ctr MARE, Dept Oceanog & Fisheries, P-9901862 Horta, Portugal.; Fontes, J (corresponding author), Univ Azores IMAR UAz, Inst Marine Res, Dept Oceanog & Fisheries, P-9901862 Horta, Portugal.	fontes@uac.pt	Santos, Ricardo/B-3960-2008	Santos, Ricardo/0000-0002-2536-1369; Fontes, Jorge/0000-0002-8451-5532	Fundacao para a Ciencia e Tecnologia [SFRH/BD/12788/2003]; FCT [FCT- OCTI/BSE/41207/2001]; MARMACII [INTERREG/ 05/MAC/4.2/A4]; Programmatic and Pluriannual programs; UI&D through the Programmatic and Pluriannual programs of FCT/MCTES [531]; Azorean DRCT, FEDER	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); MARMACII; Programmatic and Pluriannual programs; UI&D through the Programmatic and Pluriannual programs of FCT/MCTES; Azorean DRCT, FEDER	This study was supported by the Fundacao para a Ciencia e Tecnologia funded JF (SFRH/BD/12788/2003), and FCT supported the project through MAREFISH (FCT- OCTI/BSE/41207/2001), MARMACII (INTERREG/ 05/MAC/4.2/A4) and Programmatic and Pluriannual programs. IMAR-DOP is UI&D #531 funded through the Programmatic and Pluriannual programs of FCT/MCTES and Azorean DRCT, part FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors would like to acknowledge the effort of Bernardo Broitman, Pedro Afonso, Robert Warner, Norberto Serpa, the crews of R.V. Arquipelago and R.V. Aguas vivas. FCT/MCTES (SFRH/BD/12788/2003 and FLAD. IMAR-DOP is UI&D #531 funded through the Programmatic and Pluriannual programs of FCT/MCTES and Azorean DRCT, part FEDER. This paper is a contribution to MAREFISH (FCT- OCTI/BSE/41207/2001) and MARMACII (INTERREG/05/MAC/4.2/A4).	Agnew DJ, 2000, CAN J FISH AQUAT SCI, V57, P2479, DOI 10.1139/cjfas-57-12-2479; AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3; Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; ANDERSON J T, 1988, Journal of Northwest Atlantic Fishery Science, V8, P55; Bashmatchnikov I, 2004, SST STATIONARY ANOMA, P148; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Beaugrand G, 2010, CLIM RES, V41, P15, DOI 10.3354/cr00838; Beaugrand G, 2010, GLOBAL CHANGE BIOL, V16, P1268, DOI 10.1111/j.1365-2486.2009.02063.x; Biktashev VN, 2003, J PLANKTON RES, V25, P21, DOI 10.1093/plankt/25.1.21; Brodeur RD, 2008, MAR ECOL PROG SER, V366, P187, DOI 10.3354/meps07539; Caselle JE, 2010, B MAR SCI, V86, P355; Castonguay M, 2008, CAN J FISH AQUAT SCI, V65, P1528, DOI 10.1139/F08-126; Chambers R.C., 1997, EARLY LIFE HIST RECR; Conover WJ, 1999, PRACTICAL NONPARAMET; CUSHING D H, 1975, P278; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Findlay AM, 2002, MAR ECOL PROG SER, V238, P237, DOI 10.3354/meps238237; Fontes J, 2009, J FISH BIOL, V75, P1271, DOI 10.1111/j.1095-8649.2009.02363.x; Fontes J, 2011, J SEA RES, V65, P1, DOI 10.1016/j.seares.2010.05.001; Fontes J, 2010, SCI MAR, V74, P721, DOI 10.3989/scimar.2010.74n4721; Fox HE, 2012, MAR ECOL PROG SER, V463, P259, DOI 10.3354/meps09838; FREEDMAN DA, 1983, AM STAT, V37, P152, DOI 10.2307/2685877; Green BS, 2004, J EXP MAR BIOL ECOL, V299, P115, DOI 10.1016/j.jembe.2003.09.001; HEMING TA, 1982, CAN J FISH AQUAT SCI, V39, P184, DOI 10.1139/f82-021; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; HOUDE ED, 1989, FISH B-NOAA, V87, P471; Kristiansen T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017456; Laidig TE, 2007, FISH B-NOAA, V105, P39; MCCORMICK MI, 1995, MAR ECOL PROG SER, V118, P59, DOI 10.3354/meps118059; Meekan MG, 2003, MAR ECOL PROG SER, V256, P193, DOI 10.3354/meps256193; Minto C, 2008, NATURE, V452, P344, DOI 10.1038/nature06605; Murphy HM, 2014, OECOLOGIA, V175, P1201, DOI 10.1007/s00442-014-2968-9; Planque B, 2008, MAR ECOL PROG SER, V357, P213, DOI 10.3354/meps07274; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; Porteiro Felipe Mora, 1996, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, V14A, P23; Sampey A, 2007, MAR ECOL PROG SER, V339, P243, DOI 10.3354/meps339243; Schmiing M, 2013, MAR ECOL PROG SER, V474, P201, DOI 10.3354/meps10099; Sponaugle S, 2006, MAR ECOL PROG SER, V308, P1, DOI 10.3354/meps308001; Stige LC, 2015, PROG OCEANOGR, V134, P138, DOI 10.1016/j.pocean.2015.01.009; THRESHER RE, 1989, NATURE, V341, P641, DOI 10.1038/341641a0; Vaida F, 2005, BIOMETRIKA, V92, P351, DOI 10.1093/biomet/92.2.351; Wilson JR, 2008, ESTUAR COAST SHELF S, V79, P483, DOI 10.1016/j.ecss.2008.05.001; WOODS JD, 1995, ICES J MAR SCI, V52, P723, DOI 10.1016/1054-3139(95)80085-9	45	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165648	10.1371/journal.pone.0165648	http://dx.doi.org/10.1371/journal.pone.0165648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824889	Green Submitted, Green Published, gold			2022-12-26	WOS:000387615200025
J	Alzeidan, R; Rabiee, F; Mandil, A; Hersi, A; Fayed, A				Alzeidan, Rasmieh; Rabiee, Fatemeh; Mandil, Ahmed; Hersi, Ahmad; Fayed, Amel			Non-Communicable Disease Risk Factors among Employees and Their Families of a Saudi University: An Epidemiological Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; DIABETES-MELLITUS; CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; ARABIA; PREDICTION; KINGDOM; HYPERCHOLESTEROLEMIA; PREVALENCE; OBESITY	Objectives To assess the prevalence of noncommunicable disease (NCD) risk factors among Saudi university employees and their families; to estimate the cardiovascular risk (CVR) amongst the study population in the following 10years. Methods The NCD risk factors prevalence was estimated using a cross-sectional approach for a sample of employees and their families aged >= 18 years old, in a Saudi university (Riyadh in Kingdom of Saudi Arabia; KSA). WHO STEPwise standardized tools were used to estimate NCD risk factors and the Framingham Coronary Heart Risk Score calculator was used to calculate the CVR. Results Five thousand and two hundred subjects were invited, of whom 4,500 participated in the study, providing a response rate of 87%. The mean age of participants was 39.3 +/- 13.4 years. The majority of participants reported low fruit/vegetables consumption (88%), and physically inactive (77%). More than two thirds of the cohort was found to be either overweight or obese (72%), where 36% were obese, and 59% had abdominal obesity. Of the total cohort, 22 - 37% were found to suffer from dyslipidaemia, 22% either diabetes or hypertension, with rather low reported current tobacco use (12%). One quarter of participants was estimated to have > 10% risk to develop cardiovascular disease within the following 10-years. Conclusion The prevalence of NCD risk factors was found to be substantially high among the university employees and their families in this study.	[Alzeidan, Rasmieh; Hersi, Ahmad] King Saud Univ, Coll Med, Cardiac Sci Dept, Riyadh, Saudi Arabia; [Rabiee, Fatemeh] Birmingham City Univ, Sch Hlth Sci, Fac Hlth Educ & Life Sci, Birmingham, W Midlands, England; [Mandil, Ahmed] King Saud Univ, Coll Med, Family & Community Med Dept, Riyadh, Saudi Arabia; [Fayed, Amel] Princess Nourah Bint Abdulrahman Univ, Coll Med, Riyadh, Saudi Arabia; [Fayed, Amel] Univ Alexandria, High Inst Publ Hlth, Dept Biostat, Alexandria, Egypt; [Mandil, Ahmed] Univ Alexandria, High Inst Publ Hlth, Dept Epidemiol, Alexandria, Egypt	King Saud University; Birmingham City University; King Saud University; Princess Nourah bint Abdulrahman University; Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University	Alzeidan, R (corresponding author), King Saud Univ, Coll Med, Cardiac Sci Dept, Riyadh, Saudi Arabia.	ras_zeidan@hotmail.com	Fayed, Amel/H-8588-2016; Hersi, Ahmad/ABC-9266-2020	Fayed, Amel/0000-0003-3395-0486; Mandil, Ahmed/0000-0002-0903-3277	King Abdulaziz City for Science and Technology (KACST) [MS-34-5]	King Abdulaziz City for Science and Technology (KACST)	We are grateful and appreciative of the King Abdulaziz City for Science and Technology (KACST) (http://gdrg.kacst.edu.sa/Site/ar/Default.aspx) for supporting this work through the research grant number (MS-34-5) to AH. The funder had no role in study design, data collection, data analysis, decision or writing-up the manuscript.	Aaronson PI, 2013, CARDIOVASCULAR GLANC, V4, P76; Abalkhail BA, 2000, PREV MED, V31, P390, DOI 10.1006/pmed.2000.0713; Al Alwan I, 2013, INT J HEALTH SCI-IJH, V7, P3, DOI 10.12816/0006015; Al-Daghri NM, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-76; Al-Hazzaa HM, 2014, J PHYS ACT HEALTH, V11, P1202, DOI 10.1123/jpah.2012-0427; Al-Nakeeb Y, 2012, INT J ENV RES PUB HE, V9, P1490, DOI 10.3390/ijerph9041490; Al-Nooh AA, 2014, CARDIOLRESPRACT, V2014; Al-Rubeaan K, 2015, J DIABETES, V7, P622, DOI 10.1111/1753-0407.12224; Al-Zalabani AH, 2015, J TAIBAH UNIV MED SC, V10, P208, DOI 10.1016/j.jtumed.2014.11.001; Alhyas Layla, 2011, JRSM Short Rep, V2, P55, DOI 10.1258/shorts.2011.011019; Alsheikh-Ali AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102830; Amin TT, 2014, ASIAN PAC J CANCER P, V15, P7897, DOI 10.7314/APJCP.2014.15.18.7897; ANOKUTE CC, 1990, J ROY SOC HEALTH, V110, P201, DOI 10.1177/146642409011000604; Aswin K, 2014, J Family Med Prim Care, V3, P255, DOI 10.4103/2249-4863.141624; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Basulaiman M, 2015, NUTR DIETARY S, V7, P9; Basulaiman M, 2014, ANN EPIDEMIOL, V24, P801, DOI 10.1016/j.annepidem.2014.08.001; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Carnethon M, 2009, CIRCULATION, V120, P1725, DOI 10.1161/CIRCULATIONAHA.109.192653; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; El Bcheraoui C, 2014, INT J HYPERTENS, V2014, DOI 10.1155/2014/564679; El Bcheraoui C, 2014, INT J PUBLIC HEALTH, V59, P1011, DOI 10.1007/s00038-014-0612-4; Elkum N, 2014, DIABETIC MED, V31, P531, DOI 10.1111/dme.12386; Eriksen M, 2012, TOBACCO ATLAS; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guptha Soneil, 2014, Indian Heart J, V66, P280, DOI 10.1016/j.ihj.2014.03.005; Hajat C, 2010, PROG CARDIOVASC DIS, V53, P28, DOI 10.1016/j.pcad.2010.05.002; Kaukua J, 2001, DIABETES OBES METAB, V3, P17, DOI 10.1046/j.1463-1326.2001.00093.x; Lee HM, 2010, EUR RESPIR J, V36, P1002, DOI 10.1183/09031936.00042410; Mahfouz AA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/960292; Mattei J, 2013, J NUTR, V143, P1753, DOI 10.3945/jn.113.180141; Memish ZA, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140236; Mitwalli AH, 2013, J SAUDI HEART ASSOC, V25, P19, DOI 10.1016/j.jsha.2012.10.002; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Musaiger AO, 2012, INT J GEN MED, V5, P199, DOI 10.2147/IJGM.S29663; Patel JV, 2006, ATHEROSCLEROSIS, V185, P297, DOI 10.1016/j.atherosclerosis.2005.06.005; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sharma Divya, 2012, Indian Heart J, V64, P356, DOI 10.1016/j.ihj.2012.06.001; Soofi MA, 2015, J SAUDI HEART ASSOC, V27, P152, DOI 10.1016/j.jsha.2015.03.003; STEPwise, 2009, STEPWISE APPR NONC D; Tool-WHO S, 2009, TOOL WHO S WHO STEPS; WHO S, 2008, COND SURV DAT ENTR 4; WHO-EMRO, 2014, NONC DIS EMRO; WHO-HBA1C, 2011, WHO HBA1C USE GLYCAT; WHO-NCD-Profile, 2014, WHO NCD PROFILE NONC; WHO-NCD-status, 2014, GLOBAL STATUS REPORT; WHO-Obesity-EMRO, 2013, WHO OBESITY EMRO OBE; WHO-Workplace-Diet-PA, 2008, WHO WORKPLACE DIET P; World Health Organization, 2008, WAIST CIRCUMFERENCE	50	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165036	10.1371/journal.pone.0165036	http://dx.doi.org/10.1371/journal.pone.0165036			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814369	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000386911100006
J	Hannan, JP; Laskowski, J; Thurman, JM; Hageman, GS; Holers, VM				Hannan, Jonathan P.; Laskowski, Jennifer; Thurman, Joshua M.; Hageman, Gregory S.; Holers, V. Michael			Mapping the Complement Factor H-Related Protein 1 (CFHR1):C3b/C3d Interactions	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; HEPARIN-BINDING DOMAIN; MACULAR DEGENERATION; RECEPTOR 2; REGULATORY DOMAINS; CRYSTAL-STRUCTURE; SELF-ASSOCIATION; IDENTIFICATION; C3D; SITE	Complement factor H-related protein 1 (CFHR1) is a complement regulator which has been reported to regulate complement by blocking C5 convertase activity and interfering with C5b surface association. CFHR1 also competes with complement factor H (CFH) for binding to C3b, and may act as an antagonist of CFH-directed regulation on cell surfaces. We have employed site-directed mutagenesis in conjunction with ELISA-based and functional assays to isolate the binding interaction that CFHR1 undertakes with complement components C3b and C3d to a single shared interface. The C3b/C3d: CFHR1 interface is identical to that which occurs between the two C-terminal domains (SCR19-20) of CFH and C3b. Moreover, we have been able to corroborate that dimerization of CFHR1 is necessary for this molecule to bind effectively to C3b and C3d, or compete with CFH. Finally, we have established that CFHR1 competes with complement factor H-like protein 1 (CFHL-1) for binding to C3b. CFHL-1 is a CFH gene splice variant, which is almost identical to the N-terminal 7 domains of CFH (SCR1-7). CFHR1, therefore, not only competes with the C-terminus of CFH for binding to C3b, but also sterically blocks the interaction that the N-terminus of CFH undertakes with C3b, and which is required for CFH-regulation.	[Hannan, Jonathan P.; Laskowski, Jennifer; Thurman, Joshua M.; Holers, V. Michael] Univ Colorado, Sch Med, Dept Med, Aurora, CO 80045 USA; [Hageman, Gregory S.] Univ Utah, Sharon Eccles Ctr Translat Med, John A Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Utah System of Higher Education; University of Utah	Hannan, JP (corresponding author), Univ Colorado, Sch Med, Dept Med, Aurora, CO 80045 USA.	Jonathan.Hannan@ucdenver.edu		Hannan, Jonathan/0000-0003-3318-2341; Thurman, Joshua Michael/0000-0002-3476-9956	Moran Center for Translational Medicine at the University of Utah; Department of Medicine at the University of Colorado Denver; Beckman Initiative for Macular Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051749] Funding Source: NIH RePORTER	Moran Center for Translational Medicine at the University of Utah; Department of Medicine at the University of Colorado Denver; Beckman Initiative for Macular Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The generation of constructs for wild type recombinant CFH and CFHR1 was made possible in part by funding to JPH provided by a services agreement between the Moran Center for Translational Medicine at the University of Utah and the Department of Medicine at the University of Colorado Denver. Additional funding for this research was provided by a research grant from the Beckman Initiative for Macular Research to VMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorlo M, 2015, FEBS J, V282, P3883, DOI 10.1111/febs.13399; Bhattacharjee A, 2015, J BIOL CHEM, V290, P9500, DOI 10.1074/jbc.M114.630871; Blackmore TK, 1996, J IMMUNOL, V157, P5422; Blackmore TK, 1998, J IMMUNOL, V160, P3342; Blaum BS, 2015, NAT CHEM BIOL, V11, P77, DOI [10.1038/NCHEMBIO.1696, 10.1038/nchembio.1696]; Buhlmann D, 2016, J IMMUNOL, V197, P620, DOI 10.4049/jimmunol.1600053; Clark SJ, 2014, J IMMUNOL, V193, P4962, DOI 10.4049/jimmunol.1401613; Clemenza L, 2000, J IMMUNOL, V165, P3839, DOI 10.4049/jimmunol.165.7.3839; de Jorge EG, 2013, P NATL ACAD SCI USA, V110, P4685, DOI 10.1073/pnas.1219260110; Eberhardt HU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078617; Esparza-Gordillo J, 2004, IMMUNOGENETICS, V56, P77, DOI 10.1007/s00251-004-0660-7; Fernando AN, 2007, J MOL BIOL, V368, P564, DOI 10.1016/j.jmb.2007.02.038; Ferreira VP, 2009, J IMMUNOL, V182, P7009, DOI 10.4049/jimmunol.0804031; Fritsche LG, 2010, HUM MOL GENET, V19, P4694, DOI 10.1093/hmg/ddq399; Gale DP, 2010, LANCET, V376, P794, DOI 10.1016/S0140-6736(10)60670-8; GORDON DL, 1995, J IMMUNOL, V155, P348; Hageman GS, 2006, ANN MED, V38, P592, DOI 10.1080/07853890601097030; Hakobyan S, 2010, KIDNEY INT, V78, P782, DOI 10.1038/ki.2010.275; Hannan JP, 2016, CURR PROTEIN PEPT SC, V17, P463, DOI 10.2174/1389203717666151201192124; Hebecker M, 2012, J BIOL CHEM, V287, P19528, DOI 10.1074/jbc.M112.364471; Heinen S, 2009, BLOOD, V114, P2439, DOI 10.1182/blood-2009-02-205641; Herbert AP, 2007, J BIOL CHEM, V282, P18960, DOI 10.1074/jbc.M609636200; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Isenman DE, 2010, J IMMUNOL, V184, P1946, DOI 10.4049/jimmunol.0902919; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Jozsi M, 2015, TRENDS IMMUNOL, V36, P374, DOI 10.1016/j.it.2015.04.008; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; KLICKSTEIN LB, 1987, J EXP MED, V165, P1095, DOI 10.1084/jem.165.4.1095; Kuhn S, 1996, EUR J IMMUNOL, V26, P2383, DOI 10.1002/eji.1830261017; KUHN S, 1995, J IMMUNOL, V155, P5663; McRae JL, 2005, J IMMUNOL, V174, P6250, DOI 10.4049/jimmunol.174.10.6250; Morgan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032187; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; Nan RD, 2008, J MOL BIOL, V375, P891, DOI 10.1016/j.jmb.2007.11.015; Okemefuna AI, 2008, J MOL BIOL, V375, P80, DOI 10.1016/j.jmb.2007.09.026; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; Perkins SJ, 2012, IMMUNOBIOLOGY, V217, P281, DOI 10.1016/j.imbio.2011.10.003; REID KBM, 1989, IMMUNOL TODAY, V10, P177, DOI 10.1016/0167-5699(89)90317-4; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; Sharma AK, 1996, P NATL ACAD SCI USA, V93, P10996, DOI 10.1073/pnas.93.20.10996; Shaw CD, 2010, J MOL BIOL, V404, P697, DOI 10.1016/j.jmb.2010.10.005; Thiel J, 2012, J ALLERGY CLIN IMMUN, V129, P801, DOI 10.1016/j.jaci.2011.09.027; Tortajada A, 2013, J CLIN INVEST, V123, P2434, DOI 10.1172/JCI68280; van den Elsen JMH, 2011, SCIENCE, V332, P608, DOI 10.1126/science.1201954; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Young KA, 2007, J BIOL CHEM, V282, P36614, DOI 10.1074/jbc.M706324200	49	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166200	10.1371/journal.pone.0166200	http://dx.doi.org/10.1371/journal.pone.0166200			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814381	Green Published, Green Submitted, gold			2022-12-26	WOS:000386911100036
J	Choi, DH; Ban, HY; Seo, BS; Lee, KJ; Lee, BW				Choi, Doug-Hwan; Ban, Ho-Young; Seo, Beom-Seok; Lee, Kyu-Jong; Lee, Byun-Woo			Phenology and Seed Yield Performance of Determinate Soybean Cultivars Grown at Elevated Temperatures in a Temperate Region	PLOS ONE			English	Article							BOUNDARY-LINE; GENOTYPES; DURATION; CLIMATE; STRESS; SIZE	Increased temperature means and fluctuations associated with climate change are predicted to exert profound effects on the seed yield of soybean. We conducted an experiment to evaluate the impacts of global warming on the phenology and yield of two determinate soybean cultivars in a temperate region (37.27 8 degrees N, 126.99 degrees E; Suwon, South Korea). These two soybean cultivars, Sinpaldalkong [maturity group (MG) IV] and Daewonkong (MG VI), were cultured on various sowing dates within a four-year period, under no water-stress conditions. Soybeans were kept in greenhouses controlled at the current ambient temperature (AT), AT+ 1.5 degrees C, AT+ 3.0 degrees C, and AT+ 5.0 degrees C throughout the growth periods. Growth periods (VE-R7) were significantly prolonged by the elevated temperatures, especially the R1-R5 period. Cultivars exhibited no significant differences in seed yield at the AT+ 1.5 degrees C and AT+ 3.0 degrees C treatments, compared to AT, while a significant yield reduction was observed at the AT+ 5.0 degrees C treatment. Yield reductions resulted from limited seed number, which was due to an overall low numbers of pods and seeds per pod. Heat stress conditions induced a decrease in pod number to a greater degree than in seed number per pod. Individual seed weight exhibited no significant variation among temperature elevation treatments; thus, seed weight likely had negligible impacts on overall seed yield. A boundary line analysis (using quantile regression) estimated optimum temperatures for seed number at 26.4 to 26.8 degrees C (VE-R5) for both cultivars; the optimum temperatures (R5-R7) for single seed weight were estimated at 25.2 degrees C for the Sinpaldalkong smaller-seeded cultivar, and at 22.3 degrees C for the Daewonkong larger-seeded cultivar. The optimum growing season (VE-R7) temperatures for seed yield, which were estimated by combining the two boundary lines for seed number and seed weight, were 26.4 and 25.0 inverted perpendicular C for the Sinpaldalkong and Daewonkong cultivars, respectively. Considering the current soybean growing season temperature, which ranges from 21.7 (in the north) to 24.6 degrees C (in the south) in South Korea, and the temperature response of potential soybean yields, further warming of less than approximately 1 degrees C would not become a critical limiting factor for soybean production in South Korea.	[Choi, Doug-Hwan; Ban, Ho-Young; Seo, Beom-Seok; Lee, Byun-Woo] Seoul Natl Univ, Coll Agr & Life Sci, Dept Plant Sci, Seoul, South Korea; [Lee, Kyu-Jong; Lee, Byun-Woo] Seoul Natl Univ, Coll Agr & Life Sci, Res Inst Agr & Life Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Lee, BW (corresponding author), Seoul Natl Univ, Coll Agr & Life Sci, Dept Plant Sci, Seoul, South Korea.; Lee, BW (corresponding author), Seoul Natl Univ, Coll Agr & Life Sci, Res Inst Agr & Life Sci, Seoul, South Korea.	leebw@snu.ac.kr		, Byun-Woo/0000-0003-2284-1348	Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea [PJ0101072016]	Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This study was conducted with the support of the Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ0101072016), Rural Development Administration, Republic of Korea (www.rda.go.kr). DC, HB, BS, KL, and BL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaah G., 2012, PRINCIPLES PLANT GEN; BAKER JT, 1989, CROP SCI, V29, P98, DOI 10.2135/cropsci1989.0011183X002900010024x; Boote K. J., 1997, Advances in carbon dioxide effects research. Proceedings of a symposium, Cincinnati, Ohio, USA, 7-12 November 1993., P179; Boote K. J., 1998, Agricultural systems modeling and simulation., P651; Boote KJ, 2010, DECIS SUPPORT SYST, V4, P19; Brek Z., 1992, TECHNOLOGY PRODUCTIO; CREGAN PB, 1984, CROP SCI, V24, P659, DOI 10.2135/cropsci1984.0011183X002400040008x; Djanaguiraman M, 2011, ENVIRON EXP BOT, V71, P215, DOI 10.1016/j.envexpbot.2010.12.006; DORNBOS DL, 1991, CAN J PLANT SCI, V71, P373, DOI 10.4141/cjps91-052; EGLI DB, 1980, AGRON J, V72, P560, DOI 10.2134/agronj1980.00021962007200030036x; ELLIOTT JA, 1993, SOIL SCI SOC AM J, V57, P82, DOI 10.2136/sssaj1993.03615995005700010016x; EPHRATH J E, 1991, Biotronics, V20, P1; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Gibson LR, 1996, CROP SCI, V36, P98, DOI 10.2135/cropsci1996.0011183X003600060034x; GRIMM SS, 1994, AGRON J, V86, P31, DOI 10.2134/agronj1994.00021962008600010007x; Ha TJ, 2009, KOREAN J CROP SCI, V4, P104; Hartman GL, 2011, FOOD SECUR, V3, P5, DOI 10.1007/s12571-010-0108-x; Hatfield JL, 2011, AGRON J, V103, P351, DOI 10.2134/agronj2010.0303; Hatfield J.L., 2014, ENCY AGR FOOD SYSTEM, P256, DOI [10.1016/b978-0-444-52512-3.00003-6, DOI 10.1016/B978-0-444-52512-3.00003-6]; Hatfield J. L., 2008, EFFECTS CLIMATE CHAN, P362; HESKETH JD, 1973, CROP SCI, V13, P250, DOI 10.2135/cropsci1973.0011183X001300020030x; Jones JW, 2010, DECIS SUPPORT SYST, V4, P123; Kim ChangKug, 2001, Korean Journal of Crop Science, V46, P241; Korea Meteorological Administration, 2014, KOR CLIM CHANG ASS R; Kumagai E, 2014, AGR FOREST METEOROL, V198, P265, DOI 10.1016/j.agrformet.2014.08.016; LAWN RJ, 1985, CROP SCI, V25, P137, DOI 10.2135/cropsci1985.0011183X002500010034x; Lecoeur J, 1996, CROP SCI, V36, P331, DOI 10.2135/cropsci1996.0011183X003600020020x; Pachauri R.K., 2014, CLIM CHANG 2013 PHYS, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, 10.1017/cbo9781107415324]; PANDEY JP, 1973, CROP SCI, V13, P505, DOI 10.2135/cropsci1973.0011183X001300050004x; Purcell LC, 2014, ARKANSAS SOYBEAN HDB; Puteh A. B., 2013, Australian Journal of Crop Science, V7, P1472; Qiu LJ, 2010, SOYBEAN: BOTANY, PRODUCTION AND USES, P1, DOI 10.1079/9781845936440.0001; Ruiz-Vera UM, 2013, PLANT PHYSIOL, V162, P410, DOI 10.1104/pp.112.211938; Sadras VO, 2008, CROP SCI, V48, P408, DOI 10.2135/cropsci2007.05.0292; Sage RF, 2007, PLANT CELL ENVIRON, V30, P1086, DOI 10.1111/j.1365-3040.2007.01682.x; Salem MA, 2007, CROP SCI, V47, P219, DOI 10.2135/cropsci2006.07.0443; Setiyono TD, 2007, FIELD CROP RES, V100, P257, DOI 10.1016/j.fcr.2006.07.011; SEXTON PJ, 1994, CROP SCI, V34, P84, DOI 10.2135/cropsci1994.0011183X003400010015x; Shatar TM, 2004, J AGR SCI-CAMBRIDGE, V142, P553, DOI 10.1017/S0021859604004642; Siebers MH, 2015, GLOBAL CHANGE BIOL, V21, P3114, DOI 10.1111/gcb.12935; Summerfield RJ, 1980, ADV LEGUME SCI, P17; SWANK JC, 1987, CROP SCI, V27, P85, DOI 10.2135/cropsci1987.0011183X002700010022x; Tacarindua CRP, 2013, FIELD CROP RES, V154, P74, DOI 10.1016/j.fcr.2013.07.021; Tischner T, 2003, CROP SCI, V43, P464, DOI 10.2135/cropsci2003.0464; Tubiello FN, 2007, EUR J AGRON, V26, P215, DOI 10.1016/j.eja.2006.10.002; Vachani S., 2014, ADAPTATION CLIMATE C, P1, DOI DOI 10.4337/9781781954737.00006; Wang J, 2006, CROP SCI, V46, P2171, DOI 10.2135/cropsci2006.02.0092; WEBB RA, 1972, J HORTIC SCI BIOTECH, V47, P309, DOI 10.1080/00221589.1972.11514472; Whigham D. K., 1983, Potential productivity of field crops under different environments., P205; Wiebold WJ, 2012, INTEGRATED PEST CROP, V22, P117; Woodworth CM, 2013, EARLY NAMED SOYBEAN, P635	51	28	28	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165977	10.1371/journal.pone.0165977	http://dx.doi.org/10.1371/journal.pone.0165977			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812185	gold, Green Published, Green Submitted			2022-12-26	WOS:000386910000087
J	Graczyk, MB; Queiros, SMD				Graczyk, Michelle B.; Duarte Queiros, Silvio M.			Intraday Seasonalities and Nonstationarity of Trading Volume in Financial Markets: Individual and Cross-Sectional Features	PLOS ONE			English	Article							STATISTICAL PROPERTIES; TRADED VOLUME; PRICES; INFORMATION; MODEL	We study the intraday behaviour of the statistical moments of the trading volume of the blue chip equities that composed the Dow Jones Industrial Average index between 2003 and 2014. By splitting that time interval into semesters, we provide a quantitative account of the nonstationary nature of the intraday statistical properties as well. Explicitly, we prove the well-known boolean OR-shape exhibited by the average trading volume-as well as the volatility of the price fluctuations-experienced a significant change from 2008 (the year of the-subprime" financial crisis) onwards. That has resulted in a faster relaxation after the market opening and relates to a consistent decrease in the convexity of the average trading volume intraday profile. Simultaneously, the last part of the session has become steeper as well, a modification that is likely to have been triggered by the new short-selling rules that were introduced in 2007 by the Securities and Exchange Commission. The combination of both results reveals that the [has been turning into a coproduct. Additionally, the analysis of higher-order cumulants-namely the skewness and the kurtosis-shows that the morning and the afternoon parts of the trading session are each clearly associated with different statistical features and hence dynamical rules. Concretely, we claim that the large initial trading volume is due to wayward stocks whereas the large volume during the last part of the session hinges on a cohesive increase of the trading volume. That dissimilarity between the two parts of the trading session is stressed in periods of higher uproar in the market.	[Graczyk, Michelle B.; Duarte Queiros, Silvio M.] Ctr Brasileiro Pesquisas Fis, Rio De Janeiro, RJ, Brazil; [Duarte Queiros, Silvio M.] Natl Inst Sci & Technol Complex Syst, Rio De Janeiro, RJ, Brazil	Centro Brasileiro de Pesquisas Fisicas	Queiros, SMD (corresponding author), Ctr Brasileiro Pesquisas Fis, Rio De Janeiro, RJ, Brazil.; Queiros, SMD (corresponding author), Natl Inst Sci & Technol Complex Syst, Rio De Janeiro, RJ, Brazil.	sdqueiro@google.com	Queirós, Sílvio M. Duarte/L-1170-2016	Queirós, Sílvio M. Duarte/0000-0001-6915-1892	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Dr Silvio M. Duarte Queiros) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (Ms. Michelle Bau Graczyk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admati AR, 1988, REV FINANC STUD, V1, P3, DOI 10.1093/rfs/1.1.3; Alfi V, 2009, CENT EUR J PHYS, V7, P483, DOI [10.2478/S11534-009-0059-z, 10.2478/s11534-009-0059-z]; Allez R, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/025010; Andersen T. G., 1997, J EMPIR FINANC, V2-3, P115, DOI DOI 10.1016/S0927-5398(97)00004-2; [Anonymous], 2013, NAT PHYS, V9, P119; Anteneodo C, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/10/P10023; Bak P., 1997, NATURE WORKS SCI SEL; Borland L, 2016, CHAOS SOLITON FRACT, V88, P59, DOI 10.1016/j.chaos.2016.03.014; Bouchaud JP, 2009, HANDB FINANC, P57, DOI 10.1016/B978-012374258-2.50006-3; Bouchaud JP, 2000, INTRO ECONOPHYSICS C; Camargo S, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046702; Camargo S, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-30974-9; CLARK PK, 1973, ECONOMETRICA, V41, P135, DOI 10.2307/1913889; COPELAND TE, 1976, J FINANC, V31, P1149, DOI 10.2307/2326280; Cortines AAG, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/30003; de Souza J, 2006, EUR PHYS J B, V50, P165, DOI 10.1140/epjb/e2006-00130-1; Queiros SMD, 2008, BRAZ J PHYS, V38, P203, DOI 10.1590/S0103-97332008000200001; Queiros SMD, 2016, CHAOS SOLITON FRACT, V88, P1, DOI 10.1016/j.chaos.2016.03.022; Queiros SMD, 2016, CHAOS SOLITON FRACT, V88, P24, DOI 10.1016/j.chaos.2015.12.024; Eisler Z, 2006, EUR PHYS J B, V51, P145, DOI 10.1140/epjb/e2006-00189-6; GARMAN MB, 1976, J FINANC ECON, V3, P257, DOI 10.1016/0304-405X(76)90006-4; Good PI, 1999, RESAMPLING METHODS P, DOI [10.1007/0-8176-4444-X, DOI 10.1007/0-8176-4444-X]; Gopikrishnan P, 2000, PHYS REV E, V62, pR4493, DOI 10.1103/PhysRevE.62.R4493; Graczyk MB, 2016, INTRADAY SEASONALITI; Graczyk MB, 2016, NONSTATIONARITY INTR; JAIN PC, 1988, J FINANC QUANT ANAL, V23, P269, DOI 10.2307/2331067; Jensen HJ, 1988, SELF ORG CRITICALITY; KARPOFF JM, 1987, J FINANC QUANT ANAL, V22, P109, DOI 10.2307/2330874; Lee KE, 2007, PHYSICA A, V383, P65, DOI 10.1016/j.physa.2007.04.112; Lillo F, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.016119; Mantegna RN, 1999, INTRO ECONOPHYSICS C; Mu GH, 2009, EUR PHYS J B, V68, P145, DOI 10.1140/epjb/e2009-00059-9; Newman MEJ, 1996, P ROY SOC B-BIOL SCI, V263, P1605, DOI 10.1098/rspb.1996.0235; Osorio R., 2004, NONEXTENSIVE ENTROPY; Queiros SMD, 2007, PHYSICA A, V383, P10, DOI 10.1016/j.physa.2007.04.082; Queiros SMD, 2005, EUROPHYS LETT, V71, P339, DOI 10.1209/epl/i2005-10109-0; Rocha P, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.052122; Sornette D, 2003, RISK MAG, V16, P67; Varian HR, 2000, VARIANTS EC THEORY S	39	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165057	10.1371/journal.pone.0165057	http://dx.doi.org/10.1371/journal.pone.0165057			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812141	Green Published, gold, Green Submitted			2022-12-26	WOS:000386910000021
J	Ishida, T; Takechi, S				Ishida, Takumi; Takechi, Shinji			Nrf2-ARE-Dependent Alterations in Zinc Transporter mRNA Expression in HepG2 Cells	PLOS ONE			English	Article							TERT-BUTYLHYDROQUINONE; OXIDATIVE STRESS; SUBUNIT GENE; ACRODERMATITIS-ENTEROPATHICA; INDUCIBLE EXPRESSION; RESPONSIVE ELEMENT; MAMMALIAN ZINC; BRAIN ZINC; ANTIOXIDANT; MOUSE	Zinc transporters are solute carrier family members. To date, 10 zinc transporters (ZnTs) and 14 Zrt-, Irt-like proteins (ZIPs) have been identified. ZnTs control intracellular zinc levels by effluxing zinc from the cytoplasm into the extracellular fluid, intracellular vesicles, and organelles; ZIPs also contribute to control intracellular zinc levels with influxing zinc into the cytoplasm. Recently, changes in zinc transporter expression have been observed in some stress-induced diseases, such as Alzheimer's disease and diabetes mellitus. However, little is known regarding the mechanisms that regulate zinc transporter expression. To address this, we have investigated the effect of a well-established stress response pathway, the nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant responsive element (ARE) pathway, on zinc transporter mRNA levels. Exposure to 10(-4) M tert-butylhydroquinone (t-BHQ), which activates Nrf2-ARE signaling, for 6 h significantly increases ZnT-1, ZnT-3, and ZnT-6 mRNAs levels, and significantly decreases ZnT-10 and ZIP-3 mRNA levels. These changes are not observed with 10(-6) M t-BHQ, which does not activate Nrf2-ARE signaling. Furthermore, t-BHQ exposure does not affect metal responsive element transcription, a cis element that is activated in response to intracellular free zinc accumulation. From these results, we believe that the transcription of ZnT-1, ZnT-3, ZnT-6, ZnT-10, and ZIP-3 is influenced by the Nrf2-ARE signal transduction pathway.	[Ishida, Takumi; Takechi, Shinji] Sojo Univ, Fac Pharmaceut Sci, Nishi Ku, 4-22-1 Ikeda, Kumamoto 8600082, Japan	Sojo University	Ishida, T (corresponding author), Sojo Univ, Fac Pharmaceut Sci, Nishi Ku, 4-22-1 Ikeda, Kumamoto 8600082, Japan.	ishida@ph.sojo-u.ac.jp		Takechi, Shinji/0000-0002-4397-9410				Bosomworth HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065475; Bosomworth HJ, 2012, METALLOMICS, V4, P771, DOI 10.1039/c2mt20088k; Cauchi S, 2010, MOL GENET METAB, V100, P77, DOI 10.1016/j.ymgme.2010.01.001; Chowanadisai W, 2005, J NUTR, V135, P1002, DOI 10.1093/jn/135.5.1002; Desouki MM, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-37; FRILING RS, 1990, P NATL ACAD SCI USA, V87, P6258, DOI 10.1073/pnas.87.16.6258; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; Hudson FN, 2000, BBA-GENE STRUCT EXPR, V1492, P447, DOI 10.1016/S0167-4781(00)00128-7; JACKSON MJ, 1989, ZINC HUMAN BIOL, P1; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Kobayashi A, 2004, METHOD ENZYMOL, V378, P273; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; Lee JM, 2001, BIOCHEM BIOPH RES CO, V280, P286, DOI 10.1006/bbrc.2000.4106; Li J, 2005, TOXICOL SCI, V83, P313, DOI 10.1093/toxsci/kfi027; LI Y, 1994, EUR J BIOCHEM, V226, P31, DOI 10.1111/j.1432-1033.1994.tb20023.x; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; Mulcahy RT, 1997, BIOL CHEM, V272, P7445; Nakamura Y, 2003, BIOCHEMISTRY-US, V42, P4300, DOI 10.1021/bi0340090; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Peters MMCG, 1996, CANCER RES, V56, P1006; PRESTERA T, 1995, MOL MED, V1, P827, DOI 10.1007/BF03401897; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Sensi SL, 2011, J NEUROSCI, V31, P16076, DOI 10.1523/JNEUROSCI.3454-11.2011; Shibuya N, 2012, J VET MED SCI, V74, P583, DOI 10.1292/jvms.11-0412; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; TAKEDA A, 1995, BRAIN RES, V695, P53, DOI 10.1016/0006-8993(95)00916-E; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Wang YH, 2013, BIOL TRACE ELEM RES, V154, P418, DOI 10.1007/s12011-013-9737-1; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627	36	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166100	10.1371/journal.pone.0166100	http://dx.doi.org/10.1371/journal.pone.0166100			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812191	Green Submitted, Green Published, gold			2022-12-26	WOS:000386910000102
J	Won, YH; Lee, MY; Choi, YC; Ha, Y; Kim, H; Kim, DY; Kim, MS; Yu, JH; Seo, JH; Kim, M; Cho, SR; Kang, SW				Won, Yu Hui; Lee, Min-Young; Choi, Young-Chul; Ha, Yoon; Kim, Hyongbum; Kim, Do-Young; Kim, Myung-Sun; Yu, Ji Hea; Seo, Jung Hwa; Kim, MinGi; Cho, Sung-Rae; Kang, Seong-Woong			Elucidation of Relevant Neuroinflammation Mechanisms Using Gene Expression Profiling in Patients with Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							HEXANUCLEOTIDE REPEAT; SPINAL-CORD; RECEPTOR; CELLS; INFLAMMATION; CHEMOKINES; INDUCTION; PATHWAY; C9ORF72; TOLLIP	Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by damage of motor neurons. Recent reports indicate that inflammatory responses occurring within the central nervous system contribute to the pathogenesis of ALS. We aimed to investigate disease-specific gene expression associated with neuroinflammation by conducting transcriptome analysis on fibroblasts from three patients with sporadic ALS and three normal controls. Several pathways were found to be upregulated in patients with ALS, among which the toll-like receptor (TLR) and NOD-like receptor (NLR) signaling pathways are related to the immune response. Genes-toll-interacting protein (TOLLIP), mitogen-activated protein kinase 9 (MAPK9), interleukin-1 beta (IL-1 beta), interleukin-8 (IL-8), and chemokine (C-X-C motif) ligand 1 (CXCL1)-related to these two pathways were validated using western blotting. This study validated the genes that are associated with TLR and NLR signaling pathways from different types of patient-derived cells. Not only fibroblasts but also induced pluripotent stem cells (iPSCs) and neural rosettes from the same origins showed similar expression patterns. Furthermore, expression of TOLLIP, a regulator of TLR signaling pathway, decreased with cellular aging as judged by changes in its expression through multiple passages. TOLLIP expression was downregulated in ALS cells under conditions of inflammation induced by lipopolysaccharide. Our data suggest that the TLR and NLR signaling pathways are involved in pathological innate immunity and neuroinflammation associated with ALS and that TOLLIP, MAPK9, IL-1 beta, IL-8, and CXCL1 play a role in ALS-specific immune responses. Moreover, changes of TOLLIP expression might be associated with progression of ALS.	[Won, Yu Hui] Chonbuk Natl Univ, Dept Phys Med & Rehabil, Res Inst Clin Med, Biomed Res Inst,Chonbuk Natl Univ Hosp, Jeonju, South Korea; [Lee, Min-Young; Kim, Myung-Sun; Yu, Ji Hea; Seo, Jung Hwa; Kim, MinGi; Cho, Sung-Rae] Yonsei Univ, Dept & Res Inst Rehabil Med, Coll Med, Seoul, South Korea; [Choi, Young-Chul] Yonsei Univ, Gangnam Severance Hosp, Dept Neurol, Coll Med, Seoul, South Korea; [Ha, Yoon] Yonsei Univ, Spine & Spinal Cord Inst, Dept Neurosurg, Coll Med, Seoul, South Korea; [Kim, Hyongbum] Yonsei Univ, Dept Pharmacol, Coll Med, Seoul, South Korea; [Kim, Do-Young] Yonsei Univ, Cutaneous Biol Res Inst, Dept Dermatol, Coll Med, Seoul, South Korea; [Kim, Hyongbum; Yu, Ji Hea; Seo, Jung Hwa; Kim, MinGi; Cho, Sung-Rae] Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea; [Kang, Seong-Woong] Yonsei Univ, Rehabil Inst Neuromuscular Dis, Gangnam Severance Hosp, Dept Rehabil Med,Coll Med, Seoul, South Korea; [Won, Yu Hui; Kang, Seong-Woong] Yonsei Univ, Dept Med, Grad Sch, Seoul, South Korea	Jeonbuk National University; Jeonbuk National University Hospital; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University	Cho, SR (corresponding author), Yonsei Univ, Dept & Res Inst Rehabil Med, Coll Med, Seoul, South Korea.; Cho, SR (corresponding author), Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea.; Kang, SW (corresponding author), Yonsei Univ, Rehabil Inst Neuromuscular Dis, Gangnam Severance Hosp, Dept Rehabil Med,Coll Med, Seoul, South Korea.; Kang, SW (corresponding author), Yonsei Univ, Dept Med, Grad Sch, Seoul, South Korea.	srcho918@yuhs.ac; kswoong@yuhs.ac	Kim, Hyongbum Henry/D-5804-2019	Kim, Hyongbum Henry/0000-0002-4693-738X; Choi, Young-Chul/0000-0001-5525-6861; Cho, Sung-Rae/0000-0003-1429-2684; Kang, Seong-Woong/0000-0002-7279-3893	National Research Foundation (SRC) [NRF-2014R1A2A1A11052042, 2015M3A9B4067068]; Ministry of Science and Technology, Republic of Korea; Korean Health Technology RD Project (YHW) [HI15C1529]; Ministry of Health & Welfare, Republic of Korea; "Dongwha" Faculty Research Assistance Program of Yonsei University College of Medicine (SRC) [6-2016-0126]	National Research Foundation (SRC); Ministry of Science and Technology, Republic of Korea(Ministry of Science & Technology (MOST), Republic of Korea); Korean Health Technology RD Project (YHW); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); "Dongwha" Faculty Research Assistance Program of Yonsei University College of Medicine (SRC)	This study was supported by grants from the National Research Foundation (SRC, NRF-2014R1A2A1A11052042; 2015M3A9B4067068), the Ministry of Science and Technology, Republic of Korea; the Korean Health Technology R&D Project (YHW, HI15C1529), Ministry of Health & Welfare, Republic of Korea; the "Dongwha" Faculty Research Assistance Program of Yonsei University College of Medicine (SRC, 6-2016-0126).	Ai B, 2015, MOL ECOL RESOUR, V15, P619, DOI 10.1111/1755-0998.12333; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Bendotti C, 2005, NEURODEGENER DIS, V2, P128, DOI 10.1159/000089617; Bowerman M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00214; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Byeon JS, 2010, INT J CANCER, V127, P2758, DOI 10.1002/ijc.25301; Casula M, 2011, NEUROSCIENCE, V179, P233, DOI 10.1016/j.neuroscience.2011.02.001; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Cribbs DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-179; Cruts M, 1993, GENEREVIEWS R; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dhawan P, 2002, J LEUKOCYTE BIOL, V72, P9; Didierlaurent A, 2006, MOL CELL BIOL, V26, P735, DOI 10.1128/MCB.26.3.735-742.2006; Elliott JL, 2001, MOL BRAIN RES, V95, P172, DOI 10.1016/S0169-328X(01)00242-X; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Gijselinck I, 2012, LANCET NEUROL, V11, P54, DOI 10.1016/S1474-4422(11)70261-7; Gillingwater TH, 2013, NEUROPATH APPL NEURO, V39, P320, DOI 10.1111/nan.12014; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Graves MC, 2004, AMYOTROPH LATERAL SC, V5, P213, DOI 10.1080/14660820410020286; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim Woo Jin, 2013, International Journal of Industrial Entomology, V27, P271; Kirk K, 2014, ANN NEUROL, V76, P620, DOI 10.1002/ana.24244; Kuhle J, 2009, EUR J NEUROL, V16, P771, DOI 10.1111/j.1468-1331.2009.02560.x; Lee DR, 2015, STEM CELL REP, V4, P821, DOI 10.1016/j.stemcr.2015.04.002; Lee EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092447; Lee MY, 2013, NEUROREHAB NEURAL RE, V27, P561, DOI 10.1177/1545968313481277; Letiembre M, 2009, NEUROBIOL AGING, V30, P759, DOI 10.1016/j.neurobiolaging.2007.08.018; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li T, 2004, MOL IMMUNOL, V41, P85, DOI 10.1016/j.molimm.2004.03.009; Lin JQ, 2013, FUNGAL GENET BIOL, V56, P78, DOI 10.1016/j.fgb.2013.04.007; Liu Y, 2009, J BIOL CHEM, V284, P3691, DOI 10.1074/jbc.M804446200; Luan J, 1997, J LEUKOCYTE BIOL, V62, P588, DOI 10.1002/jlb.62.5.588; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Meissner F, 2010, P NATL ACAD SCI USA, V107, P13046, DOI 10.1073/pnas.1002396107; Omari KM, 2006, GLIA, V53, P24, DOI 10.1002/glia.20246; Park CY, 2014, P NATL ACAD SCI USA, V111, P9253, DOI 10.1073/pnas.1323941111; Piao YS, 2003, BRAIN PATHOLOGY ZURI, V13, P10, DOI DOI 10.1111/J.1750-3639.2003.TB00002.X; Raman R, 2015, NEUROPATH APPL NEURO, V41, P201, DOI 10.1111/nan.12147; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sabatelli M, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.02.009; Seo JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074405; Shaw PJ, 2010, EUR J IMMUNOL, V40, P624, DOI 10.1002/eji.200940211; Takeda Kiyoshi, 2007, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1412s77; Tateishi T, 2010, J NEUROIMMUNOL, V222, P76, DOI 10.1016/j.jneuroim.2010.03.004; van der Meer JWM, 2010, P NATL ACAD SCI USA, V107, P12741, DOI 10.1073/pnas.1007946107; Verbeke H, 2011, CYTOKINE GROWTH F R, V22, P345, DOI 10.1016/j.cytogfr.2011.09.002; Vlahopoulos S, 1999, BLOOD, V94, P1878, DOI 10.1182/blood.V94.6.1878; Xia Q, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.69; Xie T, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.014; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200; Zhang RZ, 2005, J NEUROIMMUNOL, V159, P215, DOI 10.1016/j.jneuroim.2004.10.009; Zhao WH, 2010, GLIA, V58, P231, DOI 10.1002/glia.20919	59	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165290	10.1371/journal.pone.0165290	http://dx.doi.org/10.1371/journal.pone.0165290			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812125	Green Submitted, Green Published, gold			2022-12-26	WOS:000386910000025
J	Czech-Kowalska, J; Czekuc-Kryskiewicz, E; Pludowski, P; Zaniuk, K; Jaworski, M; Luba, A; Grzybowska, K; Pilat, K; Dobrzanska, A				Czech-Kowalska, Justyna; Czekuc-Kryskiewicz, Edyta; Pludowski, Pawel; Zaniuk, Katarzyna; Jaworski, Maciej; Luba, Anna; Grzybowska, Karolina; Pilat, Krystyna; Dobrzanska, Anna			The Clinical and Biochemical Predictors of Bone Mass in Preterm Infants	PLOS ONE			English	Article							SERUM ALKALINE-PHOSPHATASE; BIRTH-WEIGHT INFANTS; HIGH-TURNOVER OSTEOPENIA; X-RAY ABSORPTIOMETRY; CHRONIC LUNG-DISEASE; DEXAMETHASONE TREATMENT; PREMATURE-INFANTS; GESTATIONAL-AGE; METABOLISM; MINERALIZATION	Background Metabolic bone disease of prematurity still occurs in preterm infants, although a significant improvement in neonatal care has been observed in recent decades. Dual-energy X-ray absorptiometry (DXA) is the precise technique for assessing bone mineral content (BMC) in preterm infants, but is not widely available. Aim To investigate the clinical and biochemical parameters, including bone metabolism markers as potential predictors of BMC, in preterm infants up to 3 months corrected age (CA). Materials and Methods Ca-P homeostasis, iPTH, 25-hydroxyvitamin D, osteocalcin, N-terminal propeptide, crosslinked C-telopeptide and amino-terminal pro C-type natriuretic peptide and the DXA scans were prospectively performed in 184 preterm infants (<= 34 weeks' gestation) between term age and 3 mo CA. Lower bone mass was defined as BMC below or equal to respective median value for the whole study group, rounded to the nearest whole number. Results The appropriate quality DXA scans were available for 160 infants (87%) examined at term and for 130 (71%) tested at 3 mo CA. Higher iPTH level was the only independent predictor of lower BMC at term, whereas lower BMC at 3 mo CA was associated both with lower urinary phosphate excretion and higher serum osteocalcin level. ROC analysis showed that iPTH >43.6 pg/mL provided 40% sensitivity and 88% specificity in identification of preterm infants with lower BMC at term. In turn, urinary phosphate excretion (TRP>97% or UP/Cr <= 0.74 mg/mg) and serum osteocalcin >172 ng/mL provided 40% sensitivity and 93% specificity in identification of infants with decreased BMC at 3 mo CA. Conclusion Serum iPTH might to be a simple predictor of reduced BMC in preterm infants at term age, but urinary phosphate excretion and serum osteocalcin might predict reduced BMC at 3 mo CA. These results represent a promising diagnostic tool based on simple, widely available biochemical measurements for bone mass assessment in preterm infants.	[Czech-Kowalska, Justyna; Luba, Anna; Grzybowska, Karolina; Pilat, Krystyna; Dobrzanska, Anna] Childrens Mem Hlth Inst, Dept Neonatol & Neonatal Intens Care, Warsaw, Poland; [Czekuc-Kryskiewicz, Edyta; Pludowski, Pawel; Jaworski, Maciej] Childrens Mem Hlth Inst, Dept Biochem Radioimmunol & Expt Med, Warsaw, Poland; [Zaniuk, Katarzyna] Holy Family Hosp, Dept Neonatol, Warsaw, Poland	Children's Memorial Health Institute; Children's Memorial Health Institute	Czech-Kowalska, J (corresponding author), Childrens Mem Hlth Inst, Dept Neonatol & Neonatal Intens Care, Warsaw, Poland.	j.kowalska@ipczd.pl	Czech-Kowalska, Justyna/B-4306-2014; Płudowski, Paweł/P-2154-2018	Czech-Kowalska, Justyna/0000-0001-7563-3951; Płudowski, Paweł/0000-0001-8475-7112; Dobrzanska, Anna/0000-0003-2927-2344; Czekuc-Kryskiewicz, Edyta/0000-0002-3220-3780; Grzybowska, Karolina/0000-0002-2899-8170; Jaworski, Maciej/0000-0002-6758-371X	statutory grant of the Children's' Memorial Health Institute [173/2007]; statutory grant of the Children's Memorial Health [23/2004]	statutory grant of the Children's' Memorial Health Institute; statutory grant of the Children's Memorial Health	A statutory grant of the Children's' Memorial Health Institute No. 173/2007 (JCK).Prof Anna Dobrzanska is a recipient of a statutory grant of the Children's Memorial Health 23/2004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly Hany, 2004, J Perinatol, V24, P305, DOI 10.1038/sj.jp.7211083; Backstrom MC, 2000, ACTA PAEDIATR, V89, P867, DOI 10.1080/080352500750043792; Backstrom MC, 1999, ARCH DIS CHILD-FETAL, V80, pF161, DOI 10.1136/fn.80.3.F161; Baird J, 2011, OSTEOPOROSIS INT, V22, P1323, DOI 10.1007/s00198-010-1344-9; BEYERS N, 1994, BONE, V15, P5, DOI 10.1016/8756-3282(94)90884-2; Bowden SA, 2016, J PEDIAT ENDOCRINOL; Christmann V, 2014, J PEDIATR GASTR NUTR, V58, P398, DOI 10.1097/MPG.0000000000000251; Crofton PM, 2000, PEDIATR RES, V48, P155, DOI 10.1203/00006450-200008000-00007; Czech-Kowalska J, 2015, ANN NUTR METAB, V67, P33, DOI 10.1159/000437099; Faerk J, 2002, ARCH DIS CHILD-FETAL, V87, pF133, DOI 10.1136/fn.87.2.F133; Fenton TR, 2013, BMC PEDIATR, V13, P1, DOI DOI 10.1186/1471-2431-13-1; Figueras-Aloy J, 2014, J PEDIATR-US, V164, P499, DOI 10.1016/j.jpeds.2013.10.089; Gilsanz V, 1999, NUTR BONE DEV, V41, P147; Harrison CM, 2008, ACTA PAEDIATR, V97, P407, DOI 10.1111/j.1651-2227.2007.00721.x; Hung YL, 2011, J PAEDIATR CHILD H, V47, P134, DOI 10.1111/j.1440-1754.2010.01901.x; Kelly A, 2014, CLIN PEDIATR, V53, P1077, DOI 10.1177/0009922814535661; Lapillonne A, 2000, ACTA PAEDIATR, V89, P772, DOI 10.1080/080352500750043620; Lee SM, 2012, J KOREAN MED SCI, V27, P1552, DOI 10.3346/jkms.2012.27.12.1552; Litmanovitz I, 2004, J PERINAT MED, V32, P58, DOI 10.1515/JPM.2004.010; Lothe A, 2011, J PAEDIATR CHILD H, V47, P550, DOI 10.1111/j.1440-1754.2011.02019.x; Martinez-Mesa J, 2013, OSTEOPOROSIS INT, V24, P7, DOI 10.1007/s00198-012-2114-7; Mitchell SM, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-47; Moreira A, 2013, J PAEDIATR CHILD H, V49, pE12, DOI 10.1111/jpc.12052; Moyer-Mileur LJ, 2000, PEDIATRICS, V106, P1088, DOI 10.1542/peds.106.5.1088; Naylor KE, 1999, PEDIATR RES, V45, P363, DOI 10.1203/00006450-199903000-00012; Neve A, 2013, J CELL PHYSIOL, V228, P1149, DOI 10.1002/jcp.24278; Ng PC, 2002, ARCH DIS CHILD-FETAL, V86, pF49, DOI 10.1136/fn.86.1.F49; Picaud JC, 2002, ACTA PAEDIATR, V91, P1189, DOI 10.1080/080352502320777423; Pieltain C, 2013, WORLD REV NUTR DIET, V106, P181, DOI 10.1159/000342680; Prickett TCR, 2008, J CLIN ENDOCR METAB, V93, P225, DOI 10.1210/jc.2007-1815; Rigo J, 2000, CLIN PERINATOL, V27, P147, DOI 10.1016/S0095-5108(05)70011-7; Rigo J, 1998, J PEDIATR GASTR NUTR, V27, P184, DOI 10.1097/00005176-199808000-00011; Rigo J, 2007, ACTA PAEDIATR, V96, P969, DOI 10.1111/j.1651-2227.2007.00336.x; Routine administration of vitamin K to newborns, 1998, CAN FAM PHYS, V44, P1083; Staub E, 2014, J PEDIATR GASTR NUTR, V58, P404, DOI 10.1097/MPG.0000000000000244; Szulc P, 2000, OSTEOPOROSIS INT, V11, P281, DOI 10.1007/s001980070116; Tsukahara H, 1998, METABOLISM, V47, P333, DOI 10.1016/S0026-0495(98)90266-9; Tuchman S, 2008, J PEDIATR-US, V153, P484, DOI 10.1016/j.jpeds.2008.04.028; van de Lagemaat M, 2013, J NUTR, V143, P1439, DOI [10.3945/jn.113.178111, DOI 10.3945/JN.113.178111]; van de Lagemaat M, 2014, CLIN ENDOCRINOL OXF; van de Lagemaat M, 2013, EUR J NUTR, V52, P1781, DOI 10.1007/s00394-012-0481-7; van de Lagemaat M, 2012, BONE, V51, P441, DOI 10.1016/j.bone.2012.06.017; van der Sluis IM, 2002, HORM RES, V57, P170, DOI 10.1159/000058378; Vignochi CM, 2012, AM J PERINAT, V29, P573, DOI 10.1055/s-0032-1310520; Visser F, 2012, ACTA PAEDIATR, V101, P562, DOI 10.1111/j.1651-2227.2012.02626.x; Viswanathan S, 2014, JPEN-PARENTER ENTER, V38, P982, DOI 10.1177/0148607113499590; Yorifuji J, 2008, J CLIN ENDOCRINOLOGY, P1784; Zoch ML, 2016, BONE, V82, P42, DOI 10.1016/j.bone.2015.05.046	48	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165727	10.1371/journal.pone.0165727	http://dx.doi.org/10.1371/journal.pone.0165727			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806112	Green Published, gold, Green Submitted			2022-12-26	WOS:000386715500052
J	Kinsey, CM; Hamlington, KL; O'Toole, J; Stapleton, R; Bates, JHT				Kinsey, C. Matthew; Hamlington, Katharine L.; O'Toole, Jacqueline; Stapleton, Renee; Bates, Jason H. T.			Predicting the Mortality Benefit of CT Screening for Second Lung Cancer in a High-Risk Population	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; ED AMERICAN-COLLEGE; STAGE-I; COMPUTED-TOMOGRAPHY; FOLLOW-UP; MANAGEMENT; SURVEILLANCE; DIAGNOSIS; RESECTION; TUMORS	Patients who survive an index lung cancer (ILC) after surgical resection continue to be at significant risk for a metachronous lung cancer (MLC). Indeed, this risk is much higher than the risk of developing an ILC in heavy smokers. There is currently little evidence upon which to base guidelines for screening at-risk patients for MLC, and the risk-reward tradeoffs for screening this patient population are unknown. The goal of this investigation was to estimate the maximum mortality benefit of CT screening for MLC. We developed a computational model to estimate the maximum rates of CT detection of MLC and surgical resection to be expected in a given population as a function of time after resection of an ILC. Applying the model to a hypothetical high-risk population suggests that screening for MLC within 5 years after resection of an ILC may identify only a very small number of treatable cancers. The risk of death from a potentially resectable MLC increases dramatically past this point, however, suggesting that screening after 5 years is imperative. The model also predicts a substantial detection gap for MLC that demonstrates the benefit to be gained as more sensitive screening methods are developed.	[Kinsey, C. Matthew; Hamlington, Katharine L.; Stapleton, Renee; Bates, Jason H. T.] Univ Vermont, Coll Med, Div Pulm & Crit Care, Burlington, VT 05405 USA; [O'Toole, Jacqueline] Univ Vermont, Coll Med, Dept Med, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Kinsey, CM (corresponding author), Univ Vermont, Coll Med, Div Pulm & Crit Care, Burlington, VT 05405 USA.	Matt.Kinsey@uvmhealth.org		Hamlington, Katharine/0000-0002-5221-2123	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076122, K23HL133476] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL076122, K23 HL133476] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aberle DR, 2013, NEW ENGL J MED, V369, P920, DOI 10.1056/NEJMoa1208962; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Alberg AJ, 2008, SEMIN RESP CRIT CARE, V29, P223, DOI 10.1055/s-2008-1076742; Bae MK, 2011, ANN THORAC SURG, V92, P256, DOI 10.1016/j.athoracsur.2011.02.034; Battafarano RJ, 2004, J THORAC CARDIOV SUR, V127, P836, DOI 10.1016/j.jtcvs.2003.08.055; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; Colt HG, 2013, CHEST, V143, pE437, DOI 10.1378/chest.12-2365; de Koning HJ, 2014, ANN INTERN MED, V160, P311, DOI 10.7326/M13-2316; Endo C, 2012, ANN THORAC SURG, V93, P1061, DOI 10.1016/j.athoracsur.2012.01.004; Friberg S, 1997, J SURG ONCOL, V65, P284, DOI 10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2; Howington JA, 2013, CHEST, V143, pE278, DOI 10.1378/chest.12-2359; Infante M, 2013, EUR RESPIR J, V42, P1706, DOI 10.1183/09031936.00186212; Johnson BE, 1998, JNCI-J NATL CANCER I, V90, P1335, DOI 10.1093/jnci/90.18.1335; Korst RJ, 2006, ANN THORAC SURG, V82, P1009, DOI 10.1016/j.athoracsur.2006.03.062; Lubin JH, 2007, AM J EPIDEMIOL, V166, P479, DOI 10.1093/aje/kwm089; MARTINI N, 1995, J THORAC CARDIOV SUR, V109, P120, DOI 10.1016/S0022-5223(95)70427-2; McMahon PM, 2012, RISK ANAL, V32, pS166, DOI 10.1111/j.1539-6924.2011.01714.x; Reich JM, 2015, LUNG CANCER, V87, P96, DOI 10.1016/j.lungcan.2014.12.002; Ripley RT, 2014, ANN THORAC SURG, V98, P968, DOI 10.1016/j.athoracsur.2014.04.098; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Wood DE, 2012, J NATL COMPR CANC NE, V10, P240, DOI 10.6004/jnccn.2012.0022	21	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165471	10.1371/journal.pone.0165471	http://dx.doi.org/10.1371/journal.pone.0165471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806080	Green Submitted, Green Published, gold			2022-12-26	WOS:000386715500032
J	Saryeddine, L; Zibara, K; Kassem, N; Badran, B; El-Zein, N				Saryeddine, Lilian; Zibara, Kazem; Kassem, Nouhad; Badran, Bassam; El-Zein, Nabil			EGF-Induced VEGF Exerts a PI3K-Dependent Positive Feedback on ERK and AKT through VEGFR2 in Hematological In Vitro Models	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ACTIVATED PROTEIN-KINASES; CELL-GROWTH; ANTIANGIOGENIC THERAPY; ANGIOGENESIS; PATHWAY	EGFR and VEGFR pathways play major roles in solid tumor growth and progression, however, little is known about these pathways in haematological tumors. This study investigated the crosstalk between EGFR and VEGFR2 signaling in two hematological in vitro models: THP1, a human monocytic leukemia, and Raji, a Burkitt's lymphoma, cell lines. Results showed that both cell lines express EGFR and VEGFR2 and responded to EGF stimulation by activating EGFR, triggering VEGF production and phosphorylating ERK, AKT, and p38 very early, with a peak of expression at 10-20min. Blocking EGFR using Tyrphostin resulted in inhibiting EGFR induced activation of ERK, AKT, and p38. In addition, EGF stimulation caused a significant and immediate increase, within 1min, in pVEGFR2 in both cell lines, which peaked at similar to 5-10 min after treatment. Selective inhibition of VEGFR2 by DMH4, anti-VEGFR2 antibody or siRNA diminished EGF-induced pAKT and pERK, indicating a positive feedback exerted by EGFR-induced VEGF. Similarly, the specific PI3K inhibitor LY294002, suppressed AKT and ERK phosphorylation showing that VEGF feedback is PI3K-dependent. On the other hand, phosphorylation of p38, initiated by EGFR and independent of VEGF feedback, was diminished using PLC inhibitor U73122. Moreover, measurement of intracellular [Ca2+] and ROS following VEGFR2 inhibition and EGF treatment proved that VEGFR2 is not implicated in EGF-induced Ca2+ release whereas it boosts EGF-induced ROS production. Furthermore, a significant decrease in pAKT, pERK and pp38 was shown following the addition of the ROS inhibitor NAC. These results contribute to the understanding of the crosstalk between EGFR and VEGFR in haematological malignancies and their possible combined blockade in therapy.	[Saryeddine, Lilian; Zibara, Kazem; Kassem, Nouhad; El-Zein, Nabil] Lebanese Univ, EDST, PRASE, ER045, Beirut, Lebanon; [Zibara, Kazem; El-Zein, Nabil] Lebanese Univ, Fac Sci 1, Dept Biol, Lab Cardiovasc Dis & Stem Cells, Beirut, Lebanon; [Badran, Bassam] Lebanese Univ, Fac Sci 1, Dept Biochem, Beirut, Lebanon	Lebanese University; Lebanese University; Lebanese University	El-Zein, N (corresponding author), Lebanese Univ, EDST, PRASE, ER045, Beirut, Lebanon.; El-Zein, N (corresponding author), Lebanese Univ, Fac Sci 1, Dept Biol, Lab Cardiovasc Dis & Stem Cells, Beirut, Lebanon.	nabilzein@hotmail.fr		Zibara, Kazem/0000-0002-9887-072X; el zein, nabil/0000-0002-8596-5359	Lebanese National Council for Scientific Research, Lebanese University grant [ER045]	Lebanese National Council for Scientific Research, Lebanese University grant	This work was supported by grants from Lebanese National Council for Scientific Research (KZ, NEZ), Lebanese University grant and ER045 (KZ).	Atmaca A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-524; Chatterjee S, 2013, J CLIN INVEST, V123, P1732, DOI 10.1172/JCI65385; Chen S, 2013, ONCOL REP, V29, P260, DOI 10.3892/or.2012.2097; Chien MH, 2009, CARCINOGENESIS, V30, P2005, DOI 10.1093/carcin/bgp244; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Demyanets S, 2011, BASIC RES CARDIOL, V106, P217, DOI 10.1007/s00395-010-0141-0; Dias S, 2000, J CLIN INVEST, V106, P511, DOI 10.1172/JCI8978; Dong XW, 2007, CRIT REV ONCOL HEMAT, V62, P105, DOI 10.1016/j.critrevonc.2006.11.006; El Zein N, 2006, CELL SIGNAL, V18, P162, DOI 10.1016/j.cellsig.2005.03.027; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Franovic A, 2007, P NATL ACAD SCI USA, V104, P13092, DOI 10.1073/pnas.0702387104; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Johnston JB, 2006, CURR MED CHEM, V13, P3483, DOI 10.2174/092986706779026174; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Larsen AK, 2011, PHARMACOL THERAPEUT, V131, P80, DOI 10.1016/j.pharmthera.2011.03.012; Lee SH, 2015, ANN SURG TREAT RES, V89, P1, DOI 10.4174/astr.2015.89.1.1; Mahtouk K, 2004, BLOOD, V103, P1829, DOI 10.1182/blood-2003-05-1510; Musumeci F, 2012, J MED CHEM, V55, P10797, DOI 10.1021/jm301085w; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Paniagua RT, 2011, J AM ACAD DERMATOL, V65, P389, DOI 10.1016/j.jaad.2010.04.026; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Ruan J, 2009, ANN ONCOL, V20, P413, DOI 10.1093/annonc/mdn666; Sauer H, 2001, CELL PHYSIOL BIOCHEM, V11, P173, DOI 10.1159/000047804; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Shibuya Masabumi, 2011, Genes Cancer, V2, P1097, DOI 10.1177/1947601911423031; Sun JZ, 2012, HEMATOL ONCOL, V30, P89, DOI 10.1002/hon.1002; Tabernero J, 2007, MOL CANCER RES, V5, P203, DOI 10.1158/1541-7786.MCR-06-0404; Tan CS, 2016, LUNG CANCER, V93, P59, DOI 10.1016/j.lungcan.2016.01.003; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; Witsch E, 2010, PHYSIOLOGY, V25, P85, DOI 10.1152/physiol.00045.2009; Yart A, 2001, J BIOL CHEM, V276, P8856, DOI 10.1074/jbc.M006966200	32	27	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165876	10.1371/journal.pone.0165876	http://dx.doi.org/10.1371/journal.pone.0165876			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806094	Green Published, gold, Green Submitted			2022-12-26	WOS:000386715500067
J	Barnes, EA; Chen, CH; Sedan, O; Cornfield, DN				Barnes, Elizabeth A.; Chen, Chih-Hsin; Sedan, Oshra; Cornfield, David N.			Loss of smooth muscle cell hypoxia inducible factor-1 alpha underlies increased vascular contractility in pulmonary hypertension	FASEB JOURNAL			English	Article						MLCK; pMLC; prolyl hydroxylase domain; PAH; vasoconstriction	ARTERIAL-HYPERTENSION; IN-VIVO; TRANSCRIPTION; EXPRESSION; PROTEIN; MICE; TONE	Pulmonary arterial hypertension (PAH) is an often fatal disease with limited treatment options. Whereas current data support the notion that, in pulmonary artery endothelial cells (PAECs), expression of transcription factor hypoxia inducible factor-1 alpha (HIF-1 alpha) is increased, the role of HIF-1 alpha in pulmonary artery smooth muscle cells (PASMCs) remains controversial. This study investigates the hypothesis that, in PASMCs from patients with PAH, decreases in HIF-1 alpha expression and activity underlie augmented pulmonary vascular contractility. PASMCs and tissues were isolated from nonhypertensive control patients and patients with PAH. Compared with controls, HIF-1 alpha and Kv1.5 protein expression were decreased in PAH smooth muscle cells (primary culture). Myosin light chain (MLC) phosphorylation and MLC kinase (MLCK) activitymajor determinants of vascular tonewere increased in patients with PAH. Cofactors involved in prolyl hydroxylase domain activity were increased in PAH smooth muscle cells. Functionally, PASMC contractility was inversely correlated with HIF-1 alpha activity. In PASMCs derived from patients with PAH, HIF-1 alpha expression is decreased, and MLCK activity, MLC phosphorylation, and cell contraction are increased. We conclude that compromised PASMC HIF-1 alpha expression may contribute to the increased tone that characterizes pulmonary hypertension.	[Barnes, Elizabeth A.; Chen, Chih-Hsin; Sedan, Oshra; Cornfield, David N.] Stanford Univ, Sch Med, Ctr Excellence Pulm Biol, Dept Pediat, Stanford, CA 94305 USA	Stanford University	Cornfield, DN (corresponding author), Stanford Univ, Sch Med, Ctr Excellence Pulm Biol, 770 Welch Rd, Stanford, CA 94305 USA.	dcornfield@stanford.edu			U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL060784, HL0706280]; Cardiovascular Medical Research and Education Fund (University of Pennsylvania, PA, USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060784] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cardiovascular Medical Research and Education Fund (University of Pennsylvania, PA, USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. A. J. Giaccia (Stanford University) for providing the HIF-1 alpha<SUP>CA</SUP> construct. This research was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants HL060784 and HL0706280 (to D.N.C.). Tissue sections were provided by the Pulmonary Hypertensive Breakthrough Initiative (PHBI). Funding for the PHBI is provided by the Cardiovascular Medical Research and Education Fund (University of Pennsylvania, PA, USA). The authors declare no conflicts of interest.	Ahmad A, 2013, AM J RESP CELL MOL, V49, P78, DOI 10.1165/rcmb.2012-0107OC; Ball MK, 2014, AM J RESP CRIT CARE, V189, P314, DOI 10.1164/rccm.201302-0302OC; Benza RL, 2010, CIRCULATION, V122, P164, DOI 10.1161/CIRCULATIONAHA.109.898122; Bonnet S, 2007, P NATL ACAD SCI USA, V104, P11418, DOI 10.1073/pnas.0610467104; Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008; Dai ZY, 2016, CIRCULATION, V133, P2447, DOI 10.1161/CIRCULATIONAHA.116.021494; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fijalkowska I, 2010, AM J PATHOL, V176, P1130, DOI 10.2353/ajpath.2010.090832; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Formenti F, 2011, FASEB J, V25, P2001, DOI 10.1096/fj.10-177378; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Kapitsinou PP, 2016, MOL CELL BIOL, V36, P1584, DOI 10.1128/MCB.01055-15; Kim YM, 2013, CIRC RES, V112, P1230, DOI 10.1161/CIRCRESAHA.112.300646; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Pozeg ZI, 2003, CIRCULATION, V107, P2037, DOI 10.1161/01.CIR.0000062688.76508.B3; Remillard CV, 2007, AM J PHYSIOL-CELL PH, V292, pC1837, DOI 10.1152/ajpcell.00405.2006; Samizo K, 1999, BIOCHEM BIOPH RES CO, V261, P95, DOI 10.1006/bbrc.1999.0956; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Tuder RM, 2001, J PATHOL, V195, P367, DOI 10.1002/path.953; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Ying LH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0376; Yu AY, 1998, AM J PHYSIOL-LUNG C, V275, pL818, DOI 10.1152/ajplung.1998.275.4.L818; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Yuan XJ, 1998, LANCET, V351, P726, DOI 10.1016/S0140-6736(05)78495-6	27	26	26	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					650	662		10.1096/fj.201600557R	http://dx.doi.org/10.1096/fj.201600557R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27811062	Green Published			2022-12-26	WOS:000394235400018
J	Samanta, D; Widom, J; Borbat, PP; Freed, JH; Crane, BR				Samanta, Dipanjan; Widom, Joanne; Borbat, Peter P.; Freed, Jack H.; Crane, Brian R.			Bacterial Energy Sensor Aer Modulates the Activity of the Chemotaxis Kinase CheA Based on the Redox State of the Flavin Cofactor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-BILAYER NANODISCS; AEROTAXIS RECEPTOR AER; PAIR DISTANCE DISTRIBUTIONS; ESCHERICHIA-COLI; TIKHONOV REGULARIZATION; MEMBRANE-PROTEINS; SIGNAL TRANSDUCER; PULSED ESR; PAS DOMAIN; CHEMORECEPTOR	Flagellated bacteria modulate their swimming behavior in response to environmental cues through the CheA/CheY signaling pathway. In addition to responding to external chemicals, bacteria also monitor internal conditions that reflect the availability of oxygen, light, and reducing equivalents, in a process termed "energy taxis." In Escherichia coli, the transmembrane receptor Aer is the primary energy sensor for motility. Genetic and physiological data suggest that Aer monitors the electron transport chain through the redox state of its FAD cofactor. However, direct biochemical data correlating FAD redox chemistry with CheA kinase activity have been lacking. Here, we test this hypothesis via functional reconstitution of Aer into nanodiscs. As purified, Aer contains fully oxidized FAD, which can be chemically reduced to the anionic semiquinone (ASQ). Oxidized Aer activates CheA, whereas ASQ Aer reversibly inhibits CheA. Under these conditions, Aer cannot be further reduced to the hydroquinone, in contrast to the proposed Aer signaling model. Pulse ESR spectroscopy of the ASQ corroborates a potential mechanism for signaling in that the resulting distance between the two flavin-binding PAS (Per-Arnt-Sim) domains implies that they tightly sandwich the signal-transducing HAMP domain in the kinase-off state. Aer appears to follow oligomerization patterns observed for related chemoreceptors, as higher loading of Aer dimers into nanodiscs increases kinase activity. These results provide a new methodological platform to study Aer function along with new mechanistic details into its signal transduction process.	[Samanta, Dipanjan; Widom, Joanne; Borbat, Peter P.; Freed, Jack H.; Crane, Brian R.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Samanta, Dipanjan; Borbat, Peter P.; Freed, Jack H.] Cornell Univ, Natl Biomed Ctr Adv ESR Technol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Crane, BR (corresponding author), Cornell Univ, Phys Sci Bldg, Ithaca, NY 14853 USA.	bc69@cornell.edu	Borbat, Petr P/A-8658-2014; borbat, peter/B-1616-2016		National Institutes of Health [GM066775, P41GM103521, R01EB003150]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123779, R01GM066775, P41GM103521, P41GM103485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM066775 (to B. R. C.) and P41GM103521 and R01EB003150 (to J. H. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Airola MV, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001479; Amin DN, 2007, J BACTERIOL, V189, P7206, DOI 10.1128/JB.00871-07; Amin DN, 2012, J BIOL CHEM, V287, P41697, DOI 10.1074/jbc.M112.415588; Amin DN, 2010, J BACTERIOL, V192, P1193, DOI 10.1128/JB.01391-09; Amin DN, 2006, J BACTERIOL, V188, P894, DOI 10.1128/JB.188.3.894-901.2006; Barnakov AN, 1998, J BACTERIOL, V180, P6713, DOI 10.1128/JB.180.24.6713-6718.1998; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Bayburt TH, 2006, ARCH BIOCHEM BIOPHYS, V450, P215, DOI 10.1016/j.abb.2006.03.013; Bhatnagar J, 2012, BIOPHYS J, V102, P2192, DOI 10.1016/j.bpj.2012.03.038; Bibikov SI, 2000, P NATL ACAD SCI USA, V97, P5830, DOI 10.1073/pnas.100118697; Bibikov SI, 2004, J BACTERIOL, V186, P3730, DOI 10.1128/JB.186.12.3730-3737.2004; Bibikov SI, 1997, J BACTERIOL, V179, P4075, DOI 10.1128/jb.179.12.4075-4079.1997; Boldog T, 2007, METHOD ENZYMOL, V423, P317, DOI 10.1016/S0076-6879(07)23014-9; Boldog T, 2006, P NATL ACAD SCI USA, V103, P11509, DOI 10.1073/pnas.0604988103; Briegel A, 2012, P NATL ACAD SCI USA, V109, P3766, DOI 10.1073/pnas.1115719109; Chiang YW, 2005, J MAGN RESON, V177, P184, DOI 10.1016/j.jmr.2005.07.021; Chiang YW, 2005, J MAGN RESON, V172, P279, DOI 10.1016/j.jmr.2004.10.012; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Feng XH, 1997, J BACTERIOL, V179, P6714, DOI 10.1128/jb.179.21.6714-6720.1997; Garcia D, 2016, MOL MICROBIOL, V100, P156, DOI 10.1111/mmi.13308; Gosink KK, 2006, J BACTERIOL, V188, P3487, DOI 10.1128/JB.188.10.3487-3493.2006; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hill S, 1996, P NATL ACAD SCI USA, V93, P2143, DOI 10.1073/pnas.93.5.2143; Karasawa A, 2013, J BIOL CHEM, V288, P29862, DOI 10.1074/jbc.M113.499327; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; Li MS, 2004, J BACTERIOL, V186, P3687, DOI 10.1128/JB.186.12.3687-3694.2004; Liu B, 2010, CURR OPIN PLANT BIOL, V13, P578, DOI 10.1016/j.pbi.2010.09.005; Macheroux P, 1998, BIOCHEM J, V332, P413, DOI 10.1042/bj3320413; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Parkinson JS, 2015, TRENDS MICROBIOL, V23, P257, DOI 10.1016/j.tim.2015.03.003; Parkinson JS, 2010, ANNU REV MICROBIOL, V64, P101, DOI 10.1146/annurev.micro.112408.134215; Rebbapragada A, 1997, P NATL ACAD SCI USA, V94, P10541, DOI 10.1073/pnas.94.20.10541; Repik A, 2000, MOL MICROBIOL, V36, P806, DOI 10.1046/j.1365-2958.2000.01910.x; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Samanta D, 2015, P NATL ACAD SCI USA, V112, P2455, DOI 10.1073/pnas.1414155112; Srivastava M, 2016, IEEE ACCESS, V4, P3862, DOI 10.1109/ACCESS.2016.2587581; Studdert CA, 2004, P NATL ACAD SCI USA, V101, P2117, DOI 10.1073/pnas.0308622100; Taylor BL, 2007, MOL MICROBIOL, V65, P1415, DOI 10.1111/j.1365-2958.2007.05889.x; Taylor BL, 1999, ANNU REV MICROBIOL, V53, P103, DOI 10.1146/annurev.micro.53.1.103; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Taylor BL, 2001, ANTIOXID REDOX SIGN, V3, P867, DOI 10.1089/15230860152665037; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524	42	14	14	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25809	25814		10.1074/jbc.C116.757492	http://dx.doi.org/10.1074/jbc.C116.757492			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27803157	Green Published, hybrid			2022-12-26	WOS:000390345200005
J	He, YQ; Jin, M; Chen, KN; Zhang, HL; Yang, H; Zhuo, F; Zhao, DJ; Zeng, HT; Yao, XJ; Zhang, Z; Chen, L; Zhou, YP; Duan, ZJ				He, Yaqing; Jin, Miao; Chen, Kena; Zhang, Hailong; Yang, Hong; Zhuo, Fei; Zhao, Dejian; Zeng, Huatang; Yao, Xiangjie; Zhang, Zhen; Chen, Long; Zhou, Yuanping; Duan, Zhao-jun			Gastroenteritis Outbreaks Associated with the Emergence of the New GII.4 Sydney Norovirus Variant during the Epidemic of 2012/13 in Shenzhen City, China	PLOS ONE			English	Article							NORWALK-LIKE VIRUS; UNITED-STATES; MULTIPLE OUTBREAKS; STRAIN; IDENTIFICATION; RECOMBINATION; CALICIVIRUSES; DYNAMICS	Noroviruses (NoVs) are the leading cause of gastroenteritis outbreaks in humans worldwide. Since late 2012, a new GII. 4 variant Sydney 2012 has caused a significant increase in NoV epidemics in several countries. From November of 2012 to January of 2013, three gastroenteritis outbreaks occurred in two social welfare homes (Outbreaks A and B) and a factory (Outbreak C) in Shenzhen city of China. Feces and swabs were collected for laboratory tests for causative agents. While no bacterial pathogen was identified, all three outbreaks were caused by NoVs with detection rates of 26.2% (16/61) at Outbreak A, 35.2% (38/108) at Outbreak B), and 59.3% (16/27) at Outbreaks C. For Outbreak B, 25 of the 29 symptomatic individuals (86.2%) and 13 of the 79 asymptomatic individuals (16.5%) were found NoV-positive. For Outbreak C, an asymptomatic food handler was NoV-positive. All thirteen NoV sequences from the three outbreaks were classified into genogroup II and genotype 4 (GII.4), which we identified to be the GII.4 Sydney 2012 variant. The genome of two isolates from Outbreaks A and B were recombinant with the opening reading frame (ORF) 1 of GII.4 Osaka 2007 and ORF2 and 3 of the GII.4 New Orleans. Our study indicated that the GII.4 Sydney 2012 variant emerged and caused the outbreaks in China.	[He, Yaqing; Zhou, Yuanping] Southern Med Univ, Guangzhou, Guangdong, Peoples R China; [He, Yaqing; Zhang, Hailong; Yang, Hong; Zhao, Dejian; Zeng, Huatang; Yao, Xiangjie; Zhang, Zhen; Chen, Long] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Peoples R China; [Jin, Miao; Chen, Kena; Duan, Zhao-jun] China CDC, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol & Viral Dis, Beijing, Peoples R China; [Zhuo, Fei] Shenzhen Luohu Ctr Dis Control & Prevent, Shenzhen, Peoples R China	Southern Medical University - China; Shenzhen Center for Disease Control & Prevention (SZCDC); Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Zhou, YP (corresponding author), Southern Med Univ, Guangzhou, Guangdong, Peoples R China.; Duan, ZJ (corresponding author), China CDC, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol & Viral Dis, Beijing, Peoples R China.	yuanpingzhou@163.com; zhaojund@126.com	Chen, Long/N-4705-2019	Chen, Long/0000-0003-1110-6495	Key Project of Science and Technology - Ministry of Science and Technology of China [2012ZX10004215]; Health Industry Research - National Health and Family Planning Commission of China [201302004]; National Natural Science foundation of China [81470856]	Key Project of Science and Technology - Ministry of Science and Technology of China; Health Industry Research - National Health and Family Planning Commission of China; National Natural Science foundation of China(National Natural Science Foundation of China (NSFC))	The research was supported by The Key Project of Science and Technology (Grant No. 2012ZX10004215) funded by the Ministry of Science and Technology of China and the Health Industry Research (Grant No. 201302004) funded by National Health and Family Planning Commission of China to Miao Jin. The study was also supported by the National Natural Science foundation of China (Grant No. 81470856) to Yuanping Zhou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088978; Belliot G, 2003, J VIROL, V77, P10957, DOI 10.1128/JVI.77.20.10957-10974.2003; Belliot G, 2010, J CLIN MICROBIOL, V48, P994, DOI 10.1128/JCM.01888-09; Bennett S, 2013, EURO SURVEILL, V18; Bertolotti-Ciarlet A, 2003, J VIROL, V77, P11603, DOI 10.1128/JVI.77.21.11603-11615.2003; Bull RA, 2006, J CLIN MICROBIOL, V44, P327, DOI 10.1128/JCM.44.2.327-333.2006; Bull RA, 2011, TRENDS MICROBIOL, V19, P233, DOI 10.1016/j.tim.2011.01.002; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P55; Chan MCW, 2014, EMERG INFECT DIS, V20, P658, DOI [10.3201/eid2004.131457, 10.3201/eid2004.13457]; Drinka PJ, 2005, J AM GERIATR SOC, V53, P1839, DOI 10.1111/j.1532-5415.2005.53528_6.x; Eden JS, 2013, J VIROL, V87, P6270, DOI 10.1128/JVI.03464-12; Eden JS, 2010, J CLIN VIROL, V49, P265, DOI 10.1016/j.jcv.2010.09.001; Fonager J, 2013, EURO SURVEILL, V18; Fonager J, 2013, EUROSURVEILLANCE, V18, DOI DOI 10.2807/1560-7917.ES2013.18.25.20506; Green KY., 2001, FIELDS VIROLOGY, V4, P841; Han TH, 2011, ARCH VIROL, V156, P323, DOI 10.1007/s00705-010-0844-4; Hutson AM, 2004, TRENDS MICROBIOL, V12, P279, DOI 10.1016/j.tim.2004.04.005; Jiang X, 1999, J VIROL METHODS, V83, P145, DOI 10.1016/S0166-0934(99)00114-7; Johnston CP, 2007, CLIN INFECT DIS, V45, P534, DOI 10.1086/520666; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; KAPLAN JE, 1982, ANN INTERN MED, V96, P756, DOI 10.7326/0003-4819-96-6-756; Khanna N, 2003, J HOSP INFECT, V55, P131, DOI 10.1016/S0195-6701(03)00257-3; KOBAYASHI S, 1991, EPIDEMIOL INFECT, V107, P81, DOI 10.1017/S0950268800048706; Koopmans M, 2000, J INFECT DIS, V181, pS262, DOI 10.1086/315573; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Leshem E, 2013, EMERG INFECT DIS, V19, P1231, DOI 10.3201/eid1908.130458; Lopman BA, 2004, CLIN INFECT DIS, V39, P318, DOI 10.1086/421948; Lopman BA, 2011, CLIN INFECT DIS, V52, P466, DOI 10.1093/cid/ciq163; Mans J, 2010, J CLIN VIROL, V49, P258, DOI 10.1016/j.jcv.2010.08.011; Marks PJ, 2003, EPIDEMIOL INFECT, V131, P727, DOI 10.1017/S0950268803008689; Marshall JA, 2001, J MED MICROBIOL, V50, P143, DOI 10.1099/0022-1317-50-2-143; Matthews JE, 2012, EPIDEMIOL INFECT, V140, P1161, DOI 10.1017/S0950268812000234; Mattison K, 2010, J MED VIROL, V82, P321, DOI 10.1002/jmv.21682; Meijer A, 2012, EUROSURVEILLANCE, V17, P2; Mesquita JR, 2010, EMERG INFECT DIS, V16, P980, DOI 10.3201/eid1606.091861; Motomura K, 2010, J VIROL, V84, P8085, DOI 10.1128/JVI.02125-09; Noel JS, 1999, J INFECT DIS, V179, P1334, DOI 10.1086/314783; O'Reilly CE, 2007, CLIN INFECT DIS, V44, P506, DOI 10.1086/511043; Ozawa K, 2007, J CLIN MICROBIOL, V45, P3996, DOI 10.1128/JCM.01516-07; Pang XLL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011599; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; My PVT, 2013, INFECT GENET EVOL, V18, P335, DOI 10.1016/j.meegid.2013.04.014; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Siebenga JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000884; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Thongprachum A, 2014, INFECT GENET EVOL, V23, P65, DOI 10.1016/j.meegid.2014.01.030; Tu ETV, 2008, CLIN INFECT DIS, V46, P413, DOI 10.1086/525259; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Wang QH, 2005, EMERG INFECT DIS, V11, P1874, DOI 10.3201/eid1112.050485; Webby RJ, 2007, CLIN INFECT DIS, V44, P1026, DOI 10.1086/512807; White P, 2002, J MED VIROL, V68, P113, DOI 10.1002/jmv.10177; Widdowson MA, 2004, J INFECT DIS, V190, P27, DOI 10.1086/420888; Yan HN, 2003, J VIROL METHODS, V114, P37, DOI 10.1016/j.jviromet.2003.08.009; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	55	5	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165880	10.1371/journal.pone.0165880	http://dx.doi.org/10.1371/journal.pone.0165880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829005	Green Submitted, Green Published, gold			2022-12-26	WOS:000387724300065
J	Tang, B; Wang, K; Jia, YP; Zhu, P; Fang, Y; Zhang, ZJ; Mao, XH; Li, Q; Zeng, DZ				Tang, Bin; Wang, Kun; Jia, Yin-ping; Zhu, Pan; Fang, Yao; Zhang, Zhu-jun; Mao, Xu-hu; Li, Qian; Zeng, Dong-zhu			Fusobacterium nucleatum-Induced Impairment of Autophagic Flux Enhances the Expression of Proinflammatory Cytokines via ROS in Caco-2 Cells	PLOS ONE			English	Article							EPITHELIAL-CELLS; VACUOLATING CYTOTOXIN; COLORECTAL-CANCER; INFLAMMATION; GENERATION; INFECTION; PATHWAY; DISEASE; MECHANISMS; MICROBIOTA	Fusobacterium nucleatum (F. nucleatum) plays a critical role in gastrointestinal inflammation. However, the exact mechanism by which F. nucleatum contributes to inflammation is unclear. In the present study, it was revealed that F. nucleatum could induce the production of proinflammatory cytokines (IL- 8, IL- 1 beta and TNF-alpha) and reactive oxygen species (ROS) in Caco-2 colorectal) adenocarcinoma cells. Furthermore, ROS scavengers (NAC or Tiron) could decrease the production of proinflammatory cytokines during F. nucleatum infection. In addition, we observed that autophagy is impaired in Caco-2 cells after F. nucleatum infection. The production of proinflammatory cytokines and ROS induced by F. nucleatum was enhanced with either autophagy pharmacologic inhibitors (3-methyladenine, bafilomycin A1) or RNA interference in essential autophagy genes (ATG5 or ATG12) in Caco-2 cells. Taken together, these results indicate that F. nucleatum-induced impairment of autophagic flux enhances the expression of proinflammatory cytokines via ROS in Caco-2 Cells.	[Tang, Bin; Wang, Kun; Jia, Yin-ping; Zhu, Pan; Fang, Yao; Zhang, Zhu-jun; Mao, Xu-hu; Li, Qian] Third Mil Med Univ, Southwest Hosp, Dept Clin Microbiol & Immunol, Chongqing, Peoples R China; [Tang, Bin; Wang, Kun; Jia, Yin-ping; Zhu, Pan; Fang, Yao; Zhang, Zhu-jun; Mao, Xu-hu; Li, Qian] Third Mil Med Univ, Coll Med Lab Sci, Chongqing, Peoples R China; [Zeng, Dong-zhu] Third Mil Med Univ, Southwest Hosp, Dept Gen Surg, Chongqing, Peoples R China; [Zeng, Dong-zhu] Third Mil Med Univ, Southwest Hosp, Ctr Minimal Invas Gastrointestinal Surg, Chongqing, Peoples R China; [Tang, Bin] Emei Sanat PLA Rocket Force, Emeishan, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University	Li, Q (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Clin Microbiol & Immunol, Chongqing, Peoples R China.; Li, Q (corresponding author), Third Mil Med Univ, Coll Med Lab Sci, Chongqing, Peoples R China.; Zeng, DZ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Gen Surg, Chongqing, Peoples R China.; Zeng, DZ (corresponding author), Third Mil Med Univ, Southwest Hosp, Ctr Minimal Invas Gastrointestinal Surg, Chongqing, Peoples R China.	liqianjane@163.com; zdz1140@163.com	bin, tang/AAK-9399-2020	bin, tang/0000-0002-1762-3883	National Natural Science Foundation of China (NSFC) [81301482, 81501796]; project of medical science and technology for training youth scholars of PLA [14QNP054]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); project of medical science and technology for training youth scholars of PLA	This work was supported by a grant from National Natural Science Foundation of China (NSFC, 81301482 and 81501796), and the project of medical science and technology for training youth scholars of PLA (14QNP054).; This work was supported by Grant Nos. 81301482 (for B.T.) and 81501796 (for Q.L.) from National Natural Science Foundation of China (NSFC,), and the project of medical science and technology for training youth scholars of PLA (14QNP054) (for B.T.).	Amano A, 2006, J BIOCHEM, V140, P161, DOI 10.1093/jb/mvj162; Bashir A, 2015, TUMOR BIOL, DOI [10.1007/a13277-015-4724-0, DOI 10.1007/A13277-015-4724-0]; Choudhury S, 2015, FREE RADICAL RES, V49, P1371, DOI 10.3109/10715762.2015.1075016; Cremer TJ, 2009, AUTOPHAGY, V5, P125, DOI 10.4161/auto.5.1.7305; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Dewaele M, 2010, AUTOPHAGY, V6, P838, DOI 10.4161/auto.6.7.12113; FALKLER WA, 1982, J PERIODONTOL, V53, P762, DOI 10.1902/jop.1982.53.12.762; Flanagan L, 2014, EUR J CLIN MICROBIOL, V33, P1381, DOI 10.1007/s10096-014-2081-3; Fubini B, 2003, FREE RADICAL BIO MED, V34, P1507, DOI 10.1016/S0891-5849(03)00149-7; HSU CY, 1995, ACTA CYTOL, V39, P114; Huang J, 2014, NAT REV MICROBIOL, V12, P101, DOI 10.1038/nrmicro3160; Kayath CA, 2010, MICROBES INFECT, V12, P956, DOI 10.1016/j.micinf.2010.06.006; Kim M, 2010, CELL HOST MICROBE, V8, P20, DOI 10.1016/j.chom.2010.06.006; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Leavy O, 2014, NAT REV IMMUNOL, V14, P357, DOI 10.1038/nri3685; Leung A, 2015, EXPERT REV GASTROENT, V9, P651, DOI 10.1586/17474124.2015.1001745; Liu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085280; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Marcato LG, 2008, ORAL MICROBIOL IMMUN, V23, P353, DOI 10.1111/j.1399-302X.2008.00432.x; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Pi J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140935; Py BF, 2007, AUTOPHAGY, V3, P117, DOI 10.4161/auto.3618; Raju D, 2012, GASTROENTEROLOGY, V142, P1160, DOI 10.1053/j.gastro.2012.01.043; Rasul A, 2013, MOLECULES, V18, P1418, DOI 10.3390/molecules18021418; Ray Katrina, 2011, Nat Rev Gastroenterol Hepatol, V8, P662, DOI 10.1038/nrgastro.2011.208; ROVIN BH, 1990, KIDNEY INT, V37, P1509, DOI 10.1038/ki.1990.142; Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007; Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606; Tang B, 2015, AUTOPHAGY, V11, P344, DOI 10.1080/15548627.2015.1023682; Tang B, 2012, AUTOPHAGY, V8, P1045, DOI 10.4161/auto.20159; Terebiznik MR, 2009, AUTOPHAGY, V5, P370, DOI 10.4161/auto.5.3.7663; Underwood MA, 2014, PREV MED, V65, P133, DOI 10.1016/j.ypmed.2014.05.010	35	30	31	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165701	10.1371/journal.pone.0165701	http://dx.doi.org/10.1371/journal.pone.0165701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828984	Green Published, Green Submitted, gold			2022-12-26	WOS:000387724300055
J	Liu, YQ; Yang, FQ; Pu, HT; Su, JP; Liu, ZJ; Dhiloo, KH; Wang, ZY				Liu, Yongqiang; Yang, Fuqian; Pu, Hongtie; Su, Junping; Liu, Zongjiang; Dhiloo, Khalid Hussain; Wang, Zhongyue			The Sublethal Effects of beta-Ecdysterone, a Highly Active Compound from Achyranthes bidentata Blume, on Grape Phylloxera, Daktulosphaira vitifoliae Fitch	PLOS ONE			English	Article							INSECT GROWTH-REGULATOR; LIFE-HISTORY; PLANT; COCCINELLIDAE; LEPIDOPTERA; HOMOPTERA; FECUNDITY; SUSCEPTIBILITY; PESTICIDES; MANAGEMENT	Grape phylloxera, Daktulosphaira vitifoliae (Fitch) (Hemiptera, Phylloxeridae), is a very destructive insect pest of grapevines. Intercropping of Achyranthes bidentata Blume (f. Amaranthaceae) and Vitis spp. grapevines can be useful to control this pest. In the present study, the toxicity of 22 compounds, known to be present in A. bidentata, to grape phylloxera was evaluated. All treatments were toxic towards grape phylloxera but the degree of toxicity differed between treatments. Among the 22 tested compounds, several of which proved toxic towards grape phylloxera. However beta-ecdysterone had higher toxic effects against grape phylloxera, with LC50 values of 175.73 mg a.i. liter(-1). In addition, we assessed the sublethal effects of LC10, LC20 and LC40 of beta- ecdysterone on grape phylloxera. The fourth instar and adult developmental periods and total life span were significantly prolonged by LC40 of beta- ecdysterone. Fecundity decreased when grape phylloxera were exposed to LC20 and LC40 of beta- ecdysterone. In addition, LC40 of beta- ecdysterone decreased the intrinsic rate of increase (r(m)) and the finite rate of increase (.) and prolonged the population doubling time (DT). The net reproductive rate (R-0) was significantly reduced by both the LC20 and LC40 beta-ecdysterone treatments. Our results demonstrated that beta- ecdysterone had higher toxic effects and significant sublethal effects on grape phylloxera, and showed potential control of grape phylloxera.	[Liu, Yongqiang; Su, Junping; Liu, Zongjiang; Dhiloo, Khalid Hussain; Wang, Zhongyue] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing, Peoples R China; [Yang, Fuqian; Pu, Hongtie] Plant Protect Stn Zhongfang Cty, Zhongfang, Hunan Province, Peoples R China; [Dhiloo, Khalid Hussain] Sindh Agr Univ, Dept Entomol, Fac Crop Protect, Tandojam, Pakistan	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Sindh Agricultural University	Wang, ZY (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing, Peoples R China.	wangzhy0301@sina.com			National Technology System project for Grape Industry [nycytx-30]	National Technology System project for Grape Industry	This study was financially supported by the National Technology System project for Grape Industry (nycytx-30). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanassiou CG, 2005, J ECON ENTOMOL, V98, P1733, DOI 10.1603/0022-0493-98.5.1733; Ayyanath MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074532; BECHMANN RK, 1994, ENVIRON TOXICOL CHEM, V13, P1509, DOI 10.1897/1552-8618(1994)13[1509:UOLTAL]2.0.CO;2; Benheim D, 2012, ANN APPL BIOL, V161, P91, DOI 10.1111/j.1744-7348.2012.00561.x; Bickerton M. W, 2011, THESIS; BIRCH LC, 1948, J ANIM ECOL, V17, P15, DOI 10.2307/1605; CAMPS F, 1993, PHYTOCHEMISTRY, V32, P1361, DOI 10.1016/0031-9422(93)85139-I; CAMPS F, 1991, ECOLOGICAL CHEM BIOC, P331; Carey J. R., 1993, APPL DEMOGRAPHY BIOL; Chao ZM, 1999, CHIN PHARM J, V34, P587; Charleston DS, 2004, THESIS; CHAZEAU J, 1991, ENTOMOPHAGA, V36, P275, DOI 10.1007/BF02374563; Clouse SD, 1996, CURR BIOL, V6, P658, DOI 10.1016/S0960-9822(09)00442-4; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Dixon AFG, 1987, APHIDS THEIR BIOL NA, VA, P269; Downie DA, 2001, EVOLUTION, V55, P1345, DOI 10.1111/j.0014-3820.2001.tb00657.x; Forbes VE, 1999, ENVIRON TOXICOL CHEM, V18, P1544, DOI 10.1002/etc.5620180729; Forneck A, 2009, ENTOMOL EXP APPL, V131, P1, DOI 10.1111/j.1570-7458.2008.00811.x; Francisco C, 1993, PHYTOCHEMISTRY, V32, P1361, DOI DOI 10.1016/0031-9422(93)85139-I; GALBRAITH MN, 1966, CHEM COMMUN, P905, DOI 10.1039/c19660000905; GRANETT J, 1985, J ECON ENTOMOL, V78, P1463, DOI 10.1093/jee/78.6.1463; Granett J, 2001, ANNU REV ENTOMOL, V46, P387, DOI 10.1146/annurev.ento.46.1.387; He YX, 2011, J ECON ENTOMOL, V104, P833, DOI 10.1603/EC10281; Herbert K, 2008, J ECON ENTOMOL, V101, P1934, DOI 10.1603/0022-0493-101.6.1934; Hoffmann M, 2016, AUST J GRAPE WINE R, V22, P271, DOI 10.1111/ajgw.12219; HU AM, 2004, JIANGSU PHARM CLIN R, V12, P18; Huang Z, 2008, PAK J BOT, V40, P1983; Hummel JD, 2009, THESIS; IZHEVSKY SS, 1988, ENTOMOPHAGA, V33, P101, DOI 10.1007/BF02372318; James DG, 2002, J ECON ENTOMOL, V95, P729, DOI 10.1603/0022-0493-95.4.729; Jeyabalan D, 2003, BIORESOURCE TECHNOL, V89, P185, DOI 10.1016/S0960-8524(03)00036-1; KAIRO MTK, 1995, J APPL ENTOMOL, V119, P487, DOI 10.1111/j.1439-0418.1995.tb01322.x; King PD, 1985, YITIS, V24, P32; Kovganko N, 1990, STEROIDS ECOLOGICAL; Kraiss H, 2008, PEST MANAG SCI, V64, P660, DOI 10.1002/ps.1541; [李娟 LI Juan], 2007, [中国药学杂志, Chinese Pharmaceutical Journal], V42, P178; Liu Xiaochun, 1998, Acta Phytophylacica Sinica, V25, P156; Liu YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128038; Meng D.L., 2004, THESIS; NAKANISHI K, 1966, J CHEM SOC CHEM COMM, V24, P915; Nicolov S, 1996, ACTA HORTIC, V426, P75; Pan HS, 2014, J PEST SCI, V87, P731, DOI 10.1007/s10340-014-0610-6; Powell KS, 2013, ADV INSECT PHYSIOL, V45, P159, DOI 10.1016/B978-0-12-417165-7.00004-0; Stark JD, 1997, ECOTOX ENVIRON SAFE, V37, P273, DOI 10.1006/eesa.1997.1552; Tapondjou LA, 2002, J STORED PROD RES, V38, P395, DOI 10.1016/S0022-474X(01)00044-3; TRUMAN JW, 1983, J INSECT PHYSIOL, V29, P895, DOI 10.1016/0022-1910(83)90052-5; Walthall WK, 1997, ECOTOX ENVIRON SAFE, V37, P45, DOI 10.1006/eesa.1997.1521; Wang AH, 2005, J ECON ENTOMOL, V98, P1144, DOI 10.1603/0022-0493-98.4.1144; WAPSHERE AJ, 1987, AM J ENOL VITICULT, V38, P216; Wei S, 1997, CHIN J CHIN MAT MED, V22, P293; WILLIAMS RN, 1988, ANN ENTOMOL SOC AM, V81, P1, DOI 10.1093/aesa/81.1.1; Xu D, 2011, BIOL CONTROL, V56, P239, DOI 10.1016/j.biocontrol.2010.11.011; Yu Jie, 2012, Acta Entomologica Sinica, V55, P386; Zhang HuaGe, 2009, Journal of Fruit Science, V26, P306; Zhong GH, 2001, J APPL ENTOMOL, V125, P563, DOI 10.1046/j.1439-0418.2001.00590.x; 赵素霞, 2011, [中药材, Journal of Chinese Medicinal Materials], V34, P690	56	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165860	10.1371/journal.pone.0165860	http://dx.doi.org/10.1371/journal.pone.0165860			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824901	gold, Green Submitted, Green Published			2022-12-26	WOS:000387615200039
J	Park, YB; Ha, CW; Kim, JA; Rhim, JH; Park, YG; Chung, JY; Lee, HJ				Park, Yong-Beom; Ha, Chul-Won; Kim, Jin-A; Rhim, Ji-Heon; Park, Yong-Geun; Chung, Jun Young; Lee, Han-Jun			Effect of Transplanting Various Concentrations of a Composite of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells and Hyaluronic Acid Hydrogel on Articular Cartilage Repair in a Rabbit Model	PLOS ONE			English	Article							HUMAN BONE-MARROW; CHONDROGENIC DIFFERENTIATION; STROMAL CELLS; CLINICAL-USE; IN-VITRO; DEFECTS; CHONDROCYTES; THERAPY; TISSUE; COCULTURE	Background Mesenchymal stem cells (MSCs) are known to have therapeutic potential for cartilage repair. However, the optimal concentration of MSCs for cartilage repair remains unclear. Therefore, we aimed to explore the feasibility of cartilage repair by human umbilical cord blood-derived MSCs (hUCB-MSCs) and to determine the optimal concentrations of the MSCs in a rabbit model. Methods Osteochondral defects were created in the trochlear groove of femur in 55 rabbits. Four experimental groups (11 rabbits/group) were treated by transplanting the composite of hUCB-MSCs and HA with various MSCs concentrations (0.1, 0.5, 1.0, and 1.5 x 10(7) cells/ ml). One control group was left untreated. At 4, 8, and 16 weeks post-transplantation, the degree of cartilage repair was evaluated grossly and histologically. Findings Overall, transplanting hUCB-MSCs and HA hydrogel resulted in cartilage repair tissue with better quality than the control without transplantation (P = 0.015 in 0.1, P = 0.004 in 0.5, P = 0.004 in 1.0, P = 0.132 in 1.5 x 10(7) cells/ml). Interestingly, high cell concentration of hUCB-MSCs (1.5x10(7) cells/ml) was inferior to low cell concentrations (0.1, 0.5, and 1.0 x 10(7) cells/ml) in cartilage repair (P = 0.394, P = 0.041, P = 0.699, respectively). The 0.5 x 10(7) cells/ml group showed the highest cartilage repair score at 4, 8 and 16 weeks post transplantation, and followed by 0.1x10(7) cells/ml group or 1.0 x 10(7) cell/ml group. Conclusions The results of this study suggest that transplantation of the composite of hUCB-MSCs and HA is beneficial for cartilage repair. In addition, this study shows that optimal MSC concentration needs to be determined for better cartilage repair.	[Park, Yong-Beom; Lee, Han-Jun] Chung Ang Univ, Coll Med, Chung Ang Univ Hosp, Dept Orthoped Surg, 102 Heukseok Ro, Seoul 06973, South Korea; [Ha, Chul-Won; Kim, Jin-A; Rhim, Ji-Heon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthopaed Surg, 81 Irwon Ro, Seoul 06351, South Korea; [Ha, Chul-Won; Kim, Jin-A; Rhim, Ji-Heon] Samsung Med Ctr, Stem Cell & Regenerat Med Res Inst, 81 Irwon Ro, Seoul 06351, South Korea; [Ha, Chul-Won] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea; [Park, Yong-Geun] Jeju Natl Univ, Sch Med, Jeju Natl Univ Hosp, Dept Orthoped Surg, 15 Aran 13 Gil, Jeju Si 63241, South Korea; [Chung, Jun Young] Ajou Univ, Sch Med, Ajou Univ Hosp, Dept Orthopaed Surg, 164 World Cup Ro, Suwon 16499, South Korea	Chung Ang University; Chung Ang University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Jeju National University; Ajou University; Ajou University Hospital	Ha, CW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthopaed Surg, 81 Irwon Ro, Seoul 06351, South Korea.; Ha, CW (corresponding author), Samsung Med Ctr, Stem Cell & Regenerat Med Res Inst, 81 Irwon Ro, Seoul 06351, South Korea.; Ha, CW (corresponding author), Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea.	chulwon.ha@gmail.com	Ha, C/GZL-9046-2022	Park, Yong-Beom/0000-0002-3741-2311; CHUNG, JUN YOUNG/0000-0002-6944-5812	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C3484]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant (HI14C3484) of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea. The funding sources had no involvement in the study design, collection, data analysis, data interpretation, writing of the manuscript, or the decision to submit the manuscript for publication.	Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Choi YS, 2008, CYTOTHERAPY, V10, P165, DOI 10.1080/14653240701817002; Chung JY, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt427; De Bari C, 2003, J CELL BIOL, V160, P909, DOI 10.1083/jcb.200212064; Fischer J, 2010, ARTHRITIS RHEUM-US, V62, P2696, DOI 10.1002/art.27565; Fisher MB, 2015, TISSUE ENG PT A, V21, P850, DOI [10.1089/ten.tea.2014.0384, 10.1089/ten.TEA.2014.0384]; Flynn A, 2007, CYTOTHERAPY, V9, P717, DOI 10.1080/14653240701584578; Giovannini S, 2010, EUR CELLS MATER, V20, P245; GUERNE PA, 1995, ARTHRITIS RHEUM-US, V38, P960, DOI 10.1002/art.1780380712; Ha CW, 2015, STEM CELL TRANSL MED, V4, P1044, DOI 10.5966/sctm.2014-0264; Haleem AM, 2010, CARTILAGE, V1, P253, DOI 10.1177/1947603510366027; Ibrahim AM, 2015, MICROSC RES TECHNIQ, V78, P667, DOI 10.1002/jemt.22520; Isakova IA, 2007, STEM CELLS, V25, P3261, DOI 10.1634/stemcells.2007-0543; Jeong SY, 2013, STEM CELLS, V31, P2136, DOI 10.1002/stem.1471; Kao IT, 2008, CHINESE J PHYSIOL, V51, P252; Kim SM, 2008, CANCER RES, V68, P9614, DOI 10.1158/0008-5472.CAN-08-0451; Koga H, 2008, CELL TISSUE RES, V333, P207, DOI 10.1007/s00441-008-0633-5; Lee KBL, 2007, STEM CELLS, V25, P2964, DOI 10.1634/stemcells.2006-0311; Lee M, 2014, BIOCHEM BIOPH RES CO, V446, P983, DOI 10.1016/j.bbrc.2014.03.051; Li YY, 2014, ACTA BIOMATER, V10, P1919, DOI 10.1016/j.actbio.2014.01.002; Martin JA, 2003, J BONE JOINT SURG AM, V85A, P106, DOI 10.2106/00004623-200300002-00014; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; ODRISCOLL SW, 1986, J BONE JOINT SURG AM, V68A, P1017, DOI 10.2106/00004623-198668070-00008; Osiecka-Iwan A, 2003, CELL TRANSPLANT, V12, P389, DOI 10.3727/000000003108746939; Park YB, 2015, J ORTHOP RES, V33, P1580, DOI 10.1002/jor.22950; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105; Seo Seung-Suk, 2011, Knee Surg Relat Res, V23, P185, DOI 10.5792/ksrr.2011.23.4.185; Smith GD, 2005, ARTHROSCOPY, V21, P1462, DOI 10.1016/j.arthro.2005.09.007; Steck E, 2009, STEM CELLS DEV, V18, P969, DOI 10.1089/scd.2008.0213; Tipnis S, 2010, IMMUNOL CELL BIOL, V88, P795, DOI 10.1038/icb.2010.47; Veronesi F, 2013, STEM CELLS DEV, V22, P181, DOI 10.1089/scd.2012.0373; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504; Wakitani S, 2011, J TISSUE ENG REGEN M, V5, P146, DOI 10.1002/term.299; Wang M, 2009, IMMUNOLOGY, V126, P220, DOI 10.1111/j.1365-2567.2008.02891.x; Wong KL, 2013, ARTHROSCOPY, V29, P2020, DOI 10.1016/j.arthro.2013.09.074; Yang SE, 2004, CYTOTHERAPY, V6, P476, DOI 10.1080/14653240410005041; Yang SH, 2008, SPINE, V33, P1951, DOI 10.1097/BRS.0b013e31817e6974; Zhang X, 2011, J CELL BIOCHEM, V112, P1206, DOI 10.1002/jcb.23042; Zhao QJ, 2009, CYTOTHERAPY, V11, P414, DOI 10.1080/14653240902849754	43	24	25	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165446	10.1371/journal.pone.0165446	http://dx.doi.org/10.1371/journal.pone.0165446			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824874	Green Published, gold, Green Submitted			2022-12-26	WOS:000387615200018
J	Chen, XG; Wang, YY; Nelson, D; Tian, S; Mulvey, E; Patel, B; Conti, I; Jaen, J; Rollins, BJ				Chen, Xuguang; Wang, Yunyue; Nelson, David; Tian, Sara; Mulvey, Erin; Patel, Bhumi; Conti, Ilaria; Jaen, Juan; Rollins, Barrett J.			CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in Mice	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CHEMOKINE RECEPTOR 2; BREAST-CANCER; MACROPHAGE RECRUITMENT; INFLAMMATORY MONOCYTES; MCP-1; ANGIOGENESIS; EXPRESSION; CELLS	Chronic inflammation is a hallmark of cancer. Inflammatory chemokines, such as C-C chemokine ligand 2 (CCL2), are often present in tumors but their roles in cancer initiation and maintenance are not clear. Here we report that CCL2 promotes mammary carcinoma development in a clinically relevant murine model of breast cancer. Targeted disruption of Ccl2 slowed the growth of activated Her2/neu-driven mammary tumors and prolonged host survival. Disruption of Ccl2 was associated with a decrease in the development and mobilization of endothelial precursor cells (EPCs) which can contribute to tumor neovascularization. In contrast, disruption of Ccr2, which encodes CCL2's sole signaling receptor, accelerated tumor development, shortened host survival, and mobilized EPCs. However, pharmacological inhibition of CCR2 phenocopied Ccl2 disruption rather than Ccr2 disruption, suggesting that the Ccr2(-/-) phenotype is a consequence of unanticipated alterations not linked to intact CCL2/CCR2 signaling. Consistent with this explanation, Ccr2(-/-) monocytes are more divergent from wild type monocytes than Ccl2(-/-) monocytes in their expression of genes involved in key developmental and functional pathways. Taken together, our data suggest a tumor-promoting role for CCL2 acting through CCR2 on the tumor microenvironment and support the targeting of this chemokine/receptor pair in breast cancer.	[Chen, Xuguang; Wang, Yunyue; Nelson, David; Tian, Sara; Mulvey, Erin; Patel, Bhumi; Conti, Ilaria; Rollins, Barrett J.] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Chen, Xuguang; Wang, Yunyue; Nelson, David; Tian, Sara; Mulvey, Erin; Patel, Bhumi; Conti, Ilaria; Rollins, Barrett J.] Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA; [Chen, Xuguang; Wang, Yunyue; Rollins, Barrett J.] Harvard Med Sch, Boston, MA 02115 USA; [Jaen, Juan] ChemoCentryx Inc, Mountain View, CA 94043 USA; [Conti, Ilaria] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Jaen, Juan] Arcus Biosci Inc, Hayward, CA 94545 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Eli Lilly	Rollins, BJ (corresponding author), Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.; Rollins, BJ (corresponding author), Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA.; Rollins, BJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	Barrett_Rollins@dfci.harvard.edu						Allavena P, 2011, EXP CELL RES, V317, P664, DOI 10.1016/j.yexcr.2010.11.013; Balkwill FR, 2012, J CELL SCI, V125, P5591, DOI 10.1242/jcs.116392; Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; Dwyer RM, 2007, CLIN CANCER RES, V13, P5020, DOI 10.1158/1078-0432.CCR-07-0731; Fang WB, 2012, J BIOL CHEM, V287, P36593, DOI 10.1074/jbc.M112.365999; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Gazzaniga S, 2007, J INVEST DERMATOL, V127, P2031, DOI 10.1038/sj.jid.5700827; Goede V, 1999, INT J CANCER, V82, P765, DOI 10.1002/(SICI)1097-0215(19990827)82:5<765::AID-IJC23>3.0.CO;2-F; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Haringman JJ, 2006, ARTHRITIS RHEUM, V54, P2387, DOI 10.1002/art.21975; Hong KH, 2005, BLOOD, V105, P1405, DOI 10.1182/blood-2004-08-3178; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; HUANG SY, 1994, CANCER IMMUNOL IMMUN, V39, P231, DOI 10.1007/BF01525986; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Kitamura T, 2015, J EXP MED, V212, P1043, DOI 10.1084/jem.20141836; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Li M, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25474; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; MATSUSHIMA K, 1989, J EXP MED, V169, P1485, DOI 10.1084/jem.169.4.1485; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; NEGUS RPM, 1995, J CLIN INVEST, V95, P2391, DOI 10.1172/JCI117933; Owens Marilyn A, 2004, Clin Breast Cancer, V5, P63, DOI 10.3816/CBC.2004.n.011; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Saji H, 2001, CANCER, V92, P1085, DOI 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Spring H, 2005, P NATL ACAD SCI USA, V102, P18111, DOI 10.1073/pnas.0507158102; Svensson S, 2015, CLIN CANC RES; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Takahashi M, 2009, CLIN EXP METASTAS, V26, P817, DOI 10.1007/s10585-009-9281-8; Takahashi M, 2009, J IMMUNOL, V183, P3463, DOI 10.4049/jimmunol.0802812; Ueno T, 2000, CLIN CANCER RES, V6, P3282; YOSHIMURA T, 1989, J EXP MED, V169, P1449, DOI 10.1084/jem.169.4.1449; Zhang J, 2010, JNCI-J NATL CANCER I, V102, P522, DOI 10.1093/jnci/djq044	50	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165595	10.1371/journal.pone.0165595	http://dx.doi.org/10.1371/journal.pone.0165595			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820834	gold, Green Published			2022-12-26	WOS:000387614800013
J	Gaut, L; Robert, N; Delalande, A; Bonnin, MA; Pichon, C; Duprez, D				Gaut, Ludovic; Robert, Nicolas; Delalande, Antony; Bonnin, Marie-Ange; Pichon, Chantal; Duprez, Delphine			EGR1 Regulates Transcription Downstream of Mechanical Signals during Tendon Formation and Healing	PLOS ONE			English	Article							GENE-EXPRESSION; STEM-CELLS; SCLERAXIS EXPRESSION; ACHILLES TENDONS; DIFFERENTIATION; RAT; TENOMODULIN; FIBROBLASTS; PROMOTES; MUSCLE	Background Tendon is a mechanical tissue that transmits forces generated by muscle to bone in order to allow body motion. The molecular pathways that sense mechanical forces during tendon formation, homeostasis and repair are not known. EGR1 is a mechanosensitive transcription factor involved in tendon formation, homeostasis and repair. We hypothesized that EGR1 senses mechanical signals to promote tendon gene expression. Methodology/ Principal findings Using in vitro and in vivo models, we show that the expression of Egr1 and tendon genes is downregulated in 3D-engineered tendons made of mesenchymal stem cells when tension is released as well as in tendon homeostasis and healing when mechanical signals are reduced. We further demonstrate that EGR1 overexpression prevents tendon gene down-regulation in 3D-engineered tendons when tension is released. Lastly, ultrasound and microbubbles mediated EGR1 overexpression prevents the downregulation of tendon gene expression during tendon healing in reduced load conditions. Conclusion/ Significance These results show that Egr1 expression is sensitive to mechanical signals in tendon cells. Moreover, EGR1 overexpression prevents the downregulation of tendon gene expression in the absence of mechanical signals in 3D-engineered tendons and tendon healing. These results show that EGR1 induces a transcriptional response downstream of mechanical signals in tendon cells and open new avenues to use EGR1 to promote tendon healing in reduced load conditions.	[Gaut, Ludovic; Robert, Nicolas; Bonnin, Marie-Ange; Duprez, Delphine] UPMC Univ Paris 06, Sorbonne Univ, IBPS Dev Biol Lab, CNRS,UMR7622,INSERM,U1156, F-75005 Paris, France; [Delalande, Antony; Pichon, Chantal] CNRS, UPR4301 CBM, 45071 Rue Charles Sadron, Orleans 2, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS)	Duprez, D (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, IBPS Dev Biol Lab, CNRS,UMR7622,INSERM,U1156, F-75005 Paris, France.	delphine.duprez@upmc.fr	Duprez, Delphine/K-1856-2017	Duprez, Delphine/0000-0003-0248-7417; Bonnin, Marie-Ange/0000-0002-6521-3387; Delalande, Anthony/0000-0001-8280-4616; PICHON, Chantal/0000-0003-3161-3937	Fondation pour la Recherche Medicale [FRM DEQ20140329500]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the Fondation pour la Recherche Medicale (FRM DEQ20140329500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberton P, 2015, STEM CELLS DEV, V24, P597, DOI 10.1089/scd.2014.0314; Aoki KR, 2001, TOXICON, V39, P1815, DOI 10.1016/S0041-0101(01)00101-5; Bagchi RA, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0243-8; Bayer ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086078; Bayer ML, 2010, BIOMATERIALS, V31, P4889, DOI 10.1016/j.biomaterials.2010.02.062; Berthet E, 2013, J ORTHOP RES, V31, P1475, DOI 10.1002/jor.22382; Bougault C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036964; Breidenbach AP, 2015, TISSUE ENG PT A, V21, P438, DOI [10.1089/ten.tea.2013.0768, 10.1089/ten.TEA.2013.0768]; Brown JP, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0043-z; Brown JP, 2014, J BIOMECH, V47, P214, DOI 10.1016/j.jbiomech.2013.09.018; Chan KM, 2008, WOUND REPAIR REGEN, V16, P399, DOI 10.1111/j.1524-475X.2008.00379.x; Delalande A, 2011, J CONTROL RELEASE, V156, P223, DOI 10.1016/j.jconrel.2011.08.020; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Eliasson P, 2013, J APPL PHYSIOL, V114, P1519, DOI 10.1152/japplphysiol.01500.2012; Eliasson P, 2009, J APPL PHYSIOL, V107, P399, DOI 10.1152/japplphysiol.91563.2008; Guerquin MJ, 2013, J CLIN INVEST, V123, P3564, DOI 10.1172/JCI67521; Hammerman M, 2014, J APPL PHYSIOL, V116, P54, DOI 10.1152/japplphysiol.00741.2013; Havis E, 2014, DEVELOPMENT, V141, P3683, DOI 10.1242/dev.108654; Heinemeier KM, 2011, J MUSCULOSKEL NEURON, V11, P115; Jelinsky SA, 2010, J ORTHOP RES, V28, P289, DOI 10.1002/jor.20999; Kapacce Z, 2008, MATRIX BIOL, V27, P371, DOI 10.1016/j.matbio.2007.11.006; Kapacee Z, 2010, MATRIX BIOL, V29, P668, DOI 10.1016/j.matbio.2010.08.005; Lavagnino M, 2015, J ORTHOP RES, V33, P813, DOI 10.1002/jor.22871; Lejard V, 2007, J BIOL CHEM, V282, P17665, DOI 10.1074/jbc.M610113200; Lejard V, 2011, J BIOL CHEM, V286, P5855, DOI 10.1074/jbc.M110.153106; Liu HH, 2015, STEM CELLS, V33, P443, DOI 10.1002/stem.1866; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeda T, 2011, CURR BIOL, V21, P933, DOI 10.1016/j.cub.2011.04.007; Mendias CL, 2012, J ORTHOP RES, V30, P606, DOI 10.1002/jor.21550; Morawietz H, 1999, CIRC RES, V84, P678, DOI 10.1161/01.RES.84.6.678; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Nourissat G, 2015, NAT REV RHEUMATOL, V11, P223, DOI 10.1038/nrrheum.2015.26; Pardo PS, 2011, J BIOL CHEM, V286, P2559, DOI 10.1074/jbc.M110.149153; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Scott A, 2011, J ORTHOP RES, V29, P289, DOI 10.1002/jor.21220; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Shwartz Y, 2013, DIFFERENTIATION, V86, P104, DOI 10.1016/j.diff.2013.07.003; Stula M, 2000, MOL CELL BIOCHEM, V210, P101, DOI 10.1023/A:1007126218740; Sugimoto Y, 2013, DEVELOPMENT, V140, P2280, DOI 10.1242/dev.096354; Tao X, 2015, CELL PHYSIOL BIOCHEM, V35, P699, DOI 10.1159/000369730; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; Wang JHC, 2012, J HAND THER, V25, P133, DOI 10.1016/j.jht.2011.07.004; Wu XQ, 2010, ARTERIOSCL THROM VAS, V30, P471, DOI 10.1161/ATVBAHA.109.184259; Yeung CYC, 2015, SCI REP-UK, V5, DOI 10.1038/srep13555	47	40	41	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166237	10.1371/journal.pone.0166237	http://dx.doi.org/10.1371/journal.pone.0166237			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820865	Green Published, Green Submitted, gold			2022-12-26	WOS:000387614800043
J	Hansen, ZR; Everts, KL; Fry, WE; Gevens, AJ; Grunwald, NJ; Gugino, BK; Johnson, DA; Johnson, SB; Judelson, HS; Knaus, BJ; McGrath, MT; Myers, KL; Ristaino, JB; Roberts, PD; Secor, GA; Smart, CD				Hansen, Zachariah R.; Everts, Kathryne L.; Fry, William E.; Gevens, Amanda J.; Gruenwald, Niklaus J.; Gugino, Beth K.; Johnson, Dennis A.; Johnson, Steven B.; Judelson, Howard S.; Knaus, Brian J.; McGrath, Margaret T.; Myers, Kevin L.; Ristaino, Jean B.; Roberts, Pamela D.; Secor, Gary A.; Smart, Christine D.			Genetic Variation within Clonal Lineages of Phytophthora infestans Revealed through Genotyping-By-Sequencing, and Implications for Late Blight Epidemiology	PLOS ONE			English	Article							IRISH POTATO FAMINE; NEIGHBOR-JOINING METHOD; EASTERN UNITED-STATES; SEXUAL REPRODUCTION; R-PACKAGE; POPULATIONS; TOMATO; DIVERSITY; MARKERS; AGGRESSIVENESS	Genotyping-by-sequencing (GBS) was performed on 257 Phytophthora infestans isolates belonging to four clonal lineages to study within-lineage diversity. The four lineages used in the study were US-8 (n = 28), US-11 (n = 27), US-23 (n = 166), and US-24 (n = 36), with isolates originating from 23 of the United States and Ontario, Canada. The majority of isolates were collected between 2010 and 2014 (94%), with the remaining isolates collected from 1994 to 2009, and 2015. Between 3,774 and 5,070 single-nucleotide polymorphisms (SNPs) were identified within each lineage and were used to investigate relationships among individuals. K-means hierarchical clustering revealed three clusters within lineage US-23, with US-23 isolates clustering more by collection year than by geographic origin. K-means hierarchical clustering did not reveal significant clustering within the smaller US-8, US-11, and US-24 data sets. Neighbor-joining (NJ) trees were also constructed for each lineage. All four NJ trees revealed evidence for pathogen dispersal and overwintering within regions, as well as long-distance pathogen transport across regions. In the US-23 NJ tree, grouping by year was more prominent than grouping by region, which indicates the importance of long-distance pathogen transport as a source of initial late blight inoculum. Our results support previous studies that found significant genetic diversity within clonal lineages of P. infestans and show that GBS offers sufficiently high resolution to detect sub-structuring within clonal populations.	[Hansen, Zachariah R.; Smart, Christine D.] Cornell Univ, Plant Pathol & Plant Microbe Biol Sect, Geneva, NY 14456 USA; [Everts, Kathryne L.] Univ Maryland, Dept Plant Sci & Landscape Architecture, Salisbury, MD USA; [Fry, William E.; Myers, Kevin L.] Cornell Univ, Plant Pathol & Plant Microbe Biol Sect, Ithaca, NY USA; [Gevens, Amanda J.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Gruenwald, Niklaus J.; Knaus, Brian J.] ARS, Hort Crops Res Lab, USDA, Corvallis, OR USA; [Gugino, Beth K.] Penn State Univ, Dept Plant Pathol & Environm Microbiol, University Pk, PA 16802 USA; [Johnson, Dennis A.] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Johnson, Steven B.] Univ Maine Cooperat Extens, Presque Isle, ME USA; [Judelson, Howard S.] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [McGrath, Margaret T.] Cornell Univ, Plant Pathol & Plant Microbe Biol Sect, Riverhead, NY USA; [Ristaino, Jean B.] North Carolina State Univ, Dept Plant Pathol, Raleigh, NC USA; [Roberts, Pamela D.] Univ Florida, Dept Plant Pathol, Immokalee, FL USA; [Secor, Gary A.] North Dakota State Univ, Dept Plant Pathol, Fargo, ND USA	Cornell University; Cornell University; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Washington State University; University of Maine System; University of Maine Orono; University of California System; University of California Riverside; Cornell University; University of North Carolina; North Carolina State University; State University System of Florida; University of Florida; North Dakota State University Fargo	Smart, CD (corresponding author), Cornell Univ, Plant Pathol & Plant Microbe Biol Sect, Geneva, NY 14456 USA.	cds14@cornell.edu	Ristaino, Jean Beagle/N-3616-2018; Myers, Kevin/GZK-8865-2022	Ristaino, Jean Beagle/0000-0002-9458-0514; Hansen, Zachariah/0000-0001-8962-0094; Smart, Christine/0000-0003-4162-9502; Everts, Kathryne/0000-0002-5482-8466	United States Department of Agriculture, National Institute of Food and Agriculture [2011-68004-30154]; United States Department of Agriculture, National Institute of Food and Agriculture Pre-Doctoral Fellowship [2016-67011-25176]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016290] Funding Source: NIH RePORTER; ARS [ARS-0423109] Funding Source: Federal RePORTER	United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); United States Department of Agriculture, National Institute of Food and Agriculture Pre-Doctoral Fellowship; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding for this work was provided by the United States Department of Agriculture, National Institute of Food and Agriculture Grant no. 2011-68004-30154. Additional support for Z. R. Hansen was provided by the United States Department of Agriculture, National Institute of Food and Agriculture Pre-Doctoral Fellowship no. 2016-67011-25176.	Abu-El Samen FM, 2003, PLANT PATHOL, V52, P314, DOI 10.1046/j.1365-3059.2003.00858.x; Abu-El Samen FM, 2003, PHYTOPATHOLOGY, V93, P293, DOI 10.1094/PHYTO.2003.93.3.293; CATEN CE, 1968, CAN J BOTANY, V46, P329, DOI 10.1139/b68-055; Cooke DEL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002940; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Danies G, 2013, PLANT DIS, V97, P873, DOI 10.1094/PDIS-07-12-0682-RE; Danies G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116354; de Bary A., 1861, GEGENWARTIG HERRSCHE, P75; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Frost KE, 2016, PLANT DIS, V100, P180, DOI 10.1094/PDIS-04-15-0462-RE; Fry WE, 2015, PHYTOPATHOLOGY, V105, P966, DOI 10.1094/PHYTO-01-15-0005-FI; Fry WE, 2013, PLANT DIS, V97, P296, DOI 10.1094/PDIS-08-12-0791-FE; Fry WE, 1997, PLANT DIS, V81, P1349, DOI 10.1094/PDIS.1997.81.12.1349; Fu YB, 2014, GENET RESOUR CROP EV, V61, P579, DOI 10.1007/s10722-013-0058-1; Gavino PD, 2000, PLANT DIS, V84, P731, DOI 10.1094/PDIS.2000.84.7.731; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; GOODWIN SB, 1995, PLANT DIS, V79, P1181, DOI 10.1094/PD-79-1181; GOODWIN SB, 1995, PHYTOPATHOLOGY, V85, P669, DOI 10.1094/Phyto-85-669; Goodwin SB, 1998, PHYTOPATHOLOGY, V88, P939, DOI 10.1094/PHYTO.1998.88.9.939; Goodwin SB, 1997, PHYTOPATHOLOGY, V87, P462, DOI 10.1094/PHYTO.1997.87.4.462; GOODWIN SB, 1994, PHYTOPATHOLOGY, V84, P553, DOI 10.1094/Phyto-84-553; GOODWIN SB, 1994, P NATL ACAD SCI USA, V91, P11591, DOI 10.1073/pnas.91.24.11591; Griffith GW, 1998, APPL ENVIRON MICROB, V64, P4007; Grunwald NJ, 2003, PHYTOPATHOLOGY, V93, P738, DOI 10.1094/PHYTO.2003.93.6.738; Grunwald NJ, 2016, ANN REV PHY IN PRESS; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Haverkort AJ, 2008, POTATO RES, V51, P47, DOI 10.1007/s11540-008-9089-y; Hirst JM, 1960, ANN APPL BIOL, V48, P489, DOI 10.1111/j.1744-7348.1960.tb03554.x; Hu CH, 2012, PLANT DIS, V96, P1323, DOI 10.1094/PDIS-03-11-0156-RE; Jaime-Garcia R, 2000, PHYTOPATHOLOGY, V90, P1188, DOI 10.1094/PHYTO.2000.90.11.1188; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kamvar ZN, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00208; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Knaus BJ, 2016, MOL ECOL RE IN PRESS; Lees AK, 2006, PLANT PATHOL, V55, P311, DOI 10.1111/j.1365-3059.2006.01359.x; LEGARD DE, 1995, PHYTOPATHOLOGY, V85, P1356, DOI 10.1094/Phyto-85-1356; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2012, G3-GENES GENOM GENET, V2, P1529, DOI 10.1534/g3.112.004150; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Martin MD, 2014, MOL BIOL EVOL, V31, P1414, DOI 10.1093/molbev/msu086; Milgroom MG., 2015, POPULATION BIOL PLAN; Milgroom MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106740; Miller JS, 1998, PHYTOPATHOLOGY, V88, P190, DOI 10.1094/PHYTO.1998.88.3.190; Mizubuti Eduardo S. G., 2006, P445, DOI 10.1007/1-4020-4581-6_17; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Peters RD, 2014, CAN J PLANT PATHOL, V36, P73, DOI 10.1080/07060661.2014.892900; PREVOSTI A, 1975, THEOR APPL GENET, V45, P231, DOI 10.1007/BF00831894; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saville A, 2015, PLANT DIS, V99, P659, DOI 10.1094/PDIS-05-14-0452-RE; Smart C. D., 2001, Biological Invasions, V3, P235, DOI 10.1023/A:1015200920772; Summers CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143665; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Yoshida K, 2013, ELIFE, V2, DOI 10.7554/eLife.00731; Zwankhuizen MJ, 1998, PHYTOPATHOLOGY, V88, P754, DOI 10.1094/PHYTO.1998.88.8.754	55	17	18	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165690	10.1371/journal.pone.0165690	http://dx.doi.org/10.1371/journal.pone.0165690			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812174	gold, Green Published, Green Submitted			2022-12-26	WOS:000386910000048
J	Chakraborty, N; Wang, M; Solocinski, J; Kim, W; Argento, A				Chakraborty, Nilay; Wang, Mian; Solocinski, Jason; Kim, Wonsuk; Argento, Alan			Imaging of Scleral Collagen Deformation Using Combined Confocal Raman Microspectroscopy and Polarized Light Microscopy Techniques	PLOS ONE			English	Article							SOFT-TISSUES; STRAIN; EYE; SPECTROSCOPY; GLAUCOMA; ELASTIN; BOVINE; TENDON; MODEL	This work presents an optospectroscopic characterization technique for soft tissue microstructure using site-matched confocal Raman microspectroscopy and polarized light microscopy. Using the technique, the microstructure of soft tissue samples is directly observed by polarized light microscopy during loading while spatially correlated spectroscopic information is extracted from the same plane, verifying the orientation and arrangement of the collagen fibers. Results show the response and orientation of the collagen fiber arrangement in its native state as well as during tensile and compressive loadings in a porcine sclera model. An example is also given showing how the data can be used with a finite element program to estimate the strain in individual collagen fibers. The measurements demonstrate features that indicate microstructural reorganization and damage of the sclera's collagen fiber arrangement under loading. The site-matched confocal Raman microspectroscopic characterization of the tissue provides a qualitative measure to relate the change in fibrillar arrangement with possible chemical damage to the collagen microstructure. Tests and analyses presented here can potentially be used to determine the stress-strain behavior, and fiber reorganization of the collagen microstructure in soft tissue during viscoelastic response.	[Chakraborty, Nilay; Wang, Mian; Solocinski, Jason; Kim, Wonsuk; Argento, Alan] Univ Michigan, Dept Mech Engn, Dearborn, MI 48128 USA	University of Michigan System; University of Michigan	Chakraborty, N (corresponding author), Univ Michigan, Dept Mech Engn, Dearborn, MI 48128 USA.	nilay@umich.edu	Chakraborty, Nilay/AAK-4812-2020	Chakraborty, Nilay/0000-0001-8138-3506; Kim, Wonsuk/0000-0002-4351-0321	National Science Foundation [CMMI 1130275]; University of Michigan's research seed fund UM [U038726, U046888]	National Science Foundation(National Science Foundation (NSF)); University of Michigan's research seed fund UM	This work was partly funded by the National Science Foundation under Grant CMMI 1130275 (AA) and by the University of Michigan's research seed fund UM project Nos. U038726 and U046888 (NC). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ammar DA, 2013, INVEST OPHTH VIS SCI, V54, P5258, DOI 10.1167/iovs.12-11513; Avetisov SE, 2013, J BIOMECH, V46, P1648, DOI 10.1016/j.jbiomech.2013.04.008; Beattie JR, 2011, INVEST OPHTH VIS SCI, V52, P1593, DOI 10.1167/iovs.10-6554; Billiar KL, 1997, J BIOMECH, V30, P753, DOI 10.1016/S0021-9290(97)00019-5; Camp CH, 2014, NAT PHOTONICS, V8, P627, DOI [10.1038/nphoton.2014.145, 10.1038/NPHOTON.2014.145]; Cheng VWT, 2007, J MATER SCI, V42, P8957, DOI 10.1007/s10853-007-1653-3; COLEMAN DJ, 1969, ARCH OPHTHALMOL-CHIC, V82, P637; Dehring KA, 2006, APPL SPECTROSC, V60, P366, DOI 10.1366/000370206776593582; Dieing T, 2008, VIB SPECTROSC, V48, P22, DOI 10.1016/j.vibspec.2008.03.004; Doehring TC, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3116155; Duma SM, 2002, ARCH OPHTHALMOL-CHIC, V120, P1517, DOI 10.1001/archopht.120.11.1517; Gasior-Glogowska M, 2013, J MECH BEHAV BIOMED, V18, P240, DOI 10.1016/j.jmbbm.2012.11.023; Han M, 2005, OPT EXPRESS, V13, P5791, DOI 10.1364/OPEX.13.005791; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hill MR, 2012, J BIOMECH, V45, P762, DOI 10.1016/j.jbiomech.2011.11.016; HOELTZEL DA, 1992, J BIOMECH ENG-T ASME, V114, P202, DOI 10.1115/1.2891373; Hollman KW, 2002, CORNEA, V21, P68, DOI 10.1097/00003226-200201000-00015; Igra O., 2001, HANDBOOK OF SHOCK WA, V2, P1; Kim W, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006847; Kivell TL, 2009, ANAT SCI EDUC, V2, P173, DOI 10.1002/ase.95; Krause AC, 1932, ARCH OPHTHALMOL-CHIC, V7, P598; Liu R, 2015, SENSOR ACTUAT B-CHEM, V219, P283, DOI 10.1016/j.snb.2015.04.124; Matousek P, 2007, CHEM SOC REV, V36, P1292, DOI 10.1039/b614777c; Mattson MS, 2010, INVEST OPHTH VIS SCI, V51, P3120, DOI 10.1167/iovs.09-4001; McBrien NA, 2009, OPTOMETRY VISION SCI, V86, P23, DOI 10.1097/OPX.0b013e3181940669; Morris MD, 2001, BIOS 2001 THE INTERN; Myers KM, 2010, ACTA BIOMATER, V6, P4327, DOI 10.1016/j.actbio.2010.06.007; Nahas A, 2013, BIOMED OPT EXPRESS, V4, P2138, DOI 10.1364/BOE.4.002138; QUIGLEY HA, 1991, CURR EYE RES, V10, P877, DOI 10.3109/02713689109013884; Ruiz-Ederra J, 2005, EXP EYE RES, V81, P561, DOI 10.1016/j.exer.2005.03.014; Sander EA, 2009, P NATL ACAD SCI USA, V106, P17675, DOI 10.1073/pnas.0903716106; Scott R, 2011, PHILOS T R SOC B, V366, P251, DOI 10.1098/rstb.2010.0234; Screen HRC, 2004, P I MECH ENG H, V218, P109, DOI 10.1243/095441104322984004; Sherwood D, 2014, INVEST OPHTH VIS SCI, V55, P1124, DOI 10.1167/iovs.13-13295; Tower TT, 2002, ANN BIOMED ENG, V30, P1221, DOI 10.1114/1.1527047; Tseng Y, 2001, BIOPHYS J, V81, P1643, DOI 10.1016/S0006-3495(01)75818-3; Voytik-Harbin SL, 2003, MICROSC MICROANAL, V9, P74, DOI 10.1017/S1431927603030046; Wang YN, 2000, J BIOMECH, V33, P483, DOI 10.1016/S0021-9290(99)00194-3	39	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165520	10.1371/journal.pone.0165520	http://dx.doi.org/10.1371/journal.pone.0165520			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806070	Green Published, Green Submitted, gold			2022-12-26	WOS:000386715500034
J	Jacob, AE; Turner, CE; Amack, JD				Jacob, Andrew E.; Turner, Christopher E.; Amack, Jeffrey D.			Evolution and Expression of Paxillin Genes in Teleost Fish	PLOS ONE			English	Article							FOCAL ADHESION LOCALIZATION; MESSENGER-RNA; TYROSINE PHOSPHORYLATION; MYOTENDINOUS JUNCTION; PROTEIN PAXILLIN; KUPFFERS VESICLE; CELL-ADHESION; ZEBRAFISH; INTEGRIN; HIC-5	Background Paxillin family proteins regulate intracellular signaling downstream of extracellular matrix adhesion. Tissue expression patterns and cellular functions of Paxillin proteins during embryo development remain poorly understood. Additionally, the evolution of this gene family has not been thoroughly investigated. Results This report characterizes the evolution and expression of a novel Paxillin gene, called Paxillin-b, in Teleosts. Alignments indicate that Teleost Paxillin-a and Paxillin-b proteins are highly homologous to each other and to human Paxillin. Phylogenetic and synteny analyses suggest that these genes originated from the duplication of an ancestral Paxillin gene that was in a common ancestor of Teleosts and Tetrapods. Analysis of the spatiotemporal expression profiles of Paxillin-a and Paxillin-b using zebrafish revealed both overlapping and distinct domains for Paxillin-a and Paxillin-b during embryo development. Localization of zebrafish Paxillin orthologs expressed in mammalian cells demonstrated that both proteins localize to focal adhesions, similar to mammalian Paxillin. This suggests these proteins regulate adhesion-dependent processes in their endogenous tissues. Conclusion Paxillin-a and Paxillin-b were generated by duplication in Teleosts. These genes likely play similar roles as Paxillin genes in other organisms. This work provides a framework for functional investigation of Paxillin family members during development using the zebrafish as an in vivo model system.	[Jacob, Andrew E.; Turner, Christopher E.; Amack, Jeffrey D.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Turner, CE; Amack, JD (corresponding author), SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA.	turnerce@upstate.edu; amackj@upstate.edu		Amack, Jeffrey/0000-0002-5465-9754	National Institute of Health [R01 GM47607, R01 HL095690]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047607] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health R01 GM47607 to CET (https://grants.nih.gov/grants/oer.htm); National Institute of Health R01 HL095690 to JDA (https://grants.nih.gov/grants/oer.htm).	Ablooglu AJ, 2007, DEV DYNAM, V236, P2268, DOI 10.1002/dvdy.21229; Amack JD, 2004, CURR BIOL, V14, P685, DOI 10.1016/j.cub.2004.04.002; Bataille L, 2010, DEV CELL, V19, P317, DOI 10.1016/j.devcel.2010.07.008; Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Bukahrova T, 2005, J CELL SCI, V118, P4295, DOI 10.1242/jcs.02557; Chen GC, 2005, MOL CELL BIOL, V25, P979, DOI 10.1128/MCB.25.3.979-987.2005; Chen PW, 2010, CELL ADHES MIGR, V4, P527, DOI 10.4161/cam.4.4.12399; Chicurel ME, 1998, NATURE, V392, P730, DOI 10.1038/33719; Compagnon J, 2014, DEV CELL, V31, P774, DOI 10.1016/j.devcel.2014.11.003; Cortesio CL, 2011, J BIOL CHEM, V286, P9998, DOI 10.1074/jbc.M110.187294; Costa ML, 2003, BRAZ J MED BIOL RES, V36, P1117, DOI 10.1590/S0100-879X2003000800019; Crawford BD, 2003, MOL BIOL CELL, V14, P3065, DOI 10.1091/mbc.E02-08-0537; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Deakin NO, 2014, J CELL BIOL, V206, P395, DOI 10.1083/jcb.201403039; Deakin Nicholas O, 2012, Genes Cancer, V3, P362, DOI 10.1177/1947601912458582; DIX DJ, 1990, J CELL BIOL, V111, P1885, DOI 10.1083/jcb.111.5.1885; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Furthauer M., 2001, R01RR15402 NIH; Gao CL, 2010, DEV DYNAM, V239, P2190, DOI 10.1002/dvdy.22355; Ghogomu SM, 2006, J BIOL CHEM, V281, P1755, DOI 10.1074/jbc.M505869200; Glasauer SMK, 2014, MOL GENET GENOMICS, V289, P1045, DOI 10.1007/s00438-014-0889-2; Goody MF, 2010, DEV BIOL, V344, P809, DOI 10.1016/j.ydbio.2010.05.513; Gros J, 2010, CURR BIOL, V20, P1993, DOI 10.1016/j.cub.2010.09.063; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Iioka H, 2007, NAT CELL BIOL, V9, P813, DOI 10.1038/ncb1607; Ishibe S, 2003, MOL CELL, V12, P1275, DOI 10.1016/S1097-2765(03)00406-4; Ivaska J, 2011, ANNU REV CELL DEV BI, V27, P291, DOI 10.1146/annurev-cellbio-092910-154017; Jin H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-19; Julich D, 2009, DEVELOPMENT, V136, P2913, DOI 10.1242/dev.038935; Kim-Kaneyama J, 2011, J MOL CELL CARDIOL, V50, P77, DOI 10.1016/j.yjmcc.2010.09.024; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Louis A, 2015, NUCLEIC ACIDS RES, V43, pD682, DOI 10.1093/nar/gku1112; Mackin NA, 2004, MOL BIOL CELL, V15, P1904, DOI 10.1091/mbc.E04-01-0004; Mardakheh FK, 2015, DEV CELL, V35, P344, DOI 10.1016/j.devcel.2015.10.005; Nishiya N, 1999, J BIOL CHEM, V274, P9847, DOI 10.1074/jbc.274.14.9847; Nishiya N, 2001, MOL CELL BIOL, V21, P5332, DOI 10.1128/MCB.21.16.5332-5345.2001; Norton WHJ, 2005, DEVELOPMENT, V132, P4963, DOI 10.1242/dev.02084; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Parsons MJ, 2002, DEVELOPMENT, V129, P3137; Pascoal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068021; Postel R, 2008, DEV BIOL, V318, P92, DOI 10.1016/j.ydbio.2008.03.024; Snow CJ, 2009, GENE EXPR PATTERNS, V9, P37, DOI 10.1016/j.gep.2008.08.003; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka T, 2010, CANCER SCI, V101, P363, DOI 10.1111/j.1349-7006.2009.01398.x; Tumbarello DA, 2005, J CELL SCI, V118, P4849, DOI 10.1242/jcs.02615; TURNER CE, 1991, EXP CELL RES, V192, P651, DOI 10.1016/0014-4827(91)90090-H; Warner A, 2011, MOL BIOL CELL, V22, P2551, DOI 10.1091/mbc.E10-12-0941; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; Wheeler GN, 2001, GENE, V262, P291, DOI 10.1016/S0378-1119(00)00512-6; Yano T, 2012, DEVELOPMENT, V139, P2916, DOI 10.1242/dev.075572; Yuminamochi T, 2003, J HISTOCHEM CYTOCHEM, V51, P513, DOI 10.1177/002215540305100413	58	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165266	10.1371/journal.pone.0165266	http://dx.doi.org/10.1371/journal.pone.0165266			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806088	Green Published, Green Submitted, gold			2022-12-26	WOS:000386715500024
J	Ramirez-Lopez, MT; Arco, R; Decara, J; Vazquez, M; Blanco, RN; Alen, F; Suarez, J; de Heras, RG; de Fonseca, FR				Teresa Ramirez-Lopez, Maria; Arco, Raquel; Decara, Juan; Vazquez, Mariam; Noemi Blanco, Rosario; Alen, Francisco; Suarez, Juan; Gomez de Heras, Raquel; Rodriguez de Fonseca, Fernando			Exposure to a Highly Caloric Palatable Diet during the Perinatal Period Affects the Expression of the Endogenous Cannabinoid System in the Brain, Liver and Adipose Tissue of Adult Rat Offspring	PLOS ONE			English	Article							HIGH-FAT DIET; MONOGLYCERIDE LIPASE DEFICIENCY; HYPOTHALAMIC GENE-EXPRESSION; CB1 RECEPTOR ANTAGONIST; JUNK FOOD DIET; ENDOCANNABINOID SYSTEM; BODY-WEIGHT; INDUCED OBESITY; DEVELOPMENTAL ORIGINS; MICE LEADS	Recent studies have linked gestational exposure to highly caloric diets with a disrupted endogenous cannabinoid system (ECS). In the present study, we have extended these studies by analyzing the impact of the exposure to a palatable diet during gestation and lactation on a) the adult expression of endocannabinoid-related behaviors, b) the metabolic profile of adult offspring and c) the mRNA expression of the signaling machinery of the ECS in the hypothalamus, the liver and the adipose tissue of adult offspring of both sexes. Exposure to a palatable diet resulted in a) sex-dimorphic and perinatal diet specific feeding behaviors, including the differential response to the inhibitory effects of the cannabinoid receptor inverse agonist AM251, b) features of metabolic syndrome including increased adiposity, hyperleptinemia, hypertriglyceridemia and hypercholesterolemia and c) tissue and sex-specific changes in the expression of both CB1 and CB2 receptors and in that of the endocannabinoid-degrading enzymes FAAH and MAGL, being the adipose tissue the most affected organ analyzed. Since the effects were observed in adult animals that were weaned while consuming a normal diet, the present results indicate that the ECS is one of the targets of maternal programming of the offspring energy expenditure. These results clearly indicate that the maternal diet has long-term effects on the development of pups through multiple alterations of signaling homeostatic pathways that include the ECS. The potential relevance of these alterations for the current obesity epidemic is discussed.	[Teresa Ramirez-Lopez, Maria; Noemi Blanco, Rosario; Gomez de Heras, Raquel] Univ Complutense Madrid, Dept Psicobiol, Fac Psicol, Campus Somosaguas S-N, Madrid 28223, Spain; [Arco, Raquel; Decara, Juan; Vazquez, Mariam; Alen, Francisco; Suarez, Juan; Rodriguez de Fonseca, Fernando] Univ Malaga, Inst Invest Biomed Malaga IBIMA, Unidad Gest Clin Salud Mental, Hosp Reg Univ Malaga, Malaga 29010, Spain	Complutense University of Madrid; Universidad de Malaga	de Heras, RG (corresponding author), Univ Complutense Madrid, Dept Psicobiol, Fac Psicol, Campus Somosaguas S-N, Madrid 28223, Spain.; de Fonseca, FR (corresponding author), Univ Malaga, Inst Invest Biomed Malaga IBIMA, Unidad Gest Clin Salud Mental, Hosp Reg Univ Malaga, Malaga 29010, Spain.	rgomezhe@psi.ucm.es; fernando.rodriguez@ibima.eu	de Heras, Raquel Gomez/F-3484-2016; Ramírez-López, María Teresa/AAB-5705-2021; Alen, Francisco/I-3890-2017; Suarez, Juan/I-5188-2015; Decara Del Olmo, Juan Manuel/I-1931-2015	de Heras, Raquel Gomez/0000-0002-5846-1059; Ramírez-López, María Teresa/0000-0002-3944-5264; Alen, Francisco/0000-0002-3847-3503; Suarez, Juan/0000-0001-5254-9802; RODRIGUEZ DE FONSECA, FERNANDO/0000-0002-4516-5795; Blanco Velilla, Rosario Noemi/0000-0003-0265-6655; Decara Del Olmo, Juan Manuel/0000-0002-9868-015X; Arco Gonzalez, Rocio/0000-0002-5618-5687	Instituto de Salud Carlos III UEDR-FEDER, Ministerio de Economia y Competitividad UE/ERDF [PI13/0226, CP12/03109, PSI-2012-35388]; Red de TrastornosAdictivos UE/ERDF [RD12/0028/0001]; CIBERobn, Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, UE/ERDF [PI45403, CTS-8221, CTS-433]; Consejeria de Salud, Junta de Andalucia [PI0232/2008, PI0029/2008, SAS111224]; FPU predoctoral fellowship of the Spanish Ministerio de Educacion, Cultura y Deporte [AP-2009-0225]; National System of Health, ISCIII [CP12/03109]; Instituto de Salud Carlos III, Ministerio de Economia y Competitividad [PI13/0226, CP12/03109, PSI-2012-35388, PI16/01374]; Red de Trastornos Adictivos [RD12/0028/0001]; Consejeria de Salud, Junta de Andalucia, UE/ERDF [SAS111224, SAF2010-20521]	Instituto de Salud Carlos III UEDR-FEDER, Ministerio de Economia y Competitividad UE/ERDF; Red de TrastornosAdictivos UE/ERDF; CIBERobn, Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, UE/ERDF; Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); FPU predoctoral fellowship of the Spanish Ministerio de Educacion, Cultura y Deporte; National System of Health, ISCIII; Instituto de Salud Carlos III, Ministerio de Economia y Competitividad; Red de Trastornos Adictivos(Instituto de Salud Carlos III); Consejeria de Salud, Junta de Andalucia, UE/ERDF	This work was supported by the Instituto de Salud Carlos III UEDR-FEDER, Ministerio de Economia y Competitividad UE/ERDF (PI13/0226 to F.R.F., CP12/03109 to J.S. and PSI-2012-35388 to R.G.H.), Red de TrastornosAdictivos UE/ERDF (RD12/0028/0001 to F.R.F.), CIBERobn, Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, UE/ERDF (PI45403, CTS-8221, CTS-433 to F.R.F.), Consejeria de Salud, Junta de Andalucia (PI0232/2008, PI0029/2008 and SAS111224 to J.S. and F.R.F. M.T. Ramirez-Lopez has been funded by a FPU predoctoral fellowship of the Spanish Ministerio de Educacion, Cultura y Deporte (AP-2009-0225); J.S. holds "Miguel Servet" research contract from the National System of Health, ISCIII (grant numbersCP12/03109).; This work was supported by the Instituto de Salud Carlos III, Ministerio de Economia y Competitividad con-founded by UE-ERDF program (CP12/03109 and PI16/01374 to J.S., PI13/0226 to FRF, and PSI-2012-35388 to R.G.H.), Red de Trastornos Adictivos (RD12/0028/0001 to F.R.F.), CIBERobn, Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, UE/ERDF (PI45403, CTS-8221, CTS-433 to F.R.F.), Consejeria de Salud, Junta de Andalucia, UE/ERDF (SAF2010-20521 and SAS111224 to F.R.F. M.T. Ramirez-Lopez has been funded by a FPU predoctoral fellowship of the Spanish Ministerio de Educacion, Cultura y Deporte (AP-2009-0225). JS holds a "Miguel Servet" research contract from the National System of Health, ISCIII (grant number CP12/03109).	Ahmadi SA, 2008, ARCH IRAN MED, V11, P318, DOI 08113/AIM.0014; Alen F, 2013, VITAM HORM, V92, P165, DOI 10.1016/B978-0-12-410473-0.00007-6; Alonso M, 2012, BRIT J PHARMACOL, V165, P2274, DOI 10.1111/j.1476-5381.2011.01698.x; Artmann A, 2008, BBA-MOL CELL BIOL L, V1781, P200, DOI 10.1016/j.bbalip.2008.01.006; Asarian L, 2006, PHILOS T R SOC B, V361, P1251, DOI 10.1098/rstb.2006.1860; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bayol SA, 2008, J PHYSIOL-LONDON, V586, P3219, DOI 10.1113/jphysiol.2008.153817; Bayol SA, 2007, BRIT J NUTR, V98, P843, DOI 10.1017/S0007114507812037; Bello NT, 2012, PHYSIOL BEHAV, V105, P720, DOI 10.1016/j.physbeh.2011.09.021; Berger A, 2001, P NATL ACAD SCI USA, V98, P6402, DOI 10.1073/pnas.101119098; Blasio A, 2014, BEHAV PHARMACOL, V25, P609, DOI 10.1097/FBP.0000000000000059; Brand T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031169; Brinton RD, 2012, ENDOCRINOLOGY, V153, P3571, DOI 10.1210/en.2012-1340; Brion MJA, 2010, AM J CLIN NUTR, V91, P748, DOI 10.3945/ajcn.2009.28623; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Catalano PM, 2009, AM J CLIN NUTR, V90, P1303, DOI 10.3945/ajcn.2008.27416; Cluny NL, 2013, AUTON NEUROSCI-BASIC, V179, P122, DOI 10.1016/j.autneu.2013.09.015; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Cota D, 2007, ENDOCRINOLOGY, V148, P1574, DOI 10.1210/en.2005-1649; Cota D, 2006, BRAIN RES REV, V51, P85, DOI 10.1016/j.brainresrev.2005.10.004; Coupe B, 2009, AM J PHYSIOL-REG I, V297, pR813, DOI 10.1152/ajpregu.00201.2009; Cristino L, 2014, BIOFACTORS, V40, P389, DOI 10.1002/biof.1168; Dahlhoff M, 2014, BBA-MOL BASIS DIS, V1842, P304, DOI 10.1016/j.bbadis.2013.11.021; de Fonseca FR, 2000, METABOLISM, V49, P709, DOI 10.1053/meta.2000.6251; Dearden L, 2014, ENDOCRINOLOGY, V155, P2144, DOI 10.1210/en.2014-1131; DEFONSECA FR, 1994, LIFE SCI, V54, P159, DOI 10.1016/0024-3205(94)00585-0; Desai M, 2005, AM J PHYSIOL-REG I, V288, pR91, DOI 10.1152/ajpregu.00340.2004; Deshmukh RR, 2012, PHARMACOL RES, V66, P276, DOI 10.1016/j.phrs.2012.06.004; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 2008, TRENDS PHARMACOL SCI, V29, P229, DOI 10.1016/j.tips.2008.03.001; Di Marzo V, 2008, DRUG DISCOV TODAY, V13, P1026, DOI 10.1016/j.drudis.2008.09.001; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; DiPatrizio NV, 2008, J NEUROSCI, V28, P9702, DOI 10.1523/JNEUROSCI.1171-08.2008; Droste SM, 2010, PHARMACOL BIOCHEM BE, V95, P443, DOI 10.1016/j.pbb.2010.03.005; El-Talatini MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004579; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fromentin G, 1997, BRIT J NUTR, V77, P299, DOI 10.1079/BJN19970031; Gallou-Kabani C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014398; Gluckman PD, 2004, TRENDS ENDOCRIN MET, V15, P183, DOI 10.1016/j.tem.2004.03.002; Gomez R, 2002, J NEUROSCI, V22, P9612; Haas MJ, 2012, OBESITY, V20, P721, DOI 10.1038/oby.2011.323; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Harrold JA, 2002, BRAIN RES, V952, P232, DOI 10.1016/S0006-8993(02)03245-6; Heyne A, 2009, ADDICT BIOL, V14, P373, DOI 10.1111/j.1369-1600.2009.00175.x; HOOK EB, 1980, INT J OBESITY, V4, P338; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Jimenez-Chillaron JC, 2006, DIABETOLOGIA, V49, P1974, DOI 10.1007/s00125-006-0311-7; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Keimpema E, 2013, BIOCHEM SOC T, V41, P1569, DOI 10.1042/BST20130117; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lage R, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv011; LUCAS A, 1991, CIBA F SYMP, V156, P38; Mackie K, 2005, HANDB EXP PHARMACOL, V168, P299; Decara JM, 2012, DIS MODEL MECH, V5, P660, DOI 10.1242/dmm.009233; Martin-Garcia E, 2010, J NEUROCHEM, V112, P1338, DOI 10.1111/j.1471-4159.2009.06549.x; Mathes CM, 2008, AM J PHYSIOL-REG I, V295, pR67, DOI 10.1152/ajpregu.00150.2008; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Mazier W, 2015, TRENDS ENDOCRIN MET, V26, P524, DOI 10.1016/j.tem.2015.07.007; MCCLINTOCK MK, 1984, PHYSIOL BEHAV, V32, P701, DOI 10.1016/0031-9384(84)90181-1; Mennella JA, 2004, PEDIATRICS, V113, P840, DOI 10.1542/peds.113.4.840; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Muhlhausler BS, 2006, FASEB J, V20, P1257, DOI 10.1096/fj.05-5241fje; Nivoit P, 2009, DIABETOLOGIA, V52, P1133, DOI 10.1007/s00125-009-1316-9; Ong ZY, 2011, FASEB J, V25, P2167, DOI 10.1096/fj.10-178392; Orloff NC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01076; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Paxinos G., RAT BRAIN STEREOTAXI, VSeventh; Polotsky HN, 2010, SEMIN REPROD MED, V28, P426, DOI 10.1055/s-0030-1262902; Primeaux SD, 2011, PEPTIDES, V32, P1270, DOI 10.1016/j.peptides.2011.03.022; Ragab SMM, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0087-1; Romero-Zerbo SY, 2012, J NEUROENDOCRINOL, V24, P1106, DOI 10.1111/j.1365-2826.2012.02325.x; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Schank JC, 2001, PHYSIOL BEHAV, V72, P129, DOI 10.1016/S0031-9384(00)00395-4; Schank Jeffrey C, 2004, Nonlinear Dynamics Psychol Life Sci, V8, P147; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V291, pE792, DOI 10.1152/ajpendo.00078.2006; Starowicz KM, 2008, OBESITY, V16, P553, DOI 10.1038/oby.2007.106; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Taschler U, 2011, J BIOL CHEM, V286, P17467, DOI 10.1074/jbc.M110.215434; Ramirez-Lopez MT, 2016, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00339; Tibirica E, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-5; Timofeeva E, 2009, J NEUROENDOCRINOL, V21, P982, DOI 10.1111/j.1365-2826.2009.01921.x; Tourino C, 2010, INT J OBESITY, V34, P557, DOI 10.1038/ijo.2009.262; Trillou CR, 2004, INT J OBESITY, V28, P640, DOI 10.1038/sj.ijo.0802583; Vahatalo LH, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2015.1; Verty ANA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140592; Vickers Mark H, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P17, DOI 10.1097/MED.0b013e328013da48; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Vida M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090016; Vucetic Z, 2011, NEUROPSYCHOPHARMACOL, V36, P1199, DOI 10.1038/npp.2011.4; Vucetic Z, 2010, ENDOCRINOLOGY, V151, P4756, DOI 10.1210/en.2010-0505; Vujic N, 2016, ATHEROSCLEROSIS, V244, P9, DOI 10.1016/j.atherosclerosis.2015.10.109; WARNICK GR, 1990, CLIN CHEM, V36, P15; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Yoshida R, 2010, P NATL ACAD SCI USA, V107, P935, DOI 10.1073/pnas.0912048107	95	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165432	10.1371/journal.pone.0165432	http://dx.doi.org/10.1371/journal.pone.0165432			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806128	Green Submitted, Green Published, gold			2022-12-26	WOS:000386715500029
J	Wolters, M; Pala, V; Russo, P; Rise, P; Moreno, LA; De Henauw, S; Mehlig, K; Veidebaum, T; Molnar, D; Tornaritis, M; Galli, C; Ahrens, W; Bornhorst, C				Wolters, Maike; Pala, Valeria; Russo, Paola; Rise, Patrizia; Moreno, Luis A.; De Henauw, Stefaan; Mehlig, Kirsten; Veidebaum, Toomas; Molnar, Denes; Tornaritis, Michael; Galli, Claudio; Ahrens, Wolfgang; Boernhorst, Claudia		IDEFICS I Family Consortia	Associations of Whole Blood n-3 and n-6 Polyunsaturated Fatty Acids with Blood Pressure in Children and Adolescents - Results from the IDEFICS/I.Family Cohort	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; LONG-CHAIN OMEGA-3-FATTY-ACIDS; EICOSAPENTAENOIC ACID; GENDER-DIFFERENCES; PHYSICAL-ACTIVITY; METABOLIC HEALTH; REFERENCE VALUES; SCHOOL-CHILDREN; OBESE CHILDREN; LIPID PROFILE	Background Polyunsaturated n-3 and n-6 polyunsaturated fatty acids (PUFA) are precursors of biologically active metabolites that affect blood pressure (BP) regulation. This study investigated the association of n-3 and n-6 PUFA and BP in children and adolescents. Methods In a subsample of 1267 children aged 2-9 years at baseline of the European IDEFICS (Identification and prevention of dietary-and lifestyle-induced health effects in children and infants) cohort whole blood fatty acids were measured by a validated gas chromatographic method. Systolic and diastolic BP was measured at baseline and after two and six years. Mixed-effects models were used to assess the associations between fatty acids at baseline and BP z-scores over time adjusting for relevant covariables. Models were further estimated stratified by sex and weight status. Results The baseline level of arachidonic acid was positively associated with subsequent systolic BP (beta = 0.08, P = 0.002) and diastolic BP (beta = 0.07, P< 0.001). In thin/normal weight children, baseline alpha-linolenic (beta = -1.13, P = 0.003) and eicosapentaenoic acid (beta = -0.85, P = 0.003) levels were inversely related to baseline and also to subsequent systolic BP and alpha-linolenic acid to subsequent diastolic BP. In overweight/obese children, baseline eicosapentaenoic acid level was positively associated with baseline diastolic BP (beta = 0.54, P = 0.005). Conclusions Low blood arachidonic acid levels in the whole sample and high n-3 PUFA levels in thin/normal weight children are associated with lower and therefore healthier BP. The beneficial effects of high n-3 PUFA on BP were not observed in overweight/obese children, suggesting that they may have been overlaid by the unfavorable effects of excess weight.	[Wolters, Maike; Ahrens, Wolfgang; Boernhorst, Claudia] Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany; [Pala, Valeria] Fdn IRCCS Ist Nazl Tumori, Dept Prevent & Predict Med, Epidemiol & Prevent Unit, Milan, Italy; [Russo, Paola] CNR, Inst Food Sci, Epidemiol & Populat Genet, Avellino, Italy; [Rise, Patrizia; Galli, Claudio] Univ Milan, Dept Pharmacol & Biomol Sci, DiSFeB, Milan, Italy; [Moreno, Luis A.] Univ Zaragoza, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, GENUD Growth Exercise Nutr & Dev Res Grp, IA2,IIS Aragon, Zaragoza, Spain; [De Henauw, Stefaan] Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth, Ghent, Belgium; [Mehlig, Kirsten] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Publ Hlth & Community Med, Gothenburg, Sweden; [Veidebaum, Toomas] Natl Inst Hlth Dev, Tallinn, Estonia; [Molnar, Denes] Univ Pecs, Natl Inst Hlth Promot, Pecs, Hungary; [Tornaritis, Michael] Res & Educ Inst Child Hlth, Nicosia, Cyprus; [Ahrens, Wolfgang] Univ Bremen, Fac Math & Comp Sci, Inst Stat, Bremen, Germany	Leibniz Institute for Prevention Research & Epidemiology (BIPS); Fondazione IRCCS Istituto Nazionale Tumori Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); University of Milan; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Zaragoza; Ghent University; University of Gothenburg; National Institute for Health Development - Estonia; University of Pecs; Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Bremen	Wolters, M (corresponding author), Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany.	wolters@leibniz-bips.de	Mehlig, Kirsten/AAT-3468-2020; Russo, Paola/AAW-8308-2020; Molnár, Dénes/AAB-6820-2022; Moreno, Luis/S-1780-2019; Pala, Valeria/K-4738-2016; Ahrens, Wolfgang/A-2740-2012	Moreno, Luis/0000-0003-0454-653X; Pala, Valeria/0000-0001-5438-970X; Bornhorst, Claudia/0000-0001-9004-1540; Ahrens, Wolfgang/0000-0003-3777-570X; Wolters, Maike/0000-0002-4943-2141	European Commission within the Sixth RTD Framework Programme [016181]; European Commission within the Seventh RTD Framework Programme FP7 [266044 (KBBE 2010-4)]	European Commission within the Sixth RTD Framework Programme; European Commission within the Seventh RTD Framework Programme FP7	The baseline data collection and the first follow-up work as part of the I DEFICS Study (www.idefics.eu) were financially supported by the European Commission within the Sixth RTD Framework Programme Contract No. 016181 (FOOD). The most recent follow-up was conducted in the framework of the I.Family study (www.ifamilystudy.eu/) which was funded by the European Commission within the Seventh RTD Framework Programme Contract No. FP7 266044 (KBBE 2010-4).	Ahrens W, 2011, INT J OBESITY, V35, pS3, DOI 10.1038/ijo.2011.30; Ahrens W, 2016, INT J EPIDEMIOL ACCE; Alkerwi A, 2015, PUBLIC HEALTH NUTR, V18, P1831, DOI 10.1017/S1368980014002596; Alpert BS, 2007, BLOOD PRESS MONIT, V12, P345, DOI 10.1097/MBP.0b013e3282c9abf7; Barba G, 2014, INT J OBESITY, V38, pS48, DOI 10.1038/ijo.2014.135; Beaulieu-Jones BR, 2015, J NUTR, V145, P931, DOI 10.3945/jn.114.209619; Bonafini S, 2015, PROSTAG OTH LIPID M, V120, P72, DOI 10.1016/j.prostaglandins.2015.03.006; Burns Trudy L, 2009, J Pediatr, V155, DOI 10.1016/j.jpeds.2009.04.044; Cabo J, 2012, BRIT J NUTR, V107, pS195, DOI 10.1017/S0007114512001584; Childs CE, 2008, P NUTR SOC, V67, P19, DOI 10.1017/S0029665108005983; Chiolero A, 2007, J HYPERTENS, V25, P2209, DOI 10.1097/HJH.0b013e3282ef48b2; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Damsgaard CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109368; Damsgaard CT, 2013, BRIT J NUTR, V110, P1304, DOI 10.1017/S0007114513000585; Damsgaard CT, 2006, J NUTR, V136, P94, DOI 10.1093/jn/136.1.94; De Henauw S, 2011, INT J OBESITY, V35, pS16, DOI 10.1038/ijo.2011.31; Djousse L, 2005, HYPERTENSION, V45, P368, DOI 10.1161/01.HYP.0000154679.41568.e6; Ebbesson SOE, 2015, INT J CIRCUMPOL HEAL, V74, DOI 10.3402/ijch.v74.28055; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Falaschetti E, 2010, EUR HEART J, V31, P3063, DOI 10.1093/eurheartj/ehq355; Fan F, 2015, CURR OPIN NEPHROL HY, V24, P37, DOI 10.1097/MNH.0000000000000088; Farajian P, 2015, J HYPERTENS, V33, P1174, DOI 10.1097/HJH.0000000000000536; Fekete K, 2015, OBES REV, V16, P488, DOI 10.1111/obr.12280; de Moraes ACF, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000232; Fischer R, 2014, J LIPID RES, V55, P1150, DOI 10.1194/jlr.M047357; Friedemann C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4759; Geleijnse JM, 2002, J HYPERTENS, V20, P1493, DOI 10.1097/00004872-200208000-00010; Harika RK, 2011, BRIT J NUTR, V106, P307, DOI 10.1017/S0007114511001528; Hermanussen M, 2008, Georgian Med News, P84; Jackson LV, 2007, ARCH DIS CHILD, V92, P298, DOI 10.1136/adc.2005.081216; Julian-Almarcegui C, 2016, NUTR METAB CARDIOVAS, V26, P541, DOI 10.1016/j.numecd.2016.01.014; Kaikkonen JE, 2012, AM J CLIN NUTR, V95, P1422, DOI 10.3945/ajcn.111.030387; Kivimaki M, 2008, AM J CLIN NUTR, V87, P1876, DOI 10.1093/ajcn/87.6.1876; Knerr I, 2008, DIABETES CARE, V31, P726, DOI 10.2337/dc07-1392; Kollias A, 2012, EUR J PUBLIC HEALTH, V22, P389, DOI 10.1093/eurpub/ckr082; Lauritzen L, 2012, BRIT J NUTR, V107, P697, DOI 10.1017/S0007114511002418; Li SX, 2004, HYPERTENSION, V43, P541, DOI 10.1161/01.HYP.0000115922.98155.23; Liang YJ, 2011, BIOMED ENVIRON SCI, V24, P459, DOI 10.3967/0895-3988.2011.05.002; Lin Y, 2015, NUTR J, V14, DOI 10.1186/1475-2891-14-10; Lohner S, 2013, ANN NUTR METAB, V62, P98, DOI 10.1159/000345599; Marangoni F, 2004, ANAL BIOCHEM, V326, P267, DOI 10.1016/j.ab.2003.12.016; Marrero NM, 2014, HYPERTENSION, V63, P1026, DOI 10.1161/HYPERTENSIONAHA.113.02264; Martin L, 2015, INT J OBESITY, V39, P45, DOI 10.1038/ijo.2014.167; Miller PE, 2014, AM J HYPERTENS, V27, P885, DOI 10.1093/ajh/hpu024; Miyajima T, 2001, HYPERTENS RES, V24, P537, DOI 10.1291/hypres.24.537; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; National Institutes of Health, 2005, NIH PUBLICATION; Nyantika AN, 2015, J NUTR HEALTH AGING, V19, P498, DOI 10.1007/s12603-015-0463-6; Pedersen MH, 2010, J PEDIATR-US, V157, P395, DOI 10.1016/j.jpeds.2010.04.001; Ratnayake WMN, 2009, ANN NUTR METAB, V55, P8, DOI 10.1159/000228994; Reinehr T, 2015, J CLIN ENDOCR METAB, V100, P301, DOI 10.1210/jc.2014-2674; Rise P, 2007, PROSTAG LEUKOTR ESS, V76, P363, DOI 10.1016/j.plefa.2007.05.003; Rise P, 2013, PROSTAG LEUKOTR ESS, V89, P215, DOI 10.1016/j.plefa.2013.06.009; Sarkis A, 2004, CURR OPIN NEPHROL HY, V13, P205, DOI 10.1097/00041552-200403000-00009; Seven E, 2014, J HYPERTENS, V32, P1488, DOI 10.1097/HJH.0000000000000207; Skilton MR, 2013, HYPERTENSION, V61, P972, DOI 10.1161/HYPERTENSIONAHA.111.01030; Tomova A, 2015, J PEDIATR ENDOCR MET, V28, P859, DOI 10.1515/jpem-2014-0363; Totland TH, 2013, PUBLIC HEALTH NUTR, V16, P673, DOI 10.1017/S1368980012003060; Ulu A, 2013, J CARDIOVASC PHARM, V62, P285, DOI 10.1097/FJC.0b013e318298e460; United Nations, 1997, INTERNATIONAL STANDA; Virtanen JK, 2012, HYPERTENS RES, V35, P1000, DOI 10.1038/hr.2012.80; Williams ES, 2007, CLIN NUTR, V26, P474, DOI 10.1016/j.clnu.2007.03.004; Wolters M, 2014, INT J OBESITY, V38, pS86, DOI 10.1038/ijo.2014.139; Wolters M, 2015, J CLIN ENDOCR METAB, V100, P3760, DOI 10.1210/jc.2015-2693; Xi B, 2016, AM J HYPERTENS, V29, P217, DOI 10.1093/ajh/hpv091; Yang B, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0226-3; Yang B, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010058; Zeng FF, 2014, J NUTR, V144, P1240, DOI 10.3945/jn.114.192286; Zhai Y, 2015, BIOMED ENVIRON SCI, V28, P401, DOI 10.3967/bes2015.057; Zheng ZJ, 1999, AM J EPIDEMIOL, V150, P492, DOI 10.1093/oxfordjournals.aje.a010038	71	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165981	10.1371/journal.pone.0165981	http://dx.doi.org/10.1371/journal.pone.0165981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806134	Green Published, Green Submitted, gold			2022-12-26	WOS:000386715500074
J	Lin, TY; Chen, YJ; Chen, WL; Peng, TC				Lin, Tzu-Yu; Chen, Ying-Jen; Chen, Wei-Liang; Peng, Tao-Chun			The Relationship between Nonalcoholic Fatty Liver Disease and Retinopathy in NHANES III	PLOS ONE			English	Article							RETINAL MICROVASCULAR ABNORMALITIES; DIABETIC-RETINOPATHY; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS RISK; PREVALENCE	Background Nonalcoholic fatty liver disease (NAFLD), an emerging multisystem disease, has the similar pathogenesis with diabetes and is prevalent in diabetes. This study investigated whether NAFLD is associated with retinopathy in individuals with diabetes and without diabetes. Methods The association between NAFLD and retinopathy was investigated in 5963 participants aged 40 years and older who participated in the NHANES III, a nationally representative, population-based and cross-sectional study. NAFLD was detected via ultrasonography, and fundus photographs were obtained to grade retinopathy patterns. We performed multi-variate logistic regression analysis to investigate the relationship between the presence of retinopathy and NAFLD and diabetes. Results After adjusting for multiple covariates, NAFLD population had no evidence of retinopathy increase in population without diabetes (odds ratio [OR]: 0.77; 95% confidence interval [CI]: 0.48 to 1.26). In addition, NAFLD in individuals with diabetes was not significantly associated with retinopathy (OR: 0.77; 95% CI: 0.47 to 1.26), independent of age, gender, ethnicity, waist circumference, serum high-density lipoprotein (HDL) cholesterol, serum triglycerides, systolic blood pressure, and glycated hemoglobin. Conclusions In the US general population, NAFLD is not a precipitating factor of retinopathy in population with or without diabetes.	[Lin, Tzu-Yu] Taipei Med Univ, Shuang Ho Hosp, Dept Ophthalmol, New Taipei, Taiwan; [Chen, Ying-Jen] Triserv Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Chen, Ying-Jen; Chen, Wei-Liang; Peng, Tao-Chun] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Chen, Wei-Liang; Peng, Tao-Chun] Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan; [Chen, Wei-Liang] Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan; [Chen, Wei-Liang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan	Taipei Medical University; Shuang Ho Hospital; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Tri-Service General Hospital; National Defense Medical Center	Peng, TC (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Peng, TC (corresponding author), Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan.	koigojaff@gmail.com	Peng, Tao‑Chun/AAY-7035-2020					Adams LA, 2009, AM J GASTROENTEROL, V104, P861, DOI 10.1038/ajg.2009.67; [Anonymous], 1994, Vital Health Stat 1, P1; Cortez-Pinto H, 1999, CLIN NUTR, V18, P353, DOI 10.1016/S0261-5614(99)80015-6; Crawford TN, 2009, CURR DIABETES REV, V5, P8, DOI 10.2174/157339909787314149; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; Gardner TW, 2011, ARCH OPHTHALMOL-CHIC, V129, P230, DOI 10.1001/archophthalmol.2010.362; Hanley AJG, 2005, DIABETES, V54, P3140, DOI 10.2337/diabetes.54.11.3140; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Keenan JD, 2009, AM J OPHTHALMOL, V147, P934, DOI 10.1016/j.ajo.2008.12.009; Kim BY, 2014, J DIABETES INVEST, V5, P170, DOI 10.1111/jdi.12139; KLEIN R, 1994, ARCH INTERN MED, V154, P2169, DOI 10.1001/archinte.154.19.2169; Leite NC, 2011, LIVER INT, V31, P700, DOI 10.1111/j.1478-3231.2011.02482.x; Leite NC, 2009, LIVER INT, V29, P113, DOI 10.1111/j.1478-3231.2008.01718.x; Liccardo D, 2014, J GASTROENTEROL, P1; Manchanayake J, 2011, J GASTROEN HEPATOL, V26, P510, DOI 10.1111/j.1440-1746.2010.06528.x; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Ortiz-Lopez C, 2012, DIABETES CARE, V35, P873, DOI 10.2337/dc11-1849; Sanyal Arun J, 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572; Smits MM, 2013, J GASTROEN HEPATOL, V28, P664, DOI 10.1111/jgh.12106; Targher G, 2008, DIABETOLOGIA, V51, P444, DOI 10.1007/s00125-007-0897-4; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Wong TY, 2004, INVEST OPHTH VIS SCI, V45, P2949, DOI 10.1167/iovs.04-0069; Wong TY, 2002, BRIT J OPHTHALMOL, V86, P1007, DOI 10.1136/bjo.86.9.1007; Wong TY, 2001, SURV OPHTHALMOL, V46, P59, DOI 10.1016/S0039-6257(01)00234-X; Yan LH, 2016, J DIABETES INVEST, V7, P889, DOI 10.1111/jdi.12518; Yang W, 2015, HEPATOL INT, V9, P278, DOI 10.1007/s12072-015-9607-3	30	11	11	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165970	10.1371/journal.pone.0165970	http://dx.doi.org/10.1371/journal.pone.0165970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802330	Green Published, gold, Green Submitted			2022-12-26	WOS:000386714200072
J	Nakamori, M; Hosomi, N; Ishikawa, K; Imamura, E; Shishido, T; Ohshita, T; Yoshikawa, M; Tsuga, K; Wakabayashi, S; Maruyama, H; Matsumoto, M				Nakamori, Masahiro; Hosomi, Naohisa; Ishikawa, Kenichi; Imamura, Eiji; Shishido, Takeo; Ohshita, Tomohiko; Yoshikawa, Mineka; Tsuga, Kazuhiro; Wakabayashi, Shinichi; Maruyama, Hirofumi; Matsumoto, Masayasu			Prediction of Pneumonia in Acute Stroke Patients Using Tongue Pressure Measurements	PLOS ONE			English	Article							SWALLOWING ABILITY; ELDERLY PERSONS; MANN ASSESSMENT; DYSPHAGIA; PROBE	Swallowing dysfunction caused by stroke is a risk factor for aspiration pneumonia. Tongue pressure measurement is a simple and noninvasive method for evaluating swallowing dysfunction. We have hypothesized that low tongue pressure may be able to predict pneumonia occurrence in acute stroke patients. Tongue pressure was measured using balloon-type equipment in 220 acute stroke patients. The modified Mann Assessment of Swallowing Ability (MASA) score was evaluated independently on the same day. Tongue pressure was measured every week thereafter. An improvement in tongue pressure was observed within the first 2 weeks. Receiver operating curve analysis was performed to determine the ability of tongue pressure to predict modified MASA score < 95, which suggests swallowing dysfunction. The optimal cutoff for tongue pressure was 21.6 kPa (chi(2) = 45.82, p<0.001, sensitivity 95.9%, specificity 91.8%, area under the curve = 0.97). The tongue pressure was significantly lower in patients with pneumonia than in those without pneumonia. Using a Cox proportional hazard model for pneumonia onset with a cutoff tongue pressure value of 21.6 kPa and adjustment for age, sex, and National Institutes of Health Stroke Scale score at admission, the tongue pressure had additional predictive power for pneumonia onset (hazard ratio, 7.95; 95% confidence interval, 2.09 to 52.11; p = 0.0013). In the group with low tongue pressure, 27 of 95 patients showed improvement of tongue pressure within 2 weeks. Pneumonia occurred frequently in patients without improvement of tongue pressure, but not in patients with improvement (31/68 and 2/27, p<0.001). Tongue pressure is a sensitive indicator for predicting pneumonia occurrence in acute stroke patients.	[Nakamori, Masahiro; Hosomi, Naohisa; Shishido, Takeo; Maruyama, Hirofumi; Matsumoto, Masayasu] Hiroshima Univ, Dept Clin Neurosci & Therapeut, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Nakamori, Masahiro; Ishikawa, Kenichi; Imamura, Eiji; Ohshita, Tomohiko] Suiseikai Kajikawa Hosp, Dept Neurol, Hiroshima, Japan; [Yoshikawa, Mineka; Tsuga, Kazuhiro] Hiroshima Univ, Dept Adv Prosthodont, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Wakabayashi, Shinichi] Suiseikai Kajikawa Hosp, Dept Neurosurg, Hiroshima, Japan	Hiroshima University; Hiroshima University	Hosomi, N (corresponding author), Hiroshima Univ, Dept Clin Neurosci & Therapeut, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan.	nhosomi@hiroshima-u.ac.jp	Maruyama, Hirofumi/B-9333-2011; Tsuga, Kazuhiro/AAL-1592-2021; Hosomi, Naohisa/H-8660-2019	Maruyama, Hirofumi/0000-0001-7613-8717; 	Japan Society for the Promotion of Science (JSPS) KAKENHI [15K08615]; Smoking Research Foundation; Tsuchiya Foundation	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Smoking Research Foundation; Tsuchiya Foundation(Tsuchiya Foundation)	This study was supported in part by research grants from the Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant Number 15K08615), the Smoking Research Foundation, and the Tsuchiya Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Antonios N, 2010, J STROKE CEREBROVASC, V19, P49, DOI 10.1016/j.jstrokecerebrovasdis.2009.03.007; Carnaby-Mann G, 2008, PHYS MED REH CLIN N, V19, P747, DOI 10.1016/j.pmr.2008.05.008; Gonzalez-Fernandez M, 2011, AM J SPEECH-LANG PAT, V20, P331, DOI 10.1044/1058-0360(2011/10-0082); Harms H, 2012, J NEUROL NEUROSUR PS, V83, P1225, DOI 10.1136/jnnp-2012-302194; Hasan ZN, 2010, NEUROSCIENCES, V15, P90; Hayashi R, 2002, INT J PROSTHODONT, V15, P385; Hinchey JA, 2005, STROKE, V36, P1972, DOI 10.1161/01.STR.0000177529.86868.8d; Hinds NP, 1998, QJM-MON J ASSOC PHYS, V91, P829, DOI 10.1093/qjmed/91.12.829; Hirota N, 2010, STROKE, V41, P2982, DOI 10.1161/STROKEAHA.110.594960; LYDEN P, 1994, STROKE, V25, P2220, DOI 10.1161/01.STR.25.11.2220; Mano T, 2014, NEUROLOGY, V82, P255, DOI 10.1212/WNL.0000000000000041; Nakamori M, 2016, CLIN NEUROPHYSIOL, V127, P1669, DOI 10.1016/j.clinph.2015.07.032; Nilsson H, 1998, DYSPHAGIA, V13, P32, DOI 10.1007/PL00009547; Oh JC, 2015, OCCUP THER INT; Ono T, 2007, GERODONTOLOGY, V24, P143, DOI 10.1111/j.1741-2358.2007.00172.x; Robbins J, 2007, ARCH PHYS MED REHAB, V88, P150, DOI 10.1016/j.apmr.2006.11.002; Shaker R, 1988, Dysphagia, V3, P79, DOI 10.1007/BF02412424; Smithard DG, 1996, STROKE, V27, P1200, DOI 10.1161/01.STR.27.7.1200; Tsuga K, 2011, J ORAL REHABIL, V38, P680, DOI 10.1111/j.1365-2842.2011.02202.x; Tsuga K, 2012, GERODONTOLOGY, V29, pE1078, DOI 10.1111/j.1741-2358.2011.00615.x; Utanohara Y, 2008, DYSPHAGIA, V23, P286, DOI 10.1007/s00455-007-9142-z; Yoshida M, 2006, DYSPHAGIA, V21, P61, DOI 10.1007/s00455-005-9011-6; Yoshikawa M, 2005, J GERONTOL A-BIOL, V60, P506, DOI 10.1093/gerona/60.4.506; Yoshikawa M, 2011, DYSPHAGIA, V26, P232, DOI 10.1007/s00455-010-9291-3	25	33	35	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165837	10.1371/journal.pone.0165837	http://dx.doi.org/10.1371/journal.pone.0165837			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802333	gold, Green Published, Green Submitted			2022-12-26	WOS:000386714200061
